e Control Agents|reproductive control agents|mesh-ancestor
101527791|NCT00548483|Dexamethasone|dexamethasone|mesh-list
101527792|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527793|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
101527794|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
101527795|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527796|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527797|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101527798|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
101527799|NCT00548483|Hormones|hormones|mesh-ancestor
101527800|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527801|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101527802|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527803|NCT04635852|Fentanyl|fentanyl|mesh-list
101527804|NCT04635852|Morphine|morphine|mesh-list
101527805|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101527806|NCT04635852|Narcotics|narcotics|mesh-ancestor
101527807|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527808|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527809|NCT04635852|Analgesics|analgesics|mesh-ancestor
101527810|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
101342208|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527811|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527812|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101527813|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101527814|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
101527815|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
101527816|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
101527818|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527819|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101527820|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101527821|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101527822|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527823|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527824|NCT00548561|Protective Agents|protective agents|mesh-ancestor
101527826|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101527827|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101527828|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
101527829|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
101527830|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
101527831|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527832|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527833|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
101527834|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527835|NCT00548678|Aspirin|aspirin|mesh-list
101527836|NCT00548678|Diclofenac|diclofenac|mesh-list
101527837|NCT00548678|Ketorolac|ketorolac|mesh-list
101527838|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101527839|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342289|NCT01646034|Docetaxel|docetaxel|mesh-list
101527840|NCT00548678|Analgesics|analgesics|mesh-ancestor
101527841|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
101527842|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527843|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527844|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527845|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527846|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101527848|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527849|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527850|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101527851|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527852|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
101527853|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
101527854|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101527855|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527856|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101527857|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
101527858|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527859|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101527860|NCT04684199|Melatonin|melatonin|mesh-list
101527861|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
101527862|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527863|NCT04684199|Protective Agents|protective agents|mesh-ancestor
101527864|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527865|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101527866|NCT00560586|Budesonide|budesonide|mesh-list
101527867|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342413|NCT01466088|Donepezil|donepezil|mesh-list
101527868|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101527869|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
101527870|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527871|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527872|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101527873|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101527875|NCT00560586|Hormones|hormones|mesh-ancestor
101527876|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527877|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
101527878|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101527879|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527880|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527881|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101527882|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527883|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527884|NCT00549107|Simendan|simendan|mesh-list
101527885|NCT00549107|Milrinone|milrinone|mesh-list
101527886|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101527888|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101527889|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101527890|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101527891|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527892|NCT00549107|Protective Agents|protective agents|mesh-ancestor
101527893|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527894|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101527895|NCT00549146|Fluticasone|fluticasone|mesh-list
101527897|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101527898|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101527899|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101527900|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101527901|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
101320690|NCT00276835|Genistein|genistein|mesh-list
101527902|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527903|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527904|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101527905|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
101527906|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
101527907|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101527908|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101527909|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101527910|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101527913|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527914|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
101527915|NCT00549146|Hormones|hormones|mesh-ancestor
101527916|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527917|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
101527918|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
101527919|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101527920|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527921|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527922|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
101527923|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527924|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527925|NCT00549419|Dobutamine|dobutamine|mesh-list
101527926|NCT00549419|Norepinephrine|norepinephrine|mesh-list
101527927|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101527928|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101527929|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
101527930|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101527931|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527932|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527933|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
101527934|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
101527935|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101527936|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101527937|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101527938|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101527939|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101527940|NCT00549419|Protective Agents|protective agents|mesh-ancestor
101527942|NCT04643691|Spironolactone|spironolactone|mesh-list
101527943|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101527944|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101527945|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101527946|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101527947|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527948|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101527949|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
101527950|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101527951|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527952|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101527953|NCT04643691|Diuretics|diuretics|mesh-ancestor
101527954|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
101527955|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
101527956|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
101331384|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
101527957|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527958|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
101527959|NCT00549536|Calcium|calcium|mesh-list
101527960|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101527961|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527963|NCT00549614|Acipimox|acipimox|mesh-list
101527964|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101527965|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
101527966|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527967|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101527968|NCT00559026|Dacarbazine|dacarbazine|mesh-list
101527969|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101527970|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
101527971|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527972|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527973|NCT00549887|Insulin|insulin|mesh-list
101527974|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101527975|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101527976|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527977|NCT00549926|Atorvastatin|atorvastatin|mesh-list
101527978|NCT00549926|Pravastatin|pravastatin|mesh-list
101527979|NCT00549926|Pitavastatin|pitavastatin|mesh-list
101527980|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101527981|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101527983|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527984|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101527985|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101527986|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411360|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
101527987|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
101527988|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101527989|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101527990|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527991|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101527992|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101527993|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101527994|NCT00550004|Gemcitabine|gemcitabine|mesh-list
101527995|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101527996|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
101527997|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101527998|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101527999|NCT04634721|Bupivacaine|bupivacaine|mesh-list
101528000|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
101528001|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
101528002|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528003|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528004|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
101528005|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528006|NCT00550160|Artesunate|artesunate|mesh-list
101528007|NCT00550160|Amodiaquine|amodiaquine|mesh-list
101528008|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
101528009|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101528010|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101528011|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528012|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528013|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
101528014|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
101528015|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101528016|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
101528017|NCT00550199|Gemcitabine|gemcitabine|mesh-list
101528019|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528020|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
101528021|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528022|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528023|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101528024|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528026|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101528027|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528028|NCT04643301|Incretins|incretins|mesh-ancestor
101528029|NCT04643301|Hormones|hormones|mesh-ancestor
101528030|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528031|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
101528032|NCT00550433|Estrogens|estrogens|mesh-list
101528033|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101528034|NCT00550433|Hormones|hormones|mesh-ancestor
101528035|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528036|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528037|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101528038|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101528040|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101528042|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528043|NCT04634058|Antibodies|antibodies|mesh-list
101528044|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
101528045|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
101528046|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528047|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101528048|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101528049|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528050|NCT00560820|Deferasirox|deferasirox|mesh-list
101528051|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101528052|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
101528053|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
101528054|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528055|NCT00550784|Paclitaxel|paclitaxel|mesh-list
101528056|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
101528057|NCT00550784|Melphalan|melphalan|mesh-list
101528058|NCT00550784|Topotecan|topotecan|mesh-list
101528059|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101528060|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528061|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
101528062|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
101528063|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528064|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528065|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528066|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
101528067|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528068|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528069|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101528070|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
101528071|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101528072|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101528073|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528074|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528076|NCT00550901|Razoxane|razoxane|mesh-list
101528077|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528078|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101528079|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101528080|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528081|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528082|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528083|NCT00550901|Protective Agents|protective agents|mesh-ancestor
101528084|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528085|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
101528086|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528087|NCT04633746|Endostatins|endostatins|mesh-list
101342821|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101528088|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528089|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101528090|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101528091|NCT04633746|Growth Substances|growth substances|mesh-ancestor
101528092|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528094|NCT00551018|Tenofovir|tenofovir|mesh-list
101528095|NCT00551018|Emtricitabine|emtricitabine|mesh-list
101528096|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
101528097|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528098|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101528099|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101528100|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528101|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342868|NCT00011804|Topiramate|topiramate|mesh-list
101528103|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101528104|NCT00551096|Gemcitabine|gemcitabine|mesh-list
101528105|NCT00551096|Capecitabine|capecitabine|mesh-list
101528106|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528107|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
101528108|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528109|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528110|NCT00551252|Gemcitabine|gemcitabine|mesh-list
101528111|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
101528112|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528113|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
101528114|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528115|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528116|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101528117|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528118|NCT01125761|Clemastine|clemastine|mesh-list
101528119|NCT01125761|Dexamethasone|dexamethasone|mesh-list
101528120|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
101528121|NCT01125761|BB 1101|bb 1101|mesh-list
101528122|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528123|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
101528124|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
101528125|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528126|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528127|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101528128|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
101528129|NCT01125761|Hormones|hormones|mesh-ancestor
101528130|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528131|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101528132|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528133|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101528134|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528135|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528136|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
101528137|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528138|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101528139|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
101528141|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528142|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101528143|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
101528144|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
101528145|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528146|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528147|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528148|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
101528149|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
101528150|NCT05408312|Vaccines|vaccines|mesh-list
101528151|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
101528152|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528153|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101528154|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
101528155|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528156|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
101528157|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101528158|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528159|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
101528160|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528161|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
101528162|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528163|NCT00553124|Vitamin E|vitamin e|mesh-list
101528164|NCT00553124|Selenium|selenium|mesh-list
101528165|NCT00553124|Vitamins|vitamins|mesh-ancestor
101320875|NCT00276055|Docetaxel|docetaxel|mesh-list
101528166|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
101528167|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528168|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
101528169|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528170|NCT00553124|Protective Agents|protective agents|mesh-ancestor
101528171|NCT00553124|Trace Elements|trace elements|mesh-ancestor
101528172|NCT04640181|Enoxaparin|enoxaparin|mesh-list
101528173|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
101528174|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101528175|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
101528176|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101528177|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
101528178|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528179|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528180|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
101528181|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101528182|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101528183|NCT00559455|Leucovorin|leucovorin|mesh-list
101528184|NCT00559455|Fluorouracil|fluorouracil|mesh-list
101528185|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
101528186|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
101528187|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528188|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528189|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528190|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528191|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
101528192|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528194|NCT00559455|Protective Agents|protective agents|mesh-ancestor
101528195|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
101528196|NCT00559455|Vitamins|vitamins|mesh-ancestor
101528197|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
101528198|NCT00559494|Minocycline|minocycline|mesh-list
101528199|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101528200|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528201|NCT05209412|Aspirin|aspirin|mesh-list
101528202|NCT05209412|Paclitaxel|paclitaxel|mesh-list
101528203|NCT05209412|Clopidogrel|clopidogrel|mesh-list
101528204|NCT05209412|Ticagrelor|ticagrelor|mesh-list
101528205|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101528206|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528207|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
101528208|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
101528209|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343089|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101528210|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528211|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528212|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528213|NCT05209412|Analgesics|analgesics|mesh-ancestor
101528214|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
101528215|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528216|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528217|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528218|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528219|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101528220|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101528221|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101528222|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528223|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528224|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
101528225|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101528226|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101528227|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101528228|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
101528229|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528230|NCT05186675|Epinephrine|epinephrine|mesh-list
101528231|NCT05186675|Racepinephrine|racepinephrine|mesh-list
101528232|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
101528233|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528234|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528235|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528236|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528237|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528238|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528239|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101528240|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528241|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
101528242|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528243|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101528244|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528245|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
101528246|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
101528248|NCT04639362|Venetoclax|venetoclax|mesh-list
101528249|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
101528250|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528251|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101528252|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101528253|NCT04639284|Antibodies|antibodies|mesh-list
101528254|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
101528255|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528256|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101528257|NCT04639284|Growth Substances|growth substances|mesh-ancestor
101528258|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
101528259|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528260|NCT00559689|Budesonide|budesonide|mesh-list
101528261|NCT00559689|Beclomethasone|beclomethasone|mesh-list
101528262|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528263|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528264|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
101528265|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528266|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528267|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101528268|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528269|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
101528270|NCT00559689|Hormones|hormones|mesh-ancestor
101528271|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528272|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101528273|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528274|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101528275|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528276|NCT00561288|Acetaminophen|acetaminophen|mesh-list
101528277|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528278|NCT00561288|Analgesics|analgesics|mesh-ancestor
101528279|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
101528280|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528281|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528282|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
101528283|NCT00561327|Losartan|losartan|mesh-list
101528284|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101528285|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101528286|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101528287|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101528288|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528290|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528291|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
101528292|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528293|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528294|NCT03454620|Irinotecan|irinotecan|mesh-list
101528295|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101528296|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528297|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528298|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528299|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331482|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
101331486|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101528300|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
101528301|NCT04628559|Ketamine|ketamine|mesh-list
101528302|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101528303|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528304|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528306|NCT04628559|Analgesics|analgesics|mesh-ancestor
101528307|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
101528308|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528309|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101528310|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528311|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528312|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528313|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528314|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528315|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101528316|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101528317|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
101528318|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
101528319|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101223238|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223239|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223240|NCT01517321|Incretins|incretins|mesh-ancestor
101223241|NCT01517321|Hormones|hormones|mesh-ancestor
101223242|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223243|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101223244|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223245|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223246|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223247|NCT01517334|Minocycline|minocycline|mesh-list
101223248|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223249|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223250|NCT01517347|Interleukin-2|interleukin-2|mesh-list
101223251|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223252|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223253|NCT01517347|Analgesics|analgesics|mesh-ancestor
101223254|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
101223255|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223256|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223257|NCT01517360|Oxytocin|oxytocin|mesh-list
101223258|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
101223259|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223260|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223261|NCT01517399|Vitamin K|vitamin k|mesh-list
101223262|NCT01517399|Digoxin|digoxin|mesh-list
101223263|NCT01517399|Midazolam|midazolam|mesh-list
101223264|NCT01517399|Caffeine|caffeine|mesh-list
101223265|NCT01517399|Omeprazole|omeprazole|mesh-list
101223266|NCT01517399|Warfarin|warfarin|mesh-list
101223267|NCT01517399|Vitamins|vitamins|mesh-ancestor
101223268|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
101223269|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223270|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101223271|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223272|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223273|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101223274|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343269|NCT00277017|Growth Substances|growth substances|mesh-ancestor
101223276|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223278|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
101223279|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
101223280|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
101223281|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223282|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223283|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
101223284|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101223285|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101223286|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223287|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101223288|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101223289|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
101223290|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101223291|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101223292|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101223293|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101223294|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101223295|NCT01517399|Protective Agents|protective agents|mesh-ancestor
101223296|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101223297|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101223298|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
101223299|NCT01517399|Coagulants|coagulants|mesh-ancestor
101223301|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101223302|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223303|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223304|NCT01517555|Acetaminophen|acetaminophen|mesh-list
101223305|NCT01517555|Liraglutide|liraglutide|mesh-list
101223306|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223307|NCT01517555|Analgesics|analgesics|mesh-ancestor
101223308|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
101223309|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223310|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223311|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
101223312|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223313|NCT01517555|Incretins|incretins|mesh-ancestor
101223314|NCT01517555|Hormones|hormones|mesh-ancestor
101223315|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223316|NCT01517568|Liraglutide|liraglutide|mesh-list
101343289|NCT00276900|Sertraline|sertraline|mesh-list
101343290|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
101223317|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223318|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223319|NCT01517568|Incretins|incretins|mesh-ancestor
101223320|NCT01517568|Hormones|hormones|mesh-ancestor
101223321|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223322|NCT01517607|Mesalamine|mesalamine|mesh-list
101223323|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101223324|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223325|NCT01517607|Analgesics|analgesics|mesh-ancestor
101223326|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
101223327|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223328|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223329|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101223330|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101223331|NCT01517724|Bortezomib|bortezomib|mesh-list
101223332|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223333|NCT01517815|Tazobactam|tazobactam|mesh-list
101223334|NCT01517815|Piperacillin|piperacillin|mesh-list
101223335|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101223336|NCT01517815|Doripenem|doripenem|mesh-list
101223337|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223338|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223339|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101223340|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223341|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223342|NCT01517828|Midazolam|midazolam|mesh-list
101223343|NCT01517828|Ketamine|ketamine|mesh-list
101223344|NCT01517828|Analgesics|analgesics|mesh-ancestor
101223345|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
101223346|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223347|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223348|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101223349|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223350|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
101223351|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
101223352|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223353|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101223354|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101223355|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223356|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223357|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101223358|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223359|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101223360|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101223361|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223362|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
101223363|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
101223364|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
101223365|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
101223366|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101223367|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101223370|NCT01517854|Urological Agents|urological agents|mesh-ancestor
101343308|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343309|NCT00276783|Pemetrexed|pemetrexed|mesh-list
101223372|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223373|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223374|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223375|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223376|NCT01517932|Analgesics|analgesics|mesh-ancestor
101223377|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
101223378|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223379|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101223380|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101223381|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101223382|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223383|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223384|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223385|NCT01517997|Paclitaxel|paclitaxel|mesh-list
101223386|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223387|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223388|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223389|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223390|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343342|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223391|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223392|NCT01518062|Estrogens|estrogens|mesh-list
101223393|NCT01518062|Hormones|hormones|mesh-ancestor
101223394|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223395|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223397|NCT01518101|Liraglutide|liraglutide|mesh-list
101223398|NCT01518101|Vildagliptin|vildagliptin|mesh-list
101223399|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223400|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223401|NCT01518101|Incretins|incretins|mesh-ancestor
101223402|NCT01518101|Hormones|hormones|mesh-ancestor
101223403|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223404|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101223405|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223406|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223407|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223408|NCT01516944|Capecitabine|capecitabine|mesh-list
101223409|NCT01516944|Tegafur|tegafur|mesh-list
101223410|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
101223411|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101223412|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
101223413|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223414|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223415|NCT01518166|Liraglutide|liraglutide|mesh-list
101223416|NCT01518166|Griseofulvin|griseofulvin|mesh-list
101223417|NCT01518166|Digoxin|digoxin|mesh-list
101223418|NCT01518166|Lisinopril|lisinopril|mesh-list
101223419|NCT01518166|Atorvastatin|atorvastatin|mesh-list
101223420|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101223421|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101223422|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
101223423|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223424|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101223425|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101223426|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223427|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223428|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223429|NCT01518166|Incretins|incretins|mesh-ancestor
101223430|NCT01518166|Hormones|hormones|mesh-ancestor
101223431|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223432|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101223433|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101223434|NCT01518166|Protective Agents|protective agents|mesh-ancestor
101223435|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101223436|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223437|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223438|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
101223439|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223440|NCT01518231|Aspirin|aspirin|mesh-list
101223441|NCT01518231|Edaravone|edaravone|mesh-list
101223442|NCT01518231|Warfarin|warfarin|mesh-list
101223443|NCT01518231|Atorvastatin|atorvastatin|mesh-list
101223444|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101223445|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223446|NCT01518231|Analgesics|analgesics|mesh-ancestor
101223447|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
101343432|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101343435|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
101223448|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223449|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223451|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101223452|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101223453|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101223454|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223455|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101223456|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101223457|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223458|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
101223459|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101223460|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101223461|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
101223462|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101223463|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101223464|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
101223465|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101223466|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
101223467|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101223468|NCT01518231|Protective Agents|protective agents|mesh-ancestor
101223469|NCT01518413|Irinotecan|irinotecan|mesh-list
101223470|NCT01518413|Sorafenib|sorafenib|mesh-list
101223471|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101223472|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223473|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223474|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223475|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223476|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101223477|NCT01518465|Dexamethasone|dexamethasone|mesh-list
101223478|NCT01518465|Lenalidomide|lenalidomide|mesh-list
101223479|NCT01518465|Dalteparin|dalteparin|mesh-list
101223480|NCT01518465|Tinzaparin|tinzaparin|mesh-list
101223481|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101223482|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101223483|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
101223484|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
101223485|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223486|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223488|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
101223489|NCT01518465|Hormones|hormones|mesh-ancestor
101223490|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223491|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101223492|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223493|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
101223494|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101223495|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101223496|NCT01518465|Growth Substances|growth substances|mesh-ancestor
101223497|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
101223498|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
101223499|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101223500|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101223501|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223502|NCT01518569|Urinastatin|urinastatin|mesh-list
101223503|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101223504|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101223505|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223506|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223507|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223508|NCT01518595|Bosentan|bosentan|mesh-list
101223510|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101223511|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223512|NCT01518608|Alfentanil|alfentanil|mesh-list
101223513|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101223514|NCT01518608|Narcotics|narcotics|mesh-ancestor
101223515|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223516|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223517|NCT01518608|Analgesics|analgesics|mesh-ancestor
101223518|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
101223519|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223520|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223522|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
101223523|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101223524|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223525|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101223526|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223527|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223528|NCT01518634|Imipramine|imipramine|mesh-list
101223529|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101223530|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343609|NCT00275613|Rituximab|rituximab|mesh-list
101223531|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223532|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101223533|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101223534|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101223535|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223536|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223537|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223538|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223539|NCT01518712|Metformin|metformin|mesh-list
101223540|NCT01518712|Canagliflozin|canagliflozin|mesh-list
101223541|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223542|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223543|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101223544|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223545|NCT01518725|Vitamin D|vitamin d|mesh-list
101223546|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
101223547|NCT01518725|Vitamins|vitamins|mesh-ancestor
101223548|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
101223549|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223550|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101223551|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223552|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101223553|NCT01518790|Laxatives|laxatives|mesh-ancestor
101223554|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101223555|NCT01518855|Amlodipine|amlodipine|mesh-list
101223556|NCT01518855|Nifedipine|nifedipine|mesh-list
101223557|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223558|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101223559|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343651|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223560|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223561|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223562|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223564|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
101223565|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223566|NCT01518933|Silybin|silybin|mesh-list
101223567|NCT01518933|Silymarin|silymarin|mesh-list
101223568|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
101223569|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223570|NCT01518933|Protective Agents|protective agents|mesh-ancestor
101223571|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223572|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223573|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223574|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
101223575|NCT01518959|Vitamin D|vitamin d|mesh-list
101223576|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223577|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223578|NCT01518959|Vitamins|vitamins|mesh-ancestor
101223579|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
101223580|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101223581|NCT01518998|Amlodipine|amlodipine|mesh-list
101223582|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223583|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101223584|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101223585|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223586|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223587|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223588|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
101223589|NCT01519011|Azacitidine|azacitidine|mesh-list
101343680|NCT00275457|Pramipexole|pramipexole|mesh-list
101223590|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101223591|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
101223592|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223593|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223594|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223595|NCT01519037|Cinacalcet|cinacalcet|mesh-list
101223596|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223597|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223598|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101223599|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
101223600|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223601|NCT01519076|Coal Tar|coal tar|mesh-list
101223602|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
101223603|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
101223604|NCT01519102|Hormones|hormones|mesh-list
101223605|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223606|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223607|NCT01519128|Rilpivirine|rilpivirine|mesh-list
101223608|NCT01519128|Digoxin|digoxin|mesh-list
101223609|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101331640|NCT00035035|Pemetrexed|pemetrexed|mesh-list
101223610|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101223611|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223612|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223613|NCT01519128|Protective Agents|protective agents|mesh-ancestor
101223614|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223615|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101223616|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101223618|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223619|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101223620|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101223622|NCT01519154|Propofol|propofol|mesh-list
101223623|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223625|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223626|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223627|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
101223628|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
101223629|NCT01519154|Analgesics|analgesics|mesh-ancestor
101223630|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
101223631|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223632|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101223633|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101343776|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
101223634|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101223635|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223636|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223637|NCT01519297|Irbesartan|irbesartan|mesh-list
101223638|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223639|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101223640|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101223641|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223642|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101223643|NCT01519310|Metronidazole|metronidazole|mesh-list
101223644|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
101223645|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223646|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101223647|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101223648|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223649|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223650|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223651|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223652|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223653|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101223654|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101223655|NCT01519336|Ritonavir|ritonavir|mesh-list
101223656|NCT01519336|Darunavir|darunavir|mesh-list
101223657|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101223658|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101223659|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223660|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223661|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223662|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101223663|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101223664|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
101223665|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223666|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101223667|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101223668|NCT01519401|Drospirenone|drospirenone|mesh-list
101223669|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101223671|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101223672|NCT01519401|Estradiol|estradiol|mesh-list
101223673|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101223674|NCT01519401|Estrogens|estrogens|mesh-ancestor
101223675|NCT01519401|Hormones|hormones|mesh-ancestor
101223676|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223677|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223678|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101223679|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
101223680|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223681|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101223682|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101223683|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101223684|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101223685|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
101223686|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101223687|NCT01519401|Diuretics|diuretics|mesh-ancestor
101223688|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
101223689|NCT01519544|Acetazolamide|acetazolamide|mesh-list
101223691|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
101223692|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101223693|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223694|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223695|NCT01519544|Diuretics|diuretics|mesh-ancestor
101223696|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
101223697|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223698|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223699|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223700|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101223701|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101223702|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223703|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
101223704|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
101223705|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223706|NCT01519687|Tofisopam|tofisopam|mesh-list
101223707|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
101223708|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223709|NCT01519726|Midazolam|midazolam|mesh-list
101223710|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101223711|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101223712|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223713|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223714|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101223715|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101223716|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223717|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223718|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
101223720|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
101223721|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
101223722|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223723|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223724|NCT01519752|Oxiconazole|oxiconazole|mesh-list
101223725|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
101223726|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223727|NCT01519856|Piribedil|piribedil|mesh-list
101223730|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
101223731|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
101223732|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223733|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223734|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223735|NCT01519986|Vitamin D|vitamin d|mesh-list
101223736|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
101223737|NCT01519986|Vitamins|vitamins|mesh-ancestor
101223738|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
101223739|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223740|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101223741|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223742|NCT01520012|Esomeprazole|esomeprazole|mesh-list
101223743|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101223744|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101223745|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101223746|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223747|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223748|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101223749|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101223750|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223751|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101223752|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101223753|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101223754|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
101343999|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344000|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101223755|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223756|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101223758|NCT01520103|Vinorelbine|vinorelbine|mesh-list
101223759|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101223760|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101223762|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223763|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223764|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
101321155|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101223765|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223766|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223767|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223768|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223769|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223770|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
101223771|NCT01520116|Timolol|timolol|mesh-list
101223772|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101223773|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101223774|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223775|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223776|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223777|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223778|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101331694|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101223779|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223781|NCT01520181|beta-Lactams|beta-lactams|mesh-list
101223782|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223783|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223784|NCT01520285|Felodipine|felodipine|mesh-list
101223785|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101223786|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101223787|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101223789|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223790|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101223791|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223792|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101223793|NCT01520298|Acetaminophen|acetaminophen|mesh-list
101223794|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223795|NCT01520298|Analgesics|analgesics|mesh-ancestor
101223796|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
101223797|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223798|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223799|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
101223800|NCT01520350|Aripiprazole|aripiprazole|mesh-list
101223801|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
101223802|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101223803|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101223804|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101223805|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223806|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223807|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
101223808|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
101223809|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223810|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223811|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101223812|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101223813|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
101223814|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101223815|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101223816|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101223817|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101223818|NCT01520389|Irinotecan|irinotecan|mesh-list
101223819|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101223820|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101223821|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223822|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223823|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223824|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223825|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
101223826|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223827|NCT01520415|Lidocaine|lidocaine|mesh-list
101223828|NCT01520415|Bupivacaine|bupivacaine|mesh-list
101223829|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
101223830|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
101223831|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223832|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223833|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
101223834|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223835|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101223836|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101223837|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101223838|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344161|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223839|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223840|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101223841|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101223842|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223843|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223844|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101223845|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101223846|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223847|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
101223848|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223849|NCT01520467|Anastrozole|anastrozole|mesh-list
101223850|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101223851|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223852|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101223853|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101223854|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223855|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223856|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101223857|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331788|NCT00000752|Cefuroxime|cefuroxime|mesh-list
101223858|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223859|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223860|NCT01520584|Vitamins|vitamins|mesh-list
101223861|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
101223862|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223863|NCT01520753|Insulin|insulin|mesh-list
101223864|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101223865|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
101223866|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
101223867|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101223868|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
101223869|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223870|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223871|NCT01520766|Methamphetamine|methamphetamine|mesh-list
101223872|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101223873|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223874|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
101223875|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
101223876|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223877|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
101223878|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223879|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223880|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223881|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101331806|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
101223882|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101223883|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101223884|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101223885|NCT01520792|Acetaminophen|acetaminophen|mesh-list
101223886|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101223887|NCT01520792|Analgesics|analgesics|mesh-ancestor
101223888|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
101223889|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223890|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223891|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
101223892|NCT01520818|Insulin|insulin|mesh-list
101223894|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
101223895|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
101223896|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101223897|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
101223898|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223899|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223901|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101223902|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
101223903|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
101223904|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101223905|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
101223906|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101223907|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223908|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223909|NCT01520896|Ketoconazole|ketoconazole|mesh-list
101223910|NCT01520896|Naloxegol|naloxegol|mesh-list
101223911|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
101223912|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223913|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101223914|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101223915|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223916|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223917|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101223918|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
101223919|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223920|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223921|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101223922|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101223923|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
101223924|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223925|NCT01521130|Levetiracetam|levetiracetam|mesh-list
101223926|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
101223927|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
101223928|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
101223929|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223930|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
101223931|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223932|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321299|NCT00083902|Hormones|hormones|mesh-ancestor
101223933|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101223934|NCT01521312|Saxagliptin|saxagliptin|mesh-list
101223935|NCT01521312|Incretins|incretins|mesh-ancestor
101223936|NCT01521312|Hormones|hormones|mesh-ancestor
101223937|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223938|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223939|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101223940|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223941|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223942|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223944|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101223945|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
101223946|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223947|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
101223948|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101223949|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223950|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223951|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223952|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331847|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101223953|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223954|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223955|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223956|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101223957|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
101223958|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223959|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223960|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101223961|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101223962|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101223963|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101223964|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101223965|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
101223967|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223968|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101223969|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
101223970|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
101223971|NCT01521455|Hormones|hormones|mesh-ancestor
101223972|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223973|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
101223974|NCT01521481|Anesthetics|anesthetics|mesh-list
101223975|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223976|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223977|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101223978|NCT01521520|Hematinics|hematinics|mesh-ancestor
101223979|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101344546|NCT00128427|Colchicine|colchicine|mesh-list
101344554|NCT00006099|Antibodies|antibodies|mesh-list
101223980|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101223982|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101223983|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
101223984|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223985|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223986|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101223987|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
101223988|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
101223989|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223990|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101223991|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101223992|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101223993|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223994|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223995|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223996|NCT01521624|Metformin|metformin|mesh-list
101223997|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223998|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223999|NCT01521689|Rituximab|rituximab|mesh-list
101224000|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331922|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101224002|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
101224004|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224005|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101224006|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101224007|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101224008|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
101224009|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331931|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
101224010|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224012|NCT01521767|Urological Agents|urological agents|mesh-ancestor
101224013|NCT01521793|Retinol acetate|retinol acetate|mesh-list
101224014|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101224015|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
101224016|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224017|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101224018|NCT01521793|Protective Agents|protective agents|mesh-ancestor
101224019|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224020|NCT01521819|Ranibizumab|ranibizumab|mesh-list
101331942|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344717|NCT00019071|Cladribine|cladribine|mesh-list
101224021|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101224022|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224023|NCT01521819|Growth Substances|growth substances|mesh-ancestor
101224024|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224025|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224026|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224028|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
101224029|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
101224030|NCT01521936|Vitamins|vitamins|mesh-list
101224031|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
101224032|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224033|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101224034|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101224035|NCT01521962|Alogliptin|alogliptin|mesh-list
101224036|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224037|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224038|NCT01521962|Incretins|incretins|mesh-ancestor
101224039|NCT01521962|Hormones|hormones|mesh-ancestor
101224040|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224041|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101224042|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224043|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224044|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224046|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101224047|NCT01521975|Telbivudine|telbivudine|mesh-list
101344872|NCT00020046|Thalidomide|thalidomide|mesh-list
101224048|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
101224049|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224050|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101224051|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101224052|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224053|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224054|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
101224055|NCT01522040|Analgesics|analgesics|mesh-ancestor
101344920|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344921|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101224056|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
101224057|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224058|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224059|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
101224060|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224061|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101224062|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
101224063|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101224064|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224065|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224066|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101224067|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
101224068|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101224069|NCT01522092|Escitalopram|escitalopram|mesh-list
101345058|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224070|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101224071|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101224072|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224073|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224074|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224075|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
101224076|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224077|NCT01522105|Daptomycin|daptomycin|mesh-list
101224078|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101224079|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224080|NCT01522326|Ibuprofen|ibuprofen|mesh-list
101224081|NCT01522326|Metoclopramide|metoclopramide|mesh-list
101224082|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224083|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224084|NCT01522326|Analgesics|analgesics|mesh-ancestor
101224085|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
101224086|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224087|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345167|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101224088|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224089|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224090|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101224091|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224092|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224093|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
101224094|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
101224095|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101345234|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
101224097|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101224098|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
101224099|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224100|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101224101|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224102|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224103|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224104|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101224105|NCT01522534|Morphine|morphine|mesh-list
101224106|NCT01522534|Mepivacaine|mepivacaine|mesh-list
101224107|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101224108|NCT01522534|Narcotics|narcotics|mesh-ancestor
101332031|NCT00000794|Leucovorin|leucovorin|mesh-list
101332032|NCT00000794|Clarithromycin|clarithromycin|mesh-list
101224109|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332033|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
101332034|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
101224110|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224111|NCT01522534|Analgesics|analgesics|mesh-ancestor
101224112|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
101224113|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224114|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
101224115|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
101224116|NCT01522547|Pomalidomide|pomalidomide|mesh-list
101224117|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
101224118|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224119|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101224120|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224121|NCT01522547|Growth Substances|growth substances|mesh-ancestor
101224122|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224123|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224124|NCT01522612|Leucovorin|leucovorin|mesh-list
101224125|NCT01522612|Fluorouracil|fluorouracil|mesh-list
101224126|NCT01522612|Cetuximab|cetuximab|mesh-list
101224127|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
101224128|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224129|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224130|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224131|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224132|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
101224133|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224135|NCT01522612|Protective Agents|protective agents|mesh-ancestor
101224136|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
101224137|NCT01522612|Vitamins|vitamins|mesh-ancestor
101224138|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
101224139|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224140|NCT01522625|Tenofovir|tenofovir|mesh-list
101224141|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
101224142|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224143|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101224144|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101224145|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224146|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224147|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101224148|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101224149|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101224150|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101224151|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224152|NCT01522729|Fentanyl|fentanyl|mesh-list
101332062|NCT00036283|Celecoxib|celecoxib|mesh-list
101224153|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101224154|NCT01522729|Narcotics|narcotics|mesh-ancestor
101224155|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224156|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224157|NCT01522729|Analgesics|analgesics|mesh-ancestor
101224158|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
101224159|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224160|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101224161|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101224162|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
101224165|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101224166|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224167|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345708|NCT00023868|Antidotes|antidotes|mesh-ancestor
101345709|NCT00023868|Protective Agents|protective agents|mesh-ancestor
101224168|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224169|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
101224170|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224171|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
101224172|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224173|NCT01522846|Heparin|heparin|mesh-list
101224174|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
101224175|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101224176|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101224177|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224178|NCT01522872|Dexamethasone|dexamethasone|mesh-list
101224180|NCT01522872|Bortezomib|bortezomib|mesh-list
101224181|NCT01522872|Pomalidomide|pomalidomide|mesh-list
101224182|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
101224183|NCT01522872|BB 1101|bb 1101|mesh-list
101224184|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224185|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
101224186|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
101224187|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224188|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224189|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224190|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
101224191|NCT01522872|Hormones|hormones|mesh-ancestor
101224192|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224193|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101224194|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224195|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224196|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321350|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224197|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224198|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
101224199|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101224200|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224201|NCT01522872|Growth Substances|growth substances|mesh-ancestor
101224202|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224203|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101224204|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
101224206|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
101224207|NCT01522989|Palbociclib|palbociclib|mesh-list
101224208|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
101224209|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224211|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224212|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224213|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
101224214|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346050|NCT00025740|Paroxetine|paroxetine|mesh-list
101224215|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101224216|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224218|NCT01523002|Pyronaridine|pyronaridine|mesh-list
101224219|NCT01523002|Metoprolol|metoprolol|mesh-list
101224220|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101224221|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101224222|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
101224224|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224225|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224226|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101224227|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101346389|NCT04022876|Pemetrexed|pemetrexed|mesh-list
101224228|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101224229|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101224230|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224231|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224233|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101224234|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101224235|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224236|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224237|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
101224238|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
101224239|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101224240|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
101224241|NCT01523015|Docetaxel|docetaxel|mesh-list
101224242|NCT01523015|Fluorouracil|fluorouracil|mesh-list
101224243|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
101224244|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224245|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224246|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224247|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224248|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224249|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
101224250|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224251|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224252|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
101224253|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224254|NCT01523041|Insulin|insulin|mesh-list
101224255|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101224256|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
101224257|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
101224259|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
101224260|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224261|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224262|NCT01523054|Metoprolol|metoprolol|mesh-list
101224263|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101224264|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101224265|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
101224266|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
101224267|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224268|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224269|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101224270|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101224271|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101224272|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
101224273|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224274|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224275|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
101224276|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
101224277|NCT01523080|Acetaminophen|acetaminophen|mesh-list
101224278|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224279|NCT01523080|Analgesics|analgesics|mesh-ancestor
101224280|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
101346673|NCT00029250|Allicin|allicin|mesh-list
101224281|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224282|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224283|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
101224284|NCT01523093|Ondansetron|ondansetron|mesh-list
101224285|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
101224286|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
101224287|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332208|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
101224288|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224289|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224290|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
101224291|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224292|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101224293|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101224294|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
101224295|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346838|NCT00030459|Vinblastine|vinblastine|mesh-list
101224296|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224297|NCT01523119|Ondansetron|ondansetron|mesh-list
101224298|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
101224299|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
101224300|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224301|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224302|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224303|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
101224304|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224305|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101224306|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101224307|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
101224308|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224309|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224310|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
101224311|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224312|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224313|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101224314|NCT01523314|Dexamethasone|dexamethasone|mesh-list
101224315|NCT01523314|Bevacizumab|bevacizumab|mesh-list
101347088|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224316|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101224317|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224318|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
101224319|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
101224320|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224321|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224322|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224323|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
101224324|NCT01523314|Hormones|hormones|mesh-ancestor
101224325|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224326|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101224327|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224328|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224329|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321367|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101224330|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224331|NCT01523314|Growth Substances|growth substances|mesh-ancestor
101224332|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224333|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101224335|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
101347178|NCT00031473|Ribavirin|ribavirin|mesh-list
101224336|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224337|NCT01523327|Protective Agents|protective agents|mesh-ancestor
101224338|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224339|NCT01523379|Parecoxib|parecoxib|mesh-list
101224340|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101224341|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101224342|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224343|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224344|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224345|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224346|NCT01523379|Analgesics|analgesics|mesh-ancestor
101224347|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
101224348|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347326|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101224349|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224350|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224351|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224352|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
101224353|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101224354|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
101224355|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101224356|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224357|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224360|NCT01523431|Leucovorin|leucovorin|mesh-list
101224361|NCT01523431|Fluorouracil|fluorouracil|mesh-list
101224362|NCT01523431|Irinotecan|irinotecan|mesh-list
101224363|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
101224364|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224365|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224366|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224367|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224368|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
101224369|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224370|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101224371|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101224372|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347495|NCT00396396|Antidotes|antidotes|mesh-ancestor
101224374|NCT01523431|Protective Agents|protective agents|mesh-ancestor
101224375|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
101224376|NCT01523431|Vitamins|vitamins|mesh-ancestor
101224377|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
101224378|NCT01523483|Progesterone|progesterone|mesh-list
101224379|NCT01523483|Progestins|progestins|mesh-ancestor
101224380|NCT01523483|Hormones|hormones|mesh-ancestor
101224381|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224382|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224383|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
101224384|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
101224385|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224386|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
101224387|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224388|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224389|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
101224391|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
101347661|NCT02548559|Cannabidiol|cannabidiol|mesh-list
101224392|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
101224393|NCT01523574|Calcium|calcium|mesh-list
101224394|NCT01523574|Vitamins|vitamins|mesh-ancestor
101224395|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
101224396|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224397|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101224398|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101224399|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224400|NCT01523574|Analgesics|analgesics|mesh-ancestor
101224401|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
101224403|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
101224404|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224405|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101224406|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
101224407|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101224408|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224409|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224410|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
101224411|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101224412|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
101224413|NCT01523574|Protective Agents|protective agents|mesh-ancestor
101224414|NCT01523639|Metformin|metformin|mesh-list
101224415|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224416|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224417|NCT01523678|Paclitaxel|paclitaxel|mesh-list
101224418|NCT01523678|Carboplatin|carboplatin|mesh-list
101224419|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101224420|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224421|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224422|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224423|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224424|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224425|NCT01523847|Doxorubicin|doxorubicin|mesh-list
101224426|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101224427|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224428|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101224429|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101224430|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224431|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224432|NCT01523860|Rituximab|rituximab|mesh-list
101332344|NCT00000899|Lamivudine|lamivudine|mesh-list
101224433|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101224434|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
101224435|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224436|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224437|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
101224438|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224439|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332365|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101224440|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101224441|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
101224442|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224443|NCT01523860|Analgesics|analgesics|mesh-ancestor
101224444|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
101224445|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224446|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101224447|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101224448|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224452|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
101224453|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224454|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224455|NCT01524081|Amoxicillin|amoxicillin|mesh-list
101224456|NCT01524081|Metronidazole|metronidazole|mesh-list
101224457|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
101224458|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
101224459|NCT01524081|Cefuroxime|cefuroxime|mesh-list
101224460|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
101224461|NCT01524081|Fluconazole|fluconazole|mesh-list
101224462|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101224463|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101224464|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224465|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101224466|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101224467|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
101224468|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101224469|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101224470|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224471|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224472|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101224473|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
101321378|NCT00084097|Omalizumab|omalizumab|mesh-list
101224474|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224475|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224476|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101224477|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101224478|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101224479|NCT01524094|Leucovorin|leucovorin|mesh-list
101224480|NCT01524094|Fluorouracil|fluorouracil|mesh-list
101224481|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
101224482|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
101224483|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
101224484|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224485|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348253|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
101224487|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224488|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
101224489|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224490|NCT01524094|Antidotes|antidotes|mesh-ancestor
101224491|NCT01524094|Protective Agents|protective agents|mesh-ancestor
101224492|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
101224493|NCT01524094|Vitamins|vitamins|mesh-ancestor
101224494|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
101224495|NCT01524237|Ketamine|ketamine|mesh-list
101224496|NCT01524237|Analgesics|analgesics|mesh-ancestor
101224497|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
101224500|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101224501|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101224502|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
101224503|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
101224504|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224505|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101224506|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101224507|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224508|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224509|NCT01524315|Vitamins|vitamins|mesh-list
101224510|NCT01524315|Thiamine|thiamine|mesh-list
101224511|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
101224512|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
101224513|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224515|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348487|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224517|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
101224518|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101224519|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224520|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224521|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224522|NCT01524367|Analgesics|analgesics|mesh-ancestor
101224523|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
101224524|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224525|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101224526|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101224527|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101224528|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
101224529|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224530|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224531|NCT01524432|Clotrimazole|clotrimazole|mesh-list
101224532|NCT01524432|Miconazole|miconazole|mesh-list
101224533|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
101224534|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101224535|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224536|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101348863|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
101224537|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101224538|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224539|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224540|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101224541|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
101321382|NCT00084214|Paclitaxel|paclitaxel|mesh-list
101224542|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348930|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
101224543|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224544|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101224547|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224548|NCT01524497|Trazodone|trazodone|mesh-list
101224549|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101224551|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224552|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224553|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101224554|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101224555|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101224556|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224557|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224558|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224559|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
101224560|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101224561|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
101349127|NCT00275639|Losartan|losartan|mesh-list
101224563|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
101224564|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224565|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
101224566|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224567|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224568|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101224569|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101224570|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101224571|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
101224572|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224573|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101349194|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101224574|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101224576|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101224577|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101224578|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101224579|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
101224580|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224581|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101224584|NCT01524705|Insulin|insulin|mesh-list
101224585|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101349261|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224586|NCT01524705|Metformin|metformin|mesh-list
101224589|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101224590|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224591|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224592|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101224593|NCT01524705|Incretins|incretins|mesh-ancestor
101224594|NCT01524705|Hormones|hormones|mesh-ancestor
101224595|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224596|NCT01524731|Dexamethasone|dexamethasone|mesh-list
101349326|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224598|NCT01524731|BB 1101|bb 1101|mesh-list
101224599|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349395|NCT00129857|HU 211|hu 211|mesh-list
101224600|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
101224601|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
101224602|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224603|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224604|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224605|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
101224606|NCT01524731|Hormones|hormones|mesh-ancestor
101224607|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224608|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101224609|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349472|NCT00042003|Decitabine|decitabine|mesh-list
101224610|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224611|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224612|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224614|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224615|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224616|NCT01524744|Analgesics|analgesics|mesh-ancestor
101224617|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
101349546|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224618|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224619|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224620|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224621|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224622|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224623|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224624|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
101224625|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101224626|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224627|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224629|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101224630|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224632|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224633|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224634|NCT01524809|Insulin|insulin|mesh-list
101224635|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101224636|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
101224637|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
101224638|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101224639|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
101349680|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101224640|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101224641|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224642|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224644|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
101224645|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
101224646|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224647|NCT01524861|Protective Agents|protective agents|mesh-ancestor
101224648|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224649|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
101224650|NCT01524861|Vitamins|vitamins|mesh-ancestor
101224651|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
101224652|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
101224653|NCT01524874|Vitamin D|vitamin d|mesh-list
101224654|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
101224655|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
101224656|NCT01524874|Calcitriol|calcitriol|mesh-list
101224657|NCT01524874|Vitamins|vitamins|mesh-list
101224658|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
101224659|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224660|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101224661|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101224662|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101349737|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
101349761|NCT05697783|Methadone|methadone|mesh-list
101224663|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224664|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224665|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101224666|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
101224667|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101224668|NCT01524939|Antibodies|antibodies|mesh-list
101224669|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
101224670|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
101224671|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224672|NCT01525004|Vaccines|vaccines|mesh-list
101224673|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
101224674|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224676|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224677|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224679|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
101224680|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224681|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224682|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224683|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224684|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
101224685|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101224686|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224687|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224688|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101224689|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101224690|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101224691|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224693|NCT01525537|Dsuvia|dsuvia|mesh-list
101224694|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101224695|NCT01525537|Narcotics|narcotics|mesh-ancestor
101224696|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224697|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224698|NCT01525537|Analgesics|analgesics|mesh-ancestor
101224699|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
101224700|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224701|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101224702|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101224703|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
101224705|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
101224706|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224707|NCT01525706|Ethanol|ethanol|mesh-list
101224708|NCT01525706|Paclitaxel|paclitaxel|mesh-list
101224709|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101224710|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101224711|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224712|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224713|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224714|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224715|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224716|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101224717|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224718|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224719|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224720|NCT01525719|Everolimus|everolimus|mesh-list
101224721|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101224722|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101224723|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224724|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224725|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224730|NCT01525771|Docetaxel|docetaxel|mesh-list
101224731|NCT01525771|Capecitabine|capecitabine|mesh-list
101224732|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224733|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224734|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224735|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224736|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224737|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101224738|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
101224739|NCT01525823|Metformin|metformin|mesh-list
101224740|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224741|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224742|NCT01525836|Rituximab|rituximab|mesh-list
101350204|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224743|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224744|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224745|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
101224746|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224747|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224748|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101224749|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101224750|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101224751|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224752|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101224753|NCT01525914|Dutasteride|dutasteride|mesh-list
101224754|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101224755|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101224756|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224757|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224759|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224760|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224761|NCT01526005|Nicotine|nicotine|mesh-list
101224762|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101224763|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
101224764|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224765|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224766|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101224769|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224770|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224771|NCT01526070|Aflibercept|aflibercept|mesh-list
101224772|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101224773|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224774|NCT01526070|Growth Substances|growth substances|mesh-ancestor
101224775|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224776|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224777|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224779|NCT01526083|Warfarin|warfarin|mesh-list
101224780|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
101224781|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
101224782|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101332572|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
101224783|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101224784|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224785|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224786|NCT01526122|Aspirin|aspirin|mesh-list
101224787|NCT01526122|Clopidogrel|clopidogrel|mesh-list
101224788|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224789|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224790|NCT01526122|Analgesics|analgesics|mesh-ancestor
101224791|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
101224792|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224793|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224794|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224795|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224796|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101224797|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101224798|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224799|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101224800|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101224801|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224802|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
101224803|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101224804|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101224805|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101224806|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
101224807|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350741|NCT02882100|Vaccines|vaccines|mesh-list
101224808|NCT01526161|Fluticasone|fluticasone|mesh-list
101224809|NCT01526161|Xhance|xhance|mesh-list
101224810|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101224811|NCT01526161|Montelukast|montelukast|mesh-list
101224812|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224813|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101224814|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
101350802|NCT02451943|Doxorubicin|doxorubicin|mesh-list
101224817|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101224818|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
101224819|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224820|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101224821|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101224822|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101224823|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101224824|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
101224825|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321399|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224826|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224827|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101224828|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
101224829|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224830|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101224831|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101224833|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101224834|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224835|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224836|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
101224837|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224839|NCT01526278|Calcitriol|calcitriol|mesh-list
101224840|NCT01526278|Maxmarvil|maxmarvil|mesh-list
101224841|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101224842|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332627|NCT00015171|Analgesics|analgesics|mesh-ancestor
101224844|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101224845|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224846|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224847|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101224848|NCT01526278|Vitamins|vitamins|mesh-ancestor
101224849|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
101224850|NCT01526317|Metformin|metformin|mesh-list
101224851|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101332645|NCT00000986|Aldesleukin|aldesleukin|mesh-list
101224853|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224854|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101224855|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101224856|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
101224857|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224858|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101224859|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101224860|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224861|NCT01526369|Paclitaxel|paclitaxel|mesh-list
101224862|NCT01526369|Trastuzumab|trastuzumab|mesh-list
101224863|NCT01526369|Lapatinib|lapatinib|mesh-list
101351159|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101224864|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101224865|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224866|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224867|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224868|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351221|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101224869|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224870|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224871|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101224872|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224873|NCT01526395|Propofol|propofol|mesh-list
101224874|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101224875|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224876|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224877|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101224878|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
101224879|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
101224880|NCT01526460|Atorvastatin|atorvastatin|mesh-list
101224881|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101224882|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101224883|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101224884|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
101224885|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224887|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101224888|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224889|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
101224890|NCT01526499|Docetaxel|docetaxel|mesh-list
101224891|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224892|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
101351361|NCT04752163|Azacitidine|azacitidine|mesh-list
101351362|NCT04752163|Venetoclax|venetoclax|mesh-list
101224893|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224894|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224895|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101224896|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
101224897|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351465|NCT04671966|Cetrorelix|cetrorelix|mesh-list
101224898|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224899|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101224900|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
101224901|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
101224902|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
101224903|NCT01526525|Acetaminophen|acetaminophen|mesh-list
101224904|NCT01526525|Parecoxib|parecoxib|mesh-list
101224905|NCT01526525|Ketamine|ketamine|mesh-list
101224906|NCT01526525|Morphine|morphine|mesh-list
101224907|NCT01526525|Tramadol|tramadol|mesh-list
101224908|NCT01526525|Analgesics|analgesics|mesh-ancestor
101351513|NCT04603183|Paclitaxel|paclitaxel|mesh-list
101224910|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224911|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224912|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101224913|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101224914|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
101224915|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
101224916|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101224917|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101224918|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101224919|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101224920|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224921|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101224922|NCT01526525|Narcotics|narcotics|mesh-ancestor
101224923|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101224924|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
101224925|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101224926|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101224927|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224928|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101224929|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224930|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224931|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
101224932|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
101224933|NCT01526564|Vitamins|vitamins|mesh-ancestor
101224934|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
101224935|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224936|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
101224937|NCT01526616|Metformin|metformin|mesh-list
101224938|NCT01526616|Spironolactone|spironolactone|mesh-list
101224939|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101224940|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224941|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101224942|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351841|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224943|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224944|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101224945|NCT01526616|Diuretics|diuretics|mesh-ancestor
101224946|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
101224947|NCT01526694|Thalidomide|thalidomide|mesh-list
101224948|NCT01526694|Dexamethasone|dexamethasone|mesh-list
101224950|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101224951|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
101224952|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
101224953|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101224954|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224955|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101224956|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
101224957|NCT01526694|Hormones|hormones|mesh-ancestor
101224958|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224959|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101224960|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224961|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101224962|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
101224963|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224964|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224965|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
101224967|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101224968|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224969|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101332741|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
101224970|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224971|NCT01526694|Growth Substances|growth substances|mesh-ancestor
101224972|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224973|NCT01526837|Bevacizumab|bevacizumab|mesh-list
101224974|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101224975|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101224976|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101224977|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101224978|NCT01526837|Growth Substances|growth substances|mesh-ancestor
101224979|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224980|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
101224981|NCT01526850|Cyclosporine|cyclosporine|mesh-list
101224982|NCT01526850|Cyclosporins|cyclosporins|mesh-list
101224983|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
101224984|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101224985|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101224986|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101224987|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
101224988|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101224989|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
101224990|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101224991|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101224992|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101224993|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101224995|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101224997|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101224998|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101224999|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225000|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101225001|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225003|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101225004|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
101225005|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
101225006|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101225007|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
101225008|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101225009|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225010|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225011|NCT01526980|Insulin|insulin|mesh-list
101225012|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101225013|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
101225014|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
101225015|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101225016|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
101225017|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101225018|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225019|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225020|NCT01527019|Cephalosporins|cephalosporins|mesh-list
101225021|NCT01527019|Norfloxacin|norfloxacin|mesh-list
101225022|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225023|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352584|NCT00039975|Amlodipine|amlodipine|mesh-list
101225024|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101225025|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101225026|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225027|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225029|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101225030|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101225031|NCT01527032|Thalidomide|thalidomide|mesh-list
101225032|NCT01527032|Dexamethasone|dexamethasone|mesh-list
101225033|NCT01527032|Melphalan|melphalan|mesh-list
101225034|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225035|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
101225036|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
101321411|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225037|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225038|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225039|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225040|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
101225042|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225043|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101225044|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225045|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101225046|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
101352789|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352790|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
101225047|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225048|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101225049|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225050|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
101225051|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
101225052|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225053|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225054|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225055|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225056|NCT01527032|Growth Substances|growth substances|mesh-ancestor
101225057|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
101225058|NCT01527097|Atorvastatin|atorvastatin|mesh-list
101225059|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101225060|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101225061|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
101225062|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225063|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101225064|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101225065|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225066|NCT01527279|Antazoline|antazoline|mesh-list
101225067|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101225068|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
101225069|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
101225070|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225071|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225072|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225073|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101225074|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101225075|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101225076|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225077|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225078|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225079|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225080|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101225081|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101225082|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
101225083|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225084|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225085|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101225086|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101225087|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
101225088|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
101225089|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101225090|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101225091|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
101225092|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225093|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101225094|NCT01527422|Prednisone|prednisone|mesh-list
101225095|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
101225096|NCT01527422|Doxorubicin|doxorubicin|mesh-list
101225097|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101225098|NCT01527422|Vincristine|vincristine|mesh-list
101353048|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
101225100|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225101|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
101225102|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225103|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101225104|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101225105|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
101321415|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101225106|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225107|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225108|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101225109|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225110|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353090|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353091|NCT00049374|Thalidomide|thalidomide|mesh-list
101225112|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225113|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225114|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
101225115|NCT01527422|Hormones|hormones|mesh-ancestor
101225116|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225117|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353151|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
101225118|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101225120|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
101225121|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225122|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101225123|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
101225124|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225125|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101225126|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225127|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225128|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353217|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353241|NCT00022217|Paclitaxel|paclitaxel|mesh-list
101225129|NCT01527474|Escitalopram|escitalopram|mesh-list
101225130|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101225131|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101225132|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225133|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225134|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225135|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
101225136|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225137|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
101225138|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
101353274|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225139|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101225140|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225141|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225142|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
101225143|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
101225144|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225145|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225146|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
101225147|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
101225148|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225149|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225150|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
101225151|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
101353338|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225152|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225153|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225154|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
101225155|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
101225156|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225157|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225158|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
101225159|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
101225160|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225161|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225162|NCT01527669|Lovastatin|lovastatin|mesh-list
101225163|NCT01527669|L 647318|l 647318|mesh-list
101225164|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
101225165|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101225166|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101225167|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
101225168|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225169|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101225170|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101225171|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225172|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
101225173|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101225174|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
101321420|NCT00084370|Celecoxib|celecoxib|mesh-list
101225175|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225176|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225177|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
101225178|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225179|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101225180|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225181|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225182|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101353452|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101225183|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101225184|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101225185|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225186|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225187|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225188|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225189|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
101225190|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225192|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101225193|NCT01527864|Carboplatin|carboplatin|mesh-list
101225194|NCT01527864|Endostatins|endostatins|mesh-list
101225195|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101225196|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225197|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353526|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353534|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
101225198|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
101225199|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225200|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225201|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225202|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225203|NCT01527864|Growth Substances|growth substances|mesh-ancestor
101225204|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225205|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353585|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101225206|NCT01527890|Fentanyl|fentanyl|mesh-list
101225207|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101225208|NCT01527890|Narcotics|narcotics|mesh-ancestor
101225209|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225210|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353643|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225211|NCT01527890|Analgesics|analgesics|mesh-ancestor
101225212|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
101225213|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225214|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101225215|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101225216|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
101225217|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
101225218|NCT01527903|Midazolam|midazolam|mesh-list
101225219|NCT01527903|Propofol|propofol|mesh-list
101225220|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101225221|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225222|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353710|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
101225223|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101225224|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
101353778|NCT00024206|Orantinib|orantinib|mesh-list
101225225|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
101225226|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101225227|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101225228|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225229|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225230|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
101225231|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
101225232|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225233|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225234|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
101225235|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
101225236|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101225237|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101225238|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225239|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
101225240|NCT01527968|Coagulants|coagulants|mesh-ancestor
101225242|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
101225243|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
101225244|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353904|NCT00052416|Thalidomide|thalidomide|mesh-list
101225245|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225246|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225247|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101225248|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225249|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225251|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101225252|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101225253|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225254|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
101225255|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225256|NCT01528137|Lactoferrin|lactoferrin|mesh-list
101225257|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
101225258|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225259|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225260|NCT01528163|Methotrexate|methotrexate|mesh-list
101225261|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101225262|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
101225263|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101225264|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225265|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225266|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
101353970|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225267|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225268|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225269|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
101225270|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225271|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101225272|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225273|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
101225274|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354015|NCT00052845|Protective Agents|protective agents|mesh-ancestor
101225275|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225276|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
101225277|NCT01528176|Vitamin D|vitamin d|mesh-list
101354081|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225278|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101225279|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225280|NCT01528176|Vitamins|vitamins|mesh-ancestor
101225281|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
101225282|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101225283|NCT01528371|Midazolam|midazolam|mesh-list
101225284|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101225285|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101225286|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225287|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225288|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101225289|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225290|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225291|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101225292|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
101225294|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
101225295|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
101225296|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225297|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225300|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101225301|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225302|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225303|NCT01528540|Pregabalin|pregabalin|mesh-list
101225304|NCT01528540|Antioxidants|antioxidants|mesh-list
101225305|NCT01528540|Analgesics|analgesics|mesh-ancestor
101225306|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
101225307|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225308|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225309|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
101225310|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101225311|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225312|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225313|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101225314|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101225315|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225316|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225317|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225318|NCT01528540|Protective Agents|protective agents|mesh-ancestor
101225319|NCT01528618|Cisplatin|cisplatin|mesh-list
101225320|NCT01528618|Gemcitabine|gemcitabine|mesh-list
101225321|NCT01528618|Fluorouracil|fluorouracil|mesh-list
101225322|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225323|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225324|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
101225325|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225326|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225327|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
101225328|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225329|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
101225330|NCT01528644|Iron|iron|mesh-list
101225331|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
101225332|NCT01528644|Calcium|calcium|mesh-list
101225333|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101225334|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225335|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101225336|NCT01528644|Trace Elements|trace elements|mesh-ancestor
101225337|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
101225338|NCT01528644|Hematinics|hematinics|mesh-ancestor
101225339|NCT01528722|Bupivacaine|bupivacaine|mesh-list
101354368|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225340|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
101225341|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
101225342|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225343|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225344|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
101225345|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225347|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
101225348|NCT01528800|Vitamins|vitamins|mesh-ancestor
101225349|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
101225350|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225351|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101225352|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101225353|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225354|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
101225355|NCT01528800|Coagulants|coagulants|mesh-ancestor
101225356|NCT01528813|Amorolfine|amorolfine|mesh-list
101225357|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
101225358|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225359|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
101225360|NCT01528826|Vinorelbine|vinorelbine|mesh-list
101225361|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225362|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354427|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225363|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101225364|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
101225365|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225366|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225373|NCT01528865|Tenofovir|tenofovir|mesh-list
101225374|NCT01528865|Lamivudine|lamivudine|mesh-list
101225375|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
101225376|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225377|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101225378|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225379|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225380|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225381|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101225382|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101225383|NCT01528930|Amikacin|amikacin|mesh-list
101225384|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225385|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225386|NCT01528943|Epoprostenol|epoprostenol|mesh-list
101225387|NCT01528943|Tezosentan|tezosentan|mesh-list
101225388|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101225389|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101225390|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
101225391|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
101225392|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101225393|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225394|NCT01529125|Lamivudine|lamivudine|mesh-list
101225395|NCT01529125|Zidovudine|zidovudine|mesh-list
101225396|NCT01529125|Nevirapine|nevirapine|mesh-list
101225397|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101321431|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225398|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225399|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225400|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225401|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
101225402|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225403|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101225404|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101225405|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
101225406|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101225407|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101225408|NCT01529138|Sirolimus|sirolimus|mesh-list
101225409|NCT01529138|Temsirolimus|temsirolimus|mesh-list
101225410|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
101225411|NCT01529138|Axitinib|axitinib|mesh-list
101225412|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225413|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354535|NCT00054405|Growth Substances|growth substances|mesh-ancestor
101225414|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225415|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225416|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
101225417|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225418|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225419|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225420|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225421|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225422|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
101225423|NCT01529164|Leucovorin|leucovorin|mesh-list
101225424|NCT01529164|Fluorouracil|fluorouracil|mesh-list
101225425|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
101225426|NCT01529164|Endostar protein|endostar protein|mesh-list
101225427|NCT01529164|Endostatins|endostatins|mesh-list
101225428|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
101225429|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225430|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225431|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225432|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225433|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
101225434|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225435|NCT01529164|Antidotes|antidotes|mesh-ancestor
101225436|NCT01529164|Protective Agents|protective agents|mesh-ancestor
101225437|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
101225438|NCT01529164|Vitamins|vitamins|mesh-ancestor
101225439|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
101225440|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225441|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225442|NCT01529164|Growth Substances|growth substances|mesh-ancestor
101225443|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
101225444|NCT01529177|Metformin|metformin|mesh-list
101225445|NCT01529177|Citric Acid|citric acid|mesh-list
101225446|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
101225447|NCT01529177|Clomiphene|clomiphene|mesh-list
101225448|NCT01529177|Enclomiphene|enclomiphene|mesh-list
101225449|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
101225450|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225451|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225452|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
101225453|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101225454|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
101225455|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
101225456|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225457|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101225458|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
101225459|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225460|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101225461|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
101225462|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101225463|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101225464|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101225465|NCT01529190|Pregabalin|pregabalin|mesh-list
101225466|NCT01529190|Analgesics|analgesics|mesh-ancestor
101225467|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
101225468|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225469|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225470|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
101225471|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101225472|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101333028|NCT02970916|Growth Substances|growth substances|mesh-ancestor
101225473|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225474|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101225476|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225477|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225478|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225479|NCT01529229|Prednisolone|prednisolone|mesh-list
101225480|NCT01529229|Betamethasone|betamethasone|mesh-list
101225481|NCT01529229|Desloratadine|desloratadine|mesh-list
101225482|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101225483|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225484|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
101528320|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101354701|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
101225486|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225487|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225488|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101225489|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225490|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101225491|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
101225492|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101225493|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225494|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225495|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225496|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101225497|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101225498|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
101225499|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
101225500|NCT01529242|Prednisolone|prednisolone|mesh-list
101225501|NCT01529242|Betamethasone|betamethasone|mesh-list
101225502|NCT01529242|Desloratadine|desloratadine|mesh-list
101225503|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101225504|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225505|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
101225507|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225508|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225509|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101225510|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225511|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101354832|NCT00027716|Bortezomib|bortezomib|mesh-list
101225512|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
101225513|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101225514|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225515|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225516|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225517|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101225518|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101225519|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
101225520|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
101225521|NCT01529255|Telbivudine|telbivudine|mesh-list
101225522|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
101225523|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225524|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225525|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225526|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225527|NCT01529294|Iloperidone|iloperidone|mesh-list
101225528|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101225532|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225533|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
101225535|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101225536|NCT01529320|Prednisolone|prednisolone|mesh-list
101225537|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
101225538|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
101225539|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101225540|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
101225541|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225542|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
101225543|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
101225544|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225545|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225546|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225547|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
101225548|NCT01529320|Hormones|hormones|mesh-ancestor
101355073|NCT00028847|Cytarabine|cytarabine|mesh-list
101225549|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225550|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101225551|NCT01529320|Protective Agents|protective agents|mesh-ancestor
101225552|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101225553|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225554|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
101225555|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
101225557|NCT01529476|Levofloxacin|levofloxacin|mesh-list
101355137|NCT00398463|Tirofiban|tirofiban|mesh-list
101355138|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101225558|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
101225559|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101225560|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225561|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225562|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101225563|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101225564|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225565|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225566|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225567|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101225568|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101225570|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101225571|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101225572|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225573|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225574|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225575|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225576|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101225577|NCT01529541|Anagliptin|anagliptin|mesh-list
101225578|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225579|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225580|NCT01529541|Incretins|incretins|mesh-ancestor
101225581|NCT01529541|Hormones|hormones|mesh-ancestor
101225582|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225583|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101225584|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
101225585|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225586|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225587|NCT01529554|Everolimus|everolimus|mesh-list
101225588|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101225589|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225590|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225591|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225592|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225593|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
101225594|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225595|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225597|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101225598|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225599|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225600|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225601|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225602|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225603|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101225604|NCT01529619|Protective Agents|protective agents|mesh-ancestor
101225605|NCT01529710|Praziquantel|praziquantel|mesh-list
101225606|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
101225607|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101225608|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225609|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101225610|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101225611|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101225612|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225613|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225614|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101225615|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225616|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225617|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225618|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225619|NCT01529892|Methamphetamine|methamphetamine|mesh-list
101225620|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101225621|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225623|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
101225624|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225625|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
101225626|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225627|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225628|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
101225629|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101225630|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101225631|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225632|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101225634|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225635|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225636|NCT01530022|Lacosamide|lacosamide|mesh-list
101225637|NCT01530022|Carbamazepine|carbamazepine|mesh-list
101225638|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
101225639|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101225640|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101225641|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225642|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225643|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
101225644|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225645|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225646|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225647|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101225648|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101225649|NCT01530022|Analgesics|analgesics|mesh-ancestor
101225650|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
101225651|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225652|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101225653|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101225654|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
101225655|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101225656|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225657|NCT01530126|Becaplermin|becaplermin|mesh-list
101225658|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
101225659|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101225660|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225661|NCT01530126|Growth Substances|growth substances|mesh-ancestor
101225663|NCT01530152|Lidocaine|lidocaine|mesh-list
101225664|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
101225665|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
101225666|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225667|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225668|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
101225669|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225670|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101225671|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101225672|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101225673|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225674|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225676|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101225677|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101225678|NCT01530217|Analgesics|analgesics|mesh-ancestor
101225679|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
101225680|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225681|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355897|NCT00031889|Exemestane|exemestane|mesh-list
101225682|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101225683|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101225684|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101225685|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225686|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225688|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
101225689|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101225690|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225691|NCT01530295|Docetaxel|docetaxel|mesh-list
101225692|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225693|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
101225694|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
101225695|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225696|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225697|NCT01530308|Dopamine|dopamine|mesh-list
101225698|NCT01530308|Haloperidol|haloperidol|mesh-list
101225699|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
101225700|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
101225701|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
101333169|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225702|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
101225703|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
101225704|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225705|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225706|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225707|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101225708|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225711|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225712|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225713|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101225714|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101225715|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
101225716|NCT01530308|Protective Agents|protective agents|mesh-ancestor
101225718|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
101225719|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101225720|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101225721|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225722|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225723|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101225724|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101225725|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225726|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101225727|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
101225728|NCT01530451|Coagulants|coagulants|mesh-ancestor
101225729|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101225730|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
101225731|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225732|NCT01530490|Cabergoline|cabergoline|mesh-list
101225733|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101225734|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
101225735|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
101225736|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101225738|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
101225739|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
101225740|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225741|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225742|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225743|NCT01530503|Capecitabine|capecitabine|mesh-list
101225744|NCT01530503|Mitomycins|mitomycins|mesh-list
101225745|NCT01530503|Mitomycin|mitomycin|mesh-list
101225746|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225747|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
101225748|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225749|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225750|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225751|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
101225752|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225753|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225755|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101225756|NCT01530542|Narcotics|narcotics|mesh-ancestor
101225757|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225758|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225759|NCT01530542|Analgesics|analgesics|mesh-ancestor
101225760|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
101225761|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225762|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
101225763|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
101356328|NCT00033449|Gefitinib|gefitinib|mesh-list
101225764|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225765|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225766|NCT01530594|Lenalidomide|lenalidomide|mesh-list
101225767|NCT01530594|Bortezomib|bortezomib|mesh-list
101225768|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
101225769|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225770|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225771|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225772|NCT01530594|Growth Substances|growth substances|mesh-ancestor
101225773|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101225774|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225775|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
101225776|NCT01530607|Goserelin|goserelin|mesh-list
101225777|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225778|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
101225779|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225780|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101225781|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101225782|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
101225783|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225784|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225785|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101225786|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101225788|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
101225789|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
101225790|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225791|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225792|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101225793|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101225794|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225795|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225796|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225797|NCT01530620|Urological Agents|urological agents|mesh-ancestor
101225798|NCT01530698|Vaccines|vaccines|mesh-list
101225799|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
101225800|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225801|NCT01530711|Terlipressin|terlipressin|mesh-list
101225802|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101225803|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101225804|NCT01530737|Antithrombins|antithrombins|mesh-list
101225805|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
101225806|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101225807|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
101225808|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225809|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225810|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
101225811|NCT01530763|Amoxicillin|amoxicillin|mesh-list
101225812|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
101225813|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
101225814|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
101225815|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101225816|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101225817|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225819|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101225820|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225821|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225822|NCT01530815|Bupivacaine|bupivacaine|mesh-list
101225823|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
101225824|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
101225825|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356740|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225826|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225827|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
101225828|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225829|NCT01530984|Ipilimumab|ipilimumab|mesh-list
101225830|NCT01530984|Sargramostim|sargramostim|mesh-list
101225831|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101225832|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225833|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101225834|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225835|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
101225836|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225837|NCT01531049|Nicotine|nicotine|mesh-list
101225839|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101225840|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
101225841|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101225842|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225843|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101225844|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101225845|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
101225846|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225847|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225848|NCT01531114|Ticagrelor|ticagrelor|mesh-list
101225849|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101225850|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101225851|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101225852|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101225853|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101225854|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
101225855|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101225856|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225857|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225858|NCT01531140|Bisacodyl|bisacodyl|mesh-list
101225859|NCT01531140|Senna Extract|senna extract|mesh-list
101225860|NCT01531140|Sennosides|sennosides|mesh-list
101225861|NCT01531140|Cathartics|cathartics|mesh-ancestor
101225862|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101225863|NCT01531140|Laxatives|laxatives|mesh-ancestor
101225864|NCT01531166|Interferons|interferons|mesh-list
101225865|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
101225866|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
101225867|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101225868|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225869|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
101225870|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225871|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
101225872|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225874|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225875|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225876|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
101225878|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101225879|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357176|NCT00064428|PENTA|penta|mesh-list
101225881|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225882|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225883|NCT01531244|Dactinomycin|dactinomycin|mesh-list
101225884|NCT01531244|Cactinomycin|cactinomycin|mesh-list
101225885|NCT01531244|Melphalan|melphalan|mesh-list
101225886|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101225887|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
101225888|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225890|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101225891|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101225892|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
101225893|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225894|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101225895|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225896|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101225897|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101225898|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357270|NCT00065130|Insulin|insulin|mesh-list
101225899|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225901|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101225902|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101225903|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225904|NCT01531322|Vaccines|vaccines|mesh-list
101225905|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101225906|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
101225907|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225909|NCT01531361|Vemurafenib|vemurafenib|mesh-list
101225910|NCT01531361|Crizotinib|crizotinib|mesh-list
101225911|NCT01531361|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101225912|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225913|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225914|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225915|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225917|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225918|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
101225919|NCT01531517|Propolis|propolis|mesh-list
101225920|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
101225921|NCT01531517|Vitamins|vitamins|mesh-ancestor
101225922|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
101225923|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225924|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225925|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
101225926|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
101225927|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101225928|NCT01531569|Estrogens|estrogens|mesh-ancestor
101225929|NCT01531569|Hormones|hormones|mesh-ancestor
101225930|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101225931|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225932|NCT01531595|Bevacizumab|bevacizumab|mesh-list
101225933|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
101357477|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
101528321|NCT04683341|Tenofovir|tenofovir|mesh-list
101225935|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101225936|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225937|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225938|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225939|NCT01531595|Growth Substances|growth substances|mesh-ancestor
101225940|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225941|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
101225942|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101225943|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357545|NCT00070083|Hormones|hormones|mesh-ancestor
101225945|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225947|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
101225948|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101225949|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101225950|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
101225951|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225952|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357606|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225954|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101225955|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
101225956|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101225957|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101225958|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101225959|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101225960|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101225961|NCT01531712|Gemcitabine|gemcitabine|mesh-list
101225962|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
101225963|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101225964|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101225966|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225967|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225968|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225969|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225971|NCT01531764|Afatinib|afatinib|mesh-list
101225972|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101225973|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225974|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
101225975|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
101225976|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
101225977|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225978|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225979|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225980|NCT01531777|Apatinib|apatinib|mesh-list
101225981|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225982|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101225983|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101225984|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225985|NCT01531790|Carboplatin|carboplatin|mesh-list
101225986|NCT01531790|Pemetrexed|pemetrexed|mesh-list
101225987|NCT01531790|Endostar protein|endostar protein|mesh-list
101225988|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101225989|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357875|NCT04732598|Bevacizumab|bevacizumab|mesh-list
101225990|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101225991|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101225992|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101225993|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101225994|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101225995|NCT01531790|Growth Substances|growth substances|mesh-ancestor
101225996|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101225997|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101225998|NCT01531829|Heparin|heparin|mesh-list
101225999|NCT01531829|Plasminogen|plasminogen|mesh-list
101226000|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101226001|NCT01531829|Tinzaparin|tinzaparin|mesh-list
101226002|NCT01531829|Dalteparin|dalteparin|mesh-list
101226003|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101226004|NCT01531829|Nadroparin|nadroparin|mesh-list
101226005|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
101226006|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101226007|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101226008|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226009|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101226010|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226012|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
101226013|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
101226014|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226015|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226016|NCT01531920|Ethanol|ethanol|mesh-list
101358037|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
101226017|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101226018|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226019|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226020|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226021|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101226022|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226023|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101226024|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226025|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226026|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101226027|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
101226028|NCT01532076|Coagulants|coagulants|mesh-ancestor
101226029|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
101226030|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226031|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
101226032|NCT01532115|Opicapone|opicapone|mesh-list
101226033|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226034|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226035|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101226036|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101226037|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226038|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226039|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226040|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101226041|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101226042|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101226043|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
101226044|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101226045|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358351|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101226046|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226047|NCT01532232|Varenicline|varenicline|mesh-list
101226048|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101226049|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101226050|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
101226051|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226052|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226053|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226055|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101226056|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101358550|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
101226057|NCT01532466|Rocuronium|rocuronium|mesh-list
101226060|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101226061|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226062|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226063|NCT01532544|Heparin|heparin|mesh-list
101226064|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101226065|NCT01532544|Tinzaparin|tinzaparin|mesh-list
101226066|NCT01532544|Dalteparin|dalteparin|mesh-list
101226067|NCT01532544|Eptifibatide|eptifibatide|mesh-list
101226068|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
101226069|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101226070|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101358608|NCT00410878|Analgesics|analgesics|mesh-ancestor
101226071|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226072|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101226073|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
101226074|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101226075|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101226076|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
101226077|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101226078|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101226079|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101226080|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226081|NCT01532804|Bevacizumab|bevacizumab|mesh-list
101226082|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
101226083|NCT01532804|Raltitrexed|raltitrexed|mesh-list
101226084|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101226085|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226086|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101226087|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101226088|NCT01532804|Growth Substances|growth substances|mesh-ancestor
101226089|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226090|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101226091|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101226092|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
101226093|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226094|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101226095|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226096|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101226097|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
101226098|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226099|NCT01532856|Thalidomide|thalidomide|mesh-list
101226100|NCT01532856|Dexamethasone|dexamethasone|mesh-list
101226101|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
101226102|NCT01532856|Prednisone|prednisone|mesh-list
101226103|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
101226104|NCT01532856|Melphalan|melphalan|mesh-list
101226105|NCT01532856|BB 1101|bb 1101|mesh-list
101226106|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226107|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
101226108|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226109|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226110|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101226111|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
101226112|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226115|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226116|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
101226117|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
101226118|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226119|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226121|NCT01532856|Hormones|hormones|mesh-ancestor
101226122|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226123|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101226124|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
101226125|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226126|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
101226127|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226128|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226129|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101226130|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101226131|NCT01532856|Growth Substances|growth substances|mesh-ancestor
101226132|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
101226134|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101226136|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226137|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226138|NCT01532895|Analgesics|analgesics|mesh-ancestor
101226139|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
101226140|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226141|NCT01532960|Poly ICLC|poly iclc|mesh-list
101226142|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
101226143|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
101226144|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226145|NCT01533090|Bisacodyl|bisacodyl|mesh-list
101226146|NCT01533090|Cathartics|cathartics|mesh-ancestor
101226147|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226148|NCT01533090|Laxatives|laxatives|mesh-ancestor
101226149|NCT01533129|Testosterone|testosterone|mesh-list
101226150|NCT01533129|Androgens|androgens|mesh-ancestor
101226151|NCT01533129|Hormones|hormones|mesh-ancestor
101226152|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226153|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226154|NCT01533155|Quinidine|quinidine|mesh-list
101362564|NCT00044954|Cyclosporins|cyclosporins|mesh-list
101226155|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
101226156|NCT01533155|Morphine|morphine|mesh-list
101226157|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101226158|NCT01533155|Narcotics|narcotics|mesh-ancestor
101226159|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226160|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226161|NCT01533155|Analgesics|analgesics|mesh-ancestor
101226162|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
101226163|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226164|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101226165|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101226166|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226167|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226168|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226169|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101226171|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101226172|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101226173|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226174|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226175|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101226176|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101226177|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101226178|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101362752|NCT00075231|Ritonavir|ritonavir|mesh-list
101226179|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101226180|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101226181|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101226182|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226183|NCT01533220|Pheniramine|pheniramine|mesh-list
101226184|NCT01533220|Naphazoline|naphazoline|mesh-list
101226185|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226186|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101226187|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101226188|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226189|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226190|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226191|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
101226192|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101226193|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226194|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
101226195|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
101226196|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101226197|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
101226198|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
101226199|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101226201|NCT01533272|Emtricitabine|emtricitabine|mesh-list
101226203|NCT01533272|Maraviroc|maraviroc|mesh-list
101226204|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
101226205|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226206|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101226207|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101226208|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226209|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226210|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101226211|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101226212|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101226213|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101226214|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
101226215|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101226216|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226217|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101226218|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101362905|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226219|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101226220|NCT01533324|Leucovorin|leucovorin|mesh-list
101226221|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101226222|NCT01533324|Antidotes|antidotes|mesh-ancestor
101226223|NCT01533324|Protective Agents|protective agents|mesh-ancestor
101226224|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226225|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
101226226|NCT01533324|Vitamins|vitamins|mesh-ancestor
101226227|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
101226228|NCT01533376|Timolol|timolol|mesh-list
101226229|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
101226230|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101226231|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101226233|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226234|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226235|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226236|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101226237|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101226238|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101226239|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101226241|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101226243|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101226244|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226245|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226246|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226247|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333435|NCT00038974|Ribavirin|ribavirin|mesh-list
101226248|NCT01533389|Urological Agents|urological agents|mesh-ancestor
101226249|NCT01533441|Vitamin K|vitamin k|mesh-list
101226250|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
101226251|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
101226252|NCT01533441|Vitamins|vitamins|mesh-ancestor
101226253|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
101226254|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226255|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101226256|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101226257|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226258|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
101226259|NCT01533441|Coagulants|coagulants|mesh-ancestor
101226260|NCT01533506|Stiripentol|stiripentol|mesh-list
101226261|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
101226262|NCT01533545|Epinephrine|epinephrine|mesh-list
101226263|NCT01533545|Mepivacaine|mepivacaine|mesh-list
101226264|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101226265|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101226266|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226267|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226268|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226269|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226270|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101226271|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101226272|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
101226273|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226274|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101226276|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
101226277|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
101226278|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101226279|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
101226280|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
101226281|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226282|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
101226283|NCT01533558|Caspofungin|caspofungin|mesh-list
101226284|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
101226285|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226286|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226287|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226288|NCT01533662|Phenylephrine|phenylephrine|mesh-list
101226289|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
101226290|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101226291|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
101226292|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
101226293|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226294|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226295|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
101363389|NCT00132379|Docetaxel|docetaxel|mesh-list
101226296|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101226297|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
101226298|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226299|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101226300|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101226301|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101226302|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226303|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226304|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226305|NCT01533662|Protective Agents|protective agents|mesh-ancestor
101226306|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101226307|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101226308|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226309|NCT01533740|Leucovorin|leucovorin|mesh-list
101226310|NCT01533740|Folic Acid|folic acid|mesh-list
101226311|NCT01533740|Bevacizumab|bevacizumab|mesh-list
101226312|NCT01533740|Fluorouracil|fluorouracil|mesh-list
101226313|NCT01533740|Irinotecan|irinotecan|mesh-list
101226314|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
101363520|NCT00399672|Ribavirin|ribavirin|mesh-list
101226315|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101226316|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226317|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101226318|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101226319|NCT01533740|Growth Substances|growth substances|mesh-ancestor
101226320|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226321|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
101226323|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226325|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226326|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
101226327|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101226328|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101226329|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226330|NCT01533740|Antidotes|antidotes|mesh-ancestor
101226331|NCT01533740|Protective Agents|protective agents|mesh-ancestor
101226332|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
101226333|NCT01533740|Vitamins|vitamins|mesh-ancestor
101226334|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
101226335|NCT01533740|Hematinics|hematinics|mesh-ancestor
101226336|NCT01533818|Amoxicillin|amoxicillin|mesh-list
101226337|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226338|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226340|NCT01533870|Naloxegol|naloxegol|mesh-list
101226341|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101226342|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
101226343|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226344|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226345|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
101226346|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101226347|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226348|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226349|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101226350|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101226351|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101226353|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101226354|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101226355|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101226356|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226357|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
101363770|NCT00080847|Oblimersen|oblimersen|mesh-list
101363771|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363772|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
101363773|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363774|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363775|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363776|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
101363777|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363778|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363779|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101226358|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226359|NCT01534026|Aspirin|aspirin|mesh-list
101226360|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226361|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226362|NCT01534026|Analgesics|analgesics|mesh-ancestor
101226363|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
101226364|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226365|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226366|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226367|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226368|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101226369|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101226370|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226371|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101226372|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101226373|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226374|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
101226375|NCT01534169|Dexamethasone|dexamethasone|mesh-list
101226376|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226377|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
101226378|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
101226379|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226380|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226381|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226382|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
101226384|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226385|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101226386|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226387|NCT01534247|Metronidazole|metronidazole|mesh-list
101226388|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226389|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226390|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101226391|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101226393|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226394|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226395|NCT01534312|Analgesics|analgesics|mesh-ancestor
101226396|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
101226397|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226398|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226399|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363914|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
101226400|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226401|NCT01534442|Atropine|atropine|mesh-list
101226402|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101226403|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101226404|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101226405|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
101226406|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226407|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226408|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101226409|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226411|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
101226412|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101226413|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101226414|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
101226415|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226416|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226417|NCT01534455|Lapatinib|lapatinib|mesh-list
101226418|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226419|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101226420|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333668|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
101226421|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226422|NCT01534494|Psilocybin|psilocybin|mesh-list
101226423|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
101226424|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226425|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101226426|NCT01534546|Capecitabine|capecitabine|mesh-list
101226427|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
101226428|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101226429|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
101364092|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101226430|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226431|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226432|NCT01534585|Paclitaxel|paclitaxel|mesh-list
101226433|NCT01534585|Mitogens|mitogens|mesh-list
101226434|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101226435|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226436|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
101226437|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
101226438|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
101226439|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226440|NCT01534702|Cytarabine|cytarabine|mesh-list
101226441|NCT01534702|Clofarabine|clofarabine|mesh-list
101226442|NCT01534702|Idarubicin|idarubicin|mesh-list
101226443|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101226444|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
101321515|NCT00084916|Sirolimus|sirolimus|mesh-list
101226445|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226446|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226447|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
101226455|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226456|NCT01534754|Mesalamine|mesalamine|mesh-list
101226457|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226458|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226459|NCT01534754|Analgesics|analgesics|mesh-ancestor
101226460|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
101226461|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226462|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226463|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226464|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226465|NCT01534806|Ketorolac|ketorolac|mesh-list
101226466|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226467|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226468|NCT01534806|Analgesics|analgesics|mesh-ancestor
101226469|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
101226470|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226471|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226472|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226473|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226474|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101226475|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226476|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226477|NCT01534845|Temozolomide|temozolomide|mesh-list
101364356|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364363|NCT00047762|Bevacizumab|bevacizumab|mesh-list
101226478|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101226479|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
101226480|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226481|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226482|NCT01534858|Polihexanide|polihexanide|mesh-list
101226483|NCT01534858|Betaine|betaine|mesh-list
101226484|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226485|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
101226486|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101226487|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
101226489|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101226490|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
101226491|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226492|NCT01534884|Rituximab|rituximab|mesh-list
101226493|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101226494|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226495|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
101226496|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226497|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226499|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101226500|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226501|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
101226502|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364481|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226503|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226504|NCT01535027|Alendronate|alendronate|mesh-list
101226505|NCT01535027|Teriparatide|teriparatide|mesh-list
101226506|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101226507|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101226508|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226509|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101226510|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101364537|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364551|NCT00147394|Risperidone|risperidone|mesh-list
101226511|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
101321521|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226512|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226513|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101226514|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101226515|NCT01535079|Ibuprofen|ibuprofen|mesh-list
101226516|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226517|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226518|NCT01535079|Analgesics|analgesics|mesh-ancestor
101226519|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
101226520|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226521|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226522|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226523|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226524|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101226525|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226526|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226528|NCT01535092|Protective Agents|protective agents|mesh-ancestor
101226529|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226530|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101226531|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226532|NCT01535157|Ketoconazole|ketoconazole|mesh-list
101226533|NCT01535157|Fenretinide|fenretinide|mesh-list
101226534|NCT01535157|Retinamide|retinamide|mesh-list
101226535|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
101226536|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226537|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101226538|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226539|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226540|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226541|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101226542|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
101226543|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226544|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226545|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101226546|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226547|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101226548|NCT01535157|Protective Agents|protective agents|mesh-ancestor
101226550|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226552|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101226553|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101226554|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364780|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226555|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226557|NCT01535417|Celecoxib|celecoxib|mesh-list
101226558|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226559|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226560|NCT01535417|Analgesics|analgesics|mesh-ancestor
101226561|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
101226562|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226563|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226564|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226565|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226566|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101226567|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101364896|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
101226568|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226569|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226570|NCT01535469|Fluconazole|fluconazole|mesh-list
101226571|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
101226572|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226573|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101226574|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226575|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226576|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226577|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101226578|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
101226579|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364962|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226580|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226581|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101226582|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101226584|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101226585|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101226587|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226588|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226589|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226590|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101226591|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101226592|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
101226593|NCT01535547|Isavuconazole|isavuconazole|mesh-list
101226594|NCT01535547|Tacrolimus|tacrolimus|mesh-list
101226595|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226596|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
101226597|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226598|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101226599|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226600|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226601|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
101226602|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226604|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226605|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226607|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
101226608|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226609|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226610|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101226611|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226612|NCT01535690|Methylene Blue|methylene blue|mesh-list
101226613|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226614|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226616|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101226617|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101226618|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101226619|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101226620|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101226621|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101226622|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101226623|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226624|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226625|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226626|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226627|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
101226628|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101226629|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101226630|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226631|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
101226632|NCT01535781|Coagulants|coagulants|mesh-ancestor
101226633|NCT01535820|Ortho Evra|ortho evra|mesh-list
101226634|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101226635|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
101226636|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101226637|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226638|NCT01535859|Cabergoline|cabergoline|mesh-list
101226639|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101226640|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101226641|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
101226642|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
101226643|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226644|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226645|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226646|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101226647|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101226648|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
101226649|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226650|NCT01535989|Sirolimus|sirolimus|mesh-list
101226651|NCT01535989|Temsirolimus|temsirolimus|mesh-list
101226652|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
101226653|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101226654|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101226655|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226656|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226658|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
101226659|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226660|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226661|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226662|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226663|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226664|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
101226665|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101226666|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
101226667|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
101226668|NCT01536002|Propofol|propofol|mesh-list
101226669|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101226670|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226671|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226672|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101226673|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
101226674|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
101226675|NCT01536028|Insulin|insulin|mesh-list
101226676|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101226677|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
101226678|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
101226679|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101226680|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
101226681|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226682|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226683|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226685|NCT01536054|Sargramostim|sargramostim|mesh-list
101226686|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226687|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226688|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226689|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226690|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
101226691|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226692|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
101226693|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226694|NCT01536132|Simendan|simendan|mesh-list
101226695|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101226696|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101226697|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101226698|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101226699|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226700|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226701|NCT01536132|Protective Agents|protective agents|mesh-ancestor
101226702|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226703|NCT01536158|Acetaminophen|acetaminophen|mesh-list
101226704|NCT01536158|Ibuprofen|ibuprofen|mesh-list
101226705|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101226706|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101226707|NCT01536158|Analgesics|analgesics|mesh-ancestor
101226708|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
101226709|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226710|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226712|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226713|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101226714|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226715|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226716|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
101226717|NCT01536223|Cisplatin|cisplatin|mesh-list
101226718|NCT01536223|Docetaxel|docetaxel|mesh-list
101226719|NCT01536223|Fluorouracil|fluorouracil|mesh-list
101226720|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226721|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101226722|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101226723|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101226724|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226725|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
101226726|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101226727|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226728|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
101226729|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226730|NCT01536249|Pramipexole|pramipexole|mesh-list
101226731|NCT01536249|Cimetidine|cimetidine|mesh-list
101226732|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101226733|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226734|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101226735|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
101226736|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
101226737|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226738|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226739|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226740|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101226741|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226742|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226743|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
101226744|NCT01536249|Protective Agents|protective agents|mesh-ancestor
101226745|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101226746|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101226747|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
101226748|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
101226749|NCT01536301|Morphine|morphine|mesh-list
101226750|NCT01536301|Oxycodone|oxycodone|mesh-list
101226751|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101226752|NCT01536301|Narcotics|narcotics|mesh-ancestor
101226753|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334083|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
101226754|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226755|NCT01536301|Analgesics|analgesics|mesh-ancestor
101226756|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
101226757|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226759|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101226760|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101226761|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
101226764|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226765|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101226766|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101226767|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101226768|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101226769|NCT01536431|Insulin|insulin|mesh-list
101226770|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101226771|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226772|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226773|NCT01536470|Norepinephrine|norepinephrine|mesh-list
101226774|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101226775|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101226776|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
101226777|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226778|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226779|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226780|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
101226781|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
101226782|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226783|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101226784|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
101226785|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
101226786|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226787|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226788|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226790|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
101226791|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226792|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226793|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226794|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
101226795|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
101226796|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226797|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226798|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226800|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
101319345|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101226801|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226802|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226803|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226804|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
101226805|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
101226806|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101226807|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226808|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226809|NCT01536665|Liraglutide|liraglutide|mesh-list
101226810|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101226811|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226812|NCT01536665|Incretins|incretins|mesh-ancestor
101226813|NCT01536665|Hormones|hormones|mesh-ancestor
101226814|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226815|NCT01536691|Ondansetron|ondansetron|mesh-list
101226816|NCT01536691|Aprepitant|aprepitant|mesh-list
101226817|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
101226818|NCT01536691|Ramosetron|ramosetron|mesh-list
101226819|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
101226820|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
101226821|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226822|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226823|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226824|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
101226825|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101226826|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101226827|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101226828|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
101226829|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226830|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226831|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101226832|NCT01536717|Carticaine|carticaine|mesh-list
101226833|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
101226834|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
101226835|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226836|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226837|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
101226838|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226839|NCT01536743|Palbociclib|palbociclib|mesh-list
101226840|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226841|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101226842|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226843|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226844|NCT01536873|Dolutegravir|dolutegravir|mesh-list
101226846|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101226847|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226848|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226849|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101226850|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101226851|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
101226852|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226853|NCT01537055|Amoxicillin|amoxicillin|mesh-list
101226854|NCT01537055|Levofloxacin|levofloxacin|mesh-list
101226856|NCT01537055|Lansoprazole|lansoprazole|mesh-list
101226857|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
101226858|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226859|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226860|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101334210|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226861|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101226862|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101226863|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226864|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226865|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226866|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101226867|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226869|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226870|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101226871|NCT01537094|Vitamins|vitamins|mesh-list
101226872|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
101226873|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
101226874|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226875|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
101226876|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226877|NCT01537094|Protective Agents|protective agents|mesh-ancestor
101226878|NCT01537107|Sirolimus|sirolimus|mesh-list
101226879|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101226880|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226881|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226882|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226883|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226884|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
101226885|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226886|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
101226887|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226888|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226889|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101226890|NCT01537146|Ropivacaine|ropivacaine|mesh-list
101226891|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
101226892|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
101226894|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226895|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
101226896|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226897|NCT01537250|Levofloxacin|levofloxacin|mesh-list
101226898|NCT01537250|Ofloxacin|ofloxacin|mesh-list
101226899|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
101226900|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101226901|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226902|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101226903|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101226904|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101226905|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101226906|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226907|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226908|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101226909|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101226911|NCT01537354|Beractant|beractant|mesh-list
101226912|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101226913|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
101226914|NCT01537380|Cefazolin|cefazolin|mesh-list
101226916|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101226917|NCT01537471|Meclizine|meclizine|mesh-list
101226918|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
101226919|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
101226920|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
101226921|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226922|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226923|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226924|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101226925|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
101226926|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
101226927|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101226928|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226929|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101226930|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
101226931|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101226932|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
101226933|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101226934|NCT01537575|Antibodies|antibodies|mesh-list
101226935|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
101226936|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101226937|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
101226938|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226939|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101226940|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
101226941|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226942|NCT01537744|Azacitidine|azacitidine|mesh-list
101226943|NCT01537744|Romidepsin|romidepsin|mesh-list
101226944|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101226945|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
101226946|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226947|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226949|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101226950|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101226951|NCT01537770|Lidocaine|lidocaine|mesh-list
101226952|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
101226953|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
101226954|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101226955|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226956|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
101226957|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226958|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101226959|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101226960|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101226961|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101226962|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226964|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
101226965|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
101226966|NCT01537809|Vitamins|vitamins|mesh-list
101226967|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
101226968|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226969|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101226970|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101226971|NCT01537861|Thalidomide|thalidomide|mesh-list
101226972|NCT01537861|Dexamethasone|dexamethasone|mesh-list
101226973|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
101226974|NCT01537861|Lenalidomide|lenalidomide|mesh-list
101226975|NCT01537861|Bortezomib|bortezomib|mesh-list
101226976|NCT01537861|Pomalidomide|pomalidomide|mesh-list
101226977|NCT01537861|Lenograstim|lenograstim|mesh-list
101226978|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101226979|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
101226980|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101226981|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101226982|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101226983|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
101226984|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101226985|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101226986|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101226987|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101226988|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
101226989|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
101226990|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101226991|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101226992|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
101226993|NCT01537861|Hormones|hormones|mesh-ancestor
101226994|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101226995|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101226997|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101226998|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101226999|NCT01537861|Growth Substances|growth substances|mesh-ancestor
101227000|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227001|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
101227002|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227003|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227004|NCT01538095|Trebananib|trebananib|mesh-list
101227005|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101227006|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101227007|NCT01538095|Growth Substances|growth substances|mesh-ancestor
101227008|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227009|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227010|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227011|NCT01538108|Paclitaxel|paclitaxel|mesh-list
101227012|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101227013|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227014|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227015|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
101227016|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227017|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227018|NCT01538225|Nabiximols|nabiximols|mesh-list
101227019|NCT01538225|Analgesics|analgesics|mesh-ancestor
101227020|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
101227021|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227022|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227023|NCT01538316|Genistein|genistein|mesh-list
101227024|NCT01538316|Quercetin|quercetin|mesh-list
101227025|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
101227026|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227027|NCT01538316|Protective Agents|protective agents|mesh-ancestor
101227028|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227029|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101227030|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227031|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334453|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101227034|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101227035|NCT01538316|Estrogens|estrogens|mesh-ancestor
101227036|NCT01538316|Hormones|hormones|mesh-ancestor
101227037|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227038|NCT01538329|Amantadine|amantadine|mesh-list
101227039|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101334515|NCT00018174|Fluoxetine|fluoxetine|mesh-list
101227041|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
101227042|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227043|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
101227044|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227045|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227046|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227047|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227048|NCT01538329|Analgesics|analgesics|mesh-ancestor
101227049|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
101227050|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227051|NCT01538381|Afatinib|afatinib|mesh-list
101227052|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227053|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227054|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227055|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227056|NCT01538394|Nicotine|nicotine|mesh-list
101227057|NCT01538394|Varenicline|varenicline|mesh-list
101227058|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101227059|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
101227060|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227061|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227062|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101227063|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101227064|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
101227065|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227066|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227067|NCT01538446|Clopidogrel|clopidogrel|mesh-list
101227068|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101227069|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101227070|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101227071|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101227073|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
101227074|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227075|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227076|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227078|NCT01538459|Bupivacaine|bupivacaine|mesh-list
101227079|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227080|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
101227081|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
101227082|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227083|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227084|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227085|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
101227086|NCT01538459|Hormones|hormones|mesh-ancestor
101227087|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227088|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227089|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227090|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
101227091|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
101227092|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227093|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
101227094|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
101227095|NCT01538485|Vitamin D|vitamin d|mesh-list
101227096|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101227097|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227098|NCT01538485|Vitamins|vitamins|mesh-ancestor
101227099|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
101227100|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101227101|NCT01538511|Insulin|insulin|mesh-list
101227102|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101227103|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
101227104|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
101227105|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101227106|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
101227107|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101227108|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227109|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227112|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227113|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227114|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227115|NCT01538563|ON 01910|on 01910|mesh-list
101227116|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227117|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227119|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227120|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
101227121|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227122|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227123|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
101227124|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227125|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227126|NCT01538641|Rituximab|rituximab|mesh-list
101227127|NCT01538641|Gemcitabine|gemcitabine|mesh-list
101227129|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101227130|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227131|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
101227132|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227133|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227134|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101227135|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
101227136|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227138|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227139|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227140|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101227141|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101227142|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227143|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227144|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227145|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101227146|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227147|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
101227148|NCT01538693|Dexetimide|dexetimide|mesh-list
101227149|NCT01538693|Citalopram|citalopram|mesh-list
101334580|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
101334584|NCT00018213|Naltrexone|naltrexone|mesh-list
101227150|NCT01538693|Escitalopram|escitalopram|mesh-list
101227151|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101227152|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227153|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227154|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227155|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227156|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
101227157|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227160|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
101227161|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
101227162|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227163|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101227164|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101227165|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
101227166|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101227167|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
101227168|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227169|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
101227170|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101227171|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227172|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101227173|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
101227174|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
101227175|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101227176|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101227177|NCT01538732|Alitretinoin|alitretinoin|mesh-list
101227178|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227179|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
101227180|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
101227181|NCT01538771|Hematinics|hematinics|mesh-ancestor
101227182|NCT01538797|Ranitidine|ranitidine|mesh-list
101227183|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101227184|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101227185|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227186|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101227187|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
101227188|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
101227189|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227190|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227191|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227192|NCT01538849|Esomeprazole|esomeprazole|mesh-list
101227193|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101227194|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227195|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101227196|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227197|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227198|NCT01538875|Labetalol|labetalol|mesh-list
101227199|NCT01538875|Hydralazine|hydralazine|mesh-list
101227200|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101227203|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227204|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227205|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227206|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101227207|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
101227208|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
101227209|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227211|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101227213|NCT01538901|Imiquimod|imiquimod|mesh-list
101227214|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101227215|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
101227216|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227217|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227218|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
101227219|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101227220|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
101227221|NCT01538927|Coagulants|coagulants|mesh-ancestor
101227222|NCT01538940|Vaccines|vaccines|mesh-list
101227223|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
101227224|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227225|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101227226|NCT01538953|Disinfectants|disinfectants|mesh-list
101227227|NCT01538953|Eusol|eusol|mesh-list
101227228|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227229|NCT01539018|Sorafenib|sorafenib|mesh-list
101227230|NCT01539018|Tegafur|tegafur|mesh-list
101334798|NCT00045877|Aldesleukin|aldesleukin|mesh-list
101227231|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227232|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227233|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227234|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227235|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101227237|NCT01539044|Atropine|atropine|mesh-list
101227238|NCT01539044|Neostigmine|neostigmine|mesh-list
101227239|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101227241|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101227242|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
101227243|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227244|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227245|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101227246|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
101227247|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
101334860|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227248|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
101227249|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101227250|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101227251|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101227252|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319346|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227253|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227254|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101227255|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227256|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101227257|NCT01539174|Prednisone|prednisone|mesh-list
101227258|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
101227259|NCT01539174|Rituximab|rituximab|mesh-list
101227260|NCT01539174|Doxorubicin|doxorubicin|mesh-list
101227261|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101227262|NCT01539174|Vincristine|vincristine|mesh-list
101227263|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101227264|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
101227265|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227266|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227267|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101227268|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
101227269|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227270|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227271|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101227272|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101227275|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101227276|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227277|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227278|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
101227280|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227281|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227282|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101227283|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227284|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
101227285|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227287|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101227288|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101227289|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101227290|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
101227291|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319347|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227292|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227293|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227294|NCT01539265|Urological Agents|urological agents|mesh-ancestor
101227295|NCT01539330|Voriconazole|voriconazole|mesh-list
101227296|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
101227297|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227298|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101227299|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227300|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227301|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227302|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101227303|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101227304|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227305|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227306|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101227307|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
101227308|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101227309|NCT01539408|Misoprostol|misoprostol|mesh-list
101227310|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101227311|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
101335017|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227312|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101227313|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227314|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101227315|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227316|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
101227317|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
101227318|NCT01539473|Tedizolid|tedizolid|mesh-list
101227319|NCT01539473|Tyramine|tyramine|mesh-list
101227320|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227321|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227322|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
101227323|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
101227324|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227325|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227326|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101227327|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227328|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227329|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227331|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227333|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227334|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227335|NCT01539577|Dexamethasone|dexamethasone|mesh-list
101227336|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227337|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
101227338|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
101227339|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227340|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227341|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227342|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
101227344|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227345|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227346|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227348|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227349|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227350|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101227351|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227352|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
101227353|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101227354|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
101227355|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227356|NCT01539616|Fenofibrate|fenofibrate|mesh-list
101335129|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227357|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101227358|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
101227359|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227360|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101227361|NCT01539655|Omeprazole|omeprazole|mesh-list
101227362|NCT01539655|Ranitidine|ranitidine|mesh-list
101227363|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101227364|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101227365|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227366|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101227367|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227368|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227369|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101227370|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
101227371|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
101335296|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
101227372|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227373|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227374|NCT01539681|Sorafenib|sorafenib|mesh-list
101227375|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227376|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227377|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227378|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227379|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
101227380|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101227381|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101227382|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
101227383|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227384|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227385|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227386|NCT01539707|Urological Agents|urological agents|mesh-ancestor
101227388|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
101227389|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101227390|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
101227391|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101227392|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227393|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101227394|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101227395|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101227396|NCT01539733|Haloperidol|haloperidol|mesh-list
101227397|NCT01539733|Olanzapine|olanzapine|mesh-list
101227398|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
101227399|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
101227400|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
101227401|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227402|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227403|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227404|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101227405|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101227406|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227407|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227408|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101227409|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335470|NCT00392067|Calcipotriene|calcipotriene|mesh-list
101227410|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227411|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227412|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227413|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
101227414|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101227415|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
101227416|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101227417|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101227418|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
101227419|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101227420|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
101227421|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227422|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335504|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227423|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101227424|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
101227425|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227426|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227427|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101456923|NCT00245739|Darunavir|darunavir|mesh-list
101227428|NCT01540032|Salicylates|salicylates|mesh-list
101227429|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101227430|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227431|NCT01540032|Analgesics|analgesics|mesh-ancestor
101227432|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
101227433|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227434|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227436|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227437|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101227438|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227439|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227441|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101227442|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227443|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227444|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101227445|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
101227447|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
101227449|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101227450|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
101335570|NCT00050596|Docetaxel|docetaxel|mesh-list
101227451|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227452|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227453|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101227454|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
101227455|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227456|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227457|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101227458|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227459|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101227460|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227461|NCT01540136|Nedaplatin|nedaplatin|mesh-list
101227462|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227463|NCT01540240|Zidovudine|zidovudine|mesh-list
101227464|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
101457246|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101227465|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227466|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101227467|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101457321|NCT00242346|Candesartan|candesartan|mesh-list
101227470|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227471|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321610|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227472|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101227473|NCT01540435|Bevacizumab|bevacizumab|mesh-list
101227474|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101227476|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101457384|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227477|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101227478|NCT01540435|Growth Substances|growth substances|mesh-ancestor
101536202|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227479|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227480|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227481|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
101227482|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101227483|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101227484|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227485|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227486|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227487|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101227488|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227489|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227490|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227491|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227492|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
101227493|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101227494|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
101227495|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101227496|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227497|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227498|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101227500|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227501|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227502|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227503|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227504|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101227505|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101227506|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101227507|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101227508|NCT01540682|Cetuximab|cetuximab|mesh-list
101227509|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101227510|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227511|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101227512|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101227513|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
101227514|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227516|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101227517|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
101227518|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
101227520|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227521|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
101227522|NCT01540721|Acetaminophen|acetaminophen|mesh-list
101227523|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227524|NCT01540721|Analgesics|analgesics|mesh-ancestor
101227525|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
101227526|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227527|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227528|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
101227529|NCT01540734|Acetaminophen|acetaminophen|mesh-list
101227530|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227531|NCT01540734|Analgesics|analgesics|mesh-ancestor
101227532|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
101227533|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227534|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227535|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
101227537|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
101227538|NCT01540747|Inositol|inositol|mesh-list
101227539|NCT01540747|Melatonin|melatonin|mesh-list
101227540|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
101227541|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227542|NCT01540747|Protective Agents|protective agents|mesh-ancestor
101227543|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227544|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227545|NCT01540747|Hematinics|hematinics|mesh-ancestor
101227546|NCT01540747|Vitamins|vitamins|mesh-ancestor
101227547|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
101227548|NCT01540812|Cytarabine|cytarabine|mesh-list
101227549|NCT01540812|Dexamethasone|dexamethasone|mesh-list
101227550|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
101227551|NCT01540812|Prednisone|prednisone|mesh-list
101227552|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
101227553|NCT01540812|Fludarabine|fludarabine|mesh-list
101227554|NCT01540812|Vincristine|vincristine|mesh-list
101227555|NCT01540812|Daunorubicin|daunorubicin|mesh-list
101227556|NCT01540812|Idarubicin|idarubicin|mesh-list
101227557|NCT01540812|Methotrexate|methotrexate|mesh-list
101227558|NCT01540812|Pegaspargase|pegaspargase|mesh-list
101227559|NCT01540812|Asparaginase|asparaginase|mesh-list
101227560|NCT01540812|BB 1101|bb 1101|mesh-list
101227561|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227562|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
101227563|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
101227564|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227565|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227566|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227567|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
101227568|NCT01540812|Hormones|hormones|mesh-ancestor
101227569|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227570|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227571|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227572|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
101227573|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458140|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227574|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227575|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101227577|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101227578|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
101227579|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
101227580|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227581|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101227582|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227583|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101227584|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227586|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101227587|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335761|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227588|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101227589|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
101227590|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101227591|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101227592|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101227593|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227594|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101227595|NCT01540877|Anesthetics|anesthetics|mesh-list
101227596|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101335792|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227597|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
101227598|NCT01540877|Capsaicin|capsaicin|mesh-list
101227599|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227600|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227601|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
101227602|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227603|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
101227604|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
101227605|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101227606|NCT01541059|Ropivacaine|ropivacaine|mesh-list
101227607|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
101227608|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
101227609|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227610|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227611|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
101227612|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227614|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101458462|NCT00563758|Tegaserod|tegaserod|mesh-list
101227615|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
101227616|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227617|NCT01541124|Morphine|morphine|mesh-list
101227618|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101227619|NCT01541124|Narcotics|narcotics|mesh-ancestor
101227620|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227621|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227622|NCT01541124|Analgesics|analgesics|mesh-ancestor
101227623|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
101227624|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227625|NCT01541137|Diclofenac|diclofenac|mesh-list
101227626|NCT01541137|Parecoxib|parecoxib|mesh-list
101335880|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
101227627|NCT01541137|Valdecoxib|valdecoxib|mesh-list
101335882|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227628|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101227629|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227630|NCT01541137|Analgesics|analgesics|mesh-ancestor
101227631|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
101227633|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227634|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227635|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227636|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101336362|NCT00055939|Exatecan|exatecan|mesh-list
101227637|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336521|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101227638|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227639|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101227640|NCT01541189|Valsartan|valsartan|mesh-list
101227641|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101227642|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101227643|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101227644|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227647|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101227648|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101227649|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227650|NCT01541280|Azacitidine|azacitidine|mesh-list
101227651|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101227653|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227654|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227655|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227656|NCT01541293|Lidocaine|lidocaine|mesh-list
101227657|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101227658|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
101227659|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227660|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227661|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
101227662|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227663|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101227664|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101227665|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101227666|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227667|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227668|NCT01541332|Dexamethasone|dexamethasone|mesh-list
101227669|NCT01541332|Doxorubicin|doxorubicin|mesh-list
101227670|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101227671|NCT01541332|Pomalidomide|pomalidomide|mesh-list
101227672|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227673|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
101227674|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
101227675|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227676|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227677|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101227678|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
101227679|NCT01541332|Hormones|hormones|mesh-ancestor
101337052|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101227680|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227681|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101227682|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227683|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101227684|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101227685|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101227686|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227687|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227688|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
101227689|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101227690|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101227691|NCT01541332|Growth Substances|growth substances|mesh-ancestor
101227692|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227693|NCT01541436|Capsaicin|capsaicin|mesh-list
101227694|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
101227695|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
101227696|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
101227699|NCT01541475|Dexetimide|dexetimide|mesh-list
101227700|NCT01541475|Citalopram|citalopram|mesh-list
101227701|NCT01541475|Bupropion|bupropion|mesh-list
101227702|NCT01541475|Escitalopram|escitalopram|mesh-list
101227703|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101227704|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227705|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227706|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227707|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227708|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
101227709|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227710|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101227711|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101227712|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
101227713|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
101227714|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227715|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101227716|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101227717|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
101227718|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101227719|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
101321659|NCT00085501|Paclitaxel|paclitaxel|mesh-list
101227720|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227721|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101337872|NCT00067912|Analgesics|analgesics|mesh-ancestor
101227722|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
101227723|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101227724|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227725|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227726|NCT01541605|Methylphenidate|methylphenidate|mesh-list
101227727|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101227728|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227729|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101227730|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101227731|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227732|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227733|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
101227734|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227735|NCT01541631|Albendazole|albendazole|mesh-list
101227736|NCT01541631|Praziquantel|praziquantel|mesh-list
101227737|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
101227738|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101227739|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227740|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
101227741|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101227742|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101227743|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
101227744|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338367|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
101227745|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227746|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227747|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227749|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
101227750|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227751|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101227752|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101227753|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101227755|NCT01541085|Darunavir|darunavir|mesh-list
101227756|NCT01541085|Efavirenz|efavirenz|mesh-list
101227757|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101227758|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101227759|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
101227760|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227761|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227762|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101227763|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101227764|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
101227765|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227766|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101227767|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227768|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101339067|NCT00077233|Leucovorin|leucovorin|mesh-list
101227769|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101227770|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101339368|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101227771|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101227772|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101227773|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101227774|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101227775|NCT01541943|Losartan|losartan|mesh-list
101227776|NCT01541943|Atorvastatin|atorvastatin|mesh-list
101227777|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101227778|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101227779|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
101339725|NCT00081055|Busulfan|busulfan|mesh-list
101227780|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227781|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101227782|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101339999|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101227784|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101227785|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101321666|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
101227786|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101227787|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101227789|NCT01541956|Vildagliptin|vildagliptin|mesh-list
101227790|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340267|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101340268|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101340269|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340270|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
101340271|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340272|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340273|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101340274|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227792|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101227793|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
101227794|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227795|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227796|NCT01542047|Carboplatin|carboplatin|mesh-list
101227797|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227798|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
101340579|NCT00138970|Cyclosporine|cyclosporine|mesh-list
101227800|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101227801|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227802|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227803|NCT01542099|Remifentanil|remifentanil|mesh-list
101227804|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101227805|NCT01542099|Narcotics|narcotics|mesh-ancestor
101227806|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227807|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227808|NCT01542099|Analgesics|analgesics|mesh-ancestor
101227809|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
101227810|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227811|NCT01542138|Niacinamide|niacinamide|mesh-list
101227813|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
101227814|NCT01542138|Desonide|desonide|mesh-list
101227815|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
101227816|NCT01542138|Vitamins|vitamins|mesh-ancestor
101227818|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227819|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101227820|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
101227821|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227822|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101227823|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
101227824|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227825|NCT01542190|Ketorolac|ketorolac|mesh-list
101227826|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101341181|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227827|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101227828|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227829|NCT01542190|Analgesics|analgesics|mesh-ancestor
101227830|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
101227831|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227832|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227833|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227834|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227835|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101227836|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227837|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227838|NCT01542242|Liraglutide|liraglutide|mesh-list
101227839|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101341510|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101227840|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227841|NCT01542242|Incretins|incretins|mesh-ancestor
101227842|NCT01542242|Hormones|hormones|mesh-ancestor
101411432|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227843|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101227844|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
101227845|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101227847|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227848|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101227849|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101227850|NCT01542268|Protective Agents|protective agents|mesh-ancestor
101227851|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227852|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
101227853|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101227854|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
101227855|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
101321674|NCT00085579|Aldesleukin|aldesleukin|mesh-list
101227856|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227857|NCT01542424|Insulin|insulin|mesh-list
101227858|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101227859|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
101341677|NCT02972255|Meropenem|meropenem|mesh-list
101341681|NCT05468671|Oxycodone|oxycodone|mesh-list
101227860|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
101227861|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
101341777|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227862|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101227864|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227865|NCT01542437|Afatinib|afatinib|mesh-list
101227866|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227867|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101227868|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227869|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227870|NCT01542450|Insulin|insulin|mesh-list
101227871|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101227872|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
101341987|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227873|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
101227874|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
101227875|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
101227876|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227877|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227878|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
101227879|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227880|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227881|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
101227882|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227883|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227885|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101227887|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
101227888|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101227889|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227890|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
101342270|NCT02993029|Celecoxib|celecoxib|mesh-list
101227892|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
101227893|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227894|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227895|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
101227896|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227897|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101227898|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
101227899|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101227900|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227901|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227902|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101227904|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101227905|NCT01542710|Timolol|timolol|mesh-list
101227906|NCT01542710|Bimatoprost|bimatoprost|mesh-list
101227907|NCT01542710|Travoprost|travoprost|mesh-list
101227908|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101227909|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101227910|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
101227911|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411434|NCT00460369|Lumefantrine|lumefantrine|mesh-list
101227912|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227913|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227914|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101458588|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227915|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101227916|NCT01542723|Nadroparin|nadroparin|mesh-list
101227917|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
101227918|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101227919|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101227920|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227921|NCT01542762|Nadroparin|nadroparin|mesh-list
101227922|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
101227923|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101227924|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101227925|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227926|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
101227927|NCT01542801|Norfloxacin|norfloxacin|mesh-list
101227928|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227929|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227930|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342777|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101342778|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101227931|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101227932|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227933|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227934|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227935|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101227936|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101227938|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
101227939|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227940|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227942|NCT01542918|Lenalidomide|lenalidomide|mesh-list
101227943|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101343015|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227944|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101227945|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
101227946|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227947|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227948|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101227949|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101227950|NCT01542918|Growth Substances|growth substances|mesh-ancestor
101227951|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
101227952|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101227953|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
101227954|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227955|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101343322|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227956|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101227957|NCT01543139|Valproic Acid|valproic acid|mesh-list
101227958|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
101227959|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227960|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227961|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
101227962|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227963|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227964|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
101227965|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101227966|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227967|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101227968|NCT01543165|Ketorolac|ketorolac|mesh-list
101227969|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101227970|NCT01543165|Morphine|morphine|mesh-list
101227971|NCT01543165|Analgesics|analgesics|mesh-list
101227972|NCT01543165|Nefopam|nefopam|mesh-list
101227973|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101227974|NCT01543165|Narcotics|narcotics|mesh-ancestor
101227975|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101227976|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227977|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
101227978|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101227979|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101227980|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101227981|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101227982|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101227983|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101227984|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101227985|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227987|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101227988|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343979|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
101227989|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101227990|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101227991|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
101227992|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101227993|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101227994|NCT01543347|Temocillin|temocillin|mesh-list
101321683|NCT00085696|Rituximab|rituximab|mesh-list
101227995|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101227996|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101227997|NCT01543386|Curcumin|curcumin|mesh-list
101227998|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101227999|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228000|NCT01543386|Analgesics|analgesics|mesh-ancestor
101228001|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
101228002|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228003|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228004|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228005|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228006|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228007|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228008|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228010|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
101228011|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
101228012|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228013|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228014|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228015|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101228016|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228017|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101344516|NCT00394485|Procaterol|procaterol|mesh-list
101228018|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
101228019|NCT01543399|Hormones|hormones|mesh-ancestor
101228020|NCT01543464|Temozolomide|temozolomide|mesh-list
101228021|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101228022|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
101228023|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228024|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228025|NCT01543555|Atorvastatin|atorvastatin|mesh-list
101228026|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101228027|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228028|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
101344741|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
101528322|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
101228029|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228030|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228031|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228032|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228034|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
101228035|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101345037|NCT00020943|Hormones|hormones|mesh-ancestor
101228036|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228037|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228038|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
101228039|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228040|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228041|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228042|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
101228043|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101228044|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
101345445|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
101228045|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228046|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
101228047|NCT01543737|Protective Agents|protective agents|mesh-ancestor
101228048|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
101228049|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101228050|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228051|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228053|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101228054|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
101228055|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228056|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101228057|NCT01543906|Protective Agents|protective agents|mesh-ancestor
101228058|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228059|NCT01543932|Clopidogrel|clopidogrel|mesh-list
101228060|NCT01543932|Ticagrelor|ticagrelor|mesh-list
101345966|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228061|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101228062|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101321689|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228064|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101228065|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101228066|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
101228067|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228068|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228069|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228070|NCT01543945|Dexamethasone|dexamethasone|mesh-list
101228071|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
101346205|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346206|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346207|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346208|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346215|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
101228072|NCT01543945|Ondansetron|ondansetron|mesh-list
101228073|NCT01543945|Antiemetics|antiemetics|mesh-list
101228074|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
101228075|NCT01543945|BB 1101|bb 1101|mesh-list
101228076|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228077|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
101228078|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228079|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228080|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228081|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
101228082|NCT01543945|Hormones|hormones|mesh-ancestor
101228083|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228084|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101228085|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228086|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
101228087|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228088|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228089|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
101346331|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228090|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
101228091|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101228092|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101228093|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
101228094|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228095|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101228096|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
101228097|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
101228098|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101228099|NCT01543971|Lenograstim|lenograstim|mesh-list
101228100|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101228101|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
101228102|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228103|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228104|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228106|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101347008|NCT00031083|Interferons|interferons|mesh-list
101228107|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228108|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228109|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228110|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101228111|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228112|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228113|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228114|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
101228116|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
101228117|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
101228118|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228119|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228120|NCT01544192|Tocopherols|tocopherols|mesh-list
101228121|NCT01544192|Vitamin E|vitamin e|mesh-list
101228122|NCT01544192|Tocotrienols|tocotrienols|mesh-list
101228123|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
101228126|NCT01544192|Protective Agents|protective agents|mesh-ancestor
101228127|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228128|NCT01544192|Vitamins|vitamins|mesh-ancestor
101228129|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
101228130|NCT01544283|Triamcinolone|triamcinolone|mesh-list
101228131|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101228132|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101228133|NCT01544283|Lidocaine|lidocaine|mesh-list
101228134|NCT01544283|Tetracaine|tetracaine|mesh-list
101228135|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101228136|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101228137|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
101228138|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228139|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228140|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
101228141|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228142|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101228143|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101228144|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101228145|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228146|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228147|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347762|NCT00034164|Paclitaxel|paclitaxel|mesh-list
101228148|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
101228150|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228151|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228152|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
101228153|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228154|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
101228155|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228156|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
101228157|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
101228158|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101228159|NCT01544504|Norepinephrine|norepinephrine|mesh-list
101228160|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101228161|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101228162|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228163|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228164|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228165|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228166|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
101228168|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228169|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101228170|NCT01544517|Amoxicillin|amoxicillin|mesh-list
101228171|NCT01544517|Levofloxacin|levofloxacin|mesh-list
101228172|NCT01544517|Tinidazole|tinidazole|mesh-list
101228173|NCT01544517|Esomeprazole|esomeprazole|mesh-list
101228174|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101228175|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101228176|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228177|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101348758|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
101348759|NCT05428683|Triamcinolone|triamcinolone|mesh-list
101228178|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228179|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528323|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228180|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228181|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101228182|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101348838|NCT04888377|Aspirin|aspirin|mesh-list
101228183|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101228184|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228185|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101228186|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101228187|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
101228188|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101228189|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101228190|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101228192|NCT01544634|Propranolol|propranolol|mesh-list
101228193|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101348984|NCT00276575|Growth Substances|growth substances|mesh-ancestor
101228194|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101228195|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228196|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228197|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228198|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228199|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101228200|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228201|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228202|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349353|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101228204|NCT01544634|Hormones|hormones|mesh-ancestor
101228205|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228206|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101228207|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101228208|NCT01544673|Linezolid|linezolid|mesh-list
101228209|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101228210|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228211|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101228212|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228213|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228214|NCT01544725|Ketamine|ketamine|mesh-list
101228215|NCT01544725|Propofol|propofol|mesh-list
101228216|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228217|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228218|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228219|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228220|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
101228221|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
101228222|NCT01544725|Analgesics|analgesics|mesh-ancestor
101228223|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
101228224|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228225|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101228226|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101228227|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101228228|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228229|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228231|NCT01544751|Atorvastatin|atorvastatin|mesh-list
101228232|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101351429|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
101228233|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228234|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101228235|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228236|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
101228237|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228238|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228239|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228240|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228241|NCT01544829|Theobromine|theobromine|mesh-list
101351757|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101228242|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101228243|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
101228244|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228245|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228246|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101228247|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
101228248|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228249|NCT01544842|Triamcinolone|triamcinolone|mesh-list
101228250|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101228251|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101352138|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101228253|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101228254|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228255|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
101228256|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228257|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101228258|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228259|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228260|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228261|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
101321713|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228263|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228264|NCT01544881|Insulin|insulin|mesh-list
101228265|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228266|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228267|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101228268|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
101228269|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101228270|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
101354194|NCT00025298|Protective Agents|protective agents|mesh-ancestor
101228271|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228272|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228273|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101228275|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101228276|NCT01544907|Paclitaxel|paclitaxel|mesh-list
101354671|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
101228277|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101228278|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228279|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101228280|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101228281|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354990|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
101228282|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228284|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101228285|NCT01544959|Esmolol|esmolol|mesh-list
101228286|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101228287|NCT01544959|Narcotics|narcotics|mesh-ancestor
101228288|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228289|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228290|NCT01544959|Analgesics|analgesics|mesh-ancestor
101228291|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
101228292|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228293|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101228294|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228295|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
101228296|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
101228297|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101228298|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228299|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228300|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228301|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101228303|NCT01544972|Ibuprofen|ibuprofen|mesh-list
101356931|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228304|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101228305|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228306|NCT01544972|Analgesics|analgesics|mesh-ancestor
101228307|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
101228308|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228309|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228310|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228312|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101228313|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228314|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228316|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101228317|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228318|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228319|NCT01545024|Incretins|incretins|mesh-ancestor
101228320|NCT01545024|Hormones|hormones|mesh-ancestor
101228321|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228322|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101228323|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
101228324|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228325|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228326|NCT01545284|Acitretin|acitretin|mesh-list
101228327|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
101228328|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
101228329|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
101228330|NCT01545297|Remifentanil|remifentanil|mesh-list
101228331|NCT01545297|Propofol|propofol|mesh-list
101228332|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228333|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228334|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228335|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228336|NCT01545297|Analgesics|analgesics|mesh-ancestor
101358188|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228337|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
101228338|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228339|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101228340|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101228341|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101228342|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228343|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228344|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228345|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228346|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
101228348|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101228349|NCT01545297|Narcotics|narcotics|mesh-ancestor
101228350|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
101228351|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228352|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228353|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228354|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228355|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101228356|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
101228357|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228359|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101228360|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
101228361|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228362|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228363|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228364|NCT01545635|Thrombin|thrombin|mesh-list
101228365|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
101228366|NCT01545635|Coagulants|coagulants|mesh-ancestor
101228367|NCT01545778|Oxycodone|oxycodone|mesh-list
101228368|NCT01545778|Tapentadol|tapentadol|mesh-list
101228369|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101228370|NCT01545778|Narcotics|narcotics|mesh-ancestor
101458820|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
101228371|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228372|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228374|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
101228375|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228376|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101228377|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101228378|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228379|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358778|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101228380|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101228381|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228382|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
101228383|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228384|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228385|NCT01545804|Lenalidomide|lenalidomide|mesh-list
101228386|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
101228387|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228388|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101228389|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101228390|NCT01545804|Growth Substances|growth substances|mesh-ancestor
101228391|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
101228392|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228393|NCT01545830|Vitamin D|vitamin d|mesh-list
101228394|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
101228395|NCT01545830|Vitamins|vitamins|mesh-ancestor
101228396|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
101228397|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228398|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101228399|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101228400|NCT01545856|Levodopa|levodopa|mesh-list
101228401|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101228402|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101228403|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
101228404|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228405|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228406|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228407|NCT01545947|Azacitidine|azacitidine|mesh-list
101228408|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101228409|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101228410|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
101228411|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228413|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228414|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228415|NCT01546051|BCI-838|bci-838|mesh-list
101228416|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101228417|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101228418|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228419|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228420|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228421|NCT01546090|Alprazolam|alprazolam|mesh-list
101228422|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228423|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228424|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228425|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101228426|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228427|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228429|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
101228430|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228431|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228432|NCT01546103|Vitamin D|vitamin d|mesh-list
101228433|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
101228434|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
101228435|NCT01546103|Vitamins|vitamins|mesh-list
101228436|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
101228437|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228438|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101228439|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101228440|NCT01546116|Lamivudine|lamivudine|mesh-list
101228441|NCT01546116|Adefovir|adefovir|mesh-list
101228442|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101228443|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101228444|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101228445|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358879|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228446|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228447|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
101228448|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228449|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101228450|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101228451|NCT01546389|Chloroquine|chloroquine|mesh-list
101228452|NCT01546389|Amebicides|amebicides|mesh-ancestor
101228453|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101228455|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228456|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
101228457|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228460|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228461|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228462|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101228463|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228464|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228465|NCT01546597|Metformin|metformin|mesh-list
101228466|NCT01546597|Ranolazine|ranolazine|mesh-list
101228467|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101459501|NCT04635683|Growth Substances|growth substances|mesh-ancestor
101228468|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228469|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101228470|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228471|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228472|NCT01546701|Morphine|morphine|mesh-list
101228473|NCT01546701|Buprenorphine|buprenorphine|mesh-list
101228474|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101228475|NCT01546701|Narcotics|narcotics|mesh-ancestor
101228476|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228477|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228478|NCT01546701|Analgesics|analgesics|mesh-ancestor
101228480|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228481|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101228482|NCT01546896|Alprazolam|alprazolam|mesh-list
101228483|NCT01546896|Buspirone|buspirone|mesh-list
101228484|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228485|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228486|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228487|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101228488|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228489|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228490|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
101228491|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
101228492|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228493|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459567|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
101459582|NCT00566761|Hormones|hormones|mesh-ancestor
101228494|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101228495|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
101228496|NCT01546935|Oseltamivir|oseltamivir|mesh-list
101228497|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
101228498|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228499|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228500|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228501|NCT01546961|Chloroquine|chloroquine|mesh-list
101228502|NCT01546961|Amebicides|amebicides|mesh-ancestor
101228503|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101228504|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101228505|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228506|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
101228507|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228508|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
101228509|NCT01547104|Glimepiride|glimepiride|mesh-list
101228510|NCT01547104|Linagliptin|linagliptin|mesh-list
101228511|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101228512|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228513|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228514|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228515|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
101228516|NCT01547104|Incretins|incretins|mesh-ancestor
101228517|NCT01547104|Hormones|hormones|mesh-ancestor
101459627|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101459631|NCT04593238|Calcium|calcium|mesh-list
101228518|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228519|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101228520|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
101228522|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228523|NCT01547143|Cyclosporine|cyclosporine|mesh-list
101228524|NCT01547143|Dexamethasone|dexamethasone|mesh-list
101228525|NCT01547143|Etoposide|etoposide|mesh-list
101228526|NCT01547143|Cyclosporins|cyclosporins|mesh-list
101228527|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
101228528|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228529|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
101228530|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
101228531|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228532|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228533|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228534|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
101228535|NCT01547143|Hormones|hormones|mesh-ancestor
101228536|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228537|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101228538|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228539|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228540|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228541|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101228542|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101228543|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101228544|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459731|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
101459739|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
101228545|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
101228546|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
101228547|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228548|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101228549|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228550|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101228551|NCT01547169|Insulin|insulin|mesh-list
101228552|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101228553|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
101228554|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228555|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228556|NCT01547221|Clotrimazole|clotrimazole|mesh-list
101228557|NCT01547221|Miconazole|miconazole|mesh-list
101228558|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101459784|NCT04591444|Fluorides|fluorides|mesh-list
101228559|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228560|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
101228561|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101228562|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101228563|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228564|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459829|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
101228565|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101228566|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
101228567|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228568|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228569|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101228570|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101228571|NCT01547312|Interferons|interferons|mesh-list
101228572|NCT01547312|Ribavirin|ribavirin|mesh-list
101228573|NCT01547312|Grazoprevir|grazoprevir|mesh-list
101228574|NCT01547312|Liver Extracts|liver extracts|mesh-list
101228575|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228576|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
101228577|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228578|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
101228579|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228580|NCT01547312|Hematinics|hematinics|mesh-ancestor
101228581|NCT01547325|Doxycycline|doxycycline|mesh-list
101228582|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101228583|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459888|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
101228584|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
101228585|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101228586|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101228589|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101228590|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101228591|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228592|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
101228593|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228594|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228595|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228596|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228597|NCT01547377|Trace Elements|trace elements|mesh-ancestor
101228598|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
101228599|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228600|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
101228601|NCT01547377|Protective Agents|protective agents|mesh-ancestor
101228602|NCT01547416|Fentanyl|fentanyl|mesh-list
101228603|NCT01547416|Ropivacaine|ropivacaine|mesh-list
101228604|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
101228605|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
101228606|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228607|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228608|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
101228609|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228611|NCT01547416|Narcotics|narcotics|mesh-ancestor
101228612|NCT01547416|Analgesics|analgesics|mesh-ancestor
101228613|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101228614|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228615|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
101228616|NCT01547455|Atorvastatin|atorvastatin|mesh-list
101228617|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101459939|NCT00567814|Oxazepam|oxazepam|mesh-list
101228618|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228619|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
101228620|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228621|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228622|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228623|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228624|NCT01547494|Vitamins|vitamins|mesh-list
101228625|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
101228626|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228627|NCT01547520|Meperidine|meperidine|mesh-list
101228628|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101228629|NCT01547520|Narcotics|narcotics|mesh-ancestor
101228630|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228631|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228632|NCT01547520|Analgesics|analgesics|mesh-ancestor
101228633|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
101228634|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228636|NCT01547546|GDC-0084|gdc-0084|mesh-list
101459980|NCT00253617|Trioxsalen|trioxsalen|mesh-list
101228638|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228639|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
101228640|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101228641|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228642|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228643|NCT01548001|Methotrexate|methotrexate|mesh-list
101228644|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101228645|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
101228646|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101228647|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228648|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101228649|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
101228650|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228651|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228652|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
101228653|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228654|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101228655|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228664|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460038|NCT04587115|Analgesics|analgesics|mesh-ancestor
101228667|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228668|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228669|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
101228670|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228671|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228672|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
101228673|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228674|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228675|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228676|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101228677|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101228678|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101460087|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
101228680|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
101228681|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228682|NCT01548144|Pemetrexed|pemetrexed|mesh-list
101228683|NCT01548144|Crizotinib|crizotinib|mesh-list
101228684|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228685|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228686|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228687|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101228688|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101228689|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228690|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101228691|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101228692|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228693|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
101228694|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228695|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228696|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228697|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228698|NCT01548170|Ketoconazole|ketoconazole|mesh-list
101228699|NCT01548170|Sunitinib|sunitinib|mesh-list
101228700|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228701|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101228702|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101228703|NCT01548170|Growth Substances|growth substances|mesh-ancestor
101228704|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228705|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
101228706|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228707|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228708|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228709|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
101228710|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228711|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101228712|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101460271|NCT00254007|Citalopram|citalopram|mesh-list
101228713|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101228715|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228716|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101228717|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
101228718|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228719|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228720|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228721|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228723|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
101228725|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101228726|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101228727|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101228728|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
101460420|NCT04582786|Morphine|morphine|mesh-list
101228730|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228731|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
101228732|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
101228733|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101228734|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228735|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228736|NCT01548248|Insulin|insulin|mesh-list
101228737|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101228738|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
101460467|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460473|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228739|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
101228740|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101228741|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228742|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
101228743|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101228744|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101228745|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228746|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101228747|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101228748|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
101228749|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228750|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228751|NCT01548326|Atorvastatin|atorvastatin|mesh-list
101228752|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101228753|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101228754|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
101228755|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228756|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101228757|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101228758|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228759|NCT01548482|Sirolimus|sirolimus|mesh-list
101228760|NCT01548482|Temsirolimus|temsirolimus|mesh-list
101228761|NCT01548482|Trebananib|trebananib|mesh-list
101460689|NCT00224549|Amlodipine|amlodipine|mesh-list
101228762|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
101228763|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101228764|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228765|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101228766|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228767|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
101228768|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228769|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
101228770|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228771|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228772|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228773|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228774|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101228776|NCT01548482|Growth Substances|growth substances|mesh-ancestor
101228777|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
101228779|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
101228780|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101228781|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228783|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101228784|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101228785|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
101228786|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228787|NCT01548612|Nitroprusside|nitroprusside|mesh-list
101228788|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228789|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228790|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101228791|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228792|NCT01548677|Trastuzumab|trastuzumab|mesh-list
101228793|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101228794|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228795|NCT01548703|BCI-838|bci-838|mesh-list
101228796|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101228797|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101228798|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228799|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228800|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228801|NCT01548794|Lidocaine|lidocaine|mesh-list
101228802|NCT01548794|Bupivacaine|bupivacaine|mesh-list
101228803|NCT01548794|Anesthetics|anesthetics|mesh-list
101228804|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
101228805|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228806|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228807|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
101228808|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228809|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101228810|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101228811|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101228812|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228813|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228814|NCT01548807|Everolimus|everolimus|mesh-list
101228815|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101460909|NCT00572065|Cytarabine|cytarabine|mesh-list
101460910|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
101460911|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101228816|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228817|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228818|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228819|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101228820|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
101228821|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228822|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228824|NCT01548859|Sevoflurane|sevoflurane|mesh-list
101228825|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101228826|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228827|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228828|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228829|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101228830|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228831|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228832|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101228833|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
101228834|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
101228835|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
101228836|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
101228837|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228838|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228839|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101228841|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
101228842|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101228843|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
101228844|NCT01548911|Calicheamicins|calicheamicins|mesh-list
101228845|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101461018|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461019|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228846|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228847|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
101228848|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
101228849|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
101228850|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228851|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101228852|NCT01548924|Paclitaxel|paclitaxel|mesh-list
101228853|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101228854|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228855|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
101228856|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
101228857|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
101228858|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228861|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228862|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101228863|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101228864|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228865|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228866|NCT01548950|Urological Agents|urological agents|mesh-ancestor
101228867|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228868|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101228869|NCT01549093|Carboplatin|carboplatin|mesh-list
101228870|NCT01549093|Gemcitabine|gemcitabine|mesh-list
101228871|NCT01549093|Endostar protein|endostar protein|mesh-list
101228872|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411454|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
101228873|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101228874|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
101461142|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
101461143|NCT00254865|Estradiol|estradiol|mesh-list
101228875|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228876|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101228877|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101228878|NCT01549093|Growth Substances|growth substances|mesh-ancestor
101228879|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228880|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101228881|NCT01549158|Torsemide|torsemide|mesh-list
101228883|NCT01549158|Diuretics|diuretics|mesh-ancestor
101228884|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
101228885|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228886|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101228887|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228888|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228889|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228890|NCT01549171|Iloprost|iloprost|mesh-list
101228891|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101228892|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228893|NCT01549236|Benzonidazole|benzonidazole|mesh-list
101228895|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
101228896|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228897|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101228898|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101228899|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101228900|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101228901|NCT01549301|Lenograstim|lenograstim|mesh-list
101228902|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101228903|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
101228904|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228905|NCT01549418|Aspirin|aspirin|mesh-list
101228906|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101228907|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228908|NCT01549418|Analgesics|analgesics|mesh-ancestor
101228909|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
101228910|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228911|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228912|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228913|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228914|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101228915|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101228916|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228917|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101228918|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101228919|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461330|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
101228920|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
101228921|NCT01549431|Dexamethasone|dexamethasone|mesh-list
101228922|NCT01549431|Panobinostat|panobinostat|mesh-list
101228923|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228924|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
101228925|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
101228926|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228927|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228928|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228930|NCT01549431|Hormones|hormones|mesh-ancestor
101228931|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101228932|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101228933|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228934|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101228935|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228936|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228937|NCT01549496|Amlodipine|amlodipine|mesh-list
101228938|NCT01549496|Diltiazem|diltiazem|mesh-list
101411457|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
101228939|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101228940|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101359251|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
101228941|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101228942|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228943|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101228944|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228945|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
101228946|NCT01549548|Ponatinib|ponatinib|mesh-list
101228947|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101228948|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101228949|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228950|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228952|NCT01549574|Esomeprazole|esomeprazole|mesh-list
101228953|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101228954|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228955|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101228956|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228957|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228960|NCT01549600|Psyllium|psyllium|mesh-list
101228961|NCT01549600|Cathartics|cathartics|mesh-ancestor
101461479|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101228962|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228963|NCT01549691|Alprazolam|alprazolam|mesh-list
101228964|NCT01549691|Zopiclone|zopiclone|mesh-list
101228965|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101228966|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228967|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228968|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101228969|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101228970|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101228971|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
101228972|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
101228973|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101228974|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228975|NCT01549704|Ropivacaine|ropivacaine|mesh-list
101228976|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
101228977|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
101228978|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101228979|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228980|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
101228981|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228982|NCT01549743|Celecoxib|celecoxib|mesh-list
101228983|NCT01549743|Rebamipide|rebamipide|mesh-list
101228984|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101228985|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101228986|NCT01549743|Analgesics|analgesics|mesh-ancestor
101228987|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
101461543|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
101461544|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461545|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101228988|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101228989|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101228990|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101228991|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101228992|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101228993|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101228994|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101228995|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101228996|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101228997|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101228998|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
101228999|NCT01549743|Protective Agents|protective agents|mesh-ancestor
101229000|NCT01549795|Capecitabine|capecitabine|mesh-list
101229001|NCT01549795|Liver Extracts|liver extracts|mesh-list
101229002|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229003|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
101229004|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229005|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229006|NCT01549795|Hematinics|hematinics|mesh-ancestor
101229007|NCT01549847|Piracetam|piracetam|mesh-list
101229008|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101229009|NCT01549847|Protective Agents|protective agents|mesh-ancestor
101229010|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229011|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
101229012|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
101229013|NCT01549938|Vitamin D|vitamin d|mesh-list
101229014|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229015|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229016|NCT01549938|Vitamins|vitamins|mesh-ancestor
101229017|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
101229018|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101229019|NCT01549990|Sevoflurane|sevoflurane|mesh-list
101229020|NCT01549990|Desflurane|desflurane|mesh-list
101229022|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101229023|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
101229024|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
101229025|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229026|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229027|NCT01550055|Irinotecan|irinotecan|mesh-list
101229028|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101229029|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101229030|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229031|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229032|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229033|NCT01550107|Allopurinol|allopurinol|mesh-list
101229034|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
101229035|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229036|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229037|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
101229038|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229039|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101229040|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
101229041|NCT01550107|Protective Agents|protective agents|mesh-ancestor
101229042|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229043|NCT01550146|Dexamethasone|dexamethasone|mesh-list
101229044|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
101229045|NCT01550146|BB 1101|bb 1101|mesh-list
101229046|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229047|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
101229048|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
101229049|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229050|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359280|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101229051|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229052|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
101229053|NCT01550146|Hormones|hormones|mesh-ancestor
101229054|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229055|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229056|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229057|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229058|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229059|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461767|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229060|NCT01550302|Bupivacaine|bupivacaine|mesh-list
101229061|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
101229062|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
101229063|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229064|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229065|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
101229066|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229067|NCT01550354|Alfentanil|alfentanil|mesh-list
101229068|NCT01550354|Propofol|propofol|mesh-list
101229069|NCT01550354|Rocuronium|rocuronium|mesh-list
101229070|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101229071|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229072|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229073|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101229074|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
101229075|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
101229076|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101229077|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101229078|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101229079|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229080|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101229082|NCT01550354|Analgesics|analgesics|mesh-ancestor
101229083|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
101229084|NCT01550419|Atorvastatin|atorvastatin|mesh-list
101229085|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101461835|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229088|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229089|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101229090|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101229091|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229092|NCT01550445|Prednisolone|prednisolone|mesh-list
101229093|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229094|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
101229096|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229097|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229098|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461889|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229099|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229100|NCT01550640|Remifentanil|remifentanil|mesh-list
101229101|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101229102|NCT01550640|Narcotics|narcotics|mesh-ancestor
101229103|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229104|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229105|NCT01550640|Analgesics|analgesics|mesh-ancestor
101229106|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
101229107|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229108|NCT01550653|Liraglutide|liraglutide|mesh-list
101229109|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229110|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229111|NCT01550653|Incretins|incretins|mesh-ancestor
101461929|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229113|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229114|NCT01550770|Propofol|propofol|mesh-list
101229115|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101229116|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229117|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229118|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101229119|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
101229120|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
101229121|NCT01550848|Gemcitabine|gemcitabine|mesh-list
101229122|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101229123|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229124|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
101229125|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229126|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229127|NCT01550900|Metformin|metformin|mesh-list
101229128|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359347|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359349|NCT00399048|Hydromorphone|hydromorphone|mesh-list
101229129|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229130|NCT01550926|Orlistat|orlistat|mesh-list
101229131|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229132|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229133|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101229134|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101229135|NCT01551004|REP 3123|rep 3123|mesh-list
101229136|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229137|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229138|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
101229139|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
101229140|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101229141|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101229142|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229143|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229144|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229145|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229147|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101359370|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101229148|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101229149|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229150|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229151|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229152|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229153|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
101229154|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101229155|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101229156|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229157|NCT01551147|Montelukast|montelukast|mesh-list
101229158|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101229159|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
101229160|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101229161|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229162|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229163|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229164|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101229165|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101229166|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229167|NCT01551225|Escitalopram|escitalopram|mesh-list
101359391|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229168|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101229169|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101229170|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229171|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229172|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229173|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
101229174|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229175|NCT01551290|Infliximab|infliximab|mesh-list
101229176|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101229177|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229178|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
101462180|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101229179|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229180|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229181|NCT01551329|Ketamine|ketamine|mesh-list
101229182|NCT01551329|Analgesics|analgesics|mesh-ancestor
101229183|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
101229184|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229185|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229186|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101229187|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101229188|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
101229189|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
101229190|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229191|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101229192|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101359425|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229193|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462221|NCT00236223|Analgesics|analgesics|mesh-ancestor
101229194|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229195|NCT01551368|Nimodipine|nimodipine|mesh-list
101229196|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101229197|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101229198|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229199|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229200|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229201|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229202|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
101229203|NCT01551394|Gentamicins|gentamicins|mesh-list
101229204|NCT01551394|Meropenem|meropenem|mesh-list
101229205|NCT01551394|Ampicillin|ampicillin|mesh-list
101229206|NCT01551394|Cefotaxime|cefotaxime|mesh-list
101229207|NCT01551394|Cefoxitin|cefoxitin|mesh-list
101229208|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229209|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229210|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101229211|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229212|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229213|NCT01551459|Sunitinib|sunitinib|mesh-list
101229214|NCT01551459|Dacarbazine|dacarbazine|mesh-list
101359438|NCT00041054|Etoposide|etoposide|mesh-list
101229215|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229216|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229217|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229218|NCT01551459|Growth Substances|growth substances|mesh-ancestor
101229219|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229220|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229221|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101229222|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229223|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229224|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101229225|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
101462352|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
101229227|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101229228|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101229229|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229230|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229231|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101229232|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
101229233|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
101229234|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359529|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229235|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229236|NCT01551511|Dronabinol|dronabinol|mesh-list
101229237|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
101229238|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229239|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101229240|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229241|NCT01551511|Analgesics|analgesics|mesh-ancestor
101229242|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
101229243|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229244|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101229245|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101229246|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229247|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229249|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229250|NCT01551589|Docetaxel|docetaxel|mesh-list
101229251|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229252|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
101229253|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
101229254|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
101229255|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229256|NCT01551615|Metformin|metformin|mesh-list
101229257|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462517|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229258|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229259|NCT01551628|BCT-100|bct-100|mesh-list
101229260|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229261|NCT01551641|Thalidomide|thalidomide|mesh-list
101229262|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229263|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
101229264|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229265|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
101229266|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229267|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229268|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229269|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229270|NCT01551641|Growth Substances|growth substances|mesh-ancestor
101229271|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229272|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229273|NCT01551667|Antibodies|antibodies|mesh-list
101229274|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
101229275|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359570|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229276|NCT01551680|Iniparib|iniparib|mesh-list
101229277|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101229278|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229279|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229280|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229281|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101229282|NCT01551719|Vancomycin|vancomycin|mesh-list
101229283|NCT01551719|Linezolid|linezolid|mesh-list
101229284|NCT01551719|Daptomycin|daptomycin|mesh-list
101229285|NCT01551719|Penicillins|penicillins|mesh-list
101229287|NCT01551719|Cephalosporins|cephalosporins|mesh-list
101229288|NCT01551719|Teicoplanin|teicoplanin|mesh-list
101229289|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462588|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229290|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101229291|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229292|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229293|NCT01551797|Acetaminophen|acetaminophen|mesh-list
101229294|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229295|NCT01551797|Analgesics|analgesics|mesh-ancestor
101229296|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
101229297|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229298|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229299|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
101229300|NCT01551810|Vaccines|vaccines|mesh-list
101229301|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
101229302|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229303|NCT01551823|Vaccines|vaccines|mesh-list
101229304|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
101229305|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229306|NCT01551836|Acetaminophen|acetaminophen|mesh-list
101229307|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229308|NCT01551836|Analgesics|analgesics|mesh-ancestor
101229309|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
101229310|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229311|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229312|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
101229313|NCT01552005|Saxagliptin|saxagliptin|mesh-list
101229314|NCT01552005|Incretins|incretins|mesh-ancestor
101229315|NCT01552005|Hormones|hormones|mesh-ancestor
101229316|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229317|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229318|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101229319|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229320|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229321|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229322|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229323|NCT01552018|Saxagliptin|saxagliptin|mesh-list
101229324|NCT01552018|Incretins|incretins|mesh-ancestor
101229325|NCT01552018|Hormones|hormones|mesh-ancestor
101229326|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229327|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229328|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101229329|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229330|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229331|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229332|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229333|NCT01552044|Spironolactone|spironolactone|mesh-list
101229334|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101229335|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229336|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229337|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229338|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101229339|NCT01552044|Diuretics|diuretics|mesh-ancestor
101229340|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
101229341|NCT01552122|Vitamin D|vitamin d|mesh-list
101229342|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
101229344|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
101229345|NCT01552122|Calcium|calcium|mesh-list
101229346|NCT01552122|Vitamins|vitamins|mesh-ancestor
101229347|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
101229348|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229349|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229350|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101229351|NCT01552122|Antacids|antacids|mesh-ancestor
101229352|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229353|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229354|NCT01552148|Morphine|morphine|mesh-list
101229355|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101229356|NCT01552148|Narcotics|narcotics|mesh-ancestor
101229357|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229358|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229359|NCT01552148|Analgesics|analgesics|mesh-ancestor
101229360|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
101229361|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229362|NCT01552187|Colchicine|colchicine|mesh-list
101229363|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
101229364|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229365|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
101229366|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
101229367|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
101229368|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229369|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462850|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229370|NCT01552330|Artesunate|artesunate|mesh-list
101229371|NCT01552330|Primaquine|primaquine|mesh-list
101229372|NCT01552330|Pyronaridine|pyronaridine|mesh-list
101229373|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101229375|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101229376|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101229377|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229378|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229379|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
101229380|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
101229381|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101229382|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
101229385|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229386|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229387|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229388|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
101229389|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229390|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
101229391|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229392|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
101229393|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229394|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101229396|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229397|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229398|NCT01552798|Aspirin|aspirin|mesh-list
101229399|NCT01552798|Acetaminophen|acetaminophen|mesh-list
101462957|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229400|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101229401|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229403|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
101229404|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229405|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229406|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229407|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229408|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101229409|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101229410|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229411|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101229412|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101229413|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229414|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
101229415|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101229416|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
101229417|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101229418|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101463076|NCT00410540|Analgesics|analgesics|mesh-ancestor
101463082|NCT00201812|Dexamethasone|dexamethasone|mesh-list
101229419|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101229420|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229421|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229422|NCT01552850|Oxycodone|oxycodone|mesh-list
101229423|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101229424|NCT01552850|Narcotics|narcotics|mesh-ancestor
101229425|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229426|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229427|NCT01552850|Analgesics|analgesics|mesh-ancestor
101229428|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
101229429|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229430|NCT01552863|Oxycodone|oxycodone|mesh-list
101229431|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101463139|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101229432|NCT01552863|Narcotics|narcotics|mesh-ancestor
101229433|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229434|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229435|NCT01552863|Analgesics|analgesics|mesh-ancestor
101229436|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
101229437|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229438|NCT01552967|Capecitabine|capecitabine|mesh-list
101229439|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229440|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
101229441|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229442|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229443|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
101463188|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229444|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229445|NCT01552993|Acetaminophen|acetaminophen|mesh-list
101229446|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229447|NCT01552993|Analgesics|analgesics|mesh-ancestor
101229448|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
101229449|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229450|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229451|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
101229452|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
101229453|NCT01553006|Cefditoren|cefditoren|mesh-list
101229454|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229455|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229456|NCT01553019|Gemcitabine|gemcitabine|mesh-list
101229458|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
101229459|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463249|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229460|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229461|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
101229462|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101229463|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
101229464|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101229465|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229466|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101229467|NCT01553357|Dexamethasone|dexamethasone|mesh-list
101229468|NCT01553357|Lenalidomide|lenalidomide|mesh-list
101229469|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229470|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
101229471|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
101229472|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229473|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229474|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463301|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101229475|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
101229476|NCT01553357|Hormones|hormones|mesh-ancestor
101229477|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229478|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229479|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229480|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
101229481|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229482|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229483|NCT01553357|Growth Substances|growth substances|mesh-ancestor
101229484|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229485|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
101229486|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
101229487|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101463433|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101229488|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101229489|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101229490|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229491|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229492|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229493|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101229494|NCT01553500|Cathartics|cathartics|mesh-ancestor
101229495|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229496|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101229497|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
101229498|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
101229499|NCT01553721|Udenafil|udenafil|mesh-list
101229500|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101229501|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101229502|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229503|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229505|NCT01553773|Estrogens|estrogens|mesh-ancestor
101229507|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229508|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229509|NCT01553786|Lenalidomide|lenalidomide|mesh-list
101229510|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
101229511|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229512|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229513|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229514|NCT01553786|Growth Substances|growth substances|mesh-ancestor
101229515|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229516|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229517|NCT01553903|Tamoxifen|tamoxifen|mesh-list
101229518|NCT01553903|Letrozole|letrozole|mesh-list
101229519|NCT01553903|Anastrozole|anastrozole|mesh-list
101229520|NCT01553903|Exemestane|exemestane|mesh-list
101229521|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229522|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101229523|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101229524|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229525|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229526|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101229527|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229528|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229529|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229530|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229531|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101229532|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101229533|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101229534|NCT01553942|Pemetrexed|pemetrexed|mesh-list
101229535|NCT01553942|Afatinib|afatinib|mesh-list
101229536|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229537|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229538|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229539|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101229540|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101229541|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101229542|NCT01553981|Tadalafil|tadalafil|mesh-list
101229543|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
101463677|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
101229544|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101229545|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101229546|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463678|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
101229547|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229548|NCT01553981|Urological Agents|urological agents|mesh-ancestor
101229549|NCT01554059|Bevacizumab|bevacizumab|mesh-list
101229550|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
101229551|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101229552|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229553|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229554|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229555|NCT01554059|Growth Substances|growth substances|mesh-ancestor
101229556|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229557|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229558|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
101229559|NCT01554111|Cathartics|cathartics|mesh-ancestor
101229560|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229561|NCT01554124|Meropenem|meropenem|mesh-list
101229562|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229563|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229564|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101229565|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101229566|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101229567|NCT01554345|Vitamin E|vitamin e|mesh-list
101229568|NCT01554345|Selenium|selenium|mesh-list
101229569|NCT01554345|Vitamins|vitamins|mesh-ancestor
101229570|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
101229571|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229572|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
101359780|NCT00041327|Zidovudine|zidovudine|mesh-list
101359781|NCT00041327|Prednisone|prednisone|mesh-list
101359783|NCT00041327|Doxorubicin|doxorubicin|mesh-list
101229573|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229574|NCT01554345|Protective Agents|protective agents|mesh-ancestor
101229576|NCT01554397|Cisplatin|cisplatin|mesh-list
101229577|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229578|NCT01554540|Treprostinil|treprostinil|mesh-list
101229579|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101229580|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101229581|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101229582|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101229583|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
101229584|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229585|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229586|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101229587|NCT01554631|Acarbose|acarbose|mesh-list
101229588|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101463860|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101229589|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229590|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229591|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229592|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229593|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101229594|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101229595|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229596|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
101229597|NCT01554813|Vaccines|vaccines|mesh-list
101229598|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
101229599|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229600|NCT01554826|Vaccines|vaccines|mesh-list
101229601|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
101229602|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463920|NCT00232700|Escitalopram|escitalopram|mesh-list
101229603|NCT01554852|Thalidomide|thalidomide|mesh-list
101229604|NCT01554852|Dexamethasone|dexamethasone|mesh-list
101229605|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
101229606|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
101229608|NCT01554852|Lenalidomide|lenalidomide|mesh-list
101229609|NCT01554852|Bortezomib|bortezomib|mesh-list
101229610|NCT01554852|Vorinostat|vorinostat|mesh-list
101229611|NCT01554852|BB 1101|bb 1101|mesh-list
101229612|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229613|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
101229614|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229615|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229616|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101229617|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
101229618|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229619|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229620|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101229621|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229622|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
101229623|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
101229624|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229625|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229626|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
101229627|NCT01554852|Hormones|hormones|mesh-ancestor
101229628|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229629|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229630|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229631|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229632|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229633|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229634|NCT01554852|Growth Substances|growth substances|mesh-ancestor
101229635|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229636|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
101464027|NCT00259974|Rituximab|rituximab|mesh-list
101229637|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229638|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229639|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101229640|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
101229641|NCT01554930|Mannitol|mannitol|mesh-list
101229642|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
101229643|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229644|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
101229645|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
101229647|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229648|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229649|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
101229650|NCT01554930|Hormones|hormones|mesh-ancestor
101229651|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229652|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101229653|NCT01554930|Protective Agents|protective agents|mesh-ancestor
101229654|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
101229655|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101229656|NCT01554930|Diuretics|diuretics|mesh-ancestor
101229657|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
101229658|NCT01554969|Capecitabine|capecitabine|mesh-list
101229659|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229660|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
101229661|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229662|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229663|NCT01554995|Linezolid|linezolid|mesh-list
101229664|NCT01554995|Delpazolid|delpazolid|mesh-list
101229665|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464114|NCT04672759|Durvalumab|durvalumab|mesh-list
101229666|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229667|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101229668|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229669|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229670|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101229671|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101229672|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229673|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229674|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229675|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
101229676|NCT01555060|Hematinics|hematinics|mesh-ancestor
101229677|NCT01555099|Budesonide|budesonide|mesh-list
101229678|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229679|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101229680|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
101229681|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229682|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229683|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101229684|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
101229685|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
101229686|NCT01555099|Hormones|hormones|mesh-ancestor
101229687|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229688|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101229689|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101229690|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
101229691|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229692|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229693|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101229694|NCT01555112|Protective Agents|protective agents|mesh-ancestor
101229695|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101229696|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101229697|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229698|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229699|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
101229702|NCT01555190|Inositol|inositol|mesh-list
101229703|NCT01555190|Hematinics|hematinics|mesh-ancestor
101229704|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
101229705|NCT01555190|Vitamins|vitamins|mesh-ancestor
101229706|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
101229707|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229708|NCT01555216|Ropivacaine|ropivacaine|mesh-list
101229709|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
101229711|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229713|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
101229714|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229715|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
101229716|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101229717|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101229718|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
101229719|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229720|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101229721|NCT01555476|Ibuprofen|ibuprofen|mesh-list
101229722|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101229723|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229724|NCT01555476|Analgesics|analgesics|mesh-ancestor
101229725|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
101229726|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229727|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229728|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229729|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229730|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101229731|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229732|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229733|NCT01555580|Molgramostim|molgramostim|mesh-list
101229734|NCT01555580|Sargramostim|sargramostim|mesh-list
101229735|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
101229736|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229737|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229738|NCT01555658|Heparin|heparin|mesh-list
101229739|NCT01555658|Bivalirudin|bivalirudin|mesh-list
101229740|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
101229741|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101229742|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101229743|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229744|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
101229745|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101229746|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229747|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229748|NCT01555710|Carboplatin|carboplatin|mesh-list
101229750|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
101229751|NCT01555710|Ifosfamide|ifosfamide|mesh-list
101229752|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229753|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101229754|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101229755|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101229757|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229758|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101229759|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
101229760|NCT01555788|Pancrelipase|pancrelipase|mesh-list
101229761|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229762|NCT01555814|Amisulpride|amisulpride|mesh-list
101229763|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101229764|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101229765|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101229766|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229767|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101229768|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101229769|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
101229770|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229771|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229772|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101229773|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
101229774|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101229775|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229777|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
101229778|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229779|NCT01555879|Abatacept|abatacept|mesh-list
101229780|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101229781|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229782|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101229783|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229784|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229785|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
101229786|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229787|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229788|NCT01555918|Isavuconazole|isavuconazole|mesh-list
101229789|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
101229790|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229791|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
101229792|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101229793|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
101229794|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229795|NCT01555970|Expectorants|expectorants|mesh-ancestor
101229796|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
101229797|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101464602|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101229798|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
101229799|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229801|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229802|NCT01555970|Antidotes|antidotes|mesh-ancestor
101229803|NCT01556035|Lenalidomide|lenalidomide|mesh-list
101229804|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
101229805|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229806|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229807|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229808|NCT01556035|Growth Substances|growth substances|mesh-ancestor
101229809|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229810|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229811|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101229812|NCT01556191|Fulvestrant|fulvestrant|mesh-list
101229813|NCT01556191|Gefitinib|gefitinib|mesh-list
101464662|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229814|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229815|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101229816|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229817|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229818|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229819|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101229820|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101229821|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229822|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229823|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229824|NCT01556321|Caffeine|caffeine|mesh-list
101229825|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101229826|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229827|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101229828|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229829|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229830|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101359892|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229831|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101229832|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
101229833|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229834|NCT01556334|Azithromycin|azithromycin|mesh-list
101229838|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
101229839|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229840|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229841|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229842|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101229843|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229844|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229845|NCT01556477|Lenalidomide|lenalidomide|mesh-list
101229846|NCT01556477|Azacitidine|azacitidine|mesh-list
101229847|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
101359896|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
101229849|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229850|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229851|NCT01556477|Growth Substances|growth substances|mesh-ancestor
101229852|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229853|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229854|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229855|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
101229856|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229857|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229858|NCT01556529|Unithiol|unithiol|mesh-list
101229859|NCT01556529|Antidotes|antidotes|mesh-ancestor
101229860|NCT01556529|Protective Agents|protective agents|mesh-ancestor
101229861|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229862|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
101229863|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
101229864|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229865|NCT01556542|Paclitaxel|paclitaxel|mesh-list
101229866|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101229867|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229868|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101229869|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101229870|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101229871|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229872|NCT05847660|Cetrorelix|cetrorelix|mesh-list
101229873|NCT05847660|Progesterone|progesterone|mesh-list
101229874|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
101229875|NCT05847660|Progestins|progestins|mesh-ancestor
101229876|NCT05847660|Hormones|hormones|mesh-ancestor
101464983|NCT04721054|Bupivacaine|bupivacaine|mesh-list
101229877|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229878|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229879|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101229881|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101229882|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229883|NCT05847413|Verapamil|verapamil|mesh-list
101229884|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101229885|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101229886|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229887|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229888|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229889|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229890|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
101229891|NCT05847322|Azithromycin|azithromycin|mesh-list
101229892|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101229893|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101229894|NCT05847257|Ubiquinone|ubiquinone|mesh-list
101229895|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
101229896|NCT05847257|Letrozole|letrozole|mesh-list
101229897|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229898|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101229899|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101229900|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229901|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229902|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101359950|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
101229903|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229904|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229905|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229908|NCT05847244|Metformin|metformin|mesh-list
101229909|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101229910|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229911|NCT05847205|Hirudins|hirudins|mesh-list
101229912|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
101229913|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101229914|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229915|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229916|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229917|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
101229918|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101229919|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101229920|NCT05847088|Dexamethasone|dexamethasone|mesh-list
101229921|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229923|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
101229924|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229925|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229926|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101229927|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
101229928|NCT05847088|Hormones|hormones|mesh-ancestor
101229929|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229930|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101229931|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465184|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101229932|NCT05847049|Nepafenac|nepafenac|mesh-list
101229933|NCT05847049|Aflibercept|aflibercept|mesh-list
101229934|NCT05847049|Eplerenone|eplerenone|mesh-list
101229935|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101229936|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101229937|NCT05847049|Growth Substances|growth substances|mesh-ancestor
101229938|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229939|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
101229940|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465249|NCT04548271|Apatinib|apatinib|mesh-list
101229941|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101229942|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
101229943|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101229944|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101229945|NCT05847049|Diuretics|diuretics|mesh-ancestor
101229946|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
101229947|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101229948|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101229949|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101229950|NCT05847049|Analgesics|analgesics|mesh-ancestor
101229951|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
101229952|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101229953|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101229954|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101229955|NCT05846867|Leucovorin|leucovorin|mesh-list
101229956|NCT05846867|Fluorouracil|fluorouracil|mesh-list
101229957|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
101229958|NCT05846867|Irinotecan|irinotecan|mesh-list
101229959|NCT05846867|Calcium|calcium|mesh-list
101229960|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
101465311|NCT00269061|Pioglitazone|pioglitazone|mesh-list
101229961|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101229962|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229963|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
101229964|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229965|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101229966|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101229967|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101229968|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
101229969|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101229970|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101229971|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229973|NCT05846867|Protective Agents|protective agents|mesh-ancestor
101229974|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
101229975|NCT05846867|Vitamins|vitamins|mesh-ancestor
101229976|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
101229977|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
101229978|NCT05840744|Antithrombins|antithrombins|mesh-list
101229979|NCT05840744|Thrombin|thrombin|mesh-list
101229980|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
101229981|NCT05840744|Coagulants|coagulants|mesh-ancestor
101229982|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101229983|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
101229984|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101229985|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229986|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
101229988|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101229989|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101229990|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101229991|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101229992|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101229993|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
101465474|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
101229994|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101229995|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
101229996|NCT05840640|Lenograstim|lenograstim|mesh-list
101229997|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101229998|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
101229999|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230000|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101230001|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230002|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
101230003|NCT05840536|Furosemide|furosemide|mesh-list
101230004|NCT05840536|Diuretics|diuretics|mesh-ancestor
101230005|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
101230006|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230007|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101230008|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230009|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230010|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101230011|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101230012|NCT05840406|Acetaminophen|acetaminophen|mesh-list
101465610|NCT00236912|Metronidazole|metronidazole|mesh-list
101230014|NCT05840406|Ketoprofen|ketoprofen|mesh-list
101230015|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
101230016|NCT05840406|Tramadol|tramadol|mesh-list
101230017|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
101230018|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101230019|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230020|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230021|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101230022|NCT05840406|Analgesics|analgesics|mesh-ancestor
101230023|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
101230024|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230025|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101230026|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230027|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230028|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230029|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230030|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230031|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
101465665|NCT04544059|Lenalidomide|lenalidomide|mesh-list
101465666|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
101230032|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101230033|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230034|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230035|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101230036|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230037|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101230038|NCT05840406|Narcotics|narcotics|mesh-ancestor
101230039|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230040|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
101230041|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
101230042|NCT05840328|Bupivacaine|bupivacaine|mesh-list
101230043|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230044|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
101230045|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230046|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360015|NCT00212212|Selenium|selenium|mesh-list
101230048|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230049|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101230050|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101230051|NCT05840328|Analgesics|analgesics|mesh-ancestor
101230052|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101230053|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230054|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230055|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230056|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230057|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230059|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230060|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
101230061|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230062|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230063|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
101230064|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230065|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101230066|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101230067|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230068|NCT05839899|Misoprostol|misoprostol|mesh-list
101230069|NCT05839899|Mifepristone|mifepristone|mesh-list
101230070|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101230071|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
101230072|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101230073|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230074|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101230075|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230076|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
101230077|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101230078|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101230079|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101230080|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101230081|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
101230082|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101230083|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101230084|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
101230085|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230086|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
101230087|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101230088|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101230089|NCT05839652|Midodrine|midodrine|mesh-list
101230090|NCT05839652|Droxidopa|droxidopa|mesh-list
101230091|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
101230092|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
101466117|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230093|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230094|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230096|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101230097|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230098|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230099|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230100|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230101|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230102|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101230103|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101230104|NCT05839574|Letrozole|letrozole|mesh-list
101230105|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230107|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101230108|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230109|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230110|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101230111|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
101230112|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230113|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230114|NCT05839561|Letrozole|letrozole|mesh-list
101230115|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230116|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101230117|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101230118|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230119|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230120|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101230121|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466469|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230122|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230123|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230124|NCT05839548|Epinephrine|epinephrine|mesh-list
101230125|NCT05839548|Racepinephrine|racepinephrine|mesh-list
101230126|NCT05839548|Mepivacaine|mepivacaine|mesh-list
101230128|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
101230129|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230130|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230131|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230132|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230133|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230134|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230135|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101230136|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101230137|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
101230138|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230139|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101230140|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
101230141|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
101230142|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
101230143|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101360110|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230144|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230145|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
101230146|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230147|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
101230148|NCT05839522|Antibodies|antibodies|mesh-list
101230149|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
101230150|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
101230151|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
101230152|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
101230153|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230154|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
101230156|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230157|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101230158|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101230159|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
101230160|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230161|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230162|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101230163|NCT05839470|Leucovorin|leucovorin|mesh-list
101230164|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
101230165|NCT05839470|Irinotecan|irinotecan|mesh-list
101230166|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
101230167|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230168|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101230169|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101230170|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230171|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230172|NCT05839470|Antidotes|antidotes|mesh-ancestor
101230173|NCT05839470|Protective Agents|protective agents|mesh-ancestor
101230174|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230175|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
101230176|NCT05839470|Vitamins|vitamins|mesh-ancestor
101360129|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230177|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
101230178|NCT05839236|Atorvastatin|atorvastatin|mesh-list
101230179|NCT05839236|Calcium|calcium|mesh-list
101230180|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101230181|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230182|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101230183|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101360140|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
101230184|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
101230185|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230186|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101230187|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101230188|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230189|NCT05839197|Apatinib|apatinib|mesh-list
101466953|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230190|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230191|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230192|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230193|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230199|NCT05839054|Methamphetamine|methamphetamine|mesh-list
101230200|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101230201|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467026|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467027|NCT04923776|Carboplatin|carboplatin|mesh-list
101230202|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
101230203|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
101230204|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230206|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230207|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230208|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230209|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101230210|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101230213|NCT05838846|Milrinone|milrinone|mesh-list
101230214|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101230215|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101230216|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
101230217|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101230218|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101230219|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230220|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230221|NCT05838846|Protective Agents|protective agents|mesh-ancestor
101230222|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230223|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
101230224|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
101230225|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
101230226|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101230227|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467152|NCT04613596|Pemetrexed|pemetrexed|mesh-list
101230244|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230245|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
101230246|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230247|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230248|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
101230249|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230250|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230251|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230252|NCT05823753|Cannabidiol|cannabidiol|mesh-list
101230253|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
101230254|NCT05823311|Cisplatin|cisplatin|mesh-list
101230255|NCT05823311|Gemcitabine|gemcitabine|mesh-list
101230256|NCT05823311|Lenvatinib|lenvatinib|mesh-list
101230257|NCT05823311|Tislelizumab|tislelizumab|mesh-list
101230258|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230259|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101230260|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
101230261|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230262|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230263|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230264|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230265|NCT05813158|Bupivacaine|bupivacaine|mesh-list
101230266|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230267|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
101230268|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230269|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230270|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
101230271|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230272|NCT05805683|Calcitonin|calcitonin|mesh-list
101230273|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
101230274|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101230275|NCT05805683|Katacalcin|katacalcin|mesh-list
101230276|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101230277|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230278|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101230279|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101230281|NCT05782361|Tepotinib|tepotinib|mesh-list
101230282|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230283|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230284|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230285|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230286|NCT05780801|Glycerol|glycerol|mesh-list
101230287|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101230288|NCT05780801|Protective Agents|protective agents|mesh-ancestor
101230289|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230290|NCT05753670|Tamsulosin|tamsulosin|mesh-list
101230291|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101230292|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101467464|NCT02952534|Rucaparib|rucaparib|mesh-list
101230293|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101230294|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230295|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230296|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230297|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230298|NCT05753670|Urological Agents|urological agents|mesh-ancestor
101230299|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
101230300|NCT05753059|Amiloride|amiloride|mesh-list
101230301|NCT05753059|Diuretics|diuretics|mesh-ancestor
101230302|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
101230303|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230304|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101230305|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101230306|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230307|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230308|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101230309|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101230310|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467572|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230311|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101230312|NCT05726032|Empagliflozin|empagliflozin|mesh-list
101230313|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101230314|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230315|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101230316|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230317|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
101230318|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101230319|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101230320|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230321|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
101230322|NCT05686005|Coagulants|coagulants|mesh-ancestor
101230323|NCT05671991|Empagliflozin|empagliflozin|mesh-list
101230324|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101321914|NCT04762953|Paclitaxel|paclitaxel|mesh-list
101230325|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230326|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101230327|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230329|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101230330|NCT05660681|Protective Agents|protective agents|mesh-ancestor
101230331|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230332|NCT05624268|Psilocybin|psilocybin|mesh-list
101230333|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
101230334|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230335|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101230336|NCT05600114|Cannabidiol|cannabidiol|mesh-list
101467626|NCT00915837|Triamcinolone|triamcinolone|mesh-list
101230337|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101230338|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
101230340|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101230341|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101230342|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101230343|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
101230344|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230345|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101230346|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230347|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467666|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230348|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101230349|NCT05585112|Lidocaine|lidocaine|mesh-list
101230350|NCT05585112|Carticaine|carticaine|mesh-list
101230351|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
101230352|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
101230353|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230355|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
101230356|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230357|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101230358|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101230359|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101230360|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230361|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230362|NCT05552443|Hydromorphone|hydromorphone|mesh-list
101230363|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101230364|NCT05552443|Narcotics|narcotics|mesh-ancestor
101230365|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230366|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230367|NCT05552443|Analgesics|analgesics|mesh-ancestor
101230368|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
101230369|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230370|NCT05527483|Listerine|listerine|mesh-list
101230371|NCT05527483|Fluorides|fluorides|mesh-list
101230372|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
101230373|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
101230374|NCT05527483|Protective Agents|protective agents|mesh-ancestor
101230375|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230376|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101230377|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230379|NCT05527470|Gemcitabine|gemcitabine|mesh-list
101230380|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230381|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101230382|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
101230383|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230384|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101230385|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
101230386|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230387|NCT05458102|Voriconazole|voriconazole|mesh-list
101230388|NCT05458102|Cobicistat|cobicistat|mesh-list
101230389|NCT05458102|Rifabutin|rifabutin|mesh-list
101230390|NCT05458102|Vesatolimod|vesatolimod|mesh-list
101230391|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
101230392|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230393|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101230394|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101230395|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230396|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230397|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101230398|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
101230399|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230400|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230401|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101230403|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101230404|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
101230405|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101230406|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101230407|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
101230408|NCT05439356|Colchicine|colchicine|mesh-list
101230409|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
101230410|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230411|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
101230412|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
101230413|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
101230414|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230415|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230416|NCT05335356|Ustekinumab|ustekinumab|mesh-list
101230417|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
101230418|NCT05323487|Bumetanide|bumetanide|mesh-list
101230419|NCT05323487|Diuretics|diuretics|mesh-ancestor
101230420|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
101230421|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230422|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101230423|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230424|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230433|NCT05301322|Vaccines|vaccines|mesh-list
101468055|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
101230434|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
101230435|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230436|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101230437|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
101230438|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230439|NCT05266807|Vancomycin|vancomycin|mesh-list
101230440|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
101230441|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101468116|NCT01645423|Atorvastatin|atorvastatin|mesh-list
101230442|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230444|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101230445|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230446|NCT05224050|Nicotine|nicotine|mesh-list
101230447|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101230448|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
101230449|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230450|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230451|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101230452|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101230453|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
101230454|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230455|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468179|NCT01647256|Nikkomycin|nikkomycin|mesh-list
101230456|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
101230457|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101230458|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101230459|NCT05150704|Prednisolone|prednisolone|mesh-list
101230460|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
101230461|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101230462|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
101230463|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230464|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
101230465|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
101230466|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230467|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230469|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
101230470|NCT05150704|Hormones|hormones|mesh-ancestor
101230472|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101230473|NCT05150704|Protective Agents|protective agents|mesh-ancestor
101230474|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101230475|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230476|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101230477|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101230478|NCT05116241|Vaccines|vaccines|mesh-list
101230479|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
101230480|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230482|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101230483|NCT05095259|Epinephrine|epinephrine|mesh-list
101230484|NCT05095259|Glucagon|glucagon|mesh-list
101230485|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101230486|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230487|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230488|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230489|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230490|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230491|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468368|NCT02279563|Xhance|xhance|mesh-list
101230493|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101230494|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
101230495|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230496|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101230497|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101230498|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
101230499|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
101230500|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101230501|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230502|NCT05095259|Hormones|hormones|mesh-ancestor
101468423|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
101230503|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230504|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
101230505|NCT05064280|Lenvatinib|lenvatinib|mesh-list
101230506|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230507|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230508|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230509|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230510|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230511|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360375|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230513|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
101230514|NCT05049278|Norepinephrine|norepinephrine|mesh-list
101230515|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101230516|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
101230517|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
101230518|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230519|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230520|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
101230521|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101230522|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
101360385|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230523|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
101230524|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101230525|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230526|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230527|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230528|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230529|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230530|NCT05049278|Protective Agents|protective agents|mesh-ancestor
101230532|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101230533|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
101230534|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101230535|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230536|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101230537|NCT04982614|Vaccines|vaccines|mesh-list
101230538|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
101230539|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230540|NCT04982354|Fludarabine|fludarabine|mesh-list
101230541|NCT04982354|Melphalan|melphalan|mesh-list
101230542|NCT04982354|Busulfan|busulfan|mesh-list
101230543|NCT04982354|Midostaurin|midostaurin|mesh-list
101230544|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321923|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
101230545|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230547|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
101230548|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230549|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101230550|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
101230551|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101230552|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230553|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230554|NCT04953754|Melatonin|melatonin|mesh-list
101230555|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
101230556|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230558|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230559|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230560|NCT04932382|Misoprostol|misoprostol|mesh-list
101230561|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101230562|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
101230563|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101230564|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230565|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101230566|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230567|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
101230568|NCT04909801|Adalimumab|adalimumab|mesh-list
101230569|NCT04909801|Methotrexate|methotrexate|mesh-list
101230570|NCT04909801|Abatacept|abatacept|mesh-list
101230571|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101230572|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
101230573|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101230574|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230575|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101230576|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
101230577|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230578|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230579|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101230580|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230581|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101230582|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230583|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
101230584|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230585|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101230586|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101230587|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230588|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230589|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230591|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101230592|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
101468916|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101230593|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230594|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230595|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101230596|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
101230597|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
101230598|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101230599|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101230600|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101230601|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230602|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230603|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230604|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230605|NCT04895592|Dexamethasone|dexamethasone|mesh-list
101230606|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
101230608|NCT04895592|BB 1101|bb 1101|mesh-list
101230609|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230610|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
101230611|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
101230612|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230613|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230614|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230615|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
101230616|NCT04895592|Hormones|hormones|mesh-ancestor
101230617|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230618|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101230619|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230620|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230621|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230622|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230623|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
101230624|NCT04861103|Enoxaparin|enoxaparin|mesh-list
101230625|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
101230626|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101230627|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101230628|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230630|NCT04843761|Phentolamine|phentolamine|mesh-list
101230631|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101230632|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
101230633|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230634|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
101230635|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230636|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101230637|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101230638|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230639|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469143|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230640|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230641|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101230642|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230643|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
101230644|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101230645|NCT04843761|Protective Agents|protective agents|mesh-ancestor
101230646|NCT04835129|Dexamethasone|dexamethasone|mesh-list
101230647|NCT04835129|Pomalidomide|pomalidomide|mesh-list
101230648|NCT04835129|Elotuzumab|elotuzumab|mesh-list
101230649|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101230650|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230651|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
101230652|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
101230653|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230654|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230655|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230656|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
101230657|NCT04835129|Hormones|hormones|mesh-ancestor
101230658|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230659|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101230660|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230661|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
101230662|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101469262|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
101230663|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101230664|NCT04835129|Growth Substances|growth substances|mesh-ancestor
101230665|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
101230666|NCT04799249|Carboplatin|carboplatin|mesh-list
101230667|NCT04799249|Gemcitabine|gemcitabine|mesh-list
101230668|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230669|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101230670|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
101230671|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230673|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101230674|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101230675|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101469350|NCT00244127|Vincristine|vincristine|mesh-list
101230676|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
101469362|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
101230677|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230678|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101230679|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230680|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230681|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101230682|NCT04699604|Levocetirizine|levocetirizine|mesh-list
101230683|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101230684|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101230685|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
101230686|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
101230687|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230690|NCT04614974|Famotidine|famotidine|mesh-list
101230691|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101230692|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230693|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101230694|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
101230695|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
101230696|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230697|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230698|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230699|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
101230700|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230701|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230702|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230703|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230704|NCT04603066|Ondansetron|ondansetron|mesh-list
101230705|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
101230706|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
101230707|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230708|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230709|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230710|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
101230711|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
101230712|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101230713|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101230714|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
101230715|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230716|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230717|NCT04591431|Nivolumab|nivolumab|mesh-list
101230718|NCT04591431|Trastuzumab|trastuzumab|mesh-list
101230720|NCT04591431|Atezolizumab|atezolizumab|mesh-list
101230721|NCT04591431|Pertuzumab|pertuzumab|mesh-list
101230722|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101230723|NCT04591431|Everolimus|everolimus|mesh-list
101230724|NCT04591431|Palbociclib|palbociclib|mesh-list
101230725|NCT04591431|Lapatinib|lapatinib|mesh-list
101230726|NCT04591431|Vemurafenib|vemurafenib|mesh-list
101230727|NCT04591431|Maytansine|maytansine|mesh-list
101230728|NCT04591431|Talazoparib|talazoparib|mesh-list
101230729|NCT04591431|Ponatinib|ponatinib|mesh-list
101230730|NCT04591431|Ipatasertib|ipatasertib|mesh-list
101230731|NCT04591431|Tepotinib|tepotinib|mesh-list
101230732|NCT04591431|Pralsetinib|pralsetinib|mesh-list
101230733|NCT04591431|Entrectinib|entrectinib|mesh-list
101230734|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230735|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230736|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230737|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230738|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101230739|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230740|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230741|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230742|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
101230743|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230744|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101230745|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
101230746|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
101230747|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
101230748|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
101230749|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
101230750|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101230751|NCT04571164|Rotigotine|rotigotine|mesh-list
101230752|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
101230753|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
101230754|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230755|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230756|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230758|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101230759|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101230760|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230761|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
101230762|NCT04559880|Coagulants|coagulants|mesh-ancestor
101230763|NCT04542369|Carboplatin|carboplatin|mesh-list
101230764|NCT04542369|Etoposide|etoposide|mesh-list
101230765|NCT04542369|Tislelizumab|tislelizumab|mesh-list
101230766|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230767|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101230768|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101230769|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101230770|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230771|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230772|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230773|NCT04496596|Suramin|suramin|mesh-list
101230774|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
101230775|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
101469878|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230776|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101230777|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230778|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230779|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101230780|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101230781|NCT04477850|Luspatercept|luspatercept|mesh-list
101230782|NCT04477850|Hematinics|hematinics|mesh-ancestor
101230783|NCT04346654|Dexamethasone|dexamethasone|mesh-list
101230784|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230785|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
101469936|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101230786|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
101230787|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230788|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230789|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230790|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
101230791|NCT04346654|Hormones|hormones|mesh-ancestor
101230792|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101230793|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101230794|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230795|NCT04312503|Olanzapine|olanzapine|mesh-list
101230796|NCT04312503|Risperidone|risperidone|mesh-list
101230797|NCT04312503|Aripiprazole|aripiprazole|mesh-list
101230798|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101230799|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101230800|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101230801|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
101230802|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528324|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101469997|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469998|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230803|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230804|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230805|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101230806|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101230807|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230808|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101230809|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101230810|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
101230811|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
101230812|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
101230813|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230814|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101230815|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101321950|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230816|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101230817|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230818|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
101230819|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
101230820|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101230821|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101230822|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101230823|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101230824|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101230825|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101230826|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101230827|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230828|NCT04310540|Edetic Acid|edetic acid|mesh-list
101230829|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101230830|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
101470107|NCT00247481|Docetaxel|docetaxel|mesh-list
101230831|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
101230832|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230833|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
101230834|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101230835|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101230836|NCT04305444|Everolimus|everolimus|mesh-list
101230837|NCT04305444|Pomalidomide|pomalidomide|mesh-list
101230838|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101230839|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230840|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230841|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230842|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230843|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
101230844|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230845|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230846|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101230847|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101230848|NCT04305444|Growth Substances|growth substances|mesh-ancestor
101230849|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
101230850|NCT04297332|Nicotine|nicotine|mesh-list
101230851|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101230852|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
101230853|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230854|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230855|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101230856|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101230857|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
101230858|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230859|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230861|NCT04273776|Suvorexant|suvorexant|mesh-list
101230862|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101230863|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101230864|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230865|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230866|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101230867|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
101230868|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
101230869|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230870|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230871|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101230872|NCT04249063|Lidocaine|lidocaine|mesh-list
101230873|NCT04249063|Anesthetics|anesthetics|mesh-list
101230874|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
101230875|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101230876|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230877|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
101230878|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230879|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101230880|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101230881|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101230882|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101230883|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230884|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
101230885|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101230887|NCT04245722|Fludarabine|fludarabine|mesh-list
101230888|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
101230889|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230890|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
101230891|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230892|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230893|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101230894|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
101230895|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230896|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470465|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230897|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101230898|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230899|NCT04239040|Nivolumab|nivolumab|mesh-list
101230900|NCT04239040|Ipilimumab|ipilimumab|mesh-list
101230901|NCT04239040|Vaccines|vaccines|mesh-list
101230902|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
101230903|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230904|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230905|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230906|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230907|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230908|NCT04205409|Nivolumab|nivolumab|mesh-list
101230909|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101230910|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230911|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101230912|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230913|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101230914|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
101230915|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101230916|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101230917|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230918|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230919|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230920|NCT04198116|Guanfacine|guanfacine|mesh-list
101230921|NCT04198116|Varenicline|varenicline|mesh-list
101230922|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101230923|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101230924|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
101470572|NCT00249860|Ribavirin|ribavirin|mesh-list
101230925|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360657|NCT00217555|Topotecan|topotecan|mesh-list
101230926|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230927|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230928|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101230929|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101230930|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101230931|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101230932|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230934|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101230935|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101230936|NCT04192955|Analgesics|analgesics|mesh-ancestor
101230938|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101230939|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230940|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101230941|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230942|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101230943|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230944|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230945|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101230946|NCT04184869|Belinostat|belinostat|mesh-list
101230947|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101230948|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101230949|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
101230950|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230951|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230953|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101230954|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
101230955|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101230956|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230957|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101230958|NCT04175262|Sunitinib|sunitinib|mesh-list
101230959|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230961|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101470824|NCT01640002|Bromides|bromides|mesh-list
101230962|NCT04175262|Growth Substances|growth substances|mesh-ancestor
101230963|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230964|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101230965|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101230966|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101230967|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230969|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101230970|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101230971|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
101230972|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101230973|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101230974|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230975|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101230976|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101230977|NCT04137536|Antibodies|antibodies|mesh-list
101230978|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101230979|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
101230980|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230981|NCT04087421|Glycerol|glycerol|mesh-list
101230982|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101230983|NCT04087421|Protective Agents|protective agents|mesh-ancestor
101230984|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230985|NCT04080531|Vaccines|vaccines|mesh-list
101230986|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
101230987|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230988|NCT04070378|Daratumumab|daratumumab|mesh-list
101230989|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101230991|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101230992|NCT04023071|Rituximab|rituximab|mesh-list
101230993|NCT04023071|Fludarabine|fludarabine|mesh-list
101230994|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
101230995|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101230996|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
101230997|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101230998|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101230999|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101231000|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
101231001|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231002|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231003|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101231004|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231005|NCT04014075|Trastuzumab|trastuzumab|mesh-list
101231006|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101231007|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231008|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231009|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
101231010|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
101231011|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231012|NCT04009109|Dexamethasone|dexamethasone|mesh-list
101231013|NCT04009109|Lenalidomide|lenalidomide|mesh-list
101231014|NCT04009109|Daratumumab|daratumumab|mesh-list
101231015|NCT04009109|Ixazomib|ixazomib|mesh-list
101231016|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231017|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
101231018|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
101231019|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231020|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231021|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231022|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
101231023|NCT04009109|Hormones|hormones|mesh-ancestor
101321967|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231024|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231025|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231026|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231027|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
101231028|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101231029|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101231030|NCT04009109|Growth Substances|growth substances|mesh-ancestor
101231031|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
101231032|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
101231033|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231034|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231036|NCT03983993|Niraparib|niraparib|mesh-list
101231037|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231038|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231039|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101231040|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231041|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231042|NCT03964090|Cytarabine|cytarabine|mesh-list
101231043|NCT03964090|Isavuconazole|isavuconazole|mesh-list
101231044|NCT03964090|Methotrexate|methotrexate|mesh-list
101231045|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101231046|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
101231047|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101231048|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231049|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101231050|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
101231051|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231052|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471406|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
101231053|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231054|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231055|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101231056|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231057|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
101231058|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231059|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101231060|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
101231061|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231062|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
101231063|NCT03944577|Evolocumab|evolocumab|mesh-list
101231064|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101231065|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101231066|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101231067|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
101231068|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231069|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101231070|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
101231071|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231072|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101231073|NCT03909152|Anastrozole|anastrozole|mesh-list
101231074|NCT03909152|Onapristone|onapristone|mesh-list
101231075|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231076|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231077|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101231078|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101231079|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231080|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231081|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101231082|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
101231083|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231084|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231085|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101231086|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
101231087|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101231088|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101471765|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101231090|NCT03778424|Rufinamide|rufinamide|mesh-list
101231091|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
101231092|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101231093|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101231094|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231095|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231096|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101471829|NCT00253175|Topiramate|topiramate|mesh-list
101231097|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231098|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
101231100|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
101231101|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
101231102|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231103|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231104|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101471893|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
101471900|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231108|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101231109|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101231110|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471959|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231123|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101231124|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231125|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231126|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101231127|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101231128|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
101231129|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231131|NCT03664180|Calcium heparin|calcium heparin|mesh-list
101231132|NCT03664180|Enoxaparin|enoxaparin|mesh-list
101231133|NCT03664180|Hirudins|hirudins|mesh-list
101231134|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
101231135|NCT03664180|Bivalirudin|bivalirudin|mesh-list
101231136|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
101231137|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101231138|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101231139|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231140|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
101231141|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101231142|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
101231143|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231144|NCT03652870|Dexetimide|dexetimide|mesh-list
101231145|NCT03652870|Citalopram|citalopram|mesh-list
101231146|NCT03652870|Nortriptyline|nortriptyline|mesh-list
101231147|NCT03652870|Escitalopram|escitalopram|mesh-list
101231148|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101231149|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101231150|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231151|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231152|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231153|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
101231154|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231157|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
101231158|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
101472070|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
101231159|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231160|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101231161|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101231162|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
101231163|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101231164|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101231165|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101231166|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101231167|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101231168|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
101231170|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101231171|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
101231172|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
101231173|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472116|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101231174|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231175|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
101231176|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231177|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231178|NCT03648905|Protective Agents|protective agents|mesh-ancestor
101231179|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
101231180|NCT03634852|Dexamethasone|dexamethasone|mesh-list
101231181|NCT03634852|Triamcinolone|triamcinolone|mesh-list
101231182|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101231183|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101231184|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101231185|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101231186|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101231187|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231188|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
101231189|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
101231190|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231191|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231192|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231193|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
101231195|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231196|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231197|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231198|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101231199|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231200|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231201|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101231202|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231203|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231204|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101231205|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
101231206|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101231207|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101231208|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101231209|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101231210|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231211|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
101231212|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101231213|NCT03625986|Nicotine|nicotine|mesh-list
101231214|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101231215|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
101231216|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231217|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231218|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101231219|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101231220|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
101231222|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231224|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231225|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101231226|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
101231227|NCT03593811|Ondansetron|ondansetron|mesh-list
101231228|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
101231229|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
101231230|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231231|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231232|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231233|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
101231234|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231235|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101231236|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101321979|NCT00006122|Analgesics|analgesics|mesh-ancestor
101231237|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
101231238|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472429|NCT01601314|Analgesics|analgesics|mesh-ancestor
101231239|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231240|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101231241|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
101472433|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
101231242|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
101231243|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101231244|NCT03588754|Propranolol|propranolol|mesh-list
101231245|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101231246|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101231247|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101231248|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231249|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231250|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231251|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101231252|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231253|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
101231254|NCT03569085|Sevoflurane|sevoflurane|mesh-list
101231256|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101231257|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101231258|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
101231259|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
101231260|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231261|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231262|NCT03564340|Cemiplimab|cemiplimab|mesh-list
101231263|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231264|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231265|NCT03552575|Valsartan|valsartan|mesh-list
101231266|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101231267|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231268|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101231269|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101231270|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231271|NCT03528902|Tamoxifen|tamoxifen|mesh-list
101231272|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101231273|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
101231274|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231275|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231276|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231277|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231278|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101472607|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
101231279|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101231280|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101231282|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101231284|NCT03495388|Oxycodone|oxycodone|mesh-list
101231285|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101231286|NCT03495388|Narcotics|narcotics|mesh-ancestor
101231287|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231288|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231289|NCT03495388|Analgesics|analgesics|mesh-ancestor
101231290|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
101231291|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231293|NCT03463408|Ipilimumab|ipilimumab|mesh-list
101231294|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231295|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231296|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101472733|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
101231297|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231298|NCT03420144|Hormones|hormones|mesh-list
101231299|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231300|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231301|NCT03418038|Vitamins|vitamins|mesh-list
101231302|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
101231303|NCT03418038|Cytarabine|cytarabine|mesh-list
101231304|NCT03418038|Dexamethasone|dexamethasone|mesh-list
101231305|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
101231306|NCT03418038|Rituximab|rituximab|mesh-list
101231307|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101231308|NCT03418038|Cisplatin|cisplatin|mesh-list
101231309|NCT03418038|Carboplatin|carboplatin|mesh-list
101231310|NCT03418038|Gemcitabine|gemcitabine|mesh-list
101231311|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
101231312|NCT03418038|Etoposide|etoposide|mesh-list
101472828|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231313|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
101231314|NCT03418038|Ifosfamide|ifosfamide|mesh-list
101231315|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
101231316|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
101231317|NCT03418038|Antibodies|antibodies|mesh-list
101231318|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
101231319|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101231320|NCT03418038|BB 1101|bb 1101|mesh-list
101231321|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
101231322|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231323|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
101231324|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231325|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231326|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231327|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
101472896|NCT01609387|Vitamins|vitamins|mesh-ancestor
101231328|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
101231329|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231330|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231331|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
101231332|NCT03418038|Hormones|hormones|mesh-ancestor
101231333|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231334|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231335|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
101231336|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231337|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472940|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
101472950|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
101231338|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101231339|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
101231340|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101231341|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231342|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101231343|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
101231344|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231345|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231346|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
101231347|NCT03418038|Protective Agents|protective agents|mesh-ancestor
101231348|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101231349|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
101231350|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
101231351|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231352|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101231353|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101231354|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101231355|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
101231356|NCT03386539|Everolimus|everolimus|mesh-list
101231357|NCT03386539|Tacrolimus|tacrolimus|mesh-list
101231358|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231359|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
101231360|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231361|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101231362|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231363|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231364|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101231365|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231366|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231367|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231368|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101231369|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
101231370|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101231371|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231373|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101231374|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231375|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231376|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
101231377|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231378|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473220|NCT00271206|Hormones|hormones|mesh-ancestor
101231379|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101231380|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
101231381|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231382|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
101231383|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
101231384|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231385|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231386|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101473279|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
101473280|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101231387|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231388|NCT03366103|Navitoclax|navitoclax|mesh-list
101231389|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231390|NCT03344419|Ketamine|ketamine|mesh-list
101231391|NCT03344419|Analgesics|analgesics|mesh-ancestor
101231392|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
101231393|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231394|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231395|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101231397|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
101231398|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
101231399|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231400|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101231401|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101231402|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231403|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231404|NCT03321526|Norepinephrine|norepinephrine|mesh-list
101231405|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101231406|NCT03321526|Serotonin|serotonin|mesh-list
101231407|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101231409|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101231410|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101231411|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101231412|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231413|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231414|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101231415|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101231416|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101231417|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231418|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231419|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
101231420|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
101231421|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231422|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101231423|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101231425|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101231426|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231427|NCT03297593|Nivolumab|nivolumab|mesh-list
101231428|NCT03297593|Ipilimumab|ipilimumab|mesh-list
101231429|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101473610|NCT00290823|Dexamethasone|dexamethasone|mesh-list
101231430|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231431|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231432|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231433|NCT03263650|Prednisone|prednisone|mesh-list
101231434|NCT03263650|Carboplatin|carboplatin|mesh-list
101231435|NCT03263650|Olaparib|olaparib|mesh-list
101231436|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231437|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231438|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
101231439|NCT03263650|Hormones|hormones|mesh-ancestor
101231440|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231441|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231442|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231443|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101231444|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231445|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231446|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101231447|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
101231448|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
101231449|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231450|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
101231451|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101231452|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101231453|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
101231454|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231455|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231456|NCT03217669|Sirolimus|sirolimus|mesh-list
101231457|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101231458|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231459|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231460|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473791|NCT00258245|Thalidomide|thalidomide|mesh-list
101473792|NCT00258245|Dexamethasone|dexamethasone|mesh-list
101231461|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
101231462|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231463|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
101231464|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231465|NCT03196427|Vedolizumab|vedolizumab|mesh-list
101231466|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231467|NCT03185819|Midazolam|midazolam|mesh-list
101231468|NCT03185819|Esketamine|esketamine|mesh-list
101231469|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101231470|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101231471|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231472|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231473|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101231474|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101231475|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101231476|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101231477|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
101231478|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
101231479|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
101231480|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
101231481|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231482|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231483|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
101231484|NCT03153111|Macitentan|macitentan|mesh-list
101231485|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101231486|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101231487|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231488|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101231489|NCT03126435|Gemcitabine|gemcitabine|mesh-list
101231490|NCT03126435|Paclitaxel|paclitaxel|mesh-list
101231491|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101231492|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
101473970|NCT01334710|Sorafenib|sorafenib|mesh-list
101231493|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231494|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231495|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101231496|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
101231497|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
101231498|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
101231499|NCT03119584|Linaclotide|linaclotide|mesh-list
101231500|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101231501|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
101231502|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231503|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231504|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
101231505|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231506|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474016|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231507|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231508|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231509|NCT03084939|Capecitabine|capecitabine|mesh-list
101231510|NCT03084939|Trastuzumab|trastuzumab|mesh-list
101231512|NCT03084939|Maytansine|maytansine|mesh-list
101231513|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101474071|NCT01332292|Fluticasone|fluticasone|mesh-list
101231514|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101231515|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
101231516|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231517|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231518|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231519|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231520|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231521|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101231522|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
101231523|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
101231524|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
101231526|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
101231527|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
101231528|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231529|NCT03047005|Naltrexone|naltrexone|mesh-list
101231530|NCT03047005|Bupropion|bupropion|mesh-list
101231531|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101231532|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101474217|NCT00259766|Budesonide|budesonide|mesh-list
101231533|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231535|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231536|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101231537|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
101231538|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101231539|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101231540|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101231541|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231542|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231543|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
101231544|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231545|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101231546|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101231547|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231549|NCT03020030|Cytarabine|cytarabine|mesh-list
101231550|NCT03020030|Dexamethasone|dexamethasone|mesh-list
101231551|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
101231553|NCT03020030|Doxorubicin|doxorubicin|mesh-list
101231554|NCT03020030|Methotrexate|methotrexate|mesh-list
101231555|NCT03020030|Etoposide|etoposide|mesh-list
101231556|NCT03020030|Vincristine|vincristine|mesh-list
101231557|NCT03020030|Asparaginase|asparaginase|mesh-list
101231558|NCT03020030|Dasatinib|dasatinib|mesh-list
101231559|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
101231560|NCT03020030|Pegaspargase|pegaspargase|mesh-list
101231561|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
101231562|NCT03020030|Razoxane|razoxane|mesh-list
101231563|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
101231564|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231565|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
101231566|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231567|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231568|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101231569|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
101231570|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231571|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231572|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101231573|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231575|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
101231576|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231577|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101231578|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
101231579|NCT03020030|Hormones|hormones|mesh-ancestor
101231580|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231581|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231582|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231583|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231584|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101231585|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231586|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101231587|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
101231588|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101231589|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101231590|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
101231591|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231592|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101231593|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101231594|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101231595|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
101231596|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231597|NCT03020030|Antidotes|antidotes|mesh-ancestor
101231598|NCT03020030|Protective Agents|protective agents|mesh-ancestor
101231599|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
101231600|NCT03020030|Vitamins|vitamins|mesh-ancestor
101231601|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
101231603|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
101231604|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
101231605|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231606|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101231607|NCT03011684|Tamoxifen|tamoxifen|mesh-list
101231608|NCT03011684|Letrozole|letrozole|mesh-list
101231609|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231610|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101231611|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101231612|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231613|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231614|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101231615|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101474673|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
101231616|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231617|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231618|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231619|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101231620|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101231636|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231637|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
101231638|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231639|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231640|NCT02946996|Metformin|metformin|mesh-list
101231641|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101231642|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231643|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
101231644|NCT02870907|Thiotepa|thiotepa|mesh-list
101231645|NCT02870907|Carboplatin|carboplatin|mesh-list
101231646|NCT02870907|Etoposide|etoposide|mesh-list
101231647|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
101231648|NCT02870907|Vincristine|vincristine|mesh-list
101231649|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231650|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
101231651|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231652|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231653|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101231654|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
101231655|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231656|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231657|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101231658|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101231659|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231660|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101231661|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231662|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101231663|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101231664|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101231665|NCT02823574|Nivolumab|nivolumab|mesh-list
101231666|NCT02823574|Ipilimumab|ipilimumab|mesh-list
101231667|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231668|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231669|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231670|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231671|NCT02641028|Aticaprant|aticaprant|mesh-list
101231672|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101231673|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231674|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
101231675|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231677|NCT02525796|Amiloride|amiloride|mesh-list
101231678|NCT02525796|Cinacalcet|cinacalcet|mesh-list
101231679|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101231680|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
101231681|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231682|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231683|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101231684|NCT02525796|Diuretics|diuretics|mesh-ancestor
101231685|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
101231686|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231687|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101231688|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101231689|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101231690|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101231691|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231692|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231693|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101231694|NCT02360280|Midazolam|midazolam|mesh-list
101231695|NCT02360280|Ketamine|ketamine|mesh-list
101231696|NCT02360280|Analgesics|analgesics|mesh-ancestor
101231697|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
101231698|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231699|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231700|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101231701|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101231702|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
101231703|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
101231704|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231705|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101231706|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101475014|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101231707|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231708|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231709|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101231710|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101231711|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101231712|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101231713|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101231714|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
101231715|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
101231716|NCT02201251|Topiramate|topiramate|mesh-list
101231717|NCT02201251|Levetiracetam|levetiracetam|mesh-list
101231718|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
101231719|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101231720|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231721|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
101231722|NCT02192021|Doxorubicin|doxorubicin|mesh-list
101231723|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101231724|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231725|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231726|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231727|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475113|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101231728|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231729|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231730|NCT02174575|Sevoflurane|sevoflurane|mesh-list
101231731|NCT02174575|Desflurane|desflurane|mesh-list
101231732|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101231733|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101231734|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
101231735|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
101231736|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101231737|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231738|NCT01889810|Vitamin D|vitamin d|mesh-list
101231739|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
101231740|NCT01889810|Vitamins|vitamins|mesh-ancestor
101231741|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
101231742|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231743|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101231744|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101231745|NCT01840592|Doxorubicin|doxorubicin|mesh-list
101231746|NCT01840592|Sorafenib|sorafenib|mesh-list
101475250|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
101231747|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101231748|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231749|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101231750|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101231752|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231753|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231754|NCT01734694|Vancomycin|vancomycin|mesh-list
101231755|NCT01734694|Linezolid|linezolid|mesh-list
101231756|NCT01734694|Daptomycin|daptomycin|mesh-list
101231757|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101231758|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101231759|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231760|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101231761|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231762|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231763|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101231764|NCT01703949|Nivolumab|nivolumab|mesh-list
101231765|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101231766|NCT01703949|Antibodies|antibodies|mesh-list
101231767|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
101231768|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101231769|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
101231770|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
101231771|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231772|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231773|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231774|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231775|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
101231776|NCT01599234|Nabiximols|nabiximols|mesh-list
101231777|NCT01599234|Analgesics|analgesics|mesh-ancestor
101231778|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
101231779|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231780|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231781|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101231783|NCT01468896|Interleukin-12|interleukin-12|mesh-list
101231784|NCT01468896|Antibodies|antibodies|mesh-list
101231785|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
101231786|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101231787|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
101231788|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231789|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231790|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101231791|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101231792|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101231793|NCT01468896|Growth Substances|growth substances|mesh-ancestor
101231794|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
101231795|NCT01251861|Bicalutamide|bicalutamide|mesh-list
101231796|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
101361354|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231824|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
101231825|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231826|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101231827|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101231828|NCT00843882|Growth Substances|growth substances|mesh-ancestor
101231829|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
101231830|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231831|NCT00843882|Hematinics|hematinics|mesh-ancestor
101231832|NCT00716625|Sunitinib|sunitinib|mesh-list
101231833|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231834|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101231835|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101231836|NCT00716625|Growth Substances|growth substances|mesh-ancestor
101231837|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231838|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
101231839|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231840|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231841|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231842|NCT00713817|Nabiximols|nabiximols|mesh-list
101231843|NCT00713817|Analgesics|analgesics|mesh-ancestor
101231844|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
101231845|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231846|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231847|NCT00713323|Nabiximols|nabiximols|mesh-list
101231848|NCT00713323|Analgesics|analgesics|mesh-ancestor
101231849|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
101231850|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231852|NCT00713193|Cyclosporine|cyclosporine|mesh-list
101231853|NCT00713193|Prednisone|prednisone|mesh-list
101231854|NCT00713193|Cyclosporins|cyclosporins|mesh-list
101231855|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231856|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
101231857|NCT00713193|Hormones|hormones|mesh-ancestor
101231858|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231859|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231860|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231861|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231863|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231864|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101231865|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
101231866|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
101231867|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231868|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231869|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231871|NCT00710554|Nabiximols|nabiximols|mesh-list
101231872|NCT00710554|Analgesics|analgesics|mesh-ancestor
101231873|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
101231874|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475714|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101231875|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231877|NCT00710424|Analgesics|analgesics|mesh-ancestor
101231878|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
101231879|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231880|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231881|NCT00674609|Nabiximols|nabiximols|mesh-list
101231882|NCT00674609|Analgesics|analgesics|mesh-ancestor
101231883|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
101231884|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231885|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231886|NCT00026312|Vitamin A|vitamin a|mesh-list
101231887|NCT00026312|Aldesleukin|aldesleukin|mesh-list
101231888|NCT00026312|Interleukin-2|interleukin-2|mesh-list
101231890|NCT00026312|Dinutuximab|dinutuximab|mesh-list
101231891|NCT00026312|Isotretinoin|isotretinoin|mesh-list
101231892|NCT00026312|Sargramostim|sargramostim|mesh-list
101231893|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101231894|NCT00026312|Vitamins|vitamins|mesh-ancestor
101231895|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
101231896|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231897|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231898|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101231899|NCT00026312|Analgesics|analgesics|mesh-ancestor
101231900|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
101231901|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231902|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
101231903|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101231904|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101231905|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
101231906|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231907|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
101475826|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231908|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101231909|NCT01556646|Tolvaptan|tolvaptan|mesh-list
101231910|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101231911|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231912|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
101231913|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231914|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
101231915|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
101231916|NCT01556672|Adalimumab|adalimumab|mesh-list
101231917|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101231918|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101231919|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101231920|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
101231921|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101231922|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
101231923|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101231924|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231925|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101231926|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
101231927|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101231928|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
101231929|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231930|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231931|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101231932|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
101475930|NCT00301860|Cyclosporine|cyclosporine|mesh-list
101231933|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
101231934|NCT01556698|Protective Agents|protective agents|mesh-ancestor
101231936|NCT01556737|Daidzein|daidzein|mesh-list
101231937|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101231938|NCT01556737|Protective Agents|protective agents|mesh-ancestor
101231939|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231940|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231941|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231942|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231943|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231944|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
101231945|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101231946|NCT01556737|Estrogens|estrogens|mesh-ancestor
101231947|NCT01556737|Hormones|hormones|mesh-ancestor
101475986|NCT00267683|Glyburide|glyburide|mesh-list
101231948|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231949|NCT01556815|Sorafenib|sorafenib|mesh-list
101231950|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
101231951|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231952|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231953|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231954|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231955|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101231956|NCT01556815|Estrogens|estrogens|mesh-ancestor
101231958|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101231959|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231960|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101231961|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101231962|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101231963|NCT01557075|Atorvastatin|atorvastatin|mesh-list
101231964|NCT01557075|Pravastatin|pravastatin|mesh-list
101231965|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101231966|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101231967|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101231968|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
101231969|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231970|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101231971|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231972|NCT01557114|Ipilimumab|ipilimumab|mesh-list
101231973|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101231974|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231975|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101231976|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231978|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101231979|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101231980|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101231981|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231982|NCT01557140|Carvedilol|carvedilol|mesh-list
101231983|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101231984|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101476133|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
101476152|NCT00296751|Fentanyl|fentanyl|mesh-list
101231985|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
101231986|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101231987|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101231988|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101231989|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101231990|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
101231991|NCT01557140|Protective Agents|protective agents|mesh-ancestor
101231992|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101231993|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101231994|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101231995|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
101476193|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
101231996|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101231997|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101231999|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232000|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101232001|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232002|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232003|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101232004|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232005|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
101232006|NCT01557257|Naltrexone|naltrexone|mesh-list
101232007|NCT01557257|Oxycodone|oxycodone|mesh-list
101232008|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101232009|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101232010|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232011|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
101232012|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232014|NCT01557257|Narcotics|narcotics|mesh-ancestor
101232015|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476314|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101232016|NCT01557257|Analgesics|analgesics|mesh-ancestor
101232017|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
101232018|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232019|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232020|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232021|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232022|NCT01557270|Analgesics|analgesics|mesh-ancestor
101232023|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
101232024|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232025|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101232026|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101232027|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101232028|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232029|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232030|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232031|NCT01557335|Aspirin|aspirin|mesh-list
101232032|NCT01557335|Omeprazole|omeprazole|mesh-list
101232033|NCT01557335|Clopidogrel|clopidogrel|mesh-list
101232034|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232035|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232036|NCT01557335|Analgesics|analgesics|mesh-ancestor
101232037|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
101232038|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232039|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232040|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232041|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476426|NCT00269867|Antibodies|antibodies|mesh-list
101232042|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101232043|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101232044|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232045|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101232046|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101232047|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232049|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101232050|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101232051|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101232052|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
101232053|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232054|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101232058|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101232059|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232060|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232061|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232062|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232063|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
101232064|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232065|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232066|NCT01557439|Levocetirizine|levocetirizine|mesh-list
101232067|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101232068|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101232069|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
101232070|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
101361535|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232071|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232072|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232073|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232074|NCT01557478|Melatonin|melatonin|mesh-list
101232075|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
101232076|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232078|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232079|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232080|NCT01557634|Insulin|insulin|mesh-list
101232081|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101232082|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232083|NCT01557647|Treprostinil|treprostinil|mesh-list
101232084|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232086|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232087|NCT01557712|Ketamine|ketamine|mesh-list
101232088|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101232089|NCT01557712|Analgesics|analgesics|mesh-ancestor
101232090|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
101232091|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232092|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232093|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101232094|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232095|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
101232097|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232098|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101232099|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101232100|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232101|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232102|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101232103|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101232104|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232105|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101232106|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
101476818|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232107|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101232108|NCT01557764|Trastuzumab|trastuzumab|mesh-list
101232110|NCT01557764|Antibodies|antibodies|mesh-list
101232111|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101232112|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
101232113|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232114|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232115|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232116|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101476890|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101232117|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232118|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232121|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232122|NCT01557816|Analgesics|analgesics|mesh-ancestor
101232123|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
101232124|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232125|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232126|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232127|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232128|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
101476949|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232129|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101232130|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232131|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232132|NCT01557829|Silicon|silicon|mesh-list
101232133|NCT01557829|Trace Elements|trace elements|mesh-ancestor
101232134|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
101232135|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232136|NCT01557907|Insulin|insulin|mesh-list
101232137|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101232138|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101232139|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232140|NCT01557985|Bupivacaine|bupivacaine|mesh-list
101477011|NCT00307944|Pantoprazole|pantoprazole|mesh-list
101232141|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232142|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
101232143|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232144|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232145|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
101232146|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232147|NCT01558011|Docetaxel|docetaxel|mesh-list
101232148|NCT01558011|Capecitabine|capecitabine|mesh-list
101232149|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
101232150|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232151|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101232152|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101232153|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101232154|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232155|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232156|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
101232157|NCT01558167|Rituximab|rituximab|mesh-list
101232158|NCT01558167|Lenalidomide|lenalidomide|mesh-list
101232159|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101232160|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232161|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477137|NCT00273377|Dexamethasone|dexamethasone|mesh-list
101477139|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
101232162|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
101232163|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232164|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232165|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101232166|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101232167|NCT01558167|Growth Substances|growth substances|mesh-ancestor
101232168|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
101232169|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101232170|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
101232171|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232172|NCT01558193|Vitamins|vitamins|mesh-list
101232173|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
101232174|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
101232175|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232176|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232177|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232178|NCT01558193|Analgesics|analgesics|mesh-ancestor
101232179|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
101232180|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232181|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232182|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232183|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101232184|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
101232185|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232186|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101232187|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232188|NCT01558245|Kallikreins|kallikreins|mesh-list
101232189|NCT01558245|Coagulants|coagulants|mesh-ancestor
101232190|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101232191|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
101232192|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101232193|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232194|NCT01558310|Ustekinumab|ustekinumab|mesh-list
101232195|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232197|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
101232198|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101232199|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232200|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101232201|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232202|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
101232203|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232204|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
101232205|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
101232206|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101232207|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101232208|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232209|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232210|NCT01558466|Urological Agents|urological agents|mesh-ancestor
101232211|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101232213|NCT01558622|Meperidine|meperidine|mesh-list
101232214|NCT01558622|Tramadol|tramadol|mesh-list
101232215|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232216|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232217|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101477455|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
101232218|NCT01558622|Narcotics|narcotics|mesh-ancestor
101232219|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232220|NCT01558622|Analgesics|analgesics|mesh-ancestor
101232221|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
101232222|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232223|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232224|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232225|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232226|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232227|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101232228|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101232229|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232230|NCT01558648|Analgesics|analgesics|mesh-list
101232231|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
101232232|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232233|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232235|NCT01558713|Bupivacaine|bupivacaine|mesh-list
101232236|NCT01558713|Ropivacaine|ropivacaine|mesh-list
101232237|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
101232238|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232239|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
101232240|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232241|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232242|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
101232243|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232244|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101232245|NCT01558713|Narcotics|narcotics|mesh-ancestor
101232246|NCT01558713|Analgesics|analgesics|mesh-ancestor
101232247|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101477563|NCT00277472|Valsartan|valsartan|mesh-list
101477569|NCT00277472|Diuretics|diuretics|mesh-ancestor
101232248|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232249|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
101232251|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101232252|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232253|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232254|NCT01558869|Capecitabine|capecitabine|mesh-list
101232255|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
101232256|NCT01558869|Irinotecan|irinotecan|mesh-list
101232257|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232258|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
101232259|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232260|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477618|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
101232261|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101232262|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232263|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232265|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232266|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101232267|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232268|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
101232269|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232270|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101232271|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101232272|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101232273|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232274|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232275|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232276|NCT01558960|Melphalan|melphalan|mesh-list
101232277|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101232278|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
101232279|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232280|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232281|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101232282|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232283|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
101232284|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232285|NCT01558986|Cefazolin|cefazolin|mesh-list
101232286|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232287|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232288|NCT01559025|Vildagliptin|vildagliptin|mesh-list
101232289|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101232290|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101232291|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232292|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
101232293|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232294|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232295|NCT01559051|Anesthetics|anesthetics|mesh-list
101361681|NCT00125437|Diuretics|diuretics|mesh-ancestor
101232296|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232297|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232298|NCT01559142|Infliximab|infliximab|mesh-list
101232299|NCT01559142|Azathioprine|azathioprine|mesh-list
101232300|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101232301|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232302|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232303|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232304|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232305|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
101232306|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361690|NCT00125671|Warfarin|warfarin|mesh-list
101232307|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232308|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232309|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232310|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
101232311|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232312|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101232313|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101232314|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101232315|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232316|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232318|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101232319|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101232321|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232322|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232323|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101232324|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101232325|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
101232326|NCT01559285|Ropivacaine|ropivacaine|mesh-list
101232327|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232328|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
101232329|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232330|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232331|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
101232332|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232333|NCT01559298|Aspirin|aspirin|mesh-list
101232334|NCT01559298|Clopidogrel|clopidogrel|mesh-list
101232335|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232336|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232337|NCT01559298|Analgesics|analgesics|mesh-ancestor
101232338|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
101232339|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232340|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232341|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232342|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232343|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101232344|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101232345|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232346|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101232347|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101232348|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232349|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
101232350|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101232351|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101232352|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101477918|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232353|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
101232354|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232356|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101232357|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101232358|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101232359|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
101232360|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101232361|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232362|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101232363|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101232364|NCT01559480|Progestins|progestins|mesh-ancestor
101232366|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232367|NCT01559545|Metronidazole|metronidazole|mesh-list
101232368|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232369|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232370|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101232371|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101232372|NCT01559584|Triamcinolone|triamcinolone|mesh-list
101232373|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101232374|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101232375|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101232376|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232377|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
101232378|NCT01559584|Hormones|hormones|mesh-ancestor
101232379|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232380|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232381|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232382|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
101232383|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232384|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232385|NCT01559727|Prednisone|prednisone|mesh-list
101232386|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232387|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
101232388|NCT01559727|Hormones|hormones|mesh-ancestor
101232389|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232390|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232391|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101232392|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232393|NCT01559740|Bupivacaine|bupivacaine|mesh-list
101232394|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232395|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
101232396|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232397|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232398|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
101232399|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232400|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101232401|NCT01559753|Amoxicillin|amoxicillin|mesh-list
101232402|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
101232403|NCT01559753|Tobramycin|tobramycin|mesh-list
101232404|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101232405|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
101232406|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
101232407|NCT01559753|Cefotaxime|cefotaxime|mesh-list
101232408|NCT01559753|Cefoxitin|cefoxitin|mesh-list
101232409|NCT01559753|Netilmicin|netilmicin|mesh-list
101477964|NCT00279461|Vitamins|vitamins|mesh-list
101232410|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232411|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101232412|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232413|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232414|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101232415|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
101232416|NCT01559974|Vitamin D|vitamin d|mesh-list
101232417|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101232418|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232419|NCT01559974|Vitamins|vitamins|mesh-ancestor
101232420|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
101232421|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101232422|NCT01560117|Rituximab|rituximab|mesh-list
101232423|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232424|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232425|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
101232426|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232427|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232430|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
101232431|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232432|NCT05570669|Emollients|emollients|mesh-ancestor
101232433|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232434|NCT05570669|Cathartics|cathartics|mesh-ancestor
101232435|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232436|NCT05570383|Antacids|antacids|mesh-list
101232437|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232438|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232439|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
101232440|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232441|NCT05570084|Tamsulosin|tamsulosin|mesh-list
101232442|NCT05570084|Silodosin|silodosin|mesh-list
101232443|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101232444|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101478039|NCT00279734|Abatacept|abatacept|mesh-list
101232445|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101232446|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232447|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232448|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232449|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232450|NCT05570084|Urological Agents|urological agents|mesh-ancestor
101232451|NCT05569668|Paclitaxel|paclitaxel|mesh-list
101232452|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101232453|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232454|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
101232455|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
101232456|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528325|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101232457|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232458|NCT05569655|Furosemide|furosemide|mesh-list
101232459|NCT05569655|Tolvaptan|tolvaptan|mesh-list
101232460|NCT05569655|Diuretics|diuretics|mesh-ancestor
101232461|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
101232462|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232463|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101232464|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232465|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232466|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101232467|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101232468|NCT05569590|Propolis|propolis|mesh-list
101232469|NCT05569590|Fluorides|fluorides|mesh-list
101232470|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
101232471|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
101232472|NCT05569590|Protective Agents|protective agents|mesh-ancestor
101478165|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101232473|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232474|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101232475|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232476|NCT05569577|Estrogens|estrogens|mesh-list
101232477|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
101232478|NCT05569577|Hormones|hormones|mesh-ancestor
101232479|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232480|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232481|NCT05569577|Progestins|progestins|mesh-ancestor
101232482|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101232483|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
101232484|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232485|NCT05569031|Lofexidine|lofexidine|mesh-list
101478226|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232486|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101232487|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101232488|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101232489|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232490|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232491|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232492|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232493|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101232494|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
101232495|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101232496|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232497|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101232498|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
101232499|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478282|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
101232500|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101232501|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101232502|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101232503|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232504|NCT05564741|Norepinephrine|norepinephrine|mesh-list
101232505|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101232506|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101478339|NCT00317343|Anticoagulants|anticoagulants|mesh-list
101232507|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232508|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232509|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232510|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232511|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
101232513|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232514|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101232515|NCT05522582|Methotrexate|methotrexate|mesh-list
101232516|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101232517|NCT05522582|Antibodies|antibodies|mesh-list
101232518|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101232519|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
101232520|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232521|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101232522|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
101232523|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101232524|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478396|NCT00417053|Busulfan|busulfan|mesh-list
101232525|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
101232526|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232527|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232528|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232529|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232530|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101232531|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232532|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232533|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101232534|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232535|NCT05491304|Dexamethasone|dexamethasone|mesh-list
101232536|NCT05491304|Etoposide|etoposide|mesh-list
101232537|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361775|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232538|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
101232539|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
101232540|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232541|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232542|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232543|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
101232544|NCT05491304|Hormones|hormones|mesh-ancestor
101232545|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232546|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101232547|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232548|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101232549|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101232550|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232551|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232552|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232553|NCT05391555|Remifentanil|remifentanil|mesh-list
101232554|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101232555|NCT05391555|Narcotics|narcotics|mesh-ancestor
101232556|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232557|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232558|NCT05391555|Analgesics|analgesics|mesh-ancestor
101232559|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
101478516|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232560|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232561|NCT05388656|Estradiol|estradiol|mesh-list
101232562|NCT05388656|Progesterone|progesterone|mesh-list
101232563|NCT05388656|Estrogens|estrogens|mesh-ancestor
101232564|NCT05388656|Hormones|hormones|mesh-ancestor
101232565|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232566|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232567|NCT05388656|Progestins|progestins|mesh-ancestor
101232568|NCT05372393|Anesthetics|anesthetics|mesh-list
101232569|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232570|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232571|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
101232572|NCT05219604|Promethazine|promethazine|mesh-list
101478570|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232573|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101232574|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232575|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232576|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232577|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232578|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
101232579|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
101232580|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232581|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
101232582|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
101232583|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232584|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101232585|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
101232586|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
101232587|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232588|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232589|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101232590|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
101232591|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478704|NCT00283751|Insulin|insulin|mesh-list
101232592|NCT05137080|Dexamethasone|dexamethasone|mesh-list
101232593|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232594|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
101232595|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
101232596|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232597|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232598|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232599|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
101232600|NCT05137080|Hormones|hormones|mesh-ancestor
101232601|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232602|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101232603|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232604|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
101232605|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232606|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232607|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101232608|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232609|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478769|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
101232610|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232612|NCT04787731|Lidocaine|lidocaine|mesh-list
101232613|NCT04787731|Bupivacaine|bupivacaine|mesh-list
101232614|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
101232615|NCT04787731|Anesthetics|anesthetics|mesh-list
101232616|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232617|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232618|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
101232619|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232620|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101232621|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101232622|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101232623|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232624|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232625|NCT04713358|Nalmefene|nalmefene|mesh-list
101232626|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101232627|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232628|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
101232629|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232630|NCT04705051|Venglustat|venglustat|mesh-list
101232631|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478825|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478827|NCT00284258|Irinotecan|irinotecan|mesh-list
101232632|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232634|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232635|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232636|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232637|NCT04496999|Midostaurin|midostaurin|mesh-list
101232638|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232639|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101232640|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232641|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232642|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
101232643|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101232644|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232645|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101232646|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232647|NCT04464265|Propofol|propofol|mesh-list
101232648|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232649|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232650|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232651|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232652|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
101232653|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
101232655|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232657|NCT04421079|Resveratrol|resveratrol|mesh-list
101232658|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
101232659|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232660|NCT04421079|Protective Agents|protective agents|mesh-ancestor
101232661|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232662|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232663|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101232664|NCT04410406|Ivermectin|ivermectin|mesh-list
101232665|NCT04410406|Albendazole|albendazole|mesh-list
101232666|NCT04410406|Moxidectin|moxidectin|mesh-list
101232667|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
101232668|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232669|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101232670|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232671|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
101232672|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
101232673|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101232674|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101232675|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478932|NCT00319059|Annexin A5|annexin a5|mesh-list
101232677|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
101232678|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232679|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
101232681|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101232682|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232683|NCT04393506|Apatinib|apatinib|mesh-list
101232684|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101232685|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232686|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101232687|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232688|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232689|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232690|NCT04349826|Azithromycin|azithromycin|mesh-list
101232691|NCT04349826|Cefixime|cefixime|mesh-list
101232692|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232693|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232694|NCT04298853|Morphine|morphine|mesh-list
101232695|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101232696|NCT04298853|Narcotics|narcotics|mesh-ancestor
101232697|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232698|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232699|NCT04298853|Analgesics|analgesics|mesh-ancestor
101232700|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
101232701|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232702|NCT04232683|Tamsulosin|tamsulosin|mesh-list
101322087|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
101232703|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101232704|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101232705|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101478973|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101232706|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
101232707|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232708|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232709|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232710|NCT04232683|Urological Agents|urological agents|mesh-ancestor
101232711|NCT04227483|Prednisolone|prednisolone|mesh-list
101232712|NCT04227483|Deflazacort|deflazacort|mesh-list
101232713|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232714|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
101232715|NCT04227483|Hormones|hormones|mesh-ancestor
101232716|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232717|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232718|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101232719|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232720|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232721|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
101232722|NCT04182672|Triamcinolone|triamcinolone|mesh-list
101232723|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101232724|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101232725|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101232726|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232727|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
101479018|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
101232729|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232730|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232732|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
101232733|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232734|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232735|NCT04101227|Ondansetron|ondansetron|mesh-list
101232736|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
101232737|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
101479062|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
101232738|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232739|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232740|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101232741|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
101232742|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101232743|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101232744|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101232745|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
101232746|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232747|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232748|NCT04047004|Doxorubicin|doxorubicin|mesh-list
101232749|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232750|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101232751|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101232752|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232753|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232754|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232755|NCT03893435|Valsartan|valsartan|mesh-list
101232756|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101232757|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101232758|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101232759|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101232760|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232762|NCT03813121|Ketamine|ketamine|mesh-list
101232763|NCT03813121|Analgesics|analgesics|mesh-ancestor
101232764|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
101232765|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232766|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232767|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101232768|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232769|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
101232770|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
101232771|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232772|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101232773|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101232774|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232775|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232776|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101232777|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232778|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101232779|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101232780|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101232781|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
101232782|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
101232784|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101232785|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
101232786|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232787|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232788|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101232789|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101232790|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
101232791|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232792|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232793|NCT03676725|Lidocaine|lidocaine|mesh-list
101232794|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
101232795|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
101232796|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232797|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479399|NCT00313599|Paclitaxel|paclitaxel|mesh-list
101232798|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
101232799|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232800|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101232801|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101232802|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101232803|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101232804|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232806|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232807|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232808|NCT03471507|Analgesics|analgesics|mesh-ancestor
101232809|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
101232810|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232811|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232812|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232813|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232814|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101232815|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232816|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232817|NCT03470922|Nivolumab|nivolumab|mesh-list
101232818|NCT03470922|Relatlimab|relatlimab|mesh-list
101232819|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232820|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232821|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101232822|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232824|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101232825|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232826|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232827|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232828|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232830|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232831|NCT03205423|Gabapentin|gabapentin|mesh-list
101232832|NCT03205423|Analgesics|analgesics|mesh-ancestor
101232833|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
101232834|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232835|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232836|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
101232837|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101232838|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101232839|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232841|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101232842|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101232843|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232844|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232845|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
101232846|NCT03104400|Adalimumab|adalimumab|mesh-list
101232847|NCT03104400|Upadacitinib|upadacitinib|mesh-list
101232848|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101232849|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232850|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479708|NCT00288236|Hormones|hormones|mesh-ancestor
101232851|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101232852|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101232853|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232854|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232855|NCT03104374|Upadacitinib|upadacitinib|mesh-list
101232856|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101232857|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101232858|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232859|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232861|NCT03008369|Lenvatinib|lenvatinib|mesh-list
101232862|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232863|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101232864|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232865|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232867|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101232868|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232869|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232870|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101232871|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232872|NCT02918006|Vaccines|vaccines|mesh-list
101232873|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
101232874|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232875|NCT02917772|Nivolumab|nivolumab|mesh-list
101232876|NCT02917772|Ipilimumab|ipilimumab|mesh-list
101232877|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232878|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232879|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101479827|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
101232880|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232882|NCT02909686|Resveratrol|resveratrol|mesh-list
101232883|NCT02909686|Pycnogenols|pycnogenols|mesh-list
101232884|NCT02909686|Turmeric extract|turmeric extract|mesh-list
101232885|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101232886|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101232887|NCT02909686|Analgesics|analgesics|mesh-ancestor
101232888|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
101232889|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232890|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232891|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101232892|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101232893|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232894|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232895|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232896|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
101232897|NCT02909686|Protective Agents|protective agents|mesh-ancestor
101479943|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101232898|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101232899|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101232900|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
101232901|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101232902|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
101232903|NCT02713373|Cetuximab|cetuximab|mesh-list
101232904|NCT02713373|Antibodies|antibodies|mesh-list
101232905|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
101322102|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
101232906|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101232907|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
101232908|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232909|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232910|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101480023|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101232911|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232912|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
101232913|NCT02686593|Clofarabine|clofarabine|mesh-list
101232914|NCT02686593|Analgesics|analgesics|mesh-ancestor
101232915|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
101232916|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232917|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232918|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232919|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101232920|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101232921|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232922|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480081|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101232923|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232924|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
101232926|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232927|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
101232928|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232929|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232930|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
101232931|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232932|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101232933|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
101232934|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232935|NCT02583282|Doxycycline|doxycycline|mesh-list
101232936|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101232937|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101232938|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
101232939|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480138|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101232940|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480139|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480140|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480141|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101232941|NCT02553941|Azacitidine|azacitidine|mesh-list
101232942|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232943|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
101232944|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101232945|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232946|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101232947|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101232948|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101232950|NCT02546492|Hormones|hormones|mesh-ancestor
101232951|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232952|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232953|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232954|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480207|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101232957|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101232958|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101232959|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232960|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101232961|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101232962|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480268|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101232968|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
101232969|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101232970|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232971|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101232972|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101232973|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101232974|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
101232975|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101232976|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101232977|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
101232978|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101232979|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
101232980|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101232981|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101232982|NCT02065609|Trastuzumab|trastuzumab|mesh-list
101232983|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101232984|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101232985|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
101232986|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101232987|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101232988|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
101232989|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
101232990|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480333|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101232991|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232992|NCT01561482|Metformin|metformin|mesh-list
101232993|NCT01561482|Simvastatin|simvastatin|mesh-list
101232994|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101232995|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101232996|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101232997|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101232998|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
101232999|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233000|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233001|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101233002|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233003|NCT01561586|Cisplatin|cisplatin|mesh-list
101233004|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233005|NCT01562704|Acetaminophen|acetaminophen|mesh-list
101233006|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101233007|NCT01562704|Analgesics|analgesics|mesh-ancestor
101233008|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
101233009|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233010|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233011|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
101233012|NCT01564095|Tryptophan|tryptophan|mesh-list
101233013|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101233014|NCT01564095|Tacrolimus|tacrolimus|mesh-list
101233015|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233016|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
101233017|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233018|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101233019|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233020|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480367|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
101480368|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480369|NCT00291785|Antidotes|antidotes|mesh-ancestor
101480372|NCT00291785|Vitamins|vitamins|mesh-ancestor
101233021|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101233022|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233023|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233024|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
101233025|NCT01564238|Calcium|calcium|mesh-list
101233026|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101233027|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233028|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101233029|NCT01564576|Bromides|bromides|mesh-list
101233030|NCT01564576|Rocuronium|rocuronium|mesh-list
101233031|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
101233032|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101233033|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101233034|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101233035|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233036|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233037|NCT01564823|Metronidazole|metronidazole|mesh-list
101233038|NCT01564823|Adalimumab|adalimumab|mesh-list
101233039|NCT01564823|Azathioprine|azathioprine|mesh-list
101233040|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101233041|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233042|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233043|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233044|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233045|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101233046|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101233047|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
101233048|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233049|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233050|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233051|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233052|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
101233053|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233055|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
101233057|NCT01565265|Cetrorelix|cetrorelix|mesh-list
101233058|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101233059|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101233060|NCT01565265|Hormones|hormones|mesh-ancestor
101233061|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233062|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233063|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101233064|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
101233065|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101233066|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
101233067|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
101233068|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101233069|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101233070|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101233071|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233072|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233073|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
101233074|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233075|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233076|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101233077|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233078|NCT01566422|Vancomycin|vancomycin|mesh-list
101233079|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233080|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233081|NCT01566760|Fesoterodine|fesoterodine|mesh-list
101233082|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101233083|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101480450|NCT00324831|Sargramostim|sargramostim|mesh-list
101233084|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
101233085|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233086|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233087|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233088|NCT01566760|Urological Agents|urological agents|mesh-ancestor
101233089|NCT01566890|Regadenoson|regadenoson|mesh-list
101233090|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101233091|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101233092|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
101233093|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
101233094|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233095|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233096|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233097|NCT01567072|Ibuprofen|ibuprofen|mesh-list
101233098|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101233099|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101233100|NCT01567072|Analgesics|analgesics|mesh-ancestor
101233101|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
101233102|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233103|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233104|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233105|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233106|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101233107|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233108|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233109|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101233110|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
101233111|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101233112|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101233113|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233114|NCT01568632|Imetelstat|imetelstat|mesh-list
101233115|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
101233116|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233117|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322117|NCT00088582|Octreotide|octreotide|mesh-list
101233118|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101233120|NCT01568645|Carvedilol|carvedilol|mesh-list
101233121|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233122|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101233123|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233124|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233125|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101233126|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101233127|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
101233129|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233130|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480547|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101233131|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
101233132|NCT01568645|Protective Agents|protective agents|mesh-ancestor
101233133|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101233134|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233135|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101233136|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
101233137|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101233138|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101233140|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101233141|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101362007|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
101233142|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233143|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233144|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233145|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
101233146|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233147|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101233148|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233149|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233150|NCT01569685|Sertraline|sertraline|mesh-list
101233151|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101233152|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233153|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233154|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101233155|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101233156|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233157|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233158|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233160|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233161|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101233162|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101233163|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101233164|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101233165|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
101362011|NCT02965911|Fenofibrate|fenofibrate|mesh-list
101362012|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101233166|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233167|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233169|NCT01570088|Hematinics|hematinics|mesh-ancestor
101233170|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
101233171|NCT01570088|Vitamins|vitamins|mesh-ancestor
101233172|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
101233173|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233174|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101233175|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101233176|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
101233177|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233178|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233179|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101233180|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101233181|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
101233182|NCT01570478|Hormones|hormones|mesh-ancestor
101233183|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233184|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
101233185|NCT01570504|Ivermectin|ivermectin|mesh-list
101233186|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101233187|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233188|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101233189|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233190|NCT01570569|Losartan|losartan|mesh-list
101233191|NCT01570569|Midazolam|midazolam|mesh-list
101233192|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
101233193|NCT01570569|Caffeine|caffeine|mesh-list
101233194|NCT01570569|Omeprazole|omeprazole|mesh-list
101233195|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101233197|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233198|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233199|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101233200|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101233201|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233202|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101233203|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
101233204|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
101233205|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
101233206|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
101233207|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233208|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233209|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101233210|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101233211|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101233212|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101233213|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101233214|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101233215|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233216|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101233217|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101233218|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
101233219|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101233220|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233221|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101233222|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
101233223|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
101233224|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101233225|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101233226|NCT01570582|Paclitaxel|paclitaxel|mesh-list
101233227|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101233228|NCT01570582|Carboplatin|carboplatin|mesh-list
101233229|NCT01570582|Gemcitabine|gemcitabine|mesh-list
101233230|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101233231|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233232|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101233233|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101233234|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101233235|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233236|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233237|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
101233238|NCT01570608|Ranibizumab|ranibizumab|mesh-list
101233239|NCT01570608|Verteporfin|verteporfin|mesh-list
101233240|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101233241|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101233242|NCT01570608|Growth Substances|growth substances|mesh-ancestor
101233243|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480794|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233244|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
101233245|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233246|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101233247|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
101233248|NCT01570660|Pioglitazone|pioglitazone|mesh-list
101233249|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233250|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233251|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
101233252|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233253|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
101233254|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233255|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233256|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101233257|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
101233258|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233259|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233260|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101233261|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
101480847|NCT00325767|Albuterol|albuterol|mesh-list
101233262|NCT01570790|Combretastatin|combretastatin|mesh-list
101233263|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101233264|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233265|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101233266|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101233267|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101233268|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233269|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101233270|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233271|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233272|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101233273|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101233274|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233275|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233276|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101233277|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233278|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480891|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
101233279|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101233280|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101233281|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233282|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233283|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101233284|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233285|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233286|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101233287|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101233288|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233289|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233290|NCT01570985|Triamcinolone|triamcinolone|mesh-list
101233291|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101233292|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101233293|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101233294|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233295|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
101233297|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233298|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233299|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233300|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
101233301|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480947|NCT00305487|Hormones|hormones|mesh-ancestor
101233302|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233304|NCT01571024|Fluorouracil|fluorouracil|mesh-list
101233305|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
101233306|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
101233307|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233308|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233309|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233310|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322140|NCT00088855|Doxorubicin|doxorubicin|mesh-list
101233311|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
101233312|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233314|NCT01571024|Protective Agents|protective agents|mesh-ancestor
101233315|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
101233316|NCT01571024|Vitamins|vitamins|mesh-ancestor
101233317|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
101233318|NCT01571037|Milrinone|milrinone|mesh-list
101233319|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101233320|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233321|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
101233322|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101233323|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101233324|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233325|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233326|NCT01571037|Protective Agents|protective agents|mesh-ancestor
101233328|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
101233329|NCT01571050|Antacids|antacids|mesh-ancestor
101233330|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233331|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233332|NCT01571063|Vitamin D|vitamin d|mesh-list
101233333|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
101233335|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
101233336|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233337|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101233338|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101233339|NCT01571167|Varenicline|varenicline|mesh-list
101233340|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101233341|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101233342|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
101233343|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528326|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233344|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233345|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233346|NCT01571206|Infliximab|infliximab|mesh-list
101233347|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101233348|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233349|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
101233350|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233351|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233352|NCT01571219|Infliximab|infliximab|mesh-list
101233353|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101233354|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233355|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
101233356|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233357|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233358|NCT01571323|Misoprostol|misoprostol|mesh-list
101233359|NCT01571323|Oxytocin|oxytocin|mesh-list
101233360|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
101233361|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101233362|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233363|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101233364|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
101233365|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101233366|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233367|NCT01571414|Ritonavir|ritonavir|mesh-list
101233368|NCT01571414|Lopinavir|lopinavir|mesh-list
101233369|NCT01571414|Efavirenz|efavirenz|mesh-list
101233370|NCT01571414|Rifampin|rifampin|mesh-list
101233371|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101233372|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101233373|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101233374|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233375|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233376|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101233377|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101233378|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
101233379|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233380|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101233381|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101233382|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101233383|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101233384|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101481093|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233385|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101233386|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101233387|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101233388|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101233389|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101233391|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233392|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
101233393|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101233394|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101233395|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101233396|NCT01571570|Simeprevir|simeprevir|mesh-list
101233397|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
101233398|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233399|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
101233400|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233401|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233402|NCT01571583|Interferons|interferons|mesh-list
101233403|NCT01571583|Ribavirin|ribavirin|mesh-list
101233404|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
101233405|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
101233406|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101233407|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233408|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
101233409|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233410|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
101233411|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233412|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
101233413|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233414|NCT01571609|Insulin|insulin|mesh-list
101233415|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233416|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233417|NCT01571648|Azacitidine|azacitidine|mesh-list
101233418|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233419|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
101481133|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
101233420|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233422|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233423|NCT01571687|Antioxidants|antioxidants|mesh-list
101233424|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233425|NCT01571687|Protective Agents|protective agents|mesh-ancestor
101233426|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233427|NCT01571791|Ketorolac|ketorolac|mesh-list
101233428|NCT01571791|Lidocaine|lidocaine|mesh-list
101233429|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
101233430|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
101233431|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233432|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233433|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
101233434|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233435|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101233436|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101233437|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101233438|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233439|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233440|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101233441|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101233442|NCT01571791|Analgesics|analgesics|mesh-ancestor
101233443|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233444|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233445|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101362075|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233446|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233448|NCT01571804|Analgesics|analgesics|mesh-ancestor
101233449|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
101233450|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233451|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233452|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
101233453|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101233454|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233455|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233456|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101233457|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101233458|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101233459|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233460|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233461|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
101233462|NCT01571856|Astringents|astringents|mesh-ancestor
101233463|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233464|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
101233465|NCT01571882|Policosanol|policosanol|mesh-list
101233466|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101233467|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101233468|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
101233469|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233470|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233471|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233472|NCT01571921|Tocotrienols|tocotrienols|mesh-list
101233473|NCT01571921|Vitamin E|vitamin e|mesh-list
101233474|NCT01571921|Tocopherols|tocopherols|mesh-list
101233475|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
101233476|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233477|NCT01571921|Protective Agents|protective agents|mesh-ancestor
101233478|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233479|NCT01571921|Vitamins|vitamins|mesh-ancestor
101233480|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
101233481|NCT01571960|Vaccines|vaccines|mesh-list
101233482|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
101233483|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233484|NCT01572012|Ondansetron|ondansetron|mesh-list
101233485|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
101233486|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
101233487|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233488|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233489|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233490|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
101233491|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101233492|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101233493|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101233494|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
101233495|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233496|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233497|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101233498|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101233499|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
101233500|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233501|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101233502|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233504|NCT01571908|Succinylcholine|succinylcholine|mesh-list
101233505|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101233506|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101233507|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101233508|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233509|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233510|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101233511|NCT01572116|Lidocaine|lidocaine|mesh-list
101233512|NCT01572116|Epinephrine|epinephrine|mesh-list
101233513|NCT01572116|Racepinephrine|racepinephrine|mesh-list
101233514|NCT01572116|Sufentanil|sufentanil|mesh-list
101233515|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
101233516|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
101233517|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
101233518|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233519|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233520|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
101233521|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233522|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101233523|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101233524|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101233525|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233526|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233527|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101233528|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101481360|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
101233529|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481364|NCT00297284|Modafinil|modafinil|mesh-list
101233530|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233531|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101233532|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101233533|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
101233534|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101233535|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101233536|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
101233537|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
101233538|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101233539|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101233540|NCT01572116|Narcotics|narcotics|mesh-ancestor
101233541|NCT01572116|Analgesics|analgesics|mesh-ancestor
101233542|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101233543|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101233544|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
101233545|NCT01572129|Clopidogrel|clopidogrel|mesh-list
101233546|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233547|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101233548|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101233549|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101233550|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
101233551|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233552|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233553|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233554|NCT01572181|Fludarabine|fludarabine|mesh-list
101233555|NCT01572181|Busulfan|busulfan|mesh-list
101233556|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
101233557|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233558|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233559|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233560|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
101233561|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233562|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
101233563|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101233564|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101233566|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233567|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233569|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
101233570|NCT01572285|BB 1101|bb 1101|mesh-list
101233571|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233572|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
101233573|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
101233574|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233578|NCT01572285|Hormones|hormones|mesh-ancestor
101233579|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233580|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101233581|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233582|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
101233583|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233584|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233585|NCT01572324|Leucovorin|leucovorin|mesh-list
101233586|NCT01572324|Fluorouracil|fluorouracil|mesh-list
101233587|NCT01572324|Capecitabine|capecitabine|mesh-list
101233588|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
101233589|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
101233590|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233591|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233592|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233593|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233594|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
101233595|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233596|NCT01572324|Antidotes|antidotes|mesh-ancestor
101233597|NCT01572324|Protective Agents|protective agents|mesh-ancestor
101233598|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
101362144|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
101233599|NCT01572324|Vitamins|vitamins|mesh-ancestor
101233600|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
101233601|NCT01572350|Triamcinolone|triamcinolone|mesh-list
101233602|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101233603|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101233604|NCT01572350|Bevacizumab|bevacizumab|mesh-list
101233605|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101233606|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101233607|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233608|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101233609|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101233610|NCT01572350|Growth Substances|growth substances|mesh-ancestor
101362147|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233611|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233612|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
101233613|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233614|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
101233615|NCT01572350|Hormones|hormones|mesh-ancestor
101233616|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233617|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233618|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
101233619|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233620|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233621|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
101233622|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
101233623|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101233624|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101233625|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233626|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233627|NCT01572363|Urological Agents|urological agents|mesh-ancestor
101233628|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
101233629|NCT01572454|Remifentanil|remifentanil|mesh-list
101233630|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101233631|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233634|NCT01572454|Analgesics|analgesics|mesh-ancestor
101233635|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
101233636|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233637|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101233638|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101233639|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101233640|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101233641|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233642|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233643|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101233644|NCT01572454|Narcotics|narcotics|mesh-ancestor
101233645|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
101233646|NCT01572545|Denosumab|denosumab|mesh-list
101233647|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101233648|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233649|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
101233650|NCT01572558|Meropenem|meropenem|mesh-list
101233651|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233652|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233653|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101233654|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101233655|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233656|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233657|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233658|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101233659|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101233661|NCT01572597|Clarithromycin|clarithromycin|mesh-list
101233662|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
101233663|NCT01572597|Rabeprazole|rabeprazole|mesh-list
101233664|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233665|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233666|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101233667|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101233668|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101233669|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233670|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101233671|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233672|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233673|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101362595|NCT00044993|Docetaxel|docetaxel|mesh-list
101233674|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101233675|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101233676|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
101233677|NCT01572597|Expectorants|expectorants|mesh-ancestor
101233678|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101233679|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101362985|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233680|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
101233681|NCT01572597|Protective Agents|protective agents|mesh-ancestor
101233682|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233684|NCT01572623|Atorvastatin|atorvastatin|mesh-list
101233685|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101233686|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101233687|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
101233688|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363513|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233689|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233691|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233692|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233693|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101233694|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101233695|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101233696|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
101233697|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233698|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233699|NCT01572649|Lixisenatide|lixisenatide|mesh-list
101233700|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233701|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233702|NCT01572688|Melphalan|melphalan|mesh-list
101233703|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101233704|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
101233705|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233706|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233707|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101233708|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101233709|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
101233710|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233711|NCT01572805|Melatonin|melatonin|mesh-list
101364937|NCT00149539|Naloxone|naloxone|mesh-list
101233712|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
101233713|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233714|NCT01572805|Protective Agents|protective agents|mesh-ancestor
101233715|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233716|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233717|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
101233718|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
101233719|NCT01572831|Protective Agents|protective agents|mesh-ancestor
101233720|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233721|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
101233722|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101233723|NCT01572857|Antibodies|antibodies|mesh-list
101233724|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
101233725|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233726|NCT01572961|Aspirin|aspirin|mesh-list
101233727|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101233728|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101233729|NCT01572961|Analgesics|analgesics|mesh-ancestor
101233730|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
101233731|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233732|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233733|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233734|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101233735|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101233736|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101233737|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233738|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233739|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101233740|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365817|NCT00152893|Vitamins|vitamins|mesh-ancestor
101233741|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
101233743|NCT01573013|Trace Elements|trace elements|mesh-ancestor
101233745|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233746|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101233747|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101233748|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101233749|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
101233750|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233751|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233752|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101233753|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233754|NCT01573286|Glucagon|glucagon|mesh-list
101233755|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101233756|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233757|NCT01573286|Hormones|hormones|mesh-ancestor
101233758|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233759|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233760|NCT01573286|Incretins|incretins|mesh-ancestor
101233761|NCT01573338|Carboplatin|carboplatin|mesh-list
101233762|NCT01573338|Etoposide|etoposide|mesh-list
101233764|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101233765|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101233766|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101233767|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233768|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233769|NCT01573377|Metformin|metformin|mesh-list
101233770|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
101233771|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101233772|NCT01573377|Cyproterone|cyproterone|mesh-list
101233773|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101367124|NCT00052559|Fluorouracil|fluorouracil|mesh-list
101233774|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233775|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101233776|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101233777|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101233778|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
101233779|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101233780|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101233781|NCT01573377|Estrogens|estrogens|mesh-ancestor
101233782|NCT01573377|Hormones|hormones|mesh-ancestor
101233783|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233784|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
101233785|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
101233786|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233787|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101233789|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101233790|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
101233791|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233792|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233793|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101368091|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101233794|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233795|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101233796|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322175|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
101233797|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101233798|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233799|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233800|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233801|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
101233802|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233803|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101233804|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101233805|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101233806|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101233808|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233809|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233810|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101233811|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101233812|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101233813|NCT01573663|Dipropizine|dipropizine|mesh-list
101233814|NCT01573663|Ambroxol|ambroxol|mesh-list
101233815|NCT01573663|Expectorants|expectorants|mesh-ancestor
101233816|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
101233817|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
101233818|NCT01573715|Cisatracurium|cisatracurium|mesh-list
101233819|NCT01573715|Atracurium|atracurium|mesh-list
101233820|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101233821|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101233822|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233823|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233824|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101233825|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101233826|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101233827|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
101233828|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233829|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233830|NCT01573741|Ketamine|ketamine|mesh-list
101233831|NCT01573741|Analgesics|analgesics|mesh-ancestor
101233832|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
101233833|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233834|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233835|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101233836|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101233837|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
101233838|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
101233839|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101233840|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101233841|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101233842|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233843|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233844|NCT01573806|Exenatide|exenatide|mesh-list
101233845|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233846|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233847|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101233848|NCT01573806|Incretins|incretins|mesh-ancestor
101233849|NCT01573806|Hormones|hormones|mesh-ancestor
101233850|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233851|NCT01573975|Clarithromycin|clarithromycin|mesh-list
101233852|NCT01573975|Rabeprazole|rabeprazole|mesh-list
101233853|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101369668|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101233854|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233855|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101233856|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233857|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233858|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233859|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233860|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101233861|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101322184|NCT00088933|Metronidazole|metronidazole|mesh-list
101233862|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101233863|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
101233864|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101233865|NCT01574027|Vitamin D|vitamin d|mesh-list
101233866|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
101233867|NCT01574027|Vitamins|vitamins|mesh-ancestor
101233868|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
101233869|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233870|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101233873|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101233874|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101233875|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101233876|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233877|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233878|NCT01574131|Fenofibrate|fenofibrate|mesh-list
101233879|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369981|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101233880|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
101233881|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233882|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233883|NCT01574261|Inositol|inositol|mesh-list
101233884|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
101233885|NCT01574261|Vitamins|vitamins|mesh-ancestor
101233886|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
101233887|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233888|NCT01574313|Tocopherols|tocopherols|mesh-list
101233889|NCT01574313|Vitamin E|vitamin e|mesh-list
101233890|NCT01574313|Tocotrienols|tocotrienols|mesh-list
101233891|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
101233892|NCT01574313|Niacin|niacin|mesh-list
101233893|NCT01574313|Diphenidol|diphenidol|mesh-list
101233894|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
101233895|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233896|NCT01574313|Protective Agents|protective agents|mesh-ancestor
101233897|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233898|NCT01574313|Vitamins|vitamins|mesh-ancestor
101233899|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
101233900|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101233901|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
101233902|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101233903|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
101233904|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
101233905|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
101233906|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
101233907|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101233908|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101233909|NCT01574508|Insulin|insulin|mesh-list
101233910|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101233911|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233912|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233913|NCT01574638|Rifapentine|rifapentine|mesh-list
101233914|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101233915|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
101233916|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233917|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233918|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
101233919|NCT01574742|Minocycline|minocycline|mesh-list
101233920|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101233921|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233922|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
101370839|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
101233923|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233924|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233925|NCT01575158|Citalopram|citalopram|mesh-list
101233926|NCT01575158|Clomipramine|clomipramine|mesh-list
101233927|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322188|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
101233928|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101233929|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101233930|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233931|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101233932|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
101233933|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233934|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101233935|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
101233937|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101233939|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101233940|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233941|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
101233942|NCT01575301|Liraglutide|liraglutide|mesh-list
101233944|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233945|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233946|NCT01575301|Incretins|incretins|mesh-ancestor
101233947|NCT01575301|Hormones|hormones|mesh-ancestor
101233948|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233949|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101233950|NCT01575405|Tenofovir|tenofovir|mesh-list
101233951|NCT01575405|Glycerol|glycerol|mesh-list
101233952|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
101233953|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233954|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101233955|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101233956|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233957|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233958|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101233959|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101233960|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101233961|NCT01575405|Protective Agents|protective agents|mesh-ancestor
101233962|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233964|NCT01575418|Glycerol|glycerol|mesh-list
101233965|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
101233966|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233967|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101233968|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101233969|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233970|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233971|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101233972|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101233973|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101233975|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233976|NCT01575483|Saxagliptin|saxagliptin|mesh-list
101233977|NCT01575483|Incretins|incretins|mesh-ancestor
101233978|NCT01575483|Hormones|hormones|mesh-ancestor
101233979|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101233980|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101233981|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101233982|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
101233983|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101233984|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101233985|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101233986|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101233987|NCT01575613|Lumefantrine|lumefantrine|mesh-list
101233988|NCT01575613|Artemether|artemether|mesh-list
101233989|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101233990|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
101233991|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101233992|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101233993|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101233994|NCT01575626|Sevoflurane|sevoflurane|mesh-list
101233995|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101233996|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101233997|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
101233998|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
101233999|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234000|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234001|NCT01575639|Prednisolone|prednisolone|mesh-list
101234002|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372233|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
101234003|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
101234004|NCT01575639|Hormones|hormones|mesh-ancestor
101234005|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234006|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234007|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234008|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234009|NCT01575652|Lisinopril|lisinopril|mesh-list
101234010|NCT01575652|Perindopril|perindopril|mesh-list
101234011|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101234012|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101234013|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234014|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234015|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101234016|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101234017|NCT01575652|Protective Agents|protective agents|mesh-ancestor
101234018|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234019|NCT01575678|Melatonin|melatonin|mesh-list
101234020|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
101234021|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234022|NCT01575678|Protective Agents|protective agents|mesh-ancestor
101234023|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234024|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234025|NCT01575717|Vitamin D|vitamin d|mesh-list
101234026|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
101234027|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
101234028|NCT01575717|Vitamins|vitamins|mesh-list
101234029|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
101234030|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234031|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101234032|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234033|NCT01575782|Chloroquine|chloroquine|mesh-list
101234034|NCT01575782|Amebicides|amebicides|mesh-ancestor
101372765|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
101234035|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101234036|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101234037|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234038|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
101234039|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234040|NCT01575795|Ticagrelor|ticagrelor|mesh-list
101234041|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101234042|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101234043|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101234044|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101234045|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
101234046|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234047|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234048|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234049|NCT01576029|Docetaxel|docetaxel|mesh-list
101234050|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373111|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234052|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
101234053|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
101234054|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234055|NCT01576094|Simendan|simendan|mesh-list
101234056|NCT01576094|Milrinone|milrinone|mesh-list
101234057|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101234058|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
101234059|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101234060|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101234061|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234062|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234063|NCT01576094|Protective Agents|protective agents|mesh-ancestor
101234064|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234065|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101373112|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101234067|NCT01576185|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101234068|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234069|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234070|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234071|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234072|NCT01576263|Ropivacaine|ropivacaine|mesh-list
101234075|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234076|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234077|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
101234078|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234079|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
101234080|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101234081|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234082|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234083|NCT01576419|Celecoxib|celecoxib|mesh-list
101234084|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101234085|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234086|NCT01576419|Analgesics|analgesics|mesh-ancestor
101234087|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
101373754|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101234088|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234089|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234090|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234091|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234092|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101234093|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101234095|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234096|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101234097|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101234098|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234100|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
101234101|NCT01576627|Trace Elements|trace elements|mesh-ancestor
101234102|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
101234103|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234104|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
101234105|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
101234106|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101234107|NCT01576627|Protective Agents|protective agents|mesh-ancestor
101234108|NCT01576640|Bupropion|bupropion|mesh-list
101234109|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101234110|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
101234111|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101234112|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101234113|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101234114|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234115|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234116|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
101234117|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234118|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234119|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101374523|NCT00063089|Antibodies|antibodies|mesh-list
101322230|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
101234120|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101234121|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234122|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101234123|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101234124|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101234125|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234126|NCT01576692|Aldesleukin|aldesleukin|mesh-list
101234127|NCT01576692|Antibodies|antibodies|mesh-list
101234128|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
101234129|NCT01576692|Sargramostim|sargramostim|mesh-list
101234130|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
101374922|NCT00097032|Risperidone|risperidone|mesh-list
101374923|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101234131|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234132|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234133|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101234134|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101234135|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
101234136|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234138|NCT01576731|Emtricitabine|emtricitabine|mesh-list
101234139|NCT01576731|Lopinavir|lopinavir|mesh-list
101234140|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
101234141|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
101234142|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234143|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101234144|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101234145|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234146|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234147|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101234148|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101234149|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101234150|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101234151|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234152|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101234153|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101234154|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101234155|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101234156|NCT01576770|Lidocaine|lidocaine|mesh-list
101234157|NCT01576770|Tetracaine|tetracaine|mesh-list
101234158|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
101234159|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
101234160|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
101234161|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234162|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234163|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
101481845|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
101234164|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234165|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101234166|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101234167|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101234168|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234169|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234170|NCT01576848|Caseins|caseins|mesh-list
101234171|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
101234172|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
101234173|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234174|NCT01577017|Letrozole|letrozole|mesh-list
101234175|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101234176|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234177|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101234178|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234179|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234180|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101234181|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
101234182|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234183|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234184|NCT01577043|Racecadotril|racecadotril|mesh-list
101234185|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
101234186|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234187|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234188|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234189|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234190|NCT01577121|Indomethacin|indomethacin|mesh-list
101234191|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101234192|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234193|NCT01577121|Analgesics|analgesics|mesh-ancestor
101234194|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
101234195|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234196|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234197|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234198|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234199|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
101234200|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
101234201|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234205|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
101234206|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101234207|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234208|NCT01577199|Clomiphene|clomiphene|mesh-list
101234209|NCT01577199|Enclomiphene|enclomiphene|mesh-list
101234210|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
101234211|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101234212|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
101234213|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234214|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234215|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101234216|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
101234217|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234218|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101234219|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101234220|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
101234221|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234222|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234223|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101234224|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101234225|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234226|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234227|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234228|NCT01577368|Tazobactam|tazobactam|mesh-list
101234229|NCT01577368|Piperacillin|piperacillin|mesh-list
101234230|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101234231|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234232|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234233|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101234234|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234235|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234236|NCT01577407|Nefopam|nefopam|mesh-list
101234237|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234238|NCT01577407|Analgesics|analgesics|mesh-ancestor
101234239|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
101234240|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234241|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234243|NCT01577459|Tedizolid|tedizolid|mesh-list
101234244|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234245|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234246|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
101234247|NCT01577524|Povidone|povidone|mesh-list
101234248|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
101234249|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
101234250|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101234251|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234252|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101234253|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
101234254|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234255|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101234256|NCT01577589|Cephalosporins|cephalosporins|mesh-list
101234257|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234258|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234259|NCT01577693|Dutasteride|dutasteride|mesh-list
101482174|NCT00420030|Abciximab|abciximab|mesh-list
101234260|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101234261|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101234262|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234263|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234264|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
101234265|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234266|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234267|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101234268|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
101234269|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234270|NCT01577849|Vitamin D|vitamin d|mesh-list
101234271|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
101234272|NCT01577849|Vitamins|vitamins|mesh-ancestor
101234273|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
101234274|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234275|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101482229|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101234276|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234277|NCT01577862|Rifampin|rifampin|mesh-list
101234278|NCT01577862|Colistin|colistin|mesh-list
101234279|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101234280|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
101234281|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234282|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234283|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
101234284|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101234285|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234286|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234287|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101234288|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101234289|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101234290|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101234291|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101482280|NCT00304460|Aldesleukin|aldesleukin|mesh-list
101234292|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101234293|NCT01577914|Carvedilol|carvedilol|mesh-list
101234294|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101234295|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101234296|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
101234297|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234298|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234299|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482366|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
101234300|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101234301|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
101234302|NCT01577914|Protective Agents|protective agents|mesh-ancestor
101234303|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101234304|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234305|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234306|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
101234307|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101234308|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101234309|NCT01577940|Ropivacaine|ropivacaine|mesh-list
101234310|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
101234311|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
101234312|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234313|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234314|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
101234315|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482421|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234316|NCT01577992|Levodopa|levodopa|mesh-list
101234317|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101234318|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101234319|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
101234320|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234321|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234322|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234323|NCT01578057|Ethanol|ethanol|mesh-list
101234324|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101234325|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234326|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234327|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234328|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
101234329|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234330|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
101234331|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
101234332|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
101234334|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234335|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234336|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234337|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234338|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
101234339|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101234340|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234341|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234342|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234343|NCT01578161|Analgesics|analgesics|mesh-ancestor
101234344|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
101234345|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234346|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101234347|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101234348|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101234349|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
101234350|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234351|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234352|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
101234353|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101234354|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234355|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234356|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234357|NCT01578174|Analgesics|analgesics|mesh-ancestor
101234358|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
101234359|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234360|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101234361|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101234362|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101234363|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
101234364|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234365|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234366|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
101234367|NCT01578200|Calcium|calcium|mesh-list
101234368|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234369|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234370|NCT01578200|Antacids|antacids|mesh-ancestor
101234371|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234372|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234373|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
101234374|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234375|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234376|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482510|NCT00332904|Spironolactone|spironolactone|mesh-list
101234377|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234378|NCT01578252|Ondansetron|ondansetron|mesh-list
101234379|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
101234380|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
101234381|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234382|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234383|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234384|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
101234385|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
101234386|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101234387|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101234388|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
101234389|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234390|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234391|NCT01578265|Ondansetron|ondansetron|mesh-list
101234392|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
101234393|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
101234394|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234395|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234396|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234397|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
101234398|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
101234399|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101234400|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101234401|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
101234402|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234403|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234404|NCT01578304|Fesoterodine|fesoterodine|mesh-list
101234405|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101234406|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101234407|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
101234408|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234409|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234410|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234411|NCT01578304|Urological Agents|urological agents|mesh-ancestor
101234412|NCT01578343|Dexamethasone|dexamethasone|mesh-list
101234413|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
101234414|NCT01578343|Fludarabine|fludarabine|mesh-list
101234415|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
101234416|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
101234417|NCT01578343|Vorinostat|vorinostat|mesh-list
101234418|NCT01578343|BB 1101|bb 1101|mesh-list
101234419|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234420|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
101234421|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
101234422|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234423|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234424|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234425|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
101234426|NCT01578343|Hormones|hormones|mesh-ancestor
101234427|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234428|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234429|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234430|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234431|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234432|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234433|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101234434|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
101234435|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101234436|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
101234437|NCT01578343|Analgesics|analgesics|mesh-ancestor
101234438|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
101234439|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101234440|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101234441|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101482598|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234442|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
101234444|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
101234445|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
101234446|NCT01578434|Vitamins|vitamins|mesh-list
101234447|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
101234448|NCT01578434|Calcium|calcium|mesh-list
101234449|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
101234450|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234451|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234452|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101234453|NCT01578434|Antacids|antacids|mesh-ancestor
101234454|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234455|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234456|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101234457|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
101234458|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101234459|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
101234460|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234461|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234462|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101234463|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101234464|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234465|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234466|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101234467|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101234468|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101234469|NCT01578473|Vitamin D|vitamin d|mesh-list
101234470|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
101234471|NCT01578473|Vitamins|vitamins|mesh-list
101234472|NCT01578473|Vitamin E|vitamin e|mesh-list
101234473|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
101234474|NCT01578473|Testosterone|testosterone|mesh-list
101234475|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
101234476|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
101234477|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101482637|NCT00329628|Enoxaparin|enoxaparin|mesh-list
101234478|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
101234479|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234480|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101234481|NCT01578473|Androgens|androgens|mesh-ancestor
101234482|NCT01578473|Hormones|hormones|mesh-ancestor
101234483|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234484|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234485|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234486|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
101234487|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
101234488|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234489|NCT01578473|Protective Agents|protective agents|mesh-ancestor
101234490|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234491|NCT01578564|SOR-C13|sor-c13|mesh-list
101234492|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234493|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101234494|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234495|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234496|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234497|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234498|NCT01578603|Calcium|calcium|mesh-list
101234499|NCT01578603|Caseins|caseins|mesh-list
101234500|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234501|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234502|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
101234503|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
101234504|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234505|NCT01578629|Aspirin|aspirin|mesh-list
101234506|NCT01578629|Vitamin E|vitamin e|mesh-list
101234507|NCT01578629|Tocopherols|tocopherols|mesh-list
101234508|NCT01578629|Tocotrienols|tocotrienols|mesh-list
101234509|NCT01578629|Vitamins|vitamins|mesh-ancestor
101234510|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
101234511|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234512|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101234513|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234514|NCT01578629|Analgesics|analgesics|mesh-ancestor
101234515|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
101234516|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234517|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234518|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234519|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101234520|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101234521|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234522|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101234523|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101234524|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234525|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
101234526|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
101234527|NCT01578629|Protective Agents|protective agents|mesh-ancestor
101234528|NCT01578668|Pemetrexed|pemetrexed|mesh-list
101234529|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101234530|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234531|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234532|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234533|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101482663|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101234534|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101234535|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234537|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101234538|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101234539|NCT01578720|Growth Substances|growth substances|mesh-ancestor
101234540|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234541|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
101234542|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234543|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
101234545|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
101234546|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234547|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234548|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101234549|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101234550|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
101234551|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101234552|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101234553|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
101234554|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234555|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234556|NCT01578889|Vaccines|vaccines|mesh-list
101234557|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
101234558|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234560|NCT01578928|Hormones|hormones|mesh-ancestor
101234561|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234562|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234563|NCT01579019|Ritonavir|ritonavir|mesh-list
101234564|NCT01579019|Ribavirin|ribavirin|mesh-list
101234565|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101234566|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101234567|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101234568|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234569|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234570|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234571|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101234572|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101234573|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
101234574|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234575|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101234576|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101234577|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
101234578|NCT01579058|Bisoprolol|bisoprolol|mesh-list
101234579|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101234580|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
101234581|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
101234582|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234583|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234584|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101234585|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101234586|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101234587|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101234588|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234589|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234591|NCT01579110|Prednisone|prednisone|mesh-list
101234592|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234593|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
101234594|NCT01579110|Hormones|hormones|mesh-ancestor
101234595|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234596|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234597|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234598|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234599|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101234600|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
101234601|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
101234602|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
101234603|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101234604|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234605|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234606|NCT01579149|Plerixafor|plerixafor|mesh-list
101234607|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101234608|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101234609|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
101482791|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234610|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234612|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
101234613|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234614|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234615|NCT01579227|Tamoxifen|tamoxifen|mesh-list
101234616|NCT01579227|Tocotrienols|tocotrienols|mesh-list
101234617|NCT01579227|Vitamin E|vitamin e|mesh-list
101234618|NCT01579227|Tocopherols|tocopherols|mesh-list
101234619|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101234620|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
101234621|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234622|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234623|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234624|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234625|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101234626|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101234627|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101234628|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
101234629|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234630|NCT01579227|Protective Agents|protective agents|mesh-ancestor
101234631|NCT01579227|Vitamins|vitamins|mesh-ancestor
101234632|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
101234633|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101234634|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101234635|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101234636|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234637|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234638|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234639|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234640|NCT01579279|Analgesics|analgesics|mesh-ancestor
101234641|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
101234642|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234643|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
101234644|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101234645|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
101234646|NCT01579383|Sumatriptan|sumatriptan|mesh-list
101234647|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101234648|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101234649|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101482880|NCT00451139|Artemether|artemether|mesh-list
101234650|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
101234651|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234652|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234653|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234654|NCT01579448|Vaccines|vaccines|mesh-list
101234655|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
101234656|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234657|NCT01579461|Mirabegron|mirabegron|mesh-list
101234658|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101234659|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101234660|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101234661|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
101234662|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234663|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234664|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234665|NCT01579461|Urological Agents|urological agents|mesh-ancestor
101234666|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
101234667|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101234668|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101234669|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101234670|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234671|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234672|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
101234673|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101234674|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234675|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101234676|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234677|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
101234678|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101234679|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101234681|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
101234683|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101234684|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
101234685|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234686|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
101234687|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
101483128|NCT00334464|Warfarin|warfarin|mesh-list
101234688|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234689|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234691|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
101234692|NCT01579539|Hormones|hormones|mesh-ancestor
101234693|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234694|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101234695|NCT01579539|Protective Agents|protective agents|mesh-ancestor
101234696|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234697|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234698|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101483189|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
101234699|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101234701|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234702|NCT01579630|Pemetrexed|pemetrexed|mesh-list
101234703|NCT01579630|Gefitinib|gefitinib|mesh-list
101234704|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234705|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234706|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234707|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101234708|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101234709|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234710|NCT01579695|Tesamorelin|tesamorelin|mesh-list
101234711|NCT01579695|Growth Substances|growth substances|mesh-ancestor
101234712|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234713|NCT01579760|Aflibercept|aflibercept|mesh-list
101234714|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101234715|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101234717|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234718|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
101234719|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234720|NCT01579786|Acetaminophen|acetaminophen|mesh-list
101234721|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234722|NCT01579786|Analgesics|analgesics|mesh-ancestor
101234723|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
101234724|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234725|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234726|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
101234727|NCT01579838|Eculizumab|eculizumab|mesh-list
101234728|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101234729|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101234730|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
101234731|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234733|NCT01579864|Succinylcholine|succinylcholine|mesh-list
101234734|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101234735|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101234736|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101234737|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234738|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234739|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101234740|NCT01579890|Diclofenac|diclofenac|mesh-list
101234741|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101234742|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101234743|NCT01579890|Analgesics|analgesics|mesh-ancestor
101234744|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
101234745|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483356|NCT00453635|Carboplatin|carboplatin|mesh-list
101234746|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234747|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234749|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101234750|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234751|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234752|NCT01579903|Factor VIII|factor viii|mesh-list
101234753|NCT01579903|Coagulants|coagulants|mesh-ancestor
101234755|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234756|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101234757|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101234758|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101234759|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234760|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234761|NCT01579994|Crizotinib|crizotinib|mesh-list
101234762|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234763|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234764|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234765|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234766|NCT01580228|Ofatumumab|ofatumumab|mesh-list
101234767|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234768|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
101234769|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101234770|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101234771|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
101234772|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101234773|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
101234774|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234775|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234776|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101234777|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234778|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234779|NCT01581476|Quinapril|quinapril|mesh-list
101234780|NCT01581476|Atorvastatin|atorvastatin|mesh-list
101234781|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101234782|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101234783|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101234784|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
101234785|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234786|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101234787|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101234788|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234789|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
101234791|NCT01582321|Cantharidin|cantharidin|mesh-list
101234792|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234793|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234794|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
101234795|NCT01582438|Citric Acid|citric acid|mesh-list
101234796|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
101234797|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
101234798|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101234799|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
101234800|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
101234801|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234802|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
101234803|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101234804|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101483465|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
101234805|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234806|NCT01582438|Urological Agents|urological agents|mesh-ancestor
101234807|NCT01582711|Isoniazid|isoniazid|mesh-list
101234808|NCT01582711|Rifapentine|rifapentine|mesh-list
101234809|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
101234810|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234811|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234812|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101234813|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101234814|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
101234815|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483512|NCT00230477|Adefovir|adefovir|mesh-list
101234816|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101234817|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101234818|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
101234820|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
101234821|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
101234822|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234823|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483569|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101234824|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234825|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234826|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101234828|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101234829|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101234830|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234831|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
101234832|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
101234833|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
101234834|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234835|NCT01583972|Vitamin A|vitamin a|mesh-list
101234836|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
101234837|NCT01583972|Vitamins|vitamins|mesh-ancestor
101234838|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
101234839|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234840|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
101234841|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234842|NCT01583972|Protective Agents|protective agents|mesh-ancestor
101234843|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101483638|NCT00337506|Dexamethasone|dexamethasone|mesh-list
101234844|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234845|NCT01584362|Oxfendazole|oxfendazole|mesh-list
101234846|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
101234847|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101234848|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234849|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
101234850|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
101234851|NCT01584921|Hematinics|hematinics|mesh-ancestor
101234852|NCT01586013|Propofol|propofol|mesh-list
101234853|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101234854|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234855|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234856|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101234857|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
101234858|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
101234859|NCT01586845|Cyclosporine|cyclosporine|mesh-list
101234860|NCT01586845|Tacrolimus|tacrolimus|mesh-list
101234861|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101234862|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
101234863|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234864|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101234865|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234866|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234867|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
101234868|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234869|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
101234870|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101234871|NCT01587339|Pregabalin|pregabalin|mesh-list
101234872|NCT01587339|Zonisamide|zonisamide|mesh-list
101234873|NCT01587339|Lacosamide|lacosamide|mesh-list
101234874|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101234875|NCT01587339|Ezogabine|ezogabine|mesh-list
101234876|NCT01587339|Analgesics|analgesics|mesh-ancestor
101234877|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
101234878|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234879|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234880|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
101234881|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101234882|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234883|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234884|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101234885|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101234886|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101234887|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234888|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101234889|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101234890|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101234891|NCT01587378|Metformin|metformin|mesh-list
101234892|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101322279|NCT00423826|Cytarabine|cytarabine|mesh-list
101234893|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234894|NCT01587482|Paclitaxel|paclitaxel|mesh-list
101234895|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101234896|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234897|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
101483828|NCT00308321|Hormones|hormones|mesh-ancestor
101234898|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
101234899|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
101234900|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234901|NCT01587625|Oxytocin|oxytocin|mesh-list
101234902|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
101234903|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234904|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234905|NCT01587820|Cisplatin|cisplatin|mesh-list
101234906|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234907|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101234908|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101234909|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234910|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
101234911|NCT01588171|Enoxaparin|enoxaparin|mesh-list
101234912|NCT01588171|Bemiparin|bemiparin|mesh-list
101234913|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
101234914|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101234915|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101234916|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234917|NCT01588873|Desogestrel|desogestrel|mesh-list
101234919|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101234920|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101234921|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101234922|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
101234923|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234924|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234925|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101234926|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101234927|NCT01588873|Progestins|progestins|mesh-ancestor
101234928|NCT01588873|Hormones|hormones|mesh-ancestor
101234929|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234930|NCT01589367|Metformin|metformin|mesh-list
101234931|NCT01589367|Letrozole|letrozole|mesh-list
101483990|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101234932|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101234933|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234934|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234935|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101234936|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101234937|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234938|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234939|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101234940|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
101234941|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234943|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
101234944|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
101234945|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101234946|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234947|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
101234948|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101234949|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101234950|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101234951|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101234952|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101234953|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234954|NCT01589614|Erythromycin|erythromycin|mesh-list
101234955|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
101234956|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101234957|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
101234958|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101234959|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101234960|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101234961|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101234962|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234963|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234964|NCT01589861|Lapatinib|lapatinib|mesh-list
101234965|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234966|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234967|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234968|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234969|NCT01590173|Prednisolone|prednisolone|mesh-list
101234970|NCT01590173|Heparin|heparin|mesh-list
101234971|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101234972|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
101234973|NCT01590173|Hormones|hormones|mesh-ancestor
101234974|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234975|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234976|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101234977|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101234978|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
101234979|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101234980|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101234981|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484233|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
101234983|NCT01590199|Pasireotide|pasireotide|mesh-list
101234984|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101234985|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101234986|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101234987|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234990|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101234991|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484287|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101234992|NCT01590199|Hormones|hormones|mesh-ancestor
101234993|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101234994|NCT01590225|Ribavirin|ribavirin|mesh-list
101234995|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101234996|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
101234997|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
101234998|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101234999|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
101235000|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235001|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
101235002|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484345|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235003|NCT01590342|Diclofenac|diclofenac|mesh-list
101484347|NCT00418925|Hormones|hormones|mesh-ancestor
101235004|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101235005|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101235006|NCT01590342|Analgesics|analgesics|mesh-ancestor
101235007|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
101235008|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235009|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235010|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235011|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235012|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101235013|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235014|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235016|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
101235017|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101235018|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
101235019|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235020|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235021|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101235022|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101235023|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101235024|NCT01590537|Trace Elements|trace elements|mesh-ancestor
101235025|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
101235026|NCT01590641|Vesatolimod|vesatolimod|mesh-list
101235027|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
101235028|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235029|NCT01590654|Vesatolimod|vesatolimod|mesh-list
101235030|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
101235031|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235032|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
101235033|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101235034|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101235035|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101235036|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235037|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235038|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
101235039|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235040|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235041|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101235042|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235043|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101235044|NCT01590732|Carboplatin|carboplatin|mesh-list
101235045|NCT01590732|Etoposide|etoposide|mesh-list
101235046|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
101235047|NCT01590732|Ifosfamide|ifosfamide|mesh-list
101235048|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
101235049|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
101235050|NCT01590732|Romidepsin|romidepsin|mesh-list
101235051|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235052|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101235053|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101235055|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484407|NCT00311870|Lisinopril|lisinopril|mesh-list
101235056|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235057|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235058|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101235059|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
101235060|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
101235061|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
101235062|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
101235063|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
101235064|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101235065|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101235066|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101235067|NCT01590823|Dabigatran|dabigatran|mesh-list
101235068|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
101235069|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101235070|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
101235071|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235072|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235073|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
101235074|NCT01590836|Insulin|insulin|mesh-list
101235075|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101235076|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
101235077|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
101235078|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235079|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235080|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
101235081|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
101235082|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101235083|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235084|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235085|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101235086|NCT01590901|Probucol|probucol|mesh-list
101235087|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101235088|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101235089|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
101235090|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235091|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101235092|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
101235093|NCT01590901|Protective Agents|protective agents|mesh-ancestor
101235094|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235095|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
101235096|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101235097|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235098|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235099|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
101235100|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235101|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235102|NCT01591031|Sevoflurane|sevoflurane|mesh-list
101235103|NCT01591031|Rocuronium|rocuronium|mesh-list
101235104|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101235105|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101235106|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
101235107|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
101235108|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235109|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235110|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101235111|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101235112|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101235113|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235114|NCT01591070|Tacrolimus|tacrolimus|mesh-list
101235115|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235116|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
101235117|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484432|NCT00312104|Insulin|insulin|mesh-list
101235118|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101235120|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235121|NCT01591083|Esomeprazole|esomeprazole|mesh-list
101235122|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101235123|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235124|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101235125|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235126|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235127|NCT01591122|Prednisone|prednisone|mesh-list
101235128|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
101235129|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235130|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
101235131|NCT01591122|Hormones|hormones|mesh-ancestor
101235132|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235133|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235134|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101235135|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235136|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101235137|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235138|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235140|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101235141|NCT01591135|Paclitaxel|paclitaxel|mesh-list
101235142|NCT01591135|Fluorouracil|fluorouracil|mesh-list
101235143|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101235144|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235145|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
101235146|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
101235147|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
101235148|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235149|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
101235150|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101235151|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235152|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
101235153|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235154|NCT01591148|Propofol|propofol|mesh-list
101235155|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101235156|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235157|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235158|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101235159|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
101235160|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
101235161|NCT01591226|Mannitol|mannitol|mesh-list
101235162|NCT01591226|Caffeine|caffeine|mesh-list
101235163|NCT01591226|Citric Acid|citric acid|mesh-list
101235164|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
101484446|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235165|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
101235166|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101235167|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
101235168|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
101235169|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235170|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101235171|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235172|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101235173|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235174|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101235175|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101235176|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
101235177|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235178|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101235179|NCT01591226|Diuretics|diuretics|mesh-ancestor
101235180|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
101235181|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101235182|NCT01591434|Laxatives|laxatives|mesh-ancestor
101235183|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235184|NCT01591551|Natalizumab|natalizumab|mesh-list
101235186|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235187|NCT01591668|Vesatolimod|vesatolimod|mesh-list
101235188|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
101235189|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235190|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101235191|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
101235192|NCT01591850|Ritonavir|ritonavir|mesh-list
101235193|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101235194|NCT01591850|Rifampin|rifampin|mesh-list
101235195|NCT01591850|Ketoconazole|ketoconazole|mesh-list
101235196|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101235197|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101235198|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
101235199|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235200|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235201|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101235202|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235203|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
101235204|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235205|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101235206|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101235207|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101235208|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
101235209|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235210|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
101235211|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235212|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101235213|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101235214|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101235215|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101235216|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101235217|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101235218|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
101235219|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101235220|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101235221|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
101235222|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235223|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235225|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
101235226|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235227|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235228|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235229|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101235230|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101235231|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101235232|NCT01591902|Tesamorelin|tesamorelin|mesh-list
101235233|NCT01591902|Growth Substances|growth substances|mesh-ancestor
101235234|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235235|NCT01591980|Pregabalin|pregabalin|mesh-list
101235236|NCT01591980|Analgesics|analgesics|mesh-ancestor
101235237|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
101235238|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235239|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235240|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
101235241|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101235242|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235243|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235244|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101235245|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101235246|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101235247|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235248|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101235249|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101235250|NCT01592019|Diclofenac|diclofenac|mesh-list
101235251|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101235252|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101235253|NCT01592019|Analgesics|analgesics|mesh-ancestor
101235254|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
101235255|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235256|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235257|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235258|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235259|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101235260|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235261|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235262|NCT01592032|Vancomycin|vancomycin|mesh-list
101235263|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101235264|NCT01592032|Linezolid|linezolid|mesh-list
101235265|NCT01592032|Daptomycin|daptomycin|mesh-list
101235266|NCT01592032|Tigecycline|tigecycline|mesh-list
101235267|NCT01592032|Teicoplanin|teicoplanin|mesh-list
101235268|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
101235269|NCT01592032|Heparin|heparin|mesh-list
101235270|NCT01592032|Calcium heparin|calcium heparin|mesh-list
101235271|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101235272|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
101235273|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101235274|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101235275|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235276|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101235277|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235278|NCT01592136|Ponatinib|ponatinib|mesh-list
101235279|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235280|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101235281|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235282|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235283|NCT01592162|Remifentanil|remifentanil|mesh-list
101235284|NCT01592162|Propofol|propofol|mesh-list
101235285|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101235286|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235287|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235288|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101235289|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
101235291|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235292|NCT01592162|Narcotics|narcotics|mesh-ancestor
101235293|NCT01592162|Analgesics|analgesics|mesh-ancestor
101235294|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
101235295|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235296|NCT01592201|Olanzapine|olanzapine|mesh-list
101235297|NCT01592201|Risperidone|risperidone|mesh-list
101235298|NCT01592201|Aripiprazole|aripiprazole|mesh-list
101235299|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
101235300|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101235301|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
101235302|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235303|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235304|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235305|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101235306|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235307|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101235308|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101235309|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
101235310|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
101235311|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
101235312|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235313|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235315|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101235316|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235317|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
101235319|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101235320|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101235321|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101235322|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101235323|NCT01592214|Benzocaine|benzocaine|mesh-list
101235324|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
101235325|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
101235326|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235327|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235328|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
101235329|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235330|NCT01592227|Acetaminophen|acetaminophen|mesh-list
101235331|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101235332|NCT01592227|Analgesics|analgesics|mesh-ancestor
101235333|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
101235334|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235335|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235336|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
101235337|NCT01592253|Sirolimus|sirolimus|mesh-list
101235338|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235339|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235340|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101235341|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235342|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
101235343|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235344|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
101235345|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235346|NCT01592279|Liraglutide|liraglutide|mesh-list
101235347|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235348|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235349|NCT01592279|Incretins|incretins|mesh-ancestor
101235350|NCT01592279|Hormones|hormones|mesh-ancestor
101235351|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235352|NCT01592305|Ritonavir|ritonavir|mesh-list
101235353|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101235354|NCT01592305|Tenofovir|tenofovir|mesh-list
101235355|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101235356|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101235357|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
101235358|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235359|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235360|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101235361|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235362|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
101235363|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235364|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101235365|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101235366|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101235367|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235368|NCT01592318|Ritonavir|ritonavir|mesh-list
101235369|NCT01592318|Lactams|lactams|mesh-list
101235370|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101484549|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484551|NCT00347685|Tramadol|tramadol|mesh-list
101235371|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101235372|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
101235373|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235374|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235376|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235377|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
101235378|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235379|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101235380|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101235381|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235383|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101235384|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
101235385|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235386|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235387|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101235388|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101235389|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
101235390|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235391|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235392|NCT01592630|Ropivacaine|ropivacaine|mesh-list
101235393|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
101235394|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
101235395|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235396|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235397|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
101235398|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235399|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
101235400|NCT01592981|Rituximab|rituximab|mesh-list
101235402|NCT01592981|Bortezomib|bortezomib|mesh-list
101235403|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235404|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
101235405|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235406|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235407|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101235408|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
101235409|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235410|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235411|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101235412|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101235413|NCT01593033|Micronutrients|micronutrients|mesh-list
101235414|NCT01593033|Trace Elements|trace elements|mesh-list
101235415|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235416|NCT01593046|Cabotegravir|cabotegravir|mesh-list
101235417|NCT01593046|Rilpivirine|rilpivirine|mesh-list
101484607|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
101484617|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
101235418|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101235419|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101235420|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235421|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235423|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235424|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
101235425|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235426|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101235427|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235428|NCT01593124|Imiquimod|imiquimod|mesh-list
101235429|NCT01593124|Nonoxynol|nonoxynol|mesh-list
101235430|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101235431|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
101235432|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235433|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235434|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
101235435|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101235436|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101235437|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101484679|NCT00343707|Paroxetine|paroxetine|mesh-list
101235438|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
101235439|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235440|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101235441|NCT01593137|Metformin|metformin|mesh-list
101235442|NCT01593137|Liraglutide|liraglutide|mesh-list
101235443|NCT01593137|Glimepiride|glimepiride|mesh-list
101235444|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235445|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235446|NCT01593137|Incretins|incretins|mesh-ancestor
101235447|NCT01593137|Hormones|hormones|mesh-ancestor
101235448|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235449|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101235450|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235451|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
101235452|NCT01593150|Dabigatran|dabigatran|mesh-list
101235453|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
101235454|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101235455|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101235456|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322317|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101235457|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235458|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
101235459|NCT01593163|Ibuprofen|ibuprofen|mesh-list
101235460|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101235461|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101235462|NCT01593163|Analgesics|analgesics|mesh-ancestor
101235463|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
101235464|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484785|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101235465|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235466|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235467|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235468|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101235469|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235470|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235471|NCT01593280|Morphine|morphine|mesh-list
101235472|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235473|NCT01593280|Narcotics|narcotics|mesh-ancestor
101235474|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235476|NCT01593280|Analgesics|analgesics|mesh-ancestor
101235477|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
101235478|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235479|NCT01593293|Pemetrexed|pemetrexed|mesh-list
101235480|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235481|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235482|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235483|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101235484|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235485|NCT01593306|Paclitaxel|paclitaxel|mesh-list
101235486|NCT01593306|Cisplatin|cisplatin|mesh-list
101235487|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101235488|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235489|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
101235490|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
101235491|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484906|NCT00348504|Protective Agents|protective agents|mesh-ancestor
101484908|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
101235492|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235493|NCT01593319|Ropivacaine|ropivacaine|mesh-list
101235494|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
101235495|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
101235496|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235497|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235498|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
101235499|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235500|NCT01593332|Rituximab|rituximab|mesh-list
101235501|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101235502|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235503|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
101235504|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235505|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235506|NCT01593371|Metformin|metformin|mesh-list
101235507|NCT01593371|Pioglitazone|pioglitazone|mesh-list
101484962|NCT00344526|Hormones|hormones|mesh-ancestor
101235508|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235509|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235511|NCT01593397|Propofol|propofol|mesh-list
101235512|NCT01593397|Anesthetics|anesthetics|mesh-list
101235513|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101235514|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235515|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235516|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101235517|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
101235518|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235519|NCT01593397|Narcotics|narcotics|mesh-ancestor
101235520|NCT01593397|Analgesics|analgesics|mesh-ancestor
101235521|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
101235522|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235523|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101235524|NCT01593410|Dexamethasone|dexamethasone|mesh-list
101235525|NCT01593410|Lenalidomide|lenalidomide|mesh-list
101235526|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235527|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
101235528|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
101322321|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235529|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235530|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235531|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235532|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
101235534|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235535|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101235536|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235537|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
101235538|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101235539|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101235540|NCT01593410|Growth Substances|growth substances|mesh-ancestor
101235541|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
101235542|NCT01593501|Vitamin D|vitamin d|mesh-list
101485063|NCT00315536|Analgesics|analgesics|mesh-ancestor
101235543|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
101235544|NCT01593501|Vitamins|vitamins|mesh-ancestor
101235545|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
101235546|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235547|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101235548|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101235549|NCT01593514|Lactitol|lactitol|mesh-list
101235550|NCT01593514|Vaccines|vaccines|mesh-list
101235551|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
101235552|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235553|NCT01593514|Cathartics|cathartics|mesh-ancestor
101235554|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235555|NCT01593566|Bupivacaine|bupivacaine|mesh-list
101235556|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101235557|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
101235558|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235559|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235560|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
101235561|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235563|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
101235564|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235565|NCT01593605|Protective Agents|protective agents|mesh-ancestor
101235566|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235567|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235568|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101235569|NCT01593644|Adenosine|adenosine|mesh-list
101235570|NCT01593644|Dipyridamole|dipyridamole|mesh-list
101235571|NCT01593644|Analgesics|analgesics|mesh-ancestor
101235572|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
101235573|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235574|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235575|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101235576|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
101235577|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101235578|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
101235579|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
101235580|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235581|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235583|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235584|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101235585|NCT01593774|Melatonin|melatonin|mesh-list
101235586|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
101235587|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235588|NCT01593774|Protective Agents|protective agents|mesh-ancestor
101235589|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235590|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235591|NCT01593826|Budesonide|budesonide|mesh-list
101235592|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
101235593|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101235594|NCT01593826|Charcoal|charcoal|mesh-list
101235595|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235596|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101235597|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
101235598|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485227|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235599|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235600|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101235601|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
101235602|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
101235603|NCT01593826|Hormones|hormones|mesh-ancestor
101235604|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235605|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101235606|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101235607|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101235608|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
101235609|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235610|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235611|NCT01593826|Antidotes|antidotes|mesh-ancestor
101235612|NCT01593826|Protective Agents|protective agents|mesh-ancestor
101235613|NCT01593930|Lidocaine|lidocaine|mesh-list
101235614|NCT01593930|Carticaine|carticaine|mesh-list
101235615|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
101235616|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
101235617|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235618|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235619|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
101235620|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235621|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101375815|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235622|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101235623|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101235624|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235625|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235626|NCT01593995|Mitogens|mitogens|mesh-list
101235627|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
101235628|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235629|NCT01594047|Ketamine|ketamine|mesh-list
101235630|NCT01594047|Methadone|methadone|mesh-list
101235631|NCT01594047|Analgesics|analgesics|mesh-ancestor
101235632|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
101235633|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235634|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235635|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101235636|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101235637|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
101235638|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
101235639|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235640|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101235641|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101235642|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235643|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235644|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235645|NCT01594047|Narcotics|narcotics|mesh-ancestor
101235646|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
101235647|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101235649|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101235650|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
101235651|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
101235652|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235653|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235655|NCT01594099|Cisplatin|cisplatin|mesh-list
101235656|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101235657|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235658|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101235659|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101235660|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101235661|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235662|NCT01594177|Paclitaxel|paclitaxel|mesh-list
101235663|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
101235664|NCT01594177|Trastuzumab|trastuzumab|mesh-list
101235665|NCT01594177|Epirubicin|epirubicin|mesh-list
101235666|NCT01594177|Afatinib|afatinib|mesh-list
101235667|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101235668|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235669|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
101235670|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485366|NCT00344994|Protective Agents|protective agents|mesh-ancestor
101235672|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235673|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235674|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
101235675|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235676|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235677|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101235678|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
101235679|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101235680|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101235681|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101235682|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101235683|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101235684|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235685|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101235687|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101235688|NCT01594229|Venetoclax|venetoclax|mesh-list
101235689|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101235690|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235692|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235693|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235694|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101235695|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
101235696|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235697|NCT01594242|Bortezomib|bortezomib|mesh-list
101235698|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235699|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
101235700|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235701|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235702|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101235703|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101235704|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235705|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235706|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235707|NCT01594268|Everolimus|everolimus|mesh-list
101235708|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101235709|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101235710|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235712|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235713|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
101235714|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235715|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235716|NCT01594346|Vitamin E|vitamin e|mesh-list
101485460|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235717|NCT01594346|Tocopherols|tocopherols|mesh-list
101235718|NCT01594346|Tocotrienols|tocotrienols|mesh-list
101235719|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
101235720|NCT01594346|Vitamins|vitamins|mesh-ancestor
101235721|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
101235722|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235723|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
101235724|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235725|NCT01594346|Protective Agents|protective agents|mesh-ancestor
101235726|NCT01594489|Aminophylline|aminophylline|mesh-list
101235727|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101235728|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
101235729|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235730|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235731|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101235732|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101235733|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101235734|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101235735|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375873|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101235736|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235737|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101235738|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101235739|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
101235740|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235741|NCT01594489|Protective Agents|protective agents|mesh-ancestor
101235742|NCT01594502|Dutasteride|dutasteride|mesh-list
101235743|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101235744|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101235745|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235746|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235747|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
101235748|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235749|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235751|NCT01594619|Naloxegol|naloxegol|mesh-list
101235752|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101235753|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101235754|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235755|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235756|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536219|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
101235757|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235758|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
101235759|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101235760|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
101235761|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235762|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
101235763|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101235764|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101235765|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235766|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
101235767|NCT01594671|Coagulants|coagulants|mesh-ancestor
101235768|NCT01594697|Metformin|metformin|mesh-list
101235769|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235770|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235772|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
101485772|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101235773|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235774|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235775|NCT01594866|Dexetimide|dexetimide|mesh-list
101235776|NCT01594866|Citalopram|citalopram|mesh-list
101235777|NCT01594866|Escitalopram|escitalopram|mesh-list
101235778|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101235780|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235781|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235783|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
101235784|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235785|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101235786|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101235787|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
101235788|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
101235789|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235790|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101235791|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101235792|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
101235793|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101485827|NCT00319319|Mecamylamine|mecamylamine|mesh-list
101235794|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
101235795|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101235797|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101235798|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
101235799|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235800|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235801|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101235802|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101235803|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101235805|NCT01594905|Entecavir|entecavir|mesh-list
101235806|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
101235807|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235808|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101235809|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235810|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235811|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235812|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101235813|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235814|NCT01594918|Prednisone|prednisone|mesh-list
101235815|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
101235816|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101235817|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
101235818|NCT01594918|Hormones|hormones|mesh-ancestor
101235819|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235820|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235821|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101235822|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235823|NCT01594918|Analgesics|analgesics|mesh-ancestor
101235824|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
101235825|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235826|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101235827|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101235828|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235829|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235830|NCT01595009|Everolimus|everolimus|mesh-list
101235831|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101235832|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101235833|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235834|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235835|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235836|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
101235837|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235838|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235839|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
101235840|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
101235841|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235842|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235843|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101235845|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101235846|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101235847|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
101235848|NCT01595152|Fesoterodine|fesoterodine|mesh-list
101235849|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101235850|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101235851|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
101235852|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235853|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235854|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235855|NCT01595152|Urological Agents|urological agents|mesh-ancestor
101235856|NCT01595334|Cetrorelix|cetrorelix|mesh-list
101235857|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101235858|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
101235859|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235860|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235861|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
101235862|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235863|NCT01595399|Atropine|atropine|mesh-list
101235864|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101235865|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101235866|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101235867|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
101235868|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235869|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235870|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101235871|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
101235873|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
101235874|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101235875|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101235876|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
101235877|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101235878|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235879|NCT01595425|Esomeprazole|esomeprazole|mesh-list
101235880|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101235881|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101235882|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101235883|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235884|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235886|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101235887|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235888|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
101235889|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101235890|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101235892|NCT01595633|Adefovir|adefovir|mesh-list
101235893|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
101235894|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235895|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101235896|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235897|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235898|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235899|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101235900|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101235901|NCT01595685|Entecavir|entecavir|mesh-list
101235902|NCT01595685|Telbivudine|telbivudine|mesh-list
101235903|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
101235904|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235905|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101235906|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235907|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235908|NCT01595724|Dienogest|dienogest|mesh-list
101235909|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101235910|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
101235911|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101235912|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235913|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101235914|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101235915|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101235916|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101235917|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101235918|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235919|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101235920|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101235922|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101235923|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
101235924|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101235925|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101235926|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235927|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235928|NCT01595737|Protective Agents|protective agents|mesh-ancestor
101235929|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235930|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
101235931|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101235932|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101486210|NCT00352443|Everolimus|everolimus|mesh-list
101235933|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235934|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
101235935|NCT01595763|Coagulants|coagulants|mesh-ancestor
101235936|NCT01595789|Liraglutide|liraglutide|mesh-list
101235937|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235938|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235941|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101235942|NCT01595815|Calcium|calcium|mesh-list
101235943|NCT01595815|Ionophores|ionophores|mesh-list
101235944|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
101235945|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101235946|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235947|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101235948|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235949|NCT01595828|Pitavastatin|pitavastatin|mesh-list
101235950|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101235951|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101235952|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101235953|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
101235954|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235955|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235956|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101235957|NCT01595867|Naltrexone|naltrexone|mesh-list
101235958|NCT01595867|Morphine|morphine|mesh-list
101486279|NCT00352677|Bafetinib|bafetinib|mesh-list
101235959|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101235960|NCT01595867|Narcotics|narcotics|mesh-ancestor
101235961|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101235962|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235963|NCT01595867|Analgesics|analgesics|mesh-ancestor
101235964|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
101235965|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101235966|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101235967|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101235968|NCT01595880|Metformin|metformin|mesh-list
101235969|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101235970|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235971|NCT01595893|Vitamin D|vitamin d|mesh-list
101235972|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
101235973|NCT01595893|Vitamins|vitamins|mesh-ancestor
101235974|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
101235976|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101235977|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101235978|NCT01595958|Cyclosporine|cyclosporine|mesh-list
101235979|NCT01595958|Cyclosporins|cyclosporins|mesh-list
101235980|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235981|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235982|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101235983|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
101235984|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235985|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
101235986|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101235987|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
101235988|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101235989|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101235990|NCT01595984|Cyclosporine|cyclosporine|mesh-list
101235991|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
101235992|NCT01595984|Everolimus|everolimus|mesh-list
101235993|NCT01595984|Cyclosporins|cyclosporins|mesh-list
101235994|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101235995|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101235996|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486357|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
101235997|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
101235998|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101235999|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
101236000|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236001|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
101236002|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236003|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101236004|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101236005|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101236006|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236007|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101236008|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101236009|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
101236010|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236011|NCT01596010|Norethindrone|norethindrone|mesh-list
101236012|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
101236014|NCT01596010|Estrogens|estrogens|mesh-ancestor
101486432|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236015|NCT01596010|Hormones|hormones|mesh-ancestor
101236016|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236017|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236018|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101236019|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
101236020|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236021|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101236022|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101236023|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101236024|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101236025|NCT01596075|Cannabidiol|cannabidiol|mesh-list
101236026|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
101236027|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
101236028|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
101236029|NCT01596114|Protective Agents|protective agents|mesh-ancestor
101236030|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236031|NCT01596140|Sirolimus|sirolimus|mesh-list
101236032|NCT01596140|Everolimus|everolimus|mesh-list
101236033|NCT01596140|Temsirolimus|temsirolimus|mesh-list
101236034|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
101236035|NCT01596140|Vemurafenib|vemurafenib|mesh-list
101236036|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101236037|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236038|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236039|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101236040|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
101236041|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236042|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236043|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236044|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236045|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101236046|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
101236047|NCT01596166|Ketorolac|ketorolac|mesh-list
101236048|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101236049|NCT01596166|Metoclopramide|metoclopramide|mesh-list
101486529|NCT00324389|Interferons|interferons|mesh-list
101236050|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236051|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236052|NCT01596166|Analgesics|analgesics|mesh-ancestor
101236053|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
101236054|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236055|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236056|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236057|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236058|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101236059|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236060|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236061|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
101486616|NCT00332085|Chromium|chromium|mesh-list
101236062|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
101236063|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236064|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101236065|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101236066|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
101236067|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236068|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101236069|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101236070|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236071|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
101236072|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
101236073|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
101236074|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236075|NCT01596296|Dinoprostone|dinoprostone|mesh-list
101236076|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
101236077|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236078|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236079|NCT01596387|Propofol|propofol|mesh-list
101236080|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101236081|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236082|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236083|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101236084|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
101236085|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
101236086|NCT01596400|Granisetron|granisetron|mesh-list
101236087|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
101236088|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
101236089|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236090|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486675|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
101236091|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236092|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101236093|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236094|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
101236095|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236096|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236097|NCT01596413|Granisetron|granisetron|mesh-list
101236098|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
101236099|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
101236100|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236101|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236102|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236103|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101236104|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236105|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
101236106|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236107|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236108|NCT01596426|Granisetron|granisetron|mesh-list
101236109|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
101236110|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
101236111|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236112|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236113|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411545|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236114|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101236115|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236116|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
101236117|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236118|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375984|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101236120|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101236121|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
101236122|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
101236123|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236124|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
101236125|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236126|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
101236127|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236128|NCT01596556|Nicotine|nicotine|mesh-list
101236129|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101236130|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
101236131|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236132|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236133|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101236134|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101236135|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101236136|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322386|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236137|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236139|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236140|NCT01596647|Diclofenac|diclofenac|mesh-list
101236141|NCT01596647|Midazolam|midazolam|mesh-list
101236142|NCT01596647|Caffeine|caffeine|mesh-list
101236143|NCT01596647|Omeprazole|omeprazole|mesh-list
101236144|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101236145|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101236146|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236147|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236148|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101236149|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101236150|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101236151|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101236152|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
101236153|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
101236154|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
101236155|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
101236156|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236157|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236158|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101236159|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101236160|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236161|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101236162|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101236163|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
101236164|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101236165|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236166|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101236167|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236168|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236169|NCT01596647|Analgesics|analgesics|mesh-ancestor
101236170|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
101486887|NCT00325949|Analgesics|analgesics|mesh-ancestor
101236172|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236173|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236174|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101236176|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
101236177|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
101236178|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236179|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236180|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
101236181|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236182|NCT01596673|Hydrocodone|hydrocodone|mesh-list
101236183|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101236184|NCT01596673|Narcotics|narcotics|mesh-ancestor
101236185|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236186|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236187|NCT01596673|Analgesics|analgesics|mesh-ancestor
101236188|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
101236189|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236190|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
101236191|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236192|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
101236193|NCT01596686|Cathartics|cathartics|mesh-ancestor
101236194|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236195|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
101236196|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101236197|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101236198|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236199|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
101236200|NCT01596738|Coagulants|coagulants|mesh-ancestor
101236201|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
101236202|NCT01596764|Naloxone|naloxone|mesh-list
101236203|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
101236204|NCT01596764|Loperamide|loperamide|mesh-list
101236205|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
101236206|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101236207|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236208|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
101236209|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236210|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322389|NCT00089518|Valsartan|valsartan|mesh-list
101236211|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236212|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236213|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236215|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236216|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236217|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
101236218|NCT01596777|Naltrexone|naltrexone|mesh-list
101236219|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
101236220|NCT01596777|Loperamide|loperamide|mesh-list
101236221|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
101236222|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236223|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236224|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236225|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236226|NCT01596777|Analgesics|analgesics|mesh-ancestor
101236227|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
101236228|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236229|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236230|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236231|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236232|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101236233|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101236234|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
101236235|NCT01596803|Vitamin E|vitamin e|mesh-list
101236236|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
101236237|NCT01596803|Tocopherols|tocopherols|mesh-list
101236238|NCT01596803|Antioxidants|antioxidants|mesh-list
101236239|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236240|NCT01596803|Protective Agents|protective agents|mesh-ancestor
101236241|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236242|NCT01596803|Vitamins|vitamins|mesh-ancestor
101236243|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
101236244|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
101236245|NCT01596855|Hematinics|hematinics|mesh-ancestor
101236246|NCT01596868|Cisplatin|cisplatin|mesh-list
101236247|NCT01596868|Gemcitabine|gemcitabine|mesh-list
101236249|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236250|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101236252|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236253|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487033|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
101236254|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236255|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236256|NCT01596894|Azithromycin|azithromycin|mesh-list
101236257|NCT01596894|Metronidazole|metronidazole|mesh-list
101236258|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236259|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236260|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101236261|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101236262|NCT01596907|Ephedrine|ephedrine|mesh-list
101236263|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
101236264|NCT01596907|Caffeine|caffeine|mesh-list
101236265|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101236266|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236267|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101236268|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236269|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236270|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101236271|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101236272|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
101236273|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236274|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
101236275|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
101236276|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236277|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101487121|NCT00426972|Estradiol|estradiol|mesh-list
101236278|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236279|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101236280|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101236281|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236282|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
101236283|NCT01596998|Epinephrine|epinephrine|mesh-list
101236285|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
101236286|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
101236287|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101236288|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101236289|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236290|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236291|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236292|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236293|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101236294|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101236295|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
101236296|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236297|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101236298|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236299|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
101236300|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
101236301|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101236302|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
101236303|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
101236304|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236305|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
101236306|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101236307|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
101236308|NCT01597011|Coagulants|coagulants|mesh-ancestor
101236309|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
101236310|NCT01597167|Analgesics|analgesics|mesh-ancestor
101236311|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
101236312|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236313|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236314|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
101236315|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236318|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101236319|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101236320|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236321|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101236322|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
101236323|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236325|NCT01597206|Trace Elements|trace elements|mesh-ancestor
101236326|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
101236327|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236328|NCT01597232|Chrysarobin|chrysarobin|mesh-list
101236329|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236330|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236331|NCT01597232|Analgesics|analgesics|mesh-ancestor
101236332|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
101236333|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236334|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236335|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236336|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236337|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
101236338|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101236339|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101236340|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236341|NCT01597310|Pramipexole|pramipexole|mesh-list
101236342|NCT01597310|Warfarin|warfarin|mesh-list
101236343|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
101236344|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
101487267|NCT00432432|Infliximab|infliximab|mesh-list
101236345|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236346|NCT01597310|Protective Agents|protective agents|mesh-ancestor
101236347|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236348|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101236350|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
101236351|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
101236352|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236353|NCT01597336|Plasminogen|plasminogen|mesh-list
101236354|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101236355|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101236356|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101236357|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236358|NCT01597427|Clonidine|clonidine|mesh-list
101236359|NCT01597427|Analgesics|analgesics|mesh-ancestor
101236360|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
101236361|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236362|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236363|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101236364|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
101236365|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
101236366|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101236367|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101236368|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101236369|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236370|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236371|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236372|NCT01597518|Riluzole|riluzole|mesh-list
101236373|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
101236374|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101236375|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101236376|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236377|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236378|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236379|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101236380|NCT01597518|Protective Agents|protective agents|mesh-ancestor
101236381|NCT01597531|Liraglutide|liraglutide|mesh-list
101236382|NCT01597531|Orlistat|orlistat|mesh-list
101236383|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101236384|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236385|NCT01597531|Incretins|incretins|mesh-ancestor
101236386|NCT01597531|Hormones|hormones|mesh-ancestor
101236387|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236388|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236389|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236390|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101236391|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236392|NCT01597609|Sibutramine|sibutramine|mesh-list
101236393|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
101236394|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101236395|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
101236396|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101236397|NCT01597648|Maraviroc|maraviroc|mesh-list
101236398|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101236399|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101236400|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101236401|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236402|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101236403|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101236404|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
101236405|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236406|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101236407|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101236408|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101236409|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236410|NCT01597661|Bupropion|bupropion|mesh-list
101236411|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
101236412|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101236413|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101236414|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101236415|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101236416|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101236417|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236418|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
101236419|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236420|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236421|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101236422|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101236423|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236425|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101236426|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101236427|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
101236428|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236429|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236430|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
101236431|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101236432|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236433|NCT01597726|Misoprostol|misoprostol|mesh-list
101236434|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101236435|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
101236436|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236437|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236438|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101236439|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236440|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
101236442|NCT01597765|Vitamin E|vitamin e|mesh-list
101236443|NCT01597765|Tocopherols|tocopherols|mesh-list
101236444|NCT01597765|Tocotrienols|tocotrienols|mesh-list
101236445|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
101236446|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
101236447|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101236448|NCT01597765|Deferiprone|deferiprone|mesh-list
101236449|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
101236450|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236451|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
101236452|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236453|NCT01597765|Expectorants|expectorants|mesh-ancestor
101236454|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236456|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
101236457|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236458|NCT01597765|Protective Agents|protective agents|mesh-ancestor
101236459|NCT01597765|Antidotes|antidotes|mesh-ancestor
101236460|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101236461|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
101236462|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
101236463|NCT01597817|Chitosan|chitosan|mesh-list
101236464|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101236465|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101236466|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
101236467|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236468|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236469|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
101236470|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
101236471|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
101487771|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
101236472|NCT01597817|Coagulants|coagulants|mesh-ancestor
101236473|NCT01597895|Maraviroc|maraviroc|mesh-list
101236474|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101236475|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101236476|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236477|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101236478|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101236479|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
101236480|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236481|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101236482|NCT01597934|Tenofovir|tenofovir|mesh-list
101236483|NCT01597934|Entecavir|entecavir|mesh-list
101236484|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101236485|NCT01597934|Adefovir|adefovir|mesh-list
101236486|NCT01597934|Lamivudine|lamivudine|mesh-list
101236487|NCT01597934|Telbivudine|telbivudine|mesh-list
101236488|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
101376115|NCT00237484|Ribavirin|ribavirin|mesh-list
101236489|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236490|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101236491|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101236492|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236493|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236494|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101236495|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101236496|NCT01597986|Isavuconazole|isavuconazole|mesh-list
101236497|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101236498|NCT01597986|Norethindrone|norethindrone|mesh-list
101236499|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
101236501|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
101322409|NCT00089830|Squalamine|squalamine|mesh-list
101236503|NCT01597986|Estradiol|estradiol|mesh-list
101236504|NCT01597986|Estrogens|estrogens|mesh-ancestor
101236505|NCT01597986|Hormones|hormones|mesh-ancestor
101236506|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236507|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236508|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101236509|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236510|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101236511|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101236512|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101236513|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
101236514|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236515|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101236516|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
101236517|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236518|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236519|NCT01598012|Analgesics|analgesics|mesh-ancestor
101236520|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
101236521|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236522|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236523|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236524|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236525|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101236526|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487924|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236527|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236528|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
101236529|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101236530|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
101236531|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101236532|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
101236533|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236534|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236535|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
101236536|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
101236537|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101236538|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
101236539|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101236540|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
101236541|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236542|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236543|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
101236544|NCT01598259|Melatonin|melatonin|mesh-list
101236545|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
101236546|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236547|NCT01598259|Protective Agents|protective agents|mesh-ancestor
101236548|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236549|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236550|NCT01598337|Aspirin|aspirin|mesh-list
101236551|NCT01598337|Tirofiban|tirofiban|mesh-list
101236552|NCT01598337|Clopidogrel|clopidogrel|mesh-list
101236553|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101236554|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101236555|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236556|NCT01598337|Analgesics|analgesics|mesh-ancestor
101236557|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
101236558|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236559|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236560|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236561|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236562|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101236563|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101236564|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236565|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488217|NCT00330746|Gemcitabine|gemcitabine|mesh-list
101236566|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101236567|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236568|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
101236569|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101236570|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101236571|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101236572|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
101376185|NCT00076440|Leuprolide|leuprolide|mesh-list
101236573|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236575|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101236576|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101236577|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101236578|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
101236579|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236580|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236581|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101236582|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236583|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101236584|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101236585|NCT01598363|Protective Agents|protective agents|mesh-ancestor
101236586|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236588|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
101236589|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
101236590|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236591|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236592|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236593|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236594|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101236596|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101236597|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
101236598|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
101236599|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101236600|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101236601|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101236602|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
101236603|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101236604|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101236605|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101236606|NCT01598558|Rituximab|rituximab|mesh-list
101236607|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101236608|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236609|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
101236610|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236611|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236612|NCT01598584|Gemcitabine|gemcitabine|mesh-list
101236613|NCT01598584|Mirtazapine|mirtazapine|mesh-list
101236614|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101236615|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
101236616|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236617|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236618|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101236619|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101236620|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101236621|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
101236622|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
101236623|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236624|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236625|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101236626|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101236627|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236628|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101488388|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236629|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101236630|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101236631|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236632|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101236633|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236635|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101236638|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101236639|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236640|NCT01598649|Mannitol|mannitol|mesh-list
101236641|NCT01598649|Caseins|caseins|mesh-list
101236642|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101236643|NCT01598649|Diuretics|diuretics|mesh-ancestor
101236644|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
101236645|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488443|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
101236646|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
101236647|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
101236648|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236649|NCT01598675|Methamphetamine|methamphetamine|mesh-list
101236650|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101236651|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236652|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
101236653|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
101236654|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236655|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
101236656|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236657|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236658|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236659|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101236660|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101236661|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101236662|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101236664|NCT01598883|Calcium heparin|calcium heparin|mesh-list
101236665|NCT01598883|Antithrombins|antithrombins|mesh-list
101236666|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
101236667|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101236668|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101376204|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101236669|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236670|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101236671|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
101236672|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236673|NCT01598948|Mipomersen|mipomersen|mesh-list
101236674|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101236675|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101236676|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
101236677|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236678|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101236679|NCT01599000|Lumefantrine|lumefantrine|mesh-list
101236680|NCT01599000|Artemether|artemether|mesh-list
101236681|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101236682|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
101236683|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101236684|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101236685|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236686|NCT01599013|Carboplatin|carboplatin|mesh-list
101236687|NCT01599013|Gemcitabine|gemcitabine|mesh-list
101236688|NCT01599013|Vinblastine|vinblastine|mesh-list
101236689|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236690|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101236691|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
101236692|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236693|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101236694|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101236695|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236696|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236697|NCT01599078|Paclitaxel|paclitaxel|mesh-list
101236698|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101236699|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236700|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
101236701|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236702|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236703|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236705|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101236706|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101236707|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236708|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236709|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101236710|NCT01599130|Entecavir|entecavir|mesh-list
101236711|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
101236712|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236713|NCT01599273|Triamcinolone|triamcinolone|mesh-list
101236714|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236715|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
101236716|NCT01599273|Hormones|hormones|mesh-ancestor
101236717|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488834|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236718|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236720|NCT01599312|Trace Elements|trace elements|mesh-ancestor
101236721|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
101236722|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236723|NCT01599338|Liraglutide|liraglutide|mesh-list
101236725|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236726|NCT01599338|Incretins|incretins|mesh-ancestor
101236727|NCT01599338|Hormones|hormones|mesh-ancestor
101236728|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236729|NCT01599364|Ritonavir|ritonavir|mesh-list
101236730|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101236731|NCT01599364|Lamivudine|lamivudine|mesh-list
101236732|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101236733|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101236734|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
101236736|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236737|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101236738|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101236739|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
101236740|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236741|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101236742|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101236743|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101236744|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101236745|NCT01599377|Tofacitinib|tofacitinib|mesh-list
101236746|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101236747|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101236748|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236749|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236750|NCT05691088|Acetaminophen|acetaminophen|mesh-list
101236751|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236752|NCT05691088|Analgesics|analgesics|mesh-ancestor
101236753|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
101236754|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236756|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
101236758|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
101236759|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
101236760|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236761|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236762|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236763|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101236764|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101236765|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
101489021|NCT00334685|Pregabalin|pregabalin|mesh-list
101236766|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236767|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236768|NCT05690321|Opium|opium|mesh-list
101236769|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101236770|NCT05690321|Narcotics|narcotics|mesh-ancestor
101236771|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236772|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236773|NCT05690321|Analgesics|analgesics|mesh-ancestor
101236774|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
101236775|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236776|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
101236778|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
101236779|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236780|NCT05690191|Rituximab|rituximab|mesh-list
101236781|NCT05690191|Lenalidomide|lenalidomide|mesh-list
101236782|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101236783|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489084|NCT00436761|Melphalan|melphalan|mesh-list
101236784|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
101236785|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236786|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236787|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101236788|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101236789|NCT05690191|Growth Substances|growth substances|mesh-ancestor
101236790|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
101236791|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101236792|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101236793|NCT05689983|Budesonide|budesonide|mesh-list
101236794|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
101236795|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236796|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101236797|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
101236798|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236799|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236800|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101236801|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236802|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
101236803|NCT05689983|Hormones|hormones|mesh-ancestor
101236804|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101236805|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101236806|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101236807|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101236808|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236809|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236810|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236811|NCT05689957|Rocuronium|rocuronium|mesh-list
101236812|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101489230|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
101236813|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101236814|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101236815|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236816|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236817|NCT05689671|Paclitaxel|paclitaxel|mesh-list
101236818|NCT05689671|Carboplatin|carboplatin|mesh-list
101236819|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
101236820|NCT05689671|Pemetrexed|pemetrexed|mesh-list
101236821|NCT05689671|Atezolizumab|atezolizumab|mesh-list
101236822|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101236823|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236824|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101236825|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236826|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236827|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236828|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101489289|NCT00420836|Tobramycin|tobramycin|mesh-list
101236829|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101236830|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236831|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101236832|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101236833|NCT05689632|Vitamin D|vitamin d|mesh-list
101236834|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
101236835|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
101236836|NCT05689632|Vitamins|vitamins|mesh-list
101236837|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
101236838|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236839|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101236840|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101236841|NCT05689619|Silybin|silybin|mesh-list
101236842|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101236843|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236844|NCT05689619|Protective Agents|protective agents|mesh-ancestor
101236846|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
101236847|NCT05689242|Nalbuphine|nalbuphine|mesh-list
101322440|NCT00006167|Androgens|androgens|mesh-ancestor
101236848|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101236849|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236850|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236851|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101236852|NCT05689242|Analgesics|analgesics|mesh-ancestor
101236853|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
101236854|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236855|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101236856|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101236857|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101236858|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
101236859|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236860|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236861|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101236862|NCT05689242|Narcotics|narcotics|mesh-ancestor
101236863|NCT05689229|Colistin|colistin|mesh-list
101236864|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236865|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236866|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101236867|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101236868|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236869|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101236870|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236871|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101489470|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236872|NCT05688046|Growth Substances|growth substances|mesh-ancestor
101236873|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236874|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101236875|NCT05646563|Eculizumab|eculizumab|mesh-list
101236876|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101236877|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101236878|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
101236879|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236880|NCT05618132|Acetylcholine|acetylcholine|mesh-list
101236881|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
101236882|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101236883|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
101236884|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101236885|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236886|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236887|NCT05553808|Docetaxel|docetaxel|mesh-list
101236888|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236889|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
101236890|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
101236891|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236892|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236893|NCT05540184|Allopurinol|allopurinol|mesh-list
101236894|NCT05540184|Trimetazidine|trimetazidine|mesh-list
101236895|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
101236896|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236897|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101236898|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
101236899|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101236900|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101236902|NCT05540184|Protective Agents|protective agents|mesh-ancestor
101236903|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236904|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
101236905|NCT05473195|Isoniazid|isoniazid|mesh-list
101236906|NCT05473195|Ethionamide|ethionamide|mesh-list
101236907|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
101236908|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236926|NCT05344911|Propofol|propofol|mesh-list
101236927|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101236928|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489591|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
101236929|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236930|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101236931|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
101236932|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
101236933|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101236934|NCT05344911|Narcotics|narcotics|mesh-ancestor
101236935|NCT05344911|Analgesics|analgesics|mesh-ancestor
101236936|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
101236937|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236938|NCT05344417|Iodine|iodine|mesh-list
101236939|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101236940|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236941|NCT05344417|Trace Elements|trace elements|mesh-ancestor
101236942|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
101236943|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236944|NCT05338021|Vancomycin|vancomycin|mesh-list
101236945|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236946|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236947|NCT05338008|Vancomycin|vancomycin|mesh-list
101236948|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236949|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236950|NCT05281328|Octreotide|octreotide|mesh-list
101236951|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101236952|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101236953|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236954|NCT05251376|Morphine|morphine|mesh-list
101236955|NCT05251376|Methadone|methadone|mesh-list
101236956|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101236957|NCT05251376|Narcotics|narcotics|mesh-ancestor
101236958|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236959|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236960|NCT05251376|Analgesics|analgesics|mesh-ancestor
101236961|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
101236962|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101236963|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
101236964|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
101236975|NCT05191446|Ethanol|ethanol|mesh-list
101236976|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101236977|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236978|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101236979|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236980|NCT05189483|Paclitaxel|paclitaxel|mesh-list
101236981|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101236982|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101236983|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101236984|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
101236985|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
101376380|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
101376381|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236986|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
101236987|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101236989|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101236990|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101236991|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
101236992|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101236993|NCT05121974|Azithromycin|azithromycin|mesh-list
101236994|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
101236995|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101236996|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101236997|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
101236998|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101236999|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237000|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237001|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237002|NCT05064878|Fenfluramine|fenfluramine|mesh-list
101237003|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101237004|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101237005|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101237006|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237007|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237008|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
101237009|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237010|NCT04969250|Vaccines|vaccines|mesh-list
101237011|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
101237012|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237013|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
101237014|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237015|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237016|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237017|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237018|NCT04873557|Copper|copper|mesh-list
101237019|NCT04873557|Trace Elements|trace elements|mesh-ancestor
101237020|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
101237021|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237022|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
101237023|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101237024|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237025|NCT04789616|Maraviroc|maraviroc|mesh-list
101237026|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101237027|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101489793|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237028|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237029|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101237030|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101237031|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
101237032|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237033|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101237034|NCT04785300|Dasatinib|dasatinib|mesh-list
101237035|NCT04785300|Quercetin|quercetin|mesh-list
101237036|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237037|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237038|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237039|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237040|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
101489816|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
101237041|NCT04785300|Protective Agents|protective agents|mesh-ancestor
101237042|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237043|NCT04753216|Bevacizumab|bevacizumab|mesh-list
101237044|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101237045|NCT04753216|Irinotecan|irinotecan|mesh-list
101237046|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
101237047|NCT04753216|Antibodies|antibodies|mesh-list
101237048|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
101237050|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
101237051|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322460|NCT00090025|Protective Agents|protective agents|mesh-ancestor
101237053|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237054|NCT04753216|Growth Substances|growth substances|mesh-ancestor
101237055|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237056|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237057|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
101237058|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101237059|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237060|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237061|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237062|NCT04742634|Decitabine|decitabine|mesh-list
101237063|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489918|NCT00446433|Lenalidomide|lenalidomide|mesh-list
101237064|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
101237065|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237066|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237067|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237069|NCT04714619|Anastrozole|anastrozole|mesh-list
101237070|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237071|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101237072|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101237073|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237074|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237075|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101237076|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
101237077|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237078|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237079|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237080|NCT04690855|Atezolizumab|atezolizumab|mesh-list
101376481|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237081|NCT04690855|Talazoparib|talazoparib|mesh-list
101237082|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237083|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237084|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237085|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237086|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101237087|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237088|NCT04689945|Morphine|morphine|mesh-list
101376488|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
101237089|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101237091|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237092|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237093|NCT04689945|Analgesics|analgesics|mesh-ancestor
101237094|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
101237095|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237096|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101237097|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
101237098|NCT04643574|Fludarabine|fludarabine|mesh-list
101237099|NCT04643574|Interleukin-2|interleukin-2|mesh-list
101237100|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237101|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
101237102|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237103|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237104|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237105|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
101237106|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237107|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237108|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237109|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237111|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
101237112|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237113|NCT04563494|Dexamethasone|dexamethasone|mesh-list
101237114|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237115|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
101237116|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
101237117|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237118|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237119|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101237121|NCT04563494|Hormones|hormones|mesh-ancestor
101322469|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237122|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237123|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237124|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237125|NCT04541173|Bevacizumab|bevacizumab|mesh-list
101237126|NCT04541173|Atezolizumab|atezolizumab|mesh-list
101237127|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237128|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237129|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237130|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237131|NCT04541173|Growth Substances|growth substances|mesh-ancestor
101237132|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490069|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
101237134|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237135|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237136|NCT04530747|Metformin|metformin|mesh-list
101237137|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101237138|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237139|NCT04464174|Carboplatin|carboplatin|mesh-list
101237140|NCT04464174|Gemcitabine|gemcitabine|mesh-list
101237141|NCT04464174|Capecitabine|capecitabine|mesh-list
101237142|NCT04464174|Ipatasertib|ipatasertib|mesh-list
101237143|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237144|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101237145|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
101237146|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237147|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237148|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237149|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
101237150|NCT04456296|Testosterone|testosterone|mesh-list
101237151|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
101237152|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
101237154|NCT04456296|Androgens|androgens|mesh-ancestor
101237156|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237157|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237158|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237159|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237160|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
101237161|NCT04408118|Paclitaxel|paclitaxel|mesh-list
101237162|NCT04408118|Atezolizumab|atezolizumab|mesh-list
101237163|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237164|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237165|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237166|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237167|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237168|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237169|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237170|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237171|NCT04403321|Tacrolimus|tacrolimus|mesh-list
101237172|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237173|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
101237174|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237175|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101237176|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237177|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237178|NCT04265755|Erenumab|erenumab|mesh-list
101237179|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101237180|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237181|NCT04265755|Analgesics|analgesics|mesh-ancestor
101237182|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
101237183|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376565|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101237184|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237186|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101237187|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237188|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237189|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237190|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
101237191|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101237192|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101237193|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
101490182|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101237195|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237196|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237198|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237199|NCT04182334|TEMPO|tempo|mesh-list
101237202|NCT04182334|Protective Agents|protective agents|mesh-ancestor
101237203|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237204|NCT04123444|Iloprost|iloprost|mesh-list
101237205|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101237206|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
101237207|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101237208|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
101237209|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237210|NCT03967197|Lidocaine|lidocaine|mesh-list
101237211|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
101237212|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
101237213|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237214|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237215|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
101237216|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237217|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101237218|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101237219|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101237220|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101237221|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237222|NCT03935646|Adderall|adderall|mesh-list
101237223|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101237224|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237225|NCT03871153|Paclitaxel|paclitaxel|mesh-list
101237227|NCT03871153|Durvalumab|durvalumab|mesh-list
101237228|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237229|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237230|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237231|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237232|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237233|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237234|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237235|NCT03547999|Nivolumab|nivolumab|mesh-list
101237236|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237237|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237238|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237239|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237240|NCT03536728|Eflornithine|eflornithine|mesh-list
101376619|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
101237241|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237243|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101237244|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101237245|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237246|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101237247|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237248|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237249|NCT03517423|Brivaracetam|brivaracetam|mesh-list
101237250|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
101237251|NCT03470675|Ketamine|ketamine|mesh-list
101237252|NCT03470675|Morphine|morphine|mesh-list
101237253|NCT03470675|Analgesics|analgesics|mesh-ancestor
101237254|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
101237255|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237256|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237257|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101237258|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101237259|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
101237260|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
101490392|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
101237261|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237262|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101237263|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101237264|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237265|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237266|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101237267|NCT03470675|Narcotics|narcotics|mesh-ancestor
101237269|NCT03462251|Bevacizumab|bevacizumab|mesh-list
101237270|NCT03462251|Capecitabine|capecitabine|mesh-list
101237271|NCT03462251|Fulvestrant|fulvestrant|mesh-list
101237272|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101237273|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237274|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237275|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237276|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237277|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237278|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237279|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237280|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237281|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237282|NCT03462251|Growth Substances|growth substances|mesh-ancestor
101237283|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237284|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237285|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101237286|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
101237288|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101237289|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101237290|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
101237291|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237292|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101237294|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
101237295|NCT03340766|Blinatumomab|blinatumomab|mesh-list
101237296|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237297|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237298|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237299|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237300|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
101237301|NCT03294954|Fludarabine|fludarabine|mesh-list
101237302|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237303|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
101237304|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237305|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237306|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237307|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
101237308|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237309|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237310|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237311|NCT03274414|Cisplatin|cisplatin|mesh-list
101237312|NCT03274414|Etoposide|etoposide|mesh-list
101237313|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237314|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237315|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101237316|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237317|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237318|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237319|NCT03272685|Nicotine|nicotine|mesh-list
101237320|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101237321|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
101237322|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237323|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237324|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101237325|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101237326|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
101237327|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237328|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237329|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
101237331|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237332|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101490688|NCT00346229|Doxorubicin|doxorubicin|mesh-list
101237333|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237336|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101237338|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
101237339|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237340|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101237341|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
101237342|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237343|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101237344|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
101237345|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237346|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237347|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237348|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237349|NCT05705388|Liraglutide|liraglutide|mesh-list
101490754|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
101237350|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101237351|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237353|NCT05705388|Hormones|hormones|mesh-ancestor
101237354|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237355|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
101237356|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101237357|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101237358|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237359|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
101237360|NCT05705336|Coagulants|coagulants|mesh-ancestor
101237361|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
101237362|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101237363|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
101237364|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237365|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237366|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237367|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
101237368|NCT05704959|Povidone|povidone|mesh-list
101237369|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
101237370|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
101237371|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101237372|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237373|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
101237374|NCT05704894|Hematinics|hematinics|mesh-ancestor
101237375|NCT05704816|Anesthetics|anesthetics|mesh-list
101237376|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237377|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237378|NCT05704595|Diuretics|diuretics|mesh-list
101237379|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
101237380|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237381|NCT05704400|Rituximab|rituximab|mesh-list
101237382|NCT05704400|Daratumumab|daratumumab|mesh-list
101237383|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237384|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237385|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
101237386|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237387|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237389|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237390|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
101237391|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
101237392|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101237393|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237394|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101237395|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237396|NCT05703997|Atezolizumab|atezolizumab|mesh-list
101237397|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237398|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237399|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237400|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237402|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101237403|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237404|NCT05703555|Maytansine|maytansine|mesh-list
101237405|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237406|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237407|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237408|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237409|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237410|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237411|NCT05703373|Micronutrients|micronutrients|mesh-list
101237412|NCT05703373|Trace Elements|trace elements|mesh-list
101237413|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237414|NCT05702190|Opium|opium|mesh-list
101237415|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101237416|NCT05702190|Narcotics|narcotics|mesh-ancestor
101237417|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237418|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237419|NCT05702190|Analgesics|analgesics|mesh-ancestor
101237420|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
101237421|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237422|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
101237423|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101237424|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
101237425|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101237426|NCT05701124|Ranibizumab|ranibizumab|mesh-list
101237427|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237428|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237429|NCT05701124|Growth Substances|growth substances|mesh-ancestor
101237430|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237431|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237432|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237433|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
101237435|NCT05645380|Docetaxel|docetaxel|mesh-list
101237436|NCT05645380|Doxorubicin|doxorubicin|mesh-list
101237437|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
101237438|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237439|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
101237440|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237441|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237442|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237443|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
101237444|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237445|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237446|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237447|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237448|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237449|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237450|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101237451|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101237452|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237453|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237454|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237455|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237456|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
101237457|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
101237458|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237459|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
101237460|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
101237461|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237462|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237463|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237464|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
101237465|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
101237466|NCT05476939|Everolimus|everolimus|mesh-list
101237467|NCT05476939|TIC10 compound|tic10 compound|mesh-list
101237468|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101237469|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237470|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237471|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491209|NCT00449514|Tamoxifen|tamoxifen|mesh-list
101237472|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237473|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
101237474|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237475|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237476|NCT05458232|Tadalafil|tadalafil|mesh-list
101237477|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
101237478|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101237479|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101237480|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237481|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237482|NCT05458232|Urological Agents|urological agents|mesh-ancestor
101237484|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101237485|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237486|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
101237487|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101237488|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101237489|NCT05271799|Gepotidacin|gepotidacin|mesh-list
101237490|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237491|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237492|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237493|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237494|NCT05270733|Ustekinumab|ustekinumab|mesh-list
101237495|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237496|NCT05253417|Cannabidiol|cannabidiol|mesh-list
101237497|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
101237498|NCT05184803|Docetaxel|docetaxel|mesh-list
101237499|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
101237500|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237501|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237502|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237504|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237506|NCT05030506|Lenvatinib|lenvatinib|mesh-list
101237507|NCT05030506|Belzutifan|belzutifan|mesh-list
101237508|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237509|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237510|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237511|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237512|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237513|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237514|NCT04911621|Temozolomide|temozolomide|mesh-list
101237515|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237516|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
101237517|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237518|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237519|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
101237520|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
101237521|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101237522|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101237523|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
101237524|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237525|NCT04764643|Expectorants|expectorants|mesh-ancestor
101237526|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
101237527|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101237529|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237530|NCT04764643|Protective Agents|protective agents|mesh-ancestor
101237531|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237532|NCT04764643|Antidotes|antidotes|mesh-ancestor
101237533|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
101237534|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101237535|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
101237536|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
101237537|NCT04706429|Trientine|trientine|mesh-list
101237538|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
101237539|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
101237540|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237541|NCT04558892|Enoxaparin|enoxaparin|mesh-list
101237542|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
101237544|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101237545|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237547|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
101237548|NCT04551885|Fludarabine|fludarabine|mesh-list
101237550|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237551|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
101237552|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237553|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237554|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237555|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
101237556|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237557|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237558|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237559|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101237560|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101237561|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
101237562|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237563|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237564|NCT04304820|Cyclosporine|cyclosporine|mesh-list
101237565|NCT04304820|Cyclosporins|cyclosporins|mesh-list
101237566|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101237567|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237568|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237569|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237570|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
101237571|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237572|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
101237573|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237574|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237575|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237576|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101237577|NCT04199728|Liraglutide|liraglutide|mesh-list
101237578|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101237579|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237580|NCT04199728|Incretins|incretins|mesh-ancestor
101237581|NCT04199728|Hormones|hormones|mesh-ancestor
101237582|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237583|NCT04166435|Temozolomide|temozolomide|mesh-list
101237584|NCT04166435|Olaparib|olaparib|mesh-list
101237585|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237586|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
101237588|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237589|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101237590|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237591|NCT04077515|Sirolimus|sirolimus|mesh-list
101237592|NCT04077515|Temsirolimus|temsirolimus|mesh-list
101237593|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
101237594|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101237595|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237596|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101237597|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237598|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
101237599|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491709|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237600|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
101237601|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237602|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237603|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237604|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237605|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
101237606|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237607|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101237608|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237609|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237610|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
101237611|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237612|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237613|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101237615|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237616|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
101237617|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
101237618|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101237619|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
101237620|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101237621|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
101237622|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237623|NCT03841110|Aldesleukin|aldesleukin|mesh-list
101237624|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
101237626|NCT03841110|Nivolumab|nivolumab|mesh-list
101237627|NCT03841110|Fludarabine|fludarabine|mesh-list
101237628|NCT03841110|Atezolizumab|atezolizumab|mesh-list
101237630|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
101237631|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237632|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237633|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237634|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
101237635|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237637|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237638|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237639|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237640|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101237641|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101237642|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
101237643|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237644|NCT03810313|Aflibercept|aflibercept|mesh-list
101237645|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237646|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237647|NCT03810313|Growth Substances|growth substances|mesh-ancestor
101237648|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237649|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237650|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237651|NCT03802630|Aflibercept|aflibercept|mesh-list
101237652|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237653|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237654|NCT03802630|Growth Substances|growth substances|mesh-ancestor
101237655|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237656|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237657|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237658|NCT03785691|Ondansetron|ondansetron|mesh-list
101237659|NCT03785691|Mirtazapine|mirtazapine|mesh-list
101237660|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
101237661|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
101237662|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237663|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237664|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101237665|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
101237666|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237667|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101237668|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101237669|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
101237670|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492041|NCT00426101|Dexamethasone|dexamethasone|mesh-list
101237671|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237672|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101237673|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322521|NCT00091312|Leucovorin|leucovorin|mesh-list
101237674|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101237675|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
101237676|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
101237677|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101237678|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101237679|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237680|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101237681|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101237682|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101237683|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
101237684|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101237685|NCT03780829|Cycloserine|cycloserine|mesh-list
101237686|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101237687|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237688|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101237690|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101237691|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
101492109|NCT04705337|Simendan|simendan|mesh-list
101237692|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237693|NCT03736863|Apatinib|apatinib|mesh-list
101237694|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237695|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237696|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237697|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237698|NCT03710564|Aflibercept|aflibercept|mesh-list
101237699|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237700|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237701|NCT03710564|Growth Substances|growth substances|mesh-ancestor
101237702|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237703|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237704|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237705|NCT03703492|Estradiol|estradiol|mesh-list
101237706|NCT03703492|Estrogens|estrogens|mesh-ancestor
101237707|NCT03703492|Hormones|hormones|mesh-ancestor
101237708|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237709|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237710|NCT03624127|Apremilast|apremilast|mesh-list
101237711|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
101237712|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101237713|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237714|NCT03624127|Analgesics|analgesics|mesh-ancestor
101492212|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
101237715|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
101237716|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237717|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237718|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237719|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237720|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101237721|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101237722|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237723|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237724|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237725|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237726|NCT03499899|Carboplatin|carboplatin|mesh-list
101237727|NCT03499899|Spartalizumab|spartalizumab|mesh-list
101237728|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237729|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237730|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237731|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237732|NCT03481634|Aflibercept|aflibercept|mesh-list
101237733|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237734|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237735|NCT03481634|Growth Substances|growth substances|mesh-ancestor
101237736|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237737|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237738|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237739|NCT03476642|Epinephrine|epinephrine|mesh-list
101237740|NCT03476642|Ropivacaine|ropivacaine|mesh-list
101237741|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101237742|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
101322522|NCT00091312|Fluorouracil|fluorouracil|mesh-list
101237743|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101237744|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237745|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
101237746|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237747|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101237748|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101237749|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101237750|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237751|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237752|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101237753|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101237754|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
101237755|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101237756|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101237776|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237777|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237778|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237779|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237780|NCT03149003|Bevacizumab|bevacizumab|mesh-list
101237781|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237782|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237783|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492476|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237784|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237785|NCT03149003|Growth Substances|growth substances|mesh-ancestor
101237786|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237787|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
101237788|NCT03148275|Trametinib|trametinib|mesh-list
101237789|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237790|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237791|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237792|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237793|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
101237794|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101237795|NCT03106454|Norethindrone|norethindrone|mesh-list
101237796|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
101237797|NCT03106454|Estradiol|estradiol|mesh-list
101237798|NCT03106454|Estrogens|estrogens|mesh-ancestor
101237799|NCT03106454|Hormones|hormones|mesh-ancestor
101237800|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237801|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237802|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101237803|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
101237804|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101237805|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101237806|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101237807|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101237808|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101237809|NCT03106454|Trace Elements|trace elements|mesh-ancestor
101376894|NCT00241540|Esomeprazole|esomeprazole|mesh-list
101237810|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
101237811|NCT02990806|Infliximab|infliximab|mesh-list
101237812|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101237813|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237814|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101237815|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101237816|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237817|NCT02965703|Aspirin|aspirin|mesh-list
101237818|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101237819|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237820|NCT02965703|Analgesics|analgesics|mesh-ancestor
101237822|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237823|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237824|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237825|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237826|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101237827|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101237828|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237829|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101237830|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101237831|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237832|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
101237834|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101237835|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
101237836|NCT02938442|Doxorubicin|doxorubicin|mesh-list
101237837|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101237838|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101237839|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
101237840|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237841|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237842|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237843|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237844|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237845|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237846|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237847|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
101237848|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237849|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237850|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237851|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
101237852|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101492660|NCT00469443|Growth Substances|growth substances|mesh-ancestor
101492663|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
101237853|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101237854|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101237855|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237857|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101237858|NCT02650271|Tenofovir|tenofovir|mesh-list
101237859|NCT02650271|Entecavir|entecavir|mesh-list
101237860|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
101237861|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237862|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101237863|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101237864|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237865|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237866|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101237867|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101237868|NCT02420821|Bevacizumab|bevacizumab|mesh-list
101237869|NCT02420821|Atezolizumab|atezolizumab|mesh-list
101237870|NCT02420821|Sunitinib|sunitinib|mesh-list
101237871|NCT02420821|Antibodies|antibodies|mesh-list
101237872|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101237873|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101237874|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237875|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101237876|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101237877|NCT02420821|Growth Substances|growth substances|mesh-ancestor
101237878|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237879|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322537|NCT00091312|Antidotes|antidotes|mesh-ancestor
101237881|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101237882|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237883|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101237884|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237885|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
101237886|NCT02811263|Hematinics|hematinics|mesh-ancestor
101237887|NCT02398773|Estradiol|estradiol|mesh-list
101237888|NCT02398773|Estrogens|estrogens|mesh-ancestor
101237890|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237891|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237893|NCT02229084|Docetaxel|docetaxel|mesh-list
101237894|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
101237895|NCT02229084|Doxorubicin|doxorubicin|mesh-list
101237896|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101237897|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
101376918|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
101237898|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237899|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101237900|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237901|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237902|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237903|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237904|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237905|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
101237906|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237907|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237908|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237909|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
101237910|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101492812|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101237911|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101237912|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101237913|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237914|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237915|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101237916|NCT02188121|Losartan|losartan|mesh-list
101237917|NCT02188121|Simvastatin|simvastatin|mesh-list
101237918|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101237919|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101237920|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
101237921|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237922|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101237923|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101237924|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237925|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101237926|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101237927|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101237928|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101237929|NCT02039063|Quetmolimab|quetmolimab|mesh-list
101237930|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101237931|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237932|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
101237933|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237934|NCT01970410|Teriflunomide|teriflunomide|mesh-list
101237935|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101237936|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101237937|NCT01970410|Analgesics|analgesics|mesh-ancestor
101237938|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
101237939|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237940|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237941|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237942|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237943|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237944|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
101237945|NCT01746173|Plerixafor|plerixafor|mesh-list
101237946|NCT01746173|Prednisone|prednisone|mesh-list
101237947|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
101237948|NCT01746173|Melphalan|melphalan|mesh-list
101237949|NCT01746173|Busulfan|busulfan|mesh-list
101237950|NCT01746173|Gemcitabine|gemcitabine|mesh-list
101237951|NCT01746173|Doxorubicin|doxorubicin|mesh-list
101237952|NCT01746173|Etoposide|etoposide|mesh-list
101237953|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
101492938|NCT02957409|Valsartan|valsartan|mesh-list
101237954|NCT01746173|Vincristine|vincristine|mesh-list
101237955|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101237956|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
101237957|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237958|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101237959|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101237960|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
101237961|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237963|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101237964|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101237965|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
101237966|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101237967|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101237968|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101237969|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101237970|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101237971|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
101237973|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101237974|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101237975|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101237976|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
101237977|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
101237978|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
101237979|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101237980|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101237981|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
101237982|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101237983|NCT01694004|Benzocaine|benzocaine|mesh-list
101237984|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
101237985|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
101237986|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492982|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
101237987|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237988|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
101237989|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101237990|NCT01545843|Fluoxetine|fluoxetine|mesh-list
101237991|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101237992|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101237993|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101237994|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101237995|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101237996|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
101237997|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101237998|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101237999|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
101238000|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101238001|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101238002|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101238003|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238004|NCT00843791|Pioglitazone|pioglitazone|mesh-list
101238005|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101238006|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238007|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238008|NCT03187769|Olanzapine|olanzapine|mesh-list
101238009|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
101238010|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
101238011|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238012|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238013|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238014|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101238015|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101238016|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238017|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101376952|NCT00099060|Lapatinib|lapatinib|mesh-list
101238018|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101238019|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101238020|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238021|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238022|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238023|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
101238024|NCT03161353|Tamoxifen|tamoxifen|mesh-list
101493128|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
101238025|NCT03161353|Carboplatin|carboplatin|mesh-list
101238026|NCT03161353|Docetaxel|docetaxel|mesh-list
101238027|NCT03161353|Trastuzumab|trastuzumab|mesh-list
101238028|NCT03161353|Letrozole|letrozole|mesh-list
101238029|NCT03161353|Pertuzumab|pertuzumab|mesh-list
101376981|NCT02962024|Morphine|morphine|mesh-list
101238030|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238032|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
101238033|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
101238034|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238035|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238036|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101238037|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101238038|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238039|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101238040|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238041|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238042|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238043|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101238044|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101238045|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101493305|NCT00432653|Rituximab|rituximab|mesh-list
101238046|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101238048|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
101238049|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238050|NCT03134196|Valacyclovir|valacyclovir|mesh-list
101238051|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
101238052|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238053|NCT02956382|Venetoclax|venetoclax|mesh-list
101238054|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238055|NCT02939573|Dapsone|dapsone|mesh-list
101238056|NCT02939573|Colchicine|colchicine|mesh-list
101238057|NCT02939573|Azathioprine|azathioprine|mesh-list
101238058|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
101238059|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238060|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101238061|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101238062|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101238063|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238064|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238065|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
101238066|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101238067|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238068|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
101238069|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238070|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238071|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
101238072|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101238073|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101238074|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101238075|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493448|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
101238077|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101238078|NCT02876107|Paclitaxel|paclitaxel|mesh-list
101238079|NCT02876107|Carboplatin|carboplatin|mesh-list
101238080|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101238081|NCT02876107|Panitumumab|panitumumab|mesh-list
101238082|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101238083|NCT02876107|Antibodies|antibodies|mesh-list
101238084|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
101238086|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101238087|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238088|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101238089|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101238091|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238092|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
101238093|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238094|NCT02855229|Methylphenidate|methylphenidate|mesh-list
101238095|NCT02855229|Modafinil|modafinil|mesh-list
101238096|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101238097|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238098|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101238099|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101238100|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238101|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238102|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
101238103|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238104|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101238105|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101238106|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101238107|NCT02829931|Bevacizumab|bevacizumab|mesh-list
101238108|NCT02829931|Nivolumab|nivolumab|mesh-list
101238109|NCT02829931|Ipilimumab|ipilimumab|mesh-list
101238110|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238111|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238112|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101238113|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101493577|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238114|NCT02829931|Growth Substances|growth substances|mesh-ancestor
101238115|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238116|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
101238117|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101238118|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238119|NCT02815566|Tenofovir|tenofovir|mesh-list
101238120|NCT02815566|Emtricitabine|emtricitabine|mesh-list
101238121|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
101238122|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238123|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101238124|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101238125|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238126|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238127|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101238128|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101238129|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
101238130|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238131|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
101238132|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238133|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238134|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101238135|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
101238136|NCT02727803|Melphalan|melphalan|mesh-list
101238138|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
101238139|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101238140|NCT02727803|Rituximab|rituximab|mesh-list
101238141|NCT02727803|Fludarabine|fludarabine|mesh-list
101238142|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
101238143|NCT02727803|Clofarabine|clofarabine|mesh-list
101238144|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101238146|NCT02727803|Antibodies|antibodies|mesh-list
101238147|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
101238148|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101238149|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238150|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
101238151|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238152|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238153|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101238154|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
101238155|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238156|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238157|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101238158|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101238161|NCT02702492|Nivolumab|nivolumab|mesh-list
101238162|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238163|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493674|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238164|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101238165|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238166|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101238167|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
101238168|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101238169|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238170|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
101238172|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
101238173|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238174|NCT02652455|Aldesleukin|aldesleukin|mesh-list
101238175|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
101238177|NCT02652455|Fludarabine|fludarabine|mesh-list
101238178|NCT02652455|Interleukin-2|interleukin-2|mesh-list
101238179|NCT02652455|Antibodies|antibodies|mesh-list
101238180|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
101238181|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
101238182|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238183|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
101238184|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238185|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238186|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101238187|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
101238188|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238189|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238190|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101238191|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238192|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101238193|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238194|NCT02652455|Analgesics|analgesics|mesh-ancestor
101238195|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
101238196|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238197|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101238198|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101238199|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
101238200|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238201|NCT02491983|Letrozole|letrozole|mesh-list
101238202|NCT02491983|Fulvestrant|fulvestrant|mesh-list
101238203|NCT02491983|Palbociclib|palbociclib|mesh-list
101238204|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238205|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101238207|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238208|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238209|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101238210|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238211|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238212|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238213|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101238214|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101238215|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238217|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238218|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238219|NCT02467478|Incretins|incretins|mesh-ancestor
101238220|NCT02467478|Hormones|hormones|mesh-ancestor
101238221|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238222|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101238223|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
101238224|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238225|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238226|NCT02466243|Lenabasum|lenabasum|mesh-list
101238227|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101238228|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101238229|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238230|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238231|NCT02466243|Hormones|hormones|mesh-ancestor
101238232|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238233|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238234|NCT02321098|Amorolfine|amorolfine|mesh-list
101238235|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
101238236|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238237|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101238238|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
101238239|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101238240|NCT02185417|Diuretics|diuretics|mesh-ancestor
101238241|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
101238242|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238243|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101238244|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238245|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238246|NCT02158234|Cisplatin|cisplatin|mesh-list
101238247|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
101238248|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238249|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238250|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
101238251|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238252|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
101238253|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238254|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238255|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101238256|NCT01953926|Trastuzumab|trastuzumab|mesh-list
101238257|NCT01953926|Fulvestrant|fulvestrant|mesh-list
101238258|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238259|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238260|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101238261|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101493851|NCT02957630|Hormones|hormones|mesh-ancestor
101493856|NCT02957630|Diuretics|diuretics|mesh-ancestor
101238262|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101238263|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238264|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238266|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101238267|NCT01859026|Mitogens|mitogens|mesh-list
101238268|NCT01859026|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101238269|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238270|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238271|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238272|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238273|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101238274|NCT01843374|Tremelimumab|tremelimumab|mesh-list
101238275|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238276|NCT01657591|Vemurafenib|vemurafenib|mesh-list
101238277|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238278|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238279|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238280|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238281|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
101238282|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101238283|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101238284|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238285|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
101238286|NCT01599468|Coagulants|coagulants|mesh-ancestor
101238288|NCT01599572|Trace Elements|trace elements|mesh-ancestor
101238289|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
101238290|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238291|NCT01599598|Imidacloprid|imidacloprid|mesh-list
101238292|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
101238293|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322576|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
101238294|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238295|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238296|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101238297|NCT01599702|Hematinics|hematinics|mesh-ancestor
101238298|NCT01599728|Substance P|substance p|mesh-list
101238299|NCT01599728|Neurokinin A|neurokinin a|mesh-list
101238300|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238301|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494037|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101238302|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238304|NCT01599819|BAX 855|bax 855|mesh-list
101238305|NCT01599819|Coagulants|coagulants|mesh-ancestor
101238306|NCT01599858|Omeprazole|omeprazole|mesh-list
101238307|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101238308|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238309|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101238310|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494104|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238311|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238312|NCT01599871|Theophylline|theophylline|mesh-list
101238313|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101238314|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
101238315|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238316|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238317|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101238318|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
101494166|NCT00481923|Rimonabant|rimonabant|mesh-list
101238319|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101238320|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238321|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238322|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238323|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101238324|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101238325|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
101238326|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238327|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
101238328|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101238329|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
101238330|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238331|NCT01599884|Expectorants|expectorants|mesh-ancestor
101238333|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101238334|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
101238335|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238336|NCT01599884|Protective Agents|protective agents|mesh-ancestor
101238337|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238338|NCT01599884|Antidotes|antidotes|mesh-ancestor
101238340|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
101238341|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238342|NCT01599936|Antivenins|antivenins|mesh-list
101238343|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
101238344|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238345|NCT01599962|Cinacalcet|cinacalcet|mesh-list
101238346|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101238347|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238348|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101238349|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238350|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238351|NCT01599975|Methylphenidate|methylphenidate|mesh-list
101238352|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101238353|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238354|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101238355|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101238356|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238357|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238358|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
101238359|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238360|NCT01599988|Caseins|caseins|mesh-list
101238361|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
101238362|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
101238363|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238364|NCT01600430|Vitamin D|vitamin d|mesh-list
101238365|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
101238366|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
101238367|NCT01600430|Vitamins|vitamins|mesh-list
101238368|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
101238369|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238370|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101238371|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101238372|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
101238373|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101238374|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101238375|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494380|NCT00438152|Ritonavir|ritonavir|mesh-list
101238376|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
101238377|NCT01600599|Coagulants|coagulants|mesh-ancestor
101238378|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
101238379|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
101238380|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101238381|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101238382|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238383|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238384|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238385|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238386|NCT01602029|Ondansetron|ondansetron|mesh-list
101238387|NCT01602029|Simvastatin|simvastatin|mesh-list
101238388|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101238389|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101238391|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238392|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101238393|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101238394|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238395|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
101238396|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
101238397|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238398|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238399|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238401|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238402|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101238403|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101238404|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
101238405|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238406|NCT01602874|Metronidazole|metronidazole|mesh-list
101238407|NCT01602874|Clarithromycin|clarithromycin|mesh-list
101238408|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
101238409|NCT01602874|Tigecycline|tigecycline|mesh-list
101238410|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238411|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101238412|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101238413|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101238414|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101238415|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238416|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238417|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101238418|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101238419|NCT01602887|Palbociclib|palbociclib|mesh-list
101238420|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238421|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238422|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238423|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238424|NCT01603264|Trastuzumab|trastuzumab|mesh-list
101238425|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238426|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238427|NCT01603680|Anesthetics|anesthetics|mesh-list
101238428|NCT01603680|Mepivacaine|mepivacaine|mesh-list
101238429|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
101238430|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238431|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238432|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
101238433|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238434|NCT01604213|Metformin|metformin|mesh-list
101238435|NCT01604213|Vildagliptin|vildagliptin|mesh-list
101238436|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238437|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238438|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101238439|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
101494525|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238440|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238441|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238442|NCT01605240|Acetaminophen|acetaminophen|mesh-list
101238443|NCT01605240|Ibuprofen|ibuprofen|mesh-list
101238444|NCT01605240|Codeine|codeine|mesh-list
101238445|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238446|NCT01605240|Analgesics|analgesics|mesh-ancestor
101238447|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
101238448|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238449|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238450|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
101238451|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101238452|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238453|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238454|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101238455|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238456|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238457|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101238458|NCT01605240|Narcotics|narcotics|mesh-ancestor
101238459|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238460|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
101238461|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101238463|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101238464|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
101238465|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
101238466|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238467|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238468|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101238469|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101238470|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101238471|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
101238472|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238473|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238474|NCT01605279|Protective Agents|protective agents|mesh-ancestor
101238475|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101238476|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
101238477|NCT01606072|Coagulants|coagulants|mesh-ancestor
101238478|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101238479|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
101238480|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238481|NCT01606722|Ritonavir|ritonavir|mesh-list
101238482|NCT01606722|Darunavir|darunavir|mesh-list
101238483|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101238484|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101238485|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
101238486|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238487|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238488|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101238489|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101238490|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
101238491|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238492|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101238493|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101238494|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
101238495|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101238496|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
101238497|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238498|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238499|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101238500|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
101238501|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101238503|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238504|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238505|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101238506|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238507|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
101238508|NCT01607983|Protective Agents|protective agents|mesh-ancestor
101238510|NCT01608217|Dronabinol|dronabinol|mesh-list
101238511|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238512|NCT01608217|Analgesics|analgesics|mesh-ancestor
101238513|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
101238514|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238515|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238516|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
101238517|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
101238518|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101238519|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101238520|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101238521|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238522|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238523|NCT01608217|Hormones|hormones|mesh-ancestor
101238524|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238525|NCT01608594|Ipilimumab|ipilimumab|mesh-list
101238526|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238527|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238528|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101238529|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238530|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101494789|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
101238531|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238532|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
101238533|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238535|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
101238536|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101238537|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238538|NCT01609153|Olanzapine|olanzapine|mesh-list
101238539|NCT01609153|Amisulpride|amisulpride|mesh-list
101238540|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
101238541|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
101238542|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238543|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238544|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238545|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101238546|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101238547|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238548|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101238549|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101238550|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101238551|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494916|NCT00440609|Growth Substances|growth substances|mesh-ancestor
101238552|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238553|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238555|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101238556|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
101238557|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101238558|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
101238559|NCT01610141|Warfarin|warfarin|mesh-list
101238560|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
101238561|NCT01610310|Interferon-beta|interferon-beta|mesh-list
101494967|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238562|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238563|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
101238564|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238565|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
101238566|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238567|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
101238568|NCT01610362|Antibodies|antibodies|mesh-list
101238569|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
101238570|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101238571|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101238572|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
101238573|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
101238574|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238575|NCT01610401|Metformin|metformin|mesh-list
101238576|NCT01610401|Caffeine|caffeine|mesh-list
101238577|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238578|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238579|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101238580|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101238582|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238583|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101238584|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101238585|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
101238586|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238587|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
101238588|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238589|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101238590|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101238591|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238592|NCT01610869|Nintedanib|nintedanib|mesh-list
101238593|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238594|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238595|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238596|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238597|NCT01610921|Adenosine|adenosine|mesh-list
101238598|NCT01610921|Analgesics|analgesics|mesh-ancestor
101238599|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
101238600|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238601|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238602|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101238604|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101238605|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
101238606|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
101238607|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238608|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238609|NCT01610934|Liraglutide|liraglutide|mesh-list
101238610|NCT01610934|Glimepiride|glimepiride|mesh-list
101238611|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238612|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238613|NCT01610934|Incretins|incretins|mesh-ancestor
101238614|NCT01610934|Hormones|hormones|mesh-ancestor
101238615|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238616|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101238617|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238618|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
101238619|NCT01610947|Adalimumab|adalimumab|mesh-list
101238620|NCT01610947|Infliximab|infliximab|mesh-list
101377293|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
101238621|NCT01610947|Golimumab|golimumab|mesh-list
101238622|NCT01610947|Etanercept|etanercept|mesh-list
101238623|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101238624|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101238625|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238626|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238627|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238628|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238629|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101238630|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238631|NCT01610947|Analgesics|analgesics|mesh-ancestor
101238632|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
101238633|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238634|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238635|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238636|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
101238637|NCT01610999|Plerixafor|plerixafor|mesh-list
101238638|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101238639|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101238640|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
101238641|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238642|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
101238643|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101238644|NCT01611038|Protective Agents|protective agents|mesh-ancestor
101238645|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238646|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238647|NCT01611077|Amlodipine|amlodipine|mesh-list
101238648|NCT01611077|Candesartan|candesartan|mesh-list
101238649|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
101238650|NCT01611077|Olmesartan|olmesartan|mesh-list
101238651|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101238652|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101238653|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101238654|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238655|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238656|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101238657|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238658|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238659|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101238660|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101238661|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
101238662|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238664|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101238665|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238666|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238667|NCT01611324|Epinephrine|epinephrine|mesh-list
101238668|NCT01611324|Mepivacaine|mepivacaine|mesh-list
101238669|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101238670|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101238678|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238679|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101238680|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101238681|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
101238682|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
101238683|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101238684|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
101238685|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
101238686|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238687|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
101495443|NCT00440778|Abciximab|abciximab|mesh-list
101238688|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
101238689|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101238690|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238691|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238692|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238693|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
101238695|NCT01611415|Diuretics|diuretics|mesh-ancestor
101238696|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
101238697|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238698|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101495506|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
101238699|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238700|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238701|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101238703|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
101495576|NCT00441519|Aspirin|aspirin|mesh-list
101238704|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101238705|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238706|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238707|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238709|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101238710|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
101238711|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238712|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238713|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
101238714|NCT01611506|Capecitabine|capecitabine|mesh-list
101238715|NCT01611506|Cetuximab|cetuximab|mesh-list
101238716|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238717|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101238718|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
101238719|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238720|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101238721|NCT01611675|Vemurafenib|vemurafenib|mesh-list
101238722|NCT01611675|Leflunomide|leflunomide|mesh-list
101238723|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238724|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238725|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238726|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238727|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238728|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
101495817|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
101238729|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238730|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101238731|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
101238732|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238733|NCT01611727|Cisplatin|cisplatin|mesh-list
101238734|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238735|NCT01611896|Selenium|selenium|mesh-list
101238736|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
101238737|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495886|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
101238738|NCT01611896|Protective Agents|protective agents|mesh-ancestor
101238739|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238740|NCT01611896|Trace Elements|trace elements|mesh-ancestor
101238741|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
101238742|NCT01611909|Terpin|terpin|mesh-list
101238743|NCT01611909|Expectorants|expectorants|mesh-ancestor
101238744|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
101238745|NCT01611961|Docetaxel|docetaxel|mesh-list
101238746|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377395|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101238747|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
101238748|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
101238749|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101238750|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238751|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101238752|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238753|NCT01612065|Misoprostol|misoprostol|mesh-list
101238754|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101238755|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
101377401|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
101238756|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101238757|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238758|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101238759|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101238760|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
101238761|NCT01612078|Droxidopa|droxidopa|mesh-list
101238762|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101238763|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101238764|NCT01612247|Aspirin|aspirin|mesh-list
101238765|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
101238766|NCT01612247|Methotrexate|methotrexate|mesh-list
101238767|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238768|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
101238769|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238770|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101496172|NCT00456560|Paroxetine|paroxetine|mesh-list
101238771|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101238772|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
101238773|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238774|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238775|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101238776|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101238777|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
101238778|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101238779|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101238780|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
101238781|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238782|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496251|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101238783|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101238784|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101238785|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101238786|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238787|NCT01612247|Analgesics|analgesics|mesh-ancestor
101238788|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
101238789|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238790|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238791|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101238793|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101238794|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101238796|NCT01612273|Aspirin|aspirin|mesh-list
101238797|NCT01612273|Triflusal|triflusal|mesh-list
101238798|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101238799|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238800|NCT01612273|Analgesics|analgesics|mesh-ancestor
101496366|NCT00458081|Hormones|hormones|mesh-ancestor
101238801|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
101238802|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238803|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238804|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238805|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238806|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101238807|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101238808|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238809|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101238810|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101238811|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238812|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
101238813|NCT01612286|Endostatins|endostatins|mesh-list
101238814|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101238815|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101238816|NCT01612286|Growth Substances|growth substances|mesh-ancestor
101238817|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238818|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
101238819|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238821|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101238822|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238823|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238824|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238825|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238826|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
101238827|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238828|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238830|NCT01612377|Prednisolone|prednisolone|mesh-list
101238831|NCT01612377|Dipyridamole|dipyridamole|mesh-list
101238832|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238833|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
101238834|NCT01612377|Hormones|hormones|mesh-ancestor
101238835|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238836|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238837|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101238838|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238839|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101238840|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238841|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322609|NCT00006206|Acamprosate|acamprosate|mesh-list
101238842|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101238843|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
101238846|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238847|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238848|NCT01612468|Liraglutide|liraglutide|mesh-list
101238849|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238850|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238851|NCT01612468|Incretins|incretins|mesh-ancestor
101238852|NCT01612468|Hormones|hormones|mesh-ancestor
101238853|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238854|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101238855|NCT01612507|Cephalosporins|cephalosporins|mesh-list
101238856|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101238857|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238858|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101238859|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101238860|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238861|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238862|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101238863|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238864|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238865|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238866|NCT01612741|Acarbose|acarbose|mesh-list
101238867|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101238868|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238869|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238870|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238871|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238872|NCT01612832|Pregabalin|pregabalin|mesh-list
101238873|NCT01612832|Analgesics|analgesics|mesh-ancestor
101238874|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
101238875|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238876|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238877|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
101238878|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101238879|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101238880|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238881|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101238882|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101238883|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101238884|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101238885|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101238887|NCT01612871|Letrozole|letrozole|mesh-list
101238888|NCT01612871|Anastrozole|anastrozole|mesh-list
101238889|NCT01612871|Exemestane|exemestane|mesh-list
101238890|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238891|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101238892|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101238893|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238894|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238895|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101238896|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
101238897|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238898|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238899|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101238900|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101238901|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101238902|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101238903|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101238904|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101238905|NCT01612910|Protective Agents|protective agents|mesh-ancestor
101238906|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238907|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238908|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101238909|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101238910|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322632|NCT00390195|Everolimus|everolimus|mesh-list
101238912|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101238913|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101238914|NCT01612975|Analgesics|analgesics|mesh-ancestor
101238915|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
101238916|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101238917|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238918|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101238919|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238920|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
101238921|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101238922|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238923|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238924|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
101497067|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377567|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238925|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101238926|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101238927|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238928|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101238929|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101238930|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377573|NCT00067535|Cocaine|cocaine|mesh-list
101238931|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238932|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238933|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101238934|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
101238935|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101238936|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238937|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101238938|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101238939|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101238940|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
101238941|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238942|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101238943|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238944|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238945|NCT01613079|Methotrexate|methotrexate|mesh-list
101238946|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101238947|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
101497148|NCT00490308|Estradiol|estradiol|mesh-list
101238948|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101238949|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238950|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101238951|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
101238952|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238953|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238954|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
101238955|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238956|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101238957|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101238958|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
101238959|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101238960|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101238961|NCT01613092|Vancomycin|vancomycin|mesh-list
101238962|NCT01613092|Clindamycin|clindamycin|mesh-list
101238963|NCT01613092|Cefazolin|cefazolin|mesh-list
101238964|NCT01613092|Cephalexin|cephalexin|mesh-list
101238965|NCT01613092|Bacitracin|bacitracin|mesh-list
101497202|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
101238966|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101238967|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238968|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101238969|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238970|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238971|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101238972|NCT01613105|Acarbose|acarbose|mesh-list
101238973|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101238974|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101238975|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238976|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101238977|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238978|NCT01613170|Estrogens|estrogens|mesh-list
101238979|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101238980|NCT01613170|Hormones|hormones|mesh-ancestor
101238981|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101238982|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101238984|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
101238985|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238986|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
101238987|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101238988|NCT01613209|Candesartan|candesartan|mesh-list
101238989|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
101238991|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101238992|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101238993|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101238994|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101238995|NCT01613300|Ofatumumab|ofatumumab|mesh-list
101238996|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101238997|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
101238998|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101238999|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101239000|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239001|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
101239002|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
101239004|NCT01613469|Antidotes|antidotes|mesh-ancestor
101239005|NCT01613469|Protective Agents|protective agents|mesh-ancestor
101239006|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239007|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
101239008|NCT01613469|Vitamins|vitamins|mesh-ancestor
101239009|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
101239010|NCT01613482|Trastuzumab|trastuzumab|mesh-list
101239011|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101239012|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239013|NCT01613534|Sucralfate|sucralfate|mesh-list
101239014|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101377619|NCT00424801|Nicorandil|nicorandil|mesh-list
101239015|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239016|NCT01613547|Amoxicillin|amoxicillin|mesh-list
101239017|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239018|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239019|NCT01613573|Hormones|hormones|mesh-list
101239020|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239021|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239022|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101239023|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
101239024|NCT01613664|Coagulants|coagulants|mesh-ancestor
101239025|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
101239026|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101239027|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101239028|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101239029|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
101239030|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497508|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239031|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239032|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239035|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239036|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239037|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101239038|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239039|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239040|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101239041|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
101239042|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101239043|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101239044|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101239045|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
101239046|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239047|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101239048|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101239049|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239050|NCT01613807|Insulin|insulin|mesh-list
101239051|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101239052|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
101497656|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
101239053|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101239056|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239057|NCT01613820|Scopolamine|scopolamine|mesh-list
101239058|NCT01613820|Ketamine|ketamine|mesh-list
101239059|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101239060|NCT01613820|Analgesics|analgesics|mesh-ancestor
101239061|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
101239062|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239063|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239064|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101239065|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239066|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
101239067|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
101239068|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239069|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101239070|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101239071|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239072|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239073|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101239075|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
101239076|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239077|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
101239078|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101239079|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
101239080|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101239081|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
101239082|NCT01613846|Sorafenib|sorafenib|mesh-list
101239083|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239084|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101239085|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239086|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239087|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101239088|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101497851|NCT00492258|Sorafenib|sorafenib|mesh-list
101239089|NCT01613963|Cyclosporine|cyclosporine|mesh-list
101239090|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
101239091|NCT01613963|Prednisolone|prednisolone|mesh-list
101239092|NCT01613963|Adalimumab|adalimumab|mesh-list
101239093|NCT01613963|Infliximab|infliximab|mesh-list
101239094|NCT01613963|Etanercept|etanercept|mesh-list
101239095|NCT01613963|Methotrexate|methotrexate|mesh-list
101239096|NCT01613963|Azathioprine|azathioprine|mesh-list
101239097|NCT01613963|Cyclosporins|cyclosporins|mesh-list
101239098|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101239099|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239100|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
101239101|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239102|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239103|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101239104|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
101239105|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239106|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101239107|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
101239108|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239109|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
101239110|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239111|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101239112|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101239113|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
101239114|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239115|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101239116|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101239117|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101239118|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
101239119|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239120|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239121|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
101239122|NCT01613963|Hormones|hormones|mesh-ancestor
101239123|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239124|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101239125|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239126|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239127|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101239128|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239129|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239130|NCT01613963|Analgesics|analgesics|mesh-ancestor
101239131|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
101239132|NCT01613976|Panobinostat|panobinostat|mesh-list
101239133|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239134|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101239135|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239136|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239137|NCT01614041|Tandospirone|tandospirone|mesh-list
101498042|NCT00468182|Interferons|interferons|mesh-list
101239138|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101239139|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239140|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239141|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239142|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239143|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101239144|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
101239145|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239146|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239147|NCT01614132|Cisplatin|cisplatin|mesh-list
101239148|NCT01614132|Vincristine|vincristine|mesh-list
101239149|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239150|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239151|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101239152|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101239153|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239154|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239155|NCT01614223|Betamethasone|betamethasone|mesh-list
101239156|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239157|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
101239158|NCT01614223|Hormones|hormones|mesh-ancestor
101239159|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239160|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239161|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101239162|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239163|NCT01614236|Pregabalin|pregabalin|mesh-list
101239164|NCT01614236|Analgesics|analgesics|mesh-ancestor
101239165|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
101239166|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239167|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239168|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
101239169|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101239170|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377699|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
101239171|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239172|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101239173|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101239174|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239175|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239176|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239177|NCT01614301|Pioglitazone|pioglitazone|mesh-list
101239178|NCT01614301|Sirolimus|sirolimus|mesh-list
101239179|NCT01614301|Etoricoxib|etoricoxib|mesh-list
101239180|NCT01614301|Temsirolimus|temsirolimus|mesh-list
101239181|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
101239182|NCT01614301|Dacarbazine|dacarbazine|mesh-list
101239183|NCT01614301|Trofosfamide|trofosfamide|mesh-list
101498213|NCT00499707|Metformin|metformin|mesh-list
101239184|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239185|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239186|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101239187|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239188|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239189|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101239190|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
101239191|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239192|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239193|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239194|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101239195|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
101239196|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101239198|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239199|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239200|NCT01614301|Analgesics|analgesics|mesh-ancestor
101239201|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
101239202|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239203|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239204|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239205|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101239206|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101239208|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101239209|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101239210|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239211|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239212|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101239213|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239214|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498450|NCT01243788|Xhance|xhance|mesh-list
101239215|NCT01614405|Ritonavir|ritonavir|mesh-list
101239216|NCT01614405|Lopinavir|lopinavir|mesh-list
101239217|NCT01614405|Tenofovir|tenofovir|mesh-list
101239218|NCT01614405|Emtricitabine|emtricitabine|mesh-list
101239219|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101239220|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101239221|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101239222|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
101498477|NCT01243827|Protective Agents|protective agents|mesh-ancestor
101239223|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239224|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239225|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101239226|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101239227|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
101239228|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239229|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101239230|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101239231|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101239232|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101239233|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
101239234|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101239235|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
101239236|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239237|NCT01614431|Expectorants|expectorants|mesh-ancestor
101239238|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239239|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101239240|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
101239241|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239242|NCT01614431|Protective Agents|protective agents|mesh-ancestor
101239243|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239245|NCT01614496|Insulin|insulin|mesh-list
101239246|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239247|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239248|NCT01614535|Remifentanil|remifentanil|mesh-list
101239249|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101239250|NCT01614535|Narcotics|narcotics|mesh-ancestor
101239251|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239252|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239253|NCT01614535|Analgesics|analgesics|mesh-ancestor
101239254|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
101498669|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498671|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
101239255|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239257|NCT01614938|Docetaxel|docetaxel|mesh-list
101239258|NCT01614938|Cetuximab|cetuximab|mesh-list
101239259|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239260|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
101239261|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239262|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239263|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239264|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101239265|NCT01614964|Lumefantrine|lumefantrine|mesh-list
101239266|NCT01614964|Artemether|artemether|mesh-list
101239267|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101322654|NCT00091936|Lamivudine|lamivudine|mesh-list
101239268|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
101239269|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101239270|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101239271|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239272|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101239273|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101239275|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
101239276|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239277|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101239278|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101239280|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101239281|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239283|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
101239284|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239285|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101239286|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101239287|NCT01615042|Growth Substances|growth substances|mesh-ancestor
101498885|NCT00599950|Mitomycins|mitomycins|mesh-list
101239288|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
101239289|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239290|NCT01615055|Fluoxetine|fluoxetine|mesh-list
101239291|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101239292|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101239293|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239294|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239295|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239296|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
101239297|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239298|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101239299|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
101239300|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239301|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101498922|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101239302|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101239303|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239304|NCT01615081|Insulin|insulin|mesh-list
101239305|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239306|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239307|NCT01615107|Oxytocin|oxytocin|mesh-list
101239308|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
101239309|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239310|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239311|NCT01615185|Amisulpride|amisulpride|mesh-list
101239312|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101239313|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239314|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239315|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239316|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239317|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101239318|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
101239319|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239320|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239321|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101239322|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
101239324|NCT01615211|Trilostane|trilostane|mesh-list
101239325|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239326|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101239327|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101239328|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239329|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239330|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101239331|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
101239332|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499033|NCT00475358|Analgesics|analgesics|mesh-ancestor
101499034|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
101239333|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239334|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101239335|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
101239336|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239337|NCT01615224|Misoprostol|misoprostol|mesh-list
101239338|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101239339|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
101239340|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239341|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239342|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101239343|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239344|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
101499082|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
101239345|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101239346|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101239347|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101239348|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101239349|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
101239350|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239351|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239352|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101239353|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101239354|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101239355|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101239356|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101239357|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101239358|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101239359|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101239361|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
101239362|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239363|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
101239364|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239365|NCT01615445|Resveratrol|resveratrol|mesh-list
101239366|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
101239367|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239368|NCT01615445|Protective Agents|protective agents|mesh-ancestor
101239369|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239370|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239371|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101239372|NCT01615601|Ritonavir|ritonavir|mesh-list
101239373|NCT01615601|Darunavir|darunavir|mesh-list
101239374|NCT01615601|Etravirine|etravirine|mesh-list
101239375|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101239376|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101239377|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101239378|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101239379|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239380|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499184|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
101239381|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101239382|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
101239383|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239384|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101239385|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101239386|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101239387|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101239388|NCT01615614|Rilpivirine|rilpivirine|mesh-list
101239389|NCT01615614|Rifabutin|rifabutin|mesh-list
101239390|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101239391|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101239392|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239393|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239394|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
101239395|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239397|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101239398|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239399|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101239400|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
101239401|NCT01615627|Treprostinil|treprostinil|mesh-list
101239402|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101239403|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101239404|NCT01615757|Cytarabine|cytarabine|mesh-list
101239405|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101239406|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
101239407|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239408|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239409|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
101239410|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239411|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101239412|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
101239413|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239414|NCT01615796|Gepotidacin|gepotidacin|mesh-list
101239415|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101239416|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239417|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499446|NCT01246440|Catumaxomab|catumaxomab|mesh-list
101499447|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239418|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239419|NCT01615913|Ketoconazole|ketoconazole|mesh-list
101239420|NCT01615913|Terbinafine|terbinafine|mesh-list
101239421|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
101239422|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239423|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101239424|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101239425|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239426|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499508|NCT01325428|Afatinib|afatinib|mesh-list
101239427|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101239428|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
101239429|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239430|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239431|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101239432|NCT01615978|Liraglutide|liraglutide|mesh-list
101239433|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239434|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239435|NCT01615978|Incretins|incretins|mesh-ancestor
101239436|NCT01615978|Hormones|hormones|mesh-ancestor
101239437|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239438|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
101239439|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101239440|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
101239441|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
101499663|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239442|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239443|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239444|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239445|NCT01616004|Analgesics|analgesics|mesh-ancestor
101239446|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
101239447|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239448|NCT01616069|Simendan|simendan|mesh-list
101239449|NCT01616069|Epinephrine|epinephrine|mesh-list
101239450|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101239451|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101239452|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
101239453|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239454|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239455|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239456|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101239457|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101239458|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
101239459|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239460|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101239461|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239462|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
101239463|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
101239464|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101239465|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101239466|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
101239467|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101239468|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101239471|NCT01616108|Bupivacaine|bupivacaine|mesh-list
101239472|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
101239473|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
101239474|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239475|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239476|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
101239477|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239478|NCT01616186|Everolimus|everolimus|mesh-list
101239480|NCT01616186|Sunitinib|sunitinib|mesh-list
101239481|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101239482|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101239483|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239484|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239485|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101239486|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
101239487|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239488|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239489|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101239490|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101239491|NCT01616186|Growth Substances|growth substances|mesh-ancestor
101239492|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101239494|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239495|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239496|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101239498|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
101239499|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239500|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
101239501|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
101239502|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101239503|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101239504|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239505|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239506|NCT01616381|Urological Agents|urological agents|mesh-ancestor
101239507|NCT01616407|Methylphenidate|methylphenidate|mesh-list
101239508|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101239509|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101239510|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239511|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101500057|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239512|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101239513|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239514|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239516|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239518|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239519|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
101239520|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101239521|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
101239523|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
101239524|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239525|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
101500097|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
101239526|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101239527|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101239528|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239529|NCT01616485|Urological Agents|urological agents|mesh-ancestor
101239531|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239532|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239533|NCT01616615|Analgesics|analgesics|mesh-ancestor
101239534|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
101239535|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239536|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239537|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239538|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239539|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101239540|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101239541|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239542|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101239543|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101239544|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239545|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
101239546|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101239547|NCT01616680|Antibodies|antibodies|mesh-list
101239548|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
101239549|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101239551|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
101239552|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239553|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101239554|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239555|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
101239556|NCT01616732|Testosterone|testosterone|mesh-list
101239557|NCT01616732|Androgens|androgens|mesh-ancestor
101239558|NCT01616732|Hormones|hormones|mesh-ancestor
101239559|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239560|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239561|NCT01616784|Insulin|insulin|mesh-list
101239562|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101239563|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
101239564|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239565|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239566|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
101239567|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239568|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101239569|NCT01616875|Cisplatin|cisplatin|mesh-list
101239570|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239571|NCT01616888|Paclitaxel|paclitaxel|mesh-list
101239572|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101239573|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239574|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101239575|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239576|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239577|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239579|NCT01616927|Somatostatin|somatostatin|mesh-list
101239580|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239581|NCT01616927|Hormones|hormones|mesh-ancestor
101239582|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239583|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239585|NCT01616966|Propofol|propofol|mesh-list
101239587|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101239588|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239589|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239590|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239592|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
101239593|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101239594|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101239595|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101239596|NCT01616966|Narcotics|narcotics|mesh-ancestor
101239597|NCT01616966|Analgesics|analgesics|mesh-ancestor
101239598|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
101239599|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239600|NCT01616992|Bupivacaine|bupivacaine|mesh-list
101239601|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
101239602|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
101239603|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239604|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239605|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
101239606|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239607|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
101239608|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101239609|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239610|NCT01617135|Levodopa|levodopa|mesh-list
101239611|NCT01617135|Carbidopa|carbidopa|mesh-list
101239612|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101239613|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101239614|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101239615|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
101239616|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239617|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239618|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239619|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101239620|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239621|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101239622|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
101239623|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
101239624|NCT01617200|Olanzapine|olanzapine|mesh-list
101239625|NCT01617200|Asenapine|asenapine|mesh-list
101378540|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239626|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
101239627|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
101239628|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239629|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239630|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239631|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101239632|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239633|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378566|NCT00253318|Dexamethasone|dexamethasone|mesh-list
101239634|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239635|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101239636|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101239637|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239638|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239639|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239640|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
101239641|NCT01617213|Lenalidomide|lenalidomide|mesh-list
101239642|NCT01617213|Melphalan|melphalan|mesh-list
101239643|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
101239644|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239645|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101239646|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101239647|NCT01617213|Growth Substances|growth substances|mesh-ancestor
101239648|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
101239649|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239650|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101239651|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
101378999|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239652|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239654|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101239655|NCT01617226|Azacitidine|azacitidine|mesh-list
101239656|NCT01617226|Vorinostat|vorinostat|mesh-list
101239657|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101239659|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239660|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239661|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239662|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101239663|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
101239664|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101239665|NCT01617317|Antibodies|antibodies|mesh-list
101380536|NCT00268255|Gefitinib|gefitinib|mesh-list
101239666|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
101239667|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101239668|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
101239669|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239670|NCT01617356|Lidocaine|lidocaine|mesh-list
101239671|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
101239672|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
101239673|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239674|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239675|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
101239676|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239677|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101239678|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101239679|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101239680|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239681|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239682|NCT01617538|Atorvastatin|atorvastatin|mesh-list
101239683|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101381384|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239684|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411596|NCT04697992|Vitamins|vitamins|mesh-list
101239685|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
101239686|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239687|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101239688|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101239689|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239690|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101239691|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239692|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381785|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
101239693|NCT01617564|Bupivacaine|bupivacaine|mesh-list
101239694|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
101239695|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
101239696|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239697|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239698|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
101239699|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239701|NCT01617590|Leflunomide|leflunomide|mesh-list
101239702|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101239703|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
101239704|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101239705|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239706|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101239707|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
101239708|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239709|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239710|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
101239711|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239712|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101239713|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101239714|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
101239715|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239716|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101239717|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
101239718|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101239719|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239720|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239721|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239722|NCT01617694|Analgesics|analgesics|mesh-ancestor
101239723|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
101239724|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239725|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101239726|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101239727|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101239728|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
101239729|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239730|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239732|NCT01617707|Propofol|propofol|mesh-list
101239733|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101239734|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239735|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239736|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239737|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
101384134|NCT00079430|Paclitaxel|paclitaxel|mesh-list
101239738|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
101239739|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101239740|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101239741|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239742|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239743|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
101239744|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
101239745|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239746|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239747|NCT01617733|Pasireotide|pasireotide|mesh-list
101384375|NCT00299923|Analgesics|analgesics|mesh-ancestor
101239748|NCT01617733|Hormones|hormones|mesh-ancestor
101239749|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239750|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239751|NCT01617746|Bosentan|bosentan|mesh-list
101239752|NCT01617746|Ambrisentan|ambrisentan|mesh-list
101239754|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101239755|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239756|NCT01617772|Atorvastatin|atorvastatin|mesh-list
101239757|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101239758|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101239759|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
101239760|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385121|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101239761|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101239762|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101239763|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239764|NCT01617798|Metolazone|metolazone|mesh-list
101239765|NCT01617798|Furosemide|furosemide|mesh-list
101239766|NCT01617798|Diuretics|diuretics|mesh-ancestor
101239767|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
101239768|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239769|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101385212|NCT00087282|Growth Substances|growth substances|mesh-ancestor
101385215|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101239770|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239771|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239772|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101239773|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101239774|NCT01617811|Anesthetics|anesthetics|mesh-list
101239775|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239776|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239778|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101385947|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101239779|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239780|NCT01617824|Incretins|incretins|mesh-ancestor
101239781|NCT01617824|Hormones|hormones|mesh-ancestor
101239782|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239783|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101239784|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101239785|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239786|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239787|NCT01617928|Paclitaxel|paclitaxel|mesh-list
101239788|NCT01617928|Carboplatin|carboplatin|mesh-list
101239790|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101239791|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239792|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
101239793|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239794|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239795|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239796|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101239797|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239798|NCT01618006|Aspirin|aspirin|mesh-list
101239799|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239800|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239801|NCT01618006|Analgesics|analgesics|mesh-ancestor
101239802|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
101239803|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239804|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239805|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239806|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239807|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101239808|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101239809|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239810|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101239811|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101239812|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239813|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
101239814|NCT01618253|Sorafenib|sorafenib|mesh-list
101239815|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239816|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101239817|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239818|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239819|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101239820|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239821|NCT01618396|Midazolam|midazolam|mesh-list
101239822|NCT01618396|Propofol|propofol|mesh-list
101239823|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101239824|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239825|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239826|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239827|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
101239828|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
101239829|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101239830|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101239831|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239832|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239833|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
101239834|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
101239835|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239836|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239837|NCT01618188|Insulin|insulin|mesh-list
101239838|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101239839|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
101239840|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
101239841|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101239842|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101239843|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389196|NCT05943795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239845|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101239846|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239847|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
101239848|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239849|NCT01618474|Docetaxel|docetaxel|mesh-list
101239850|NCT01618474|Capecitabine|capecitabine|mesh-list
101390387|NCT05561751|Propranolol|propranolol|mesh-list
101239851|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239852|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
101239853|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
101239854|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
101239855|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239856|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101239857|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
101239858|NCT01618513|Octreotide|octreotide|mesh-list
101239859|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239860|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101239861|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239862|NCT01618539|Propofol|propofol|mesh-list
101239863|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101239864|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239865|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239866|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101239867|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
101239868|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
101239869|NCT01618591|Azithromycin|azithromycin|mesh-list
101239870|NCT01618591|Levofloxacin|levofloxacin|mesh-list
101239871|NCT01618591|Rifaximin|rifaximin|mesh-list
101239872|NCT01618591|Loperamide|loperamide|mesh-list
101239873|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
101239874|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239875|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239876|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101239877|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101239878|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101392282|NCT04712942|Azacitidine|azacitidine|mesh-list
101239880|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239881|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239882|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101239883|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101239884|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239885|NCT01618643|Acetic Acid|acetic acid|mesh-list
101239886|NCT01618643|Retinol acetate|retinol acetate|mesh-list
101392890|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239887|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101239888|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239889|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101239890|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
101239891|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239892|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101239893|NCT01618643|Protective Agents|protective agents|mesh-ancestor
101239894|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101239895|NCT01618760|Risperidone|risperidone|mesh-list
101239896|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101239897|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
101239898|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239899|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239900|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239901|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101239902|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239903|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239904|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239905|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101239906|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
101239907|NCT01618773|Adapalene|adapalene|mesh-list
101239908|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101239910|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239911|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239912|NCT01618773|Analgesics|analgesics|mesh-ancestor
101394745|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
101239913|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
101239914|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239915|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239916|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239917|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101239918|NCT01618799|Lamotrigine|lamotrigine|mesh-list
101239919|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
101239920|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101239921|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101395434|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101395507|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
101395660|NCT00313885|SR 46349B|sr 46349b|mesh-list
101239922|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239923|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101239924|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239925|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101239926|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239927|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239928|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101239929|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101239930|NCT01618825|Lamotrigine|lamotrigine|mesh-list
101239931|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
101239932|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101239933|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101239934|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239935|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101396120|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
101396122|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101239936|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239937|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101239938|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101239939|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101239940|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101396556|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101239941|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101239942|NCT01618877|Levetiracetam|levetiracetam|mesh-list
101239943|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
101239944|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
101239945|NCT01618890|Propranolol|propranolol|mesh-list
101239946|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101322715|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101239948|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101239949|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101239950|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239951|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239952|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101239953|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101239954|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
101239955|NCT01618903|Levetiracetam|levetiracetam|mesh-list
101239956|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
101397215|NCT00084812|Safingol|safingol|mesh-list
101239957|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
101239958|NCT01618929|Montelukast|montelukast|mesh-list
101239959|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101239960|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
101239961|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101239962|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
101239963|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101239964|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239965|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101239966|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101239967|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239968|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
101239969|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101239970|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
101239971|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101239972|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
101239973|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101239974|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101239975|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
101239976|NCT01619046|Factor VIII|factor viii|mesh-list
101239977|NCT01619046|Coagulants|coagulants|mesh-ancestor
101239978|NCT01619072|Misoprostol|misoprostol|mesh-list
101239979|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101239980|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
101239981|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101398400|NCT00331084|Dexamethasone|dexamethasone|mesh-list
101398401|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
101398402|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101398422|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
101398423|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101398495|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101239982|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239983|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101239984|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101239985|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
101239986|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
101239987|NCT01619137|Povidone|povidone|mesh-list
101239988|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
101239989|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
101239990|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101239991|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101239992|NCT01619150|Etoricoxib|etoricoxib|mesh-list
101239993|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101239994|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101239995|NCT01619150|Analgesics|analgesics|mesh-ancestor
101239996|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
101239997|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101239998|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101239999|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240000|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240001|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101240002|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101240003|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400027|NCT05952557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101240004|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240006|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240007|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
101240008|NCT01619163|Hormones|hormones|mesh-ancestor
101240009|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240010|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240011|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101400724|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
101240012|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240013|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101240014|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101322720|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240018|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
101240019|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101240020|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240021|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240022|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
101240023|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240024|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240025|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101240026|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240027|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101240028|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240029|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
101240030|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240031|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101240032|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101240034|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
101240035|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240036|NCT01619280|Nitroprusside|nitroprusside|mesh-list
101240037|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240038|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
101240039|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101240040|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240041|NCT01619436|Clonidine|clonidine|mesh-list
101240042|NCT01619436|Analgesics|analgesics|mesh-ancestor
101240043|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
101240044|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240045|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240046|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240047|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
101240048|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
101240049|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101240050|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101240051|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101240052|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101402762|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402763|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101240054|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240055|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101240056|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
101240057|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240058|NCT01619527|Darunavir|darunavir|mesh-list
101240059|NCT01619527|Cobicistat|cobicistat|mesh-list
101240060|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101240061|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101240062|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
101403397|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240063|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240064|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240065|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101240066|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101240067|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
101240068|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240069|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101240070|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101240071|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101500559|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240072|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101240073|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101240074|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240075|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240076|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240077|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240079|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
101500618|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240080|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240081|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
101240082|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240084|NCT01619644|Valproic Acid|valproic acid|mesh-list
101240085|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
101240086|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322724|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240087|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240088|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
101240089|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240090|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500674|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500675|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240092|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101240093|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240094|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240095|NCT01619683|Enclomiphene|enclomiphene|mesh-list
101240096|NCT01619683|Clomiphene|clomiphene|mesh-list
101240097|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
101240098|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101240099|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
101240100|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240101|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240102|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101240103|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
101240104|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101240105|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101240106|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101240107|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
101240108|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
101240109|NCT01619761|Melphalan|melphalan|mesh-list
101240110|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
101240111|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101240112|NCT01619761|Rituximab|rituximab|mesh-list
101240113|NCT01619761|Fludarabine|fludarabine|mesh-list
101240114|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
101240115|NCT01619761|Lenalidomide|lenalidomide|mesh-list
101240116|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101240117|NCT01619761|Tacrolimus|tacrolimus|mesh-list
101240118|NCT01619761|Antibodies|antibodies|mesh-list
101240119|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
101240120|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101240121|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240122|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
101240123|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240124|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240125|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101240126|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
101403801|NCT01055314|Doxorubicin|doxorubicin|mesh-list
101240127|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240128|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240129|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101240130|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240131|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
101240132|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101240133|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240134|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101240135|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101240136|NCT01619761|Growth Substances|growth substances|mesh-ancestor
101240137|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
101240138|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240139|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101240140|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
101240141|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240142|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240143|NCT01619891|Vitamin D|vitamin d|mesh-list
101240144|NCT01619891|Vitamins|vitamins|mesh-ancestor
101240145|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
101240146|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322729|NCT00092365|Analgesics|analgesics|mesh-ancestor
101240147|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240148|NCT01620112|Lidocaine|lidocaine|mesh-list
101240149|NCT01620112|Clonidine|clonidine|mesh-list
101240150|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
101240151|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
101240152|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240153|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240154|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
101240155|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240156|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101240157|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101240158|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101240159|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240160|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240161|NCT01620112|Analgesics|analgesics|mesh-ancestor
101240162|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240164|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
101240165|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101240166|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101240167|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101240168|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501085|NCT01240941|Exemestane|exemestane|mesh-list
101240169|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240170|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101240171|NCT01620229|Antibodies|antibodies|mesh-list
101240172|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
101240173|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101240174|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
101240175|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
101240176|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240177|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240178|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240179|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
101240180|NCT01620268|Leflunomide|leflunomide|mesh-list
101240181|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240182|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240183|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240184|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
101240185|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240186|NCT01620307|Sirolimus|sirolimus|mesh-list
101240187|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240188|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240189|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240190|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240191|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
101240192|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240193|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
101240194|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240195|NCT01620320|Dobutamine|dobutamine|mesh-list
101240196|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101240197|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
101240198|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
101240199|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240200|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240201|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101240202|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101240203|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101240204|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
101240205|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240206|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240207|NCT01620320|Protective Agents|protective agents|mesh-ancestor
101240209|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101240210|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
101240211|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
101240212|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101240214|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240215|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240216|NCT01620424|Insulin|insulin|mesh-list
101322747|NCT00093028|Bortezomib|bortezomib|mesh-list
101240217|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101240219|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
101240220|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101240221|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
101240222|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101240223|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240224|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240225|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
101240226|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
101240228|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240229|NCT01620450|Insulin|insulin|mesh-list
101240230|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101240231|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240232|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240233|NCT01620463|Liraglutide|liraglutide|mesh-list
101240234|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240235|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240236|NCT01620463|Incretins|incretins|mesh-ancestor
101240237|NCT01620463|Hormones|hormones|mesh-ancestor
101403964|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
101240238|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240239|NCT01620476|Liraglutide|liraglutide|mesh-list
101240240|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240241|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240242|NCT01620476|Incretins|incretins|mesh-ancestor
101240243|NCT01620476|Hormones|hormones|mesh-ancestor
101240244|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240245|NCT01620684|Metyrapone|metyrapone|mesh-list
101240246|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
101240247|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240248|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240249|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
101501450|NCT01303861|Nicotine|nicotine|mesh-list
101240250|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101240251|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101240252|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
101240253|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240254|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101240255|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101240256|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240257|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501507|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240258|NCT01620814|Misoprostol|misoprostol|mesh-list
101240259|NCT01620814|Dinoprostone|dinoprostone|mesh-list
101240260|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101240261|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
101240262|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101240263|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240264|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101240265|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101240266|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
101240267|NCT01620840|Lacosamide|lacosamide|mesh-list
101240268|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
101240269|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101240270|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101240271|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240272|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240273|NCT01620944|Ritonavir|ritonavir|mesh-list
101240274|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101240275|NCT01620944|Tenofovir|tenofovir|mesh-list
101240276|NCT01620944|Lamivudine|lamivudine|mesh-list
101240277|NCT01620944|Emtricitabine|emtricitabine|mesh-list
101240278|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101240279|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101240280|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101240281|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240282|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240283|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101240284|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101240286|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240287|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101501792|NCT00485004|Sirolimus|sirolimus|mesh-list
101240288|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101240289|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101240290|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101240291|NCT01621022|Bupropion|bupropion|mesh-list
101240292|NCT01621022|Nicotine|nicotine|mesh-list
101240293|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101240294|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
101240295|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240296|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240297|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101240298|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101240299|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
101240300|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240301|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240302|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101240303|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
101240304|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501987|NCT04697511|Midazolam|midazolam|mesh-list
101240305|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101240306|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101240307|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240308|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
101240309|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101240310|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101240311|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240312|NCT01621100|Hydromorphone|hydromorphone|mesh-list
101240313|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101502056|NCT00485576|Eculizumab|eculizumab|mesh-list
101240314|NCT01621100|Narcotics|narcotics|mesh-ancestor
101240315|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240316|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240317|NCT01621100|Analgesics|analgesics|mesh-ancestor
101240318|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
101240319|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240320|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
101240321|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101240322|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240323|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502079|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240324|NCT01621165|Prazosin|prazosin|mesh-list
101240325|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240326|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101240327|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101240328|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101240329|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101240330|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240331|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240332|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240333|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
101502178|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
101240334|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101240335|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
101240336|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101240337|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
101240338|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240339|NCT01621217|Cetuximab|cetuximab|mesh-list
101240340|NCT01621217|Mitomycins|mitomycins|mesh-list
101240341|NCT01621217|Mitomycin|mitomycin|mesh-list
101240342|NCT01621217|Fluorouracil|fluorouracil|mesh-list
101240343|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240344|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240345|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240346|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
101240349|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240350|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
101240351|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240352|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240353|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
101240354|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240356|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
101322756|NCT00093067|Daptomycin|daptomycin|mesh-list
101240357|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101240358|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101502264|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502265|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502266|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240359|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240360|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101240361|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101502323|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101240362|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240363|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240364|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
101240365|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240367|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240368|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240369|NCT01621321|Voriconazole|voriconazole|mesh-list
101240370|NCT01621321|Prednisolone|prednisolone|mesh-list
101240371|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240372|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
101240373|NCT01621321|Hormones|hormones|mesh-ancestor
101240374|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240375|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240376|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101240377|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240378|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
101240379|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240380|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101240381|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101502382|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101502389|NCT00486486|Timolol|timolol|mesh-list
101240382|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240383|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240384|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101240385|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101240386|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101240387|NCT01621373|Propofol|propofol|mesh-list
101240388|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101240389|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240390|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240391|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101240392|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
101240393|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
101240395|NCT01621386|Montelukast|montelukast|mesh-list
101240396|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240397|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
101240398|NCT01621386|Hormones|hormones|mesh-ancestor
101240399|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502455|NCT01301833|Biguanides|biguanides|mesh-list
101240400|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240401|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101240402|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240403|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101240404|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
101240405|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101240406|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
101240407|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101240409|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240410|NCT01621451|Aspirin|aspirin|mesh-list
101240411|NCT01621451|Clopidogrel|clopidogrel|mesh-list
101240412|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101240413|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101240414|NCT01621451|Analgesics|analgesics|mesh-ancestor
101240415|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
101240416|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240417|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240418|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240419|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240420|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101240421|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101240422|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240423|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101240424|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101240425|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240426|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
101240427|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101240428|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101240429|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101240430|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
101240431|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502667|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
101240432|NCT01621620|Yohimbine|yohimbine|mesh-list
101240433|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
101240434|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
101240435|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240436|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240437|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101240438|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101240439|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101240440|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101240441|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240442|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240443|NCT01621620|Urological Agents|urological agents|mesh-ancestor
101240444|NCT01621698|Fentanyl|fentanyl|mesh-list
101240445|NCT01621698|Bupivacaine|bupivacaine|mesh-list
101240446|NCT01621698|Propofol|propofol|mesh-list
101240447|NCT01621698|Atracurium|atracurium|mesh-list
101240448|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
101240449|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
101240450|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240451|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240452|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
101240453|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240454|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101240455|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101240456|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
101240457|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101240458|NCT01621698|Narcotics|narcotics|mesh-ancestor
101240459|NCT01621698|Analgesics|analgesics|mesh-ancestor
101240460|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101240461|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101240462|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101240463|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101240464|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101240465|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101240466|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
101240467|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502727|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502729|NCT00487253|Miltefosine|miltefosine|mesh-list
101240468|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240470|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101240471|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101240472|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101240473|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101240474|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
101240475|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240476|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404309|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101240477|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240479|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101240480|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101240481|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101240482|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101240483|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
101240484|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240485|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240486|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240487|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
101240488|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101240489|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101240490|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240491|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101240492|NCT01621893|Calcium|calcium|mesh-list
101404328|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240493|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101240494|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240495|NCT01621971|Milrinone|milrinone|mesh-list
101240496|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101240497|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101240498|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
101240499|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101240500|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101240501|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404335|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240502|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240503|NCT01621971|Protective Agents|protective agents|mesh-ancestor
101240504|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240505|NCT01622075|Paclitaxel|paclitaxel|mesh-list
101240506|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101240507|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101240508|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240509|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
101240510|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
101240511|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
101240512|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240513|NCT01622283|Cetirizine|cetirizine|mesh-list
101240514|NCT01622283|Levocetirizine|levocetirizine|mesh-list
101240515|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101240516|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101240517|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101240518|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
101240519|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
101240520|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240521|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404392|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240522|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240523|NCT01622361|Tamoxifen|tamoxifen|mesh-list
101240524|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
101240525|NCT01622361|Docetaxel|docetaxel|mesh-list
101240526|NCT01622361|Doxorubicin|doxorubicin|mesh-list
101240527|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101240528|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240529|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
101240530|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240531|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240532|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101240533|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
101240534|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240535|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240536|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101240538|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
101240539|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
101240540|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240541|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101240542|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101240543|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240544|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101240545|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
101503290|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101240546|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240547|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101240548|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101240549|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101240550|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240551|NCT01622439|Prednisone|prednisone|mesh-list
101240552|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
101240553|NCT01622439|Rituximab|rituximab|mesh-list
101240554|NCT01622439|Doxorubicin|doxorubicin|mesh-list
101240555|NCT01622439|Vincristine|vincristine|mesh-list
101240556|NCT01622439|Valproic Acid|valproic acid|mesh-list
101240557|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240558|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
101240559|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240560|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240561|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101240562|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
101240563|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240564|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240565|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101404467|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101240566|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240567|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240568|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101240569|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101240570|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240571|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240572|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
101240573|NCT01622439|Hormones|hormones|mesh-ancestor
101240574|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240575|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101240576|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101240577|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
101240578|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
101240579|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
101240580|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
101240582|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240583|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
101240584|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101240585|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240586|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240587|NCT01622504|Naloxone|naloxone|mesh-list
101240588|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101503493|NCT00497003|Metoprolol|metoprolol|mesh-list
101240589|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240590|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
101240591|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240593|NCT01622556|Busulfan|busulfan|mesh-list
101240594|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
101240595|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240596|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240597|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240598|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
101240599|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240600|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
101240601|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101240602|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101240603|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101240604|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101240605|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101404550|NCT00431236|Hormones|hormones|mesh-ancestor
101240606|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
101240607|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240608|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101240609|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101240610|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240612|NCT01622790|Abacavir|abacavir|mesh-list
101240613|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
101240614|NCT01622790|Dolutegravir|dolutegravir|mesh-list
101240615|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101240616|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101240617|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240618|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240619|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
101240620|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240621|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101240622|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101240623|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101240624|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101240625|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
101240626|NCT01622881|Nefopam|nefopam|mesh-list
101240627|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101240628|NCT01622881|Analgesics|analgesics|mesh-ancestor
101240629|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
101240630|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240631|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240632|NCT01622933|Interferons|interferons|mesh-list
101240633|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
101240634|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240635|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
101503843|NCT05146245|Risperidone|risperidone|mesh-list
101240636|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240637|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
101240638|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240639|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
101240640|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101240641|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101240642|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240644|NCT01622946|Coagulants|coagulants|mesh-ancestor
101240645|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101240646|NCT01622972|Laxatives|laxatives|mesh-ancestor
101240647|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101240648|NCT01623024|Vitamin D|vitamin d|mesh-list
101240649|NCT01623024|Vitamins|vitamins|mesh-ancestor
101240650|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
101240651|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240652|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240653|NCT01623102|Bevacizumab|bevacizumab|mesh-list
101240654|NCT01623102|Cisplatin|cisplatin|mesh-list
101240655|NCT01623102|Gemcitabine|gemcitabine|mesh-list
101240656|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240657|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240658|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101240659|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101240660|NCT01623102|Growth Substances|growth substances|mesh-ancestor
101240661|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240662|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101240663|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240664|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
101240665|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240666|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101240667|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
101240668|NCT01623206|Coagulants|coagulants|mesh-ancestor
101240669|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101240670|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
101240671|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240672|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101240673|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101240674|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240675|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101240676|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101240677|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
101240678|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
101240679|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240680|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
101240681|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240682|NCT01623349|Olaparib|olaparib|mesh-list
101240683|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101240684|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504178|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240685|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240686|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240687|NCT01623362|Fluorides|fluorides|mesh-list
101240688|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
101240690|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240691|NCT01623375|Insulin|insulin|mesh-list
101240692|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101240693|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
101240695|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240696|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
101240698|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240699|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240700|NCT01623440|Naltrexone|naltrexone|mesh-list
101240701|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101240702|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101240703|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240704|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
101240705|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240706|NCT01623505|Varenicline|varenicline|mesh-list
101240707|NCT01623505|Nicotine|nicotine|mesh-list
101240708|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101240709|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101240710|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
101240711|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404755|NCT00432406|Infliximab|infliximab|mesh-list
101240712|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240713|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240715|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
101240716|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240717|NCT01623570|Menotropins|menotropins|mesh-list
101240719|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
101240720|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101240721|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240723|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101240724|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240725|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
101240726|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240727|NCT01623635|Ropivacaine|ropivacaine|mesh-list
101240728|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
101240729|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
101504432|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
101240730|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240731|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240732|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
101240733|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240734|NCT01623713|Risperidone|risperidone|mesh-list
101240735|NCT01623713|Iloperidone|iloperidone|mesh-list
101240736|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101240737|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
101404855|NCT00403026|Growth Substances|growth substances|mesh-ancestor
101240738|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240739|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240740|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240741|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101240742|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101240743|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240744|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240745|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101240746|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
101240747|NCT01623778|Interferons|interferons|mesh-list
101240748|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
101240749|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
101240750|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240751|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
101240752|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240753|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
101240754|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240756|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240757|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240758|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
101240759|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240760|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240761|NCT01623921|Celecoxib|celecoxib|mesh-list
101240762|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101240763|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101240764|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101240765|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
101240766|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240767|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101240768|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101240769|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240770|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101240771|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101240773|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
101240774|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240775|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240776|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240777|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240778|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101240779|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101240782|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240783|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
101240784|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
101240785|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
101240786|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240787|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240788|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101240789|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101240790|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240791|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
101240792|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240793|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
101240794|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240795|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240796|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101240797|NCT01624051|Cisplatin|cisplatin|mesh-list
101240798|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240799|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
101240800|NCT01624064|Enalapril|enalapril|mesh-list
101240801|NCT01624064|Calcium|calcium|mesh-list
101240802|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101240803|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101240804|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101240805|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240806|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240807|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
101240808|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240809|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240810|NCT01624103|Lidocaine|lidocaine|mesh-list
101240811|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
101240812|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
101240813|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
101240814|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240815|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240816|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
101405209|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405210|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405211|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405213|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101240817|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240818|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101240819|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101240820|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101240821|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240822|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240824|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101405217|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405218|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405219|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240826|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101240827|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240828|NCT01624116|Incretins|incretins|mesh-ancestor
101240829|NCT01624116|Hormones|hormones|mesh-ancestor
101240830|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240831|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101240832|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405226|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
101405227|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405228|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405229|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405230|NCT00434239|Growth Substances|growth substances|mesh-ancestor
101405231|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101240833|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240834|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240835|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101240836|NCT01624129|Fluticasone|fluticasone|mesh-list
101240837|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101240838|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101240839|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
101240840|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240841|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240842|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101240843|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
101240844|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
101240845|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101240846|NCT01624207|Atorvastatin|atorvastatin|mesh-list
101240847|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101240848|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101240849|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
101240850|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240851|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101405262|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405263|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101405264|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405266|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101240852|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101240853|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240854|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101240856|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240857|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240858|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101240859|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240860|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240861|NCT01624337|Piperaquine|piperaquine|mesh-list
101240862|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
101240863|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101240864|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101240865|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240866|NCT01624428|Varenicline|varenicline|mesh-list
101240867|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101240868|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101240869|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
101240870|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240871|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240872|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240874|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240875|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240876|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101240877|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101240878|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240879|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240880|NCT01624493|Carboplatin|carboplatin|mesh-list
101240881|NCT01624493|Gemcitabine|gemcitabine|mesh-list
101240882|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240883|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240884|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
101240885|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240886|NCT01624649|Methylphenidate|methylphenidate|mesh-list
101240889|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240890|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101240891|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101240892|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240893|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240895|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240896|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101240897|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101240898|NCT01624675|Risperidone|risperidone|mesh-list
101240899|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101240900|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
101240901|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101240902|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240903|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240904|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101240905|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101240906|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240907|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101240908|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101240909|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
101240910|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
101240911|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240912|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240913|NCT01624766|Denosumab|denosumab|mesh-list
101240914|NCT01624766|Everolimus|everolimus|mesh-list
101405400|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101405401|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405402|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405403|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
101405405|NCT00132093|Eplerenone|eplerenone|mesh-list
101322795|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
101240915|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101240916|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101240917|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101240918|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240919|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240920|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240921|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
101240922|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240923|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240924|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101240925|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101240926|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101240928|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101240929|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
101240930|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240931|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101240932|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101240933|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101240934|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101240935|NCT01625026|Cathartics|cathartics|mesh-ancestor
101240936|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101240937|NCT01625260|Gemcitabine|gemcitabine|mesh-list
101240938|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101240939|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
101240940|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240941|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240942|NCT01625351|Sirolimus|sirolimus|mesh-list
101240943|NCT01625351|Fludarabine|fludarabine|mesh-list
101240944|NCT01625351|Melphalan|melphalan|mesh-list
101240945|NCT01625351|Busulfan|busulfan|mesh-list
101240946|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
101240947|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
101240948|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240949|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240950|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240951|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
101240952|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240953|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101240954|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101240955|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101240956|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
101240957|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101405565|NCT04728386|Eusol|eusol|mesh-list
101240958|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
101240959|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101240960|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101240961|NCT01625429|Paclitaxel|paclitaxel|mesh-list
101240962|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101240963|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240964|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101240965|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101240966|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101240967|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240968|NCT01625494|Amlodipine|amlodipine|mesh-list
101240969|NCT01625494|Irbesartan|irbesartan|mesh-list
101240970|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101240971|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101240972|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101240973|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240974|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101240975|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240976|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
101240977|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101240978|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101240979|NCT01625520|Everolimus|everolimus|mesh-list
101240980|NCT01625520|Pasireotide|pasireotide|mesh-list
101240981|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101240982|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101240983|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528752|NCT04654026|Analgesics|analgesics|mesh-ancestor
101240984|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101240985|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101240986|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
101240987|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240988|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101240990|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101240991|NCT01625572|Morphine|morphine|mesh-list
101240992|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101240993|NCT01625572|Narcotics|narcotics|mesh-ancestor
101240994|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101240995|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101240996|NCT01625572|Analgesics|analgesics|mesh-ancestor
101240997|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
101240998|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101240999|NCT01625715|Ketotifen|ketotifen|mesh-list
101241000|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
101241001|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
101241002|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101241003|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
101241004|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
101241005|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241006|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241007|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241008|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101241009|NCT01625741|Rituximab|rituximab|mesh-list
101241010|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241011|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241012|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
101241013|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241014|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241016|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
101241017|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241018|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
101241019|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241020|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
101241021|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241022|NCT01625806|Ketoconazole|ketoconazole|mesh-list
101241023|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
101241024|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241025|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101241026|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101241027|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241028|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241029|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101241030|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241031|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241032|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241033|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101241034|NCT01625871|Lumefantrine|lumefantrine|mesh-list
101241035|NCT01625871|Artemether|artemether|mesh-list
101241036|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101241037|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
101241038|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101241039|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101241040|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241041|NCT01625936|Bevacizumab|bevacizumab|mesh-list
101241042|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241043|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528813|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241044|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101241045|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101241046|NCT01625936|Growth Substances|growth substances|mesh-ancestor
101241047|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241048|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101241049|NCT01625156|Sirolimus|sirolimus|mesh-list
101241050|NCT01625156|Temsirolimus|temsirolimus|mesh-list
101241051|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
101241052|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101241053|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241054|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101241055|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241056|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
101241057|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405663|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241058|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
101241059|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241060|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241061|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241062|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241063|NCT01626222|Everolimus|everolimus|mesh-list
101241064|NCT01626222|Exemestane|exemestane|mesh-list
101241065|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101241066|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241067|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241068|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241069|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241070|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
101241071|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241072|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241073|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101241074|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101241075|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101241076|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241077|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241078|NCT01626339|Bevacizumab|bevacizumab|mesh-list
101241079|NCT01626339|Ranibizumab|ranibizumab|mesh-list
101241080|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241081|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241082|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101241083|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101241084|NCT01626339|Growth Substances|growth substances|mesh-ancestor
101241085|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241086|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
101241087|NCT01626443|Folic Acid|folic acid|mesh-list
101241088|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
101241089|NCT01626443|Inositol|inositol|mesh-list
101241090|NCT01626443|Hematinics|hematinics|mesh-ancestor
101241091|NCT01626443|Vitamins|vitamins|mesh-ancestor
101241092|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
101241093|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241094|NCT01626469|Captopril|captopril|mesh-list
101241095|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101241096|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
101241097|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241098|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241099|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241100|NCT01626534|Clopidogrel|clopidogrel|mesh-list
101241101|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101241102|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101405694|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241103|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101241104|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101241105|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
101241106|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241107|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241108|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241109|NCT01626560|Vancomycin|vancomycin|mesh-list
101241110|NCT01626560|Daptomycin|daptomycin|mesh-list
101241111|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101241112|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528944|NCT02902640|Trimethoprim|trimethoprim|mesh-list
101241113|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
101241114|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101241115|NCT01626651|Ketoconazole|ketoconazole|mesh-list
101241116|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
101241117|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241118|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101241119|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101241120|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241121|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241122|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101241123|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241124|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241125|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241126|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101241128|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101241129|NCT01626911|Tinzaparin|tinzaparin|mesh-list
101241130|NCT01626911|Dalteparin|dalteparin|mesh-list
101241131|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
101241132|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101241133|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101241134|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241136|NCT01627041|Decitabine|decitabine|mesh-list
101241137|NCT01627041|Daunorubicin|daunorubicin|mesh-list
101241138|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241139|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
101241140|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241141|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241142|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
101241143|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241144|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241145|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
101241147|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101241148|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101241149|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101241150|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241151|NCT01627106|Amiodarone|amiodarone|mesh-list
101241152|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241153|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101241154|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101241155|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241156|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241157|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101241158|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101241159|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101241160|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241161|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101529067|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101241162|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101241163|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101241164|NCT01627132|Dasatinib|dasatinib|mesh-list
101241165|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241166|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241167|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241168|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241169|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
101241170|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101241171|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101241172|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241173|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241174|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241175|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241176|NCT01627145|Urological Agents|urological agents|mesh-ancestor
101241177|NCT01627158|Budesonide|budesonide|mesh-list
101241178|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
101241179|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101241180|NCT01627158|Charcoal|charcoal|mesh-list
101241181|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405798|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
101241183|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
101241184|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241185|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241186|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101241187|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
101241188|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
101241189|NCT01627158|Hormones|hormones|mesh-ancestor
101241190|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241191|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101241192|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101529157|NCT00562419|Irinotecan|irinotecan|mesh-list
101529163|NCT00562458|Anastrozole|anastrozole|mesh-list
101241193|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101241194|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241195|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241196|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241197|NCT01627158|Antidotes|antidotes|mesh-ancestor
101241198|NCT01627158|Protective Agents|protective agents|mesh-ancestor
101241200|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
101241201|NCT01627171|Cathartics|cathartics|mesh-ancestor
101241202|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241203|NCT01627171|Laxatives|laxatives|mesh-ancestor
101241204|NCT01627223|Lamivudine|lamivudine|mesh-list
101241205|NCT01627223|Entecavir|entecavir|mesh-list
101241206|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101241207|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101241208|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204432|NCT01423487|Metformin|metformin|mesh-list
101241209|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241210|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
101241211|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241212|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101241213|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101241214|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
101241215|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101241216|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101241217|NCT01627236|Prednisolone|prednisolone|mesh-list
101241218|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
101241219|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101241220|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
101241221|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241222|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
101241223|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
101241224|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241225|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241226|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241227|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
101241228|NCT01627236|Hormones|hormones|mesh-ancestor
101241229|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241230|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101405914|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405915|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
101241231|NCT01627236|Protective Agents|protective agents|mesh-ancestor
101241232|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101241233|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241235|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101241236|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241237|NCT01627262|Analgesics|analgesics|mesh-ancestor
101241238|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
101405941|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101241239|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405942|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101241240|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241241|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241243|NCT01627353|Dexamethasone|dexamethasone|mesh-list
101241244|NCT01627353|Lidocaine|lidocaine|mesh-list
101529359|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101241245|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
101529360|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101241246|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241247|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
101241248|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
101241249|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241250|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241251|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241252|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
101241253|NCT01627353|Hormones|hormones|mesh-ancestor
101241254|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241255|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101241256|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241257|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241258|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
101241259|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
101241260|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241261|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
101241262|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241263|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101241264|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101241265|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241266|NCT01627353|Analgesics|analgesics|mesh-ancestor
101241267|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
101406066|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
101241268|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241269|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241270|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
101241272|NCT01627379|Panitumumab|panitumumab|mesh-list
101241273|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241274|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241275|NCT01627431|Aspirin|aspirin|mesh-list
101241276|NCT01627431|Clopidogrel|clopidogrel|mesh-list
101241277|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529460|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241278|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241279|NCT01627431|Analgesics|analgesics|mesh-ancestor
101241280|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
101241281|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529461|NCT01188811|Protective Agents|protective agents|mesh-ancestor
101241282|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241283|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241284|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241285|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101241286|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101241287|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241288|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101241289|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101241290|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241291|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
101241292|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101241293|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101241294|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101241295|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
101406139|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406141|NCT00103103|Fluorouracil|fluorouracil|mesh-list
101241296|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241297|NCT01627587|Ketoconazole|ketoconazole|mesh-list
101241298|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
101241299|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241300|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101241301|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101241302|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241303|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241304|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101241305|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241306|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241307|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529493|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101529494|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241308|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101241310|NCT01627626|Miotics|miotics|mesh-ancestor
101241311|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
101241312|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241313|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241314|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101241315|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101241316|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241317|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241318|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241319|NCT01627639|Acetazolamide|acetazolamide|mesh-list
101241320|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
101241321|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101241322|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241323|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406241|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241324|NCT01627639|Diuretics|diuretics|mesh-ancestor
101241325|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
101241326|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241327|NCT01627678|Molgramostim|molgramostim|mesh-list
101241328|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101241329|NCT01627678|Sargramostim|sargramostim|mesh-list
101241330|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
101241331|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241332|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241333|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101241334|NCT01627678|Antacids|antacids|mesh-ancestor
101241335|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241336|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241338|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101241339|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101241340|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241341|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101241342|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101241343|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
101241345|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101529581|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
101241346|NCT01627834|Ropinirole|ropinirole|mesh-list
101241347|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101241348|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101241349|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
101241350|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
101241351|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241352|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241353|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241354|NCT01627847|Ropinirole|ropinirole|mesh-list
101241355|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101241356|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101241357|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
101241358|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
101241359|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241360|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529671|NCT04617015|Bromides|bromides|mesh-list
101241361|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241362|NCT01627873|Fentanyl|fentanyl|mesh-list
101241363|NCT01627873|Remifentanil|remifentanil|mesh-list
101241364|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101241365|NCT01627873|Narcotics|narcotics|mesh-ancestor
101241366|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241367|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241368|NCT01627873|Analgesics|analgesics|mesh-ancestor
101241369|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
101241370|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241371|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101241372|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101241373|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
101241374|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
101241375|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
101241376|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101241377|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241378|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
101241379|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
101241380|NCT01627938|Razoxane|razoxane|mesh-list
101241381|NCT01627938|Analgesics|analgesics|mesh-ancestor
101241382|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
101241383|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241384|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529735|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
101241386|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101241387|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101241388|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241389|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241390|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101241391|NCT01627938|Protective Agents|protective agents|mesh-ancestor
101241392|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101241393|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101241394|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
101241395|NCT01628055|Antibodies|antibodies|mesh-list
101241396|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
101241397|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101241398|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101241399|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
101241400|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
101241401|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241402|NCT01628341|Insulin|insulin|mesh-list
101241403|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241404|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241405|NCT01628354|Ranibizumab|ranibizumab|mesh-list
101241406|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101241407|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101241408|NCT01628354|Growth Substances|growth substances|mesh-ancestor
101241409|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241410|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
101241411|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241412|NCT01628445|Liraglutide|liraglutide|mesh-list
101241413|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241414|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241415|NCT01628445|Incretins|incretins|mesh-ancestor
101241416|NCT01628445|Hormones|hormones|mesh-ancestor
101241417|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241419|NCT01628471|Genistein|genistein|mesh-list
101241420|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241421|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
101241422|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241423|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241424|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529819|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
101529820|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529836|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
101241425|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101241426|NCT01628471|Protective Agents|protective agents|mesh-ancestor
101241427|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241428|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241429|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
101241430|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101204658|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
101241431|NCT01628471|Estrogens|estrogens|mesh-ancestor
101241432|NCT01628471|Hormones|hormones|mesh-ancestor
101241433|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241434|NCT01628562|Remifentanil|remifentanil|mesh-list
101241435|NCT01628562|Esmolol|esmolol|mesh-list
101241436|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101241437|NCT01628562|Narcotics|narcotics|mesh-ancestor
101241438|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241439|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241440|NCT01628562|Analgesics|analgesics|mesh-ancestor
101529857|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101241441|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
101241442|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241443|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101241444|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101241445|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101241446|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241447|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241448|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241449|NCT01628666|Vancomycin|vancomycin|mesh-list
101241450|NCT01628666|Cefazolin|cefazolin|mesh-list
101241451|NCT01628666|Cephalexin|cephalexin|mesh-list
101241452|NCT01628666|Bacitracin|bacitracin|mesh-list
101241453|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101241454|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241455|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101241456|NCT01628731|Furosemide|furosemide|mesh-list
101241457|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
101241458|NCT01628731|Diuretics|diuretics|mesh-ancestor
101241459|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
101529915|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241460|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241461|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101241462|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241463|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241464|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241465|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101241466|NCT01628770|Hematinics|hematinics|mesh-ancestor
101241467|NCT01628783|Escitalopram|escitalopram|mesh-list
101241468|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101241469|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101241470|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241471|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241472|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241473|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
101241474|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241476|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101241477|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101241478|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101241479|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241480|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241481|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101241482|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101241484|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241485|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241487|NCT01629082|Clofarabine|clofarabine|mesh-list
101241488|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
101241489|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241490|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101241491|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101241492|NCT01629082|Growth Substances|growth substances|mesh-ancestor
101241493|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
101241494|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241495|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241496|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
101241497|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241498|NCT01629173|Ethylene|ethylene|mesh-list
101241499|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101241500|NCT01629173|Growth Substances|growth substances|mesh-ancestor
101241501|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241502|NCT01629199|Mitogens|mitogens|mesh-list
101241503|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101241504|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241505|NCT01629212|Octylonium|octylonium|mesh-list
101241506|NCT01629212|Bromides|bromides|mesh-list
101204732|NCT01425099|Dolutegravir|dolutegravir|mesh-list
101241507|NCT01629212|Tiropramide|tiropramide|mesh-list
101241508|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
101241509|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
101241510|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
101406381|NCT00136734|Methylphenidate|methylphenidate|mesh-list
101241511|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241512|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241513|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241514|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241515|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241516|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241517|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241518|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101241519|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101241520|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241521|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241522|NCT01629225|Candesartan|candesartan|mesh-list
101241523|NCT01629225|Candesartan cilexetil|candesartan cilexetil|mesh-list
101241524|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241525|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101241526|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101241527|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241529|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241530|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241531|NCT01629277|Insulin|insulin|mesh-list
101241532|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241533|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241534|NCT01629368|Carbamazepine|carbamazepine|mesh-list
101241535|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
101241536|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
101241537|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101241538|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241539|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241540|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101530022|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530023|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241541|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241542|NCT01629368|Analgesics|analgesics|mesh-ancestor
101241543|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
101241544|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241545|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101241546|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241547|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241548|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101241549|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101241551|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101241552|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241553|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241554|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241555|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241556|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241557|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101241558|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
101241559|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241560|NCT01629446|Lofexidine|lofexidine|mesh-list
101241561|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241562|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101241563|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241564|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
101530056|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530057|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530058|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530095|NCT02114060|Vaccines|vaccines|mesh-list
101241565|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241566|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101241567|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101241568|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101241569|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241570|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241571|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241572|NCT01629511|Gemcitabine|gemcitabine|mesh-list
101241573|NCT01629511|Methotrexate|methotrexate|mesh-list
101241574|NCT01629511|Clofarabine|clofarabine|mesh-list
101241576|NCT01629511|Tacrolimus|tacrolimus|mesh-list
101241577|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
101241578|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101241579|NCT01629511|Lenograstim|lenograstim|mesh-list
101530135|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
101241580|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241581|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
101241582|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241583|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241584|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101241585|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
101241586|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101241587|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241588|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
101241589|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241590|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101241591|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241592|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
101241593|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241594|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101241595|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101530206|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530207|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101241596|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101241597|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
101241598|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101241599|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101241601|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
101241602|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101241603|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241604|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241605|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
101241606|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241607|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241608|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241609|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241611|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241612|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101241613|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241614|NCT01629680|Moxaverine|moxaverine|mesh-list
101530265|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
101530266|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
101530267|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
101241615|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
101241616|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
101241617|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241618|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241619|NCT01629732|Ribavirin|ribavirin|mesh-list
101241620|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
101241621|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241622|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
101241623|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241625|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241626|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241627|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101241628|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241629|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101241630|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101241631|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101406456|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
101406457|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406458|NCT00137007|Azithromycin|azithromycin|mesh-list
101406459|NCT00137007|Ampicillin|ampicillin|mesh-list
101406460|NCT00137007|Sulbactam|sulbactam|mesh-list
101241632|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241633|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241634|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101241635|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241636|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241637|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241638|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241640|NCT01630018|Belotecan|belotecan|mesh-list
101241641|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101241644|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241645|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241646|NCT01630057|Zonisamide|zonisamide|mesh-list
101241647|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
101241648|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241649|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241650|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241651|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241652|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241653|NCT01630070|Paclitaxel|paclitaxel|mesh-list
101241654|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101241655|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241656|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530415|NCT01956812|Gemcitabine|gemcitabine|mesh-list
101530416|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530417|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
101241657|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101241658|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101241659|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241660|NCT01630083|Capecitabine|capecitabine|mesh-list
101241661|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
101241662|NCT01630083|Epirubicin|epirubicin|mesh-list
101241663|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241664|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
101241665|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241666|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241667|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101241668|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101241670|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241671|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101241672|NCT01630096|Laxatives|laxatives|mesh-ancestor
101530456|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241673|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241674|NCT01630148|Bemiparin|bemiparin|mesh-list
101241675|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
101241676|NCT01630187|Carbetocin|carbetocin|mesh-list
101241677|NCT01630187|Oxytocin|oxytocin|mesh-list
101241678|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
101241679|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101241680|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241681|NCT01630226|Cisplatin|cisplatin|mesh-list
101241682|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241683|NCT01630278|Ibuprofen|ibuprofen|mesh-list
101241684|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101241685|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241686|NCT01630278|Analgesics|analgesics|mesh-ancestor
101241687|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
101241688|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241689|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241690|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241691|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241692|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101241693|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241694|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241696|NCT01630343|Tramadol|tramadol|mesh-list
101241697|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241698|NCT01630343|Analgesics|analgesics|mesh-ancestor
101241699|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
101241700|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241701|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241702|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
101241703|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101530517|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101530518|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241704|NCT01630343|Narcotics|narcotics|mesh-ancestor
101241705|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241707|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101241708|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241709|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241710|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
101241711|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241712|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
101241713|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241714|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530562|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241715|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101530563|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241716|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
101241717|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530564|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530565|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241718|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241719|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101241720|NCT01630564|Aldesleukin|aldesleukin|mesh-list
101241721|NCT01630564|Interleukin-2|interleukin-2|mesh-list
101241722|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241723|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241724|NCT01630564|Analgesics|analgesics|mesh-ancestor
101241725|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
101241726|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241727|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241728|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101241729|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101241730|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
101241731|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241732|NCT01630642|Clopidogrel|clopidogrel|mesh-list
101241733|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101241734|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101241735|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101241736|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101241737|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
101241738|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241739|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241740|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241741|NCT01630655|Felodipine|felodipine|mesh-list
101241742|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241743|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241744|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241746|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241747|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241748|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241749|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
101241750|NCT01630720|Vitamin D|vitamin d|mesh-list
101241751|NCT01630720|Vitamins|vitamins|mesh-list
101241752|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
101241753|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406494|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530632|NCT04629144|Belimumab|belimumab|mesh-list
101241754|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101241755|NCT01630733|Docetaxel|docetaxel|mesh-list
101241756|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241757|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
101241758|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
101241759|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
101241760|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241761|NCT01630902|Felodipine|felodipine|mesh-list
101241762|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241763|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241764|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241765|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241766|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241767|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241768|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241769|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
101241770|NCT01630915|Clopidogrel|clopidogrel|mesh-list
101241771|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101241772|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101241773|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101241774|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101241775|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
101241776|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241777|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241778|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241779|NCT01630941|Denosumab|denosumab|mesh-list
101241780|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101241781|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241782|NCT01631058|Prednisone|prednisone|mesh-list
101241783|NCT01631058|Everolimus|everolimus|mesh-list
101241784|NCT01631058|Lactitol|lactitol|mesh-list
101241785|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241786|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
101241787|NCT01631058|Hormones|hormones|mesh-ancestor
101241788|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241789|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241790|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101241791|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241792|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101241793|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241794|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241795|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241796|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101241797|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
101241798|NCT01631058|Cathartics|cathartics|mesh-ancestor
101530702|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530703|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
101530704|NCT01804829|Antibodies|antibodies|mesh-list
101530705|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
101530711|NCT00565422|Escitalopram|escitalopram|mesh-list
101241799|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241800|NCT01631097|Tivozanib|tivozanib|mesh-list
101241801|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101241802|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241803|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241804|NCT01631136|Cisplatin|cisplatin|mesh-list
101241805|NCT01631136|Gemcitabine|gemcitabine|mesh-list
101241807|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241808|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241809|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
101241810|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241811|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241812|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101241813|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101241814|NCT01631201|Azithromycin|azithromycin|mesh-list
101241815|NCT01631201|KRM 1648|krm 1648|mesh-list
101241816|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101241817|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241818|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101241819|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
101241820|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
101241821|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
101241822|NCT01631305|Calcium|calcium|mesh-list
101241823|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241824|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241825|NCT01631305|Antacids|antacids|mesh-ancestor
101406504|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406505|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406506|NCT00104624|Docetaxel|docetaxel|mesh-list
101406507|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530720|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101530721|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
101530722|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530723|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530724|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101530725|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530726|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101530727|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101530728|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101530729|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530730|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530731|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530732|NCT01789736|Travoprost|travoprost|mesh-list
101241826|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241827|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241828|NCT01631357|Cisplatin|cisplatin|mesh-list
101241829|NCT01631357|Gemcitabine|gemcitabine|mesh-list
101241830|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241831|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101241832|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
101241833|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241834|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
101241835|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241836|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241837|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241838|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241839|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241840|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241841|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241842|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101241843|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101241844|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101241845|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101241846|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101241847|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
101241848|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241849|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241850|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241851|NCT01631383|Analgesics|analgesics|mesh-ancestor
101241852|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
101241853|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241854|NCT01631396|Neostigmine|neostigmine|mesh-list
101241855|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101241856|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241857|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241858|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241859|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241860|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530763|NCT01779947|Estradiol|estradiol|mesh-list
101241861|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101241862|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
101241863|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241864|NCT01631409|Aspirin|aspirin|mesh-list
101241865|NCT01631409|Atenolol|atenolol|mesh-list
101241866|NCT01631409|Enalapril|enalapril|mesh-list
101241867|NCT01631409|Enalaprilat|enalaprilat|mesh-list
101241868|NCT01631409|Amlodipine|amlodipine|mesh-list
101241869|NCT01631409|Isosorbide|isosorbide|mesh-list
101241870|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101241871|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101241872|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
101241873|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101241874|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241875|NCT01631409|Analgesics|analgesics|mesh-ancestor
101241876|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
101241877|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241878|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241879|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241880|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241881|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101241882|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101241883|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530791|NCT01758458|Interleukin-2|interleukin-2|mesh-list
101530792|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530793|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
101530794|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530795|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530796|NCT01758458|Analgesics|analgesics|mesh-ancestor
101530797|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
101530798|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530799|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241884|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101241885|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101241886|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241888|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101241889|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
101241890|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101241891|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101241892|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
101241894|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101241895|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101241896|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101241897|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241898|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241899|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101241900|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241901|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101241902|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
101241903|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101530850|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
101241904|NCT01631409|Diuretics|diuretics|mesh-ancestor
101241905|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
101241906|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101241907|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101241908|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
101241909|NCT01631448|Coagulants|coagulants|mesh-ancestor
101241911|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101241912|NCT01631513|Narcotics|narcotics|mesh-ancestor
101241913|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322847|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
101241914|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241916|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
101241917|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241918|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101241919|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101530904|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530905|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
101530906|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530907|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241920|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241921|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241922|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
101241923|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241925|NCT01631526|Vitamins|vitamins|mesh-ancestor
101241926|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
101241927|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241928|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101241929|NCT01631539|Irinotecan|irinotecan|mesh-list
101241930|NCT01631539|Cetuximab|cetuximab|mesh-list
101241931|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101241932|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101241933|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241934|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241935|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101241936|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101241937|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
101530979|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
101241938|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101241939|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101241940|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241941|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
101241942|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241943|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241944|NCT01631669|Celecoxib|celecoxib|mesh-list
101241945|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101241946|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101241947|NCT01631669|Analgesics|analgesics|mesh-ancestor
101241948|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
101241949|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241950|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241951|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101241952|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101241953|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101241954|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101241955|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241956|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241958|NCT01631838|Vitamin E|vitamin e|mesh-list
101241959|NCT01631838|Tocopherols|tocopherols|mesh-list
101241960|NCT01631838|Tocovid|tocovid|mesh-list
101241961|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
101241962|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241963|NCT01631838|Protective Agents|protective agents|mesh-ancestor
101241964|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241965|NCT01631838|Vitamins|vitamins|mesh-ancestor
101241966|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
101241967|NCT01631877|Enoxaparin|enoxaparin|mesh-list
101241968|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
101531028|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101531029|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101531030|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101241969|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
101241970|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101241971|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101241972|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241973|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101241974|NCT01631968|Colistin|colistin|mesh-list
101241975|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101241976|NCT01631994|Metoclopramide|metoclopramide|mesh-list
101241977|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
101241978|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
101241979|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101241980|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241981|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101241982|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101241983|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101241984|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
101241985|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101241986|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241987|NCT01632007|Alogliptin|alogliptin|mesh-list
101241988|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101241989|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101241990|NCT01632007|Incretins|incretins|mesh-ancestor
101241991|NCT01632007|Hormones|hormones|mesh-ancestor
101241992|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101241993|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101241994|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
101241995|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101241996|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101241997|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
101241998|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101406549|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406551|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101406552|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101531087|NCT00565656|Bevacizumab|bevacizumab|mesh-list
101242000|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101242001|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242002|NCT01632189|Varenicline|varenicline|mesh-list
101242003|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101242004|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101242005|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
101242006|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242007|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242008|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242009|NCT01632371|Paclitaxel|paclitaxel|mesh-list
101242010|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101242011|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101242012|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242013|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
101531158|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531159|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
101242014|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
101242015|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
101242016|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242017|NCT01632436|Pixantrone|pixantrone|mesh-list
101242018|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101242019|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101242020|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242021|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242022|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242023|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
101242024|NCT01632514|Vitamin D|vitamin d|mesh-list
101242025|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242026|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242027|NCT01632514|Vitamins|vitamins|mesh-ancestor
101242028|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
101242029|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101205251|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101242030|NCT01632540|Beclomethasone|beclomethasone|mesh-list
101242031|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242032|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
101242033|NCT01632540|Hormones|hormones|mesh-ancestor
101531218|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
101531219|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101531220|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242034|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242035|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242036|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101242037|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101242038|NCT01632592|Tesamorelin|tesamorelin|mesh-list
101242039|NCT01632592|Growth Substances|growth substances|mesh-ancestor
101242040|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242042|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242043|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242044|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101411661|NCT00461968|Simvastatin|simvastatin|mesh-list
101242045|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242046|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
101242047|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242048|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
101242049|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242050|NCT01632722|Bevacizumab|bevacizumab|mesh-list
101242051|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242052|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242053|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101242054|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242055|NCT01632722|Growth Substances|growth substances|mesh-ancestor
101242056|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242057|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242058|NCT01632761|Vitamin D|vitamin d|mesh-list
101242059|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
101242060|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
101242061|NCT01632761|Vitamins|vitamins|mesh-list
101242062|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
101242063|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242064|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101242065|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242066|NCT01632826|Pomalidomide|pomalidomide|mesh-list
101242067|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
101242068|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242069|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101242070|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242071|NCT01632826|Growth Substances|growth substances|mesh-ancestor
101242072|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242073|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242074|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
101242075|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101242076|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
101242077|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531270|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101531271|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101531272|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242078|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242079|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101242080|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101242081|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101242082|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
101242083|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242084|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242085|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101242086|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
101242088|NCT01633086|Protective Agents|protective agents|mesh-ancestor
101242089|NCT01633099|Decitabine|decitabine|mesh-list
101242090|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242091|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
101242092|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242093|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242094|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242095|NCT01633203|Capecitabine|capecitabine|mesh-list
101242096|NCT01633203|Epirubicin|epirubicin|mesh-list
101242097|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242098|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242099|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
101242100|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242101|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101242102|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101242103|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101242104|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242105|NCT01633294|Gentamicins|gentamicins|mesh-list
101242106|NCT01633294|Ampicillin|ampicillin|mesh-list
101242107|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242108|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242109|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101242110|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242111|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242112|NCT01633359|Atorvastatin|atorvastatin|mesh-list
101242113|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101531299|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242114|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101242115|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101242116|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
101242117|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242118|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101242119|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242120|NCT01633450|Zinc|zinc|mesh-list
101242121|NCT01633450|Trace Elements|trace elements|mesh-ancestor
101242122|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
101242123|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242124|NCT01633476|Valacyclovir|valacyclovir|mesh-list
101242125|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
101242126|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242127|NCT01633593|Donepezil|donepezil|mesh-list
101242128|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101242129|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242130|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242131|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
101242132|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242133|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242134|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
101242135|NCT01633645|Gemcitabine|gemcitabine|mesh-list
101242136|NCT01633645|Bortezomib|bortezomib|mesh-list
101531330|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
101242137|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242138|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531331|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
101242140|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242141|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
101242142|NCT01633658|Vitamin D|vitamin d|mesh-list
101242143|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242144|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242145|NCT01633658|Vitamins|vitamins|mesh-ancestor
101242146|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
101242147|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101242148|NCT01633749|Vaccines|vaccines|mesh-list
101242149|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
101242150|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242151|NCT01633762|Vancomycin|vancomycin|mesh-list
101242152|NCT01633762|Gentamicins|gentamicins|mesh-list
101242153|NCT01633762|Meropenem|meropenem|mesh-list
101242154|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242155|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242156|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101242157|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242158|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242159|NCT01633957|Warfarin|warfarin|mesh-list
101242160|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
101242162|NCT01633970|Paclitaxel|paclitaxel|mesh-list
101242163|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101242164|NCT01633970|Bevacizumab|bevacizumab|mesh-list
101242165|NCT01633970|Carboplatin|carboplatin|mesh-list
101242166|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
101406573|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
101406574|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406575|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101406576|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101242167|NCT01633970|Pemetrexed|pemetrexed|mesh-list
101242168|NCT01633970|Atezolizumab|atezolizumab|mesh-list
101242169|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101242170|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406577|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
101242171|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101242172|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101242173|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101242174|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242175|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242176|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101242177|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242178|NCT01633970|Growth Substances|growth substances|mesh-ancestor
101242179|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242180|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242181|NCT01633970|Antidotes|antidotes|mesh-ancestor
101242182|NCT01633970|Protective Agents|protective agents|mesh-ancestor
101242183|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
101242184|NCT01633970|Vitamins|vitamins|mesh-ancestor
101242185|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
101242186|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242187|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101242188|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242189|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101242190|NCT01633983|Methotrexate|methotrexate|mesh-list
101242191|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101242192|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
101242193|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101242194|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242195|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242196|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
101322865|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101242197|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242198|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242199|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
101242200|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242201|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101242202|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242204|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242205|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242207|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531435|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242209|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242210|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
101242211|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242212|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242213|NCT01634295|Niacin|niacin|mesh-list
101242214|NCT01634295|Amlodipine|amlodipine|mesh-list
101242215|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242216|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101242217|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242218|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242219|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242220|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242221|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
101242222|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101242223|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
101242224|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101242225|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
101242226|NCT01634295|Vitamins|vitamins|mesh-ancestor
101242227|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
101242228|NCT01634321|Leuprolide|leuprolide|mesh-list
101242229|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101242230|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
101242231|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101242232|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242233|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101242234|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242235|NCT01634347|Propranolol|propranolol|mesh-list
101242236|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101242237|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101242238|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101242239|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242240|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242241|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242242|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101242243|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242244|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
101242245|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101242246|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
101242247|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242248|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101242249|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242250|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242251|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531467|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242253|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
101242254|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242255|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101242256|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242257|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242258|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242259|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101242260|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
101242261|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242262|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101242263|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242264|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242265|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242266|NCT01634412|Amitriptyline|amitriptyline|mesh-list
101242267|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
101242268|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101242269|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
101242270|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242271|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101242272|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242273|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101242274|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242275|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242276|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242277|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242278|NCT01634412|Analgesics|analgesics|mesh-ancestor
101242279|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
101242280|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101242281|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101242282|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242283|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242284|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101242285|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242287|NCT01634438|Calcium heparin|calcium heparin|mesh-list
101242288|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
101242289|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101242290|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101242291|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242292|NCT01634594|Nicardipine|nicardipine|mesh-list
101242293|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
101242294|NCT01634594|Remifentanil|remifentanil|mesh-list
101242295|NCT01634594|Sevoflurane|sevoflurane|mesh-list
101531521|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101531522|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
101242296|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101242297|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242298|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242299|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242301|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
101242302|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242303|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101242304|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101242307|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242308|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242309|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101242310|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101242311|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
101242312|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
101242313|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101242314|NCT01634594|Narcotics|narcotics|mesh-ancestor
101242315|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242316|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101242317|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242318|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242319|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101242320|NCT01634685|Capecitabine|capecitabine|mesh-list
101242321|NCT01634685|Bavituximab|bavituximab|mesh-list
101242322|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242323|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
101242324|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242325|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242326|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242327|NCT01634698|Vitamin A|vitamin a|mesh-list
101242328|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
101242329|NCT01634698|Vitamins|vitamins|mesh-ancestor
101242330|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
101242331|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242332|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
101242333|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242334|NCT01634698|Protective Agents|protective agents|mesh-ancestor
101242335|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101242336|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242337|NCT01634763|Ceritinib|ceritinib|mesh-list
101242338|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242339|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101242340|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242341|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242342|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
101242343|NCT01634789|Estrogens|estrogens|mesh-list
101242344|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101531556|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531557|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
101242345|NCT01634789|Hormones|hormones|mesh-ancestor
101242346|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242347|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242348|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101242349|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101242350|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
101242351|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101242353|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242354|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242355|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
101242356|NCT01634893|Sorafenib|sorafenib|mesh-list
101242357|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242358|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101242359|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242360|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242361|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
101242362|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242363|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242364|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242365|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242366|NCT01634906|Atorvastatin|atorvastatin|mesh-list
101242367|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101242368|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101242369|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101242371|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242372|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101242373|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101242374|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242375|NCT01634932|Iron|iron|mesh-list
101242376|NCT01634932|Trace Elements|trace elements|mesh-ancestor
101242377|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
101242378|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242379|NCT01634945|Amodiaquine|amodiaquine|mesh-list
101242380|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
101242381|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242382|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242383|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242384|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101242385|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101242386|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
101242387|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242389|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242390|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101242391|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
101242392|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531583|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242393|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
101242394|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101242395|NCT01635114|Resveratrol|resveratrol|mesh-list
101242396|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
101242397|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242398|NCT01635114|Protective Agents|protective agents|mesh-ancestor
101242399|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242400|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242401|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101242402|NCT01635205|Anesthetics|anesthetics|mesh-list
101242403|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242404|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242406|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242407|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
101242408|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242409|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242410|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
101242411|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242412|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242413|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
101242414|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242415|NCT01635400|Irinotecan|irinotecan|mesh-list
101242416|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101242417|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101242418|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406602|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406603|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101242419|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242420|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242421|NCT01635530|Doxycycline|doxycycline|mesh-list
101242422|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
101242423|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242424|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242425|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
101242426|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242427|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242428|NCT01635608|Acetaminophen|acetaminophen|mesh-list
101242429|NCT01635608|Amoxicillin|amoxicillin|mesh-list
101242430|NCT01635608|Talinolol|talinolol|mesh-list
101242431|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242432|NCT01635608|Analgesics|analgesics|mesh-ancestor
101242433|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
101242434|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242435|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242436|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
101242437|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242438|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531676|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242439|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101242440|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101531681|NCT04604223|Pioglitazone|pioglitazone|mesh-list
101242441|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
101242442|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242443|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242444|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101242445|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242446|NCT01635686|Etanercept|etanercept|mesh-list
101242447|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101242448|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242449|NCT01635686|Analgesics|analgesics|mesh-ancestor
101242450|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
101242451|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242452|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242453|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242454|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242455|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101242456|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322908|NCT00006245|Paclitaxel|paclitaxel|mesh-list
101242457|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
101242458|NCT01635751|Pregabalin|pregabalin|mesh-list
101242459|NCT01635751|Analgesics|analgesics|mesh-ancestor
101242460|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
101242461|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242462|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531717|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
101531718|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242463|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
101531720|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
101242464|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101242465|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242466|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242467|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242468|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101242469|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242470|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242471|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242472|NCT01635777|Miltefosine|miltefosine|mesh-list
101242473|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
101242474|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242475|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242476|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242477|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242478|NCT01635790|Bevacizumab|bevacizumab|mesh-list
101242479|NCT01635790|Ranibizumab|ranibizumab|mesh-list
101242480|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242481|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242482|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531723|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101242483|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242484|NCT01635790|Growth Substances|growth substances|mesh-ancestor
101242485|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205697|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242486|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242487|NCT01635803|Bevacizumab|bevacizumab|mesh-list
101242488|NCT01635803|Ranibizumab|ranibizumab|mesh-list
101242489|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242490|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242491|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101242492|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242493|NCT01635803|Growth Substances|growth substances|mesh-ancestor
101242494|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242495|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242496|NCT01635816|Vaccines|vaccines|mesh-list
101242497|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
101242498|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242499|NCT01635829|Carbamazepine|carbamazepine|mesh-list
101242500|NCT01635829|Phenytoin|phenytoin|mesh-list
101242501|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
101242502|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
101242503|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242504|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242505|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242506|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242507|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242508|NCT01635829|Analgesics|analgesics|mesh-ancestor
101242509|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
101242510|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242511|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101242512|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242513|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531795|NCT01155583|Azacitidine|azacitidine|mesh-list
101531796|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242515|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101242516|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101242517|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101242519|NCT01635946|Atorvastatin|atorvastatin|mesh-list
101242520|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101242521|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101242522|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
101242523|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242524|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101242525|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101242526|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242527|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
101242528|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242529|NCT01635972|Isavuconazole|isavuconazole|mesh-list
101242530|NCT01635972|Bupropion|bupropion|mesh-list
101242531|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101242532|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
101242533|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242534|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101242535|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101242536|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101242537|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242538|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
101242539|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242540|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242541|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101242542|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101242543|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242544|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
101242545|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242546|NCT01636037|Levodopa|levodopa|mesh-list
101242547|NCT01636037|Carbidopa|carbidopa|mesh-list
101242548|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101242549|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101242550|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101242551|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
101242552|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242553|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242554|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242555|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101242556|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242557|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101242558|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
101242559|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
101242560|NCT01636128|Eflornithine|eflornithine|mesh-list
101242561|NCT01636128|Sulindac|sulindac|mesh-list
101242562|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242563|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101242564|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242565|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242566|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242567|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101242568|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531842|NCT01155466|Protective Agents|protective agents|mesh-ancestor
101531844|NCT00561899|Piperaquine|piperaquine|mesh-list
101242569|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242570|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101242571|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242572|NCT01636128|Analgesics|analgesics|mesh-ancestor
101242573|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
101242574|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242575|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242576|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242577|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242578|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101242579|NCT01636141|Dapansutrile|dapansutrile|mesh-list
101242580|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242581|NCT01636180|Clopidogrel|clopidogrel|mesh-list
101322921|NCT00094315|Cocaine|cocaine|mesh-list
101242582|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101242583|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101242584|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101242585|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101242586|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
101242588|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242589|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242591|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
101242592|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242593|NCT01636271|Darapladib|darapladib|mesh-list
101242594|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101242595|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242596|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242597|NCT01636310|Nicotine|nicotine|mesh-list
101242598|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101242599|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
101242600|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242601|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242602|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101242603|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101242604|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101242605|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242606|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242607|NCT01636323|Nicotine|nicotine|mesh-list
101242608|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101242609|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
101242610|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242611|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242612|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101242613|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101242614|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
101242615|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242616|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242617|NCT01636336|Nicotine|nicotine|mesh-list
101242618|NCT01636336|Progesterone|progesterone|mesh-list
101242619|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101531862|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101531863|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101242620|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
101242621|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242622|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242623|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101242624|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101242625|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
101242626|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242627|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242628|NCT01636336|Progestins|progestins|mesh-ancestor
101242630|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242631|NCT01636401|Bromides|bromides|mesh-list
101242632|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
101242633|NCT01636505|Cetrorelix|cetrorelix|mesh-list
101242634|NCT01636505|Buserelin|buserelin|mesh-list
101242635|NCT01636505|Ganirelix|ganirelix|mesh-list
101242636|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101242638|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101242639|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242640|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101242641|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242642|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101242643|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
101242644|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242645|NCT01636557|Vitamin K|vitamin k|mesh-list
101242646|NCT01636557|Midazolam|midazolam|mesh-list
101242647|NCT01636557|Caffeine|caffeine|mesh-list
101242648|NCT01636557|Omeprazole|omeprazole|mesh-list
101242649|NCT01636557|Warfarin|warfarin|mesh-list
101242650|NCT01636557|Vitamins|vitamins|mesh-ancestor
101242651|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
101242652|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242653|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101242654|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101242655|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242656|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101242657|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101242658|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101242659|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101242660|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
101242662|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
101242663|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
101242664|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242665|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242666|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
101242667|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101242668|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101242669|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242670|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101242671|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101242672|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
101242673|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101242674|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101242675|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101242676|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101242677|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101242678|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
101242679|NCT01636557|Coagulants|coagulants|mesh-ancestor
101242680|NCT01636570|Vitamin D|vitamin d|mesh-list
101242681|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
101242682|NCT01636570|Vitamins|vitamins|mesh-ancestor
101242683|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
101242684|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242685|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101242686|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242688|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101242689|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242690|NCT01636609|Cytarabine|cytarabine|mesh-list
101242691|NCT01636609|Azacitidine|azacitidine|mesh-list
101242692|NCT01636609|Tosedostat|tosedostat|mesh-list
101242693|NCT01636609|Glycine|glycine|mesh-list
101242694|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101242695|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
101242696|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242697|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242698|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
101242699|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242700|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242701|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
101242702|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242703|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242704|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
101242705|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242706|NCT01636622|Paclitaxel|paclitaxel|mesh-list
101242707|NCT01636622|Carboplatin|carboplatin|mesh-list
101242708|NCT01636622|Vemurafenib|vemurafenib|mesh-list
101242709|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101242710|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242711|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
101242712|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
101242713|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
101242714|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242715|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101242716|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242717|NCT01636700|Tramadol|tramadol|mesh-list
101242718|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101242719|NCT01636700|Narcotics|narcotics|mesh-ancestor
101242720|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242721|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242722|NCT01636700|Analgesics|analgesics|mesh-ancestor
101242723|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
101242724|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242725|NCT01635426|Aspirin|aspirin|mesh-list
101242726|NCT01635426|Clopidogrel|clopidogrel|mesh-list
101242727|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101242728|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242729|NCT01635426|Analgesics|analgesics|mesh-ancestor
101242730|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
101531900|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242731|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242732|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242733|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242734|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242735|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101242736|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101242737|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242738|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101242739|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101242740|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242741|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
101242742|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101242743|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101242744|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101242745|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
101242746|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242747|NCT01636869|Bupivacaine|bupivacaine|mesh-list
101242748|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
101242749|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
101242750|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531925|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531926|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101242751|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242752|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
101242753|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242755|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101242756|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
101242757|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
101242758|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101242759|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101242760|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242761|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101242762|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242763|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242764|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101242765|NCT01636908|Everolimus|everolimus|mesh-list
101242766|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101242767|NCT01636908|Sorafenib|sorafenib|mesh-list
101242768|NCT01636908|Sunitinib|sunitinib|mesh-list
101242769|NCT01636908|Dasatinib|dasatinib|mesh-list
101242770|NCT01636908|Lapatinib|lapatinib|mesh-list
101242771|NCT01636908|Vemurafenib|vemurafenib|mesh-list
101242772|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101242773|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101242774|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242775|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242776|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242777|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
101242778|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242779|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242780|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101242781|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101242782|NCT01636908|Growth Substances|growth substances|mesh-ancestor
101242783|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
101242784|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
101242785|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101242786|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
101242787|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
101242788|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101242789|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242790|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242791|NCT01636999|Analgesics|analgesics|mesh-ancestor
101242792|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
101242793|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242794|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
101242795|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
101531988|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531989|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
101242796|NCT01637025|Coagulants|coagulants|mesh-ancestor
101242797|NCT01637155|Vitamin D|vitamin d|mesh-list
101242798|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
101242800|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
101242801|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242802|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101242803|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101242804|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101242805|NCT01637194|Cetuximab|cetuximab|mesh-list
101242806|NCT01637194|Everolimus|everolimus|mesh-list
101242807|NCT01637194|Antibodies|antibodies|mesh-list
101242808|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
101242809|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101242810|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
101242811|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242812|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242813|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101411709|NCT00462475|Hormones|hormones|mesh-list
101242814|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101242815|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242816|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242817|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101242818|NCT01637233|Ritonavir|ritonavir|mesh-list
101242819|NCT01637233|Lopinavir|lopinavir|mesh-list
101242820|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101242821|NCT01637233|Darunavir|darunavir|mesh-list
101242822|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
101242823|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101242825|NCT01637233|Lamivudine|lamivudine|mesh-list
101242826|NCT01637233|Emtricitabine|emtricitabine|mesh-list
101242827|NCT01637233|Zidovudine|zidovudine|mesh-list
101242828|NCT01637233|Maraviroc|maraviroc|mesh-list
101242829|NCT01637233|Abacavir|abacavir|mesh-list
101242830|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
101242831|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101242832|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
101242833|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101242834|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242835|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242836|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101242837|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101532019|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101242838|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
101242839|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532021|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
101242840|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101242841|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101242842|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242843|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
101242844|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101242845|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101242846|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101242847|NCT01637259|Ritonavir|ritonavir|mesh-list
101242848|NCT01637259|Lopinavir|lopinavir|mesh-list
101242849|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101242850|NCT01637259|Darunavir|darunavir|mesh-list
101242851|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
101242852|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101242853|NCT01637259|Tenofovir|tenofovir|mesh-list
101242854|NCT01637259|Lamivudine|lamivudine|mesh-list
101242855|NCT01637259|Emtricitabine|emtricitabine|mesh-list
101242856|NCT01637259|Zidovudine|zidovudine|mesh-list
101242857|NCT01637259|Maraviroc|maraviroc|mesh-list
101242858|NCT01637259|Abacavir|abacavir|mesh-list
101242859|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
101242860|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101242861|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
101242862|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101242863|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242864|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242865|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101242866|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101532051|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101242867|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
101242868|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242869|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101242870|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101242871|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242872|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
101242873|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101242874|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101242875|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101242876|NCT01637376|Temoporfin|temoporfin|mesh-list
101242877|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242878|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101242879|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101242880|NCT01637454|Terlipressin|terlipressin|mesh-list
101242881|NCT01637454|Norepinephrine|norepinephrine|mesh-list
101242883|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101532110|NCT04590612|Carbidopa|carbidopa|mesh-list
101242884|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101532111|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101242885|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101242886|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
101242887|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242888|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242889|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242891|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
101242892|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242893|NCT01637532|Interferons|interferons|mesh-list
101242894|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
101242895|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
101242896|NCT01637532|Carboplatin|carboplatin|mesh-list
101242897|NCT01637532|Doxorubicin|doxorubicin|mesh-list
101242898|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242899|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101242900|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101242901|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101242902|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242903|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242904|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
101242905|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242906|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
101242907|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242909|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
101242910|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
101242911|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242912|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532172|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
101242914|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101242915|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
101242916|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101242917|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242918|NCT01637558|Ritonavir|ritonavir|mesh-list
101242919|NCT01637558|Lopinavir|lopinavir|mesh-list
101242920|NCT01637558|Nevirapine|nevirapine|mesh-list
101242921|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101242922|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101242923|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101242924|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242925|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242926|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101242927|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101242928|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
101242929|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242930|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101242931|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101242932|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101532236|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532237|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
101532238|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101242933|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242934|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101242935|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101242937|NCT01637571|Lansoprazole|lansoprazole|mesh-list
101242938|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101242939|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101242940|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101242941|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242942|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242943|NCT01637636|Rifampin|rifampin|mesh-list
101242944|NCT01637636|Ketoconazole|ketoconazole|mesh-list
101532285|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
101242945|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101242946|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
101242947|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101242948|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242949|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
101242950|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101242951|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242952|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242954|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101242955|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101242956|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101242957|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101242958|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101242960|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101242961|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101242962|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101242963|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
101242964|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101242965|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242966|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101242967|NCT01637675|Tanshinone|tanshinone|mesh-list
101242968|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
101242969|NCT01637675|Citric Acid|citric acid|mesh-list
101242970|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
101242971|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
101242972|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101242973|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
101242974|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
101242975|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242976|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
101242977|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101242978|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101242979|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101242980|NCT01637675|Urological Agents|urological agents|mesh-ancestor
101242981|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101242982|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101242983|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101242985|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
101242986|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101242987|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101242988|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101242989|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101242990|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101242991|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242992|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532324|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101242993|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
101242995|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101242996|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
101242997|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101242998|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101242999|NCT01637766|Melphalan|melphalan|mesh-list
101243000|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101243001|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
101243002|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243003|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243004|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101243005|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243006|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
101243007|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243008|NCT01637818|Acetaminophen|acetaminophen|mesh-list
101243009|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101243010|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101406744|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
101243011|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101243012|NCT01637818|Analgesics|analgesics|mesh-ancestor
101243013|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
101243014|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243015|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243016|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
101243017|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243018|NCT01637844|Telbivudine|telbivudine|mesh-list
101243019|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
101243020|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243021|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243023|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243025|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243026|NCT01637948|Listerine|listerine|mesh-list
101243027|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101243028|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243029|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101243030|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
101243031|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101243032|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
101243033|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243034|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406762|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243035|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101406763|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
101243036|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101243037|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243038|NCT01638078|Thalidomide|thalidomide|mesh-list
101243039|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243040|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
101243041|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243042|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
101243043|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101243044|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243045|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101243046|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101243047|NCT01638078|Growth Substances|growth substances|mesh-ancestor
101243048|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
101243049|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243050|NCT01638182|Vitamins|vitamins|mesh-list
101243051|NCT01638182|Vitamin K|vitamin k|mesh-list
101243052|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
101243053|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
101243054|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
101243055|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243056|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101243057|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243058|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243059|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
101243060|NCT01638182|Coagulants|coagulants|mesh-ancestor
101243061|NCT01638234|Melatonin|melatonin|mesh-list
101532473|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243062|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
101243063|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243064|NCT01638234|Protective Agents|protective agents|mesh-ancestor
101243065|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243066|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243068|NCT01638247|Goserelin|goserelin|mesh-list
101243069|NCT01638247|Exemestane|exemestane|mesh-list
101243070|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101243071|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101243072|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
101243073|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243074|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243075|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101243076|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243077|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101243078|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101243079|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101243080|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101243081|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101243082|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243083|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243084|NCT01638247|Hormones|hormones|mesh-ancestor
101243085|NCT01638260|Liraglutide|liraglutide|mesh-list
101243086|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243087|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243088|NCT01638260|Incretins|incretins|mesh-ancestor
101243089|NCT01638260|Hormones|hormones|mesh-ancestor
101243090|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243091|NCT01638273|Pregabalin|pregabalin|mesh-list
101243092|NCT01638273|Analgesics|analgesics|mesh-ancestor
101243093|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
101243094|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243096|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
101243097|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101243098|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101243099|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243100|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101243101|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101243102|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532554|NCT00562835|Thiamine|thiamine|mesh-list
101243103|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243104|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101243105|NCT01638299|Insulin|insulin|mesh-list
101243106|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243107|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243108|NCT01638325|Insulin|insulin|mesh-list
101243109|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101243110|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
101243111|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243112|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243113|NCT01638364|Ethanol|ethanol|mesh-list
101243114|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101243115|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243116|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243117|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243118|NCT01638377|Naltrexone|naltrexone|mesh-list
101243119|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101243120|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101243121|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243122|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
101243123|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243124|NCT01638403|Modafinil|modafinil|mesh-list
101532570|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101243125|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101243126|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243127|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101243128|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101243129|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101243130|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243131|NCT01638442|Tosedostat|tosedostat|mesh-list
101243132|NCT01638442|Glycine|glycine|mesh-list
101243133|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243134|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243135|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
101243136|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243137|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243138|NCT01638624|Propofol|propofol|mesh-list
101243139|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101243140|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243141|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243142|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101243143|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
101243144|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
101243145|NCT01638650|Ritonavir|ritonavir|mesh-list
101243146|NCT01638650|Saquinavir|saquinavir|mesh-list
101243147|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101243148|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101243149|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101243150|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
101243151|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243153|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101243154|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101243155|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
101243156|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243157|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101243158|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101243159|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243160|NCT01638663|Tolvaptan|tolvaptan|mesh-list
101243161|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101243162|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243163|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
101243164|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243165|NCT01638676|Metformin|metformin|mesh-list
101243166|NCT01638676|Vemurafenib|vemurafenib|mesh-list
101243167|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243168|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243169|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243170|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101243171|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243172|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243173|NCT01638689|Escitalopram|escitalopram|mesh-list
101406810|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
101243174|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101243175|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101243176|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101243177|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243178|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243179|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
101243180|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243181|NCT01638715|Infliximab|infliximab|mesh-list
101243182|NCT01638715|Rituximab|rituximab|mesh-list
101243183|NCT01638715|Abatacept|abatacept|mesh-list
101243184|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101243185|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532738|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243187|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243188|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243189|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101243190|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243191|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243192|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101243193|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101243194|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243195|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243196|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
101243197|NCT01638767|NuvaRing|nuvaring|mesh-list
101243198|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
101243199|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243200|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243201|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101243202|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101243203|NCT01638780|Resveratrol|resveratrol|mesh-list
101243204|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
101243205|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243206|NCT01638780|Protective Agents|protective agents|mesh-ancestor
101243207|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243208|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532867|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
101243209|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101243210|NCT01638858|Ranibizumab|ranibizumab|mesh-list
101243211|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101243212|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101243214|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532868|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
101532874|NCT04610879|Analgesics|analgesics|mesh-ancestor
101243215|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
101243216|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243217|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
101243218|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
101243219|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
101243220|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243221|NCT01638962|Acetaminophen|acetaminophen|mesh-list
101243222|NCT01638962|Aspirin|aspirin|mesh-list
101243223|NCT01638962|Ibuprofen|ibuprofen|mesh-list
101243224|NCT01638962|Celecoxib|celecoxib|mesh-list
101243225|NCT01638962|Diclofenac|diclofenac|mesh-list
101243226|NCT01638962|Naproxen|naproxen|mesh-list
101243227|NCT01638962|Indomethacin|indomethacin|mesh-list
101243228|NCT01638962|Etoricoxib|etoricoxib|mesh-list
101532928|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243229|NCT01638962|Meloxicam|meloxicam|mesh-list
101243230|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101243231|NCT01638962|Etodolac|etodolac|mesh-list
101243232|NCT01638962|Lornoxicam|lornoxicam|mesh-list
101243233|NCT01638962|Nabumetone|nabumetone|mesh-list
101243234|NCT01638962|Tenoxicam|tenoxicam|mesh-list
101243235|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
101243236|NCT01638962|Analgesics|analgesics|mesh-list
101243237|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101243238|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
101243239|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243240|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243241|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
101243242|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101243243|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243244|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243245|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101243246|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532929|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
101243247|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243248|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101243249|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
101243250|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101243251|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243252|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101243254|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243257|NCT01638988|Enclomiphene|enclomiphene|mesh-list
101243258|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
101243259|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243260|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243261|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101243262|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
101243263|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243264|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101243265|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
101243266|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243267|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101243268|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101243269|NCT01639027|Drotaverin|drotaverin|mesh-list
101243270|NCT01639027|Analgesics|analgesics|mesh-ancestor
101243271|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
101406858|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406860|NCT00135096|Insulin|insulin|mesh-list
101243272|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243273|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243274|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
101243275|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
101243276|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
101243277|NCT01639066|Tenofovir|tenofovir|mesh-list
101243278|NCT01639066|Entecavir|entecavir|mesh-list
101243279|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
101243280|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243281|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101243282|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243283|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243284|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243285|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101243286|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101243287|NCT01639092|Tenofovir|tenofovir|mesh-list
101243288|NCT01639092|Entecavir|entecavir|mesh-list
101243289|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
101243290|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243291|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101243292|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243293|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243294|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243295|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101243296|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101243297|NCT01639261|Interferons|interferons|mesh-list
101243298|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
101243299|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243300|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
101243301|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243302|NCT01639326|Irinotecan|irinotecan|mesh-list
101243303|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101243304|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101243305|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243306|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243307|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243308|NCT01639456|Aldesleukin|aldesleukin|mesh-list
101243309|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
101243310|NCT01639456|Fludarabine|fludarabine|mesh-list
101243311|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243312|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
101243313|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243314|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533067|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243315|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101243317|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243318|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243319|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101243320|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101243321|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101243322|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
101243323|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243326|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101243327|NCT01639521|Methotrexate|methotrexate|mesh-list
101243328|NCT01639521|Vinblastine|vinblastine|mesh-list
101243329|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243330|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101243331|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
101243332|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243333|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101243334|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101243335|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101533127|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243336|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243337|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101243338|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
101243339|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243340|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243341|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243342|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101243343|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243344|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
101243345|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243346|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101243347|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101243348|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
101243349|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
101243350|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
101243351|NCT01639547|Ribavirin|ribavirin|mesh-list
101243352|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101533216|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101243354|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243355|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
101243356|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243358|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101243359|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243360|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
101243361|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101243362|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101533287|NCT00575406|Prednisolone|prednisolone|mesh-list
101533288|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
101243363|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
101243364|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243365|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243366|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243367|NCT01639794|Urological Agents|urological agents|mesh-ancestor
101243368|NCT01639807|Latanoprost|latanoprost|mesh-list
101243369|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101243370|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101243371|NCT01639885|Interferons|interferons|mesh-list
101243372|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
101243373|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
101243374|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243375|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
101243376|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243377|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
101243378|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243379|NCT01639898|Dexamethasone|dexamethasone|mesh-list
101243380|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
101243381|NCT01639898|Lenalidomide|lenalidomide|mesh-list
101243382|NCT01639898|BB 1101|bb 1101|mesh-list
101243383|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243384|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
101243385|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
101243386|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243387|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243388|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101243389|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
101243390|NCT01639898|Hormones|hormones|mesh-ancestor
101243391|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243392|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101243393|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243394|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
101243395|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243396|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206604|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243397|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
101533411|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243398|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101243399|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101243400|NCT01639898|Growth Substances|growth substances|mesh-ancestor
101243401|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
101243402|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
101243403|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101243404|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101243405|NCT01640743|Prednisolone|prednisolone|mesh-list
101243406|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
101243407|NCT01640743|Everolimus|everolimus|mesh-list
101243408|NCT01640743|Tacrolimus|tacrolimus|mesh-list
101243409|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101243410|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
101243411|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243412|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
101243413|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243414|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101243415|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243416|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243417|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101243420|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243421|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
101243422|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
101243423|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243424|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101243425|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
101243426|NCT01640743|Hormones|hormones|mesh-ancestor
101243427|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243428|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101243429|NCT01640743|Protective Agents|protective agents|mesh-ancestor
101243430|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101243431|NCT01641016|Efavirenz|efavirenz|mesh-list
101243432|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101243433|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101533539|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101243434|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243435|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243436|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
101243437|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243438|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101243439|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101243440|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101243441|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101243442|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101243443|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101243445|NCT01642771|Fluorouracil|fluorouracil|mesh-list
101243446|NCT01642771|Capecitabine|capecitabine|mesh-list
101243447|NCT01642771|Epirubicin|epirubicin|mesh-list
101243448|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243449|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101243450|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533602|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101243451|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101243452|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243453|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
101243454|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101243455|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243456|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
101243457|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243458|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101243459|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101243460|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101243461|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243463|NCT01642979|Levamisole|levamisole|mesh-list
101243464|NCT01642979|Cyclosporins|cyclosporins|mesh-list
101243465|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
101243466|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533661|NCT00577161|Pixantrone|pixantrone|mesh-list
101243467|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243468|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243469|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
101243470|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243471|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
101243472|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243473|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243475|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101243476|NCT01642979|Hormones|hormones|mesh-ancestor
101243477|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533710|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101533711|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243478|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101243479|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
101243480|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
101243481|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101243482|NCT01643031|Clopidogrel|clopidogrel|mesh-list
101243483|NCT01643031|Ticagrelor|ticagrelor|mesh-list
101243484|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101243485|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101243486|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101243487|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101243488|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
101243489|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243490|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243491|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533812|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
101243492|NCT01643434|Clonidine|clonidine|mesh-list
101243493|NCT01643434|Spironolactone|spironolactone|mesh-list
101243494|NCT01643434|Analgesics|analgesics|mesh-ancestor
101243495|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
101243496|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243497|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243498|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101243499|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
101243500|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
101243501|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101243502|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101243503|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101243504|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
101406994|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243505|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406995|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243506|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243507|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101243508|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
101243509|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243510|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101243511|NCT01643434|Diuretics|diuretics|mesh-ancestor
101243512|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
101243513|NCT01643941|Vaccines|vaccines|mesh-list
101243514|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
101243515|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243516|NCT01643980|Progesterone|progesterone|mesh-list
101243517|NCT01643980|Progestins|progestins|mesh-ancestor
101533932|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243518|NCT01643980|Hormones|hormones|mesh-ancestor
101243519|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243520|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243521|NCT01645228|Calcium|calcium|mesh-list
101243522|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101243523|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243524|NCT01645839|Cytarabine|cytarabine|mesh-list
101243525|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407021|NCT04702360|Ivacaftor|ivacaftor|mesh-list
101243526|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
101243527|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243528|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243529|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
101243530|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243531|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243532|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
101243533|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243534|NCT01646437|Aspirin|aspirin|mesh-list
101243535|NCT01646437|Vitamin D|vitamin d|mesh-list
101243536|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
101243537|NCT01646437|Vitamins|vitamins|mesh-ancestor
101243538|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
101243539|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243540|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101243541|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101243542|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101243543|NCT01646437|Analgesics|analgesics|mesh-ancestor
101243544|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
101243545|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243546|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243548|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101243549|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243550|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243551|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101243552|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101243553|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243554|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
101243555|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101243556|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
101243557|NCT01646619|Analgesics|analgesics|mesh-ancestor
101243558|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
101407029|NCT00138060|Fluorouracil|fluorouracil|mesh-list
101243559|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243560|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243562|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243563|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101243564|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
101243565|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101243566|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101243567|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243568|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101243569|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
101243570|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243571|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101243572|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101243573|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243574|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534106|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101243575|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
101243576|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243577|NCT01648218|Insulin|insulin|mesh-list
101243578|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101243579|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
101243580|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
101243581|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
101243582|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
101243583|NCT01648218|Protamines|protamines|mesh-list
101243584|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243585|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243586|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
101243587|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243588|NCT01648218|Coagulants|coagulants|mesh-ancestor
101243589|NCT01648465|Everolimus|everolimus|mesh-list
101243590|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101534167|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534168|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243591|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101243592|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243593|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534170|NCT04577430|Analgesics|analgesics|mesh-ancestor
101243594|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243595|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
101243596|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243597|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243599|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
101243600|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
101243601|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243602|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243603|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
101243604|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243605|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
101243606|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243607|NCT01649024|Tremelimumab|tremelimumab|mesh-list
101534231|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534232|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101243608|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243609|NCT01649960|Sirolimus|sirolimus|mesh-list
101243610|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101243611|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243612|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101243613|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243614|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
101243615|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243616|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
101243617|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243619|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101243620|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
101243621|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243622|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243623|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101243624|NCT01650012|Diuretics|diuretics|mesh-ancestor
101243625|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
101243626|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101243627|NCT01650090|Cisplatin|cisplatin|mesh-list
101534290|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
101243628|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534291|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
101534297|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
101243630|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101243631|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
101243632|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
101243633|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243634|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243635|NCT01650181|Selenium|selenium|mesh-list
101243636|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
101243637|NCT01650181|Metformin|metformin|mesh-list
101243638|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243639|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243640|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
101243641|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243642|NCT01650181|Protective Agents|protective agents|mesh-ancestor
101243643|NCT01650181|Trace Elements|trace elements|mesh-ancestor
101243644|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
101243645|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
101243646|NCT01650181|Vitamins|vitamins|mesh-ancestor
101243647|NCT01650272|Minoxidil|minoxidil|mesh-list
101243648|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101243649|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101243650|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
101243651|NCT01650376|Paclitaxel|paclitaxel|mesh-list
101243652|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101243653|NCT01650376|Carboplatin|carboplatin|mesh-list
101243654|NCT01650376|Olaparib|olaparib|mesh-list
101243655|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101243656|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243657|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101243658|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101243659|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534352|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101534353|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101534356|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
101243660|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243661|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101243662|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243663|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
101243664|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101243665|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
101243666|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243667|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
101243668|NCT01650415|Hematinics|hematinics|mesh-ancestor
101243669|NCT01650428|Bevacizumab|bevacizumab|mesh-list
101243670|NCT01650428|Fluorouracil|fluorouracil|mesh-list
101243671|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
101243672|NCT01650428|Irinotecan|irinotecan|mesh-list
101243673|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101243674|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243675|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101243676|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101243677|NCT01650428|Growth Substances|growth substances|mesh-ancestor
101243678|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243679|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
101243680|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
101243681|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243682|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101243683|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243684|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
101243685|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101243686|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101243687|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243688|NCT01650441|Beclomethasone|beclomethasone|mesh-list
101243689|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
101243690|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101243691|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
101243692|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243693|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243694|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101243695|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
101243696|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101243697|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101243698|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101243699|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
101243700|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243701|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243702|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101243703|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
101243704|NCT01650441|Hormones|hormones|mesh-ancestor
101243705|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243706|NCT01650493|Listerine|listerine|mesh-list
101243707|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
101243708|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
101243709|NCT01650493|Protective Agents|protective agents|mesh-ancestor
101243710|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243711|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101243712|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243713|NCT01650506|Metformin|metformin|mesh-list
101243714|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101243715|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101243716|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243717|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243718|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101243719|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243720|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243721|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
101243722|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243723|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243724|NCT01650649|Lofexidine|lofexidine|mesh-list
101243725|NCT01650649|Clonidine|clonidine|mesh-list
101243726|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101243727|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101243728|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243729|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
101243730|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243731|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101243732|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101243733|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101243734|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101243735|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243736|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243737|NCT01650649|Analgesics|analgesics|mesh-ancestor
101243738|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
101243739|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
101243740|NCT01650662|Cyclosporine|cyclosporine|mesh-list
101243741|NCT01650662|Cyclosporins|cyclosporins|mesh-list
101243742|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243743|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243747|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
101243748|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243749|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101243750|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243751|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101243752|NCT01650727|Rituximab|rituximab|mesh-list
101243753|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101243754|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243755|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
101243756|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243757|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243758|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101243759|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101243760|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101243761|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407099|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101243762|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243763|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243764|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243765|NCT01650740|Analgesics|analgesics|mesh-ancestor
101243766|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
101243767|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243768|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
101243769|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101243770|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
101243771|NCT01650870|Lactulose|lactulose|mesh-list
101243773|NCT01650883|Vitamin D|vitamin d|mesh-list
101243774|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
101243775|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
101243777|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
101243778|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243779|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101243780|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101243781|NCT01650961|Palonosetron|palonosetron|mesh-list
101243782|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
101243783|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
101243784|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243785|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243786|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101243787|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101243788|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101243789|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
101243790|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243791|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243792|NCT01651130|Carbetocin|carbetocin|mesh-list
101243793|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
101243794|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243795|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243796|NCT01651156|Tolvaptan|tolvaptan|mesh-list
101243797|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101243798|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243799|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
101243800|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243801|NCT01651169|Methylphenidate|methylphenidate|mesh-list
101323006|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
101243802|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101243804|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101243805|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101243806|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101243807|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243808|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
101243809|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243810|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
101243811|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101243812|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243813|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243814|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
101243815|NCT01651182|Coagulants|coagulants|mesh-ancestor
101243816|NCT01651312|Mirabegron|mirabegron|mesh-list
101243817|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101243818|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101243819|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101243820|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101243821|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243822|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243823|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243824|NCT01651312|Urological Agents|urological agents|mesh-ancestor
101243825|NCT01651325|Isavuconazole|isavuconazole|mesh-list
101243826|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
101243827|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
101243828|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
101243829|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101243830|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101243831|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243832|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243833|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243834|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
101243835|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243836|NCT01651364|Cabergoline|cabergoline|mesh-list
101243837|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101243838|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101243839|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
101243840|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
101243841|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243842|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243843|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243844|NCT01651377|Pramipexole|pramipexole|mesh-list
101243845|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
101243846|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243847|NCT01651377|Protective Agents|protective agents|mesh-ancestor
101207066|NCT01435252|Cetuximab|cetuximab|mesh-list
101243848|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243849|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101243850|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101243851|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
101243852|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
101243853|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243854|NCT01651390|Sirolimus|sirolimus|mesh-list
101243855|NCT01651390|Paclitaxel|paclitaxel|mesh-list
101243856|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101243857|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243858|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
101243859|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
101243860|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
101243861|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243862|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101243863|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243864|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101243865|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
101243866|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243867|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
101243868|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243869|NCT01651416|Lumefantrine|lumefantrine|mesh-list
101243871|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
101243872|NCT01651416|Piperaquine|piperaquine|mesh-list
101243873|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
101243874|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101243876|NCT01651416|Amodiaquine|amodiaquine|mesh-list
101243878|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
101243879|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101243880|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101243881|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243882|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101243883|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243884|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243885|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101243886|NCT01651481|Montelukast|montelukast|mesh-list
101243887|NCT01651481|Levocetirizine|levocetirizine|mesh-list
101243888|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101243889|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
101243890|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101243891|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534504|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
101243892|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101243893|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243894|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101243895|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101243896|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243897|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101243898|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101243899|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
101243900|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
101243901|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243902|NCT01651520|Flumazenil|flumazenil|mesh-list
101243903|NCT01651520|Antidotes|antidotes|mesh-ancestor
101243904|NCT01651520|Protective Agents|protective agents|mesh-ancestor
101243905|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243906|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
101243907|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
101243909|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243910|NCT01651572|Rocuronium|rocuronium|mesh-list
101243911|NCT01651572|Cisatracurium|cisatracurium|mesh-list
101243912|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101243913|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101243914|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101243915|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243916|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243917|NCT01651585|Valacyclovir|valacyclovir|mesh-list
101243918|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
101243919|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243920|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101243921|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
101243923|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
101243924|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243925|NCT01651728|Simvastatin|simvastatin|mesh-list
101243926|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101243927|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101243928|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
101243929|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243930|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101243931|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101243932|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243933|NCT01651923|Heparin|heparin|mesh-list
101243934|NCT01651923|Calcium heparin|calcium heparin|mesh-list
101243935|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
101407165|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
101243936|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101243937|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101243938|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243940|NCT01651962|Terbutaline|terbutaline|mesh-list
101243941|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101243942|NCT01651962|Narcotics|narcotics|mesh-ancestor
101243943|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243944|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243945|NCT01651962|Analgesics|analgesics|mesh-ancestor
101243946|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
101243947|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101243948|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101243949|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101243950|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
101243951|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
101243952|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101243953|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
101243954|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101243955|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
101243956|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
101243957|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
101243958|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101243959|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101243960|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101243961|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101243962|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
101243963|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101243964|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243965|NCT01651988|Propofol|propofol|mesh-list
101243966|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101243967|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101243968|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243969|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101243970|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
101243971|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
101243972|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
101243973|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
101243974|NCT01652014|Fludarabine|fludarabine|mesh-list
101243975|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
101243976|NCT01652014|Tacrolimus|tacrolimus|mesh-list
101243977|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101243978|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
101243979|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101243980|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101243981|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101243983|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101243984|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101243985|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101243986|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101243987|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
101243988|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101243989|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101243990|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101243991|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101243992|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
101243993|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101243994|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243995|NCT01652118|Clarithromycin|clarithromycin|mesh-list
101243996|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101243997|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101243998|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101243999|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244000|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244001|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101244002|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101244003|NCT01652157|Pancrelipase|pancrelipase|mesh-list
101244004|NCT01652157|Pancreatin|pancreatin|mesh-list
101244005|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244006|NCT01652183|Acetaminophen|acetaminophen|mesh-list
101244007|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244009|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
101244010|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244011|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244012|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
101244013|NCT01652196|Leucovorin|leucovorin|mesh-list
101244014|NCT01652196|Fluorouracil|fluorouracil|mesh-list
101244015|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
101244016|NCT01652196|Aflibercept|aflibercept|mesh-list
101244017|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
101244018|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101244019|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
101244020|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244021|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244022|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244023|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244024|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
101244025|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244026|NCT01652196|Antidotes|antidotes|mesh-ancestor
101244027|NCT01652196|Protective Agents|protective agents|mesh-ancestor
101244028|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
101244029|NCT01652196|Vitamins|vitamins|mesh-ancestor
101244030|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
101244031|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101244032|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101244033|NCT01652196|Growth Substances|growth substances|mesh-ancestor
101244034|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
101244035|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101244036|NCT01652313|Rasagiline|rasagiline|mesh-list
101244037|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101244038|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244039|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244040|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101244041|NCT01652313|Protective Agents|protective agents|mesh-ancestor
101244042|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244043|NCT01652326|Diazepam|diazepam|mesh-list
101244044|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101244045|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
101244046|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
101244047|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
101244048|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244049|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244050|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244051|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101244052|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244053|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101244054|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101244055|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101244056|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101244057|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101244058|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101534510|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244059|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
101244060|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
101244061|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
101244062|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
101244063|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244064|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244066|NCT01652339|Valsartan|valsartan|mesh-list
101534512|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
101244067|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101244068|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101244069|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101244070|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244071|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244072|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244073|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244074|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244075|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101244076|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101244078|NCT01652378|Ondansetron|ondansetron|mesh-list
101244079|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
101244080|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
101244081|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244082|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244083|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
101244084|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244085|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101244086|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101244087|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101244088|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244089|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244090|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
101244091|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
101244092|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244093|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
101244094|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
101244095|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101244096|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101244097|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
101244098|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244099|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
101244100|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101244101|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101244102|NCT01652417|Prednisolone|prednisolone|mesh-list
101244103|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
101244104|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101244105|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
101244106|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244107|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
101244108|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
101244109|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244110|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244111|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244112|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
101244114|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244115|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101244116|NCT01652417|Protective Agents|protective agents|mesh-ancestor
101244117|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101244118|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244119|NCT01652534|Amantadine|amantadine|mesh-list
101244120|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101244121|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101244122|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
101244123|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244124|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
101244125|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244126|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244127|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244128|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244129|NCT01652534|Analgesics|analgesics|mesh-ancestor
101244130|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
101244131|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244132|NCT01652547|Pasireotide|pasireotide|mesh-list
101244133|NCT01652547|Somatostatin|somatostatin|mesh-list
101244134|NCT01652547|Hormones|hormones|mesh-ancestor
101244135|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244136|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244137|NCT01652560|Bevacizumab|bevacizumab|mesh-list
101244138|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101244139|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244140|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101244141|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101244142|NCT01652560|Growth Substances|growth substances|mesh-ancestor
101244143|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244144|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
101244145|NCT01652586|Midazolam|midazolam|mesh-list
101244146|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
101244147|NCT01652586|Remifentanil|remifentanil|mesh-list
101244148|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101244149|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244150|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244151|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244152|NCT01652586|Analgesics|analgesics|mesh-ancestor
101244153|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
101244154|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244155|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101244156|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101244157|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101244158|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244159|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244160|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244161|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101244162|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101244163|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101244164|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101244165|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101244166|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
101244167|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
101244168|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
101244169|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
101244170|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101244171|NCT01652586|Narcotics|narcotics|mesh-ancestor
101244172|NCT01652599|Dexamethasone|dexamethasone|mesh-list
101244173|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244174|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
101244175|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
101244176|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244177|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244178|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244179|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
101244180|NCT01652599|Hormones|hormones|mesh-ancestor
101244181|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244182|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101244183|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244184|NCT01652638|Heparin|heparin|mesh-list
101244185|NCT01652638|Calcium heparin|calcium heparin|mesh-list
101244186|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
101244187|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101244188|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101244189|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244190|NCT01652781|Azacitidine|azacitidine|mesh-list
101244191|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244192|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
101244193|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244194|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244195|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244196|NCT01652794|Carboplatin|carboplatin|mesh-list
101244197|NCT01652794|Gemcitabine|gemcitabine|mesh-list
101244198|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244199|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244200|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
101244201|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244202|NCT01652820|Carboplatin|carboplatin|mesh-list
101244203|NCT01652820|Gemcitabine|gemcitabine|mesh-list
101244204|NCT01652820|Docetaxel|docetaxel|mesh-list
101244205|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244206|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244207|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
101244208|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244209|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
101244210|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
101244211|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
101244212|NCT01652859|Amphotericin B|amphotericin b|mesh-list
101244213|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101244214|NCT01652859|Amebicides|amebicides|mesh-ancestor
101244215|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101244216|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101244217|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244218|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244219|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
101244220|NCT01652898|Esmolol|esmolol|mesh-list
101244221|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101244222|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101244223|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101244224|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244225|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244226|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207423|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
101244227|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244228|NCT01652924|Anesthetics|anesthetics|mesh-list
101244229|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244230|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244231|NCT01653015|Vaccines|vaccines|mesh-list
101244232|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
101244233|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244234|NCT01653041|Everolimus|everolimus|mesh-list
101244235|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101244236|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407233|NCT00438139|Hormones|hormones|mesh-ancestor
101244238|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244239|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244240|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
101244241|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244242|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244243|NCT01653067|Cytarabine|cytarabine|mesh-list
101244244|NCT01653067|Sirolimus|sirolimus|mesh-list
101244245|NCT01653067|Dexamethasone|dexamethasone|mesh-list
101244246|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
101244247|NCT01653067|Rituximab|rituximab|mesh-list
101244248|NCT01653067|Temsirolimus|temsirolimus|mesh-list
101244249|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
101244250|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101244251|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244252|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
101244253|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244254|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101244255|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244256|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
101244257|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
101244258|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244259|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244260|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
101244261|NCT01653067|Hormones|hormones|mesh-ancestor
101244263|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101244264|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244265|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244266|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244267|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
101244268|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
101244269|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244270|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244271|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101244272|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244273|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101244274|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
101244275|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101244277|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101244278|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
101244279|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244280|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101244281|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101244282|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244284|NCT01653171|Simethicone|simethicone|mesh-list
101244285|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101244286|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
101244287|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244288|NCT01653171|Expectorants|expectorants|mesh-ancestor
101244289|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244290|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101244291|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
101244292|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244293|NCT01653171|Protective Agents|protective agents|mesh-ancestor
101244294|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244295|NCT01653171|Antidotes|antidotes|mesh-ancestor
101244296|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
101244297|NCT01653171|Emollients|emollients|mesh-ancestor
101244298|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
101244299|NCT01653236|Ribavirin|ribavirin|mesh-list
101244300|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101244301|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
101244302|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244303|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
101244304|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244305|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
101244306|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244307|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101244308|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244309|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244310|NCT01653457|Memantine|memantine|mesh-list
101244311|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101244312|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101244313|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
101244314|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244315|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244316|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244318|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101244319|NCT01653470|Leucovorin|leucovorin|mesh-list
101244320|NCT01653470|Paclitaxel|paclitaxel|mesh-list
101244321|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101244322|NCT01653470|Carboplatin|carboplatin|mesh-list
101244323|NCT01653470|Fluorouracil|fluorouracil|mesh-list
101244324|NCT01653470|Irinotecan|irinotecan|mesh-list
101244325|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101244326|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244327|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101244328|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101244329|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101244330|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244331|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
101244332|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244333|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244334|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
101244335|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244336|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101244337|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101244338|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244339|NCT01653470|Antidotes|antidotes|mesh-ancestor
101244340|NCT01653470|Protective Agents|protective agents|mesh-ancestor
101244341|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
101244342|NCT01653470|Vitamins|vitamins|mesh-ancestor
101244343|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
101244344|NCT01653522|Doxycycline|doxycycline|mesh-list
101244345|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244346|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244347|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
101244348|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101244349|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101244350|NCT01653561|Apatinib|apatinib|mesh-list
101244351|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244352|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101244353|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244354|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244355|NCT01653639|Factor VIII|factor viii|mesh-list
101244356|NCT01653639|Coagulants|coagulants|mesh-ancestor
101244357|NCT01653665|Sargramostim|sargramostim|mesh-list
101244358|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
101244359|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244360|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
101534525|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244361|NCT01653717|Fludarabine|fludarabine|mesh-list
101244362|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
101244363|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244364|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
101244365|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244366|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101244367|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101244368|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
101244369|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244370|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244371|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101244372|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244373|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
101244374|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101244375|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
101244376|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101244377|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244378|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244379|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101244380|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101244381|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244383|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244384|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101244385|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
101244386|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101244387|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244388|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101244389|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101244390|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101244391|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101244392|NCT01654081|Irinotecan|irinotecan|mesh-list
101244393|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101244394|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101244395|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407259|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
101407260|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
101244396|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244397|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244399|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101244400|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244401|NCT01654120|Incretins|incretins|mesh-ancestor
101244402|NCT01654120|Hormones|hormones|mesh-ancestor
101244403|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244404|NCT01654146|Paclitaxel|paclitaxel|mesh-list
101244405|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101244406|NCT01654146|Carboplatin|carboplatin|mesh-list
101244407|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101244408|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244409|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
101244410|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
101244411|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
101244412|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244413|NCT01654185|Letrozole|letrozole|mesh-list
101244414|NCT01654185|Exemestane|exemestane|mesh-list
101244415|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101244416|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244417|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101244418|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244419|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244420|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101244421|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
101244422|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244423|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244424|NCT01654211|Ritonavir|ritonavir|mesh-list
101244425|NCT01654211|Lactams|lactams|mesh-list
101244426|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101244427|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101244428|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
101244429|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244430|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244431|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244432|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101244433|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
101244434|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244435|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101244436|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101244437|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244438|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
101244439|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101244440|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101244441|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244442|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101244443|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244444|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244445|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101244446|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
101244447|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244448|NCT01654497|HU 211|hu 211|mesh-list
101244449|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101244450|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
101244451|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
101244452|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244453|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244454|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244455|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101244456|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101244457|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244458|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244459|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101244460|NCT01654497|Protective Agents|protective agents|mesh-ancestor
101244461|NCT01654562|Simvastatin|simvastatin|mesh-list
101244462|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101244463|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101244464|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
101244465|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244466|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101244467|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101244468|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244469|NCT01654575|Methotrexate|methotrexate|mesh-list
101244470|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101244471|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
101244472|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101244473|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244474|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244475|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
101244476|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244477|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244478|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
101244479|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244480|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101244481|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244482|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
101244483|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101244484|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101244486|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101244487|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244488|NCT01654692|Ipilimumab|ipilimumab|mesh-list
101244489|NCT01654692|Fotemustine|fotemustine|mesh-list
101244490|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101244491|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407273|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244492|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101244493|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244494|NCT01654705|Pantoprazole|pantoprazole|mesh-list
101244495|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101244496|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244497|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101244498|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244499|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244500|NCT01654718|Pantoprazole|pantoprazole|mesh-list
101244501|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101244502|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244503|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101244504|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244505|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244506|NCT01654809|Vaccines|vaccines|mesh-list
101244507|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
101244508|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244509|NCT01654913|Chrysarobin|chrysarobin|mesh-list
101244510|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101244511|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244512|NCT01654913|Analgesics|analgesics|mesh-ancestor
101244513|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
101244514|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244515|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244516|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244517|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101244518|NCT01654939|Rifaximin|rifaximin|mesh-list
101244519|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244520|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244521|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244522|NCT01654965|Topotecan|topotecan|mesh-list
101244523|NCT01654965|Lenograstim|lenograstim|mesh-list
101244524|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101244525|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
101244526|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244527|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101244528|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101244529|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244530|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244531|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244532|NCT01655004|Exemestane|exemestane|mesh-list
101244533|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244534|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101244535|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101244536|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244537|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244538|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101244539|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101244540|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244541|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244543|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101244544|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
101244545|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101244546|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
101244547|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244548|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244549|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
101244550|NCT01655082|Nicotine|nicotine|mesh-list
101244551|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101244552|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
101244553|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244554|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244555|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101244556|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101244557|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
101244558|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244559|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244560|NCT01655095|Prucalopride|prucalopride|mesh-list
101244561|NCT01655095|Bisacodyl|bisacodyl|mesh-list
101244562|NCT01655095|Laxatives|laxatives|mesh-ancestor
101244563|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244564|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101244565|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101244566|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
101244568|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244569|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244571|NCT01655108|Minoxidil|minoxidil|mesh-list
101244572|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101244573|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244574|NCT01655147|Rifampin|rifampin|mesh-list
101244575|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
101244576|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101244577|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
101244578|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101244579|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244580|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
101244581|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101244582|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244583|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244584|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101244585|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101244586|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101244587|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101244588|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101244589|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101244590|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244591|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101244592|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
101244593|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244594|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244595|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101244596|NCT01655199|Albuterol|albuterol|mesh-list
101244597|NCT01655199|Ipratropium|ipratropium|mesh-list
101244598|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101244599|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
101244600|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244601|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244603|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244604|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
101244605|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101244606|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101244607|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101244608|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101244609|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244610|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244611|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244612|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101244613|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
101244614|NCT01655212|Valganciclovir|valganciclovir|mesh-list
101244615|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
101244616|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244617|NCT01655303|Propranolol|propranolol|mesh-list
101244618|NCT01655303|Metoprolol|metoprolol|mesh-list
101244619|NCT01655303|Verapamil|verapamil|mesh-list
101244620|NCT01655303|Diltiazem|diltiazem|mesh-list
101244621|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101244622|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101244623|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244624|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244625|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244626|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244627|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101244628|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101244629|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244630|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
101244631|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
101407291|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244632|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244633|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101244634|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101244635|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244636|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244637|NCT01655316|Verapamil|verapamil|mesh-list
101244638|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101244639|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101244640|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244641|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244642|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244643|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244644|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244645|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
101244646|NCT01655524|Aminophylline|aminophylline|mesh-list
101244647|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101244648|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
101244649|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244650|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244651|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101244652|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244653|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101244654|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101244655|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244656|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244657|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101244658|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101244659|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
101244660|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244661|NCT01655524|Protective Agents|protective agents|mesh-ancestor
101244662|NCT01655628|Cisplatin|cisplatin|mesh-list
101244663|NCT01655628|Gemcitabine|gemcitabine|mesh-list
101244664|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244665|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244666|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
101244667|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244668|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
101244669|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101244670|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101244671|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244672|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
101244673|NCT01655641|Coagulants|coagulants|mesh-ancestor
101244674|NCT01655706|Aripiprazole|aripiprazole|mesh-list
101244675|NCT01655706|Escitalopram|escitalopram|mesh-list
101244676|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101244677|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101244678|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244679|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244680|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244681|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
101407301|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
101244682|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244683|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
101244684|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101244685|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101244686|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101244687|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101244688|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
101244689|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
101244690|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101244691|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101244692|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101244693|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101244694|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101244695|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101244696|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101244697|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101244698|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244699|NCT01655758|Timolol|timolol|mesh-list
101244700|NCT01655758|Bimatoprost|bimatoprost|mesh-list
101244701|NCT01655758|Travoprost|travoprost|mesh-list
101244702|NCT01655758|Dorzolamide|dorzolamide|mesh-list
101244703|NCT01655758|Latanoprost|latanoprost|mesh-list
101244704|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101244705|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101244706|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244707|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244708|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244709|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244710|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101244711|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101244712|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101244713|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101244714|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101244715|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244716|NCT01655810|Vitamin D|vitamin d|mesh-list
101244717|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
101244718|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
101244719|NCT01655810|Vitamins|vitamins|mesh-list
101244720|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
101244721|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
101244722|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244723|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244724|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101244725|NCT01655810|Antacids|antacids|mesh-ancestor
101244726|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244727|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244728|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
101411745|NCT00462631|Paclitaxel|paclitaxel|mesh-list
101244729|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101244730|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101244731|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101244732|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244733|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244734|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
101244735|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244736|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244737|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101244738|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244739|NCT01655875|Plerixafor|plerixafor|mesh-list
101244740|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244741|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101244742|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
101244743|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244744|NCT01655888|Tremelimumab|tremelimumab|mesh-list
101244745|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244746|NCT01655914|Flumazenil|flumazenil|mesh-list
101244747|NCT01655914|Antidotes|antidotes|mesh-ancestor
101244748|NCT01655914|Protective Agents|protective agents|mesh-ancestor
101244749|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207950|NCT03512496|Caffeine|caffeine|mesh-list
101244750|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
101244751|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
101244752|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244753|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244754|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
101244755|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101244756|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101244757|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244758|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
101244759|NCT01655927|Coagulants|coagulants|mesh-ancestor
101244760|NCT01655966|Vitamin D|vitamin d|mesh-list
101244761|NCT01655966|Interferons|interferons|mesh-list
101244762|NCT01655966|Ribavirin|ribavirin|mesh-list
101244763|NCT01655966|Vitamins|vitamins|mesh-ancestor
101244764|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
101244765|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244766|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101244767|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244768|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
101244769|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244770|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
101244771|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244772|NCT01655992|Capecitabine|capecitabine|mesh-list
101244773|NCT01655992|Tegafur|tegafur|mesh-list
101244774|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244775|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
101244776|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244777|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244778|NCT01656005|Beclomethasone|beclomethasone|mesh-list
101244779|NCT01656005|Carvedilol|carvedilol|mesh-list
101244780|NCT01656005|Bisoprolol|bisoprolol|mesh-list
101244781|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
101244782|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
101244783|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101244784|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
101244785|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244786|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244787|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101244788|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244789|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101323073|NCT00095251|Analgesics|analgesics|mesh-ancestor
101244790|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101244791|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101244792|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244793|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244794|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244795|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
101244796|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101244797|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
101244798|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101244799|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101244800|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101244801|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
101244802|NCT01656005|Protective Agents|protective agents|mesh-ancestor
101244803|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101244804|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244805|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244806|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244807|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101244808|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101244809|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
101244810|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101244811|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244812|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
101244813|NCT01656005|Hormones|hormones|mesh-ancestor
101244814|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101244815|NCT01656018|Rilpivirine|rilpivirine|mesh-list
101244816|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101244817|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101244818|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244819|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244820|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
101244821|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244822|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244823|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101244824|NCT01656057|Acetaminophen|acetaminophen|mesh-list
101244825|NCT01656057|Metformin|metformin|mesh-list
101244827|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101244828|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101534573|NCT00591201|Infliximab|infliximab|mesh-list
101244829|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244830|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244831|NCT01656057|Analgesics|analgesics|mesh-ancestor
101244832|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
101244833|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244834|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
101244835|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101244836|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101244837|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
101244838|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244839|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101244840|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101407354|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407355|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244841|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244842|NCT01656070|Vitamin D|vitamin d|mesh-list
101244843|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
101244844|NCT01656070|Vitamins|vitamins|mesh-ancestor
101244845|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
101244846|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244847|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101244848|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244849|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101244850|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101407378|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244851|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101244852|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
101244853|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244854|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244855|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244856|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101244857|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
101244858|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244860|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101244861|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101244862|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244863|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244864|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
101244865|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244866|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101244867|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101244868|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
101244869|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101244870|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101244871|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244872|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
101244873|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101244874|NCT01656226|Protective Agents|protective agents|mesh-ancestor
101244875|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244876|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101244877|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
101244878|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101244879|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
101244880|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101244881|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
101244882|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244883|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244884|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
101244885|NCT01656512|Vitamin D|vitamin d|mesh-list
101244886|NCT01656512|Diphosphonates|diphosphonates|mesh-list
101244887|NCT01656512|Calcium|calcium|mesh-list
101244888|NCT01656512|Vitamins|vitamins|mesh-ancestor
101244889|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
101244890|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244891|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101244892|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101244893|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101407406|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101407407|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
101407408|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407409|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244894|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
101244895|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407410|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244896|NCT01656616|Antidotes|antidotes|mesh-list
101244897|NCT01656616|Protective Agents|protective agents|mesh-ancestor
101244898|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244899|NCT01656642|Atezolizumab|atezolizumab|mesh-list
101244900|NCT01656642|Vemurafenib|vemurafenib|mesh-list
101244901|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101244902|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407411|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101244903|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407412|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101407414|NCT00439855|Enoxaparin|enoxaparin|mesh-list
101244904|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244905|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101244907|NCT01656668|Theobromine|theobromine|mesh-list
101244908|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101244909|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
101244910|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244911|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244912|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101244913|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244914|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244915|NCT01656720|Methoxamine|methoxamine|mesh-list
101244916|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
101407428|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407430|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101244917|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
101244918|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244919|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244920|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101244921|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101244922|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101244923|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101244924|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244925|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244926|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407433|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407434|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101244927|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
101244928|NCT01656798|Citric Acid|citric acid|mesh-list
101244929|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
101244930|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
101244931|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101244932|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
101244933|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
101244934|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244935|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
101244936|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101244937|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101244938|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244939|NCT01656798|Urological Agents|urological agents|mesh-ancestor
101244940|NCT01656811|Albuterol|albuterol|mesh-list
101244941|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101244942|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
101244943|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244944|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244945|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101244946|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
101244947|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
101244948|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101244949|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101244951|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101244952|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
101244953|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244954|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244955|NCT01656980|Carmustine|carmustine|mesh-list
101244956|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101244957|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
101244958|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244959|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101244960|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
101244961|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
101244962|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
101407449|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244963|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244964|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244965|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101244966|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101244967|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
101244968|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
101244969|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244970|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244971|NCT01657071|Aspirin|aspirin|mesh-list
101244972|NCT01657071|Clopidogrel|clopidogrel|mesh-list
101244973|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101244974|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101244975|NCT01657071|Analgesics|analgesics|mesh-ancestor
101208162|NCT00113763|Panitumumab|panitumumab|mesh-list
101244976|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
101244977|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101244978|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101244979|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101244981|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101244982|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101244983|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101244984|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101244985|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101244986|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101244988|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101244989|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101244990|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101244991|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
101244992|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101244993|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
101244994|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101244995|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101244996|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101244997|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101244998|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
101323086|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101244999|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245000|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245001|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245003|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
101245004|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245005|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101245006|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101245007|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245008|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245009|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101245010|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245012|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245013|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101245014|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101245015|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101245016|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101245017|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101245018|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245019|NCT01657240|Analgesics|analgesics|mesh-ancestor
101245020|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
101245021|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245022|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245023|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245024|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245025|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101245026|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101245027|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101245028|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
101245029|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
101245030|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245031|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245032|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101245033|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245035|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101245036|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101245037|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
101245038|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245039|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245040|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407544|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407545|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407546|NCT00107471|Topotecan|topotecan|mesh-list
101245041|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
101245042|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
101245043|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
101245044|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245045|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
101245046|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101245047|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101245048|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101407560|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407561|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407562|NCT02957266|Gemcitabine|gemcitabine|mesh-list
101245049|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101245050|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101245051|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245052|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
101245053|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245054|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245055|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101245056|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245057|NCT01657448|Methenamine|methenamine|mesh-list
101245058|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
101245059|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
101245060|NCT01657448|Methylene Blue|methylene blue|mesh-list
101245061|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101245062|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245063|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245064|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245065|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245066|NCT01657487|Fluticasone|fluticasone|mesh-list
101245068|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101245069|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101245070|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245071|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101245072|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
101245073|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245074|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245075|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245076|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245077|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245078|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101245079|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101245080|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101245081|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101245082|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245083|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245084|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245085|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
101245086|NCT01657487|Hormones|hormones|mesh-ancestor
101245087|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245089|NCT01657578|Omeprazole|omeprazole|mesh-list
101245090|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101245091|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245092|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101245093|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245094|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245095|NCT01657656|Vitamin D|vitamin d|mesh-list
101245096|NCT01657656|Vitamins|vitamins|mesh-ancestor
101245097|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
101245098|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245099|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101245100|NCT01657669|Aflibercept|aflibercept|mesh-list
101245101|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101245102|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101245103|NCT01657669|Growth Substances|growth substances|mesh-ancestor
101245104|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245105|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
101245106|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245108|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245109|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101245110|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
101245111|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
101245112|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245113|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245114|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101245115|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101245116|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
101245117|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245118|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245119|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
101323101|NCT00095329|Sirolimus|sirolimus|mesh-list
101245120|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101245121|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245122|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245123|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245125|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
101245126|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245127|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101245128|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101245129|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101245130|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245131|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245132|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245133|NCT01657825|Isavuconazole|isavuconazole|mesh-list
101245134|NCT01657825|Warfarin|warfarin|mesh-list
101245135|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
101245136|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
101245137|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245138|NCT01657838|Ketoconazole|ketoconazole|mesh-list
101245139|NCT01657838|Isavuconazole|isavuconazole|mesh-list
101245141|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245142|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101245143|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101245144|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245145|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245146|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101245148|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245149|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245150|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101245151|NCT01657851|Tamsulosin|tamsulosin|mesh-list
101245152|NCT01657851|Dutasteride|dutasteride|mesh-list
101245153|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101245154|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101245155|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101245156|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245157|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245158|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245159|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245160|NCT01657851|Urological Agents|urological agents|mesh-ancestor
101245161|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101245162|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101245163|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245164|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245165|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245166|NCT01657864|Lamotrigine|lamotrigine|mesh-list
101245167|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
101245168|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101245169|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101245170|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245171|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101245172|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245173|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101245174|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101245175|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245176|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101245177|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101245178|NCT01657890|Isavuconazole|isavuconazole|mesh-list
101245179|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
101245180|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245181|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101245182|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101245183|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
101245184|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245185|NCT01657929|Antacids|antacids|mesh-ancestor
101323115|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245186|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245187|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245188|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101245189|NCT01657955|Chlorambucil|chlorambucil|mesh-list
101245190|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101245191|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
101245192|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245193|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245194|NCT01657513|Adalimumab|adalimumab|mesh-list
101245195|NCT01657513|Infliximab|infliximab|mesh-list
101245196|NCT01657513|Etanercept|etanercept|mesh-list
101245197|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101245199|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245200|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245201|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245202|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101245203|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245204|NCT01657513|Analgesics|analgesics|mesh-ancestor
101245205|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
101407639|NCT00440479|Bortezomib|bortezomib|mesh-list
101245206|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245207|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245208|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245209|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
101245210|NCT01657981|Darexaban|darexaban|mesh-list
101245211|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101245212|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
101245213|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101245214|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
101245215|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245216|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245217|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
101245218|NCT01658007|Sirolimus|sirolimus|mesh-list
101245219|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245220|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245221|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101245222|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245223|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
101245224|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245225|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
101245226|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245227|NCT01658033|Leucovorin|leucovorin|mesh-list
101245228|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
101245229|NCT01658033|Bevacizumab|bevacizumab|mesh-list
101245230|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245231|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101245232|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101245233|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101245234|NCT01658033|Growth Substances|growth substances|mesh-ancestor
101245235|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245236|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
101245237|NCT01658033|Antidotes|antidotes|mesh-ancestor
101245238|NCT01658033|Protective Agents|protective agents|mesh-ancestor
101245239|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
101245240|NCT01658033|Vitamins|vitamins|mesh-ancestor
101245241|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
101245242|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
101245243|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101245244|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245245|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245246|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
101245247|NCT01658124|Coagulants|coagulants|mesh-ancestor
101245248|NCT01658176|Exemestane|exemestane|mesh-list
101534607|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101407659|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407662|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101245249|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245250|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101245251|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101245252|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245253|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245254|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101245255|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245256|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323122|NCT00095524|Aripiprazole|aripiprazole|mesh-list
101245257|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245259|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101245260|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
101245261|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245262|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245264|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101245265|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
101245266|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245267|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245268|NCT01658215|Nicotine|nicotine|mesh-list
101245269|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101245271|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245272|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245273|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101245274|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101245275|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
101245276|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245277|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245278|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
101245279|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101245280|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245281|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
101245282|NCT01658319|Fludarabine|fludarabine|mesh-list
101245283|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
101245284|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245285|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101245286|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
101245287|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245288|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245289|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
101245290|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245291|NCT01658358|Doxorubicin|doxorubicin|mesh-list
101245292|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101245293|NCT01658358|Lapatinib|lapatinib|mesh-list
101245294|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101245295|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245296|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101245297|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101245298|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245299|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245300|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101245301|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101245302|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101245303|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101245304|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245305|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
101245306|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101245307|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
101245308|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245309|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
101245310|NCT01658449|Protective Agents|protective agents|mesh-ancestor
101245311|NCT01658462|Docetaxel|docetaxel|mesh-list
101245312|NCT01658462|Nintedanib|nintedanib|mesh-list
101245313|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245314|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101245315|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101245316|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245317|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245318|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101245319|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245320|NCT01658527|Bicalutamide|bicalutamide|mesh-list
101245321|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
101245322|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323124|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101245323|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245324|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245326|NCT01658553|Trametinib|trametinib|mesh-list
101245327|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245328|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101245329|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245330|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245331|NCT01658774|Albendazole|albendazole|mesh-list
101245332|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245333|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
101245334|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101245335|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245336|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
101245337|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101245338|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101245340|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
101245341|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245342|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245344|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245345|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245346|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101245347|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101245349|NCT01658878|Ipilimumab|ipilimumab|mesh-list
101245350|NCT01658878|Sorafenib|sorafenib|mesh-list
101245351|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101245352|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245353|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101245354|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245355|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101245356|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245357|NCT01658891|Beclomethasone|beclomethasone|mesh-list
101245358|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
101245359|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101245360|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
101245361|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245362|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245363|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245364|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
101407750|NCT03279328|Emollients|emollients|mesh-ancestor
101245365|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101245366|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101245368|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245369|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245370|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245371|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245372|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
101245373|NCT01658891|Hormones|hormones|mesh-ancestor
101245374|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245375|NCT01659008|Estradiol|estradiol|mesh-list
101245376|NCT01659008|Estrogens|estrogens|mesh-ancestor
101245377|NCT01659008|Hormones|hormones|mesh-ancestor
101245378|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245379|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245380|NCT01659047|Idelalisib|idelalisib|mesh-list
101245381|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245382|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245383|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245384|NCT01659086|Vaccines|vaccines|mesh-list
101245385|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
101245386|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245387|NCT01659099|Prednisone|prednisone|mesh-list
101245388|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
101245389|NCT01659099|Rituximab|rituximab|mesh-list
101245390|NCT01659099|Doxorubicin|doxorubicin|mesh-list
101245391|NCT01659099|Vincristine|vincristine|mesh-list
101245392|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
101245393|NCT01659099|Bleomycin|bleomycin|mesh-list
101245394|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245395|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
101245396|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245397|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245398|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101245399|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
101245400|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245401|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245402|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101407767|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
101245403|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101245404|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101245405|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101245406|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101245407|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245408|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245410|NCT01659099|Hormones|hormones|mesh-ancestor
101534645|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534646|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534647|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
101245411|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245412|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245413|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101245415|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101245416|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245417|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
101245418|NCT01659190|Antacids|antacids|mesh-ancestor
101245419|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245420|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245421|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
101245422|NCT01659242|Methotrexate|methotrexate|mesh-list
101245423|NCT01659242|Leflunomide|leflunomide|mesh-list
101245424|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101245425|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
101245426|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407773|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407774|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101245427|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245428|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101245429|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
101245430|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245431|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245432|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245433|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245434|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101245435|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245436|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
101245437|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245438|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101245439|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245440|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101245441|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245443|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
101245444|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245445|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245446|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245447|NCT01659281|Artesunate|artesunate|mesh-list
101245448|NCT01659281|Mefloquine|mefloquine|mesh-list
101245449|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
101245450|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101245451|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101245452|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245453|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245454|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
101245455|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
101245456|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101245457|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
101245458|NCT01659346|Carvedilol|carvedilol|mesh-list
101245459|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101245460|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101245461|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245462|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245463|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245464|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245465|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101245466|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
101245467|NCT01659346|Protective Agents|protective agents|mesh-ancestor
101245468|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101245469|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101245470|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101245471|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
101245472|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101245473|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101245474|NCT01659359|Lidocaine|lidocaine|mesh-list
101245475|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
101245477|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245478|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245480|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245481|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101245482|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101245483|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101245484|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101245485|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245487|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101245488|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245489|NCT01659372|Analgesics|analgesics|mesh-ancestor
101245490|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
101245491|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245492|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245493|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245494|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245495|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
101245496|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101245497|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245498|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245499|NCT01659437|Clarithromycin|clarithromycin|mesh-list
101245500|NCT01659437|Streptomycin|streptomycin|mesh-list
101245501|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245502|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245503|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101245504|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245505|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245506|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101245507|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101245508|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
101245509|NCT01659476|Miotics|miotics|mesh-ancestor
101245510|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
101245511|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245512|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245513|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101245514|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101245515|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245516|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101245517|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101245518|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
101245519|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245520|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245521|NCT01659515|Arbekacin|arbekacin|mesh-list
101245522|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245523|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245524|NCT01659619|Erythromycin|erythromycin|mesh-list
101245525|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
101245526|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101245527|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
101245528|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101245529|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245530|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245531|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101245532|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245533|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245534|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
101245535|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101245536|NCT01659684|Antibodies|antibodies|mesh-list
101245537|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
101245538|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101245539|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
101245540|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245541|NCT01659788|Ubiquinone|ubiquinone|mesh-list
101245542|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
101245543|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
101245544|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245546|NCT01659827|Bupivacaine|bupivacaine|mesh-list
101245547|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
101245548|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
101245549|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245550|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245551|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
101245552|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245553|NCT01659892|Montelukast|montelukast|mesh-list
101245554|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245555|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245556|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101245557|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245558|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245559|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245560|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101245561|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101245562|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245563|NCT01659905|Montelukast|montelukast|mesh-list
101245564|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245565|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245566|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101245567|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534654|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
101245568|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245569|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245570|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101245571|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101245572|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245573|NCT01659918|Montelukast|montelukast|mesh-list
101245574|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245575|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245576|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101245577|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323169|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101245578|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245579|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245580|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101245581|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101245582|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245584|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101245585|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
101245586|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101245587|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245588|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245589|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245590|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101245591|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101245592|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245593|NCT01659944|Metoprolol|metoprolol|mesh-list
101245594|NCT01659944|Eliglustat|eliglustat|mesh-list
101245595|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101245596|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101245597|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
101245598|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
101245599|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245600|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245601|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101245602|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101245603|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101245604|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245605|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245606|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245607|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245608|NCT01659775|Ondansetron|ondansetron|mesh-list
101407844|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245609|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
101245610|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
101245611|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245612|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245613|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245614|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
101245615|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245616|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101245617|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101245618|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
101245619|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245620|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245621|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101245622|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
101245623|NCT01660295|Certoparin|certoparin|mesh-list
101245624|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
101245625|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101245626|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245627|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245628|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101245629|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
101245630|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
101245631|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245632|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245633|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245634|NCT01660295|Analgesics|analgesics|mesh-ancestor
101245635|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
101245636|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245637|NCT01660373|Tirofiban|tirofiban|mesh-list
101245638|NCT01660373|Ticagrelor|ticagrelor|mesh-list
101245639|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101245640|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101245641|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101245642|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101245643|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
101245644|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245645|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245646|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245647|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101245648|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245649|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101245651|NCT01660386|Saxagliptin|saxagliptin|mesh-list
101245652|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101245653|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245654|NCT01660386|Incretins|incretins|mesh-ancestor
101245655|NCT01660386|Hormones|hormones|mesh-ancestor
101407855|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101245656|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245657|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101245658|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
101245659|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245660|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245661|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101245662|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245663|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
101245665|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245666|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
101245667|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
101245668|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245669|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245670|NCT01660477|Ritonavir|ritonavir|mesh-list
101245671|NCT01660477|Lopinavir|lopinavir|mesh-list
101245672|NCT01660477|Isavuconazole|isavuconazole|mesh-list
101245673|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101245674|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101245675|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
101245676|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245677|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245679|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101245680|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
101245681|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245682|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101245683|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101245684|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
101245685|NCT01660542|Docetaxel|docetaxel|mesh-list
101245686|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245687|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101245688|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101245689|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101245690|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245691|NCT01660594|Calcium|calcium|mesh-list
101245692|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101245693|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245694|NCT01660620|Betaxolol|betaxolol|mesh-list
101245695|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101245696|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
101245697|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
101245698|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245699|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245700|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101245701|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101245702|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101245703|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101245704|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245705|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245706|NCT01660750|Dexamethasone|dexamethasone|mesh-list
101245707|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
101245708|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101245709|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
101245710|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245711|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245712|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101245713|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
101245714|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245715|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245716|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101245717|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245719|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
101245720|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245721|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245722|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
101245723|NCT01660750|Hormones|hormones|mesh-ancestor
101245724|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245725|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245726|NCT01660854|Proguanil|proguanil|mesh-list
101245727|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101245728|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
101245729|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101245730|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101245731|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245732|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
101245733|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245734|NCT01660867|Dexamethasone|dexamethasone|mesh-list
101245735|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245736|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
101245737|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
101245738|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245739|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245740|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245741|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
101407880|NCT00442741|Epothilone B|epothilone b|mesh-list
101245742|NCT01660867|Hormones|hormones|mesh-ancestor
101245743|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245744|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245745|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245746|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101245747|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101245748|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101245749|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
101245750|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245751|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101534670|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534671|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101534672|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101245752|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101245753|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245754|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101245755|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101245756|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101245757|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
101245758|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245759|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101245760|NCT01660997|Dexamethasone|dexamethasone|mesh-list
101245762|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245763|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
101245764|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
101245765|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245766|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245767|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245768|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
101245769|NCT01660997|Hormones|hormones|mesh-ancestor
101245770|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245771|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245772|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245773|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
101245774|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245775|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245777|NCT01661101|Dabigatran|dabigatran|mesh-list
101245778|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101245779|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245780|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101245781|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245782|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245783|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
101245784|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101245785|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
101245786|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
101245787|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101245788|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
101245789|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101245790|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101245792|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245793|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245794|NCT01661257|Infliximab|infliximab|mesh-list
101245795|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101245796|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245797|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245798|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245799|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245800|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101245801|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101245802|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101245803|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245804|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
101245805|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101245806|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
101245807|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
101245808|NCT01661309|Vitamins|vitamins|mesh-ancestor
101245809|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
101245810|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245811|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
101245812|NCT01661322|Aspirin|aspirin|mesh-list
101245813|NCT01661322|Clopidogrel|clopidogrel|mesh-list
101245814|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101245815|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101245817|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
101245818|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245819|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245820|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245821|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101245822|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101245823|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245824|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245825|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101245826|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101245827|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245828|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
101245829|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101245830|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101245831|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101245832|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
101245833|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245834|NCT01661335|Dexamethasone|dexamethasone|mesh-list
101245835|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
101245836|NCT01661335|Ondansetron|ondansetron|mesh-list
101245837|NCT01661335|Aprepitant|aprepitant|mesh-list
101245838|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
101245839|NCT01661335|BB 1101|bb 1101|mesh-list
101245840|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245841|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
101245842|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
101245843|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245844|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245845|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245846|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
101245847|NCT01661335|Hormones|hormones|mesh-ancestor
101245848|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245849|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245850|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245852|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245853|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245854|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
101245855|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101245856|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101245857|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101245858|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
101245859|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245860|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101245861|NCT01661439|Heparin|heparin|mesh-list
101245862|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101245863|NCT01661439|Tinzaparin|tinzaparin|mesh-list
101245864|NCT01661439|Dalteparin|dalteparin|mesh-list
101245865|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
101245866|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101245867|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101245868|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245870|NCT01661530|Vitamins|vitamins|mesh-ancestor
101245871|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
101245872|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245873|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
101245874|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245875|NCT01661530|Protective Agents|protective agents|mesh-ancestor
101245876|NCT01661556|Miconazole|miconazole|mesh-list
101245877|NCT01661556|Hydroquinone|hydroquinone|mesh-list
101245878|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
101245879|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101245880|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101245881|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101245882|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245883|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245884|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101245885|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
101245886|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245887|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245888|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101407950|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101407951|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245889|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101245891|NCT01661556|Protective Agents|protective agents|mesh-ancestor
101245892|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101245894|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
101245895|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245896|NCT01661777|Diuretics|diuretics|mesh-list
101245897|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
101245898|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101245899|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
101245900|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245901|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
101245902|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245903|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245904|NCT01661855|Riluzole|riluzole|mesh-list
101245905|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
101245906|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101245907|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101245908|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101245909|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407964|NCT00138567|Vildagliptin|vildagliptin|mesh-list
101245910|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245911|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101245912|NCT01661855|Protective Agents|protective agents|mesh-ancestor
101245913|NCT01661868|Olaparib|olaparib|mesh-list
101245914|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101245915|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101245916|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245917|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245918|NCT01662037|Bosentan|bosentan|mesh-list
101245919|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101245920|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101245921|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245923|NCT01662089|Trace Elements|trace elements|mesh-ancestor
101245924|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
101245925|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245926|NCT01662128|Capecitabine|capecitabine|mesh-list
101245927|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101245928|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
101245929|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245930|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245931|NCT01662180|Hormones|hormones|mesh-list
101245932|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101245933|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245934|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245935|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
101245937|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
101245938|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
101245939|NCT01662193|Vitamins|vitamins|mesh-list
101245940|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
101245941|NCT01662193|Calcium|calcium|mesh-list
101245942|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
101245943|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245944|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101245947|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101245948|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245949|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
101245950|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101245951|NCT01662401|Bupivacaine|bupivacaine|mesh-list
101245952|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
101245953|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
101245954|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245955|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245956|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
101245957|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245958|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
101245959|NCT01662466|Testosterone|testosterone|mesh-list
101245960|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
101245961|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
101245962|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101245963|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101245964|NCT01662466|Androgens|androgens|mesh-ancestor
101245965|NCT01662466|Hormones|hormones|mesh-ancestor
101245966|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245967|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245968|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245969|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245970|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
101245971|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101245972|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
101245973|NCT01662518|Dexamethasone|dexamethasone|mesh-list
101245974|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101245975|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
101245976|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
101245977|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245978|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245979|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101245980|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
101245981|NCT01662518|Hormones|hormones|mesh-ancestor
101245982|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101245983|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101245984|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101245985|NCT01662622|Sevoflurane|sevoflurane|mesh-list
101245986|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101245987|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101245988|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
101245989|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
101245990|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101245991|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245992|NCT01662674|Metformin|metformin|mesh-list
101245993|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101245994|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101245995|NCT01662687|Granisetron|granisetron|mesh-list
101245996|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
101245997|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
101245998|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101245999|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246000|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246001|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101246002|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101246003|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
101246004|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246005|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246006|NCT01662700|Artesunate|artesunate|mesh-list
101246007|NCT01662700|Chloroquine|chloroquine|mesh-list
101246008|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
101246009|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101246010|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101246011|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246012|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246013|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
101246014|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
101246015|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101246016|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
101246017|NCT01662700|Amebicides|amebicides|mesh-ancestor
101246018|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246019|NCT01662804|Interleukin-2|interleukin-2|mesh-list
101246021|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101246022|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
101246023|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246024|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246025|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246026|NCT01662804|Analgesics|analgesics|mesh-ancestor
101246027|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
101246028|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246029|NCT01662869|Leucovorin|leucovorin|mesh-list
101246030|NCT01662869|Folic Acid|folic acid|mesh-list
101246031|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
101246032|NCT01662869|Fluorouracil|fluorouracil|mesh-list
101246033|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
101246034|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246035|NCT01662869|Antidotes|antidotes|mesh-ancestor
101246036|NCT01662869|Protective Agents|protective agents|mesh-ancestor
101246037|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246038|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
101246039|NCT01662869|Vitamins|vitamins|mesh-ancestor
101246040|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
101246041|NCT01662869|Hematinics|hematinics|mesh-ancestor
101246042|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
101246043|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246044|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101246045|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101246046|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
101246047|NCT01662921|Insulin|insulin|mesh-list
101246048|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101246049|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
101246050|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
101246051|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
101246052|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101246053|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246054|NCT01663038|Aspirin|aspirin|mesh-list
101246055|NCT01663038|Clopidogrel|clopidogrel|mesh-list
101246056|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246058|NCT01663038|Analgesics|analgesics|mesh-ancestor
101246059|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
101246060|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246061|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246062|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246063|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246064|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101246065|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101246066|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246067|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101246068|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246069|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246070|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
101246071|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101246072|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101246073|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101246074|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
101246075|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246076|NCT01663077|Clozapine|clozapine|mesh-list
101246077|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101246078|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
101246079|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246080|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246081|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246082|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101246083|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101246084|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246085|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101246087|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
101246088|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101246089|NCT01663090|Hematinics|hematinics|mesh-ancestor
101246090|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101246091|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101246092|NCT01663168|Rifabutin|rifabutin|mesh-list
101246093|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246094|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246095|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101246096|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
101246097|NCT01663441|Oprelvekin|oprelvekin|mesh-list
101246098|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246099|NCT01661985|Azithromycin|azithromycin|mesh-list
101246100|NCT01661985|Doxycycline|doxycycline|mesh-list
101246101|NCT01661985|Lymecycline|lymecycline|mesh-list
101246102|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246103|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246104|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
101246105|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101246106|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101246108|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101246109|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
101246110|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246111|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246112|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
101246113|NCT01663662|Tolvaptan|tolvaptan|mesh-list
101246114|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101246115|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246116|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
101246117|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246118|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101246119|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101246120|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246122|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101246123|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101246124|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246125|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246126|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101246127|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
101246128|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246129|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246130|NCT01663961|Digoxin|digoxin|mesh-list
101246131|NCT01663961|Mirabegron|mirabegron|mesh-list
101246132|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101246133|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101246134|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246135|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246136|NCT01663961|Protective Agents|protective agents|mesh-ancestor
101246137|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246138|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101246139|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101246140|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246141|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246142|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246143|NCT01663961|Urological Agents|urological agents|mesh-ancestor
101246144|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
101246145|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101246146|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101246147|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101246148|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246149|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246151|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246152|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246153|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101246154|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246155|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101246156|NCT01664065|Cephalosporins|cephalosporins|mesh-list
101246157|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246158|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246159|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
101246161|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
101246162|NCT01664221|Hematinics|hematinics|mesh-ancestor
101246163|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
101246164|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101246165|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
101246166|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246167|NCT01664260|Expectorants|expectorants|mesh-ancestor
101246168|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246169|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101246170|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
101246171|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246172|NCT01664260|Protective Agents|protective agents|mesh-ancestor
101209361|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
101246173|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246174|NCT01664260|Antidotes|antidotes|mesh-ancestor
101246175|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
101246176|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246177|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246178|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246179|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246180|NCT01664520|Analgesics|analgesics|mesh-ancestor
101246181|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
101246182|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246183|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101246184|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101534705|NCT00583986|Albuterol|albuterol|mesh-list
101246185|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246186|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246187|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246188|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246189|NCT01664650|Genistein|genistein|mesh-list
101246190|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101246191|NCT01664650|Protective Agents|protective agents|mesh-ancestor
101246192|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246193|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246194|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101246195|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246196|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246197|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
101246198|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101246199|NCT01664650|Estrogens|estrogens|mesh-ancestor
101246200|NCT01664650|Hormones|hormones|mesh-ancestor
101246201|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246202|NCT01664676|Liraglutide|liraglutide|mesh-list
101246203|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101246204|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246205|NCT01664676|Incretins|incretins|mesh-ancestor
101246206|NCT01664676|Hormones|hormones|mesh-ancestor
101246207|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246208|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
101246209|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
101246210|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246211|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101246213|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246214|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246215|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246216|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246217|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101246218|NCT01664728|Hormones|hormones|mesh-ancestor
101246219|NCT01664754|Carboplatin|carboplatin|mesh-list
101246220|NCT01664754|Pemetrexed|pemetrexed|mesh-list
101246221|NCT01664754|Exemestane|exemestane|mesh-list
101246222|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246223|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246224|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246225|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101246226|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101246227|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101246228|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101246229|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101246230|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246231|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246232|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246233|NCT01664819|Antioxidants|antioxidants|mesh-list
101246234|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246235|NCT01664819|Protective Agents|protective agents|mesh-ancestor
101246236|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246237|NCT01664845|Metformin|metformin|mesh-list
101246238|NCT01664845|Ribavirin|ribavirin|mesh-list
101246239|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101246240|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246241|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
101246242|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246243|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
101246244|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246245|NCT01664871|Fluorides|fluorides|mesh-list
101246246|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
101246247|NCT01664871|Protective Agents|protective agents|mesh-ancestor
101246248|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246249|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101246250|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101246251|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246252|NCT01665066|Nicotine|nicotine|mesh-list
101246253|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101246254|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
101246255|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246256|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246257|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101246258|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101246259|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
101246260|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246261|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246262|NCT01665079|Propofol|propofol|mesh-list
101246263|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246264|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408096|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
101246265|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246266|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101246267|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
101246268|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
101246269|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
101246270|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101246271|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101246272|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246273|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
101246274|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
101246275|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246276|NCT01665209|Morphine|morphine|mesh-list
101246277|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101246278|NCT01665209|Narcotics|narcotics|mesh-ancestor
101246279|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246280|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246281|NCT01665209|Analgesics|analgesics|mesh-ancestor
101246282|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
101246283|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246284|NCT01665222|Morphine|morphine|mesh-list
101246285|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101246287|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246288|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246289|NCT01665222|Analgesics|analgesics|mesh-ancestor
101246290|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
101246291|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246292|NCT01665235|Aspirin|aspirin|mesh-list
101246293|NCT01665235|Amlodipine|amlodipine|mesh-list
101246294|NCT01665235|Clopidogrel|clopidogrel|mesh-list
101246295|NCT01665235|Atorvastatin|atorvastatin|mesh-list
101246296|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246297|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246298|NCT01665235|Analgesics|analgesics|mesh-ancestor
101246299|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
101246300|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246301|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246302|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246303|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246304|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101246305|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101246306|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246307|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101246308|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246309|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246310|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
101246311|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101246312|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101246313|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
101246314|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101246315|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101246316|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101246317|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101246318|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101246319|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
101246320|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246321|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101246322|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101246323|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246324|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101246325|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
101246326|NCT01665248|Listerine|listerine|mesh-list
101246327|NCT01665248|Fluorides|fluorides|mesh-list
101246328|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
101246329|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
101246330|NCT01665248|Protective Agents|protective agents|mesh-ancestor
101246331|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246332|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101246333|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246334|NCT01665378|Folic Acid|folic acid|mesh-list
101246335|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
101246336|NCT01665378|Micronutrients|micronutrients|mesh-list
101246337|NCT01665378|Trace Elements|trace elements|mesh-list
101246338|NCT01665378|Hematinics|hematinics|mesh-ancestor
101246339|NCT01665378|Vitamins|vitamins|mesh-ancestor
101246340|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246341|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
101246342|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101246343|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101246344|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246345|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246346|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101246347|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101246349|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246350|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246351|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246352|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
101246353|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101246354|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
101246355|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101246356|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101246357|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246358|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101246359|NCT01665417|Docetaxel|docetaxel|mesh-list
101246360|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246361|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101246362|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101246363|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101246364|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246365|NCT01665469|Lycopene|lycopene|mesh-list
101246366|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246367|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
101246368|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246369|NCT01665469|Protective Agents|protective agents|mesh-ancestor
101246370|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246371|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101246372|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101246373|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246374|NCT01664507|Epinephrine|epinephrine|mesh-list
101246375|NCT01664507|Racepinephrine|racepinephrine|mesh-list
101246376|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
101246377|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101246378|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246379|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246380|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246381|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246382|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246383|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101246384|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101246385|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
101246386|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246387|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101246388|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246389|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
101246390|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
101246391|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101246392|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
101246393|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246394|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246395|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246396|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209571|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
101246398|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
101246399|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246400|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101246401|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101246402|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246403|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246405|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246406|NCT01665638|Canagliflozin|canagliflozin|mesh-list
101246407|NCT01665638|Somatostatin|somatostatin|mesh-list
101246408|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101246409|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246410|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101246411|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246412|NCT01665638|Hormones|hormones|mesh-ancestor
101246413|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246414|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101246415|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101246416|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246417|NCT01665742|Tocopherols|tocopherols|mesh-list
101246418|NCT01665742|Vitamin E|vitamin e|mesh-list
101246419|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
101246420|NCT01665742|Lycopene|lycopene|mesh-list
101246421|NCT01665742|Vitamins|vitamins|mesh-ancestor
101246422|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
101246423|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246424|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
101246425|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246426|NCT01665742|Protective Agents|protective agents|mesh-ancestor
101246427|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246428|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101246429|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101246430|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246431|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
101246432|NCT01665781|Hematinics|hematinics|mesh-ancestor
101246433|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101246434|NCT01665846|Hematinics|hematinics|mesh-ancestor
101246435|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101246436|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101246437|NCT01666041|Fenofibrate|fenofibrate|mesh-list
101246438|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101246439|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
101246440|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246441|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101246442|NCT01666067|Simvastatin|simvastatin|mesh-list
101246443|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101246444|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101246445|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101246446|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
101246447|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246448|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101246449|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101246450|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246451|NCT01666171|Metformin|metformin|mesh-list
101246452|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101246453|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246454|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101246455|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101246456|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101246457|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101246458|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
101246459|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246460|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101246461|NCT01666223|Cathartics|cathartics|mesh-ancestor
101246462|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246463|NCT01666236|Triamcinolone|triamcinolone|mesh-list
101246464|NCT01666236|Ranibizumab|ranibizumab|mesh-list
101246465|NCT01666236|Verteporfin|verteporfin|mesh-list
101246466|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101246467|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101246468|NCT01666236|Growth Substances|growth substances|mesh-ancestor
101246469|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246470|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101246472|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246473|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
101246474|NCT01666236|Hormones|hormones|mesh-ancestor
101246475|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246476|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101308442|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308443|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
101408164|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408168|NCT00444184|Timolol|timolol|mesh-list
101308444|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308445|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308446|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
101308447|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308448|NCT02047292|Tacrine|tacrine|mesh-list
101308449|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101308450|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308451|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308452|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
101451782|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451783|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451784|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101451785|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451786|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451787|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451788|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101451789|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
101451790|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
101451791|NCT00196586|Interferons|interferons|mesh-list
101451792|NCT00196586|Ribavirin|ribavirin|mesh-list
101451793|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
101451794|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
101451795|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101451796|NCT00196586|Interleukin-2|interleukin-2|mesh-list
101451797|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451798|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
101451799|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451800|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
101451801|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451802|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
101451803|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451804|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101451805|NCT00196586|Analgesics|analgesics|mesh-ancestor
101451806|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
101451807|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451825|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101451827|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451828|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
101451829|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101451830|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
101451831|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451832|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101451833|NCT00208182|Risperidone|risperidone|mesh-list
101451834|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101451835|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
101451836|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451837|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451838|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451839|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101451840|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451841|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451842|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451843|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101451844|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
101451845|NCT00226395|Oxymorphone|oxymorphone|mesh-list
101451846|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101451847|NCT00226395|Narcotics|narcotics|mesh-ancestor
101451848|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451849|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451850|NCT00226395|Analgesics|analgesics|mesh-ancestor
101451851|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
101451852|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308453|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308454|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308455|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101308457|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308459|NCT00005823|Cytarabine|cytarabine|mesh-list
101308460|NCT00005823|Etoposide|etoposide|mesh-list
101308461|NCT00005823|Daunorubicin|daunorubicin|mesh-list
101308462|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
101451853|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101451854|NCT00208221|Telmisartan|telmisartan|mesh-list
101451855|NCT00208221|Ramipril|ramipril|mesh-list
101451856|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451857|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101451858|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101451859|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451860|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101451861|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451862|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451863|NCT00196625|Ritonavir|ritonavir|mesh-list
101451874|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101451875|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101451876|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101451877|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
101451878|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101451879|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101451880|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
101451881|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451883|NCT00208260|Fluorouracil|fluorouracil|mesh-list
101451884|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
101451885|NCT00208260|Folfirinox|folfirinox|mesh-list
101408188|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451886|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
101408189|NCT00451399|Metformin|metformin|mesh-list
101451887|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451888|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451889|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451890|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451892|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451893|NCT00208260|Antidotes|antidotes|mesh-ancestor
101451894|NCT00208260|Protective Agents|protective agents|mesh-ancestor
101451895|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451896|NCT00208260|Vitamins|vitamins|mesh-ancestor
101451897|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
101451898|NCT00226473|Dacarbazine|dacarbazine|mesh-list
101451899|NCT00226473|Vindesine|vindesine|mesh-list
101451900|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451901|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101451902|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
101408196|NCT04698772|Analgesics|analgesics|mesh-ancestor
101451903|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451904|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101451905|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101451906|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101451907|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451908|NCT00208299|Adenosine|adenosine|mesh-list
101451909|NCT00208299|Regadenoson|regadenoson|mesh-list
101451910|NCT00208299|Analgesics|analgesics|mesh-ancestor
101451911|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
101451912|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451913|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451914|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451915|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451916|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101451917|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
101451918|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
101451919|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308463|NCT00005823|Idarubicin|idarubicin|mesh-list
101308464|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
101308465|NCT00005823|Tretinoin|tretinoin|mesh-list
101308466|NCT00005823|Thioguanine|thioguanine|mesh-list
101308467|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308468|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308469|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101308470|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308472|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308473|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308474|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
101308475|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
101308476|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308477|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308478|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
101308479|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451920|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451921|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101451923|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101451924|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101451925|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451926|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451927|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451935|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451936|NCT00196703|Memantine|memantine|mesh-list
101451937|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101451938|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101451939|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
101451940|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451941|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408219|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
101451942|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451943|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101451944|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101451945|NCT00413322|Fluorouracil|fluorouracil|mesh-list
101451946|NCT00413322|Belinostat|belinostat|mesh-list
101451947|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
101451948|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451949|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451950|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451951|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451952|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
101451953|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451954|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101451955|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451956|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
101451957|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
101451958|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101451959|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101451960|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451961|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451962|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451963|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101451964|NCT00410657|Prednisone|prednisone|mesh-list
101451965|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
101308480|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101308481|NCT00005823|Analgesics|analgesics|mesh-ancestor
101308482|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
101308483|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308484|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
101308485|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308486|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
101308487|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
101308488|NCT00005826|Rubitecan|rubitecan|mesh-list
101451966|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101451967|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101451968|NCT00410657|Prednisolone|prednisolone|mesh-list
101451969|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
101451970|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
101451971|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101451972|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
101451973|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451974|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
101451975|NCT00410657|Hormones|hormones|mesh-ancestor
101451976|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451977|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451978|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101451979|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451980|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
101451981|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
101451982|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451983|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101451984|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101451985|NCT00410657|Protective Agents|protective agents|mesh-ancestor
101451986|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451987|NCT00196820|Capecitabine|capecitabine|mesh-list
101451988|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451989|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
101451990|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451991|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451992|NCT00410696|Lenograstim|lenograstim|mesh-list
101451993|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101452004|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452005|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452006|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
101452007|NCT00203372|Bevacizumab|bevacizumab|mesh-list
101452008|NCT00203372|Docetaxel|docetaxel|mesh-list
101452009|NCT00203372|Doxorubicin|doxorubicin|mesh-list
101452010|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452011|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
101452012|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452013|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452014|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452015|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
101452016|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452017|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452018|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452019|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101452020|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101452021|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101452022|NCT00203372|Growth Substances|growth substances|mesh-ancestor
101452023|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101452024|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452025|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452026|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452027|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408276|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101452028|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101452029|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101452030|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452031|NCT00226551|Isoproterenol|isoproterenol|mesh-list
101308489|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452033|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101452034|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452035|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452036|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452037|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452038|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101452039|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
101452040|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452041|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408277|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101452042|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
101452043|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101452044|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
101452045|NCT00226551|Protective Agents|protective agents|mesh-ancestor
101452046|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
101452048|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452049|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
101452050|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452051|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452052|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101452053|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452054|NCT00208533|Aripiprazole|aripiprazole|mesh-list
101452055|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452056|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452057|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101452067|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
101452068|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101452069|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101452071|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101452073|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
101452074|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101452075|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452076|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452077|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452078|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452079|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101452080|NCT00226668|Hormones|hormones|mesh-ancestor
101452081|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452082|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452083|NCT00208572|Citalopram|citalopram|mesh-list
101452084|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101452085|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101452086|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452087|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452088|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452089|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
101452090|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452091|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101452092|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452093|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452094|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
101452095|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101452096|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452097|NCT00226707|Analgesics|analgesics|mesh-ancestor
101452098|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
101452100|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452101|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452102|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452103|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101452104|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452105|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
101452106|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101452107|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452108|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452109|NCT00203528|Valproic Acid|valproic acid|mesh-list
101452110|NCT00203528|Risperidone|risperidone|mesh-list
101308490|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101308491|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308492|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308493|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308495|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308496|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
101452111|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101452112|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
101452113|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452114|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452115|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452116|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101452117|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452118|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452136|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452137|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452138|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452139|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452140|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452141|NCT00203567|Analgesics|analgesics|mesh-ancestor
101452142|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
101452143|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452144|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101452145|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452146|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452147|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101452148|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101452150|NCT00226746|Gemcitabine|gemcitabine|mesh-list
101452151|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452152|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452153|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452154|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452155|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452156|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452157|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452158|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
101452159|NCT00203606|Interferons|interferons|mesh-list
101452160|NCT00203606|Ribavirin|ribavirin|mesh-list
101452161|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
101452162|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
101452163|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101452164|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452165|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
101452166|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452167|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
101452168|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452169|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
101452170|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452171|NCT00203684|Flunisolide|flunisolide|mesh-list
101452172|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452173|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101452174|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
101452175|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
101452176|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101452177|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452178|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452179|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452180|NCT00226785|Analgesics|analgesics|mesh-ancestor
101452181|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
101452182|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452188|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452189|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
101452190|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452191|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308497|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308498|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452193|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101452194|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452195|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452196|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
101452197|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452198|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452199|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101452200|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
101452201|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452202|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
101452204|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
101452205|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452206|NCT00203723|Risperidone|risperidone|mesh-list
101452207|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101452208|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
101452209|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452210|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452211|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452212|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101452213|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452214|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452215|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452216|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101452217|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
101408317|NCT00452062|Hormones|hormones|mesh-ancestor
101408320|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452219|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101452220|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452221|NCT00226902|Analgesics|analgesics|mesh-ancestor
101452222|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
101452223|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452224|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452225|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452226|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452227|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101452228|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
101452229|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452230|NCT00226980|Thalidomide|thalidomide|mesh-list
101452231|NCT00226980|Capecitabine|capecitabine|mesh-list
101452232|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452233|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
101452234|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452235|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452236|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452237|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
101452238|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452239|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
101452240|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101452241|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452242|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101452243|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101452244|NCT00226980|Growth Substances|growth substances|mesh-ancestor
101452245|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
101452246|NCT00203801|Artesunate|artesunate|mesh-list
101452247|NCT00203801|Lumefantrine|lumefantrine|mesh-list
101452248|NCT00203801|Artemether|artemether|mesh-list
101452249|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
101452250|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
101452251|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101452252|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101452262|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101452263|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452264|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452265|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101452266|NCT00197327|Bupivacaine|bupivacaine|mesh-list
101452267|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
101452268|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
101308500|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308501|NCT00005838|Paclitaxel|paclitaxel|mesh-list
101308502|NCT00005838|Vinorelbine|vinorelbine|mesh-list
101308503|NCT00005838|Carboplatin|carboplatin|mesh-list
101452269|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452270|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452271|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
101452272|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452273|NCT00227097|Anticoagulants|anticoagulants|mesh-list
101452274|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
101452275|NCT00208923|Busulfan|busulfan|mesh-list
101452277|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452278|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
101452279|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452280|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452281|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452282|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
101452283|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452284|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452285|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452286|NCT00227136|Serotonin|serotonin|mesh-list
101452287|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101452288|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
101452289|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452290|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452291|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452293|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101452294|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101452295|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101452296|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
101452297|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452298|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452299|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452300|NCT00197444|Nedaplatin|nedaplatin|mesh-list
101452301|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452302|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101452303|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101452304|NCT00204074|Estradiol|estradiol|mesh-list
101452305|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101452306|NCT00204074|Estrogens|estrogens|mesh-ancestor
101452307|NCT00204074|Hormones|hormones|mesh-ancestor
101452308|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452309|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452310|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101452311|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
101452312|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101452313|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101452314|NCT00227292|Escitalopram|escitalopram|mesh-list
101452315|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101452316|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101452317|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452318|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452320|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
101452321|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452323|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
101452324|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
101452325|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452326|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452327|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452328|NCT00230529|Infliximab|infliximab|mesh-list
101452329|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101452330|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452331|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
101452332|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452333|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452334|NCT00230568|Donepezil|donepezil|mesh-list
101452335|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101452336|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452337|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308504|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308505|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308506|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308507|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452338|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
101452339|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452340|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452341|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
101452342|NCT00227331|Amoxicillin|amoxicillin|mesh-list
101452343|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101452344|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452345|NCT00197561|Selenium|selenium|mesh-list
101452346|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
101452347|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452348|NCT00197561|Protective Agents|protective agents|mesh-ancestor
101452349|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452350|NCT00197561|Trace Elements|trace elements|mesh-ancestor
101452351|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
101452352|NCT00227409|Edetic Acid|edetic acid|mesh-list
101452354|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
101452355|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452356|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452357|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
101452358|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101452359|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
101452360|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
101452361|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452362|NCT00227409|Antidotes|antidotes|mesh-ancestor
101452363|NCT00227409|Protective Agents|protective agents|mesh-ancestor
101452364|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101452366|NCT00197639|Indinavir|indinavir|mesh-list
101452367|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101452368|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101452369|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
101452370|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452371|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452372|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101452373|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101452374|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
101452375|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452376|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101452377|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101452378|NCT00227448|Phenylephrine|phenylephrine|mesh-list
101452379|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
101452380|NCT00227448|Midodrine|midodrine|mesh-list
101452381|NCT00227448|Norepinephrine|norepinephrine|mesh-list
101452382|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101452383|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
101452384|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
101452385|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452387|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
101452388|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101452389|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
101452390|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
101452391|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101452392|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101452393|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101452394|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452395|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452405|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
101452406|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101452407|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452408|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101452409|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
101452410|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101452411|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452412|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452413|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452414|NCT00204269|Testosterone|testosterone|mesh-list
101452415|NCT00204269|Androgens|androgens|mesh-ancestor
101452416|NCT00204269|Hormones|hormones|mesh-ancestor
101308508|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308509|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308511|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101308512|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
101452417|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452418|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452419|NCT00197756|Vitamins|vitamins|mesh-list
101452420|NCT00197756|Vitamin A|vitamin a|mesh-list
101452421|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
101452422|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
101452423|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452424|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
101452425|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452426|NCT00197756|Protective Agents|protective agents|mesh-ancestor
101452427|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101452428|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452429|NCT00227565|Carboplatin|carboplatin|mesh-list
101452430|NCT00227565|Pemetrexed|pemetrexed|mesh-list
101452431|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452432|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452433|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452434|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101452435|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101452436|NCT00204308|Tenofovir|tenofovir|mesh-list
101452437|NCT00204308|Emtricitabine|emtricitabine|mesh-list
101452438|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
101452439|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452440|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101452441|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101452442|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452443|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452444|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101452445|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101452446|NCT00204347|Risperidone|risperidone|mesh-list
101452447|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101452448|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
101452449|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246477|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101452450|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452451|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452452|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101452453|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452454|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452455|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452456|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101452457|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
101452459|NCT00227682|Thalidomide|thalidomide|mesh-list
101452460|NCT00227682|Dexamethasone|dexamethasone|mesh-list
101452464|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
101452465|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452466|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452467|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452468|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
101452469|NCT00227682|Hormones|hormones|mesh-ancestor
101452470|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452471|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452472|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452473|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452474|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
101452475|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
101452476|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101452477|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452478|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101452479|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101452480|NCT00227682|Growth Substances|growth substances|mesh-ancestor
101452481|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
101452482|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
101308513|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308514|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
101308515|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308516|NCT00005850|Gemcitabine|gemcitabine|mesh-list
101308517|NCT00005850|Fluoxetine|fluoxetine|mesh-list
101452483|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452484|NCT00227682|Protective Agents|protective agents|mesh-ancestor
101452485|NCT00227682|Vitamins|vitamins|mesh-ancestor
101408442|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101452486|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
101452487|NCT00230763|Timolol|timolol|mesh-list
101452488|NCT00230763|Latanoprost|latanoprost|mesh-list
101452489|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101452490|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101452491|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452492|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452493|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452494|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408443|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101452495|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101452496|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101452497|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101452498|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101452499|NCT00204386|Topiramate|topiramate|mesh-list
101452500|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
101452501|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452502|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452503|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
101452504|NCT04721964|Trace Elements|trace elements|mesh-ancestor
101452505|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
101452506|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452507|NCT00197834|Valproic Acid|valproic acid|mesh-list
101452508|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
101452509|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452510|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452511|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
101452512|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452513|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452514|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
101452515|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452516|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452517|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452518|NCT00197912|Celecoxib|celecoxib|mesh-list
101452519|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
101452520|NCT00197912|Interleukin-2|interleukin-2|mesh-list
101452523|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452524|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452525|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452526|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
101452527|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452528|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452529|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452530|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101452531|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452532|NCT00197912|Analgesics|analgesics|mesh-ancestor
101452558|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452559|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452560|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452561|NCT00204542|Diclofenac|diclofenac|mesh-list
101452562|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101452563|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452564|NCT00204542|Analgesics|analgesics|mesh-ancestor
101452565|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
101452566|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452567|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452568|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452569|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452570|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101452571|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452572|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308519|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308521|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308522|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101308523|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101308524|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452574|NCT00230958|Ribavirin|ribavirin|mesh-list
101452575|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
101452576|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
101452577|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101452578|NCT00230958|Taribavirin|taribavirin|mesh-list
101452579|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452580|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
101452581|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452585|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452586|NCT00227955|Imipramine|imipramine|mesh-list
101452587|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101452588|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452589|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452590|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101452591|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101452592|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452593|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452594|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452595|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452596|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452597|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
101452598|NCT00228033|Calcium|calcium|mesh-list
101452599|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452600|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452601|NCT00228033|Antacids|antacids|mesh-ancestor
101452602|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452603|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452604|NCT00230997|Galantamine|galantamine|mesh-list
101452605|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101452606|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452607|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408461|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408462|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101408463|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408465|NCT00143364|Varenicline|varenicline|mesh-list
101452608|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
101452609|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452610|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452611|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101452613|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452614|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
101452615|NCT00204581|Aldesleukin|aldesleukin|mesh-list
101452616|NCT00204581|Interleukin-2|interleukin-2|mesh-list
101452617|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452618|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101452619|NCT00204581|Analgesics|analgesics|mesh-ancestor
101452620|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
101452621|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452622|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452623|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101452624|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101452625|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
101452626|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452627|NCT00231075|Paclitaxel|paclitaxel|mesh-list
101452628|NCT00231075|Carboplatin|carboplatin|mesh-list
101452629|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452630|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452631|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452632|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452633|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308525|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308526|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
101308527|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308528|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101308529|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452634|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452635|NCT00198146|Daclizumab|daclizumab|mesh-list
101452636|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452637|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
101452638|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452639|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101452640|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452641|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
101452642|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452644|NCT02962518|Triamcinolone|triamcinolone|mesh-list
101452645|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452646|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
101452647|NCT02962518|Hormones|hormones|mesh-ancestor
101452648|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452649|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452650|NCT00204659|Rituximab|rituximab|mesh-list
101452651|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101452652|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452665|NCT00204737|Prednisone|prednisone|mesh-list
101452666|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452667|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
101452668|NCT00204737|Hormones|hormones|mesh-ancestor
101452669|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452670|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452671|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452672|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452673|NCT00198380|Gefitinib|gefitinib|mesh-list
101452674|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452675|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101452676|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452677|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452678|NCT00228267|Propofol|propofol|mesh-list
101246478|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
101452680|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452681|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452682|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101452683|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
101452684|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
101452686|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101452687|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101452688|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452689|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452690|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452691|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452692|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101452693|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452694|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452695|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101452696|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101452697|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
101452698|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
101452699|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452700|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452701|NCT00198536|Ecabet|ecabet|mesh-list
101452702|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452703|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101452704|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452705|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
101452706|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452707|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308530|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101308531|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101308532|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101452708|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101452709|NCT00198536|Protective Agents|protective agents|mesh-ancestor
101452710|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452711|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452713|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101452714|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452746|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101452747|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452748|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452749|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452750|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
101452751|NCT00198614|Protective Agents|protective agents|mesh-ancestor
101452752|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101452753|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101452754|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452755|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
101452756|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101452757|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101452769|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101452770|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101452771|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452772|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101452773|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452774|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
101452775|NCT02963324|Ivermectin|ivermectin|mesh-list
101452776|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101452777|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452778|NCT00228540|Modafinil|modafinil|mesh-list
101452780|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452781|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101452782|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101452783|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101452784|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452785|NCT00231621|Topiramate|topiramate|mesh-list
101452786|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
101452787|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452788|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452789|NCT00474526|Vaccines|vaccines|mesh-list
101452790|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101452791|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
101452792|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452793|NCT00231660|Topiramate|topiramate|mesh-list
101452794|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
101452795|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452796|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452797|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101452798|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101452799|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101452801|NCT00198848|Hematinics|hematinics|mesh-ancestor
101452802|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
101452803|NCT00198848|Vitamins|vitamins|mesh-ancestor
101452804|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
101452805|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452806|NCT00478426|Sunitinib|sunitinib|mesh-list
101452807|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452808|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101452809|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101452810|NCT00478426|Growth Substances|growth substances|mesh-ancestor
101452811|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452812|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
101452813|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101452814|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452815|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452817|NCT00231855|Topotecan|topotecan|mesh-list
101308533|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308534|NCT00005853|Etanercept|etanercept|mesh-list
101308535|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101308536|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101308537|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101308538|NCT00005853|Analgesics|analgesics|mesh-ancestor
101308539|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
101452818|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452819|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452820|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452821|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452822|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452823|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101452824|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101452831|NCT00199004|Methotrexate|methotrexate|mesh-list
101452832|NCT00199004|Vincristine|vincristine|mesh-list
101452833|NCT00199004|Doxorubicin|doxorubicin|mesh-list
101452834|NCT00199004|Daunorubicin|daunorubicin|mesh-list
101452835|NCT00199004|Asparaginase|asparaginase|mesh-list
101452836|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
101452837|NCT00199004|Thioguanine|thioguanine|mesh-list
101452838|NCT00199004|Vindesine|vindesine|mesh-list
101452839|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452840|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
101408515|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
101452841|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452842|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452843|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452844|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
101246479|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101452845|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452846|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452847|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452848|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101452849|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452850|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
101452851|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
101452852|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452853|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452854|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
101452855|NCT00199004|Hormones|hormones|mesh-ancestor
101452856|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452857|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452858|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101452859|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
101452860|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101452861|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452862|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
101452863|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408525|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408526|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452865|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101452866|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101452867|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
101452868|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452869|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452870|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452871|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452872|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452873|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101452874|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101452875|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101452876|NCT00228852|Fludarabine|fludarabine|mesh-list
101452877|NCT00228852|Busulfan|busulfan|mesh-list
101452878|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452879|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452880|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452881|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
101452882|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452883|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
101452884|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308540|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308541|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452885|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452888|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452889|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
101452890|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452891|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452893|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101452894|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452895|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452896|NCT00477412|Cytarabine|cytarabine|mesh-list
101452897|NCT00477412|Dexamethasone|dexamethasone|mesh-list
101452898|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
101452902|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101452903|NCT00477412|Methotrexate|methotrexate|mesh-list
101452904|NCT00477412|Vincristine|vincristine|mesh-list
101452905|NCT00477412|Bortezomib|bortezomib|mesh-list
101452906|NCT00477412|Daunorubicin|daunorubicin|mesh-list
101452907|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101452908|NCT00477412|Antibodies|antibodies|mesh-list
101452909|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
101452910|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101452911|NCT00477412|BB 1101|bb 1101|mesh-list
101452912|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452913|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
101452914|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452915|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452916|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101452917|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
101452918|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452919|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452920|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101452921|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452922|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
101452923|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
101452924|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452925|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452926|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
101452927|NCT00477412|Hormones|hormones|mesh-ancestor
101452928|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452929|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452930|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101452931|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101452932|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101452933|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452934|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101452935|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
101452936|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101452937|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452938|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
101452939|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101452940|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101452941|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101452942|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
101452943|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452944|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452945|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452946|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452947|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452948|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
101452949|NCT00410774|Bevacizumab|bevacizumab|mesh-list
101452950|NCT00410774|Gemcitabine|gemcitabine|mesh-list
101452951|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101452952|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452953|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101452954|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101452955|NCT00410774|Growth Substances|growth substances|mesh-ancestor
101452956|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452957|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
101452958|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101452959|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
101452960|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308542|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308543|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308544|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308545|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452961|NCT00228930|Tamoxifen|tamoxifen|mesh-list
101452962|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101452963|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
101452964|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101452965|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452966|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452967|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452968|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101452969|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101452970|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101452971|NCT00410852|Insulin|insulin|mesh-list
101452974|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452976|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452977|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101452978|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452979|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
101452980|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
101452981|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452982|NCT00204893|Calcium|calcium|mesh-list
101452983|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452984|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452985|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
101246480|NCT01666249|Antibodies|antibodies|mesh-list
101452986|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101452988|NCT00232011|Analgesics|analgesics|mesh-ancestor
101452989|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
101452990|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452991|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452992|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452993|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452994|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
101452995|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452996|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
101452997|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101452998|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408582|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
101408583|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101408584|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
101452999|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453001|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101453002|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101453003|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
101453004|NCT00232089|Tegaserod|tegaserod|mesh-list
101453005|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101453006|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
101453007|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453008|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453009|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453010|NCT00205166|Caffeine|caffeine|mesh-list
101453011|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101453012|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453013|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101453014|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453015|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453016|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101453017|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101453018|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
101453019|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453021|NCT00229125|Lorazepam|lorazepam|mesh-list
101453022|NCT00229125|Analgesics|analgesics|mesh-ancestor
101453023|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
101453024|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453025|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453026|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
101453027|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101453028|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101308546|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
101308547|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
101308548|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453029|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453030|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453031|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101453032|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101453033|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453034|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453035|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
101453037|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
101453038|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453039|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101453040|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
101453041|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
101453042|NCT00205283|Nelfinavir|nelfinavir|mesh-list
101453043|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101453044|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101453046|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453047|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453048|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101453050|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
101453051|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453052|NCT00232167|Indiplon|indiplon|mesh-list
101453053|NCT00232167|Sertraline|sertraline|mesh-list
101453054|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453055|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453056|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101453057|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453058|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453059|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453060|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453061|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
101453062|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453063|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101453064|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453065|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
101453066|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
101453067|NCT00205322|Leucovorin|leucovorin|mesh-list
101453068|NCT00205322|Capecitabine|capecitabine|mesh-list
101453069|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
101453070|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101453071|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
101453072|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453073|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453074|NCT00205322|Antidotes|antidotes|mesh-ancestor
101453075|NCT00205322|Protective Agents|protective agents|mesh-ancestor
101453076|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453077|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
101453078|NCT00205322|Vitamins|vitamins|mesh-ancestor
101453079|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
101453080|NCT00232206|Docetaxel|docetaxel|mesh-list
101453081|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453082|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101453083|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101453084|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453085|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453086|NCT00229242|Diuretics|diuretics|mesh-list
101453087|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
101453088|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453090|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453091|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453092|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101453093|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453094|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453095|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453096|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453097|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
101453098|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453099|NCT00205634|Clarithromycin|clarithromycin|mesh-list
101308549|NCT00005859|Tipifarnib|tipifarnib|mesh-list
101308550|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308551|NCT00005862|Semaxinib|semaxinib|mesh-list
101308552|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408635|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
101453100|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453101|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453102|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101453103|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453104|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453105|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101453107|NCT00232362|Pioglitazone|pioglitazone|mesh-list
101453108|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
101453109|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101453110|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453111|NCT00205751|Thalidomide|thalidomide|mesh-list
101453112|NCT00205751|Dexamethasone|dexamethasone|mesh-list
101453114|NCT00205751|Melphalan|melphalan|mesh-list
101453115|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453116|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
101453117|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
101408637|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408640|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
101453118|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453119|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453132|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
101453133|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453134|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453135|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101453136|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101453137|NCT00205751|Growth Substances|growth substances|mesh-ancestor
101453138|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
101453140|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453141|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453142|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101453143|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453144|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453145|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453146|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453147|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
101453148|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453149|NCT00205946|Bupropion|bupropion|mesh-list
101453150|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101453151|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453152|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453153|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101453154|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453155|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453156|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453157|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
101453158|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453159|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453160|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101453161|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101453162|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453164|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
101453165|NCT00229515|Temsirolimus|temsirolimus|mesh-list
101453166|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
101453167|NCT00229515|Tirofiban|tirofiban|mesh-list
101453168|NCT00229515|Abciximab|abciximab|mesh-list
101453169|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453170|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453171|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101453172|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453173|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
101453174|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453175|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
101453176|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453177|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453178|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308553|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101308554|NCT00005862|Growth Substances|growth substances|mesh-ancestor
101453179|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453181|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101453184|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101453185|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
101453186|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
101453187|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101453188|NCT00229515|Protective Agents|protective agents|mesh-ancestor
101453189|NCT00206024|Esomeprazole|esomeprazole|mesh-list
101453190|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101453191|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453192|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101453193|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453194|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453195|NCT00206063|Ximelagatran|ximelagatran|mesh-list
101453196|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
101453197|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101453198|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
101453199|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453200|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453201|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
101453202|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101453203|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453204|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453205|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453206|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453207|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453208|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453210|NCT00229593|Testosterone|testosterone|mesh-list
101453211|NCT00229593|Androgens|androgens|mesh-ancestor
101453212|NCT00229593|Hormones|hormones|mesh-ancestor
101453213|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453214|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453215|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101453216|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
101453217|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101453218|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101453219|NCT00229632|Idebenone|idebenone|mesh-list
101453220|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
101453221|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453222|NCT00229632|Protective Agents|protective agents|mesh-ancestor
101453223|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453224|NCT00206180|Esomeprazole|esomeprazole|mesh-list
101453225|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101453226|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453227|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101453228|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453229|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453230|NCT00206219|Methotrexate|methotrexate|mesh-list
101453231|NCT00206219|Gefitinib|gefitinib|mesh-list
101453232|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101453233|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
101453234|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101453235|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453236|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101453237|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
101453238|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453239|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453240|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
101453241|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453242|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101453243|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453244|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
101453245|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453246|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101453247|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453248|NCT00206258|Pramlintide|pramlintide|mesh-list
101308555|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308556|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308557|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308558|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101308559|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453249|NCT00206258|Glucagon|glucagon|mesh-list
101453250|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453251|NCT00206258|Hormones|hormones|mesh-ancestor
101453252|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453256|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453257|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453259|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453260|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453261|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453262|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453263|NCT00411125|Calcitonin|calcitonin|mesh-list
101453264|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
101453265|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101453266|NCT00411125|Katacalcin|katacalcin|mesh-list
101453267|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453268|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453269|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453270|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
101453271|NCT00411164|Hydromorphone|hydromorphone|mesh-list
101453272|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101453273|NCT00411164|Narcotics|narcotics|mesh-ancestor
101453274|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534911|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534912|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534915|NCT00571337|Infliximab|infliximab|mesh-list
101453275|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453276|NCT00411164|Analgesics|analgesics|mesh-ancestor
101453277|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
101453278|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453279|NCT00411203|Tamoxifen|tamoxifen|mesh-list
101453280|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101453281|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453282|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453283|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453284|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453285|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453286|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101453287|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101453288|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453289|NCT00411281|Cytarabine|cytarabine|mesh-list
101453290|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101453291|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
101534944|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453292|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453293|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453294|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
101453295|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453296|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453297|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
101453298|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453299|NCT00206414|Gefitinib|gefitinib|mesh-list
101453300|NCT00206414|Fulvestrant|fulvestrant|mesh-list
101453301|NCT00206414|Anastrozole|anastrozole|mesh-list
101453302|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453303|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453304|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453305|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453306|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453307|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101453308|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101453309|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453310|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453311|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453312|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101453313|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101453314|NCT00232674|Budesonide|budesonide|mesh-list
101534971|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453315|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308560|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308561|NCT00005865|Vinorelbine|vinorelbine|mesh-list
101308562|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101453316|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101453317|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
101453318|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453319|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453320|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101453321|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
101453322|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
101453323|NCT00232674|Hormones|hormones|mesh-ancestor
101453334|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453335|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453336|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453338|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101453339|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101453340|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453341|NCT00206570|Estradiol|estradiol|mesh-list
101453342|NCT00206570|Estrogens|estrogens|mesh-ancestor
101453343|NCT00206570|Hormones|hormones|mesh-ancestor
101453344|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453345|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453346|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
101453347|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101453348|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
101453349|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453350|NCT01056159|Albuterol|albuterol|mesh-list
101453351|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101453352|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
101453353|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453354|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453355|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101453356|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
101453357|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
101453358|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101453359|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101453360|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101453361|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101453362|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
101453363|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453364|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453365|NCT00206765|Risperidone|risperidone|mesh-list
101453366|NCT00206765|Paroxetine|paroxetine|mesh-list
101453367|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101453368|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
101453369|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453370|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453371|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453372|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453373|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453374|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453375|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453376|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101453377|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
101453378|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101453379|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453380|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453381|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101453382|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453383|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101453384|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101453385|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453386|NCT00424710|Ranibizumab|ranibizumab|mesh-list
101453398|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453399|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453400|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453401|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453402|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308563|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308564|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308565|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308566|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308567|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308568|NCT00005868|Docetaxel|docetaxel|mesh-list
101453403|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453404|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101453406|NCT00206999|Imipramine|imipramine|mesh-list
101453407|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101453408|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453409|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453410|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101453411|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453412|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453413|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453414|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
101453415|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453416|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453417|NCT00229944|Azithromycin|azithromycin|mesh-list
101453418|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453419|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453420|NCT00207077|Cetuximab|cetuximab|mesh-list
101453421|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101453422|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101453423|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453424|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453425|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453426|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453428|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101453429|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453430|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
101453431|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101453432|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101453433|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453434|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101453435|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101453436|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
101453437|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453438|NCT00207155|Cetuximab|cetuximab|mesh-list
101453439|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101453440|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453441|NCT00232947|Vaccines|vaccines|mesh-list
101453442|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
101453443|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453444|NCT00413712|Adenosine|adenosine|mesh-list
101453445|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
101453446|NCT00413712|Calcium|calcium|mesh-list
101453447|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453448|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453449|NCT00413712|Analgesics|analgesics|mesh-ancestor
101453450|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
101453463|NCT00207311|Interferons|interferons|mesh-list
101453464|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
101453465|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
101453466|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101453467|NCT00207311|Orlistat|orlistat|mesh-list
101453468|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453469|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
101453470|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453471|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
101453472|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453473|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453474|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453475|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101453476|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101453477|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101453478|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101308569|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308570|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308571|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308572|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453479|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453480|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453481|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453483|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453484|NCT00233025|Analgesics|analgesics|mesh-ancestor
101453485|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
101453486|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453487|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453488|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453489|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
101453490|NCT00207428|Carbamazepine|carbamazepine|mesh-list
101453491|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
101453492|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
101453493|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453494|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453495|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453496|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453497|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101453498|NCT00207428|Analgesics|analgesics|mesh-ancestor
101453499|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
101453500|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453501|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101453502|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453503|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453504|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101453505|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101453506|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
101453507|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453508|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101453509|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453510|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453511|NCT00207584|Doxycycline|doxycycline|mesh-list
101453515|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535058|NCT00572663|Antidotes|antidotes|mesh-ancestor
101453517|NCT00207662|Infliximab|infliximab|mesh-list
101453518|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101453519|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453520|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
101453521|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453522|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453523|NCT00207701|Infliximab|infliximab|mesh-list
101453524|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101453525|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453526|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101453527|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453528|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453529|NCT00207779|Heparin|heparin|mesh-list
101453530|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
101453531|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101453532|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101453533|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453534|NCT00230373|Imiquimod|imiquimod|mesh-list
101453535|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101453536|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
101453537|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453538|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453539|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
101453540|NCT00230451|Paclitaxel|paclitaxel|mesh-list
101453541|NCT00230451|Fluorouracil|fluorouracil|mesh-list
101453542|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101453543|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453544|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
101453545|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
101453546|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453547|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453548|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
101453549|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101453550|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453551|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
101453552|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453553|NCT00411320|Dexamethasone|dexamethasone|mesh-list
101453554|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453555|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
101453556|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
101453557|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453558|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453559|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453560|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
101453561|NCT00411320|Hormones|hormones|mesh-ancestor
101453562|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453563|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453564|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453565|NCT00233337|Artemether|artemether|mesh-list
101453566|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101453567|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
101453568|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101453569|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101453570|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453571|NCT00230490|Adefovir|adefovir|mesh-list
101453572|NCT00230490|Pradefovir|pradefovir|mesh-list
101453573|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
101453574|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453575|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101453576|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101453577|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453578|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453579|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101453580|NCT01089556|Pregabalin|pregabalin|mesh-list
101453581|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101453582|NCT01089556|Analgesics|analgesics|mesh-ancestor
101453583|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
101453584|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453585|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453588|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453589|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453590|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453591|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101453592|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453593|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453594|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453595|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101453596|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453597|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453598|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453599|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
101453600|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101453601|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101453602|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453603|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
101453604|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
101453605|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453606|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453607|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101453608|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101453609|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
101453610|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453611|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535083|NCT03451110|Lemborexant|lemborexant|mesh-list
101453612|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101453613|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
101453614|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101453615|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101453616|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101453617|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
101453618|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453619|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453620|NCT00424580|Montelukast|montelukast|mesh-list
101453621|NCT00424580|Desloratadine|desloratadine|mesh-list
101308573|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308574|NCT00005871|Fluorouracil|fluorouracil|mesh-list
101308576|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
101308577|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453622|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101453623|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
101453624|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101453625|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453626|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453627|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453628|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101453629|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101453630|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453631|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101453632|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
101453633|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453634|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101453635|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101453636|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
101453637|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
101453639|NCT00233532|Trandolapril|trandolapril|mesh-list
101453640|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101453641|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101453642|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453643|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453644|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453645|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453646|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
101453647|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101453648|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
101453649|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453650|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101453651|NCT00233571|Adalimumab|adalimumab|mesh-list
101453652|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101453653|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453654|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453658|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101453660|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453661|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101453662|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246481|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
101453663|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453664|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453666|NCT00233610|Bicalutamide|bicalutamide|mesh-list
101453667|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101453668|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453669|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453670|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453671|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453672|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453673|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101453674|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101453675|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453676|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
101453677|NCT00208130|Topiramate|topiramate|mesh-list
101453678|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
101453679|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453680|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453681|NCT00237237|Vildagliptin|vildagliptin|mesh-list
101453682|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453683|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453684|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101453685|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
101308578|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308579|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308580|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308581|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
101308582|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308583|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101453686|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453687|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453689|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453690|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453691|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453692|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453693|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453694|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453695|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
101453696|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
101453697|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453698|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453699|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101453700|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101453701|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
101453702|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101453703|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101453704|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101453705|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101453706|NCT01087723|Heparin|heparin|mesh-list
101453707|NCT01087723|Bivalirudin|bivalirudin|mesh-list
101453708|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
101453709|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101453710|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101535109|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101453711|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453712|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
101453713|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101453714|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
101453715|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453716|NCT00208208|Ziprasidone|ziprasidone|mesh-list
101453717|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101453718|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
101453719|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453720|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453722|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453723|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453729|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
101453730|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101453731|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453732|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453733|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453734|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453735|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453736|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453737|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453738|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101453739|NCT01085812|Analgesics|analgesics|mesh-ancestor
101453740|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
101453741|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453742|NCT01085734|Bevacizumab|bevacizumab|mesh-list
101453743|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101453744|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453745|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101453746|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101453747|NCT01085734|Growth Substances|growth substances|mesh-ancestor
101453748|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453749|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308584|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308585|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308586|NCT00005874|Rubitecan|rubitecan|mesh-list
101308587|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408792|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453750|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101453751|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
101453752|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101453753|NCT00208403|Protective Agents|protective agents|mesh-ancestor
101453754|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453755|NCT01084603|Nicotine|nicotine|mesh-list
101453756|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101453757|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
101453758|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453759|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453760|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101453761|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101453762|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101453763|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453764|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453765|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
101453766|NCT00208442|Diuretics|diuretics|mesh-ancestor
101453767|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
101453768|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453769|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101453770|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453771|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453773|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453774|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453775|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101453776|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453777|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
101453778|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453779|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
101453780|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453781|NCT00208520|Lamotrigine|lamotrigine|mesh-list
101453782|NCT00208520|Carbamazepine|carbamazepine|mesh-list
101453783|NCT00208520|Levetiracetam|levetiracetam|mesh-list
101453784|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
101453785|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
101453786|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101453787|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453788|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453789|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453790|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453791|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453792|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453796|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
101453797|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101453798|NCT00208520|Analgesics|analgesics|mesh-ancestor
101453799|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
101453800|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453801|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101453802|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101453803|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101453804|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453805|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453806|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101453807|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453808|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453809|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453810|NCT00208559|Ziprasidone|ziprasidone|mesh-list
101453811|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101453812|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
101453813|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453814|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453815|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453816|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101408820|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101453817|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101453818|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453819|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101308588|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101308589|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308590|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453820|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101453821|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
101453822|NCT00233805|Sirolimus|sirolimus|mesh-list
101453823|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453824|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453825|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101453826|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453827|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
101453828|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408823|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408825|NCT00401492|Gemcitabine|gemcitabine|mesh-list
101453830|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453831|NCT01084135|Rivastigmine|rivastigmine|mesh-list
101453832|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101453833|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453834|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453835|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
101453836|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453837|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453838|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101453839|NCT01084135|Protective Agents|protective agents|mesh-ancestor
101453840|NCT01083316|Dexamethasone|dexamethasone|mesh-list
101453841|NCT01083316|Bortezomib|bortezomib|mesh-list
101453842|NCT01083316|Melphalan|melphalan|mesh-list
101453843|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453844|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
101453845|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
101453846|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453847|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453848|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453849|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
101453850|NCT01083316|Hormones|hormones|mesh-ancestor
101453851|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453852|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453853|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453854|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101453855|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
101453856|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453857|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101453858|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453859|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
101453861|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101453862|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453863|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101453867|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
101453869|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
101453870|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
101453871|NCT00208793|Vitamins|vitamins|mesh-list
101453872|NCT00208793|Calcium|calcium|mesh-list
101453873|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
101453874|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453875|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101453876|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101453877|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
101453878|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101453879|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101453880|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453881|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101453882|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101453883|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
101453884|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453885|NCT01081873|Leuprolide|leuprolide|mesh-list
101453886|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101453887|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
101453888|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101453889|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453890|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453891|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453892|NCT00237471|Insulin|insulin|mesh-list
101308591|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308593|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308594|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101453893|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453894|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453895|NCT00237510|Terazosin|terazosin|mesh-list
101453896|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101453897|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101453898|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101453899|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
101453900|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453901|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453902|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453903|NCT00237510|Urological Agents|urological agents|mesh-ancestor
101453904|NCT01081795|Topiramate|topiramate|mesh-list
101453905|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
101453906|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453907|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453908|NCT00233961|Lenograstim|lenograstim|mesh-list
101453909|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101453910|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
101453911|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453912|NCT00234000|Azacitidine|azacitidine|mesh-list
101453913|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
101453914|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101453915|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
101453916|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453917|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453918|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453919|NCT00234117|Rabeprazole|rabeprazole|mesh-list
101453920|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101453921|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453922|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101453923|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453924|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453925|NCT00209144|Insulin|insulin|mesh-list
101453926|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453927|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453928|NCT00209222|Cytarabine|cytarabine|mesh-list
101453929|NCT00209222|Dexamethasone|dexamethasone|mesh-list
101453930|NCT00209222|Prednisone|prednisone|mesh-list
101453931|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
101453932|NCT00209222|Melphalan|melphalan|mesh-list
101453933|NCT00209222|Rituximab|rituximab|mesh-list
101453934|NCT00209222|Doxorubicin|doxorubicin|mesh-list
101453935|NCT00209222|Etoposide|etoposide|mesh-list
101453936|NCT00209222|Vincristine|vincristine|mesh-list
101453937|NCT00209222|Cisplatin|cisplatin|mesh-list
101453942|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101453944|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453945|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453946|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101453947|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101453948|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453949|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
101453950|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
101453951|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453952|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453953|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
101453954|NCT00209222|Hormones|hormones|mesh-ancestor
101453955|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453956|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453957|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101453958|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101408873|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
101408877|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453959|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101453960|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453961|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101453962|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
101453963|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
101453964|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453965|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308595|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308596|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308597|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453966|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
101453967|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
101453968|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453969|NCT00234195|Bupropion|bupropion|mesh-list
101453970|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101453971|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
101453972|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453973|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101453974|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101453975|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453976|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453977|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
101453978|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453979|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453980|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101453981|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101453982|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453983|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101453984|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
101453985|NCT00209261|Coagulants|coagulants|mesh-ancestor
101453986|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101453987|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
101453988|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453989|NCT00209300|Mesalamine|mesalamine|mesh-list
101453990|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535272|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535273|NCT00586131|Citric Acid|citric acid|mesh-list
101535274|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
101453992|NCT00209300|Analgesics|analgesics|mesh-ancestor
101453993|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
101453994|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453995|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453996|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101453997|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453999|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101454000|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101454001|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454002|NCT00237588|Losartan|losartan|mesh-list
101454003|NCT00237588|Amlodipine|amlodipine|mesh-list
101454004|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101454005|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101454006|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454008|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101454009|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454011|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101454012|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101454013|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101454014|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101454015|NCT00411437|Oxybutynin|oxybutynin|mesh-list
101454016|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101454017|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101454018|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
101454019|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454020|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454021|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454022|NCT00411437|Urological Agents|urological agents|mesh-ancestor
101454023|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
101454024|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
101454025|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454026|NCT00234312|Sertraline|sertraline|mesh-list
101454027|NCT00234312|Escitalopram|escitalopram|mesh-list
101454028|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101454029|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101454030|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454031|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454032|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454033|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
101454034|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308598|NCT00005880|Budesonide|budesonide|mesh-list
101308599|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308600|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101308601|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
101454035|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454036|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454037|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
101454038|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101454039|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454040|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101454041|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
101454042|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101454043|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454044|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454045|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454046|NCT00237627|Doxorubicin|doxorubicin|mesh-list
101454047|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101454048|NCT00237627|Bortezomib|bortezomib|mesh-list
101454049|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101454050|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454051|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101454052|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454053|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454054|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454055|NCT00209495|Dexamethasone|dexamethasone|mesh-list
101454056|NCT00209495|Pregabalin|pregabalin|mesh-list
101454057|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101454058|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
101454060|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454061|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454062|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454064|NCT00209495|Hormones|hormones|mesh-ancestor
101454065|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454066|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101454067|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454068|NCT00209495|Analgesics|analgesics|mesh-ancestor
101454069|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
101454070|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
101454071|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101454072|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454073|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454074|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101454075|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101454076|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454083|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454084|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454085|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101454086|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
101454087|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
101454088|NCT00234390|Hormones|hormones|mesh-ancestor
101454089|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454090|NCT00209534|Fospropofol|fospropofol|mesh-list
101454091|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101408934|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101454092|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454093|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454094|NCT00209573|Fospropofol|fospropofol|mesh-list
101454095|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101454096|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454097|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454098|NCT00209612|Paclitaxel|paclitaxel|mesh-list
101454099|NCT00209612|Irinotecan|irinotecan|mesh-list
101454100|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101454101|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454102|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454103|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454104|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454105|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454106|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101308602|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308603|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308604|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101454107|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454108|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454109|NCT01081249|Oxytocin|oxytocin|mesh-list
101454110|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
101454111|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101454112|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454113|NCT00234429|Gefitinib|gefitinib|mesh-list
101454114|NCT00234429|Raltitrexed|raltitrexed|mesh-list
101454115|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454116|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454117|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454118|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454119|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454120|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
101454121|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101454122|NCT00209651|Irinotecan|irinotecan|mesh-list
101454123|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101454124|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454125|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454126|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454127|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454128|NCT02961855|Diclofenac|diclofenac|mesh-list
101454129|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101454130|NCT02961855|Lidocaine|lidocaine|mesh-list
101454131|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
101454132|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
101454133|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535328|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
101535329|NCT00586443|Bevacizumab|bevacizumab|mesh-list
101454134|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454135|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
101454136|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454137|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101454138|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101454139|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101454140|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454141|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454142|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101454143|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101454144|NCT02961855|Analgesics|analgesics|mesh-ancestor
101454145|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454149|NCT00209690|Docetaxel|docetaxel|mesh-list
101454150|NCT00209690|Fluorouracil|fluorouracil|mesh-list
101454151|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454152|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454153|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454154|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454155|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454156|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
101454157|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454158|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454159|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
101454160|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454161|NCT01081132|Guanfacine|guanfacine|mesh-list
101454162|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101454163|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101454164|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101454165|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101454166|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
101454167|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454168|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454169|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454170|NCT00234468|Gefitinib|gefitinib|mesh-list
101454171|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454172|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454173|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454174|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454175|NCT01080625|Phenylephrine|phenylephrine|mesh-list
101454176|NCT01080625|Epinephrine|epinephrine|mesh-list
101308605|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
101308606|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
101308607|NCT00005880|Hormones|hormones|mesh-ancestor
101454177|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
101454178|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101454179|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101454180|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
101454181|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454182|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454183|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454184|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101454185|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101454186|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
101454187|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454188|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101454189|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
101454191|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
101454192|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101454193|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101454194|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
101454195|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101454196|NCT01080625|Protective Agents|protective agents|mesh-ancestor
101454198|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454199|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454200|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454201|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454202|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454203|NCT00414180|Bupropion|bupropion|mesh-list
101454204|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101454205|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454206|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409003|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409004|NCT00456898|Analgesics|analgesics|mesh-ancestor
101454207|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101454208|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101454209|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454210|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454211|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
101454212|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454213|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454214|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101454215|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101454216|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454221|NCT01089790|Hormones|hormones|mesh-ancestor
101454222|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454223|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101454224|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
101454225|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454226|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454227|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
101454228|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101454229|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101454230|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101454231|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454232|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454233|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
101454234|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454235|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454236|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101454237|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454239|NCT01084330|Irinotecan|irinotecan|mesh-list
101454240|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454241|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454242|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454243|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454244|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454245|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101454246|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308608|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308609|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
101308610|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308611|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454247|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454248|NCT00209807|Reboxetine|reboxetine|mesh-list
101454249|NCT00209807|Escitalopram|escitalopram|mesh-list
101454250|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101454251|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101454252|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454253|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454254|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454255|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
101454256|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454257|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454258|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454259|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101454260|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
101454261|NCT00209846|Gaboxadol|gaboxadol|mesh-list
101454262|NCT00209846|Analgesics|analgesics|mesh-ancestor
101454263|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
101454264|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454265|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454266|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
101454267|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
101454268|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
101454269|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454270|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454271|NCT01082068|Letrozole|letrozole|mesh-list
101454272|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454273|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101454274|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101454275|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454276|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454277|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101454278|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409044|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454279|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409045|NCT00144066|Gefitinib|gefitinib|mesh-list
101454280|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454281|NCT01086748|Risperidone|risperidone|mesh-list
101535360|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101454282|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101454283|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
101454284|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454285|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454286|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454291|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454293|NCT00237705|Metoclopramide|metoclopramide|mesh-list
101454294|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
101454295|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
101454296|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454297|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454298|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454299|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101454300|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454301|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
101454302|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454303|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454304|NCT00209885|Lidocaine|lidocaine|mesh-list
101454305|NCT00209885|Droperidol|droperidol|mesh-list
101454306|NCT00209885|Ketamine|ketamine|mesh-list
101454307|NCT00209885|Gabapentin|gabapentin|mesh-list
101454308|NCT00209885|Esketamine|esketamine|mesh-list
101454309|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
101454310|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
101454311|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454312|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454313|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
101454314|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454315|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101308612|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101308613|NCT00005883|Protective Agents|protective agents|mesh-ancestor
101308614|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308615|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308617|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101308618|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
101308619|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308620|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308621|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308622|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308623|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101308624|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101308625|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101454316|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101454317|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101454318|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454319|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454320|NCT00209885|Analgesics|analgesics|mesh-ancestor
101454321|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101454322|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101454323|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
101454324|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101454325|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101454326|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454327|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
101454328|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101454329|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454330|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454331|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
101454332|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454333|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101454334|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
101454335|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
101454336|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454337|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101454338|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101454339|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454340|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
101454341|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
101454342|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101454343|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101454344|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101454345|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454346|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454347|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
101454348|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454349|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454350|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101454351|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454352|NCT00209924|Gaboxadol|gaboxadol|mesh-list
101454353|NCT00209924|Analgesics|analgesics|mesh-ancestor
101454354|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
101454355|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454356|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454360|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454361|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454363|NCT00209963|Analgesics|analgesics|mesh-ancestor
101454364|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
101454365|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308627|NCT00005889|Glycerol|glycerol|mesh-list
101308628|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308629|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308630|NCT00005889|Hormones|hormones|mesh-ancestor
101308631|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308632|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101308633|NCT00005889|Protective Agents|protective agents|mesh-ancestor
101308634|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
101454366|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454367|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
101454368|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
101454369|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
101454370|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454371|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454372|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
101454373|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101454374|NCT00210002|Hematinics|hematinics|mesh-ancestor
101454375|NCT02277886|Esomeprazole|esomeprazole|mesh-list
101454376|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101454377|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454378|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101454379|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454380|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454381|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101454382|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101454383|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101454384|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101454385|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101454386|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101454387|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101454388|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101454389|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454390|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454391|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454392|NCT00210041|Gemcitabine|gemcitabine|mesh-list
101454393|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454394|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454395|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
101454396|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454397|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
101454398|NCT04990804|Analgesics|analgesics|mesh-list
101454399|NCT04990804|Narcotics|narcotics|mesh-ancestor
101454400|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411817|NCT00116402|Fluticasone|fluticasone|mesh-list
101454401|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454402|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
101454403|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454404|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
101454405|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101454406|NCT04991662|Phenylephrine|phenylephrine|mesh-list
101454407|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
101454408|NCT04991662|Norepinephrine|norepinephrine|mesh-list
101454409|NCT04991662|Metaraminol|metaraminol|mesh-list
101454410|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101454411|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
101454412|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
101454413|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454414|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454415|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
101454416|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101454417|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
101454418|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
101454419|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101454420|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101454421|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101454422|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
101454423|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308635|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308636|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
101454424|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454425|NCT04991662|Protective Agents|protective agents|mesh-ancestor
101454426|NCT04997941|Tamoxifen|tamoxifen|mesh-list
101454427|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101454428|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
101454429|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454432|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454433|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101454434|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101454435|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101454436|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
101454437|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101454438|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
101454440|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454441|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454442|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101454443|NCT00210158|Analgesics|analgesics|mesh-ancestor
101454444|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
101454445|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454446|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101454447|NCT00413790|Darifenacin|darifenacin|mesh-list
101454448|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101454449|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101454450|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
101454451|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454452|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454453|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454454|NCT00413790|Urological Agents|urological agents|mesh-ancestor
101454455|NCT01059903|Rotigotine|rotigotine|mesh-list
101454456|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
101454457|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
101454458|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454459|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454460|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454462|NCT04996771|Etoposide|etoposide|mesh-list
101454463|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
101454464|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454465|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101454466|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101454467|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454468|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454469|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454470|NCT00210314|Cytarabine|cytarabine|mesh-list
101454471|NCT00210314|Methotrexate|methotrexate|mesh-list
101454472|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101454473|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
101454474|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101454475|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454476|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454477|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
101454478|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454479|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454480|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
101454481|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454482|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101454483|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454484|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
101454485|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454486|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101454487|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
101454488|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454489|NCT00210392|Bortezomib|bortezomib|mesh-list
101454490|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454491|NCT00413829|Ranibizumab|ranibizumab|mesh-list
101454492|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454493|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101454494|NCT00413829|Growth Substances|growth substances|mesh-ancestor
101308637|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308638|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454495|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454496|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
101454497|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454498|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
101454499|NCT02210104|Ipilimumab|ipilimumab|mesh-list
101454500|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454501|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
101454503|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454504|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101454505|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
101454506|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454507|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454508|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101454509|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101454510|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101454511|NCT02210182|Pentamidine|pentamidine|mesh-list
101454512|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
101409146|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101454513|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454514|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101454515|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101454516|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101454517|NCT00210509|Almotriptan|almotriptan|mesh-list
101454519|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
101454520|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454521|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454522|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454523|NCT02210260|Heroin|heroin|mesh-list
101454524|NCT02210260|Bupivacaine|bupivacaine|mesh-list
101454525|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
101454526|NCT02210260|Anesthetics|anesthetics|mesh-list
101454527|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454528|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454529|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
101454530|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454531|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101454532|NCT02210260|Narcotics|narcotics|mesh-ancestor
101454533|NCT02210260|Analgesics|analgesics|mesh-ancestor
101454534|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101454535|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101454536|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454537|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454538|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409152|NCT00144183|Zidovudine|zidovudine|mesh-list
101454539|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454540|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101454541|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101454542|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
101454543|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454544|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454545|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101454546|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454547|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
101454548|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
101454549|NCT00210587|Hematinics|hematinics|mesh-ancestor
101454550|NCT00210665|Trabectedin|trabectedin|mesh-list
101454551|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101454552|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
101454553|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454554|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454555|NCT04570345|Aspirin|aspirin|mesh-list
101454557|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101454558|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101454559|NCT04570345|Analgesics|analgesics|mesh-ancestor
101454560|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
101454561|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454562|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454563|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101454564|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454565|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101454566|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101308639|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308640|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
101308641|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454567|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454568|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101454569|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101454570|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454572|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101454573|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101454574|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101246482|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454581|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454582|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454583|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101454584|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101454585|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
101454586|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101454588|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454589|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
101454590|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454591|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
101454592|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101454593|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454595|NCT00234858|Verapamil|verapamil|mesh-list
101454596|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101454597|NCT00234858|Trandolapril|trandolapril|mesh-list
101454598|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101454599|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101454600|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101454601|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101454602|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454603|NCT00234858|Diuretics|diuretics|mesh-ancestor
101454604|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
101454605|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454606|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101454607|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454608|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101454609|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101454610|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
101454611|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101454612|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
101454613|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454614|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101454615|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101454616|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
101454617|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454618|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454619|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
101454620|NCT00210743|Hematinics|hematinics|mesh-ancestor
101454621|NCT04569916|Irinotecan|irinotecan|mesh-list
101454622|NCT04569916|Apatinib|apatinib|mesh-list
101454623|NCT04569916|Antibodies|antibodies|mesh-list
101454624|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
101454625|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454626|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101454627|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454628|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454629|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454630|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454631|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454632|NCT00210782|Topiramate|topiramate|mesh-list
101454633|NCT00210782|Phenytoin|phenytoin|mesh-list
101454634|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
101454635|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454636|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454637|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101454638|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101308642|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308643|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101454639|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454640|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454641|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101454642|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409205|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
101409207|NCT00466102|Everolimus|everolimus|mesh-list
101454663|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454664|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454665|NCT00237900|Leucovorin|leucovorin|mesh-list
101454666|NCT00237900|Fluorouracil|fluorouracil|mesh-list
101454667|NCT00237900|Gefitinib|gefitinib|mesh-list
101454668|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
101454669|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454670|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454671|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454672|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454673|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
101454674|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454675|NCT00237900|Antidotes|antidotes|mesh-ancestor
101454676|NCT00237900|Protective Agents|protective agents|mesh-ancestor
101454677|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
101454678|NCT00237900|Vitamins|vitamins|mesh-ancestor
101454679|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
101454680|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454681|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454682|NCT00210821|Topiramate|topiramate|mesh-list
101454683|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
101454684|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454685|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454686|NCT00237939|Aripiprazole|aripiprazole|mesh-list
101454687|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
101454688|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454689|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101454690|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454691|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454692|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454693|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
101454694|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
101454695|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454696|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535405|NCT00575549|Dobutamine|dobutamine|mesh-list
101454697|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101454707|NCT00210860|Topiramate|topiramate|mesh-list
101454708|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
101454709|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454710|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454711|NCT00210899|Vancomycin|vancomycin|mesh-list
101454712|NCT00210899|Ceftazidime|ceftazidime|mesh-list
101454713|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
101454714|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101454715|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101454716|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454717|NCT04568863|Melatonin|melatonin|mesh-list
101454718|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
101454719|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454720|NCT04568863|Protective Agents|protective agents|mesh-ancestor
101454721|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454722|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454723|NCT00210938|Doripenem|doripenem|mesh-list
101454724|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101454725|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454726|NCT02278081|Lansoprazole|lansoprazole|mesh-list
101454727|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
101454728|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101454729|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454730|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101454731|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454732|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454733|NCT00211016|Doripenem|doripenem|mesh-list
101454734|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101454735|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454736|NCT00238017|Artesunate|artesunate|mesh-list
101454737|NCT00238017|Amodiaquine|amodiaquine|mesh-list
101308645|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
101308646|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
101308647|NCT00005898|Fludarabine|fludarabine|mesh-list
101308648|NCT00005898|Cyclosporins|cyclosporins|mesh-list
101454738|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
101454739|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101454740|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101454741|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454742|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535406|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101454743|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
101454744|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
101454745|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101454746|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
101454747|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
101454748|NCT00238056|Domperidone|domperidone|mesh-list
101454749|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
101454750|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
101454751|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454752|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454753|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454754|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454755|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
101454756|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454757|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454758|NCT04566952|Olaparib|olaparib|mesh-list
101454759|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101454760|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454761|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454762|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454763|NCT04567069|Vaccines|vaccines|mesh-list
101454764|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
101454765|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454772|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454773|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101454774|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
101454775|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454776|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
101454777|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
101454778|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
101454779|NCT00238173|Carboplatin|carboplatin|mesh-list
101454780|NCT00238173|Etoposide|etoposide|mesh-list
101454781|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
101454782|NCT00238173|Mannitol|mannitol|mesh-list
101454783|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101454784|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454785|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
101454786|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454787|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454788|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101454789|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
101454790|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454791|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454792|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101454793|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101454794|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101454795|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454796|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454797|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
101454798|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454799|NCT00238173|Expectorants|expectorants|mesh-ancestor
101454800|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
101454801|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101454802|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
101454803|NCT00238173|Protective Agents|protective agents|mesh-ancestor
101454804|NCT00238173|Antidotes|antidotes|mesh-ancestor
101454805|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101454806|NCT00238173|Diuretics|diuretics|mesh-ancestor
101454807|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
101454808|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
101454809|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101454810|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
101454811|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
101454812|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
101454813|NCT00211133|Hematinics|hematinics|mesh-ancestor
101454814|NCT00238212|Sorafenib|sorafenib|mesh-list
101454815|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308650|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308651|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
101454816|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454818|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454819|NCT00211250|Valproic Acid|valproic acid|mesh-list
101454820|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
101454821|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454822|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454823|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
101454824|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454825|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454826|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
101454827|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454828|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454829|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454830|NCT00238251|Temozolomide|temozolomide|mesh-list
101454832|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101454833|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
101454834|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454835|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454836|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101454844|NCT02210884|Vitamins|vitamins|mesh-list
101454845|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
101454846|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454847|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101454848|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101454849|NCT00238290|Trastuzumab|trastuzumab|mesh-list
101454850|NCT00238290|Letrozole|letrozole|mesh-list
101454851|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101454852|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454853|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101454854|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101454855|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454856|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454857|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101454858|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
101454859|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454860|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454861|NCT00211328|Anecortave|anecortave|mesh-list
101454862|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454863|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101454864|NCT00211328|Growth Substances|growth substances|mesh-ancestor
101454865|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454866|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
101454868|NCT00238329|Interferons|interferons|mesh-list
101454869|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
101454870|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
101454871|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101454872|NCT00238329|Thalidomide|thalidomide|mesh-list
101454873|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454874|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
101454875|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454876|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
101454877|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454878|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454879|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
101454880|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535434|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
101454881|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454882|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101454883|NCT00238329|Growth Substances|growth substances|mesh-ancestor
101454884|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101454885|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
101454886|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
101454887|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454888|NCT00211367|Anecortave|anecortave|mesh-list
101454889|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454890|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101454891|NCT00211367|Growth Substances|growth substances|mesh-ancestor
101308652|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308654|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308655|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
101454892|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454893|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
101454894|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454895|NCT00238368|Cytarabine|cytarabine|mesh-list
101454896|NCT00238368|Prednisone|prednisone|mesh-list
101454897|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
101454898|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
101454899|NCT00238368|Busulfan|busulfan|mesh-list
101454900|NCT00238368|Rituximab|rituximab|mesh-list
101454901|NCT00238368|Doxorubicin|doxorubicin|mesh-list
101454902|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101454903|NCT00238368|Etoposide|etoposide|mesh-list
101454904|NCT00238368|Vincristine|vincristine|mesh-list
101454905|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101454906|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454907|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
101454908|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454909|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101454912|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454913|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454914|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101454915|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101454916|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101454917|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101454918|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101454919|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454920|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101454921|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
101454922|NCT00238368|Hormones|hormones|mesh-ancestor
101454923|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101454924|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101454925|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101454926|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101454927|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
101454928|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
101454929|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454930|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454931|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454932|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454933|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
101454934|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
101454935|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454936|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454937|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101454938|NCT00238368|Protective Agents|protective agents|mesh-ancestor
101454939|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101454940|NCT02894593|Ethanol|ethanol|mesh-list
101454941|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
101454942|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101454943|NCT02894593|Listerine|listerine|mesh-list
101454944|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
101454945|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101454946|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454947|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454948|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454949|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
101454950|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101454951|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
101454952|NCT02894593|Protective Agents|protective agents|mesh-ancestor
101454953|NCT00211406|Anecortave|anecortave|mesh-list
101454954|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454955|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101454956|NCT00211406|Growth Substances|growth substances|mesh-ancestor
101454957|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454958|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101454959|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454960|NCT02894554|Lamivudine|lamivudine|mesh-list
101454961|NCT02894554|Telbivudine|telbivudine|mesh-list
101308656|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308657|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308658|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308659|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308660|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
101454962|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101454963|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101454964|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454965|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454966|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
101454967|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101454968|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101454969|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101454971|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101454972|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101454973|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101454974|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101454975|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454976|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
101454977|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101454978|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
101454979|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454980|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454981|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454985|NCT02894710|Lidocaine|lidocaine|mesh-list
101454986|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
101454987|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
101454988|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454989|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454990|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
101454991|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454992|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101454993|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101454994|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101454995|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101454996|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454998|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101454999|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101455000|NCT00211484|Growth Substances|growth substances|mesh-ancestor
101455001|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455002|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101455003|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455004|NCT05428072|Aspirin|aspirin|mesh-list
101455005|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455006|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455007|NCT05428072|Analgesics|analgesics|mesh-ancestor
101455008|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
101455009|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455010|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455011|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455012|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455013|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101455014|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101455015|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455016|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101455017|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101455018|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455019|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
101455020|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
101455021|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455022|NCT00211562|Vitamin E|vitamin e|mesh-list
101455023|NCT00211562|Olanzapine|olanzapine|mesh-list
101455024|NCT00211562|Vitamins|vitamins|mesh-ancestor
101455025|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
101455027|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
101308661|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308662|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
101308663|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101308664|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308665|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
101308666|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
101308667|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308668|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308669|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
101308670|NCT00005898|Hormones|hormones|mesh-ancestor
101333875|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455028|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
101455029|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455030|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455031|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101455032|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101455033|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455034|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455035|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101455036|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455037|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535465|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
101455038|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455039|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455040|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
101455041|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
101455042|NCT00211562|Protective Agents|protective agents|mesh-ancestor
101455044|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455045|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101455046|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
101455047|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101455048|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
101455049|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101455050|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101455051|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101455052|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455055|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455056|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455057|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101455058|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455059|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101455060|NCT05427175|Methotrexate|methotrexate|mesh-list
101455061|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101455062|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
101455063|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101455064|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455065|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455066|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
101455067|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455068|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455069|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
101409419|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101409420|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455070|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455071|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101455072|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455073|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
101455074|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455075|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101455076|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
101455077|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101455078|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101455079|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101411845|NCT00116480|Misoprostol|misoprostol|mesh-list
101455080|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101308671|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455081|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455083|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455084|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455085|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101455086|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455088|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455089|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455090|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101455091|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101455092|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
101455093|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455094|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101455095|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101409477|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101455096|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101455097|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101455098|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101455099|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101455100|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
101455101|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101455102|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101455103|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101409478|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101455104|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455105|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455106|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
101455107|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455108|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455109|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101455110|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455111|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101455112|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101455113|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455114|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455115|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455116|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455117|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455118|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101455119|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
101455125|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
101455126|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455127|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455128|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
101455129|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455130|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455131|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
101455132|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409503|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455133|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455134|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455135|NCT05426824|Pegaspargase|pegaspargase|mesh-list
101455136|NCT05426824|Asparaginase|asparaginase|mesh-list
101455137|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455138|NCT00238797|Gefitinib|gefitinib|mesh-list
101455139|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455140|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409504|NCT00421447|Anastrozole|anastrozole|mesh-list
101409505|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101455141|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455142|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455143|NCT05426044|Metformin|metformin|mesh-list
101455144|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101455145|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455146|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
101455147|NCT05425654|Busulfan|busulfan|mesh-list
101455148|NCT05425654|Carmustine|carmustine|mesh-list
101455149|NCT05425654|Rituximab|rituximab|mesh-list
101455150|NCT05425654|Methotrexate|methotrexate|mesh-list
101455151|NCT05425654|Vincristine|vincristine|mesh-list
101455152|NCT05425654|Lenalidomide|lenalidomide|mesh-list
101455153|NCT05425654|Procarbazine|procarbazine|mesh-list
101455154|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455155|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
101455156|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308672|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101308673|NCT00005898|Protective Agents|protective agents|mesh-ancestor
101308674|NCT00386412|Valganciclovir|valganciclovir|mesh-list
101308675|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
101308676|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308677|NCT00386529|Aspirin|aspirin|mesh-list
101308678|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101308679|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101308680|NCT00386529|Analgesics|analgesics|mesh-ancestor
101308681|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
101308682|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308683|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308684|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308685|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308686|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101308687|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101308688|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455157|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455158|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101455159|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
101455160|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455161|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455163|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455164|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101455165|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
101455166|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101455167|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455168|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
101455169|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455170|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455171|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101455172|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101455173|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101455174|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
101455175|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
101455176|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
101455177|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101455178|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101455179|NCT05425654|Growth Substances|growth substances|mesh-ancestor
101455180|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
101455181|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
101455182|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455183|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455184|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101455185|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455187|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101455188|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101455189|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455190|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
101455206|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101455208|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455209|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455210|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
101455211|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101308689|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101308690|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101308691|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308693|NCT00005922|Triamcinolone|triamcinolone|mesh-list
101308694|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101308695|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101308696|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101308697|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308698|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
101455212|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455213|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101455214|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
101455215|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455216|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455217|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455218|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455219|NCT04669366|Sunitinib|sunitinib|mesh-list
101455220|NCT04669366|Axitinib|axitinib|mesh-list
101455221|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455222|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409563|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
101409564|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455223|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101455224|NCT04669366|Growth Substances|growth substances|mesh-ancestor
101455225|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455226|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
101455227|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101455228|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455229|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455230|NCT04721301|Maraviroc|maraviroc|mesh-list
101455231|NCT04721301|Nivolumab|nivolumab|mesh-list
101455232|NCT04721301|Ipilimumab|ipilimumab|mesh-list
101455233|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455234|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455235|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101455236|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455237|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101455238|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101455239|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101455240|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101455241|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
101455242|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455243|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101455244|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
101455245|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101455246|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455247|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101455248|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
101455249|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455250|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455251|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455252|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455267|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
101455269|NCT04668469|Azithromycin|azithromycin|mesh-list
101455270|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
101455271|NCT04668469|Ivermectin|ivermectin|mesh-list
101455272|NCT04668469|Lactoferrin|lactoferrin|mesh-list
101455273|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
101455274|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
101455275|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455276|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455277|NCT04668469|Analgesics|analgesics|mesh-ancestor
101455278|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
101455279|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455280|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
101455281|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101308700|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308701|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308702|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308703|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
101308704|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308705|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308706|NCT00005925|Muscimol|muscimol|mesh-list
101308707|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101308708|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
101308709|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
101308710|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101308711|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246483|NCT01666262|Vaccines|vaccines|mesh-list
101308712|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308713|NCT00005928|Ramipril|ramipril|mesh-list
101308714|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101308715|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
101455282|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455283|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
101455284|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101455285|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101455286|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455287|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455288|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455289|NCT04668469|Trace Elements|trace elements|mesh-ancestor
101455290|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
101455291|NCT04668469|Protective Agents|protective agents|mesh-ancestor
101455292|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101455293|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101455294|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
101455295|NCT04668469|Coagulants|coagulants|mesh-ancestor
101455296|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
101455297|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101455298|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455299|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101455300|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
101455301|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455302|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455303|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455304|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455305|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
101455306|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101455307|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455308|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101455309|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
101455310|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455311|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455312|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455313|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455315|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455316|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455317|NCT00211952|Analgesics|analgesics|mesh-ancestor
101455325|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455326|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455327|NCT00239109|Olanzapine|olanzapine|mesh-list
101455328|NCT00239109|Ziprasidone|ziprasidone|mesh-list
101455329|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
101455330|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
101308716|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308717|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308718|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101308719|NCT00005931|Semaxinib|semaxinib|mesh-list
101308720|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101308721|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101308722|NCT00005931|Growth Substances|growth substances|mesh-ancestor
101308723|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455331|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455332|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455333|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455334|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101455335|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101455336|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455337|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455338|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101455339|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455340|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455341|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455342|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455343|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
101455344|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101455346|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
101455347|NCT00212030|Nicorandil|nicorandil|mesh-list
101455349|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101455350|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
101455351|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
101455352|NCT00212030|Vitamins|vitamins|mesh-ancestor
101455353|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
101455354|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455355|NCT00212069|Carboplatin|carboplatin|mesh-list
101455356|NCT00212069|Gemcitabine|gemcitabine|mesh-list
101455357|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455358|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455359|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
101455360|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455361|NCT00212108|Celecoxib|celecoxib|mesh-list
101455362|NCT00212108|Gefitinib|gefitinib|mesh-list
101455363|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455364|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455365|NCT00212108|Analgesics|analgesics|mesh-ancestor
101455366|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
101455367|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455368|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455369|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455370|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455371|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101455372|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101455373|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455374|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455375|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455376|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101455377|NCT00212186|Selenium|selenium|mesh-list
101455378|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
101455379|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455380|NCT00212186|Protective Agents|protective agents|mesh-ancestor
101455381|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455382|NCT00212186|Trace Elements|trace elements|mesh-ancestor
101455383|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
101455384|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101455385|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101455386|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
101455389|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455390|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455391|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101308724|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
101308725|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308726|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101308727|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308728|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308729|NCT00005934|Azacitidine|azacitidine|mesh-list
101308730|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308731|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
101308732|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308733|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308734|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455392|NCT00212342|Norethindrone|norethindrone|mesh-list
101455393|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
101455394|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101455395|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101455396|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101455397|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
101455398|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101455399|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455400|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101455401|NCT00212342|Estrogens|estrogens|mesh-ancestor
101455402|NCT00212342|Hormones|hormones|mesh-ancestor
101455403|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455404|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101455405|NCT00414414|Prednisone|prednisone|mesh-list
101455406|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455407|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
101455408|NCT00414414|Hormones|hormones|mesh-ancestor
101455409|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455410|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455411|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101455412|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455414|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455415|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101455416|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455417|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455419|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455420|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101455421|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455422|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455423|NCT00411593|Bevacizumab|bevacizumab|mesh-list
101455424|NCT00411593|Bortezomib|bortezomib|mesh-list
101455425|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455426|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455427|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101455428|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101455429|NCT00411593|Growth Substances|growth substances|mesh-ancestor
101455430|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455431|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
101455432|NCT00239382|Meloxicam|meloxicam|mesh-list
101455433|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455434|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455435|NCT00239382|Analgesics|analgesics|mesh-ancestor
101455436|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
101455437|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455438|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455439|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455440|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455441|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101455442|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101308736|NCT00005940|Cyclosporine|cyclosporine|mesh-list
101308737|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
101455443|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455444|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455445|NCT00239421|Fluticasone|fluticasone|mesh-list
101455446|NCT00239421|Xhance|xhance|mesh-list
101455447|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
101455448|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
101455449|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101455450|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455451|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101455452|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
101455453|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455454|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455455|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101455456|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
101455457|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455458|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101455463|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455464|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455465|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
101455466|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101455467|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
101455468|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
101455469|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101455470|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
101455471|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455472|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455473|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101455474|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
101455475|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
101455476|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101455477|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
101455478|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455479|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455480|NCT00239499|Fluticasone|fluticasone|mesh-list
101455481|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
101455482|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101455483|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455484|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101455485|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
101455486|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455487|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455488|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101455489|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
101455490|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455491|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101455492|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
101455493|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101455495|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528424|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101455496|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455497|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101455498|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101455500|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455501|NCT00212615|Capecitabine|capecitabine|mesh-list
101455502|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
101455503|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455504|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
101409757|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455505|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455506|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455507|NCT00222573|Metoprolol|metoprolol|mesh-list
101455508|NCT00222573|Clopidogrel|clopidogrel|mesh-list
101455509|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101455510|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101455511|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101455512|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101409773|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455513|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
101455514|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455515|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308739|NCT00005940|Methotrexate|methotrexate|mesh-list
101308740|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101308741|NCT00005940|Cyclosporins|cyclosporins|mesh-list
101308742|NCT00005940|Antibodies|antibodies|mesh-list
101308743|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
101308744|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101308745|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308746|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
101308747|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308748|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455516|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455517|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101455518|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101455519|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
101455520|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
101455521|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455522|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101221706|NCT01509001|Glimepiride|glimepiride|mesh-list
101455523|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101455524|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101455525|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455526|NCT00212654|Landiolol|landiolol|mesh-list
101455530|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455531|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455532|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455533|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101455534|NCT00239538|Valsartan|valsartan|mesh-list
101455535|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101455537|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101455538|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101455539|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101221763|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455540|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455541|NCT00239538|Diuretics|diuretics|mesh-ancestor
101455542|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
101455543|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455544|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101455545|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455546|NCT00212810|Topiramate|topiramate|mesh-list
101455547|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
101455548|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101455549|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455550|NCT00222651|Tenecteplase|tenecteplase|mesh-list
101455551|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101455552|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101455553|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455554|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101455555|NCT00239616|Hematinics|hematinics|mesh-ancestor
101455556|NCT00213122|Miglitol|miglitol|mesh-list
101455557|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455558|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455559|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101455560|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455561|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101455563|NCT00213200|Tetracaine|tetracaine|mesh-list
101455564|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101455565|NCT00213200|Narcotics|narcotics|mesh-ancestor
101455566|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455567|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455568|NCT00213200|Analgesics|analgesics|mesh-ancestor
101455569|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
101455570|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455571|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
101308749|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308750|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
101308751|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308752|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308753|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308754|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101308755|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
101308756|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101308757|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308759|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
101308760|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308761|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101308762|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308763|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
101308764|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308765|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101308766|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101308767|NCT00005940|Trace Elements|trace elements|mesh-ancestor
101308768|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
101308769|NCT00005943|Aldesleukin|aldesleukin|mesh-list
101308770|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308772|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101308773|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
101308774|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308775|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
101308777|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308778|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
101308779|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308780|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308781|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308782|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
101308783|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308784|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308785|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101455572|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
101308786|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308787|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101308788|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308789|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308790|NCT00005949|Aldesleukin|aldesleukin|mesh-list
101455573|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101455574|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101455575|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455576|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455577|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
101455578|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455579|NCT00213278|Vinblastine|vinblastine|mesh-list
101455580|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101455581|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455582|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101455583|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101455584|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101455585|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455587|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
101455588|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101455590|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101455591|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455592|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101455593|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
101455594|NCT00239967|Rimonabant|rimonabant|mesh-list
101455595|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101455596|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101455597|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101455604|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101455605|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455606|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
101455607|NCT00213512|Rituximab|rituximab|mesh-list
101455608|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455609|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455610|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
101455611|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455612|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455613|NCT00213551|Antioxidants|antioxidants|mesh-list
101455614|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455615|NCT00213551|Protective Agents|protective agents|mesh-ancestor
101455616|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455617|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101455618|NCT00213590|Cyclosporine|cyclosporine|mesh-list
101455619|NCT00213590|Cyclosporins|cyclosporins|mesh-list
101455620|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455621|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455622|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455623|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
101455624|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455625|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
101455626|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455627|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455628|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455629|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101455630|NCT00240045|Octreotide|octreotide|mesh-list
101455631|NCT00240045|Midodrine|midodrine|mesh-list
101455632|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455633|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101455634|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455636|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
101455637|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455638|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455639|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101455640|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101455641|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101455642|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101308791|NCT00005949|Interleukin-2|interleukin-2|mesh-list
101308792|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308793|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455643|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455644|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455645|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455646|NCT00243672|Atorvastatin|atorvastatin|mesh-list
101455647|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
101455648|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101455649|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101455650|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
101455651|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455652|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101455653|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101455654|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455655|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101455656|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101455657|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101455658|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
101455659|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455660|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101455662|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101455663|NCT00243711|Protective Agents|protective agents|mesh-ancestor
101455668|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101455670|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455671|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455672|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
101455673|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
101455674|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
101455675|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455676|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
101455677|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
101455678|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455679|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101455680|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
101455681|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
101455682|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455683|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455684|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101455685|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101455686|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101455687|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101455688|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
101455689|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455690|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101455691|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101455692|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455693|NCT00243750|Methotrexate|methotrexate|mesh-list
101455694|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101455695|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
101455696|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101455697|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455698|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455700|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455701|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455702|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455703|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455704|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101246484|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
101455705|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455706|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
101455707|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455708|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101455709|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
101455710|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101455711|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455712|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455713|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101308794|NCT00005949|Analgesics|analgesics|mesh-ancestor
101308795|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
101308796|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308797|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308798|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101308799|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101308800|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
101308801|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308802|NCT00005952|Temozolomide|temozolomide|mesh-list
101308803|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308804|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
101308805|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308806|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308807|NCT00005955|Temozolomide|temozolomide|mesh-list
101411882|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
101308808|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308809|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
101308810|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308811|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308812|NCT00005958|Gemcitabine|gemcitabine|mesh-list
101308813|NCT00005958|Docetaxel|docetaxel|mesh-list
101308814|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409990|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455715|NCT00243789|Protective Agents|protective agents|mesh-ancestor
101455716|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455717|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
101455718|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101455719|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
101455720|NCT00214058|Carboplatin|carboplatin|mesh-list
101455721|NCT00214058|Docetaxel|docetaxel|mesh-list
101455722|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455723|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
101455724|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
101455725|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
101455726|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455727|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101455728|NCT00240318|Calcium|calcium|mesh-list
101455729|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101455730|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455731|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101455732|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101455733|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
101455736|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101455737|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455738|NCT00243945|Rotigotine|rotigotine|mesh-list
101455739|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
101455740|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
101455741|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455742|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455743|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455744|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
101455745|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101455746|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455747|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101308815|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
101308816|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308817|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308819|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308820|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308821|NCT00005961|Carmustine|carmustine|mesh-list
101455748|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101455749|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455750|NCT00240396|Narcotics|narcotics|mesh-list
101455751|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455752|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455753|NCT00240396|Analgesics|analgesics|mesh-ancestor
101455754|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
101455755|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455756|NCT00214331|Azithromycin|azithromycin|mesh-list
101455757|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
101455758|NCT00214331|Gentamicins|gentamicins|mesh-list
101455759|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455760|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455761|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101455762|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101455763|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455764|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455765|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455766|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101455767|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101455768|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101455769|NCT00243984|Topiramate|topiramate|mesh-list
101455770|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
101455771|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101455772|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455773|NCT00214370|Fentanyl|fentanyl|mesh-list
101455774|NCT00214370|Propofol|propofol|mesh-list
101455775|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101455776|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455777|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455778|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101455779|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
101455780|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
101455781|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101455782|NCT00214370|Narcotics|narcotics|mesh-ancestor
101455783|NCT00214370|Analgesics|analgesics|mesh-ancestor
101455784|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
101455785|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455786|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101455787|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101455788|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
101455789|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101455790|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
101455791|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455792|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455793|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101455794|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101455795|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
101455796|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101455797|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
101455798|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455799|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455800|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
101455802|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
101455803|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
101455804|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101455806|NCT00244023|Hormones|hormones|mesh-ancestor
101455818|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455819|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101455820|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308823|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308824|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
101455821|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
101455822|NCT00240474|Diuretics|diuretics|mesh-ancestor
101455823|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
101455824|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101455825|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101455826|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101455828|NCT00214604|Pravastatin|pravastatin|mesh-list
101455829|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101455830|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101455831|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
101455832|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455833|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101455834|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101455835|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455836|NCT00214643|Clindamycin|clindamycin|mesh-list
101455837|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
101455838|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
101455840|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455841|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455842|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101455843|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455844|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455845|NCT00414531|Atorvastatin|atorvastatin|mesh-list
101455846|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101455847|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101455848|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
101455849|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455850|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101455851|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101455852|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455854|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
101455855|NCT00214682|Vitamins|vitamins|mesh-ancestor
101455856|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
101455857|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455858|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
101455859|NCT00214682|Hematinics|hematinics|mesh-ancestor
101455860|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
101455861|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101455862|NCT00240513|Minocycline|minocycline|mesh-list
101455863|NCT00240513|Tretinoin|tretinoin|mesh-list
101455864|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101455865|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455866|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455867|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
101455868|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455869|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
101455872|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
101455873|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455874|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455875|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101455876|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101455877|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
101455878|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455880|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455881|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455882|NCT00214955|Fentanyl|fentanyl|mesh-list
101455883|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101455884|NCT00214955|Narcotics|narcotics|mesh-ancestor
101455885|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455886|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455887|NCT00214955|Analgesics|analgesics|mesh-ancestor
101455888|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
101455889|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455890|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101455891|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101455892|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
101455893|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
101308825|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308826|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308827|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308828|NCT00005964|Prednisone|prednisone|mesh-list
101308829|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
101308830|NCT00005964|Doxorubicin|doxorubicin|mesh-list
101308831|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101455894|NCT00244179|Interferons|interferons|mesh-list
101455895|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
101455896|NCT00244179|Infliximab|infliximab|mesh-list
101455897|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455898|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
101455899|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455900|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101455901|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455902|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455903|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455904|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455906|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
101455907|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101455908|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455909|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455910|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455911|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
101455912|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455913|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455915|NCT00240630|Sumatriptan|sumatriptan|mesh-list
101455916|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455917|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455918|NCT00240630|Analgesics|analgesics|mesh-ancestor
101455919|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
101455920|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455921|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455922|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455923|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455924|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
101455925|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101455926|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455927|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455928|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101455929|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101455930|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101455931|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
101455932|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455933|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101455934|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101455935|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455936|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455937|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455938|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455939|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455940|NCT00244296|Analgesics|analgesics|mesh-ancestor
101455941|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
101455998|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455999|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101456000|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456001|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456002|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
101456003|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101456004|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
101456005|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456006|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308834|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308835|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
101308836|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456007|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101456008|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456009|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101456010|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101456011|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101456012|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456013|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456024|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101456025|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456026|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456027|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456028|NCT04668352|Dactolisib|dactolisib|mesh-list
101456029|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456030|NCT00215462|Vinorelbine|vinorelbine|mesh-list
101456031|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101456032|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456033|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456034|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456035|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456036|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410202|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101456037|NCT00215501|Fluorouracil|fluorouracil|mesh-list
101456038|NCT00215501|Capecitabine|capecitabine|mesh-list
101456039|NCT00215501|Irinotecan|irinotecan|mesh-list
101456040|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456041|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
101456042|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456043|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456044|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456045|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
101456046|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456047|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101456048|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101456049|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456050|NCT00240786|Acetaminophen|acetaminophen|mesh-list
101456051|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101456052|NCT00240786|Analgesics|analgesics|mesh-ancestor
101456053|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
101456054|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456055|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456056|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
101456057|NCT00215579|Risperidone|risperidone|mesh-list
101456058|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101456059|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
101456060|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456061|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456062|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456063|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101456064|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456065|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456066|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456067|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101456068|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
101456069|NCT00556621|Gemcitabine|gemcitabine|mesh-list
101456070|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456071|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456072|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
101456073|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456075|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101456076|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
101456077|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101456080|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535570|NCT00197106|Xhance|xhance|mesh-list
101456082|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456083|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456084|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
101456085|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456086|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456087|NCT00411866|Ketoconazole|ketoconazole|mesh-list
101308837|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308838|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308840|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308841|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308842|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308843|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101456088|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
101456089|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456090|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101456091|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101456092|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456093|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456094|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101456095|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456096|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456097|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456098|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101456100|NCT04667299|Metronidazole|metronidazole|mesh-list
101456101|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
101456102|NCT04667299|Rabeprazole|rabeprazole|mesh-list
101456103|NCT04667299|Bismuth|bismuth|mesh-list
101456104|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456105|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456106|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456107|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101456108|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101535600|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
101456109|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101456110|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456111|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101456112|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456114|NCT04667299|Diuretics|diuretics|mesh-ancestor
101456115|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
101456116|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456117|NCT04667299|Expectorants|expectorants|mesh-ancestor
101456118|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456119|NCT04667143|Metformin|metformin|mesh-list
101456120|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456121|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456122|NCT00240825|Acetaminophen|acetaminophen|mesh-list
101456123|NCT00240825|Ibuprofen|ibuprofen|mesh-list
101456124|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101456125|NCT00240825|Analgesics|analgesics|mesh-ancestor
101456126|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
101456127|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456128|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456129|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
101456130|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101456131|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456132|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456133|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101456134|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456135|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456136|NCT04666675|Upadacitinib|upadacitinib|mesh-list
101456137|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101456138|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101456139|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456140|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456141|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456142|NCT00244530|Nifedipine|nifedipine|mesh-list
101456143|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101456144|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456145|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456146|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101308844|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535636|NCT00587496|Analgesics|analgesics|mesh-ancestor
101308845|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308846|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456147|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456148|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
101456149|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
101456157|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
101456158|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535659|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456159|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456161|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101456162|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456163|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456164|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101456165|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456166|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456168|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101456169|NCT00557011|Adderall|adderall|mesh-list
101456170|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101456171|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456172|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
101456173|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
101456174|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456175|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
101456176|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456177|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456178|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456179|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101456180|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101456181|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456182|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101456183|NCT04666324|Simethicone|simethicone|mesh-list
101456184|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
101456185|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456186|NCT04666324|Emollients|emollients|mesh-ancestor
101456187|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101456189|NCT04720833|Calcium|calcium|mesh-list
101456190|NCT04720833|Vitamins|vitamins|mesh-ancestor
101456191|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
101456192|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456193|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101456194|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101456195|NCT00244608|Budesonide|budesonide|mesh-list
101456196|NCT00244608|Terbutaline|terbutaline|mesh-list
101456197|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
101456198|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456199|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101456200|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
101456201|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456202|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456203|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101456204|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456205|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
101456206|NCT00244608|Hormones|hormones|mesh-ancestor
101456207|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456208|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101456209|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101456210|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101456211|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456212|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411895|NCT00464347|Bevacizumab|bevacizumab|mesh-list
101456213|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456214|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
101456215|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
101456216|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101456217|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
101456218|NCT04666168|Fludarabine|fludarabine|mesh-list
101456225|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456226|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456227|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308848|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
101456229|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101456230|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101456231|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101456232|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456233|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456234|NCT00240942|Letrozole|letrozole|mesh-list
101456235|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456236|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101456237|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101456238|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456239|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456240|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101456241|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456242|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456243|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456244|NCT00215891|Interferons|interferons|mesh-list
101456245|NCT00215891|Ribavirin|ribavirin|mesh-list
101456246|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456247|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
101456248|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456249|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
101456250|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456251|NCT02961816|Pyridoxine|pyridoxine|mesh-list
101456252|NCT02961816|Dexamethasone|dexamethasone|mesh-list
101456253|NCT02961816|Rituximab|rituximab|mesh-list
101456254|NCT02961816|Gemcitabine|gemcitabine|mesh-list
101456255|NCT02961816|Melphalan|melphalan|mesh-list
101456256|NCT02961816|Busulfan|busulfan|mesh-list
101456257|NCT02961816|Panobinostat|panobinostat|mesh-list
101456258|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456259|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456260|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
101456261|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456262|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456263|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456264|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
101456265|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
101456266|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456267|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456268|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
101456269|NCT02961816|Hormones|hormones|mesh-ancestor
101456270|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456271|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456272|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456273|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
101456274|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456275|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101456276|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
101456277|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101410335|NCT00425932|Rituximab|rituximab|mesh-list
101456278|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456279|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101456280|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456281|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
101456282|NCT02961816|Vitamins|vitamins|mesh-ancestor
101456283|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
101456284|NCT04665232|Progesterone|progesterone|mesh-list
101456285|NCT04665232|Progestins|progestins|mesh-ancestor
101456286|NCT04665232|Hormones|hormones|mesh-ancestor
101456287|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456294|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456295|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
101456296|NCT04665076|Fludarabine|fludarabine|mesh-list
101456297|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456298|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
101456299|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456300|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456301|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101456302|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
101456303|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456304|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308850|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308851|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308852|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308853|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308854|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308855|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101308857|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308858|NCT00005970|Tamoxifen|tamoxifen|mesh-list
101308859|NCT00005970|Paclitaxel|paclitaxel|mesh-list
101308860|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
101308861|NCT00005970|Doxorubicin|doxorubicin|mesh-list
101308862|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101308863|NCT00005970|Trastuzumab|trastuzumab|mesh-list
101308864|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101308865|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101308866|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101308867|NCT00005970|Antibodies|antibodies|mesh-list
101308868|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
101308869|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101308870|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101308871|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308872|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308873|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101308874|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101308875|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456305|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101456306|NCT00241020|Octreotide|octreotide|mesh-list
101456307|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456308|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456309|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456310|NCT00216047|Trastuzumab|trastuzumab|mesh-list
101410352|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101456311|NCT00216047|Vatalanib|vatalanib|mesh-list
101410353|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101456312|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456313|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456314|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101456315|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456316|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456317|NCT04665310|Tacrolimus|tacrolimus|mesh-list
101456318|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456319|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
101456320|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456321|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101456322|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456323|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456324|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
101456325|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101456326|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456327|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101456328|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
101456329|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101308876|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308877|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308878|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
101456330|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456331|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456332|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456333|NCT00216164|Rituximab|rituximab|mesh-list
101456334|NCT00216164|Gemcitabine|gemcitabine|mesh-list
101456335|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456336|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456337|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
101456338|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456339|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456340|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456341|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
101456342|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456343|NCT04664803|Cefdinir|cefdinir|mesh-list
101456344|NCT04664803|Cefetamet|cefetamet|mesh-list
101456345|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456346|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456347|NCT04664725|Repaglinide|repaglinide|mesh-list
101456348|NCT04664725|Bupropion|bupropion|mesh-list
101456349|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101456350|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
101456351|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456352|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101456353|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101456354|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456355|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456356|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
101456359|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101456360|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101456362|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456363|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
101456364|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
101456365|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
101456366|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456367|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456368|NCT00241098|Valsartan|valsartan|mesh-list
101456369|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101456370|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101456371|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101456372|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456373|NCT00216281|Clozapine|clozapine|mesh-list
101456374|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101456375|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101456376|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101456377|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456378|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456379|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456380|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456381|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456382|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101456383|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
101456384|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101456386|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456387|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456388|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
101456389|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
101456390|NCT00241137|Valsartan|valsartan|mesh-list
101456391|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101456392|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101456393|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101456394|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456395|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101456396|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
101456397|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
101308879|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535727|NCT00195429|Tacrolimus|tacrolimus|mesh-list
101308881|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101456398|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456399|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101456400|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101456401|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456402|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101410387|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410391|NCT00115089|Hormones|hormones|mesh-ancestor
101456404|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
101456405|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456406|NCT00216398|Lanreotide|lanreotide|mesh-list
101456407|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456408|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
101456409|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101456410|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456411|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456412|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
101456413|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456414|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456415|NCT00216437|Capecitabine|capecitabine|mesh-list
101456416|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456417|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
101456418|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456419|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456420|NCT00244920|Squalamine|squalamine|mesh-list
101456421|NCT00244920|Leuprolide|leuprolide|mesh-list
101456422|NCT00244920|Bicalutamide|bicalutamide|mesh-list
101456423|NCT00244920|Hormones|hormones|mesh-list
101456424|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
101456425|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456426|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456434|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456435|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101456436|NCT00244920|Protective Agents|protective agents|mesh-ancestor
101456437|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101456438|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101410401|NCT00115167|Hematinics|hematinics|mesh-ancestor
101456439|NCT00244920|Growth Substances|growth substances|mesh-ancestor
101456440|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101456441|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
101456442|NCT00216515|Galantamine|galantamine|mesh-list
101456443|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101456444|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456445|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456446|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
101456447|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456448|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456449|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101456450|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
101456451|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456452|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
101456453|NCT00244959|Anastrozole|anastrozole|mesh-list
101456454|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456455|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456456|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101456457|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101456458|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456459|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456460|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101456461|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456462|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456463|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456465|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456466|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456467|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101456468|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101456469|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456470|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308883|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308884|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333876|NCT00041431|Hormones|hormones|mesh-list
101456471|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456472|NCT00216554|Risperidone|risperidone|mesh-list
101456473|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101456474|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
101456475|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456476|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456477|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456478|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101456479|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456480|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456481|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456482|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101456483|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
101456484|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
101456485|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101456486|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101456487|NCT00241254|Prednisolone|prednisolone|mesh-list
101456488|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
101456489|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
101456490|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101456491|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
101456492|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456493|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
101456494|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456496|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101456497|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
101456498|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456499|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456500|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101456501|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456502|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
101456503|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
101456504|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456505|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456506|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
101456507|NCT00241254|Hormones|hormones|mesh-ancestor
101456508|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456509|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101456510|NCT00241254|Protective Agents|protective agents|mesh-ancestor
101456511|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456512|NCT00216632|Risperidone|risperidone|mesh-list
101456513|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101456514|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
101456515|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456516|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456517|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456518|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101456519|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456520|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456521|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456522|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101456523|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
101456524|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101456525|NCT04662736|Tedizolid|tedizolid|mesh-list
101456526|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456527|NCT04662658|Xenon|xenon|mesh-list
101456528|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101456529|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
101456530|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
101456531|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456532|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456533|NCT00216788|Esomeprazole|esomeprazole|mesh-list
101456534|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101456535|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456536|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101456537|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456538|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775337|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775338|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775339|NCT00656292|Simvastatin|simvastatin|mesh-list
101775340|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101775341|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101775343|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775344|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101775345|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101775346|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775347|NCT00352417|Atreleuton|atreleuton|mesh-list
101775348|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101775349|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775350|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775351|NCT00944541|Maraviroc|maraviroc|mesh-list
101775352|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101775353|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101775354|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775355|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101775356|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101775357|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
101775358|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775359|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101775361|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775362|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775363|NCT00323869|Bevacizumab|bevacizumab|mesh-list
101775364|NCT00323869|Carboplatin|carboplatin|mesh-list
101775365|NCT00323869|Gemcitabine|gemcitabine|mesh-list
101535860|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775366|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775367|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775368|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101775369|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101775370|NCT00323869|Growth Substances|growth substances|mesh-ancestor
101775371|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775372|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
101775373|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101775374|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
101775375|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410494|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
101775376|NCT00323557|Molgramostim|molgramostim|mesh-list
101775377|NCT00323557|Sargramostim|sargramostim|mesh-list
101775378|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101775379|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
101775380|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775381|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775382|NCT00558363|Dutasteride|dutasteride|mesh-list
101775383|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101775384|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101775385|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775386|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775387|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775388|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775389|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775390|NCT00323479|Anastrozole|anastrozole|mesh-list
101775391|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101775392|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775393|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101775394|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101775395|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775396|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775397|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101775398|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775399|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775400|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775401|NCT00352105|Fluorouracil|fluorouracil|mesh-list
101775402|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775403|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
101308885|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101775404|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775405|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101775406|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775407|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
101775408|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775410|NCT03988075|Ibuprofen|ibuprofen|mesh-list
101775411|NCT03988075|Hydrocodone|hydrocodone|mesh-list
101775412|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775413|NCT03988075|Analgesics|analgesics|mesh-ancestor
101775414|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
101775415|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775416|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775417|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
101775418|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101775419|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775420|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775421|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101775422|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775423|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775424|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101775425|NCT03988075|Narcotics|narcotics|mesh-ancestor
101775426|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775427|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
101775428|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
101775429|NCT00944853|Zinc|zinc|mesh-list
101775430|NCT00944853|Trace Elements|trace elements|mesh-ancestor
101775431|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
101775432|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775433|NCT03985891|Antibodies|antibodies|mesh-list
101775434|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101775435|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
101775436|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775437|NCT00350779|Metformin|metformin|mesh-list
101775438|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101775439|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
101775440|NCT00350779|Glipizide|glipizide|mesh-list
101775441|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775442|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775443|NCT00350779|Incretins|incretins|mesh-ancestor
101775444|NCT00350779|Hormones|hormones|mesh-ancestor
101775445|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775446|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101775447|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
101775448|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535944|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
101775449|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775451|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775452|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101775453|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775454|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775455|NCT00676520|Everolimus|everolimus|mesh-list
101775456|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101775457|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101775458|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775459|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775460|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775461|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
101775462|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775464|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
101775466|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
101775467|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775468|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
101775469|NCT02559908|Protective Agents|protective agents|mesh-ancestor
101775470|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101775471|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101775472|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101775473|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775474|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775475|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775476|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775478|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
101775479|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775480|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
101775481|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775482|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
101775483|NCT02558972|Droxidopa|droxidopa|mesh-list
101775484|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101775485|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101775486|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
101775487|NCT00809718|Rifapentine|rifapentine|mesh-list
101775488|NCT00809718|Rifampin|rifampin|mesh-list
101775489|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101775490|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101775491|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
101775492|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775493|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101775494|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101775495|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775496|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775497|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101775498|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
101775499|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101775500|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
101775501|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775502|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101775503|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101775504|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101775505|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101775506|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101775507|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101775508|NCT05427266|Bupivacaine|bupivacaine|mesh-list
101775509|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
101775510|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
101775511|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410610|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101410611|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
101775512|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775513|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
101775514|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775515|NCT00575042|Fenofibrate|fenofibrate|mesh-list
101775516|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101775517|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
101775518|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775519|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101775520|NCT00656058|Montelukast|montelukast|mesh-list
101775521|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101775522|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
101775523|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101775524|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
101775525|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775526|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775527|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101775528|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101775529|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775531|NCT00537316|Azathioprine|azathioprine|mesh-list
101775532|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101775533|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775534|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
101775535|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775536|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775537|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
101775538|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775539|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101775540|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775541|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775542|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
101775543|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775544|NCT00803868|Varenicline|varenicline|mesh-list
101775545|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101775546|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101775547|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
101775548|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775549|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775550|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775553|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
101775554|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
101775556|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
101775557|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775558|NCT00655980|Hematinics|hematinics|mesh-ancestor
101775559|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
101775560|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101775561|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
101775562|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
101775563|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775564|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775565|NCT00655980|Analgesics|analgesics|mesh-ancestor
101775566|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
101775567|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775568|NCT01063621|Apomorphine|apomorphine|mesh-list
101775569|NCT01063621|Emetics|emetics|mesh-ancestor
101775570|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775571|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
101775572|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775573|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775574|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
101775575|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
101433015|NCT00158132|Amantadine|amantadine|mesh-list
101775576|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775577|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775578|NCT02533141|Simvastatin|simvastatin|mesh-list
101775579|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101775580|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101775581|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
101775582|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775583|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101775584|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101775585|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775586|NCT00809796|Pentamidine|pentamidine|mesh-list
101775587|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
101775588|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775589|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101775590|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101775591|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101775592|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
101775593|NCT05589454|Atorvastatin|atorvastatin|mesh-list
101775594|NCT05589454|Calcium|calcium|mesh-list
101775595|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101775596|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775597|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101775598|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101775599|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101775600|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
101775601|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775602|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101775603|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101775604|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775605|NCT00803946|Ibuprofen|ibuprofen|mesh-list
101775606|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101775607|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775608|NCT00803946|Analgesics|analgesics|mesh-ancestor
101775609|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
101775610|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775611|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775612|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775613|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775614|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101775615|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775616|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775617|NCT00676130|Trimethoprim|trimethoprim|mesh-list
101775618|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101775619|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
101775621|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101775622|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775623|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
101775624|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101775625|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101775626|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101775627|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775628|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775629|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101775630|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101775631|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101775632|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101775634|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
101775635|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
101775636|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775637|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
101775638|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101775639|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
101775640|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775641|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
101775642|NCT05436002|Protective Agents|protective agents|mesh-ancestor
101775643|NCT02560376|Exenatide|exenatide|mesh-list
101775644|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775645|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775646|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101775647|NCT02560376|Incretins|incretins|mesh-ancestor
101775648|NCT02560376|Hormones|hormones|mesh-ancestor
101775649|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775651|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775652|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
101775654|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101775655|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
101775656|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
101775657|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775658|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775659|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101411906|NCT00464347|Hormones|hormones|mesh-ancestor
101775660|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101775661|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775662|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101775663|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101775664|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101775665|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
101775666|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101536066|NCT00564590|Melatonin|melatonin|mesh-list
101536067|NCT00564590|Omeprazole|omeprazole|mesh-list
101536068|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
101775667|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101775668|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
101775669|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101775671|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101775672|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775673|NCT00921830|Analgesics|analgesics|mesh-ancestor
101775674|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
101775675|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775676|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775677|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775678|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775679|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101775680|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775681|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775682|NCT02560220|Mitomycins|mitomycins|mesh-list
101775683|NCT02560220|Mitomycin|mitomycin|mesh-list
101775684|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101775685|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775686|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
101775687|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775688|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101775689|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775690|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
101775691|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775692|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
101775693|NCT04836832|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101775694|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775695|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101775697|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775698|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101775699|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775700|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775701|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
101775702|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
101775703|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775704|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775705|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101775706|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775707|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775708|NCT00675506|Hormones|hormones|mesh-list
101775709|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101775710|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775711|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775712|NCT05435378|Vitamins|vitamins|mesh-list
101775713|NCT05435378|Folic Acid|folic acid|mesh-list
101775714|NCT05435378|Niacinamide|niacinamide|mesh-list
101775715|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
101410705|NCT00115518|Cetuximab|cetuximab|mesh-list
101775716|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
101775717|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775718|NCT05435378|Hematinics|hematinics|mesh-ancestor
101775719|NCT05589220|Nicotine|nicotine|mesh-list
101775720|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101775721|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
101775722|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433155|NCT04724486|Cetrorelix|cetrorelix|mesh-list
101775723|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775724|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101775725|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101775726|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
101775727|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775728|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775729|NCT03895840|Triamcinolone|triamcinolone|mesh-list
101775730|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101775731|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101775732|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101775733|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775734|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
101775735|NCT03895840|Hormones|hormones|mesh-ancestor
101775736|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775737|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775738|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775739|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
101775740|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775741|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775742|NCT00310375|Ezogabine|ezogabine|mesh-list
101775743|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
101775744|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775745|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775746|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
101775747|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101775748|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101775749|NCT00309907|Prednisolone|prednisolone|mesh-list
101775750|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
101775751|NCT00309907|Etanercept|etanercept|mesh-list
101775752|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101775753|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
101775754|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775755|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
101775756|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
101775757|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775758|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775759|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775760|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
101775761|NCT00309907|Hormones|hormones|mesh-ancestor
101308904|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101775762|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775764|NCT00309907|Protective Agents|protective agents|mesh-ancestor
101775765|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101775766|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775767|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101775768|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775769|NCT00309907|Analgesics|analgesics|mesh-ancestor
101775770|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
101775771|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775772|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775773|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
101775774|NCT00655824|Ofatumumab|ofatumumab|mesh-list
101775775|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775776|NCT03985969|Indomethacin|indomethacin|mesh-list
101775777|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101775778|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101775779|NCT03985969|Analgesics|analgesics|mesh-ancestor
101775780|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
101775781|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775782|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775783|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775784|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775785|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
101775786|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
101775787|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101775788|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101775789|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775790|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775791|NCT01061437|Lansoprazole|lansoprazole|mesh-list
101775792|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
101775793|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101775794|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775795|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101775796|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775797|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775799|NCT00575588|Saxagliptin|saxagliptin|mesh-list
101775800|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775801|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775802|NCT00575588|Incretins|incretins|mesh-ancestor
101775803|NCT00575588|Hormones|hormones|mesh-ancestor
101775804|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775805|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101775806|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
101775807|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410723|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101410726|NCT05589753|Diuretics|diuretics|mesh-ancestor
101246485|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775808|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775809|NCT01058317|Propranolol|propranolol|mesh-list
101775810|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101775811|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101775812|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
101775813|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775814|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775815|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775816|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101775817|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101775818|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
101775819|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101775820|NCT00810030|Hematinics|hematinics|mesh-ancestor
101775821|NCT00675428|Natalizumab|natalizumab|mesh-list
101775822|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
101775823|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775824|NCT00760916|Treprostinil|treprostinil|mesh-list
101775825|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101775826|NCT00761228|Apomorphine|apomorphine|mesh-list
101775827|NCT00761228|Emetics|emetics|mesh-ancestor
101775828|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775829|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
101775830|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775831|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101775832|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
101775833|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
101775834|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775835|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775836|NCT00758732|Carboplatin|carboplatin|mesh-list
101775837|NCT00758732|Docetaxel|docetaxel|mesh-list
101775838|NCT00758732|Doxorubicin|doxorubicin|mesh-list
101775839|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101775840|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775841|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
101775842|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
101775843|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775844|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775845|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101775846|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101775847|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101775848|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775849|NCT02559674|Paclitaxel|paclitaxel|mesh-list
101775850|NCT02559674|Gemcitabine|gemcitabine|mesh-list
101775851|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101775852|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775854|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101775855|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775856|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775857|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101775858|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
101775859|NCT00761540|Liraglutide|liraglutide|mesh-list
101775860|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101775861|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775862|NCT00761540|Incretins|incretins|mesh-ancestor
101775863|NCT00761540|Hormones|hormones|mesh-ancestor
101775864|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775865|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101775866|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101775867|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101775868|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101775869|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775871|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775872|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101775873|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
101775875|NCT00759200|Interferons|interferons|mesh-list
101775876|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
101775877|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
101775878|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775879|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
101775880|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775881|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
101775882|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775883|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
101775885|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101775886|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775887|NCT01299753|Propranolol|propranolol|mesh-list
101775888|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101775889|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101775890|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
101775891|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775892|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775893|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775894|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101775895|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101775896|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
101775897|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
101775898|NCT02559440|Phenylephrine|phenylephrine|mesh-list
101775899|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
101775900|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775901|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
101775902|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101775903|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101775904|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101775905|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
101775906|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775907|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775908|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775909|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
101775910|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
101775911|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775912|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
101775913|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101775914|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
101410762|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410763|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775915|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101775917|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101775918|NCT02559440|Protective Agents|protective agents|mesh-ancestor
101775919|NCT00674570|Cycloserine|cycloserine|mesh-list
101775920|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
101775921|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775922|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101775923|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101775924|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101775925|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
101775926|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101775927|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
101775928|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775929|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
101775930|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101775931|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101775932|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775933|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775934|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
101775935|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775936|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775937|NCT00940719|Vitamin D|vitamin d|mesh-list
101775938|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
101775939|NCT00940719|Vitamins|vitamins|mesh-ancestor
101775940|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
101775941|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775942|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101775943|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101775944|NCT00940953|Azelastine|azelastine|mesh-list
101775946|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101775947|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101775948|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
101775949|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101775950|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775951|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101775952|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
101775953|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
101775954|NCT00940953|Hormones|hormones|mesh-ancestor
101775955|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101775956|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101775957|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775958|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775960|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101775961|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101775962|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
101775963|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
101775964|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775965|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
101775966|NCT00759824|Doxorubicin|doxorubicin|mesh-list
101775967|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101775968|NCT00759824|Vindesine|vindesine|mesh-list
101775969|NCT00759824|Valproic Acid|valproic acid|mesh-list
101775970|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101775971|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
101775972|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101775973|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101775974|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101775975|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
101775976|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101775978|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101775979|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101775980|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101775981|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101775982|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101775983|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
101775984|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
101775985|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775986|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
101775987|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101775988|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101775989|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101775990|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101775991|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
101775992|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
101775993|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
101775994|NCT00561951|Fesoterodine|fesoterodine|mesh-list
101775995|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101775996|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101775997|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
101775998|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101775999|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776000|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776001|NCT00561951|Urological Agents|urological agents|mesh-ancestor
101776003|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101776004|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101776005|NCT00762398|Analgesics|analgesics|mesh-ancestor
101776006|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
101776007|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776008|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776009|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776010|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776011|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
101776012|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
101776013|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776014|NCT00762632|Everolimus|everolimus|mesh-list
101776015|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101776016|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776017|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776018|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776019|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776020|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
101776021|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776022|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776023|NCT00322387|Plerixafor|plerixafor|mesh-list
101776024|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101776025|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101776026|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
101776027|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776028|NCT00561015|Ribavirin|ribavirin|mesh-list
101776029|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
101776030|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101776031|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
101776032|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776033|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
101776034|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776035|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776036|NCT04012047|Cromakalim|cromakalim|mesh-list
101776037|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101776038|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101776039|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
101776040|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776041|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776042|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776043|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776044|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
101410820|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101776045|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101776046|NCT00941265|Levodopa|levodopa|mesh-list
101776047|NCT00941265|Benserazide|benserazide|mesh-list
101776048|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101776049|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101776050|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
101776051|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776052|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776053|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776054|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776055|NCT00941343|Alfuzosin|alfuzosin|mesh-list
101776056|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101776057|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101776058|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101776059|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
101776060|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776061|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776062|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776063|NCT00941343|Urological Agents|urological agents|mesh-ancestor
101776064|NCT00561795|Paclitaxel|paclitaxel|mesh-list
101776065|NCT00561795|Carboplatin|carboplatin|mesh-list
101776066|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101776067|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776068|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101776069|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101776070|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101776071|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776073|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776074|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
101776075|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776076|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776077|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776078|NCT00560703|Doxycycline|doxycycline|mesh-list
101776079|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410851|NCT00447577|Hormones|hormones|mesh-ancestor
101776080|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776081|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
101776082|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101776083|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101776084|NCT00308737|Insulin|insulin|mesh-list
101776085|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776086|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776087|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101776088|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
101776089|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776090|NCT00941499|Leucovorin|leucovorin|mesh-list
101776091|NCT00941499|Bevacizumab|bevacizumab|mesh-list
101776092|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101776093|NCT00941499|Cetuximab|cetuximab|mesh-list
101776094|NCT00941499|Fluorouracil|fluorouracil|mesh-list
101776095|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
101776096|NCT00941499|Antibodies|antibodies|mesh-list
101776097|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
101776098|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101433524|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776099|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776100|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101776101|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101776102|NCT00941499|Growth Substances|growth substances|mesh-ancestor
101776103|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776104|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
101776105|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
101776106|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
101776107|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776108|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776109|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776110|NCT00941499|Antidotes|antidotes|mesh-ancestor
101776111|NCT00941499|Protective Agents|protective agents|mesh-ancestor
101776112|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
101776113|NCT00941499|Vitamins|vitamins|mesh-ancestor
101776114|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
101776115|NCT04752384|Buprenorphine|buprenorphine|mesh-list
101776116|NCT04752384|Tramadol|tramadol|mesh-list
101776117|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101776118|NCT04752384|Narcotics|narcotics|mesh-ancestor
101776119|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776120|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776121|NCT04752384|Analgesics|analgesics|mesh-ancestor
101776122|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
101308919|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
101776123|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776124|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101776125|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
101776126|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
101410884|NCT00447967|Leucovorin|leucovorin|mesh-list
101776127|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101776128|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
101776129|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776130|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776131|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776132|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776133|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101776134|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
101776135|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776136|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410901|NCT00447967|Vitamins|vitamins|mesh-ancestor
101776137|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101776139|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
101776140|NCT00945789|Protective Agents|protective agents|mesh-ancestor
101776141|NCT00945789|Hematinics|hematinics|mesh-ancestor
101776142|NCT00941811|Imiquimod|imiquimod|mesh-list
101776143|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101776144|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
101776145|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776146|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776147|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
101776148|NCT02553018|Methotrexate|methotrexate|mesh-list
101776149|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101776150|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
101776151|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101776152|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776153|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776154|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
101410905|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
101776155|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776156|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776157|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
101776158|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776159|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101776160|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776161|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
101776162|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776163|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101776164|NCT00941967|Gemcitabine|gemcitabine|mesh-list
101776165|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
101776166|NCT00941967|Sorafenib|sorafenib|mesh-list
101776167|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776168|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
101776169|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776170|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776171|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776172|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776173|NCT00655746|Dasatinib|dasatinib|mesh-list
101776174|NCT00655746|Omeprazole|omeprazole|mesh-list
101776175|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101776176|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101776177|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101776178|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776179|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776180|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776181|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776182|NCT00338455|Dobutamine|dobutamine|mesh-list
101776183|NCT00338455|Milrinone|milrinone|mesh-list
101776184|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101776185|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101776186|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
101776187|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
101776188|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776189|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776190|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101776191|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101776192|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101776193|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
101776194|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776195|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776196|NCT00338455|Protective Agents|protective agents|mesh-ancestor
101776197|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101776198|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
101776199|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101776200|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101776201|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776202|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
101776203|NCT00678392|Sorafenib|sorafenib|mesh-list
101776204|NCT00678392|Axitinib|axitinib|mesh-list
101776205|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776206|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776207|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246486|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
101776208|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776210|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776211|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
101776212|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776213|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101776214|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776215|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776216|NCT00804336|Everolimus|everolimus|mesh-list
101776217|NCT00804336|Pasireotide|pasireotide|mesh-list
101776218|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101776219|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776220|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776221|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776222|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776223|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
101776224|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776225|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776226|NCT00804336|Hormones|hormones|mesh-ancestor
101536104|NCT04605419|Calcium|calcium|mesh-list
101776227|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776228|NCT00942201|Dexamethasone|dexamethasone|mesh-list
101776229|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
101776230|NCT00942201|BB 1101|bb 1101|mesh-list
101776231|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776232|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
101776233|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
101776234|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776235|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776236|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101776237|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
101776238|NCT00942201|Hormones|hormones|mesh-ancestor
101776239|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776240|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101776241|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776242|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101776243|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776244|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776246|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101776247|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
101776248|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101776249|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
101433672|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776250|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776251|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776252|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
101776253|NCT00946179|Vaccines|vaccines|mesh-list
101776254|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
101776255|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776257|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
101776258|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
101776259|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776260|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776261|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
101776262|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776263|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101776264|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101776265|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101776266|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776267|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776268|NCT00942591|Interferons|interferons|mesh-list
101776269|NCT00942591|Interferon-beta|interferon-beta|mesh-list
101776270|NCT00942591|Atorvastatin|atorvastatin|mesh-list
101776271|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
101776272|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776273|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
101776274|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776275|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101776276|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101776277|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
101776278|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776279|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101776280|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101776281|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776282|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
101776283|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776284|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101776285|NCT00946335|Temozolomide|temozolomide|mesh-list
101776287|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101776288|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
101776289|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776290|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776291|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101776292|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776293|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
101776294|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101776295|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776296|NCT00762944|Cimetidine|cimetidine|mesh-list
101776297|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101776298|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101776299|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101776300|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
101776301|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
101776302|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776303|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776304|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776305|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101776306|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101776307|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776309|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101776310|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
101776311|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
101776312|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
101776313|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
101411002|NCT03276325|Dexamethasone|dexamethasone|mesh-list
101776314|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776315|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776316|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101776317|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101776318|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776319|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776320|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776321|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776322|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776323|NCT00763178|Analgesics|analgesics|mesh-ancestor
101776324|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
101776325|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776326|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
101776327|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776328|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
101776329|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101776330|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101776331|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776333|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101776334|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776335|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776336|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
101776337|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776338|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776339|NCT00678080|Metformin|metformin|mesh-list
101776340|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776341|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776342|NCT00658320|Cyclosporine|cyclosporine|mesh-list
101776343|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
101776344|NCT00658320|Everolimus|everolimus|mesh-list
101776345|NCT00658320|Cyclosporins|cyclosporins|mesh-list
101776346|NCT00658320|Basiliximab|basiliximab|mesh-list
101776347|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776348|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776349|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776350|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
101776351|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776352|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
101776353|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776354|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101776355|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776356|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101776357|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101776358|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776359|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776360|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101776361|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101776362|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
101776363|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101776364|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
101776365|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101776366|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776367|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776368|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776369|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101776370|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
101776371|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
101776372|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776373|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101776374|NCT00806754|Ciclesonide|ciclesonide|mesh-list
101776375|NCT00806754|Azelastine|azelastine|mesh-list
101776376|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
101776377|NCT00806754|Hormones|hormones|mesh-ancestor
101776378|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411940|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776379|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776380|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101776381|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101776382|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
101776383|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776384|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776385|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776386|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101776387|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776388|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776389|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101776390|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101776391|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
101776392|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
101776393|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776394|NCT00764816|Caseins|caseins|mesh-list
101776395|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
101776396|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
101776397|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776398|NCT00322153|Memantine|memantine|mesh-list
101776399|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101776400|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101776401|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
101776402|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776403|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776404|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776405|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101776406|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101776407|NCT00806910|Conivaptan|conivaptan|mesh-list
101776408|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101776409|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776410|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101776411|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776412|NCT00807066|Gefitinib|gefitinib|mesh-list
101776413|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776414|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776415|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776416|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776417|NCT00804960|Letrozole|letrozole|mesh-list
101776418|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776419|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101776420|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101776421|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776422|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776423|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101776424|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
101776425|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776426|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776428|NCT00805116|Vitamins|vitamins|mesh-ancestor
101776429|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
101776430|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776431|NCT03985735|Anesthetics|anesthetics|mesh-list
101776432|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776433|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776434|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101776435|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101776436|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776437|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101776438|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776439|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776440|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776441|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
101776442|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776443|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101776444|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101776445|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101776446|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776447|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
101776448|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101776449|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
101776450|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101776452|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101776453|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776454|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776455|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776456|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776457|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776458|NCT00672620|Analgesics|analgesics|mesh-ancestor
101776459|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
101776460|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776461|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
101776462|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776463|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
101776464|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101776465|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101776466|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776467|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101776468|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
101776469|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101776470|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101776471|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101776472|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101776473|NCT00764972|Sorafenib|sorafenib|mesh-list
101776474|NCT00764972|Vinorelbine|vinorelbine|mesh-list
101776475|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776476|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776477|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776478|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246487|NCT01666301|Hematinics|hematinics|mesh-ancestor
101776480|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
101776481|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
101776482|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
101776483|NCT00673790|Losartan|losartan|mesh-list
101776484|NCT00673790|Lisinopril|lisinopril|mesh-list
101776485|NCT00673790|Nebivolol|nebivolol|mesh-list
101776486|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101776487|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101776488|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101776489|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101776490|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776491|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101776492|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
101776493|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536133|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
101776494|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101776495|NCT00673790|Protective Agents|protective agents|mesh-ancestor
101776496|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776497|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
101776498|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101776499|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101776500|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101776501|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101776502|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776503|NCT00763646|Docetaxel|docetaxel|mesh-list
101776504|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776505|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
101776506|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
101776507|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
101776508|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776509|NCT00763880|Lidocaine|lidocaine|mesh-list
101776510|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
101776511|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
101776512|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776513|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411131|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101776514|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
101776515|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776516|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101776517|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101776518|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101776519|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776520|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776521|NCT00657150|Enoxaparin|enoxaparin|mesh-list
101776522|NCT00657150|Dabigatran|dabigatran|mesh-list
101776523|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
101776524|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101776525|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101776526|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776527|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
101776528|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101776529|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101776530|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776531|NCT00770354|Letrozole|letrozole|mesh-list
101776532|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776533|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101776534|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101776535|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776536|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776537|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101776538|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
101776539|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776540|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776541|NCT00670748|Aldesleukin|aldesleukin|mesh-list
101411154|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776542|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
101776543|NCT00670748|Fludarabine|fludarabine|mesh-list
101776544|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
101776545|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776546|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
101776547|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776548|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776549|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101776550|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
101776551|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776552|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776553|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101776554|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776555|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
101776556|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101776557|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101776558|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
101776559|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776560|NCT00646776|Ritonavir|ritonavir|mesh-list
101776561|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101776562|NCT00646776|Rifabutin|rifabutin|mesh-list
101776563|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101776564|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101776565|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
101776566|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776567|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776568|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101776569|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101776570|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
101776571|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776572|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101776573|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101776574|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101776575|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101776576|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
101776577|NCT02558114|Ribavirin|ribavirin|mesh-list
101776578|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
101776579|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776580|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
101776581|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776582|NCT00770666|Bupropion|bupropion|mesh-list
101776583|NCT00770666|Nicotine|nicotine|mesh-list
101776584|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101776585|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
101776586|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776587|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776588|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101776589|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101776590|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
101776591|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776592|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776593|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101776594|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
101776595|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776596|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101776597|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776598|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776600|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101776601|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101776602|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776603|NCT00764036|Artesunate|artesunate|mesh-list
101776604|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
101776605|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101776606|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101776607|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776608|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776609|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
101776610|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
101776611|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101776612|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
101776613|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101776614|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776615|NCT00811200|Triamcinolone|triamcinolone|mesh-list
101776616|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101776617|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101776618|NCT00811200|Ranibizumab|ranibizumab|mesh-list
101776619|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101776620|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101776621|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101776623|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776624|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101776625|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776626|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776627|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
101776629|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776630|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776631|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
101776632|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776633|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776634|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
101776635|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101776636|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101776637|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101776638|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
101776639|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776640|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101776641|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101776642|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776643|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776644|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776645|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101776646|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101776647|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101776648|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776649|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101776650|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101776651|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101776652|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101308985|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776653|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776655|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101776656|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101776657|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
101776658|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776659|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776660|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101776661|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101776662|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
101776663|NCT00770744|Olanzapine|olanzapine|mesh-list
101776664|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
101776665|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
101776666|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776667|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776668|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101776669|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101776670|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101776671|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776672|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776673|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101776674|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776675|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776676|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776677|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776678|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
101776679|NCT00655668|Lenalidomide|lenalidomide|mesh-list
101776680|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
101776681|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776682|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101776683|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101776685|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
101776686|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776687|NCT00770900|Montelukast|montelukast|mesh-list
101776688|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776689|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776690|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101776691|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
101776692|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776693|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776694|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101776695|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101776696|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776698|NCT00766220|Cetuximab|cetuximab|mesh-list
101776699|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101776700|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101776701|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776702|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776703|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776704|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101776705|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
101776706|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101776707|NCT00770978|Cephalosporins|cephalosporins|mesh-list
101776708|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101776709|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776710|NCT00764426|Ethanol|ethanol|mesh-list
101776711|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101776712|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776713|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776714|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776715|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
101776716|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
101776717|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
101776718|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
101776719|NCT00764582|Levofloxacin|levofloxacin|mesh-list
101776720|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101776721|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101776722|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411244|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101776723|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776724|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101776725|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101776726|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776727|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776728|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776729|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101776730|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101776731|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101776732|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
101776733|NCT04048226|Ketamine|ketamine|mesh-list
101776734|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101776735|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776736|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776737|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101776738|NCT04048226|Analgesics|analgesics|mesh-ancestor
101776739|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
101776740|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776741|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101776742|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101776743|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101776744|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
101776745|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776746|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776747|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101776748|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101776749|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
101776750|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
101776751|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101776752|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101776753|NCT00811746|Eszopiclone|eszopiclone|mesh-list
101776754|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101776755|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776756|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776757|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
101776758|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
101776759|NCT04048070|Sufentanil|sufentanil|mesh-list
101776760|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101776761|NCT04048070|Narcotics|narcotics|mesh-ancestor
101776762|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776763|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776764|NCT04048070|Analgesics|analgesics|mesh-ancestor
101776765|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
101776766|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776767|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101776768|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101776769|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
101776770|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
101776771|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101776772|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101776773|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776774|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776775|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101776776|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776777|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776778|NCT00571064|Donepezil|donepezil|mesh-list
101776779|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101776780|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776781|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776782|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
101776783|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776784|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776785|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
101776786|NCT00811980|Vancomycin|vancomycin|mesh-list
101776787|NCT00811980|Linezolid|linezolid|mesh-list
101776788|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101776789|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776790|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101776791|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776792|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776793|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101776794|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
101776795|NCT00775034|Coagulants|coagulants|mesh-ancestor
101776796|NCT00813696|Gemcitabine|gemcitabine|mesh-list
101776797|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776798|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776799|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
101776800|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776801|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
101776802|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101776803|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776804|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776805|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
101776806|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776807|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776808|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
101776809|NCT02557490|Raltitrexed|raltitrexed|mesh-list
101776810|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776811|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101776812|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
101776813|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776814|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101776815|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776816|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
101776817|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101776818|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101776819|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101776820|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101776821|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776822|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776823|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
101776824|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776825|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776826|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101411276|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776827|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411277|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
101411279|NCT00458458|Leuprolide|leuprolide|mesh-list
101776829|NCT00807534|Ipratropium|ipratropium|mesh-list
101776830|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
101776831|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101776832|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
101776833|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776834|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776835|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776836|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776837|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101776838|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
101776839|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776840|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776841|NCT05589064|Vitamin D|vitamin d|mesh-list
101776842|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
101776843|NCT05589064|Vitamins|vitamins|mesh-ancestor
101776844|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
101776845|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776846|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101776847|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101776848|NCT00807690|Tacrolimus|tacrolimus|mesh-list
101776849|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101776850|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
101776851|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776852|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101776853|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776854|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776855|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101309007|NCT00005994|Ondansetron|ondansetron|mesh-list
101776856|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
101776858|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776859|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776860|NCT00814086|Paclitaxel|paclitaxel|mesh-list
101776861|NCT00814086|Cisplatin|cisplatin|mesh-list
101776862|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101776863|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776864|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
101776865|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101776866|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
101776867|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776868|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101776869|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101776870|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101776871|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101776872|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776873|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776874|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776875|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
101776876|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776878|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101776879|NCT00654732|Doxorubicin|doxorubicin|mesh-list
101776880|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101776881|NCT00654732|Dacarbazine|dacarbazine|mesh-list
101776882|NCT00654732|Bleomycin|bleomycin|mesh-list
101776883|NCT00654732|Vinblastine|vinblastine|mesh-list
101776884|NCT00654732|Antibodies|antibodies|mesh-list
101776885|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
101776886|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101776888|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
101776889|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776890|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776891|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101776892|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101246488|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101776893|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101776894|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101776895|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776896|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776897|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101776898|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
101776899|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101776900|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
101776901|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
101776902|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101776903|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
101776904|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101776905|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
101776906|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776907|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776908|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101776909|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
101776910|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101776911|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
101776912|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776913|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776914|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101776915|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
101776916|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
101776917|NCT00771368|Protective Agents|protective agents|mesh-ancestor
101434339|NCT00191022|Paroxetine|paroxetine|mesh-list
101776918|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
101776919|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101776920|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101776921|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101776922|NCT00771680|Insulin|insulin|mesh-list
101776923|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101776924|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
101536185|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776925|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
101309009|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
101776926|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101776927|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
101776928|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
101776929|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101776930|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101776931|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411320|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411321|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
101776933|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101776934|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101776935|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776936|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776937|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
101776938|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101776939|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
101776941|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
101776942|NCT00669032|Protective Agents|protective agents|mesh-ancestor
101776943|NCT00775580|Atenolol|atenolol|mesh-list
101776944|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101776945|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101776946|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
101776947|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
101776948|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776949|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776950|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101776951|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101776952|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101776953|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
101776954|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776955|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776956|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
101776957|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101776958|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246489|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101776959|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776960|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
101776961|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776962|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776963|NCT00654498|Pramipexole|pramipexole|mesh-list
101776964|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
101776965|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776966|NCT00654498|Protective Agents|protective agents|mesh-ancestor
101776967|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776968|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101776969|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101776970|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
101776971|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
101776972|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776973|NCT00670046|Valproic Acid|valproic acid|mesh-list
101776974|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
101776975|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101776976|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101776977|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
101776978|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101776979|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776980|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
101776981|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101776982|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101776983|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101776984|NCT00560391|Dexamethasone|dexamethasone|mesh-list
101776985|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
101776986|NCT00560391|Lenalidomide|lenalidomide|mesh-list
101776987|NCT00560391|Dasatinib|dasatinib|mesh-list
101776988|NCT00560391|BB 1101|bb 1101|mesh-list
101776989|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101776990|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
101776991|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
101776992|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101776993|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101776994|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101776995|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
101776997|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101776998|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101777000|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777001|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777002|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777003|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
101777004|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777005|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777006|NCT00560391|Growth Substances|growth substances|mesh-ancestor
101777007|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777008|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777009|NCT00775736|Insulin|insulin|mesh-list
101777010|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101777011|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
101777012|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
101777013|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101777014|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
101777015|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101777016|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101777017|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777019|NCT00537238|Levetiracetam|levetiracetam|mesh-list
101777020|NCT00537238|Analgesics|analgesics|mesh-ancestor
101777021|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
101777022|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777023|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777024|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
101777025|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101777026|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101777027|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777028|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101777029|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101777030|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777031|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777033|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
101777034|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
101777035|NCT03982771|Bortezomib|bortezomib|mesh-list
101777036|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777037|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
101777038|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777039|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777040|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101411468|NCT00460681|Thymopentin|thymopentin|mesh-list
101777041|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
101777042|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777043|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777044|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101777045|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101777046|NCT00775814|Candesartan|candesartan|mesh-list
101777047|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
101777048|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101777049|NCT00775814|Diuretics|diuretics|mesh-ancestor
101777050|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
101777051|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777052|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101777053|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101777054|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777055|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101777056|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101777057|NCT00942747|Sirolimus|sirolimus|mesh-list
101777058|NCT00942747|Temsirolimus|temsirolimus|mesh-list
101777059|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
101777060|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777061|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777062|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777063|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777064|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
101777065|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777066|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777067|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309017|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
101777068|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411507|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
101777069|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101777070|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
101777071|NCT00946491|Haloperidol|haloperidol|mesh-list
101777072|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
101777073|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
101777074|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
101777075|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777076|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777077|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777078|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101777079|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777080|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777081|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101777082|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101777083|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
101777084|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777085|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777086|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101777087|NCT05355610|Gentamicins|gentamicins|mesh-list
101777088|NCT05355610|Dexamethasone|dexamethasone|mesh-list
101777089|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
101777090|NCT05355610|BB 1101|bb 1101|mesh-list
101777091|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101777092|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
101777093|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
101777094|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777095|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777096|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777098|NCT05355610|Hormones|hormones|mesh-ancestor
101777100|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101777101|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777102|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777103|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777104|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777105|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777106|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777107|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101777108|NCT00552669|Sirolimus|sirolimus|mesh-list
101777109|NCT00552669|Paclitaxel|paclitaxel|mesh-list
101777110|NCT00552669|Temsirolimus|temsirolimus|mesh-list
101777111|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
101777112|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101777113|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777114|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101777115|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101777116|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101777117|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777118|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777119|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777120|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101777121|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
101777122|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777123|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
101777124|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777125|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777126|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777127|NCT00943059|Acipimox|acipimox|mesh-list
101777128|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101777129|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
101777130|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777131|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101777132|NCT00943137|Fluorouracil|fluorouracil|mesh-list
101777133|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
101777134|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777135|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101777136|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777137|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777138|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
101777139|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777140|NCT00772616|Sufentanil|sufentanil|mesh-list
101777141|NCT00772616|Remifentanil|remifentanil|mesh-list
101777142|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101777143|NCT00772616|Narcotics|narcotics|mesh-ancestor
101777144|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777145|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777146|NCT00772616|Analgesics|analgesics|mesh-ancestor
101777147|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
101777148|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777149|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101777150|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101777151|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
101777152|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
101777153|NCT00768404|Phentermine|phentermine|mesh-list
101777154|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101777155|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777156|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
101777157|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101777158|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
101777159|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
101777160|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777161|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
101777162|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777163|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777164|NCT05406622|Sirolimus|sirolimus|mesh-list
101777165|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777166|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777167|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101777168|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777169|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
101777170|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777171|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
101777172|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777173|NCT00776282|Loratadine|loratadine|mesh-list
101777174|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
101777175|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
101777176|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101777177|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101777178|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101777179|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
101777180|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
101777181|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777182|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777184|NCT00943293|Fludarabine|fludarabine|mesh-list
101777185|NCT00943293|Melphalan|melphalan|mesh-list
101777186|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
101777187|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777188|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777189|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777190|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
101777191|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777192|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101777193|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
101777194|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101777195|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777196|NCT00776360|Oxytocin|oxytocin|mesh-list
101777197|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
101777198|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101777199|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777200|NCT00946725|Atenolol|atenolol|mesh-list
101777201|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101777202|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101777203|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
101777204|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
101777205|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777206|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777207|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101777208|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101777209|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101777210|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
101777211|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777212|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777213|NCT03041740|Perflubron|perflubron|mesh-list
101777214|NCT03041740|Bromides|bromides|mesh-list
101777215|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
101777216|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101777217|NCT00772694|Sorafenib|sorafenib|mesh-list
101777218|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777219|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777220|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777221|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777222|NCT00776438|Vaccines|vaccines|mesh-list
101777223|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
101777224|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777226|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777227|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777228|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777229|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777230|NCT00952029|Leucovorin|leucovorin|mesh-list
101777231|NCT00952029|Bevacizumab|bevacizumab|mesh-list
101777232|NCT00952029|Fluorouracil|fluorouracil|mesh-list
101777233|NCT00952029|Irinotecan|irinotecan|mesh-list
101777234|NCT00952029|Calcium|calcium|mesh-list
101777235|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
101777236|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777237|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777238|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777239|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777240|NCT00952029|Growth Substances|growth substances|mesh-ancestor
101777241|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777242|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777243|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101777245|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777246|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101777247|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777248|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
101777249|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101777250|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101777252|NCT00952029|Antidotes|antidotes|mesh-ancestor
101777253|NCT00952029|Protective Agents|protective agents|mesh-ancestor
101777254|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
101777255|NCT00952029|Vitamins|vitamins|mesh-ancestor
101777256|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
101777257|NCT00667862|Panobinostat|panobinostat|mesh-list
101777259|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101777260|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777261|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777262|NCT00952185|Antibodies|antibodies|mesh-list
101777263|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
101777264|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777265|NCT00776516|Rifampin|rifampin|mesh-list
101777266|NCT00776516|Mirabegron|mirabegron|mesh-list
101777267|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101777268|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
101777269|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777270|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777271|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
101777272|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101777273|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777274|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777275|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101777276|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101777277|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101777278|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101777279|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101777280|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101777281|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101777282|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101777283|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101777284|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
101777285|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777286|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777287|NCT00776516|Urological Agents|urological agents|mesh-ancestor
101777288|NCT00768638|Atorvastatin|atorvastatin|mesh-list
101777289|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101777290|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101777291|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
101777292|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777293|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101777294|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101777295|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777296|NCT02557958|Azithromycin|azithromycin|mesh-list
101777297|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777299|NCT00776672|Fosinopril|fosinopril|mesh-list
101777300|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101777301|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777302|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777303|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777304|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101777305|NCT00535132|Risperidone|risperidone|mesh-list
101777306|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101777307|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101777308|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
101777310|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777311|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777312|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101777313|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777314|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777315|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101777316|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101777317|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
101777318|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101777319|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101777320|NCT00570908|Capecitabine|capecitabine|mesh-list
101777321|NCT00570908|Sunitinib|sunitinib|mesh-list
101777322|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101777323|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
101777324|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777325|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777326|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777327|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777328|NCT00570908|Growth Substances|growth substances|mesh-ancestor
101777329|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777330|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777331|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777332|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777334|NCT00773084|Spironolactone|spironolactone|mesh-list
101777335|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101777336|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777337|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777338|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777339|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101777340|NCT00773084|Diuretics|diuretics|mesh-ancestor
101777341|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
101777342|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101777343|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777344|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777345|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777346|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101777347|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101411949|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
101777348|NCT00773084|Protective Agents|protective agents|mesh-ancestor
101777349|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
101777350|NCT00321919|Hematinics|hematinics|mesh-ancestor
101777351|NCT00781391|Warfarin|warfarin|mesh-list
101777352|NCT00781391|Edoxaban|edoxaban|mesh-list
101777353|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
101777354|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101777355|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
101777356|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101777358|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777359|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777360|NCT00534976|Montelukast|montelukast|mesh-list
101777361|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101777362|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
101777363|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101777364|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777365|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777366|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777367|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101777368|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101777369|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777370|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101777371|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
101777372|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101777373|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101777374|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777375|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777376|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777378|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101777379|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
101777380|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777381|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777382|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411996|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
101777383|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
101777384|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101777385|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101777386|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777387|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101777388|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
101777389|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101777390|NCT00776828|Protective Agents|protective agents|mesh-ancestor
101777391|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101777392|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101777393|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777394|NCT01063933|Peramivir|peramivir|mesh-list
101777395|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
101777396|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777397|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777398|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777399|NCT02556866|Prednisone|prednisone|mesh-list
101777400|NCT02556866|Rituximab|rituximab|mesh-list
101412034|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777401|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777402|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777403|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
101777404|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777405|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777406|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536521|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777407|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
101536522|NCT04571151|Halobetasol|halobetasol|mesh-list
101777409|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777410|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101777411|NCT00308113|Ubiquinone|ubiquinone|mesh-list
101777412|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
101777413|NCT00308113|Prednisone|prednisone|mesh-list
101777414|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101777415|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
101777416|NCT00308113|Hormones|hormones|mesh-ancestor
101777417|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777418|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777419|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101777420|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777421|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
101777422|NCT00308113|Vitamins|vitamins|mesh-ancestor
101777423|NCT03903640|Nivolumab|nivolumab|mesh-list
101777424|NCT03903640|Ipilimumab|ipilimumab|mesh-list
101309031|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777425|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777426|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777427|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101777428|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777430|NCT03982849|Hydroquinone|hydroquinone|mesh-list
101777431|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
101777432|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777433|NCT03982849|Protective Agents|protective agents|mesh-ancestor
101777434|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777435|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101777436|NCT05357872|Anesthetics|anesthetics|mesh-list
101777437|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412102|NCT00117026|Benphothiamine|benphothiamine|mesh-list
101777438|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777440|NCT00777218|Propranolol|propranolol|mesh-list
101777441|NCT00777218|Zonisamide|zonisamide|mesh-list
101777442|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101777443|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101777444|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
101777445|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777446|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777447|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777448|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101777449|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101777450|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
101777451|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
101777452|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101777453|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101777454|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101777455|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101777456|NCT04047758|Letrozole|letrozole|mesh-list
101777458|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777459|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101777460|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101777461|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777462|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777463|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101777464|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
101412137|NCT00117065|Hematinics|hematinics|mesh-ancestor
101777465|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777466|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777467|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777468|NCT00307801|Dienogest|dienogest|mesh-list
101777469|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101777470|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101777471|NCT00307801|Estradiol|estradiol|mesh-list
101777472|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101777473|NCT00307801|Estrogens|estrogens|mesh-ancestor
101777474|NCT00307801|Hormones|hormones|mesh-ancestor
101777475|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777476|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777477|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101777478|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
101777479|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101777480|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101777481|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101777482|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101777483|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101777484|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777485|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101777486|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777487|NCT00671060|Misoprostol|misoprostol|mesh-list
101777488|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101777489|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
101777490|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101777491|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777493|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777494|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
101777495|NCT05354986|Povidone|povidone|mesh-list
101777496|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
101777497|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
101777498|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
101777499|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101777500|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101777501|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
101777502|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777503|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777504|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777505|NCT00773552|Urological Agents|urological agents|mesh-ancestor
101777506|NCT04002700|Haloperidol|haloperidol|mesh-list
101777507|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
101777508|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
101777509|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
101777510|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
101777511|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777512|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777513|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777514|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777515|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777516|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101777517|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101777518|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
101777519|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777520|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777521|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101777522|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
101777523|NCT04098653|Busulfan|busulfan|mesh-list
101777524|NCT04098653|Decitabine|decitabine|mesh-list
101777525|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777526|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
101777527|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777528|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777529|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101777530|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
101777531|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777532|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777533|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101777534|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101777535|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
101777536|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777537|NCT05297123|Tretinoin|tretinoin|mesh-list
101777538|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
101777539|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777540|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
101777541|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
101777542|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101777543|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777544|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777545|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777546|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777547|NCT00773630|Cilostazol|cilostazol|mesh-list
101777548|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101777549|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
101777550|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777551|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777552|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101777553|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
101777554|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101777555|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101777556|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777557|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101777559|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101777560|NCT00773630|Protective Agents|protective agents|mesh-ancestor
101777561|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101412299|NCT00475189|Estrogens|estrogens|mesh-ancestor
101777562|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101777563|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777564|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101777566|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
101777567|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101777568|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101777569|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777571|NCT03646474|Coagulants|coagulants|mesh-ancestor
101777572|NCT00808002|Tenofovir|tenofovir|mesh-list
101777574|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
101777575|NCT00808002|Maraviroc|maraviroc|mesh-list
101777576|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
101777577|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777578|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101777579|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101777580|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777581|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777582|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101777583|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777584|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101777585|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101777586|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101777587|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101777588|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101777590|NCT00307489|Emtricitabine|emtricitabine|mesh-list
101777591|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
101777592|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777593|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101777594|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101777595|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777596|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777597|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101777598|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777599|NCT00812292|Rilpivirine|rilpivirine|mesh-list
101777600|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101777601|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101777602|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777603|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777604|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
101777605|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777606|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101777607|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777608|NCT00812370|Bivalirudin|bivalirudin|mesh-list
101777609|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
101777610|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101777611|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777612|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777613|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777614|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
101777615|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101777616|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777617|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
101777618|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101777619|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777620|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
101412401|NCT00475969|Analgesics|analgesics|mesh-ancestor
101777621|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777622|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101777623|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101777624|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777625|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777626|NCT00762359|Lansoprazole|lansoprazole|mesh-list
101777627|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
101777628|NCT00762359|Gefarnate|gefarnate|mesh-list
101777629|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101777630|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777631|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101777632|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777633|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777634|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101777636|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101777637|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
101777638|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777639|NCT00770042|Ritonavir|ritonavir|mesh-list
101777640|NCT00770042|Ketoconazole|ketoconazole|mesh-list
101777641|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101309042|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
101777642|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101777643|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777644|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777645|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777646|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101777647|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777648|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
101777649|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777650|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101777651|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101777652|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
101777653|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101777654|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101777655|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
101777656|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777657|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777658|NCT00654186|Lenalidomide|lenalidomide|mesh-list
101777659|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
101777660|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777661|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777662|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777663|NCT00654186|Growth Substances|growth substances|mesh-ancestor
101777664|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777665|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777667|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101777668|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435089|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777669|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
101777670|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
101777671|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
101777672|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777674|NCT03979105|Analgesics|analgesics|mesh-ancestor
101777675|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
101777676|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777677|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777678|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101777679|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101777680|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
101777681|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
101777682|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777683|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101777684|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101777685|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777686|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777687|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
101777688|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101777689|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777690|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
101777691|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101777692|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101777693|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777695|NCT04100447|Coagulants|coagulants|mesh-ancestor
101777696|NCT03274804|Maraviroc|maraviroc|mesh-list
101777697|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
101777698|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777699|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777700|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101777701|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777702|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101777703|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101777705|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101777706|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
101777707|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777708|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101777709|NCT00761891|Aspirin|aspirin|mesh-list
101777710|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101777711|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101777712|NCT00761891|Analgesics|analgesics|mesh-ancestor
101777713|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
101777714|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777715|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777716|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101777717|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777718|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101777719|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101777720|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777721|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101777722|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101777723|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777724|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
101777725|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
101777726|NCT00321685|Leucovorin|leucovorin|mesh-list
101777727|NCT00321685|Folic Acid|folic acid|mesh-list
101777728|NCT00321685|Bevacizumab|bevacizumab|mesh-list
101777729|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101777730|NCT00321685|Fluorouracil|fluorouracil|mesh-list
101777731|NCT00321685|Capecitabine|capecitabine|mesh-list
101777732|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
101777733|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
101777734|NCT00321685|Antibodies|antibodies|mesh-list
101777735|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
101777736|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101777737|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
101777738|NCT00321685|Calcium|calcium|mesh-list
101777739|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
101777740|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777741|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777742|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101435174|NCT00161837|Vaccines|vaccines|mesh-list
101777743|NCT00321685|Growth Substances|growth substances|mesh-ancestor
101777744|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777745|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777746|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
101777747|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101777748|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101777749|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
101777750|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777751|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101777752|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777754|NCT00321685|Protective Agents|protective agents|mesh-ancestor
101777755|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
101777756|NCT00321685|Vitamins|vitamins|mesh-ancestor
101777757|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
101777759|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
101777760|NCT00777998|Thalidomide|thalidomide|mesh-list
101777761|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101777762|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
101777763|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777764|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
101777765|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777766|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777770|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777771|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777772|NCT00777998|Trace Elements|trace elements|mesh-ancestor
101777773|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
101777793|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
101777794|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101777795|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
101777796|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777797|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
101777798|NCT00778076|Protective Agents|protective agents|mesh-ancestor
101777800|NCT00306787|Famciclovir|famciclovir|mesh-list
101777801|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
101777802|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777803|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101412727|NCT00478114|Sorafenib|sorafenib|mesh-list
101777804|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777805|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777806|NCT00778232|Gabapentin|gabapentin|mesh-list
101777807|NCT00778232|Analgesics|analgesics|mesh-ancestor
101777808|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
101777809|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777810|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777811|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
101777812|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101777813|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101777814|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777815|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435238|NCT00161993|Antibodies|antibodies|mesh-list
101777816|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101777817|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101777818|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777819|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412770|NCT00118937|Metformin|metformin|mesh-list
101777820|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
101777821|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101777822|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101777823|NCT00774488|Incretins|incretins|mesh-ancestor
101777824|NCT00774488|Hormones|hormones|mesh-ancestor
101777825|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777826|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777828|NCT01066195|Gefitinib|gefitinib|mesh-list
101777829|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777830|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777831|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777832|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101777833|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101777834|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777835|NCT00774644|Clarithromycin|clarithromycin|mesh-list
101777836|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777837|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777838|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101777839|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777840|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777841|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101777842|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101777843|NCT05123092|Morphine|morphine|mesh-list
101777844|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101777845|NCT05123092|Narcotics|narcotics|mesh-ancestor
101777846|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777847|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777848|NCT05123092|Analgesics|analgesics|mesh-ancestor
101777849|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
101777850|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777851|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101777852|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101777853|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777854|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777855|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777856|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777858|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
101777859|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777860|NCT00667394|Bevacizumab|bevacizumab|mesh-list
101777861|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777862|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777863|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777864|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777865|NCT00667394|Growth Substances|growth substances|mesh-ancestor
101777866|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777867|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777868|NCT05357326|Atropine|atropine|mesh-list
101777869|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101777870|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101777871|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101777872|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101777873|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101777874|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
101777875|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777876|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777877|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101412898|NCT00117663|Hormones|hormones|mesh-list
101777878|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
101777879|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
101777880|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
101777881|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101777882|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101777883|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
101777884|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777885|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777886|NCT00778466|Metformin|metformin|mesh-list
101777887|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101777888|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777889|NCT00761735|Ribavirin|ribavirin|mesh-list
101777890|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101777891|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
101777892|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777893|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
101777894|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777896|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777897|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101777898|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777899|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777900|NCT00778544|Amoxicillin|amoxicillin|mesh-list
101777901|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
101777902|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
101777903|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101777904|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101777905|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101777906|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777907|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777908|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101777909|NCT04001374|Ticagrelor|ticagrelor|mesh-list
101777910|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101777911|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101777912|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101777913|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101777914|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
101777915|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777916|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777917|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777918|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
101412940|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101777919|NCT05265910|Loratadine|loratadine|mesh-list
101309054|NCT00006012|Paclitaxel|paclitaxel|mesh-list
101777920|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101777921|NCT05265910|Dextrans|dextrans|mesh-list
101412946|NCT00119483|Testosterone|testosterone|mesh-list
101777922|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101777923|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101777924|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
101777925|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101777926|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101777927|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101777928|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101777929|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
101777930|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
101777931|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101777932|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777933|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777934|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101777935|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101777936|NCT05265910|Analgesics|analgesics|mesh-ancestor
101777937|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
101777938|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101777939|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101777940|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777941|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
101777942|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
101777943|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
101777945|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101777946|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101777947|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101777948|NCT00991978|Bevacizumab|bevacizumab|mesh-list
101777949|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
101777950|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777951|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777952|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101777953|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101777954|NCT00991978|Growth Substances|growth substances|mesh-ancestor
101777955|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777956|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101777957|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101777958|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777959|NCT00645528|Insulin|insulin|mesh-list
101777960|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101777961|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777962|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101777963|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
101777964|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777965|NCT00812448|Protective Agents|protective agents|mesh-ancestor
101777966|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777967|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101435387|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
101777968|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101777969|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413051|NCT00119639|Sorafenib|sorafenib|mesh-list
101777970|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101777971|NCT00295633|Metformin|metformin|mesh-list
101777972|NCT00295633|Pioglitazone|pioglitazone|mesh-list
101777973|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
101777974|NCT00295633|Saxagliptin|saxagliptin|mesh-list
101777975|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101777976|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101777977|NCT00295633|Incretins|incretins|mesh-ancestor
101777978|NCT00295633|Hormones|hormones|mesh-ancestor
101777979|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101777980|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101777981|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
101777982|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777983|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777984|NCT00570674|Paclitaxel|paclitaxel|mesh-list
101777985|NCT00570674|Carboplatin|carboplatin|mesh-list
101777986|NCT00570674|Cetuximab|cetuximab|mesh-list
101777987|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101777988|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101777989|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101777990|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101777991|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101777992|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101777993|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101777994|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101777995|NCT00808314|Dipyridamole|dipyridamole|mesh-list
101777996|NCT00808314|Regadenoson|regadenoson|mesh-list
101777997|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101777998|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101777999|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778000|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101778001|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
101778002|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101778003|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101778004|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
101778005|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
101778006|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778007|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778008|NCT04992052|Bone wax|bone wax|mesh-list
101778009|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
101778010|NCT04992052|Coagulants|coagulants|mesh-ancestor
101778011|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101778012|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101778013|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
101778014|NCT00768989|Ritonavir|ritonavir|mesh-list
101778015|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101778016|NCT00768989|Tenofovir|tenofovir|mesh-list
101778017|NCT00768989|Emtricitabine|emtricitabine|mesh-list
101778018|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
101778019|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101778020|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101778021|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
101778022|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778023|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778024|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101778025|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101778026|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
101778027|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778028|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101778029|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101778030|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101778031|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101778032|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101778033|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101778034|NCT00779714|Cytarabine|cytarabine|mesh-list
101778035|NCT00779714|Paclitaxel|paclitaxel|mesh-list
101778036|NCT00779714|Cisplatin|cisplatin|mesh-list
101778037|NCT00779714|Dacarbazine|dacarbazine|mesh-list
101778038|NCT00779714|Treosulfan|treosulfan|mesh-list
101778039|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101778040|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778041|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537477|NCT03451682|Procyanidin|procyanidin|mesh-list
101778042|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
101778043|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537478|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
101778044|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778045|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778046|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
101778047|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
101778048|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778049|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778050|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
101778051|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778052|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101778053|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
101778055|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101778056|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101778057|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
101778058|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778059|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778060|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778062|NCT00814944|Temsirolimus|temsirolimus|mesh-list
101778063|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
101778064|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778065|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778066|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101778067|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778068|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
101778069|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778070|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
101778071|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778072|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101778073|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778074|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778075|NCT00779792|Triamcinolone|triamcinolone|mesh-list
101778076|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101778077|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101778078|NCT00779792|Clobetasol|clobetasol|mesh-list
101778079|NCT00779792|Mineral Oil|mineral oil|mesh-list
101778080|NCT00779792|Tacrolimus|tacrolimus|mesh-list
101778081|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101778082|NCT00779792|Glycerol|glycerol|mesh-list
101778083|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778084|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
101778085|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778086|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101778087|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778088|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778089|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778090|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
101778091|NCT00779792|Hormones|hormones|mesh-ancestor
101778092|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778093|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101778094|NCT00779792|Protective Agents|protective agents|mesh-ancestor
101778095|NCT00779792|Emollients|emollients|mesh-ancestor
101778096|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778097|NCT00992134|Cytarabine|cytarabine|mesh-list
101778098|NCT00992134|Rituximab|rituximab|mesh-list
101778099|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101778100|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101778101|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778102|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
101778103|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778104|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101778105|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778106|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
101778107|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778108|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
101778109|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778110|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778111|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101778112|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
101778113|NCT02551536|Fexofenadine|fexofenadine|mesh-list
101778114|NCT02551536|Montelukast|montelukast|mesh-list
101778115|NCT02551536|Levocetirizine|levocetirizine|mesh-list
101778116|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101778117|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
101778118|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101778119|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
101778120|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778121|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778122|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101778123|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101778124|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778125|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101778126|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101778127|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101778128|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
101778129|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
101778130|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778131|NCT00815022|Fentanyl|fentanyl|mesh-list
101778132|NCT00815022|Morphine|morphine|mesh-list
101778133|NCT00815022|Bupivacaine|bupivacaine|mesh-list
101778134|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
101778135|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
101778136|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778137|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413203|NCT00481663|Metformin|metformin|mesh-list
101778138|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
101778139|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778140|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101778141|NCT00815022|Narcotics|narcotics|mesh-ancestor
101778142|NCT00815022|Analgesics|analgesics|mesh-ancestor
101778143|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101778144|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101778145|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
101778146|NCT00774722|Metronidazole|metronidazole|mesh-list
101778147|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778148|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778149|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101778150|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101778152|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
101778153|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778154|NCT04045548|Dinoprostone|dinoprostone|mesh-list
101778155|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
101778156|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101778157|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778159|NCT00780104|Sirolimus|sirolimus|mesh-list
101778160|NCT00780104|Etoposide|etoposide|mesh-list
101778161|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
101778162|NCT00780104|Temsirolimus|temsirolimus|mesh-list
101778163|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
101778164|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101778165|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778166|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101778167|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101778168|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778169|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778170|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778171|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
101778172|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
101778173|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778174|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778175|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
101778176|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778177|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778178|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101778179|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
101778180|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101778181|NCT00780104|Analgesics|analgesics|mesh-ancestor
101778182|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
101778183|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778185|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
101778186|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101778187|NCT04047680|Grazoprevir|grazoprevir|mesh-list
101778188|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101778189|NCT04047680|Ledipasvir|ledipasvir|mesh-list
101778190|NCT04047680|Velpatasvir|velpatasvir|mesh-list
101778191|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101778192|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101778193|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101778194|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
101778195|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435608|NCT03516604|Citalopram|citalopram|mesh-list
101778196|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778197|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101778198|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101778199|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
101778200|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778201|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101778202|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101778203|NCT00774878|Fulvestrant|fulvestrant|mesh-list
101778204|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101778205|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778206|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101778207|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101778208|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
101778209|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778210|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778211|NCT00815256|Riboflavin|riboflavin|mesh-list
101778212|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
101778213|NCT00815256|Vitamins|vitamins|mesh-ancestor
101778214|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
101778215|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778216|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101778217|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778218|NCT00778778|Cefprozil|cefprozil|mesh-list
101778219|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778220|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778221|NCT00305773|Vorinostat|vorinostat|mesh-list
101778222|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778223|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101778224|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778225|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778226|NCT00780182|Brincidofovir|brincidofovir|mesh-list
101778227|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
101778228|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778229|NCT00812994|Escitalopram|escitalopram|mesh-list
101778230|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101778231|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101778232|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101778233|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778234|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778235|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
101778236|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778237|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101778238|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101778239|NCT00784394|Protective Agents|protective agents|mesh-ancestor
101411982|NCT00465244|Lorazepam|lorazepam|mesh-list
101778240|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778241|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413288|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
101778242|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
101778243|NCT00305695|Imidazole|imidazole|mesh-list
101778244|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101778245|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778246|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778247|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778248|NCT00784472|Morphine|morphine|mesh-list
101778249|NCT00784472|Oxycodone|oxycodone|mesh-list
101778250|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101778251|NCT00784472|Narcotics|narcotics|mesh-ancestor
101778252|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778253|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778254|NCT00784472|Analgesics|analgesics|mesh-ancestor
101778255|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
101778256|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778257|NCT00779012|Infliximab|infliximab|mesh-list
101778258|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101778259|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778260|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101413291|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101778261|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778262|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101778263|NCT00647556|Adapalene|adapalene|mesh-list
101778264|NCT00647556|Tretinoin|tretinoin|mesh-list
101778265|NCT00647556|Emollients|emollients|mesh-list
101778266|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101778267|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101778268|NCT00647556|Analgesics|analgesics|mesh-ancestor
101778269|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
101778270|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778271|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778272|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778273|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413309|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101778275|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778276|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
101778277|NCT03978559|Trimethoprim|trimethoprim|mesh-list
101778278|NCT03978559|Caspofungin|caspofungin|mesh-list
101778279|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
101778280|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
101778281|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778282|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
101778283|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
101778284|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778285|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778286|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778287|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
101778288|NCT03978559|Hormones|hormones|mesh-ancestor
101778289|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778290|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101778291|NCT03978559|Protective Agents|protective agents|mesh-ancestor
101778292|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101778293|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778294|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
101778295|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101778296|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101778297|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101778298|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778299|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778300|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101413329|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778301|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101778302|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101778303|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
101778304|NCT00813072|Docetaxel|docetaxel|mesh-list
101778305|NCT00813072|Irinotecan|irinotecan|mesh-list
101778306|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778307|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101778308|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101778309|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101778310|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778311|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101778312|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101778313|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778314|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101778315|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101778316|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778317|NCT00813228|Incretins|incretins|mesh-ancestor
101778318|NCT00813228|Hormones|hormones|mesh-ancestor
101778319|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778320|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101778321|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
101778322|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778323|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778324|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
101778325|NCT00808704|Hematinics|hematinics|mesh-ancestor
101778326|NCT00320515|Pemetrexed|pemetrexed|mesh-list
101778327|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778328|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778329|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778330|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101778331|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101778332|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101778333|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101778334|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101778335|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778336|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
101778337|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101778338|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
101778339|NCT00815568|Fludarabine|fludarabine|mesh-list
101778340|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
101778342|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778343|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778344|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
101778345|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778346|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778347|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
101778348|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778349|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
101778350|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101778351|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101778352|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
101778354|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101778355|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101778356|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778357|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778358|NCT00815646|Urological Agents|urological agents|mesh-ancestor
101778359|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
101778360|NCT01066351|Hematinics|hematinics|mesh-ancestor
101778361|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101778362|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101778363|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778364|NCT00661778|Bevacizumab|bevacizumab|mesh-list
101778365|NCT00661778|Docetaxel|docetaxel|mesh-list
101778366|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101778367|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778368|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101778369|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101778370|NCT00661778|Growth Substances|growth substances|mesh-ancestor
101778371|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778372|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
101778373|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101778374|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101778375|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101778376|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778378|NCT01062139|Levocetirizine|levocetirizine|mesh-list
101778379|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101778380|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101778381|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
101778382|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
101778383|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778384|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778385|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778386|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101778387|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101778388|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101778389|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101778390|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101778391|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778393|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778394|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778395|NCT00653328|Doxorubicin|doxorubicin|mesh-list
101778396|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101778397|NCT00653328|Atrasentan|atrasentan|mesh-list
101778398|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101778399|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778400|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101778401|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101778402|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778403|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778404|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101778405|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101778406|NCT01664182|Bevacizumab|bevacizumab|mesh-list
101778407|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101778408|NCT01664182|Sunitinib|sunitinib|mesh-list
101778409|NCT01664182|Trebananib|trebananib|mesh-list
101778410|NCT01664182|Sorafenib|sorafenib|mesh-list
101778411|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
101778412|NCT01664182|Antibodies|antibodies|mesh-list
101778413|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
101778414|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101778415|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
101778416|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778417|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101778418|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101778419|NCT01664182|Growth Substances|growth substances|mesh-ancestor
101778420|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778421|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
101778422|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
101435831|NCT00192777|Capecitabine|capecitabine|mesh-list
101778423|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101778424|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778425|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778427|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
101778428|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101778429|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101778430|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778431|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778432|NCT00780728|Urological Agents|urological agents|mesh-ancestor
101778433|NCT00809172|Cyclosporine|cyclosporine|mesh-list
101778434|NCT00809172|Methotrexate|methotrexate|mesh-list
101778435|NCT00809172|Cyclosporins|cyclosporins|mesh-list
101778436|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101778437|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
101778438|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101778439|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778440|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778441|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
101778442|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778443|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778444|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778445|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778446|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101778447|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778448|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
101778449|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101778450|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101778451|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
101778452|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778453|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101778455|NCT00784862|Anastrozole|anastrozole|mesh-list
101778456|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101778457|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
101778458|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778459|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778460|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101778461|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778462|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101778463|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101778464|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101778465|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101778466|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101778467|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778468|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778469|NCT00784940|Tamoxifen|tamoxifen|mesh-list
101778470|NCT00784940|Anastrozole|anastrozole|mesh-list
101778471|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101778472|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
101778473|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778474|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778475|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101778476|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778477|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101778478|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101778479|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101778480|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101778481|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101778482|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309099|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
101778483|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778485|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101778486|NCT00790244|Ifosfamide|ifosfamide|mesh-list
101778487|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
101778488|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101778489|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778490|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101778491|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101778492|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778493|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778494|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101778495|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
101778496|NCT00785018|Complement C1s|complement c1s|mesh-list
101778497|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101778498|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101778499|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
101778500|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778501|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101778502|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778503|NCT00534352|Ritonavir|ritonavir|mesh-list
101778504|NCT00534352|Darunavir|darunavir|mesh-list
101778505|NCT00534352|Etravirine|etravirine|mesh-list
101778506|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101778507|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101778508|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
101778509|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778510|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778511|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101778512|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101778513|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
101778514|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778515|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101778516|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101778517|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101778518|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101778519|NCT00642174|Clopidogrel|clopidogrel|mesh-list
101778520|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101778521|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101778522|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101778523|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101778524|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101778526|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778527|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778528|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778529|NCT02550444|Clonidine|clonidine|mesh-list
101778530|NCT02550444|Analgesics|analgesics|mesh-ancestor
101778531|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
101778532|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778533|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778534|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101778535|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
101778536|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
101778537|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101778538|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101778539|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101778540|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101778541|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778542|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778543|NCT00665366|Valproic Acid|valproic acid|mesh-list
101778544|NCT00665366|Aripiprazole|aripiprazole|mesh-list
101778545|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
101778546|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778547|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101778548|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101778549|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778550|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778551|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
101778552|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
101778553|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778554|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778555|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101778556|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101778557|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
101778558|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101778559|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101778560|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101778561|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101778562|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778563|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
101778564|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
101778565|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
101778566|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101778567|NCT00775684|Exenatide|exenatide|mesh-list
101778568|NCT00775684|Glimepiride|glimepiride|mesh-list
101778569|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101435984|NCT05781698|Analgesics|analgesics|mesh-ancestor
101778570|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778571|NCT00775684|Incretins|incretins|mesh-ancestor
101778572|NCT00775684|Hormones|hormones|mesh-ancestor
101778573|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778574|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101778575|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
101778576|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778577|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778578|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101778579|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101778580|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778581|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
101778582|NCT02556008|Cannabidiol|cannabidiol|mesh-list
101778583|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
101778584|NCT00992524|Misoprostol|misoprostol|mesh-list
101778585|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101778586|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
101778587|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101778588|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778590|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778591|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
101778593|NCT00642018|Docetaxel|docetaxel|mesh-list
101778594|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778595|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101778596|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101778597|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101778598|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778599|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778600|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
101778601|NCT00642018|Hormones|hormones|mesh-ancestor
101778602|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778603|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778604|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101778605|NCT00532948|Capecitabine|capecitabine|mesh-list
101778606|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778608|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778609|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778610|NCT00998920|Equol|equol|mesh-list
101778611|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
101778612|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101778613|NCT00998920|Estrogens|estrogens|mesh-ancestor
101778614|NCT00998920|Hormones|hormones|mesh-ancestor
101778615|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778616|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778617|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
101778618|NCT00992758|Antibodies|antibodies|mesh-list
101778619|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
101778620|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778621|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778622|NCT00641706|Bortezomib|bortezomib|mesh-list
101778623|NCT00641706|Vorinostat|vorinostat|mesh-list
101778624|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778625|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101778626|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778627|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778628|NCT00995332|Cytarabine|cytarabine|mesh-list
101778629|NCT00995332|Tretinoin|tretinoin|mesh-list
101778630|NCT00995332|Valproic Acid|valproic acid|mesh-list
101778631|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778632|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
101778633|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778634|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778635|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
101778636|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778637|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778638|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
101778639|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778640|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
101778641|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778642|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
101778643|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436057|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
101778645|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778646|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
101778647|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101778648|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778649|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778651|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
101778652|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
101778653|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778654|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778655|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
101778656|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778657|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101778658|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101778659|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101778660|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101778661|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778662|NCT00999232|Erythromycin|erythromycin|mesh-list
101778663|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
101778664|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101778665|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
101778666|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778667|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778668|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778669|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101778670|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778671|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778672|NCT00993070|Capsaicin|capsaicin|mesh-list
101778673|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
101778674|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778675|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
101778676|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778677|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778678|NCT00993304|Liraglutide|liraglutide|mesh-list
101778679|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101778680|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778681|NCT00993304|Incretins|incretins|mesh-ancestor
101778682|NCT00993304|Hormones|hormones|mesh-ancestor
101778683|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778685|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
101778686|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101778687|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101778688|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778689|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101778690|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
101778691|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778692|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101778693|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101778694|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101778695|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413669|NCT01241383|Bosentan|bosentan|mesh-list
101778696|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778697|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
101778698|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778699|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101778700|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101778701|NCT00993694|Dapsone|dapsone|mesh-list
101778702|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778703|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
101778704|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101778705|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101778706|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101778707|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778708|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778709|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
101778710|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778711|NCT00640926|Radezolid|radezolid|mesh-list
101778712|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
101778713|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778714|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778715|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101778716|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778717|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778719|NCT00821496|Norethindrone|norethindrone|mesh-list
101778720|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
101778721|NCT00821496|Norinyl|norinyl|mesh-list
101778722|NCT00821496|Estradiol|estradiol|mesh-list
101778723|NCT00821496|Estrogens|estrogens|mesh-ancestor
101778724|NCT00821496|Hormones|hormones|mesh-ancestor
101778725|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778726|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778727|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101778728|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
101778729|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101778730|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101778731|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101778732|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101778733|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101778734|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101778735|NCT02550912|Vitamin D|vitamin d|mesh-list
101778736|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
101778737|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
101778738|NCT02550912|Vitamins|vitamins|mesh-list
101778739|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
101778740|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778741|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101778742|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101778743|NCT00999700|Cisplatin|cisplatin|mesh-list
101778744|NCT00999700|Docetaxel|docetaxel|mesh-list
101778745|NCT00999700|Fluorouracil|fluorouracil|mesh-list
101778747|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778748|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101778749|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101778750|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101778751|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778752|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
101778753|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101778754|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101778755|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
101778756|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778757|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101778758|NCT00818298|Ziprasidone|ziprasidone|mesh-list
101411995|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
101778759|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101778760|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
101778761|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309110|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
101778762|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778763|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778765|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101778766|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778767|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778768|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101778769|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
101778770|NCT00821574|Valsartan|valsartan|mesh-list
101778771|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101778772|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101778773|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101778774|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101778775|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778776|NCT00821574|Diuretics|diuretics|mesh-ancestor
101778777|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
101778778|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778779|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101778780|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101778781|NCT00995800|Fluticasone|fluticasone|mesh-list
101778783|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
101778784|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778785|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101778786|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
101778787|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778788|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778789|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101778790|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
101778791|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778792|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101778793|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101778794|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101778795|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101778796|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
101778797|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778798|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778799|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101778802|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
101778803|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778804|NCT00319501|Diazepam|diazepam|mesh-list
101778805|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101778806|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
101778807|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
101778808|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
101778809|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778810|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778811|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778812|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101778813|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778814|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101778815|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101778816|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101778817|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101778818|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778819|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101778820|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
101778821|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
101778822|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
101778823|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
101778824|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778825|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778827|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
101778828|NCT00994006|Levulinic acid|levulinic acid|mesh-list
101778829|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778830|NCT00994006|Cathartics|cathartics|mesh-ancestor
101778831|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778832|NCT00994006|Antacids|antacids|mesh-ancestor
101778833|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778834|NCT00818610|Amoxicillin|amoxicillin|mesh-list
101778835|NCT00818610|Clarithromycin|clarithromycin|mesh-list
101778836|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101778837|NCT00818610|Cefuroxime|cefuroxime|mesh-list
101778838|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
101778839|NCT00818610|Lactams|lactams|mesh-list
101778840|NCT00818610|beta-Lactams|beta-lactams|mesh-list
101778841|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778842|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778843|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101778844|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778845|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778846|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101778847|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101778848|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101778849|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101778850|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101778851|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101778852|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101778853|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778854|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101778855|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101778856|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101778857|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
101778858|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778859|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778860|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101778861|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101778862|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
101778863|NCT00627042|Ramucirumab|ramucirumab|mesh-list
101778864|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101778865|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778866|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
101778867|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778868|NCT00319111|Bosentan|bosentan|mesh-list
101778869|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101778870|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101778871|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778872|NCT00994396|Vitamin D|vitamin d|mesh-list
101778873|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
101778874|NCT00994396|Vitamins|vitamins|mesh-ancestor
101778875|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
101778876|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778877|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101778878|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101778879|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
101778880|NCT00816426|Rifampin|rifampin|mesh-list
101778881|NCT00816426|Isoniazid|isoniazid|mesh-list
101778882|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
101778883|NCT00816426|Kanamycin|kanamycin|mesh-list
101778884|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101778885|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778886|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101778887|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101778888|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778889|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778890|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778891|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101778892|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
101778893|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
101778894|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101778895|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101778896|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101778897|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101778898|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101778899|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101778900|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101778901|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101778902|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101778903|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
101778904|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101778905|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101778906|NCT00996190|Phenylephrine|phenylephrine|mesh-list
101778907|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
101778908|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101778909|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
101778910|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
101778911|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778912|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778913|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
101778914|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101778915|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
101778916|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101778917|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101778918|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101778919|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101778920|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101778921|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778922|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778923|NCT00996190|Protective Agents|protective agents|mesh-ancestor
101778924|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
101778925|NCT00640224|Drospirenone|drospirenone|mesh-list
101778926|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101778927|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101778929|NCT00640224|Estrogens|estrogens|mesh-ancestor
101778930|NCT00640224|Hormones|hormones|mesh-ancestor
101778931|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101778932|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778933|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101778934|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
101778935|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101778936|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101778937|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101778938|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101778940|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101778941|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
101778942|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101778943|NCT00640224|Diuretics|diuretics|mesh-ancestor
101778944|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
101778945|NCT01000792|Cetirizine|cetirizine|mesh-list
101778946|NCT01000792|Levocetirizine|levocetirizine|mesh-list
101436354|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101778947|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101778948|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101778949|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
101778950|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
101778951|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101778952|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778953|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778954|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101778955|NCT02550756|Capsaicin|capsaicin|mesh-list
101778956|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
101778957|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778958|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
101778959|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778960|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778962|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101778963|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101778964|NCT01001260|Analgesics|analgesics|mesh-ancestor
101778965|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
101778966|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101778967|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778968|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778970|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101778971|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101778972|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778973|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101778974|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101778975|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778976|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
101778977|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
101778978|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101778979|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
101778980|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101778981|NCT00996424|Expectorants|expectorants|mesh-ancestor
101778982|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101778983|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101778984|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
101778985|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778986|NCT00996424|Protective Agents|protective agents|mesh-ancestor
101778987|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101778988|NCT00996424|Antidotes|antidotes|mesh-ancestor
101778989|NCT05220280|Infliximab|infliximab|mesh-list
101778990|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
101778991|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101778992|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101778993|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101778994|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101778995|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101778996|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101778997|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
101778998|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101778999|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779000|NCT00318643|Mitomycins|mitomycins|mesh-list
101779001|NCT00318643|Mitomycin|mitomycin|mesh-list
101779002|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101779003|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779004|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
101779005|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779006|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779007|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779008|NCT00994708|Esomeprazole|esomeprazole|mesh-list
101779009|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101779010|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779011|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101779012|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779013|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779015|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779016|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
101779017|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779018|NCT01001962|Metformin|metformin|mesh-list
101779019|NCT01001962|Empagliflozin|empagliflozin|mesh-list
101779020|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101779021|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779022|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101779023|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779025|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
101779026|NCT01066429|BB 1101|bb 1101|mesh-list
101779027|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779028|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779029|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779030|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
101779031|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
101779032|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779033|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779035|NCT01066429|Hormones|hormones|mesh-ancestor
101779036|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779037|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101779038|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
101779039|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779040|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779041|NCT00994786|Pregabalin|pregabalin|mesh-list
101779042|NCT00994786|Analgesics|analgesics|mesh-ancestor
101779043|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
101779044|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779045|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779046|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
101779047|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101779048|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101779049|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779050|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101779051|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101779052|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101779053|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779055|NCT00994942|Morphine|morphine|mesh-list
101779056|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101779057|NCT00994942|Narcotics|narcotics|mesh-ancestor
101779058|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779059|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779060|NCT00994942|Analgesics|analgesics|mesh-ancestor
101779061|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
101779062|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779063|NCT01002898|Ritonavir|ritonavir|mesh-list
101779064|NCT01002898|Lopinavir|lopinavir|mesh-list
101779065|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101779066|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101779067|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
101779068|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779069|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779070|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101779071|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101779072|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
101779073|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779074|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101779075|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779076|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
101779077|NCT01003054|Busulfan|busulfan|mesh-list
101779078|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
101537652|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779079|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779080|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
101779081|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779082|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779083|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101779084|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
101779085|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779086|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779087|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101779088|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779089|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779090|NCT01004068|Clomiphene|clomiphene|mesh-list
101779091|NCT01004068|Enclomiphene|enclomiphene|mesh-list
101779092|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
101779093|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101779094|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779095|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779096|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779097|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101779099|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779100|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101779101|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101779102|NCT01004224|Infigratinib|infigratinib|mesh-list
101779104|NCT00530920|Ritonavir|ritonavir|mesh-list
101779105|NCT00530920|Tipranavir|tipranavir|mesh-list
101779106|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101779107|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101779108|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
101779109|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779110|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779111|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101779112|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101779113|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
101779114|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779115|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101779116|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779117|NCT01004380|Carboplatin|carboplatin|mesh-list
101779118|NCT01004380|Farletuzumab|farletuzumab|mesh-list
101779119|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779120|NCT01003522|Anesthetics|anesthetics|mesh-list
101779121|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
101779122|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779123|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779124|NCT01003678|Clofarabine|clofarabine|mesh-list
101779125|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779126|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
101779127|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779128|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779130|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779131|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
101779132|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
101779133|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779134|NCT04000126|Lidocaine|lidocaine|mesh-list
101779135|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
101779136|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
101779137|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779138|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779139|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
101779140|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779141|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101779142|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101779143|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101779144|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101779145|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779147|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779148|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
101779149|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779151|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101779152|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779153|NCT01005238|Lamivudine|lamivudine|mesh-list
101779154|NCT01005238|Telbivudine|telbivudine|mesh-list
101779155|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101779156|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779157|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779158|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779159|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
101537771|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
101779160|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779161|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101779162|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101779163|NCT01005472|Temozolomide|temozolomide|mesh-list
101779165|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101779166|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
101779167|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779168|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414177|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
101779169|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101779170|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101779171|NCT01005472|Growth Substances|growth substances|mesh-ancestor
101779172|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779173|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
101779175|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779176|NCT01005550|Ropivacaine|ropivacaine|mesh-list
101779177|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
101779178|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
101779179|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779180|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779181|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
101538004|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538005|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538006|NCT02211222|Lenvatinib|lenvatinib|mesh-list
101779182|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779184|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
101779185|NCT03999580|Vitamins|vitamins|mesh-ancestor
101779186|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
101779187|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779188|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101779189|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101779190|NCT00768755|Pemetrexed|pemetrexed|mesh-list
101779191|NCT00768755|Axitinib|axitinib|mesh-list
101538129|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
101779192|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779193|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779194|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779195|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101779196|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779197|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779198|NCT01005628|Bortezomib|bortezomib|mesh-list
101779199|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779200|NCT00530842|Fluticasone|fluticasone|mesh-list
101779201|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
101779203|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101779204|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779205|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101779206|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
101779207|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779208|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779209|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101779210|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
101779211|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779212|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101779213|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
101779214|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101779215|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
101779216|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779217|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779218|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101779219|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101779220|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101779221|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779222|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
101309244|NCT05679453|Lornoxicam|lornoxicam|mesh-list
101779224|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779225|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
101779226|NCT01005784|Cetrorelix|cetrorelix|mesh-list
101779227|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101779228|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
101779229|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779230|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779231|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779232|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779233|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101779234|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538347|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538348|NCT00475865|Teriflunomide|teriflunomide|mesh-list
101538349|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
101779235|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779236|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779237|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779238|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
101779239|NCT05733364|Vitamins|vitamins|mesh-ancestor
101779240|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
101779241|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779242|NCT01006720|Neostigmine|neostigmine|mesh-list
101779243|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101538402|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538407|NCT00474383|Hormones|hormones|mesh-ancestor
101779244|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779245|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779246|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
101779247|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538461|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779248|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779249|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101779250|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
101779251|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779252|NCT01006798|Vaccines|vaccines|mesh-list
101779253|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
101779254|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779255|NCT01006876|Warfarin|warfarin|mesh-list
101779256|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
101779257|NCT03882424|Bevacizumab|bevacizumab|mesh-list
101779258|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779259|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779260|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101779261|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101779262|NCT03882424|Growth Substances|growth substances|mesh-ancestor
101779263|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779264|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
101779265|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
101779266|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
101779267|NCT03879772|Beclomethasone|beclomethasone|mesh-list
101779268|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779269|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309265|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
101779270|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779271|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101779272|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
101779273|NCT03879772|Hormones|hormones|mesh-ancestor
101779274|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779275|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779276|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101779277|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
101779278|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
101779279|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101779280|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
101779281|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
101779282|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779283|NCT01007500|Dexamethasone|dexamethasone|mesh-list
101779284|NCT01007500|Ondansetron|ondansetron|mesh-list
101538831|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101779285|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538832|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
101538839|NCT01083602|Bortezomib|bortezomib|mesh-list
101779286|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
101779287|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
101779288|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779289|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779290|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779291|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
101779292|NCT01007500|Hormones|hormones|mesh-ancestor
101779293|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779294|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101779295|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779296|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
101779297|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779298|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101779299|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101779300|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
101779301|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414367|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
101779302|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779303|NCT01007578|Paclitaxel|paclitaxel|mesh-list
101779304|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101779305|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779306|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
101779307|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
101779308|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
101779309|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779310|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
101779311|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101779312|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
101779313|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779314|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
101779315|NCT05130814|Protective Agents|protective agents|mesh-ancestor
101779316|NCT00642954|Dexamethasone|dexamethasone|mesh-list
101779317|NCT00642954|Lenalidomide|lenalidomide|mesh-list
101779318|NCT00642954|Vorinostat|vorinostat|mesh-list
101779319|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779320|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
101539013|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
101779321|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
101539014|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779322|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779323|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779324|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779325|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
101779326|NCT00642954|Hormones|hormones|mesh-ancestor
101779327|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779328|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101779329|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779330|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
101779331|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101779332|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101779333|NCT00642954|Growth Substances|growth substances|mesh-ancestor
101779334|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
101779335|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101779336|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779337|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779338|NCT00816660|Factor VIII|factor viii|mesh-list
101779339|NCT00816660|Coagulants|coagulants|mesh-ancestor
101779340|NCT00819000|Interferon-beta|interferon-beta|mesh-list
101779341|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
101779343|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
101779344|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101539197|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
101539209|NCT00556127|Cytarabine|cytarabine|mesh-list
101779345|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
101779346|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779347|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779348|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779349|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779350|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
101779351|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779352|NCT00640146|Bromides|bromides|mesh-list
101539266|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779354|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
101779355|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101779356|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779357|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
101779358|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779359|NCT00819078|Bupropion|bupropion|mesh-list
101779360|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101539329|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
101779361|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
101779362|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101779363|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101779364|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101779365|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101779366|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779367|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
101779368|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779369|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779370|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101779371|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779372|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779373|NCT01008046|Metformin|metformin|mesh-list
101779374|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
101779375|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101779376|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101779377|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779378|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
101779379|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779380|NCT01008046|Expectorants|expectorants|mesh-ancestor
101779381|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
101779382|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101779383|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
101779384|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779385|NCT01008046|Protective Agents|protective agents|mesh-ancestor
101779386|NCT01008046|Antidotes|antidotes|mesh-ancestor
101779387|NCT00317473|Vaccines|vaccines|mesh-list
101779388|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
101779389|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779390|NCT00530218|Ganciclovir|ganciclovir|mesh-list
101779391|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101779392|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
101779393|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779394|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779395|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779396|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779397|NCT00761267|Fluconazole|fluconazole|mesh-list
101436812|NCT01359956|Interferons|interferons|mesh-list
101779398|NCT00761267|Anidulafungin|anidulafungin|mesh-list
101539676|NCT04538820|Dexamethasone|dexamethasone|mesh-list
101779399|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
101779400|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779401|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101779402|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779403|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779404|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779405|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101779406|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779407|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779408|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779409|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101779410|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101779412|NCT00303667|Aldesleukin|aldesleukin|mesh-list
101779413|NCT00303667|Cyclosporine|cyclosporine|mesh-list
101779414|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
101779415|NCT00303667|Fludarabine|fludarabine|mesh-list
101779416|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
101779417|NCT00303667|Interleukin-2|interleukin-2|mesh-list
101779418|NCT00303667|Cyclosporins|cyclosporins|mesh-list
101779419|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
101539881|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
101779420|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779421|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
101779422|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779423|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779424|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101779425|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
101539929|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101779426|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779427|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779428|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101779429|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779430|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
101779431|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
101779432|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779433|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779434|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
101539992|NCT01125046|Antibodies|antibodies|mesh-list
101779436|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101779437|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101779438|NCT00303667|Analgesics|analgesics|mesh-ancestor
101779439|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
101779440|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779441|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101779442|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101779443|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101779444|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101779445|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540070|NCT01124617|Tapentadol|tapentadol|mesh-list
101779446|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779447|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779448|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101779449|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101779450|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101779452|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779453|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540184|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779454|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101779455|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101779456|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
101779457|NCT01008358|Tremelimumab|tremelimumab|mesh-list
101779458|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779459|NCT01008592|Levocetirizine|levocetirizine|mesh-list
101779460|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101779461|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101779462|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
101414729|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101779463|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
101779464|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779465|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779466|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779467|NCT01062529|Somatostatin|somatostatin|mesh-list
101779468|NCT01062529|Hormones|hormones|mesh-ancestor
101414730|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536377|NCT02277678|Narcotics|narcotics|mesh-ancestor
101779469|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779470|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779471|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
101779472|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779473|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779474|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779475|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779476|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101779477|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101779479|NCT00302731|Estradiol|estradiol|mesh-list
101779480|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101779481|NCT00302731|Progesterone|progesterone|mesh-list
101779482|NCT00302731|Estrogens|estrogens|mesh-list
101309360|NCT04803084|TEMPO|tempo|mesh-list
101414738|NCT00405366|Sorafenib|sorafenib|mesh-list
101779483|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779484|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779485|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101779486|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
101779487|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779488|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101779489|NCT00302731|Progestins|progestins|mesh-ancestor
101414746|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
101779490|NCT00780143|Cytarabine|cytarabine|mesh-list
101779491|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779492|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
101779493|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779494|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779495|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
101779496|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779497|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779498|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
101779499|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779500|NCT01007968|Panobinostat|panobinostat|mesh-list
101779501|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779502|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101779503|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779504|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414758|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414759|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
101779505|NCT00779909|Vitamin D|vitamin d|mesh-list
101779506|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
101779507|NCT00779909|Vitamins|vitamins|mesh-ancestor
101779508|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
101779509|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779510|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414771|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101779511|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101779512|NCT05559112|Vitamin D|vitamin d|mesh-list
101779513|NCT05559112|Vitamins|vitamins|mesh-ancestor
101779514|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
101779515|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779516|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101779517|NCT00302107|Mirtazapine|mirtazapine|mesh-list
101779518|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
101779519|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101779520|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101779521|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
101779522|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
101779523|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779524|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779525|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779526|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101779527|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101779528|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779529|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101779530|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101779531|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101540950|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779532|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779533|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101779534|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101779536|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101779537|NCT02602301|Oxytocin|oxytocin|mesh-list
101779538|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
101779539|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779540|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779541|NCT00316225|Pemetrexed|pemetrexed|mesh-list
101779542|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779543|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779544|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779545|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101436957|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
101779546|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779547|NCT04988152|Sotrovimab|sotrovimab|mesh-list
101779548|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
101779549|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779550|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
101779551|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101779552|NCT00636168|Ipilimumab|ipilimumab|mesh-list
101779553|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779554|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779555|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101779556|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779557|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101779558|NCT00759941|Latanoprost|latanoprost|mesh-list
101779559|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101541098|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779560|NCT00759941|Brinzolamide|brinzolamide|mesh-list
101779561|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101779562|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779563|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779565|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101779566|NCT00315445|Oxycodone|oxycodone|mesh-list
101779567|NCT00315445|Buprenorphine|buprenorphine|mesh-list
101779568|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101779569|NCT00315445|Analgesics|analgesics|mesh-ancestor
101541191|NCT04577027|Travoprost|travoprost|mesh-list
101779571|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779572|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779573|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
101779574|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101779575|NCT00315445|Narcotics|narcotics|mesh-ancestor
101779576|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779577|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101779578|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101779579|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779580|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779581|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101779582|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101779583|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101779584|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101779585|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779586|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
101779587|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779588|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779589|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101779590|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779591|NCT00779675|Infliximab|infliximab|mesh-list
101779592|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101779593|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779594|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779595|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779596|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779597|NCT04102943|Tacrolimus|tacrolimus|mesh-list
101779598|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779599|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
101779600|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779601|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101779602|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779603|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779604|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101779605|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
101779606|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779607|NCT00315055|Vaccines|vaccines|mesh-list
101779608|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
101779609|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779610|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
101779611|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101779612|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779613|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
101779614|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779615|NCT00293293|Taxane|taxane|mesh-list
101779616|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779617|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
101779618|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779619|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779620|NCT05774574|Cannabidiol|cannabidiol|mesh-list
101779621|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
101779622|NCT05774275|Doxorubicin|doxorubicin|mesh-list
101779623|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101779624|NCT05774275|Antibodies|antibodies|mesh-list
101779625|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101779626|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
101779627|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779628|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101779629|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779630|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101779631|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101779632|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779633|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779634|NCT05774028|Dexamethasone|dexamethasone|mesh-list
101779635|NCT05774028|Gemcitabine|gemcitabine|mesh-list
101779636|NCT05774028|Etoposide|etoposide|mesh-list
101779637|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
101779638|NCT05774028|Pegaspargase|pegaspargase|mesh-list
101779639|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779640|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
101779641|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
101779642|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779643|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779644|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779645|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
101779646|NCT05774028|Hormones|hormones|mesh-ancestor
101779647|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779648|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541319|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541320|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779649|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779650|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779651|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
101779652|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779653|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101779654|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101779655|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101779656|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779657|NCT05774028|Analgesics|analgesics|mesh-ancestor
101779658|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
101779659|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
101779660|NCT05774015|Antacids|antacids|mesh-ancestor
101779661|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779662|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779663|NCT05773911|Chitosan|chitosan|mesh-list
101779664|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101779665|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101779666|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
101779667|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779668|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101779669|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
101779670|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
101779671|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
101779672|NCT05773911|Coagulants|coagulants|mesh-ancestor
101779673|NCT05773859|Vaccines|vaccines|mesh-list
101779674|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
101779675|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779676|NCT05773846|Ropivacaine|ropivacaine|mesh-list
101779677|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
101779678|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
101779679|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779680|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779681|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
101779682|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779683|NCT05773807|Propofol|propofol|mesh-list
101779684|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101779685|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779686|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779687|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101779689|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
101779690|NCT05773183|Testosterone|testosterone|mesh-list
101779691|NCT05773183|Androgens|androgens|mesh-ancestor
101779692|NCT05773183|Hormones|hormones|mesh-ancestor
101779693|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779694|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779695|NCT05773092|Osimertinib|osimertinib|mesh-list
101779696|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779697|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779698|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779699|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779700|NCT05732051|Niacinamide|niacinamide|mesh-list
101779702|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
101779703|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
101779704|NCT05732051|Vitamins|vitamins|mesh-ancestor
101779705|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
101779706|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779707|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101779708|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
101779709|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779710|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101779711|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
101779712|NCT05667922|Tacrolimus|tacrolimus|mesh-list
101779713|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779714|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
101779715|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779716|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101779717|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779718|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779719|NCT05667909|Rituximab|rituximab|mesh-list
101779720|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779721|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779722|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
101779723|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779724|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779725|NCT05667896|Tacrolimus|tacrolimus|mesh-list
101779726|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
101779727|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779728|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
101779729|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779730|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101779731|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779732|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779733|NCT05667896|Hormones|hormones|mesh-ancestor
101779734|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779735|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
101779736|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
101779737|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779742|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
101779743|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309393|NCT04360473|Analgesics|analgesics|mesh-ancestor
101779744|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779745|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101779746|NCT05667883|Hormones|hormones|mesh-ancestor
101779747|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779748|NCT05667805|Thrombin|thrombin|mesh-list
101779749|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
101779750|NCT05667805|Coagulants|coagulants|mesh-ancestor
101779751|NCT05644496|Meloxicam|meloxicam|mesh-list
101779752|NCT05644496|Bupivacaine|bupivacaine|mesh-list
101779753|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
101779754|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
101779755|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779756|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779757|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
101541352|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779758|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779759|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101779760|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101779761|NCT05644496|Analgesics|analgesics|mesh-ancestor
101779762|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779763|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779764|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101779765|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101779766|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779767|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779768|NCT05613608|Cannabidiol|cannabidiol|mesh-list
101779769|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
101779770|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101779771|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101779772|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101437186|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779773|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779774|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779775|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779776|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
101779777|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779778|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101779779|NCT05567562|Clopidogrel|clopidogrel|mesh-list
101779780|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779781|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779782|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101779783|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101779784|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101779785|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101779786|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
101779787|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779789|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101779790|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101779791|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779792|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779793|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779794|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779795|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101779806|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779808|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779809|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
101779810|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779811|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779813|NCT05476770|Dexamethasone|dexamethasone|mesh-list
101779814|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
101779815|NCT05476770|Methotrexate|methotrexate|mesh-list
101779816|NCT05476770|Fludarabine|fludarabine|mesh-list
101779817|NCT05476770|Vincristine|vincristine|mesh-list
101779818|NCT05476770|Azacitidine|azacitidine|mesh-list
101779819|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101779820|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
101779821|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
101779822|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779823|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779824|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101779825|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
101779826|NCT05476770|Hormones|hormones|mesh-ancestor
101779827|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779828|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101779829|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779830|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101779831|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
101779832|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779833|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101779834|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
101779835|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779836|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101779837|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779838|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101779839|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779840|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
101779841|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779842|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779843|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
101779844|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779845|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101779846|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
101779847|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
101779848|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
101779849|NCT05475678|Carboplatin|carboplatin|mesh-list
101779850|NCT05475678|Docetaxel|docetaxel|mesh-list
101779851|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779852|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101779853|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101779854|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101779855|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779856|NCT05438888|Warfarin|warfarin|mesh-list
101779857|NCT05438888|Apixaban|apixaban|mesh-list
101779858|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
101779859|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101779860|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
101779861|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101779862|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101779863|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779864|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779865|NCT05430074|Calpastatin|calpastatin|mesh-list
101779866|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101779867|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
101779868|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779869|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779876|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101779877|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101779878|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101779879|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309423|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
101779880|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779881|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101779882|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101779883|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101779884|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101779885|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779886|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779887|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779888|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101779889|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101779890|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
101779891|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101779892|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101779893|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
101779895|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101779896|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779897|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779898|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779899|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101779900|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
101779901|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779902|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101779903|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101779904|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779905|NCT05286957|Tislelizumab|tislelizumab|mesh-list
101541381|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
101541384|NCT01643499|Leucovorin|leucovorin|mesh-list
101779906|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779907|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779908|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
101779909|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779910|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101779911|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779912|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779913|NCT05255276|Itraconazole|itraconazole|mesh-list
101779915|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
101779916|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101779917|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101779918|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101779919|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101779920|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779921|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101779922|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779923|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779924|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779925|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101779926|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101779927|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
101779928|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101779929|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
101412031|NCT03272503|Pimozide|pimozide|mesh-list
101779930|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101779931|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101779932|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101779933|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101779934|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101779935|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101779936|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101779937|NCT05243199|Valsartan|valsartan|mesh-list
101779938|NCT05243199|Irbesartan|irbesartan|mesh-list
101779939|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101779940|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101779941|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101779942|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101779943|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779944|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
101779945|NCT05227716|Analgesics|analgesics|mesh-ancestor
101779946|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
101779947|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101779948|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779949|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
101779950|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101779951|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101779952|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
101779953|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101779954|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101779955|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779956|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101779957|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
101779958|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101779959|NCT05195996|Propranolol|propranolol|mesh-list
101779960|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101779961|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101779962|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101779963|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101779964|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541390|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101779965|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779966|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101779967|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101779968|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
101779969|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101779970|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
101779971|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
101779972|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779973|NCT05101564|Tamoxifen|tamoxifen|mesh-list
101779974|NCT05101564|Fulvestrant|fulvestrant|mesh-list
101779975|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101779976|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
101779977|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101779978|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779979|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101779980|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779981|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101779982|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101779983|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101779984|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101779985|NCT05073484|Antibodies|antibodies|mesh-list
101779986|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
101779987|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
101779988|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779989|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
101779990|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101779991|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101779992|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101779993|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101779994|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
101779995|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101779996|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
101779997|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101779998|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
101779999|NCT05025865|Protective Agents|protective agents|mesh-ancestor
101780000|NCT05005741|Dulaglutide|dulaglutide|mesh-list
101780002|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101780003|NCT05005741|Incretins|incretins|mesh-ancestor
101780004|NCT05005741|Hormones|hormones|mesh-ancestor
101780005|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780006|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780007|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780008|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101780009|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101780010|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101780011|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780012|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
101780013|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101780014|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101780015|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101780016|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780017|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780018|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101780019|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780020|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780021|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
101780022|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780023|NCT04974216|Rituximab|rituximab|mesh-list
101780024|NCT04974216|Lenalidomide|lenalidomide|mesh-list
101780025|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780026|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541401|NCT01643499|Antidotes|antidotes|mesh-ancestor
101780027|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
101780028|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780029|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780030|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101780031|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101780032|NCT04974216|Growth Substances|growth substances|mesh-ancestor
101780033|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
101780035|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
101780036|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
101780037|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780038|NCT04972552|Vitamins|vitamins|mesh-ancestor
101780039|NCT04924699|Trastuzumab|trastuzumab|mesh-list
101780040|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101780041|NCT04924699|Maytansine|maytansine|mesh-list
101780042|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780043|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780044|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780045|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780046|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780047|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780048|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780049|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
101780050|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
101780051|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
101780052|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780053|NCT04907539|Denosumab|denosumab|mesh-list
101780054|NCT04907539|Nivolumab|nivolumab|mesh-list
101780055|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780056|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780057|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780058|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780059|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101780060|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780061|NCT04877288|Cyclosporine|cyclosporine|mesh-list
101780062|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
101780063|NCT04877288|Abatacept|abatacept|mesh-list
101780064|NCT04877288|Tacrolimus|tacrolimus|mesh-list
101437493|NCT03789916|Analgesics|analgesics|mesh-ancestor
101780065|NCT04877288|Cyclosporins|cyclosporins|mesh-list
101780066|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780067|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
101780068|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780071|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780072|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
101780073|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780074|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101780075|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780076|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101780077|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780078|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101780079|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
101780080|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780081|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780082|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541410|NCT01116739|Fluorides|fluorides|mesh-list
101541411|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
101780084|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780085|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101780086|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101780087|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
101780088|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780089|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780090|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101780091|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101780092|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101780093|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780094|NCT04802590|Venetoclax|venetoclax|mesh-list
101780095|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780096|NCT04776993|Methimazole|methimazole|mesh-list
101780097|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
101780098|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780099|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780100|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780101|NCT04671875|Antibodies|antibodies|mesh-list
101780102|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101780103|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
101780104|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780105|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
101780106|NCT04664972|Docetaxel|docetaxel|mesh-list
101780107|NCT04664972|Doxorubicin|doxorubicin|mesh-list
101780108|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780109|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
101780110|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780111|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780112|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780113|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
101780114|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780115|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309459|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
101780116|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780117|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780118|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780119|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780120|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101780121|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101780122|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101780123|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780125|NCT04652076|Carboplatin|carboplatin|mesh-list
101780126|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
101780127|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780128|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780129|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780130|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780131|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780132|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780133|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780134|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780135|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
101780136|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101780137|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
101780139|NCT04632069|Expectorants|expectorants|mesh-ancestor
101780140|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
101780141|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101780142|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
101780143|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780144|NCT04632069|Protective Agents|protective agents|mesh-ancestor
101780145|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780146|NCT04632069|Antidotes|antidotes|mesh-ancestor
101780147|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
101780148|NCT04618913|Apixaban|apixaban|mesh-list
101780149|NCT04618913|Edoxaban|edoxaban|mesh-list
101780150|NCT04618913|Dabigatran|dabigatran|mesh-list
101780151|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101780152|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
101780153|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101780158|NCT04547907|Paclitaxel|paclitaxel|mesh-list
101780159|NCT04547907|Docetaxel|docetaxel|mesh-list
101780160|NCT04547907|Carboplatin|carboplatin|mesh-list
101780161|NCT04547907|Trastuzumab|trastuzumab|mesh-list
101780162|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780163|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780164|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780165|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780166|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780167|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780168|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780169|NCT04545944|Midazolam|midazolam|mesh-list
101780170|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101780171|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101780172|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780173|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780174|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101780175|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101780176|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101780177|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101780178|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
101309485|NCT03002259|Hormones|hormones|mesh-ancestor
101780179|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
101780180|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
101780181|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
101780182|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780183|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780184|NCT04522804|Psilocybin|psilocybin|mesh-list
101780185|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
101780186|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780187|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101780188|NCT04393285|Letrozole|letrozole|mesh-list
101780189|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780190|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101780191|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101780192|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780193|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780194|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101780195|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780196|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780197|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780198|NCT04391283|Osimertinib|osimertinib|mesh-list
101780199|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780200|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101780201|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780202|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780203|NCT04374799|Heparin|heparin|mesh-list
101780204|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
101780205|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101780206|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101780207|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780229|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780230|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780231|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780232|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780233|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
101780234|NCT04207086|Lenvatinib|lenvatinib|mesh-list
101780235|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780236|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780238|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780239|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101780240|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780241|NCT04194359|Bevacizumab|bevacizumab|mesh-list
101780242|NCT04194359|Capecitabine|capecitabine|mesh-list
101780243|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
101780244|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780245|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780246|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101780247|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101780248|NCT04194359|Growth Substances|growth substances|mesh-ancestor
101780249|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780250|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101780251|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780252|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
101780253|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780255|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
101780256|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
101780257|NCT04118010|Vitamins|vitamins|mesh-list
101780258|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
101780259|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780260|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101780261|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101780262|NCT04113863|Anastrozole|anastrozole|mesh-list
101780263|NCT04113863|Tretinoin|tretinoin|mesh-list
101780264|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780265|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780266|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101780267|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101780268|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780269|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780270|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101780271|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780272|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780273|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780274|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
101780275|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
101780276|NCT04053491|Anesthetics|anesthetics|mesh-list
101780277|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780278|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780279|NCT04041232|Glycerol|glycerol|mesh-list
101780283|NCT04030000|Paclitaxel|paclitaxel|mesh-list
101780284|NCT04030000|Carboplatin|carboplatin|mesh-list
101780285|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780286|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780287|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780288|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780289|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780290|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780291|NCT04010539|Azithromycin|azithromycin|mesh-list
101780292|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
101780293|NCT04010539|Gepotidacin|gepotidacin|mesh-list
101780294|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780295|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780296|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101780297|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780298|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780299|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780301|NCT03957590|Tislelizumab|tislelizumab|mesh-list
101780302|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780303|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780304|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780305|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780306|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780307|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780308|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780313|NCT03921866|Palbociclib|palbociclib|mesh-list
101780314|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780315|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101780316|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780317|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780319|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101780320|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101780321|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101780322|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780323|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780324|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
101780325|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780326|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780327|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
101780328|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
101780329|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780330|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101780331|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101780332|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
101780333|NCT03919955|Urological Agents|urological agents|mesh-ancestor
101780338|NCT03760588|Valsartan|valsartan|mesh-list
101780339|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101780340|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101780341|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101780342|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101780343|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780344|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101541455|NCT01640574|Chloroquine|chloroquine|mesh-list
101541456|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101780349|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780350|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780351|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536526|NCT01133977|Lenvatinib|lenvatinib|mesh-list
101780352|NCT03656081|Itraconazole|itraconazole|mesh-list
101780353|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101780354|NCT03656081|Amphotericin B|amphotericin b|mesh-list
101780355|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
101780356|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780357|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101780358|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101780359|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780360|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780361|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101780362|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780363|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437779|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
101780364|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780365|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101780366|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101780367|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101780368|NCT03656081|Amebicides|amebicides|mesh-ancestor
101780369|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780370|NCT03649048|Cisplatin|cisplatin|mesh-list
101780371|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780372|NCT03642626|Vidarabine|vidarabine|mesh-list
101780373|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
101780374|NCT03642626|Fludarabine|fludarabine|mesh-list
101780375|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
101780376|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
101780377|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101780378|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101780379|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780380|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
101780381|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780382|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780383|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780384|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
101780385|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780386|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780387|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780388|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780389|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
101780390|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
101780391|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780392|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780393|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
101414891|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780394|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780395|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780396|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780397|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780405|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101780406|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780407|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
101780408|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780409|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101780410|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
101780411|NCT03604406|Vaccines|vaccines|mesh-list
101780412|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
101780413|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780414|NCT03599635|Bupivacaine|bupivacaine|mesh-list
101780415|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
101780416|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
101780417|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780418|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780419|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
101780420|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780421|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
101780422|NCT03573700|Fludarabine|fludarabine|mesh-list
101780423|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780424|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
101780425|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780426|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780427|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780428|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
101780429|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780430|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780431|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780432|NCT03534947|Imiquimod|imiquimod|mesh-list
101780433|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101780434|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
101780435|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780436|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780437|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
101780438|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
101780439|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101780440|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780441|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780442|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101780443|NCT03530371|Analgesics|analgesics|mesh-ancestor
101780444|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
101780445|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780446|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101780447|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101780448|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101780449|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101780450|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309516|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
101780451|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780452|NCT03521830|Nivolumab|nivolumab|mesh-list
101780453|NCT03521830|Ipilimumab|ipilimumab|mesh-list
101780454|NCT03521830|Relatlimab|relatlimab|mesh-list
101780455|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780456|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780457|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780458|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780459|NCT03496610|Bupivacaine|bupivacaine|mesh-list
101780460|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
101780461|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
101780462|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780463|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780464|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
101541469|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
101780465|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780466|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
101780467|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101780468|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101780469|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780470|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780471|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101780472|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101780473|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
101780474|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780475|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780477|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101780478|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
101780479|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101780480|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101780481|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780482|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780483|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
101780484|NCT03434730|Cyclosporine|cyclosporine|mesh-list
101780485|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
101780486|NCT03434730|Lenograstim|lenograstim|mesh-list
101780487|NCT03434730|Cyclosporins|cyclosporins|mesh-list
101780488|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101780489|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
101780490|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780491|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780492|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780493|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780494|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
101780495|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780496|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
101780497|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780498|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101780499|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101780500|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780501|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101780502|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
101780503|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780505|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101780506|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780507|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780508|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780509|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101780510|NCT03418649|Diuretics|diuretics|mesh-ancestor
101780511|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
101780512|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101780513|NCT03315832|Valsartan|valsartan|mesh-list
101780514|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101780515|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101780516|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101780517|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780518|NCT03260920|Oxytocin|oxytocin|mesh-list
101780519|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
101780520|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101780521|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780522|NCT03124355|Bromides|bromides|mesh-list
101780523|NCT03124355|Galantamine|galantamine|mesh-list
101780524|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101780525|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
101780526|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101780527|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780528|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780529|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
101780530|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541476|NCT01116427|Abatacept|abatacept|mesh-list
101780531|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780532|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101780533|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
101780534|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780535|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
101780536|NCT03122652|Teriflunomide|teriflunomide|mesh-list
101780537|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101780538|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101780539|NCT03122652|Analgesics|analgesics|mesh-ancestor
101780540|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
101780541|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780542|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780543|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780544|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780545|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780546|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
101780548|NCT03011268|Infliximab|infliximab|mesh-list
101780549|NCT03011268|Golimumab|golimumab|mesh-list
101780550|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101780551|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101780552|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780553|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780554|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101780555|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780556|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780557|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
101780558|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780559|NCT02944578|Curcumin|curcumin|mesh-list
101780560|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101780561|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101780562|NCT02944578|Analgesics|analgesics|mesh-ancestor
101780563|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
101780564|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780565|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780567|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780568|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780569|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780570|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780571|NCT02889523|Prednisolone|prednisolone|mesh-list
101780572|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
101780573|NCT02889523|Rituximab|rituximab|mesh-list
101780574|NCT02889523|Doxorubicin|doxorubicin|mesh-list
101780575|NCT02889523|Vincristine|vincristine|mesh-list
101780576|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780577|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
101780578|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780579|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780580|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780581|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
101780582|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780583|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780584|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780594|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780595|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
101780596|NCT02889523|Hormones|hormones|mesh-ancestor
101780597|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780598|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780599|NCT02771626|Nivolumab|nivolumab|mesh-list
101780600|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780601|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780602|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780603|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780604|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
101780605|NCT02616302|Lansoprazole|lansoprazole|mesh-list
101780606|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101780607|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780608|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101780609|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780610|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780611|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101780612|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101780613|NCT02469753|Analgesics|analgesics|mesh-ancestor
101780614|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
101780615|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780616|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780617|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780618|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780644|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780655|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
101780656|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101780657|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101780658|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780659|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
101780660|NCT02314988|Coagulants|coagulants|mesh-ancestor
101780661|NCT02272790|Paclitaxel|paclitaxel|mesh-list
101780662|NCT02272790|Carboplatin|carboplatin|mesh-list
101780663|NCT02272790|Gemcitabine|gemcitabine|mesh-list
101438073|NCT00167648|Estradiol|estradiol|mesh-list
101780664|NCT02272790|Adavosertib|adavosertib|mesh-list
101780665|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309525|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
101780666|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780667|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414909|NCT00495547|Azacitidine|azacitidine|mesh-list
101780668|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780669|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414910|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
101780670|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780672|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
101780673|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780674|NCT02113657|Ipilimumab|ipilimumab|mesh-list
101780675|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780676|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780677|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780678|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780679|NCT02035787|Metformin|metformin|mesh-list
101780680|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101780681|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536544|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
101780682|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
101780683|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101780684|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101780685|NCT01850355|Buspirone|buspirone|mesh-list
101780686|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101780687|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101780688|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780689|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780690|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101780691|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101780692|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
101780693|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780694|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780695|NCT01582776|Lenalidomide|lenalidomide|mesh-list
101780696|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
101780697|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
101780698|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780699|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101780700|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101780701|NCT01582776|Growth Substances|growth substances|mesh-ancestor
101780702|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
101780703|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780704|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780705|NCT01464164|Prednisone|prednisone|mesh-list
101780706|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780707|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
101780708|NCT01464164|Hormones|hormones|mesh-ancestor
101780709|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780710|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780711|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780712|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780713|NCT01377389|Ipilimumab|ipilimumab|mesh-list
101780714|NCT01377389|Leuprolide|leuprolide|mesh-list
101780715|NCT01377389|Goserelin|goserelin|mesh-list
101780716|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780717|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780718|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780719|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780720|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101780721|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
101780722|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101780723|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780724|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780725|NCT01194271|Ipilimumab|ipilimumab|mesh-list
101780726|NCT01194271|Leuprolide|leuprolide|mesh-list
101780727|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780728|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780729|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780730|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780731|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101541527|NCT01116232|Sirolimus|sirolimus|mesh-list
101780732|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
101780733|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101780734|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780735|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780736|NCT01119508|Temozolomide|temozolomide|mesh-list
101780737|NCT01119508|Ipilimumab|ipilimumab|mesh-list
101780738|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780739|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
101780740|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780741|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780742|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780743|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101780744|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
101780745|NCT00602459|Rituximab|rituximab|mesh-list
101780746|NCT00602459|Fludarabine|fludarabine|mesh-list
101780747|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
101780748|NCT00602459|Lenalidomide|lenalidomide|mesh-list
101780749|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101780750|NCT00602459|Antibodies|antibodies|mesh-list
101780751|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
101780752|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101780753|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780754|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
101780755|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780756|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780757|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780758|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
101780759|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780760|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780761|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780762|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780763|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
101780764|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101780765|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101780766|NCT00602459|Growth Substances|growth substances|mesh-ancestor
101780767|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101780768|NCT00199069|Cytarabine|cytarabine|mesh-list
101780769|NCT00199069|Dexamethasone|dexamethasone|mesh-list
101780770|NCT00199069|Prednisolone|prednisolone|mesh-list
101780771|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
101780772|NCT00199069|Ifosfamide|ifosfamide|mesh-list
101780773|NCT00199069|Methotrexate|methotrexate|mesh-list
101780774|NCT00199069|Vincristine|vincristine|mesh-list
101780775|NCT00199069|Doxorubicin|doxorubicin|mesh-list
101780776|NCT00199069|Daunorubicin|daunorubicin|mesh-list
101780777|NCT00199069|Asparaginase|asparaginase|mesh-list
101780778|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
101780779|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
101780780|NCT00199069|Thioguanine|thioguanine|mesh-list
101780781|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780782|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
101780783|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780784|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780785|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101780786|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
101780787|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780788|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780789|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101780790|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780791|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
101780792|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
101780793|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780794|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780795|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
101541537|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101780796|NCT00199069|Hormones|hormones|mesh-ancestor
101780797|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780798|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541545|NCT04550351|Vaccines|vaccines|mesh-list
101780799|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101780801|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101780802|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780803|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
101780804|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
101780805|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780806|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101780807|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101780808|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
101780809|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780810|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101780811|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780812|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780813|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780814|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101780815|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101780816|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101780817|NCT00199069|Analgesics|analgesics|mesh-ancestor
101780818|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
101780819|NCT00199043|Allopurinol|allopurinol|mesh-list
101780820|NCT00199043|Rasburicase|rasburicase|mesh-list
101780821|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
101780822|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780823|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780824|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
101780825|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101780826|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101780827|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
101780828|NCT00199043|Protective Agents|protective agents|mesh-ancestor
101780829|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780830|NCT02601989|Tadalafil|tadalafil|mesh-list
101780831|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
101780832|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101780833|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101780834|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780835|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780836|NCT02601989|Urological Agents|urological agents|mesh-ancestor
101780837|NCT01067053|Bevacizumab|bevacizumab|mesh-list
101780838|NCT01067053|Capecitabine|capecitabine|mesh-list
101780839|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
101780840|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101780841|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780842|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101780843|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101780844|NCT01067053|Growth Substances|growth substances|mesh-ancestor
101780845|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780846|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
101780847|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780848|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
101780849|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780850|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
101780851|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101780852|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101780853|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101780854|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780855|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780856|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
101780857|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541546|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
101780858|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780859|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101780860|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780862|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
101780863|NCT01067365|Enclomiphene|enclomiphene|mesh-list
101780864|NCT01067365|Clomiphene|clomiphene|mesh-list
101780865|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
101780866|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
101780867|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101780868|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
101780869|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
101780870|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780871|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101780872|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
101780873|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780874|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780875|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101780876|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
101780877|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101780878|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101780879|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101780880|NCT00568776|Inositol|inositol|mesh-list
101780881|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
101780882|NCT00568776|Vitamins|vitamins|mesh-ancestor
101780883|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
101780884|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780885|NCT01067443|Amphotericin B|amphotericin b|mesh-list
101309535|NCT02648997|Ipilimumab|ipilimumab|mesh-list
101780886|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101780887|NCT01067443|Miltefosine|miltefosine|mesh-list
101780888|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101780889|NCT01067443|Amebicides|amebicides|mesh-ancestor
101780890|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101780891|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101780892|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101780893|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101780894|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
101780895|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780896|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
101780897|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101780898|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
101780899|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101780900|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101780901|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101780902|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780903|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780904|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
101780905|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780906|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780907|NCT00822666|Clopidogrel|clopidogrel|mesh-list
101780908|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101780909|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101780910|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101780911|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101780912|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
101780913|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780914|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780915|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780917|NCT00816816|Fluorouracil|fluorouracil|mesh-list
101780918|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780919|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101780920|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101780921|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101780922|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780923|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
101780924|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101780925|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101780926|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
101780927|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780928|NCT00816894|Olanzapine|olanzapine|mesh-list
101780929|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
101780930|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
101780931|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780932|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780933|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780934|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101780935|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101780936|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101780937|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101780938|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101780939|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101780940|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780941|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780942|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780944|NCT00635154|Dexamethasone|dexamethasone|mesh-list
101780945|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
101780946|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101780947|NCT00635154|BB 1101|bb 1101|mesh-list
101780948|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101780949|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
101780950|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
101780951|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780952|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780953|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780954|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
101780955|NCT00635154|Hormones|hormones|mesh-ancestor
101780956|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780957|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780958|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780960|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101780961|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101780962|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780963|NCT00822744|Escitalopram|escitalopram|mesh-list
101780964|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101780965|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101780966|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101780967|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780968|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780969|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
101780970|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780971|NCT00819468|Teduglutide|teduglutide|mesh-list
101414919|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
101414920|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780972|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101780973|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101780974|NCT00819468|Protective Agents|protective agents|mesh-ancestor
101780975|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780977|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101780978|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
101780979|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101780980|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780981|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101780982|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101780983|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
101780984|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101780985|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101780986|NCT00778817|Mitotane|mitotane|mesh-list
101780987|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101780988|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101780989|NCT00293059|Dienogest|dienogest|mesh-list
101780990|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101780991|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101780992|NCT00293059|Estradiol|estradiol|mesh-list
101780993|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101780994|NCT00293059|Estrogens|estrogens|mesh-ancestor
101780995|NCT00293059|Hormones|hormones|mesh-ancestor
101780996|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101780997|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101780998|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101780999|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
101781000|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101781001|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101781002|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101781003|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101781005|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
101781006|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101781007|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781008|NCT00756275|Nicotine|nicotine|mesh-list
101781009|NCT00756275|Varenicline|varenicline|mesh-list
101781010|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101781011|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
101781012|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781013|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781014|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101781015|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101781016|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781017|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781018|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781019|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
101781020|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101781021|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
101781022|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101781023|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
101781024|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536567|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101781025|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781026|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
101781027|NCT00298831|Rocuronium|rocuronium|mesh-list
101781028|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101781029|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101781030|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101781031|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781032|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781033|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101781034|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101781035|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781036|NCT00758069|Incretins|incretins|mesh-ancestor
101781037|NCT00758069|Hormones|hormones|mesh-ancestor
101781038|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781039|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101781040|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
101781041|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781042|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781044|NCT01067677|Promethazine|promethazine|mesh-list
101781045|NCT01067677|Ondansetron|ondansetron|mesh-list
101781046|NCT01067677|Metoclopramide|metoclopramide|mesh-list
101781047|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
101781048|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
101781049|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781050|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781051|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781052|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
101781053|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781054|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101781055|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101781056|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
101781057|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781058|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781059|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101781060|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101781061|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781062|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
101781063|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
101781064|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
101781065|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101781066|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
101781067|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
101781068|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101781069|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101781071|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
101781072|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
101781073|NCT03979651|Trametinib|trametinib|mesh-list
101781074|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
101781075|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101781076|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101781077|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781078|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781079|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781080|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781081|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781082|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781083|NCT02600741|Droperidol|droperidol|mesh-list
101781084|NCT02600741|Haloperidol|haloperidol|mesh-list
101781085|NCT02600741|Pimozide|pimozide|mesh-list
101781086|NCT02600741|Olanzapine|olanzapine|mesh-list
101781087|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
101781088|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
101781089|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
101781090|NCT02600741|Risperidone|risperidone|mesh-list
101781091|NCT02600741|Aripiprazole|aripiprazole|mesh-list
101781092|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101781093|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101781094|NCT02600741|Ziprasidone|ziprasidone|mesh-list
101781095|NCT02600741|Clozapine|clozapine|mesh-list
101781096|NCT02600741|Asenapine|asenapine|mesh-list
101781097|NCT02600741|Loxapine|loxapine|mesh-list
101781098|NCT02600741|Iloperidone|iloperidone|mesh-list
101781099|NCT02600741|Perphenazine|perphenazine|mesh-list
101781100|NCT02600741|Fluphenazine|fluphenazine|mesh-list
101541606|NCT04528797|Prednisolone|prednisolone|mesh-list
101781101|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
101781102|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101781103|NCT02600741|Thioridazine|thioridazine|mesh-list
101781104|NCT02600741|Thiothixene|thiothixene|mesh-list
101781105|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101781106|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
101781107|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781108|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781109|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781110|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101781111|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781112|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781113|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781114|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101781115|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
101781116|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
101781117|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
101781118|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781119|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781120|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101781121|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781122|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781123|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781124|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
101781125|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101781126|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101781127|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101781128|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101781129|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101781130|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
101781131|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
101781132|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101781133|NCT01065649|Nortriptyline|nortriptyline|mesh-list
101781134|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101781135|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781136|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781137|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101781138|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781139|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781140|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781141|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781142|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781143|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781144|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
101781145|NCT01065727|Natalizumab|natalizumab|mesh-list
101781146|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
101781147|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101781148|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
101781149|NCT01065727|Analgesics|analgesics|mesh-ancestor
101781150|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
101781151|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781152|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781153|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781154|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101781155|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101781156|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781157|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781158|NCT01065805|Alovudine|alovudine|mesh-list
101781159|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
101781160|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781161|NCT00311623|Sirolimus|sirolimus|mesh-list
101781162|NCT00311623|Temsirolimus|temsirolimus|mesh-list
101541619|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101781163|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
101781164|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101781165|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781166|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101781167|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781168|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
101781169|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781170|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
101781171|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781172|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781173|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781174|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781175|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
101781176|NCT01067989|Pamidronate|pamidronate|mesh-list
101781177|NCT01067989|Celecoxib|celecoxib|mesh-list
101781178|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
101781179|NCT01067989|Capecitabine|capecitabine|mesh-list
101781180|NCT01067989|Methotrexate|methotrexate|mesh-list
101781181|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781182|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
101781183|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781184|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781185|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101781186|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
101781187|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781188|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781189|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101781190|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101781191|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
101781192|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101781193|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
101781194|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101781195|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781196|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438606|NCT05994599|NuvaRing|nuvaring|mesh-list
101781197|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101781198|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101781199|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101781200|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101781201|NCT01067989|Analgesics|analgesics|mesh-ancestor
101781202|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
101781203|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781204|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781205|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101781206|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101781207|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101781208|NCT00633594|Rituximab|rituximab|mesh-list
101781209|NCT00633594|Lenalidomide|lenalidomide|mesh-list
101781210|NCT00633594|Bortezomib|bortezomib|mesh-list
101781211|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101781213|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
101781214|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781215|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781216|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101781217|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541638|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101781218|NCT00633594|Growth Substances|growth substances|mesh-ancestor
101781219|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101781220|NCT04840888|Itraconazole|itraconazole|mesh-list
101781221|NCT04840888|Carbamazepine|carbamazepine|mesh-list
101781222|NCT04840888|Omeprazole|omeprazole|mesh-list
101781223|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101781224|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781225|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101781226|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781227|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781228|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
101781229|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781230|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101781231|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101781232|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101781233|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
101781234|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781235|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781236|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101781237|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
101781238|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
101781239|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781240|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781241|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781242|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101781243|NCT04840888|Analgesics|analgesics|mesh-ancestor
101781244|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
101781245|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781246|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101781247|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781248|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101781249|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101781250|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101781251|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101781252|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781253|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781254|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781255|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781256|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781257|NCT00755807|Analgesics|analgesics|mesh-ancestor
101781258|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
101781259|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781260|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781261|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781262|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
101781263|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
101781264|NCT05372224|Vitamin D|vitamin d|mesh-list
101781265|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101781266|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781267|NCT05372224|Vitamins|vitamins|mesh-ancestor
101781268|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
101781269|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101781270|NCT00631410|Sunitinib|sunitinib|mesh-list
101438672|NCT05993975|Dexmedetomidine|dexmedetomidine|mesh-list
101781271|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781272|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101781273|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101781274|NCT00631410|Growth Substances|growth substances|mesh-ancestor
101781275|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781276|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
101781277|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781278|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781279|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781280|NCT00817284|Bevacizumab|bevacizumab|mesh-list
101781281|NCT00817284|Irinotecan|irinotecan|mesh-list
101781282|NCT00817284|Temozolomide|temozolomide|mesh-list
101781283|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101781284|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781285|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101781286|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101781287|NCT00817284|Growth Substances|growth substances|mesh-ancestor
101781288|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781289|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
101781290|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101781291|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101781292|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781293|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781294|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101781295|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
101781296|NCT04096157|Isavuconazole|isavuconazole|mesh-list
101781297|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
101781298|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781299|NCT00823290|Sorafenib|sorafenib|mesh-list
101781300|NCT00823290|Panobinostat|panobinostat|mesh-list
101781301|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781302|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781303|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781304|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781305|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101781306|NCT00755417|Gabapentin|gabapentin|mesh-list
101781308|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
101781309|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781310|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781311|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
101781312|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101781313|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781314|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781315|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781316|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101781317|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101781318|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781319|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781320|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
101781321|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
101781322|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101781323|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101781324|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101781325|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101781326|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541663|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101781327|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781328|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781329|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781330|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781331|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101781332|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781333|NCT00825864|Dexamethasone|dexamethasone|mesh-list
101781334|NCT00825864|Diclofenac|diclofenac|mesh-list
101781335|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
101781336|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101781338|NCT00825864|BB 1101|bb 1101|mesh-list
101781339|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781340|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
101781341|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
101781342|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781343|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781344|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101438747|NCT05880459|Nalbuphine|nalbuphine|mesh-list
101781345|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
101781346|NCT00825864|Hormones|hormones|mesh-ancestor
101781347|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781348|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101781349|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781350|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101781351|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101781352|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101781353|NCT00825864|Analgesics|analgesics|mesh-ancestor
101781354|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
101781355|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412066|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
101781356|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101781357|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781358|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781359|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
101781360|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101781361|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101781362|NCT00527332|Fentanyl|fentanyl|mesh-list
101781363|NCT00527332|Morphine|morphine|mesh-list
101781364|NCT00527332|Bupivacaine|bupivacaine|mesh-list
101781365|NCT00527332|Propofol|propofol|mesh-list
101781366|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
101781367|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
101781368|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781369|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781370|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
101781371|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781372|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101781373|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101781374|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
101781375|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101781376|NCT00527332|Narcotics|narcotics|mesh-ancestor
101781377|NCT00527332|Analgesics|analgesics|mesh-ancestor
101309565|NCT02373813|Analgesics|analgesics|mesh-ancestor
101781378|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101781379|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101541690|NCT04315909|Vitamin E|vitamin e|mesh-list
101541691|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101781380|NCT00820092|Hormones|hormones|mesh-ancestor
101781381|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781382|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781383|NCT00823602|Buserelin|buserelin|mesh-list
101781384|NCT00823602|Ganirelix|ganirelix|mesh-list
101781385|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
101781386|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781387|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781388|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101781389|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
101781390|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101781391|NCT00820326|Dolasetron|dolasetron|mesh-list
101781392|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
101781393|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
101781394|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781395|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781396|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781397|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101781398|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101781400|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781401|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781402|NCT00916097|Docetaxel|docetaxel|mesh-list
101781403|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781404|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101781405|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101781406|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101781407|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781408|NCT00629772|Infliximab|infliximab|mesh-list
101781409|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101781410|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781411|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781412|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781413|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781414|NCT00526630|Methylphenidate|methylphenidate|mesh-list
101781415|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101781416|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781417|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101781418|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781419|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536623|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781420|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781421|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
101781422|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781423|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
101781424|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101781425|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101781426|NCT00755183|Testosterone|testosterone|mesh-list
101781427|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
101781428|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
101781429|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101781430|NCT00755183|Androgens|androgens|mesh-ancestor
101781431|NCT00755183|Hormones|hormones|mesh-ancestor
101781432|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781433|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781434|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101781435|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781436|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
101781437|NCT00826254|Vitamins|vitamins|mesh-list
101781438|NCT00826254|Vitamin K|vitamin k|mesh-list
101781439|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
101781440|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781441|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101781442|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101781443|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781444|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
101781445|NCT00826254|Coagulants|coagulants|mesh-ancestor
101781446|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101781447|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
101781448|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781450|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101781451|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781452|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781453|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101781454|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781455|NCT00820482|Menotropins|menotropins|mesh-list
101781456|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101781457|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
101781458|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101781459|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781460|NCT00754793|Dexetimide|dexetimide|mesh-list
101781461|NCT00754793|Citalopram|citalopram|mesh-list
101781462|NCT00754793|Escitalopram|escitalopram|mesh-list
101781463|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101781464|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781465|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781466|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781467|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781468|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
101781469|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781470|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101781471|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101781472|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
101781473|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
101781474|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781475|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101781476|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101781477|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781478|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101781479|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781480|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781481|NCT00826566|Caffeine|caffeine|mesh-list
101781482|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101781483|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781484|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101781485|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781486|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781487|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101781488|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101781489|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
101781490|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781491|NCT03999190|Raclopride|raclopride|mesh-list
101781492|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
101781493|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101781494|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781495|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101781496|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781497|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781498|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541718|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781499|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
101781500|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781501|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101781502|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781503|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781504|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781505|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101781507|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101781508|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781509|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
101781510|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101781511|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
101781512|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781513|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781514|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101781515|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
101781516|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101781517|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
101781518|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781519|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781520|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101781521|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
101781522|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
101781523|NCT00626028|Protective Agents|protective agents|mesh-ancestor
101781524|NCT00826644|Etoposide|etoposide|mesh-list
101781525|NCT00826644|Belotecan|belotecan|mesh-list
101781526|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781527|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101781528|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101781530|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781531|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781532|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101781533|NCT00826722|Levetiracetam|levetiracetam|mesh-list
101781534|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
101781535|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
101781536|NCT04922944|Vaccines|vaccines|mesh-list
101781537|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
101781538|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781539|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
101781540|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781541|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781542|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781543|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781544|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
101781545|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781546|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781547|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781548|NCT04044378|Ifosfamide|ifosfamide|mesh-list
101781549|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101781550|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
101781551|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781552|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536637|NCT00471315|Analgesics|analgesics|mesh-ancestor
101781553|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101781554|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
101781555|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101781556|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101781557|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101781558|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101781559|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
101781560|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781561|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541735|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781562|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101781563|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101781564|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101781565|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781566|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781567|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781568|NCT00821028|Paclitaxel|paclitaxel|mesh-list
101781569|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101781570|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781571|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101781572|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101781573|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101781574|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781575|NCT00826878|Tivozanib|tivozanib|mesh-list
101781576|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781577|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781578|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781579|NCT00827034|Warfarin|warfarin|mesh-list
101781580|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
101781581|NCT02600585|Vaccines|vaccines|mesh-list
101781582|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
101781583|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781584|NCT00525148|Afatinib|afatinib|mesh-list
101781585|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781586|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781587|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781588|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781589|NCT00754325|Dasatinib|dasatinib|mesh-list
101781590|NCT00754325|Fulvestrant|fulvestrant|mesh-list
101781591|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781592|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781593|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781594|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781595|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101781596|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101781597|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101781598|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
101781599|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781600|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781601|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
101781602|NCT00524680|Vitamin D|vitamin d|mesh-list
101781603|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101781604|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781605|NCT00524680|Vitamins|vitamins|mesh-ancestor
101781606|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
101781607|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101781608|NCT00298363|Tenofovir|tenofovir|mesh-list
101781609|NCT00298363|Emtricitabine|emtricitabine|mesh-list
101781610|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101781611|NCT00298363|Entecavir|entecavir|mesh-list
101781612|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
101781613|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781614|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101781615|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101781616|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781617|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781618|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101781619|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101781620|NCT00821262|Propofol|propofol|mesh-list
101781621|NCT00821262|Sevoflurane|sevoflurane|mesh-list
101781622|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101781623|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781624|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781625|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101781626|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
101781627|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
101781628|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101781629|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101781630|NCT00524368|Ritonavir|ritonavir|mesh-list
101781631|NCT00524368|Darunavir|darunavir|mesh-list
101781632|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101781633|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101781634|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
101781635|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781636|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781637|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101781638|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101781639|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
101781640|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781641|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101781642|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101781643|NCT00777101|Capecitabine|capecitabine|mesh-list
101781644|NCT00777101|Lapatinib|lapatinib|mesh-list
101781645|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101781646|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
101781647|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781649|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781650|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781651|NCT00830856|Lamivudine|lamivudine|mesh-list
101781652|NCT00830856|Nevirapine|nevirapine|mesh-list
101781653|NCT00830856|Stavudine|stavudine|mesh-list
101781654|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
101781655|NCT00830856|Fluconazole|fluconazole|mesh-list
101781656|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101781657|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101781658|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781659|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781660|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
101781661|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781662|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101781663|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101781664|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
101781665|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101781666|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101781667|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101781668|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
101781669|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781670|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781671|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101781672|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101781673|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101781674|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101781676|NCT01068067|Tacrolimus|tacrolimus|mesh-list
101781677|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781678|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
101781679|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781680|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101781681|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781682|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781683|NCT00524134|Carvedilol|carvedilol|mesh-list
101781684|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101781685|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101781686|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781687|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781688|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781689|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781690|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101781691|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
101781692|NCT00524134|Protective Agents|protective agents|mesh-ancestor
101781693|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101781694|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781695|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101781696|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
101781697|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101781698|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101781699|NCT00777023|Gabapentin|gabapentin|mesh-list
101781700|NCT00777023|Analgesics|analgesics|mesh-ancestor
101781701|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
101781702|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781703|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781704|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
101781705|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101781706|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101781707|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781708|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781709|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101781710|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101781711|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781712|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781713|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
101781714|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101309599|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
101781715|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101439128|NCT05572515|Hormones|hormones|mesh-ancestor
101781716|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
101781717|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101781718|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101781719|NCT00297037|Analgesics|analgesics|mesh-ancestor
101781720|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
101781721|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781722|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781723|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781724|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781725|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781726|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781727|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
101781728|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101781729|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781730|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781731|NCT00292981|Complement C1s|complement c1s|mesh-list
101781732|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101781733|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101781734|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
101781735|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781736|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101781737|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781738|NCT02598869|Triamcinolone|triamcinolone|mesh-list
101781739|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101781740|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101781741|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101781742|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781743|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
101781744|NCT02598869|Hormones|hormones|mesh-ancestor
101781745|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781746|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781747|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781748|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
101781749|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781750|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781751|NCT04095455|Ketamine|ketamine|mesh-list
101781752|NCT04095455|Analgesics|analgesics|mesh-ancestor
101781753|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
101781754|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781755|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781756|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101781757|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101781758|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
101781759|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
101781760|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781761|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101781762|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101781763|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414942|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781764|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781765|NCT04095299|Capecitabine|capecitabine|mesh-list
101781766|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101781767|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
101781768|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781769|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781771|NCT00296725|Imipramine|imipramine|mesh-list
101781772|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101781773|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781774|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781775|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781776|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781777|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
101781778|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781779|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101781780|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781781|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781782|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101781783|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101781784|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781785|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101781786|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101781787|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781789|NCT00523978|Flecainide|flecainide|mesh-list
101781790|NCT00523978|Propafenone|propafenone|mesh-list
101781791|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101781792|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101781793|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781794|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781795|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781796|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781797|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101781798|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
101781799|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
101781800|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781801|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101781802|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101781803|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781804|NCT00296647|Bupropion|bupropion|mesh-list
101781805|NCT00296647|Nicotine|nicotine|mesh-list
101781806|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101781807|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
101781808|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781809|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781810|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101781811|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101781812|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781813|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781814|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781815|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101781816|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
101781817|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101781818|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101781819|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101781820|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781821|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
101781822|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101414944|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781823|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101781824|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781825|NCT00754013|Donepezil|donepezil|mesh-list
101781826|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101781827|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781828|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781829|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781830|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781831|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781832|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
101781833|NCT00523744|Amlodipine|amlodipine|mesh-list
101781834|NCT00523744|Valsartan|valsartan|mesh-list
101781835|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101781836|NCT00523744|Olmesartan|olmesartan|mesh-list
101781837|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101781838|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101781839|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101781840|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101781841|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781842|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101781843|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781844|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
101781845|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101781846|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101781849|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101781850|NCT03979625|Heparin|heparin|mesh-list
101781851|NCT03979625|Antibodies|antibodies|mesh-list
101781852|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
101781853|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781854|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
101781855|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101781856|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101781857|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781859|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
101781860|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101781861|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439281|NCT05453903|Cytarabine|cytarabine|mesh-list
101781862|NCT00752219|Metronidazole|metronidazole|mesh-list
101781863|NCT00752219|Meropenem|meropenem|mesh-list
101781864|NCT00752219|Ceftazidime|ceftazidime|mesh-list
101781865|NCT00752219|Avibactam|avibactam|mesh-list
101781866|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781867|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101781868|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101781869|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101781870|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101781871|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781872|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781873|NCT02598791|Glucagon|glucagon|mesh-list
101781874|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101781875|NCT02598791|Incretins|incretins|mesh-ancestor
101781876|NCT02598791|Hormones|hormones|mesh-ancestor
101781877|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101781878|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541768|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101781879|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781880|NCT00827346|Clopidogrel|clopidogrel|mesh-list
101781881|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101781882|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101781883|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101781884|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101781885|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
101781886|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781887|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781888|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781890|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101781891|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101781892|NCT00997750|Analgesics|analgesics|mesh-ancestor
101781893|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
101781894|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781895|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781896|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781897|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101781898|NCT00622908|Besifloxacin|besifloxacin|mesh-list
101781899|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101781900|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101781901|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101781902|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101781903|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781904|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781905|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781906|NCT00997828|Everolimus|everolimus|mesh-list
101781907|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101781908|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101781909|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781910|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781911|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101781912|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
101781913|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781914|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781915|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
101781916|NCT02598635|Vitamin D|vitamin d|mesh-list
101781917|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101781918|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781919|NCT02598635|Vitamins|vitamins|mesh-ancestor
101781920|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
101781921|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101781922|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
101781923|NCT04093271|Promethazine|promethazine|mesh-list
101781924|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101781925|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101781926|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101781927|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781929|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
101781930|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
101781931|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781932|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
101781933|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
101781934|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101781935|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101781936|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
101781937|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
101781938|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781939|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781940|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101781941|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
101781942|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781944|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781945|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781946|NCT04094909|Paclitaxel|paclitaxel|mesh-list
101781947|NCT04094909|Cisplatin|cisplatin|mesh-list
101781948|NCT04094909|Carboplatin|carboplatin|mesh-list
101781949|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
101781950|NCT04094909|Pemetrexed|pemetrexed|mesh-list
101781951|NCT04094909|Endostatins|endostatins|mesh-list
101781952|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101781953|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101781954|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101781955|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101781956|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101781957|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781958|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101781959|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101781960|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101781961|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101781962|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101781963|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101781964|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101781965|NCT04094909|Growth Substances|growth substances|mesh-ancestor
101781966|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781967|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
101781968|NCT02599571|Nicotine|nicotine|mesh-list
101781969|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101781970|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
101781971|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781972|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781973|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101781974|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101781975|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
101781976|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781977|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781978|NCT00296491|Fluticasone|fluticasone|mesh-list
101781980|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101781982|NCT00296491|Montelukast|montelukast|mesh-list
101781983|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101781984|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101781985|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
101781986|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101781987|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101781988|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101781989|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
101781990|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
101781991|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101781992|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101781993|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101781994|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101781995|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
101781996|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101781997|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101781998|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101781999|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
101782000|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782001|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101782002|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101782003|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
101782004|NCT00296491|Hormones|hormones|mesh-ancestor
101782005|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
101782006|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101782007|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101782008|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782009|NCT02599493|Rifampin|rifampin|mesh-list
101782010|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101782011|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
101782012|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101782013|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782014|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
101782015|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101782016|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782017|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782018|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101782019|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101782020|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101782021|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101782022|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101782023|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101782024|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
101782025|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
101782026|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782028|NCT00296335|Mitomycin|mitomycin|mesh-list
101782029|NCT00296335|Doxifluridine|doxifluridine|mesh-list
101782030|NCT00296335|Floxuridine|floxuridine|mesh-list
101782031|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782032|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101782033|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
101782034|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782035|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101782036|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782037|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782038|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
101782039|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782040|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
101782041|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782042|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
101782043|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101782044|NCT04094597|Lactoferrin|lactoferrin|mesh-list
101782045|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782046|NCT01065961|Dexamethasone|dexamethasone|mesh-list
101782047|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
101782049|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782050|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
101782051|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
101782052|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782053|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782054|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782055|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
101782056|NCT01065961|Hormones|hormones|mesh-ancestor
101782057|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782058|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782059|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782060|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782061|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782062|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782063|NCT01068223|Cetirizine|cetirizine|mesh-list
101782064|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101782065|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101782066|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101782067|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
101782068|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
101782069|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782070|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782071|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782073|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782074|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
101782075|NCT04234360|Hormones|hormones|mesh-ancestor
101782076|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782077|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782078|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782079|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782080|NCT02600273|Nicotine|nicotine|mesh-list
101782081|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101782082|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
101782083|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541806|NCT01181011|Amlodipine|amlodipine|mesh-list
101782084|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782085|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101782086|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101782087|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
101782088|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782089|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782091|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782092|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782093|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101782094|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782095|NCT01068301|Plerixafor|plerixafor|mesh-list
101782096|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101782097|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101782098|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
101782099|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782100|NCT04999228|Infliximab|infliximab|mesh-list
101782101|NCT04999228|Mesalamine|mesalamine|mesh-list
101782102|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101782103|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782104|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101782105|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782106|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782107|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101782108|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101782109|NCT04999228|Analgesics|analgesics|mesh-ancestor
101782110|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
101782111|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782112|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782113|NCT01564810|Cetuximab|cetuximab|mesh-list
101782114|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782115|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782116|NCT04093895|Taurolidine|taurolidine|mesh-list
101782117|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782118|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101782119|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782120|NCT00624780|Pregabalin|pregabalin|mesh-list
101782121|NCT00624780|Lorazepam|lorazepam|mesh-list
101782122|NCT00624780|Analgesics|analgesics|mesh-ancestor
101782123|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
101782124|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782125|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782126|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
101782127|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782128|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782129|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782130|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782131|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101782132|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101309626|NCT00006051|Fluorouracil|fluorouracil|mesh-list
101782133|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782134|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782135|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
101782136|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
101782137|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782138|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101782139|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
101782140|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
101782141|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782142|NCT02599337|Sorafenib|sorafenib|mesh-list
101782143|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782144|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782145|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782146|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782147|NCT00831636|Cytarabine|cytarabine|mesh-list
101782148|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782149|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
101782150|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782151|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782152|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
101782153|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782154|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782155|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
101782156|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782157|NCT00750737|Amphotericin B|amphotericin b|mesh-list
101439576|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
101782158|NCT00750737|Posaconazole|posaconazole|mesh-list
101782159|NCT00750737|Amebicides|amebicides|mesh-ancestor
101782160|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101782161|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101782162|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782163|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101782164|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
101782165|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101782166|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101782167|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101782168|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536678|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782169|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782170|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101782171|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
101782172|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782173|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782174|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
101782175|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782176|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782177|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
101782178|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
101782179|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
101782180|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782181|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
101782182|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101782183|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
101782184|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101782185|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782186|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782187|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782188|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
101782189|NCT02597699|Lidocaine|lidocaine|mesh-list
101782190|NCT02597699|Sufentanil|sufentanil|mesh-list
101782191|NCT02597699|Remifentanil|remifentanil|mesh-list
101782193|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
101782194|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
101782195|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782196|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782197|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
101782198|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782199|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101782200|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101309634|NCT00006054|Cyclosporine|cyclosporine|mesh-list
101782201|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101782202|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782203|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782204|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101782205|NCT02597699|Narcotics|narcotics|mesh-ancestor
101782206|NCT02597699|Analgesics|analgesics|mesh-ancestor
101782207|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101782208|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101782209|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
101782210|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
101414953|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101414957|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101782211|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782212|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101782213|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782214|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782215|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101782216|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782217|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782218|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101782219|NCT00744653|Bleomycin|bleomycin|mesh-list
101782220|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101782221|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782222|NCT00998218|Ranolazine|ranolazine|mesh-list
101782223|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101782224|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782225|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782226|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101782227|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101782228|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
101782229|NCT00311311|Sirolimus|sirolimus|mesh-list
101782230|NCT00311311|Prednisone|prednisone|mesh-list
101782231|NCT00311311|Tacrolimus|tacrolimus|mesh-list
101782232|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782233|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
101782234|NCT00311311|Hormones|hormones|mesh-ancestor
101782235|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782236|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439673|NCT05090085|Z 350|z 350|mesh-list
101782237|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782238|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782239|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782240|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
101782241|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101782242|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782243|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782244|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101782245|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101782246|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
101782247|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101782248|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782249|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
101782250|NCT04089605|Dexamethasone|dexamethasone|mesh-list
101782251|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
101782252|NCT04089605|Ranibizumab|ranibizumab|mesh-list
101782253|NCT04089605|BB 1101|bb 1101|mesh-list
101782254|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782255|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
101782256|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
101309639|NCT00006054|Methotrexate|methotrexate|mesh-list
101782257|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782258|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782259|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782260|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
101782262|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782263|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782264|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782265|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782266|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782267|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782268|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101782269|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101782270|NCT04089605|Growth Substances|growth substances|mesh-ancestor
101782271|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
101782272|NCT00521404|Gemcitabine|gemcitabine|mesh-list
101782273|NCT00521404|Antibodies|antibodies|mesh-list
101782274|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
101782275|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782276|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782277|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
101782278|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782279|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782281|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101782282|NCT00311155|Olmesartan|olmesartan|mesh-list
101782283|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101782284|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101782285|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782286|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782287|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782288|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782289|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782290|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
101782291|NCT00311155|Diuretics|diuretics|mesh-ancestor
101782292|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
101782293|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101782294|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101782295|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101782296|NCT03981601|Lovastatin|lovastatin|mesh-list
101782297|NCT03981601|L 647318|l 647318|mesh-list
101782298|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
101782299|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101782300|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101782301|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
101782302|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782303|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101782304|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101782305|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782306|NCT00274651|Belinostat|belinostat|mesh-list
101782307|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782308|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101782309|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536713|NCT00470184|Capecitabine|capecitabine|mesh-list
101782310|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782311|NCT00274261|Nonoxynol|nonoxynol|mesh-list
101782312|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101782313|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101782314|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782315|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101782316|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
101782317|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101782318|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101782320|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101782321|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101782323|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782324|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
101782325|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782326|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782327|NCT01068847|Cycloserine|cycloserine|mesh-list
101782329|NCT01068847|Nifedipine|nifedipine|mesh-list
101782330|NCT01068847|Tizanidine|tizanidine|mesh-list
101782331|NCT01068847|Naloxone|naloxone|mesh-list
101782332|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101782333|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782334|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
101782335|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782336|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782337|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782338|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782339|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782340|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
101782341|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
101782342|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101782343|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101782344|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782345|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101541844|NCT04546373|Niraparib|niraparib|mesh-list
101782346|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
101782347|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101782348|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
101782349|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101782350|NCT01068847|Analgesics|analgesics|mesh-ancestor
101782351|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
101782352|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101782353|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101782354|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
101782355|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
101782356|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101782357|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101782358|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101782359|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101782360|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782361|NCT00827892|Pioglitazone|pioglitazone|mesh-list
101782362|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101782363|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782364|NCT01070875|Heparin|heparin|mesh-list
101782365|NCT01070875|Calcium heparin|calcium heparin|mesh-list
101782366|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
101782367|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101782368|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101782369|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782370|NCT04043676|Ponatinib|ponatinib|mesh-list
101782371|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536719|NCT04570254|Vitamins|vitamins|mesh-list
101782372|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782373|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782374|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782375|NCT01325935|Clopidogrel|clopidogrel|mesh-list
101782376|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101782377|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101782378|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101782379|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101782380|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
101782381|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782382|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782383|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782384|NCT02549742|Bleomycin|bleomycin|mesh-list
101782385|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101782386|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782388|NCT00521014|Rituximab|rituximab|mesh-list
101782389|NCT00521014|Etoposide|etoposide|mesh-list
101782390|NCT00521014|Melphalan|melphalan|mesh-list
101782391|NCT00521014|Carmustine|carmustine|mesh-list
101782392|NCT00521014|Sargramostim|sargramostim|mesh-list
101782393|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782394|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782395|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
101782396|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782397|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782398|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782399|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101782400|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101782401|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782402|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541849|NCT01645410|Atorvastatin|atorvastatin|mesh-list
101782403|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782404|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
101782405|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
101782406|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782407|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782408|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101782409|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
101782410|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101782411|NCT00825552|Risperidone|risperidone|mesh-list
101782412|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101782413|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
101782414|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782415|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782416|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782417|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101782418|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782419|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782420|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782421|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101782422|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
101782423|NCT00291577|Docetaxel|docetaxel|mesh-list
101782424|NCT00291577|Sunitinib|sunitinib|mesh-list
101782425|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782426|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
101782427|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
101782428|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
101782429|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782430|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101782431|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101782432|NCT00291577|Growth Substances|growth substances|mesh-ancestor
101782433|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782434|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
101782435|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782436|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782437|NCT00520936|Pemetrexed|pemetrexed|mesh-list
101782438|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782439|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782440|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782441|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101782442|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101782443|NCT02549430|Letrozole|letrozole|mesh-list
101782444|NCT02549430|Fulvestrant|fulvestrant|mesh-list
101782445|NCT02549430|Palbociclib|palbociclib|mesh-list
101782446|NCT02549430|Anastrozole|anastrozole|mesh-list
101782447|NCT02549430|Exemestane|exemestane|mesh-list
101782448|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782449|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101782451|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782452|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782453|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101782454|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101782455|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782456|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782457|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782458|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101782459|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782460|NCT00943839|Sunitinib|sunitinib|mesh-list
101439876|NCT04837014|Acetaminophen|acetaminophen|mesh-list
101782461|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541868|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
101782462|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541876|NCT04546256|Xhance|xhance|mesh-list
101782463|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101782465|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782466|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
101782467|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782468|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782469|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782470|NCT00832182|Insulin|insulin|mesh-list
101782471|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101782472|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
101782473|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
101782474|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
101782475|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
101782476|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101782477|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782478|NCT00952497|Capecitabine|capecitabine|mesh-list
101782479|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782480|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782481|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
101782482|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782483|NCT00828282|Simvastatin|simvastatin|mesh-list
101782484|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101782485|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101782486|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
101782487|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782488|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101782489|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101782490|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782491|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
101782492|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101782493|NCT00952575|Antibodies|antibodies|mesh-list
101782494|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101782495|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
101782496|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
101782497|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782498|NCT03865732|Pregnanolone|pregnanolone|mesh-list
101782499|NCT03865732|Ganaxolone|ganaxolone|mesh-list
101782500|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
101782501|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782502|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782503|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782504|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
101782505|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
101782506|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
101782507|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782508|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
101782509|NCT00944307|Antacids|antacids|mesh-list
101536743|NCT00470067|Doxorubicin|doxorubicin|mesh-list
101782510|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
101782511|NCT00944307|TEMPO|tempo|mesh-list
101782512|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101782513|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101782514|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
101782515|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782516|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101782517|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101782518|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782519|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782520|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782521|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
101782522|NCT00944307|Protective Agents|protective agents|mesh-ancestor
101782523|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782524|NCT00944385|Urinastatin|urinastatin|mesh-list
101782525|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101782526|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101782527|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782528|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782529|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782530|NCT00953355|Metformin|metformin|mesh-list
101782531|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101782532|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782533|NCT00944463|Gemcitabine|gemcitabine|mesh-list
101782534|NCT00944463|Simvastatin|simvastatin|mesh-list
101782535|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782536|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
101439963|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
101782537|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782538|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782539|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101782540|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101782541|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101782542|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101782543|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782544|NCT00956397|Rifaximin|rifaximin|mesh-list
101782545|NCT00956397|Lactulose|lactulose|mesh-list
101782546|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101782547|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782548|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782549|NCT05300373|Adenosine|adenosine|mesh-list
101782550|NCT05300373|Analgesics|analgesics|mesh-ancestor
101782551|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
101782552|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782553|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782554|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101782555|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
101782556|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101782557|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
101782558|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
101782559|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782560|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782561|NCT00953589|Ribavirin|ribavirin|mesh-list
101782562|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
101782563|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782564|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
101782565|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782566|NCT00947739|Camptothecin|camptothecin|mesh-list
101782567|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782568|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782569|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101782570|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101782571|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782572|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782573|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
101782574|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782575|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782576|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
101782577|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101782578|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101782579|NCT00947895|Prednisolone|prednisolone|mesh-list
101782580|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
101782581|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101782582|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
101782583|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101782585|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782586|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782587|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782588|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
101782589|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
101782590|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782591|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782592|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
101782593|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101782594|NCT00947895|Protective Agents|protective agents|mesh-ancestor
101782595|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782596|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782597|NCT00623766|Dexamethasone|dexamethasone|mesh-list
101782598|NCT00623766|Prednisone|prednisone|mesh-list
101782599|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
101782600|NCT00623766|Prednisolone|prednisolone|mesh-list
101782601|NCT00623766|Triamcinolone|triamcinolone|mesh-list
101782602|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
101782603|NCT00623766|Betamethasone|betamethasone|mesh-list
101782604|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
101782605|NCT00623766|Ipilimumab|ipilimumab|mesh-list
101782606|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782607|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
101782608|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
101782609|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782610|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782611|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782612|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
101440027|NCT04673357|Ustekinumab|ustekinumab|mesh-list
101782613|NCT00623766|Hormones|hormones|mesh-ancestor
101782614|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782615|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101782616|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782617|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782618|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101782619|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782620|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101782621|NCT00623766|Protective Agents|protective agents|mesh-ancestor
101782622|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101782623|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
101782624|NCT00832494|Paclitaxel|paclitaxel|mesh-list
101782625|NCT00832494|Carboplatin|carboplatin|mesh-list
101782626|NCT00832494|Vadimezan|vadimezan|mesh-list
101782627|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782628|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782629|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
101782630|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
101782631|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
101782632|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782633|NCT00837564|Escitalopram|escitalopram|mesh-list
101782634|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101782635|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101782636|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782637|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782638|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782639|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
101782640|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782641|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
101782642|NCT00954135|Sorafenib|sorafenib|mesh-list
101782643|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782644|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
101782645|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782646|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782647|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101782648|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
101536751|NCT00584636|Budesonide|budesonide|mesh-list
101782649|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782650|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782651|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101782652|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782654|NCT00832806|Varenicline|varenicline|mesh-list
101782655|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101782656|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101541897|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
101782657|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
101782658|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782659|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782660|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782661|NCT00832884|Lacosamide|lacosamide|mesh-list
101782662|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
101782663|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101782664|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101782665|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782666|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782667|NCT02549118|Tenoxicam|tenoxicam|mesh-list
101782668|NCT02549118|Meperidine|meperidine|mesh-list
101782669|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101782670|NCT02549118|Narcotics|narcotics|mesh-ancestor
101782671|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782672|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782673|NCT02549118|Analgesics|analgesics|mesh-ancestor
101782674|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
101782675|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782676|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101782677|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101782678|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101782679|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782680|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782681|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101782682|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782683|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782684|NCT00957177|Pregabalin|pregabalin|mesh-list
101782685|NCT00957177|Analgesics|analgesics|mesh-ancestor
101782686|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
101782687|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782688|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782689|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
101782690|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782691|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782692|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782693|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782694|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101782695|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782696|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782697|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782698|NCT04337580|Omeprazole|omeprazole|mesh-list
101782699|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101782700|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782701|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101782702|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782703|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782704|NCT00828594|Sorafenib|sorafenib|mesh-list
101782705|NCT00828594|Everolimus|everolimus|mesh-list
101782706|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782707|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782708|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782709|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782710|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101782712|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
101782713|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782714|NCT00550407|Lamotrigine|lamotrigine|mesh-list
101782715|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
101782716|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782717|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782718|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782719|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782720|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782721|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101782722|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782723|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782724|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782725|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101782726|NCT00957411|Cetuximab|cetuximab|mesh-list
101782727|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782728|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101782729|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
101782730|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
101782731|NCT00837954|Coagulants|coagulants|mesh-ancestor
101782732|NCT00954525|Gemcitabine|gemcitabine|mesh-list
101782733|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101782734|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782735|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
101782736|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782737|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782738|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782739|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782740|NCT00838032|Haloperidol|haloperidol|mesh-list
101782741|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101782742|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
101782743|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
101782744|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782745|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101782746|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782747|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782748|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782749|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
101782750|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
101782751|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782752|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782753|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101782754|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
101782755|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782756|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782757|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101782758|NCT00954603|Haloperidol|haloperidol|mesh-list
101782759|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101782760|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
101782761|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
101782762|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782763|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101782764|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782765|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782766|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782767|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
101782768|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
101782769|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782770|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101782771|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101782772|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
101782773|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782774|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782775|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101782776|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101782778|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101782779|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782780|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782781|NCT02548806|Clonidine|clonidine|mesh-list
101782782|NCT02548806|Analgesics|analgesics|mesh-ancestor
101782783|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
101782784|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782785|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782786|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101782787|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
101782788|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
101782789|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101782790|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101782791|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101782792|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541912|NCT02214680|Timolol|timolol|mesh-list
101782793|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782794|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782795|NCT00549939|Alfuzosin|alfuzosin|mesh-list
101782796|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101782797|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101782798|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101782799|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
101782800|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782801|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782802|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782803|NCT00549939|Urological Agents|urological agents|mesh-ancestor
101782804|NCT00272779|Emtricitabine|emtricitabine|mesh-list
101782805|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101782806|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
101782807|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782808|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101782809|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101782810|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782811|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782812|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101782813|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101782814|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101782815|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101782816|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782817|NCT00957879|Calcitriol|calcitriol|mesh-list
101782818|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
101782819|NCT00957879|Vitamin D|vitamin d|mesh-list
101782820|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782821|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782822|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101782823|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782824|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782825|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101782826|NCT00957879|Vitamins|vitamins|mesh-ancestor
101782827|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
101782828|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101782829|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
101782830|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782831|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782832|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
101440253|NCT04414722|Amoxicillin|amoxicillin|mesh-list
101782833|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782834|NCT00838266|Protective Agents|protective agents|mesh-ancestor
101782835|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782836|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
101782837|NCT04011033|Interleukin-2|interleukin-2|mesh-list
101782838|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101782839|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
101782840|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782841|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782842|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101782843|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
101782844|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782845|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782846|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101782847|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101782848|NCT04011033|Analgesics|analgesics|mesh-ancestor
101782849|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
101782850|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782851|NCT00998608|Risperidone|risperidone|mesh-list
101782852|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101782853|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
101782854|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101782855|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541916|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101541926|NCT02756208|Vaccines|vaccines|mesh-list
101782856|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782857|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101782858|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101782859|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101782860|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101782861|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101782862|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
101782863|NCT04011813|Antioxidants|antioxidants|mesh-list
101782864|NCT04011813|Hypotaurine|hypotaurine|mesh-list
101782865|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782866|NCT04011813|Protective Agents|protective agents|mesh-ancestor
101782867|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782868|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101782869|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101782870|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782871|NCT00998686|Incretins|incretins|mesh-ancestor
101782872|NCT00998686|Hormones|hormones|mesh-ancestor
101782873|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782874|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101782875|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782876|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782877|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782878|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101782879|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101782880|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782881|NCT00958269|Incretins|incretins|mesh-ancestor
101782882|NCT00958269|Hormones|hormones|mesh-ancestor
101782883|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101782884|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101782885|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782886|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782887|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782888|NCT02547402|CXA-10|cxa-10|mesh-list
101782889|NCT02547402|Simvastatin|simvastatin|mesh-list
101782890|NCT02547402|Ezetimibe|ezetimibe|mesh-list
101782891|NCT02547402|Pravastatin|pravastatin|mesh-list
101782892|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101782893|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101782894|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101782895|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
101782896|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782897|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101782898|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101782899|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782900|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782901|NCT01068925|Dolutegravir|dolutegravir|mesh-list
101782902|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101782903|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101782904|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782905|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782906|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101782907|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101782908|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
101541927|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
101541929|NCT04545788|Linezolid|linezolid|mesh-list
101782909|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782910|NCT00834600|Amlodipine|amlodipine|mesh-list
101782911|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101782912|NCT00834600|Olmesartan|olmesartan|mesh-list
101782913|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101782914|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101782915|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101782916|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101782917|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782918|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101782919|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782920|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
101782921|NCT00834600|Diuretics|diuretics|mesh-ancestor
101782922|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
101782923|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101782924|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101782925|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101782926|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
101782927|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101782928|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
101782929|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782930|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
101782931|NCT00958425|Protective Agents|protective agents|mesh-ancestor
101782932|NCT02547480|Irinotecan|irinotecan|mesh-list
101782933|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101782934|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101782935|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782936|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782937|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782938|NCT00838656|Paclitaxel|paclitaxel|mesh-list
101782939|NCT00838656|Carboplatin|carboplatin|mesh-list
101782940|NCT00838656|Gemcitabine|gemcitabine|mesh-list
101782941|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101782942|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782943|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101782944|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101782945|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101782946|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782947|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101782948|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
101782949|NCT00829608|Vaccines|vaccines|mesh-list
101782950|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
101782951|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782952|NCT00553605|Ketoprofen|ketoprofen|mesh-list
101782953|NCT00553605|Parecoxib|parecoxib|mesh-list
101782954|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101782955|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101782956|NCT00553605|Analgesics|analgesics|mesh-ancestor
101782957|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
101782958|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782959|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782960|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782962|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101782963|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782964|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782965|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101782966|NCT00838968|Interferons|interferons|mesh-list
101782967|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
101782968|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101782969|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
101782970|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101782971|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
101782972|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782973|NCT04010955|Edoxaban|edoxaban|mesh-list
101782974|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101782976|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101541941|NCT02756013|Paclitaxel|paclitaxel|mesh-list
101782977|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
101782978|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782979|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782981|NCT00948987|Aspirin|aspirin|mesh-list
101782982|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101782983|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101782984|NCT00948987|Analgesics|analgesics|mesh-ancestor
101782985|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
101782986|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101782987|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101782988|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101782989|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101782990|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101782991|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101782992|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101782993|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101782994|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101782995|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101782996|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
101782997|NCT00744497|Prednisone|prednisone|mesh-list
101782998|NCT00744497|Docetaxel|docetaxel|mesh-list
101782999|NCT00744497|Dasatinib|dasatinib|mesh-list
101783000|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783001|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
101783002|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
101783003|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
101783004|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783005|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783006|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
101783007|NCT00744497|Hormones|hormones|mesh-ancestor
101783008|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783009|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783010|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101783011|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783012|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783013|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
101783014|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101783015|NCT00949065|Antibodies|antibodies|mesh-list
101783016|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
101783017|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101783018|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
101783019|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536759|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
101783020|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101783021|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783022|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783023|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783024|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783025|NCT05351385|Dimercaprol|dimercaprol|mesh-list
101783026|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
101783027|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
101783028|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783029|NCT00955227|Ezetimibe|ezetimibe|mesh-list
101783030|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101783031|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101783032|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
101783033|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783034|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101783035|NCT00949299|Buprenorphine|buprenorphine|mesh-list
101783036|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101783037|NCT00949299|Narcotics|narcotics|mesh-ancestor
101541949|NCT01680042|Phenytoin|phenytoin|mesh-list
101783038|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783039|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783041|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
101783042|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783043|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101783044|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101783045|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101783046|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101783047|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
101783048|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783049|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101783050|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101783051|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783052|NCT00271609|Bevacizumab|bevacizumab|mesh-list
101783053|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783054|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783055|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101783056|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101783057|NCT00271609|Growth Substances|growth substances|mesh-ancestor
101783058|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783059|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
101783060|NCT00548847|Interferons|interferons|mesh-list
101783061|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
101783062|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
101783063|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101783064|NCT00548847|Molgramostim|molgramostim|mesh-list
101783065|NCT00548847|Sargramostim|sargramostim|mesh-list
101783066|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783067|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
101783068|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783069|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
101783070|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783071|NCT00949377|Bromides|bromides|mesh-list
101783072|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
101783073|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
101783074|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101783075|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783076|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
101783077|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783078|NCT00290407|Rituximab|rituximab|mesh-list
101783079|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783080|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783081|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
101783082|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783083|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783084|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
101783085|NCT02597387|Analgesics|analgesics|mesh-ancestor
101783086|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
101783087|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783088|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783089|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783090|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101783091|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783092|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783093|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783094|NCT01069081|Cisplatin|cisplatin|mesh-list
101783095|NCT01069081|Docetaxel|docetaxel|mesh-list
101541968|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101783096|NCT01069081|Esomeprazole|esomeprazole|mesh-list
101783097|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783098|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
101783099|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
101783100|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
101783101|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783102|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101783103|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783104|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101783105|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783106|NCT00949455|Lapatinib|lapatinib|mesh-list
101783107|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783108|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783109|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783110|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783111|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
101783112|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
101783113|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783114|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101783115|NCT00955695|Gefitinib|gefitinib|mesh-list
101783116|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783117|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783118|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783119|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783120|NCT00955773|Everolimus|everolimus|mesh-list
101783121|NCT00955773|Trametinib|trametinib|mesh-list
101783122|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101783123|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783124|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783125|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783126|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783127|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
101783128|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783129|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783130|NCT00549549|Celecoxib|celecoxib|mesh-list
101783131|NCT00549549|Indomethacin|indomethacin|mesh-list
101783132|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101783133|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101440566|NCT03914625|BB 1101|bb 1101|mesh-list
101783134|NCT00549549|Analgesics|analgesics|mesh-ancestor
101783135|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
101783136|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783137|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783138|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783139|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783140|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101783141|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101783142|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783143|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783144|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
101783145|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
101783146|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783147|NCT00622284|Glimepiride|glimepiride|mesh-list
101783148|NCT00622284|Linagliptin|linagliptin|mesh-list
101783149|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783150|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783151|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783152|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783153|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
101783154|NCT00622284|Incretins|incretins|mesh-ancestor
101541971|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541973|NCT01646307|Atorvastatin|atorvastatin|mesh-list
101783156|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783157|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101783158|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
101783159|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783160|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783161|NCT00269113|Rituximab|rituximab|mesh-list
101783162|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783163|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783164|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
101783165|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783166|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783167|NCT01069159|Propranolol|propranolol|mesh-list
101783168|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101783169|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101783170|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
101783171|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783172|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783173|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783174|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783175|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101783176|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
101783177|NCT03975205|Doxorubicin|doxorubicin|mesh-list
101783178|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101783179|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783180|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101783181|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783182|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783183|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783184|NCT01325779|Heparin|heparin|mesh-list
101783185|NCT01325779|Enoxaparin|enoxaparin|mesh-list
101783186|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
101783187|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101783188|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101783189|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783190|NCT05170659|Relatlimab|relatlimab|mesh-list
101783191|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783192|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783193|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101783194|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783195|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
101783196|NCT05352165|Fluorouracil|fluorouracil|mesh-list
101783197|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783198|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783199|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101783200|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783201|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
101783202|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783203|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783204|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
101783205|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783206|NCT00956163|Diphosphonates|diphosphonates|mesh-list
101783207|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
101783208|NCT00956163|Listerine|listerine|mesh-list
101783209|NCT00956163|Fluorides|fluorides|mesh-list
101783210|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
101783211|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101783212|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
101783213|NCT00956163|Protective Agents|protective agents|mesh-ancestor
101783214|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783215|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101783216|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783218|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783219|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101783220|NCT00956319|Estazolam|estazolam|mesh-list
101783221|NCT00956319|Zolpidem|zolpidem|mesh-list
101783222|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101783223|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101783224|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783225|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783226|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101783227|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
101783228|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
101783229|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783230|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783231|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
101783232|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101783233|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101783234|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101783235|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
101783236|NCT00835848|Exenatide|exenatide|mesh-list
101783237|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783238|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783239|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101783240|NCT00835848|Incretins|incretins|mesh-ancestor
101783241|NCT00835848|Hormones|hormones|mesh-ancestor
101783242|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783243|NCT00961857|Metformin|metformin|mesh-list
101783244|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101783245|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783246|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783248|NCT00961857|Hormones|hormones|mesh-ancestor
101783249|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783250|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101783251|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
101783252|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783253|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783254|NCT02547792|Vaccines|vaccines|mesh-list
101783255|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
101783256|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783257|NCT00830466|Sirolimus|sirolimus|mesh-list
101783258|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101783259|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783260|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101783261|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783262|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
101783263|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783264|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
101783265|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783266|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101783267|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101783268|NCT00843570|Nafarelin|nafarelin|mesh-list
101783269|NCT00843570|Estradiol|estradiol|mesh-list
101783270|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101783271|NCT00843570|Progesterone|progesterone|mesh-list
101783272|NCT00843570|Estrogens|estrogens|mesh-ancestor
101783273|NCT00843570|Hormones|hormones|mesh-ancestor
101783274|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783275|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783276|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101783277|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
101783278|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783279|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101783280|NCT00843570|Progestins|progestins|mesh-ancestor
101783281|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101783282|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
101783283|NCT02547870|Rilpivirine|rilpivirine|mesh-list
101783284|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101783285|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101783286|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783287|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783288|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
101783289|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783290|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101783291|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101414983|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783293|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
101783294|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
101783295|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783296|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783297|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
101783298|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783299|NCT00621504|Clarithromycin|clarithromycin|mesh-list
101783300|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
101783301|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101783302|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101783303|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783304|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101783305|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783306|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783307|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101783308|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101783309|NCT00548145|Ezetimibe|ezetimibe|mesh-list
101783310|NCT00548145|Pitavastatin|pitavastatin|mesh-list
101783311|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101783312|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101783313|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
101783314|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783315|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101783316|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101783317|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783319|NCT00547911|Entacapone|entacapone|mesh-list
101783320|NCT00547911|Droxidopa|droxidopa|mesh-list
101783321|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101783322|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101783323|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
101783324|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783325|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783326|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783327|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101783328|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783329|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101783330|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
101783331|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
101783332|NCT00839280|Vitamins|vitamins|mesh-ancestor
101783333|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
101783334|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783335|NCT00836628|Busulfan|busulfan|mesh-list
101783336|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
101783337|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783338|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783339|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
101783340|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783341|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101783342|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783343|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101783344|NCT00962637|Citric Acid|citric acid|mesh-list
101783345|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
101783346|NCT00962637|Enclomiphene|enclomiphene|mesh-list
101783347|NCT00962637|Clomiphene|clomiphene|mesh-list
101783348|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
101783349|NCT00962637|Testosterone|testosterone|mesh-list
101783350|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
101783351|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101783352|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
101783353|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
101783354|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783355|NCT00962637|Androgens|androgens|mesh-ancestor
101783356|NCT00962637|Hormones|hormones|mesh-ancestor
101783357|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783358|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414991|NCT00146250|Analgesics|analgesics|mesh-ancestor
101783360|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
101783361|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101783362|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
101783363|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783364|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101783365|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101783366|NCT00839358|Midodrine|midodrine|mesh-list
101783367|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
101783368|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
101783369|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783370|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783371|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101783372|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101783373|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101783374|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101783375|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
101783376|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783377|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783378|NCT00962715|Interferons|interferons|mesh-list
101783379|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
101783380|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
101783381|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101783382|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783383|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
101783384|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783385|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
101783386|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783387|NCT00963027|Treprostinil|treprostinil|mesh-list
101783388|NCT00963027|Esomeprazole|esomeprazole|mesh-list
101783389|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101783390|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783391|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101783392|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309719|NCT00006084|Lintuzumab|lintuzumab|mesh-list
101783393|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783394|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101783395|NCT00837174|Bortezomib|bortezomib|mesh-list
101783396|NCT00837174|Vorinostat|vorinostat|mesh-list
101783397|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783398|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101783399|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783400|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783401|NCT04042974|Dinoprostone|dinoprostone|mesh-list
101783402|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
101783403|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783404|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783405|NCT00844350|Letrozole|letrozole|mesh-list
101783406|NCT00844350|Oxytocin|oxytocin|mesh-list
101783407|NCT00844350|Clomiphene|clomiphene|mesh-list
101783408|NCT00844350|Enclomiphene|enclomiphene|mesh-list
101783409|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
101783410|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783411|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
101783412|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783413|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783414|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783415|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101783416|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101783417|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783418|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101783419|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
101783420|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783421|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101783422|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
101783423|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101541992|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
101783424|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101783425|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
101783426|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783427|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
101783428|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783429|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783430|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101783431|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
101783432|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783433|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783434|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101783435|NCT00839826|Enoxaparin|enoxaparin|mesh-list
101783436|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
101783437|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101783438|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
101783439|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101783440|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101783441|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783442|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783443|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
101783444|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101783445|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101783446|NCT00844662|Sevelamer|sevelamer|mesh-list
101783447|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
101783448|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
101783449|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783450|NCT04678089|Bortezomib|bortezomib|mesh-list
101783451|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783452|NCT00963573|Loratadine|loratadine|mesh-list
101783453|NCT00963573|Betamethasone|betamethasone|mesh-list
101783454|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783455|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
101783456|NCT00963573|Hormones|hormones|mesh-ancestor
101783457|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783458|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783459|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101783460|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
101783461|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
101783462|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783463|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101783464|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101783465|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101783467|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
101783468|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783469|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783470|NCT05299593|Timolol|timolol|mesh-list
101783471|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101783472|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101783473|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
101783474|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783475|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783476|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783477|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783478|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542002|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
101783479|NCT00844740|Cinacalcet|cinacalcet|mesh-list
101783480|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101783481|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783482|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101783483|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
101783484|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783485|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
101783486|NCT00963729|Docetaxel|docetaxel|mesh-list
101783487|NCT00963729|Fluorouracil|fluorouracil|mesh-list
101783488|NCT00963729|Letrozole|letrozole|mesh-list
101783489|NCT00963729|Epirubicin|epirubicin|mesh-list
101783490|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783491|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
101783492|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783493|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783494|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101783495|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
101783496|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783497|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783498|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101783499|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
101783500|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
101783501|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
101783502|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
101783503|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783504|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101783505|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101783506|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783507|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101783508|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
101783509|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783510|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101783511|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101783512|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783513|NCT00964041|Cycloserine|cycloserine|mesh-list
101783514|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101783515|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783516|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101783517|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
101783518|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101783519|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
101783520|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783521|NCT04009317|Crizotinib|crizotinib|mesh-list
101783522|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783523|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783524|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783525|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783526|NCT03641547|Capecitabine|capecitabine|mesh-list
101783527|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783528|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783529|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
101542028|NCT04544228|Bupivacaine|bupivacaine|mesh-list
101542029|NCT04544228|Neostigmine|neostigmine|mesh-list
101783530|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783531|NCT00851370|Omalizumab|omalizumab|mesh-list
101783532|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101783533|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101783534|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
101783535|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
101783536|NCT00967629|Calcium|calcium|mesh-list
101783537|NCT00967629|Sevelamer|sevelamer|mesh-list
101783538|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101783539|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783540|NCT00967629|Antacids|antacids|mesh-ancestor
101783541|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783542|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783543|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
101783544|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
101783545|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101783546|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
101783547|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783548|NCT00840606|Buspirone|buspirone|mesh-list
101783549|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101783550|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101783551|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783552|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783553|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101783554|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101783555|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
101783556|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783557|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783558|NCT00840684|Cytarabine|cytarabine|mesh-list
101783559|NCT00840684|Melphalan|melphalan|mesh-list
101783560|NCT00840684|Busulfan|busulfan|mesh-list
101783561|NCT00840684|Daunorubicin|daunorubicin|mesh-list
101783562|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
101783563|NCT00840684|Amsacrine|amsacrine|mesh-list
101783564|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783565|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
101783566|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783567|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783568|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
101783569|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783570|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783571|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
101783572|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783573|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101783574|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
101783575|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101783576|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101783577|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101783578|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783579|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783580|NCT00840684|Analgesics|analgesics|mesh-ancestor
101783581|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
101783582|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783583|NCT00574080|Cytarabine|cytarabine|mesh-list
101783584|NCT00574080|Thalidomide|thalidomide|mesh-list
101783585|NCT00574080|Dexamethasone|dexamethasone|mesh-list
101783586|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
101542040|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101783587|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
101783588|NCT00574080|Melphalan|melphalan|mesh-list
101783589|NCT00574080|Carmustine|carmustine|mesh-list
101783590|NCT00574080|Cisplatin|cisplatin|mesh-list
101783591|NCT00574080|Etoposide|etoposide|mesh-list
101783592|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
101783593|NCT00574080|Doxorubicin|doxorubicin|mesh-list
101783594|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101783595|NCT00574080|Bortezomib|bortezomib|mesh-list
101783596|NCT00574080|BB 1101|bb 1101|mesh-list
101783597|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783598|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
101783599|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783600|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783601|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101783602|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
101783603|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783604|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783605|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101783606|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783607|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
101783608|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
101309730|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
101783609|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783610|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783611|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
101783612|NCT00574080|Hormones|hormones|mesh-ancestor
101783613|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783614|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101783615|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
101783616|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783617|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101783618|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101783619|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783620|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783621|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
101783622|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
101783623|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783624|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101783625|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
101783626|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101783627|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101783628|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101783629|NCT00574080|Growth Substances|growth substances|mesh-ancestor
101783630|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
101783631|NCT00845364|Perhexiline|perhexiline|mesh-list
101783632|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101783633|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101783634|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783635|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101783636|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783637|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
101783638|NCT00546351|Lacosamide|lacosamide|mesh-list
101783639|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
101783640|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101783641|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101783642|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101783643|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783644|NCT00267865|Leucovorin|leucovorin|mesh-list
101783645|NCT00267865|Rituximab|rituximab|mesh-list
101783646|NCT00267865|Methotrexate|methotrexate|mesh-list
101783647|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783648|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783649|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
101783650|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783651|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783652|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101783653|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
101783654|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101783655|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783656|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
101783657|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783658|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783659|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783660|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101783661|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783662|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101783663|NCT00267865|Antidotes|antidotes|mesh-ancestor
101783664|NCT00267865|Protective Agents|protective agents|mesh-ancestor
101783665|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
101783667|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
101783669|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
101783670|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
101783671|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783672|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783673|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
101783674|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783675|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783676|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101783677|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101783678|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536779|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101783679|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783680|NCT00546117|Lansoprazole|lansoprazole|mesh-list
101783681|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
101783682|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101783683|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783684|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101783685|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783686|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783687|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101783688|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101783689|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101783690|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
101783691|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783692|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101783693|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101783694|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783695|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
101783696|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101783697|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101783698|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783699|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
101783700|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783701|NCT00967707|Gabapentin|gabapentin|mesh-list
101783702|NCT00967707|Donepezil|donepezil|mesh-list
101783703|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101783704|NCT00967707|Analgesics|analgesics|mesh-ancestor
101783705|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
101783706|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783707|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783708|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
101783709|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101783710|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101783711|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783712|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101783713|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101783714|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101783715|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783716|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783717|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
101783718|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101783719|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783720|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
101783721|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
101783722|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101783723|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101783724|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101783725|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101783727|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101783728|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101783729|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783730|NCT00845598|Fluticasone|fluticasone|mesh-list
101783731|NCT00845598|Xhance|xhance|mesh-list
101783732|NCT00845598|Azelastine|azelastine|mesh-list
101783733|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783734|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101783735|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
101783736|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309752|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783737|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783738|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101441176|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101783739|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
101783740|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783741|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101783742|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101783743|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783744|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783745|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101783746|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101783747|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
101783748|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
101783749|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783750|NCT00251719|Lansoprazole|lansoprazole|mesh-list
101783751|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
101783752|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101783753|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783754|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101783755|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783756|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783757|NCT00845754|Ketorolac|ketorolac|mesh-list
101783758|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101783759|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101783760|NCT00845754|Analgesics|analgesics|mesh-ancestor
101783761|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
101783762|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783763|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783764|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783765|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783766|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101783767|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783768|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783769|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101783770|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
101783771|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
101783772|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783773|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
101783774|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783775|NCT00841386|Riboflavin|riboflavin|mesh-list
101783776|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
101783777|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
101783778|NCT00841386|Vitamins|vitamins|mesh-ancestor
101783779|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
101783780|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783781|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101783782|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783784|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101783785|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
101783786|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
101783787|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783788|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783789|NCT00968331|Rituximab|rituximab|mesh-list
101783790|NCT00968331|Lenalidomide|lenalidomide|mesh-list
101783791|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783793|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
101783794|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783795|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783796|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101783797|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101783798|NCT00968331|Growth Substances|growth substances|mesh-ancestor
101783799|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
101783800|NCT00852228|Cetuximab|cetuximab|mesh-list
101783801|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
101783802|NCT00852228|Irinotecan|irinotecan|mesh-list
101783803|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783804|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783805|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101783806|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101783807|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783808|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783809|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
101783810|NCT00267007|Hematinics|hematinics|mesh-ancestor
101783811|NCT00841854|Metronidazole|metronidazole|mesh-list
101783812|NCT00841854|Tetracycline|tetracycline|mesh-list
101783813|NCT00841854|Pantoprazole|pantoprazole|mesh-list
101783814|NCT00841854|Bismuth|bismuth|mesh-list
101783815|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101783816|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101783817|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101783818|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101783819|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101783820|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783821|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101783822|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783823|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783824|NCT00841854|Antacids|antacids|mesh-ancestor
101783825|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101783826|NCT00848562|Nicorandil|nicorandil|mesh-list
101783827|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783828|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101783829|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
101783830|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
101783831|NCT00848562|Vitamins|vitamins|mesh-ancestor
101783832|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
101783833|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783834|NCT02879409|Insulin|insulin|mesh-list
101783835|NCT02879409|Metformin|metformin|mesh-list
101783836|NCT02879409|Pioglitazone|pioglitazone|mesh-list
101783837|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101783838|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
101783839|NCT02879409|Liraglutide|liraglutide|mesh-list
101783840|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101783841|NCT02879409|Gliclazide|gliclazide|mesh-list
101783842|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783843|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783844|NCT02879409|Incretins|incretins|mesh-ancestor
101783845|NCT02879409|Hormones|hormones|mesh-ancestor
101783846|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783847|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101783848|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
101415005|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
101783849|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783850|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783851|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101783852|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101783853|NCT02546154|Hematinics|hematinics|mesh-ancestor
101783855|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
101783856|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
101783857|NCT03943095|Protective Agents|protective agents|mesh-ancestor
101783858|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783859|NCT00848640|Sorafenib|sorafenib|mesh-list
101783860|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783861|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101783862|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783863|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783864|NCT00968565|Citric Acid|citric acid|mesh-list
101783865|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
101783866|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
101783867|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101783868|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
101783869|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
101783870|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783871|NCT00848796|Heparin|heparin|mesh-list
101783872|NCT00848796|Calcium heparin|calcium heparin|mesh-list
101783873|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
101783874|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101783875|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101783876|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783877|NCT00965289|Rituximab|rituximab|mesh-list
101783878|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783879|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783880|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
101783881|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783882|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783883|NCT04042506|Nivolumab|nivolumab|mesh-list
101783884|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101783885|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783886|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101783887|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783888|NCT00251641|Infliximab|infliximab|mesh-list
101783889|NCT00251641|Methotrexate|methotrexate|mesh-list
101783890|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101783891|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
101783892|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441342|NCT01286272|Bortezomib|bortezomib|mesh-list
101783893|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783894|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783895|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
101783896|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783897|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783898|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
101783899|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783900|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101783901|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783902|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
101783903|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783904|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101783905|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101783906|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542067|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101542069|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101783907|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101783908|NCT00250705|Aripiprazole|aripiprazole|mesh-list
101783909|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
101783910|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101783911|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101783912|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101783913|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101783914|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783915|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
101783916|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
101783917|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101783918|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783919|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101783920|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101783921|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
101783922|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101783923|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101783924|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101783925|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101783926|NCT00849030|Tamoxifen|tamoxifen|mesh-list
101783927|NCT00849030|Anastrozole|anastrozole|mesh-list
101783928|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101783929|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246490|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783930|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783932|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101783933|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783934|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101783935|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101783936|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101783937|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101783938|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101783939|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783940|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783941|NCT00842400|Metformin|metformin|mesh-list
101783942|NCT00842400|Probenecid|probenecid|mesh-list
101783943|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783944|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783945|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
101783946|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
101783947|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783948|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
101783949|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783950|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783951|NCT00849264|Fluorouracil|fluorouracil|mesh-list
101783952|NCT00849264|Endostar protein|endostar protein|mesh-list
101783953|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
101783954|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783955|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101783956|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101783957|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783958|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
101783959|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783960|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101783961|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101783962|NCT00849264|Growth Substances|growth substances|mesh-ancestor
101783963|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
101783965|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783966|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783967|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101783969|NCT00842556|Glimepiride|glimepiride|mesh-list
101783970|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101783971|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783972|NCT00842556|Incretins|incretins|mesh-ancestor
101783973|NCT00842556|Hormones|hormones|mesh-ancestor
101783974|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101783975|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101783976|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
101783977|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783978|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783979|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101783980|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101783981|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101783982|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
101783983|NCT00849966|Celecoxib|celecoxib|mesh-list
101783984|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101783985|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101783986|NCT00849966|Analgesics|analgesics|mesh-ancestor
101783987|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
101783988|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101783989|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101783990|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101783991|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101783992|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101783993|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101783994|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101783995|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101783996|NCT00853008|Cytarabine|cytarabine|mesh-list
101783997|NCT00853008|Dexamethasone|dexamethasone|mesh-list
101783998|NCT00853008|Prednisone|prednisone|mesh-list
101783999|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
101784000|NCT00853008|Methotrexate|methotrexate|mesh-list
101784001|NCT00853008|Vincristine|vincristine|mesh-list
101784002|NCT00853008|Daunorubicin|daunorubicin|mesh-list
101784003|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
101784004|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
101784005|NCT00853008|Teniposide|teniposide|mesh-list
101784006|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784007|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
101784008|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
101784009|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784010|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784011|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784012|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
101784013|NCT00853008|Hormones|hormones|mesh-ancestor
101784014|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784015|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784016|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784017|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101784018|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
101784019|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101784020|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784021|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
101784022|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784023|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784024|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784025|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101784026|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784027|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
101784028|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784029|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784030|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
101784031|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784032|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784033|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784034|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784035|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784036|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101784037|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101784038|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101784039|NCT00853008|Analgesics|analgesics|mesh-ancestor
101784040|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
101784041|NCT02545530|Clonidine|clonidine|mesh-list
101784042|NCT02545530|Analgesics|analgesics|mesh-ancestor
101784043|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
101784044|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784045|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784046|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101784047|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
101542133|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542134|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784049|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101784050|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101784051|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101784052|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101784053|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784054|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784055|NCT00853320|Oxycodone|oxycodone|mesh-list
101784056|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101784057|NCT00853320|Narcotics|narcotics|mesh-ancestor
101784058|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784059|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784060|NCT00853320|Analgesics|analgesics|mesh-ancestor
101784061|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
101784062|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784063|NCT00547521|Methotrexate|methotrexate|mesh-list
101784064|NCT00547521|Abatacept|abatacept|mesh-list
101784065|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101784066|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
101784067|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101784068|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784069|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784070|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
101784071|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784072|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784073|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784074|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784075|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101784076|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784077|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
101784078|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784079|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784080|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101784081|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101784082|NCT00850044|Ritonavir|ritonavir|mesh-list
101784083|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101784084|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101784085|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784086|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784087|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784088|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101784089|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101784090|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
101784091|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784092|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101784093|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101784094|NCT00266227|Rituximab|rituximab|mesh-list
101784095|NCT00266227|Methotrexate|methotrexate|mesh-list
101784096|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101784097|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784098|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
101784099|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784100|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784101|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101784102|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
101309763|NCT00006114|Analgesics|analgesics|mesh-ancestor
101784103|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101784104|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784106|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784107|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784108|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784109|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101784110|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536794|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
101784111|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784112|NCT04233216|Islatravir|islatravir|mesh-list
101784113|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
101784114|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784115|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784116|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784117|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101784118|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784119|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101784120|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
101784121|NCT00968877|Vitamin D|vitamin d|mesh-list
101784122|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101784123|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784124|NCT00968877|Vitamins|vitamins|mesh-ancestor
101784125|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
101784126|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101784127|NCT00850122|Cefazolin|cefazolin|mesh-list
101784128|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101784129|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784130|NCT00968955|Ropivacaine|ropivacaine|mesh-list
101784131|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
101784132|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
101784133|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784134|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784135|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
101784136|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784137|NCT00853554|Hydromorphone|hydromorphone|mesh-list
101784138|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101784139|NCT00853554|Narcotics|narcotics|mesh-ancestor
101784140|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784141|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784142|NCT00853554|Analgesics|analgesics|mesh-ancestor
101784143|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
101784144|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784146|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101784147|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101784148|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784149|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784150|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784151|NCT00573768|Diclofenac|diclofenac|mesh-list
101784152|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101784153|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101784154|NCT00573768|Analgesics|analgesics|mesh-ancestor
101784155|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
101784156|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784157|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784158|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784159|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784160|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101784161|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784162|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784163|NCT00965913|Nicotine|nicotine|mesh-list
101784164|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101784165|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
101784166|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784167|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784168|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101784169|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101415033|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784170|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
101784171|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309764|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
101784172|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784174|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
101784175|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784176|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101784177|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101784178|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784179|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784180|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
101784181|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784182|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784184|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
101784185|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784186|NCT00965991|Metformin|metformin|mesh-list
101784187|NCT00965991|Glyburide|glyburide|mesh-list
101784188|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784189|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784190|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101784191|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101784192|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784193|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784194|NCT00853944|Incretins|incretins|mesh-ancestor
101784195|NCT00853944|Hormones|hormones|mesh-ancestor
101784196|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784197|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784198|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784199|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784200|NCT02545452|Anastrozole|anastrozole|mesh-list
101784201|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
101784202|NCT02545452|Nonoxynol|nonoxynol|mesh-list
101784203|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784204|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784205|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101784206|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101784207|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784208|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784209|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101784210|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
101784211|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784212|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784213|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101784214|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
101784215|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101784216|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101784217|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101784218|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101784219|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101784220|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101784221|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101784222|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
101784223|NCT00547365|Antibodies|antibodies|mesh-list
101784224|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
101784225|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101784226|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101784227|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
101784228|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784229|NCT00854178|Anesthetics|anesthetics|mesh-list
101542169|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101784230|NCT00854178|Isoflurane|isoflurane|mesh-list
101784231|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784232|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784233|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
101784234|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101784235|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
101784236|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
101784237|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784238|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
101784239|NCT00850746|Z 338|z 338|mesh-list
101784240|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309770|NCT00006117|Gemcitabine|gemcitabine|mesh-list
101784241|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784242|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101784243|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101784244|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784245|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784246|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784247|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784248|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101784249|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
101784250|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784251|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784252|NCT00969813|Tofacitinib|tofacitinib|mesh-list
101784253|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101784254|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784255|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784256|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784258|NCT00854256|Mitomycin|mitomycin|mesh-list
101784259|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101784260|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784261|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
101784262|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784263|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784264|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784265|NCT00855972|Naltrexone|naltrexone|mesh-list
101784267|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101784268|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784269|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
101784270|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784271|NCT02544906|Propofol|propofol|mesh-list
101784272|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101784273|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784274|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784275|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101784276|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
101784277|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
101784278|NCT00861276|Nicotine|nicotine|mesh-list
101784279|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101784280|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
101784281|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784282|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784283|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101784284|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101784285|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
101784286|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784287|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784288|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101784289|NCT02544828|Hematinics|hematinics|mesh-ancestor
101784290|NCT00861510|ON 01910|on 01910|mesh-list
101784291|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784292|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784293|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784294|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542186|NCT04543565|Tenofovir|tenofovir|mesh-list
101784295|NCT01095003|Capecitabine|capecitabine|mesh-list
101784296|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784297|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
101784298|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784299|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784300|NCT00854646|ON 01910|on 01910|mesh-list
101784301|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784302|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784303|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784304|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784305|NCT00856362|Moxidectin|moxidectin|mesh-list
101784306|NCT00856362|Midazolam|midazolam|mesh-list
101784307|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101784308|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101784309|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784310|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784311|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101784312|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101784313|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784314|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101784315|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
101784316|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
101784317|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
101784318|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
101784319|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784320|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784321|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
101784322|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101784323|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784324|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
101784325|NCT00854802|Ribavirin|ribavirin|mesh-list
101784326|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101784327|NCT00854802|Cyclosporine|cyclosporine|mesh-list
101784328|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
101784329|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784330|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
101784331|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784332|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
101784333|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784334|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784335|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784336|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
101784337|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784338|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784339|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101784340|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
101784341|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101784342|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784343|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
101784344|NCT04119024|Fludarabine|fludarabine|mesh-list
101784345|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
101784346|NCT04119024|Interleukin-2|interleukin-2|mesh-list
101784347|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784348|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
101784349|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784350|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784351|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101784352|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
101784353|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784354|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784355|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101784356|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784357|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
101784358|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101784359|NCT04119024|Analgesics|analgesics|mesh-ancestor
101784360|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
101542196|NCT01647555|Cetuximab|cetuximab|mesh-list
101784361|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784363|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101784364|NCT00966771|Copper|copper|mesh-list
101784365|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
101784366|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101784367|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
101784368|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101784369|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784370|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101784371|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101784372|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101784373|NCT00966771|Trace Elements|trace elements|mesh-ancestor
101784374|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
101784375|NCT00856596|Sertaconazole|sertaconazole|mesh-list
101784376|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
101784377|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784378|NCT00855114|Everolimus|everolimus|mesh-list
101784379|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101784380|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784381|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784382|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784383|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784384|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
101784385|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784386|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784387|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
101784388|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784389|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
101784390|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101784391|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
101784392|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784393|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784394|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101784395|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
101784396|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
101784397|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101784398|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
101784399|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784400|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784401|NCT00970905|Ondansetron|ondansetron|mesh-list
101784402|NCT00970905|Aprepitant|aprepitant|mesh-list
101784404|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
101784405|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784406|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784407|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784408|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
101784409|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784410|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101784411|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101784412|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
101784413|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784414|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784415|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101784416|NCT00619476|Gabapentin|gabapentin|mesh-list
101784417|NCT00619476|Analgesics|analgesics|mesh-ancestor
101784418|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
101784419|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784420|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784421|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
101784422|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101784423|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101784424|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784425|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784426|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101784427|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101784428|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784429|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784430|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
101542207|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784432|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101784433|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784434|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784435|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784436|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784437|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
101784438|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784439|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784440|NCT00857142|Oxymorphone|oxymorphone|mesh-list
101784441|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101784442|NCT00857142|Narcotics|narcotics|mesh-ancestor
101784443|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784444|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784445|NCT00857142|Analgesics|analgesics|mesh-ancestor
101784446|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
101784447|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784448|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101784449|NCT00865176|Eplerenone|eplerenone|mesh-list
101784450|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101784451|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101784452|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784453|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784454|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101784455|NCT00865176|Diuretics|diuretics|mesh-ancestor
101784456|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
101784457|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101784458|NCT00973869|Curcumin|curcumin|mesh-list
101309780|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784459|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101784460|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101784462|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
101784463|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784464|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784465|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784466|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784467|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784468|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784469|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784470|NCT00959439|Naproxen|naproxen|mesh-list
101784471|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101784473|NCT00959439|Analgesics|analgesics|mesh-ancestor
101784474|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
101784475|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784476|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784477|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784478|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784479|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
101784480|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101784481|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784482|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784483|NCT04041492|Vitamin D|vitamin d|mesh-list
101784484|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
101784485|NCT04041492|Vitamins|vitamins|mesh-ancestor
101784486|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
101784487|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784488|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101784489|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101784490|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
101784491|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
101784492|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542219|NCT01681563|Ofatumumab|ofatumumab|mesh-list
101784493|NCT00857376|Protective Agents|protective agents|mesh-ancestor
101441959|NCT02897206|Imipenem|imipenem|mesh-list
101784494|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784496|NCT00857376|Vitamins|vitamins|mesh-ancestor
101784497|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
101784498|NCT00618072|Metformin|metformin|mesh-list
101784499|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
101784500|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784501|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784502|NCT00959517|Artesunate|artesunate|mesh-list
101784503|NCT00959517|Chloroquine|chloroquine|mesh-list
101784504|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
101784505|NCT00959517|Primaquine|primaquine|mesh-list
101784506|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
101784507|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101784508|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
101784509|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101784510|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101784511|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784512|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784513|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
101784514|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
101784515|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101784516|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
101784517|NCT00959517|Amebicides|amebicides|mesh-ancestor
101784518|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784519|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101784520|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784521|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784522|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101784523|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101784524|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
101784525|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
101784526|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784527|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784528|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
101784529|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784530|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101784531|NCT00865410|Bupropion|bupropion|mesh-list
101784532|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101784533|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
101784534|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784535|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101784536|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101784537|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246491|NCT01666379|Fentanyl|fentanyl|mesh-list
101784538|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784539|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
101784540|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784541|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784542|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101784543|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101784544|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784545|NCT00974181|Paclitaxel|paclitaxel|mesh-list
101784546|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101784547|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784548|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784549|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784550|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784551|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784552|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784553|NCT00971607|Sevoflurane|sevoflurane|mesh-list
101784554|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101784555|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101542223|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784556|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
101784557|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
101784558|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542224|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784559|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784560|NCT00971685|Dexamethasone|dexamethasone|mesh-list
101784561|NCT00971685|Lenalidomide|lenalidomide|mesh-list
101784562|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784563|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
101784564|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
101784565|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784566|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784567|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784568|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
101784570|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784571|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784572|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784573|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
101784574|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101784575|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101784576|NCT00971685|Growth Substances|growth substances|mesh-ancestor
101784577|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
101784579|NCT03861052|Tirzepatide|tirzepatide|mesh-list
101784580|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784581|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784582|NCT03861052|Incretins|incretins|mesh-ancestor
101784583|NCT03861052|Hormones|hormones|mesh-ancestor
101784584|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784585|NCT00971763|Prednisolone|prednisolone|mesh-list
101784586|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
101784587|NCT00971763|Rituximab|rituximab|mesh-list
101784588|NCT00971763|Gemcitabine|gemcitabine|mesh-list
101784589|NCT00971763|Vincristine|vincristine|mesh-list
101784590|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784591|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
101784592|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784593|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784594|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101784595|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
101784596|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784597|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784598|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101784599|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101784600|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101784601|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
101784602|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784603|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784604|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784605|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784606|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784607|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
101784608|NCT00971763|Hormones|hormones|mesh-ancestor
101784609|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784610|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784611|NCT00781196|Folic Acid|folic acid|mesh-list
101784612|NCT00781196|Hematinics|hematinics|mesh-ancestor
101784613|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
101784614|NCT00781196|Vitamins|vitamins|mesh-ancestor
101784615|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
101784616|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784617|NCT00865644|Imiquimod|imiquimod|mesh-list
101784618|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101784619|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
101784620|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784621|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784622|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
101784623|NCT00785330|Rituximab|rituximab|mesh-list
101784624|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101784625|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784626|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
101784627|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784628|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542230|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101784629|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101784630|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101784631|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784632|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101784633|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101784634|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784635|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784636|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
101784637|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784638|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
101784639|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101784640|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101784641|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784642|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
101784643|NCT05279469|Coagulants|coagulants|mesh-ancestor
101784644|NCT00790946|Valsartan|valsartan|mesh-list
101784645|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101784646|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101784647|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101784648|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784649|NCT05179239|Paclitaxel|paclitaxel|mesh-list
101784650|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101784651|NCT05179239|Cisplatin|cisplatin|mesh-list
101784652|NCT05179239|Carboplatin|carboplatin|mesh-list
101784653|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784654|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784655|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784656|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784657|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784658|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784659|NCT00972075|Melatonin|melatonin|mesh-list
101784660|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
101784661|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784662|NCT00972075|Protective Agents|protective agents|mesh-ancestor
101784663|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784664|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784665|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101784666|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101784667|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
101784668|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784669|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784670|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101784671|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
101784673|NCT00974805|Hormones|hormones|mesh-ancestor
101309789|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784674|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784675|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
101784676|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
101784677|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101784678|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
101784679|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
101784680|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784681|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784682|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101784683|NCT00781352|Analgesics|analgesics|mesh-ancestor
101784684|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
101784685|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784686|NCT00791024|Lidocaine|lidocaine|mesh-list
101784687|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
101784688|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
101784689|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784690|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784691|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
101784692|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784693|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101784694|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101784695|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101784696|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784697|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784698|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101784699|NCT03897244|Amoxicillin|amoxicillin|mesh-list
101784700|NCT03897244|Metronidazole|metronidazole|mesh-list
101784701|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101784702|NCT03897244|Rabeprazole|rabeprazole|mesh-list
101784703|NCT03897244|Bismuth|bismuth|mesh-list
101784704|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101784705|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784706|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
101784707|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101784708|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101784709|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101784710|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784711|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784712|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784713|NCT03897244|Antacids|antacids|mesh-ancestor
101784714|NCT00666536|Amlodipine|amlodipine|mesh-list
101784715|NCT00666536|Valsartan|valsartan|mesh-list
101784716|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101784717|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101784718|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101784719|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784720|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784721|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101784722|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412109|NCT00473980|Celecoxib|celecoxib|mesh-list
101784723|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
101784724|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101784725|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101784726|NCT00519532|Rotigotine|rotigotine|mesh-list
101784727|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
101784728|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
101784729|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784730|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784731|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784732|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101784733|NCT00666458|Saxagliptin|saxagliptin|mesh-list
101784734|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784735|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784736|NCT00666458|Incretins|incretins|mesh-ancestor
101784737|NCT00666458|Hormones|hormones|mesh-ancestor
101784738|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784739|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101784740|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784741|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784742|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784743|NCT00974961|Bupivacaine|bupivacaine|mesh-list
101784744|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
101784745|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
101784746|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
101784747|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784748|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784749|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
101784750|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784751|NCT00511108|Pioglitazone|pioglitazone|mesh-list
101784752|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101784753|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784754|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542248|NCT02215382|Atropine|atropine|mesh-list
101784755|NCT00511108|Incretins|incretins|mesh-ancestor
101784756|NCT00511108|Hormones|hormones|mesh-ancestor
101784757|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784758|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101784759|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784760|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784761|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784762|NCT00781586|Caffeine|caffeine|mesh-list
101784763|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784764|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101784765|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101784766|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784767|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784768|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101784769|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101784770|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
101784771|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784772|NCT00510952|Insulin|insulin|mesh-list
101784773|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101784774|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
101784775|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
101784776|NCT00510952|Protamines|protamines|mesh-list
101784777|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784778|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784779|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
101784780|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784781|NCT00510952|Coagulants|coagulants|mesh-ancestor
101784782|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
101784783|NCT00617604|Alefacept|alefacept|mesh-list
101784784|NCT00617604|Tacrolimus|tacrolimus|mesh-list
101784785|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784786|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
101784787|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784788|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101784789|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442232|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784790|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784791|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101784792|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784793|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101784794|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
101784795|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101784796|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784797|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784798|NCT01012570|Adalimumab|adalimumab|mesh-list
101784799|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101784800|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784801|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784802|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101784803|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101784804|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
101784805|NCT00661622|Molgramostim|molgramostim|mesh-list
101784806|NCT00661622|Sargramostim|sargramostim|mesh-list
101784807|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
101784808|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784809|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784810|NCT00781820|Bifonazole|bifonazole|mesh-list
101784811|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
101784812|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784813|NCT00786110|Paclitaxel|paclitaxel|mesh-list
101784814|NCT00786110|Sorafenib|sorafenib|mesh-list
101784815|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784816|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784817|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784818|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784819|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784820|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784821|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784822|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784823|NCT00791804|Fentanyl|fentanyl|mesh-list
101784824|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101784825|NCT00791804|Narcotics|narcotics|mesh-ancestor
101784826|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784827|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784828|NCT00791804|Analgesics|analgesics|mesh-ancestor
101784829|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
101784830|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784831|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101784832|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101784833|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
101784834|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
101784835|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
101784836|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
101536878|NCT01132807|Hormones|hormones|mesh-ancestor
101784837|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
101784838|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784839|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784840|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101784841|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101784842|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
101784843|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
101784844|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784845|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784847|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784848|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101784849|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784850|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784851|NCT00792584|Efavirenz|efavirenz|mesh-list
101784852|NCT00792584|Etravirine|etravirine|mesh-list
101784853|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101784854|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101784855|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784856|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784857|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
101784858|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784859|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101784860|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101784861|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101784862|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101784863|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101784864|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101784865|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
101784866|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
101442313|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
101784867|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101784868|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
101784869|NCT04093752|Tirzepatide|tirzepatide|mesh-list
101784870|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784871|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784872|NCT04093752|Incretins|incretins|mesh-ancestor
101784873|NCT04093752|Hormones|hormones|mesh-ancestor
101784874|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784875|NCT02544282|Acetaminophen|acetaminophen|mesh-list
101784876|NCT02544282|Sufentanil|sufentanil|mesh-list
101784877|NCT02544282|Tramadol|tramadol|mesh-list
101784878|NCT02544282|Pirinitramide|pirinitramide|mesh-list
101784879|NCT02544282|Propofol|propofol|mesh-list
101784880|NCT02544282|Sevoflurane|sevoflurane|mesh-list
101784881|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
101784882|NCT02544282|Atracurium|atracurium|mesh-list
101784883|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101784884|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542266|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784885|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784886|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101784887|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
101784888|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
101784889|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101784890|NCT02544282|Analgesics|analgesics|mesh-ancestor
101784891|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
101784892|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784893|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
101784894|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101784895|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101784896|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101784897|NCT02544282|Narcotics|narcotics|mesh-ancestor
101784898|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101536889|NCT01089543|Rabeprazole|rabeprazole|mesh-list
101784899|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
101784900|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101784901|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101784902|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101784903|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101784904|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101784905|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
101784906|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784907|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784908|NCT04041648|Treprostinil|treprostinil|mesh-list
101784909|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101784910|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101784911|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
101784912|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
101784913|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101784914|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
101784915|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784916|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784917|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784918|NCT00663962|Pregabalin|pregabalin|mesh-list
101784919|NCT00663962|Analgesics|analgesics|mesh-ancestor
101784920|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
101784921|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784922|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784923|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
101784924|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101784925|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101784926|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784927|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101784928|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101784929|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101784930|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784931|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101784933|NCT00858624|Analgesics|analgesics|mesh-ancestor
101784934|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
101784935|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101784936|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784937|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101784938|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101784939|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
101784940|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
101784941|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101784942|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101542282|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784943|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101542283|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784944|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101784945|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784946|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101784947|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101784948|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784950|NCT00960453|Hormones|hormones|mesh-ancestor
101784951|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784952|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101784953|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
101784954|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784955|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784956|NCT00265759|Letrozole|letrozole|mesh-list
101784957|NCT00265759|Anastrozole|anastrozole|mesh-list
101784958|NCT00265759|Exemestane|exemestane|mesh-list
101784959|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784960|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101784961|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101784962|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784963|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101784964|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101784965|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
101784966|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784967|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784968|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784969|NCT00972387|Prednisone|prednisone|mesh-list
101784970|NCT00972387|Prednisolone|prednisolone|mesh-list
101784971|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
101784972|NCT00972387|Doxorubicin|doxorubicin|mesh-list
101784973|NCT00972387|Vincristine|vincristine|mesh-list
101784974|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101784975|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
101784976|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101784977|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101784978|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101784979|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
101784980|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415045|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
101784981|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101784982|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101784983|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101784984|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101784985|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101784986|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101784987|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101784988|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
101784989|NCT00972387|Hormones|hormones|mesh-ancestor
101784990|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101784991|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101784992|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101784993|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101784994|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101784995|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101784996|NCT00744263|Vaccines|vaccines|mesh-list
101784997|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101784998|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
101784999|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785000|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
101785001|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101785002|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101785003|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542292|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785004|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785005|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785006|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785007|NCT00866736|Dasatinib|dasatinib|mesh-list
101785008|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785009|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785010|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785011|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785012|NCT00792818|Ibuprofen|ibuprofen|mesh-list
101785013|NCT00792818|Curcumin|curcumin|mesh-list
101785014|NCT00792818|Turmeric extract|turmeric extract|mesh-list
101785015|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101785016|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101785017|NCT00792818|Analgesics|analgesics|mesh-ancestor
101785018|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
101785019|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785020|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785021|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785022|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785023|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101785024|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785025|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785026|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785027|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
101785028|NCT00792818|Protective Agents|protective agents|mesh-ancestor
101785029|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
101785030|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101785031|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785032|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
101785033|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785034|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
101785035|NCT00975351|Vitamins|vitamins|mesh-ancestor
101785036|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
101785037|NCT01071187|Varenicline|varenicline|mesh-list
101785038|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101785039|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101785040|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
101785041|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785042|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785043|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785044|NCT00618774|Amlodipine|amlodipine|mesh-list
101785045|NCT00618774|Telmisartan|telmisartan|mesh-list
101785046|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785047|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101785048|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785049|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785050|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101785051|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785052|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
101785053|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101785054|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101785055|NCT00917345|Captopril|captopril|mesh-list
101785056|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101785057|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
101785058|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785059|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785060|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785061|NCT00793052|Dexamethasone|dexamethasone|mesh-list
101785062|NCT00793052|Etoricoxib|etoricoxib|mesh-list
101785063|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785064|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
101785065|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
101785066|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785067|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785068|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785069|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
101785070|NCT00793052|Hormones|hormones|mesh-ancestor
101785071|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785072|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101785073|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785074|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101785075|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101785076|NCT00793052|Analgesics|analgesics|mesh-ancestor
101785077|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
101785078|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785079|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101785080|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101785081|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785082|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785083|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101785084|NCT02555852|Esomeprazole|esomeprazole|mesh-list
101785085|NCT02555852|Omeprazole|omeprazole|mesh-list
101785086|NCT02555852|Rabeprazole|rabeprazole|mesh-list
101785087|NCT02555852|Pantoprazole|pantoprazole|mesh-list
101785088|NCT02555852|Lansoprazole|lansoprazole|mesh-list
101785089|NCT02555852|Famotidine|famotidine|mesh-list
101785090|NCT02555852|Ranitidine|ranitidine|mesh-list
101785091|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101785092|NCT02555852|Cimetidine|cimetidine|mesh-list
101785093|NCT02555852|Nizatidine|nizatidine|mesh-list
101442542|NCT00171431|Tegaserod|tegaserod|mesh-list
101785094|NCT02555852|Lafutidine|lafutidine|mesh-list
101785095|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
101785097|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101785098|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
101785099|NCT02555852|Histamine|histamine|mesh-list
101785100|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
101785101|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785102|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101785103|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785104|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785106|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
101785107|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
101785108|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785109|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785110|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
101785111|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101785112|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101785113|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785114|NCT04091009|Buprenorphine|buprenorphine|mesh-list
101785115|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101785116|NCT04091009|Naloxone|naloxone|mesh-list
101785117|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101785118|NCT04091009|Narcotics|narcotics|mesh-ancestor
101785119|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785120|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785121|NCT04091009|Analgesics|analgesics|mesh-ancestor
101542320|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
101542321|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785122|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
101785123|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785124|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101785125|NCT02597231|Melatonin|melatonin|mesh-list
101785126|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
101785127|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785128|NCT02597231|Protective Agents|protective agents|mesh-ancestor
101785129|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785130|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785131|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
101785132|NCT00545571|Hematinics|hematinics|mesh-ancestor
101785133|NCT00783380|Vaccines|vaccines|mesh-list
101785134|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
101785135|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785136|NCT04008225|Dimercaprol|dimercaprol|mesh-list
101785137|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
101785138|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
101785139|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785140|NCT00748709|Afatinib|afatinib|mesh-list
101785141|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785142|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785143|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785144|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785145|NCT02597309|Canagliflozin|canagliflozin|mesh-list
101785146|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101785147|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785148|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785149|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785150|NCT00863148|Busulfan|busulfan|mesh-list
101785151|NCT00863148|Clofarabine|clofarabine|mesh-list
101785152|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
101536934|NCT01088529|Prednisone|prednisone|mesh-list
101785153|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785154|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785155|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
101785156|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785157|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785158|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785159|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101785160|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785161|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
101785162|NCT00786734|Pitavastatin|pitavastatin|mesh-list
101785163|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101309818|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785164|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101785166|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
101785167|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785168|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442605|NCT00171587|Vatalanib|vatalanib|mesh-list
101785169|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101785170|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
101785171|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101785172|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785173|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785174|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101785175|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101785176|NCT00867126|Pioglitazone|pioglitazone|mesh-list
101785177|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785178|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785179|NCT00748553|Paclitaxel|paclitaxel|mesh-list
101785180|NCT00748553|Azacitidine|azacitidine|mesh-list
101785181|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101785182|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101785183|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785184|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
101785185|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
101785186|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
101785187|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246492|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101785188|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785189|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
101785190|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542330|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785191|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
101785192|NCT00661388|Hematinics|hematinics|mesh-ancestor
101785193|NCT00972855|Bicalutamide|bicalutamide|mesh-list
101785194|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
101785195|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785196|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785197|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785198|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785199|NCT00972933|Ipilimumab|ipilimumab|mesh-list
101785200|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101785201|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785202|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101785203|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785204|NCT00263575|Fentanyl|fentanyl|mesh-list
101785205|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101785206|NCT00263575|Narcotics|narcotics|mesh-ancestor
101785207|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785208|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785209|NCT00263575|Analgesics|analgesics|mesh-ancestor
101785210|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
101785211|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785212|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101785213|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101785214|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
101785215|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
101785216|NCT00975663|Tacrolimus|tacrolimus|mesh-list
101785217|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785218|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
101785219|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785220|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101785221|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785222|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785223|NCT00570128|Donepezil|donepezil|mesh-list
101785224|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101785225|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785226|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785227|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
101785228|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785229|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785230|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
101785232|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101785233|NCT00960921|Trace Elements|trace elements|mesh-ancestor
101785234|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
101785235|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785237|NCT00863460|Cytarabine|cytarabine|mesh-list
101785238|NCT00863460|Prednisone|prednisone|mesh-list
101785239|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
101785240|NCT00863460|Busulfan|busulfan|mesh-list
101785241|NCT00863460|Thiotepa|thiotepa|mesh-list
101785242|NCT00863460|Carmustine|carmustine|mesh-list
101785243|NCT00863460|Methotrexate|methotrexate|mesh-list
101785244|NCT00863460|Etoposide|etoposide|mesh-list
101785245|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785246|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
101785247|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785249|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785250|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
101785251|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785252|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785253|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101785254|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785255|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
101785256|NCT00863460|Hormones|hormones|mesh-ancestor
101246493|NCT01666379|Narcotics|narcotics|mesh-ancestor
101542335|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101785257|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785258|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101785259|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101785260|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
101785261|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101785262|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785263|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
101785264|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
101785265|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785266|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101785267|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101785268|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101785269|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101785270|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101785271|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
101785272|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785273|NCT00262951|Interferons|interferons|mesh-list
101785274|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
101785275|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
101785276|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101785277|NCT00262951|Cisplatin|cisplatin|mesh-list
101785278|NCT00262951|Fluorouracil|fluorouracil|mesh-list
101785279|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785280|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
101785281|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785282|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785283|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785284|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
101785285|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785286|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
101785287|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785288|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
101785289|NCT02597153|Analgesics|analgesics|mesh-ancestor
101785290|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
101785291|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785292|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785293|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785294|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101785295|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101785296|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785297|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785298|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
101785299|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785300|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
101785301|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101785302|NCT00262873|Bortezomib|bortezomib|mesh-list
101785303|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785304|NCT00975819|Sirolimus|sirolimus|mesh-list
101785305|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101785306|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785307|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101785308|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785309|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
101785310|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785311|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
101785312|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785313|NCT00859872|Haloperidol|haloperidol|mesh-list
101785314|NCT00859872|Risperidone|risperidone|mesh-list
101785315|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
101785316|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101785317|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
101785318|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785319|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785320|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785321|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101542346|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
101785322|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101785323|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785324|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101785325|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101785326|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
101785327|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
101785328|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
101785329|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785330|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785331|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101785332|NCT02555696|Paclitaxel|paclitaxel|mesh-list
101785333|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101785334|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785335|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101785336|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101785337|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101785338|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785339|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
101785340|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785341|NCT05147493|Dexamethasone|dexamethasone|mesh-list
101785342|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
101785343|NCT05147493|Lenalidomide|lenalidomide|mesh-list
101785344|NCT05147493|Bortezomib|bortezomib|mesh-list
101785345|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785346|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
101785347|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785348|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785349|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785350|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
101785351|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785352|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785353|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101785354|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785355|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
101785356|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
101785357|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785358|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785359|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
101785360|NCT05147493|Hormones|hormones|mesh-ancestor
101785361|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785362|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101785363|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785364|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785365|NCT05147493|Growth Substances|growth substances|mesh-ancestor
101785366|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785367|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101785368|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101309839|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101785369|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785370|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101785371|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101785372|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785373|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785374|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
101785375|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785376|NCT03974425|Aflibercept|aflibercept|mesh-list
101785377|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785378|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785379|NCT03974425|Growth Substances|growth substances|mesh-ancestor
101785380|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785381|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785382|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785383|NCT00975897|Leucovorin|leucovorin|mesh-list
101785384|NCT00975897|Bevacizumab|bevacizumab|mesh-list
101785385|NCT00975897|Cetuximab|cetuximab|mesh-list
101785386|NCT00975897|Fluorouracil|fluorouracil|mesh-list
101785387|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
101785388|NCT00975897|Irinotecan|irinotecan|mesh-list
101785389|NCT00975897|Calcium|calcium|mesh-list
101785390|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
101415052|NCT00497107|Vitamins|vitamins|mesh-ancestor
101785391|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101785392|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785393|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785394|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785395|NCT00975897|Growth Substances|growth substances|mesh-ancestor
101785396|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785397|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785398|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101785399|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
101785400|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785401|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785402|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785403|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
101785404|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101785405|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101785406|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785407|NCT00975897|Antidotes|antidotes|mesh-ancestor
101785408|NCT00975897|Protective Agents|protective agents|mesh-ancestor
101785409|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
101785410|NCT00975897|Vitamins|vitamins|mesh-ancestor
101785411|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
101785412|NCT00867672|Decitabine|decitabine|mesh-list
101785413|NCT00867672|Tretinoin|tretinoin|mesh-list
101785414|NCT00867672|Valproic Acid|valproic acid|mesh-list
101785415|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785416|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
101785417|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785418|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785419|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785420|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
101785421|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
101785422|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
101785423|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
101785424|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785425|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785426|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
101785427|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101785428|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785429|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101785430|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
101785431|NCT00783926|Vaccines|vaccines|mesh-list
101785432|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
101785433|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785434|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
101785435|NCT00783926|Coagulants|coagulants|mesh-ancestor
101785436|NCT01071499|Morphine|morphine|mesh-list
101785437|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101785438|NCT01071499|Narcotics|narcotics|mesh-ancestor
101785439|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785440|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785441|NCT01071499|Analgesics|analgesics|mesh-ancestor
101785442|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
101785443|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785444|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
101785445|NCT00961155|Montelukast|montelukast|mesh-list
101785446|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101785447|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
101785448|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785449|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785450|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101785451|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
101785452|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101785453|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101785454|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101785455|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
101542353|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785456|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785457|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785458|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101785459|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785460|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785461|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101785462|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101785463|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101785464|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101785465|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101785466|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785467|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785468|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101785469|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785470|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785472|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
101785473|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
101785474|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101785475|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
101785476|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101785477|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
101785478|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785479|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785480|NCT00793754|Aspirin|aspirin|mesh-list
101785481|NCT00793754|Atorvastatin|atorvastatin|mesh-list
101785482|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101785483|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101785484|NCT00793754|Analgesics|analgesics|mesh-ancestor
101785485|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
101785486|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785487|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785488|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785489|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785490|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101785491|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101785492|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785493|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101785494|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101785495|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785496|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
101785497|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101785498|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101785499|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
101785500|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101785501|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101785502|NCT02596763|Baclofen|baclofen|mesh-list
101785503|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101785504|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785505|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101309864|NCT00006174|Letrozole|letrozole|mesh-list
101785506|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785507|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101785508|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
101785509|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
101785510|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785511|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785512|NCT00973323|Warfarin|warfarin|mesh-list
101785513|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
101785514|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
101785515|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101785516|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
101785517|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101785518|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
101785519|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785520|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785521|NCT00793988|Anesthetics|anesthetics|mesh-list
101785522|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785523|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785525|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785526|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785528|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101785529|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
101785530|NCT00787436|Thalidomide|thalidomide|mesh-list
101785531|NCT00787436|Timolol|timolol|mesh-list
101785532|NCT00787436|Propranolol|propranolol|mesh-list
101785533|NCT00787436|Nadolol|nadolol|mesh-list
101785534|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785535|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
101785536|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785537|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
101785538|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101785539|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785540|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785541|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785542|NCT00787436|Growth Substances|growth substances|mesh-ancestor
101785543|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785544|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785545|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101785546|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101785547|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101785548|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785549|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785550|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101785551|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785552|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
101785554|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
101785555|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785556|NCT03945981|Lamivudine|lamivudine|mesh-list
101785557|NCT03945981|Dolutegravir|dolutegravir|mesh-list
101785558|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101785559|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101785560|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785561|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785562|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
101785563|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785564|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101785565|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101785566|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101785567|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101785568|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
101785569|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785570|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
101785571|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785572|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785573|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101785574|NCT00979563|Irinotecan|irinotecan|mesh-list
101785575|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101785576|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101785577|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785578|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785579|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785581|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101785582|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101785583|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101542368|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101542376|NCT01202227|Analgesics|analgesics|mesh-ancestor
101785584|NCT00745901|Norgestimate|norgestimate|mesh-list
101785585|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101785586|NCT00745901|Estradiol|estradiol|mesh-list
101785587|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101785588|NCT00745901|Estrogens|estrogens|mesh-ancestor
101785589|NCT00745901|Hormones|hormones|mesh-ancestor
101785590|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785591|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785592|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101785595|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101785596|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101785597|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101785598|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101785599|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785600|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101785601|NCT00745901|Diuretics|diuretics|mesh-ancestor
101785602|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
101785603|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101785604|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101785605|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785606|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
101785607|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785608|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785609|NCT00860340|Spironolactone|spironolactone|mesh-list
101785610|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101785611|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785612|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785613|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785614|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101785615|NCT00860340|Diuretics|diuretics|mesh-ancestor
101785616|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
101785617|NCT00784316|Metoprolol|metoprolol|mesh-list
101785618|NCT00784316|Amiodarone|amiodarone|mesh-list
101785619|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101785620|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785621|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
101785622|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
101785623|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785624|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785625|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101785626|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101785627|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101785628|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
101785629|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785630|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785631|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
101785632|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101785633|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785634|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101785635|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101785636|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101785637|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785638|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101785639|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101785640|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101785641|NCT00286429|Insulin|insulin|mesh-list
101785642|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101785643|NCT00286429|Alogliptin|alogliptin|mesh-list
101785644|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785645|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785646|NCT00286429|Incretins|incretins|mesh-ancestor
101785647|NCT00286429|Hormones|hormones|mesh-ancestor
101785648|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785649|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101785650|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
101785651|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542396|NCT01682772|Olaparib|olaparib|mesh-list
101785652|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785653|NCT00665444|Aripiprazole|aripiprazole|mesh-list
101785654|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
101785655|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101785656|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101785657|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101785658|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785659|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785660|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
101785661|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
101785662|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785663|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785664|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101785665|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101785666|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
101785667|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101785668|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101785669|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101785670|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101785671|NCT00864006|Valproic Acid|valproic acid|mesh-list
101785672|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
101785673|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785674|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785675|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
101785676|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101785677|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785678|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
101785679|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101785680|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785681|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101785682|NCT00860496|Cyclosporine|cyclosporine|mesh-list
101785684|NCT00860496|Cyclosporins|cyclosporins|mesh-list
101785685|NCT00860496|Tofacitinib|tofacitinib|mesh-list
101785686|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785687|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
101785688|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785689|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101785690|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785691|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785692|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
101785693|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785694|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
101785695|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785696|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101785697|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785698|NCT00864162|Ramipril|ramipril|mesh-list
101785699|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101785700|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
101785701|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785702|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785703|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785704|NCT00787826|Vaccines|vaccines|mesh-list
101785706|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785707|NCT00795314|Fentanyl|fentanyl|mesh-list
101785708|NCT00795314|Butorphanol|butorphanol|mesh-list
101785709|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101785710|NCT00795314|Narcotics|narcotics|mesh-ancestor
101785711|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785712|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785713|NCT00795314|Analgesics|analgesics|mesh-ancestor
101785714|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
101785715|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785716|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101785717|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101785718|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
101785719|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
101785720|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
101785721|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
101785722|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101542401|NCT01649037|Terlipressin|terlipressin|mesh-list
101542402|NCT01649037|Epinephrine|epinephrine|mesh-list
101785723|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101785724|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
101785725|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785726|NCT00864240|Clobetasol|clobetasol|mesh-list
101785727|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785728|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
101785729|NCT00864240|Hormones|hormones|mesh-ancestor
101785730|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785731|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785732|NCT00979641|Docetaxel|docetaxel|mesh-list
101785733|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785734|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101785735|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101785736|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101785737|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785738|NCT00864318|Paclitaxel|paclitaxel|mesh-list
101785739|NCT00864318|Etoposide|etoposide|mesh-list
101785740|NCT00864318|Ifosfamide|ifosfamide|mesh-list
101785741|NCT00864318|Carboplatin|carboplatin|mesh-list
101785742|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101785743|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785744|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101785745|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101785746|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101785747|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785748|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101785749|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101785750|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785751|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785752|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
101785753|NCT00788060|Everolimus|everolimus|mesh-list
101785754|NCT00788060|Sunitinib|sunitinib|mesh-list
101785755|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101785756|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785757|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785758|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785759|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785760|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
101785761|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785762|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785763|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785764|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785765|NCT00788060|Growth Substances|growth substances|mesh-ancestor
101785766|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785767|NCT00788138|Vitamin D|vitamin d|mesh-list
101785768|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
101785769|NCT00788138|Vitamins|vitamins|mesh-ancestor
101785770|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
101785771|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785772|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101785773|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101785774|NCT00864396|Lansoprazole|lansoprazole|mesh-list
101785775|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101785776|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785777|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101785778|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785779|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785780|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
101785781|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101785782|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101785783|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101785784|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
101785785|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785786|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101785787|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101785788|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785789|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785790|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101785791|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101785792|NCT00961467|Thalidomide|thalidomide|mesh-list
101785794|NCT00961467|Melphalan|melphalan|mesh-list
101785795|NCT00961467|Lenalidomide|lenalidomide|mesh-list
101785796|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101785797|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
101785799|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785800|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785801|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101785802|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785803|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101785804|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
101785805|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785806|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101785807|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785808|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
101785809|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785810|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785811|NCT00961467|Growth Substances|growth substances|mesh-ancestor
101785812|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785813|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
101785814|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101785815|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785816|NCT00980031|Eplerenone|eplerenone|mesh-list
101785817|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101785818|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
101785819|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785820|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785821|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101785822|NCT00980031|Diuretics|diuretics|mesh-ancestor
101785823|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
101785824|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785825|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
101785826|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101785827|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785828|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785829|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785830|NCT00980109|Oseltamivir|oseltamivir|mesh-list
101785831|NCT00980109|Zanamivir|zanamivir|mesh-list
101785832|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
101785833|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785834|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785835|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785836|NCT04988841|Nivolumab|nivolumab|mesh-list
101785837|NCT04988841|Ipilimumab|ipilimumab|mesh-list
101785838|NCT04988841|Laxatives|laxatives|mesh-list
101785839|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101785840|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101785841|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785842|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101785843|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785844|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785845|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101785846|NCT00980187|Indapamide|indapamide|mesh-list
101785847|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101785848|NCT00980187|Diuretics|diuretics|mesh-ancestor
101785849|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
101785850|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785851|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101785852|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101785853|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785854|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
101415056|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101785855|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101785857|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101785858|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101785859|NCT00284089|Growth Substances|growth substances|mesh-ancestor
101785860|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785861|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101785862|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785863|NCT00984633|Bromides|bromides|mesh-list
101785864|NCT00984633|Propofol|propofol|mesh-list
101785865|NCT00984633|Sevoflurane|sevoflurane|mesh-list
101785866|NCT00984633|Rocuronium|rocuronium|mesh-list
101785867|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101785868|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785869|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785870|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101785871|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
101785872|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
101785873|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101785874|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101785875|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
101785876|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101785877|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101785878|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101785879|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785880|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101785881|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785882|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785883|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785884|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101785885|NCT00976755|Everolimus|everolimus|mesh-list
101785886|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101785887|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785888|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785889|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785890|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101785891|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
101785892|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785893|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785894|NCT00864474|Maraviroc|maraviroc|mesh-list
101785895|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101785896|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101537059|NCT04575389|Protective Agents|protective agents|mesh-ancestor
101785897|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785898|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101785899|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101785900|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
101785901|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785902|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101785903|NCT00283387|Betaine|betaine|mesh-list
101785904|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101785905|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
101785906|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101785907|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
101785908|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785909|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101785910|NCT00788294|Tanezumab|tanezumab|mesh-list
101785911|NCT00788294|Analgesics|analgesics|mesh-ancestor
101785912|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
101785913|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785914|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785915|NCT00795548|Azacitidine|azacitidine|mesh-list
101785916|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101785917|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
101785918|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785919|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542417|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
101785920|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785921|NCT00282919|Azithromycin|azithromycin|mesh-list
101785922|NCT00282919|Chloroquine|chloroquine|mesh-list
101785923|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101443310|NCT01968733|Solithromycin|solithromycin|mesh-list
101785924|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785926|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101785927|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101785928|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
101785929|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101785931|NCT00984789|Gestodene|gestodene|mesh-list
101785932|NCT00984789|Norelgestromin|norelgestromin|mesh-list
101785933|NCT00984789|Femovan|femovan|mesh-list
101785934|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101785935|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101785936|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101785937|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
101785938|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101785939|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785940|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101785941|NCT00984789|Estrogens|estrogens|mesh-ancestor
101785942|NCT00984789|Hormones|hormones|mesh-ancestor
101785943|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785944|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101785945|NCT00984789|Progestins|progestins|mesh-ancestor
101785946|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101785947|NCT00864552|Factor VIII|factor viii|mesh-list
101785948|NCT00864552|Coagulants|coagulants|mesh-ancestor
101785949|NCT04046822|Liraglutide|liraglutide|mesh-list
101785950|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101785951|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785952|NCT04046822|Incretins|incretins|mesh-ancestor
101785953|NCT04046822|Hormones|hormones|mesh-ancestor
101785954|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101785955|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101785956|NCT04007835|Gefitinib|gefitinib|mesh-list
101785957|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785958|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101785959|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101785960|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785961|NCT00800930|Butyric Acid|butyric acid|mesh-list
101785962|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
101785963|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
101785964|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537080|NCT00587327|Atosiban|atosiban|mesh-list
101785965|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785966|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785967|NCT00868062|Polygeline|polygeline|mesh-list
101785968|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
101785969|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
101785970|NCT00742781|Vitamin D|vitamin d|mesh-list
101785971|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
101785972|NCT00742781|Vitamins|vitamins|mesh-ancestor
101785973|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
101785974|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785975|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101785976|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101785977|NCT00280735|Carboplatin|carboplatin|mesh-list
101785978|NCT00280735|Docetaxel|docetaxel|mesh-list
101785979|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101785980|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
101785981|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
101785982|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
101785983|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101785984|NCT03975283|Bupivacaine|bupivacaine|mesh-list
101785985|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101785986|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
101785987|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542432|NCT02279511|Adenosine|adenosine|mesh-list
101785988|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785989|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
101785990|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101785991|NCT01070407|Cloricromen|cloricromen|mesh-list
101785992|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101785993|NCT00801086|Ethanol|ethanol|mesh-list
101785994|NCT00801086|Tempol|tempol|mesh-list
101309898|NCT00006198|Doxorubicin|doxorubicin|mesh-list
101785995|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101785996|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101785997|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101785998|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101785999|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
101786000|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786001|NCT00801086|Protective Agents|protective agents|mesh-ancestor
101786002|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101786003|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786004|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101786005|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101786006|NCT00788606|Bevacizumab|bevacizumab|mesh-list
101786007|NCT00788606|Rituximab|rituximab|mesh-list
101786008|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101537086|NCT00587444|Heparin|heparin|mesh-list
101786009|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786010|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786011|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101786012|NCT00788606|Growth Substances|growth substances|mesh-ancestor
101786013|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786014|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
101786015|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
101786016|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786017|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
101786018|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
101786019|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101786020|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101786021|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786022|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786023|NCT00795938|Urological Agents|urological agents|mesh-ancestor
101786024|NCT00260065|Decitabine|decitabine|mesh-list
101786025|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786026|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
101786027|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786028|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786029|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786030|NCT01071655|Fluorouracil|fluorouracil|mesh-list
101786031|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
101786032|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786033|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786034|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786035|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786036|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
101786037|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786038|NCT02531581|Furosemide|furosemide|mesh-list
101786039|NCT02531581|Diuretics|diuretics|mesh-list
101786040|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
101786041|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786042|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101786043|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786044|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786045|NCT04046510|Oxytocin|oxytocin|mesh-list
101786046|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
101786047|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101786048|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786049|NCT00506350|Vaccines|vaccines|mesh-list
101786050|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
101786051|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786052|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
101786053|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
101786054|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
101786055|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101786056|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786057|NCT00742625|Cytarabine|cytarabine|mesh-list
101786058|NCT00742625|Bortezomib|bortezomib|mesh-list
101786059|NCT00742625|Daunorubicin|daunorubicin|mesh-list
101786060|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786061|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
101786062|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786063|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786064|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
101786065|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786066|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786067|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
101786068|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786069|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101786070|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101786071|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101786072|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786073|NCT00801788|Oxycodone|oxycodone|mesh-list
101786074|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101786075|NCT00801788|Narcotics|narcotics|mesh-ancestor
101443464|NCT00555022|Bromides|bromides|mesh-list
101786076|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786077|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786078|NCT00801788|Analgesics|analgesics|mesh-ancestor
101786079|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
101786080|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786081|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101786082|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786083|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
101786084|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101786085|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786086|NCT00796250|Prednisolone|prednisolone|mesh-list
101786087|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101786088|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
101786089|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101786090|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
101786092|NCT00796250|Azathioprine|azathioprine|mesh-list
101786093|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101786094|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
101786095|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786096|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
101786097|NCT00796250|Hormones|hormones|mesh-ancestor
101786098|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786099|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786100|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101786101|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786102|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
101786103|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
101786104|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786105|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786106|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101786107|NCT00796250|Protective Agents|protective agents|mesh-ancestor
101786108|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101786109|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101786110|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786111|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
101786112|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786113|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786114|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786115|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
101786116|NCT00788918|Interferons|interferons|mesh-list
101786117|NCT00788918|Ribavirin|ribavirin|mesh-list
101786118|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786119|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
101786120|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786121|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
101786122|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786123|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
101786124|NCT02596373|Analgesics|analgesics|mesh-ancestor
101786125|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
101786126|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786127|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786128|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786129|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101786130|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101786131|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786132|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786133|NCT00801866|Bevacizumab|bevacizumab|mesh-list
101786134|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786135|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786136|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786137|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101537133|NCT00587873|Antidotes|antidotes|mesh-ancestor
101786138|NCT00801866|Growth Substances|growth substances|mesh-ancestor
101786141|NCT03973879|Atezolizumab|atezolizumab|mesh-list
101786142|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101786143|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786144|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786145|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786146|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101786147|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101786148|NCT00860964|Estradiol|estradiol|mesh-list
101786149|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101443553|NCT01807546|ON 01910|on 01910|mesh-list
101786150|NCT00860964|Estrogens|estrogens|mesh-ancestor
101786151|NCT00860964|Hormones|hormones|mesh-ancestor
101786152|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786153|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786154|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101786155|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
101786156|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101786157|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101786158|NCT00861042|Lacosamide|lacosamide|mesh-list
101786159|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
101786160|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101786161|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101786162|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786163|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786164|NCT04088903|Daratumumab|daratumumab|mesh-list
101786165|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786166|NCT00861120|Doxorubicin|doxorubicin|mesh-list
101786167|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101786168|NCT00861120|Panitumumab|panitumumab|mesh-list
101786169|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101786170|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786171|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101786172|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101786173|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786174|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786175|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786176|NCT00740051|Glimepiride|glimepiride|mesh-list
101542474|NCT02215733|Diuretics|diuretics|mesh-list
101542475|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101786177|NCT00740051|Linagliptin|linagliptin|mesh-list
101786178|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101786179|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101786180|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786181|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786182|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
101786183|NCT00740051|Incretins|incretins|mesh-ancestor
101786184|NCT00740051|Hormones|hormones|mesh-ancestor
101786185|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786186|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101786187|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
101786188|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786189|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786190|NCT00864864|Sunitinib|sunitinib|mesh-list
101786191|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786192|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786193|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101786194|NCT00864864|Growth Substances|growth substances|mesh-ancestor
101537136|NCT00587873|Vitamins|vitamins|mesh-ancestor
101786195|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786196|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
101786197|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101786198|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786199|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786200|NCT00868764|Granisetron|granisetron|mesh-list
101786201|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
101786202|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
101786203|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786204|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786205|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786206|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101786207|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101786209|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786210|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786211|NCT00518986|Modafinil|modafinil|mesh-list
101786212|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101786213|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786214|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101786215|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101786216|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101786217|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786218|NCT00864942|Lenalidomide|lenalidomide|mesh-list
101786219|NCT00864942|Rituximab|rituximab|mesh-list
101786220|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101786221|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
101786222|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786223|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786224|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101786225|NCT00864942|Growth Substances|growth substances|mesh-ancestor
101786226|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
101786227|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786228|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786229|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786230|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101786231|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
101786232|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786233|NCT00870402|Spironolactone|spironolactone|mesh-list
101786234|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101786235|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
101786236|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786237|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415064|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
101786238|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101786239|NCT00870402|Diuretics|diuretics|mesh-ancestor
101786240|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
101786241|NCT00742235|Vitamin D|vitamin d|mesh-list
101786242|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
101786243|NCT00742235|Vitamins|vitamins|mesh-ancestor
101786244|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
101786245|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786246|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101786247|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101786248|NCT00742079|Cycloserine|cycloserine|mesh-list
101786249|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101786250|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786251|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101786252|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
101786253|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786254|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
101786257|NCT04730362|Sevoflurane|sevoflurane|mesh-list
101786258|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
101786259|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786260|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786261|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101786262|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101786263|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
101786264|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101786265|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101786266|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
101786267|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101786268|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101786269|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
101786270|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786271|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786272|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101786273|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101786274|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
101786275|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101786276|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
101786277|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786278|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786279|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101786280|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101786281|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101786282|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
101786283|NCT00870480|Finasteride|finasteride|mesh-list
101786284|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101786285|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101786286|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786287|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786288|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101786289|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786290|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786291|NCT00870480|Urological Agents|urological agents|mesh-ancestor
101786292|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
101786293|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786294|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101786295|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101786296|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101786297|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101786298|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
101786299|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101786300|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786301|NCT00616902|Vitamins|vitamins|mesh-ancestor
101786302|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
101786303|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101786304|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
101786305|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101786306|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101786307|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101786308|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786309|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786310|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786311|NCT00801944|Urological Agents|urological agents|mesh-ancestor
101786312|NCT00870636|Bevacizumab|bevacizumab|mesh-list
101786313|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786314|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786315|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786316|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101786317|NCT00870636|Growth Substances|growth substances|mesh-ancestor
101786318|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786319|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101786320|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101786321|NCT00870714|Ketoconazole|ketoconazole|mesh-list
101786322|NCT00870714|Docetaxel|docetaxel|mesh-list
101786323|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786324|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
101786325|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
101786326|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
101786327|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786328|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
101786329|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786330|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101786331|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786332|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786333|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101786334|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101786335|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786336|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786337|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101786338|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101786339|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
101786340|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786341|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
101786342|NCT02598011|Flucytosine|flucytosine|mesh-list
101786343|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
101786344|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786345|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
101786346|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786347|NCT00869310|Dexamethasone|dexamethasone|mesh-list
101786348|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
101786349|NCT00869310|Aprepitant|aprepitant|mesh-list
101786350|NCT00869310|Metoclopramide|metoclopramide|mesh-list
101786351|NCT00869310|BB 1101|bb 1101|mesh-list
101786352|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786353|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
101786354|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
101786355|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786356|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786357|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786358|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
101786359|NCT00869310|Hormones|hormones|mesh-ancestor
101786360|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786361|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101786362|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786363|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
101786364|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786365|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786366|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101786367|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786368|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101786369|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101786370|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
101786372|NCT00662558|Tramadol|tramadol|mesh-list
101542510|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101542515|NCT01201798|Hormones|hormones|mesh-ancestor
101412160|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101786373|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101786374|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101786375|NCT00662558|Analgesics|analgesics|mesh-ancestor
101786376|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
101786377|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786378|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786379|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786380|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786381|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101786382|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101786383|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786384|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786385|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101786386|NCT00662558|Narcotics|narcotics|mesh-ancestor
101786387|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786388|NCT00869700|Lumefantrine|lumefantrine|mesh-list
101786389|NCT00869700|Artemether|artemether|mesh-list
101786390|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101786391|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
101786392|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101786393|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101786394|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786395|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
101786396|NCT00869856|Hematinics|hematinics|mesh-ancestor
101786397|NCT00876486|genexol-PM|genexol-pm|mesh-list
101786398|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786399|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
101786400|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
101786401|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
101786402|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786403|NCT00802334|Ritonavir|ritonavir|mesh-list
101786404|NCT00802334|Lopinavir|lopinavir|mesh-list
101786405|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101786406|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101786407|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
101786408|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786409|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786410|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101786411|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101786412|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
101786413|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786414|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101786415|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786416|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101786417|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101786418|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101786419|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786420|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786421|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101786422|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101786423|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101786424|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
101786425|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786426|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786427|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101786428|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101786429|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
101786430|NCT00796796|Sirolimus|sirolimus|mesh-list
101786431|NCT00796796|Temsirolimus|temsirolimus|mesh-list
101786432|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
101786433|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101786434|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786435|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786436|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786437|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
101542519|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786438|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786439|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786440|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786441|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786442|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101786443|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
101443842|NCT00199017|Cladribine|cladribine|mesh-list
101786444|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
101786445|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101786446|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
101786447|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786448|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101786449|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786450|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101786451|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
101786452|NCT00739973|Amlodipine|amlodipine|mesh-list
101786453|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101786454|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101786455|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786456|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786457|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101786458|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786459|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
101786461|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
101786462|NCT00802568|Busulfan|busulfan|mesh-list
101786463|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101786464|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786465|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786466|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
101786467|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786468|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786469|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
101786470|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786471|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
101786472|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101786473|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101786474|NCT00802802|Efavirenz|efavirenz|mesh-list
101786475|NCT00802802|Rifampin|rifampin|mesh-list
101786476|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101786477|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101786478|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786479|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786480|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
101786481|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786482|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101786483|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786484|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101786485|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101786486|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101786487|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101786488|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101786489|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
101786490|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786491|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
101786492|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101786493|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101786494|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101786495|NCT00802958|Clobetasol|clobetasol|mesh-list
101786496|NCT00802958|Halobetasol|halobetasol|mesh-list
101786497|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101542525|NCT01201798|Protective Agents|protective agents|mesh-ancestor
101786498|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786500|NCT00802958|Hormones|hormones|mesh-ancestor
101786501|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786502|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786503|NCT01565512|Bupivacaine|bupivacaine|mesh-list
101786504|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
101786505|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
101786506|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786507|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786508|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
101786509|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786510|NCT04895930|Aflutinib|aflutinib|mesh-list
101786511|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101786512|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786513|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786514|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101786515|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101786516|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
101786517|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786518|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786519|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101786520|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
101786521|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101786522|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101786523|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101786524|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
101786525|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786526|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786528|NCT00789308|Sirolimus|sirolimus|mesh-list
101786529|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
101786530|NCT00789308|Etanercept|etanercept|mesh-list
101786531|NCT00789308|Heparin|heparin|mesh-list
101786532|NCT00789308|Dextrans|dextrans|mesh-list
101786533|NCT00789308|Tacrolimus|tacrolimus|mesh-list
101786534|NCT00789308|Cyclosporins|cyclosporins|mesh-list
101786535|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
101786536|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101786537|NCT00789308|Basiliximab|basiliximab|mesh-list
101786538|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786539|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
101786540|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786541|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101786542|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786543|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786544|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
101786545|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786546|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
101786547|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786548|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101786549|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786550|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101786551|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
101786552|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786553|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
101786554|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101786555|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101786556|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101786557|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101786558|NCT00789308|Analgesics|analgesics|mesh-ancestor
101786559|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
101786560|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786561|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786562|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786563|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
101786564|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
101542537|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786565|NCT00518284|Paclitaxel|paclitaxel|mesh-list
101786566|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101542539|NCT04532684|Pregabalin|pregabalin|mesh-list
101786567|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101786568|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786569|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101786570|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
101786571|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101786572|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786573|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
101786574|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786575|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786576|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101786577|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101786578|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786579|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786580|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786581|NCT00871104|Vancomycin|vancomycin|mesh-list
101786582|NCT00871104|Imipenem|imipenem|mesh-list
101786583|NCT00871104|Fosfomycin|fosfomycin|mesh-list
101786584|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786585|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786586|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
101786587|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101786588|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786589|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
101786590|NCT00727415|Fludarabine|fludarabine|mesh-list
101786591|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
101786592|NCT00727415|Lenalidomide|lenalidomide|mesh-list
101443995|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
101786593|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786594|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
101786595|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786596|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786597|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101786598|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
101786599|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786600|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786601|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101786602|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786604|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101786605|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101786606|NCT00727415|Growth Substances|growth substances|mesh-ancestor
101786607|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
101786609|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101786610|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786611|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101786612|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
101786613|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
101786614|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786615|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786616|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786617|NCT00544557|Etanercept|etanercept|mesh-list
101786618|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101786619|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101786620|NCT00544557|Analgesics|analgesics|mesh-ancestor
101786621|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
101786622|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786623|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786624|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786625|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786626|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786627|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786628|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
101786629|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
101786630|NCT00877110|Vincristine|vincristine|mesh-list
101542544|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786631|NCT00877110|Topotecan|topotecan|mesh-list
101786632|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786633|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
101786634|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786635|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786636|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101786637|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
101786638|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786639|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786640|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101786641|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101786642|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101786643|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101786644|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101786645|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101786646|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101786647|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786648|NCT00727259|Ribavirin|ribavirin|mesh-list
101786649|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101786650|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
101786651|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786652|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
101786653|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786654|NCT00789386|Midazolam|midazolam|mesh-list
101786655|NCT00789386|Remifentanil|remifentanil|mesh-list
101786656|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101786657|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101786658|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786659|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786660|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101786662|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101786663|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101786664|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
101786665|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
101786666|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
101786667|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
101786668|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786669|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786670|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101786671|NCT00789386|Narcotics|narcotics|mesh-ancestor
101786672|NCT00789386|Analgesics|analgesics|mesh-ancestor
101786673|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
101786674|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786675|NCT00789464|Trimethoprim|trimethoprim|mesh-list
101786676|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
101786677|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101786678|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786679|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
101786680|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101786681|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101786682|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101786683|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786684|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786685|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101786686|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101786687|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786688|NCT00797030|Cyclosporine|cyclosporine|mesh-list
101786689|NCT00797030|Cyclosporins|cyclosporins|mesh-list
101786690|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786691|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786692|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786693|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
101786694|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786695|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
101786696|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786697|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
101786698|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786699|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101786700|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
101786701|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
101786702|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786703|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
101786704|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
101786705|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101786706|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101786707|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786708|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786709|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101786710|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101786711|NCT00877266|Mepivacaine|mepivacaine|mesh-list
101786712|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
101786713|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
101786714|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786715|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786716|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
101786717|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786719|NCT02553824|Phentermine|phentermine|mesh-list
101786720|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
101786721|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101786722|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786723|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101786724|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
101786725|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101786726|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
101786727|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
101786728|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786729|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101786730|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786731|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786733|NCT04039854|Sevoflurane|sevoflurane|mesh-list
101786734|NCT04039854|Desflurane|desflurane|mesh-list
101786735|NCT04039854|Isoflurane|isoflurane|mesh-list
101786736|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101786737|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786738|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786739|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101786740|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
101786741|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
101786742|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101786743|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101786744|NCT04045730|Paclitaxel|paclitaxel|mesh-list
101786745|NCT04045730|Gemcitabine|gemcitabine|mesh-list
101786746|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
101786747|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101786748|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786749|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
101786750|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
101786751|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
101786752|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786753|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101786754|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
101786755|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786756|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101786758|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
101786759|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
101786760|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
101786761|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786762|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786763|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786764|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101786765|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786766|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786767|NCT00977301|Ritonavir|ritonavir|mesh-list
101786768|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
101786769|NCT00977301|Olanzapine|olanzapine|mesh-list
101786770|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101415077|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
101542559|NCT01649466|Insulin|insulin|mesh-list
101786771|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101786772|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
101786773|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786774|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786775|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101786776|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101786777|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
101786778|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786779|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101786780|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786781|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
101786782|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
101786784|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786785|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786786|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101786787|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101786788|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786789|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101786790|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101786791|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101786792|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786793|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786794|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
101786795|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101786796|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101786797|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786798|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101786799|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101786800|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786801|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786802|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
101786803|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786804|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
101786805|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786806|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
101786807|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786808|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786809|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101786810|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
101786811|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786812|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786813|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101786814|NCT00984945|Vaccines|vaccines|mesh-list
101786815|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
101786816|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786817|NCT00879918|Nicotine|nicotine|mesh-list
101786818|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101786819|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
101786820|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786821|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786823|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101786824|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101786825|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786826|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786827|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
101786828|NCT01565590|Propofol|propofol|mesh-list
101786829|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101786830|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786831|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786832|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101786833|NCT01565590|Analgesics|analgesics|mesh-ancestor
101542569|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786834|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
101786835|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786836|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101786837|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101786838|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101786839|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
101786840|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786841|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786842|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101786843|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
101786845|NCT00877422|Vitamin D|vitamin d|mesh-list
101786846|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
101786847|NCT00877422|Vitamins|vitamins|mesh-ancestor
101786848|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
101786849|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786850|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101786851|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101786852|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
101786853|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101786854|NCT04039698|Velpatasvir|velpatasvir|mesh-list
101786855|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
101786856|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786857|NCT04006821|Apatinib|apatinib|mesh-list
101786858|NCT04006821|Antibodies|antibodies|mesh-list
101786859|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
101786860|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786861|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786862|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101786863|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786864|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786865|NCT00803816|Everolimus|everolimus|mesh-list
101786866|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101786867|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101786868|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786869|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786870|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101786871|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
101786872|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786873|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786874|NCT00797264|Ketamine|ketamine|mesh-list
101786875|NCT00797264|Morphine|morphine|mesh-list
101786876|NCT00797264|Analgesics|analgesics|mesh-ancestor
101786877|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
101786878|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786879|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786880|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101786881|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101786882|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
101786883|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
101786884|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786885|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101786886|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101786887|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786888|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786889|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101786890|NCT00797264|Narcotics|narcotics|mesh-ancestor
101786891|NCT00981201|Celecoxib|celecoxib|mesh-list
101786892|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101786893|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101786894|NCT00981201|Analgesics|analgesics|mesh-ancestor
101786895|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
101786896|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786897|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786898|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786899|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786900|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101542580|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786901|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101786902|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786903|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786905|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101786906|NCT05279391|Heparin|heparin|mesh-list
101786907|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101786908|NCT05279391|Tinzaparin|tinzaparin|mesh-list
101786909|NCT05279391|Dalteparin|dalteparin|mesh-list
101786910|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101786911|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
101786912|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
101786913|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786914|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786915|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101786916|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
101786917|NCT05279391|Hormones|hormones|mesh-ancestor
101786918|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786919|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101786920|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786922|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101786923|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101786924|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786925|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101786926|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101786927|NCT00789620|Lidocaine|lidocaine|mesh-list
101786928|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101786929|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
101786930|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101786931|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786932|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
101786933|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101786934|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101786935|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101786936|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101786937|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786938|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786939|NCT03970265|Meropenem|meropenem|mesh-list
101786940|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101786941|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786942|NCT00877656|Zanolimumab|zanolimumab|mesh-list
101786943|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101786944|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101786945|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101786946|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101786947|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786948|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786949|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101786950|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
101786951|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101786952|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
101786953|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786954|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101786955|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101786956|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101786957|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542586|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542588|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101786958|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786959|NCT00797420|Fluconazole|fluconazole|mesh-list
101786960|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
101786961|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101786962|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101786963|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101786964|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101786965|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786966|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101786967|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
101786968|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101786969|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786970|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101786974|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786975|NCT00872274|Sumatriptan|sumatriptan|mesh-list
101786976|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101786977|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101786978|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101786979|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
101786980|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101786981|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309953|NCT00387582|Ranibizumab|ranibizumab|mesh-list
101786982|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786983|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101786984|NCT00872586|Olmesartan|olmesartan|mesh-list
101786985|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101786986|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101786987|NCT00872586|Diuretics|diuretics|mesh-ancestor
101786988|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
101786989|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101786990|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101786991|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101786992|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101786993|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101786994|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101786995|NCT00726557|Interferons|interferons|mesh-list
101786996|NCT00726557|Ribavirin|ribavirin|mesh-list
101786997|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
101786998|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
101786999|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101787000|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787001|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
101787002|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787003|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
101787004|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542600|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101787005|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
101787006|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787007|NCT00803972|Insulin|insulin|mesh-list
101787008|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101787009|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
101787010|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101787011|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787012|NCT00880386|Losartan|losartan|mesh-list
101787013|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101787014|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101787015|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101787016|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101787017|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787018|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101787019|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101787020|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787021|NCT00804050|Vitamins|vitamins|mesh-list
101787022|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
101787023|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787024|NCT00877734|Baclofen|baclofen|mesh-list
101787025|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101787026|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787027|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101787028|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787029|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101787030|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
101787031|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
101787032|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787033|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787040|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787041|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101787042|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787043|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787044|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101787045|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
101787046|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
101787047|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787048|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787049|NCT00804206|Bevacizumab|bevacizumab|mesh-list
101787050|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787051|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787052|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787053|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787054|NCT00804206|Growth Substances|growth substances|mesh-ancestor
101309954|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787055|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787056|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787057|NCT00877812|Glycine|glycine|mesh-list
101787058|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
101787059|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787060|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787061|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787062|NCT00981903|Tinzaparin|tinzaparin|mesh-list
101787063|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101787064|NCT00981903|Dalteparin|dalteparin|mesh-list
101787065|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
101787066|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101787067|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101787068|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787069|NCT00738881|Pemetrexed|pemetrexed|mesh-list
101787070|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101787071|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787072|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542618|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787073|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787074|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101787075|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101787076|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787078|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101787079|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
101787080|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787081|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787082|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101787083|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101787084|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
101787085|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787086|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787087|NCT03921723|Dolutegravir|dolutegravir|mesh-list
101787088|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101787089|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101787090|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787091|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787092|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787093|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787094|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
101787095|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787096|NCT00872664|Carotenoids|carotenoids|mesh-list
101787097|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
101787098|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787099|NCT00872664|Protective Agents|protective agents|mesh-ancestor
101787100|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787101|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
101787102|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101787103|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101787104|NCT00878124|Ubiquinone|ubiquinone|mesh-list
101787105|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
101787106|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
101787107|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787108|NCT00878124|Vitamins|vitamins|mesh-ancestor
101787109|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
101787110|NCT00978315|Vitamin D|vitamin d|mesh-list
101787111|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101787112|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787113|NCT00978315|Vitamins|vitamins|mesh-ancestor
101787114|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
101787115|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101787116|NCT00978393|Liraglutide|liraglutide|mesh-list
101787117|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101787118|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787119|NCT00978393|Incretins|incretins|mesh-ancestor
101787120|NCT00978393|Hormones|hormones|mesh-ancestor
101787121|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787122|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
101787123|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787124|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787125|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101787126|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787127|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101787128|NCT00872976|Dasatinib|dasatinib|mesh-list
101787129|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101787130|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
101787131|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787132|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787133|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787134|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787135|NCT00544167|Paclitaxel|paclitaxel|mesh-list
101787136|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
101787137|NCT00544167|Doxorubicin|doxorubicin|mesh-list
101787138|NCT00544167|Sorafenib|sorafenib|mesh-list
101787139|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787140|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787141|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787142|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787143|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787144|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787145|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787146|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
101787147|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787148|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787149|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101787150|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
101787151|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101787152|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101787153|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101787154|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787155|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787156|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787157|NCT00659438|Bicalutamide|bicalutamide|mesh-list
101787158|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
101787159|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
101787160|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787161|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787162|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787163|NCT05225844|Apatinib|apatinib|mesh-list
101787164|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787165|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787166|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787167|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787168|NCT00878514|Alprazolam|alprazolam|mesh-list
101787169|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101787170|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787171|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787172|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101787173|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101787174|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787175|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
101787176|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
101787177|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787178|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787179|NCT00804440|Ibuprofen|ibuprofen|mesh-list
101787180|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101787181|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787182|NCT00804440|Analgesics|analgesics|mesh-ancestor
101787183|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
101787184|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787185|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787186|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787187|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787188|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101787189|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787190|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787191|NCT00880854|Tremelimumab|tremelimumab|mesh-list
101787192|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787193|NCT00543855|Donepezil|donepezil|mesh-list
101787194|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101787195|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787196|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787197|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
101787198|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787199|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787200|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
101787201|NCT00797810|Cytarabine|cytarabine|mesh-list
101787202|NCT00797810|Dexamethasone|dexamethasone|mesh-list
101542640|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787204|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
101787205|NCT00797810|Ifosfamide|ifosfamide|mesh-list
101787206|NCT00797810|Rituximab|rituximab|mesh-list
101787207|NCT00797810|Vincristine|vincristine|mesh-list
101787208|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787209|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
101787210|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787211|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787212|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101787213|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
101787214|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787215|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787216|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101787217|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787218|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787219|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
101787220|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
101787221|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787222|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787223|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
101787224|NCT00797810|Hormones|hormones|mesh-ancestor
101787225|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787226|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101787227|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101787228|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
101787229|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
101787230|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787231|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787232|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787233|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787234|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787235|NCT00873210|Sunitinib|sunitinib|mesh-list
101787236|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787237|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787238|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787239|NCT00873210|Growth Substances|growth substances|mesh-ancestor
101787240|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787241|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787242|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787243|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787244|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787245|NCT00978471|Thiotepa|thiotepa|mesh-list
101787246|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101787247|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
101787248|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787249|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787250|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101787251|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787252|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
101787253|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787254|NCT00804674|Bupivacaine|bupivacaine|mesh-list
101787255|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
101787256|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
101787257|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787258|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787259|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
101787260|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787261|NCT00881088|PENTA|penta|mesh-list
101787262|NCT00881088|Nadroparin|nadroparin|mesh-list
101787263|NCT00881088|Fondaparinux|fondaparinux|mesh-list
101787264|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101787265|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
101787266|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101787268|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787269|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787271|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101787272|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101787273|NCT00978549|Docetaxel|docetaxel|mesh-list
101787274|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787275|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787276|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787277|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787278|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787279|NCT00656084|Rituximab|rituximab|mesh-list
101787280|NCT00656084|Gemcitabine|gemcitabine|mesh-list
101787281|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
101787282|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787283|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787284|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
101787285|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787286|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787287|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101787288|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
101787289|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787290|NCT00656084|Analgesics|analgesics|mesh-ancestor
101787291|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
101787292|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787293|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101787294|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787295|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787296|NCT00881166|Paclitaxel|paclitaxel|mesh-list
101787297|NCT00881166|Etoposide|etoposide|mesh-list
101787298|NCT00881166|Docetaxel|docetaxel|mesh-list
101787299|NCT00881166|Carboplatin|carboplatin|mesh-list
101787300|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101787301|NCT00881166|Topotecan|topotecan|mesh-list
101787302|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787303|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787304|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787305|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787306|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787307|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787308|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101787309|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787310|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787311|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787312|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101787313|NCT00804752|Vitamin D|vitamin d|mesh-list
101787314|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
101787315|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
101787316|NCT00804752|Vitamins|vitamins|mesh-list
101787317|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
101787318|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787319|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101787320|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101787321|NCT05225766|Bupivacaine|bupivacaine|mesh-list
101787322|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
101787323|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
101787324|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787325|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787326|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
101787327|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787328|NCT00804830|Bevacizumab|bevacizumab|mesh-list
101787329|NCT00804830|Doxorubicin|doxorubicin|mesh-list
101787330|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787331|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787332|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787333|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787334|NCT00804830|Growth Substances|growth substances|mesh-ancestor
101787335|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787336|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787337|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101787338|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101542653|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101787339|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787340|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412180|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101787341|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787342|NCT00982215|Acetaminophen|acetaminophen|mesh-list
101787343|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787344|NCT00982215|Analgesics|analgesics|mesh-ancestor
101787345|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
101787346|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787347|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787349|NCT00613938|Oxycodone|oxycodone|mesh-list
101787350|NCT00613938|Tapentadol|tapentadol|mesh-list
101787351|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101787352|NCT00613938|Narcotics|narcotics|mesh-ancestor
101787353|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787354|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787355|NCT00613938|Analgesics|analgesics|mesh-ancestor
101787356|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
101787357|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787358|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101787359|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101787360|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787361|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787362|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
101787363|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787364|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101787365|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101787366|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787367|NCT00805064|Triamcinolone|triamcinolone|mesh-list
101787368|NCT00805064|Bevacizumab|bevacizumab|mesh-list
101787369|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787370|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787371|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787372|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787374|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787375|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787376|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787377|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
101787378|NCT00805064|Hormones|hormones|mesh-ancestor
101787379|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787380|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
101787381|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101787382|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
101787383|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787384|NCT00655928|Expectorants|expectorants|mesh-ancestor
101787385|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
101787386|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101787387|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
101787388|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787389|NCT00655928|Protective Agents|protective agents|mesh-ancestor
101787390|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787391|NCT00655928|Antidotes|antidotes|mesh-ancestor
101787392|NCT00873756|Bevacizumab|bevacizumab|mesh-list
101787393|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787394|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787395|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787396|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787397|NCT00873756|Growth Substances|growth substances|mesh-ancestor
101787398|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787399|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787400|NCT00873834|Fluoxetine|fluoxetine|mesh-list
101787401|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101787402|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101787403|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542661|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787404|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787406|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
101787407|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787408|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101787409|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
101787410|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101309978|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
101787412|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101787413|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787414|NCT00655850|Paclitaxel|paclitaxel|mesh-list
101787415|NCT00655850|Gemcitabine|gemcitabine|mesh-list
101787416|NCT00655850|Bevacizumab|bevacizumab|mesh-list
101787417|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787418|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787419|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787420|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787421|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787422|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787423|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101787425|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787426|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787427|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787428|NCT00655850|Growth Substances|growth substances|mesh-ancestor
101787429|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787430|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787431|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
101787432|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787433|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787434|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
101787436|NCT00805298|Racepinephrine|racepinephrine|mesh-list
101787437|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
101787438|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787439|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
101787440|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
101787441|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787442|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787443|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787444|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
101787445|NCT00805298|Hormones|hormones|mesh-ancestor
101787446|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787447|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101787448|NCT00805298|Protective Agents|protective agents|mesh-ancestor
101787449|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101787450|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101787451|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
101787452|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787453|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787454|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101787455|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101787456|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101787457|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
101787458|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
101787459|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
101787460|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101787461|NCT00881400|Cefprozil|cefprozil|mesh-list
101787462|NCT00881400|Cephalosporins|cephalosporins|mesh-list
101787463|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101787464|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787465|NCT00246571|Sunitinib|sunitinib|mesh-list
101787466|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787467|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101787468|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101787469|NCT00246571|Growth Substances|growth substances|mesh-ancestor
101787470|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787471|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
101787472|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787473|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787474|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787475|NCT02553044|Vitamin D|vitamin d|mesh-list
101787476|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
101787477|NCT02553044|Vitamins|vitamins|mesh-ancestor
101787478|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
101787479|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787480|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101787481|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101787482|NCT00545103|Mesalamine|mesalamine|mesh-list
101787483|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101787484|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787485|NCT00545103|Analgesics|analgesics|mesh-ancestor
101787486|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
101787487|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787488|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787489|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787490|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787492|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101787493|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787495|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101787496|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787497|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787498|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
101787499|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787500|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
101787501|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787502|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
101787503|NCT00809744|Vitamin D|vitamin d|mesh-list
101787504|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101787505|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787506|NCT00809744|Vitamins|vitamins|mesh-ancestor
101787507|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
101787508|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101787509|NCT00246337|Rizatriptan|rizatriptan|mesh-list
101787510|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101787511|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
101787512|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787513|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787514|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787515|NCT05012943|Vaccines|vaccines|mesh-list
101787516|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
101787517|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787518|NCT01581853|Ritonavir|ritonavir|mesh-list
101787519|NCT01581853|Lopinavir|lopinavir|mesh-list
101787520|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101787521|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101787522|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
101787523|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787524|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787525|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787526|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787527|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
101787528|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787529|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101787530|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101787531|NCT01070641|Carvedilol|carvedilol|mesh-list
101787532|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101787533|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101787534|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
101787535|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787536|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787537|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787538|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101787539|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
101787540|NCT01070641|Protective Agents|protective agents|mesh-ancestor
101787541|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101787542|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415089|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415091|NCT04726982|Acetazolamide|acetazolamide|mesh-list
101787543|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101787544|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
101787545|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101787546|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101787547|NCT00982449|Fialuridine|fialuridine|mesh-list
101787548|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
101787549|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787550|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101787551|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787552|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787553|NCT02593721|Ibuprofen|ibuprofen|mesh-list
101787554|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101787555|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787556|NCT02593721|Analgesics|analgesics|mesh-ancestor
101787557|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
101787558|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309982|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101787559|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787560|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787561|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787562|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101787563|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787564|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787565|NCT00985647|Lamivudine|lamivudine|mesh-list
101787566|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101787567|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101787568|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787569|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787570|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
101787571|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787572|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787573|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787574|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101787575|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
101787576|NCT00806468|Coagulants|coagulants|mesh-ancestor
101787577|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101787578|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
101787579|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787580|NCT00982527|Fenoldopam|fenoldopam|mesh-list
101787581|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101787582|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
101787583|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
101787584|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
101787585|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787586|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787587|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787588|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
101787589|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101787590|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
101787591|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101787592|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787593|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101787594|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101787595|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101787596|NCT00725621|Infliximab|infliximab|mesh-list
101787597|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101787598|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787599|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787600|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787601|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787602|NCT00613626|Etoposide|etoposide|mesh-list
101787603|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787604|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787605|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101787606|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787607|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787608|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787609|NCT00725543|Infliximab|infliximab|mesh-list
101787610|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101787611|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787612|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787613|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787614|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787615|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
101787616|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101787617|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787618|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101787619|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
101787620|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101787621|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787622|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787623|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787624|NCT00616434|Interferons|interferons|mesh-list
101787625|NCT00616434|Interferon-beta|interferon-beta|mesh-list
101787626|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
101787627|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787628|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
101787629|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787630|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
101787631|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787632|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101787633|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101787634|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787635|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101787636|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787637|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787638|NCT00257725|Methylphenidate|methylphenidate|mesh-list
101787639|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101787640|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787641|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101787642|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101787643|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787644|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787645|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
101787646|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787647|NCT00544869|Tolvaptan|tolvaptan|mesh-list
101787648|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101787649|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787650|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
101787651|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787652|NCT02593643|Midazolam|midazolam|mesh-list
101787653|NCT02593643|Ketamine|ketamine|mesh-list
101787654|NCT02593643|Analgesics|analgesics|mesh-ancestor
101787655|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
101787656|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787657|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787658|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101787659|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101787660|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
101787661|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
101787662|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787663|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101787664|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101787665|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787666|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787667|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101787668|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101787669|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101787670|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101787671|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787672|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
101787673|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
101787674|NCT00881556|Fludarabine|fludarabine|mesh-list
101787675|NCT00881556|Busulfan|busulfan|mesh-list
101787676|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
101787677|NCT00881556|Lorazepam|lorazepam|mesh-list
101787678|NCT00881556|Tacrolimus|tacrolimus|mesh-list
101787679|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787680|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787681|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787682|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
101787683|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787684|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101787685|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787686|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
101787687|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101787688|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101787689|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101787690|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
101787691|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
101787692|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
101787693|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787694|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787695|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101787696|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787697|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101787698|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101787699|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787700|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
101787701|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
101787702|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787703|NCT00881634|Cetirizine|cetirizine|mesh-list
101787704|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
101787705|NCT00881634|Ephedrine|ephedrine|mesh-list
101787706|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101787707|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101787708|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101787709|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
101787710|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
101787711|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445128|NCT04654819|Anesthetics|anesthetics|mesh-list
101787712|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787713|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787714|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101787715|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
101787716|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787717|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101787718|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101787719|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
101787720|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101787721|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101787722|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
101787723|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101787724|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
101787725|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101787726|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787727|NCT00878670|Analgesics|analgesics|mesh-ancestor
101787728|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
101787729|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787730|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787731|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787732|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787733|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101787734|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
101787735|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787736|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101787737|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787738|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101787739|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101787740|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101787741|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787742|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787743|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787744|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787745|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101787746|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
101787747|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787748|NCT00652028|Fentanyl|fentanyl|mesh-list
101787749|NCT00652028|Midazolam|midazolam|mesh-list
101787750|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
101787751|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101787752|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787753|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787754|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787755|NCT00652028|Analgesics|analgesics|mesh-ancestor
101787756|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
101787757|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787758|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101787759|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101787760|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101787761|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
101787762|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787763|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787764|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101787765|NCT00652028|Narcotics|narcotics|mesh-ancestor
101787766|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101787767|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101787768|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
101787769|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
101787770|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101787771|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101787772|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787773|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
101787774|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
101787775|NCT00799136|Prednisone|prednisone|mesh-list
101787776|NCT00799136|Vincristine|vincristine|mesh-list
101787777|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787778|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
101787779|NCT00799136|Hormones|hormones|mesh-ancestor
101787780|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787781|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787782|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101787783|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787784|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101787785|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
101787786|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
101787787|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
101787788|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787789|NCT02592395|Folfirinox|folfirinox|mesh-list
101787790|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787792|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787793|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101787794|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101787795|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101787796|NCT00733421|Etoricoxib|etoricoxib|mesh-list
101787797|NCT00733421|Tramadol|tramadol|mesh-list
101787798|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101787799|NCT00733421|Narcotics|narcotics|mesh-ancestor
101787800|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542714|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
101787801|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787802|NCT00733421|Analgesics|analgesics|mesh-ancestor
101787803|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
101787804|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787805|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101787806|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101787807|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787808|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787809|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101787810|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101787811|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787812|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787813|NCT00613080|Leucovorin|leucovorin|mesh-list
101787814|NCT00613080|Fluorouracil|fluorouracil|mesh-list
101787815|NCT00613080|Capecitabine|capecitabine|mesh-list
101787816|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
101787817|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
101787818|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787819|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101787820|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787821|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787822|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
101787823|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787824|NCT00613080|Antidotes|antidotes|mesh-ancestor
101787825|NCT00613080|Protective Agents|protective agents|mesh-ancestor
101787826|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
101787827|NCT00613080|Vitamins|vitamins|mesh-ancestor
101787828|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
101787829|NCT00917891|Dapivirine|dapivirine|mesh-list
101787830|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787831|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787832|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
101787833|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787834|NCT00732875|Infliximab|infliximab|mesh-list
101787835|NCT00732875|Methotrexate|methotrexate|mesh-list
101787836|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101787837|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
101787838|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101787839|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787840|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101787841|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
101787842|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787843|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787844|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787845|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787846|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101787847|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787848|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
101787849|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101787850|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101787851|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101787852|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787853|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787854|NCT00881790|Fluorides|fluorides|mesh-list
101787855|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
101787856|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
101787857|NCT00881790|Protective Agents|protective agents|mesh-ancestor
101412187|NCT00117182|Diuretics|diuretics|mesh-ancestor
101787858|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787859|NCT00810446|Rifabutin|rifabutin|mesh-list
101787860|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101787861|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787862|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101787863|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
101787864|NCT00810524|Lamivudine|lamivudine|mesh-list
101787865|NCT00810524|Adefovir|adefovir|mesh-list
101787866|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101787867|NCT00810524|Telbivudine|telbivudine|mesh-list
101787868|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101787869|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101787870|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787871|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787872|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
101787873|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787874|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787875|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787876|NCT00810680|Valproic Acid|valproic acid|mesh-list
101787877|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
101787878|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787879|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787880|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
101787881|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101787882|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787883|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
101787884|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101787885|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787886|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101787887|NCT00799448|Insulin|insulin|mesh-list
101787888|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101787889|NCT00799448|Repaglinide|repaglinide|mesh-list
101787890|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
101787891|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
101787892|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
101787893|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101787894|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787895|NCT00806936|Insulin|insulin|mesh-list
101787896|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101787897|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101787898|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787899|NCT00799682|Travoprost|travoprost|mesh-list
101787900|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101787901|NCT00799682|Latanoprost|latanoprost|mesh-list
101787902|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101787903|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101787904|NCT03829020|Metformin|metformin|mesh-list
101787905|NCT03829020|Nelfinavir|nelfinavir|mesh-list
101787906|NCT03829020|Bortezomib|bortezomib|mesh-list
101787907|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101787908|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787909|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787910|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101787911|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101787912|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
101787913|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787914|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787915|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101787916|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101787917|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
101787918|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101787919|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101787920|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787921|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101787922|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
101787923|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787925|NCT00874926|Coagulants|coagulants|mesh-ancestor
101787926|NCT00810914|Bupivacaine|bupivacaine|mesh-list
101787927|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
101787928|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
101787929|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101787930|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787931|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
101787932|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787933|NCT00878904|Epirubicin|epirubicin|mesh-list
101787934|NCT00878904|Panobinostat|panobinostat|mesh-list
101787935|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101787936|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542722|NCT04531748|Melatonin|melatonin|mesh-list
101787937|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101787938|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101787939|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787940|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787941|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101787942|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
101787943|NCT00737711|Hematinics|hematinics|mesh-ancestor
101787944|NCT00807326|Simethicone|simethicone|mesh-list
101787945|NCT00807326|Loperamide|loperamide|mesh-list
101787946|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
101787947|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787948|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
101787949|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787950|NCT00807326|Emollients|emollients|mesh-ancestor
101787951|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
101787952|NCT00875082|Montelukast|montelukast|mesh-list
101787953|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101787954|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
101787955|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101787956|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
101787957|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787958|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787959|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101787960|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101787961|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787962|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
101787963|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101787964|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101787965|NCT02552342|Prednisolone|prednisolone|mesh-list
101787966|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
101787967|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101787968|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
101787969|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101787970|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
101787971|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
101787972|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101787973|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787974|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101787975|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
101787976|NCT02552342|Hormones|hormones|mesh-ancestor
101787977|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101787978|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101787979|NCT02552342|Protective Agents|protective agents|mesh-ancestor
101787980|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101787981|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787982|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101787983|NCT00811226|Olmesartan|olmesartan|mesh-list
101787984|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101787985|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101787986|NCT00811226|Diuretics|diuretics|mesh-ancestor
101787987|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
101787988|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101787989|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101787990|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101787991|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787992|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101787993|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101787994|NCT00238303|Vorinostat|vorinostat|mesh-list
101787995|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101787996|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101787997|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101787998|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101787999|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101788000|NCT00811460|Incretins|incretins|mesh-ancestor
101788001|NCT00811460|Hormones|hormones|mesh-ancestor
101788002|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101788003|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788004|NCT00875238|Doxorubicin|doxorubicin|mesh-list
101788005|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101788006|NCT00875238|Trastuzumab|trastuzumab|mesh-list
101788007|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101788008|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788009|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101788010|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101788011|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788012|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788013|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101788014|NCT00732251|Allopurinol|allopurinol|mesh-list
101788015|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
101788016|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788017|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788018|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
101788019|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788020|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101788021|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
101788022|NCT00732251|Protective Agents|protective agents|mesh-ancestor
101788023|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788024|NCT00882024|Tranilast|tranilast|mesh-list
101788025|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101788026|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788028|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
101788029|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788030|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788031|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788032|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788033|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101788034|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788035|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788036|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101788037|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101788038|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
101788039|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
101788040|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788041|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101788042|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101788043|NCT00799760|Oseltamivir|oseltamivir|mesh-list
101788045|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
101788046|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788047|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788048|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788049|NCT00799838|Amoxicillin|amoxicillin|mesh-list
101788050|NCT00799838|Ketoprofen|ketoprofen|mesh-list
101788051|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788052|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788053|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101788054|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788055|NCT00799838|Analgesics|analgesics|mesh-ancestor
101788056|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
101788057|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788058|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788059|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788060|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788061|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101788062|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788063|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788064|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
101788065|NCT00737477|Hematinics|hematinics|mesh-ancestor
101788067|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
101788068|NCT00800150|Melphalan|melphalan|mesh-list
101788069|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788070|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101788071|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
101788072|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788073|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788074|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
101542732|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
101788075|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788076|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101788077|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
101788078|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101788079|NCT00800306|Simendan|simendan|mesh-list
101788080|NCT00800306|Dobutamine|dobutamine|mesh-list
101788081|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101788082|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
101788083|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101788084|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101788085|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788086|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788087|NCT00800306|Protective Agents|protective agents|mesh-ancestor
101788088|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788089|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
101788090|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
101788091|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788092|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101788093|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101788094|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101788095|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101788096|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788097|NCT01581775|Valproic Acid|valproic acid|mesh-list
101788098|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
101788099|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788100|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788101|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
101788102|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788103|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788104|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
101788105|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788106|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788107|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788108|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101788109|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788110|NCT01072747|Heparin|heparin|mesh-list
101788111|NCT01072747|Calcium heparin|calcium heparin|mesh-list
101788112|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
101788113|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101788114|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101788115|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788116|NCT00879372|Tianeptine|tianeptine|mesh-list
101788117|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101788118|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
101788119|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788120|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
101788121|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101788122|NCT00731783|Mupirocin|mupirocin|mesh-list
101788123|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101788124|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788125|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
101788126|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788127|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788128|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101788129|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788130|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788131|NCT03691350|Nicotine|nicotine|mesh-list
101788132|NCT03691350|Dimercaprol|dimercaprol|mesh-list
101788133|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101788134|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
101788135|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788136|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788137|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101788138|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101788139|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
101788140|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788141|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788142|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
101788143|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
101788144|NCT02592083|Tamoxifen|tamoxifen|mesh-list
101788145|NCT02592083|Goserelin|goserelin|mesh-list
101788146|NCT02592083|Palbociclib|palbociclib|mesh-list
101788147|NCT02592083|Exemestane|exemestane|mesh-list
101788148|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101788149|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101788150|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
101788151|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101788152|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788153|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101788154|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788155|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101788156|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101788157|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101788158|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101788159|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788160|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788161|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101788162|NCT04589676|Naloxone|naloxone|mesh-list
101788163|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101788164|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788165|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
101788166|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788167|NCT00724451|Ribavirin|ribavirin|mesh-list
101788168|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101788169|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101788170|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
101788171|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788172|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
101788173|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788174|NCT00724373|Ribavirin|ribavirin|mesh-list
101788175|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101788176|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
101788177|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788178|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
101788179|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788180|NCT02594579|Vitamin D|vitamin d|mesh-list
101788181|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
101788182|NCT02594579|Vitamins|vitamins|mesh-ancestor
101788183|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
101788184|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788185|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101788186|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101788187|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101788188|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101788189|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101788190|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788191|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788192|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
101788193|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788194|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101788195|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101788196|NCT00724061|Interferons|interferons|mesh-list
101788197|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
101788198|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
101788199|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101788200|NCT00724061|Furocoumarins|furocoumarins|mesh-list
101788201|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788202|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
101788203|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788204|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
101788205|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788206|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788207|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101788208|NCT02594423|Bevacizumab|bevacizumab|mesh-list
101788209|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310013|NCT00006246|Busulfan|busulfan|mesh-list
101788210|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788211|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101788212|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101788213|NCT02594423|Growth Substances|growth substances|mesh-ancestor
101788214|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788215|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
101788216|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
101542743|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
101788218|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101788219|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101788220|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101788221|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
101788222|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788223|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101788224|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101788225|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788226|NCT00875784|Sumatriptan|sumatriptan|mesh-list
101788227|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101788228|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101788229|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101788230|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
101788231|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788232|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788233|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788234|NCT00731549|Aripiprazole|aripiprazole|mesh-list
101788235|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
101788236|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788237|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101788238|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788239|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788240|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788241|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
101788242|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
101788243|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788244|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788245|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101445638|NCT00201396|Leucovorin|leucovorin|mesh-list
101788246|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101788248|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101788249|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101788250|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101788251|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101788252|NCT00882570|Cefdinir|cefdinir|mesh-list
101788253|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788254|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788255|NCT00882882|Metformin|metformin|mesh-list
101788256|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101788257|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788258|NCT00882960|Fentanyl|fentanyl|mesh-list
101788259|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788260|NCT00882960|Narcotics|narcotics|mesh-ancestor
101788261|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788262|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788263|NCT00882960|Analgesics|analgesics|mesh-ancestor
101788264|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
101788265|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788266|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788267|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788268|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
101788269|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
101788270|NCT00883194|Ropivacaine|ropivacaine|mesh-list
101788271|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
101788272|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
101788273|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788274|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788275|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
101788276|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788277|NCT00888732|Insulin|insulin|mesh-list
101788278|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101788279|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
101788280|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
101542745|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788281|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101788282|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101788283|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788284|NCT00730925|Paclitaxel|paclitaxel|mesh-list
101788285|NCT00730925|Afatinib|afatinib|mesh-list
101788286|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101788287|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788288|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788289|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788290|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
101788291|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788292|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101788293|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788294|NCT00236899|Paclitaxel|paclitaxel|mesh-list
101788295|NCT00236899|Docetaxel|docetaxel|mesh-list
101788296|NCT00236899|Gemcitabine|gemcitabine|mesh-list
101788297|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101788298|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788299|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788300|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788301|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
101246494|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788302|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788303|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101788305|NCT00611130|Vigabatrin|vigabatrin|mesh-list
101788306|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
101788307|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788308|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788309|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
101788310|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788311|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788312|NCT00885690|Olanzapine|olanzapine|mesh-list
101788313|NCT00885690|Sertindole|sertindole|mesh-list
101788314|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
101788315|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
101788316|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788317|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788318|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788319|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101788320|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788321|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788322|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788323|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101788324|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101788325|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788326|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788327|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788328|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
101788329|NCT00888810|Topotecan|topotecan|mesh-list
101788330|NCT00888810|Lapatinib|lapatinib|mesh-list
101788331|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101788332|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101788333|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788334|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788335|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788336|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101788337|NCT00256243|Paclitaxel|paclitaxel|mesh-list
101788338|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
101788339|NCT00256243|Carboplatin|carboplatin|mesh-list
101788340|NCT00256243|Doxorubicin|doxorubicin|mesh-list
101788341|NCT00256243|Trastuzumab|trastuzumab|mesh-list
101788342|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101788343|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788344|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788345|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788346|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101542755|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101788347|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788348|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788349|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
101788350|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788351|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788352|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101788353|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
101788354|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101788355|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101788356|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101788357|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101788358|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788359|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101788360|NCT00236197|Rabeprazole|rabeprazole|mesh-list
101788361|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101788362|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788363|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101788364|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788365|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788366|NCT02541708|Folic Acid|folic acid|mesh-list
101788367|NCT02541708|Hematinics|hematinics|mesh-ancestor
101788368|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
101788369|NCT02541708|Vitamins|vitamins|mesh-ancestor
101788370|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
101788373|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
101788374|NCT03973567|Serotonin|serotonin|mesh-list
101788375|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101788376|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788377|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101788378|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
101788379|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788380|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788381|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788382|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101788383|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101788384|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
101788385|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
101788386|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
101788387|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788388|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101788389|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101788390|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788391|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101788392|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
101788393|NCT00885924|Coagulants|coagulants|mesh-ancestor
101788394|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101788395|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
101788396|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788397|NCT01071889|Flumazenil|flumazenil|mesh-list
101788398|NCT01071889|Antidotes|antidotes|mesh-ancestor
101788399|NCT01071889|Protective Agents|protective agents|mesh-ancestor
101788400|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788401|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
101788402|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
101788403|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788404|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788405|NCT03973411|Ondansetron|ondansetron|mesh-list
101788406|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
101788407|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
101788408|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788409|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788410|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788411|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
101542777|NCT04531475|Lansoprazole|lansoprazole|mesh-list
101788412|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788413|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101788414|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101788415|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
101788416|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788417|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788418|NCT00883506|Lisinopril|lisinopril|mesh-list
101788419|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101788420|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
101788421|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788422|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788423|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101788424|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101788425|NCT00883506|Protective Agents|protective agents|mesh-ancestor
101788426|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788427|NCT00278395|Vorinostat|vorinostat|mesh-list
101788428|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788429|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101788430|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788431|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788432|NCT00889044|Clopidogrel|clopidogrel|mesh-list
101788433|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101788434|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101788435|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101788436|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101788437|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
101788438|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788439|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788440|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788442|NCT00886002|Buprenorphine|buprenorphine|mesh-list
101788443|NCT00886002|Naloxone|naloxone|mesh-list
101788444|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788445|NCT00886002|Narcotics|narcotics|mesh-ancestor
101788446|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788447|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788448|NCT00886002|Analgesics|analgesics|mesh-ancestor
101788449|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
101788450|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788451|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788452|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788453|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
101788454|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
101788455|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101788456|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
101788457|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101788458|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
101788459|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788460|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788461|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101788462|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101788463|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101788464|NCT00883818|Azithromycin|azithromycin|mesh-list
101788465|NCT00883818|Doxycycline|doxycycline|mesh-list
101788466|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788467|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788468|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
101788469|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101788470|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101788471|NCT00889356|Clindamycin|clindamycin|mesh-list
101788472|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
101788473|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
101788474|NCT00889356|Amphotericin B|amphotericin b|mesh-list
101788475|NCT00889356|Tetracycline|tetracycline|mesh-list
101788476|NCT00889356|Ketoconazole|ketoconazole|mesh-list
101788477|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101788478|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788479|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788480|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101788481|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542786|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101542787|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
101542788|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788482|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788483|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
101788484|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101788485|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101788486|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101788487|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101788488|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101788489|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788490|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101788491|NCT00889356|Amebicides|amebicides|mesh-ancestor
101788492|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101788493|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101788494|NCT00889434|Tocotrienols|tocotrienols|mesh-list
101788495|NCT00889434|Vitamin E|vitamin e|mesh-list
101788496|NCT00889434|Tocopherols|tocopherols|mesh-list
101788497|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
101788498|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788499|NCT00889434|Protective Agents|protective agents|mesh-ancestor
101788500|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788501|NCT00889434|Vitamins|vitamins|mesh-ancestor
101788502|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
101788503|NCT00612534|Sufentanil|sufentanil|mesh-list
101788504|NCT00612534|Dsuvia|dsuvia|mesh-list
101788505|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788506|NCT00612534|Narcotics|narcotics|mesh-ancestor
101788507|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788508|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788509|NCT00612534|Analgesics|analgesics|mesh-ancestor
101788510|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
101788511|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788512|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788513|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788514|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
101788515|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
101788516|NCT02542254|Albuterol|albuterol|mesh-list
101788517|NCT02542254|Ipratropium|ipratropium|mesh-list
101788518|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101788519|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
101788520|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788521|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788522|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101788523|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
101788524|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
101788525|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788526|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101788527|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101788528|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101788529|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
101788530|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788531|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788532|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101788533|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
101788534|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
101788535|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101788536|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788537|NCT00736853|Acetaminophen|acetaminophen|mesh-list
101788538|NCT00736853|Tramadol|tramadol|mesh-list
101788539|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788540|NCT00736853|Analgesics|analgesics|mesh-ancestor
101788541|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
101788542|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788543|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788544|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
101788545|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788546|NCT00736853|Narcotics|narcotics|mesh-ancestor
101788547|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415106|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788549|NCT04037514|Ibuprofen|ibuprofen|mesh-list
101788550|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101788551|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788552|NCT04037514|Analgesics|analgesics|mesh-ancestor
101788553|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
101788554|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788555|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788556|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788557|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788558|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101788559|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788560|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788561|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
101788562|NCT00730847|Vaccines|vaccines|mesh-list
101788563|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
101788564|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788565|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
101788566|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101788567|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788568|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788569|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788570|NCT00573066|Analgesics|analgesics|mesh-ancestor
101788571|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
101788572|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788573|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101788574|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101788575|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101788576|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
101788577|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788578|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788579|NCT02541552|Ropivacaine|ropivacaine|mesh-list
101788580|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
101788581|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
101788582|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788583|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788584|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
101788585|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788586|NCT00886314|Midazolam|midazolam|mesh-list
101788587|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788588|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101788589|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788590|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788591|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101788592|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788593|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788594|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788595|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
101788596|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
101788597|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
101788598|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
101788599|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788600|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788601|NCT00890214|Epoprostenol|epoprostenol|mesh-list
101788602|NCT00890214|Heparin|heparin|mesh-list
101788603|NCT00890214|Calcium heparin|calcium heparin|mesh-list
101788604|NCT00890214|Tezosentan|tezosentan|mesh-list
101788605|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
101788606|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101788607|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101788608|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788609|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101788610|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101788611|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
101788612|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101788613|NCT00730691|Vortioxetine|vortioxetine|mesh-list
101788614|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101788615|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101788616|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788617|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788618|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788619|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788620|NCT00730691|Analgesics|analgesics|mesh-ancestor
101788621|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
101788622|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788623|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101788624|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788625|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
101788626|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101788627|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788628|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788629|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101788630|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
101788631|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101788632|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101788633|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101788634|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101788635|NCT00886860|Misoprostol|misoprostol|mesh-list
101788636|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101788637|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
101788638|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788639|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788640|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101788641|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788642|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
101788644|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101788645|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788646|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788647|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101788648|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788650|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
101788651|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788653|NCT02543034|Emollients|emollients|mesh-ancestor
101788654|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788655|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
101788656|NCT00278161|Rituximab|rituximab|mesh-list
101788657|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788658|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
101788659|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788660|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788661|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101788662|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
101788663|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788664|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788665|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101788666|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101788667|NCT02541396|Ketamine|ketamine|mesh-list
101788668|NCT02541396|Oxycodone|oxycodone|mesh-list
101788669|NCT02541396|Analgesics|analgesics|mesh-ancestor
101788670|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
101788671|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788672|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788673|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101788674|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788675|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
101788676|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
101788677|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788678|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101788679|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101788680|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788681|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788682|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788683|NCT02541396|Narcotics|narcotics|mesh-ancestor
101788684|NCT00890604|Acetaminophen|acetaminophen|mesh-list
101542800|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788685|NCT00890604|Ibuprofen|ibuprofen|mesh-list
101788686|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788687|NCT00890604|Analgesics|analgesics|mesh-ancestor
101788688|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
101788689|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788690|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788691|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
101788692|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101788693|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788694|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788695|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101788696|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788697|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788698|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
101788699|NCT00255151|Lansoprazole|lansoprazole|mesh-list
101788700|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101788701|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788702|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101788703|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788704|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788705|NCT03973957|Fentanyl|fentanyl|mesh-list
101788706|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101788707|NCT03973957|Narcotics|narcotics|mesh-ancestor
101788708|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788709|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788710|NCT03973957|Analgesics|analgesics|mesh-ancestor
101788711|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
101788712|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788713|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788714|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788715|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
101788716|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
101788717|NCT00658658|Panitumumab|panitumumab|mesh-list
101412232|NCT00117260|Estrogens|estrogens|mesh-ancestor
101788718|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101788719|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788720|NCT00723203|Panobinostat|panobinostat|mesh-list
101788721|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788722|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101788723|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788724|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788725|NCT00891072|Acetic Acid|acetic acid|mesh-list
101788727|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
101788728|NCT00891072|Carboplatin|carboplatin|mesh-list
101788729|NCT00891072|Retinol acetate|retinol acetate|mesh-list
101788730|NCT00891072|Gossypol|gossypol|mesh-list
101788731|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101788732|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788733|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788734|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788735|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101788736|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788737|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788738|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788739|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101788740|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
101788741|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788742|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101788743|NCT00891072|Protective Agents|protective agents|mesh-ancestor
101788744|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101788745|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
101788746|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788747|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101788748|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101788749|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101788750|NCT02591927|Insulin|insulin|mesh-list
101788751|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101788752|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788753|NCT00891150|Oxytocin|oxytocin|mesh-list
101788754|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
101542808|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101788755|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788756|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788757|NCT00800462|Bromides|bromides|mesh-list
101788758|NCT00800462|Oxybutynin|oxybutynin|mesh-list
101788759|NCT00800462|Darifenacin|darifenacin|mesh-list
101788760|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
101788761|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
101788762|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
101788763|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788764|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788766|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101788767|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
101788768|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788769|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788770|NCT00800462|Urological Agents|urological agents|mesh-ancestor
101788771|NCT00233389|Rebamipide|rebamipide|mesh-list
101788772|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101788773|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788774|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
101788775|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788776|NCT00233389|Protective Agents|protective agents|mesh-ancestor
101788777|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788778|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788779|NCT00891306|Cyclosporine|cyclosporine|mesh-list
101788780|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
101788781|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
101788782|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101788783|NCT00891306|Cyclosporins|cyclosporins|mesh-list
101788784|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788785|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788786|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788787|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
101788788|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788789|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
101788790|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788791|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788792|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788793|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101788794|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101788795|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788796|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101788797|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
101788798|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788799|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788800|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
101788801|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
101788802|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788803|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788804|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
101788805|NCT00891306|Hormones|hormones|mesh-ancestor
101788806|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101788807|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101788808|NCT00891306|Protective Agents|protective agents|mesh-ancestor
101788809|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101788810|NCT00807872|Antibodies|antibodies|mesh-list
101788811|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101788812|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
101788813|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788814|NCT00813722|Losartan|losartan|mesh-list
101788815|NCT00813722|Atenolol|atenolol|mesh-list
101788816|NCT00813722|Amlodipine|amlodipine|mesh-list
101788817|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101788818|NCT00813722|Calcium|calcium|mesh-list
101788819|NCT00813722|Diuretics|diuretics|mesh-list
101788820|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101788821|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101788822|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788823|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101788824|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101788825|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101788826|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788827|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
101788828|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101788829|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101788830|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101788831|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
101788832|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101788833|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101788834|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
101788835|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788836|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
101788837|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
101788838|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788839|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101788840|NCT00812318|Cabotegravir|cabotegravir|mesh-list
101788841|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101788842|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101788843|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788844|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788845|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101788846|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101788847|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
101788848|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788849|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
101788850|NCT00812396|Testosterone|testosterone|mesh-list
101788851|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
101788852|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
101788853|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101788854|NCT00812396|Androgens|androgens|mesh-ancestor
101788855|NCT00812396|Hormones|hormones|mesh-ancestor
101788856|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101788857|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788858|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101788859|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788860|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
101788861|NCT00807950|Simvastatin|simvastatin|mesh-list
101788862|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101788863|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101788864|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
101788865|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788866|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101788867|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101788868|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788869|NCT00649220|Memantine|memantine|mesh-list
101788870|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101788871|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101788872|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
101788873|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788874|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788875|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788876|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101788877|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101788878|NCT00654368|Etanercept|etanercept|mesh-list
101788879|NCT00654368|Methotrexate|methotrexate|mesh-list
101788880|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101788881|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
101788882|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101788883|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788884|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101788885|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
101788886|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788887|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542826|NCT04531163|Expectorants|expectorants|mesh-ancestor
101788888|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101788889|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788890|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101788891|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101788892|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
101788893|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788894|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101788895|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101788896|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101788898|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
101788899|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101788900|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788901|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101788903|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101788904|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
101788905|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788906|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788907|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
101788908|NCT00808184|Midazolam|midazolam|mesh-list
101788909|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101788910|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101788911|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788912|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788913|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101788914|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101788915|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101788916|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101788917|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
101788918|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
101788919|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
101788920|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
101788921|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101788922|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788923|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101788924|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101788925|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
101788926|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788927|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101788928|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101788929|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788930|NCT00647426|Carboplatin|carboplatin|mesh-list
101788931|NCT00647426|Docetaxel|docetaxel|mesh-list
101788932|NCT00647426|Sorafenib|sorafenib|mesh-list
101788933|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788934|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788935|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788936|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
101788937|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788938|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101788939|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788940|NCT00647348|Simvastatin|simvastatin|mesh-list
101788941|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101788942|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101788943|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
101788944|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788945|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101788946|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101788947|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788948|NCT00647270|Adalimumab|adalimumab|mesh-list
101788949|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101788950|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101788951|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101788952|NCT00645944|Eszopiclone|eszopiclone|mesh-list
101788953|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101788954|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101788955|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788956|NCT00813332|Docetaxel|docetaxel|mesh-list
101788957|NCT00813332|Endostar protein|endostar protein|mesh-list
101788958|NCT00813332|Endostatins|endostatins|mesh-list
101788959|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101788960|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101788961|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101788962|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101788963|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788965|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101788966|NCT00813332|Growth Substances|growth substances|mesh-ancestor
101788967|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101788968|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101788969|NCT04708496|Efavirenz|efavirenz|mesh-list
101788970|NCT04708496|Dolutegravir|dolutegravir|mesh-list
101788971|NCT04708496|Lumefantrine|lumefantrine|mesh-list
101788972|NCT04708496|Artemether|artemether|mesh-list
101788973|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101788974|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101788975|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101788976|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101788977|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101788978|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
101788979|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788980|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101788981|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101788982|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101788983|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101788984|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101788985|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101788986|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101788987|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101788988|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101788989|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101788990|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
101788991|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101788992|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101788993|NCT00646958|Linezolid|linezolid|mesh-list
101788994|NCT00646958|Radezolid|radezolid|mesh-list
101788995|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
101788996|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101788997|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101788998|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101788999|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789000|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789001|NCT00813410|Insulin|insulin|mesh-list
101789002|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101789003|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789004|NCT00642746|Leucovorin|leucovorin|mesh-list
101789006|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
101789008|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101789009|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
101789010|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789011|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101789012|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789013|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789014|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
101789015|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789016|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101789017|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101789018|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789019|NCT00642746|Antidotes|antidotes|mesh-ancestor
101789020|NCT00642746|Protective Agents|protective agents|mesh-ancestor
101789021|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
101789022|NCT00642746|Vitamins|vitamins|mesh-ancestor
101789023|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
101789024|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789025|NCT00814268|Aspirin|aspirin|mesh-list
101789026|NCT00814268|Clopidogrel|clopidogrel|mesh-list
101789027|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101789028|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101789029|NCT00814268|Analgesics|analgesics|mesh-ancestor
101789030|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
101789031|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789032|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789033|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789034|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789035|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101789036|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101789037|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789038|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101789039|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101789040|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789041|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
101789042|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101789043|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101789044|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101789045|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
101789046|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789048|NCT00817622|Vitamins|vitamins|mesh-ancestor
101789049|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
101789050|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789051|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
101789052|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789053|NCT00817622|Protective Agents|protective agents|mesh-ancestor
101789054|NCT00808418|Docetaxel|docetaxel|mesh-list
101789055|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789056|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789057|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789058|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789059|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789060|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
101789061|NCT00642668|Hematinics|hematinics|mesh-ancestor
101789062|NCT00817934|Bisacodyl|bisacodyl|mesh-list
101789063|NCT00817934|Cathartics|cathartics|mesh-ancestor
101789064|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789065|NCT00817934|Laxatives|laxatives|mesh-ancestor
101789066|NCT00729833|Sunitinib|sunitinib|mesh-list
101789067|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789068|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789069|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789070|NCT00729833|Growth Substances|growth substances|mesh-ancestor
101789071|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789072|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789073|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789074|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789075|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789076|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
101789077|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789078|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789079|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101789080|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101789081|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789082|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789083|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789084|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101789085|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101789086|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
101789087|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789088|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101789089|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101542857|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789090|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542858|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101789091|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789092|NCT00814736|Urological Agents|urological agents|mesh-ancestor
101789093|NCT00818090|Paclitaxel|paclitaxel|mesh-list
101789094|NCT00818090|Cisplatin|cisplatin|mesh-list
101789095|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101789096|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789097|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789098|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789099|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789100|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789101|NCT00642356|Levodopa|levodopa|mesh-list
101789102|NCT00642356|Carbidopa|carbidopa|mesh-list
101789103|NCT00642356|Entacapone|entacapone|mesh-list
101789104|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101789105|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101789106|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101789107|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
101789108|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789109|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789110|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789111|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101789112|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789113|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101789114|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101789115|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
101789116|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
101789117|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101789118|NCT00642278|Canagliflozin|canagliflozin|mesh-list
101789119|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101789120|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789121|NCT00642278|Incretins|incretins|mesh-ancestor
101789122|NCT00642278|Hormones|hormones|mesh-ancestor
101789123|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789124|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101789125|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
101789126|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789127|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789128|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101789129|NCT00812786|Cyclosporine|cyclosporine|mesh-list
101789130|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
101789131|NCT00812786|Everolimus|everolimus|mesh-list
101789132|NCT00812786|Tacrolimus|tacrolimus|mesh-list
101789133|NCT00812786|Cyclosporins|cyclosporins|mesh-list
101789134|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101789135|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
101789136|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789137|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101789138|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789139|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789140|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
101789141|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789142|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
101789143|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789144|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101789145|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789146|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789147|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101789148|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101789149|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
101789150|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789152|NCT00815048|Fentanyl|fentanyl|mesh-list
101789153|NCT00815048|Remifentanil|remifentanil|mesh-list
101789154|NCT00815048|Succinylcholine|succinylcholine|mesh-list
101789155|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101789156|NCT00815048|Narcotics|narcotics|mesh-ancestor
101789157|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789158|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789159|NCT00815048|Analgesics|analgesics|mesh-ancestor
101789160|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
101789161|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789162|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101789163|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101789164|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
101789165|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
101789166|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101789167|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101789168|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
101789169|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101789170|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789171|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
101789172|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
101789173|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101789174|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101789175|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
101789176|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789177|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789178|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101789179|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101789180|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101789181|NCT02551796|Levofloxacin|levofloxacin|mesh-list
101789182|NCT02551796|Ofloxacin|ofloxacin|mesh-list
101789183|NCT02551796|Tobramycin|tobramycin|mesh-list
101789184|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101789185|NCT02551796|Dexamethasone|dexamethasone|mesh-list
101789186|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
101789187|NCT02551796|BB 1101|bb 1101|mesh-list
101789188|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
101789189|NCT02551796|Dipivefrin|dipivefrin|mesh-list
101789190|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789191|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
101789192|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
101789193|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789194|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789195|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789196|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
101789197|NCT02551796|Hormones|hormones|mesh-ancestor
101789198|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789199|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789200|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789201|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
101789202|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789203|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789204|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101789205|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789206|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789207|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101789208|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101789209|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101789210|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101789211|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101789212|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
101789213|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
101412267|NCT00117000|Testosterone|testosterone|mesh-list
101789214|NCT02551796|Protective Agents|protective agents|mesh-ancestor
101789215|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101789216|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
101789217|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789218|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101789219|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101789220|NCT00723125|Paclitaxel|paclitaxel|mesh-list
101789221|NCT00723125|Bevacizumab|bevacizumab|mesh-list
101789222|NCT00723125|Carboplatin|carboplatin|mesh-list
101789223|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101310054|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789224|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101789226|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789227|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789228|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789229|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789230|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789231|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789232|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789233|NCT00723125|Growth Substances|growth substances|mesh-ancestor
101789234|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789235|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789236|NCT00640562|Risperidone|risperidone|mesh-list
101789237|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101789238|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101789239|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
101789240|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789241|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789242|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789243|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101789244|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789245|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789246|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789247|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101789248|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
101789249|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101789250|NCT00815204|Dexamethasone|dexamethasone|mesh-list
101789251|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789252|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
101789253|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
101789254|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789255|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789256|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789257|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
101789258|NCT00815204|Hormones|hormones|mesh-ancestor
101789259|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789260|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789261|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789262|NCT00721955|Loxapine|loxapine|mesh-list
101789263|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101789264|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789265|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789266|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789267|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789268|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101789269|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
101789270|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789271|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789272|NCT00585689|Carboplatin|carboplatin|mesh-list
101789273|NCT00585689|Gemcitabine|gemcitabine|mesh-list
101789274|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101789275|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789276|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101789277|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
101789278|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789279|NCT00815282|Vaccines|vaccines|mesh-list
101789280|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
101789281|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789282|NCT02593019|Adavosertib|adavosertib|mesh-list
101789283|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789284|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542879|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789285|NCT00729365|Ramipril|ramipril|mesh-list
101789286|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101789287|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
101789288|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789289|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789290|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789291|NCT00818870|Omeprazole|omeprazole|mesh-list
101789292|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101789293|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789294|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101789295|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789296|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789297|NCT00254293|Abatacept|abatacept|mesh-list
101789298|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101789299|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101789300|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789301|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789302|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789303|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789304|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
101789305|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789306|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789307|NCT00736385|Metformin|metformin|mesh-list
101789308|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101789309|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789310|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101789311|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
101789312|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789313|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789314|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789315|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789316|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
101789317|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789318|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
101789319|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101789320|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789321|NCT00253747|Methylphenidate|methylphenidate|mesh-list
101789322|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101789323|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789324|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101789325|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101789326|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101789327|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789328|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
101789329|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789330|NCT00252733|Candesartan|candesartan|mesh-list
101789331|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
101789332|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789333|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101789334|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101789335|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789336|NCT03974035|Ropivacaine|ropivacaine|mesh-list
101789337|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
101789338|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
101789339|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789340|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789341|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
101789342|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789343|NCT00275821|Ranibizumab|ranibizumab|mesh-list
101789344|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789345|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789346|NCT00275821|Growth Substances|growth substances|mesh-ancestor
101789347|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789349|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789350|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
101789351|NCT00275509|Dexamethasone|dexamethasone|mesh-list
101789352|NCT00275509|Prednisone|prednisone|mesh-list
101789353|NCT00275509|Tacrolimus|tacrolimus|mesh-list
101789354|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
101789355|NCT00275509|Daclizumab|daclizumab|mesh-list
101789356|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789357|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
101789358|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
101789359|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789360|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789361|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789362|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
101789363|NCT00275509|Hormones|hormones|mesh-ancestor
101789364|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789365|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789366|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789367|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789368|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
101789369|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101789370|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789371|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789372|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101789373|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101789374|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
101789375|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789376|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789377|NCT01072045|Prednisone|prednisone|mesh-list
101789378|NCT01072045|Propranolol|propranolol|mesh-list
101789379|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789380|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
101789381|NCT01072045|Hormones|hormones|mesh-ancestor
101789382|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789383|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789384|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789385|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789386|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101789387|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101789388|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
101789389|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789390|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789391|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101789392|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789393|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789394|NCT01073059|Ertapenem|ertapenem|mesh-list
101789395|NCT01073059|Valproic Acid|valproic acid|mesh-list
101789396|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
101789397|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789398|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789399|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
101789400|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789401|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789402|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
101789403|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789404|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789405|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789406|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789407|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789408|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
101789409|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
101789410|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789411|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789412|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789413|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
101789414|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789415|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789416|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789417|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
101789418|NCT00252499|Fenofibrate|fenofibrate|mesh-list
101789419|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542912|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789420|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789421|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101789422|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
101789423|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789424|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101789425|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101789426|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
101789427|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789428|NCT00163657|Cyclosporine|cyclosporine|mesh-list
101789429|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
101789430|NCT00163657|Tacrolimus|tacrolimus|mesh-list
101789431|NCT00163657|Cyclosporins|cyclosporins|mesh-list
101789432|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789433|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
101789434|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789435|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101789436|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789437|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789438|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
101789439|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789440|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
101789441|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789442|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101789443|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789444|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101789445|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
101789446|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789447|NCT01073683|Docetaxel|docetaxel|mesh-list
101789448|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789449|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789450|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789451|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789452|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789453|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101789454|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
101789455|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789456|NCT00230971|Metronidazole|metronidazole|mesh-list
101789457|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
101789458|NCT00230971|Tigecycline|tigecycline|mesh-list
101789459|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789460|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789461|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101789462|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101789463|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101789464|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789465|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789466|NCT00211081|Spironolactone|spironolactone|mesh-list
101789467|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101789468|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
101789469|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789470|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789471|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101789472|NCT00211081|Diuretics|diuretics|mesh-ancestor
101789473|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
101789474|NCT00884676|Sunitinib|sunitinib|mesh-list
101789475|NCT00884676|Epothilone B|epothilone b|mesh-list
101789476|NCT00884676|Epothilones|epothilones|mesh-list
101789477|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789478|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789479|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789480|NCT00884676|Growth Substances|growth substances|mesh-ancestor
101789481|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789482|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789483|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101542919|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101789489|NCT00891384|Lenalidomide|lenalidomide|mesh-list
101789490|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
101789491|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789492|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789493|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789494|NCT00891384|Growth Substances|growth substances|mesh-ancestor
101789495|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789496|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789497|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101789498|NCT00887328|Plasminogen|plasminogen|mesh-list
101789499|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101789500|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101789501|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789502|NCT00609336|Gemcitabine|gemcitabine|mesh-list
101789503|NCT00609336|Capecitabine|capecitabine|mesh-list
101789504|NCT00609336|Docetaxel|docetaxel|mesh-list
101789505|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
101789506|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101789507|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
101789508|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789509|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789510|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789511|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789512|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789513|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
101789514|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101789515|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789516|NCT02541084|Aflibercept|aflibercept|mesh-list
101789517|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789518|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789519|NCT02541084|Growth Substances|growth substances|mesh-ancestor
101789520|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789521|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789522|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789523|NCT04397406|Fentanyl|fentanyl|mesh-list
101789524|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
101789525|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
101789526|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101789527|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789528|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789529|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101789530|NCT04397406|Analgesics|analgesics|mesh-ancestor
101789531|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
101789532|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789533|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101789534|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101789535|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101789536|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
101789537|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789538|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789539|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101789540|NCT04397406|Narcotics|narcotics|mesh-ancestor
101789541|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101789542|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101789543|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
101789546|NCT00891540|Ropivacaine|ropivacaine|mesh-list
101789547|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
101789548|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
101789549|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789550|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789551|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
101789552|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415120|NCT00497497|Growth Substances|growth substances|mesh-ancestor
101789553|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101789554|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
101789555|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789556|NCT00891696|Sirolimus|sirolimus|mesh-list
101789557|NCT00891696|Nitroprusside|nitroprusside|mesh-list
101789558|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789559|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789560|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101789561|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789562|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
101789563|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789564|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
101789565|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789566|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789567|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789568|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789569|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101789570|NCT00640328|Ofatumumab|ofatumumab|mesh-list
101789571|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101789572|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789573|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
101789574|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789575|NCT04036890|Minocycline|minocycline|mesh-list
101789576|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789577|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789578|NCT00162097|Efavirenz|efavirenz|mesh-list
101789579|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101789580|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101789581|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310073|NCT00006261|Doxorubicin|doxorubicin|mesh-list
101789582|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789583|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789584|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
101789585|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789586|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101789587|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101789588|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101789589|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101789590|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101789591|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101789592|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
101789593|NCT02550782|Bupivacaine|bupivacaine|mesh-list
101789594|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
101789595|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
101789596|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789597|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789598|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
101789599|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789600|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101789601|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101789602|NCT02550782|Analgesics|analgesics|mesh-ancestor
101789603|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101789604|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101789605|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101789606|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
101789607|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789608|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789609|NCT05278728|Irinotecan|irinotecan|mesh-list
101789610|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
101446984|NCT00408551|Leucovorin|leucovorin|mesh-list
101789611|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101789612|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101789613|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789614|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542932|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
101789615|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789616|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789618|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101789619|NCT01073761|Darunavir|darunavir|mesh-list
101789620|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101789621|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101789622|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
101789623|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789624|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789625|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101789626|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101789627|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
101789628|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789629|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101789630|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101789631|NCT00819104|Metoprolol|metoprolol|mesh-list
101789632|NCT00819104|Amlodipine|amlodipine|mesh-list
101789633|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789634|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101789635|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101789636|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789637|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101789638|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789639|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789640|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101789641|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
101789642|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
101789643|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789644|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101789645|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101789646|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101789647|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101789648|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789649|NCT02542098|Hydrocodone|hydrocodone|mesh-list
101789650|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101789651|NCT02542098|Narcotics|narcotics|mesh-ancestor
101789652|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789653|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789654|NCT02542098|Analgesics|analgesics|mesh-ancestor
101789655|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
101789656|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789657|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
101789658|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789659|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101789660|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
101789661|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789662|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
101789663|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101789664|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789665|NCT00885066|Gemcitabine|gemcitabine|mesh-list
101789666|NCT00885066|Capecitabine|capecitabine|mesh-list
101789667|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101789668|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101789669|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
101789670|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789671|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789672|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789673|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789674|NCT00888108|Docetaxel|docetaxel|mesh-list
101789675|NCT00888108|Navitoclax|navitoclax|mesh-list
101789676|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789677|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789678|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789679|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789680|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789681|NCT00885300|Cloxacillin|cloxacillin|mesh-list
101542939|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101789682|NCT00885300|Heparin|heparin|mesh-list
101789683|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
101789684|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101447060|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101789685|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101789686|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789687|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789688|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789689|NCT00888186|Levodopa|levodopa|mesh-list
101789690|NCT00888186|Carbidopa|carbidopa|mesh-list
101789691|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101789692|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101789693|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
101789694|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789695|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789696|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789697|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101789698|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789699|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101789700|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101789701|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789702|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789703|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789704|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789705|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101789706|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101789707|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
101789708|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789709|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789710|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101789711|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101789712|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
101789713|NCT00892398|Ranibizumab|ranibizumab|mesh-list
101789714|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789715|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789716|NCT00892398|Growth Substances|growth substances|mesh-ancestor
101789717|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789718|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789719|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789720|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
101789721|NCT00892476|Calcium|calcium|mesh-list
101789722|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101789723|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789724|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101789725|NCT02541786|Rabeprazole|rabeprazole|mesh-list
101789726|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
101789727|NCT02541786|Lansoprazole|lansoprazole|mesh-list
101789729|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789730|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101789731|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789732|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789733|NCT00888342|Ethanol|ethanol|mesh-list
101789734|NCT00888342|Zopiclone|zopiclone|mesh-list
101789735|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101789736|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789737|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789738|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789739|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101789740|NCT00608868|Gefitinib|gefitinib|mesh-list
101789741|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789742|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789743|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789744|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789745|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101542947|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542960|NCT04530617|Camostat|camostat|mesh-list
101789746|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
101789747|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789748|NCT04036500|Estradiol|estradiol|mesh-list
101789749|NCT04036500|Estrogens|estrogens|mesh-ancestor
101789750|NCT04036500|Hormones|hormones|mesh-ancestor
101789751|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789752|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789753|NCT00895674|Sorafenib|sorafenib|mesh-list
101789754|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789755|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101789756|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789757|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789758|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
101789759|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101789760|NCT04035330|Eusol|eusol|mesh-list
101789761|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
101789762|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789763|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101789764|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789765|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
101789766|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
101789767|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789768|NCT04035096|Protective Agents|protective agents|mesh-ancestor
101789769|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789770|NCT04035096|Vitamins|vitamins|mesh-ancestor
101789771|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
101789772|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
101789773|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101789774|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
101789775|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789776|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789777|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101789778|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789779|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101789781|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789782|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789783|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101789784|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789785|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
101789786|NCT00608322|Protective Agents|protective agents|mesh-ancestor
101789787|NCT00608244|Tacrolimus|tacrolimus|mesh-list
101789788|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101789789|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
101789790|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789791|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101789792|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789793|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789794|NCT00893100|Diltiazem|diltiazem|mesh-list
101789795|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101789796|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101789797|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101310080|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789798|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789799|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101789800|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789801|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789802|NCT00896376|Trastuzumab|trastuzumab|mesh-list
101789803|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789804|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789805|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
101789806|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
101789807|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101789808|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789809|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101542966|NCT01686009|Ketamine|ketamine|mesh-list
101789812|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101789813|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
101789814|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789815|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789816|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789817|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101789818|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101789819|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789820|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101789821|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101789822|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
101789823|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101789824|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101789825|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101789826|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101789827|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
101789828|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101789829|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101789830|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
101789831|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789832|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789833|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101789834|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789835|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
101789836|NCT00901368|Hormones|hormones|mesh-ancestor
101789837|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789838|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
101789839|NCT00901524|Interferons|interferons|mesh-list
101789840|NCT00901524|Ribavirin|ribavirin|mesh-list
101789841|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
101789842|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
101789843|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101789844|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789845|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
101789846|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789847|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
101789848|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789849|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
101789850|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789851|NCT00893412|Tramadol|tramadol|mesh-list
101789852|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101789853|NCT00893412|Narcotics|narcotics|mesh-ancestor
101789854|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101789855|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789856|NCT00893412|Analgesics|analgesics|mesh-ancestor
101789857|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
101789858|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789859|NCT00893490|Mitomycins|mitomycins|mesh-list
101789860|NCT00893490|Mitomycin|mitomycin|mesh-list
101789861|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101789862|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789863|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
101789864|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789865|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101789866|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789867|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
101789868|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789870|NCT00638690|Prednisolone|prednisolone|mesh-list
101789871|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
101789872|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789873|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
101789874|NCT00638690|Hormones|hormones|mesh-ancestor
101789875|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101789876|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789877|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101789878|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789879|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101789880|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789881|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789882|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
101789883|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101789884|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
101789885|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789886|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789887|NCT00893724|Tocopherols|tocopherols|mesh-list
101789889|NCT00893724|Tocotrienols|tocotrienols|mesh-list
101789890|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
101789891|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
101789892|NCT00893724|Niacinamide|niacinamide|mesh-list
101789894|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
101789895|NCT00893724|Ubiquinone|ubiquinone|mesh-list
101789896|NCT00893724|Minocycline|minocycline|mesh-list
101789897|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
101789898|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101789899|NCT00893724|Vitamins|vitamins|mesh-ancestor
101789900|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
101789901|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789902|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
101789903|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789904|NCT00893724|Protective Agents|protective agents|mesh-ancestor
101789905|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789906|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789907|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
101789908|NCT00893724|Expectorants|expectorants|mesh-ancestor
101789909|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789910|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101789911|NCT00893724|Antidotes|antidotes|mesh-ancestor
101789912|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
101789913|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101789914|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
101789915|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101789916|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789917|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
101789918|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101789919|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
101789920|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789921|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789922|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101789923|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
101789924|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101789925|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
101789926|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789927|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789928|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101789929|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
101789930|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
101789931|NCT00893880|Protective Agents|protective agents|mesh-ancestor
101789932|NCT00815594|Bevacizumab|bevacizumab|mesh-list
101789933|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789934|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789935|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101789936|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101789937|NCT00815594|Growth Substances|growth substances|mesh-ancestor
101789938|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789939|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101789940|NCT00897312|Interferons|interferons|mesh-list
101789941|NCT00897312|Ribavirin|ribavirin|mesh-list
101789942|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
101789944|NCT00897312|Tremelimumab|tremelimumab|mesh-list
101789945|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789946|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
101789947|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789948|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
101789949|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789950|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
101789951|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789952|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101789953|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101789954|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101789955|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101789956|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101789957|NCT02540460|Delpazolid|delpazolid|mesh-list
101789958|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
101789959|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101789960|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101789961|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101789962|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789963|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789964|NCT00543387|Docetaxel|docetaxel|mesh-list
101789965|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789966|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789967|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789968|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789969|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789970|NCT03455556|Atezolizumab|atezolizumab|mesh-list
101789971|NCT03455556|Maytansine|maytansine|mesh-list
101789973|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
101789974|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101789975|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789976|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101789977|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789978|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
101789979|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789980|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101789981|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101789982|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101789983|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101789984|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
101447360|NCT00209859|Hormones|hormones|mesh-ancestor
101789986|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101789987|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
101789988|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101789989|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101789990|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101789991|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101789992|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
101789993|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101789994|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101789996|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101789997|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
101789998|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101789999|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790000|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101790001|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101790002|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
101790003|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790004|NCT00983151|Tramadol|tramadol|mesh-list
101542990|NCT04536662|Hormones|hormones|mesh-ancestor
101790005|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101790006|NCT00983151|Narcotics|narcotics|mesh-ancestor
101790007|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790008|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790009|NCT00983151|Analgesics|analgesics|mesh-ancestor
101790010|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
101790011|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790012|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
101790013|NCT00635570|NuvaRing|nuvaring|mesh-list
101790014|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101790015|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101790016|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
101790017|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101790018|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790019|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101790020|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101790022|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101790023|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790024|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101790025|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101790026|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790027|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790028|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790029|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
101790030|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101790031|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790032|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101790033|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
101790034|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101790035|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790036|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790037|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790038|NCT00986115|Memantine|memantine|mesh-list
101790039|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101790040|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101790041|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
101790042|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790043|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790044|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790045|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101790046|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101790047|NCT04035876|Apatinib|apatinib|mesh-list
101790048|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790049|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790050|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790051|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790052|NCT00902070|Rocuronium|rocuronium|mesh-list
101790053|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101790054|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101790055|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101790056|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790057|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790058|NCT00635492|Insulin|insulin|mesh-list
101447432|NCT00216840|Hormones|hormones|mesh-ancestor
101790059|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101790060|NCT00635492|Exenatide|exenatide|mesh-list
101790061|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101790062|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543000|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790064|NCT00635492|Incretins|incretins|mesh-ancestor
101790065|NCT00635492|Hormones|hormones|mesh-ancestor
101790066|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790067|NCT00543309|Milrinone|milrinone|mesh-list
101790068|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101790069|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101790070|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101790071|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
101790072|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101790073|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101790074|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790075|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790076|NCT00543309|Protective Agents|protective agents|mesh-ancestor
101790077|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790078|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
101790079|NCT00569582|Mifepristone|mifepristone|mesh-list
101790080|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101790081|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
101790082|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101790083|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790084|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101790085|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101790086|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101790087|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
101790088|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101790089|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101790090|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
101790091|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790092|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
101790093|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101790094|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101790096|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101790097|NCT00988845|Protective Agents|protective agents|mesh-ancestor
101790098|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790099|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790100|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101790101|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101790102|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790103|NCT00902460|Midazolam|midazolam|mesh-list
101790104|NCT00902460|Tofacitinib|tofacitinib|mesh-list
101790105|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101790106|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101790107|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790108|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790109|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101790110|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790111|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790112|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101790113|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
101790114|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
101790115|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
101790116|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
101790117|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790118|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790119|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101790120|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790121|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790122|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
101790123|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101790124|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790125|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101790126|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790127|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101790128|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
101790129|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101790130|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
101790131|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790132|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
101790133|NCT00809198|Protective Agents|protective agents|mesh-ancestor
101790134|NCT00809198|Laxatives|laxatives|mesh-ancestor
101790135|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101790136|NCT00986505|Lidocaine|lidocaine|mesh-list
101790137|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790138|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
101790139|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790140|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790141|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
101790142|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790143|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101790144|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101790145|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101790146|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101790147|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790148|NCT03667443|Inositol|inositol|mesh-list
101790149|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
101790150|NCT03667443|Vitamins|vitamins|mesh-ancestor
101790151|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
101790152|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790153|NCT00902772|Lorazepam|lorazepam|mesh-list
101790154|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
101790155|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
101790156|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
101790157|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790158|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790159|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101790160|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101790161|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790162|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101790163|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790164|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790165|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
101790166|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
101790167|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790168|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790169|NCT00894660|Amodiaquine|amodiaquine|mesh-list
101790170|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
101790171|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101790172|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101790173|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790174|NCT00721409|Letrozole|letrozole|mesh-list
101790175|NCT00721409|Palbociclib|palbociclib|mesh-list
101790176|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790177|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101790178|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101790179|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790180|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790181|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101790182|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
101790183|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790184|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543026|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790185|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790186|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
101790187|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101790188|NCT00542997|Antibodies|antibodies|mesh-list
101790189|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
101543027|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
101790190|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790191|NCT00903084|Tenofovir|tenofovir|mesh-list
101790192|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
101790193|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790194|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101790195|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101790196|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790197|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790198|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101790200|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
101790201|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790202|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
101790203|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790204|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790205|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790206|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790207|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
101790208|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101790209|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
101790210|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790211|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790213|NCT02591771|Racepinephrine|racepinephrine|mesh-list
101790214|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
101790215|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101790216|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101790217|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790218|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790219|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790220|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790221|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101790222|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790223|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
101790224|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790225|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790226|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790228|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
101790229|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101790230|NCT00986817|Terlipressin|terlipressin|mesh-list
101790231|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101790232|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101790233|NCT00572832|Vaccines|vaccines|mesh-list
101790234|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
101790235|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790236|NCT02591849|Glucagon|glucagon|mesh-list
101790237|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101790238|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101790239|NCT02591849|Hormones|hormones|mesh-ancestor
101790240|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790241|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790242|NCT02591849|Incretins|incretins|mesh-ancestor
101790243|NCT00898794|Bevacizumab|bevacizumab|mesh-list
101790244|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790245|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543038|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
101790246|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101790247|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101790248|NCT00898794|Growth Substances|growth substances|mesh-ancestor
101790249|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790250|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
101790251|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
101790252|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
101790253|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
101790254|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543049|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101790255|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101790256|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790257|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101790258|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790259|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790260|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790261|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790262|NCT00898950|Aspirin|aspirin|mesh-list
101790263|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
101790264|NCT00898950|Salicylates|salicylates|mesh-list
101790265|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101790266|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101790267|NCT00898950|Analgesics|analgesics|mesh-ancestor
101790268|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
101790269|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790270|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790271|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101790272|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790273|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101790274|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101790275|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790276|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101790277|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101790278|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790279|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
101790280|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790281|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
101790282|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
101790283|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790284|NCT03622515|Anesthetics|anesthetics|mesh-list
101790285|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790286|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790287|NCT05279235|Favipiravir|favipiravir|mesh-list
101790288|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
101790289|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790290|NCT00229723|Gefitinib|gefitinib|mesh-list
101790291|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790292|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790293|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790294|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790295|NCT04035798|Memantine|memantine|mesh-list
101790296|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101790297|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101790299|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790300|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790301|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790302|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101790303|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101790304|NCT01075477|Rituximab|rituximab|mesh-list
101790305|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790306|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790307|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
101790308|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790309|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790310|NCT01075555|Sorafenib|sorafenib|mesh-list
101790311|NCT01075555|Pravastatin|pravastatin|mesh-list
101790312|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790313|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790314|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790315|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790316|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101790317|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101790318|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
101790319|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101790320|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101790321|NCT00627926|Interferons|interferons|mesh-list
101790322|NCT00627926|Ribavirin|ribavirin|mesh-list
101790323|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
101790324|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
101790325|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101790326|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790327|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
101790328|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790329|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
101790330|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790331|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
101790332|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790333|NCT00228553|Modafinil|modafinil|mesh-list
101790334|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101790335|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790336|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101790337|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101790338|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101790339|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790340|NCT00922506|Doxazosin|doxazosin|mesh-list
101790341|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101790342|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101790343|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101790344|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
101790345|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790346|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790347|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790348|NCT00922506|Urological Agents|urological agents|mesh-ancestor
101790349|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101790350|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101790351|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101790352|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101790353|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790354|NCT00816140|Clarithromycin|clarithromycin|mesh-list
101790355|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101790356|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790357|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101790358|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790359|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790360|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101790361|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101790362|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101790364|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790365|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790366|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790367|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790368|NCT00903942|Paclitaxel|paclitaxel|mesh-list
101790369|NCT00903942|Carboplatin|carboplatin|mesh-list
101790370|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101790371|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101790372|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790373|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
101790374|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
101790375|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
101790376|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790377|NCT00904020|Lidocaine|lidocaine|mesh-list
101790378|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790379|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
101790380|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790381|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790382|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
101790383|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790384|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101790385|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101790386|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101790387|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101790388|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790389|NCT00895362|Cetuximab|cetuximab|mesh-list
101790390|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101790391|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790392|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790393|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790394|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790395|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790396|NCT00904098|Frovatriptan|frovatriptan|mesh-list
101790397|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101790398|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
101790399|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790400|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790401|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790402|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
101790403|NCT00904176|Digoxin|digoxin|mesh-list
101790404|NCT00904176|Warfarin|warfarin|mesh-list
101790405|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101790406|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790408|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790409|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
101790410|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101790411|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101790412|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790413|NCT00904176|Protective Agents|protective agents|mesh-ancestor
101790414|NCT02540070|Ketorolac|ketorolac|mesh-list
101790415|NCT02540070|Epinephrine|epinephrine|mesh-list
101790416|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
101790417|NCT02540070|Morphine|morphine|mesh-list
101790418|NCT02540070|Ropivacaine|ropivacaine|mesh-list
101790419|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101790420|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790421|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790422|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101790423|NCT02540070|Analgesics|analgesics|mesh-ancestor
101790424|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
101790425|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790426|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101790427|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101790428|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101790429|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790430|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790431|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790432|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101790433|NCT02540070|Narcotics|narcotics|mesh-ancestor
101790434|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790435|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
101790436|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101790437|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790438|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
101790439|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790440|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790441|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
101790442|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
101310109|NCT00006267|Rubitecan|rubitecan|mesh-list
101790443|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101790444|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101790445|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101790446|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790447|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101790448|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790449|NCT00905814|Axitinib|axitinib|mesh-list
101790450|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790451|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790452|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790453|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790454|NCT00900510|Trimethoprim|trimethoprim|mesh-list
101790455|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101790456|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
101790457|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101790458|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790459|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
101790460|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101790461|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101790462|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101790463|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790464|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790465|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101790466|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101790467|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101790468|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101790469|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
101790470|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101412287|NCT00475189|Mestranol|mestranol|mesh-list
101790471|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101790472|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790473|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
101790474|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790475|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790477|NCT00906048|Rifampin|rifampin|mesh-list
101790478|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101790479|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790480|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101790481|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101790482|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101790483|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790484|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790485|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790486|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101790487|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101790488|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101790489|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
101790490|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
101790491|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101790492|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101790493|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101790494|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101790495|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101790496|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101790497|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101790498|NCT00906126|Misoprostol|misoprostol|mesh-list
101790499|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101790500|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
101790501|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101790502|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790503|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101543078|NCT04535960|Hormones|hormones|mesh-ancestor
101790505|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
101790507|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101790508|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101790509|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790510|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790511|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101790512|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790513|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101790514|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101790515|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101790516|NCT00643760|Pregabalin|pregabalin|mesh-list
101790517|NCT00643760|Gabapentin|gabapentin|mesh-list
101790518|NCT00643760|Analgesics|analgesics|mesh-ancestor
101790519|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
101790520|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790521|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790522|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
101790523|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101790524|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101790525|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790526|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101790527|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101790528|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790529|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790530|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790531|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101790532|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101790533|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790534|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
101790535|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
101790536|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101790537|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101790538|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
101790539|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790540|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101790541|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101790542|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790543|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790545|NCT00906360|Cetuximab|cetuximab|mesh-list
101790546|NCT00906360|Sunitinib|sunitinib|mesh-list
101790547|NCT00906360|Antibodies|antibodies|mesh-list
101790548|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
101790549|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101790550|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
101790551|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790552|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790553|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101790554|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101790555|NCT00906360|Growth Substances|growth substances|mesh-ancestor
101790556|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
101790557|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790558|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790559|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790560|NCT00643604|Treprostinil|treprostinil|mesh-list
101790561|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101790562|NCT00603798|Imiquimod|imiquimod|mesh-list
101790563|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101790564|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
101790565|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790566|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790567|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
101790568|NCT00819572|Antibodies|antibodies|mesh-list
101790569|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
101543093|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790570|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
101790571|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790572|NCT00630812|Mannitol|mannitol|mesh-list
101790573|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101790574|NCT00630812|Diuretics|diuretics|mesh-ancestor
101790575|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
101790576|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790577|NCT00906516|Bevacizumab|bevacizumab|mesh-list
101790578|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790579|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790580|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101790581|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101790582|NCT00906516|Growth Substances|growth substances|mesh-ancestor
101790583|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790584|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
101790585|NCT00629798|Fludarabine|fludarabine|mesh-list
101790586|NCT00629798|Melphalan|melphalan|mesh-list
101790587|NCT00629798|Busulfan|busulfan|mesh-list
101790589|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790590|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790591|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790592|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
101790593|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790594|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101790595|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
101790596|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101790597|NCT00160615|Levetiracetam|levetiracetam|mesh-list
101790598|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
101790599|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
101790600|NCT00906594|Latanoprost|latanoprost|mesh-list
101790601|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101790602|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101790603|NCT03970759|Fluorides|fluorides|mesh-list
101790604|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
101790605|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
101790606|NCT03970759|Protective Agents|protective agents|mesh-ancestor
101790607|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790608|NCT00905190|Ondansetron|ondansetron|mesh-list
101790609|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
101790610|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
101790611|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790612|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790613|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101790615|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790616|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101790617|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101790618|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
101790619|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790620|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790621|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101790622|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
101790623|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
101790624|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790625|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
101790626|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790627|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790628|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790629|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790630|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101790631|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101790632|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101790633|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790634|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790635|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790636|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101790637|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790638|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101790639|NCT00627458|Vaccines|vaccines|mesh-list
101790640|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
101790641|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790642|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
101415158|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415159|NCT00127907|Vasopressins|vasopressins|mesh-list
101790643|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790644|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790646|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
101790647|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
101790648|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790649|NCT00816218|Pioglitazone|pioglitazone|mesh-list
101790650|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101790651|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790652|NCT00819728|Docetaxel|docetaxel|mesh-list
101790653|NCT00819728|Irinotecan|irinotecan|mesh-list
101790654|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790655|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
101790656|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
101790657|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
101448031|NCT00184613|Insulin|insulin|mesh-list
101790658|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790659|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101790660|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101790661|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790662|NCT00906828|Levodopa|levodopa|mesh-list
101790663|NCT00906828|Carbidopa|carbidopa|mesh-list
101790664|NCT00906828|Entacapone|entacapone|mesh-list
101790665|NCT00906828|Tolcapone|tolcapone|mesh-list
101790666|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101790667|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101790668|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
101790669|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790670|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790671|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790672|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101790673|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790674|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101790675|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
101790676|NCT00819806|Vaccines|vaccines|mesh-list
101790677|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
101790678|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790679|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790680|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790681|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101790683|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790684|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790685|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101790686|NCT00909402|Capecitabine|capecitabine|mesh-list
101790687|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790688|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101790689|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
101790690|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790691|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
101790692|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101790693|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101790694|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790695|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
101790696|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790697|NCT00821444|Ziprasidone|ziprasidone|mesh-list
101790698|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101790699|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
101790700|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790701|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790702|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790703|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101790704|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790705|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790706|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790707|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101790708|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
101790709|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
101790710|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
101790711|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790712|NCT00819962|Bupivacaine|bupivacaine|mesh-list
101790713|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790714|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
101790715|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790716|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790717|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
101790718|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790719|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101790720|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101790721|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101790722|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101790723|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790724|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790725|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
101790726|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790727|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101790728|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101790729|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101790730|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101790731|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101790733|NCT00927498|Daunorubicin|daunorubicin|mesh-list
101790734|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
101790735|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101790736|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790737|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101790738|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101790739|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790740|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790741|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790742|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
101790743|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
101790744|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
101790745|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790746|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101790747|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
101790748|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
101790749|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790750|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790751|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
101790752|NCT00159913|Citric Acid|citric acid|mesh-list
101790753|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
101790754|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
101790755|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101790756|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
101790757|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
101790758|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790759|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
101790760|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101790761|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101790762|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790763|NCT00159913|Urological Agents|urological agents|mesh-ancestor
101790764|NCT05498259|Rituximab|rituximab|mesh-list
101790765|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101790766|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790767|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
101790768|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790769|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790770|NCT00821600|Risperidone|risperidone|mesh-list
101790771|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101790772|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
101790773|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790774|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543106|NCT04530227|Pemetrexed|pemetrexed|mesh-list
101790775|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790777|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790778|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790779|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790780|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101790781|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
101790782|NCT00987207|Cyclosporine|cyclosporine|mesh-list
101790783|NCT00987207|Cyclosporins|cyclosporins|mesh-list
101790784|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790785|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790786|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790787|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
101790788|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790789|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
101790790|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790791|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790792|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101790793|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101790794|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101790795|NCT00604188|Buprenorphine|buprenorphine|mesh-list
101790796|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101790797|NCT00604188|Narcotics|narcotics|mesh-ancestor
101790798|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790799|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790800|NCT00604188|Analgesics|analgesics|mesh-ancestor
101790801|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
101790802|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790803|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101790804|NCT00820352|Bosentan|bosentan|mesh-list
101790805|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101790806|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101790807|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790809|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101790811|NCT00927732|Quinidine|quinidine|mesh-list
101790812|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
101790813|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101790814|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
101790815|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
101790816|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790817|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790818|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101790819|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101790820|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790821|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790822|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790823|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
101790824|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101790825|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101790826|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101790827|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790828|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101790829|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101790830|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
101790831|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101790832|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101790833|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101790834|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101790835|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101790836|NCT00227539|Pemetrexed|pemetrexed|mesh-list
101790837|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101790838|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543116|NCT01199263|Paclitaxel|paclitaxel|mesh-list
101543117|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101790839|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543119|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790840|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790841|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101790842|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101790843|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101790844|NCT00927966|Everolimus|everolimus|mesh-list
101790845|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101790846|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790847|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790848|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790849|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101790850|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
101790851|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790852|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790853|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101790854|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
101790855|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101790856|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101790857|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101790858|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790859|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790860|NCT00720941|Sunitinib|sunitinib|mesh-list
101790861|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790862|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101790863|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101790864|NCT00720941|Growth Substances|growth substances|mesh-ancestor
101790865|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790866|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
101790867|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790868|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790869|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790870|NCT00924222|Propofol|propofol|mesh-list
101790871|NCT00924222|Sevoflurane|sevoflurane|mesh-list
101790872|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101790873|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790874|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790875|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101790876|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
101790877|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
101790878|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101790879|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101790881|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101448259|NCT00218244|Lobeline|lobeline|mesh-list
101790882|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
101790883|NCT01075711|Hormones|hormones|mesh-ancestor
101790884|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101790885|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790886|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101790887|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790888|NCT01073371|Prilocaine|prilocaine|mesh-list
101790889|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790890|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
101790891|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790892|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790893|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
101790894|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790895|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
101790896|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101790897|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101790898|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790899|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
101790900|NCT03970213|Coagulants|coagulants|mesh-ancestor
101790901|NCT00821834|Ticlopidine|ticlopidine|mesh-list
101790902|NCT00821834|Clopidogrel|clopidogrel|mesh-list
101790903|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543126|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101543127|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
101790904|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101790905|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101790906|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101790907|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
101790908|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790909|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790910|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790911|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101790912|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101790913|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101790914|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101790915|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790916|NCT04005417|Fluorides|fluorides|mesh-list
101790917|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
101790918|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
101790919|NCT04005417|Protective Agents|protective agents|mesh-ancestor
101790920|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790921|NCT01073839|Gemcitabine|gemcitabine|mesh-list
101790922|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790923|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101790924|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
101790925|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790926|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101790927|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790928|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101790929|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790930|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790931|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
101790932|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790933|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
101790934|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790935|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790936|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790937|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790938|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101790939|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101790940|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101790941|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790942|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790943|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790945|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101790946|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790947|NCT00987441|Sufentanil|sufentanil|mesh-list
101790948|NCT00987441|Dsuvia|dsuvia|mesh-list
101790949|NCT00987441|Ropivacaine|ropivacaine|mesh-list
101790950|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
101790951|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
101790952|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101790953|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790954|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
101790955|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790956|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101790957|NCT00987441|Narcotics|narcotics|mesh-ancestor
101790958|NCT00987441|Analgesics|analgesics|mesh-ancestor
101790959|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101790960|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101790961|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
101790962|NCT00584987|Fluticasone|fluticasone|mesh-list
101790963|NCT00584987|Xhance|xhance|mesh-list
101790964|NCT00584987|Phenylephrine|phenylephrine|mesh-list
101790965|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
101790966|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101790967|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101790968|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
101790969|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101790970|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790971|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101790972|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
101790973|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
101790974|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101790975|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101790976|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101790977|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
101790978|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101790979|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790980|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
101790981|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
101790982|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101790983|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101790984|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
101790985|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101790986|NCT00584987|Protective Agents|protective agents|mesh-ancestor
101790987|NCT00727961|Doxorubicin|doxorubicin|mesh-list
101790988|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101790989|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101790990|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101790991|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101790992|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101790993|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101790994|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101790995|NCT00568958|Naltrexone|naltrexone|mesh-list
101790996|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101790997|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101790998|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101790999|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
101791000|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791001|NCT00821912|Docetaxel|docetaxel|mesh-list
101791002|NCT00821912|Capecitabine|capecitabine|mesh-list
101791003|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791004|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791005|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791006|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791007|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791008|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791009|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
101791010|NCT00727649|Loperamide|loperamide|mesh-list
101791011|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
101791012|NCT00727649|Psyllium|psyllium|mesh-list
101791013|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791014|NCT00727649|Cathartics|cathartics|mesh-ancestor
101791015|NCT04006041|Paclitaxel|paclitaxel|mesh-list
101791016|NCT04006041|Cisplatin|cisplatin|mesh-list
101791017|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791018|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791019|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791020|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791021|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791022|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791023|NCT00225277|Pioglitazone|pioglitazone|mesh-list
101791024|NCT00225277|Glimepiride|glimepiride|mesh-list
101791025|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101791026|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791027|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101791028|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791029|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
101791030|NCT00821054|Lapatinib|lapatinib|mesh-list
101791031|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791032|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791033|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791034|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791035|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101791036|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791037|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
101791038|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791039|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791040|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101543140|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543141|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
101791041|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791042|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101791043|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101791044|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791045|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791046|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791047|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791048|NCT04388319|Zonisamide|zonisamide|mesh-list
101791049|NCT04388319|Bupropion|bupropion|mesh-list
101791050|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101791051|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
101791052|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101791053|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101791054|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101791055|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791056|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791057|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
101791058|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791059|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791060|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101791061|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101791062|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791063|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
101791064|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101791065|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101791066|NCT04085627|Amlodipine|amlodipine|mesh-list
101791067|NCT04085627|Valsartan|valsartan|mesh-list
101791068|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101791069|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101791070|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101791071|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791072|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791073|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101791074|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791075|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791076|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101791077|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101791078|NCT04085393|Granisetron|granisetron|mesh-list
101791079|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
101791081|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791082|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791083|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791084|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101791085|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101791087|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791088|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791089|NCT00717275|Temozolomide|temozolomide|mesh-list
101791090|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101791091|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
101791092|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791093|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791094|NCT04006353|Rifampin|rifampin|mesh-list
101791095|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101791096|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
101791097|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791098|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791099|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
101791100|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101791101|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791102|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791103|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101448482|NCT00211848|Ribavirin|ribavirin|mesh-list
101415167|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791104|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101791105|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101791106|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101791107|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101791108|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101791109|NCT01075789|Lidocaine|lidocaine|mesh-list
101791110|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
101791111|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
101791112|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791113|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791114|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
101791115|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791116|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101791117|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101791118|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101791119|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791120|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791121|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
101791122|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791123|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
101791124|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791125|NCT00584909|Paclitaxel|paclitaxel|mesh-list
101791126|NCT00584909|Carboplatin|carboplatin|mesh-list
101791127|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791128|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791129|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791130|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791131|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791132|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791133|NCT03947099|Ketamine|ketamine|mesh-list
101791134|NCT03947099|Analgesics|analgesics|mesh-ancestor
101791135|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
101791136|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791137|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791138|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101791139|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101791140|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
101791141|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
101791142|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791144|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101791145|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791146|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791147|NCT05361915|Abivertinib|abivertinib|mesh-list
101791148|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791149|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791150|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791151|NCT00929058|Bevacizumab|bevacizumab|mesh-list
101791152|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101791153|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791154|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101791155|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101791156|NCT00929058|Growth Substances|growth substances|mesh-ancestor
101791157|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791158|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
101791159|NCT00907452|Thalidomide|thalidomide|mesh-list
101791161|NCT00907452|Prednisone|prednisone|mesh-list
101791162|NCT00907452|Lenalidomide|lenalidomide|mesh-list
101791163|NCT00907452|Melphalan|melphalan|mesh-list
101791164|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791165|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
101791166|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
101791167|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791168|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791169|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791170|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
101791171|NCT00907452|Hormones|hormones|mesh-ancestor
101791172|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101791173|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101791174|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791175|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
101415175|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
101791176|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101791177|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101791179|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
101791180|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101791181|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
101791182|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791183|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101791184|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791185|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
101791186|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791187|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791189|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791190|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
101791191|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791192|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791193|NCT00925392|Doripenem|doripenem|mesh-list
101791194|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791195|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791196|NCT05315271|Ketamine|ketamine|mesh-list
101791197|NCT05315271|Bupivacaine|bupivacaine|mesh-list
101791198|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
101791199|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
101791200|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791201|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791202|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
101791203|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791204|NCT05315271|Analgesics|analgesics|mesh-ancestor
101791205|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101791206|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101791207|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
101791208|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101791209|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101791211|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791212|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
101791213|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101791214|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101791215|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791216|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101791217|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101791218|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
101791219|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791220|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101791221|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
101791222|NCT05313477|Vitamin D|vitamin d|mesh-list
101791223|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
101791224|NCT05313477|Calcium|calcium|mesh-list
101791225|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101791226|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791227|NCT05313477|Antacids|antacids|mesh-ancestor
101791228|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791229|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791230|NCT05313477|Vitamins|vitamins|mesh-ancestor
101791231|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
101791232|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101791233|NCT00224107|Silodosin|silodosin|mesh-list
101791234|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101791235|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101791236|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101791237|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791238|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791239|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791240|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543149|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
101791241|NCT00224107|Urological Agents|urological agents|mesh-ancestor
101791242|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
101791243|NCT04696731|Fludarabine|fludarabine|mesh-list
101791244|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791245|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
101791246|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791247|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101791248|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101791249|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
101791250|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791251|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791252|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101791253|NCT04004871|Paclitaxel|paclitaxel|mesh-list
101791254|NCT04004871|Cisplatin|cisplatin|mesh-list
101791255|NCT04004871|Fluorouracil|fluorouracil|mesh-list
101791256|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791257|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791258|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791259|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791260|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791261|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791262|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
101791263|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791264|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791265|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
101791266|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791267|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101791268|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101791269|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101791270|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
101791271|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791272|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101791273|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101791274|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791275|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
101791276|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
101791277|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791278|NCT00822380|Iron|iron|mesh-list
101791279|NCT00822380|Trace Elements|trace elements|mesh-list
101791280|NCT00822380|Folic Acid|folic acid|mesh-list
101791281|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
101791282|NCT00822380|Micronutrients|micronutrients|mesh-list
101791283|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791284|NCT00822380|Hematinics|hematinics|mesh-ancestor
101791285|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
101791286|NCT00822380|Vitamins|vitamins|mesh-ancestor
101791287|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
101791288|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791289|NCT00822380|Protective Agents|protective agents|mesh-ancestor
101791290|NCT00720083|Cisplatin|cisplatin|mesh-list
101791291|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791292|NCT00209131|Tamsulosin|tamsulosin|mesh-list
101791293|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101791294|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101791295|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101791296|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791297|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791298|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791299|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791300|NCT00209131|Urological Agents|urological agents|mesh-ancestor
101791301|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
101791302|NCT00907608|Hematinics|hematinics|mesh-ancestor
101791303|NCT00224029|Oxybutynin|oxybutynin|mesh-list
101791304|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
101791305|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
101791306|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791307|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791309|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101791310|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
101791311|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791312|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791313|NCT00224029|Urological Agents|urological agents|mesh-ancestor
101791315|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
101791316|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791317|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791318|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791319|NCT00907764|Regadenoson|regadenoson|mesh-list
101791320|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101791321|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101791322|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
101791323|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
101791324|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791325|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791326|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791327|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101791328|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
101791329|NCT02550314|Coagulants|coagulants|mesh-ancestor
101791330|NCT01073527|Adenosine|adenosine|mesh-list
101791331|NCT01073527|Albuterol|albuterol|mesh-list
101791332|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791333|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
101791334|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791335|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791336|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101791337|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791338|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
101791339|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101791340|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101791341|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101791342|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791343|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791344|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791345|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791346|NCT01073527|Analgesics|analgesics|mesh-ancestor
101791347|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
101791348|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101791349|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791350|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101791351|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
101791352|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
101791353|NCT02538432|Gemcitabine|gemcitabine|mesh-list
101791354|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791355|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
101791356|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791357|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791358|NCT00719849|Cyclosporine|cyclosporine|mesh-list
101791359|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
101791360|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
101791361|NCT00719849|Fludarabine|fludarabine|mesh-list
101791362|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
101791363|NCT00719849|Cyclosporins|cyclosporins|mesh-list
101791364|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101791365|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791366|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
101791367|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791368|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543203|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543204|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101791369|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101791370|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
101791371|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791372|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791373|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101791374|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791375|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
101791376|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791377|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
101791378|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791379|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
101791380|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101791381|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101791382|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101791383|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
101791384|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791386|NCT00822536|Clopidogrel|clopidogrel|mesh-list
101791387|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101791388|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101791389|NCT00822536|Analgesics|analgesics|mesh-ancestor
101791390|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
101791391|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791392|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791393|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791394|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101791395|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101791396|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101791397|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791398|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101791399|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101791400|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791401|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
101448786|NCT00219921|Morphine|morphine|mesh-list
101791402|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101791403|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101791404|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101791405|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
101791406|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791408|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101791409|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791410|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101791411|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791412|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791413|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101791414|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101791415|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101791416|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791417|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101791418|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101791419|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101791420|NCT02592941|Deflazacort|deflazacort|mesh-list
101791421|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791422|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791423|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
101791424|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791425|NCT00822614|Fentanyl|fentanyl|mesh-list
101791426|NCT00822614|Morphine|morphine|mesh-list
101791427|NCT00822614|Oxycodone|oxycodone|mesh-list
101791428|NCT00822614|Hydromorphone|hydromorphone|mesh-list
101791429|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101791430|NCT00822614|Narcotics|narcotics|mesh-ancestor
101791431|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791432|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791433|NCT00822614|Analgesics|analgesics|mesh-ancestor
101543216|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791434|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
101791435|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791436|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101791437|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101791438|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
101791440|NCT04087967|Cytarabine|cytarabine|mesh-list
101791441|NCT04087967|Decitabine|decitabine|mesh-list
101791442|NCT04087967|Idarubicin|idarubicin|mesh-list
101791443|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791444|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
101791445|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791446|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791447|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
101791448|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310149|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
101791449|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791451|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791452|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791453|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101791454|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101791455|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101791456|NCT00926016|Pioglitazone|pioglitazone|mesh-list
101791457|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101791458|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791459|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101791460|NCT04017104|Edotreotide|edotreotide|mesh-list
101791461|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101791462|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791463|NCT00827138|Rebastinib|rebastinib|mesh-list
101791464|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791465|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791466|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791467|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791468|NCT00817466|Epinephrine|epinephrine|mesh-list
101791469|NCT00817466|Racepinephrine|racepinephrine|mesh-list
101791470|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
101791471|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101791472|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791473|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791474|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246495|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791475|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791476|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448862|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791477|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101791478|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791479|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
101791480|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791481|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101791482|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791483|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
101791484|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
101791485|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101791486|NCT00930072|Clonidine|clonidine|mesh-list
101791487|NCT00930072|Bupivacaine|bupivacaine|mesh-list
101791488|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
101791489|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
101791490|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791491|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791492|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
101791493|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791494|NCT00930072|Analgesics|analgesics|mesh-ancestor
101791495|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101791496|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
101791497|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
101543224|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791498|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101791499|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101791500|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791501|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791502|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791503|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791504|NCT00626522|Bromides|bromides|mesh-list
101791505|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
101791506|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791507|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
101791508|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791509|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791510|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101791511|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791512|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101791513|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101791514|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791515|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791516|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791517|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791518|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
101791519|NCT00926640|Etoposide|etoposide|mesh-list
101791520|NCT00926640|Belinostat|belinostat|mesh-list
101791521|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791522|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791523|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101791524|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101791525|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791526|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791527|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101791528|NCT00931398|Methylphenidate|methylphenidate|mesh-list
101791529|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101791530|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791531|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101791532|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101791533|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791534|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791535|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
101791536|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791537|NCT00827216|Erythromycin|erythromycin|mesh-list
101791538|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
101791539|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101791540|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
101791541|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791542|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791543|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791544|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101791545|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791546|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791547|NCT00822848|Sorafenib|sorafenib|mesh-list
101791548|NCT00822848|Epirubicin|epirubicin|mesh-list
101791549|NCT00822848|Ifosfamide|ifosfamide|mesh-list
101791550|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791551|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791552|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791553|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791554|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101791555|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101791556|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101791557|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101791558|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
101791560|NCT00926718|Rocuronium|rocuronium|mesh-list
101791561|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101791562|NCT00926718|Narcotics|narcotics|mesh-ancestor
101791563|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791564|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791565|NCT00926718|Analgesics|analgesics|mesh-ancestor
101791566|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
101791567|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791568|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101791569|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101791570|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101791571|NCT00823004|Letrozole|letrozole|mesh-list
101791572|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
101791573|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
101791574|NCT00823004|Buserelin|buserelin|mesh-list
101791575|NCT00823004|Ganirelix|ganirelix|mesh-list
101791576|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791577|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101791578|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101791579|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791580|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791581|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101791582|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101791583|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101791584|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791585|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101246496|NCT01666379|Analgesics|analgesics|mesh-ancestor
101791586|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101791587|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101791588|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
101791589|NCT00827450|Caffeine|caffeine|mesh-list
101791590|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101791591|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791592|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101791593|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791594|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791595|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101791596|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101791597|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
101791598|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791599|NCT00930306|Tolbutamide|tolbutamide|mesh-list
101791600|NCT00930306|Midazolam|midazolam|mesh-list
101791601|NCT00930306|Caffeine|caffeine|mesh-list
101791602|NCT00930306|Omeprazole|omeprazole|mesh-list
101791603|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101791604|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101791605|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791606|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791607|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101791608|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101791609|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101791610|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101791611|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
101791612|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
101791613|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
101791614|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
101791615|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791616|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791617|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101791618|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101791619|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791620|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101791621|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101791622|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
101791623|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101791624|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791625|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101791626|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101791627|NCT00830882|Albuterol|albuterol|mesh-list
101791628|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791629|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
101791630|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791631|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791632|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101791633|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791634|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
101791635|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101791636|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101791637|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101791638|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101791639|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
101791640|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791641|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791642|NCT00823238|Tobramycin|tobramycin|mesh-list
101791643|NCT00823238|Ceftazidime|ceftazidime|mesh-list
101791644|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791645|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791646|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
101791647|NCT00827684|Sirolimus|sirolimus|mesh-list
101791648|NCT00827684|Irinotecan|irinotecan|mesh-list
101791649|NCT00827684|Temsirolimus|temsirolimus|mesh-list
101791650|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
101791651|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101791652|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101791653|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791654|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791655|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791657|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791658|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
101791659|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791660|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791661|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791662|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101791663|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
101791664|NCT00927030|Melatonin|melatonin|mesh-list
101791665|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
101791666|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791667|NCT00927030|Protective Agents|protective agents|mesh-ancestor
101791668|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791669|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791670|NCT00931866|Diclofenac|diclofenac|mesh-list
101791671|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101791672|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101791673|NCT00931866|Analgesics|analgesics|mesh-ancestor
101791674|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
101791675|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791676|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791677|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791678|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101791679|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101791680|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791681|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791682|NCT00827840|Risperidone|risperidone|mesh-list
101791683|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101791684|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101791685|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
101791686|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791687|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791688|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791689|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101791690|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101791691|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791692|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101791693|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101791694|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
101791695|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101791696|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101791697|NCT00827996|Adalimumab|adalimumab|mesh-list
101791698|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101791699|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791700|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101791701|NCT00936780|Paclitaxel|paclitaxel|mesh-list
101791702|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791703|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791704|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791705|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791706|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791707|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791708|NCT00823550|Lamivudine|lamivudine|mesh-list
101791709|NCT00823550|Entecavir|entecavir|mesh-list
101791710|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101791711|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101791712|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791713|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791714|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
101791715|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791716|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101791717|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101791718|NCT00932100|Heparin|heparin|mesh-list
101791719|NCT00932100|Calcium heparin|calcium heparin|mesh-list
101791720|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101791721|NCT00932100|Tinzaparin|tinzaparin|mesh-list
101791722|NCT00932100|Dalteparin|dalteparin|mesh-list
101791723|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
101791724|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101791725|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101791726|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791727|NCT00828230|Budesonide|budesonide|mesh-list
101791728|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791729|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101791730|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
101791731|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791732|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791733|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101791734|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
101791735|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
101791736|NCT00828230|Hormones|hormones|mesh-ancestor
101791737|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101791738|NCT04469556|Leucovorin|leucovorin|mesh-list
101791739|NCT04469556|Paclitaxel|paclitaxel|mesh-list
101791740|NCT04469556|Gemcitabine|gemcitabine|mesh-list
101791741|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
101791742|NCT04469556|Irinotecan|irinotecan|mesh-list
101791743|NCT04469556|Folfirinox|folfirinox|mesh-list
101791744|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791745|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791746|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791747|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791748|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791749|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791750|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791751|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
101791752|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101791753|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543252|NCT02218814|Bupivacaine|bupivacaine|mesh-list
101791754|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791756|NCT04469556|Protective Agents|protective agents|mesh-ancestor
101791757|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791758|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
101791759|NCT04469556|Vitamins|vitamins|mesh-ancestor
101791760|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
101791761|NCT00937092|Dopamine|dopamine|mesh-list
101791762|NCT00937092|Furosemide|furosemide|mesh-list
101791763|NCT00937092|Diuretics|diuretics|mesh-ancestor
101791764|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
101791765|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791766|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101791767|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791768|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791769|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101791770|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
101791771|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
101791772|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791773|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
101791774|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791775|NCT00937092|Protective Agents|protective agents|mesh-ancestor
101791776|NCT04124601|Nivolumab|nivolumab|mesh-list
101791777|NCT04124601|Ipilimumab|ipilimumab|mesh-list
101791778|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101791779|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791780|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101791781|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791783|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
101412334|NCT00475618|Fluorides|fluorides|mesh-list
101791784|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
101791785|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791786|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791787|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
101791788|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791789|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101791790|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101791791|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101791792|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791793|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791795|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791796|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791797|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791798|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791799|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791800|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
101791801|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101791802|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791803|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791804|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101791805|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101791806|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791807|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791808|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791809|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101791810|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
101791811|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101791812|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791813|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101791814|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101791815|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101791816|NCT00932880|Amlodipine|amlodipine|mesh-list
101543271|NCT01198132|Interferons|interferons|mesh-list
101791817|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101791818|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101791819|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791820|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791821|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101791822|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791823|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791824|NCT00937482|Cediranib|cediranib|mesh-list
101791825|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791826|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791827|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791828|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791829|NCT00931086|Belimumab|belimumab|mesh-list
101791830|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791831|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
101791832|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791833|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101791834|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101791835|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791836|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101791837|NCT04453839|Protective Agents|protective agents|mesh-ancestor
101791838|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791839|NCT03977454|Ropivacaine|ropivacaine|mesh-list
101791840|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
101791841|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
101791842|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791843|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791844|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
101791845|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791846|NCT02549066|Milrinone|milrinone|mesh-list
101791847|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101791848|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101791849|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
101791850|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101791851|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101791852|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791853|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791854|NCT02549066|Protective Agents|protective agents|mesh-ancestor
101791855|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791856|NCT00831350|Ranibizumab|ranibizumab|mesh-list
101791857|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101791858|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101791859|NCT00831350|Growth Substances|growth substances|mesh-ancestor
101791860|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791861|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
101791862|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791863|NCT00938184|Paroxetine|paroxetine|mesh-list
101791864|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101791865|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101791866|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101791867|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791868|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101791869|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
101791870|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791871|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101791872|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
101791873|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101791874|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101791875|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101791876|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791877|NCT00938262|Rifampin|rifampin|mesh-list
101791878|NCT00938262|Ketoconazole|ketoconazole|mesh-list
101791879|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101791880|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
101791881|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791882|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791883|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
101791884|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101791885|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791886|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791887|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101791888|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101791889|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101791890|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101791891|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101791892|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101791893|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
101791894|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101791895|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101791896|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101791897|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
101791898|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101791899|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791900|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101791901|NCT00933426|Paclitaxel|paclitaxel|mesh-list
101791902|NCT00933426|Lenalidomide|lenalidomide|mesh-list
101791903|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791904|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791905|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791906|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791907|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791908|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791909|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
101791910|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791911|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101791912|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101791913|NCT00933426|Growth Substances|growth substances|mesh-ancestor
101791914|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
101791915|NCT04013958|Ketamine|ketamine|mesh-list
101791916|NCT04013958|Analgesics|analgesics|mesh-ancestor
101791917|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
101791918|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791919|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791920|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101791921|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101791922|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
101791923|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
101791924|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537209|NCT00589238|Paclitaxel|paclitaxel|mesh-list
101791925|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101791926|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101791927|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543296|NCT02216669|Imidazole|imidazole|mesh-list
101791928|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791930|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101791931|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101791932|NCT00933582|Analgesics|analgesics|mesh-ancestor
101791933|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
101791934|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791935|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791936|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101791937|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101791938|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
101791939|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101791940|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791941|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791942|NCT00938730|Warfarin|warfarin|mesh-list
101791943|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
101791944|NCT00933816|Fluorouracil|fluorouracil|mesh-list
101791945|NCT00933816|Sorafenib|sorafenib|mesh-list
101791946|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791947|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
101791948|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791949|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101791950|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791951|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
101791952|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791953|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101791954|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791955|NCT00538785|Palivizumab|palivizumab|mesh-list
101791956|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
101791957|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791958|NCT01563939|Remifentanil|remifentanil|mesh-list
101791959|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101791960|NCT01563939|Narcotics|narcotics|mesh-ancestor
101791961|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101791962|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101791963|NCT01563939|Analgesics|analgesics|mesh-ancestor
101791964|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
101791965|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101791966|NCT03287271|Paclitaxel|paclitaxel|mesh-list
101791967|NCT03287271|Carboplatin|carboplatin|mesh-list
101791968|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101791969|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101791970|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101791971|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101791972|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101791973|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791974|NCT00990405|Amoxicillin|amoxicillin|mesh-list
101791975|NCT00990405|Clarithromycin|clarithromycin|mesh-list
101791976|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101791977|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101791978|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101791979|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101791980|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791981|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101791982|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101791983|NCT00990639|Candesartan|candesartan|mesh-list
101791984|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
101791985|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101791986|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101791987|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101791988|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791990|NCT03742947|Coagulants|coagulants|mesh-ancestor
101791991|NCT05359497|Liver Extracts|liver extracts|mesh-list
101791992|NCT05359497|Hematinics|hematinics|mesh-ancestor
101791993|NCT00990795|Cyclosporine|cyclosporine|mesh-list
101791994|NCT00990795|Cyclosporins|cyclosporins|mesh-list
101791995|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449393|NCT00191243|Docetaxel|docetaxel|mesh-list
101791996|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101791997|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101791998|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
101791999|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792000|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
101792001|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792002|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792003|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792004|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101792005|NCT00622700|Teriflunomide|teriflunomide|mesh-list
101792006|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101792007|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101792008|NCT00622700|Analgesics|analgesics|mesh-ancestor
101792009|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
101792010|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792011|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792012|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792013|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792014|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792015|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
101792016|NCT00831506|Digoxin|digoxin|mesh-list
101792017|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792018|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101792019|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792020|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792021|NCT00831506|Protective Agents|protective agents|mesh-ancestor
101792022|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792023|NCT02842359|Irbesartan|irbesartan|mesh-list
101792024|NCT02842359|Atorvastatin|atorvastatin|mesh-list
101792025|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101792026|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101792027|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
101792028|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792029|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101792030|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101792031|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792032|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792033|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101792034|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101792035|NCT00828776|Heparin|heparin|mesh-list
101792036|NCT00828776|Calcium heparin|calcium heparin|mesh-list
101792037|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
101792038|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101792039|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101792040|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792041|NCT00622466|Paclitaxel|paclitaxel|mesh-list
101792042|NCT00622466|Sorafenib|sorafenib|mesh-list
101792043|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101792044|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792045|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101792046|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101792047|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101792048|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792049|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101792050|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792051|NCT04043858|Midodrine|midodrine|mesh-list
101792052|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
101792053|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
101792054|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792055|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792056|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101792057|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101792058|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101792059|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101792060|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792061|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792062|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792063|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101792064|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101792065|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792066|NCT00823862|Ribavirin|ribavirin|mesh-list
101792067|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
101792068|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792069|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
101792070|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792071|NCT00537771|Tamoxifen|tamoxifen|mesh-list
101792072|NCT00537771|Anastrozole|anastrozole|mesh-list
101792073|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101792075|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792076|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792077|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792078|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792079|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101792080|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101792081|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101792082|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101792083|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101792084|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792085|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792086|NCT00823940|Glucagon|glucagon|mesh-list
101792087|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101792088|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101792089|NCT00823940|Hormones|hormones|mesh-ancestor
101792090|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792091|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792092|NCT00823940|Incretins|incretins|mesh-ancestor
101792093|NCT00829322|Modafinil|modafinil|mesh-list
101792094|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101792095|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792096|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101792097|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101792098|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101792099|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792100|NCT00623480|Factor VIII|factor viii|mesh-list
101792101|NCT00623480|Coagulants|coagulants|mesh-ancestor
101792102|NCT02513667|Ceritinib|ceritinib|mesh-list
101792103|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792104|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101792105|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792106|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792107|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
101792108|NCT03823911|Grazoprevir|grazoprevir|mesh-list
101792109|NCT03823911|Ledipasvir|ledipasvir|mesh-list
101792110|NCT03823911|Velpatasvir|velpatasvir|mesh-list
101792111|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101792112|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101792113|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
101792114|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792115|NCT00829634|Methamphetamine|methamphetamine|mesh-list
101792116|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101792117|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792118|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
101792119|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
101792120|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792121|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
101543315|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
101792122|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792123|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792124|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792125|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101792126|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101792127|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792128|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101792129|NCT04003467|Teriparatide|teriparatide|mesh-list
101792130|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792131|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792132|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101792133|NCT00832208|Amphotericin B|amphotericin b|mesh-list
101792134|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101792135|NCT00832208|Amebicides|amebicides|mesh-ancestor
101792136|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101792137|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101792138|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792139|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101792140|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
101792142|NCT05361057|Azacitidine|azacitidine|mesh-list
101792143|NCT05361057|Daunorubicin|daunorubicin|mesh-list
101792144|NCT05361057|Venetoclax|venetoclax|mesh-list
101792145|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101792146|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
101792147|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792148|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792149|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
101792150|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792151|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792152|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
101792153|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792154|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792155|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101792156|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792157|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101792158|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
101792159|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101792160|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792161|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792162|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101792163|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792164|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792165|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792166|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101792167|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101792168|NCT00832364|Etanercept|etanercept|mesh-list
101792169|NCT00832364|Acitretin|acitretin|mesh-list
101792170|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101792171|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101792172|NCT00832364|Analgesics|analgesics|mesh-ancestor
101792173|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
101792174|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792175|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792176|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792177|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792178|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101792179|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792180|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
101792181|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
101792182|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792183|NCT00832442|Metoprolol|metoprolol|mesh-list
101792184|NCT00832442|Carvedilol|carvedilol|mesh-list
101792185|NCT00832442|Nebivolol|nebivolol|mesh-list
101792186|NCT00832442|Bisoprolol|bisoprolol|mesh-list
101543326|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792187|NCT00832442|Bucindolol|bucindolol|mesh-list
101792188|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101543327|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792189|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792190|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792192|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
101792193|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792194|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792195|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101792196|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101792197|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792198|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792199|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792200|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
101792201|NCT00832442|Protective Agents|protective agents|mesh-ancestor
101792202|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792203|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792204|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792205|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
101792206|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101792207|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101792208|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101792209|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101792210|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101792211|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
101792212|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101792213|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
101792214|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101792215|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101792216|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101792217|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
101792218|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792219|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792220|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101792221|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101792222|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101792223|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792224|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792225|NCT00830492|Clomiphene|clomiphene|mesh-list
101792226|NCT00830492|Enclomiphene|enclomiphene|mesh-list
101792227|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
101792228|NCT00830492|Buserelin|buserelin|mesh-list
101792229|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101792230|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
101792231|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792232|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792233|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101792234|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
101792235|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792236|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101792237|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101792238|NCT00830570|Warfarin|warfarin|mesh-list
101792239|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
101792240|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
101792241|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792242|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792243|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543338|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792244|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792245|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792246|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101792248|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
101792249|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792250|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792251|NCT02550080|Dapsone|dapsone|mesh-list
101792252|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792253|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
101792254|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101792255|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101792256|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101792257|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792258|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792259|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
101792260|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101792261|NCT02547350|Pirarubicin|pirarubicin|mesh-list
101792262|NCT02547350|Epirubicin|epirubicin|mesh-list
101792263|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792264|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101792265|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792266|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101792267|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792268|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792269|NCT00838214|Prednisone|prednisone|mesh-list
101792270|NCT00838214|Budesonide|budesonide|mesh-list
101792271|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792272|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
101792273|NCT00838214|Hormones|hormones|mesh-ancestor
101792274|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792275|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792276|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792277|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792278|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101792279|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
101792280|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792281|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101792282|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
101792283|NCT00621764|Vaccines|vaccines|mesh-list
101792284|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
101792285|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792286|NCT00838370|Fluorouracil|fluorouracil|mesh-list
101792287|NCT00838370|Capecitabine|capecitabine|mesh-list
101792288|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
101792289|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792290|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101792291|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792292|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792293|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
101792294|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543355|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792295|NCT00537381|Prednisone|prednisone|mesh-list
101449666|NCT00123656|Fluticasone|fluticasone|mesh-list
101543356|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543357|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543358|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101543359|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101543360|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
101543361|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543362|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101543363|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101543364|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101792297|NCT00537381|Intetumumab|intetumumab|mesh-list
101792298|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792299|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
101792300|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
101792301|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
101792302|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792303|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792304|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
101792305|NCT00537381|Hormones|hormones|mesh-ancestor
101792306|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792307|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792308|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792309|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792310|NCT00833300|Haloperidol|haloperidol|mesh-list
101792311|NCT00833300|Olanzapine|olanzapine|mesh-list
101792312|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
101792313|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
101792314|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
101792315|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792316|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792317|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101792318|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101792319|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101792320|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792321|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101792322|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101792323|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101792324|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792325|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792326|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792327|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
101792328|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101792329|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
101792330|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101792331|NCT00833378|Ritonavir|ritonavir|mesh-list
101792332|NCT00833378|Lopinavir|lopinavir|mesh-list
101792333|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101792334|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101792335|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792345|NCT05359341|Empagliflozin|empagliflozin|mesh-list
101792346|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101543365|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101543366|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101543367|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101543368|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101543369|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543370|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101543371|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
101543372|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792347|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101792348|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792349|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792350|NCT05359341|Incretins|incretins|mesh-ancestor
101792351|NCT05359341|Hormones|hormones|mesh-ancestor
101792352|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792353|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792354|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792355|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792356|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101792357|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101792358|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792359|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792360|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792361|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792362|NCT00838760|Darunavir|darunavir|mesh-list
101792363|NCT00838760|TMC-310911|tmc-310911|mesh-list
101792364|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101792365|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101792366|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792367|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792368|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792369|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101792370|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101792371|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
101792372|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792373|NCT03791398|Nivolumab|nivolumab|mesh-list
101792374|NCT03791398|TIC10 compound|tic10 compound|mesh-list
101792375|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792376|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792377|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101792378|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792379|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
101792380|NCT00838838|Testosterone|testosterone|mesh-list
101792381|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
101792382|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
101792383|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101792384|NCT00838838|Androgens|androgens|mesh-ancestor
101792385|NCT00838838|Hormones|hormones|mesh-ancestor
101246497|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
101792386|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792387|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792388|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792389|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792390|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
101792391|NCT05360979|Endostatins|endostatins|mesh-list
101792392|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792393|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101792394|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101792395|NCT05360979|Growth Substances|growth substances|mesh-ancestor
101792396|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792397|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
101792398|NCT00833534|Rituximab|rituximab|mesh-list
101792399|NCT00833534|Lenalidomide|lenalidomide|mesh-list
101792400|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792401|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792402|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
101792403|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792404|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792405|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101792406|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101792407|NCT00833534|Growth Substances|growth substances|mesh-ancestor
101792408|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
101792409|NCT05591001|Ketamine|ketamine|mesh-list
101543373|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543378|NCT03113955|Epirubicin|epirubicin|mesh-list
101792410|NCT05591001|Propofol|propofol|mesh-list
101792411|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101792412|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792413|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792414|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101792415|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
101792416|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
101792417|NCT05591001|Analgesics|analgesics|mesh-ancestor
101792418|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
101792419|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792420|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101792421|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101412348|NCT00475696|Analgesics|analgesics|mesh-ancestor
101792422|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101792423|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792424|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792425|NCT00517192|Ritonavir|ritonavir|mesh-list
101792426|NCT00517192|Darunavir|darunavir|mesh-list
101792427|NCT00517192|Tipranavir|tipranavir|mesh-list
101792428|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101792429|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101792430|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792431|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792432|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792433|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101543381|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792434|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101792435|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
101792436|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792437|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101792438|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101792439|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
101792440|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101792441|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792442|NCT00833768|Sevelamer|sevelamer|mesh-list
101792443|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
101792444|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
101792445|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792446|NCT00510484|Pancrelipase|pancrelipase|mesh-list
101792447|NCT00510484|Pancreatin|pancreatin|mesh-list
101792448|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101792449|NCT00839228|Perhexiline|perhexiline|mesh-list
101792450|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792451|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792452|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792453|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792454|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792455|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
101792456|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
101792457|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792458|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
101792459|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
101792461|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
101792462|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792463|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
101792464|NCT05590221|Fludarabine|fludarabine|mesh-list
101792465|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792466|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
101792467|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792468|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792469|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101792470|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
101792471|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792472|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792473|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101792474|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
101792475|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101792476|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792477|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792478|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792479|NCT00622388|Ofatumumab|ofatumumab|mesh-list
101792480|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792481|NCT01156389|Ritonavir|ritonavir|mesh-list
101792482|NCT01156389|Artesunate|artesunate|mesh-list
101792484|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101792485|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101792486|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101792487|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792488|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792489|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792490|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101792491|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101792492|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
101792493|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792494|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101792495|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101792496|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
101792497|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101792498|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101792499|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792500|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
101792501|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101792502|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
101792503|NCT04043624|Lidocaine|lidocaine|mesh-list
101792504|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
101792505|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
101792506|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792507|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792508|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
101792509|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792510|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792511|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101792512|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101792513|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792514|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792515|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
101792516|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101792517|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101792518|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792519|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
101792520|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792521|NCT00625742|Ibuprofen|ibuprofen|mesh-list
101792522|NCT00625742|Atenolol|atenolol|mesh-list
101792523|NCT00625742|Melatonin|melatonin|mesh-list
101792524|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101792525|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101792527|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
101792528|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792529|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792530|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792531|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792532|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101792533|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792534|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792535|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
101792536|NCT00625742|Protective Agents|protective agents|mesh-ancestor
101415215|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
101792537|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792539|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792540|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
101792541|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
101792542|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101792543|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101792544|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101792545|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792546|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792547|NCT05589441|Insulin|insulin|mesh-list
101792548|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101792549|NCT05589441|Albuterol|albuterol|mesh-list
101792550|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792551|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792552|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101792553|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
101792554|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792555|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101792556|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
101792558|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792559|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101792560|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101792561|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101792562|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792563|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792564|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792565|NCT00825188|Amlodipine|amlodipine|mesh-list
101792566|NCT00825188|Eplerenone|eplerenone|mesh-list
101792567|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792568|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792569|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792570|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792571|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792572|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792573|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
101792574|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101792575|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
101792576|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792577|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101792578|NCT00825188|Diuretics|diuretics|mesh-ancestor
101792579|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
101792580|NCT00834470|Atropine|atropine|mesh-list
101792581|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101792582|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792583|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101792584|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
101792585|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792586|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792587|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101792588|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
101792589|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
101792590|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
101792591|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101792592|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101792593|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
101792594|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543406|NCT02219789|Fulvestrant|fulvestrant|mesh-list
101792595|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792597|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792598|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101792599|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101792600|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101792601|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792602|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792603|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792604|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792605|NCT05407467|Curcumin|curcumin|mesh-list
101792606|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101792607|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101792608|NCT05407467|Analgesics|analgesics|mesh-ancestor
101792609|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
101792610|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792611|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792612|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792613|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792614|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792615|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792616|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792617|NCT01010152|Codeine|codeine|mesh-list
101792618|NCT01010152|Analgesics|analgesics|mesh-ancestor
101792619|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
101792620|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792621|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792622|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101792623|NCT01010152|Narcotics|narcotics|mesh-ancestor
101792624|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792625|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
101792626|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
101792627|NCT05407233|Insulin|insulin|mesh-list
101792628|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101792629|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792630|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792631|NCT02549846|Atorvastatin|atorvastatin|mesh-list
101792632|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101792633|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101792634|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101792635|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
101792636|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792637|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101792638|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101792639|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792640|NCT05407155|Paclitaxel|paclitaxel|mesh-list
101792641|NCT05407155|Bevacizumab|bevacizumab|mesh-list
101792642|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101792643|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792644|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
101792645|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
101792646|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
101792647|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792648|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792649|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101543430|NCT02219867|Ketamine|ketamine|mesh-list
101792650|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101792651|NCT05407155|Growth Substances|growth substances|mesh-ancestor
101792652|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792653|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
101792655|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101792656|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
101792657|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792658|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792659|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101792660|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101792661|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
101792662|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792663|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792665|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101792666|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101792667|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792668|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792669|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101792670|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101792671|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
101792672|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792673|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792675|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101792676|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
101792677|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
101792678|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101792679|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
101792680|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792681|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792682|NCT02548286|Amlodipine|amlodipine|mesh-list
101792683|NCT02548286|Candesartan|candesartan|mesh-list
101792684|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
101792685|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792686|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792687|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792688|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792689|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792690|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792691|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101792692|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101792693|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101792694|NCT05360433|Oxycodone|oxycodone|mesh-list
101792695|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101792696|NCT05360433|Narcotics|narcotics|mesh-ancestor
101792697|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792698|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792699|NCT05360433|Analgesics|analgesics|mesh-ancestor
101792700|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
101792701|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792702|NCT00834860|Ribavirin|ribavirin|mesh-list
101543439|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543440|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101543441|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101543442|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543443|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543444|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
101543445|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101792704|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
101792705|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792706|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
101792707|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792708|NCT04696575|Lamivudine|lamivudine|mesh-list
101792709|NCT04696575|Carboplatin|carboplatin|mesh-list
101792710|NCT04696575|Etoposide|etoposide|mesh-list
101792711|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
101792712|NCT04696575|Atezolizumab|atezolizumab|mesh-list
101792713|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
101792714|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101792715|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792716|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101792717|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101792718|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101792719|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792720|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792721|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101792722|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792723|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101792724|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101792726|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792727|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101792728|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101792729|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
101792730|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792731|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
101792732|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792733|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
101792734|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
101792735|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
101792736|NCT00825422|Ropivacaine|ropivacaine|mesh-list
101792737|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
101792738|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
101792739|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792740|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792741|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
101792742|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792743|NCT00505414|Morphine|morphine|mesh-list
101792744|NCT00505414|Tapentadol|tapentadol|mesh-list
101792745|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101792746|NCT00505414|Narcotics|narcotics|mesh-ancestor
101792747|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792748|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792749|NCT00505414|Analgesics|analgesics|mesh-ancestor
101792750|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
101792751|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792752|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101792753|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101792754|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792755|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792756|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792757|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792758|NCT02549924|Resveratrol|resveratrol|mesh-list
101792759|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
101792760|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792761|NCT02549924|Protective Agents|protective agents|mesh-ancestor
101792762|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792763|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792764|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101792765|NCT01813227|Dexamethasone|dexamethasone|mesh-list
101792767|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101543451|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792768|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792769|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
101792770|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792771|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792772|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792773|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
101792774|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
101792775|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792776|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101792777|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
101792778|NCT01813227|Hormones|hormones|mesh-ancestor
101792779|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792780|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792781|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
101792782|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
101792783|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792784|NCT00989469|Irinotecan|irinotecan|mesh-list
101792785|NCT00989469|Sorafenib|sorafenib|mesh-list
101792786|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101792787|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101792788|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792789|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792790|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792791|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101792792|NCT01010308|Nadolol|nadolol|mesh-list
101792793|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101792794|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101792795|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792796|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792797|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792798|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792799|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792800|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792801|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
101792802|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
101792803|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792804|NCT02548052|Betamethasone|betamethasone|mesh-list
101792805|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
101792806|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101792807|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
101792808|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101792809|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792810|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
101792811|NCT02548052|Hormones|hormones|mesh-ancestor
101792812|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792813|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792814|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101792815|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
101792816|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
101792817|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101792818|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101792819|NCT04590417|Estradiol|estradiol|mesh-list
101450183|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
101792820|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101792821|NCT04590417|Cyproterone|cyproterone|mesh-list
101792822|NCT04590417|Estrogens|estrogens|mesh-ancestor
101792823|NCT04590417|Hormones|hormones|mesh-ancestor
101792824|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792825|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792826|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101792827|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
101543453|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543454|NCT04533243|Fentanyl|fentanyl|mesh-list
101543455|NCT04533243|Morphine|morphine|mesh-list
101543456|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101792828|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792829|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101792830|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
101792831|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
101792832|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792833|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101792835|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
101792836|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792837|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
101792838|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792839|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792840|NCT00989625|Naproxen|naproxen|mesh-list
101792841|NCT00989625|Sumatriptan|sumatriptan|mesh-list
101792842|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101792844|NCT00989625|Analgesics|analgesics|mesh-ancestor
101792845|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
101792846|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792847|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792848|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792849|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792850|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
101792851|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101792852|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792853|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792854|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101792855|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101792856|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101792857|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
101792858|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792859|NCT00841256|Glycerol|glycerol|mesh-list
101792860|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101792861|NCT00841256|Protective Agents|protective agents|mesh-ancestor
101792862|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792863|NCT00989703|Methotrexate|methotrexate|mesh-list
101792864|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101792865|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
101792866|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792867|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792868|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101792869|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
101792870|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792871|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792872|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792873|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792874|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101792875|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792876|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
101792877|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101792878|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101792879|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
101792880|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101792881|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792882|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
101792883|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792884|NCT00625586|Gemcitabine|gemcitabine|mesh-list
101792885|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101792886|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
101792887|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543464|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101792888|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792889|NCT02547116|Rifampin|rifampin|mesh-list
101792890|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101792891|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
101792892|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101792893|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450258|NCT00193271|Docetaxel|docetaxel|mesh-list
101792894|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
101792895|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101792896|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310264|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792897|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792898|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101792899|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101792900|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101792901|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101792902|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101792903|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101792904|NCT02549690|Testosterone|testosterone|mesh-list
101792905|NCT02549690|Androgens|androgens|mesh-ancestor
101792906|NCT02549690|Hormones|hormones|mesh-ancestor
101792907|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792908|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792909|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
101792910|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101792911|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101792912|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792913|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101792914|NCT02549768|Analgesics|analgesics|mesh-ancestor
101792915|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
101792916|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101792917|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101792918|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101792919|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101792920|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
101792921|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101792922|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792923|NCT00841724|Fludarabine|fludarabine|mesh-list
101792924|NCT00841724|Busulfan|busulfan|mesh-list
101792925|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
101792926|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792927|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543483|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543484|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101543485|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543486|NCT04532931|Acetaminophen|acetaminophen|mesh-list
101543487|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
101543488|NCT04532931|Artesunate|artesunate|mesh-list
101543489|NCT04532931|Favipiravir|favipiravir|mesh-list
101543490|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101792928|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101792930|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792931|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
101792932|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101792933|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101792934|NCT00843362|Dinoprostone|dinoprostone|mesh-list
101792935|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
101792936|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101792937|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792938|NCT00841802|Prednisone|prednisone|mesh-list
101792939|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
101792940|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101792941|NCT00841802|Hormones|hormones|mesh-ancestor
101792942|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792943|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792944|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101792945|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792946|NCT00621140|Linagliptin|linagliptin|mesh-list
101792947|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792948|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792949|NCT00621140|Incretins|incretins|mesh-ancestor
101792950|NCT00621140|Hormones|hormones|mesh-ancestor
101792951|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101792952|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101792953|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792954|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792955|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792956|NCT00207727|Ustekinumab|ustekinumab|mesh-list
101792957|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
101792958|NCT00841880|Felodipine|felodipine|mesh-list
101792959|NCT00841880|Ramipril|ramipril|mesh-list
101792960|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101792961|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792962|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792963|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792964|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101792965|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101792966|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101792967|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101792968|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101792969|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792970|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
101792971|NCT00843440|Bevacizumab|bevacizumab|mesh-list
101792972|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101792973|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101792974|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101792975|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101792976|NCT00843440|Growth Substances|growth substances|mesh-ancestor
101792977|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792978|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
101792979|NCT00504556|Warfarin|warfarin|mesh-list
101792980|NCT00504556|Edoxaban|edoxaban|mesh-list
101792981|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
101792982|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101792983|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
101792984|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101792985|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
101792986|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101792987|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101792988|NCT00206323|Topiramate|topiramate|mesh-list
101792989|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
101543491|NCT04532931|Amodiaquine|amodiaquine|mesh-list
101543492|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
101792990|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101792991|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101792992|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
101792993|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101792994|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101792995|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
101792996|NCT00842114|Interferons|interferons|mesh-list
101792997|NCT00842114|Prednisone|prednisone|mesh-list
101792998|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
101792999|NCT00842114|Vincristine|vincristine|mesh-list
101793001|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
101793002|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793003|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793004|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101793005|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
101793006|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793007|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793008|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101793009|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793010|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
101793011|NCT00842114|Hormones|hormones|mesh-ancestor
101793012|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793013|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101793014|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
101793015|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793016|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101793017|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101793018|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
101793019|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
101793020|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
101793021|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793022|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793023|NCT00536991|Calcitriol|calcitriol|mesh-list
101793024|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101793025|NCT00536991|Ketoconazole|ketoconazole|mesh-list
101793026|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
101793027|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101793028|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101793029|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101793030|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793031|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
101793032|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793033|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101793034|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101793035|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793036|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793037|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101793038|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
101793039|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793040|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793041|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101793042|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101793043|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101793044|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793045|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101793046|NCT00536991|Vitamins|vitamins|mesh-ancestor
101793047|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
101793048|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101793049|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101793050|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101793051|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101793052|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793053|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793054|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793055|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101543504|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101793057|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101793058|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793059|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793060|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793061|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101793062|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101793063|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
101793064|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101793065|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101793066|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
101793067|NCT00504166|Alendronate|alendronate|mesh-list
101793068|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101793069|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793070|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
101793071|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101793072|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101793073|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101793074|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
101793075|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793076|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101793077|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101793078|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793079|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101793080|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793081|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
101793082|NCT02546648|Coagulants|coagulants|mesh-ancestor
101793083|NCT00842504|Micafungin|micafungin|mesh-list
101793084|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
101793085|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793086|NCT00842582|Azacitidine|azacitidine|mesh-list
101793087|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793088|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
101793089|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793090|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793091|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793092|NCT00843908|Imidacloprid|imidacloprid|mesh-list
101793093|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
101793094|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793095|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793096|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793097|NCT00842660|Gemcitabine|gemcitabine|mesh-list
101793098|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793099|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
101793100|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793101|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793102|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101793103|NCT00509236|Glipizide|glipizide|mesh-list
101793104|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793105|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793106|NCT00509236|Incretins|incretins|mesh-ancestor
101793107|NCT00509236|Hormones|hormones|mesh-ancestor
101793108|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793109|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101793110|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793111|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793112|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793113|NCT00842894|Insulin|insulin|mesh-list
101793114|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101793115|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
101793116|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
101793117|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
101793118|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101543512|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101793119|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793120|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793121|NCT00508924|Heparin|heparin|mesh-list
101793122|NCT00508924|Argatroban|argatroban|mesh-list
101793123|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
101793124|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101793125|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793126|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793127|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
101793128|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101793129|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793130|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793131|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101793132|NCT00836576|Benazepril|benazepril|mesh-list
101793133|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101793134|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793135|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793136|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793139|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793140|NCT00844064|Trabedersen|trabedersen|mesh-list
101793141|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793142|NCT04688788|Fexofenadine|fexofenadine|mesh-list
101793143|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
101793144|NCT04688788|Rituximab|rituximab|mesh-list
101793145|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
101793146|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101793147|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793148|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
101793149|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793150|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793151|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793152|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
101793153|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
101793154|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793155|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793156|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
101793157|NCT04688788|Hormones|hormones|mesh-ancestor
101310294|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
101793158|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793159|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101793160|NCT04688788|Protective Agents|protective agents|mesh-ancestor
101793161|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101793162|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101793163|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101793164|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
101793165|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
101793166|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793167|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793168|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
101793169|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
101793170|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793171|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793172|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793173|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
101793174|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101793175|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793176|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793177|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
101793178|NCT00844142|Etanercept|etanercept|mesh-list
101793179|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101793180|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793181|NCT00844142|Analgesics|analgesics|mesh-ancestor
101793182|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
101793183|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793184|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415228|NCT00402662|Everolimus|everolimus|mesh-list
101415229|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
101415230|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101793186|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793187|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793188|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793189|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
101450574|NCT00223548|Mesna|mesna|mesh-list
101793190|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793191|NCT00837044|Naproxen|naproxen|mesh-list
101793192|NCT00837044|Sumatriptan|sumatriptan|mesh-list
101793193|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101793194|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793195|NCT00837044|Analgesics|analgesics|mesh-ancestor
101793196|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
101793197|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793198|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793199|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793200|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793201|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
101793202|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101793203|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793204|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793205|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101793206|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101793207|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101793208|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
101793209|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793210|NCT01013272|Lamivudine|lamivudine|mesh-list
101793211|NCT01013272|Entecavir|entecavir|mesh-list
101793212|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101793213|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101793214|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793215|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793216|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
101793217|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793218|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101793219|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101793220|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
101793221|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
101793222|NCT04232085|Melphalan|melphalan|mesh-list
101793223|NCT04232085|Fludarabine|fludarabine|mesh-list
101793224|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
101793225|NCT04232085|Tacrolimus|tacrolimus|mesh-list
101793226|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793227|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
101793228|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793229|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793230|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101793231|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
101793232|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793233|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793234|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101793235|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101793236|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793237|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101793238|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101793239|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
101793240|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101793241|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793242|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101793243|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
101793244|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793246|NCT01010698|Cimetidine|cimetidine|mesh-list
101793247|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
101793248|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793249|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101543527|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
101793250|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793251|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101793252|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
101793253|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
101793254|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793255|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793256|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793257|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101793258|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101793259|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793260|NCT03541486|Gemcitabine|gemcitabine|mesh-list
101793261|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793262|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
101793263|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793264|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793265|NCT00620750|Naltrexone|naltrexone|mesh-list
101450629|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
101793266|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101793267|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101793268|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793269|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
101793270|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793271|NCT02547896|Diclofenac|diclofenac|mesh-list
101412376|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101793272|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101793273|NCT02547896|Codeine|codeine|mesh-list
101793274|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793275|NCT02547896|Analgesics|analgesics|mesh-ancestor
101793276|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
101793277|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793278|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793279|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793280|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793281|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101793282|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793283|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793284|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793285|NCT02547896|Narcotics|narcotics|mesh-ancestor
101793286|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793287|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
101793288|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793289|NCT01564251|Gemcitabine|gemcitabine|mesh-list
101793290|NCT01564251|GDC-0575|gdc-0575|mesh-list
101793291|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793292|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
101793293|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793294|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543532|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101543533|NCT02213627|Menotropins|menotropins|mesh-list
101543534|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101543535|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
101793295|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793296|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793297|NCT00508144|Pemetrexed|pemetrexed|mesh-list
101793298|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793299|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793300|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793301|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101793302|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101793303|NCT00844454|Ethanol|ethanol|mesh-list
101793304|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101793305|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793306|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793307|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793308|NCT02545712|Ethanol|ethanol|mesh-list
101793309|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
101793310|NCT02545712|Sorbitol|sorbitol|mesh-list
101793311|NCT02545712|Glycerol|glycerol|mesh-list
101793312|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101793313|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793314|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793315|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793316|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101793317|NCT02545712|Protective Agents|protective agents|mesh-ancestor
101793318|NCT02545712|Cathartics|cathartics|mesh-ancestor
101793319|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793320|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
101793321|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
101793322|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
101793323|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793324|NCT01011010|Doxorubicin|doxorubicin|mesh-list
101793325|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101793326|NCT01011010|Mitomycins|mitomycins|mesh-list
101793327|NCT01011010|Mitomycin|mitomycin|mesh-list
101793328|NCT01011010|Sorafenib|sorafenib|mesh-list
101793329|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101793330|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793331|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101793332|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101793333|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793334|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793335|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793336|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
101793337|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101793338|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
101793339|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101793340|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
101450704|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793341|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793342|NCT00851708|Expectorants|expectorants|mesh-ancestor
101793343|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793344|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101793345|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
101793346|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793347|NCT00851708|Protective Agents|protective agents|mesh-ancestor
101793348|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793349|NCT00851708|Antidotes|antidotes|mesh-ancestor
101793351|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101793352|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
101793353|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793354|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
101793355|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793356|NCT00621842|Lamotrigine|lamotrigine|mesh-list
101793357|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
101543591|NCT02279147|Neostigmine|neostigmine|mesh-list
101793358|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101793359|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793360|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793361|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101793362|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793363|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101793364|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101793365|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793366|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793367|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101793368|NCT04849455|Morphine|morphine|mesh-list
101793369|NCT04849455|Ropivacaine|ropivacaine|mesh-list
101793370|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
101793371|NCT04849455|Anesthetics|anesthetics|mesh-list
101793372|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793373|NCT04849455|Narcotics|narcotics|mesh-ancestor
101793374|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793375|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793376|NCT04849455|Analgesics|analgesics|mesh-ancestor
101793377|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
101793378|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793379|NCT02545010|Paclitaxel|paclitaxel|mesh-list
101793380|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101793381|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793382|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101793383|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101793384|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101793385|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793386|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101793387|NCT01013506|Letrozole|letrozole|mesh-list
101793388|NCT01013506|Goserelin|goserelin|mesh-list
101793389|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793390|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793391|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793392|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793393|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101793394|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101793395|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101793396|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
101793397|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793398|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793399|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101793400|NCT00844688|Gemcitabine|gemcitabine|mesh-list
101793401|NCT00844688|Sorafenib|sorafenib|mesh-list
101793402|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793403|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
101793404|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793405|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793406|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793407|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793408|NCT04541680|Nintedanib|nintedanib|mesh-list
101793409|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793410|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793411|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246498|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793412|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793413|NCT00855530|Amibegron|amibegron|mesh-list
101793414|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101793415|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101793416|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101793417|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793418|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793419|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543600|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543601|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
101793421|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101793422|NCT00855608|Adalimumab|adalimumab|mesh-list
101793423|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101793424|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793425|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793426|NCT00851864|Tinzaparin|tinzaparin|mesh-list
101793427|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101793428|NCT00851864|Dalteparin|dalteparin|mesh-list
101793429|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
101793430|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101793431|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793432|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793433|NCT00851942|Cosyntropin|cosyntropin|mesh-list
101793434|NCT00851942|Hormones|hormones|mesh-ancestor
101793435|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793436|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793437|NCT00503776|Amifostine|amifostine|mesh-list
101793438|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101793439|NCT00503776|Protective Agents|protective agents|mesh-ancestor
101793440|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793441|NCT02545634|Sulfalene|sulfalene|mesh-list
101793442|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793443|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101793444|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
101793445|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101793446|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101793447|NCT05260671|Cetuximab|cetuximab|mesh-list
101793448|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101793449|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793450|NCT00855686|Memantine|memantine|mesh-list
101793451|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101793452|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101793453|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
101793454|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793455|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793456|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793457|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101793458|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101793459|NCT00619112|Temozolomide|temozolomide|mesh-list
101793460|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101793461|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
101793462|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793463|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793464|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
101793465|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
101793466|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793467|NCT00845156|Protective Agents|protective agents|mesh-ancestor
101793468|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793469|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
101793470|NCT00845156|Vitamins|vitamins|mesh-ancestor
101793471|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
101793472|NCT00852332|Curcumin|curcumin|mesh-list
101793473|NCT00852332|Docetaxel|docetaxel|mesh-list
101793474|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793475|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101793476|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415237|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793477|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101793478|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793479|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101793480|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793481|NCT00852332|Analgesics|analgesics|mesh-ancestor
101793482|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
101793483|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793484|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793485|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793486|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793487|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793488|NCT00852410|Lidocaine|lidocaine|mesh-list
101793489|NCT00852410|Epinephrine|epinephrine|mesh-list
101793490|NCT00852410|Racepinephrine|racepinephrine|mesh-list
101793491|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
101793492|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
101793493|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
101793494|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793495|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793496|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
101793497|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793498|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101793499|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101793500|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101793501|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793502|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793503|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101793504|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101793505|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793506|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793507|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101793508|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101793509|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
101793510|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101793511|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793512|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
101793513|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
101793514|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101793515|NCT00992121|Bevacizumab|bevacizumab|mesh-list
101793516|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101793517|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793518|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101793519|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101793520|NCT00992121|Growth Substances|growth substances|mesh-ancestor
101793521|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793522|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
101793523|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101793524|NCT04420299|Bemiparin|bemiparin|mesh-list
101793525|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
101793526|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101793527|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793528|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793529|NCT00992199|Fluorouracil|fluorouracil|mesh-list
101793530|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793531|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
101793532|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793533|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793534|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793535|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
101793536|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793537|NCT00856310|Fasinumab|fasinumab|mesh-list
101793538|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793539|NCT00856310|Analgesics|analgesics|mesh-ancestor
101793540|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
101543617|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793541|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793542|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793544|NCT02773485|Gemcitabine|gemcitabine|mesh-list
101793545|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793546|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793547|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
101793548|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793549|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
101793551|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793552|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793553|NCT00992355|Tobramycin|tobramycin|mesh-list
101793554|NCT00992355|Dexamethasone|dexamethasone|mesh-list
101793555|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
101793556|NCT00992355|Ketorolac|ketorolac|mesh-list
101793557|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101793558|NCT00992355|BB 1101|bb 1101|mesh-list
101793559|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793560|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
101793561|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
101793562|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543624|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793563|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793564|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101793565|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
101450939|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
101793566|NCT00992355|Hormones|hormones|mesh-ancestor
101793567|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793568|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101793569|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793570|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793571|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793572|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793573|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101793574|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793575|NCT00992355|Analgesics|analgesics|mesh-ancestor
101793576|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
101793577|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793578|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101793579|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101793580|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793581|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
101793583|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793584|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793585|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793586|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793587|NCT00856622|Timolol|timolol|mesh-list
101793588|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101793589|NCT00856622|Latanoprost|latanoprost|mesh-list
101793590|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101793591|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101793592|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101793593|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793594|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793595|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793596|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793597|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101793598|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101793599|NCT00856700|Incretins|incretins|mesh-list
101793600|NCT00856700|Hormones|hormones|mesh-ancestor
101793601|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793602|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793604|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
101793605|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101543627|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
101793606|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101793607|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793608|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793609|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793610|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793611|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793612|NCT00618956|Analgesics|analgesics|mesh-ancestor
101793613|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
101793614|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793615|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
101793616|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793617|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101793618|NCT00845546|Loratadine|loratadine|mesh-list
101793619|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
101793620|NCT00845546|Ephedrine|ephedrine|mesh-list
101793621|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
101793622|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
101793623|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101793624|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101793625|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101793626|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
101793627|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
101793628|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793629|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412383|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
101793630|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793631|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101793632|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
101793633|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793634|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101793635|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793636|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
101793637|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101793638|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101793639|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
101793640|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793641|NCT00852956|Betahistine|betahistine|mesh-list
101793642|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
101793643|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
101793644|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
101543635|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793645|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793646|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793647|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793648|NCT00716417|Afatinib|afatinib|mesh-list
101793649|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793650|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793651|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793652|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793653|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
101793654|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101793655|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793656|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793657|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101793658|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101793659|NCT02592863|Protective Agents|protective agents|mesh-ancestor
101793660|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793661|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
101543636|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793662|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101793664|NCT00719537|Aspirin|aspirin|mesh-list
101793665|NCT00719537|Progesterone|progesterone|mesh-list
101793666|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101793667|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101793668|NCT00719537|Analgesics|analgesics|mesh-ancestor
101793669|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
101793670|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793671|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793672|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793673|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793674|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101793675|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793676|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793677|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101793678|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101793679|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793680|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
101793681|NCT00719537|Progestins|progestins|mesh-ancestor
101793682|NCT00719537|Hormones|hormones|mesh-ancestor
101793683|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793685|NCT00853190|Hydrocodone|hydrocodone|mesh-list
101793686|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793687|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793688|NCT00853190|Narcotics|narcotics|mesh-ancestor
101793689|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793690|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793691|NCT00853190|Analgesics|analgesics|mesh-ancestor
101793692|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
101793693|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793694|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
101793695|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793696|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
101793697|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
101793698|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101793699|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
101793700|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
101793701|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793702|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101793703|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
101793704|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
101793705|NCT00573794|Adalimumab|adalimumab|mesh-list
101793706|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101793707|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793708|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793709|NCT00715793|Temozolomide|temozolomide|mesh-list
101793710|NCT00715793|Decitabine|decitabine|mesh-list
101793711|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101793712|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
101793713|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793714|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793715|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793716|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
101793717|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793718|NCT00924014|Furosemide|furosemide|mesh-list
101793719|NCT00924014|Conivaptan|conivaptan|mesh-list
101793720|NCT00924014|Diuretics|diuretics|mesh-ancestor
101793721|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
101793722|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793723|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101793724|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793725|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793726|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101793727|NCT00853268|Oxycodone|oxycodone|mesh-list
101793728|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793729|NCT00853268|Narcotics|narcotics|mesh-ancestor
101793730|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793731|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793732|NCT00853268|Analgesics|analgesics|mesh-ancestor
101793733|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
101793734|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793735|NCT00845780|Amiodarone|amiodarone|mesh-list
101793736|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101793737|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
101793738|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101793739|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793740|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793741|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101793742|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101793743|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101793744|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793745|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101793746|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101793747|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101793748|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
101793749|NCT00853502|Testosterone|testosterone|mesh-list
101793750|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
101793751|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
101793752|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101793753|NCT00853502|Androgens|androgens|mesh-ancestor
101793755|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793756|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793757|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101793758|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793759|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
101793760|NCT00853736|Oxycodone|oxycodone|mesh-list
101793761|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793762|NCT00853736|Narcotics|narcotics|mesh-ancestor
101793763|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793764|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793765|NCT00853736|Analgesics|analgesics|mesh-ancestor
101793766|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
101793767|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793768|NCT00857168|Testosterone|testosterone|mesh-list
101793769|NCT00857168|Androgens|androgens|mesh-ancestor
101793770|NCT00857168|Hormones|hormones|mesh-ancestor
101793771|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793772|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793773|NCT00857324|Vorinostat|vorinostat|mesh-list
101793774|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543675|NCT01640639|Thalidomide|thalidomide|mesh-list
101793775|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101793776|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793777|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793778|NCT00853892|Oxycodone|oxycodone|mesh-list
101793779|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101793780|NCT00853892|Narcotics|narcotics|mesh-ancestor
101793781|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793782|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793783|NCT00853892|Analgesics|analgesics|mesh-ancestor
101793784|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
101793785|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793786|NCT00857558|Saxagliptin|saxagliptin|mesh-list
101793787|NCT00857558|Incretins|incretins|mesh-ancestor
101793788|NCT00857558|Hormones|hormones|mesh-ancestor
101793789|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793790|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793791|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101793792|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793793|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793794|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793795|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793796|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101793797|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
101793798|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793799|NCT00715559|Cysteamine|cysteamine|mesh-list
101793800|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101793801|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793802|NCT05289869|Oxytocin|oxytocin|mesh-list
101793803|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
101793804|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101793805|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793806|NCT00620282|Liraglutide|liraglutide|mesh-list
101793807|NCT00620282|Glimepiride|glimepiride|mesh-list
101793808|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793809|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793810|NCT00620282|Incretins|incretins|mesh-ancestor
101793811|NCT00620282|Hormones|hormones|mesh-ancestor
101793812|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793813|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101793814|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310389|NCT00005875|Rubitecan|rubitecan|mesh-list
101793815|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
101793816|NCT05684861|Isotretinoin|isotretinoin|mesh-list
101793817|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
101793818|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
101793819|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101793820|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101793821|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793822|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
101793823|NCT04042688|Coagulants|coagulants|mesh-ancestor
101793824|NCT02590133|Fluorouracil|fluorouracil|mesh-list
101793825|NCT02590133|Endostar protein|endostar protein|mesh-list
101793826|NCT02590133|Endostatins|endostatins|mesh-list
101793827|NCT02590133|Nedaplatin|nedaplatin|mesh-list
101793828|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
101793829|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793830|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793831|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793832|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793833|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
101793834|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793835|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101793836|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101543684|NCT01640639|Growth Substances|growth substances|mesh-ancestor
101793837|NCT02590133|Growth Substances|growth substances|mesh-ancestor
101793838|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
101793839|NCT00854204|Darunavir|darunavir|mesh-list
101793840|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101793841|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101793842|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793843|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793844|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793845|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101793846|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101793847|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
101793848|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793849|NCT00857870|Metformin|metformin|mesh-list
101793850|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
101793851|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101793852|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793853|NCT00848432|Risperidone|risperidone|mesh-list
101793854|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101793855|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
101793856|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793857|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793858|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793859|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101793860|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101793861|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793862|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793863|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101793864|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
101793865|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101793866|NCT00854750|Hormones|hormones|mesh-ancestor
101793867|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793868|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793870|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
101793871|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101793872|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793873|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
101793874|NCT00858338|Floxuridine|floxuridine|mesh-list
101793875|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793876|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
101793877|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793878|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793879|NCT00515086|Everolimus|everolimus|mesh-list
101793880|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101793881|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793882|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793883|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793884|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793885|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
101793886|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793887|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793888|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
101793889|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793890|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793891|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793892|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793893|NCT00849368|Azathioprine|azathioprine|mesh-list
101793894|NCT00849368|Allopurinol|allopurinol|mesh-list
101793895|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
101793896|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793897|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793898|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
101543693|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101793900|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101793901|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
101793902|NCT00849368|Protective Agents|protective agents|mesh-ancestor
101793903|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793904|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101793905|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793906|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793907|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
101793908|NCT02544932|Warfarin|warfarin|mesh-list
101793909|NCT02544932|Dabigatran|dabigatran|mesh-list
101793910|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
101793911|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
101793912|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101793913|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
101793914|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793915|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793916|NCT02544854|Propofol|propofol|mesh-list
101793917|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101793918|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793919|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793920|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101793921|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
101793922|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
101793923|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
101793924|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
101793925|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793926|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101793927|NCT02544776|Amlodipine|amlodipine|mesh-list
101793928|NCT02544776|Clomiphene|clomiphene|mesh-list
101793929|NCT02544776|Enclomiphene|enclomiphene|mesh-list
101793930|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
101793931|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793932|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101793933|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101793934|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101793935|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101793936|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793937|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101793938|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101793939|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451304|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
101310415|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793940|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793941|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101793942|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
101793943|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101793944|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101793945|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101793946|NCT00859118|Axitinib|axitinib|mesh-list
101793947|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101793948|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101793949|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101793950|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793951|NCT00849602|Chloroquine|chloroquine|mesh-list
101793952|NCT00849602|Amebicides|amebicides|mesh-ancestor
101793953|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101793954|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101793955|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101793956|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
101793957|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101793958|NCT00859274|Budesonide|budesonide|mesh-list
101793959|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101793960|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101793961|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
101793962|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793963|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793964|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101793965|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793966|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
101793967|NCT00859274|Hormones|hormones|mesh-ancestor
101793968|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101793969|NCT00859352|Midazolam|midazolam|mesh-list
101793970|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101793971|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101793972|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101793973|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793974|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101793975|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101793976|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101793977|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101793978|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
101793979|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
101793980|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
101793981|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
101415253|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101793982|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793983|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793984|NCT00861926|Beclomethasone|beclomethasone|mesh-list
101793985|NCT00861926|Albuterol|albuterol|mesh-list
101793986|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
101793987|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101793988|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
101793989|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101793990|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101793991|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101793992|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
101793993|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101793994|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101793995|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101793996|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101793997|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101793998|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101793999|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
101794000|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101794001|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794002|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
101794003|NCT00861926|Hormones|hormones|mesh-ancestor
101794004|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794005|NCT00849992|Imiquimod|imiquimod|mesh-list
101794006|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101794007|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
101794008|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794009|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794010|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
101794011|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
101310417|NCT00005887|Efaproxiral|efaproxiral|mesh-list
101794012|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101794013|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794014|NCT02544698|Vaccines|vaccines|mesh-list
101794015|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
101794016|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794017|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
101794018|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101794019|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
101794020|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794021|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794022|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101794023|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794024|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101794025|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101794026|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101794027|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794028|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794029|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794031|NCT00862472|Cloprostenol|cloprostenol|mesh-list
101794032|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
101794033|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101794034|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
101794035|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101794036|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794037|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101794038|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101794039|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101794040|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794041|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794042|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794043|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101794044|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101794045|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
101794046|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794047|NCT00850382|Cytarabine|cytarabine|mesh-list
101794048|NCT00850382|Daunorubicin|daunorubicin|mesh-list
101794049|NCT00850382|Dasatinib|dasatinib|mesh-list
101794050|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794051|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
101794052|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794053|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794054|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
101794055|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794056|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794057|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
101794058|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794059|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794060|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101794061|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101794062|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794063|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101794064|NCT00860366|Uric Acid|uric acid|mesh-list
101794065|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
101794066|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794067|NCT00860366|Protective Agents|protective agents|mesh-ancestor
101794068|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794069|NCT00862628|Rebamipide|rebamipide|mesh-list
101310421|NCT00006339|Didanosine|didanosine|mesh-list
101794070|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101794071|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794072|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
101794073|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794074|NCT00862628|Protective Agents|protective agents|mesh-ancestor
101794075|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794076|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794077|NCT00507442|Dexamethasone|dexamethasone|mesh-list
101794078|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
101794079|NCT00507442|Lenalidomide|lenalidomide|mesh-list
101794080|NCT00507442|Bortezomib|bortezomib|mesh-list
101794081|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794082|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
101794083|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794084|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794085|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101794086|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
101794087|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794088|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794089|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101794090|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794091|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
101794092|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
101794093|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794094|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794095|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
101794097|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794098|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101794099|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101794100|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101794101|NCT00507442|Growth Substances|growth substances|mesh-ancestor
101794102|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
101794103|NCT00862706|Telbivudine|telbivudine|mesh-list
101794104|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
101794105|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794106|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101794107|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794108|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794109|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101794111|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
101794112|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794113|NCT00850850|Physostigmine|physostigmine|mesh-list
101794114|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101794115|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794116|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794117|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794118|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794119|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794120|NCT00850850|Miotics|miotics|mesh-ancestor
101794121|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
101794122|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794123|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101794124|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794125|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794126|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101794127|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101794128|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794129|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794130|NCT00863096|Vaccines|vaccines|mesh-list
101794131|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
101794132|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794133|NCT00870272|Misoprostol|misoprostol|mesh-list
101794134|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101794135|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
101794136|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101794137|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794138|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101794139|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794140|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
101794141|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
101794142|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794143|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794144|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101794145|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
101794146|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794147|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794148|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794149|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794150|NCT00502996|Rituximab|rituximab|mesh-list
101794151|NCT00502996|Methotrexate|methotrexate|mesh-list
101794152|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101794153|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794154|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
101794155|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794156|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794157|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101794158|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
101794159|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101794160|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794161|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
101794162|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794163|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794164|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794165|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101794166|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794167|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101794169|NCT00865436|Glyburide|glyburide|mesh-list
101794170|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794171|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794172|NCT00715403|Nintedanib|nintedanib|mesh-list
101794173|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794174|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101794175|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794176|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794177|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
101794178|NCT01013584|Vitamin D|vitamin d|mesh-list
101794179|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101794180|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794181|NCT01013584|Vitamins|vitamins|mesh-ancestor
101794182|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
101794183|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101794184|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
101794185|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101794186|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101794187|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794188|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
101794189|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
101794190|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794191|NCT00864188|Beta Carotene|beta carotene|mesh-list
101794192|NCT00864188|Carotenoids|carotenoids|mesh-list
101794193|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
101794194|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794195|NCT00864188|Protective Agents|protective agents|mesh-ancestor
101794196|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794197|NCT00864188|Provitamins|provitamins|mesh-ancestor
101794198|NCT00864188|Vitamins|vitamins|mesh-ancestor
101794199|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
101794200|NCT00865670|Azithromycin|azithromycin|mesh-list
101794201|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794202|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794203|NCT00864344|Sertraline|sertraline|mesh-list
101794204|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794205|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794206|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101794207|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101794208|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794209|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794210|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794211|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
101794212|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794213|NCT00864500|Clobetasol|clobetasol|mesh-list
101794214|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794215|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
101794216|NCT00864500|Hormones|hormones|mesh-ancestor
101794217|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543750|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794218|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794220|NCT00864734|Glyburide|glyburide|mesh-list
101794221|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794222|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794223|NCT00864812|Fluticasone|fluticasone|mesh-list
101794224|NCT00864812|Xhance|xhance|mesh-list
101794225|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
101794226|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101794227|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101794228|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794229|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101794230|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
101794231|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794232|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794233|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101794234|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794235|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794236|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101794237|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
101794238|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101794239|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794240|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794241|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794242|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101794243|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101794244|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101794245|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794247|NCT00864812|Hormones|hormones|mesh-ancestor
101794248|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794249|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
101794250|NCT02590055|Gemcitabine|gemcitabine|mesh-list
101794251|NCT02590055|Docetaxel|docetaxel|mesh-list
101794252|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794253|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
101794254|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794255|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794256|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
101794257|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
101794258|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101794259|NCT00864890|Dexetimide|dexetimide|mesh-list
101794260|NCT00864890|Citalopram|citalopram|mesh-list
101794261|NCT00864890|Escitalopram|escitalopram|mesh-list
101794262|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101794263|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101794264|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794265|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794266|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794267|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
101794268|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794269|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101794270|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794271|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794272|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101794273|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101794274|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
101794275|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
101794276|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794277|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101794278|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101794279|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794280|NCT00919295|Mirtazapine|mirtazapine|mesh-list
101794281|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794282|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794283|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101794284|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
101794285|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
101794286|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543766|NCT01641419|Dexamethasone|dexamethasone|mesh-list
101310446|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101794287|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794288|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794289|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101794290|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101794291|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794292|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101794293|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101794294|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101794295|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794296|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101794297|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101794298|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
101794299|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101794300|NCT00865748|Metformin|metformin|mesh-list
101794301|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794302|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794303|NCT00865982|Docetaxel|docetaxel|mesh-list
101794304|NCT00865982|Capecitabine|capecitabine|mesh-list
101794305|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794306|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
101794307|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
101794308|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
101794309|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794310|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794311|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
101794312|NCT00866060|Memantine|memantine|mesh-list
101794313|NCT00866060|Donepezil|donepezil|mesh-list
101794314|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101794315|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794316|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451683|NCT00196391|Hormones|hormones|mesh-ancestor
101794317|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794318|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794319|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794320|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
101794321|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101794322|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101794323|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
101794324|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101794325|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101794326|NCT00871052|Vitamin D|vitamin d|mesh-list
101794327|NCT00871052|Calcipotriene|calcipotriene|mesh-list
101794328|NCT00871052|Vitamins|vitamins|mesh-ancestor
101794329|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
101794330|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794331|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101794332|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794333|NCT00502840|Rituximab|rituximab|mesh-list
101794334|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101794335|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794336|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
101794337|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794338|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794339|NCT00514540|Carboplatin|carboplatin|mesh-list
101794340|NCT00514540|Docetaxel|docetaxel|mesh-list
101794341|NCT00514540|Etoposide|etoposide|mesh-list
101794342|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794343|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
101794344|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
101794345|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
101794346|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794347|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101794348|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101794349|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543771|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
101543775|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
101794350|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794352|NCT03121534|Nivolumab|nivolumab|mesh-list
101794353|NCT03121534|Blinatumomab|blinatumomab|mesh-list
101794354|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794355|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
101794356|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
101794357|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794358|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794359|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794360|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
101794361|NCT03121534|Hormones|hormones|mesh-ancestor
101794362|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794363|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101794364|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794365|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101794366|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101794367|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794368|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101794369|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
101794370|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101794371|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
101794372|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794373|NCT04615624|Furosemide|furosemide|mesh-list
101794374|NCT04615624|Diuretics|diuretics|mesh-ancestor
101794375|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
101794376|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794377|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101794378|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794379|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794380|NCT00713609|Clindamycin|clindamycin|mesh-list
101794381|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
101794382|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
101794383|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101794384|NCT00713609|Tazarotene|tazarotene|mesh-list
101794385|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794386|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794387|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101794388|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794389|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794390|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794391|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
101794392|NCT00513682|Pancrelipase|pancrelipase|mesh-list
101794393|NCT00513682|Pancreatin|pancreatin|mesh-list
101794394|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794395|NCT00493012|Vitamin D|vitamin d|mesh-list
101794396|NCT00493012|Vitamins|vitamins|mesh-ancestor
101794397|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
101794398|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794399|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101794400|NCT00918593|Bleomycin|bleomycin|mesh-list
101794401|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794402|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794403|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
101794404|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
101794405|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
101794406|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794407|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794408|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
101794409|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794410|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101310454|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794411|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794412|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794413|NCT05684705|Rifabutin|rifabutin|mesh-list
101794414|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543790|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101794415|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794416|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101794417|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
101794418|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
101794419|NCT05238233|Pilocarpine|pilocarpine|mesh-list
101794420|NCT05238233|Tropicamide|tropicamide|mesh-list
101794421|NCT05238233|Miotics|miotics|mesh-ancestor
101794422|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
101794423|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794424|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794425|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101794426|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101794427|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794428|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794429|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794430|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
101794431|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101794432|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101794434|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
101794435|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794436|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
101794437|NCT00617708|Gemcitabine|gemcitabine|mesh-list
101794438|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101794439|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101794440|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794441|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
101794442|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794443|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794444|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101794445|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794446|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
101794447|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794448|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
101794449|NCT04083209|Narcotics|narcotics|mesh-ancestor
101794450|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794451|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794452|NCT04083209|Analgesics|analgesics|mesh-ancestor
101794453|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
101794454|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794455|NCT00864968|Nabumetone|nabumetone|mesh-list
101794456|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101794457|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101794458|NCT00864968|Analgesics|analgesics|mesh-ancestor
101794459|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
101543791|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
101543793|NCT01641458|Fluorouracil|fluorouracil|mesh-list
101543794|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101543795|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
101543801|NCT01641536|Entecavir|entecavir|mesh-list
101794460|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794461|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794462|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794463|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794464|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101794465|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101794466|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794467|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794468|NCT00876044|Aflibercept|aflibercept|mesh-list
101794469|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101794470|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101794471|NCT00876044|Growth Substances|growth substances|mesh-ancestor
101794472|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794473|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
101794474|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794476|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794477|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794478|NCT00871208|Retapamulin|retapamulin|mesh-list
101794479|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
101794480|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101794481|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101794482|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101794483|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
101794484|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794485|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794486|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543819|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101794487|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543820|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543821|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543822|NCT02754011|Capecitabine|capecitabine|mesh-list
101543823|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101543824|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
101543825|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543826|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543827|NCT02755844|Metformin|metformin|mesh-list
101543828|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
101543829|NCT02755844|Olaparib|olaparib|mesh-list
101543830|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543831|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
101543832|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543833|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543834|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543835|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
101543836|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543837|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794488|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101794489|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101794490|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101794491|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794492|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794493|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794494|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794495|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101794496|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794497|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794498|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
101794499|NCT00866450|Calcium|calcium|mesh-list
101794500|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101794501|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794502|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101794503|NCT03894969|Vaccines|vaccines|mesh-list
101794504|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
101794505|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794506|NCT00876434|Sirolimus|sirolimus|mesh-list
101794507|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794508|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794509|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794510|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794511|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
101794512|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794513|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
101794514|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794515|NCT00871442|Fentanyl|fentanyl|mesh-list
101794516|NCT00871442|Bupivacaine|bupivacaine|mesh-list
101794517|NCT00871442|Anesthetics|anesthetics|mesh-list
101794518|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
101794519|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794520|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543838|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101543839|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543840|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101543841|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543842|NCT01601106|Prednisolone|prednisolone|mesh-list
101543843|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543844|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
101543859|NCT01601184|Temozolomide|temozolomide|mesh-list
101543860|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543861|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
101543862|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543863|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415269|NCT01245166|Acarbose|acarbose|mesh-list
101415270|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415271|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415272|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101415273|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415274|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415275|NCT00146601|Fulvestrant|fulvestrant|mesh-list
101794521|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
101794522|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794523|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101794525|NCT00871442|Analgesics|analgesics|mesh-ancestor
101794526|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101794527|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101794528|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
101794529|NCT05355597|Clonidine|clonidine|mesh-list
101794530|NCT05355597|Epinephrine|epinephrine|mesh-list
101794531|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101794532|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101794533|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794534|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794535|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794536|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794537|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101794538|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101794539|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
101794540|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794541|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101794542|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794543|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
101794544|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
101794545|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101794547|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
101794548|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101794549|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
101794550|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101794551|NCT00866528|Paclitaxel|paclitaxel|mesh-list
101794552|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101794553|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794554|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
101794555|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
101794556|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
101794557|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794558|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101794559|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
101794560|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794561|NCT00992667|Acetovanillone|acetovanillone|mesh-list
101794562|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101794563|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101794564|NCT00992667|Analgesics|analgesics|mesh-ancestor
101794565|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
101794566|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794567|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794568|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794569|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794570|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
101794571|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794572|NCT00992667|Protective Agents|protective agents|mesh-ancestor
101794573|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794574|NCT05171972|Ofatumumab|ofatumumab|mesh-list
101794575|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794576|NCT00992823|Iron|iron|mesh-list
101794577|NCT00992823|Trace Elements|trace elements|mesh-ancestor
101794578|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
101794579|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794580|NCT03894813|Metronidazole|metronidazole|mesh-list
101794581|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794582|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794583|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101794584|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101794585|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
101415276|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415277|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415278|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101543864|NCT01643759|Buprenorphine|buprenorphine|mesh-list
101543865|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101543866|NCT01643759|Narcotics|narcotics|mesh-ancestor
101794586|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101794587|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
101794588|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794589|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794590|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101794591|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794592|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
101794593|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101794594|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794595|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794596|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794597|NCT00876824|Amphotericin B|amphotericin b|mesh-list
101794598|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101794599|NCT00876824|Amebicides|amebicides|mesh-ancestor
101794600|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101794601|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101794602|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794603|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794604|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
101794605|NCT00866684|Cyclosporine|cyclosporine|mesh-list
101794606|NCT00866684|Sirolimus|sirolimus|mesh-list
101794607|NCT00866684|Azathioprine|azathioprine|mesh-list
101794608|NCT00866684|Tacrolimus|tacrolimus|mesh-list
101794609|NCT00866684|Cyclosporins|cyclosporins|mesh-list
101794610|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794611|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
101794612|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794613|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101794614|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794615|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794616|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
101794617|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794618|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794619|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794620|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794621|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794622|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101794623|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
101794624|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794626|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794627|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794628|NCT00866762|Vorinostat|vorinostat|mesh-list
101794629|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101794630|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794631|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794632|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794633|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
101794634|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101794635|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
101794636|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794637|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794638|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794639|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
101794640|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794641|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
101794642|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101794643|NCT00876902|Protective Agents|protective agents|mesh-ancestor
101794644|NCT00993135|Methotrexate|methotrexate|mesh-list
101794645|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101794646|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
101794647|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101794648|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794649|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794650|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
101794651|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543873|NCT04488237|Vitamin D|vitamin d|mesh-list
101794652|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794653|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794654|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794655|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101794656|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794657|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
101794658|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794659|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101794660|NCT00866996|Methylphenidate|methylphenidate|mesh-list
101794661|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101794662|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101794663|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794664|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101794665|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101794666|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101310507|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794667|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794668|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
101794669|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794670|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101794671|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794672|NCT00871910|Dexamethasone|dexamethasone|mesh-list
101794673|NCT00871910|Ondansetron|ondansetron|mesh-list
101794675|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794676|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
101794677|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
101794678|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794679|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794680|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101794681|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
101794682|NCT00871910|Hormones|hormones|mesh-ancestor
101794683|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794684|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101794685|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794686|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
101794687|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794688|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101794689|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101794690|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
101794691|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794692|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794693|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101794694|NCT05355441|Analgesics|analgesics|mesh-list
101794695|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
101794696|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794697|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794698|NCT01564329|Endostar protein|endostar protein|mesh-list
101794699|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101794700|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101794701|NCT01564329|Growth Substances|growth substances|mesh-ancestor
101794702|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794703|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
101794704|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794705|NCT05213481|Tepotinib|tepotinib|mesh-list
101794706|NCT05213481|Carbamazepine|carbamazepine|mesh-list
101794707|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
101794708|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
101794709|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101794710|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794711|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794712|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794713|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101794714|NCT05213481|Analgesics|analgesics|mesh-ancestor
101794715|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
101794716|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794717|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101794718|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794719|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794720|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101543879|NCT04528628|Serotonin|serotonin|mesh-list
101794721|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101794723|NCT00993525|Ranibizumab|ranibizumab|mesh-list
101794724|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101794725|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101794726|NCT00993525|Growth Substances|growth substances|mesh-ancestor
101794727|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794728|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
101794729|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794730|NCT00993681|Vaccines|vaccines|mesh-list
101794731|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
101794732|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794733|NCT03892707|Folic Acid|folic acid|mesh-list
101794734|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
101794735|NCT03892707|Celecoxib|celecoxib|mesh-list
101794736|NCT03892707|Etoricoxib|etoricoxib|mesh-list
101794737|NCT03892707|Meloxicam|meloxicam|mesh-list
101794738|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101794739|NCT03892707|Nimesulide|nimesulide|mesh-list
101794740|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101794741|NCT03892707|Benphothiamine|benphothiamine|mesh-list
101794742|NCT03892707|Vitamins|vitamins|mesh-ancestor
101794743|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
101794744|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794745|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101794746|NCT03892707|Analgesics|analgesics|mesh-ancestor
101794747|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
101794748|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794749|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794750|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101794751|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101794752|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794753|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794754|NCT03892707|Hematinics|hematinics|mesh-ancestor
101794755|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101794756|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
101794757|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
101794758|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
101794759|NCT00513604|Aldesleukin|aldesleukin|mesh-list
101794760|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
101794762|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
101794763|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794764|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
101794765|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794766|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794767|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101794768|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
101794769|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452124|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
101794770|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794771|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101794772|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794773|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
101794774|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101794775|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101794776|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
101794777|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794779|NCT00872144|Analgesics|analgesics|mesh-ancestor
101794780|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
101794781|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310541|NCT00005941|Cyclosporine|cyclosporine|mesh-list
101794782|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794784|NCT00867152|Lopinavir|lopinavir|mesh-list
101794785|NCT00867152|Darunavir|darunavir|mesh-list
101794786|NCT00867152|Dolutegravir|dolutegravir|mesh-list
101794787|NCT00867152|Etravirine|etravirine|mesh-list
101794788|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101794789|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101794790|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101794791|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794792|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794793|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101794794|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101794795|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
101543883|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101794796|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794797|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101794798|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101794799|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101794800|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101794801|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101794802|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101794803|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101794804|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
101794805|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794806|NCT00872378|Exenatide|exenatide|mesh-list
101794807|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794808|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794809|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101794810|NCT00872378|Incretins|incretins|mesh-ancestor
101794811|NCT00872378|Hormones|hormones|mesh-ancestor
101794812|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794813|NCT00994071|Temozolomide|temozolomide|mesh-list
101794814|NCT00994071|Veliparib|veliparib|mesh-list
101543957|NCT01644071|Dexetimide|dexetimide|mesh-list
101794815|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101794816|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
101794817|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794818|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794819|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101794820|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794821|NCT00994149|Diazoxide|diazoxide|mesh-list
101794822|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101794823|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
101794824|NCT00573248|Nicotine|nicotine|mesh-list
101794825|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101794826|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
101794827|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794828|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794829|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101794830|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101794831|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
101794832|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794833|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794835|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
101794836|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794837|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
101794838|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101794839|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
101794840|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794841|NCT00994305|Expectorants|expectorants|mesh-ancestor
101794842|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
101794843|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101794844|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
101794845|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794846|NCT00994305|Protective Agents|protective agents|mesh-ancestor
101794847|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452203|NCT00197249|Vaccines|vaccines|mesh-list
101794848|NCT00994305|Antidotes|antidotes|mesh-ancestor
101794849|NCT00877760|Interferons|interferons|mesh-list
101794850|NCT00877760|Entecavir|entecavir|mesh-list
101794851|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794852|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
101794853|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794855|NCT04083911|Decitabine|decitabine|mesh-list
101794856|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
101794857|NCT04083911|Aclarubicin|aclarubicin|mesh-list
101794858|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101794859|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
101794860|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794861|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794862|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
101794863|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794864|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794865|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
101794866|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794867|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794868|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415379|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794869|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101794870|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101794871|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101794872|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101794873|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
101794874|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101794875|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101794876|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
101794877|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794878|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101794879|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101794880|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544730|NCT01649336|Paclitaxel|paclitaxel|mesh-list
101794881|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794883|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101794884|NCT00994383|Narcotics|narcotics|mesh-ancestor
101544792|NCT01580163|Methadone|methadone|mesh-list
101794885|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794886|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794887|NCT00994383|Analgesics|analgesics|mesh-ancestor
101794888|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
101794889|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794890|NCT02588417|Dexamethasone|dexamethasone|mesh-list
101794891|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
101794892|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101794893|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
101794894|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
101794895|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794896|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794898|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
101794899|NCT02588417|Hormones|hormones|mesh-ancestor
101794900|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794901|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101794902|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794903|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
101544864|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794904|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
101794905|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794906|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
101794907|NCT00532935|Metformin|metformin|mesh-list
101794908|NCT00532935|Pioglitazone|pioglitazone|mesh-list
101794909|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101794910|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101794911|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794913|NCT00532935|Hormones|hormones|mesh-ancestor
101794914|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101794915|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101794916|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
101794917|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794918|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794919|NCT00994539|Morphine|morphine|mesh-list
101452276|NCT00208923|Fludarabine|fludarabine|mesh-list
101794920|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101794921|NCT00994539|Narcotics|narcotics|mesh-ancestor
101794922|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101794923|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794925|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
101794926|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101794927|NCT00878306|Ritonavir|ritonavir|mesh-list
101794928|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101794929|NCT00878306|Efavirenz|efavirenz|mesh-list
101794930|NCT00878306|Disulfiram|disulfiram|mesh-list
101794931|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101794932|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101794933|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
101794934|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794935|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794936|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101794937|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101794938|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
101794939|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794940|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101794941|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101794942|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101794943|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101794944|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101794945|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101794946|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101794947|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101794948|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101794949|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101794950|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101794952|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101545284|NCT04055142|Cidofovir|cidofovir|mesh-list
101794953|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101794954|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101794955|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101794956|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101545324|NCT01689896|Testosterone|testosterone|mesh-list
101794957|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794958|NCT00994617|Diuretics|diuretics|mesh-ancestor
101794960|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794961|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101794962|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794963|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
101794964|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101794965|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101794966|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
101794967|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
101794968|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101794969|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537221|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
101794970|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794971|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
101794972|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794973|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101794974|NCT00919451|Cyclosporine|cyclosporine|mesh-list
101794975|NCT00919451|Cyclosporins|cyclosporins|mesh-list
101794976|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101794977|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794978|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101794979|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
101794980|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101794981|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
101794982|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101794983|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101794984|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101794985|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101794986|NCT03016312|Atezolizumab|atezolizumab|mesh-list
101794987|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101794988|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794989|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101794990|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101794991|NCT05059223|Reboxetine|reboxetine|mesh-list
101794992|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
101794993|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101794994|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101794995|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101452353|NCT00227409|Calcium|calcium|mesh-list
101794996|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101794997|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101794998|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
101794999|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795000|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795001|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101795002|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
101795003|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795004|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101795005|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101795006|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795007|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795009|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101795010|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
101795011|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795012|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101795013|NCT01014052|Protective Agents|protective agents|mesh-ancestor
101795014|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795015|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
101795016|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795017|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795018|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795019|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795020|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
101795021|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101795022|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101795023|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101795024|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795025|NCT01015300|Bevacizumab|bevacizumab|mesh-list
101795026|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795027|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795028|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101795029|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101795030|NCT01015300|Growth Substances|growth substances|mesh-ancestor
101795031|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795032|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
101795033|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
101795034|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
101795035|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795036|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
101795037|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795038|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101795039|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101795040|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
101795041|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795042|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795043|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101795044|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101795045|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101795046|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
101795047|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101795048|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795049|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795050|NCT02589041|Ropivacaine|ropivacaine|mesh-list
101795051|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
101795052|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
101795053|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795054|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795055|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
101795056|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795057|NCT00492232|Zolpidem|zolpidem|mesh-list
101795058|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101795059|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101795060|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795061|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795062|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101795063|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
101795064|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
101795065|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795066|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795067|NCT02587871|Cytarabine|cytarabine|mesh-list
101795068|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101795069|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
101795070|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795071|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795072|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
101795073|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795074|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795075|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
101795076|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795077|NCT00919919|Progesterone|progesterone|mesh-list
101795078|NCT00919919|Progestins|progestins|mesh-ancestor
101795080|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795081|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795082|NCT00491764|Posaconazole|posaconazole|mesh-list
101795083|NCT00491764|Terbinafine|terbinafine|mesh-list
101795084|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
101795085|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795086|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101795087|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101795088|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101795089|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101795090|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101795092|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795093|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101795094|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101795095|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795096|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795097|NCT02586311|Amlodipine|amlodipine|mesh-list
101795098|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101795099|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101545595|NCT04828226|Analgesics|analgesics|mesh-ancestor
101795101|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795102|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101795103|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795104|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101795105|NCT05557721|Lidocaine|lidocaine|mesh-list
101795106|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
101795107|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
101795108|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795109|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795110|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
101795111|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795112|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101795113|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101795114|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101795115|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795116|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795117|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101795118|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
101795119|NCT00615836|Coagulants|coagulants|mesh-ancestor
101795120|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101795121|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
101795122|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795123|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
101795124|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101795125|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795126|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795127|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101795128|NCT05139212|Analgesics|analgesics|mesh-ancestor
101795129|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
101795130|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795131|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101795132|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101795133|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101795134|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101795135|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795136|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795138|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101795139|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101795140|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101795141|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
101795142|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795143|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795144|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795145|NCT00878540|Mirtazapine|mirtazapine|mesh-list
101795146|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
101795147|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795148|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101795149|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
101795150|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
101795151|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795152|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795153|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795154|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101795155|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101795156|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795157|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101795158|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101795159|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101795160|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101795161|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101795162|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101795163|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
101795164|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101795165|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
101795166|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101795167|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
101795168|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
101795169|NCT04018274|Estradiol|estradiol|mesh-list
101795170|NCT04018274|Estrogens|estrogens|mesh-ancestor
101795171|NCT04018274|Hormones|hormones|mesh-ancestor
101795172|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795173|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795174|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101795175|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795176|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101795177|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101795178|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101795179|NCT00873002|Sorafenib|sorafenib|mesh-list
101795180|NCT00873002|Panobinostat|panobinostat|mesh-list
101795181|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795182|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795183|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795184|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795185|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101795186|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
101795187|NCT00491530|Atorvastatin|atorvastatin|mesh-list
101795188|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101795189|NCT00491530|Simvastatin|simvastatin|mesh-list
101795190|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
101795191|NCT00491530|Calcium|calcium|mesh-list
101795192|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101795193|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795194|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101795195|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101795196|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101795197|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
101795198|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795199|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101795200|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101795201|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795202|NCT00617240|Metformin|metformin|mesh-list
101795203|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101795204|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795205|NCT00615290|Tipranavir|tipranavir|mesh-list
101795206|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101795207|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101795208|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
101795209|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795210|NCT02587169|Doxorubicin|doxorubicin|mesh-list
101795211|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101795212|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101795213|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795214|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101795215|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101795216|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795217|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795218|NCT00873236|Interferons|interferons|mesh-list
101795219|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
101795220|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
101795221|NCT00873236|Bevacizumab|bevacizumab|mesh-list
101795222|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795223|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795224|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101795225|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101795226|NCT00873236|Growth Substances|growth substances|mesh-ancestor
101795227|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795228|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101795229|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
101795230|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795231|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
101795232|NCT00868010|Donepezil|donepezil|mesh-list
101795233|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101795234|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795235|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795236|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
101795237|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795238|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795239|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
101795240|NCT05683301|Amlodipine|amlodipine|mesh-list
101795241|NCT05683301|Perindopril|perindopril|mesh-list
101795242|NCT05683301|Indapamide|indapamide|mesh-list
101795243|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
101795244|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101795245|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101795246|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795247|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795248|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101795249|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795250|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
101795251|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101795252|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
101795253|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795254|NCT05683301|Diuretics|diuretics|mesh-ancestor
101795255|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
101795256|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101795257|NCT04770623|Docetaxel|docetaxel|mesh-list
101795258|NCT04770623|Irinotecan|irinotecan|mesh-list
101795259|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795260|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795261|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795262|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
101795263|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795264|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101795265|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101795266|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795267|NCT05653661|Paclitaxel|paclitaxel|mesh-list
101795268|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101795269|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101795270|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795271|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795272|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795273|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
101795274|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795275|NCT00873392|Nicotine|nicotine|mesh-list
101795276|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101795277|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
101795278|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795279|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795280|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101795281|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101795282|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
101795283|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795284|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795285|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
101795286|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101795287|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101795288|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795289|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101795290|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101795291|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795292|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795293|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795294|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101795295|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
101795296|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795297|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795298|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101795299|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101795300|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101795301|NCT04658147|Nivolumab|nivolumab|mesh-list
101795302|NCT04658147|Relatlimab|relatlimab|mesh-list
101795303|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795304|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795305|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101795306|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795307|NCT00879164|Bupivacaine|bupivacaine|mesh-list
101795308|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
101795309|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
101795310|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795311|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795312|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
101795313|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795314|NCT04731155|Alirocumab|alirocumab|mesh-list
101795315|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101795316|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101795317|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101795318|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
101795319|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795320|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101795321|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
101795322|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795323|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101795324|NCT04729049|Morphine|morphine|mesh-list
101795325|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101795326|NCT04729049|Narcotics|narcotics|mesh-ancestor
101795327|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795328|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795329|NCT04729049|Analgesics|analgesics|mesh-ancestor
101795330|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
101795331|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795332|NCT02585765|Pioglitazone|pioglitazone|mesh-list
101795333|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101795334|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795335|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
101795336|NCT04634669|Bupropion|bupropion|mesh-list
101795337|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101795338|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
101795339|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795340|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101795341|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101795342|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795343|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795344|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
101795345|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795346|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795347|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101795348|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101795349|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795350|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
101795351|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
101795352|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101795353|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101795354|NCT02585531|Dexamethasone|dexamethasone|mesh-list
101795355|NCT02585531|Epinephrine|epinephrine|mesh-list
101795356|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795357|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
101795358|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
101795359|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795360|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795361|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795362|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
101795363|NCT02585531|Hormones|hormones|mesh-ancestor
101795364|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795365|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101795366|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795367|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101795368|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101795369|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
101795370|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795371|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795372|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101795373|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101795374|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101795375|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
101795376|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
101795377|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
101795378|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101795379|NCT00920153|Cytarabine|cytarabine|mesh-list
101795380|NCT00920153|Dexamethasone|dexamethasone|mesh-list
101795381|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
101795382|NCT00920153|Gemcitabine|gemcitabine|mesh-list
101795383|NCT00920153|Doxorubicin|doxorubicin|mesh-list
101795384|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101795385|NCT00920153|Etoposide|etoposide|mesh-list
101795386|NCT00920153|Vincristine|vincristine|mesh-list
101795387|NCT00920153|Melphalan|melphalan|mesh-list
101795388|NCT00920153|Vinorelbine|vinorelbine|mesh-list
101795389|NCT00920153|Ifosfamide|ifosfamide|mesh-list
101795390|NCT00920153|Dacarbazine|dacarbazine|mesh-list
101795391|NCT00920153|Carmustine|carmustine|mesh-list
101795392|NCT00920153|Bleomycin|bleomycin|mesh-list
101795393|NCT00920153|Vindesine|vindesine|mesh-list
101795394|NCT00920153|Mitoguazone|mitoguazone|mesh-list
101795395|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795396|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
101795397|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
101795398|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795399|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795400|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795401|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
101795402|NCT00920153|Hormones|hormones|mesh-ancestor
101795403|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795404|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101795405|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795406|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101795407|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
101795408|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795409|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101795410|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101795411|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101795412|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795413|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101795414|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
101795415|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795416|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795417|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
101795418|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795419|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795421|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101795422|NCT00920153|Protective Agents|protective agents|mesh-ancestor
101795423|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101795424|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
101795425|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101795426|NCT04080713|Budesonide|budesonide|mesh-list
101795427|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795428|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101795429|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
101795430|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795431|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795432|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101795433|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
101795434|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
101246499|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101795436|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795438|NCT04081805|Estrogens|estrogens|mesh-ancestor
101795439|NCT04081805|Hormones|hormones|mesh-ancestor
101795440|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795441|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795442|NCT05519189|Ropivacaine|ropivacaine|mesh-list
101795443|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
101795444|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
101795445|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795446|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795447|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
101795448|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795450|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
101795451|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795452|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795453|NCT03930017|Vaccines|vaccines|mesh-list
101795454|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
101795455|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795456|NCT00533949|Paclitaxel|paclitaxel|mesh-list
101795457|NCT00533949|Carboplatin|carboplatin|mesh-list
101795458|NCT00533949|Cetuximab|cetuximab|mesh-list
101795459|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101795460|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795461|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795462|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795463|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
101795464|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795465|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795466|NCT00485134|Vaccines|vaccines|mesh-list
101795467|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
101795468|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795469|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101795470|NCT02585141|Clindamycin|clindamycin|mesh-list
101795471|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
101795472|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
101795473|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795474|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101795475|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795476|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795477|NCT04079231|Aflibercept|aflibercept|mesh-list
101795478|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101795479|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101795480|NCT04079231|Growth Substances|growth substances|mesh-ancestor
101795481|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795482|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
101795483|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795484|NCT00994695|Vaccines|vaccines|mesh-list
101795485|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
101795486|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795487|NCT04521803|Rifampin|rifampin|mesh-list
101795488|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101795489|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
101795490|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101795491|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795492|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
101795493|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101795494|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545641|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101795495|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795496|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101795497|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101795498|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101795499|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101795500|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101795501|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101795503|NCT00920465|Mifepristone|mifepristone|mesh-list
101795504|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101795505|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
101795506|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795507|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795508|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101795509|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795510|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
101795511|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101795512|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101795513|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101795514|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101795515|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
101795516|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101795517|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101452892|NCT00228891|Insulin|insulin|mesh-list
101795518|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
101795519|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795520|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
101795521|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101795522|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101795523|NCT03890367|Vaccines|vaccines|mesh-list
101795524|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
101795525|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795526|NCT00994773|Tenofovir|tenofovir|mesh-list
101795527|NCT00994773|Entecavir|entecavir|mesh-list
101795528|NCT00994773|Simvastatin|simvastatin|mesh-list
101795529|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
101795530|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795531|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101795532|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101795533|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795534|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795535|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101795536|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101795537|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101795538|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101795539|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
101795540|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101795541|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101795542|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
101795543|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101795544|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
101795545|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101795546|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
101795547|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795548|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795549|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
101795550|NCT03084237|Docetaxel|docetaxel|mesh-list
101795551|NCT03084237|Trastuzumab|trastuzumab|mesh-list
101795552|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795553|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795554|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795555|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101545647|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101795556|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795557|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795558|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
101795559|NCT00996021|Dolutegravir|dolutegravir|mesh-list
101795560|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101795561|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101795562|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795563|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101795564|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101795565|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795566|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795567|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795568|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101795569|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
101795570|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795571|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795572|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101795573|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101795574|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101795575|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101795576|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101795577|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101795578|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101795579|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
101795581|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101795582|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101795583|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795584|NCT04515329|Cyclosporine|cyclosporine|mesh-list
101795585|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
101795586|NCT04515329|Cyclosporins|cyclosporins|mesh-list
101795587|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795588|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795589|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795590|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
101795591|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795592|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
101795593|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795594|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
101795595|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101795596|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101795597|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101795598|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101795599|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
101795600|NCT02584751|Omeprazole|omeprazole|mesh-list
101795601|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101795602|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795603|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101795604|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795605|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795606|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101795607|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
101795608|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795609|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795610|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101795611|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
101795612|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101795613|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
101795614|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795615|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101795616|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
101795617|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
101795618|NCT02584751|Protective Agents|protective agents|mesh-ancestor
101795619|NCT00999219|Zolpidem|zolpidem|mesh-list
101795620|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101795621|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101795622|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795623|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795624|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101795625|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
101795626|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
101795627|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795628|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795629|NCT00996177|Fentanyl|fentanyl|mesh-list
101795630|NCT00996177|Morphine|morphine|mesh-list
101795631|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101795632|NCT00996177|Narcotics|narcotics|mesh-ancestor
101795633|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795634|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795635|NCT00996177|Analgesics|analgesics|mesh-ancestor
101795636|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
101795637|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795638|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101795639|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101795640|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
101795641|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
101795643|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101795644|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
101795645|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795646|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795647|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101795648|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101795649|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
101795650|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795651|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795652|NCT00999297|Capsaicin|capsaicin|mesh-list
101795653|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
101795654|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
101795655|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
101795656|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795657|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795658|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
101795659|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795660|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795661|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795662|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795663|NCT05371223|Gemcitabine|gemcitabine|mesh-list
101795664|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101795665|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101795666|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
101795667|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795668|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795669|NCT00532779|Naltrexone|naltrexone|mesh-list
101795670|NCT00532779|Bupropion|bupropion|mesh-list
101795671|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101795672|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101795673|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795674|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
101795675|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795676|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101795677|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
101795678|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795679|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101795680|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101795681|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795682|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795683|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
101795684|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795685|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101795686|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101795687|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795688|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101795689|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
101795690|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795691|NCT00996411|Salvinorin A|salvinorin a|mesh-list
101795692|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
101795693|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795694|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795696|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795697|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795698|NCT04120805|Hemostatics|hemostatics|mesh-list
101795699|NCT04120805|Coagulants|coagulants|mesh-ancestor
101795700|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
101795701|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795702|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795703|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101795704|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795705|NCT00500110|Docetaxel|docetaxel|mesh-list
101795706|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
101795707|NCT00500110|Leuprolide|leuprolide|mesh-list
101795708|NCT00500110|Goserelin|goserelin|mesh-list
101795709|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795710|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795711|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795712|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101795713|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795714|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795715|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795716|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101795717|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
101795718|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795719|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795720|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101795721|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
101795722|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795723|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795724|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101795725|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795726|NCT05304533|Itraconazole|itraconazole|mesh-list
101795727|NCT05304533|Verapamil|verapamil|mesh-list
101795728|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
101795729|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795730|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101795731|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101795732|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795733|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795734|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101795735|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
101795736|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795737|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795738|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101795739|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101795740|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101795741|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795742|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101795743|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
101795745|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795746|NCT04077827|Propofol|propofol|mesh-list
101795747|NCT04077827|Desflurane|desflurane|mesh-list
101795748|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101795749|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795750|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795751|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101795752|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
101795753|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
101795754|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101795755|NCT00996723|Dasatinib|dasatinib|mesh-list
101795756|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795757|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795758|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795759|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795760|NCT05332587|Rituximab|rituximab|mesh-list
101795761|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795762|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795763|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
101795764|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795765|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101795766|NCT00996879|Midazolam|midazolam|mesh-list
101795767|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101795768|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101795769|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795770|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795771|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101795772|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101795773|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101795774|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101795775|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
101795776|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
101795777|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
101795778|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
101795779|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795780|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795782|NCT02582177|Clotrimazole|clotrimazole|mesh-list
101795783|NCT02582177|Miconazole|miconazole|mesh-list
101795784|NCT02582177|Dexamethasone|dexamethasone|mesh-list
101795785|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
101795786|NCT02582177|Betamethasone|betamethasone|mesh-list
101795787|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
101795788|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101795790|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101795791|NCT02582177|BB 1101|bb 1101|mesh-list
101795792|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795793|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
101795794|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
101795795|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795796|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795797|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795798|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
101795799|NCT02582177|Hormones|hormones|mesh-ancestor
101795800|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795801|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101795802|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795803|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
101795804|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795805|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795806|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101795807|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
101795808|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
101795809|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795810|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101795811|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101795812|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101795813|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
101795814|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101795815|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101795816|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101795817|NCT02626715|Vidarabine|vidarabine|mesh-list
101795818|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
101795819|NCT02626715|Fludarabine|fludarabine|mesh-list
101795820|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
101795821|NCT02626715|Thiotepa|thiotepa|mesh-list
101795822|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101795823|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
101795824|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795825|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795826|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101795827|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
101795828|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795829|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
101795830|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795831|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795832|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101795833|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
101795834|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101795835|NCT05325177|Ibuprofen|ibuprofen|mesh-list
101795836|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101795837|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101795838|NCT05325177|Analgesics|analgesics|mesh-ancestor
101795839|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
101795840|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795841|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795842|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795843|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101795844|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101795845|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795846|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795847|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101795848|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
101795849|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101795850|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101795851|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101795852|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795853|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795854|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
101795855|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795856|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795857|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101795858|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795859|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101795860|NCT00997191|Triamcinolone|triamcinolone|mesh-list
101795861|NCT00997191|Bevacizumab|bevacizumab|mesh-list
101795862|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101795863|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795864|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101795865|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101795866|NCT00997191|Growth Substances|growth substances|mesh-ancestor
101795867|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795868|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
101795869|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795870|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
101795871|NCT00997191|Hormones|hormones|mesh-ancestor
101795872|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795873|NCT00997269|Ubiquinone|ubiquinone|mesh-list
101795874|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
101795875|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
101795876|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795877|NCT00997269|Vitamins|vitamins|mesh-ancestor
101795878|NCT02582099|Gentamicins|gentamicins|mesh-list
101795879|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101795880|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101795881|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101795882|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795883|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795885|NCT00997347|Mifepristone|mifepristone|mesh-list
101795886|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101795887|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
101795888|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795889|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795890|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101795891|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795892|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
101795893|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101795894|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101795895|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101795896|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101795897|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
101795898|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101795899|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101795900|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
101795901|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795902|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
101795903|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101795904|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101795905|NCT00997581|Apremilast|apremilast|mesh-list
101795906|NCT00997581|Indomethacin|indomethacin|mesh-list
101795907|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101795908|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101795909|NCT00997581|Analgesics|analgesics|mesh-ancestor
101795910|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
101795911|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795912|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795913|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795914|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101795915|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101795916|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101795917|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795918|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795919|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
101795920|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
101795921|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101795922|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101795923|NCT05183139|Dexamethasone|dexamethasone|mesh-list
101795924|NCT05183139|Lenalidomide|lenalidomide|mesh-list
101795925|NCT05183139|Pomalidomide|pomalidomide|mesh-list
101795926|NCT05183139|Ixazomib|ixazomib|mesh-list
101795927|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101795928|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
101795929|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
101795930|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795931|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795932|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101795934|NCT05183139|Hormones|hormones|mesh-ancestor
101795935|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101795936|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101795937|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795938|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
101795939|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101795940|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101795941|NCT05183139|Growth Substances|growth substances|mesh-ancestor
101795942|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
101795943|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
101795944|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795945|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795946|NCT00999843|Sorafenib|sorafenib|mesh-list
101795947|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795948|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101795949|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101795950|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795951|NCT00997659|Chromium|chromium|mesh-list
101795952|NCT00997659|Picolinic acid|picolinic acid|mesh-list
101795953|NCT00997659|Trace Elements|trace elements|mesh-ancestor
101795954|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
101795955|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795956|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101795957|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
101795958|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
101795959|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795960|NCT03827213|Bupivacaine|bupivacaine|mesh-list
101795961|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
101795962|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
101795963|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101795964|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453331|NCT00206492|Tamoxifen|tamoxifen|mesh-list
101795965|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
101795966|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795968|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101795969|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101795970|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101795971|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101795972|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795973|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
101795974|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101795975|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101795976|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101795977|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101795978|NCT04077983|Paclitaxel|paclitaxel|mesh-list
101795979|NCT04077983|Gemcitabine|gemcitabine|mesh-list
101795980|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101795981|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101795982|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
101795983|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
101795984|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
101795985|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795986|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101795987|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
101795988|NCT03822845|Edetic Acid|edetic acid|mesh-list
101795989|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101795990|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
101795991|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
101795992|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101795993|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
101795994|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101795995|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101795996|NCT01000233|Inositol|inositol|mesh-list
101795997|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
101795998|NCT01000233|Vitamins|vitamins|mesh-ancestor
101795999|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
101796000|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796001|NCT04075955|Olanzapine|olanzapine|mesh-list
101796002|NCT04075955|Aprepitant|aprepitant|mesh-list
101796003|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
101796004|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
101796005|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796006|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796007|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796008|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101796009|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101796010|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796011|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796012|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101796013|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101796014|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796015|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796016|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796017|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
101796018|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101796019|NCT00484198|Pioglitazone|pioglitazone|mesh-list
101796020|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101796021|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796022|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
101796023|NCT04077905|Doxorubicin|doxorubicin|mesh-list
101796024|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101796025|NCT04077905|Etoposide|etoposide|mesh-list
101796026|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101796027|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796028|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101796029|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101796030|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796031|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796032|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796033|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101796034|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
101796035|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
101796036|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796037|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796038|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101796039|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
101796040|NCT04077905|Hormones|hormones|mesh-ancestor
101453405|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
101796041|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101796042|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101796043|NCT04077905|Protective Agents|protective agents|mesh-ancestor
101796045|NCT04282187|Decitabine|decitabine|mesh-list
101796046|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101796047|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101796048|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
101796049|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796050|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796051|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796052|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101796053|NCT04471246|Cephalexin|cephalexin|mesh-list
101796054|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796055|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796056|NCT04276259|Naltrexone|naltrexone|mesh-list
101796057|NCT04276259|Buprenorphine|buprenorphine|mesh-list
101796058|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101796059|NCT04276259|Narcotics|narcotics|mesh-ancestor
101796060|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796061|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796062|NCT04276259|Analgesics|analgesics|mesh-ancestor
101796063|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
101796064|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796065|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101796066|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101796067|NCT00499486|Sirolimus|sirolimus|mesh-list
101796068|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796069|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796070|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101796071|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796072|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
101796073|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796074|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
101796075|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796076|NCT01019278|Cisplatin|cisplatin|mesh-list
101796077|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796078|NCT01014520|Gabapentin|gabapentin|mesh-list
101796080|NCT01014520|Analgesics|analgesics|mesh-ancestor
101796081|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
101796082|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101796083|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796084|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
101796085|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101796086|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101796087|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101796088|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101796089|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101796090|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101796091|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101796092|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796093|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
101796094|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101796095|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
101796096|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101796097|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101796098|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101796099|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101796100|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
101796101|NCT01016002|Temoporfin|temoporfin|mesh-list
101796102|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796103|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101796104|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101796105|NCT01019434|Sirolimus|sirolimus|mesh-list
101796106|NCT01019434|Temozolomide|temozolomide|mesh-list
101796107|NCT01019434|Temsirolimus|temsirolimus|mesh-list
101796108|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
101796109|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101796110|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
101796111|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101796112|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796113|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101796114|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101796115|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101796116|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
101796117|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101796118|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101796119|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101796120|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101796121|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
101796122|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101796123|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101796124|NCT00499252|Paclitaxel|paclitaxel|mesh-list
101796125|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101796126|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101796127|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101796128|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101796129|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101796130|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248625|NCT04505878|Protective Agents|protective agents|mesh-ancestor
101248627|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
101248628|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248629|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248630|NCT04404881|Bevacizumab|bevacizumab|mesh-list
101248631|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101537225|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
101248632|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248633|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101248634|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101248635|NCT04404881|Growth Substances|growth substances|mesh-ancestor
101248636|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248637|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248638|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
101248639|NCT04370509|Axitinib|axitinib|mesh-list
101248640|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248641|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248642|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248643|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248644|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248645|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248646|NCT04335058|Iron|iron|mesh-list
101248647|NCT04335058|Lactoferrin|lactoferrin|mesh-list
101248648|NCT04335058|Trace Elements|trace elements|mesh-ancestor
101248649|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
101323498|NCT00390390|Lansoprazole|lansoprazole|mesh-list
101248650|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248651|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248652|NCT04319224|Nivolumab|nivolumab|mesh-list
101248653|NCT04319224|Ipilimumab|ipilimumab|mesh-list
101248654|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248655|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248656|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248657|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248658|NCT04280562|Acetaminophen|acetaminophen|mesh-list
101248659|NCT04280562|Analgesics|analgesics|mesh-list
101248660|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248661|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
101248662|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248663|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248664|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
101248665|NCT04257448|Paclitaxel|paclitaxel|mesh-list
101248666|NCT04257448|Gemcitabine|gemcitabine|mesh-list
101248667|NCT04257448|Lenalidomide|lenalidomide|mesh-list
101248668|NCT04257448|Azacitidine|azacitidine|mesh-list
101248669|NCT04257448|Durvalumab|durvalumab|mesh-list
101248670|NCT04257448|Romidepsin|romidepsin|mesh-list
101248671|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101248672|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248673|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248674|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248675|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248676|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248677|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101248679|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
101248680|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248681|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101248682|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101248683|NCT04257448|Growth Substances|growth substances|mesh-ancestor
101248684|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248685|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248686|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248687|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101248688|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101248689|NCT04075136|Triamcinolone|triamcinolone|mesh-list
101248690|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101248691|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101248710|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
101248712|NCT03959566|Bedaquiline|bedaquiline|mesh-list
101248713|NCT03959566|Midazolam|midazolam|mesh-list
101248714|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101248715|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101248716|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248717|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248718|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101248719|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101248720|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248721|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248722|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
101248723|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
101248724|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
101248725|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
101248726|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248727|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248728|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248729|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248730|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101248731|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101248732|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248733|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248734|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
101248735|NCT03909529|Digoxin|digoxin|mesh-list
101248736|NCT03909529|Spironolactone|spironolactone|mesh-list
101248737|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101248738|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
101248739|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248740|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248741|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101248742|NCT03909529|Diuretics|diuretics|mesh-ancestor
101248743|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
101248744|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101248745|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101248746|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248747|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248757|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248758|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248759|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248760|NCT03380546|Insulin|insulin|mesh-list
101248761|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101248762|NCT03380546|Acarbose|acarbose|mesh-list
101248763|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
101248764|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248765|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248766|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101248767|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248768|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415558|NCT00500344|Ranibizumab|ranibizumab|mesh-list
101415559|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101415560|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101415561|NCT00500344|Growth Substances|growth substances|mesh-ancestor
101415562|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415563|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
101415564|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248769|NCT03318094|Nitroprusside|nitroprusside|mesh-list
101248770|NCT03318094|Phentolamine|phentolamine|mesh-list
101248771|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101248772|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
101248773|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101248774|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
101248775|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101248776|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248777|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
101248778|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248779|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248780|NCT03268499|Cisplatin|cisplatin|mesh-list
101248781|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248782|NCT03250624|Ivermectin|ivermectin|mesh-list
101248783|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101248784|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248785|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
101248786|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101248787|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101248788|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101248789|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101248790|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248791|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101248792|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101248793|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101248794|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248796|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248797|NCT03122717|Gefitinib|gefitinib|mesh-list
101248798|NCT03122717|Osimertinib|osimertinib|mesh-list
101248799|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248800|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248801|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248802|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248804|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248805|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
101248806|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248807|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
101248808|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248809|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248810|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101248811|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101248812|NCT03069326|Growth Substances|growth substances|mesh-ancestor
101248813|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248814|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211959|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101248815|NCT03015740|Nivolumab|nivolumab|mesh-list
101248821|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248822|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248823|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248824|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415568|NCT01245868|Lidocaine|lidocaine|mesh-list
101415569|NCT01245868|Bupivacaine|bupivacaine|mesh-list
101248875|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248876|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248878|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248879|NCT01930955|Amoxicillin|amoxicillin|mesh-list
101248880|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248881|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248882|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
101248883|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
101248884|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101248885|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248886|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248894|NCT02066636|Nivolumab|nivolumab|mesh-list
101248895|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248896|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248897|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248898|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248899|NCT02036086|Vemurafenib|vemurafenib|mesh-list
101248900|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545793|NCT04396587|Hydromorphone|hydromorphone|mesh-list
101248901|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248902|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248903|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248904|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
101248905|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101248906|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101248907|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101248908|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101248909|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248910|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
101248911|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323526|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248912|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248913|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101248914|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248916|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
101248917|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248918|NCT01681446|Interferons|interferons|mesh-list
101248919|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
101248920|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248921|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
101248922|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248923|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
101248924|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248925|NCT01681875|Nicotine|nicotine|mesh-list
101248926|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101248927|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
101248928|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248929|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248930|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101248931|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101248932|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
101248933|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248934|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248935|NCT01682577|Perindopril|perindopril|mesh-list
101248936|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101248937|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
101248938|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248939|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248940|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101248941|NCT01683760|Fluconazole|fluconazole|mesh-list
101248942|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
101248943|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248944|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101248945|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101248946|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248947|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248948|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101545796|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545797|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545798|NCT04396587|Analgesics|analgesics|mesh-ancestor
101545803|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
101248949|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
101248950|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248951|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248955|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101248956|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101248957|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101248958|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101248959|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101248960|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
101248961|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248962|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248963|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248965|NCT01684982|Everolimus|everolimus|mesh-list
101248966|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101248967|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248968|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248969|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248970|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248971|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
101248972|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248973|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248974|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248975|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248976|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101248977|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
101248978|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
101248979|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
101248980|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248981|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
101248982|NCT01685489|Docetaxel|docetaxel|mesh-list
101248983|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248984|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248985|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248986|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248987|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248988|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101248989|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
101248990|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248991|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101248992|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
101248993|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248994|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
101248995|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101248996|NCT01685489|Protective Agents|protective agents|mesh-ancestor
101248997|NCT01686386|Dexamethasone|dexamethasone|mesh-list
101248998|NCT01686386|Lenalidomide|lenalidomide|mesh-list
101248999|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101249000|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249001|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
101249002|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
101545817|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545818|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101415570|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
101415571|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
101415572|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415573|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415581|NCT00500422|Gemcitabine|gemcitabine|mesh-list
101249003|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249004|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249005|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249006|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
101249007|NCT01686386|Hormones|hormones|mesh-ancestor
101249008|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249009|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101249010|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249011|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
101249012|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101249013|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101249014|NCT01686386|Growth Substances|growth substances|mesh-ancestor
101249015|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
101249016|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101249017|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
101249018|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249019|NCT01686594|Methoxsalen|methoxsalen|mesh-list
101249020|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101249021|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
101249022|NCT01687517|Vaccines|vaccines|mesh-list
101249023|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
101249029|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249030|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249031|NCT01687751|Analgesics|analgesics|mesh-ancestor
101249032|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
101249033|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249034|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101249035|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101249036|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101249037|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
101249038|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249039|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249040|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101212179|NCT04624945|Thromboplastin|thromboplastin|mesh-list
101249041|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101249042|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101249043|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101249044|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101249045|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
101249046|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
101249047|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
101249048|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
101249049|NCT01688362|Dexamethasone|dexamethasone|mesh-list
101249050|NCT01688362|Bupivacaine|bupivacaine|mesh-list
101249051|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249052|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
101249053|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
101249054|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249055|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249056|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249057|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
101249058|NCT01688362|Hormones|hormones|mesh-ancestor
101249059|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249060|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101249061|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249062|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101249063|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
101249064|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249065|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
101249066|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101249067|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101545819|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101545820|NCT01193257|Prednisone|prednisone|mesh-list
101545821|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545822|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
101545823|NCT01193257|Hormones|hormones|mesh-ancestor
101249068|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249069|NCT01689753|Citric Acid|citric acid|mesh-list
101249070|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
101249071|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
101249072|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101249073|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
101249074|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
101249075|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249076|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
101249077|NCT01690039|Furosemide|furosemide|mesh-list
101249078|NCT01690039|Diuretics|diuretics|mesh-ancestor
101249079|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
101249080|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249081|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101249082|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249083|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249084|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249085|NCT01690091|Metformin|metformin|mesh-list
101249086|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249087|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249088|NCT01690104|Rifampin|rifampin|mesh-list
101249089|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101249090|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
101249091|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101249092|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249093|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
101249098|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101249099|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101249100|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101249101|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101249102|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101249103|NCT01690221|Diltiazem|diltiazem|mesh-list
101249104|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101249105|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101249106|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249107|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249108|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101249109|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249110|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
101249111|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101249112|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
101249113|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249114|NCT01690286|Ketoconazole|ketoconazole|mesh-list
101249115|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
101249116|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249117|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101249118|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101249119|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249120|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249121|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101249122|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249123|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249124|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249125|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101249126|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
101249127|NCT01690325|Bevacizumab|bevacizumab|mesh-list
101249128|NCT01690325|Docetaxel|docetaxel|mesh-list
101545829|NCT02893371|Carbamazepine|carbamazepine|mesh-list
101545830|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
101545831|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101249129|NCT01690325|Trastuzumab|trastuzumab|mesh-list
101249131|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249132|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
101249133|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249134|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249135|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101249136|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
101249137|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249138|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249139|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101249140|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101249141|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101249142|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101249143|NCT01690325|Growth Substances|growth substances|mesh-ancestor
101249144|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
101249145|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249146|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249147|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249148|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101249149|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101249150|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249151|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249152|NCT01690338|Bromides|bromides|mesh-list
101249153|NCT01690338|Rocuronium|rocuronium|mesh-list
101249154|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
101249155|NCT01690338|Cisatracurium|cisatracurium|mesh-list
101249156|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
101249157|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101249158|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101249159|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101249160|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420753|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101249165|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249166|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249167|NCT01690364|Anesthetics|anesthetics|mesh-list
101249168|NCT01690364|Cisatracurium|cisatracurium|mesh-list
101249169|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
101249170|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249171|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249172|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101249173|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101249174|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249175|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101249176|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101249177|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101249178|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
101249179|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249180|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249181|NCT01690403|Rifapentine|rifapentine|mesh-list
101249182|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101249183|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
101249184|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101249185|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249186|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
101249187|NCT01690468|Carboplatin|carboplatin|mesh-list
101545845|NCT02893371|Mirtazapine|mirtazapine|mesh-list
101545846|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
101545847|NCT02893371|Doxepin|doxepin|mesh-list
101545848|NCT02893371|Citalopram|citalopram|mesh-list
101545849|NCT02893371|Bupropion|bupropion|mesh-list
101545850|NCT02893371|Sertraline|sertraline|mesh-list
101545851|NCT02893371|Fluoxetine|fluoxetine|mesh-list
101545852|NCT02893371|Paroxetine|paroxetine|mesh-list
101545853|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101545854|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101545855|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101545856|NCT02893371|Escitalopram|escitalopram|mesh-list
101249188|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249189|NCT01690507|Cytarabine|cytarabine|mesh-list
101249190|NCT01690507|Decitabine|decitabine|mesh-list
101249191|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
101249192|NCT01690507|Lenograstim|lenograstim|mesh-list
101249193|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249194|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
101249195|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249196|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249197|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
101249198|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249199|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249200|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
101249201|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249202|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249203|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101249204|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101249205|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
101249206|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101249207|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101249208|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249209|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101249210|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249211|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249212|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249213|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249214|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101249215|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
101249216|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101249217|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249218|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101249219|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101249220|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101249221|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
101249222|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101249223|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249224|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101249225|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249226|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249227|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249228|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249229|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101249236|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249237|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249238|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249239|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101249240|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
101249241|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249243|NCT01690572|Protective Agents|protective agents|mesh-ancestor
101249244|NCT01690598|Topotecan|topotecan|mesh-list
101249245|NCT01690598|Veliparib|veliparib|mesh-list
101249246|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101249247|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249248|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249249|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249250|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249251|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101249252|NCT01690637|Oseltamivir|oseltamivir|mesh-list
101249253|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
101545857|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101545858|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
101545859|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249254|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249255|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249256|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249257|NCT01690702|Paclitaxel|paclitaxel|mesh-list
101249258|NCT01690702|Docetaxel|docetaxel|mesh-list
101249259|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
101249260|NCT01690702|Epirubicin|epirubicin|mesh-list
101249261|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101249262|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212403|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
101249263|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249264|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249265|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249266|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249267|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249268|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
101249269|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249270|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249271|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101249272|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
101249273|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101249274|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101249275|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101249276|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249277|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249279|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
101249280|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
101249281|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249282|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249283|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
101249284|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249285|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101249286|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101249287|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101249288|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249289|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249290|NCT01690780|Ibuprofen|ibuprofen|mesh-list
101249291|NCT01690780|Morphine|morphine|mesh-list
101249292|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101249293|NCT01690780|Narcotics|narcotics|mesh-ancestor
101249294|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249295|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249296|NCT01690780|Analgesics|analgesics|mesh-ancestor
101249297|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
101249298|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249307|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101249308|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
101249309|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
101249310|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
101249311|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249312|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249313|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249314|NCT01690871|Dactolisib|dactolisib|mesh-list
101249315|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249316|NCT01690884|Adenosine|adenosine|mesh-list
101249317|NCT01690884|Analgesics|analgesics|mesh-ancestor
101249318|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
101249319|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249320|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249321|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101249322|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101249323|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101249324|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
101249325|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
101249326|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545872|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
101415584|NCT00500422|Bortezomib|bortezomib|mesh-list
101415586|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
101249327|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249328|NCT01690962|Vitamins|vitamins|mesh-list
101249329|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
101249330|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
101249331|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
101249332|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
101249333|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249334|NCT01690962|Hematinics|hematinics|mesh-ancestor
101249335|NCT01690975|Benzonatate|benzonatate|mesh-list
101249336|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
101249337|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249338|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
101249339|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249340|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249341|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249342|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249343|NCT01691001|Analgesics|analgesics|mesh-ancestor
101249344|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
101249345|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249346|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101249347|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101249348|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101249349|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
101249350|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249351|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249352|NCT01691053|Spironolactone|spironolactone|mesh-list
101249353|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101249354|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249355|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249356|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249357|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101249358|NCT01691053|Diuretics|diuretics|mesh-ancestor
101249359|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
101249360|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
101249362|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249363|NCT01691365|Vitamins|vitamins|mesh-list
101249379|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249380|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249381|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249382|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101249383|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101249384|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249385|NCT01691469|Montelukast|montelukast|mesh-list
101249386|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101249387|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249388|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101249389|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249390|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249391|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415591|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415592|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415593|NCT01245946|Doxycycline|doxycycline|mesh-list
101545873|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545874|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101545875|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
101545876|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
101545877|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545878|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101249392|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101249393|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101249394|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249396|NCT01691495|Fondaparinux|fondaparinux|mesh-list
101249397|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101249398|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
101249399|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101249400|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
101249401|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249402|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249403|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
101249404|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101249405|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101249406|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
101249407|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
101249408|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249409|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
101249410|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101249411|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101249412|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101249413|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249414|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249415|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
101249416|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249417|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249418|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101249419|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249420|NCT01691677|Beclomethasone|beclomethasone|mesh-list
101249421|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249425|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249426|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101249427|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249428|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101249429|NCT01691742|Laxatives|laxatives|mesh-list
101249430|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249431|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101249432|NCT01691807|Ofatumumab|ofatumumab|mesh-list
101249433|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101249434|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
101249435|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249436|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249437|NCT01691872|Ezogabine|ezogabine|mesh-list
101249438|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
101249439|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249440|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249441|NCT01691937|Sufentanil|sufentanil|mesh-list
101249442|NCT01691937|Ropivacaine|ropivacaine|mesh-list
101249443|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
101249444|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
101249445|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249446|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249447|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
101249448|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249449|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101249450|NCT01691937|Narcotics|narcotics|mesh-ancestor
101249451|NCT01691937|Analgesics|analgesics|mesh-ancestor
101249452|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101249453|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101249454|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
101249455|NCT01691976|Estrogens|estrogens|mesh-list
101249456|NCT01691976|Hormones|hormones|mesh-ancestor
101249457|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545884|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101545885|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101249458|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249459|NCT01692132|Prucalopride|prucalopride|mesh-list
101249460|NCT01692132|Laxatives|laxatives|mesh-ancestor
101249461|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249462|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101249463|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101249464|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
101249465|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249466|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249467|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249468|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
101249469|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249470|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249471|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249472|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249473|NCT01692210|Analgesics|analgesics|mesh-ancestor
101323624|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
101249474|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
101249475|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249476|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101249477|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101249479|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
101249480|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249481|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249482|NCT01692457|Golimumab|golimumab|mesh-list
101249483|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101249484|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249485|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249486|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
101249487|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249488|NCT01692483|Prednisone|prednisone|mesh-list
101249489|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
101249490|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249491|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
101249492|NCT01692483|Hormones|hormones|mesh-ancestor
101249493|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249501|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101249503|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101249504|NCT01692678|Dacarbazine|dacarbazine|mesh-list
101249505|NCT01692678|Trabectedin|trabectedin|mesh-list
101249506|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101249507|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
101249508|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249509|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249510|NCT01692704|Gemcitabine|gemcitabine|mesh-list
101249511|NCT01692704|Floxuridine|floxuridine|mesh-list
101249512|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249513|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249514|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
101249515|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249516|NCT01692808|Vitamin D|vitamin d|mesh-list
101249517|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
101249518|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
101249519|NCT01692808|Vitamins|vitamins|mesh-list
101249520|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
101249521|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249522|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101249523|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101249524|NCT01692834|Cyclosporine|cyclosporine|mesh-list
101249525|NCT01692834|Cyclosporins|cyclosporins|mesh-list
101249526|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545893|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101249527|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249528|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249529|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
101249530|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249531|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
101249532|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249533|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101249534|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249535|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101249536|NCT01692886|Vaccines|vaccines|mesh-list
101249537|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101249538|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
101249539|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249540|NCT01692925|Factor VIII|factor viii|mesh-list
101249541|NCT01692925|Coagulants|coagulants|mesh-ancestor
101249542|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
101249543|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101545903|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101249544|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
101249545|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249546|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249547|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101249548|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249549|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
101249550|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101249551|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
101249552|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249553|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249554|NCT01693081|Apomorphine|apomorphine|mesh-list
101249555|NCT01693081|Emetics|emetics|mesh-ancestor
101249556|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249557|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
101249558|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249559|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249560|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
101249574|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249575|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249576|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249577|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
101249578|NCT01693289|Metformin|metformin|mesh-list
101249579|NCT01693289|Letrozole|letrozole|mesh-list
101249580|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249581|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249582|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249583|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101249584|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101249585|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249586|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249587|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101249588|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
101249589|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249590|NCT01693302|Insulin|insulin|mesh-list
101249591|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101249592|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249593|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249594|NCT01693328|Fentanyl|fentanyl|mesh-list
101249595|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101249596|NCT01693328|Narcotics|narcotics|mesh-ancestor
101249597|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249598|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249599|NCT01693328|Analgesics|analgesics|mesh-ancestor
101249600|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
101249601|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249602|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101249603|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101249604|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
101249605|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
101249606|NCT01693393|Cyclosporine|cyclosporine|mesh-list
101249607|NCT01693393|Cyclosporins|cyclosporins|mesh-list
101545905|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249608|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249609|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249610|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249611|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
101249612|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249613|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
101249614|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249615|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
101249616|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249617|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101249618|NCT01693419|Gemcitabine|gemcitabine|mesh-list
101249619|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101249620|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249621|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
101249622|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249623|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249624|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101249633|NCT01693445|Irinotecan|irinotecan|mesh-list
101249634|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249635|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101249636|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101249637|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212771|NCT03613792|Narcotics|narcotics|mesh-ancestor
101249638|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249639|NCT01693601|Panobinostat|panobinostat|mesh-list
101249640|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249641|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101249642|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249643|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249644|NCT01693640|Abatacept|abatacept|mesh-list
101249645|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101249646|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249647|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101249648|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249649|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249650|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
101249651|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249652|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249653|NCT01693679|Lamivudine|lamivudine|mesh-list
101249654|NCT01693679|Adefovir|adefovir|mesh-list
101249655|NCT01693679|Telbivudine|telbivudine|mesh-list
101249656|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101249657|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101249658|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249659|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249661|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249662|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101249663|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101249664|NCT01693718|Fluorouracil|fluorouracil|mesh-list
101249665|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
101249666|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249667|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
101249668|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249669|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249670|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249671|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
101249672|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249673|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
101249674|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249675|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101545912|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101249676|NCT01693809|Caffeine|caffeine|mesh-list
101249677|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101249678|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249679|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101249680|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249681|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249682|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101249683|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101249684|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
101249685|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249686|NCT01693822|Axitinib|axitinib|mesh-list
101249687|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249688|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101249689|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249690|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249691|NCT01694017|Tenofovir|tenofovir|mesh-list
101249697|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249698|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249699|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101249700|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101249701|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
101249702|NCT05288816|Ravulizumab|ravulizumab|mesh-list
101249703|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101249704|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249705|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
101249706|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249707|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
101249708|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249709|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249710|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212852|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
101249711|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249712|NCT05288738|Analgesics|analgesics|mesh-ancestor
101249713|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
101249714|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249715|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101249716|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101249717|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101249718|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
101249719|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249720|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249721|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101249722|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249723|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
101249724|NCT05288725|Hormones|hormones|mesh-ancestor
101249725|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249726|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249727|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249728|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
101249729|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
101249730|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101249731|NCT05288465|Protective Agents|protective agents|mesh-ancestor
101249732|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249733|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
101249734|NCT05288374|Celecoxib|celecoxib|mesh-list
101249735|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101249736|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249737|NCT05288374|Analgesics|analgesics|mesh-ancestor
101249738|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
101249739|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249740|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545924|NCT02893176|Macitentan|macitentan|mesh-list
101249741|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249742|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249743|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101249744|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101249745|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249746|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249748|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101249749|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101249750|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101249751|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249752|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
101249754|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249755|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249756|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249757|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
101249758|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249759|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249760|NCT05288179|Pirfenidone|pirfenidone|mesh-list
101249770|NCT05288127|Talazoparib|talazoparib|mesh-list
101249771|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101249772|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249773|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249774|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249775|NCT05291455|Lacosamide|lacosamide|mesh-list
101249776|NCT05291455|Phenobarbital|phenobarbital|mesh-list
101249777|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
101249778|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101249779|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101249780|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249781|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249782|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249783|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249784|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249785|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101249786|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101249787|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249788|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
101249789|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
101249790|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101249791|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101249792|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101249793|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101249794|NCT05291195|Eusol|eusol|mesh-list
101249795|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
101249796|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249797|NCT05291104|Folic Acid|folic acid|mesh-list
101249798|NCT05291104|Choline|choline|mesh-list
101249799|NCT05291104|Hematinics|hematinics|mesh-ancestor
101249800|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
101249801|NCT05291104|Vitamins|vitamins|mesh-ancestor
101249802|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
101249803|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249804|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
101249805|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101249806|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
101249807|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249808|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249809|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101249810|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
101249811|NCT05291052|Capecitabine|capecitabine|mesh-list
101249812|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
101249813|NCT05291052|Lenvatinib|lenvatinib|mesh-list
101249814|NCT05291052|Tislelizumab|tislelizumab|mesh-list
101415606|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249815|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249817|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249818|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249819|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101249820|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249821|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101249822|NCT05290948|Bevacizumab|bevacizumab|mesh-list
101249823|NCT05290948|Acetazolamide|acetazolamide|mesh-list
101249824|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101249825|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249826|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101249834|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249835|NCT05290948|Diuretics|diuretics|mesh-ancestor
101249836|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
101249837|NCT05290935|Paclitaxel|paclitaxel|mesh-list
101249838|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101249839|NCT05290935|Antibodies|antibodies|mesh-list
101249840|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101249841|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249842|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
101249843|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249844|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249845|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249846|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
101249847|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249848|NCT05290857|Hemostatics|hemostatics|mesh-list
101249849|NCT05290857|Coagulants|coagulants|mesh-ancestor
101249850|NCT05290506|Linagliptin|linagliptin|mesh-list
101249851|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101249852|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249853|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249854|NCT05290506|Incretins|incretins|mesh-ancestor
101249855|NCT05290506|Hormones|hormones|mesh-ancestor
101249856|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249857|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
101249858|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249859|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249860|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
101249861|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249862|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101249863|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249864|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249865|NCT05290324|Midazolam|midazolam|mesh-list
101249866|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101249867|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101249868|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249869|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249870|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101249871|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101249872|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101249873|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101249874|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
101249875|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
101249876|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
101249877|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
101249878|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249879|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249880|NCT05292742|Capecitabine|capecitabine|mesh-list
101249881|NCT05292742|Trastuzumab|trastuzumab|mesh-list
101249882|NCT05292742|Pertuzumab|pertuzumab|mesh-list
101249883|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101249884|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
101249885|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249886|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415617|NCT00501124|Clevudine|clevudine|mesh-list
101249887|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101249889|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249890|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249891|NCT05292573|Metformin|metformin|mesh-list
101249892|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249893|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249894|NCT05291910|Paclitaxel|paclitaxel|mesh-list
101249895|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101249899|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101249900|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101249901|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249902|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
101249903|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101249904|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101249905|NCT05291793|Prednisolone|prednisolone|mesh-list
101249906|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
101249907|NCT05291793|Tenoxicam|tenoxicam|mesh-list
101249908|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101249909|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
101249910|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101249911|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
101249912|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
101249913|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249914|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249915|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101249916|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
101249917|NCT05291793|Hormones|hormones|mesh-ancestor
101249918|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101249919|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101249920|NCT05291793|Protective Agents|protective agents|mesh-ancestor
101249921|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101249922|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101249923|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101249924|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101249925|NCT05291793|Analgesics|analgesics|mesh-ancestor
101249926|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
101249927|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249928|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101249929|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249930|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249931|NCT05294926|Rocuronium|rocuronium|mesh-list
101249932|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101249933|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101249934|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101249935|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249936|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249937|NCT05294887|Bisoprolol|bisoprolol|mesh-list
101249938|NCT05294887|Diltiazem|diltiazem|mesh-list
101249939|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101249940|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101249941|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545935|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101545937|NCT04328805|Ibuprofen|ibuprofen|mesh-list
101249942|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101249943|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249944|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249945|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101249946|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
101249947|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
101249948|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249949|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101249950|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101249951|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101249952|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101249953|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
101249955|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101249956|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249957|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
101249958|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101249959|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
101249960|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249961|NCT05294744|Expectorants|expectorants|mesh-ancestor
101249962|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
101249963|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101249964|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
101249965|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249966|NCT05294744|Protective Agents|protective agents|mesh-ancestor
101249971|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249972|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249973|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101249974|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
101249976|NCT05294666|Cyclosporine|cyclosporine|mesh-list
101249977|NCT05294666|Tacrolimus|tacrolimus|mesh-list
101249978|NCT05294666|Cyclosporins|cyclosporins|mesh-list
101249979|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101249980|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
101249981|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249982|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101249983|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101249984|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101249985|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
101249986|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101249987|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
101249988|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101249989|NCT05294640|Lidocaine|lidocaine|mesh-list
101249990|NCT05294640|Epinephrine|epinephrine|mesh-list
101249991|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
101249992|NCT05294640|Anesthetics|anesthetics|mesh-list
101249993|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101249994|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101249995|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
101249996|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101249997|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101249998|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101249999|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101250000|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250001|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250002|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101250003|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101250004|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250005|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250006|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101250007|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101250009|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101250010|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250011|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
101250013|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101250014|NCT05294536|Liraglutide|liraglutide|mesh-list
101250015|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250016|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250017|NCT05294536|Incretins|incretins|mesh-ancestor
101250018|NCT05294536|Hormones|hormones|mesh-ancestor
101250019|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250021|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101250022|NCT05294484|Diuretics|diuretics|mesh-ancestor
101250023|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
101250024|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250025|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101250026|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250027|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250028|NCT05294406|Piperaquine|piperaquine|mesh-list
101250029|NCT05294406|Artenimol|artenimol|mesh-list
101250030|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
101250031|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101250032|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101250033|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250034|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
101250035|NCT05294393|Ropivacaine|ropivacaine|mesh-list
101250036|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
101250037|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
101250038|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250039|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250040|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
101250041|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250047|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250048|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101250050|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250051|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101250052|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250053|NCT05293808|Aspirin|aspirin|mesh-list
101250054|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101250055|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250056|NCT05293808|Analgesics|analgesics|mesh-ancestor
101250057|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
101250058|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250059|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250060|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250061|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250062|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101250063|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101250064|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250065|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101250066|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101250067|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250068|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
101250069|NCT05293704|Mizoribine|mizoribine|mesh-list
101250070|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101250071|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250072|NCT05293704|Analgesics|analgesics|mesh-ancestor
101250073|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
101250074|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250075|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250076|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250077|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250078|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101250079|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250080|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101250081|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250082|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
101250083|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101250084|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101545952|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101250085|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213233|NCT02425943|Mannitol|mannitol|mesh-list
101545953|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250086|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250087|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250088|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
101250089|NCT05293574|Norethindrone|norethindrone|mesh-list
101250090|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
101250091|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101250092|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101250093|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101250094|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
101250095|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250096|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250097|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101250098|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101250099|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
101250100|NCT05293119|Tofacitinib|tofacitinib|mesh-list
101250101|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250102|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250103|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101250104|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101250105|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250106|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250107|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250108|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101250109|NCT05296863|Minoxidil|minoxidil|mesh-list
101250115|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250116|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
101250117|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250118|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250119|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101250120|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
101250121|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250122|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250123|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101250124|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250126|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
101250127|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250128|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101250129|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101250130|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
101250131|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250132|NCT05296369|Folic Acid|folic acid|mesh-list
101250133|NCT05296369|Hematinics|hematinics|mesh-ancestor
101250134|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250135|NCT05296369|Vitamins|vitamins|mesh-ancestor
101250136|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
101250137|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250139|NCT05296317|Epirubicin|epirubicin|mesh-list
101250140|NCT05296317|Lenograstim|lenograstim|mesh-list
101250141|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250142|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
101250143|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250144|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250145|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101250146|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
101250147|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545960|NCT04389294|Antibodies|antibodies|mesh-list
101545963|NCT01176916|Exemestane|exemestane|mesh-list
101250148|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250149|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101250150|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101250151|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101250152|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101250153|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101250154|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250155|NCT05296005|Leucovorin|leucovorin|mesh-list
101250156|NCT05296005|Docetaxel|docetaxel|mesh-list
101250157|NCT05296005|Fluorouracil|fluorouracil|mesh-list
101250158|NCT05296005|Capecitabine|capecitabine|mesh-list
101250159|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
101250160|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250161|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101250162|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250163|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250164|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250165|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
101250166|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101250167|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250168|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
101250169|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250171|NCT05296005|Protective Agents|protective agents|mesh-ancestor
101250172|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250173|NCT05296005|Vitamins|vitamins|mesh-ancestor
101250174|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
101250175|NCT05295836|Glycerol|glycerol|mesh-list
101250176|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101250177|NCT05295836|Protective Agents|protective agents|mesh-ancestor
101250178|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250179|NCT05294900|Paclitaxel|paclitaxel|mesh-list
101250180|NCT05294900|Carboplatin|carboplatin|mesh-list
101250181|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101250182|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250183|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101250184|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250186|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250188|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101250189|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250190|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250191|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101250192|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250193|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250194|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
101250195|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250196|NCT05273242|Artesunate|artesunate|mesh-list
101250197|NCT05273242|Infliximab|infliximab|mesh-list
101250198|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250199|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101250200|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250201|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250202|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250203|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250204|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
101250205|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101250206|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101250207|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250208|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
101250209|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
101250210|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101250211|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
101250212|NCT05269095|Anesthetics|anesthetics|mesh-list
101250213|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250214|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250215|NCT05267938|Lidocaine|lidocaine|mesh-list
101250216|NCT05267938|Epinephrine|epinephrine|mesh-list
101250217|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
101250218|NCT05267938|Anesthetics|anesthetics|mesh-list
101250219|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250220|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250221|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
101250222|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250223|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101250224|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101250225|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101250226|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250227|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546030|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250228|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101250229|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101250230|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250231|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250232|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101250233|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101250234|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
101250235|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101213384|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101250236|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250237|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
101250238|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
101250239|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101250240|NCT05267431|Methotrexate|methotrexate|mesh-list
101250241|NCT05267431|Hydroquinone|hydroquinone|mesh-list
101250242|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101250243|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
101250244|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250245|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250246|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101250247|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
101250248|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250249|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250250|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250251|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250252|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101250253|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250254|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
101250255|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250256|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101250258|NCT05267431|Protective Agents|protective agents|mesh-ancestor
101250259|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101250261|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101250262|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250263|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101250264|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250265|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250266|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101250267|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101250268|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
101250269|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250270|NCT05264896|Leucovorin|leucovorin|mesh-list
101250271|NCT05264896|Docetaxel|docetaxel|mesh-list
101250272|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
101250273|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250274|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
101250275|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250276|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250277|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250278|NCT05264896|Antidotes|antidotes|mesh-ancestor
101250279|NCT05264896|Protective Agents|protective agents|mesh-ancestor
101250280|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250281|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250283|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
101250284|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
101250285|NCT05264584|Febuxostat|febuxostat|mesh-list
101250286|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101250287|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
101250288|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250289|NCT05264584|Expectorants|expectorants|mesh-ancestor
101250290|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250291|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101250292|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
101250293|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250294|NCT05264584|Protective Agents|protective agents|mesh-ancestor
101250295|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250296|NCT05264584|Antidotes|antidotes|mesh-ancestor
101250297|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
101250298|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250299|NCT05262686|Aldesleukin|aldesleukin|mesh-list
101250300|NCT05262686|Interleukin-2|interleukin-2|mesh-list
101546039|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250302|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250303|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250304|NCT05262686|Analgesics|analgesics|mesh-ancestor
101250305|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
101250306|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250307|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250308|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250309|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
101250310|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101250311|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101250312|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
101250313|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250314|NCT05238714|Venglustat|venglustat|mesh-list
101250315|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250316|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250319|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
101250320|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250321|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250322|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
101250323|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250324|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101250325|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101250326|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101250327|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250328|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250329|NCT05236608|Nivolumab|nivolumab|mesh-list
101250330|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250331|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250332|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250333|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250334|NCT05225402|Norepinephrine|norepinephrine|mesh-list
101250341|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
101250342|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
101250343|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250344|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101250345|NCT05220826|Ethanol|ethanol|mesh-list
101250346|NCT05220826|Ethylene|ethylene|mesh-list
101250347|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101250348|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250349|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250350|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250351|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101250352|NCT05220826|Growth Substances|growth substances|mesh-ancestor
101250353|NCT05210413|Spartalizumab|spartalizumab|mesh-list
101250354|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250355|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250356|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250357|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250358|NCT05203705|Enoxaparin|enoxaparin|mesh-list
101250359|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
101250360|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101250361|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101250362|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250363|NCT05202561|Vaccines|vaccines|mesh-list
101250364|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
101250365|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250366|NCT05192629|Midazolam|midazolam|mesh-list
101250367|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
101250368|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101250369|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250370|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250371|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101546052|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101250372|NCT05192629|Analgesics|analgesics|mesh-ancestor
101250373|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
101250374|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250375|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101250376|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101250377|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101250378|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250379|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250380|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250381|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101250382|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101250383|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101250384|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101250385|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101250386|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
101250388|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
101250389|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
101213531|NCT01042379|Doxorubicin|doxorubicin|mesh-list
101250390|NCT05189444|Amoxicillin|amoxicillin|mesh-list
101250391|NCT05189444|Clarithromycin|clarithromycin|mesh-list
101250392|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
101250393|NCT05189444|Esomeprazole|esomeprazole|mesh-list
101250395|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250396|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101250397|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250398|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101250399|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250400|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101250401|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250402|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101250403|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101250411|NCT05175274|Colchicine|colchicine|mesh-list
101250412|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
101250413|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250414|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101250415|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250416|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250417|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250418|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250419|NCT05129137|Acetaminophen|acetaminophen|mesh-list
101250420|NCT05129137|Nefopam|nefopam|mesh-list
101250421|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250422|NCT05129137|Analgesics|analgesics|mesh-ancestor
101250423|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
101250424|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250425|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250426|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
101250427|NCT05110898|Olmesartan|olmesartan|mesh-list
101250428|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101250429|NCT05110898|Indapamide|indapamide|mesh-list
101250430|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101250431|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101250432|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101250433|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250434|NCT05110898|Diuretics|diuretics|mesh-ancestor
101250435|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
101250436|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250437|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101250438|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250439|NCT05098041|Rifampin|rifampin|mesh-list
101546062|NCT02893254|Adalimumab|adalimumab|mesh-list
101250440|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101250441|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
101250442|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101250443|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250444|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
101250445|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101250446|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250447|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250448|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101250449|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101250450|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101250451|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101250452|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101250453|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101250455|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250456|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250457|NCT05096065|Leuprolide|leuprolide|mesh-list
101250458|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101250459|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
101250460|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250461|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250462|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101250463|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250464|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101250465|NCT05083572|Rifaximin|rifaximin|mesh-list
101250466|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250467|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250468|NCT05030025|Lamivudine|lamivudine|mesh-list
101250469|NCT05030025|Abacavir|abacavir|mesh-list
101250470|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
101250471|NCT05030025|Dolutegravir|dolutegravir|mesh-list
101250472|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101250479|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101250480|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101250481|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101250482|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101250483|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
101250484|NCT05013567|Ibuprofen|ibuprofen|mesh-list
101250485|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101250486|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250487|NCT05013567|Analgesics|analgesics|mesh-ancestor
101250488|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
101250489|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250490|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250491|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250492|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250493|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101250494|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250495|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250496|NCT05008926|Naloxegol|naloxegol|mesh-list
101250497|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101250498|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250499|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
101250500|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250501|NCT04989621|Rituximab|rituximab|mesh-list
101250502|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250503|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250504|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
101415632|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
101415633|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415634|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415635|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250505|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250506|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250508|NCT04989049|Hematinics|hematinics|mesh-ancestor
101250509|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250510|NCT04989049|Vitamins|vitamins|mesh-ancestor
101250511|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
101250512|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250513|NCT04984044|Vitamin D|vitamin d|mesh-list
101250514|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
101250515|NCT04984044|Vitamins|vitamins|mesh-ancestor
101250516|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
101250517|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250518|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101250519|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101250520|NCT04975802|Caffeine|caffeine|mesh-list
101250521|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101250522|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250523|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101250524|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250525|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250526|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101250527|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101250528|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
101250529|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250530|NCT04964700|Natalizumab|natalizumab|mesh-list
101250531|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
101250532|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250533|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101250535|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101250536|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101250537|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101250538|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250539|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213685|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
101420754|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250550|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
101250551|NCT04899843|Astringents|astringents|mesh-ancestor
101250552|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250553|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250554|NCT04897802|Exenatide|exenatide|mesh-list
101250555|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250556|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323823|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
101250557|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101250558|NCT04897802|Incretins|incretins|mesh-ancestor
101250559|NCT04897802|Hormones|hormones|mesh-ancestor
101250560|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250561|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
101250562|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250563|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
101250564|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
101250565|NCT04882332|Vitamins|vitamins|mesh-ancestor
101250566|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
101250567|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250568|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250569|NCT04882332|Hematinics|hematinics|mesh-ancestor
101250570|NCT04871425|Fentanyl|fentanyl|mesh-list
101250571|NCT04871425|Ketamine|ketamine|mesh-list
101250572|NCT04871425|Analgesics|analgesics|mesh-ancestor
101250573|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
101250574|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250575|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250576|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101546088|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546089|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250577|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101250578|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
101250579|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
101250580|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250581|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101250582|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101250583|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250584|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250585|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101250586|NCT04871425|Narcotics|narcotics|mesh-ancestor
101250587|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101250588|NCT04869605|Chrysarobin|chrysarobin|mesh-list
101250589|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101250590|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250591|NCT04869605|Analgesics|analgesics|mesh-ancestor
101250592|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
101250593|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250594|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250595|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250596|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250597|NCT04835584|Dasatinib|dasatinib|mesh-list
101250598|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250599|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250600|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250601|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250602|NCT04774315|Omalizumab|omalizumab|mesh-list
101250603|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101250604|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101250605|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250606|NCT04767503|Propofol|propofol|mesh-list
101250607|NCT04767503|Desflurane|desflurane|mesh-list
101250608|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101250609|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101250610|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250620|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250621|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
101250622|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250623|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101250624|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101250625|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101250626|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250627|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250628|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101250629|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
101250630|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101250631|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101250632|NCT04750967|Analgesics|analgesics|mesh-ancestor
101250633|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101250634|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101250635|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250636|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250637|NCT04722679|Anticoagulants|anticoagulants|mesh-list
101250638|NCT04696380|Nicotine|nicotine|mesh-list
101250639|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101250640|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
101250641|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250642|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250643|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101250644|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101250645|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101250646|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250647|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250648|NCT04672772|Paclitaxel|paclitaxel|mesh-list
101250649|NCT04672772|Cetuximab|cetuximab|mesh-list
101250650|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101250651|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250652|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
101546097|NCT00592215|Misoprostol|misoprostol|mesh-list
101250653|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250654|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250655|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250656|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250657|NCT04671082|Tolperisone|tolperisone|mesh-list
101250658|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101250659|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250660|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101250661|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250662|NCT04669587|Palbociclib|palbociclib|mesh-list
101250663|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250664|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250665|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250666|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250667|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
101250668|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101250669|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
101250670|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250671|NCT04658823|Vitamin E|vitamin e|mesh-list
101250672|NCT04658823|Tocopherols|tocopherols|mesh-list
101250673|NCT04658823|Tocotrienols|tocotrienols|mesh-list
101250674|NCT04658823|Tocovid|tocovid|mesh-list
101250675|NCT04658823|Vitamins|vitamins|mesh-ancestor
101250676|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
101250677|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250678|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
101250686|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
101250687|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250688|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250689|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
101250690|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250691|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250692|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250693|NCT04602078|Gemcitabine|gemcitabine|mesh-list
101250695|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250696|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101250697|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
101250698|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250699|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250700|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250701|NCT04588857|Dexamethasone|dexamethasone|mesh-list
101250702|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250703|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
101250704|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
101250705|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250706|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250707|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250708|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
101250709|NCT04588857|Hormones|hormones|mesh-ancestor
101250710|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250711|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101250712|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250713|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
101250714|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
101250715|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250716|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250717|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250718|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
101250719|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
101250720|NCT04562831|Niacinamide|niacinamide|mesh-list
101250721|NCT04562831|Niacin|niacin|mesh-list
101250722|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
101250723|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
101250724|NCT04562831|Vitamins|vitamins|mesh-ancestor
101250725|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
101250726|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250727|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101250728|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
101250729|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250730|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101250731|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
101250732|NCT04545242|Dexamethasone|dexamethasone|mesh-list
101250733|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250734|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
101250735|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
101250736|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250737|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250738|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250739|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
101250740|NCT04545242|Hormones|hormones|mesh-ancestor
101250741|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250742|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101250743|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250744|NCT04542980|Autoantibodies|autoantibodies|mesh-list
101250745|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
101250746|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250747|NCT04529499|Favipiravir|favipiravir|mesh-list
101250748|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
101250749|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250750|NCT04523428|Venetoclax|venetoclax|mesh-list
101250751|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
101250762|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
101250763|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250764|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101250765|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101250766|NCT04490707|Growth Substances|growth substances|mesh-ancestor
101250767|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
101250768|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250769|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101250770|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
101213911|NCT01461460|Tedizolid|tedizolid|mesh-list
101250771|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250772|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250773|NCT04464577|Itraconazole|itraconazole|mesh-list
101250774|NCT04464577|Fluconazole|fluconazole|mesh-list
101250775|NCT04464577|Bupropion|bupropion|mesh-list
101250776|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101250777|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
101250778|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101250779|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101250780|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101250781|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101250782|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250783|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
101250784|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250785|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250786|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101250787|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101250788|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250789|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
101250790|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250791|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101250792|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101250793|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
101250794|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250795|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101250796|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101250797|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101250798|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
101250799|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250800|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250802|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101250803|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
101250804|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250805|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250806|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101250807|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250808|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
101250809|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250810|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101250811|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101250812|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101250813|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
101250814|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101250815|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250822|NCT04375683|Flumatinib|flumatinib|mesh-list
101250823|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101250824|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250825|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250826|NCT04356742|Metformin|metformin|mesh-list
101250827|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
101250828|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101250829|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250830|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101250831|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250832|NCT04353284|Gabexate|gabexate|mesh-list
101250833|NCT04353284|Camostat|camostat|mesh-list
101250834|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
101250835|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250836|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250837|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101250838|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101250839|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
101250840|NCT04348864|Antibodies|antibodies|mesh-list
101250841|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
101213988|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250842|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250843|NCT04328012|Losartan|losartan|mesh-list
101250844|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101250845|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101250846|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101250847|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101250848|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250849|NCT04310150|Hemostatics|hemostatics|mesh-list
101250850|NCT04310150|Coagulants|coagulants|mesh-ancestor
101250851|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101250852|NCT04294147|Erenumab|erenumab|mesh-list
101250853|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101250854|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250855|NCT04294147|Analgesics|analgesics|mesh-ancestor
101250856|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
101250857|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250858|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250859|NCT04292873|Vitamin D|vitamin d|mesh-list
101250860|NCT04292873|Vitamins|vitamins|mesh-ancestor
101250861|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
101250862|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250863|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101250864|NCT04264637|Azelastine|azelastine|mesh-list
101250865|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101250866|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
101250867|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250868|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546125|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
101250869|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101250870|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
101250871|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101250872|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250873|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250874|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101250875|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101250876|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101250884|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250885|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
101250886|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250887|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
101250888|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250889|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101250904|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250905|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250906|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250907|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250908|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101250909|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
101250910|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250911|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101250913|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250914|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101250915|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101250916|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250917|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250918|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101250919|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
101250920|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101250921|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250923|NCT04169438|Emollients|emollients|mesh-ancestor
101250924|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
101250925|NCT04159818|Doxorubicin|doxorubicin|mesh-list
101250926|NCT04159818|Nivolumab|nivolumab|mesh-list
101250927|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250928|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101250929|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101250930|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101250931|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250932|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250933|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250934|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250935|NCT04157881|Rabeprazole|rabeprazole|mesh-list
101250936|NCT04157881|Dabigatran|dabigatran|mesh-list
101250937|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
101250938|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101250939|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
101250940|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250941|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250942|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
101250943|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101546138|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101250944|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250945|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101250946|NCT04151563|Docetaxel|docetaxel|mesh-list
101250947|NCT04151563|Nivolumab|nivolumab|mesh-list
101250948|NCT04151563|Ipilimumab|ipilimumab|mesh-list
101250949|NCT04151563|Ramucirumab|ramucirumab|mesh-list
101250950|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101250951|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
101250952|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101250953|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101250954|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250955|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101250956|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101250957|NCT04136262|Methotrexate|methotrexate|mesh-list
101250958|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101250959|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
101250960|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101250961|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250962|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101250963|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
101250983|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101250984|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101250985|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101250986|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101250987|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101250988|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101250989|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101250990|NCT04096066|Dexamethasone|dexamethasone|mesh-list
101250992|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101250993|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
101250994|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
101250995|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101250996|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101250997|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101250998|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
101250999|NCT04096066|Hormones|hormones|mesh-ancestor
101251000|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251001|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101251002|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251003|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
101412513|NCT05367336|Analgesics|analgesics|mesh-ancestor
101251004|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101251005|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101251006|NCT04096066|Growth Substances|growth substances|mesh-ancestor
101251007|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
101251009|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251010|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
101251011|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251012|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251013|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
101251014|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251015|NCT04012177|Niacinamide|niacinamide|mesh-list
101251017|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
101251018|NCT04012177|Azithromycin|azithromycin|mesh-list
101251019|NCT04012177|Choline|choline|mesh-list
101251020|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251021|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251022|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
101251039|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251040|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251041|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
101251042|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
101251043|NCT04002518|Cimetidine|cimetidine|mesh-list
101546148|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101251044|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101251045|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251046|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101251047|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
101251048|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
101251049|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251050|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251051|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251052|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101251053|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101251054|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251056|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251057|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251058|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251059|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251060|NCT03990883|Lidocaine|lidocaine|mesh-list
101251061|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251062|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
101251063|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251064|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251065|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
101251066|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251067|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101251068|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101251069|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101251070|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251071|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251072|NCT03984890|Vitamin D|vitamin d|mesh-list
101251073|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
101251074|NCT03984890|Vitamins|vitamins|mesh-ancestor
101251075|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
101251076|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251077|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101251078|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101251079|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
101251080|NCT03926091|Docetaxel|docetaxel|mesh-list
101251081|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101251082|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
101251086|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
101251087|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251088|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251089|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101251090|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
101251091|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
101251092|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
101251093|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
101251094|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251095|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251096|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537340|NCT01080300|Gabapentin|gabapentin|mesh-list
101251097|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251098|NCT03922451|Cefazolin|cefazolin|mesh-list
101251099|NCT03922451|Tazobactam|tazobactam|mesh-list
101251100|NCT03922451|Piperacillin|piperacillin|mesh-list
101251101|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101251102|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251103|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251104|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101251105|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251106|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251107|NCT05802433|Vitamin D|vitamin d|mesh-list
101251108|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
101251109|NCT05802433|Vitamins|vitamins|mesh-ancestor
101251110|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
101546157|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101546158|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101251111|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251112|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101251113|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101251114|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101251115|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101251116|NCT05802303|Estradiol|estradiol|mesh-list
101251117|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101251119|NCT05802303|Hormones|hormones|mesh-ancestor
101251120|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251121|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251122|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101251123|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
101251124|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101251125|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101251126|NCT05802290|Nivolumab|nivolumab|mesh-list
101251127|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251128|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251129|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251130|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251131|NCT05802225|Pertuzumab|pertuzumab|mesh-list
101251132|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251133|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251134|NCT05802212|Metformin|metformin|mesh-list
101251135|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101251136|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251138|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251139|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251140|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101251141|NCT05802108|Evolocumab|evolocumab|mesh-list
101251142|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101251143|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101251144|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
101251145|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251146|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251147|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101251148|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101546166|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
101546167|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546168|NCT01113541|Ziprasidone|ziprasidone|mesh-list
101546169|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101546170|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
101546171|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546172|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546173|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546174|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101546175|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546176|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251149|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101251150|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
101251151|NCT05802082|Anesthetics|anesthetics|mesh-list
101251152|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251153|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251154|NCT05801900|Ibuprofen|ibuprofen|mesh-list
101251155|NCT05801900|Ketorolac|ketorolac|mesh-list
101251158|NCT05801900|Analgesics|analgesics|mesh-ancestor
101251159|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
101251160|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251161|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251162|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251163|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251164|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101251165|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251166|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251167|NCT05801523|Ethanol|ethanol|mesh-list
101251168|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101251169|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251170|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251171|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251172|NCT05801484|Linezolid|linezolid|mesh-list
101251173|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251174|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251175|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101251176|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251177|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251178|NCT05801380|Memantine|memantine|mesh-list
101251179|NCT05801380|Donepezil|donepezil|mesh-list
101251180|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101251181|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251182|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251183|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
101251184|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251185|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251186|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
101251187|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101251188|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101251189|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
101251190|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101251191|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101251192|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
101251193|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
101251194|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251195|NCT05801367|Protective Agents|protective agents|mesh-ancestor
101251196|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251197|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101251198|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251199|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101251200|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251201|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
101251202|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251203|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
101251204|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
101251205|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251206|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101251207|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
101251208|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101251209|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101251210|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101251211|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251212|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251213|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101251214|NCT05801237|Antibodies|antibodies|mesh-list
101251215|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
101251216|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101546177|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546178|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101251217|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
101251218|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251219|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251220|NCT05801133|Pirfenidone|pirfenidone|mesh-list
101251221|NCT05801133|Analgesics|analgesics|mesh-ancestor
101251222|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
101251223|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251224|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251225|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251226|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251227|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251241|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251242|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251243|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251245|NCT05800847|Analgesics|analgesics|mesh-ancestor
101251246|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
101251247|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251248|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251249|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
101251250|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101251251|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101251252|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251253|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101323950|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
101251254|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101251255|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101251256|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251257|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251258|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
101251259|NCT05800834|Lidocaine|lidocaine|mesh-list
101251260|NCT05800834|Morphine|morphine|mesh-list
101251261|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251262|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
101251263|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251264|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251265|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
101251266|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251267|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101251268|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101251269|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101251270|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251271|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251272|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101251273|NCT05800834|Narcotics|narcotics|mesh-ancestor
101251274|NCT05800834|Analgesics|analgesics|mesh-ancestor
101251275|NCT05800756|Trastuzumab|trastuzumab|mesh-list
101251276|NCT05800756|Letrozole|letrozole|mesh-list
101251277|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251278|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251279|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101251280|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101251281|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251282|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251283|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101251284|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
101251285|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251286|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251287|NCT05800197|Tamoxifen|tamoxifen|mesh-list
101251288|NCT05800197|Letrozole|letrozole|mesh-list
101214447|NCT01467648|Doripenem|doripenem|mesh-list
101251298|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
101251299|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251300|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251301|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101251302|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101251303|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101251304|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101251305|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
101251306|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101251307|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
101251308|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101251309|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101251311|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251312|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251313|NCT05797597|Analgesics|analgesics|mesh-ancestor
101251314|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
101251315|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251316|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251317|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251318|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251320|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101251321|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251322|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101251323|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101251324|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251325|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
101251326|NCT05794750|Capecitabine|capecitabine|mesh-list
101251327|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
101251328|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101251329|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
101251330|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251331|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251332|NCT05792293|Atorvastatin|atorvastatin|mesh-list
101251333|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101251334|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101251335|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
101251336|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251337|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101251338|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101251339|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251340|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
101251341|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101251342|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251343|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251344|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251346|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
101251347|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251348|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101251349|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101251350|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101251351|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
101251352|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251353|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251354|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
101251361|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251362|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
101251363|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251364|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251365|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
101251366|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251368|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
101251369|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251370|NCT05756504|Ketorolac|ketorolac|mesh-list
101251371|NCT05756504|Tramadol|tramadol|mesh-list
101251372|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251373|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251374|NCT05756504|Analgesics|analgesics|mesh-ancestor
101251375|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
101251376|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546188|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
101251377|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251378|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251380|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101323978|NCT00400777|Diuretics|diuretics|mesh-ancestor
101251381|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251382|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251383|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101251384|NCT05756504|Narcotics|narcotics|mesh-ancestor
101251385|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251386|NCT05699603|Fluorouracil|fluorouracil|mesh-list
101251387|NCT05699603|Calcipotriene|calcipotriene|mesh-list
101251388|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
101251389|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251390|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101251391|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251392|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101251393|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
101251394|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251395|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251396|NCT05697510|Siltuximab|siltuximab|mesh-list
101251397|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251398|NCT05691400|Palbociclib|palbociclib|mesh-list
101251399|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251400|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251401|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251402|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251403|NCT05657925|Ondansetron|ondansetron|mesh-list
101251404|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
101251405|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
101251406|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251407|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251408|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251409|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
101251410|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251411|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101251412|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101251413|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
101251414|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251415|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251416|NCT05656508|Vaccines|vaccines|mesh-list
101251417|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
101251418|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251419|NCT05622812|Lidocaine|lidocaine|mesh-list
101251420|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251421|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
101251422|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251423|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251425|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251426|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101251427|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101251428|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101251429|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251430|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251431|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
101251432|NCT05611229|Nivolumab|nivolumab|mesh-list
101251433|NCT05611229|Ipilimumab|ipilimumab|mesh-list
101251434|NCT05611229|Trametinib|trametinib|mesh-list
101251435|NCT05611229|Vemurafenib|vemurafenib|mesh-list
101251436|NCT05611229|Dabrafenib|dabrafenib|mesh-list
101251437|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251438|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251439|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251440|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251441|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251442|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251443|NCT05601154|Listerine|listerine|mesh-list
101251444|NCT05601154|Fluorides|fluorides|mesh-list
101251445|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
101251446|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
101415659|NCT00501397|Ketoconazole|ketoconazole|mesh-list
101251447|NCT05601154|Protective Agents|protective agents|mesh-ancestor
101251448|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251449|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101251450|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251451|NCT05566665|Meropenem|meropenem|mesh-list
101251452|NCT05566665|Tazobactam|tazobactam|mesh-list
101251453|NCT05566665|Ceftazidime|ceftazidime|mesh-list
101251454|NCT05566665|Avibactam|avibactam|mesh-list
101251455|NCT05566665|Ceftolozane|ceftolozane|mesh-list
101251456|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
101251457|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
101251458|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251459|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251460|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101251461|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251462|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251463|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101251464|NCT05559476|Vaccines|vaccines|mesh-list
101251465|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
101251466|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251467|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101251468|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251472|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
101251473|NCT05521984|Carmustine|carmustine|mesh-list
101251474|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101251475|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251476|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101251477|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251478|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101251480|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251481|NCT05497323|Adapalene|adapalene|mesh-list
101251482|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251483|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251484|NCT05497323|Analgesics|analgesics|mesh-ancestor
101251485|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
101251486|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251487|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251488|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251489|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251490|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251491|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101251492|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101251493|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101251494|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251495|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251496|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101251497|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251498|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251499|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
101251500|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251511|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101251513|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101251514|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101251515|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101251517|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
101251518|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
101251519|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
101251520|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251521|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251522|NCT05345782|Bupivacaine|bupivacaine|mesh-list
101251523|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251524|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
101251525|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251526|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251527|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
101251528|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251529|NCT05309655|Adenosine|adenosine|mesh-list
101251530|NCT05309655|Analgesics|analgesics|mesh-ancestor
101251531|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
101251532|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251533|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251534|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101251535|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
101251536|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101251537|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
101251538|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
101251539|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251540|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251541|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101251542|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
101251543|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251544|NCT05265767|Factor VIII|factor viii|mesh-list
101251545|NCT05265767|Coagulants|coagulants|mesh-ancestor
101251546|NCT05219799|Propranolol|propranolol|mesh-list
101251547|NCT05219799|Phentolamine|phentolamine|mesh-list
101251548|NCT05219799|Isoproterenol|isoproterenol|mesh-list
101251549|NCT05219799|Norepinephrine|norepinephrine|mesh-list
101251550|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101251551|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101251552|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
101251553|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251554|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251555|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251556|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101415667|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415668|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251557|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101251558|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
101251559|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101251560|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101251561|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
101251562|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
101251563|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251564|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101251565|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101251566|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101251567|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101251568|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101251576|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251577|NCT05161468|Triamcinolone|triamcinolone|mesh-list
101251578|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101251579|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101251580|NCT05161468|Lidocaine|lidocaine|mesh-list
101324008|NCT00101335|Celecoxib|celecoxib|mesh-list
101251581|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
101251582|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
101251583|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101251584|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
101251585|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
101251586|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251587|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251588|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
101251589|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251590|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101251591|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101251592|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101251593|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251594|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251595|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
101251596|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415669|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251601|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251602|NCT05108389|Hemostatics|hemostatics|mesh-list
101251603|NCT05108389|Coagulants|coagulants|mesh-ancestor
101251604|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
101251605|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101251606|NCT05104762|Antibodies|antibodies|mesh-list
101251607|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
101251608|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101251609|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
101251610|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251611|NCT05083312|Fluticasone|fluticasone|mesh-list
101251612|NCT05083312|Xhance|xhance|mesh-list
101251613|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251614|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101251615|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
101251616|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251617|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251618|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101251619|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101251620|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251621|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101251622|NCT05027425|Durvalumab|durvalumab|mesh-list
101251623|NCT05027425|Tremelimumab|tremelimumab|mesh-list
101251624|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251625|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251626|NCT05003648|Pramipexole|pramipexole|mesh-list
101251627|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
101251628|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251629|NCT05003648|Protective Agents|protective agents|mesh-ancestor
101251630|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251631|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101251632|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101251633|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
101251634|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
101251635|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546197|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101251636|NCT04991480|Niraparib|niraparib|mesh-list
101251637|NCT04991480|Talazoparib|talazoparib|mesh-list
101251638|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101251639|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251650|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
101251651|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251652|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251653|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251654|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101251655|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101251656|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251657|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101251658|NCT04858425|Niclosamide|niclosamide|mesh-list
101251659|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
101251660|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101251661|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
101251662|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101251663|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251664|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
101546198|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101546199|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546200|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546202|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
101251706|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251707|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101251711|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101251713|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251714|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
101251716|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251717|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101251718|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101251719|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101251720|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101251721|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101251722|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101251723|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101546206|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101546207|NCT04328766|Fexuprazan|fexuprazan|mesh-list
101251724|NCT04824092|Growth Substances|growth substances|mesh-ancestor
101251725|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101251726|NCT04762758|Naltrexone|naltrexone|mesh-list
101251727|NCT04762758|Baclofen|baclofen|mesh-list
101251728|NCT04762758|Sorbitol|sorbitol|mesh-list
101251729|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101251730|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101251731|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251732|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
101251733|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251734|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101251735|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101251736|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101251737|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
101251738|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
101251739|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251740|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251741|NCT04762758|Cathartics|cathartics|mesh-ancestor
101251742|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101251743|NCT04732065|Dopamine|dopamine|mesh-list
101251744|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101251745|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
101251746|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
101251747|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251748|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251749|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
101251750|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251751|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251752|NCT04732065|Protective Agents|protective agents|mesh-ancestor
101251753|NCT04717908|Linezolid|linezolid|mesh-list
101251754|NCT04717908|Cycloserine|cycloserine|mesh-list
101251755|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
101251756|NCT04717908|Bedaquiline|bedaquiline|mesh-list
101251757|NCT04717908|Clofazimine|clofazimine|mesh-list
101251758|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101251759|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251760|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101251761|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251762|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251763|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101251764|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101251765|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
101251766|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
101251767|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251768|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
101251769|NCT04665895|Fluticasone|fluticasone|mesh-list
101251770|NCT04665895|Xhance|xhance|mesh-list
101251771|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251772|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101251773|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
101251774|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251775|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251776|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101251777|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
101251778|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
101251779|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101546225|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101546241|NCT01601093|Sulbactam|sulbactam|mesh-list
101251794|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101251795|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101251796|NCT04530058|Metformin|metformin|mesh-list
101251797|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101251798|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251804|NCT04500574|Latanoprost|latanoprost|mesh-list
101251805|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101251806|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101251807|NCT04483505|Fulvestrant|fulvestrant|mesh-list
101251808|NCT04483505|Palbociclib|palbociclib|mesh-list
101251809|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101251810|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251811|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101251812|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101251813|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101251814|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251815|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251816|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251817|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251818|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251819|NCT04461535|Hormones|hormones|mesh-list
101214957|NCT01471067|Busulfan|busulfan|mesh-list
101251820|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101251821|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101251823|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101251824|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251825|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251826|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251827|NCT04445662|Varenicline|varenicline|mesh-list
101251828|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101251829|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101251830|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
101251831|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251832|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251833|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251834|NCT04416282|Terlipressin|terlipressin|mesh-list
101251835|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101251836|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101251837|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101251838|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101251839|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251840|NCT04375150|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101251841|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251842|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251843|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251844|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101251845|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251853|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101251854|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546244|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546245|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546246|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101546247|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251855|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251856|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251857|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
101251858|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101251859|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101251860|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251861|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101251862|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251863|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101251864|NCT04112498|Nivolumab|nivolumab|mesh-list
101251865|NCT04112498|Relatlimab|relatlimab|mesh-list
101251866|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251867|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251868|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251869|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251870|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
101251871|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251872|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251873|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101251874|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251875|NCT04042051|Trastuzumab|trastuzumab|mesh-list
101251876|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101546260|NCT02485418|Propofol|propofol|mesh-list
101251877|NCT04042051|Maytansine|maytansine|mesh-list
101251878|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251879|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251880|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101251881|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
101251882|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
101251883|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101251884|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251885|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
101251886|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
101251887|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
101251888|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251889|NCT04033991|Sunitinib|sunitinib|mesh-list
101251890|NCT04033991|Axitinib|axitinib|mesh-list
101251891|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251892|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101251893|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101251894|NCT04033991|Growth Substances|growth substances|mesh-ancestor
101251895|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251896|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
101251897|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101251898|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251899|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251900|NCT03961360|Aspirin|aspirin|mesh-list
101251901|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101251902|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251903|NCT03961360|Analgesics|analgesics|mesh-ancestor
101251904|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
101251905|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251906|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251907|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251908|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251909|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101251910|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101546261|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101546262|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546263|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251911|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251912|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101251918|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251919|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251921|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101251922|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
101251923|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251924|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101251925|NCT03769285|Niacinamide|niacinamide|mesh-list
101251927|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
101251928|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
101251929|NCT03769285|Vitamins|vitamins|mesh-ancestor
101251930|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
101251931|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251932|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101251933|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
101251934|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251935|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101251936|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101251937|NCT03749187|Temozolomide|temozolomide|mesh-list
101251938|NCT03749187|Pamiparib|pamiparib|mesh-list
101251939|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101251940|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101251941|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
101251942|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251943|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251944|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251945|NCT03738553|Trastuzumab|trastuzumab|mesh-list
101251946|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251947|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251948|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
101251949|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
101251950|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
101251951|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251952|NCT03642132|Bevacizumab|bevacizumab|mesh-list
101251953|NCT03642132|Avelumab|avelumab|mesh-list
101251954|NCT03642132|Talazoparib|talazoparib|mesh-list
101251955|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101251956|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101251957|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101251958|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101251959|NCT03642132|Growth Substances|growth substances|mesh-ancestor
101251960|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251961|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
101251962|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101251963|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101251964|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251965|NCT03632330|Midazolam|midazolam|mesh-list
101251966|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
101251967|NCT03632330|Propofol|propofol|mesh-list
101251968|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101251969|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101251970|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101251971|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101251972|NCT03632330|Analgesics|analgesics|mesh-ancestor
101251973|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
101251974|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101251975|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101546264|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101546265|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
101546266|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
101546267|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
101251976|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101546268|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101251977|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101251978|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
101251979|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101251980|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251981|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101251982|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
101251983|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
101251992|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101251993|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101251994|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
101251995|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
101251996|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101251997|NCT03572764|Cytarabine|cytarabine|mesh-list
101251998|NCT03572764|Daunorubicin|daunorubicin|mesh-list
101251999|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252000|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
101252001|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252002|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252003|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
101252004|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252005|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252006|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
101252007|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252008|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101252009|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101252010|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101252011|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252012|NCT03560752|Vaccines|vaccines|mesh-list
101252013|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
101252014|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252015|NCT03506061|Ivacaftor|ivacaftor|mesh-list
101252016|NCT03506061|Elexacaftor|elexacaftor|mesh-list
101252017|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101252018|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412525|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252019|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252020|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
101252021|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101252022|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101252023|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252024|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
101252025|NCT03475342|Coagulants|coagulants|mesh-ancestor
101252026|NCT03466151|Sirolimus|sirolimus|mesh-list
101252027|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252028|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252029|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101252030|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252031|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
101252032|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252033|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
101252034|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252035|NCT03452930|Benzimidazole|benzimidazole|mesh-list
101252036|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
101252037|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101252038|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252039|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101252040|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101252041|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252042|NCT03253289|Meclizine|meclizine|mesh-list
101252043|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
101252044|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
101252045|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252046|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252047|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546283|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546284|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415679|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415680|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252048|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101252049|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
101252050|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
101252051|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324060|NCT00101764|Triamcinolone|triamcinolone|mesh-list
101252052|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252057|NCT03227705|Progestins|progestins|mesh-ancestor
101252058|NCT03227705|Hormones|hormones|mesh-ancestor
101252059|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252060|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252061|NCT03219268|Margetuximab|margetuximab|mesh-list
101252062|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252063|NCT03176953|Topiramate|topiramate|mesh-list
101252064|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
101252065|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101252066|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252067|NCT03150004|Cytarabine|cytarabine|mesh-list
101252068|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
101252069|NCT03150004|Cladribine|cladribine|mesh-list
101252070|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252071|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
101252072|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252073|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252074|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
101252075|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252076|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252077|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
101252078|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252079|NCT03150004|Analgesics|analgesics|mesh-ancestor
101252080|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
101252081|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252082|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101252083|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101252084|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252085|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
101252086|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252087|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252088|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252089|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252090|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
101252091|NCT03082534|Cetuximab|cetuximab|mesh-list
101252092|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252093|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252094|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252095|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252096|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
101252097|NCT03056339|Fludarabine|fludarabine|mesh-list
101252098|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
101252099|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252100|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
101252101|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252102|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252103|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101252104|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
101252105|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252106|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252107|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101252108|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252109|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
101252110|NCT02960230|Nivolumab|nivolumab|mesh-list
101252111|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415686|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415687|NCT00147264|Telmisartan|telmisartan|mesh-list
101415688|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415689|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101546285|NCT01112059|Doxycycline|doxycycline|mesh-list
101546286|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252112|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252113|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252114|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252115|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
101252116|NCT02816021|Azacitidine|azacitidine|mesh-list
101252117|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252118|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252119|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252120|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252121|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252122|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
101252123|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252124|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
101252125|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252126|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252127|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252130|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101252131|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252133|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101252134|NCT02351869|Midazolam|midazolam|mesh-list
101252135|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
101252136|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101252137|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101252138|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252139|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252140|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101252141|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101252142|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101252143|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101252144|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
101252145|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
101252146|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
101252147|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
101252148|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252149|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252150|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101252151|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252152|NCT02351869|Analgesics|analgesics|mesh-ancestor
101252153|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
101252154|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252155|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
101252156|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252157|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252158|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252159|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252160|NCT02237820|Dexamethasone|dexamethasone|mesh-list
101252161|NCT02237820|Prednisone|prednisone|mesh-list
101252162|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252163|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
101252164|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
101252165|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252166|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252167|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252168|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
101252169|NCT02237820|Hormones|hormones|mesh-ancestor
101252170|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252171|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252172|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252173|NCT02160353|Prednisolone|prednisolone|mesh-list
101252174|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
101252175|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252176|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
101252177|NCT02160353|Hormones|hormones|mesh-ancestor
101252178|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252179|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252180|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252181|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252182|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101252183|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252184|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252185|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
101252186|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252187|NCT02152358|Acyclovir|acyclovir|mesh-list
101252188|NCT02152358|Ganciclovir|ganciclovir|mesh-list
101252189|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101252190|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
101252191|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324074|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101252192|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252193|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252194|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252195|NCT01892371|Cytarabine|cytarabine|mesh-list
101252196|NCT01892371|Azacitidine|azacitidine|mesh-list
101252197|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252198|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
101252199|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252208|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101252209|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101252210|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101252211|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
101252212|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252213|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252214|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101252215|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
101252216|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
101252217|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
101252218|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101252219|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101252220|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
101252221|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252222|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252224|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
101252225|NCT01817751|Valproic Acid|valproic acid|mesh-list
101252226|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252227|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252228|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252229|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252230|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
101252231|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101252232|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101252233|NCT01817751|Urological Agents|urological agents|mesh-ancestor
101252234|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
101252235|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
101252236|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252237|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252238|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
101252239|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101252240|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252241|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101252242|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101252243|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101252244|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252245|NCT01748149|Vemurafenib|vemurafenib|mesh-list
101252246|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252247|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252248|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252249|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252250|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101252251|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101252252|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252254|NCT00812669|Rituximab|rituximab|mesh-list
101252255|NCT00812669|Fludarabine|fludarabine|mesh-list
101252256|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
101252257|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546295|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546296|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252258|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
101252259|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252260|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252261|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101252262|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
101252263|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252264|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252265|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101252266|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215410|NCT01474174|Vaccines|vaccines|mesh-list
101252273|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101252274|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101252275|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
101252276|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252277|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101252278|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101252279|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252280|NCT03870880|Risperidone|risperidone|mesh-list
101252281|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101252282|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
101252283|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252284|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252285|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252286|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101252287|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101252288|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252289|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101252290|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101252291|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
101252292|NCT03861377|Remifentanil|remifentanil|mesh-list
101252293|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101252294|NCT03861377|Narcotics|narcotics|mesh-ancestor
101252295|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252296|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252297|NCT03861377|Analgesics|analgesics|mesh-ancestor
101252298|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
101252299|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252300|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101252301|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101252302|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252303|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
101252304|NCT03836144|Diuretics|diuretics|mesh-ancestor
101252305|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
101252306|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252307|NCT03836144|Expectorants|expectorants|mesh-ancestor
101252308|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
101252309|NCT03796416|Misoprostol|misoprostol|mesh-list
101252310|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101252311|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
101252312|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101252313|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252314|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101252315|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252316|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
101252317|NCT03785106|Vitamins|vitamins|mesh-list
101252318|NCT03785106|Pyridoxine|pyridoxine|mesh-list
101252319|NCT03785106|Pyridoxal|pyridoxal|mesh-list
101252320|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
101546301|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101252321|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
101546302|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101546303|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
101546304|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546305|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252322|NCT03785106|Isoniazid|isoniazid|mesh-list
101252323|NCT03785106|Rifapentine|rifapentine|mesh-list
101252324|NCT03785106|Rifampin|rifampin|mesh-list
101252325|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
101252326|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252327|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
101252328|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252329|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252330|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101252331|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101252332|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
101252333|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252334|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101252335|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101252336|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
101252342|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101252343|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101252344|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101252346|NCT03782142|Dolutegravir|dolutegravir|mesh-list
101252347|NCT03782142|Rilpivirine|rilpivirine|mesh-list
101252348|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
101252349|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
101252350|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252351|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101252352|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252353|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252354|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252355|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101252356|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101252357|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101252358|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101252359|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101252360|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101252361|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252362|NCT03770299|Paclitaxel|paclitaxel|mesh-list
101252363|NCT03770299|Vinorelbine|vinorelbine|mesh-list
101252364|NCT03770299|Docetaxel|docetaxel|mesh-list
101252365|NCT03770299|Carboplatin|carboplatin|mesh-list
101252366|NCT03770299|Gemcitabine|gemcitabine|mesh-list
101252367|NCT03770299|Nivolumab|nivolumab|mesh-list
101252368|NCT03770299|Pemetrexed|pemetrexed|mesh-list
101252369|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101252371|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
101252372|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
101252373|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
101252374|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252375|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252376|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
101252377|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252378|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252379|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252380|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101252381|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252382|NCT03760835|Dexamethasone|dexamethasone|mesh-list
101252383|NCT03760835|Prednisone|prednisone|mesh-list
101252384|NCT03760835|Prednisolone|prednisolone|mesh-list
101252385|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
101252386|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101252387|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101252388|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101252389|NCT03760835|Cortisone|cortisone|mesh-list
101252390|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
101252391|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252392|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
101252393|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
101252394|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252395|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546312|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
101546313|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101252396|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252397|NCT03760835|Hormones|hormones|mesh-ancestor
101537362|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252398|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252399|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252400|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252401|NCT03759496|Durvalumab|durvalumab|mesh-list
101252402|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252403|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252404|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
101252405|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252406|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252412|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
101252413|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252414|NCT03724409|Octreotide|octreotide|mesh-list
101252415|NCT03724409|Edotreotide|edotreotide|mesh-list
101252416|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252417|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252418|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215559|NCT01475552|Abciximab|abciximab|mesh-list
101252419|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101252420|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252421|NCT03715829|PF-06700841|pf-06700841|mesh-list
101252422|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252423|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252424|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252425|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
101252426|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
101252427|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101252428|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101252429|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252430|NCT03704441|Bupivacaine|bupivacaine|mesh-list
101252431|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
101252432|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
101252433|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252434|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252435|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
101252436|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252437|NCT03673826|Dexamethasone|dexamethasone|mesh-list
101252438|NCT03673826|Lenalidomide|lenalidomide|mesh-list
101252439|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252440|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
101252441|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
101252442|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252443|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252444|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252445|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
101252447|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252448|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252449|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252450|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
101252451|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101252452|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101252453|NCT03673826|Growth Substances|growth substances|mesh-ancestor
101252454|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101252455|NCT03660839|Artefenomel|artefenomel|mesh-list
101252456|NCT03660839|Ferroquine|ferroquine|mesh-list
101252457|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
101252458|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101252459|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101252460|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252461|NCT03660241|Abrocitinib|abrocitinib|mesh-list
101252462|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252463|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252464|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252465|NCT03651102|Thalidomide|thalidomide|mesh-list
101546320|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
101546321|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101252466|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
101252467|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252468|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
101252469|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252470|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
101252471|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252472|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252473|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101252474|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101252475|NCT03651102|Growth Substances|growth substances|mesh-ancestor
101252476|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
101252477|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252500|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252501|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101252502|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252522|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252523|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252524|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252525|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252526|NCT03573115|Adapalene|adapalene|mesh-list
101252527|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101252528|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101252529|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101252530|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252531|NCT03573115|Analgesics|analgesics|mesh-ancestor
101252532|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
101252533|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252534|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252535|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252536|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252537|NCT03569475|Milnacipran|milnacipran|mesh-list
101252538|NCT03569475|Fluoxetine|fluoxetine|mesh-list
101252539|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
101252540|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101252541|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101252542|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101252543|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252544|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252545|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
101252546|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252547|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101252552|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252553|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101252554|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252556|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
101252557|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252558|NCT03546556|Alovudine|alovudine|mesh-list
101252559|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
101252561|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252562|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
101252563|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252564|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101252565|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252566|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252567|NCT03533712|Folic Acid|folic acid|mesh-list
101252568|NCT03533712|Hematinics|hematinics|mesh-ancestor
101252569|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
101252570|NCT03533712|Vitamins|vitamins|mesh-ancestor
101252571|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
101252572|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252573|NCT03523520|Naltrexone|naltrexone|mesh-list
101546327|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546328|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
101546330|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
101252574|NCT03523520|Bromides|bromides|mesh-list
101252575|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
101252576|NCT03523520|Naloxegol|naloxegol|mesh-list
101252577|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
101252578|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101252579|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252580|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
101252581|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252582|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101252583|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
101252584|NCT03518242|Capecitabine|capecitabine|mesh-list
101252585|NCT03518242|Methotrexate|methotrexate|mesh-list
101252586|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252587|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
101252588|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252589|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324131|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252590|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101252591|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
101252592|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252593|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252594|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101252595|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252596|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
101252597|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101252598|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
101252599|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101252600|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101252601|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252602|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101252603|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252605|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101252606|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252607|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
101252608|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252609|NCT03435185|Lidocaine|lidocaine|mesh-list
101252610|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
101252611|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
101252612|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252613|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252614|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
101252615|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252616|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101252617|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101252618|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101252625|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252627|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252628|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252629|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101252630|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252631|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
101252632|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252633|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
101252634|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252635|NCT03325439|Brivaracetam|brivaracetam|mesh-list
101252636|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
101252637|NCT03242772|Amphetamine|amphetamine|mesh-list
101252638|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101252639|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252640|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
101252641|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
101252642|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252643|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
101546337|NCT01607762|Risperidone|risperidone|mesh-list
101415691|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415692|NCT00501904|Metformin|metformin|mesh-list
101415693|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101252644|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252645|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252647|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101252648|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101252649|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101252650|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101252651|NCT03236311|Adenosine|adenosine|mesh-list
101252652|NCT03236311|Regadenoson|regadenoson|mesh-list
101252653|NCT03236311|Analgesics|analgesics|mesh-ancestor
101252654|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
101252655|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252656|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252657|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101252658|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101252659|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101252660|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
101252661|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
101252662|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252663|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252664|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101252665|NCT03234686|Deferiprone|deferiprone|mesh-list
101252666|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101252667|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
101252668|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
101252669|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252670|NCT03223974|Paclitaxel|paclitaxel|mesh-list
101252671|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101252672|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252673|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
101252674|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
101252675|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
101252676|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252677|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
101252678|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101252679|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252681|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
101252682|NCT03190369|Protective Agents|protective agents|mesh-ancestor
101252683|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252684|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
101252685|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
101252686|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252687|NCT05438108|Bevacizumab|bevacizumab|mesh-list
101252688|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252692|NCT05438108|Growth Substances|growth substances|mesh-ancestor
101252693|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252694|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
101252695|NCT05437783|Azithromycin|azithromycin|mesh-list
101252696|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252697|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252698|NCT05437718|Ropivacaine|ropivacaine|mesh-list
101252699|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
101252700|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
101252701|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252702|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252703|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
101252704|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546338|NCT01607762|Aripiprazole|aripiprazole|mesh-list
101252705|NCT05437497|Propofol|propofol|mesh-list
101252706|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101252707|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252708|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252709|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101252710|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
101252711|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
101252712|NCT05437471|Letrozole|letrozole|mesh-list
101252713|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
101252714|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252715|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101215861|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252716|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101252717|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252718|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252719|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101252720|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
101252721|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252722|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252723|NCT05437471|Progestins|progestins|mesh-ancestor
101252724|NCT05437471|Hormones|hormones|mesh-ancestor
101252725|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
101252726|NCT05437432|Methamphetamine|methamphetamine|mesh-list
101252727|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101252728|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252729|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
101252730|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
101252731|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252732|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
101252733|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252734|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252735|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
101252736|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101252737|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101252738|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101252739|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101252740|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
101252741|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101252742|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252743|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
101252744|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101252745|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252746|NCT05437224|Ambrisentan|ambrisentan|mesh-list
101252747|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101252748|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
101252749|NCT05436990|Vactosertib|vactosertib|mesh-list
101252750|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252751|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252752|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252753|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252754|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252755|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252756|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
101252757|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101252758|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101252759|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546363|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101546364|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101546365|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
101546366|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101546367|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
101546368|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546369|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
101252765|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101252766|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101252767|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
101252768|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252769|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252770|NCT05426811|Raltitrexed|raltitrexed|mesh-list
101252771|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252772|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
101252773|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252774|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252775|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101252776|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252777|NCT05357859|Vitamin D|vitamin d|mesh-list
101252778|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
101252780|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
101252781|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252782|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101252783|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101252784|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
101252785|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101252786|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
101252787|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101252788|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
101252789|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252790|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252791|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
101252792|NCT04895046|Niraparib|niraparib|mesh-list
101252793|NCT04895046|Dostarlimab|dostarlimab|mesh-list
101252794|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101252795|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252796|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252797|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252798|NCT04765514|Temozolomide|temozolomide|mesh-list
101252799|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101252800|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
101252801|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252802|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252803|NCT04590586|Thalidomide|thalidomide|mesh-list
101252804|NCT04590586|Apremilast|apremilast|mesh-list
101252805|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101252806|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101252807|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252808|NCT04590586|Analgesics|analgesics|mesh-ancestor
101412542|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
101252809|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
101252810|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252811|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252812|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252813|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252814|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101252815|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101252816|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252817|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252818|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252819|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
101252820|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
101252821|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101252822|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252823|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101252824|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101252825|NCT04590586|Growth Substances|growth substances|mesh-ancestor
101252826|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
101252827|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252828|NCT04312009|Losartan|losartan|mesh-list
101252829|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101252835|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
101252836|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101252837|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252838|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252839|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
101252840|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
101252841|NCT03850483|PF-06700841|pf-06700841|mesh-list
101252842|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101252843|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252844|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252845|NCT03563742|Tenofovir|tenofovir|mesh-list
101252846|NCT03563742|Lamivudine|lamivudine|mesh-list
101252847|NCT03563742|Rilpivirine|rilpivirine|mesh-list
101252848|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
101252849|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252850|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101252851|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101252852|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252853|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252854|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101252855|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101252856|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
101252857|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252858|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252859|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101252860|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252862|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101252863|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252864|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252865|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
101252866|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252867|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252868|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101252869|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
101252870|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252871|NCT03230097|BI 409306|bi 409306|mesh-list
101252872|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101252873|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252874|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252875|NCT02968940|Avelumab|avelumab|mesh-list
101252876|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101252877|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252878|NCT02663908|Leuprolide|leuprolide|mesh-list
101252879|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101252880|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
101252881|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101252882|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252883|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101252884|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252885|NCT02333292|Ritonavir|ritonavir|mesh-list
101252886|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
101252887|NCT02333292|Grazoprevir|grazoprevir|mesh-list
101252888|NCT02333292|Ledipasvir|ledipasvir|mesh-list
101252889|NCT02333292|Velpatasvir|velpatasvir|mesh-list
101252890|NCT02333292|Simeprevir|simeprevir|mesh-list
101546376|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546377|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252891|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101252892|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101252893|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
101252894|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252895|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252896|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101252897|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101252898|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
101252899|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252904|NCT02203773|Decitabine|decitabine|mesh-list
101252905|NCT02203773|Venetoclax|venetoclax|mesh-list
101252906|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546378|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101252907|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
101252908|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252909|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252910|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252911|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
101252912|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252913|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101252914|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101252915|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101252916|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101252917|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101252918|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101252919|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101252920|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101252921|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252923|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
101252924|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101252925|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
101252926|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101252927|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252928|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101252929|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101252930|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101252931|NCT02175030|Trace Elements|trace elements|mesh-ancestor
101252932|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
101252933|NCT01555541|Cytarabine|cytarabine|mesh-list
101252934|NCT01555541|Etoposide|etoposide|mesh-list
101252935|NCT01555541|Ofatumumab|ofatumumab|mesh-list
101252936|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101252937|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252938|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101252939|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101252940|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252941|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252942|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101252944|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
101252945|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101252946|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101252947|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
101252948|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252949|NCT01398852|Riboflavin|riboflavin|mesh-list
101252950|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
101252951|NCT01398852|Vitamins|vitamins|mesh-ancestor
101252952|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
101252953|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252954|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101252955|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101252956|NCT01398839|Riboflavin|riboflavin|mesh-list
101252957|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
101252958|NCT01398839|Vitamins|vitamins|mesh-ancestor
101252959|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
101252960|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252961|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101252962|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101252963|NCT00496795|Docetaxel|docetaxel|mesh-list
101252964|NCT00496795|Epirubicin|epirubicin|mesh-list
101252965|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252966|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101252967|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101252968|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101546385|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101546386|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101252969|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252970|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101252971|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101252980|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252981|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101252982|NCT03133260|Aspirin|aspirin|mesh-list
101252983|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101252984|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101252985|NCT03133260|Analgesics|analgesics|mesh-ancestor
101252986|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
101252987|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101252988|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101252989|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101252990|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101252991|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101252992|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101252993|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101252994|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101252995|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101252996|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101252997|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
101252998|NCT03096834|Erenumab|erenumab|mesh-list
101252999|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101253000|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253001|NCT03096834|Analgesics|analgesics|mesh-ancestor
101253002|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
101253003|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253004|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253005|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
101253006|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101253007|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
101253008|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253009|NCT03056014|Expectorants|expectorants|mesh-ancestor
101253010|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
101253011|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101253012|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
101253013|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253014|NCT03056014|Protective Agents|protective agents|mesh-ancestor
101253015|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253016|NCT03056014|Antidotes|antidotes|mesh-ancestor
101253017|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
101253018|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
101253019|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253020|NCT03126812|Paclitaxel|paclitaxel|mesh-list
101253021|NCT03126812|Carboplatin|carboplatin|mesh-list
101253022|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
101253023|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101253024|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253025|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101253026|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101253027|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101253028|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253029|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253030|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253031|NCT03026972|Vaccines|vaccines|mesh-list
101253032|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
101253033|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253034|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
101253035|NCT03012815|Gabapentin|gabapentin|mesh-list
101415699|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101253036|NCT03012815|Lorazepam|lorazepam|mesh-list
101253037|NCT03012815|Valproic Acid|valproic acid|mesh-list
101415700|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101415702|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101253038|NCT03012815|Analgesics|analgesics|mesh-ancestor
101253039|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
101253040|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253041|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253049|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253050|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253052|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
101253053|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
101253054|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253055|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101253056|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
101253057|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
101253058|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253059|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101253060|NCT03001011|Sevelamer|sevelamer|mesh-list
101253061|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
101253062|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
101253063|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253065|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
101253066|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253067|NCT02979535|Vaccines|vaccines|mesh-list
101253068|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
101253069|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253070|NCT02978716|Carboplatin|carboplatin|mesh-list
101253071|NCT02978716|Gemcitabine|gemcitabine|mesh-list
101253072|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253073|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253074|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
101253075|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253076|NCT02973321|Metformin|metformin|mesh-list
101253077|NCT02973321|Liraglutide|liraglutide|mesh-list
101253078|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253079|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253080|NCT02973321|Incretins|incretins|mesh-ancestor
101253081|NCT02973321|Hormones|hormones|mesh-ancestor
101253082|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253083|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101253084|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101253085|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253086|NCT02943785|Edoxaban|edoxaban|mesh-list
101253087|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101253088|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
101253089|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101253090|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
101253091|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253092|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253093|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
101253094|NCT02908334|Sertraline|sertraline|mesh-list
101253095|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
101253096|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101253097|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101253098|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101253099|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101253100|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253101|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253102|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
101253103|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253104|NCT02886286|Fentanyl|fentanyl|mesh-list
101253105|NCT02886286|Morphine|morphine|mesh-list
101253106|NCT02886286|Hydromorphone|hydromorphone|mesh-list
101253107|NCT02886286|Bupivacaine|bupivacaine|mesh-list
101546408|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101546409|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546410|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546411|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546412|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
101253108|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
101253109|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
101253110|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253111|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253120|NCT02865187|Vitamin D|vitamin d|mesh-list
101253121|NCT02865187|Vitamins|vitamins|mesh-ancestor
101253122|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
101253123|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253124|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101253125|NCT02787551|Metformin|metformin|mesh-list
101253126|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
101253127|NCT02787551|Pioglitazone|pioglitazone|mesh-list
101253128|NCT02787551|Liraglutide|liraglutide|mesh-list
101253129|NCT02787551|Exenatide|exenatide|mesh-list
101253130|NCT02787551|Dulaglutide|dulaglutide|mesh-list
101253131|NCT02787551|Lixisenatide|lixisenatide|mesh-list
101253132|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101412544|NCT00117273|Estradiol|estradiol|mesh-list
101253133|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101253134|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
101253135|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253136|NCT02787551|Incretins|incretins|mesh-ancestor
101253137|NCT02787551|Hormones|hormones|mesh-ancestor
101253138|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253139|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101253140|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253141|NCT02735044|Insulin|insulin|mesh-list
101253142|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101253143|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
101253144|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253145|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253146|NCT02692651|Vancomycin|vancomycin|mesh-list
101253148|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101253149|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253150|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
101253151|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253152|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253153|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253154|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253155|NCT02654314|Melatonin|melatonin|mesh-list
101253156|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
101253157|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253158|NCT02654314|Protective Agents|protective agents|mesh-ancestor
101253159|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253160|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253161|NCT02626962|Nivolumab|nivolumab|mesh-list
101253162|NCT02626962|Ipilimumab|ipilimumab|mesh-list
101253163|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253164|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253165|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253166|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253167|NCT02623998|Metformin|metformin|mesh-list
101253168|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
101253169|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101216310|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253170|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253171|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253172|NCT02623998|Incretins|incretins|mesh-ancestor
101253173|NCT02623998|Hormones|hormones|mesh-ancestor
101253174|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253175|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101253176|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101253177|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546417|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101546418|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101546419|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
101546420|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
101546424|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
101253178|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253179|NCT02608684|Gemcitabine|gemcitabine|mesh-list
101253180|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
101253187|NCT02587520|Vaccines|vaccines|mesh-list
101253188|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
101253189|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253190|NCT02584829|Interferons|interferons|mesh-list
101253191|NCT02584829|Interferon-beta|interferon-beta|mesh-list
101253192|NCT02584829|Avelumab|avelumab|mesh-list
101253193|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101253194|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253195|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
101253196|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324191|NCT00101998|Alvimopan|alvimopan|mesh-list
101253197|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253198|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
101253199|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253200|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
101253201|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253202|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253203|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253204|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253205|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
101253206|NCT02512172|Azacitidine|azacitidine|mesh-list
101253207|NCT02512172|Romidepsin|romidepsin|mesh-list
101253208|NCT02512172|Cc-486|cc-486|mesh-list
101253209|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253210|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253211|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253212|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253213|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253214|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
101253215|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253216|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101253217|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101253218|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
101253220|NCT02499367|Nivolumab|nivolumab|mesh-list
101253221|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253222|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
101253223|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253224|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253225|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101253226|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
101253227|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253228|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253229|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101546428|NCT01111825|Temsirolimus|temsirolimus|mesh-list
101546429|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
101546430|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546431|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546432|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546433|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546434|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
101546435|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546436|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546437|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546438|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546439|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101546440|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
101546441|NCT01175590|Besifloxacin|besifloxacin|mesh-list
101253230|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101253231|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101253232|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101253233|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253234|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253235|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253236|NCT02497612|Artefenomel|artefenomel|mesh-list
101253237|NCT02497612|Ferroquine|ferroquine|mesh-list
101253238|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
101253239|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101253240|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101253241|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253242|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101253243|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253244|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253245|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
101253246|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
101253247|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
101253248|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253250|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253260|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101253262|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253263|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253264|NCT02381652|Triamcinolone|triamcinolone|mesh-list
101253265|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101253266|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101253267|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
101253268|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101253269|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253270|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
101253271|NCT02381652|Hormones|hormones|mesh-ancestor
101253272|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253273|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253274|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253275|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
101253276|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253277|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253278|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101253279|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
101253280|NCT02381652|Protective Agents|protective agents|mesh-ancestor
101253281|NCT02368301|Dexamethasone|dexamethasone|mesh-list
101253282|NCT02368301|Lenalidomide|lenalidomide|mesh-list
101253283|NCT02368301|Elotuzumab|elotuzumab|mesh-list
101253284|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253285|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
101253286|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
101253287|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253288|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253289|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253291|NCT02368301|Hormones|hormones|mesh-ancestor
101253292|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253293|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253294|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253295|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
101546442|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101253296|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101253297|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101546443|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253298|NCT02368301|Growth Substances|growth substances|mesh-ancestor
101253299|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
101253301|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101253302|NCT02367794|Carboplatin|carboplatin|mesh-list
101253303|NCT02367794|Atezolizumab|atezolizumab|mesh-list
101253304|NCT02367794|Antibodies|antibodies|mesh-list
101253305|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101253306|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253307|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
101253308|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
101253309|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
101253310|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253311|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
101253312|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253313|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253314|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253315|NCT02363998|Lofexidine|lofexidine|mesh-list
101253316|NCT02363998|Clonidine|clonidine|mesh-list
101253317|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101253325|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
101253326|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253327|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253328|NCT02363998|Analgesics|analgesics|mesh-ancestor
101253329|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
101253330|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
101253331|NCT02325466|Aspirin|aspirin|mesh-list
101253332|NCT02325466|Ticagrelor|ticagrelor|mesh-list
101253333|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101253334|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253335|NCT02325466|Analgesics|analgesics|mesh-ancestor
101253336|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
101253337|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253338|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253339|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253340|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253341|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101253342|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101253343|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253344|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101253345|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101253346|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253347|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
101324266|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
101253348|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101253349|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101253350|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101253351|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
101253352|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253353|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101253354|NCT02323100|Glycerol|glycerol|mesh-list
101253355|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101253356|NCT02323100|Protective Agents|protective agents|mesh-ancestor
101253357|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253358|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253359|NCT02322710|Petrolatum|petrolatum|mesh-list
101253360|NCT02322710|Emollients|emollients|mesh-ancestor
101253361|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253362|NCT02283281|Dronabinol|dronabinol|mesh-list
101253363|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
101253364|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253366|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253367|NCT02283281|Analgesics|analgesics|mesh-ancestor
101253368|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
101253369|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324568|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546459|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101546460|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101415707|NCT00502060|Cediranib|cediranib|mesh-list
101253370|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101253371|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101253372|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324712|NCT00401206|Analgesics|analgesics|mesh-ancestor
101253373|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253374|NCT02283281|Hormones|hormones|mesh-ancestor
101253375|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253376|NCT02162563|Leucovorin|leucovorin|mesh-list
101253377|NCT02162563|Bevacizumab|bevacizumab|mesh-list
101253378|NCT02162563|Panitumumab|panitumumab|mesh-list
101253379|NCT02162563|Fluorouracil|fluorouracil|mesh-list
101253380|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
101253381|NCT02162563|Irinotecan|irinotecan|mesh-list
101253382|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
101253383|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253384|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253388|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253390|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
101253391|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253392|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253393|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253394|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
101253395|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101253396|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101253397|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253398|NCT02162563|Antidotes|antidotes|mesh-ancestor
101253399|NCT02162563|Protective Agents|protective agents|mesh-ancestor
101253400|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
101253401|NCT02162563|Vitamins|vitamins|mesh-ancestor
101253402|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
101253403|NCT02127086|Analgesics|analgesics|mesh-list
101253404|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
101253405|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253406|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253407|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101253408|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101253409|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
101253410|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101253411|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101253412|NCT02106195|Belumosudil|belumosudil|mesh-list
101253413|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253414|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253415|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253416|NCT02075177|Ketoconazole|ketoconazole|mesh-list
101253417|NCT02075177|Fenretinide|fenretinide|mesh-list
101253418|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
101253419|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253420|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101253421|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101253422|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253423|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253424|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101253425|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
101253426|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253427|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253428|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101253429|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253430|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101253431|NCT02075177|Protective Agents|protective agents|mesh-ancestor
101253432|NCT02050919|Sorafenib|sorafenib|mesh-list
101253433|NCT02050919|Epirubicin|epirubicin|mesh-list
101253434|NCT02050919|Ifosfamide|ifosfamide|mesh-list
101253435|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
101253436|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253437|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253438|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415711|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415712|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253439|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253440|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101253441|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101253442|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101253443|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101253444|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
101253446|NCT02040857|Letrozole|letrozole|mesh-list
101253447|NCT02040857|Palbociclib|palbociclib|mesh-list
101253448|NCT02040857|Anastrozole|anastrozole|mesh-list
101253449|NCT02040857|Exemestane|exemestane|mesh-list
101253450|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101253451|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253452|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101253453|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253454|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253455|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101253456|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
101253462|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101253463|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253464|NCT01997463|Albuterol|albuterol|mesh-list
101253465|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101253466|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
101253467|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253468|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253469|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101253470|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101253471|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
101253472|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101253473|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101253474|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101253475|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101253476|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
101253477|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253478|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253479|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
101253480|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101253481|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253482|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253483|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253484|NCT01976754|Analgesics|analgesics|mesh-ancestor
101253485|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
101253486|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253487|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101253488|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101253489|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101253490|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101253491|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253492|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253494|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
101253495|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253496|NCT01916317|Lidocaine|lidocaine|mesh-list
101253497|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
101253498|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
101253499|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253500|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253501|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
101325044|NCT00109096|Pemetrexed|pemetrexed|mesh-list
101253502|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253503|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101253504|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101253505|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101253506|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101253507|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253510|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546466|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
101546467|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101253511|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
101253512|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
101253513|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253514|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253515|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253516|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
101253518|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253519|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253520|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253521|NCT01863186|Lofexidine|lofexidine|mesh-list
101253522|NCT01863186|Clonidine|clonidine|mesh-list
101253523|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101253525|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253533|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253534|NCT01863186|Analgesics|analgesics|mesh-ancestor
101253535|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
101253536|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
101253537|NCT01828840|Fentanyl|fentanyl|mesh-list
101253538|NCT01828840|Morphine|morphine|mesh-list
101253539|NCT01828840|Methadone|methadone|mesh-list
101253540|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101253541|NCT01828840|Narcotics|narcotics|mesh-ancestor
101253542|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253543|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253544|NCT01828840|Analgesics|analgesics|mesh-ancestor
101253545|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
101253546|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253547|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101253548|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101253549|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
101253550|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
101253551|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
101253553|NCT01817426|Infliximab|infliximab|mesh-list
101253554|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101253555|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253556|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253557|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253558|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253559|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101253560|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253561|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253562|NCT01741103|Incretins|incretins|mesh-ancestor
101253563|NCT01741103|Hormones|hormones|mesh-ancestor
101253564|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253565|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101253566|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
101253567|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253568|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253569|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101253570|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
101253571|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253572|NCT01630590|Androgens|androgens|mesh-list
101253573|NCT01630590|Hormones|hormones|mesh-ancestor
101253574|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253575|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253576|NCT01619085|Nintedanib|nintedanib|mesh-list
101253577|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253578|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253579|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253580|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253581|NCT01499095|Insulin|insulin|mesh-list
101253582|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101253583|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
101253584|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253585|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253587|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101253588|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
101546475|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101253589|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253590|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253591|NCT01488890|Vaccines|vaccines|mesh-list
101253592|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
101253593|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253594|NCT01436396|Vaccines|vaccines|mesh-list
101253595|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
101253598|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
101253599|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
101253600|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253601|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253602|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253603|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
101253604|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253605|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101253606|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101253607|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
101253608|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253609|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253611|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101253612|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
101253613|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253614|NCT01380938|Ribavirin|ribavirin|mesh-list
101253615|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101253616|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
101253617|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
101253618|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253619|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
101253620|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253621|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
101253622|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253623|NCT01374516|Vaccines|vaccines|mesh-list
101253624|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
101253625|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253626|NCT01373281|Vaccines|vaccines|mesh-list
101253627|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
101253628|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253629|NCT01346787|Dexamethasone|dexamethasone|mesh-list
101253630|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
101253631|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253632|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
101253633|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253634|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253635|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101253636|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
101253637|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253638|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253639|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101253640|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253641|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
101253642|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
101253643|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253644|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253645|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
101253646|NCT01346787|Hormones|hormones|mesh-ancestor
101253647|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253648|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253649|NCT01254422|Vaccines|vaccines|mesh-list
101253650|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
101253651|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253652|NCT01204242|Lidocaine|lidocaine|mesh-list
101253653|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
101253654|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
101253655|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253656|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546483|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101546484|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
101546485|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253657|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
101253658|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253659|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101253660|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101253661|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101253662|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101253663|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253665|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
101253666|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253667|NCT01150045|Leucovorin|leucovorin|mesh-list
101253668|NCT01150045|Celecoxib|celecoxib|mesh-list
101253669|NCT01150045|Fluorouracil|fluorouracil|mesh-list
101253670|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
101253671|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
101253682|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
101253683|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101253684|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253685|NCT01150045|Analgesics|analgesics|mesh-ancestor
101253686|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
101253687|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253688|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253689|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253690|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101253691|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101253692|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253693|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
101253694|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
101253695|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253696|NCT01098032|Expectorants|expectorants|mesh-ancestor
101253697|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
101253698|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101253699|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
101253700|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253701|NCT01098032|Protective Agents|protective agents|mesh-ancestor
101253702|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253703|NCT00945009|Dactinomycin|dactinomycin|mesh-list
101253704|NCT00945009|Cactinomycin|cactinomycin|mesh-list
101253705|NCT00945009|Doxorubicin|doxorubicin|mesh-list
101253706|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101253707|NCT00945009|Vincristine|vincristine|mesh-list
101253708|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101253709|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253710|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101253711|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101253712|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253713|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253714|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101253715|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101253716|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101253717|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101253718|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101253719|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253720|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101253721|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101253722|NCT00942877|Cediranib|cediranib|mesh-list
101253723|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253724|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101253725|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253726|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253727|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101253728|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101253729|NCT00896389|Diuretics|diuretics|mesh-ancestor
101253730|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
101253731|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253732|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101253733|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546490|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
101546491|NCT01602302|Adalimumab|adalimumab|mesh-list
101253734|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253735|NCT00880893|Vaccines|vaccines|mesh-list
101253736|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
101253737|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253738|NCT00579527|Cyclosporine|cyclosporine|mesh-list
101253750|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253751|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101253752|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253753|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253754|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
101253755|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253756|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253757|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253758|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101253759|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253760|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101253761|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
101253762|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101253763|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253765|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
101253766|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253767|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253768|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
101253769|NCT00579527|Hormones|hormones|mesh-ancestor
101253770|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253771|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101253772|NCT00579527|Protective Agents|protective agents|mesh-ancestor
101253773|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253774|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101253775|NCT01904123|Tyrphostins|tyrphostins|mesh-list
101253776|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253777|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253778|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253779|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
101253780|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101253781|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253783|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101253784|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
101253785|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253786|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253787|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
101253788|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101253789|NCT00066950|Fluorides|fluorides|mesh-list
101253790|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
101253791|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
101253792|NCT00066950|Protective Agents|protective agents|mesh-ancestor
101253793|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253794|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101253795|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253796|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
101253797|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253798|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101253799|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
101253800|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101253801|NCT01694134|Prednisolone|prednisolone|mesh-list
101253802|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
101253804|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101253805|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
101253806|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
101546499|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546500|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101546501|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546502|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101546503|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101546504|NCT01602302|Analgesics|analgesics|mesh-ancestor
101546505|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
101253808|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253809|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253816|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253818|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
101253819|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
101253820|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253821|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
101253822|NCT01694134|Hormones|hormones|mesh-ancestor
101253823|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253824|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101253825|NCT01694134|Protective Agents|protective agents|mesh-ancestor
101253826|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253827|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253828|NCT01694212|Diclofenac|diclofenac|mesh-list
101253829|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101253830|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101253831|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101253832|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253833|NCT01694212|Analgesics|analgesics|mesh-ancestor
101253834|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
101253835|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253836|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253837|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253838|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253839|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101253840|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253841|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253842|NCT01694264|Entecavir|entecavir|mesh-list
101253843|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
101253844|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253845|NCT01694355|Vitamin D|vitamin d|mesh-list
101253846|NCT01694355|Vitamins|vitamins|mesh-ancestor
101253847|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
101253848|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253849|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101253850|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101253851|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101253852|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253853|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
101253854|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253855|NCT01694407|Tenofovir|tenofovir|mesh-list
101253856|NCT01694407|Emtricitabine|emtricitabine|mesh-list
101253857|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
101253858|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253859|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101253860|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101253861|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253862|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325722|NCT00007826|Vaccines|vaccines|mesh-list
101253863|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101253864|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101253865|NCT01694459|Heparin|heparin|mesh-list
101546507|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253866|NCT01694459|Calcium heparin|calcium heparin|mesh-list
101253867|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
101546508|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546509|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
101546510|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101546511|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546512|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101546513|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253868|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101253869|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101253870|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253871|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101253872|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
101253873|NCT01694498|Coagulants|coagulants|mesh-ancestor
101253874|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101253875|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
101253879|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101253880|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253881|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101253882|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101253883|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101253884|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253885|NCT01694693|Abatacept|abatacept|mesh-list
101253886|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101253887|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253888|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101253889|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253890|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101253891|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
101253892|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253893|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253894|NCT01694732|Varenicline|varenicline|mesh-list
101253895|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101253896|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101253897|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
101253898|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253899|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253900|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253901|NCT01694797|Metoprolol|metoprolol|mesh-list
101253902|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101253903|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101253904|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
101253905|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
101253906|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253907|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325726|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
101253908|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101253909|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101253910|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101253911|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101253912|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253913|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253914|NCT01695005|Prednisone|prednisone|mesh-list
101253915|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253916|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
101253917|NCT01695005|Hormones|hormones|mesh-ancestor
101253918|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253919|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253920|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101253921|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253922|NCT01695057|Vorinostat|vorinostat|mesh-list
101253923|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101253924|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101253925|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253926|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253927|NCT01695070|Melatonin|melatonin|mesh-list
101253928|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
101415715|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
101415716|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
101415717|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101415718|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101415720|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
101253929|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253930|NCT01695070|Protective Agents|protective agents|mesh-ancestor
101253931|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253932|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101253934|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253935|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253936|NCT01695109|Incretins|incretins|mesh-ancestor
101253937|NCT01695109|Hormones|hormones|mesh-ancestor
101253938|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101253939|NCT01695122|Valproic Acid|valproic acid|mesh-list
101253940|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
101253941|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253942|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253943|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
101253944|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101253945|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253946|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
101253951|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
101253952|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253953|NCT01695148|Protective Agents|protective agents|mesh-ancestor
101253954|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253955|NCT01695174|Rifaximin|rifaximin|mesh-list
101253956|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101253957|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101253958|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101253959|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
101253960|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
101253961|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253962|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253963|NCT01695226|Celecoxib|celecoxib|mesh-list
101253964|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101253965|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101253966|NCT01695226|Analgesics|analgesics|mesh-ancestor
101253967|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
101253968|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101253969|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253970|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101253971|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101253972|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101253973|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101253974|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101253975|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101253976|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
101253977|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
101253978|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
101253979|NCT01695356|Avobenzone|avobenzone|mesh-list
101253980|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
101253981|NCT01695356|Benzophenone|benzophenone|mesh-list
101253982|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101253983|NCT01695356|Protective Agents|protective agents|mesh-ancestor
101253984|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253985|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
101253986|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101253987|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
101253988|NCT01695460|Vitamins|vitamins|mesh-list
101253990|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253991|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101253992|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101253993|NCT01695707|Pioglitazone|pioglitazone|mesh-list
101415726|NCT00502138|Pramlintide|pramlintide|mesh-list
101546519|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
101546520|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546521|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
101253994|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101253995|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253996|NCT01695733|Vaccines|vaccines|mesh-list
101253997|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
101253998|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101253999|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
101254000|NCT01695759|Hematinics|hematinics|mesh-ancestor
101254001|NCT01695798|Vaccines|vaccines|mesh-list
101254002|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
101217128|NCT01485692|Olanzapine|olanzapine|mesh-list
101254003|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254004|NCT01695824|Warfarin|warfarin|mesh-list
101254005|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
101254006|NCT01695850|Sennosides|sennosides|mesh-list
101254007|NCT01695850|Laxatives|laxatives|mesh-ancestor
101254008|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254009|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
101254010|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101254011|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
101254012|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254013|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254014|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101254015|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101254016|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101254017|NCT01696110|Heparin|heparin|mesh-list
101254018|NCT01696110|Calcium heparin|calcium heparin|mesh-list
101254019|NCT01696110|Tirofiban|tirofiban|mesh-list
101254020|NCT01696110|Bivalirudin|bivalirudin|mesh-list
101254029|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101254031|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101254032|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101254033|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254034|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254035|NCT01696370|Trimetazidine|trimetazidine|mesh-list
101325833|NCT00114010|Antacids|antacids|mesh-ancestor
101254036|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
101254038|NCT01696383|Travoprost|travoprost|mesh-list
101254039|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101254040|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101254041|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
101254042|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254043|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254044|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254045|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101254046|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101254047|NCT01696409|Vitamin D|vitamin d|mesh-list
101254048|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
101254049|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
101546524|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101254050|NCT01696409|Vitamins|vitamins|mesh-list
101254051|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
101546526|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254052|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254053|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101254054|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101254056|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
101254057|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254058|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
101254059|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
101254060|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254061|NCT01696448|Protective Agents|protective agents|mesh-ancestor
101254062|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254063|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
101254064|NCT01696448|Vitamins|vitamins|mesh-ancestor
101254065|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
101254066|NCT01696461|Plerixafor|plerixafor|mesh-list
101254067|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101254068|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254069|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
101254070|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254071|NCT01696474|Bortezomib|bortezomib|mesh-list
101254072|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254073|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
101254074|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101254075|NCT01696500|Antibodies|antibodies|mesh-list
101217207|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
101254076|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
101254077|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101254078|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
101254079|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254080|NCT01696526|Vitamin D|vitamin d|mesh-list
101254081|NCT01696526|Vitamins|vitamins|mesh-ancestor
101254082|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
101254083|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254084|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101254086|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101254087|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254088|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101254089|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
101254092|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254093|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254094|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101254095|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254096|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254098|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
101254099|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254100|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101254101|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101254102|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254103|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254104|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
101254105|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
101254106|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254107|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254108|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101254109|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101254110|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
101254111|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101254112|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101254113|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101254114|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101254115|NCT01696630|Desflurane|desflurane|mesh-list
101254116|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101254117|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
101254118|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
101254119|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254120|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254121|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101254122|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
101254123|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254124|NCT01696799|Econazole|econazole|mesh-list
101254125|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
101254126|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254127|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101254128|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254130|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254131|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101254132|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
101254133|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254134|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254135|NCT01696825|Diazepam|diazepam|mesh-list
101254136|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101254137|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
101254139|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
101254140|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254141|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254142|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254143|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101254144|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254145|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101254146|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101254147|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101254148|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101254149|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254150|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101254151|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
101254152|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
101254153|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
101254154|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
101254155|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254156|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254158|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
101254159|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254160|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101254161|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254162|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254167|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101254169|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101254170|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101254171|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254172|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254174|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254175|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101254176|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254177|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101254178|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101254179|NCT01697059|Amoxicillin|amoxicillin|mesh-list
101254180|NCT01697059|Piperacillin|piperacillin|mesh-list
101254181|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101254182|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254183|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254184|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101254185|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254186|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254187|NCT01697098|Dexamethasone|dexamethasone|mesh-list
101254188|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
101254189|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
101254190|NCT01697098|BB 1101|bb 1101|mesh-list
101254191|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546559|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
101546560|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101546561|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101546562|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101254192|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
101254193|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
101254194|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254195|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254196|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254198|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254199|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254200|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254201|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
101254202|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254203|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254204|NCT01697111|Dienogest|dienogest|mesh-list
101254205|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101254206|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
101254207|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254208|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254209|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101254210|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101254211|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101254212|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101254213|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
101254214|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254215|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254216|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254217|NCT01697150|Pancrelipase|pancrelipase|mesh-list
101254218|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254219|NCT01697228|Vitamin D|vitamin d|mesh-list
101254220|NCT01697228|Vitamins|vitamins|mesh-ancestor
101254221|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
101325925|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
101254222|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254223|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101254224|NCT01697293|Paclitaxel|paclitaxel|mesh-list
101254225|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
101254226|NCT01697293|Doxorubicin|doxorubicin|mesh-list
101254227|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101254228|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101254229|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101254230|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254231|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101254232|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101254237|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254239|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101254240|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
101254241|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101254242|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101254243|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101254244|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101254245|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254246|NCT01697306|Gemcitabine|gemcitabine|mesh-list
101254247|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
101254248|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101254249|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
101254250|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254251|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254252|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101254253|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
101254254|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254256|NCT01697410|Norepinephrine|norepinephrine|mesh-list
101254257|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101254258|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101254259|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
101254260|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254261|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254262|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254263|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
101254264|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
101254265|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254266|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101254267|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101254268|NCT01697436|Ribavirin|ribavirin|mesh-list
101254269|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
101254270|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254271|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
101254272|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254273|NCT01697605|Infigratinib|infigratinib|mesh-list
101254274|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254275|NCT01697618|Insulin|insulin|mesh-list
101254276|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101254277|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
101254278|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
101254279|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101254280|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254281|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254282|NCT01697631|Insulin|insulin|mesh-list
101254283|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101254284|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
101254285|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
101254286|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101254287|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
101254288|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101254289|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254290|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254291|NCT01697657|Insulin|insulin|mesh-list
101254292|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101254293|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
101254294|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
101254295|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
101254296|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
101254297|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
101254298|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254299|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254300|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101254301|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101254302|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217460|NCT01487226|Paclitaxel|paclitaxel|mesh-list
101254303|NCT01697722|Beclomethasone|beclomethasone|mesh-list
101254310|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
101254311|NCT01697735|Atorvastatin|atorvastatin|mesh-list
101254312|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101254313|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101254314|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101254315|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
101254316|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254317|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101254318|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101254319|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254320|NCT01697787|Artesunate|artesunate|mesh-list
101254321|NCT01697787|Lumefantrine|lumefantrine|mesh-list
101254322|NCT01697787|Artemether|artemether|mesh-list
101254323|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101254324|NCT01697787|Amodiaquine|amodiaquine|mesh-list
101254325|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
101254326|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101254327|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101254328|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254329|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254330|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
101254331|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
101254332|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101254333|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
101254334|NCT01697826|Clindamycin|clindamycin|mesh-list
101415735|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
101415736|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254335|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
101415737|NCT00502411|Doxorubicin|doxorubicin|mesh-list
101254336|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
101254337|NCT01697826|Clotrimazole|clotrimazole|mesh-list
101254338|NCT01697826|Miconazole|miconazole|mesh-list
101326057|NCT00115375|Clopidogrel|clopidogrel|mesh-list
101254339|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254340|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254341|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101254342|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254343|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254344|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101254345|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
101254346|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101254347|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254348|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101254349|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
101254350|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254351|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254352|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101254353|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101254354|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101254355|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101254356|NCT01698164|Estradiol|estradiol|mesh-list
101254357|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101254358|NCT01698164|Progesterone|progesterone|mesh-list
101254359|NCT01698164|Estrogens|estrogens|mesh-ancestor
101254360|NCT01698164|Hormones|hormones|mesh-ancestor
101254361|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254362|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254363|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101254364|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
101254365|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254366|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101254367|NCT01698164|Progestins|progestins|mesh-ancestor
101254368|NCT01698177|Vaccines|vaccines|mesh-list
101254369|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
101254370|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254371|NCT01698203|Ropivacaine|ropivacaine|mesh-list
101254372|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
101254379|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
101254380|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101254381|NCT01698476|Vitamins|vitamins|mesh-ancestor
101254382|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
101254383|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254384|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101254385|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101254386|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254387|NCT01698541|Tacrolimus|tacrolimus|mesh-list
101254388|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254389|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
101254390|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254391|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101254392|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415744|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415745|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101415746|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415747|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101415749|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
101254393|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254394|NCT01698567|Antithrombins|antithrombins|mesh-list
101254395|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
101254396|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101254397|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
101254398|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254399|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254400|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
101254401|NCT01698593|Epinephrine|epinephrine|mesh-list
101254402|NCT01698593|Bupivacaine|bupivacaine|mesh-list
101254403|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
101254404|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
101254405|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254406|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254407|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
101254408|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254409|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101254410|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101254411|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
101254412|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254413|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254414|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101254415|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101254416|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
101254417|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101254418|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
101254419|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
101254420|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
101254421|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101254422|NCT01698645|Fentanyl|fentanyl|mesh-list
101254423|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101254424|NCT01698645|Narcotics|narcotics|mesh-ancestor
101254425|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254426|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254427|NCT01698645|Analgesics|analgesics|mesh-ancestor
101254428|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
101254429|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254430|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101254431|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101254432|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
101254433|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
101254434|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
101254435|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254436|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254437|NCT01698723|Ribavirin|ribavirin|mesh-list
101254438|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
101254439|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254440|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
101254441|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254451|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254452|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254453|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254454|NCT01698788|Dexamethasone|dexamethasone|mesh-list
101254455|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
101254456|NCT01698788|BB 1101|bb 1101|mesh-list
101254457|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254458|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
101254459|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
101254460|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254461|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254462|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254463|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
101254464|NCT01698788|Hormones|hormones|mesh-ancestor
101254465|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254466|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254467|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546576|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101254468|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
101254469|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254470|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254471|NCT01698931|Glyburide|glyburide|mesh-list
101254472|NCT01698931|Repaglinide|repaglinide|mesh-list
101254473|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254474|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254475|NCT01699113|Rabeprazole|rabeprazole|mesh-list
101254476|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101254477|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254478|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101254479|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254480|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254481|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101254482|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101254483|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101254484|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
101254485|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254486|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101254487|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101254488|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254489|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
101254490|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101254491|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
101254492|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254493|NCT01699204|Expectorants|expectorants|mesh-ancestor
101254494|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
101254495|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101254496|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
101254497|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254498|NCT01699204|Protective Agents|protective agents|mesh-ancestor
101254499|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254500|NCT01699204|Antidotes|antidotes|mesh-ancestor
101254501|NCT01699282|Antivitamins K|antivitamins k|mesh-list
101254502|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
101254504|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254505|NCT01699360|Cyclosporine|cyclosporine|mesh-list
101254506|NCT01699360|Sirolimus|sirolimus|mesh-list
101254507|NCT01699360|Tacrolimus|tacrolimus|mesh-list
101254508|NCT01699360|Cyclosporins|cyclosporins|mesh-list
101254509|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254510|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
101254511|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254520|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101254521|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254522|NCT01699412|Dexamethasone|dexamethasone|mesh-list
101254523|NCT01699412|Clobetasol|clobetasol|mesh-list
101254524|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254525|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
101254526|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
101254527|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254528|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254529|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254530|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
101254531|NCT01699412|Hormones|hormones|mesh-ancestor
101254532|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254533|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254535|NCT01699438|Mesalamine|mesalamine|mesh-list
101254536|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101254537|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101254538|NCT01699438|Analgesics|analgesics|mesh-ancestor
101254539|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
101254540|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254541|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254542|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546585|NCT04310254|Antidotes|antidotes|mesh-ancestor
101254543|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101254544|NCT01699490|Valsartan|valsartan|mesh-list
101254545|NCT01699490|Fluoxetine|fluoxetine|mesh-list
101254546|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101254547|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101254548|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101254549|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254550|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101254551|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101254552|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101254553|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254554|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
101254555|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254556|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101254557|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
101254558|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254559|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101254560|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254561|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254562|NCT01699594|Mannitol|mannitol|mesh-list
101254563|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
101254564|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101254565|NCT01699594|Diuretics|diuretics|mesh-ancestor
101254566|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
101254567|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254568|NCT01699594|Miotics|miotics|mesh-ancestor
101254569|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
101254570|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254571|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101254572|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101254573|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
101254574|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101254575|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101254576|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
101254577|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254578|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254589|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254590|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101254591|NCT01699724|Sertraline|sertraline|mesh-list
101254592|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
101254593|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254594|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101254595|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101254596|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101254597|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254598|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254599|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
101254600|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254601|NCT01699776|Digoxin|digoxin|mesh-list
101254602|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101254603|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101254604|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217741|NCT01489059|Ipilimumab|ipilimumab|mesh-list
101254605|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254606|NCT01699776|Protective Agents|protective agents|mesh-ancestor
101254607|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254608|NCT01699802|Anesthetics|anesthetics|mesh-list
101254609|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254610|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254611|NCT01699828|Buspirone|buspirone|mesh-list
101254612|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101415764|NCT00502567|Pemetrexed|pemetrexed|mesh-list
101415765|NCT00502567|Cetuximab|cetuximab|mesh-list
101415766|NCT00502567|Cediranib|cediranib|mesh-list
101415767|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415768|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415769|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415772|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
101254613|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101254614|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254615|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254616|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254617|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101254618|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
101254619|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254620|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254621|NCT01699854|Capsaicin|capsaicin|mesh-list
101254622|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
101254623|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101254624|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
101254625|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254626|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254627|NCT01699919|Lidocaine|lidocaine|mesh-list
101254628|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
101254629|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
101254630|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254631|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254632|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
101254633|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254634|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101254635|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101254636|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101254637|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101254638|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254639|NCT01699932|Metformin|metformin|mesh-list
101254640|NCT01699932|Glimepiride|glimepiride|mesh-list
101254641|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101254652|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101254653|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254654|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101254655|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101254656|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101254657|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254658|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101254659|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254660|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
101254661|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101254662|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101254663|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254664|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254665|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415773|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101415774|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546589|NCT01603511|Charcoal|charcoal|mesh-list
101254666|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101254667|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101254668|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101254669|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254670|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254671|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
101254672|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101254673|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
101254674|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101254675|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254676|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254677|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101254678|NCT01700322|Clopidogrel|clopidogrel|mesh-list
101254679|NCT01700322|Ticagrelor|ticagrelor|mesh-list
101254680|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101254681|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101254682|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101254683|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101254684|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101254685|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
101254686|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254687|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254688|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254689|NCT01700400|Bevacizumab|bevacizumab|mesh-list
101254690|NCT01700400|Carboplatin|carboplatin|mesh-list
101254691|NCT01700400|Pemetrexed|pemetrexed|mesh-list
101254692|NCT01700400|Everolimus|everolimus|mesh-list
101254693|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101254694|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254695|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101254696|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101254697|NCT01700400|Growth Substances|growth substances|mesh-ancestor
101254698|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254699|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
101254700|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254701|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254702|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101254703|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101254704|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101254705|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101254711|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101254712|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101254713|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254714|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254715|NCT01700426|Vitamins|vitamins|mesh-list
101254716|NCT01700426|Vitamin E|vitamin e|mesh-list
101254717|NCT01700426|Tocopherols|tocopherols|mesh-list
101254718|NCT01700426|Tocotrienols|tocotrienols|mesh-list
101254719|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
101254720|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
101254721|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254722|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
101254723|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254724|NCT01700426|Protective Agents|protective agents|mesh-ancestor
101254725|NCT01700478|Vasopressins|vasopressins|mesh-list
101254726|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
101254727|NCT01700478|Misoprostol|misoprostol|mesh-list
101254728|NCT01700478|Diuretics|diuretics|mesh-list
101254729|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254730|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101254731|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
101254732|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254733|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101254734|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546608|NCT01609127|Capecitabine|capecitabine|mesh-list
101546610|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
101254736|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
101254737|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
101254738|NCT01700478|Coagulants|coagulants|mesh-ancestor
101254739|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101254740|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101254741|NCT01700491|Ropivacaine|ropivacaine|mesh-list
101254742|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
101254743|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
101254744|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254745|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254746|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
101254747|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254748|NCT01700504|Gentamicins|gentamicins|mesh-list
101254749|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254750|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254751|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101254752|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254753|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254754|NCT01700608|Plerixafor|plerixafor|mesh-list
101254755|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101254756|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254757|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
101254758|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254759|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101254760|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101254761|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254762|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
101254763|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
101254764|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
101254765|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254766|NCT01700790|Ritonavir|ritonavir|mesh-list
101254767|NCT01700790|Lopinavir|lopinavir|mesh-list
101254768|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101537397|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
101254769|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101254770|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
101254771|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254772|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254774|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254775|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
101254776|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254777|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101254778|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101254779|NCT01700803|Iodine|iodine|mesh-list
101254788|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
101254789|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
101254790|NCT01700881|Vitamin E|vitamin e|mesh-list
101254791|NCT01700881|Vitamins|vitamins|mesh-ancestor
101254792|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
101254793|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254794|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
101254795|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254796|NCT01700881|Protective Agents|protective agents|mesh-ancestor
101254797|NCT01701076|Dexamethasone|dexamethasone|mesh-list
101254799|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101254800|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254801|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
101254802|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
101254803|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254804|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254805|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254806|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
101254807|NCT01701076|Hormones|hormones|mesh-ancestor
101254808|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254809|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415783|NCT00502567|Vitamins|vitamins|mesh-ancestor
101254810|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254811|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415784|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
101546613|NCT01609166|Allopurinol|allopurinol|mesh-list
101254812|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
101254813|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101254814|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101254815|NCT01701076|Growth Substances|growth substances|mesh-ancestor
101254816|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
101254817|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101254818|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
101254819|NCT01701089|Selegiline|selegiline|mesh-list
101254820|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
101254821|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254822|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101254823|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101254824|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101254825|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254826|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254827|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101254828|NCT01701089|Protective Agents|protective agents|mesh-ancestor
101254829|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217955|NCT01489943|Midazolam|midazolam|mesh-list
101254830|NCT01701180|Oxytocin|oxytocin|mesh-list
101254831|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
101254832|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101254833|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254834|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101254835|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254836|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254837|NCT01701232|Rituximab|rituximab|mesh-list
101254838|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101254839|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254840|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
101254841|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254842|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101254843|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101254844|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101254845|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254846|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101254847|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
101254848|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101254857|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101254858|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
101254859|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254860|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
101254861|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254862|NCT01701336|Cloricromen|cloricromen|mesh-list
101254863|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101254864|NCT01701349|Paclitaxel|paclitaxel|mesh-list
101254865|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
101254866|NCT01701349|Combretastatin|combretastatin|mesh-list
101254867|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101254868|NCT01701349|Carboplatin|carboplatin|mesh-list
101254869|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101254870|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254871|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101254872|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101254873|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101254874|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254875|NCT01701453|Clopidogrel|clopidogrel|mesh-list
101254876|NCT01701453|Ticagrelor|ticagrelor|mesh-list
101254877|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101254878|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101254879|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101254880|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101254881|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101254882|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
101254883|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254884|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254885|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546620|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
101254886|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101254887|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101254888|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254889|NCT01701479|Aldesleukin|aldesleukin|mesh-list
101254890|NCT01701479|Interleukin-2|interleukin-2|mesh-list
101254891|NCT01701479|Dinutuximab|dinutuximab|mesh-list
101254892|NCT01701479|Isotretinoin|isotretinoin|mesh-list
101254893|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254894|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101254895|NCT01701479|Analgesics|analgesics|mesh-ancestor
101254896|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
101254897|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254898|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254899|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101254900|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254901|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
101254902|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254903|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
101254904|NCT01701518|Dexamethasone|dexamethasone|mesh-list
101254905|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254906|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
101254907|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
101254908|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254909|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254910|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101254911|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
101254913|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101254914|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101254915|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254916|NCT01701583|Omalizumab|omalizumab|mesh-list
101254917|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101254918|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101254923|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254924|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254925|NCT01701739|Protective Agents|protective agents|mesh-ancestor
101254926|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254927|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
101254928|NCT01701778|Sevoflurane|sevoflurane|mesh-list
101254929|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
101254930|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101254931|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254932|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254933|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101254934|NCT01701778|Analgesics|analgesics|mesh-ancestor
101254935|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
101254936|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254937|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101254938|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101254939|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101254940|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101254941|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101254942|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254943|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101254944|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101254945|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
101546628|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546629|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546630|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546631|NCT00592566|Dexamethasone|dexamethasone|mesh-list
101546632|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101546633|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254947|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
101254948|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
101254949|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101254950|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
101254951|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254952|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101254953|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101254954|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101254955|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101326347|NCT00116896|Cisplatin|cisplatin|mesh-list
101254956|NCT01701856|Interferons|interferons|mesh-list
101254957|NCT01701856|Interferon-beta|interferon-beta|mesh-list
101254958|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
101254959|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101254960|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
101254961|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254962|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
101254963|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254964|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101254966|NCT01701882|Emtricitabine|emtricitabine|mesh-list
101254967|NCT01701882|Rilpivirine|rilpivirine|mesh-list
101254968|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
101254969|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101254970|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101254971|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101254972|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101254973|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254974|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101254975|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101254976|NCT01701921|Pregabalin|pregabalin|mesh-list
101254977|NCT01701921|Analgesics|analgesics|mesh-ancestor
101254978|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
101254979|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101254980|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101254981|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
101254982|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101218106|NCT01490437|Hormones|hormones|mesh-ancestor
101254983|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101254984|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101254985|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101254987|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101254988|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101254989|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101254990|NCT01702038|Rituximab|rituximab|mesh-list
101254998|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101254999|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101255000|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255001|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255002|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255003|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101255004|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101255005|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
101255006|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255007|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101255008|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255009|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
101255010|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255011|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101255012|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101255013|NCT01702129|Doxorubicin|doxorubicin|mesh-list
101255014|NCT01702129|Cetuximab|cetuximab|mesh-list
101255015|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101255016|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255017|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255018|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255019|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255020|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255021|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255023|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255024|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
101546644|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
101255025|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255026|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101255027|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255028|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255029|NCT01702207|Tacrolimus|tacrolimus|mesh-list
101255030|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255031|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
101255032|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255033|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101255034|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255035|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255036|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
101255037|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101255038|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255039|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255040|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255041|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255042|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255043|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255044|NCT01702389|Remifentanil|remifentanil|mesh-list
101255045|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101255046|NCT01702389|Narcotics|narcotics|mesh-ancestor
101255047|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255048|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255049|NCT01702389|Analgesics|analgesics|mesh-ancestor
101255050|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
101255051|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255052|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
101255053|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101255054|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255055|NCT01702506|Antacids|antacids|mesh-list
101218183|NCT01490944|Vitamins|vitamins|mesh-ancestor
101255056|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255057|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101255058|NCT01702610|Temozolomide|temozolomide|mesh-list
101255065|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101255066|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255067|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255068|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255069|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101255070|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101255071|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
101255072|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101255073|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101255074|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255075|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
101255076|NCT01702636|Coagulants|coagulants|mesh-ancestor
101255077|NCT01702649|Biapenem|biapenem|mesh-list
101255078|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255079|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
101255080|NCT01702688|Giapreza|giapreza|mesh-list
101255081|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
101255082|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101255083|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101255084|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255085|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255086|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255087|NCT01702701|Fluticasone|fluticasone|mesh-list
101255088|NCT01702701|Montelukast|montelukast|mesh-list
101255089|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255090|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101255091|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
101255092|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255093|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255094|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101255095|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
101255096|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101255097|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101546646|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101255098|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101255099|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
101255100|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255101|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101255102|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101255103|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255105|NCT01702714|Carboplatin|carboplatin|mesh-list
101255106|NCT01702714|Gemcitabine|gemcitabine|mesh-list
101255107|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101255108|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255109|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
101255110|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
101255111|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
101255112|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255113|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101255114|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
101255115|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101255116|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101255117|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
101255118|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255119|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101255120|NCT01702857|Vaccines|vaccines|mesh-list
101255121|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
101255122|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
101255123|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255124|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101255125|NCT01702857|Antacids|antacids|mesh-ancestor
101255126|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255136|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255137|NCT01703104|Folic Acid|folic acid|mesh-list
101255138|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
101255139|NCT01703104|Proguanil|proguanil|mesh-list
101255140|NCT01703104|Hematinics|hematinics|mesh-ancestor
101255141|NCT01703104|Vitamins|vitamins|mesh-ancestor
101255142|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
101255143|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255144|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
101255145|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101255146|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101255147|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255148|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
101255149|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255150|NCT01703130|Ropivacaine|ropivacaine|mesh-list
101255151|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255152|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
101255153|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255154|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255155|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
101255156|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255157|NCT01703234|Ramipril|ramipril|mesh-list
101255158|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101255159|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255160|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255161|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255162|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101255163|NCT01703312|Omalizumab|omalizumab|mesh-list
101255164|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101255165|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101255166|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101255167|NCT01703325|Triamcinolone|triamcinolone|mesh-list
101255168|NCT01703325|Clobetasol|clobetasol|mesh-list
101255169|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255170|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
101255171|NCT01703325|Hormones|hormones|mesh-ancestor
101255172|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255173|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255174|NCT01703351|Fentanyl|fentanyl|mesh-list
101546652|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255175|NCT01703351|Ropivacaine|ropivacaine|mesh-list
101255176|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255177|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
101255178|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255179|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255180|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
101255181|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255182|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101255183|NCT01703351|Narcotics|narcotics|mesh-ancestor
101255184|NCT01703351|Analgesics|analgesics|mesh-ancestor
101255185|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101255186|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101255187|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
101255188|NCT01703364|Lenalidomide|lenalidomide|mesh-list
101255189|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
101255190|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255191|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101255192|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101255193|NCT01703364|Growth Substances|growth substances|mesh-ancestor
101255194|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
101255195|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255196|NCT01703390|Cetuximab|cetuximab|mesh-list
101255197|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255201|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101255202|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255203|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255204|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
101255205|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
101255206|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101255207|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255208|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255209|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255210|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101255211|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101255212|NCT01703559|Phentolamine|phentolamine|mesh-list
101255213|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101255214|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101255215|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101255216|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101255217|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
101255218|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255219|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255220|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255221|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101255222|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
101255223|NCT01703624|Bromides|bromides|mesh-list
101255224|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
101255225|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101255226|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101255227|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101255228|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
101255229|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255230|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255231|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255232|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101255233|NCT01703637|Vildagliptin|vildagliptin|mesh-list
101255234|NCT01703637|Saxagliptin|saxagliptin|mesh-list
101255235|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255236|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255237|NCT01703637|Incretins|incretins|mesh-ancestor
101255238|NCT01703637|Hormones|hormones|mesh-ancestor
101546659|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546660|NCT00622830|Darapladib|darapladib|mesh-list
101546661|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101546662|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546663|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255239|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255240|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101255241|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255242|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255243|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255244|NCT01703728|Menotropins|menotropins|mesh-list
101255245|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101255246|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
101255247|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101255248|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255249|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
101255250|NCT01703754|Ifosfamide|ifosfamide|mesh-list
101255251|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101255252|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
101255253|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255254|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255255|NCT01703910|Paclitaxel|paclitaxel|mesh-list
101255256|NCT01703910|Etoposide|etoposide|mesh-list
101255257|NCT01703910|Vinorelbine|vinorelbine|mesh-list
101255258|NCT01703910|Docetaxel|docetaxel|mesh-list
101255259|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101255260|NCT01703910|Cisplatin|cisplatin|mesh-list
101255261|NCT01703910|Gemcitabine|gemcitabine|mesh-list
101255262|NCT01703910|Doxorubicin|doxorubicin|mesh-list
101255263|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101255264|NCT01703910|Fluorouracil|fluorouracil|mesh-list
101255265|NCT01703910|Capecitabine|capecitabine|mesh-list
101255266|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
101255267|NCT01703910|Irinotecan|irinotecan|mesh-list
101255268|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
101255269|NCT01703910|Pemetrexed|pemetrexed|mesh-list
101255270|NCT01703910|Cetuximab|cetuximab|mesh-list
101255271|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101255272|NCT01703910|Sorafenib|sorafenib|mesh-list
101255280|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101255281|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101255282|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218418|NCT01492712|Propofol|propofol|mesh-list
101255283|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255284|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101255285|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
101255286|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101255287|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255288|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255289|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255290|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255291|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
101255292|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255293|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101255294|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101255295|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101255296|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255297|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101255298|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
101255300|NCT01704027|Hormones|hormones|mesh-ancestor
101255301|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255302|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255303|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
101255304|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101255305|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255306|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255307|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255309|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
101255310|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255311|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101255312|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101255313|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101255314|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
101255315|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255316|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255317|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101255318|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101255320|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
101546667|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255321|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
101255322|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
101255323|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255324|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255325|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
101255326|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
101255327|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255328|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255329|NCT01704417|Insulin|insulin|mesh-list
101255330|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101255331|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
101255332|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255333|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255334|NCT01704469|Anesthetics|anesthetics|mesh-list
101255335|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
101255336|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255337|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255338|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
101255339|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255340|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
101255341|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101255342|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
101255343|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255344|NCT01704482|Expectorants|expectorants|mesh-ancestor
101255352|NCT01704508|Lumefantrine|lumefantrine|mesh-list
101255354|NCT01704508|Piperaquine|piperaquine|mesh-list
101255355|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101255356|NCT01704508|Artenimol|artenimol|mesh-list
101255357|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
101255358|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101255359|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101255360|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255361|NCT01704534|Ustekinumab|ustekinumab|mesh-list
101255362|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
101255363|NCT01704612|Ropivacaine|ropivacaine|mesh-list
101255364|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255365|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
101255366|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255367|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255368|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
101255369|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255370|NCT01704638|Digoxin|digoxin|mesh-list
101255371|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
101255372|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101255373|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101255374|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255375|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255376|NCT01704638|Protective Agents|protective agents|mesh-ancestor
101255377|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255378|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101255379|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101255380|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255381|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101255382|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101255383|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101255384|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255385|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255386|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
101255387|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101255388|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
101255389|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101255390|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255391|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101546669|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
101546670|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546671|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255393|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101255394|NCT01704690|Cisplatin|cisplatin|mesh-list
101255396|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101255397|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255398|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101255399|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101255400|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101255401|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255402|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
101255403|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101255404|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255405|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
101255406|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255407|NCT01704703|Panitumumab|panitumumab|mesh-list
101255408|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255409|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255410|NCT01704716|Aldesleukin|aldesleukin|mesh-list
101255411|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
101255412|NCT01704716|Melphalan|melphalan|mesh-list
101255413|NCT01704716|Busulfan|busulfan|mesh-list
101255414|NCT01704716|Carboplatin|carboplatin|mesh-list
101255423|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255424|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101255425|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
101255426|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255427|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255428|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101255429|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101255430|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255431|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255432|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255433|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101255434|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101255435|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101255436|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101255437|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255438|NCT01704716|Analgesics|analgesics|mesh-ancestor
101255439|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
101255440|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255441|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101255442|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101255443|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
101255444|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255446|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
101255447|NCT01704794|Proguanil|proguanil|mesh-list
101255448|NCT01704794|Hematinics|hematinics|mesh-ancestor
101255449|NCT01704794|Vitamins|vitamins|mesh-ancestor
101255450|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
101255451|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255452|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
101415787|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415788|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415789|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
101415790|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
101415791|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
101255454|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101255455|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255456|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
101415792|NCT00502684|Etodolac|etodolac|mesh-list
101415793|NCT00502684|Propranolol|propranolol|mesh-list
101255457|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255458|NCT01704872|Dinutuximab|dinutuximab|mesh-list
101255459|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255460|NCT01704898|Efavirenz|efavirenz|mesh-list
101255461|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101255462|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101255463|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255464|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255465|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
101255466|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255467|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101255468|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255469|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101255470|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101255471|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101255472|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101255473|NCT01705002|Bevacizumab|bevacizumab|mesh-list
101255474|NCT01705002|Capecitabine|capecitabine|mesh-list
101255475|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255476|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255477|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101255478|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101255479|NCT01705002|Growth Substances|growth substances|mesh-ancestor
101255480|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255481|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
101255482|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101255483|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
101420755|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255491|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101255492|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255493|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255494|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255495|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255496|NCT01705223|Vaccines|vaccines|mesh-list
101255497|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
101255498|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255499|NCT01705249|Norethindrone|norethindrone|mesh-list
101255500|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
101255501|NCT01705249|Estradiol|estradiol|mesh-list
101255502|NCT01705249|Estrogens|estrogens|mesh-ancestor
101255503|NCT01705249|Hormones|hormones|mesh-ancestor
101255504|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255505|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255506|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101255507|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
101255508|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101255509|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101255510|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101255511|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101255512|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101255513|NCT01705314|Vitamin D|vitamin d|mesh-list
101255514|NCT01705314|Vitamins|vitamins|mesh-ancestor
101326780|NCT00402181|Siltuximab|siltuximab|mesh-list
101255515|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
101255516|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255517|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101255519|NCT01705340|Lapatinib|lapatinib|mesh-list
101255520|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255521|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255522|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546687|NCT01110382|Doripenem|doripenem|mesh-list
101546688|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101546694|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
101255523|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255524|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255525|NCT01705379|Lactitol|lactitol|mesh-list
101255526|NCT01705379|Cathartics|cathartics|mesh-ancestor
101255527|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101255528|NCT01705392|Bevacizumab|bevacizumab|mesh-list
101255529|NCT01705392|Dacarbazine|dacarbazine|mesh-list
101255530|NCT01705392|Propranolol|propranolol|mesh-list
101255531|NCT01705392|Enalapril|enalapril|mesh-list
101255532|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255533|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255534|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101255535|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101255536|NCT01705392|Growth Substances|growth substances|mesh-ancestor
101255537|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255538|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
101255539|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101255540|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101255541|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
101255542|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255543|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255544|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101255545|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101255546|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
101255547|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101255548|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
101255549|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101255550|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255551|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255552|NCT01705457|Vitamin A|vitamin a|mesh-list
101255553|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
101255558|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255559|NCT01705457|Protective Agents|protective agents|mesh-ancestor
101255560|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101255561|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255562|NCT01705470|Furosemide|furosemide|mesh-list
101255563|NCT01705470|Diuretics|diuretics|mesh-ancestor
101255564|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
101255565|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255566|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101255567|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255568|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255569|NCT01705483|Paclitaxel|paclitaxel|mesh-list
101255570|NCT01705483|Docetaxel|docetaxel|mesh-list
101255571|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101255572|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255573|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
101255574|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
101255575|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
101255576|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255577|NCT01705639|Melatonin|melatonin|mesh-list
101255578|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
101255579|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255580|NCT01705639|Protective Agents|protective agents|mesh-ancestor
101255581|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326849|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
101255582|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255584|NCT01705743|Sevoflurane|sevoflurane|mesh-list
101546704|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546705|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546706|NCT01609517|Bupivacaine|bupivacaine|mesh-list
101546707|NCT01609517|Anesthetics|anesthetics|mesh-list
101546708|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255585|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101255586|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101255587|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
101255588|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
101255589|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255591|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255592|NCT01705743|Analgesics|analgesics|mesh-ancestor
101255593|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
101255594|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255595|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101255596|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255597|NCT01705769|Micronutrients|micronutrients|mesh-list
101255598|NCT01705769|Trace Elements|trace elements|mesh-list
101255599|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255600|NCT01705795|Antibodies|antibodies|mesh-list
101255601|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
101255602|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255603|NCT01705808|Protein C|protein c|mesh-list
101255604|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
101255605|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101255606|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101255607|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255608|NCT01705938|Dolcanatide|dolcanatide|mesh-list
101255609|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101255610|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
101255611|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255612|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101255613|NCT01705951|Nicotine|nicotine|mesh-list
101255614|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101255615|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
101255616|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255617|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255618|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101255619|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101255620|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
101255621|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255622|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255623|NCT01706055|Interferons|interferons|mesh-list
101255624|NCT01706055|Interferon-beta|interferon-beta|mesh-list
101255625|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
101255626|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255643|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255645|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255646|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255647|NCT01706315|Gepotidacin|gepotidacin|mesh-list
101255648|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255649|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255650|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255651|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255652|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101255653|NCT01706354|Anesthetics|anesthetics|mesh-list
101255654|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
101255655|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255656|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255657|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
101255658|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255659|NCT01706367|Vaccines|vaccines|mesh-list
101255660|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
101255661|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255662|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
101255663|NCT01706471|Everolimus|everolimus|mesh-list
101255664|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101255665|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101255666|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546716|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
101546717|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
101546718|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101546719|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546720|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
101255667|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255668|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101255669|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
101255670|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255671|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255672|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101255673|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101255674|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
101255676|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255679|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101255680|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101255681|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101255682|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101255683|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
101255684|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255685|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255692|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255693|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255694|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101255695|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
101255696|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255697|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255698|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101255699|NCT01706627|Melatonin|melatonin|mesh-list
101255700|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
101255701|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255702|NCT01706627|Protective Agents|protective agents|mesh-ancestor
101255703|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255704|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255705|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
101255706|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101255707|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255708|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101255709|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101255710|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255711|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255712|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255713|NCT01706874|Listerine|listerine|mesh-list
101255714|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101255715|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255716|NCT01706887|Amiloride|amiloride|mesh-list
101255717|NCT01706887|Diuretics|diuretics|mesh-ancestor
101255718|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
101255719|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255720|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101255721|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255722|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255723|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255724|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101255725|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101255726|NCT01707082|Midazolam|midazolam|mesh-list
101255727|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101255728|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101255729|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255730|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546724|NCT02489006|Olaparib|olaparib|mesh-list
101546725|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101546729|NCT01173601|Serotonin|serotonin|mesh-list
101255731|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101255732|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101255733|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101255734|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101255735|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
101218852|NCT01495195|Selegiline|selegiline|mesh-list
101255737|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
101255738|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
101255739|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255740|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255741|NCT01707134|Insulin|insulin|mesh-list
101255742|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101255743|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
101255744|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
101255745|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
101255746|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
101255747|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255748|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255749|NCT01707160|Insulin|insulin|mesh-list
101255750|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101255751|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
101255752|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
101255753|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101255761|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101255762|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101255763|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255764|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255765|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
101255766|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
101255767|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101255768|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
101255769|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101255770|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255771|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255772|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101255773|NCT01707251|Ibuprofen|ibuprofen|mesh-list
101255774|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101255775|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255776|NCT01707251|Analgesics|analgesics|mesh-ancestor
101255777|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
101255778|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255779|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255780|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255781|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255782|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101255783|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255784|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255785|NCT01707316|Canagliflozin|canagliflozin|mesh-list
101255786|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101255787|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255788|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255789|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255790|NCT01707342|Simeprevir|simeprevir|mesh-list
101255791|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
101255792|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255793|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
101255794|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255795|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255796|NCT01707394|Apixaban|apixaban|mesh-list
101255797|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101255798|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
101255799|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101255800|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101546736|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101255801|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255802|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255803|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
101546737|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255804|NCT01707407|Ketoconazole|ketoconazole|mesh-list
101255805|NCT01707407|Pomalidomide|pomalidomide|mesh-list
101255806|NCT01707407|Carbamazepine|carbamazepine|mesh-list
101255807|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
101255808|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
101255809|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218930|NCT01495624|Dexamethasone|dexamethasone|mesh-list
101255810|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101255811|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101255812|NCT01707407|Growth Substances|growth substances|mesh-ancestor
101255813|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
101255814|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255815|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
101255816|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255817|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101255818|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255819|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255820|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255821|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101255829|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101255830|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255832|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
101255833|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255834|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255835|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255836|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101255837|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101255838|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101255839|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101255840|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101255841|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255842|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
101255843|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101255844|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
101255845|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101255846|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101255847|NCT01707537|Vaccines|vaccines|mesh-list
101255848|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
101255849|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255850|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
101255851|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
101255852|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255853|NCT01707615|Protective Agents|protective agents|mesh-ancestor
101255854|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255855|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101255856|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101255857|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255858|NCT01707732|Enoxaparin|enoxaparin|mesh-list
101255859|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
101255860|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101255861|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101255862|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255863|NCT01707745|Bevacizumab|bevacizumab|mesh-list
101255864|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101255865|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255866|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101255867|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101255868|NCT01707745|Growth Substances|growth substances|mesh-ancestor
101255869|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255870|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
101255871|NCT01707823|Aspirin|aspirin|mesh-list
101255872|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101255873|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101255874|NCT01707823|Analgesics|analgesics|mesh-ancestor
101255875|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
101255876|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255877|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415802|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101255878|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255879|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255880|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101255881|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101327024|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255882|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255883|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101255884|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101255885|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255886|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
101255887|NCT01707849|Everolimus|everolimus|mesh-list
101255895|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101255896|NCT01707940|Ketoconazole|ketoconazole|mesh-list
101255897|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
101255898|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255899|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101255900|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101255901|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255902|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255903|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101255904|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
101255905|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101255906|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255907|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101255908|NCT01707953|Midodrine|midodrine|mesh-list
101255909|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
101255910|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
101255911|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255912|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255913|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101255914|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101255915|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101255916|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101255917|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
101255918|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255919|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255920|NCT01708005|Vitamin D|vitamin d|mesh-list
101255921|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
101255922|NCT01708005|Vitamins|vitamins|mesh-ancestor
101255923|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
101255924|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255925|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101255926|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101255927|NCT01708044|Pramlintide|pramlintide|mesh-list
101255928|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101255929|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255930|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
101255931|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101255932|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101255933|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255934|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
101255935|NCT01708239|Coagulants|coagulants|mesh-ancestor
101255936|NCT01708330|Lidocaine|lidocaine|mesh-list
101255937|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
101255938|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
101255939|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255940|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255941|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
101255942|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255943|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101255944|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101255945|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101415805|NCT00502684|Analgesics|analgesics|mesh-ancestor
101415806|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
101415808|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101255946|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255947|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255948|NCT01708369|Aspirin|aspirin|mesh-list
101255949|NCT01708369|Ethanol|ethanol|mesh-list
101255950|NCT01708369|Oseltamivir|oseltamivir|mesh-list
101255951|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101255958|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101255959|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101255960|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101255961|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255962|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101255963|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101255964|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101255965|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
101255966|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101255967|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101255968|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255969|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
101255970|NCT01708447|Lidocaine|lidocaine|mesh-list
101255971|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
101255972|NCT01708447|Anesthetics|anesthetics|mesh-list
101255973|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255974|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255975|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
101255976|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101255977|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101255978|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101255979|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101255980|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101255981|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255983|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101255984|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
101255985|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101255986|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101255987|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101255988|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101255989|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101255990|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101255991|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101255992|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101255993|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
101255994|NCT01708642|Epinephrine|epinephrine|mesh-list
101255995|NCT01708642|Racepinephrine|racepinephrine|mesh-list
101255996|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
101255997|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101255998|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101255999|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256000|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256001|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256002|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256003|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101256004|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101256005|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
101256006|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256007|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256008|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101327095|NCT00122590|Ritonavir|ritonavir|mesh-list
101256009|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
101256010|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
101256011|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101256012|NCT01708707|Morphine|morphine|mesh-list
101256013|NCT01708707|Buprenorphine|buprenorphine|mesh-list
101256014|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101415814|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101415815|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415819|NCT00502879|Etanercept|etanercept|mesh-list
101256016|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256017|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256018|NCT01708707|Analgesics|analgesics|mesh-ancestor
101256019|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
101256020|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256030|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101256031|NCT01708798|Diuretics|diuretics|mesh-ancestor
101256032|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
101256033|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256034|NCT01708837|Propofol|propofol|mesh-list
101256035|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101256036|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256037|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256038|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101256039|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
101256040|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
101256041|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
101256042|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101256043|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
101256044|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101256045|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
101256046|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327135|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256047|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256048|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
101256049|NCT01708876|Artesunate|artesunate|mesh-list
101256050|NCT01708876|Chloroquine|chloroquine|mesh-list
101256051|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101256052|NCT01708876|Primaquine|primaquine|mesh-list
101256053|NCT01708876|Mefloquine|mefloquine|mesh-list
101256054|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
101256055|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101256056|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101256057|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256058|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256059|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
101256060|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
101256061|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101256062|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
101256063|NCT01708876|Amebicides|amebicides|mesh-ancestor
101256064|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256065|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256066|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256067|NCT01708876|Analgesics|analgesics|mesh-ancestor
101256068|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
101256069|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256070|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256071|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256072|NCT01708876|Filaricides|filaricides|mesh-ancestor
101256073|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
101256074|NCT01709019|Vaccines|vaccines|mesh-list
101256075|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
101256076|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256077|NCT01709071|Vaccines|vaccines|mesh-list
101256078|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
101256079|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256080|NCT01709292|Vemurafenib|vemurafenib|mesh-list
101256081|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256082|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256083|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256084|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256085|NCT01709370|Letrozole|letrozole|mesh-list
101256086|NCT01709370|Palbociclib|palbociclib|mesh-list
101256087|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256088|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101256096|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256097|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
101256098|NCT01709630|Analgesics|analgesics|mesh-ancestor
101256099|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
101256100|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256101|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256102|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
101546738|NCT01609673|Everolimus|everolimus|mesh-list
101546739|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101256103|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256104|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101256105|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
101256106|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101256107|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256108|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256109|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256110|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
101256111|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256113|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256114|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256115|NCT01709656|Analgesics|analgesics|mesh-ancestor
101256116|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
101256117|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256118|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256119|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256120|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256121|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101256122|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101256123|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256124|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256125|NCT01709682|Amiodarone|amiodarone|mesh-list
101256126|NCT01709682|Sotalol|sotalol|mesh-list
101256127|NCT01709682|Flecainide|flecainide|mesh-list
101256128|NCT01709682|Propafenone|propafenone|mesh-list
101256129|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101256130|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
101256131|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101256132|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256133|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256134|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101256135|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101256136|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101256137|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256138|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101256139|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101256140|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101256141|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101256142|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101256143|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256144|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256145|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256146|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
101256148|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256149|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101256150|NCT01709760|Methotrexate|methotrexate|mesh-list
101256151|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101256152|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
101256153|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256154|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256164|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256165|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101256166|NCT01709825|Sulfalene|sulfalene|mesh-list
101256167|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256168|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101256169|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
101256170|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101256171|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101256172|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
101256173|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101256174|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256175|NCT01709942|Cetrorelix|cetrorelix|mesh-list
101256176|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101256177|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
101546741|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256178|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256179|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256181|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256182|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101256183|NCT01709955|Cathartics|cathartics|mesh-ancestor
101256184|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256185|NCT01709994|Aspirin|aspirin|mesh-list
101256186|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256187|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256188|NCT01709994|Analgesics|analgesics|mesh-ancestor
101256189|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
101256190|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256191|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256192|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256193|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256194|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101256195|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101256196|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256197|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101256198|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101256199|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256200|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
101256201|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
101256202|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
101256203|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256204|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256205|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256206|NCT01710072|Aspirin|aspirin|mesh-list
101256207|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256208|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256209|NCT01710072|Analgesics|analgesics|mesh-ancestor
101256210|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
101256211|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256212|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256213|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256214|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256215|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101256216|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101256217|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256218|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101256219|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101256227|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256228|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256229|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
101256230|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
101256231|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256232|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256233|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101256234|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101256236|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101256237|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101256238|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101256239|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101256240|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
101256241|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546747|NCT01173055|Milnacipran|milnacipran|mesh-list
101546748|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
101546749|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101415823|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
101256242|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
101256243|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101256244|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101256246|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
101256247|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101256248|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
101256249|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256250|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
101256251|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
101256252|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256253|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256254|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256255|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
101256256|NCT01710228|Hormones|hormones|mesh-ancestor
101256257|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256258|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101256259|NCT01710228|Protective Agents|protective agents|mesh-ancestor
101256260|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101256261|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256262|NCT01710384|Betamethasone|betamethasone|mesh-list
101256263|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256264|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
101256265|NCT01710384|Hormones|hormones|mesh-ancestor
101327370|NCT00128401|Cycloserine|cycloserine|mesh-list
101256266|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256267|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256268|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256269|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256270|NCT01710462|Domperidone|domperidone|mesh-list
101256271|NCT01710462|Pantoprazole|pantoprazole|mesh-list
101256272|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101256273|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256274|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101256275|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256276|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256277|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
101256278|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
101256279|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256280|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256281|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101256282|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
101256283|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256284|NCT01710488|Levofloxacin|levofloxacin|mesh-list
101256285|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
101256286|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101256287|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256288|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101256296|NCT01710540|Metformin|metformin|mesh-list
101256297|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101256298|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256299|NCT01710553|Metformin|metformin|mesh-list
101256300|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101256301|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256302|NCT01710566|Misoprostol|misoprostol|mesh-list
101415829|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256303|NCT01710566|Oxytocin|oxytocin|mesh-list
101256304|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
101256305|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256306|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256307|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101256308|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
101256309|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101256310|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256311|NCT01710592|Docetaxel|docetaxel|mesh-list
101256312|NCT01710592|Capecitabine|capecitabine|mesh-list
101546762|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
101256313|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
101256315|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256316|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256317|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256318|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
101256319|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256320|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101256321|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
101256322|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101256323|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101256324|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101256325|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256326|NCT01710631|Eszopiclone|eszopiclone|mesh-list
101256327|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101256328|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256329|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256330|NCT01710670|Ethanol|ethanol|mesh-list
101256331|NCT01710670|Brivaracetam|brivaracetam|mesh-list
101256332|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101256333|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219450|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101256334|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256335|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256337|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101256338|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101256339|NCT01710696|Estradiol|estradiol|mesh-list
101256340|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101256341|NCT01710696|Estrogens|estrogens|mesh-ancestor
101256342|NCT01710696|Hormones|hormones|mesh-ancestor
101256343|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256344|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256345|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101256346|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
101256347|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256348|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101256349|NCT01710722|Ephedrine|ephedrine|mesh-list
101256350|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
101327424|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101256351|NCT01710722|Caffeine|caffeine|mesh-list
101256352|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101256353|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256354|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101256355|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256360|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256361|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
101256362|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
101256363|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256364|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101256365|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256366|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101256367|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256368|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256369|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
101256370|NCT01710748|Everolimus|everolimus|mesh-list
101256371|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101256372|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256373|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256374|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256375|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256376|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
101256377|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256378|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256379|NCT01710826|Venglustat|venglustat|mesh-list
101256380|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256381|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256382|NCT01710904|Oxycodone|oxycodone|mesh-list
101256383|NCT01710904|Naloxone|naloxone|mesh-list
101256384|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101256385|NCT01710904|Narcotics|narcotics|mesh-ancestor
101256386|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256387|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256388|NCT01710904|Analgesics|analgesics|mesh-ancestor
101256389|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
101256390|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256391|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101256392|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101256393|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101256394|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256395|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256396|NCT01711060|Oxytocin|oxytocin|mesh-list
101256397|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
101256398|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256399|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256400|NCT01711073|Plerixafor|plerixafor|mesh-list
101256401|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101256402|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101256403|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
101256404|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256405|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
101256406|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101256407|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
101256408|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219524|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256409|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256410|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256411|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256412|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101256413|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101256414|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101256415|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256416|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256417|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256419|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256420|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256421|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256422|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
101256423|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256424|NCT01711125|Baclofen|baclofen|mesh-list
101256425|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101256431|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
101256432|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256433|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256434|NCT01711229|Acetaminophen|acetaminophen|mesh-list
101256435|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256436|NCT01711229|Analgesics|analgesics|mesh-ancestor
101256437|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
101256438|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546798|NCT00593619|Hematinics|hematinics|mesh-ancestor
101256439|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256440|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
101327488|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
101256443|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256444|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101256445|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256446|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256447|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
101256448|NCT01711437|Simethicone|simethicone|mesh-list
101256449|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
101256450|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
101256451|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101256452|NCT01711437|Citric Acid|citric acid|mesh-list
101256453|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
101256454|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101256455|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
101256456|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101256457|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
101256458|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
101256459|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256460|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
101256461|NCT01711437|Protective Agents|protective agents|mesh-ancestor
101256462|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256463|NCT01711437|Vitamins|vitamins|mesh-ancestor
101256464|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
101256465|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
101256466|NCT01711437|Emollients|emollients|mesh-ancestor
101256467|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256468|NCT01711437|Cathartics|cathartics|mesh-ancestor
101256469|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256470|NCT01711437|Antacids|antacids|mesh-ancestor
101256471|NCT01711437|Laxatives|laxatives|mesh-ancestor
101256472|NCT01711463|Fluticasone|fluticasone|mesh-list
101256473|NCT01711463|Xhance|xhance|mesh-list
101256474|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256475|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101256476|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
101256477|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256478|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256479|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256480|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256481|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256482|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101256483|NCT01711476|Complement Factor H|complement factor h|mesh-list
101256484|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101219613|NCT01500005|Vitamin D|vitamin d|mesh-list
101256485|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256486|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
101256487|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256489|NCT01711489|Isavuconazole|isavuconazole|mesh-list
101327524|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
101256490|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101256491|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256492|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101256493|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
101256494|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101256495|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256496|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256497|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256498|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
101256508|NCT01711528|Ichthammol|ichthammol|mesh-list
101256509|NCT01711528|BB 1101|bb 1101|mesh-list
101256510|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546804|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546805|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256511|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
101256512|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
101256513|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256514|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256515|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256516|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
101256517|NCT01711528|Hormones|hormones|mesh-ancestor
101256518|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256519|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101256520|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256521|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
101256522|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256523|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256524|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256525|NCT01711567|Tenofovir|tenofovir|mesh-list
101256526|NCT01711567|Entecavir|entecavir|mesh-list
101256527|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
101256528|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256529|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101256530|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101256531|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256532|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256533|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101256534|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101256535|NCT01711593|Dimercaprol|dimercaprol|mesh-list
101256536|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
101256537|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
101256538|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256539|NCT01711671|Dexamethasone|dexamethasone|mesh-list
101256540|NCT01711671|Lenalidomide|lenalidomide|mesh-list
101256541|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256542|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
101256543|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
101256544|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256545|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256546|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256547|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
101256548|NCT01711671|Hormones|hormones|mesh-ancestor
101256549|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256550|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101256551|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256552|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
101256553|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101256554|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101256555|NCT01711671|Growth Substances|growth substances|mesh-ancestor
101256556|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
101256557|NCT01711697|Paclitaxel|paclitaxel|mesh-list
101256558|NCT01711697|Carboplatin|carboplatin|mesh-list
101256559|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101256560|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256561|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256562|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256563|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
101256564|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256565|NCT01711723|Darapladib|darapladib|mesh-list
101256566|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101256570|NCT01711749|Calcium|calcium|mesh-list
101256571|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256572|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256573|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101256574|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101256575|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
101256576|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256577|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101327568|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546811|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101546812|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
101256578|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101256579|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256580|NCT01711814|Peficitinib|peficitinib|mesh-list
101256581|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256582|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256583|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256584|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
101256585|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256586|NCT01711827|Isavuconazole|isavuconazole|mesh-list
101256587|NCT01711827|Prednisone|prednisone|mesh-list
101256588|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256589|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
101256590|NCT01711827|Hormones|hormones|mesh-ancestor
101256591|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101256592|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256593|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101256594|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256595|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
101256596|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256597|NCT01711905|Vitamin D|vitamin d|mesh-list
101256598|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
101256599|NCT01711905|Vitamins|vitamins|mesh-ancestor
101256600|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
101256601|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256602|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101256603|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256604|NCT01711931|Everolimus|everolimus|mesh-list
101256605|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101256606|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256607|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256608|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256609|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256610|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
101256611|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256612|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256613|NCT01711957|Liver Extracts|liver extracts|mesh-list
101256614|NCT01711957|Hematinics|hematinics|mesh-ancestor
101256615|NCT01711970|Paclitaxel|paclitaxel|mesh-list
101256616|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101256617|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256618|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256619|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256620|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101256621|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256622|NCT01712100|Irbesartan|irbesartan|mesh-list
101256623|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256624|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101256625|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101256626|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256627|NCT01712113|Irbesartan|irbesartan|mesh-list
101256628|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256629|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101256630|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101256631|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256632|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101256633|NCT01712126|Irbesartan|irbesartan|mesh-list
101256634|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256635|NCT01712126|Diuretics|diuretics|mesh-ancestor
101256636|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
101256651|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256652|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101256653|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101256655|NCT01712295|Salicylates|salicylates|mesh-list
101256656|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256657|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256658|NCT01712295|Analgesics|analgesics|mesh-ancestor
101256659|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
101256660|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256661|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256662|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101256663|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256664|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101256665|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256666|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256667|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256668|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
101256669|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
101256670|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
101256671|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101256672|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
101256673|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256674|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101256675|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101256676|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327637|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256677|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256678|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256679|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
101256680|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256681|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101256682|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101256683|NCT01712347|Bevacizumab|bevacizumab|mesh-list
101256684|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101256685|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256686|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101256687|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101256688|NCT01712347|Growth Substances|growth substances|mesh-ancestor
101256689|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256690|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
101256691|NCT01712464|Oxytocin|oxytocin|mesh-list
101256695|NCT01712477|Midazolam|midazolam|mesh-list
101256696|NCT01712477|Propofol|propofol|mesh-list
101256697|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101256698|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256699|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256700|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101256701|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
101256702|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
101256703|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101256704|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101256705|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256706|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256707|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
101219870|NCT01501136|Mesna|mesna|mesh-list
101256709|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256710|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256711|NCT01710761|Caffeine|caffeine|mesh-list
101256712|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101256713|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256714|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101256715|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256716|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256717|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101256718|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101256719|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
101256720|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256721|NCT01712568|Ropinirole|ropinirole|mesh-list
101256722|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101256723|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101415839|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415840|NCT00503347|Bavituximab|bavituximab|mesh-list
101415841|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415842|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256724|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
101256725|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
101256726|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256727|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256728|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256729|NCT01712646|Oxytocin|oxytocin|mesh-list
101256730|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
101256731|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101256732|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256733|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
101256734|NCT01712828|Promethazine|promethazine|mesh-list
101256735|NCT01712828|Sirolimus|sirolimus|mesh-list
101256736|NCT01712828|Quinidine|quinidine|mesh-list
101256737|NCT01712828|Lenalidomide|lenalidomide|mesh-list
101256738|NCT01712828|Temsirolimus|temsirolimus|mesh-list
101256739|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
101256740|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
101256741|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256742|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101256743|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101256744|NCT01712828|Growth Substances|growth substances|mesh-ancestor
101256745|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
101256746|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256747|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256748|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256749|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256750|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101256751|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101256752|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256753|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101256754|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
101256755|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101256756|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101256757|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256758|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
101256759|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
101256760|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
101256761|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256762|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
101256763|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
101256764|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101256765|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101256775|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101256776|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
101256777|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101327695|NCT00009984|Thalidomide|thalidomide|mesh-list
101256779|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101256780|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101256781|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
101256782|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101256783|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101256784|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256785|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101256786|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101256787|NCT01712893|Goserelin|goserelin|mesh-list
101256788|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101256789|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256790|NCT01712919|Paclitaxel|paclitaxel|mesh-list
101256791|NCT01712919|Cetuximab|cetuximab|mesh-list
101256792|NCT01712919|Nedaplatin|nedaplatin|mesh-list
101256793|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101256794|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256795|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256796|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256797|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
101546831|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
101546832|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101546833|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546834|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101256798|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256799|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101256800|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
101256801|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101256802|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256803|NCT01712997|Bosentan|bosentan|mesh-list
101256804|NCT01712997|Iloprost|iloprost|mesh-list
101256805|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256806|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101256807|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256808|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101256809|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
101256811|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
101256812|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256813|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
101256814|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
101256815|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
101256816|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101256817|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256818|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
101546839|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101546840|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256819|NCT01713101|Coagulants|coagulants|mesh-ancestor
101256820|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
101256821|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256822|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101256823|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256824|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101256825|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256826|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256827|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256828|NCT01713127|Remifentanil|remifentanil|mesh-list
101256829|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101256830|NCT01713127|Narcotics|narcotics|mesh-ancestor
101256831|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256832|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256833|NCT01713127|Analgesics|analgesics|mesh-ancestor
101256834|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
101256857|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
101256858|NCT01713231|Vitamins|vitamins|mesh-list
101256859|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
101256860|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256861|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101256862|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256863|NCT01713309|Lenograstim|lenograstim|mesh-list
101256864|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101256865|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
101256866|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256867|NCT01713361|Enoxaparin|enoxaparin|mesh-list
101327753|NCT00010023|Capecitabine|capecitabine|mesh-list
101256868|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
101256869|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101256870|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101256871|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256872|NCT01713387|Gemcitabine|gemcitabine|mesh-list
101256873|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101256874|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
101256875|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256876|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256877|NCT01713426|Pregabalin|pregabalin|mesh-list
101256878|NCT01713426|Capsaicin|capsaicin|mesh-list
101256879|NCT01713426|Analgesics|analgesics|mesh-ancestor
101546841|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546842|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
101546843|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256880|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
101256881|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256882|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256884|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101256885|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256886|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256887|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256894|NCT01713556|Propranolol|propranolol|mesh-list
101256895|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101256896|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101256897|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
101256898|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101256899|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256900|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256901|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101256902|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256903|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
101256904|NCT01713647|Losartan|losartan|mesh-list
101256905|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101256906|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256907|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101256908|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101256909|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256910|NCT01713725|Omalizumab|omalizumab|mesh-list
101256911|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101256912|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101256913|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
101256914|NCT01713738|Rituximab|rituximab|mesh-list
101256915|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101256916|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256917|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
101256918|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256919|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101256920|NCT01713777|Lamotrigine|lamotrigine|mesh-list
101256921|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
101256922|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101256923|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256924|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256925|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256926|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256927|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101256928|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101256929|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256930|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101256931|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101256932|NCT01713803|Buprenorphine|buprenorphine|mesh-list
101256933|NCT01713803|Naloxone|naloxone|mesh-list
101256934|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101256935|NCT01713803|Narcotics|narcotics|mesh-ancestor
101256936|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101256937|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256938|NCT01713803|Analgesics|analgesics|mesh-ancestor
101256939|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
101256940|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101256941|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101256942|NCT01713920|Amlodipine|amlodipine|mesh-list
101256943|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101256944|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101256945|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101256946|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546846|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
101546847|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546848|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101546849|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546850|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101256947|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101256948|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256949|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
101256950|NCT01713972|Dabrafenib|dabrafenib|mesh-list
101256951|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256952|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101256953|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256954|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256955|NCT01714011|Aripiprazole|aripiprazole|mesh-list
101256956|NCT01714011|Ziprasidone|ziprasidone|mesh-list
101256967|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101256968|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101256969|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
101256970|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101256971|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101256972|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101256973|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101256974|NCT01714037|Gemcitabine|gemcitabine|mesh-list
101256975|NCT01714037|Docetaxel|docetaxel|mesh-list
101256976|NCT01714037|Pemetrexed|pemetrexed|mesh-list
101256977|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256978|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101256979|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
101256980|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101256981|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
101256982|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
101256983|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
101256984|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101256985|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101256986|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101256987|NCT01714089|Interferons|interferons|mesh-list
101256988|NCT01714089|Interferon-beta|interferon-beta|mesh-list
101256989|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
101256991|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101256992|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
101256993|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101256994|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
101256995|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101256996|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101256997|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101256998|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101256999|NCT01714089|Analgesics|analgesics|mesh-ancestor
101257000|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
101257001|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257002|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257003|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257004|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101257005|NCT01714102|Resveratrol|resveratrol|mesh-list
101257006|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
101257007|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257008|NCT01714102|Protective Agents|protective agents|mesh-ancestor
101257009|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257010|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257011|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101257013|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101257014|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101257015|NCT01714115|Growth Substances|growth substances|mesh-ancestor
101257016|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257017|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
101257018|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257019|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101257020|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101257021|NCT01714128|Estradiol|estradiol|mesh-list
101257022|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101257023|NCT01714128|Estrogens|estrogens|mesh-ancestor
101546855|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546856|NCT00594126|Imetelstat|imetelstat|mesh-list
101546861|NCT01605344|Leucovorin|leucovorin|mesh-list
101257053|NCT01714206|Digoxin|digoxin|mesh-list
101257054|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257055|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101257056|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257057|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257058|NCT01714206|Protective Agents|protective agents|mesh-ancestor
101257059|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257060|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101257061|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257062|NCT01714297|Dalteparin|dalteparin|mesh-list
101257063|NCT01714297|Tinzaparin|tinzaparin|mesh-list
101257064|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101257065|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
101257066|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101257067|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101257068|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257076|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257077|NCT01714401|Albuterol|albuterol|mesh-list
101257078|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101257079|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
101257080|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257081|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257082|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101257083|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
101257084|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
101257085|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101257086|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101257087|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101257088|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101257089|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257090|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257091|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257092|NCT01714414|Lamivudine|lamivudine|mesh-list
101257093|NCT01714414|Zidovudine|zidovudine|mesh-list
101257094|NCT01714414|Efavirenz|efavirenz|mesh-list
101257095|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101257096|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101257097|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257098|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257099|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
101257100|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257101|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257102|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257103|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
101257104|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101257105|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101257106|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101257107|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101257108|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101257109|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101257110|NCT01714427|Dexamethasone|dexamethasone|mesh-list
101257111|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257112|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
101257113|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
101257114|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257115|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257116|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257117|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
101257119|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257120|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101257121|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257122|NCT01714557|Tazobactam|tazobactam|mesh-list
101257123|NCT01714557|Piperacillin|piperacillin|mesh-list
101257124|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101257125|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257126|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257127|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101257128|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546864|NCT01605344|Atorvastatin|atorvastatin|mesh-list
101257129|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257130|NCT01714570|Tazobactam|tazobactam|mesh-list
101257131|NCT01714570|Piperacillin|piperacillin|mesh-list
101257132|NCT01714570|Imipenem|imipenem|mesh-list
101257133|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101257134|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257135|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257136|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101257137|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257147|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101257148|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101257149|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257151|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101257152|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257153|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257154|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257155|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257156|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
101257157|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257158|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257159|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
101257160|NCT01714817|Prednisone|prednisone|mesh-list
101257161|NCT01714817|Abatacept|abatacept|mesh-list
101257162|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257163|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
101257164|NCT01714817|Hormones|hormones|mesh-ancestor
101257165|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257166|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257167|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101257168|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257169|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101257170|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101257171|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
101257172|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257173|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257174|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257175|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412636|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101257176|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101257177|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257178|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257179|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
101257180|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257181|NCT01714843|Linaclotide|linaclotide|mesh-list
101257182|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101257183|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
101257184|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257185|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257186|NCT01714856|Ropinirole|ropinirole|mesh-list
101257187|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101257188|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101257189|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
101257190|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
101257191|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257192|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257193|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257194|NCT01714895|Insulin|insulin|mesh-list
101257195|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101257196|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101257197|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257198|NCT01714908|Etoposide|etoposide|mesh-list
101257199|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101546868|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546869|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546870|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
101546871|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546873|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101257200|NCT01714908|Cisplatin|cisplatin|mesh-list
101257208|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101257209|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101257210|NCT01715077|Ipilimumab|ipilimumab|mesh-list
101257211|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257212|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257213|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101257214|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257215|NCT01715090|Insulin|insulin|mesh-list
101257216|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257217|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257218|NCT01715142|Paclitaxel|paclitaxel|mesh-list
101257219|NCT01715142|Gemcitabine|gemcitabine|mesh-list
101257220|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101257221|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101257222|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257223|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101257224|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101257225|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101257226|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257227|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101257228|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
101257229|NCT01715168|Doxorubicin|doxorubicin|mesh-list
101257230|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101257231|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101257232|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257233|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101257234|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101257235|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257236|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257238|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
101257239|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
101257240|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257241|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101257242|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257243|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257244|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
101257245|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257246|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257247|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101257248|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
101257249|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101257250|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
101257251|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257252|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257253|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101257254|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
101257255|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
101257256|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101257257|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101257258|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257259|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257260|NCT01715363|Leucovorin|leucovorin|mesh-list
101257261|NCT01715363|Folic Acid|folic acid|mesh-list
101257262|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
101257263|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
101257264|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257265|NCT01715363|Antidotes|antidotes|mesh-ancestor
101257266|NCT01715363|Protective Agents|protective agents|mesh-ancestor
101257271|NCT01715363|Hematinics|hematinics|mesh-ancestor
101257272|NCT01715441|Irinotecan|irinotecan|mesh-list
101257273|NCT01715441|Sorafenib|sorafenib|mesh-list
101257274|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101327812|NCT00010062|Fluorouracil|fluorouracil|mesh-list
101257275|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415845|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
101415846|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
101257276|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257277|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257278|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257279|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257280|NCT01715493|Muramidase|muramidase|mesh-list
101257281|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257282|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101257283|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
101257284|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101257285|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101257286|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101257287|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257288|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257289|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257290|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
101257291|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257292|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101257293|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101257294|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
101257295|NCT01715584|Sevoflurane|sevoflurane|mesh-list
101257296|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101257297|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101257298|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
101257299|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
101257300|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257301|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257302|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101257303|NCT01715584|Analgesics|analgesics|mesh-ancestor
101257304|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
101257305|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257306|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
101257307|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
101257308|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257309|NCT01715597|Protective Agents|protective agents|mesh-ancestor
101257310|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257312|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
101257313|NCT01715610|Clindamycin|clindamycin|mesh-list
101257314|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
101257315|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
101257316|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101257317|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257318|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257319|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101257320|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257321|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257322|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101257323|NCT01715636|Tenofovir|tenofovir|mesh-list
101257324|NCT01715636|Emtricitabine|emtricitabine|mesh-list
101257325|NCT01715636|Rilpivirine|rilpivirine|mesh-list
101257326|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
101257327|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257328|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101546875|NCT01605344|Antidotes|antidotes|mesh-ancestor
101546876|NCT01605344|Protective Agents|protective agents|mesh-ancestor
101546877|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
101257329|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101257330|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257331|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257332|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257333|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257334|NCT01715688|Lidocaine|lidocaine|mesh-list
101257335|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
101257336|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
101257337|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257338|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257347|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101257348|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257349|NCT01715701|Trace Elements|trace elements|mesh-ancestor
101257350|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
101257351|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257353|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
101257354|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257355|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257356|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257357|NCT01715922|Fluconazole|fluconazole|mesh-list
101257358|NCT01715922|Flucytosine|flucytosine|mesh-list
101257359|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
101257360|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257361|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101257362|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101257363|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257364|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257365|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101257366|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
101257367|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257368|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257369|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101257370|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101257371|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
101257372|NCT01715935|Everolimus|everolimus|mesh-list
101257373|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101257374|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257375|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257376|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257377|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257378|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
101257379|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257380|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257381|NCT01715987|Tenofovir|tenofovir|mesh-list
101257382|NCT01715987|Entecavir|entecavir|mesh-list
101257383|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
101257384|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257385|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101257386|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101257387|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257388|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257389|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257390|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257391|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101257392|NCT01716273|Laxatives|laxatives|mesh-ancestor
101257393|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257394|NCT01716338|Glyburide|glyburide|mesh-list
101257395|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257396|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257397|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101546913|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546914|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101546915|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
101546916|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546917|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
101546918|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257398|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101257399|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101257400|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257401|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257402|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257403|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257408|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257409|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257410|NCT01716442|Rituximab|rituximab|mesh-list
101257411|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327830|NCT00020761|Paclitaxel|paclitaxel|mesh-list
101257412|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257413|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
101257414|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257415|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257416|NCT01716572|Erythromycin|erythromycin|mesh-list
101257417|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
101257418|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101257419|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
101257420|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101257421|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257422|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257423|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101257424|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257425|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257426|NCT01716611|Tolvaptan|tolvaptan|mesh-list
101257427|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101257428|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257429|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
101257430|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257431|NCT01716624|Oxybutynin|oxybutynin|mesh-list
101257432|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
101257433|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101257434|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101257435|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101257436|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257437|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257438|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
101257439|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257440|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257441|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101257442|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257443|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
101257444|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
101257445|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101257446|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101257447|NCT01716624|Urological Agents|urological agents|mesh-ancestor
101257449|NCT01716637|Curcumin|curcumin|mesh-list
101257450|NCT01716637|Resveratrol|resveratrol|mesh-list
101257451|NCT01716637|Quercetin|quercetin|mesh-list
101257452|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101257453|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101257454|NCT01716637|Analgesics|analgesics|mesh-ancestor
101257455|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
101257456|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257457|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257459|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257460|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257461|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257462|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
101257463|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257464|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257465|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257466|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
101257467|NCT01716637|Protective Agents|protective agents|mesh-ancestor
101546925|NCT04328064|Calcium|calcium|mesh-list
101257468|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101257469|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
101257470|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257471|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
101257472|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257473|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257474|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101257475|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
101257477|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257478|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101257480|NCT01716767|Menthol|menthol|mesh-list
101257481|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
101412649|NCT00476983|Saquinavir|saquinavir|mesh-list
101257482|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257483|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257484|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
101257485|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101257486|NCT01716858|Sulforaphane|sulforaphane|mesh-list
101257487|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101257488|NCT01716858|Protective Agents|protective agents|mesh-ancestor
101257489|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257490|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257491|NCT01716949|Fluorouracil|fluorouracil|mesh-list
101257492|NCT01716949|Capecitabine|capecitabine|mesh-list
101257493|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
101257494|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
101257495|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257496|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101257497|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257498|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257499|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
101257500|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257501|NCT01717027|Oxycodone|oxycodone|mesh-list
101257502|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257503|NCT01717027|Narcotics|narcotics|mesh-ancestor
101257504|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257505|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257506|NCT01717027|Analgesics|analgesics|mesh-ancestor
101257507|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
101257508|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257509|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
101257510|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101257511|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257512|NCT01717118|Vaccines|vaccines|mesh-list
101257513|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
101257514|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257515|NCT01717157|Fentanyl|fentanyl|mesh-list
101257516|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257517|NCT01717157|Narcotics|narcotics|mesh-ancestor
101257518|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257519|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257520|NCT01717157|Analgesics|analgesics|mesh-ancestor
101257521|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
101257522|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257523|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101257524|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101257525|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
101257526|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
101257527|NCT01717222|Lidocaine|lidocaine|mesh-list
101257528|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
101546930|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
101546931|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257529|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
101257530|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257531|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257532|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
101257533|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257534|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257535|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101257536|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101257537|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257538|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257539|NCT01717235|Ropinirole|ropinirole|mesh-list
101257540|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101257541|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101257542|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
101257543|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
101257544|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257545|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257546|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257547|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
101257548|NCT01717300|Anacetrapib|anacetrapib|mesh-list
101257549|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101257550|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101257552|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257553|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101257554|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257555|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101257556|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257558|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257559|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101257560|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101257561|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257562|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257564|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101257565|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101257566|NCT01717599|Analgesics|analgesics|mesh-ancestor
101257567|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
101257568|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257569|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257570|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101257571|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257572|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101257573|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257574|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257575|NCT01717612|Thrombin|thrombin|mesh-list
101257576|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
101257577|NCT01717612|Coagulants|coagulants|mesh-ancestor
101257578|NCT01717625|Montelukast|montelukast|mesh-list
101257579|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101257580|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
101257581|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101257582|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
101257583|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101257584|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257585|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101257586|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101257587|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257589|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101257590|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101257591|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257592|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
101257593|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101257594|NCT01717729|Iodine|iodine|mesh-list
101257595|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101257596|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257597|NCT01717729|Trace Elements|trace elements|mesh-ancestor
101257598|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
101257599|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257600|NCT01716260|Chloroquine|chloroquine|mesh-list
101257601|NCT01716260|Primaquine|primaquine|mesh-list
101257602|NCT01716260|Amebicides|amebicides|mesh-ancestor
101257603|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101257604|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101257605|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257606|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
101257607|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257608|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101257609|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257610|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257611|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257612|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257613|NCT01717846|Abatacept|abatacept|mesh-list
101257614|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101257615|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257616|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257617|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257618|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257619|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
101257620|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257621|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257622|NCT01717911|Metformin|metformin|mesh-list
101257623|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101257624|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
101257625|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257631|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
101257632|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257633|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257634|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101257635|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101257636|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
101257637|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257639|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257640|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257641|NCT01717963|Naltrexone|naltrexone|mesh-list
101257642|NCT01717963|Buprenorphine|buprenorphine|mesh-list
101257643|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101257644|NCT01717963|Naloxone|naloxone|mesh-list
101257645|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257646|NCT01717963|Narcotics|narcotics|mesh-ancestor
101257647|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257648|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257649|NCT01717963|Analgesics|analgesics|mesh-ancestor
101257650|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
101257651|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257652|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101257653|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101257654|NCT01718054|Chloroquine|chloroquine|mesh-list
101257655|NCT01718054|Amebicides|amebicides|mesh-ancestor
101257656|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101257657|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101257658|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257659|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
101257660|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257661|NCT01718093|Metformin|metformin|mesh-list
101257662|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101257663|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257664|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257665|NCT01718093|Incretins|incretins|mesh-ancestor
101257666|NCT01718093|Hormones|hormones|mesh-ancestor
101546939|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257667|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546940|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257668|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101257669|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101257670|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257671|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257672|NCT01718223|Temoporfin|temoporfin|mesh-list
101257673|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257674|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101257675|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101257676|NCT01718236|Rocuronium|rocuronium|mesh-list
101257677|NCT01718236|Succinylcholine|succinylcholine|mesh-list
101257678|NCT01718236|Neostigmine|neostigmine|mesh-list
101257679|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101257680|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101257681|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101257682|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257683|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257684|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101257685|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257686|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257687|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
101257688|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257689|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101257690|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
101257691|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101257692|NCT01718288|Aspirin|aspirin|mesh-list
101257693|NCT01718288|Iloprost|iloprost|mesh-list
101257694|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101257702|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101257703|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101257704|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257705|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101257706|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101257707|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257708|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
101257709|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
101257711|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101257712|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101257713|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
101257714|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257715|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
101257716|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257717|NCT01718314|Lidocaine|lidocaine|mesh-list
101257718|NCT01718314|Misoprostol|misoprostol|mesh-list
101257719|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
101257720|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
101257721|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257722|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257723|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
101257724|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257725|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101257726|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101257727|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101257728|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101257729|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257730|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101257731|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
101257732|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101257733|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101257734|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257735|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
101257736|NCT01718327|Sunitinib|sunitinib|mesh-list
101257737|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257738|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101257739|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101257740|NCT01718327|Growth Substances|growth substances|mesh-ancestor
101257741|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415854|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257742|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
101257743|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101257744|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257745|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257746|NCT01718340|Metformin|metformin|mesh-list
101257747|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257748|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257749|NCT01718366|Vitamin D|vitamin d|mesh-list
101257750|NCT01718366|Azacitidine|azacitidine|mesh-list
101257751|NCT01718366|Deferasirox|deferasirox|mesh-list
101257752|NCT01718366|Vitamins|vitamins|mesh-ancestor
101257753|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
101257754|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257755|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101257756|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101257757|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
101257758|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257759|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257760|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257761|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101257762|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
101257772|NCT01718496|Morphine|morphine|mesh-list
101257773|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257774|NCT01718496|Narcotics|narcotics|mesh-ancestor
101257775|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257776|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257777|NCT01718496|Analgesics|analgesics|mesh-ancestor
101257778|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
101257779|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257780|NCT01718587|Lamivudine|lamivudine|mesh-list
101257781|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
101257782|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101257783|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101257784|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257785|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257786|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257787|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257788|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257789|NCT01718613|Vasopressins|vasopressins|mesh-list
101257790|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
101257791|NCT01718613|Norepinephrine|norepinephrine|mesh-list
101257792|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101257793|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101257794|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257795|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257796|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257797|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257798|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
101257799|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
101257800|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257801|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101257802|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
101257803|NCT01718613|Coagulants|coagulants|mesh-ancestor
101257804|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101257805|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
101257806|NCT01718626|Docetaxel|docetaxel|mesh-list
101257807|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257808|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101257809|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101257810|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101257811|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257812|NCT01718652|Canagliflozin|canagliflozin|mesh-list
101257813|NCT01718652|Cyclosporine|cyclosporine|mesh-list
101257814|NCT01718652|Cyclosporins|cyclosporins|mesh-list
101257815|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257816|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257817|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101257818|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
101257819|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257820|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
101257821|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257822|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
101257823|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257824|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101257825|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101257826|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257828|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
101257829|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257885|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
101257886|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
101257887|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257888|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257889|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101257890|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
101257891|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101257892|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101257893|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101257894|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
101257895|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257896|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257897|NCT01719133|Histamine|histamine|mesh-list
101257898|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
101257899|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
101257900|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
101257901|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257902|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257903|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257904|NCT01719159|Rituximab|rituximab|mesh-list
101257905|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101257906|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257907|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
101257908|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257909|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101257910|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
101257911|NCT01719185|Phentermine|phentermine|mesh-list
101221033|NCT01506115|Trioxsalen|trioxsalen|mesh-list
101257912|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101257913|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257915|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101257916|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
101257917|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
101257918|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101257919|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257920|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537411|NCT00590915|Asparaginase|asparaginase|mesh-list
101257921|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257922|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
101257923|NCT01719185|Vitamins|vitamins|mesh-ancestor
101257924|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
101257925|NCT01719302|Gemcitabine|gemcitabine|mesh-list
101257926|NCT01719302|Docetaxel|docetaxel|mesh-list
101257927|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101257928|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
101257929|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257930|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101257931|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101257932|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101257933|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101257934|NCT01719419|Orlistat|orlistat|mesh-list
101257954|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101257955|NCT01719601|Narcotics|narcotics|mesh-ancestor
101257956|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101257957|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257958|NCT01719601|Analgesics|analgesics|mesh-ancestor
101257959|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
101257960|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327869|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257962|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101257963|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546952|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546953|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257964|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257965|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
101257966|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101257967|NCT01719614|Metformin|metformin|mesh-list
101257968|NCT01719614|Rilpivirine|rilpivirine|mesh-list
101257969|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101257970|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101257971|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101257972|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101257973|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101257974|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257975|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
101257976|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257977|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257978|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257979|NCT01719627|Maraviroc|maraviroc|mesh-list
101257980|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101257981|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101257982|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101257983|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101257984|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101257985|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
101257986|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101257987|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101258008|NCT01719770|Rocuronium|rocuronium|mesh-list
101258009|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101258010|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101258011|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101258012|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258013|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258014|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
101258015|NCT01719835|Prednisolone|prednisolone|mesh-list
101258016|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
101258017|NCT01719835|Gemcitabine|gemcitabine|mesh-list
101258018|NCT01719835|Doxorubicin|doxorubicin|mesh-list
101258019|NCT01719835|Vincristine|vincristine|mesh-list
101258020|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101258021|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
101258022|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258023|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258024|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101258025|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
101258026|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258027|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258028|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101258029|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101258030|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
101258031|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101258032|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101258033|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101258034|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258035|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101258036|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101258037|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101258038|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101258039|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258040|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
101258041|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
101258042|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258055|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258056|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258057|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258058|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258059|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
101221178|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
101258060|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
101258061|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258062|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101258063|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258064|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258065|NCT01719952|Oxytocin|oxytocin|mesh-list
101258066|NCT01719952|Carbetocin|carbetocin|mesh-list
101258067|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
101258068|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258069|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258070|NCT01719978|Epinephrine|epinephrine|mesh-list
101258071|NCT01719978|Racepinephrine|racepinephrine|mesh-list
101258072|NCT01719978|Mepivacaine|mepivacaine|mesh-list
101258073|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
101258074|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101258075|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101258076|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
101258077|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258078|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258079|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258080|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101258081|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101258082|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
101258083|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258084|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101258085|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
101258086|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
101258087|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
101258088|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101258089|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
101258090|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
101258091|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258092|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
101258094|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
101258095|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258096|NCT01720459|Protective Agents|protective agents|mesh-ancestor
101258097|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258098|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327893|NCT00020917|Irinotecan|irinotecan|mesh-list
101258099|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101258100|NCT01720537|Bococizumab|bococizumab|mesh-list
101258101|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101258102|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101258103|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101258104|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
101258131|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258132|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258133|NCT01723852|Vitamin D|vitamin d|mesh-list
101258134|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
101258135|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
101258136|NCT01723852|Vitamins|vitamins|mesh-list
101258137|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
101258138|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258139|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258140|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258141|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
101258142|NCT01724229|Clotrimazole|clotrimazole|mesh-list
101258143|NCT01724229|Miconazole|miconazole|mesh-list
101258144|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258145|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101258146|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101258147|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101258148|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258149|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258150|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101258151|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
101258152|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258187|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258188|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101258189|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101258210|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258211|NCT01727427|Analgesics|analgesics|mesh-ancestor
101258212|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
101258213|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258214|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258215|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258216|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101258217|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101258218|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258219|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101258220|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101258221|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258222|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
101258223|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
101258224|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101258225|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
101258226|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101258227|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
101258228|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101258229|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
101258230|NCT01727427|Coagulants|coagulants|mesh-ancestor
101258231|NCT01727778|Antibodies|antibodies|mesh-list
101258232|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
101258233|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
101258234|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258235|NCT01728025|Ranolazine|ranolazine|mesh-list
101258236|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101258237|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258238|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258239|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
101258240|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101258241|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258242|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101258243|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101258244|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258245|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258246|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258247|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101258248|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101258249|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
101258250|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101258251|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258252|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101258253|NCT01730157|Ipilimumab|ipilimumab|mesh-list
101258254|NCT01730157|Antibodies|antibodies|mesh-list
101258255|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
101258292|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258293|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258295|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258401|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
101258402|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258403|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258404|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258405|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258406|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258407|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101258408|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101258409|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101258410|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101258411|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
101258412|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
101258413|NCT01731132|Copper|copper|mesh-list
101258414|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
101258415|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101258416|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
101258417|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258418|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258419|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101258420|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101258421|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101258422|NCT01731132|Trace Elements|trace elements|mesh-ancestor
101258423|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
101258424|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
101258425|NCT01731158|Bevacizumab|bevacizumab|mesh-list
101258426|NCT01731158|Sunitinib|sunitinib|mesh-list
101258427|NCT01731158|Everolimus|everolimus|mesh-list
101258428|NCT01731158|Sorafenib|sorafenib|mesh-list
101258429|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101258430|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258431|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101258432|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101258433|NCT01731158|Growth Substances|growth substances|mesh-ancestor
101258434|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258435|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
101258436|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101258437|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258438|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258439|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258440|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101258441|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
101258442|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
101258448|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258450|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101258451|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101258452|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101258453|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
101258454|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
101258455|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
101258456|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
101258457|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258458|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258459|NCT01731275|Quetmolimab|quetmolimab|mesh-list
101258460|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101258461|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547007|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258462|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
101547008|NCT01606046|Anesthetics|anesthetics|mesh-list
101258463|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258465|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
101258466|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258467|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
101258468|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258469|NCT01731327|Tofacitinib|tofacitinib|mesh-list
101258470|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101258471|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258472|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258473|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258474|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
101258475|NCT01731340|Calcium|calcium|mesh-list
101258476|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258477|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258478|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258479|NCT01731431|Glyburide|glyburide|mesh-list
101258480|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101258481|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258482|NCT01731457|Etanercept|etanercept|mesh-list
101258483|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258484|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258485|NCT01731457|Analgesics|analgesics|mesh-ancestor
101258486|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
101258487|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258488|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258489|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258490|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258491|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258492|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101258493|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
101258494|NCT01731561|Rituximab|rituximab|mesh-list
101258495|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101258496|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258497|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
101258498|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258499|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258500|NCT01731574|Dapivirine|dapivirine|mesh-list
101258501|NCT01731574|Miconazole|miconazole|mesh-list
101258502|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101258503|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101258504|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
101258505|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258506|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
101258507|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101258508|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101258509|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258510|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258511|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101258512|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327940|NCT00021073|Vitamins|vitamins|mesh-ancestor
101258526|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101258527|NCT01731652|Imiquimod|imiquimod|mesh-list
101258528|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101258529|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
101258530|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547017|NCT02892942|Cetrorelix|cetrorelix|mesh-list
101258531|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258532|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
101258533|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
101258534|NCT01731756|Salicylates|salicylates|mesh-list
101258536|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258537|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
101258538|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
101258539|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101258540|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258541|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258542|NCT01731756|Analgesics|analgesics|mesh-ancestor
101258543|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
101258544|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258545|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258546|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258547|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258548|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101258549|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258550|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258551|NCT01731756|Emollients|emollients|mesh-ancestor
101258552|NCT01731795|Dexamethasone|dexamethasone|mesh-list
101258553|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
101258554|NCT01731795|BB 1101|bb 1101|mesh-list
101258555|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258556|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
101258557|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
101258558|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258559|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258560|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258561|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
101258562|NCT01731795|Hormones|hormones|mesh-ancestor
101258563|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258564|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258565|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258566|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
101258567|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258568|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258569|NCT01731899|Agomelatine|agomelatine|mesh-list
101258570|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101258571|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258576|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101258577|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101258578|NCT01731925|Growth Substances|growth substances|mesh-ancestor
101258579|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258580|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
101258581|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258582|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258583|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258584|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
101258585|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101258586|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101258587|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
101258588|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101258589|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
101258590|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258591|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258592|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101258593|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258594|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258595|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101258596|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
101258597|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101258598|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
101258599|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101258600|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258601|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101258602|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258603|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258604|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
101258605|NCT01732146|Hematinics|hematinics|mesh-ancestor
101258606|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101258608|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258610|NCT01732224|Telbivudine|telbivudine|mesh-list
101258611|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
101258612|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258613|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101258614|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101258615|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258616|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258617|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101258618|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101258619|NCT01732250|Meropenem|meropenem|mesh-list
101258620|NCT01732250|Colistin|colistin|mesh-list
101258621|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101258622|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258623|NCT01732276|Gefitinib|gefitinib|mesh-list
101258624|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258625|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101258626|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258627|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258628|NCT01732328|Vitamin D|vitamin d|mesh-list
101258629|NCT01732328|Calcium|calcium|mesh-list
101258630|NCT01732328|Vitamins|vitamins|mesh-ancestor
101258631|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
101258632|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258633|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258634|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258635|NCT01732367|Tenofovir|tenofovir|mesh-list
101258636|NCT01732367|Lamivudine|lamivudine|mesh-list
101258637|NCT01732367|Adefovir|adefovir|mesh-list
101258638|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
101258639|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258640|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101258641|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101258642|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258643|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258644|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101258660|NCT01732666|Nefopam|nefopam|mesh-list
101258661|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101258662|NCT01732666|Narcotics|narcotics|mesh-ancestor
101258663|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258664|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258665|NCT01732666|Analgesics|analgesics|mesh-ancestor
101258666|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
101258667|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258668|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258669|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101258670|NCT01732744|Eusol|eusol|mesh-list
101258671|NCT01732744|Castor Oil|castor oil|mesh-list
101258672|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101258673|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
101258674|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258675|NCT01732744|Cathartics|cathartics|mesh-ancestor
101258676|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258677|NCT01732861|Lenalidomide|lenalidomide|mesh-list
101258678|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
101258679|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258680|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101258681|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101258682|NCT01732861|Growth Substances|growth substances|mesh-ancestor
101258683|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101258684|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258685|NCT01733017|Lycopene|lycopene|mesh-list
101258686|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258687|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
101258688|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547040|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
101258689|NCT01733017|Protective Agents|protective agents|mesh-ancestor
101258690|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258691|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101258692|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101258693|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258694|NCT01733030|Cycloserine|cycloserine|mesh-list
101258695|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101258696|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258697|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101258698|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
101258699|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101258700|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
101258701|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258702|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
101258703|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101258704|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258711|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101258712|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101258713|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
101258714|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258715|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258716|NCT01733095|Ambrisentan|ambrisentan|mesh-list
101258717|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101258718|NCT01733108|Canagliflozin|canagliflozin|mesh-list
101258719|NCT01733108|Glyburide|glyburide|mesh-list
101258720|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101258721|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258722|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101258723|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258724|NCT01733134|Tolvaptan|tolvaptan|mesh-list
101258725|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101258726|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258727|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
101258728|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258729|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
101258730|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101258731|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101258732|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101258733|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258734|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258735|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
101258736|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258737|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258738|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101258739|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258740|NCT01733342|Anesthetics|anesthetics|mesh-list
101258741|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258742|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258743|NCT01733394|Lamotrigine|lamotrigine|mesh-list
101258744|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
101258745|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101258746|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101258747|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258748|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258749|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258750|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101258751|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101258752|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258753|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101258754|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101258755|NCT01733459|Metformin|metformin|mesh-list
101258756|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101258757|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258758|NCT01733485|Aspirin|aspirin|mesh-list
101258759|NCT01733485|Indomethacin|indomethacin|mesh-list
101258760|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101258761|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101258762|NCT01733485|Analgesics|analgesics|mesh-ancestor
101258763|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
101258764|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258765|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258766|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258767|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258768|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101258769|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101258770|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258796|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258797|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101258798|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101258799|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
101258800|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258801|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258802|NCT01733823|Nimorazole|nimorazole|mesh-list
101258803|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101258804|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101258805|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101258806|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258807|NCT01733836|Metformin|metformin|mesh-list
101258808|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101258809|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258810|NCT01733966|Amoxicillin|amoxicillin|mesh-list
101258811|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
101258812|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
101258813|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101258814|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
101258815|NCT01733966|Secnidazole|secnidazole|mesh-list
101258816|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101258817|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258818|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258819|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258820|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101258826|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101258827|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101258829|NCT01733979|Trace Elements|trace elements|mesh-ancestor
101258830|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
101258831|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258832|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101258833|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101258834|NCT01734044|Dexamethasone|dexamethasone|mesh-list
101258835|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
101258836|NCT01734044|BB 1101|bb 1101|mesh-list
101258837|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258838|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
101258839|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
101258840|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258841|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258842|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258843|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
101258844|NCT01734044|Hormones|hormones|mesh-ancestor
101258845|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258846|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258847|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258848|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
101258849|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258850|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258851|NCT01734057|Dexamethasone|dexamethasone|mesh-list
101258852|NCT01734057|Rituximab|rituximab|mesh-list
101258853|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101258854|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258855|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
101258856|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258857|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101258858|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101258859|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
101258860|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
101258861|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258862|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258863|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
101258864|NCT01734057|Hormones|hormones|mesh-ancestor
101258865|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101258866|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101258867|NCT01734096|Candesartan|candesartan|mesh-list
101258868|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
101258869|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101258870|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101258871|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101258872|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258873|NCT01734252|Argatroban|argatroban|mesh-list
101258874|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
101258875|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101258876|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101258877|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258878|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258879|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
101258880|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101258881|NCT01734330|Nicotine|nicotine|mesh-list
101258882|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101258883|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
101258884|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258885|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258886|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101258887|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101258888|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
101258889|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258890|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258897|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258898|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258900|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
101258901|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
101258902|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258903|NCT01734564|Poly I-C|poly i-c|mesh-list
101258904|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101258905|NCT01734564|Poly ICLC|poly iclc|mesh-list
101258906|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
101258907|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
101258908|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258909|NCT01734564|Laxatives|laxatives|mesh-ancestor
101258910|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258911|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
101258912|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101258913|NCT01734798|Gemcitabine|gemcitabine|mesh-list
101258914|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258915|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101258916|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
101258917|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258918|NCT01734824|Denosumab|denosumab|mesh-list
101258919|NCT01734824|Teriparatide|teriparatide|mesh-list
101258920|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
101258921|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101258922|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258923|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101258924|NCT01734915|Iproplatin|iproplatin|mesh-list
101258925|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101258926|NCT01734954|Midazolam|midazolam|mesh-list
101258927|NCT01734954|Analgesics|analgesics|mesh-list
101258928|NCT01734954|Anesthetics|anesthetics|mesh-list
101258929|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
101258930|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
101258931|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258932|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258933|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101258934|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101327968|NCT00021307|Temozolomide|temozolomide|mesh-list
101258935|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101547062|NCT00595140|Octreotide|octreotide|mesh-list
101258936|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101258937|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101258938|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101258939|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
101258940|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
101258942|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101258943|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258944|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
101258945|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258947|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
101258948|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258949|NCT01735019|Remifentanil|remifentanil|mesh-list
101258950|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101258951|NCT01735019|Narcotics|narcotics|mesh-ancestor
101258952|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101258953|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258954|NCT01735019|Analgesics|analgesics|mesh-ancestor
101258955|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
101258956|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101258957|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
101258958|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101258959|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
101258960|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258961|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
101258962|NCT01735058|Protective Agents|protective agents|mesh-ancestor
101258978|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258979|NCT01735097|Vitamin E|vitamin e|mesh-list
101258980|NCT01735097|Vitamins|vitamins|mesh-ancestor
101258981|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
101258982|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101258983|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
101258984|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258985|NCT01735097|Protective Agents|protective agents|mesh-ancestor
101258986|NCT01735123|Caseins|caseins|mesh-list
101258987|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
101258988|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
101258989|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258990|NCT01735227|Omeprazole|omeprazole|mesh-list
101258991|NCT01735227|Pantoprazole|pantoprazole|mesh-list
101258992|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101258993|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101258994|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101258995|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101258996|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101258997|NCT01735240|Ketoconazole|ketoconazole|mesh-list
101258998|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
101258999|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259000|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101259001|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101259002|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259003|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259004|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101259005|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101259006|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259007|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259008|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101259009|NCT01735318|Lisinopril|lisinopril|mesh-list
101259010|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101259011|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
101259012|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259013|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259014|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259015|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101259016|NCT01735318|Protective Agents|protective agents|mesh-ancestor
101259017|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259018|NCT01735344|Lisinopril|lisinopril|mesh-list
101259019|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101259020|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
101259044|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
101259045|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259046|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259047|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259049|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101259050|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101259051|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259052|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259053|NCT01735487|Nicotine|nicotine|mesh-list
101259054|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101259055|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
101259056|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259057|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259058|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101259059|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101259060|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
101259061|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259062|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259063|NCT01735669|Remifentanil|remifentanil|mesh-list
101259064|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
101259065|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101259066|NCT01735669|Narcotics|narcotics|mesh-ancestor
101259067|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259068|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259069|NCT01735669|Analgesics|analgesics|mesh-ancestor
101259072|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101259073|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
101259074|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
101259075|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259076|NCT01735747|Vincristine|vincristine|mesh-list
101259077|NCT01735747|Temozolomide|temozolomide|mesh-list
101259079|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101259080|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259081|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
101259082|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
101259083|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
101259084|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259085|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101259086|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
101259087|NCT01735864|Indirubin|indirubin|mesh-list
101259088|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101259089|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259090|NCT01735890|Amlodipine|amlodipine|mesh-list
101259091|NCT01735890|Valsartan|valsartan|mesh-list
101259092|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101259093|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259094|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101259095|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101259096|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259097|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259098|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259099|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
101259100|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101259101|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101259102|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
101259103|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
101259105|NCT01736020|Propofol|propofol|mesh-list
101547073|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259106|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101259107|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259108|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259109|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259110|NCT01736020|Analgesics|analgesics|mesh-ancestor
101259111|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
101259112|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259113|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101259114|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101259115|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101259116|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259117|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259118|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259119|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101259120|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
101259121|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
101259122|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101259123|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101259124|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101259125|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101259126|NCT01736033|Tamsulosin|tamsulosin|mesh-list
101259127|NCT01736033|Finasteride|finasteride|mesh-list
101259128|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101259129|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101259130|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101259131|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259132|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259133|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259134|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259135|NCT01736033|Urological Agents|urological agents|mesh-ancestor
101259136|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101259137|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101259138|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259139|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
101259140|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259141|NCT01736150|Sevelamer|sevelamer|mesh-list
101259142|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
101259143|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
101259150|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101259151|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259152|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259153|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101259154|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
101259155|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
101259156|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101259157|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101259158|NCT01736410|Trastuzumab|trastuzumab|mesh-list
101259159|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259160|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101259161|NCT01736423|Ramosetron|ramosetron|mesh-list
101259162|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
101259163|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
101259164|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259165|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259166|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101259167|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101259168|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
101259169|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259170|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259171|NCT01736449|Bevacizumab|bevacizumab|mesh-list
101259172|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101259173|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259174|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101259175|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101259177|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259178|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101259179|NCT01736488|Atenolol|atenolol|mesh-list
101259180|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101259181|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259182|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
101259183|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
101259184|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259185|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259186|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101259187|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101259188|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101259189|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
101259190|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259191|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259192|NCT01736514|Allopurinol|allopurinol|mesh-list
101259193|NCT01736514|Febuxostat|febuxostat|mesh-list
101259194|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
101259195|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259196|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259197|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
101259198|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259199|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101259200|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
101259201|NCT01736514|Protective Agents|protective agents|mesh-ancestor
101259202|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259203|NCT01736670|Triamcinolone|triamcinolone|mesh-list
101259204|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101259205|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101259206|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101259207|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259208|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
101259209|NCT01736670|Hormones|hormones|mesh-ancestor
101327980|NCT00021385|Carboplatin|carboplatin|mesh-list
101259210|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259211|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259219|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101259220|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101259222|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259223|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259224|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101259225|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101259226|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
101259227|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259228|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101259229|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101259230|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101259231|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101259232|NCT01736800|Temozolomide|temozolomide|mesh-list
101259233|NCT01736800|Topotecan|topotecan|mesh-list
101259234|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101259235|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
101259236|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259237|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259238|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101259239|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101259240|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259241|NCT01736813|Maraviroc|maraviroc|mesh-list
101259242|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101259243|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101259244|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259245|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101259246|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101259247|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
101259248|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259249|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101259250|NCT01736878|Sorafenib|sorafenib|mesh-list
101259251|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259252|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101259253|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259254|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259255|NCT01736891|Rasagiline|rasagiline|mesh-list
101259256|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101259257|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259258|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259259|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101259260|NCT01736891|Protective Agents|protective agents|mesh-ancestor
101259261|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259262|NCT01737008|Cisplatin|cisplatin|mesh-list
101259263|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259264|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
101259265|NCT01737073|Narcotics|narcotics|mesh-ancestor
101259266|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259267|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259268|NCT01737073|Analgesics|analgesics|mesh-ancestor
101259269|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
101259270|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259271|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
101259272|NCT01737086|Astringents|astringents|mesh-ancestor
101259273|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259274|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259275|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
101259276|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101259277|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259278|NCT01737177|Rituximab|rituximab|mesh-list
101259279|NCT01737177|Lenalidomide|lenalidomide|mesh-list
101259280|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101259281|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101259283|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
101259284|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259285|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259286|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101259287|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101259288|NCT01737177|Growth Substances|growth substances|mesh-ancestor
101259289|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101259290|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101259291|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
101259292|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259293|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
101259294|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259295|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
101259296|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101259297|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101259298|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259299|NCT01737203|Urological Agents|urological agents|mesh-ancestor
101259300|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
101259301|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101259302|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259303|NCT01737294|Capsaicin|capsaicin|mesh-list
101259304|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
101259305|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259306|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
101259307|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259308|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259309|NCT01737307|Fluorides|fluorides|mesh-list
101259310|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
101259311|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
101259312|NCT01737307|Protective Agents|protective agents|mesh-ancestor
101259313|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259314|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101259315|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101259316|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259317|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
101259318|NCT01737346|Lomustine|lomustine|mesh-list
101259319|NCT01737346|Procarbazine|procarbazine|mesh-list
101259320|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101259321|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
101259322|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259323|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259324|NCT01737359|Tenofovir|tenofovir|mesh-list
101259325|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
101259326|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259327|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101259328|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101259329|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259330|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259331|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101259332|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101259333|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
101259334|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101259335|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101259336|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
101259337|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259338|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259339|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259340|NCT01737411|Urological Agents|urological agents|mesh-ancestor
101259341|NCT01737541|Fluoxetine|fluoxetine|mesh-list
101259342|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101259343|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101259344|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101259345|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259346|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259347|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
101259348|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259349|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101259350|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
101259351|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259377|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
101259378|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101259379|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101259380|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101259381|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259382|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259383|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259384|NCT01737918|Urological Agents|urological agents|mesh-ancestor
101259385|NCT01738035|Budesonide|budesonide|mesh-list
101259386|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259387|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101259388|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
101259389|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259390|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259391|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101259392|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
101259393|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
101259394|NCT01738035|Hormones|hormones|mesh-ancestor
101259395|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259396|NCT01738087|Fluticasone|fluticasone|mesh-list
101259398|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
101259399|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259400|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101259401|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
101259421|NCT01738100|Analgesics|analgesics|mesh-ancestor
101259422|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
101259423|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259424|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101547097|NCT02271191|Nicardipine|nicardipine|mesh-list
101547105|NCT00595374|Insulin|insulin|mesh-list
101259425|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101259426|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101259427|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101259428|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
101259429|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259430|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259431|NCT01738178|Caffeine|caffeine|mesh-list
101259432|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101259433|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259434|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101259435|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259436|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259437|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101259438|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101259439|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
101259440|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259441|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
101259442|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101259443|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
101259444|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259445|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
101259446|NCT01738243|Protective Agents|protective agents|mesh-ancestor
101259447|NCT01738282|Baclofen|baclofen|mesh-list
101259448|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101259449|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259450|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101259451|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259452|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101259453|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
101259477|NCT01738451|Dabrafenib|dabrafenib|mesh-list
101259478|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259479|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101259480|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259481|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259482|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
101259483|NCT01738542|Bosentan|bosentan|mesh-list
101259484|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101259485|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259486|NCT01738724|Goserelin|goserelin|mesh-list
101259487|NCT01738724|Dienogest|dienogest|mesh-list
101259488|NCT01738724|Desogestrel|desogestrel|mesh-list
101259489|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101259490|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259491|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101259492|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
101259493|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101259494|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259495|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101259496|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101259497|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101259498|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101259499|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
101259500|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259501|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101259502|NCT01738724|Progestins|progestins|mesh-ancestor
101259503|NCT01738724|Hormones|hormones|mesh-ancestor
101259504|NCT01738763|Inositol|inositol|mesh-list
101259505|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259521|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259522|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
101259523|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101259524|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259525|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259527|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101259528|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101259529|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547106|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101259530|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
101259531|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259532|NCT01738893|Gabapentin|gabapentin|mesh-list
101259533|NCT01738893|Analgesics|analgesics|mesh-ancestor
101259534|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
101259535|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259536|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259537|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
101259538|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101259539|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101259540|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259541|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259542|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101259543|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101259544|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259545|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259546|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
101259547|NCT01738945|Amlodipine|amlodipine|mesh-list
101259548|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259549|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101259550|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101259551|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259552|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259553|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259554|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
101259555|NCT01739049|Liraglutide|liraglutide|mesh-list
101259556|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101259557|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259558|NCT01739049|Incretins|incretins|mesh-ancestor
101259559|NCT01739049|Hormones|hormones|mesh-ancestor
101259560|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259561|NCT01739127|Risperidone|risperidone|mesh-list
101259562|NCT01739127|Aripiprazole|aripiprazole|mesh-list
101259563|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101259564|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101259565|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
101259591|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259592|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101259593|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101259594|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259595|NCT01739218|Paclitaxel|paclitaxel|mesh-list
101259596|NCT01739218|Bevacizumab|bevacizumab|mesh-list
101259597|NCT01739218|Carboplatin|carboplatin|mesh-list
101259598|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101259599|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259600|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101259601|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101259602|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101259603|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259604|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101259605|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101259606|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101259607|NCT01739218|Growth Substances|growth substances|mesh-ancestor
101259608|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259609|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
101259610|NCT01739413|Anesthetics|anesthetics|mesh-list
101259611|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259612|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259613|NCT01739439|Gemcitabine|gemcitabine|mesh-list
101259628|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259629|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259630|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259631|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101259632|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101259633|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415886|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101259634|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101259635|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101259636|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259637|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
101259638|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101259639|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101259640|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101259641|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
101259642|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259643|NCT01739582|Enclomiphene|enclomiphene|mesh-list
101259644|NCT01739582|Clomiphene|clomiphene|mesh-list
101259645|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
101259646|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101259647|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
101259648|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259649|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259650|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101259651|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
101259652|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101259653|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101259654|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101259655|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
101259656|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
101259657|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101259658|NCT01739673|Riboflavin|riboflavin|mesh-list
101259659|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259660|NCT01739673|Vitamins|vitamins|mesh-ancestor
101259661|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
101259662|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259663|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101259664|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259665|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
101259666|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
101259667|NCT01739855|Calcium|calcium|mesh-list
101259668|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259669|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259671|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259672|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101259673|NCT01739855|Vitamins|vitamins|mesh-ancestor
101259674|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
101259689|NCT01739920|Povidone|povidone|mesh-list
101259690|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
101259691|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
101259692|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101259693|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259694|NCT01739985|Dexamethasone|dexamethasone|mesh-list
101259695|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
101259696|NCT01739985|Droperidol|droperidol|mesh-list
101259697|NCT01739985|Ondansetron|ondansetron|mesh-list
101259698|NCT01739985|BB 1101|bb 1101|mesh-list
101259699|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259700|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
101259701|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
101259702|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259703|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259704|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101259705|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
101259706|NCT01739985|Hormones|hormones|mesh-ancestor
101259707|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259708|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101259709|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259710|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
101259711|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259712|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259713|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
101259714|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259715|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101259716|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101547119|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259717|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
101259718|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259719|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101259720|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101259721|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101259722|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259723|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259724|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101259725|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101259726|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
101259727|NCT01740245|Biguanides|biguanides|mesh-list
101259728|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
101259729|NCT01740245|Polihexanide|polihexanide|mesh-list
101259730|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101259731|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259732|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
101259733|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101259734|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259735|NCT01740271|Epirubicin|epirubicin|mesh-list
101259736|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101259737|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259738|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101259755|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259756|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
101259757|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
101259758|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259759|NCT01740518|Protective Agents|protective agents|mesh-ancestor
101259760|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259761|NCT01740518|Vitamins|vitamins|mesh-ancestor
101259762|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
101259763|NCT01740921|Aspirin|aspirin|mesh-list
101259764|NCT01740921|Liraglutide|liraglutide|mesh-list
101259765|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101259766|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259767|NCT01740921|Analgesics|analgesics|mesh-ancestor
101259768|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
101259769|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259770|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259771|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259772|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259773|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101259774|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101259775|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259776|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101259777|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101259778|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259779|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
101259780|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101259781|NCT01740921|Incretins|incretins|mesh-ancestor
101259782|NCT01740921|Hormones|hormones|mesh-ancestor
101259783|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259784|NCT01740947|Amphotericin B|amphotericin b|mesh-list
101259785|NCT01740947|Tobramycin|tobramycin|mesh-list
101259786|NCT01740947|Colistin|colistin|mesh-list
101259787|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101259788|NCT01740947|Amebicides|amebicides|mesh-ancestor
101259789|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101259790|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101259791|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259792|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101259793|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
101259794|NCT01740960|Dronabinol|dronabinol|mesh-list
101259795|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
101259796|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259797|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101259798|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259804|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259805|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259807|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259808|NCT01741038|Cetuximab|cetuximab|mesh-list
101259809|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101259810|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259811|NCT01741077|Folic Acid|folic acid|mesh-list
101259812|NCT01741077|Hematinics|hematinics|mesh-ancestor
101259813|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259814|NCT01741077|Vitamins|vitamins|mesh-ancestor
101259815|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
101259816|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259817|NCT01741142|Escitalopram|escitalopram|mesh-list
101259818|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101259819|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101412753|NCT00117468|Progesterone|progesterone|mesh-list
101259820|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101259821|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259822|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259823|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
101259824|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259825|NCT01741181|Vitamin D|vitamin d|mesh-list
101259826|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
101259827|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
101259828|NCT01741181|Vitamins|vitamins|mesh-list
101259829|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
101259830|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259831|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101259832|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259833|NCT01741285|Fluticasone|fluticasone|mesh-list
101259834|NCT01741285|Beclomethasone|beclomethasone|mesh-list
101259835|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259836|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101259837|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
101259838|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259839|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259840|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101259841|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
101259842|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259843|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101259844|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
101259845|NCT01741285|Hormones|hormones|mesh-ancestor
101259846|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259847|NCT01741324|Vitamin D|vitamin d|mesh-list
101259848|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
101259849|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
101259850|NCT01741324|Vitamins|vitamins|mesh-list
101259851|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
101259852|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259853|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101259854|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101259855|NCT01741376|Progesterone|progesterone|mesh-list
101259856|NCT01741376|Progestins|progestins|mesh-ancestor
101259857|NCT01741376|Hormones|hormones|mesh-ancestor
101259858|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259859|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259860|NCT01741389|Melatonin|melatonin|mesh-list
101259861|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
101259862|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259863|NCT01741389|Protective Agents|protective agents|mesh-ancestor
101259864|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259865|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101259866|NCT01741493|Upadacitinib|upadacitinib|mesh-list
101259867|NCT01741493|Tofacitinib|tofacitinib|mesh-list
101259868|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101259895|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259896|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101259897|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
101259898|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259899|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259900|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101259901|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101259902|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101259903|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101259904|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
101259905|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259906|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101259907|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101259910|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101259912|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101259913|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
101259914|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
101259915|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259916|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259922|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259923|NCT01741649|Povidone|povidone|mesh-list
101259924|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
101259925|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
101259926|NCT01741727|ABT-414|abt-414|mesh-list
101259927|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
101259928|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
101259929|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259930|NCT01741753|Prednisone|prednisone|mesh-list
101259931|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259932|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
101259933|NCT01741753|Hormones|hormones|mesh-ancestor
101259934|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259935|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259936|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101259937|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101259938|NCT01741831|Darunavir|darunavir|mesh-list
101259939|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101259940|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101259941|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
101259943|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259944|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101259945|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101259946|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
101259947|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259948|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
101259949|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101259950|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259951|NCT01742247|Palmidrol|palmidrol|mesh-list
101259952|NCT01742247|Analgesics|analgesics|mesh-ancestor
101259953|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
101259954|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101259955|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259956|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101259957|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101259958|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259959|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101259960|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
101259961|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101259962|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101259963|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101259964|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101259965|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259966|NCT01742247|Hormones|hormones|mesh-ancestor
101259967|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101259968|NCT01742273|Vitamin K|vitamin k|mesh-list
101259969|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
101259970|NCT01742273|Vitamins|vitamins|mesh-ancestor
101259971|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
101259972|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101259973|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101259974|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101259975|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101259976|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
101259977|NCT01742273|Coagulants|coagulants|mesh-ancestor
101259978|NCT01742338|Prednisone|prednisone|mesh-list
101259979|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
101259980|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101259981|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101259982|NCT01742338|Prednisolone|prednisolone|mesh-list
101259983|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
101259984|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101259985|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
101259986|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101259987|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
101260007|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101260008|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260009|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260010|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260011|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101260012|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
101260013|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
101260014|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
101260015|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101260016|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101260018|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101260019|NCT01742429|Amoxicillin|amoxicillin|mesh-list
101260020|NCT01742429|Metronidazole|metronidazole|mesh-list
101260021|NCT01742429|Levofloxacin|levofloxacin|mesh-list
101260022|NCT01742429|Tetracycline|tetracycline|mesh-list
101260023|NCT01742429|Bismuth|bismuth|mesh-list
101260024|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101260025|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101260026|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260027|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260028|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101260029|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101260030|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101260031|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101260032|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101260033|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260034|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260035|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260036|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101260037|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101260039|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260040|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101260041|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
101260042|NCT01742533|Hormones|hormones|mesh-list
101260043|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260044|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260051|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260052|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260053|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101260054|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260055|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101260056|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
101260057|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260058|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260060|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101260061|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260062|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260063|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260064|NCT01742637|Analgesics|analgesics|mesh-ancestor
101260065|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
101260066|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260067|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260068|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260069|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260070|NCT01742663|Diclofenac|diclofenac|mesh-list
101260071|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260072|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260073|NCT01742663|Analgesics|analgesics|mesh-ancestor
101260074|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
101260075|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260076|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260077|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260078|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260079|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101260080|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260081|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260082|NCT01742676|Tacrolimus|tacrolimus|mesh-list
101260083|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260084|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
101260085|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260086|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260087|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260088|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260089|NCT01742689|Indomethacin|indomethacin|mesh-list
101260090|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101537419|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260091|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260092|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260093|NCT01742689|Analgesics|analgesics|mesh-ancestor
101260094|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
101260095|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260096|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260097|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260098|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260099|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
101260100|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
101260101|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260102|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101260103|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260104|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260105|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
101260106|NCT01742689|Coagulants|coagulants|mesh-ancestor
101260107|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101260108|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
101260109|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
101260111|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
101260112|NCT01742702|Albuterol|albuterol|mesh-list
101260113|NCT01742702|Caseins|caseins|mesh-list
101260114|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101260115|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
101260121|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101328053|NCT00021814|Doxazosin|doxazosin|mesh-list
101260122|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101260124|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101260125|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260126|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260127|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260128|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
101260129|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
101260130|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
101260131|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260132|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
101260133|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101260134|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101260135|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101260136|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260137|NCT01742767|Pemetrexed|pemetrexed|mesh-list
101260138|NCT01742767|Cisplatin|cisplatin|mesh-list
101260139|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260140|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260141|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260142|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260143|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101260144|NCT01742793|Lenalidomide|lenalidomide|mesh-list
101260145|NCT01742793|Romidepsin|romidepsin|mesh-list
101260146|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
101260147|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260148|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101547145|NCT02271464|Bevacizumab|bevacizumab|mesh-list
101260149|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260150|NCT01742793|Growth Substances|growth substances|mesh-ancestor
101260151|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260152|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260153|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101260154|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101260155|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260156|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260157|NCT01742845|Ropivacaine|ropivacaine|mesh-list
101260158|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
101260159|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
101260160|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260161|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260162|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
101260163|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260164|NCT01742988|Rituximab|rituximab|mesh-list
101260165|NCT01742988|Venetoclax|venetoclax|mesh-list
101260166|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101260167|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260168|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
101260169|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260170|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260171|NCT01743014|Ramipril|ramipril|mesh-list
101260172|NCT01743014|Clopidogrel|clopidogrel|mesh-list
101260173|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101260174|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101260175|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101260176|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101260177|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
101260178|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260179|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260180|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260181|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101260182|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
101260183|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260184|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260191|NCT01743066|Protective Agents|protective agents|mesh-ancestor
101260192|NCT01743079|Lamivudine|lamivudine|mesh-list
101260193|NCT01743079|Telbivudine|telbivudine|mesh-list
101260194|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101260195|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101260196|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260197|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260198|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
101260199|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260200|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101260201|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101260202|NCT01743118|Calcipotriene|calcipotriene|mesh-list
101260203|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260204|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
101260205|NCT01743144|Analgesics|analgesics|mesh-ancestor
101260206|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
101260207|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260208|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260209|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
101260210|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260211|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101260212|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
101260213|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101260214|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101260215|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260216|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101260217|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
101260218|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260219|NCT01743157|Bevacizumab|bevacizumab|mesh-list
101260220|NCT01743157|Ipilimumab|ipilimumab|mesh-list
101547152|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
101260221|NCT01743157|Interleukin-2|interleukin-2|mesh-list
101260222|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101260223|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260224|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260225|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260226|NCT01743157|Growth Substances|growth substances|mesh-ancestor
101260227|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260228|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260229|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101260230|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260231|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260232|NCT01743157|Analgesics|analgesics|mesh-ancestor
101260233|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
101260234|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260235|NCT01743235|Buspirone|buspirone|mesh-list
101260236|NCT01743235|Testosterone|testosterone|mesh-list
101260237|NCT01743235|Androgens|androgens|mesh-ancestor
101260238|NCT01743235|Hormones|hormones|mesh-ancestor
101260239|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260240|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260241|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260242|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260243|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260244|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260245|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101260246|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
101260247|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260248|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260249|NCT01743300|Sunitinib|sunitinib|mesh-list
101260250|NCT01743300|Midazolam|midazolam|mesh-list
101260251|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101260252|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260253|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260254|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260258|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101260259|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
101260260|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
101260261|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
101260262|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
101260263|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328059|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
101260264|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260265|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260266|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260267|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260268|NCT01743300|Growth Substances|growth substances|mesh-ancestor
101260269|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260270|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260271|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260272|NCT01743326|Anesthetics|anesthetics|mesh-list
101260273|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260274|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260275|NCT01743365|Afatinib|afatinib|mesh-list
101260276|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260277|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260278|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260279|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260280|NCT01743378|Ropivacaine|ropivacaine|mesh-list
101260281|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
101260282|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
101260283|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260284|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260285|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
101260286|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260287|NCT01743456|Anesthetics|anesthetics|mesh-list
101260288|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260289|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260290|NCT01743508|Misoprostol|misoprostol|mesh-list
101260291|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101547159|NCT02271464|Growth Substances|growth substances|mesh-ancestor
101260292|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
101260293|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260294|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260295|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101260296|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260297|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
101260298|NCT01743690|Nystatin|nystatin|mesh-list
101260299|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101260300|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260301|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
101260302|NCT01743690|Hormones|hormones|mesh-ancestor
101260303|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260304|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260305|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260306|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260307|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
101260308|NCT01743690|Ionophores|ionophores|mesh-ancestor
101260309|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101260310|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260311|NCT01743755|Dexamethasone|dexamethasone|mesh-list
101260312|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260313|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
101260314|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
101260315|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260316|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260317|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260318|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
101260319|NCT01743755|Hormones|hormones|mesh-ancestor
101260320|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260321|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101260322|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260323|NCT01743794|Ropivacaine|ropivacaine|mesh-list
101260324|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
101260325|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
101260326|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260344|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260345|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101260346|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260347|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
101260348|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
101260349|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
101260350|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260351|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101260352|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
101260353|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101260354|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
101260355|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101260356|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
101260357|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260358|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260359|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
101260360|NCT01743911|Tadalafil|tadalafil|mesh-list
101260361|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
101260362|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101260363|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101260364|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260365|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260366|NCT01743911|Urological Agents|urological agents|mesh-ancestor
101260367|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
101260368|NCT01744106|Ephedrine|ephedrine|mesh-list
101260369|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101260370|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
101260371|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260372|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260373|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101260374|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101260375|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
101260376|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101260377|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101260378|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
101260379|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260380|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260381|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260382|NCT01744184|Midazolam|midazolam|mesh-list
101260383|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
101260384|NCT01744184|Entonox|entonox|mesh-list
101260385|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101260386|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260409|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260410|NCT01744236|Incretins|incretins|mesh-ancestor
101260411|NCT01744236|Hormones|hormones|mesh-ancestor
101260412|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260413|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101260414|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
101260415|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260416|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260417|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101260418|NCT01744249|Axitinib|axitinib|mesh-list
101260419|NCT01744249|Octreotide|octreotide|mesh-list
101260420|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260421|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260422|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260423|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260424|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260425|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101260426|NCT01744288|Clopidogrel|clopidogrel|mesh-list
101260427|NCT01744288|Ticagrelor|ticagrelor|mesh-list
101260428|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101260429|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101260430|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101260431|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101260432|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
101260433|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260434|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260435|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260436|NCT01744314|Indomethacin|indomethacin|mesh-list
101260437|NCT01744314|Pantoprazole|pantoprazole|mesh-list
101260455|NCT01744366|Goserelin|goserelin|mesh-list
101260456|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101260457|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260458|NCT01744379|Lesinurad|lesinurad|mesh-list
101260459|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
101260460|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260461|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
101260462|NCT01744444|Gabapentin|gabapentin|mesh-list
101260463|NCT01744444|Memantine|memantine|mesh-list
101260464|NCT01744444|Analgesics|analgesics|mesh-ancestor
101260465|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
101260466|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260467|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260468|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
101260469|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260470|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101328071|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260471|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260472|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260473|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101260474|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101260475|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260476|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415898|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101260477|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
101260478|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101260479|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101260480|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
101260481|NCT01744470|Tacrolimus|tacrolimus|mesh-list
101260482|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260483|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
101260484|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260485|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260486|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260487|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260488|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101260489|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
101260490|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260491|NCT01744587|Protective Agents|protective agents|mesh-ancestor
101260492|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260493|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101260494|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101260498|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260499|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260500|NCT01744756|Bevacizumab|bevacizumab|mesh-list
101260501|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101260502|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260503|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260504|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260505|NCT01744756|Growth Substances|growth substances|mesh-ancestor
101260506|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260507|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260508|NCT01744873|Bisoprolol|bisoprolol|mesh-list
101260509|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260510|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
101260511|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
101260512|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260513|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260514|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101260515|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101260516|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101260517|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260518|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260519|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260520|NCT01744886|Benzocaine|benzocaine|mesh-list
101260521|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
101260522|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
101260523|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260524|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260525|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
101260526|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260527|NCT01744626|Rituximab|rituximab|mesh-list
101260528|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101260529|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260530|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
101260531|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260532|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260533|NCT01744964|Apomorphine|apomorphine|mesh-list
101260534|NCT01744964|Emetics|emetics|mesh-ancestor
101260535|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260536|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
101260537|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260538|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260539|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
101260540|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
101260541|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260542|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415908|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260543|NCT01745081|Mannitol|mannitol|mesh-list
101260544|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101260545|NCT01745081|Diuretics|diuretics|mesh-ancestor
101260546|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
101260547|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260548|NCT01745159|Tacrolimus|tacrolimus|mesh-list
101260549|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260550|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
101260551|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260552|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260553|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260554|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260555|NCT01745263|Vitamin D|vitamin d|mesh-list
101260556|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
101260557|NCT01745263|Vitamins|vitamins|mesh-ancestor
101260558|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
101260559|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260560|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101260561|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101260562|NCT01745302|Gefitinib|gefitinib|mesh-list
101260563|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260564|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260565|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260566|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260567|NCT01745328|Amoxicillin|amoxicillin|mesh-list
101260600|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260601|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
101260602|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
101260603|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260604|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260607|NCT01745601|Escitalopram|escitalopram|mesh-list
101260608|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101260609|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101260610|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101260611|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260615|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101260616|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101260617|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
101260618|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
101260619|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260620|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101260621|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101260622|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
101260623|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101260624|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
101260625|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260626|NCT01745614|Nimesulide|nimesulide|mesh-list
101260627|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260628|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260629|NCT01745614|Analgesics|analgesics|mesh-ancestor
101260630|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
101260631|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260632|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260633|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260634|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260635|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101260636|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260637|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260638|NCT01745640|Dexamethasone|dexamethasone|mesh-list
101260639|NCT01745640|Pomalidomide|pomalidomide|mesh-list
101260640|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260641|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
101260642|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
101260643|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260644|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260645|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101260646|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
101260647|NCT01745640|Hormones|hormones|mesh-ancestor
101260648|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260649|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101260650|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260651|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
101260652|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260653|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260654|NCT01745640|Growth Substances|growth substances|mesh-ancestor
101260655|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260656|NCT01745666|Epinephrine|epinephrine|mesh-list
101260657|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101260658|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101260659|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260660|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260661|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260662|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260663|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101260664|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101260665|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
101260666|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260667|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101260668|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101260669|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
101260670|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
101260671|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101260672|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
101260673|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260674|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260675|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101260676|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101260677|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101260678|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260680|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260681|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260682|NCT01745770|Analgesics|analgesics|mesh-ancestor
101260683|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
101260684|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260702|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101260703|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101260704|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260705|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260706|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260707|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260708|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101260709|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101260711|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260712|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260713|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260714|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260715|NCT01746277|Docetaxel|docetaxel|mesh-list
101260716|NCT01746277|Pemetrexed|pemetrexed|mesh-list
101260717|NCT01746277|Gefitinib|gefitinib|mesh-list
101260718|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260719|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
101260720|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
101260721|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
101547188|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101260722|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260723|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260724|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260725|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101260726|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260727|NCT01746485|Treprostinil|treprostinil|mesh-list
101260728|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260729|NCT01746563|Ranibizumab|ranibizumab|mesh-list
101260730|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260731|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101260732|NCT01746563|Growth Substances|growth substances|mesh-ancestor
101260733|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260734|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
101260735|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260736|NCT01746602|Timolol|timolol|mesh-list
101260737|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101260738|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101260739|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260740|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260741|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260742|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260743|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101260760|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101260761|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101260762|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260763|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260764|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101260765|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
101260766|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260767|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260768|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260769|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260770|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260771|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260772|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
101260773|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260774|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101260775|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101260776|NCT01746719|Etodolac|etodolac|mesh-list
101260777|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260778|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101260779|NCT01746719|Analgesics|analgesics|mesh-ancestor
101260780|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
101260781|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260782|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260783|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260784|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260785|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101260786|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101260787|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260788|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260789|NCT01746771|Paclitaxel|paclitaxel|mesh-list
101260790|NCT01746771|Trastuzumab|trastuzumab|mesh-list
101260791|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101260792|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260793|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
101260794|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
101260795|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
101260796|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260797|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101260798|NCT01746823|Cyclosporine|cyclosporine|mesh-list
101260799|NCT01746823|Cyclosporins|cyclosporins|mesh-list
101260800|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260801|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260802|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547198|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260803|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
101260804|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260805|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
101260829|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101260830|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
101260831|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260832|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101260833|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101260834|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
101260835|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260836|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260837|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101260838|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101260839|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101260840|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101260841|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260842|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101260843|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
101528327|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260845|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101260846|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101260847|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101260848|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
101260849|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101260850|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101260851|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
101260852|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
101260853|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101260854|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101260855|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101260856|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
101260875|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260877|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
101260878|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260879|NCT01747148|Radavirsen|radavirsen|mesh-list
101260880|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
101260881|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260882|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
101260883|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101328108|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101260884|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101260885|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260886|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
101260887|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260888|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260889|NCT01747174|Adenosine|adenosine|mesh-list
101260890|NCT01747174|Nitroprusside|nitroprusside|mesh-list
101260891|NCT01747174|Analgesics|analgesics|mesh-ancestor
101260892|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
101260893|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101260894|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260895|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101260896|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
101260897|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101260898|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
101260899|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
101260900|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260901|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260902|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101260903|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101547201|NCT01109524|Vinorelbine|vinorelbine|mesh-list
101260904|NCT01747226|Fluorides|fluorides|mesh-list
101260905|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
101260906|NCT01747226|Protective Agents|protective agents|mesh-ancestor
101260907|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260908|NCT01747252|Resveratrol|resveratrol|mesh-list
101260909|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
101260910|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260911|NCT01747252|Protective Agents|protective agents|mesh-ancestor
101260926|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101260927|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101260928|NCT01747564|Mirabegron|mirabegron|mesh-list
101260929|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101260930|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101260931|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101260932|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
101260933|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260934|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260935|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260936|NCT01747564|Urological Agents|urological agents|mesh-ancestor
101260937|NCT01747590|Zolpidem|zolpidem|mesh-list
101260938|NCT01747590|Alprazolam|alprazolam|mesh-list
101260939|NCT01747590|Caffeine|caffeine|mesh-list
101260940|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101260941|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260942|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101260943|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260944|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260945|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101260946|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101260947|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
101260948|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101260949|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101260950|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101260951|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101260952|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101260953|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
101260954|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
101260955|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101260956|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101260957|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101260958|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
101260959|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
101260960|NCT01747616|Chitosan|chitosan|mesh-list
101260961|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101260962|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101260963|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101260964|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
101260965|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101260966|NCT01747616|Expectorants|expectorants|mesh-ancestor
101260967|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
101260968|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101260969|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
101260970|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260971|NCT01747616|Protective Agents|protective agents|mesh-ancestor
101260979|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
101260980|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
101260981|NCT01747616|Coagulants|coagulants|mesh-ancestor
101260982|NCT01747642|Sorafenib|sorafenib|mesh-list
101260983|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260984|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101260985|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101260986|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260987|NCT01747668|Tocopherols|tocopherols|mesh-list
101260988|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
101260989|NCT01747668|Vitamin E|vitamin e|mesh-list
101260990|NCT01747668|Vitamins|vitamins|mesh-ancestor
101547210|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101260991|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
101260992|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101260993|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
101260994|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101260995|NCT01747668|Protective Agents|protective agents|mesh-ancestor
101260996|NCT01747707|Docetaxel|docetaxel|mesh-list
101260997|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101260998|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101260999|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101261000|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101261001|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261002|NCT01747720|Vitamin D|vitamin d|mesh-list
101261003|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
101261004|NCT01747720|Vitamins|vitamins|mesh-ancestor
101261005|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
101261006|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261007|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261008|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261009|NCT01747746|Enoxaparin|enoxaparin|mesh-list
101261010|NCT01747746|Warfarin|warfarin|mesh-list
101261011|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
101261012|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
101261013|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101261014|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
101261015|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101261016|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
101261017|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261018|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261019|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101261020|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101261021|NCT01747798|Auranofin|auranofin|mesh-list
101261022|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261023|NCT01747993|Tamsulosin|tamsulosin|mesh-list
101261024|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101261025|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101261026|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101261027|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261028|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261029|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261030|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261031|NCT01747993|Urological Agents|urological agents|mesh-ancestor
101261032|NCT01748019|Namitecan|namitecan|mesh-list
101261033|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101261034|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261035|NCT01748084|Rituximab|rituximab|mesh-list
101261036|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101261037|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261038|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
101261039|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261040|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261041|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101261042|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
101261050|NCT01748253|Amlodipine|amlodipine|mesh-list
101261051|NCT01748253|Telmisartan|telmisartan|mesh-list
101261052|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101261053|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101261054|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101261055|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261056|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261057|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261058|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261059|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101261060|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101261061|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101261062|NCT01748279|Atorvastatin|atorvastatin|mesh-list
101261063|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
101547216|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261064|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101261065|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101261066|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
101261067|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261068|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101261069|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101261070|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261071|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101261072|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
101261073|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261074|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261075|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101261076|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261077|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101261078|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101261079|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101261080|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261081|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261082|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101261083|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101261084|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261085|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101261086|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
101261087|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101261088|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101261090|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101261091|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101328123|NCT00022126|Cytarabine|cytarabine|mesh-list
101261092|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101261093|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
101261094|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
101261095|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261096|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261097|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261098|NCT01748370|Vitamin D|vitamin d|mesh-list
101261099|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
101261100|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
101261101|NCT01748370|Vitamins|vitamins|mesh-list
101261102|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
101261103|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261104|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261105|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261106|NCT01748396|Calcitriol|calcitriol|mesh-list
101261107|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
101261119|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261121|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
101261122|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
101261123|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
101261124|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261125|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261126|NCT01748435|Capsaicin|capsaicin|mesh-list
101261127|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
101261128|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
101261129|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
101261130|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261131|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261132|NCT01748487|Dexamethasone|dexamethasone|mesh-list
101261133|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
101261134|NCT01748487|BB 1101|bb 1101|mesh-list
101261135|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261136|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
101261137|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
101261138|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261139|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261140|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261141|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
101261142|NCT01748487|Hormones|hormones|mesh-ancestor
101261143|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261144|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101261145|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261146|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
101261147|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261148|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261149|NCT01748500|Pantoprazole|pantoprazole|mesh-list
101261150|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101261151|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261152|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101261153|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261154|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261155|NCT01748526|Canagliflozin|canagliflozin|mesh-list
101261156|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101261157|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261158|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101261159|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261160|NCT01748539|Brodalumab|brodalumab|mesh-list
101261161|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101261162|NCT01748630|Fentanyl|fentanyl|mesh-list
101261163|NCT01748630|Midazolam|midazolam|mesh-list
101261164|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
101261165|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101261166|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261167|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261168|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101261169|NCT01748630|Analgesics|analgesics|mesh-ancestor
101261170|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
101261182|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
101261183|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
101261184|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101261185|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261186|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261187|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
101261188|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
101261189|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
101261190|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
101261191|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261192|NCT01748669|Protective Agents|protective agents|mesh-ancestor
101261193|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261194|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101261195|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261196|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101261197|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261198|NCT01748721|Antibodies|antibodies|mesh-list
101261199|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101261200|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
101261201|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261202|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101261203|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101261204|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
101261205|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261206|NCT01748773|Capecitabine|capecitabine|mesh-list
101261207|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
101261208|NCT01748773|Trastuzumab|trastuzumab|mesh-list
101261209|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101261210|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
101261211|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261212|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261213|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101261214|NCT01748838|Mannitol|mannitol|mesh-list
101261215|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101261216|NCT01748838|Diuretics|diuretics|mesh-ancestor
101261217|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
101261218|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261219|NCT01748929|Albendazole|albendazole|mesh-list
101261220|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
101261221|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101261222|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261223|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
101261224|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101261225|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101261226|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101261227|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101261228|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101261229|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261230|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261231|NCT01749072|Vinorelbine|vinorelbine|mesh-list
101261232|NCT01749072|Ifosfamide|ifosfamide|mesh-list
101261233|NCT01749072|Gefitinib|gefitinib|mesh-list
101261234|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101261246|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261247|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101261248|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101261249|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261250|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261251|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101261252|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
101261253|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261254|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261255|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101261256|NCT01749098|Ketamine|ketamine|mesh-list
101261257|NCT01749098|Analgesics|analgesics|mesh-ancestor
101261258|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
101261259|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261260|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261261|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101261262|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261263|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
101261265|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261266|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101261267|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101261268|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261269|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261270|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
101261271|NCT01749111|Methotrexate|methotrexate|mesh-list
101261272|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101261273|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101261274|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
101261275|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261276|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261277|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101261278|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
101261279|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261280|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261281|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101261282|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101261283|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
101261284|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261285|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101261286|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
101415930|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415931|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547246|NCT01172275|Expectorants|expectorants|mesh-ancestor
101261287|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
101261288|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261289|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101261290|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101261292|NCT01749150|Ribavirin|ribavirin|mesh-list
101261293|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101261294|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
101261295|NCT01749150|Lactams|lactams|mesh-list
101261296|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101261297|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101261320|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101261321|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101261322|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261323|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261324|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101261325|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101261326|NCT01749319|Baclofen|baclofen|mesh-list
101261327|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101261328|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261329|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101261330|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261331|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101261332|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
101261333|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
101261334|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261335|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261336|NCT01749371|Vitamins|vitamins|mesh-list
101261337|NCT01749371|Vitamin E|vitamin e|mesh-list
101261338|NCT01749371|Tocopherols|tocopherols|mesh-list
101261339|NCT01749371|Tocotrienols|tocotrienols|mesh-list
101261340|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
101261342|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261343|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
101261344|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261345|NCT01749371|Protective Agents|protective agents|mesh-ancestor
101261346|NCT01749384|Bevacizumab|bevacizumab|mesh-list
101261348|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
101261349|NCT01749384|Antibodies|antibodies|mesh-list
101261350|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
101261351|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101261352|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
101261354|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101261355|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101261356|NCT01749384|Growth Substances|growth substances|mesh-ancestor
101261357|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261358|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
101261359|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
101261360|NCT01749397|Fluorouracil|fluorouracil|mesh-list
101261362|NCT01749397|Veliparib|veliparib|mesh-list
101261364|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
101261365|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261366|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101261367|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261368|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101261370|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261371|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101261372|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261374|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101261375|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101261376|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101261377|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261378|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261379|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
101261380|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261381|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261382|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101261383|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261386|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101261387|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261388|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261389|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101261390|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261391|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261392|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261393|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
101261395|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
101261396|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
101261397|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261404|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101261405|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101261406|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261408|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101261409|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
101261410|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261411|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101261412|NCT01749579|Fentanyl|fentanyl|mesh-list
101261413|NCT01749579|Midazolam|midazolam|mesh-list
101261414|NCT01749579|Propofol|propofol|mesh-list
101261415|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101261416|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261417|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261418|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261420|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
101261421|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261422|NCT01749579|Narcotics|narcotics|mesh-ancestor
101261423|NCT01749579|Analgesics|analgesics|mesh-ancestor
101261424|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
101261425|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261426|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101261427|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101261428|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261429|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261430|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
101261431|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
101261432|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261433|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261434|NCT01750060|Fentanyl|fentanyl|mesh-list
101261435|NCT01750060|Naltrexone|naltrexone|mesh-list
101261436|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261437|NCT01750060|Narcotics|narcotics|mesh-ancestor
101261438|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261439|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261440|NCT01750060|Analgesics|analgesics|mesh-ancestor
101261441|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
101261442|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261443|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101261444|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261445|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
101261446|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
101261447|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101261448|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101261449|NCT01750099|Lidocaine|lidocaine|mesh-list
101261450|NCT01750099|Epinephrine|epinephrine|mesh-list
101261451|NCT01750099|Fentanyl|fentanyl|mesh-list
101261452|NCT01750099|Bupivacaine|bupivacaine|mesh-list
101261453|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101261454|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
101261455|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261456|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261457|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
101261458|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261459|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101261465|NCT01750099|Narcotics|narcotics|mesh-ancestor
101261466|NCT01750099|Analgesics|analgesics|mesh-ancestor
101261467|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101261468|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261469|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
101261470|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101261471|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101261472|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261473|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261474|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101261475|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101261476|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
101261477|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101261478|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261479|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
101261480|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
101261481|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101261483|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101261484|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101261485|NCT01750359|Analgesics|analgesics|mesh-ancestor
101261486|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
101261487|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261488|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261489|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261490|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547269|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
101261491|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261492|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261493|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261494|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101261495|NCT01750385|Cephalosporins|cephalosporins|mesh-list
101261496|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261497|NCT01750437|Esomeprazole|esomeprazole|mesh-list
101261498|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101261499|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261500|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101261501|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261502|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261503|NCT01750463|Chrysarobin|chrysarobin|mesh-list
101261504|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101261505|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101261506|NCT01750463|Analgesics|analgesics|mesh-ancestor
101261507|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
101261508|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261509|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261510|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101261511|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261512|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101261513|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
101261514|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101261515|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
101261516|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261517|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261518|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101261519|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101261520|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101261521|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101261522|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101261523|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261524|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101261525|NCT01750541|Valproic Acid|valproic acid|mesh-list
101261527|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
101261528|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
101261551|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
101261552|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101261553|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261554|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261555|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
101261556|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261557|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261558|NCT01750723|Acetazolamide|acetazolamide|mesh-list
101261559|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
101261560|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101261561|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261562|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261563|NCT01750723|Diuretics|diuretics|mesh-ancestor
101261564|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
101261565|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261566|NCT01750762|Lenalidomide|lenalidomide|mesh-list
101261567|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
101261568|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261569|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101261570|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101261571|NCT01750762|Growth Substances|growth substances|mesh-ancestor
101261572|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
101261573|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261574|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
101261575|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101261576|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
101261577|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101261578|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
101261579|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261580|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261601|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261602|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101261603|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101261604|NCT01750983|Growth Substances|growth substances|mesh-ancestor
101261605|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
101261606|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261607|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101261608|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101261609|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261611|NCT01751009|Vitamin A|vitamin a|mesh-list
101261612|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
101261613|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
101261614|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261615|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
101261616|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261617|NCT01751009|Protective Agents|protective agents|mesh-ancestor
101261618|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101261619|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261620|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101261621|NCT01751074|Darapladib|darapladib|mesh-list
101261622|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101261623|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101261624|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
101261625|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261627|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101261628|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261629|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101261630|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
101261631|NCT01751204|Calcium|calcium|mesh-list
101261632|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261633|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261634|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261635|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
101261636|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261637|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261638|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101261639|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261655|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
101261656|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261657|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261658|NCT01751347|Lidocaine|lidocaine|mesh-list
101261659|NCT01751347|Bupivacaine|bupivacaine|mesh-list
101261660|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
101261661|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
101261662|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261663|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261664|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
101261665|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261666|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101261667|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101261668|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101261669|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261670|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261671|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
101261672|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101261673|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101528328|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101261674|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261675|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261676|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
101261677|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261678|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261679|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101547281|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
101261680|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261681|NCT01751763|Sorafenib|sorafenib|mesh-list
101261682|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261683|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101261684|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261685|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261686|NCT01751828|Sertraline|sertraline|mesh-list
101261687|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
101261688|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261689|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101261690|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101261691|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261692|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261693|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261694|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
101261695|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261697|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101261709|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
101261710|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
101261711|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261712|NCT01752075|Lenalidomide|lenalidomide|mesh-list
101261713|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
101261714|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261715|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101261716|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101222144|NCT01511562|Cytarabine|cytarabine|mesh-list
101261717|NCT01752075|Growth Substances|growth substances|mesh-ancestor
101261718|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
101261719|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261720|NCT01752153|Silymarin|silymarin|mesh-list
101261721|NCT01752153|Deferoxamine|deferoxamine|mesh-list
101261722|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
101261723|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261724|NCT01752153|Protective Agents|protective agents|mesh-ancestor
101261725|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261726|NCT01752153|Siderophores|siderophores|mesh-ancestor
101261727|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101261728|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
101261729|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
101261730|NCT01752205|Paclitaxel|paclitaxel|mesh-list
101261731|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101261732|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101261733|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261734|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
101261735|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
101261736|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
101261737|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261738|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101261739|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261740|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
101261741|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101261742|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261743|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261744|NCT01752244|Vitamins|vitamins|mesh-ancestor
101261745|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
101261746|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
101261747|NCT01752270|Cyproterone|cyproterone|mesh-list
101261748|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
101261749|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
101261750|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
101261751|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261752|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261753|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261754|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101261755|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
101261756|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261757|NCT01752322|Lidocaine|lidocaine|mesh-list
101261758|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
101547286|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
101261759|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
101261787|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261788|NCT01752699|Narcotics|narcotics|mesh-ancestor
101261789|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261790|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261791|NCT01752699|Analgesics|analgesics|mesh-ancestor
101261792|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
101261793|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261794|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
101261795|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261796|NCT01752790|Azathioprine|azathioprine|mesh-list
101261797|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261798|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
101261799|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261800|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101261801|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261807|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261808|NCT01752959|Remifentanil|remifentanil|mesh-list
101261809|NCT01752959|Esmolol|esmolol|mesh-list
101261810|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101261811|NCT01752959|Narcotics|narcotics|mesh-ancestor
101261812|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261813|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261814|NCT01752959|Analgesics|analgesics|mesh-ancestor
101261815|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
101261816|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261817|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101261818|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101261819|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101261820|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261821|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261822|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261824|NCT01752998|Narcotics|narcotics|mesh-ancestor
101261825|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261826|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261827|NCT01752998|Analgesics|analgesics|mesh-ancestor
101261828|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
101261829|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261830|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101261831|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101261832|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
101261833|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261834|NCT01753102|Estradiol|estradiol|mesh-list
101261835|NCT01753102|Estrogens|estrogens|mesh-ancestor
101261836|NCT01753102|Hormones|hormones|mesh-ancestor
101261837|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261838|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261839|NCT01753128|Imipramine|imipramine|mesh-list
101547288|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
101261840|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101261841|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
101261842|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261843|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101261844|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101261845|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261846|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261847|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
101261848|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547290|NCT02272517|Vortioxetine|vortioxetine|mesh-list
101261849|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261850|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101261851|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
101261852|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101261853|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101261854|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101261855|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261856|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261857|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
101261858|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261859|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261860|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101261861|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261863|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
101261864|NCT01753375|Vitamins|vitamins|mesh-ancestor
101261865|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
101261866|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261867|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101261868|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101261869|NCT01753453|Plerixafor|plerixafor|mesh-list
101261870|NCT01753453|Lenograstim|lenograstim|mesh-list
101261871|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101261872|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
101261878|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101261879|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101261880|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
101261881|NCT01753752|Chitosan|chitosan|mesh-list
101261882|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101261883|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101261884|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101261885|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
101261886|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261887|NCT01753752|Expectorants|expectorants|mesh-ancestor
101261888|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261889|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101261890|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
101261891|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261892|NCT01753752|Protective Agents|protective agents|mesh-ancestor
101261893|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261894|NCT01753752|Antidotes|antidotes|mesh-ancestor
101261895|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101261896|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101261897|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
101261898|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101261899|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
101261900|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
101261901|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
101261902|NCT01753752|Coagulants|coagulants|mesh-ancestor
101261903|NCT01753882|Escitalopram|escitalopram|mesh-list
101261904|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101261905|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101261906|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101261907|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261908|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261909|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
101547308|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
101261910|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261913|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101261914|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101261915|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261916|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261917|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101261918|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101261919|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101261920|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101261921|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
101261922|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
101261923|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
101261924|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
101261925|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101261926|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261927|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101261928|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101261929|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261930|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101261931|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101261932|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
101261933|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101261934|NCT01754181|Insulin|insulin|mesh-list
101261935|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101261936|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261937|NCT01754220|Montelukast|montelukast|mesh-list
101261938|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101261939|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261940|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101261941|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
101261942|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101261943|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261944|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101261953|NCT01754324|Narcotics|narcotics|mesh-ancestor
101261954|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101261955|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261956|NCT01754324|Analgesics|analgesics|mesh-ancestor
101261957|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
101261958|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101261959|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
101261960|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101261961|NCT01754649|Misoprostol|misoprostol|mesh-list
101261962|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101261963|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
101261964|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261965|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261966|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101261967|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101261968|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
101261970|NCT01754701|Trace Elements|trace elements|mesh-ancestor
101261971|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
101261972|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261973|NCT01754805|Methotrexate|methotrexate|mesh-list
101261974|NCT01754805|Peficitinib|peficitinib|mesh-list
101261975|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101261976|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
101328185|NCT00022204|Vitamin E|vitamin e|mesh-list
101261977|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101261978|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261979|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101261980|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
101261981|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261982|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101261983|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
101261984|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261985|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101261986|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101261987|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
101261988|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101261989|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101261990|NCT01754831|Fluorides|fluorides|mesh-list
101261991|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
101261992|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
101261993|NCT01754831|Protective Agents|protective agents|mesh-ancestor
101261994|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101261995|NCT01754844|AZD7624|azd7624|mesh-list
101261996|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101261997|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101261998|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101261999|NCT01754870|Rituximab|rituximab|mesh-list
101262000|NCT01754870|Lenalidomide|lenalidomide|mesh-list
101262001|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101262002|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101262003|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262004|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
101262005|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262006|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262007|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101262008|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101262009|NCT01754870|Growth Substances|growth substances|mesh-ancestor
101262010|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
101262011|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101262012|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
101262013|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262020|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101262021|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262022|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262024|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
101262025|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
101262026|NCT01754961|Vitamins|vitamins|mesh-list
101262027|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
101262028|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262029|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262030|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262031|NCT01754974|Ribavirin|ribavirin|mesh-list
101262032|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101262033|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
101262034|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262035|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
101262036|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262037|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
101262038|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
101262039|NCT01755078|Calcium|calcium|mesh-list
101262040|NCT01755078|Sevelamer|sevelamer|mesh-list
101262041|NCT01755078|Calcium acetate|calcium acetate|mesh-list
101262042|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262043|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262044|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262045|NCT01755078|Antacids|antacids|mesh-ancestor
101262046|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262047|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262048|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
101262049|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
101262051|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262052|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
101262053|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262054|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262055|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
101262056|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262057|NCT01755182|Somatostatin|somatostatin|mesh-list
101262058|NCT01755182|Hormones|hormones|mesh-ancestor
101262059|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262060|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262061|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
101547334|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262062|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262063|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262064|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101262065|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101262066|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262067|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262068|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262069|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101262070|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101262071|NCT01755299|Caffeine|caffeine|mesh-list
101262072|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101262073|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262074|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101262075|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262076|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262077|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101262078|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101262079|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
101262080|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262081|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
101262082|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101262104|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262105|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101262106|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101262107|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101262108|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262109|NCT01755403|Benzonidazole|benzonidazole|mesh-list
101262110|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262111|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
101262112|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262113|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101262114|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101262115|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101262116|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262117|NCT01755468|Insulin|insulin|mesh-list
101262118|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101262119|NCT01755468|Metformin|metformin|mesh-list
101262120|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
101262121|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
101262123|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262124|NCT01755494|Metformin|metformin|mesh-list
101262125|NCT01755494|Saxagliptin|saxagliptin|mesh-list
101262126|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262127|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262128|NCT01755494|Incretins|incretins|mesh-ancestor
101262129|NCT01755494|Hormones|hormones|mesh-ancestor
101262130|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262131|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101262132|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262133|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262134|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262135|NCT01755520|Aspirin|aspirin|mesh-list
101262136|NCT01755520|Ticagrelor|ticagrelor|mesh-list
101262137|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101262138|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101262139|NCT01755520|Analgesics|analgesics|mesh-ancestor
101262140|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
101262158|NCT01755559|Lumefantrine|lumefantrine|mesh-list
101262159|NCT01755559|Artemether|artemether|mesh-list
101262160|NCT01755559|Piperaquine|piperaquine|mesh-list
101262161|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101262162|NCT01755559|Amodiaquine|amodiaquine|mesh-list
101262163|NCT01755559|Artenimol|artenimol|mesh-list
101262164|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
101262165|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101262166|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101262167|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262168|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262169|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
101262171|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101262172|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
101262173|NCT01755572|Liraglutide|liraglutide|mesh-list
101262174|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262175|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262176|NCT01755572|Incretins|incretins|mesh-ancestor
101262177|NCT01755572|Hormones|hormones|mesh-ancestor
101262178|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262179|NCT01755611|Minocycline|minocycline|mesh-list
101262180|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262181|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262182|NCT01755663|Metoprolol|metoprolol|mesh-list
101262183|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101262184|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101262185|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
101262186|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
101262187|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262188|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262189|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101262190|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101262191|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101262192|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262193|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262194|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262195|NCT01754792|Inositol|inositol|mesh-list
101262196|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
101262197|NCT01754792|Vitamins|vitamins|mesh-ancestor
101262198|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
101262199|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262201|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262226|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262227|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101262228|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101262229|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547350|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101262230|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262231|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
101262232|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262233|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
101262234|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
101262235|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262236|NCT01755923|Docetaxel|docetaxel|mesh-list
101262237|NCT01755923|Gefitinib|gefitinib|mesh-list
101262238|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262239|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
101262240|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
101262241|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
101262242|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547352|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262243|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101262244|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262245|NCT01756040|Lactulose|lactulose|mesh-list
101262246|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101262247|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262248|NCT01756105|Insulin|insulin|mesh-list
101262249|NCT01756105|Metformin|metformin|mesh-list
101262250|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
101262251|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
101262252|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
101262253|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262268|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101262269|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101262270|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101262271|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262272|NCT01756183|Paclitaxel|paclitaxel|mesh-list
101262273|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101262274|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262275|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101262276|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101262277|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101262278|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262279|NCT01756261|Aflibercept|aflibercept|mesh-list
101262280|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101262281|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101262282|NCT01756261|Growth Substances|growth substances|mesh-ancestor
101262283|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262284|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101262285|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262286|NCT01756404|Canagliflozin|canagliflozin|mesh-list
101262287|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101262288|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262289|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262290|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262291|NCT01756417|Metformin|metformin|mesh-list
101262292|NCT01756417|Canagliflozin|canagliflozin|mesh-list
101262293|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262294|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262295|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101262296|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262297|NCT01756430|Carvedilol|carvedilol|mesh-list
101262298|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101262299|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101262300|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262301|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262302|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262303|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262304|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101262305|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
101262306|NCT01756430|Protective Agents|protective agents|mesh-ancestor
101262307|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101262308|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101262309|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262310|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
101262311|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101262312|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101262313|NCT01756443|Lidocaine|lidocaine|mesh-list
101262314|NCT01756443|Epinephrine|epinephrine|mesh-list
101262330|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101262331|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262332|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262333|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101262334|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101262335|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
101262336|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101262337|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101262338|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
101262339|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
101262340|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101262341|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
101262342|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101262343|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262344|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262345|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101262346|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101262347|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262348|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262349|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262350|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101262351|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
101262352|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101262353|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262354|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101262355|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101262356|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101262358|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101262359|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262360|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
101262361|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262362|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
101262363|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262364|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262365|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101262366|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101262367|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262368|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262369|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262370|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
101262371|NCT01756547|Diuretics|diuretics|mesh-ancestor
101262372|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
101262373|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262374|NCT01756547|Expectorants|expectorants|mesh-ancestor
101262393|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262394|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101262395|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101262396|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
101262398|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
101262399|NCT01756664|Petrolatum|petrolatum|mesh-list
101262400|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101262401|NCT01756664|Protective Agents|protective agents|mesh-ancestor
101262402|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262403|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262404|NCT01756664|Emollients|emollients|mesh-ancestor
101262405|NCT01756768|Palbociclib|palbociclib|mesh-list
101262406|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262407|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101262408|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262409|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262410|NCT01756781|Palbociclib|palbociclib|mesh-list
101262411|NCT01756781|Midazolam|midazolam|mesh-list
101262412|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101262413|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101262414|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262415|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262416|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101262417|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101262418|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101262419|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101262420|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
101262421|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
101262422|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
101262423|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
101262424|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262425|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262426|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262427|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101262428|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262429|NCT01756989|Thalidomide|thalidomide|mesh-list
101262430|NCT01756989|Celecoxib|celecoxib|mesh-list
101262431|NCT01756989|Etoposide|etoposide|mesh-list
101262432|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
101262433|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101262434|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262435|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101262450|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
101262451|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
101415948|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101262452|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262453|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262454|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101262455|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101262456|NCT01756989|Growth Substances|growth substances|mesh-ancestor
101262457|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
101262458|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
101262459|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101262460|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101262461|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101262462|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101262463|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262464|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262465|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262466|NCT01757106|Sevoflurane|sevoflurane|mesh-list
101262467|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101262468|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101262469|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
101262470|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
101262471|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262472|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262473|NCT01757236|Vancomycin|vancomycin|mesh-list
101262474|NCT01757236|Rifampin|rifampin|mesh-list
101262475|NCT01757236|Clindamycin|clindamycin|mesh-list
101262476|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
101262477|NCT01757236|Linezolid|linezolid|mesh-list
101262478|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101262479|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
101262480|NCT01757236|Trimethoprim|trimethoprim|mesh-list
101262481|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
101262482|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101262483|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262484|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101262485|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
101262486|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
101262487|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101262488|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262489|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262490|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101262491|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101262492|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101262493|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101262494|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101262498|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
101262499|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101262500|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101262501|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101262502|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101262503|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101262504|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101262505|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
101262506|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101262507|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101262508|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
101262509|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101262510|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101262511|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262512|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101262513|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101547360|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262514|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101262515|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101262516|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101262517|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101262518|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101262520|NCT01757262|Ticagrelor|ticagrelor|mesh-list
101262521|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101262522|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101262523|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101262524|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101262525|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
101262526|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262527|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262528|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262529|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
101262530|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101262531|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262532|NCT01757431|Eculizumab|eculizumab|mesh-list
101262533|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101262534|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262535|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
101262536|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262537|NCT01757457|Abciximab|abciximab|mesh-list
101262538|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
101262539|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101262540|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
101262541|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101262542|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262544|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101262546|NCT01757587|Vildagliptin|vildagliptin|mesh-list
101262547|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262548|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262549|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101262550|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262551|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262552|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262553|NCT01757639|Ipilimumab|ipilimumab|mesh-list
101262554|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101262555|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262556|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101262557|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262558|NCT01757756|Midazolam|midazolam|mesh-list
101262559|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101262560|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101262561|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262562|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262563|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101262564|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101262580|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262581|NCT01757769|Urological Agents|urological agents|mesh-ancestor
101262583|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101262584|NCT01757795|Protective Agents|protective agents|mesh-ancestor
101262585|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262586|NCT01757808|Ranolazine|ranolazine|mesh-list
101262587|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101262588|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101262589|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262590|NCT01757860|Vitamin D|vitamin d|mesh-list
101262591|NCT01757860|Vitamins|vitamins|mesh-ancestor
101262592|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
101262593|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262594|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262595|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
101262596|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101262597|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101262598|NCT01757899|Prednisolone|prednisolone|mesh-list
101262599|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
101262600|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101262601|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
101262602|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262603|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
101262604|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
101262605|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262606|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262607|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262608|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
101262609|NCT01757899|Hormones|hormones|mesh-ancestor
101262610|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262611|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101262612|NCT01757899|Protective Agents|protective agents|mesh-ancestor
101328225|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
101262613|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262614|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262615|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
101262616|NCT01758029|Testosterone|testosterone|mesh-list
101262617|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
101262618|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
101262619|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101262620|NCT01758029|Androgens|androgens|mesh-ancestor
101262621|NCT01758029|Hormones|hormones|mesh-ancestor
101262622|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262623|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262624|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262629|NCT01758094|Hormones|hormones|mesh-ancestor
101262630|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262631|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262632|NCT01758107|Cyclosporine|cyclosporine|mesh-list
101262633|NCT01758107|Cyclosporins|cyclosporins|mesh-list
101262634|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262635|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262636|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262637|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
101262638|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262639|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
101262640|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262641|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262642|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262643|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101262644|NCT01758120|Prednisone|prednisone|mesh-list
101262645|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
101262646|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262647|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
101262648|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262649|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262650|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101262651|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
101262652|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262653|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262654|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101262655|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262656|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
101262657|NCT01758120|Hormones|hormones|mesh-ancestor
101262658|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262659|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262660|NCT01758146|Tamoxifen|tamoxifen|mesh-list
101262661|NCT01758146|Letrozole|letrozole|mesh-list
101262662|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262663|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101262664|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101262665|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262666|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262667|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101262668|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
101262669|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262670|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262671|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262672|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101262673|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101262674|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101262675|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101262676|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
101262677|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
101262678|NCT01758185|Vaccines|vaccines|mesh-list
101262679|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
101262680|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262681|NCT01758198|Methotrexate|methotrexate|mesh-list
101262682|NCT01758198|Abatacept|abatacept|mesh-list
101262683|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101328229|NCT00022360|Taurolidine|taurolidine|mesh-list
101262684|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
101262685|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101262686|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262687|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101262688|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
101262689|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262690|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547406|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101262691|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262692|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262693|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101262694|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262721|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262722|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262723|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262725|NCT01758380|Vildagliptin|vildagliptin|mesh-list
101262726|NCT01758380|Gliclazide|gliclazide|mesh-list
101262727|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262728|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262729|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101262730|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262731|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262732|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262733|NCT01758393|Prednisone|prednisone|mesh-list
101262734|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101262735|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
101262736|NCT01758393|Hormones|hormones|mesh-ancestor
101262737|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262738|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262739|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262740|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262741|NCT01758471|Acarbose|acarbose|mesh-list
101262742|NCT01758471|Glipizide|glipizide|mesh-list
101262743|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101262744|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262745|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262746|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262762|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101262763|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101262764|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
101262765|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262766|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262767|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262768|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262769|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101262770|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262771|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
101262772|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189953|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
101262773|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101262774|NCT01758666|Antidotes|antidotes|mesh-ancestor
101262775|NCT01758666|Protective Agents|protective agents|mesh-ancestor
101262776|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
101262778|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
101262779|NCT01758744|Treprostinil|treprostinil|mesh-list
101190258|NCT00004482|Cyclosporine|cyclosporine|mesh-list
101262780|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101262781|NCT01758809|Bupivacaine|bupivacaine|mesh-list
101262782|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262783|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
101190773|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190845|NCT00005802|Fludarabine|fludarabine|mesh-list
101547428|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
101262784|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262785|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262786|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
101262787|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262788|NCT01758835|Calpastatin|calpastatin|mesh-list
101262789|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101262790|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262791|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262792|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262793|NCT01758913|Ibuprofen|ibuprofen|mesh-list
101262794|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101262795|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101262796|NCT01758913|Analgesics|analgesics|mesh-ancestor
101262797|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
101262798|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262799|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192098|NCT00384540|Dobutamine|dobutamine|mesh-list
101192324|NCT02998398|Infliximab|infliximab|mesh-list
101192474|NCT02999958|Vitamins|vitamins|mesh-ancestor
101262806|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101262807|NCT01758978|Narcotics|narcotics|mesh-ancestor
101262808|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262809|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262810|NCT01758978|Analgesics|analgesics|mesh-ancestor
101262811|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
101262812|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262813|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
101262814|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
101262815|NCT01759030|Rituximab|rituximab|mesh-list
101262816|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101262817|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262818|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
101262819|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262820|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262821|NCT01759108|Rebamipide|rebamipide|mesh-list
101262822|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101262823|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262824|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
101192834|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
101192905|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192980|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
101193051|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101262825|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262826|NCT01759108|Protective Agents|protective agents|mesh-ancestor
101262827|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262828|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193572|NCT01836432|Leucovorin|leucovorin|mesh-list
101262829|NCT01759394|Maleic acid|maleic acid|mesh-list
101262830|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262831|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262832|NCT01759485|Vitamin D|vitamin d|mesh-list
101262833|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
101262834|NCT01759485|Vitamins|vitamins|mesh-ancestor
101262835|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
101194088|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
101194236|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101194608|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101194683|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101262836|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262837|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101194832|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101194977|NCT05767827|Analgesics|analgesics|mesh-ancestor
101262838|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101262840|NCT01759524|Clonidine|clonidine|mesh-list
101262841|NCT01759524|Bupivacaine|bupivacaine|mesh-list
101262842|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262843|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
101262844|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262845|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262846|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
101262847|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195425|NCT04679376|Atorvastatin|atorvastatin|mesh-list
101195497|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101262848|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101195570|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262849|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101196097|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
101262852|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196401|NCT01385527|Triamcinolone|triamcinolone|mesh-list
101262853|NCT01759524|Analgesics|analgesics|mesh-ancestor
101262854|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101262855|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
101196646|NCT01386658|Icatibant|icatibant|mesh-list
101262856|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
101262857|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101196762|NCT01387568|Lidocaine|lidocaine|mesh-list
101262858|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101328246|NCT00000143|Ganciclovir|ganciclovir|mesh-list
101262859|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101262860|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262861|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101262862|NCT01759576|Canagliflozin|canagliflozin|mesh-list
101197059|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197283|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262863|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101197437|NCT01391520|Deferiprone|deferiprone|mesh-list
101197508|NCT01392157|Copper|copper|mesh-list
101197582|NCT01392716|Rituximab|rituximab|mesh-list
101197657|NCT01392898|Liraglutide|liraglutide|mesh-list
101197738|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
101197886|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262864|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198047|NCT01394887|Metformin|metformin|mesh-list
101262865|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198194|NCT01395667|Leucovorin|leucovorin|mesh-list
101262866|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262867|NCT01759589|Remifentanil|remifentanil|mesh-list
101262868|NCT01759589|Propofol|propofol|mesh-list
101198624|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101198794|NCT05272462|Minoxidil|minoxidil|mesh-list
101198848|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
101198924|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199078|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
101262869|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101262870|NCT01759589|Anesthetics|anesthetics|mesh-list
101262871|NCT01759589|Sevoflurane|sevoflurane|mesh-list
101199308|NCT04682626|Vitamin D|vitamin d|mesh-list
101199387|NCT04302168|Choline|choline|mesh-list
101199454|NCT03974243|Chiauranib|chiauranib|mesh-list
101199529|NCT03705338|Propofol|propofol|mesh-list
101199605|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
101262872|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199903|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
101199982|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262873|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262874|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262875|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
101200581|NCT01398501|Sorafenib|sorafenib|mesh-list
101262876|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101200803|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200879|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
101200956|NCT01401387|Pancreatin|pancreatin|mesh-list
101201127|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101262877|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101262878|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101262880|NCT01759589|Analgesics|analgesics|mesh-ancestor
101262881|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
101201652|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
101262882|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101262883|NCT01759706|Dexamethasone|dexamethasone|mesh-list
101262884|NCT01759706|Sufentanil|sufentanil|mesh-list
101202028|NCT01407432|Folic Acid|folic acid|mesh-list
101262893|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262894|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262895|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
101262896|NCT01759706|Hormones|hormones|mesh-ancestor
101202541|NCT01410968|Poly ICLC|poly iclc|mesh-list
101202617|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202689|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
101304266|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304267|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
101202836|NCT01413022|Fluorouracil|fluorouracil|mesh-list
101304268|NCT02012075|Protective Agents|protective agents|mesh-ancestor
101202988|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
101304269|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101203133|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262897|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101262898|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101262899|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262900|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262901|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
101262902|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262903|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101262904|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101262905|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
101262906|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203346|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
101203650|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
101262907|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262908|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101262909|NCT01759706|Narcotics|narcotics|mesh-ancestor
101262910|NCT01759706|Analgesics|analgesics|mesh-ancestor
101262911|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
101204319|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101262912|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101262913|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101262914|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
101262915|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262916|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
101262917|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101262918|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101262919|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101262921|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101262922|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101262923|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
101262924|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
101262926|NCT01759719|Trace Elements|trace elements|mesh-ancestor
101262927|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
101262928|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262929|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
101262930|NCT01759732|Fludarabine|fludarabine|mesh-list
101262931|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101262932|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101262933|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
101262934|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262935|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262950|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262951|NCT01759875|Ritonavir|ritonavir|mesh-list
101262952|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101262953|NCT01759875|Rabeprazole|rabeprazole|mesh-list
101262954|NCT01759875|Betaine|betaine|mesh-list
101262956|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101262957|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
101262958|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101262959|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101262960|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101262961|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101262962|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
101262963|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262964|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101262965|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101262966|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101262967|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101262968|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101262969|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
101262970|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101262971|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
101262972|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101262973|NCT01759940|Ropivacaine|ropivacaine|mesh-list
101262974|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
101262975|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
101262976|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262977|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262978|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
101262980|NCT01760018|Desflurane|desflurane|mesh-list
101262981|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101262982|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
101262983|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
101262984|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101262985|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101262986|NCT01760096|Cyclosporine|cyclosporine|mesh-list
101262996|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101262997|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
101262998|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101262999|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101263001|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263002|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101263003|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
101263004|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
101263005|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101263006|NCT01760109|Piperacillin|piperacillin|mesh-list
101263007|NCT01760109|Sulbactam|sulbactam|mesh-list
101263008|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263009|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263010|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101263011|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263012|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263013|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101263014|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
101263015|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263016|NCT01760148|Interferons|interferons|mesh-list
101263017|NCT01760148|Ribavirin|ribavirin|mesh-list
101263018|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
101263019|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
101263021|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
101263022|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263023|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
101263024|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263026|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263027|NCT01760161|Ropivacaine|ropivacaine|mesh-list
101263028|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
101263029|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
101263030|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263032|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
101263033|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263034|NCT01760174|Bupivacaine|bupivacaine|mesh-list
101263035|NCT01760174|Ropivacaine|ropivacaine|mesh-list
101263036|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
101263037|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
101263038|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263039|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263040|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
101263041|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263043|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
101263044|NCT01760226|Rituximab|rituximab|mesh-list
101263045|NCT01760226|Doxorubicin|doxorubicin|mesh-list
101263046|NCT01760226|Methotrexate|methotrexate|mesh-list
101263047|NCT01760226|Etoposide|etoposide|mesh-list
101263048|NCT01760226|Vincristine|vincristine|mesh-list
101263049|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263050|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
101263051|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263052|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263053|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101263054|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
101263060|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101263061|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263062|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263063|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263064|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
101263065|NCT01760226|Hormones|hormones|mesh-ancestor
101319348|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263066|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263067|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263068|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101263069|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
101263070|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263071|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263072|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
101263073|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
101263074|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101263075|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101263076|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101263077|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
101263078|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
101263080|NCT01760252|Capecitabine|capecitabine|mesh-list
101263081|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
101263083|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263085|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263086|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263087|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101263088|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263089|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263090|NCT01760278|Cetrorelix|cetrorelix|mesh-list
101263091|NCT01760278|Hormones|hormones|mesh-list
101263092|NCT01760278|Progesterone|progesterone|mesh-list
101263093|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101263094|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263095|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263097|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101263098|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
101263099|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263100|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
101263101|NCT01760330|Acetaminophen|acetaminophen|mesh-list
101263102|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263103|NCT01760330|Analgesics|analgesics|mesh-ancestor
101263104|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
101263105|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263106|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263108|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
101263109|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
101263111|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101263112|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263113|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263114|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263325|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263327|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101547510|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263328|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101263329|NCT01761318|Liraglutide|liraglutide|mesh-list
101263330|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547511|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263331|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263332|NCT01761318|Incretins|incretins|mesh-ancestor
101263334|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263336|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263337|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
101263338|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263339|NCT01761487|Gentamicins|gentamicins|mesh-list
101263341|NCT01761487|Colistin|colistin|mesh-list
101263342|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263343|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263344|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101263346|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263349|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263350|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101263352|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263353|NCT01761526|Rotigotine|rotigotine|mesh-list
101263354|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
101263355|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
101263356|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263357|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263358|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263359|NCT01761552|Atropine|atropine|mesh-list
101263360|NCT01761552|Neostigmine|neostigmine|mesh-list
101263361|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101263362|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101263363|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101263364|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
101263365|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263367|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101263368|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
101263369|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
101263370|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
101263371|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101263373|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
101263374|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263376|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101263377|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263378|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101263380|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263381|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101263382|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
101304276|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
101263383|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263385|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101263387|NCT01761669|Vitamin D|vitamin d|mesh-list
101263388|NCT01761669|Vitamins|vitamins|mesh-ancestor
101263389|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
101263391|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101263392|NCT01761916|Clonidine|clonidine|mesh-list
101263393|NCT01761916|Captopril|captopril|mesh-list
101263395|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
101304278|NCT02012088|Doxorubicin|doxorubicin|mesh-list
101263397|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547527|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
101263399|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
101263400|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
101263401|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101263402|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101263403|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101263404|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
101304279|NCT02012088|Vincristine|vincristine|mesh-list
101263405|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263406|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263407|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101263408|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
101263413|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263415|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263417|NCT01761994|Analgesics|analgesics|mesh-ancestor
101263418|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
101263419|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263420|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263421|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263422|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263423|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
101263424|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
101263425|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205002|NCT05385744|Teriflunomide|teriflunomide|mesh-list
101263426|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263427|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101205140|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
101205218|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101205289|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
101263429|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101263430|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205508|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
101263433|NCT01762046|Glipizide|glipizide|mesh-list
101205883|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
101263434|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101263435|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263436|NCT01762150|Gemcitabine|gemcitabine|mesh-list
101206106|NCT01429818|Metformin|metformin|mesh-list
101263437|NCT01762150|Sorafenib|sorafenib|mesh-list
101263438|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263439|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263441|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263442|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101263443|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263444|NCT01762163|Aspirin|aspirin|mesh-list
101206650|NCT01432587|Diflunisal|diflunisal|mesh-list
101206704|NCT01432873|Selenium|selenium|mesh-list
101304280|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263445|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263446|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206928|NCT01434212|Ribavirin|ribavirin|mesh-list
101304281|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
101207076|NCT01435343|Cytarabine|cytarabine|mesh-list
101263448|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
101207152|NCT01435915|Ropinirole|ropinirole|mesh-list
101263449|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207290|NCT01436929|Protective Agents|protective agents|mesh-ancestor
101207370|NCT01437462|Propofol|propofol|mesh-list
101207435|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101263450|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263451|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263452|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263453|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101263454|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101263455|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263456|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101263458|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263459|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
101263460|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
101263461|NCT01762202|Fludarabine|fludarabine|mesh-list
101263462|NCT01762202|Ofatumumab|ofatumumab|mesh-list
101263463|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263464|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
101263466|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263467|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101263469|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263470|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263471|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101208748|NCT01441986|Analgesics|analgesics|mesh-ancestor
101263474|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263475|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263477|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
101263478|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263479|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263480|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263481|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209281|NCT01445106|Nelfinavir|nelfinavir|mesh-list
101209340|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263484|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263485|NCT01762306|Hematinics|hematinics|mesh-ancestor
101209475|NCT01446211|Gusperimus|gusperimus|mesh-list
101263486|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
101263487|NCT01762306|Vitamins|vitamins|mesh-ancestor
101263488|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
101263489|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
101263490|NCT01762319|Pyridoxal|pyridoxal|mesh-list
101263491|NCT01762319|Pyridoxine|pyridoxine|mesh-list
101263493|NCT01762319|Vitamins|vitamins|mesh-ancestor
101263494|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
101328306|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263495|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209843|NCT01448330|Aspirin|aspirin|mesh-list
101263498|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263499|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101263500|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263502|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
101210288|NCT05964387|Lidocaine|lidocaine|mesh-list
101263503|NCT01762332|Remifentanil|remifentanil|mesh-list
101210362|NCT05963347|Prednisone|prednisone|mesh-list
101263505|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412868|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
101210658|NCT05960656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101263507|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210734|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
101210801|NCT05867550|Amitriptyline|amitriptyline|mesh-list
101263509|NCT01762332|Analgesics|analgesics|mesh-ancestor
101263510|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
101263511|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211101|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
101263512|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101263514|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211612|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263515|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263516|NCT01762436|Atenolol|atenolol|mesh-list
101263517|NCT01762436|Bisoprolol|bisoprolol|mesh-list
101263518|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101212052|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
101263519|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101263521|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
101212203|NCT04600414|Analgesics|analgesics|mesh-ancestor
101263522|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263523|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263524|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101263525|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101212653|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
101547554|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263527|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101212789|NCT03611881|Nicotine|nicotine|mesh-list
101304282|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263529|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263530|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
101263531|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
101213142|NCT02715609|Copper|copper|mesh-list
101263532|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101263533|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101263534|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263535|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263536|NCT01762475|Urological Agents|urological agents|mesh-ancestor
101263537|NCT01762514|Amifostine|amifostine|mesh-list
101263538|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101263539|NCT01762514|Protective Agents|protective agents|mesh-ancestor
101263540|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263541|NCT01762540|Prednisolone|prednisolone|mesh-list
101263542|NCT01762540|Calcium|calcium|mesh-list
101263543|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
101263544|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101263546|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263547|NCT01762540|Hormones|hormones|mesh-ancestor
101263548|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263549|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263550|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263553|NCT01762644|Cyclosporins|cyclosporins|mesh-list
101263554|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328307|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101263555|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263557|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
101263558|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263559|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
101263560|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263561|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
101263563|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101263564|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101263565|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263566|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101263567|NCT01762657|Cyclosporine|cyclosporine|mesh-list
101263568|NCT01762657|Lansoprazole|lansoprazole|mesh-list
101263569|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
101263570|NCT01762657|Cyclosporins|cyclosporins|mesh-list
101263571|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101304284|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101263572|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263573|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263574|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
101263575|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214632|NCT01468740|Dacarbazine|dacarbazine|mesh-list
101263576|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
101304285|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
101263577|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263578|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
101263580|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101263581|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101263582|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263584|NCT01762670|Metronidazole|metronidazole|mesh-list
101263585|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263586|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263587|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101263588|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101263589|NCT01762787|Aspirin|aspirin|mesh-list
101263590|NCT01762787|Prednisolone|prednisolone|mesh-list
101263591|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101547556|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263592|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
101263593|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101263594|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
101263595|NCT01762787|Cantharidin|cantharidin|mesh-list
101263596|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101263597|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
101263598|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263599|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263601|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
101263602|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263603|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263604|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263605|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263606|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101263607|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101263608|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263609|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101263610|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101263611|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263612|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
101263613|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
101263615|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263616|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263617|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263618|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
101263619|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
101263620|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263621|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101263624|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
101263625|NCT01762826|Vitamins|vitamins|mesh-ancestor
101263626|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
101215790|NCT01477034|Vitamin D|vitamin d|mesh-list
101215864|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101263627|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263629|NCT01762839|Oritavancin|oritavancin|mesh-list
101263631|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216306|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263632|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101263633|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101263634|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528329|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101263635|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263636|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263637|NCT01762852|Belimumab|belimumab|mesh-list
101263638|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263639|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
101263640|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263641|NCT01762878|Nemiralisib|nemiralisib|mesh-list
101263642|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101263643|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263644|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263645|NCT01762891|Acetaminophen|acetaminophen|mesh-list
101263646|NCT01762891|Celecoxib|celecoxib|mesh-list
101263648|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263649|NCT01762891|Analgesics|analgesics|mesh-ancestor
101263650|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
101216889|NCT01483781|Canagliflozin|canagliflozin|mesh-list
101263651|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263652|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263653|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
101547566|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101263654|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263656|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101263657|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101263658|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101263659|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263660|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263661|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
101263662|NCT01762995|Dolutegravir|dolutegravir|mesh-list
101217925|NCT01489865|Fluorouracil|fluorouracil|mesh-list
101263666|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263667|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101263668|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101263669|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263670|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263671|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101263672|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101218443|NCT01492894|Tacrolimus|tacrolimus|mesh-list
101263673|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
101328318|NCT00010842|Vitamin E|vitamin e|mesh-list
101218593|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218668|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
101218744|NCT01494636|Lidocaine|lidocaine|mesh-list
101263675|NCT01762995|Antacids|antacids|mesh-ancestor
101263676|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263677|NCT01762995|Trace Elements|trace elements|mesh-ancestor
101263678|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
101263679|NCT01763021|Rifampin|rifampin|mesh-list
101218969|NCT01495884|Lapatinib|lapatinib|mesh-list
101263680|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101219047|NCT01496326|Ibuprofen|ibuprofen|mesh-list
101263681|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
101219109|NCT01496742|Paclitaxel|paclitaxel|mesh-list
101263682|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263683|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263684|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
101263685|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101263686|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219626|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
101219701|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
101263687|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219928|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101263688|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101263689|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101220003|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
101263690|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101263691|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101263692|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101263693|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101220219|NCT01502267|Rituximab|rituximab|mesh-list
101263694|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101220369|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101263696|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220443|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263697|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263698|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101263699|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263701|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263702|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263703|NCT01763437|Tetracycline|tetracycline|mesh-list
101263704|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263705|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263706|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101263707|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263708|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547584|NCT01332968|Prednisone|prednisone|mesh-list
101263709|NCT01763450|Bevacizumab|bevacizumab|mesh-list
101263710|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263711|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263712|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221247|NCT01506921|Analgesics|analgesics|mesh-ancestor
101263713|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101263714|NCT01763450|Growth Substances|growth substances|mesh-ancestor
101263715|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263716|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
101263717|NCT01763463|Fluticasone|fluticasone|mesh-list
101263718|NCT01763463|Xhance|xhance|mesh-list
101263719|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101221469|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101263720|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101263721|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
101263722|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263723|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
101263724|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263725|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263726|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101263727|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101263728|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101263729|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101263730|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101263731|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101263732|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101263733|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
101263735|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263736|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
101304286|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101304287|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101304288|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101304289|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263738|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263740|NCT01763476|Paclitaxel|paclitaxel|mesh-list
101263741|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101263742|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263743|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
101263744|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
101263745|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
101304290|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101263746|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263747|NCT01763541|Anastrozole|anastrozole|mesh-list
101263749|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263750|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263751|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101263752|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101263753|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319349|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263754|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263756|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
101263757|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263758|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263759|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101263760|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
101263761|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263763|NCT01763658|Prednisolone|prednisolone|mesh-list
101263764|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101263765|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
101263766|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101263767|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
101263768|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101263770|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101263772|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
101263773|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263774|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263775|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101263776|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
101263777|NCT01763658|Hormones|hormones|mesh-ancestor
101420756|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263778|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101263779|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263780|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263781|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263782|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101263783|NCT01763658|Protective Agents|protective agents|mesh-ancestor
101263784|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
101263786|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101263787|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101263788|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263789|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
101263790|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
101263791|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
101263792|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263794|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101263795|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101263796|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101263797|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101263798|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
101263799|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263800|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263801|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263803|NCT01763788|Necitumumab|necitumumab|mesh-list
101263804|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420757|NCT05594342|Protective Agents|protective agents|mesh-ancestor
101263806|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
101304291|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101263807|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263808|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101263809|NCT01764087|Paclitaxel|paclitaxel|mesh-list
101263811|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101263812|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263813|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101263814|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101263815|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101547610|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101263816|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263817|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263819|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
101263820|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263821|NCT01764139|Vitamin D|vitamin d|mesh-list
101263822|NCT01764139|Vitamins|vitamins|mesh-ancestor
101263823|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
101263824|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263825|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101263826|NCT01764178|Valsartan|valsartan|mesh-list
101263827|NCT01764178|Pitavastatin|pitavastatin|mesh-list
101263828|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101263829|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101263830|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101263831|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263832|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101263833|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263834|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101263835|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
101263836|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263837|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263838|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101263839|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
101263840|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101263841|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
101263842|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101263843|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263844|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101263845|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101263846|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263847|NCT01764295|Olmesartan|olmesartan|mesh-list
101263848|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101263849|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263850|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101263851|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
101304293|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420758|NCT00157053|Factor VIII|factor viii|mesh-list
101263853|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263854|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101263855|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263856|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101263857|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101263858|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101263859|NCT01764451|Simvastatin|simvastatin|mesh-list
101263862|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
101263863|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263864|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263865|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101263866|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263867|NCT01763424|Calcitriol|calcitriol|mesh-list
101263868|NCT01763424|Niacinamide|niacinamide|mesh-list
101263869|NCT01763424|Niacin|niacin|mesh-list
101263870|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
101263871|NCT01763424|Calcipotriene|calcipotriene|mesh-list
101263872|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
101263873|NCT01763424|Vitamins|vitamins|mesh-ancestor
101263874|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
101263875|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263876|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416001|NCT03990467|Piperacillin|piperacillin|mesh-list
101416002|NCT03990467|Amikacin|amikacin|mesh-list
101263879|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101263880|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
101263881|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
101263882|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101263883|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101263884|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263885|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101263886|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101263888|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101263889|NCT01764555|Analgesics|analgesics|mesh-ancestor
101263891|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263892|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263895|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101263896|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
101263897|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263898|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101263899|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263900|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263901|NCT01764672|Methylphenidate|methylphenidate|mesh-list
101263902|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101263904|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101263905|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101263906|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263907|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263908|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
101263909|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263911|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101263912|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101263913|NCT01764828|Gemcitabine|gemcitabine|mesh-list
101263914|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101263916|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263917|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101263918|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101263919|NCT01764867|Dexetimide|dexetimide|mesh-list
101263920|NCT01764867|Mirtazapine|mirtazapine|mesh-list
101263921|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
101263923|NCT01764867|Citalopram|citalopram|mesh-list
101263924|NCT01764867|Bupropion|bupropion|mesh-list
101263926|NCT01764867|Paroxetine|paroxetine|mesh-list
101263927|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101263929|NCT01764867|Escitalopram|escitalopram|mesh-list
101263930|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101263931|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101263932|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263933|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263934|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263935|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
101263936|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263937|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101263938|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101263939|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
101416012|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
101263941|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101263942|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101263943|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101416013|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263944|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
101263945|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101263946|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
101263947|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101263948|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101263950|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101263952|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328379|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101263953|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101263955|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
101263956|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101263957|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
101263958|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
101263959|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101263960|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101263961|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101263962|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101263963|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101263964|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101263966|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101263967|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101263968|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101263969|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101263970|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101263971|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
101263972|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101263973|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101263974|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
101263975|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101263976|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263977|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263978|NCT01764893|Urological Agents|urological agents|mesh-ancestor
101263980|NCT01765010|Vitamin D|vitamin d|mesh-list
101263981|NCT01765010|Calcitriol|calcitriol|mesh-list
101263982|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
101263983|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101263984|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101263985|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263986|NCT01765010|Vitamins|vitamins|mesh-ancestor
101263987|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
101263988|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101263989|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101263990|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101263991|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101263992|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101263993|NCT01765023|Metformin|metformin|mesh-list
101263994|NCT01765023|Atorvastatin|atorvastatin|mesh-list
101263995|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101263996|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101263997|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101263998|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101264000|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264001|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264002|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101264003|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264004|NCT01765088|Temozolomide|temozolomide|mesh-list
101264005|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101264006|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
101264007|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264009|NCT01765231|Entecavir|entecavir|mesh-list
101264010|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
101264011|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264012|NCT01765257|Rasagiline|rasagiline|mesh-list
101264013|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101264014|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264015|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264016|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101264017|NCT01765257|Protective Agents|protective agents|mesh-ancestor
101264018|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264019|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
101328389|NCT00023218|Ritonavir|ritonavir|mesh-list
101264020|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101264021|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101304294|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101304295|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
101264022|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264024|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264025|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264027|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264028|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264029|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
101264031|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264032|NCT01765452|Clopidogrel|clopidogrel|mesh-list
101264033|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264034|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101264035|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101304296|NCT02012088|Hormones|hormones|mesh-ancestor
101264037|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
101264038|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264039|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264040|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264041|NCT01765556|Ketoconazole|ketoconazole|mesh-list
101264043|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
101264044|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264045|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101264046|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101264047|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264048|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264050|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
101264051|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264052|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264053|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101264054|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264055|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264056|NCT01765608|Zonisamide|zonisamide|mesh-list
101264057|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
101264058|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101264059|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264060|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264061|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101264062|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264063|NCT01765738|Minocycline|minocycline|mesh-list
101264066|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264067|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101264068|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
101264070|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101264071|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264072|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264073|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101264074|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101264075|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101264076|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101264077|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101264078|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101264079|NCT01765790|Antibodies|antibodies|mesh-list
101264080|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
101264081|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
101264082|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264083|NCT01765829|Droperidol|droperidol|mesh-list
101264085|NCT01765829|Pimozide|pimozide|mesh-list
101264087|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
101264088|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
101264090|NCT01765829|Aripiprazole|aripiprazole|mesh-list
101264091|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101264092|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101264093|NCT01765829|Ziprasidone|ziprasidone|mesh-list
101264094|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
101264095|NCT01765829|Clozapine|clozapine|mesh-list
101264096|NCT01765829|Asenapine|asenapine|mesh-list
101264097|NCT01765829|Amisulpride|amisulpride|mesh-list
101264098|NCT01765829|Perphenazine|perphenazine|mesh-list
101264099|NCT01765829|Sertindole|sertindole|mesh-list
101264102|NCT01765829|Clothiapine|clothiapine|mesh-list
101264103|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101264104|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
101264105|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264106|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264107|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264108|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264109|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264110|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264111|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101264114|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
101264115|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264116|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264117|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101264118|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101264119|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264120|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
101264122|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101264123|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101264124|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101264125|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101264126|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101264129|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101264130|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101264132|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547642|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
101264133|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264134|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
101264135|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264136|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264137|NCT01765881|Misoprostol|misoprostol|mesh-list
101264138|NCT01765881|Dinoprostone|dinoprostone|mesh-list
101264139|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101264140|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
101264141|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264142|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264143|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101264144|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264145|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
101264147|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101264148|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264149|NCT01766063|Interferons|interferons|mesh-list
101264150|NCT01766063|Interferon-beta|interferon-beta|mesh-list
101264151|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
101264152|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264153|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
101264154|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264155|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
101264156|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264157|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101264158|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
101264160|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101264161|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264162|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264163|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101264165|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
101264166|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264167|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101264169|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101264170|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
101264171|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264172|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264174|NCT01766089|Narcotics|narcotics|mesh-ancestor
101264175|NCT01766154|Tirofiban|tirofiban|mesh-list
101264176|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101264177|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101264178|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264179|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264180|NCT01766180|Resveratrol|resveratrol|mesh-list
101264181|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
101264182|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264183|NCT01766180|Protective Agents|protective agents|mesh-ancestor
101264185|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264186|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264187|NCT01766258|Carbidopa|carbidopa|mesh-list
101264188|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101264189|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101264190|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
101264191|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264192|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264193|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264194|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101264195|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264196|NCT01766323|Modafinil|modafinil|mesh-list
101264197|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101264198|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264199|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101264201|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101264202|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264203|NCT01766375|Cyclosporine|cyclosporine|mesh-list
101264204|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
101264205|NCT01766375|Methotrexate|methotrexate|mesh-list
101264206|NCT01766375|Cyclosporins|cyclosporins|mesh-list
101264208|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
101264209|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264210|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264211|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101264213|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264214|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264215|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264216|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264217|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101264218|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264219|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
101264220|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264222|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
101264223|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264224|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101264225|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101264226|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101264227|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
101264228|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264229|NCT01766414|Complement C1s|complement c1s|mesh-list
101264230|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101264231|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101264232|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
101264233|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264234|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101264235|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264237|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101264238|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264239|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101264240|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
101264241|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264242|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264244|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264246|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
101264248|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264249|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101264250|NCT01766583|Growth Substances|growth substances|mesh-ancestor
101264251|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
101264253|NCT01766609|Triamcinolone|triamcinolone|mesh-list
101264255|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101264256|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101264257|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264258|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
101264260|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264261|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264262|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264263|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
101264264|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264265|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264266|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
101264268|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
101264269|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264270|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101264271|NCT01766843|Charcoal|charcoal|mesh-list
101264272|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101264273|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
101264275|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264276|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101264277|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264278|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
101264280|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264283|NCT01766843|Protective Agents|protective agents|mesh-ancestor
101264284|NCT01766960|Morphine|morphine|mesh-list
101264285|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101264286|NCT01766960|Narcotics|narcotics|mesh-ancestor
101264287|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264288|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264289|NCT01766960|Analgesics|analgesics|mesh-ancestor
101264290|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
101328431|NCT02024607|Leucovorin|leucovorin|mesh-list
101264291|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264293|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
101264294|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264295|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264296|NCT01767090|Leuprolide|leuprolide|mesh-list
101264297|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101264298|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
101264299|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264300|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264302|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264304|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101264305|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101264306|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101264307|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101264308|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264309|NCT01767259|Diuretics|diuretics|mesh-ancestor
101264310|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
101264311|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264312|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101264313|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264315|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101264316|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101264317|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101264318|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
101264320|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547652|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101264321|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264322|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264325|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101264326|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101264327|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101264328|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264330|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
101264331|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264332|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101264334|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
101264335|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
101264336|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101264338|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264339|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264340|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264341|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101264342|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264343|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
101264344|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264345|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101264347|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264348|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264349|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101264350|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264351|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101264352|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
101264353|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264354|NCT01767428|Acetaminophen|acetaminophen|mesh-list
101264355|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101264357|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
101264358|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264359|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264360|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
101264361|NCT01767454|Ipilimumab|ipilimumab|mesh-list
101264364|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264365|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264366|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101264367|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264368|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264369|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264370|NCT01767532|Cephalexin|cephalexin|mesh-list
101264371|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264372|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264375|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264377|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264378|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101264379|NCT01767545|Growth Substances|growth substances|mesh-ancestor
101264380|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264381|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
101264382|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264383|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
101264384|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
101547661|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101547672|NCT01326702|Veliparib|veliparib|mesh-list
101264385|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264386|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264387|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
101264389|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264390|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101264392|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264393|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264395|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264396|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264397|NCT01767623|Vemurafenib|vemurafenib|mesh-list
101264398|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264399|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264400|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264401|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264402|NCT01767714|Plerixafor|plerixafor|mesh-list
101264404|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101264406|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264407|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101264408|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101264409|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
101264410|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264411|NCT01767896|Vaccines|vaccines|mesh-list
101264412|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
101264413|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264414|NCT01768039|Vitamin D|vitamin d|mesh-list
101264416|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
101264417|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264418|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101264420|NCT01767610|Fenofibrate|fenofibrate|mesh-list
101264421|NCT01767610|Pitavastatin|pitavastatin|mesh-list
101264422|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101264424|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264425|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264426|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101264427|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101264428|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264429|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101264430|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264431|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264432|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264433|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264434|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101264435|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101264436|NCT01768078|Betamethasone|betamethasone|mesh-list
101264437|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264438|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
101264439|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264440|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
101264441|NCT01768078|Hormones|hormones|mesh-ancestor
101264442|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264443|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264444|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101264445|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264446|NCT01768182|Leucovorin|leucovorin|mesh-list
101264447|NCT01768182|Folic Acid|folic acid|mesh-list
101264448|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
101264449|NCT01768182|Antidotes|antidotes|mesh-ancestor
101264450|NCT01768182|Protective Agents|protective agents|mesh-ancestor
101264451|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264452|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
101264453|NCT01768182|Vitamins|vitamins|mesh-ancestor
101264454|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
101264455|NCT01768182|Hematinics|hematinics|mesh-ancestor
101264456|NCT01768195|Entecavir|entecavir|mesh-list
101264457|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
101264458|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264459|NCT01768208|Saxagliptin|saxagliptin|mesh-list
101264460|NCT01768208|Incretins|incretins|mesh-ancestor
101264461|NCT01768208|Hormones|hormones|mesh-ancestor
101264462|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264463|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264464|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101264465|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
101264466|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264467|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264468|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101264469|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101264470|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264471|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264472|NCT01768260|Aspirin|aspirin|mesh-list
101264473|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101264476|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
101264477|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264478|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264479|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264480|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264481|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101264482|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101264483|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264484|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264485|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101264486|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264487|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
101264488|NCT01768273|Midazolam|midazolam|mesh-list
101264489|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101264490|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101264491|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264492|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264493|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101264494|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264495|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264496|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101264497|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
101264498|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
101264499|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
101264500|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
101264501|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264502|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264504|NCT01768299|Mifepristone|mifepristone|mesh-list
101264505|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101264506|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
101264507|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101264508|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264509|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101264510|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264511|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
101264512|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101264513|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101264514|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101264515|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101264516|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
101264517|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101264518|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101264519|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
101264520|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264521|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
101264522|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101264523|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101264525|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101264527|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264528|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264529|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264531|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264532|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
101264533|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264534|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264535|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264536|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101264537|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101264538|NCT01768351|Calcitriol|calcitriol|mesh-list
101264539|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101264540|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264541|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101264542|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264543|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264544|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101264545|NCT01768351|Vitamins|vitamins|mesh-ancestor
101264546|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
101264548|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101264549|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101264550|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264551|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101264552|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
101264553|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101264554|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101264556|NCT01768377|Fentanyl|fentanyl|mesh-list
101264557|NCT01768377|Midazolam|midazolam|mesh-list
101264558|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
101264559|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
101264560|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264561|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264562|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
101264563|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264564|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101264565|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101264566|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101264567|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264568|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264569|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101264570|NCT01768377|Narcotics|narcotics|mesh-ancestor
101264571|NCT01768377|Analgesics|analgesics|mesh-ancestor
101264572|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101264573|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101264574|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
101264575|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101264576|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101264577|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264578|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264580|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
101264581|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264582|NCT01768390|Fluorides|fluorides|mesh-list
101264583|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
101264584|NCT01768390|Protective Agents|protective agents|mesh-ancestor
101264585|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264586|NCT01768455|Glimepiride|glimepiride|mesh-list
101264587|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101264588|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101264589|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264590|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264591|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
101264592|NCT01768481|Atorvastatin|atorvastatin|mesh-list
101264593|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101264594|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101264595|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
101264596|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264597|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264598|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101264599|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264600|NCT01768507|Resveratrol|resveratrol|mesh-list
101264601|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
101264602|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264603|NCT01768507|Protective Agents|protective agents|mesh-ancestor
101264604|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264605|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264606|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101264607|NCT01768663|Itraconazole|itraconazole|mesh-list
101328484|NCT00000173|Vitamin E|vitamin e|mesh-list
101264608|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
101264609|NCT01768663|Rifampin|rifampin|mesh-list
101264610|NCT01768663|Ivacaftor|ivacaftor|mesh-list
101264611|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
101264612|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264613|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101264614|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101264615|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264616|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264617|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101264618|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
101264619|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264620|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264621|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101264622|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264623|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101264624|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101264625|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264626|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101264627|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101264628|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
101264629|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
101264630|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101264631|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101264632|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101264633|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101264634|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101416029|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416030|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101264635|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101264636|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101264637|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101264638|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264639|NCT01768741|Liver Extracts|liver extracts|mesh-list
101264640|NCT01768741|Hematinics|hematinics|mesh-ancestor
101264641|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
101264643|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101264644|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
101264645|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
101264646|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264647|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264649|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264651|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101264652|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
101264653|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264654|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264655|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
101264656|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101264658|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264659|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264660|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101264661|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264664|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264665|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264666|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101264667|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101264668|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
101264669|NCT01768884|Protective Agents|protective agents|mesh-ancestor
101264670|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
101264673|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101264674|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
101264675|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264676|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264677|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
101264678|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264679|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264680|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
101264681|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264684|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264685|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101264686|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101264687|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264688|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
101264689|NCT01768897|Protective Agents|protective agents|mesh-ancestor
101264690|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
101264692|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
101264694|NCT01768988|Analgesics|analgesics|mesh-ancestor
101264695|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
101264696|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264697|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264698|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
101264699|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101264700|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264701|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264702|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101264703|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101264704|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101264705|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264706|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264708|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264709|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264710|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264711|NCT01769066|Pemetrexed|pemetrexed|mesh-list
101264712|NCT01769066|Gefitinib|gefitinib|mesh-list
101264713|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264714|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264715|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264716|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101264718|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101264720|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101264721|NCT01769079|Diuretics|diuretics|mesh-ancestor
101264722|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
101264723|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264724|NCT01769118|Caffeine|caffeine|mesh-list
101264725|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101264726|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264727|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101264728|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264729|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264730|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101264731|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101264732|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
101264733|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264734|NCT01769183|Squalamine|squalamine|mesh-list
101264735|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101264736|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101264737|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264738|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101264739|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101264740|NCT01769183|Protective Agents|protective agents|mesh-ancestor
101264741|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264742|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264743|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264744|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101264745|NCT01769183|Growth Substances|growth substances|mesh-ancestor
101264746|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
101264747|NCT01769235|Clindamycin|clindamycin|mesh-list
101264748|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
101264749|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
101264750|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101264751|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264753|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101264754|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264755|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264756|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264757|NCT01769482|Udenafil|udenafil|mesh-list
101264758|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101264759|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101264760|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264761|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264762|NCT01769625|Vitamin D|vitamin d|mesh-list
101264763|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
101264764|NCT01769625|Celecoxib|celecoxib|mesh-list
101264765|NCT01769625|Vitamins|vitamins|mesh-ancestor
101264766|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
101264767|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264768|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101264769|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101264770|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101264771|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101264773|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
101264774|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264775|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264776|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101264777|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101264778|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101264779|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264780|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264781|NCT01769651|Methadone|methadone|mesh-list
101264782|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101264783|NCT01769651|Narcotics|narcotics|mesh-ancestor
101264784|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264785|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264786|NCT01769651|Analgesics|analgesics|mesh-ancestor
101264787|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
101264788|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264789|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
101264790|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264791|NCT01769664|Clindamycin|clindamycin|mesh-list
101264792|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
101264793|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
101264794|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101264795|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101264797|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101264798|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264799|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264800|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264801|NCT01769677|Hydrocodone|hydrocodone|mesh-list
101264802|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101264803|NCT01769677|Narcotics|narcotics|mesh-ancestor
101264804|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101264805|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264806|NCT01769677|Analgesics|analgesics|mesh-ancestor
101264807|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
101264808|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264809|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
101264810|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264811|NCT01769703|Dabigatran|dabigatran|mesh-list
101264812|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
101264813|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101264814|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
101264815|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264816|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264817|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
101264818|NCT01769768|Bupropion|bupropion|mesh-list
101264819|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101264820|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
101264821|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101264822|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101328541|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
101264823|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101264824|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101264825|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264828|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264829|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101264830|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101264832|NCT01769781|Anastrozole|anastrozole|mesh-list
101264833|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101264834|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264835|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101264836|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101264837|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264838|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264839|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101264840|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
101264841|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264842|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264843|NCT01769820|Dexamethasone|dexamethasone|mesh-list
101264844|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101264845|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
101264846|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
101264847|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264848|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264849|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264850|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
101264851|NCT01769820|Hormones|hormones|mesh-ancestor
101264852|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264853|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101264855|NCT01769833|Interferons|interferons|mesh-list
101264856|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
101264857|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
101264858|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101264859|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264860|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
101264862|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
101264863|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264868|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101264869|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
101264870|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264871|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264873|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
101264874|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
101264875|NCT01769898|Hormones|hormones|mesh-ancestor
101264876|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101264877|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101264878|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101264879|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101264880|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
101264881|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101264882|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264883|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101264884|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264885|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
101264886|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101264887|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101264888|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
101264890|NCT01769911|Etoposide|etoposide|mesh-list
101264891|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
101264892|NCT01769911|Melphalan|melphalan|mesh-list
101264895|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101264896|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264897|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101264898|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101264899|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264900|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264901|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101264902|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
101264903|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
101264905|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101264906|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
101264907|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264908|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101264909|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
101264910|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101264911|NCT01769950|Choline|choline|mesh-list
101264913|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101264914|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
101264915|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264916|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264917|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264918|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
101264919|NCT01770041|Acetaminophen|acetaminophen|mesh-list
101264920|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101264921|NCT01770041|Analgesics|analgesics|mesh-ancestor
101264922|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
101264923|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264924|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264925|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
101264926|NCT01770080|Peppermint oil|peppermint oil|mesh-list
101416047|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101416048|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
101416049|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101416051|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101264927|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101264928|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
101264929|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
101264930|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264931|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264932|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101264933|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
101264934|NCT01770106|Denosumab|denosumab|mesh-list
101264935|NCT01770106|Alendronate|alendronate|mesh-list
101264936|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101264937|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264938|NCT01770132|Gemcitabine|gemcitabine|mesh-list
101264939|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101264940|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101264942|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101264943|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
101264944|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264945|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264946|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
101264947|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101264948|NCT01770171|Paclitaxel|paclitaxel|mesh-list
101264949|NCT01770171|Bevacizumab|bevacizumab|mesh-list
101264950|NCT01770171|Carboplatin|carboplatin|mesh-list
101264951|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101264953|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
101264954|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
101264955|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
101264956|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264957|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264958|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264959|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101264960|NCT01770171|Growth Substances|growth substances|mesh-ancestor
101264963|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101264964|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101264965|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101264966|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264967|NCT01770210|Atorvastatin|atorvastatin|mesh-list
101264968|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101264969|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101264970|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
101264971|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264972|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101264973|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101264974|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264975|NCT01770223|Ribavirin|ribavirin|mesh-list
101264976|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101264977|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
101528330|NCT04628676|Epinephrine|epinephrine|mesh-list
101264978|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264979|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
101264980|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416055|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101264982|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101264983|NCT01770236|Analgesics|analgesics|mesh-ancestor
101416057|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101264985|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101264986|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101264987|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
101264988|NCT01770301|Paclitaxel|paclitaxel|mesh-list
101264989|NCT01770301|Bevacizumab|bevacizumab|mesh-list
101264990|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101264991|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101264993|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
101264994|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
101264995|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101264996|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101264997|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101264999|NCT01770301|Growth Substances|growth substances|mesh-ancestor
101265000|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265001|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
101265002|NCT01770444|Cytarabine|cytarabine|mesh-list
101265003|NCT01770444|Thioguanine|thioguanine|mesh-list
101265004|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265005|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
101265006|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265008|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
101265009|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265011|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
101265012|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265014|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101265015|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101265016|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
101265017|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265018|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101265019|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
101265020|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
101265022|NCT01770470|Coagulants|coagulants|mesh-ancestor
101265023|NCT01770600|Risperidone|risperidone|mesh-list
101265024|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101265025|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
101265026|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265027|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265028|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265029|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101265030|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101265031|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265032|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265033|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101265034|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
101265035|NCT01770769|Cloxacillin|cloxacillin|mesh-list
101265036|NCT01770769|Cephalothin|cephalothin|mesh-list
101265044|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265045|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265048|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101265050|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265051|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265052|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101265053|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101265054|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101265055|NCT01770899|Montelukast|montelukast|mesh-list
101265056|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101265057|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
101265058|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101265059|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
101265060|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265061|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265062|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101265063|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101265064|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265065|NCT01770964|Pregabalin|pregabalin|mesh-list
101265066|NCT01770964|Analgesics|analgesics|mesh-ancestor
101265067|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
101265068|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265069|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265070|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
101265071|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101265073|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265075|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101265076|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101265077|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101265078|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265080|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101265081|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101265082|NCT01771081|Growth Substances|growth substances|mesh-ancestor
101265083|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265085|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265086|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
101265087|NCT01771146|Irinotecan|irinotecan|mesh-list
101265088|NCT01771146|Folfirinox|folfirinox|mesh-list
101265089|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265090|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101265091|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101265092|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265093|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265094|NCT01771185|Metformin|metformin|mesh-list
101265095|NCT01771185|Gliclazide|gliclazide|mesh-list
101265096|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265097|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265098|NCT01771198|Simvastatin|simvastatin|mesh-list
101265099|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101265100|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101265101|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
101265102|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265103|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101265104|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101265105|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265106|NCT01771289|Docetaxel|docetaxel|mesh-list
101265107|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265108|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
101265109|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
101265110|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
101265111|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265112|NCT01771302|Calcium|calcium|mesh-list
101265113|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101265114|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265115|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
101265116|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101265117|NCT01771328|Cortisone|cortisone|mesh-list
101265125|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
101265126|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547779|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101265127|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265128|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265130|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265131|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101265132|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265133|NCT01771458|Tamoxifen|tamoxifen|mesh-list
101265134|NCT01771458|Trastuzumab|trastuzumab|mesh-list
101265135|NCT01771458|Everolimus|everolimus|mesh-list
101265138|NCT01771458|Dasatinib|dasatinib|mesh-list
101265139|NCT01771458|Lapatinib|lapatinib|mesh-list
101265140|NCT01771458|Vemurafenib|vemurafenib|mesh-list
101265141|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101265142|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265143|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101265144|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101265146|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265147|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101265148|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
101265149|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265151|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101265152|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101265153|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
101265154|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265155|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265157|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101265158|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101265159|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101265161|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265162|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101265163|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101265164|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
101265165|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101265166|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265168|NCT01771822|Ibuprofen|ibuprofen|mesh-list
101265169|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101265170|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265172|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
101265173|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265174|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265175|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265176|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265177|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101265178|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265179|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265180|NCT01771874|Bupropion|bupropion|mesh-list
101265181|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101265182|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101265183|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101265184|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101265185|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101265186|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101265187|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265188|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265189|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
101265190|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265191|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265192|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101265193|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265194|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265195|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
101265196|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
101265197|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101265198|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
101265199|NCT01771978|Diltiazem|diltiazem|mesh-list
101265200|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101547788|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101265201|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101265202|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101265203|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265204|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101265205|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265206|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
101265207|NCT01772056|Fluticasone|fluticasone|mesh-list
101265208|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265209|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101265210|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
101265211|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265212|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265213|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101265214|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101265215|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
101265216|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101265217|NCT01772212|Terbinafine|terbinafine|mesh-list
101265218|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
101265219|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265220|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265221|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265222|NCT01772238|Amoxicillin|amoxicillin|mesh-list
101265223|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101265224|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
101265225|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
101265226|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265227|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265228|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101265229|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265230|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265231|NCT01772251|Insulin|insulin|mesh-list
101265232|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101265233|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265236|NCT01772290|Rabeprazole|rabeprazole|mesh-list
101265237|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
101265238|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265239|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101265240|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265241|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265242|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265243|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101265244|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
101265245|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265246|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265247|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101265248|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101265249|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265250|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101265251|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101265252|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101265253|NCT01772381|Dexamethasone|dexamethasone|mesh-list
101265254|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265255|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
101265256|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
101265257|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265258|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265259|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265260|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
101265261|NCT01772381|Hormones|hormones|mesh-ancestor
101265262|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265263|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101265264|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416061|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101265265|NCT01772563|Itraconazole|itraconazole|mesh-list
101265266|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
101265267|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265268|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101265269|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265270|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265271|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265272|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101265273|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
101265274|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101265275|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265276|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101265277|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
101265278|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
101265279|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101265280|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
101265281|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265283|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101265284|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101265285|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265286|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265287|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265288|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101265289|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265290|NCT01772641|Varenicline|varenicline|mesh-list
101265291|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101265292|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101265293|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
101265294|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101265295|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265296|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265298|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265299|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101265300|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265301|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265302|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
101265304|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265305|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265306|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101265307|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265308|NCT01772940|Ritonavir|ritonavir|mesh-list
101265309|NCT01772940|Lopinavir|lopinavir|mesh-list
101265310|NCT01772940|Tenofovir|tenofovir|mesh-list
101265311|NCT01772940|Lamivudine|lamivudine|mesh-list
101265312|NCT01772940|Emtricitabine|emtricitabine|mesh-list
101265313|NCT01772940|Zidovudine|zidovudine|mesh-list
101265314|NCT01772940|Nevirapine|nevirapine|mesh-list
101265315|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101265316|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101265317|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
101265318|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265319|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265320|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101265321|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101265322|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
101265323|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101265324|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101416068|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265325|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101265326|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101265327|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101265328|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
101265329|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101265330|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101265331|NCT01772953|Treosulfan|treosulfan|mesh-list
101265332|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101265333|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
101265334|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265335|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265337|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101265338|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
101265339|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265340|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101265343|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101265344|NCT01773005|Analgesics|analgesics|mesh-ancestor
101265345|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
101265346|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101265347|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101265348|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
101265349|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101265350|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101265351|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101265352|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101265353|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101265354|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101265356|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
101304880|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101304881|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
101304882|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101304883|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101304884|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
101308886|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308887|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308888|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101308889|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
101308890|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308891|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308892|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101308893|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101308894|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101308895|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101308896|NCT00005976|Carboplatin|carboplatin|mesh-list
101308897|NCT00005976|NSC 366140|nsc 366140|mesh-list
101308898|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308899|NCT00005979|Leucovorin|leucovorin|mesh-list
101308900|NCT00005979|Fluorouracil|fluorouracil|mesh-list
101308901|NCT00005979|Irinotecan|irinotecan|mesh-list
101308902|NCT00005979|Calcium|calcium|mesh-list
101308903|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
101308905|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308906|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
101319350|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
101308907|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308908|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308909|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308910|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412901|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
101308911|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
101308912|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101308913|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308914|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308915|NCT00005979|Antidotes|antidotes|mesh-ancestor
101308916|NCT00005979|Protective Agents|protective agents|mesh-ancestor
101308917|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
101308921|NCT00005985|Dexamethasone|dexamethasone|mesh-list
101308922|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
101308924|NCT00005985|Etoposide|etoposide|mesh-list
101308925|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
101308926|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308927|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
101308928|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308929|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308930|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308931|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
101308932|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308933|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308934|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308935|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101308936|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
101308937|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
101308938|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308939|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308940|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
101308941|NCT00005985|Hormones|hormones|mesh-ancestor
101308942|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308943|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101308944|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101308945|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101308946|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101308947|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308948|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308949|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
101308950|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
101308951|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101308952|NCT00005985|Analgesics|analgesics|mesh-ancestor
101308953|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
101308954|NCT00005988|Leucovorin|leucovorin|mesh-list
101308955|NCT00005988|Cyclosporine|cyclosporine|mesh-list
101308956|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
101308957|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
101308958|NCT00005988|Methotrexate|methotrexate|mesh-list
101308959|NCT00005988|Cyclosporins|cyclosporins|mesh-list
101308960|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
101308961|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101308962|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
101308963|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101308964|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101308965|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101308966|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
101308967|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101308968|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101308969|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101308970|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101308971|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
101308972|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101308973|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101308974|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
101308975|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
101308976|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101308977|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101416085|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
101416087|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
101308978|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101308979|NCT00005988|Antidotes|antidotes|mesh-ancestor
101308980|NCT00005988|Protective Agents|protective agents|mesh-ancestor
101308981|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
101308982|NCT00005988|Vitamins|vitamins|mesh-ancestor
101308989|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
101308990|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101308991|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101308992|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
101308993|NCT00005988|Hormones|hormones|mesh-ancestor
101308994|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101308995|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101308996|NCT00005991|Gemcitabine|gemcitabine|mesh-list
101308997|NCT00005991|Doxorubicin|doxorubicin|mesh-list
101308999|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309000|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
101309001|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309002|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309003|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101309004|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101309005|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309006|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309008|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
101309010|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309011|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309012|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309013|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
101309014|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309015|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101309016|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101309018|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309019|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309020|NCT00006000|Irinotecan|irinotecan|mesh-list
101309021|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309022|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101309023|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309024|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309025|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309026|NCT00006003|Semaxinib|semaxinib|mesh-list
101309027|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101309028|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101309029|NCT00006003|Growth Substances|growth substances|mesh-ancestor
101309030|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309032|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309033|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101309034|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309035|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309036|NCT00006006|Interferons|interferons|mesh-list
101309037|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
101309038|NCT00006006|Thalidomide|thalidomide|mesh-list
101309039|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309040|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
101309041|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309047|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101309048|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101309050|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
101309051|NCT00006009|Visilizumab|visilizumab|mesh-list
101309052|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
101309053|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309055|NCT00006012|Etoposide|etoposide|mesh-list
101309056|NCT00006012|Topotecan|topotecan|mesh-list
101309057|NCT00006012|Amifostine|amifostine|mesh-list
101309058|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309059|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309060|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309061|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309062|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528351|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101309063|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547798|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309065|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309066|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309067|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309068|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101309069|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101309070|NCT00006012|Protective Agents|protective agents|mesh-ancestor
101309071|NCT00006015|Leucovorin|leucovorin|mesh-list
101309072|NCT00006015|Fluorouracil|fluorouracil|mesh-list
101309073|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
101309074|NCT00006015|Trastuzumab|trastuzumab|mesh-list
101309075|NCT00006015|Calcium|calcium|mesh-list
101309076|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
101309077|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101309078|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309079|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
101309080|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309081|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309082|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309083|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309084|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
101309085|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309086|NCT00006015|Antidotes|antidotes|mesh-ancestor
101309087|NCT00006015|Protective Agents|protective agents|mesh-ancestor
101309088|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
101309089|NCT00006015|Vitamins|vitamins|mesh-ancestor
101309090|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
101309091|NCT00006018|Paclitaxel|paclitaxel|mesh-list
101309092|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309093|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309094|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309095|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309096|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309097|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309098|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
101309100|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
101309101|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309105|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
101309106|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309107|NCT00006024|Temozolomide|temozolomide|mesh-list
101309108|NCT00006024|Lomustine|lomustine|mesh-list
101309109|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309111|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309112|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309113|NCT00006027|Paclitaxel|paclitaxel|mesh-list
101309114|NCT00006027|Cisplatin|cisplatin|mesh-list
101309115|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309116|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309117|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309118|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309119|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309120|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309121|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101309122|NCT00386646|Laxatives|laxatives|mesh-ancestor
101309123|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309124|NCT00386685|Trastuzumab|trastuzumab|mesh-list
101309125|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309126|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309127|NCT00006030|Tamoxifen|tamoxifen|mesh-list
101309128|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101309129|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
101309130|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309131|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309132|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101309133|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328608|NCT00000191|Carbamazepine|carbamazepine|mesh-list
101309134|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101309136|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101309137|NCT00006033|Methotrexate|methotrexate|mesh-list
101309138|NCT00006033|Interleukin-2|interleukin-2|mesh-list
101309139|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101309140|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
101309141|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309142|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309143|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309144|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
101309145|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309146|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309147|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309148|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309149|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101309150|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309151|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
101309152|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309153|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309154|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101309155|NCT00006033|Analgesics|analgesics|mesh-ancestor
101309156|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
101309157|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309158|NCT00006036|Lurtotecan|lurtotecan|mesh-list
101309159|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309160|NCT00006039|Interferons|interferons|mesh-list
101309161|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
101309162|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309163|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
101309164|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309165|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
101309166|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309167|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
101309168|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
101309169|NCT00006042|Fludarabine|fludarabine|mesh-list
101309170|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
101309171|NCT00006042|Tacrolimus|tacrolimus|mesh-list
101309172|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309173|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
101309174|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309175|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309176|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309177|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
101309178|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309179|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309180|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101309181|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309182|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
101309183|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101309184|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309185|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101309186|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101309187|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
101309188|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309189|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309190|NCT05680974|Antibodies|antibodies|mesh-list
101309191|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
101309192|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309193|NCT00386763|Lumefantrine|lumefantrine|mesh-list
101309194|NCT00386763|Artemether|artemether|mesh-list
101309195|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101309196|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
101309197|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101309198|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101309199|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309200|NCT05680662|Metformin|metformin|mesh-list
101309201|NCT05680662|Quercetin|quercetin|mesh-list
101309202|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101328616|NCT00000191|Analgesics|analgesics|mesh-ancestor
101309203|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309204|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
101309205|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416095|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101309206|NCT05680662|Protective Agents|protective agents|mesh-ancestor
101309207|NCT05680545|Sevoflurane|sevoflurane|mesh-list
101309208|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101309209|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101309210|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
101309211|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
101309212|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309213|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309214|NCT05680389|Minocycline|minocycline|mesh-list
101309215|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309216|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309217|NCT05680194|Diphosphonates|diphosphonates|mesh-list
101309218|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101309219|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309220|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
101309221|NCT00386802|Clotrimazole|clotrimazole|mesh-list
101309222|NCT00386802|Miconazole|miconazole|mesh-list
101309223|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309224|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101309226|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101309227|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309228|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309229|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101309230|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
101309231|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309232|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309233|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101309234|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101309235|NCT00386841|Escitalopram|escitalopram|mesh-list
101309236|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101309237|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101309238|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309239|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309240|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309241|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
101309242|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309243|NCT05679453|Etodolac|etodolac|mesh-list
101309245|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101309246|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101309249|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309250|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309251|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309252|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309253|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101309254|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101309255|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309256|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309258|NCT05679375|Analgesics|analgesics|mesh-ancestor
101309259|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
101309261|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309262|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101309263|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101309264|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
101309266|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309267|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101309268|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101309269|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309270|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309271|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
101309272|NCT05679336|Rituximab|rituximab|mesh-list
101309273|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309274|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
101309275|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416102|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101309276|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309277|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309278|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
101309279|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309280|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309281|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101309282|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309283|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
101309284|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101309285|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309286|NCT05626725|Insulin|insulin|mesh-list
101309287|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101309288|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309289|NCT05597163|Atropine|atropine|mesh-list
101309290|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101309291|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101309292|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101309293|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
101309294|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309295|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309296|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101309297|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
101309298|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
101309299|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
101309300|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101309301|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101309302|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
101309303|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309304|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309305|NCT05550129|Metformin|metformin|mesh-list
101309306|NCT05550129|Sotorasib|sotorasib|mesh-list
101309307|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101309308|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309309|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101309310|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309311|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309312|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309313|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
101309315|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
101309316|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
101309317|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101309318|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309319|NCT00386997|Amphotericin B|amphotericin b|mesh-list
101309320|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101309321|NCT00386997|Amebicides|amebicides|mesh-ancestor
101309322|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101547809|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309323|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101309324|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309325|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309326|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
101309327|NCT03940131|Panitumumab|panitumumab|mesh-list
101309328|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309329|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309330|NCT05160597|Edetic Acid|edetic acid|mesh-list
101309331|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101309332|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
101309333|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
101309334|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309335|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
101309336|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101309337|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101309338|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
101309339|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101309340|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309341|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
101309346|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309347|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309348|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101309349|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309351|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309352|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
101309353|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309354|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101309355|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309356|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309357|NCT04833387|Antibodies|antibodies|mesh-list
101309358|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
101309359|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309361|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
101309362|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309363|NCT04803084|Protective Agents|protective agents|mesh-ancestor
101309364|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309365|NCT04793685|Prazosin|prazosin|mesh-list
101309366|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101309367|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101309368|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101309369|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101309370|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101309371|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309372|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309373|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309374|NCT04552080|Amoxicillin|amoxicillin|mesh-list
101309375|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309376|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309377|NCT03834909|Tenofovir|tenofovir|mesh-list
101309378|NCT03834909|Emtricitabine|emtricitabine|mesh-list
101309379|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101309380|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
101309382|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101309383|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309384|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309385|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309386|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101309387|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101309388|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
101309389|NCT04360473|Ketamine|ketamine|mesh-list
101309390|NCT04360473|Anesthetics|anesthetics|mesh-list
101309391|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309392|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309394|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
101309395|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309396|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101309397|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101309398|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
101309399|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101309400|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101309401|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309402|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309403|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101309406|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309407|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101309408|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
101309409|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309410|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
101309411|NCT04305795|Cemiplimab|cemiplimab|mesh-list
101309412|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309413|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309414|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101309415|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309416|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
101309417|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101547811|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101309419|NCT03913221|Caffeine|caffeine|mesh-list
101309420|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
101309421|NCT03913221|Citric Acid|citric acid|mesh-list
101309422|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
101309424|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101309425|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
101309426|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
101309427|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309428|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101309429|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309430|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101309431|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309432|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101309433|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101309434|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
101309435|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309436|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
101309437|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101309438|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
101309439|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
101309440|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309441|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309442|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101309443|NCT03869736|Analgesics|analgesics|mesh-ancestor
101309444|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
101309447|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
101309448|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
101309449|NCT03786081|Carboplatin|carboplatin|mesh-list
101309450|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309451|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309452|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101309453|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101309454|NCT03786081|Growth Substances|growth substances|mesh-ancestor
101309455|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309456|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
101309457|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101309458|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328645|NCT00023881|Bortezomib|bortezomib|mesh-list
101309460|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101309461|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309462|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101309463|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309465|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101309466|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101309467|NCT03741933|Analgesics|analgesics|mesh-ancestor
101309468|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
101309469|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309470|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309471|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309472|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309473|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101309474|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101309475|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309476|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309477|NCT03002259|Dexamethasone|dexamethasone|mesh-list
101309478|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309479|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
101309480|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
101309481|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309482|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309483|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547823|NCT01348763|Maraviroc|maraviroc|mesh-list
101309484|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
101309486|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309487|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101309488|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309489|NCT03000387|Nicotine|nicotine|mesh-list
101309490|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101309491|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
101309492|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309493|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309494|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101309495|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101309498|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309499|NCT00387504|Fenretinide|fenretinide|mesh-list
101309500|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309501|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101309502|NCT00387504|Protective Agents|protective agents|mesh-ancestor
101309503|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309504|NCT02936505|Cyclosporine|cyclosporine|mesh-list
101309505|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
101309506|NCT02936505|Tacrolimus|tacrolimus|mesh-list
101309507|NCT02936505|Cyclosporins|cyclosporins|mesh-list
101309508|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
101309509|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101309510|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309511|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
101309512|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309513|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101309514|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309515|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309517|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309518|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309519|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309520|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101309521|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309522|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101309523|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
101309524|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309527|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101309528|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309529|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309530|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
101309531|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101309532|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309533|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309536|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309537|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309538|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101309539|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309540|NCT02593110|Telmisartan|telmisartan|mesh-list
101309541|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101309542|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101309543|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101309544|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309545|NCT02373813|Folic Acid|folic acid|mesh-list
101309546|NCT02373813|Etanercept|etanercept|mesh-list
101309547|NCT02373813|Methotrexate|methotrexate|mesh-list
101309548|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101309549|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
101309550|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309551|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309552|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309553|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
101309554|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547830|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309555|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309556|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309557|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309561|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309562|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309563|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101309564|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101309566|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
101309567|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309568|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309569|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309570|NCT02373813|Hematinics|hematinics|mesh-ancestor
101309571|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
101309573|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
101309574|NCT01959204|Oxycodone|oxycodone|mesh-list
101309575|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101309576|NCT01959204|Narcotics|narcotics|mesh-ancestor
101309577|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309578|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309579|NCT01959204|Analgesics|analgesics|mesh-ancestor
101309580|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
101309581|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309582|NCT01853748|Paclitaxel|paclitaxel|mesh-list
101309583|NCT01853748|Maytansine|maytansine|mesh-list
101309584|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101309585|NCT01853748|Trastuzumab|trastuzumab|mesh-list
101309586|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309587|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309588|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309589|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309590|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309591|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309592|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309593|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
101309594|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
101309595|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
101309596|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309598|NCT00006045|Etoposide|etoposide|mesh-list
101309600|NCT00006045|Lintuzumab|lintuzumab|mesh-list
101309601|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309602|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309603|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101309604|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309605|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309606|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309607|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309609|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
101309610|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309611|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309612|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
101309614|NCT00006045|Analgesics|analgesics|mesh-ancestor
101309615|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
101309616|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309617|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309618|NCT00006048|Gemcitabine|gemcitabine|mesh-list
101309619|NCT00006048|Gefitinib|gefitinib|mesh-list
101309620|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309621|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309622|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
101309623|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309624|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101309625|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309627|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309628|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
101319351|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101416112|NCT03809429|Cetrorelix|cetrorelix|mesh-list
101309629|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309630|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309631|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309633|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309635|NCT00006054|Prednisone|prednisone|mesh-list
101309636|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
101309641|NCT00006054|Cyclosporins|cyclosporins|mesh-list
101309642|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101309643|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309644|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
101309645|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309646|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309647|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309648|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
101309649|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309650|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309651|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101309652|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309653|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
101309655|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309656|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101309657|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101309658|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
101309659|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309660|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309661|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
101309662|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309663|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309664|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101309665|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328737|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309666|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309667|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101309668|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309669|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
101309670|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309671|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101309672|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
101309673|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
101309674|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309675|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309676|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101309677|NCT00006054|Protective Agents|protective agents|mesh-ancestor
101309678|NCT00006063|Pancrelipase|pancrelipase|mesh-list
101309680|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309681|NCT00006066|Aldesleukin|aldesleukin|mesh-list
101309682|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309683|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101309684|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101309685|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
101309686|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309687|NCT00006072|Rituximab|rituximab|mesh-list
101309688|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309689|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309690|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
101309691|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309692|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309693|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
101309694|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101309695|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101309696|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309697|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
101309698|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
101309699|NCT00006078|Lycopene|lycopene|mesh-list
101309700|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309701|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
101309704|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309705|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101309706|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101309707|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309710|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309711|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309712|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309713|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309714|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328758|NCT00024193|Melphalan|melphalan|mesh-list
101309715|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309716|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101309717|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
101309718|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309720|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309721|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309722|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
101309723|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309724|NCT00006096|Cisplatin|cisplatin|mesh-list
101309725|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309726|NCT00006105|Gemcitabine|gemcitabine|mesh-list
101309727|NCT00006105|Amifostine|amifostine|mesh-list
101309728|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309729|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309731|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309732|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101309733|NCT00006105|Protective Agents|protective agents|mesh-ancestor
101309734|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309735|NCT00006108|Paclitaxel|paclitaxel|mesh-list
101309736|NCT00006108|Capecitabine|capecitabine|mesh-list
101309737|NCT00006108|Trastuzumab|trastuzumab|mesh-list
101309738|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309739|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309740|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309741|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309742|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309743|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309744|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309745|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
101309746|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309748|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309749|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
101309750|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309751|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309753|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
101309754|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309755|NCT00006114|Vinorelbine|vinorelbine|mesh-list
101309756|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
101309757|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309758|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309759|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101309760|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309761|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309762|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309769|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309771|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
101309772|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309773|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
101309774|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309775|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309777|NCT00006120|Docetaxel|docetaxel|mesh-list
101309778|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309779|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309781|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
101309782|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
101309783|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309784|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
101309785|NCT00006123|Thiotepa|thiotepa|mesh-list
101309786|NCT00006123|Carmustine|carmustine|mesh-list
101309787|NCT00006123|Carboplatin|carboplatin|mesh-list
101309788|NCT00006123|Trastuzumab|trastuzumab|mesh-list
101309790|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
101309791|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309792|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309793|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309794|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
101309795|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309796|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309797|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101309798|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309799|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
101309800|NCT00006126|Busulfan|busulfan|mesh-list
101309801|NCT00006126|Fludarabine|fludarabine|mesh-list
101309802|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
101309803|NCT00006126|Etoposide|etoposide|mesh-list
101309804|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309805|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
101309806|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309807|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309808|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101309809|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
101309810|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309811|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309812|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101309813|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101309815|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101309822|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309823|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309824|NCT00006132|Acyclovir|acyclovir|mesh-list
101309825|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
101309826|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309827|NCT00006135|Acyclovir|acyclovir|mesh-list
101309828|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
101309829|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309830|NCT00006144|Ritonavir|ritonavir|mesh-list
101309831|NCT00006144|Lopinavir|lopinavir|mesh-list
101309832|NCT00006144|Emtricitabine|emtricitabine|mesh-list
101309833|NCT00006144|Stavudine|stavudine|mesh-list
101309834|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101309835|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101309836|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
101309837|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309838|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309840|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101309841|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
101309842|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309843|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101309844|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101309845|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101309846|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309847|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
101309848|NCT00006168|Methotrexate|methotrexate|mesh-list
101309849|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101309850|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
101309851|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309852|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309853|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547858|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101309854|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
101309855|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309856|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309858|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309859|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101309860|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309861|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
101309862|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101309863|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309865|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309866|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101309867|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101309868|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309869|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309870|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101309871|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
101309872|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309873|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309874|NCT00006180|Alendronate|alendronate|mesh-list
101309878|NCT00006195|Risperidone|risperidone|mesh-list
101309879|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101309880|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
101309881|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309882|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309883|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309884|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101309885|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101309886|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101309887|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101309888|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101309889|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
101309890|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
101309891|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
101309892|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309893|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309894|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101309895|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101309896|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309897|NCT00006198|Thalidomide|thalidomide|mesh-list
101309899|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101309900|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309901|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101309902|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101309903|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309904|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309905|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101309906|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
101309907|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309908|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
101309909|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309910|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309911|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101309912|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101309913|NCT00006198|Growth Substances|growth substances|mesh-ancestor
101309914|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
101309915|NCT00006204|Naltrexone|naltrexone|mesh-list
101309916|NCT00006204|Fluoxetine|fluoxetine|mesh-list
101309917|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101309918|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101309919|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547872|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309924|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309925|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309926|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101309927|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
101309928|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101309929|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101309930|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101309931|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101309932|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101309933|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309934|NCT00006216|Ganciclovir|ganciclovir|mesh-list
101309935|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101309936|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
101309937|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309938|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101309939|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309940|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309941|NCT00006219|Clarithromycin|clarithromycin|mesh-list
101309942|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101309943|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101309944|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309945|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101309946|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101309947|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101309948|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101309949|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101309950|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101309951|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
101309952|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309955|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101309956|NCT00387582|Growth Substances|growth substances|mesh-ancestor
101309957|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309958|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
101309959|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309960|NCT00006228|Aldesleukin|aldesleukin|mesh-list
101309961|NCT00006228|Trastuzumab|trastuzumab|mesh-list
101309962|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101309963|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309964|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101309965|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101309966|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
101309967|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101309968|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101309969|NCT03751800|Dienogest|dienogest|mesh-list
101309970|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
101309971|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
101309972|NCT03751800|Estradiol|estradiol|mesh-list
101309973|NCT03751800|Estrogens|estrogens|mesh-ancestor
101309974|NCT03751800|Hormones|hormones|mesh-ancestor
101309975|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101309976|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309977|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101309979|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101309981|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101309983|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101309984|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101309985|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101309986|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101309988|NCT00006240|Dexamethasone|dexamethasone|mesh-list
101309989|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101309990|NCT00006240|Sargramostim|sargramostim|mesh-list
101309991|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101309993|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
101309994|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101309995|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101309996|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101309997|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
101309998|NCT00006240|Hormones|hormones|mesh-ancestor
101319352|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101547882|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101309999|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310000|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101310001|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310002|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
101310003|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
101310004|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101310005|NCT02972463|Antibodies|antibodies|mesh-list
101310006|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
101310007|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310008|NCT00006243|Sargramostim|sargramostim|mesh-list
101310009|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
101310010|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
101310011|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310012|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310014|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
101310015|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310016|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310017|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
101310018|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310019|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310020|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310021|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310022|NCT00006249|Interferons|interferons|mesh-list
101310023|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
101310024|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310031|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
101310032|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310033|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
101310034|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310035|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310036|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310037|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
101310038|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310039|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310040|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310041|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310042|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
101310043|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
101310044|NCT00006258|Methotrexate|methotrexate|mesh-list
101310045|NCT00006258|Etoposide|etoposide|mesh-list
101310046|NCT00006258|Vincristine|vincristine|mesh-list
101310047|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310048|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
101310049|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310050|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310051|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310052|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
101310053|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310055|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310056|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101310057|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
101310058|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101310059|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310060|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
101310061|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310062|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310063|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101310064|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310065|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310066|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310067|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310068|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101310069|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310070|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310071|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
101310072|NCT00006261|Docetaxel|docetaxel|mesh-list
101310074|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310075|NCT00006261|Fludarabine|fludarabine|mesh-list
101310076|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
101310077|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310078|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
101310079|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310081|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310087|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310088|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310089|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310090|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310091|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310092|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310093|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310094|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
101310095|NCT00006264|Zidovudine|zidovudine|mesh-list
101310096|NCT00006264|Aldesleukin|aldesleukin|mesh-list
101310097|NCT00006264|Ganciclovir|ganciclovir|mesh-list
101310098|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101310099|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
101310100|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310101|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101310102|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310103|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310104|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
101310105|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310106|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310107|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310108|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310110|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310111|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310112|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310113|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310114|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310115|NCT00006270|Cosyntropin|cosyntropin|mesh-list
101310116|NCT00006270|Metyrapone|metyrapone|mesh-list
101310117|NCT00006270|Hormones|hormones|mesh-ancestor
101310118|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310119|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310120|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
101310121|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310122|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310123|NCT00006276|Paclitaxel|paclitaxel|mesh-list
101310124|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310125|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310126|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
101310127|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310128|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310129|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310130|NCT00006279|Nevirapine|nevirapine|mesh-list
101310131|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101310132|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310133|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310134|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310137|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310138|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310139|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101310140|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101310141|NCT00006291|Aldesleukin|aldesleukin|mesh-list
101310142|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310143|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310144|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310145|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
101310146|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310148|NCT00006294|Lisinopril|lisinopril|mesh-list
101310150|NCT00006294|Doxazosin|doxazosin|mesh-list
101310151|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101310152|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101310153|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101310154|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310155|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101310156|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310157|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
101310158|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101310159|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101310160|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310161|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101310162|NCT00006294|Protective Agents|protective agents|mesh-ancestor
101310163|NCT00006294|Diuretics|diuretics|mesh-ancestor
101310164|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
101310165|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101310166|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101310167|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101310168|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101310169|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101310170|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101310171|NCT00005818|Irinotecan|irinotecan|mesh-list
101310172|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310173|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310174|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310175|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310176|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310177|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101310178|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
101310179|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101310180|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
101310181|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101310182|NCT00006324|Estradiol|estradiol|mesh-list
101310183|NCT00006324|Estrogens|estrogens|mesh-ancestor
101310184|NCT00006324|Hormones|hormones|mesh-ancestor
101310185|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310186|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310187|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101310188|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
101310189|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101310190|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101310191|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101310192|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101310193|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101310194|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101310196|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310197|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101310198|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
101310199|NCT00005824|Busulfan|busulfan|mesh-list
101310200|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310201|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
101310202|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310203|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310204|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310205|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
101310206|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310207|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310208|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310209|NCT00005827|Genistein|genistein|mesh-list
101310210|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101310211|NCT00005827|Protective Agents|protective agents|mesh-ancestor
101310212|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310213|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310214|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310215|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310216|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310217|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
101310218|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101310219|NCT00005827|Estrogens|estrogens|mesh-ancestor
101310220|NCT00005827|Hormones|hormones|mesh-ancestor
101310221|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310222|NCT00005830|Doxorubicin|doxorubicin|mesh-list
101310223|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310224|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310225|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310227|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310228|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310229|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310230|NCT00005833|Tipifarnib|tipifarnib|mesh-list
101310231|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310232|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
101310233|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310234|NCT00006330|Digoxin|digoxin|mesh-list
101310235|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101310236|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101310237|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310238|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310239|NCT00006330|Protective Agents|protective agents|mesh-ancestor
101310240|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310241|NCT00005839|Capecitabine|capecitabine|mesh-list
101310242|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
101310243|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310244|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
101310245|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310246|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310247|NCT00005842|Trastuzumab|trastuzumab|mesh-list
101310248|NCT00005842|Tipifarnib|tipifarnib|mesh-list
101310249|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310250|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310251|NCT00005845|Tipifarnib|tipifarnib|mesh-list
101310252|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310253|NCT00005848|Tipifarnib|tipifarnib|mesh-list
101310254|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310255|NCT00005851|Cyclosporine|cyclosporine|mesh-list
101310259|NCT00005851|Cyclosporins|cyclosporins|mesh-list
101310260|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310261|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310262|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
101310263|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310265|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
101310266|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310267|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310268|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
101310269|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310270|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310271|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310272|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101310273|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310274|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101310275|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
101310276|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101310277|NCT00005854|Cyclosporine|cyclosporine|mesh-list
101310278|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
101310279|NCT00005854|Methotrexate|methotrexate|mesh-list
101310280|NCT00005854|Cyclosporins|cyclosporins|mesh-list
101310281|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310282|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
101310283|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310284|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310285|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310286|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
101310287|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310288|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310289|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310290|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101310291|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
101416128|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310293|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310295|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310296|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310297|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101310298|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310299|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
101310300|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310301|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101310302|NCT00005857|Docetaxel|docetaxel|mesh-list
101310303|NCT00005857|Trastuzumab|trastuzumab|mesh-list
101310304|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310305|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
101310306|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310307|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310308|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310309|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310310|NCT00005860|Leucovorin|leucovorin|mesh-list
101310311|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
101310312|NCT00005860|Floxuridine|floxuridine|mesh-list
101310313|NCT00005860|Calcium|calcium|mesh-list
101310314|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
101310315|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101310316|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310318|NCT00005860|Antidotes|antidotes|mesh-ancestor
101310319|NCT00005860|Protective Agents|protective agents|mesh-ancestor
101310320|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
101310321|NCT00005860|Vitamins|vitamins|mesh-ancestor
101310322|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
101310323|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310324|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
101310325|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310326|NCT00005863|Cytarabine|cytarabine|mesh-list
101310327|NCT00005863|Fludarabine|fludarabine|mesh-list
101310328|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
101310329|NCT00005863|Etoposide|etoposide|mesh-list
101310330|NCT00005863|Daunorubicin|daunorubicin|mesh-list
101310331|NCT00005863|Tretinoin|tretinoin|mesh-list
101310332|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310333|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310334|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
101310335|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310336|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310337|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
101310338|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310339|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310340|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310341|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310342|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310343|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
101310344|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310345|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310346|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
101310347|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310348|NCT00005866|Cyclosporine|cyclosporine|mesh-list
101310349|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
101310350|NCT00005866|Busulfan|busulfan|mesh-list
101310351|NCT00005866|Methotrexate|methotrexate|mesh-list
101310352|NCT00005866|Cyclosporins|cyclosporins|mesh-list
101310353|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310354|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
101310355|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310356|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310357|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310358|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
101310359|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310360|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310361|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310362|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101310363|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
101310364|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101310365|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310366|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
101310367|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310368|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310369|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101310370|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310371|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
101310372|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310373|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101310374|NCT00005869|Gemcitabine|gemcitabine|mesh-list
101310375|NCT00005869|Rubitecan|rubitecan|mesh-list
101310376|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310377|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
101310378|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310382|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310383|NCT00005872|Rubitecan|rubitecan|mesh-list
101310384|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310385|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310386|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310387|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310388|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310390|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310391|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310392|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310393|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310394|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310395|NCT00005878|Celecoxib|celecoxib|mesh-list
101310396|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101310397|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101310398|NCT00005878|Analgesics|analgesics|mesh-ancestor
101310399|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
101310400|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310401|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310402|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310403|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310404|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101310405|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101310406|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310407|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310408|NCT00005884|Eflornithine|eflornithine|mesh-list
101310409|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310410|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101310411|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101310412|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101310413|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310414|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101310416|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310418|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
101310419|NCT00006339|Ritonavir|ritonavir|mesh-list
101310420|NCT00006339|Indinavir|indinavir|mesh-list
101310422|NCT00006339|Stavudine|stavudine|mesh-list
101310423|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
101310424|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101310425|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101310426|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
101310427|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310428|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310429|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310430|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310431|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
101310432|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310433|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101310434|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101412922|NCT00480064|Lomustine|lomustine|mesh-list
101310436|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
101547900|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547902|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310437|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310439|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101310440|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101310441|NCT00005890|Hormones|hormones|mesh-ancestor
101310442|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310443|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310444|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
101310445|NCT00005893|Busulfan|busulfan|mesh-list
101310447|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310448|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
101310449|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310450|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310451|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310452|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
101310453|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310455|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310456|NCT00005896|Lenograstim|lenograstim|mesh-list
101310457|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310458|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
101310459|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310460|NCT00386503|Artesunate|artesunate|mesh-list
101310461|NCT00386503|Amodiaquine|amodiaquine|mesh-list
101310462|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
101310463|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101310464|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101310465|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310466|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310467|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
101310472|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101310473|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101310474|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101310475|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310476|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
101310477|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101310478|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310480|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
101310481|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310483|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
101310484|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310485|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310486|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310487|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
101310488|NCT00006345|Hormones|hormones|mesh-ancestor
101310489|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310490|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101310491|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310492|NCT00005920|Caspofungin|caspofungin|mesh-list
101310493|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
101310494|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310495|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310496|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310497|NCT00005926|Gemcitabine|gemcitabine|mesh-list
101310498|NCT00005926|Trastuzumab|trastuzumab|mesh-list
101310499|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310500|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
101310501|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310502|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310503|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310504|NCT00005935|Cyclosporine|cyclosporine|mesh-list
101310505|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
101310506|NCT00005935|Cyclosporins|cyclosporins|mesh-list
101310508|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310509|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547911|NCT01340768|Hormones|hormones|mesh-ancestor
101310510|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
101310511|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310512|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
101310513|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310514|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310515|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310516|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101310517|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310518|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310519|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101310520|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
101310524|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
101310525|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310526|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310527|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310528|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
101310529|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310530|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101310531|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101310532|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
101310533|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329150|NCT00025597|Carboplatin|carboplatin|mesh-list
101310534|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310535|NCT00005938|Exatecan|exatecan|mesh-list
101310536|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310537|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310538|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310539|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310540|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310542|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
101310543|NCT00005941|Fludarabine|fludarabine|mesh-list
101310544|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
101310545|NCT00005941|Cyclosporins|cyclosporins|mesh-list
101310546|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310547|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310548|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
101310549|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310550|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310551|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
101310552|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310553|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310554|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
101310555|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310556|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
101310557|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310558|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101310559|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310560|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101310561|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
101310562|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101310563|NCT00005944|Leucovorin|leucovorin|mesh-list
101310564|NCT00005944|Fluorouracil|fluorouracil|mesh-list
101310565|NCT00005944|Mitomycins|mitomycins|mesh-list
101310566|NCT00005944|Mitomycin|mitomycin|mesh-list
101310567|NCT00005944|Calcium|calcium|mesh-list
101310568|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
101310569|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101310570|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310571|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
101310572|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310573|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310574|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310575|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310579|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
101310580|NCT00005944|Vitamins|vitamins|mesh-ancestor
101310581|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
101310582|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310583|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
101310584|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310585|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310586|NCT00387699|Bevacizumab|bevacizumab|mesh-list
101310587|NCT00387699|Etoposide|etoposide|mesh-list
101310588|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310594|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310595|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310596|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310597|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310598|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310599|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310600|NCT00005959|Prednisone|prednisone|mesh-list
101310601|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
101310602|NCT00005959|Rituximab|rituximab|mesh-list
101310603|NCT00005959|Doxorubicin|doxorubicin|mesh-list
101310604|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310605|NCT00005959|Vincristine|vincristine|mesh-list
101310606|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310607|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
101310608|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310609|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310610|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310611|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
101310612|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310613|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310614|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310615|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101310616|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310617|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310618|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310619|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310620|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310621|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
101310622|NCT00005959|Hormones|hormones|mesh-ancestor
101310623|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310624|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101310625|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310627|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310628|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310629|NCT00387738|Histamine|histamine|mesh-list
101310630|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
101310631|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
101310632|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101310633|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310634|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310635|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
101310636|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310637|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310638|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
101310639|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310640|NCT00005968|Irofulven|irofulven|mesh-list
101310641|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310643|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310645|NCT00387777|Buprenorphine|buprenorphine|mesh-list
101310646|NCT00387777|Analgesics|analgesics|mesh-list
101310647|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101310648|NCT00387777|Narcotics|narcotics|mesh-ancestor
101310649|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101310650|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310651|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
101310652|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310653|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101310654|NCT00005971|Alvocidib|alvocidib|mesh-list
101310655|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547934|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101310656|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310657|NCT00005971|Growth Substances|growth substances|mesh-ancestor
101310658|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310659|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310660|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310661|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310663|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310664|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310665|NCT00005974|Growth Substances|growth substances|mesh-ancestor
101310666|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310667|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310668|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310669|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310671|NCT00005977|Cytarabine|cytarabine|mesh-list
101310672|NCT00005977|Dexamethasone|dexamethasone|mesh-list
101310673|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
101310674|NCT00005977|Ifosfamide|ifosfamide|mesh-list
101310675|NCT00005977|Doxorubicin|doxorubicin|mesh-list
101310676|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310677|NCT00005977|Methotrexate|methotrexate|mesh-list
101310678|NCT00005977|Etoposide|etoposide|mesh-list
101310679|NCT00005977|Vincristine|vincristine|mesh-list
101310680|NCT00005977|Lenograstim|lenograstim|mesh-list
101310681|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
101310682|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310683|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
101310684|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310685|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310686|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310687|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
101310688|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310689|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310690|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310691|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310692|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
101310693|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
101310694|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310695|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310696|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
101310697|NCT00005977|Hormones|hormones|mesh-ancestor
101310698|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310699|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101310700|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310701|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310702|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310703|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310704|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101310705|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
101310706|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101310707|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310710|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101310711|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310712|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310713|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
101310714|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310716|NCT00005977|Protective Agents|protective agents|mesh-ancestor
101310717|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
101310718|NCT00005977|Vitamins|vitamins|mesh-ancestor
101310719|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
101310720|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310721|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416129|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310722|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310723|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310724|NCT00005980|Doxorubicin|doxorubicin|mesh-list
101310725|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310726|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310727|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310728|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310729|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310730|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310731|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310732|NCT00005986|Interferons|interferons|mesh-list
101310733|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
101310734|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
101310735|NCT00005986|Busulfan|busulfan|mesh-list
101310736|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310737|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
101310738|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310739|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310740|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310741|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
101310742|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310743|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310744|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310745|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
101310746|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310747|NCT00005989|Tipifarnib|tipifarnib|mesh-list
101310748|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310749|NCT00005998|Cytarabine|cytarabine|mesh-list
101310750|NCT00005998|Dexamethasone|dexamethasone|mesh-list
101310751|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
101310752|NCT00005998|Carmustine|carmustine|mesh-list
101310753|NCT00005998|Etoposide|etoposide|mesh-list
101310754|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
101310755|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310756|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
101310757|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310758|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101310759|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310760|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
101310761|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310762|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310763|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310764|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101310765|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
101310766|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
101310767|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310768|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310769|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
101310770|NCT00005998|Hormones|hormones|mesh-ancestor
101310771|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101310773|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310774|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310775|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310776|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310777|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310778|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
101310779|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
101310780|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310781|NCT00005998|Analgesics|analgesics|mesh-ancestor
101310782|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
101310783|NCT00006351|Gemcitabine|gemcitabine|mesh-list
101310784|NCT00006351|Lonafarnib|lonafarnib|mesh-list
101310785|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310786|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
101416141|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416142|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310787|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310788|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310789|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310791|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101310792|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101310793|NCT00006001|Growth Substances|growth substances|mesh-ancestor
101310794|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310795|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310796|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310797|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310798|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310799|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310800|NCT00006007|Gemcitabine|gemcitabine|mesh-list
101310801|NCT00006007|Pemetrexed|pemetrexed|mesh-list
101310802|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310803|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
101310804|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310805|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310806|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310807|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101310808|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310809|NCT00006010|Gemcitabine|gemcitabine|mesh-list
101310810|NCT00006010|Docetaxel|docetaxel|mesh-list
101329174|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
101310811|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310812|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
101310813|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310814|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310815|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
101310816|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
101310817|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
101310818|NCT00006013|Semaxinib|semaxinib|mesh-list
101310819|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101310820|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101310821|NCT00006013|Growth Substances|growth substances|mesh-ancestor
101310822|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310823|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310824|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310825|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310826|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310827|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310828|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
101310829|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310830|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310831|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310832|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310833|NCT00006016|Thalidomide|thalidomide|mesh-list
101310834|NCT00006016|Doxorubicin|doxorubicin|mesh-list
101310835|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310836|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310837|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310838|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310839|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310840|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310841|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310842|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310843|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
101310844|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310845|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
101310846|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101310847|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310848|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101310849|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101310850|NCT00006016|Growth Substances|growth substances|mesh-ancestor
101310851|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
101310852|NCT00006019|Azacitidine|azacitidine|mesh-list
101310853|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101310854|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310855|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
101310856|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310857|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310858|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310859|NCT00006022|Aldesleukin|aldesleukin|mesh-list
101310860|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
101310861|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310862|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310863|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310864|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
101310865|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310866|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310867|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
101310868|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310870|NCT00006025|Temozolomide|temozolomide|mesh-list
101310871|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310872|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310873|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310874|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310875|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310876|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310877|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
101310879|NCT00386659|Lopinavir|lopinavir|mesh-list
101310880|NCT00386659|Tenofovir|tenofovir|mesh-list
101310881|NCT00386659|Abacavir|abacavir|mesh-list
101310882|NCT00386659|Efavirenz|efavirenz|mesh-list
101310883|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
101310884|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101310885|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101310886|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
101310887|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310888|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310889|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310890|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310892|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310893|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101310894|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101310895|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101310896|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310897|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101310898|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101310899|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101310900|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101310901|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101310902|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
101310904|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310905|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310906|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
101310907|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310908|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
101310909|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
101310910|NCT00387933|Vatalanib|vatalanib|mesh-list
101310911|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310912|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101310913|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310914|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310915|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
101310916|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101310917|NCT00006034|Doxorubicin|doxorubicin|mesh-list
101310918|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101310919|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101310920|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310921|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310922|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310923|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310924|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310925|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310926|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101310927|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
101310928|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310929|NCT00006037|Fluorouracil|fluorouracil|mesh-list
101310931|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
101310932|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310933|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310934|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310935|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310936|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
101310937|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310938|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101310939|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310940|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310941|NCT00006040|Etoposide|etoposide|mesh-list
101310942|NCT00006040|Antibodies|antibodies|mesh-list
101310945|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310946|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310947|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310948|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310949|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310950|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310951|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310954|NCT00006363|Etoposide|etoposide|mesh-list
101310955|NCT00006363|Daunorubicin|daunorubicin|mesh-list
101310956|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
101310958|NCT00006363|Interleukin-2|interleukin-2|mesh-list
101310959|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101310960|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310961|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101310962|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101310963|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310964|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310965|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310966|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
101310967|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
101310968|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101310969|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310970|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
101310971|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101310972|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
101310973|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101310974|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101310975|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101310976|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101310977|NCT00006363|Analgesics|analgesics|mesh-ancestor
101310978|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
101310979|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101310980|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101310981|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101310982|NCT05680870|Omeprazole|omeprazole|mesh-list
101310983|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101310984|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101310985|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101310986|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101310987|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101310988|NCT00006366|Fluorouracil|fluorouracil|mesh-list
101310990|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
101310991|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547956|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
101310992|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101310993|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101310994|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101310995|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
101310996|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311002|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
101311003|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101311004|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101311005|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311006|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311007|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311008|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311009|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311010|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
101311011|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311012|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101311013|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101311014|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101311015|NCT00006372|Gemcitabine|gemcitabine|mesh-list
101311016|NCT00006372|Doxorubicin|doxorubicin|mesh-list
101311017|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101311018|NCT00006372|Vinorelbine|vinorelbine|mesh-list
101311019|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311020|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
101311021|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311022|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311023|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311024|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311025|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311026|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311027|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311028|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311029|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311031|NCT00006378|Paclitaxel|paclitaxel|mesh-list
101311032|NCT00006378|Carboplatin|carboplatin|mesh-list
101311033|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311034|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311035|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311036|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311037|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101311038|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311039|NCT00006381|Celecoxib|celecoxib|mesh-list
101311040|NCT00006381|Trastuzumab|trastuzumab|mesh-list
101311041|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311043|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101311044|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101311045|NCT00006381|Analgesics|analgesics|mesh-ancestor
101311047|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311048|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311049|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311050|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311051|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101311052|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101311058|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
101311059|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311060|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
101311061|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311062|NCT00386815|Pemetrexed|pemetrexed|mesh-list
101311063|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311064|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311065|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311066|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101311067|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311069|NCT05679388|Itraconazole|itraconazole|mesh-list
101311070|NCT05679388|Relugolix|relugolix|mesh-list
101311071|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101311072|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101311073|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311074|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311075|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311076|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311077|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311078|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
101311079|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311080|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101311081|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101311082|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
101311083|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101311084|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101311085|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
101329199|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
101311086|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311087|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311088|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
101311089|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101311090|NCT05678296|Analgesics|analgesics|mesh-list
101311091|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311092|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
101311093|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311094|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311095|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101311096|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311098|NCT00006396|Nevirapine|nevirapine|mesh-list
101311099|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
101311100|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311101|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101311102|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311103|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311104|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
101311105|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311106|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311112|NCT03996148|Propofol|propofol|mesh-list
101311113|NCT03996148|Desflurane|desflurane|mesh-list
101311114|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101311115|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311116|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311117|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101311118|NCT03996148|Analgesics|analgesics|mesh-ancestor
101311119|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
101311120|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416153|NCT01249690|Pirarubicin|pirarubicin|mesh-list
101311121|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101311122|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101311123|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101311124|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101311125|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311126|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311127|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101311128|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
101311129|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
101311130|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101311131|NCT03996148|Narcotics|narcotics|mesh-ancestor
101311132|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101311133|NCT00006399|Donepezil|donepezil|mesh-list
101311134|NCT00006399|Progesterone|progesterone|mesh-list
101311135|NCT00006399|Estrogens|estrogens|mesh-list
101311136|NCT00006399|Progestins|progestins|mesh-ancestor
101311137|NCT00006399|Hormones|hormones|mesh-ancestor
101311138|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311139|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311140|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101311141|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311142|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311144|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311145|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
101311147|NCT05660200|Trace Elements|trace elements|mesh-ancestor
101311148|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
101311149|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311150|NCT05552404|Aminophylline|aminophylline|mesh-list
101311151|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101311152|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
101311153|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311154|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311155|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101329203|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101311156|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
101311157|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101311158|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101311159|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311160|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311161|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101311164|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311165|NCT05552404|Protective Agents|protective agents|mesh-ancestor
101311166|NCT05546320|Aspirin|aspirin|mesh-list
101311167|NCT05546320|Metoprolol|metoprolol|mesh-list
101311168|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
101311169|NCT05546320|Clopidogrel|clopidogrel|mesh-list
101311170|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101311171|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101311173|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
101311174|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311175|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311176|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311177|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311178|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101311179|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101311180|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311181|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101311182|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101311183|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311184|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
101311185|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101311186|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101311187|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101311188|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
101547995|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
101311189|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547997|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101311191|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
101311192|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101311193|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311194|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
101311195|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101311196|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101311197|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
101311198|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
101311199|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101311200|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101311201|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101311202|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
101311203|NCT05535595|Perindopril|perindopril|mesh-list
101311204|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101311205|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311206|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311207|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311208|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101311211|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101311212|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311213|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
101311214|NCT05470816|Coagulants|coagulants|mesh-ancestor
101311220|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101311221|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101311222|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101311223|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
101311224|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329210|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
101311225|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311226|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311227|NCT05431543|Miotics|miotics|mesh-ancestor
101311228|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
101311229|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311230|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101311231|NCT05401786|Ipilimumab|ipilimumab|mesh-list
101311232|NCT05401786|Cemiplimab|cemiplimab|mesh-list
101311233|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311234|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311235|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101311236|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311237|NCT05285683|Levodopa|levodopa|mesh-list
101311238|NCT05285683|Carbidopa|carbidopa|mesh-list
101311239|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101311240|NCT05285683|Methylphenidate|methylphenidate|mesh-list
101311241|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101311242|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311243|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101311244|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101311245|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101311246|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311247|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
101311248|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311249|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101311250|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101311251|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101311252|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311253|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101311254|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
101311255|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
101311256|NCT05247970|Midazolam|midazolam|mesh-list
101311257|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101311258|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101311259|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311260|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311261|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101311262|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101311267|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
101311268|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
101311269|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311270|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311271|NCT00006441|Lamivudine|lamivudine|mesh-list
101311272|NCT00006441|Zidovudine|zidovudine|mesh-list
101311273|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101311274|NCT00006441|Aldesleukin|aldesleukin|mesh-list
101311275|NCT00006441|Nelfinavir|nelfinavir|mesh-list
101311276|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101311277|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311278|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311279|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311280|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
101311281|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311282|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311283|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311284|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
101311285|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311286|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101311287|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101311288|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311290|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311291|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
101311293|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311294|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311295|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311296|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
101311297|NCT05147233|Hormones|hormones|mesh-ancestor
101311298|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311299|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311300|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311301|NCT03926845|Thiamidol|thiamidol|mesh-list
101311302|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311303|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311305|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311306|NCT00006453|Carboplatin|carboplatin|mesh-list
101311307|NCT00006453|Gemcitabine|gemcitabine|mesh-list
101311313|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101548014|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101548015|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548016|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
101548017|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101548018|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
101548019|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
101548020|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548021|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311314|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311315|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311316|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311317|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101311318|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311319|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311321|NCT00006459|Gemcitabine|gemcitabine|mesh-list
101311322|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311323|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311324|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311325|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311326|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101311327|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311328|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311329|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
101311330|NCT03876106|LUT014|lut014|mesh-list
101311331|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311333|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311334|NCT00388011|Morphine|morphine|mesh-list
101311335|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101311336|NCT00388011|Narcotics|narcotics|mesh-ancestor
101311337|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311338|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311339|NCT00388011|Analgesics|analgesics|mesh-ancestor
101311340|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
101311341|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311342|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101311343|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
101311344|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311346|NCT00388089|Topotecan|topotecan|mesh-list
101311347|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311348|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311349|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311350|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311351|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311353|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101311354|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311355|NCT00388128|Caffeine|caffeine|mesh-list
101311358|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101311359|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311360|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311361|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101311362|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101311363|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
101311364|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311366|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311367|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
101311368|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311369|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311370|NCT00006465|Capecitabine|capecitabine|mesh-list
101311371|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
101311372|NCT00006465|Irinotecan|irinotecan|mesh-list
101311373|NCT00006465|Camptothecin|camptothecin|mesh-list
101311374|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311375|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
101311376|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311377|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311378|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311379|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311380|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311381|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311382|NCT04575181|Insulin|insulin|mesh-list
101311383|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101311384|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
101311385|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101311386|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311387|NCT00006468|Leucovorin|leucovorin|mesh-list
101311388|NCT00006468|Fluorouracil|fluorouracil|mesh-list
101548026|NCT00600912|SMOFlipid|smoflipid|mesh-list
101311389|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
101311390|NCT00006468|Calcium|calcium|mesh-list
101311391|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
101311392|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101311393|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311394|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
101311395|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311396|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311397|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311398|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311399|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
101311400|NCT00006468|Antidotes|antidotes|mesh-ancestor
101311401|NCT00006468|Protective Agents|protective agents|mesh-ancestor
101311402|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
101311403|NCT00006468|Vitamins|vitamins|mesh-ancestor
101311404|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
101311405|NCT00006471|Fenretinide|fenretinide|mesh-list
101311406|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311407|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101311408|NCT00006471|Protective Agents|protective agents|mesh-ancestor
101311409|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311410|NCT00006474|Temozolomide|temozolomide|mesh-list
101311411|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101311412|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311413|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
101311414|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311415|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311416|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311418|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101311419|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
101311420|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311421|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311422|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311423|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101311424|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101311425|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311426|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101311427|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101311428|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
101311429|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
101311430|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101311431|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101311432|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311433|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
101311434|NCT04192435|Coagulants|coagulants|mesh-ancestor
101311436|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
101311437|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311438|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
101311439|NCT03765229|Entinostat|entinostat|mesh-list
101311440|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311441|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311442|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101311443|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311444|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101311445|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311446|NCT03624517|Octreotide|octreotide|mesh-list
101311447|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311448|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311449|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311450|NCT00423397|Interferons|interferons|mesh-list
101311451|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
101311452|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
101311453|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101311454|NCT00423397|Gefitinib|gefitinib|mesh-list
101311455|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311456|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
101311457|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311458|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
101311459|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548035|NCT00601302|Amlodipine|amlodipine|mesh-list
101311460|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311461|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311462|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311463|NCT03352765|Rituximab|rituximab|mesh-list
101311464|NCT03352765|Melphalan|melphalan|mesh-list
101311465|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101311466|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311467|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311468|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
101311469|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311470|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311471|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311472|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
101311473|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311474|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101311475|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311477|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101311478|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
101311479|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101311480|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
101311481|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101311482|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
101311483|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311484|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
101311485|NCT03265405|Hormones|hormones|mesh-ancestor
101311486|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311487|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311488|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311489|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311490|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
101311491|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
101311492|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311493|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311494|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101311495|NCT03265405|Protective Agents|protective agents|mesh-ancestor
101311497|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311498|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311499|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101311500|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311501|NCT02966548|Nivolumab|nivolumab|mesh-list
101311502|NCT02966548|Relatlimab|relatlimab|mesh-list
101311503|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311504|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311505|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101311506|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311507|NCT02890069|Everolimus|everolimus|mesh-list
101311508|NCT02890069|Panobinostat|panobinostat|mesh-list
101311509|NCT02890069|Spartalizumab|spartalizumab|mesh-list
101311510|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101311512|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311513|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311514|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311515|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
101311516|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311517|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311518|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101311519|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101311520|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311521|NCT02425501|Aflibercept|aflibercept|mesh-list
101311522|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101311523|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101311524|NCT02425501|Growth Substances|growth substances|mesh-ancestor
101311525|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311526|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
101311527|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311528|NCT02409238|Metformin|metformin|mesh-list
101311529|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101311530|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311531|NCT00006480|Aldesleukin|aldesleukin|mesh-list
101311532|NCT00006480|Ganciclovir|ganciclovir|mesh-list
101311533|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101311534|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311535|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311536|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311537|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
101311538|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311539|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311540|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311541|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311542|NCT00006483|Sargramostim|sargramostim|mesh-list
101311543|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
101311544|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412942|NCT00480142|Analgesics|analgesics|mesh-ancestor
101311545|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101311546|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311547|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101311548|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101311549|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311550|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101329228|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101311551|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311553|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101311554|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311558|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311559|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311560|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311561|NCT00006591|Ritonavir|ritonavir|mesh-list
101311562|NCT00006591|Amprenavir|amprenavir|mesh-list
101311563|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101311564|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101311565|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101311566|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311567|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311568|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311569|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311570|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
101311571|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311572|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101311573|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101311574|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101311575|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
101311576|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101311577|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
101311578|NCT00006630|Antibodies|antibodies|mesh-list
101311579|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
101311580|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101311581|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101311582|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
101311583|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311584|NCT00006669|Prednisone|prednisone|mesh-list
101311585|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
101311586|NCT00006669|Rituximab|rituximab|mesh-list
101311587|NCT00006669|Doxorubicin|doxorubicin|mesh-list
101311588|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101311589|NCT00006669|Etoposide|etoposide|mesh-list
101311590|NCT00006669|Vincristine|vincristine|mesh-list
101311591|NCT00006669|Sargramostim|sargramostim|mesh-list
101311592|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311593|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
101311594|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311595|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311596|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311597|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
101311598|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311599|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311600|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101311601|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311602|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311603|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311604|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311605|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311606|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311607|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
101311609|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311610|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311611|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311612|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311613|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311614|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101311617|NCT00006708|Etoposide|etoposide|mesh-list
101311618|NCT00006708|Ifosfamide|ifosfamide|mesh-list
101412951|NCT00119483|Hormones|hormones|mesh-ancestor
101311619|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311620|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311621|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
101311622|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311624|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311625|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311626|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311627|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311628|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311629|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311630|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
101311631|NCT00006747|Cytarabine|cytarabine|mesh-list
101311632|NCT00006747|Methotrexate|methotrexate|mesh-list
101311633|NCT00006747|Etoposide|etoposide|mesh-list
101311634|NCT00006747|Melphalan|melphalan|mesh-list
101311635|NCT00006747|Carmustine|carmustine|mesh-list
101311636|NCT00006747|Tacrolimus|tacrolimus|mesh-list
101311637|NCT00006747|Sargramostim|sargramostim|mesh-list
101311638|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101311639|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
101311640|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101311641|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311642|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311643|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
101311644|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311645|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311646|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
101311647|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311648|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101311649|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311650|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
101311651|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311652|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311653|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311654|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311655|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311656|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
101311657|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311658|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101311659|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311660|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
101311661|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101311662|NCT00006786|Leucovorin|leucovorin|mesh-list
101311663|NCT00006786|Bevacizumab|bevacizumab|mesh-list
101311664|NCT00006786|Fluorouracil|fluorouracil|mesh-list
101311665|NCT00006786|Irinotecan|irinotecan|mesh-list
101311666|NCT00006786|Calcium|calcium|mesh-list
101311667|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
101311668|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311671|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101311672|NCT00006786|Growth Substances|growth substances|mesh-ancestor
101548056|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311673|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311674|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
101311675|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101311676|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
101311677|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311678|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311679|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311680|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
101311681|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311682|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311684|NCT00006786|Antidotes|antidotes|mesh-ancestor
101311685|NCT00006786|Protective Agents|protective agents|mesh-ancestor
101311686|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
101311687|NCT00006786|Vitamins|vitamins|mesh-ancestor
101311688|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
101311689|NCT00006825|Doxorubicin|doxorubicin|mesh-list
101311690|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101311691|NCT00006825|Trastuzumab|trastuzumab|mesh-list
101311692|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311693|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311694|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101311695|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329257|NCT00026143|Interferons|interferons|mesh-list
101311696|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311697|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311698|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101311699|NCT00006864|Aldesleukin|aldesleukin|mesh-list
101311700|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311701|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311702|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311703|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
101311704|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311705|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
101311706|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311707|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101311708|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
101311709|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311710|NCT00006981|Immunotoxins|immunotoxins|mesh-list
101311711|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
101311712|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
101311713|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311714|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
101311715|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311716|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311717|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101311718|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
101311719|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101311720|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311722|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311723|NCT00387556|Ondansetron|ondansetron|mesh-list
101311724|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
101311725|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
101311726|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311727|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311728|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311729|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
101311730|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101311731|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101311732|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101311733|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
101311734|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101311735|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311736|NCT03780790|Bupivacaine|bupivacaine|mesh-list
101311737|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
101311738|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
101311739|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101311740|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311741|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
101311742|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311743|NCT00388167|Caspofungin|caspofungin|mesh-list
101311744|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
101311745|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311746|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311747|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311748|NCT00006043|Temozolomide|temozolomide|mesh-list
101311749|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311750|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
101311751|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311752|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311754|NCT00006049|Carboplatin|carboplatin|mesh-list
101311755|NCT00006049|Gefitinib|gefitinib|mesh-list
101311756|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311757|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311758|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311759|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311760|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
101311761|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311762|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311763|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311764|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
101311765|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311766|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101311767|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311768|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311769|NCT00006055|Cyclosporine|cyclosporine|mesh-list
101311770|NCT00006055|Prednisone|prednisone|mesh-list
101311771|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
101311772|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
101311773|NCT00006055|Cyclosporins|cyclosporins|mesh-list
101311775|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311776|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
101311777|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311778|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311779|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101311780|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
101311781|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311784|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311787|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311788|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311789|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311790|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
101311791|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311792|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
101311793|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101311794|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
101311795|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
101311796|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311797|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311798|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101311799|NCT00006055|Protective Agents|protective agents|mesh-ancestor
101311800|NCT00006070|Etanercept|etanercept|mesh-list
101311801|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101311802|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101311804|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
101311805|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311806|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311807|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101311808|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311809|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101311810|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311811|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
101311812|NCT00006079|Eflornithine|eflornithine|mesh-list
101311813|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311814|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101311815|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101311816|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101311817|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311818|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101311819|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311820|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311821|NCT00006082|Rubitecan|rubitecan|mesh-list
101311822|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311823|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311824|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311825|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311826|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311827|NCT00006088|Vinorelbine|vinorelbine|mesh-list
101311828|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101311833|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311834|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
101311835|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311836|NCT00006094|Fluorouracil|fluorouracil|mesh-list
101311837|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
101311838|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
101311839|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311840|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311841|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311842|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311843|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
101311844|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311845|NCT00006100|Aldesleukin|aldesleukin|mesh-list
101311846|NCT00006100|Fludarabine|fludarabine|mesh-list
101311847|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
101311848|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311849|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311850|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
101311851|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311852|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311853|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
101311854|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311855|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101311856|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101311857|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
101311858|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311860|NCT00006103|Fluorouracil|fluorouracil|mesh-list
101311861|NCT00006103|Irinotecan|irinotecan|mesh-list
101311862|NCT00006103|Calcium|calcium|mesh-list
101311863|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
101311864|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101311865|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311866|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
101311867|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311868|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311869|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311870|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311871|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
101311872|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311873|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311874|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311875|NCT00006103|Antidotes|antidotes|mesh-ancestor
101311876|NCT00006103|Protective Agents|protective agents|mesh-ancestor
101311877|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
101311878|NCT00006103|Vitamins|vitamins|mesh-ancestor
101311879|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
101311880|NCT00006106|Fluorouracil|fluorouracil|mesh-list
101311881|NCT00006106|Dl1520|dl1520|mesh-list
101311882|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311883|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
101311884|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311885|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311886|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311887|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
101311888|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311889|NCT00006112|Leucovorin|leucovorin|mesh-list
101311890|NCT00006112|Fluorouracil|fluorouracil|mesh-list
101311891|NCT00006112|Mitomycins|mitomycins|mesh-list
101311892|NCT00006112|Mitomycin|mitomycin|mesh-list
101311893|NCT00006112|Calcium|calcium|mesh-list
101311894|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
101311895|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101311896|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311897|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
101311898|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311899|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311900|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311901|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311902|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
101311904|NCT00006112|Protective Agents|protective agents|mesh-ancestor
101311905|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
101311906|NCT00006112|Vitamins|vitamins|mesh-ancestor
101311907|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
101311908|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101311910|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101311911|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311912|NCT00006115|Leucovorin|leucovorin|mesh-list
101311913|NCT00006115|Fluorouracil|fluorouracil|mesh-list
101311914|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
101311915|NCT00006115|Irinotecan|irinotecan|mesh-list
101311916|NCT00006115|Calcium|calcium|mesh-list
101311917|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
101311918|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101311919|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311920|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
101311921|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311922|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311923|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311924|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101311925|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
101311926|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101311927|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101311928|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311929|NCT00006115|Antidotes|antidotes|mesh-ancestor
101311930|NCT00006115|Protective Agents|protective agents|mesh-ancestor
101311931|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
101311932|NCT00006115|Vitamins|vitamins|mesh-ancestor
101311933|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
101311934|NCT00006118|Paclitaxel|paclitaxel|mesh-list
101311937|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311938|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101311939|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101311941|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311942|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101311943|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
101311944|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
101311945|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311946|NCT00006124|Celecoxib|celecoxib|mesh-list
101311947|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101311948|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101311949|NCT00006124|Analgesics|analgesics|mesh-ancestor
101311950|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
101311951|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101311952|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311954|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101311955|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101311956|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101311957|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101311958|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101311960|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101311961|NCT00006127|Protective Agents|protective agents|mesh-ancestor
101311962|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311963|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101311964|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101311965|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101311966|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101311967|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
101311968|NCT00006133|Norethindrone|norethindrone|mesh-list
101311969|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
101311970|NCT00006133|Estradiol|estradiol|mesh-list
101311971|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101311974|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101311975|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101311976|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101311977|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
101311978|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101311979|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101311980|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101311981|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101311982|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101311983|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101311984|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101311985|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311986|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
101311987|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
101311988|NCT00006136|Hematinics|hematinics|mesh-ancestor
101311989|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101311990|NCT00006145|Valganciclovir|valganciclovir|mesh-list
101311991|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
101311992|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101311993|NCT00006154|Ritonavir|ritonavir|mesh-list
101311994|NCT00006154|Indinavir|indinavir|mesh-list
101311995|NCT00006154|Aldesleukin|aldesleukin|mesh-list
101311996|NCT00006154|Abacavir|abacavir|mesh-list
101311997|NCT00006154|Didanosine|didanosine|mesh-list
101311998|NCT00006154|Stavudine|stavudine|mesh-list
101311999|NCT00006154|Efavirenz|efavirenz|mesh-list
101312000|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101312001|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101312002|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101312003|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312007|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
101312008|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312009|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101312010|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312012|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312013|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312014|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101312015|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101312016|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101312017|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101312018|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101312019|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
101312020|NCT00006157|Desipramine|desipramine|mesh-list
101412956|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
101312021|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101312022|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
101312023|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101312024|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312025|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312026|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101312027|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101312028|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312030|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312031|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548079|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548080|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
101312032|NCT00006190|Lamivudine|lamivudine|mesh-list
101312034|NCT00006190|Stavudine|stavudine|mesh-list
101312036|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312037|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312038|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312039|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312040|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
101312041|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312042|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101312043|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101312044|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101312045|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312046|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101312047|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101312048|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101312051|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101312052|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
101312056|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
101312057|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312058|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101312059|NCT00006199|Topotecan|topotecan|mesh-list
101312060|NCT00006199|Tipifarnib|tipifarnib|mesh-list
101312061|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101312062|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312063|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312064|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312065|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312066|NCT00006205|Topiramate|topiramate|mesh-list
101312067|NCT00006205|Ondansetron|ondansetron|mesh-list
101312069|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
101312070|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312071|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312072|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312073|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
101312074|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
101312075|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101312076|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101312077|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
101312078|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312079|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312080|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
101312081|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101312082|NCT00006208|Emtricitabine|emtricitabine|mesh-list
101312083|NCT00006208|Efavirenz|efavirenz|mesh-list
101312084|NCT00006208|Didanosine|didanosine|mesh-list
101312086|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
101312087|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312088|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312089|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312090|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312091|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312092|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101312093|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101312094|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101312095|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312096|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101312097|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101312098|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101312099|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101548100|NCT01169779|Metformin|metformin|mesh-list
101312100|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
101312101|NCT00006211|Nelfinavir|nelfinavir|mesh-list
101312102|NCT00006211|Capravirine|capravirine|mesh-list
101312103|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101312104|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101312105|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
101312106|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312107|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312108|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101312109|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101312110|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
101312111|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312112|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312113|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312114|NCT00006214|Flutamide|flutamide|mesh-list
101329288|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312120|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312121|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
101312122|NCT00006220|Tretinoin|tretinoin|mesh-list
101312123|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312124|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
101312125|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
101312126|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
101312127|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101312128|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
101312129|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312130|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101312131|NCT00006223|Protective Agents|protective agents|mesh-ancestor
101312132|NCT03761953|Oritavancin|oritavancin|mesh-list
101312133|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312134|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312135|NCT00006226|Thalidomide|thalidomide|mesh-list
101312136|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312137|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
101312138|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312139|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
101312140|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312141|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312142|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101312143|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101312145|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312146|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312147|NCT00006232|Dexamethasone|dexamethasone|mesh-list
101312148|NCT00006232|Doxorubicin|doxorubicin|mesh-list
101312149|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101312150|NCT00006232|Vincristine|vincristine|mesh-list
101312151|NCT00006232|Idarubicin|idarubicin|mesh-list
101312152|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312153|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
101312154|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
101312155|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312156|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312157|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312160|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312161|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312162|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312163|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101312164|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312165|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312166|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312167|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312168|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312174|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101312175|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312176|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101312177|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312178|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312179|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312180|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312181|NCT00006241|Lenograstim|lenograstim|mesh-list
101312182|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101312183|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
101312184|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312185|NCT00006247|Semaxinib|semaxinib|mesh-list
101312187|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101312188|NCT00006247|Growth Substances|growth substances|mesh-ancestor
101312189|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312190|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312191|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312192|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101312193|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312194|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312195|NCT00006250|Dexamethasone|dexamethasone|mesh-list
101312196|NCT00006250|Fludarabine|fludarabine|mesh-list
101312197|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
101312198|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
101312199|NCT00006250|Chlorambucil|chlorambucil|mesh-list
101312200|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312201|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
101312202|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
101312203|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312204|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312206|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
101312207|NCT00006250|Hormones|hormones|mesh-ancestor
101312208|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312209|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312210|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312211|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312212|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
101312213|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312214|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312215|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
101312219|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312220|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312221|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312223|NCT00006265|Cytarabine|cytarabine|mesh-list
101312224|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
101312225|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312226|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
101312227|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312228|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312229|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
101312230|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312231|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312233|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312234|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101312236|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
101312237|NCT00007527|Buprenorphine|buprenorphine|mesh-list
101312238|NCT00007527|Naloxone|naloxone|mesh-list
101312239|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101312240|NCT00007527|Narcotics|narcotics|mesh-ancestor
101312241|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312242|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312243|NCT00007527|Analgesics|analgesics|mesh-ancestor
101312244|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
101312245|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312246|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101312247|NCT00006280|Tobramycin|tobramycin|mesh-list
101312248|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312249|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312251|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101312252|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101312253|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312254|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312255|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312257|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312258|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101312259|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
101312260|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101312261|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101312262|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312263|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312265|NCT00007605|Sotalol|sotalol|mesh-list
101312266|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101312267|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
101312268|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101312269|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312270|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312271|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101312272|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101312273|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312274|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312278|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101312279|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101312280|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101312281|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312282|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312283|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
101312284|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
101312285|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312287|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101312288|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312289|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101312290|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312291|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312293|NCT03709888|Memantine|memantine|mesh-list
101312294|NCT03709888|Analgesics|analgesics|mesh-ancestor
101312295|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
101312296|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312297|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312298|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
101312299|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101312300|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312301|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312302|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101312303|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101312304|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101312305|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312306|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101312307|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101312308|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101312309|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
101312310|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312311|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101312312|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101312313|NCT00007683|Aspirin|aspirin|mesh-list
101312314|NCT00007683|Warfarin|warfarin|mesh-list
101312315|NCT00007683|Clopidogrel|clopidogrel|mesh-list
101416207|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101312316|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101312317|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101312318|NCT00007683|Analgesics|analgesics|mesh-ancestor
101312319|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
101312320|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312321|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312322|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312323|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312324|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101312325|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101312326|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312327|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101312328|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101312329|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312335|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312336|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
101312337|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101312338|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
101312339|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312341|NCT00006337|Istradefylline|istradefylline|mesh-list
101312342|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101312343|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101312344|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
101312345|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312346|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312347|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312348|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101312349|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101312350|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101312351|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
101312352|NCT00006340|Ganciclovir|ganciclovir|mesh-list
101312353|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101312354|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
101312355|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
101312356|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312357|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312358|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312359|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312361|NCT00006229|Paclitaxel|paclitaxel|mesh-list
101312363|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312364|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312365|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312366|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312367|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312368|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312369|NCT00006343|Interferons|interferons|mesh-list
101312370|NCT00006343|Cytarabine|cytarabine|mesh-list
101312371|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
101312372|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
101312373|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312374|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
101312375|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312376|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312377|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
101312378|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312379|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312380|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
101312381|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312382|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101312383|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312385|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312386|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312387|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312388|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312389|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312392|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101312394|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101312395|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101312396|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101312397|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312398|NCT00006349|Vitamin E|vitamin e|mesh-list
101312399|NCT00006349|Donepezil|donepezil|mesh-list
101312402|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312403|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101312404|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312405|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312406|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
101312407|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312408|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
101312409|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
101312410|NCT00006349|Protective Agents|protective agents|mesh-ancestor
101312411|NCT00006352|Antibodies|antibodies|mesh-list
101312412|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101312413|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
101312414|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
101312415|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312416|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101312418|NCT00007878|Fluorouracil|fluorouracil|mesh-list
101312419|NCT00007878|Bortezomib|bortezomib|mesh-list
101312420|NCT00007878|Calcium|calcium|mesh-list
101312421|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
101312422|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101312423|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312424|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
101312425|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312426|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312427|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312431|NCT00007878|Protective Agents|protective agents|mesh-ancestor
101312432|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
101312434|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
101312435|NCT00006355|NSC 366140|nsc 366140|mesh-list
101312436|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312437|NCT00006358|Thalidomide|thalidomide|mesh-list
101312438|NCT00006358|Temozolomide|temozolomide|mesh-list
101312439|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312440|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
101312441|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312442|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312443|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312444|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
101548199|NCT01099579|Ritonavir|ritonavir|mesh-list
101312445|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312446|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
101312447|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312448|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312449|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101312450|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101312451|NCT00006358|Growth Substances|growth substances|mesh-ancestor
101312452|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312454|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548234|NCT02878837|Midazolam|midazolam|mesh-list
101312455|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101312456|NCT00006361|Growth Substances|growth substances|mesh-ancestor
101312457|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312458|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312459|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312460|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101312461|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312462|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312463|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
101312464|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312466|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101312467|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312468|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312469|NCT00007917|Gemcitabine|gemcitabine|mesh-list
101312470|NCT00007917|Alvocidib|alvocidib|mesh-list
101312471|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312472|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
101312473|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312474|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312475|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
101312476|NCT00007917|Growth Substances|growth substances|mesh-ancestor
101312477|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312478|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101312479|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312480|NCT00006367|Cytarabine|cytarabine|mesh-list
101312481|NCT00006367|Busulfan|busulfan|mesh-list
101312482|NCT00006367|Idarubicin|idarubicin|mesh-list
101312483|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312484|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
101312486|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312488|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312489|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312490|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
101312491|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312492|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
101312493|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312494|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312496|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312497|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312498|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312500|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101312501|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312502|NCT00007956|Antibodies|antibodies|mesh-list
101312503|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101312504|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
101312505|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312506|NCT00006373|Etoposide|etoposide|mesh-list
101312508|NCT00006373|Ifosfamide|ifosfamide|mesh-list
101312509|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312510|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312511|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101548335|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
101548339|NCT04328480|Colchicine|colchicine|mesh-list
101312512|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312513|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312514|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312515|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101312516|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312517|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
101312518|NCT00006376|Tipifarnib|tipifarnib|mesh-list
101312519|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312520|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
101312521|NCT00006379|Fludarabine|fludarabine|mesh-list
101312522|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
101312523|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101312524|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312525|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
101312526|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312527|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312528|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312529|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
101312530|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312531|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312532|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312533|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312535|NCT00006385|Interferons|interferons|mesh-list
101312536|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
101312537|NCT00006385|Sargramostim|sargramostim|mesh-list
101312538|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
101312539|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312540|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
101312541|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548408|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101312542|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
101312543|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312544|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101312545|NCT00007995|Interferons|interferons|mesh-list
101312546|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
101312548|NCT00007995|Melphalan|melphalan|mesh-list
101312549|NCT00007995|Busulfan|busulfan|mesh-list
101548410|NCT00594542|Lidocaine|lidocaine|mesh-list
101312550|NCT00007995|Sargramostim|sargramostim|mesh-list
101312551|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312552|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
101312553|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312554|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312555|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312556|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
101312557|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312558|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312559|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312560|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
101312561|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312562|NCT00006388|Tamoxifen|tamoxifen|mesh-list
101312563|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101312564|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
101312565|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312566|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312567|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312568|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312569|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101312570|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101312571|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101548462|NCT00596804|Veltuzumab|veltuzumab|mesh-list
101312572|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
101312573|NCT00008034|Capecitabine|capecitabine|mesh-list
101312574|NCT00008034|Epirubicin|epirubicin|mesh-list
101312575|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312576|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
101312577|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312578|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312579|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312580|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
101312581|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312582|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312583|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312584|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312585|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
101312586|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101312587|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312588|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101548479|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101312589|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312591|NCT00006391|Topotecan|topotecan|mesh-list
101312592|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312593|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101312594|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312595|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312596|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312597|NCT00006394|Hormones|hormones|mesh-list
101312598|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312599|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312600|NCT00008073|Doxorubicin|doxorubicin|mesh-list
101312601|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101312602|NCT00008073|Octreotide|octreotide|mesh-list
101312603|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548522|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
101548523|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
101312604|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312605|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312606|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312607|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312608|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312609|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312610|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312611|NCT00006397|Ritonavir|ritonavir|mesh-list
101312612|NCT00006397|Indinavir|indinavir|mesh-list
101312613|NCT00006397|Didanosine|didanosine|mesh-list
101312614|NCT00006397|Stavudine|stavudine|mesh-list
101312615|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101312616|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101312618|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312619|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312621|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101548563|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
101312622|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
101312623|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312624|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101312625|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101312626|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
101312627|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312628|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312629|NCT00006412|Fenofibrate|fenofibrate|mesh-list
101312630|NCT00006412|Pravastatin|pravastatin|mesh-list
101312631|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101312632|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
101312633|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312634|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101548615|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312635|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101312636|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101312637|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312638|NCT00008112|Cisplatin|cisplatin|mesh-list
101312639|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312640|NCT00006427|Amitriptyline|amitriptyline|mesh-list
101312641|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101312642|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
101312643|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101312644|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101312645|NCT00006427|Analgesics|analgesics|mesh-ancestor
101312646|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
101312647|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312648|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312649|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101312650|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101312651|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312652|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312653|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
101312654|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312655|NCT00008151|Cyclosporine|cyclosporine|mesh-list
101312656|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
101312657|NCT00008151|Methotrexate|methotrexate|mesh-list
101312658|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
101312659|NCT00008151|Fludarabine|fludarabine|mesh-list
101312660|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
101312661|NCT00008151|Cyclosporins|cyclosporins|mesh-list
101312662|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101312663|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
101312664|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101312665|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312666|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312667|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
101312668|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312669|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312670|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101312671|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312672|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101312673|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312674|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
101312675|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312676|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312677|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
101312678|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312679|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101312682|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
101312683|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312684|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101312685|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
101312686|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
101312687|NCT00006448|Methadone|methadone|mesh-list
101312688|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101312689|NCT00006448|Narcotics|narcotics|mesh-ancestor
101416350|NCT03890952|Growth Substances|growth substances|mesh-ancestor
101312690|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312691|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312692|NCT00006448|Analgesics|analgesics|mesh-ancestor
101312693|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
101312694|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312695|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
101312696|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
101312698|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
101312699|NCT00008190|Melphalan|melphalan|mesh-list
101312701|NCT00008190|Etoposide|etoposide|mesh-list
101312702|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312703|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
101312704|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312705|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312706|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312707|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
101312708|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312709|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312710|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312711|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312712|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312713|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312714|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312715|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101312716|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101312717|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
101312718|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312719|NCT00006451|Cyclosporine|cyclosporine|mesh-list
101312720|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
101312721|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
101312722|NCT00006451|Methotrexate|methotrexate|mesh-list
101312723|NCT00006451|Cyclosporins|cyclosporins|mesh-list
101312724|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101312725|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312726|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
101312727|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312728|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312729|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312730|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
101548847|NCT00600639|Albuterol|albuterol|mesh-list
101312731|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312732|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312736|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101312737|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312738|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
101312739|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
101312740|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312741|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101312742|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312743|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
101312744|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312745|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101312746|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312748|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
101312749|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312750|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312751|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
101312752|NCT00006451|Hormones|hormones|mesh-ancestor
101416408|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312753|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312754|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101312755|NCT00006451|Protective Agents|protective agents|mesh-ancestor
101312756|NCT00006454|Paclitaxel|paclitaxel|mesh-list
101312757|NCT00006454|Carboplatin|carboplatin|mesh-list
101312758|NCT00006454|Topotecan|topotecan|mesh-list
101312759|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312760|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312761|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416410|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
101312762|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312763|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312764|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312765|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101312766|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312767|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312769|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
101312770|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312771|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312772|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
101312773|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312774|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329380|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
101312775|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312776|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312777|NCT00006457|Oltipraz|oltipraz|mesh-list
101312778|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
101312779|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312781|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101312782|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
101312785|NCT00006457|Protective Agents|protective agents|mesh-ancestor
101312786|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312787|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312788|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101312789|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312790|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312791|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312793|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
101312794|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312795|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312796|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
101312797|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312798|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312799|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312800|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312801|NCT00006463|Trabectedin|trabectedin|mesh-list
101312802|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312803|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
101312804|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312805|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312806|NCT00008307|Cyclosporine|cyclosporine|mesh-list
101312807|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
101312808|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
101312809|NCT00008307|Fludarabine|fludarabine|mesh-list
101416454|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416455|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312811|NCT00008307|Melphalan|melphalan|mesh-list
101312812|NCT00008307|Cyclosporins|cyclosporins|mesh-list
101312813|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101312814|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312815|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312816|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
101312817|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312818|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312819|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
101312820|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312821|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312822|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
101312823|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312824|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
101549088|NCT01322490|Molgramostim|molgramostim|mesh-list
101312825|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312826|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101312827|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101312828|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101312829|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
101312830|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101312831|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101312833|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
101312834|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312835|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312836|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
101312837|NCT00008307|Hormones|hormones|mesh-ancestor
101312838|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101312839|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101312840|NCT00008307|Protective Agents|protective agents|mesh-ancestor
101312841|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312842|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
101312843|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101312844|NCT00006469|Paclitaxel|paclitaxel|mesh-list
101312845|NCT00006469|Carboplatin|carboplatin|mesh-list
101312846|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312848|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312849|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312850|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312851|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312852|NCT00006472|Paclitaxel|paclitaxel|mesh-list
101312853|NCT00006472|Carboplatin|carboplatin|mesh-list
101312854|NCT00006472|Fluorouracil|fluorouracil|mesh-list
101549146|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
101549147|NCT01320722|Vitamin D|vitamin d|mesh-list
101549148|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
101549149|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
101549150|NCT01320722|Vitamins|vitamins|mesh-list
101549151|NCT01320722|Allopurinol|allopurinol|mesh-list
101549152|NCT01320722|Probenecid|probenecid|mesh-list
101549153|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
101549154|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312855|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312856|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312857|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312858|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312859|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312860|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312861|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
101312862|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101312863|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101312864|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
101312865|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312866|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
101312867|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312868|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101312869|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312870|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312872|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101312873|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101549186|NCT02890875|Heparin|heparin|mesh-list
101312874|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312875|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312876|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312877|NCT00006484|Paclitaxel|paclitaxel|mesh-list
101312878|NCT00006484|Carboplatin|carboplatin|mesh-list
101312879|NCT00006484|Tirapazamine|tirapazamine|mesh-list
101312880|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312881|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312882|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312884|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312885|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312886|NCT00006487|Etoposide|etoposide|mesh-list
101312887|NCT00006487|Tirapazamine|tirapazamine|mesh-list
101312888|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312889|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312890|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101312891|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101312892|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312893|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312894|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
101549242|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101312896|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312897|NCT00008463|Interferons|interferons|mesh-list
101312898|NCT00008463|Ribavirin|ribavirin|mesh-list
101312899|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
101312900|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
101312901|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101312902|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312903|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
101312904|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101312905|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
101312906|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329387|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
101312907|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
101312908|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312909|NCT00006508|Insulin|insulin|mesh-list
101312910|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101312911|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312912|NCT00006682|Docetaxel|docetaxel|mesh-list
101312913|NCT00006682|Vinorelbine|vinorelbine|mesh-list
101312914|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312915|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312916|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312917|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312918|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312919|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312920|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
101312921|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312922|NCT00006760|Vinorelbine|vinorelbine|mesh-list
101312923|NCT00006760|Ifosfamide|ifosfamide|mesh-list
101312924|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101312925|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312926|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
101312927|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
101312928|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
101312930|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312931|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
101312932|NCT00008736|Metoclopramide|metoclopramide|mesh-list
101312933|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
101312934|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
101312935|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312936|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312937|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312938|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101312939|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101312940|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
101312941|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101312942|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312943|NCT00006799|Megestrol|megestrol|mesh-list
101312944|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
101312945|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101312946|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101312947|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101312948|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
101312949|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101312950|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312951|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101312952|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101312953|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101312954|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312955|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
101312956|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101312957|NCT00006877|Temozolomide|temozolomide|mesh-list
101312958|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101312959|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
101319353|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101549384|NCT01075321|Growth Substances|growth substances|mesh-ancestor
101312960|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312961|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101312962|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
101312963|NCT00007033|Analgesics|analgesics|mesh-ancestor
101312964|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
101329400|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
101312965|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101312966|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101312968|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312969|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101312970|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
101312971|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101312972|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101312973|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312974|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549431|NCT00626665|Tadalafil|tadalafil|mesh-list
101312976|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101312977|NCT00388401|Alvimopan|alvimopan|mesh-list
101312978|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101312979|NCT00007189|Celecoxib|celecoxib|mesh-list
101312980|NCT00007189|Naproxen|naproxen|mesh-list
101312981|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101312982|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101312988|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101312989|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101312990|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101312991|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101312992|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101312993|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
101312995|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101312996|NCT00388219|Narcotics|narcotics|mesh-ancestor
101312997|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101312998|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313000|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
101313001|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313002|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101313004|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313005|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
101313006|NCT00388336|Hematinics|hematinics|mesh-ancestor
101313007|NCT00007306|Hormones|hormones|mesh-list
101313008|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
101313009|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412995|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101313010|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313011|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313012|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
101313013|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101313014|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
101549528|NCT01303172|Gemcitabine|gemcitabine|mesh-list
101313015|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313016|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101313018|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
101313019|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313020|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
101313021|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101313022|NCT00007423|Protective Agents|protective agents|mesh-ancestor
101313023|NCT00007735|Doxycycline|doxycycline|mesh-list
101313024|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101313025|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313026|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
101313027|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101313028|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101313029|NCT00007774|Haloperidol|haloperidol|mesh-list
101313030|NCT00007774|Olanzapine|olanzapine|mesh-list
101313031|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
101313032|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
101313033|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
101313034|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313035|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313036|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313037|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101313038|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101313039|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313040|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313041|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101549574|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
101313042|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313043|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313045|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313046|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
101313047|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101313048|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
101313049|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101313050|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
101313051|NCT00007813|Carboplatin|carboplatin|mesh-list
101313052|NCT00007813|Etoposide|etoposide|mesh-list
101313053|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313054|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
101313055|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313056|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313057|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101313058|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
101313059|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313060|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313061|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101549615|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549616|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313062|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101313063|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101313064|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101313065|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313066|NCT00007852|Cytarabine|cytarabine|mesh-list
101313067|NCT00007852|Rituximab|rituximab|mesh-list
101313068|NCT00007852|Etoposide|etoposide|mesh-list
101313069|NCT00007852|Melphalan|melphalan|mesh-list
101313070|NCT00007852|Carmustine|carmustine|mesh-list
101313071|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101313072|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313073|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
101313074|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313075|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313076|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101313077|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101549658|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
101313078|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101313079|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313080|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313081|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329437|NCT00000461|Niacin|niacin|mesh-list
101313082|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
101313083|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
101313084|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313085|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313086|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101313087|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
101313088|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101313089|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101313091|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
101313092|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101549659|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
101313093|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
101313094|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313095|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313096|NCT00007969|Verteporfin|verteporfin|mesh-list
101313097|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
101313098|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101313099|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
101313100|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101313101|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
101313102|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313105|NCT00008008|Sargramostim|sargramostim|mesh-list
101313106|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313107|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
101313108|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313110|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101313112|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313113|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313114|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101313116|NCT00008047|Fluorouracil|fluorouracil|mesh-list
101313117|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
101313118|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101313119|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313120|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
101313121|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
101313122|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
101313123|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313124|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
101313125|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101313126|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313127|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
101313128|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313129|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
101313130|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313131|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313132|NCT00008086|Calcitriol|calcitriol|mesh-list
101313134|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528353|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313135|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313136|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313137|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101313138|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313139|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313140|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101313141|NCT00008086|Vitamins|vitamins|mesh-ancestor
101313142|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
101313144|NCT00008125|Carboplatin|carboplatin|mesh-list
101313145|NCT00008125|Gemcitabine|gemcitabine|mesh-list
101313146|NCT00008125|Docetaxel|docetaxel|mesh-list
101313147|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313148|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101313149|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
101313150|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313151|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
101313152|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549792|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
101313153|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
101313154|NCT00008203|Interferons|interferons|mesh-list
101313156|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
101313163|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
101313164|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313165|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313166|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101313167|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
101313168|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313169|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313170|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101313171|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
101313172|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313173|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313174|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
101549846|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
101549852|NCT01102426|Hormones|hormones|mesh-ancestor
101313175|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
101313176|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101313177|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313178|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313179|NCT00008242|Thalidomide|thalidomide|mesh-list
101313180|NCT00008242|Dexamethasone|dexamethasone|mesh-list
101313181|NCT00008242|Doxorubicin|doxorubicin|mesh-list
101313182|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101313183|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313184|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
101313185|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
101313186|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313187|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549911|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313188|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313189|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
101313190|NCT00008242|Hormones|hormones|mesh-ancestor
101313191|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313192|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313193|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313194|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101313195|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101313196|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101313197|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313198|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313199|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313200|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
101313201|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
101313202|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101313203|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313204|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101313205|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101313206|NCT00008242|Growth Substances|growth substances|mesh-ancestor
101313207|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
101313208|NCT00008281|Leucovorin|leucovorin|mesh-list
101313209|NCT00008281|Fluorouracil|fluorouracil|mesh-list
101313210|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
101313211|NCT00008281|Calcium|calcium|mesh-list
101313212|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
101313213|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313214|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313215|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
101313216|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313217|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101313218|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313219|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101313220|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
101313221|NCT00008281|Antidotes|antidotes|mesh-ancestor
101416617|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
101416618|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313222|NCT00008281|Protective Agents|protective agents|mesh-ancestor
101313223|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
101313224|NCT00008281|Vitamins|vitamins|mesh-ancestor
101313225|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
101313226|NCT00008359|Amphotericin B|amphotericin b|mesh-list
101313227|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101313228|NCT00008359|Caspofungin|caspofungin|mesh-list
101313229|NCT00008359|Amebicides|amebicides|mesh-ancestor
101313230|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101313232|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313233|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101313235|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313236|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313238|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
101313239|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416623|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313240|NCT00008476|Capsaicin|capsaicin|mesh-list
101313241|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
101313242|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
101313243|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
101313244|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313245|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313246|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101313247|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313248|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
101313250|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313251|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313253|NCT00008554|Abacavir|abacavir|mesh-list
101313254|NCT00008554|Nelfinavir|nelfinavir|mesh-list
101313256|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313257|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313258|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313259|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313260|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
101313261|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313262|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313263|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313265|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101313266|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
101313267|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
101313268|NCT05636566|Propofol|propofol|mesh-list
101313269|NCT05636566|Sevoflurane|sevoflurane|mesh-list
101313270|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101313271|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313272|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313273|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101550196|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
101313274|NCT05636566|Analgesics|analgesics|mesh-ancestor
101313275|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
101313276|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313277|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101313278|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101313279|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101313280|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313281|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313282|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313284|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
101313285|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
101313286|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101313287|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101313288|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101313289|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101313290|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313292|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101313293|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
101313296|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101313298|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101313299|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101313300|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
101313301|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313302|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313303|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313304|NCT05637268|Paclitaxel|paclitaxel|mesh-list
101313305|NCT05637268|Cisplatin|cisplatin|mesh-list
101313306|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101313307|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313308|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
101313309|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
101313310|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
101313311|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313312|NCT05637216|Losartan|losartan|mesh-list
101313313|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313314|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313315|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101313316|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101313317|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313318|NCT05638087|Dexamethasone|dexamethasone|mesh-list
101313319|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313320|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
101313321|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
101313322|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313323|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313324|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313325|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
101313326|NCT05638087|Hormones|hormones|mesh-ancestor
101416698|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
101416699|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101416700|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416702|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
101416703|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101313327|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313329|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313330|NCT05638633|Vitamins|vitamins|mesh-list
101313331|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
101313332|NCT05638633|Prednisolone|prednisolone|mesh-list
101313333|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101313334|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
101313335|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101313336|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
101313337|NCT05638633|Corticosterone|corticosterone|mesh-list
101313338|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101313339|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
101313340|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
101313341|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313342|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313343|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
101313344|NCT05638633|Hormones|hormones|mesh-ancestor
101313345|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313346|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313347|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313348|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
101313349|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
101313350|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313351|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313352|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101313353|NCT05638633|Protective Agents|protective agents|mesh-ancestor
101313354|NCT05638984|Decitabine|decitabine|mesh-list
101313357|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313358|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313359|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313360|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
101313361|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101313362|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101313363|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
101313364|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313365|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101313366|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
101313367|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313368|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101313370|NCT05639257|Lamotrigine|lamotrigine|mesh-list
101313371|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
101313372|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101313373|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313374|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313375|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313376|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313377|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101313378|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101313379|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313380|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313381|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101313382|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313383|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101313385|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
101313386|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101313387|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313388|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313389|NCT00000115|Diuretics|diuretics|mesh-ancestor
101313390|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
101416751|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101416752|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
101416753|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313391|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313393|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101313398|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313399|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313400|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313401|NCT00000139|Acyclovir|acyclovir|mesh-list
101313402|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
101313403|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313404|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101313405|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101313406|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313407|NCT00000142|Cidofovir|cidofovir|mesh-list
101313408|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
101313409|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313410|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313411|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313414|NCT00000145|Trace Elements|trace elements|mesh-ancestor
101313415|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
101313416|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313417|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313418|NCT00000145|Protective Agents|protective agents|mesh-ancestor
101313420|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101313421|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101313422|NCT00000151|Analgesics|analgesics|mesh-ancestor
101313423|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
101313424|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313425|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313426|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313427|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313428|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101313429|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101313430|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313431|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101313432|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101313433|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313434|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
101313436|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101313437|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101313438|NCT00000157|Analgesics|analgesics|mesh-ancestor
101313439|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
101313440|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313441|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313442|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313443|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313444|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101313445|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101313446|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313447|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101313448|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101313449|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313450|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
101313451|NCT00000172|Galantamine|galantamine|mesh-list
101313454|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313456|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313457|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313458|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101313459|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
101313460|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313461|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
101416806|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
101416807|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416810|NCT03117309|Nivolumab|nivolumab|mesh-list
101313462|NCT00000175|Testosterone|testosterone|mesh-list
101313463|NCT00000175|Estrogens|estrogens|mesh-list
101313464|NCT00000175|Androgens|androgens|mesh-ancestor
101313465|NCT00000175|Hormones|hormones|mesh-ancestor
101313466|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313467|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313468|NCT00000187|Ritanserin|ritanserin|mesh-list
101313469|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101313470|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
101313471|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313472|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313473|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313475|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101313476|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313477|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313478|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101313479|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101313480|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
101313481|NCT00000205|Buprenorphine|buprenorphine|mesh-list
101313482|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101313483|NCT00000205|Narcotics|narcotics|mesh-ancestor
101313484|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313485|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313486|NCT00000205|Analgesics|analgesics|mesh-ancestor
101313487|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
101313488|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313489|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101313490|NCT00000214|Buprenorphine|buprenorphine|mesh-list
101313491|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101313492|NCT00000214|Narcotics|narcotics|mesh-ancestor
101313493|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313494|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313495|NCT00000214|Analgesics|analgesics|mesh-ancestor
101313496|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
101416818|NCT00140166|Niacin|niacin|mesh-list
101313497|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313498|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101313499|NCT00000220|Buprenorphine|buprenorphine|mesh-list
101313500|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101313501|NCT00000220|Narcotics|narcotics|mesh-ancestor
101313502|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313503|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313504|NCT00000220|Analgesics|analgesics|mesh-ancestor
101313505|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
101313506|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313507|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101313508|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
101313509|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101313510|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
101313511|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
101313514|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101313515|NCT00000256|Analgesics|analgesics|mesh-ancestor
101313516|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
101313517|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313518|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
101313519|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101313520|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
101313521|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313522|NCT00000421|Prednisone|prednisone|mesh-list
101313523|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313524|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
101416834|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
101313526|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313527|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313528|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313529|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313530|NCT00000427|Alendronate|alendronate|mesh-list
101313531|NCT00000427|Hormones|hormones|mesh-list
101313532|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
101313533|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313534|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313535|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101313536|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313538|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101313539|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
101313540|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313541|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101313542|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313543|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313544|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313545|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
101313546|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313547|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313548|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101313549|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101313550|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313551|NCT00388479|Alvimopan|alvimopan|mesh-list
101313552|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101313553|NCT00000463|Warfarin|warfarin|mesh-list
101313554|NCT00000463|Lovastatin|lovastatin|mesh-list
101313555|NCT00000463|L 647318|l 647318|mesh-list
101313556|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
101313557|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
101313558|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
101313559|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101313560|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101313561|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
101313562|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313563|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101313564|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101313565|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313566|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101313567|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
101313568|NCT00000466|Progesterone|progesterone|mesh-list
101329476|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313569|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101313570|NCT00000466|Estrogens|estrogens|mesh-list
101313573|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416857|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
101313574|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313575|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101313576|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101313577|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101313578|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
101313579|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101313580|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101313582|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101313583|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313584|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313585|NCT00000472|Heparin|heparin|mesh-list
101313586|NCT00000472|Plasminogen|plasminogen|mesh-list
101313587|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101313588|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
101313589|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101313590|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101313591|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313593|NCT00000478|Diltiazem|diltiazem|mesh-list
101313594|NCT00000478|Nifedipine|nifedipine|mesh-list
101313595|NCT00000478|Isosorbide|isosorbide|mesh-list
101313596|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101313597|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101313598|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101313599|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313600|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313601|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313602|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313603|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313604|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
101313605|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101313606|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313607|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313608|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
101313609|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
101313610|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313611|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101313612|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101313613|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101313614|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313615|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313616|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101313617|NCT00000478|Diuretics|diuretics|mesh-ancestor
101313618|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
101313619|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101313620|NCT00388882|Bromides|bromides|mesh-list
101313621|NCT00388882|Albuterol|albuterol|mesh-list
101313622|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
101313623|NCT00388882|Ipratropium|ipratropium|mesh-list
101313624|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101313625|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
101313626|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313627|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313628|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101313629|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
101313630|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
101313631|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101313632|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
101313634|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313636|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
101313637|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101313638|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101313639|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101313640|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101313641|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313642|NCT00388999|Lectins|lectins|mesh-list
101313643|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
101313644|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
101313645|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313646|NCT00388999|Coagulants|coagulants|mesh-ancestor
101313647|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
101313648|NCT00000487|Diuretics|diuretics|mesh-list
101313649|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
101313650|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313651|NCT00000493|Propranolol|propranolol|mesh-list
101313652|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101313653|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101313654|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313655|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313656|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313657|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313658|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313659|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313660|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313661|NCT00000499|Metoprolol|metoprolol|mesh-list
101313662|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
101313663|NCT00000499|Hydralazine|hydralazine|mesh-list
101313664|NCT00000499|Reserpine|reserpine|mesh-list
101313665|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313666|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313667|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
101313668|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
101313669|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313670|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313671|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101313672|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101313673|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101313674|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313675|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313676|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313677|NCT00000499|Diuretics|diuretics|mesh-ancestor
101313678|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
101313679|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101313680|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313681|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313682|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101313683|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101313684|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313685|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313690|NCT00000514|Reserpine|reserpine|mesh-list
101313691|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313692|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313693|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
101313694|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
101313695|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313696|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313697|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101313698|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101313699|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101313700|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313701|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313702|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313703|NCT00000514|Diuretics|diuretics|mesh-ancestor
101313704|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
101313705|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101313706|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313707|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101313708|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101313709|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101313710|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313711|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101313712|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313713|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101313714|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313715|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101313716|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313717|NCT00000517|Warfarin|warfarin|mesh-list
101313718|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
101313719|NCT00000520|Aspirin|aspirin|mesh-list
101313720|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
101313721|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101313722|NCT00000520|Antibodies|antibodies|mesh-list
101313723|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
101313724|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101313725|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101313726|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101313727|NCT00000520|Analgesics|analgesics|mesh-ancestor
101313728|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
101313729|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313730|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313731|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101313732|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101313733|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101313734|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101313735|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313736|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101313737|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101313738|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313739|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
101313740|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
101313741|NCT00000526|Flecainide|flecainide|mesh-list
101313742|NCT00000526|Moricizine|moricizine|mesh-list
101313743|NCT00000526|Encainide|encainide|mesh-list
101313744|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313746|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101313747|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313748|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313750|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101313751|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
101313752|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313753|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313754|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313755|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313756|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101313757|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101313758|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101313760|NCT00000553|Simvastatin|simvastatin|mesh-list
101313761|NCT00000553|Antioxidants|antioxidants|mesh-list
101313762|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101313763|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101313764|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
101313765|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313766|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101313767|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101313768|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313769|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313770|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
101313772|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
101313773|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313774|NCT00000553|Protective Agents|protective agents|mesh-ancestor
101313775|NCT00000556|Quinidine|quinidine|mesh-list
101313776|NCT00000556|Digoxin|digoxin|mesh-list
101313777|NCT00000556|Amiodarone|amiodarone|mesh-list
101313779|NCT00000556|Sotalol|sotalol|mesh-list
101313780|NCT00000556|Flecainide|flecainide|mesh-list
101313781|NCT00000556|Propafenone|propafenone|mesh-list
101313782|NCT00000556|Procainamide|procainamide|mesh-list
101313783|NCT00000556|Moricizine|moricizine|mesh-list
101313785|NCT00000556|Diltiazem|diltiazem|mesh-list
101313786|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101313787|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
101313788|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101313789|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101313790|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416960|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
101313791|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313792|NCT00000556|Protective Agents|protective agents|mesh-ancestor
101313793|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313794|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313795|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101313796|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313797|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101313798|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101313799|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101313800|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101313801|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101313802|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101313803|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101313804|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101313805|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101313806|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101313807|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313808|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
101313809|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
101313810|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313811|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101313812|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101313813|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
101313814|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101313815|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101313816|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313817|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101313818|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101313819|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101313820|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101313821|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
101313822|NCT00000559|Hormones|hormones|mesh-list
101313823|NCT00000559|Estradiol|estradiol|mesh-list
101313824|NCT00000559|Estrogens|estrogens|mesh-list
101313825|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313826|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313827|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101313828|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
101313829|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101313830|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101537467|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
101313831|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101313832|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101313833|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101313834|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101313835|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101313836|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313837|NCT00000568|Ipratropium|ipratropium|mesh-list
101313838|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101313839|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
101313840|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313841|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313842|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101313843|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
101313844|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101313845|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
101313846|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313847|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313848|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
101313849|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101313850|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
101313851|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313852|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313853|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313854|NCT00000595|Deferoxamine|deferoxamine|mesh-list
101313855|NCT00000595|Siderophores|siderophores|mesh-ancestor
101313856|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101313857|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
101313858|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
101313859|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313860|NCT00000601|Hormones|hormones|mesh-list
101313861|NCT00000601|Progesterone|progesterone|mesh-list
101313862|NCT00000601|Estrogens|estrogens|mesh-list
101313863|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313864|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313865|NCT00000601|Progestins|progestins|mesh-ancestor
101313866|NCT00000625|Zidovudine|zidovudine|mesh-list
101313867|NCT00000625|Didanosine|didanosine|mesh-list
101313869|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
101313870|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313871|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313872|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313873|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313874|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
101313875|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313876|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313877|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313878|NCT00000637|Zidovudine|zidovudine|mesh-list
101313879|NCT00000637|Didanosine|didanosine|mesh-list
101313880|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
101313881|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313882|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313883|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313884|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313885|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
101313886|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313887|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313888|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313890|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
101313891|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
101313893|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101313894|NCT00000640|Primaquine|primaquine|mesh-list
101313895|NCT00000640|Trimethoprim|trimethoprim|mesh-list
101313900|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313901|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313902|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
101313903|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101313905|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101313906|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101313907|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101313908|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101313909|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101313910|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
101313911|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
101313912|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101313913|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313914|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313915|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101313916|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101313917|NCT00000646|Protective Agents|protective agents|mesh-ancestor
101313918|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329500|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313919|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
101313920|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101313921|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
101313922|NCT00389038|Amitriptyline|amitriptyline|mesh-list
101313923|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101313924|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
101313925|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101313926|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101313928|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
101313929|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101313930|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313931|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101313932|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101313933|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101313934|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313935|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
101313936|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101313938|NCT00000652|Didanosine|didanosine|mesh-list
101313939|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
101313940|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313941|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313942|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313943|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313944|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
101313945|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313946|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313947|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313948|NCT00000676|Fluconazole|fluconazole|mesh-list
101313949|NCT00000676|Clotrimazole|clotrimazole|mesh-list
101313950|NCT00000676|Miconazole|miconazole|mesh-list
101313951|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
101313954|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101313955|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313956|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313957|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101313958|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
101313959|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101313960|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101313961|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101313962|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101313963|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101313965|NCT00000679|Zidovudine|zidovudine|mesh-list
101313966|NCT00000679|Zalcitabine|zalcitabine|mesh-list
101313967|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
101313968|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313969|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313970|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313971|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313972|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
101313973|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313974|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313975|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313977|NCT00000682|Zalcitabine|zalcitabine|mesh-list
101313978|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
101313979|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313980|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313981|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313982|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313983|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
101313984|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313985|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101313986|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101313987|NCT00000688|Ganciclovir|ganciclovir|mesh-list
101313988|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101313989|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
101313990|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101313991|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101313992|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101313993|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313994|NCT00000712|Zidovudine|zidovudine|mesh-list
101313995|NCT00000712|Acyclovir|acyclovir|mesh-list
101313996|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
101313997|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101313998|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101313999|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314000|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314001|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
101314002|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314003|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314004|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314005|NCT00000715|Trimethoprim|trimethoprim|mesh-list
101314006|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101314007|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
101314008|NCT00000715|Pentamidine|pentamidine|mesh-list
101314009|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101314010|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314011|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
101314012|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314013|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314014|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314015|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314016|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314017|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101314018|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101314019|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314020|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
101314021|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101314022|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314023|NCT00000718|Zidovudine|zidovudine|mesh-list
101314024|NCT00000718|Zalcitabine|zalcitabine|mesh-list
101314025|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
101314026|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314027|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314028|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314029|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314030|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
101314031|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314032|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314035|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314036|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
101314037|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314038|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101417060|NCT00140790|Valsartan|valsartan|mesh-list
101314039|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314040|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314041|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314042|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
101314043|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314045|NCT00000742|Didanosine|didanosine|mesh-list
101314046|NCT00000742|Atevirdine|atevirdine|mesh-list
101314047|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
101314048|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314049|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314050|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314051|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314053|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314054|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314055|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314057|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
101314058|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314059|NCT00000748|Trimethoprim|trimethoprim|mesh-list
101314060|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101314061|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
101314062|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101314063|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314064|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
101314065|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314066|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314067|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314068|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314069|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314070|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101314071|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101314072|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314073|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314074|NCT00000751|Zidovudine|zidovudine|mesh-list
101314075|NCT00000751|Immune Sera|immune sera|mesh-list
101314076|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
101314077|NCT00000751|Antibodies|antibodies|mesh-list
101314078|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
101314079|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314080|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314081|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314083|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
101314084|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314085|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314086|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314087|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
101314088|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314090|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
101314091|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
101314092|NCT00000754|Zidovudine|zidovudine|mesh-list
101314093|NCT00000754|Zalcitabine|zalcitabine|mesh-list
101314094|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314095|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
101314096|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314097|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
101314098|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314099|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
101314100|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314101|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314102|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314103|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314104|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314105|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314107|NCT00000760|Didanosine|didanosine|mesh-list
101314108|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
101314109|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314110|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314113|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
101314114|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314115|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314116|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314118|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101314119|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
101314120|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314121|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
101314122|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314123|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314124|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101314125|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101314126|NCT00000790|Growth Substances|growth substances|mesh-ancestor
101314127|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101314128|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314130|NCT00000793|Amitriptyline|amitriptyline|mesh-list
101314131|NCT00000793|Benztropine|benztropine|mesh-list
101314132|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101314133|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
101314134|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101314135|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314136|NCT00000793|Analgesics|analgesics|mesh-ancestor
101314137|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
101314138|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314139|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314140|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101314141|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101314142|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101314143|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314145|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314146|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101314147|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101314148|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101314149|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101314150|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101314151|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
101314152|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
101314153|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101314154|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101314155|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
101314157|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
101314158|NCT00000799|Cidofovir|cidofovir|mesh-list
101314159|NCT00000799|Probenecid|probenecid|mesh-list
101314160|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
101314161|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
101314162|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101314168|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101314169|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
101314170|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101314171|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314172|NCT00000817|Analgesics|analgesics|mesh-ancestor
101314173|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
101314174|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314175|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314176|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101314177|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101314178|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101314179|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314180|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
101314181|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314182|NCT00000820|Aldesleukin|aldesleukin|mesh-list
101314183|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314184|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314185|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314186|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
101314187|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314189|NCT00000826|Dapsone|dapsone|mesh-list
101314190|NCT00000826|Rifabutin|rifabutin|mesh-list
101314191|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101314192|NCT00000826|Fluconazole|fluconazole|mesh-list
101314193|NCT00000826|Trimethoprim|trimethoprim|mesh-list
101314194|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
101314195|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314196|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314197|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101314198|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314199|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314200|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314201|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314202|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
101314203|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101314204|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101314205|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
101314206|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314207|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314208|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101314209|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101314210|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101314211|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
101314217|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
101314218|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101314219|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314220|NCT00000859|Ritonavir|ritonavir|mesh-list
101314221|NCT00000859|Nelfinavir|nelfinavir|mesh-list
101314222|NCT00000859|Indinavir|indinavir|mesh-list
101314223|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314224|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314225|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314226|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314227|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314228|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314229|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314230|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
101314231|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314232|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314233|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314234|NCT00000877|Indinavir|indinavir|mesh-list
101314235|NCT00000877|Rifabutin|rifabutin|mesh-list
101314236|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314237|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314239|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314240|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314242|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314243|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
101314244|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314245|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314246|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101314247|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314248|NCT00000883|Azithromycin|azithromycin|mesh-list
101314249|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314250|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314251|NCT00000892|Ritonavir|ritonavir|mesh-list
101314252|NCT00000892|Nelfinavir|nelfinavir|mesh-list
101314253|NCT00000892|Saquinavir|saquinavir|mesh-list
101314254|NCT00000892|Delavirdine|delavirdine|mesh-list
101314255|NCT00000892|Adefovir|adefovir|mesh-list
101314256|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101314258|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314259|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314260|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314261|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314262|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314263|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314264|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
101314265|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314266|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314267|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314268|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314269|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314270|NCT00000895|Azithromycin|azithromycin|mesh-list
101314271|NCT00000895|Nevirapine|nevirapine|mesh-list
101314272|NCT00000895|Nelfinavir|nelfinavir|mesh-list
101314273|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314274|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314275|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314276|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314278|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314279|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
101314280|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314281|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314282|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314283|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314284|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314285|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314286|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314287|NCT00000898|Ritonavir|ritonavir|mesh-list
101314288|NCT00000898|Nelfinavir|nelfinavir|mesh-list
101314289|NCT00000898|Saquinavir|saquinavir|mesh-list
101314290|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314291|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314292|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314293|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314294|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314295|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314296|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314297|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
101314298|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314299|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314300|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314301|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
101314302|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101314304|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314305|NCT00389233|Protective Agents|protective agents|mesh-ancestor
101314306|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314307|NCT00389233|Vitamins|vitamins|mesh-ancestor
101314308|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
101314309|NCT00389233|Laxatives|laxatives|mesh-ancestor
101314310|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101314311|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
101314312|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101314313|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
101314314|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314315|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101314316|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314317|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
101314318|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314319|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
101314320|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101314321|NCT00000904|Protective Agents|protective agents|mesh-ancestor
101314322|NCT00000919|Ritonavir|ritonavir|mesh-list
101314323|NCT00000919|Nelfinavir|nelfinavir|mesh-list
101314324|NCT00000919|Indinavir|indinavir|mesh-list
101314325|NCT00000919|Amprenavir|amprenavir|mesh-list
101314326|NCT00000919|Lamivudine|lamivudine|mesh-list
101314327|NCT00000919|Zidovudine|zidovudine|mesh-list
101314328|NCT00000919|Abacavir|abacavir|mesh-list
101314329|NCT00000919|Didanosine|didanosine|mesh-list
101314330|NCT00000919|Stavudine|stavudine|mesh-list
101314331|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101314332|NCT00000919|Efavirenz|efavirenz|mesh-list
101314333|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
101314334|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314335|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314336|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314337|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314338|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314340|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314341|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
101314342|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314343|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314344|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314345|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314346|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314347|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
101314348|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101314349|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101314350|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101314351|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314352|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314353|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314354|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
101314355|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101314356|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314357|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314358|NCT00000922|Lamivudine|lamivudine|mesh-list
101417132|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101314359|NCT00000922|Efavirenz|efavirenz|mesh-list
101314360|NCT00000922|Nevirapine|nevirapine|mesh-list
101314361|NCT00000922|Abacavir|abacavir|mesh-list
101314362|NCT00000922|Didanosine|didanosine|mesh-list
101314363|NCT00000922|Stavudine|stavudine|mesh-list
101314364|NCT00000922|Nelfinavir|nelfinavir|mesh-list
101314365|NCT00000922|Indinavir|indinavir|mesh-list
101314366|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314367|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314368|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314369|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314370|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
101314371|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314372|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314373|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314374|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101417138|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
101314375|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314376|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101314377|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101314378|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314379|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314380|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314381|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314382|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314383|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
101314385|NCT00000940|Amprenavir|amprenavir|mesh-list
101314386|NCT00000940|Lamivudine|lamivudine|mesh-list
101314387|NCT00000940|Abacavir|abacavir|mesh-list
101314388|NCT00000940|Stavudine|stavudine|mesh-list
101314389|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314390|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314391|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314392|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314393|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314394|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314395|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314396|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
101314397|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314398|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314399|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314400|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314401|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314402|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
101314403|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101314404|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314405|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314407|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
101314408|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314410|NCT00000952|Lamivudine|lamivudine|mesh-list
101314411|NCT00000952|Zidovudine|zidovudine|mesh-list
101314412|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314413|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314414|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314415|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314416|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314418|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314420|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314421|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314422|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314423|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314424|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314425|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
101314426|NCT00000643|Leucovorin|leucovorin|mesh-list
101314427|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
101314428|NCT00000643|Calcium|calcium|mesh-list
101314429|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
101314430|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101314431|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314432|NCT00000643|Antidotes|antidotes|mesh-ancestor
101314433|NCT00000643|Protective Agents|protective agents|mesh-ancestor
101314434|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
101314435|NCT00000643|Vitamins|vitamins|mesh-ancestor
101314436|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
101314437|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
101314438|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314439|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314440|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314441|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314442|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314443|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314444|NCT00000970|Ganciclovir|ganciclovir|mesh-list
101314445|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101314446|NCT00000970|Foscarnet|foscarnet|mesh-list
101314449|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314450|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314451|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314452|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314453|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314456|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
101314457|NCT00000973|Calcium|calcium|mesh-list
101314458|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
101314459|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101314460|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314461|NCT00000973|Antidotes|antidotes|mesh-ancestor
101314462|NCT00000973|Protective Agents|protective agents|mesh-ancestor
101314463|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
101314464|NCT00000973|Vitamins|vitamins|mesh-ancestor
101314465|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
101314466|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
101314467|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314468|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314469|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314470|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314471|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
101314472|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314473|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314474|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314476|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101314477|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314478|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101314479|NCT00000985|Acyclovir|acyclovir|mesh-list
101314480|NCT00000985|Foscarnet|foscarnet|mesh-list
101314481|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101314482|NCT00000985|Vidarabine|vidarabine|mesh-list
101314483|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
101314484|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314485|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314486|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314487|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314488|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314489|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
101314490|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101314491|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
101314492|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314494|NCT00001003|Pentamidine|pentamidine|mesh-list
101314495|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
101417176|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417177|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417178|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
101314496|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314498|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314499|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314500|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
101314501|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314502|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314503|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314504|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
101314506|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101314507|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101314508|NCT00001030|Clarithromycin|clarithromycin|mesh-list
101314509|NCT00001030|Rifabutin|rifabutin|mesh-list
101314510|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314512|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101314513|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314514|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314515|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101417181|NCT01154439|Etoposide|etoposide|mesh-list
101314516|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314517|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101314518|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314519|NCT05639127|Prednisolone|prednisolone|mesh-list
101314520|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101314521|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
101314522|NCT05639127|Hormones|hormones|mesh-ancestor
101314523|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314524|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314525|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101314526|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314527|NCT00001033|Pyridoxine|pyridoxine|mesh-list
101314528|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
101314529|NCT00001033|Levofloxacin|levofloxacin|mesh-list
101314530|NCT00001033|Rifampin|rifampin|mesh-list
101314531|NCT00001033|Isoniazid|isoniazid|mesh-list
101314532|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
101314533|NCT00001033|Ethambutol|ethambutol|mesh-list
101314534|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101314535|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314536|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314537|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101314538|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101314539|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314540|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314541|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314542|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101314543|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329553|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
101314545|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
101314546|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
101314547|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314548|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101314549|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314550|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101314551|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101314552|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101314553|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314554|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101314556|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
101314557|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101314558|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
101314559|NCT00001033|Vitamins|vitamins|mesh-ancestor
101314560|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
101314561|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314562|NCT00001036|Zidovudine|zidovudine|mesh-list
101314563|NCT00001036|Interleukin-2|interleukin-2|mesh-list
101314564|NCT00001036|Thymalfasin|thymalfasin|mesh-list
101314565|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314566|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314567|NCT00001036|Analgesics|analgesics|mesh-ancestor
101314568|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
101314569|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314573|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314574|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314575|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314576|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
101314577|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314578|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314579|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314580|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101314581|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
101314584|NCT00001045|Didanosine|didanosine|mesh-list
101314585|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
101314586|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314587|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314588|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314589|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314590|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
101314591|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314592|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314593|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314594|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314595|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314596|NCT00001048|Cytarabine|cytarabine|mesh-list
101314597|NCT00001048|Zidovudine|zidovudine|mesh-list
101314598|NCT00001048|Didanosine|didanosine|mesh-list
101314599|NCT00001048|Zalcitabine|zalcitabine|mesh-list
101314600|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101314601|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
101314602|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314603|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314605|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314606|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101314607|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
101314608|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314609|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314610|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314611|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314612|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314613|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314614|NCT00001066|Lamivudine|lamivudine|mesh-list
101314615|NCT00001066|Zidovudine|zidovudine|mesh-list
101314616|NCT00001066|Didanosine|didanosine|mesh-list
101314617|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314618|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314619|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314620|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314621|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
101314622|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314623|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314624|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314625|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
101314626|NCT00001075|Ritonavir|ritonavir|mesh-list
101314627|NCT00001075|Lamivudine|lamivudine|mesh-list
101314628|NCT00001075|Zidovudine|zidovudine|mesh-list
101314629|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314630|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314632|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314633|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314635|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314636|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
101314637|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314638|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314639|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314640|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314641|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314642|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
101314644|NCT00001084|Zidovudine|zidovudine|mesh-list
101314646|NCT00001084|Indinavir|indinavir|mesh-list
101314647|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314648|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314649|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314650|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314651|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
101314652|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314653|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314654|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314655|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
101314657|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314658|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314659|NCT00001087|Ritonavir|ritonavir|mesh-list
101314660|NCT00001087|Nelfinavir|nelfinavir|mesh-list
101314661|NCT00001087|Saquinavir|saquinavir|mesh-list
101314662|NCT00001087|Lamivudine|lamivudine|mesh-list
101314663|NCT00001087|Zidovudine|zidovudine|mesh-list
101314664|NCT00001087|Didanosine|didanosine|mesh-list
101314665|NCT00001087|Stavudine|stavudine|mesh-list
101314666|NCT00001087|Zalcitabine|zalcitabine|mesh-list
101314667|NCT00001087|Efavirenz|efavirenz|mesh-list
101314668|NCT00001087|Adefovir|adefovir|mesh-list
101314669|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101314670|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101314671|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101314672|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
101314673|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314674|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314675|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314676|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314677|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
101314678|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314679|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314680|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314681|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314682|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314683|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
101314684|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101314685|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101314686|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101314687|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314688|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314689|NCT00001105|Antibodies|antibodies|mesh-list
101314690|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101314691|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
101314693|NCT00001111|Zidovudine|zidovudine|mesh-list
101314694|NCT00001111|Nevirapine|nevirapine|mesh-list
101314695|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
101314696|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314697|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314698|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314699|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314700|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
101314701|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314702|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314703|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314704|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101314705|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101314706|NCT00001114|Interferons|interferons|mesh-list
101314707|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
101314708|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
101314709|NCT00001114|Didanosine|didanosine|mesh-list
101314710|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314711|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
101413059|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
101314712|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314713|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
101314714|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314715|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
101314716|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314717|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314718|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314719|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314720|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314721|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314722|NCT00001165|Doxorubicin|doxorubicin|mesh-list
101314723|NCT00001165|Streptozocin|streptozocin|mesh-list
101417269|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
101314725|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101314726|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314727|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101314728|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101314729|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314730|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314731|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
101314732|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101314733|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101314734|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
101314735|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314736|NCT00001180|Hormones|hormones|mesh-list
101314737|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101314738|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
101314739|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314740|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314741|NCT00389272|Acetaminophen|acetaminophen|mesh-list
101314742|NCT00389272|Ibuprofen|ibuprofen|mesh-list
101314743|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314744|NCT00389272|Analgesics|analgesics|mesh-ancestor
101314745|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
101314746|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314747|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314748|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
101314749|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101314750|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101314751|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101314752|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101314753|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314754|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314755|NCT00389311|Nonoxynol|nonoxynol|mesh-list
101314756|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101314757|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101329576|NCT00027664|Growth Substances|growth substances|mesh-ancestor
101314758|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314759|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101314760|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
101314761|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101314762|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101314764|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101314765|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314766|NCT00000114|Vitamins|vitamins|mesh-list
101314767|NCT00000114|Vitamin E|vitamin e|mesh-list
101314768|NCT00000114|Vitamin A|vitamin a|mesh-list
101314769|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
101314770|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314771|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
101314772|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314773|NCT00000114|Protective Agents|protective agents|mesh-ancestor
101314774|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
101314775|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101314776|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101314777|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
101314778|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314779|NCT00001267|Zidovudine|zidovudine|mesh-list
101314780|NCT00001267|Didanosine|didanosine|mesh-list
101314781|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
101314782|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314783|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101314784|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101314786|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
101314787|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314788|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101314789|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101314790|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
101314791|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101314792|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
101314793|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314794|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314795|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101314796|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
101314797|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101314798|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
101314799|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314800|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314801|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101314802|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
101314803|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
101314804|NCT00001303|Protective Agents|protective agents|mesh-ancestor
101314805|NCT00000120|Erythromycin|erythromycin|mesh-list
101314806|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
101314807|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101314808|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
101314809|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
101314810|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101314811|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314812|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101314813|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101314814|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314815|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314816|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101314817|NCT00001333|Topotecan|topotecan|mesh-list
101314818|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101314819|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101314820|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314821|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314822|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314823|NCT00001378|Fenretinide|fenretinide|mesh-list
101314824|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314825|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101314826|NCT00001378|Protective Agents|protective agents|mesh-ancestor
101314827|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314828|NCT00001387|Paclitaxel|paclitaxel|mesh-list
101314829|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101314830|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314831|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
101314832|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
101314833|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
101314834|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314835|NCT00388557|Ketoconazole|ketoconazole|mesh-list
101314836|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
101314837|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314838|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101314839|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314840|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314841|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314842|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101314844|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314846|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101314847|NCT00388635|Prednisone|prednisone|mesh-list
101314848|NCT00388635|Melphalan|melphalan|mesh-list
101314849|NCT00388635|Bortezomib|bortezomib|mesh-list
101314850|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101314851|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
101314852|NCT00388635|Hormones|hormones|mesh-ancestor
101314853|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314854|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314855|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101314856|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314857|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101314858|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
101314859|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314860|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101314861|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101314862|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
101314863|NCT00001474|Interleukin-2|interleukin-2|mesh-list
101314864|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314865|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314866|NCT00001474|Analgesics|analgesics|mesh-ancestor
101314867|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
101314868|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314869|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314870|NCT00001483|Sertraline|sertraline|mesh-list
101314871|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101314872|NCT00001483|Bupropion|bupropion|mesh-list
101314873|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
101314874|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101314875|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101314876|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101314877|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101314878|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314879|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314880|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
101417353|NCT00404391|Narcotics|narcotics|mesh-ancestor
101314881|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314882|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101314883|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101314884|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101314885|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
101314886|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101314887|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101314888|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314889|NCT00001495|Irinotecan|irinotecan|mesh-list
101314890|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101314891|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101314892|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314893|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314894|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314895|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101314896|NCT00001507|Antibodies|antibodies|mesh-list
101314897|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
101314898|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101314899|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
101314900|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314902|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
101314903|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314904|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
101314905|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314907|NCT00001576|Melphalan|melphalan|mesh-list
101314908|NCT00001576|Floxuridine|floxuridine|mesh-list
101314909|NCT00001576|Antidotes|antidotes|mesh-ancestor
101314910|NCT00001576|Protective Agents|protective agents|mesh-ancestor
101314911|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314912|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
101314913|NCT00001576|Vitamins|vitamins|mesh-ancestor
101314914|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
101314915|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101314916|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
101314917|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314918|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314919|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101314920|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101314921|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
101314922|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101314924|NCT00000147|Prednisone|prednisone|mesh-list
101314925|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
101314926|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101314927|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101314929|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
101314930|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101314931|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
101314932|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101314934|NCT00000147|Hormones|hormones|mesh-ancestor
101314935|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314936|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314937|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101314938|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314939|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
101314940|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
101314941|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314942|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101314943|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101314944|NCT00000147|Protective Agents|protective agents|mesh-ancestor
101314945|NCT00001624|Insulin|insulin|mesh-list
101314946|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101314948|NCT00001666|Methamphetamine|methamphetamine|mesh-list
101314949|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101314950|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314951|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
101314952|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
101314953|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314954|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
101314955|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101314956|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314957|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101314958|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101314959|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101314960|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101314963|NCT00001669|Growth Substances|growth substances|mesh-ancestor
101314964|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314966|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101314967|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101314968|NCT00001693|Analgesics|analgesics|mesh-ancestor
101314969|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
101314970|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101314971|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314972|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101314973|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101314974|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101314975|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101314976|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314977|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314978|NCT00001696|Genistein|genistein|mesh-list
101314979|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101314980|NCT00001696|Protective Agents|protective agents|mesh-ancestor
101314981|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101314982|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314983|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101314984|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101314985|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314987|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101314988|NCT00001696|Estrogens|estrogens|mesh-ancestor
101314989|NCT00001696|Hormones|hormones|mesh-ancestor
101314990|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101314991|NCT00389428|Cytarabine|cytarabine|mesh-list
101314992|NCT00389428|Daunorubicin|daunorubicin|mesh-list
101314993|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101314994|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
101314995|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101314996|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101314997|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
101314998|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101314999|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315000|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
101315001|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315002|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101315003|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101315004|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101315005|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315006|NCT00001720|Alendronate|alendronate|mesh-list
101315007|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101315008|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315009|NCT00001723|Orlistat|orlistat|mesh-list
101315010|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315011|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315012|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101315013|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101315014|NCT00001729|Ribavirin|ribavirin|mesh-list
101315015|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
101315016|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315017|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
101315021|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101315022|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101315023|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101315024|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315025|NCT00001777|Sertraline|sertraline|mesh-list
101315026|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315027|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315028|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101315029|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315030|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315031|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315032|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315033|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
101315034|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315035|NCT00000171|Melatonin|melatonin|mesh-list
101315036|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
101315037|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315038|NCT00000171|Protective Agents|protective agents|mesh-ancestor
101315039|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315040|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315041|NCT05641636|Hormones|hormones|mesh-list
101315042|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315043|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315044|NCT00000177|Estrogens|estrogens|mesh-list
101315045|NCT00000177|Hormones|hormones|mesh-ancestor
101315046|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315047|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315048|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
101315049|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101315050|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315051|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101315052|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315053|NCT00000216|Buprenorphine|buprenorphine|mesh-list
101315054|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101315055|NCT00000216|Narcotics|narcotics|mesh-ancestor
101315056|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315059|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
101315060|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315061|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101315063|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101315064|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
101315065|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
101315066|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315067|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315068|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315069|NCT00000252|Analgesics|analgesics|mesh-ancestor
101315070|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
101315071|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315072|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
101417468|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
101315073|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101315074|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315075|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315076|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101315077|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101315078|NCT05640817|Protective Agents|protective agents|mesh-ancestor
101315079|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315080|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315081|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101315082|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
101315083|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
101315084|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101315085|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
101417475|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315086|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
101315087|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315088|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315089|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315090|NCT00000255|Analgesics|analgesics|mesh-ancestor
101315091|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
101315092|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315093|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
101315094|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101315095|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
101315096|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
101315097|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315098|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315099|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315100|NCT00000258|Analgesics|analgesics|mesh-ancestor
101315101|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
101315102|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315103|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
101315104|NCT00389506|Fludarabine|fludarabine|mesh-list
101315105|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
101315106|NCT00389506|Immunotoxins|immunotoxins|mesh-list
101417482|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
101417483|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
101315107|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315108|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
101315109|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315110|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101315111|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101315112|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
101315113|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315116|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101315118|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
101315120|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101315121|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101315122|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315123|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315124|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315126|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101315127|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315128|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315129|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
101315130|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101315131|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315132|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315133|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315135|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
101315136|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315137|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101315138|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101315139|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101315140|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315141|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315142|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315143|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
101315144|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101315145|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
101315146|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315147|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315148|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315150|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315151|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315152|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315153|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315154|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
101315155|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101315156|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315157|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315158|NCT00000375|Nortriptyline|nortriptyline|mesh-list
101315159|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315162|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315163|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101315164|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101315165|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315166|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315167|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315168|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315169|NCT03295747|Peppermint oil|peppermint oil|mesh-list
101315170|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
101315171|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
101315172|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315173|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315174|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315175|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
101315177|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315178|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
101315179|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101315180|NCT03575208|Interferons|interferons|mesh-list
101315181|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
101315182|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
101315183|NCT03575208|Antibodies|antibodies|mesh-list
101315184|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
101315185|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101315186|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101315187|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315188|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
101315189|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315190|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
101315191|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315192|NCT03295552|Carboplatin|carboplatin|mesh-list
101315193|NCT03295552|Decitabine|decitabine|mesh-list
101315194|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315195|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101315196|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
101315197|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315198|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315199|NCT05629468|Azithromycin|azithromycin|mesh-list
101315200|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101315201|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101315202|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315203|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
101315204|NCT00000378|Sertraline|sertraline|mesh-list
101315205|NCT00000378|Nortriptyline|nortriptyline|mesh-list
101315206|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315207|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315208|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101315209|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315210|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315211|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315212|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315213|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
101315214|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315215|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101315216|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101315217|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315218|NCT00000381|Fluoxetine|fluoxetine|mesh-list
101315219|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101315220|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315221|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315222|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315223|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315224|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
101315225|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315226|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101315227|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315228|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315229|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101315230|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315231|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315232|NCT05631925|Propofol|propofol|mesh-list
101315233|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101315234|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315237|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
101315238|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
101315239|NCT00389701|Dexamethasone|dexamethasone|mesh-list
101315240|NCT00389701|Bortezomib|bortezomib|mesh-list
101315241|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315242|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
101315243|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
101315244|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315245|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315246|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315247|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
101315248|NCT00389701|Hormones|hormones|mesh-ancestor
101315249|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315250|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101315251|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315252|NCT00000420|Norinyl|norinyl|mesh-list
101315253|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101315254|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101315255|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101315256|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
101315257|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101315258|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315259|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101315260|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101315261|NCT00000426|Calcium|calcium|mesh-list
101315262|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101315263|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315264|NCT05551858|Proglumide|proglumide|mesh-list
101315265|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101315266|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315267|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101315269|NCT00000456|Naltrexone|naltrexone|mesh-list
101315270|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101315271|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101315272|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315273|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
101315274|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315275|NCT05519683|Escitalopram|escitalopram|mesh-list
101315276|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101315277|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315278|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315279|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315280|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315282|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315284|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101315285|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315286|NCT05442268|Analgesics|analgesics|mesh-ancestor
101315287|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
101315288|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315289|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315290|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
101315291|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101315294|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315296|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315297|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315298|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
101315299|NCT05448820|Doxorubicin|doxorubicin|mesh-list
101315300|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101315301|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315302|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101315303|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101315304|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315305|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315306|NCT00000468|Plasminogen|plasminogen|mesh-list
101315307|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101315308|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101315309|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101315310|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315311|NCT02972476|Fluticasone|fluticasone|mesh-list
101315312|NCT02972476|Xhance|xhance|mesh-list
101315313|NCT02972476|Budesonide|budesonide|mesh-list
101315314|NCT02972476|Bromides|bromides|mesh-list
101315315|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
101315316|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101315317|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101315318|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315319|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101315320|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
101315323|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101315324|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
101315325|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
101315326|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101315327|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
101315329|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315330|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101315331|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101315332|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101315333|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315334|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315335|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315336|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
101315337|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
101315338|NCT05418868|Cabotegravir|cabotegravir|mesh-list
101315339|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101315340|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101315341|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315342|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315343|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315344|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315346|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315347|NCT02972320|Temozolomide|temozolomide|mesh-list
101315348|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101315349|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
101315350|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315351|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315352|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101315355|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
101315356|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101315357|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101315358|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315359|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315360|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315361|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315362|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
101315363|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315364|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315365|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315366|NCT03164980|Trabectedin|trabectedin|mesh-list
101315367|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101315368|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
101315369|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315370|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315372|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
101315373|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
101315374|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315375|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
101315376|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315377|NCT05305456|Protective Agents|protective agents|mesh-ancestor
101315378|NCT00388986|Glyburide|glyburide|mesh-list
101315379|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101315380|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315381|NCT05233696|Paclitaxel|paclitaxel|mesh-list
101315382|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101315383|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
101315384|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101315385|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315387|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101315388|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101315389|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315390|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101315391|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101315392|NCT05223673|Trifluridine|trifluridine|mesh-list
101315393|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
101315394|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315395|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
101315396|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315397|NCT00000492|Propranolol|propranolol|mesh-list
101315398|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101315399|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101315400|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315401|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315405|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101315406|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315407|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
101315409|NCT00000504|Moricizine|moricizine|mesh-list
101315410|NCT00000504|Encainide|encainide|mesh-list
101315411|NCT00000504|Imipramine|imipramine|mesh-list
101315412|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315413|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101315414|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101315415|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315416|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315417|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101315418|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315419|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315420|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101315421|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315422|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315423|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315424|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315426|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315427|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
101315428|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315429|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
101315431|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315432|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101315433|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101315434|NCT00389935|Growth Substances|growth substances|mesh-ancestor
101315435|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
101315436|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315437|NCT05116930|Atropine|atropine|mesh-list
101315438|NCT05116930|Neostigmine|neostigmine|mesh-list
101315439|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101315440|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315441|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101315442|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
101315443|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315444|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315445|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101315446|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101315447|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
101315448|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
101315449|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101315450|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101315451|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
101315452|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315453|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315454|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101315456|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101315457|NCT00423475|Goserelin|goserelin|mesh-list
101315458|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101315459|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315460|NCT00000516|Enalapril|enalapril|mesh-list
101315461|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101315462|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
101315467|NCT00000522|Amlodipine|amlodipine|mesh-list
101315469|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
101315470|NCT00000522|Doxazosin|doxazosin|mesh-list
101315471|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101315472|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101315473|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315474|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315475|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101315476|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315477|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315478|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101315479|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
101315480|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315481|NCT00000522|Diuretics|diuretics|mesh-ancestor
101315482|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
101315483|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101315484|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101315485|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101315486|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101315487|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
101315488|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315489|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315490|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
101315491|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
101315492|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315493|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101315494|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101315496|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101315497|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101315498|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315499|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101315500|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101315501|NCT03126799|Growth Substances|growth substances|mesh-ancestor
101315502|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315503|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
101315504|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101315505|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315506|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315507|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101315508|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
101315509|NCT00000525|Triamterene|triamterene|mesh-list
101315510|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101315511|NCT00000525|Diuretics|diuretics|mesh-ancestor
101315512|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
101315513|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315514|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101315515|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315517|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101315518|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101315519|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101315520|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101315521|NCT05020483|Coagulants|coagulants|mesh-ancestor
101315522|NCT00000531|Amiodarone|amiodarone|mesh-list
101315523|NCT00000531|Sotalol|sotalol|mesh-list
101315524|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315525|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315526|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101315527|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315528|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315529|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101315530|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101315531|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315532|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315533|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101315534|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101315535|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101315536|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101315539|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315540|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315543|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315544|NCT00000534|Calcium|calcium|mesh-list
101315545|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101315546|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315547|NCT04935814|Vasopressins|vasopressins|mesh-list
101315548|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
101315549|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
101315550|NCT04935814|Coagulants|coagulants|mesh-ancestor
101315551|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101315552|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101315553|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
101315554|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315555|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101315556|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101315557|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315558|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
101315559|NCT00000555|Vitamin E|vitamin e|mesh-list
101315560|NCT00000555|Hormones|hormones|mesh-list
101315561|NCT00000555|Progesterone|progesterone|mesh-list
101315562|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101315563|NCT00000555|Estrogens|estrogens|mesh-list
101315564|NCT00000555|Vitamins|vitamins|mesh-ancestor
101315565|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
101315566|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315567|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315569|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
101315570|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315571|NCT00000555|Protective Agents|protective agents|mesh-ancestor
101315573|NCT04888858|Bupivacaine|bupivacaine|mesh-list
101315574|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
101315575|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
101315576|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315577|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315578|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
101315579|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417627|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315580|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101315581|NCT04888858|Narcotics|narcotics|mesh-ancestor
101315582|NCT04888858|Analgesics|analgesics|mesh-ancestor
101315583|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101315584|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101315585|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
101315586|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101315587|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101315588|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101315589|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315590|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315591|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315592|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315593|NCT04870957|Analgesics|analgesics|mesh-ancestor
101315594|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
101315595|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315596|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315597|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315598|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
101417634|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315600|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101315601|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315602|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101315604|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101315605|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315606|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315607|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101315608|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101315609|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315610|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
101315612|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315613|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315614|NCT00000576|Beclomethasone|beclomethasone|mesh-list
101315615|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315616|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
101315617|NCT00000576|Hormones|hormones|mesh-ancestor
101315618|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315619|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315620|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101315621|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
101315623|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
101315624|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101315625|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101315626|NCT00000579|Prednisolone|prednisolone|mesh-list
101315627|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
101315628|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101315629|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
101315631|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
101315632|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
101315633|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315634|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315635|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315636|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
101315637|NCT00000579|Hormones|hormones|mesh-ancestor
101315638|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315639|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101315640|NCT00000579|Protective Agents|protective agents|mesh-ancestor
101315641|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101315642|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315643|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
101315644|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315645|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101315646|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315647|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315648|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315649|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101315650|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
101315651|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101315652|NCT00000588|Pyridoxal|pyridoxal|mesh-list
101315653|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
101315660|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315661|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101315667|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
101315668|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101315669|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101315670|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
101315671|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315672|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101315673|NCT00390091|Abetimus|abetimus|mesh-list
101315674|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315675|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
101315676|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315677|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101315678|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
101315679|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315680|NCT04650880|Vitamin D|vitamin d|mesh-list
101315681|NCT04650880|Vitamins|vitamins|mesh-ancestor
101315682|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
101315683|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315684|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101315685|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
101315686|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101315687|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
101315688|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315689|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315690|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101315691|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
101315694|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315695|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315696|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101315697|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315698|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
101315699|NCT04601077|Protective Agents|protective agents|mesh-ancestor
101315700|NCT00000609|Amiodarone|amiodarone|mesh-list
101315701|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101315702|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
101315703|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101315704|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101315705|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315706|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101315707|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101315708|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315709|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315710|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101315711|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101315712|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101315714|NCT04547530|Vitamins|vitamins|mesh-ancestor
101315715|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
101315716|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315717|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101315718|NCT04544683|Dexamethasone|dexamethasone|mesh-list
101315719|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
101315720|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101315721|NCT04544683|BB 1101|bb 1101|mesh-list
101315722|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315723|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
101315724|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
101315725|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315726|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315727|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315728|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
101315729|NCT04544683|Hormones|hormones|mesh-ancestor
101315730|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315731|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101315732|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315734|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315735|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315736|NCT00000612|Estrogens|estrogens|mesh-list
101315737|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101315738|NCT00000612|Hormones|hormones|mesh-ancestor
101315739|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315740|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315741|NCT00000639|Itraconazole|itraconazole|mesh-list
101315742|NCT00000639|Fluconazole|fluconazole|mesh-list
101315743|NCT00000639|Amphotericin B|amphotericin b|mesh-list
101315744|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101315745|NCT00000639|Flucytosine|flucytosine|mesh-list
101315746|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
101315747|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315748|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101315750|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315751|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315752|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101417720|NCT00135122|Prednisolone|prednisolone|mesh-list
101315753|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
101315754|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315755|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315756|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101315757|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101315758|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101315760|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101315761|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101315762|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101315763|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
101315764|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
101315765|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
101315766|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315768|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
101315769|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101315770|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315772|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315773|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315774|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315775|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315776|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
101315777|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315778|NCT04495504|Ropivacaine|ropivacaine|mesh-list
101315779|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
101315780|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
101315781|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101315782|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315783|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
101315784|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315786|NCT00390208|Ranibizumab|ranibizumab|mesh-list
101417726|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
101417728|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
101315787|NCT00390208|Verteporfin|verteporfin|mesh-list
101315788|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315790|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
101315791|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315792|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315793|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101315794|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
101315795|NCT00390208|Hormones|hormones|mesh-ancestor
101315796|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315797|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101315798|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315799|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101315800|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101315801|NCT00390208|Growth Substances|growth substances|mesh-ancestor
101315802|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
101315803|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101315804|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
101315805|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101315806|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101315807|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101315808|NCT00389025|Analgesics|analgesics|mesh-ancestor
101315809|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
101315810|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101315811|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315812|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101315813|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101315815|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101315816|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101315817|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
101315818|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
101315819|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101315820|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315821|NCT00390247|Thalidomide|thalidomide|mesh-list
101315822|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101315823|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
101315824|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315825|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
101315826|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101315827|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315828|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101315831|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
101315832|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315833|NCT00000651|Zidovudine|zidovudine|mesh-list
101315834|NCT00000651|Zalcitabine|zalcitabine|mesh-list
101315835|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
101315836|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315837|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315838|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315839|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315840|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
101315841|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315842|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315843|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315844|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
101315845|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
101315846|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101315848|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315849|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101315850|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315851|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315852|NCT00000672|Didanosine|didanosine|mesh-list
101315853|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
101315854|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315855|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315856|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315857|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315858|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
101315859|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315860|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315861|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315862|NCT04321954|Lenvatinib|lenvatinib|mesh-list
101315863|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315864|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101315865|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315866|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315867|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
101315868|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
101315869|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315870|NCT00000678|Zidovudine|zidovudine|mesh-list
101315871|NCT00000678|Zalcitabine|zalcitabine|mesh-list
101315873|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315874|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315875|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315876|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315877|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
101315878|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315879|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315880|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315881|NCT00390403|Acetic Acid|acetic acid|mesh-list
101315882|NCT00390403|Temozolomide|temozolomide|mesh-list
101315883|NCT00390403|Retinol acetate|retinol acetate|mesh-list
101315884|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
101315885|NCT00390403|Gossypol|gossypol|mesh-list
101315887|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
101315888|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315889|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315890|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101315891|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315892|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101315893|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
101315894|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315895|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101315896|NCT00390403|Protective Agents|protective agents|mesh-ancestor
101315897|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101315898|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
101315899|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101315900|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101315901|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101315902|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101315903|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101315905|NCT00000681|Doxorubicin|doxorubicin|mesh-list
101315906|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101315907|NCT00000681|Bleomycin|bleomycin|mesh-list
101315908|NCT00000681|Vincristine|vincristine|mesh-list
101315909|NCT00000681|Sargramostim|sargramostim|mesh-list
101315910|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101315911|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315912|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101315913|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101315914|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315915|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315916|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101315918|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
101315919|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101315920|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
101315921|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315922|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315923|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
101315924|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315925|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315926|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315927|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
101315928|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315929|NCT00000684|Dextrans|dextrans|mesh-list
101315930|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
101315931|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
101315932|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
101315933|NCT00000687|Interferons|interferons|mesh-list
101315934|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
101315935|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
101315936|NCT00000687|Zidovudine|zidovudine|mesh-list
101315937|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315938|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
101315939|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315940|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
101315941|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315942|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
101315943|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315944|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315945|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315947|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315948|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315949|NCT00000690|Dextrans|dextrans|mesh-list
101315950|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
101315951|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
101315952|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
101315953|NCT00000696|Interferons|interferons|mesh-list
101315954|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
101315955|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
101315956|NCT00000696|Zidovudine|zidovudine|mesh-list
101315957|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101315958|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
101315959|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315960|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
101315961|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315962|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
101315963|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315964|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315965|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315966|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315967|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315968|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315969|NCT00000705|Zidovudine|zidovudine|mesh-list
101315970|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
101315971|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315972|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101315973|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101315974|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101315975|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
101315976|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315977|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101315978|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101315979|NCT00000708|Fluconazole|fluconazole|mesh-list
101315980|NCT00000708|Amphotericin B|amphotericin b|mesh-list
101315981|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101418020|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
101315982|NCT00000708|Flucytosine|flucytosine|mesh-list
101315983|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
101315984|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101315985|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101315986|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101315987|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329674|NCT00012051|Cytarabine|cytarabine|mesh-list
101315988|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101315990|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
101315991|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101315992|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101315993|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101315994|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101315996|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101315997|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101315998|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101315999|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
101418151|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101316000|NCT00000711|Zidovudine|zidovudine|mesh-list
101316001|NCT00000711|Sargramostim|sargramostim|mesh-list
101316002|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
101316003|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316004|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316005|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316006|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316007|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
101316008|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316009|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316011|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
101316012|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316013|NCT00000717|Clindamycin|clindamycin|mesh-list
101316014|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
101316015|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
101316016|NCT00000717|Primaquine|primaquine|mesh-list
101316017|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316018|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316019|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101316020|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316021|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316022|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
101316023|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101316024|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101316025|NCT00000720|Zidovudine|zidovudine|mesh-list
101316026|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
101316027|NCT00000720|Antibodies|antibodies|mesh-list
101316028|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
101316029|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316030|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316031|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316032|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316033|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
101316034|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316035|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316036|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316037|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
101316038|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316039|NCT04142983|Vaccines|vaccines|mesh-list
101316040|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
101316041|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316042|NCT00000726|Foscarnet|foscarnet|mesh-list
101316043|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101316044|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
101316045|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316046|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316047|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316048|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316049|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316050|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
101316051|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101316052|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101316053|NCT00000741|Prednisolone|prednisolone|mesh-list
101316054|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
101316055|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101316056|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
101316057|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316058|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
101316059|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
101419214|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316060|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316061|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316062|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316063|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
101316064|NCT00000741|Hormones|hormones|mesh-ancestor
101316065|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316067|NCT00000741|Protective Agents|protective agents|mesh-ancestor
101316068|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101316069|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316070|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
101316071|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101316072|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101316073|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101316074|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316075|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316076|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
101316077|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101316078|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316079|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101316080|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316081|NCT00000744|Fluconazole|fluconazole|mesh-list
101316082|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
101419904|NCT04511299|SMOFlipid|smoflipid|mesh-list
101316083|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316084|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101316085|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316086|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316087|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316088|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101316089|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316090|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316091|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316092|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101316093|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101316095|NCT04038346|Naproxen|naproxen|mesh-list
101316096|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101316097|NCT04038346|Analgesics|analgesics|mesh-ancestor
101316098|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
101316099|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420464|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
101316100|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316101|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
101316102|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101316103|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316104|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316105|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
101316106|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101316107|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316108|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316110|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101316111|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
101316112|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
101316113|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316114|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316115|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101316116|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101316117|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101316118|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
101316119|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101316120|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316121|NCT04020172|Protective Agents|protective agents|mesh-ancestor
101316122|NCT00000747|Nevirapine|nevirapine|mesh-list
101316123|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101329688|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
101316124|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316125|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316126|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316131|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101316132|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101316133|NCT00000753|Zidovudine|zidovudine|mesh-list
101316134|NCT00000753|Didanosine|didanosine|mesh-list
101316135|NCT00000753|Zalcitabine|zalcitabine|mesh-list
101316136|NCT00000753|Atevirdine|atevirdine|mesh-list
101316137|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
101316138|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316139|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316140|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316141|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316143|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316144|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316145|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316146|NCT03991741|Interleukin-2|interleukin-2|mesh-list
101316147|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316148|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101316149|NCT03991741|Analgesics|analgesics|mesh-ancestor
101316150|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
101316151|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316152|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316153|NCT00000768|Ganciclovir|ganciclovir|mesh-list
101316154|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101316155|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
101316156|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316157|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316158|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316159|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316160|NCT00000789|Zidovudine|zidovudine|mesh-list
101316161|NCT00000789|Stavudine|stavudine|mesh-list
101316162|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
101316163|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316164|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316165|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316166|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316167|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
101316168|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316169|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316170|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316171|NCT00000792|Hypericin|hypericin|mesh-list
101316172|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
101316173|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101316174|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316175|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
101316176|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316177|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316178|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316179|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316180|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
101316181|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316183|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101316184|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316185|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
101316186|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316187|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316188|NCT00390520|Vildagliptin|vildagliptin|mesh-list
101316189|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101316190|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316192|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316193|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316194|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316195|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
101316196|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101316197|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
101316198|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316200|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316201|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
101316202|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316204|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101316205|NCT00000813|Protective Agents|protective agents|mesh-ancestor
101316206|NCT03877549|Dexamethasone|dexamethasone|mesh-list
101316207|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316208|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
101316209|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
101316210|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316211|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316212|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316213|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
101316214|NCT03877549|Hormones|hormones|mesh-ancestor
101316215|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316216|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101316217|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316218|NCT00390598|Sennosides|sennosides|mesh-list
101316219|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101316220|NCT00390598|Laxatives|laxatives|mesh-ancestor
101316221|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316222|NCT00000816|Trimethoprim|trimethoprim|mesh-list
101316223|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101316224|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
101316225|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101316226|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316227|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
101316228|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101316229|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101316230|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101316231|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316232|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316233|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101316234|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101316235|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316236|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316237|NCT03801031|Lidocaine|lidocaine|mesh-list
101316238|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
101316239|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
101316240|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316244|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101316245|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101316246|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101316247|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316248|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316249|NCT00000822|Ritonavir|ritonavir|mesh-list
101316250|NCT00000822|Didanosine|didanosine|mesh-list
101316251|NCT00000822|Stavudine|stavudine|mesh-list
101316252|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316253|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101329700|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
101316254|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316255|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316256|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316257|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316258|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316259|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
101316260|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316261|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316262|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316263|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
101316264|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316265|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316266|NCT03797560|Pregabalin|pregabalin|mesh-list
101316267|NCT03797560|Analgesics|analgesics|mesh-ancestor
101316268|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
101316269|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316270|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316271|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
101316272|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101316273|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316274|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316275|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101316276|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101316278|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316279|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101316280|NCT03729271|Rifaximin|rifaximin|mesh-list
101316281|NCT03729271|Lactulose|lactulose|mesh-list
101316282|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316283|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316284|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316285|NCT03574402|Carboplatin|carboplatin|mesh-list
101316286|NCT03574402|Gemcitabine|gemcitabine|mesh-list
101316287|NCT03574402|Pemetrexed|pemetrexed|mesh-list
101316288|NCT03574402|Afatinib|afatinib|mesh-list
101316289|NCT03574402|Crizotinib|crizotinib|mesh-list
101316290|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
101316291|NCT03574402|Ensartinib|ensartinib|mesh-list
101316293|NCT03574402|Abivertinib|abivertinib|mesh-list
101316294|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316295|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316296|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
101316297|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316298|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316299|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101316300|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316301|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101316306|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101316307|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101316308|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316310|NCT00000831|Zidovudine|zidovudine|mesh-list
101316311|NCT00000831|Didanosine|didanosine|mesh-list
101316313|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316314|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316315|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316316|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316317|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
101316318|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316319|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316320|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316321|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
101316322|NCT00000849|Aldesleukin|aldesleukin|mesh-list
101316323|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316325|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316326|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
101316327|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316328|NCT03357952|Daratumumab|daratumumab|mesh-list
101316329|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316330|NCT00000855|Zidovudine|zidovudine|mesh-list
101316331|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
101316332|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316333|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316334|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316335|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316336|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
101316337|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316338|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316339|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316340|NCT00000867|Memantine|memantine|mesh-list
101316341|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101316342|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101316343|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
101316344|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101316345|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316346|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316347|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101316348|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101316351|NCT00390676|Capecitabine|capecitabine|mesh-list
101316352|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316353|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316354|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316355|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316356|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316357|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316358|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
101316360|NCT00000870|Zidovudine|zidovudine|mesh-list
101316361|NCT00000870|Didanosine|didanosine|mesh-list
101316362|NCT00000870|Stavudine|stavudine|mesh-list
101316363|NCT00000870|Aldesleukin|aldesleukin|mesh-list
101316364|NCT00000870|Indinavir|indinavir|mesh-list
101316365|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316366|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316367|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316368|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316370|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316371|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316372|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316373|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
101316374|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316375|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316376|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316377|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316378|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
101316379|NCT00390832|Hematinics|hematinics|mesh-ancestor
101316381|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
101316382|NCT00390871|Propofol|propofol|mesh-list
101316383|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101316384|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316385|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316386|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101316387|NCT00390871|Analgesics|analgesics|mesh-ancestor
101316388|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
101316389|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316390|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101316391|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101316392|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101316393|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
101316394|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101316395|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316396|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101316397|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
101316398|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
101316401|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101316402|NCT03211741|Bevacizumab|bevacizumab|mesh-list
101316403|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316404|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316405|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101316406|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101316407|NCT03211741|Growth Substances|growth substances|mesh-ancestor
101316408|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316409|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
101316410|NCT03206203|Carboplatin|carboplatin|mesh-list
101316411|NCT03206203|Atezolizumab|atezolizumab|mesh-list
101316412|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316413|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101316414|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316415|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316416|NCT00000882|Lamivudine|lamivudine|mesh-list
101316417|NCT00000882|Zidovudine|zidovudine|mesh-list
101316418|NCT00000882|Stavudine|stavudine|mesh-list
101316419|NCT00000882|Delavirdine|delavirdine|mesh-list
101316420|NCT00000882|Indinavir|indinavir|mesh-list
101316421|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316422|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316423|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316424|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316425|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
101316426|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316427|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316428|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316429|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
101316430|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316431|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316433|NCT00000888|Ritonavir|ritonavir|mesh-list
101316434|NCT00000888|Lamivudine|lamivudine|mesh-list
101316435|NCT00000888|Zidovudine|zidovudine|mesh-list
101316436|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316437|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316438|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316439|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316440|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316441|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316442|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316443|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
101316444|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316445|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316446|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316447|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316448|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316449|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
101316450|NCT00000891|Ritonavir|ritonavir|mesh-list
101316451|NCT00000891|Saquinavir|saquinavir|mesh-list
101316452|NCT00000891|Lamivudine|lamivudine|mesh-list
101316453|NCT00000891|Zidovudine|zidovudine|mesh-list
101316454|NCT00000891|Didanosine|didanosine|mesh-list
101316455|NCT00000891|Stavudine|stavudine|mesh-list
101316456|NCT00000891|Delavirdine|delavirdine|mesh-list
101316457|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316458|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316459|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316460|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316461|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316462|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316463|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316464|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
101329721|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316465|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316466|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316467|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316468|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316469|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316470|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
101316472|NCT00000903|Zidovudine|zidovudine|mesh-list
101316473|NCT00000903|Efavirenz|efavirenz|mesh-list
101316474|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101316475|NCT00000903|Nelfinavir|nelfinavir|mesh-list
101316476|NCT00000903|Indinavir|indinavir|mesh-list
101316477|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316478|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316479|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316480|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316481|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
101316482|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316483|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316484|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316485|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
101316486|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101316487|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316488|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101316489|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101316490|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101316491|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101316492|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316493|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316494|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316496|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101316497|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316498|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316499|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316500|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316501|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
101316502|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316503|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316504|NCT00000906|Ritonavir|ritonavir|mesh-list
101316505|NCT00000906|Saquinavir|saquinavir|mesh-list
101316506|NCT00000906|Methadone|methadone|mesh-list
101316507|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316508|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316509|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316510|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316511|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316512|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316513|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316514|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
101316515|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316516|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316517|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316521|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316522|NCT00000906|Analgesics|analgesics|mesh-ancestor
101316523|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
101316524|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316525|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
101316526|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
101316528|NCT02681302|Ipilimumab|ipilimumab|mesh-list
101316529|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316530|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316531|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101316532|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316533|NCT00000951|Fluconazole|fluconazole|mesh-list
101316534|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
101316535|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316536|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101329723|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316537|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316538|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316539|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316540|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101316541|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316542|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316543|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316544|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101316545|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101316547|NCT00000966|Azithromycin|azithromycin|mesh-list
101316548|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
101316549|NCT00000966|Calcium|calcium|mesh-list
101316550|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
101316551|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101316552|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316554|NCT00000966|Protective Agents|protective agents|mesh-ancestor
101316555|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
101316556|NCT00000966|Vitamins|vitamins|mesh-ancestor
101316557|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
101316558|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316559|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316560|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
101316561|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101316562|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101316563|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101316564|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316565|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316566|NCT00000969|Didanosine|didanosine|mesh-list
101316567|NCT00000969|Zalcitabine|zalcitabine|mesh-list
101316568|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
101316569|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316570|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316571|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316572|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316573|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
101316574|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316575|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316576|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316577|NCT00000975|Itraconazole|itraconazole|mesh-list
101420694|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
101316583|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316585|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316586|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316587|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316588|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316590|NCT00000978|Zalcitabine|zalcitabine|mesh-list
101316591|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
101316592|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316593|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316594|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316595|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316596|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
101316597|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316598|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316599|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316600|NCT00000999|Zidovudine|zidovudine|mesh-list
101316601|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
101316602|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316603|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316604|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316605|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316606|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
101316607|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316608|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316609|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316610|NCT00001002|Zidovudine|zidovudine|mesh-list
101316611|NCT00001002|Foscarnet|foscarnet|mesh-list
101316612|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101316613|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
101316615|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316616|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316617|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316618|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
101316619|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316620|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316621|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316622|NCT00005819|Paclitaxel|paclitaxel|mesh-list
101316626|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316627|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316628|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316629|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316630|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101316631|NCT00005819|Protective Agents|protective agents|mesh-ancestor
101316632|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316633|NCT00001005|Zidovudine|zidovudine|mesh-list
101316634|NCT00001005|Aldesleukin|aldesleukin|mesh-list
101316635|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
101316638|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316639|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316640|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
101316641|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316642|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316643|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316644|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316645|NCT00391105|Remifentanil|remifentanil|mesh-list
101316646|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101316647|NCT00391105|Narcotics|narcotics|mesh-ancestor
101316648|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316649|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316650|NCT00391105|Analgesics|analgesics|mesh-ancestor
101316651|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
101316652|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316653|NCT00391144|Triamcinolone|triamcinolone|mesh-list
101316654|NCT00391144|Bevacizumab|bevacizumab|mesh-list
101316655|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316656|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316657|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101316658|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101316659|NCT00391144|Growth Substances|growth substances|mesh-ancestor
101316660|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316661|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101316663|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
101316664|NCT00391144|Hormones|hormones|mesh-ancestor
101316665|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316666|NCT00005822|Tamoxifen|tamoxifen|mesh-list
101316667|NCT00005822|Doxorubicin|doxorubicin|mesh-list
101316668|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101316669|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101316670|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316672|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101316673|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316674|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316675|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101316676|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316677|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316678|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316679|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101316680|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101316681|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101316682|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101316683|NCT00391261|Metformin|metformin|mesh-list
101316684|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101316685|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316686|NCT00001008|Zidovudine|zidovudine|mesh-list
101316687|NCT00001008|Methadone|methadone|mesh-list
101316688|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
101316689|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316690|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316691|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316692|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316693|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
101316694|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316695|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316696|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316697|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101316698|NCT00001008|Narcotics|narcotics|mesh-ancestor
101316699|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101316700|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316701|NCT00001008|Analgesics|analgesics|mesh-ancestor
101316702|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
101316703|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316704|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
101316705|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
101316706|NCT00005825|Vinorelbine|vinorelbine|mesh-list
101316707|NCT00005825|Mitomycins|mitomycins|mesh-list
101316708|NCT00005825|Mitomycin|mitomycin|mesh-list
101316709|NCT00005825|Tretinoin|tretinoin|mesh-list
101316710|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316711|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316712|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316713|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316714|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316715|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316716|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101316717|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
101316718|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316719|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316720|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
101316721|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
101316722|NCT00001011|Zidovudine|zidovudine|mesh-list
101316723|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
101329738|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316726|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316727|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316728|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
101316729|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316730|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316731|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316732|NCT00001014|Leucovorin|leucovorin|mesh-list
101316733|NCT00001014|Trimethoprim|trimethoprim|mesh-list
101316734|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101316735|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
101316736|NCT00001014|Trimetrexate|trimetrexate|mesh-list
101316737|NCT00001014|Calcium|calcium|mesh-list
101316738|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
101316739|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101316740|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316741|NCT00001014|Antidotes|antidotes|mesh-ancestor
101316742|NCT00001014|Protective Agents|protective agents|mesh-ancestor
101316743|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
101316744|NCT00001014|Vitamins|vitamins|mesh-ancestor
101316745|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
101316746|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101316747|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316748|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
101316749|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101316751|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101316752|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316753|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316754|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101316755|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101316756|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316757|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316758|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
101316759|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316760|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
101316761|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316762|NCT00005831|Paclitaxel|paclitaxel|mesh-list
101316763|NCT00005831|Carboplatin|carboplatin|mesh-list
101316764|NCT00005831|Gemcitabine|gemcitabine|mesh-list
101316765|NCT00005831|Trastuzumab|trastuzumab|mesh-list
101316766|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316767|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316768|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316769|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316770|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316771|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246712|NCT01667718|Antacids|antacids|mesh-ancestor
101316772|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101316773|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
101316774|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101316775|NCT00005834|Thalidomide|thalidomide|mesh-list
101316776|NCT00005834|Dexamethasone|dexamethasone|mesh-list
101316777|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
101316778|NCT00005834|Etoposide|etoposide|mesh-list
101316779|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316780|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
101316781|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316782|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101316783|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101316784|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
101316785|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316786|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316787|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101316788|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316790|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
101316792|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316794|NCT00005834|Hormones|hormones|mesh-ancestor
101316795|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316796|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101316797|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316798|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101316799|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101316800|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316801|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
101316802|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101316803|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316804|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101316805|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101316806|NCT00005834|Growth Substances|growth substances|mesh-ancestor
101316807|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
101316808|NCT00001029|Zidovudine|zidovudine|mesh-list
101316809|NCT00001029|Didanosine|didanosine|mesh-list
101316810|NCT00001029|Zalcitabine|zalcitabine|mesh-list
101316811|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
101316812|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316813|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316814|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316815|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316816|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
101316817|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316818|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316819|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316820|NCT00001032|Zidovudine|zidovudine|mesh-list
101316821|NCT00001032|Zalcitabine|zalcitabine|mesh-list
101316822|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
101316823|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316824|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316825|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316826|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316827|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
101316828|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316829|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316830|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316831|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
101316832|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316833|NCT00001038|Valacyclovir|valacyclovir|mesh-list
101316834|NCT00001038|Acyclovir|acyclovir|mesh-list
101316835|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
101316836|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316838|NCT00005840|Cisplatin|cisplatin|mesh-list
101316839|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316840|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316841|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316842|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316843|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316844|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316846|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316847|NCT00005849|Paclitaxel|paclitaxel|mesh-list
101316848|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
101316849|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101316850|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316851|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
101316852|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
101316853|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
101316854|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316855|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101316856|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
101316857|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316858|NCT00001047|Clarithromycin|clarithromycin|mesh-list
101316859|NCT00001047|Ethambutol|ethambutol|mesh-list
101316860|NCT00001047|Rifabutin|rifabutin|mesh-list
101316861|NCT00001047|Clofazimine|clofazimine|mesh-list
101316862|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329765|NCT00012090|Goserelin|goserelin|mesh-list
101316863|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316864|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101316865|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316866|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246920|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316867|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316868|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316869|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
101316870|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101316871|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316872|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
101316873|NCT00005852|Cyclosporine|cyclosporine|mesh-list
101316874|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
101316875|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
101316876|NCT00005852|Cyclosporins|cyclosporins|mesh-list
101316877|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101316878|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
101316879|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316880|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
101316881|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316882|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246969|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316883|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101316884|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
101316885|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316886|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316887|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101316888|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316889|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
101316890|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316891|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101316892|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101316893|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101316894|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
101316895|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
101316896|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101316897|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101316898|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
101316899|NCT00005852|Hormones|hormones|mesh-ancestor
101528354|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101316900|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101316901|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101316902|NCT00005852|Protective Agents|protective agents|mesh-ancestor
101316903|NCT00001071|Lenograstim|lenograstim|mesh-list
101316904|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101316905|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
101316906|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316907|NCT00005855|Carmustine|carmustine|mesh-list
101316908|NCT00005855|Efaproxiral|efaproxiral|mesh-list
101316909|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101316910|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
101316911|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316912|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316913|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
101316914|NCT00001074|Didanosine|didanosine|mesh-list
101316915|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
101316916|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316917|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
101316918|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316919|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316920|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316921|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
101316922|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316923|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
101316924|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316925|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316926|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316927|NCT00005858|Immunotoxins|immunotoxins|mesh-list
101316928|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
101316929|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
101329770|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
101316930|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316931|NCT00005861|Doxorubicin|doxorubicin|mesh-list
101316932|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101316933|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101316934|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316935|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101316936|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101316937|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316938|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316941|NCT00001083|Lamivudine|lamivudine|mesh-list
101316942|NCT00001083|Zidovudine|zidovudine|mesh-list
101316943|NCT00001083|Nevirapine|nevirapine|mesh-list
101316944|NCT00001083|Stavudine|stavudine|mesh-list
101316945|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316946|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316947|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316948|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316949|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316950|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316951|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316952|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
101316953|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316954|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101316955|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316956|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316957|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316958|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
101316959|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101316960|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101316961|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
101316962|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101316963|NCT00001086|Efavirenz|efavirenz|mesh-list
101316964|NCT00001086|Abacavir|abacavir|mesh-list
101316965|NCT00001086|Indinavir|indinavir|mesh-list
101316966|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101316967|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101316968|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316969|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316970|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
101316972|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101247197|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
101316973|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101316974|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101316975|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101316976|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101316977|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101316978|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101316979|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101316980|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101316981|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101316982|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
101316984|NCT00700258|Sunitinib|sunitinib|mesh-list
101316985|NCT00700258|Temsirolimus|temsirolimus|mesh-list
101316986|NCT00700258|Axitinib|axitinib|mesh-list
101247254|NCT01679041|Fludarabine|fludarabine|mesh-list
101316987|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
101316988|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101316989|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101316990|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101316991|NCT00700258|Growth Substances|growth substances|mesh-ancestor
101316992|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101316993|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
101316994|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101316995|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101316996|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101316997|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101316999|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317000|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317001|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317002|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
101317003|NCT00001113|Interferons|interferons|mesh-list
101317004|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
101317005|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
101317007|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317008|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
101317009|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317010|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
101317011|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317013|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317014|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317015|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317016|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317017|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317018|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317019|NCT00005867|Prednisolone|prednisolone|mesh-list
101317020|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
101317021|NCT00005867|Doxorubicin|doxorubicin|mesh-list
101317022|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101317023|NCT00005867|Etoposide|etoposide|mesh-list
101317024|NCT00005867|Vincristine|vincristine|mesh-list
101317025|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
101317026|NCT00005867|Bleomycin|bleomycin|mesh-list
101317027|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317028|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
101317029|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317030|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247361|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
101317031|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317032|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
101317033|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317034|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317035|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317036|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317037|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317038|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317039|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317041|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317042|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317043|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317044|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317045|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
101317046|NCT00005867|Hormones|hormones|mesh-ancestor
101317047|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317048|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317049|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317050|NCT00005867|Analgesics|analgesics|mesh-ancestor
101317051|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
101317052|NCT00005870|Gemcitabine|gemcitabine|mesh-list
101317053|NCT00005870|Fluorouracil|fluorouracil|mesh-list
101317054|NCT00005870|Mitomycins|mitomycins|mesh-list
101317055|NCT00005870|Mitomycin|mitomycin|mesh-list
101317056|NCT00005870|Rubitecan|rubitecan|mesh-list
101317057|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317059|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317060|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317061|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317062|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
101317063|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317064|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101247411|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247413|NCT05596149|Listerine|listerine|mesh-list
101317065|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
101317066|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317067|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317068|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317070|NCT00017407|Paclitaxel|paclitaxel|mesh-list
101317071|NCT00017407|Carboplatin|carboplatin|mesh-list
101317072|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317074|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317075|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317076|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317077|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317078|NCT00008866|Didanosine|didanosine|mesh-list
101317079|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
101317080|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317081|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
101317082|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317083|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317084|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317085|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
101222196|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
101413140|NCT05233605|Analgesics|analgesics|mesh-ancestor
101317086|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317087|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
101317088|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317089|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101247527|NCT05423951|Sufentanil|sufentanil|mesh-list
101317090|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317092|NCT00001119|Indinavir|indinavir|mesh-list
101317093|NCT00001119|Amprenavir|amprenavir|mesh-list
101317094|NCT00001119|Lamivudine|lamivudine|mesh-list
101317095|NCT00001119|Zidovudine|zidovudine|mesh-list
101317096|NCT00001119|Abacavir|abacavir|mesh-list
101317097|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101317098|NCT00001119|Efavirenz|efavirenz|mesh-list
101317100|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
101317101|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317102|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101317103|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101317105|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317106|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317107|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317108|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317109|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
101317110|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247584|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101317111|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101317112|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101222686|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317113|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317114|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317115|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
101317116|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101317117|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101317118|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101317119|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101317120|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101317121|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101317122|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
101317123|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317124|NCT00009061|Ritonavir|ritonavir|mesh-list
101317125|NCT00009061|Nelfinavir|nelfinavir|mesh-list
101317126|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
101317127|NCT00009061|Lamivudine|lamivudine|mesh-list
101317129|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101317130|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101317132|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317133|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317134|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101317135|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101317136|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
101317137|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317138|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101317139|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101317140|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101317141|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101317143|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317144|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317145|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317146|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317147|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317148|NCT00009178|Fluoxetine|fluoxetine|mesh-list
101317149|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101413149|NCT00117780|Insulin|insulin|mesh-list
101317150|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101317151|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317152|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317153|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101317154|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
101317155|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317156|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101247757|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317157|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
101317159|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101317160|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101317163|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
101317165|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
101317166|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317167|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317168|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317169|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101317170|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101317171|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101317172|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101317173|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101317174|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
101317175|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101317176|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317177|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101317179|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317180|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317181|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317182|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317183|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317184|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101247816|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101317185|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101317186|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101317187|NCT00009646|Indomethacin|indomethacin|mesh-list
101317188|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101317189|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101317190|NCT00009646|Analgesics|analgesics|mesh-ancestor
101317191|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
101317192|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317193|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317194|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317195|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317196|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
101317197|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
101317198|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101317199|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101317200|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317201|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317202|NCT00009763|Cyclosporine|cyclosporine|mesh-list
101247931|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247932|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101247933|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101247934|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101247935|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101247936|NCT03476109|Omalizumab|omalizumab|mesh-list
101247937|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101247938|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101247946|NCT03366974|Clarithromycin|clarithromycin|mesh-list
101317203|NCT00009763|Paclitaxel|paclitaxel|mesh-list
101317204|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101317205|NCT00009763|Antibodies|antibodies|mesh-list
101317206|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
101317209|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317210|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317211|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317212|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317213|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317214|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317215|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
101317216|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317217|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317218|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317219|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
101317220|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317221|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247995|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317222|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317223|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101317226|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317227|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317228|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317229|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317230|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317231|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317232|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101317233|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317234|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101317235|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317236|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101317237|NCT00009802|Vitamins|vitamins|mesh-ancestor
101317239|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101317241|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317242|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317243|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
101317244|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317245|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
101317246|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317247|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317248|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317249|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
101317250|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317251|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317252|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317254|NCT00009880|Fluorouracil|fluorouracil|mesh-list
101317255|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317256|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317257|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317258|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317259|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248118|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101317260|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317261|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
101317262|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317263|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317264|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
101317265|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317266|NCT00009919|Semaxinib|semaxinib|mesh-list
101317267|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101317268|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101317269|NCT00009919|Growth Substances|growth substances|mesh-ancestor
101317270|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317271|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
101317272|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317273|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101317274|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248171|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
101248172|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248175|NCT05838599|Imiquimod|imiquimod|mesh-list
101317275|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317277|NCT00009958|Vaccines|vaccines|mesh-list
101317278|NCT00009958|Sargramostim|sargramostim|mesh-list
101317279|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
101317280|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317281|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317282|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101317283|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101317284|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101317285|NCT00009997|Tamoxifen|tamoxifen|mesh-list
101317286|NCT00009997|Paclitaxel|paclitaxel|mesh-list
101317287|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
101317288|NCT00009997|Doxorubicin|doxorubicin|mesh-list
101317289|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101317290|NCT00009997|Trastuzumab|trastuzumab|mesh-list
101317291|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101317292|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317293|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
101317294|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
101317295|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
101317296|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317297|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317298|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
101317299|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317300|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317301|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101317302|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
101317303|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101317304|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101317307|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317308|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101317309|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101317310|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
101317311|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317312|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317313|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101317314|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101317315|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101317317|NCT00010036|Irinotecan|irinotecan|mesh-list
101317318|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317319|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101317320|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317321|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317322|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317323|NCT00010075|Leucovorin|leucovorin|mesh-list
101317325|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
101317326|NCT00010075|Calcium|calcium|mesh-list
101317327|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
101317328|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101248275|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317329|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317331|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317332|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101317333|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317334|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101317335|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
101317336|NCT00010075|Antidotes|antidotes|mesh-ancestor
101317337|NCT00010075|Protective Agents|protective agents|mesh-ancestor
101317338|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
101317339|NCT00010075|Vitamins|vitamins|mesh-ancestor
101317340|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
101317341|NCT00010075|Analgesics|analgesics|mesh-ancestor
101317342|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
101317343|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317344|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101317345|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101317346|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317347|NCT00010153|Fulvestrant|fulvestrant|mesh-list
101317348|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101248329|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101248330|NCT05781308|Paclitaxel|paclitaxel|mesh-list
101317358|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101317359|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317360|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
101317361|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317362|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101317363|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101317370|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317371|NCT00005912|Voriconazole|voriconazole|mesh-list
101317372|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
101317373|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101317374|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101317375|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101317376|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101317377|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317378|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101248442|NCT05324761|Gabapentin|gabapentin|mesh-list
101248443|NCT05324761|Analgesics|analgesics|mesh-ancestor
101248444|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
101317379|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
101317380|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101317381|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317382|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101317383|NCT00010231|Calcitriol|calcitriol|mesh-list
101317384|NCT00010231|Dexamethasone|dexamethasone|mesh-list
101317385|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101317387|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
101317388|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101317389|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101317390|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101317391|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
101317393|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248501|NCT05232344|Estradiol|estradiol|mesh-list
101317394|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101317395|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101317396|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101317397|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101317398|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101317399|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101317400|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101317401|NCT00010231|Vitamins|vitamins|mesh-ancestor
101317402|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
101248561|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
101248562|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
101248563|NCT05032118|Analgesics|analgesics|mesh-ancestor
101248564|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
101248565|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248566|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101248567|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101248568|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101248569|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334285|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334286|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334287|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334288|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101334289|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334290|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101334292|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
101334293|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101334294|NCT00043654|Mifepristone|mifepristone|mesh-list
101334295|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101420812|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101334296|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
101334297|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101334298|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334299|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101420865|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
101420867|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334300|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101334301|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101334302|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
101334303|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101420875|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
101334304|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101334305|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101334306|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334307|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
101334308|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101334309|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101334311|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101334312|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334313|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
101334314|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334316|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
101334317|NCT00043810|Busulfan|busulfan|mesh-list
101334318|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
101334319|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334320|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334321|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
101334322|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334323|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334324|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
101334325|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334326|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
101334327|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101334328|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101334329|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101334330|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101334331|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334333|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334334|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334335|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101334336|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101334337|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334338|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334339|NCT00001586|Rituximab|rituximab|mesh-list
101334340|NCT00001586|Fludarabine|fludarabine|mesh-list
101334341|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
101334342|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334343|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334344|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
101334345|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334346|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334347|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334348|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
101334349|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334350|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334351|NCT00043888|Ritonavir|ritonavir|mesh-list
101334352|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
101334353|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101334354|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334355|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334356|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334357|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334358|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334360|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334361|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
101334362|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334363|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101334365|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101334366|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334367|NCT00018018|Zidovudine|zidovudine|mesh-list
101334368|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
101413177|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101334369|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334370|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101334371|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334373|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
101334374|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334375|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334376|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334377|NCT00043927|Cisplatin|cisplatin|mesh-list
101334378|NCT00043927|Etoposide|etoposide|mesh-list
101334379|NCT00043927|Topotecan|topotecan|mesh-list
101334380|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334381|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101334382|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101334383|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334384|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334385|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334386|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334387|NCT00043966|Ritonavir|ritonavir|mesh-list
101334388|NCT00043966|Lopinavir|lopinavir|mesh-list
101334389|NCT00043966|Tenofovir|tenofovir|mesh-list
101334390|NCT00043966|Emtricitabine|emtricitabine|mesh-list
101334391|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334392|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334393|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334394|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334395|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334396|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334397|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334398|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
101334399|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334402|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101334403|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334404|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101334405|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334406|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
101334407|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334408|NCT04731727|Riboflavin|riboflavin|mesh-list
101334409|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
101334410|NCT04731727|Vitamins|vitamins|mesh-ancestor
101334411|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
101334412|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334413|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101334414|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
101334415|NCT00044278|Lamotrigine|lamotrigine|mesh-list
101334416|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
101334417|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101334418|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334419|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334420|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334421|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334422|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101334423|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101334424|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334425|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334426|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101334427|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
101334429|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334430|NCT00044434|Bupropion|bupropion|mesh-list
101334431|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101334432|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334433|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334434|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101334435|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334436|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334437|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334438|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
101334439|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334440|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334441|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101334442|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334444|NCT00044473|Levofloxacin|levofloxacin|mesh-list
101334445|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101334446|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334447|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334448|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101334449|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334450|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334451|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334452|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334454|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334456|NCT00044551|IDN 5109|idn 5109|mesh-list
101334457|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334458|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101334459|NCT00018135|Calcium|calcium|mesh-list
101334460|NCT00018135|Sevelamer|sevelamer|mesh-list
101334461|NCT00018135|Calcium acetate|calcium acetate|mesh-list
101334462|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334463|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334464|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
101334465|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
101334466|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334467|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334468|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
101334469|NCT00018135|Antacids|antacids|mesh-ancestor
101334470|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334471|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101334472|NCT00397384|Cetuximab|cetuximab|mesh-list
101334473|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101334474|NCT00397384|Antibodies|antibodies|mesh-list
101334475|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
101334476|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101334477|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
101334478|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334479|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334480|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334481|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334482|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334483|NCT00397423|Lenograstim|lenograstim|mesh-list
101334484|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334485|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
101334486|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334487|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
101334488|NCT00397501|Carboplatin|carboplatin|mesh-list
101334489|NCT00397501|Methotrexate|methotrexate|mesh-list
101334490|NCT00397501|Trastuzumab|trastuzumab|mesh-list
101334491|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334492|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101334493|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
101334494|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101334495|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334496|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334497|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
101334498|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334499|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
101334500|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334501|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101334502|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334503|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
101334504|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334505|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334506|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334507|NCT00397501|Antidotes|antidotes|mesh-ancestor
101334508|NCT00397501|Protective Agents|protective agents|mesh-ancestor
101334509|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
101334510|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
101334511|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334512|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334513|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
101334514|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
101334516|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101421102|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
101334517|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334518|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334519|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334520|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334521|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
101334522|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334523|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101334524|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334525|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334526|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101421213|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421214|NCT00149253|Etoricoxib|etoricoxib|mesh-list
101421215|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421216|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101421217|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101421218|NCT00149253|Analgesics|analgesics|mesh-ancestor
101421219|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
101421220|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421221|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421222|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334527|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334528|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334530|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101334531|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101334532|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334533|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334534|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101334535|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
101334536|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
101334537|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334538|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334539|NCT00044668|Exenatide|exenatide|mesh-list
101334540|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101334541|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334542|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101334543|NCT00044668|Incretins|incretins|mesh-ancestor
101334544|NCT00044668|Hormones|hormones|mesh-ancestor
101334545|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334547|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101334548|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334549|NCT00044746|Tazobactam|tazobactam|mesh-list
101334550|NCT00044746|Piperacillin|piperacillin|mesh-list
101421335|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334551|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101334552|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334553|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334554|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101334555|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334556|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334558|NCT00044785|Fluorouracil|fluorouracil|mesh-list
101334559|NCT00044785|Irinotecan|irinotecan|mesh-list
101334560|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
101421650|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334561|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334562|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334563|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334564|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334566|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334568|NCT00044785|Protective Agents|protective agents|mesh-ancestor
101334569|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
101334570|NCT00044785|Vitamins|vitamins|mesh-ancestor
101421776|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101334571|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
101334572|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334573|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334574|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334575|NCT00044824|Fexofenadine|fexofenadine|mesh-list
101334576|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101334577|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101334578|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101334579|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
101334581|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334582|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334583|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334585|NCT00018213|Nicotine|nicotine|mesh-list
101334586|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101334587|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
101421952|NCT02953210|Midazolam|midazolam|mesh-list
101421953|NCT02953210|Ketamine|ketamine|mesh-list
101421954|NCT02953210|Ondansetron|ondansetron|mesh-list
101421955|NCT02953210|Bupivacaine|bupivacaine|mesh-list
101422474|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101422476|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422477|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
101422478|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334589|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334590|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101334591|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101334592|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
101334593|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334594|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334595|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101334596|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101334597|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
101334599|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334600|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334601|NCT00044902|Epratuzumab|epratuzumab|mesh-list
101334602|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334603|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334604|NCT00045136|Melphalan|melphalan|mesh-list
101334605|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101334606|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
101334607|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334608|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334609|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101334610|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334611|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
101423419|NCT05678114|Inositol|inositol|mesh-list
101334612|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334614|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
101334615|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334616|NCT00018291|Gabapentin|gabapentin|mesh-list
101334617|NCT00018291|Risperidone|risperidone|mesh-list
101334618|NCT00018291|Analgesics|analgesics|mesh-ancestor
101334619|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
101334620|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334621|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334622|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
101334623|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101334624|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101334625|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334626|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334627|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101334628|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101334629|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334630|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334632|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101334633|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
101334634|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101334635|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101334636|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
101334637|NCT00045175|Topotecan|topotecan|mesh-list
101334663|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334664|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101334665|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
101334667|NCT02970682|Fulvestrant|fulvestrant|mesh-list
101334668|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101334669|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101334670|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
101334671|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334672|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334673|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101334674|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334675|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101334676|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101334677|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101334678|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101334679|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101334680|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334681|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334682|NCT00045448|Docetaxel|docetaxel|mesh-list
101334683|NCT00045448|Alvocidib|alvocidib|mesh-list
101334684|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334685|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101425488|NCT04723563|Heparin|heparin|mesh-list
101334686|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101334687|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334688|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334689|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101334690|NCT00045448|Growth Substances|growth substances|mesh-ancestor
101334691|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334692|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334693|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334694|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101334695|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334696|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334697|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334698|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334699|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
101334700|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334701|NCT00045604|Irinotecan|irinotecan|mesh-list
101334702|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
101426022|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334703|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334704|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334705|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334706|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334707|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334708|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334709|NCT00045682|Paclitaxel|paclitaxel|mesh-list
101334710|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101334711|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101334712|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101334713|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334714|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101426503|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101334716|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334717|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334718|NCT00045721|Carmustine|carmustine|mesh-list
101334719|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101334720|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101334721|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
101334722|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334723|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334724|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334725|NCT04731766|Listerine|listerine|mesh-list
101334726|NCT04731766|Fluorides|fluorides|mesh-list
101334727|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
101334728|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
101334729|NCT04731766|Protective Agents|protective agents|mesh-ancestor
101334730|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334731|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101427814|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101334732|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334733|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101334734|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334735|NCT00018447|Fluorides|fluorides|mesh-list
101334736|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
101334737|NCT00018447|Protective Agents|protective agents|mesh-ancestor
101334738|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334739|NCT00001688|Ritonavir|ritonavir|mesh-list
101334740|NCT00001688|Nevirapine|nevirapine|mesh-list
101334741|NCT00001688|Stavudine|stavudine|mesh-list
101334742|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334743|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334744|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334746|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334747|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334748|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334749|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
101334750|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334751|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101334752|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334753|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101334754|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334755|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101334756|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101334757|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
101428283|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334758|NCT00389402|Ritonavir|ritonavir|mesh-list
101334759|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101334760|NCT00389402|Saquinavir|saquinavir|mesh-list
101334761|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334762|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334763|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334764|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334765|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334766|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334767|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334768|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
101334769|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428982|NCT04172987|Hormones|hormones|mesh-ancestor
101334770|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101334771|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334773|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334774|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
101334775|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334776|NCT00045799|Omeprazole|omeprazole|mesh-list
101334777|NCT00045799|Cimetidine|cimetidine|mesh-list
101334778|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
101334779|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101334780|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334781|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101334782|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334783|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334784|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101334785|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
101334786|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
101334787|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429718|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334788|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334789|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101334790|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334792|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
101334793|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
101334794|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334795|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334796|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
101334797|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334799|NCT00045877|Rituximab|rituximab|mesh-list
101334800|NCT00045877|Interleukin-2|interleukin-2|mesh-list
101334801|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334802|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334803|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
101334804|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334805|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334806|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101334807|NCT00045877|Analgesics|analgesics|mesh-ancestor
101334808|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
101334809|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334810|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334811|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334812|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
101334813|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334814|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101334815|NCT00045916|Nortriptyline|nortriptyline|mesh-list
101334816|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334817|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334818|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334819|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334820|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101334821|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334822|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334823|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334824|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101334825|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101334826|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101334827|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
101334828|NCT04380207|QPX7728|qpx7728|mesh-list
101334829|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101334830|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334831|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334832|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334833|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334834|NCT00045955|Fexofenadine|fexofenadine|mesh-list
101334835|NCT00045955|Montelukast|montelukast|mesh-list
101334836|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101334837|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
101334838|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101334839|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
101334840|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334841|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334842|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101334843|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101334844|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334845|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101334846|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101334847|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101334848|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
101334849|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
101334850|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334851|NCT00046033|Ritonavir|ritonavir|mesh-list
101334852|NCT00046033|Lopinavir|lopinavir|mesh-list
101334853|NCT00046033|Saquinavir|saquinavir|mesh-list
101334854|NCT00046033|Amprenavir|amprenavir|mesh-list
101334855|NCT00046033|Tenofovir|tenofovir|mesh-list
101432916|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101334856|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334857|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334858|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334859|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334861|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334862|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334863|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
101334864|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334865|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101433303|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
101433658|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433858|NCT00159731|Pregabalin|pregabalin|mesh-list
101334866|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334867|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101334868|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334869|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101334870|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
101334871|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334872|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101334873|NCT04369560|Hematinics|hematinics|mesh-ancestor
101334874|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101334875|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101334876|NCT00046111|Topotecan|topotecan|mesh-list
101334877|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334878|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334879|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435276|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334880|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334881|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334882|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
101334883|NCT00001724|Analgesics|analgesics|mesh-ancestor
101334884|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
101334885|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334886|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334887|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101334888|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101334889|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101334890|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334891|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101435813|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101435885|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
101334893|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334894|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
101334895|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101334896|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334897|NCT00046267|Niacin|niacin|mesh-list
101334898|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101334899|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
101334900|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334901|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101334902|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
101334903|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
101334904|NCT00046267|Vitamins|vitamins|mesh-ancestor
101334905|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
101334906|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334907|NCT00046306|Antioxidants|antioxidants|mesh-list
101334908|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436176|NCT05267873|Analgesics|analgesics|mesh-ancestor
101334909|NCT00046306|Protective Agents|protective agents|mesh-ancestor
101334910|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334911|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101334912|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334913|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334914|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334915|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334916|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334917|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334918|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334919|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
101334920|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334921|NCT00397657|Niacin|niacin|mesh-list
101334922|NCT00397657|Ezetimibe|ezetimibe|mesh-list
101334923|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101334924|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101334925|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
101334926|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334927|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101334928|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
101334929|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
101334930|NCT00397657|Vitamins|vitamins|mesh-ancestor
101334931|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
101334932|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334933|NCT00001763|Interleukin-12|interleukin-12|mesh-list
101334934|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334935|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
101334936|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334937|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101334938|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101334939|NCT00001763|Growth Substances|growth substances|mesh-ancestor
101334940|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101334941|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334942|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
101334943|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101334944|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
101334945|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334946|NCT00397735|Expectorants|expectorants|mesh-ancestor
101334947|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
101334948|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101334949|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
101334950|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334952|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334953|NCT00397735|Antidotes|antidotes|mesh-ancestor
101334954|NCT00046384|Aripiprazole|aripiprazole|mesh-list
101334955|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334956|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334957|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101334958|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101334959|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334960|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334961|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
101334962|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
101334963|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334964|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334965|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101334966|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101334967|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
101334968|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101334969|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101334970|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101334971|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101334972|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101334973|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334974|NCT04258410|Quercetin|quercetin|mesh-list
101334975|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
101334976|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334977|NCT04258410|Protective Agents|protective agents|mesh-ancestor
101334978|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334979|NCT00046462|Metformin|metformin|mesh-list
101334980|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
101334981|NCT00046462|Glyburide|glyburide|mesh-list
101334983|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101334984|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334985|NCT00001766|Ritonavir|ritonavir|mesh-list
101334986|NCT00001766|Nelfinavir|nelfinavir|mesh-list
101334987|NCT00001766|Amprenavir|amprenavir|mesh-list
101334988|NCT00001766|Abacavir|abacavir|mesh-list
101334989|NCT00001766|Efavirenz|efavirenz|mesh-list
101334990|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101334991|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101334992|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
101334993|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334994|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334995|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101334996|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334997|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
101334998|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334999|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101335000|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101335001|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101335002|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101335003|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101335004|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101335005|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101335006|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101335007|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101335008|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101335009|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
101335010|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335011|NCT00046501|Insulin|insulin|mesh-list
101335012|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
101335013|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101335014|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
101335015|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
101335016|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101335019|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
101335020|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335021|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101335022|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101335023|NCT00046735|Growth Substances|growth substances|mesh-ancestor
101335024|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
101335025|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335026|NCT00001784|Mexiletine|mexiletine|mesh-list
101335027|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101335028|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101335029|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101335030|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335031|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335032|NCT00046813|Nicotine|nicotine|mesh-list
101335033|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101335034|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
101335035|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335036|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335037|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101335038|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101335039|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
101335040|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335041|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335042|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
101335043|NCT00046852|Melphalan|melphalan|mesh-list
101335045|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101335046|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335047|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
101335052|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335053|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335054|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335055|NCT00046969|Cisplatin|cisplatin|mesh-list
101335056|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335057|NCT00001805|Rituximab|rituximab|mesh-list
101335058|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335059|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335060|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
101335061|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335062|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335064|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335065|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335066|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
101335067|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335068|NCT04733781|Lidocaine|lidocaine|mesh-list
101335069|NCT04733781|Epinephrine|epinephrine|mesh-list
101335070|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
101335071|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
101335072|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335073|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335074|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
101335075|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335076|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101335077|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101335078|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101335079|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335080|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335081|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101335082|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101335083|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
101335084|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335085|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101335086|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101335087|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
101335088|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101335089|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
101335090|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
101335091|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
101335092|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101335093|NCT00047164|Ipilimumab|ipilimumab|mesh-list
101335094|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335095|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335096|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101335097|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335098|NCT00047203|Alvocidib|alvocidib|mesh-list
101335099|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335100|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101335101|NCT00047203|Growth Substances|growth substances|mesh-ancestor
101335103|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335104|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335105|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335107|NCT04163874|Pancrelipase|pancrelipase|mesh-list
101335108|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335109|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101335110|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335111|NCT00047242|Irinotecan|irinotecan|mesh-list
101335112|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101335113|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101335114|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335115|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335116|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335117|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335118|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335119|NCT00047281|Thalidomide|thalidomide|mesh-list
101335120|NCT00047281|Celecoxib|celecoxib|mesh-list
101335121|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
101335122|NCT00047281|Etoposide|etoposide|mesh-list
101335123|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335124|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
101335125|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335126|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335127|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335128|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
101335130|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335131|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335132|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335133|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335134|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335135|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335136|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101335137|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335138|NCT00047281|Analgesics|analgesics|mesh-ancestor
101335139|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
101335140|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335141|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335142|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101335143|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335144|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
101335145|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335146|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438319|NCT02904499|Dabigatran|dabigatran|mesh-list
101335147|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101335148|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101335149|NCT00047281|Growth Substances|growth substances|mesh-ancestor
101335150|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
101335151|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101335152|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101335153|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335154|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101335155|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335156|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335157|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335158|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
101335159|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335161|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101335162|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101335163|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101335164|NCT00047632|Interferons|interferons|mesh-list
101335165|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
101335166|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335167|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
101335168|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335169|NCT00047671|Citalopram|citalopram|mesh-list
101335170|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101335171|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335172|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335173|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335174|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335175|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
101335176|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335177|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101335178|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335179|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335180|NCT00047710|Bevacizumab|bevacizumab|mesh-list
101335181|NCT00047710|Capecitabine|capecitabine|mesh-list
101335182|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335190|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
101335195|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335196|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101335197|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335198|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101335199|NCT00047749|Protective Agents|protective agents|mesh-ancestor
101335200|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335201|NCT00047749|Analgesics|analgesics|mesh-ancestor
101335202|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
101335203|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335204|NCT00047827|Amphotericin B|amphotericin b|mesh-list
101335205|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101335206|NCT00047827|Micafungin|micafungin|mesh-list
101335207|NCT00047827|Amebicides|amebicides|mesh-ancestor
101335208|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101335209|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101335210|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335211|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335212|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
101335213|NCT00048139|Capecitabine|capecitabine|mesh-list
101335214|NCT00048139|Irinotecan|irinotecan|mesh-list
101335215|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335216|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
101335217|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335218|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335219|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101335220|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335221|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335222|NCT00048334|Romidepsin|romidepsin|mesh-list
101335223|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335224|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487428|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335225|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101335226|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335227|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335229|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101335230|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335231|NCT00048373|Analgesics|analgesics|mesh-ancestor
101335232|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
101335233|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335234|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335235|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335236|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335237|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335238|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335239|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
101335240|NCT05641337|Insulin|insulin|mesh-list
101335241|NCT05641337|Metformin|metformin|mesh-list
101335242|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
101335243|NCT05641337|Linagliptin|linagliptin|mesh-list
101335244|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101335245|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101335246|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335247|NCT05641337|Incretins|incretins|mesh-ancestor
101335248|NCT05641337|Hormones|hormones|mesh-ancestor
101335249|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101335250|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101335251|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
101335252|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335253|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335254|NCT00048412|Fludarabine|fludarabine|mesh-list
101335255|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
101335260|NCT00048607|Aprepitant|aprepitant|mesh-list
101335267|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
101335268|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438523|NCT05995249|Antiviral Agents|antiviral agents|mesh-ancestor
101335269|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101335270|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335271|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335272|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101335273|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101335274|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335276|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
101335277|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335278|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335279|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101335280|NCT00048646|Progesterone|progesterone|mesh-list
101335281|NCT00048646|Progestins|progestins|mesh-ancestor
101335282|NCT00048646|Hormones|hormones|mesh-ancestor
101335283|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101335284|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335285|NCT00048763|Cilostazol|cilostazol|mesh-list
101335286|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101456566|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456567|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456571|NCT00241332|Fentanyl|fentanyl|mesh-list
101456572|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101456573|NCT00241332|Narcotics|narcotics|mesh-ancestor
101456574|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456575|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456576|NCT00241332|Analgesics|analgesics|mesh-ancestor
101456577|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
101456578|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456579|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101456580|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101456581|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
101456582|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
101456583|NCT00216866|Dalteparin|dalteparin|mesh-list
101456584|NCT00216866|Tinzaparin|tinzaparin|mesh-list
101456585|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101456586|NCT00216866|Warfarin|warfarin|mesh-list
101456587|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
101456588|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101456589|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101456590|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456591|NCT00557206|Docetaxel|docetaxel|mesh-list
101456592|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
101456593|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456594|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456595|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456596|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456597|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456598|NCT00241371|Clofarabine|clofarabine|mesh-list
101456599|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101456600|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
101456601|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456602|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456603|NCT04660786|Vitamin D|vitamin d|mesh-list
101335288|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335289|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335290|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101335291|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
101335292|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101335293|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101335294|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335295|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101335297|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101335298|NCT00048763|Protective Agents|protective agents|mesh-ancestor
101335299|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101335300|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101335301|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335302|NCT05576298|Insulin|insulin|mesh-list
101335303|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101335304|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
101335305|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101335306|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335307|NCT00048802|Valproic Acid|valproic acid|mesh-list
101335308|NCT00048802|Olanzapine|olanzapine|mesh-list
101335309|NCT00048802|Risperidone|risperidone|mesh-list
101456604|NCT04660786|Triamcinolone|triamcinolone|mesh-list
101456605|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101456606|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101456607|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101456608|NCT04660786|Vitamins|vitamins|mesh-ancestor
101456609|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
101456610|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456611|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101456612|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456613|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
101456614|NCT04660786|Hormones|hormones|mesh-ancestor
101456615|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456616|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456617|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
101456618|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456619|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456620|NCT00217178|Folic Acid|folic acid|mesh-list
101456621|NCT00217178|Vitamins|vitamins|mesh-ancestor
101456622|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
101456623|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456624|NCT00217178|Hematinics|hematinics|mesh-ancestor
101456625|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
101456626|NCT00241449|Tamoxifen|tamoxifen|mesh-list
101456627|NCT00241449|Fulvestrant|fulvestrant|mesh-list
101456628|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101456629|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456630|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456631|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456632|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101335311|NCT00048802|Ziprasidone|ziprasidone|mesh-list
101335312|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101335313|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
101335314|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335315|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335316|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335317|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101335318|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101335319|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335320|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335321|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101335322|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
101335323|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
101335324|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
101335325|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335326|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335327|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101335328|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335329|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335330|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335331|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335332|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
101335333|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
101335334|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
101335335|NCT00048841|Alendronate|alendronate|mesh-list
101335336|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101335337|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335339|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101456633|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456634|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101456635|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101456636|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101456637|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101456638|NCT00412100|Oxycodone|oxycodone|mesh-list
101456639|NCT00412100|Naloxone|naloxone|mesh-list
101456640|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101456641|NCT00412100|Narcotics|narcotics|mesh-ancestor
101456646|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456647|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101456648|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101335340|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
101335341|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335343|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
101335344|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335345|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335346|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
101335347|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335348|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335349|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
101335350|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335351|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
101335352|NCT00049114|Doxorubicin|doxorubicin|mesh-list
101335353|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101335354|NCT00049114|Tipifarnib|tipifarnib|mesh-list
101335355|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335356|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
101335357|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335358|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335359|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335360|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
101335361|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335362|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335363|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335364|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335365|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335366|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335367|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335368|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
101335369|NCT00049192|Oblimersen|oblimersen|mesh-list
101335370|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335371|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335372|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456649|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101456650|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101456651|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
101456652|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456653|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101456654|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101456655|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456656|NCT04659499|Paclitaxel|paclitaxel|mesh-list
101456657|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101456658|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335373|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335374|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
101335375|NCT05576181|Fludarabine|fludarabine|mesh-list
101335377|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335378|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
101335379|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335380|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335381|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335382|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
101335383|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335384|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335385|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335386|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335387|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335388|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335389|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335390|NCT00049387|Temozolomide|temozolomide|mesh-list
101335391|NCT00049387|Tipifarnib|tipifarnib|mesh-list
101335392|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335393|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
101335394|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335395|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335396|NCT05640791|Paclitaxel|paclitaxel|mesh-list
101335397|NCT05640791|Gemcitabine|gemcitabine|mesh-list
101335398|NCT05640791|Durvalumab|durvalumab|mesh-list
101335399|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335400|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335401|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
101335402|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335403|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456659|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456660|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456661|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456662|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456663|NCT00241527|Esomeprazole|esomeprazole|mesh-list
101456664|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101456665|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456666|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101456667|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456668|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335404|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335405|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335406|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
101335407|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335408|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
101335409|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101335410|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
101335411|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335412|NCT00391911|Expectorants|expectorants|mesh-ancestor
101335413|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
101335414|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101335415|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
101335416|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335417|NCT00391911|Protective Agents|protective agents|mesh-ancestor
101335418|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335420|NCT02970409|Heparin|heparin|mesh-list
101335421|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
101335422|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101335423|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101335424|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335425|NCT00049582|Decitabine|decitabine|mesh-list
101335426|NCT00049582|Azacitidine|azacitidine|mesh-list
101335427|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335428|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
101335429|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335430|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335431|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335432|NCT00049660|Capecitabine|capecitabine|mesh-list
101456669|NCT04648813|Bromides|bromides|mesh-list
101456670|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
101456671|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101456672|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
101456673|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456674|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456675|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101456676|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456677|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
101456678|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101456679|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
101456680|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456681|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456682|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
101456683|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
101456684|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101456685|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101335433|NCT00049660|Vinorelbine|vinorelbine|mesh-list
101335434|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335435|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
101335436|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439295|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335437|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335438|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335440|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335441|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335442|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
101335443|NCT05640713|Fludarabine|fludarabine|mesh-list
101335444|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335445|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
101335446|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335447|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456686|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
101456687|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
101456688|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456689|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456690|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
101456691|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101456692|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101456693|NCT00558181|Prednisolone|prednisolone|mesh-list
101456694|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
101456695|NCT00558181|Rituximab|rituximab|mesh-list
101456696|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101456697|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
101456698|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456699|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456700|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
101456701|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456702|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456703|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456704|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
101456705|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
101456706|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456707|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456708|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
101456709|NCT00558181|Hormones|hormones|mesh-ancestor
101456710|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456711|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101456712|NCT00558181|Protective Agents|protective agents|mesh-ancestor
101456733|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101456734|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456735|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456736|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456737|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101456738|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
101456739|NCT00245505|Mesalamine|mesalamine|mesh-list
101456740|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101456741|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101456742|NCT00245505|Analgesics|analgesics|mesh-ancestor
101456743|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
101456744|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456745|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456746|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439547|NCT05194293|Durvalumab|durvalumab|mesh-list
101456747|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456748|NCT04647838|Tepotinib|tepotinib|mesh-list
101456749|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456750|NCT00217373|Interferons|interferons|mesh-list
101335448|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335449|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
101335450|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335451|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335452|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335453|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
101335454|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101335455|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335456|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101335457|NCT00049777|Heparin|heparin|mesh-list
101335458|NCT00049777|Calcium heparin|calcium heparin|mesh-list
101335459|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101335460|NCT00049777|Tinzaparin|tinzaparin|mesh-list
101335461|NCT00049777|Dalteparin|dalteparin|mesh-list
101456751|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
101456752|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
101456753|NCT00217373|Metronidazole|metronidazole|mesh-list
101456754|NCT00217373|Vaccines|vaccines|mesh-list
101456755|NCT00217373|Sargramostim|sargramostim|mesh-list
101456756|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
101456757|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456758|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456759|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
101456760|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456761|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456762|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101456763|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101456764|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
101456766|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
101456767|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456768|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456769|NCT00217412|Vorinostat|vorinostat|mesh-list
101456770|NCT00217412|Isotretinoin|isotretinoin|mesh-list
101456771|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456811|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456813|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456814|NCT00245661|Temazepam|temazepam|mesh-list
101456815|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101456816|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456817|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456818|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101456819|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456820|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456821|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
101456822|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
101456823|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456824|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456825|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
101456826|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101456827|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456828|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456829|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101456830|NCT04646317|Analgesics|analgesics|mesh-ancestor
101456831|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
101456832|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456833|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101456834|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101456835|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101456836|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
101456837|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456838|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456839|NCT00217568|Carboplatin|carboplatin|mesh-list
101335463|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101335464|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101335465|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335466|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335467|NCT00392028|Ertapenem|ertapenem|mesh-list
101335468|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335469|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335471|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
101335472|NCT00389558|Amikacin|amikacin|mesh-list
101335473|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335474|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335475|NCT00049972|Paroxetine|paroxetine|mesh-list
101335476|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101335477|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335478|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335479|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335480|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335481|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
101335482|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335483|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101456840|NCT00217568|Docetaxel|docetaxel|mesh-list
101456841|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456842|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456843|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456844|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456845|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456846|NCT04646161|Misoprostol|misoprostol|mesh-list
101456847|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101456848|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
101456849|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101456850|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456851|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101456852|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456853|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
101456854|NCT00241722|Alvimopan|alvimopan|mesh-list
101456855|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456857|NCT00558337|Carbidopa|carbidopa|mesh-list
101456858|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101456859|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101456860|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101456861|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
101456862|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456863|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456864|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456865|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101456866|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456867|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101456868|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
101456869|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
101335484|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335485|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335486|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101335487|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101335488|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335489|NCT00389636|Becaplermin|becaplermin|mesh-list
101335490|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
101335491|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101335492|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101335493|NCT00389636|Growth Substances|growth substances|mesh-ancestor
101335494|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335495|NCT00050206|Olanzapine|olanzapine|mesh-list
101335496|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
101335497|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
101335498|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335499|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335500|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335501|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101335502|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101335503|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335505|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101335506|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335507|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335508|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335509|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335510|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
101335511|NCT00050245|Rituximab|rituximab|mesh-list
101335512|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335513|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335514|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
101456870|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101456871|NCT00558376|Laxatives|laxatives|mesh-ancestor
101456872|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456873|NCT00217646|Sorafenib|sorafenib|mesh-list
101456874|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456878|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
101456880|NCT00558493|Clevudine|clevudine|mesh-list
101456881|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
101456882|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440083|NCT04621435|Copper|copper|mesh-list
101456883|NCT04645303|Triamcinolone|triamcinolone|mesh-list
101456884|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101456885|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101335515|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335516|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335517|NCT00050362|Rofecoxib|rofecoxib|mesh-list
101335518|NCT00050362|Bupivacaine|bupivacaine|mesh-list
101335519|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
101335520|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
101335521|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335522|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335523|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
101456886|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
101456887|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101456888|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456889|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
101456890|NCT04645303|Hormones|hormones|mesh-ancestor
101456891|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456892|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456893|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456894|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
101456895|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456896|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456897|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101456898|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
101456899|NCT04645303|Protective Agents|protective agents|mesh-ancestor
101456900|NCT00217607|Paclitaxel|paclitaxel|mesh-list
101456901|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101456902|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456903|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456904|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456905|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456906|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456907|NCT04644484|Vaccines|vaccines|mesh-list
101456908|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
101456909|NCT04644484|Antibodies|antibodies|mesh-list
101456910|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
101456911|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101456912|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101456914|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456915|NCT04644250|Paclitaxel|paclitaxel|mesh-list
101456916|NCT04644250|Carboplatin|carboplatin|mesh-list
101456917|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101456918|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456919|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456920|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456921|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456922|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456924|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101413228|NCT00481819|Tacrolimus|tacrolimus|mesh-list
101456925|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101456926|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
101456927|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456928|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456929|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101456930|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101456931|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
101456932|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456933|NCT00558883|Acarbose|acarbose|mesh-list
101456934|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101456935|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456936|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456937|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456938|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456939|NCT04644094|Dexamethasone|dexamethasone|mesh-list
101440149|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101456940|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101456941|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
101456942|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
101456943|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456944|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335524|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335525|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101335526|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335527|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335528|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335529|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101456945|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101456946|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
101456961|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456962|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101456964|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456965|NCT04643821|Protective Agents|protective agents|mesh-ancestor
101456966|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456967|NCT04643821|Antidotes|antidotes|mesh-ancestor
101456968|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101456969|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101456970|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101456971|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101456972|NCT04643821|Vitamins|vitamins|mesh-ancestor
101456973|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
101456974|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101456975|NCT00218075|Levodopa|levodopa|mesh-list
101456976|NCT00218075|Carbidopa|carbidopa|mesh-list
101456977|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101456978|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101456979|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
101456980|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456981|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456982|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456983|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101456984|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456985|NCT00218114|Valproic Acid|valproic acid|mesh-list
101456986|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
101456987|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456988|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456990|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456991|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456992|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
101456993|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101456994|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456995|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101456996|NCT00424788|Natalizumab|natalizumab|mesh-list
101456997|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
101456998|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456999|NCT00218153|Naltrexone|naltrexone|mesh-list
101457000|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101457001|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101457002|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457003|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
101457004|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457005|NCT04642846|Fluorides|fluorides|mesh-list
101457006|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
101457007|NCT04642846|Protective Agents|protective agents|mesh-ancestor
101457008|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457009|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
101457010|NCT00245895|Hematinics|hematinics|mesh-ancestor
101457026|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101457027|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
101457028|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457029|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101457030|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101457031|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457032|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457033|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
101335531|NCT00050362|Analgesics|analgesics|mesh-ancestor
101335532|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335533|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335534|NCT00050401|Vancomycin|vancomycin|mesh-list
101335535|NCT00050401|Tobramycin|tobramycin|mesh-list
101335536|NCT00050401|Meropenem|meropenem|mesh-list
101335537|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335538|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335539|NCT05640362|Benzydamine|benzydamine|mesh-list
101335540|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335541|NCT00050440|Dexamethasone|dexamethasone|mesh-list
101335542|NCT00050440|Trabectedin|trabectedin|mesh-list
101457034|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457035|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457036|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101457037|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101457038|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457039|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
101457040|NCT00218309|Hydromorphone|hydromorphone|mesh-list
101457041|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101457042|NCT00218309|Narcotics|narcotics|mesh-ancestor
101457043|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457044|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457045|NCT00218309|Analgesics|analgesics|mesh-ancestor
101457046|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
101457047|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457048|NCT00218348|Amphetamine|amphetamine|mesh-list
101457049|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
101457050|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101457051|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457052|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
101457053|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
101457054|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457055|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
101457056|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457057|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457058|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457059|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101457060|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101457061|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457062|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101457063|NCT00559312|Fluticasone|fluticasone|mesh-list
101457064|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101457065|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101457066|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457067|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101457068|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
101457069|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457074|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101457075|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101457076|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101457077|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101457078|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457079|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457080|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457081|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
101457083|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457084|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
101457085|NCT00559351|Fluorouracil|fluorouracil|mesh-list
101457086|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457087|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
101457088|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335543|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335544|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
101335545|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
101335546|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335547|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335548|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335549|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
101335550|NCT00050440|Hormones|hormones|mesh-ancestor
101335551|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101335552|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101335553|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335554|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335555|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
101335556|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335557|NCT00050479|Celecoxib|celecoxib|mesh-list
101335558|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457089|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457090|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457091|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
101457092|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457093|NCT00218504|Dronabinol|dronabinol|mesh-list
101457094|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
101457095|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457096|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457097|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457098|NCT00218504|Analgesics|analgesics|mesh-ancestor
101457099|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
101457100|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457101|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101457102|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101457103|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457104|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457105|NCT00218504|Hormones|hormones|mesh-ancestor
101457106|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457107|NCT00559429|Docetaxel|docetaxel|mesh-list
101457108|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101457109|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457110|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
101457111|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
101457112|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
101457113|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457114|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457115|NCT00559429|Analgesics|analgesics|mesh-ancestor
101457116|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
101457117|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457118|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457119|NCT00218621|Buprenorphine|buprenorphine|mesh-list
101457120|NCT00218621|Methadone|methadone|mesh-list
101457121|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101457122|NCT00218621|Narcotics|narcotics|mesh-ancestor
101457123|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457124|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457125|NCT00218621|Analgesics|analgesics|mesh-ancestor
101457126|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
101457127|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457128|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101457129|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
101335559|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335560|NCT00050479|Analgesics|analgesics|mesh-ancestor
101335561|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
101335562|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335563|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335564|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335565|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335566|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101335567|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335568|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335569|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335571|NCT00050596|Ipilimumab|ipilimumab|mesh-list
101335572|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335573|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
101335574|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335575|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335576|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335577|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335578|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101335579|NCT00050635|Octreotide|octreotide|mesh-list
101335580|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335581|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101335582|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335583|NCT00050674|Lenograstim|lenograstim|mesh-list
101457130|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457131|NCT00246168|Acetaminophen|acetaminophen|mesh-list
101457132|NCT00246168|Tramadol|tramadol|mesh-list
101457133|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457134|NCT00246168|Analgesics|analgesics|mesh-ancestor
101457135|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
101457136|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457137|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457138|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
101457139|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101457140|NCT00246168|Narcotics|narcotics|mesh-ancestor
101457154|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457155|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101457156|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101457157|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457158|NCT00246207|Methylphenidate|methylphenidate|mesh-list
101457159|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101457160|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457161|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101457162|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101457163|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457164|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335584|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101335585|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
101335586|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335587|NCT00050713|Sirolimus|sirolimus|mesh-list
101335588|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335589|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457165|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
101457166|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457167|NCT04639804|Celecoxib|celecoxib|mesh-list
101457168|NCT04639804|Naproxen|naproxen|mesh-list
101457169|NCT04639804|Aceclofenac|aceclofenac|mesh-list
101457170|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457171|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457172|NCT04639804|Analgesics|analgesics|mesh-ancestor
101457173|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
101457174|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457175|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457177|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457178|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101457179|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101457180|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457181|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457182|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
101457183|NCT00218855|Thalidomide|thalidomide|mesh-list
101457184|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457185|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
101457186|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457187|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
101457188|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101457189|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457190|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101457191|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101457192|NCT00218855|Growth Substances|growth substances|mesh-ancestor
101457193|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
101457194|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457195|NCT00246246|Risperidone|risperidone|mesh-list
101457196|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101457197|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
101457198|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457199|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457211|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457213|NCT04628884|Heparin|heparin|mesh-list
101457214|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
101457215|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101457216|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101457217|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457218|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101457219|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
101457220|NCT00412334|Ribavirin|ribavirin|mesh-list
101457221|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
101457222|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457223|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
101457224|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457225|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
101457226|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457227|NCT00561379|Rituximab|rituximab|mesh-list
101457228|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457229|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457230|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
101457231|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457232|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457233|NCT04629118|Sirolimus|sirolimus|mesh-list
101457234|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101457235|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457236|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101457237|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457238|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
101457239|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457240|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
101335590|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335591|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335592|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
101335593|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457241|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457243|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
101457244|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457245|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101457247|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457248|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457249|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101457250|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101457251|NCT00246285|Risperidone|risperidone|mesh-list
101457252|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101457253|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
101457254|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457255|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457256|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457257|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101457258|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101457259|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457260|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457261|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101457274|NCT00246363|Protective Agents|protective agents|mesh-ancestor
101457275|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457276|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
101457277|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101457278|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101457279|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457280|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457281|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457282|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457283|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
101457284|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
101457285|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457286|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
101457287|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101457288|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457289|NCT00246402|Acipimox|acipimox|mesh-list
101457290|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101457291|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
101457292|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457293|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101457294|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
101457295|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101413237|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101457296|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457297|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101457298|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
101457299|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101457300|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
101457301|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457302|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457303|NCT04628143|Nafamostat|nafamostat|mesh-list
101457304|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457305|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457306|NCT04628143|Analgesics|analgesics|mesh-ancestor
101457307|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
101457308|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457309|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457310|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457311|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457312|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
101457313|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
101457314|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457315|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457316|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101457317|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101335594|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
101335595|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335596|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
101335597|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
101335598|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
101335599|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335600|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335601|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
101335602|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457318|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101457319|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457320|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
101457322|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
101457323|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101457330|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457332|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457333|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457334|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101457335|NCT00219245|Protective Agents|protective agents|mesh-ancestor
101457336|NCT04627363|Bevacizumab|bevacizumab|mesh-list
101457337|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457338|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457339|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101457340|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101457341|NCT04627363|Growth Substances|growth substances|mesh-ancestor
101457342|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457343|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
101457344|NCT00219323|Omalizumab|omalizumab|mesh-list
101457345|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101457346|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457347|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457348|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
101457349|NCT00246597|Hematinics|hematinics|mesh-ancestor
101457350|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
101457351|NCT04626739|Fludarabine|fludarabine|mesh-list
101457352|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457353|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
101457354|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457355|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457356|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101457357|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
101528425|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101457358|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457359|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457360|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101457361|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101457362|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
101457363|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457364|NCT04627129|Itraconazole|itraconazole|mesh-list
101457365|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
101457366|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457367|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101457368|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101457369|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457370|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457371|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101457372|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
101457373|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457374|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457375|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101457376|NCT00246636|Fenofibrate|fenofibrate|mesh-list
101457377|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101457378|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
101335603|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335604|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101335605|NCT00050830|Protective Agents|protective agents|mesh-ancestor
101335606|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
101335607|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
101440621|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101335608|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101335609|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101457379|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457380|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101457381|NCT00219440|Metformin|metformin|mesh-list
101457382|NCT00219440|Pioglitazone|pioglitazone|mesh-list
101457383|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101457385|NCT00246675|Furosemide|furosemide|mesh-list
101457386|NCT00246675|Diuretics|diuretics|mesh-ancestor
101457387|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
101457388|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457405|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101457406|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101457407|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
101457408|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457409|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101457410|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457411|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
101457412|NCT00242463|Nandrolone|nandrolone|mesh-list
101457413|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
101457414|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
101457415|NCT00242463|Androgens|androgens|mesh-ancestor
101457416|NCT00242463|Hormones|hormones|mesh-ancestor
101457417|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457418|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457419|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
101457420|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101457421|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
101457422|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
101457423|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101457424|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
101457425|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457426|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457427|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457428|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457429|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101457430|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101457431|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101457432|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457433|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457434|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457436|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101457437|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101457438|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101457439|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457440|NCT00219596|Timolol|timolol|mesh-list
101457441|NCT00219596|Latanoprost|latanoprost|mesh-list
101457442|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101457449|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101457450|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101457451|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101457452|NCT04626193|Amoxicillin|amoxicillin|mesh-list
101457453|NCT04626193|Doxycycline|doxycycline|mesh-list
101457454|NCT04626193|Levofloxacin|levofloxacin|mesh-list
101457455|NCT04626193|Esomeprazole|esomeprazole|mesh-list
101457456|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101457457|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457458|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101457459|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457460|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101457461|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440767|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
101457462|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335610|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335611|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335612|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101335613|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101335614|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
101335615|NCT00051142|Travoprost|travoprost|mesh-list
101335616|NCT00051142|Latanoprost|latanoprost|mesh-list
101335617|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101335618|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101457463|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
101457464|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101457465|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101457466|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101457467|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101457468|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101457469|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457470|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101457471|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101457472|NCT00242541|Octreotide|octreotide|mesh-list
101457473|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457474|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101457475|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457476|NCT04625608|Acetaminophen|acetaminophen|mesh-list
101457477|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457478|NCT04625608|Analgesics|analgesics|mesh-ancestor
101457479|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
101457480|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457481|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457482|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
101457483|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
101457484|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101457485|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
101457486|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
101457487|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457488|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457489|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457490|NCT00219713|Analgesics|analgesics|mesh-ancestor
101457491|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
101457492|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457493|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
101457494|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457495|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101457496|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457497|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457498|NCT00242697|Anesthetics|anesthetics|mesh-list
101457499|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457500|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457501|NCT04625179|Melatonin|melatonin|mesh-list
101457502|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
101457503|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
101457504|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457505|NCT04625179|Protective Agents|protective agents|mesh-ancestor
101457506|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457507|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457508|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101457509|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
101457510|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
101457511|NCT02962232|Paclitaxel|paclitaxel|mesh-list
101457514|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
101457515|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
101457516|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
101457517|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457518|NCT00246909|Pantoprazole|pantoprazole|mesh-list
101457519|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101457520|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457521|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101335619|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101335620|NCT00051181|Travoprost|travoprost|mesh-list
101335621|NCT00051181|Latanoprost|latanoprost|mesh-list
101335622|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101457522|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457523|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457524|NCT00219869|Galantamine|galantamine|mesh-list
101457525|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101457526|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457527|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457528|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
101457529|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457530|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457531|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101457532|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
101457533|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457534|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
101457535|NCT04624360|Dexamethasone|dexamethasone|mesh-list
101457536|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457537|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
101457538|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
101457539|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457540|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457541|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457542|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
101457544|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457545|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101457546|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457547|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
101457548|NCT00219908|Analgesics|analgesics|mesh-ancestor
101457549|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
101457550|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457551|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457552|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457553|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101457554|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101457555|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457556|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457557|NCT00242736|Esomeprazole|esomeprazole|mesh-list
101457558|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101457559|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457560|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101457561|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457562|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457563|NCT00242775|Fluticasone|fluticasone|mesh-list
101457564|NCT00242775|Budesonide|budesonide|mesh-list
101457565|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
101457566|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101457567|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457568|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101457569|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
101457570|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457571|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457572|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457573|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457574|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457575|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101457576|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
101457577|NCT00242775|Hormones|hormones|mesh-ancestor
101528426|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101457578|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457579|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101457580|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101457581|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101457582|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457586|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
101457588|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
101457589|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457590|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
101457591|NCT00562198|Carbidopa|carbidopa|mesh-list
101335623|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101335624|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101335626|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101335627|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335628|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457592|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101457593|NCT00562198|Entacapone|entacapone|mesh-list
101457594|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101457595|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101457596|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
101457597|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457598|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457599|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457600|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101457601|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457602|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101457603|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
101457604|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
101457605|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101457606|NCT00220064|Leucovorin|leucovorin|mesh-list
101457607|NCT00220064|Fluorouracil|fluorouracil|mesh-list
101457608|NCT00220064|Irinotecan|irinotecan|mesh-list
101457609|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
101457610|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457611|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457612|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457613|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457614|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
101457615|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457616|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101457617|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101457618|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457619|NCT00220064|Antidotes|antidotes|mesh-ancestor
101457620|NCT00220064|Protective Agents|protective agents|mesh-ancestor
101457621|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
101457622|NCT00220064|Vitamins|vitamins|mesh-ancestor
101457623|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
101457624|NCT00220103|Capecitabine|capecitabine|mesh-list
101457625|NCT00220103|Epirubicin|epirubicin|mesh-list
101457626|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457627|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457628|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
101457629|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457630|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101457631|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101457632|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101457633|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457634|NCT00247026|Ubiquinone|ubiquinone|mesh-list
101457635|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
101457636|NCT00247026|Curcumin|curcumin|mesh-list
101457637|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457638|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457639|NCT00247026|Analgesics|analgesics|mesh-ancestor
101457640|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
101457641|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457642|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457643|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457644|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457645|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457646|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457647|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457648|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
101457649|NCT00247026|Vitamins|vitamins|mesh-ancestor
101457650|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
101457651|NCT01580683|Vitamins|vitamins|mesh-ancestor
101457652|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
101457653|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457654|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
101335629|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101335630|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335631|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335632|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335633|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
101335634|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335635|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335636|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101457662|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457663|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101457664|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457665|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
101457666|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101457667|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101457669|NCT04623385|Isotretinoin|isotretinoin|mesh-list
101457670|NCT04623385|Testosterone|testosterone|mesh-list
101457671|NCT04623385|Androgens|androgens|mesh-ancestor
101457672|NCT04623385|Hormones|hormones|mesh-ancestor
101457673|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457674|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457675|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457676|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
101457677|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457678|NCT00220220|Amlodipine|amlodipine|mesh-list
101457679|NCT00220220|Olmesartan|olmesartan|mesh-list
101457680|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101457681|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101457682|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101457683|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457684|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457685|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101457686|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457687|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
101457688|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101457689|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101457690|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
101457691|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101457692|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
101457693|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457694|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457695|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457696|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457697|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101457698|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
101457699|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457700|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457701|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101457702|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
101457703|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
101457704|NCT00242853|Protective Agents|protective agents|mesh-ancestor
101457705|NCT00220259|Fluticasone|fluticasone|mesh-list
101457706|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457707|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101457708|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
101457709|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457710|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457711|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457712|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457713|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457714|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101457715|NCT04622956|Methotrexate|methotrexate|mesh-list
101457716|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101457717|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
101335637|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101335638|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335639|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
101335640|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101335641|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335642|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335643|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335645|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
101335646|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457718|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101457719|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457725|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457726|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101457727|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457728|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
101457729|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457730|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101457732|NCT04622566|Lenvatinib|lenvatinib|mesh-list
101457733|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457734|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413244|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
101457735|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101457736|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457737|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101457738|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457739|NCT04622488|Diclofenac|diclofenac|mesh-list
101457740|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457741|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457742|NCT04622488|Analgesics|analgesics|mesh-ancestor
101457743|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
101457744|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457745|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457746|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457747|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457748|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101457749|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457750|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457751|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
101457752|NCT00220298|Testosterone|testosterone|mesh-list
101457754|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
101457755|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101457756|NCT00220298|Androgens|androgens|mesh-ancestor
101457757|NCT00220298|Hormones|hormones|mesh-ancestor
101457758|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457759|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457760|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101457761|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457762|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
101457763|NCT00412412|Trastuzumab|trastuzumab|mesh-list
101457764|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101457765|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457766|NCT04621669|Metformin|metformin|mesh-list
101457767|NCT04621669|Digoxin|digoxin|mesh-list
101457768|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101457769|NCT04621669|Calcium|calcium|mesh-list
101457770|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101457771|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457772|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101457773|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101457774|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101457775|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
101457776|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335647|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101335648|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101335650|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101335651|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335652|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335653|NCT00051298|Olanzapine|olanzapine|mesh-list
101335654|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
101457777|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101457778|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101457779|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457780|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101457781|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101457782|NCT04621669|Protective Agents|protective agents|mesh-ancestor
101457783|NCT00412646|Etravirine|etravirine|mesh-list
101457784|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101457785|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101457786|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457787|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457791|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
101457793|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
101457794|NCT00243009|Cyclosporins|cyclosporins|mesh-list
101457795|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457796|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457797|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
101457798|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457799|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457800|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
101457801|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457802|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457803|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
101457804|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457805|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457806|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457807|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101457808|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101457809|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101457810|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
101457811|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101457812|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
101457813|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101457814|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101457815|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
101457816|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457817|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101457818|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101457819|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457820|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457822|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457823|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457824|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101457825|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
101457826|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457827|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457828|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101457829|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101457830|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457831|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
101457832|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101457833|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101457834|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101457835|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457836|NCT00562705|Hormones|hormones|mesh-list
101335656|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335657|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335658|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101335659|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101335660|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101335661|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335662|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101335663|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101457837|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457838|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457839|NCT04620967|Insulin|insulin|mesh-list
101457840|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101457841|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
101457842|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
101457843|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101457844|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101457845|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457846|NCT00220493|Methylphenidate|methylphenidate|mesh-list
101457847|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101457848|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457849|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101457850|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101457851|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457852|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457853|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
101457854|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457855|NCT04620616|Menthol|menthol|mesh-list
101457856|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
101457857|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457858|NCT00220532|Folic Acid|folic acid|mesh-list
101457863|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
101457864|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457865|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101457866|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457867|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
101457868|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457869|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
101457870|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457871|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457872|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101457873|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
101457874|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457875|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457876|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101457878|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457879|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101457880|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101457881|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101457882|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457883|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101457884|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457885|NCT04620031|Propofol|propofol|mesh-list
101457886|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101457887|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457888|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457889|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101457890|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
101457891|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
101457892|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101457893|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101335664|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101335665|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335666|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335667|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335668|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
101335670|NCT00398008|Buprenorphine|buprenorphine|mesh-list
101335671|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101335672|NCT00398008|Narcotics|narcotics|mesh-ancestor
101335673|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101335674|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335675|NCT00398008|Analgesics|analgesics|mesh-ancestor
101335676|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
101335677|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335678|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101335679|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101457894|NCT00220649|Leucovorin|leucovorin|mesh-list
101457895|NCT00220649|Gemcitabine|gemcitabine|mesh-list
101457896|NCT00220649|Fluorouracil|fluorouracil|mesh-list
101457897|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
101457898|NCT00220649|Irinotecan|irinotecan|mesh-list
101457899|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457900|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
101457901|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457902|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457903|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457904|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
101457905|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457906|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101457907|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101457908|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457909|NCT00220649|Antidotes|antidotes|mesh-ancestor
101457910|NCT00220649|Protective Agents|protective agents|mesh-ancestor
101457911|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
101457912|NCT00220649|Vitamins|vitamins|mesh-ancestor
101457913|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
101457914|NCT04619758|Emollients|emollients|mesh-list
101457915|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457916|NCT04619914|Letrozole|letrozole|mesh-list
101457917|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457918|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101457919|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101457920|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101441647|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457921|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457922|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101457923|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
101457924|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457925|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457926|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
101457927|NCT00220766|Antibodies|antibodies|mesh-list
101457928|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
101457929|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101457930|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101457931|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
101457932|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
101457946|NCT00220844|Desipramine|desipramine|mesh-list
101457947|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101457948|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
101457949|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457950|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457951|NCT00220844|Analgesics|analgesics|mesh-ancestor
101335683|NCT00051493|Carboplatin|carboplatin|mesh-list
101335684|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335685|NCT00051532|Seocalcitol|seocalcitol|mesh-list
101335686|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335687|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335688|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
101335689|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335690|NCT00051571|Docetaxel|docetaxel|mesh-list
101335691|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335692|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
101457952|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
101457953|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457954|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457955|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101457956|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101457957|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457958|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457959|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457960|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457961|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457962|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
101457963|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101457964|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457965|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101457966|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
101457967|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101457968|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457969|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457970|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457971|NCT04619251|Itraconazole|itraconazole|mesh-list
101457972|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
101457973|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457974|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101457975|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101457976|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457977|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457978|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101457979|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
101457980|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457981|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457982|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101457983|NCT00243399|Oxandrolone|oxandrolone|mesh-list
101457984|NCT00243399|Androgens|androgens|mesh-ancestor
101457985|NCT00243399|Hormones|hormones|mesh-ancestor
101457986|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457987|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457988|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
101457989|NCT00220922|Ethanol|ethanol|mesh-list
101457990|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101457991|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457992|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458002|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458003|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
101458004|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458005|NCT00221039|Methoxsalen|methoxsalen|mesh-list
101458006|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101335693|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335694|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335695|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335696|NCT05573958|Aspirin|aspirin|mesh-list
101335697|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
101335698|NCT05573958|Clopidogrel|clopidogrel|mesh-list
101335699|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101335700|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101335701|NCT05573958|Analgesics|analgesics|mesh-ancestor
101335702|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
101335703|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335704|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335705|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335706|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335707|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458007|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
101458008|NCT00562939|Vaccines|vaccines|mesh-list
101458009|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101458010|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
101458011|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458012|NCT00221156|Acarbose|acarbose|mesh-list
101458013|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101458014|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458015|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458016|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101458017|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458018|NCT04617613|Amoxicillin|amoxicillin|mesh-list
101458019|NCT04617613|Metronidazole|metronidazole|mesh-list
101458020|NCT04617613|Clarithromycin|clarithromycin|mesh-list
101458021|NCT04617613|Omeprazole|omeprazole|mesh-list
101458022|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458023|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458024|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101458025|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101458026|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101458027|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458028|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101458029|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458030|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458031|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101458032|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101458033|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458034|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
101458035|NCT04617652|Analgesics|analgesics|mesh-ancestor
101458036|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
101458037|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458038|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458039|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
101458040|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458041|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101458042|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
101458043|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101458044|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458045|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458046|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101458047|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
101458048|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101458049|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101335708|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101335709|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335710|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101335711|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335712|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335713|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
101335714|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101335715|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101335716|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101335717|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
101335718|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335719|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101335720|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
101335721|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101335722|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
101335723|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
101335724|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
101458050|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101458051|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458052|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101458053|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101458054|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458055|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458059|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101458060|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458062|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101458063|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
101458064|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101458065|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458066|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101458067|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
101458068|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458069|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458070|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
101458071|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458072|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101458073|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458074|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
101442272|NCT05420350|Bupropion|bupropion|mesh-list
101458075|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458076|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101458078|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101458079|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101458080|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
101458081|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
101458082|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458083|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458084|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458085|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
101458087|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458088|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101458089|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101458090|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335725|NCT00051688|Tezacitabine|tezacitabine|mesh-list
101335726|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335727|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335728|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335729|NCT00051844|Capravirine|capravirine|mesh-list
101335730|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101335731|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101335732|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335733|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335734|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
101335735|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335736|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101335737|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101458091|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458092|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101458093|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
101458094|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458095|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458096|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101458097|NCT00221429|Valproic Acid|valproic acid|mesh-list
101458098|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458099|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458100|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458101|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
101458102|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458103|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458104|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458105|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
101458106|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
101458107|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458108|NCT00563017|Risperidone|risperidone|mesh-list
101458109|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101458110|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
101458111|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458112|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458113|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458114|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101458115|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458116|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458117|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458118|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101458119|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
101458120|NCT00563056|Fluticasone|fluticasone|mesh-list
101458121|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
101458122|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101458123|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
101458124|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458125|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458126|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101458131|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458132|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458133|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458134|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458135|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
101458136|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101458138|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458139|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
101458141|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101458142|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
101335738|NCT00052000|Antibodies|antibodies|mesh-list
101335739|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101335740|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
101335741|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335742|NCT00052039|Interferons|interferons|mesh-list
101335743|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
101335744|NCT00052039|Azathioprine|azathioprine|mesh-list
101335745|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335746|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
101335747|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335748|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
101335749|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458143|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458144|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101458145|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458146|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458147|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458148|NCT00563212|Interferons|interferons|mesh-list
101458149|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
101458150|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458151|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
101458152|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458153|NCT00563251|Azithromycin|azithromycin|mesh-list
101458154|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458155|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458156|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101458157|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101458158|NCT00251082|Estradiol|estradiol|mesh-list
101458159|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101458160|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
101458161|NCT00251082|Estrogens|estrogens|mesh-ancestor
101458162|NCT00251082|Hormones|hormones|mesh-ancestor
101458163|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458164|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458165|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101458166|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
101458167|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101458168|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101458169|NCT00251082|Progestins|progestins|mesh-ancestor
101458170|NCT00221624|Ribavirin|ribavirin|mesh-list
101458171|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101458172|NCT00221624|Amantadine|amantadine|mesh-list
101458173|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
101458174|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458175|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
101458176|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458177|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101458178|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101458179|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
101458180|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442624|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458181|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458182|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458183|NCT00221624|Analgesics|analgesics|mesh-ancestor
101458184|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
101458185|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458186|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
101458187|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101458188|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
101458189|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101458190|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101458191|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458192|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458193|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
101458194|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101458195|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
101335750|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335751|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335752|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
101335753|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335754|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335755|NCT00052117|Capravirine|capravirine|mesh-list
101335756|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101335757|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101335758|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458196|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458197|NCT04615702|Acetaminophen|acetaminophen|mesh-list
101458198|NCT04615702|Metronidazole|metronidazole|mesh-list
101458199|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
101458205|NCT04615702|Bilirubin|bilirubin|mesh-list
101458206|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458207|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458208|NCT04615702|Analgesics|analgesics|mesh-ancestor
101458209|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
101458210|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458211|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
101458212|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458213|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458214|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101458215|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101458216|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458217|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458218|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101458219|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458220|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458221|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101458222|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101458223|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458224|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101458225|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458226|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101458227|NCT04615702|Narcotics|narcotics|mesh-ancestor
101458228|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458229|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458230|NCT04615702|Hormones|hormones|mesh-ancestor
101458231|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458232|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
101458233|NCT04615702|Protective Agents|protective agents|mesh-ancestor
101458234|NCT04615351|Metformin|metformin|mesh-list
101458235|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101458236|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458237|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
101458238|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101458239|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
101458240|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458241|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
101458242|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458243|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101458244|NCT04614727|Calcium|calcium|mesh-list
101458245|NCT04614727|Fluorides|fluorides|mesh-list
101458246|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101458247|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458248|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
101458249|NCT04614727|Protective Agents|protective agents|mesh-ancestor
101458250|NCT04614298|Brodalumab|brodalumab|mesh-list
101458251|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
101458252|NCT04614259|Bupivacaine|bupivacaine|mesh-list
101458253|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
101458254|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
101458255|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458256|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335759|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335760|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
101335762|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101335763|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101335764|NCT00052273|Capecitabine|capecitabine|mesh-list
101335765|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335766|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
101335767|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335768|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335769|NCT00052312|Paclitaxel|paclitaxel|mesh-list
101335770|NCT00052312|Doxorubicin|doxorubicin|mesh-list
101335771|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101335772|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335773|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335774|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101335775|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101458257|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
101458258|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458259|NCT00412763|Silymarin|silymarin|mesh-list
101458260|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
101458261|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458262|NCT00412763|Protective Agents|protective agents|mesh-ancestor
101458263|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458264|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
101458265|NCT00563446|Hematinics|hematinics|mesh-ancestor
101458266|NCT00563485|Doxazosin|doxazosin|mesh-list
101458267|NCT00563485|Terazosin|terazosin|mesh-list
101458268|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101458269|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101458270|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101458271|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101458272|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458275|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458276|NCT00563485|Urological Agents|urological agents|mesh-ancestor
101458277|NCT00251277|Rituximab|rituximab|mesh-list
101458278|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458279|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458280|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
101458281|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458282|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458283|NCT00412802|Enoxaparin|enoxaparin|mesh-list
101458284|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
101458285|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
101458286|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458287|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101458288|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458289|NCT00563524|Fezakinumab|fezakinumab|mesh-list
101458290|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
101335780|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335781|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335783|NCT00052351|Paclitaxel|paclitaxel|mesh-list
101335784|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
101335785|NCT00052351|Doxorubicin|doxorubicin|mesh-list
101335786|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101335787|NCT00052351|Vaccines|vaccines|mesh-list
101335788|NCT00052351|Sargramostim|sargramostim|mesh-list
101335789|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
101335790|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335791|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101458300|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
101458301|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458316|NCT00251355|Gemcitabine|gemcitabine|mesh-list
101458317|NCT00251355|Fluorouracil|fluorouracil|mesh-list
101458318|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101458319|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
101458320|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458321|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458322|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458323|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
101458324|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458325|NCT02962388|Anagrelide|anagrelide|mesh-list
101458326|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458327|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101458328|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458329|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101458330|NCT04613167|Evolocumab|evolocumab|mesh-list
101458331|NCT04613167|Alirocumab|alirocumab|mesh-list
101458332|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101458333|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101458334|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101458335|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
101458336|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458337|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101458338|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
101458339|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458340|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101335794|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335795|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335796|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335797|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335798|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335799|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335800|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
101335801|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335802|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335803|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335804|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335805|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335806|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335807|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458341|NCT04613284|Durvalumab|durvalumab|mesh-list
101458342|NCT04613284|Endostar protein|endostar protein|mesh-list
101458343|NCT04613284|Endostatins|endostatins|mesh-list
101458344|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458345|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458346|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101458348|NCT04613284|Growth Substances|growth substances|mesh-ancestor
101458349|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458350|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
101458351|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101458352|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
101458353|NCT00248118|Bupropion|bupropion|mesh-list
101458354|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101458355|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
101458356|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458357|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101458358|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101458359|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458360|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458361|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
101458362|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458363|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458364|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101458365|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458366|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458367|NCT04612894|Apatinib|apatinib|mesh-list
101458368|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458369|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101458370|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458371|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458372|NCT00251394|Rituximab|rituximab|mesh-list
101458373|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458374|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458375|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
101458376|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458377|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458378|NCT00221975|Lamotrigine|lamotrigine|mesh-list
101458379|NCT00221975|Valproic Acid|valproic acid|mesh-list
101458380|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458381|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458382|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458383|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
101458384|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101335808|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101335809|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101335810|NCT00052390|Bevacizumab|bevacizumab|mesh-list
101335811|NCT00052390|Doxorubicin|doxorubicin|mesh-list
101335812|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101335813|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335814|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335815|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101335816|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101335817|NCT00052390|Growth Substances|growth substances|mesh-ancestor
101335818|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335819|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
101335820|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335821|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335822|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335823|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458385|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458386|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458387|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
101458388|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101458389|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458390|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101458391|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101458392|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101458393|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
101458394|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458395|NCT04612582|Thalidomide|thalidomide|mesh-list
101458396|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
101458397|NCT04612582|Bortezomib|bortezomib|mesh-list
101458398|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458399|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
101458400|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458401|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458402|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101458403|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
101458404|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458405|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458407|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
101458408|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458409|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458410|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101458411|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101458412|NCT04612582|Growth Substances|growth substances|mesh-ancestor
101458413|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
101458414|NCT00248157|Octreotide|octreotide|mesh-list
101458415|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458416|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101458417|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458418|NCT00251472|Paclitaxel|paclitaxel|mesh-list
101458419|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101458420|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458423|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101458424|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458426|NCT00222053|Thalidomide|thalidomide|mesh-list
101458427|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458428|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
101335824|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335827|NCT00052468|Carboplatin|carboplatin|mesh-list
101335828|NCT00052468|Gemcitabine|gemcitabine|mesh-list
101335829|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335830|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335831|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
101335832|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335833|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335834|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335835|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335836|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
101458429|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458430|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
101458431|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458432|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458433|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101458434|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101458435|NCT00222053|Growth Substances|growth substances|mesh-ancestor
101458436|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
101458437|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458438|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101458439|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
101458440|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458441|NCT04611958|Bupivacaine|bupivacaine|mesh-list
101458442|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
101458443|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
101458444|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458445|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458446|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
101458447|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458448|NCT00412919|Azacitidine|azacitidine|mesh-list
101458449|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101458450|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
101458451|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458452|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458453|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458454|NCT00222170|Rabeprazole|rabeprazole|mesh-list
101458455|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101458456|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458457|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101458458|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458459|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458460|NCT04611724|Folfirinox|folfirinox|mesh-list
101458461|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458463|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101458464|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
101458465|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458466|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458467|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458468|NCT00563836|Catumaxomab|catumaxomab|mesh-list
101458469|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458470|NCT00563875|Aspirin|aspirin|mesh-list
101458471|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101458472|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458473|NCT00563875|Analgesics|analgesics|mesh-ancestor
101458474|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
101458475|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458476|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335838|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335839|NCT00052585|Leucovorin|leucovorin|mesh-list
101335840|NCT00052585|Fluorouracil|fluorouracil|mesh-list
101335841|NCT00052585|Irinotecan|irinotecan|mesh-list
101335842|NCT00052585|Gefitinib|gefitinib|mesh-list
101335843|NCT00052585|Calcium|calcium|mesh-list
101335844|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
101335845|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101335846|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335847|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
101335848|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335849|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335850|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335851|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335852|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
101335853|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101335854|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335855|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335856|NCT00052585|Antidotes|antidotes|mesh-ancestor
101335857|NCT00052585|Protective Agents|protective agents|mesh-ancestor
101335858|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
101335860|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
101335861|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335862|NCT00052780|Temozolomide|temozolomide|mesh-list
101335863|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101335864|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335865|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
101335866|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335867|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458477|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458478|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458479|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458480|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101458481|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458482|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101458483|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101458484|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458485|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
101458486|NCT04611685|Parecoxib|parecoxib|mesh-list
101458487|NCT04611685|Loxoprofen|loxoprofen|mesh-list
101458488|NCT04611685|Tramadol|tramadol|mesh-list
101458489|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101458490|NCT04611685|Narcotics|narcotics|mesh-ancestor
101458491|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458492|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458493|NCT04611685|Analgesics|analgesics|mesh-ancestor
101335868|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335869|NCT00052936|Prednisone|prednisone|mesh-list
101335870|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
101335871|NCT00052936|Rituximab|rituximab|mesh-list
101335872|NCT00052936|Doxorubicin|doxorubicin|mesh-list
101335873|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101335874|NCT00052936|Vincristine|vincristine|mesh-list
101335875|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335876|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
101335877|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335878|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335879|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335881|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335883|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335884|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335885|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101335886|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335887|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335923|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335924|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
101335925|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335927|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
101335928|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101335929|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101335930|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335931|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335932|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
101335933|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
101335934|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335987|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101335988|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101335989|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101335990|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101335991|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101335992|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101335993|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101335994|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101335995|NCT00053716|Alprostadil|alprostadil|mesh-list
101335996|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101335997|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101335998|NCT00053716|Urological Agents|urological agents|mesh-ancestor
101335999|NCT02970175|Terlipressin|terlipressin|mesh-list
101336000|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101336001|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101336002|NCT00053833|Irinotecan|irinotecan|mesh-list
101336003|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101336004|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336005|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336043|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101336044|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336045|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336046|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336047|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
101336048|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336049|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101336062|NCT00053950|NSC 366140|nsc 366140|mesh-list
101336112|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336113|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101336114|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101336115|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336116|NCT05560230|Clonidine|clonidine|mesh-list
101336117|NCT05560230|Analgesics|analgesics|mesh-ancestor
101336118|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
101413270|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101336119|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336120|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336121|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101336122|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
101336123|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
101336124|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101336125|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101336126|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101336127|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
101336128|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336129|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336130|NCT00054457|Docetaxel|docetaxel|mesh-list
101336131|NCT00054457|Capecitabine|capecitabine|mesh-list
101336132|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336133|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336134|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336135|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336136|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336145|NCT00054535|Vaccines|vaccines|mesh-list
101336160|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336161|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336163|NCT00054886|Sunitinib|sunitinib|mesh-list
101336164|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336165|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336166|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101336167|NCT00054886|Growth Substances|growth substances|mesh-ancestor
101336168|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336169|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336170|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443739|NCT01718158|Ribavirin|ribavirin|mesh-list
101336171|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336172|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336173|NCT02970097|Fentanyl|fentanyl|mesh-list
101336174|NCT02970097|Midazolam|midazolam|mesh-list
101336175|NCT02970097|Ropivacaine|ropivacaine|mesh-list
101336177|NCT02970097|Narcotics|narcotics|mesh-ancestor
101336219|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
101336220|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336221|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336222|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336223|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336224|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
101336225|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336226|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101336227|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336228|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101336229|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336230|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
101336232|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101336233|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
101336234|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336236|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101336274|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
101336275|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336276|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336277|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336278|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101336279|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336281|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
101336282|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
101336283|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
101336284|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101336285|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101336286|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336288|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336337|NCT00055861|Growth Substances|growth substances|mesh-ancestor
101336338|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336339|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336340|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
101336341|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336342|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336343|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336344|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336345|NCT00392106|Amiodarone|amiodarone|mesh-list
101336346|NCT00392106|Flecainide|flecainide|mesh-list
101336347|NCT00392106|Propafenone|propafenone|mesh-list
101336348|NCT00392106|Dofetilide|dofetilide|mesh-list
101336349|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101336350|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
101336351|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101336352|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336353|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336354|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101336355|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101336356|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336357|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336389|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
101336391|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336392|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
101336393|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336394|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336395|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336396|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
101336397|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443743|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
101336398|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336399|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101336400|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336401|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
101336402|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336403|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
101336404|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336405|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336406|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101336408|NCT00056329|Tocopherols|tocopherols|mesh-list
101336409|NCT00056329|Vitamins|vitamins|mesh-ancestor
101336410|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
101336411|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336412|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
101336414|NCT00056329|Protective Agents|protective agents|mesh-ancestor
101336439|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101336440|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
101336441|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336442|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336443|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336444|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336445|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
101336446|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336447|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101336448|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336449|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101336450|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
101336451|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336452|NCT00398437|Trastuzumab|trastuzumab|mesh-list
101336498|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336499|NCT05410197|Gemcitabine|gemcitabine|mesh-list
101336500|NCT05410197|Lenvatinib|lenvatinib|mesh-list
101336501|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336502|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336503|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
101336504|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336505|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336506|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336507|NCT03262454|Atezolizumab|atezolizumab|mesh-list
101336508|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101336509|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336510|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336511|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336512|NCT00057031|Calcitriol|calcitriol|mesh-list
101336513|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336514|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336515|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101336516|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336517|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336518|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101336519|NCT00057031|Vitamins|vitamins|mesh-ancestor
101336520|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
101336522|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
101336523|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336525|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336526|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336527|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336539|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336540|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336541|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336542|NCT00057343|Rituximab|rituximab|mesh-list
101336543|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336544|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336545|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
101336546|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336547|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336548|NCT00057382|Doxorubicin|doxorubicin|mesh-list
101336549|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101336550|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336551|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101336552|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336553|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336554|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336555|NCT00057421|Prednisolone|prednisolone|mesh-list
101336556|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336557|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
101336558|NCT00057421|Hormones|hormones|mesh-ancestor
101336559|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336590|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336591|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
101336592|NCT05309304|Cefazolin|cefazolin|mesh-list
101336593|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336594|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336595|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
101336596|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336597|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336598|NCT00058006|Celecoxib|celecoxib|mesh-list
101336599|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101336600|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101336601|NCT00058006|Analgesics|analgesics|mesh-ancestor
101336602|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
101336603|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336604|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336605|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336651|NCT00058201|Calcium|calcium|mesh-list
101336652|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
101336653|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336654|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
101336655|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336656|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336657|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336658|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336659|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336660|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
101336661|NCT00058201|Antidotes|antidotes|mesh-ancestor
101336662|NCT00058201|Protective Agents|protective agents|mesh-ancestor
101336664|NCT00058201|Vitamins|vitamins|mesh-ancestor
101336712|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336713|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336714|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336715|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101336716|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101336717|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101336718|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
101336719|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336720|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336721|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336722|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336723|NCT00058903|Sertraline|sertraline|mesh-list
101336724|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
101336725|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101336726|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101336727|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101336728|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336729|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336730|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336731|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
101336732|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336762|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336764|NCT05223582|Hormones|hormones|mesh-ancestor
101336765|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336766|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336767|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336768|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336769|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101336770|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336771|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336772|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
101336773|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336774|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101336775|NCT00059722|Gefitinib|gefitinib|mesh-list
101336776|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336777|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336778|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336779|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336780|NCT02969239|Phenylephrine|phenylephrine|mesh-list
101336839|NCT00060112|Oblimersen|oblimersen|mesh-list
101336891|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101336892|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
101336893|NCT05105685|Hormones|hormones|mesh-list
101336894|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336895|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336896|NCT05325164|Morphine|morphine|mesh-list
101336897|NCT05325164|Methadone|methadone|mesh-list
101336898|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101336899|NCT05325164|Narcotics|narcotics|mesh-ancestor
101336900|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336901|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336902|NCT05325164|Analgesics|analgesics|mesh-ancestor
101336903|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
101336904|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336905|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
101336906|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
101336907|NCT00060385|Prednisone|prednisone|mesh-list
101336908|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
101336909|NCT00060385|Doxorubicin|doxorubicin|mesh-list
101336910|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101336911|NCT00060385|Etoposide|etoposide|mesh-list
101336912|NCT00060385|Vincristine|vincristine|mesh-list
101336913|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336914|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
101336942|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101336943|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101336944|NCT02968693|Calcium|calcium|mesh-list
101336945|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336946|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336947|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336948|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
101336949|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
101336950|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101336951|NCT02968693|Protective Agents|protective agents|mesh-ancestor
101336952|NCT00060502|Infliximab|infliximab|mesh-list
101336953|NCT00060502|Gemcitabine|gemcitabine|mesh-list
101336954|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336955|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
101336956|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336957|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336958|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101336959|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336960|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336961|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101336962|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336963|NCT05312372|Paclitaxel|paclitaxel|mesh-list
101336964|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336965|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336966|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336967|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336968|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336969|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336970|NCT05038410|Wobenzym|wobenzym|mesh-list
101336971|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101336972|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
101336973|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336974|NCT05030493|Bevacizumab|bevacizumab|mesh-list
101336975|NCT05030493|Panitumumab|panitumumab|mesh-list
101336976|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458501|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458502|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458504|NCT00563914|Amodiaquine|amodiaquine|mesh-list
101458505|NCT00563914|Ferroquine|ferroquine|mesh-list
101458506|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
101336977|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336978|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336979|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101336980|NCT05030493|Growth Substances|growth substances|mesh-ancestor
101336981|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336982|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336983|NCT02968498|Methamphetamine|methamphetamine|mesh-list
101336984|NCT02968498|Lactulose|lactulose|mesh-list
101336985|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101336986|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101336987|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336988|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
101336989|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
101337036|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337037|NCT00061243|Vaccines|vaccines|mesh-list
101337038|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
101337039|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337040|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101337041|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101337042|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101337043|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101337044|NCT00061321|Nevirapine|nevirapine|mesh-list
101337045|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101337046|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101337047|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337048|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337049|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
101337050|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337051|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101337053|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101337054|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101337055|NCT00061360|Cyclosporine|cyclosporine|mesh-list
101337056|NCT00061360|Sirolimus|sirolimus|mesh-list
101337057|NCT00061360|Cyclosporins|cyclosporins|mesh-list
101337058|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337059|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337060|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337061|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
101337062|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337063|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
101337064|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337065|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
101337066|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337067|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101337078|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337079|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337080|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337081|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101337082|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101337083|NCT02968342|Progesterone|progesterone|mesh-list
101337084|NCT02968342|Progestins|progestins|mesh-ancestor
101337085|NCT02968342|Hormones|hormones|mesh-ancestor
101337086|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337087|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337088|NCT02968303|Vemurafenib|vemurafenib|mesh-list
101337089|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337090|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337093|NCT00061516|Brinzolamide|brinzolamide|mesh-list
101337137|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337138|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337139|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337140|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337141|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337142|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337143|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337144|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337146|NCT00398554|Prednisone|prednisone|mesh-list
101337147|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
101337148|NCT00398554|Doxorubicin|doxorubicin|mesh-list
101337149|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101337150|NCT00398554|Etoposide|etoposide|mesh-list
101337151|NCT00398554|Vincristine|vincristine|mesh-list
101337152|NCT00398554|Vinblastine|vinblastine|mesh-list
101337197|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337198|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337199|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337200|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337201|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
101337202|NCT00062023|Aspirin|aspirin|mesh-list
101337203|NCT00062023|Sulindac|sulindac|mesh-list
101337204|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101337205|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101337206|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337207|NCT00062023|Analgesics|analgesics|mesh-ancestor
101337208|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
101444266|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
101337209|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337210|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337211|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337212|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337213|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458507|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101458508|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101458509|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458510|NCT00563953|Doxorubicin|doxorubicin|mesh-list
101458511|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101458512|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458513|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101458514|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101458515|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458516|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458517|NCT00563992|Valproic Acid|valproic acid|mesh-list
101458518|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458519|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458520|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458521|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
101458522|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458523|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458524|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458525|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
101458526|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
101458527|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458528|NCT00251550|Pemetrexed|pemetrexed|mesh-list
101458529|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458530|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458531|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458532|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101458533|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101458534|NCT04611373|Levamisole|levamisole|mesh-list
101458535|NCT04611373|Acetazolamide|acetazolamide|mesh-list
101458536|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
101458537|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101458538|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458539|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458540|NCT04611373|Diuretics|diuretics|mesh-ancestor
101458541|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
101458542|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458543|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101458544|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
101337215|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337216|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101337217|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337218|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337219|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
101337220|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101337221|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337222|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337223|NCT00062062|Paclitaxel|paclitaxel|mesh-list
101337224|NCT00062062|Carboplatin|carboplatin|mesh-list
101337225|NCT00062062|Gefitinib|gefitinib|mesh-list
101337226|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101337227|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337228|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337229|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337230|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337231|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337237|NCT00392340|Topotecan|topotecan|mesh-list
101337269|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337270|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337271|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
101337272|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337273|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337274|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101337275|NCT00062179|Celecoxib|celecoxib|mesh-list
101337276|NCT00062179|Paclitaxel|paclitaxel|mesh-list
101337277|NCT00062179|Carboplatin|carboplatin|mesh-list
101337278|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101337279|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337280|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337281|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337282|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337283|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337284|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101337285|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337286|NCT00062179|Analgesics|analgesics|mesh-ancestor
101337287|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
101337288|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337289|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337290|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337291|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337292|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337293|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337294|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337295|NCT00062257|Irofulven|irofulven|mesh-list
101337296|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337297|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
101337298|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337299|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337300|NCT00062296|Rituximab|rituximab|mesh-list
101337301|NCT00062296|Epirubicin|epirubicin|mesh-list
101458545|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
101458546|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
101458547|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101458548|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458549|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458550|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101458551|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
101337302|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337303|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337304|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
101337305|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337306|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337307|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337308|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101337309|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337310|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337311|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337312|NCT05183984|Bevacizumab|bevacizumab|mesh-list
101337313|NCT05183984|Niraparib|niraparib|mesh-list
101337314|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337315|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337316|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101337317|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101337318|NCT05183984|Growth Substances|growth substances|mesh-ancestor
101444338|NCT04171453|Pregabalin|pregabalin|mesh-list
101337319|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337320|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101337321|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101337355|NCT00062881|Mafosfamide|mafosfamide|mesh-list
101337356|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101337357|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
101337358|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337359|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337360|NCT00389909|Doxapram|doxapram|mesh-list
101337361|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101337362|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337363|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
101337364|NCT00063076|Bexarotene|bexarotene|mesh-list
101337365|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337366|NCT00063193|Minocycline|minocycline|mesh-list
101337367|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337368|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337369|NCT00063310|Leuprolide|leuprolide|mesh-list
101337370|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101337371|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
101337372|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101337376|NCT00063388|Cetuximab|cetuximab|mesh-list
101337413|NCT02967172|Analgesics|analgesics|mesh-ancestor
101337414|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
101337415|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337416|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
101337417|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
101337418|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101337419|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101337420|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
101337421|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337422|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337423|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101337425|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
101337475|NCT00392418|Micronutrients|micronutrients|mesh-list
101337476|NCT00392418|Trace Elements|trace elements|mesh-list
101337477|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337478|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
101337479|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
101337480|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101337481|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101337482|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337483|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337484|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337485|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337486|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101337487|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
101337488|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101337489|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101337490|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
101337491|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337492|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337493|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101337494|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
101337495|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101337496|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101337497|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101337498|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101337499|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337500|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337501|NCT00423748|Ambrisentan|ambrisentan|mesh-list
101337502|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101337503|NCT02967211|Insulin|insulin|mesh-list
101337504|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101337505|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
101337520|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337521|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337522|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
101337523|NCT00398749|Hematinics|hematinics|mesh-ancestor
101337524|NCT00398788|Hydromorphone|hydromorphone|mesh-list
101337525|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101337526|NCT00398788|Narcotics|narcotics|mesh-ancestor
101337527|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101337528|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337529|NCT00398788|Analgesics|analgesics|mesh-ancestor
101337530|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
101337532|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
101337586|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337587|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337588|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101337589|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101337590|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101337591|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101337592|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
101337593|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
101337594|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337595|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
101337596|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
101337597|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
101337598|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101337599|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101337600|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
101337601|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101337602|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101337603|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101337604|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101337605|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101337639|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337640|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337641|NCT00066001|Metronidazole|metronidazole|mesh-list
101337642|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337643|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337644|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101337645|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101337646|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101337708|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337709|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101337710|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337711|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337712|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337713|NCT04388475|Temozolomide|temozolomide|mesh-list
101337714|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337715|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
101337716|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337717|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337719|NCT00389987|Piperacillin|piperacillin|mesh-list
101337720|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337721|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337722|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337723|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101337764|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
101337765|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
101337766|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337767|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337768|NCT00067093|Vitamin K|vitamin k|mesh-list
101337769|NCT00067093|Heparin|heparin|mesh-list
101337770|NCT00067093|Calcium heparin|calcium heparin|mesh-list
101337771|NCT00067093|Idraparinux|idraparinux|mesh-list
101337772|NCT00067093|Vitamins|vitamins|mesh-ancestor
101337773|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
101337774|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337775|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
101337776|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101337777|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101337778|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337779|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101337780|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
101337781|NCT00067093|Coagulants|coagulants|mesh-ancestor
101337782|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101337783|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
101337784|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101337785|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
101337786|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337787|NCT00398905|Enoxaparin|enoxaparin|mesh-list
101337788|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
101337789|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101337815|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101337816|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101337817|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101337818|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101337819|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337820|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337821|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337823|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
101337824|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337825|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337826|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337827|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
101337828|NCT00065533|Pemetrexed|pemetrexed|mesh-list
101337829|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337830|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337869|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337870|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337871|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337873|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
101337874|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337875|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337876|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337877|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
101337878|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101337879|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
101337880|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337881|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337882|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101337883|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337884|NCT00067951|Metformin|metformin|mesh-list
101337926|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337927|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337928|NCT00068653|Celecoxib|celecoxib|mesh-list
101337929|NCT00068653|Gefitinib|gefitinib|mesh-list
101337930|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101337931|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337932|NCT00068653|Analgesics|analgesics|mesh-ancestor
101337933|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
101337934|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337935|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337936|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337989|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337990|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337991|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
101337992|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
101337993|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101337994|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101337995|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101337997|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
101337998|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101337999|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
101338000|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338001|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338002|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
101338003|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338004|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
101338008|NCT00069706|Latanoprost|latanoprost|mesh-list
101338048|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
101338050|NCT00070174|Methotrexate|methotrexate|mesh-list
101338051|NCT00070174|Etoposide|etoposide|mesh-list
101338052|NCT00070174|Daunorubicin|daunorubicin|mesh-list
101338053|NCT00070174|Asparaginase|asparaginase|mesh-list
101338054|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
101338055|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
101338056|NCT00070174|Cyclosporins|cyclosporins|mesh-list
101338057|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338058|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
101338059|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338060|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338061|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338062|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
101338063|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338064|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338070|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
101338110|NCT00070252|Tipifarnib|tipifarnib|mesh-list
101338111|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338112|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338113|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338114|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338115|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338116|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338118|NCT00070447|Prednisone|prednisone|mesh-list
101338119|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
101338120|NCT00070447|Rituximab|rituximab|mesh-list
101338121|NCT00070447|Doxorubicin|doxorubicin|mesh-list
101338122|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101338123|NCT00070447|Vincristine|vincristine|mesh-list
101338124|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338125|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
101338172|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338173|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101338174|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101338175|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101338176|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338177|NCT00070525|Tipifarnib|tipifarnib|mesh-list
101338178|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338179|NCT00070642|Dacarbazine|dacarbazine|mesh-list
101338180|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338181|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
101338182|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338183|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338184|NCT00070759|Daclizumab|daclizumab|mesh-list
101338185|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338234|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338235|NCT02966743|Analgesics|analgesics|mesh-ancestor
101338236|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
101338237|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338238|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101338239|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101338240|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101338241|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
101444707|NCT02434744|Metformin|metformin|mesh-list
101338242|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338243|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338244|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101338245|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101338246|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101338247|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338248|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101338249|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
101338250|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
101338251|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
101338252|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
101338253|NCT00071539|Immunotoxins|immunotoxins|mesh-list
101338254|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
101338288|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
101338289|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101338290|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
101338291|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338292|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338293|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101338294|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
101338295|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101338296|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
101338297|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338298|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338299|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101338300|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
101338350|NCT04730596|Ketamine|ketamine|mesh-list
101338351|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101338352|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338353|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338354|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338355|NCT04730596|Analgesics|analgesics|mesh-ancestor
101338356|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
101338357|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338358|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101338359|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101338360|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101338361|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101338362|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338363|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338364|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101338365|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101338366|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
101338368|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101338370|NCT00072085|Aldesleukin|aldesleukin|mesh-list
101338404|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
101338405|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338406|NCT00072163|Thalidomide|thalidomide|mesh-list
101338407|NCT00072163|Temozolomide|temozolomide|mesh-list
101338408|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338409|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
101338410|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338411|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338412|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338413|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
101338414|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338415|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
101338416|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101338417|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338418|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101338419|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101338461|NCT00072553|Leucovorin|leucovorin|mesh-list
101338462|NCT00072553|Celecoxib|celecoxib|mesh-list
101338463|NCT00072553|Fluorouracil|fluorouracil|mesh-list
101338464|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
101338465|NCT00072553|Calcium|calcium|mesh-list
101338466|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
101338467|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101338468|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338469|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
101338470|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338471|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338472|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338473|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338474|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
101338475|NCT00072553|Antidotes|antidotes|mesh-ancestor
101338476|NCT00072553|Protective Agents|protective agents|mesh-ancestor
101338477|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
101338478|NCT00072553|Vitamins|vitamins|mesh-ancestor
101338479|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
101338480|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101338481|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338482|NCT00072553|Analgesics|analgesics|mesh-ancestor
101338483|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
101338484|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338485|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338486|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338487|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101338488|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101338489|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338491|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338492|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458552|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101458553|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
101458554|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101458555|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458556|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101458557|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101458558|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101458559|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458565|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338493|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
101338494|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338495|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338496|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101338497|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338498|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101338499|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338500|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338502|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338503|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
101338504|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338505|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338506|NCT02966704|Caseins|caseins|mesh-list
101338507|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
101338508|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
101338509|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338510|NCT00072748|EKB 569|ekb 569|mesh-list
101338511|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338512|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101338513|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338514|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338515|NCT00072787|Cisplatin|cisplatin|mesh-list
101338516|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338517|NCT00072826|Acetylcholine|acetylcholine|mesh-list
101338518|NCT00072826|Oxypurinol|oxypurinol|mesh-list
101338519|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101338615|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
101338616|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338617|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338618|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338619|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
101338620|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
101338621|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101338622|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101338623|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
101338624|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338628|NCT00073840|Albuterol|albuterol|mesh-list
101338680|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338681|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
101338682|NCT00074191|Hormones|hormones|mesh-ancestor
101338683|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338684|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101338685|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338686|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101338746|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338747|NCT04730245|Rifaximin|rifaximin|mesh-list
101338748|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101338749|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338750|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338751|NCT00074620|Hirudins|hirudins|mesh-list
101338752|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
101338753|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101338813|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338814|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101338815|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101338816|NCT00075205|Rimonabant|rimonabant|mesh-list
101338822|NCT00075205|Hormones|hormones|mesh-ancestor
101338885|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338886|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
101338887|NCT00075673|Celecoxib|celecoxib|mesh-list
101338888|NCT00075673|Vinorelbine|vinorelbine|mesh-list
101338889|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101338890|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338891|NCT00075673|Analgesics|analgesics|mesh-ancestor
101338892|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
101338893|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338894|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338895|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338896|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338897|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101338898|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101338899|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338900|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445912|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338901|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338906|NCT00075712|Paclitaxel|paclitaxel|mesh-list
101338942|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101338943|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101338944|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101338945|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101338946|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101338947|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101338948|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101338950|NCT03958383|Ipilimumab|ipilimumab|mesh-list
101338951|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413290|NCT00482248|Omalizumab|omalizumab|mesh-list
101338952|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338953|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101338954|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339003|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
101339004|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339005|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339006|NCT00076726|Infliximab|infliximab|mesh-list
101339007|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101339008|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339009|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101339010|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101339011|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339012|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101339013|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339014|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339015|NCT00077077|Capecitabine|capecitabine|mesh-list
101339016|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339017|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
101339018|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339019|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339020|NCT00077116|Cytarabine|cytarabine|mesh-list
101339021|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
101339022|NCT00077116|Busulfan|busulfan|mesh-list
101339023|NCT00077116|Idarubicin|idarubicin|mesh-list
101339024|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
101339025|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339026|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
101339055|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339056|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101339057|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101339058|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101339059|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339060|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
101339061|NCT00077194|Romidepsin|romidepsin|mesh-list
101339062|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339063|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339064|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101339065|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339066|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339068|NCT00077233|Fluorouracil|fluorouracil|mesh-list
101339115|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339116|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339117|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339118|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339119|NCT00077428|Doxorubicin|doxorubicin|mesh-list
101339120|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101339121|NCT00077428|Bortezomib|bortezomib|mesh-list
101339122|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339123|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339124|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339125|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339126|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339127|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339128|NCT00077467|Bortezomib|bortezomib|mesh-list
101339129|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339130|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
101339131|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339132|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447523|NCT00590629|Vitamins|vitamins|mesh-ancestor
101339133|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101339172|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339173|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
101339174|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
101339175|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339176|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339177|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101339178|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
101339179|NCT04711213|Hormones|hormones|mesh-ancestor
101413301|NCT01240642|Vadimezan|vadimezan|mesh-list
101339180|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339181|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339182|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339237|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339238|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101339239|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
101339240|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339241|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339243|NCT01350128|Ipratropium|ipratropium|mesh-list
101339244|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
101339245|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101339246|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
101339247|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339300|NCT00079105|Vincristine|vincristine|mesh-list
101339301|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
101339302|NCT00079105|Bleomycin|bleomycin|mesh-list
101339303|NCT00079105|Vinblastine|vinblastine|mesh-list
101339304|NCT00079105|Procarbazine|procarbazine|mesh-list
101339305|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
101339306|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339307|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
101339308|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339309|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339310|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339311|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
101339312|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339313|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339314|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339315|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339360|NCT00079222|Itraconazole|itraconazole|mesh-list
101339361|NCT00079222|Voriconazole|voriconazole|mesh-list
101339362|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
101339363|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339364|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101339365|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101339366|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339367|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339369|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
101339371|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339423|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339424|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101339425|NCT00079456|Sirolimus|sirolimus|mesh-list
101339426|NCT00079456|Temsirolimus|temsirolimus|mesh-list
101339427|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
101339428|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339429|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339430|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339431|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339432|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
101339433|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339439|NCT04467086|Propranolol|propranolol|mesh-list
101339486|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339487|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339488|NCT00079924|Teriparatide|teriparatide|mesh-list
101339489|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101339490|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101339491|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339492|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101339493|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101339494|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
101339495|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339496|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101339550|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101339552|NCT00080158|Escitalopram|escitalopram|mesh-list
101339553|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101339554|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101339555|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101339556|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339557|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449167|NCT00122837|Analgesics|analgesics|mesh-ancestor
101339558|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
101339559|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339560|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101339561|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
101339562|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101339563|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101339564|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
101339606|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101339607|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101339608|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101339609|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339610|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339611|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
101339612|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
101339613|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339614|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339615|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101339616|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101339617|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
101339618|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101339619|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101339620|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101339621|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101339664|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339665|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339666|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339667|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339669|NCT00080743|Gefitinib|gefitinib|mesh-list
101339670|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339671|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101339672|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
101339673|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339674|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339726|NCT00081055|Methotrexate|methotrexate|mesh-list
101339727|NCT00081055|Cyclosporins|cyclosporins|mesh-list
101339728|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339729|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
101339730|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339731|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339732|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339733|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
101339734|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339735|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339736|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339788|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339789|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101339790|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339791|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339792|NCT00081757|Thalidomide|thalidomide|mesh-list
101339856|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339857|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339858|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
101339859|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339860|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339861|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101339862|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101339863|NCT03152097|Protective Agents|protective agents|mesh-ancestor
101339864|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339865|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339866|NCT00082186|Bosentan|bosentan|mesh-list
101339867|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339921|NCT00083083|Docetaxel|docetaxel|mesh-list
101339922|NCT00083083|Carboplatin|carboplatin|mesh-list
101339923|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101339924|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339925|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339927|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339928|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339929|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339930|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339931|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339932|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339933|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101339934|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
101339935|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
101339936|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101339979|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101339980|NCT00083590|Protective Agents|protective agents|mesh-ancestor
101339981|NCT03151746|Gabapentin|gabapentin|mesh-list
101339982|NCT03151746|Analgesics|analgesics|mesh-ancestor
101339983|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
101339984|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339985|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339986|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
101339987|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101339988|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101339989|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339990|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101339991|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101339992|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101339993|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339994|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339995|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
101339996|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
101339997|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101339998|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340000|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101340001|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101340031|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
101340032|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
101340033|NCT03151707|Vitamins|vitamins|mesh-ancestor
101340034|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
101451146|NCT00126074|Tedisamil|tedisamil|mesh-list
101340035|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340101|NCT00135499|Vincristine|vincristine|mesh-list
101340102|NCT00135499|Bleomycin|bleomycin|mesh-list
101340103|NCT00135499|Vindesine|vindesine|mesh-list
101340104|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340105|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
101340106|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340107|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340108|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101340109|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
101340110|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340111|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340112|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340113|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340114|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101340115|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101340116|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340117|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340118|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340119|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
101340120|NCT00135499|Hormones|hormones|mesh-ancestor
101340121|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340122|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101340123|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101340124|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340125|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340126|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340127|NCT03151434|Hydromorphone|hydromorphone|mesh-list
101340128|NCT03151434|Bupivacaine|bupivacaine|mesh-list
101340129|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
101340130|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
101340131|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340136|NCT03151434|Narcotics|narcotics|mesh-ancestor
101340145|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
101340146|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101340147|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101340148|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340149|NCT00135811|Cyclosporine|cyclosporine|mesh-list
101340150|NCT00135811|Dexamethasone|dexamethasone|mesh-list
101340151|NCT00135811|Cyclosporins|cyclosporins|mesh-list
101340152|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340153|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
101340154|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
101340155|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340156|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340157|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340158|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
101340159|NCT00135811|Hormones|hormones|mesh-ancestor
101340160|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340161|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101340203|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101340204|NCT00135967|Protective Agents|protective agents|mesh-ancestor
101340206|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
101340207|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
101340208|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340209|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340210|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340211|NCT00136201|Tigecycline|tigecycline|mesh-list
101340212|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340213|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340214|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101340215|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340264|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
101340266|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101340275|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340276|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101340277|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101340278|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101340279|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101340321|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340322|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
101340323|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340324|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101340325|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101340326|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101340327|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101340328|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340382|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
101340383|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340384|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340385|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101340386|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101340387|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340388|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340389|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340390|NCT00137410|Celecoxib|celecoxib|mesh-list
101340391|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101340392|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340393|NCT00137410|Analgesics|analgesics|mesh-ancestor
101340394|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
101340395|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340396|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340397|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340440|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101340441|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340442|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340452|NCT00137995|Cytarabine|cytarabine|mesh-list
101340453|NCT00137995|Dexamethasone|dexamethasone|mesh-list
101340454|NCT00137995|Rituximab|rituximab|mesh-list
101340501|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340502|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340503|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340504|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101340505|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
101340506|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101340507|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101340508|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
101340509|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340565|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340566|NCT03893825|Risperidone|risperidone|mesh-list
101340567|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101340568|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
101340569|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340570|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340571|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340572|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101340573|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101340574|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340575|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340576|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101340577|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
101340578|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
101340580|NCT00138970|Prednisolone|prednisolone|mesh-list
101453258|NCT00411047|Gefitinib|gefitinib|mesh-list
101340581|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101340583|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101340584|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
101340585|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101340586|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
101340587|NCT00138970|Daclizumab|daclizumab|mesh-list
101340617|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340618|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340619|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
101340620|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340621|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
101340622|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340623|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101340624|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340625|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101340683|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
101340684|NCT03861767|Metformin|metformin|mesh-list
101340685|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340686|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340687|NCT00139360|Bevacizumab|bevacizumab|mesh-list
101340688|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340689|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340690|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101340691|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101340692|NCT00139360|Growth Substances|growth substances|mesh-ancestor
101340693|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340694|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
101340695|NCT00139516|Nicotine|nicotine|mesh-list
101340696|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101340697|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
101340698|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340699|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340700|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101340701|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101340702|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
101340703|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454655|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101340704|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340705|NCT00139555|Amlodipine|amlodipine|mesh-list
101340706|NCT00139555|Benazepril|benazepril|mesh-list
101340733|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340734|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101340735|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
101340736|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340737|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101340738|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101340739|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101340740|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340741|NCT00139633|Carboplatin|carboplatin|mesh-list
101340742|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340743|NCT00139711|Docetaxel|docetaxel|mesh-list
101340798|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340799|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101340800|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101340801|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
101340802|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340803|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101340804|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101340805|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
101340806|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
101340807|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340863|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
101340864|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101340865|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340866|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
101340867|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
101455266|NCT04668469|Vitamins|vitamins|mesh-list
101340868|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340869|NCT00140452|Thalidomide|thalidomide|mesh-list
101340870|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340871|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
101340872|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340873|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
101340874|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340875|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340876|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101340877|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101340878|NCT00140452|Growth Substances|growth substances|mesh-ancestor
101340879|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
101340922|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340923|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101340924|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101340925|NCT00140764|Metronidazole|metronidazole|mesh-list
101340926|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340927|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340928|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101340929|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101340930|NCT00138736|Lectins|lectins|mesh-list
101340931|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
101340932|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
101340933|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340934|NCT00138736|Coagulants|coagulants|mesh-ancestor
101340985|NCT00141193|Analgesics|analgesics|mesh-ancestor
101340986|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
101340987|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455811|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
101455812|NCT00240474|Amlodipine|amlodipine|mesh-list
101340988|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340989|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340990|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340991|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101340992|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101340993|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340994|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340996|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101341046|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341047|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341048|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341049|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
101341050|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341051|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
101341052|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341113|NCT00141895|Misoprostol|misoprostol|mesh-list
101341114|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101341116|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101341117|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341118|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101341119|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341120|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
101341121|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
101341122|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101341178|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
101341179|NCT00142402|Modafinil|modafinil|mesh-list
101341180|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101341182|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101341183|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101341184|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101341185|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341241|NCT02780427|Analgesics|analgesics|mesh-ancestor
101341242|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
101456289|NCT00216008|Docetaxel|docetaxel|mesh-list
101341243|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341244|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101341245|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101341247|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
101341248|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341249|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341250|NCT00142987|Tegaserod|tegaserod|mesh-list
101341251|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101341252|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
101341253|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341254|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341255|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341299|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341301|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
101341302|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
101341303|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101341304|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101341305|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341306|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341307|NCT00143221|Urological Agents|urological agents|mesh-ancestor
101341308|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
101341309|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341310|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
101341311|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101341312|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101341313|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341314|NCT00143260|Urological Agents|urological agents|mesh-ancestor
101341315|NCT00143299|Varenicline|varenicline|mesh-list
101341316|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101341317|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101341318|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341319|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341320|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341321|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341323|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101341324|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341325|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101341326|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101341327|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101341328|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341329|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341330|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341331|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341332|NCT00143377|Urological Agents|urological agents|mesh-ancestor
101458566|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
101458567|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101458568|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101458569|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341333|NCT02972216|Docetaxel|docetaxel|mesh-list
101341334|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341335|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
101341336|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
101341337|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
101341338|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341339|NCT04726345|Fexofenadine|fexofenadine|mesh-list
101341340|NCT04726345|Terfenadine|terfenadine|mesh-list
101341341|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101341342|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101341343|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101341345|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
101341396|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341397|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341399|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341400|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101341401|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101341402|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101341403|NCT00140803|Verteporfin|verteporfin|mesh-list
101341404|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341405|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
101341406|NCT00140803|Hormones|hormones|mesh-ancestor
101341407|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341408|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341409|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341410|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
101341411|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101341412|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
101341413|NCT00143806|Cyclosporine|cyclosporine|mesh-list
101341414|NCT00143806|Alefacept|alefacept|mesh-list
101341415|NCT00143806|Cyclosporins|cyclosporins|mesh-list
101341416|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341417|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341418|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341419|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
101341420|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341421|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
101341422|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341426|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
101341445|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101341446|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101341447|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341448|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
101341449|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341450|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101341451|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101341452|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101341453|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101341454|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
101341455|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101341456|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
101341457|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341458|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341459|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101341469|NCT00144274|Ambroxol|ambroxol|mesh-list
101341504|NCT00404716|Protective Agents|protective agents|mesh-ancestor
101341505|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101341506|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101341507|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341508|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
101341509|NCT00404794|Prednisolone|prednisolone|mesh-list
101341511|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
101341512|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101341513|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
101341514|NCT00404794|Tacrolimus|tacrolimus|mesh-list
101341515|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101341516|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
101341517|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341518|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
101341562|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101341563|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
101341564|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
101457400|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101341565|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341566|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341567|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101341568|NCT00404833|Protective Agents|protective agents|mesh-ancestor
101341569|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101341570|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
101341572|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
101341573|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341574|NCT05595109|Protective Agents|protective agents|mesh-ancestor
101341575|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341576|NCT03128021|Milnacipran|milnacipran|mesh-list
101341577|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
101341578|NCT03128021|Escitalopram|escitalopram|mesh-list
101341579|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101341580|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101341581|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341582|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341583|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341584|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
101341585|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341586|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341587|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
101341588|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341589|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101341608|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101341609|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
101341610|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
101341611|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341612|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341613|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341614|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101341615|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101341616|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341618|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
101341619|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
101341620|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341621|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341622|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
101341623|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341664|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341665|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101341667|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
101341668|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
101341669|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
101341670|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341671|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341673|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341674|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341675|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101341676|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341678|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101341679|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341680|NCT05468671|Remifentanil|remifentanil|mesh-list
101341682|NCT05468671|Propofol|propofol|mesh-list
101341683|NCT05468671|Rocuronium|rocuronium|mesh-list
101341684|NCT05468671|Flumazenil|flumazenil|mesh-list
101341685|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101341686|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341687|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341688|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101341689|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
101341690|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
101341691|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101341692|NCT05468671|Narcotics|narcotics|mesh-ancestor
101341693|NCT05468671|Analgesics|analgesics|mesh-ancestor
101341694|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
101341695|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341696|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101341697|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101341699|NCT05468671|Antidotes|antidotes|mesh-ancestor
101341700|NCT05468671|Protective Agents|protective agents|mesh-ancestor
101341701|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
101458570|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
101458571|NCT04610164|Coagulants|coagulants|mesh-ancestor
101458572|NCT00222443|Irinotecan|irinotecan|mesh-list
101341702|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
101341703|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341704|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341705|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
101341706|NCT05461807|Apixaban|apixaban|mesh-list
101341707|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101341708|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
101341709|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101341710|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
101341711|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341712|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341713|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
101341714|NCT03079427|Cisplatin|cisplatin|mesh-list
101341715|NCT03079427|Gemcitabine|gemcitabine|mesh-list
101341716|NCT03079427|Capecitabine|capecitabine|mesh-list
101341717|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341719|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
101341761|NCT02958163|Doxorubicin|doxorubicin|mesh-list
101341762|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101341763|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341764|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101341765|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101341766|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341767|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341768|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101341769|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101341770|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341771|NCT02985866|Pancrelipase|pancrelipase|mesh-list
101341772|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341773|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
101341774|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
101341775|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
101341776|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341778|NCT01806792|Vitamins|vitamins|mesh-ancestor
101341779|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
101341780|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101341781|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101341782|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341784|NCT05228431|Capecitabine|capecitabine|mesh-list
101341814|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
101341815|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
101341816|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460662|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101341817|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341818|NCT05197075|Darunavir|darunavir|mesh-list
101341819|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101341820|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101341821|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
101341822|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341823|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341824|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101341825|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101341875|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341876|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341877|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101341878|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341879|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341880|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341881|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101341882|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
101341883|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101341884|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101341885|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101341887|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341888|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341889|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
101341890|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101341891|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341892|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341893|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341894|NCT04871308|Analgesics|analgesics|mesh-ancestor
101341895|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
101341896|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341897|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101341898|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101341899|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101341900|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
101341901|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341902|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341903|NCT01806363|Telmisartan|telmisartan|mesh-list
101341904|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
101341905|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101341906|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101341915|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
101341916|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341917|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341918|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
101341919|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341920|NCT02964403|Indomethacin|indomethacin|mesh-list
101341921|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101341922|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341923|NCT02964403|Analgesics|analgesics|mesh-ancestor
101341924|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
101341927|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341977|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101341978|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101341979|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101341980|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101341981|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101341982|NCT00405340|Rituximab|rituximab|mesh-list
101341983|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341984|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341985|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
101341986|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341988|NCT04713319|Calcium|calcium|mesh-list
101341989|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341990|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341991|NCT00393471|Etanercept|etanercept|mesh-list
101341993|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342034|NCT04341181|Atezolizumab|atezolizumab|mesh-list
101342035|NCT04341181|Pertuzumab|pertuzumab|mesh-list
101342036|NCT04341181|Avelumab|avelumab|mesh-list
101342037|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101342038|NCT04341181|Niraparib|niraparib|mesh-list
101342039|NCT04341181|Axitinib|axitinib|mesh-list
101342040|NCT04341181|Vemurafenib|vemurafenib|mesh-list
101342041|NCT04341181|Maytansine|maytansine|mesh-list
101342042|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342043|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342044|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342045|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463480|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101342046|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342047|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101342048|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101342049|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342050|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342051|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342052|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342053|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
101342054|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
101342055|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
101342056|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342057|NCT01806324|Losartan|losartan|mesh-list
101342058|NCT01806324|Atorvastatin|atorvastatin|mesh-list
101342059|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101342060|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101342061|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
101342082|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342083|NCT01805895|Minocycline|minocycline|mesh-list
101342084|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342085|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342087|NCT01805856|Piperacillin|piperacillin|mesh-list
101342088|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342089|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342090|NCT01805817|Copper|copper|mesh-list
101342091|NCT01805817|Drospirenone|drospirenone|mesh-list
101342092|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
101342093|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101342094|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101342095|NCT01805817|Estradiol|estradiol|mesh-list
101342096|NCT01805817|Estrogens|estrogens|mesh-ancestor
101342145|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101342146|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342147|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342148|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
101342149|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342150|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342151|NCT03969823|Osimertinib|osimertinib|mesh-list
101342152|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342153|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342154|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342155|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342156|NCT00391157|Dexamethasone|dexamethasone|mesh-list
101342210|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
101342211|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342212|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
101342214|NCT01723839|Fludarabine|fludarabine|mesh-list
101342215|NCT01723839|Lenalidomide|lenalidomide|mesh-list
101342216|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342217|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
101342218|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342219|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342220|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342221|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
101342222|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342223|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342224|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342269|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342271|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101342272|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342273|NCT02993029|Analgesics|analgesics|mesh-ancestor
101342274|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
101342275|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342276|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342277|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342278|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342279|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101342280|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101342281|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342282|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342283|NCT02825641|Oxytocin|oxytocin|mesh-list
101342284|NCT02825641|Dinoprostone|dinoprostone|mesh-list
101342288|NCT01646034|Paclitaxel|paclitaxel|mesh-list
101342330|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101342331|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342332|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342333|NCT01466478|Calcitriol|calcitriol|mesh-list
101342334|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101342335|NCT01466478|Calcipotriene|calcipotriene|mesh-list
101342336|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101342337|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342338|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342339|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101342340|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101342341|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342392|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342394|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
101342395|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
101342396|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342397|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342398|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342399|NCT01466127|Oxytocin|oxytocin|mesh-list
101342400|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
101342401|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342402|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342403|NCT00009191|Sertraline|sertraline|mesh-list
101342404|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
101342405|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101342406|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101342407|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101342408|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466597|NCT05896930|Rifampin|rifampin|mesh-list
101342410|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342448|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342449|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342450|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
101342451|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
101342452|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101342453|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101342454|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101342455|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
101342456|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101342457|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
101342458|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342459|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342460|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101342461|NCT00009698|Aldesleukin|aldesleukin|mesh-list
101342462|NCT00009698|Interleukin-2|interleukin-2|mesh-list
101342509|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342510|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342511|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342512|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342513|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101342514|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342515|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342516|NCT00009815|Antidotes|antidotes|mesh-ancestor
101342517|NCT00009815|Protective Agents|protective agents|mesh-ancestor
101342518|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
101342574|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342575|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342576|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342577|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342578|NCT00010088|Leucovorin|leucovorin|mesh-list
101342579|NCT00010088|Gemcitabine|gemcitabine|mesh-list
101342580|NCT00010088|Fluorouracil|fluorouracil|mesh-list
101342581|NCT00010088|Calcium|calcium|mesh-list
101342582|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
101342583|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342584|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
101342585|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342586|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342587|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342588|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342589|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342590|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
101342591|NCT00010088|Antidotes|antidotes|mesh-ancestor
101342592|NCT00010088|Protective Agents|protective agents|mesh-ancestor
101342593|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
101342594|NCT00010088|Vitamins|vitamins|mesh-ancestor
101342595|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
101342596|NCT01465503|Heparin|heparin|mesh-list
101342597|NCT01465503|Calcium heparin|calcium heparin|mesh-list
101342598|NCT01465503|Hirudins|hirudins|mesh-list
101342599|NCT01465503|Bivalirudin|bivalirudin|mesh-list
101342600|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
101342601|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458573|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101458574|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101458575|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458576|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458577|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458578|NCT00222482|Valproic Acid|valproic acid|mesh-list
101458579|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
101458580|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458581|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458582|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
101458583|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458584|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458585|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
101458586|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458587|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458589|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
101458590|NCT04610125|Fludarabine|fludarabine|mesh-list
101458591|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458592|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
101342602|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101342603|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342604|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
101342605|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101342606|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
101342607|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342608|NCT00010166|Gemcitabine|gemcitabine|mesh-list
101342609|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342610|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
101342611|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342612|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342613|NCT01465152|Metformin|metformin|mesh-list
101342614|NCT01465152|Repaglinide|repaglinide|mesh-list
101342615|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101342616|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342617|NCT01465113|Vitamin D|vitamin d|mesh-list
101342618|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
101342619|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
101342620|NCT01465113|Vitamins|vitamins|mesh-list
101342621|NCT01465113|Metformin|metformin|mesh-list
101342656|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101342658|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342659|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342660|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101342661|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342662|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342664|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
101342665|NCT00010361|Fludarabine|fludarabine|mesh-list
101342666|NCT00010361|Cyclosporins|cyclosporins|mesh-list
101342667|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342668|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342715|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342716|NCT01464606|Dactinomycin|dactinomycin|mesh-list
101342717|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
101342718|NCT01464606|Ifosfamide|ifosfamide|mesh-list
101342719|NCT01464606|Doxorubicin|doxorubicin|mesh-list
101342720|NCT01464606|Vincristine|vincristine|mesh-list
101342721|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342722|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
101342723|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342724|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342725|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342726|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
101468328|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
101342727|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342728|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342729|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342730|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342731|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342732|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101342773|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
101342774|NCT00011375|Rolipram|rolipram|mesh-list
101342775|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
101342776|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101342779|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342780|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342781|NCT00847938|Neostigmine|neostigmine|mesh-list
101342782|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101342783|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342784|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342785|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469149|NCT00242918|Docetaxel|docetaxel|mesh-list
101342786|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342832|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342833|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342834|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342835|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342836|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342837|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342838|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101342839|NCT00009932|Protective Agents|protective agents|mesh-ancestor
101342840|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342897|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342898|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
101342900|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
101342901|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
101342902|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101342903|NCT00847314|Androgens|androgens|mesh-ancestor
101342904|NCT00847314|Hormones|hormones|mesh-ancestor
101342905|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342906|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342907|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101342908|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342909|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
101342910|NCT00011999|Paclitaxel|paclitaxel|mesh-list
101342911|NCT00011999|Cisplatin|cisplatin|mesh-list
101342912|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342913|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342914|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342915|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342952|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342953|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342954|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342955|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
101342956|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
101342957|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342958|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
101342959|NCT00012311|Ifosfamide|ifosfamide|mesh-list
101342960|NCT00012311|Thiotepa|thiotepa|mesh-list
101342962|NCT00012311|Docetaxel|docetaxel|mesh-list
101342963|NCT00012311|Doxorubicin|doxorubicin|mesh-list
101342964|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101342965|NCT00012311|Fluorouracil|fluorouracil|mesh-list
101342966|NCT00012311|Methotrexate|methotrexate|mesh-list
101342967|NCT00012311|Etoposide|etoposide|mesh-list
101342968|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343010|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101343011|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101343013|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343014|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343016|NCT00012467|Interferons|interferons|mesh-list
101343017|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
101343018|NCT00012467|Itraconazole|itraconazole|mesh-list
101343019|NCT00012467|Fluconazole|fluconazole|mesh-list
101343020|NCT00012467|Amphotericin B|amphotericin b|mesh-list
101343022|NCT00012467|Flucytosine|flucytosine|mesh-list
101343071|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101343072|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343073|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101343074|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343075|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343076|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101343078|NCT00846690|Phenylephrine|phenylephrine|mesh-list
101343079|NCT00846690|Benzocaine|benzocaine|mesh-list
101343080|NCT00846690|Tetracaine|tetracaine|mesh-list
101343081|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
101343082|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
101343083|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343084|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343132|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343133|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343134|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343135|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343136|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343137|NCT00012857|Acetaminophen|acetaminophen|mesh-list
101343138|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101343139|NCT00012857|Analgesics|analgesics|mesh-ancestor
101343140|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
101343141|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343142|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343143|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
101343193|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
101343194|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343195|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343196|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101343197|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101343198|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
101343199|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101343200|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101343201|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101343202|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101343204|NCT00845910|Docetaxel|docetaxel|mesh-list
101343205|NCT00845910|Capecitabine|capecitabine|mesh-list
101343219|NCT00680628|Enoxaparin|enoxaparin|mesh-list
101343253|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
101343254|NCT00013598|Pioglitazone|pioglitazone|mesh-list
101343255|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101343256|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343257|NCT00277017|Interferons|interferons|mesh-list
101343258|NCT00277017|Thalidomide|thalidomide|mesh-list
101343259|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343260|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
101343261|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343262|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343263|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
101343264|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343317|NCT00276705|Doxorubicin|doxorubicin|mesh-list
101343318|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101343319|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343320|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
101343321|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343323|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343324|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
101343325|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343326|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343327|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101343379|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
101343380|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343381|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343382|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343383|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343384|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343385|NCT00014183|Gefitinib|gefitinib|mesh-list
101343386|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343387|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101343388|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343389|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343403|NCT00014339|Prednisone|prednisone|mesh-list
101343443|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
101343444|NCT00014573|Carmustine|carmustine|mesh-list
101343445|NCT00014573|Sargramostim|sargramostim|mesh-list
101343446|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343447|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343448|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343449|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343450|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343451|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343452|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343453|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
101471440|NCT01680679|Vaccines|vaccines|mesh-list
101343454|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343455|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343456|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343457|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
101343458|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101343459|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101343460|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101343461|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
101343462|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343463|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
101343464|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101343465|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101343466|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101343467|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343493|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
101343494|NCT00276198|Vitamin D|vitamin d|mesh-list
101343495|NCT00276198|Vitamin A|vitamin a|mesh-list
101343496|NCT00276198|Vitamins|vitamins|mesh-ancestor
101343497|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
101343498|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343499|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101343500|NCT00276081|Gabapentin|gabapentin|mesh-list
101343501|NCT00276081|Estrogens|estrogens|mesh-list
101343502|NCT00276081|Analgesics|analgesics|mesh-ancestor
101343503|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
101343504|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343505|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343506|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
101343507|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101343508|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343509|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343510|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343511|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101343512|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101343513|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343514|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343515|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
101343516|NCT00276081|Hormones|hormones|mesh-ancestor
101343517|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343519|NCT00276003|Irinotecan|irinotecan|mesh-list
101343520|NCT00276003|Allopurinol|allopurinol|mesh-list
101343521|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343522|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
101343523|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343524|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343525|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101343526|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343527|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343528|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
101343529|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343533|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343534|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
101343535|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
101343536|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101343537|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101343538|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343539|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343540|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101343541|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101343542|NCT00015041|Buprenorphine|buprenorphine|mesh-list
101343544|NCT00015041|Narcotics|narcotics|mesh-ancestor
101343595|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101343596|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101343597|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343598|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343599|NCT00275652|Lamivudine|lamivudine|mesh-list
101343600|NCT00275652|Telbivudine|telbivudine|mesh-list
101343601|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101343602|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101343603|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343604|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343605|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
101343607|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101343657|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343658|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101343659|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
101343660|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101343661|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343662|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
101343663|NCT00015626|Metformin|metformin|mesh-list
101343664|NCT00015626|Pioglitazone|pioglitazone|mesh-list
101343665|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
101343666|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101343723|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101343725|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
101343726|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343727|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343728|NCT00015860|Prednisone|prednisone|mesh-list
101343729|NCT00015860|Vincristine|vincristine|mesh-list
101343730|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
101343731|NCT00015860|Daunorubicin|daunorubicin|mesh-list
101343732|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343733|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
101343734|NCT00015860|Hormones|hormones|mesh-ancestor
101343735|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343736|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343740|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343785|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343786|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343787|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343788|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101343789|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
101343790|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101343791|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343792|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
101343793|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101343794|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101343795|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101343796|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
101343797|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343799|NCT00275106|Protective Agents|protective agents|mesh-ancestor
101343800|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
101343802|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
101343843|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
101343844|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343845|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343846|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
101343847|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101343848|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343849|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343850|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343851|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101343852|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101343853|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343854|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343855|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
101343856|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101343857|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101343858|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
101343859|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
101343860|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
101343861|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
101343862|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343865|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
101343898|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343899|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343900|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343901|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343902|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343903|NCT00016016|Growth Substances|growth substances|mesh-ancestor
101343904|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101343905|NCT00130455|Escitalopram|escitalopram|mesh-list
101343906|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101343907|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343908|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343962|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343963|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343964|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343965|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343966|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343967|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101343968|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343969|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101343970|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343971|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343972|NCT00394368|Fluticasone|fluticasone|mesh-list
101343974|NCT00394368|Beclomethasone|beclomethasone|mesh-list
101343975|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
101343976|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101343977|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343978|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101343984|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101344019|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344020|NCT00130065|Folic Acid|folic acid|mesh-list
101344021|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
101344022|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
101344023|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101344024|NCT00130065|Hematinics|hematinics|mesh-ancestor
101344025|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
101344026|NCT00130065|Vitamins|vitamins|mesh-ancestor
101344027|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
101344028|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344029|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
101344030|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101344031|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101344032|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344033|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101344034|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344035|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344036|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101344037|NCT00016328|Sirolimus|sirolimus|mesh-list
101344038|NCT00016328|Temsirolimus|temsirolimus|mesh-list
101344039|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
101344075|NCT00016406|Paclitaxel|paclitaxel|mesh-list
101344076|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
101344077|NCT00016406|Doxorubicin|doxorubicin|mesh-list
101344078|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344079|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344080|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344081|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344082|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
101413347|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
101344083|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344084|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344085|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
101344086|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344087|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344088|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344089|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
101344090|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344091|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344092|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344093|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344094|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344095|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
101344096|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344097|NCT00016445|Hormones|hormones|mesh-list
101344098|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344099|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344100|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
101344101|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344102|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344103|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
101344104|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101344105|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
101344118|NCT00129597|Ketamine|ketamine|mesh-list
101344119|NCT00129597|Analgesics|analgesics|mesh-ancestor
101344120|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
101344121|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344122|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344123|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101344124|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101344125|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
101344126|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
101344127|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101344128|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101344129|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101344130|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344131|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344132|NCT00016601|Ritonavir|ritonavir|mesh-list
101344133|NCT00016601|Nelfinavir|nelfinavir|mesh-list
101344134|NCT00016601|Indinavir|indinavir|mesh-list
101344136|NCT00016601|Efavirenz|efavirenz|mesh-list
101344137|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101344172|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344173|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
101344174|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344175|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344176|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
101344177|NCT00016835|Metronidazole|metronidazole|mesh-list
101344178|NCT00016835|Doxycycline|doxycycline|mesh-list
101344179|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344180|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344181|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101344182|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101344183|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
101344184|NCT00016874|Paclitaxel|paclitaxel|mesh-list
101344185|NCT00016874|Cisplatin|cisplatin|mesh-list
101344186|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344187|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344188|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344189|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344231|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101344232|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344233|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344234|NCT00017030|Trabectedin|trabectedin|mesh-list
101344235|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344236|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
101344237|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475178|NCT00264212|Irbesartan|irbesartan|mesh-list
101344238|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344239|NCT00017069|Dexamethasone|dexamethasone|mesh-list
101344240|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
101344241|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101344242|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
101344243|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
101344244|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344245|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344246|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101344247|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
101344248|NCT00017069|Hormones|hormones|mesh-ancestor
101344249|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344250|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101475934|NCT00301860|Melphalan|melphalan|mesh-list
101344251|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344252|NCT00129285|Modafinil|modafinil|mesh-list
101344259|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
101344280|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344281|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101344282|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
101344283|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101344284|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101344285|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101344286|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344287|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344293|NCT00017147|Carmustine|carmustine|mesh-list
101344346|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344347|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344348|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344349|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344350|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344351|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344352|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344353|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344354|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344355|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
101344356|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
101344357|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
101344358|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101344359|NCT00128934|Estradiol|estradiol|mesh-list
101344360|NCT00128934|Estrogens|estrogens|mesh-ancestor
101344361|NCT00128934|Hormones|hormones|mesh-ancestor
101344362|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344363|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344364|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101344401|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344402|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
101344403|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344404|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344405|NCT00128739|Budesonide|budesonide|mesh-list
101344406|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101344407|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101344408|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
101344409|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344410|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344411|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101344412|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
101344414|NCT00128739|Hormones|hormones|mesh-ancestor
101344416|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
101344461|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101344462|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344463|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101344464|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101344465|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101344466|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
101344467|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101344468|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101344469|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101344470|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344471|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
101344472|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101477733|NCT00315549|Penicillins|penicillins|mesh-list
101344473|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101344474|NCT00017576|Calcitriol|calcitriol|mesh-list
101344475|NCT00017576|Carboplatin|carboplatin|mesh-list
101344476|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344477|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101344478|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344479|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101344480|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344481|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344482|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101344483|NCT00017576|Vitamins|vitamins|mesh-ancestor
101344484|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
101344485|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101344486|NCT00017654|Cyclosporine|cyclosporine|mesh-list
101344487|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
101344488|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
101344489|NCT00017654|Cyclosporins|cyclosporins|mesh-list
101344504|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101344505|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101344507|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
101344508|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344509|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101344510|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
101344512|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344513|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101344514|NCT00017654|Protective Agents|protective agents|mesh-ancestor
101344515|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
101344517|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101344518|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
101344519|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344520|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344521|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101344522|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
101344523|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
101344524|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101344560|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101344561|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101344562|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101344563|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
101344564|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344565|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344566|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344567|NCT00018642|Haloperidol|haloperidol|mesh-list
101344568|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101344569|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
101344570|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
101344571|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101344572|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101344573|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101344574|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101344577|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
101344618|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101344619|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
101344620|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101344621|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101344622|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344623|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344624|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101344625|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101344626|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
101344627|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101344628|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101478687|NCT00283634|Bortezomib|bortezomib|mesh-list
101344629|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
101344630|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
101344679|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344680|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344681|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344682|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344683|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344684|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344685|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344686|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101344687|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
101344689|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479244|NCT00286403|Fenoldopam|fenoldopam|mesh-list
101344690|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101344691|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101344692|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
101344693|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101344694|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344735|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101344737|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101344738|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344739|NCT00019227|Calcium|calcium|mesh-list
101344740|NCT00019227|Daclizumab|daclizumab|mesh-list
101344742|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101344743|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344744|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344745|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
101344746|NCT00019227|Antidotes|antidotes|mesh-ancestor
101344747|NCT00019227|Protective Agents|protective agents|mesh-ancestor
101344748|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
101344749|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
101344750|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344751|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101344752|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101344753|NCT00019344|Alvocidib|alvocidib|mesh-list
101344755|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
101344791|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344792|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101344793|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101344794|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101344795|NCT00019539|Thalidomide|thalidomide|mesh-list
101344796|NCT00019539|Bevacizumab|bevacizumab|mesh-list
101344797|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344798|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344799|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101344800|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101344801|NCT00019539|Growth Substances|growth substances|mesh-ancestor
101344802|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344803|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
101344804|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344805|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
101344806|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
101344807|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344808|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344809|NCT00019695|Alendronate|alendronate|mesh-list
101344810|NCT00019695|Ketoconazole|ketoconazole|mesh-list
101480185|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
101344845|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344846|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344849|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344850|NCT00019968|Melphalan|melphalan|mesh-list
101344851|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344852|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
101344853|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344854|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344855|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344856|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344857|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
101344858|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344859|NCT00020007|Paclitaxel|paclitaxel|mesh-list
101344860|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344861|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344862|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344863|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344864|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344865|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344866|NCT00142454|Imiquimod|imiquimod|mesh-list
101344873|NCT00020046|Docetaxel|docetaxel|mesh-list
101344896|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344898|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344899|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344900|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101344901|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344902|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344965|NCT00020709|Docetaxel|docetaxel|mesh-list
101344966|NCT00020709|Etoposide|etoposide|mesh-list
101344967|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
101344968|NCT00020709|Gefitinib|gefitinib|mesh-list
101344969|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344970|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344971|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344972|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344973|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344974|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344975|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344976|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345031|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345032|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345033|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345034|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345035|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345036|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
101345038|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345039|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345040|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101482127|NCT00328692|Rolofylline|rolofylline|mesh-list
101345041|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
101345042|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101345094|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345095|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345096|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345097|NCT00021138|Nicotine|nicotine|mesh-list
101345098|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101345099|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
101345100|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345101|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345102|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101345103|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101345104|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
101345105|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345106|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345107|NCT00020670|Vaccines|vaccines|mesh-list
101345108|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
101345109|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345110|NCT05574179|Midazolam|midazolam|mesh-list
101482310|NCT00328965|Lacidipine|lacidipine|mesh-list
101345111|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
101345112|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101345113|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345114|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345115|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101345116|NCT05574179|Analgesics|analgesics|mesh-ancestor
101345117|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
101345118|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345119|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101345120|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101345121|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101345122|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
101345123|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345124|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345137|NCT00021294|Triamcinolone|triamcinolone|mesh-list
101345138|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345139|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
101345140|NCT00021294|Hormones|hormones|mesh-ancestor
101345141|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345142|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345143|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413374|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
101345144|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345145|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345146|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101345147|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101345148|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101345149|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345150|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101345196|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345197|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345198|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
101345199|NCT00021489|Abacavir|abacavir|mesh-list
101345200|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101483673|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
101345201|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345202|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101345203|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
101345204|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345205|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345207|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345208|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101345209|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101345210|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
101345211|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101345212|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101345213|NCT00021528|Mirtazapine|mirtazapine|mesh-list
101345251|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345252|NCT00021645|Vitamin E|vitamin e|mesh-list
101345253|NCT00021645|Vitamins|vitamins|mesh-ancestor
101345254|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
101484496|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101345255|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345256|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
101345257|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345258|NCT00021645|Protective Agents|protective agents|mesh-ancestor
101345259|NCT05573204|Vitamin E|vitamin e|mesh-list
101345260|NCT05573204|Vitamins|vitamins|mesh-ancestor
101345261|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
101345262|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345263|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
101345264|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345265|NCT05573204|Protective Agents|protective agents|mesh-ancestor
101345266|NCT00021996|Valdecoxib|valdecoxib|mesh-list
101345267|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101345268|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101345269|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345308|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345309|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345310|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
101345311|NCT00022230|Aldesleukin|aldesleukin|mesh-list
101345312|NCT00022230|Paclitaxel|paclitaxel|mesh-list
101345313|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
101345314|NCT00022230|Doxorubicin|doxorubicin|mesh-list
101345315|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101345316|NCT00022230|Sargramostim|sargramostim|mesh-list
101345317|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345318|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345319|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345320|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345321|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345323|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345369|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345370|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345372|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345373|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
101345374|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345375|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
101345376|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345377|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345378|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101345379|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101345380|NCT00022581|Growth Substances|growth substances|mesh-ancestor
101345381|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
101345382|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345383|NCT05551871|Simvastatin|simvastatin|mesh-list
101345432|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345433|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101345434|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
101345435|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101345436|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345437|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
101345438|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
101345439|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345440|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101345441|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101345442|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345443|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345444|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345446|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345447|NCT00022737|Antidotes|antidotes|mesh-ancestor
101345448|NCT00022737|Protective Agents|protective agents|mesh-ancestor
101345450|NCT00022737|Vitamins|vitamins|mesh-ancestor
101345490|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
101345491|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101345492|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
101345493|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345494|NCT02971878|Protective Agents|protective agents|mesh-ancestor
101345495|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345496|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
101345497|NCT02971878|Vitamins|vitamins|mesh-ancestor
101345498|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
101345499|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
101345500|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
101345501|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345554|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345555|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
101345556|NCT00023244|Hormones|hormones|mesh-ancestor
101345557|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345558|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345559|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345560|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345561|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345621|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
101345622|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345625|NCT00023751|Calcium|calcium|mesh-list
101345626|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
101345627|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101345628|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345629|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
101345630|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345631|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345632|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345633|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345634|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
101345636|NCT00023751|Protective Agents|protective agents|mesh-ancestor
101345637|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
101345638|NCT00023751|Vitamins|vitamins|mesh-ancestor
101345639|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
101345640|NCT00023790|Silicon|silicon|mesh-list
101345641|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
101345642|NCT00023790|Trace Elements|trace elements|mesh-ancestor
101345643|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
101345644|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345645|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
101345646|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101345647|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101345648|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345672|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101345673|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
101345674|NCT02971982|Hormones|hormones|mesh-ancestor
101345675|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345676|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345677|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
101345678|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345679|NCT00023829|Bicalutamide|bicalutamide|mesh-list
101345680|NCT00023829|Flutamide|flutamide|mesh-list
101345681|NCT00023829|Hormones|hormones|mesh-list
101345682|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345683|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345684|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
101345688|NCT00023868|Leucovorin|leucovorin|mesh-list
101345735|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345736|NCT00024141|Fluorouracil|fluorouracil|mesh-list
101345737|NCT00024141|Irinotecan|irinotecan|mesh-list
101345738|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
101345739|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345740|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345741|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345742|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345743|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
101345744|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345745|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101345746|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345747|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345748|NCT05239286|Anesthetics|anesthetics|mesh-list
101345793|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345794|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345795|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345797|NCT00024531|Calcium|calcium|mesh-list
101345798|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101345799|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345800|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101345801|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101345802|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
101345803|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345804|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101345805|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101345806|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345807|NCT00024570|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101345808|NCT00024570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345809|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
101345810|NCT05080049|Hematinics|hematinics|mesh-ancestor
101345811|NCT00024687|Immunotoxins|immunotoxins|mesh-list
101345812|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
101345813|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
101345814|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345815|NCT05072444|QPX7728|qpx7728|mesh-list
101345816|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101345817|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345818|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345821|NCT00025038|Cytarabine|cytarabine|mesh-list
101345841|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
101345842|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345843|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
101345844|NCT05055830|Acetaminophen|acetaminophen|mesh-list
101345845|NCT05055830|Methadone|methadone|mesh-list
101345846|NCT05055830|Caffeine|caffeine|mesh-list
101345847|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101345848|NCT05055830|Analgesics|analgesics|mesh-ancestor
101345849|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
101345850|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345851|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345852|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
101345853|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101345854|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101345855|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345856|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345857|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101345900|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345901|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345902|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345903|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345904|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345905|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345906|NCT00025194|Estramustine|estramustine|mesh-list
101345907|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345908|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
101345965|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
101345967|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345968|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345969|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
101345970|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345971|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345972|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345973|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345974|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345975|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345976|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345977|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345978|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345979|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345980|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345981|NCT00025467|Thalidomide|thalidomide|mesh-list
101345982|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345983|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
101345984|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346018|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346019|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
101346020|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346021|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489891|NCT00446082|Pasireotide|pasireotide|mesh-list
101346024|NCT00025584|Bortezomib|bortezomib|mesh-list
101346025|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346026|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
101346027|NCT00025623|Carboplatin|carboplatin|mesh-list
101346028|NCT00025623|Doxorubicin|doxorubicin|mesh-list
101346085|NCT00026052|Riluzole|riluzole|mesh-list
101346086|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
101346087|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101346088|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101346089|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346090|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346094|NCT00026091|Fenretinide|fenretinide|mesh-list
101346146|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
101346147|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346148|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346149|NCT04726280|Ropivacaine|ropivacaine|mesh-list
101346150|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101346151|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
101346152|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
101346153|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346154|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346155|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
101346156|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346157|NCT00026520|Interferons|interferons|mesh-list
101346158|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
101346159|NCT00026520|Thalidomide|thalidomide|mesh-list
101346160|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346161|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
101346162|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346163|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
101346164|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346165|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346166|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
101346199|NCT00027066|Aspirin|aspirin|mesh-list
101346200|NCT00027066|Warfarin|warfarin|mesh-list
101346201|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346202|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346203|NCT00027066|Analgesics|analgesics|mesh-ancestor
101346204|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
101346209|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101346210|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101346211|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490832|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
101346212|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101346213|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101346214|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346216|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
101346217|NCT04473950|Naloxone|naloxone|mesh-list
101346218|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101346219|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346220|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
101346221|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346247|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101346248|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101346249|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101346250|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346251|NCT04206488|Digoxin|digoxin|mesh-list
101346252|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101346253|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101346254|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346255|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346256|NCT04206488|Protective Agents|protective agents|mesh-ancestor
101346257|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346258|NCT00027495|Curcumin|curcumin|mesh-list
101346259|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346260|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346261|NCT00027495|Analgesics|analgesics|mesh-ancestor
101346305|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346306|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346307|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
101346308|NCT00027690|Gefitinib|gefitinib|mesh-list
101346309|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346310|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346311|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346312|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346313|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
101346314|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346315|NCT00027807|Aldesleukin|aldesleukin|mesh-list
101346316|NCT00027807|Molgramostim|molgramostim|mesh-list
101346317|NCT00027807|Sargramostim|sargramostim|mesh-list
101346318|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
101346319|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346320|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346321|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101346322|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101346323|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
101346324|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346325|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
101346326|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101346327|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
101346328|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
101346329|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346330|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346332|NCT00392522|Analgesics|analgesics|mesh-ancestor
101346333|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
101346334|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346335|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
101346349|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346350|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101346351|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101346352|NCT00027885|Growth Substances|growth substances|mesh-ancestor
101346353|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
101346354|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346355|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346356|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346357|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101491225|NCT00348998|Bevacizumab|bevacizumab|mesh-list
101346358|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346359|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346361|NCT00027924|Cyclosporine|cyclosporine|mesh-list
101346362|NCT00027924|Methotrexate|methotrexate|mesh-list
101346363|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
101346364|NCT00027924|Fludarabine|fludarabine|mesh-list
101346365|NCT00027924|Busulfan|busulfan|mesh-list
101346366|NCT00027924|Cyclosporins|cyclosporins|mesh-list
101346406|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346407|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346408|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101346409|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101346410|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346411|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346412|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
101346413|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101346414|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
101346415|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346416|NCT00395499|Risperidone|risperidone|mesh-list
101346417|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101346428|NCT03960125|Imipramine|imipramine|mesh-list
101346468|NCT03959969|Oxycodone|oxycodone|mesh-list
101346469|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346470|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346471|NCT03959969|Analgesics|analgesics|mesh-ancestor
101346472|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
101346473|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346474|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346475|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346476|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346477|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101346478|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346479|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491273|NCT00456339|Hormones|hormones|mesh-ancestor
101346480|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101346481|NCT03959969|Narcotics|narcotics|mesh-ancestor
101346482|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346483|NCT00028314|Ritonavir|ritonavir|mesh-list
101346484|NCT00028314|Lopinavir|lopinavir|mesh-list
101346525|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346526|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346527|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101346528|NCT03959852|Narcotics|narcotics|mesh-ancestor
101346529|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101346531|NCT00028431|Antibodies|antibodies|mesh-list
101346532|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
101346533|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346534|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346535|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346536|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101346537|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346538|NCT00028587|Paclitaxel|paclitaxel|mesh-list
101346539|NCT00028587|Carboplatin|carboplatin|mesh-list
101346541|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346542|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346543|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346580|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101346581|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346582|NCT00028743|Paclitaxel|paclitaxel|mesh-list
101346583|NCT00028743|Carboplatin|carboplatin|mesh-list
101346584|NCT00028743|Topotecan|topotecan|mesh-list
101346585|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346586|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346587|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346588|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346589|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346590|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346591|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101346592|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346593|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346594|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101346596|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101346597|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346598|NCT03959501|Incretins|incretins|mesh-ancestor
101346637|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346638|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
101346640|NCT00028899|Asparaginase|asparaginase|mesh-list
101346641|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
101346642|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
101346643|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346644|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
101346645|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346646|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346647|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
101346648|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346652|NCT00028899|Analgesics|analgesics|mesh-ancestor
101346702|NCT00029523|Methotrexate|methotrexate|mesh-list
101346703|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101346704|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
101346705|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101346706|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346707|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346708|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
101346709|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346710|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346711|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346712|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346713|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101346714|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346728|NCT00029679|Borage oil|borage oil|mesh-list
101346762|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
101346763|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101346764|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
101346765|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346766|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101346767|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
101346768|NCT00395772|Coagulants|coagulants|mesh-ancestor
101346769|NCT00029874|Minocycline|minocycline|mesh-list
101346770|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101346771|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346772|NCT00030030|Silymarin|silymarin|mesh-list
101346773|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
101346774|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346775|NCT00030030|Protective Agents|protective agents|mesh-ancestor
101346776|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346777|NCT00030069|Calcitriol|calcitriol|mesh-list
101346778|NCT00030069|Dexamethasone|dexamethasone|mesh-list
101346779|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346780|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
101346786|NCT00030069|Hormones|hormones|mesh-ancestor
101346822|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346823|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346824|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346825|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346826|NCT00030420|Analgesics|analgesics|mesh-ancestor
101346827|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
101346828|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346829|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346830|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346885|NCT00030654|Vinblastine|vinblastine|mesh-list
101346886|NCT00030654|Docetaxel|docetaxel|mesh-list
101346887|NCT00030654|Doxorubicin|doxorubicin|mesh-list
101346888|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101346889|NCT00030654|Bicalutamide|bicalutamide|mesh-list
101346890|NCT00030654|Flutamide|flutamide|mesh-list
101346891|NCT00030654|Estramustine|estramustine|mesh-list
101346892|NCT00030654|Hormones|hormones|mesh-list
101346893|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346894|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346895|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346896|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346897|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346898|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346948|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101346949|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346950|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101346951|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101346952|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346953|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
101346954|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101346955|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101346956|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101346957|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
101346958|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346959|NCT00030732|Gemcitabine|gemcitabine|mesh-list
101346960|NCT00030732|Capecitabine|capecitabine|mesh-list
101346961|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346962|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
101346963|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346964|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346965|NCT00030810|Docetaxel|docetaxel|mesh-list
101346966|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346967|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346968|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346969|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346971|NCT00030849|Interferons|interferons|mesh-list
101346995|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346996|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101346997|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101346998|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
101346999|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347000|NCT03698006|Ropivacaine|ropivacaine|mesh-list
101347001|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101347002|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
101347003|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
101347004|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347005|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347006|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
101347007|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347009|NCT00031083|Interferon-beta|interferon-beta|mesh-list
101347010|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347011|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
101347012|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347013|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
101493536|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
101347014|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347016|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101347017|NCT03559985|Analgesics|analgesics|mesh-ancestor
101347047|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347048|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347049|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347050|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347051|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
101347052|NCT04712058|Tenofovir|tenofovir|mesh-list
101347053|NCT04712058|Emtricitabine|emtricitabine|mesh-list
101494078|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101347054|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101347056|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347057|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101347058|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347059|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347060|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347061|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101347063|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
101347104|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101347105|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347106|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347107|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347108|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347109|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
101347110|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347111|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101347112|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
101347113|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347114|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101347115|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347116|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347117|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101347118|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101347119|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101347158|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
101347159|NCT00031434|Valganciclovir|valganciclovir|mesh-list
101347160|NCT00031434|Ganciclovir|ganciclovir|mesh-list
101347161|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101347162|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
101347163|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495287|NCT00478101|Fentanyl|fentanyl|mesh-list
101347164|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347165|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347166|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347167|NCT03152123|Phentermine|phentermine|mesh-list
101347168|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101347169|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347221|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101347223|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101347224|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
101347225|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101347226|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347227|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101347228|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101347229|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347230|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347231|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
101347285|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347286|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347288|NCT00031902|Rituximab|rituximab|mesh-list
101347289|NCT00031902|Vincristine|vincristine|mesh-list
101347290|NCT00031902|Bleomycin|bleomycin|mesh-list
101347291|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347292|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347293|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
101347294|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347295|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347296|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101347297|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347298|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347299|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347300|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347341|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101347342|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101347343|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101347344|NCT00032019|Prednisone|prednisone|mesh-list
101347345|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
101347346|NCT00032019|Rituximab|rituximab|mesh-list
101347347|NCT00032019|Doxorubicin|doxorubicin|mesh-list
101347348|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101347349|NCT00032019|Etoposide|etoposide|mesh-list
101347350|NCT00032019|Vincristine|vincristine|mesh-list
101347351|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347352|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
101347353|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347354|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347355|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101347356|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
101347357|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347358|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347359|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101347360|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347367|NCT00032019|Hormones|hormones|mesh-ancestor
101347396|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
101347397|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101347398|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101347399|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347400|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347401|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101347402|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
101347403|NCT00032136|Tamoxifen|tamoxifen|mesh-list
101347404|NCT00032136|Exemestane|exemestane|mesh-list
101347405|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347406|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101347407|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
101347408|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347409|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347410|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347411|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347412|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101347455|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347456|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347458|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
101347459|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
101347460|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347461|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347462|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101347463|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101347464|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101347517|NCT00033033|Reserpine|reserpine|mesh-list
101347518|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101347519|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101347520|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101496843|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
101347521|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347522|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347523|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347524|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101347525|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347526|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347527|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347528|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
101347529|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347530|NCT03150368|Docetaxel|docetaxel|mesh-list
101347531|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347532|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347536|NCT00033072|Selegiline|selegiline|mesh-list
101347574|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347575|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101347576|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
101347578|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101347579|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101347581|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347582|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347583|NCT02984384|Aspirin|aspirin|mesh-list
101347584|NCT02984384|Heparin|heparin|mesh-list
101347585|NCT02984384|Enoxaparin|enoxaparin|mesh-list
101347586|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101347587|NCT02984384|Tinzaparin|tinzaparin|mesh-list
101347588|NCT02984384|Dalteparin|dalteparin|mesh-list
101347590|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101347635|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347636|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
101347637|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101347638|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347639|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347640|NCT00033618|Epothilones|epothilones|mesh-list
101347641|NCT00033618|Epothilone B|epothilone b|mesh-list
101347642|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347643|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347644|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347645|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347700|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101347701|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347702|NCT02971410|Simvastatin|simvastatin|mesh-list
101347703|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101347704|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101347705|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
101347706|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347707|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101347708|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101347709|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347710|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
101347711|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101347712|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101347713|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101347714|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347715|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347716|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
101347719|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101347755|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347756|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347757|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347758|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347759|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101347760|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101347761|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101347763|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101347820|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101347821|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101347822|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101347823|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101347824|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347825|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347826|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347827|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101347828|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
101347829|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347830|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347877|NCT00034749|Risperidone|risperidone|mesh-list
101347878|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101347879|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
101347880|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347881|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347882|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347883|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101347884|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101347885|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347886|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347887|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101347889|NCT00034788|Becaplermin|becaplermin|mesh-list
101347939|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347940|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
101347941|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
101347942|NCT01806272|Vitamins|vitamins|mesh-ancestor
101347943|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
101347944|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347945|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
101347946|NCT01806272|Hematinics|hematinics|mesh-ancestor
101347947|NCT00034983|Aprepitant|aprepitant|mesh-list
101347948|NCT00034983|Paroxetine|paroxetine|mesh-list
101347949|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101347950|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347951|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347953|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347999|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101348000|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
101348001|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348002|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348003|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
101348004|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348005|NCT00393614|Levetiracetam|levetiracetam|mesh-list
101348006|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
101348007|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
101348008|NCT00035256|Teriparatide|teriparatide|mesh-list
101348009|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101348010|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348011|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348012|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348018|NCT00035295|Aprepitant|aprepitant|mesh-list
101348058|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348059|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348062|NCT02971254|Sevoflurane|sevoflurane|mesh-list
101348063|NCT02971254|Desflurane|desflurane|mesh-list
101348064|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348065|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101348066|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
101348067|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
101348068|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348069|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348070|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
101348071|NCT01805882|Ledipasvir|ledipasvir|mesh-list
101348072|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
101348073|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348074|NCT00035802|Topiramate|topiramate|mesh-list
101348075|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
101348118|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348119|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
101348120|NCT00035958|Hormones|hormones|mesh-ancestor
101348121|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348122|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348123|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101348124|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348125|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101348126|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
101348127|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101348128|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348129|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
101348130|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348131|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
101348132|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348133|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101348134|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348135|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
101348171|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348173|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101348175|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101348176|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
101348177|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348178|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348179|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
101348180|NCT00036114|Aripiprazole|aripiprazole|mesh-list
101348181|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348182|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348233|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348234|NCT00036309|Analgesics|analgesics|mesh-ancestor
101348235|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
101348236|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348237|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348238|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348239|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
101348240|NCT00036348|Aripiprazole|aripiprazole|mesh-list
101348241|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348242|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348243|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101348244|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348245|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348247|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
101348294|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348295|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348296|NCT00036582|Clozapine|clozapine|mesh-list
101348297|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101348298|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
101348299|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348300|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348301|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348302|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101348303|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348304|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348305|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348355|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101348356|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101499954|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
101348357|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348359|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101348360|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101348361|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348362|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
101348363|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348364|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348365|NCT00036894|Lenalidomide|lenalidomide|mesh-list
101348366|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
101348367|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348368|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101348369|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101348370|NCT00036894|Growth Substances|growth substances|mesh-ancestor
101348371|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101348372|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348373|NCT01465685|Methylphenidate|methylphenidate|mesh-list
101348411|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
101348412|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348413|NCT01465412|Adenosine|adenosine|mesh-list
101348414|NCT01465412|Analgesics|analgesics|mesh-ancestor
101348415|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
101348416|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348417|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348418|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101348419|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
101348420|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101348421|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
101348422|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
101348423|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348424|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348425|NCT01465373|Progesterone|progesterone|mesh-list
101348426|NCT01465373|Progestins|progestins|mesh-ancestor
101348427|NCT01465373|Hormones|hormones|mesh-ancestor
101348428|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183789|NCT03218592|Tenofovir|tenofovir|mesh-list
101348429|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348467|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348468|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348469|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101348470|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
101348471|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348472|NCT01464944|Aspirin|aspirin|mesh-list
101348473|NCT01464944|Acetaminophen|acetaminophen|mesh-list
101348474|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348475|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348476|NCT01464944|Analgesics|analgesics|mesh-ancestor
101348477|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
101348478|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500578|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101348479|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348488|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
101348526|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
101348527|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348528|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101348529|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348530|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348531|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348532|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101348533|NCT00393731|Misoprostol|misoprostol|mesh-list
101348534|NCT00393731|Oxytocin|oxytocin|mesh-list
101348535|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
101348536|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101348537|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348538|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101348539|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
101348540|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101348541|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348542|NCT00038025|Pentostatin|pentostatin|mesh-list
101348543|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348544|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101348585|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101348586|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101348587|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101348588|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101348589|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101348590|NCT00038259|Aldesleukin|aldesleukin|mesh-list
101348591|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348592|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101348593|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101348594|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
101348595|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348596|NCT00847418|Esketamine|esketamine|mesh-list
101501366|NCT01306162|Dabigatran|dabigatran|mesh-list
101348597|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348598|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348599|NCT05433597|Cisplatin|cisplatin|mesh-list
101348600|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348601|NCT00847262|Amlodipine|amlodipine|mesh-list
101348602|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101348603|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101348604|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348605|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348606|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348608|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
101348635|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
101348636|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101348637|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101348638|NCT00396747|Prednisolone|prednisolone|mesh-list
101348639|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
101348640|NCT00396747|Infliximab|infliximab|mesh-list
101348641|NCT00396747|Methotrexate|methotrexate|mesh-list
101348642|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101348643|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
101348644|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101348645|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
101348646|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101348647|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348648|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348649|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
101348650|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348651|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348652|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
101348653|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348654|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101348655|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348656|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
101348657|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348658|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101348687|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348688|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101348689|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
101348690|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
101348691|NCT05432934|Dexamethasone|dexamethasone|mesh-list
101348692|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348693|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
101348694|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
101348695|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348696|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348697|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348698|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
101348700|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348745|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101348746|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101348747|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348749|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
101348750|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
101348751|NCT00846677|Vitamins|vitamins|mesh-list
101348752|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
101348753|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348754|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348755|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348756|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
101348757|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348760|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348761|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348762|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101348763|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348764|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348765|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348766|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348767|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348768|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348769|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
101348770|NCT05428683|Hormones|hormones|mesh-ancestor
101348771|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348772|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101348773|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101348774|NCT00846443|Cisplatin|cisplatin|mesh-list
101348775|NCT00846443|Pemetrexed|pemetrexed|mesh-list
101348788|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348789|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348790|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101348791|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
101348792|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
101348793|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101348794|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101348795|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101348796|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348797|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502200|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348798|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348799|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
101348800|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
101348801|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101348802|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101348803|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
101348804|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101348805|NCT00846326|Protective Agents|protective agents|mesh-ancestor
101348806|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
101348807|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101348808|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348809|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348810|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348811|NCT00846248|Chromium|chromium|mesh-list
101348812|NCT00846248|Trace Elements|trace elements|mesh-ancestor
101348813|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
101348814|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348815|NCT00846131|Sorafenib|sorafenib|mesh-list
101348816|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348817|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101348818|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348819|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348820|NCT05116059|Amphotericin B|amphotericin b|mesh-list
101348821|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101348822|NCT05116059|Amebicides|amebicides|mesh-ancestor
101458593|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458594|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458595|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101458596|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
101348823|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101348824|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101348825|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348826|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348827|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
101348828|NCT00845936|Metformin|metformin|mesh-list
101348829|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348830|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348831|NCT00277082|Camptothecin|camptothecin|mesh-list
101348832|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101348833|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348834|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101348835|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348836|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348837|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348839|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348840|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348841|NCT04888377|Analgesics|analgesics|mesh-ancestor
101348842|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
101348843|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348844|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348845|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348846|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348847|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348848|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348849|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348850|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348851|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101348852|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348853|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
101348855|NCT00277043|Docetaxel|docetaxel|mesh-list
101348865|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348866|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348867|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101348868|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101348869|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348870|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348871|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348933|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348934|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
101348935|NCT00276809|Hormones|hormones|mesh-ancestor
101348936|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348937|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101348938|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348939|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
101348940|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101348941|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101348942|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348943|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348944|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
101348945|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348946|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101348948|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
101348949|NCT00276770|Protective Agents|protective agents|mesh-ancestor
101348950|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348951|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
101348952|NCT00276731|Carboplatin|carboplatin|mesh-list
101348953|NCT00276731|Etoposide|etoposide|mesh-list
101348954|NCT00276731|Vincristine|vincristine|mesh-list
101348955|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348956|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
101348957|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348958|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348959|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101348960|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
101348962|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348979|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101348980|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101348981|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348982|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101348983|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101348985|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348986|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
101348987|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101348988|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101348989|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348990|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348991|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348992|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
101348993|NCT00276536|Interferons|interferons|mesh-list
101348994|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
101348995|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101348996|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348997|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
101349004|NCT04430790|Doxapram|doxapram|mesh-list
101349032|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101349033|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349035|NCT00276068|Desipramine|desipramine|mesh-list
101349036|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
101349037|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
101349038|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349039|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349040|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
101349041|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349042|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101349043|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101349044|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101349045|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349046|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349047|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101349048|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
101349049|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101349085|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101349086|NCT00397098|Amibegron|amibegron|mesh-list
101349087|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101349088|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101349089|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349090|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349091|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349092|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349093|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349094|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101349095|NCT00275834|Zonisamide|zonisamide|mesh-list
101349147|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349148|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349149|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101349150|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349151|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
101349152|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349217|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349218|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349219|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349220|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349221|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101349222|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
101349223|NCT00041652|Labetuzumab|labetuzumab|mesh-list
101349224|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349225|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349226|NCT03430596|Pramipexole|pramipexole|mesh-list
101349284|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504345|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
101349285|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101349286|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349288|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
101349354|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349355|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101349357|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
101349358|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349359|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101349360|NCT00041691|Labetuzumab|labetuzumab|mesh-list
101349361|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349362|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349363|NCT00394394|Enalapril|enalapril|mesh-list
101349416|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101349417|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
101349418|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101349419|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349420|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349421|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
101349423|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349483|NCT00129038|Analgesics|analgesics|mesh-ancestor
101349484|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
101349485|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349486|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349487|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349488|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349489|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101349490|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101349491|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349492|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101349493|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101349494|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349495|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
101349496|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101349497|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349498|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
101349499|NCT00470223|Doxorubicin|doxorubicin|mesh-list
101349540|NCT00128804|Provitamins|provitamins|mesh-ancestor
101349542|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
101349543|NCT00097851|Docetaxel|docetaxel|mesh-list
101349544|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349613|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101528543|NCT04711304|Protective Agents|protective agents|mesh-ancestor
101349614|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101349615|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101349616|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101349617|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101349618|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101349619|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101349620|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101349621|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
101349622|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349676|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349677|NCT05765305|Chromium|chromium|mesh-list
101349678|NCT05765305|Letrozole|letrozole|mesh-list
101349679|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349748|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349760|NCT05697783|Fentanyl|fentanyl|mesh-list
101349820|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101349821|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349894|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349895|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101349964|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349965|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101349966|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101349967|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101349968|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
101349969|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
101349970|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101349979|NCT05258721|Fluorides|fluorides|mesh-list
101349980|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
101349983|NCT05232032|Nociceptin|nociceptin|mesh-list
101350030|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101350031|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101528877|NCT04652427|Analgesics|analgesics|mesh-ancestor
101350032|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350033|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
101350034|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101350035|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101350036|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350037|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
101350038|NCT05037162|Coagulants|coagulants|mesh-ancestor
101350039|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
101350040|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350041|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350042|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350044|NCT05022654|Irinotecan|irinotecan|mesh-list
101350090|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350091|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101350092|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350094|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
101350095|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
101350096|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350098|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
101350099|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350100|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101350102|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350151|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101350152|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
101350154|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350155|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350156|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101350157|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
101350158|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101350159|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350160|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350161|NCT04846348|Analgesics|analgesics|mesh-ancestor
101350162|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350163|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350213|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350214|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350215|NCT04654689|Curcumin|curcumin|mesh-list
101350216|NCT04654689|Resveratrol|resveratrol|mesh-list
101350217|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350218|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350219|NCT04654689|Analgesics|analgesics|mesh-ancestor
101350220|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
101350221|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350222|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350223|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350288|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101350289|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101350291|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350294|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101350361|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
101350362|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350363|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101350364|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350365|NCT04315948|Interferons|interferons|mesh-list
101350366|NCT04315948|Ritonavir|ritonavir|mesh-list
101350367|NCT04315948|Lopinavir|lopinavir|mesh-list
101350368|NCT04315948|Interferon-beta|interferon-beta|mesh-list
101529592|NCT05387408|Analgesics|analgesics|mesh-ancestor
101350369|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
101350370|NCT04315948|Remdesivir|remdesivir|mesh-list
101350371|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101350372|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
101350425|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350426|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
101350427|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350428|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350429|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350430|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
101530068|NCT02179151|CKD732|ckd732|mesh-list
101350431|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350432|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350433|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350434|NCT04199026|Sirolimus|sirolimus|mesh-list
101350435|NCT04199026|Doxorubicin|doxorubicin|mesh-list
101350436|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101350437|NCT04199026|Daunorubicin|daunorubicin|mesh-list
101350438|NCT04199026|Irinotecan|irinotecan|mesh-list
101350488|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
101350489|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350490|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101350491|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101350492|NCT04134936|Growth Substances|growth substances|mesh-ancestor
101350493|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
101350494|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350554|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350555|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350556|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350557|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350558|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350625|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350626|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350627|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
101350628|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350629|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350630|NCT03427463|Morphine|morphine|mesh-list
101350631|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101350695|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101350696|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
101350697|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350698|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
101350699|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
101350700|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350701|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530299|NCT01998035|Azacitidine|azacitidine|mesh-list
101350702|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350703|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
101350705|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350706|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101350707|NCT03098225|Protective Agents|protective agents|mesh-ancestor
101350708|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101350709|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350710|NCT03017131|Aldesleukin|aldesleukin|mesh-list
101350711|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
101350713|NCT03017131|Interleukin-2|interleukin-2|mesh-list
101350714|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350715|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
101350716|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350717|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350718|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350719|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
101350734|NCT02990468|Cisplatin|cisplatin|mesh-list
101350745|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101350746|NCT02855944|Cisplatin|cisplatin|mesh-list
101350747|NCT02855944|Carboplatin|carboplatin|mesh-list
101350820|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350893|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350894|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350895|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
101350896|NCT00630032|Docetaxel|docetaxel|mesh-list
101530465|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101350897|NCT00630032|Fluorouracil|fluorouracil|mesh-list
101350898|NCT00630032|Epirubicin|epirubicin|mesh-list
101350899|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350961|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350962|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350963|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101350964|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101350966|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
101351031|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351032|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351033|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351034|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101351035|NCT05770960|Codeine|codeine|mesh-list
101351036|NCT05770960|Naloxegol|naloxegol|mesh-list
101351037|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101351038|NCT05770960|Narcotics|narcotics|mesh-ancestor
101351039|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351040|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351041|NCT05770960|Analgesics|analgesics|mesh-ancestor
101351042|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
101351043|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351044|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
101351046|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101351093|NCT05750875|Gabapentin|gabapentin|mesh-list
101351094|NCT05750875|Analgesics|analgesics|mesh-ancestor
101351095|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
101351098|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
101351163|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351164|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351165|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351167|NCT05637606|Norepinephrine|norepinephrine|mesh-list
101351232|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351233|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101351234|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
101351235|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351236|NCT05408247|Protective Agents|protective agents|mesh-ancestor
101351237|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351238|NCT05408247|Antidotes|antidotes|mesh-ancestor
101351239|NCT05375942|Infliximab|infliximab|mesh-list
101351240|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101351242|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351243|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101351244|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351245|NCT05209308|Rituximab|rituximab|mesh-list
101351246|NCT05209308|Venetoclax|venetoclax|mesh-list
101351247|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351248|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351291|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351292|NCT04892511|Nitroprusside|nitroprusside|mesh-list
101351370|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351371|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
101351372|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351373|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531069|NCT00564564|Clomipramine|clomipramine|mesh-list
101351374|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101351375|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
101351376|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351377|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351378|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101351379|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351380|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
101351381|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
101351382|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351383|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101351384|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
101351385|NCT04752163|Hormones|hormones|mesh-ancestor
101351386|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351400|NCT04752163|Antidotes|antidotes|mesh-ancestor
101351427|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351428|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351430|NCT04702256|Prednisone|prednisone|mesh-list
101351431|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
101351432|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101351434|NCT04702256|Prednisolone|prednisolone|mesh-list
101351496|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351497|NCT04622553|Mexiletine|mexiletine|mesh-list
101351498|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351567|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351568|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351569|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101351570|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101351571|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
101351572|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351573|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351574|NCT04512079|Enoxaparin|enoxaparin|mesh-list
101351575|NCT04512079|Apixaban|apixaban|mesh-list
101351576|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
101351577|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101351578|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101351579|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351629|NCT04332341|Vitamins|vitamins|mesh-ancestor
101351630|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
101351631|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351632|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101351633|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
101351634|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351635|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101351636|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
101351637|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
101351638|NCT04323657|Fludarabine|fludarabine|mesh-list
101351639|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351640|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
101351641|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351642|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351643|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101351644|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
101351688|NCT04189107|BB 1101|bb 1101|mesh-list
101351689|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351690|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
101351691|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
101351692|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351693|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351694|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101351695|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
101351696|NCT04189107|Hormones|hormones|mesh-ancestor
101351697|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351698|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351699|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351700|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
101351701|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351702|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351703|NCT04124991|Durvalumab|durvalumab|mesh-list
101351707|NCT04004221|Tislelizumab|tislelizumab|mesh-list
101351743|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351745|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351746|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101351747|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351748|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351749|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101531771|NCT04603833|Docetaxel|docetaxel|mesh-list
101351750|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101351751|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101351752|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351753|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351754|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
101351755|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351756|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101351758|NCT03671811|Megestrol|megestrol|mesh-list
101351759|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
101351800|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
101351801|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101351802|NCT03589729|Protective Agents|protective agents|mesh-ancestor
101351803|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351804|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351806|NCT03585686|Vemurafenib|vemurafenib|mesh-list
101351807|NCT03585686|Cladribine|cladribine|mesh-list
101351808|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351809|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
101351810|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351811|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351812|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
101351813|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351814|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351815|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
101351816|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351817|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101351818|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351819|NCT03479307|Ketotifen|ketotifen|mesh-list
101351820|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101351854|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351855|NCT03364036|Cladribine|cladribine|mesh-list
101351856|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351857|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351858|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
101351859|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351861|NCT03338790|Docetaxel|docetaxel|mesh-list
101351862|NCT03338790|Nivolumab|nivolumab|mesh-list
101351863|NCT03338790|Rucaparib|rucaparib|mesh-list
101351871|NCT03338790|Hormones|hormones|mesh-ancestor
101351921|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351995|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
101351997|NCT02511418|Simvastatin|simvastatin|mesh-list
101351998|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101351999|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101352000|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
101352001|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352002|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101352003|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101352004|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532498|NCT01151098|Narcotics|narcotics|mesh-ancestor
101352005|NCT02278250|Carboplatin|carboplatin|mesh-list
101352006|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352007|NCT02250326|Paclitaxel|paclitaxel|mesh-list
101352008|NCT02250326|Azacitidine|azacitidine|mesh-list
101352009|NCT02250326|Cc-486|cc-486|mesh-list
101352011|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352056|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352057|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352058|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
101352059|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352060|NCT00038766|Semapimod|semapimod|mesh-list
101352063|NCT00038766|Analgesics|analgesics|mesh-ancestor
101352127|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101352128|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101352129|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352130|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
101352131|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101352132|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101352133|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352134|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101352135|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101352136|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352137|NCT00042588|Antibodies|antibodies|mesh-list
101352139|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
101352140|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352141|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
101352142|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352143|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352144|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
101352145|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
101352146|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
101352148|NCT00018824|Naltrexone|naltrexone|mesh-list
101352182|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352183|NCT00018902|Fluoxetine|fluoxetine|mesh-list
101352184|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101352185|NCT00018902|Citalopram|citalopram|mesh-list
101352186|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101352187|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101352188|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101352189|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352190|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352191|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
101352192|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352208|NCT00038961|PENTA|penta|mesh-list
101352243|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
101352244|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101352246|NCT00039039|Paclitaxel|paclitaxel|mesh-list
101352247|NCT00039039|Carboplatin|carboplatin|mesh-list
101352248|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352249|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352250|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352251|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352252|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352253|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352254|NCT00019097|Melphalan|melphalan|mesh-list
101352255|NCT00019097|Sargramostim|sargramostim|mesh-list
101352256|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101352257|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352258|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
101352259|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352260|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352261|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352262|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352300|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
101352301|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352303|NCT00039234|Histamine|histamine|mesh-list
101352304|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
101352305|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352306|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352307|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352308|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
101352309|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352310|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
101352311|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
101352312|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352313|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352314|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352315|NCT00019331|Aldesleukin|aldesleukin|mesh-list
101352316|NCT00019331|Sargramostim|sargramostim|mesh-list
101352317|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
101352318|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352319|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352320|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352321|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352322|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
101352323|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352324|NCT00039273|Panitumumab|panitumumab|mesh-list
101352325|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352326|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352327|NCT00019409|Cytarabine|cytarabine|mesh-list
101352328|NCT00019409|Prednisone|prednisone|mesh-list
101352329|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
101352330|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101533137|NCT04580199|Ethanol|ethanol|mesh-list
101352331|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101352332|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101352333|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
101352334|NCT00019409|Methotrexate|methotrexate|mesh-list
101458597|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458598|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458599|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101458600|NCT00564148|Bevacizumab|bevacizumab|mesh-list
101458601|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458602|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458603|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101458604|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101458605|NCT00564148|Growth Substances|growth substances|mesh-ancestor
101352335|NCT00019409|Vincristine|vincristine|mesh-list
101352336|NCT00019409|Daunorubicin|daunorubicin|mesh-list
101352337|NCT00019409|Asparaginase|asparaginase|mesh-list
101352338|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
101352408|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352409|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101352410|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101352411|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352412|NCT00039390|Capecitabine|capecitabine|mesh-list
101352481|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352482|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352483|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352484|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
101352554|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101533255|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352556|NCT00020189|Alvocidib|alvocidib|mesh-list
101352627|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352628|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352629|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352630|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
101352631|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352632|NCT00040053|Ondansetron|ondansetron|mesh-list
101352633|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
101352634|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
101352635|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352636|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352637|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352693|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352694|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352695|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352765|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352766|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352767|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352769|NCT00020774|Lonafarnib|lonafarnib|mesh-list
101352770|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352771|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
101352838|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352839|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352840|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352911|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101352912|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352986|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101352987|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101352988|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353058|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353059|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353130|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353131|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101353132|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353133|NCT00022022|Docetaxel|docetaxel|mesh-list
101353202|NCT00049569|Antidotes|antidotes|mesh-ancestor
101353203|NCT00049569|Protective Agents|protective agents|mesh-ancestor
101353204|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
101353205|NCT00049569|Vitamins|vitamins|mesh-ancestor
101353216|NCT00022178|Epirubicin|epirubicin|mesh-list
101353276|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
101353277|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101353278|NCT00022412|Vitamins|vitamins|mesh-ancestor
101533725|NCT00577668|Thalidomide|thalidomide|mesh-list
101353348|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
101353350|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353351|NCT00022841|Pamidronate|pamidronate|mesh-list
101353352|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101353354|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
101353419|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353494|NCT00023387|Rifampin|rifampin|mesh-list
101353495|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
101353496|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353497|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353498|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101353499|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101353500|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
101353501|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353502|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101353503|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101353504|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353505|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353506|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353507|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101353508|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101353509|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101353510|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101353511|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101353527|NCT00050973|Bexarotene|bexarotene|mesh-list
101353549|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353550|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353551|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
101353552|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353618|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353619|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353693|NCT00051753|Amoxicillin|amoxicillin|mesh-list
101353694|NCT00051753|Levofloxacin|levofloxacin|mesh-list
101353695|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
101353696|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
101353709|NCT00024050|Cyclosporine|cyclosporine|mesh-list
101353764|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353765|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
101353766|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353767|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353768|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353834|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353835|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353837|NCT00024518|Interferons|interferons|mesh-list
101353844|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
101353908|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353909|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353910|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353911|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101353912|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101353913|NCT00052416|Growth Substances|growth substances|mesh-ancestor
101353977|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353978|NCT00052689|Gemcitabine|gemcitabine|mesh-list
101353979|NCT00052689|Bortezomib|bortezomib|mesh-list
101353980|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353981|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
101354047|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354048|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354050|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354123|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534385|NCT04584710|Dactolisib|dactolisib|mesh-list
101354124|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354125|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354126|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354127|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101354128|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101354192|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354193|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101354195|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354267|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354268|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354269|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354270|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354271|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354272|NCT00025532|Antibodies|antibodies|mesh-list
101354273|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101354274|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
101354275|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354276|NCT00053430|Thalidomide|thalidomide|mesh-list
101354278|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
101354331|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354332|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354333|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354334|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354335|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354336|NCT00025688|Paclitaxel|paclitaxel|mesh-list
101354337|NCT00025688|Carboplatin|carboplatin|mesh-list
101354338|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354339|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354340|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354341|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354342|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354343|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354344|NCT00025727|Ritonavir|ritonavir|mesh-list
101354345|NCT00025727|Lopinavir|lopinavir|mesh-list
101354392|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101354393|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101354395|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
101354396|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101354397|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
101354398|NCT00053976|Daclizumab|daclizumab|mesh-list
101354399|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354400|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
101354401|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
101354402|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354403|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354404|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101354405|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
101354406|NCT00053976|Hormones|hormones|mesh-ancestor
101354407|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354452|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101354453|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354454|NCT00026195|Irinotecan|irinotecan|mesh-list
101354455|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101534499|NCT00568217|Ibuprofen|ibuprofen|mesh-list
101354456|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354457|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354458|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354522|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354523|NCT00054405|Analgesics|analgesics|mesh-ancestor
101354524|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
101354595|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
101354596|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354597|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354598|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354665|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101354666|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101354667|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101354668|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101354669|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354670|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101354672|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101354673|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
101354674|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
101354675|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101354676|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354677|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
101354678|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
101354679|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354680|NCT00055302|Anastrozole|anastrozole|mesh-list
101354681|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354721|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354722|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354723|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354724|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101354725|NCT00055614|Topotecan|topotecan|mesh-list
101354726|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101354727|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354728|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354729|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354731|NCT00027521|Bleomycin|bleomycin|mesh-list
101354788|NCT00027638|Thalidomide|thalidomide|mesh-list
101354789|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354790|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
101354791|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354792|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
101354793|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354794|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354806|NCT00055809|Antibodies|antibodies|mesh-list
101354856|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354857|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101354858|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
101354859|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354860|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101354861|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
101354862|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101354863|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101354864|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101354865|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354866|NCT00055965|Carboplatin|carboplatin|mesh-list
101354867|NCT00055965|Gemcitabine|gemcitabine|mesh-list
101354868|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354869|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354870|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
101354871|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354872|NCT00027833|Leucovorin|leucovorin|mesh-list
101354873|NCT00027833|Fluorouracil|fluorouracil|mesh-list
101354874|NCT00027833|Irinotecan|irinotecan|mesh-list
101354875|NCT00027833|Calcium|calcium|mesh-list
101354876|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
101354878|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354908|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354909|NCT00056004|Zileuton|zileuton|mesh-list
101354910|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101354911|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354978|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354979|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354981|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101354982|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101354983|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354984|NCT00028535|Paclitaxel|paclitaxel|mesh-list
101354985|NCT00028535|Trastuzumab|trastuzumab|mesh-list
101354986|NCT00028535|Interleukin-12|interleukin-12|mesh-list
101354987|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354988|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354989|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354991|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354992|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354993|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354994|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354995|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
101354996|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354997|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354998|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354999|NCT00028535|Growth Substances|growth substances|mesh-ancestor
101355000|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355001|NCT00056277|Lamotrigine|lamotrigine|mesh-list
101355002|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
101355013|NCT00028574|Gabapentin|gabapentin|mesh-list
101355026|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355027|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
101355029|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
101355030|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
101355031|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101355097|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355098|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355099|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355100|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
101355101|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355102|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355103|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101355104|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355105|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
101355106|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
101355107|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355110|NCT00028886|Hormones|hormones|mesh-ancestor
101355158|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355159|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355160|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
101355161|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355162|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355227|NCT00423696|Antidotes|antidotes|mesh-ancestor
101355228|NCT00423696|Protective Agents|protective agents|mesh-ancestor
101355229|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
101355230|NCT00423696|Vitamins|vitamins|mesh-ancestor
101355231|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
101355232|NCT00029315|Plasminogen|plasminogen|mesh-list
101355233|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101355234|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101355297|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355298|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355299|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
101355300|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
101355301|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355302|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355304|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101355363|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355364|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355365|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355366|NCT00057564|Thalidomide|thalidomide|mesh-list
101355367|NCT00057564|Dexamethasone|dexamethasone|mesh-list
101355368|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
101355431|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101355433|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101355445|NCT00057720|Topotecan|topotecan|mesh-list
101355503|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101355504|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101355505|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355506|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355507|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
101355508|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101355509|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101355510|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101355511|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355512|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
101355514|NCT00030719|Busulfan|busulfan|mesh-list
101355515|NCT00030719|Carboplatin|carboplatin|mesh-list
101355516|NCT00030719|Etoposide|etoposide|mesh-list
101355517|NCT00030719|Vincristine|vincristine|mesh-list
101355518|NCT00030719|Dinutuximab|dinutuximab|mesh-list
101355519|NCT00030719|Isotretinoin|isotretinoin|mesh-list
101355520|NCT00030719|Antibodies|antibodies|mesh-list
101355521|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101355522|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355523|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
101355524|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355525|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355526|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355527|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
101355528|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355529|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355530|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101355531|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355532|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355534|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355548|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
101355549|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355550|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355551|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
101355619|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355620|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355621|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
101355622|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355623|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355624|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355625|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101355626|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101355627|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101355628|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
101355629|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101355630|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101355631|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
101355632|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101355633|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101355634|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101355635|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101355636|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101355637|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101355638|NCT00058305|Vincristine|vincristine|mesh-list
101355639|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
101355640|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355642|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355667|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355668|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101355669|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355670|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101355737|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101355738|NCT00396071|Vildagliptin|vildagliptin|mesh-list
101355739|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101355740|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355741|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101355742|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
101355743|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355744|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355745|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101355746|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101355800|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355803|NCT00031616|Brivudine|brivudine|mesh-list
101355872|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101355873|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101355874|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101355875|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101355877|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101355878|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355879|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101355886|NCT00059631|Bortezomib|bortezomib|mesh-list
101355936|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355937|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101355942|NCT00059865|Gemcitabine|gemcitabine|mesh-list
101356008|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101356009|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
101356010|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356011|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101356012|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101356081|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356082|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
101356083|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101356153|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356154|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356155|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
101356164|NCT00060684|Hormones|hormones|mesh-ancestor
101356224|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356225|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356226|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101356227|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101356295|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356297|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
101356367|NCT00033683|Docetaxel|docetaxel|mesh-list
101356368|NCT00033683|Fluorouracil|fluorouracil|mesh-list
101356369|NCT00033683|Methotrexate|methotrexate|mesh-list
101356371|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356372|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
101356373|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356374|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356375|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101356376|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
101356377|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356378|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356379|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101356380|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356381|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356382|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356383|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
101356384|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356385|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101356424|NCT00061425|Epratuzumab|epratuzumab|mesh-list
101356425|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356426|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356427|NCT00061464|Gemcitabine|gemcitabine|mesh-list
101356428|NCT00061464|Pemetrexed|pemetrexed|mesh-list
101356429|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356430|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
101356431|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356432|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356433|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356434|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101356435|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101356436|NCT00061503|Travoprost|travoprost|mesh-list
101356438|NCT00061542|Timolol|timolol|mesh-list
101356483|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
101356484|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356485|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356558|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356559|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356560|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356561|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101356562|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
101356563|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
101356627|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356628|NCT00034736|Levofloxacin|levofloxacin|mesh-list
101356629|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101356630|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356631|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356632|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356633|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356634|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356635|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356693|NCT00034892|Risperidone|risperidone|mesh-list
101356694|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101356695|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
101356696|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356697|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356698|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356699|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101356700|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356701|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356702|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356756|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356757|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356758|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356759|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356760|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356762|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356763|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356764|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356765|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356766|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356767|NCT00035126|Epothilones|epothilones|mesh-list
101356768|NCT00035126|Epothilone B|epothilone b|mesh-list
101356769|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356819|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101356820|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
101356821|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356822|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101356823|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
101356824|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356826|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
101356827|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356828|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101356829|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101356830|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356831|NCT00035321|Olanzapine|olanzapine|mesh-list
101356832|NCT00035321|Fluoxetine|fluoxetine|mesh-list
101356833|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
101356879|NCT00035477|Azimilide|azimilide|mesh-list
101356880|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101356881|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101356882|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356883|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356884|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101356885|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356886|NCT00062712|Sirolimus|sirolimus|mesh-list
101356887|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101356888|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356889|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356890|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356891|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356892|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
101356893|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356894|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
101356895|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356896|NCT00062790|Dutasteride|dutasteride|mesh-list
101356897|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101356898|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101356930|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356932|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356933|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356934|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356935|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
101356936|NCT00036023|Hematinics|hematinics|mesh-ancestor
101356937|NCT00036062|Sivelestat|sivelestat|mesh-list
101356938|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101356939|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101356940|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356941|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356942|NCT00036101|Aripiprazole|aripiprazole|mesh-list
101356943|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356944|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356945|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101356946|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356947|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356948|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356949|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
101356950|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
101356951|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356952|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356953|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101356954|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101356980|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357052|NCT00063687|Oxypurinol|oxypurinol|mesh-list
101357053|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357054|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357062|NCT00063726|Bortezomib|bortezomib|mesh-list
101357126|NCT00037115|Interferons|interferons|mesh-list
101357127|NCT00037115|Interferon-beta|interferon-beta|mesh-list
101357128|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
101357129|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
101357130|NCT00037115|Methotrexate|methotrexate|mesh-list
101357131|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101357132|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
101357133|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101357134|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357135|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357136|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
101357137|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357138|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357139|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357140|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357141|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101357185|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101357259|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357260|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357261|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101357262|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101357263|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357264|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357265|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357327|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101357328|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101357329|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357330|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357331|NCT00038168|Paclitaxel|paclitaxel|mesh-list
101357332|NCT00038168|Estramustine|estramustine|mesh-list
101357333|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357334|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357335|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357336|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357337|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357338|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357339|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357389|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357390|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357391|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357392|NCT00065559|Celecoxib|celecoxib|mesh-list
101357393|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101357394|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101357395|NCT00065559|Analgesics|analgesics|mesh-ancestor
101357396|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
101357397|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357398|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357399|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357400|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357401|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101357402|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101357403|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357404|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357449|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101357453|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
101357520|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101357521|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357522|NCT00070083|Prednisone|prednisone|mesh-list
101357523|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
101357524|NCT00070083|Rituximab|rituximab|mesh-list
101357525|NCT00070083|Doxorubicin|doxorubicin|mesh-list
101357526|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101357593|NCT00070200|Isotretinoin|isotretinoin|mesh-list
101357594|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357665|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
101357666|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
101357667|NCT00066417|Thiotepa|thiotepa|mesh-list
101357668|NCT00066417|Fludarabine|fludarabine|mesh-list
101357669|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
101357670|NCT00066417|Cyclosporins|cyclosporins|mesh-list
101357682|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
101357738|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357739|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101357740|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101357742|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101357743|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357747|NCT00070551|Cytarabine|cytarabine|mesh-list
101357808|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357809|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357810|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
101357882|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357883|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357884|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357885|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357886|NCT04732598|Growth Substances|growth substances|mesh-ancestor
101357887|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357888|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357889|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101357890|NCT00067080|Deferasirox|deferasirox|mesh-list
101357891|NCT00067080|Deferoxamine|deferoxamine|mesh-list
101357944|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101357945|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
101357946|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357947|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357948|NCT00071097|Darunavir|darunavir|mesh-list
101357949|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101357950|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101357951|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
101357952|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357953|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357954|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101357955|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101357956|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
101357957|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357958|NCT00067353|Fluorides|fluorides|mesh-list
101357964|NCT00071136|Pemetrexed|pemetrexed|mesh-list
101358006|NCT01349673|Hormones|hormones|mesh-ancestor
101358007|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358008|NCT00071253|Valproic Acid|valproic acid|mesh-list
101358009|NCT00071253|Olanzapine|olanzapine|mesh-list
101358010|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
101358011|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
101358012|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358013|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358014|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358015|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358071|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
101358072|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358073|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101358074|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101358075|NCT00067743|Growth Substances|growth substances|mesh-ancestor
101358076|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
101358077|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358078|NCT00396968|Plerixafor|plerixafor|mesh-list
101358079|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101358080|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101358081|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
101358082|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358083|NCT00067860|Hormones|hormones|mesh-list
101358086|NCT00071448|Insulin|insulin|mesh-list
101358135|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358136|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358137|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
101358138|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101358139|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101358140|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
101358141|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358142|NCT01406197|Progesterone|progesterone|mesh-list
101358143|NCT01406197|Progestins|progestins|mesh-ancestor
101358144|NCT01406197|Hormones|hormones|mesh-ancestor
101358145|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358146|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358147|NCT00038402|Paclitaxel|paclitaxel|mesh-list
101358148|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
101358149|NCT00038402|Fluorouracil|fluorouracil|mesh-list
101358150|NCT00038402|Trastuzumab|trastuzumab|mesh-list
101358151|NCT00038402|Epirubicin|epirubicin|mesh-list
101358152|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101358153|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358154|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
101358155|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
101358156|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358157|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358158|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358159|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
101358160|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358161|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358162|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358163|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
101358164|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101358165|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
101358172|NCT00144703|Sirolimus|sirolimus|mesh-list
101358179|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358180|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358181|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358182|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358183|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358184|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
101358185|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
101358186|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101358187|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
101358189|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
101358190|NCT00144820|Protective Agents|protective agents|mesh-ancestor
101358191|NCT00071643|Escitalopram|escitalopram|mesh-list
101358192|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101358193|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101358194|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358237|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358238|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101358239|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101358244|NCT00202345|Hematinics|hematinics|mesh-ancestor
101358309|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101358310|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358382|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358384|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
101358385|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358386|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358387|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358388|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358389|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358390|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358391|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
101358392|NCT00410644|Hydromorphone|hydromorphone|mesh-list
101358393|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101358394|NCT00410644|Narcotics|narcotics|mesh-ancestor
101358395|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358396|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358397|NCT00410644|Analgesics|analgesics|mesh-ancestor
101358398|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
101358399|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358400|NCT00038831|Fludarabine|fludarabine|mesh-list
101358401|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
101358402|NCT00038831|Melphalan|melphalan|mesh-list
101358403|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
101358404|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101358405|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
101358406|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358407|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358408|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
101358409|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358410|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358411|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
101358412|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358413|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358414|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
101358415|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101458606|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458607|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
101458608|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
101458609|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101458610|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458611|NCT04609540|Trastuzumab|trastuzumab|mesh-list
101458612|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358416|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358417|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
101358418|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
101358419|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
101358420|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101358421|NCT00071955|Antibodies|antibodies|mesh-list
101358422|NCT00071955|Sargramostim|sargramostim|mesh-list
101358423|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101358424|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
101358425|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358426|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101358427|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101358428|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101358429|NCT00203554|Protective Agents|protective agents|mesh-ancestor
101358430|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358431|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
101358432|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358433|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358434|NCT00071994|Gefitinib|gefitinib|mesh-list
101358435|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358436|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358437|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358438|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358469|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358470|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358471|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
101358472|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
101358540|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101358541|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358542|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
101358543|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101358610|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358611|NCT00410995|Naproxen|naproxen|mesh-list
101358612|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358613|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358614|NCT00410995|Analgesics|analgesics|mesh-ancestor
101358615|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
101358616|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358617|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358618|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358619|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358620|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
101358621|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358622|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358623|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358624|NCT00039338|Cisplatin|cisplatin|mesh-list
101358625|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358626|NCT00072228|Gemcitabine|gemcitabine|mesh-list
101358627|NCT00072228|Soblidotin|soblidotin|mesh-list
101358629|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
101358666|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101358667|NCT00072345|Growth Substances|growth substances|mesh-ancestor
101358668|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
101358669|NCT00039455|Trastuzumab|trastuzumab|mesh-list
101358670|NCT00039455|Alvocidib|alvocidib|mesh-list
101358671|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358672|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358673|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
101358674|NCT00039455|Growth Substances|growth substances|mesh-ancestor
101358675|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358676|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358677|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358678|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358679|NCT00205231|Etanercept|etanercept|mesh-list
101358680|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358681|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358682|NCT00205231|Analgesics|analgesics|mesh-ancestor
101358683|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
101358684|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358685|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358686|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358687|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358691|NCT00072462|Tamoxifen|tamoxifen|mesh-list
101358717|NCT00205738|Olanzapine|olanzapine|mesh-list
101358718|NCT00205738|Risperidone|risperidone|mesh-list
101358719|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101358721|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358722|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358723|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358724|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358725|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358726|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358727|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458613|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458614|NCT00564187|Irbesartan|irbesartan|mesh-list
101458615|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101458616|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101458617|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101458618|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458619|NCT00222677|Aspirin|aspirin|mesh-list
101458620|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101458621|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458622|NCT00222677|Analgesics|analgesics|mesh-ancestor
101458623|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
101458624|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458625|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458626|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458627|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101458628|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101458629|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101458632|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101458633|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458634|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
101458635|NCT00564460|Finasteride|finasteride|mesh-list
101458636|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101458637|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101458638|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458639|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458640|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
101458641|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458642|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458643|NCT00564460|Urological Agents|urological agents|mesh-ancestor
101458645|NCT04609033|Morphine|morphine|mesh-list
101458646|NCT04609033|Bupivacaine|bupivacaine|mesh-list
101458647|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
101458648|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
101458649|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458650|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458651|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
101458652|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458653|NCT04609033|Analgesics|analgesics|mesh-ancestor
101458654|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101458655|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101458656|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
101458657|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101458658|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101458659|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458660|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458661|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101458662|NCT04609033|Narcotics|narcotics|mesh-ancestor
101458663|NCT00248313|Sirolimus|sirolimus|mesh-list
101458664|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458665|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534727|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534728|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101534729|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101534730|NCT00569699|Growth Substances|growth substances|mesh-ancestor
101458666|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101458667|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358728|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101358730|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
101358731|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
101358732|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358733|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358734|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101358735|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101358736|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358737|NCT00205816|Tigecycline|tigecycline|mesh-list
101458668|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
101458669|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458670|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
101458671|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458672|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101458673|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101458674|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101458675|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458676|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458677|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458678|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458679|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458681|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
101458682|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101458683|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
101458684|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458685|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458686|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101458687|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
101458688|NCT00222833|Aripiprazole|aripiprazole|mesh-list
101458689|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
101458690|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458691|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101458692|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101458693|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458694|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458695|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
101458696|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
101458697|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458698|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458699|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101458700|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101458711|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458712|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101458713|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458714|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458715|NCT00251706|Amiodarone|amiodarone|mesh-list
101458716|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101458717|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
101458718|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101458719|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458720|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458721|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101458722|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101458723|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458724|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458725|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101458726|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101458727|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101458728|NCT00199121|Zidovudine|zidovudine|mesh-list
101458729|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
101358738|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358739|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358740|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101358741|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358742|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358743|NCT00072540|Celecoxib|celecoxib|mesh-list
101458730|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458731|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101458732|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101458733|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458734|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
101458735|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458736|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101458737|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101458738|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
101458739|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101458740|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101458741|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458742|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
101458743|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101458744|NCT00199160|Sorafenib|sorafenib|mesh-list
101458745|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458746|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101458747|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458748|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458749|NCT04607629|Omalizumab|omalizumab|mesh-list
101458750|NCT04607629|Budesonide|budesonide|mesh-list
101458751|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
101458752|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101458753|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101458754|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458755|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101458756|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
101458757|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458758|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458759|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101458760|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
101458761|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
101458762|NCT04607629|Hormones|hormones|mesh-ancestor
101458763|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458764|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101458773|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
101458774|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101458775|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101458776|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458777|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458778|NCT00251784|Urological Agents|urological agents|mesh-ancestor
101458779|NCT00248430|Aldesleukin|aldesleukin|mesh-list
101458780|NCT00248430|Melphalan|melphalan|mesh-list
101458781|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101458782|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
101458783|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458784|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458785|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101458786|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458787|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
101458788|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458789|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101458790|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101458791|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
101458792|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458793|NCT05556356|Acetaminophen|acetaminophen|mesh-list
101458794|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458795|NCT05556356|Analgesics|analgesics|mesh-ancestor
101458796|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
101458797|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458798|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458799|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
101358745|NCT00072540|Mitogens|mitogens|mesh-list
101358746|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358747|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358748|NCT00072540|Analgesics|analgesics|mesh-ancestor
101358749|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
101358750|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358751|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358752|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458800|NCT00564655|Epinephrine|epinephrine|mesh-list
101458801|NCT00564655|Racepinephrine|racepinephrine|mesh-list
101458802|NCT00564655|Bupivacaine|bupivacaine|mesh-list
101458803|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
101458804|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
101458805|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
101458806|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458807|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458808|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
101458809|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458810|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101458811|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101458812|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458813|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458814|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458815|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101458816|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101458817|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
101458818|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101458819|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
101458821|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
101458822|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101458823|NCT04606537|Itraconazole|itraconazole|mesh-list
101458824|NCT04606537|Rifampin|rifampin|mesh-list
101458825|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
101458826|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458827|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101458828|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458829|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458830|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458831|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101458835|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101534849|NCT00584532|Estrogens|estrogens|mesh-ancestor
101458836|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101458837|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
101458838|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458839|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
101458840|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101458841|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101458842|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101458843|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101458844|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101458845|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101458846|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101458848|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101458849|NCT04606225|Losartan|losartan|mesh-list
101458850|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101458851|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101458852|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101458853|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101458854|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458855|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101358753|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358754|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101358755|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358756|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358757|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358758|NCT00206050|Esomeprazole|esomeprazole|mesh-list
101358759|NCT00206050|Pantoprazole|pantoprazole|mesh-list
101358760|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101358761|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358762|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101358763|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358764|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358765|NCT00206089|Ximelagatran|ximelagatran|mesh-list
101358766|NCT00206089|Melagatran|melagatran|mesh-list
101358767|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
101358768|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101358769|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
101358770|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413431|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358771|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358772|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
101358773|NCT00072579|Sargramostim|sargramostim|mesh-list
101358774|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
101358775|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358776|NCT04732247|Oxytocin|oxytocin|mesh-list
101358777|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
101358779|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358780|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101358781|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
101358782|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358783|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358784|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358785|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358786|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358787|NCT00206167|Budesonide|budesonide|mesh-list
101358788|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
101458856|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458857|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101458858|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358789|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358790|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101358791|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
101358792|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358793|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358794|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101358795|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
101458860|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101458861|NCT04719507|Narcotics|narcotics|mesh-ancestor
101458862|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101458863|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458864|NCT04719507|Analgesics|analgesics|mesh-ancestor
101458865|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
101458866|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458867|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101458868|NCT04605952|Antibodies|antibodies|mesh-list
101458869|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
101458870|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
101458871|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458872|NCT04605562|Palbociclib|palbociclib|mesh-list
101458873|NCT04605562|Antibodies|antibodies|mesh-list
101458874|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
101458875|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
101458876|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458877|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458878|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101458879|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458880|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458881|NCT00251901|Esomeprazole|esomeprazole|mesh-list
101458882|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101458883|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458884|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101458885|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458886|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458887|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
101458888|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101458889|NCT00564772|Ritonavir|ritonavir|mesh-list
101458890|NCT00564772|Lopinavir|lopinavir|mesh-list
101458891|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
101458892|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101458893|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101458894|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
101458895|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458896|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458897|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101458898|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101458899|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
101458900|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458905|NCT00251940|Glyburide|glyburide|mesh-list
101458906|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101458907|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458908|NCT04604938|Losartan|losartan|mesh-list
101458909|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101458910|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101458911|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101458912|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101458913|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458914|NCT00565006|Anacetrapib|anacetrapib|mesh-list
101458915|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101458916|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101458917|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
101458918|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458919|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101458920|NCT00565123|Levofloxacin|levofloxacin|mesh-list
101458921|NCT00565123|Ofloxacin|ofloxacin|mesh-list
101458922|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101458923|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101458924|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101358796|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
101358797|NCT00206167|Hormones|hormones|mesh-ancestor
101358798|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358799|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101358800|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101358801|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101358802|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458925|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458926|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101458927|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101458928|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101458929|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458930|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458931|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458932|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101458933|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458934|NCT04604509|Bupropion|bupropion|mesh-list
101458935|NCT04604509|Nicotine|nicotine|mesh-list
101458936|NCT04604509|Varenicline|varenicline|mesh-list
101458937|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101458938|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
101458939|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458940|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458941|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101458942|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101458943|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
101458944|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458945|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458946|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101458947|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
101458948|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101458949|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101458950|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101458951|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458952|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
101458953|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101458954|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458955|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458956|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
101458957|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101458958|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458959|NCT04603729|Dexamethasone|dexamethasone|mesh-list
101458960|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
101458961|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101458962|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101458964|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
101458965|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101458966|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
101458967|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101458968|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
101458969|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
101458970|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458975|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458976|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101458977|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101458978|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101458979|NCT04603729|Protective Agents|protective agents|mesh-ancestor
101458980|NCT04603924|Niclosamide|niclosamide|mesh-list
101458981|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
101458982|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101458983|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
101458984|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101458985|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458986|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
101458987|NCT04603573|Listerine|listerine|mesh-list
101458988|NCT04603573|Fluorides|fluorides|mesh-list
101458989|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
101358803|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358804|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358806|NCT00039611|Fluorouracil|fluorouracil|mesh-list
101358807|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
101358808|NCT00039611|Calcium|calcium|mesh-list
101358809|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
101358810|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101358811|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358812|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
101458990|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
101458991|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
101458992|NCT04603573|Protective Agents|protective agents|mesh-ancestor
101458993|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458994|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101458995|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101458996|NCT05361824|Acetaminophen|acetaminophen|mesh-list
101458997|NCT05361824|Ketorolac|ketorolac|mesh-list
101458998|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101458999|NCT05361824|Analgesics|analgesics|mesh-ancestor
101459000|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
101459001|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459002|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459003|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
101459004|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101459005|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459006|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459007|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101459008|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459009|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358815|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358816|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358817|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
101358818|NCT00039611|Antidotes|antidotes|mesh-ancestor
101358819|NCT00039611|Protective Agents|protective agents|mesh-ancestor
101358820|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
101358821|NCT00039611|Vitamins|vitamins|mesh-ancestor
101358822|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
101358823|NCT00068289|Bortezomib|bortezomib|mesh-list
101358824|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358825|NCT00039767|Lepirudin|lepirudin|mesh-list
101358826|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
101358827|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101358828|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
101358829|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459058|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459059|NCT00565240|Letrozole|letrozole|mesh-list
101459060|NCT00565240|NuvaRing|nuvaring|mesh-list
101459061|NCT00565240|Desogestrel|desogestrel|mesh-list
101459062|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459063|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101459064|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101459065|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459066|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459067|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101459068|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
101459069|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459070|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459071|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101459072|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
101459073|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101459074|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101459075|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101459076|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101459077|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101459079|NCT00565240|Hormones|hormones|mesh-ancestor
101459080|NCT04602247|Fesoterodine|fesoterodine|mesh-list
101459081|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101459082|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101459083|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
101459084|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459085|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459086|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459087|NCT04602247|Urological Agents|urological agents|mesh-ancestor
101459088|NCT00252330|Amibegron|amibegron|mesh-list
101459089|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101459090|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101459091|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101459092|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
101459093|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459094|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459095|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459096|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101459097|NCT04602013|Paclitaxel|paclitaxel|mesh-list
101459098|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101459099|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101459100|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358830|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358831|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
101358832|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101358833|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101358834|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
101358835|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358836|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101358837|NCT00072618|Protective Agents|protective agents|mesh-ancestor
101358838|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358839|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358840|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358841|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358842|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101459101|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101459102|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101459103|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101459104|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459105|NCT04601701|Dexamethasone|dexamethasone|mesh-list
101459106|NCT04601701|Bevacizumab|bevacizumab|mesh-list
101459107|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459108|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459112|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459113|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459114|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459115|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
101459116|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
101459117|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459118|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459119|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
101459121|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459122|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101459123|NCT00252369|Infliximab|infliximab|mesh-list
101459124|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101459125|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101459126|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459127|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
101459128|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459129|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459130|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
101459131|NCT00252369|Coagulants|coagulants|mesh-ancestor
101459132|NCT00565318|Benphothiamine|benphothiamine|mesh-list
101459133|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101459134|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
101459135|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459136|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
101459137|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
101459138|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459139|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
101459140|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
101459141|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101459142|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101459143|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459144|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459145|NCT05201144|Urological Agents|urological agents|mesh-ancestor
101459146|NCT00252408|Hormones|hormones|mesh-list
101459147|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459148|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459149|NCT04601389|Omalizumab|omalizumab|mesh-list
101459150|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101459151|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101358843|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358844|NCT00072618|Analgesics|analgesics|mesh-ancestor
101358845|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
101358846|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358847|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358848|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459152|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101459153|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459154|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
101459155|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459156|NCT00565396|Losartan|losartan|mesh-list
101459157|NCT00565396|Fosinopril|fosinopril|mesh-list
101459158|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101459159|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101459160|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101459161|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101459162|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459163|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101459164|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
101459165|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459166|NCT04601116|Atorvastatin|atorvastatin|mesh-list
101459167|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101459168|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101459169|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
101459170|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459171|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101459172|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101459173|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459174|NCT00249132|Risperidone|risperidone|mesh-list
101459175|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101459176|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
101459177|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459178|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459179|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459186|NCT04600492|Riociguat|riociguat|mesh-list
101459187|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
101459188|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459189|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101459190|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459191|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459192|NCT00414648|Sirolimus|sirolimus|mesh-list
101459193|NCT00414648|Temsirolimus|temsirolimus|mesh-list
101459194|NCT00414648|MTOR Inhibitors|mtor inhibitors|mesh-list
101459195|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101459196|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459197|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101459198|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459199|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
101459200|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459201|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
101459202|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459203|NCT00414648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459204|NCT00414648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459205|NCT00414648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459206|NCT00414687|Iloprost|iloprost|mesh-list
101459207|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101459208|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
101459209|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
101459210|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101459211|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101459212|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459213|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
101459214|NCT04599205|Coagulants|coagulants|mesh-ancestor
101459215|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
101459216|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
101459217|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459218|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459219|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459220|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
101358849|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
101358850|NCT00039884|Hematinics|hematinics|mesh-ancestor
101358851|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
101358852|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358853|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358854|NCT00399204|Metformin|metformin|mesh-list
101459221|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459222|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459223|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459224|NCT05055128|Lansoprazole|lansoprazole|mesh-list
101459225|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
101459226|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101459228|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101459230|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459231|NCT00565591|Albuterol|albuterol|mesh-list
101459232|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101459233|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
101459234|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459235|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459236|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101459237|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459238|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
101459239|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101459240|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101459241|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101459242|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101459243|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
101459244|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459245|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459246|NCT00252603|Galantamine|galantamine|mesh-list
101459247|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101459248|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459249|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459252|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459253|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101459254|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
101459255|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459256|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
101459258|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101459259|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101459260|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459261|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101459262|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101459263|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459264|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459265|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459266|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101459267|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
101459268|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101459269|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459270|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101459271|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101459272|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101459273|NCT00565708|Aspirin|aspirin|mesh-list
101459274|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101459275|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101459276|NCT00565708|Analgesics|analgesics|mesh-ancestor
101459277|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
101459278|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459279|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459280|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459281|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459282|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101459283|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101459284|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459285|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101459286|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358856|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358857|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358858|NCT00411034|Hydromorphone|hydromorphone|mesh-list
101358859|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101358861|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358862|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358863|NCT00411034|Analgesics|analgesics|mesh-ancestor
101358864|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
101358865|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358866|NCT00411073|Darapladib|darapladib|mesh-list
101358867|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101358868|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358869|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358870|NCT00411190|Acetaminophen|acetaminophen|mesh-list
101358871|NCT00411190|Ibuprofen|ibuprofen|mesh-list
101358872|NCT00411190|Atorvastatin|atorvastatin|mesh-list
101358873|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101459287|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459288|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
101459289|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101459290|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
101459291|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459292|NCT04598542|Triamcinolone|triamcinolone|mesh-list
101459293|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101459294|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101459295|NCT04598542|Lorecivivint|lorecivivint|mesh-list
101459296|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101459297|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459298|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
101459299|NCT04598542|Hormones|hormones|mesh-ancestor
101459300|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459301|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459302|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459303|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
101459304|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459305|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459306|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101459308|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101459309|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459310|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101459311|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459312|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459313|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101459314|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101459315|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
101459316|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459317|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459318|NCT04598191|Iloprost|iloprost|mesh-list
101459319|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101459320|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101459322|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101459323|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459324|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459325|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358874|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101358875|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
101358876|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358877|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101358878|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101358880|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358882|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
101459326|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459327|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
101459328|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459329|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459330|NCT00249171|Risperidone|risperidone|mesh-list
101459331|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101459332|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
101459333|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459334|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459335|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459336|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101459337|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459338|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459339|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459340|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101459341|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
101459342|NCT00565981|Fludarabine|fludarabine|mesh-list
101459343|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
101459344|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
101459345|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459346|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101459347|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
101459348|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459349|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459350|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
101459351|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459352|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459353|NCT04952519|Amantadine|amantadine|mesh-list
101459354|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101459355|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101459356|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
101459357|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459358|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
101459359|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459360|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459361|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459362|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101459363|NCT04952519|Analgesics|analgesics|mesh-ancestor
101459364|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
101459365|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459366|NCT00414921|Clonidine|clonidine|mesh-list
101459367|NCT00414921|Methylphenidate|methylphenidate|mesh-list
101459368|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101459369|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459370|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101459371|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459372|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459373|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459374|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
101459375|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459376|NCT00414921|Analgesics|analgesics|mesh-ancestor
101459377|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
101459378|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459379|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101459380|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
101358883|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358884|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358885|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
101358886|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358887|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358888|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358889|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358890|NCT00411229|Capecitabine|capecitabine|mesh-list
101358891|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
101358892|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358893|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
101358894|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358895|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358896|NCT00411268|Hydromorphone|hydromorphone|mesh-list
101459382|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101459383|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101459384|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101459385|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
101459386|NCT04597762|Cyclosporine|cyclosporine|mesh-list
101459387|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
101459388|NCT04597762|Cyclosporins|cyclosporins|mesh-list
101459389|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535630|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101459390|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459391|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459392|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
101459393|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459394|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
101459402|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459403|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101459404|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101459405|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101459406|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459407|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459408|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459409|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101459410|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101459412|NCT00252798|Carboplatin|carboplatin|mesh-list
101459413|NCT00252798|Gefitinib|gefitinib|mesh-list
101459414|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101459415|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459416|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101459417|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101459418|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101459419|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459420|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459421|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459422|NCT02961660|Odalasvir|odalasvir|mesh-list
101459423|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
101459424|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459425|NCT00403013|Anesthetics|anesthetics|mesh-list
101459426|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459427|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459428|NCT00566332|Fludarabine|fludarabine|mesh-list
101459429|NCT00566332|Chlorambucil|chlorambucil|mesh-list
101459430|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459431|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459432|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101459433|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
101459434|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
101459435|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101358897|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101358898|NCT00411268|Narcotics|narcotics|mesh-ancestor
101358899|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358900|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358901|NCT00411268|Analgesics|analgesics|mesh-ancestor
101358902|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
101358903|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358904|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101358905|NCT00039962|Thymalfasin|thymalfasin|mesh-list
101358906|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
101358907|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358908|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101459436|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
101459437|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459438|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101459439|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101459440|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459441|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459442|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459443|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101459444|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459445|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459446|NCT04595929|Leucovorin|leucovorin|mesh-list
101459447|NCT04595929|Docetaxel|docetaxel|mesh-list
101459448|NCT04595929|Fluorouracil|fluorouracil|mesh-list
101459449|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
101459450|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459451|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101459452|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101459453|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101459454|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459455|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
101459456|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101459457|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101459458|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
101459459|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459460|NCT04595929|Antidotes|antidotes|mesh-ancestor
101459461|NCT04595929|Protective Agents|protective agents|mesh-ancestor
101459467|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
101459468|NCT04595812|Misoprostol|misoprostol|mesh-list
101459469|NCT04595812|Hemostatics|hemostatics|mesh-list
101459471|NCT04595812|Carbetocin|carbetocin|mesh-list
101459472|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
101459473|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101459474|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459475|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101459476|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
101459477|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101459478|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459479|NCT04595812|Coagulants|coagulants|mesh-ancestor
101459480|NCT00249366|Lorazepam|lorazepam|mesh-list
101459481|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
101459482|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
101459483|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
101459484|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459485|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459486|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459487|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101459488|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459489|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101459490|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459491|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459492|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
101459493|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
101459494|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358909|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
101358910|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358911|NCT00424333|Insulin|insulin|mesh-list
101358912|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101358913|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358914|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358915|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101358916|NCT00206557|Estradiol|estradiol|mesh-list
101358917|NCT00206557|Estrogens|estrogens|mesh-ancestor
101358918|NCT00206557|Hormones|hormones|mesh-ancestor
101358919|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358920|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358921|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101358922|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101358923|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101459495|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459496|NCT04635683|Lenalidomide|lenalidomide|mesh-list
101459497|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
101459498|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459499|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459500|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459502|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459503|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459504|NCT00249405|Citalopram|citalopram|mesh-list
101459505|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101459506|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459507|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459508|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459509|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459510|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
101459511|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459512|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101459513|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
101459514|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459515|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
101459516|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101459517|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
101459518|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101459519|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459520|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101459521|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101459522|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101459523|NCT00253110|Haloperidol|haloperidol|mesh-list
101459524|NCT00253110|Risperidone|risperidone|mesh-list
101459525|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
101459526|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101459527|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
101459528|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459529|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459530|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459531|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101459532|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459533|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459541|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101459542|NCT00566683|Meperidine|meperidine|mesh-list
101459543|NCT00566683|Diazepam|diazepam|mesh-list
101459544|NCT00566683|Alfentanil|alfentanil|mesh-list
101459545|NCT00566683|Propofol|propofol|mesh-list
101358924|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101358925|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101358926|NCT00068484|Bortezomib|bortezomib|mesh-list
101358927|NCT00068484|Topotecan|topotecan|mesh-list
101358928|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358929|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101459546|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101459547|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459548|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459549|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101459550|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
101459551|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
101459552|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101459553|NCT00566683|Narcotics|narcotics|mesh-ancestor
101459554|NCT00566683|Analgesics|analgesics|mesh-ancestor
101459555|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
101459556|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459557|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101459558|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
101459559|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
101459560|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
101459561|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459562|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101459563|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101459564|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101459565|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459566|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459568|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
101459569|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459570|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459571|NCT00566761|Triamcinolone|triamcinolone|mesh-list
101459572|NCT00566761|Bevacizumab|bevacizumab|mesh-list
101459573|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459574|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459575|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459576|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459577|NCT00566761|Growth Substances|growth substances|mesh-ancestor
101459578|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459579|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459580|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459581|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
101459583|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459584|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101459585|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459586|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459587|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459588|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459589|NCT04593706|Dexamethasone|dexamethasone|mesh-list
101459590|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
101459591|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101459592|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101459593|NCT04593706|Prednisolone|prednisolone|mesh-list
101459594|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
101459595|NCT04593706|Triamcinolone|triamcinolone|mesh-list
101459596|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101459597|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101459598|NCT04593706|Betamethasone|betamethasone|mesh-list
101459599|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
101459600|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101459601|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
101413460|NCT00118326|Lenograstim|lenograstim|mesh-list
101459602|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
101459604|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101459605|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
101459619|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101459620|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459621|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101459622|NCT04593706|Protective Agents|protective agents|mesh-ancestor
101459623|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358930|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358932|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459624|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
101459625|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459626|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459628|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459629|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
101459630|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101459632|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101459633|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459634|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459636|NCT04593160|Diclofenac|diclofenac|mesh-list
101459637|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101459638|NCT04593160|Analgesics|analgesics|mesh-ancestor
101459639|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
101459640|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459641|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459642|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
101459643|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101459644|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459645|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459646|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101459647|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459648|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459649|NCT00253149|Risperidone|risperidone|mesh-list
101459650|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101459651|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
101459652|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459653|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459654|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459655|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101459656|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459657|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459658|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459659|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101459661|NCT04539236|Lenalidomide|lenalidomide|mesh-list
101459662|NCT04539236|Luspatercept|luspatercept|mesh-list
101459663|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
101459664|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459665|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459666|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459667|NCT04539236|Growth Substances|growth substances|mesh-ancestor
101459668|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459669|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459670|NCT04539236|Hematinics|hematinics|mesh-ancestor
101459671|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101459672|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101459673|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459674|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459675|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459677|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459678|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101459679|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
101459680|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459681|NCT00567034|Naltrexone|naltrexone|mesh-list
101459682|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101459683|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101459684|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459685|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
101459686|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459687|NCT04484363|Azacitidine|azacitidine|mesh-list
101459688|NCT04484363|Pevonedistat|pevonedistat|mesh-list
101459689|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101459690|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
101358934|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
101358935|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358937|NCT00206635|Interferon-beta|interferon-beta|mesh-list
101358938|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
101358939|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358940|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
101358941|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459691|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459692|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459693|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459695|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101459696|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101459697|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101459698|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101459699|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101459700|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459701|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459702|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101459703|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459704|NCT00253188|Galantamine|galantamine|mesh-list
101459705|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101459706|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459707|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459708|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
101459709|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459710|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459711|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101459712|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
101459713|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459714|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
101459715|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
101459716|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101459717|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101459718|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101459719|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459720|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
101459721|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
101459722|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
101459723|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459724|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459725|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
101459726|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459728|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101459729|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101459730|NCT04591795|Analgesics|analgesics|mesh-ancestor
101459732|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459733|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459734|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459735|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459736|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101459737|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459738|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459745|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459746|NCT04719585|Analgesics|analgesics|mesh-ancestor
101459747|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
101459748|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459749|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101459750|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459751|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358942|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
101358943|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358944|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101358945|NCT00206674|Sargramostim|sargramostim|mesh-list
101358946|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
101358947|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358948|NCT00206713|Sargramostim|sargramostim|mesh-list
101358949|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
101358950|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358951|NCT00040040|Bupropion|bupropion|mesh-list
101358952|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101358953|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
101358954|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358955|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101358956|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101358957|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358958|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358959|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
101459752|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459753|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459754|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
101459755|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459756|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
101459757|NCT04592029|Bevacizumab|bevacizumab|mesh-list
101459758|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459759|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459760|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459761|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459762|NCT04592029|Growth Substances|growth substances|mesh-ancestor
101459763|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459764|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459765|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101459767|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
101459768|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
101459769|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101459770|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459771|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
101459772|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
101459773|NCT00253227|Galantamine|galantamine|mesh-list
101459774|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101459775|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459776|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459777|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
101459778|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459779|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459780|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101459781|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
101459782|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459783|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
101459785|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
101459786|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
101459787|NCT04591444|Protective Agents|protective agents|mesh-ancestor
101459788|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459789|NCT04591327|Anesthetics|anesthetics|mesh-list
101459790|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358960|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358961|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358962|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101358963|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101358964|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358965|NCT00068523|Cyclosporine|cyclosporine|mesh-list
101358966|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
101358967|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
101358968|NCT00068523|Fludarabine|fludarabine|mesh-list
101358969|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
101358970|NCT00068523|Cyclosporins|cyclosporins|mesh-list
101358971|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101358972|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358973|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
101358974|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358975|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459791|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459792|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101413472|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
101459793|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101459794|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
101459795|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459796|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101459797|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459798|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459799|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459800|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101459801|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101459802|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101459803|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459804|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459805|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101459806|NCT00253305|Terbinafine|terbinafine|mesh-list
101459812|NCT04591600|Ivermectin|ivermectin|mesh-list
101459813|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101459814|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459815|NCT04591405|Vaccines|vaccines|mesh-list
101459816|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
101459817|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459818|NCT04590742|Melatonin|melatonin|mesh-list
101459819|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
101459820|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459821|NCT04590742|Protective Agents|protective agents|mesh-ancestor
101459822|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459823|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459824|NCT00253344|Docetaxel|docetaxel|mesh-list
101459825|NCT00253344|Lenalidomide|lenalidomide|mesh-list
101459826|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459827|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
101459828|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
101459830|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459831|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
101459832|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459833|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459834|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459835|NCT00253344|Growth Substances|growth substances|mesh-ancestor
101459836|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
101459837|NCT00567463|Fluticasone|fluticasone|mesh-list
101358976|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358977|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
101358978|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358979|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358980|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101358981|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358982|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
101358983|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358984|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
101358985|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459838|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459839|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101459840|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
101459841|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459842|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459843|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101459844|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459845|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101459846|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101459847|NCT00253422|Fulvestrant|fulvestrant|mesh-list
101459848|NCT00253422|Anastrozole|anastrozole|mesh-list
101459849|NCT00253422|Exemestane|exemestane|mesh-list
101459850|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101459851|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459852|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101459853|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101459854|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101459855|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459856|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459857|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101459858|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101536272|NCT00474903|Esomeprazole|esomeprazole|mesh-list
101536273|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101459859|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459860|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459861|NCT04590625|Carboplatin|carboplatin|mesh-list
101459862|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101459863|NCT04590625|Apatinib|apatinib|mesh-list
101459864|NCT04590625|Cisplatin|cisplatin|mesh-list
101459865|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459866|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459867|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459868|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459869|NCT00253461|Topotecan|topotecan|mesh-list
101459870|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101459871|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101459872|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101459873|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459874|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459875|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459876|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101459877|NCT00567658|Esomeprazole|esomeprazole|mesh-list
101459878|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101459881|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459882|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459883|NCT00567697|Ranibizumab|ranibizumab|mesh-list
101459884|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459885|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459886|NCT00567697|Growth Substances|growth substances|mesh-ancestor
101459887|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459889|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459890|NCT04589494|Morphine|morphine|mesh-list
101459891|NCT04589494|Tramadol|tramadol|mesh-list
101459892|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101459893|NCT04589494|Narcotics|narcotics|mesh-ancestor
101536557|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
101358987|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101358988|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358989|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
101358990|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
101358991|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358992|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459894|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459895|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459896|NCT04589494|Analgesics|analgesics|mesh-ancestor
101459897|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
101537112|NCT00587873|Leucovorin|leucovorin|mesh-list
101459898|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459899|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
101459900|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101459901|NCT04589299|Antibodies|antibodies|mesh-list
101459902|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
101459903|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459904|NCT00253500|Epirubicin|epirubicin|mesh-list
101459905|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101459906|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459907|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101459909|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459910|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459911|NCT04589143|Agomelatine|agomelatine|mesh-list
101459912|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101459913|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459914|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459915|NCT04588987|Apatinib|apatinib|mesh-list
101459916|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459917|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459918|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459919|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459920|NCT00253539|Tamoxifen|tamoxifen|mesh-list
101459921|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101459922|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
101459923|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459924|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459925|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101459926|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459927|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101459928|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101459929|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101459931|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459932|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
101459933|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
101459934|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101459935|NCT00567775|Insulin|insulin|mesh-list
101459936|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101459937|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101459938|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459940|NCT00567814|Metyrapone|metyrapone|mesh-list
101459941|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
101459942|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459943|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459944|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101459945|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459946|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459947|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101459948|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459949|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459950|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
101459951|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
101459952|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459958|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
101358993|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
101358994|NCT00068523|Hormones|hormones|mesh-ancestor
101358995|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358996|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101358997|NCT00068523|Protective Agents|protective agents|mesh-ancestor
101358998|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
101358999|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101359000|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101359001|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487379|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101459959|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
101459960|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459961|NCT00253578|Sorafenib|sorafenib|mesh-list
101459962|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459963|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101459964|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459965|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459966|NCT04588285|Ambroxol|ambroxol|mesh-list
101459967|NCT04588285|Expectorants|expectorants|mesh-ancestor
101459968|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459969|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
101459970|NCT04153565|Pemetrexed|pemetrexed|mesh-list
101459971|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459972|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101459973|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101459974|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459975|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459976|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101459977|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101459978|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
101459979|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101459981|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459982|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
101459983|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101459984|NCT04587778|Ketamine|ketamine|mesh-list
101459985|NCT04587778|Esketamine|esketamine|mesh-list
101459986|NCT04587778|Analgesics|analgesics|mesh-ancestor
101459987|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
101459988|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459989|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459990|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101459991|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101459992|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
101459993|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
101459994|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459995|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101413483|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
101459996|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101459997|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459998|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459999|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460000|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460002|NCT04587505|Tramadol|tramadol|mesh-list
101460003|NCT04587505|Anesthetics|anesthetics|mesh-list
101460004|NCT04587505|Ropivacaine|ropivacaine|mesh-list
101460005|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460006|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460007|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101460008|NCT04587505|Narcotics|narcotics|mesh-ancestor
101460009|NCT04587505|Analgesics|analgesics|mesh-ancestor
101460010|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
101460011|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460012|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
101460013|NCT04128683|Bromocriptine|bromocriptine|mesh-list
101460014|NCT04128683|Amisulpride|amisulpride|mesh-list
101359002|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359005|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101359006|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101359007|NCT00206947|Ziprasidone|ziprasidone|mesh-list
101359008|NCT00206947|Donepezil|donepezil|mesh-list
101359009|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101359010|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359011|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359012|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
101359013|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487380|NCT05198960|Analgesics|analgesics|mesh-ancestor
101460015|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460016|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460017|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460018|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460019|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460020|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460021|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
101460022|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460023|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460024|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101460039|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
101460040|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460041|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101460042|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
101460043|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460044|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460045|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460046|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460047|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460048|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460049|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
101460050|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
101460051|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
101460052|NCT00403247|Pyridoxine|pyridoxine|mesh-list
101460053|NCT00403247|Vitamins|vitamins|mesh-ancestor
101460054|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
101460055|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460056|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
101460057|NCT00403247|Hematinics|hematinics|mesh-ancestor
101460058|NCT00253773|Acetaminophen|acetaminophen|mesh-list
101460059|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460060|NCT00253773|Analgesics|analgesics|mesh-ancestor
101460061|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
101460062|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460063|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460064|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
101460065|NCT00403286|Fluticasone|fluticasone|mesh-list
101460066|NCT00403286|Xhance|xhance|mesh-list
101460067|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
101460068|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101460069|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460070|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101460071|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
101460072|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460073|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460074|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101460075|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
101460076|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460077|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101460078|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101359014|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359015|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
101359016|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101359017|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
101359018|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101359019|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460079|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101460080|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101460081|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
101460082|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460083|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460084|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101460085|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101460086|NCT04585867|Bupivacaine|bupivacaine|mesh-list
101460088|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
101460089|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460094|NCT00253851|Calcium heparin|calcium heparin|mesh-list
101460095|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
101460096|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101460097|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101460098|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460099|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101460100|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101460101|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101460102|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
101460103|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460104|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101460105|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101460106|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460108|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101460109|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460110|NCT04585438|Analgesics|analgesics|mesh-ancestor
101460111|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
101460112|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460113|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460114|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460115|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460116|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101460117|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460118|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460119|NCT00223223|Levetiracetam|levetiracetam|mesh-list
101460120|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
101460121|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
101460122|NCT00567931|Tryptophan|tryptophan|mesh-list
101460123|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101460124|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460125|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460126|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
101460127|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101460128|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460129|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101460130|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
101460131|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101460132|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460133|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460134|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460135|NCT04585321|Diclofenac|diclofenac|mesh-list
101460136|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101460137|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101460138|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460139|NCT04585321|Analgesics|analgesics|mesh-ancestor
101460140|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
101460141|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460142|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359020|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359021|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359022|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101359023|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
101359024|NCT00068757|Paclitaxel|paclitaxel|mesh-list
101460143|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460144|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460145|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101460146|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460147|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460148|NCT00412997|Panobinostat|panobinostat|mesh-list
101460149|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460150|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101460151|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460152|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460153|NCT00253929|Adenosine|adenosine|mesh-list
101460154|NCT00253929|Nitroprusside|nitroprusside|mesh-list
101460155|NCT00253929|Acetylcholine|acetylcholine|mesh-list
101460156|NCT00253929|Caffeine|caffeine|mesh-list
101460157|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101460158|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460159|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101460160|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460164|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
101460165|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460166|NCT00253929|Analgesics|analgesics|mesh-ancestor
101460167|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
101460168|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460169|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101460170|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
101460171|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101460172|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
101460173|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101460174|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101460175|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101460176|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
101460177|NCT00568048|Bevacizumab|bevacizumab|mesh-list
101460178|NCT00568048|Temozolomide|temozolomide|mesh-list
101460179|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101460180|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460181|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460182|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460183|NCT00568048|Growth Substances|growth substances|mesh-ancestor
101460184|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460185|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460186|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101460187|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
101460188|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460189|NCT04584580|Heparin|heparin|mesh-list
101460190|NCT04584580|Enoxaparin|enoxaparin|mesh-list
101460191|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101460192|NCT04584580|Tinzaparin|tinzaparin|mesh-list
101460193|NCT04584580|Dalteparin|dalteparin|mesh-list
101460194|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
101460195|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101460196|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101460197|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460198|NCT00250029|Capecitabine|capecitabine|mesh-list
101460199|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
101460200|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101460201|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
101460202|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460203|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460204|NCT00223418|Aripiprazole|aripiprazole|mesh-list
101460205|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460206|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460207|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460208|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460209|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460210|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460211|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
101460212|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
101359025|NCT00068757|Trastuzumab|trastuzumab|mesh-list
101359026|NCT00068757|Lonafarnib|lonafarnib|mesh-list
101359027|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359028|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359029|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359030|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
101460213|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460214|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460215|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101460216|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101460217|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
101460218|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101460219|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101460220|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101460221|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460222|NCT04584736|Ezetimibe|ezetimibe|mesh-list
101460223|NCT04584736|Pitavastatin|pitavastatin|mesh-list
101460224|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101460225|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101460226|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
101460227|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460228|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101460229|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101460230|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460236|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460237|NCT04584307|Pomalidomide|pomalidomide|mesh-list
101460238|NCT04584307|Elotuzumab|elotuzumab|mesh-list
101460239|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
101460240|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460241|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460242|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460243|NCT04584307|Growth Substances|growth substances|mesh-ancestor
101460244|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460245|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460246|NCT04584034|Albuterol|albuterol|mesh-list
101460247|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
101460248|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
101460249|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460250|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460251|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101460252|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
101460253|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
101460254|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101460255|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101460256|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101460257|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101460258|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
101460259|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460260|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460261|NCT04583410|Nicotine|nicotine|mesh-list
101460262|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101460263|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
101460264|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460265|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460266|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101460267|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101460268|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
101460269|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460270|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460272|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101460273|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101460274|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460275|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460276|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460278|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359031|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359032|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359033|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359034|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460279|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101413503|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
101460280|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460281|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460282|NCT00223613|Insulin|insulin|mesh-list
101460283|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460284|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460285|NCT04583137|Lidocaine|lidocaine|mesh-list
101460286|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
101460287|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
101460288|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460289|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460290|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
101460291|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460292|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101460293|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101460294|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101460295|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460296|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460297|NCT00223691|Acarbose|acarbose|mesh-list
101460298|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
101460299|NCT00223691|Promethazine|promethazine|mesh-list
101460300|NCT00223691|Ibuprofen|ibuprofen|mesh-list
101460301|NCT00223691|Celecoxib|celecoxib|mesh-list
101460302|NCT00223691|Indomethacin|indomethacin|mesh-list
101460315|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
101460316|NCT00223691|Caffeine|caffeine|mesh-list
101460317|NCT00223691|Methylphenidate|methylphenidate|mesh-list
101460318|NCT00223691|Modafinil|modafinil|mesh-list
101460319|NCT00223691|Rivastigmine|rivastigmine|mesh-list
101460320|NCT00223691|Ranitidine|ranitidine|mesh-list
101460321|NCT00223691|Yohimbine|yohimbine|mesh-list
101460322|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101460323|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101460324|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101460325|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460326|NCT00223691|Analgesics|analgesics|mesh-ancestor
101460327|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
101460328|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460329|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460330|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460331|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460332|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101460333|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460334|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460335|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101460336|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101460337|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101460338|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101460339|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101460341|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460342|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101460343|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101460344|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460345|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
101460346|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
101460347|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101460348|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101460349|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101460350|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101460351|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460352|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101460353|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101460354|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
101460355|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101460356|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101359036|NCT00206986|Analgesics|analgesics|mesh-ancestor
101359037|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
101359038|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359039|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359040|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101359041|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
101359042|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
101359043|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101460357|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460358|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
101460359|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
101460360|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
101460361|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
101460362|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101460363|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
101460364|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
101460365|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101460366|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
101460367|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460368|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101460369|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101460370|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101460371|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
101460374|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101460375|NCT00223691|Diuretics|diuretics|mesh-ancestor
101460376|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
101460377|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101460378|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460379|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101460380|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
101460381|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101460382|NCT00223691|Protective Agents|protective agents|mesh-ancestor
101460383|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
101460384|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101460385|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101460386|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101460387|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101460388|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101460389|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
101460390|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
101460391|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101460392|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101460393|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
101460394|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
101460395|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101460396|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
101460397|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101460398|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101460399|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101460400|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101460401|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101460402|NCT00223691|Urological Agents|urological agents|mesh-ancestor
101460403|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460404|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460405|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101460406|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101460407|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460408|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
101460409|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101460410|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
101460412|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101460413|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
101460414|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460415|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460416|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101460417|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359044|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101359045|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101359046|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101359047|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359048|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359049|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101359050|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359051|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359053|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460418|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460419|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460421|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101460422|NCT04582786|Narcotics|narcotics|mesh-ancestor
101460423|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460424|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460425|NCT04582786|Analgesics|analgesics|mesh-ancestor
101460426|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
101460427|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460428|NCT00223769|Oxandrolone|oxandrolone|mesh-list
101460429|NCT00223769|Androgens|androgens|mesh-ancestor
101460430|NCT00223769|Hormones|hormones|mesh-ancestor
101460431|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460432|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460433|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
101460434|NCT04582084|Etanercept|etanercept|mesh-list
101460435|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101460436|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460437|NCT04582084|Analgesics|analgesics|mesh-ancestor
101460438|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
101460439|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460440|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460441|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460442|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460443|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101460444|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460445|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
101460449|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460450|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460451|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
101460452|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460453|NCT00223925|Maribavir|maribavir|mesh-list
101460454|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
101460455|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460456|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
101460457|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460458|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460459|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
101460460|NCT04581967|Doxorubicin|doxorubicin|mesh-list
101460461|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460462|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
101460463|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460464|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460465|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101460466|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
101460468|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460469|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101460470|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101460471|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101460472|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101460475|NCT00223964|Hematinics|hematinics|mesh-ancestor
101460476|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
101359054|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359055|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359057|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101359058|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101359059|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460477|NCT00224081|Hematinics|hematinics|mesh-ancestor
101460478|NCT04581265|Paclitaxel|paclitaxel|mesh-list
101460479|NCT04581265|Ifosfamide|ifosfamide|mesh-list
101460480|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101460481|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101460482|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460483|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
101460484|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
101460485|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
101460486|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460487|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101460488|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
101460489|NCT04580797|PF-06700841|pf-06700841|mesh-list
101460490|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101460491|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460492|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460493|NCT00568477|Rituximab|rituximab|mesh-list
101460494|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101460495|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460496|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
101460497|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460498|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460500|NCT00568711|Rifampin|rifampin|mesh-list
101460501|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101460502|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460503|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
101460504|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101460505|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101460506|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101460507|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
101460508|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
101460509|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101460510|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460511|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460512|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101460513|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101460514|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101460515|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101460516|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101460529|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460530|NCT00415116|Growth Substances|growth substances|mesh-ancestor
101460531|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460533|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460534|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101460535|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460536|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460538|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101460539|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101460540|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460541|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460542|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101460543|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
101460544|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
101460545|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460546|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460547|NCT00254202|Iloperidone|iloperidone|mesh-list
101359060|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359061|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
101359062|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359063|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101460548|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460549|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460550|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460551|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460552|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460553|NCT00568984|Metformin|metformin|mesh-list
101460554|NCT00568984|Repaglinide|repaglinide|mesh-list
101460555|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460556|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460557|NCT00254241|Risperidone|risperidone|mesh-list
101460558|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101460559|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101460560|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
101460561|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460562|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460563|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460565|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460566|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460567|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460568|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460569|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
101460570|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460571|NCT00224315|Risperidone|risperidone|mesh-list
101460572|NCT00224315|Ziprasidone|ziprasidone|mesh-list
101460573|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101460574|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
101460575|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460576|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460577|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460578|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460579|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460580|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460581|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460588|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101460589|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460590|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460592|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
101460593|NCT00224354|Immunotoxins|immunotoxins|mesh-list
101460594|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460595|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101460596|NCT00224354|Analgesics|analgesics|mesh-ancestor
101460597|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
101460598|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460599|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460600|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
101460601|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
101460602|NCT00569296|Aldesleukin|aldesleukin|mesh-list
101460603|NCT00569296|Sargramostim|sargramostim|mesh-list
101460604|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
101460605|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460606|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460607|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101460608|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101460609|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
101460610|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460611|NCT00569335|Bevacizumab|bevacizumab|mesh-list
101460612|NCT00569335|Irinotecan|irinotecan|mesh-list
101460613|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101460614|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460615|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460616|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460617|NCT00569335|Growth Substances|growth substances|mesh-ancestor
101460618|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460619|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460620|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101460621|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359064|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101359065|NCT00072852|Irinotecan|irinotecan|mesh-list
101359066|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101359067|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359068|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460622|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460623|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460624|NCT00254319|Bevacizumab|bevacizumab|mesh-list
101460625|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101460626|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460627|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460628|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460629|NCT00254319|Growth Substances|growth substances|mesh-ancestor
101460630|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460631|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460632|NCT00569452|Insulin|insulin|mesh-list
101460633|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101460634|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460635|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460636|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
101460638|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101460639|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460640|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101460641|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101460642|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460643|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460644|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460645|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101460646|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101460647|NCT00224471|Vaccines|vaccines|mesh-list
101460648|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
101460649|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460650|NCT00569920|Dexamethasone|dexamethasone|mesh-list
101460651|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
101460652|NCT00569920|BB 1101|bb 1101|mesh-list
101460653|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460669|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101460670|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460671|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460672|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101460673|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460674|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460675|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460676|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460677|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460678|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101460679|NCT00570193|Ranibizumab|ranibizumab|mesh-list
101460680|NCT00570193|Verteporfin|verteporfin|mesh-list
101460681|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460682|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101460683|NCT00570193|Growth Substances|growth substances|mesh-ancestor
101460684|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460685|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
101460686|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460687|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101460688|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460690|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101460691|NCT00224549|Irbesartan|irbesartan|mesh-list
101460692|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101460693|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101460694|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460695|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460696|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101460697|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460698|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
101460699|NCT00224549|Diuretics|diuretics|mesh-ancestor
101460700|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
101359069|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359070|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359071|NCT00207532|Folic Acid|folic acid|mesh-list
101359072|NCT00207532|Hematinics|hematinics|mesh-ancestor
101359073|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
101359074|NCT00207532|Vitamins|vitamins|mesh-ancestor
101359075|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
101359076|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359077|NCT00040391|Leucovorin|leucovorin|mesh-list
101359078|NCT00040391|Fluorouracil|fluorouracil|mesh-list
101359079|NCT00040391|Irinotecan|irinotecan|mesh-list
101359080|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
101359081|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359082|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359083|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359084|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359085|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
101359086|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359087|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101359088|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359089|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359090|NCT00040391|Antidotes|antidotes|mesh-ancestor
101359091|NCT00040391|Protective Agents|protective agents|mesh-ancestor
101359092|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
101460701|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101460702|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101460703|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101460704|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
101460705|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101460706|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
101460707|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460708|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460709|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101460710|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
101460711|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
101460724|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101460725|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
101460726|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
101460727|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460728|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101460729|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101460730|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460731|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460733|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460734|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460735|NCT00254475|Valsartan|valsartan|mesh-list
101460736|NCT00254475|Simvastatin|simvastatin|mesh-list
101460737|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101460738|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101460739|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
101460740|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359094|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
101359095|NCT00207688|Infliximab|infliximab|mesh-list
101359096|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101359097|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359098|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460741|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101460742|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101460743|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460744|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101460745|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101460746|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101460747|NCT00570856|Folic Acid|folic acid|mesh-list
101460748|NCT00570856|Hematinics|hematinics|mesh-ancestor
101460749|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
101460750|NCT00570856|Vitamins|vitamins|mesh-ancestor
101460751|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
101460752|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460753|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
101460754|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
101460755|NCT00570934|Vitamin D|vitamin d|mesh-list
101460756|NCT00570934|Calcium|calcium|mesh-list
101460757|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101460758|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460759|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101460760|NCT00570934|Vitamins|vitamins|mesh-ancestor
101460761|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
101460762|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
101460763|NCT00254553|Testosterone|testosterone|mesh-list
101460764|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
101460765|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
101460766|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101460767|NCT00254553|Androgens|androgens|mesh-ancestor
101460768|NCT00254553|Hormones|hormones|mesh-ancestor
101460769|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460770|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460771|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101460772|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460773|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
101460774|NCT00571129|Mitomycins|mitomycins|mesh-list
101460775|NCT00571129|Mitomycin|mitomycin|mesh-list
101460776|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101460779|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460781|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460782|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101460783|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460784|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
101460785|NCT03453931|Hormones|hormones|mesh-ancestor
101460786|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460787|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460788|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101460789|NCT03453931|Protective Agents|protective agents|mesh-ancestor
101460790|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101460791|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460792|NCT00571246|Topiramate|topiramate|mesh-list
101460793|NCT00571246|Lamotrigine|lamotrigine|mesh-list
101460794|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
101460795|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460796|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460797|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101460798|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460799|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460800|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101460801|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460802|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413516|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460803|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460804|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460805|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101460807|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101460808|NCT00254631|Narcotics|narcotics|mesh-ancestor
101359099|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359100|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359101|NCT00207766|Infliximab|infliximab|mesh-list
101359102|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101359103|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359104|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
101359105|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359106|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359107|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
101359108|NCT00040469|Busulfan|busulfan|mesh-list
101359109|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
101359110|NCT00040469|Phenytoin|phenytoin|mesh-list
101359111|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359112|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
101359113|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460809|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460810|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460811|NCT00254631|Analgesics|analgesics|mesh-ancestor
101460812|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
101460813|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460814|NCT00571285|Vitamin D|vitamin d|mesh-list
101460815|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
101460816|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
101460817|NCT00571285|Vitamins|vitamins|mesh-list
101460818|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
101460819|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460820|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101460821|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101460822|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101460823|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101460824|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460825|NCT00571636|Fentanyl|fentanyl|mesh-list
101460826|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101460827|NCT00571636|Narcotics|narcotics|mesh-ancestor
101460828|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460829|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460830|NCT00571636|Analgesics|analgesics|mesh-ancestor
101460831|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
101460832|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460833|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101460834|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101460835|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
101460836|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
101460838|NCT00571675|Docetaxel|docetaxel|mesh-list
101460839|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460840|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
101460841|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
101460842|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
101460843|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460844|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460845|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
101460846|NCT00571675|Hormones|hormones|mesh-ancestor
101460847|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460848|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460849|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101460854|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101460855|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101460856|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
101460857|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460858|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101460859|NCT00254709|Sirolimus|sirolimus|mesh-list
101460860|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359114|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359115|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359116|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
101359117|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359119|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101359120|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359121|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
101359122|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101359123|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101460861|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460862|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101460863|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460864|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
101460865|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460866|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
101460867|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460868|NCT00224822|Aripiprazole|aripiprazole|mesh-list
101460869|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460870|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460871|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460872|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460873|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460874|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460875|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
101460876|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
101460877|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460878|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460879|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101460880|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101460881|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
101460882|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101460883|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101460884|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101460885|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460886|NCT00571870|Cetrorelix|cetrorelix|mesh-list
101460887|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101460888|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
101460889|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101460890|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460891|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
101460892|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460893|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101460894|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460895|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460896|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101460897|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101460898|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460899|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460900|NCT00572026|Methylphenidate|methylphenidate|mesh-list
101460901|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101460902|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460903|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101460904|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101460905|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101460906|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460907|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
101460908|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359124|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359125|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101359126|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101359128|NCT00207844|Selenious Acid|selenious acid|mesh-list
101359129|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
101359130|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
101460912|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
101460913|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460915|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
101460916|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460917|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460918|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
101460927|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460929|NCT00572299|Prednisone|prednisone|mesh-list
101460930|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460931|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
101460932|NCT00572299|Hormones|hormones|mesh-ancestor
101460933|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460934|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460935|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101460936|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460937|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101460938|NCT00234936|Adalimumab|adalimumab|mesh-list
101460939|NCT00234936|Methotrexate|methotrexate|mesh-list
101460940|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101460941|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
101460942|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101460943|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460944|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101460945|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
101460946|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460947|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460948|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
101460949|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460950|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101460951|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460952|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
101460953|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460954|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101460955|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101460956|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460957|NCT00413075|Belinostat|belinostat|mesh-list
101460958|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460959|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101460960|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460961|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460962|NCT00572650|Vildagliptin|vildagliptin|mesh-list
101460963|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460964|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460965|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101460966|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
101460967|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460968|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460969|NCT00572689|Exenatide|exenatide|mesh-list
101460970|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460971|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460972|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101460973|NCT00572689|Incretins|incretins|mesh-ancestor
101460974|NCT00572689|Hormones|hormones|mesh-ancestor
101460975|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460976|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
101460977|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101460978|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359131|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359132|NCT00207844|Protective Agents|protective agents|mesh-ancestor
101359133|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359134|NCT00207844|Trace Elements|trace elements|mesh-ancestor
101359135|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
101359136|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
101460979|NCT00224978|Chloroquine|chloroquine|mesh-list
101460980|NCT00224978|Amebicides|amebicides|mesh-ancestor
101460981|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101460985|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460986|NCT00572884|Permethrin|permethrin|mesh-list
101460987|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460988|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460989|NCT00573001|Ritonavir|ritonavir|mesh-list
101460990|NCT00573001|Lopinavir|lopinavir|mesh-list
101460991|NCT00573001|Tenofovir|tenofovir|mesh-list
101460992|NCT00573001|Emtricitabine|emtricitabine|mesh-list
101460993|NCT00573001|Zidovudine|zidovudine|mesh-list
101460994|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101460995|NCT00573001|Nevirapine|nevirapine|mesh-list
101460996|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101460997|NCT00573001|Efavirenz|efavirenz|mesh-list
101460998|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101460999|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101461000|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
101461001|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461002|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461003|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101461004|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101461005|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
101461006|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461007|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101461008|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461009|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101461010|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101461011|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
101461012|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101461013|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101461014|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101461015|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101461016|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101461017|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101461020|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101461021|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461022|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461023|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461025|NCT00225056|Capecitabine|capecitabine|mesh-list
101461026|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461027|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461028|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461029|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461030|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461031|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101461032|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
101461033|NCT00225173|Prednisone|prednisone|mesh-list
101461035|NCT00225173|Gemcitabine|gemcitabine|mesh-list
101461036|NCT00225173|Doxorubicin|doxorubicin|mesh-list
101461037|NCT00225173|Etoposide|etoposide|mesh-list
101461038|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
101461039|NCT00225173|Vincristine|vincristine|mesh-list
101461040|NCT00225173|Vinorelbine|vinorelbine|mesh-list
101461041|NCT00225173|Bleomycin|bleomycin|mesh-list
101461042|NCT00225173|Vinblastine|vinblastine|mesh-list
101359139|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359140|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359141|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359142|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359143|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359144|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359146|NCT00072930|Hormones|hormones|mesh-ancestor
101461043|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461044|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
101461045|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461046|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461047|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101461048|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
101461049|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461050|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461051|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101461052|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101461053|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
101461057|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461058|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461059|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
101461061|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461062|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461063|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101461064|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461065|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461066|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461067|NCT00234975|Ritonavir|ritonavir|mesh-list
101461068|NCT00234975|Lopinavir|lopinavir|mesh-list
101461069|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101461070|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101461071|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
101461073|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461074|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101461075|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101461076|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
101461077|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461078|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101461079|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461080|NCT00235014|Verapamil|verapamil|mesh-list
101461081|NCT00235014|Trandolapril|trandolapril|mesh-list
101461082|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101461083|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101461084|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461085|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461086|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101461087|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461088|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
101461089|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101461090|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
101461091|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461092|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461093|NCT00225290|Thalidomide|thalidomide|mesh-list
101461094|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461095|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
101461096|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461097|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
101461098|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461099|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461100|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101461101|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101461102|NCT00225290|Growth Substances|growth substances|mesh-ancestor
101359147|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359148|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359149|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101359150|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101359151|NCT00411307|Hydromorphone|hydromorphone|mesh-list
101359152|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101359153|NCT00411307|Narcotics|narcotics|mesh-ancestor
101359154|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359155|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359156|NCT00411307|Analgesics|analgesics|mesh-ancestor
101359157|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
101359158|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359159|NCT00040508|Sirolimus|sirolimus|mesh-list
101359160|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359161|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359162|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359163|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359164|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
101359165|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359166|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
101359167|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359168|NCT00424411|Insulin|insulin|mesh-list
101359169|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101359170|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359171|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359172|NCT00072969|Daclizumab|daclizumab|mesh-list
101359173|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359174|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
101359175|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359176|NCT00424606|Docetaxel|docetaxel|mesh-list
101359177|NCT00424606|Epirubicin|epirubicin|mesh-list
101359179|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359192|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
101359193|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359194|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359195|NCT00040586|Interleukin-2|interleukin-2|mesh-list
101359196|NCT00040586|Antibodies|antibodies|mesh-list
101359197|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101359198|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
101359199|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359200|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359202|NCT00040586|Analgesics|analgesics|mesh-ancestor
101359203|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
101359204|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359205|NCT00208117|Sertraline|sertraline|mesh-list
101359206|NCT00208117|Simvastatin|simvastatin|mesh-list
101359207|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101359208|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101359209|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
101461103|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
101461104|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461105|NCT00573547|Fluoxetine|fluoxetine|mesh-list
101461106|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101461107|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461108|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461109|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461110|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461111|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
101461112|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461113|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101461114|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461115|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461116|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101461117|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461118|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461120|NCT00573664|Analgesics|analgesics|mesh-ancestor
101461121|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
101461122|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461124|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
101461125|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101461126|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461127|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461128|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461129|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101461130|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101461131|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461132|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461133|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
101461134|NCT00573742|Candesartan|candesartan|mesh-list
101461135|NCT00573742|Candesartan cilexetil|candesartan cilexetil|mesh-list
101461136|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461137|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101461138|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101461139|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461140|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101359210|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359211|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101359212|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101359213|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359214|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359215|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359216|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359217|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359218|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359219|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359220|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
101359221|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359222|NCT00208156|Mifepristone|mifepristone|mesh-list
101359223|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101359224|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
101359225|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101461144|NCT00254865|Estrogens|estrogens|mesh-ancestor
101461145|NCT00254865|Hormones|hormones|mesh-ancestor
101461146|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461147|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461148|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101461149|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101461150|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101461151|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101461152|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101461154|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101461155|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101461156|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461157|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101461158|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
101461159|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461160|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461161|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101461162|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461163|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101461164|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101461165|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101461166|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101461167|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101461168|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
101461169|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461170|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461171|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
101461172|NCT00235053|Hormones|hormones|mesh-ancestor
101461173|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461174|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
101461175|NCT00574015|Acetaminophen|acetaminophen|mesh-list
101461176|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101461177|NCT00574015|Hydrocodone|hydrocodone|mesh-list
101461178|NCT00574015|Bupivacaine|bupivacaine|mesh-list
101461179|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
101461180|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
101461181|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359226|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359227|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101359228|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101359229|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101359230|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
101359231|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101461182|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461183|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
101461184|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461185|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101461186|NCT00574015|Analgesics|analgesics|mesh-ancestor
101461187|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
101461188|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101461189|NCT00574015|Narcotics|narcotics|mesh-ancestor
101461190|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
101461191|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461192|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101461193|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461194|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461200|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461201|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461202|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101461203|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461204|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461205|NCT00574093|Ranibizumab|ranibizumab|mesh-list
101461206|NCT00574093|Verteporfin|verteporfin|mesh-list
101461207|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101461208|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101461209|NCT00574093|Growth Substances|growth substances|mesh-ancestor
101461210|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461211|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101461212|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461213|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101461214|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
101461216|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101461217|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101461218|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101461219|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461220|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461221|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461222|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
101461223|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461224|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461225|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101461226|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101461227|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461228|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461229|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461230|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461231|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461232|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101461233|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461234|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461235|NCT00574483|Quinacrine|quinacrine|mesh-list
101461236|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
101461237|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101461238|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
101461239|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101461240|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461241|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
101461242|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101461243|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
101461244|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461245|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359232|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101359233|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
101359234|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359235|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
101461246|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461247|NCT00235092|Sirolimus|sirolimus|mesh-list
101461248|NCT00235092|Paclitaxel|paclitaxel|mesh-list
101461249|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101461250|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461251|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461252|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461253|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461254|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461255|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461256|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461257|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101461258|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
101461259|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461260|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
101461263|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
101461264|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461265|NCT00574639|Alprazolam|alprazolam|mesh-list
101461266|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101461267|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461268|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461269|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101461270|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461271|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461272|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
101461273|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
101461274|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461275|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461276|NCT00255255|Budesonide|budesonide|mesh-list
101461277|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
101461278|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461279|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101461280|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
101461281|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461282|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461283|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101461284|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461285|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
101461286|NCT00255255|Hormones|hormones|mesh-ancestor
101461287|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461288|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101461289|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101461290|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101461291|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
101461292|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461293|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461294|NCT00574756|Ranolazine|ranolazine|mesh-list
101461295|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101461296|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461297|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461298|NCT03453346|Ribavirin|ribavirin|mesh-list
101461299|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
101461300|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
101413538|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461301|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461302|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
101461303|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461304|NCT00575068|Galiximab|galiximab|mesh-list
101461305|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461306|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461307|NCT00575224|Interferons|interferons|mesh-list
101461308|NCT00575224|Ribavirin|ribavirin|mesh-list
101461309|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461310|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
101461311|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359236|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101359237|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101359238|NCT00040625|Pemetrexed|pemetrexed|mesh-list
101359239|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359240|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359241|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359242|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101359243|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101461312|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
101461313|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461314|NCT00225797|Oxymorphone|oxymorphone|mesh-list
101461315|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101461316|NCT00225797|Narcotics|narcotics|mesh-ancestor
101461317|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461318|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461319|NCT00225797|Analgesics|analgesics|mesh-ancestor
101461320|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
101461321|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461322|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101461323|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
101461324|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101461325|NCT00591487|Lidocaine|lidocaine|mesh-list
101461326|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
101461327|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
101461328|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461329|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461331|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461332|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101461333|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101461336|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461337|NCT00225875|Rituximab|rituximab|mesh-list
101461338|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101461339|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461340|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
101461341|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461342|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461343|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
101461344|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101461345|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461346|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
101461347|NCT00255372|Lactulose|lactulose|mesh-list
101461348|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101461349|NCT00225914|Paroxetine|paroxetine|mesh-list
101461350|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101461351|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461352|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461353|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461354|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461355|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
101461356|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461357|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101461358|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461359|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461360|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101461361|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461362|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461363|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101461364|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101461365|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101461366|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461367|NCT00235248|Aspirin|aspirin|mesh-list
101461368|NCT00235248|Warfarin|warfarin|mesh-list
101461369|NCT00235248|Clopidogrel|clopidogrel|mesh-list
101359244|NCT00208195|Valproic Acid|valproic acid|mesh-list
101359245|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
101359246|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359247|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359248|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
101359249|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359250|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461370|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101461371|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101461372|NCT00235248|Analgesics|analgesics|mesh-ancestor
101461373|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
101461374|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461375|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461376|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461377|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461378|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101461379|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101461380|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461381|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101461382|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101461383|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461384|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
101461385|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101461386|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101461387|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101461388|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
101461389|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461390|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
101461391|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
101461392|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461393|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
101461394|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101461395|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
101461396|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461397|NCT03451435|Expectorants|expectorants|mesh-ancestor
101461398|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461399|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101461400|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
101461401|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461402|NCT03451435|Protective Agents|protective agents|mesh-ancestor
101461403|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461404|NCT03451435|Antidotes|antidotes|mesh-ancestor
101461406|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
101461408|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
101461409|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461410|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
101461411|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461412|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101461413|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101461414|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101461415|NCT00255450|Hematinics|hematinics|mesh-ancestor
101461416|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101461417|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101461418|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
101461419|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101461420|NCT04573855|Antibodies|antibodies|mesh-list
101461421|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
101461422|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461423|NCT00226109|Spironolactone|spironolactone|mesh-list
101461424|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101461425|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
101461426|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461427|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461428|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101461429|NCT00226109|Diuretics|diuretics|mesh-ancestor
101461430|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
101461431|NCT04573426|Acetaminophen|acetaminophen|mesh-list
101359252|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101359253|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359254|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359255|NCT00208234|Omalizumab|omalizumab|mesh-list
101359256|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101359257|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101359258|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101359259|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461432|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101461433|NCT04573426|Analgesics|analgesics|mesh-ancestor
101461434|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
101461435|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461436|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461437|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
101461438|NCT00235287|Candesartan|candesartan|mesh-list
101461439|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
101461440|NCT00235287|Enalapril|enalapril|mesh-list
101461441|NCT00235287|Enalaprilat|enalaprilat|mesh-list
101461442|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461443|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101461444|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101461445|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461446|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101461447|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
101461448|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461449|NCT00255489|Gefitinib|gefitinib|mesh-list
101461450|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461451|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101461452|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461453|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461454|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
101461455|NCT04573153|Sorbitol|sorbitol|mesh-list
101461456|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
101461457|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101461458|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101461459|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461460|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461461|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461462|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461463|NCT04573153|Cathartics|cathartics|mesh-ancestor
101461464|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101461465|NCT00255528|Metoprolol|metoprolol|mesh-list
101461466|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101461467|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461468|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
101461469|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
101461470|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461471|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461472|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101461473|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101461474|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101461475|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
101461476|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461477|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461478|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101461484|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101461485|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101461486|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
101461487|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461488|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461489|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101461490|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101461491|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
101461492|NCT04572724|Valsartan|valsartan|mesh-list
101461493|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101359260|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
101359261|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359262|NCT00208273|Letrozole|letrozole|mesh-list
101359263|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359264|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101359265|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101461494|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461495|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101461496|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101461497|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461498|NCT00255567|Paromomycin|paromomycin|mesh-list
101461499|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101461500|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461501|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461502|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101461503|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101461504|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
101461505|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101461506|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
101461507|NCT03450967|Durvalumab|durvalumab|mesh-list
101461508|NCT03450967|Tremelimumab|tremelimumab|mesh-list
101461509|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101461510|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461511|NCT00255606|Prednisone|prednisone|mesh-list
101461512|NCT00255606|Docetaxel|docetaxel|mesh-list
101461513|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461514|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461515|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461516|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461517|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461518|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461519|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
101461520|NCT00255606|Hormones|hormones|mesh-ancestor
101461521|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461522|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461523|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461524|NCT00226343|Valproic Acid|valproic acid|mesh-list
101461525|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
101461526|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461527|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461528|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
101461529|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461530|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461531|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
101461532|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461533|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461534|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461535|NCT03450499|Ketamine|ketamine|mesh-list
101461536|NCT03450499|Analgesics|analgesics|mesh-ancestor
101461537|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
101461538|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461539|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461540|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101461541|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101461542|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
101461546|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101461547|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461559|NCT01580839|Plasminogen|plasminogen|mesh-list
101461560|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101461561|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101461562|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461563|NCT03450226|Bupivacaine|bupivacaine|mesh-list
101461564|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
101461565|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
101359267|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461566|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461567|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461568|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
101461569|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461570|NCT00226421|Oxymorphone|oxymorphone|mesh-list
101461571|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101461572|NCT00226421|Narcotics|narcotics|mesh-ancestor
101461573|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461574|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461575|NCT00226421|Analgesics|analgesics|mesh-ancestor
101461576|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
101461577|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461578|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101461579|NCT04572373|SMOFlipid|smoflipid|mesh-list
101461580|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101461581|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101461582|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101461583|NCT03450109|Goserelin|goserelin|mesh-list
101461584|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461585|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461586|NCT00413387|Budesonide|budesonide|mesh-list
101461587|NCT00413387|Beclomethasone|beclomethasone|mesh-list
101461588|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
101461589|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461590|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101461591|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
101461592|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461593|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461594|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101461595|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461596|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
101461597|NCT00413387|Hormones|hormones|mesh-ancestor
101461598|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461599|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101461600|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101461601|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101461602|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
101461603|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461604|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461605|NCT00413426|Darifenacin|darifenacin|mesh-list
101461606|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101461607|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101461608|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
101461609|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461610|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461611|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461616|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101461618|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
101461619|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101461620|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101461621|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461622|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461623|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461624|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461625|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461626|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101461627|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101461628|NCT00255762|Growth Substances|growth substances|mesh-ancestor
101461629|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461630|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
101461631|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
101461632|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101461634|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461635|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101461636|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461637|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461638|NCT00255879|Olanzapine|olanzapine|mesh-list
101461639|NCT00255879|Risperidone|risperidone|mesh-list
101359268|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101359269|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
101359270|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359271|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359272|NCT00208312|Adenosine|adenosine|mesh-list
101359273|NCT00208312|Regadenoson|regadenoson|mesh-list
101359274|NCT00208312|Analgesics|analgesics|mesh-ancestor
101359275|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
101359276|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359277|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461640|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101461641|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101461642|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
101461643|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461644|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461645|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461646|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101461647|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461648|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461649|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461650|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101461651|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
101461652|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
101461653|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
101461654|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461655|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101461656|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101461657|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461658|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461659|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461660|NCT00413504|PENTA|penta|mesh-list
101461661|NCT00413504|Fondaparinux|fondaparinux|mesh-list
101461662|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101461663|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
101461664|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101461665|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
101461666|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461667|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461668|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
101461669|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101461670|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101461671|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101461672|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461673|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101461674|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461675|NCT04710498|Atezolizumab|atezolizumab|mesh-list
101461676|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101461677|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461678|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101461679|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461680|NCT00226538|Rifampin|rifampin|mesh-list
101461681|NCT00226538|Fluconazole|fluconazole|mesh-list
101461682|NCT00226538|Diclofenac|diclofenac|mesh-list
101461683|NCT00226538|Phenytoin|phenytoin|mesh-list
101461684|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101461694|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461695|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101461696|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
101461697|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461698|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461701|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101461702|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101359278|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101461703|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101461704|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101461705|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101461706|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101461707|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
101461708|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101461709|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461710|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101461711|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
101461712|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461713|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101461714|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101461715|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
101461716|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101461717|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101461718|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461719|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101461720|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
101461721|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101461722|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101461723|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101461724|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461725|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461726|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461727|NCT00226694|Citalopram|citalopram|mesh-list
101461728|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101461729|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461730|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461731|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461732|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461733|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
101461734|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461735|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101461736|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461737|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461738|NCT00255996|Linezolid|linezolid|mesh-list
101461739|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461740|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461741|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101461742|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461743|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461744|NCT00226889|Bosentan|bosentan|mesh-list
101461745|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461753|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101461754|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101461755|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101461756|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
101461757|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461758|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461759|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461760|NCT00227084|Hemostatics|hemostatics|mesh-list
101461761|NCT00227084|Coagulants|coagulants|mesh-ancestor
101461762|NCT00227123|Risperidone|risperidone|mesh-list
101461763|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101461764|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101461765|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
101461766|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461768|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461769|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101461770|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461771|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461772|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359281|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
101359282|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
101359283|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359284|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359285|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101359286|NCT00040781|Gefitinib|gefitinib|mesh-list
101359287|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359288|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101359289|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359290|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359291|NCT00068952|Temozolomide|temozolomide|mesh-list
101359292|NCT00068952|Carmustine|carmustine|mesh-list
101461773|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101461774|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
101461775|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461776|NCT00235521|Iloprost|iloprost|mesh-list
101461777|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101461778|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
101461779|NCT00235560|Sirolimus|sirolimus|mesh-list
101461780|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461781|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461782|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101461783|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461784|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
101461785|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461786|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
101461787|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461788|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
101461789|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101461790|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101461791|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101461792|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461793|NCT00227357|Buprenorphine|buprenorphine|mesh-list
101461794|NCT00227357|Methadone|methadone|mesh-list
101461795|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101461796|NCT00227357|Naloxone|naloxone|mesh-list
101461797|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101461798|NCT00227357|Narcotics|narcotics|mesh-ancestor
101461799|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461800|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461801|NCT00227357|Analgesics|analgesics|mesh-ancestor
101461802|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
101461803|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461804|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101461805|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
101461806|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461807|NCT00198133|Pemetrexed|pemetrexed|mesh-list
101461808|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461809|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461810|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461811|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101461812|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101461836|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
101461837|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461838|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461839|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461840|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461841|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461843|NCT00235794|Temsirolimus|temsirolimus|mesh-list
101461844|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
101461845|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101461846|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359293|NCT00068952|Lomustine|lomustine|mesh-list
101359294|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359295|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
101359296|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461847|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461848|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461850|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461851|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461852|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461853|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461854|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101461855|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
101461856|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
101461857|NCT00256269|Irinotecan|irinotecan|mesh-list
101461858|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461859|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101461860|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101461861|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461862|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461863|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101461864|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
101461868|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
101461869|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101461870|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101461871|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461872|NCT00235911|Budesonide|budesonide|mesh-list
101461873|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
101461874|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461875|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101461876|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
101461877|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461878|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461879|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101461880|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
101461881|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
101461882|NCT00235911|Hormones|hormones|mesh-ancestor
101461883|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461884|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101461885|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101461886|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101461887|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
101461888|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461890|NCT00256347|Morphine|morphine|mesh-list
101461891|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101461892|NCT00256347|Narcotics|narcotics|mesh-ancestor
101461893|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461894|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461895|NCT00256347|Analgesics|analgesics|mesh-ancestor
101461896|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
101461897|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461898|NCT00227747|Capecitabine|capecitabine|mesh-list
101461899|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
101461900|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101461901|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
101461902|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461903|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461904|NCT00235950|Clopidogrel|clopidogrel|mesh-list
101461905|NCT00235950|Atorvastatin|atorvastatin|mesh-list
101461906|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101461907|NCT00235950|Simvastatin|simvastatin|mesh-list
101461908|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101461909|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101461910|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
101461911|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461912|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101461913|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101359298|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
101359299|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359300|NCT00208546|Bevacizumab|bevacizumab|mesh-list
101359302|NCT00208546|Capecitabine|capecitabine|mesh-list
101359303|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
101359304|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359305|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359306|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101359307|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101359308|NCT00208546|Growth Substances|growth substances|mesh-ancestor
101359309|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359310|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359311|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359312|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
101359313|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359314|NCT00208585|Sertraline|sertraline|mesh-list
101359315|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359316|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359317|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359318|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359319|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461914|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461915|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101461916|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101461917|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101461918|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101461919|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
101461920|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461921|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461922|NCT00227942|Zolpidem|zolpidem|mesh-list
101461923|NCT00227942|Estrogens|estrogens|mesh-list
101461924|NCT00227942|Hormones|hormones|mesh-ancestor
101461925|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461926|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461927|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101461928|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101461930|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101461931|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
101461932|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
101461933|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101461934|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461935|NCT00227981|Fluoxetine|fluoxetine|mesh-list
101461939|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461941|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
101461942|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461943|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101359320|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359321|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359323|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359324|NCT00040859|Capecitabine|capecitabine|mesh-list
101359325|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
101359326|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359327|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
101359328|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359329|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359330|NCT00208702|Sertraline|sertraline|mesh-list
101359331|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359332|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359333|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359334|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359335|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359336|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359337|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359338|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
101359339|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359340|NCT00208741|Tiagabine|tiagabine|mesh-list
101359341|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
101359342|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101359343|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461944|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
101461945|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461946|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101461947|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101461948|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461949|NCT00236028|Infliximab|infliximab|mesh-list
101461950|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101461951|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461952|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
101461953|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101461954|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461955|NCT00256542|Lidocaine|lidocaine|mesh-list
101461956|NCT00256542|Heparin|heparin|mesh-list
101461957|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101461958|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
101461959|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461960|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461961|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
101461962|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461963|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101461964|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101461965|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101359345|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359348|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359350|NCT00399048|Oxycodone|oxycodone|mesh-list
101359351|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101359352|NCT00399048|Narcotics|narcotics|mesh-ancestor
101359353|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359354|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359355|NCT00399048|Analgesics|analgesics|mesh-ancestor
101359356|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
101359357|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359358|NCT00208819|Valproic Acid|valproic acid|mesh-list
101359359|NCT00208819|Olanzapine|olanzapine|mesh-list
101359360|NCT00208819|Risperidone|risperidone|mesh-list
101359361|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101359362|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101359363|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
101461966|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461967|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461968|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
101461969|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101461970|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101461971|NCT00228020|Cyclosporine|cyclosporine|mesh-list
101461972|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
101461973|NCT00228020|Prednisone|prednisone|mesh-list
101461974|NCT00228020|Cyclosporins|cyclosporins|mesh-list
101461975|NCT00228020|Basiliximab|basiliximab|mesh-list
101461976|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461977|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
101461978|NCT00228020|Hormones|hormones|mesh-ancestor
101461979|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101461980|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461981|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461982|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461983|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461984|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461985|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101461987|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
101461988|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461989|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
101461990|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461991|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101461992|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101461993|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101461994|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
101461995|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101461996|NCT00236067|Tiagabine|tiagabine|mesh-list
101461997|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
101461998|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101461999|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462000|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359364|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359365|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359366|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359367|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101359368|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101359369|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359371|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101359372|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
101359373|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
101359374|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
101462001|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462002|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
101462003|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462004|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462017|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462018|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101462019|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101462020|NCT00236145|Fentanyl|fentanyl|mesh-list
101462021|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101462022|NCT00236145|Narcotics|narcotics|mesh-ancestor
101462023|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462024|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462025|NCT00236145|Analgesics|analgesics|mesh-ancestor
101462026|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
101462027|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462028|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101462029|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101462030|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
101462031|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
101462032|NCT00228254|Vitamin A|vitamin a|mesh-list
101462033|NCT00228254|Vitamins|vitamins|mesh-ancestor
101462034|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
101462035|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462036|NCT00195676|Adalimumab|adalimumab|mesh-list
101462037|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101462038|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462039|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462040|NCT00194077|Aripiprazole|aripiprazole|mesh-list
101462041|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
101462042|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462043|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462044|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462045|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462046|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462047|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
101462048|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
101462049|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462050|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462051|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101462052|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101462053|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
101462054|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101462055|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101462056|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101462057|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462058|NCT00193609|Capecitabine|capecitabine|mesh-list
101462059|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
101462060|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462061|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
101462062|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462063|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462064|NCT00228410|Vancomycin|vancomycin|mesh-list
101462065|NCT00228410|Tigecycline|tigecycline|mesh-list
101462066|NCT00228410|Aztreonam|aztreonam|mesh-list
101462067|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359375|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359376|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359377|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359378|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359379|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359380|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359381|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
101359382|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359383|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
101359384|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
101359385|NCT00208858|Topiramate|topiramate|mesh-list
101462068|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462069|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101462072|NCT00193180|Docetaxel|docetaxel|mesh-list
101462073|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
101462074|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462075|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462076|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462077|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462078|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462079|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101462080|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462081|NCT00193063|Gemcitabine|gemcitabine|mesh-list
101462082|NCT00193063|Trastuzumab|trastuzumab|mesh-list
101462083|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462084|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
101462085|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462086|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462087|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462088|NCT00228488|Gefitinib|gefitinib|mesh-list
101462089|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462090|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101462091|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462092|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462093|NCT00228527|Esomeprazole|esomeprazole|mesh-list
101462094|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101462095|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462096|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101462097|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462098|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462099|NCT00191854|Paclitaxel|paclitaxel|mesh-list
101462100|NCT00191854|Carboplatin|carboplatin|mesh-list
101462101|NCT00191854|Gemcitabine|gemcitabine|mesh-list
101462102|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101462103|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462104|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462105|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462106|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462107|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462108|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462109|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
101462110|NCT00228605|Fentanyl|fentanyl|mesh-list
101462111|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101462112|NCT00228605|Narcotics|narcotics|mesh-ancestor
101462113|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462114|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462115|NCT00228605|Analgesics|analgesics|mesh-ancestor
101462116|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
101462117|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462118|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101462119|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101462120|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
101462121|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
101462122|NCT00191815|Gemcitabine|gemcitabine|mesh-list
101462123|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359387|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359388|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359389|NCT00041015|Etoposide|etoposide|mesh-list
101359390|NCT00041015|Topotecan|topotecan|mesh-list
101359392|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359393|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359394|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359395|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462124|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462125|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
101462126|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462127|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101462128|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101462129|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462130|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101462131|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462132|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
101462133|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462134|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462135|NCT00191308|Pemetrexed|pemetrexed|mesh-list
101462136|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462137|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462138|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462139|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101462140|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101462141|NCT00228839|Infliximab|infliximab|mesh-list
101462145|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462146|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462147|NCT00191269|Gemcitabine|gemcitabine|mesh-list
101462148|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462149|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
101462150|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462151|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462152|NCT00228878|Insulin|insulin|mesh-list
101462153|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
101462154|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462155|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462156|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
101462157|NCT00228995|Hematinics|hematinics|mesh-ancestor
101462158|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
101462159|NCT00413946|Hematinics|hematinics|mesh-ancestor
101462160|NCT00229112|Tazobactam|tazobactam|mesh-list
101462161|NCT00229112|Piperacillin|piperacillin|mesh-list
101462162|NCT00229112|Ertapenem|ertapenem|mesh-list
101462163|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101462164|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462165|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462166|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462167|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101462168|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462169|NCT00256737|Omeprazole|omeprazole|mesh-list
101462170|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101462171|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462172|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101462173|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462174|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462175|NCT00191191|Pemetrexed|pemetrexed|mesh-list
101462176|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462177|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462178|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462179|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101359396|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359397|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101359398|NCT00073047|Daclizumab|daclizumab|mesh-list
101359399|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359400|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
101359401|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359402|NCT00208897|Fluoxetine|fluoxetine|mesh-list
101359403|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359404|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359405|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359406|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359407|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359408|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
101359409|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359410|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101359411|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359412|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359413|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101359414|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101359415|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462181|NCT00414024|Tegaserod|tegaserod|mesh-list
101462182|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101462183|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
101462184|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462185|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462186|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462187|NCT00256893|Ropinirole|ropinirole|mesh-list
101462188|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101462189|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101462190|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
101462191|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
101462192|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462193|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462194|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462195|NCT00229385|Ziprasidone|ziprasidone|mesh-list
101462196|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101462197|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
101462198|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462199|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462200|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462201|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462202|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462203|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462204|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462205|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462206|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
101462207|NCT00236223|Dexamethasone|dexamethasone|mesh-list
101462208|NCT00236223|Ketamine|ketamine|mesh-list
101462209|NCT00236223|Gabapentin|gabapentin|mesh-list
101462210|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462211|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
101359416|NCT00208936|Fluorouracil|fluorouracil|mesh-list
101359417|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359418|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
101359419|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359420|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359421|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359422|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
101359423|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359424|NCT00209014|Thalidomide|thalidomide|mesh-list
101359426|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
101462212|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
101462213|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462214|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462215|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462218|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462219|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462220|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462222|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
101462223|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101462224|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101462225|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
101462226|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
101462227|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462228|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101462229|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101462230|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462231|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462232|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
101462233|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101462234|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462235|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462236|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
101462238|NCT00229424|Lafutidine|lafutidine|mesh-list
101462239|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101462240|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462241|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101462242|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
101462243|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
101462244|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462245|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462246|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462247|NCT00256932|Alvimopan|alvimopan|mesh-list
101462248|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462249|NCT00191152|Gemcitabine|gemcitabine|mesh-list
101462250|NCT00191152|Capecitabine|capecitabine|mesh-list
101462251|NCT00191152|Docetaxel|docetaxel|mesh-list
101462252|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462253|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
101462254|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462255|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462256|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462257|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462258|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462259|NCT00257049|Levofloxacin|levofloxacin|mesh-list
101462260|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462261|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462262|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462263|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462264|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359427|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359428|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
101359429|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359430|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359431|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462265|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462266|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462267|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462268|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101462269|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101462270|NCT01059188|Docetaxel|docetaxel|mesh-list
101462271|NCT01059188|Cetuximab|cetuximab|mesh-list
101462272|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462273|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462274|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462275|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462276|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462277|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462278|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101462279|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101462280|NCT00236301|Estradiol|estradiol|mesh-list
101462281|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101462282|NCT00236301|Estrogens|estrogens|mesh-ancestor
101462283|NCT00236301|Hormones|hormones|mesh-ancestor
101462284|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462285|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462286|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101462287|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
101462288|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101462294|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462295|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462296|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462297|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462298|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101462299|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101462300|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101462301|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101462302|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462303|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462304|NCT00236379|Olanzapine|olanzapine|mesh-list
101462305|NCT00236379|Risperidone|risperidone|mesh-list
101462306|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101462307|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
101462308|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462309|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462310|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462311|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462312|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462313|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462314|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462315|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462316|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
101462317|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
101462318|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
101462319|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462320|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462321|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101462322|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462323|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101462324|NCT00229775|Chloroquine|chloroquine|mesh-list
101462325|NCT00229775|Artemether|artemether|mesh-list
101462326|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
101462327|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
101462328|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101462329|NCT00229775|Amebicides|amebicides|mesh-ancestor
101462330|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101359432|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101359433|NCT00209014|Growth Substances|growth substances|mesh-ancestor
101359434|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359435|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359436|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
101359437|NCT00041054|Carboplatin|carboplatin|mesh-list
101359439|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359440|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359441|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359442|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359443|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359444|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359445|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101359446|NCT00041054|Protective Agents|protective agents|mesh-ancestor
101359447|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359448|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101359449|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101359450|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101359452|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
101359453|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359454|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359455|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359456|NCT00209209|Interferons|interferons|mesh-list
101359457|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
101359458|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
101359459|NCT00209209|Prednisone|prednisone|mesh-list
101359460|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
101359479|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359481|NCT00209209|Hormones|hormones|mesh-ancestor
101359482|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359483|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101359484|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
101359485|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359486|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359487|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359488|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359489|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359490|NCT00041093|Docetaxel|docetaxel|mesh-list
101359491|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359492|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359493|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359494|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359495|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359496|NCT00399087|Prednisone|prednisone|mesh-list
101462331|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101462332|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462333|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
101462334|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462335|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101462336|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462337|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462338|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462339|NCT00257127|Vaccines|vaccines|mesh-list
101462340|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101462341|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
101462342|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462343|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101462344|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101462345|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462346|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101462347|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462348|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
101462349|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462350|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462351|NCT00236418|Topiramate|topiramate|mesh-list
101462353|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462354|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462355|NCT00236457|Risperidone|risperidone|mesh-list
101462356|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101462357|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
101462358|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462372|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101462373|NCT00199277|Trace Elements|trace elements|mesh-ancestor
101462374|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
101462375|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462376|NCT00199277|Hematinics|hematinics|mesh-ancestor
101462377|NCT00236535|Acetaminophen|acetaminophen|mesh-list
101462378|NCT00236535|Tramadol|tramadol|mesh-list
101462379|NCT00236535|Hydrocodone|hydrocodone|mesh-list
101462380|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101462381|NCT00236535|Analgesics|analgesics|mesh-ancestor
101462382|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
101462383|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359497|NCT00399087|Docetaxel|docetaxel|mesh-list
101359498|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359499|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359500|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359501|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359502|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359503|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359504|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
101359505|NCT00399087|Hormones|hormones|mesh-ancestor
101359506|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359507|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359508|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101359509|NCT00209482|Metformin|metformin|mesh-list
101359510|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359511|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359512|NCT00041171|Docetaxel|docetaxel|mesh-list
101359513|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359514|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359515|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359516|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359517|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359518|NCT00209521|Propofol|propofol|mesh-list
101359519|NCT00209521|Fospropofol|fospropofol|mesh-list
101359520|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101359521|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359522|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359523|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101359524|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
101359525|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
101359526|NCT00209638|Irinotecan|irinotecan|mesh-list
101359527|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101462384|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462385|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
101462386|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101462387|NCT00236535|Narcotics|narcotics|mesh-ancestor
101462388|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462389|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
101462390|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
101462391|NCT00193219|Leucovorin|leucovorin|mesh-list
101462392|NCT00193219|Bevacizumab|bevacizumab|mesh-list
101462393|NCT00193219|Cetuximab|cetuximab|mesh-list
101462394|NCT00193219|Fluorouracil|fluorouracil|mesh-list
101462395|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
101462396|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462397|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359528|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359530|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359531|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359533|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101462398|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462399|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101462400|NCT00193219|Growth Substances|growth substances|mesh-ancestor
101462401|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462402|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
101462403|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
101462404|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462405|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462406|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101462407|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
101462408|NCT00193219|Antidotes|antidotes|mesh-ancestor
101462409|NCT00193219|Protective Agents|protective agents|mesh-ancestor
101462410|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
101462411|NCT00193219|Vitamins|vitamins|mesh-ancestor
101462412|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
101462413|NCT00199316|Morphine|morphine|mesh-list
101462414|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101462415|NCT00199316|Narcotics|narcotics|mesh-ancestor
101462416|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462417|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462418|NCT00199316|Analgesics|analgesics|mesh-ancestor
101462419|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
101462420|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462421|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
101462422|NCT00196339|Cyproterone|cyproterone|mesh-list
101462423|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
101462424|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
101462425|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462428|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101462429|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
101462430|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101462431|NCT00257361|Cycloserine|cycloserine|mesh-list
101462432|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462433|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462434|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101462435|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
101462436|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462437|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
101462438|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462439|NCT00199355|Istradefylline|istradefylline|mesh-list
101462440|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101462441|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101462442|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101462443|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
101462444|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462445|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462446|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462448|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101462450|NCT00179959|Petrolatum|petrolatum|mesh-list
101462451|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462452|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462453|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101462454|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462455|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462456|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
101462457|NCT00179959|Emollients|emollients|mesh-ancestor
101462458|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
101462459|NCT00199394|Istradefylline|istradefylline|mesh-list
101462460|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101462461|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101462462|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101359534|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359536|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359537|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359538|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359539|NCT00209677|Gemcitabine|gemcitabine|mesh-list
101359540|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462463|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
101462464|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462465|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462466|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462467|NCT00236574|Galantamine|galantamine|mesh-list
101462468|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101462469|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462470|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462471|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
101462472|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462473|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462474|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101462475|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
101462476|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462477|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
101462478|NCT00199433|Istradefylline|istradefylline|mesh-list
101462479|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101462480|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101462481|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101462482|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
101462483|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462484|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462485|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462486|NCT00199472|Diuretics|diuretics|mesh-list
101462487|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
101462488|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462490|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101462491|NCT00199511|Diuretics|diuretics|mesh-ancestor
101462492|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
101462493|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462494|NCT00236613|Topiramate|topiramate|mesh-list
101462495|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
101462496|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462497|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462498|NCT00236652|Levofloxacin|levofloxacin|mesh-list
101462500|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462501|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462502|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462503|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101462504|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462505|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462506|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462507|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101462508|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101462509|NCT00257595|Cetirizine|cetirizine|mesh-list
101462510|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101462511|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101462512|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101462513|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
101462514|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
101462515|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462516|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462518|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
101462519|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101462520|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462521|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101359541|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
101359542|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359543|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359545|NCT00209716|Docetaxel|docetaxel|mesh-list
101359546|NCT00209716|Fluorouracil|fluorouracil|mesh-list
101359547|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359548|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359549|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359550|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359551|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359553|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359554|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359555|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
101359556|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359557|NCT00209755|Ribavirin|ribavirin|mesh-list
101359558|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
101359559|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359560|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
101359561|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359562|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
101462522|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
101462523|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462524|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462525|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462526|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462527|NCT00236691|Topiramate|topiramate|mesh-list
101462528|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
101462529|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462530|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462531|NCT00236730|Topiramate|topiramate|mesh-list
101462532|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
101462533|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462534|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462536|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101462537|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101462538|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
101462539|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462540|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101462541|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101462542|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462543|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
101462544|NCT04709172|Cefditoren|cefditoren|mesh-list
101462545|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462546|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462547|NCT00199784|Phenylephrine|phenylephrine|mesh-list
101462548|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
101462549|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101462550|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
101462551|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
101462552|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462553|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462554|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
101462555|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101359564|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101359565|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
101359566|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101359567|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101359568|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359569|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101359571|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359572|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101359573|NCT00209833|Cytarabine|cytarabine|mesh-list
101359574|NCT00209833|Fludarabine|fludarabine|mesh-list
101359575|NCT00209833|Etoposide|etoposide|mesh-list
101359576|NCT00209833|Idarubicin|idarubicin|mesh-list
101359577|NCT00209833|Daunorubicin|daunorubicin|mesh-list
101359578|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359579|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359580|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
101359581|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359582|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359583|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
101359584|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359585|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359586|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359587|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359589|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
101359590|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462556|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
101462557|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101462558|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101462559|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101462560|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101462561|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101462562|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462563|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462564|NCT00199784|Protective Agents|protective agents|mesh-ancestor
101462565|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101462566|NCT00236769|Norelgestromin|norelgestromin|mesh-list
101462567|NCT00236769|Estradiol|estradiol|mesh-list
101462568|NCT00236769|Estrogens|estrogens|mesh-ancestor
101462569|NCT00236769|Hormones|hormones|mesh-ancestor
101462570|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462571|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462577|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101462579|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
101462580|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
101462581|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359591|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359592|NCT00041210|Prednisone|prednisone|mesh-list
101359593|NCT00041210|Doxorubicin|doxorubicin|mesh-list
101359594|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101359595|NCT00041210|Bleomycin|bleomycin|mesh-list
101359596|NCT00041210|Etoposide|etoposide|mesh-list
101359597|NCT00041210|Vincristine|vincristine|mesh-list
101359598|NCT00041210|Dacarbazine|dacarbazine|mesh-list
101359599|NCT00041210|Vinblastine|vinblastine|mesh-list
101359600|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
101359601|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359602|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462582|NCT00415311|Coagulants|coagulants|mesh-ancestor
101462583|NCT00199940|Ziprasidone|ziprasidone|mesh-list
101462584|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101462585|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
101462586|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462587|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462589|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462590|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462591|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462592|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462593|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462594|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
101462595|NCT00236808|Levofloxacin|levofloxacin|mesh-list
101462596|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462597|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462598|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462599|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462600|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101462601|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462602|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462603|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462604|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101462605|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101462606|NCT00199979|Nevirapine|nevirapine|mesh-list
101462607|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101462608|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101462609|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462610|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462611|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
101462612|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462613|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101462614|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101462615|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101462617|NCT00257634|Dexamethasone|dexamethasone|mesh-list
101462618|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462619|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
101462620|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
101462621|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462622|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462623|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462624|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
101462625|NCT00257634|Hormones|hormones|mesh-ancestor
101462626|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462627|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462628|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462630|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
101462631|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462632|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462633|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
101462634|NCT00410306|Testosterone|testosterone|mesh-list
101359603|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359604|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359605|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359606|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359607|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359608|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
101359609|NCT00041210|Hormones|hormones|mesh-ancestor
101359610|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359611|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359612|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101359613|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359614|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359615|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359616|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359617|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359618|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
101359619|NCT00209872|Lidocaine|lidocaine|mesh-list
101359620|NCT00209872|Ketamine|ketamine|mesh-list
101359621|NCT00209872|Gabapentin|gabapentin|mesh-list
101359622|NCT00209872|Esketamine|esketamine|mesh-list
101359623|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
101359624|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
101359625|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359626|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359627|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
101359628|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359629|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101359630|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101359631|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101462635|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
101462636|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
101462637|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101462638|NCT00410306|Androgens|androgens|mesh-ancestor
101462639|NCT00410306|Hormones|hormones|mesh-ancestor
101462640|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462643|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462645|NCT00257712|Hormones|hormones|mesh-list
101462646|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
101462647|NCT00257712|Tesamorelin|tesamorelin|mesh-list
101462648|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462649|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462650|NCT00257712|Growth Substances|growth substances|mesh-ancestor
101462651|NCT00179647|Dexamethasone|dexamethasone|mesh-list
101462652|NCT00179647|Lenalidomide|lenalidomide|mesh-list
101462653|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359632|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359633|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462654|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
101462655|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
101462656|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462657|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462658|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462659|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
101462660|NCT00179647|Hormones|hormones|mesh-ancestor
101462661|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462662|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462663|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462664|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
101462665|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462666|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101462667|NCT00179647|Growth Substances|growth substances|mesh-ancestor
101462668|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
101462669|NCT00257751|Aprotinin|aprotinin|mesh-list
101462670|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
101462671|NCT00257751|Coagulants|coagulants|mesh-ancestor
101462672|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101462673|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101462674|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
101462675|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462676|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462677|NCT00179413|Interferons|interferons|mesh-list
101462678|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
101462679|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
101462680|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101462681|NCT00179413|Colchicine|colchicine|mesh-list
101462682|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462683|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
101462684|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462685|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
101462686|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462687|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
101462688|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462689|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462690|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462691|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462692|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462693|NCT00236886|Topiramate|topiramate|mesh-list
101462694|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
101462695|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462696|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462697|NCT00257790|Tobramycin|tobramycin|mesh-list
101462698|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462699|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462700|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
101462701|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462702|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
101462703|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101462704|NCT00236964|Hematinics|hematinics|mesh-ancestor
101462705|NCT00200252|Oxytocin|oxytocin|mesh-list
101462706|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
101462707|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101462708|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462709|NCT00177307|Bevacizumab|bevacizumab|mesh-list
101462710|NCT00177307|Capecitabine|capecitabine|mesh-list
101462711|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
101462712|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462713|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462714|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462715|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101462719|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462721|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462723|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101462724|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462725|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462726|NCT00257829|Diuretics|diuretics|mesh-ancestor
101462727|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
101462728|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462729|NCT00176644|Estradiol|estradiol|mesh-list
101359634|NCT00209872|Analgesics|analgesics|mesh-ancestor
101359635|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101359636|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101359637|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
101359638|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101359639|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101359640|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359641|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
101359642|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101359643|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462730|NCT00176644|Estrogens|estrogens|mesh-ancestor
101462731|NCT00176644|Hormones|hormones|mesh-ancestor
101462732|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462733|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462734|NCT02484664|Celecoxib|celecoxib|mesh-list
101462735|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101462736|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101462737|NCT02484664|Analgesics|analgesics|mesh-ancestor
101462738|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
101462739|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462740|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462741|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462742|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462743|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101462744|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101462745|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462746|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462747|NCT00257868|Rivastigmine|rivastigmine|mesh-list
101462748|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101462749|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462750|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462751|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
101462752|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462753|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462754|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101462755|NCT00257868|Protective Agents|protective agents|mesh-ancestor
101462756|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
101462758|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101462759|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
101462760|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462761|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462762|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101462763|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
101462764|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462765|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462766|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101462767|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101462768|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462769|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101462770|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462771|NCT00176488|Vinorelbine|vinorelbine|mesh-list
101462772|NCT00176488|Epirubicin|epirubicin|mesh-list
101462773|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101462774|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462775|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
101462776|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
101462777|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
101462778|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462779|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101462780|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462781|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101462782|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462783|NCT00200447|Carbidopa|carbidopa|mesh-list
101462784|NCT00200447|Levodopa|levodopa|mesh-list
101359644|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359645|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
101359646|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
101359647|NCT00209950|Gaboxadol|gaboxadol|mesh-list
101359648|NCT00209950|Analgesics|analgesics|mesh-ancestor
101359649|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
101462785|NCT00200447|Entacapone|entacapone|mesh-list
101462786|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101462793|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101462794|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462795|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101462796|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
101462797|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462798|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101462799|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462800|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462801|NCT00175825|Brivaracetam|brivaracetam|mesh-list
101462802|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
101537984|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462803|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
101462804|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
101462805|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462806|NCT04710329|Protective Agents|protective agents|mesh-ancestor
101462807|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462808|NCT04710329|Vitamins|vitamins|mesh-ancestor
101462809|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
101462810|NCT00200525|Apomorphine|apomorphine|mesh-list
101462811|NCT00200525|Emetics|emetics|mesh-ancestor
101462812|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462813|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
101462814|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462815|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462816|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
101462818|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462819|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462820|NCT00174967|Febuxostat|febuxostat|mesh-list
101462821|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
101462822|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462823|NCT00200564|Ketamine|ketamine|mesh-list
101462824|NCT00200564|Analgesics|analgesics|mesh-ancestor
101462825|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
101462826|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462827|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462828|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101462829|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101462830|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
101462831|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
101462832|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462833|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101462834|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101462835|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462836|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462837|NCT00174265|Olanzapine|olanzapine|mesh-list
101462838|NCT00174265|Asenapine|asenapine|mesh-list
101462839|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
101462840|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
101462841|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462842|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462843|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462844|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462845|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462846|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462847|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462848|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101462849|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462851|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462852|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462853|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
101462854|NCT00200603|Calcium|calcium|mesh-list
101462855|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101462860|NCT00258063|Norelgestromin|norelgestromin|mesh-list
101359650|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359651|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359653|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
101359654|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
101359655|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359656|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359657|NCT00209989|Tipifarnib|tipifarnib|mesh-list
101359658|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359659|NCT00210028|Tamoxifen|tamoxifen|mesh-list
101359660|NCT00210028|Tipifarnib|tipifarnib|mesh-list
101359661|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101359662|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
101359663|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359664|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359665|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462861|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
101462862|NCT00258063|Estradiol|estradiol|mesh-list
101462863|NCT00258063|Estrogens|estrogens|mesh-ancestor
101462864|NCT00258063|Hormones|hormones|mesh-ancestor
101462865|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101462866|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462867|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101540006|NCT01124734|Interleukin-2|interleukin-2|mesh-list
101462868|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101462869|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101462870|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101462871|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101462872|NCT00258102|Levofloxacin|levofloxacin|mesh-list
101462873|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462874|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462875|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462876|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101462877|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101462878|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462879|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462880|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462881|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101462882|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101462883|NCT00265278|Modafinil|modafinil|mesh-list
101462884|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101462885|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462886|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101462887|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101462888|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101462889|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462890|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
101462891|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101462892|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462893|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
101462894|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101462895|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462896|NCT00258297|Gefitinib|gefitinib|mesh-list
101462897|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101462898|NCT00258297|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101462899|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462900|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101359666|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359667|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101359668|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101359669|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101359670|NCT00041288|Cyclosporine|cyclosporine|mesh-list
101359671|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
101359672|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
101359673|NCT00041288|Methotrexate|methotrexate|mesh-list
101359674|NCT00041288|Fludarabine|fludarabine|mesh-list
101359675|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
101359676|NCT00041288|Tacrolimus|tacrolimus|mesh-list
101359677|NCT00041288|Cyclosporins|cyclosporins|mesh-list
101462901|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462902|NCT00258336|Rituximab|rituximab|mesh-list
101462903|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
101462904|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101462905|NCT00258336|Antibodies|antibodies|mesh-list
101462906|NCT00258336|Sargramostim|sargramostim|mesh-list
101462907|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101462908|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462909|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462910|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
101462911|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462912|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462913|NCT00171925|Vitamin D|vitamin d|mesh-list
101462914|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
101462915|NCT00171925|Calcium|calcium|mesh-list
101462916|NCT00171925|Vitamins|vitamins|mesh-ancestor
101462917|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
101462918|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462919|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101462920|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101462921|NCT00201305|Leucovorin|leucovorin|mesh-list
101462922|NCT00201305|Gemcitabine|gemcitabine|mesh-list
101462923|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101462924|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
101540094|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101462925|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462929|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462930|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
101462932|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
101462933|NCT00265551|Olanzapine|olanzapine|mesh-list
101462934|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
101462935|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
101462936|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462937|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462938|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462939|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462940|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462941|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462942|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462943|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101462944|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101462945|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101462946|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462947|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462948|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
101462949|NCT00201344|Leucovorin|leucovorin|mesh-list
101462950|NCT00201344|Antidotes|antidotes|mesh-ancestor
101462951|NCT00201344|Protective Agents|protective agents|mesh-ancestor
101462952|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462953|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
101462954|NCT00201344|Vitamins|vitamins|mesh-ancestor
101462955|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
101462956|NCT00201383|Cisplatin|cisplatin|mesh-list
101462958|NCT00201422|Amoxicillin|amoxicillin|mesh-list
101462959|NCT00201422|Clarithromycin|clarithromycin|mesh-list
101462960|NCT00201422|Omeprazole|omeprazole|mesh-list
101359678|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359679|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
101359680|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359681|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359682|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359683|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
101359684|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462961|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101462962|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101462963|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101462964|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101462965|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101462966|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462967|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462968|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101462969|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101462970|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101462971|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
101462972|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101462973|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101462974|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101462975|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101462976|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462977|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
101462978|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462979|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462980|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101462981|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462982|NCT00265746|Metformin|metformin|mesh-list
101462983|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462984|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462985|NCT00201539|Morphine|morphine|mesh-list
101462986|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101462987|NCT00201539|Narcotics|narcotics|mesh-ancestor
101462988|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462989|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462990|NCT00201539|Analgesics|analgesics|mesh-ancestor
101462991|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
101462992|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101462993|NCT00265824|Bevacizumab|bevacizumab|mesh-list
101462994|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101462995|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101462997|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101462998|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101463004|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463006|NCT00201695|Doxorubicin|doxorubicin|mesh-list
101463007|NCT00201695|Vincristine|vincristine|mesh-list
101463008|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
101463009|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463010|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
101463011|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
101463012|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463013|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463014|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463015|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
101463016|NCT00201695|Hormones|hormones|mesh-ancestor
101463017|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463018|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463019|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463020|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463021|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101463022|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101463023|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359685|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359686|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101359687|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101359688|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
101359689|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101463024|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463025|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101463026|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463027|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463028|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463029|NCT00410345|Mifepristone|mifepristone|mesh-list
101463030|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101463031|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
101463032|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101463033|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463034|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101463035|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101463036|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101463037|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
101463038|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101463039|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101463040|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
101463041|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463042|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
101463043|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101463044|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101463045|NCT00265863|Mitomycins|mitomycins|mesh-list
101463046|NCT00265863|Mitomycin|mitomycin|mesh-list
101463047|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463048|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463049|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
101463050|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463051|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101463052|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463053|NCT00410462|Doxorubicin|doxorubicin|mesh-list
101463054|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101463055|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463056|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463057|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101463058|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101463059|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463060|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463061|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
101463062|NCT00258765|Docetaxel|docetaxel|mesh-list
101463063|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463064|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463065|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463066|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463071|NCT00410540|Hydromorphone|hydromorphone|mesh-list
101463072|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101463073|NCT00410540|Narcotics|narcotics|mesh-ancestor
101463074|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463075|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463077|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
101463078|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463079|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
101463080|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463081|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463083|NCT00201812|Etanercept|etanercept|mesh-list
101463084|NCT00201812|Docetaxel|docetaxel|mesh-list
101463085|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
101463086|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463087|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
101463088|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
101463089|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463090|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463091|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359690|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359691|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
101359692|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101359693|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359694|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101359695|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101463092|NCT00201812|Hormones|hormones|mesh-ancestor
101463093|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463094|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463095|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463096|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463097|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463098|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463099|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463100|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101463101|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101463102|NCT00201812|Analgesics|analgesics|mesh-ancestor
101463103|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
101463104|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463105|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463106|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
101463107|NCT00258843|Vaccines|vaccines|mesh-list
101463108|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
101463109|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463110|NCT04709094|Bupropion|bupropion|mesh-list
101463111|NCT04709094|Warfarin|warfarin|mesh-list
101463112|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101463113|NCT04709094|Norethindrone|norethindrone|mesh-list
101463114|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
101463115|NCT04709094|Norinyl|norinyl|mesh-list
101463116|NCT04709094|Estradiol|estradiol|mesh-list
101463117|NCT04709094|Estrogens|estrogens|mesh-ancestor
101463118|NCT04709094|Hormones|hormones|mesh-ancestor
101463119|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463120|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463121|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101463122|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
101463123|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101463124|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101463125|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
101463126|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101463127|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
101463128|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463129|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101463130|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101463131|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463132|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463133|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
101463134|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463135|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101540103|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463136|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101463140|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101463141|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101463142|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
101463144|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463145|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101463146|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101463147|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463148|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463149|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101463150|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
101463151|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463152|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463153|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101359697|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
101359698|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359699|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359700|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101359701|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
101359702|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359703|NCT00073164|Valproic Acid|valproic acid|mesh-list
101359705|NCT00073164|Risperidone|risperidone|mesh-list
101359706|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101359707|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
101463154|NCT00202007|Risperidone|risperidone|mesh-list
101463155|NCT00202007|Aripiprazole|aripiprazole|mesh-list
101463156|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101463157|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
101463158|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463159|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463160|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463161|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101463162|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101463163|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463164|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463165|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101463166|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
101463167|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
101463168|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
101463169|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101463170|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101463171|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101463172|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101463173|NCT00171301|Deferasirox|deferasirox|mesh-list
101463174|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101463175|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
101463176|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
101463177|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463178|NCT00266058|Ritonavir|ritonavir|mesh-list
101463179|NCT00266058|Lopinavir|lopinavir|mesh-list
101463180|NCT00266058|Efavirenz|efavirenz|mesh-list
101463181|NCT00266058|Lumefantrine|lumefantrine|mesh-list
101463182|NCT00266058|Artemether|artemether|mesh-list
101463183|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101463184|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101463185|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101463186|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
101463187|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463189|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101463190|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101463191|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
101463192|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463193|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101463194|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101463195|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101463196|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101463197|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101463198|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101463199|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101463200|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101463201|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101463203|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101463204|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101463205|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
101359708|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359709|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359710|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359711|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101359712|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101359713|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359714|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359715|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101359716|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
101359717|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
101359718|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
101359719|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463206|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463207|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101463220|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463221|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101463222|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463223|NCT00202163|Testosterone|testosterone|mesh-list
101463224|NCT00202163|Androgens|androgens|mesh-ancestor
101463225|NCT00202163|Hormones|hormones|mesh-ancestor
101463226|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463227|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463228|NCT00476554|Sapacitabine|sapacitabine|mesh-list
101463229|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463230|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101463231|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101463232|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463233|NCT00202241|Testosterone|testosterone|mesh-list
101463234|NCT00202241|Androgens|androgens|mesh-ancestor
101463235|NCT00202241|Hormones|hormones|mesh-ancestor
101463236|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463237|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463238|NCT00266136|Cytarabine|cytarabine|mesh-list
101463239|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
101463240|NCT00266136|Daunorubicin|daunorubicin|mesh-list
101463241|NCT00266136|Thioguanine|thioguanine|mesh-list
101463242|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463243|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
101463244|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463245|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463246|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101463247|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
101463248|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463250|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101463251|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101463252|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
101463253|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
101463254|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463255|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463256|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101463257|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101463258|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463259|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101463260|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
101463261|NCT00230594|Coagulants|coagulants|mesh-ancestor
101463262|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101463263|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
101463264|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463265|NCT00259077|Omeprazole|omeprazole|mesh-list
101540116|NCT00577109|Vitamins|vitamins|mesh-ancestor
101463266|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101537555|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
101463267|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463268|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101463269|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359720|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359721|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101359722|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101359723|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359724|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
101359725|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359726|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
101359727|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
101359729|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101359730|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359731|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101463270|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463275|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101463276|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463277|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463278|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463279|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463280|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463281|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101463282|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101463283|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101463284|NCT00479674|Growth Substances|growth substances|mesh-ancestor
101463285|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463286|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
101463287|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101463288|NCT02962310|Calcium|calcium|mesh-list
101463289|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101463290|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463291|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101463292|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101463293|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
101463294|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463295|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101463296|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101463297|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463298|NCT00259116|Methocarbamol|methocarbamol|mesh-list
101463299|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101463300|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463302|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463303|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
101463304|NCT00415779|Docetaxel|docetaxel|mesh-list
101463305|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463306|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463307|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463308|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463309|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463310|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101463311|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463312|NCT00259155|Rifaximin|rifaximin|mesh-list
101463313|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463314|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463315|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463316|NCT00479401|Pramipexole|pramipexole|mesh-list
101463317|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
101463318|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463319|NCT00479401|Protective Agents|protective agents|mesh-ancestor
101463320|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463321|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101463322|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101359732|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101359733|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101359734|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359735|NCT00210340|Rituximab|rituximab|mesh-list
101540128|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101359736|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359737|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359738|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
101359739|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359740|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463323|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
101463324|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
101463325|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463326|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101463327|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101463328|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101463329|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
101463330|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463331|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463332|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463333|NCT00230789|Urological Agents|urological agents|mesh-ancestor
101463334|NCT00478777|Dexamethasone|dexamethasone|mesh-list
101463335|NCT00478777|Lenalidomide|lenalidomide|mesh-list
101463336|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463337|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
101463338|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
101463339|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463340|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463341|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463342|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
101463344|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463345|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463346|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463347|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
101463348|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101463349|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101463350|NCT00478777|Growth Substances|growth substances|mesh-ancestor
101463351|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
101463352|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
101463353|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
101463354|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463355|NCT00477607|Protective Agents|protective agents|mesh-ancestor
101463356|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463357|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
101463358|NCT00477607|Vitamins|vitamins|mesh-ancestor
101463359|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
101463360|NCT00230867|Acyclovir|acyclovir|mesh-list
101463361|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
101463362|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463363|NCT00266214|Lidocaine|lidocaine|mesh-list
101463364|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
101463365|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
101463366|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463367|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463368|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
101463369|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463370|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101463371|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101463372|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101463373|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463374|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463375|NCT00266253|Metformin|metformin|mesh-list
101463376|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463377|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463378|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
101359741|NCT00411541|Dexamethasone|dexamethasone|mesh-list
101359742|NCT00411541|Vincristine|vincristine|mesh-list
101359743|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463379|NCT00230984|Testosterone|testosterone|mesh-list
101463380|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
101463381|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
101463382|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101463383|NCT00230984|Androgens|androgens|mesh-ancestor
101463384|NCT00230984|Hormones|hormones|mesh-ancestor
101463385|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463386|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463387|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463388|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463389|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
101463390|NCT00415350|Azithromycin|azithromycin|mesh-list
101463391|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463392|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463393|NCT00231023|Triamcinolone|triamcinolone|mesh-list
101463394|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101463395|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101463396|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101463397|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463398|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
101463399|NCT00231023|Hormones|hormones|mesh-ancestor
101463400|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463401|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463402|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463403|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
101463404|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463405|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463406|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101463407|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
101463408|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463409|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101463410|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101463411|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463412|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463413|NCT00231140|Thalidomide|thalidomide|mesh-list
101463414|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463415|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
101463416|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463432|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101463434|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463435|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463436|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463437|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
101463438|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463439|NCT00266487|Vitamins|vitamins|mesh-list
101463440|NCT00266487|Folic Acid|folic acid|mesh-list
101463441|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
101463442|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
101463443|NCT00266487|Pyridoxal|pyridoxal|mesh-list
101463444|NCT00266487|Pyridoxine|pyridoxine|mesh-list
101463445|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
101463446|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
101463447|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463448|NCT00266487|Hematinics|hematinics|mesh-ancestor
101463449|NCT00231452|Artesunate|artesunate|mesh-list
101463450|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
101463451|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
101463452|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101463453|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
101463454|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101463455|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101463456|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463457|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463458|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
101463459|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
101463460|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101463461|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
101463462|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101463463|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463464|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359744|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
101359745|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
101359746|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359747|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359748|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101359749|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
101359750|NCT00411541|Hormones|hormones|mesh-ancestor
101359751|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463465|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101463466|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
101463467|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101463468|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101463469|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101463470|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463471|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463472|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
101463473|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463474|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463475|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101463476|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463477|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101463479|NCT00477490|Coagulants|coagulants|mesh-ancestor
101463482|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463484|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
101463485|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463486|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463487|NCT00231569|Mipomersen|mipomersen|mesh-list
101463488|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101463489|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101463490|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
101463491|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463492|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101463493|NCT00477334|Famciclovir|famciclovir|mesh-list
101463494|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
101463495|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463496|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101463497|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463498|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463499|NCT00231608|Topiramate|topiramate|mesh-list
101463500|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
101463501|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463502|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463503|NCT00266604|Topiramate|topiramate|mesh-list
101463504|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
101463505|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463506|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463507|NCT04561336|Cetuximab|cetuximab|mesh-list
101463508|NCT04561336|Avelumab|avelumab|mesh-list
101463509|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101463510|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463511|NCT00259428|Dronedarone|dronedarone|mesh-list
101463512|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101463513|NCT00231647|Topiramate|topiramate|mesh-list
101463514|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
101463515|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463516|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463517|NCT04560751|Lenvatinib|lenvatinib|mesh-list
101463518|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463519|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101463520|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463521|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463522|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101463523|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101463524|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101463525|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101359752|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101359753|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359754|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359755|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359756|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359757|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487381|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
101463526|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463527|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463528|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463529|NCT00266643|Analgesics|analgesics|mesh-ancestor
101463530|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
101463531|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463532|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
101463533|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463534|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
101463535|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
101463536|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463537|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463538|NCT04560049|Phenol|phenol|mesh-list
101463539|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
101463540|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101463541|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463542|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
101463543|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101463544|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101463545|NCT04559425|Dexamethasone|dexamethasone|mesh-list
101463546|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
101463547|NCT04559425|BB 1101|bb 1101|mesh-list
101463548|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463549|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
101463550|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
101463551|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463552|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463553|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463554|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
101463570|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101463571|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463572|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101463573|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101463574|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101463575|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463576|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463577|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
101463578|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463579|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463580|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101463581|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
101463582|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101463583|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463584|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463585|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101463586|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101463587|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463588|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
101463589|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101463590|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101463591|NCT04559113|Prednisolone|prednisolone|mesh-list
101463592|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
101463593|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101463594|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
101463595|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463596|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
101463597|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
101463598|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463599|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463600|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463601|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
101463602|NCT04559113|Hormones|hormones|mesh-ancestor
101359758|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359759|NCT00210379|Rituximab|rituximab|mesh-list
101359760|NCT00210379|Methotrexate|methotrexate|mesh-list
101359761|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359762|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359763|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
101463603|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463604|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101463605|NCT04559113|Protective Agents|protective agents|mesh-ancestor
101463606|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463607|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463608|NCT00266721|Pancrelipase|pancrelipase|mesh-list
101463609|NCT00266721|Pancreatin|pancreatin|mesh-list
101463610|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463611|NCT04559074|Amlodipine|amlodipine|mesh-list
101463612|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101463613|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101463614|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463619|NCT02211976|Bisacodyl|bisacodyl|mesh-list
101463620|NCT02211976|Cathartics|cathartics|mesh-ancestor
101463621|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463622|NCT02211976|Laxatives|laxatives|mesh-ancestor
101463623|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
101463624|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
101463625|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463626|NCT00231959|Pramipexole|pramipexole|mesh-list
101463627|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
101463628|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463629|NCT00231959|Protective Agents|protective agents|mesh-ancestor
101463630|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463631|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101463632|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101463633|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
101463634|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
101463635|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463636|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
101463637|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101463638|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101463639|NCT00231998|Analgesics|analgesics|mesh-ancestor
101463640|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
101463641|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463642|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463643|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463644|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463645|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463646|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463647|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
101463648|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101463649|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463650|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463652|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463653|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
101463654|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
101463655|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463656|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463657|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463658|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
101463659|NCT00266838|Hormones|hormones|mesh-ancestor
101463660|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463661|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463662|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463663|NCT00232037|Tegaserod|tegaserod|mesh-list
101463664|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101463665|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
101463666|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463667|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463668|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463669|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
101359764|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359765|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359766|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101359767|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
101359768|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101359769|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101359770|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
101359771|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463670|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101463671|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101463673|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
101463674|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101463675|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
101463676|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463679|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463680|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463681|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463682|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
101463683|NCT02212210|Hormones|hormones|mesh-ancestor
101463684|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463685|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101463690|NCT00232076|Cyclosporins|cyclosporins|mesh-list
101463691|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463692|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463693|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463694|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
101463695|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463696|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
101463697|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463698|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463699|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463700|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101463701|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
101463702|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101463703|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101463704|NCT00232115|Analgesics|analgesics|mesh-ancestor
101463705|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
101463706|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463707|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463708|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463709|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463710|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463711|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463712|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
101463713|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101463714|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463715|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463716|NCT04558021|Niclosamide|niclosamide|mesh-list
101463717|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
101463718|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101463719|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
101463721|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463722|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
101463723|NCT00232154|Azithromycin|azithromycin|mesh-list
101463724|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463725|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463726|NCT00259662|Atorvastatin|atorvastatin|mesh-list
101463727|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101463728|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101463729|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
101463730|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463731|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101359772|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
101359773|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359774|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101359775|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359776|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101359777|NCT00041327|Interferons|interferons|mesh-list
101359778|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
101463732|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101463733|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463734|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
101463735|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101463736|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
101463737|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463738|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
101463739|NCT04557943|Protective Agents|protective agents|mesh-ancestor
101463740|NCT04557475|Aspirin|aspirin|mesh-list
101463741|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101463742|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101463743|NCT04557475|Analgesics|analgesics|mesh-ancestor
101463744|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
101463745|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463746|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463747|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463748|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101463749|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101463750|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101463751|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463752|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101463753|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101463754|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463756|NCT00232271|Enoxaparin|enoxaparin|mesh-list
101463757|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
101463761|NCT04557397|Itraconazole|itraconazole|mesh-list
101463762|NCT04557397|Rifampin|rifampin|mesh-list
101463763|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
101463764|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463765|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101463766|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101463767|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463768|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463769|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101463770|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
101463771|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463772|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463773|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101463774|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101463775|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
101463776|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463777|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
101463778|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101463779|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101463780|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101463781|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101463782|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101463783|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101463784|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101463785|NCT04557202|Tamsulosin|tamsulosin|mesh-list
101463786|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101463787|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101463788|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101463789|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
101463790|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463791|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463792|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359779|NCT00041327|Lamivudine|lamivudine|mesh-list
101359782|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
101359784|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101359785|NCT00041327|Etoposide|etoposide|mesh-list
101359786|NCT00041327|Vincristine|vincristine|mesh-list
101463793|NCT04557202|Urological Agents|urological agents|mesh-ancestor
101463794|NCT00232349|Galantamine|galantamine|mesh-list
101463795|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101463796|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463797|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463798|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
101463799|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463800|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463801|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101463802|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
101463803|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463804|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
101463805|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
101463806|NCT00259701|Acetylcholine|acetylcholine|mesh-list
101463807|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540209|NCT00577694|Clofarabine|clofarabine|mesh-list
101463808|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101463809|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
101463810|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463811|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463812|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463813|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101463814|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101463815|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463816|NCT04566211|Amoxicillin|amoxicillin|mesh-list
101463817|NCT04566211|Metronidazole|metronidazole|mesh-list
101463818|NCT04566211|Clarithromycin|clarithromycin|mesh-list
101463819|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101463820|NCT04566211|Pantoprazole|pantoprazole|mesh-list
101463821|NCT04566211|Bismuth|bismuth|mesh-list
101463822|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463823|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463824|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101463825|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101463826|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101463836|NCT00259779|Budesonide|budesonide|mesh-list
101463837|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
101463838|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463839|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
101463840|NCT00259779|Hormones|hormones|mesh-ancestor
101463841|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463842|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463843|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463844|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463845|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
101463846|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463847|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101463848|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101463849|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
101463850|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101463851|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101463852|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101463853|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
101463854|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463855|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463856|NCT02211079|Tolbutamide|tolbutamide|mesh-list
101463857|NCT02211079|Midazolam|midazolam|mesh-list
101463858|NCT02211079|Caffeine|caffeine|mesh-list
101463859|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101463861|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101463862|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463863|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101359788|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
101359789|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463864|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101463865|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463866|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101463867|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
101463868|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
101463869|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
101463870|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
101463871|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463872|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463873|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101463874|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101463875|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463876|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101463877|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101463878|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
101463879|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463880|NCT00232622|Streptokinase|streptokinase|mesh-list
101463881|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101463882|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101463883|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463884|NCT00232661|Tamoxifen|tamoxifen|mesh-list
101463885|NCT00232661|Anastrozole|anastrozole|mesh-list
101463886|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101463887|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
101463888|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463889|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463890|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463894|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101463895|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101463896|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101463897|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463898|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463899|NCT00267267|Atorvastatin|atorvastatin|mesh-list
101463900|NCT00267267|Simvastatin|simvastatin|mesh-list
101463902|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101463903|NCT00267267|Torcetrapib|torcetrapib|mesh-list
101463904|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101463905|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101463906|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
101463907|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463908|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101463909|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101463910|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463911|NCT04564690|Vitamin E|vitamin e|mesh-list
101463912|NCT04564690|Selenium|selenium|mesh-list
101463913|NCT04564690|Vitamins|vitamins|mesh-ancestor
101463914|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
101463915|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463916|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
101463917|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463918|NCT04564690|Protective Agents|protective agents|mesh-ancestor
101463919|NCT04564690|Trace Elements|trace elements|mesh-ancestor
101463921|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101463922|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101463923|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101463924|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463925|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463926|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
101463927|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463928|NCT04564456|Fluticasone|fluticasone|mesh-list
101463930|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101463931|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101463932|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101463933|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101463934|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
101359790|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359791|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359792|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
101359793|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359794|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359795|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101359796|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101463935|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463936|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463937|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101463938|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101463939|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
101463940|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101463941|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101463942|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101463943|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101463944|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
101463945|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463946|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463948|NCT04564456|Hormones|hormones|mesh-ancestor
101463949|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463950|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
101463951|NCT04564144|Meclizine|meclizine|mesh-list
101463952|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
101463953|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
101463954|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463955|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463956|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463957|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101463958|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
101463959|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
101463960|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463961|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463965|NCT00267306|Visilizumab|visilizumab|mesh-list
101463966|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
101463967|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463968|NCT00259896|Exenatide|exenatide|mesh-list
101463969|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101463970|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463971|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101463972|NCT00259896|Incretins|incretins|mesh-ancestor
101463973|NCT00259896|Hormones|hormones|mesh-ancestor
101463974|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463975|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
101463976|NCT04721795|Atorvastatin|atorvastatin|mesh-list
101463977|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101463978|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101463979|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
101463980|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463981|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101463982|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101463983|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463984|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463985|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463986|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101463987|NCT04564222|Micronutrients|micronutrients|mesh-list
101463988|NCT04564222|Trace Elements|trace elements|mesh-list
101463989|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463990|NCT00232817|Nicotine|nicotine|mesh-list
101463991|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101463992|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
101463993|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101463994|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463995|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101463996|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101463997|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
101359797|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359798|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359799|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359800|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101359801|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
101359802|NCT00041327|Hormones|hormones|mesh-ancestor
101359803|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359804|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463998|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101463999|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464000|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
101464001|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101464002|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
101464003|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464004|NCT00267384|Expectorants|expectorants|mesh-ancestor
101464005|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101464006|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101464007|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
101464008|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464009|NCT00267384|Protective Agents|protective agents|mesh-ancestor
101464010|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464011|NCT00267384|Antidotes|antidotes|mesh-ancestor
101464012|NCT00259935|Topotecan|topotecan|mesh-list
101464013|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101464014|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101464015|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464016|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464017|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464019|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464020|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464021|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101464022|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464023|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
101464024|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464025|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
101464026|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464028|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464029|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464030|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
101464031|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464032|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464033|NCT00232895|Propofol|propofol|mesh-list
101464034|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101464035|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464054|NCT04673812|Naloxone|naloxone|mesh-list
101464055|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
101464056|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
101464057|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464058|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464059|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
101464060|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464061|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101464062|NCT04673812|Narcotics|narcotics|mesh-ancestor
101464063|NCT04673812|Analgesics|analgesics|mesh-ancestor
101464064|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101464065|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101464066|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
101464067|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101464068|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
101464069|NCT00260052|Hematinics|hematinics|mesh-ancestor
101464070|NCT04673500|Lidocaine|lidocaine|mesh-list
101464071|NCT04673500|Propofol|propofol|mesh-list
101464072|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
101464073|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
101464074|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464075|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464076|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
101359805|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101359806|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
101359807|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359808|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
101359809|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359810|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359811|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101359812|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464077|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464078|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101464079|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101464080|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101464081|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464082|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464083|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101464084|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101464085|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
101464086|NCT00233012|Topiramate|topiramate|mesh-list
101464087|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
101464088|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101464089|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464090|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
101464091|NCT00267540|Vitamin D|vitamin d|mesh-list
101464092|NCT00267540|Vitamins|vitamins|mesh-ancestor
101464093|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
101464094|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464101|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
101464102|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464103|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464104|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101464105|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101464106|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464107|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101464108|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101464109|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101464110|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101464111|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
101464112|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464113|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464115|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101464116|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464117|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464118|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
101464119|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464120|NCT04672330|Tislelizumab|tislelizumab|mesh-list
101464121|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464122|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464123|NCT00260247|Carbamazepine|carbamazepine|mesh-list
101464124|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
101464125|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
101464126|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
101464127|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101464128|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464129|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464130|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101464131|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101464132|NCT00260247|Analgesics|analgesics|mesh-ancestor
101464133|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
101464134|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464135|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101464136|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464137|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464138|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101464139|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101359813|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101359814|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101359815|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
101359816|NCT00210457|Lanreotide|lanreotide|mesh-list
101359817|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359818|NCT00210496|Topiramate|topiramate|mesh-list
101359819|NCT00210496|Almotriptan|almotriptan|mesh-list
101464140|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101464141|NCT04671589|Meropenem|meropenem|mesh-list
101464142|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464143|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464144|NCT00260325|Valdecoxib|valdecoxib|mesh-list
101464145|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101464146|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101464147|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464148|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464149|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101464150|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101464151|NCT00260325|Analgesics|analgesics|mesh-ancestor
101464152|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
101464153|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464154|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464155|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464156|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464157|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101464158|NCT04671160|Dalteparin|dalteparin|mesh-list
101464159|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
101464160|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101464161|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464162|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464163|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
101464168|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
101464169|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464170|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464171|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464173|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464174|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464175|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464176|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464177|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101464178|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464179|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
101464180|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464181|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464182|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101464183|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464184|NCT00233636|Gefitinib|gefitinib|mesh-list
101464185|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464186|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464187|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464188|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464189|NCT00267657|Reserpine|reserpine|mesh-list
101464190|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101464191|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101464192|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101464193|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464194|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464195|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101464196|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101464197|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101464198|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464199|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464200|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
101464201|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464202|NCT04670809|Clevidipine|clevidipine|mesh-list
101464203|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101464204|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464205|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359820|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
101359821|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359822|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359823|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101359824|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
101464206|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101464207|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464209|NCT00233714|Temsirolimus|temsirolimus|mesh-list
101464210|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
101464211|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464212|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464213|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101464214|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464215|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
101464216|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464217|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
101464218|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464219|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464220|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464221|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464222|NCT04670497|Epinephrine|epinephrine|mesh-list
101464223|NCT04670497|Racepinephrine|racepinephrine|mesh-list
101464224|NCT04670497|Bupivacaine|bupivacaine|mesh-list
101464225|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
101464226|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
101464227|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
101464228|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464229|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464230|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
101464231|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464232|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101464237|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101464238|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101464239|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
101464240|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101464241|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
101464243|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
101464244|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101464245|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101464246|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464247|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464248|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464249|NCT00260364|Bevacizumab|bevacizumab|mesh-list
101464250|NCT00260364|Gemcitabine|gemcitabine|mesh-list
101464251|NCT00260364|Capecitabine|capecitabine|mesh-list
101464252|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101464253|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464254|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464255|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101464256|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464257|NCT00260364|Growth Substances|growth substances|mesh-ancestor
101464258|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464259|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464260|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464261|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
101464262|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464263|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464264|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464265|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
101464266|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464267|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464268|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101464269|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464271|NCT00233792|Temsirolimus|temsirolimus|mesh-list
101464272|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
101464273|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464274|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464275|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359825|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359826|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359827|NCT00210535|Topiramate|topiramate|mesh-list
101359828|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
101359829|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359830|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359831|NCT00210574|Topiramate|topiramate|mesh-list
101359832|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
101359833|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359834|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464276|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464277|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
101464278|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464279|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
101464280|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464281|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464282|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464283|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464284|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
101464285|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464286|NCT00556192|Rituximab|rituximab|mesh-list
101464287|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464288|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464289|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
101464290|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464291|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464292|NCT00556270|Fentanyl|fentanyl|mesh-list
101464293|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101464294|NCT00556270|Narcotics|narcotics|mesh-ancestor
101464295|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464296|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464297|NCT00556270|Analgesics|analgesics|mesh-ancestor
101464298|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
101413594|NCT00484744|Ibuprofen|ibuprofen|mesh-list
101464299|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464300|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101464301|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101464302|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
101464307|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
101464308|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101464309|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464310|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464311|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
101540407|NCT02215005|Ramipril|ramipril|mesh-list
101464312|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464313|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464314|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
101464315|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
101464316|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
101464317|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464318|NCT00267813|Bupropion|bupropion|mesh-list
101464319|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101464320|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101464321|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101464322|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101464323|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101464324|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464325|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464326|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
101464327|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464328|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464329|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101464330|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101464331|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464332|NCT00234026|Gemcitabine|gemcitabine|mesh-list
101464333|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464334|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
101359835|NCT00210691|Risperidone|risperidone|mesh-list
101359836|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101359837|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
101359838|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359839|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359840|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464335|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464336|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464337|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
101464338|NCT00234143|Hematinics|hematinics|mesh-ancestor
101464339|NCT00234182|Interferons|interferons|mesh-list
101464340|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
101464341|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
101464342|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464343|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
101464344|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464345|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
101464346|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464347|NCT04669990|Remdesivir|remdesivir|mesh-list
101464348|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
101464349|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464350|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
101464351|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464352|NCT00556348|Bevacizumab|bevacizumab|mesh-list
101464353|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464354|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464355|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101464356|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464357|NCT00556348|Growth Substances|growth substances|mesh-ancestor
101464358|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464359|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464360|NCT00556387|Ketamine|ketamine|mesh-list
101464361|NCT00556387|Analgesics|analgesics|mesh-ancestor
101464362|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
101464363|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464364|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464365|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101464366|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101464367|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
101464368|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
101464369|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464370|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101464371|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101464372|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464373|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464378|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464379|NCT04556110|Perindopril|perindopril|mesh-list
101464380|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101464381|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
101464382|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464383|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464384|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101464385|NCT00234299|Aspirin|aspirin|mesh-list
101464386|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101464387|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101464388|NCT00234299|Analgesics|analgesics|mesh-ancestor
101464389|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
101464390|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464391|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464392|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464393|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464394|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101464395|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464396|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464397|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101464398|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101464399|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359841|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101359842|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101359843|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359844|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359845|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101359846|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
101464400|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
101464401|NCT04556032|Ergothioneine|ergothioneine|mesh-list
101464402|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
101464403|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464404|NCT04556032|Protective Agents|protective agents|mesh-ancestor
101464405|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464406|NCT04556071|Bevacizumab|bevacizumab|mesh-list
101464407|NCT04556071|Niraparib|niraparib|mesh-list
101464408|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464409|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464410|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101464411|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464412|NCT04556071|Growth Substances|growth substances|mesh-ancestor
101464413|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464414|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464415|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101464416|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464417|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464418|NCT04563871|Osimertinib|osimertinib|mesh-list
101464419|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464420|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464421|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464422|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464423|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101464424|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
101464425|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101464426|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101464427|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101464428|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464429|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464430|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
101464431|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101464432|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464433|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464434|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101464435|NCT02211118|Analgesics|analgesics|mesh-ancestor
101464436|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
101464437|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464438|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101464439|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101464440|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101464442|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464443|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464448|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464449|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464450|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464451|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464452|NCT00234455|Sirolimus|sirolimus|mesh-list
101464453|NCT00234455|Temsirolimus|temsirolimus|mesh-list
101464454|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
101464455|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464456|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464457|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101464458|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464459|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
101464460|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464461|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
101464462|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464463|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101464464|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464465|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359847|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
101359848|NCT00210730|Hematinics|hematinics|mesh-ancestor
101359849|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101359850|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101359851|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101359852|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359853|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359854|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101359855|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101359856|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101464466|NCT00234572|Lanreotide|lanreotide|mesh-list
101464467|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464468|NCT00260793|Ropinirole|ropinirole|mesh-list
101464469|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101464470|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101464471|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
101464472|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
101464473|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464474|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464475|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464476|NCT00415935|Methotrexate|methotrexate|mesh-list
101464477|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101464478|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
101464479|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464480|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464481|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464482|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
101464483|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464484|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464485|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464486|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464487|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101464488|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464489|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
101464490|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464491|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464492|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101464493|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464494|NCT02211391|Caseins|caseins|mesh-list
101464495|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
101464496|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
101464497|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464498|NCT04562311|Tislelizumab|tislelizumab|mesh-list
101464499|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464500|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464501|NCT00234689|Naltrexone|naltrexone|mesh-list
101464502|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101464503|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101464504|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464505|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
101464506|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464508|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
101464509|NCT04561960|Protective Agents|protective agents|mesh-ancestor
101464510|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464511|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
101464512|NCT04561921|Nordefrin|nordefrin|mesh-list
101464513|NCT04561921|Mepivacaine|mepivacaine|mesh-list
101464514|NCT04561921|Analgesics|analgesics|mesh-ancestor
101464515|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
101464516|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464525|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101464526|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
101464527|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464528|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
101359857|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
101359858|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359859|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359860|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101359861|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101359862|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
101359863|NCT00210808|Topiramate|topiramate|mesh-list
101359864|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
101359865|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101464529|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101464530|NCT04561687|Azelastine|azelastine|mesh-list
101464531|NCT04561687|Budesonide|budesonide|mesh-list
101464532|NCT04561687|Montelukast|montelukast|mesh-list
101464533|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464534|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101464535|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
101464536|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464537|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464538|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101464539|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101464540|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
101464541|NCT04561687|Hormones|hormones|mesh-ancestor
101464542|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464543|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101464544|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
101464545|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101464546|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101464547|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464548|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101464549|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464550|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101464551|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101464552|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101464553|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
101464554|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
101464555|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464556|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
101464557|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101464558|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464559|NCT00234845|Adalimumab|adalimumab|mesh-list
101464560|NCT00234845|Methotrexate|methotrexate|mesh-list
101464561|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101464562|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
101464563|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464564|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464565|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464566|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
101464567|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464568|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464569|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464570|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464571|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101464572|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464573|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
101464574|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464575|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464576|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101464577|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464578|NCT02211625|Oxycodone|oxycodone|mesh-list
101464579|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101464580|NCT02211625|Narcotics|narcotics|mesh-ancestor
101464585|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464586|NCT00234923|Ritonavir|ritonavir|mesh-list
101464587|NCT00234923|Lopinavir|lopinavir|mesh-list
101464588|NCT00234923|Lamivudine|lamivudine|mesh-list
101464589|NCT00234923|Zidovudine|zidovudine|mesh-list
101359866|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359867|NCT00210847|Acetaminophen|acetaminophen|mesh-list
101359868|NCT00210847|Tramadol|tramadol|mesh-list
101359869|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101359870|NCT00210847|Analgesics|analgesics|mesh-ancestor
101464590|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101464591|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101464592|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101464593|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
101464594|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464595|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464596|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101464597|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101464598|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
101464599|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464600|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101464601|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101464603|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464604|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
101464605|NCT02213887|Pantoprazole|pantoprazole|mesh-list
101464606|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101464607|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101464608|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101464609|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464610|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464611|NCT00234962|Ritonavir|ritonavir|mesh-list
101464612|NCT00234962|Lopinavir|lopinavir|mesh-list
101464613|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101464614|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101464615|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
101464616|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464617|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464618|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101464619|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101464620|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
101464621|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464622|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101464623|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101464624|NCT04551703|Epinephrine|epinephrine|mesh-list
101464625|NCT04551703|Racepinephrine|racepinephrine|mesh-list
101464626|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
101464627|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101464628|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101464629|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
101464630|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464631|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464632|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464633|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101464634|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101464635|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
101464636|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464637|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101464638|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
101464639|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
101464640|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
101464641|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101464642|NCT00235001|Verapamil|verapamil|mesh-list
101464643|NCT00235001|Trandolapril|trandolapril|mesh-list
101464644|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101464645|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101464646|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464647|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464648|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101464649|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464650|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
101464656|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464657|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
101359871|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
101359872|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101359873|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359874|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
101359875|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101359876|NCT00210847|Narcotics|narcotics|mesh-ancestor
101359877|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359878|NCT00210886|Levofloxacin|levofloxacin|mesh-list
101464659|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464660|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464661|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101464663|NCT00424944|Vaccines|vaccines|mesh-list
101464664|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
101464665|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464666|NCT02214004|Trastuzumab|trastuzumab|mesh-list
101464667|NCT02214004|Letrozole|letrozole|mesh-list
101464668|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464669|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464670|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101464671|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101464672|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464673|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464674|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101464675|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101464676|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464677|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464678|NCT00235079|Colchicine|colchicine|mesh-list
101464679|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
101464680|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464681|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
101464682|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
101464683|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464684|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464685|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464686|NCT00260988|Dalteparin|dalteparin|mesh-list
101464687|NCT00260988|Tinzaparin|tinzaparin|mesh-list
101464688|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101464689|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
101464690|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101464691|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464692|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464693|NCT00235157|Sirolimus|sirolimus|mesh-list
101464694|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464695|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464696|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101464697|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464698|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
101464699|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464700|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
101464701|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464702|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
101464703|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101464704|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464705|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464706|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
101464707|NCT04550338|Coagulants|coagulants|mesh-ancestor
101464708|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
101464709|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101464710|NCT04550611|Antibodies|antibodies|mesh-list
101464711|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
101464712|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101464713|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
101464714|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464715|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
101464716|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101464717|NCT00261027|Exemestane|exemestane|mesh-list
101464718|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359879|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101359880|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359881|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359882|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359883|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359884|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359885|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464719|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101464720|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101464721|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464725|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464727|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
101464728|NCT00235235|Gemcitabine|gemcitabine|mesh-list
101464729|NCT00235235|Doxorubicin|doxorubicin|mesh-list
101464730|NCT00235235|Capecitabine|capecitabine|mesh-list
101464731|NCT00235235|Vinorelbine|vinorelbine|mesh-list
101464732|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464733|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
101464734|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464735|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464736|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101464737|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
101464738|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464739|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464740|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101464741|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464742|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
101464743|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101464744|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101464745|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101464746|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464747|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101464748|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101464749|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101464750|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464751|NCT00268359|Bevacizumab|bevacizumab|mesh-list
101464752|NCT00268359|Irinotecan|irinotecan|mesh-list
101464753|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101464754|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464755|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101464756|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464757|NCT00268359|Growth Substances|growth substances|mesh-ancestor
101464758|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464759|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464760|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101464761|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101464762|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464763|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464764|NCT00235274|Secretin|secretin|mesh-list
101464765|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101464766|NCT00235274|Hormones|hormones|mesh-ancestor
101464767|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464768|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464769|NCT00268398|Leucovorin|leucovorin|mesh-list
101464770|NCT00268398|Folic Acid|folic acid|mesh-list
101464771|NCT00268398|Fluorouracil|fluorouracil|mesh-list
101464772|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
101464773|NCT00268398|Irinotecan|irinotecan|mesh-list
101464774|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
101464775|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
101464776|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464777|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464778|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464779|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464780|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
101464781|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359886|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359887|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101359888|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101359889|NCT00210925|Topiramate|topiramate|mesh-list
101359890|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
101359893|NCT00211003|Doripenem|doripenem|mesh-list
101464782|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101464783|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101464784|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464785|NCT00268398|Antidotes|antidotes|mesh-ancestor
101464786|NCT00268398|Protective Agents|protective agents|mesh-ancestor
101464787|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
101464788|NCT00268398|Vitamins|vitamins|mesh-ancestor
101464789|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
101464790|NCT00268398|Hematinics|hematinics|mesh-ancestor
101464791|NCT00235313|Nicotine|nicotine|mesh-list
101464792|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101464793|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
101464798|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
101464799|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413602|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464800|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464802|NCT04549012|Oxytocin|oxytocin|mesh-list
101464803|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
101464804|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464805|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464806|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101464807|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101464808|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464809|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
101464810|NCT04549012|Coagulants|coagulants|mesh-ancestor
101464811|NCT00261105|Telithromycin|telithromycin|mesh-list
101464812|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464813|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464814|NCT00235508|Eszopiclone|eszopiclone|mesh-list
101464815|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101464816|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464817|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464818|NCT00268515|Cyclosporine|cyclosporine|mesh-list
101464819|NCT00268515|Prednisone|prednisone|mesh-list
101464820|NCT00268515|Azathioprine|azathioprine|mesh-list
101464821|NCT00268515|Tacrolimus|tacrolimus|mesh-list
101464822|NCT00268515|Cyclosporins|cyclosporins|mesh-list
101464823|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464824|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
101464825|NCT00268515|Hormones|hormones|mesh-ancestor
101464826|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464827|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464828|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101464829|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464830|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464831|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
101464832|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101464833|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464834|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464835|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
101464836|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464837|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464838|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464839|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
101464840|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464841|NCT04548700|Prednisone|prednisone|mesh-list
101464842|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
101464843|NCT04548700|Vincristine|vincristine|mesh-list
101464845|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464846|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
101464847|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464848|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464849|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359894|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101359895|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359897|NCT00211120|Hematinics|hematinics|mesh-ancestor
101359898|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
101359899|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359900|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
101359901|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359902|NCT00211315|Anecortave|anecortave|mesh-list
101359903|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101359904|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464850|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
101464851|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464852|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464853|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101464854|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464855|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
101464856|NCT04548700|Hormones|hormones|mesh-ancestor
101464857|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464858|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101464859|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101464860|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101464861|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101464862|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464863|NCT04548700|Analgesics|analgesics|mesh-ancestor
101464864|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
101464865|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464887|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464888|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464889|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464890|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464891|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101464892|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464893|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
101464894|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464895|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101464897|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464898|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464899|NCT00268554|Dipyridamole|dipyridamole|mesh-list
101464900|NCT00268554|Caffeine|caffeine|mesh-list
101464901|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101464902|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464903|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101464904|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464905|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464906|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101464907|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101464908|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
101464909|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464910|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101464911|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101464912|NCT00268593|Prednisone|prednisone|mesh-list
101464913|NCT00268593|Docetaxel|docetaxel|mesh-list
101464914|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464915|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
101464916|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
101464917|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464918|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464924|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101464925|NCT04555525|Sarecycline|sarecycline|mesh-list
101464926|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464927|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359906|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359907|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359908|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464928|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464929|NCT00261183|Melatonin|melatonin|mesh-list
101464930|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
101464931|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464932|NCT00261183|Protective Agents|protective agents|mesh-ancestor
101464933|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464934|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464935|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
101464936|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101464937|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464938|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464939|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101464940|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464941|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101464942|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101464943|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
101464944|NCT04554979|Anticoagulants|anticoagulants|mesh-list
101464945|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464946|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
101464947|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101464948|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101464949|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464950|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464951|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101464952|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
101464953|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101464954|NCT00261222|Amodiaquine|amodiaquine|mesh-list
101464955|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
101464956|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101464957|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101464958|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464959|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
101464960|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
101464961|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464962|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464963|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
101464964|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101464965|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101464966|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101464967|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
101464968|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464969|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464970|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464971|NCT00268671|Docetaxel|docetaxel|mesh-list
101464972|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464973|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101464974|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101464975|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101464976|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464977|NCT04554433|Ethanol|ethanol|mesh-list
101464978|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101464979|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464980|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464981|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464982|NCT04721054|Lidocaine|lidocaine|mesh-list
101464984|NCT04721054|Anesthetics|anesthetics|mesh-list
101464985|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
101464986|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464987|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464988|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
101464992|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101464993|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464994|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464995|NCT02212639|Digoxin|digoxin|mesh-list
101464996|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101359910|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101359911|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101359912|NCT00211354|Growth Substances|growth substances|mesh-ancestor
101359913|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359914|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359915|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359916|NCT00211393|Ketoconazole|ketoconazole|mesh-list
101359917|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
101359918|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101359919|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101359920|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101359921|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359922|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359923|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101359924|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
101359925|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101359926|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359927|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101359929|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101359930|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101359931|NCT00211432|Growth Substances|growth substances|mesh-ancestor
101359932|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359933|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359934|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464997|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101464998|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464999|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465000|NCT02212639|Protective Agents|protective agents|mesh-ancestor
101465001|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465002|NCT02212756|Metformin|metformin|mesh-list
101465003|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465004|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465005|NCT02212795|Levofloxacin|levofloxacin|mesh-list
101465006|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
101465007|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101465008|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465009|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465010|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101465011|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465012|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465013|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465014|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465015|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101465016|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465017|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101359936|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101359937|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101359938|NCT00211471|Growth Substances|growth substances|mesh-ancestor
101359939|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359940|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
101359941|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359942|NCT00211588|Galantamine|galantamine|mesh-list
101359943|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101359944|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487382|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465018|NCT00261261|Midazolam|midazolam|mesh-list
101465019|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465020|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101465021|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465022|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465023|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101465024|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101465025|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465026|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465027|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
101465028|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
101465029|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
101465030|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
101465031|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465032|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465033|NCT00235820|Adalimumab|adalimumab|mesh-list
101465034|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101465035|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465036|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465037|NCT00268710|Docetaxel|docetaxel|mesh-list
101465038|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465039|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
101465040|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
101465041|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
101465042|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465043|NCT00261300|Pantoprazole|pantoprazole|mesh-list
101465044|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101465045|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465046|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101465047|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465048|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465050|NCT02212990|Ibuprofen|ibuprofen|mesh-list
101465051|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101465052|NCT02212990|Analgesics|analgesics|mesh-ancestor
101465053|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
101465054|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465055|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465056|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
101465057|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101465058|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465059|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465063|NCT00235859|Adalimumab|adalimumab|mesh-list
101465064|NCT00235859|Methotrexate|methotrexate|mesh-list
101465065|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101465066|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
101465067|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465068|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465069|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101465070|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
101465071|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465072|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465073|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
101465074|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359945|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359947|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359948|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359949|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101359951|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465075|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101465076|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101465077|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
101465078|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465079|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101465080|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101465081|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465082|NCT02213029|Oxytocin|oxytocin|mesh-list
101465083|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
101465084|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465085|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465086|NCT02213146|Insulin|insulin|mesh-list
101465087|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
101465088|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101465089|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465090|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465091|NCT00268749|Glycine|glycine|mesh-list
101465092|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
101465093|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465094|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465095|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465096|NCT00235898|Leucovorin|leucovorin|mesh-list
101465097|NCT00235898|Fluorouracil|fluorouracil|mesh-list
101465098|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
101465099|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465100|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101465101|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465102|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101465103|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
101465104|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465105|NCT00235898|Antidotes|antidotes|mesh-ancestor
101465106|NCT00235898|Protective Agents|protective agents|mesh-ancestor
101465107|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
101465108|NCT00235898|Vitamins|vitamins|mesh-ancestor
101465109|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
101465110|NCT02213224|Amlodipine|amlodipine|mesh-list
101465111|NCT02213224|Telmisartan|telmisartan|mesh-list
101465112|NCT02213224|Perindopril|perindopril|mesh-list
101465113|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465114|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101465115|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465116|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465117|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465118|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465119|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
101465120|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101465121|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101465122|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101465123|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
101465124|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465125|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
101465126|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101465127|NCT00268788|Antibodies|antibodies|mesh-list
101465128|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
101465129|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101465130|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
101465131|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465135|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465136|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101465137|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101465138|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359952|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
101359953|NCT00211705|Pravastatin|pravastatin|mesh-list
101359954|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101359955|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101359956|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
101359957|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465139|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465140|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101465141|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
101465142|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465143|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465144|NCT00261339|Pantoprazole|pantoprazole|mesh-list
101465145|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101465146|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465147|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101465148|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465149|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465150|NCT04553380|Insulin|insulin|mesh-list
101465151|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
101465152|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465153|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465154|NCT00236015|Tiagabine|tiagabine|mesh-list
101465155|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
101465156|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101465157|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465158|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465159|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465160|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
101465161|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465162|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465163|NCT00261378|Doxorubicin|doxorubicin|mesh-list
101465164|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101465165|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101465166|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465167|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101465168|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465169|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465170|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465171|NCT04553458|Ethanol|ethanol|mesh-list
101465172|NCT04553458|Sorafenib|sorafenib|mesh-list
101465173|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465174|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101465175|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465176|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465177|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101465178|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465179|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465180|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465182|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
101465183|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101465185|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465186|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465187|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
101465188|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465189|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465190|NCT04552951|Vitamin D|vitamin d|mesh-list
101465191|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
101465192|NCT04552951|Vitamins|vitamins|mesh-ancestor
101465193|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
101465194|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465195|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101465196|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465197|NCT02213419|Ethanol|ethanol|mesh-list
101465198|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101465199|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465200|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101359958|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101359959|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101359960|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359961|NCT00211744|Topiramate|topiramate|mesh-list
101359962|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
101465201|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465202|NCT00236093|Fentanyl|fentanyl|mesh-list
101465207|NCT00236093|Analgesics|analgesics|mesh-ancestor
101465208|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
101465209|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465210|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465211|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465212|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
101465213|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
101465214|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
101465215|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101465216|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465217|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
101465218|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
101465219|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465220|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465221|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465222|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
101465223|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101465224|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465225|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465227|NCT02213653|Trace Elements|trace elements|mesh-ancestor
101465228|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
101465229|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465230|NCT04552444|Biapenem|biapenem|mesh-list
101465231|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465232|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
101465233|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465234|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101465235|NCT02213848|Calcium|calcium|mesh-list
101465236|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465237|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465238|NCT00261573|Galantamine|galantamine|mesh-list
101465239|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101465240|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465241|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465242|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
101465243|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465244|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465245|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101465246|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
101465247|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465248|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
101465250|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465251|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101465252|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465253|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465254|NCT04541719|Remifentanil|remifentanil|mesh-list
101465255|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465256|NCT04541719|Narcotics|narcotics|mesh-ancestor
101465257|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465258|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465259|NCT04541719|Analgesics|analgesics|mesh-ancestor
101465260|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
101465261|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465262|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101465263|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
101465264|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465265|NCT00261612|Dexamethasone|dexamethasone|mesh-list
101465266|NCT00261612|Rituximab|rituximab|mesh-list
101465267|NCT00261612|Bortezomib|bortezomib|mesh-list
101465268|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101465269|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465270|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
101359963|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359964|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359965|NCT00211939|Atorvastatin|atorvastatin|mesh-list
101359966|NCT00211939|Calcium|calcium|mesh-list
101359967|NCT00211939|Sevelamer|sevelamer|mesh-list
101359968|NCT00211939|Calcium acetate|calcium acetate|mesh-list
101359969|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465271|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465272|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465273|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465274|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
101465275|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
101465278|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
101465279|NCT00261612|Hormones|hormones|mesh-ancestor
101465280|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465281|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101465282|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101465283|NCT04547764|Calcium|calcium|mesh-list
101465284|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465285|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465286|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465287|NCT04547608|Propofol|propofol|mesh-list
101465288|NCT04547608|Rocuronium|rocuronium|mesh-list
101465289|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101465290|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465291|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465292|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465293|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
101465294|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
101465295|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101465296|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101465297|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101465298|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465299|NCT00236249|Lidocaine|lidocaine|mesh-list
101465300|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
101465301|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
101465302|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465303|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465304|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
101465305|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465306|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101465307|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101465308|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101465309|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465310|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465312|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465313|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465314|NCT04547452|Antibodies|antibodies|mesh-list
101465315|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
101465316|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465317|NCT04547335|Voriconazole|voriconazole|mesh-list
101465318|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
101465319|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465320|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101465321|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465322|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465323|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465324|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101465325|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
101465326|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465327|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465328|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101465330|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101359970|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359971|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101359972|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101359973|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
101359974|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359975|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101465331|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
101465332|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465333|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101465334|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465335|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465336|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465337|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
101465338|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465339|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465340|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101465341|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465342|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465343|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101465344|NCT00236327|Fentanyl|fentanyl|mesh-list
101465348|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465349|NCT00236327|Analgesics|analgesics|mesh-ancestor
101465350|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
101465351|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465352|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465353|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465354|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
101465355|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
101465357|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465358|NCT00236366|Narcotics|narcotics|mesh-ancestor
101465359|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465360|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465361|NCT00236366|Analgesics|analgesics|mesh-ancestor
101465362|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
101465363|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465364|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465365|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465366|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
101465367|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
101465368|NCT04547179|Erenumab|erenumab|mesh-list
101465369|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101465370|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465371|NCT04547179|Analgesics|analgesics|mesh-ancestor
101465372|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
101465373|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465374|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465375|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
101465376|NCT00236405|Hematinics|hematinics|mesh-ancestor
101465377|NCT00236444|Risperidone|risperidone|mesh-list
101465378|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101465379|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
101465380|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465381|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465382|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465383|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101465384|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540763|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101465385|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465386|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465387|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101465388|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
101465390|NCT00269217|Niacinamide|niacinamide|mesh-list
101465391|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
101465392|NCT00269217|Simvastatin|simvastatin|mesh-list
101465393|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101465394|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101465395|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
101359976|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101359977|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359978|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
101359979|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
101359980|NCT00211978|Calcium|calcium|mesh-list
101359981|NCT00211978|Calcium acetate|calcium acetate|mesh-list
101359982|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101465396|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465397|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101465398|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101465399|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465400|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
101465401|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
101465402|NCT00269217|Vitamins|vitamins|mesh-ancestor
101465403|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
101465404|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465405|NCT04546282|Osimertinib|osimertinib|mesh-list
101465406|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465407|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101465408|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465409|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465410|NCT00236483|Acetaminophen|acetaminophen|mesh-list
101465411|NCT00236483|Tramadol|tramadol|mesh-list
101465412|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101465413|NCT00236483|Analgesics|analgesics|mesh-ancestor
101465414|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
101465415|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465416|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465417|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
101465428|NCT04545931|Coagulants|coagulants|mesh-ancestor
101465429|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101465430|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
101465431|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465432|NCT00236522|Levofloxacin|levofloxacin|mesh-list
101465433|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101465434|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465435|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465436|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101465437|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465438|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465439|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465440|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465441|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101465442|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465444|NCT00261729|Paroxetine|paroxetine|mesh-list
101465445|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101465446|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465447|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465448|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465449|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465450|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
101465451|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465452|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101465453|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
101465454|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465455|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101465456|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465457|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465458|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465459|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101465460|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101465461|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101465462|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101359983|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359984|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
101359985|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
101359986|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359987|NCT00212017|Voglibose|voglibose|mesh-list
101359988|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101359989|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359990|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101359991|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465463|NCT00236561|Topiramate|topiramate|mesh-list
101465464|NCT00236561|Propranolol|propranolol|mesh-list
101465465|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101465466|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101465467|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
101465468|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465469|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465470|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465471|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101465472|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465473|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
101465475|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465476|NCT02215330|Eplerenone|eplerenone|mesh-list
101465477|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101465478|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
101465479|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465480|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465487|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465488|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465489|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465490|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465492|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
101465493|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
101465494|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
101465495|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465496|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465497|NCT02214706|Sirolimus|sirolimus|mesh-list
101465498|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465499|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465500|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101465501|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465502|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
101465503|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101465504|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
101465505|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465506|NCT00236600|Topiramate|topiramate|mesh-list
101465507|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
101465508|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465509|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465510|NCT00236639|Topiramate|topiramate|mesh-list
101465511|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
101465512|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465513|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465515|NCT04545463|Cathartics|cathartics|mesh-ancestor
101465516|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465517|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
101465518|NCT00236678|Hematinics|hematinics|mesh-ancestor
101465519|NCT00269334|Paroxetine|paroxetine|mesh-list
101465520|NCT00269334|Citalopram|citalopram|mesh-list
101465521|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101465522|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465523|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465524|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465525|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101359992|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359993|NCT00212095|Ketoconazole|ketoconazole|mesh-list
101359994|NCT00212095|Docetaxel|docetaxel|mesh-list
101359995|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359996|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101465526|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
101465527|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465528|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101465529|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
101465530|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465531|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101465532|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465533|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465534|NCT04541251|Paclitaxel|paclitaxel|mesh-list
101465535|NCT04541251|Carboplatin|carboplatin|mesh-list
101465536|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101465537|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465538|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
101465539|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
101465540|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
101465541|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465542|NCT00236717|Topiramate|topiramate|mesh-list
101465543|NCT00236717|Carbamazepine|carbamazepine|mesh-list
101465544|NCT00236717|Valproic Acid|valproic acid|mesh-list
101465545|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
101465546|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465547|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465548|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465549|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465550|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
101465551|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465555|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465556|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101465558|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
101465559|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465560|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101465561|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465562|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101465563|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101465564|NCT00236756|Topiramate|topiramate|mesh-list
101465565|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
101465566|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465567|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465568|NCT00269412|Rifaximin|rifaximin|mesh-list
101465569|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465570|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465571|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465572|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101465573|NCT00236795|Norelgestromin|norelgestromin|mesh-list
101465574|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101465575|NCT00236795|Estradiol|estradiol|mesh-list
101465576|NCT00236795|Estrogens|estrogens|mesh-ancestor
101465577|NCT00236795|Hormones|hormones|mesh-ancestor
101465578|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465579|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465580|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101465581|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
101465582|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465583|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101465584|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101465585|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101465586|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101465587|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101465588|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101465589|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101465590|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101465592|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
101465593|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465594|NCT00236834|Levofloxacin|levofloxacin|mesh-list
101465595|NCT00236834|Imipenem|imipenem|mesh-list
101359997|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359998|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359999|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360000|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
101360001|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465596|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101465597|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465598|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465599|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101465600|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465601|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465602|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465603|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465604|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101465605|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465606|NCT00236873|Topiramate|topiramate|mesh-list
101465607|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
101465608|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465609|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465611|NCT00236912|Levofloxacin|levofloxacin|mesh-list
101465612|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465613|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465614|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101465615|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101465616|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101465617|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101465618|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101465619|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465620|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465621|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465622|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101465624|NCT02215447|Paclitaxel|paclitaxel|mesh-list
101465625|NCT02215447|Carboplatin|carboplatin|mesh-list
101465626|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101465627|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465628|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
101465629|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
101465630|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
101465631|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465633|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
101465634|NCT00237068|Lansoprazole|lansoprazole|mesh-list
101465635|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
101465636|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101465637|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465638|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101465639|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465640|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465641|NCT00269568|Misoprostol|misoprostol|mesh-list
101465642|NCT00269568|Mifepristone|mifepristone|mesh-list
101465643|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101465644|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
101465645|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465646|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465647|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101465648|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465649|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
101465650|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101465651|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101465652|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101465653|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101465654|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
101465655|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101465656|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101465657|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
101465658|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101360002|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101360003|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101360004|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360005|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101360006|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
101360007|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465659|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
101465660|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101465661|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101465662|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
101465663|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101465664|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465667|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465668|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101465669|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101465670|NCT04544059|Growth Substances|growth substances|mesh-ancestor
101465671|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
101465672|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465673|NCT00269607|Naltrexone|naltrexone|mesh-list
101465674|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101465675|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101465676|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465677|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
101465678|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465679|NCT00237224|Letrozole|letrozole|mesh-list
101465680|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465681|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101465682|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101465683|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465684|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465685|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101465686|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
101465687|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101465688|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465689|NCT00237263|Entacapone|entacapone|mesh-list
101465690|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101465691|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101465692|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101465693|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540875|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465694|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465700|NCT00262275|Clopidogrel|clopidogrel|mesh-list
101465701|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101465702|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101465703|NCT00262275|Analgesics|analgesics|mesh-ancestor
101465704|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
101465705|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465706|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465707|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465708|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465709|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101465710|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101465711|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465712|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101465713|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101465714|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465715|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
101465716|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101465717|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101465718|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101465719|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
101360008|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360009|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101360010|NCT00212173|Sibutramine|sibutramine|mesh-list
101360011|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360012|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360013|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
101360014|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101360016|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
101360017|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360018|NCT00212212|Protective Agents|protective agents|mesh-ancestor
101360019|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360020|NCT00212212|Trace Elements|trace elements|mesh-ancestor
101465720|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465721|NCT02214979|Telmisartan|telmisartan|mesh-list
101465722|NCT02214979|Ramipril|ramipril|mesh-list
101465723|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465724|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101465725|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101465726|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465727|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101465728|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
101465729|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465730|NCT00237341|Fentanyl|fentanyl|mesh-list
101465731|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465732|NCT00237341|Narcotics|narcotics|mesh-ancestor
101465733|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465734|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465735|NCT00237341|Analgesics|analgesics|mesh-ancestor
101465736|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
101465737|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465738|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465739|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465740|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
101465741|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
101465742|NCT04539301|Anticoagulants|anticoagulants|mesh-list
101465743|NCT00237419|Infliximab|infliximab|mesh-list
101465744|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101465745|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465746|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101465747|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465748|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465749|NCT04539106|Ranibizumab|ranibizumab|mesh-list
101465750|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101465751|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101465752|NCT04539106|Growth Substances|growth substances|mesh-ancestor
101465753|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465754|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
101465755|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465756|NCT00237497|Zopiclone|zopiclone|mesh-list
101465757|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101465758|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465759|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465760|NCT00416130|Vorinostat|vorinostat|mesh-list
101465761|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465762|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101465763|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465764|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465765|NCT00416169|Galantamine|galantamine|mesh-list
101465769|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
101465770|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465771|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360022|NCT00212290|Pioglitazone|pioglitazone|mesh-list
101360023|NCT00212290|Nateglinide|nateglinide|mesh-list
101360024|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101360025|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360026|NCT00073203|Paroxetine|paroxetine|mesh-list
101360027|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101360028|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101360029|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465772|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101465773|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
101465774|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465775|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
101465776|NCT00237536|Lonidamine|lonidamine|mesh-list
101465777|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465778|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101465779|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465780|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101465781|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
101465782|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465783|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101465784|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101465785|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101465786|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465787|NCT02215720|Sirolimus|sirolimus|mesh-list
101465788|NCT02215720|Cetuximab|cetuximab|mesh-list
101465789|NCT02215720|Temsirolimus|temsirolimus|mesh-list
101465790|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
101465791|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101465792|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465793|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101465794|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465795|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465796|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101465797|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
101465798|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465799|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465800|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465801|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101465802|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
101465803|NCT00416208|Bortezomib|bortezomib|mesh-list
101465804|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465805|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101465806|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101465807|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465808|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465809|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465810|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465811|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465812|NCT02215798|Analgesics|analgesics|mesh-ancestor
101465813|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
101465814|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465815|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
101465816|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465817|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
101465818|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101465819|NCT02215057|Lidocaine|lidocaine|mesh-list
101465820|NCT02215057|Anesthetics|anesthetics|mesh-list
101465821|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
101465822|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465823|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465824|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
101465825|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465826|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101360030|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360031|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360032|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
101360033|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360034|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101360035|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360036|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465827|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101465828|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101465829|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465830|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465831|NCT00269685|Vasopressins|vasopressins|mesh-list
101465832|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
101465833|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
101465834|NCT00269685|Coagulants|coagulants|mesh-ancestor
101465835|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101465836|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101465856|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465858|NCT04539418|Coagulants|coagulants|mesh-ancestor
101465859|NCT00269724|Oxybutynin|oxybutynin|mesh-list
101465860|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
101465861|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
101465862|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465863|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465864|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101465865|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101465866|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
101465867|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465868|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465869|NCT00269724|Urological Agents|urological agents|mesh-ancestor
101465870|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101465871|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
101465872|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
101465873|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101465874|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101465875|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465876|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
101465877|NCT04710017|Coagulants|coagulants|mesh-ancestor
101465878|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101465879|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101465880|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101465881|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
101465882|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101465883|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465884|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101465885|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101465886|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101465887|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101465888|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465889|NCT04538521|Niacin|niacin|mesh-list
101465890|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
101465891|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101465894|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101465895|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
101465896|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
101465898|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
101465899|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465900|NCT00269763|Fentanyl|fentanyl|mesh-list
101465901|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465902|NCT00269763|Narcotics|narcotics|mesh-ancestor
101465903|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465904|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465905|NCT00269763|Analgesics|analgesics|mesh-ancestor
101465906|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
101465907|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360037|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101360038|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101360039|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465908|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101465909|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101465910|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
101465911|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
101465912|NCT00237575|Gemcitabine|gemcitabine|mesh-list
101465913|NCT00237575|Sargramostim|sargramostim|mesh-list
101465914|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465915|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101465916|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
101465917|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465918|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
101465919|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465920|NCT00269802|Methylphenidate|methylphenidate|mesh-list
101465921|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101465922|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465923|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101465924|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465925|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465926|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465927|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
101465928|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465929|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101465930|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101465931|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101465932|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
101465933|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465934|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101465935|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101465936|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465937|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
101465938|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101465939|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
101465940|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465941|NCT00237614|Expectorants|expectorants|mesh-ancestor
101465942|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
101465943|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101465944|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
101465945|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465946|NCT00237614|Protective Agents|protective agents|mesh-ancestor
101465947|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465948|NCT00237614|Antidotes|antidotes|mesh-ancestor
101465949|NCT00269841|Infliximab|infliximab|mesh-list
101465950|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101465951|NCT00269841|Antibodies|antibodies|mesh-list
101465952|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
101465953|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101465954|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
101465955|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465956|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465957|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101465958|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101465959|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
101465960|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465961|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465962|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
101465963|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
101465964|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101465978|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465979|NCT04538365|Triclosan|triclosan|mesh-list
101465980|NCT04538365|Propranolol|propranolol|mesh-list
101465981|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101465982|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101465983|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101465984|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101465985|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101465986|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
101465987|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465988|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101360042|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360043|NCT00212602|Aprepitant|aprepitant|mesh-list
101360044|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
101360045|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
101360046|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
101360047|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465989|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101465990|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101465991|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
101465992|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465993|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465994|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101465995|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465996|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
101465997|NCT00414245|Metformin|metformin|mesh-list
101465998|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465999|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466000|NCT00269880|Heparin|heparin|mesh-list
101466001|NCT00269880|Abciximab|abciximab|mesh-list
101466002|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
101466003|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101466004|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101466005|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466006|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466007|NCT00237653|Valganciclovir|valganciclovir|mesh-list
101466008|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
101466009|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466010|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
101466011|NCT00269958|Hematinics|hematinics|mesh-ancestor
101466012|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
101466013|NCT02215876|Doxorubicin|doxorubicin|mesh-list
101466014|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466015|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
101466016|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466017|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466018|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101466019|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
101466020|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466021|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466022|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101466023|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466024|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101466025|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101466030|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101466031|NCT00237731|Narcotics|narcotics|mesh-ancestor
101466032|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466033|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466034|NCT00237731|Analgesics|analgesics|mesh-ancestor
101466035|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
101466036|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466037|NCT04542226|Bromides|bromides|mesh-list
101466038|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
101466040|NCT00270036|Hematinics|hematinics|mesh-ancestor
101466041|NCT00262392|Pamidronate|pamidronate|mesh-list
101466042|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101466043|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466044|NCT04537780|Montelukast|montelukast|mesh-list
101466045|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466046|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466047|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101466048|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466049|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466050|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466051|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101466052|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101540897|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360048|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360049|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360050|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101360051|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360052|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360054|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101466053|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466054|NCT00237887|Adalimumab|adalimumab|mesh-list
101466055|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101466056|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466057|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466058|NCT02215993|Ticagrelor|ticagrelor|mesh-list
101466059|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101466060|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466061|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101466062|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101466063|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101466064|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
101466065|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466066|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466067|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466068|NCT02216149|Capecitabine|capecitabine|mesh-list
101466069|NCT02216149|Tegafur|tegafur|mesh-list
101466070|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
101466071|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101466072|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
101466073|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466074|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466075|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
101466077|NCT00238004|Niacinamide|niacinamide|mesh-list
101466078|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
101466079|NCT00238004|Vitamins|vitamins|mesh-ancestor
101466080|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
101466081|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466082|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101466083|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
101466084|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466085|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101466086|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
101466087|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101466088|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101466089|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101466090|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
101466091|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466092|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101466093|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101466094|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466095|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
101466096|NCT00238043|Hematinics|hematinics|mesh-ancestor
101466097|NCT00415584|Cinacalcet|cinacalcet|mesh-list
101466098|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101466099|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466103|NCT04536922|Aldesleukin|aldesleukin|mesh-list
101466104|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
101466105|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
101466106|NCT04536922|Fludarabine|fludarabine|mesh-list
101466107|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466108|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
101466109|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466110|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466111|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101466112|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
101466113|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466114|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466115|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101360055|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101360056|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
101466116|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466118|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101466119|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101466120|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
101466122|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
101466124|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101466125|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466126|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101466127|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
101466128|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
101466129|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466130|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466131|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466132|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466133|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101466134|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466135|NCT00238160|Fluorouracil|fluorouracil|mesh-list
101466136|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466137|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
101466138|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466139|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101466140|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466141|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
101466142|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466143|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
101466145|NCT00415701|Etomidate|etomidate|mesh-list
101466146|NCT00415701|Cosyntropin|cosyntropin|mesh-list
101466147|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101466148|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466149|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466150|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101466151|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
101466152|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
101466153|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466154|NCT00415701|Hormones|hormones|mesh-ancestor
101466155|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466156|NCT02961998|Celecoxib|celecoxib|mesh-list
101466157|NCT02961998|Sorafenib|sorafenib|mesh-list
101466158|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466159|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101466160|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466161|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466162|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101466163|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466164|NCT02961998|Analgesics|analgesics|mesh-ancestor
101466165|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
101466166|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466167|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466168|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466169|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466170|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101466171|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466176|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466177|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101466179|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
101466180|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466181|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466182|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466183|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466184|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
101466185|NCT00262587|Hormones|hormones|mesh-ancestor
101466186|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466188|NCT00238199|Calcitriol|calcitriol|mesh-list
101466189|NCT00238199|Docetaxel|docetaxel|mesh-list
101466190|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466191|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101466192|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101466193|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101360057|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360058|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360059|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360060|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101360061|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
101360062|NCT00212875|Hematinics|hematinics|mesh-ancestor
101360063|NCT00213070|Miglitol|miglitol|mesh-list
101360064|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541043|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101360065|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360066|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101466194|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466195|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101466196|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466197|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101466198|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466199|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101466200|NCT00238199|Vitamins|vitamins|mesh-ancestor
101466201|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
101466202|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101466203|NCT04536493|Lidocaine|lidocaine|mesh-list
101466204|NCT04536493|Epinephrine|epinephrine|mesh-list
101466205|NCT04536493|Racepinephrine|racepinephrine|mesh-list
101466206|NCT04536493|Tetracaine|tetracaine|mesh-list
101466207|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
101466208|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
101466209|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
101466210|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466211|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466212|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
101466213|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466214|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101466215|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101466216|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101466217|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466218|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466219|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101466220|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101466221|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101466222|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466223|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101466224|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101466225|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
101466226|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466227|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466228|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
101466229|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
101466230|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101466231|NCT04536181|Prednisone|prednisone|mesh-list
101466232|NCT04536181|Prednisolone|prednisolone|mesh-list
101466233|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466234|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
101466235|NCT04536181|Hormones|hormones|mesh-ancestor
101466236|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466237|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466238|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101466239|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466240|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
101466241|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
101466242|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466243|NCT02216227|Iodine|iodine|mesh-list
101466244|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
101466252|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466253|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
101466254|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466255|NCT02216227|Trace Elements|trace elements|mesh-ancestor
101466256|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
101360067|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360068|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101360069|NCT00213109|Miglitol|miglitol|mesh-list
101360070|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360071|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360072|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101466257|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466258|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466259|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
101466260|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
101466261|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101466262|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466263|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466264|NCT00238277|Temozolomide|temozolomide|mesh-list
101466265|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101466266|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
101466267|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466268|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466269|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101466270|NCT02216266|Physostigmine|physostigmine|mesh-list
101466271|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101466272|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466273|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466274|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
101466275|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466276|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466277|NCT02216266|Miotics|miotics|mesh-ancestor
101466278|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
101466279|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466280|NCT00238316|Letrozole|letrozole|mesh-list
101466281|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466282|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101466283|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101466284|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466285|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466286|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101466287|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466288|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466289|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466290|NCT04535518|Aspirin|aspirin|mesh-list
101466291|NCT04535518|Infliximab|infliximab|mesh-list
101466292|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
101466293|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101466294|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
101466295|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101466296|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101466297|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466298|NCT04535518|Analgesics|analgesics|mesh-ancestor
101466299|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
101466300|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466301|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466302|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466303|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466304|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101466305|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101466306|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466307|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466308|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466309|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466310|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
101466311|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
101466312|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101466313|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466314|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466327|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466328|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101360073|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360074|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101360075|NCT00213226|Dexamethasone|dexamethasone|mesh-list
101360076|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360077|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
101360078|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
101466329|NCT00238472|Nateglinide|nateglinide|mesh-list
101466330|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101466331|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466332|NCT00238628|Bexarotene|bexarotene|mesh-list
101466333|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466334|NCT02216617|Docetaxel|docetaxel|mesh-list
101466335|NCT02216617|Afatinib|afatinib|mesh-list
101466336|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466337|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
101466338|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
101466339|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
101466340|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466341|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101466342|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466344|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101466345|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466346|NCT00262977|Analgesics|analgesics|mesh-ancestor
101466348|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466349|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466350|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466351|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466352|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101466353|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101466354|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466355|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466356|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466357|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466358|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
101466359|NCT00238667|Aspirin|aspirin|mesh-list
101466360|NCT00238667|Heparin|heparin|mesh-list
101466361|NCT00238667|Calcium heparin|calcium heparin|mesh-list
101466362|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101466363|NCT00238667|Dalteparin|dalteparin|mesh-list
101466364|NCT00238667|Dipyridamole|dipyridamole|mesh-list
101466365|NCT00238667|Warfarin|warfarin|mesh-list
101466366|NCT00238667|Anticoagulants|anticoagulants|mesh-list
101466367|NCT00238667|Clopidogrel|clopidogrel|mesh-list
101466368|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101466369|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466370|NCT00238667|Analgesics|analgesics|mesh-ancestor
101466371|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
101466372|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466373|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466374|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466375|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466376|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101466377|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101466378|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466379|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466380|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466381|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466382|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
101466394|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101466395|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466396|NCT04534465|Mannitol|mannitol|mesh-list
101466397|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101466398|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101466399|NCT04534465|Diuretics|diuretics|mesh-ancestor
101466400|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
101466401|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466402|NCT04534465|Laxatives|laxatives|mesh-ancestor
101466403|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466404|NCT02216656|Cinacalcet|cinacalcet|mesh-list
101466405|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101466406|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360079|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360080|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360081|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360082|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
101360083|NCT00213226|Hormones|hormones|mesh-ancestor
101360084|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101360085|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101360086|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360087|NCT00213265|Vaccines|vaccines|mesh-list
101466407|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101466408|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466409|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466410|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
101466411|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466412|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
101466413|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101466414|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101466415|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466416|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466417|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466418|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101466420|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101466421|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
101466422|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466423|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466424|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101466425|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101466426|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
101466427|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466428|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466429|NCT00263094|Rofecoxib|rofecoxib|mesh-list
101466430|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101466431|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466432|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466433|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466434|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101466435|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466436|NCT00263094|Analgesics|analgesics|mesh-ancestor
101466437|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
101466438|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466439|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466440|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466441|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466442|NCT00238784|Budesonide|budesonide|mesh-list
101466443|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
101466444|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466445|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101466454|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101466455|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101466456|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101466457|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
101466458|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466459|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466461|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
101466462|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101466463|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101466464|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101466465|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466466|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466467|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360088|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101360089|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
101360090|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360091|NCT00213538|Methotrexate|methotrexate|mesh-list
101360092|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101466468|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
101466470|NCT04533724|Amisulpride|amisulpride|mesh-list
101466471|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101466472|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101466473|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466474|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466475|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101466476|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101466477|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
101413638|NCT05062356|Ketorolac|ketorolac|mesh-list
101466478|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466479|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466480|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101466481|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
101466482|NCT00238901|Basiliximab|basiliximab|mesh-list
101466483|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466484|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
101466485|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466486|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
101466487|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466489|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101466490|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
101466491|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466492|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466493|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466494|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466495|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
101466496|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466497|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466498|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101466499|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
101466500|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466501|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466502|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466503|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466504|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
101466505|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466506|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466507|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101466508|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
101466511|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466512|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466513|NCT04532671|Ether|ether|mesh-list
101466514|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101466515|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
101466516|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
101466517|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466518|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466519|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
101466520|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466521|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466522|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101466523|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
101466524|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466525|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466526|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466527|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466528|NCT00238082|Beclomethasone|beclomethasone|mesh-list
101466529|NCT00238082|Norflurane|norflurane|mesh-list
101466530|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360093|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101360094|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
101466531|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
101466532|NCT00238082|Hormones|hormones|mesh-ancestor
101466533|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466534|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466535|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466536|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466537|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
101466538|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466539|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
101466540|NCT02217007|Acamprosate|acamprosate|mesh-list
101466541|NCT02217007|Calcium|calcium|mesh-list
101466542|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101466543|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466544|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101466545|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101466546|NCT05897658|Levetiracetam|levetiracetam|mesh-list
101466547|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
101466548|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
101466549|NCT05897385|Lidocaine|lidocaine|mesh-list
101466550|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
101466551|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
101466552|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466553|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466554|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
101466555|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466556|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101466557|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101466558|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101466559|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466560|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466562|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101466563|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466564|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466565|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101466566|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101466567|NCT05897372|Protective Agents|protective agents|mesh-ancestor
101466568|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466569|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
101466570|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101466571|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
101466572|NCT05897307|Ropivacaine|ropivacaine|mesh-list
101466573|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
101466574|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
101466575|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466576|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466577|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
101466578|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466579|NCT05897294|Voriconazole|voriconazole|mesh-list
101466580|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
101466581|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466589|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466590|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101466591|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101466592|NCT05897086|Laxatives|laxatives|mesh-ancestor
101466593|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466594|NCT05896943|Ustekinumab|ustekinumab|mesh-list
101466595|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466596|NCT05896930|Amoxicillin|amoxicillin|mesh-list
101466598|NCT05896930|Meropenem|meropenem|mesh-list
101466599|NCT05896930|Ertapenem|ertapenem|mesh-list
101466600|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466601|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466602|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101466603|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
101466604|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
101466605|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101466606|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466607|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466608|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101360095|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101360096|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360097|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360098|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
101360099|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360100|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360101|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360102|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360103|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101360104|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466609|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101466610|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101466611|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101466612|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101466613|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101466614|NCT05896839|Sirolimus|sirolimus|mesh-list
101466615|NCT05896839|Prednisone|prednisone|mesh-list
101466616|NCT05896839|Cortisone|cortisone|mesh-list
101466617|NCT05896839|Nivolumab|nivolumab|mesh-list
101466618|NCT05896839|Ipilimumab|ipilimumab|mesh-list
101466619|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466620|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
101466621|NCT05896839|Hormones|hormones|mesh-ancestor
101466622|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466623|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466624|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101466625|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466626|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466627|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101466628|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466629|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466630|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466631|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101466632|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
101466633|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466634|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
101466635|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
101466636|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101466637|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
101466638|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466639|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466640|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466641|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466642|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101466643|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
101466644|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466645|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466648|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
101466649|NCT05896800|Protective Agents|protective agents|mesh-ancestor
101466650|NCT05896787|Paclitaxel|paclitaxel|mesh-list
101466651|NCT05896787|Carboplatin|carboplatin|mesh-list
101466652|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101466653|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466654|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101466655|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101466656|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101466657|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466658|NCT05896761|Rilpivirine|rilpivirine|mesh-list
101466659|NCT05896761|Cabotegravir|cabotegravir|mesh-list
101466660|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101466661|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101466662|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360105|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
101360106|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360107|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101360108|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
101360109|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101466663|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466664|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
101466665|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466666|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101466667|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101466668|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101466669|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101466670|NCT05896748|Rilpivirine|rilpivirine|mesh-list
101466671|NCT05896748|Cabotegravir|cabotegravir|mesh-list
101466672|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101466673|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101466674|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466675|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466676|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
101466677|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466678|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101466679|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101466680|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101466681|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101466682|NCT05896631|Bupivacaine|bupivacaine|mesh-list
101466683|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
101466684|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
101466685|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466686|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466687|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
101466688|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466689|NCT05896605|Azathioprine|azathioprine|mesh-list
101466690|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
101466691|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466692|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101466693|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466694|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466695|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
101466696|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466697|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466698|NCT05896553|Oxytocin|oxytocin|mesh-list
101466699|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
101466700|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101466701|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466702|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
101466704|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
101466705|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
101466706|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101466707|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466708|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101466709|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101466710|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466711|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
101466712|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101466713|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
101466714|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466715|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
101466716|NCT05896319|Protective Agents|protective agents|mesh-ancestor
101466717|NCT05896059|Tislelizumab|tislelizumab|mesh-list
101466718|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466719|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466721|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
101466722|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466723|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
101466724|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466725|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101360111|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360112|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360113|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360114|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360115|NCT00213694|Celecoxib|celecoxib|mesh-list
101360116|NCT00213694|Docetaxel|docetaxel|mesh-list
101466726|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466727|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466728|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
101466729|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101466730|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101466731|NCT05893771|Prednisolone|prednisolone|mesh-list
101466732|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
101466733|NCT05893771|Bupivacaine|bupivacaine|mesh-list
101466734|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101466735|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
101466736|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
101466737|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
101466738|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466739|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466740|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
101466741|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466742|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466743|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
101466744|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
101466745|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466746|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
101466747|NCT05893771|Hormones|hormones|mesh-ancestor
101466748|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466749|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101466750|NCT05893771|Protective Agents|protective agents|mesh-ancestor
101466751|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101466752|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466753|NCT05876715|Nivolumab|nivolumab|mesh-list
101466754|NCT05876715|Ipilimumab|ipilimumab|mesh-list
101466755|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466756|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466757|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101466758|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466759|NCT05867849|Cannabidiol|cannabidiol|mesh-list
101466760|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
101466761|NCT05853120|Doxycycline|doxycycline|mesh-list
101466762|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466763|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466764|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
101466765|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101466766|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101466767|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
101466768|NCT05841160|Ecopipam|ecopipam|mesh-list
101466769|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466770|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466771|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101466772|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101466773|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466774|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466775|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466776|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466777|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101466778|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101466779|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466780|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101466781|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101466782|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
101466783|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466784|NCT05815758|Ketotifen|ketotifen|mesh-list
101466785|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101466786|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101466787|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101466788|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101466789|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101360117|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360118|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
101360119|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
101360120|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
101360121|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360122|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101360123|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360125|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
101466790|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101466791|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101466792|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101466793|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466794|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466796|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
101466797|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101466798|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101466799|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
101466800|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
101466801|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101466802|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101466803|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101466804|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101466805|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466806|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466807|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466808|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466809|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101466810|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
101466811|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101466813|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101466814|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101466815|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466816|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466817|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101466818|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101466819|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101466820|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101466821|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
101466822|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
101466823|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
101466824|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
101466825|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466826|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466827|NCT05681390|Tislelizumab|tislelizumab|mesh-list
101466828|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466829|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466830|NCT05669547|Hormones|hormones|mesh-list
101541077|NCT02213159|Morphine|morphine|mesh-list
101466831|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466833|NCT05669079|Decitabine|decitabine|mesh-list
101466834|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
101466835|NCT05669079|Lenograstim|lenograstim|mesh-list
101466836|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101466837|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
101466838|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466839|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466840|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466841|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101466842|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
101466843|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466844|NCT05669079|Hematinics|hematinics|mesh-ancestor
101466845|NCT05661188|Atezolizumab|atezolizumab|mesh-list
101466846|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101360126|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360127|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360128|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360130|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101360131|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101360132|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360133|NCT00214084|Allopurinol|allopurinol|mesh-list
101360134|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
101466847|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466848|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466849|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466850|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
101466851|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101466852|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466853|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466854|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466855|NCT05658510|Analgesics|analgesics|mesh-ancestor
101466856|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
101466857|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466858|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101466859|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101466860|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101466861|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
101466862|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466863|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466864|NCT05611905|Probenecid|probenecid|mesh-list
101466865|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
101466866|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
101466880|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466881|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
101466882|NCT05579626|Ezetimibe|ezetimibe|mesh-list
101466883|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101466884|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101466885|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101466886|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
101466887|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466888|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101466889|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466890|NCT05455658|Vaccines|vaccines|mesh-list
101466891|NCT05455658|Sargramostim|sargramostim|mesh-list
101466892|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
101466893|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466894|NCT05442567|Vedolizumab|vedolizumab|mesh-list
101466895|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466896|NCT05434546|Pregnanolone|pregnanolone|mesh-list
101466897|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
101466898|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466899|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466900|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
101466901|NCT05400122|Fludarabine|fludarabine|mesh-list
101466902|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
101466903|NCT05400122|Vactosertib|vactosertib|mesh-list
101466904|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101466905|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
101466906|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466907|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466908|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101466909|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
101466910|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466911|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466912|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101466913|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101466914|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
101360135|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360136|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360137|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
101360138|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360139|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101360141|NCT00214084|Protective Agents|protective agents|mesh-ancestor
101360142|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360143|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
101360144|NCT00214240|Antibodies|antibodies|mesh-list
101360145|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
101360146|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101360147|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101360148|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
101360149|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360150|NCT00214318|Metoprolol|metoprolol|mesh-list
101360151|NCT00214318|Carvedilol|carvedilol|mesh-list
101360152|NCT00214318|Terbutaline|terbutaline|mesh-list
101360153|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101360154|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101360155|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
101360156|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
101360157|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360158|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466915|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101466916|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466917|NCT05386472|Ritonavir|ritonavir|mesh-list
101466918|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
101466919|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101466920|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101466921|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
101466922|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466923|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466924|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101466925|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101466926|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
101466927|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466928|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101466929|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101466941|NCT05359939|Choline|choline|mesh-list
101466942|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
101466943|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101466944|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
101466945|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360159|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101360161|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101360162|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360163|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360164|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360165|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
101466946|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101466947|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101466948|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
101466949|NCT05251909|Benralizumab|benralizumab|mesh-list
101466950|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466951|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466952|NCT05250791|Lidocaine|lidocaine|mesh-list
101466954|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
101466955|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466956|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466957|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
101466958|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466959|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101466960|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101466961|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101466962|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101466963|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466964|NCT05241873|Carboplatin|carboplatin|mesh-list
101466965|NCT05241873|Pemetrexed|pemetrexed|mesh-list
101466966|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466967|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466968|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466969|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101466970|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101466971|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
101466972|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101466973|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466974|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101466975|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466976|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
101466977|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
101466978|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466979|NCT05145764|Suvorexant|suvorexant|mesh-list
101466980|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101466981|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101466982|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101466983|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466984|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101466985|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466986|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466987|NCT05276973|Paclitaxel|paclitaxel|mesh-list
101466988|NCT05276973|Carboplatin|carboplatin|mesh-list
101466989|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101466990|NCT05276973|Ipatasertib|ipatasertib|mesh-list
101466991|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101466992|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466993|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
101466994|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
101466995|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
101466996|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466997|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101466998|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466999|NCT05085496|Atezolizumab|atezolizumab|mesh-list
101467011|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
101467012|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467013|NCT04983836|Anesthetics|anesthetics|mesh-list
101467014|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360166|NCT00214318|Protective Agents|protective agents|mesh-ancestor
101360167|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101360168|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467015|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467017|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467018|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101467019|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
101467020|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467021|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467022|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101467023|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
101467024|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
101467025|NCT04933383|Hormones|hormones|mesh-ancestor
101467028|NCT04923776|Etoposide|etoposide|mesh-list
101467029|NCT04923776|Atezolizumab|atezolizumab|mesh-list
101467030|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467031|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101467032|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101467033|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101467034|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467035|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467036|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467037|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467038|NCT04899583|Sirolimus|sirolimus|mesh-list
101467039|NCT04899583|Paclitaxel|paclitaxel|mesh-list
101467040|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101467041|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467042|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
101467043|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
101467044|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
101467045|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467046|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467047|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467048|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101467049|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
101467050|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101467051|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
101467052|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467053|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
101467054|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101467055|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
101467056|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467057|NCT04868565|Caffeine|caffeine|mesh-list
101467058|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
101467059|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467060|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101467062|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101467063|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467064|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101467065|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101467066|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
101467067|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467068|NCT04716881|Naltrexone|naltrexone|mesh-list
101467069|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101467070|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101467071|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467072|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
101467073|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467074|NCT04711824|Paclitaxel|paclitaxel|mesh-list
101467075|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101467076|NCT04711824|Cisplatin|cisplatin|mesh-list
101467077|NCT04711824|Carboplatin|carboplatin|mesh-list
101467078|NCT04711824|Gemcitabine|gemcitabine|mesh-list
101467079|NCT04711824|Capecitabine|capecitabine|mesh-list
101467080|NCT04711824|Durvalumab|durvalumab|mesh-list
101467081|NCT04711824|Olaparib|olaparib|mesh-list
101467082|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101467083|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360169|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101360170|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
101360171|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101360172|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101360173|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101467085|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
101467086|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
101467087|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467088|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101467089|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
101467090|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467091|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467092|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467093|NCT04589845|Trastuzumab|trastuzumab|mesh-list
101467094|NCT04589845|Atezolizumab|atezolizumab|mesh-list
101467095|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101467097|NCT04589845|Ipatasertib|ipatasertib|mesh-list
101467098|NCT04589845|Pralsetinib|pralsetinib|mesh-list
101467099|NCT04589845|Entrectinib|entrectinib|mesh-list
101467100|NCT04589845|Inavolisib|inavolisib|mesh-list
101467101|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467102|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467103|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467104|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467105|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101467106|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101467107|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101467108|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101467109|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
101467110|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
101467111|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
101467112|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467113|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467114|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467115|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101467116|NCT04582266|Remdesivir|remdesivir|mesh-list
101467117|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
101467118|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467119|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
101467120|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467121|NCT04528134|Listerine|listerine|mesh-list
101467122|NCT04528134|Fluorides|fluorides|mesh-list
101467123|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
101467124|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
101467125|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
101467126|NCT04528134|Protective Agents|protective agents|mesh-ancestor
101467127|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467128|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101467129|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467130|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101467131|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101467132|NCT04521920|Narcotics|narcotics|mesh-ancestor
101467133|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467134|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467135|NCT04521920|Analgesics|analgesics|mesh-ancestor
101467136|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
101467137|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467140|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101467141|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
101467142|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467143|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467144|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467145|NCT04452877|Trametinib|trametinib|mesh-list
101467146|NCT04452877|Dabrafenib|dabrafenib|mesh-list
101467147|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467148|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467149|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467150|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467151|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
101360174|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360175|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360177|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
101360178|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101360179|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101467153|NCT04613596|Adagrasib|adagrasib|mesh-list
101467154|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467155|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467156|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467157|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467158|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467159|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101467160|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101467162|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101467163|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101467164|NCT04381143|Analgesics|analgesics|mesh-ancestor
101467165|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
101467166|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467167|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467168|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467169|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101467170|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101467171|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101467172|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467173|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101467174|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101467175|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467177|NCT04370093|Pioglitazone|pioglitazone|mesh-list
101467178|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101467179|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467180|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
101467181|NCT04298229|Diuretics|diuretics|mesh-list
101467182|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101467183|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467184|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101467185|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467186|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
101467187|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
101467188|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101467189|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101467190|NCT04177433|Prednisolone|prednisolone|mesh-list
101467191|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
101467192|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101467193|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
101467194|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467195|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
101467196|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
101467197|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467198|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467199|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467200|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
101467201|NCT04177433|Hormones|hormones|mesh-ancestor
101467202|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467203|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101467204|NCT04177433|Protective Agents|protective agents|mesh-ancestor
101467205|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467206|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467207|NCT04166383|Nivolumab|nivolumab|mesh-list
101467208|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467209|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467210|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467218|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467219|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
101467220|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101467221|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101360180|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101360181|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360182|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101360183|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
101360184|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467222|NCT04101877|Bevacizumab|bevacizumab|mesh-list
101467223|NCT04101877|Aflibercept|aflibercept|mesh-list
101467224|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467225|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467226|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101467227|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467228|NCT04101877|Growth Substances|growth substances|mesh-ancestor
101467229|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467230|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
101467231|NCT04101838|Vaccines|vaccines|mesh-list
101467232|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
101467233|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467234|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
101467235|NCT04026958|Clarithromycin|clarithromycin|mesh-list
101467236|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467237|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467238|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101467239|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467240|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467241|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101467242|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101467243|NCT04024254|Folic Acid|folic acid|mesh-list
101467244|NCT04024254|Hematinics|hematinics|mesh-ancestor
101467245|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
101467246|NCT04024254|Vitamins|vitamins|mesh-ancestor
101467247|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
101467248|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467250|NCT04023331|Trace Elements|trace elements|mesh-ancestor
101467251|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
101467252|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467253|NCT03939182|Abexinostat|abexinostat|mesh-list
101467254|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101467255|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467256|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467257|NCT03887702|Tenofovir|tenofovir|mesh-list
101467258|NCT03887702|Entecavir|entecavir|mesh-list
101467259|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
101467260|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467261|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101467262|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101467263|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467264|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467265|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101467266|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101467267|NCT03878589|Oxytocin|oxytocin|mesh-list
101467268|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
101467269|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101467270|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467271|NCT03875287|Decitabine|decitabine|mesh-list
101467272|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101467273|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
101467274|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467275|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467276|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467277|NCT03832010|Triamcinolone|triamcinolone|mesh-list
101467278|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
101467279|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467292|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467293|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467294|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101467295|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101467296|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467298|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
101467299|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467300|NCT03598426|Dexamethasone|dexamethasone|mesh-list
101360186|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101360187|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360188|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101360189|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360190|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360191|NCT00069459|Bupropion|bupropion|mesh-list
101360192|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101360193|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360194|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360195|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101360196|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101360197|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360198|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360199|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
101360200|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360201|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360202|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101467301|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467302|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
101467303|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
101467304|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467305|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467306|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467307|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
101467308|NCT03598426|Hormones|hormones|mesh-ancestor
101467309|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467310|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467311|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467312|NCT03568890|Aspirin|aspirin|mesh-list
101467313|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
101467314|NCT03568890|Apixaban|apixaban|mesh-list
101467315|NCT03568890|Edoxaban|edoxaban|mesh-list
101467316|NCT03568890|Dabigatran|dabigatran|mesh-list
101467317|NCT03568890|Clopidogrel|clopidogrel|mesh-list
101467318|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101467319|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101467320|NCT03568890|Analgesics|analgesics|mesh-ancestor
101467321|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
101467322|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467323|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467324|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467325|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101467326|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101467327|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101467328|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467329|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101467330|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101467331|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467332|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
101467333|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101467334|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101467335|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101467336|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
101467337|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360203|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101360204|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360205|NCT00214630|Atorvastatin|atorvastatin|mesh-list
101360206|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101360207|NCT00214630|Calcium|calcium|mesh-list
101360208|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101360209|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360210|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101360211|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101360212|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
101467338|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101467339|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
101467340|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101467345|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467346|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467347|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467349|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467350|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467351|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467352|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467353|NCT03494322|Cetuximab|cetuximab|mesh-list
101467354|NCT03494322|Avelumab|avelumab|mesh-list
101467355|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467356|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467357|NCT03480191|Daptomycin|daptomycin|mesh-list
101467358|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467359|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467360|NCT03478878|Vitamin A|vitamin a|mesh-list
101467361|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
101467362|NCT03478878|Vitamins|vitamins|mesh-ancestor
101467363|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
101467364|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467365|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
101467366|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467367|NCT03478878|Protective Agents|protective agents|mesh-ancestor
101467368|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101467369|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467370|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
101467371|NCT03441633|Apixaban|apixaban|mesh-list
101467372|NCT03441633|Dabigatran|dabigatran|mesh-list
101467373|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101467374|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
101467375|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101467376|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467377|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467378|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467379|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
101467380|NCT03436862|Nivolumab|nivolumab|mesh-list
101467381|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467382|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467383|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467384|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467385|NCT03424005|Bevacizumab|bevacizumab|mesh-list
101467386|NCT03424005|Carboplatin|carboplatin|mesh-list
101467387|NCT03424005|Gemcitabine|gemcitabine|mesh-list
101467388|NCT03424005|Capecitabine|capecitabine|mesh-list
101467389|NCT03424005|Trastuzumab|trastuzumab|mesh-list
101467390|NCT03424005|Atezolizumab|atezolizumab|mesh-list
101467391|NCT03424005|Fulvestrant|fulvestrant|mesh-list
101467392|NCT03424005|Ipatasertib|ipatasertib|mesh-list
101467393|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101467394|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
101467395|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
101467396|NCT03424005|Inavolisib|inavolisib|mesh-list
101467397|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467398|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467399|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101360213|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360214|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101360215|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101360216|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360217|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101360218|NCT00214825|Eplerenone|eplerenone|mesh-list
101360219|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467400|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101467401|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467402|NCT03424005|Growth Substances|growth substances|mesh-ancestor
101467403|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467404|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
101467405|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101467406|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
101467407|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467408|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467409|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101467410|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101467411|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
101467412|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467413|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
101467422|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467423|NCT03373760|Durvalumab|durvalumab|mesh-list
101467424|NCT03373760|Ipilimumab|ipilimumab|mesh-list
101467425|NCT03373760|Tremelimumab|tremelimumab|mesh-list
101467426|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
101467427|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101467428|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
101467429|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467430|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467431|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
101467432|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467433|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467434|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467435|NCT03354728|Vaccines|vaccines|mesh-list
101467436|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
101467437|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467438|NCT03290794|Aflibercept|aflibercept|mesh-list
101467439|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101467440|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467441|NCT03290794|Growth Substances|growth substances|mesh-ancestor
101467442|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467443|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
101467444|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467445|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
101467446|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467447|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467448|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467449|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467450|NCT02986100|Rucaparib|rucaparib|mesh-list
101467451|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467452|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467453|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467454|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467455|NCT02965027|Prazosin|prazosin|mesh-list
101467456|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467457|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101467458|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101467459|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101467460|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
101467461|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467462|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467463|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467465|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467466|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360220|NCT00214825|Diuretics|diuretics|mesh-ancestor
101360221|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
101360222|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360223|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101360224|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360225|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360226|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101360227|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
101467467|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467468|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467469|NCT02949934|Tolcapone|tolcapone|mesh-list
101467470|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101467471|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101467472|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101467473|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467474|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467475|NCT02935634|Nivolumab|nivolumab|mesh-list
101467476|NCT02935634|Ipilimumab|ipilimumab|mesh-list
101467477|NCT02935634|Relatlimab|relatlimab|mesh-list
101467478|NCT02935634|Rucaparib|rucaparib|mesh-list
101467479|NCT02935634|Linrodostat|linrodostat|mesh-list
101467491|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467492|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101467494|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467495|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467496|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467497|NCT02740712|Vitamin K|vitamin k|mesh-list
101467498|NCT02740712|Rucaparib|rucaparib|mesh-list
101467499|NCT02740712|Digoxin|digoxin|mesh-list
101467500|NCT02740712|Midazolam|midazolam|mesh-list
101467501|NCT02740712|Caffeine|caffeine|mesh-list
101467502|NCT02740712|Omeprazole|omeprazole|mesh-list
101467503|NCT02740712|Warfarin|warfarin|mesh-list
101467504|NCT02740712|Vitamins|vitamins|mesh-ancestor
101467505|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
101467506|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467507|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101467508|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101467509|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467510|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101467511|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101467512|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101467513|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101467514|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
101467515|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
101467516|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
101467517|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
101467518|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467519|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467520|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
101467521|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101467522|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101467523|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467524|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101467525|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101467526|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
101467527|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101467528|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467529|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101467530|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101467531|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101467532|NCT02740712|Protective Agents|protective agents|mesh-ancestor
101467533|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101467534|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101467535|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
101467536|NCT02740712|Coagulants|coagulants|mesh-ancestor
101467537|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467538|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360228|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101360229|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101360230|NCT00214864|Docetaxel|docetaxel|mesh-list
101360231|NCT00214864|Capecitabine|capecitabine|mesh-list
101360232|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360233|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
101360234|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
101360235|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
101360236|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360237|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360238|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
101360239|NCT00214942|Fentanyl|fentanyl|mesh-list
101360240|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101360241|NCT00214942|Narcotics|narcotics|mesh-ancestor
101360242|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360243|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360244|NCT00214942|Analgesics|analgesics|mesh-ancestor
101360245|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
101360246|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467539|NCT02684578|Metformin|metformin|mesh-list
101467540|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101467541|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467542|NCT02580305|Memantine|memantine|mesh-list
101467543|NCT02580305|Donepezil|donepezil|mesh-list
101487419|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101467547|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467548|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
101467549|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467550|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467551|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
101467552|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101467553|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101467554|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
101467555|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101467556|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101467557|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101467558|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
101467559|NCT02279394|Dexamethasone|dexamethasone|mesh-list
101467560|NCT02279394|Lenalidomide|lenalidomide|mesh-list
101467561|NCT02279394|Elotuzumab|elotuzumab|mesh-list
101467562|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467563|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
101467564|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
101467565|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467566|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467567|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467568|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
101467569|NCT02279394|Hormones|hormones|mesh-ancestor
101467570|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467571|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467573|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
101467574|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101467575|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467576|NCT02279394|Growth Substances|growth substances|mesh-ancestor
101467577|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
101360247|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101360248|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101360249|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
101360250|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
101360251|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101360252|NCT00069498|Mesalamine|mesalamine|mesh-list
101360253|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
101360254|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360255|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360256|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101360257|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360258|NCT00069498|Analgesics|analgesics|mesh-ancestor
101467578|NCT02229578|Lidocaine|lidocaine|mesh-list
101467579|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
101467580|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
101467581|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467582|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467583|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
101467584|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467585|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101467586|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101467587|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101467588|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467589|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467590|NCT01821781|Fludarabine|fludarabine|mesh-list
101467591|NCT01821781|Melphalan|melphalan|mesh-list
101467592|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
101467593|NCT01821781|Thiotepa|thiotepa|mesh-list
101467594|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467595|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467596|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101467597|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
101467598|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467599|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101467600|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
101467601|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101467602|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467603|NCT01555463|Azelaic acid|azelaic acid|mesh-list
101467604|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467605|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
101467606|NCT01482715|Rucaparib|rucaparib|mesh-list
101467607|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467608|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467609|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467610|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467611|NCT01257919|Azelaic acid|azelaic acid|mesh-list
101467612|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467615|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101467617|NCT01081951|Olaparib|olaparib|mesh-list
101467618|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101467619|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467620|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
101467621|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
101467622|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
101467623|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467624|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467625|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467627|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101467628|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101467629|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101467630|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360260|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360261|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360262|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360263|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360264|NCT00214981|Modafinil|modafinil|mesh-list
101360265|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101360266|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467631|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
101467632|NCT00915837|Hormones|hormones|mesh-ancestor
101467633|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467634|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467635|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101467636|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
101467637|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467638|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467639|NCT00239096|Losartan|losartan|mesh-list
101467640|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101467641|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467642|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101467643|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101467644|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467645|NCT04532554|Hormones|hormones|mesh-list
101467646|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467647|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467648|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
101467649|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101467650|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467651|NCT02217163|Dexamethasone|dexamethasone|mesh-list
101467652|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
101467653|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101467654|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
101467655|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467656|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101467657|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101467658|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
101467659|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467660|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467661|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101467662|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467664|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
101467665|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467667|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
101467668|NCT02217163|Hormones|hormones|mesh-ancestor
101467669|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467670|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467671|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101467672|NCT02217202|Laxatives|laxatives|mesh-ancestor
101467673|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467674|NCT00239174|Surinabant|surinabant|mesh-list
101467675|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101467676|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101467677|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467678|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467679|NCT00239174|Hormones|hormones|mesh-ancestor
101467680|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467681|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467698|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467699|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101467700|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467701|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360267|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101360268|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101360269|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101542563|NCT01200589|Rituximab|rituximab|mesh-list
101543166|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
101360270|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360272|NCT00397241|Dorzolamide|dorzolamide|mesh-list
101360273|NCT00397241|Latanoprost|latanoprost|mesh-list
101360274|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
101360275|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101360276|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101360277|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
101543660|NCT01642433|Prazosin|prazosin|mesh-list
101467702|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467704|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101467705|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467707|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467708|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467709|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467710|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467711|NCT04531072|Ritonavir|ritonavir|mesh-list
101467712|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101467713|NCT04531072|Lumefantrine|lumefantrine|mesh-list
101467715|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101467716|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101467717|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101467718|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467719|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467720|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467721|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101467722|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101467723|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
101467724|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467725|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101467726|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101467727|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
101544576|NCT01684085|Lorazepam|lorazepam|mesh-list
101467728|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101467729|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101467730|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101413686|NCT00485368|Perindopril|perindopril|mesh-list
101467732|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101467733|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101467734|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467735|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545134|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
101545194|NCT01687439|Growth Substances|growth substances|mesh-ancestor
101467736|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467737|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
101467759|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467760|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467761|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467762|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467763|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467764|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467765|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101467766|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
101467767|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
101467768|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467769|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101467770|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101360278|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360279|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360280|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360281|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101360282|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101360283|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101360284|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101360285|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101360286|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360287|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101467771|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467772|NCT00263484|Growth Substances|growth substances|mesh-ancestor
101467773|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
101467774|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101467776|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101467777|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101467778|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
101467779|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
101467780|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467781|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467782|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
101467783|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
101467784|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467785|NCT02217514|Midazolam|midazolam|mesh-list
101546761|NCT00593502|Oseltamivir|oseltamivir|mesh-list
101467786|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101467787|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101467788|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467789|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467790|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101467791|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101467792|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101467802|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101467803|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467804|NCT02217553|Vitamins|vitamins|mesh-ancestor
101467805|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
101467806|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101467807|NCT02217631|Prednisolone|prednisolone|mesh-list
101467808|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101467809|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
101467810|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101467811|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
101467812|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101467813|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
101467814|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467815|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
101467816|NCT02217631|Hormones|hormones|mesh-ancestor
101467817|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467818|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467819|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467820|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467821|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
101467822|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
101467823|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467824|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467825|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101467826|NCT02217631|Protective Agents|protective agents|mesh-ancestor
101467827|NCT02217670|Metformin|metformin|mesh-list
101467828|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101467829|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467830|NCT00239291|Gefitinib|gefitinib|mesh-list
101467831|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467832|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467833|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360289|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360290|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360291|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360292|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360293|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101360294|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101360295|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
101360296|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360297|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548255|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
101360298|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101360299|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101360300|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
101360302|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101467834|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467835|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
101467836|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
101467837|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467839|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467840|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101467841|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467842|NCT00239330|Atorvastatin|atorvastatin|mesh-list
101467843|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101467844|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101467845|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101467846|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
101467847|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467848|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101467849|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101467850|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467851|NCT02218021|Oxycodone|oxycodone|mesh-list
101467852|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101548865|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101467853|NCT02218021|Narcotics|narcotics|mesh-ancestor
101467854|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467855|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467856|NCT02218021|Analgesics|analgesics|mesh-ancestor
101467857|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
101467858|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467859|NCT00239369|Telmisartan|telmisartan|mesh-list
101467879|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467880|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467881|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101467882|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101467883|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
101467884|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101467885|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
101467886|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549319|NCT01114828|Tolvaptan|tolvaptan|mesh-list
101467887|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467888|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
101467889|NCT02218177|Ranibizumab|ranibizumab|mesh-list
101467890|NCT02218177|Aflibercept|aflibercept|mesh-list
101467891|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101467892|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101467893|NCT02218177|Growth Substances|growth substances|mesh-ancestor
101467894|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467895|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
101467896|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467897|NCT00263718|Betamethasone|betamethasone|mesh-list
101360303|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360304|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101360305|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101360306|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101549898|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549899|NCT04325061|Dexamethasone|dexamethasone|mesh-list
101549900|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
101549901|NCT04325061|BB 1101|bb 1101|mesh-list
101549903|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
101360307|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360308|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101360309|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360310|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360311|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101467898|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
101467899|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101467900|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
101467901|NCT00263718|Calcipotriene|calcipotriene|mesh-list
101467902|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101467903|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467904|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
101467905|NCT00263718|Hormones|hormones|mesh-ancestor
101467906|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467907|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467908|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101467909|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101467910|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101467911|NCT02218645|Brotizolam|brotizolam|mesh-list
101467912|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101467913|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467918|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101467919|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101467920|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467921|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101467922|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467923|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101467924|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467925|NCT02278861|Tretinoin|tretinoin|mesh-list
101467926|NCT02278861|Isotretinoin|isotretinoin|mesh-list
101467927|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
101467928|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
101467929|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467930|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
101467931|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101467932|NCT02278861|Protective Agents|protective agents|mesh-ancestor
101467933|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467934|NCT01642030|Buprenorphine|buprenorphine|mesh-list
101467935|NCT01642030|Hydromorphone|hydromorphone|mesh-list
101467936|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101467937|NCT01642030|Narcotics|narcotics|mesh-ancestor
101467938|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101467939|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467940|NCT01642030|Analgesics|analgesics|mesh-ancestor
101467941|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
101467942|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467943|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101467944|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
101467945|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101467946|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
101467947|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467948|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467949|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101467950|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
101467951|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
101467952|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101467953|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
101467954|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360312|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360313|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360314|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467955|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467956|NCT00263796|Oxytocin|oxytocin|mesh-list
101467957|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
101467958|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101467959|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467960|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101467961|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101467962|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467963|NCT01642108|Incretins|incretins|mesh-ancestor
101467965|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467966|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101467967|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467968|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467969|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467970|NCT00250185|Acetylcholine|acetylcholine|mesh-list
101467971|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
101467972|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101467973|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
101467974|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467975|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467976|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467977|NCT00239486|Pramipexole|pramipexole|mesh-list
101467978|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
101467979|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467980|NCT00239486|Protective Agents|protective agents|mesh-ancestor
101467981|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467982|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101467983|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101467986|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467987|NCT01642966|Ticagrelor|ticagrelor|mesh-list
101467988|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101467989|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101467990|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101467991|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101467992|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101467993|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
101467994|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467995|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467996|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467998|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467999|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468000|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468001|NCT01643278|Ipilimumab|ipilimumab|mesh-list
101468002|NCT01643278|Dasatinib|dasatinib|mesh-list
101468003|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101468004|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468005|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101468006|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468007|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468008|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468009|NCT01643629|Minoxidil|minoxidil|mesh-list
101468010|NCT01643629|Finasteride|finasteride|mesh-list
101468011|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468012|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
101468013|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101468014|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101468015|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468016|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468017|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
101468018|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468019|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468020|NCT01643629|Urological Agents|urological agents|mesh-ancestor
101468021|NCT01644253|Rituximab|rituximab|mesh-list
101360316|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101360317|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101360318|NCT00041483|Growth Substances|growth substances|mesh-ancestor
101360319|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360320|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
101468022|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
101468023|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101468024|NCT01644253|Idelalisib|idelalisib|mesh-list
101468025|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
101468026|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101468027|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468028|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
101468029|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468030|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468031|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101468032|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
101468033|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468034|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468035|NCT01644799|Lenalidomide|lenalidomide|mesh-list
101468036|NCT01644799|Idelalisib|idelalisib|mesh-list
101468037|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
101468038|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468039|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101468040|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101468041|NCT01644799|Growth Substances|growth substances|mesh-ancestor
101468042|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
101468043|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468044|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468045|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468047|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
101468048|NCT01644838|Scopolamine|scopolamine|mesh-list
101468049|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101468050|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
101468051|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
101468052|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468053|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468054|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468056|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101468058|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468059|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468060|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101468062|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468063|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101468064|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
101468065|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
101468066|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101468067|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101468069|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468070|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
101468071|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
101468072|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
101468073|NCT01644955|Carboplatin|carboplatin|mesh-list
101468074|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468075|NCT01644994|Cisplatin|cisplatin|mesh-list
101468076|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468077|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
101468078|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101468079|NCT04528888|Heparin|heparin|mesh-list
101468080|NCT04528888|Enoxaparin|enoxaparin|mesh-list
101468081|NCT04528888|Calcium heparin|calcium heparin|mesh-list
101468082|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468083|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
101468084|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
101468085|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468086|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468087|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468088|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
101468089|NCT04528888|Hormones|hormones|mesh-ancestor
101360321|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360322|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
101360323|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101360324|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
101360325|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360327|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468090|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468091|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101468092|NCT04528888|Protective Agents|protective agents|mesh-ancestor
101468093|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468094|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468095|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
101468096|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101468097|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101468098|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468100|NCT01645384|Calcium|calcium|mesh-list
101468101|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101468102|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468103|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101468104|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101468105|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
101468106|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468107|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101468108|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101468109|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468110|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101468111|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101468112|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468113|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468114|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
101468115|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468117|NCT01645423|Calcium|calcium|mesh-list
101468118|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101468119|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468120|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101468121|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101468122|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
101468123|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468124|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101468125|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101468126|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468127|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
101468128|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101468129|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101468145|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468147|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468148|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468149|NCT01646281|Flecainide|flecainide|mesh-list
101468150|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101468151|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101468152|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101468153|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468154|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468156|NCT01646554|Aflibercept|aflibercept|mesh-list
101468157|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468158|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101468159|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101468160|NCT01646554|Growth Substances|growth substances|mesh-ancestor
101468161|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468162|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101360328|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360329|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101360330|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101360331|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360332|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360333|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360334|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360335|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
101360336|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101360337|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
101468163|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
101468164|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
101468165|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468166|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
101468167|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
101468168|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468169|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101468170|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468171|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468173|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101468174|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468175|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468176|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
101468177|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
101468178|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468180|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
101468181|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468182|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468183|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468184|NCT00239954|Escitalopram|escitalopram|mesh-list
101468185|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101468188|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468190|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
101468191|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468193|NCT04528927|Doxycycline|doxycycline|mesh-list
101468194|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101468195|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468196|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
101468197|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101468198|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101468199|NCT04720287|Bupivacaine|bupivacaine|mesh-list
101468200|NCT04720287|Neostigmine|neostigmine|mesh-list
101468201|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
101468202|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
101468203|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468204|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468205|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
101468206|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468207|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101468208|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468209|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468210|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
101468211|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468212|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101468213|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
101468214|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
101468215|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
101468216|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101468217|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
101468218|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360338|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360339|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360340|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360341|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360342|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101360343|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101468219|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468220|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468221|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
101468222|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
101468223|NCT00264108|Hematinics|hematinics|mesh-ancestor
101468224|NCT01647412|Curcumin|curcumin|mesh-list
101468225|NCT01647412|Hormones|hormones|mesh-list
101468226|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468227|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468228|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468229|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468230|NCT01647412|Analgesics|analgesics|mesh-ancestor
101468231|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
101468232|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468233|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468234|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468235|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468236|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468237|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468238|NCT01647529|Ganciclovir|ganciclovir|mesh-list
101468239|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101468240|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
101468241|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468242|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101468243|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468244|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468245|NCT00240032|Cetirizine|cetirizine|mesh-list
101468246|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
101468247|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
101468248|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101468249|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101468250|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101468251|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
101468252|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
101468253|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468254|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468255|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468256|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101468257|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
101468263|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468264|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101468265|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468266|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468267|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101468268|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
101468269|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468270|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468271|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
101468272|NCT01647646|Hormones|hormones|mesh-ancestor
101468273|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468274|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
101468275|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
101468276|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101468277|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101468278|NCT01647685|Prednisolone|prednisolone|mesh-list
101468279|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
101468280|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101468281|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
101468282|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468283|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
101468284|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
101360344|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360345|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360346|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360347|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360348|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
101360349|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101360350|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
101360351|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360352|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468285|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468286|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468287|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468288|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
101468289|NCT01647685|Hormones|hormones|mesh-ancestor
101468290|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468291|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101468293|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468294|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468295|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101468296|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101468297|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101468298|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
101468299|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468300|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101468301|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101468302|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468303|NCT01648036|Heparin|heparin|mesh-list
101468304|NCT01648036|Calcium heparin|calcium heparin|mesh-list
101468305|NCT01648036|Dalteparin|dalteparin|mesh-list
101468306|NCT01648036|Tinzaparin|tinzaparin|mesh-list
101468307|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101468308|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
101468309|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101468310|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101468311|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468312|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101468313|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101468314|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101468315|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
101468316|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468317|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101468318|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101468319|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468320|NCT01648231|Losartan|losartan|mesh-list
101468321|NCT01648231|Amlodipine|amlodipine|mesh-list
101468322|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468323|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101468324|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468325|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468326|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101468330|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101468331|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101468332|NCT00264186|Norepinephrine|norepinephrine|mesh-list
101468333|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
101468334|NCT00264186|Acetylcholine|acetylcholine|mesh-list
101468335|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101468336|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101468337|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468338|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468339|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468340|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360353|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360354|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360355|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101360356|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101360357|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360358|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360359|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360360|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468341|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
101468342|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
101468343|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468344|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101468345|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
101468346|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101468347|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
101468348|NCT00240422|Telmisartan|telmisartan|mesh-list
101468350|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468351|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101468352|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101468353|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468354|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101468355|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
101468356|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468357|NCT00264225|Codeine|codeine|mesh-list
101468358|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101468359|NCT00264225|Narcotics|narcotics|mesh-ancestor
101468360|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468361|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468363|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
101468364|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468365|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
101468366|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468367|NCT02279563|Fluticasone|fluticasone|mesh-list
101468369|NCT02279563|Azelastine|azelastine|mesh-list
101468370|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468371|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101468372|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
101468373|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468374|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468375|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468376|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468377|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468378|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101468379|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101468380|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468381|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468382|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101468383|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101468384|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
101468385|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
101468386|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468387|NCT02279758|Metformin|metformin|mesh-list
101468388|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101468389|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468390|NCT01649245|Interferons|interferons|mesh-list
101468391|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468392|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
101468393|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468394|NCT01649284|Afatinib|afatinib|mesh-list
101468395|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468396|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468397|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413702|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468398|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468399|NCT00415740|Levodopa|levodopa|mesh-list
101360361|NCT00215722|Cetuximab|cetuximab|mesh-list
101360362|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101360363|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360364|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101360365|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
101360366|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468416|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
101468417|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
101468418|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468419|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
101468420|NCT01649635|Prednisone|prednisone|mesh-list
101468421|NCT01649635|Lenograstim|lenograstim|mesh-list
101468422|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468424|NCT01649635|Hormones|hormones|mesh-ancestor
101468425|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468426|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468427|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468428|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468429|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101468430|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468431|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101468432|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101468433|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468434|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468435|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101468436|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101468437|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101468438|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
101468439|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
101468441|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
101468442|NCT00250536|Androgens|androgens|mesh-ancestor
101468443|NCT00250536|Hormones|hormones|mesh-ancestor
101468444|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468445|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468446|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
101468447|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101468448|NCT00240617|Naproxen|naproxen|mesh-list
101468449|NCT00240617|Sumatriptan|sumatriptan|mesh-list
101468450|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468451|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468452|NCT00240617|Analgesics|analgesics|mesh-ancestor
101468453|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
101468454|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468455|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468456|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468457|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468458|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
101468473|NCT00240656|Captopril|captopril|mesh-list
101468474|NCT00240656|Spironolactone|spironolactone|mesh-list
101468475|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101468476|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
101468477|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468478|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468479|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101468480|NCT00240656|Diuretics|diuretics|mesh-ancestor
101468481|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
101468482|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101468483|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101468484|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468485|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468486|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468487|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468488|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
101468489|NCT00240656|Protective Agents|protective agents|mesh-ancestor
101468490|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101468491|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468492|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101360369|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360370|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
101360371|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360372|NCT00215956|Topotecan|topotecan|mesh-list
101360373|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101360374|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360376|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468493|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
101468494|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101468495|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101468496|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101468497|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
101468498|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468499|NCT00250575|Clozapine|clozapine|mesh-list
101468500|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101468501|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
101468502|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468503|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468504|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468505|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101468506|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101468507|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468508|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468509|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
101468510|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
101468511|NCT00240695|Galantamine|galantamine|mesh-list
101468512|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101468513|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468514|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468515|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
101468516|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468521|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
101468522|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
101468523|NCT00240734|Hematinics|hematinics|mesh-ancestor
101468525|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468526|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468527|NCT04720248|Analgesics|analgesics|mesh-ancestor
101468528|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
101468529|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468530|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468531|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468532|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468533|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
101468534|NCT01646515|Udenafil|udenafil|mesh-list
101468535|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101468536|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101468537|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468538|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468539|NCT00240773|Acetaminophen|acetaminophen|mesh-list
101468540|NCT00240773|Naproxen|naproxen|mesh-list
101468541|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468542|NCT00240773|Analgesics|analgesics|mesh-ancestor
101468543|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
101468544|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468545|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468546|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
101468547|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468548|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468549|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468550|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
101468551|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101468552|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360377|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360378|NCT00215995|Cisplatin|cisplatin|mesh-list
101360379|NCT00215995|Irinotecan|irinotecan|mesh-list
101360380|NCT00215995|Gefitinib|gefitinib|mesh-list
101360381|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360382|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101360383|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360384|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468553|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468554|NCT01688401|Melphalan|melphalan|mesh-list
101468555|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101468556|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
101468557|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468558|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468559|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101468560|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468561|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
101468562|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468563|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101468564|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101468565|NCT04708821|Dexamethasone|dexamethasone|mesh-list
101468566|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101468567|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468568|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
101468569|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
101188479|NCT00002898|Ifosfamide|ifosfamide|mesh-list
101468570|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468571|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468572|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468573|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
101468574|NCT04708821|Hormones|hormones|mesh-ancestor
101468575|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468576|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468577|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468578|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101468579|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101468580|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468581|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468582|NCT04708821|Analgesics|analgesics|mesh-ancestor
101468583|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
101468584|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468585|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101468586|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101468587|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
101468590|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468591|NCT00240812|Ibuprofen|ibuprofen|mesh-list
101468592|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
101468593|NCT00240812|Ephedrine|ephedrine|mesh-list
101468594|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101468595|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468596|NCT00240812|Analgesics|analgesics|mesh-ancestor
101468597|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
101468598|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468599|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468600|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468601|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468602|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101468603|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468604|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468605|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101468606|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
101468607|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468608|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468609|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
101468610|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101188564|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101468611|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101360386|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101360388|NCT00216034|Tegafur|tegafur|mesh-list
101468612|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
101468613|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468614|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468615|NCT01688518|Lidocaine|lidocaine|mesh-list
101468616|NCT01688518|Tetracaine|tetracaine|mesh-list
101468617|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
101468618|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
101468619|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468620|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468621|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
101188601|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468622|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468624|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101468625|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101468626|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468627|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468628|NCT00240851|Acetaminophen|acetaminophen|mesh-list
101468629|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468630|NCT00240851|Analgesics|analgesics|mesh-ancestor
101468631|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
101468632|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468633|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468634|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
101468635|NCT00240929|Palivizumab|palivizumab|mesh-list
101468636|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
101468637|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468638|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
101468639|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101468640|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
101468641|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
101468642|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468643|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468644|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468645|NCT00250692|Analgesics|analgesics|mesh-ancestor
101468646|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
101468647|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468648|NCT01688791|Paclitaxel|paclitaxel|mesh-list
101468649|NCT01688791|Carboplatin|carboplatin|mesh-list
101468650|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101468651|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468652|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468653|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
101468654|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
101468655|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468657|NCT01688947|Analgesics|analgesics|mesh-ancestor
101468658|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
101468659|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468660|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468661|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
101468664|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468665|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101468667|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101468668|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468669|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468670|NCT00241007|Valsartan|valsartan|mesh-list
101468671|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101468672|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468673|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101468674|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101468675|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468676|NCT00241007|Diuretics|diuretics|mesh-ancestor
101468677|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
101468678|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188752|NCT00003114|Lomustine|lomustine|mesh-list
101468679|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101468680|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468681|NCT01689142|Insulin|insulin|mesh-list
101468682|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101360389|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360390|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
101360391|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360392|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360393|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101360394|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
101360395|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468683|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
101468684|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101468685|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468686|NCT00241046|Letrozole|letrozole|mesh-list
101468687|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468688|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101468689|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101468690|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468691|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468692|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101468693|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
101468694|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468695|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468696|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
101468697|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101468698|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101468699|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468700|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101468701|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468702|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101468703|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468704|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101468705|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468706|NCT01689298|Oxytocin|oxytocin|mesh-list
101468707|NCT01689298|Carbetocin|carbetocin|mesh-list
101468708|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
101468709|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101468710|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468711|NCT00241085|Valsartan|valsartan|mesh-list
101468712|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468713|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101468714|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101468715|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468717|NCT00241124|Lisinopril|lisinopril|mesh-list
101468718|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101468719|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101468720|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101468721|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468722|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101468723|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
101468724|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468725|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101468726|NCT00241124|Protective Agents|protective agents|mesh-ancestor
101468727|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468728|NCT00241163|Thrombin|thrombin|mesh-list
101468729|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
101468730|NCT00241163|Coagulants|coagulants|mesh-ancestor
101468731|NCT02277106|Brexanolone|brexanolone|mesh-list
101468736|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
101468737|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
101468738|NCT00241241|Interferons|interferons|mesh-list
101468739|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
101468740|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
101468741|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101468742|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468743|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
101468744|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101468745|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
101468746|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360396|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101360398|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360399|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
101360400|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101360401|NCT00216034|Protective Agents|protective agents|mesh-ancestor
101360402|NCT00216073|Capecitabine|capecitabine|mesh-list
101360403|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
101360404|NCT00216073|Trastuzumab|trastuzumab|mesh-list
101360405|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360406|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
101468747|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
101468748|NCT02279602|Combretastatin|combretastatin|mesh-list
101468749|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101468750|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468751|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468752|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
101468753|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101468754|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468755|NCT00241436|Anastrozole|anastrozole|mesh-list
101468756|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468757|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468758|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101468759|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101468760|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468761|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468762|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101468763|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
101468764|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468765|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468766|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
101468767|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101468768|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468770|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468771|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468772|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468773|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468774|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
101468775|NCT01685359|Hematinics|hematinics|mesh-ancestor
101468776|NCT02278978|Nintedanib|nintedanib|mesh-list
101468777|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468778|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468779|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468780|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468781|NCT02218762|Fluticasone|fluticasone|mesh-list
101468782|NCT02218762|Xhance|xhance|mesh-list
101468783|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101468784|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101468785|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468786|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101468787|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
101468788|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468789|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468790|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468791|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
101189190|NCT00003558|Leucovorin|leucovorin|mesh-list
101468792|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468793|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101468794|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101468795|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101468796|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101468797|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468798|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468799|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468800|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
101360407|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360408|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360409|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101360411|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
101360412|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360413|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468801|NCT02218762|Hormones|hormones|mesh-ancestor
101468808|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101468809|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468810|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101468811|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468812|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468813|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101468814|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468815|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468816|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
101468817|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468818|NCT00241553|Esomeprazole|esomeprazole|mesh-list
101468819|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101468820|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468821|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101468822|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468823|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468824|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
101468825|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101468826|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101468827|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468828|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
101468829|NCT02219152|Coagulants|coagulants|mesh-ancestor
101468830|NCT00264615|Lamotrigine|lamotrigine|mesh-list
101468831|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
101468833|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468834|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468835|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101468836|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468837|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101468838|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101468839|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468840|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468841|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101468843|NCT02219191|Atorvastatin|atorvastatin|mesh-list
101468844|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101468845|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101468846|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
101468847|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413705|NCT05058612|Midodrine|midodrine|mesh-list
101468848|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101468849|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101468850|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468851|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101468852|NCT04529512|Dexamethasone|dexamethasone|mesh-list
101468853|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468854|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
101468855|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
101468856|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468857|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468858|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101468859|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
101468860|NCT04529512|Hormones|hormones|mesh-ancestor
101468861|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468862|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468863|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468864|NCT04720131|Capecitabine|capecitabine|mesh-list
101468865|NCT04720131|Apatinib|apatinib|mesh-list
101360414|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
101360415|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
101360416|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360417|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101360418|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360419|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
101468866|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101468867|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
101468868|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468869|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468870|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101468875|NCT02219737|Rituximab|rituximab|mesh-list
101468876|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101468878|NCT02219737|Etoposide|etoposide|mesh-list
101468879|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
101468880|NCT02219737|Ifosfamide|ifosfamide|mesh-list
101468881|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
101468882|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
101468883|NCT02219737|Antibodies|antibodies|mesh-list
101468884|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
101468885|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101468887|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468888|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468889|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468890|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101468891|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101468892|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101468893|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468894|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468895|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101468896|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
101468897|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
101468898|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468899|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468900|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
101468901|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
101468902|NCT02219893|Immunotoxins|immunotoxins|mesh-list
101468903|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
101468904|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
101468905|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
101468906|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468907|NCT02218606|Prednisone|prednisone|mesh-list
101468908|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
101468909|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468910|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
101468912|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468913|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468914|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468915|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468917|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468918|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468919|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
101468920|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101468921|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
101468922|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101468923|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468924|NCT02210806|Albuterol|albuterol|mesh-list
101468925|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101468926|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
101468927|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468928|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468929|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101468930|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468931|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
101468932|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101468933|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101360420|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101360421|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360423|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
101360424|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101360425|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360426|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360427|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360428|NCT00216190|Analgesics|analgesics|mesh-ancestor
101360429|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
101360430|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360431|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101360432|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101360433|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360434|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360435|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360436|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360437|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101468934|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101468935|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101468936|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468937|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468938|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468940|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101468941|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101468942|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487420|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101468943|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468945|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
101468946|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468947|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101468948|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
101468949|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468950|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101468951|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101468952|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468953|NCT02219659|Fentanyl|fentanyl|mesh-list
101468954|NCT02219659|Midazolam|midazolam|mesh-list
101468955|NCT02219659|Propofol|propofol|mesh-list
101468956|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101468957|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101468958|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468959|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101468960|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
101468961|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
101468962|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101468963|NCT02219659|Narcotics|narcotics|mesh-ancestor
101468964|NCT02219659|Analgesics|analgesics|mesh-ancestor
101468965|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
101468966|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468967|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101468968|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101468969|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360438|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101360439|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360440|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360441|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101360442|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
101360443|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
101360444|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
101360445|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
101468970|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101468971|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
101468972|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
101468973|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468974|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468975|NCT00241982|Prednisolone|prednisolone|mesh-list
101468976|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101468977|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
101468978|NCT00241982|Hormones|hormones|mesh-ancestor
101468979|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468980|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190292|NCT00004488|Vitamins|vitamins|mesh-ancestor
101468981|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101468982|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468983|NCT02212015|Paclitaxel|paclitaxel|mesh-list
101468984|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101468985|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468986|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101468987|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101468988|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101468989|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468990|NCT04720859|Canagliflozin|canagliflozin|mesh-list
101468991|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101468992|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468993|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101190442|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101468994|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468995|NCT02961842|Ephedrine|ephedrine|mesh-list
101468996|NCT02961842|Fentanyl|fentanyl|mesh-list
101468997|NCT02961842|Bupivacaine|bupivacaine|mesh-list
101468998|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
101468999|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
101469000|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469001|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469002|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
101469003|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469004|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101469005|NCT02961842|Narcotics|narcotics|mesh-ancestor
101469006|NCT02961842|Analgesics|analgesics|mesh-ancestor
101469007|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101469008|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101469009|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
101469011|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
101469012|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
101469013|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101469014|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469015|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469016|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469017|NCT00272805|Carvedilol|carvedilol|mesh-list
101190642|NCT00005064|Bortezomib|bortezomib|mesh-list
101469029|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469030|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
101469031|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101469032|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101469033|NCT00242177|Pioglitazone|pioglitazone|mesh-list
101469034|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469035|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469036|NCT00264927|Satavaptan|satavaptan|mesh-list
101469037|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101469038|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469039|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
101469040|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360447|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
101360448|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360449|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
101360450|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360451|NCT00216346|Amphotericin B|amphotericin b|mesh-list
101360452|NCT00216346|Paromomycin|paromomycin|mesh-list
101469041|NCT00242372|Insulin|insulin|mesh-list
101469042|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469043|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469044|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101469045|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101469046|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101469047|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469048|NCT00242411|Budesonide|budesonide|mesh-list
101469049|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
101469050|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469051|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469052|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
101469053|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469054|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469055|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469056|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469057|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
101469058|NCT00242411|Hormones|hormones|mesh-ancestor
101469059|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469060|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101469061|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101469062|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101469063|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469064|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469065|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469066|NCT02962037|Melatonin|melatonin|mesh-list
101469067|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
101469068|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469069|NCT02962037|Protective Agents|protective agents|mesh-ancestor
101469070|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469071|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469072|NCT00282399|Decitabine|decitabine|mesh-list
101469073|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101469074|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
101469075|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469076|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469077|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469078|NCT00242450|Metoclopramide|metoclopramide|mesh-list
101469083|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101469084|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101469085|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101469086|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
101469087|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469088|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469089|NCT00273039|Paroxetine|paroxetine|mesh-list
101469090|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101469091|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101469092|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469093|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469094|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469095|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
101469096|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469097|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101469098|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
101469099|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469100|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101469101|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101469102|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469103|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
101469104|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101360453|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101360454|NCT00216346|Amebicides|amebicides|mesh-ancestor
101360455|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101360456|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101360457|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360458|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360459|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
101469105|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469106|NCT00242606|Lamotrigine|lamotrigine|mesh-list
101469107|NCT00242606|Levetiracetam|levetiracetam|mesh-list
101469108|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
101469109|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
101469110|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101469111|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413711|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101469112|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469113|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469114|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469115|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101469116|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469117|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469118|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469119|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101469120|NCT00242762|Docetaxel|docetaxel|mesh-list
101469121|NCT00242762|Gefitinib|gefitinib|mesh-list
101469122|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469123|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469124|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469125|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469126|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469127|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469128|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469129|NCT00242801|Gefitinib|gefitinib|mesh-list
101469130|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469131|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469132|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469133|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469134|NCT00242879|Ritonavir|ritonavir|mesh-list
101469135|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101469136|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101469137|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
101469138|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469139|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469140|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101469141|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101469142|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
101469144|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101469145|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101469146|NCT00282594|Insulin|insulin|mesh-list
101469147|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469152|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469153|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469154|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469155|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469156|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469157|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469159|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469160|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469161|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469162|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469163|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469164|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
101469165|NCT00242996|Carmustine|carmustine|mesh-list
101469166|NCT00242996|Rituximab|rituximab|mesh-list
101469167|NCT00242996|Etoposide|etoposide|mesh-list
101469168|NCT00242996|Sargramostim|sargramostim|mesh-list
101469169|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469170|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
101469171|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360461|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360462|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360463|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101360464|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101360465|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101360466|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360467|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469172|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469173|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469174|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
101469175|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469176|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469177|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469178|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469179|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469180|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101469181|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101469182|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469183|NCT00273390|Infliximab|infliximab|mesh-list
101469184|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101469185|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469186|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
101469187|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101469188|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469189|NCT00243035|Bortezomib|bortezomib|mesh-list
101469190|NCT00243035|Tipifarnib|tipifarnib|mesh-list
101469191|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469192|NCT00243113|Docetaxel|docetaxel|mesh-list
101469193|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469194|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469195|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469196|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469197|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469198|NCT00273429|Timolol|timolol|mesh-list
101469199|NCT00273429|Dorzolamide|dorzolamide|mesh-list
101469200|NCT00273429|Latanoprost|latanoprost|mesh-list
101469201|NCT00273429|Maleic acid|maleic acid|mesh-list
101469202|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469203|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469204|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101469205|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101469206|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469207|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469208|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469209|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101469210|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101469211|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101469212|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101469213|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101469214|NCT00273468|Granisetron|granisetron|mesh-list
101469215|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
101469216|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
101469217|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469218|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469219|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101469220|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101469224|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469225|NCT00243464|Betamethasone|betamethasone|mesh-list
101469226|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
101469227|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101469228|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
101469229|NCT00243464|Calcipotriene|calcipotriene|mesh-list
101469230|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101469231|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469232|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
101469233|NCT00243464|Hormones|hormones|mesh-ancestor
101360468|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360469|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360470|NCT00216424|Capecitabine|capecitabine|mesh-list
101360471|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360472|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
101360473|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469234|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469235|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469236|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469237|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469238|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
101469239|NCT00273507|Paclitaxel|paclitaxel|mesh-list
101469240|NCT00273507|Carboplatin|carboplatin|mesh-list
101469241|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469242|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469243|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469244|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469245|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469246|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469247|NCT00282945|Metformin|metformin|mesh-list
101469248|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
101469249|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469250|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469251|NCT00273546|Docetaxel|docetaxel|mesh-list
101469252|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469253|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469254|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469255|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469256|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469257|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
101469258|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469260|NCT00243737|Artesunate|artesunate|mesh-list
101469261|NCT00243737|Mefloquine|mefloquine|mesh-list
101469263|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101469264|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101469265|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469266|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469267|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
101469268|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
101469269|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101200345|NCT00678730|Hormones|hormones|mesh-ancestor
101469270|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
101469271|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
101469272|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101469273|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
101469274|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469275|NCT00273702|Expectorants|expectorants|mesh-ancestor
101469276|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469277|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101469278|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
101469279|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469280|NCT00273702|Protective Agents|protective agents|mesh-ancestor
101469281|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469282|NCT00273702|Antidotes|antidotes|mesh-ancestor
101469283|NCT00243815|Ibuprofen|ibuprofen|mesh-list
101469284|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101469285|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201245|NCT01403415|Hormones|hormones|mesh-ancestor
101469286|NCT00243815|Analgesics|analgesics|mesh-ancestor
101469287|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
101469288|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469289|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469290|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469291|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469292|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101469293|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469294|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469319|NCT00273741|Methylphenidate|methylphenidate|mesh-list
101469320|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101360475|NCT00216463|Mipomersen|mipomersen|mesh-list
101360476|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101360477|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101360478|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
101360479|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360480|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101469321|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469322|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101469323|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101202514|NCT01410630|Telbivudine|telbivudine|mesh-list
101469324|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469325|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469326|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
101469327|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469328|NCT02279134|Paclitaxel|paclitaxel|mesh-list
101469329|NCT02279134|Nedaplatin|nedaplatin|mesh-list
101469330|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469331|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469332|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469333|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469334|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469335|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469336|NCT00243893|Doxycycline|doxycycline|mesh-list
101469337|NCT00243893|Minocycline|minocycline|mesh-list
101469338|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101469339|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469340|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
101469341|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101203974|NCT01420900|Tacrine|tacrine|mesh-list
101203975|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101203976|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203978|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
101204029|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204030|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
101204031|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204032|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204033|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204034|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
101204035|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
101204036|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204037|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204038|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
101204039|NCT01421173|Hormones|hormones|mesh-ancestor
101469351|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469352|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
101469353|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469354|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469355|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469356|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
101469357|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469358|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469359|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469360|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469361|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469363|NCT00244127|Hormones|hormones|mesh-ancestor
101469364|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469365|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469366|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469367|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469368|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469369|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469370|NCT00244166|Prednisolone|prednisolone|mesh-list
101469371|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469372|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
101469373|NCT00244166|Hormones|hormones|mesh-ancestor
101469374|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469375|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469376|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469377|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469378|NCT00273975|Lamivudine|lamivudine|mesh-list
101469379|NCT00273975|Zidovudine|zidovudine|mesh-list
101469380|NCT00273975|Nevirapine|nevirapine|mesh-list
101469381|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101469382|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101469383|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469384|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469385|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
101360481|NCT00216502|Galantamine|galantamine|mesh-list
101360482|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101360483|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360484|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360485|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360486|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360487|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360488|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101360489|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
101360490|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360491|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
101360492|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
101360493|NCT00216541|Hematinics|hematinics|mesh-ancestor
101469386|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469387|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101469388|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101469389|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
101469390|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101469391|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101469392|NCT00244283|Sevoflurane|sevoflurane|mesh-list
101469393|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101469394|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101469395|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
101469396|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
101469397|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469398|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469399|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
101469400|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101469401|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
101469402|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469403|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101469404|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101469405|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101469406|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487421|NCT00428025|Analgesics|analgesics|mesh-ancestor
101487422|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
101469410|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469412|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469413|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469414|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
101469415|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469416|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469417|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
101469418|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469419|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
101469420|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469421|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469422|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469423|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469424|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
101469425|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101469426|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469427|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469428|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469430|NCT00244439|Malathion|malathion|mesh-list
101469431|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469432|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469433|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101469434|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469435|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469436|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360495|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101469437|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101469438|NCT00417144|Ganirelix|ganirelix|mesh-list
101469439|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
101469440|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101469441|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
101469442|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101469443|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469444|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101469445|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469446|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469447|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
101469448|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469449|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
101469450|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469451|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
101469452|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469453|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469454|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469455|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469456|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
101469457|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101469458|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469459|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469460|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469461|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101469463|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
101469464|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101469465|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
101469466|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101469467|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469468|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101469469|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469470|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469473|NCT00244517|Remifentanil|remifentanil|mesh-list
101469474|NCT00244517|Sevoflurane|sevoflurane|mesh-list
101469475|NCT00244517|Desflurane|desflurane|mesh-list
101469476|NCT00244517|Isoflurane|isoflurane|mesh-list
101469477|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
101469478|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101221903|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
101469479|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469480|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101469481|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101469483|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101469484|NCT00244517|Narcotics|narcotics|mesh-ancestor
101469485|NCT00244517|Analgesics|analgesics|mesh-ancestor
101469486|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
101469487|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469488|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
101469489|NCT00274092|Ipratropium|ipratropium|mesh-list
101469490|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469491|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
101469492|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469493|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469494|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469495|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469496|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
101469497|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101469498|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469499|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469500|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469501|NCT00244556|Etanercept|etanercept|mesh-list
101469502|NCT00244556|Methotrexate|methotrexate|mesh-list
101469503|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101469504|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
101469505|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101469506|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469507|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101469508|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
101360497|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360498|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360499|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360500|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101360501|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360502|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360503|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360504|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101360505|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
101360506|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
101469509|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469510|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469511|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
101469512|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469513|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101469514|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469515|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
101469516|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469517|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101469518|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101469519|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101469520|NCT00244556|Analgesics|analgesics|mesh-ancestor
101469521|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
101469522|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469523|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469524|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101469525|NCT00274131|Pramipexole|pramipexole|mesh-list
101469526|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
101469527|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469528|NCT00274131|Protective Agents|protective agents|mesh-ancestor
101469529|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469530|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101469531|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101469532|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
101469533|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
101469534|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469535|NCT00274170|Octreotide|octreotide|mesh-list
101469536|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101469537|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469538|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469539|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
101469540|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469541|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469542|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469543|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469547|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469548|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469549|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469550|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469551|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101469552|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101469553|NCT00244907|Protective Agents|protective agents|mesh-ancestor
101469554|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469555|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469556|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469557|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
101469558|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101469559|NCT00244907|Estrogens|estrogens|mesh-ancestor
101469561|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469562|NCT00244946|Cytarabine|cytarabine|mesh-list
101469563|NCT00244946|Etoposide|etoposide|mesh-list
101469564|NCT00244946|Melphalan|melphalan|mesh-list
101469565|NCT00244946|Carmustine|carmustine|mesh-list
101469566|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101360507|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101360508|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
101360509|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360510|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360511|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360512|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360513|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101360514|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
101360515|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360516|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360517|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101360518|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
101360519|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
101360520|NCT00041561|Protective Agents|protective agents|mesh-ancestor
101360521|NCT00216619|Topiramate|topiramate|mesh-list
101360522|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
101360523|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101360524|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360525|NCT00216658|Fentanyl|fentanyl|mesh-list
101360526|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101360527|NCT00216658|Narcotics|narcotics|mesh-ancestor
101360528|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360529|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360530|NCT00216658|Analgesics|analgesics|mesh-ancestor
101360531|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
101469567|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469568|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101469569|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101469570|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469571|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469572|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101469573|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
101469574|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
101469575|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469576|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469577|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
101469578|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469579|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469580|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
101469581|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469582|NCT00245024|Sulindac|sulindac|mesh-list
101469583|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101469584|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101469585|NCT00245024|Analgesics|analgesics|mesh-ancestor
101469586|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
101469587|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469588|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469589|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469590|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360532|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360533|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101360534|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101360536|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
101360537|NCT00216697|Bortezomib|bortezomib|mesh-list
101469591|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469592|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101469593|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469594|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469595|NCT00274326|Satavaptan|satavaptan|mesh-list
101469596|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101469597|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469598|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
101469599|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469600|NCT00245141|Dactinomycin|dactinomycin|mesh-list
101469601|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
101469602|NCT00245141|Vincristine|vincristine|mesh-list
101469603|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469604|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
101469605|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469606|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469607|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469608|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
101469609|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469610|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469611|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469612|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469613|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469614|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469615|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469619|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101469620|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469621|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101469622|NCT00416637|Bevacizumab|bevacizumab|mesh-list
101469623|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469624|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469625|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101469626|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101469627|NCT00416637|Growth Substances|growth substances|mesh-ancestor
101469628|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469629|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
101469630|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
101469631|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469632|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
101469633|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101469634|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101469635|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469636|NCT00245258|Urological Agents|urological agents|mesh-ancestor
101469637|NCT02961803|Biotin|biotin|mesh-list
101469638|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
101469639|NCT02961803|Vitamins|vitamins|mesh-ancestor
101469640|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
101469641|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469642|NCT00245297|Factor VIII|factor viii|mesh-list
101469643|NCT00245297|Coagulants|coagulants|mesh-ancestor
101469644|NCT00274404|Valacyclovir|valacyclovir|mesh-list
101469645|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
101469646|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469647|NCT00283764|Latanoprost|latanoprost|mesh-list
101469648|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101469649|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101469650|NCT00245336|Thrombin|thrombin|mesh-list
101469651|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
101469652|NCT00245336|Coagulants|coagulants|mesh-ancestor
101469653|NCT00274443|Carboplatin|carboplatin|mesh-list
101469654|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101469655|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469656|NCT00245375|Acetaminophen|acetaminophen|mesh-list
101469657|NCT00245375|Ibuprofen|ibuprofen|mesh-list
101360538|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360539|NCT00216775|Interferons|interferons|mesh-list
101360541|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
101360542|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
101360543|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469658|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101469659|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101469660|NCT00245375|Analgesics|analgesics|mesh-ancestor
101469661|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
101469662|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469663|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469664|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469665|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469666|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101469667|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469668|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469669|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
101469670|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101469671|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
101469672|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
101469673|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469674|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
101469675|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469676|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
101469677|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469679|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469680|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469681|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469682|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469683|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
101469684|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101469685|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469686|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469687|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469688|NCT00245453|Azithromycin|azithromycin|mesh-list
101469689|NCT00245453|Clarithromycin|clarithromycin|mesh-list
101469690|NCT00245453|Telithromycin|telithromycin|mesh-list
101469691|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101469695|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469696|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101469697|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101469698|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
101469699|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101469700|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101469701|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
101469702|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469703|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469704|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101469705|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
101469706|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
101469707|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101469708|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469709|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469710|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469711|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101469712|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101469713|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101469714|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469716|NCT00245609|Alprazolam|alprazolam|mesh-list
101469717|NCT00245609|Analgesics|analgesics|mesh-ancestor
101469718|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
101469719|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469720|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469721|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
101469722|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101469723|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469724|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360544|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
101360545|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360546|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
101360547|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360548|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
101469725|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469726|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101469728|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469729|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469730|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101469731|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
101469732|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
101469733|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469734|NCT00274599|Telmisartan|telmisartan|mesh-list
101469735|NCT00274599|Ramipril|ramipril|mesh-list
101469736|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101469737|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101469738|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101469739|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469740|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101469741|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
101469742|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469743|NCT00274638|Losartan|losartan|mesh-list
101469744|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101469745|NCT00274638|Telmisartan|telmisartan|mesh-list
101469746|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101469747|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101469748|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101469749|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101469750|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469751|NCT00274638|Diuretics|diuretics|mesh-ancestor
101469752|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
101469753|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469754|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101469755|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469756|NCT00274677|Lamotrigine|lamotrigine|mesh-list
101469757|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
101469758|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101469759|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469760|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469761|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469762|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469763|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101469764|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469765|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469766|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469769|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101469770|NCT00245921|Estradiol|estradiol|mesh-list
101469771|NCT00245921|Estrogens|estrogens|mesh-ancestor
101469772|NCT00245921|Hormones|hormones|mesh-ancestor
101469773|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469774|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469775|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101469776|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
101469777|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101469778|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101469779|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101469780|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101469781|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101469782|NCT00274794|Rituximab|rituximab|mesh-list
101469783|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101469784|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469785|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
101469786|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469787|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469788|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
101469789|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101469790|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101360549|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360550|NCT00041639|Labetuzumab|labetuzumab|mesh-list
101360551|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101360552|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360553|NCT00216892|Betamethasone|betamethasone|mesh-list
101469791|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101469792|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469793|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469794|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
101469795|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469796|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469797|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101469798|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469799|NCT00284193|Thrombin|thrombin|mesh-list
101469800|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101469801|NCT00284193|Factor VIII|factor viii|mesh-list
101469802|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
101469803|NCT00284193|Coagulants|coagulants|mesh-ancestor
101469804|NCT00246194|Risperidone|risperidone|mesh-list
101469805|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101469806|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
101469807|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469808|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469809|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469810|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101469811|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469812|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469813|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469814|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101469815|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
101469816|NCT00284232|Insulin|insulin|mesh-list
101469817|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469818|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469819|NCT00246233|Methylphenidate|methylphenidate|mesh-list
101469820|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101469821|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469822|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101469823|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101469824|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469825|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469826|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
101469827|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469828|NCT00274833|Temozolomide|temozolomide|mesh-list
101469829|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101469830|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469831|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
101469832|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469833|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469834|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469835|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469836|NCT00274872|Leucovorin|leucovorin|mesh-list
101469841|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101469842|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469843|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
101469844|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469845|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101469846|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469847|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469848|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
101469849|NCT00274872|Antidotes|antidotes|mesh-ancestor
101469851|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
101469852|NCT00274872|Vitamins|vitamins|mesh-ancestor
101469853|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
101469854|NCT00246272|Risperidone|risperidone|mesh-list
101469855|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101469856|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
101469857|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469858|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360554|NCT00216892|Calcipotriene|calcipotriene|mesh-list
101360555|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360556|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
101360557|NCT00216892|Hormones|hormones|mesh-ancestor
101360558|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101360559|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469859|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469860|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101469861|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469862|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469863|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469864|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101469865|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
101469866|NCT00284271|Prednisone|prednisone|mesh-list
101469867|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
101469868|NCT00284271|Vincristine|vincristine|mesh-list
101469869|NCT00284271|Bleomycin|bleomycin|mesh-list
101469870|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
101469871|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469872|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
101469873|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469874|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469875|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469876|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
101469877|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469879|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469880|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101469882|NCT00284271|Hormones|hormones|mesh-ancestor
101469883|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469884|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101469885|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469886|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469887|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469888|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469890|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101469891|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
101469892|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101469893|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
101469894|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469895|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101469896|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469897|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101469898|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469899|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469900|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469901|NCT00274911|Vincristine|vincristine|mesh-list
101469902|NCT00274911|Lomustine|lomustine|mesh-list
101469903|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469904|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469905|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469907|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469914|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469915|NCT00246467|Antacids|antacids|mesh-ancestor
101469916|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469918|NCT00277251|Alendronate|alendronate|mesh-list
101469919|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101469920|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469921|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
101469922|NCT00416676|Carboplatin|carboplatin|mesh-list
101469923|NCT00416676|Etoposide|etoposide|mesh-list
101469924|NCT00416676|Vincristine|vincristine|mesh-list
101469925|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469926|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
101469927|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360560|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360561|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360562|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360563|NCT00216931|Iloprost|iloprost|mesh-list
101360564|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101469928|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101469929|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469930|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
101469931|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469932|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469933|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101469934|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101469935|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101469937|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469938|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101469939|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101469940|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101469941|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101469942|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469943|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
101469944|NCT00284427|Vitamins|vitamins|mesh-ancestor
101469945|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
101469946|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469947|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
101469948|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469949|NCT00284427|Protective Agents|protective agents|mesh-ancestor
101469950|NCT00246701|Simvastatin|simvastatin|mesh-list
101469951|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101469952|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101469953|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
101469954|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469955|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101469956|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101469957|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469958|NCT00284505|Thalidomide|thalidomide|mesh-list
101469959|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101469960|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
101469961|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469962|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
101469963|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101469964|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469965|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101469966|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101469967|NCT00284505|Growth Substances|growth substances|mesh-ancestor
101469968|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
101469969|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469970|NCT00246974|Gemcitabine|gemcitabine|mesh-list
101469971|NCT00246974|Gefitinib|gefitinib|mesh-list
101469972|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469973|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101469974|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
101469975|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469976|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469980|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
101469981|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469982|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469983|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
101469984|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469985|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101469986|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101469987|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101469989|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469990|NCT00247052|Diclofenac|diclofenac|mesh-list
101469991|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101360565|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
101360566|NCT00217009|Furocoumarins|furocoumarins|mesh-list
101360567|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360568|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101469992|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101469994|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
101469995|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469996|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469999|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101470000|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470001|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470002|NCT00277602|Riluzole|riluzole|mesh-list
101470003|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
101470004|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101470005|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101470006|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470007|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470008|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470009|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101470010|NCT00277602|Protective Agents|protective agents|mesh-ancestor
101470011|NCT00277641|Lamotrigine|lamotrigine|mesh-list
101470012|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
101470013|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101470014|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470015|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470016|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101470017|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470018|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470019|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470020|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470021|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470022|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101470023|NCT00247130|Omeprazole|omeprazole|mesh-list
101470025|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101470026|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101470027|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470028|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101470029|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470030|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470031|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101470032|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
101470033|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
101470034|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470035|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470036|NCT00247169|Progesterone|progesterone|mesh-list
101470037|NCT00247169|Progestins|progestins|mesh-ancestor
101470038|NCT00247169|Hormones|hormones|mesh-ancestor
101470039|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470040|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470041|NCT00247208|Paclitaxel|paclitaxel|mesh-list
101470042|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101470043|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470044|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470045|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470046|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470051|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470052|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470053|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470055|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101470056|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101470057|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101470058|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470059|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470061|NCT00277758|Ribavirin|ribavirin|mesh-list
101470062|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
101360570|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
101360571|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
101360572|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470063|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101470064|NCT00277758|Interleukin-2|interleukin-2|mesh-list
101470065|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470066|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
101470067|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470068|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
101470069|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470070|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
101470071|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470072|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470073|NCT00277758|Analgesics|analgesics|mesh-ancestor
101470074|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
101470075|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470076|NCT00247364|Levetiracetam|levetiracetam|mesh-list
101470077|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
101470078|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
101470079|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
101470080|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
101470081|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470082|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
101470083|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470084|NCT00424814|Ritonavir|ritonavir|mesh-list
101470085|NCT00424814|Lopinavir|lopinavir|mesh-list
101470086|NCT00424814|Lamivudine|lamivudine|mesh-list
101470087|NCT00424814|Zidovudine|zidovudine|mesh-list
101470088|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101470089|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101470090|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101470091|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
101470092|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470093|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470094|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101470095|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101470096|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
101470097|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470098|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101470099|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101470100|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101470101|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101470102|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
101470103|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101470104|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101470105|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
101470106|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470108|NCT00247481|Gefitinib|gefitinib|mesh-list
101470109|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470110|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470111|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470112|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470113|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470114|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470115|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470116|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
101470117|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101470121|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470122|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
101470123|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470124|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470125|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101470126|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470128|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
101470129|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
101470130|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470131|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470132|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470133|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
101470134|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360573|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360574|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101360575|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101470135|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101470136|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470137|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
101470138|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470139|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470142|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101470143|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
101470144|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101470145|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101470146|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470147|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101470148|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470149|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470150|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101470151|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
101470152|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
101470153|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470154|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470155|NCT00247715|Antacids|antacids|mesh-ancestor
101470156|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101470157|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
101470158|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
101470159|NCT00285090|Vitamin D|vitamin d|mesh-list
101470160|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
101470161|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
101470162|NCT00285090|Vitamins|vitamins|mesh-list
101470163|NCT00285090|Calcium|calcium|mesh-list
101470164|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
101470165|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470166|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101470167|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101470168|NCT00417222|Olmesartan|olmesartan|mesh-list
101470169|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101470170|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101470171|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101470172|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101470173|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470174|NCT00278070|Vinorelbine|vinorelbine|mesh-list
101470175|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101470176|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470177|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470178|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470179|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470180|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470181|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
101470182|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101470183|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470184|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101470185|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101470186|NCT00247910|Diuretics|diuretics|mesh-ancestor
101470187|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101470188|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470189|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101470200|NCT00278187|Growth Substances|growth substances|mesh-ancestor
101470201|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470202|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
101470203|NCT00247988|Carboplatin|carboplatin|mesh-list
101470204|NCT00247988|Docetaxel|docetaxel|mesh-list
101470205|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470206|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470207|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470208|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470209|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470210|NCT00248144|Famciclovir|famciclovir|mesh-list
101470211|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
101470212|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470213|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101360576|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101360577|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360578|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360579|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360580|NCT00217048|Urological Agents|urological agents|mesh-ancestor
101360581|NCT00217204|Pancrelipase|pancrelipase|mesh-list
101360582|NCT00217204|Pancreatin|pancreatin|mesh-list
101360583|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360584|NCT00412126|Insulin|insulin|mesh-list
101470215|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470216|NCT00278265|Methotrexate|methotrexate|mesh-list
101470217|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
101470218|NCT00278265|Fludarabine|fludarabine|mesh-list
101470219|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101470220|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
101470221|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101470222|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470223|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470224|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
101470225|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470226|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470227|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
101470228|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470229|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101470230|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470232|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470233|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101470234|NCT00248183|Naluzotan|naluzotan|mesh-list
101470235|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101470236|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101470237|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
101470238|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470239|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470240|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470241|NCT00278343|Cediranib|cediranib|mesh-list
101470242|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470243|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470244|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470245|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470246|NCT00248261|Ziprasidone|ziprasidone|mesh-list
101470247|NCT00248261|Sertraline|sertraline|mesh-list
101470248|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
101470249|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470250|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101470251|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101470252|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470256|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470257|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470258|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470259|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470260|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470261|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101470262|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
101470263|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
101470264|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101470265|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470266|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
101470268|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470269|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470270|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470271|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470272|NCT00248339|Ribavirin|ribavirin|mesh-list
101470273|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101470274|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
101470275|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
101360585|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101360586|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360588|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
101360589|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101360590|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
101360591|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360592|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360593|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360594|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
101360595|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
101360596|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101470276|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212539|NCT03972488|Octreotide|octreotide|mesh-list
101470277|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
101470278|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470279|NCT00248339|Hematinics|hematinics|mesh-ancestor
101470280|NCT00278421|Prednisone|prednisone|mesh-list
101470281|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
101470282|NCT00278421|Rituximab|rituximab|mesh-list
101470283|NCT00278421|Doxorubicin|doxorubicin|mesh-list
101470284|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101470285|NCT00278421|Vincristine|vincristine|mesh-list
101470286|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470287|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
101470288|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212990|NCT03323437|Risperidone|risperidone|mesh-list
101470289|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470290|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101470291|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
101470292|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470293|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470294|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101470295|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470296|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101470297|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470298|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470299|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470300|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470301|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
101470303|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470304|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101470305|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101470306|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470307|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470308|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470309|NCT00248456|Betamethasone|betamethasone|mesh-list
101470310|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
101470311|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101470312|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
101470313|NCT00248456|Calcipotriene|calcipotriene|mesh-list
101470314|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101470315|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470316|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
101470317|NCT00248456|Hormones|hormones|mesh-ancestor
101470318|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470319|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470320|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101470321|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
101470322|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
101470323|NCT00278460|Gemcitabine|gemcitabine|mesh-list
101470324|NCT00278460|Docetaxel|docetaxel|mesh-list
101470325|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470326|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
101470331|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470333|NCT00248729|Etomidate|etomidate|mesh-list
101360597|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360598|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360599|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360600|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
101360601|NCT00041678|Aripiprazole|aripiprazole|mesh-list
101360602|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360603|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360604|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101360605|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360606|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360607|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360608|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
101470334|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101470335|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101470336|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470337|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470338|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101470339|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470340|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470341|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101470342|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
101470343|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
101470344|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
101470345|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
101470346|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470347|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470348|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
101470349|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470350|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
101470351|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101470352|NCT00248963|Estradiol|estradiol|mesh-list
101470353|NCT00248963|Estrogens|estrogens|mesh-ancestor
101470354|NCT00248963|Hormones|hormones|mesh-ancestor
101470355|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101217765|NCT01489202|Cobalt|cobalt|mesh-list
101470356|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470357|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101470358|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
101470359|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101470360|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101470361|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101470362|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101470363|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101470364|NCT00249041|Etanercept|etanercept|mesh-list
101470365|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101470366|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470367|NCT00249041|Analgesics|analgesics|mesh-ancestor
101470368|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
101470369|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470370|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470371|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470372|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470373|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470374|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470375|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
101470377|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101470378|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101470379|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101470380|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101470381|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
101470382|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218174|NCT01490944|Iron|iron|mesh-list
101470383|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470384|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360609|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
101360610|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360611|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360612|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101360613|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101360614|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
101360615|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101470385|NCT00278772|Valproic Acid|valproic acid|mesh-list
101470386|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
101470387|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470388|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470389|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
101218312|NCT01491503|Cetirizine|cetirizine|mesh-list
101470390|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470391|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470392|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
101470393|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470394|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470395|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470396|NCT00249119|Risperidone|risperidone|mesh-list
101470397|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470400|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470402|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470403|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470404|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470405|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470406|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101470407|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
101470408|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101470409|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101470410|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470411|NCT00249158|Risperidone|risperidone|mesh-list
101470412|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470413|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
101470414|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470415|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470416|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470417|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470418|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470419|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470420|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470421|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101470422|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
101470423|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101470424|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101470425|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101470426|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101470428|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101470429|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470430|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101470431|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470432|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470433|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470434|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470435|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470436|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101470437|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101470438|NCT00278967|Bisacodyl|bisacodyl|mesh-list
101470439|NCT00278967|Cathartics|cathartics|mesh-ancestor
101470440|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470441|NCT00278967|Laxatives|laxatives|mesh-ancestor
101470442|NCT00249236|Risperidone|risperidone|mesh-list
101470443|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470444|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
101470445|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360616|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101360617|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101360618|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101360619|NCT00217243|Lidocaine|lidocaine|mesh-list
101360620|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
101360621|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
101360622|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360623|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360624|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
101360625|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360626|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101470446|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470447|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470448|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470449|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470450|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470451|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470452|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101470453|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
101470455|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101470457|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101470458|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470459|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470460|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101470461|NCT00285675|Vitamins|vitamins|mesh-ancestor
101470462|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
101470463|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101470464|NCT02215096|GSK2636771|gsk2636771|mesh-list
101470466|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470467|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470468|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470475|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101470476|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470477|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101470478|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101470479|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470480|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470482|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470483|NCT00249431|Sertraline|sertraline|mesh-list
101470484|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
101470485|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470486|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101470487|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101470488|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470489|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470490|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470491|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
101470492|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470493|NCT00249509|Bupropion|bupropion|mesh-list
101470494|NCT00249509|Nefazodone|nefazodone|mesh-list
101470495|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101470496|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
101470497|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470498|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101470499|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101470500|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470501|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470502|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
101360628|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101360629|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360630|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360631|NCT00217282|Bevacizumab|bevacizumab|mesh-list
101360632|NCT00217282|Gemcitabine|gemcitabine|mesh-list
101360633|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
101360634|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470503|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470504|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470505|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101470506|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101470507|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470508|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101470509|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101470510|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470511|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
101470512|NCT00279084|Chrysarobin|chrysarobin|mesh-list
101470513|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
101470514|NCT00279084|Hematinics|hematinics|mesh-ancestor
101470515|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101470516|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470517|NCT00279084|Analgesics|analgesics|mesh-ancestor
101470518|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
101470519|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470520|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470521|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470522|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470523|NCT00249587|Methadone|methadone|mesh-list
101470524|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101470525|NCT00249587|Narcotics|narcotics|mesh-ancestor
101470526|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470527|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470528|NCT00249587|Analgesics|analgesics|mesh-ancestor
101470529|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
101470530|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470531|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
101470532|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
101470534|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101470535|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470536|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101470543|NCT00279162|Hormones|hormones|mesh-ancestor
101470544|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470545|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470546|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101470547|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
101470548|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
101470549|NCT00249704|Vitamin D|vitamin d|mesh-list
101470550|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
101470551|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
101470552|NCT00249704|Vitamins|vitamins|mesh-list
101470553|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
101470554|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470555|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101470556|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101470557|NCT00249782|Metronidazole|metronidazole|mesh-list
101470558|NCT00249782|Dapsone|dapsone|mesh-list
101470559|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470560|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101470561|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101470562|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101470563|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
101470564|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101470565|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360635|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360636|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101360637|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101360638|NCT00217282|Growth Substances|growth substances|mesh-ancestor
101360639|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360640|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
101360641|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360642|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
101360643|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360644|NCT00217477|Gemcitabine|gemcitabine|mesh-list
101360645|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360646|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
101360647|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360648|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360649|NCT00217516|Selenium|selenium|mesh-list
101360650|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
101360651|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360652|NCT00217516|Protective Agents|protective agents|mesh-ancestor
101360653|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360654|NCT00217516|Trace Elements|trace elements|mesh-ancestor
101360655|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
101360656|NCT00217555|Gemcitabine|gemcitabine|mesh-list
101470566|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470567|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
101470568|NCT00279240|Metformin|metformin|mesh-list
101470569|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101470570|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470571|NCT00249860|Interferons|interferons|mesh-list
101470573|NCT00249860|Interferon-beta|interferon-beta|mesh-list
101470574|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
101470575|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470576|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
101470577|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470578|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
101470579|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470580|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
101470581|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470582|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101470583|NCT00249899|Atorvastatin|atorvastatin|mesh-list
101470584|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101470585|NCT00249899|Simvastatin|simvastatin|mesh-list
101470586|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101470587|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101470588|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101470589|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
101470590|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470591|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101470592|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470593|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101470594|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101470595|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101470596|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
101360658|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360659|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
101360660|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360661|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360662|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101360663|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360664|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360665|NCT00217711|Capecitabine|capecitabine|mesh-list
101360667|NCT00217711|Irinotecan|irinotecan|mesh-list
101470597|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470598|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101470599|NCT00249977|Capecitabine|capecitabine|mesh-list
101470600|NCT00249977|Irinotecan|irinotecan|mesh-list
101470601|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470602|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470603|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
101470604|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470605|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101470606|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470607|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470612|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470613|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470615|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
101470616|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470617|NCT00286026|Azithromycin|azithromycin|mesh-list
101470618|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101470619|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470620|NCT00250172|Rolipram|rolipram|mesh-list
101470621|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
101470622|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470623|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101470624|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101470625|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470626|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470627|NCT02961608|Tacrolimus|tacrolimus|mesh-list
101470628|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470629|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
101470630|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470631|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101470632|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470633|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470634|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101470635|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470636|NCT00286143|Fentanyl|fentanyl|mesh-list
101470637|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101470638|NCT00286143|Narcotics|narcotics|mesh-ancestor
101470639|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470640|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470641|NCT00286143|Analgesics|analgesics|mesh-ancestor
101470642|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
101470643|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470644|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101470645|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101470646|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
101470647|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
101470648|NCT00286260|Levetiracetam|levetiracetam|mesh-list
101470649|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
101470651|NCT00250367|Risperidone|risperidone|mesh-list
101470652|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101470653|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
101470654|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470655|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360668|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360669|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
101360670|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360671|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413737|NCT05058417|Empagliflozin|empagliflozin|mesh-list
101360672|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101360673|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360674|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360675|NCT00217789|Dimercaprol|dimercaprol|mesh-list
101360676|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
101470656|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470657|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101470658|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101470659|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470660|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101470661|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101470662|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
101470663|NCT00250562|Valsartan|valsartan|mesh-list
101470664|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101470665|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101470666|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101470667|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101470668|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470669|NCT00250562|Diuretics|diuretics|mesh-ancestor
101470670|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
101470671|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470672|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101470673|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470674|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
101470675|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
101470676|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101470677|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
101470678|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101470679|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
101470688|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
101470689|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470690|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470691|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470692|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470693|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
101470694|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101470695|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470696|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470697|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101470699|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101470700|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
101470702|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
101470703|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101470704|NCT00250796|Thalidomide|thalidomide|mesh-list
101470705|NCT00250796|Octreotide|octreotide|mesh-list
101470706|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470707|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
101470708|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470709|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470711|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470712|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
101470713|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101470714|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101470715|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101470716|NCT00250796|Growth Substances|growth substances|mesh-ancestor
101470717|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
101470718|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470719|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101470720|NCT00286416|Omalizumab|omalizumab|mesh-list
101470721|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101470722|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101360677|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
101360678|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360679|NCT00217828|Citalopram|citalopram|mesh-list
101360680|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101470723|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
101470724|NCT00250874|Docetaxel|docetaxel|mesh-list
101470725|NCT00250874|Doxorubicin|doxorubicin|mesh-list
101470726|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101470727|NCT00250874|Trastuzumab|trastuzumab|mesh-list
101470728|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470729|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470730|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470731|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470732|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470733|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101470734|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470735|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470736|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470737|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470738|NCT00279825|Levodopa|levodopa|mesh-list
101470739|NCT00279825|Carbidopa|carbidopa|mesh-list
101470740|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101470741|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101470742|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101470743|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
101470744|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470745|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470746|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487423|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470758|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470759|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470760|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
101470761|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470762|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101470763|NCT00250991|Eptifibatide|eptifibatide|mesh-list
101470764|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101470765|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101470766|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470767|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101470768|NCT00286611|Amifostine|amifostine|mesh-list
101470769|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101470770|NCT00286611|Protective Agents|protective agents|mesh-ancestor
101470771|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470772|NCT00416832|Prednisone|prednisone|mesh-list
101470773|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
101470774|NCT00416832|Dacarbazine|dacarbazine|mesh-list
101470775|NCT00416832|Doxorubicin|doxorubicin|mesh-list
101470776|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101470777|NCT00416832|Etoposide|etoposide|mesh-list
101470778|NCT00416832|Vincristine|vincristine|mesh-list
101470779|NCT00416832|Procarbazine|procarbazine|mesh-list
101470780|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470781|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
101470782|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470783|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470784|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101470785|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
101470786|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470787|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470788|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101470789|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101470790|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470791|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470792|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470793|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470794|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
101470795|NCT00416832|Hormones|hormones|mesh-ancestor
101470796|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470797|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101360681|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101360682|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360683|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360684|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360685|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
101360686|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360687|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101360688|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
101470798|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101470799|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470800|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470801|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470802|NCT00251030|Nelfinavir|nelfinavir|mesh-list
101470803|NCT00251030|Omeprazole|omeprazole|mesh-list
101470804|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101470805|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470806|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101470807|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470808|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470809|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101470813|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101470814|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
101470815|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470816|NCT00286689|Hormones|hormones|mesh-list
101470817|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470818|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470819|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101470820|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470821|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470822|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470823|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101470825|NCT01640002|Propantheline|propantheline|mesh-list
101470826|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
101470827|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101470828|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101470829|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101470830|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101470831|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
101470832|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470833|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470834|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470835|NCT00279903|Cortisone|cortisone|mesh-list
101470836|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
101470837|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101470838|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101470839|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101470840|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470841|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470842|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
101470843|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470844|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470845|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101470846|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470847|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470848|NCT01640275|Propofol|propofol|mesh-list
101470850|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101470851|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101470852|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470853|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101470854|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
101470855|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
101470856|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101470857|NCT04529356|Acetaminophen|acetaminophen|mesh-list
101360689|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360691|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360692|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
101360693|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360694|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360695|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360696|NCT00073437|Infliximab|infliximab|mesh-list
101470858|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470860|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
101470861|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470862|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470863|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
101470864|NCT01640665|Capecitabine|capecitabine|mesh-list
101470865|NCT01640665|Sorafenib|sorafenib|mesh-list
101470866|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470867|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
101470868|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470869|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470870|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470871|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470872|NCT01640782|Leucovorin|leucovorin|mesh-list
101470873|NCT01640782|Docetaxel|docetaxel|mesh-list
101470874|NCT01640782|Fluorouracil|fluorouracil|mesh-list
101470875|NCT01640782|Irinotecan|irinotecan|mesh-list
101470876|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
101470877|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470878|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470879|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470880|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470881|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470882|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
101470883|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470885|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
101470886|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470887|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101470888|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470889|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470890|NCT01640782|Antidotes|antidotes|mesh-ancestor
101470891|NCT01640782|Protective Agents|protective agents|mesh-ancestor
101470892|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
101470894|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
101470895|NCT00251186|Capecitabine|capecitabine|mesh-list
101470896|NCT00251186|Cetuximab|cetuximab|mesh-list
101470897|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470898|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
101470899|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470900|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470901|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470902|NCT01641250|Cytarabine|cytarabine|mesh-list
101470903|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470904|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
101470905|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470906|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470907|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
101470908|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470909|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470910|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
101470911|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470912|NCT01641289|Acetaminophen|acetaminophen|mesh-list
101470913|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470914|NCT01641289|Analgesics|analgesics|mesh-ancestor
101470915|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
101470916|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470917|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470918|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
101470919|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
101470920|NCT01641406|Bevacizumab|bevacizumab|mesh-list
101470921|NCT01641406|Docetaxel|docetaxel|mesh-list
101470922|NCT01641406|Capecitabine|capecitabine|mesh-list
101360697|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101360698|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360699|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360700|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360701|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360702|NCT00218101|Buprenorphine|buprenorphine|mesh-list
101413769|NCT00118794|Artemether|artemether|mesh-list
101360703|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101360704|NCT00218101|Narcotics|narcotics|mesh-ancestor
101360705|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360706|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360707|NCT00218101|Analgesics|analgesics|mesh-ancestor
101470923|NCT01641406|Trastuzumab|trastuzumab|mesh-list
101470924|NCT01641406|Epirubicin|epirubicin|mesh-list
101470925|NCT01641406|Vinorelbine|vinorelbine|mesh-list
101470926|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470927|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
101470928|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470929|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101470930|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101470931|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
101470932|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470933|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470934|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101470935|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470936|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101470937|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101470938|NCT01641406|Growth Substances|growth substances|mesh-ancestor
101470939|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101470940|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470941|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470942|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470943|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101470944|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
101470945|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101470946|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101470947|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470948|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470949|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101470950|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101470951|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
101470952|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101470953|NCT01641523|Protective Agents|protective agents|mesh-ancestor
101470954|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470956|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101470957|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470958|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101470962|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470963|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470964|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
101470965|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470967|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101470968|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470969|NCT01685827|Eflornithine|eflornithine|mesh-list
101470970|NCT01685827|Nifurtimox|nifurtimox|mesh-list
101470971|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470972|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101470973|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101470974|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101470975|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470976|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101470977|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470978|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470980|NCT05140096|Isavuconazole|isavuconazole|mesh-list
101360708|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
101360709|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360710|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101360712|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101360713|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
101360714|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360715|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360716|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101360717|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101360718|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360719|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470981|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
101470982|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
101470983|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101470984|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101470985|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101470986|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470987|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470988|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101470989|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
101470990|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101470991|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470992|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101470993|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101470994|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470995|NCT00251459|Ranibizumab|ranibizumab|mesh-list
101470996|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101470997|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101470998|NCT00251459|Growth Substances|growth substances|mesh-ancestor
101470999|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471000|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101471001|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471002|NCT04823065|Scopolamine|scopolamine|mesh-list
101471003|NCT04823065|Loperamide|loperamide|mesh-list
101471004|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
101471005|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101471006|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471007|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101471008|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
101471009|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
101471010|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471011|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471012|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
101471013|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101471014|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
101471015|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471016|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471017|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101471018|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
101471019|NCT00280176|Fluorouracil|fluorouracil|mesh-list
101471020|NCT00280176|Bortezomib|bortezomib|mesh-list
101471021|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
101471022|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471023|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471024|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471025|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471026|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
101471027|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471028|NCT00280215|Losartan|losartan|mesh-list
101471029|NCT00280215|Lisinopril|lisinopril|mesh-list
101471030|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101471031|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101360720|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360722|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
101360723|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
101360724|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360725|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360726|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471036|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471037|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
101471038|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101471039|NCT00280215|Protective Agents|protective agents|mesh-ancestor
101471040|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471041|NCT00251498|Cetuximab|cetuximab|mesh-list
101471042|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101471043|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471044|NCT02271334|Albuterol|albuterol|mesh-list
101471045|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101471046|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
101471047|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471048|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471049|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101471050|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
101471051|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
101471052|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471053|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101413773|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
101471054|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471055|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471056|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471057|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471058|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471059|NCT02276755|Vitamin D|vitamin d|mesh-list
101471060|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
101471061|NCT02276755|Vitamins|vitamins|mesh-ancestor
101471062|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
101471063|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471064|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101471065|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101471067|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101471068|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
101471069|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471070|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471071|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101471072|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
101471073|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101471074|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471075|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471076|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471077|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471078|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471079|NCT04455139|Melphalan|melphalan|mesh-list
101471080|NCT04455139|Topotecan|topotecan|mesh-list
101471081|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101471082|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
101471083|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471084|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471085|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101471086|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471087|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
101471088|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471089|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101471090|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101471091|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471092|NCT00251654|Anesthetics|anesthetics|mesh-list
101471093|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360727|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101360728|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360729|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360730|NCT00218218|Nicotine|nicotine|mesh-list
101360731|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101360732|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
101360733|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360734|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360735|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101360736|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101360737|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360738|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471094|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471095|NCT00286923|Topiramate|topiramate|mesh-list
101471096|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
101471097|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471098|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471099|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
101471100|NCT00251732|Nortriptyline|nortriptyline|mesh-list
101471118|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471120|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101471121|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471122|NCT00251849|KRM 1648|krm 1648|mesh-list
101471123|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101471124|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
101471125|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471126|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471127|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
101471128|NCT00251888|Irinotecan|irinotecan|mesh-list
101471129|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471130|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101471131|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101471132|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471133|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471134|NCT00251966|Esomeprazole|esomeprazole|mesh-list
101471135|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101471136|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471137|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101471138|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471139|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471140|NCT00252044|Pergolide|pergolide|mesh-list
101471141|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
101471142|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
101471143|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471144|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471145|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471147|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471148|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471149|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101471150|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471151|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471152|NCT00280605|Alfuzosin|alfuzosin|mesh-list
101471153|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101471154|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101471155|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101471156|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471183|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471184|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471185|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
101471186|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101360739|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360740|NCT00218374|Gabapentin|gabapentin|mesh-list
101360741|NCT00218374|Analgesics|analgesics|mesh-ancestor
101360742|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
101360743|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360744|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360745|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
101360746|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101471187|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101471188|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
101471189|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
101471190|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101471191|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101471192|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471193|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471194|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471195|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471196|NCT00280644|Leflunomide|leflunomide|mesh-list
101471197|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471198|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471199|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471200|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
101471201|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471205|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101471206|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101471207|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101471208|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471209|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471210|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471211|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471212|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471213|NCT00252317|Captopril|captopril|mesh-list
101471214|NCT00252317|Trandolapril|trandolapril|mesh-list
101471215|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101471216|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
101471217|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471218|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471219|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101471220|NCT00252356|Amibegron|amibegron|mesh-list
101471221|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101471222|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471223|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471224|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471225|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471226|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471227|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471228|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101471229|NCT02753998|Paclitaxel|paclitaxel|mesh-list
101471230|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471231|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471232|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471233|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471234|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471235|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471236|NCT02754154|Warfarin|warfarin|mesh-list
101471237|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
101471238|NCT02754154|Dabigatran|dabigatran|mesh-list
101471239|NCT02754154|Apixaban|apixaban|mesh-list
101471240|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
101471241|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101471242|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
101471243|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101471244|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
101471245|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471246|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471247|NCT00252434|Methamphetamine|methamphetamine|mesh-list
101360747|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101360748|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360749|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360750|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101360751|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101360752|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360753|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360754|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
101360755|NCT00218413|Vaccines|vaccines|mesh-list
101360756|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
101360757|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360758|NCT00042068|Meloxicam|meloxicam|mesh-list
101471248|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101471249|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471250|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
101471251|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
101471252|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471253|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
101471254|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471255|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471257|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101471258|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101471259|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471260|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101471261|NCT00280839|Topiramate|topiramate|mesh-list
101471262|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
101471263|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471264|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471265|NCT00280878|Rituximab|rituximab|mesh-list
101471266|NCT00280878|Gemcitabine|gemcitabine|mesh-list
101471267|NCT00280878|Vinorelbine|vinorelbine|mesh-list
101471268|NCT00280878|Ifosfamide|ifosfamide|mesh-list
101471269|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101471270|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471271|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
101471272|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471273|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471277|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471278|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471279|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471280|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471281|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101471282|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
101471283|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101471285|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101471286|NCT02758717|Antibodies|antibodies|mesh-list
101471287|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
101471288|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101471289|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
101471290|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
101471291|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471292|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471293|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101471294|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471295|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
101471296|NCT00287313|Vitamin K|vitamin k|mesh-list
101471297|NCT00287313|Vitamins|vitamins|mesh-ancestor
101471298|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
101471299|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471300|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101471301|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101360760|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360761|NCT00042068|Analgesics|analgesics|mesh-ancestor
101360762|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
101360763|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360764|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360765|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360766|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471302|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471303|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
101471304|NCT00287313|Coagulants|coagulants|mesh-ancestor
101471305|NCT01680250|Sirolimus|sirolimus|mesh-list
101471306|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471307|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471308|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101471309|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471310|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
101471311|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471312|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
101471313|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471314|NCT00280956|Natalizumab|natalizumab|mesh-list
101471315|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
101471316|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471317|NCT02279875|Rifampin|rifampin|mesh-list
101471318|NCT02279875|Isoniazid|isoniazid|mesh-list
101471319|NCT02279875|Linezolid|linezolid|mesh-list
101471320|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
101471321|NCT02279875|Ethambutol|ethambutol|mesh-list
101471322|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101471323|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
101471324|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471325|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471326|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
101471327|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101471328|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471329|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471330|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101471331|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101471332|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101471333|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101471334|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101471335|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101471336|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101471337|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101471338|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
101471339|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101471340|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101471341|NCT00280995|Mipomersen|mipomersen|mesh-list
101471342|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101471343|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101471344|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
101471345|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471353|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471354|NCT00287352|Amantadine|amantadine|mesh-list
101471355|NCT00287352|Olanzapine|olanzapine|mesh-list
101471356|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
101471357|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
101471358|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471359|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471360|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471361|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471362|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471363|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471364|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471365|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101471366|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101360767|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101360768|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101360769|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360770|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360771|NCT00218530|Lofexidine|lofexidine|mesh-list
101360772|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101360773|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101360774|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360775|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
101360776|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360777|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101471367|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471368|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471369|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471370|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
101471371|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101471372|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101471373|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
101471374|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471375|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
101471376|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101471377|NCT00287352|Analgesics|analgesics|mesh-ancestor
101471378|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
101471379|NCT04823962|Molgramostim|molgramostim|mesh-list
101471380|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471381|NCT00252668|Etanercept|etanercept|mesh-list
101471382|NCT00252668|Methotrexate|methotrexate|mesh-list
101471383|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101471384|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
101471385|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471386|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471387|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471388|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
101471389|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471390|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471391|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101471392|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471393|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101471394|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471395|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
101471396|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471397|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101471398|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101471399|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101471400|NCT00252668|Analgesics|analgesics|mesh-ancestor
101471401|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
101471402|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471403|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471404|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471405|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
101471407|NCT02271997|Trace Elements|trace elements|mesh-ancestor
101471408|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
101471409|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471410|NCT02271997|Hematinics|hematinics|mesh-ancestor
101471411|NCT00287391|Rabeprazole|rabeprazole|mesh-list
101471412|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101471413|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471414|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101471445|NCT01680718|Oxytocin|oxytocin|mesh-list
101471446|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
101471447|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471448|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471449|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
101360779|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101360780|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101360781|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360782|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360783|NCT00218569|Naltrexone|naltrexone|mesh-list
101360784|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101360785|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101360786|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360787|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
101471450|NCT01680718|Coagulants|coagulants|mesh-ancestor
101471451|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101471452|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101471453|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
101471454|NCT01680796|Dexamethasone|dexamethasone|mesh-list
101471455|NCT01680796|Bortezomib|bortezomib|mesh-list
101471456|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471457|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
101471458|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
101471459|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471460|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471461|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471462|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
101471463|NCT01680796|Hormones|hormones|mesh-ancestor
101471466|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471468|NCT00252785|Theophylline|theophylline|mesh-list
101471469|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
101471470|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471471|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101471472|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
101471473|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471474|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471475|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101471476|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
101471477|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
101471478|NCT00252785|Hormones|hormones|mesh-ancestor
101471479|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471480|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101471481|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471482|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471483|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471484|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471485|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471486|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101471487|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471488|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
101471489|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101471490|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101471491|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
101471492|NCT01680913|Anesthetics|anesthetics|mesh-list
101471493|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471494|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471495|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
101471497|NCT01680952|Tacrolimus|tacrolimus|mesh-list
101471498|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471499|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
101471500|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471501|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101471502|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471503|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471504|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101471505|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471506|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101471507|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
101471508|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360788|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360789|NCT00218608|Disulfiram|disulfiram|mesh-list
101360790|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101360791|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101360792|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360793|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360794|NCT00042146|Zolpidem|zolpidem|mesh-list
101360795|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101360796|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101360797|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360798|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360799|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101360800|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
101471509|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471510|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
101471511|NCT00252824|Budesonide|budesonide|mesh-list
101471512|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
101471513|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471514|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101471515|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
101471516|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471517|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471518|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101471519|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
101471520|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
101471521|NCT00252824|Hormones|hormones|mesh-ancestor
101471522|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471523|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101471524|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471525|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471526|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471527|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471528|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471529|NCT00281190|Dimercaprol|dimercaprol|mesh-list
101471530|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
101471531|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
101471532|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471533|NCT00252863|Fluticasone|fluticasone|mesh-list
101471535|NCT00252863|Budesonide|budesonide|mesh-list
101471549|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101471550|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
101471551|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
101471552|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101471553|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
101471555|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471556|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101471557|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101471558|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101471559|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471560|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471561|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471562|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
101471563|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471564|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101471565|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
101471566|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101471567|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101471568|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101471569|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360801|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
101360802|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360803|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360804|NCT00412321|Siltuximab|siltuximab|mesh-list
101360805|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360806|NCT00219232|Rivastigmine|rivastigmine|mesh-list
101360807|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101360808|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360809|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360810|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
101360811|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360812|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360813|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101360814|NCT00219232|Protective Agents|protective agents|mesh-ancestor
101360815|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
101360816|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101360817|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360818|NCT00219310|Famciclovir|famciclovir|mesh-list
101360819|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
101360820|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360821|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101360822|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360823|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360824|NCT00219388|Simendan|simendan|mesh-list
101360825|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101360826|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
101360827|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101360828|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101360829|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360830|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360831|NCT00219388|Protective Agents|protective agents|mesh-ancestor
101360832|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471570|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
101471571|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101471572|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101471573|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
101471574|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
101471575|NCT01681537|Cytarabine|cytarabine|mesh-list
101471576|NCT01681537|Etoposide|etoposide|mesh-list
101471577|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
101471578|NCT01681537|Lenalidomide|lenalidomide|mesh-list
101471579|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471580|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360834|NCT00219466|Tocopherols|tocopherols|mesh-list
101360835|NCT00219466|Vitamin E|vitamin e|mesh-list
101360836|NCT00219466|Tocotrienols|tocotrienols|mesh-list
101360837|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
101360838|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
101360839|NCT00219466|Trace Elements|trace elements|mesh-ancestor
101360840|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
101360841|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360842|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
101360843|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360844|NCT00219466|Protective Agents|protective agents|mesh-ancestor
101360845|NCT00219466|Vitamins|vitamins|mesh-ancestor
101360846|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
101360847|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
101471581|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101471582|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101471583|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471584|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471585|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471586|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
101471587|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
101471588|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471589|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471590|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
101471591|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471592|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101471593|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101471594|NCT01681537|Growth Substances|growth substances|mesh-ancestor
101471595|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
101471596|NCT01681537|Analgesics|analgesics|mesh-ancestor
101471601|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471603|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101471604|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
101471605|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
101471606|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471607|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471608|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
101471609|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471610|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101471611|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471612|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471613|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471614|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471615|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471616|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101471617|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101471618|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
101471619|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471620|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471621|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101471622|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101471623|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
101471624|NCT02279914|Misoprostol|misoprostol|mesh-list
101471625|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101471626|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
101471627|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471628|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471629|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101471630|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471631|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
101360848|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101360849|NCT00042302|Paclitaxel|paclitaxel|mesh-list
101360850|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101360851|NCT00042302|Carboplatin|carboplatin|mesh-list
101413783|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
101360852|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101360853|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360854|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101360855|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101360856|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101360857|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360858|NCT00219700|Ibuprofen|ibuprofen|mesh-list
101360859|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101471632|NCT00281307|Tocopherols|tocopherols|mesh-list
101471633|NCT00281307|Vitamin E|vitamin e|mesh-list
101471634|NCT00281307|Tocotrienols|tocotrienols|mesh-list
101471635|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
101471636|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
101471637|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471638|NCT00281307|Protective Agents|protective agents|mesh-ancestor
101471639|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471640|NCT00281307|Vitamins|vitamins|mesh-ancestor
101471641|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
101471642|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101471643|NCT01682746|Trioxsalen|trioxsalen|mesh-list
101471644|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471645|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
101471646|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101471648|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101471649|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101471651|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101471652|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
101471653|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
101471654|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101471655|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471656|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471657|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101471658|NCT01683175|Cisplatin|cisplatin|mesh-list
101471659|NCT01683175|Vinorelbine|vinorelbine|mesh-list
101471660|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471661|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471662|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471663|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471664|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471665|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471666|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471667|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471668|NCT01683253|Dopamine|dopamine|mesh-list
101471669|NCT01683253|Levodopa|levodopa|mesh-list
101471670|NCT01683253|Carbidopa|carbidopa|mesh-list
101471675|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471676|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471677|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471678|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101471679|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471680|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101471681|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
101471682|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
101471683|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471684|NCT01683253|Protective Agents|protective agents|mesh-ancestor
101471686|NCT01683292|Emetics|emetics|mesh-ancestor
101471687|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471688|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
101471689|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471690|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101360860|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360861|NCT00219700|Analgesics|analgesics|mesh-ancestor
101360862|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
101360863|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360864|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360865|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360866|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360867|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101471691|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
101471692|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
101471693|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471694|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471695|NCT00253058|Cetirizine|cetirizine|mesh-list
101471696|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101471697|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101471698|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101471699|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
101471700|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
101471701|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471702|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471703|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471704|NCT01683682|Carboplatin|carboplatin|mesh-list
101471705|NCT01683682|Vinorelbine|vinorelbine|mesh-list
101471706|NCT01683682|Nintedanib|nintedanib|mesh-list
101471707|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471708|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471709|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471710|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471711|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471712|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471713|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471714|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471715|NCT00287742|Risperidone|risperidone|mesh-list
101471716|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101471717|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
101471718|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471719|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471720|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471721|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471722|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471723|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471724|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471725|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101471726|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
101471727|NCT04527562|Colchicine|colchicine|mesh-list
101471728|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
101471729|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471730|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471731|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471732|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471733|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471734|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471735|NCT01684072|Vaccines|vaccines|mesh-list
101471736|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
101471737|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471738|NCT01684111|Vinorelbine|vinorelbine|mesh-list
101471739|NCT01684111|Nintedanib|nintedanib|mesh-list
101471740|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101471741|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471745|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471747|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471748|NCT00253136|Risperidone|risperidone|mesh-list
101471749|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101471750|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
101471751|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471752|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360868|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360869|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360870|NCT00219739|Interferons|interferons|mesh-list
101360871|NCT00219739|Cytarabine|cytarabine|mesh-list
101360872|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
101360873|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360874|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
101360875|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360876|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360877|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
101360878|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360879|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101360880|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
101360881|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360882|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101360883|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360884|NCT00219778|Mifepristone|mifepristone|mesh-list
101471753|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471754|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471755|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471756|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471757|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471758|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101471759|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
101471760|NCT01684306|Modafinil|modafinil|mesh-list
101471761|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101471762|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471763|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101471764|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101471766|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471768|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
101471769|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
101471770|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471771|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471772|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
101471773|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471774|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101471775|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101471776|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101471777|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471778|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471779|NCT00416871|Interferons|interferons|mesh-list
101471780|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
101471781|NCT00416871|Aldesleukin|aldesleukin|mesh-list
101471782|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471783|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
101471784|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471785|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
101471786|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471787|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101471788|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101471789|NCT01684657|Asenapine|asenapine|mesh-list
101471790|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471791|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471792|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471793|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360885|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101360886|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
101360887|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101360888|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360889|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101360890|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101360891|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101360892|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
101471794|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471795|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
101471796|NCT00416910|Fludarabine|fludarabine|mesh-list
101471797|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
101471798|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471799|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
101471800|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471801|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471802|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101471803|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
101471804|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471805|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471806|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101471807|NCT00416910|Analgesics|analgesics|mesh-ancestor
101471808|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
101471809|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471810|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101471818|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
101471819|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471820|NCT02279992|Carboplatin|carboplatin|mesh-list
101471821|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101471822|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471823|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101471824|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101471825|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101471826|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471827|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471828|NCT02279992|Urological Agents|urological agents|mesh-ancestor
101471830|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
101471831|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471832|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471833|NCT00287820|Olanzapine|olanzapine|mesh-list
101471834|NCT00287820|Risperidone|risperidone|mesh-list
101471835|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101471836|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
101471837|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471838|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471839|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471840|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471841|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471842|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471843|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471844|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101471845|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
101471846|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
101471847|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
101471848|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471849|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471850|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101471851|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101471852|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471853|NCT02272348|Insulin|insulin|mesh-list
101471854|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471855|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471856|NCT00253214|Galantamine|galantamine|mesh-list
101360893|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101360894|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101360895|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
101360896|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101360897|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
101360898|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101360899|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101360900|NCT00219856|Propofol|propofol|mesh-list
101360901|NCT00219856|Desflurane|desflurane|mesh-list
101360902|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101471857|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101471858|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471859|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471860|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
101471861|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471862|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471863|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101471864|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
101471865|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471866|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
101471867|NCT00287859|Topotecan|topotecan|mesh-list
101471868|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101471869|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101471870|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471871|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471872|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471873|NCT01684969|Haloperidol|haloperidol|mesh-list
101471874|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
101471875|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
101471876|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
101471877|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471878|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471891|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
101471892|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471895|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471896|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471897|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101471898|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471899|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471901|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471902|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101471903|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
101471904|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101471905|NCT04527679|Lenvatinib|lenvatinib|mesh-list
101471906|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471907|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471908|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471909|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471910|NCT01685281|Metadoxine|metadoxine|mesh-list
101471911|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101471912|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101471913|NCT00417066|Ganirelix|ganirelix|mesh-list
101471914|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
101471915|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101471916|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
101471917|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101471918|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471919|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101471920|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101360903|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360904|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360905|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101360906|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
101360907|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
101360908|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101360909|NCT00042458|Pramlintide|pramlintide|mesh-list
101360910|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101360911|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471921|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471922|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
101471923|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471925|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101471926|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101471927|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471928|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101471929|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101471930|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471931|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471932|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471933|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101471934|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101471935|NCT01685515|Decitabine|decitabine|mesh-list
101471936|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
101471937|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471938|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
101471939|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471940|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471948|NCT00253487|Temozolomide|temozolomide|mesh-list
101471949|NCT00253487|Busulfan|busulfan|mesh-list
101471950|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101471951|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101471952|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
101471953|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471954|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471955|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471956|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
101471957|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471958|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101471960|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
101471961|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101471962|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471963|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101471964|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
101471965|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471966|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471967|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471968|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471969|NCT04527211|Ivermectin|ivermectin|mesh-list
101471970|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101471971|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471972|NCT00253526|Bevacizumab|bevacizumab|mesh-list
101471973|NCT00253526|Gemcitabine|gemcitabine|mesh-list
101471974|NCT00253526|Antibodies|antibodies|mesh-list
101471975|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
101471976|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101471977|NCT00253526|Mitogens|mitogens|mesh-list
101471978|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101471979|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471980|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101471981|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101471982|NCT00253526|Growth Substances|growth substances|mesh-ancestor
101471983|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471984|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
101360912|NCT00219895|Ibuprofen|ibuprofen|mesh-list
101360913|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101360914|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101360915|NCT00219895|Analgesics|analgesics|mesh-ancestor
101360916|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
101360917|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360918|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360919|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101360920|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101360921|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101360922|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471985|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
101471986|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471987|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
101471988|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471989|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471990|NCT01686217|Niacinamide|niacinamide|mesh-list
101471991|NCT01686217|Peficitinib|peficitinib|mesh-list
101471992|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471993|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471994|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471995|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
101471996|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471997|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
101471998|NCT01686217|Vitamins|vitamins|mesh-ancestor
101471999|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
101472000|NCT00253565|Capecitabine|capecitabine|mesh-list
101472001|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
101472002|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472003|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
101472004|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472005|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472006|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472007|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472008|NCT01686529|Bevacizumab|bevacizumab|mesh-list
101472009|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472010|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472011|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101472015|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101472016|NCT01686607|Itraconazole|itraconazole|mesh-list
101472017|NCT01686607|Fluconazole|fluconazole|mesh-list
101472018|NCT01686607|Voriconazole|voriconazole|mesh-list
101472019|NCT01686607|Amphotericin B|amphotericin b|mesh-list
101472020|NCT01686607|Caspofungin|caspofungin|mesh-list
101472021|NCT01686607|Micafungin|micafungin|mesh-list
101472022|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
101472023|NCT01686607|Clotrimazole|clotrimazole|mesh-list
101472024|NCT01686607|Miconazole|miconazole|mesh-list
101472025|NCT01686607|Anidulafungin|anidulafungin|mesh-list
101472026|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472027|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101472028|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101472029|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472030|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472031|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101472032|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
101472033|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472034|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472035|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101472036|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101472037|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101472038|NCT01686607|Amebicides|amebicides|mesh-ancestor
101472039|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101472040|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101472041|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101360923|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360925|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101360926|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360927|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101360928|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360929|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360930|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101360931|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
101360932|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101360933|NCT00219973|Bemiparin|bemiparin|mesh-list
101472042|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101472043|NCT01686802|Ibuprofen|ibuprofen|mesh-list
101472044|NCT01686802|Morphine|morphine|mesh-list
101472045|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101472046|NCT01686802|Narcotics|narcotics|mesh-ancestor
101472047|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472048|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472049|NCT01686802|Analgesics|analgesics|mesh-ancestor
101472050|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
101472051|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472052|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101472053|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101472054|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472055|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472056|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101472057|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472058|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472059|NCT00253721|Melphalan|melphalan|mesh-list
101472060|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472061|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
101472062|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472063|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472064|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101472065|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472066|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
101472067|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472068|NCT00281892|Vidarabine|vidarabine|mesh-list
101472069|NCT00281892|Fludarabine|fludarabine|mesh-list
101472071|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472072|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472073|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
101472074|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472075|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472076|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
101472077|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472078|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
101472079|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472080|NCT02274571|Estrogens|estrogens|mesh-list
101472081|NCT02274571|Hormones|hormones|mesh-ancestor
101472082|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472083|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472088|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
101472090|NCT00281931|Fludarabine|fludarabine|mesh-list
101472091|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
101472092|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472093|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
101472094|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472095|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472096|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472097|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
101360934|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
101360935|NCT00220051|Capecitabine|capecitabine|mesh-list
101360936|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
101360937|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360938|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
101360939|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360940|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360941|NCT00077415|Gemcitabine|gemcitabine|mesh-list
101360942|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472098|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472099|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472100|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101472101|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472102|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472103|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
101472104|NCT01687348|Lidocaine|lidocaine|mesh-list
101472105|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
101472106|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
101472107|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472108|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472109|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
101472110|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472111|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101472112|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101472113|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101472114|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472115|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472117|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472118|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101472119|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101472120|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101472121|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472122|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472123|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472124|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472125|NCT01687582|Liraglutide|liraglutide|mesh-list
101472126|NCT01687582|Exenatide|exenatide|mesh-list
101472127|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101472128|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472129|NCT01687582|Incretins|incretins|mesh-ancestor
101472130|NCT01687582|Hormones|hormones|mesh-ancestor
101472131|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472132|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101472133|NCT01687699|Spironolactone|spironolactone|mesh-list
101472134|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101472135|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
101472136|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472137|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472138|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101472139|NCT01687699|Diuretics|diuretics|mesh-ancestor
101472140|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
101472141|NCT00287937|Paclitaxel|paclitaxel|mesh-list
101472142|NCT00287937|Carboplatin|carboplatin|mesh-list
101472143|NCT00287937|Vorinostat|vorinostat|mesh-list
101472144|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101472145|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472146|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472147|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472148|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472149|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472150|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101472151|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472152|NCT01687894|Vasopressins|vasopressins|mesh-list
101472153|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
101360944|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360945|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360946|NCT00042536|Naltrexone|naltrexone|mesh-list
101360947|NCT00042536|Yohimbine|yohimbine|mesh-list
101360948|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101360949|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101360950|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472154|NCT01687894|Propofol|propofol|mesh-list
101472164|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
101472165|NCT01687894|Coagulants|coagulants|mesh-ancestor
101472166|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101472167|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101472168|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
101472170|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101472171|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101472172|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472173|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472174|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472175|NCT01688089|Levodopa|levodopa|mesh-list
101472176|NCT01688089|Carbidopa|carbidopa|mesh-list
101472177|NCT01688089|Entacapone|entacapone|mesh-list
101472178|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101472179|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101472180|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
101472181|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472182|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472183|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472184|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101472185|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472186|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101472188|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101472189|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472190|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472191|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472192|NCT00288171|Allopurinol|allopurinol|mesh-list
101472193|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
101472194|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472195|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472196|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
101472197|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472198|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101472199|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
101472200|NCT00288171|Protective Agents|protective agents|mesh-ancestor
101472201|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472202|NCT00253955|Levofloxacin|levofloxacin|mesh-list
101472203|NCT00253955|Tazobactam|tazobactam|mesh-list
101472204|NCT00253955|Piperacillin|piperacillin|mesh-list
101472205|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101472206|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101472207|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472208|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472209|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101472210|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101472211|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472212|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472213|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472214|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101472215|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101472216|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101472217|NCT00288249|Sagopilone|sagopilone|mesh-list
101472218|NCT00288249|Epothilones|epothilones|mesh-list
101472219|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472220|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472234|NCT01600573|Topotecan|topotecan|mesh-list
101360951|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
101360952|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360953|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
101360954|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
101472235|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101472236|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101472237|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472238|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472239|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472240|NCT01600612|Oxytocin|oxytocin|mesh-list
101472241|NCT01600612|Carbetocin|carbetocin|mesh-list
101472242|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
101472243|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101472244|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472245|NCT01600768|Lactams|lactams|mesh-list
101472246|NCT01600768|beta-Lactams|beta-lactams|mesh-list
101472247|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472248|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472249|NCT00414947|Vildagliptin|vildagliptin|mesh-list
101472250|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101472251|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472252|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101472253|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
101472254|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472255|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472256|NCT00288444|Docetaxel|docetaxel|mesh-list
101472257|NCT00288444|Lonafarnib|lonafarnib|mesh-list
101472258|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472259|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472260|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472261|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472262|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472263|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472264|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101472265|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
101472266|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472267|NCT00415064|Dexamethasone|dexamethasone|mesh-list
101472268|NCT00415064|Lenalidomide|lenalidomide|mesh-list
101472269|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472270|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
101472271|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
101472272|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472273|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472274|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101472275|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
101472276|NCT00415064|Hormones|hormones|mesh-ancestor
101472277|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472278|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101472279|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472280|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
101472286|NCT00415103|Palonosetron|palonosetron|mesh-list
101472287|NCT00415103|Granisetron|granisetron|mesh-list
101472288|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
101472289|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
101472290|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472291|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472292|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101472293|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101472294|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472295|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472296|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101472297|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101472298|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
101472299|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
101472300|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
101472301|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472302|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472303|NCT00417729|Acarbose|acarbose|mesh-list
101472304|NCT00417729|Glyburide|glyburide|mesh-list
101472305|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101472306|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472307|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360955|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101360956|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101360957|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101360958|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472308|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101472309|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472310|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
101472311|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101472312|NCT00254189|Estradiol|estradiol|mesh-list
101472313|NCT00254189|Estrogens|estrogens|mesh-ancestor
101472314|NCT00254189|Hormones|hormones|mesh-ancestor
101472315|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472316|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472317|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101472318|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
101472319|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101472320|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101472321|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101472322|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101472323|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101472324|NCT01600807|Gemcitabine|gemcitabine|mesh-list
101472325|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101472326|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472327|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
101472328|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472329|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472330|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472331|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472332|NCT00288483|Policosanol|policosanol|mesh-list
101472333|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101472335|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
101472336|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472337|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101472338|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101472339|NCT01600963|Bedaquiline|bedaquiline|mesh-list
101472340|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
101472341|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
101472342|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472343|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472344|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101472345|NCT00288522|Lanreotide|lanreotide|mesh-list
101472346|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472347|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
101472348|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472349|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413797|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101472350|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472351|NCT01601002|Mirtazapine|mirtazapine|mesh-list
101472360|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101472361|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472362|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472363|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101472364|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101472365|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101472366|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472367|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101472368|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101472369|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
101472370|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101472371|NCT00288561|Ranibizumab|ranibizumab|mesh-list
101472372|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101472373|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101472374|NCT00288561|Growth Substances|growth substances|mesh-ancestor
101472375|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472376|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
101472377|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472378|NCT01607086|Lamotrigine|lamotrigine|mesh-list
101472379|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
101472380|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101472381|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360959|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360960|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360961|NCT00042536|Urological Agents|urological agents|mesh-ancestor
101360962|NCT00220129|Capecitabine|capecitabine|mesh-list
101360963|NCT00220129|Epirubicin|epirubicin|mesh-list
101472382|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472383|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101472384|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472385|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101472386|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472387|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472388|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472389|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101472390|NCT01607125|Vortioxetine|vortioxetine|mesh-list
101472391|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472392|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472393|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101472394|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472395|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472396|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472397|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101472398|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101472399|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472400|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472401|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472402|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
101472403|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101472404|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101472405|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101472406|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101472407|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101472408|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
101472409|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101472410|NCT00254345|Protective Agents|protective agents|mesh-ancestor
101472411|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472412|NCT00254618|Mesalamine|mesalamine|mesh-list
101472413|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101472414|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101472426|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101472427|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472428|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
101472430|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
101472431|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472432|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472434|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472435|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101472436|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
101472437|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101472438|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472439|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472440|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101472441|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
101472442|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101472443|NCT00254657|Levetiracetam|levetiracetam|mesh-list
101472444|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
101472445|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
101472446|NCT02482753|Exemestane|exemestane|mesh-list
101472447|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472448|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101472449|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101472450|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472451|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472452|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101360964|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360965|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360966|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
101360967|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101360968|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101360969|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101360970|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360971|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360972|NCT00220168|Capecitabine|capecitabine|mesh-list
101360973|NCT00220168|Irinotecan|irinotecan|mesh-list
101472453|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
101472454|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472455|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472456|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101472457|NCT00254735|Clomipramine|clomipramine|mesh-list
101472458|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472459|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472460|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101472461|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472462|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472463|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472464|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101472465|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101472466|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101472467|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472468|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472469|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472470|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
101472471|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
101472472|NCT00288873|Vitamin D|vitamin d|mesh-list
101472473|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
101472474|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101472475|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472476|NCT00288873|Vitamins|vitamins|mesh-ancestor
101472477|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
101472482|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472483|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472485|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472486|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101472487|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101472488|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101472489|NCT01608139|Analgesics|analgesics|mesh-ancestor
101472490|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
101472491|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472492|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472493|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472494|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472495|NCT01607671|Timolol|timolol|mesh-list
101472496|NCT01607671|Maleic acid|maleic acid|mesh-list
101472497|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472498|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472499|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101472500|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101472501|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472502|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472503|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472504|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101472505|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472506|NCT00288951|Travoprost|travoprost|mesh-list
101472507|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472508|NCT00254774|Valproic Acid|valproic acid|mesh-list
101472509|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101472510|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472511|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101360974|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101360975|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
101472512|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101472513|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472514|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472515|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472516|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
101472517|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472518|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472519|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
101472520|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472521|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
101472522|NCT01608334|Fentanyl|fentanyl|mesh-list
101472523|NCT01608334|Sufentanil|sufentanil|mesh-list
101472524|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101472525|NCT01608334|Narcotics|narcotics|mesh-ancestor
101472526|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472527|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472528|NCT01608334|Analgesics|analgesics|mesh-ancestor
101472529|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
101472530|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472531|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101472532|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101472533|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
101472534|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
101472535|NCT01608373|Lidocaine|lidocaine|mesh-list
101472536|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
101472537|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
101472538|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472539|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472540|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
101472541|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472542|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101472543|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101472544|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101472545|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472546|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472547|NCT01608412|Everolimus|everolimus|mesh-list
101472548|NCT01608412|Tacrolimus|tacrolimus|mesh-list
101472551|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472552|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101472553|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472554|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472555|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101472556|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472557|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472558|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101472559|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472560|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472561|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101472562|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472563|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472564|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472565|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
101472566|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472567|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101472568|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472569|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472570|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472571|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472572|NCT00254930|Risperidone|risperidone|mesh-list
101472573|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101472574|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
101472575|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472576|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472577|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472579|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472580|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101360976|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472581|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472582|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101472583|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
101472584|NCT02273440|Theophylline|theophylline|mesh-list
101472585|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101472586|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
101472587|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472588|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472589|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101472590|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
101472591|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101472592|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472593|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472594|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
101472595|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101472596|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101472597|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
101472598|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472599|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
101472600|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101472601|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101472602|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101472603|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
101472604|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472605|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472606|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472608|NCT00270075|Hematinics|hematinics|mesh-ancestor
101472609|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
101472610|NCT01588756|Goralatide|goralatide|mesh-list
101472611|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
101472612|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472613|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472614|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472615|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101472616|NCT01588756|Growth Substances|growth substances|mesh-ancestor
101472617|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472618|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101472619|NCT01588756|Protective Agents|protective agents|mesh-ancestor
101472620|NCT04719104|Bilirubin|bilirubin|mesh-list
101472621|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
101472628|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101472629|NCT01588795|Vitamins|vitamins|mesh-ancestor
101472630|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
101472631|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472632|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101472633|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101472634|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
101472635|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472636|NCT00107614|Rituximab|rituximab|mesh-list
101472637|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472638|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472639|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
101472640|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472641|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472642|NCT00255242|Simvastatin|simvastatin|mesh-list
101472643|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101472644|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101472645|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
101472646|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472647|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101472648|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101472649|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472650|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
101472651|NCT00270114|Hematinics|hematinics|mesh-ancestor
101472652|NCT00107380|Prednisone|prednisone|mesh-list
101472653|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
101472654|NCT00107380|Rituximab|rituximab|mesh-list
101472655|NCT00107380|Doxorubicin|doxorubicin|mesh-list
101472656|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101472657|NCT00107380|Vincristine|vincristine|mesh-list
101472658|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
101472659|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472660|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
101360977|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360978|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101360979|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101360980|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101360981|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101360982|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101360983|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101360984|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101360985|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472661|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472662|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472663|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472664|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
101472665|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472666|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472667|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101472668|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472669|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101472670|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101472671|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101472672|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472673|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472674|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
101472675|NCT00107380|Hormones|hormones|mesh-ancestor
101472676|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472677|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101472678|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101472679|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472680|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472681|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472682|NCT00270153|Enalapril|enalapril|mesh-list
101472683|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101472684|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
101472685|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472686|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472687|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472688|NCT04054531|Paclitaxel|paclitaxel|mesh-list
101472689|NCT04054531|Carboplatin|carboplatin|mesh-list
101472690|NCT04054531|Pemetrexed|pemetrexed|mesh-list
101472692|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472694|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472695|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472696|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472697|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472698|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101472699|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101472700|NCT00289263|Paclitaxel|paclitaxel|mesh-list
101472701|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101472702|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472703|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472704|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472705|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472706|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472707|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101472708|NCT00255437|Hematinics|hematinics|mesh-ancestor
101472709|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101472710|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101472711|NCT00255476|Gefitinib|gefitinib|mesh-list
101472712|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472713|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472714|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472715|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472716|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
101472717|NCT00270270|Hematinics|hematinics|mesh-ancestor
101472718|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101472719|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101472720|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472721|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101472722|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472723|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472724|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101472725|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101472726|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472727|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472728|NCT00289419|Ketorolac|ketorolac|mesh-list
101472729|NCT00289419|Epinephrine|epinephrine|mesh-list
101472730|NCT00289419|Racepinephrine|racepinephrine|mesh-list
101472731|NCT00289419|Morphine|morphine|mesh-list
101472732|NCT00289419|Ropivacaine|ropivacaine|mesh-list
101472734|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101472735|NCT00289419|Narcotics|narcotics|mesh-ancestor
101472736|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472737|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472738|NCT00289419|Analgesics|analgesics|mesh-ancestor
101472739|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
101472740|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472741|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
101472742|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
101472743|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101472744|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101472745|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472746|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472747|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101472748|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472749|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472750|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101472751|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101472752|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472753|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472754|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101472755|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101472756|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
101472757|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101472758|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
101472759|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
101472760|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
101472761|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101472762|NCT00255554|Escitalopram|escitalopram|mesh-list
101472763|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101472764|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101472796|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472797|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472798|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101472799|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472800|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
101472801|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101472802|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472803|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101472804|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101472805|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
101472806|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472807|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472812|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472813|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472814|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
101472815|NCT00255749|Hematinics|hematinics|mesh-ancestor
101472816|NCT04482361|Antibodies|antibodies|mesh-list
101472817|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
101472818|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472819|NCT00270543|Leucovorin|leucovorin|mesh-list
101472820|NCT00270543|Fluorouracil|fluorouracil|mesh-list
101472821|NCT00270543|Docetaxel|docetaxel|mesh-list
101472822|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
101472823|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472824|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472825|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101360986|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101360987|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360988|NCT00042575|Analgesics|analgesics|mesh-ancestor
101360989|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
101360990|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101360991|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
101360992|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472826|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472827|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
101472829|NCT00270543|Antidotes|antidotes|mesh-ancestor
101472830|NCT00270543|Protective Agents|protective agents|mesh-ancestor
101472831|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
101472832|NCT00270543|Vitamins|vitamins|mesh-ancestor
101472833|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
101472834|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472835|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472836|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472837|NCT02960919|Amoxicillin|amoxicillin|mesh-list
101472838|NCT02960919|Gentamicins|gentamicins|mesh-list
101472839|NCT02960919|Penicillins|penicillins|mesh-list
101472840|NCT02960919|Ampicillin|ampicillin|mesh-list
101472841|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101472842|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472843|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101472844|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472845|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472846|NCT00270582|Gemcitabine|gemcitabine|mesh-list
101472847|NCT00270582|Docetaxel|docetaxel|mesh-list
101472848|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472849|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472850|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
101472851|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472852|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472853|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472854|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472855|NCT01600456|Sertraline|sertraline|mesh-list
101472856|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472857|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472858|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101472859|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101472860|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472861|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472862|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472863|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
101472864|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472865|NCT00289809|Ifosfamide|ifosfamide|mesh-list
101472866|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472867|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
101472868|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472869|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472870|NCT00256100|PENTA|penta|mesh-list
101472871|NCT00256100|Fondaparinux|fondaparinux|mesh-list
101472872|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101472873|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
101472874|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101472875|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
101472876|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472877|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472878|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
101472879|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101472881|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101472882|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101472883|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
101472884|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472885|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
101472886|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472887|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
101360993|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
101360994|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101360995|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
101360996|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101360997|NCT00077454|Temozolomide|temozolomide|mesh-list
101360998|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101360999|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361000|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
101361001|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361002|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361003|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472888|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472889|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472890|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101472891|NCT01609387|Tocopherols|tocopherols|mesh-list
101472892|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
101472893|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472894|NCT01609387|Protective Agents|protective agents|mesh-ancestor
101472895|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472897|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
101472898|NCT00256178|Simvastatin|simvastatin|mesh-list
101472899|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101472900|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101472901|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
101472902|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472903|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101472904|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101472905|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472906|NCT02488408|Cytarabine|cytarabine|mesh-list
101472907|NCT02488408|Decitabine|decitabine|mesh-list
101472908|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101472909|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
101472910|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472911|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472912|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
101472913|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472914|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472915|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
101472916|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472917|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472918|NCT00270777|Promethazine|promethazine|mesh-list
101472919|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
101472921|NCT00270777|Epinephrine|epinephrine|mesh-list
101472922|NCT00270777|Racepinephrine|racepinephrine|mesh-list
101472923|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
101472924|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472925|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101472926|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101472927|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101472928|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472929|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472930|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472931|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101472932|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101472933|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
101472934|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472935|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101472936|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
101472937|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
101472938|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
101472939|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101361004|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361005|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101361006|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101361007|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101361008|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101472941|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
101472942|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101472943|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
101472944|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
101472945|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101472946|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101472947|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101472948|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472949|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
101472951|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
101472952|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
101472953|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101472954|NCT00256256|Glucagon|glucagon|mesh-list
101472955|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101472956|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101472981|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472982|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472983|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101472984|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
101472985|NCT00270816|Interferons|interferons|mesh-list
101472986|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472987|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
101472988|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101472989|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
101472990|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472991|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101472992|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
101472993|NCT01609816|Dasatinib|dasatinib|mesh-list
101472994|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472995|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101472996|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472997|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472998|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
101472999|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473000|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473001|NCT00290082|Midazolam|midazolam|mesh-list
101473002|NCT00290082|Loxapine|loxapine|mesh-list
101473003|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101473004|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101473005|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473006|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473007|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101473008|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473014|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
101473015|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473016|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473017|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101473018|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101473019|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
101473020|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
101473021|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473022|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473023|NCT02270437|Epinephrine|epinephrine|mesh-list
101473024|NCT02270437|Racepinephrine|racepinephrine|mesh-list
101473026|NCT02270437|Ropivacaine|ropivacaine|mesh-list
101473027|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
101473028|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
101473029|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
101473030|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473031|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473032|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
101473033|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473034|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101473035|NCT02270437|Narcotics|narcotics|mesh-ancestor
101473036|NCT02270437|Analgesics|analgesics|mesh-ancestor
101361009|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
101361010|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361011|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361012|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101473037|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101473038|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101473039|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
101473040|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101473041|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101473042|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
101473043|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473044|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473045|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101473046|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101473047|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
101473048|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101473049|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
101473050|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
101473051|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
101473052|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101473053|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
101473054|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
101473056|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
101473057|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473058|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
101473059|NCT02270749|Hematinics|hematinics|mesh-ancestor
101473060|NCT02270788|Leucovorin|leucovorin|mesh-list
101473061|NCT02270788|Cytarabine|cytarabine|mesh-list
101473062|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
101473063|NCT02270788|Methotrexate|methotrexate|mesh-list
101473064|NCT02270788|Sorafenib|sorafenib|mesh-list
101473065|NCT02270788|Crenolanib|crenolanib|mesh-list
101473066|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101473067|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
101473068|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101473069|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473070|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473071|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
101473072|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473073|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473074|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101473075|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473076|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101473077|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473078|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
101473079|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473080|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101473081|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
101473082|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473087|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
101473088|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101473089|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473091|NCT02270827|Aminophylline|aminophylline|mesh-list
101473092|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473093|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101473094|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
101473095|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473096|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473097|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101473098|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101473099|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101473100|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101473101|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473102|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473103|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101473104|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101473105|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
101473106|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473107|NCT02270827|Protective Agents|protective agents|mesh-ancestor
101473108|NCT00290121|Olanzapine|olanzapine|mesh-list
101473109|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
101361013|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101361014|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101361015|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101361016|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101473110|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
101473111|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473112|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473113|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473114|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101473115|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473116|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473117|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473118|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101473119|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101473120|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101473121|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473122|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473123|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
101473124|NCT04709744|Vitamin D|vitamin d|mesh-list
101473125|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
101473126|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
101473127|NCT04709744|Vitamins|vitamins|mesh-list
101473128|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
101473129|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473130|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101473131|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473132|NCT02271295|Enoxaparin|enoxaparin|mesh-list
101473133|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
101473134|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101473135|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101473136|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473137|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101473138|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101473139|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101473140|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101473141|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473142|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473143|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473144|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
101473145|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473146|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101473147|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
101473148|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473149|NCT02271646|Bupivacaine|bupivacaine|mesh-list
101473150|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
101473151|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
101473152|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473159|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473160|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473161|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473162|NCT02271958|Mifepristone|mifepristone|mesh-list
101473163|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101473164|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
101473165|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101473166|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473167|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101473168|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101473169|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101473170|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
101473171|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101473172|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101473173|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
101473174|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473175|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
101361017|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101361018|NCT00412555|Oseltamivir|oseltamivir|mesh-list
101361019|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
101361020|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361021|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487383|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473176|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101473177|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101473178|NCT00257036|Levofloxacin|levofloxacin|mesh-list
101473179|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101473180|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473181|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473182|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101473183|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473184|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473185|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473186|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473187|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101473188|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473190|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101473191|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
101473192|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473193|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473194|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473195|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101473196|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473197|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473198|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473199|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101473200|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
101473201|NCT02272270|Minocycline|minocycline|mesh-list
101473202|NCT02272270|Temozolomide|temozolomide|mesh-list
101473203|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101473204|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
101473205|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473206|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473207|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473208|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473209|NCT02272387|Vitamin D|vitamin d|mesh-list
101473210|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
101473211|NCT02272387|Vitamins|vitamins|mesh-ancestor
101473212|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
101473213|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473214|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101473215|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473216|NCT00257114|Bortezomib|bortezomib|mesh-list
101473217|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473218|NCT00271206|Progesterone|progesterone|mesh-list
101473219|NCT00271206|Progestins|progestins|mesh-ancestor
101473222|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473224|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
101473225|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101473226|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101473227|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473228|NCT02272660|Parecoxib|parecoxib|mesh-list
101473229|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101473230|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101473231|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473232|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473233|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101473234|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101473235|NCT02272660|Analgesics|analgesics|mesh-ancestor
101473236|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
101473237|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473238|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473239|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361022|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361023|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
101361024|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361025|NCT00042653|Cinacalcet|cinacalcet|mesh-list
101361026|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473240|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473241|NCT02272699|Paclitaxel|paclitaxel|mesh-list
101473242|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
101473243|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101473244|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473245|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473246|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473247|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473248|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473249|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101473250|NCT02272738|Paclitaxel|paclitaxel|mesh-list
101473251|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101473252|NCT02272738|Gemcitabine|gemcitabine|mesh-list
101473253|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101473254|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473255|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473256|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473257|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473258|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473259|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473260|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
101473261|NCT00271245|Selenium|selenium|mesh-list
101473262|NCT00271245|Selenic Acid|selenic acid|mesh-list
101473263|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
101473264|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473265|NCT00271245|Protective Agents|protective agents|mesh-ancestor
101473266|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473267|NCT00271245|Trace Elements|trace elements|mesh-ancestor
101473268|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
101473269|NCT02272855|Ipilimumab|ipilimumab|mesh-list
101473270|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101473271|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473272|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101473273|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473274|NCT00257270|Gabapentin|gabapentin|mesh-list
101473275|NCT00257270|Analgesics|analgesics|mesh-ancestor
101473276|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
101473277|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473278|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473281|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473282|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473283|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473284|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101473285|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101473286|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473287|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473288|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
101473289|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
101473290|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473291|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473292|NCT00257348|Docetaxel|docetaxel|mesh-list
101473309|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473311|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473312|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
101473313|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473314|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
101473315|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473316|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101473317|NCT00257426|Octreotide|octreotide|mesh-list
101473318|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473319|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473320|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361027|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361028|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101361029|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
101361030|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361032|NCT00073593|Bivalirudin|bivalirudin|mesh-list
101473321|NCT01601509|Tramazoline|tramazoline|mesh-list
101473322|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
101473323|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
101473324|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473325|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473326|NCT00416325|Lycopene|lycopene|mesh-list
101473327|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473328|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
101473329|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473330|NCT00416325|Protective Agents|protective agents|mesh-ancestor
101473331|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473332|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101473333|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101473334|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473335|NCT00257465|Vaccines|vaccines|mesh-list
101473336|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
101473337|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473338|NCT01601899|Tenofovir|tenofovir|mesh-list
101473339|NCT01601899|Lamivudine|lamivudine|mesh-list
101473340|NCT01601899|Efavirenz|efavirenz|mesh-list
101473341|NCT01601899|Stavudine|stavudine|mesh-list
101473342|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
101473343|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473344|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101473345|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101473346|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473347|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473348|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101473349|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101473350|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101473373|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473374|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
101473375|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473376|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101473377|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101473378|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101473380|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101473381|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101473382|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101473383|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
101473384|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
101473385|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473386|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473387|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473388|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101473389|NCT01602289|Gefitinib|gefitinib|mesh-list
101473390|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473391|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101473392|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473393|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473394|NCT00257621|Ritonavir|ritonavir|mesh-list
101473395|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101473396|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101473397|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
101473398|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473399|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473400|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101473401|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101473402|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
101473420|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473421|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101473422|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
101361034|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
101361035|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101361036|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101361037|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361038|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
101361039|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101361040|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361041|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361042|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
101361043|NCT00073593|Coagulants|coagulants|mesh-ancestor
101361044|NCT00220480|Escitalopram|escitalopram|mesh-list
101473423|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473424|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473425|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101473426|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473427|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
101473428|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473429|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
101473430|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101473431|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101473432|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101473433|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
101473434|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473435|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473436|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
101473437|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
101473438|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473439|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473440|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
101473441|NCT00290628|Hormones|hormones|mesh-ancestor
101473442|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473443|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101473444|NCT00290628|Protective Agents|protective agents|mesh-ancestor
101473445|NCT01602523|Budesonide|budesonide|mesh-list
101473446|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
101473447|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473448|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101473449|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
101473450|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473451|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473452|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101473453|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
101473454|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
101473455|NCT01602523|Hormones|hormones|mesh-ancestor
101473456|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473457|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101473458|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101473459|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101473460|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
101473461|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473495|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473496|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473497|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101473498|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
101473499|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473500|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473501|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101473502|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101473503|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101473504|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101361045|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101361046|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361047|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361048|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361049|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361051|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361052|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
101361053|NCT00220675|Hematinics|hematinics|mesh-ancestor
101361054|NCT00042731|Lycopene|lycopene|mesh-list
101361055|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361056|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
101361057|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361058|NCT00042731|Protective Agents|protective agents|mesh-ancestor
101361059|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361060|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101473505|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473506|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473507|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473521|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473523|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473524|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101473525|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101473526|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101473527|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101473528|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473529|NCT02961101|Decitabine|decitabine|mesh-list
101473530|NCT02961101|Antibodies|antibodies|mesh-list
101473531|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
101473532|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473533|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473534|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
101473535|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473536|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473537|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473538|NCT01602913|Paroxetine|paroxetine|mesh-list
101473539|NCT01602913|Pravastatin|pravastatin|mesh-list
101473540|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101473541|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101473542|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101473543|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473544|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473545|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
101473546|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473547|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101473548|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
101473549|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473550|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101473551|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473552|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473553|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101473554|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101473555|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
101473556|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101473557|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101473558|NCT00257699|Metronidazole|metronidazole|mesh-list
101473559|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
101361061|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101361062|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361063|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
101361064|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473560|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473561|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473562|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101473563|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101473564|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101473565|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473566|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473567|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473578|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101473580|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473581|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
101473582|NCT01603030|Hormones|hormones|mesh-ancestor
101473583|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473584|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473585|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473586|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473587|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
101473588|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
101473589|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473590|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473591|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101473592|NCT01603030|Protective Agents|protective agents|mesh-ancestor
101473593|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473594|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473595|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101473596|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473597|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473598|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473599|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101473600|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
101473601|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101473602|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101473603|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101473604|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101473606|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473607|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473608|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473609|NCT00290823|Albendazole|albendazole|mesh-list
101473611|NCT00290823|Omeprazole|omeprazole|mesh-list
101473612|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473613|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
101473614|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
101473615|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473616|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473617|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473618|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
101473619|NCT00290823|Hormones|hormones|mesh-ancestor
101473620|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473621|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473622|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473623|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101473624|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101473625|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473626|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473627|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
101473628|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101473629|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473630|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
101473635|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473636|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101473637|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
101473638|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473639|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101361065|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361066|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361067|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361068|NCT00077493|Antibodies|antibodies|mesh-list
101361069|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
101361070|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101361071|NCT00077493|Immunotoxins|immunotoxins|mesh-list
101361072|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
101361073|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
101361074|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361075|NCT00220831|Vitamin E|vitamin e|mesh-list
101361076|NCT00220831|Vitamins|vitamins|mesh-ancestor
101361077|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
101361078|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361079|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
101361080|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361081|NCT00220831|Protective Agents|protective agents|mesh-ancestor
101361082|NCT00220909|Lansoprazole|lansoprazole|mesh-list
101361083|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
101361084|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101361085|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361086|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101361087|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473640|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473641|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473642|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473643|NCT00271284|Insulin|insulin|mesh-list
101473644|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101473645|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
101473646|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
101473647|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
101473648|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473649|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473650|NCT00257816|Topotecan|topotecan|mesh-list
101473651|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473652|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101473653|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473654|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473655|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473656|NCT00271323|Docetaxel|docetaxel|mesh-list
101473657|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473658|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473659|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473660|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473661|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473662|NCT01603342|Clopidogrel|clopidogrel|mesh-list
101473663|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101473664|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101473665|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101473666|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101473667|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
101473668|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473669|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473670|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473671|NCT00257855|Lamotrigine|lamotrigine|mesh-list
101361088|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361090|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101361091|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101361092|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361093|NCT02966067|Anesthetics|anesthetics|mesh-list
101361094|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101473672|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
101473673|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101473674|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101473675|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473676|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473677|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473678|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101473679|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473680|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473681|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473682|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101473683|NCT01603498|Dexamethasone|dexamethasone|mesh-list
101473684|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
101473685|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101473686|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101473687|NCT01603498|Prednisolone|prednisolone|mesh-list
101473688|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
101473689|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101473690|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
101473691|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473692|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
101473693|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
101473694|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473695|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473696|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473697|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
101473698|NCT01603498|Hormones|hormones|mesh-ancestor
101473699|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473700|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473701|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473710|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473712|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
101473713|NCT01603654|Cathartics|cathartics|mesh-ancestor
101473714|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473715|NCT00257972|Aripiprazole|aripiprazole|mesh-list
101473716|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
101473717|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473718|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101473719|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473720|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473721|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473722|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
101473723|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
101473724|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473725|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473726|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101473727|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101473728|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
101473729|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101473731|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101473732|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101473733|NCT01603693|Calcium|calcium|mesh-list
101473734|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473735|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473736|NCT00258050|Lapatinib|lapatinib|mesh-list
101473737|NCT00258050|Midazolam|midazolam|mesh-list
101473738|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101473739|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101473740|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361095|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361096|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361098|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101361099|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101361100|NCT00042809|Paclitaxel|paclitaxel|mesh-list
101361101|NCT00042809|Trastuzumab|trastuzumab|mesh-list
101361102|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101473741|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473742|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101473743|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473744|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473745|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101473746|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
101473747|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
101473748|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
101473749|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
101473750|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473751|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473752|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473753|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101473754|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473755|NCT00271401|Heparin|heparin|mesh-list
101473756|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
101473757|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101473758|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101473759|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473760|NCT00258089|Levofloxacin|levofloxacin|mesh-list
101473761|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101473762|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473763|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473764|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101473765|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473766|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473767|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473768|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473779|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473780|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101473781|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101473782|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473783|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473784|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101473785|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101473786|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473787|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473788|NCT00258245|Aspirin|aspirin|mesh-list
101473789|NCT00258245|Vitamins|vitamins|mesh-list
101473790|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
101473793|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
101473794|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
101473795|NCT00258245|Bortezomib|bortezomib|mesh-list
101473796|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
101473797|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101473798|NCT00258245|BB 1101|bb 1101|mesh-list
101473799|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
101473800|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473801|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473802|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
101473803|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
101473804|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473805|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473806|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
101473807|NCT00258245|Hormones|hormones|mesh-ancestor
101473808|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361103|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361104|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361105|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361106|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361107|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361108|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361109|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361110|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101473809|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473810|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473811|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
101473812|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473813|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473814|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101473815|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101473816|NCT00258245|Analgesics|analgesics|mesh-ancestor
101473817|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
101473818|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473819|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101473820|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101473821|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101473822|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101473823|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
101473824|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
101473825|NCT00258245|Protective Agents|protective agents|mesh-ancestor
101473826|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473827|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
101473828|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
101473829|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473830|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473831|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101473832|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101473833|NCT00258245|Growth Substances|growth substances|mesh-ancestor
101473834|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101473835|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
101473837|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473840|NCT01604629|Infliximab|infliximab|mesh-list
101473841|NCT01604629|Golimumab|golimumab|mesh-list
101473842|NCT01604629|Etanercept|etanercept|mesh-list
101473843|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101473844|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101473845|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101473846|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101473847|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
101473848|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473849|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101473850|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101473851|NCT01604629|Analgesics|analgesics|mesh-ancestor
101473852|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
101473853|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473854|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473855|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473856|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
101473857|NCT00258284|Docetaxel|docetaxel|mesh-list
101473858|NCT00258284|Capecitabine|capecitabine|mesh-list
101473859|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473860|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473861|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473862|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473863|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473864|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473865|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
101473866|NCT00290940|Metformin|metformin|mesh-list
101473867|NCT00290940|Pioglitazone|pioglitazone|mesh-list
101473868|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473869|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473870|NCT00258323|Fluorouracil|fluorouracil|mesh-list
101473871|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361111|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361112|NCT00073710|Calcitriol|calcitriol|mesh-list
101361113|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101361114|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361115|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101361116|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361117|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361118|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101361120|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
101361121|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101361122|NCT00042848|Modafinil|modafinil|mesh-list
101361123|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101361124|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473872|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
101473873|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473874|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473875|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473876|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
101473877|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473878|NCT01604863|Paclitaxel|paclitaxel|mesh-list
101473879|NCT01604863|Etoposide|etoposide|mesh-list
101473880|NCT01604863|Docetaxel|docetaxel|mesh-list
101473881|NCT01604863|Carboplatin|carboplatin|mesh-list
101473882|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101473883|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473884|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473885|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473886|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473887|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473888|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101473889|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101473890|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473891|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
101473892|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101473893|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473894|NCT00258479|Modafinil|modafinil|mesh-list
101473895|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101473896|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473897|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101473898|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101473899|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101473900|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473901|NCT00271518|Hormones|hormones|mesh-list
101473902|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473903|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473904|NCT01340014|Timolol|timolol|mesh-list
101473905|NCT01340014|Dorzolamide|dorzolamide|mesh-list
101473906|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101473907|NCT01340014|Brinzolamide|brinzolamide|mesh-list
101473908|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101473909|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101473910|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101473911|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
101473914|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473915|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101473916|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101473917|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101361125|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101361126|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101361127|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101361128|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361129|NCT00221260|Anesthetics|anesthetics|mesh-list
101361130|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361131|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361132|NCT00402259|Esomeprazole|esomeprazole|mesh-list
101361133|NCT00402259|Omeprazole|omeprazole|mesh-list
101361134|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101473918|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473919|NCT00258557|Darunavir|darunavir|mesh-list
101473920|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101473921|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101473922|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
101473923|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473924|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473925|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101473926|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101473927|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
101473928|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473929|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101473930|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
101473931|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473932|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
101473933|NCT00271635|Vitamins|vitamins|mesh-ancestor
101473934|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
101473935|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473936|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
101473937|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473938|NCT00271635|Protective Agents|protective agents|mesh-ancestor
101473939|NCT00258596|Sirolimus|sirolimus|mesh-list
101473940|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473941|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473942|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101473943|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473944|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
101473945|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473946|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
101473947|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473948|NCT01339273|Anesthetics|anesthetics|mesh-list
101473949|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
101473950|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473951|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473952|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
101473953|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473954|NCT04709315|Choline|choline|mesh-list
101473955|NCT04709315|Rocuronium|rocuronium|mesh-list
101473956|NCT04709315|Succinylcholine|succinylcholine|mesh-list
101473957|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101473958|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101473959|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101473960|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473961|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473962|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
101473963|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101473964|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
101473965|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473966|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101473967|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101473968|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
101473969|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101473971|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473972|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101361135|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361136|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101361137|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361138|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361139|NCT02965677|Paclitaxel|paclitaxel|mesh-list
101361140|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361141|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473973|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473974|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473975|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
101473976|NCT00271713|Vitamin D|vitamin d|mesh-list
101473977|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
101473978|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
101473979|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
101473980|NCT00271713|Vitamins|vitamins|mesh-list
101473981|NCT00271713|Calcium|calcium|mesh-list
101473982|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
101473983|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473988|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101473989|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101473990|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473991|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473992|NCT01334554|Urological Agents|urological agents|mesh-ancestor
101473993|NCT00291213|Levetiracetam|levetiracetam|mesh-list
101473994|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
101473995|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
101473996|NCT01332799|Allopurinol|allopurinol|mesh-list
101473997|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
101473998|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473999|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474000|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
101474001|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474002|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101474003|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
101474004|NCT01332799|Protective Agents|protective agents|mesh-ancestor
101474005|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474006|NCT00258791|Ibuprofen|ibuprofen|mesh-list
101474007|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474008|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474009|NCT00258791|Analgesics|analgesics|mesh-ancestor
101474010|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
101474011|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474012|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474013|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474014|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474015|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101474017|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474018|NCT00291369|Interferons|interferons|mesh-list
101474019|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
101474020|NCT00291369|Interleukin-2|interleukin-2|mesh-list
101474021|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101474022|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
101474023|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474024|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
101474025|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474026|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
101474027|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474028|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474029|NCT00291369|Analgesics|analgesics|mesh-ancestor
101474030|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
101474031|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474032|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101474033|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101474034|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101474035|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
101474036|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361142|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361143|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361144|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361145|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361146|NCT00402376|Carvedilol|carvedilol|mesh-list
101361147|NCT00402376|Perindopril|perindopril|mesh-list
101361148|NCT00402376|Pravastatin|pravastatin|mesh-list
101361149|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101361150|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101361151|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
101361152|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474037|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101474038|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101474039|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101474040|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474041|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
101474042|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101474043|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
101474044|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474045|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474046|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101474047|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474048|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101474049|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
101474050|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474051|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474052|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101474053|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
101474060|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474061|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474062|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474063|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474064|NCT01332331|Ambrisentan|ambrisentan|mesh-list
101474065|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474067|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474068|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101474069|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474070|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474072|NCT01332292|Xhance|xhance|mesh-list
101474073|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474074|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101474075|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
101474076|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474077|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474078|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101474079|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474080|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101474081|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101474082|NCT00259142|Chloroquine|chloroquine|mesh-list
101474083|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
101474084|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
101474085|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101474086|NCT00259142|Amebicides|amebicides|mesh-ancestor
101474087|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101474088|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101474089|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474090|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
101474091|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474092|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101474093|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474094|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474095|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101474096|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
101361153|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361154|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361155|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101361156|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
101361157|NCT00402376|Protective Agents|protective agents|mesh-ancestor
101361158|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101361159|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361160|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101361161|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
101361162|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101361163|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101474097|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101474098|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101474099|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101474100|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474101|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
101474102|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
101474103|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
101474104|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101474105|NCT00259181|Protective Agents|protective agents|mesh-ancestor
101474106|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474107|NCT00291720|Spironolactone|spironolactone|mesh-list
101474108|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101474109|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
101474110|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474111|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474112|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101474113|NCT00291720|Diuretics|diuretics|mesh-ancestor
101474114|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
101474115|NCT00259220|Erythromycin|erythromycin|mesh-list
101474116|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
101474117|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101474118|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
101474119|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474120|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474121|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474122|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101474123|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474124|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474126|NCT00291759|Anastrozole|anastrozole|mesh-list
101474130|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474131|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474132|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474133|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101474134|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101474135|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101474136|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101474137|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101474138|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474139|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474141|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101474142|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474143|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474144|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474145|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474146|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
101474147|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474148|NCT04709081|Itraconazole|itraconazole|mesh-list
101474149|NCT04709081|Digoxin|digoxin|mesh-list
101474150|NCT04709081|Midazolam|midazolam|mesh-list
101361164|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101361165|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101361166|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
101361167|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101474151|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101474152|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101474153|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474154|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474155|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101474156|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101474157|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474158|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101474159|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
101474161|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
101474162|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
101474163|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474164|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474165|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
101474166|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474167|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101474168|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101474169|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474170|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101474171|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
101474172|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474173|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101474174|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101474175|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101474176|NCT04709081|Protective Agents|protective agents|mesh-ancestor
101474177|NCT00272064|Insulin|insulin|mesh-list
101474178|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101474179|NCT00272064|Metformin|metformin|mesh-list
101474180|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
101474181|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
101474182|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101474183|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474184|NCT00259376|Dronedarone|dronedarone|mesh-list
101474185|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101474186|NCT01332019|Interferons|interferons|mesh-list
101474187|NCT01332019|Interferon-beta|interferon-beta|mesh-list
101474188|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
101474189|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474190|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
101474191|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474192|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
101474193|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474194|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101474195|NCT00415376|Levetiracetam|levetiracetam|mesh-list
101474196|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
101474197|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
101474203|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474204|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101474206|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474207|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474208|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
101474209|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474210|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101474211|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474212|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
101474213|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474214|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101474215|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101474216|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474218|NCT00259766|Terbutaline|terbutaline|mesh-list
101474219|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
101474220|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474221|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101474222|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
101474223|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474224|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474225|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101361168|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101361169|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361170|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101361171|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361172|NCT00042887|Mitomycins|mitomycins|mesh-list
101361173|NCT00042887|Mitomycin|mitomycin|mesh-list
101361174|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361175|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474226|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474227|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
101474228|NCT00259766|Hormones|hormones|mesh-ancestor
101474229|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474230|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101474231|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101474232|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101474233|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
101474234|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474235|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474236|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
101474237|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
101474238|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101474239|NCT00292071|Caspofungin|caspofungin|mesh-list
101474240|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
101474241|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474242|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474243|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474244|NCT00292110|Methadone|methadone|mesh-list
101474245|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101474246|NCT00292110|Narcotics|narcotics|mesh-ancestor
101474247|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474248|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474249|NCT00292110|Analgesics|analgesics|mesh-ancestor
101474250|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
101474251|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474252|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
101474253|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474254|NCT00259805|Rituximab|rituximab|mesh-list
101474255|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101474256|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474257|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
101474258|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474259|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474260|NCT00259883|Paroxetine|paroxetine|mesh-list
101474261|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101474262|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474263|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474264|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474265|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474266|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
101474282|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474283|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474285|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474286|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
101474287|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474288|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474289|NCT00259922|Alvimopan|alvimopan|mesh-list
101474290|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474291|NCT00272454|Aspirin|aspirin|mesh-list
101474292|NCT00272454|Cilostazol|cilostazol|mesh-list
101474293|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474294|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474295|NCT00272454|Analgesics|analgesics|mesh-ancestor
101474296|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
101474297|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361176|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
101361177|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361178|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101361179|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361180|NCT00122746|Cisplatin|cisplatin|mesh-list
101361181|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361182|NCT00122785|Dexamethasone|dexamethasone|mesh-list
101361183|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474298|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474299|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474300|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474301|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101474302|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101474303|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474304|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101474305|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101474306|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474307|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
101474308|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101474309|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
101474310|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101474311|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474312|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
101474313|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101474314|NCT00272454|Protective Agents|protective agents|mesh-ancestor
101474315|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101474316|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101474317|NCT00272493|Vaccines|vaccines|mesh-list
101474318|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
101474319|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474320|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
101474321|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101474322|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
101474323|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474324|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474325|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
101474326|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474327|NCT00260039|Vaccines|vaccines|mesh-list
101474332|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
101474333|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474334|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474335|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474336|NCT00417768|Plasminogen|plasminogen|mesh-list
101474337|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101474338|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101474339|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101474340|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474341|NCT00272610|Vitamin A|vitamin a|mesh-list
101474342|NCT00272610|Vitamins|vitamins|mesh-ancestor
101474343|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
101474344|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474345|NCT00260351|Vaccines|vaccines|mesh-list
101474346|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
101474347|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474348|NCT00272688|Levodopa|levodopa|mesh-list
101474349|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101474350|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101474351|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
101474352|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474353|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474354|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474355|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
101474356|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474357|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474358|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
101474359|NCT00260390|Hormones|hormones|mesh-ancestor
101474360|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474361|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361185|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
101361186|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361187|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361188|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361189|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
101361190|NCT00122785|Hormones|hormones|mesh-ancestor
101361191|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361192|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101361193|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361194|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101361195|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101361196|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361197|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361198|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361199|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361200|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474362|NCT00260624|Escitalopram|escitalopram|mesh-list
101474363|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101474364|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474365|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474366|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474367|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474368|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
101474369|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474370|NCT00292695|Ifosfamide|ifosfamide|mesh-list
101474371|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474372|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474373|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
101474374|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474375|NCT00292734|Zolpidem|zolpidem|mesh-list
101474376|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101474377|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101474378|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474379|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474380|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101474381|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
101474382|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
101474383|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474384|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474385|NCT00260702|Omalizumab|omalizumab|mesh-list
101474386|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101474387|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101474388|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474389|NCT00260819|Bosentan|bosentan|mesh-list
101474390|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474391|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101474392|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474393|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
101474394|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
101474395|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474396|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474397|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101361201|NCT00122824|Analgesics|analgesics|mesh-ancestor
101361202|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
101361203|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361204|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
101474398|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101474402|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101474403|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474405|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
101474406|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101474407|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101474408|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474409|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474410|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
101474411|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
101474412|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101474413|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
101474414|NCT00424853|Cisplatin|cisplatin|mesh-list
101474415|NCT00424853|Gemcitabine|gemcitabine|mesh-list
101474416|NCT00424853|Docetaxel|docetaxel|mesh-list
101474417|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474418|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101474419|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
101474420|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474421|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
101474422|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
101474423|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
101474424|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
101474425|NCT00298506|Tacrolimus|tacrolimus|mesh-list
101474426|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474427|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
101474428|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474429|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101474430|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474431|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474432|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101474433|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474434|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101474435|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
101474436|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474437|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474438|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101474439|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101474440|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474441|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474442|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474443|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474444|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474445|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
101474446|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474447|NCT00424931|Modafinil|modafinil|mesh-list
101474448|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101474449|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474450|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101474451|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101474452|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101474453|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474454|NCT00298545|Calcitriol|calcitriol|mesh-list
101474455|NCT00298545|Calcium|calcium|mesh-list
101474456|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101474457|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474458|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101474459|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474460|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474461|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101474463|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
101474464|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101474465|NCT01331161|Vaccines|vaccines|mesh-list
101361206|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
101361207|NCT00077532|Ipilimumab|ipilimumab|mesh-list
101361208|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
101361209|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361210|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361211|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101361212|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361213|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101361214|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
101361215|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361216|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101474466|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
101474467|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474468|NCT00424970|Acetazolamide|acetazolamide|mesh-list
101474469|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
101474470|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101474471|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474478|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474479|NCT01331005|Analgesics|analgesics|mesh-ancestor
101474480|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
101474481|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474482|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474483|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474484|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474485|NCT01330459|Acetaminophen|acetaminophen|mesh-list
101474486|NCT01330459|Ibuprofen|ibuprofen|mesh-list
101474487|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101474488|NCT01330459|Lidocaine|lidocaine|mesh-list
101474489|NCT01330459|Hydrocodone|hydrocodone|mesh-list
101474490|NCT01330459|Lorazepam|lorazepam|mesh-list
101474491|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
101474492|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
101474493|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474494|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474495|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
101474496|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474497|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101474498|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101474499|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101474500|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474501|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474502|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474503|NCT01330459|Analgesics|analgesics|mesh-ancestor
101474504|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
101474505|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474506|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474507|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474508|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101474509|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474510|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101474511|NCT01330459|Narcotics|narcotics|mesh-ancestor
101474512|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
101474513|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474514|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
101474515|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
101474516|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
101474517|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474518|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101474519|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101474520|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101474521|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474522|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
101474523|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
101361217|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101361218|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361219|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361220|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474524|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474525|NCT00293085|Docetaxel|docetaxel|mesh-list
101474526|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474527|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
101474528|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
101474529|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
101474530|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474531|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101474532|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101474533|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474534|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
101474535|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474536|NCT00298662|Interferons|interferons|mesh-list
101474537|NCT00298662|Interferon-beta|interferon-beta|mesh-list
101474538|NCT00298662|Tacrolimus|tacrolimus|mesh-list
101474539|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
101474540|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474541|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
101474546|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101474547|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474548|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474549|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101474550|NCT01330381|Prucalopride|prucalopride|mesh-list
101474551|NCT01330381|Laxatives|laxatives|mesh-ancestor
101474552|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474553|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101474554|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101474555|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
101474556|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474557|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474558|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474559|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
101474560|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474561|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
101474562|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474563|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101474564|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474565|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474566|NCT01330108|Ambrisentan|ambrisentan|mesh-list
101474567|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474568|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
101474569|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101474570|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101474571|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101474572|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474573|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474574|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
101474575|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474576|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474577|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101474578|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474579|NCT00261170|Bupropion|bupropion|mesh-list
101474580|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101474581|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
101474582|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474583|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101474584|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474585|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474586|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474587|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
101474588|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361221|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361222|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361224|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
101361225|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361226|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
101361227|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474589|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474590|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101474591|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101474593|NCT00261287|Ciclesonide|ciclesonide|mesh-list
101474594|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
101474595|NCT00261287|Hormones|hormones|mesh-ancestor
101474596|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474597|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474598|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101474599|NCT00261326|Simvastatin|simvastatin|mesh-list
101474600|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101474601|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101474602|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
101474603|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474604|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101474605|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101474606|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474608|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
101474609|NCT00293163|Protective Agents|protective agents|mesh-ancestor
101474614|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101474615|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474617|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474618|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
101474619|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474620|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474621|NCT00298779|Bortezomib|bortezomib|mesh-list
101474622|NCT00298779|Omeprazole|omeprazole|mesh-list
101474623|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474624|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101474625|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474626|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101474627|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474628|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474629|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101474630|NCT00261482|Norelgestromin|norelgestromin|mesh-list
101474631|NCT00261482|Estradiol|estradiol|mesh-list
101474632|NCT00261482|Estrogens|estrogens|mesh-ancestor
101474633|NCT00261482|Hormones|hormones|mesh-ancestor
101474634|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474635|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474636|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101474637|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
101474638|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101474639|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101474640|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101474641|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101474642|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
101474643|NCT00261521|Hematinics|hematinics|mesh-ancestor
101474644|NCT00298857|Valproic Acid|valproic acid|mesh-list
101474645|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
101474646|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474647|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474648|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
101474649|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474650|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474651|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
101474652|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101474653|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474654|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361229|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101361230|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101361231|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361232|NCT00122941|Micronutrients|micronutrients|mesh-list
101361233|NCT00122941|Trace Elements|trace elements|mesh-list
101361234|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361235|NCT00077688|Paclitaxel|paclitaxel|mesh-list
101361236|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361237|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361238|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361239|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361240|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361241|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361242|NCT00397319|Hormones|hormones|mesh-list
101361243|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361244|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361245|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
101361246|NCT02965443|Saxagliptin|saxagliptin|mesh-list
101474655|NCT00261560|Acetaminophen|acetaminophen|mesh-list
101474656|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474657|NCT00261560|Analgesics|analgesics|mesh-ancestor
101474658|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
101474659|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474660|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474661|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
101474662|NCT00261599|Midazolam|midazolam|mesh-list
101474663|NCT00261599|Fospropofol|fospropofol|mesh-list
101474664|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101474665|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101474666|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474667|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474668|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101474669|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101474670|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474671|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101474672|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
101474674|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
101474675|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
101474676|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474677|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474678|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101474679|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474680|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474683|NCT00293358|Carboplatin|carboplatin|mesh-list
101474685|NCT00293358|Ifosfamide|ifosfamide|mesh-list
101474686|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
101474687|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474688|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101474689|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101474690|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101474691|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474692|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361247|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101361248|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361249|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101361250|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361251|NCT02965443|Incretins|incretins|mesh-ancestor
101361252|NCT02965443|Hormones|hormones|mesh-ancestor
101487384|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474693|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474694|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
101474695|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
101474696|NCT00261677|Hematinics|hematinics|mesh-ancestor
101474697|NCT00298974|Acetaminophen|acetaminophen|mesh-list
101474698|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101474699|NCT00298974|Hydrocodone|hydrocodone|mesh-list
101474700|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474701|NCT00298974|Analgesics|analgesics|mesh-ancestor
101474702|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
101474703|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474704|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474705|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
101474706|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101474707|NCT00298974|Narcotics|narcotics|mesh-ancestor
101474708|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101474709|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
101474710|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
101474711|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474712|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474713|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474714|NCT00293436|Celecoxib|celecoxib|mesh-list
101474715|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101474716|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474717|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101474718|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474719|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474720|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474721|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474722|NCT00293436|Analgesics|analgesics|mesh-ancestor
101474723|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
101474724|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474725|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474726|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474727|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474728|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101474729|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101474730|NCT00261872|Methylphenidate|methylphenidate|mesh-list
101474731|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101474732|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474733|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101474734|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101474735|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474736|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474737|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
101474738|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474739|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
101474740|NCT00293475|Rituximab|rituximab|mesh-list
101474741|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101474742|NCT00293475|Carboplatin|carboplatin|mesh-list
101474743|NCT00293475|Methotrexate|methotrexate|mesh-list
101474744|NCT00293475|Mannitol|mannitol|mesh-list
101474745|NCT00293475|Antibodies|antibodies|mesh-list
101474746|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
101474747|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101474748|NCT00293475|Antidotes|antidotes|mesh-list
101474749|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
101474750|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474751|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474752|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361253|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361254|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101361255|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361256|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474759|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
101474761|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101474762|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474763|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101474764|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101474765|NCT00293475|Diuretics|diuretics|mesh-ancestor
101474766|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
101474767|NCT00293475|Protective Agents|protective agents|mesh-ancestor
101474768|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
101474769|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
101474770|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474771|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474772|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
101474773|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
101474774|NCT00261911|Sibutramine|sibutramine|mesh-list
101474775|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
101474776|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474777|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
101474778|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101474779|NCT00299013|Prednisolone|prednisolone|mesh-list
101474780|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101474781|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
101474782|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101474783|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
101474784|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101474785|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
101474786|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474787|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
101474788|NCT00299013|Hormones|hormones|mesh-ancestor
101474789|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474790|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474791|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474792|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474793|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
101474794|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
101474795|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474796|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474797|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101474798|NCT00299013|Protective Agents|protective agents|mesh-ancestor
101474799|NCT00293514|Thrombin|thrombin|mesh-list
101474800|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
101474801|NCT00293514|Coagulants|coagulants|mesh-ancestor
101474802|NCT00299091|Efavirenz|efavirenz|mesh-list
101474803|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101474804|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101474805|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474806|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474807|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
101474808|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474809|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101474810|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101474811|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101474812|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101474813|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101474814|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101474815|NCT00299208|Azithromycin|azithromycin|mesh-list
101474816|NCT00299208|Artesunate|artesunate|mesh-list
101474817|NCT00299208|Quinine|quinine|mesh-list
101474818|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474819|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474820|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
101474821|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101474822|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101474827|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
101474828|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101474829|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474830|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101361258|NCT00042965|Capecitabine|capecitabine|mesh-list
101361259|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361260|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
101361261|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361262|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361263|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101474831|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474832|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474833|NCT00299208|Analgesics|analgesics|mesh-ancestor
101474834|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
101474835|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
101474836|NCT00418119|Hematinics|hematinics|mesh-ancestor
101474837|NCT00293592|Dexamethasone|dexamethasone|mesh-list
101474838|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474839|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
101474840|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
101474841|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474842|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474843|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101474844|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
101474845|NCT00293592|Hormones|hormones|mesh-ancestor
101474846|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474847|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474848|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474849|NCT00293631|Ketorolac|ketorolac|mesh-list
101474850|NCT00293631|Lornoxicam|lornoxicam|mesh-list
101474851|NCT00293631|Piroxicam|piroxicam|mesh-list
101474852|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474853|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101474854|NCT00293631|Analgesics|analgesics|mesh-ancestor
101474855|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
101474856|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474857|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474858|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474859|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474860|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101474861|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474862|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474863|NCT00262262|Levetiracetam|levetiracetam|mesh-list
101474864|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
101474865|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
101474866|NCT00293670|Goserelin|goserelin|mesh-list
101474867|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474868|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474869|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
101474870|NCT00262379|Hematinics|hematinics|mesh-ancestor
101474871|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
101474872|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
101474873|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
101474874|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101474875|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101474876|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474877|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101474878|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474879|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474880|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101474881|NCT00262418|Ivermectin|ivermectin|mesh-list
101474882|NCT00262418|Permethrin|permethrin|mesh-list
101474883|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101474884|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474885|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474886|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474887|NCT00299286|Lapatinib|lapatinib|mesh-list
101474888|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474889|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101474890|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474891|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474892|NCT00293787|Timolol|timolol|mesh-list
101474893|NCT00293787|Travoprost|travoprost|mesh-list
101474894|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101361264|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
101361265|NCT00123175|Progestins|progestins|mesh-list
101361266|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101413842|NCT00118950|Metformin|metformin|mesh-list
101361267|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101361268|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101361269|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
101361270|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361271|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474895|NCT00293787|Latanoprost|latanoprost|mesh-list
101474896|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101474899|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101474900|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
101474901|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101474902|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474903|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101474904|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474906|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
101474907|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101474908|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474909|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474910|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474911|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101474912|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474913|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101474914|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
101474915|NCT00299364|Hormones|hormones|mesh-ancestor
101474916|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101474917|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
101474918|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474919|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101474920|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
101474921|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474922|NCT00262769|Cisplatin|cisplatin|mesh-list
101474923|NCT00262769|Gemcitabine|gemcitabine|mesh-list
101474924|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474925|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101474926|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
101474927|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474928|NCT00299520|Linezolid|linezolid|mesh-list
101474929|NCT00299520|Iclaprim|iclaprim|mesh-list
101474930|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474931|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474932|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101474933|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474934|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474935|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101474936|NCT00261755|Analgesics|analgesics|mesh-list
101474937|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
101474938|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101474939|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474940|NCT00262808|Leucovorin|leucovorin|mesh-list
101474941|NCT00262808|Fluorouracil|fluorouracil|mesh-list
101474942|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
101474943|NCT00262808|Calcium|calcium|mesh-list
101474944|NCT00262808|Sargramostim|sargramostim|mesh-list
101474945|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
101474946|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101474947|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474948|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
101474949|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474950|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101474951|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474952|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474953|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
101474954|NCT00262808|Antidotes|antidotes|mesh-ancestor
101474955|NCT00262808|Protective Agents|protective agents|mesh-ancestor
101361272|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101361273|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101361274|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101361275|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101361276|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361277|NCT00123175|Hormones|hormones|mesh-ancestor
101361278|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361279|NCT00077727|Galantamine|galantamine|mesh-list
101361280|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101361281|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361282|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361283|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
101361284|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361285|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361286|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101361287|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
101361288|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361289|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
101361290|NCT00123292|Plasminogen|plasminogen|mesh-list
101361291|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
101361292|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101361293|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101361294|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361295|NCT00043004|Leucovorin|leucovorin|mesh-list
101361296|NCT00043004|Bevacizumab|bevacizumab|mesh-list
101361297|NCT00043004|Fluorouracil|fluorouracil|mesh-list
101474956|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
101474957|NCT00262808|Vitamins|vitamins|mesh-ancestor
101474958|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
101474959|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
101474960|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
101474961|NCT00262886|Fludarabine|fludarabine|mesh-list
101474962|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
101474963|NCT00262886|Tacrolimus|tacrolimus|mesh-list
101474964|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101474965|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474966|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
101474967|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474968|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101474969|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101474970|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
101474975|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
101474976|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101474977|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474978|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101474979|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101474980|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
101474981|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101474982|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474983|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101474984|NCT00263003|Irbesartan|irbesartan|mesh-list
101361298|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
101361299|NCT00043004|Calcium|calcium|mesh-list
101361300|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
101361301|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361302|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361303|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101361304|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101361305|NCT00043004|Growth Substances|growth substances|mesh-ancestor
101361306|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361307|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
101361308|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101474985|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101474986|NCT00263003|Diuretics|diuretics|mesh-ancestor
101474987|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
101474988|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474989|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101474990|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101474991|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474992|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101474993|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101474994|NCT00299559|Camphor|camphor|mesh-list
101474995|NCT00299559|Menthol|menthol|mesh-list
101474996|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
101474997|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
101474998|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101474999|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475000|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101475001|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475002|NCT00263198|Letrozole|letrozole|mesh-list
101475003|NCT00263198|Vatalanib|vatalanib|mesh-list
101475004|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475005|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101475006|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101475007|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475008|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475009|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101475010|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
101475011|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475012|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475013|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101475015|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101475016|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
101475017|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475018|NCT00294099|Antacids|antacids|mesh-ancestor
101475019|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475020|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101475021|NCT00299676|Galantamine|galantamine|mesh-list
101475022|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101475023|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475024|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475025|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
101475026|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475027|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475028|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101475029|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
101475030|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475031|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
101475032|NCT00263276|Metformin|metformin|mesh-list
101475033|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
101475034|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101475035|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475036|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101361310|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361311|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361312|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361313|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
101361314|NCT00043004|Antidotes|antidotes|mesh-ancestor
101361315|NCT00043004|Protective Agents|protective agents|mesh-ancestor
101361316|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
101361317|NCT00043004|Vitamins|vitamins|mesh-ancestor
101361318|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
101361319|NCT00123331|Cyclosporine|cyclosporine|mesh-list
101361321|NCT00123331|Cyclosporins|cyclosporins|mesh-list
101475037|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475038|NCT00299754|Misoprostol|misoprostol|mesh-list
101475047|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101475048|NCT00263315|Amebicides|amebicides|mesh-ancestor
101475049|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101475050|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101475051|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475052|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101475053|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
101475054|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
101475055|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475056|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101475057|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475058|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475059|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
101475060|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475061|NCT00263393|Atenolol|atenolol|mesh-list
101475062|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101475063|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101475064|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475065|NCT00263393|Diuretics|diuretics|mesh-ancestor
101475066|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
101475067|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475068|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101475069|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475070|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475071|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101475072|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
101475073|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
101475074|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475075|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101475076|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101475077|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101475078|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475079|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475080|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
101475081|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475082|NCT00299871|Lixisenatide|lixisenatide|mesh-list
101475083|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101475084|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475085|NCT00299910|Montelukast|montelukast|mesh-list
101475086|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101475087|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
101475088|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101475089|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101475090|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475091|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475092|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101475093|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101361322|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361323|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361324|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361325|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
101361326|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361327|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
101361328|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361329|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
101361330|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361331|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101361332|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487385|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475094|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475095|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
101475096|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
101475097|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475098|NCT00425594|Bisacodyl|bisacodyl|mesh-list
101475099|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101475100|NCT00425594|Cathartics|cathartics|mesh-ancestor
101475101|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101475102|NCT00425594|Laxatives|laxatives|mesh-ancestor
101475103|NCT00294255|Risperidone|risperidone|mesh-list
101475104|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101475105|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
101475108|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475110|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475111|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475112|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475114|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
101475115|NCT00263705|Capecitabine|capecitabine|mesh-list
101475116|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475117|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
101475118|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475119|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475120|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101475121|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101475122|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
101475123|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475124|NCT00263744|Antacids|antacids|mesh-ancestor
101475125|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475126|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101475127|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101475128|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
101475129|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475130|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101475131|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475132|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101475133|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475134|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475135|NCT00300222|Capsaicin|capsaicin|mesh-list
101475136|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
101475137|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101475138|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
101475139|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475140|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475141|NCT00263978|Defibrotide|defibrotide|mesh-list
101475142|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101475143|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101475144|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475145|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101475146|NCT00264134|Carboplatin|carboplatin|mesh-list
101475147|NCT00264134|Docetaxel|docetaxel|mesh-list
101361333|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361334|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361335|NCT00123370|Modafinil|modafinil|mesh-list
101361336|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101361337|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475148|NCT00264134|Irinotecan|irinotecan|mesh-list
101475149|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475150|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475151|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475152|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475153|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475154|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101475155|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475156|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475157|NCT00300339|Clopidogrel|clopidogrel|mesh-list
101475158|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101475159|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101475160|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101475161|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101475162|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
101475163|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475164|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475165|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475166|NCT00264173|Valproic Acid|valproic acid|mesh-list
101475167|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
101475168|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475169|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475170|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
101475171|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475172|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475173|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
101475193|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475194|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475195|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
101475197|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
101475198|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101475199|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475200|NCT00294567|Amlodipine|amlodipine|mesh-list
101475201|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
101475202|NCT00294567|Calcium|calcium|mesh-list
101475203|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101475204|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475205|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475206|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475207|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475208|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
101475209|NCT00294606|Phenylephrine|phenylephrine|mesh-list
101475210|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
101475211|NCT00294606|Norepinephrine|norepinephrine|mesh-list
101475212|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101475213|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
101475214|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
101475215|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475216|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475217|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
101475218|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101475219|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
101475220|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
101475221|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101475222|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101475223|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101475224|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475226|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475228|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
101475229|NCT04708964|Analgesics|analgesics|mesh-ancestor
101475230|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
101475231|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361338|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101361339|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101361340|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101361341|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361343|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101361344|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101361345|NCT00043043|Analgesics|analgesics|mesh-ancestor
101361346|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
101475232|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475233|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475234|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475235|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475236|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475237|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475238|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475239|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475240|NCT00264368|Ganciclovir|ganciclovir|mesh-list
101475241|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101475242|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
101475243|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475244|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101475245|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475246|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475247|NCT00264407|Hormones|hormones|mesh-list
101475248|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475249|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475251|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101475252|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101475253|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475254|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475255|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
101475256|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475257|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101475258|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101475259|NCT00264446|Eniluracil|eniluracil|mesh-list
101475260|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475261|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475262|NCT00264485|Fentanyl|fentanyl|mesh-list
101475263|NCT00264485|Morphine|morphine|mesh-list
101475264|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101475265|NCT00264485|Narcotics|narcotics|mesh-ancestor
101475266|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475267|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475268|NCT00264485|Analgesics|analgesics|mesh-ancestor
101475269|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
101475270|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475271|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101475272|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101475273|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
101475274|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
101475275|NCT00294918|Hormones|hormones|mesh-list
101475276|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475277|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475278|NCT00264680|Lamotrigine|lamotrigine|mesh-list
101475279|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
101475280|NCT00264680|Valproic Acid|valproic acid|mesh-list
101475281|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101475282|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475283|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475284|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101475285|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361347|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361348|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361349|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361350|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361351|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101361352|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475286|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101475287|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475288|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475289|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475290|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101475291|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475292|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
101475293|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475294|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
101475295|NCT00300729|Celecoxib|celecoxib|mesh-list
101475296|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475300|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475301|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475302|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475303|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475304|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475305|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475306|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475307|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475308|NCT00264719|Metoclopramide|metoclopramide|mesh-list
101475309|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
101475310|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
101475311|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475312|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475313|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101475314|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101475315|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101475316|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
101475317|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475318|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475319|NCT00264914|Satavaptan|satavaptan|mesh-list
101475320|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101475321|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475322|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
101475323|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475324|NCT00264953|Prednisone|prednisone|mesh-list
101475325|NCT00264953|Etoposide|etoposide|mesh-list
101475327|NCT00264953|Doxorubicin|doxorubicin|mesh-list
101475328|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101475329|NCT00264953|Bleomycin|bleomycin|mesh-list
101475330|NCT00264953|Vinblastine|vinblastine|mesh-list
101475331|NCT00264953|Procarbazine|procarbazine|mesh-list
101475332|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475333|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
101475334|NCT00264953|Hormones|hormones|mesh-ancestor
101475335|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475336|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475337|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101475338|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475339|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101475340|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475341|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475342|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475343|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475344|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475345|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475346|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475347|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475348|NCT00300846|Aripiprazole|aripiprazole|mesh-list
101475349|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
101475350|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475351|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101361353|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361355|NCT00077805|Enoxaparin|enoxaparin|mesh-list
101361356|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
101361357|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
101475352|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475353|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475354|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475355|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
101475356|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
101475357|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475358|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475359|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101475360|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101475361|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
101475362|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101475363|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101475364|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101475365|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101475366|NCT00294996|Doxorubicin|doxorubicin|mesh-list
101475367|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475368|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475375|NCT00265031|Etoposide|etoposide|mesh-list
101475376|NCT00265031|Vincristine|vincristine|mesh-list
101475377|NCT00265031|Doxorubicin|doxorubicin|mesh-list
101475378|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101475379|NCT00265031|Bleomycin|bleomycin|mesh-list
101475380|NCT00265031|Procarbazine|procarbazine|mesh-list
101475381|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475382|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
101475383|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475384|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475385|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475386|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
101475387|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475388|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475389|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475390|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475391|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
101475392|NCT00265031|Hormones|hormones|mesh-ancestor
101475393|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475394|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101475395|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101475396|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475397|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475398|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475399|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475400|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475401|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475402|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475403|NCT00300924|Acetaminophen|acetaminophen|mesh-list
101475404|NCT00300924|Rizatriptan|rizatriptan|mesh-list
101475405|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475406|NCT00300924|Analgesics|analgesics|mesh-ancestor
101475407|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
101475408|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475409|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475410|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
101475411|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101475412|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
101475413|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475414|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475415|NCT00265070|Gefitinib|gefitinib|mesh-list
101475416|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475417|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101475418|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475419|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475420|NCT00295035|Celecoxib|celecoxib|mesh-list
101475421|NCT00295035|Curcumin|curcumin|mesh-list
101475422|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101361358|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101361359|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101361360|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361362|NCT00043082|Doxorubicin|doxorubicin|mesh-list
101361363|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101361364|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361365|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361366|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475423|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475424|NCT00295035|Analgesics|analgesics|mesh-ancestor
101475425|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
101475426|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475427|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475428|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475429|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475430|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475431|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475432|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475433|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475434|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475435|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101475436|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101475437|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101475443|NCT00418275|Plasminogen|plasminogen|mesh-list
101475444|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101475445|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101475446|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475447|NCT00265304|Ketoprofen|ketoprofen|mesh-list
101475448|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475449|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475450|NCT00265304|Analgesics|analgesics|mesh-ancestor
101475451|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
101475452|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475453|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475454|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475455|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475456|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475457|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475458|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475459|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
101475460|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101475461|NCT00265460|Lobeline|lobeline|mesh-list
101475462|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101475463|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
101475464|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475465|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475466|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101475467|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101475468|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
101475469|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475470|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475471|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
101475473|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101475475|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475476|NCT00265694|Carboplatin|carboplatin|mesh-list
101475477|NCT00265694|Gemcitabine|gemcitabine|mesh-list
101475478|NCT00265694|Vinorelbine|vinorelbine|mesh-list
101475479|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475480|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475481|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
101475482|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475483|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361367|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101361368|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361369|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361370|NCT00123877|Esorubicin|esorubicin|mesh-list
101361371|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361372|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475484|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475485|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475486|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475487|NCT00265733|Paclitaxel|paclitaxel|mesh-list
101475488|NCT00265733|Capecitabine|capecitabine|mesh-list
101475489|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101475490|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101475491|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475492|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475493|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475494|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475495|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475496|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475497|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
101475498|NCT00265772|Prednisolone|prednisolone|mesh-list
101475499|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475500|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
101475501|NCT00265772|Hormones|hormones|mesh-ancestor
101475502|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475503|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475504|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101475505|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475506|NCT00265811|Cetuximab|cetuximab|mesh-list
101475511|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
101475512|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413857|NCT00486343|Analgesics|analgesics|mesh-ancestor
101475513|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475514|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475515|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
101475516|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
101475517|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101475518|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101475519|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101475520|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475521|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475522|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475523|NCT00265928|Rituximab|rituximab|mesh-list
101475524|NCT00265928|Bortezomib|bortezomib|mesh-list
101475525|NCT00265928|Antibodies|antibodies|mesh-list
101475526|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
101475527|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101475528|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101475529|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
101475530|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475531|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101475532|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475533|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475534|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475535|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
101475536|NCT00295347|Spironolactone|spironolactone|mesh-list
101475537|NCT00295347|Escitalopram|escitalopram|mesh-list
101475538|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101475539|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101475540|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475541|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475542|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475543|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
101475544|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475545|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101475546|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
101475547|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475548|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101475549|NCT00295347|Diuretics|diuretics|mesh-ancestor
101361373|NCT00123916|Benzonidazole|benzonidazole|mesh-list
101361374|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361375|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
101361376|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361377|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101361378|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101475550|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
101475551|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475552|NCT00265967|Irbesartan|irbesartan|mesh-list
101475553|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475554|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101475555|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101475556|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475557|NCT00295386|Zopiclone|zopiclone|mesh-list
101475558|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101475559|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475560|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475561|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101475562|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101475563|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475564|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101475565|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101475566|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475567|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475568|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
101475569|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475570|NCT00295425|Cyclosporine|cyclosporine|mesh-list
101475571|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
101475572|NCT00295425|Cyclosporins|cyclosporins|mesh-list
101475573|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475574|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475575|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475578|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
101475579|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475580|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
101475581|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475582|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101475583|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475584|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475585|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101475586|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
101475587|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101475588|NCT00266123|Sirolimus|sirolimus|mesh-list
101475589|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101475590|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475591|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475592|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475593|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
101475594|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475595|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
101475596|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475597|NCT00266162|Bosentan|bosentan|mesh-list
101475598|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475599|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101475600|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475601|NCT00295464|Betamethasone|betamethasone|mesh-list
101475602|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475603|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
101475604|NCT00295464|Hormones|hormones|mesh-ancestor
101475605|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475606|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475607|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101475608|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
101475609|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101475610|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101475611|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475612|NCT00301392|Pitavastatin|pitavastatin|mesh-list
101475613|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101361380|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361381|NCT00073827|Albuterol|albuterol|mesh-list
101361382|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101361383|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
101361384|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361385|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475614|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101475615|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101475616|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
101475617|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475618|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475619|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101475620|NCT00415844|Levodopa|levodopa|mesh-list
101475621|NCT00415844|Carbidopa|carbidopa|mesh-list
101475622|NCT00415844|Entacapone|entacapone|mesh-list
101475623|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101475624|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101475625|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101475626|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
101475627|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475628|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475629|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475630|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101475631|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475632|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101475633|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101475634|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
101475635|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
101475636|NCT00415883|Valsartan|valsartan|mesh-list
101475637|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475638|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101475639|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101475640|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475641|NCT00295542|Atenolol|atenolol|mesh-list
101475642|NCT00295542|Valsartan|valsartan|mesh-list
101475643|NCT00295542|Telmisartan|telmisartan|mesh-list
101475644|NCT00295542|Carvedilol|carvedilol|mesh-list
101475645|NCT00295542|Olmesartan|olmesartan|mesh-list
101475646|NCT00295542|Enalapril|enalapril|mesh-list
101475647|NCT00295542|Lisinopril|lisinopril|mesh-list
101475648|NCT00295542|Nebivolol|nebivolol|mesh-list
101475649|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
101475657|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101475658|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101475659|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475660|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101475661|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475662|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475663|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475664|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
101475665|NCT00295542|Protective Agents|protective agents|mesh-ancestor
101475666|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101475667|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475668|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101475669|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
101475670|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101475671|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101475672|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101475673|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
101475674|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475675|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
101475676|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101475677|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101475678|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
101475679|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
101475680|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361386|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101361387|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101361388|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
101361389|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101487386|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101475681|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101475682|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101475683|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101475684|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101475685|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101475686|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101475687|NCT00266318|Interferons|interferons|mesh-list
101475689|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
101475690|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475691|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
101475692|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475693|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
101475694|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475695|NCT00266357|Gaboxadol|gaboxadol|mesh-list
101475696|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475697|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475698|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475699|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475700|NCT00266357|Analgesics|analgesics|mesh-ancestor
101475701|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
101475702|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
101475703|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
101475704|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
101475705|NCT00301509|Ribavirin|ribavirin|mesh-list
101475706|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
101475707|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475708|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
101475709|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475710|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
101475711|NCT00295698|Filaricides|filaricides|mesh-ancestor
101475712|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
101475713|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
101475715|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475716|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101475717|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475718|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475719|NCT00266552|Risperidone|risperidone|mesh-list
101475720|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101475725|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101475726|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475727|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475728|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475729|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101475731|NCT00301587|Folic Acid|folic acid|mesh-list
101475732|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
101475733|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101475734|NCT00301587|Norgestimate|norgestimate|mesh-list
101475735|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101475736|NCT00301587|Estradiol|estradiol|mesh-list
101475737|NCT00301587|Estrogens|estrogens|mesh-ancestor
101475738|NCT00301587|Hormones|hormones|mesh-ancestor
101475739|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101475740|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475741|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101475742|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
101475743|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101475744|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101475745|NCT00301587|Hematinics|hematinics|mesh-ancestor
101475746|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
101475747|NCT00301587|Vitamins|vitamins|mesh-ancestor
101475748|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
101475749|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101475750|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101475751|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101361390|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101361391|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101361392|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101361393|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101361394|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361395|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361397|NCT02970539|Ramucirumab|ramucirumab|mesh-list
101475752|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101475753|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475754|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475755|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475756|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475757|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475758|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475759|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101475760|NCT00266591|Topiramate|topiramate|mesh-list
101475761|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
101475762|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101475763|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475764|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
101475765|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101475766|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101475767|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101475768|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475769|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475770|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
101475771|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475772|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475773|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101475774|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475775|NCT00295776|Lamotrigine|lamotrigine|mesh-list
101475776|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
101475777|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101475778|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475779|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475780|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101475781|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475782|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101475783|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475784|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475785|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475786|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101475787|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
101475788|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
101475789|NCT00266747|Amibegron|amibegron|mesh-list
101475790|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101475794|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475795|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475796|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475797|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101475798|NCT00266786|Ketorolac|ketorolac|mesh-list
101475799|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101475800|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475801|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475802|NCT00266786|Analgesics|analgesics|mesh-ancestor
101475803|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
101475804|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475805|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475806|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475807|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475808|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475809|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475810|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475811|NCT00295815|Lomustine|lomustine|mesh-list
101361398|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361399|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361400|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361401|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361402|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361403|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361404|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
101361405|NCT00124111|Fluorouracil|fluorouracil|mesh-list
101361406|NCT00124111|Methotrexate|methotrexate|mesh-list
101475812|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475813|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
101475814|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475815|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475816|NCT00295971|Fludarabine|fludarabine|mesh-list
101475817|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
101475818|NCT00295971|Thiotepa|thiotepa|mesh-list
101475819|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101475820|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475821|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475822|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
101475823|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475824|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475825|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
101475827|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475828|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
101475829|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475830|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
101475831|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475832|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475833|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475834|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475835|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475836|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475837|NCT00267176|Analgesics|analgesics|mesh-ancestor
101475838|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
101475839|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475840|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475841|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475842|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475843|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
101475844|NCT00296010|Doxorubicin|doxorubicin|mesh-list
101475845|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101475846|NCT00296010|Methotrexate|methotrexate|mesh-list
101475847|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475848|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
101475849|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475850|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475851|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475852|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
101475853|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475854|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475855|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475856|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475857|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475858|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475859|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475860|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101475864|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
101475865|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
101475866|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101475867|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101475868|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
101361407|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361408|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
101361409|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361410|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361411|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361412|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
101361413|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361414|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361415|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475869|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475870|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475871|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475872|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475873|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475874|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475875|NCT00267215|Analgesics|analgesics|mesh-ancestor
101475876|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
101475877|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475878|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475879|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475880|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475881|NCT00296049|Vancomycin|vancomycin|mesh-list
101475882|NCT00296049|Daptomycin|daptomycin|mesh-list
101475883|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101475884|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475885|NCT00267254|Atorvastatin|atorvastatin|mesh-list
101475886|NCT00267254|Simvastatin|simvastatin|mesh-list
101475887|NCT00267254|Torcetrapib|torcetrapib|mesh-list
101475888|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101475889|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101475890|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
101475891|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475892|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101475893|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101475894|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475895|NCT00301782|Carboplatin|carboplatin|mesh-list
101475896|NCT00301782|Etoposide|etoposide|mesh-list
101475897|NCT00301782|Vincristine|vincristine|mesh-list
101475898|NCT00301782|Bleomycin|bleomycin|mesh-list
101475899|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
101475900|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475901|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101475902|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475903|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475904|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475905|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475906|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101475907|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101475908|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101475909|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101475910|NCT00267332|Modafinil|modafinil|mesh-list
101475911|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101475912|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475913|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101475914|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101475915|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101475916|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475917|NCT04718649|Celecoxib|celecoxib|mesh-list
101475918|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475919|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475920|NCT04718649|Analgesics|analgesics|mesh-ancestor
101475921|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
101475923|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361416|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
101361417|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361418|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101361419|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
101361420|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361421|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
101361422|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361423|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101361424|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101475924|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475925|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475926|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475927|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475928|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475929|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475931|NCT00301860|Methotrexate|methotrexate|mesh-list
101475932|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
101475933|NCT00301860|Fludarabine|fludarabine|mesh-list
101475937|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101475938|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
101475939|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101475940|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475941|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475943|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475944|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475945|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
101475946|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475947|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101475948|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475949|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
101475950|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475951|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101475952|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
101475953|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101475954|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101475955|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475956|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
101475957|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475958|NCT00301899|Trastuzumab|trastuzumab|mesh-list
101475959|NCT00301899|Pertuzumab|pertuzumab|mesh-list
101475960|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101475961|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475962|NCT00296127|Celecoxib|celecoxib|mesh-list
101475963|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101475964|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475965|NCT00296127|Analgesics|analgesics|mesh-ancestor
101475966|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
101475967|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101475968|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475969|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101475970|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475971|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101475972|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101475973|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475974|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475975|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
101475976|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101475977|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
101475978|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475979|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101475980|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101475981|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
101475982|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361426|NCT00124150|Analgesics|analgesics|mesh-ancestor
101361427|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
101361428|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361429|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361430|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
101361431|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361432|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101475983|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475984|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101475985|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
101475987|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101475988|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475989|NCT00267722|Visilizumab|visilizumab|mesh-list
101475990|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
101475991|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475992|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101475993|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475994|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101475995|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475996|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475997|NCT00267917|Fenoterol|fenoterol|mesh-list
101475998|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
101475999|NCT00267917|Ipratropium|ipratropium|mesh-list
101476000|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476001|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
101476002|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476003|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476004|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476009|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101476011|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101476012|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
101476013|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476014|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476015|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101476016|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476017|NCT00296361|Tacrolimus|tacrolimus|mesh-list
101476018|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476019|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
101476020|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476021|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101476022|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476023|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476024|NCT00415922|Levodopa|levodopa|mesh-list
101476025|NCT00415922|Carbidopa|carbidopa|mesh-list
101476026|NCT00415922|Entacapone|entacapone|mesh-list
101476027|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101476028|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101476029|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101476030|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
101476031|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476032|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476033|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476034|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101476035|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476036|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101476037|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101476038|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
101476039|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
101476040|NCT00415961|Paclitaxel|paclitaxel|mesh-list
101476041|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476042|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476043|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476044|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476045|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361434|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101361435|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361436|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361437|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101361438|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
101361439|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361440|NCT02958046|Domperidone|domperidone|mesh-list
101361441|NCT02958046|Lansoprazole|lansoprazole|mesh-list
101361442|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
101361443|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101361444|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361445|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101361446|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361447|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361448|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
101476046|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476047|NCT00416039|Midazolam|midazolam|mesh-list
101476048|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101476049|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101476050|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476051|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476052|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101476053|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476054|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476055|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101476056|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
101476057|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
101476058|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
101476059|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
101476060|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476061|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476062|NCT00296478|Progesterone|progesterone|mesh-list
101476063|NCT00296478|Progestins|progestins|mesh-ancestor
101476064|NCT00296478|Hormones|hormones|mesh-ancestor
101476065|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476066|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476067|NCT00268151|Capecitabine|capecitabine|mesh-list
101476068|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
101476069|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476070|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
101476071|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476073|NCT00418080|Bicalutamide|bicalutamide|mesh-list
101476074|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
101476075|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101476086|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
101476087|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476088|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476089|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
101476090|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476091|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101476092|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476093|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101476094|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101476095|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101476096|NCT00302289|Caffeine|caffeine|mesh-list
101476097|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101476098|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361450|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361451|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361452|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101361453|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
101361454|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361455|NCT00073905|Gemcitabine|gemcitabine|mesh-list
101361456|NCT00073905|Capecitabine|capecitabine|mesh-list
101361457|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361458|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
101361459|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361460|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361461|NCT00124267|Quinine|quinine|mesh-list
101361462|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
101361463|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101361464|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101361465|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361466|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101361467|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361468|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101361469|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361470|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101361471|NCT00124267|Analgesics|analgesics|mesh-ancestor
101361472|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
101361473|NCT00077844|Enoxaparin|enoxaparin|mesh-list
101476099|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101476100|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476101|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476102|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101476103|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101476104|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
101476105|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476107|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101476108|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
101476109|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476110|NCT00296634|Antacids|antacids|mesh-ancestor
101476111|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476112|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476113|NCT00268619|Ramipril|ramipril|mesh-list
101476114|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101476115|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
101476116|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476117|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476118|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101476119|NCT00296712|Dexetimide|dexetimide|mesh-list
101476120|NCT00296712|Citalopram|citalopram|mesh-list
101476121|NCT00296712|Bupropion|bupropion|mesh-list
101476122|NCT00296712|Escitalopram|escitalopram|mesh-list
101476123|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101476124|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361474|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
101361475|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
101361476|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101361477|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101361478|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361479|NCT00043121|Leucovorin|leucovorin|mesh-list
101361480|NCT00043121|Fluorouracil|fluorouracil|mesh-list
101361481|NCT00043121|Capecitabine|capecitabine|mesh-list
101361482|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
101361483|NCT00043121|Calcium|calcium|mesh-list
101361484|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
101361485|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101476125|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476126|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476127|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476128|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
101476129|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476130|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101476131|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101476132|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
101476134|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476135|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101476136|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101476137|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476138|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101476143|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101476144|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101476145|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476147|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101476148|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101476149|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
101476150|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476151|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101476153|NCT00296751|Meperidine|meperidine|mesh-list
101476154|NCT00296751|Bupivacaine|bupivacaine|mesh-list
101476155|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
101476156|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
101476157|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476158|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476159|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
101476160|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476161|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101476162|NCT00296751|Narcotics|narcotics|mesh-ancestor
101476163|NCT00296751|Analgesics|analgesics|mesh-ancestor
101476164|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101476165|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101476166|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
101476167|NCT00302367|Methylphenidate|methylphenidate|mesh-list
101476168|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101476169|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476170|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476171|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476172|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476173|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476174|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
101476175|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476176|NCT00296790|Zolpidem|zolpidem|mesh-list
101476177|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101476178|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101476179|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476180|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361486|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361487|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
101361488|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361489|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361490|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361491|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476181|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101476182|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
101476183|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
101476184|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476185|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476186|NCT00302406|Methylphenidate|methylphenidate|mesh-list
101476187|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101476188|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476189|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476190|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476191|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476192|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476194|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476195|NCT00268814|Methadone|methadone|mesh-list
101476197|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101476198|NCT00268814|Narcotics|narcotics|mesh-ancestor
101476199|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476200|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476201|NCT00268814|Analgesics|analgesics|mesh-ancestor
101476202|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
101476203|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476204|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
101476205|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476206|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
101476207|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101476208|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476209|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
101476214|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476215|NCT00296868|Protective Agents|protective agents|mesh-ancestor
101476216|NCT00268970|Paclitaxel|paclitaxel|mesh-list
101476217|NCT00268970|Satraplatin|satraplatin|mesh-list
101476218|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476219|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476220|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476221|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476222|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476223|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476224|NCT00296946|Bromides|bromides|mesh-list
101476225|NCT00296946|Ipratropium|ipratropium|mesh-list
101476226|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
101476227|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476229|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476230|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476231|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476232|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476233|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101476234|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476235|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476236|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476237|NCT00269048|Darapladib|darapladib|mesh-list
101476238|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101476239|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476240|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476241|NCT00302523|Tacrolimus|tacrolimus|mesh-list
101476242|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476243|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
101476244|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361492|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
101361493|NCT00043121|Antidotes|antidotes|mesh-ancestor
101361494|NCT00043121|Protective Agents|protective agents|mesh-ancestor
101361495|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
101361496|NCT00043121|Vitamins|vitamins|mesh-ancestor
101476245|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101476246|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476247|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476248|NCT02960412|Furosemide|furosemide|mesh-list
101476249|NCT02960412|Diuretics|diuretics|mesh-ancestor
101476250|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
101476251|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476252|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101476253|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476254|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476255|NCT00269126|Fluticasone|fluticasone|mesh-list
101476256|NCT00269126|Xhance|xhance|mesh-list
101476257|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101476258|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101476259|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476260|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476261|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
101476262|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476263|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476264|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476265|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476266|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
101476267|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101476268|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101476269|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101476270|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101476271|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
101476272|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476273|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476274|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
101476275|NCT00269126|Hormones|hormones|mesh-ancestor
101476276|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476277|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
101476278|NCT00269204|Niacin|niacin|mesh-list
101476279|NCT00269204|Niacinamide|niacinamide|mesh-list
101476280|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
101476284|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101476285|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
101476286|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
101476287|NCT00269204|Vitamins|vitamins|mesh-ancestor
101476288|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
101476289|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476291|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
101476292|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476293|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
101476294|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476295|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476296|NCT00269243|Quinapril|quinapril|mesh-list
101476297|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101476298|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
101476299|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476300|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476301|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101476302|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101476303|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101476304|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476305|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476306|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
101476307|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476308|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
101476309|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
101476310|NCT00297219|Calcium|calcium|mesh-list
101361497|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
101361498|NCT00402415|Sirolimus|sirolimus|mesh-list
101361499|NCT00402415|Sunitinib|sunitinib|mesh-list
101361500|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101361501|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361502|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361503|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361504|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
101361505|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361506|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
101476311|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101476312|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476313|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101476315|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
101476316|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101476317|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476318|NCT00418353|Dexamethasone|dexamethasone|mesh-list
101476319|NCT00418353|Betamethasone|betamethasone|mesh-list
101476320|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
101476321|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101476322|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
101476323|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
101476324|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101476325|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476326|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
101476327|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
101476328|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476329|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476330|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476331|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
101476332|NCT00418353|Hormones|hormones|mesh-ancestor
101476333|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476334|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101476335|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476336|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476337|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476338|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476339|NCT00418392|Minocycline|minocycline|mesh-list
101476340|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101476341|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476342|NCT00269555|Genistein|genistein|mesh-list
101476343|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101476344|NCT00269555|Protective Agents|protective agents|mesh-ancestor
101476345|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476346|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476347|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101476348|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476349|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476350|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
101476351|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101476352|NCT00269555|Estrogens|estrogens|mesh-ancestor
101476355|NCT00418431|Bevacizumab|bevacizumab|mesh-list
101476356|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101476357|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476358|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101476359|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101476360|NCT00418431|Growth Substances|growth substances|mesh-ancestor
101476361|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476362|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
101476363|NCT00269594|Lamotrigine|lamotrigine|mesh-list
101476364|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
101476365|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101476366|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476367|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361507|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361508|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101361509|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361510|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361511|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101361512|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101361513|NCT00402415|Growth Substances|growth substances|mesh-ancestor
101361514|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
101361515|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101476368|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101476369|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476370|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101476371|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476372|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476373|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476374|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101476375|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101476376|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101476377|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476378|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
101476379|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101476380|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
101476381|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476382|NCT00302835|Analgesics|analgesics|mesh-list
101476383|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
101476384|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476385|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476386|NCT00269750|Oxybutynin|oxybutynin|mesh-list
101476387|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
101476388|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
101476389|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476390|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476391|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101476392|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101476393|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476394|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476395|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476396|NCT00269750|Urological Agents|urological agents|mesh-ancestor
101476397|NCT00269789|Methylphenidate|methylphenidate|mesh-list
101476398|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101476399|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476400|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476401|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476402|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476403|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476404|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
101476405|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476406|NCT00302913|Clopidogrel|clopidogrel|mesh-list
101476407|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101476408|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101476409|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101476410|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101476411|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
101476412|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476413|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476414|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476415|NCT00269828|Paclitaxel|paclitaxel|mesh-list
101476416|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101476417|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101476418|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476419|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476420|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361516|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101361517|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361518|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101361519|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361520|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361521|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361522|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
101361523|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361525|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101361526|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101476421|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476422|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476425|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101476427|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
101476428|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101476429|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
101476430|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476431|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476432|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101476433|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476434|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
101476435|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476436|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476437|NCT00269906|Abciximab|abciximab|mesh-list
101476438|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
101476439|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101476440|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
101476441|NCT00269945|Hematinics|hematinics|mesh-ancestor
101476442|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
101476443|NCT00269984|Hematinics|hematinics|mesh-ancestor
101476445|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
101476446|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101476447|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476448|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
101476449|NCT00270023|Hematinics|hematinics|mesh-ancestor
101476450|NCT00297375|Acetaminophen|acetaminophen|mesh-list
101476451|NCT00297375|Tramadol|tramadol|mesh-list
101476452|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101476453|NCT00297375|Analgesics|analgesics|mesh-ancestor
101476454|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
101476455|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476456|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476457|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
101476458|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101476459|NCT00297375|Narcotics|narcotics|mesh-ancestor
101476460|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476461|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
101476462|NCT00270062|Hematinics|hematinics|mesh-ancestor
101476463|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
101476464|NCT00270101|Hematinics|hematinics|mesh-ancestor
101476465|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
101476466|NCT00270140|Hematinics|hematinics|mesh-ancestor
101476467|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
101476468|NCT00270179|Hematinics|hematinics|mesh-ancestor
101476469|NCT00297570|Interferons|interferons|mesh-list
101476470|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
101476471|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476472|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
101476473|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476474|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101476475|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476476|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476477|NCT00270335|Propofol|propofol|mesh-list
101476478|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101361527|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361528|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101361529|NCT00124306|Analgesics|analgesics|mesh-ancestor
101361530|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
101361531|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476479|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476480|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476481|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101476482|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
101476483|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
101476484|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101476485|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
101476486|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476487|NCT00270491|Paclitaxel|paclitaxel|mesh-list
101476488|NCT00270491|Capecitabine|capecitabine|mesh-list
101476489|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476490|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476491|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476492|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476493|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476494|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476495|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476496|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
101476497|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
101476498|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
101476499|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101476500|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
101476506|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476507|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101476508|NCT00297765|Tacrolimus|tacrolimus|mesh-list
101476509|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476510|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
101476511|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476512|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101476513|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476514|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476515|NCT00270569|Cisplatin|cisplatin|mesh-list
101476516|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476517|NCT00297804|Paclitaxel|paclitaxel|mesh-list
101476518|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476519|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476521|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476522|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476523|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476524|NCT00270647|Vitamins|vitamins|mesh-list
101476525|NCT00270647|Vitamin E|vitamin e|mesh-list
101476526|NCT00270647|Beta Carotene|beta carotene|mesh-list
101476527|NCT00270647|Carotenoids|carotenoids|mesh-list
101476528|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
101476529|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476530|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
101476531|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476532|NCT00270647|Protective Agents|protective agents|mesh-ancestor
101476533|NCT00270647|Provitamins|provitamins|mesh-ancestor
101476534|NCT00297960|Olanzapine|olanzapine|mesh-list
101476535|NCT00297960|Ziprasidone|ziprasidone|mesh-list
101476536|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
101476537|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
101476538|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476539|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476540|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476541|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101476542|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476543|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476544|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476545|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101476546|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476547|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476548|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361532|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361533|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101361534|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476549|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476550|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
101476551|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101476552|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101476553|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
101476554|NCT00270881|Cytarabine|cytarabine|mesh-list
101476555|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
101476556|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476557|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
101476558|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476559|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476560|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101476561|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
101476562|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476563|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476564|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101476565|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476566|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
101476567|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
101476568|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476569|NCT00298194|Z 338|z 338|mesh-list
101476570|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101476571|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476572|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476576|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476577|NCT00418548|Etanercept|etanercept|mesh-list
101476578|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101476579|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101476580|NCT00418548|Analgesics|analgesics|mesh-ancestor
101476581|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
101476582|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476583|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476584|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476585|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476586|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476587|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476588|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
101476589|NCT00418587|Vitamin D|vitamin d|mesh-list
101476590|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
101476591|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
101476592|NCT00418587|Vitamins|vitamins|mesh-list
101476593|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
101476594|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476595|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101476597|NCT00416273|Bortezomib|bortezomib|mesh-list
101476598|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476599|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
101476600|NCT00306462|Nifedipine|nifedipine|mesh-list
101476601|NCT00306462|Analgesics|analgesics|mesh-ancestor
101476602|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
101476603|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476604|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476605|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
101476606|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476607|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101476608|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
101476609|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101476610|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476611|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476612|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101476613|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
101476614|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476615|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
101476616|NCT00416390|Lycopene|lycopene|mesh-list
101476617|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476618|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
101476619|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476620|NCT00416390|Protective Agents|protective agents|mesh-ancestor
101361536|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361538|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361539|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
101361540|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361541|NCT00124384|Modafinil|modafinil|mesh-list
101476621|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476622|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101476623|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101476624|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476625|NCT00416429|Interferons|interferons|mesh-list
101476626|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
101476627|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
101476628|NCT00416429|Aldesleukin|aldesleukin|mesh-list
101476629|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101476630|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
101476631|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476632|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
101476633|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476634|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
101476635|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476636|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101476637|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101476638|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101476639|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101476640|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101476641|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
101476642|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476643|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101476644|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101476645|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101476646|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101476653|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476654|NCT00271271|Gemcitabine|gemcitabine|mesh-list
101476655|NCT00271271|Vinorelbine|vinorelbine|mesh-list
101476656|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
101476657|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476658|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
101476659|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476660|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476661|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476662|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476663|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476664|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476665|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101476666|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476667|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476668|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476669|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476670|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476672|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476673|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476674|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
101476675|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476676|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476677|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476678|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476679|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
101476680|NCT00271349|Hormones|hormones|mesh-ancestor
101476681|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476682|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
101476683|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101476684|NCT00306696|Spironolactone|spironolactone|mesh-list
101476685|NCT00306696|Furosemide|furosemide|mesh-list
101476686|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101476687|NCT00306696|Diuretics|diuretics|mesh-ancestor
101361542|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101361543|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361544|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101361545|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101361546|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101476688|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
101476689|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476690|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101476691|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476692|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476693|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101476694|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
101476695|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476696|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101476697|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101476698|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101476699|NCT00271427|Selenium|selenium|mesh-list
101476700|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
101476701|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476702|NCT00271427|Protective Agents|protective agents|mesh-ancestor
101476703|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476704|NCT00271427|Trace Elements|trace elements|mesh-ancestor
101476705|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
101476706|NCT00271466|Fentanyl|fentanyl|mesh-list
101476707|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101476708|NCT00271466|Narcotics|narcotics|mesh-ancestor
101476709|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476710|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476711|NCT00271466|Analgesics|analgesics|mesh-ancestor
101476712|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
101476713|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476714|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101476715|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101476735|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101476736|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101476737|NCT00306774|Vitamin D|vitamin d|mesh-list
101476738|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
101476739|NCT00306774|Vitamins|vitamins|mesh-ancestor
101476740|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
101476741|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476742|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101476743|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101476744|NCT00306813|Lenalidomide|lenalidomide|mesh-list
101476745|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
101537614|NCT04565184|Amodiaquine|amodiaquine|mesh-list
101476746|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476747|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101476748|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101476749|NCT00306813|Growth Substances|growth substances|mesh-ancestor
101476750|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101476751|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476752|NCT00271973|Oxycodone|oxycodone|mesh-list
101476753|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101476754|NCT00271973|Narcotics|narcotics|mesh-ancestor
101476755|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476756|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476758|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
101476759|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476760|NCT00306969|Bexarotene|bexarotene|mesh-list
101476761|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476762|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
101476763|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101476764|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476765|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101476766|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
101476767|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476768|NCT00272051|Xaliproden|xaliproden|mesh-list
101361547|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361549|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361550|NCT00124540|Misoprostol|misoprostol|mesh-list
101361551|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101476769|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101476770|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101476771|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
101476775|NCT00307203|Bupropion|bupropion|mesh-list
101476776|NCT00307203|Nicotine|nicotine|mesh-list
101476777|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101476778|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
101476779|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476780|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476781|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101476782|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101476783|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476784|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476785|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476786|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101476787|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
101476788|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476789|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476790|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101476791|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476792|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
101476793|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101476794|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101476795|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476796|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
101476797|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101476798|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476799|NCT00272207|Nabilone|nabilone|mesh-list
101476800|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
101476801|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
101476802|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476803|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476804|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476805|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101476806|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476807|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476808|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476809|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101476810|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
101476811|NCT00307515|Coagulants|coagulants|mesh-ancestor
101476812|NCT00272285|Granisetron|granisetron|mesh-list
101476813|NCT00272285|Ramosetron|ramosetron|mesh-list
101476814|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
101476815|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
101476816|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476817|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476819|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101476820|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101476821|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
101476822|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476823|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476824|NCT00272324|Aspirin|aspirin|mesh-list
101476825|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101476826|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101476827|NCT00272324|Analgesics|analgesics|mesh-ancestor
101476828|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
101476829|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476830|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476831|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476832|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476833|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101476834|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101476835|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361552|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
101361553|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361554|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361555|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101361556|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361557|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
101361558|NCT00124696|Cocaethylene|cocaethylene|mesh-list
101361559|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476836|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101476837|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101476838|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476839|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
101476840|NCT00307593|Infliximab|infliximab|mesh-list
101476841|NCT00307593|Rituximab|rituximab|mesh-list
101476842|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101476855|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476856|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476857|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101476859|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476860|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101476861|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101476862|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101476863|NCT00272480|Lamivudine|lamivudine|mesh-list
101476864|NCT00272480|Zidovudine|zidovudine|mesh-list
101476865|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101476866|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101476867|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476868|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476869|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
101476870|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476871|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101476872|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101476873|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
101476874|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
101476875|NCT00307671|Prednisone|prednisone|mesh-list
101476876|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
101476877|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101476878|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101476879|NCT00307671|Prednisolone|prednisolone|mesh-list
101476880|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
101476881|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
101476882|NCT00307671|Methotrexate|methotrexate|mesh-list
101476883|NCT00307671|Azathioprine|azathioprine|mesh-list
101476884|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101476885|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
101476886|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101476887|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
101476888|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476889|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476891|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
101476892|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476893|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476894|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101476895|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476896|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
101476897|NCT00307671|Hormones|hormones|mesh-ancestor
101476898|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476899|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101476900|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101476901|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
101476902|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476903|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476904|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
101476905|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
101476906|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476914|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
101476915|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
101361560|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361561|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361562|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361563|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
101361564|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361565|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361566|NCT00043277|Bivalirudin|bivalirudin|mesh-list
101361567|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
101361568|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101361569|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361570|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476916|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476917|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476918|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101476919|NCT00307671|Protective Agents|protective agents|mesh-ancestor
101476920|NCT00272558|Carboplatin|carboplatin|mesh-list
101476921|NCT00272558|Vinorelbine|vinorelbine|mesh-list
101476922|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476923|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101476924|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476925|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476926|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476927|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476928|NCT00272597|Risperidone|risperidone|mesh-list
101476929|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101476930|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
101476931|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476932|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476933|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476934|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101476935|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476936|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476937|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476938|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101476939|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
101476940|NCT00272636|Amiodarone|amiodarone|mesh-list
101476941|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101476942|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
101476943|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101476944|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101476945|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476946|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101476947|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101476948|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101476950|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101476951|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101476952|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101476953|NCT00281970|Docetaxel|docetaxel|mesh-list
101476954|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476955|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
101476956|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
101476957|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476958|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476959|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
101476960|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101476961|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101476962|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476963|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
101476964|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
101476965|NCT00307827|Visilizumab|visilizumab|mesh-list
101476966|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
101476967|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361571|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361572|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
101361573|NCT00074022|Docetaxel|docetaxel|mesh-list
101361574|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361575|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361576|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361577|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101476968|NCT00272753|Budesonide|budesonide|mesh-list
101476969|NCT00272753|Albuterol|albuterol|mesh-list
101476970|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
101476971|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476972|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476973|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
101476974|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476981|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101476982|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101476983|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101476984|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
101476985|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476986|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476987|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
101476988|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476989|NCT00272831|Cilostazol|cilostazol|mesh-list
101476990|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101476991|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
101476992|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476993|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476994|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476995|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476996|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101476997|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101476998|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476999|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101477000|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477001|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101477002|NCT00272831|Protective Agents|protective agents|mesh-ancestor
101477003|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101477004|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101477005|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477006|NCT00416468|Valsartan|valsartan|mesh-list
101477007|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477008|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101477009|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101477010|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477012|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101477013|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101477014|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101477015|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477016|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477017|NCT00416507|Gemcitabine|gemcitabine|mesh-list
101477018|NCT00416507|Fluorouracil|fluorouracil|mesh-list
101477019|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477020|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101477021|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
101477022|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477023|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477024|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
101477025|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477026|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
101477027|NCT00282126|Diuretics|diuretics|mesh-ancestor
101477028|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
101477029|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477030|NCT00282126|Expectorants|expectorants|mesh-ancestor
101477031|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477032|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101477033|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361578|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361579|NCT00124813|Thalidomide|thalidomide|mesh-list
101361580|NCT00124813|Idarubicin|idarubicin|mesh-list
101361581|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361582|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
101361583|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361584|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
101361585|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101361586|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361587|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101477034|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477035|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477036|NCT00272909|Piclozotan|piclozotan|mesh-list
101477037|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101477038|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101477039|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
101477040|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477041|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477054|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477055|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101477056|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101477057|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
101477058|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
101477059|NCT00273026|Fluticasone|fluticasone|mesh-list
101477060|NCT00273026|Xhance|xhance|mesh-list
101477061|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101477062|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477063|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477064|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
101477065|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477066|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477067|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477068|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477069|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101477070|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101477071|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101477072|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101477073|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101477074|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
101477075|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477076|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477077|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101477078|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477079|NCT00282360|Trimetazidine|trimetazidine|mesh-list
101477080|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477081|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
101477082|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101477083|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101477084|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477085|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477086|NCT00418704|Docetaxel|docetaxel|mesh-list
101477087|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101477088|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477089|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
101477090|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
101477091|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
101477092|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477093|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101477094|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477095|NCT00313950|Vaccines|vaccines|mesh-list
101477096|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
101477097|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477098|NCT00273299|Valsartan|valsartan|mesh-list
101477099|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101477100|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101361588|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101361589|NCT00124813|Growth Substances|growth substances|mesh-ancestor
101361590|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
101361591|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361592|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361593|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101361594|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101361595|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361596|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361597|NCT00124930|Olanzapine|olanzapine|mesh-list
101477101|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101477102|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101477103|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477108|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477109|NCT00418782|Naproxen|naproxen|mesh-list
101477110|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413908|NCT00486694|Chloroquine|chloroquine|mesh-list
101477111|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101477112|NCT00418782|Analgesics|analgesics|mesh-ancestor
101477113|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
101477114|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477115|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477116|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477117|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477118|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
101477119|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101477120|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477121|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477123|NCT00273338|Docetaxel|docetaxel|mesh-list
101477124|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477125|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
101477126|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
101477127|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101477128|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477129|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101477130|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477131|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101477132|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477133|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101477134|NCT00273338|Vitamins|vitamins|mesh-ancestor
101477135|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
101477136|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101477138|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477140|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
101477141|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477142|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477143|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101477144|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
101477145|NCT00273377|Hormones|hormones|mesh-ancestor
101477146|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477147|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101477148|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477149|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
101477150|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477151|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101477152|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101477153|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477154|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477155|NCT00273416|Urological Agents|urological agents|mesh-ancestor
101477156|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101477157|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
101477158|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361598|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
101361599|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
101361600|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361601|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361602|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361603|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101361604|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101361605|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477159|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101477160|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101477161|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477162|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477163|NCT00273455|Timolol|timolol|mesh-list
101477164|NCT00273455|Bimatoprost|bimatoprost|mesh-list
101477165|NCT00273455|Dorzolamide|dorzolamide|mesh-list
101477166|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477167|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477168|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101477169|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101477170|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
101477171|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477172|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477173|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101477174|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477197|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477198|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477199|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
101477200|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477201|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
101477202|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101477203|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101477204|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101477205|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101477206|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
101477207|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477208|NCT00308334|Domperidone|domperidone|mesh-list
101477209|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
101477210|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
101477211|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477212|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477213|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101477214|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101477215|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
101477216|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477217|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477218|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
101477219|NCT00273767|Hematinics|hematinics|mesh-ancestor
101477220|NCT00314379|Vitamin E|vitamin e|mesh-list
101477221|NCT00314379|Vitamins|vitamins|mesh-ancestor
101477222|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
101477223|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477224|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
101477225|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477226|NCT00314379|Protective Agents|protective agents|mesh-ancestor
101477227|NCT00273884|Cytarabine|cytarabine|mesh-list
101477231|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477232|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477233|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
101477234|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477235|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477236|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
101477237|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477238|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477239|NCT00308373|Metformin|metformin|mesh-list
101477240|NCT00308373|Pioglitazone|pioglitazone|mesh-list
101477241|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101477242|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101477243|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361606|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361607|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101361608|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361609|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361610|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361611|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361612|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
101361613|NCT00124969|Amlodipine|amlodipine|mesh-list
101361614|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477244|NCT00273962|Albuterol|albuterol|mesh-list
101477245|NCT00273962|Ipratropium|ipratropium|mesh-list
101477246|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477247|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
101477248|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477249|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477250|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477251|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477252|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
101477253|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101477254|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101477255|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101477256|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101477257|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
101477258|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477259|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477260|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101477261|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477262|NCT00274001|Nevirapine|nevirapine|mesh-list
101477263|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101477264|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101477265|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477266|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477267|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
101477268|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477269|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101477270|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101477271|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101477272|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101477273|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
101477274|NCT00274040|Ipratropium|ipratropium|mesh-list
101477275|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477276|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
101477277|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477278|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477279|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477280|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477281|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
101477282|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101477283|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477284|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477285|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477286|NCT00314457|Bupivacaine|bupivacaine|mesh-list
101477287|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
101477288|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
101477289|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477290|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477291|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
101477292|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477293|NCT00308451|Chromium|chromium|mesh-list
101477294|NCT00308451|Biotin|biotin|mesh-list
101477295|NCT00308451|Picolinic acid|picolinic acid|mesh-list
101477296|NCT00308451|Trace Elements|trace elements|mesh-ancestor
101477297|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
101477298|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477299|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
101361615|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101361616|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361617|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361618|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101361619|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361620|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477310|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477311|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477312|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
101477313|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101477314|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477315|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477316|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477317|NCT00274118|Telmisartan|telmisartan|mesh-list
101477318|NCT00274118|Enalapril|enalapril|mesh-list
101477319|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477320|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101477321|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101477322|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477323|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101477324|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101477325|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477326|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101477327|NCT00308490|Hematinics|hematinics|mesh-ancestor
101477328|NCT00416585|Isotretinoin|isotretinoin|mesh-list
101477329|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
101477330|NCT00308529|Bevacizumab|bevacizumab|mesh-list
101477331|NCT00308529|Carboplatin|carboplatin|mesh-list
101477332|NCT00308529|Irinotecan|irinotecan|mesh-list
101477333|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477334|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477335|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101477336|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101477337|NCT00308529|Growth Substances|growth substances|mesh-ancestor
101477338|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477339|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
101477340|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101477341|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477342|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477343|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477344|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
101477345|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
101477346|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101477348|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
101477349|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101477350|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101477351|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477352|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101477353|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477354|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477355|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101477356|NCT00274274|Insulin|insulin|mesh-list
101477357|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101477358|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
101477359|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
101477360|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101477361|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477362|NCT00308607|Interferons|interferons|mesh-list
101477363|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
101477364|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
101477365|NCT00308607|Bevacizumab|bevacizumab|mesh-list
101477366|NCT00308607|Dacarbazine|dacarbazine|mesh-list
101477367|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477369|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101477370|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101477371|NCT00308607|Growth Substances|growth substances|mesh-ancestor
101361621|NCT00043316|Interferons|interferons|mesh-list
101361622|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
101361623|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361624|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
101361625|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361626|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
101361627|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361628|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361629|NCT00125008|Vaccines|vaccines|mesh-list
101477372|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477373|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
101477374|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
101477375|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477376|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
101477377|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101477378|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
101477379|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477380|NCT00314613|Risperidone|risperidone|mesh-list
101477381|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
101477382|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101477383|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
101477384|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477385|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477386|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477387|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101477388|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477389|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101477390|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101477391|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
101477393|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101477394|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477395|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477396|NCT00314652|Buprenorphine|buprenorphine|mesh-list
101477397|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101477398|NCT00314652|Narcotics|narcotics|mesh-ancestor
101477399|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477400|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477401|NCT00314652|Analgesics|analgesics|mesh-ancestor
101477402|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
101477403|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477404|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101477405|NCT00274391|Amiloride|amiloride|mesh-list
101477406|NCT00274391|Diuretics|diuretics|mesh-ancestor
101477407|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
101477408|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477409|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101477410|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101477411|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477412|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477413|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101477414|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101477415|NCT00274430|Dexamethasone|dexamethasone|mesh-list
101477416|NCT00274430|Tadalafil|tadalafil|mesh-list
101477417|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477418|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
101477419|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
101477420|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477421|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477422|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101477423|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
101477425|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477426|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101477427|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477428|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477429|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101361630|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
101361631|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361632|NCT00125047|Vaccines|vaccines|mesh-list
101361633|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
101361634|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361635|NCT00078000|Sunitinib|sunitinib|mesh-list
101361636|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361637|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101361638|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101361639|NCT00078000|Growth Substances|growth substances|mesh-ancestor
101361640|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477430|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101477431|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477432|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477433|NCT00274430|Urological Agents|urological agents|mesh-ancestor
101477434|NCT00274508|Bromides|bromides|mesh-list
101477435|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
101477436|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477437|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
101477438|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477439|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477440|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477441|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477446|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477447|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
101477448|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
101477449|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477450|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
101477451|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477452|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477453|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477454|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477456|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101477457|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477458|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477459|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477460|NCT00308763|Bupropion|bupropion|mesh-list
101477461|NCT00308763|Nicotine|nicotine|mesh-list
101477462|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101477463|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
101477464|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477465|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477466|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101477467|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101477468|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477469|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477470|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477471|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101477472|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
101477473|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101477474|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101477475|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101477476|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477477|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
101477478|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101477479|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101477480|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477481|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101477482|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101477483|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
101477484|NCT00274820|Thalidomide|thalidomide|mesh-list
101477485|NCT00274820|Dexamethasone|dexamethasone|mesh-list
101477486|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
101361641|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
101361643|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361644|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361645|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101361646|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
101361647|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101361648|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101477487|NCT00274820|Vitamins|vitamins|mesh-ancestor
101477488|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
101477489|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477490|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477492|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
101477493|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477494|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101477496|NCT00274820|Hormones|hormones|mesh-ancestor
101477497|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477498|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101477499|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477500|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
101477501|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477502|NCT00274820|Protective Agents|protective agents|mesh-ancestor
101477503|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477504|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
101477505|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
101477506|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101477507|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477508|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101477509|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101477510|NCT00274820|Growth Substances|growth substances|mesh-ancestor
101477511|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101477512|NCT00308841|Lidocaine|lidocaine|mesh-list
101477513|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
101477515|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477516|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477517|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
101477518|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477519|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101477520|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101477521|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101477522|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477523|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477525|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
101477526|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101477527|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
101477528|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477529|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477530|NCT00274898|Celecoxib|celecoxib|mesh-list
101477531|NCT00274898|Docetaxel|docetaxel|mesh-list
101477532|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477533|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101477534|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101477535|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101477536|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477537|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101477538|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101477539|NCT00274898|Analgesics|analgesics|mesh-ancestor
101477540|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
101477541|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477542|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477543|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477544|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477545|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101477546|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101477547|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477548|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
101361649|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101361650|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361651|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361653|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361654|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361655|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101361656|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477549|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101477550|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101477551|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477552|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
101477553|NCT00308880|Coagulants|coagulants|mesh-ancestor
101477554|NCT00277199|Abatacept|abatacept|mesh-list
101477555|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101477556|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477557|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477558|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477559|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477560|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
101477561|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477562|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477564|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101477565|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477566|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101477567|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101477568|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477570|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
101477571|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477572|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101477573|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101477574|NCT00277511|Levofloxacin|levofloxacin|mesh-list
101477575|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101477576|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477577|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101477578|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101477579|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477580|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477581|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477582|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477583|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101477584|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101477591|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
101477592|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477593|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477594|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477596|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101477597|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477598|NCT00277589|Trace Elements|trace elements|mesh-ancestor
101477599|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
101477600|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477601|NCT00315042|Penicillins|penicillins|mesh-list
101477602|NCT00315042|Telithromycin|telithromycin|mesh-list
101477603|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101477604|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477605|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101477606|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
101477607|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101477608|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101477609|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101361657|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101361658|NCT00043355|Interferons|interferons|mesh-list
101361659|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
101361660|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361661|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
101361662|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361663|NCT00125398|Fospropofol|fospropofol|mesh-list
101361664|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101477610|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477611|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477612|NCT00315081|Bromocriptine|bromocriptine|mesh-list
101477613|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101477614|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101477615|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
101477616|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477617|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477619|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
101477620|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477621|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477622|NCT00277706|Vitamin D|vitamin d|mesh-list
101477623|NCT00277706|Calcium|calcium|mesh-list
101477624|NCT00277706|Vitamins|vitamins|mesh-ancestor
101477625|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
101477626|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477627|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101477628|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101477629|NCT00277862|Ribavirin|ribavirin|mesh-list
101477630|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
101477631|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
101477632|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101477633|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101477634|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
101477635|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477636|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
101477637|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477638|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
101477639|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477640|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477641|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
101477642|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
101477643|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477644|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
101477645|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477646|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477648|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101477649|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477650|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101477651|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101477652|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101477653|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477654|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
101477655|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101477659|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101477660|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477661|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
101477662|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477663|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
101477664|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477665|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
101477666|NCT00278213|Fludarabine|fludarabine|mesh-list
101477667|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
101477668|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
101477669|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
101477670|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477671|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
101477672|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361665|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361666|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361667|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
101361668|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101361669|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
101361670|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101477673|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477674|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101477675|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
101477676|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477677|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477678|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101477679|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101477680|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
101477681|NCT00278213|Analgesics|analgesics|mesh-ancestor
101477682|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
101477683|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477684|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101477685|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477686|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477687|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477688|NCT00278252|Etoposide|etoposide|mesh-list
101477689|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101477690|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477691|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101477692|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477693|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477694|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477695|NCT00315432|Interferons|interferons|mesh-list
101477696|NCT00315432|Ribavirin|ribavirin|mesh-list
101477697|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477698|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
101477699|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477700|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
101477701|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477702|NCT00278330|Vorinostat|vorinostat|mesh-list
101477703|NCT00278330|Alvocidib|alvocidib|mesh-list
101477704|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477705|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101477706|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477707|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477708|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101477709|NCT00278330|Growth Substances|growth substances|mesh-ancestor
101477710|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477711|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101477712|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101477713|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101477714|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101477715|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
101477716|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477717|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101477718|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101477719|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477720|NCT00278369|Aldesleukin|aldesleukin|mesh-list
101477721|NCT00278369|Interleukin-2|interleukin-2|mesh-list
101477722|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
101477723|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477724|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101477725|NCT00278369|Analgesics|analgesics|mesh-ancestor
101477726|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
101477727|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477728|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477734|NCT00315549|Telithromycin|telithromycin|mesh-list
101477735|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101477736|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477737|NCT00278408|Prednisone|prednisone|mesh-list
101477738|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
101477739|NCT00278408|Rituximab|rituximab|mesh-list
101361671|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361672|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361673|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361674|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
101361675|NCT00125437|Spironolactone|spironolactone|mesh-list
101477740|NCT00278408|Doxorubicin|doxorubicin|mesh-list
101477741|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101477742|NCT00278408|Vincristine|vincristine|mesh-list
101477743|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477744|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
101477745|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477746|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477747|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101477748|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
101477749|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477750|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477751|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101477752|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101477753|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101477754|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101477755|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477756|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477757|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477758|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
101477759|NCT00278408|Hormones|hormones|mesh-ancestor
101477760|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477761|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101477762|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101477763|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101477764|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101477765|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101477766|NCT00315666|Memantine|memantine|mesh-list
101477767|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101477768|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101477769|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
101477770|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477771|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477772|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477773|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101477774|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101477775|NCT00315744|Fluticasone|fluticasone|mesh-list
101477777|NCT00315744|Albuterol|albuterol|mesh-list
101477778|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101477779|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477780|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477781|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
101477782|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477783|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477784|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477785|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477786|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101477787|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101477788|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101477789|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101477790|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101477791|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
101477792|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477793|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477794|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
101477795|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101477796|NCT00309543|Leucovorin|leucovorin|mesh-list
101477797|NCT00309543|Fluorouracil|fluorouracil|mesh-list
101477798|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
101477799|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477800|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101477807|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
101477808|NCT00309543|Vitamins|vitamins|mesh-ancestor
101477809|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
101477810|NCT00315861|Pemetrexed|pemetrexed|mesh-list
101477811|NCT00315861|Topotecan|topotecan|mesh-list
101361676|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101361677|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
101361678|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361679|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361680|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101361682|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
101361683|NCT00125554|Metyrapone|metyrapone|mesh-list
101361684|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
101361685|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361686|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361687|NCT00043394|Trastuzumab|trastuzumab|mesh-list
101477812|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477813|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477814|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477815|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101477816|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101477817|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101477818|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101477819|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
101477820|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101477821|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477822|NCT00315900|Valproic Acid|valproic acid|mesh-list
101477823|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101477824|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
101477825|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101477826|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101477827|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101477828|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477829|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477830|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
101477831|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477832|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477833|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
101477834|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477835|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
101477836|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101477837|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
101477838|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477839|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101477840|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101477841|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
101477842|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101477843|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101477844|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101477845|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477846|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477847|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101477848|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101477849|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
101477850|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477851|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477852|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101477853|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101477854|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
101477855|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
101477856|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
101477857|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101477858|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101477859|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477860|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477861|NCT00309816|Urological Agents|urological agents|mesh-ancestor
101361688|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361689|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361691|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
101361692|NCT00125827|Clofarabine|clofarabine|mesh-list
101361693|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361694|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
101361695|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361696|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361697|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101361698|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101361699|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101361700|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361701|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477862|NCT00279266|Thiamine|thiamine|mesh-list
101477863|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101477864|NCT00279266|Vitamins|vitamins|mesh-ancestor
101477865|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
101477866|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477867|NCT00316095|Telmisartan|telmisartan|mesh-list
101477868|NCT00316095|Simvastatin|simvastatin|mesh-list
101477869|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101477870|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101477871|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
101477881|NCT00279344|Narcotics|narcotics|mesh-ancestor
101477882|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101477883|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477884|NCT00279344|Analgesics|analgesics|mesh-ancestor
101477885|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
101477886|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477887|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101477888|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101477889|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
101477890|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
101477891|NCT00418860|Aspirin|aspirin|mesh-list
101477892|NCT00418860|Clopidogrel|clopidogrel|mesh-list
101477893|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101477894|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101477895|NCT00418860|Analgesics|analgesics|mesh-ancestor
101477896|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
101477897|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477898|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477899|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477900|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101477901|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101477902|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101477903|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477904|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101477905|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101477906|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477907|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
101477908|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101477909|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101477910|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101477911|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
101477912|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477913|NCT00316212|INS 50589|ins 50589|mesh-list
101477914|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101477915|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101477916|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
101361702|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361703|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101477917|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477919|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477921|NCT00309855|Testosterone|testosterone|mesh-list
101477922|NCT00309855|Dutasteride|dutasteride|mesh-list
101477923|NCT00309855|Androgens|androgens|mesh-ancestor
101477924|NCT00309855|Hormones|hormones|mesh-ancestor
101477925|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477926|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477927|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101477928|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477929|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101477930|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101477931|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477932|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477933|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
101477934|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101477935|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101477942|NCT00309894|Ketoconazole|ketoconazole|mesh-list
101477943|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
101477944|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101477945|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101477946|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101477947|NCT00309894|Sargramostim|sargramostim|mesh-list
101477948|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101477949|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
101477950|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477951|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
101477952|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477953|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101477954|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101477955|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477956|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477957|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101477958|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
101477959|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477960|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101477962|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
101477963|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
101477965|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
101477966|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477967|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101477968|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101477969|NCT00316329|Artesunate|artesunate|mesh-list
101477970|NCT00316329|Amodiaquine|amodiaquine|mesh-list
101477971|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
101477972|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101477973|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101477974|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477975|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477976|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
101477977|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
101477978|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101477979|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
101477980|NCT00279539|Mitogens|mitogens|mesh-list
101477981|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
101477982|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
101477983|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477984|NCT00279539|Growth Substances|growth substances|mesh-ancestor
101477985|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477986|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
101477987|NCT00279578|Factor VIII|factor viii|mesh-list
101477988|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101477989|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101477990|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477991|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
101477992|NCT00279578|Coagulants|coagulants|mesh-ancestor
101477993|NCT00279617|Levetiracetam|levetiracetam|mesh-list
101477994|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
101361704|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101361705|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
101361706|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361707|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361708|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101361709|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101361710|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
101361711|NCT00125905|Bupropion|bupropion|mesh-list
101361712|NCT00125905|Nicotine|nicotine|mesh-list
101361713|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101361714|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
101477995|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
101477996|NCT00310011|Paclitaxel|paclitaxel|mesh-list
101477997|NCT00310011|Gemcitabine|gemcitabine|mesh-list
101477998|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101477999|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478000|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478001|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478002|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478003|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478004|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478005|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
101478006|NCT00316407|Paclitaxel|paclitaxel|mesh-list
101478007|NCT00316407|Carboplatin|carboplatin|mesh-list
101478008|NCT00316407|Lapatinib|lapatinib|mesh-list
101478017|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
101478018|NCT00310089|Docetaxel|docetaxel|mesh-list
101478019|NCT00310089|Doxorubicin|doxorubicin|mesh-list
101478020|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101478021|NCT00310089|Cediranib|cediranib|mesh-list
101478022|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478023|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
101478024|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478025|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478026|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101478027|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
101478028|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478029|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478030|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101478031|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478032|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478033|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478034|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478035|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478036|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478037|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478038|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478040|NCT00279734|Vaccines|vaccines|mesh-list
101478041|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
101478042|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478043|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101478044|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478045|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101478046|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478047|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478048|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478049|NCT00310128|Cytarabine|cytarabine|mesh-list
101478050|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
101478051|NCT00310128|Rituximab|rituximab|mesh-list
101478052|NCT00310128|Etoposide|etoposide|mesh-list
101478053|NCT00310128|Antibodies|antibodies|mesh-list
101478054|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
101478055|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101478056|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
101478057|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478058|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361715|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361716|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361717|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101361718|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101361719|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101361720|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361721|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361722|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101361723|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
101361724|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361725|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101478059|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478060|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478061|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478062|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478063|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478064|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478065|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478066|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478067|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
101478068|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
101478069|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478070|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478071|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478073|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
101478074|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478075|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478076|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
101478092|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528427|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101478094|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478095|NCT00416819|Leucovorin|leucovorin|mesh-list
101478096|NCT00416819|Cytarabine|cytarabine|mesh-list
101478097|NCT00416819|Rituximab|rituximab|mesh-list
101478098|NCT00416819|Methotrexate|methotrexate|mesh-list
101478099|NCT00416819|Etoposide|etoposide|mesh-list
101478100|NCT00416819|Temozolomide|temozolomide|mesh-list
101478101|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
101478102|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
101478103|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101478104|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478105|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
101478106|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478107|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478108|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101478109|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
101478110|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101478111|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478112|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
101478113|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478114|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478115|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478116|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101478117|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478118|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101478119|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478120|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478121|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478122|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
101361726|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361727|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361728|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
101361729|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101361730|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101478123|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478124|NCT00416819|Antidotes|antidotes|mesh-ancestor
101478125|NCT00416819|Protective Agents|protective agents|mesh-ancestor
101478126|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
101478127|NCT00416819|Vitamins|vitamins|mesh-ancestor
101478128|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
101478129|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101478130|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
101478131|NCT00310206|Vaccines|vaccines|mesh-list
101478132|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
101478133|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478134|NCT00280007|Bevacizumab|bevacizumab|mesh-list
101478135|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101478155|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478156|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101478157|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101478159|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478160|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
101478161|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
101478162|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101478163|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101478164|NCT00280280|Baclofen|baclofen|mesh-list
101478166|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478167|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101478168|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478169|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101478170|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
101478171|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
101478172|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478173|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478174|NCT00316758|Metformin|metformin|mesh-list
101478175|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478176|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478177|NCT00280358|Fluticasone|fluticasone|mesh-list
101478179|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
101478180|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478181|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101478182|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
101478183|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478184|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478185|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101478186|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
101478187|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478188|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101478189|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101478190|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101478191|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101478192|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
101478199|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478200|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478201|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
101478202|NCT00280436|Casopitant|casopitant|mesh-list
101478203|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
101478204|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
101478205|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478206|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478207|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478208|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101478209|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478210|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478211|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
101478212|NCT00280514|Cefpirome|cefpirome|mesh-list
101478213|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101361731|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361732|NCT00078117|Buprenorphine|buprenorphine|mesh-list
101361733|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101361734|NCT00078117|Narcotics|narcotics|mesh-ancestor
101361735|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361736|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361737|NCT00078117|Analgesics|analgesics|mesh-ancestor
101478214|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478215|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478216|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478217|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478218|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478219|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478220|NCT00280553|Bupivacaine|bupivacaine|mesh-list
101478221|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
101478222|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
101478223|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478224|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478225|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
101478227|NCT00316875|Doxorubicin|doxorubicin|mesh-list
101478228|NCT00316875|Lapatinib|lapatinib|mesh-list
101478229|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478230|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478231|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478232|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478233|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478234|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478235|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478236|NCT00316953|Dasatinib|dasatinib|mesh-list
101478237|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478238|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478239|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478240|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478241|NCT00419172|Rifampin|rifampin|mesh-list
101478242|NCT00419172|Deferasirox|deferasirox|mesh-list
101478243|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101478244|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
101478245|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478246|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478247|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
101478248|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101478249|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478250|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478251|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101478252|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101478253|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101478254|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101478255|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101478256|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101478257|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101478258|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
101478263|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478264|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478265|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478266|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478267|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478268|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478269|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101478270|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478271|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478273|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101478274|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478275|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361738|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
101361739|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361740|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101361741|NCT00125983|Ritonavir|ritonavir|mesh-list
101361742|NCT00125983|Lopinavir|lopinavir|mesh-list
101361743|NCT00125983|Norinyl|norinyl|mesh-list
101361744|NCT00125983|Ortho Evra|ortho evra|mesh-list
101361745|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101361746|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101361747|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
101361748|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478276|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478277|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478278|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478279|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478280|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478281|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101478283|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101478284|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478285|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101478286|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101478287|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101478288|NCT00280865|Pioglitazone|pioglitazone|mesh-list
101478289|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478290|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478291|NCT00317031|Naltrexone|naltrexone|mesh-list
101478292|NCT00317031|Acamprosate|acamprosate|mesh-list
101478293|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101478294|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101478295|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478296|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
101478297|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478298|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101478299|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101478300|NCT00317070|Protective Agents|protective agents|mesh-ancestor
101478301|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478302|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101478303|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
101478304|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478305|NCT00281255|Allopurinol|allopurinol|mesh-list
101478306|NCT00281255|Dobutamine|dobutamine|mesh-list
101478307|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
101478308|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478309|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478310|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
101478311|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478312|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101478313|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
101478314|NCT00281255|Protective Agents|protective agents|mesh-ancestor
101478315|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478316|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101478317|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
101478318|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
101478319|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478320|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101478321|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101478322|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101478323|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
101478324|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478325|NCT00317187|Vaccines|vaccines|mesh-list
101478326|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
101478327|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478328|NCT00310908|Tramadol|tramadol|mesh-list
101478329|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101478330|NCT00310908|Narcotics|narcotics|mesh-ancestor
101361749|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361751|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101361752|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
101361753|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361754|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101361755|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101361756|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101361757|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101361758|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101361759|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
101361760|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101478331|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478332|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478338|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478340|NCT00317343|Bivalirudin|bivalirudin|mesh-list
101478341|NCT00317343|Thrombin|thrombin|mesh-list
101478342|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
101478343|NCT00317343|Coagulants|coagulants|mesh-ancestor
101478344|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
101478345|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101478346|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
101478347|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478348|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478349|NCT00416858|Fluorouracil|fluorouracil|mesh-list
101478350|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478351|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
101478352|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478353|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478354|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478355|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
101478356|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478357|NCT00416897|Dexamethasone|dexamethasone|mesh-list
101478358|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478359|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
101478360|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
101478361|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478362|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478363|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478364|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
101478365|NCT00416897|Hormones|hormones|mesh-ancestor
101478366|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478367|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101478368|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478369|NCT00417014|Prednisolone|prednisolone|mesh-list
101478370|NCT00417014|Vinblastine|vinblastine|mesh-list
101478371|NCT00417014|Procarbazine|procarbazine|mesh-list
101478372|NCT00417014|Chlorambucil|chlorambucil|mesh-list
101478373|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478374|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
101478375|NCT00417014|Hormones|hormones|mesh-ancestor
101478376|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478377|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478378|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101478379|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478380|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478381|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478382|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478383|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478384|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478385|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361761|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361762|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101361763|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101361765|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101361766|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101361767|NCT00126022|Protective Agents|protective agents|mesh-ancestor
101361768|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478386|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
101478387|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
101478388|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478389|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
101478390|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101478391|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101478392|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478393|NCT00317421|Urological Agents|urological agents|mesh-ancestor
101478394|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
101478397|NCT00417053|Carboplatin|carboplatin|mesh-list
101478398|NCT00417053|Doxorubicin|doxorubicin|mesh-list
101478399|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101478400|NCT00417053|Etoposide|etoposide|mesh-list
101478401|NCT00417053|Vincristine|vincristine|mesh-list
101478402|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
101478403|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478404|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
101478405|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478414|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478415|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478416|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478417|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478418|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478419|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478420|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
101478421|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101478422|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
101478423|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478424|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478425|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101478426|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
101478427|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
101478428|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101478429|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
101478430|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478431|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478432|NCT00317499|Etanercept|etanercept|mesh-list
101478433|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478434|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478435|NCT00317499|Analgesics|analgesics|mesh-ancestor
101478436|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
101478437|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478438|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478439|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478440|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478441|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478442|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478443|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
101478444|NCT00281606|Ritonavir|ritonavir|mesh-list
101478445|NCT00281606|Lopinavir|lopinavir|mesh-list
101478446|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101478447|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101478448|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101478449|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478450|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478451|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101478452|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101478453|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
101478454|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361769|NCT00402454|Rifampin|rifampin|mesh-list
101361770|NCT00402454|Isoniazid|isoniazid|mesh-list
101361771|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
101361772|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101361773|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
101361774|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101361776|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
101478455|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101478456|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101478457|NCT00317538|Infliximab|infliximab|mesh-list
101478458|NCT00317538|Etanercept|etanercept|mesh-list
101478459|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101478460|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478461|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478462|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478463|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478464|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478465|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478466|NCT00317538|Analgesics|analgesics|mesh-ancestor
101478467|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
101478468|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478469|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478470|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478471|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
101478476|NCT00317577|Timolol|timolol|mesh-list
101478477|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101478478|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101478479|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101478480|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
101478481|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478482|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478483|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478484|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101478485|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101478486|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101478487|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101478488|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101478489|NCT00317655|Ibuprofen|ibuprofen|mesh-list
101478490|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478491|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478492|NCT00317655|Analgesics|analgesics|mesh-ancestor
101478493|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
101478494|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478495|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478496|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478497|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478498|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101478499|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478500|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478501|NCT00281996|Gemcitabine|gemcitabine|mesh-list
101478502|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
101478503|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478504|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
101478505|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478506|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478507|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478508|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478509|NCT00311259|Melatonin|melatonin|mesh-list
101478510|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
101478511|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478512|NCT00311259|Protective Agents|protective agents|mesh-ancestor
101478513|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478514|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478515|NCT00317733|Ketoprofen|ketoprofen|mesh-list
101361777|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101361778|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361779|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361780|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101361781|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101478517|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478518|NCT00317733|Analgesics|analgesics|mesh-ancestor
101478519|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
101478520|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478521|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478522|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478523|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478524|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101478525|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478526|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478527|NCT00311337|Bortezomib|bortezomib|mesh-list
101478528|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478529|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
101478530|NCT00317811|Bortezomib|bortezomib|mesh-list
101478531|NCT00317811|Melphalan|melphalan|mesh-list
101478532|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478533|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101478534|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
101478535|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478536|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101478537|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478538|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
101478539|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478540|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
101478541|NCT00317811|Protective Agents|protective agents|mesh-ancestor
101478542|NCT00317811|Vitamins|vitamins|mesh-ancestor
101478550|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478551|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478552|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478553|NCT00282386|Analgesics|analgesics|mesh-ancestor
101478554|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
101478555|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478556|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478557|NCT00317850|Gabapentin|gabapentin|mesh-list
101478558|NCT00317850|Analgesics|analgesics|mesh-ancestor
101478559|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
101478560|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478561|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478562|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
101478563|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101478564|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101478565|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478566|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478567|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101478568|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101478569|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478571|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
101478572|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
101478573|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101478574|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101478575|NCT00282503|Prednisolone|prednisolone|mesh-list
101478576|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
101478577|NCT00282503|Methoxsalen|methoxsalen|mesh-list
101478578|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101478579|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
101478580|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478581|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
101478582|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
101478583|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478584|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478585|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478586|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
101478587|NCT00282503|Hormones|hormones|mesh-ancestor
101361782|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101361783|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101361784|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101361785|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101361786|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101361788|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
101361789|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101478588|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478589|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101478590|NCT00282503|Protective Agents|protective agents|mesh-ancestor
101478591|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101478592|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478593|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101478594|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478595|NCT00317928|Metformin|metformin|mesh-list
101478596|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478597|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478598|NCT00282698|Insulin|insulin|mesh-list
101478599|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478600|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478601|NCT00317967|Atorvastatin|atorvastatin|mesh-list
101478602|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101478603|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101478604|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
101478605|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478606|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101478607|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101478608|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478609|NCT00318084|Esomeprazole|esomeprazole|mesh-list
101478610|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101478613|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478614|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478615|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101478616|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101478617|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101478618|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
101478619|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478620|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478621|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478622|NCT00282932|Urological Agents|urological agents|mesh-ancestor
101478623|NCT00318162|Naltrexone|naltrexone|mesh-list
101478624|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101478625|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101478626|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478627|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
101478628|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478629|NCT00283088|Plasminogen|plasminogen|mesh-list
101478630|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101478631|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101478632|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101478633|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478634|NCT00318201|Erythromycin|erythromycin|mesh-list
101478635|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
101478636|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101478637|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
101478638|NCT00318201|Diltiazem|diltiazem|mesh-list
101478639|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101478640|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101478641|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101478642|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478643|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101478644|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478645|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
101361791|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101361792|NCT00402493|Latanoprost|latanoprost|mesh-list
101361793|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478646|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478647|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478648|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478649|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101478650|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478651|NCT00311688|Interleukin-2|interleukin-2|mesh-list
101478652|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478653|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478654|NCT00311688|Analgesics|analgesics|mesh-ancestor
101478655|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
101478656|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478657|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478658|NCT00283478|Gemcitabine|gemcitabine|mesh-list
101478659|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478660|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
101478661|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478662|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478663|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101478664|NCT00318318|Estrogens|estrogens|mesh-ancestor
101478666|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478667|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478668|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
101478669|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101478670|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478671|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478672|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478673|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
101478674|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
101478675|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101478676|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101478677|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478678|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478679|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478680|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478681|NCT00283556|Irinotecan|irinotecan|mesh-list
101478682|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101478690|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478691|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478692|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478693|NCT00318513|Bevacizumab|bevacizumab|mesh-list
101478694|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101478695|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478696|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101478697|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101478698|NCT00318513|Growth Substances|growth substances|mesh-ancestor
101478699|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478700|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
101478702|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478703|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478705|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101478706|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
101478707|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
101478708|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478709|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478710|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
101478711|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478712|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478713|NCT00283790|Zolpidem|zolpidem|mesh-list
101478714|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101478715|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101478716|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478717|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478718|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101478719|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
101478720|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
101478721|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361794|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101361796|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
101361797|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361798|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361799|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361800|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361801|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101361802|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478722|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478723|NCT00318669|Paroxetine|paroxetine|mesh-list
101478724|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101478725|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101478726|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101478727|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478728|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478729|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
101478730|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478731|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101478732|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
101478733|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478734|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101478735|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101478736|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478737|NCT00283829|Docetaxel|docetaxel|mesh-list
101478738|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478739|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478740|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478741|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478742|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478743|NCT00311961|Prednisolone|prednisolone|mesh-list
101478744|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101478745|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
101478746|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101478747|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
101478748|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101478749|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
101478750|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478764|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101478765|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101478766|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478767|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478768|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101478770|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
101478771|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478772|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478773|NCT00312000|Capecitabine|capecitabine|mesh-list
101478774|NCT00312000|Irinotecan|irinotecan|mesh-list
101478775|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478776|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
101478777|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478778|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478779|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101478780|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478781|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478782|NCT00283985|Dexamethasone|dexamethasone|mesh-list
101478783|NCT00283985|Methotrexate|methotrexate|mesh-list
101478784|NCT00283985|Asparaginase|asparaginase|mesh-list
101478785|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478786|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
101478787|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
101478788|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478789|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478790|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478792|NCT00283985|Hormones|hormones|mesh-ancestor
101478793|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478794|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101478795|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478796|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101478797|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
101478798|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101478799|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101478800|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
101478801|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478802|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
101478803|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478804|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101478805|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478806|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
101478807|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478808|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101478809|NCT00419250|Lenalidomide|lenalidomide|mesh-list
101478810|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
101478811|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478814|NCT00419250|Growth Substances|growth substances|mesh-ancestor
101478815|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
101478816|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478818|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
101478819|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
101478820|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478821|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478822|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478823|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101478824|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
101478826|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478828|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101478829|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478830|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478831|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478832|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478833|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
101478834|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
101478835|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478836|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478837|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
101478838|NCT00284336|Doxorubicin|doxorubicin|mesh-list
101478839|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101478840|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478841|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
101478842|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478843|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478844|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101478845|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
101478846|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478847|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478848|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101478849|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478850|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478851|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478852|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478853|NCT00312156|Insulin|insulin|mesh-list
101478854|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101478855|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
101478856|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
101478857|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
101478858|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
101478859|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
101478860|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478861|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478862|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
101478863|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101478864|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
101478865|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
101478866|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478867|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361803|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361804|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101361805|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101361806|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101361807|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101361808|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101361809|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101361810|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
101478868|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478869|NCT00318825|Analgesics|analgesics|mesh-ancestor
101478870|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
101478871|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478872|NCT00284531|Daclizumab|daclizumab|mesh-list
101478873|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101478874|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
101478875|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478876|NCT00312273|Aminophylline|aminophylline|mesh-list
101478877|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101478878|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
101478879|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478880|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478881|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101478882|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
101478883|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101478884|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101478885|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478889|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
101478890|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478891|NCT00312273|Protective Agents|protective agents|mesh-ancestor
101478892|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
101478893|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
101478894|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478895|NCT00284687|Artesunate|artesunate|mesh-list
101478896|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
101478897|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101478898|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101478899|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478900|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478901|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
101478902|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
101478903|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101478904|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
101478905|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
101478906|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101478907|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478908|NCT00284765|Analgesics|analgesics|mesh-ancestor
101478909|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
101478910|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478911|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478912|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101478913|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478914|NCT00318981|Methylphenidate|methylphenidate|mesh-list
101478915|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101478916|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478917|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101478918|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101478919|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101478920|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478921|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
101478922|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478923|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
101478924|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478925|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478926|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101478927|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
101361811|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361812|NCT00402532|Everolimus|everolimus|mesh-list
101361813|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101361814|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101361815|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361816|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361817|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361818|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
101361819|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478928|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478929|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478930|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478931|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478933|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478934|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478935|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101478936|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
101478937|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
101478938|NCT00312546|Valproic Acid|valproic acid|mesh-list
101478939|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
101478940|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478941|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478942|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
101478943|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478944|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478945|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
101478946|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101478947|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478948|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478949|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101478950|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101478951|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101478952|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101478953|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
101478954|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478955|NCT00425009|Metformin|metformin|mesh-list
101478960|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
101478961|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478962|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478963|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478964|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478965|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478966|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478967|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478968|NCT00319215|Zopiclone|zopiclone|mesh-list
101478970|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478971|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478972|NCT00285155|Bupropion|bupropion|mesh-list
101478974|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
101478975|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478976|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101478977|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101478978|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101478979|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478980|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
101478981|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478982|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478983|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101478984|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101478985|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478986|NCT00319293|Metformin|metformin|mesh-list
101478987|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101361820|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361821|NCT00126061|Tedisamil|tedisamil|mesh-list
101361822|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101361823|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101361824|NCT00126061|Protective Agents|protective agents|mesh-ancestor
101361825|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361826|NCT00043589|Donepezil|donepezil|mesh-list
101361827|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101361828|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361829|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478988|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478989|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
101478990|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478991|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
101478992|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478993|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478994|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101478995|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
101478996|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101478997|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478998|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478999|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479000|NCT00285389|Dexamethasone|dexamethasone|mesh-list
101479001|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
101479003|NCT00285389|Chlorambucil|chlorambucil|mesh-list
101479004|NCT00285389|Rituximab|rituximab|mesh-list
101479005|NCT00285389|Vincristine|vincristine|mesh-list
101479006|NCT00285389|Doxorubicin|doxorubicin|mesh-list
101479007|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479008|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
101479009|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479010|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479011|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101479012|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
101479013|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479014|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479015|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101479016|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101479017|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101479019|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
101479020|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479021|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101479022|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
101479023|NCT00285389|Hormones|hormones|mesh-ancestor
101479024|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479025|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101479026|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479031|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101479032|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479033|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479034|NCT00285428|Veltuzumab|veltuzumab|mesh-list
101479035|NCT00285428|Antibodies|antibodies|mesh-list
101479036|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
101479037|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479038|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479039|NCT00312819|Disulfiram|disulfiram|mesh-list
101479040|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101479041|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101479042|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479043|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479044|NCT00319488|Budesonide|budesonide|mesh-list
101479045|NCT00319488|Albuterol|albuterol|mesh-list
101479046|NCT00319488|Montelukast|montelukast|mesh-list
101479047|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101479048|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361830|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
101361831|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101361832|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361833|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
101479049|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101479050|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
101479051|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479052|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479053|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101479054|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
101479055|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
101479056|NCT00319488|Hormones|hormones|mesh-ancestor
101479057|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479059|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101479060|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101479061|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479063|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479064|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101479065|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101479066|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101479067|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
101479068|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479069|NCT00285623|Thrombin|thrombin|mesh-list
101479070|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
101479071|NCT00285623|Coagulants|coagulants|mesh-ancestor
101479072|NCT00285662|Artesunate|artesunate|mesh-list
101479073|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
101479074|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
101479075|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101479076|NCT00285662|Amodiaquine|amodiaquine|mesh-list
101479077|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
101479078|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101479079|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101479080|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479081|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479082|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
101479083|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
101479084|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101479085|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
101479086|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101479087|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479088|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479089|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101479090|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101479091|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
101479092|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101479093|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101479094|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101479095|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101479096|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
101479097|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479098|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479101|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101479102|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101479103|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479105|NCT00319566|Hormones|hormones|mesh-ancestor
101479106|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479107|NCT00319605|Levetiracetam|levetiracetam|mesh-list
101479108|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
101479109|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
101479110|NCT00313053|Vincristine|vincristine|mesh-list
101479111|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479112|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479113|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479114|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479115|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479116|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479117|NCT00285896|Glucagon|glucagon|mesh-list
101479118|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101361834|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
101361835|NCT00399399|Azathioprine|azathioprine|mesh-list
101361836|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361837|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
101361838|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361839|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361840|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361841|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
101479119|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101479120|NCT00285896|Hormones|hormones|mesh-ancestor
101479121|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479122|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479124|NCT00319683|Eniluracil|eniluracil|mesh-list
101479125|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479126|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479127|NCT00286052|Naloxone|naloxone|mesh-list
101479128|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101479129|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479130|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
101479131|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479132|NCT00319761|Calcitriol|calcitriol|mesh-list
101479133|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101479134|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479135|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101479136|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101479137|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479138|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101479139|NCT00319761|Vitamins|vitamins|mesh-ancestor
101479140|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
101479141|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101479142|NCT00286130|Leucovorin|leucovorin|mesh-list
101479143|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
101479144|NCT00286130|Irinotecan|irinotecan|mesh-list
101479145|NCT00286130|Cetuximab|cetuximab|mesh-list
101479146|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479147|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101479148|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479149|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479150|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479151|NCT00286130|Antidotes|antidotes|mesh-ancestor
101479152|NCT00286130|Protective Agents|protective agents|mesh-ancestor
101479153|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479154|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
101479155|NCT00286130|Vitamins|vitamins|mesh-ancestor
101479156|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
101479157|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101479158|NCT00286208|Misoprostol|misoprostol|mesh-list
101479159|NCT00286208|Mifepristone|mifepristone|mesh-list
101479160|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101479161|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
101479162|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479163|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479164|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101479165|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101479166|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
101479167|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101479168|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101479169|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101479170|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101479171|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
101479176|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
101479177|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101479178|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101479179|NCT00319800|Irinotecan|irinotecan|mesh-list
101479180|NCT00319800|Gefitinib|gefitinib|mesh-list
101479181|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101361842|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361843|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361844|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101361845|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
101361846|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361847|NCT00126100|Lenograstim|lenograstim|mesh-list
101361848|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101361849|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
101479182|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479183|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479184|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479185|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479186|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479187|NCT00313131|Metronidazole|metronidazole|mesh-list
101479188|NCT00313131|Fluconazole|fluconazole|mesh-list
101479189|NCT00313131|Clotrimazole|clotrimazole|mesh-list
101479190|NCT00313131|Miconazole|miconazole|mesh-list
101479191|NCT00313131|Tinidazole|tinidazole|mesh-list
101479192|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479193|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101479194|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101479195|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101479196|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
101479197|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101479198|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101479199|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479200|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479201|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101479202|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479203|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479204|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479205|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101479206|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101479207|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101479208|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101479209|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
101479210|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101479211|NCT00319878|Cyclosporine|cyclosporine|mesh-list
101479212|NCT00319878|Sirolimus|sirolimus|mesh-list
101479213|NCT00319878|Cyclosporins|cyclosporins|mesh-list
101479214|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479215|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479216|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479217|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
101479218|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479219|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
101479220|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479221|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
101479222|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479223|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101479224|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101479225|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479226|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479228|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101479229|NCT00286364|Hormones|hormones|mesh-ancestor
101479230|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479231|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479232|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101479233|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479234|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479235|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101479236|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479237|NCT00319917|Tacrolimus|tacrolimus|mesh-list
101479238|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479239|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
101479240|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361850|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361851|NCT00123253|Tesamorelin|tesamorelin|mesh-list
101361852|NCT00123253|Growth Substances|growth substances|mesh-ancestor
101361853|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361855|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
101361856|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101361857|NCT00074100|Amonafide|amonafide|mesh-list
101479241|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101479276|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479277|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479278|NCT00320073|Pemetrexed|pemetrexed|mesh-list
101479279|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101479280|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479281|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479282|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479283|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101479284|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101479285|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479286|NCT00286871|Tacrolimus|tacrolimus|mesh-list
101479287|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479288|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
101479289|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479290|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101479291|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479292|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479294|NCT00417326|Glycine|glycine|mesh-list
101479295|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101479296|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
101479297|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479298|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479299|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
101479300|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479301|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479302|NCT00320229|Abciximab|abciximab|mesh-list
101479303|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
101479304|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101479305|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101479306|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479307|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479308|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101479309|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479310|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479311|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479312|NCT00417404|Vitamins|vitamins|mesh-list
101479313|NCT00417404|Vitamin A|vitamin a|mesh-list
101479314|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
101479315|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
101479316|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479317|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
101479318|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479319|NCT00417404|Protective Agents|protective agents|mesh-ancestor
101479320|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101479321|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479322|NCT00417443|Clonidine|clonidine|mesh-list
101479323|NCT00417443|Analgesics|analgesics|mesh-ancestor
101479324|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
101479325|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479326|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479327|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101479328|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
101479329|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
101479330|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101479331|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101479332|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101479333|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
101479334|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479335|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361858|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361859|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
101361860|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361861|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361862|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361863|NCT00126256|Leucovorin|leucovorin|mesh-list
101361864|NCT00126256|Fluorouracil|fluorouracil|mesh-list
101361865|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
101361866|NCT00126256|Irinotecan|irinotecan|mesh-list
101361867|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
101479336|NCT00313482|Prednisone|prednisone|mesh-list
101479337|NCT00313482|Docetaxel|docetaxel|mesh-list
101479338|NCT00313482|Sargramostim|sargramostim|mesh-list
101479339|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479340|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479341|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479342|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479343|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479344|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101479345|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
101479346|NCT00313482|Hormones|hormones|mesh-ancestor
101479349|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101479350|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
101479352|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
101479353|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479354|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479355|NCT00320307|Abacavir|abacavir|mesh-list
101479356|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101479357|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101479358|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479359|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479360|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
101479361|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479362|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101479363|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101479364|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
101479365|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479366|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479367|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479368|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479370|NCT02960906|Ipilimumab|ipilimumab|mesh-list
101479371|NCT02960906|Sunitinib|sunitinib|mesh-list
101479372|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101479373|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479374|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101479375|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479376|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101479377|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101479378|NCT02960906|Growth Substances|growth substances|mesh-ancestor
101479379|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479380|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
101479381|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479382|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479383|NCT00287066|Insulin|insulin|mesh-list
101479384|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101479385|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479386|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479387|NCT00313521|Thiotepa|thiotepa|mesh-list
101479388|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101479389|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
101479390|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479391|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479392|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101479393|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479394|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
101479395|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479396|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
101361868|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361869|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361870|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361871|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361872|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
101361873|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479397|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101479398|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479400|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101479402|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479403|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479404|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479405|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479406|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479407|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479408|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479409|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479410|NCT00287300|Azithromycin|azithromycin|mesh-list
101479411|NCT00287300|Artesunate|artesunate|mesh-list
101479412|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
101479413|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
101479414|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101479415|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101479416|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479417|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
101479418|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101479431|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101479432|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
101479433|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101479434|NCT00320580|Norelgestromin|norelgestromin|mesh-list
101479436|NCT00320580|Estrogens|estrogens|mesh-ancestor
101479437|NCT00320580|Hormones|hormones|mesh-ancestor
101479438|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479439|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479440|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101479441|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
101479442|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479443|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101479444|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101479445|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101479446|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
101479447|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101479448|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101479449|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479450|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
101479451|NCT00320619|Coagulants|coagulants|mesh-ancestor
101479452|NCT00287456|Insulin|insulin|mesh-list
101479453|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101479454|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479455|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479456|NCT00313833|Buprenorphine|buprenorphine|mesh-list
101479457|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101479458|NCT00313833|Narcotics|narcotics|mesh-ancestor
101479459|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479460|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479461|NCT00313833|Analgesics|analgesics|mesh-ancestor
101479462|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
101479463|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479464|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101479465|NCT00287495|Sorafenib|sorafenib|mesh-list
101479466|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479467|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479468|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479469|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479470|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101361874|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101361875|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101361876|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361877|NCT00126256|Antidotes|antidotes|mesh-ancestor
101361878|NCT00126256|Protective Agents|protective agents|mesh-ancestor
101479471|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101479472|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
101479473|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479474|NCT00320658|Antacids|antacids|mesh-ancestor
101479475|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479476|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101479477|NCT00287534|Tamoxifen|tamoxifen|mesh-list
101479478|NCT00287534|Anastrozole|anastrozole|mesh-list
101479479|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101479480|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479481|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479482|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479487|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101479488|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101479489|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101479490|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479491|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479492|NCT00320697|Bupropion|bupropion|mesh-list
101479493|NCT00320697|Nicotine|nicotine|mesh-list
101479494|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101479495|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
101479496|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479497|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479498|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101479499|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101479500|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
101479501|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479502|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479503|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101479504|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479505|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479506|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101479507|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101479508|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101479509|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
101479510|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101479511|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101479512|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479513|NCT00287651|Insulin|insulin|mesh-list
101479514|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101479515|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479516|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479517|NCT00322296|Bexarotene|bexarotene|mesh-list
101479518|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479519|NCT00320736|Galantamine|galantamine|mesh-list
101479520|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101479521|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479522|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479523|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
101479524|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479525|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479526|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101479527|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
101479528|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479529|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
101479530|NCT00287768|Docetaxel|docetaxel|mesh-list
101479531|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479532|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479533|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479534|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479535|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479536|NCT00320775|Aflibercept|aflibercept|mesh-list
101479537|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101361879|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
101361881|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
101361882|NCT00043667|Daclizumab|daclizumab|mesh-list
101361883|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361884|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
101361885|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361886|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
101479538|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101479539|NCT00320775|Growth Substances|growth substances|mesh-ancestor
101479540|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479541|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
101479542|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479543|NCT00320814|Aflibercept|aflibercept|mesh-list
101479544|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101479545|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101479546|NCT00320814|Growth Substances|growth substances|mesh-ancestor
101479547|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479548|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
101479549|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479550|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
101479551|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479552|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479559|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
101479560|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479561|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101479562|NCT00287885|Docetaxel|docetaxel|mesh-list
101479563|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479564|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479565|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479566|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479567|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479568|NCT00287924|Methotrexate|methotrexate|mesh-list
101479569|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101479570|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
101479571|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479572|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479573|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101479574|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
101479575|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479576|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479577|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101479578|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479579|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101479580|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479581|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
101479582|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479583|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101479584|NCT00287963|Topotecan|topotecan|mesh-list
101479585|NCT00287963|Vinorelbine|vinorelbine|mesh-list
101479586|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101479587|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479588|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479589|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479590|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479591|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479592|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479593|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479594|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479595|NCT00320892|Atropine|atropine|mesh-list
101479596|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101479597|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101479598|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101479599|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101479600|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
101479601|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479602|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479603|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101479604|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
101361887|NCT00074139|Docetaxel|docetaxel|mesh-list
101361888|NCT00074139|Doxorubicin|doxorubicin|mesh-list
101361889|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101361890|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361891|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
101361892|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361893|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101361894|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361895|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
101361896|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479605|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
101479606|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
101479607|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101479608|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101479609|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
101479610|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479611|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479612|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101479613|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
101479614|NCT00288002|Docetaxel|docetaxel|mesh-list
101479615|NCT00288002|Capecitabine|capecitabine|mesh-list
101479616|NCT00288002|Trastuzumab|trastuzumab|mesh-list
101479617|NCT00288002|Epirubicin|epirubicin|mesh-list
101479618|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479619|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
101479620|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479621|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479622|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101479623|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
101479629|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479630|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101479631|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
101479632|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101479633|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479634|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101479635|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479636|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479637|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
101479639|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101479640|NCT00322569|Tacrolimus|tacrolimus|mesh-list
101479641|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479642|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479643|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479644|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479645|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479646|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479647|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101479648|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101479649|NCT00322569|Analgesics|analgesics|mesh-ancestor
101479650|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
101479651|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479652|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479653|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101479654|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479655|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
101479656|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479657|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
101479658|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101479659|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479660|NCT00288041|Paclitaxel|paclitaxel|mesh-list
101479661|NCT00288041|Carboplatin|carboplatin|mesh-list
101479662|NCT00288041|Bortezomib|bortezomib|mesh-list
101479663|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479664|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479665|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479666|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361897|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361898|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101361899|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101361900|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361901|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101361902|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101361903|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101361904|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479667|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479668|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479669|NCT00320970|Candesartan|candesartan|mesh-list
101479670|NCT00320970|Candesartan cilexetil|candesartan cilexetil|mesh-list
101479671|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101479672|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101479673|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101479674|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479675|NCT00288158|Allopurinol|allopurinol|mesh-list
101479676|NCT00288158|Probenecid|probenecid|mesh-list
101479677|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
101479678|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479679|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479680|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
101479681|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479682|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101479683|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
101479684|NCT00288158|Protective Agents|protective agents|mesh-ancestor
101479685|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479686|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
101479687|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101479688|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479689|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479690|NCT00288197|Voriconazole|voriconazole|mesh-list
101479691|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
101479692|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479693|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101479697|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101479698|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479699|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479700|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479701|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101479702|NCT00288236|Rimonabant|rimonabant|mesh-list
101479703|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101479704|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101479705|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101479706|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479707|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479709|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479710|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479712|NCT00321126|Trace Elements|trace elements|mesh-ancestor
101479713|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
101479714|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479715|NCT00288353|Aripiprazole|aripiprazole|mesh-list
101479716|NCT00288353|Ziprasidone|ziprasidone|mesh-list
101479717|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479718|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479719|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101479720|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479721|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479722|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479723|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
101479724|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
101479725|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479726|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479727|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101361905|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361906|NCT00126373|Bupropion|bupropion|mesh-list
101361907|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101361908|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479728|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101479729|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
101479730|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101479731|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101479732|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101479733|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101479734|NCT00288431|Sirolimus|sirolimus|mesh-list
101479735|NCT00288431|Doxorubicin|doxorubicin|mesh-list
101479736|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479737|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479738|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101479739|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479740|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479741|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479742|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101479743|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479744|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
101479745|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479746|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
101479747|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479748|NCT00321165|Taurolidine|taurolidine|mesh-list
101479749|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479750|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101479751|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479752|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
101479753|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
101479754|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101479755|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479756|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479757|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479758|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479759|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101479760|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
101479761|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
101479762|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479768|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479769|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479770|NCT00321009|Enoxaparin|enoxaparin|mesh-list
101479771|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
101479772|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101479773|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101479774|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479775|NCT00417677|Sirolimus|sirolimus|mesh-list
101479776|NCT00417677|Sunitinib|sunitinib|mesh-list
101479777|NCT00417677|Temsirolimus|temsirolimus|mesh-list
101479778|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
101479779|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479780|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101479781|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101479782|NCT00417677|Growth Substances|growth substances|mesh-ancestor
101479783|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479784|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
101479785|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101479786|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479787|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479788|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479789|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
101479790|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101479791|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479792|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479793|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
101479794|NCT00417716|Bevacizumab|bevacizumab|mesh-list
101479795|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101479796|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479797|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101361909|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101361910|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101361911|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101361912|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101361913|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361914|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
101479798|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101479799|NCT00417716|Growth Substances|growth substances|mesh-ancestor
101479800|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479801|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
101479802|NCT00288470|Hylan|hylan|mesh-list
101479803|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
101479804|NCT00288470|Protective Agents|protective agents|mesh-ancestor
101479805|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479806|NCT00321360|Propofol|propofol|mesh-list
101479807|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101479808|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479809|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479810|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101479811|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
101479812|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
101479813|NCT00288548|Metoprolol|metoprolol|mesh-list
101479814|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101479815|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101479816|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
101479817|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
101479818|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479819|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479820|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101479821|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101479822|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101479823|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
101479824|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479825|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479828|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
101479829|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479830|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479831|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101479832|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101479833|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479836|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479837|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479838|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101479839|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479840|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479841|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479842|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
101479843|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
101479844|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479845|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479846|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101479847|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101479848|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
101479849|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101479850|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101479851|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101479852|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101479853|NCT00288743|Insulin|insulin|mesh-list
101479854|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479855|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479856|NCT00321633|Carboplatin|carboplatin|mesh-list
101479857|NCT00321633|Docetaxel|docetaxel|mesh-list
101479858|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479859|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479860|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361916|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361917|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101361918|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101361919|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361920|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101361921|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361922|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361923|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361924|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101361925|NCT00043706|Antibodies|antibodies|mesh-list
101361926|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101479861|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479862|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479863|NCT00288782|Mirtazapine|mirtazapine|mesh-list
101479864|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
101479865|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101479866|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101479867|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
101479868|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
101479869|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479870|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479871|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479872|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101479873|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101479874|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479875|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101479876|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101479877|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101479878|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
101479879|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101479880|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101479881|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
101479882|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101479883|NCT01059825|Metformin|metformin|mesh-list
101479884|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101479885|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
101479886|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101479887|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479888|NCT01059825|Incretins|incretins|mesh-ancestor
101479889|NCT01059825|Hormones|hormones|mesh-ancestor
101479890|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479891|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101479892|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
101479893|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479894|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479895|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101479896|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
101479897|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101479898|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101479899|NCT00321750|Analgesics|analgesics|mesh-ancestor
101479900|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
101479901|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479902|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479903|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101479904|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101479911|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101479912|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101479913|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
101479914|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361927|NCT00043706|Mitogens|mitogens|mesh-list
101361928|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
101361929|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361930|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479915|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479916|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
101479917|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101479918|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479919|NCT00323154|Nalbuphine|nalbuphine|mesh-list
101479920|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101479921|NCT00323154|Narcotics|narcotics|mesh-ancestor
101479922|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101479923|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479924|NCT00323154|Analgesics|analgesics|mesh-ancestor
101479925|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
101479926|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479927|NCT00289250|Artesunate|artesunate|mesh-list
101479928|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
101479929|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
101479930|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101479931|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
101479932|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101479933|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101479934|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479935|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479936|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
101479937|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
101479938|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101479939|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
101479940|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101479941|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479942|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479944|NCT00323505|Interferons|interferons|mesh-list
101479945|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
101479946|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
101479947|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479948|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
101479949|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479950|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
101479951|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479952|NCT00289406|Amlodipine|amlodipine|mesh-list
101479953|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101479954|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101479955|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101479956|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479957|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101479958|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479959|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
101479960|NCT00323544|Tenofovir|tenofovir|mesh-list
101479961|NCT00323544|Lamivudine|lamivudine|mesh-list
101479962|NCT00323544|Emtricitabine|emtricitabine|mesh-list
101479963|NCT00323544|Zidovudine|zidovudine|mesh-list
101479964|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101479965|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
101479966|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479967|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101479968|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101479970|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479971|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101479972|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101479973|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
101479974|NCT00289445|Leucovorin|leucovorin|mesh-list
101479990|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101479991|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479992|NCT00323583|Leucovorin|leucovorin|mesh-list
101479993|NCT00323583|Paclitaxel|paclitaxel|mesh-list
101479994|NCT00323583|Fluorouracil|fluorouracil|mesh-list
101479995|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
101479996|NCT00323583|Calcium|calcium|mesh-list
101479997|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101479998|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479999|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480000|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
101361931|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361933|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361934|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101480001|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480002|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480003|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101480004|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480005|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
101480006|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480007|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480008|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
101480009|NCT00323583|Antidotes|antidotes|mesh-ancestor
101480010|NCT00323583|Protective Agents|protective agents|mesh-ancestor
101480011|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
101480012|NCT00323583|Vitamins|vitamins|mesh-ancestor
101480013|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
101480014|NCT00289601|Eptifibatide|eptifibatide|mesh-list
101480015|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101480016|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
101480017|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101480018|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
101480019|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480020|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
101480021|NCT00323778|Protective Agents|protective agents|mesh-ancestor
101480022|NCT00323817|Z 338|z 338|mesh-list
101480024|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480025|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480026|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
101480027|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480028|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480029|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480030|NCT00289835|Paclitaxel|paclitaxel|mesh-list
101480031|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101480032|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101480033|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480034|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480035|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480036|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480037|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480038|NCT00303225|Tecovirimat|tecovirimat|mesh-list
101480039|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
101480044|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480045|NCT00290030|Alfuzosin|alfuzosin|mesh-list
101480046|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101480047|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101480048|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101480049|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480050|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480051|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480052|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480053|NCT00290030|Urological Agents|urological agents|mesh-ancestor
101480054|NCT00303264|Esomeprazole|esomeprazole|mesh-list
101480055|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101480056|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480057|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101480058|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480059|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480060|NCT00290069|Sirolimus|sirolimus|mesh-list
101480061|NCT00290069|Tacrolimus|tacrolimus|mesh-list
101480062|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480063|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
101480064|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480065|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101480066|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480067|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480068|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480069|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361935|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361936|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361937|NCT00126607|Trastuzumab|trastuzumab|mesh-list
101361938|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101361939|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361940|NCT00074178|Cytarabine|cytarabine|mesh-list
101480070|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101480071|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480072|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
101480073|NCT04718259|Midazolam|midazolam|mesh-list
101480074|NCT04718259|Bupivacaine|bupivacaine|mesh-list
101480075|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
101480076|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
101480077|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480078|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480079|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
101480080|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480082|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101480083|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101480084|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480085|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480086|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101480087|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
101480088|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
101480089|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
101480090|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480091|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480092|NCT00290108|Propofol|propofol|mesh-list
101480093|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101480094|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480095|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480096|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101480097|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
101480098|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
101480099|NCT00323973|Bisoprolol|bisoprolol|mesh-list
101480100|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480101|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
101480102|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
101480103|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480104|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480105|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101480106|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101480107|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101480108|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480109|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480113|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480114|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480115|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480116|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480117|NCT00290264|Budesonide|budesonide|mesh-list
101480118|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
101480119|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480120|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101480121|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
101480122|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480123|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480124|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101480125|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
101480126|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
101480127|NCT00290264|Hormones|hormones|mesh-ancestor
101480128|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480129|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101480130|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101480131|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101480132|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480133|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480134|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480135|NCT00324051|Olanzapine|olanzapine|mesh-list
101480136|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
101361941|NCT00074178|Dexamethasone|dexamethasone|mesh-list
101361942|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
101361943|NCT00074178|Methotrexate|methotrexate|mesh-list
101361944|NCT00074178|Etoposide|etoposide|mesh-list
101361945|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
101361946|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101361947|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
101361948|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361949|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480137|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
101480142|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480143|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480144|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480145|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101480146|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101480147|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101480148|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480149|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480150|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
101480151|NCT00303381|Interferons|interferons|mesh-list
101480152|NCT00303381|Interferon-beta|interferon-beta|mesh-list
101480153|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
101480154|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480155|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
101480156|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480157|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
101480158|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480159|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101480160|NCT00290420|Chloroquine|chloroquine|mesh-list
101480161|NCT00290420|Amebicides|amebicides|mesh-ancestor
101480162|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480163|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480164|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480165|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
101480166|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480167|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101480168|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101480169|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101480170|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480171|NCT00324129|Mocetinostat|mocetinostat|mesh-list
101480172|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101480173|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480174|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480175|NCT00303537|Metformin|metformin|mesh-list
101480176|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480177|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480178|NCT00290849|Bivalirudin|bivalirudin|mesh-list
101480179|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
101480180|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101480181|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
101480197|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480198|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480199|NCT00303615|Anastrozole|anastrozole|mesh-list
101480200|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
101480201|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480202|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480203|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101480204|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101480205|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480206|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480208|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
101480209|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361950|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101361951|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
101361952|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101361953|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101361954|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101361955|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101361956|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
101480210|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480211|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
101480212|NCT00303615|Hormones|hormones|mesh-ancestor
101480213|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
101480214|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101480215|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480216|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480217|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101480218|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480219|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480220|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480221|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480222|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101480223|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
101480224|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101480225|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480226|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101480227|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101480228|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101480229|NCT00291122|Celecoxib|celecoxib|mesh-list
101480230|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101480231|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480232|NCT00291122|Analgesics|analgesics|mesh-ancestor
101480233|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
101480234|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480235|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480236|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480237|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480238|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101480239|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101480251|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101480252|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101480253|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480254|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480255|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480256|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
101480257|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480258|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480259|NCT00303771|Leucovorin|leucovorin|mesh-list
101480260|NCT00303771|Fluorouracil|fluorouracil|mesh-list
101480261|NCT00303771|Irinotecan|irinotecan|mesh-list
101480262|NCT00303771|Calcium|calcium|mesh-list
101480263|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
101480264|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101480265|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480266|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
101480267|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480269|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480270|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480271|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
101480272|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101480273|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480274|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480275|NCT00303771|Antidotes|antidotes|mesh-ancestor
101480276|NCT00303771|Protective Agents|protective agents|mesh-ancestor
101480277|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
101480278|NCT00303771|Vitamins|vitamins|mesh-ancestor
101480279|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
101480280|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
101361958|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361959|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101361960|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
101361961|NCT00074178|Hormones|hormones|mesh-ancestor
101361962|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101361963|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101361964|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101480281|NCT00303810|Thiotepa|thiotepa|mesh-list
101480282|NCT00303810|Lomustine|lomustine|mesh-list
101480283|NCT00303810|Carboplatin|carboplatin|mesh-list
101480284|NCT00303810|Methotrexate|methotrexate|mesh-list
101480285|NCT00303810|Etoposide|etoposide|mesh-list
101480286|NCT00303810|Vincristine|vincristine|mesh-list
101480287|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
101480288|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480289|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
101480290|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480291|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480292|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101480293|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
101480294|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480295|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480296|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101480297|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101480298|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
101480299|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101480300|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480301|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
101480302|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
101480303|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480304|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101480305|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101480306|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101480312|NCT00324480|Vorinostat|vorinostat|mesh-list
101480313|NCT00324480|Alvocidib|alvocidib|mesh-list
101480314|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480315|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101480316|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480317|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480318|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
101480319|NCT00324480|Growth Substances|growth substances|mesh-ancestor
101480320|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480321|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101480322|NCT00303888|Docetaxel|docetaxel|mesh-list
101480323|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480324|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480325|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480326|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480327|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480328|NCT00291707|Pemetrexed|pemetrexed|mesh-list
101480329|NCT00291707|Cetuximab|cetuximab|mesh-list
101480330|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480331|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480332|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480334|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101480335|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480336|NCT00324519|Misoprostol|misoprostol|mesh-list
101480337|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101480338|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
101480339|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101480340|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480341|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101480342|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480343|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
101480344|NCT00291746|Esomeprazole|esomeprazole|mesh-list
101361965|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
101361966|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101361967|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101361968|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
101361969|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
101361970|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101361971|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101361972|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101361973|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101361974|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101361975|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480345|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101480346|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480347|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101480348|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480349|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480350|NCT00303927|Capecitabine|capecitabine|mesh-list
101480351|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480352|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
101480353|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480354|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480355|NCT00419484|Pioglitazone|pioglitazone|mesh-list
101480356|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480357|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480358|NCT00291785|Leucovorin|leucovorin|mesh-list
101480359|NCT00291785|Folic Acid|folic acid|mesh-list
101480360|NCT00291785|Fluorouracil|fluorouracil|mesh-list
101480361|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
101480362|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
101480363|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480364|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480365|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480366|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480370|NCT00291785|Protective Agents|protective agents|mesh-ancestor
101480371|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
101480373|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
101480374|NCT00291785|Hematinics|hematinics|mesh-ancestor
101480375|NCT00324558|Bemiparin|bemiparin|mesh-list
101480376|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
101480377|NCT00291863|Simvastatin|simvastatin|mesh-list
101480378|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101480379|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101480383|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101480386|NCT00304200|Sunitinib|sunitinib|mesh-list
101480387|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101480388|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
101480389|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480390|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480391|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101480392|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101480393|NCT00304200|Growth Substances|growth substances|mesh-ancestor
101480394|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480395|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101480396|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101480397|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480398|NCT00291980|Vaccines|vaccines|mesh-list
101480399|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
101480400|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480401|NCT00324597|Gemcitabine|gemcitabine|mesh-list
101480402|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
101361976|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
101361977|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101361978|NCT00126646|Antibodies|antibodies|mesh-list
101361979|NCT00126646|Immunotoxins|immunotoxins|mesh-list
101361980|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
101361981|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
101361982|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361983|NCT00126763|Fentanyl|fentanyl|mesh-list
101361984|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101480403|NCT00324597|Imetelstat|imetelstat|mesh-list
101480404|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480405|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
101480406|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480407|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480408|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101480409|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480410|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
101480411|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101480412|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101480413|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480414|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101480415|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480416|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101480417|NCT00304317|Celecoxib|celecoxib|mesh-list
101480418|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101480419|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480420|NCT00304317|Analgesics|analgesics|mesh-ancestor
101480421|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
101480422|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480423|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480424|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480425|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480426|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101480427|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101480428|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480429|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480430|NCT00324792|Insulin|insulin|mesh-list
101480431|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480432|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480433|NCT00292214|Acetaminophen|acetaminophen|mesh-list
101480434|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480435|NCT00292214|Analgesics|analgesics|mesh-ancestor
101480436|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
101480437|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480438|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480439|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
101480440|NCT00324831|Prednisone|prednisone|mesh-list
101480441|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
101480442|NCT00324831|Rituximab|rituximab|mesh-list
101480443|NCT00324831|Doxorubicin|doxorubicin|mesh-list
101480444|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101480445|NCT00324831|Vincristine|vincristine|mesh-list
101480446|NCT00324831|Vaccines|vaccines|mesh-list
101480447|NCT00324831|Antibodies|antibodies|mesh-list
101480448|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
101480449|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101480451|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101480465|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480466|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480467|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480468|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
101480470|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480471|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480472|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101480473|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480474|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480475|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480476|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
101361985|NCT00126763|Narcotics|narcotics|mesh-ancestor
101361986|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101361987|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101361988|NCT00126763|Analgesics|analgesics|mesh-ancestor
101361989|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
101480477|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101480478|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
101480479|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480480|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480481|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
101480482|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480483|NCT00304434|Oseltamivir|oseltamivir|mesh-list
101480484|NCT00304434|Probenecid|probenecid|mesh-list
101480485|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
101480486|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480487|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480488|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480489|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
101480490|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
101480491|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480492|NCT00292409|Aripiprazole|aripiprazole|mesh-list
101480493|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
101480494|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480495|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101480496|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480497|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480498|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480499|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
101480500|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
101480501|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480502|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480503|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101480504|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101480505|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
101480506|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101480507|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101480508|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101480509|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101480510|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101480516|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480517|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
101480518|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101480519|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
101480520|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480521|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480522|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101480523|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
101480524|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
101480525|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101480526|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
101480527|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480528|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480529|NCT00324948|Alprostadil|alprostadil|mesh-list
101480530|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101480531|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
101480532|NCT00324948|Urological Agents|urological agents|mesh-ancestor
101480533|NCT00304551|Ribavirin|ribavirin|mesh-list
101480534|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101480535|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
101480536|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
101480537|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480538|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
101480539|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480540|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
101480541|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480542|NCT00325026|Misoprostol|misoprostol|mesh-list
101480543|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101480544|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
101361990|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101361991|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101361992|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101361993|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
101361994|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
101361995|NCT00402571|Acetaminophen|acetaminophen|mesh-list
101361996|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101361997|NCT00402571|Analgesics|analgesics|mesh-ancestor
101361998|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
101361999|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362000|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362001|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
101362002|NCT00126880|Lamivudine|lamivudine|mesh-list
101480545|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101480546|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480548|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480549|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
101480550|NCT00325104|Calcium|calcium|mesh-list
101480551|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
101480552|NCT00325104|Hormones|hormones|mesh-list
101480553|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101480554|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480555|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480556|NCT00292526|Enalapril|enalapril|mesh-list
101480557|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101480558|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
101480559|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480560|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480561|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480562|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
101480563|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
101480564|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101480565|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
101480566|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480567|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480568|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101480569|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
101480570|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101480571|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101480572|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101480573|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480574|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480575|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480576|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480577|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
101480578|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101480583|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
101480584|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480585|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480586|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480587|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480588|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101480589|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101480590|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480591|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480592|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
101480593|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480594|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480595|NCT00325182|Levetiracetam|levetiracetam|mesh-list
101480596|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
101480597|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
101362003|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101362004|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362005|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362006|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362008|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362009|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101362010|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101480598|NCT00292799|Metformin|metformin|mesh-list
101480599|NCT00292799|Orlistat|orlistat|mesh-list
101480600|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480601|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480602|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480603|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480604|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101480605|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101480606|NCT00304629|Galantamine|galantamine|mesh-list
101480607|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101480608|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480609|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480610|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
101480611|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480612|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480613|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101480614|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
101480615|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480616|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
101480617|NCT00292838|Fluticasone|fluticasone|mesh-list
101480618|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480619|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101480620|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
101480621|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480622|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480623|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101480624|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
101480625|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
101480626|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101480627|NCT00304668|Dapivirine|dapivirine|mesh-list
101480628|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101480629|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101480630|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
101480631|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480632|NCT00292955|Cetuximab|cetuximab|mesh-list
101480633|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480634|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480635|NCT00293072|Rituximab|rituximab|mesh-list
101480636|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480637|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480638|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
101480639|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480640|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480641|NCT00293111|Etodolac|etodolac|mesh-list
101480642|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101480643|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480644|NCT00293111|Analgesics|analgesics|mesh-ancestor
101480645|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
101480646|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480647|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480648|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480649|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480650|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101480651|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101480654|NCT00304785|Latanoprost|latanoprost|mesh-list
101480655|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101537640|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480656|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101480657|NCT00293150|Eplerenone|eplerenone|mesh-list
101480658|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101362013|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
101362014|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480659|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
101480660|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480661|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480662|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101480663|NCT00293150|Diuretics|diuretics|mesh-ancestor
101480664|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
101480665|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480666|NCT00293228|Isoniazid|isoniazid|mesh-list
101480667|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
101480668|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480669|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480670|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101480672|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
101480673|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480674|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101480675|NCT00293345|Gemcitabine|gemcitabine|mesh-list
101480676|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480677|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
101480678|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480679|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480680|NCT00293501|Tinzaparin|tinzaparin|mesh-list
101480681|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101480682|NCT00293501|Dalteparin|dalteparin|mesh-list
101480683|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
101480684|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101480685|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101480686|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480687|NCT00325455|Anacetrapib|anacetrapib|mesh-list
101480688|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101480689|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101480690|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
101480691|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480692|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101480693|NCT00293657|Lornoxicam|lornoxicam|mesh-list
101480694|NCT00293657|Piroxicam|piroxicam|mesh-list
101480695|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101480696|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480697|NCT00293657|Analgesics|analgesics|mesh-ancestor
101480698|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
101480699|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480700|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480701|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101480702|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480703|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101480704|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480705|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480706|NCT00293696|Goserelin|goserelin|mesh-list
101480707|NCT00293696|Bicalutamide|bicalutamide|mesh-list
101480708|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480709|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480710|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
101480711|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
101480712|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480713|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480714|NCT00293735|Labetalol|labetalol|mesh-list
101480715|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101480716|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101480717|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480718|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480719|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480720|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480721|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480722|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
101480723|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
101362015|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101362017|NCT00127075|Estrogens|estrogens|mesh-ancestor
101362018|NCT00127075|Hormones|hormones|mesh-ancestor
101487387|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101480727|NCT00304980|Lumefantrine|lumefantrine|mesh-list
101480728|NCT00304980|Artemether|artemether|mesh-list
101480729|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
101480730|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
101480731|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101480732|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101480733|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
101480734|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480735|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480736|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480737|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101480738|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480739|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480740|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101480741|NCT00293891|Tacrolimus|tacrolimus|mesh-list
101480742|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480743|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
101480744|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480745|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101480746|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480747|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480748|NCT00293930|Tacrolimus|tacrolimus|mesh-list
101480749|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480750|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
101480751|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480752|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101480753|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480754|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480755|NCT00305019|Clevudine|clevudine|mesh-list
101480756|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
101480757|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480758|NCT00293969|Morphine|morphine|mesh-list
101480759|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101480760|NCT00293969|Narcotics|narcotics|mesh-ancestor
101480761|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480762|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480763|NCT00293969|Analgesics|analgesics|mesh-ancestor
101480764|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
101480765|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480766|NCT00294008|Risperidone|risperidone|mesh-list
101480767|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101480768|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
101480769|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480770|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480771|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480772|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101480773|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480774|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480775|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480776|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101480777|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
101480778|NCT00294086|Valsartan|valsartan|mesh-list
101480779|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101480780|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101480781|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101480782|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480783|NCT00325689|Risperidone|risperidone|mesh-list
101480784|NCT00325689|Aripiprazole|aripiprazole|mesh-list
101480785|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101480786|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101480787|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
101480788|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480789|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480790|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480791|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101480792|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480793|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362019|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362020|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362022|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101362023|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101362024|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
101362025|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362026|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
101362027|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480797|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
101480798|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
101480799|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101480800|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101480801|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101480802|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101480803|NCT00294164|Hormones|hormones|mesh-list
101480804|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480805|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480806|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101480807|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101480808|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101480809|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101480810|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480811|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480812|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480813|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480814|NCT00417833|Bevacizumab|bevacizumab|mesh-list
101480815|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480816|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480817|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101480818|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101480819|NCT00417833|Growth Substances|growth substances|mesh-ancestor
101480820|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480821|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101480822|NCT00417872|Metronidazole|metronidazole|mesh-list
101480823|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
101480824|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480825|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480826|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480827|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480828|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
101480829|NCT00294203|Hematinics|hematinics|mesh-ancestor
101480830|NCT00305292|Modafinil|modafinil|mesh-list
101480831|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101480832|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480833|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101480834|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101480835|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101480836|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480837|NCT00305331|Domperidone|domperidone|mesh-list
101480838|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
101480839|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
101480840|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480841|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480842|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101480843|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101480844|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
101480845|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480846|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480848|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101480849|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
101362028|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362029|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362030|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362031|NCT00127114|Analgesics|analgesics|mesh-ancestor
101362032|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
101362033|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362034|NCT00043784|Enoxaparin|enoxaparin|mesh-list
101362035|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
101362036|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101480850|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480851|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480852|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101480853|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
101480854|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
101480855|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101480856|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101480857|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101480858|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101480859|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480860|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480861|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480862|NCT00294359|Bevacizumab|bevacizumab|mesh-list
101480863|NCT00294359|Capecitabine|capecitabine|mesh-list
101480864|NCT00294359|Mitomycins|mitomycins|mesh-list
101480865|NCT00294359|Mitomycin|mitomycin|mesh-list
101480866|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480868|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101480869|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101480870|NCT00294359|Growth Substances|growth substances|mesh-ancestor
101480871|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480872|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101480873|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101480875|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480876|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101480877|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
101480878|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101480879|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480880|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
101480881|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101480882|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480883|NCT00305370|Aripiprazole|aripiprazole|mesh-list
101480884|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
101480885|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480886|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101480887|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480888|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480889|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480890|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
101480892|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480893|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480894|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101480895|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101480897|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101480898|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101480899|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101480900|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101480901|NCT00325806|Ramipril|ramipril|mesh-list
101480902|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101480903|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
101480904|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480905|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480906|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101362037|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101362038|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362039|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101362040|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
101480908|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480909|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101480910|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
101480911|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480912|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480913|NCT00294593|Leucovorin|leucovorin|mesh-list
101480914|NCT00294593|Folic Acid|folic acid|mesh-list
101480915|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
101480916|NCT00294593|Antidotes|antidotes|mesh-ancestor
101480917|NCT00294593|Protective Agents|protective agents|mesh-ancestor
101480918|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480919|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
101480920|NCT00294593|Vitamins|vitamins|mesh-ancestor
101480921|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
101480922|NCT00294593|Hematinics|hematinics|mesh-ancestor
101480923|NCT00325845|Hylan|hylan|mesh-list
101480924|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
101480925|NCT00325845|Protective Agents|protective agents|mesh-ancestor
101480926|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480927|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
101480928|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480929|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480930|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101480931|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480932|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480933|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480934|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480935|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101480936|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101480937|NCT00325962|Verapamil|verapamil|mesh-list
101480938|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101480939|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101480940|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101480944|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
101480945|NCT00305487|Ciclesonide|ciclesonide|mesh-list
101480946|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
101480948|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480949|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480950|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101480951|NCT00294944|Idazoxan|idazoxan|mesh-list
101480952|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101480953|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101480954|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101480955|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
101480956|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480957|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480958|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480959|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101480960|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
101480961|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480962|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101480963|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101480964|NCT00295100|Tamoxifen|tamoxifen|mesh-list
101480965|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101480966|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
101480967|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480968|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480969|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480970|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480971|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101480972|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101480973|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101480974|NCT00326235|Buspirone|buspirone|mesh-list
101480975|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101480976|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101362041|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362043|NCT00399477|Pramipexole|pramipexole|mesh-list
101362044|NCT00399477|Rasagiline|rasagiline|mesh-list
101362045|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101362046|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101362047|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
101362048|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362049|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362050|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480977|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480978|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480979|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480980|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101480981|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
101480982|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101480983|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480984|NCT00295178|Vancomycin|vancomycin|mesh-list
101480985|NCT00295178|Daptomycin|daptomycin|mesh-list
101480986|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101480987|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480988|NCT00305838|Tamoxifen|tamoxifen|mesh-list
101480989|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101480990|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
101480991|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480992|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480993|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101480994|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480995|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101480996|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101480997|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101480998|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101480999|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101481000|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101481001|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
101481002|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481003|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101481004|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101481005|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481006|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101481007|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
101481020|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
101481021|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101481022|NCT00326352|Narcotics|narcotics|mesh-ancestor
101481023|NCT00326352|Analgesics|analgesics|mesh-ancestor
101481024|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
101481025|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481026|NCT00419601|Fentanyl|fentanyl|mesh-list
101481027|NCT00419601|Remifentanil|remifentanil|mesh-list
101481028|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101481029|NCT00419601|Narcotics|narcotics|mesh-ancestor
101481030|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481031|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481033|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
101481034|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481035|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101481036|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101481037|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
101481038|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
101481039|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101481040|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
101481041|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101481042|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
101481043|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
101362051|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101362052|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362053|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101362054|NCT00399477|Protective Agents|protective agents|mesh-ancestor
101362055|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
101362056|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
101362057|NCT00127270|Darifenacin|darifenacin|mesh-list
101362058|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101481044|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481045|NCT00295607|Antibodies|antibodies|mesh-list
101481046|NCT00295607|Tacrolimus|tacrolimus|mesh-list
101481047|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
101481048|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481049|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481050|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481051|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481052|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481053|NCT00326391|Methylphenidate|methylphenidate|mesh-list
101481054|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101481055|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481056|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101481057|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481058|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481059|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481060|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
101481061|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481062|NCT00295685|Antacids|antacids|mesh-list
101481063|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481064|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101481065|NCT00306150|Aprotinin|aprotinin|mesh-list
101481066|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
101481067|NCT00306150|Coagulants|coagulants|mesh-ancestor
101481068|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101481069|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101481070|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
101481071|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481072|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481073|NCT00417911|Bortezomib|bortezomib|mesh-list
101481074|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481081|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101481082|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481083|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
101481084|NCT00306267|Hematinics|hematinics|mesh-ancestor
101481085|NCT00326508|Daclizumab|daclizumab|mesh-list
101481086|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481087|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
101481088|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481089|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
101481090|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
101481091|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
101481092|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481094|NCT00295841|Cytarabine|cytarabine|mesh-list
101481095|NCT00295841|Clofarabine|clofarabine|mesh-list
101481096|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481097|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
101481098|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481099|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481100|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
101481101|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481102|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481103|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
101481104|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481105|NCT00326664|Cediranib|cediranib|mesh-list
101481106|NCT00326664|Maleic acid|maleic acid|mesh-list
101481107|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481108|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481109|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362059|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101362060|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
101362061|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362062|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362063|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362064|NCT00127270|Urological Agents|urological agents|mesh-ancestor
101362065|NCT00043823|Bevacizumab|bevacizumab|mesh-list
101362066|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101481110|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481111|NCT00295919|Ketoconazole|ketoconazole|mesh-list
101481112|NCT00295919|Fenretinide|fenretinide|mesh-list
101481113|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
101481114|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481115|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101481116|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481117|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481118|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481119|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101481120|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
101481121|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481122|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481123|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101481124|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481125|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101481126|NCT00295919|Protective Agents|protective agents|mesh-ancestor
101481127|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
101481128|NCT00295958|Immunotoxins|immunotoxins|mesh-list
101481129|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101481130|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
101481131|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481132|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
101481134|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
101481135|NCT00295997|Busulfan|busulfan|mesh-list
101481136|NCT00295997|Methotrexate|methotrexate|mesh-list
101481137|NCT00295997|Fludarabine|fludarabine|mesh-list
101481138|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
101481139|NCT00295997|Tacrolimus|tacrolimus|mesh-list
101481140|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101481141|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481142|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
101481143|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481144|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481147|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481149|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101481150|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101481151|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
101481152|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101481153|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481154|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
101481155|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
101481156|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481157|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101481158|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101481159|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481160|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481161|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101481162|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
101481163|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481164|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481165|NCT00418067|Sirolimus|sirolimus|mesh-list
101481166|NCT00418067|Paclitaxel|paclitaxel|mesh-list
101481167|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101481168|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362068|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362069|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362070|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362071|NCT00043823|Growth Substances|growth substances|mesh-ancestor
101362072|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362073|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362074|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481169|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
101481170|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
101481171|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
101481172|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481173|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481174|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481175|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481176|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
101481177|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481178|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
101481179|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481181|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481182|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
101481183|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481184|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481185|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481186|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481187|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
101481188|NCT00296348|Tacrolimus|tacrolimus|mesh-list
101481189|NCT00296348|Daclizumab|daclizumab|mesh-list
101481190|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481191|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
101481192|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481193|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481194|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481195|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481196|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481197|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481198|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101481199|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
101481200|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481201|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481203|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101481204|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101481205|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101481206|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
101481207|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481208|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101481209|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101481210|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481211|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
101481212|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
101481213|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101481214|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481215|NCT00296465|Citric Acid|citric acid|mesh-list
101481225|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
101481226|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481227|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481228|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481229|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101481230|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
101481231|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101362076|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362077|NCT00074334|Immunotoxins|immunotoxins|mesh-list
101362078|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
101362079|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
101362080|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362081|NCT00127387|Etanercept|etanercept|mesh-list
101362082|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101362083|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362084|NCT00127387|Analgesics|analgesics|mesh-ancestor
101481232|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
101481233|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101481234|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101481235|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101481236|NCT00326859|Remifentanil|remifentanil|mesh-list
101481237|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101481238|NCT00326859|Narcotics|narcotics|mesh-ancestor
101481239|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481240|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481241|NCT00326859|Analgesics|analgesics|mesh-ancestor
101481242|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
101481243|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481244|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101481245|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101481246|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481247|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481248|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481249|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481250|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481251|NCT00296699|Analgesics|analgesics|mesh-ancestor
101481252|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
101481253|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481254|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
101481255|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481256|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
101481257|NCT00296777|Bupropion|bupropion|mesh-list
101481258|NCT00296777|Imipramine|imipramine|mesh-list
101481259|NCT00296777|Escitalopram|escitalopram|mesh-list
101481260|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101481261|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481262|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481263|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481264|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481265|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
101481266|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481267|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101481268|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
101481269|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481270|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101481271|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
101481272|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101481273|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481274|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481275|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101481276|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101481277|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481279|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101481280|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481281|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481289|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
101481290|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481291|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101481292|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
101481293|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362086|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362087|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362088|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362090|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362091|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362092|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
101362093|NCT00043862|Topotecan|topotecan|mesh-list
101481294|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101481295|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
101481296|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101481297|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481298|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481299|NCT00296972|Interferons|interferons|mesh-list
101481300|NCT00296972|Ribavirin|ribavirin|mesh-list
101481301|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481302|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
101481303|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481304|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
101481305|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481306|NCT00297011|Valacyclovir|valacyclovir|mesh-list
101481307|NCT00297011|Clobetasol|clobetasol|mesh-list
101481308|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
101481309|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481310|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481311|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
101481312|NCT00297011|Hormones|hormones|mesh-ancestor
101481313|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481314|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481315|NCT00327093|Bevacizumab|bevacizumab|mesh-list
101481317|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101481318|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481319|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101481320|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101481321|NCT00327093|Growth Substances|growth substances|mesh-ancestor
101481322|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481323|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101481324|NCT00297050|Peramivir|peramivir|mesh-list
101481325|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
101481326|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481327|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481328|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481329|NCT00297128|Capecitabine|capecitabine|mesh-list
101481330|NCT00297128|Cetuximab|cetuximab|mesh-list
101481331|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481332|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
101481333|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481334|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481335|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101481336|NCT00327132|Amoxicillin|amoxicillin|mesh-list
101481337|NCT00327132|Clarithromycin|clarithromycin|mesh-list
101481338|NCT00327132|Omeprazole|omeprazole|mesh-list
101481339|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481340|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481341|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101481342|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101481343|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101481344|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481345|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481346|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101481347|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101481348|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481349|NCT00297206|Valacyclovir|valacyclovir|mesh-list
101481351|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362094|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101362095|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101362096|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362097|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362098|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362099|NCT00127504|Azithromycin|azithromycin|mesh-list
101362100|NCT00127504|Rifampin|rifampin|mesh-list
101362101|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362102|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362103|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101362104|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
101481352|NCT04485195|Procainamide|procainamide|mesh-list
101481353|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101481354|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101481355|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101481356|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481357|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481358|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
101481359|NCT04478019|Povidone|povidone|mesh-list
101481361|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
101481362|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101481363|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481365|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101481366|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481367|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101481368|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101481369|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101481370|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481371|NCT04392531|Cyclosporine|cyclosporine|mesh-list
101481372|NCT04392531|Cyclosporins|cyclosporins|mesh-list
101481373|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481374|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481375|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481376|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
101481377|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481378|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
101481379|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481380|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
101481381|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481382|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481383|NCT00297323|Topiramate|topiramate|mesh-list
101481384|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
101481385|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101481386|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481387|NCT00327288|Docetaxel|docetaxel|mesh-list
101481388|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481389|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
101481390|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
101481391|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
101481392|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481393|NCT04333134|Fluzoparib|fluzoparib|mesh-list
101481394|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101481395|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481396|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481397|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481398|NCT00327327|Gemcitabine|gemcitabine|mesh-list
101481399|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481400|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
101481401|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481402|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481403|NCT00297362|Galantamine|galantamine|mesh-list
101362106|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362107|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362108|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362109|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101362110|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101362111|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101362112|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101362113|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101362114|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101362115|NCT00043901|Lamotrigine|lamotrigine|mesh-list
101362116|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
101362117|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101362118|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101362119|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362120|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101362121|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362122|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101362123|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481404|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101481405|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481406|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481407|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
101481408|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481409|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481410|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101481411|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
101481412|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481413|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
101481414|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
101481415|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101481416|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
101481417|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481418|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481419|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101481420|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
101481421|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101481422|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
101481425|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101481426|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
101481427|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
101481428|NCT04231773|Protective Agents|protective agents|mesh-ancestor
101481429|NCT00297674|Clarithromycin|clarithromycin|mesh-list
101481430|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481431|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481432|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101481433|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481434|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481435|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101362124|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362125|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362126|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101362127|NCT00127777|Amantadine|amantadine|mesh-list
101362128|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101362129|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101362130|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
101481436|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481437|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101481438|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101481439|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481440|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101481441|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
101481442|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481443|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101481444|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481445|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481446|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481447|NCT04718714|Midazolam|midazolam|mesh-list
101481448|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
101481449|NCT04718714|Propofol|propofol|mesh-list
101481450|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101481451|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481452|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481453|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101481454|NCT04718714|Analgesics|analgesics|mesh-ancestor
101481455|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
101481456|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481457|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101481458|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101481459|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101481460|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481461|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481462|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481463|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101481464|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
101481465|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
101481466|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101481467|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101481468|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481469|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481470|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
101481471|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
101481472|NCT00298025|Cetrorelix|cetrorelix|mesh-list
101481473|NCT00298025|Menotropins|menotropins|mesh-list
101481474|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101481475|NCT00298025|Hormones|hormones|mesh-list
101481476|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101481477|NCT00298025|Ganirelix|ganirelix|mesh-list
101481478|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481479|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481480|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
101481481|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101481482|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
101481483|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101481484|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
101481485|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101481486|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
101481487|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481488|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481489|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481490|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
101481491|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481492|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
101481493|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101481494|NCT00298181|Protective Agents|protective agents|mesh-ancestor
101481495|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101481498|NCT03754140|Polidocanol|polidocanol|mesh-list
101481499|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101481500|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101481501|NCT00298415|Paclitaxel|paclitaxel|mesh-list
101362131|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362132|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
101362133|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362134|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362135|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362136|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362137|NCT00127777|Analgesics|analgesics|mesh-ancestor
101362138|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
101362139|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481502|NCT00298415|Vinorelbine|vinorelbine|mesh-list
101481503|NCT00298415|Carboplatin|carboplatin|mesh-list
101481504|NCT00298415|Gemcitabine|gemcitabine|mesh-list
101481505|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101481506|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101481507|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481508|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101481509|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101481510|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101481511|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481512|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481513|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
101481514|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481515|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481517|NCT00298454|Diuretics|diuretics|mesh-ancestor
101481518|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
101481519|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481520|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101481521|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481522|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481523|NCT00298571|Epinephrine|epinephrine|mesh-list
101481524|NCT00298571|Bupivacaine|bupivacaine|mesh-list
101481525|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
101481526|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
101481527|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481528|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481529|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
101481530|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481531|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101481532|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101481533|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481534|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481535|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481536|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101481537|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101481538|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
101481539|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101481540|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
101481541|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
101481542|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
101481543|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101481544|NCT00298688|Gefitinib|gefitinib|mesh-list
101481545|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481546|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481547|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481548|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481549|NCT05457894|Vaccines|vaccines|mesh-list
101481550|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
101481551|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481552|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
101481553|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481554|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481555|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101362140|NCT00399633|Sumatriptan|sumatriptan|mesh-list
101362141|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101362142|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101362143|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101362145|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481556|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
101481557|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481558|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481559|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481560|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481562|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481563|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481564|NCT00299039|Acetaminophen|acetaminophen|mesh-list
101481565|NCT00299039|Ibuprofen|ibuprofen|mesh-list
101481566|NCT00299039|Codeine|codeine|mesh-list
101481567|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101481568|NCT00299039|Analgesics|analgesics|mesh-ancestor
101481594|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481595|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101481596|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481597|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481598|NCT00299390|Sagopilone|sagopilone|mesh-list
101481599|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481600|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
101481601|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
101481602|NCT00299819|Sifalimumab|sifalimumab|mesh-list
101481603|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101481604|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
101481605|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481606|NCT00299858|Theophylline|theophylline|mesh-list
101481607|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101481608|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
101481609|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481610|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481611|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101481612|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
101481613|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101481614|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481615|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481619|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
101481620|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481621|NCT05455944|Pregabalin|pregabalin|mesh-list
101481622|NCT05455944|Analgesics|analgesics|mesh-ancestor
101481623|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
101481624|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481625|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481626|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
101481627|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101481628|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481629|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481630|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101481631|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101481632|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481633|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481634|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481635|NCT00299936|Ribavirin|ribavirin|mesh-list
101481636|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101481637|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
101481638|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481639|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
101481640|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481641|NCT00300014|Triamcinolone|triamcinolone|mesh-list
101481642|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481643|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
101481644|NCT00300014|Hormones|hormones|mesh-ancestor
101481645|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362146|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362148|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
101362149|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101362150|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481646|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481647|NCT00300131|Everolimus|everolimus|mesh-list
101481648|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101481649|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481650|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481651|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481652|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481653|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
101481654|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481655|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481656|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
101481657|NCT01785459|Bupivacaine|bupivacaine|mesh-list
101481658|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
101481659|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
101481660|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481661|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481662|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
101481663|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481664|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
101481665|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
101481666|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101481667|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101481668|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481669|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481670|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101481671|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
101481672|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481673|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481674|NCT04716894|Itraconazole|itraconazole|mesh-list
101481675|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
101481676|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481677|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101481678|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101481679|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481680|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481681|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101481682|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
101481683|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101481684|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481685|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101481686|NCT00300287|Vildagliptin|vildagliptin|mesh-list
101481687|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101481689|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101481691|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481692|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481694|NCT00300404|Folic Acid|folic acid|mesh-list
101481695|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
101481696|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
101481697|NCT00300404|Antidotes|antidotes|mesh-ancestor
101414078|NCT00145236|Nebivolol|nebivolol|mesh-list
101481698|NCT00300404|Protective Agents|protective agents|mesh-ancestor
101481699|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481700|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
101481701|NCT00300404|Vitamins|vitamins|mesh-ancestor
101481702|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
101481703|NCT00300404|Hematinics|hematinics|mesh-ancestor
101481704|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
101481705|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101481706|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101481707|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481708|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362152|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101362153|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
101362154|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
101362155|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
101362156|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101362157|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362158|NCT00402610|Rifampin|rifampin|mesh-list
101481709|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481710|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481711|NCT01539447|Naproxen|naproxen|mesh-list
101481712|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101481713|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101481714|NCT01539447|Analgesics|analgesics|mesh-ancestor
101481715|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
101481716|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481717|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481718|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481719|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481720|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
101481721|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101481722|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481723|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481724|NCT00300443|Bimatoprost|bimatoprost|mesh-list
101481725|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101481726|NCT00300560|Colistin|colistin|mesh-list
101481727|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481728|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481729|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101481730|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
101481731|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481732|NCT00300716|Memantine|memantine|mesh-list
101481733|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101481734|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101481735|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
101481736|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481737|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481738|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481739|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101481740|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101481741|NCT00300794|Ketamine|ketamine|mesh-list
101481742|NCT00300794|Analgesics|analgesics|mesh-ancestor
101481743|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
101481744|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481745|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481746|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101481747|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101481748|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
101481749|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
101481750|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481751|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101481752|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101481753|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481754|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481755|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
101481756|NCT05373303|Hematinics|hematinics|mesh-ancestor
101481757|NCT00300833|Tirofiban|tirofiban|mesh-list
101481758|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101481759|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101481760|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481770|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481771|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481772|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481773|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481774|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481775|NCT00300950|Gemcitabine|gemcitabine|mesh-list
101481776|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481777|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
101362159|NCT00402610|Isoniazid|isoniazid|mesh-list
101362160|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
101362161|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101362162|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
101362163|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362164|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362165|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
101362166|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362167|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362168|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362169|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101362170|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101362171|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101362172|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101362173|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101362174|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101362175|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101362176|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101362177|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
101362178|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101362179|NCT00402766|Dexamethasone|dexamethasone|mesh-list
101362181|NCT00402766|Pemetrexed|pemetrexed|mesh-list
101362182|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
101414114|NCT00489073|Analgesics|analgesics|mesh-ancestor
101362183|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362184|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
101362208|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362209|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101362210|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101362211|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101362212|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101362213|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101362214|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101362215|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101362216|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101362217|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
101362218|NCT00043940|Bivalirudin|bivalirudin|mesh-list
101362219|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
101362220|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101362221|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
101362222|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362223|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362224|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
101362225|NCT04711434|Antibodies|antibodies|mesh-list
101362226|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
101362227|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362228|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
101362230|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362260|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362261|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362262|NCT00078195|Omalizumab|omalizumab|mesh-list
101362263|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
101362264|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
101362265|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101362266|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
101362267|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362268|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101362269|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101362270|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
101362271|NCT00044291|Toremifene|toremifene|mesh-list
101362325|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362326|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101362327|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101362328|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101362329|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101362331|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362395|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
101362396|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362397|NCT00403000|Dutasteride|dutasteride|mesh-list
101362398|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101362399|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101362400|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362464|NCT00074841|Amebicides|amebicides|mesh-ancestor
101362465|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101362466|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101362467|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
101362468|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362532|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101362534|NCT04731740|Lenvatinib|lenvatinib|mesh-list
101362535|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101362536|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362537|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101362538|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362539|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362540|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362541|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
101362543|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101362544|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
101362545|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362546|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362547|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362548|NCT04263298|Capecitabine|capecitabine|mesh-list
101362549|NCT04263298|Fulvestrant|fulvestrant|mesh-list
101362550|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362551|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
101362552|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362553|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362554|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362555|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101362583|NCT00079092|Procarbazine|procarbazine|mesh-list
101362584|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362585|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
101362586|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362587|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
101362588|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101537699|NCT03450434|Histamine|histamine|mesh-list
101362589|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362590|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362591|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362592|NCT00079092|Growth Substances|growth substances|mesh-ancestor
101362649|NCT00045227|Docetaxel|docetaxel|mesh-list
101362650|NCT00045227|Vaccines|vaccines|mesh-list
101362651|NCT00045227|Sargramostim|sargramostim|mesh-list
101362652|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
101362653|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362654|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362655|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101362659|NCT00075075|Infliximab|infliximab|mesh-list
101362720|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
101362721|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362722|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
101362723|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362790|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
101362791|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362792|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362794|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101362795|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362797|NCT00045500|Hormones|hormones|mesh-ancestor
101362860|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362861|NCT03399838|Midazolam|midazolam|mesh-list
101362862|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
101362863|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101362864|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362865|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362866|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362867|NCT03399838|Analgesics|analgesics|mesh-ancestor
101362868|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
101362869|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362870|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101362871|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101362872|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101362873|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
101362874|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362875|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362876|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101362877|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101362878|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101362885|NCT00079287|Paclitaxel|paclitaxel|mesh-list
101362916|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362918|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362919|NCT02839915|Leucovorin|leucovorin|mesh-list
101362920|NCT02839915|Folic Acid|folic acid|mesh-list
101362921|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
101362922|NCT02839915|Antidotes|antidotes|mesh-ancestor
101362923|NCT02839915|Protective Agents|protective agents|mesh-ancestor
101362924|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362925|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
101362926|NCT02839915|Vitamins|vitamins|mesh-ancestor
101362927|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
101362928|NCT02839915|Hematinics|hematinics|mesh-ancestor
101362929|NCT00045812|Ezetimibe|ezetimibe|mesh-list
101362930|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101362931|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101362979|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101362980|NCT00079560|Analgesics|analgesics|mesh-ancestor
101362981|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
101362982|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362983|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101362984|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101362987|NCT00079560|Hormones|hormones|mesh-ancestor
101363046|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363047|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
101363048|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363049|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363117|NCT00130858|Topotecan|topotecan|mesh-list
101363118|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363119|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101363120|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363121|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363122|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363123|NCT00130897|Sunitinib|sunitinib|mesh-list
101363124|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363125|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101363126|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101363127|NCT00130897|Growth Substances|growth substances|mesh-ancestor
101363128|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363129|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
101363130|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101363131|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363141|NCT00079872|Pemetrexed|pemetrexed|mesh-list
101363175|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363176|NCT00131053|Cytarabine|cytarabine|mesh-list
101363177|NCT00131053|Dexamethasone|dexamethasone|mesh-list
101363178|NCT00131053|Prednisolone|prednisolone|mesh-list
101363179|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
101363180|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
101363244|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101363245|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363246|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363247|NCT00131482|Thrombin|thrombin|mesh-list
101363248|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
101363249|NCT00131482|Coagulants|coagulants|mesh-ancestor
101363250|NCT00397709|Rifampin|rifampin|mesh-list
101363314|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
101363315|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363316|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101363317|NCT00403663|Narcotics|narcotics|mesh-ancestor
101363318|NCT00403663|Analgesics|analgesics|mesh-ancestor
101363319|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101363320|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101363321|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
101363322|NCT00403780|Pregabalin|pregabalin|mesh-list
101363323|NCT00403780|Analgesics|analgesics|mesh-ancestor
101363324|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
101363325|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363326|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363327|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
101363328|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101363329|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363330|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363331|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101363370|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363371|NCT00132106|Phentolamine|phentolamine|mesh-list
101363372|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101537931|NCT00191789|Gemcitabine|gemcitabine|mesh-list
101363373|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101363374|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101363375|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363376|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363379|NCT00080340|Gefitinib|gefitinib|mesh-list
101363437|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101363439|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101363440|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101363510|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363511|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363512|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363514|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363519|NCT00399672|Interferons|interferons|mesh-list
101363578|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101363579|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101363580|NCT00133393|Protective Agents|protective agents|mesh-ancestor
101363581|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363582|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
101363647|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363648|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101363649|NCT00133744|Folic Acid|folic acid|mesh-list
101363650|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
101363651|NCT00133744|Vitamins|vitamins|mesh-ancestor
101537979|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101363653|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363654|NCT00133744|Hematinics|hematinics|mesh-ancestor
101363655|NCT00080808|Phentolamine|phentolamine|mesh-list
101363656|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
101363657|NCT00080808|Alprostadil|alprostadil|mesh-list
101363658|NCT00080808|Papaverine|papaverine|mesh-list
101363660|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101363713|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101363714|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101363715|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
101363716|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
101363785|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363786|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
101363787|NCT00080847|Hormones|hormones|mesh-ancestor
101538022|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101363788|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363789|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363790|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363856|NCT00080925|Prednisone|prednisone|mesh-list
101363857|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
101363858|NCT00080925|Rituximab|rituximab|mesh-list
101363929|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101363930|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363931|NCT00047294|Thalidomide|thalidomide|mesh-list
101363932|NCT00047294|Celecoxib|celecoxib|mesh-list
101363933|NCT00047294|Temozolomide|temozolomide|mesh-list
101363934|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363935|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
101363936|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363937|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363938|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363939|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363940|NCT00047294|Analgesics|analgesics|mesh-ancestor
101363941|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
101363942|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363943|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363944|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363945|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363946|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101363947|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101363948|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363949|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363958|NCT00042822|Romidepsin|romidepsin|mesh-list
101363981|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363982|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101364054|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101364055|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
101364056|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101364057|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
101364058|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364059|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
101364123|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101364124|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101364125|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
101364126|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364127|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364193|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101364194|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
101364195|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364196|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101364197|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101364262|NCT00146146|Androgens|androgens|mesh-ancestor
101364263|NCT00146146|Hormones|hormones|mesh-ancestor
101364264|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364265|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
101364266|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101364267|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
101364268|NCT00146224|Hematinics|hematinics|mesh-ancestor
101364269|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
101364270|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364271|NCT00146341|Telmisartan|telmisartan|mesh-list
101364328|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364329|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
101364330|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364331|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538174|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364332|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364333|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364334|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364335|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364336|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
101364394|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364395|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364467|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101364468|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101364469|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364470|NCT00147121|Rituximab|rituximab|mesh-list
101364471|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101364472|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364538|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101364539|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
101364540|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364541|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364608|NCT00147628|Urological Agents|urological agents|mesh-ancestor
101364609|NCT00147667|Erythromycin|erythromycin|mesh-list
101364610|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
101364611|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101364682|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364683|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
101364684|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364685|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538242|NCT00479765|Paclitaxel|paclitaxel|mesh-list
101364686|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
101364687|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364688|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364689|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
101364690|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364691|NCT00048425|Simendan|simendan|mesh-list
101364692|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101364745|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101364746|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364748|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101364749|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364750|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364751|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101364752|NCT00405847|Analgesics|analgesics|mesh-ancestor
101364753|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
101364810|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101364811|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364812|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364813|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364814|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101364815|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101364816|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538282|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
101364817|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
101364870|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
101364871|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364872|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364873|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101364874|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
101364875|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101364876|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364877|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101364934|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364935|NCT00149539|Buprenorphine|buprenorphine|mesh-list
101364936|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101364938|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101364939|NCT00149539|Narcotics|narcotics|mesh-ancestor
101364940|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364941|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364942|NCT00149539|Analgesics|analgesics|mesh-ancestor
101365002|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365003|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365005|NCT00049088|Bevacizumab|bevacizumab|mesh-list
101365075|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365076|NCT00150046|Everolimus|everolimus|mesh-list
101365077|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101365078|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365079|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365080|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365081|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365141|NCT00150280|Analgesics|analgesics|mesh-ancestor
101365142|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
101365143|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365144|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365145|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365146|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365147|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101365148|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365149|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365150|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101365151|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
101365152|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365153|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365201|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365202|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101365203|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101365204|NCT00150631|Candesartan|candesartan|mesh-list
101365205|NCT00150631|Candesartan cilexetil|candesartan cilexetil|mesh-list
101365206|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101365207|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101365208|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101365270|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365271|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365272|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365281|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
101365341|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
101365342|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365343|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365344|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
101365345|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365346|NCT00151255|Analgesics|analgesics|mesh-ancestor
101365347|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
101365348|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365349|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101365350|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101365351|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365352|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101365403|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365404|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365405|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
101365406|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101365471|NCT00082563|Chloroquine|chloroquine|mesh-list
101365472|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101365473|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365474|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365476|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101365477|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101365478|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
101365479|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365480|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101365481|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101365482|NCT00082563|Analgesics|analgesics|mesh-ancestor
101365483|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
101365484|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365485|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365486|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365487|NCT00082563|Filaricides|filaricides|mesh-ancestor
101365490|NCT00151528|Pregabalin|pregabalin|mesh-list
101365531|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365532|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365533|NCT00151567|Urological Agents|urological agents|mesh-ancestor
101365602|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
101365603|NCT00152035|Adderall|adderall|mesh-list
101365604|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101365605|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365606|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
101365607|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
101365608|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101365609|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
101365671|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101365672|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365673|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
101365674|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365675|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365676|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
101365677|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101365678|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101365738|NCT00152620|Hormones|hormones|mesh-ancestor
101365740|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101365811|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101365812|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
101365813|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365814|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101365815|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365816|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
101365876|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365877|NCT00083070|Temozolomide|temozolomide|mesh-list
101365878|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101365879|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
101365881|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365945|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
101365946|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101365947|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
101365948|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
101365949|NCT00050531|Molgramostim|molgramostim|mesh-list
101365950|NCT00050531|Sargramostim|sargramostim|mesh-list
101365951|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365952|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
101365953|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365954|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
101365955|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365956|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365957|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365959|NCT00083148|Capecitabine|capecitabine|mesh-list
101366009|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366010|NCT00050609|Urological Agents|urological agents|mesh-ancestor
101366011|NCT00153673|Celecoxib|celecoxib|mesh-list
101366012|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101366013|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101366079|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101366080|NCT00154180|Estradiol|estradiol|mesh-list
101366081|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101366150|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366151|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101366152|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101366153|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366154|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366155|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366156|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
101366157|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366158|NCT00043914|Lamotrigine|lamotrigine|mesh-list
101366159|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
101366160|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101366211|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366212|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
101366213|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366220|NCT00083343|Caspofungin|caspofungin|mesh-list
101538637|NCT01087970|Pemetrexed|pemetrexed|mesh-list
101366282|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366283|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366284|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366285|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366354|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366355|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
101366356|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101366357|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366358|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366359|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366363|NCT00155350|Pioglitazone|pioglitazone|mesh-list
101366423|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366424|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101414302|NCT00490243|Hormones|hormones|mesh-ancestor
101366425|NCT00083577|Growth Substances|growth substances|mesh-ancestor
101366426|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366427|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366429|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101366430|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366431|NCT00154414|Incretins|incretins|mesh-ancestor
101366432|NCT00154414|Hormones|hormones|mesh-ancestor
101366433|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101366434|NCT00406744|Bevacizumab|bevacizumab|mesh-list
101366435|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101366436|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366482|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366483|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
101366484|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366485|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366486|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101366487|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101366488|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366489|NCT00044187|Sibutramine|sibutramine|mesh-list
101366490|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
101366491|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101366492|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
101366493|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101366494|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
101538743|NCT01085045|Bromides|bromides|mesh-list
101366495|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101366496|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101366544|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366545|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
101366546|NCT00157300|Hematinics|hematinics|mesh-ancestor
101366547|NCT00157378|Haloperidol|haloperidol|mesh-list
101366548|NCT00157378|Risperidone|risperidone|mesh-list
101366549|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
101366550|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101366551|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
101366552|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101366553|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366554|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366555|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101366556|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101366557|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101366605|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366606|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366607|NCT00406978|Growth Substances|growth substances|mesh-ancestor
101366608|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101366609|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101366610|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101366611|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101366612|NCT00157651|Warfarin|warfarin|mesh-list
101366613|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
101366614|NCT00044343|Lapatinib|lapatinib|mesh-list
101366673|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366674|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101366675|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101366747|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
101366749|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366750|NCT00158587|Primaquine|primaquine|mesh-list
101366751|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
101366752|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101366753|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101366754|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366755|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101366757|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101366758|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101366759|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101366760|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366761|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366762|NCT00158782|Lapatinib|lapatinib|mesh-list
101366763|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366764|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101366765|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366766|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366803|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101366804|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101366805|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101366806|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366810|NCT04724473|Tretinoin|tretinoin|mesh-list
101366873|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
101366874|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101366875|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101366876|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101366877|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101366878|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101366879|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101366880|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366881|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366882|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366883|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366884|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366885|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366886|NCT00052052|Interferons|interferons|mesh-list
101366887|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
101366933|NCT00159835|Simvastatin|simvastatin|mesh-list
101366934|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101366935|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101366936|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
101366937|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366938|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101366939|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101366940|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101366941|NCT00052169|Docetaxel|docetaxel|mesh-list
101366942|NCT00052169|Gefitinib|gefitinib|mesh-list
101366943|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101366944|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
101366945|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
101366946|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
101366947|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366995|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101366996|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101366998|NCT00160186|Pancrelipase|pancrelipase|mesh-list
101366999|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101367000|NCT05567484|Itraconazole|itraconazole|mesh-list
101367001|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
101367002|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367003|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101367012|NCT00160264|Vitamin D|vitamin d|mesh-list
101367061|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
101367062|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367063|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367064|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367065|NCT00160576|Levetiracetam|levetiracetam|mesh-list
101367066|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
101367067|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
101367068|NCT00160849|Lopinavir|lopinavir|mesh-list
101367069|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101367070|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101367071|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
101367072|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367073|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367074|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101367075|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101367076|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
101367077|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367121|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367122|NCT00052559|Bevacizumab|bevacizumab|mesh-list
101367123|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101367125|NCT00052559|Antibodies|antibodies|mesh-list
101367126|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
101367127|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101367128|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367191|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367192|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
101367193|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101367194|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101367261|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367262|NCT00044538|Taxane|taxane|mesh-list
101367263|NCT00044538|IDN 5109|idn 5109|mesh-list
101367264|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367265|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
101367266|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367267|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367268|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
101367269|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
101367329|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101367330|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101367331|NCT00053105|Prednisolone|prednisolone|mesh-list
101367332|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
101367333|NCT00053105|Pixantrone|pixantrone|mesh-list
101367334|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101367335|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
101367336|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367337|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101367338|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
101367339|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367340|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
101367341|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101367393|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101367394|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
101367395|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101367396|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367397|NCT00162526|Tocopherols|tocopherols|mesh-list
101367398|NCT00162526|Vitamin E|vitamin e|mesh-list
101367399|NCT00162526|Tocotrienols|tocotrienols|mesh-list
101367400|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
101367401|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
101538977|NCT04671563|Tenofovir|tenofovir|mesh-list
101367402|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367403|NCT00162526|Protective Agents|protective agents|mesh-ancestor
101367404|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367405|NCT00162526|Vitamins|vitamins|mesh-ancestor
101367406|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
101367455|NCT00162721|Ifosfamide|ifosfamide|mesh-list
101367456|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101367457|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101367525|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367526|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101367527|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
101367528|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367592|NCT00053300|Thalidomide|thalidomide|mesh-list
101367593|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101367594|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
101367595|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101367662|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101367663|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
101367664|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
101367665|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101367667|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101367734|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
101367735|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101367809|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101367810|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
101367811|NCT00053768|Hormones|hormones|mesh-ancestor
101367812|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101367813|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101367814|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101539043|NCT00171951|Hormones|hormones|mesh-ancestor
101367815|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101367816|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
101367817|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
101367818|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
101367819|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101367820|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367873|NCT00165178|Leucovorin|leucovorin|mesh-list
101367874|NCT00165178|Cytarabine|cytarabine|mesh-list
101367875|NCT00165178|Dexamethasone|dexamethasone|mesh-list
101367876|NCT00165178|Prednisone|prednisone|mesh-list
101367877|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
101367878|NCT00165178|Doxorubicin|doxorubicin|mesh-list
101367890|NCT00165178|Hormones|hormones|mesh-ancestor
101367946|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101367947|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101367948|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101367950|NCT00165334|Vinorelbine|vinorelbine|mesh-list
101367951|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101367952|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368012|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
101368013|NCT00165685|Sibutramine|sibutramine|mesh-list
101368014|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101368015|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101368016|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
101368017|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101368018|NCT00045279|Interferons|interferons|mesh-list
101368019|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
101368020|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
101368021|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101539065|NCT01087151|Navitoclax|navitoclax|mesh-list
101368022|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368023|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
101368024|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101368025|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
101368026|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368027|NCT00053963|Romidepsin|romidepsin|mesh-list
101368028|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368029|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368030|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101368033|NCT00165763|Donepezil|donepezil|mesh-list
101368070|NCT00054197|Vinorelbine|vinorelbine|mesh-list
101368071|NCT00054197|Gemcitabine|gemcitabine|mesh-list
101368072|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101368073|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101368074|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368075|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368076|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368077|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368078|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368079|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368080|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
101368081|NCT00045396|Tipifarnib|tipifarnib|mesh-list
101368082|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368083|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
101368084|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368085|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101368086|NCT00166426|Protective Agents|protective agents|mesh-ancestor
101368087|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368088|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368089|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368090|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368092|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368093|NCT00166426|Analgesics|analgesics|mesh-ancestor
101368094|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
101368095|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368096|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481778|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481779|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481780|NCT00327756|Ubiquinone|ubiquinone|mesh-list
101481781|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
101481782|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
101481783|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481784|NCT00327756|Vitamins|vitamins|mesh-ancestor
101481785|NCT00301106|Interleukin-12|interleukin-12|mesh-list
101481786|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101481787|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
101481788|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481789|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101481790|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101481791|NCT00301106|Growth Substances|growth substances|mesh-ancestor
101481792|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
101481793|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481794|NCT00301145|Varenicline|varenicline|mesh-list
101481795|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101481796|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101481797|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
101368097|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368098|NCT00166465|Leucovorin|leucovorin|mesh-list
101368099|NCT00166465|Fluorouracil|fluorouracil|mesh-list
101368100|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
101368101|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
101368102|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368169|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368170|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
101368243|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368244|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
101368245|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368246|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368247|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101368309|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368310|NCT00045591|Analgesics|analgesics|mesh-ancestor
101368311|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
101368312|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368313|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368314|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368315|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368316|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101368318|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368375|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368376|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101368377|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
101368378|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368380|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101368381|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368382|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
101368383|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
101368384|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101368385|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101368386|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368387|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368436|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368438|NCT00168649|Vitamin A|vitamin a|mesh-list
101368439|NCT00168649|Vitamins|vitamins|mesh-ancestor
101368440|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
101368442|NCT00168688|Micronutrients|micronutrients|mesh-list
101368507|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101368509|NCT00169000|Capecitabine|capecitabine|mesh-list
101368510|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368511|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
101368512|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
101368513|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
101368514|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368515|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368516|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
101368517|NCT00045747|Fluorouracil|fluorouracil|mesh-list
101368518|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101368519|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
101368520|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368521|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368522|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368523|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368524|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
101368565|NCT00169156|Doxorubicin|doxorubicin|mesh-list
101368566|NCT00169156|Vincristine|vincristine|mesh-list
101368567|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368568|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
101368569|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368570|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368571|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101368572|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
101368573|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368574|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368575|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101539232|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
101368576|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368577|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101368578|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101368579|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101368580|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368581|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368582|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
101368583|NCT00169156|Hormones|hormones|mesh-ancestor
101368585|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101368619|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101368620|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
101368621|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
101368622|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101368623|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101368624|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101368625|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101368626|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101368627|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101368628|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368629|NCT00398372|Rituximab|rituximab|mesh-list
101368630|NCT00398372|Epratuzumab|epratuzumab|mesh-list
101368631|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101368647|NCT00169624|Metformin|metformin|mesh-list
101368680|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368681|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
101368682|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368683|NCT00055250|Gemcitabine|gemcitabine|mesh-list
101368684|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101368753|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101368754|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368755|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368756|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101368757|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
101368758|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368759|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101368760|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
101368761|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101368762|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368763|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368764|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368765|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101368766|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368767|NCT00170872|Analgesics|analgesics|mesh-ancestor
101368768|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
101368769|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368805|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101368806|NCT00171067|Protective Agents|protective agents|mesh-ancestor
101368807|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368808|NCT00171106|Valsartan|valsartan|mesh-list
101368809|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101368810|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101368811|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101368812|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101368813|NCT00171145|Darifenacin|darifenacin|mesh-list
101368814|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101368815|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101368829|NCT00055523|Adalimumab|adalimumab|mesh-list
101368867|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368868|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101368869|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368871|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
101368937|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101368938|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101368939|NCT00171652|Analgesics|analgesics|mesh-ancestor
101368940|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
101368941|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101368942|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101368943|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101368944|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101368945|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101368946|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101368999|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101369000|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369147|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369148|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369149|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
101369150|NCT00056030|Antidotes|antidotes|mesh-ancestor
101369151|NCT00056030|Protective Agents|protective agents|mesh-ancestor
101369215|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101369217|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101369218|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101369219|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
101369223|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369282|NCT00056225|Vitamins|vitamins|mesh-list
101369283|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
101369284|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
101369285|NCT00056225|Pyridoxal|pyridoxal|mesh-list
101369286|NCT00056225|Pyridoxine|pyridoxine|mesh-list
101369287|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
101369288|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
101369355|NCT00046176|Abacavir|abacavir|mesh-list
101369356|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
101369357|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101539585|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
101369358|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101369359|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369361|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
101369425|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369426|NCT00175396|Protective Agents|protective agents|mesh-ancestor
101369427|NCT00175396|Vitamins|vitamins|mesh-ancestor
101369428|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
101369429|NCT00175396|Estrogens|estrogens|mesh-ancestor
101369430|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
101369431|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
101369432|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
101369433|NCT00056459|Vatalanib|vatalanib|mesh-list
101369434|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101369435|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369436|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369437|NCT00175435|Vaccines|vaccines|mesh-list
101369438|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
101369439|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369440|NCT00175513|Valacyclovir|valacyclovir|mesh-list
101369441|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
101369442|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101369443|NCT00175591|Bupivacaine|bupivacaine|mesh-list
101369444|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
101369445|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
101369481|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369482|NCT00056576|Zonisamide|zonisamide|mesh-list
101369483|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
101369484|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101369485|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369486|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414529|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
101369487|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101369488|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369489|NCT00175903|Carbamazepine|carbamazepine|mesh-list
101369490|NCT00175903|Levetiracetam|levetiracetam|mesh-list
101369491|NCT00175903|Valproic Acid|valproic acid|mesh-list
101369492|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
101369493|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
101369542|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101369543|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101369544|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101369545|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101369546|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369547|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369548|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369549|NCT04420533|Urological Agents|urological agents|mesh-ancestor
101369550|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
101369552|NCT00176020|Niacinamide|niacinamide|mesh-list
101369553|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
101369554|NCT00176020|Vitamins|vitamins|mesh-ancestor
101369604|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369605|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101369606|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101369607|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528380|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528381|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528382|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528383|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528384|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101528385|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101369658|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
101369659|NCT00398489|Docetaxel|docetaxel|mesh-list
101369660|NCT00398489|Trastuzumab|trastuzumab|mesh-list
101369661|NCT00398489|Epirubicin|epirubicin|mesh-list
101369662|NCT00398489|Anastrozole|anastrozole|mesh-list
101369663|NCT00398489|Goserelin|goserelin|mesh-list
101369664|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101369665|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
101369666|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369667|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101369669|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
101369710|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101369711|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101369712|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101369713|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369714|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369715|NCT00408148|Hormones|hormones|mesh-ancestor
101369775|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369776|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369777|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
101369778|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369843|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
101369844|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369845|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369846|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101369847|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101369848|NCT00397722|Paroxetine|paroxetine|mesh-list
101369849|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101369850|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101369851|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101369852|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369853|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101369906|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101414598|NCT00493324|Alefacept|alefacept|mesh-list
101369907|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101369908|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101369909|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101369973|NCT00179686|Growth Substances|growth substances|mesh-ancestor
101369974|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
101369975|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369976|NCT00179725|Doxorubicin|doxorubicin|mesh-list
101369977|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101369978|NCT00179725|Lenalidomide|lenalidomide|mesh-list
101369979|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101369980|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101369982|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101369983|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101369984|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101369985|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
101369986|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101369987|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101369989|NCT00179725|Growth Substances|growth substances|mesh-ancestor
101370033|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
101370034|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370106|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370107|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101370108|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101370109|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539956|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370110|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370111|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
101370113|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370171|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370172|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
101370173|NCT00181675|Galantamine|galantamine|mesh-list
101370174|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101370175|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370176|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370177|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
101370178|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370179|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370180|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101370181|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
101370182|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370183|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
101370184|NCT00181870|Carbamazepine|carbamazepine|mesh-list
101370185|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
101370186|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
101370187|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101370229|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101370230|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101370231|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370232|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
101370233|NCT00182221|Coagulants|coagulants|mesh-ancestor
101370234|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101370235|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370236|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370237|NCT00408538|UC-781|uc-781|mesh-list
101370238|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
101370239|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101370240|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
101370241|NCT00408655|Sirolimus|sirolimus|mesh-list
101370242|NCT00408655|Paclitaxel|paclitaxel|mesh-list
101370243|NCT00408655|Carboplatin|carboplatin|mesh-list
101370244|NCT00408655|Temsirolimus|temsirolimus|mesh-list
101370245|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
101370286|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370288|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
101370289|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370290|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101370291|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101370292|NCT00182611|Tegafur|tegafur|mesh-list
101370293|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370294|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370295|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
101370296|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370297|NCT00182650|Aldesleukin|aldesleukin|mesh-list
101370298|NCT00182650|Rituximab|rituximab|mesh-list
101370299|NCT00182650|Fludarabine|fludarabine|mesh-list
101370300|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
101370301|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370302|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370303|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
101370343|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101370344|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101370345|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370346|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
101370347|NCT00183001|Coagulants|coagulants|mesh-ancestor
101370348|NCT00183040|Hormones|hormones|mesh-list
101370412|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370413|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370415|NCT02965248|Protective Agents|protective agents|mesh-ancestor
101370416|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
101370417|NCT02965248|Vitamins|vitamins|mesh-ancestor
101370418|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
101370419|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101370420|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370421|NCT00183820|Paclitaxel|paclitaxel|mesh-list
101370422|NCT00183820|Gemcitabine|gemcitabine|mesh-list
101370423|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
101370424|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101370439|NCT00183859|Irinotecan|irinotecan|mesh-list
101370476|NCT00183976|Rituximab|rituximab|mesh-list
101370477|NCT00183976|Doxorubicin|doxorubicin|mesh-list
101370478|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101370479|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370480|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370481|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
101370482|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370483|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370484|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101370485|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101370486|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370487|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370488|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370489|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
101370490|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370491|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370492|NCT00184015|Bevacizumab|bevacizumab|mesh-list
101370493|NCT00184015|Bortezomib|bortezomib|mesh-list
101370494|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101370495|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370496|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101370497|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101370528|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370530|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
101370531|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101370532|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370533|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
101370534|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101370535|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370536|NCT00058097|Tipifarnib|tipifarnib|mesh-list
101370537|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540278|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
101370538|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101370539|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101370540|NCT00184795|Norethindrone|norethindrone|mesh-list
101370541|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
101370542|NCT00184795|Estradiol|estradiol|mesh-list
101370543|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101370544|NCT00184795|Estrogens|estrogens|mesh-ancestor
101370545|NCT00184795|Hormones|hormones|mesh-ancestor
101370546|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370547|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370548|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101370549|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
101370550|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370551|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101370552|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101370553|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101370555|NCT00058253|Docetaxel|docetaxel|mesh-list
101370579|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370580|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370581|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
101370582|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
101370583|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101370584|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101370585|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101370586|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101370587|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
101370642|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101370715|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101370716|NCT00058487|Growth Substances|growth substances|mesh-ancestor
101370717|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
101370718|NCT00185419|Desogestrel|desogestrel|mesh-list
101370719|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370720|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370721|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101370722|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101370723|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101370724|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
101370725|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101370726|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101370729|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370730|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101370731|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101370732|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101370733|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101370734|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370735|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101370736|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370737|NCT00185575|Analgesics|analgesics|mesh-ancestor
101370738|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
101370739|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370740|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
101370761|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
101370762|NCT03731832|Hormones|hormones|mesh-ancestor
101370763|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370764|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101370765|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101370766|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101370830|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370831|NCT00186745|Tinzaparin|tinzaparin|mesh-list
101370832|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101370833|NCT00186745|Dalteparin|dalteparin|mesh-list
101370834|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
101370835|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101370836|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101370837|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101370838|NCT00186823|Antibodies|antibodies|mesh-list
101370840|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370841|NCT00186862|Interleukin-2|interleukin-2|mesh-list
101370842|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370843|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101370897|NCT00187057|Hormones|hormones|mesh-ancestor
101370898|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101370899|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101370900|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101370901|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101370902|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101370903|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101370904|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101370905|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
101370906|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370907|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101370960|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101370962|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
101370963|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101370964|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101370965|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101370966|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101370967|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
101370968|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
101370969|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101370970|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101370971|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371024|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
101371025|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371100|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
101371101|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371102|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371169|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371170|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371171|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540910|NCT00580931|Niacin|niacin|mesh-list
101371172|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
101371173|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371174|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
101371175|NCT00188773|Heparin|heparin|mesh-list
101371176|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101371177|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101371178|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
101371234|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371235|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371236|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101371237|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
101371238|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101371239|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
101371240|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
101371241|NCT00189007|Allopurinol|allopurinol|mesh-list
101371242|NCT00189007|Mannitol|mannitol|mesh-list
101371243|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
101371244|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371245|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371246|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
101371247|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101371248|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101371249|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
101371250|NCT00189007|Protective Agents|protective agents|mesh-ancestor
101371251|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371252|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101371253|NCT00189007|Diuretics|diuretics|mesh-ancestor
101371254|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
101371255|NCT00399945|Tobramycin|tobramycin|mesh-list
101371256|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541092|NCT02213159|Narcotics|narcotics|mesh-ancestor
101371257|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371258|NCT00189085|Simvastatin|simvastatin|mesh-list
101371259|NCT00189085|Ezetimibe|ezetimibe|mesh-list
101371260|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101371261|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101371262|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101371263|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
101371264|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371265|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101371266|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101371267|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371268|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101371269|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101371270|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
101371272|NCT00189163|Pioglitazone|pioglitazone|mesh-list
101371273|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371274|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371275|NCT00189358|Tamoxifen|tamoxifen|mesh-list
101371276|NCT00189358|Gefitinib|gefitinib|mesh-list
101371277|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101371342|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371343|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371344|NCT00059462|Interleukin-2|interleukin-2|mesh-list
101371345|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371346|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101371347|NCT00059462|Analgesics|analgesics|mesh-ancestor
101371348|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
101371349|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371350|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371351|NCT00189826|Tacrolimus|tacrolimus|mesh-list
101371406|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371408|NCT00047268|Cytarabine|cytarabine|mesh-list
101371409|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
101371410|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371411|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
101371412|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371413|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371414|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
101371415|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371416|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371417|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
101371418|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371419|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371420|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371421|NCT00190294|Misoprostol|misoprostol|mesh-list
101371422|NCT00190294|Mifepristone|mifepristone|mesh-list
101371423|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101371424|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
101371425|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101371426|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371427|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101371428|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101371429|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
101371430|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101371431|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101371432|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101371433|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101371434|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
101371435|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101371436|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101371437|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
101371438|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101371439|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
101481798|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481799|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481800|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371440|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101371441|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101371442|NCT03238365|Nivolumab|nivolumab|mesh-list
101371443|NCT03238365|Tadalafil|tadalafil|mesh-list
101371444|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101371445|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371446|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101371448|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
101371506|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
101371507|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371508|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
101371509|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371510|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
101371511|NCT02969252|Rifamycins|rifamycins|mesh-list
101371512|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
101371513|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101371514|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371515|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541280|NCT01642524|Dextrans|dextrans|mesh-list
101371516|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101371517|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101371518|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371519|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371520|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371521|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371523|NCT00190606|Analgesics|analgesics|mesh-ancestor
101371558|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371560|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371561|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371562|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371563|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101371564|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371565|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371566|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371567|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371568|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541371|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
101371569|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371570|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371571|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371573|NCT00190918|Pemetrexed|pemetrexed|mesh-list
101371611|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101371612|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371613|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101371614|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101371615|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371619|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
101371677|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371678|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101371679|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371680|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101371681|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371682|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371683|NCT00191581|Insulin|insulin|mesh-list
101371684|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
101371685|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101371686|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101371687|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101371688|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371689|NCT00191620|Gemcitabine|gemcitabine|mesh-list
101371690|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371691|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371692|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
101371693|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371694|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371695|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371696|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371697|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371698|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371699|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371700|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371722|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101371723|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101371724|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101371725|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101371726|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371727|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
101371728|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101371729|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371787|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371788|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
101371789|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371790|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371791|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101371792|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371793|NCT00047580|Tizanidine|tizanidine|mesh-list
101371794|NCT00047580|Analgesics|analgesics|mesh-ancestor
101371795|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
101371796|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101371797|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371798|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
101371799|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101371800|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101371801|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
101371802|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
101371809|NCT02968901|Tadalafil|tadalafil|mesh-list
101371846|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101371847|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371848|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371849|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101371850|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101371851|NCT00192673|Asparaginase|asparaginase|mesh-list
101371852|NCT00192673|Pegaspargase|pegaspargase|mesh-list
101371853|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371854|NCT00192712|Gemcitabine|gemcitabine|mesh-list
101371855|NCT00192712|Irinotecan|irinotecan|mesh-list
101371856|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371857|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
101371858|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371859|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371860|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101371861|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371862|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101371863|NCT00047658|Interferons|interferons|mesh-list
101371864|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
101371865|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371866|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
101541818|NCT01641783|Paclitaxel|paclitaxel|mesh-list
101371867|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101371868|NCT00193024|Docetaxel|docetaxel|mesh-list
101371899|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371900|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371901|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371902|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371903|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371904|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
101371905|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101371906|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101371907|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
101371908|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101371909|NCT00193297|Paclitaxel|paclitaxel|mesh-list
101371910|NCT00193297|Carboplatin|carboplatin|mesh-list
101371911|NCT00193297|Topotecan|topotecan|mesh-list
101371912|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101371913|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101371914|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
101371915|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
101371916|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
101371917|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101371918|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101371919|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101371921|NCT00193336|Gefitinib|gefitinib|mesh-list
101371953|NCT00409591|Ritonavir|ritonavir|mesh-list
101371954|NCT00409591|Lopinavir|lopinavir|mesh-list
101371955|NCT00409591|Zidovudine|zidovudine|mesh-list
101371956|NCT00409591|Nevirapine|nevirapine|mesh-list
101371957|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101371958|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101371959|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101371960|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372024|NCT00193921|Vinorelbine|vinorelbine|mesh-list
101372025|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372026|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101372027|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
101372028|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372029|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101372030|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
101372031|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
101372090|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101372091|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372092|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372098|NCT00194740|Docetaxel|docetaxel|mesh-list
101372161|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372163|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101372164|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372165|NCT00195286|Tazobactam|tazobactam|mesh-list
101372230|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101372232|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
101372234|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101372301|NCT00195871|Hormones|hormones|mesh-ancestor
101372302|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372303|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541988|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
101372304|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101372305|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
101372306|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101372308|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
101372369|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372370|NCT00196378|Estrogens|estrogens|mesh-list
101372371|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101372372|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
101372373|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
101372374|NCT00196378|Hormones|hormones|mesh-ancestor
101372377|NCT00196417|Heparin|heparin|mesh-list
101372439|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372440|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372441|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
101372442|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
101372443|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372509|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101372510|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101372511|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372512|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372513|NCT00197197|Aplaviroc|aplaviroc|mesh-list
101372514|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101372515|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101372575|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372576|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
101372577|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101372578|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101372579|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101372580|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101372581|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101372582|NCT00197743|Vitamin A|vitamin a|mesh-list
101372583|NCT00197743|Beta Carotene|beta carotene|mesh-list
101372584|NCT00197743|Carotenoids|carotenoids|mesh-list
101372585|NCT00197743|Vitamins|vitamins|mesh-ancestor
101372586|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
101372587|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372588|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
101372590|NCT00197743|Protective Agents|protective agents|mesh-ancestor
101372633|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372634|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372635|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
101372636|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372703|NCT00084708|Hormones|hormones|mesh-ancestor
101372704|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101372705|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101372706|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372707|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101372708|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372709|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372710|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101372711|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101372712|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101372764|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372766|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
101372767|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101372768|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101372769|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101372770|NCT00198523|Protective Agents|protective agents|mesh-ancestor
101372771|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101372773|NCT00198562|Losartan|losartan|mesh-list
101372830|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372831|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101372832|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372834|NCT00199147|Cytarabine|cytarabine|mesh-list
101372904|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101372905|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372906|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101372907|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
101372908|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
101372909|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372974|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372975|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372976|NCT00199966|Valproic Acid|valproic acid|mesh-list
101372977|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
101372978|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542204|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372979|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101372980|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
101372981|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101372982|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101372983|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
101372984|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101372985|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101372986|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101372987|NCT00085020|Trastuzumab|trastuzumab|mesh-list
101373035|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373037|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373038|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
101373039|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101373040|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101373046|NCT02962804|Nivolumab|nivolumab|mesh-list
101373105|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373106|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
101373107|NCT00200629|Adenosine|adenosine|mesh-list
101373108|NCT00200629|Analgesics|analgesics|mesh-ancestor
101373109|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
101373110|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373113|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
101373172|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373173|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373245|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
101373246|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
101373247|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373248|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373249|NCT00221650|Ribavirin|ribavirin|mesh-list
101373250|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101373251|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
101373252|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373253|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
101373254|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373255|NCT00221689|Baclofen|baclofen|mesh-list
101373256|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101373257|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373258|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101373259|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373260|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101373261|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
101373262|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
101373263|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373278|NCT00048828|Olanzapine|olanzapine|mesh-list
101373301|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101373302|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101373372|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
101373373|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373374|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373375|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101373376|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101373377|NCT00222469|Growth Substances|growth substances|mesh-ancestor
101373378|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373379|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
101373380|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101373381|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
101373382|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373431|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373432|NCT00222976|Naproxen|naproxen|mesh-list
101373433|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101373434|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101373435|NCT00222976|Analgesics|analgesics|mesh-ancestor
101373436|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
101373437|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373438|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373439|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101373440|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373441|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
101373442|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101373443|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101373444|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373445|NCT00223015|Tacrolimus|tacrolimus|mesh-list
101373446|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101373447|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
101373448|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373449|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101373488|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373489|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373490|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373491|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101373557|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101373558|NCT00223717|Clonidine|clonidine|mesh-list
101373559|NCT00223717|Eplerenone|eplerenone|mesh-list
101373560|NCT00223717|Nebivolol|nebivolol|mesh-list
101373561|NCT00223717|Bosentan|bosentan|mesh-list
101373562|NCT00223717|Diltiazem|diltiazem|mesh-list
101373563|NCT00223717|Guanfacine|guanfacine|mesh-list
101373564|NCT00223717|Prazosin|prazosin|mesh-list
101373565|NCT00223717|Hydralazine|hydralazine|mesh-list
101373566|NCT00223717|Captopril|captopril|mesh-list
101373567|NCT00223717|Nifedipine|nifedipine|mesh-list
101373568|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101373569|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
101373622|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101373623|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
101373624|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101373625|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101373626|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101373627|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101373628|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101373629|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
101373630|NCT00223717|Coagulants|coagulants|mesh-ancestor
101373631|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101373632|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101373633|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
101373634|NCT00061919|Thalidomide|thalidomide|mesh-list
101373635|NCT00061919|Carboplatin|carboplatin|mesh-list
101373636|NCT00061919|Etoposide|etoposide|mesh-list
101373637|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
101373638|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373654|NCT00085527|Romidepsin|romidepsin|mesh-list
101373679|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373681|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
101373682|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
101373683|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373684|NCT00062036|Aldesleukin|aldesleukin|mesh-list
101373685|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
101373746|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101373747|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101373748|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101373749|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101373750|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101373751|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101373752|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101373756|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101373757|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101373758|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
101373759|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373760|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101373761|NCT00095043|Gaboxadol|gaboxadol|mesh-list
101373762|NCT00095043|Analgesics|analgesics|mesh-ancestor
101373763|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
101373764|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101373765|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373766|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
101373767|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
101373768|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
101373769|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373770|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101373771|NCT00095082|Insulin|insulin|mesh-list
101373796|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101373797|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101373798|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101373799|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101373801|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101373864|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101373865|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373866|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101373867|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101373936|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
101373938|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101373939|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101373940|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101374006|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374007|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374008|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101374009|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
101374010|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374011|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374073|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374148|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101374149|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101374150|NCT00226096|Protective Agents|protective agents|mesh-ancestor
101374151|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
101374152|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101374218|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101374220|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374222|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
101374223|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
101374224|NCT00413452|Etanercept|etanercept|mesh-list
101374225|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101374226|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101374227|NCT00413452|Analgesics|analgesics|mesh-ancestor
101374228|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
101374229|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374230|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374231|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101374232|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374233|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101374234|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374235|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
101374236|NCT00095823|Aripiprazole|aripiprazole|mesh-list
101374237|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
101374238|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374239|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101374240|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374241|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374242|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374270|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374272|NCT00062699|Vitamins|vitamins|mesh-ancestor
101374273|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
101374274|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101374275|NCT00226798|Capecitabine|capecitabine|mesh-list
101374276|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374278|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374279|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374280|NCT00399243|Sumatriptan|sumatriptan|mesh-list
101374281|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101374282|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101374283|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101374284|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
101374328|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374329|NCT00095901|Capecitabine|capecitabine|mesh-list
101374330|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374331|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
101374332|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374333|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374334|NCT00227110|Pioglitazone|pioglitazone|mesh-list
101374335|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374395|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
101542718|NCT01684059|Astringents|astringents|mesh-ancestor
101374396|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374397|NCT00227695|Rituximab|rituximab|mesh-list
101374398|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101374399|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374400|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
101374401|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374402|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101374403|NCT00227734|Capecitabine|capecitabine|mesh-list
101374404|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
101374405|NCT00227734|Cetuximab|cetuximab|mesh-list
101374406|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101374407|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
101374408|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374409|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374410|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101374411|NCT00063011|Calcium|calcium|mesh-list
101374412|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101374452|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374453|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101374454|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101374455|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101374456|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374457|NCT02967302|Triamcinolone|triamcinolone|mesh-list
101374458|NCT02967302|Morphine|morphine|mesh-list
101374459|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101374460|NCT02967302|Narcotics|narcotics|mesh-ancestor
101374461|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374462|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374463|NCT02967302|Analgesics|analgesics|mesh-ancestor
101374464|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
101374465|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101374514|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101374515|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
101374516|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374518|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
101374519|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101374520|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101374521|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101374522|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
101374524|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
101374525|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101374526|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101374527|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
101542995|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101543004|NCT01199731|Etravirine|etravirine|mesh-list
101374528|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374529|NCT00228163|Teriflunomide|teriflunomide|mesh-list
101374530|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101374574|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374575|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
101374648|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374650|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
101374651|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
101374652|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101374653|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101374654|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374655|NCT00228982|Vancomycin|vancomycin|mesh-list
101374656|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
101374657|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101374658|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101374659|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374660|NCT00229060|Doripenem|doripenem|mesh-list
101374661|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101374662|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374663|NCT00229138|Tacrolimus|tacrolimus|mesh-list
101374664|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101374665|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
101374666|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374667|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101374668|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374670|NCT00063323|Bupropion|bupropion|mesh-list
101374703|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101374704|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543124|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
101374705|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374706|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
101374707|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374769|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101374770|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101374771|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101374843|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101374844|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101374845|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374846|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
101374847|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374870|NCT00230035|Hormones|hormones|mesh-ancestor
101374911|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374912|NCT00230542|Carboplatin|carboplatin|mesh-list
101374913|NCT00230542|Pemetrexed|pemetrexed|mesh-list
101374914|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101374915|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101374916|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101374917|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101374918|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101374919|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
101374920|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101374921|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101374924|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101374925|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
101374926|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101374970|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
101374971|NCT00075738|Vitamins|vitamins|mesh-ancestor
101374972|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
101374973|NCT00230698|Topiramate|topiramate|mesh-list
101374974|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
101375042|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375044|NCT00063596|Vitamins|vitamins|mesh-ancestor
101375045|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
101375046|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375114|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375116|NCT00063713|Bortezomib|bortezomib|mesh-list
101375117|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375118|NCT00232024|Tegaserod|tegaserod|mesh-list
101375119|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101375120|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
101375121|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375122|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375123|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375124|NCT00232063|Cyclosporine|cyclosporine|mesh-list
101375125|NCT00232063|Cyclosporins|cyclosporins|mesh-list
101375126|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375127|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375128|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375129|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
101375130|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375131|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
101375132|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375133|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101375134|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375135|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101375136|NCT00232102|Tegaserod|tegaserod|mesh-list
101375137|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101375138|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
101375139|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375141|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375163|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375164|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101375165|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375166|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375167|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375168|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375169|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375170|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375230|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375231|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375232|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375233|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375301|NCT02958566|Ketamine|ketamine|mesh-list
101375302|NCT02958566|Morphine|morphine|mesh-list
101375303|NCT02958566|Gabapentin|gabapentin|mesh-list
101375304|NCT02958566|Tramadol|tramadol|mesh-list
101375305|NCT02958566|Methadone|methadone|mesh-list
101375306|NCT02958566|Hydrocodone|hydrocodone|mesh-list
101375307|NCT02958566|Hydromorphone|hydromorphone|mesh-list
101375308|NCT02958566|Orphenadrine|orphenadrine|mesh-list
101375309|NCT02958566|Bupivacaine|bupivacaine|mesh-list
101375310|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
101375311|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
101375312|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375313|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375314|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
101375315|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375316|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101375317|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101375318|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101375319|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375320|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375321|NCT02958566|Analgesics|analgesics|mesh-ancestor
101375322|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101375323|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101375324|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
101375325|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101375326|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101543325|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
101375327|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375350|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
101375351|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101375352|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101375353|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
101375354|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
101375355|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101375357|NCT00097344|Letrozole|letrozole|mesh-list
101375358|NCT00097344|Hormones|hormones|mesh-list
101375359|NCT00097344|Atamestane|atamestane|mesh-list
101375360|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
101481801|NCT00301223|Pregabalin|pregabalin|mesh-list
101481802|NCT00301223|Analgesics|analgesics|mesh-ancestor
101481803|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
101481804|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481805|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481806|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
101481807|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101481808|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481809|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481810|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101481811|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101481812|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481813|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481814|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481815|NCT00301301|Rituximab|rituximab|mesh-list
101481816|NCT00301301|Gemcitabine|gemcitabine|mesh-list
101481817|NCT00301301|Cisplatin|cisplatin|mesh-list
101481818|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101481819|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481820|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
101481821|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481822|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481823|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481824|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
101481825|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481826|NCT00301535|Chrysarobin|chrysarobin|mesh-list
101481827|NCT00301535|HBOC 201|hboc 201|mesh-list
101481833|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481834|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481835|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481836|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
101481838|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101481839|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481840|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481841|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
101481842|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481843|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481844|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101481846|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481847|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
101481848|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101481849|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101481850|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481851|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481852|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481853|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481854|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481855|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481856|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
101481857|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481858|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481859|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101481860|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
101375361|NCT00097344|Estrogens|estrogens|mesh-list
101375362|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
101375363|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
101375364|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375365|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375366|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481861|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481862|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481863|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481864|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481865|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
101481866|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481867|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481868|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101481869|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
101481870|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481871|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481872|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481873|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481875|NCT00301730|Paclitaxel|paclitaxel|mesh-list
101481876|NCT00301730|Trastuzumab|trastuzumab|mesh-list
101481877|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101481878|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481879|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
101481880|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
101481881|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
101481882|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481883|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101481884|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101481885|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101481886|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
101481887|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481888|NCT00301847|Sorafenib|sorafenib|mesh-list
101481889|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481890|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101481891|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481892|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481893|NCT00327990|Alendronate|alendronate|mesh-list
101481894|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
101481895|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101481899|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101481900|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481901|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
101481902|NCT00301925|Fluorouracil|fluorouracil|mesh-list
101481903|NCT00301925|Capecitabine|capecitabine|mesh-list
101481904|NCT00301925|Methotrexate|methotrexate|mesh-list
101481905|NCT00301925|Epirubicin|epirubicin|mesh-list
101481906|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481907|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
101481908|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481909|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481910|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101481911|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
101481912|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481913|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481914|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101481915|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
101481916|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101481917|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101481918|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
101481919|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101481920|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
101481921|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481922|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101481923|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101543965|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
101481924|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375367|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101375368|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101375369|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481925|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101481926|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101481927|NCT00328029|Busulfan|busulfan|mesh-list
101481928|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
101481929|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481930|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481931|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
101481932|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481933|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101481934|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481935|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101481936|NCT00302354|Methylphenidate|methylphenidate|mesh-list
101481937|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101481938|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481939|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101481940|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481941|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481942|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481943|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
101481944|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481945|NCT00302393|Methylphenidate|methylphenidate|mesh-list
101481946|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101481947|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481948|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101481949|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481950|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481951|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481952|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
101481953|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481954|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
101481955|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
101481956|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
101481957|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481958|NCT00328107|Coagulants|coagulants|mesh-ancestor
101481959|NCT00302432|Menthol|menthol|mesh-list
101481960|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
101481961|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
101481962|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101481963|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101481964|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
101544162|NCT01646294|Mirabegron|mirabegron|mesh-list
101481965|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481966|NCT00302549|Tacrolimus|tacrolimus|mesh-list
101481970|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101481971|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481972|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481973|NCT00419991|Tigecycline|tigecycline|mesh-list
101481974|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101481975|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101481976|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101481977|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481978|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481979|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
101481980|NCT00302627|Vitamin D|vitamin d|mesh-list
101481981|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
101481982|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
101481983|NCT00302627|Pamidronate|pamidronate|mesh-list
101481984|NCT00302627|Vitamins|vitamins|mesh-list
101481985|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
101481986|NCT00302627|Calcium|calcium|mesh-list
101481987|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
101481988|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481989|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101481990|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101481992|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481993|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101481994|NCT00302666|Dienogest|dienogest|mesh-list
101481995|NCT00302666|Nandrolone|nandrolone|mesh-list
101375370|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375372|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101375373|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101375374|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101375375|NCT00232882|Atenolol|atenolol|mesh-list
101375376|NCT00232882|Candesartan|candesartan|mesh-list
101375377|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
101375378|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101375379|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101375380|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101375381|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101375382|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375383|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101375384|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
101481996|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101481997|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
101481998|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101481999|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482000|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101482001|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101482002|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101482003|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101482004|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482005|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482006|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101482007|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482008|NCT00302666|Androgens|androgens|mesh-ancestor
101482009|NCT00302666|Hormones|hormones|mesh-ancestor
101482010|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
101482011|NCT00328302|Candesartan|candesartan|mesh-list
101482012|NCT00328302|Candesartan cilexetil|candesartan cilexetil|mesh-list
101482013|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482014|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101482015|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101482016|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482017|NCT00328380|Rifaximin|rifaximin|mesh-list
101482018|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482019|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482020|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482021|NCT00418496|Aldesleukin|aldesleukin|mesh-list
101482022|NCT00418496|Sorafenib|sorafenib|mesh-list
101482023|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482024|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101482025|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482026|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482027|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101482028|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101482029|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
101482030|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482031|NCT00302705|Valsartan|valsartan|mesh-list
101482032|NCT00302705|Enalapril|enalapril|mesh-list
101482033|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482034|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101482035|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101482036|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375385|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
101375386|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375387|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375388|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101375389|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101375390|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101375391|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
101375392|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375393|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375394|NCT00232882|Diuretics|diuretics|mesh-ancestor
101375395|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
101375396|NCT00064064|Gemcitabine|gemcitabine|mesh-list
101375397|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101375398|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
101375399|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375400|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375401|NCT00413686|Gemcitabine|gemcitabine|mesh-list
101375402|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101375403|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
101375404|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375405|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375406|NCT00233038|Ethanol|ethanol|mesh-list
101544375|NCT01605084|Darunavir|darunavir|mesh-list
101375407|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101375408|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375409|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375410|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375411|NCT00097383|Epirubicin|epirubicin|mesh-list
101375412|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375413|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375414|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101375429|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375430|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101375431|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375432|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375433|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482037|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101544394|NCT01648010|Mitomycins|mitomycins|mesh-list
101482038|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482044|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
101482045|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
101482046|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482047|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101482048|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101482049|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482050|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482051|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101482052|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101482053|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101482054|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101482055|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101482056|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101482057|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101482058|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101482059|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101482060|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101482061|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482062|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101482063|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101482064|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101482065|NCT00328458|Epothilones|epothilones|mesh-list
101482066|NCT00328458|Epothilone B|epothilone b|mesh-list
101482067|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
101482068|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
101482069|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
101482070|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482071|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482072|NCT00303017|Naproxen|naproxen|mesh-list
101482073|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482074|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482075|NCT00303017|Analgesics|analgesics|mesh-ancestor
101482076|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
101482077|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482078|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482079|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482080|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482081|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
101482082|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101482083|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482084|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482085|NCT00303056|Icatibant|icatibant|mesh-list
101482086|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482087|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482088|NCT00303056|Analgesics|analgesics|mesh-ancestor
101482089|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
101482090|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482091|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482092|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482093|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482094|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101544618|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101482095|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101482096|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482097|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101482098|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482099|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
101482100|NCT00328497|Bevacizumab|bevacizumab|mesh-list
101482101|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101375434|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101375435|NCT00064142|Growth Substances|growth substances|mesh-ancestor
101375436|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375437|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
101375438|NCT00064181|Leucovorin|leucovorin|mesh-list
101375439|NCT00064181|Celecoxib|celecoxib|mesh-list
101375440|NCT00064181|Fluorouracil|fluorouracil|mesh-list
101375441|NCT00064181|Capecitabine|capecitabine|mesh-list
101375442|NCT00064181|Irinotecan|irinotecan|mesh-list
101375443|NCT00064181|Calcium|calcium|mesh-list
101375444|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
101482102|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101482103|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482104|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482105|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101482106|NCT00328497|Growth Substances|growth substances|mesh-ancestor
101482107|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482108|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
101482109|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
101482147|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482148|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482150|NCT00419796|Analgesics|analgesics|mesh-ancestor
101482151|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
101482152|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482153|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482154|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482155|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482156|NCT00419835|Losartan|losartan|mesh-list
101482157|NCT00419835|Enalapril|enalapril|mesh-list
101482158|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101482159|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482160|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101482161|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101482162|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482163|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101482164|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482165|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482166|NCT00328809|Spironolactone|spironolactone|mesh-list
101544789|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
101482167|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101482168|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482169|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482170|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482171|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101482172|NCT00328809|Diuretics|diuretics|mesh-ancestor
101482173|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
101482175|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
101482176|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101482177|NCT00303758|Leucovorin|leucovorin|mesh-list
101482178|NCT00303758|Gemcitabine|gemcitabine|mesh-list
101482179|NCT00303758|Fluorouracil|fluorouracil|mesh-list
101482180|NCT00303758|Calcium|calcium|mesh-list
101482181|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
101544844|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
101482182|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482183|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482184|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
101482185|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482186|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101482187|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482188|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482189|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
101482190|NCT00303758|Antidotes|antidotes|mesh-ancestor
101482191|NCT00303758|Protective Agents|protective agents|mesh-ancestor
101482192|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
101482194|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
101482195|NCT00303797|Bortezomib|bortezomib|mesh-list
101482196|NCT00303797|Sorafenib|sorafenib|mesh-list
101375445|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101375446|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375447|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
101375448|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375449|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101375450|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375451|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482197|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482198|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101482199|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482200|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482201|NCT00303836|Aldesleukin|aldesleukin|mesh-list
101482202|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
101482203|NCT00303836|Fludarabine|fludarabine|mesh-list
101482204|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
101482205|NCT00303836|Interleukin-2|interleukin-2|mesh-list
101482206|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
101482207|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482208|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
101482209|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482210|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482211|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101482212|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
101482213|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482214|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482215|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101482216|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482217|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
101482221|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
101482222|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482223|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101482224|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101482225|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
101482226|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482227|NCT00303992|Trastuzumab|trastuzumab|mesh-list
101482228|NCT00303992|Irinotecan|irinotecan|mesh-list
101482230|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482231|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101482232|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101482233|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482234|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482235|NCT00304226|Amlodipine|amlodipine|mesh-list
101482236|NCT00304226|Valsartan|valsartan|mesh-list
101482237|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482238|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101482239|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482240|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482241|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101482242|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482243|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
101482244|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101482245|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101482246|NCT00332319|Casopitant|casopitant|mesh-list
101482247|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
101482248|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
101482249|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482250|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482251|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482252|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101482253|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482254|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482255|NCT00304382|Vaccines|vaccines|mesh-list
101482256|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101482257|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
101375452|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
101375453|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101375454|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101375455|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375457|NCT00064181|Protective Agents|protective agents|mesh-ancestor
101482258|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482259|NCT00304421|Rabeprazole|rabeprazole|mesh-list
101482260|NCT00304421|Pantoprazole|pantoprazole|mesh-list
101482261|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101482262|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482263|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101482264|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482265|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482266|NCT00332397|Sirolimus|sirolimus|mesh-list
101482267|NCT00332397|Temsirolimus|temsirolimus|mesh-list
101482268|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
101482269|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482270|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482271|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101482272|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482273|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
101482274|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482275|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
101482276|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482277|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101482278|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482279|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482281|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482282|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101482283|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101482284|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
101482285|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482286|NCT00304499|Oxybutynin|oxybutynin|mesh-list
101482287|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
101482288|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
101482289|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482314|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482316|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482317|NCT00304616|Olanzapine|olanzapine|mesh-list
101482318|NCT00304616|Risperidone|risperidone|mesh-list
101482319|NCT00304616|Aripiprazole|aripiprazole|mesh-list
101482320|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101482321|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101482322|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
101482323|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482324|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482325|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482326|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101482327|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101482328|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482329|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101482330|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101482331|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
101482332|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
101482333|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
101482334|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482335|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482336|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101482338|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482340|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
101482341|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101482342|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101482343|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101482344|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101482345|NCT00332436|Timolol|timolol|mesh-list
101482346|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101375458|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
101375459|NCT00064181|Vitamins|vitamins|mesh-ancestor
101375460|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
101482347|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101482348|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101482349|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
101482350|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482351|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482352|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482353|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101482354|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482355|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101482356|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101482357|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101482358|NCT00304655|Aripiprazole|aripiprazole|mesh-list
101482359|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
101482361|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101482362|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101482363|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482364|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482365|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
101482367|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482368|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482369|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101482370|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101482371|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
101482372|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101482373|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101482374|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101482375|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101482376|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101482377|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101482378|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101482379|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101482380|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
101482381|NCT00332553|Estradiol|estradiol|mesh-list
101482382|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101482383|NCT00332553|Estrogens|estrogens|mesh-list
101482384|NCT00332553|Hormones|hormones|mesh-ancestor
101482385|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482386|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482387|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101482388|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
101482389|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101482390|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101482391|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101482392|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101482393|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101482394|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101482395|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101482396|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482397|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101482398|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482399|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101482400|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101482401|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101482402|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
101545059|NCT02271165|Antibodies|antibodies|mesh-list
101482403|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101482404|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
101482405|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482406|NCT00332631|Expectorants|expectorants|mesh-ancestor
101482407|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
101482410|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482411|NCT00332631|Protective Agents|protective agents|mesh-ancestor
101482412|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482413|NCT00332631|Antidotes|antidotes|mesh-ancestor
101482414|NCT00304772|Fluconazole|fluconazole|mesh-list
101482415|NCT00304772|Micafungin|micafungin|mesh-list
101375461|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101375462|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101375463|NCT00064181|Analgesics|analgesics|mesh-ancestor
101375464|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
101375465|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375466|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375467|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482416|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
101482417|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482418|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101482419|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101482420|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482422|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101482424|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482425|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482426|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101482427|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101482428|NCT00304811|Vancomycin|vancomycin|mesh-list
101482429|NCT00304811|Rifampin|rifampin|mesh-list
101482430|NCT00304811|Gentamicins|gentamicins|mesh-list
101482431|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482432|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482433|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101482434|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
101482435|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
101482436|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101482437|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482438|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482439|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101482440|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101482441|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101482442|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101482443|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101482444|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101482445|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101482446|NCT00332787|Fluoxetine|fluoxetine|mesh-list
101482447|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101482448|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101482449|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482450|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482451|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482452|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
101482453|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482454|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101482455|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
101482456|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101482457|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101482458|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101482459|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482460|NCT00304850|Ketamine|ketamine|mesh-list
101482461|NCT00304850|Analgesics|analgesics|mesh-ancestor
101482462|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
101482463|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482464|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482465|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101482466|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101482467|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
101482468|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
101482469|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482470|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101482471|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101482472|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375468|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101375469|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101375470|NCT00233545|Miltefosine|miltefosine|mesh-list
101375471|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
101375472|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375473|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375474|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375475|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101482473|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482475|NCT00329316|Progestins|progestins|mesh-ancestor
101482476|NCT00329316|Hormones|hormones|mesh-ancestor
101482481|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482482|NCT00305201|Pravastatin|pravastatin|mesh-list
101482483|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101482484|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101482485|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
101482486|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482487|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101482488|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101482489|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482490|NCT00329355|Naproxen|naproxen|mesh-list
101482491|NCT00329355|Sumatriptan|sumatriptan|mesh-list
101482492|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482493|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482494|NCT00329355|Analgesics|analgesics|mesh-ancestor
101482495|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
101482496|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482497|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482498|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482499|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482500|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
101482501|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101482502|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528428|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
101482503|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482504|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101482505|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101482506|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101482507|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
101482508|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482509|NCT00332904|Propranolol|propranolol|mesh-list
101482511|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101482512|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101482513|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101482514|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482515|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482516|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482517|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101482518|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482519|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
101482520|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101482521|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482522|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482523|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101482524|NCT00332904|Diuretics|diuretics|mesh-ancestor
101482525|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
101482526|NCT00329394|Ketamine|ketamine|mesh-list
101482527|NCT00329394|Analgesics|analgesics|mesh-ancestor
101482528|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
101482529|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482530|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482531|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101482532|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101482533|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
101375476|NCT00233584|Budesonide|budesonide|mesh-list
101375477|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375478|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101375479|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
101375480|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375481|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375482|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101482534|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
101482535|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482536|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101482537|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101482538|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482539|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482540|NCT00305396|Sirolimus|sirolimus|mesh-list
101482541|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482542|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482543|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101482544|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482550|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482551|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482552|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
101482553|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482554|NCT00305474|Risperidone|risperidone|mesh-list
101482555|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101482556|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
101482557|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482558|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482559|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482560|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101482561|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101482562|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482563|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101482564|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101482565|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
101482566|NCT00329511|Clonidine|clonidine|mesh-list
101482567|NCT00329511|Methyldopa|methyldopa|mesh-list
101482568|NCT00329511|Analgesics|analgesics|mesh-ancestor
101482569|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
101482570|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482571|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482572|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482573|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
101482574|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
101482575|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101482576|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101482577|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101482578|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101482579|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482580|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482581|NCT00305513|Caffeine|caffeine|mesh-list
101482582|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101482583|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482584|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101482585|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482586|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482587|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101482588|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101482589|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
101482590|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482591|NCT00333021|PENTA|penta|mesh-list
101482592|NCT00333021|Fondaparinux|fondaparinux|mesh-list
101482593|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101482594|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
101482595|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101482596|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482597|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482599|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
101375483|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
101375484|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
101375486|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375487|NCT00233623|Leucovorin|leucovorin|mesh-list
101375488|NCT00233623|Fluorouracil|fluorouracil|mesh-list
101375489|NCT00233623|Irinotecan|irinotecan|mesh-list
101375490|NCT00233623|Gefitinib|gefitinib|mesh-list
101375491|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
101375492|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482600|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101482601|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482602|NCT00305552|Thalidomide|thalidomide|mesh-list
101482603|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482604|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
101482605|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482606|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
101482607|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482608|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482609|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482610|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101482611|NCT00305552|Growth Substances|growth substances|mesh-ancestor
101482612|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
101482613|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482614|NCT00329589|Bortezomib|bortezomib|mesh-list
101482615|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482620|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482622|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101482623|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101482624|NCT00305630|Triamcinolone|triamcinolone|mesh-list
101482625|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101482626|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101482627|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101482628|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482629|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
101482630|NCT00305630|Hormones|hormones|mesh-ancestor
101482631|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482632|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482633|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482634|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
101482635|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482636|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482638|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
101482639|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101482640|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
101482641|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101482642|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482643|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482644|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482645|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
101482647|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482648|NCT00305669|Sargramostim|sargramostim|mesh-list
101482649|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
101482650|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482651|NCT00305708|Fludarabine|fludarabine|mesh-list
101482652|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
101482653|NCT00305708|Busulfan|busulfan|mesh-list
101482654|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101482655|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482656|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482657|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
101482658|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482659|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482660|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
101482661|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482662|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
101375493|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101375494|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375495|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375496|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
101375497|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375498|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101375499|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101375500|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375501|NCT00233623|Antidotes|antidotes|mesh-ancestor
101375502|NCT00233623|Protective Agents|protective agents|mesh-ancestor
101482664|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101482665|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101482666|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101482667|NCT00305747|Protective Agents|protective agents|mesh-ancestor
101482668|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482669|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482670|NCT00333255|Nepafenac|nepafenac|mesh-list
101482671|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482672|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482673|NCT00333255|Analgesics|analgesics|mesh-ancestor
101482674|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
101482675|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482676|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482677|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482678|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482679|NCT00305786|Gemcitabine|gemcitabine|mesh-list
101482680|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
101482681|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482682|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
101482683|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482684|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482689|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482690|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101482691|NCT00305825|Growth Substances|growth substances|mesh-ancestor
101482692|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482693|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
101482694|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101482695|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101482696|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482697|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482698|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101482699|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482700|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482701|NCT00333294|Vinorelbine|vinorelbine|mesh-list
101482702|NCT00333294|Gefitinib|gefitinib|mesh-list
101482703|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482704|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101482705|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
101482706|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
101482707|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
101482708|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482709|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101482710|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482711|NCT00305903|Memantine|memantine|mesh-list
101482712|NCT00305903|Rivastigmine|rivastigmine|mesh-list
101482713|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101482714|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101482715|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
101482716|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482717|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482718|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482719|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101482720|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101375503|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
101375504|NCT00233623|Vitamins|vitamins|mesh-ancestor
101375505|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
101375506|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375507|NCT00064220|Soblidotin|soblidotin|mesh-list
101375508|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375509|NCT00233779|Sirolimus|sirolimus|mesh-list
101375510|NCT00233779|Heparin|heparin|mesh-list
101482721|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101482722|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482723|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
101482724|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101482725|NCT00305903|Protective Agents|protective agents|mesh-ancestor
101482726|NCT00329823|Etanercept|etanercept|mesh-list
101482727|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482728|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482730|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
101482731|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482732|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482733|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482734|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482735|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482736|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482737|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
101482738|NCT00306020|Morphine|morphine|mesh-list
101482739|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101482740|NCT00306020|Narcotics|narcotics|mesh-ancestor
101482741|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482742|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482743|NCT00306020|Analgesics|analgesics|mesh-ancestor
101482744|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
101482745|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482746|NCT00306137|Aprotinin|aprotinin|mesh-list
101482747|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
101482748|NCT00306137|Coagulants|coagulants|mesh-ancestor
101482749|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101482750|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101482751|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
101482752|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482753|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482754|NCT00329940|Letrozole|letrozole|mesh-list
101482755|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482756|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101482768|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101482770|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482771|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
101482772|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482773|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482774|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482775|NCT00330018|Valganciclovir|valganciclovir|mesh-list
101482776|NCT00330018|Acyclovir|acyclovir|mesh-list
101482777|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
101482778|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482779|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101482780|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
101482781|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482782|NCT00306254|Enoxaparin|enoxaparin|mesh-list
101482783|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
101482784|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
101482785|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101482786|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482787|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482788|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101482789|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
101482790|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101482792|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482793|NCT00333489|Valsartan|valsartan|mesh-list
101482794|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101375511|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375512|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375513|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375514|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482795|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101482796|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101482797|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482798|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
101482799|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101482800|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
101482801|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482802|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
101482803|NCT00330135|Protective Agents|protective agents|mesh-ancestor
101482804|NCT03275558|Sunitinib|sunitinib|mesh-list
101482805|NCT03275558|Axitinib|axitinib|mesh-list
101482806|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482807|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482808|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101482809|NCT03275558|Growth Substances|growth substances|mesh-ancestor
101482810|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482811|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101482812|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101482813|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482814|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482815|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101482816|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101482817|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482822|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482823|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482824|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482825|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482826|NCT00333567|Analgesics|analgesics|mesh-ancestor
101482827|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
101482828|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482829|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482830|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482831|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482832|NCT00330252|Rituximab|rituximab|mesh-list
101482833|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
101482834|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101482835|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482836|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
101482837|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482838|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482839|NCT00333645|Caspofungin|caspofungin|mesh-list
101482840|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
101482841|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482842|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482843|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482844|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
101482845|NCT00451100|Neostigmine|neostigmine|mesh-list
101482846|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101482847|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482848|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482849|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
101482850|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482851|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482852|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101482853|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
101482854|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482855|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101482856|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101482857|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101482858|NCT00420537|Cyclosporine|cyclosporine|mesh-list
101482859|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
101482860|NCT00420537|Everolimus|everolimus|mesh-list
101482861|NCT00420537|Cyclosporins|cyclosporins|mesh-list
101482862|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482863|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375515|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
101375516|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375517|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
101375518|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375519|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375520|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
101375521|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101375522|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482864|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482865|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
101482866|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482867|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
101482868|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482869|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
101482870|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482871|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101482872|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101482873|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545106|NCT02271399|Analgesics|analgesics|mesh-ancestor
101482874|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482875|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101482876|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101482877|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
101482878|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482879|NCT00451139|Lumefantrine|lumefantrine|mesh-list
101482881|NCT00451139|Quinine|quinine|mesh-list
101482882|NCT00451139|Atovaquone|atovaquone|mesh-list
101482883|NCT00451139|Proguanil|proguanil|mesh-list
101482884|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101482885|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101482886|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
101482887|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101482888|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101482889|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482894|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482895|NCT00451139|Analgesics|analgesics|mesh-ancestor
101482896|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
101482897|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482898|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482899|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
101482900|NCT00330486|Acamprosate|acamprosate|mesh-list
101482901|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101482902|NCT00451373|Vancomycin|vancomycin|mesh-list
101482903|NCT00451373|Daptomycin|daptomycin|mesh-list
101482904|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101482905|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482906|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
101482907|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101482908|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482909|NCT00451412|Heparin|heparin|mesh-list
101482910|NCT00451412|Calcium heparin|calcium heparin|mesh-list
101482911|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101482912|NCT00451412|Tinzaparin|tinzaparin|mesh-list
101482913|NCT00451412|Dalteparin|dalteparin|mesh-list
101482914|NCT00451412|Certoparin|certoparin|mesh-list
101482915|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
101482916|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101482917|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482918|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482919|NCT00451490|Agomelatine|agomelatine|mesh-list
101482920|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101482921|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482922|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482923|NCT00330525|Sibutramine|sibutramine|mesh-list
101482924|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
101482925|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101482926|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
101482927|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101375524|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375525|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375526|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375527|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375528|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
101482929|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101482930|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101482931|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482932|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482933|NCT00333918|Analgesics|analgesics|mesh-ancestor
101482934|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
101482935|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482936|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482937|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482938|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482939|NCT00451568|Metformin|metformin|mesh-list
101482940|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101482941|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482942|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101482943|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101482944|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101482945|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101482946|NCT00451724|Ketamine|ketamine|mesh-list
101482947|NCT00451724|Analgesics|analgesics|mesh-ancestor
101482948|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
101482949|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482950|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482951|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101482952|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101482953|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
101482954|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
101482955|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101482956|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101482957|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101482958|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482959|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482960|NCT00451763|Bevacizumab|bevacizumab|mesh-list
101482961|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101482967|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101482969|NCT00330798|Nepafenac|nepafenac|mesh-list
101482970|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101482971|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482972|NCT00330798|Analgesics|analgesics|mesh-ancestor
101482973|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
101482974|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482975|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482976|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101482977|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101482978|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101482979|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482980|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482981|NCT00451880|Famotidine|famotidine|mesh-list
101482982|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101482983|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482984|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101482985|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
101482986|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
101482987|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482988|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482989|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482990|NCT00451997|Cytarabine|cytarabine|mesh-list
101482991|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
101482992|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482993|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
101482994|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482995|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375530|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
101375531|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375532|NCT00076206|Temsirolimus|temsirolimus|mesh-list
101375533|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101375534|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375535|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545123|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
101375536|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375537|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375538|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
101375539|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375540|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375541|NCT00233896|Beclomethasone|beclomethasone|mesh-list
101375542|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375543|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
101375544|NCT00233896|Hormones|hormones|mesh-ancestor
101482996|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
101482997|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482998|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482999|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
101483000|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483001|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101483002|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483003|NCT00330993|Misoprostol|misoprostol|mesh-list
101483004|NCT00330993|Mifepristone|mifepristone|mesh-list
101483005|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101483006|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
101483007|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101483008|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483009|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101483010|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483011|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
101483012|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101483013|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101483014|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101483015|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101483016|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
101483017|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101483018|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101483019|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
101483020|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483021|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
101483022|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101483023|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101483024|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101483025|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483026|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101483027|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483028|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483029|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
101483036|NCT00333996|Dexamethasone|dexamethasone|mesh-list
101483037|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483038|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
101483039|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
101483040|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483041|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483042|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375545|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375546|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375548|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
101375549|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101375550|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
101375551|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375552|NCT00233935|Protective Agents|protective agents|mesh-ancestor
101375553|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375554|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101483043|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
101483044|NCT00333996|Hormones|hormones|mesh-ancestor
101483045|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483046|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483047|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483048|NCT00452192|Telmisartan|telmisartan|mesh-list
101483049|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483050|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101483051|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101483052|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483053|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101483054|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
101483055|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483056|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101483057|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101483058|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483059|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483060|NCT00334152|Casopitant|casopitant|mesh-list
101483061|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
101483062|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
101483063|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483064|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483065|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483066|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101483067|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483068|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483069|NCT04698512|Sirolimus|sirolimus|mesh-list
101483070|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101483071|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483072|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101483073|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483074|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
101483075|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483076|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
101483077|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483078|NCT00334308|Caseins|caseins|mesh-list
101483079|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
101483080|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
101483081|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483082|NCT00334347|Valproic Acid|valproic acid|mesh-list
101483083|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
101483084|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483085|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483086|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
101483087|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483088|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483089|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
101483090|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101483091|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483092|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483093|NCT00334386|Torsemide|torsemide|mesh-list
101483094|NCT00334386|Diuretics|diuretics|mesh-list
101375557|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101375559|NCT00234091|Lopinavir|lopinavir|mesh-list
101375560|NCT00234091|Nelfinavir|nelfinavir|mesh-list
101375561|NCT00234091|Lamivudine|lamivudine|mesh-list
101375562|NCT00234091|Zidovudine|zidovudine|mesh-list
101375563|NCT00234091|Nevirapine|nevirapine|mesh-list
101375564|NCT00234091|Abacavir|abacavir|mesh-list
101375565|NCT00234091|Efavirenz|efavirenz|mesh-list
101483095|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101483096|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
101483097|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483106|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101483107|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
101483108|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483109|NCT00334425|Menotropins|menotropins|mesh-list
101483110|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101483111|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
101483112|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545148|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101483113|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483114|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
101483115|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101483116|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483117|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483118|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101483119|NCT03275207|Analgesics|analgesics|mesh-ancestor
101483120|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
101483121|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483122|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101483123|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101483124|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101483125|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483126|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483127|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483129|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
101483130|NCT03275012|Morphine|morphine|mesh-list
101483131|NCT03275012|Gabapentin|gabapentin|mesh-list
101483132|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101483133|NCT03275012|Narcotics|narcotics|mesh-ancestor
101483134|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483135|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483136|NCT03275012|Analgesics|analgesics|mesh-ancestor
101483137|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
101483138|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483139|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
101483140|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101483141|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101483142|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483143|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101483144|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101483145|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483146|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483147|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
101483148|NCT00334503|Miglitol|miglitol|mesh-list
101483149|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483150|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483151|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101483152|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483153|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101483154|NCT00334581|Irbesartan|irbesartan|mesh-list
101483155|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483156|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101483157|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101375566|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101375567|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101375569|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375570|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375571|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483158|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483159|NCT00452270|Xylometazoline|xylometazoline|mesh-list
101483160|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
101483161|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101483167|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483168|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483169|NCT00452582|Urological Agents|urological agents|mesh-ancestor
101483170|NCT00334698|Cetirizine|cetirizine|mesh-list
101483171|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
101483172|NCT00334698|Ephedrine|ephedrine|mesh-list
101483173|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101483174|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101545160|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483175|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101483176|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
101483178|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483179|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483180|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483181|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101483182|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
101483183|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483184|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101483185|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
101483186|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
101483187|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101483188|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101483190|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483192|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101483193|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
101483194|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
101483195|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483196|NCT00334854|Doxorubicin|doxorubicin|mesh-list
101483197|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101483198|NCT00334854|Ifosfamide|ifosfamide|mesh-list
101483199|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101483200|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483201|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101483202|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101483203|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483204|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483205|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101483206|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
101483207|NCT00334932|Doxorubicin|doxorubicin|mesh-list
101483208|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101483209|NCT00334932|Bortezomib|bortezomib|mesh-list
101483210|NCT00334932|Melphalan|melphalan|mesh-list
101483211|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101483212|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483213|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101483214|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101483215|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483216|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483217|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101483218|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
101483219|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101483220|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483221|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
101483222|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483223|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
101483224|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
101483225|NCT00452855|Remifentanil|remifentanil|mesh-list
101483226|NCT00452855|Sevoflurane|sevoflurane|mesh-list
101375572|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101375573|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
101375574|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375575|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101375576|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101375577|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101375578|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375579|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
101483227|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
101483228|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483229|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483230|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101483231|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101483232|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
101483236|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
101483237|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483238|NCT00335088|Iodine|iodine|mesh-list
101483239|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
101483240|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
101483241|NCT00335088|Povidone|povidone|mesh-list
101483242|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101483243|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483244|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101483245|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101483246|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483247|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483248|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483249|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483250|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101483251|NCT00335088|Trace Elements|trace elements|mesh-ancestor
101483252|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
101483253|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
101483254|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
101483255|NCT00452894|Varenicline|varenicline|mesh-list
101483256|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101483257|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101483258|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
101483259|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483260|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483261|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483262|NCT00335166|Pramipexole|pramipexole|mesh-list
101483263|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
101483264|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483265|NCT00335166|Protective Agents|protective agents|mesh-ancestor
101483266|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483267|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101483268|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101483269|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
101483270|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
101483271|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483272|NCT00452972|Anesthetics|anesthetics|mesh-list
101483273|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483274|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483276|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101483277|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101483278|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
101483279|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
101483280|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483281|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483282|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483283|NCT00453050|Imiquimod|imiquimod|mesh-list
101483284|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101483285|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
101483286|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483287|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483288|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
101375580|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101375581|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101375582|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101375583|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101375584|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101375586|NCT04721704|Metronidazole|metronidazole|mesh-list
101375587|NCT04721704|Clarithromycin|clarithromycin|mesh-list
101375588|NCT04721704|Omeprazole|omeprazole|mesh-list
101483289|NCT00335400|Anesthetics|anesthetics|mesh-list
101483290|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415473|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101483291|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483292|NCT00420615|Epothilone B|epothilone b|mesh-list
101483293|NCT00420615|Epothilones|epothilones|mesh-list
101483294|NCT00420615|Omeprazole|omeprazole|mesh-list
101483295|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101483296|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483297|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101483298|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483299|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483300|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483301|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101483302|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101483303|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
101483304|NCT00453167|Paclitaxel|paclitaxel|mesh-list
101483305|NCT00453167|Gemcitabine|gemcitabine|mesh-list
101483306|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101483307|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483311|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483312|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483314|NCT00420654|Hormones|hormones|mesh-list
101483315|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483316|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483317|NCT00420693|Sevoflurane|sevoflurane|mesh-list
101483318|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101483319|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101483320|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
101483321|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
101483322|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483323|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483324|NCT00453323|Paclitaxel|paclitaxel|mesh-list
101483325|NCT00453323|Capecitabine|capecitabine|mesh-list
101483326|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101483327|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483328|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101483329|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101483330|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101483331|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483332|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483333|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
101483334|NCT00335439|Ketorolac|ketorolac|mesh-list
101483335|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101483336|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101483337|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101483338|NCT00335439|Analgesics|analgesics|mesh-ancestor
101483339|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
101483340|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483341|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483342|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483343|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483344|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101483345|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483346|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483347|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
101483348|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
101375589|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375590|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375591|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375592|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101375593|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101375594|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483349|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483350|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483351|NCT00335673|Irbesartan|irbesartan|mesh-list
101483352|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483353|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101483354|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101483355|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483357|NCT00453635|Docetaxel|docetaxel|mesh-list
101483358|NCT00453635|Trastuzumab|trastuzumab|mesh-list
101483359|NCT00453635|Vinorelbine|vinorelbine|mesh-list
101483360|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483361|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
101483362|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
101483363|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
101483364|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483365|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101483366|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101483367|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101483368|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
101483369|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101483370|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
101483371|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101483372|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
101483373|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483374|NCT00336141|Vorinostat|vorinostat|mesh-list
101483375|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483376|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101483377|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483384|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483386|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101483387|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101483388|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101483389|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483390|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483391|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483392|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483393|NCT00453908|Urological Agents|urological agents|mesh-ancestor
101483394|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101483395|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101483396|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101483397|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
101483398|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483399|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101483400|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101483401|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483402|NCT00336375|Lumefantrine|lumefantrine|mesh-list
101483403|NCT00336375|Artemether|artemether|mesh-list
101483404|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101483405|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
101483406|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101545210|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
101483407|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101483408|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483409|NCT00336414|Prednisone|prednisone|mesh-list
101483410|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
101483411|NCT00336414|Azathioprine|azathioprine|mesh-list
101483412|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483413|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
101483414|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483415|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483416|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101483417|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
101375595|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101375596|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375597|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375598|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101375599|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101483418|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483419|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483420|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101483421|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483422|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
101483423|NCT00336414|Hormones|hormones|mesh-ancestor
101483424|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483425|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483426|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
101483427|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483428|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
101483429|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
101483430|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
101483431|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483432|NCT00336453|Coagulants|coagulants|mesh-ancestor
101483433|NCT00336531|Itraconazole|itraconazole|mesh-list
101483434|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
101483435|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483436|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101483437|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101483438|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483439|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483440|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101483441|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
101483442|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483443|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483458|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483459|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101483460|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101483461|NCT00336648|Growth Substances|growth substances|mesh-ancestor
101483462|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483463|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
101483464|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483466|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483467|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101483468|NCT03274817|Escitalopram|escitalopram|mesh-list
101483469|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101483470|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101483471|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101483472|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483473|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483474|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
101415478|NCT01245556|Ipilimumab|ipilimumab|mesh-list
101483475|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483476|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101483477|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
101483478|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483479|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101483480|NCT00230204|Antibodies|antibodies|mesh-list
101483481|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
101483482|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483483|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
101483484|NCT00230321|Hematinics|hematinics|mesh-ancestor
101483485|NCT00230399|Celecoxib|celecoxib|mesh-list
101483486|NCT00230399|Capecitabine|capecitabine|mesh-list
101483487|NCT00230399|Irinotecan|irinotecan|mesh-list
101483488|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483489|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
101483490|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483491|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375600|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101375601|NCT00076284|Aplaviroc|aplaviroc|mesh-list
101375602|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101375603|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101375604|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375605|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101375606|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101375607|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
101483492|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101483493|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101483494|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483495|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101483496|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101483497|NCT00230399|Analgesics|analgesics|mesh-ancestor
101483498|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
101483499|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483500|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483501|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483502|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483503|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101483504|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101483507|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101483508|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483509|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483511|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101483513|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101483514|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101483515|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483516|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483517|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
101483518|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483519|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483520|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101483521|NCT00230516|Lansoprazole|lansoprazole|mesh-list
101483522|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101483523|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483524|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101483525|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483526|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483527|NCT00336882|Midazolam|midazolam|mesh-list
101483528|NCT00336882|Propofol|propofol|mesh-list
101483529|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101483530|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483531|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483532|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101483533|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
101483534|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
101483535|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101483536|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101483537|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101483538|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483539|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
101483540|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
101483541|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483542|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483543|NCT00336921|Alfuzosin|alfuzosin|mesh-list
101483544|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101483545|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101483546|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101483547|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483548|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528429|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483549|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483550|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375608|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375609|NCT00234403|Fulvestrant|fulvestrant|mesh-list
101375610|NCT00234403|Gefitinib|gefitinib|mesh-list
101375611|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101375612|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375613|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101483551|NCT00336921|Urological Agents|urological agents|mesh-ancestor
101483553|NCT00336960|Fluorouracil|fluorouracil|mesh-list
101483554|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
101483555|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545259|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101483556|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483557|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483558|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483559|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
101483560|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483561|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101483562|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101483563|NCT00336960|Analgesics|analgesics|mesh-ancestor
101483564|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
101483565|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483566|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483567|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483568|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101483570|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483571|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
101483572|NCT00306410|Vitamin D|vitamin d|mesh-list
101483573|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101483574|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483575|NCT00306410|Vitamins|vitamins|mesh-ancestor
101483576|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
101483577|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101483578|NCT00340080|Abacavir|abacavir|mesh-list
101483581|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483582|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483583|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
101483584|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483585|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483586|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101483587|NCT00418535|Cisplatin|cisplatin|mesh-list
101483588|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483589|NCT02960711|Metformin|metformin|mesh-list
101483590|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101483591|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483592|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101483593|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483594|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101483595|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
101483596|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101483597|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483598|NCT00306683|Diazoxide|diazoxide|mesh-list
101483599|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483600|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101483601|NCT00306722|Fospropofol|fospropofol|mesh-list
101483602|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101483603|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483604|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483605|NCT00337389|Leucovorin|leucovorin|mesh-list
101483606|NCT00337389|Bevacizumab|bevacizumab|mesh-list
101483607|NCT00337389|Fluorouracil|fluorouracil|mesh-list
101483608|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101483609|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483610|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101483611|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101483612|NCT00337389|Growth Substances|growth substances|mesh-ancestor
101483613|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483614|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
101483615|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
101483616|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483617|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483618|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375614|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101375615|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
101375616|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375617|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375618|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375619|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483619|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
101483620|NCT00337389|Antidotes|antidotes|mesh-ancestor
101545293|NCT02272647|Estradiol|estradiol|mesh-list
101483621|NCT00337389|Protective Agents|protective agents|mesh-ancestor
101483622|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
101483623|NCT00337389|Vitamins|vitamins|mesh-ancestor
101483624|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
101483625|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101483626|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101483627|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101483628|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
101483629|NCT00306878|Abatacept|abatacept|mesh-list
101483630|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101483631|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483632|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101483633|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483634|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483635|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
101483636|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483637|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483639|NCT00337506|Bortezomib|bortezomib|mesh-list
101483640|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483641|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
101483642|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
101483643|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483644|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483645|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483646|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
101483647|NCT00337506|Hormones|hormones|mesh-ancestor
101483648|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483649|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483650|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483651|NCT00307307|Niacin|niacin|mesh-list
101483652|NCT00307307|Simvastatin|simvastatin|mesh-list
101483653|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101483679|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
101483680|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483681|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
101483682|NCT00337740|Propranolol|propranolol|mesh-list
101483683|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101483684|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101483685|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483686|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483687|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483688|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483689|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101483690|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483691|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
101483692|NCT00307502|Ritonavir|ritonavir|mesh-list
101483693|NCT00307502|Lopinavir|lopinavir|mesh-list
101483694|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101483695|NCT00307502|Darunavir|darunavir|mesh-list
101483696|NCT00307502|Nelfinavir|nelfinavir|mesh-list
101483697|NCT00307502|Indinavir|indinavir|mesh-list
101483698|NCT00307502|Saquinavir|saquinavir|mesh-list
101483699|NCT00307502|Amprenavir|amprenavir|mesh-list
101483700|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
101483701|NCT00307502|Nevirapine|nevirapine|mesh-list
101483702|NCT00307502|Tipranavir|tipranavir|mesh-list
101483703|NCT00307502|Efavirenz|efavirenz|mesh-list
101483704|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101483705|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101483708|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483710|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101483711|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
101483712|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375620|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375621|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
101375622|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101375623|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101375624|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
101375625|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375626|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483713|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101483714|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101483715|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101483716|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101483717|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101483718|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101483719|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101483720|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101483721|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101483722|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101483723|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
101483724|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101483725|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101483726|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101483727|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101483728|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483729|NCT00307619|Topiramate|topiramate|mesh-list
101483730|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
101483731|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101483732|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483733|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
101483734|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101483735|NCT00307658|Antibodies|antibodies|mesh-list
101483736|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
101483737|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
101483738|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101483739|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
101483740|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483741|NCT00337545|Everolimus|everolimus|mesh-list
101483742|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101483743|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101483744|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483745|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483746|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483747|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
101483748|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483749|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483750|NCT00307775|Estradiol|estradiol|mesh-list
101483751|NCT00307775|Estrogens|estrogens|mesh-ancestor
101483752|NCT00307775|Hormones|hormones|mesh-ancestor
101483753|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483754|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483755|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
101483756|NCT00307814|Hematinics|hematinics|mesh-ancestor
101483757|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
101483758|NCT00341055|Hematinics|hematinics|mesh-ancestor
101483759|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101483760|NCT00338052|Norethindrone|norethindrone|mesh-list
101483761|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
101483762|NCT00338052|Estradiol|estradiol|mesh-list
101483763|NCT00338052|Estrogens|estrogens|mesh-ancestor
101483764|NCT00338052|Hormones|hormones|mesh-ancestor
101483765|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483766|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483767|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101483768|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
101483769|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101483770|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101483771|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101483772|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101375627|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101375628|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
101375629|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101375631|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101375632|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483773|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101483775|NCT00338091|Benazepril|benazepril|mesh-list
101483776|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101483777|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101528430|NCT01213966|Artefenomel|artefenomel|mesh-list
101483779|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101483780|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483781|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101483782|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101483783|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483785|NCT00308048|Ribavirin|ribavirin|mesh-list
101483786|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
101483787|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
101483788|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101483789|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483790|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
101483791|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483792|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
101483793|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483794|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
101483795|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483796|NCT00338130|Temozolomide|temozolomide|mesh-list
101483797|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101483798|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
101483799|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483800|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483801|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101483802|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
101483803|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
101483804|NCT00308165|Topotecan|topotecan|mesh-list
101483805|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101483806|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101483807|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483808|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483809|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483810|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101483811|NCT00338247|Capecitabine|capecitabine|mesh-list
101483812|NCT00338247|Lapatinib|lapatinib|mesh-list
101483813|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483814|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
101483815|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483816|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483817|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101483818|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483819|NCT00308321|Prednisolone|prednisolone|mesh-list
101483820|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101483821|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
101483822|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101483823|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
101483824|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101483825|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
101483826|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483827|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
101483829|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483830|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483831|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483832|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483833|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
101483834|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
101483835|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483836|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375633|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375634|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375635|NCT00234442|Gefitinib|gefitinib|mesh-list
101483837|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101483838|NCT00308321|Protective Agents|protective agents|mesh-ancestor
101483839|NCT00308360|Valproic Acid|valproic acid|mesh-list
101483840|NCT00308360|Risperidone|risperidone|mesh-list
101483841|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101483842|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
101483843|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483844|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483845|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483846|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101483847|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101483848|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483849|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101483850|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101483855|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
101483856|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101483857|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101483858|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
101483859|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483860|NCT00341250|Antacids|antacids|mesh-ancestor
101483861|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483862|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483863|NCT00308438|Teduglutide|teduglutide|mesh-list
101483864|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483865|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101483866|NCT00308438|Protective Agents|protective agents|mesh-ancestor
101483867|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483868|NCT00308477|Dexamethasone|dexamethasone|mesh-list
101483869|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483870|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
101483871|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
101483872|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483873|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483874|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483875|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
101483876|NCT00308477|Hormones|hormones|mesh-ancestor
101483877|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483878|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483879|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483880|NCT00308594|Dexamethasone|dexamethasone|mesh-list
101483881|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483882|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
101483883|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
101483884|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483885|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483886|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483887|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
101483888|NCT00308594|Hormones|hormones|mesh-ancestor
101483889|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483890|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483891|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483892|NCT00308945|Travoprost|travoprost|mesh-list
101483893|NCT00308945|Latanoprost|latanoprost|mesh-list
101483894|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101483895|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101483896|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483897|NCT00338481|Morphine|morphine|mesh-list
101483898|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101483899|NCT00338481|Narcotics|narcotics|mesh-ancestor
101483900|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101483901|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483902|NCT00338481|Analgesics|analgesics|mesh-ancestor
101483903|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
101483904|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483905|NCT00309101|Tacrolimus|tacrolimus|mesh-list
101483906|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483907|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
101483908|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483909|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101483910|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375636|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375637|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375638|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375639|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375640|NCT00076323|Primaquine|primaquine|mesh-list
101375641|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
101375642|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375643|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101375644|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375645|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
101375646|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101483911|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483912|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
101483913|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101483914|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101483915|NCT00309218|Prednisolone|prednisolone|mesh-list
101483916|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
101483917|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101483918|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
101483919|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483920|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
101483921|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
101483922|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101483926|NCT00309218|Hormones|hormones|mesh-ancestor
101483927|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483928|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101483929|NCT00309218|Protective Agents|protective agents|mesh-ancestor
101483930|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483931|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483932|NCT00309335|Phentolamine|phentolamine|mesh-list
101483933|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101483934|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101483935|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
101483936|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101483937|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483938|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483939|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483940|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101483941|NCT00309374|Simvastatin|simvastatin|mesh-list
101483942|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101483943|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101483944|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
101483945|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483946|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101483947|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101483948|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483949|NCT00309413|Cannabidiol|cannabidiol|mesh-list
101483950|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
101483951|NCT00309491|Tamoxifen|tamoxifen|mesh-list
101483952|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
101483953|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101483954|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
101483955|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483956|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483957|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483959|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101483960|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101483961|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101483962|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101483963|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101483964|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483965|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375647|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101375648|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375650|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
101375651|NCT00234637|Memantine|memantine|mesh-list
101375652|NCT00234637|Rivastigmine|rivastigmine|mesh-list
101375653|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101375654|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101375655|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
101375656|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375657|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375658|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375659|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101375660|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101375661|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101375662|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375663|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
101483966|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
101483967|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483968|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
101483969|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
101483970|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
101483971|NCT00309530|Interferons|interferons|mesh-list
101483972|NCT00309530|Fluorouracil|fluorouracil|mesh-list
101483973|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
101483974|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483975|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483976|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483977|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483978|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
101483979|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483980|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
101483981|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483982|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
101483983|NCT00309569|Fluorouracil|fluorouracil|mesh-list
101483984|NCT00309569|Methotrexate|methotrexate|mesh-list
101483985|NCT00309569|Epirubicin|epirubicin|mesh-list
101483986|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483987|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
101483988|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483989|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101483991|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
101483992|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483993|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483995|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
101483996|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101483997|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101483998|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
101483999|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101484000|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
101484001|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484002|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101484003|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101484004|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484005|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101484006|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484007|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101375664|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101375665|NCT00234637|Protective Agents|protective agents|mesh-ancestor
101375666|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101375667|NCT00234676|Estrogens|estrogens|mesh-ancestor
101375668|NCT00234676|Hormones|hormones|mesh-ancestor
101375669|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375670|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375671|NCT00076362|Octreotide|octreotide|mesh-list
101484008|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101484009|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101484010|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484011|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484012|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484013|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101484014|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101484015|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
101484016|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484017|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484018|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101484019|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101484020|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
101484021|NCT00309725|Galantamine|galantamine|mesh-list
101484022|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101484023|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484024|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484025|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
101484026|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484027|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484028|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101484029|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
101484030|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484031|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
101484032|NCT00338754|Adalimumab|adalimumab|mesh-list
101484033|NCT00338754|Antibodies|antibodies|mesh-list
101484034|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101484035|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
101484036|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484037|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101484038|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484039|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484040|NCT00338793|Prednisolone|prednisolone|mesh-list
101484041|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484042|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
101484043|NCT00338793|Hormones|hormones|mesh-ancestor
101484044|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484045|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484046|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101484047|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484048|NCT00418847|Miglustat|miglustat|mesh-list
101484049|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484050|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484051|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101484052|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101484053|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
101484054|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484055|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101484056|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484057|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484058|NCT00309881|Prednisone|prednisone|mesh-list
101484059|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
101484060|NCT00309881|Rituximab|rituximab|mesh-list
101484061|NCT00309881|Doxorubicin|doxorubicin|mesh-list
101484062|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101484063|NCT00309881|Vincristine|vincristine|mesh-list
101484064|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484065|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
101545361|NCT05654064|Narcotics|narcotics|mesh-ancestor
101484066|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484067|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375672|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375673|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101375674|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375676|NCT00234871|Amlodipine|amlodipine|mesh-list
101375677|NCT00234871|Benazepril|benazepril|mesh-list
101375678|NCT00234871|Trandolapril|trandolapril|mesh-list
101484071|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484072|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484073|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101484074|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484075|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101484076|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484077|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484078|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484079|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
101484080|NCT00309881|Hormones|hormones|mesh-ancestor
101484081|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484082|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101484083|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101484084|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484085|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484086|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484087|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
101484088|NCT00309920|Docetaxel|docetaxel|mesh-list
101484089|NCT00309920|Doxorubicin|doxorubicin|mesh-list
101484090|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101484091|NCT00309920|Fluorouracil|fluorouracil|mesh-list
101484092|NCT00309920|Epirubicin|epirubicin|mesh-list
101484093|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
101484094|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484095|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
101484096|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484097|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484098|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484099|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
101484100|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484101|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484102|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484103|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484104|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484105|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484106|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484107|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101484108|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484109|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484110|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
101484111|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484112|NCT00309920|Hematinics|hematinics|mesh-ancestor
101484113|NCT00309998|Bevacizumab|bevacizumab|mesh-list
101484114|NCT00309998|Vinorelbine|vinorelbine|mesh-list
101484115|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101484116|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484117|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101484118|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101484119|NCT00309998|Growth Substances|growth substances|mesh-ancestor
101484120|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484122|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101484123|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484124|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484125|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484126|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484127|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
101484128|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484129|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
101484130|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484131|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484132|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484133|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
101375679|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484134|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484135|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484136|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484137|NCT00310154|Docetaxel|docetaxel|mesh-list
101484142|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484143|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484144|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101484145|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484146|NCT00338910|Metronidazole|metronidazole|mesh-list
101484147|NCT00338910|Budesonide|budesonide|mesh-list
101484148|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484149|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101484150|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
101484151|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484152|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484153|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101484154|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
101484155|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
101484156|NCT00338910|Hormones|hormones|mesh-ancestor
101484157|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484158|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484159|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484160|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484161|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101484162|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
101484163|NCT00310232|Hematinics|hematinics|mesh-ancestor
101484164|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101484165|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484166|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484167|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484168|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101484169|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
101484170|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484171|NCT00310505|Amphotericin B|amphotericin b|mesh-list
101484172|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101484173|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101484174|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
101484175|NCT00310505|Amebicides|amebicides|mesh-ancestor
101484176|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484177|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101484178|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484179|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484180|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
101545400|NCT01380093|Naltrexone|naltrexone|mesh-list
101484181|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101484182|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484183|NCT00339066|Sertraline|sertraline|mesh-list
101484184|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
101484185|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484186|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101484187|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101484188|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484189|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484190|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484191|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
101484192|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484193|NCT00310583|Pregabalin|pregabalin|mesh-list
101484194|NCT00310583|Analgesics|analgesics|mesh-ancestor
101484195|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
101484196|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484197|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484198|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
101484199|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101484200|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484201|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484202|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484203|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101484204|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101484205|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484206|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484207|NCT00421044|Epothilone B|epothilone b|mesh-list
101484208|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375680|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101375681|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375682|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375683|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484214|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101484215|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484216|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
101484217|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484218|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484219|NCT00310778|Atenolol|atenolol|mesh-list
101484220|NCT00310778|Valsartan|valsartan|mesh-list
101484221|NCT00310778|Candesartan|candesartan|mesh-list
101484222|NCT00310778|Candesartan cilexetil|candesartan cilexetil|mesh-list
101484223|NCT00310778|Ramipril|ramipril|mesh-list
101484224|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484225|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101484226|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101528431|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
101484227|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484228|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101484229|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484230|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484231|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101484232|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
101484234|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484235|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484236|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101484237|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101484238|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101484239|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484240|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484241|NCT00421083|Tadalafil|tadalafil|mesh-list
101484242|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484243|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101484244|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101484245|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415508|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484246|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484247|NCT00421083|Urological Agents|urological agents|mesh-ancestor
101484248|NCT00310895|Imetelstat|imetelstat|mesh-list
101484249|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
101484250|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484251|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484252|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101484253|NCT00310934|Buprenorphine|buprenorphine|mesh-list
101484254|NCT00310934|Methadone|methadone|mesh-list
101484255|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101484256|NCT00310934|Narcotics|narcotics|mesh-ancestor
101484257|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484258|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484259|NCT00310934|Analgesics|analgesics|mesh-ancestor
101484260|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
101484261|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484262|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101484263|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
101484264|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
101484265|NCT00421122|Budesonide|budesonide|mesh-list
101484266|NCT00421122|Terbutaline|terbutaline|mesh-list
101484267|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
101484268|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101484269|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484270|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101484271|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
101484272|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484273|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484274|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101484275|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101484276|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
101484277|NCT00421122|Hormones|hormones|mesh-ancestor
101487424|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375684|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375686|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101375687|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101375688|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
101375689|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375690|NCT00234910|Ritonavir|ritonavir|mesh-list
101484280|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101484281|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101484282|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484283|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484284|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484285|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
101484286|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
101484288|NCT00311051|Ramatroban|ramatroban|mesh-list
101484289|NCT00311051|Montelukast|montelukast|mesh-list
101484290|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101484291|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101484292|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101484293|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
101484294|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484295|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484296|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101484297|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101484298|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484299|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101484300|NCT00311129|Rituximab|rituximab|mesh-list
101484301|NCT00311129|Fludarabine|fludarabine|mesh-list
101484302|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
101484303|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101484304|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484305|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
101484306|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484307|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484308|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484309|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
101484310|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484311|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484312|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
101484313|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484314|NCT00342381|Amifampridine|amifampridine|mesh-list
101484315|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101484316|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484317|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484318|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101484319|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484320|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484321|NCT00311558|Interferons|interferons|mesh-list
101484322|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
101484323|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
101484324|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101484325|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484326|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
101484327|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484328|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
101484329|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484330|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484331|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101484332|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
101484333|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101484334|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
101484335|NCT00418925|Dronabinol|dronabinol|mesh-list
101484336|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
101484337|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484338|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484339|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101484340|NCT00418925|Analgesics|analgesics|mesh-ancestor
101375691|NCT00234910|Lopinavir|lopinavir|mesh-list
101375692|NCT00234910|Tenofovir|tenofovir|mesh-list
101375693|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101375694|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101375695|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
101375696|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375697|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375698|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101484341|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
101484342|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484343|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101484344|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101484346|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484352|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484353|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
101484354|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
101484355|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101484356|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484357|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484358|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484359|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484360|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484361|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484362|NCT00311636|Paclitaxel|paclitaxel|mesh-list
101484363|NCT00311636|Docetaxel|docetaxel|mesh-list
101484364|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
101484365|NCT00311636|Doxorubicin|doxorubicin|mesh-list
101484366|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101484367|NCT00311636|Fluorouracil|fluorouracil|mesh-list
101484368|NCT00311636|Methotrexate|methotrexate|mesh-list
101484369|NCT00311636|Epirubicin|epirubicin|mesh-list
101484370|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101484371|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101484372|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484373|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484374|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484375|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484376|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484377|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484378|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
101484379|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484380|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484381|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484382|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
101484383|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484384|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484385|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101484386|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484387|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484388|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
101484389|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484390|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101484391|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
101484392|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101484393|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
101484394|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101484395|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101484396|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
101484397|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101484398|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
101484399|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101484400|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101484401|NCT00311753|Heparin|heparin|mesh-list
101484402|NCT00311753|Certoparin|certoparin|mesh-list
101484403|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
101484404|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101375700|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
101375701|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375702|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101375703|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101375704|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101484405|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101484406|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484408|NCT00311870|Nisoldipine|nisoldipine|mesh-list
101484409|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101484410|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484411|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484412|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484413|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484414|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101484415|NCT00311870|Protective Agents|protective agents|mesh-ancestor
101484416|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484417|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101484418|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484422|NCT00311987|Hormones|hormones|mesh-ancestor
101484423|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484424|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484425|NCT00342849|Succimer|succimer|mesh-list
101484426|NCT00342849|Antidotes|antidotes|mesh-ancestor
101484427|NCT00342849|Protective Agents|protective agents|mesh-ancestor
101484428|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545430|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
101484429|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
101484430|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
101484431|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484433|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101484434|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
101484435|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
101484436|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
101484437|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484438|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484439|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
101484440|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484441|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484442|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101484443|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
101484444|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484445|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484447|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484449|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101484450|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
101484451|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484452|NCT00343005|Antacids|antacids|mesh-ancestor
101484453|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484454|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484455|NCT00312182|Nelfinavir|nelfinavir|mesh-list
101484456|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101484457|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101484458|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484459|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484460|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484461|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101484462|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101484463|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
101484464|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484465|NCT00312260|Gabapentin|gabapentin|mesh-list
101484466|NCT00312260|Amitriptyline|amitriptyline|mesh-list
101375705|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375706|NCT00234949|Cephalexin|cephalexin|mesh-list
101375707|NCT00234949|Cefdinir|cefdinir|mesh-list
101375708|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375709|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375710|NCT00234988|Sibutramine|sibutramine|mesh-list
101375711|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375712|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484467|NCT00312260|Analgesics|analgesics|mesh-ancestor
101484468|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
101484469|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484470|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484471|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
101484472|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101484473|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101484474|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484475|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484476|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101484477|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101484478|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484479|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484480|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
101484481|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101484482|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
101484483|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101484484|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101484485|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101484486|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484487|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484488|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101484489|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484497|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101484498|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484499|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484500|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484501|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484502|NCT00339768|Amoxicillin|amoxicillin|mesh-list
101484503|NCT00339768|Omeprazole|omeprazole|mesh-list
101484504|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484505|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484506|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101484507|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484508|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101484509|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484510|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484511|NCT00343161|Esomeprazole|esomeprazole|mesh-list
101484512|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101484513|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
101484514|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101484515|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484516|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101484517|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484518|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484519|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101484520|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
101484521|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484522|NCT00343161|Antacids|antacids|mesh-ancestor
101484524|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
101484525|NCT00312533|Protective Agents|protective agents|mesh-ancestor
101484526|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484527|NCT00312650|Gemcitabine|gemcitabine|mesh-list
101484528|NCT00312650|Doxorubicin|doxorubicin|mesh-list
101484529|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101484530|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484531|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
101484532|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484533|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375714|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101375715|NCT00400491|Vitamin D|vitamin d|mesh-list
101375716|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
101375717|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
101375718|NCT00400491|Vitamins|vitamins|mesh-list
101375719|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
101375720|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375721|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101375722|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101375723|NCT00235105|Adalimumab|adalimumab|mesh-list
101375724|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101484534|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101484535|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101484536|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484537|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484538|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
101484539|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484540|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484541|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101484542|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101484543|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484544|NCT00343200|Urological Agents|urological agents|mesh-ancestor
101484545|NCT00312806|Pantoprazole|pantoprazole|mesh-list
101484546|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101484547|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484548|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101484550|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484552|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101484553|NCT00347685|Narcotics|narcotics|mesh-ancestor
101484554|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484555|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484556|NCT00347685|Analgesics|analgesics|mesh-ancestor
101484557|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
101484558|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484565|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484567|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484568|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484569|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
101484570|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484571|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
101484572|NCT00313001|Exenatide|exenatide|mesh-list
101484573|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
101484574|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484575|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484576|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101484577|NCT00313001|Incretins|incretins|mesh-ancestor
101484578|NCT00313001|Hormones|hormones|mesh-ancestor
101484579|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484580|NCT00343278|Valacyclovir|valacyclovir|mesh-list
101484581|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
101484582|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484583|NCT00343317|Cefoxitin|cefoxitin|mesh-list
101484584|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484585|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484586|NCT00313079|Vincristine|vincristine|mesh-list
101484587|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101484588|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484589|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484590|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484591|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484592|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484593|NCT00347724|Tramadol|tramadol|mesh-list
101375726|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375727|NCT00235144|Sirolimus|sirolimus|mesh-list
101375728|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375729|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484594|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101484595|NCT00347724|Narcotics|narcotics|mesh-ancestor
101484596|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484597|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484598|NCT00347724|Analgesics|analgesics|mesh-ancestor
101484599|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
101484600|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484601|NCT00313157|Metoprolol|metoprolol|mesh-list
101484602|NCT00313157|Verapamil|verapamil|mesh-list
101484603|NCT00313157|Carvedilol|carvedilol|mesh-list
101484604|NCT00313157|Diltiazem|diltiazem|mesh-list
101484605|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101484606|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484608|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
101484609|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484610|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484611|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101545472|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
101484612|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101484613|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101484614|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484615|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484616|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484618|NCT00313157|Protective Agents|protective agents|mesh-ancestor
101484619|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101484620|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484621|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484622|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484623|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101484624|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101484625|NCT00347763|Permethrin|permethrin|mesh-list
101484626|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484627|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484634|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484635|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
101484636|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484637|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484638|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484640|NCT00347802|Travoprost|travoprost|mesh-list
101484641|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484642|NCT00313274|Clevudine|clevudine|mesh-list
101484643|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
101484644|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484645|NCT00419042|Gemcitabine|gemcitabine|mesh-list
101484646|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101484647|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484648|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
101484649|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484650|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484651|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101484652|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484653|NCT00347841|Bimatoprost|bimatoprost|mesh-list
101484654|NCT00347841|Latanoprost|latanoprost|mesh-list
101484655|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101484656|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101484657|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484658|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
101484659|NCT00425126|Hematinics|hematinics|mesh-ancestor
101484660|NCT00343629|Sulindac|sulindac|mesh-list
101484661|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101484662|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101484663|NCT00343629|Analgesics|analgesics|mesh-ancestor
101484664|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
101484665|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375731|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375732|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
101375733|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375734|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
101375735|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375736|NCT00400530|Alendronate|alendronate|mesh-list
101375737|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484666|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484667|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484668|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484669|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484670|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101484671|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484672|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484674|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101484675|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484676|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484677|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484678|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484680|NCT00343707|Vestipitant|vestipitant|mesh-list
101484681|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101484682|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101484683|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484684|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484685|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484686|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
101484687|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484688|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101484689|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
101484690|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484691|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101484692|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101484693|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484694|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101484695|NCT00313391|Risperidone|risperidone|mesh-list
101484696|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101484699|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484702|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101484703|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484704|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484705|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101484706|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
101484707|NCT00348153|Adalimumab|adalimumab|mesh-list
101484708|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101484709|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484710|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484711|NCT00313508|Vidarabine|vidarabine|mesh-list
101484712|NCT00313508|Fludarabine|fludarabine|mesh-list
101484713|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
101484714|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484715|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484716|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
101484717|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484718|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484719|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
101484720|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484721|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
101484722|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484723|NCT00313547|Amlodipine|amlodipine|mesh-list
101484724|NCT00313547|Quinapril|quinapril|mesh-list
101375738|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101375740|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375741|NCT00235222|Stavudine|stavudine|mesh-list
101375742|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
101375743|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375744|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101375745|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375746|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484725|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484726|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101484727|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484728|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484729|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484730|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484731|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484732|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101484733|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484734|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484735|NCT00348192|Donepezil|donepezil|mesh-list
101484736|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101484737|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484738|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484739|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
101484740|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484741|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484742|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
101484743|NCT00313625|Methotrexate|methotrexate|mesh-list
101484744|NCT00313625|Melphalan|melphalan|mesh-list
101484745|NCT00313625|Busulfan|busulfan|mesh-list
101484746|NCT00313625|Tacrolimus|tacrolimus|mesh-list
101484747|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101484748|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
101484749|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101484750|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484751|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484752|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
101484753|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484754|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484755|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
101484756|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484757|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101484758|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484759|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
101484760|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484761|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101484762|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101484763|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484764|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
101484765|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484767|NCT00343980|Glimepiride|glimepiride|mesh-list
101484768|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
101484769|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101484772|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101484773|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484774|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
101484775|NCT00313742|Insulin|insulin|mesh-list
101484776|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101484777|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
101484778|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
101484779|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
101484780|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
101484781|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
101484782|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484783|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484784|NCT00313859|Simvastatin|simvastatin|mesh-list
101375748|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375749|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101375750|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101375751|NCT00235261|Dexamethasone|dexamethasone|mesh-list
101375752|NCT00235261|Pregabalin|pregabalin|mesh-list
101484786|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101484787|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
101484788|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484789|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101484790|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101484791|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484792|NCT00348231|Insulin|insulin|mesh-list
101484793|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484794|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484795|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
101484796|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484797|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101484798|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101484799|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484800|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484801|NCT00313898|Urological Agents|urological agents|mesh-ancestor
101484802|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
101484803|NCT00344058|Analgesics|analgesics|mesh-ancestor
101484804|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
101484805|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484806|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484807|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
101484808|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484809|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101484810|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
101484811|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101484812|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101484813|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484814|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484815|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
101484816|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101484817|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
101484818|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484819|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484820|NCT00313976|Interferons|interferons|mesh-list
101484821|NCT00313976|Interferon-beta|interferon-beta|mesh-list
101484822|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
101484823|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484824|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
101484825|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484826|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
101484827|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484828|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101484829|NCT00348387|Vaccines|vaccines|mesh-list
101484830|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
101484831|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484832|NCT00314171|Timolol|timolol|mesh-list
101484833|NCT00314171|Dorzolamide|dorzolamide|mesh-list
101484834|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101484835|NCT00314171|Brinzolamide|brinzolamide|mesh-list
101484836|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101484837|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101484838|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101484839|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484840|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484841|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484842|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484843|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101484847|NCT00348426|Antitoxins|antitoxins|mesh-list
101484848|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
101484849|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
101484850|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484851|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101484852|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
101375753|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375755|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
101375756|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484853|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101484854|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101484855|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101545511|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
101484856|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101484857|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484858|NCT00344253|Interferons|interferons|mesh-list
101484859|NCT00344253|Interferon-beta|interferon-beta|mesh-list
101484860|NCT00344253|Methotrexate|methotrexate|mesh-list
101484861|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101484862|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
101484863|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101484864|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484865|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101484866|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
101484867|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484868|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484869|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101484870|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484871|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101484872|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484873|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
101484874|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484875|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101484876|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
101484877|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484878|NCT00314405|Methylene Blue|methylene blue|mesh-list
101484879|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484880|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484881|NCT04715295|Azithromycin|azithromycin|mesh-list
101484882|NCT04715295|Doxycycline|doxycycline|mesh-list
101484883|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
101484884|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
101484885|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101484886|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101484887|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101484888|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
101484889|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101484890|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
101484891|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484892|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484893|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
101484894|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
101484895|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484896|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101484897|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484898|NCT00348504|Simendan|simendan|mesh-list
101484899|NCT00348504|Dobutamine|dobutamine|mesh-list
101484900|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101484901|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484902|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101484903|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101484904|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484905|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484907|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484909|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
101484910|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484911|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101484912|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101484913|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101484914|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101484915|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484916|NCT00314561|Pioglitazone|pioglitazone|mesh-list
101484925|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101484926|NCT00348582|Analgesics|analgesics|mesh-ancestor
101375758|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375759|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
101375761|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375762|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101375763|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375764|NCT00235261|Analgesics|analgesics|mesh-ancestor
101375765|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
101375766|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
101375767|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101375768|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101375769|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484927|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
101484928|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484929|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484930|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484931|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484932|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101484933|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484934|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484935|NCT00314639|Modafinil|modafinil|mesh-list
101484936|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101484937|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484938|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101484939|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101484940|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101484941|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484942|NCT00314678|Paclitaxel|paclitaxel|mesh-list
101484943|NCT00314678|Topotecan|topotecan|mesh-list
101484944|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101484945|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484946|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484947|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484948|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484949|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484950|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101484951|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101484952|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484953|NCT00344526|Dexamethasone|dexamethasone|mesh-list
101484954|NCT00344526|Melphalan|melphalan|mesh-list
101484955|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101484956|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
101484957|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
101484958|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101484959|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484960|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101484961|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
101484963|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484964|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101484965|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484966|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484968|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484969|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484970|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484971|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
101375770|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101375771|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101375772|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375773|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375774|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375775|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
101375776|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101484972|NCT00344565|Modafinil|modafinil|mesh-list
101484973|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101484974|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484975|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101484976|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101484977|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101528432|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101484978|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484979|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
101484980|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484981|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101484982|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484984|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
101484985|NCT00348738|Hematinics|hematinics|mesh-ancestor
101484986|NCT00314912|Tramiprosate|tramiprosate|mesh-list
101484987|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
101484988|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
101484989|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
101484990|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484991|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484992|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484993|NCT00314990|Folic Acid|folic acid|mesh-list
101484994|NCT00314990|Pyridoxine|pyridoxine|mesh-list
101484995|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
101484996|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
101484997|NCT00314990|Hematinics|hematinics|mesh-ancestor
101484998|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
101484999|NCT00314990|Vitamins|vitamins|mesh-ancestor
101485000|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
101485001|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485002|NCT02960126|Aspirin|aspirin|mesh-list
101485003|NCT02960126|Clopidogrel|clopidogrel|mesh-list
101485004|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101485005|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485006|NCT02960126|Analgesics|analgesics|mesh-ancestor
101485007|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
101485008|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485009|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485010|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485011|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485012|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101485013|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101485014|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485015|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101485016|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101485017|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485018|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
101485019|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101485020|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101485021|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101485022|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
101485023|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485024|NCT00315185|Cetuximab|cetuximab|mesh-list
101485025|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485026|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485027|NCT00344760|Tenofovir|tenofovir|mesh-list
101485028|NCT00344760|Lamivudine|lamivudine|mesh-list
101485029|NCT00344760|Efavirenz|efavirenz|mesh-list
101485030|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
101485031|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
101485032|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485033|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101485034|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375777|NCT00235300|Basiliximab|basiliximab|mesh-list
101375778|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
101375779|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375780|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101375781|NCT00064649|Finasteride|finasteride|mesh-list
101375782|NCT00064649|Alfuzosin|alfuzosin|mesh-list
101375784|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101375785|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375786|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375787|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
101375788|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375789|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485035|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485036|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485037|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101485038|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101485039|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101485040|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101485041|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101485042|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101485043|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101485044|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101485045|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101485046|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101485047|NCT00348894|Reboxetine|reboxetine|mesh-list
101485048|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
101485049|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101485050|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101485051|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101485052|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528433|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101485053|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485054|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
101485055|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485060|NCT00315536|Narcotics|narcotics|mesh-ancestor
101485061|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485062|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485064|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
101485065|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485066|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101485067|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101485068|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101485069|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
101485070|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485071|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485072|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
101485073|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485074|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485075|NCT00349089|Pemetrexed|pemetrexed|mesh-list
101485076|NCT00349089|Vinorelbine|vinorelbine|mesh-list
101485077|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485078|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485079|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485080|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101485081|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485082|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101485083|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
101485084|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485085|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
101375790|NCT00064649|Urological Agents|urological agents|mesh-ancestor
101375791|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101375792|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101375793|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101375794|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101375795|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375796|NCT00097734|Ertapenem|ertapenem|mesh-list
101375797|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375798|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375799|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
101375800|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375801|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375802|NCT00235651|Amphotericin B|amphotericin b|mesh-list
101485086|NCT00349128|Metformin|metformin|mesh-list
101485087|NCT00349128|Fenofibrate|fenofibrate|mesh-list
101485088|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485089|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485090|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485091|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
101485092|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485093|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485094|NCT00315848|Buprenorphine|buprenorphine|mesh-list
101485095|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485096|NCT00315848|Narcotics|narcotics|mesh-ancestor
101485097|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485098|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485099|NCT00315848|Analgesics|analgesics|mesh-ancestor
101485100|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
101485101|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485102|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101485103|NCT00349206|Sirolimus|sirolimus|mesh-list
101485104|NCT00349206|Sorafenib|sorafenib|mesh-list
101485105|NCT00349206|Temsirolimus|temsirolimus|mesh-list
101485106|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
101485107|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485108|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485109|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485110|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485111|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485112|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
101485113|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485114|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485115|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485116|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101485117|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
101485118|NCT00315887|Buprenorphine|buprenorphine|mesh-list
101485119|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485120|NCT00315887|Narcotics|narcotics|mesh-ancestor
101485121|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485122|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485123|NCT00315887|Analgesics|analgesics|mesh-ancestor
101485124|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
101485125|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485126|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101485127|NCT00421395|Epratuzumab|epratuzumab|mesh-list
101485145|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485146|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101485147|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
101485148|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
101485149|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101485150|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
101485151|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485152|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485153|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101375803|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101375804|NCT00235651|Amebicides|amebicides|mesh-ancestor
101375805|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375806|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101375807|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375808|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375809|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
101485154|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
101485155|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101485156|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
101485157|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485158|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485159|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101485160|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
101485161|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
101485162|NCT00315965|Protective Agents|protective agents|mesh-ancestor
101485163|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
101485164|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
101485165|NCT00349245|Remifentanil|remifentanil|mesh-list
101485166|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101485167|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485168|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485169|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485170|NCT00349245|Analgesics|analgesics|mesh-ancestor
101485171|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
101485172|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485173|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101485174|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101485175|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101485176|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
101485177|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485178|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485179|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485180|NCT00349245|Narcotics|narcotics|mesh-ancestor
101485181|NCT00349284|Ezetimibe|ezetimibe|mesh-list
101485182|NCT00349284|Fenofibrate|fenofibrate|mesh-list
101485183|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101485184|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485185|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
101485186|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485190|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101485192|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101485193|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101485194|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101485195|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101485196|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485197|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
101485198|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485199|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485200|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101485201|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101485202|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485203|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101485204|NCT00349362|Testosterone|testosterone|mesh-list
101485205|NCT00349362|Androgens|androgens|mesh-ancestor
101485207|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485208|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485209|NCT00316238|Olanzapine|olanzapine|mesh-list
101485210|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
101485211|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
101485212|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485213|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485214|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101485215|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101485216|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375811|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101375812|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375813|NCT00064766|Doxycycline|doxycycline|mesh-list
101375814|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485217|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485219|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101485220|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101485221|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101485222|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485223|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485224|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
101485225|NCT00349401|Ketorolac|ketorolac|mesh-list
101485226|NCT00349401|Morphine|morphine|mesh-list
101485228|NCT00349401|Narcotics|narcotics|mesh-ancestor
101485229|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485230|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485231|NCT00349401|Analgesics|analgesics|mesh-ancestor
101485232|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
101485233|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485234|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101485235|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485236|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485237|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485238|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101485239|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485240|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485241|NCT00349440|Cyclosporine|cyclosporine|mesh-list
101485242|NCT00349440|Cyclosporins|cyclosporins|mesh-list
101485243|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485244|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485245|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485246|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
101485247|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485248|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
101485249|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485250|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485251|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485252|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101485253|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
101485254|NCT00316433|Irinotecan|irinotecan|mesh-list
101485255|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485256|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101485261|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485262|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485263|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485264|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485265|NCT00316472|Niacinamide|niacinamide|mesh-list
101485266|NCT00316472|Niacin|niacin|mesh-list
101485267|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
101485268|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485269|NCT00316472|Vitamins|vitamins|mesh-ancestor
101485270|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
101485271|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485272|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485273|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
101485274|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485275|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485276|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
101485277|NCT00349557|Bevacizumab|bevacizumab|mesh-list
101485278|NCT00349557|Goserelin|goserelin|mesh-list
101485279|NCT00349557|Bicalutamide|bicalutamide|mesh-list
101485280|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485281|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485282|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485283|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485284|NCT00349557|Growth Substances|growth substances|mesh-ancestor
101485285|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485286|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
101375816|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
101375817|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101375818|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101375819|NCT00235729|Lofexidine|lofexidine|mesh-list
101375820|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101375821|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101375822|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375823|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
101375824|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375825|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101375826|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101375827|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101375828|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
101375829|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375830|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375831|NCT00235885|Adalimumab|adalimumab|mesh-list
101375832|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101375833|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101375834|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375835|NCT04728750|Pancrelipase|pancrelipase|mesh-list
101485287|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101485288|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
101485289|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
101485290|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485291|NCT00349596|Decitabine|decitabine|mesh-list
101485292|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485293|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
101485294|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485295|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485296|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485297|NCT00349635|Metformin|metformin|mesh-list
101485298|NCT00349635|Fenofibrate|fenofibrate|mesh-list
101485299|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485300|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485301|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485302|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
101485303|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485304|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485305|NCT00316745|Leucovorin|leucovorin|mesh-list
101485306|NCT00316745|Fluorouracil|fluorouracil|mesh-list
101485307|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
101485308|NCT00316745|Irinotecan|irinotecan|mesh-list
101485309|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
101485310|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485311|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485312|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485313|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485314|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
101485315|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485316|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101485317|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485318|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485319|NCT00316745|Antidotes|antidotes|mesh-ancestor
101485320|NCT00316745|Protective Agents|protective agents|mesh-ancestor
101375836|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375837|NCT00235963|Simvastatin|simvastatin|mesh-list
101375838|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101375839|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101375840|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
101375841|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375842|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101375843|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101375844|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375845|NCT00236002|Alendronate|alendronate|mesh-list
101485321|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485322|NCT00316745|Vitamins|vitamins|mesh-ancestor
101485323|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
101485324|NCT00349674|Methotrexate|methotrexate|mesh-list
101485325|NCT00349674|Azathioprine|azathioprine|mesh-list
101485326|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101485327|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
101485331|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
101485332|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485333|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485334|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485335|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485336|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101485337|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485338|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
101485339|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485340|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485341|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101485342|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485343|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485344|NCT00344955|Atorvastatin|atorvastatin|mesh-list
101485345|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101485346|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485347|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
101485348|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485349|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485350|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101485351|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485352|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101485353|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101485354|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485355|NCT00316940|Bortezomib|bortezomib|mesh-list
101485356|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101485357|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485358|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485359|NCT00316940|Analgesics|analgesics|mesh-ancestor
101485360|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
101485361|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485362|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485363|NCT00344994|Pramipexole|pramipexole|mesh-list
101485364|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
101485365|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485367|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485368|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101485369|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101485370|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
101485371|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
101485372|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485373|NCT00349791|Testosterone|testosterone|mesh-list
101485374|NCT00349791|Androgens|androgens|mesh-ancestor
101485375|NCT00349791|Hormones|hormones|mesh-ancestor
101485376|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485377|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375846|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101375847|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375849|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101375850|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375851|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375852|NCT00236275|Telbivudine|telbivudine|mesh-list
101375853|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
101485378|NCT00317096|Rituximab|rituximab|mesh-list
101485379|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485380|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485381|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
101485382|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485383|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485384|NCT00317135|Vaccines|vaccines|mesh-list
101485385|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
101485386|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485387|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
101485388|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485389|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485390|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101485391|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485392|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485393|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101485394|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
101485395|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485396|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485397|NCT00317330|Rifampin|rifampin|mesh-list
101485398|NCT00317330|Isoniazid|isoniazid|mesh-list
101485403|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485404|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
101485405|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485406|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485407|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485408|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101485409|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101485410|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101485411|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101485412|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101485413|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101485414|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101485415|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485416|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
101485417|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485419|NCT00317408|Cytarabine|cytarabine|mesh-list
101485420|NCT00317408|Cyclosporine|cyclosporine|mesh-list
101485421|NCT00317408|Dexamethasone|dexamethasone|mesh-list
101485422|NCT00317408|Prednisolone|prednisolone|mesh-list
101485423|NCT00317408|Carboplatin|carboplatin|mesh-list
101485424|NCT00317408|Methotrexate|methotrexate|mesh-list
101485425|NCT00317408|Etoposide|etoposide|mesh-list
101485426|NCT00317408|Melphalan|melphalan|mesh-list
101485427|NCT00317408|Busulfan|busulfan|mesh-list
101485428|NCT00317408|Ifosfamide|ifosfamide|mesh-list
101485429|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
101485430|NCT00317408|Idarubicin|idarubicin|mesh-list
101485431|NCT00317408|Thiotepa|thiotepa|mesh-list
101485432|NCT00317408|Carmustine|carmustine|mesh-list
101485433|NCT00317408|Vinblastine|vinblastine|mesh-list
101485434|NCT00317408|Lomustine|lomustine|mesh-list
101485435|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
101485436|NCT00317408|Vindesine|vindesine|mesh-list
101485437|NCT00317408|Cyclosporins|cyclosporins|mesh-list
101485438|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101485439|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
101485440|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485442|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
101485443|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485444|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485445|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375854|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375855|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375856|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375857|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375859|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375860|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
101375861|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485446|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
101485447|NCT00317408|Hormones|hormones|mesh-ancestor
101485448|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485449|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101485450|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485451|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101485452|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
101485453|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485454|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485455|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
101485456|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485457|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485458|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485459|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101485461|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
101485462|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485463|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485464|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101485465|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101485466|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485467|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
101485468|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485469|NCT00317408|Antidotes|antidotes|mesh-ancestor
101485470|NCT00317408|Protective Agents|protective agents|mesh-ancestor
101485471|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485472|NCT00317408|Vitamins|vitamins|mesh-ancestor
101485473|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
101485477|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
101485478|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101485479|NCT00317408|Analgesics|analgesics|mesh-ancestor
101485480|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
101485481|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101485482|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101485483|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485484|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101485485|NCT00317447|Prednisone|prednisone|mesh-list
101485486|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485487|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
101485488|NCT00317447|Hormones|hormones|mesh-ancestor
101485489|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485490|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485491|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101485492|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485493|NCT02959554|Nivolumab|nivolumab|mesh-list
101485494|NCT02959554|Sunitinib|sunitinib|mesh-list
101485495|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485496|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485497|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101485498|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485499|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485500|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485502|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485503|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101485504|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485505|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485506|NCT00345306|Progesterone|progesterone|mesh-list
101485507|NCT00345306|Progestins|progestins|mesh-ancestor
101375862|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375863|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375864|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375865|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375866|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375867|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375868|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101485509|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485510|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485512|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485513|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
101485514|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485515|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101485516|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485517|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485518|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
101485519|NCT00350181|Sirolimus|sirolimus|mesh-list
101485520|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
101485521|NCT00350181|Busulfan|busulfan|mesh-list
101485522|NCT00350181|Carmustine|carmustine|mesh-list
101485523|NCT00350181|Etoposide|etoposide|mesh-list
101485524|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485525|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
101485526|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485527|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485528|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101485529|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
101485530|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485531|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485532|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101485533|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101485534|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101485535|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485536|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485537|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101485538|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101485539|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
101485540|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485541|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485542|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
101485543|NCT00317759|Fludarabine|fludarabine|mesh-list
101485544|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
101485545|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485546|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485553|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101485554|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485555|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485556|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101485557|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485558|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
101485559|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485560|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
101485561|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485562|NCT00345501|Iloprost|iloprost|mesh-list
101485563|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101485564|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
101485565|NCT00345657|Niacin|niacin|mesh-list
101485566|NCT00345657|Lovastatin|lovastatin|mesh-list
101485567|NCT00345657|L 647318|l 647318|mesh-list
101485568|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
101485569|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485570|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
101485571|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485572|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485573|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
101485574|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485575|NCT00345657|Vitamins|vitamins|mesh-ancestor
101485576|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
101375869|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
101375870|NCT00236392|Rabeprazole|rabeprazole|mesh-list
101375871|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101375872|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101375874|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545663|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101375875|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485577|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485578|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101485579|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101485580|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485581|NCT00317876|Cyclosporine|cyclosporine|mesh-list
101485582|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
101485583|NCT00317876|Methotrexate|methotrexate|mesh-list
101485584|NCT00317876|Cyclosporins|cyclosporins|mesh-list
101485585|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485586|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
101485587|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485588|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485589|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101485590|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
101485591|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485592|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485593|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101485594|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101485595|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
101485596|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485597|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485598|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
101485599|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485600|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485601|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101485602|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485603|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
101485604|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485605|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101485606|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
101485607|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485608|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
101485609|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485610|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485611|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101485612|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
101485613|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485614|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485615|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101485616|NCT00317915|Irbesartan|irbesartan|mesh-list
101485630|NCT00317993|Ezetimibe|ezetimibe|mesh-list
101485631|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101485632|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101485633|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
101485634|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485635|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485636|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101485638|NCT00350415|Mesalamine|mesalamine|mesh-list
101485639|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101485640|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485641|NCT00350415|Analgesics|analgesics|mesh-ancestor
101485642|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
101485643|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485644|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485645|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485646|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485647|NCT00345696|Bevacizumab|bevacizumab|mesh-list
101485648|NCT00345696|Capecitabine|capecitabine|mesh-list
101485649|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
101485650|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101375878|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375879|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375880|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
101375881|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375882|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375883|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101375884|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
101485651|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485652|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485653|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485654|NCT00345696|Growth Substances|growth substances|mesh-ancestor
101485655|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485656|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
101485657|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485659|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485660|NCT00350454|Sirolimus|sirolimus|mesh-list
101485661|NCT00350454|Temsirolimus|temsirolimus|mesh-list
101485662|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
101485663|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485664|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485665|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101485666|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485667|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
101485668|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485669|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
101485670|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485671|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485672|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485673|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485674|NCT00345735|Fentanyl|fentanyl|mesh-list
101485675|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485676|NCT00345735|Narcotics|narcotics|mesh-ancestor
101485680|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
101485681|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485682|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101485683|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101485684|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
101485685|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
101485686|NCT02959749|Bevacizumab|bevacizumab|mesh-list
101485688|NCT02959749|Osimertinib|osimertinib|mesh-list
101485689|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485690|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485691|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485692|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485693|NCT02959749|Growth Substances|growth substances|mesh-ancestor
101485694|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485695|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
101485696|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
101485697|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485698|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
101485699|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485700|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485701|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485702|NCT00318383|Vaccines|vaccines|mesh-list
101485703|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
101485704|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485705|NCT00318422|Liraglutide|liraglutide|mesh-list
101485706|NCT00318422|Glimepiride|glimepiride|mesh-list
101485707|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
101485708|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485709|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485710|NCT00318422|Incretins|incretins|mesh-ancestor
101485711|NCT00318422|Hormones|hormones|mesh-ancestor
101375885|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101375886|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
101375887|NCT00097929|Vorinostat|vorinostat|mesh-list
101375888|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485712|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485713|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101485714|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485715|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
101485716|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101485717|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
101485718|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101485719|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101485720|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101485721|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485722|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485723|NCT00346047|Buprenorphine|buprenorphine|mesh-list
101485724|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485725|NCT00346047|Narcotics|narcotics|mesh-ancestor
101485726|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485727|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485728|NCT00346047|Analgesics|analgesics|mesh-ancestor
101485729|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
101485730|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485731|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101485732|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101485733|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101485734|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
101485735|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
101485736|NCT00318773|Sertraline|sertraline|mesh-list
101485737|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
101485738|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101485739|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101485740|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101485741|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101485742|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485743|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485744|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
101485745|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485746|NCT00318890|Docetaxel|docetaxel|mesh-list
101485747|NCT00318890|Amifostine|amifostine|mesh-list
101485748|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485749|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101485752|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485753|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101485754|NCT00318890|Protective Agents|protective agents|mesh-ancestor
101485755|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485756|NCT00318968|Esomeprazole|esomeprazole|mesh-list
101485757|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101485758|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101485759|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101485760|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485761|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485762|NCT00319007|Sulindac|sulindac|mesh-list
101485763|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101485764|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101485765|NCT00319007|Analgesics|analgesics|mesh-ancestor
101485766|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
101485767|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485768|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485769|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485770|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485771|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485773|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485774|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485775|NCT00350961|Gemcitabine|gemcitabine|mesh-list
101485776|NCT00350961|Capecitabine|capecitabine|mesh-list
101485777|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
101485778|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485779|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
101375890|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101375891|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375892|NCT00236470|Risperidone|risperidone|mesh-list
101375893|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375894|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
101375895|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375896|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485780|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485781|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485782|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
101485783|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101485784|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485785|NCT00421473|Atovaquone|atovaquone|mesh-list
101485786|NCT00421473|Proguanil|proguanil|mesh-list
101485787|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101485788|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485789|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
101485790|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101485791|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101485792|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485793|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485794|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
101485795|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
101485796|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101485797|NCT00319163|Estradiol|estradiol|mesh-list
101485798|NCT00319163|Estrogens|estrogens|mesh-ancestor
101485799|NCT00319163|Hormones|hormones|mesh-ancestor
101485800|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485801|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485802|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101485803|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
101485804|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485805|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101485806|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101485807|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101485808|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101485810|NCT00319202|Candesartan cilexetil|candesartan cilexetil|mesh-list
101485811|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101485812|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101485813|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101485814|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485815|NCT00421512|Bevacizumab|bevacizumab|mesh-list
101485816|NCT00421512|Sunitinib|sunitinib|mesh-list
101485817|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485818|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485819|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485820|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485821|NCT00421512|Growth Substances|growth substances|mesh-ancestor
101485822|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485826|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485828|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101485829|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101485830|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
101485831|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485832|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485833|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101485834|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101485835|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
101485836|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485837|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485838|NCT00346359|Methotrexate|methotrexate|mesh-list
101375897|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375898|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375899|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375900|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375901|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101485839|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
101485840|NCT00346359|Fludarabine|fludarabine|mesh-list
101485841|NCT00346359|Busulfan|busulfan|mesh-list
101485842|NCT00346359|Tacrolimus|tacrolimus|mesh-list
101485843|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101485844|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101485845|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
101485846|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485847|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485848|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485849|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
101485850|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485851|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485852|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485853|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485854|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101485855|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485856|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
101485857|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101485858|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101485859|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101485860|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
101485861|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101485862|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101485863|NCT00319358|Antioxidants|antioxidants|mesh-list
101485864|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485865|NCT00319358|Protective Agents|protective agents|mesh-ancestor
101485866|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485867|NCT00319514|Docetaxel|docetaxel|mesh-list
101485868|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485869|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
101485870|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485871|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
101485872|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485873|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101485874|NCT00319670|Laxatives|laxatives|mesh-ancestor
101485875|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101485876|NCT00351195|Capecitabine|capecitabine|mesh-list
101485877|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
101485878|NCT00351195|Etoposide|etoposide|mesh-list
101485879|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485880|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
101485881|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485883|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101485884|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101485885|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485886|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485887|NCT00319709|Amibegron|amibegron|mesh-list
101485888|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101485889|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101485890|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101485891|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
101485892|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485893|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485894|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485911|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101485912|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
101485913|NCT00319865|Hormones|hormones|mesh-ancestor
101485914|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485915|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101485916|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485917|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101375902|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101375903|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
101375904|NCT00236509|Topiramate|topiramate|mesh-list
101375905|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
101375906|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375907|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375908|NCT02962141|Paclitaxel|paclitaxel|mesh-list
101485918|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101485919|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485920|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485921|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485922|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485923|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
101485924|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
101485925|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485926|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485927|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101485928|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101485929|NCT00319865|Growth Substances|growth substances|mesh-ancestor
101485930|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
101485931|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
101485932|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485933|NCT00320021|Vitamins|vitamins|mesh-ancestor
101485934|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
101485935|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485936|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
101485937|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
101485938|NCT00320060|Vitamins|vitamins|mesh-ancestor
101485939|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
101485940|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485941|NCT00320099|Insulin|insulin|mesh-list
101485942|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101485943|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
101485944|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101485945|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101485946|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101485947|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
101485948|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485949|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485950|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485951|NCT00320294|Irinotecan|irinotecan|mesh-list
101485952|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485953|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101485954|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485971|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101485972|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
101485973|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101485974|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485975|NCT00351507|Vildagliptin|vildagliptin|mesh-list
101485976|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101485977|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485978|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101485979|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
101485980|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485981|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485982|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101485983|NCT00320567|Norgestimate|norgestimate|mesh-list
101485984|NCT00320567|Estradiol|estradiol|mesh-list
101485985|NCT00320567|Estrogens|estrogens|mesh-ancestor
101485986|NCT00320567|Hormones|hormones|mesh-ancestor
101485987|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485988|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485989|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101485990|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
101485991|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485992|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101485993|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101485994|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101375909|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101375910|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375911|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
101375912|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
101375913|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
101485995|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101485996|NCT00346827|Apomorphine|apomorphine|mesh-list
101485997|NCT00346827|Emetics|emetics|mesh-ancestor
101485998|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485999|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
101486000|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486001|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486002|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
101486003|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
101486004|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486005|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486006|NCT00346866|Anecortave|anecortave|mesh-list
101486007|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101486008|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101486009|NCT00346866|Growth Substances|growth substances|mesh-ancestor
101486010|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486011|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
101486012|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486013|NCT00320723|Bupropion|bupropion|mesh-list
101486014|NCT00320723|Nicotine|nicotine|mesh-list
101486015|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101486018|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486019|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101486020|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101486021|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
101486022|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486023|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486024|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101486025|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486026|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486027|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101486028|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486029|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486030|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
101486031|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101486032|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101486034|NCT00351546|Vildagliptin|vildagliptin|mesh-list
101486035|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486036|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486037|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101486039|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486040|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486041|NCT00351585|Vildagliptin|vildagliptin|mesh-list
101486042|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486043|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486044|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101486045|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
101486046|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486047|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486048|NCT00320879|Irbesartan|irbesartan|mesh-list
101486049|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101486050|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101486051|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101486052|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486053|NCT00347100|Metformin|metformin|mesh-list
101486054|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
101486055|NCT00347100|Glyburide|glyburide|mesh-list
101486056|NCT00347100|Glipizide|glipizide|mesh-list
101486057|NCT00347100|Gliclazide|gliclazide|mesh-list
101486058|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486059|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486060|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101486061|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101486062|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
101375914|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375915|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
101375916|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375917|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101375918|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
101375919|NCT00236548|Risperidone|risperidone|mesh-list
101375920|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375921|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
101486063|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486064|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486065|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486066|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486067|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101486068|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101486069|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101486070|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
101486071|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486072|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486073|NCT00321074|Tacrolimus|tacrolimus|mesh-list
101486074|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486075|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
101486076|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486077|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101486078|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486079|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486080|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
101486081|NCT00321113|Tacrolimus|tacrolimus|mesh-list
101486082|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486083|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
101486084|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486085|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101486086|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486087|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486092|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486093|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486094|NCT00347256|Cisplatin|cisplatin|mesh-list
101486095|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486096|NCT00347295|Estazolam|estazolam|mesh-list
101486097|NCT00347295|Brotizolam|brotizolam|mesh-list
101486098|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
101486099|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101486100|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486101|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486102|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486103|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486104|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
101486105|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
101486106|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486107|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486108|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101486109|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
101486110|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101486111|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
101486112|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
101486113|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486114|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486115|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486116|NCT00321191|Analgesics|analgesics|mesh-ancestor
101486117|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
101486118|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486119|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
101486120|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101486121|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
101486122|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486123|NCT00321230|Protective Agents|protective agents|mesh-ancestor
101486124|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375922|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375923|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375924|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375925|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375926|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486125|NCT00321230|Vitamins|vitamins|mesh-ancestor
101486126|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
101486127|NCT00321230|Laxatives|laxatives|mesh-ancestor
101486128|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486129|NCT00351663|Enoxaparin|enoxaparin|mesh-list
101486130|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
101486131|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101486132|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101486133|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486134|NCT00321347|Lidocaine|lidocaine|mesh-list
101486135|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
101486136|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
101486137|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486138|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486139|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
101486140|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486141|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101486142|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101486143|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101486144|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486145|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486146|NCT00351702|Isoniazid|isoniazid|mesh-list
101486147|NCT00351702|Ethambutol|ethambutol|mesh-list
101486148|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
101486149|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486150|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486151|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101486152|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101486153|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
101486154|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486155|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101486156|NCT00351975|Azacitidine|azacitidine|mesh-list
101486157|NCT00351975|Belinostat|belinostat|mesh-list
101486158|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101486159|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
101486160|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486162|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486163|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101486164|NCT00321581|Cediranib|cediranib|mesh-list
101486165|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486166|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486167|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486168|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486169|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
101486170|NCT00352092|Sirolimus|sirolimus|mesh-list
101486171|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101486172|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101486173|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486174|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101486175|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
101486176|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486177|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486178|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486179|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486180|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
101486181|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486182|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
101486183|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486184|NCT00322127|Plerixafor|plerixafor|mesh-list
101486185|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101486186|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101486187|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
101486188|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375927|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375928|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375929|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101375930|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
101375931|NCT00236587|Risperidone|risperidone|mesh-list
101375932|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101375933|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
101375934|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375935|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486189|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
101486191|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
101486192|NCT00352170|Calcium|calcium|mesh-list
101486193|NCT00352170|Vitamins|vitamins|mesh-ancestor
101486194|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
101486195|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486196|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101486197|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101486198|NCT00322166|Calcium|calcium|mesh-list
101486199|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101486200|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486201|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
101486202|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
101486203|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486204|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101486205|NCT00352287|Pioglitazone|pioglitazone|mesh-list
101486206|NCT00352287|Hormones|hormones|mesh-list
101486207|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486208|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486209|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486211|NCT00352443|Lapatinib|lapatinib|mesh-list
101486212|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101486213|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486214|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486215|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486216|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486217|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
101486218|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486219|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486220|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
101486221|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
101486222|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101486223|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101486224|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486225|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486226|NCT00352482|Urological Agents|urological agents|mesh-ancestor
101486227|NCT00322400|Paclitaxel|paclitaxel|mesh-list
101486228|NCT00322400|Docetaxel|docetaxel|mesh-list
101486229|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
101486230|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101486231|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486232|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
101486233|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
101486234|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
101486240|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101486242|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101486243|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101486244|NCT00352521|Growth Substances|growth substances|mesh-ancestor
101486245|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486246|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
101486247|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101486248|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101486249|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486250|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486251|NCT00352599|Lovastatin|lovastatin|mesh-list
101375936|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375937|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101375938|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101375939|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101375940|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375941|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101375942|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
101375944|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
101375945|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486252|NCT00352599|L 647318|l 647318|mesh-list
101486253|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
101486254|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101486255|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101486256|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
101486257|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486258|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101486259|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101486260|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486262|NCT00322595|Paroxetine|paroxetine|mesh-list
101486263|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486264|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486265|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101486266|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486267|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486268|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486269|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101486270|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486271|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486272|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486273|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486274|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
101486275|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101486276|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101486277|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101486278|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486280|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486281|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486282|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486283|NCT00331149|Ropinirole|ropinirole|mesh-list
101486284|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101486285|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101486286|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
101486287|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
101486288|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486289|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486290|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486291|NCT00331188|Vapreotide|vapreotide|mesh-list
101486292|NCT00331188|Analgesics|analgesics|mesh-ancestor
101486293|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
101486294|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486295|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486296|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486297|NCT00352833|Catumaxomab|catumaxomab|mesh-list
101486298|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486299|NCT00331305|Sertraline|sertraline|mesh-list
101486300|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486301|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486302|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101486305|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486306|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101375947|NCT00236665|Topiramate|topiramate|mesh-list
101375948|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
101375949|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375950|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375951|NCT00399282|Vitamin E|vitamin e|mesh-list
101375952|NCT00399282|Vitamins|vitamins|mesh-ancestor
101375953|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
101375954|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486307|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
101486308|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486309|NCT00322751|Topotecan|topotecan|mesh-list
101486310|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101486311|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101486312|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486313|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486314|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486315|NCT00352950|Panitumumab|panitumumab|mesh-list
101486316|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101486317|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486318|NCT00322907|Mefloquine|mefloquine|mesh-list
101486319|NCT00322907|Quinine|quinine|mesh-list
101486320|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
101486321|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101486322|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101486323|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486324|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101486325|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486326|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101486327|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486328|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486329|NCT00322907|Analgesics|analgesics|mesh-ancestor
101486330|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
101486331|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101486332|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101486333|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101486334|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101486335|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486336|NCT00331500|Analgesics|analgesics|mesh-ancestor
101486337|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
101486338|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486339|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486340|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486341|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486342|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101486343|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101486344|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101486345|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
101486346|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
101486347|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486348|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486349|NCT00322985|Lenalidomide|lenalidomide|mesh-list
101486350|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
101486351|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486352|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101486353|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101486354|NCT00322985|Growth Substances|growth substances|mesh-ancestor
101486355|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
101486356|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486358|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486359|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486360|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101486361|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486362|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486363|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486364|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101375955|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
101375956|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375957|NCT00399282|Protective Agents|protective agents|mesh-ancestor
101375958|NCT00236704|Topiramate|topiramate|mesh-list
101486365|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101486366|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486367|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486368|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486369|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
101486370|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101486371|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486372|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101486377|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486378|NCT00353067|Analgesics|analgesics|mesh-ancestor
101486379|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
101486380|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486381|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486382|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486383|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486384|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101486385|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486386|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486387|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
101486388|NCT00323219|Cefazolin|cefazolin|mesh-list
101486389|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486390|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486391|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101486392|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101486393|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486394|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486395|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486396|NCT00323375|Chloroquine|chloroquine|mesh-list
101486397|NCT00323375|Amebicides|amebicides|mesh-ancestor
101486398|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101486399|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101486400|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486401|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
101486402|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486403|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101486405|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101486406|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
101486407|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486408|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486409|NCT00331695|Progestins|progestins|mesh-ancestor
101486410|NCT00331695|Hormones|hormones|mesh-ancestor
101486411|NCT00353145|Gemcitabine|gemcitabine|mesh-list
101486412|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
101486413|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101486414|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
101486415|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486416|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486417|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101486418|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486419|NCT00353184|Montelukast|montelukast|mesh-list
101486420|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486421|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486422|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101486423|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
101486424|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486425|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486426|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101486427|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101486428|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486429|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101486430|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101486431|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101375960|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101375961|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375962|NCT00236743|Topiramate|topiramate|mesh-list
101375963|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
101375964|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486433|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486434|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
101486435|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486436|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101486437|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101486438|NCT00323804|Ribavirin|ribavirin|mesh-list
101486439|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101486440|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
101486445|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101486446|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
101486447|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486448|NCT00353340|Expectorants|expectorants|mesh-ancestor
101486449|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486450|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101486451|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
101486452|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486453|NCT00353340|Protective Agents|protective agents|mesh-ancestor
101486454|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486455|NCT00353340|Antidotes|antidotes|mesh-ancestor
101486456|NCT00323843|Isoproterenol|isoproterenol|mesh-list
101486457|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101486458|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101486459|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
101486460|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486461|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486462|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486463|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101486464|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
101486465|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486466|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486467|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486468|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101486469|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
101486470|NCT00323843|Protective Agents|protective agents|mesh-ancestor
101486471|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
101486473|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
101486474|NCT00331851|Liraglutide|liraglutide|mesh-list
101486475|NCT00331851|Glimepiride|glimepiride|mesh-list
101486476|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486477|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486479|NCT00331851|Hormones|hormones|mesh-ancestor
101486480|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486481|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101486482|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486483|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
101486484|NCT00331890|Choline|choline|mesh-list
101486485|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101486486|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
101486487|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101486488|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
101486489|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486490|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486491|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101486492|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
101486493|NCT01059773|Methotrexate|methotrexate|mesh-list
101486494|NCT01059773|Ustekinumab|ustekinumab|mesh-list
101486495|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101486496|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
101486497|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101486498|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486499|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101486500|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
101375965|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375967|NCT00236782|Norelgestromin|norelgestromin|mesh-list
101375968|NCT00236782|Estradiol|estradiol|mesh-list
101375969|NCT00236782|Estrogens|estrogens|mesh-ancestor
101375970|NCT00236782|Hormones|hormones|mesh-ancestor
101375971|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486501|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486502|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486503|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
101486504|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486505|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101486506|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486507|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
101486508|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486509|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101486510|NCT00353379|Guanfacine|guanfacine|mesh-list
101486511|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101486512|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101486516|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486517|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486518|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486519|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
101486520|NCT00324077|Dasatinib|dasatinib|mesh-list
101486521|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486522|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486523|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486524|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486526|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101486527|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486528|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486530|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
101486531|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486532|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
101486533|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486534|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
101545687|NCT01346592|Vaccines|vaccines|mesh-list
101486535|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486536|NCT00353691|Metformin|metformin|mesh-list
101486537|NCT00353691|Glimepiride|glimepiride|mesh-list
101486538|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486539|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486540|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101486541|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486542|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
101486543|NCT00332046|Casopitant|casopitant|mesh-list
101486544|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
101486545|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
101486546|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486547|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486548|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486549|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101486550|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486551|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486552|NCT00324467|Acetaminophen|acetaminophen|mesh-list
101486553|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
101486554|NCT00324467|Promethazine|promethazine|mesh-list
101486555|NCT00324467|Dexamethasone|dexamethasone|mesh-list
101486556|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
101486557|NCT00324467|Prednisone|prednisone|mesh-list
101486558|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
101486559|NCT00324467|Ifosfamide|ifosfamide|mesh-list
101486560|NCT00324467|Rituximab|rituximab|mesh-list
101486561|NCT00324467|Carboplatin|carboplatin|mesh-list
101486562|NCT00324467|Doxorubicin|doxorubicin|mesh-list
101486563|NCT00324467|Etoposide|etoposide|mesh-list
101486564|NCT00324467|Vincristine|vincristine|mesh-list
101486565|NCT00324467|Ondansetron|ondansetron|mesh-list
101486566|NCT00324467|BB 1101|bb 1101|mesh-list
101486567|NCT00324467|Mesna|mesna|mesh-list
101375972|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375973|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101375974|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
101375975|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101486568|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486569|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
101486570|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486571|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486572|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101486573|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
101486574|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486575|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486576|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101486577|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101486578|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486579|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
101486580|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
101486581|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486582|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486583|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
101486584|NCT00324467|Hormones|hormones|mesh-ancestor
101486585|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486586|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101486607|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101486608|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101486609|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486610|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
101486612|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101486613|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
101486614|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
101486615|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101486617|NCT00332085|Picolinic acid|picolinic acid|mesh-list
101486618|NCT00332085|Trace Elements|trace elements|mesh-ancestor
101486619|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
101486620|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486621|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101486622|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
101486623|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
101486624|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486625|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
101486626|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101486627|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486628|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101486629|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
101486630|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486631|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486632|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486633|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486635|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
101486636|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101486637|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
101486638|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486639|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486640|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101486641|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
101486642|NCT04714554|Erythromycin|erythromycin|mesh-list
101486643|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
101486647|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486648|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486649|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486650|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101486651|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486652|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486653|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
101486654|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
101486655|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101375976|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101375977|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101375978|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101375980|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101375981|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101375982|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486656|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486657|NCT00419471|Escitalopram|escitalopram|mesh-list
101486658|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101486659|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486660|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486661|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486662|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486663|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
101486664|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486665|NCT00426348|Valsartan|valsartan|mesh-list
101486666|NCT00426348|Probucol|probucol|mesh-list
101486667|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101486668|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101486669|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101486670|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486671|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101486672|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101486673|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
101486674|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101486676|NCT00426348|Protective Agents|protective agents|mesh-ancestor
101486677|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486678|NCT00353808|Reboxetine|reboxetine|mesh-list
101486679|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486680|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486681|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101486682|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486683|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486684|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486685|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101486686|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486687|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486688|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
101486689|NCT00324623|Fludarabine|fludarabine|mesh-list
101486690|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
101486691|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486692|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
101486693|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486694|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486695|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101486696|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
101486697|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486698|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486699|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101486700|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101486701|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
101486702|NCT00324779|Rituximab|rituximab|mesh-list
101486703|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101486704|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486705|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
101486706|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486707|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486708|NCT00324818|Azithromycin|azithromycin|mesh-list
101486709|NCT00324818|Metronidazole|metronidazole|mesh-list
101486710|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101486711|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486712|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101486713|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101486728|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486729|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
101375983|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375985|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
101375986|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101375987|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375989|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101375990|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101375991|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101375992|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101375993|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101375994|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486730|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101486731|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
101486732|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486733|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486734|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
101486735|NCT00325169|Hormones|hormones|mesh-ancestor
101486736|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486737|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
101486738|NCT00426543|Rituximab|rituximab|mesh-list
101486739|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101486740|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486741|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
101486742|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486743|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486744|NCT00325286|Carbamazepine|carbamazepine|mesh-list
101486745|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486746|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486747|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
101486748|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486749|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486750|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486751|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
101486752|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486753|NCT00325286|Analgesics|analgesics|mesh-ancestor
101486754|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
101486755|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486756|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101486757|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486758|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101486759|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101486760|NCT00325325|Everolimus|everolimus|mesh-list
101486761|NCT00325325|Tacrolimus|tacrolimus|mesh-list
101486762|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486763|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
101486764|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486765|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101486766|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486767|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486768|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101486769|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486770|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486771|NCT00354081|Vitamins|vitamins|mesh-list
101486772|NCT00354081|Folic Acid|folic acid|mesh-list
101486773|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
101486774|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
101486781|NCT00354081|Hematinics|hematinics|mesh-ancestor
101486782|NCT00325637|Losartan|losartan|mesh-list
101486783|NCT00325637|Cilnidipine|cilnidipine|mesh-list
101486784|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101486785|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101375995|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101375996|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101375997|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101486786|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101486787|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101486788|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486789|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101486790|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486791|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101486792|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486793|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
101486794|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486795|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
101486796|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486797|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486798|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101486799|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
101486800|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486801|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486802|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101486803|NCT00426582|Epothilone B|epothilone b|mesh-list
101486804|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486805|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101486806|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101486807|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101486808|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486809|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101486810|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
101486811|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101486812|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486813|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486814|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101486815|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101486816|NCT00354198|Protective Agents|protective agents|mesh-ancestor
101486817|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486818|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
101486819|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101486820|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
101486821|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486822|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
101486823|NCT00354198|Hormones|hormones|mesh-ancestor
101486824|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486825|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101486826|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101486827|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486828|NCT00325676|Pantoprazole|pantoprazole|mesh-list
101486829|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101486830|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486831|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101486832|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486833|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486834|NCT00325715|Esomeprazole|esomeprazole|mesh-list
101486835|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101486836|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486837|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101486838|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486839|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486840|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101486841|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486842|NCT00325793|Nicardipine|nicardipine|mesh-list
101486843|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101486844|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101486845|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486858|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486859|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101486860|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486861|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486862|NCT04714242|Ranibizumab|ranibizumab|mesh-list
101375998|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101375999|NCT00236860|Topiramate|topiramate|mesh-list
101376000|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
101376001|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376002|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376003|NCT00065117|Leucovorin|leucovorin|mesh-list
101376004|NCT00065117|Fluorouracil|fluorouracil|mesh-list
101376005|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
101376006|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
101486863|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101486864|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101486865|NCT04714242|Growth Substances|growth substances|mesh-ancestor
101486866|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486867|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
101486868|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486869|NCT00354276|Cytarabine|cytarabine|mesh-list
101486870|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101486871|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
101486872|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486873|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486874|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
101486875|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486876|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486877|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
101486878|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486879|NCT00325910|Metformin|metformin|mesh-list
101486880|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101486881|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486882|NCT00325949|Acetaminophen|acetaminophen|mesh-list
101486883|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101486884|NCT00325949|Hydrocodone|hydrocodone|mesh-list
101486885|NCT00325949|Oxycodone|oxycodone|mesh-list
101486886|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486888|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
101486889|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486890|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486891|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
101486892|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101486893|NCT00325949|Narcotics|narcotics|mesh-ancestor
101486894|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486895|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
101486896|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486897|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101486898|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486899|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486900|NCT00326027|Pantoprazole|pantoprazole|mesh-list
101486901|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101486902|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486903|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101486904|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486905|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486906|NCT01059318|Everolimus|everolimus|mesh-list
101486907|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101486908|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486914|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486915|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
101486916|NCT04714515|Ivermectin|ivermectin|mesh-list
101486917|NCT04714515|Montelukast|montelukast|mesh-list
101486918|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
101486919|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101486920|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101486921|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486922|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486923|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486924|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486925|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486926|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486927|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101376007|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376008|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101376009|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376010|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376011|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
101486928|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
101486929|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101486930|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486931|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101486932|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101486933|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101486934|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486935|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486936|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101486937|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486938|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486939|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486940|NCT00354354|Ipratropium|ipratropium|mesh-list
101486941|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101486942|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
101486943|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486944|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486945|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486946|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
101486947|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486948|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486949|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101486950|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
101486951|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101486952|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
101486953|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101486954|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101486955|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101486956|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101486957|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486958|NCT01058655|Everolimus|everolimus|mesh-list
101486959|NCT01058655|Tivozanib|tivozanib|mesh-list
101486960|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101486961|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486962|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486963|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486964|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486965|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
101486966|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486967|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486968|NCT00326300|Methylphenidate|methylphenidate|mesh-list
101486969|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101486970|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486971|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101486972|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486973|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486974|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486975|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
101486976|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486987|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101486988|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486989|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486990|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101486991|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486992|NCT00419549|Analgesics|analgesics|mesh-ancestor
101486993|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
101486994|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486995|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376012|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376013|NCT00065117|Antidotes|antidotes|mesh-ancestor
101376014|NCT00065117|Protective Agents|protective agents|mesh-ancestor
101376015|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
101376017|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
101376018|NCT00237016|Doxycycline|doxycycline|mesh-list
101486996|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101486997|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101486998|NCT00326378|Docetaxel|docetaxel|mesh-list
101486999|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487000|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487001|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487002|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487003|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487004|NCT00326768|Telmisartan|telmisartan|mesh-list
101487005|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101487006|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487007|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101487008|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101487009|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487010|NCT00326768|Diuretics|diuretics|mesh-ancestor
101487011|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
101487012|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487013|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101487014|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487015|NCT00326807|Naltrexone|naltrexone|mesh-list
101487016|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101487017|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101487018|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487019|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
101487020|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487021|NCT00354549|Bevacizumab|bevacizumab|mesh-list
101487022|NCT00354549|Carboplatin|carboplatin|mesh-list
101487023|NCT00354549|Gemcitabine|gemcitabine|mesh-list
101487024|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101487025|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487026|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487027|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101487028|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101487029|NCT00354549|Growth Substances|growth substances|mesh-ancestor
101487030|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487031|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
101487032|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101487034|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487035|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101487036|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487037|NCT01057251|Nebivolol|nebivolol|mesh-list
101487038|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487039|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487061|NCT00425646|Bevacizumab|bevacizumab|mesh-list
101487062|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
101487063|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487064|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487065|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101487066|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101487067|NCT00425646|Growth Substances|growth substances|mesh-ancestor
101487068|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487069|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
101487070|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101487071|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487072|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487073|NCT00327080|Acetylcholine|acetylcholine|mesh-list
101487074|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487075|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101487076|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
101487077|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487078|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376019|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376020|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376021|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
101376022|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101376023|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101376024|NCT00237133|Letrozole|letrozole|mesh-list
101487079|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487080|NCT00327119|Panitumumab|panitumumab|mesh-list
101487081|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487082|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487083|NCT00426933|Vancomycin|vancomycin|mesh-list
101487084|NCT00426933|Daptomycin|daptomycin|mesh-list
101487085|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487086|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487087|NCT00327197|Prednisolone|prednisolone|mesh-list
101487088|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487089|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
101487090|NCT00327197|Hormones|hormones|mesh-ancestor
101487091|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487095|NCT00425724|Cyclosporine|cyclosporine|mesh-list
101487096|NCT00425724|Prednisone|prednisone|mesh-list
101487097|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
101487098|NCT00425724|Cyclosporins|cyclosporins|mesh-list
101487099|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487100|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
101487101|NCT00425724|Hormones|hormones|mesh-ancestor
101487102|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487103|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487104|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487105|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487106|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487107|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487108|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487109|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
101487110|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
101487111|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487112|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487113|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487114|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101487115|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
101487117|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487118|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487119|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101487120|NCT00425724|Protective Agents|protective agents|mesh-ancestor
101487122|NCT00426972|Estrogens|estrogens|mesh-ancestor
101487123|NCT00426972|Hormones|hormones|mesh-ancestor
101487124|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487125|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487126|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
101487127|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101487128|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101487129|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
101487130|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487131|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487132|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101487133|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487134|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101487135|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101487136|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101487137|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487138|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487139|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487140|NCT00425841|Gemcitabine|gemcitabine|mesh-list
101487141|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
101487142|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101487143|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
101487144|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487145|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376025|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376026|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101376027|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101487146|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
101487147|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101487148|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
101487149|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487150|NCT00427089|Protective Agents|protective agents|mesh-ancestor
101487151|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487152|NCT00427089|Vitamins|vitamins|mesh-ancestor
101487153|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
101487154|NCT00427089|Laxatives|laxatives|mesh-ancestor
101487155|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487156|NCT00427128|Fluoxetine|fluoxetine|mesh-list
101487157|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101487158|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101487159|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487160|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487161|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487164|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101487165|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487166|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487167|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101487168|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101487169|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487170|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101487171|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101487172|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
101487173|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487175|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487176|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487177|NCT00427206|Acetaminophen|acetaminophen|mesh-list
101487178|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101487179|NCT00427206|Analgesics|analgesics|mesh-ancestor
101487180|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
101487181|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487182|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487183|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
101487184|NCT00425997|Amlodipine|amlodipine|mesh-list
101487185|NCT00425997|Valsartan|valsartan|mesh-list
101487186|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101487187|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487188|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101487189|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487190|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487191|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101487192|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487193|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487194|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101487195|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101487196|NCT00425997|Diuretics|diuretics|mesh-ancestor
101487197|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
101487198|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101487199|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
101487200|NCT00427245|Goserelin|goserelin|mesh-list
101487201|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487202|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
101487203|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487204|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487205|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101487206|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
101487207|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487208|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487209|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101487210|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487211|NCT05458076|Ritonavir|ritonavir|mesh-list
101487212|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101487213|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101487214|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
101487215|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376028|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376029|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376030|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101376031|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376032|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487216|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487217|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101487218|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101487219|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
101487220|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487221|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101487222|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101487224|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101487225|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487226|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487227|NCT00426192|Mannitol|mannitol|mesh-list
101487228|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101487229|NCT00426192|Diuretics|diuretics|mesh-ancestor
101487230|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
101487231|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487232|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101487233|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
101487237|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487238|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487239|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101487240|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101487241|NCT00432393|Levodopa|levodopa|mesh-list
101487242|NCT00432393|Carbidopa|carbidopa|mesh-list
101487243|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101487244|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101487245|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101487246|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
101487247|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487248|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487249|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487250|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101487251|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487252|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101487253|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
101487254|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
101487255|NCT05453045|Albendazole|albendazole|mesh-list
101487256|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
101487257|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101487258|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487259|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
101487260|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101487261|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101487262|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487263|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487264|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487265|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487266|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487268|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101487269|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487270|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487271|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487272|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487273|NCT02957448|Rifampin|rifampin|mesh-list
101487274|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101487275|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
101487276|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487277|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487278|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
101487279|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101487280|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487281|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376035|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376036|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376037|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376038|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376039|NCT00237211|Letrozole|letrozole|mesh-list
101376040|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376041|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101376042|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101376043|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376044|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376045|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101376046|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376047|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376048|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376049|NCT00098007|Everolimus|everolimus|mesh-list
101376050|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101376051|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376052|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487282|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101487283|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101487284|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101487285|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101487286|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101487287|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101487288|NCT00427596|Solabegron|solabegron|mesh-list
101487289|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101487290|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101487291|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101487292|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487293|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487294|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487295|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487296|NCT00432510|Complement C1s|complement c1s|mesh-list
101487297|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101487298|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101487299|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
101487300|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487301|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101487302|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487303|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
101487306|NCT05354258|Amodiaquine|amodiaquine|mesh-list
101487307|NCT05354258|Albendazole|albendazole|mesh-list
101487308|NCT05354258|Praziquantel|praziquantel|mesh-list
101487309|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
101487310|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101487311|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101487312|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487313|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101487314|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376053|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376054|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376055|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
101376056|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376057|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376058|NCT00237250|Vildagliptin|vildagliptin|mesh-list
101376059|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376060|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376061|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101376062|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
101376063|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376064|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376066|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
101376067|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101487315|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487316|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101487317|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
101487318|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
101487319|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101487320|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487321|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487322|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487323|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487324|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
101487325|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487326|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487327|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101487328|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487329|NCT02273466|Desipramine|desipramine|mesh-list
101487330|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101487331|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487332|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487333|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487334|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487335|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101487336|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101487337|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487338|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487339|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487340|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487341|NCT00427713|Capecitabine|capecitabine|mesh-list
101487342|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
101487343|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101487344|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
101487345|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487346|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487347|NCT02273505|Aspirin|aspirin|mesh-list
101487349|NCT02273505|Salicylates|salicylates|mesh-list
101487350|NCT02273505|Dipyridamole|dipyridamole|mesh-list
101487351|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101487352|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487353|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
101487354|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
101487355|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487356|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376068|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376069|NCT00237328|Heparin|heparin|mesh-list
101376070|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
101376071|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101376072|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101376073|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376074|NCT00237367|Rabeprazole|rabeprazole|mesh-list
101376075|NCT00237367|Pantoprazole|pantoprazole|mesh-list
101376076|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101376077|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376078|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101487357|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101487358|NCT02273505|Analgesics|analgesics|mesh-ancestor
101487359|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
101487360|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487361|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487362|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487363|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487364|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101487365|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487366|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487367|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101487368|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101487369|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101487370|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
101487371|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101487372|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487373|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
101487374|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
101487375|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487376|NCT05198960|Aspirin|aspirin|mesh-list
101487377|NCT05198960|Anticoagulants|anticoagulants|mesh-list
101487442|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101487443|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487444|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101487445|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487446|NCT00432627|Deferasirox|deferasirox|mesh-list
101487447|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101487448|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
101487449|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
101487450|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487451|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
101487452|NCT00419783|Ketoconazole|ketoconazole|mesh-list
101487453|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487454|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487455|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101487456|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101487457|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487458|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487459|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487460|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487461|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
101487462|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101487463|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101487464|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101487465|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
101487466|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487467|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101487469|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101487470|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487471|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487472|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487473|NCT00432861|Pancrelipase|pancrelipase|mesh-list
101376079|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376080|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376081|NCT00098046|Famciclovir|famciclovir|mesh-list
101487474|NCT00432861|Pancreatin|pancreatin|mesh-list
101487475|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487476|NCT04575233|Ropivacaine|ropivacaine|mesh-list
101487477|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
101487478|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
101487479|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487480|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487481|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
101487482|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487483|NCT04507412|Dexamethasone|dexamethasone|mesh-list
101487484|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487485|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
101487486|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
101487487|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487488|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487489|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487496|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487497|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487498|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101487499|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487500|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
101487501|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487502|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
101487503|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487504|NCT00432978|Bosentan|bosentan|mesh-list
101487505|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487506|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101487507|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487508|NCT01051791|Everolimus|everolimus|mesh-list
101487509|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101487510|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101487511|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487512|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487513|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487514|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
101487515|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487516|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487517|NCT01056510|Rituximab|rituximab|mesh-list
101487518|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101487519|NCT01056510|Chlorambucil|chlorambucil|mesh-list
101487520|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487521|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487522|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
101487523|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487524|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487525|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101487526|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
101487527|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487528|NCT01056276|Dexamethasone|dexamethasone|mesh-list
101487529|NCT01056276|Bortezomib|bortezomib|mesh-list
101487530|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101487531|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487532|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
101487533|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
101487534|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487535|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487536|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487537|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
101487538|NCT01056276|Hormones|hormones|mesh-ancestor
101487539|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487540|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487541|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487542|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101487543|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
101487544|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487545|NCT01055886|Nicotine|nicotine|mesh-list
101487546|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101487547|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
101487548|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376082|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
101376083|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376084|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101376085|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376086|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376088|NCT00065273|Risperidone|risperidone|mesh-list
101376089|NCT00065273|Clozapine|clozapine|mesh-list
101487549|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487550|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101487551|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101487552|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101487553|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487554|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487555|NCT00433095|Trastuzumab|trastuzumab|mesh-list
101487556|NCT00433095|Vinorelbine|vinorelbine|mesh-list
101487557|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487572|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
101487573|NCT03852992|Minoxidil|minoxidil|mesh-list
101487574|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487575|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487576|NCT00433173|Anastrozole|anastrozole|mesh-list
101487577|NCT00433173|Goserelin|goserelin|mesh-list
101487578|NCT00433173|Testosterone|testosterone|mesh-list
101487579|NCT00433173|Androgens|androgens|mesh-ancestor
101487580|NCT00433173|Hormones|hormones|mesh-ancestor
101487581|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487582|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487583|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487584|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487585|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101487586|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101487587|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487588|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487589|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101487590|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
101487591|NCT01055028|Paclitaxel|paclitaxel|mesh-list
101487592|NCT01055028|Bevacizumab|bevacizumab|mesh-list
101487593|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101487594|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487595|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487596|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487597|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487598|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487599|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487600|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101487601|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101487602|NCT01055028|Growth Substances|growth substances|mesh-ancestor
101487603|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487604|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
101487606|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101487607|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
101487608|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487609|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487610|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101487611|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487612|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101487613|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
101487614|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487615|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487616|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101487617|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487635|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487636|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487637|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
101487638|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376090|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101376092|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376093|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376094|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376095|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101376096|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101376097|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487639|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101487640|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101487641|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101487642|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487643|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487645|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101487646|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101487647|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487648|NCT04703127|Urological Agents|urological agents|mesh-ancestor
101487649|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
101487650|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101487651|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
101487652|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487653|NCT00428883|Expectorants|expectorants|mesh-ancestor
101487654|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487655|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101487656|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
101487657|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487658|NCT00428883|Protective Agents|protective agents|mesh-ancestor
101487659|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487660|NCT00428883|Antidotes|antidotes|mesh-ancestor
101487661|NCT04702971|Flunarizine|flunarizine|mesh-list
101487662|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
101487663|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101487664|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487665|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487666|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101487667|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487668|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101487669|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
101487670|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
101487671|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487672|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487673|NCT00433407|Trastuzumab|trastuzumab|mesh-list
101487674|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487676|NCT00433485|Sirolimus|sirolimus|mesh-list
101487677|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487678|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487679|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101487680|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487681|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
101487682|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487683|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
101487684|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487685|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
101487686|NCT02676791|Povidone|povidone|mesh-list
101487687|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
101487688|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
101487689|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101487690|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487691|NCT01600079|Vaccines|vaccines|mesh-list
101487692|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
101487693|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487694|NCT01370486|Melatonin|melatonin|mesh-list
101487695|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
101487696|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487697|NCT01370486|Protective Agents|protective agents|mesh-ancestor
101376098|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101376099|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101376100|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
101376101|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
101376102|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
101376103|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376104|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376105|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101487698|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487699|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487700|NCT00327587|Amlodipine|amlodipine|mesh-list
101487701|NCT00327587|Valsartan|valsartan|mesh-list
101487702|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101487703|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101487704|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101487705|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487706|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487707|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101487708|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487709|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487710|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101487711|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101487712|NCT00327587|Diuretics|diuretics|mesh-ancestor
101487713|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
101487714|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101487715|NCT00327665|Vaccines|vaccines|mesh-list
101487716|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101487717|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
101487718|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487719|NCT00433641|Sibutramine|sibutramine|mesh-list
101487720|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487721|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487722|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
101487723|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101487724|NCT00429234|Gemcitabine|gemcitabine|mesh-list
101487725|NCT00429234|Dasatinib|dasatinib|mesh-list
101487726|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101487727|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
101487728|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487729|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487730|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101487731|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487732|NCT00433719|Efavirenz|efavirenz|mesh-list
101487733|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101487734|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101487735|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101487736|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487737|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487738|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
101487739|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487740|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101487741|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101487742|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101487743|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101487744|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101487745|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101487746|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101487747|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101487755|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
101487757|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487758|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487759|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
101487760|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487761|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101487762|NCT04704297|Analgesics|analgesics|mesh-ancestor
101376106|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101376107|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376108|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
101376109|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
101376110|NCT00237445|Azithromycin|azithromycin|mesh-list
101376111|NCT00237445|Telithromycin|telithromycin|mesh-list
101487763|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
101487764|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101487765|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487766|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487767|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101487768|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487769|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487770|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101487772|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487773|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101487774|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101487775|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101487776|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101487777|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101487778|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487779|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487780|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487781|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
101487782|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487783|NCT00328367|Aripiprazole|aripiprazole|mesh-list
101487784|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487785|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487786|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101487787|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101487788|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487789|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487790|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
101487791|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
101487792|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487793|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487794|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101487795|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101487796|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
101487797|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101487798|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101487799|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101487800|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101487801|NCT04703088|Ondansetron|ondansetron|mesh-list
101487802|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
101487803|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
101487804|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487805|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487806|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101487807|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
101487808|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487809|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101487810|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101487811|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
101487812|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487814|NCT00328718|Fluticasone|fluticasone|mesh-list
101487816|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101487823|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101487824|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487825|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487826|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101487827|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101487828|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101487829|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101487830|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101376113|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376116|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
101376117|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
101376118|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101376119|NCT00237484|Infliximab|infliximab|mesh-list
101376120|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376121|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
101487831|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487832|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487833|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101487834|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101487835|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487836|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101487837|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101487838|NCT00328796|Lidocaine|lidocaine|mesh-list
101487839|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
101487840|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
101487841|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487842|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487843|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
101487844|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487845|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101487846|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101487847|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101487848|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487849|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487850|NCT00429468|Acetaminophen|acetaminophen|mesh-list
101487851|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101487852|NCT00429468|Hydrocodone|hydrocodone|mesh-list
101487853|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101487854|NCT00429468|Analgesics|analgesics|mesh-ancestor
101487855|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
101487856|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487857|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487858|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
101487859|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101487860|NCT00429468|Narcotics|narcotics|mesh-ancestor
101487861|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487862|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
101487863|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487864|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101487865|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487866|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487867|NCT04702698|Peposertib|peposertib|mesh-list
101487868|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101487869|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487870|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487871|NCT00328874|Ubiquinone|ubiquinone|mesh-list
101487872|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
101487873|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
101487874|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487875|NCT00328874|Vitamins|vitamins|mesh-ancestor
101487876|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101487877|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101487878|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487879|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487880|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
101487881|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101487882|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487883|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101487884|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
101487890|NCT02957643|Trace Elements|trace elements|mesh-ancestor
101487891|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
101376124|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376126|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376127|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101376128|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376129|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101376130|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376131|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376133|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
101376134|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101376135|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376136|NCT00237523|Trace Elements|trace elements|mesh-ancestor
101376137|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
101376138|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376139|NCT00098124|Milnacipran|milnacipran|mesh-list
101376140|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
101487892|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487893|NCT02957604|Evolocumab|evolocumab|mesh-list
101487894|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101487895|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101487896|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101487897|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
101487898|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487899|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101487900|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
101487901|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487902|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101487903|NCT00329069|Atorvastatin|atorvastatin|mesh-list
101487904|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101487905|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101487906|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
101487907|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487908|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101487909|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101487910|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487911|NCT00429624|Acetaminophen|acetaminophen|mesh-list
101487912|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101487913|NCT00429624|Analgesics|analgesics|mesh-ancestor
101487914|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
101487915|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487916|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487917|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
101487918|NCT00329147|Paroxetine|paroxetine|mesh-list
101487919|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101487920|NCT00329147|Desipramine|desipramine|mesh-list
101487921|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101487922|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101487923|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487925|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487926|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
101487927|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376142|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101376143|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376144|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376145|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376146|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376147|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376148|NCT00098124|Analgesics|analgesics|mesh-ancestor
101376149|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
101376150|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376151|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
101376152|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101376153|NCT04710160|Calcium|calcium|mesh-list
101376154|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101487928|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101487929|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487930|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487931|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101487932|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101487933|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487934|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101487935|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101487936|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101487937|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487938|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101487939|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101487940|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101487941|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101487942|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487943|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487944|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487945|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487946|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101487947|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487948|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487949|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
101487950|NCT00434031|Docetaxel|docetaxel|mesh-list
101487951|NCT00434031|Doxorubicin|doxorubicin|mesh-list
101487982|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
101487983|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487984|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101487985|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
101487986|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487987|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101487988|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101487989|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487990|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487992|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101488016|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101488017|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101488018|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101488019|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
101488020|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488021|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
101488022|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
101376156|NCT00065351|Lenalidomide|lenalidomide|mesh-list
101376157|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
101376158|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376159|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101376160|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101376161|NCT00065351|Growth Substances|growth substances|mesh-ancestor
101376162|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
101376163|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488023|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488024|NCT00329498|Protective Agents|protective agents|mesh-ancestor
101488025|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488026|NCT00329498|Vitamins|vitamins|mesh-ancestor
101488027|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
101488028|NCT00329537|Sargramostim|sargramostim|mesh-list
101488029|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
101488030|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488031|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
101488032|NCT00429897|Amiloride|amiloride|mesh-list
101488033|NCT00429897|Spironolactone|spironolactone|mesh-list
101488034|NCT00429897|Furosemide|furosemide|mesh-list
101488035|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101488036|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488037|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488038|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488039|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101488040|NCT00429897|Diuretics|diuretics|mesh-ancestor
101488041|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
101488042|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101488048|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488049|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101488050|NCT00429936|Fenretinide|fenretinide|mesh-list
101488051|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488052|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101488053|NCT00429936|Protective Agents|protective agents|mesh-ancestor
101488054|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488055|NCT00429975|Levofloxacin|levofloxacin|mesh-list
101488056|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
101488057|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101488058|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488059|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488060|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101488061|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101488062|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488063|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488064|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488065|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101488066|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101488067|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
101488068|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
101488069|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
101488070|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101488071|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488072|NCT04716686|Niraparib|niraparib|mesh-list
101488073|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101488074|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488075|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488076|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488077|NCT01056393|Ibalizumab|ibalizumab|mesh-list
101488078|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101488079|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488080|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101488081|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
101488082|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488083|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
101376165|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376167|NCT04709770|Emollients|emollients|mesh-ancestor
101376168|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101376169|NCT04709731|Ponatinib|ponatinib|mesh-list
101376170|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488084|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488085|NCT01055106|Metronidazole|metronidazole|mesh-list
101488086|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488087|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488088|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101488089|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101488090|NCT00329693|Quinagolide|quinagolide|mesh-list
101488091|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
101488092|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
101488093|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488094|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488095|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488096|NCT00329810|Aripiprazole|aripiprazole|mesh-list
101488097|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
101488098|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101488099|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101488100|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101488101|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488102|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488103|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
101488104|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
101488105|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488106|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488107|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101488108|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101488115|NCT00430170|Caffeine|caffeine|mesh-list
101488116|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101488117|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488118|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101488119|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488120|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488121|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101488122|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101488123|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
101488124|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488125|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488126|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488127|NCT00330044|Carboplatin|carboplatin|mesh-list
101488128|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488129|NCT00430365|Lenalidomide|lenalidomide|mesh-list
101488130|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
101488131|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488132|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101488133|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101488134|NCT00430365|Growth Substances|growth substances|mesh-ancestor
101488135|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
101488136|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488137|NCT00330239|Paroxetine|paroxetine|mesh-list
101488138|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101488139|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101488140|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101488141|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488142|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488143|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
101488144|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488145|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101488146|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
101488147|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101488148|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101488149|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101488150|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376171|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101488151|NCT01051557|Sirolimus|sirolimus|mesh-list
101488152|NCT01051557|Temsirolimus|temsirolimus|mesh-list
101488153|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
101488154|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488155|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488156|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101488157|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488158|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
101488159|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488160|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
101488161|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488162|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101488163|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488164|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488165|NCT00330278|Cefazolin|cefazolin|mesh-list
101488166|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488167|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488168|NCT00330317|Letrozole|letrozole|mesh-list
101488169|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488170|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101488171|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101488172|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488173|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488174|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101488175|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488178|NCT00430443|Annamycin|annamycin|mesh-list
101488179|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101488180|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488181|NCT00330395|Caspofungin|caspofungin|mesh-list
101488182|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
101488183|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488184|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488185|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488187|NCT00434382|Sufentanil|sufentanil|mesh-list
101488188|NCT00434382|Remifentanil|remifentanil|mesh-list
101488189|NCT00434382|Alfentanil|alfentanil|mesh-list
101488190|NCT00434382|Propofol|propofol|mesh-list
101488191|NCT00434382|Sevoflurane|sevoflurane|mesh-list
101488192|NCT00434382|Desflurane|desflurane|mesh-list
101488193|NCT00434382|Isoflurane|isoflurane|mesh-list
101488194|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101488195|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488196|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488197|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101488198|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
101488199|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
101488200|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101488201|NCT00434382|Narcotics|narcotics|mesh-ancestor
101488202|NCT00434382|Analgesics|analgesics|mesh-ancestor
101488203|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
101488204|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488205|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101488206|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488207|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101488208|NCT00330707|Interferons|interferons|mesh-list
101488209|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
101488210|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
101488211|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488212|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
101488213|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488214|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
101488215|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488216|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101488218|NCT00330746|Cetuximab|cetuximab|mesh-list
101488219|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101488220|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
101488221|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488222|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488223|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101488224|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
101488225|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101488226|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101488227|NCT00330785|Amlodipine|amlodipine|mesh-list
101488228|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101488229|NCT00330785|Atorvastatin|atorvastatin|mesh-list
101376173|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376174|NCT00398684|Nevirapine|nevirapine|mesh-list
101376175|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101376176|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101376177|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376178|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376179|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
101376180|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376181|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488230|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101488231|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101488232|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
101488233|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488234|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101488235|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101488236|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488237|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488238|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101488239|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101488240|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101488241|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488243|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101488244|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
101488245|NCT00330824|Dexamethasone|dexamethasone|mesh-list
101488246|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
101488247|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101488248|NCT00330824|BB 1101|bb 1101|mesh-list
101488249|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488250|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
101488256|NCT00330824|Hormones|hormones|mesh-ancestor
101488257|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488258|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488259|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488260|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
101488261|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488262|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488263|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488264|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101488265|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101488266|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101488267|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
101488268|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101488269|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101488270|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101488271|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101488272|NCT00330902|Artesunate|artesunate|mesh-list
101488273|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
101488274|NCT00330902|Primaquine|primaquine|mesh-list
101488275|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
101488276|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101488277|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
101488278|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101488279|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101488280|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488281|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488282|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
101488283|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
101488284|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101488285|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
101488286|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101488287|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376182|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101376183|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101376184|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101376186|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101376187|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
101488288|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488289|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101488290|NCT04703868|Rabeprazole|rabeprazole|mesh-list
101488291|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101488292|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488293|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101488294|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488295|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488296|NCT00430794|Spironolactone|spironolactone|mesh-list
101488297|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101488298|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488299|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488300|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488301|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101488302|NCT00430794|Diuretics|diuretics|mesh-ancestor
101488303|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
101488304|NCT00330980|Simvastatin|simvastatin|mesh-list
101488305|NCT00330980|Pravastatin|pravastatin|mesh-list
101488306|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101488307|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101488308|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
101488309|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488310|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101488311|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101488312|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488313|NCT00430833|Candesartan|candesartan|mesh-list
101488314|NCT00430833|Candesartan cilexetil|candesartan cilexetil|mesh-list
101488315|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488316|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101488317|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101488318|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488319|NCT00331058|Prednisolone|prednisolone|mesh-list
101488321|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
101488323|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488324|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488325|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488326|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488327|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
101488328|NCT00331097|Docetaxel|docetaxel|mesh-list
101488329|NCT00331097|Fluorouracil|fluorouracil|mesh-list
101488330|NCT00331097|Methotrexate|methotrexate|mesh-list
101488331|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488332|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
101488333|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488334|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488335|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101488336|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
101488337|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488338|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488339|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101488340|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488341|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488342|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488343|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
101488344|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101488345|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101488346|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
101488347|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101488348|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
101488349|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488350|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101376188|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101376189|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376190|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101376191|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376192|NCT00237874|Aripiprazole|aripiprazole|mesh-list
101488351|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101488352|NCT00331214|Testosterone|testosterone|mesh-list
101488353|NCT00331214|Androgens|androgens|mesh-ancestor
101488354|NCT00331214|Hormones|hormones|mesh-ancestor
101488355|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488356|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488357|NCT00434772|Glucagon|glucagon|mesh-list
101488358|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488359|NCT00434772|Hormones|hormones|mesh-ancestor
101488360|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488361|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488362|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
101488363|NCT00431028|Triamcinolone|triamcinolone|mesh-list
101488364|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488365|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
101488367|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488368|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488369|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488370|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488371|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488372|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488373|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101488374|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101488375|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488376|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101488377|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101488378|NCT00431106|Gemcitabine|gemcitabine|mesh-list
101488379|NCT00431106|Capecitabine|capecitabine|mesh-list
101488380|NCT00431106|Vinorelbine|vinorelbine|mesh-list
101488381|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101488382|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
101488383|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488384|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488385|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101488386|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488387|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488390|NCT00431145|Niacinamide|niacinamide|mesh-list
101488391|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
101488392|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101488408|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101488409|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
101488410|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488411|NCT00431262|Disulfiram|disulfiram|mesh-list
101488412|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101488413|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101488414|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488415|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488416|NCT00331604|Insulin|insulin|mesh-list
101488417|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101488418|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
101488419|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
101488420|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101488421|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
101488422|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101488423|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488424|NCT00331643|Epothilones|epothilones|mesh-list
101488425|NCT00331643|Epothilone B|epothilone b|mesh-list
101488426|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488427|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488428|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488429|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488430|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376194|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101376195|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101376196|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101376197|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488431|NCT00431340|Belinostat|belinostat|mesh-list
101488432|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488433|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101488434|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488435|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488436|NCT00431379|Tenecteplase|tenecteplase|mesh-list
101488437|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101488438|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101488439|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488440|NCT00331838|Enoxaparin|enoxaparin|mesh-list
101488441|NCT00331838|Semuloparin|semuloparin|mesh-list
101488442|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101488444|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
101488445|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101488446|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101488447|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488448|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
101488449|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488450|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101488451|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101488452|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488453|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488454|NCT00431418|Urological Agents|urological agents|mesh-ancestor
101488460|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101488461|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101488462|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488463|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488464|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101488466|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488467|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488468|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101488469|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101488471|NCT00332033|Analgesics|analgesics|mesh-ancestor
101488472|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
101488473|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488474|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488475|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101488476|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488477|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488478|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488479|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488480|NCT00435279|Eszopiclone|eszopiclone|mesh-list
101488481|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101488482|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101488483|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101488484|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101488485|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488487|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488488|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101488489|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
101488490|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101488491|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101488492|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488493|NCT00332072|Timolol|timolol|mesh-list
101488494|NCT00332072|Bimatoprost|bimatoprost|mesh-list
101488495|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101488496|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101488497|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488498|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488499|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376198|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376200|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
101376201|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376202|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376203|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101376205|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
101488500|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488501|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101488502|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488503|NCT00431613|Carboplatin|carboplatin|mesh-list
101488504|NCT00431613|Gemcitabine|gemcitabine|mesh-list
101488505|NCT00431613|Docetaxel|docetaxel|mesh-list
101488506|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488507|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101488508|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
101488509|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488510|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488511|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488512|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488513|NCT00332228|Naltrexone|naltrexone|mesh-list
101488514|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101488515|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101488516|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488517|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
101488518|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488520|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488521|NCT00332306|Lamivudine|lamivudine|mesh-list
101488522|NCT00332306|Efavirenz|efavirenz|mesh-list
101488523|NCT00332306|Nevirapine|nevirapine|mesh-list
101488524|NCT00332306|Didanosine|didanosine|mesh-list
101488525|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101488534|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101488535|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101488536|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101488537|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101488538|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101488539|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
101488540|NCT00332345|Timolol|timolol|mesh-list
101488541|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101488542|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101488543|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101488544|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488545|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488546|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488547|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488548|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101488549|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488550|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101488551|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101488552|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101488553|NCT00332384|Timolol|timolol|mesh-list
101488554|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101488555|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101488556|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101488557|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488558|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488559|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488560|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488561|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101488562|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488563|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101488564|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101376206|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101376207|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101376208|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101376209|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101376211|NCT00237913|Risperidone|risperidone|mesh-list
101376212|NCT00237913|Aripiprazole|aripiprazole|mesh-list
101488565|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101488567|NCT00435435|Acamprosate|acamprosate|mesh-list
101488568|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101488569|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101488570|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488571|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488572|NCT00332540|Timolol|timolol|mesh-list
101488573|NCT00332540|Bimatoprost|bimatoprost|mesh-list
101488574|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101488575|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101488576|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488577|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488578|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488579|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488580|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101488581|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488582|NCT00332618|Glycerol|glycerol|mesh-list
101488583|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101488584|NCT00332618|Protective Agents|protective agents|mesh-ancestor
101488585|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488586|NCT00332735|Bupivacaine|bupivacaine|mesh-list
101488587|NCT00332735|Carticaine|carticaine|mesh-list
101488588|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
101488589|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
101488590|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488615|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101488617|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488618|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101488619|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488620|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488621|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488622|NCT00332891|Amibegron|amibegron|mesh-list
101488623|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101488624|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101488625|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101488626|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488627|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488628|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488629|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488630|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101488631|NCT00332930|Interferons|interferons|mesh-list
101488632|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
101488633|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488634|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
101488635|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488636|NCT00332969|Octreotide|octreotide|mesh-list
101488637|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488638|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488639|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488640|NCT00333008|Prednisone|prednisone|mesh-list
101488648|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101488649|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
101488650|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488651|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488652|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101488653|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101488654|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488655|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
101488656|NCT00333008|Hormones|hormones|mesh-ancestor
101545809|NCT01327599|Travoprost|travoprost|mesh-list
101488657|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376214|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101376215|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
101376216|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376217|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376218|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488658|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488659|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101488660|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488661|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488662|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488663|NCT00435747|Parecoxib|parecoxib|mesh-list
101488664|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101488665|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101488666|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488667|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488668|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101488669|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488670|NCT00435747|Analgesics|analgesics|mesh-ancestor
101488671|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
101488672|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488673|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488674|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488675|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488676|NCT00333047|Letrozole|letrozole|mesh-list
101488677|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488678|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101488679|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101488680|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488681|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488682|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101488683|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488684|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488685|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488686|NCT00333086|Letrozole|letrozole|mesh-list
101488687|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488688|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101488689|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101488690|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488691|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488692|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101488693|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101488694|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488695|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488696|NCT00333125|Timolol|timolol|mesh-list
101488697|NCT00333125|Travoprost|travoprost|mesh-list
101488698|NCT00333125|Dorzolamide|dorzolamide|mesh-list
101488699|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101488700|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101488701|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101488702|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101488703|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488704|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488705|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488706|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488707|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101488715|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488716|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101488717|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
101488718|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101488719|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101488720|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488721|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488722|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488723|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101488724|NCT00333164|Protective Agents|protective agents|mesh-ancestor
101376220|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101376221|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101376222|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101376223|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101376224|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
101376225|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
101376226|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
101376227|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488725|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101488726|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101488727|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488728|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
101488729|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488730|NCT01052493|Hormones|hormones|mesh-ancestor
101488731|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488732|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488733|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
101488734|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
101488735|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
101488736|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101488737|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101488738|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488739|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488740|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488741|NCT00333281|Tadalafil|tadalafil|mesh-list
101488742|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488743|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101488745|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488746|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488747|NCT00333281|Urological Agents|urological agents|mesh-ancestor
101488748|NCT00333398|Vaccines|vaccines|mesh-list
101488749|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
101488750|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488751|NCT00333476|Squalamine|squalamine|mesh-list
101488752|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101488753|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488754|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101488755|NCT00333476|Protective Agents|protective agents|mesh-ancestor
101488756|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488757|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488758|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101488759|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101488760|NCT00333476|Growth Substances|growth substances|mesh-ancestor
101488761|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
101488762|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101488763|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101488764|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
101488765|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488766|NCT00435981|Antacids|antacids|mesh-ancestor
101488767|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488768|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488769|NCT00432081|Indomethacin|indomethacin|mesh-list
101488770|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101488771|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488772|NCT00432081|Analgesics|analgesics|mesh-ancestor
101488773|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
101488777|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488778|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
101488779|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
101488780|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101488781|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376229|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101376230|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101376231|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376232|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
101376233|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
101376234|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101488783|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488786|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
101488787|NCT00333632|Propofol|propofol|mesh-list
101488788|NCT00333632|Isoflurane|isoflurane|mesh-list
101488789|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101488790|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488791|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488792|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488793|NCT00333632|Analgesics|analgesics|mesh-ancestor
101488794|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
101488795|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488796|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101488797|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101488798|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101488799|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101488800|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488801|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488802|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101488803|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
101488804|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
101488805|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101488806|NCT00333632|Narcotics|narcotics|mesh-ancestor
101488807|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101488809|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101488810|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101488811|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
101488812|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
101488813|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101488814|NCT00436059|Bortezomib|bortezomib|mesh-list
101488815|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488816|NCT00420524|Epothilone B|epothilone b|mesh-list
101488817|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488818|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488819|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488820|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488821|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488822|NCT00432120|Clopidogrel|clopidogrel|mesh-list
101488823|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488824|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101488825|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101488826|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101488827|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
101488828|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488829|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488830|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488831|NCT00432198|Zolpidem|zolpidem|mesh-list
101488832|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101488833|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101488835|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488836|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101488837|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
101488838|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
101488839|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488840|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488841|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
101376235|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101376236|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101376237|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101376239|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
101488842|NCT00420563|Megestrol|megestrol|mesh-list
101488843|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488844|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
101488845|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488852|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101488853|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101488854|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101488856|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101488857|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101488858|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101488859|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488860|NCT00432315|Docetaxel|docetaxel|mesh-list
101488861|NCT00432315|Cisplatin|cisplatin|mesh-list
101488862|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488863|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488864|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488865|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488866|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488867|NCT00333671|Glycerol|glycerol|mesh-list
101488868|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101488869|NCT00333671|Protective Agents|protective agents|mesh-ancestor
101488870|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488871|NCT00432354|Atorvastatin|atorvastatin|mesh-list
101488872|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101488873|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101488874|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
101488875|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488876|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101488877|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101488878|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488879|NCT00333944|Pralidoxime|pralidoxime|mesh-list
101488880|NCT00333944|Antidotes|antidotes|mesh-ancestor
101488881|NCT00333944|Protective Agents|protective agents|mesh-ancestor
101488882|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488883|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
101488884|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
101488885|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488886|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101488887|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488888|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
101488889|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101488890|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101488891|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488892|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488893|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101488894|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
101488895|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488897|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488898|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
101488899|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488900|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101488901|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488902|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488903|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
101488904|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101488905|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488906|NCT03279978|Midazolam|midazolam|mesh-list
101488907|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101488908|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101488909|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101488910|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488911|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101376240|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376241|NCT00098241|Everolimus|everolimus|mesh-list
101376242|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101376243|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101488912|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101488915|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
101488916|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
101488917|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
101488918|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
101488919|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488920|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488921|NCT00438048|Pilocarpine|pilocarpine|mesh-list
101488922|NCT00438048|Miotics|miotics|mesh-ancestor
101488923|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
101488924|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488925|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488926|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101488927|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101488928|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
101488929|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101488930|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488931|NCT00334256|Tenofovir|tenofovir|mesh-list
101488932|NCT00334256|Emtricitabine|emtricitabine|mesh-list
101488933|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
101488934|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488935|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101488936|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101488937|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488938|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488939|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488940|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101488941|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
101488942|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101488943|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101488944|NCT00438087|Prednisolone|prednisolone|mesh-list
101488945|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
101488946|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101488947|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
101488948|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488949|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
101488950|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
101488951|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488952|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488953|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488954|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
101488955|NCT00438087|Hormones|hormones|mesh-ancestor
101488956|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488957|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101488958|NCT00438087|Protective Agents|protective agents|mesh-ancestor
101488959|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101488960|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488961|NCT00334412|Caspofungin|caspofungin|mesh-list
101488962|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101488963|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
101488964|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488965|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488966|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488967|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101488968|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101488969|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
101488970|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488971|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101488972|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101488973|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488974|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488975|NCT00334490|Urological Agents|urological agents|mesh-ancestor
101488976|NCT00334529|Oseltamivir|oseltamivir|mesh-list
101488977|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
101488978|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488979|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488980|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376245|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376246|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376247|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
101376248|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488981|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
101488982|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101488983|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488984|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101488985|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101488986|NCT00436293|Docetaxel|docetaxel|mesh-list
101488998|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101488999|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
101489000|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489001|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489002|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101489003|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
101489004|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
101489005|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489006|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489007|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101489008|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489009|NCT04701606|Artesunate|artesunate|mesh-list
101489010|NCT04701606|Pyronaridine|pyronaridine|mesh-list
101489011|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
101489012|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
101489013|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101489014|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101489016|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489017|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
101489018|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
101489019|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101489020|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
101489022|NCT00334685|Reboxetine|reboxetine|mesh-list
101489023|NCT00334685|Analgesics|analgesics|mesh-ancestor
101489024|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
101489025|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489026|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489027|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
101489028|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101489029|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489030|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489031|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489032|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101489033|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489034|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489035|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489036|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
101489037|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101489038|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101489039|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101489040|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489041|NCT00436371|Amisulpride|amisulpride|mesh-list
101489042|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101489043|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489044|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489045|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489046|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489047|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101489048|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
101489049|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489050|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489058|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489059|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489060|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
101376250|NCT04721119|Anesthetics|anesthetics|mesh-list
101376251|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101376252|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376253|NCT00238147|Carboplatin|carboplatin|mesh-list
101376254|NCT00238147|Docetaxel|docetaxel|mesh-list
101376255|NCT00238147|Capecitabine|capecitabine|mesh-list
101376256|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376257|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
101376258|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489061|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489062|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101489063|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101489064|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101489065|NCT00334763|Growth Substances|growth substances|mesh-ancestor
101489066|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489067|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
101489068|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
101489069|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101489070|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
101489071|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489072|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489073|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101489074|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101489075|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489076|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101489077|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101489078|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489079|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489080|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
101489081|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489082|NCT00436761|Cyclosporine|cyclosporine|mesh-list
101489083|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
101489085|NCT00436761|Busulfan|busulfan|mesh-list
101489086|NCT00436761|Cyclosporins|cyclosporins|mesh-list
101489087|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101489088|NCT00436761|Sargramostim|sargramostim|mesh-list
101489089|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489090|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489091|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489092|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
101545834|NCT02893371|Olanzapine|olanzapine|mesh-list
101489093|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489094|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
101489095|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489096|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
101489097|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101489098|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101489099|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489100|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
101489101|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
101489102|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489103|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489104|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
101489105|NCT00436761|Hormones|hormones|mesh-ancestor
101489106|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489107|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101489108|NCT00436761|Protective Agents|protective agents|mesh-ancestor
101489109|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489110|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101489111|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
101489112|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101489113|NCT00436800|Gemcitabine|gemcitabine|mesh-list
101489114|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
101489115|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489116|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
101376259|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
101376260|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376261|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101376262|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
101376264|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
101489117|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489118|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489146|NCT00436995|Hematinics|hematinics|mesh-ancestor
101489147|NCT04716179|Hormones|hormones|mesh-list
101489148|NCT04716179|Testosterone|testosterone|mesh-list
101489149|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489150|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489151|NCT04716179|Androgens|androgens|mesh-ancestor
101489152|NCT00437229|Dexamethasone|dexamethasone|mesh-list
101489153|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
101489154|NCT00437229|Ondansetron|ondansetron|mesh-list
101489155|NCT00437229|Casopitant|casopitant|mesh-list
101489156|NCT00437229|BB 1101|bb 1101|mesh-list
101489157|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489158|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
101489159|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
101489160|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489161|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489162|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489163|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
101489164|NCT00437229|Hormones|hormones|mesh-ancestor
101489165|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489166|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489167|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489177|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101489178|NCT00335192|Tenofovir|tenofovir|mesh-list
101489179|NCT00335192|Lamivudine|lamivudine|mesh-list
101489180|NCT00335192|Abacavir|abacavir|mesh-list
101489181|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
101489182|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489183|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101489184|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489185|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489186|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489187|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101489188|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101489189|NCT00437307|Topotecan|topotecan|mesh-list
101489190|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101489191|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101489192|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489193|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545839|NCT02893371|Ziprasidone|ziprasidone|mesh-list
101489194|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489195|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
101489196|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489197|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489198|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101489199|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101489200|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101489201|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101489202|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489203|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489204|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489205|NCT00335270|Ritonavir|ritonavir|mesh-list
101489206|NCT00335270|Amprenavir|amprenavir|mesh-list
101489207|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
101489208|NCT00335270|Lamivudine|lamivudine|mesh-list
101489209|NCT00335270|Abacavir|abacavir|mesh-list
101489210|NCT00335270|Calcium|calcium|mesh-list
101489211|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489212|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489213|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101489214|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101489215|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489216|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489217|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376265|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101376266|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101376267|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376268|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101376269|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376270|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376271|NCT00238225|Calcitriol|calcitriol|mesh-list
101376272|NCT00238225|Ketoconazole|ketoconazole|mesh-list
101376273|NCT00238225|Dexamethasone|dexamethasone|mesh-list
101376274|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489218|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101489219|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101489220|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
101489221|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489222|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101489223|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101489224|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101489225|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489226|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101489227|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
101489228|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489229|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
101489231|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489232|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489233|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489237|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489238|NCT00335309|Amoxicillin|amoxicillin|mesh-list
101489239|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
101489240|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
101489241|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489242|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489243|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101489244|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489245|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489246|NCT00335348|Dexamethasone|dexamethasone|mesh-list
101489247|NCT00335348|Bortezomib|bortezomib|mesh-list
101489248|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489249|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
101489250|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
101489251|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489252|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489253|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489254|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
101489255|NCT00335348|Hormones|hormones|mesh-ancestor
101489256|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489257|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489258|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489259|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101489260|NCT00437463|Ramipril|ramipril|mesh-list
101489261|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101489262|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489263|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489264|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489265|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101489266|NCT00437502|Vaccines|vaccines|mesh-list
101489267|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
101489268|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489269|NCT00420797|Phenylephrine|phenylephrine|mesh-list
101489270|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
101489271|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101489272|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
101489273|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
101489274|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489275|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489276|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
101376276|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
101376277|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376278|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376279|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376280|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
101489277|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101489278|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
101489279|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
101489280|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101489281|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101489282|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101489283|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
101489284|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489285|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489286|NCT00420797|Protective Agents|protective agents|mesh-ancestor
101489287|NCT00437619|Calcipotriene|calcipotriene|mesh-list
101489288|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
101489290|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489291|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489292|NCT00437697|Dalteparin|dalteparin|mesh-list
101489293|NCT00437697|Tinzaparin|tinzaparin|mesh-list
101489294|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101489295|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
101489296|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101489297|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101489298|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489299|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
101489300|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489301|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489302|NCT00335543|Gemcitabine|gemcitabine|mesh-list
101489303|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489304|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489305|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
101489306|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489315|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
101489316|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489317|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101489318|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101489319|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489320|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489321|NCT00335582|Clonidine|clonidine|mesh-list
101489322|NCT00335582|Analgesics|analgesics|mesh-ancestor
101489323|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
101489324|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489325|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489326|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101489327|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
101489329|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101489330|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101489331|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101489332|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
101489333|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489334|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489335|NCT00437853|Anastrozole|anastrozole|mesh-list
101489336|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489337|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489338|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101489339|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101489340|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489341|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489342|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101489343|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376282|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376283|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101376284|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376285|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
101489344|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489345|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489346|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
101489347|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101489348|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
101489349|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489350|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489351|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101489352|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101489353|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
101489354|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101489355|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
101489356|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489357|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489359|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101489360|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489361|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
101489362|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489363|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489364|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101489365|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489366|NCT00437970|Metformin|metformin|mesh-list
101489367|NCT00437970|Pioglitazone|pioglitazone|mesh-list
101489368|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489369|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489370|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101489371|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101489372|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489373|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
101489377|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489379|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101489380|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
101489381|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101489382|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
101489383|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489384|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489385|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101489386|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101489387|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489388|NCT00335933|Gabapentin|gabapentin|mesh-list
101489389|NCT00335933|Analgesics|analgesics|mesh-ancestor
101489390|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
101489391|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489392|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489393|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
101489394|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101489395|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489396|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489397|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489398|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101489399|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101489400|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489401|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489402|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
101489403|NCT00336167|Bezafibrate|bezafibrate|mesh-list
101489404|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489405|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
101489406|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489407|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489408|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
101489409|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101489410|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376286|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376287|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101376288|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101376289|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376290|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376291|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101376292|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376293|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101489412|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
101489413|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101489414|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489415|NCT00336245|Trace Elements|trace elements|mesh-ancestor
101489416|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
101489417|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
101489418|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489419|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
101489420|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489421|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489422|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489423|NCT00336401|Propofol|propofol|mesh-list
101489424|NCT00336401|Sevoflurane|sevoflurane|mesh-list
101489425|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101489426|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489427|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489428|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101489429|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
101489430|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
101489431|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101489432|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101489433|NCT00336518|Ribavirin|ribavirin|mesh-list
101489434|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101489435|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
101489436|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489437|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
101489438|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489439|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
101489440|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
101489441|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
101489442|NCT00347490|Enoxaparin|enoxaparin|mesh-list
101489452|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489453|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489455|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489456|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489457|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
101489459|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489460|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489461|NCT00336791|Paclitaxel|paclitaxel|mesh-list
101489462|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
101489463|NCT00336791|Doxorubicin|doxorubicin|mesh-list
101489464|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101489465|NCT00336791|Fluorouracil|fluorouracil|mesh-list
101489466|NCT00336791|Epirubicin|epirubicin|mesh-list
101489467|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101489468|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489469|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489471|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
101489472|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489473|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489474|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
101489475|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489476|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101489477|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101489478|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
101489479|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101489480|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376294|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101376295|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101376296|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376297|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101489481|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101489482|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101489483|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489484|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
101489485|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489486|NCT00444561|Pramlintide|pramlintide|mesh-list
101489487|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489488|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489489|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101489490|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
101489491|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101489492|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
101489493|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101489494|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489495|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101489496|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489497|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489498|NCT00336947|Tegafur|tegafur|mesh-list
101489499|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489500|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
101489501|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489502|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489503|NCT00444717|Pitavastatin|pitavastatin|mesh-list
101489504|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101489505|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101489506|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489507|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
101489508|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489518|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489519|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489520|NCT00337259|Gemcitabine|gemcitabine|mesh-list
101489521|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101489522|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
101489523|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489524|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489525|NCT04699734|Lidocaine|lidocaine|mesh-list
101489526|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101489527|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
101489528|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489529|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489530|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
101489531|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489532|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101489533|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101489534|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101489535|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489536|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489538|NCT00337298|Lisinopril|lisinopril|mesh-list
101489540|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101489541|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489542|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489543|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489544|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489545|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
101489546|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101489547|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489548|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489549|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101489550|NCT00337298|Protective Agents|protective agents|mesh-ancestor
101489551|NCT00337376|Sirolimus|sirolimus|mesh-list
101489552|NCT00337376|Paclitaxel|paclitaxel|mesh-list
101489553|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101376299|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
101376300|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101376301|NCT00076518|Fenofibrate|fenofibrate|mesh-list
101376302|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101376303|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
101376304|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376305|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101376306|NCT00065546|Choline|choline|mesh-list
101376307|NCT00065546|Estrogens|estrogens|mesh-list
101376308|NCT00065546|Hormones|hormones|mesh-ancestor
101376309|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376310|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376311|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
101376312|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101376313|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
101376314|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376315|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376316|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101376317|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
101376318|NCT00098280|Eculizumab|eculizumab|mesh-list
101376319|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101376320|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376321|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
101489554|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101489555|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489556|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489557|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489558|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
101489559|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489560|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489561|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489562|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101489563|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
101489564|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489565|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
101489566|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489567|NCT00337493|Cyclosporine|cyclosporine|mesh-list
101489568|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
101489569|NCT00337493|Tacrolimus|tacrolimus|mesh-list
101489570|NCT00337493|Cyclosporins|cyclosporins|mesh-list
101489571|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489572|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
101489573|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489584|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
101489585|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489587|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
101489588|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
101489589|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489590|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376323|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101376324|NCT00238459|Vaccines|vaccines|mesh-list
101376325|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
101376326|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376327|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
101376328|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376329|NCT00238498|Vildagliptin|vildagliptin|mesh-list
101376330|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376331|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376332|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101376333|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489592|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489593|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101489594|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101489595|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101489596|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489597|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489598|NCT00444834|Carvedilol|carvedilol|mesh-list
101489599|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101489600|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101489601|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
101489602|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489603|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489604|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489605|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101489606|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
101489607|NCT00444834|Protective Agents|protective agents|mesh-ancestor
101489608|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101489609|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489610|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489611|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
101489612|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101489613|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101489614|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101489615|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
101489616|NCT00337766|Coagulants|coagulants|mesh-ancestor
101489617|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101489618|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
101489619|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489620|NCT00444873|Lanreotide|lanreotide|mesh-list
101489621|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489622|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101489623|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
101489624|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
101489625|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101489626|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489627|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101489628|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489629|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489630|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101489631|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101489632|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489633|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489634|NCT00451113|Incretins|incretins|mesh-ancestor
101489635|NCT00451113|Hormones|hormones|mesh-ancestor
101489643|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489644|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489645|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489646|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
101489647|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376334|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376335|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376336|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101376337|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101376338|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101376339|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376340|NCT00098319|Folic Acid|folic acid|mesh-list
101376341|NCT00098319|Hematinics|hematinics|mesh-ancestor
101376342|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
101376343|NCT00098319|Vitamins|vitamins|mesh-ancestor
101376344|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
101376345|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376346|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
101376347|NCT00238732|Estrogens|estrogens|mesh-list
101376348|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101376349|NCT00238732|Hormones|hormones|mesh-ancestor
101376350|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376351|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376352|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101376353|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101376354|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376355|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101376356|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
101489648|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101489649|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101489651|NCT00451230|Cocaine|cocaine|mesh-list
101489652|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489653|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
101489654|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
101489655|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489656|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489657|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
101489658|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489659|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101489660|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101489661|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101489662|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489663|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489664|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
101489665|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489666|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
101489667|NCT00338000|Hematinics|hematinics|mesh-ancestor
101489668|NCT00338117|Galantamine|galantamine|mesh-list
101489669|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101489670|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489671|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489672|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
101489673|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489674|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489676|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
101489677|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489678|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
101376358|NCT00238927|Fluticasone|fluticasone|mesh-list
101376359|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376360|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101376361|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
101376362|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376363|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376364|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101376365|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101376366|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
101376367|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101376368|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
101376369|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
101376370|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376371|NCT00065624|Protective Agents|protective agents|mesh-ancestor
101376372|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376373|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
101376374|NCT00065624|Vitamins|vitamins|mesh-ancestor
101376375|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
101376376|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
101376377|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376378|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489679|NCT00338195|Caffeine|caffeine|mesh-list
101489680|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101489681|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415599|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101489682|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101489683|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489684|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489685|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101489686|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101489688|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489689|NCT00338273|Aripiprazole|aripiprazole|mesh-list
101489690|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
101489691|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489692|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101489693|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489694|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489695|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489696|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
101489697|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
101489698|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489699|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489700|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101489701|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101489724|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
101489725|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489726|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101489727|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101489728|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
101489729|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
101489730|NCT00338468|Hematinics|hematinics|mesh-ancestor
101489731|NCT00338507|Erdosteine|erdosteine|mesh-list
101376379|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101376382|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376383|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376384|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376385|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
101376386|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376387|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376388|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101376389|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
101489732|NCT00338507|Expectorants|expectorants|mesh-ancestor
101489733|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
101489734|NCT00445185|Vaccines|vaccines|mesh-list
101489735|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
101489736|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489737|NCT00338546|Cocaine|cocaine|mesh-list
101489738|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
101489739|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101489740|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489741|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489742|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101489743|NCT00338546|Analgesics|analgesics|mesh-ancestor
101489744|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
101489745|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489746|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101489747|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101489748|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101489749|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101489750|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489751|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489752|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
101489753|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
101489754|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101489755|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101489756|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101489771|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101489772|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489773|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489774|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489775|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
101489776|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489777|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101489778|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101489780|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415602|NCT01245946|Analgesics|analgesics|mesh-ancestor
101489781|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489782|NCT00445497|Amoxicillin|amoxicillin|mesh-list
101489783|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
101489784|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
101489785|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
101489786|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101489787|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489788|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489789|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101489790|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101489791|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489792|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489794|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101489795|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101489796|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101376391|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376393|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376394|NCT00098358|Zileuton|zileuton|mesh-list
101376395|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376396|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376397|NCT00098358|Analgesics|analgesics|mesh-ancestor
101376398|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
101489797|NCT00451776|Propofol|propofol|mesh-list
101489798|NCT00451776|Etomidate|etomidate|mesh-list
101489799|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101489800|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489801|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489802|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101489803|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
101489804|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
101489805|NCT00338936|Valsartan|valsartan|mesh-list
101489806|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101489807|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101489808|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101489809|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101489810|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489812|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
101489813|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489814|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101489815|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489820|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489821|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489822|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489823|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101489824|NCT00339014|Zonisamide|zonisamide|mesh-list
101489825|NCT00339014|Bupropion|bupropion|mesh-list
101489826|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101489827|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
101489828|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101489829|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101489830|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101489831|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489832|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489833|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
101489834|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489835|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489836|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101489837|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101489838|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489839|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
101489840|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101489841|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489842|NCT00420953|Amiodarone|amiodarone|mesh-list
101489843|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101489844|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
101489845|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101489846|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415605|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489847|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489848|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101489849|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101489850|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101489851|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376399|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376400|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376401|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376402|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376403|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101376404|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376405|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376406|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101376407|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376408|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376409|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
101376410|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376411|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376412|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101376413|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
101376414|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376415|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376416|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376417|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489852|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101489853|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101489854|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101489855|NCT00425204|Panitumumab|panitumumab|mesh-list
101489856|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101489857|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489859|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101489860|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101489861|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489862|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489863|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101489864|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
101489865|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
101489866|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489867|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489868|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101489869|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489870|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489871|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489872|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101489873|NCT00451971|Leflunomide|leflunomide|mesh-list
101489874|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489875|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489876|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489877|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
101489878|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489879|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
101489880|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489881|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376419|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101376420|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376421|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376422|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101376423|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101376424|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376425|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376426|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376427|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101376428|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101376429|NCT00239200|Lapatinib|lapatinib|mesh-list
101376430|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376431|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376432|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415610|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
101376433|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376434|NCT02961829|Niacinamide|niacinamide|mesh-list
101376435|NCT02961829|Dolutegravir|dolutegravir|mesh-list
101376436|NCT02961829|Maraviroc|maraviroc|mesh-list
101376437|NCT02961829|Auranofin|auranofin|mesh-list
101489882|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
101489883|NCT00446004|Omeprazole|omeprazole|mesh-list
101489884|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101489885|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489893|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489894|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489895|NCT03275376|Atorvastatin|atorvastatin|mesh-list
101489896|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101489897|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489898|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
101489899|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489900|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489901|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101489902|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489903|NCT00340184|Paclitaxel|paclitaxel|mesh-list
101489904|NCT00340184|Carboplatin|carboplatin|mesh-list
101489905|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101489906|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489907|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489908|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489909|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101489910|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489911|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
101489913|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489914|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101489915|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489916|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489917|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489919|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
101489920|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489921|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101489922|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101489923|NCT00446433|Growth Substances|growth substances|mesh-ancestor
101489924|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
101376439|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101376440|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
101376441|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376442|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101376443|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101376444|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376445|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376446|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101376447|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101376448|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
101376449|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376450|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101376451|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101376452|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101376453|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
101376454|NCT02961829|Vitamins|vitamins|mesh-ancestor
101376456|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376457|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
101376458|NCT00239239|Hematinics|hematinics|mesh-ancestor
101376459|NCT00414349|Analgesics|analgesics|mesh-list
101376460|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
101376461|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376462|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376463|NCT00065741|Silymarin|silymarin|mesh-list
101376464|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
101376465|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376466|NCT00065741|Protective Agents|protective agents|mesh-ancestor
101376467|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376468|NCT00098397|Romidepsin|romidepsin|mesh-list
101376469|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376470|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376471|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101376472|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489925|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489926|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101489927|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101489928|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
101489929|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489930|NCT00340574|Antacids|antacids|mesh-ancestor
101489931|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489932|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376473|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376475|NCT00239278|Budesonide|budesonide|mesh-list
101376476|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
101376477|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376478|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
101376479|NCT00239278|Hormones|hormones|mesh-ancestor
101376480|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376482|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101376483|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376484|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
101376485|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489933|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
101489934|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489935|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489936|NCT00340691|Doxycycline|doxycycline|mesh-list
101489937|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489938|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489939|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
101489940|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101489941|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101489942|NCT00452244|Gefitinib|gefitinib|mesh-list
101489943|NCT00452244|Simvastatin|simvastatin|mesh-list
101489944|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101489945|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101489946|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
101489947|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489948|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489949|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101489950|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489951|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489952|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101489955|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101489956|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101489957|NCT00446472|Growth Substances|growth substances|mesh-ancestor
101489958|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489959|NCT00446589|Teriparatide|teriparatide|mesh-list
101489960|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
101489961|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101489962|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489963|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101489964|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
101489965|NCT00452322|Testosterone|testosterone|mesh-list
101489966|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
101489967|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
101489968|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101489969|NCT00452322|Androgens|androgens|mesh-ancestor
101489970|NCT00452322|Hormones|hormones|mesh-ancestor
101528434|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489971|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489972|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489973|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489974|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489975|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
101489976|NCT00452556|Docetaxel|docetaxel|mesh-list
101489977|NCT00452556|Leuprolide|leuprolide|mesh-list
101489978|NCT00452556|Androgens|androgens|mesh-list
101489979|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489980|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489981|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489982|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101376486|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101376487|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101376489|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101376490|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101376491|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101376492|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101376493|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376494|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376496|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376497|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376498|NCT00239395|Analgesics|analgesics|mesh-ancestor
101376499|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
101376500|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376501|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376502|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376503|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376504|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101376505|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376506|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376507|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489983|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489984|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101489986|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101489987|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489988|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489989|NCT00452556|Hormones|hormones|mesh-ancestor
101489990|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489991|NCT00446667|Mannitol|mannitol|mesh-list
101489992|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101489993|NCT00446667|Diuretics|diuretics|mesh-ancestor
101489994|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
101489995|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489996|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
101489997|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
101489998|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489999|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101490000|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101490001|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101490002|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490003|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490004|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490005|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490006|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
101490007|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101490008|NCT00341432|Nicotine|nicotine|mesh-list
101490009|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101490010|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
101376509|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
101376510|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376511|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
101376512|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376513|NCT00239434|Bromides|bromides|mesh-list
101376514|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
101376515|NCT00239434|Ipratropium|ipratropium|mesh-list
101376516|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101376517|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
101376518|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376519|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376520|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101376521|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
101376522|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
101376523|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101376524|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
101376525|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490011|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545940|NCT04328805|Analgesics|analgesics|mesh-ancestor
101490012|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490013|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101490014|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101490015|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
101490016|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490017|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490018|NCT00452634|Irinotecan|irinotecan|mesh-list
101490019|NCT00452634|Simvastatin|simvastatin|mesh-list
101490020|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490021|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101490022|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101490023|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490024|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490030|NCT03277599|Tramadol|tramadol|mesh-list
101490031|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101490032|NCT03277599|Narcotics|narcotics|mesh-ancestor
101490033|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490034|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490035|NCT03277599|Analgesics|analgesics|mesh-ancestor
101490036|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
101490037|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490038|NCT00452829|Folic Acid|folic acid|mesh-list
101490039|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
101490040|NCT00452829|Inositol|inositol|mesh-list
101490041|NCT00452829|Hematinics|hematinics|mesh-ancestor
101490042|NCT00452829|Vitamins|vitamins|mesh-ancestor
101490043|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
101490044|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490045|NCT00452907|Artesunate|artesunate|mesh-list
101490046|NCT00452907|Lumefantrine|lumefantrine|mesh-list
101490047|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
101490048|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
101490049|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101490050|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
101490051|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490052|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490053|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490054|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490055|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
101490056|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
101490057|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101490058|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
101490059|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101376526|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376527|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
101376528|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101376529|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
101376530|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101376531|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
101376532|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376533|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376534|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101376535|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
101376536|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
101376537|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101376538|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
101376539|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376540|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376542|NCT00239512|Indomethacin|indomethacin|mesh-list
101490060|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490061|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490062|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101490063|NCT00446784|Methotrexate|methotrexate|mesh-list
101490064|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101490065|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
101490066|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101490067|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490068|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490070|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490071|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490072|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490073|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490074|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101490075|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490076|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
101490077|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490078|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101490079|NCT00452985|Carboplatin|carboplatin|mesh-list
101490080|NCT00452985|Docetaxel|docetaxel|mesh-list
101490081|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490082|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
101490083|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
101490084|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
101490085|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490086|NCT03277209|Plerixafor|plerixafor|mesh-list
101490087|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490088|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490089|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
101490090|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490091|NCT00453141|Betamethasone|betamethasone|mesh-list
101490092|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490093|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
101490094|NCT00453141|Hormones|hormones|mesh-ancestor
101490095|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490096|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490099|NCT00421109|Levocetirizine|levocetirizine|mesh-list
101490100|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101490101|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101490102|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
101490103|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
101376543|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376544|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376546|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
101376547|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376548|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376549|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376550|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376551|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376552|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376553|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490104|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490105|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490106|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490107|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
101490108|NCT02273583|Methotrexate|methotrexate|mesh-list
101490109|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490110|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
101490111|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490112|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415620|NCT00501241|ATI 7505|ati 7505|mesh-list
101490113|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101490114|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
101490115|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490116|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490117|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101490118|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101490119|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
101490120|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101490121|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490122|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
101490123|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490124|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490125|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101490126|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101490127|NCT00446862|Losartan|losartan|mesh-list
101490128|NCT00446862|Enalapril|enalapril|mesh-list
101490129|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101490130|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101490131|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101490132|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101490133|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490134|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101490135|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490136|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490137|NCT00446901|Selenium|selenium|mesh-list
101490138|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
101490139|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490140|NCT00446901|Protective Agents|protective agents|mesh-ancestor
101490141|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490142|NCT00446901|Trace Elements|trace elements|mesh-ancestor
101490143|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
101490144|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
101490145|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
101490146|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490147|NCT00453375|Protective Agents|protective agents|mesh-ancestor
101490148|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490149|NCT00446940|Atorvastatin|atorvastatin|mesh-list
101490150|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101490151|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101490152|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101376555|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
101376556|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101376558|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101376559|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101376560|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
101376561|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376562|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376563|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376564|NCT00239551|Lansoprazole|lansoprazole|mesh-list
101376566|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376567|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101376568|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376569|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376570|NCT00239629|Teriparatide|teriparatide|mesh-list
101376571|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
101376572|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101376573|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376574|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101376575|NCT00098436|Temozolomide|temozolomide|mesh-list
101490153|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
101490154|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490155|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101490156|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101490157|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490158|NCT00453414|Iloprost|iloprost|mesh-list
101490159|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101490160|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490162|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490163|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
101490164|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490165|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101490166|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
101490167|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490174|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101490175|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101490176|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490177|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490178|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490179|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
101490180|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490181|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
101490183|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490184|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490185|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101376576|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101376577|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
101376578|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376579|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376580|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101376581|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376582|NCT00239707|Incretins|incretins|mesh-ancestor
101376584|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376585|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376586|NCT00239746|Ibuprofen|ibuprofen|mesh-list
101376587|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101376588|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376589|NCT00239746|Analgesics|analgesics|mesh-ancestor
101376590|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
101376591|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490186|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490187|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101490188|NCT00343187|Dapsone|dapsone|mesh-list
101490189|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490190|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
101490191|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490192|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490193|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101490194|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490195|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490196|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
101490197|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490199|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490200|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
101490201|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490202|NCT00343265|Progesterone|progesterone|mesh-list
101490203|NCT00343265|Progestins|progestins|mesh-ancestor
101490204|NCT00343265|Hormones|hormones|mesh-ancestor
101545978|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490205|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490206|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490207|NCT00453609|Naltrexone|naltrexone|mesh-list
101490208|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101490209|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101490210|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490211|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
101490212|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490213|NCT00447213|Insulin|insulin|mesh-list
101490214|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101490215|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
101490216|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101490217|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490218|NCT00453648|Vitamin A|vitamin a|mesh-list
101490219|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
101490220|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
101490221|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490222|NCT00453648|Protective Agents|protective agents|mesh-ancestor
101490223|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490224|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101490225|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490227|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
101490228|NCT00343421|Vaccines|vaccines|mesh-list
101490229|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101376593|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376594|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376595|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376596|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376597|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376598|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101376599|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101376600|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376601|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376602|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
101376603|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376604|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101376605|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101490230|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
101490231|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490232|NCT00343499|Valsartan|valsartan|mesh-list
101490233|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490234|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101490235|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101490236|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490237|NCT04715360|Favipiravir|favipiravir|mesh-list
101490238|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
101490239|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490243|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
101490244|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490245|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490247|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101490248|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490249|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490250|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101490251|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101490252|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101490253|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490254|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101490255|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490256|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
101490257|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490258|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
101490259|NCT00343655|Atorvastatin|atorvastatin|mesh-list
101490260|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101490261|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101490262|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
101490263|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490264|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101546005|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490265|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101490266|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490267|NCT00453765|Montelukast|montelukast|mesh-list
101490268|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101490269|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
101490270|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101490271|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
101490272|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376607|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376608|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
101376609|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376610|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101376611|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101376612|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376613|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376614|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
101490273|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490274|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101490275|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101490276|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490277|NCT00343733|Fentanyl|fentanyl|mesh-list
101490278|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101490279|NCT00343733|Narcotics|narcotics|mesh-ancestor
101490280|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490281|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490282|NCT00343733|Analgesics|analgesics|mesh-ancestor
101490283|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
101490284|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490285|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101490286|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101490287|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
101490288|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
101490289|NCT00343811|Modafinil|modafinil|mesh-list
101490290|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101490291|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490292|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101490293|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101490294|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101490295|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490296|NCT00453804|Naltrexone|naltrexone|mesh-list
101490297|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101490298|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101490299|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490300|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
101490301|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490302|NCT00343850|Mesalamine|mesalamine|mesh-list
101490303|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101490304|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101490305|NCT00343850|Analgesics|analgesics|mesh-ancestor
101490306|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
101490307|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490308|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490325|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101490326|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
101490327|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101490328|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490329|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490330|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
101490331|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490332|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
101490333|NCT02273661|Amphotericin B|amphotericin b|mesh-list
101490334|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101490335|NCT02273661|Amebicides|amebicides|mesh-ancestor
101490336|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490337|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490338|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490339|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490340|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
101490341|NCT00344123|Ritonavir|ritonavir|mesh-list
101490342|NCT00344123|Tipranavir|tipranavir|mesh-list
101376615|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376616|NCT00239980|Dalteparin|dalteparin|mesh-list
101376617|NCT00239980|Tinzaparin|tinzaparin|mesh-list
101376618|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101376620|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101376621|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101376622|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376623|NCT00240019|Furosemide|furosemide|mesh-list
101376624|NCT00240019|Diuretics|diuretics|mesh-ancestor
101376625|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
101376626|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376627|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101376628|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376629|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376630|NCT00240058|Phenylephrine|phenylephrine|mesh-list
101376633|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101376634|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
101376635|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
101490343|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101490344|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101490345|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101490346|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490347|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490348|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490349|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490350|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490351|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
101490352|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490353|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101490354|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101490355|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101490356|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101490357|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
101490358|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101490359|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101490360|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101490361|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
101490362|NCT00344201|Coagulants|coagulants|mesh-ancestor
101490363|NCT00453960|Norethindrone|norethindrone|mesh-list
101490364|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
101490365|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101490366|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101490367|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101490368|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
101490369|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101490370|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490371|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101490385|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490386|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490387|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490388|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101376636|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376637|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376638|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
101376639|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101376640|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
101490389|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490390|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490391|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101490393|NCT00344513|Carvedilol|carvedilol|mesh-list
101490394|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101490395|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101490396|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101490397|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
101490398|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490399|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490400|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490401|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490402|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
101490403|NCT00344513|Protective Agents|protective agents|mesh-ancestor
101490404|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101490405|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490406|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101490407|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490408|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101490409|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101490410|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490411|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490412|NCT00344552|Paclitaxel|paclitaxel|mesh-list
101490413|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101490414|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490415|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
101490416|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
101490417|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
101490418|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490419|NCT00447915|Vitamin D|vitamin d|mesh-list
101490420|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
101490421|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
101490422|NCT00447915|Calcium|calcium|mesh-list
101490423|NCT00447915|Vitamins|vitamins|mesh-ancestor
101490424|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
101490425|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490426|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101490427|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101490428|NCT00344669|Albendazole|albendazole|mesh-list
101490429|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
101490430|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490431|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490432|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
101490433|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101490434|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490435|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101490439|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490440|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
101490441|NCT04715165|Bupivacaine|bupivacaine|mesh-list
101490442|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
101490443|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
101490444|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490445|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490446|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
101490447|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490448|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101490449|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101490450|NCT04715165|Analgesics|analgesics|mesh-ancestor
101490451|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101490452|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101490453|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101490454|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101490455|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376641|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
101376642|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101376643|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101376644|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101376645|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101376646|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376647|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376648|NCT00240058|Protective Agents|protective agents|mesh-ancestor
101376649|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101376650|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101376651|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101376652|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
101376653|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101376654|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
101376655|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
101490456|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490457|NCT00454233|Metformin|metformin|mesh-list
101490458|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101490459|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490460|NCT00454272|Vancomycin|vancomycin|mesh-list
101490461|NCT00454272|Teicoplanin|teicoplanin|mesh-list
101490462|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490463|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490464|NCT00344825|Fludarabine|fludarabine|mesh-list
101490465|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
101490466|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
101490467|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490468|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490469|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
101490470|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490471|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490472|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
101490473|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490474|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490476|NCT00448110|Ketorolac|ketorolac|mesh-list
101490477|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101490478|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101490479|NCT00448110|Analgesics|analgesics|mesh-ancestor
101490480|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
101490481|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490482|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490483|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490484|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490485|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101490486|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490487|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490488|NCT00448149|Everolimus|everolimus|mesh-list
101490489|NCT00448149|Sorafenib|sorafenib|mesh-list
101490490|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101490491|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101490492|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490493|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490494|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490495|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
101490496|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490497|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490498|NCT00344942|Triamcinolone|triamcinolone|mesh-list
101490499|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101376656|NCT00098553|Everolimus|everolimus|mesh-list
101376657|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101376658|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376659|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376660|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376661|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376662|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
101376663|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490500|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101490501|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101490502|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490503|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
101490504|NCT00344942|Hormones|hormones|mesh-ancestor
101490505|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490506|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490521|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
101490522|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490523|NCT00344981|Tenofovir|tenofovir|mesh-list
101490524|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
101490525|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
101490526|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490527|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101490528|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101490529|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546018|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101490530|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490531|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490532|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490533|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490534|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
101490535|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
101490536|NCT00448266|Thiotepa|thiotepa|mesh-list
101490537|NCT00448266|Carboplatin|carboplatin|mesh-list
101490538|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490539|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
101490540|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490541|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490542|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101490543|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
101490544|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490545|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490546|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101490548|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101490549|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101490550|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
101490551|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490552|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101490553|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101490554|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490555|NCT00345059|Gemcitabine|gemcitabine|mesh-list
101490556|NCT00345059|Capecitabine|capecitabine|mesh-list
101490557|NCT00345059|Docetaxel|docetaxel|mesh-list
101490558|NCT00345059|Vinorelbine|vinorelbine|mesh-list
101490559|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490560|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
101490561|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490562|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490563|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
101490564|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
101490565|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
101490566|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101490567|NCT00345098|Amibegron|amibegron|mesh-list
101490574|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490575|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101490577|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101490578|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101490579|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376664|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376666|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376667|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376668|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376669|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490580|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
101490581|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
101490582|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
101490583|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490584|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101490585|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490586|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490588|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101490589|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490590|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490591|NCT00448461|Heparin|heparin|mesh-list
101490592|NCT00448461|Bivalirudin|bivalirudin|mesh-list
101490593|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
101490594|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101490595|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101490596|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490597|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
101490598|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101490599|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490600|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490601|NCT00454662|Amlodipine|amlodipine|mesh-list
101490602|NCT00454662|Olmesartan|olmesartan|mesh-list
101490603|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101490604|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490605|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101490606|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490607|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490608|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101490609|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490610|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490611|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101490612|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101490613|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
101490614|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
101490615|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101490616|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490617|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490618|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101490619|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490620|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101490622|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490623|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
101490624|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490625|NCT00345761|Bevacizumab|bevacizumab|mesh-list
101490626|NCT00345761|Capecitabine|capecitabine|mesh-list
101490627|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
101490628|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490629|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490630|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101490631|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101490632|NCT00345761|Growth Substances|growth substances|mesh-ancestor
101490633|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490637|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490638|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
101490639|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101490640|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101490641|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
101490642|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
101490643|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490644|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376670|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
101376671|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376672|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
101376673|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376674|NCT00240253|Pramlintide|pramlintide|mesh-list
101376675|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376676|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376677|NCT00065936|Naltrexone|naltrexone|mesh-list
101490645|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
101490646|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101490647|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101490648|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
101490649|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490650|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490651|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490652|NCT00454740|Urological Agents|urological agents|mesh-ancestor
101490653|NCT03276858|Midazolam|midazolam|mesh-list
101490654|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101490655|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101490656|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101490657|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490658|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490659|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101490660|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101490661|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101490662|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101490663|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
101490664|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
101490665|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
101490666|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
101490667|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490668|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490669|NCT00421187|Amphotericin B|amphotericin b|mesh-list
101490670|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101490671|NCT00421187|Amebicides|amebicides|mesh-ancestor
101490672|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490673|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490674|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490675|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490676|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
101490677|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
101490678|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101490679|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101490680|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
101490681|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490682|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490683|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490684|NCT00454896|Urological Agents|urological agents|mesh-ancestor
101490685|NCT00346190|Alendronate|alendronate|mesh-list
101490686|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101490687|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490689|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101490690|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101490691|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490692|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101490693|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101490694|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490695|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490696|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
101490697|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490698|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490699|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
101490700|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
101490701|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
101490702|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490703|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101490704|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101376679|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101376680|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376681|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
101376682|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490705|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
101490722|NCT00455091|Adefovir|adefovir|mesh-list
101490723|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101490724|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101490725|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101490726|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490727|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490728|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
101490729|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490730|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490731|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490732|NCT00346580|Nelfinavir|nelfinavir|mesh-list
101490733|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101490734|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101490735|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490736|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490737|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490738|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490739|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490740|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
101490741|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490742|NCT00346619|Nelfinavir|nelfinavir|mesh-list
101490743|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101490744|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101490745|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490746|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490747|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490748|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490749|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490750|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
101490751|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490752|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
101490753|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101546042|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490755|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101490756|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490757|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490758|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490759|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
101490760|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101490761|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490762|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490764|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490765|NCT04698213|Avelumab|avelumab|mesh-list
101490766|NCT04698213|Axitinib|axitinib|mesh-list
101490767|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490786|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
101490787|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490788|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101490789|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490790|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
101490792|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
101490793|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490794|NCT00455130|Mannitol|mannitol|mesh-list
101490795|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101490796|NCT00455130|Diuretics|diuretics|mesh-ancestor
101490797|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
101490798|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490799|NCT00347048|Tacrolimus|tacrolimus|mesh-list
101490800|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490801|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
101490802|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490803|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101490804|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490805|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490806|NCT00347087|Irbesartan|irbesartan|mesh-list
101376683|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101376684|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101376685|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101376686|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
101376687|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490807|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490808|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101490809|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101490810|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490811|NCT00347165|Bevacizumab|bevacizumab|mesh-list
101490812|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490813|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490814|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101490815|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101490816|NCT00347165|Growth Substances|growth substances|mesh-ancestor
101490817|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490818|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
101490819|NCT00347204|Ketorolac|ketorolac|mesh-list
101490820|NCT00347204|Nepafenac|nepafenac|mesh-list
101490821|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101490822|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101490823|NCT00347204|Analgesics|analgesics|mesh-ancestor
101490838|NCT00455286|Temozolomide|temozolomide|mesh-list
101490839|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101490840|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
101490841|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101490842|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
101490843|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101490844|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490845|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490846|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
101490847|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490848|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490849|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490850|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490851|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101490852|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490853|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
101490854|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490855|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101546045|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
101490856|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101490857|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
101490858|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490859|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
101490860|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
101490861|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490862|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101490863|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
101490865|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490866|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101490867|NCT00455286|Protective Agents|protective agents|mesh-ancestor
101490868|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101490869|NCT00455364|Voriconazole|voriconazole|mesh-list
101490870|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
101490871|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490872|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101490873|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101490874|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490875|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490876|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101490877|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101490878|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490879|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490880|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101490881|NCT00347399|Bevacizumab|bevacizumab|mesh-list
101490882|NCT00347399|Verteporfin|verteporfin|mesh-list
101376688|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101376689|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101376690|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376691|NCT00240409|Pramipexole|pramipexole|mesh-list
101376692|NCT00240409|Bromocriptine|bromocriptine|mesh-list
101376693|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
101490911|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490912|NCT00347555|Antacids|antacids|mesh-ancestor
101490913|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490914|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101490915|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
101490916|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101490917|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101490918|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101490919|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101490920|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490921|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
101490922|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490923|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490924|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101490932|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101490933|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101490934|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
101490935|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490936|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101490937|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101490938|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
101490939|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
101490940|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101490941|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101490942|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101490943|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490944|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101490945|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101490946|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490947|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490948|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490949|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
101490950|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490951|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101490952|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101490953|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490954|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490955|NCT00347867|Urological Agents|urological agents|mesh-ancestor
101490956|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
101490958|NCT00449202|Estrogens|estrogens|mesh-ancestor
101490959|NCT00449202|Hormones|hormones|mesh-ancestor
101490960|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490961|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490962|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101490963|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
101490964|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
101490965|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101490966|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101490967|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490968|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490969|NCT00455715|Urological Agents|urological agents|mesh-ancestor
101490970|NCT00455754|Esomeprazole|esomeprazole|mesh-list
101490971|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101490972|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101490973|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101490974|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490975|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490976|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101490977|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
101490978|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101490979|NCT00348023|Timolol|timolol|mesh-list
101376694|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376695|NCT00240409|Protective Agents|protective agents|mesh-ancestor
101376696|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376697|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101376698|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101376699|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
101376700|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
101490980|NCT00348023|Bimatoprost|bimatoprost|mesh-list
101490981|NCT00348023|Travoprost|travoprost|mesh-list
101490982|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101490983|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101490984|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101490985|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101490986|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490987|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490988|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101490989|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490990|NCT00348062|Bimatoprost|bimatoprost|mesh-list
101490991|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101490992|NCT00348101|Enoximone|enoximone|mesh-list
101490993|NCT00348101|Esmolol|esmolol|mesh-list
101490999|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491000|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491001|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101491002|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491003|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101491004|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101491005|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491006|NCT00348101|Protective Agents|protective agents|mesh-ancestor
101491008|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
101491009|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491010|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
101491011|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491012|NCT00455871|Ranibizumab|ranibizumab|mesh-list
101491013|NCT00455871|Verteporfin|verteporfin|mesh-list
101491014|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491015|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491016|NCT00455871|Growth Substances|growth substances|mesh-ancestor
101491017|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491018|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491019|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491020|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101491021|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491023|NCT00449280|Sorafenib|sorafenib|mesh-list
101491024|NCT00449280|Temsirolimus|temsirolimus|mesh-list
101491025|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
101491026|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491027|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491028|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491029|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491030|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491031|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491032|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101491033|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
101491034|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491035|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
101491036|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491038|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491039|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
101491040|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491041|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
101491042|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491043|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491044|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491045|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491046|NCT00455910|Growth Substances|growth substances|mesh-ancestor
101491047|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491048|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376701|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376702|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376703|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376705|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101376706|NCT00240448|Telmisartan|telmisartan|mesh-list
101376707|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101376708|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101491049|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
101491050|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101491051|NCT00348296|Antibodies|antibodies|mesh-list
101491052|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
101491053|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101491054|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
101491055|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491056|NCT00449319|Daunorubicin|daunorubicin|mesh-list
101491057|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101491058|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491059|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101491060|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101491061|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491062|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491063|NCT00348335|Cyclosporine|cyclosporine|mesh-list
101491064|NCT00348335|Cyclosporins|cyclosporins|mesh-list
101491094|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491095|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
101491096|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491097|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101491098|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491100|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
101491101|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491102|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101491103|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
101491104|NCT00348413|Hormones|hormones|mesh-ancestor
101491105|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491106|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101491107|NCT00348413|Protective Agents|protective agents|mesh-ancestor
101491108|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491133|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
101491134|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101491135|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101491136|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491137|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491138|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101491139|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101491140|NCT00348491|Analgesics|analgesics|mesh-ancestor
101491141|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
101491142|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491143|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491144|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491145|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491146|NCT03274323|Travoprost|travoprost|mesh-list
101491147|NCT03274323|Latanoprost|latanoprost|mesh-list
101491148|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101491149|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101491150|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491151|NCT00348530|Verapamil|verapamil|mesh-list
101491152|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101491153|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101491154|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546049|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491155|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491156|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101491157|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491165|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
101491166|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491167|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101376709|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101376710|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376711|NCT00240448|Diuretics|diuretics|mesh-ancestor
101376712|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
101376713|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376714|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101376715|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101376716|NCT00098631|Lapatinib|lapatinib|mesh-list
101491168|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101491169|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101491170|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101491171|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101491172|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
101491173|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491174|NCT00456027|Antacids|antacids|mesh-ancestor
101491175|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491176|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101491177|NCT00448734|Docetaxel|docetaxel|mesh-list
101491178|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491179|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101491180|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101491181|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101491182|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491183|NCT00348725|Metformin|metformin|mesh-list
101491184|NCT00348725|Fenofibrate|fenofibrate|mesh-list
101491185|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491186|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491187|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101491188|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
101491189|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491190|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101491191|NCT00348764|Polidocanol|polidocanol|mesh-list
101491192|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101491193|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101491194|NCT03276156|Apatinib|apatinib|mesh-list
101491195|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491196|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491197|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491198|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491199|NCT00456144|Hormones|hormones|mesh-list
101491200|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491201|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491202|NCT00348920|Bupivacaine|bupivacaine|mesh-list
101491203|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
101491204|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
101491205|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491206|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491207|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
101491208|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491210|NCT00449514|Clomiphene|clomiphene|mesh-list
101491211|NCT00449514|Enclomiphene|enclomiphene|mesh-list
101491212|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
101491213|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101491214|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
101491215|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491216|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491217|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491218|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491219|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101491220|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101491221|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101491222|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101491223|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
101491255|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491256|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
101376717|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376718|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376719|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376720|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376721|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
101376722|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376723|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376724|NCT00076791|Tenofovir|tenofovir|mesh-list
101491257|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491258|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491259|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491260|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491261|NCT00349115|Growth Substances|growth substances|mesh-ancestor
101491262|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491263|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491264|NCT00456339|Amoxicillin|amoxicillin|mesh-list
101491265|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
101491266|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
101491269|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491270|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491271|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491272|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
101491274|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491275|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491276|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491277|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491278|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101491279|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491280|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491281|NCT00421421|Dutasteride|dutasteride|mesh-list
101491282|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101491283|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101491284|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491285|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491286|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
101491287|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491288|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491289|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
101491290|NCT00421460|Testosterone|testosterone|mesh-list
101491291|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
101491292|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
101491293|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101491294|NCT00421460|Androgens|androgens|mesh-ancestor
101491295|NCT00421460|Hormones|hormones|mesh-ancestor
101491296|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491297|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491298|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491299|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491300|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
101491301|NCT00349310|Pramipexole|pramipexole|mesh-list
101491302|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
101491303|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491304|NCT00349310|Protective Agents|protective agents|mesh-ancestor
101491305|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491306|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101546077|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
101491307|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101491308|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
101491309|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
101491310|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491311|NCT03274167|Gabapentin|gabapentin|mesh-list
101491312|NCT03274167|Analgesics|analgesics|mesh-ancestor
101491313|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
101491314|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491315|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491316|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
101491317|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101376725|NCT00076791|Emtricitabine|emtricitabine|mesh-list
101376726|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101376727|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
101376728|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376729|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101376730|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101376731|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376732|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376733|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101491318|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101491319|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491320|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491321|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101491322|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101491323|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491324|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491325|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
101491326|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
101491327|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491328|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491329|NCT00349583|Cyclosporine|cyclosporine|mesh-list
101491330|NCT00349583|Cyclosporins|cyclosporins|mesh-list
101491331|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491332|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491333|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491334|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
101491335|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491336|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
101491337|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491342|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491343|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491344|NCT00349739|Growth Substances|growth substances|mesh-ancestor
101491345|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491346|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491347|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491348|NCT00456729|Metronidazole|metronidazole|mesh-list
101491349|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491350|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491351|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101491352|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101491353|NCT00450099|Bupivacaine|bupivacaine|mesh-list
101491354|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
101491355|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
101491356|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491357|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491358|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
101491359|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491360|NCT00450138|Cisplatin|cisplatin|mesh-list
101491361|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491362|NCT00350051|Prednisone|prednisone|mesh-list
101491363|NCT00350051|Sagopilone|sagopilone|mesh-list
101491364|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491365|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
101491366|NCT00350051|Hormones|hormones|mesh-ancestor
101491367|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491368|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491369|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491370|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491371|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
101491372|NCT00350090|Hematinics|hematinics|mesh-ancestor
101491373|NCT04699110|Adenosine|adenosine|mesh-list
101491374|NCT04699110|Epinephrine|epinephrine|mesh-list
101491375|NCT04699110|Racepinephrine|racepinephrine|mesh-list
101491376|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
101491377|NCT04699110|Analgesics|analgesics|mesh-ancestor
101491378|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
101376735|NCT00240682|Cetuximab|cetuximab|mesh-list
101376736|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101376737|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376738|NCT00240721|Topiramate|topiramate|mesh-list
101376739|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
101376740|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376741|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376742|NCT00240760|Memantine|memantine|mesh-list
101491379|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491380|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491381|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101491382|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491383|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101491384|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
101491385|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
101491386|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491387|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491388|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101491389|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101491390|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
101491391|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101491392|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101491393|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
101491394|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101491395|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
101491396|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
101491397|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
101491398|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101491399|NCT00350168|Amlodipine|amlodipine|mesh-list
101491400|NCT00350168|Valsartan|valsartan|mesh-list
101491401|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491402|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101491403|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101491404|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491405|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101491406|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491407|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491408|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101491409|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101491410|NCT00105534|Azithromycin|azithromycin|mesh-list
101491424|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
101491425|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101491426|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491427|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101491428|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101491429|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491430|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491431|NCT00456963|Losartan|losartan|mesh-list
101491432|NCT00456963|Enalapril|enalapril|mesh-list
101491433|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101491434|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491435|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101491436|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101491437|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491438|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101491439|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
101491440|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491441|NCT00350597|Molgramostim|molgramostim|mesh-list
101491442|NCT00350597|Sargramostim|sargramostim|mesh-list
101491443|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
101491444|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491445|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491446|NCT00350753|Bevacizumab|bevacizumab|mesh-list
101491447|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101491448|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101376743|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101376744|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101376745|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
101376746|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376747|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376748|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491449|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491450|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491451|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491452|NCT00350753|Growth Substances|growth substances|mesh-ancestor
101491453|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491454|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491455|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491456|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491457|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491458|NCT00457119|Everolimus|everolimus|mesh-list
101491459|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101491460|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491461|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491462|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491463|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491464|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
101491465|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491466|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491467|NCT00350948|Doxorubicin|doxorubicin|mesh-list
101491468|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101491469|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101491482|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
101491483|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101491484|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101491485|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491486|NCT00351026|Methadone|methadone|mesh-list
101491487|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101491488|NCT00351026|Narcotics|narcotics|mesh-ancestor
101491489|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491490|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491491|NCT00351026|Analgesics|analgesics|mesh-ancestor
101491492|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
101491493|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491494|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
101491495|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
101491496|NCT00351104|Ketoprofen|ketoprofen|mesh-list
101491497|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101491498|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101491499|NCT00351104|Analgesics|analgesics|mesh-ancestor
101491500|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
101491501|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491502|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491503|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491504|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491505|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101491506|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491507|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491508|NCT00351143|Fluticasone|fluticasone|mesh-list
101491510|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101491511|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491512|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101491513|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
101491514|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491515|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491516|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101491517|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
101491518|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491519|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101491520|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101491521|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101376749|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101376750|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101376751|NCT00066092|Lenograstim|lenograstim|mesh-list
101376752|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101376753|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
101376754|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491522|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101491523|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
101491524|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491525|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491526|NCT00457470|Rucaparib|rucaparib|mesh-list
101491527|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101491528|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491529|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491535|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101491536|NCT00450645|Tinzaparin|tinzaparin|mesh-list
101491537|NCT00450645|Dalteparin|dalteparin|mesh-list
101491538|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
101491539|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101491540|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101491541|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491542|NCT00351182|Doxycycline|doxycycline|mesh-list
101491543|NCT00351182|Telithromycin|telithromycin|mesh-list
101491544|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491545|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491546|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
101491547|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101491548|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101491549|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
101491550|NCT00457860|Immunotoxins|immunotoxins|mesh-list
101491551|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
101491552|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
101491553|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491554|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491555|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101491556|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
101491557|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491558|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101491559|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101491560|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491561|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491562|NCT00351884|Vildagliptin|vildagliptin|mesh-list
101491563|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491564|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491565|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101491566|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
101491567|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491568|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491569|NCT00458055|Niacin|niacin|mesh-list
101491570|NCT00458055|Atorvastatin|atorvastatin|mesh-list
101491571|NCT00458055|Fenofibrate|fenofibrate|mesh-list
101491572|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101491573|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101491574|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
101491575|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491576|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101491577|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101491578|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491579|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491580|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
101491581|NCT00458055|Vitamins|vitamins|mesh-ancestor
101491582|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
101491583|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491584|NCT00450762|Carboplatin|carboplatin|mesh-list
101491585|NCT00450762|Gemcitabine|gemcitabine|mesh-list
101491586|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491587|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101491588|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
101491589|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376756|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376757|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101376758|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101376759|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376760|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376761|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101376762|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376763|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376764|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491590|NCT00450840|Simvastatin|simvastatin|mesh-list
101491591|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101491592|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101491593|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
101491594|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491595|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101491596|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101491597|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491598|NCT00352196|Risperidone|risperidone|mesh-list
101491599|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101491600|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
101491601|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491604|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101491605|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101491606|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491607|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491608|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101491611|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101491612|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
101491613|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491614|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491615|NCT00352313|Carboplatin|carboplatin|mesh-list
101491616|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491617|NCT00450957|Lycopene|lycopene|mesh-list
101491618|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491619|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
101491620|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491621|NCT00450957|Protective Agents|protective agents|mesh-ancestor
101491622|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491623|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101491624|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101491625|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491626|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
101491627|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101491628|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
101491629|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491630|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491631|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101491632|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
101491633|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101491634|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
101491635|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491636|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491637|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101491638|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491639|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
101491640|NCT00352430|Protective Agents|protective agents|mesh-ancestor
101491641|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101491642|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
101491643|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491644|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101491645|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101376765|NCT00240799|Acetaminophen|acetaminophen|mesh-list
101376766|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376767|NCT00240799|Analgesics|analgesics|mesh-ancestor
101376768|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
101376769|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376770|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376771|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
101376772|NCT00240838|Acetaminophen|acetaminophen|mesh-list
101376773|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101376774|NCT00240838|Analgesics|analgesics|mesh-ancestor
101376775|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
101376776|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376777|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376778|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
101376779|NCT02965404|Vaccines|vaccines|mesh-list
101376780|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
101376781|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376782|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
101376783|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376784|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376785|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101491646|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491647|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491648|NCT00451074|Gentamicins|gentamicins|mesh-list
101491649|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491650|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491651|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101491652|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491653|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491654|NCT00465621|Latanoprost|latanoprost|mesh-list
101491655|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101491656|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101491657|NCT00352625|Ketoprofen|ketoprofen|mesh-list
101491658|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101491659|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101491660|NCT00352625|Analgesics|analgesics|mesh-ancestor
101491661|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
101491662|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491663|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491664|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491665|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491666|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101491667|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491668|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491669|NCT00352742|Bortezomib|bortezomib|mesh-list
101491670|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101491671|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491672|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
101491673|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
101491706|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491708|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101491710|NCT00466128|Analgesics|analgesics|mesh-ancestor
101491711|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
101491712|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376787|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376788|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376789|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491713|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491714|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491715|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491720|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491721|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491723|NCT00353015|Irinotecan|irinotecan|mesh-list
101491724|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491725|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101491726|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101491727|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491728|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491729|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101491730|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491731|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491732|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491733|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491734|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
101491735|NCT00353054|Antacids|antacids|mesh-ancestor
101491736|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491737|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101491738|NCT00466401|Simvastatin|simvastatin|mesh-list
101491739|NCT00466401|Ezetimibe|ezetimibe|mesh-list
101491740|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101491741|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101491742|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
101491743|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491744|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101491745|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101491746|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491747|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101491748|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491749|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101491750|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101491751|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101491752|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
101491753|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491754|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491755|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491756|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101491757|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491758|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491759|NCT00466518|Incretins|incretins|mesh-ancestor
101491760|NCT00466518|Hormones|hormones|mesh-ancestor
101491761|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491762|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101491763|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
101491764|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491765|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491766|NCT00353561|Fluconazole|fluconazole|mesh-list
101491767|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
101491768|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491769|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101491770|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101491771|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491772|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491773|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101491774|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
101491775|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491776|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491777|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101491778|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101376790|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376791|NCT00241072|Valsartan|valsartan|mesh-list
101376792|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101376793|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101376794|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101376795|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376797|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101376798|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376799|NCT00241150|Valsartan|valsartan|mesh-list
101376800|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491779|NCT00466596|Vitamins|vitamins|mesh-list
101491780|NCT00466596|Vitamin E|vitamin e|mesh-list
101491781|NCT00466596|Tocopherols|tocopherols|mesh-list
101491782|NCT00466596|Tocotrienols|tocotrienols|mesh-list
101491783|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
101491784|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
101491807|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491808|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101491809|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
101491810|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491811|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491812|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101491813|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101491814|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
101491815|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101491816|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101491818|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491819|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491820|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101491821|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101491822|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
101491823|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491824|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101491825|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101491826|NCT00353717|Paclitaxel|paclitaxel|mesh-list
101491827|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101491828|NCT00353717|Cetuximab|cetuximab|mesh-list
101491829|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101491830|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491831|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
101491832|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
101491833|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
101491834|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491835|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101491836|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
101491837|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491838|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491869|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101491871|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
101491872|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101491873|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
101491874|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491875|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491876|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491877|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491878|NCT00466869|Betahistine|betahistine|mesh-list
101491881|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
101491882|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491883|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491884|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491885|NCT00354146|Tipifarnib|tipifarnib|mesh-list
101376801|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101376802|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101376803|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376804|NCT00076869|Amphotericin B|amphotericin b|mesh-list
101376805|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101376806|NCT00076869|Caspofungin|caspofungin|mesh-list
101376807|NCT00076869|Amebicides|amebicides|mesh-ancestor
101376808|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101376809|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101376810|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491886|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491887|NCT00458367|Risperidone|risperidone|mesh-list
101491888|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101491889|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
101491890|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491891|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491892|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491893|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101491894|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101491895|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491896|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491897|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101491898|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
101491899|NCT00354185|Belinostat|belinostat|mesh-list
101491900|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491901|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101491902|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491903|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491904|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101491905|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491906|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
101491907|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
101491908|NCT00354302|Alendronate|alendronate|mesh-list
101491909|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
101491910|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
101491911|NCT00354302|Calcium|calcium|mesh-list
101491912|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101491913|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491914|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101491915|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491916|NCT00354302|Vitamins|vitamins|mesh-ancestor
101491917|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
101491918|NCT00354302|Antacids|antacids|mesh-ancestor
101491919|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101491920|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101491921|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101491922|NCT04714229|Vaccines|vaccines|mesh-list
101491923|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
101491924|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491925|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
101491926|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101491927|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491928|NCT00354380|Artesunate|artesunate|mesh-list
101491929|NCT00354380|Amodiaquine|amodiaquine|mesh-list
101491930|NCT00354380|Methylene Blue|methylene blue|mesh-list
101491931|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
101491932|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101491933|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101491934|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491935|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491936|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
101491937|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
101491938|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101491939|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
101491940|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491941|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491942|NCT00354419|Cyclosporine|cyclosporine|mesh-list
101376811|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376812|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
101376813|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376814|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491943|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
101491944|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
101491945|NCT00354419|Cyclosporins|cyclosporins|mesh-list
101491946|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
101491947|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101491948|NCT00354419|Lenograstim|lenograstim|mesh-list
101491949|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
101491950|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491951|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
101491952|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491953|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491954|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101491960|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491961|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
101491962|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491963|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491964|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101491965|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101491966|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101491967|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
101491968|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491969|NCT00354458|Rolofylline|rolofylline|mesh-list
101491970|NCT00354458|Diuretics|diuretics|mesh-ancestor
101491971|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
101491972|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491973|NCT00458718|Rimonabant|rimonabant|mesh-list
101491974|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101491975|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101491976|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101491977|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491978|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491979|NCT00458718|Hormones|hormones|mesh-ancestor
101491980|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491981|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491982|NCT00467181|Fenoldopam|fenoldopam|mesh-list
101491983|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491984|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491985|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
101491986|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
101491987|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491988|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491989|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491990|NCT00425711|Acamprosate|acamprosate|mesh-list
101491991|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101491992|NCT03274011|Apatinib|apatinib|mesh-list
101491993|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491994|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491995|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491996|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491998|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101491999|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
101492000|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492001|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492002|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101492003|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101492004|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
101492005|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492006|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492007|NCT00467376|Insulin|insulin|mesh-list
101492008|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101492009|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
101492010|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
101492011|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101492012|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492013|NCT00426023|Ketotifen|ketotifen|mesh-list
101492014|NCT00426023|Cyclosporine|cyclosporine|mesh-list
101376816|NCT00066248|Megestrol|megestrol|mesh-list
101376817|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
101376818|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101376819|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101376820|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101376821|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
101376822|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101376823|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376824|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101492015|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101492016|NCT00426023|Cyclosporins|cyclosporins|mesh-list
101492017|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492018|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492019|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492020|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
101492021|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492022|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
101492023|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492024|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492032|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492033|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101492034|NCT00467454|Naltrexone|naltrexone|mesh-list
101492035|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101492036|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101492037|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492038|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
101492039|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492040|NCT00426101|Cyclosporine|cyclosporine|mesh-list
101492042|NCT00426101|Etoposide|etoposide|mesh-list
101492043|NCT00426101|Cyclosporins|cyclosporins|mesh-list
101492044|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492045|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
101492046|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
101492047|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492048|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492049|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492050|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
101492051|NCT00426101|Hormones|hormones|mesh-ancestor
101492052|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492053|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101492054|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492055|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101492056|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101492057|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101492058|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492059|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492060|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492061|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
101492062|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
101492063|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492064|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492065|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492066|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101492067|NCT00426140|Epothilone B|epothilone b|mesh-list
101492068|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492069|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101492071|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101492072|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492073|NCT00467493|Anastrozole|anastrozole|mesh-list
101492074|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101492075|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492076|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101492077|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101492078|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376825|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101376826|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101376827|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376828|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
101376829|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101376830|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
101492079|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492080|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101492081|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
101492082|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492083|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492084|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
101492085|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492086|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492087|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492088|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492089|NCT00458913|Bortezomib|bortezomib|mesh-list
101492090|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492091|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
101492092|NCT00458991|Caffeine|caffeine|mesh-list
101492093|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101492105|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101492106|NCT01059617|Vaccines|vaccines|mesh-list
101492108|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492110|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101492111|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
101492112|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101492113|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101492114|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492115|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492116|NCT04705337|Protective Agents|protective agents|mesh-ancestor
101492117|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492118|NCT00467571|Amoxicillin|amoxicillin|mesh-list
101492119|NCT00467571|Clarithromycin|clarithromycin|mesh-list
101492120|NCT00467571|Lansoprazole|lansoprazole|mesh-list
101492121|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
101492122|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492123|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492124|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101492125|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492126|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492127|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101492128|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101492129|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101492130|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492131|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101492132|NCT00426296|Ritonavir|ritonavir|mesh-list
101492133|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101492134|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101492135|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101492136|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
101492137|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492138|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492139|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101492140|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101492141|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
101492142|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492143|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101492144|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101492145|NCT03271905|Bromides|bromides|mesh-list
101492146|NCT03271905|Albuterol|albuterol|mesh-list
101492147|NCT03271905|Ipratropium|ipratropium|mesh-list
101492148|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
101492149|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101492150|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
101492151|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376831|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
101376832|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376833|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101376834|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
101376835|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
101376836|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376837|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376838|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101376839|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
101376840|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101376841|NCT00241189|Sirolimus|sirolimus|mesh-list
101492152|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492153|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101492154|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
101492155|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
101492160|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
101492161|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492162|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492163|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101492165|NCT00426413|Pioglitazone|pioglitazone|mesh-list
101492166|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101492167|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492168|NCT00459264|Folic Acid|folic acid|mesh-list
101492169|NCT00459264|Hematinics|hematinics|mesh-ancestor
101492170|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
101492171|NCT00459264|Vitamins|vitamins|mesh-ancestor
101492172|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
101492173|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492174|NCT00426452|Vatalanib|vatalanib|mesh-list
101492175|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492176|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492177|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492178|NCT00426491|Misoprostol|misoprostol|mesh-list
101492179|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101492180|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
101492181|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101492182|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492183|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101492184|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492185|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
101492186|NCT00426530|Everolimus|everolimus|mesh-list
101492187|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101492188|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492189|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492190|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492191|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492192|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
101492193|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492194|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492195|NCT00459420|Caffeine|caffeine|mesh-list
101492196|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101492197|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492198|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101492199|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492200|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492201|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101492202|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101492203|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
101492204|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492205|NCT00467766|Donepezil|donepezil|mesh-list
101492206|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101492207|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492208|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492209|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
101376842|NCT00241189|Methotrexate|methotrexate|mesh-list
101376843|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101376844|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
101376845|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101376846|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376847|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101376848|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
101376849|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492210|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492211|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492213|NCT04705415|Niclosamide|niclosamide|mesh-list
101492214|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
101492215|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101492216|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
101492217|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492218|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492219|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
101492220|NCT00467883|Amphotericin B|amphotericin b|mesh-list
101492221|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101492222|NCT00467883|Amebicides|amebicides|mesh-ancestor
101492223|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101492224|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492225|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492226|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492233|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101492234|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101492246|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492247|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492248|NCT00426647|Analgesics|analgesics|mesh-ancestor
101492249|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
101492250|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492251|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101492252|NCT01059071|Eflornithine|eflornithine|mesh-list
101492253|NCT01059071|Etoposide|etoposide|mesh-list
101492254|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101492255|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492256|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101492257|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101492258|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492259|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492260|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101492261|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101492262|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492263|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492264|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101376851|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101376852|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376853|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101376854|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376855|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
101376856|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376857|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101376858|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101376859|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376860|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492276|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
101492277|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101492278|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492279|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492280|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492281|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
101492282|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
101492283|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101492284|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
101492285|NCT00468351|Triamcinolone|triamcinolone|mesh-list
101492286|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101492287|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101492288|NCT00468351|Bevacizumab|bevacizumab|mesh-list
101492289|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101492290|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492291|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492292|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492293|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101492294|NCT00468351|Growth Substances|growth substances|mesh-ancestor
101492295|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492296|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
101492297|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492298|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
101492309|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492310|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492311|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101492312|NCT00468429|Growth Substances|growth substances|mesh-ancestor
101492313|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492314|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
101492315|NCT00459771|Candesartan|candesartan|mesh-list
101492316|NCT00459771|Candesartan cilexetil|candesartan cilexetil|mesh-list
101492317|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101492318|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101492319|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101492320|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492321|NCT01058369|Deferasirox|deferasirox|mesh-list
101492322|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101492323|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
101492324|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
101492325|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492326|NCT01057433|Ritonavir|ritonavir|mesh-list
101492327|NCT01057433|Lopinavir|lopinavir|mesh-list
101492328|NCT01057433|Pitavastatin|pitavastatin|mesh-list
101492329|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101492330|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101492331|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
101492332|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492333|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492334|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101492335|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101492336|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
101492337|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376862|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
101376863|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376864|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376865|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376866|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376867|NCT00241345|Valganciclovir|valganciclovir|mesh-list
101376868|NCT00241345|Ganciclovir|ganciclovir|mesh-list
101376869|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101376870|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
101376871|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376872|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101376873|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492338|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101492339|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101492340|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101492341|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101492342|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101492343|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
101492344|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101492346|NCT01058642|Analgesics|analgesics|mesh-ancestor
101492347|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
101492348|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492349|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492350|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
101492351|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101492352|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101492353|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492354|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101492355|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101492356|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101492357|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492358|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101492359|NCT00426920|Insulin|insulin|mesh-list
101492360|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101492375|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492376|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492377|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101492378|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
101492379|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101492380|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492382|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101492383|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101492384|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492385|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101492386|NCT00427271|Aspirin|aspirin|mesh-list
101492387|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101492388|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101492389|NCT00427271|Analgesics|analgesics|mesh-ancestor
101492390|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
101492391|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492392|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492393|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492394|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492395|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101492396|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101492397|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492398|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101492399|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101492400|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492401|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
101492402|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
101492403|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101492404|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101492405|NCT00460083|Analgesics|analgesics|mesh-ancestor
101492406|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
101492407|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492408|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492409|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492410|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492411|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492412|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492413|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
101492414|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101492415|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492416|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492417|NCT00427310|Fluorouracil|fluorouracil|mesh-list
101492418|NCT00427310|Heparin|heparin|mesh-list
101492419|NCT00427310|Calcium heparin|calcium heparin|mesh-list
101492420|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
101492421|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492435|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101492436|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
101492437|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492438|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
101492439|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
101492440|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492441|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492442|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492443|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
101492444|NCT00427388|Hormones|hormones|mesh-ancestor
101492445|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492446|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101492447|NCT00427388|Protective Agents|protective agents|mesh-ancestor
101492448|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101492449|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492450|NCT00427427|Trastuzumab|trastuzumab|mesh-list
101492451|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492452|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492453|NCT04704947|Alendronate|alendronate|mesh-list
101492454|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101492455|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
101492456|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101492457|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492458|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101492459|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
101492460|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492461|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492462|NCT00427466|Pemetrexed|pemetrexed|mesh-list
101492463|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492464|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492465|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492466|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101492467|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101492468|NCT00427505|Deferasirox|deferasirox|mesh-list
101492469|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101492470|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
101492471|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
101492472|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492473|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
101492474|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492475|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492477|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492478|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
101415660|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
101492479|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492480|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492481|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101376875|NCT00241423|Exenatide|exenatide|mesh-list
101376876|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101376877|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376878|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101376879|NCT00241423|Incretins|incretins|mesh-ancestor
101376880|NCT00241423|Hormones|hormones|mesh-ancestor
101376881|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376882|NCT00241501|Esomeprazole|esomeprazole|mesh-list
101376883|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101376884|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492486|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492488|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101492489|NCT00469053|Narcotics|narcotics|mesh-ancestor
101492490|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492491|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492492|NCT00469053|Analgesics|analgesics|mesh-ancestor
101492493|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
101492494|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492495|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101492496|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
101492497|NCT00469131|Tacrolimus|tacrolimus|mesh-list
101492498|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492499|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
101492500|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492501|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101492502|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492503|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492504|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492505|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492506|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101492507|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
101492508|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492509|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492510|NCT00428129|Plasminogen|plasminogen|mesh-list
101492511|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101492512|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101492513|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492514|NCT00428168|Betahistine|betahistine|mesh-list
101492515|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
101492516|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
101492517|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
101492518|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492519|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492520|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492522|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101492523|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492524|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
101492525|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
101492526|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492527|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
101492528|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492529|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492530|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
101492531|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101492532|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101492533|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101492534|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101492535|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
101492536|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101492537|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101376885|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101376886|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376887|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376888|NCT00076986|Carmustine|carmustine|mesh-list
101376889|NCT00076986|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101492538|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492539|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101492540|NCT00460473|Analgesics|analgesics|mesh-ancestor
101492541|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
101492542|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492543|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101492544|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101492545|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101492546|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
101492547|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492548|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492549|NCT00428519|Aprepitant|aprepitant|mesh-list
101492550|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
101492552|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
101492553|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492554|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492555|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492556|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101492557|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492558|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492559|NCT00428558|Cytarabine|cytarabine|mesh-list
101492560|NCT00428558|Daunorubicin|daunorubicin|mesh-list
101492561|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101492562|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
101492563|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492564|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492565|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
101492566|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492567|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492568|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
101492569|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492570|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492571|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101492572|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101492573|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492574|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101492575|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101492576|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101492577|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492578|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492579|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101492580|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101492581|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101492582|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
101492583|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492584|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492585|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101492586|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101492587|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
101492588|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
101492589|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492590|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492591|NCT01055834|Eszopiclone|eszopiclone|mesh-list
101492592|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101492593|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492594|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492595|NCT00469326|Atorvastatin|atorvastatin|mesh-list
101492596|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101492597|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101492598|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
101492599|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376890|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101376892|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376893|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376895|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101492600|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101492601|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101492602|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492603|NCT04704713|Afamelanotide|afamelanotide|mesh-list
101492604|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492605|NCT00460707|Ketoconazole|ketoconazole|mesh-list
101492607|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
101492608|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492609|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101492610|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101492611|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492612|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492613|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101492614|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
101492615|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492616|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492617|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101492618|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
101492619|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
101492620|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492621|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492622|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101492623|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492646|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492647|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101492648|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
101492649|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492650|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
101492651|NCT00469443|Leucovorin|leucovorin|mesh-list
101492652|NCT00469443|Bevacizumab|bevacizumab|mesh-list
101492653|NCT00469443|Fluorouracil|fluorouracil|mesh-list
101492654|NCT00469443|Capecitabine|capecitabine|mesh-list
101492655|NCT00469443|Irinotecan|irinotecan|mesh-list
101492656|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492657|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492658|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492659|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101492661|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492662|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
101492664|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492665|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101492666|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492667|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
101492668|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101492669|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101492670|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492672|NCT00469443|Protective Agents|protective agents|mesh-ancestor
101492673|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
101492674|NCT00469443|Vitamins|vitamins|mesh-ancestor
101492675|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
101492676|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
101492677|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101492678|NCT00428909|Acetaminophen|acetaminophen|mesh-list
101492692|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492693|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
101492694|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492695|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492696|NCT00469560|Deferasirox|deferasirox|mesh-list
101376896|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376897|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101376898|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376899|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376901|NCT00098982|Fluorouracil|fluorouracil|mesh-list
101376902|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
101492697|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101492698|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
101492699|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
101492700|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492701|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
101492702|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101492703|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101492704|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492705|NCT00469599|Vitamins|vitamins|mesh-ancestor
101492706|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
101492707|NCT00429377|Tacrolimus|tacrolimus|mesh-list
101492708|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492709|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
101492710|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492711|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101492712|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492713|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492714|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101492715|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
101492716|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
101492717|NCT00429533|Dapsone|dapsone|mesh-list
101492718|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492719|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
101492720|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101492721|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101492722|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101492723|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492724|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492725|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
101492726|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492727|NCT04704245|Petrolatum|petrolatum|mesh-list
101492728|NCT04704245|Mitogens|mitogens|mesh-list
101492729|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
101492730|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492731|NCT04704245|Emollients|emollients|mesh-ancestor
101492732|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492733|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101492734|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101492735|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
101492736|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492737|NCT00429962|Ranibizumab|ranibizumab|mesh-list
101492738|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492739|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101492740|NCT00429962|Growth Substances|growth substances|mesh-ancestor
101492741|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492752|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492753|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101492754|NCT00430079|Etanidazole|etanidazole|mesh-list
101492756|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492757|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492758|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492759|NCT00430118|Cytarabine|cytarabine|mesh-list
101492760|NCT00430118|Dexamethasone|dexamethasone|mesh-list
101492761|NCT00430118|Prednisone|prednisone|mesh-list
101492762|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
101492763|NCT00430118|Ifosfamide|ifosfamide|mesh-list
101492764|NCT00430118|Doxorubicin|doxorubicin|mesh-list
101492765|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101492766|NCT00430118|Methotrexate|methotrexate|mesh-list
101492767|NCT00430118|Etoposide|etoposide|mesh-list
101492768|NCT00430118|Vincristine|vincristine|mesh-list
101492769|NCT00430118|Daunorubicin|daunorubicin|mesh-list
101492770|NCT00430118|Asparaginase|asparaginase|mesh-list
101492771|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
101492772|NCT00430118|Thioguanine|thioguanine|mesh-list
101492773|NCT00430118|Vindesine|vindesine|mesh-list
101376905|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
101376906|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101376907|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376908|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
101376909|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376910|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101376911|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376912|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101376913|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
101376914|NCT00098982|Antidotes|antidotes|mesh-ancestor
101376915|NCT00098982|Protective Agents|protective agents|mesh-ancestor
101376916|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
101376917|NCT00098982|Vitamins|vitamins|mesh-ancestor
101376919|NCT00241618|Interferons|interferons|mesh-list
101376920|NCT00241618|Ribavirin|ribavirin|mesh-list
101376921|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
101376922|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
101376923|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376924|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
101492774|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492775|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
101492776|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492777|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492778|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101492779|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
101492780|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492781|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492782|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101492783|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101492784|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
101492785|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
101492786|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492787|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492788|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
101492789|NCT00430118|Hormones|hormones|mesh-ancestor
101492790|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492791|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101492792|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492793|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101492794|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101492795|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492796|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101492797|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
101492798|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101492799|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101492800|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
101492801|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492802|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101492803|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101492804|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101492805|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
101492806|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492807|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
101492808|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
101376925|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376926|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
101376927|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376928|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
101492809|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
101492811|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101492813|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492814|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492815|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
101492816|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101492817|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
101492818|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101492819|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101492820|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492821|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492822|NCT00461565|Urological Agents|urological agents|mesh-ancestor
101492824|NCT00430196|Analgesics|analgesics|mesh-ancestor
101492825|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
101492826|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492827|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492828|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
101492829|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101492830|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101492831|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
101492832|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
101492833|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101492834|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101492835|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101492836|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
101492837|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492838|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492839|NCT00430235|Sorafenib|sorafenib|mesh-list
101492840|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492841|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492842|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492843|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492844|NCT00470340|Gemcitabine|gemcitabine|mesh-list
101492845|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
101492846|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
101492847|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492848|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101492849|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
101492850|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492851|NCT00430469|Lactoferrin|lactoferrin|mesh-list
101492852|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492853|NCT00461643|Metformin|metformin|mesh-list
101492854|NCT00461643|Citric Acid|citric acid|mesh-list
101492855|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
101492856|NCT00461643|Clomiphene|clomiphene|mesh-list
101492857|NCT00461643|Enclomiphene|enclomiphene|mesh-list
101492858|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
101492859|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101492860|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492861|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
101492862|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101492863|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
101492864|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
101492865|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492866|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101492867|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
101492868|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492869|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101492870|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
101492871|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101492872|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101492873|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101492874|NCT00430547|Carbimazole|carbimazole|mesh-list
101492875|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
101376929|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376930|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
101376931|NCT00066482|Cisplatin|cisplatin|mesh-list
101376932|NCT00066482|Etoposide|etoposide|mesh-list
101376933|NCT00066482|Bleomycin|bleomycin|mesh-list
101376934|NCT00066482|Lenograstim|lenograstim|mesh-list
101376935|NCT00066482|Mesna|mesna|mesh-list
101376936|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492876|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
101492877|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492878|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492879|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101492885|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492886|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101492887|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101492888|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492889|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
101492890|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492891|NCT01053962|Plecanatide|plecanatide|mesh-list
101492892|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101492893|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
101492894|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492895|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101492896|NCT00461799|Orlistat|orlistat|mesh-list
101492897|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492898|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492899|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101492900|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101492901|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
101492902|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101492903|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492904|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101492905|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101492906|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101492907|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492908|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492909|NCT00430742|Hormones|hormones|mesh-ancestor
101492910|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492911|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492912|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
101492913|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
101492914|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492915|NCT03271164|Vitamin E|vitamin e|mesh-list
101492916|NCT03271164|Vitamins|vitamins|mesh-ancestor
101492917|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
101492918|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492919|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
101492920|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492921|NCT03271164|Protective Agents|protective agents|mesh-ancestor
101492922|NCT00430898|Basiliximab|basiliximab|mesh-list
101492923|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492924|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
101492925|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492926|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101492927|NCT00461916|Buserelin|buserelin|mesh-list
101492928|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
101492929|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101492930|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
101492931|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101492932|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492933|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101492934|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101492935|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492936|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101376937|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
101376938|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376939|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101376940|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101376941|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
101376942|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376943|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376944|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101492939|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101492940|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101492941|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101492942|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101492943|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492944|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
101492945|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101492962|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492963|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492964|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
101492965|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101492966|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492967|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492968|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
101492969|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
101492970|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492971|NCT00431249|Cilostazol|cilostazol|mesh-list
101492972|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101492973|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
101492974|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492975|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492976|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101492977|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
101492978|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101492979|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101492980|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492981|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101492983|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101492984|NCT00431249|Protective Agents|protective agents|mesh-ancestor
101492985|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101492986|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101492987|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492988|NCT00470886|Telmisartan|telmisartan|mesh-list
101492989|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101492990|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101492991|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101492992|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492993|NCT00431522|Valproic Acid|valproic acid|mesh-list
101492994|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
101492995|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492996|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492997|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
101492998|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492999|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493000|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
101493001|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101493002|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493005|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101493007|NCT00462111|Analgesics|analgesics|mesh-ancestor
101493008|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
101493009|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493010|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493011|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101376945|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101376946|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101376947|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101376948|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493012|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493013|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
101493014|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
101493015|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493016|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101493017|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493018|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493019|NCT00431561|Temozolomide|temozolomide|mesh-list
101493020|NCT00431561|Lomustine|lomustine|mesh-list
101493021|NCT00431561|Trabedersen|trabedersen|mesh-list
101493022|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101493023|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
101493024|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493025|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493026|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
101493027|NCT00462189|Immunotoxins|immunotoxins|mesh-list
101493028|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
101493029|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
101493030|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493031|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493032|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
101493033|NCT00431678|Levofloxacin|levofloxacin|mesh-list
101493034|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
101493035|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101493036|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493037|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493038|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101493039|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493040|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493041|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493042|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493043|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101493044|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
101493045|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493046|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493047|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101493048|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101493049|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101493050|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101493051|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101493052|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101493053|NCT00471003|Telmisartan|telmisartan|mesh-list
101493054|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101493055|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101493056|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101493057|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493058|NCT00471042|Buprenorphine|buprenorphine|mesh-list
101493059|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101493060|NCT00471042|Narcotics|narcotics|mesh-ancestor
101493061|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493062|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493063|NCT00471042|Analgesics|analgesics|mesh-ancestor
101493064|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
101493065|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493066|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101493067|NCT00462540|Bromides|bromides|mesh-list
101493068|NCT00462540|Albuterol|albuterol|mesh-list
101493069|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
101493070|NCT00462540|Ipratropium|ipratropium|mesh-list
101493071|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101493072|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
101493073|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493074|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493077|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101493078|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101376949|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101376950|NCT00066482|Protective Agents|protective agents|mesh-ancestor
101376951|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376953|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376954|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101376955|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376956|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376957|NCT00066599|Voriconazole|voriconazole|mesh-list
101376958|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
101376959|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101376960|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101376961|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101493080|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493081|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493082|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493084|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
101493085|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493086|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101493087|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
101493088|NCT04703465|Tenofovir|tenofovir|mesh-list
101493089|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
101493090|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493091|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101493092|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101493093|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493094|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493095|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101493096|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101493097|NCT00471159|Docetaxel|docetaxel|mesh-list
101493098|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493099|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
101493100|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
101493101|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
101493102|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493103|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101493104|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
101493105|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493106|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101493107|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101493108|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493109|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493110|NCT00431795|Doxorubicin|doxorubicin|mesh-list
101493111|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101493112|NCT00431795|Epirubicin|epirubicin|mesh-list
101493113|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101493114|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493115|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101493116|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493117|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493118|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493119|NCT00462657|Dimercaprol|dimercaprol|mesh-list
101493120|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
101493121|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
101493122|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493123|NCT00431990|Dexamethasone|dexamethasone|mesh-list
101493124|NCT00431990|Bortezomib|bortezomib|mesh-list
101493125|NCT00431990|Romidepsin|romidepsin|mesh-list
101493126|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493127|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
101493129|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376963|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376964|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101376965|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
101376966|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101376967|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376968|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101376969|NCT00242008|Rotigotine|rotigotine|mesh-list
101493130|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493131|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493132|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
101493133|NCT00431990|Hormones|hormones|mesh-ancestor
101493134|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493135|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101493136|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493137|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101493138|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101493139|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493140|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493141|NCT00462696|Docetaxel|docetaxel|mesh-list
101493142|NCT00462696|Epirubicin|epirubicin|mesh-list
101493143|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493144|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101493145|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101493146|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101493154|NCT00462813|Protective Agents|protective agents|mesh-ancestor
101493155|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493156|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493157|NCT01052012|Bupivacaine|bupivacaine|mesh-list
101493158|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493159|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
101493160|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493161|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493162|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
101493163|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493164|NCT00462852|Gemcitabine|gemcitabine|mesh-list
101493165|NCT00462852|Dalteparin|dalteparin|mesh-list
101493166|NCT00462852|Tinzaparin|tinzaparin|mesh-list
101493167|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101493168|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493169|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
101493170|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493171|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493172|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
101493173|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101493174|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101493175|NCT00471393|Diclofenac|diclofenac|mesh-list
101493176|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101493177|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101493178|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493179|NCT00471393|Analgesics|analgesics|mesh-ancestor
101493180|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
101493181|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493182|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493183|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493184|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493185|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101493186|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493187|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493188|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101493189|NCT00471393|Protective Agents|protective agents|mesh-ancestor
101493190|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101493191|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
101493192|NCT00432068|Octreotide|octreotide|mesh-list
101493193|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101376972|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101376973|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376974|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376976|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101376977|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
101376978|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
101376979|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101376980|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376982|NCT02962024|Bupivacaine|bupivacaine|mesh-list
101376983|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
101376984|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
101376985|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101376986|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101376987|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
101376988|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101376989|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101376990|NCT02962024|Narcotics|narcotics|mesh-ancestor
101376991|NCT02962024|Analgesics|analgesics|mesh-ancestor
101376992|NCT00066638|Romidepsin|romidepsin|mesh-list
101376993|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101376994|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101376995|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101376996|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101376997|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101376998|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
101376999|NCT00242203|Docetaxel|docetaxel|mesh-list
101377000|NCT00242203|Trastuzumab|trastuzumab|mesh-list
101377001|NCT00242203|Epirubicin|epirubicin|mesh-list
101377002|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377003|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377004|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377005|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
101493194|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101493195|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493196|NCT03273231|Ketamine|ketamine|mesh-list
101493197|NCT03273231|Analgesics|analgesics|mesh-ancestor
101493198|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
101493199|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377007|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101377008|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377009|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377010|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377011|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493200|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493201|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101493202|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101493203|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
101493204|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
101493205|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493206|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101493207|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101493208|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493209|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493210|NCT00432146|Lugol's solution|lugol's solution|mesh-list
101493211|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
101493212|NCT00432146|Coagulants|coagulants|mesh-ancestor
101493213|NCT00432302|Sagopilone|sagopilone|mesh-list
101493214|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493232|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
101493233|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493234|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493235|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101493236|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101493238|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493239|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101493240|NCT02957435|Eplerenone|eplerenone|mesh-list
101493241|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101493242|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
101493243|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493244|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493245|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101493246|NCT02957435|Diuretics|diuretics|mesh-ancestor
101493247|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
101493248|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101493249|NCT00471471|Sargramostim|sargramostim|mesh-list
101493250|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
101493251|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493252|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101493253|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101493254|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101493255|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
101493256|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493257|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493258|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101493259|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101493261|NCT00463203|Irinotecan|irinotecan|mesh-list
101493262|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101493263|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493264|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101493265|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101493266|NCT00463203|Growth Substances|growth substances|mesh-ancestor
101493267|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493268|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
101493269|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101493279|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101493281|NCT00432575|Surinabant|surinabant|mesh-list
101493282|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101493283|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101493284|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377012|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101377013|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377014|NCT00077025|Gefitinib|gefitinib|mesh-list
101377015|NCT00077025|Anastrozole|anastrozole|mesh-list
101377016|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377017|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101377018|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377019|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377020|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101377021|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101377022|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101377023|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101493285|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493286|NCT00432575|Hormones|hormones|mesh-ancestor
101493287|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493288|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493289|NCT00432614|Escitalopram|escitalopram|mesh-list
101493290|NCT00432614|Amibegron|amibegron|mesh-list
101493291|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101493292|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101493293|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101493294|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493295|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493296|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493297|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
101493298|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493299|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101493300|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101493301|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493302|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101493303|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101493304|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101493306|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101493307|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493308|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
101493309|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493310|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493311|NCT00471588|Pramipexole|pramipexole|mesh-list
101493312|NCT00471588|Amisulpride|amisulpride|mesh-list
101493313|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
101493314|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493315|NCT00471588|Protective Agents|protective agents|mesh-ancestor
101493316|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493317|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101493318|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101493319|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
101493320|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
101493321|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493322|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101493323|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101493324|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493325|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493326|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101493327|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101493328|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
101493329|NCT00463359|Imiquimod|imiquimod|mesh-list
101493330|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101493331|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
101493332|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493342|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377024|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377025|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377026|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377028|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101377029|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377030|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
101377031|NCT00066716|Celecoxib|celecoxib|mesh-list
101377032|NCT00066716|Paclitaxel|paclitaxel|mesh-list
101493343|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101493344|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101493345|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
101493346|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493347|NCT00471744|Levetiracetam|levetiracetam|mesh-list
101493348|NCT00471744|Sulthiame|sulthiame|mesh-list
101493349|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
101493350|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
101493351|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
101493352|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101493353|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493354|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
101493355|NCT00463515|Carboplatin|carboplatin|mesh-list
101493356|NCT00463515|Gemcitabine|gemcitabine|mesh-list
101493357|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493358|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493359|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
101493360|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493361|NCT00433043|Metoprolol|metoprolol|mesh-list
101493362|NCT00433043|Carvedilol|carvedilol|mesh-list
101493363|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101493364|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101493365|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101493366|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
101493367|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
101493368|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493369|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493370|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101493371|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101493372|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493373|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493374|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493375|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
101493376|NCT00433043|Protective Agents|protective agents|mesh-ancestor
101493377|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101493378|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493379|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101493380|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
101493381|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101493382|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101493383|NCT03273075|Ticagrelor|ticagrelor|mesh-list
101493384|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101493385|NCT03273075|Cangrelor|cangrelor|mesh-list
101493386|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101493387|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101493388|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101493389|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101493390|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
101493391|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493392|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493393|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493394|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101493395|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101493396|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
101493407|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493408|NCT01051466|Analgesics|analgesics|mesh-ancestor
101493409|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
101377033|NCT00066716|Carboplatin|carboplatin|mesh-list
101377034|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377035|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377036|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377037|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377038|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
101493410|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493411|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
101493412|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493413|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
101493414|NCT04446793|Bevacizumab|bevacizumab|mesh-list
101493415|NCT04446793|Onvansertib|onvansertib|mesh-list
101493416|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101493417|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493418|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101493419|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101493420|NCT04446793|Growth Substances|growth substances|mesh-ancestor
101493421|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493422|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
101493423|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101493424|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493425|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493426|NCT01051349|Daclizumab|daclizumab|mesh-list
101493427|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493428|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
101493429|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493430|NCT00433121|Olanzapine|olanzapine|mesh-list
101493431|NCT00433121|Risperidone|risperidone|mesh-list
101493432|NCT00433121|Citalopram|citalopram|mesh-list
101493433|NCT00433121|Escitalopram|escitalopram|mesh-list
101493434|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101493435|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
101493436|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493437|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493438|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493439|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101493440|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101493441|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493442|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493443|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101493444|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
101493445|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101493446|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101493447|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493449|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493450|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101493451|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
101493452|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
101493453|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493454|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
101493455|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101493456|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
101493465|NCT00463671|Antidotes|antidotes|mesh-ancestor
101493466|NCT00591526|Cytarabine|cytarabine|mesh-list
101493467|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493468|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
101493469|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493470|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493472|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493473|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493474|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
101493475|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493476|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
101493477|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101493478|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
101177146|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493479|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377039|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377041|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101377042|NCT00066716|Analgesics|analgesics|mesh-ancestor
101377043|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
101377044|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493480|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493481|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
101493482|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493483|NCT00433277|Cyclosporine|cyclosporine|mesh-list
101493484|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101493485|NCT00433277|Cyclosporins|cyclosporins|mesh-list
101493486|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493487|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493488|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493489|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
101493490|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493491|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
101493492|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493493|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
101493494|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493495|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101493496|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101493497|NCT00463827|Atorvastatin|atorvastatin|mesh-list
101493498|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101493499|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101493500|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
101493501|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493502|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101493503|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101493504|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493505|NCT00433316|Ropivacaine|ropivacaine|mesh-list
101493506|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493507|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
101493508|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493509|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493510|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
101493511|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493512|NCT00472134|Bupivacaine|bupivacaine|mesh-list
101493513|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493514|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
101493515|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493516|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493517|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
101493518|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493519|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101493520|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101493521|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493523|NCT03270969|Emtricitabine|emtricitabine|mesh-list
101493537|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101493538|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493539|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
101493540|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493541|NCT00472173|Calcium|calcium|mesh-list
101493542|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101493543|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493544|NCT00472329|Fludarabine|fludarabine|mesh-list
101493545|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493546|NCT00464217|Idarubicin|idarubicin|mesh-list
101493547|NCT00464217|Molgramostim|molgramostim|mesh-list
101493548|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101493549|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493550|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101493551|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493552|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493553|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377045|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377046|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377047|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377048|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101377049|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101377050|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377052|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101493554|NCT00433784|Clopidogrel|clopidogrel|mesh-list
101493555|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101493556|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101493557|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101493558|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101493560|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493561|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493562|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493563|NCT00464256|Rimonabant|rimonabant|mesh-list
101493564|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101493565|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101493566|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101493567|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493568|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493569|NCT00464256|Hormones|hormones|mesh-ancestor
101493570|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493571|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493572|NCT00433823|Atorvastatin|atorvastatin|mesh-list
101493573|NCT00433823|Ezetimibe|ezetimibe|mesh-list
101493574|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101493575|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101493576|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
101493578|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101493579|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101493580|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493581|NCT00464295|Capecitabine|capecitabine|mesh-list
101493582|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493583|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
101493590|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493592|NCT03270735|Thrombin|thrombin|mesh-list
101493593|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
101493594|NCT03270735|Coagulants|coagulants|mesh-ancestor
101493595|NCT04702685|Ropivacaine|ropivacaine|mesh-list
101493596|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493597|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
101493598|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493599|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493600|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
101493601|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493602|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
101493603|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101493604|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101493605|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101493606|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493607|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493608|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
101493609|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493610|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493611|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101493612|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493613|NCT00472368|Panobinostat|panobinostat|mesh-list
101493614|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493615|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101493616|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493617|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377053|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
101377054|NCT00077103|Combretastatin|combretastatin|mesh-list
101377055|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377056|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377057|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377058|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377059|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493618|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
101493619|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101493620|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493621|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493622|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101493623|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493624|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101493625|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
101493626|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
101493627|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101177314|NCT04360044|Dronabinol|dronabinol|mesh-list
101493628|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493629|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493630|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493631|NCT00464451|Analgesics|analgesics|mesh-ancestor
101493632|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
101493633|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493634|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101493635|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101493636|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101493637|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493638|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493639|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493640|NCT00433940|Prednisolone|prednisolone|mesh-list
101493641|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493642|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
101493643|NCT00433940|Hormones|hormones|mesh-ancestor
101493644|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493645|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493646|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101493647|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493648|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101493652|NCT01050764|Fludarabine|fludarabine|mesh-list
101493653|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
101493654|NCT01050764|Melphalan|melphalan|mesh-list
101493655|NCT01050764|Thiotepa|thiotepa|mesh-list
101493656|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
101493657|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101493658|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493659|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493660|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
101493661|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493662|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493663|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
101493664|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493665|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
101493666|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493667|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101493668|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
101493669|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101493670|NCT00434096|Rimonabant|rimonabant|mesh-list
101493671|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101493672|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101493673|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101493675|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493676|NCT00434096|Hormones|hormones|mesh-ancestor
101493677|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493678|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493679|NCT01050569|Nicotine|nicotine|mesh-list
101377060|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377062|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377063|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377064|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377065|NCT00242437|Thrombin|thrombin|mesh-list
101377066|NCT00242437|Hemostatics|hemostatics|mesh-list
101377067|NCT00242437|Coagulants|coagulants|mesh-ancestor
101377068|NCT00066794|Cytarabine|cytarabine|mesh-list
101493680|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101493681|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
101493682|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493683|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493684|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101493685|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101493686|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
101493687|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493688|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493689|NCT04702490|Empagliflozin|empagliflozin|mesh-list
101493690|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101493691|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493692|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101493693|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493694|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
101493695|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101493696|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493697|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493698|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493699|NCT00464763|Analgesics|analgesics|mesh-ancestor
101493700|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
101177372|NCT02718066|Nivolumab|nivolumab|mesh-list
101493701|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493702|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101493703|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101493704|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101493705|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493706|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493707|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493708|NCT00434135|Paclitaxel|paclitaxel|mesh-list
101493709|NCT00434135|Gemcitabine|gemcitabine|mesh-list
101493710|NCT00434135|Pemetrexed|pemetrexed|mesh-list
101493711|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101493712|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493713|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
101493714|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
101493715|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
101493716|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493717|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493718|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
101493719|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493726|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493727|NCT01050257|Oseltamivir|oseltamivir|mesh-list
101493728|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
101493729|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493730|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493731|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493732|NCT03272802|Riluzole|riluzole|mesh-list
101493733|NCT03272802|Edaravone|edaravone|mesh-list
101493734|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
101493735|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101493736|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101493737|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493738|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493739|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493740|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101493741|NCT03272802|Protective Agents|protective agents|mesh-ancestor
101377069|NCT00066794|Cyclosporine|cyclosporine|mesh-list
101377070|NCT00066794|Daunorubicin|daunorubicin|mesh-list
101377071|NCT00066794|Cyclosporins|cyclosporins|mesh-list
101546323|NCT01601327|Hormones|hormones|mesh-ancestor
101377072|NCT00066794|Sargramostim|sargramostim|mesh-list
101377073|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377074|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
101377075|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377076|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493742|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101493743|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
101493744|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101493745|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101493746|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101493747|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493748|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493749|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493750|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493751|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
101493752|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493753|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101493754|NCT01050062|Telmisartan|telmisartan|mesh-list
101493755|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101493756|NCT01050062|Diuretics|diuretics|mesh-ancestor
101493757|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
101493758|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493759|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101493760|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493761|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493762|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101493763|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101493764|NCT00464919|Sorafenib|sorafenib|mesh-list
101493765|NCT00464919|Tegafur|tegafur|mesh-list
101493766|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493767|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101493768|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493769|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493770|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493771|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
101493772|NCT00434174|Pemetrexed|pemetrexed|mesh-list
101177444|NCT01901250|Fluorides|fluorides|mesh-list
101493773|NCT00434174|Everolimus|everolimus|mesh-list
101493774|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493775|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493776|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493777|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101493778|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101493779|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101493780|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101493781|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493782|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
101493783|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493784|NCT00464958|Tizanidine|tizanidine|mesh-list
101493789|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
101493790|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101493791|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101493792|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
101493793|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
101493794|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101493795|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101493796|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101493797|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
101493798|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101493799|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493800|NCT00472758|Sifalimumab|sifalimumab|mesh-list
101493801|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
101493802|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493803|NCT01055444|Lidocaine|lidocaine|mesh-list
101377077|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
101377078|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377079|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377080|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
101377081|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493804|NCT01055444|Tetracaine|tetracaine|mesh-list
101493805|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493806|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
101493807|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493808|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493810|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493811|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101493812|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101493813|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101493814|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493815|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493816|NCT01055015|Morphine|morphine|mesh-list
101493817|NCT01055015|Oxycodone|oxycodone|mesh-list
101493818|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101493819|NCT01055015|Narcotics|narcotics|mesh-ancestor
101493820|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493821|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493822|NCT01055015|Analgesics|analgesics|mesh-ancestor
101493823|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
101493824|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493825|NCT00472875|Glyburide|glyburide|mesh-list
101493826|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101493827|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493828|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
101493829|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493830|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493831|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
101493832|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101493833|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493834|NCT00472953|Insulin|insulin|mesh-list
101493835|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101493836|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
101493837|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101493838|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493839|NCT02957630|Drospirenone|drospirenone|mesh-list
101493840|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
101493841|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101493842|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101493843|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
101493844|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493845|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493846|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101493847|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101493848|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101493849|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101493850|NCT02957630|Estrogens|estrogens|mesh-ancestor
101493852|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493853|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101493854|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
101493855|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101493869|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493870|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101493871|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101493872|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
101493873|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101493874|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101493875|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101493876|NCT00465192|Estradiol|estradiol|mesh-list
101493877|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101493878|NCT00465192|Estrogens|estrogens|mesh-ancestor
101493879|NCT00465192|Hormones|hormones|mesh-ancestor
101493880|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377082|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377083|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
101377084|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377085|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377086|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101377087|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101493881|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493882|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101493883|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
101493884|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493885|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101493886|NCT00434681|Acetaminophen|acetaminophen|mesh-list
101493887|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493888|NCT00434681|Analgesics|analgesics|mesh-ancestor
101493889|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
101493890|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493891|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493892|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
101493893|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101493894|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493895|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493896|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493897|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
101493898|NCT00473070|Hormones|hormones|mesh-ancestor
101493899|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493900|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493901|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101493902|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101493903|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
101493904|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
101493905|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493906|NCT04702334|Lidocaine|lidocaine|mesh-list
101493907|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
101493908|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
101493909|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
101493910|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493911|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493912|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
101493913|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493914|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101493915|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101493916|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101493917|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493918|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493922|NCT04702334|Protective Agents|protective agents|mesh-ancestor
101493923|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
101493924|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101493925|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493926|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493927|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101493928|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493929|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493930|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493931|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493932|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101493933|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
101493934|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493935|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493936|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101493937|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101493938|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101493940|NCT00435305|Meropenem|meropenem|mesh-list
101493941|NCT00435305|Tazobactam|tazobactam|mesh-list
101493942|NCT00435305|Linezolid|linezolid|mesh-list
101493943|NCT00435305|Piperacillin|piperacillin|mesh-list
101493944|NCT00435305|Ceftazidime|ceftazidime|mesh-list
101493945|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101377088|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377089|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377090|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
101377091|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101377092|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377093|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
101377094|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377095|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493946|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101493947|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493948|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101493949|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493950|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493951|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101493952|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
101493953|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101493954|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493955|NCT00465543|Analgesics|analgesics|mesh-ancestor
101493956|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
101493957|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493958|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493959|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493960|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493961|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
101493962|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493963|NCT00465543|Protective Agents|protective agents|mesh-ancestor
101493964|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101493965|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101493966|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
101493967|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493968|NCT00435500|Fluorides|fluorides|mesh-list
101493969|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
101493970|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
101493971|NCT00435500|Protective Agents|protective agents|mesh-ancestor
101493972|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493973|NCT03272412|Progesterone|progesterone|mesh-list
101493974|NCT03272412|Progestins|progestins|mesh-ancestor
101493975|NCT03272412|Hormones|hormones|mesh-ancestor
101493976|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493977|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493978|NCT00473616|Irinotecan|irinotecan|mesh-list
101493979|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101493980|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493981|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493982|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493983|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493984|NCT00435851|Hormones|hormones|mesh-list
101493985|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493986|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493987|NCT00436124|Oseltamivir|oseltamivir|mesh-list
101493988|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
101493989|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493990|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493994|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493995|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101493996|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528436|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493997|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493998|NCT00465231|Fentanyl|fentanyl|mesh-list
101493999|NCT00465231|Bupivacaine|bupivacaine|mesh-list
101494000|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
101494001|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
101494002|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494003|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494004|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
101494005|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377097|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377098|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101377099|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377100|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377101|NCT00242788|Capecitabine|capecitabine|mesh-list
101377102|NCT00242788|Gefitinib|gefitinib|mesh-list
101377103|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377104|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
101377105|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377106|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494006|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101494007|NCT00465231|Narcotics|narcotics|mesh-ancestor
101494008|NCT00465231|Analgesics|analgesics|mesh-ancestor
101494009|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101494010|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101494011|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
101494012|NCT00436241|Capecitabine|capecitabine|mesh-list
101494014|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101494015|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
101494016|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494017|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494018|NCT00481455|Temozolomide|temozolomide|mesh-list
101494019|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101494020|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101494021|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
101494022|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494023|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494024|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
101494025|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
101494026|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
101494027|NCT00481533|Oxytocin|oxytocin|mesh-list
101494028|NCT00481533|Ergonovine|ergonovine|mesh-list
101494029|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
101494030|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101494031|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494032|NCT00481572|Terlipressin|terlipressin|mesh-list
101494033|NCT00481572|Vasopressins|vasopressins|mesh-list
101494034|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
101494035|NCT00481572|Norepinephrine|norepinephrine|mesh-list
101494036|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101494038|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494039|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494040|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494041|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494042|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
101494043|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
101494044|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494045|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101494046|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
101494047|NCT00481572|Coagulants|coagulants|mesh-ancestor
101494048|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101494049|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
101494050|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101494051|NCT00474006|Daunorubicin|daunorubicin|mesh-list
101494052|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101494053|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494054|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101494055|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101494056|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494057|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494058|NCT04697745|Dexamethasone|dexamethasone|mesh-list
101494059|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
101377108|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377109|NCT00066872|Imiquimod|imiquimod|mesh-list
101377110|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101377111|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
101377112|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494060|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494061|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
101494062|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
101494063|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494081|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494082|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
101494083|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494084|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494085|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101494086|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101494087|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494088|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494089|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494090|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101494091|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494093|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
101494094|NCT00436709|Bevacizumab|bevacizumab|mesh-list
101494095|NCT00436709|Doxorubicin|doxorubicin|mesh-list
101494096|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101494097|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101494098|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101494099|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494100|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101494101|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101494102|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101494103|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494105|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
101494106|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494107|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494108|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101494109|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
101494110|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101494111|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494112|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101494113|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101494114|NCT00436709|Growth Substances|growth substances|mesh-ancestor
101494115|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
101494116|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101494117|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101494118|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101494119|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494126|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494127|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494129|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101494130|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101494131|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101494132|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101494133|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101494134|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
101494135|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494136|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494137|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494138|NCT00481728|Urological Agents|urological agents|mesh-ancestor
101494140|NCT00436943|Nicotine|nicotine|mesh-list
101494141|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101494142|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
101494143|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494144|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494145|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101377114|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
101377115|NCT00242944|Atorvastatin|atorvastatin|mesh-list
101377116|NCT00242944|Pitavastatin|pitavastatin|mesh-list
101377117|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101377118|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101377119|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
101377120|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377121|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101377122|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101377123|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494146|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101494147|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
101177821|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
101494148|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494149|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494150|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101494151|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
101494152|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494153|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101494154|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494155|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494156|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
101494157|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101494158|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494159|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494160|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101494161|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
101494162|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
101494164|NCT00481884|Emollients|emollients|mesh-ancestor
101494165|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101494167|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101494168|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101494169|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101494170|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494171|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494172|NCT00481923|Hormones|hormones|mesh-ancestor
101494173|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494174|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494175|NCT00481962|Tigecycline|tigecycline|mesh-list
101494176|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494177|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494178|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101494179|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494180|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494181|NCT00437177|Apomorphine|apomorphine|mesh-list
101494182|NCT00437177|Emetics|emetics|mesh-ancestor
101494183|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494184|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
101494185|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494186|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494187|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
101494190|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494192|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101494193|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494194|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101494195|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101494196|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494197|NCT00482079|Incretins|incretins|mesh-ancestor
101494198|NCT00482079|Hormones|hormones|mesh-ancestor
101377124|NCT00243100|Gemcitabine|gemcitabine|mesh-list
101377126|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377127|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
101377128|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377129|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377130|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101377131|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377132|NCT00099216|Rivastigmine|rivastigmine|mesh-list
101377133|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101377134|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377135|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377136|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
101494199|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494200|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101494201|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
101494202|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494203|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494204|NCT00437372|Sunitinib|sunitinib|mesh-list
101494205|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494206|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101494207|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101494208|NCT00437372|Growth Substances|growth substances|mesh-ancestor
101494209|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494210|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101494211|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101494212|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494213|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494214|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
101494215|NCT00437450|Hematinics|hematinics|mesh-ancestor
101494216|NCT04701710|Ivermectin|ivermectin|mesh-list
101494217|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101494218|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494219|NCT00437606|Ethanol|ethanol|mesh-list
101494220|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101494221|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494222|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494223|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494225|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101494226|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494227|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101494228|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494229|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494230|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494231|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
101494232|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494233|NCT00437684|Ribavirin|ribavirin|mesh-list
101494234|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101494235|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
101494236|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494237|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
101494238|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494239|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
101494240|NCT00437723|Hematinics|hematinics|mesh-ancestor
101494241|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
101494242|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101494243|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101494244|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101494245|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494246|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377138|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377139|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101377140|NCT00099216|Protective Agents|protective agents|mesh-ancestor
101377141|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
101377142|NCT00066989|Antibodies|antibodies|mesh-list
101377143|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
101377144|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101377145|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101377146|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
101377147|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377148|NCT00243178|Clopidogrel|clopidogrel|mesh-list
101377149|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101377150|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101377151|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101377152|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101377153|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
101377154|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377155|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377156|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377157|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
101377158|NCT00243256|Vitamin D|vitamin d|mesh-list
101494247|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
101494248|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494249|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494250|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101494251|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494252|NCT00482508|Omalizumab|omalizumab|mesh-list
101494253|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101494254|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101494255|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101494256|NCT00437918|Acarbose|acarbose|mesh-list
101494257|NCT00437918|Nateglinide|nateglinide|mesh-list
101494258|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101494259|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494264|NCT00437957|Valproic Acid|valproic acid|mesh-list
101494265|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101494266|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
101494267|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494268|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494269|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
101494270|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494271|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
101494272|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494273|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494274|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
101494275|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101494276|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494277|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494278|NCT03270176|Avelumab|avelumab|mesh-list
101494279|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494280|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494281|NCT00474279|Hormones|hormones|mesh-list
101377160|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377161|NCT00243256|Vitamins|vitamins|mesh-ancestor
101377162|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
101377163|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101377164|NCT00243646|Bicalutamide|bicalutamide|mesh-list
101377165|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377166|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494282|NCT00474279|Secretagogues|secretagogues|mesh-list
101494283|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494284|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494285|NCT03270696|Propofol|propofol|mesh-list
101494286|NCT03270696|Rocuronium|rocuronium|mesh-list
101494287|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101494288|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494289|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494290|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101494291|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
101494292|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
101494293|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101494294|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101494295|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101494296|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494297|NCT00437996|Clonidine|clonidine|mesh-list
101494298|NCT00437996|Sufentanil|sufentanil|mesh-list
101494299|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
101494300|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101494301|NCT00437996|Narcotics|narcotics|mesh-ancestor
101494302|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494303|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494304|NCT00437996|Analgesics|analgesics|mesh-ancestor
101494305|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
101494306|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494307|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101494308|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101494309|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
101494310|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
101494311|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101494312|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
101494313|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
101494314|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101494315|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101494316|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101494317|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494318|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494319|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494320|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
101494321|NCT04701242|Ezetimibe|ezetimibe|mesh-list
101494322|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101494323|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101494324|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
101494325|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494326|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101494327|NCT00474435|Tenofovir|tenofovir|mesh-list
101494328|NCT00474435|Emtricitabine|emtricitabine|mesh-list
101494329|NCT00474435|Efavirenz|efavirenz|mesh-list
101494330|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
101494331|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494336|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101494337|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101494338|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101494339|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494340|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101494341|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101494342|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101494343|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101377168|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377169|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377171|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377172|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377173|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101377174|NCT00099333|Incretins|incretins|mesh-ancestor
101377175|NCT00099333|Hormones|hormones|mesh-ancestor
101494344|NCT04701320|Methamphetamine|methamphetamine|mesh-list
101494345|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101494346|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494347|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
101494348|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
101494349|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494350|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
101494351|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494352|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494353|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494354|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101494355|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494356|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494357|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101494358|NCT00438113|Atenolol|atenolol|mesh-list
101494359|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101494360|NCT00438113|Terazosin|terazosin|mesh-list
101494361|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101494362|NCT00438113|Diuretics|diuretics|mesh-ancestor
101494363|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
101494364|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494365|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101494366|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494367|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494368|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101494369|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
101494370|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
101494371|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494372|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101494373|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101494374|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101494375|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494376|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494377|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101494378|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101494379|NCT00438113|Urological Agents|urological agents|mesh-ancestor
101494381|NCT00438152|Lopinavir|lopinavir|mesh-list
101494382|NCT00438152|Saquinavir|saquinavir|mesh-list
101494383|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101494384|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101494385|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101494386|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494387|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494388|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101494389|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101494390|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
101494391|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494392|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101494393|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494394|NCT00438230|Warfarin|warfarin|mesh-list
101494395|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
101494396|NCT00438269|Metronidazole|metronidazole|mesh-list
101494397|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
101494398|NCT00438269|Meropenem|meropenem|mesh-list
101494399|NCT00438269|Cefazolin|cefazolin|mesh-list
101494400|NCT00438269|Tazobactam|tazobactam|mesh-list
101377176|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377177|NCT00243724|Esomeprazole|esomeprazole|mesh-list
101377178|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101377179|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377180|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101494401|NCT00438269|Piperacillin|piperacillin|mesh-list
101494405|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101494406|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101494407|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101494408|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101494409|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494410|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494411|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494412|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101494413|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494414|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101494416|NCT00474591|Fondaparinux|fondaparinux|mesh-list
101494417|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101494418|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
101494419|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101494420|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101494421|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494422|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494423|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
101494424|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101494425|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101494426|NCT03279809|Aspirin|aspirin|mesh-list
101494427|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494428|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494429|NCT03279809|Analgesics|analgesics|mesh-ancestor
101494430|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
101494431|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494432|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494433|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494434|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494435|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101494436|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101494437|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494438|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101494439|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101494440|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494441|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
101494442|NCT00438386|Aripiprazole|aripiprazole|mesh-list
101494443|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
101494444|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494445|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101494446|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101178128|NCT01965366|Hormones|hormones|mesh-ancestor
101494447|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494448|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494449|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
101494450|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
101494451|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494452|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494453|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101494454|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101494455|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
101494456|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101494457|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101494458|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101494459|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101494460|NCT00475059|Cimetidine|cimetidine|mesh-list
101494461|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101494462|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494463|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101494464|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
101494465|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
101494466|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494467|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377182|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377183|NCT00243880|Lovastatin|lovastatin|mesh-list
101377184|NCT00243880|L 647318|l 647318|mesh-list
101377185|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
101377186|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101377187|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101377188|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
101377189|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377190|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101377191|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101377192|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377193|NCT00244075|Hormones|hormones|mesh-list
101377194|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377195|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377196|NCT00244153|Dexamethasone|dexamethasone|mesh-list
101377197|NCT00244153|Morphine|morphine|mesh-list
101377198|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377199|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
101377200|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
101377201|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377202|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377204|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
101377205|NCT00244153|Hormones|hormones|mesh-ancestor
101377206|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377207|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101377208|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377209|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101377210|NCT00244153|Narcotics|narcotics|mesh-ancestor
101377211|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494468|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494469|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101494470|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494478|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494480|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
101494481|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101494482|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494483|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494484|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101494485|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494486|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101494487|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377212|NCT00244153|Analgesics|analgesics|mesh-ancestor
101377213|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
101377214|NCT02967029|Remifentanil|remifentanil|mesh-list
101377215|NCT02967029|Esmolol|esmolol|mesh-list
101377216|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101377217|NCT02967029|Narcotics|narcotics|mesh-ancestor
101377218|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494488|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494489|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494490|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101494491|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101494492|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
101494493|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494494|NCT00475293|Panitumumab|panitumumab|mesh-list
101494495|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494496|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494497|NCT00438737|Leucovorin|leucovorin|mesh-list
101494498|NCT00438737|Bevacizumab|bevacizumab|mesh-list
101494499|NCT00438737|Cetuximab|cetuximab|mesh-list
101494500|NCT00438737|Fluorouracil|fluorouracil|mesh-list
101494501|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
101494502|NCT00438737|Calcium|calcium|mesh-list
101494503|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
101494504|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494505|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494506|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101494507|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101494508|NCT00438737|Growth Substances|growth substances|mesh-ancestor
101494509|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494510|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
101494511|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101494512|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
101494513|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494514|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101494515|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494516|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
101494517|NCT00438737|Antidotes|antidotes|mesh-ancestor
101494518|NCT00438737|Protective Agents|protective agents|mesh-ancestor
101494519|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
101494520|NCT00438737|Vitamins|vitamins|mesh-ancestor
101494521|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
101494522|NCT00438776|Olanzapine|olanzapine|mesh-list
101494523|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
101494524|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
101494526|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494527|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494528|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101494529|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101494530|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494531|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494532|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101494533|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494534|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494535|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494536|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494537|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
101494538|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101494539|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
101494546|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494547|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101494548|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101494549|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101494550|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494551|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101494552|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494553|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494554|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101494555|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101377219|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377220|NCT02967029|Analgesics|analgesics|mesh-ancestor
101377221|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
101377222|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377223|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101377224|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101377225|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101377226|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101377227|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377228|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377229|NCT00244192|Infliximab|infliximab|mesh-list
101377230|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101377231|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377232|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
101494556|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494558|NCT00439049|Modafinil|modafinil|mesh-list
101494559|NCT00439049|Amphetamine|amphetamine|mesh-list
101494560|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
101494561|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101494562|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101494563|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494564|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
101494565|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494566|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101494567|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101494568|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101494569|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101494570|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494571|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
101494572|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
101494573|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
101494574|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494575|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494576|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101494577|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494578|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494579|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101494580|NCT00475566|Everolimus|everolimus|mesh-list
101494581|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101494582|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101494583|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494584|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494585|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494586|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
101494587|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494588|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494589|NCT00439166|Doxycycline|doxycycline|mesh-list
101494590|NCT00439166|Rifampin|rifampin|mesh-list
101494591|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494592|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494593|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
101494594|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101494595|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101494596|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101494597|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
101494598|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
101494599|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494600|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494601|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377234|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377235|NCT00077181|Cytarabine|cytarabine|mesh-list
101377236|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377237|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
101377238|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377239|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377240|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
101377241|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494602|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101494603|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101494604|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101494605|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101494606|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101494607|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101494608|NCT00439283|Infliximab|infliximab|mesh-list
101494609|NCT00439283|Methotrexate|methotrexate|mesh-list
101494616|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494617|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494618|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
101494619|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494620|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101494621|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494622|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
101494623|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494624|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494625|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101494626|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494627|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494628|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
101494629|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101494630|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101494631|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494632|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494633|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494634|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494635|NCT00475800|Analgesics|analgesics|mesh-ancestor
101494636|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
101494637|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494638|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494639|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494640|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494641|NCT00439361|Carboplatin|carboplatin|mesh-list
101494642|NCT00439361|Etoposide|etoposide|mesh-list
101494643|NCT00439361|Bortezomib|bortezomib|mesh-list
101494644|NCT00439361|Ifosfamide|ifosfamide|mesh-list
101494645|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494646|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101494647|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101494648|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101494649|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494650|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494651|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101494652|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
101494653|NCT00475917|Gemcitabine|gemcitabine|mesh-list
101494654|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101494655|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
101494656|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494657|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494658|NCT00474669|Docetaxel|docetaxel|mesh-list
101494659|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494660|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
101494661|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101494662|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101494663|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377242|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377243|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
101377244|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377245|NCT00244309|Tamsulosin|tamsulosin|mesh-list
101494664|NCT00439400|Doxycycline|doxycycline|mesh-list
101494665|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494666|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494667|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
101494668|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101494669|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101494670|NCT00475956|Cediranib|cediranib|mesh-list
101494671|NCT00475956|Saracatinib|saracatinib|mesh-list
101494672|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494673|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101494674|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494675|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494676|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
101494677|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101494686|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494687|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494688|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494689|NCT00476073|Fluticasone|fluticasone|mesh-list
101494690|NCT00476073|Xhance|xhance|mesh-list
101494691|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
101494692|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494693|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101494694|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
101494695|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494696|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494697|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101494698|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
101494699|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101494700|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101494701|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101494702|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101494703|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101494704|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494705|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494706|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494707|NCT00476268|Beclomethasone|beclomethasone|mesh-list
101494708|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
101494709|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101494710|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
101494711|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494712|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494713|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101494714|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
101494715|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101494716|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101494717|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101494718|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494719|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494720|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494721|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494722|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
101494723|NCT00476268|Hormones|hormones|mesh-ancestor
101494724|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494725|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101494726|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101546395|NCT01601795|Sevoflurane|sevoflurane|mesh-list
101494727|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494728|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494729|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494730|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494731|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494732|NCT00105989|Analgesics|analgesics|mesh-ancestor
101494733|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
101494734|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494735|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
101494736|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377247|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101494737|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
101494738|NCT00476346|Vitamin D|vitamin d|mesh-list
101494739|NCT00476346|Calcium|calcium|mesh-list
101494740|NCT00476346|Vitamins|vitamins|mesh-ancestor
101494741|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
101494744|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101494746|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101494747|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494748|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494749|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494750|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
101494751|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494752|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101494753|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101494754|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101494755|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101494756|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101494757|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101494758|NCT00439712|Levocetirizine|levocetirizine|mesh-list
101494759|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101494760|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101494761|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
101494762|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
101494763|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494764|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494765|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494766|NCT00476463|Emtricitabine|emtricitabine|mesh-list
101494767|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
101494768|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494769|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101494770|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494771|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494772|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494773|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101494774|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101494775|NCT00439751|Goserelin|goserelin|mesh-list
101494776|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101494777|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494778|NCT00438243|Bromfenac|bromfenac|mesh-list
101494779|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494780|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494781|NCT00438243|Analgesics|analgesics|mesh-ancestor
101494782|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
101494783|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494784|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494785|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494786|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494787|NCT00439829|Cetrorelix|cetrorelix|mesh-list
101494788|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101494790|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101494791|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494792|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
101494793|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494794|NCT03277248|Teriflunomide|teriflunomide|mesh-list
101494795|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494796|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494797|NCT03277248|Analgesics|analgesics|mesh-ancestor
101494798|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
101494799|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494800|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494801|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494802|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101494803|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494804|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
101494805|NCT00440024|Tazarotene|tazarotene|mesh-list
101494806|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377249|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101377250|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
101377251|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377252|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377253|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377254|NCT00244309|Urological Agents|urological agents|mesh-ancestor
101494807|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
101494808|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
101494809|NCT00440063|Hematinics|hematinics|mesh-ancestor
101494810|NCT00440102|Ketamine|ketamine|mesh-list
101494811|NCT00440102|Etomidate|etomidate|mesh-list
101494812|NCT00440102|Analgesics|analgesics|mesh-ancestor
101494813|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
101494823|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494824|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494825|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101494826|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
101494827|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494828|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494829|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
101494830|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
101494831|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
101494832|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494833|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101494834|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101494835|NCT00440141|Latanoprost|latanoprost|mesh-list
101494836|NCT00440141|Brinzolamide|brinzolamide|mesh-list
101494837|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101494838|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101494839|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101494840|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101494841|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101494842|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494843|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494844|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494845|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494846|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101494847|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494848|NCT00438321|Anastrozole|anastrozole|mesh-list
101494849|NCT00438321|Goserelin|goserelin|mesh-list
101494850|NCT00438321|Testosterone|testosterone|mesh-list
101494851|NCT00438321|Androgens|androgens|mesh-ancestor
101494852|NCT00438321|Hormones|hormones|mesh-ancestor
101494853|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494854|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494855|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101494856|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494857|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101494858|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101494859|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494860|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494861|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101494862|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
101494863|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
101494864|NCT00476619|Hematinics|hematinics|mesh-ancestor
101494865|NCT03279536|Lactoferrin|lactoferrin|mesh-list
101494866|NCT03279536|Dextrans|dextrans|mesh-list
101494867|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
101494868|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494869|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
101494870|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
101494871|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
101494872|NCT03279536|Hematinics|hematinics|mesh-ancestor
101494873|NCT00440219|Prednisone|prednisone|mesh-list
101494874|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494875|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
101494876|NCT00440219|Hormones|hormones|mesh-ancestor
101494877|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377255|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101377256|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101377257|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494878|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494882|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101494883|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494884|NCT00440258|Cabergoline|cabergoline|mesh-list
101494885|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101494886|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101494887|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
101494888|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
101494889|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494890|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494891|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494892|NCT00440336|Latanoprost|latanoprost|mesh-list
101494893|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101494894|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101494895|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
101494896|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101494897|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494899|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101494900|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494901|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494902|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494903|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101494904|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494905|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101494906|NCT03270462|Tacrolimus|tacrolimus|mesh-list
101494907|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494908|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
101494909|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494910|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101494911|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494912|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494913|NCT00440609|Ranibizumab|ranibizumab|mesh-list
101494914|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101494915|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101494917|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494918|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
101494919|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494920|NCT00440648|Sevelamer|sevelamer|mesh-list
101494921|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
101494922|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
101494923|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494924|NCT00440687|Fluticasone|fluticasone|mesh-list
101494925|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494926|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101494927|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
101494928|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494929|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494930|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101494931|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
101494932|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
101494933|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101494934|NCT03271047|Nivolumab|nivolumab|mesh-list
101494935|NCT03271047|Ipilimumab|ipilimumab|mesh-list
101494936|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101494937|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494938|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101494939|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494940|NCT00440765|Bortezomib|bortezomib|mesh-list
101494941|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494942|NCT00440804|Ibuprofen|ibuprofen|mesh-list
101494943|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494944|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494945|NCT00440804|Analgesics|analgesics|mesh-ancestor
101494946|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
101494947|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494948|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377258|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377259|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377260|NCT00244348|Fluorouracil|fluorouracil|mesh-list
101377261|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
101377262|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
101377263|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377264|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377265|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377266|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377267|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
101377268|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377269|NCT00077220|Paclitaxel|paclitaxel|mesh-list
101377270|NCT00077220|Carboplatin|carboplatin|mesh-list
101377271|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377272|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494949|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101494951|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101494952|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494953|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494954|NCT00440843|Olanzapine|olanzapine|mesh-list
101494955|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
101494956|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
101494957|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494958|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494959|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494960|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101494961|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101494962|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494963|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101494964|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101494965|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101494966|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494968|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494969|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
101494970|NCT00438789|Eculizumab|eculizumab|mesh-list
101494971|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101494972|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101494973|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
101494974|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494975|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101494976|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
101494977|NCT00440921|Coagulants|coagulants|mesh-ancestor
101494978|NCT00440960|Lidocaine|lidocaine|mesh-list
101494979|NCT00440960|Midazolam|midazolam|mesh-list
101494980|NCT00440960|Alfentanil|alfentanil|mesh-list
101494981|NCT00440960|Propofol|propofol|mesh-list
101494982|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
101494983|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
101494984|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494985|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494986|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
101494987|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494988|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101494989|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101494990|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101494991|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101494992|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494993|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101377273|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377274|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377275|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377276|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377277|NCT00244426|Aspirin|aspirin|mesh-list
101377278|NCT00244426|Indobufen|indobufen|mesh-list
101377279|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101377280|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494994|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101494995|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
101494996|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101494997|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101494998|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101494999|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495000|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
101495001|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
101495002|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495003|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101495004|NCT00440960|Narcotics|narcotics|mesh-ancestor
101495005|NCT00440960|Analgesics|analgesics|mesh-ancestor
101495006|NCT00438828|Dexamethasone|dexamethasone|mesh-list
101495007|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495008|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
101495009|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
101495010|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495011|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495012|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495013|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
101495014|NCT00438828|Hormones|hormones|mesh-ancestor
101495015|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495016|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101495017|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495018|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
101495019|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495020|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101495021|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495022|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495023|NCT00106002|Pemetrexed|pemetrexed|mesh-list
101495024|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495037|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495038|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101495039|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101495040|NCT00438906|Secretin|secretin|mesh-list
101495041|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495042|NCT00438906|Hormones|hormones|mesh-ancestor
101495043|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495044|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495046|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101495047|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101495048|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101495049|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495050|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
101495051|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101495052|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101495053|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
101495054|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495055|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495056|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495057|NCT00441428|Urological Agents|urological agents|mesh-ancestor
101495058|NCT00438984|Aldesleukin|aldesleukin|mesh-list
101495059|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
101495060|NCT00438984|Interleukin-2|interleukin-2|mesh-list
101495061|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101495062|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
101495063|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495064|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495065|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101377281|NCT00244426|Analgesics|analgesics|mesh-ancestor
101377282|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
101377283|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377284|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377285|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377286|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377287|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101495066|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
101495067|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495068|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495069|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101495070|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495071|NCT00438984|Analgesics|analgesics|mesh-ancestor
101495072|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
101495073|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495074|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495075|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495076|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
101495077|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495078|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101495079|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495080|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495081|NCT00441662|Triamcinolone|triamcinolone|mesh-list
101495082|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495083|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
101495084|NCT00441662|Hormones|hormones|mesh-ancestor
101495085|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495100|NCT00441740|Vinorelbine|vinorelbine|mesh-list
101495101|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495102|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
101495103|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495104|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495105|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495106|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101495107|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101495108|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101495109|NCT02274012|Paclitaxel|paclitaxel|mesh-list
101495110|NCT02274012|Afatinib|afatinib|mesh-list
101495111|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101495112|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495113|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495114|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101495115|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101495116|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495117|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101178793|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
101495118|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495119|NCT00477048|Saquinavir|saquinavir|mesh-list
101495120|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101495121|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101495122|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
101495123|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495124|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495125|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495126|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495127|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
101495128|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495129|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101495130|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101495131|NCT00477126|Ritonavir|ritonavir|mesh-list
101495132|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101495133|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101495134|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
101495135|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495136|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495137|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495138|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495139|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
101377288|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101377289|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377290|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101377291|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101377294|NCT00398957|Naltrexone|naltrexone|mesh-list
101377295|NCT00398957|Hydromorphone|hydromorphone|mesh-list
101377296|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
101377297|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101377298|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377299|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
101377300|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377301|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101377302|NCT00398957|Narcotics|narcotics|mesh-ancestor
101377303|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377304|NCT00398957|Analgesics|analgesics|mesh-ancestor
101377305|NCT00099450|INS 50589|ins 50589|mesh-list
101377306|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101495140|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495141|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101495142|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101495143|NCT03279341|Prucalopride|prucalopride|mesh-list
101495144|NCT03279341|Bisacodyl|bisacodyl|mesh-list
101495145|NCT03279341|Laxatives|laxatives|mesh-ancestor
101495151|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495152|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495153|NCT03279341|Cathartics|cathartics|mesh-ancestor
101495154|NCT03279146|Tenofovir|tenofovir|mesh-list
101495155|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
101495156|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495157|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101495158|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101495159|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495160|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495161|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495162|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495163|NCT00442052|Aspirin|aspirin|mesh-list
101495164|NCT00442052|Omeprazole|omeprazole|mesh-list
101495165|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495166|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495167|NCT00442052|Analgesics|analgesics|mesh-ancestor
101495168|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
101495169|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495170|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495171|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495172|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495173|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101495174|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101495175|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495176|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101495177|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495178|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495179|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
101495180|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101495181|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377308|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
101377309|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377310|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377311|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377312|NCT00244504|Moxonidine|moxonidine|mesh-list
101377313|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101377314|NCT00099489|Interferons|interferons|mesh-list
101377315|NCT00099489|Interferon-beta|interferon-beta|mesh-list
101377316|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
101377317|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377318|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
101377319|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377320|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
101377321|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495182|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101495183|NCT00477282|Topotecan|topotecan|mesh-list
101495184|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101495185|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101495186|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495187|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495188|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495189|NCT00439530|Oseltamivir|oseltamivir|mesh-list
101495190|NCT00439530|Probenecid|probenecid|mesh-list
101495191|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
101495192|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495193|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495194|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495195|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
101495196|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
101495197|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495198|NCT00442325|Atorvastatin|atorvastatin|mesh-list
101495199|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101495200|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101495201|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
101495202|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495203|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101495204|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101495205|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495206|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
101495207|NCT00477516|Calcium|calcium|mesh-list
101495208|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101495209|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495210|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101495211|NCT00477711|Capecitabine|capecitabine|mesh-list
101495212|NCT00477711|Cetuximab|cetuximab|mesh-list
101495213|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495214|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495215|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
101495226|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495227|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101495228|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
101495229|NCT00477789|Allopurinol|allopurinol|mesh-list
101495230|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
101495231|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495232|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495233|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
101495234|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495235|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101495236|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
101377322|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101377323|NCT00067262|Valproic Acid|valproic acid|mesh-list
101377324|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
101377325|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377326|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377327|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
101377328|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495237|NCT00477789|Protective Agents|protective agents|mesh-ancestor
101495238|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495239|NCT00442481|Escitalopram|escitalopram|mesh-list
101495240|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101495241|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101495242|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101495243|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495244|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495245|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
101495246|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495247|NCT00442637|Bevacizumab|bevacizumab|mesh-list
101495248|NCT00442637|Capecitabine|capecitabine|mesh-list
101495249|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495250|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495251|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495252|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495253|NCT00442637|Growth Substances|growth substances|mesh-ancestor
101495254|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495255|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495256|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546515|NCT02893722|Atosiban|atosiban|mesh-list
101495257|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
101495258|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495259|NCT00442676|Celecoxib|celecoxib|mesh-list
101495260|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495261|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495262|NCT00442676|Analgesics|analgesics|mesh-ancestor
101495263|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
101495264|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495265|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178940|NCT02250612|Timolol|timolol|mesh-list
101495266|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495267|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495268|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101495269|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495270|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495271|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495272|NCT00477945|Clofarabine|clofarabine|mesh-list
101495273|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495274|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
101495275|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495276|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495277|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
101495278|NCT00442793|Hematinics|hematinics|mesh-ancestor
101495279|NCT00442832|Vancomycin|vancomycin|mesh-list
101495293|NCT00478101|Analgesics|analgesics|mesh-ancestor
101495294|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
101495295|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495296|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101495297|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101495298|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
101495299|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
101495301|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495302|NCT00443105|Tacrolimus|tacrolimus|mesh-list
101495303|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101495304|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
101495305|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495306|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101495307|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495308|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495309|NCT00443144|Hormones|hormones|mesh-list
101377329|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377330|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
101377331|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377332|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377333|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377334|NCT00244738|Castor Oil|castor oil|mesh-list
101377335|NCT00244738|Cathartics|cathartics|mesh-ancestor
101377336|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377337|NCT00077259|Epothilones|epothilones|mesh-list
101377338|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
101377339|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495310|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495311|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495312|NCT00440154|Ezetimibe|ezetimibe|mesh-list
101495313|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101495314|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101495315|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
101495316|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495317|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101495318|NCT00478374|Doxorubicin|doxorubicin|mesh-list
101495319|NCT00478374|Sorafenib|sorafenib|mesh-list
101495320|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101495321|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495322|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101495323|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101495324|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495325|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495326|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101495327|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
101495328|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101495329|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
101495330|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495331|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495332|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101495333|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
101495334|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495335|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495336|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101495337|NCT03279549|Mitogens|mitogens|mesh-list
101495338|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
101495339|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495340|NCT03271983|Metronidazole|metronidazole|mesh-list
101495341|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495347|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495348|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101495349|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495350|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495351|NCT00440349|Tamoxifen|tamoxifen|mesh-list
101495352|NCT00440349|Prednisone|prednisone|mesh-list
101495353|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495354|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
101495355|NCT00440349|Hormones|hormones|mesh-ancestor
101495356|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495357|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495358|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101495359|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495360|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101495361|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
101495362|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101495363|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101495364|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101495365|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
101495366|NCT00443339|Hematinics|hematinics|mesh-ancestor
101495367|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
101495368|NCT04700228|Bupivacaine|bupivacaine|mesh-list
101495369|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101377341|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377342|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377343|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377344|NCT00067301|Citalopram|citalopram|mesh-list
101377345|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101377346|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377347|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101495370|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
101495371|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495372|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495373|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
101495374|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495375|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101495376|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495377|NCT04700228|Analgesics|analgesics|mesh-ancestor
101495378|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101495379|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101495380|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101495381|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495382|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495383|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495384|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101495385|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101495386|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101495387|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101495388|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495389|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495390|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495391|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
101495392|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495393|NCT03278522|Ramosetron|ramosetron|mesh-list
101495394|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
101495395|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
101495396|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495397|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495398|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495399|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101495400|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
101495401|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495402|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495403|NCT00440622|Gemcitabine|gemcitabine|mesh-list
101495405|NCT00440622|Trastuzumab|trastuzumab|mesh-list
101495406|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495407|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
101495408|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495409|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495421|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495422|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495423|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495424|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495425|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101495426|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495427|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495428|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495429|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
101495430|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
101495431|NCT00440739|Urological Agents|urological agents|mesh-ancestor
101495432|NCT00443573|Protein C|protein c|mesh-list
101495433|NCT00443573|Anticoagulants|anticoagulants|mesh-list
101495434|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101495435|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101495436|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377348|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377349|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377350|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
101377351|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377352|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101377353|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377354|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495437|NCT00478764|Triamcinolone|triamcinolone|mesh-list
101495438|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495439|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
101495440|NCT00478764|Hormones|hormones|mesh-ancestor
101495441|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495442|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495444|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
101495445|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101495446|NCT03278405|Avelumab|avelumab|mesh-list
101495447|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495448|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495449|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101495450|NCT00443612|Irbesartan|irbesartan|mesh-list
101495451|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101495452|NCT00443612|Diuretics|diuretics|mesh-ancestor
101495453|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
101495454|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495455|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101495456|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101495457|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495458|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101495459|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101495460|NCT00443690|Rolofylline|rolofylline|mesh-list
101495461|NCT00443690|Diuretics|diuretics|mesh-ancestor
101495462|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
101495463|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495464|NCT00440895|Abciximab|abciximab|mesh-list
101495465|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
101495466|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101495467|NCT00440973|Bevacizumab|bevacizumab|mesh-list
101495468|NCT00440973|Interleukin-2|interleukin-2|mesh-list
101495469|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495470|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495471|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495472|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495473|NCT00440973|Growth Substances|growth substances|mesh-ancestor
101495474|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495475|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495476|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495480|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101495481|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101495483|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495484|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495485|NCT00441051|Analgesics|analgesics|mesh-ancestor
101495486|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
101495487|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495488|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495489|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495490|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495491|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495492|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495493|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495494|NCT00443963|Esomeprazole|esomeprazole|mesh-list
101495495|NCT00443963|Ranitidine|ranitidine|mesh-list
101495496|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101495497|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495498|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101495499|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377356|NCT00244972|Tipifarnib|tipifarnib|mesh-list
101377357|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377358|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101377359|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495500|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495501|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101495502|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
101495503|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
101495504|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495505|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495507|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
101495508|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495509|NCT00441207|Protective Agents|protective agents|mesh-ancestor
101495510|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495511|NCT00441207|Vitamins|vitamins|mesh-ancestor
101495512|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
101495513|NCT00444041|Bevacizumab|bevacizumab|mesh-list
101495514|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495515|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495516|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495517|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495518|NCT00444041|Growth Substances|growth substances|mesh-ancestor
101495519|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495520|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495521|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
101495522|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
101495523|NCT00441246|Ephedrine|ephedrine|mesh-list
101495524|NCT00441246|Guaifenesin|guaifenesin|mesh-list
101495525|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101495526|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101495527|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
101495528|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495529|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495530|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101495531|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
101495532|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
101495533|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101495534|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101495535|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
101495536|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495537|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495538|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495539|NCT00441246|Expectorants|expectorants|mesh-ancestor
101495540|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101495541|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101495542|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
101495543|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101495544|NCT00478959|Lenalidomide|lenalidomide|mesh-list
101495545|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
101495546|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495547|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495548|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495558|NCT00478998|Tamsulosin|tamsulosin|mesh-list
101495559|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101495560|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101495561|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101495562|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495563|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495564|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495565|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495566|NCT00478998|Urological Agents|urological agents|mesh-ancestor
101495567|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101495569|NCT00479076|Aflibercept|aflibercept|mesh-list
101495570|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495571|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495572|NCT00479076|Growth Substances|growth substances|mesh-ancestor
101495573|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377360|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377362|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
101377363|NCT00245089|Vincristine|vincristine|mesh-list
101377364|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377365|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
101377366|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377367|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495574|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495575|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495577|NCT00441519|Omeprazole|omeprazole|mesh-list
101495578|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495579|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495580|NCT00441519|Analgesics|analgesics|mesh-ancestor
101495581|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
101495582|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495583|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495584|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495585|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495586|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101495587|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101495588|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495589|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101495590|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495591|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495592|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
101495593|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101495594|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495595|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101495596|NCT00441597|Atorvastatin|atorvastatin|mesh-list
101495597|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101495598|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101495599|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
101495600|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495601|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101495602|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101495603|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495604|NCT00479193|Bacitracin|bacitracin|mesh-list
101495605|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101495606|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495607|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495608|NCT03278015|Paclitaxel|paclitaxel|mesh-list
101495609|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101495610|NCT03278015|Gemcitabine|gemcitabine|mesh-list
101495611|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101495612|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495613|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495614|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
101495615|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
101495641|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495642|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101495643|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101495644|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101495645|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495646|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495647|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495648|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495650|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101495651|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
101495652|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495653|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495654|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101495655|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495656|NCT02274090|Metformin|metformin|mesh-list
101495657|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101495658|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377368|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101377369|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
101377370|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377371|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377372|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101377373|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377374|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495659|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
101495661|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101495662|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495663|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495675|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
101495676|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
101495677|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
101495678|NCT04700670|Coagulants|coagulants|mesh-ancestor
101495679|NCT00441870|Folic Acid|folic acid|mesh-list
101495680|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
101495681|NCT00441870|Hematinics|hematinics|mesh-ancestor
101495682|NCT00441870|Vitamins|vitamins|mesh-ancestor
101495683|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
101495684|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495685|NCT04700592|Ketamine|ketamine|mesh-list
101495686|NCT04700592|Gabapentin|gabapentin|mesh-list
101495687|NCT04700592|Analgesics|analgesics|mesh-ancestor
101495688|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
101495689|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495690|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495691|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101495692|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101495693|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
101495694|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
101495695|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495696|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101495697|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101495698|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495699|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495700|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
101495701|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101495702|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101495703|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495704|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
101495705|NCT00441909|UC-781|uc-781|mesh-list
101495706|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495707|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
101495708|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495709|NCT00445016|Anesthetics|anesthetics|mesh-list
101495710|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495711|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495712|NCT00445055|Droperidol|droperidol|mesh-list
101495713|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101495714|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
101495715|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
101495716|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495717|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495718|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495719|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101495720|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101495721|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495722|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495723|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101495724|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101495726|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495727|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495728|NCT00479739|Fluticasone|fluticasone|mesh-list
101495729|NCT00479739|Xhance|xhance|mesh-list
101495744|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495745|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101377375|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377376|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377377|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377378|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377379|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377380|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101377381|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377382|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101495746|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101495747|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101495748|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495749|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495750|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495751|NCT00445094|Vancomycin|vancomycin|mesh-list
101495752|NCT00445094|Imipenem|imipenem|mesh-list
101495753|NCT00445094|Amikacin|amikacin|mesh-list
101495754|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101495755|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
101495756|NCT00445094|Cilastatin|cilastatin|mesh-list
101495757|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495758|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495759|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495760|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
101495761|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495762|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101495763|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
101495764|NCT00479778|Estrogens|estrogens|mesh-list
101495765|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101495766|NCT00479778|Hormones|hormones|mesh-ancestor
101495767|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495768|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495769|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101495770|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101495771|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
101495772|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101495773|NCT00442026|Gemcitabine|gemcitabine|mesh-list
101495774|NCT00442026|Docetaxel|docetaxel|mesh-list
101495775|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495776|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
101495777|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495778|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495779|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101495780|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101495781|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101495782|NCT00479895|Chrysarobin|chrysarobin|mesh-list
101495783|NCT00479895|HBOC 201|hboc 201|mesh-list
101495784|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495785|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495786|NCT00479895|Analgesics|analgesics|mesh-ancestor
101495787|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
101495788|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495789|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495790|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495805|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101495806|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
101495807|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101495808|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495809|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101495810|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101495811|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101495812|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
101495813|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495814|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101495815|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377384|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101377385|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377386|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
101377389|NCT00245206|Aripiprazole|aripiprazole|mesh-list
101377390|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101495816|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495818|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101495819|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495820|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495822|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101495823|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101495824|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101495825|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495826|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495827|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495828|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495829|NCT03274700|Urological Agents|urological agents|mesh-ancestor
101495830|NCT00442221|Naproxen|naproxen|mesh-list
101495831|NCT00442221|Sumatriptan|sumatriptan|mesh-list
101495832|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495833|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495834|NCT00442221|Analgesics|analgesics|mesh-ancestor
101495835|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
101495836|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495837|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495838|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495839|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495840|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
101495841|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495842|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495843|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495844|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101495845|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101495846|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101495847|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
101495848|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495849|NCT00454259|Fentanyl|fentanyl|mesh-list
101495853|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495855|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
101495856|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495857|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101495858|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101495859|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
101495860|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
101495861|NCT03278808|Azithromycin|azithromycin|mesh-list
101495862|NCT03278808|Chloroquine|chloroquine|mesh-list
101495863|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101495864|NCT03278808|Atovaquone|atovaquone|mesh-list
101495865|NCT03278808|Proguanil|proguanil|mesh-list
101495866|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101495867|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495868|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495869|NCT03278808|Amebicides|amebicides|mesh-ancestor
101495870|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101495871|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101495872|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
101495873|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495874|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495875|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495876|NCT03278808|Analgesics|analgesics|mesh-ancestor
101495877|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
101495878|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495879|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495880|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495881|NCT03278808|Filaricides|filaricides|mesh-ancestor
101377391|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
101377392|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377393|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495882|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
101495883|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
101495884|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495885|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495887|NCT00480090|Cytarabine|cytarabine|mesh-list
101495888|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495889|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
101495890|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495891|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495892|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
101495893|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495894|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101495895|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
101495896|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495897|NCT00454883|Ziprasidone|ziprasidone|mesh-list
101495898|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101495899|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
101495900|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495901|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495902|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495903|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101495904|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101495905|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495906|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495907|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101495908|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
101495909|NCT03278652|Analgesics|analgesics|mesh-list
101495910|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
101495911|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495912|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495913|NCT00454961|Lumefantrine|lumefantrine|mesh-list
101495914|NCT00454961|Artemether|artemether|mesh-list
101495915|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101495916|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
101495917|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101495918|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101495919|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495920|NCT00480207|Folic Acid|folic acid|mesh-list
101495921|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
101495922|NCT00480207|Hematinics|hematinics|mesh-ancestor
101495923|NCT00480207|Vitamins|vitamins|mesh-ancestor
101495942|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
101495943|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495944|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495945|NCT00455117|Parecoxib|parecoxib|mesh-list
101495946|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101179603|NCT05589792|Diuretics|diuretics|mesh-ancestor
101495947|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101495948|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495949|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495950|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495951|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495952|NCT00455117|Analgesics|analgesics|mesh-ancestor
101495953|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
101495954|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495955|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495956|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495957|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495958|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
101495959|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495960|NCT03274427|Trimetazidine|trimetazidine|mesh-list
101495961|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
101495962|NCT00455234|Promethazine|promethazine|mesh-list
101495963|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
101495964|NCT00455234|Haloperidol|haloperidol|mesh-list
101495965|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
101495966|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
101495967|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
101377394|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377396|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377397|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377398|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377399|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101377400|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
101495968|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495969|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495970|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495971|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101495972|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101495973|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495974|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495975|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101495976|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
101495977|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495978|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495979|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101495983|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
101495984|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
101495985|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101495986|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101495987|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101495988|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
101495989|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
101495990|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
101495991|NCT00480363|Dexamethasone|dexamethasone|mesh-list
101495992|NCT00480363|Lenalidomide|lenalidomide|mesh-list
101495993|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495994|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
101495995|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
101495996|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495997|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495998|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495999|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
101496000|NCT00480363|Hormones|hormones|mesh-ancestor
101496001|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496002|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101496003|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496004|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
101496005|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496006|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496007|NCT00480363|Growth Substances|growth substances|mesh-ancestor
101496008|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496009|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
101496010|NCT00442845|Atorvastatin|atorvastatin|mesh-list
101496011|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496012|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496013|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
101496014|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496015|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496016|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496017|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496018|NCT00455507|Istradefylline|istradefylline|mesh-list
101496019|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101496020|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101496021|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101179685|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
101496022|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
101496023|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496024|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496025|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496026|NCT00480402|Progesterone|progesterone|mesh-list
101496027|NCT00480402|Progestins|progestins|mesh-ancestor
101496028|NCT00480402|Hormones|hormones|mesh-ancestor
101496029|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496030|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377402|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
101377403|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377404|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377405|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101377406|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101496031|NCT00455585|Lamivudine|lamivudine|mesh-list
101496032|NCT00455585|Nevirapine|nevirapine|mesh-list
101496033|NCT00455585|Stavudine|stavudine|mesh-list
101496034|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101496035|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496036|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496037|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496038|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
101496039|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496040|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101496041|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101496042|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101496043|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101496044|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
101496045|NCT00455624|Androgens|androgens|mesh-list
101496046|NCT00455624|Hormones|hormones|mesh-ancestor
101496047|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496048|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496049|NCT00455897|Rituximab|rituximab|mesh-list
101496050|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101496051|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496061|NCT00443235|Prednisone|prednisone|mesh-list
101496062|NCT00443235|Melphalan|melphalan|mesh-list
101496063|NCT00443235|Bortezomib|bortezomib|mesh-list
101496064|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101496065|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
101496066|NCT00443235|Hormones|hormones|mesh-ancestor
101496067|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496068|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496069|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101496070|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496071|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101496072|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
101496073|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496074|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101496075|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496076|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
101496077|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
101496078|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496079|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496080|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496081|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496082|NCT00443235|Growth Substances|growth substances|mesh-ancestor
101496083|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496084|NCT04700943|Anesthetics|anesthetics|mesh-list
101496085|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496086|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496087|NCT00456248|Ribavirin|ribavirin|mesh-list
101496088|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
101496089|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
101496090|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496091|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
101496092|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496093|NCT00480558|Vaccines|vaccines|mesh-list
101496094|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
101496095|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496096|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
101496097|NCT04700709|Sirolimus|sirolimus|mesh-list
101496098|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101496099|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496100|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101496101|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
101496102|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377407|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377408|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377409|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
101377410|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101496103|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496104|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496105|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496106|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
101496107|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496108|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
101496109|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496110|NCT04698317|Mitogens|mitogens|mesh-list
101496111|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
101496112|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496113|NCT04700475|Citric Acid|citric acid|mesh-list
101496114|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
101496115|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
101496116|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101496117|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
101496130|NCT00480597|Capecitabine|capecitabine|mesh-list
101496131|NCT00480597|Vinorelbine|vinorelbine|mesh-list
101496132|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496133|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496134|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
101496135|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496136|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101496137|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
101496138|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
101496139|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
101496140|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101496141|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101496142|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
101496143|NCT00456482|Hormones|hormones|mesh-ancestor
101496144|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496145|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496146|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101496147|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
101496148|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101496149|NCT00480675|Prednisolone|prednisolone|mesh-list
101496150|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
101496151|NCT00480675|Bupivacaine|bupivacaine|mesh-list
101496152|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101496153|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
101496154|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
101496155|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
101496156|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496157|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496158|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
101496159|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496160|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101496161|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
101496162|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
101496163|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101496164|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
101496165|NCT00480675|Hormones|hormones|mesh-ancestor
101496166|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496167|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101496168|NCT00480675|Protective Agents|protective agents|mesh-ancestor
101496169|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101496170|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496171|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
101179828|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101496173|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101496174|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101496175|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496176|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496177|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496193|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377411|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101377412|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101377413|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101377414|NCT00245245|Factor VIII|factor viii|mesh-list
101496195|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496196|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496197|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496198|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496199|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
101496200|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
101496201|NCT00456794|Istradefylline|istradefylline|mesh-list
101496202|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101496203|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101496204|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101496205|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
101496206|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496207|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496208|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496209|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101496210|NCT00456833|Everolimus|everolimus|mesh-list
101496211|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496212|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496213|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496214|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496215|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101496216|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496217|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
101496218|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496219|NCT00456872|Lidocaine|lidocaine|mesh-list
101496220|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
101496221|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
101496222|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496223|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496224|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
101496225|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496226|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101496227|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101496228|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101496229|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496230|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496231|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
101496232|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
101496233|NCT04700046|Mexiletine|mexiletine|mesh-list
101496234|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101496235|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101496240|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496241|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496242|NCT00457067|Growth Substances|growth substances|mesh-ancestor
101496243|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496244|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496245|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496246|NCT00480870|Donepezil|donepezil|mesh-list
101496247|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101496248|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496249|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496250|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
101496252|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496253|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
101496254|NCT00457106|Risperidone|risperidone|mesh-list
101496255|NCT00457106|Paroxetine|paroxetine|mesh-list
101496256|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101496257|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
101496258|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496259|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496260|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496261|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101496262|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377415|NCT00245245|Coagulants|coagulants|mesh-ancestor
101377417|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101377418|NCT00077298|Cetuximab|cetuximab|mesh-list
101377419|NCT00077298|Irinotecan|irinotecan|mesh-list
101377420|NCT00077298|Antibodies|antibodies|mesh-list
101377421|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
101377422|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101377423|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496263|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496264|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101496265|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101496266|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
101496267|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101496268|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101496269|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496270|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101496271|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
101496272|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101496273|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496274|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496275|NCT00457145|Ranibizumab|ranibizumab|mesh-list
101496276|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496277|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496278|NCT00457145|Growth Substances|growth substances|mesh-ancestor
101496279|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496280|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496281|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496282|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101496283|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
101496284|NCT00457223|Coagulants|coagulants|mesh-ancestor
101496285|NCT00443508|Everolimus|everolimus|mesh-list
101496286|NCT00443508|Tacrolimus|tacrolimus|mesh-list
101496287|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496288|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
101496289|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496290|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101496291|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496292|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496293|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101496294|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496295|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496296|NCT00457340|Atorvastatin|atorvastatin|mesh-list
101496297|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496298|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496299|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
101496300|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496301|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496302|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496303|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496304|NCT03278379|Avelumab|avelumab|mesh-list
101496305|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101496309|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
101496310|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496311|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
101496312|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496313|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496314|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496315|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496316|NCT02956538|Growth Substances|growth substances|mesh-ancestor
101496317|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496318|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496319|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101496320|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496321|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496322|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
101496323|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496324|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101377424|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101377425|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101377427|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377428|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
101377429|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
101377430|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101377431|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377432|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377433|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377435|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496325|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496326|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496327|NCT00457769|Donepezil|donepezil|mesh-list
101496328|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101496329|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496330|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496331|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
101496332|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496333|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496334|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
101496335|NCT00457808|Sirolimus|sirolimus|mesh-list
101496336|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496337|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496338|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101496339|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496340|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
101496341|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496342|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
101496343|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496344|NCT00481143|Deferasirox|deferasirox|mesh-list
101496345|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101496346|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
101496347|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
101496348|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496349|NCT00457964|Everolimus|everolimus|mesh-list
101496350|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101496351|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496352|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496353|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496354|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496355|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
101496356|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496357|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496358|NCT00458042|Treprostinil|treprostinil|mesh-list
101496359|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101496360|NCT00458081|Rimonabant|rimonabant|mesh-list
101496361|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101496362|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101496363|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101496364|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496365|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496367|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496368|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496369|NCT00481182|Ritonavir|ritonavir|mesh-list
101496370|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
101496371|NCT00481182|Methadone|methadone|mesh-list
101496372|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101496373|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101496374|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
101496375|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377436|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377437|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377438|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377439|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
101377440|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377441|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
101377442|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377443|NCT00245440|Azithromycin|azithromycin|mesh-list
101377444|NCT00245440|Telithromycin|telithromycin|mesh-list
101496376|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496382|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496384|NCT00481182|Narcotics|narcotics|mesh-ancestor
101496385|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496386|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496387|NCT00481182|Analgesics|analgesics|mesh-ancestor
101496388|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
101496389|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496390|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
101496391|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
101496392|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
101180057|NCT05027646|Granisetron|granisetron|mesh-list
101496394|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101496395|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496396|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496397|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496398|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496399|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
101496400|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496401|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496402|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101496403|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101496404|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
101496405|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496406|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496407|NCT00458315|Paclitaxel|paclitaxel|mesh-list
101496408|NCT00458315|Bevacizumab|bevacizumab|mesh-list
101496409|NCT00458315|Gemcitabine|gemcitabine|mesh-list
101496410|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101496411|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496412|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101496413|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101496414|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101496415|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496416|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101496417|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496418|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496419|NCT00458315|Growth Substances|growth substances|mesh-ancestor
101496420|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496421|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496422|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496423|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
101496424|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101496425|NCT00444015|Dasatinib|dasatinib|mesh-list
101496426|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496427|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496428|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496429|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496430|NCT00458510|Fentanyl|fentanyl|mesh-list
101496431|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101496432|NCT00458510|Narcotics|narcotics|mesh-ancestor
101496433|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496434|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496435|NCT00458510|Analgesics|analgesics|mesh-ancestor
101496436|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
101496437|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377445|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377446|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377447|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101377448|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101377450|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496438|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101496439|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101496440|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
101496441|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
101496442|NCT00444132|Clopidogrel|clopidogrel|mesh-list
101496443|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101496444|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101496445|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101496446|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101496447|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
101496452|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101496453|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101496454|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496455|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
101496456|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496457|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496458|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101496459|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101496460|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496461|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496462|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496463|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101496464|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101496465|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101180134|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
101496466|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496467|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496469|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496470|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496472|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101496473|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101496474|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101496475|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496476|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496477|NCT00459173|Hormones|hormones|mesh-ancestor
101496478|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496479|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496480|NCT00444249|Dipivefrin|dipivefrin|mesh-list
101496481|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101496482|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
101496483|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496484|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496485|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496486|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101496487|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
101496488|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496489|NCT00459407|Protective Agents|protective agents|mesh-ancestor
101496490|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496491|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101496492|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101496493|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496494|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101496495|NCT03278262|Aflibercept|aflibercept|mesh-list
101496496|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496497|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496498|NCT03278262|Growth Substances|growth substances|mesh-ancestor
101496499|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496500|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496501|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496502|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
101377451|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377452|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377453|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
101377454|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
101377456|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377457|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
101377458|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
101377459|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
101377460|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101377461|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101377462|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377463|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377464|NCT00245596|Urological Agents|urological agents|mesh-ancestor
101377465|NCT00245674|Amisulpride|amisulpride|mesh-list
101377466|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101377467|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377468|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377469|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377470|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101496503|NCT00459485|Astringents|astringents|mesh-ancestor
101496504|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496505|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
101496506|NCT00459563|Vitamin D|vitamin d|mesh-list
101496507|NCT00459563|Calcitriol|calcitriol|mesh-list
101496508|NCT00459563|Vitamins|vitamins|mesh-ancestor
101496509|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
101496510|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496511|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101496512|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101496513|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101496514|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496515|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496521|NCT00488436|Cyclosporine|cyclosporine|mesh-list
101496522|NCT00488436|Cyclosporins|cyclosporins|mesh-list
101496523|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101496524|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496525|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496526|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496527|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
101496528|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496529|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
101496530|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496531|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
101496532|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101496533|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101496534|NCT00459719|Tacrolimus|tacrolimus|mesh-list
101496535|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496536|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
101496537|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496538|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101496539|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496540|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496541|NCT00495183|Biperiden|biperiden|mesh-list
101377472|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
101377473|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377474|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377475|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101377476|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377477|NCT00245713|Levetiracetam|levetiracetam|mesh-list
101377478|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
101496542|NCT00495183|Caffeine|caffeine|mesh-list
101496543|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101496544|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496545|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101496546|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496547|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496548|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101496549|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101496550|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
101496551|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496552|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101496553|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101496554|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
101496555|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
101496556|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496557|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101496558|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101496559|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
101496560|NCT00488670|Escitalopram|escitalopram|mesh-list
101496561|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101496562|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101496563|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496564|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496565|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496566|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
101496567|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496568|NCT00459836|Gemcitabine|gemcitabine|mesh-list
101496569|NCT00459836|Docetaxel|docetaxel|mesh-list
101496570|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496571|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
101496572|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496573|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496574|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
101496575|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
101496576|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
101496577|NCT00488709|Cytarabine|cytarabine|mesh-list
101496578|NCT00488709|Fludarabine|fludarabine|mesh-list
101496579|NCT00488709|Topotecan|topotecan|mesh-list
101496580|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496581|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496582|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
101496583|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496584|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496585|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
101496591|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496592|NCT00459992|Betahistine|betahistine|mesh-list
101496593|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
101496594|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
101496595|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
101496596|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496597|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496598|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496599|NCT00495339|Levofloxacin|levofloxacin|mesh-list
101496600|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101496601|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496602|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496603|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101496605|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496606|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496607|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496608|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101496609|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496611|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101496612|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101496613|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
101496614|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
101496615|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496616|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496617|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496618|NCT00460226|Lamotrigine|lamotrigine|mesh-list
101496619|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
101496620|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101496621|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496622|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496623|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101496624|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496625|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101496626|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101496627|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496628|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101496629|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101496630|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
101496631|NCT00495378|Hematinics|hematinics|mesh-ancestor
101496632|NCT00460304|Pramlintide|pramlintide|mesh-list
101496633|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101496634|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496635|NCT00460382|Ritonavir|ritonavir|mesh-list
101496636|NCT00460382|Darunavir|darunavir|mesh-list
101496637|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
101496638|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
101496639|NCT00460382|Etravirine|etravirine|mesh-list
101496640|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101496641|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101496642|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
101496643|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496644|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496645|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101496646|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101496647|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
101496648|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496649|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101496650|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496651|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101496652|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101496653|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101496654|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496673|NCT00488787|Ketamine|ketamine|mesh-list
101496674|NCT00488787|Analgesics|analgesics|mesh-ancestor
101496675|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
101496676|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496677|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496678|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101496679|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101496680|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
101496681|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
101496682|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496683|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101496684|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180352|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
101496685|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496686|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496687|NCT00460616|Cabergoline|cabergoline|mesh-list
101496688|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101496689|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101496690|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
101496691|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
101496692|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496693|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377481|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377482|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101377483|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
101377484|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377485|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377486|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377487|NCT00102843|Folic Acid|folic acid|mesh-list
101377488|NCT00102843|Betaine|betaine|mesh-list
101377489|NCT00102843|Hematinics|hematinics|mesh-ancestor
101496694|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496695|NCT00495651|Isoniazid|isoniazid|mesh-list
101496696|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101496697|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
101496698|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496699|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496700|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101496701|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496702|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
101496703|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496704|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496705|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
101496706|NCT00460733|Vitamin D|vitamin d|mesh-list
101496707|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
101496708|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
101496709|NCT00460733|Calcium|calcium|mesh-list
101496710|NCT00460733|Vitamins|vitamins|mesh-ancestor
101496711|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
101496718|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101496719|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
101496720|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496721|NCT00495729|Simvastatin|simvastatin|mesh-list
101496722|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496723|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496724|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
101496725|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496726|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496727|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496728|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496729|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
101496730|NCT00460928|Antibodies|antibodies|mesh-list
101496731|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
101496732|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101496733|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101496734|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
101496735|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496736|NCT00461084|Clarithromycin|clarithromycin|mesh-list
101496737|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496738|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496739|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101496740|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496741|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496742|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101496743|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496744|NCT00495846|Octreotide|octreotide|mesh-list
101496745|NCT00495846|Lanreotide|lanreotide|mesh-list
101496746|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101496747|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101496748|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496749|NCT00105482|Naltrexone|naltrexone|mesh-list
101496750|NCT00105482|Nicotine|nicotine|mesh-list
101496751|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101496752|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
101496753|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496754|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496755|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101377490|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
101377491|NCT00102843|Vitamins|vitamins|mesh-ancestor
101377492|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
101377493|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377494|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377495|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
101377496|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496756|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101496757|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
101496758|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496759|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496760|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101496761|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101496762|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
101496763|NCT00496002|Adefovir|adefovir|mesh-list
101496764|NCT00496002|Clevudine|clevudine|mesh-list
101496765|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
101496766|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496767|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101496768|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496769|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496770|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496771|NCT00489099|Vaccines|vaccines|mesh-list
101496772|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
101496773|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496774|NCT00496158|Adefovir|adefovir|mesh-list
101496775|NCT00496158|Clevudine|clevudine|mesh-list
101496776|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
101496777|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496778|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101496793|NCT01327651|Tenofovir|tenofovir|mesh-list
101496794|NCT01327651|Emtricitabine|emtricitabine|mesh-list
101496795|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
101496796|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496797|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101496798|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496799|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496800|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496801|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101496802|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101496803|NCT00496275|Cisplatin|cisplatin|mesh-list
101496804|NCT00496275|Gemcitabine|gemcitabine|mesh-list
101496805|NCT00496275|Vinorelbine|vinorelbine|mesh-list
101496806|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496807|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496808|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
101496809|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496810|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101496811|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
101496812|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
101496813|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
101496814|NCT00591604|Vitamin D|vitamin d|mesh-list
101496815|NCT00591604|Vitamins|vitamins|mesh-ancestor
101496816|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
101496817|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496818|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101496819|NCT00591643|Epinephrine|epinephrine|mesh-list
101496820|NCT00591643|Racepinephrine|racepinephrine|mesh-list
101496821|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
101496822|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101496823|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101496824|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
101496825|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496826|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496827|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496828|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101496829|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101496830|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
101496831|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496832|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377498|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377499|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101377500|NCT00245791|Levofloxacin|levofloxacin|mesh-list
101377501|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101377502|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377503|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377504|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377505|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377506|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496833|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
101496834|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
101496835|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
101496836|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101496837|NCT00461747|Thalidomide|thalidomide|mesh-list
101496838|NCT00461747|Dexamethasone|dexamethasone|mesh-list
101496839|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
101496841|NCT00461747|BB 1101|bb 1101|mesh-list
101496852|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496853|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
101496854|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496855|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496856|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496857|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
101496858|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
101496859|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496860|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496861|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101496862|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101496863|NCT00461747|Growth Substances|growth substances|mesh-ancestor
101496864|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
101496865|NCT00461825|Cyclosporine|cyclosporine|mesh-list
101496866|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
101496867|NCT00461825|Azathioprine|azathioprine|mesh-list
101496868|NCT00461825|Cyclosporins|cyclosporins|mesh-list
101496869|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496870|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496871|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496872|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
101496873|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496874|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
101496875|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496876|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
101496877|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101496878|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101496879|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101496880|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496881|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101496882|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
101496883|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496884|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
101496885|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496886|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101496887|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
101496888|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496889|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
101496890|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101496891|NCT00489372|Protective Agents|protective agents|mesh-ancestor
101496892|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496893|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496894|NCT00461903|Perindopril|perindopril|mesh-list
101496895|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101496896|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101496897|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377508|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377509|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101377510|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101377511|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
101377512|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377513|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377514|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101496898|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496899|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101496900|NCT00496392|Fentanyl|fentanyl|mesh-list
101496901|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101496902|NCT00496392|Narcotics|narcotics|mesh-ancestor
101496903|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496904|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496905|NCT00496392|Analgesics|analgesics|mesh-ancestor
101496910|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
101496911|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
101496913|NCT02893618|Choline|choline|mesh-list
101496914|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
101496915|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496916|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
101496917|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180577|NCT02430090|Fentanyl|fentanyl|mesh-list
101496918|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101496919|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496920|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
101496921|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101496922|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
101496923|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
101496924|NCT00496665|Methotrexate|methotrexate|mesh-list
101496925|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496926|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
101496927|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496928|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101496929|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101496930|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
101496931|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496932|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496933|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101496934|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101496935|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
101496936|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101496937|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496938|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
101496939|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
101496940|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496941|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101496942|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496943|NCT00496704|Gemcitabine|gemcitabine|mesh-list
101496944|NCT00496704|Capecitabine|capecitabine|mesh-list
101496945|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
101496946|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101496947|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
101496948|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496949|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496950|NCT00591916|Thrombin|thrombin|mesh-list
101496951|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
101496952|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
101496953|NCT00591916|Coagulants|coagulants|mesh-ancestor
101496954|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101496955|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
101496956|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496957|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
101496958|NCT00591916|Protective Agents|protective agents|mesh-ancestor
101377515|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
101377516|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377517|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377519|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377520|NCT00245908|Azithromycin|azithromycin|mesh-list
101377521|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377522|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377523|NCT00067496|Modafinil|modafinil|mesh-list
101496959|NCT00462215|Vaccines|vaccines|mesh-list
101496960|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
101496961|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496962|NCT00462371|Insulin|insulin|mesh-list
101496963|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101496964|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496965|NCT00497016|Atorvastatin|atorvastatin|mesh-list
101496966|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496967|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496968|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
101496969|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496970|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496971|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496972|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496973|NCT00222872|Hormones|hormones|mesh-list
101496974|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
101496975|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101496976|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496981|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496982|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101496983|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496984|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
101496985|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496986|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
101496987|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496988|NCT03273296|Amoxicillin|amoxicillin|mesh-list
101496989|NCT03273296|Azithromycin|azithromycin|mesh-list
101496990|NCT03273296|Vancomycin|vancomycin|mesh-list
101496991|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496992|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180650|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
101496993|NCT00497250|Gefitinib|gefitinib|mesh-list
101496994|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496995|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496996|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496997|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496998|NCT00462878|Vancomycin|vancomycin|mesh-list
101496999|NCT00462878|Meropenem|meropenem|mesh-list
101497000|NCT00462878|Teicoplanin|teicoplanin|mesh-list
101546640|NCT00592566|Hormones|hormones|mesh-ancestor
101497001|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497002|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497003|NCT00462956|Lapatinib|lapatinib|mesh-list
101497004|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497005|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497006|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497007|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497008|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101497009|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497010|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497011|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497012|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497013|NCT00489528|Hormones|hormones|mesh-list
101497014|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497015|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497016|NCT00463073|Bevacizumab|bevacizumab|mesh-list
101497017|NCT00463073|Cetuximab|cetuximab|mesh-list
101377524|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101377525|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377526|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101377527|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101377528|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101377529|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377530|NCT00246064|Infliximab|infliximab|mesh-list
101377531|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101377532|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497018|NCT00463073|Irinotecan|irinotecan|mesh-list
101497019|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101497020|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497021|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497022|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497023|NCT00463073|Growth Substances|growth substances|mesh-ancestor
101497024|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497025|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497026|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101497027|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497028|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497029|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497030|NCT00463112|Sibutramine|sibutramine|mesh-list
101497031|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
101497032|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101497033|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
101497034|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101497035|NCT00223028|Sirolimus|sirolimus|mesh-list
101497036|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497037|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497038|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497039|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497040|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
101497041|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497042|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
101497043|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497044|NCT00489645|Pramlintide|pramlintide|mesh-list
101497045|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101497046|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497047|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497055|NCT00463268|Vitamins|vitamins|mesh-ancestor
101497056|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
101497057|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497058|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101497059|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101497060|NCT00489723|Tamsulosin|tamsulosin|mesh-list
101497061|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101497062|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101497063|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101497064|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
101497065|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497066|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497068|NCT00489723|Urological Agents|urological agents|mesh-ancestor
101497069|NCT00105443|Sorafenib|sorafenib|mesh-list
101497070|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497071|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497072|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497073|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497074|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
101497075|NCT00489840|Anecortave|anecortave|mesh-list
101497076|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497077|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497078|NCT00489840|Growth Substances|growth substances|mesh-ancestor
101497079|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377533|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377534|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377535|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377537|NCT00246103|Fluorouracil|fluorouracil|mesh-list
101377538|NCT00246103|Epirubicin|epirubicin|mesh-list
101377539|NCT00246103|Valproic Acid|valproic acid|mesh-list
101377540|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101377541|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
101377542|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377543|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377544|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101377545|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
101377546|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377547|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377548|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101377549|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
101377550|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377551|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377552|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377553|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377554|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377555|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
101377556|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
101377557|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377558|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
101377559|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377560|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377561|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377562|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
101497080|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497081|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497082|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497083|NCT00463502|Metformin|metformin|mesh-list
101497084|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497085|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497086|NCT00489996|Gemcitabine|gemcitabine|mesh-list
101497087|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497088|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497089|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
101497090|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497091|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
101497092|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101497093|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101497094|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497095|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497096|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377563|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101377564|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101377565|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101377566|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377568|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
101377569|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377570|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377571|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101377572|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377574|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
101377575|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
101377576|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377577|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377578|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
101377579|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497097|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497098|NCT00463541|Urological Agents|urological agents|mesh-ancestor
101497099|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
101497100|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
101497101|NCT00490113|Vitamins|vitamins|mesh-ancestor
101497102|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
101497103|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497104|NCT01243203|Varenicline|varenicline|mesh-list
101497105|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101497106|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101497107|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497108|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497109|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497110|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497111|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
101497112|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101497113|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
101497114|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497115|NCT00497328|Expectorants|expectorants|mesh-ancestor
101497116|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497121|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497123|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
101497124|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
101497125|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101497126|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
101497127|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497128|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497129|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497130|NCT00466154|Aspirin|aspirin|mesh-list
101497131|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101497132|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101497133|NCT00466154|Analgesics|analgesics|mesh-ancestor
101497134|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
101497135|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497136|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497137|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497138|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497139|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101497140|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101497141|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497142|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101377581|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101377582|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377583|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377584|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377585|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
101377586|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377587|NCT00102882|Fluticasone|fluticasone|mesh-list
101377588|NCT00102882|Xhance|xhance|mesh-list
101377589|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101377590|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101377591|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377592|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101377593|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
101497143|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101497144|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497146|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101497147|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101497149|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101497150|NCT00490308|Estrogens|estrogens|mesh-ancestor
101497151|NCT00490308|Hormones|hormones|mesh-ancestor
101497152|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497153|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497154|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101497155|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
101497156|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497157|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101497158|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
101497159|NCT00463736|Analgesics|analgesics|mesh-ancestor
101497160|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
101497161|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497162|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497163|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
101497164|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497165|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101497166|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
101497167|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101497168|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497169|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497170|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101497171|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
101497172|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497173|NCT00490464|Nicardipine|nicardipine|mesh-list
101497174|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101497175|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101497176|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497177|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497178|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101497179|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497180|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
101497181|NCT00497523|Beclomethasone|beclomethasone|mesh-list
101497182|NCT00497523|Albuterol|albuterol|mesh-list
101497183|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101497184|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
101497185|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497186|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377594|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377595|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377596|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377597|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497194|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
101497195|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497196|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497197|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497198|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
101497199|NCT00497523|Hormones|hormones|mesh-ancestor
101497200|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497201|NCT00463775|Topiramate|topiramate|mesh-list
101497203|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497204|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497205|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
101497206|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497207|NCT00466232|Sorafenib|sorafenib|mesh-list
101497208|NCT00466232|Topotecan|topotecan|mesh-list
101497209|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497210|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497211|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497212|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497213|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101497214|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497215|NCT00490659|Gemcitabine|gemcitabine|mesh-list
101497216|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497217|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497219|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497220|NCT00490737|Daptomycin|daptomycin|mesh-list
101497221|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497222|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497223|NCT00497562|Tramadol|tramadol|mesh-list
101497224|NCT00497562|Amitriptyline|amitriptyline|mesh-list
101497225|NCT00497562|Fluoxetine|fluoxetine|mesh-list
101497226|NCT00497562|Hormones|hormones|mesh-list
101497227|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497228|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497229|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101497230|NCT00497562|Narcotics|narcotics|mesh-ancestor
101497231|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497232|NCT00497562|Analgesics|analgesics|mesh-ancestor
101497233|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
101497234|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497235|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101497236|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101497237|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497238|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497239|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497240|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
101497241|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101497242|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101497243|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101497244|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101497245|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101497246|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497247|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101497248|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101497249|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101497250|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
101497251|NCT00497601|Amphotericin B|amphotericin b|mesh-list
101497252|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101497253|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101497271|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497272|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497273|NCT00466466|Everolimus|everolimus|mesh-list
101377600|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101377601|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101377602|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101377603|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
101377604|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377605|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377607|NCT00102882|Hormones|hormones|mesh-ancestor
101497274|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101497275|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497276|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497277|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497278|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497279|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
101497280|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497281|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497282|NCT00490854|Insulin|insulin|mesh-list
101497283|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101497284|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
101497285|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
101497286|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
101497287|NCT00490854|Protamines|protamines|mesh-list
101497288|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497289|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497290|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
101497291|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497292|NCT00490854|Coagulants|coagulants|mesh-ancestor
101497293|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
101497294|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497295|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497296|NCT03272126|Vitamin D|vitamin d|mesh-list
101497297|NCT03272126|Vitamins|vitamins|mesh-ancestor
101497299|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497300|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101497301|NCT00491049|Levofloxacin|levofloxacin|mesh-list
101497302|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101497303|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101497304|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101497305|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497306|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497307|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101497308|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497309|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497310|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497311|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497312|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101497323|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
101497324|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101497325|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101497326|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101497327|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497328|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497329|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497330|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497331|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497332|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101497333|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497334|NCT03272321|Oxytocin|oxytocin|mesh-list
101497335|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
101497336|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497337|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497338|NCT00491127|Dexamethasone|dexamethasone|mesh-list
101377608|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377610|NCT00246220|Methylphenidate|methylphenidate|mesh-list
101377611|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101377612|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377613|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101497339|NCT00491127|Gemcitabine|gemcitabine|mesh-list
101497340|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497341|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
101497342|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
101497343|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497344|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497345|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101497346|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
101497347|NCT00491127|Hormones|hormones|mesh-ancestor
101497348|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497349|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101497350|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497351|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497352|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
101497353|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497354|NCT00491166|Bromfenac|bromfenac|mesh-list
101497355|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101497356|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101497357|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101497358|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101497359|NCT00491166|Analgesics|analgesics|mesh-ancestor
101497360|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
101497361|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497362|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497363|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497364|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497365|NCT03273062|Tolcapone|tolcapone|mesh-list
101497366|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101497367|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101497368|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101497369|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497370|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497372|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
101497373|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
101497374|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497377|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101497378|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
101497379|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497380|NCT00498225|Gemcitabine|gemcitabine|mesh-list
101497381|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497382|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
101497383|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497384|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497385|NCT00466622|Metformin|metformin|mesh-list
101497386|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497387|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497388|NCT01327612|Leucovorin|leucovorin|mesh-list
101497389|NCT01327612|Bevacizumab|bevacizumab|mesh-list
101497390|NCT01327612|Conatumumab|conatumumab|mesh-list
101497391|NCT01327612|Fluorouracil|fluorouracil|mesh-list
101497392|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
101546674|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497393|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101497394|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497395|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497396|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497397|NCT01327612|Growth Substances|growth substances|mesh-ancestor
101497398|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497399|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497400|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
101377615|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377616|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377617|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
101377618|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377620|NCT00424801|Valsartan|valsartan|mesh-list
101497401|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497402|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497403|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497404|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
101497405|NCT01327612|Antidotes|antidotes|mesh-ancestor
101497406|NCT01327612|Protective Agents|protective agents|mesh-ancestor
101497407|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
101497408|NCT01327612|Vitamins|vitamins|mesh-ancestor
101497409|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
101497410|NCT01243281|Entecavir|entecavir|mesh-list
101497411|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
101497412|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497413|NCT00464399|Everolimus|everolimus|mesh-list
101497414|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101497415|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497416|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497417|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497418|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497419|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
101497420|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497421|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497422|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
101497423|NCT04132882|Antidotes|antidotes|mesh-ancestor
101497424|NCT04132882|Protective Agents|protective agents|mesh-ancestor
101497425|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497426|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
101497427|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497428|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
101497429|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497430|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497431|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
101497432|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
101497433|NCT01243359|Bevacizumab|bevacizumab|mesh-list
101497434|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101497435|NCT01243359|Sunitinib|sunitinib|mesh-list
101497436|NCT01243359|Antibodies|antibodies|mesh-list
101497437|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
101497438|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101497439|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497440|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497441|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497442|NCT01243359|Growth Substances|growth substances|mesh-ancestor
101497443|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497444|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497445|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
101497446|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497447|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497453|NCT00498342|Expectorants|expectorants|mesh-ancestor
101497454|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497455|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101497456|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
101497457|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497458|NCT00498342|Protective Agents|protective agents|mesh-ancestor
101497459|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497460|NCT00498342|Antidotes|antidotes|mesh-ancestor
101497461|NCT00466856|Octreotide|octreotide|mesh-list
101497462|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101497463|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101497464|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497465|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
101377621|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101377622|NCT00424801|Doxazosin|doxazosin|mesh-list
101377623|NCT00424801|Lercanidipine|lercanidipine|mesh-list
101377624|NCT00424801|Pindolol|pindolol|mesh-list
101377625|NCT00424801|Moxonidine|moxonidine|mesh-list
101377626|NCT00424801|Amiloride|amiloride|mesh-list
101377627|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101377628|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101377629|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101377630|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377631|NCT00424801|Diuretics|diuretics|mesh-ancestor
101377632|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
101497466|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497467|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497468|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101497469|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497470|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497471|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497472|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497473|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101497474|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101497475|NCT00591994|Piribedil|piribedil|mesh-list
101497476|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101497477|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101497478|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
101497479|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
101497480|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497481|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497482|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497483|NCT00464594|Metformin|metformin|mesh-list
101497484|NCT00464594|Acarbose|acarbose|mesh-list
101497485|NCT00464594|Gliclazide|gliclazide|mesh-list
101497486|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497487|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497488|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101497489|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497490|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497491|NCT04397302|Valsartan|valsartan|mesh-list
101497492|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101497493|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101497494|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101497495|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101497496|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497497|NCT00466895|Lenalidomide|lenalidomide|mesh-list
101497498|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
101497499|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497500|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497501|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497502|NCT00466895|Growth Substances|growth substances|mesh-ancestor
101497503|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497504|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497505|NCT02893540|Capecitabine|capecitabine|mesh-list
101497506|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497507|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
101497509|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497510|NCT01327573|Eculizumab|eculizumab|mesh-list
101497511|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101497512|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497513|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
101497514|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497515|NCT02893384|Anesthetics|anesthetics|mesh-list
101497516|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
101377633|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377634|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101377635|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377636|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101377637|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101377638|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101497526|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
101497527|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497528|NCT00498537|Spironolactone|spironolactone|mesh-list
101497529|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101497530|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
101497531|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497532|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497533|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101497534|NCT00498537|Diuretics|diuretics|mesh-ancestor
101497535|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
101497536|NCT00491478|Sertraline|sertraline|mesh-list
101497537|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
101497538|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101497539|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101497540|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101497541|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497542|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497543|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497544|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
101497545|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497546|NCT00491517|Sirolimus|sirolimus|mesh-list
101497547|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497548|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497549|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497550|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497551|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
101497552|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497553|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
101497554|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497555|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
101497556|NCT00464789|Estrogens|estrogens|mesh-list
101497557|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101497558|NCT00464789|Hormones|hormones|mesh-ancestor
101497559|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497560|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497561|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101497562|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101497563|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
101497564|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101497565|NCT00467012|Paclitaxel|paclitaxel|mesh-list
101497566|NCT00467012|Bevacizumab|bevacizumab|mesh-list
101497567|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101497568|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497569|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101497570|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101497571|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101497572|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497573|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101497574|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497575|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497576|NCT00467012|Growth Substances|growth substances|mesh-ancestor
101497577|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497578|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497580|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101497581|NCT03272867|Diuretics|diuretics|mesh-ancestor
101497582|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
101497595|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497596|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
101497597|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377639|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101377640|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101377641|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101377642|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101377643|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
101546695|NCT00592917|Vitamin D|vitamin d|mesh-list
101377644|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497600|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101497601|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
101497602|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497603|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497604|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497605|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
101497606|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497607|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101497608|NCT01327339|Ropinirole|ropinirole|mesh-list
101497609|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101497610|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101497611|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
101497612|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
101497613|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497614|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497615|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497616|NCT01327300|Mesalamine|mesalamine|mesh-list
101497617|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101497618|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101497619|NCT01327300|Analgesics|analgesics|mesh-ancestor
101497620|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
101497621|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497622|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497623|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497624|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497625|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
101497626|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101497627|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101497628|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101497629|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497630|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497631|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497632|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497633|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497634|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101497635|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497636|NCT00592111|Prednisone|prednisone|mesh-list
101497637|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
101497638|NCT00592111|Etoposide|etoposide|mesh-list
101497639|NCT00592111|Vincristine|vincristine|mesh-list
101497640|NCT00592111|Doxorubicin|doxorubicin|mesh-list
101497641|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101497642|NCT00592111|Bleomycin|bleomycin|mesh-list
101497643|NCT00592111|Vinblastine|vinblastine|mesh-list
101497644|NCT00592111|Procarbazine|procarbazine|mesh-list
101497645|NCT00592111|Mitogens|mitogens|mesh-list
101497646|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497647|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
101497648|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497653|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497654|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101497655|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497657|NCT00592111|Hormones|hormones|mesh-ancestor
101497658|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497659|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101497660|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101546726|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497662|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497663|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377645|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101377646|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
101377647|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
101377648|NCT00424801|Vitamins|vitamins|mesh-ancestor
101377649|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
101377650|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101377651|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101497664|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101497665|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101497666|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101497667|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497668|NCT00592150|Fenoldopam|fenoldopam|mesh-list
101497669|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101497670|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
101497671|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
101497672|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
101497673|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497674|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497675|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497676|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
101497677|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101497678|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
101497679|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497680|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497681|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
101497682|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497683|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497684|NCT04377295|Ranibizumab|ranibizumab|mesh-list
101497685|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101497686|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101497687|NCT04377295|Growth Substances|growth substances|mesh-ancestor
101497688|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497689|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
101497690|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497691|NCT00491712|Triamcinolone|triamcinolone|mesh-list
101497692|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497693|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
101497694|NCT00491712|Hormones|hormones|mesh-ancestor
101497695|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497696|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497697|NCT02893111|Bortezomib|bortezomib|mesh-list
101497698|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497699|NCT04328272|Azithromycin|azithromycin|mesh-list
101497700|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
101497701|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497702|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497703|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
101497704|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101497705|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101497706|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497707|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497708|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497709|NCT04328194|Thrombin|thrombin|mesh-list
101497710|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
101497711|NCT04328194|Coagulants|coagulants|mesh-ancestor
101497712|NCT00491790|Montelukast|montelukast|mesh-list
101497713|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101497714|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497715|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101497716|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
101497717|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497718|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497719|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101497735|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497736|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497737|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377654|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
101377655|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
101377656|NCT00246298|Hematinics|hematinics|mesh-ancestor
101377657|NCT00246415|Memantine|memantine|mesh-list
101377658|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101377659|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101377660|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
101497738|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497739|NCT00498888|Urological Agents|urological agents|mesh-ancestor
101497740|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
101497741|NCT00491868|Hematinics|hematinics|mesh-ancestor
101497742|NCT00491907|Folic Acid|folic acid|mesh-list
101497743|NCT00491907|Hematinics|hematinics|mesh-ancestor
101497744|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
101497745|NCT00491907|Vitamins|vitamins|mesh-ancestor
101497746|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
101497747|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497748|NCT00499005|Carbetocin|carbetocin|mesh-list
101497749|NCT00499005|Oxytocin|oxytocin|mesh-list
101497750|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
101497751|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497752|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497753|NCT00491946|Dactinomycin|dactinomycin|mesh-list
101497754|NCT00491946|Vincristine|vincristine|mesh-list
101497755|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101497756|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497757|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
101497758|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
101497759|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
101497760|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497761|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497762|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497763|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497764|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101497765|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497766|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101497767|NCT00491985|Vaccines|vaccines|mesh-list
101497768|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
101497769|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497770|NCT02892916|Ketamine|ketamine|mesh-list
101497771|NCT02892916|Analgesics|analgesics|mesh-ancestor
101497772|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
101497773|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497774|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497775|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101497776|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101497777|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
101497778|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
101497779|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497780|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101497781|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101497782|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497787|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101497788|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
101497789|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497790|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497791|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101497792|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101497793|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497794|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
101497795|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497796|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497797|NCT00492141|Temozolomide|temozolomide|mesh-list
101497798|NCT00492141|Camptothecin|camptothecin|mesh-list
101497799|NCT00492141|Rubitecan|rubitecan|mesh-list
101377661|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377662|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377663|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497800|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101497801|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
101497802|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497803|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497804|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101497805|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101497806|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101497807|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497808|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
101497809|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101497810|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497811|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497812|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101497813|NCT04327726|Analgesics|analgesics|mesh-ancestor
101497814|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
101497815|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497816|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101181478|NCT04266912|Avelumab|avelumab|mesh-list
101497817|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101497818|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101497819|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
101497820|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497821|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497822|NCT00492219|Cimetidine|cimetidine|mesh-list
101497823|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101497824|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101497825|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101497826|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
101497827|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
101497828|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497829|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497830|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497831|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101497832|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101497833|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497834|NCT00465257|Artesunate|artesunate|mesh-list
101497835|NCT00465257|Amodiaquine|amodiaquine|mesh-list
101497836|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
101497837|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101497838|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101497839|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497840|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497841|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
101497842|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
101497843|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101497844|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
101497845|NCT04130776|Kallikreins|kallikreins|mesh-list
101497846|NCT04130776|Coagulants|coagulants|mesh-ancestor
101497847|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101497848|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
101497849|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497850|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497864|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101497865|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
101497866|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497867|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497868|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101497869|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101497871|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
101497872|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497873|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101497874|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
101497875|NCT02955810|Hormones|hormones|mesh-ancestor
101497876|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377665|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101377666|NCT00246532|Morphine|morphine|mesh-list
101377667|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101377668|NCT00246532|Narcotics|narcotics|mesh-ancestor
101377669|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497877|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101497878|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
101497879|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497880|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497881|NCT00492414|Paroxetine|paroxetine|mesh-list
101497882|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101497883|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101497884|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497885|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497886|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497887|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
101497888|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497889|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101497890|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
101497891|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101497892|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101497893|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101497894|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497895|NCT01243632|Gemcitabine|gemcitabine|mesh-list
101497896|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497897|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
101497898|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497899|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497900|NCT00467909|Micronutrients|micronutrients|mesh-list
101497901|NCT00467909|Trace Elements|trace elements|mesh-list
101497902|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497903|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101497904|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101497905|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497906|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
101497907|NCT00467948|Cefazolin|cefazolin|mesh-list
101497908|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497909|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497910|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101497911|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497912|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
101497913|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
101497918|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
101497919|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497920|NCT00592618|Expectorants|expectorants|mesh-ancestor
101497921|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497922|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101497923|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
101497924|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497925|NCT00592618|Protective Agents|protective agents|mesh-ancestor
101497926|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497927|NCT00592618|Antidotes|antidotes|mesh-ancestor
101497928|NCT01243710|Taurolidine|taurolidine|mesh-list
101497929|NCT01243710|Heparin|heparin|mesh-list
101497930|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
101497931|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101497932|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101497933|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497934|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497935|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101497936|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497937|NCT00622843|Vaccines|vaccines|mesh-list
101497938|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101497939|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
101497940|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497941|NCT01245543|Docetaxel|docetaxel|mesh-list
101377670|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377671|NCT00246532|Analgesics|analgesics|mesh-ancestor
101377672|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
101377673|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377675|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101377676|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101377677|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
101497942|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497943|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101497944|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101497945|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101497946|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497947|NCT00592930|Olanzapine|olanzapine|mesh-list
101497948|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
101497949|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
101497950|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497951|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497952|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101497953|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101497954|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101497955|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497956|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101497957|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101497958|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101497959|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101497960|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497961|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497962|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
101497963|NCT00592969|Metformin|metformin|mesh-list
101497964|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
101497965|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
101497966|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101497967|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497968|NCT01245582|Capecitabine|capecitabine|mesh-list
101497969|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
101497970|NCT01245582|Sorafenib|sorafenib|mesh-list
101497971|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497972|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
101497973|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497974|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497975|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497976|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497977|NCT00593008|Sirolimus|sirolimus|mesh-list
101497978|NCT00593008|Gemcitabine|gemcitabine|mesh-list
101497979|NCT00593008|Temsirolimus|temsirolimus|mesh-list
101497980|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
101497981|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101497982|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
101497983|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497984|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497985|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101498000|NCT00593125|Levetiracetam|levetiracetam|mesh-list
101498001|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
101498002|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
101498003|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
101498004|NCT00593164|Analgesics|analgesics|mesh-ancestor
101498005|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
101498006|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498007|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498008|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
101498009|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498010|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101498011|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
101498012|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101498013|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546770|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
101498014|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498015|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101377678|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377679|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377680|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101377681|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101377682|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
101377683|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377684|NCT00246688|Sagopilone|sagopilone|mesh-list
101498016|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
101498017|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101498018|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
101498019|NCT01316107|Nateglinide|nateglinide|mesh-list
101498020|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101498021|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498022|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101498023|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498024|NCT05654194|Azacitidine|azacitidine|mesh-list
101498025|NCT05654194|Venetoclax|venetoclax|mesh-list
101498026|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101498027|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
101498028|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498029|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498030|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498031|NCT05653453|Paclitaxel|paclitaxel|mesh-list
101498032|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101498033|NCT05653453|Gemcitabine|gemcitabine|mesh-list
101498034|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101498035|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498036|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
101498037|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
101498038|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
101498039|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498040|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101498041|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
101181711|NCT05150652|Tamoxifen|tamoxifen|mesh-list
101498043|NCT00468182|Interferon-beta|interferon-beta|mesh-list
101498048|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
101498049|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498050|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101498051|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
101498052|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
101498053|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
101498054|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498056|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
101498057|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101498058|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
101498059|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
101498060|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498061|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498062|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
101498063|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498064|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498065|NCT00465452|Protective Agents|protective agents|mesh-ancestor
101498066|NCT01379521|Everolimus|everolimus|mesh-list
101498067|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101498068|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101498069|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498070|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498071|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498072|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
101498073|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498074|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498075|NCT00468260|Epothilone B|epothilone b|mesh-list
101498076|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498077|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
101498078|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
101498079|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
101546782|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498080|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377685|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377686|NCT04728516|Amoxicillin|amoxicillin|mesh-list
101377687|NCT04728516|Pantoprazole|pantoprazole|mesh-list
101377688|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101377689|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377690|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101377691|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377692|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101377693|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498081|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
101498082|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101498083|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101498084|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
101498085|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498086|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498087|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498088|NCT01371994|Urological Agents|urological agents|mesh-ancestor
101498089|NCT00465608|Propranolol|propranolol|mesh-list
101498090|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101498091|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101498092|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498093|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498094|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498095|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498096|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101498097|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498098|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498099|NCT01371877|Vitamin D|vitamin d|mesh-list
101498100|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
101498101|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
101498102|NCT01371877|Vitamins|vitamins|mesh-list
101498103|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
101498104|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498105|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101498106|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101498107|NCT01245816|Eflornithine|eflornithine|mesh-list
101498108|NCT01245816|Sulindac|sulindac|mesh-list
101498109|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498110|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101498111|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101498112|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101498113|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498114|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101498115|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498119|NCT01245816|Analgesics|analgesics|mesh-ancestor
101498120|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
101498121|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498122|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498123|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498124|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498125|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101498126|NCT00492687|Tamoxifen|tamoxifen|mesh-list
101498127|NCT00492687|Carboplatin|carboplatin|mesh-list
101498128|NCT00492687|Temozolomide|temozolomide|mesh-list
101498129|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498130|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498131|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101498132|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
101498133|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101498134|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
101546788|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498135|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498136|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498137|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101498138|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101498139|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101498140|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101377694|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377695|NCT00400998|Fluticasone|fluticasone|mesh-list
101377696|NCT00400998|Xhance|xhance|mesh-list
101377697|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377698|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498141|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
101498142|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101498143|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498144|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498145|NCT01245855|Alprostadil|alprostadil|mesh-list
101498146|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101498147|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498148|NCT01245855|Urological Agents|urological agents|mesh-ancestor
101498149|NCT00473603|Heparin|heparin|mesh-list
101498150|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
101498151|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101498152|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101498153|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498154|NCT00492765|Interferons|interferons|mesh-list
101498155|NCT00492765|Interferon-beta|interferon-beta|mesh-list
101498156|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
101498157|NCT00492765|Simvastatin|simvastatin|mesh-list
101498158|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498159|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
101498160|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498161|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101498162|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101498163|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
101498164|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498165|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101498166|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101498167|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498168|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
101498169|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498170|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101498171|NCT00468533|Aripiprazole|aripiprazole|mesh-list
101498172|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498173|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498174|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101498175|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498176|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498177|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498178|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
101498179|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
101498180|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498181|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498182|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101498183|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101498184|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
101498185|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101498191|NCT00473720|Satraplatin|satraplatin|mesh-list
101181855|NCT02655354|Promethazine|promethazine|mesh-list
101498192|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101498193|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498194|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
101498195|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
101498196|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
101498197|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498198|NCT00499668|Ondansetron|ondansetron|mesh-list
101498199|NCT00499668|Aprepitant|aprepitant|mesh-list
101498200|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
101546813|NCT00593697|Docetaxel|docetaxel|mesh-list
101498201|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
101498202|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498203|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498204|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498205|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
101498206|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498207|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101498208|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498209|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
101377700|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377701|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377702|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101377703|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498210|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498211|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498212|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101498214|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
101498215|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101498216|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498217|NCT01366534|Vaccines|vaccines|mesh-list
101498218|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
101498219|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498220|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
101498221|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101498222|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498223|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
101498224|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
101498225|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498226|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498227|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101498228|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
101498229|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
101498230|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498231|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498232|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498233|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498234|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
101498235|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101498236|NCT01365910|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101498237|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101498238|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498239|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498240|NCT01605526|Doxorubicin|doxorubicin|mesh-list
101498241|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101498242|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498243|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101498244|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101498245|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498246|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498247|NCT00468689|Ketoconazole|ketoconazole|mesh-list
101498248|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
101498249|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498250|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101498251|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101498252|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498253|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498254|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101498268|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498269|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101498271|NCT00493077|Interferon-beta|interferon-beta|mesh-list
101498272|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
101498273|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498274|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
101498275|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498276|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
101498277|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498278|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101498279|NCT00474071|Remifentanil|remifentanil|mesh-list
101498280|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101498281|NCT00474071|Narcotics|narcotics|mesh-ancestor
101498282|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498283|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498284|NCT00474071|Analgesics|analgesics|mesh-ancestor
101498285|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
101498286|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498287|NCT00474110|Ketamine|ketamine|mesh-list
101498288|NCT00474110|Hydromorphone|hydromorphone|mesh-list
101498289|NCT00474110|Analgesics|analgesics|mesh-ancestor
101377705|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101377706|NCT00247078|Antivenins|antivenins|mesh-list
101377707|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
101377708|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377709|NCT00247117|Metformin|metformin|mesh-list
101377710|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377711|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377712|NCT00099606|Dasatinib|dasatinib|mesh-list
101498290|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
101498291|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498292|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498293|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101498294|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101498295|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
101498296|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
101498297|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498298|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101498299|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101498300|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498301|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498302|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101498303|NCT00474110|Narcotics|narcotics|mesh-ancestor
101498304|NCT00500058|Rituximab|rituximab|mesh-list
101498305|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101498306|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498307|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
101498308|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498309|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498310|NCT00468923|Candesartan|candesartan|mesh-list
101498311|NCT00468923|Candesartan cilexetil|candesartan cilexetil|mesh-list
101498312|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101498313|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101498314|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101498315|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
101498316|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498317|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101498331|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498332|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498333|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101498334|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101498335|NCT01365481|Diuretics|diuretics|mesh-ancestor
101498336|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
101498337|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101498338|NCT00493116|Interferons|interferons|mesh-list
101498339|NCT00493116|Interferon-beta|interferon-beta|mesh-list
101498340|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
101498342|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498343|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
101498344|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498345|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498346|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
101498347|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
101498348|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498349|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498350|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498351|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
101498352|NCT00493116|Hormones|hormones|mesh-ancestor
101498353|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498354|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101498355|NCT00493116|Protective Agents|protective agents|mesh-ancestor
101498356|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
101498357|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101498358|NCT00493194|Cyclosporine|cyclosporine|mesh-list
101498359|NCT00493194|Sirolimus|sirolimus|mesh-list
101498360|NCT00493194|Cyclosporins|cyclosporins|mesh-list
101498361|NCT00493194|Daclizumab|daclizumab|mesh-list
101498362|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377713|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377714|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101377715|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377716|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377717|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
101377718|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101377719|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
101377720|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377721|NCT00247507|Expectorants|expectorants|mesh-ancestor
101377722|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498363|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498364|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498365|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
101498366|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498367|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
101498368|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498369|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498370|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498371|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101498372|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498373|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101498374|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498376|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101498377|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101498378|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498379|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498382|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498383|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498384|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
101498385|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
101498386|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498387|NCT01350271|Mebendazole|mebendazole|mesh-list
101498388|NCT01350271|Piperazine|piperazine|mesh-list
101498389|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
101498390|NCT01350271|DMP 777|dmp 777|mesh-list
101498391|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
101498392|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
101498393|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101546852|NCT00594087|Eszopiclone|eszopiclone|mesh-list
101498394|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498395|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
101498396|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
101498397|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
101498398|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498399|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498400|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498401|NCT00493233|Olanzapine|olanzapine|mesh-list
101498402|NCT00493233|Risperidone|risperidone|mesh-list
101498403|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101498404|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
101498405|NCT00493233|Clozapine|clozapine|mesh-list
101498406|NCT00493233|Perphenazine|perphenazine|mesh-list
101498407|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498408|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
101498409|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498410|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498411|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498412|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498413|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498414|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498415|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101498416|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
101498417|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
101498418|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
101498419|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498420|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377723|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101377724|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
101377725|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377726|NCT00247507|Protective Agents|protective agents|mesh-ancestor
101498421|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101498422|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101498423|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498424|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498425|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
101498426|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
101498427|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
101498428|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
101498429|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498430|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
101498431|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498432|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498433|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101498434|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498435|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101498436|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
101498437|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498438|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498439|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101498440|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498441|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
101498442|NCT00500253|Protective Agents|protective agents|mesh-ancestor
101498444|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101498445|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101498446|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101498447|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101498448|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
101498449|NCT01243788|Fluticasone|fluticasone|mesh-list
101498451|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101498452|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498453|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498454|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
101498455|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498456|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498459|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498460|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101498461|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101498462|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101498463|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101498464|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498465|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498466|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498467|NCT01243827|Carvedilol|carvedilol|mesh-list
101498468|NCT01243827|Bisoprolol|bisoprolol|mesh-list
101498469|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101498470|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101498471|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498472|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498473|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498474|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498475|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498476|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
101498478|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101498479|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498480|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101498481|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
101498482|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101498483|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101498484|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
101498485|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
101498486|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498487|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101498488|NCT00500409|Vitamin D|vitamin d|mesh-list
101498489|NCT00500409|Vitamins|vitamins|mesh-ancestor
101498490|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
101377728|NCT00247507|Antidotes|antidotes|mesh-ancestor
101377730|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101377731|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377732|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377733|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377734|NCT00099645|Mifepristone|mifepristone|mesh-list
101377735|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101377736|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
101377737|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101377738|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377739|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101498491|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182152|NCT05441046|Tislelizumab|tislelizumab|mesh-list
101498492|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101498493|NCT00469352|Ranibizumab|ranibizumab|mesh-list
101498494|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498495|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498496|NCT00469352|Growth Substances|growth substances|mesh-ancestor
101498497|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498498|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498499|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498500|NCT00469430|Metronidazole|metronidazole|mesh-list
101498501|NCT00469430|Cefotaxime|cefotaxime|mesh-list
101498502|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498503|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498504|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101498505|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101498506|NCT00469469|Bevacizumab|bevacizumab|mesh-list
101498507|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101498508|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498509|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498510|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498511|NCT00469469|Growth Substances|growth substances|mesh-ancestor
101498512|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498513|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498514|NCT00500565|Bupivacaine|bupivacaine|mesh-list
101498515|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
101498517|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498518|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498519|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
101498520|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498521|NCT00469547|Ethanol|ethanol|mesh-list
101498522|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
101498523|NCT00469547|Emollients|emollients|mesh-list
101498524|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101498525|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498526|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498527|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
101498528|NCT00500604|Valsartan|valsartan|mesh-list
101498529|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101498537|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498538|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101498539|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498540|NCT00493389|Hormones|hormones|mesh-list
101498541|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101498542|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498543|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498544|NCT01605994|Antacids|antacids|mesh-list
101377740|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101377741|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101377742|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
101377743|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101377744|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101377745|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
101377746|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377747|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
101377748|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101498545|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498546|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498547|NCT00500721|Desipramine|desipramine|mesh-list
101498548|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101498549|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498550|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498551|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498552|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498553|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101498554|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101498555|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498556|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498557|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498558|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498559|NCT00469586|Insulin|insulin|mesh-list
101498560|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101498561|NCT00469586|Metformin|metformin|mesh-list
101498562|NCT00469586|Glimepiride|glimepiride|mesh-list
101498563|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182222|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101498564|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498565|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101498566|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498567|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
101498568|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
101498569|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101498570|NCT01606111|Protective Agents|protective agents|mesh-ancestor
101498571|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498572|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
101498573|NCT00493428|Baclofen|baclofen|mesh-list
101498574|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101498575|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498576|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101498577|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498578|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101498579|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
101498580|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
101498581|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498582|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498583|NCT01342510|Lidocaine|lidocaine|mesh-list
101498584|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
101498585|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
101498586|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
101498587|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498588|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498589|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
101498590|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498591|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101498592|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101498593|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101498594|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498607|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498608|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101498609|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101377749|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101377750|NCT00247663|Letrozole|letrozole|mesh-list
101377751|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377752|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101377753|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101377754|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377755|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377756|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101377757|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
101498610|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101498611|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
101498612|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498613|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101498614|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101498615|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498616|NCT00469664|Guanfacine|guanfacine|mesh-list
101498617|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498618|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101498619|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101498620|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101498621|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498622|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498623|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498624|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498625|NCT00469703|Thalidomide|thalidomide|mesh-list
101498626|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498627|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
101498628|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546947|NCT01605773|Glyburide|glyburide|mesh-list
101498629|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
101498630|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498631|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498632|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498633|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498634|NCT00469703|Growth Substances|growth substances|mesh-ancestor
101498635|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498636|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182294|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498638|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101498639|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101498640|NCT01244100|Analgesics|analgesics|mesh-ancestor
101498641|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
101498642|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498643|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498644|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498645|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498646|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101498647|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101498648|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498649|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101498650|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101498651|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498652|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
101498653|NCT01340872|Ferric maltol|ferric maltol|mesh-list
101498654|NCT01340872|Hematinics|hematinics|mesh-ancestor
101498655|NCT00469781|Bromfenac|bromfenac|mesh-list
101498667|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498668|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498670|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498672|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
101498673|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498674|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
101498675|NCT00469781|Hormones|hormones|mesh-ancestor
101377758|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377759|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377760|NCT00247702|Warfarin|warfarin|mesh-list
101377761|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
101377762|NCT01349660|Bevacizumab|bevacizumab|mesh-list
101377763|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101377764|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498676|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498677|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101498678|NCT00469781|Protective Agents|protective agents|mesh-ancestor
101498679|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101498680|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498681|NCT00474695|Ranibizumab|ranibizumab|mesh-list
101498682|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498683|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498684|NCT00474695|Growth Substances|growth substances|mesh-ancestor
101498685|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498686|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498687|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498688|NCT03271502|Anesthetics|anesthetics|mesh-list
101498689|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498690|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498691|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
101498692|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101498693|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498694|NCT00474773|Celecoxib|celecoxib|mesh-list
101498695|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101498696|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101498697|NCT00474773|Analgesics|analgesics|mesh-ancestor
101498698|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
101498699|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498700|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498701|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498702|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498703|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101498704|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101498705|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498706|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498707|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
101498708|NCT00474890|Ephedrine|ephedrine|mesh-list
101498709|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498710|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
101498711|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498712|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498713|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101498714|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498715|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
101498716|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101498717|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101498718|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
101498721|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498722|NCT00501111|Donepezil|donepezil|mesh-list
101498723|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101498724|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498725|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498726|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
101498727|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498728|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498729|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
101498730|NCT00501150|Linezolid|linezolid|mesh-list
101498731|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498732|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498733|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101498734|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498735|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377765|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498736|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
101498737|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498738|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
101498739|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498740|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498741|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101498742|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498743|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
101498744|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101498745|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
101498746|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498747|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498748|NCT01246089|Ranibizumab|ranibizumab|mesh-list
101498749|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498750|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498751|NCT01246089|Growth Substances|growth substances|mesh-ancestor
101498752|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498753|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498754|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498755|NCT00598897|Clarithromycin|clarithromycin|mesh-list
101498756|NCT00598897|Rifabutin|rifabutin|mesh-list
101498757|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101498758|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498759|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101498760|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498761|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498762|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101498763|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101498764|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101498765|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
101498766|NCT04697732|Anesthetics|anesthetics|mesh-list
101498767|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498768|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498769|NCT00501267|Oxybutynin|oxybutynin|mesh-list
101498770|NCT00501267|Solabegron|solabegron|mesh-list
101498771|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
101498772|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
101498773|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498774|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498775|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101498776|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101498777|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
101498778|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498779|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498780|NCT00501267|Urological Agents|urological agents|mesh-ancestor
101498781|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101498782|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101498783|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101498784|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498785|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
101498786|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498787|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498788|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498789|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498791|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498802|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498803|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498805|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498806|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
101498807|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
101498808|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498809|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498810|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101498811|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498812|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498813|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498814|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101498815|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101498816|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101498817|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498818|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
101377766|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101377767|NCT01349660|Growth Substances|growth substances|mesh-ancestor
101377768|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377769|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
101377770|NCT00247741|Lidocaine|lidocaine|mesh-list
101377771|NCT00247741|Carticaine|carticaine|mesh-list
101377772|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
101498819|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101498820|NCT00599287|Protective Agents|protective agents|mesh-ancestor
101498821|NCT04326166|Metformin|metformin|mesh-list
101498822|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101498823|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498824|NCT00501384|Satavaptan|satavaptan|mesh-list
101498825|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101498826|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498827|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
101498828|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498829|NCT00599560|Vasopressins|vasopressins|mesh-list
101498830|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
101498831|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
101498832|NCT00599560|Coagulants|coagulants|mesh-ancestor
101498833|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101498834|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101498835|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
101498836|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498837|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
101498838|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101546979|NCT02270606|Fluorouracil|fluorouracil|mesh-list
101498839|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
101498840|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498841|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
101498842|NCT00599716|Protective Agents|protective agents|mesh-ancestor
101498843|NCT01246284|Triamcinolone|triamcinolone|mesh-list
101498844|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101498845|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101498846|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101498847|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498848|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
101498849|NCT01246284|Hormones|hormones|mesh-ancestor
101498850|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498851|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498852|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498853|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
101498854|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498863|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498864|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498865|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498866|NCT00469976|Growth Substances|growth substances|mesh-ancestor
101498867|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498868|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498869|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101498870|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
101498871|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498872|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101498873|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101498874|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101498875|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498876|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498877|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498878|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498879|NCT00599911|Analgesics|analgesics|mesh-ancestor
101498880|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
101498881|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498882|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498883|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498884|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
101498886|NCT00599950|Mitomycin|mitomycin|mesh-list
101377774|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377775|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377776|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
101377777|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377778|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101377779|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101377780|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101377781|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377782|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498887|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101498888|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498889|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
101498890|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498891|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101498892|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498894|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
101498895|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498896|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101498897|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
101498898|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
101498899|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498900|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498901|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498902|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101498903|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498904|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498905|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101498906|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101498907|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101498908|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498909|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101498910|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498911|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
101498912|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101498913|NCT00470015|Aldesleukin|aldesleukin|mesh-list
101498914|NCT00470015|Interleukin-2|interleukin-2|mesh-list
101498915|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498916|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101498920|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498921|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101498923|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
101498924|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498925|NCT00600262|Bevacizumab|bevacizumab|mesh-list
101498926|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101498927|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498928|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101498929|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498930|NCT00600262|Growth Substances|growth substances|mesh-ancestor
101498931|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498932|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498933|NCT00600301|Triamcinolone|triamcinolone|mesh-list
101498934|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101498935|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101498936|NCT00600301|Bevacizumab|bevacizumab|mesh-list
101498937|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101498938|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101498939|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498940|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101377784|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101377785|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101377786|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
101377787|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377788|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101377789|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101377790|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377791|NCT00248053|Curcumin|curcumin|mesh-list
101377792|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101498941|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101498942|NCT00600301|Growth Substances|growth substances|mesh-ancestor
101498943|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498944|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
101498945|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498947|NCT00600301|Hormones|hormones|mesh-ancestor
101498948|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498949|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498950|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
101498951|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498952|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498953|NCT00501579|Prednisolone|prednisolone|mesh-list
101498954|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101498955|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
101498956|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101498957|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
101498958|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101498959|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
101498960|NCT00501579|Difluprednate|difluprednate|mesh-list
101498961|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498962|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
101498963|NCT00501579|Hormones|hormones|mesh-ancestor
101498964|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498965|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498966|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101498967|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498968|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
101498969|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
101498970|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498971|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101498972|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101498973|NCT00501579|Protective Agents|protective agents|mesh-ancestor
101498974|NCT00501618|Clozapine|clozapine|mesh-list
101498975|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498976|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
101498977|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498978|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498979|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498980|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101498981|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101498982|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498983|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101498984|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
101498985|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
101498986|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
101498987|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
101498988|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498989|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101498990|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499003|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499004|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499005|NCT00600691|Urological Agents|urological agents|mesh-ancestor
101499007|NCT00623077|Melphalan|melphalan|mesh-list
101499008|NCT00623077|Busulfan|busulfan|mesh-list
101377794|NCT00248053|Analgesics|analgesics|mesh-ancestor
101377795|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
101377796|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377797|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377798|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101377799|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101377800|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377801|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377802|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377803|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101377804|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101377805|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377806|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101377807|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499009|NCT00623077|Ifosfamide|ifosfamide|mesh-list
101499010|NCT00623077|Thiotepa|thiotepa|mesh-list
101499011|NCT00623077|Sargramostim|sargramostim|mesh-list
101499013|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499014|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499015|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101499016|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499017|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499018|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499019|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
101499020|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499021|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101499022|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
101499023|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101499024|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499025|NCT00623077|Protective Agents|protective agents|mesh-ancestor
101499026|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101499027|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101499028|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499029|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415863|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499030|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499031|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499032|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499035|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499036|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
101499037|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101499038|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
101499039|NCT00623116|Testosterone|testosterone|mesh-list
101499040|NCT00623116|Estrogens|estrogens|mesh-list
101499041|NCT00623116|Androgens|androgens|mesh-ancestor
101499042|NCT00623116|Hormones|hormones|mesh-ancestor
101499043|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499044|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499045|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
101499046|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
101499047|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101377808|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377809|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377810|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
101377811|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377812|NCT00248131|Octreotide|octreotide|mesh-list
101377813|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101377814|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101377815|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377816|NCT00248209|Bupropion|bupropion|mesh-list
101377817|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101377818|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377819|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377820|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101499048|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
101499049|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101499050|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101499055|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101499056|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101499057|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499058|NCT00600769|Clarithromycin|clarithromycin|mesh-list
101499059|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499060|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499061|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101499062|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499063|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499064|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101499065|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101499066|NCT00470210|Ribavirin|ribavirin|mesh-list
101499067|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101499068|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
101499069|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499070|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
101499071|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499072|NCT00600847|Loratadine|loratadine|mesh-list
101499073|NCT00600847|Desloratadine|desloratadine|mesh-list
101499074|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101499075|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
101499076|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499077|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499078|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499079|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101499080|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101499081|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
101499083|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
101499084|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
101499085|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101499086|NCT04325932|Kallikreins|kallikreins|mesh-list
101499087|NCT04325932|Coagulants|coagulants|mesh-ancestor
101499088|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101499089|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
101499090|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101499091|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547011|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
101499092|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101499093|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499094|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499095|NCT00501657|Incretins|incretins|mesh-ancestor
101499096|NCT00501657|Hormones|hormones|mesh-ancestor
101499097|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499098|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101499099|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
101377821|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377822|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377823|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377825|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377826|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499100|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499101|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499102|NCT00600964|Obatoclax|obatoclax|mesh-list
101499103|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499104|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499105|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101499106|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101499107|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499108|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499109|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499110|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499111|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499112|NCT00475397|Analgesics|analgesics|mesh-ancestor
101499113|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
101499114|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499115|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
101499116|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101499117|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
101499118|NCT00601042|Lobeline|lobeline|mesh-list
101499119|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101499124|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101499125|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
101499126|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499127|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499128|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
101499129|NCT00501696|Naltrexone|naltrexone|mesh-list
101499130|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101499131|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101499132|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499133|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
101499134|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499135|NCT00601276|Leuprolide|leuprolide|mesh-list
101499136|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
101499137|NCT00601276|Cyproterone|cyproterone|mesh-list
101499138|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101499139|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
101499140|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101499141|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499142|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101499143|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499144|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
101499145|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499146|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499147|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101499148|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
101499149|NCT00601315|Clarithromycin|clarithromycin|mesh-list
101499150|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499151|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499152|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101499153|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499154|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499155|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101499156|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101499157|NCT00470249|Carboplatin|carboplatin|mesh-list
101182815|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
101499158|NCT00470249|Gemcitabine|gemcitabine|mesh-list
101499159|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499160|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101377827|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101377828|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101377830|NCT00248248|Doxorubicin|doxorubicin|mesh-list
101377831|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101377832|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101377833|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377834|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101377835|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499161|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
101499162|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499163|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
101499164|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
101499165|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101499166|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101499167|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499168|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499169|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499170|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499171|NCT00601432|Levofloxacin|levofloxacin|mesh-list
101499172|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101499173|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499174|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499175|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101499176|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499177|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499178|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499179|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499180|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101499181|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101499182|NCT00475514|Frovatriptan|frovatriptan|mesh-list
101499183|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101499185|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499186|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499187|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499207|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101499208|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101499209|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499210|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499211|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101499212|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
101499213|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
101499214|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499215|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499217|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101499218|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101499219|NCT01246362|Analgesics|analgesics|mesh-ancestor
101499220|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
101499221|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499222|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499223|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499224|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499225|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101499226|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101499227|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499228|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499229|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
101182892|NCT02791308|Analgesics|analgesics|mesh-ancestor
101499230|NCT00470405|Pemetrexed|pemetrexed|mesh-list
101499231|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499232|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377836|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377837|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377838|NCT00248443|Dimercaprol|dimercaprol|mesh-list
101377839|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
101377840|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
101377841|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499233|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499234|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101499235|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101499236|NCT00601978|Levodopa|levodopa|mesh-list
101499237|NCT00601978|Carbidopa|carbidopa|mesh-list
101499238|NCT00601978|Entacapone|entacapone|mesh-list
101499239|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101499240|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101499243|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499244|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499245|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499246|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101499247|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499248|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101499249|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101499250|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
101499251|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
101499252|NCT00601159|Gemcitabine|gemcitabine|mesh-list
101499253|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499254|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499256|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499257|NCT00602017|Amlodipine|amlodipine|mesh-list
101499258|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101499259|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101499260|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499261|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499262|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101499263|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499264|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
101499265|NCT00470483|Paroxetine|paroxetine|mesh-list
101499266|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101499267|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499268|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499269|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499270|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499271|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
101499272|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499273|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101499274|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
101499275|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101499276|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101499277|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101499278|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499279|NCT00602095|Misoprostol|misoprostol|mesh-list
101499280|NCT00602095|Dinoprostone|dinoprostone|mesh-list
101499281|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101499282|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
101499283|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101499284|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499285|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101499286|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499287|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
101499288|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101499289|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101499290|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101499291|NCT00475553|Etonogestrel|etonogestrel|mesh-list
101499292|NCT00475553|Desogestrel|desogestrel|mesh-list
101499293|NCT00475553|NuvaRing|nuvaring|mesh-list
101499294|NCT00475553|Estradiol|estradiol|mesh-list
101377842|NCT00248482|Cisplatin|cisplatin|mesh-list
101377843|NCT00248482|Irinotecan|irinotecan|mesh-list
101377844|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
101377845|NCT00248482|Camptothecin|camptothecin|mesh-list
101377846|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377847|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101377848|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101377849|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499295|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101499296|NCT00475553|Estrogens|estrogens|mesh-ancestor
101499297|NCT00475553|Hormones|hormones|mesh-ancestor
101499298|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499299|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499300|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101499301|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
101499302|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101499303|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101499304|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101499305|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101499306|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101499307|NCT00475553|Progestins|progestins|mesh-ancestor
101499308|NCT01326481|Capecitabine|capecitabine|mesh-list
101499309|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499310|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
101499311|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499319|NCT00470522|Methotrexate|methotrexate|mesh-list
101499320|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101499321|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
101499322|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101499323|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499324|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499325|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
101499326|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499327|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499328|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
101499329|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499330|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101499331|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499332|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
101499333|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499334|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101499335|NCT00470522|Hematinics|hematinics|mesh-ancestor
101499336|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
101499337|NCT00470522|Vitamins|vitamins|mesh-ancestor
101499338|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
101499339|NCT01244178|Insulin|insulin|mesh-list
101499340|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101499341|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499342|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499343|NCT00470561|Aspirin|aspirin|mesh-list
101499344|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101499345|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101499346|NCT00470561|Analgesics|analgesics|mesh-ancestor
101499347|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
101499348|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499349|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499350|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499351|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499352|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101499353|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101499354|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499355|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101499356|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101499357|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499358|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
101499359|NCT00475826|Ezetimibe|ezetimibe|mesh-list
101499360|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101499361|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101499362|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
101377851|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101377852|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377853|NCT00103233|Trastuzumab|trastuzumab|mesh-list
101377854|NCT00103233|Vinorelbine|vinorelbine|mesh-list
101377855|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499363|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499364|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101499365|NCT00502437|Granisetron|granisetron|mesh-list
101499366|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
101499367|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
101499368|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499369|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499370|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499371|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101499372|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101499373|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
101499374|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499375|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499376|NCT00470678|Ranibizumab|ranibizumab|mesh-list
101499377|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101499378|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101499380|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499381|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
101499390|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499391|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101499392|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
101499393|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101499394|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101499395|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499396|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499397|NCT00470873|Urological Agents|urological agents|mesh-ancestor
101499398|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
101499399|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101499400|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499401|NCT00476099|Budesonide|budesonide|mesh-list
101499402|NCT00476099|Beclomethasone|beclomethasone|mesh-list
101499403|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
101499404|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499405|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101499406|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
101499407|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499408|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499409|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101499410|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
101499411|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
101499412|NCT00476099|Hormones|hormones|mesh-ancestor
101499413|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499414|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101499415|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101499416|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101499417|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
101499418|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499419|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499420|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
101499421|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101499422|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
101499423|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499424|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
101499425|NCT00493662|Protective Agents|protective agents|mesh-ancestor
101499426|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
101499427|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101499428|NCT00470912|Protective Agents|protective agents|mesh-ancestor
101499429|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377856|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377857|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377858|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377859|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377860|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377861|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377862|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
101377863|NCT00248716|Hematinics|hematinics|mesh-ancestor
101377864|NCT00067925|Calcium|calcium|mesh-list
101377865|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101377866|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499430|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
101499431|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101499432|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
101499433|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499434|NCT00476138|Protective Agents|protective agents|mesh-ancestor
101499435|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499436|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101499437|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101499438|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499439|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101499440|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101499441|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101499442|NCT00470990|Acyline|acyline|mesh-list
101499443|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499444|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499445|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499448|NCT00471029|Esomeprazole|esomeprazole|mesh-list
101499449|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101499455|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101499456|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
101499457|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101499458|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
101499459|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499460|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499461|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
101499463|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499464|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499465|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499466|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
101499467|NCT00493857|Antibodies|antibodies|mesh-list
101499468|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101499469|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
101499470|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499471|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499472|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499473|NCT00502788|Ribavirin|ribavirin|mesh-list
101499474|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101499475|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
101499476|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499477|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
101499478|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499479|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
101499480|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
101499481|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499482|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499483|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499484|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499485|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
101499486|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499487|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101377868|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377869|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101377870|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101377871|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
101377872|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377873|NCT00249106|Vaccines|vaccines|mesh-list
101377874|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
101377875|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377876|NCT00068042|Octreotide|octreotide|mesh-list
101499488|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499489|NCT00494208|Testosterone|testosterone|mesh-list
101499490|NCT00494208|Androgens|androgens|mesh-ancestor
101499491|NCT00494208|Hormones|hormones|mesh-ancestor
101499492|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499493|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499494|NCT00471341|Celecoxib|celecoxib|mesh-list
101499495|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101499496|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101499497|NCT00471341|Analgesics|analgesics|mesh-ancestor
101499498|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
101499499|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499500|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499501|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499502|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499503|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101499504|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101499505|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499506|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499507|NCT01325428|Vinorelbine|vinorelbine|mesh-list
101499509|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499510|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499511|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101499512|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101499513|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101499514|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499515|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101499516|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499537|NCT01324570|Buprenorphine|buprenorphine|mesh-list
101499538|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101499539|NCT01324570|Narcotics|narcotics|mesh-ancestor
101499540|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499541|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499542|NCT01324570|Analgesics|analgesics|mesh-ancestor
101499543|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
101499544|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499545|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101499546|NCT04325698|Paclitaxel|paclitaxel|mesh-list
101499547|NCT04325698|Bevacizumab|bevacizumab|mesh-list
101499548|NCT04325698|Carboplatin|carboplatin|mesh-list
101499549|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499550|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499551|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
101499552|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
101499553|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
101499554|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499555|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499556|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101499557|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101499558|NCT04325698|Growth Substances|growth substances|mesh-ancestor
101499559|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499560|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
101499561|NCT01324141|Fluorouracil|fluorouracil|mesh-list
101499562|NCT01324141|Mitomycins|mitomycins|mesh-list
101499563|NCT01324141|Mitomycin|mitomycin|mesh-list
101377878|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101377879|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377880|NCT00249145|Risperidone|risperidone|mesh-list
101377881|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101377882|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
101377883|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377884|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377885|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377886|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101377887|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377888|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377889|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377890|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101377891|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
101377892|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101499565|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
101499566|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499567|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499568|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499569|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499570|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
101499571|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499572|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101499573|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
101499574|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101499587|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499589|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499590|NCT01244217|Fexofenadine|fexofenadine|mesh-list
101499591|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101499592|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101499593|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101499594|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
101499595|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
101499596|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499597|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499598|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499599|NCT00471653|Temozolomide|temozolomide|mesh-list
101499600|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101183262|NCT02956122|Protective Agents|protective agents|mesh-ancestor
101499601|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
101499602|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499603|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499604|NCT00494559|Pioglitazone|pioglitazone|mesh-list
101499605|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499606|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499607|NCT00494598|Sufentanil|sufentanil|mesh-list
101499608|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101499609|NCT00494598|Narcotics|narcotics|mesh-ancestor
101499610|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499611|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499612|NCT00494598|Analgesics|analgesics|mesh-ancestor
101499613|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
101499614|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499615|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101377893|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101377894|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377897|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377898|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101499616|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101499617|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
101499618|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
101499619|NCT00503412|Cediranib|cediranib|mesh-list
101499620|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499621|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101499622|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499623|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499624|NCT00503451|Panobinostat|panobinostat|mesh-list
101499625|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499626|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101499627|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499628|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499629|NCT00471809|Azithromycin|azithromycin|mesh-list
101499630|NCT00471809|Budesonide|budesonide|mesh-list
101499631|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101499632|NCT00471809|Montelukast|montelukast|mesh-list
101499633|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499634|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101499650|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499652|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499653|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101499654|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101499655|NCT00503490|Levofloxacin|levofloxacin|mesh-list
101499656|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101499657|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499658|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499659|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101499660|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499661|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499662|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499664|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101499665|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101499666|NCT00471965|Leucovorin|leucovorin|mesh-list
101499667|NCT00471965|Doxorubicin|doxorubicin|mesh-list
101499668|NCT00471965|Fluorouracil|fluorouracil|mesh-list
101499669|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
101499670|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101499671|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499672|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101499673|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499674|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528437|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499675|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499676|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
101499677|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499678|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499679|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
101499680|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499681|NCT00471965|Antidotes|antidotes|mesh-ancestor
101499682|NCT00471965|Protective Agents|protective agents|mesh-ancestor
101499683|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
101499684|NCT00471965|Vitamins|vitamins|mesh-ancestor
101499685|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
101499686|NCT00472004|Tibolone|tibolone|mesh-list
101499687|NCT00472004|Estradiol|estradiol|mesh-list
101499688|NCT00472004|Estrogens|estrogens|mesh-ancestor
101499689|NCT00472004|Hormones|hormones|mesh-ancestor
101499690|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499691|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499711|NCT03271073|Apatinib|apatinib|mesh-list
101377899|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101377900|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377901|NCT00068081|Capsaicin|capsaicin|mesh-list
101377902|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
101377903|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101377904|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
101377905|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499712|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499713|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101499714|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499715|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499716|NCT01246557|Dexamethasone|dexamethasone|mesh-list
101499717|NCT01246557|Lenalidomide|lenalidomide|mesh-list
101499718|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499719|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
101499720|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
101499721|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499722|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499723|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499724|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
101499725|NCT01246557|Hormones|hormones|mesh-ancestor
101499726|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499727|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101499728|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499729|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
101499730|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101499731|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101499732|NCT01246557|Growth Substances|growth substances|mesh-ancestor
101499733|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
101499734|NCT00476918|Triamcinolone|triamcinolone|mesh-list
101499735|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101499736|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101499737|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101499738|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499739|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
101499740|NCT00476918|Hormones|hormones|mesh-ancestor
101499741|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499742|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499743|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499744|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
101499745|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499753|NCT00477035|Melphalan|melphalan|mesh-list
101499754|NCT00477035|Carmustine|carmustine|mesh-list
101499755|NCT00477035|Gemcitabine|gemcitabine|mesh-list
101499756|NCT00477035|Etoposide|etoposide|mesh-list
101499757|NCT00477035|Vinorelbine|vinorelbine|mesh-list
101499758|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499759|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
101499760|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499761|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101499762|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101499763|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
101499764|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499765|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499766|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101499767|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499768|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
101499769|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499770|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101499771|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101499772|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499773|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
101499774|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
101499775|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
101499776|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
101499777|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101499778|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499779|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377906|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377908|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101377909|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
101377910|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377911|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377912|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377913|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101499780|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101499781|NCT00494832|Analgesics|analgesics|mesh-ancestor
101499782|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
101499783|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499784|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101499785|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101499786|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101499787|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
101499788|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499789|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499790|NCT00477074|Dimercaprol|dimercaprol|mesh-list
101499791|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
101499792|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
101499793|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499794|NCT01323673|Clobetasol|clobetasol|mesh-list
101499795|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499796|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
101499797|NCT01323673|Hormones|hormones|mesh-ancestor
101499798|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499799|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499800|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101499801|NCT01246752|Cytarabine|cytarabine|mesh-list
101499802|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499803|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
101499804|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499805|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499806|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
101499807|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499808|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101499809|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
101499810|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499811|NCT01323634|Fluticasone|fluticasone|mesh-list
101499824|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101499825|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101499826|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101499827|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499828|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499830|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
101499831|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
101499832|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499833|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499834|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
101499835|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499836|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101499837|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101499838|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101499839|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499840|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499841|NCT00494988|Insulin|insulin|mesh-list
101499842|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101499843|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
101499844|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
101499845|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
101499846|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
101499847|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499848|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499849|NCT01323478|Vortioxetine|vortioxetine|mesh-list
101377914|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101377915|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377916|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377917|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101377918|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
101377919|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101377920|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101377921|NCT02967224|Insulin|insulin|mesh-list
101377922|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101499850|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
101499851|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101499852|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101499854|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499855|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499856|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101499857|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499858|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499859|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499860|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499861|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
101499862|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101499863|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101499864|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101499865|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101499866|NCT00472355|Apomorphine|apomorphine|mesh-list
101499867|NCT00472355|Emetics|emetics|mesh-ancestor
101499868|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499869|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
101499870|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499871|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499872|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
101499873|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
101499874|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499889|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499891|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101499892|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499893|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
101499894|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499895|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499896|NCT00472472|Paclitaxel|paclitaxel|mesh-list
101499897|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101499898|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499899|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101499900|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101499901|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
101499902|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499903|NCT00503568|Vaccines|vaccines|mesh-list
101499904|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
101499905|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499906|NCT00472550|Esomeprazole|esomeprazole|mesh-list
101499907|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101499908|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499909|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101499910|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499911|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499912|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101499913|NCT00503607|Laxatives|laxatives|mesh-ancestor
101499914|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499915|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
101499916|NCT00477503|Gallium citrate|gallium citrate|mesh-list
101499917|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
101499918|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
101499919|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499920|NCT00477503|Antidotes|antidotes|mesh-ancestor
101499921|NCT00477503|Protective Agents|protective agents|mesh-ancestor
101377923|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
101377924|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
101377925|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
101377926|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
101377927|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
101377928|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377929|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377930|NCT00099918|Vildagliptin|vildagliptin|mesh-list
101499922|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499923|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101499924|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101499925|NCT01244334|Prednisolone|prednisolone|mesh-list
101499926|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101499927|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
101499928|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101499929|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
101499930|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101499931|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
101499932|NCT01244334|Difluprednate|difluprednate|mesh-list
101499933|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499934|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
101499935|NCT01244334|Hormones|hormones|mesh-ancestor
101499969|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499970|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101499971|NCT00477737|Propofol|propofol|mesh-list
101499972|NCT00477737|Sevoflurane|sevoflurane|mesh-list
101499973|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101499974|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101499989|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
101547091|NCT02271113|Enoxaparin|enoxaparin|mesh-list
101499990|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499991|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499992|NCT00477815|Rituximab|rituximab|mesh-list
101499993|NCT00477815|Melphalan|melphalan|mesh-list
101499994|NCT00477815|Sargramostim|sargramostim|mesh-list
101499995|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101499996|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101499997|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499998|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
101499999|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500000|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500001|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101500002|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
101500003|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500004|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101500005|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500006|NCT00477854|Chromium|chromium|mesh-list
101500007|NCT00477854|Picolinic acid|picolinic acid|mesh-list
101500008|NCT00477854|Trace Elements|trace elements|mesh-ancestor
101500009|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
101500010|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500011|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101500012|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
101500013|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
101500014|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500015|NCT00477893|Adalimumab|adalimumab|mesh-list
101500016|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101500017|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500018|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500019|NCT01247337|Gemcitabine|gemcitabine|mesh-list
101500020|NCT01247337|Capecitabine|capecitabine|mesh-list
101500021|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
101500022|NCT01247337|Cetuximab|cetuximab|mesh-list
101500023|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500024|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
101500025|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500026|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500027|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500028|NCT00478049|Docetaxel|docetaxel|mesh-list
101500029|NCT00478049|Gefitinib|gefitinib|mesh-list
101500030|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500031|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
101377931|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377932|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377933|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101377934|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
101377935|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377936|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377937|NCT00249574|Buprenorphine|buprenorphine|mesh-list
101377938|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101500032|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500033|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500034|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500035|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500036|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500041|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
101500042|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500043|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500044|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101547114|NCT00595569|Insulin|insulin|mesh-list
101500045|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101500046|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500047|NCT02955927|Atropine|atropine|mesh-list
101500048|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101500049|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101500050|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101500051|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101500052|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101500053|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
101500054|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500055|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500056|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500058|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
101500059|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
101500060|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101500061|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101500062|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500063|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500064|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500065|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
101500066|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101500067|NCT01247493|Cytarabine|cytarabine|mesh-list
101500068|NCT01247493|Fludarabine|fludarabine|mesh-list
101500069|NCT01247493|Idarubicin|idarubicin|mesh-list
101500070|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500071|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500072|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
101500073|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500074|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500075|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
101500076|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500077|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
101500078|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500079|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101500080|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101500081|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101500082|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500083|NCT04325425|Carboplatin|carboplatin|mesh-list
101500084|NCT04325425|Etoposide|etoposide|mesh-list
101500085|NCT04325425|Folfirinox|folfirinox|mesh-list
101500086|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500087|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101500088|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101500089|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101500090|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500091|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500092|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
101377940|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101377941|NCT00249574|Narcotics|narcotics|mesh-ancestor
101377942|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101377943|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377944|NCT00249574|Analgesics|analgesics|mesh-ancestor
101377945|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
101377946|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101377947|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101377948|NCT00249691|Topiramate|topiramate|mesh-list
101500093|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500094|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500095|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500096|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500098|NCT00478517|Hematinics|hematinics|mesh-ancestor
101500099|NCT01321879|Telavancin|telavancin|mesh-list
101500100|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500101|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500102|NCT01321723|Teriparatide|teriparatide|mesh-list
101500103|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101500104|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500105|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101500106|NCT00478634|Irinotecan|irinotecan|mesh-list
101500107|NCT00478634|Cetuximab|cetuximab|mesh-list
101500108|NCT00478634|Everolimus|everolimus|mesh-list
101500134|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101500135|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500136|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500137|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101500138|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
101500140|NCT00478907|Analgesics|analgesics|mesh-ancestor
101500141|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
101500142|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500143|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101500144|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101500145|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101500146|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500147|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500148|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
101500149|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
101500150|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
101500151|NCT00478946|Leucovorin|leucovorin|mesh-list
101500152|NCT00478946|Antidotes|antidotes|mesh-ancestor
101500153|NCT00478946|Protective Agents|protective agents|mesh-ancestor
101500154|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500155|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
101500156|NCT00478946|Vitamins|vitamins|mesh-ancestor
101500161|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500162|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
101500163|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
101500164|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500165|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500166|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101500167|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
101500168|NCT01247961|Hormones|hormones|mesh-ancestor
101500169|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500170|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101500171|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500172|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
101500173|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500174|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500175|NCT01248078|Cephalexin|cephalexin|mesh-list
101500176|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500177|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500178|NCT00472823|Vitamin D|vitamin d|mesh-list
101377950|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101377951|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377952|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
101377953|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
101377954|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101377955|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101377956|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377957|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377958|NCT00249730|Urological Agents|urological agents|mesh-ancestor
101500179|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
101500180|NCT00472823|Calcium|calcium|mesh-list
101500181|NCT00472823|Vitamins|vitamins|mesh-ancestor
101500182|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
101500183|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500184|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101500185|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101500186|NCT02275416|Ipilimumab|ipilimumab|mesh-list
101500187|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500188|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500189|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101500190|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500191|NCT00472901|Afamelanotide|afamelanotide|mesh-list
101500192|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
101500193|NCT02483247|Paclitaxel|paclitaxel|mesh-list
101500194|NCT02483247|Doxorubicin|doxorubicin|mesh-list
101500195|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
101500196|NCT02483247|Capecitabine|capecitabine|mesh-list
101500197|NCT02483247|Nivolumab|nivolumab|mesh-list
101500198|NCT02483247|Sunitinib|sunitinib|mesh-list
101500199|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101500200|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500201|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
101500202|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500203|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528438|NCT04657107|Ketamine|ketamine|mesh-list
101500204|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500205|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101500206|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101500207|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101500208|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500209|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500210|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101500211|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500212|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
101500213|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500214|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500215|NCT02483247|Growth Substances|growth substances|mesh-ancestor
101500216|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500217|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500218|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500219|NCT02482233|Nicotine|nicotine|mesh-list
101500220|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101500221|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
101500222|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500223|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500224|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101500225|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101500226|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500227|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500228|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500229|NCT01248117|Ranibizumab|ranibizumab|mesh-list
101500231|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500232|NCT01248117|Growth Substances|growth substances|mesh-ancestor
101500233|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500234|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500235|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377960|NCT00249847|Estrogens|estrogens|mesh-list
101377961|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101377962|NCT00249847|Hormones|hormones|mesh-ancestor
101377963|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101377964|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377965|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101377966|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377967|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377968|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377969|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101377970|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
101500236|NCT01248234|Propofol|propofol|mesh-list
101500237|NCT01248234|Etomidate|etomidate|mesh-list
101500238|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101500239|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500240|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500241|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101500242|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
101500243|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
101500244|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
101500245|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
101500246|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500247|NCT00473174|Ramipril|ramipril|mesh-list
101500248|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101500249|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
101500250|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500251|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500252|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101500253|NCT00473213|Interferons|interferons|mesh-list
101500254|NCT00473213|Interferon-beta|interferon-beta|mesh-list
101500255|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500256|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
101500257|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500258|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
101500259|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500260|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
101500261|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101500262|NCT01319383|Vorinostat|vorinostat|mesh-list
101500263|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500264|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101500265|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500266|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500267|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
101500268|NCT05645029|Methamphetamine|methamphetamine|mesh-list
101500269|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
101500270|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101500271|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500272|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
101500273|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
101500274|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101500275|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500276|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
101500277|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
101500278|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500279|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
101500280|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500281|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500282|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500283|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101500284|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377971|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101377972|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377973|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377974|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101377975|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101377976|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101377977|NCT00249886|Citalopram|citalopram|mesh-list
101377978|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101377979|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101377980|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101377981|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500285|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500286|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101500287|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
101500288|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101500289|NCT05645029|Protective Agents|protective agents|mesh-ancestor
101500290|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101500292|NCT00479609|Androgens|androgens|mesh-ancestor
101500293|NCT00479609|Hormones|hormones|mesh-ancestor
101500294|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500295|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500296|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
101500297|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500298|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
101500299|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500300|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500301|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
101500302|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500303|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
101500304|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101500308|NCT02891161|Durvalumab|durvalumab|mesh-list
101500309|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500310|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500311|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
101500312|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500313|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500314|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500315|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500316|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
101500317|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101500318|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500319|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500320|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500321|NCT02955732|Analgesics|analgesics|mesh-ancestor
101500322|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
101500323|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500324|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101500325|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101500326|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500327|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500328|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500329|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500330|NCT01315678|Tobramycin|tobramycin|mesh-list
101500331|NCT01315678|Amikacin|amikacin|mesh-list
101500332|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500333|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500334|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101500335|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
101500336|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500337|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
101377983|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
101377984|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101377985|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101377986|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
101377987|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101377989|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101377990|NCT00249964|Carboplatin|carboplatin|mesh-list
101377991|NCT00249964|Temozolomide|temozolomide|mesh-list
101500338|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500339|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101500340|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101500341|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101500342|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500343|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500344|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500345|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500346|NCT00479726|Analgesics|analgesics|mesh-ancestor
101500347|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
101500348|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500349|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
101500350|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101500351|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
101500352|NCT01315249|Fluticasone|fluticasone|mesh-list
101500354|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
101500355|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101500356|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101500357|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500358|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101500359|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
101500360|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500361|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500362|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500363|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500364|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
101500365|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101500366|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101500367|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101500368|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500369|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500370|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500371|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500372|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101500373|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101500374|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101500388|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101500389|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101500390|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101500391|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500392|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500393|NCT00473486|Carboplatin|carboplatin|mesh-list
101500394|NCT00473486|Pemetrexed|pemetrexed|mesh-list
101500395|NCT00473486|Sorafenib|sorafenib|mesh-list
101500396|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500397|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500398|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500399|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101500400|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101500401|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500402|NCT05644483|Propofol|propofol|mesh-list
101377992|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101377993|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101377995|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
101377996|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
101377997|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101377998|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101377999|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
101378000|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
101378001|NCT00068276|Vitamin D|vitamin d|mesh-list
101378002|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101378003|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378004|NCT00068276|Vitamins|vitamins|mesh-ancestor
101378005|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
101378007|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
101378050|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378051|NCT00103545|Abagovomab|abagovomab|mesh-list
101378052|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101378053|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378054|NCT00068432|Celecoxib|celecoxib|mesh-list
101378055|NCT00068432|Gemcitabine|gemcitabine|mesh-list
101378056|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378057|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
101378058|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378059|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378060|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101378061|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101378062|NCT00068432|Analgesics|analgesics|mesh-ancestor
101378063|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
101378064|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378065|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378066|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101378067|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378068|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101378069|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101378070|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378071|NCT00250237|Haloperidol|haloperidol|mesh-list
101378102|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101378103|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
101378107|NCT00068471|Anidulafungin|anidulafungin|mesh-list
101378175|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378176|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101378177|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101378247|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378249|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
101378250|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378316|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378317|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
101378318|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378319|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378320|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101378322|NCT00068861|Metformin|metformin|mesh-list
101378386|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101378387|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101378401|NCT00251914|Esomeprazole|esomeprazole|mesh-list
101378458|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378459|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378460|NCT04719715|Antibodies|antibodies|mesh-list
101378461|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
101378462|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378474|NCT00252343|Amibegron|amibegron|mesh-list
101378526|NCT00252928|Troclosene|troclosene|mesh-list
101378527|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
101378528|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101378529|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
101378530|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
101378531|NCT00253123|Risperidone|risperidone|mesh-list
101378532|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101378533|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
101378534|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378535|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378536|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378537|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101378538|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378539|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378541|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101378542|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
101378543|NCT00253162|Risperidone|risperidone|mesh-list
101378544|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101378545|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
101378546|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378547|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378548|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378549|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101378550|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101378551|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101378552|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378553|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101378554|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
101378555|NCT00253201|Galantamine|galantamine|mesh-list
101378556|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101500403|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101500404|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500405|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500406|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101500407|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
101500408|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
101500409|NCT01248819|Ropivacaine|ropivacaine|mesh-list
101500410|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500411|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
101500412|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500413|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500414|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
101500415|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500416|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
101378557|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378558|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378559|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
101378560|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378561|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378562|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101378563|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
101378564|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378565|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
101378567|NCT00253318|Docetaxel|docetaxel|mesh-list
101378568|NCT00253318|Everolimus|everolimus|mesh-list
101378569|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101378570|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
101378571|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
101378572|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378573|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378574|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101378575|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
101378576|NCT00253318|Hormones|hormones|mesh-ancestor
101378577|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101378578|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378579|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378580|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
101378581|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
101378582|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
101378583|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378584|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101378585|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378586|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378587|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378588|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
101378598|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
101378599|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101378600|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101378601|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101378668|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101378742|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101378743|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101378744|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
101378745|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101378814|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101378815|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101378816|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
101378817|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
101378818|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378819|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378820|NCT00069875|Gemcitabine|gemcitabine|mesh-list
101378821|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378822|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101378823|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
101378824|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378825|NCT00255268|Goserelin|goserelin|mesh-list
101378826|NCT00255268|Bicalutamide|bicalutamide|mesh-list
101378827|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101378874|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101378875|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101378876|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
101378877|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101378878|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101378880|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101378881|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378882|NCT00255658|Sirolimus|sirolimus|mesh-list
101378883|NCT00255658|Sorafenib|sorafenib|mesh-list
101378884|NCT00255658|Temsirolimus|temsirolimus|mesh-list
101378885|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
101378886|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101378887|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101378888|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101378890|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101378936|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101378937|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101378938|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101378939|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101378940|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
101378941|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
101378942|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101378943|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101378944|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101378945|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101378946|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101379000|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
101379001|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379002|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101379003|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
101379004|NCT00256009|Misoprostol|misoprostol|mesh-list
101379005|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101379006|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
101379007|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101379008|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379009|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101379010|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379060|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101379061|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
101379062|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379132|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379133|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101379134|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101379135|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101379143|NCT00070538|Cytarabine|cytarabine|mesh-list
101379198|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379199|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101379200|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101379271|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101379272|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379343|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101379344|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379345|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101379346|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379414|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101379416|NCT00423761|Midazolam|midazolam|mesh-list
101379490|NCT00415402|Vitamin D|vitamin d|mesh-list
101379491|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
101379492|NCT00415402|Vitamins|vitamins|mesh-ancestor
101379493|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
101379494|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379495|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101379497|NCT00259402|Fluorouracil|fluorouracil|mesh-list
101379555|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379556|NCT00259792|Budesonide|budesonide|mesh-list
101379557|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
101379628|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101379629|NCT00260260|Narcotics|narcotics|mesh-ancestor
101379702|NCT00071942|Vaccines|vaccines|mesh-list
101379703|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
101379704|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379705|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379775|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101379777|NCT00072059|Hematinics|hematinics|mesh-ancestor
101379778|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
101379779|NCT00261820|Sirolimus|sirolimus|mesh-list
101379780|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
101379781|NCT00261820|Prednisolone|prednisolone|mesh-list
101379782|NCT00261820|Tacrolimus|tacrolimus|mesh-list
101379783|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101379784|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
101379785|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101379786|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101379787|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101379788|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101379789|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101379790|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379791|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101379792|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
101379793|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101379797|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
101379833|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
101379834|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101379835|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101379836|NCT00072137|Metronidazole|metronidazole|mesh-list
101379837|NCT00072137|Molgramostim|molgramostim|mesh-list
101379838|NCT00072137|Vaccines|vaccines|mesh-list
101379839|NCT00072137|Sargramostim|sargramostim|mesh-list
101379840|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101379841|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
101379901|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101379902|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101379904|NCT00262327|Growth Substances|growth substances|mesh-ancestor
101379974|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
101379975|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380047|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380121|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101380122|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380123|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
101380124|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380125|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380126|NCT00072722|Pomalidomide|pomalidomide|mesh-list
101380127|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
101380128|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380129|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101380130|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101380134|NCT00264355|Cyclosporine|cyclosporine|mesh-list
101380185|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101380186|NCT00265135|Siltuximab|siltuximab|mesh-list
101380256|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
101380257|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101380258|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101380328|NCT00266539|Morphine|morphine|mesh-list
101380329|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101380330|NCT00266539|Narcotics|narcotics|mesh-ancestor
101380331|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380332|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380333|NCT00266539|Analgesics|analgesics|mesh-ancestor
101380334|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
101380399|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380400|NCT00267553|Toremifene|toremifene|mesh-list
101380401|NCT00267553|Letrozole|letrozole|mesh-list
101380402|NCT00267553|Atamestane|atamestane|mesh-list
101380403|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380468|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101380469|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101380470|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380471|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380472|NCT00268177|Fluticasone|fluticasone|mesh-list
101380473|NCT00268177|Xhance|xhance|mesh-list
101380474|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101380475|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380476|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380477|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
101380478|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380479|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380480|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380481|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
101380482|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380483|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101380484|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101380485|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101380486|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101380487|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
101380488|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380489|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380520|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101380521|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
101380522|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380523|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380524|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380525|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101380526|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101380527|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101380528|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380529|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101380530|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
101380531|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101380532|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101380533|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101380578|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
101380579|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380580|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101380581|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101380582|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
101380583|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101380584|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
101380585|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380586|NCT00268372|Docetaxel|docetaxel|mesh-list
101380587|NCT00268372|Fluorouracil|fluorouracil|mesh-list
101380642|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101380643|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101380644|NCT00073814|Albuterol|albuterol|mesh-list
101380645|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380646|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
101380647|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380648|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380649|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380708|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
101380709|NCT00073931|Sargramostim|sargramostim|mesh-list
101380710|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
101380711|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380712|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380713|NCT00268723|Albuterol|albuterol|mesh-list
101380714|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101380715|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
101380716|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380717|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380718|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101380772|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101380773|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380774|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101380775|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101380776|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380777|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380778|NCT00269035|Risperidone|risperidone|mesh-list
101380779|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101380780|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
101380781|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380782|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380783|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380784|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101380785|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101380787|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101380832|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101380833|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101380834|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101380835|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101380836|NCT00074204|Carboplatin|carboplatin|mesh-list
101380837|NCT00074204|Gemcitabine|gemcitabine|mesh-list
101380838|NCT00074204|Docetaxel|docetaxel|mesh-list
101380839|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380840|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101380841|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
101380842|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101380843|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101380893|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101380894|NCT00269854|Infliximab|infliximab|mesh-list
101380895|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101380896|NCT00269854|Antibodies|antibodies|mesh-list
101380897|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
101380898|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101380899|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
101380900|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101380901|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101380902|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101380903|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101380904|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
101380907|NCT00269893|Abciximab|abciximab|mesh-list
101380957|NCT00270049|Hematinics|hematinics|mesh-ancestor
101380958|NCT00107016|Letrozole|letrozole|mesh-list
101380959|NCT00107016|Everolimus|everolimus|mesh-list
101381032|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381033|NCT00270556|Tenofovir|tenofovir|mesh-list
101381034|NCT00270556|Abacavir|abacavir|mesh-list
101381035|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
101381036|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381037|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101381038|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101381039|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381040|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381041|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101381042|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101381043|NCT00074438|Rituximab|rituximab|mesh-list
101381044|NCT00074438|Methotrexate|methotrexate|mesh-list
101381045|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101381046|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381054|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
101381092|NCT00107523|Pravastatin|pravastatin|mesh-list
101381093|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381094|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
101381095|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381097|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
101381161|NCT00271414|Analgesics|analgesics|mesh-ancestor
101381162|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
101381163|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381164|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101381165|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101381235|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381236|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101381237|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
101381238|NCT00272701|Esomeprazole|esomeprazole|mesh-list
101381239|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101381240|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101381303|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101381376|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101381377|NCT00273520|Telithromycin|telithromycin|mesh-list
101381378|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101381379|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381380|NCT00273559|Prednisone|prednisone|mesh-list
101381381|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101381382|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
101381383|NCT00273559|Hormones|hormones|mesh-ancestor
101381385|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381386|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381387|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381388|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101381438|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381439|NCT00274066|Fenoterol|fenoterol|mesh-list
101381440|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
101381441|NCT00274066|Ipratropium|ipratropium|mesh-list
101381509|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381510|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
101381511|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101381512|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101381513|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381514|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
101381515|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101381516|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381517|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
101381573|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381574|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101381575|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381576|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381643|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381644|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381714|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101381715|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381716|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
101381717|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101381718|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101381719|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101381720|NCT00075491|Fenretinide|fenretinide|mesh-list
101381721|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381722|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101381723|NCT00075491|Protective Agents|protective agents|mesh-ancestor
101381724|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381725|NCT00108615|Metformin|metformin|mesh-list
101381726|NCT00108615|Pioglitazone|pioglitazone|mesh-list
101381727|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101381728|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381729|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
101381730|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101381731|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
101381732|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101381733|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381734|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101381735|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381766|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101381767|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
101381768|NCT00278278|Prednisone|prednisone|mesh-list
101381769|NCT00278278|Methotrexate|methotrexate|mesh-list
101381770|NCT00278278|Etoposide|etoposide|mesh-list
101381771|NCT00278278|Vincristine|vincristine|mesh-list
101381772|NCT00278278|Ifosfamide|ifosfamide|mesh-list
101381773|NCT00278278|Lomustine|lomustine|mesh-list
101381774|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381775|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101381776|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
101381777|NCT00278278|Hormones|hormones|mesh-ancestor
101381778|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101381779|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101381780|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101381781|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101381782|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
101381783|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101381784|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101381786|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101381787|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
101381788|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101381789|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101381790|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101381791|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
101381792|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101381793|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101381794|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101381795|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101381796|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101381797|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101381798|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101381799|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500417|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101500418|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101500419|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101500420|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500421|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500422|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
101381800|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101381801|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
101381802|NCT00108771|Fentanyl|fentanyl|mesh-list
101381803|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101381871|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101381873|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101381877|NCT00109044|Escitalopram|escitalopram|mesh-list
101381941|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
101381942|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
101381943|NCT00075998|Interferons|interferons|mesh-list
101381944|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
101381945|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101381946|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
101381948|NCT00109161|Antibodies|antibodies|mesh-list
101382011|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382012|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101382013|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101382017|NCT00280033|Antacids|antacids|mesh-ancestor
101382082|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382083|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
101382154|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101382155|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
101382156|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382157|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101382158|NCT00281125|Pemetrexed|pemetrexed|mesh-list
101382160|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382224|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
101382225|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382226|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382227|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382234|NCT00416962|Analgesics|analgesics|mesh-ancestor
101382295|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101382296|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382297|NCT00076544|Ziconotide|ziconotide|mesh-list
101382298|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101382299|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382300|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382301|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382302|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382303|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101382304|NCT00076544|Protective Agents|protective agents|mesh-ancestor
101382305|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101382306|NCT00076544|Analgesics|analgesics|mesh-ancestor
101382307|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
101382308|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101382309|NCT00281788|Paclitaxel|paclitaxel|mesh-list
101382310|NCT00281788|Carboplatin|carboplatin|mesh-list
101382311|NCT00281788|Capecitabine|capecitabine|mesh-list
101382312|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101382313|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382314|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382315|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382316|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382317|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382318|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382345|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101382346|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382347|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101382348|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382349|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382350|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382351|NCT00110058|Interferons|interferons|mesh-list
101382352|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
101382353|NCT00110058|Cyclosporine|cyclosporine|mesh-list
101382354|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
101382355|NCT00110058|Fludarabine|fludarabine|mesh-list
101382358|NCT00110058|Cyclosporins|cyclosporins|mesh-list
101382414|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382415|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101382416|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101382417|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101382418|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
101382419|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101382420|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382421|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
101382422|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
101382423|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101382424|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101382425|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101382426|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
101382427|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101382428|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101382471|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101382472|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101382473|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101382474|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547261|NCT00596037|Hormones|hormones|mesh-list
101382538|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382539|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101382540|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101382607|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101382609|NCT00283621|Hematinics|hematinics|mesh-ancestor
101382681|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101382682|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382683|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
101382684|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
101382685|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
101382687|NCT00077168|Tamoxifen|tamoxifen|mesh-list
101382749|NCT00284947|Protective Agents|protective agents|mesh-ancestor
101382822|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382824|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
101382825|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382826|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101382827|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101382828|NCT00077363|Capecitabine|capecitabine|mesh-list
101382829|NCT00077363|Tipifarnib|tipifarnib|mesh-list
101382830|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101382831|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
101382832|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382833|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382883|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101382884|NCT00077441|Bortezomib|bortezomib|mesh-list
101382885|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101382886|NCT00285883|Saquinavir|saquinavir|mesh-list
101382954|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101382955|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101383027|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101383028|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101383101|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383102|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101383103|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
101383113|NCT00287170|Calcitriol|calcitriol|mesh-list
101383171|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383172|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383173|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383174|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
101383175|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383176|NCT00287326|Clonidine|clonidine|mesh-list
101383177|NCT00287326|Morphine|morphine|mesh-list
101383178|NCT00287326|Bupivacaine|bupivacaine|mesh-list
101383179|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
101383180|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
101383181|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383182|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383197|NCT00287443|Hormones|hormones|mesh-list
101383234|NCT00287794|Diazepam|diazepam|mesh-list
101383235|NCT00287794|Melatonin|melatonin|mesh-list
101383236|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
101383237|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383238|NCT00287794|Protective Agents|protective agents|mesh-ancestor
101383239|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383240|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101383241|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101383242|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
101383243|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
101383244|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
101383245|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101383246|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101383247|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101383248|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101383249|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101383250|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101383251|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101383252|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383253|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101383254|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
101383255|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
101383256|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
101383257|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
101383289|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383290|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101383361|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101383362|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101383434|NCT00401661|Alfuzosin|alfuzosin|mesh-list
101383435|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101383436|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101383437|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101383438|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101383439|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383440|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383441|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383442|NCT00401661|Urological Agents|urological agents|mesh-ancestor
101383443|NCT00289861|Risperidone|risperidone|mesh-list
101383444|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101383445|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
101383446|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101383447|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383448|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383449|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101383450|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101383452|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101383490|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101383492|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383493|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383494|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383495|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101383496|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101383497|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
101383498|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101383499|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101383500|NCT00290602|Prednisolone|prednisolone|mesh-list
101383501|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
101383554|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101383555|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101383556|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101383558|NCT02960815|Imiquimod|imiquimod|mesh-list
101383567|NCT00290719|Irinotecan|irinotecan|mesh-list
101383625|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
101383637|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
101383699|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
101383700|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
101383701|NCT00112515|Modafinil|modafinil|mesh-list
101383773|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101383775|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
101383846|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383849|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
101383922|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
101383923|NCT00130195|Daunorubicin|daunorubicin|mesh-list
101383924|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101383994|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101383995|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101383996|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
101383997|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
101383998|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101383999|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101384000|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384001|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101384002|NCT00079157|Sargramostim|sargramostim|mesh-list
101384003|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
101384004|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
101384059|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101384060|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101384061|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101384062|NCT00129727|Growth Substances|growth substances|mesh-ancestor
101384063|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384064|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384065|NCT00129688|Amikacin|amikacin|mesh-list
101384066|NCT00129688|Cloxacillin|cloxacillin|mesh-list
101384067|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384068|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384069|NCT00079352|Gemcitabine|gemcitabine|mesh-list
101384070|NCT00079352|Irinotecan|irinotecan|mesh-list
101384071|NCT00079352|Alvocidib|alvocidib|mesh-list
101384123|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384124|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
101384125|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
101384126|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384127|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101384128|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384129|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101384130|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101384131|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101384132|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
101384133|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384135|NCT00079430|Bevacizumab|bevacizumab|mesh-list
101384187|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
101384188|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384189|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384190|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101384191|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101384192|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384193|NCT00298675|Irinotecan|irinotecan|mesh-list
101384194|NCT00298675|Iniparib|iniparib|mesh-list
101384195|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101384196|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101384197|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384198|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384199|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384200|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101384201|NCT00298714|Losartan|losartan|mesh-list
101384202|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101384203|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101384204|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101384205|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101384206|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384207|NCT00079508|Bivalirudin|bivalirudin|mesh-list
101384208|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
101384209|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101384210|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
101384211|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384212|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384213|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
101384214|NCT00298870|Isoniazid|isoniazid|mesh-list
101384223|NCT00298909|Niacin|niacin|mesh-list
101384233|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
101384234|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384306|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384307|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
101384308|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
101384309|NCT00299650|Cisatracurium|cisatracurium|mesh-list
101384310|NCT00299650|Atracurium|atracurium|mesh-list
101384311|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101384312|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101384313|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384314|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384315|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101384316|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101384317|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101384318|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
101384319|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384320|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384321|NCT04727853|Irinotecan|irinotecan|mesh-list
101384364|NCT00299923|Amantadine|amantadine|mesh-list
101384365|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
101384366|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384367|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
101384368|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384369|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101384370|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101384371|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
101384372|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101384373|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384374|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101384376|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
101384378|NCT00299962|Interferons|interferons|mesh-list
101384426|NCT00300118|Budesonide|budesonide|mesh-list
101384427|NCT00300118|Mesalamine|mesalamine|mesh-list
101384428|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101384429|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101384430|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
101384431|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101384435|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
101384495|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384496|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384565|NCT00300937|Vitamins|vitamins|mesh-ancestor
101384566|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
101384567|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101384568|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
101384569|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384570|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384571|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101384572|NCT00418249|Protective Agents|protective agents|mesh-ancestor
101384573|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101384574|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101384575|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101384576|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384579|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
101384625|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101384626|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
101384627|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101384628|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101384629|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101384630|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101384631|NCT00301405|Thalidomide|thalidomide|mesh-list
101384632|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384633|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
101384634|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384635|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
101384636|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384637|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101384638|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101384639|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101384640|NCT00301405|Growth Substances|growth substances|mesh-ancestor
101384641|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101384642|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384643|NCT00301483|Chrysarobin|chrysarobin|mesh-list
101384684|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101384686|NCT00080444|Hormones|hormones|mesh-ancestor
101384687|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101384688|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101384689|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500423|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500424|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500425|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101500426|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500428|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500429|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500430|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500431|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500432|NCT01313728|Dapsone|dapsone|mesh-list
101500433|NCT01313728|Tretinoin|tretinoin|mesh-list
101500434|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500435|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
101500436|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
101500437|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500440|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101500441|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101500442|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500443|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500444|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
101500445|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500446|NCT00481364|Atorvastatin|atorvastatin|mesh-list
101500447|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101500448|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101500449|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
101500450|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500451|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101500452|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101500453|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500454|NCT00481442|Phenylephrine|phenylephrine|mesh-list
101500455|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
101500456|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101500457|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
101500458|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
101500459|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500460|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500461|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
101500462|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101500463|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
101500464|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500465|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101500466|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101500467|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500468|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500469|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500470|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500471|NCT00481442|Protective Agents|protective agents|mesh-ancestor
101500472|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
101500473|NCT04697537|Ropivacaine|ropivacaine|mesh-list
101500474|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
101500475|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500476|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500477|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101500478|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500479|NCT04697537|Analgesics|analgesics|mesh-ancestor
101500480|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
101500481|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500482|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101500483|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101500484|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500485|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500486|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500487|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384690|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
101384763|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101384764|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101384765|NCT00086892|Carboplatin|carboplatin|mesh-list
101384766|NCT00086892|Cetuximab|cetuximab|mesh-list
101384767|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101384834|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101384835|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101384836|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
101384840|NCT00201955|Rebamipide|rebamipide|mesh-list
101384904|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
101384905|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384906|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101384908|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101384976|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101384977|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101384978|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101385051|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385052|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101385053|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
101385120|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385122|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101385123|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
101385147|NCT00302536|Tacrolimus|tacrolimus|mesh-list
101385197|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385198|NCT00418288|Incretins|incretins|mesh-ancestor
101385199|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101385200|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500488|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500489|NCT00481481|Tacrolimus|tacrolimus|mesh-list
101500490|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500491|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
101500492|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500493|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101500494|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500495|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500497|NCT04516317|Quinine|quinine|mesh-list
101500498|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
101500499|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101500500|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101184162|NCT03615534|Niacin|niacin|mesh-list
101500501|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500502|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500503|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
101500504|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
101500505|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101500506|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
101500507|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101500508|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500509|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101500510|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500517|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101500518|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500519|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101500520|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500521|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500522|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500523|NCT04515147|Vaccines|vaccines|mesh-list
101500524|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101500525|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
101500526|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500534|NCT02891005|Paclitaxel|paclitaxel|mesh-list
101500535|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101500536|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500537|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101500538|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500539|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500540|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500541|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
101500542|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101500543|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101500544|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101500545|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
101385202|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385203|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385204|NCT00087282|Irinotecan|irinotecan|mesh-list
101385205|NCT00087282|Alvocidib|alvocidib|mesh-list
101385206|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101385207|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101385208|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385209|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385210|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385211|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
101385213|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385214|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101385216|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101385217|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385218|NCT00418366|Incretins|incretins|mesh-ancestor
101385219|NCT00418366|Hormones|hormones|mesh-ancestor
101385220|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101385221|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101385222|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101385223|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385224|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385225|NCT00120315|Esomeprazole|esomeprazole|mesh-list
101385226|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101385227|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101385228|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101385229|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500546|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101500547|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500548|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101500549|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101500550|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
101500551|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101500552|NCT00480116|Vaccines|vaccines|mesh-list
101500553|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
101500554|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500555|NCT00504855|Calpastatin|calpastatin|mesh-list
101500556|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101500557|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
101500558|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385230|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385232|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101385233|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
101385234|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
101385235|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385298|NCT00087399|Gabapentin|gabapentin|mesh-list
101385299|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
101385370|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101385371|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101385372|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101385373|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101385374|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
101385442|NCT00303940|Temozolomide|temozolomide|mesh-list
101385443|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101385444|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101385445|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
101385448|NCT00304018|Fludarabine|fludarabine|mesh-list
101385512|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101385517|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
101385584|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101385585|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101385591|NCT00120510|Lamivudine|lamivudine|mesh-list
101385656|NCT00305383|Taribavirin|taribavirin|mesh-list
101385730|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101385731|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385732|NCT00306124|Levodopa|levodopa|mesh-list
101385799|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101385800|NCT00082823|Growth Substances|growth substances|mesh-ancestor
101385801|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101385873|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101385874|NCT00083057|Paclitaxel|paclitaxel|mesh-list
101385875|NCT00083057|Gefitinib|gefitinib|mesh-list
101385876|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101385948|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101385949|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
101385960|NCT00307723|Bevacizumab|bevacizumab|mesh-list
101386020|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386022|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101386023|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386024|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101386025|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386026|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386027|NCT00308191|Bromides|bromides|mesh-list
101386028|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
101386029|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
101386030|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101386031|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
101386032|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101386033|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386034|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101386035|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
101386036|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101386037|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101386038|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101386039|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386040|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386041|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386072|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101386149|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101386151|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101386152|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101386220|NCT00121017|Lopinavir|lopinavir|mesh-list
101386221|NCT00121017|Tenofovir|tenofovir|mesh-list
101386223|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101386289|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101386290|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101386291|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
101386292|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
101386360|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101386370|NCT00121095|Docetaxel|docetaxel|mesh-list
101386434|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386435|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
101386443|NCT00310765|Pregabalin|pregabalin|mesh-list
101386504|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386505|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386511|NCT00311116|Vitamin E|vitamin e|mesh-list
101386579|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101386580|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
101386581|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101386582|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386583|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101386649|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101386650|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101386651|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
101386652|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101386687|NCT00089115|Rituximab|rituximab|mesh-list
101386718|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
101386719|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101386720|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386721|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
101386722|NCT00312481|Protective Agents|protective agents|mesh-ancestor
101386723|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386724|NCT00312481|Vitamins|vitamins|mesh-ancestor
101386725|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
101386726|NCT00312481|Cathartics|cathartics|mesh-ancestor
101386727|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101386728|NCT00312481|Laxatives|laxatives|mesh-ancestor
101386729|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
101386732|NCT00312520|Prednisolone|prednisolone|mesh-list
101386783|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
101386784|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101386785|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386786|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101386857|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101386858|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
101386859|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101386860|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
101386861|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101386926|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101386927|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101386928|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101386998|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101387070|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101387071|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387141|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
101387142|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387143|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387144|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387145|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101387146|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
101387147|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
101387211|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101387212|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101387213|NCT00295945|Narcotics|narcotics|mesh-ancestor
101387214|NCT00295945|Analgesics|analgesics|mesh-ancestor
101387215|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101387281|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101387282|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387283|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101387284|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
101387285|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
101387288|NCT00296218|Irbesartan|irbesartan|mesh-list
101387350|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101387356|NCT00296608|Leucovorin|leucovorin|mesh-list
101387424|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387425|NCT00297388|Risperidone|risperidone|mesh-list
101387426|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101387427|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
101387428|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387494|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
101387495|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387497|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101387566|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101387567|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
101387568|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387569|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101387636|NCT00314158|Timolol|timolol|mesh-list
101387712|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101387787|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
101387788|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101387789|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101387790|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101387791|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101387931|NCT06002646|Micronutrients|micronutrients|mesh-ancestor
101387932|NCT06002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101387933|NCT06002646|Disinfectants|disinfectants|mesh-ancestor
101387934|NCT06002646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388003|NCT06001788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388004|NCT06001788|Antiviral Agents|antiviral agents|mesh-ancestor
101388005|NCT06001788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101388006|NCT06001788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101388007|NCT06001788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101388011|NCT06001762|Tamoxifen|tamoxifen|mesh-list
101388072|NCT06001385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101388073|NCT06001385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101388074|NCT06001385|Alkylating Agents|alkylating agents|mesh-ancestor
101388075|NCT06001385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388079|NCT06001385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388140|NCT06001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388141|NCT06001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388143|NCT06001047|Vasodilator Agents|vasodilator agents|mesh-ancestor
101388144|NCT06001047|Histamine Agonists|histamine agonists|mesh-ancestor
101388145|NCT06001047|Histamine Agents|histamine agents|mesh-ancestor
101388146|NCT06001047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388147|NCT06001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388207|NCT06000462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388208|NCT06000423|Tranexamic Acid|tranexamic acid|mesh-list
101388209|NCT06000423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101388210|NCT06000423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101388212|NCT06000423|Hemostatics|hemostatics|mesh-ancestor
101388221|NCT06000137|Dsuvia|dsuvia|mesh-list
101388280|NCT05999955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101388281|NCT05999955|Antiemetics|antiemetics|mesh-ancestor
101388282|NCT05999955|Autonomic Agents|autonomic agents|mesh-ancestor
101388283|NCT05999955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101388286|NCT05999955|Glucocorticoids|glucocorticoids|mesh-ancestor
101388350|NCT05999708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101388351|NCT05999708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388352|NCT05999708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388353|NCT05999487|Dobutamine|dobutamine|mesh-list
101388354|NCT05999487|Milrinone|milrinone|mesh-list
101388355|NCT05999487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101388417|NCT05999227|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101388418|NCT05999227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101388419|NCT05999227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388420|NCT05999084|Antibodies|antibodies|mesh-list
101388421|NCT05999084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101388487|NCT05998551|Dexmedetomidine|dexmedetomidine|mesh-list
101388488|NCT05998551|Bupivacaine|bupivacaine|mesh-list
101388489|NCT05998551|Anesthetics, Local|anesthetics, local|mesh-ancestor
101388490|NCT05998551|Anesthetics|anesthetics|mesh-ancestor
101388491|NCT05998551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101388492|NCT05998551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388505|NCT05998551|Narcotics|narcotics|mesh-ancestor
101388549|NCT05998187|Botulinum Toxins|botulinum toxins|mesh-list
101388550|NCT05998187|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101388551|NCT05998187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101388553|NCT05998187|Cholinergic Agents|cholinergic agents|mesh-ancestor
101388618|NCT05997524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101388619|NCT05997524|Antimetabolites|antimetabolites|mesh-ancestor
101388620|NCT05997524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388621|NCT05997524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101388689|NCT05997238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388690|NCT05997238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388691|NCT05997225|Varenicline|varenicline|mesh-list
101388692|NCT05997225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101388693|NCT05997225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101388694|NCT05997225|Cholinergic Agents|cholinergic agents|mesh-ancestor
101388695|NCT05997225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101388696|NCT05997225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101388697|NCT05997225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388758|NCT05996549|Immunologic Factors|immunologic factors|mesh-ancestor
101388759|NCT05996549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101388832|NCT05996185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101388833|NCT05996185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101388834|NCT05996185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101388838|NCT05996185|Hormones|hormones|mesh-ancestor
101388903|NCT05995119|Antithrombins|antithrombins|mesh-ancestor
101388904|NCT05995119|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101388905|NCT05995119|Protease Inhibitors|protease inhibitors|mesh-ancestor
101388906|NCT05995119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101388908|NCT05995119|Anticoagulants|anticoagulants|mesh-ancestor
101388975|NCT05989503|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101388976|NCT05989503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101388977|NCT05989503|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101389048|NCT05971602|Oxazolidinones|oxazolidinones|mesh-list
101389049|NCT05971602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101389050|NCT05971602|Antitubercular Agents|antitubercular agents|mesh-ancestor
101389051|NCT05971602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101389052|NCT05971602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389073|NCT05966246|Mosapride|mosapride|mesh-list
101389119|NCT05952713|Mirtazapine|mirtazapine|mesh-list
101389120|NCT05952713|Agomelatine|agomelatine|mesh-list
101389121|NCT05952713|Citalopram|citalopram|mesh-list
101389122|NCT05952713|Fluoxetine|fluoxetine|mesh-list
101389123|NCT05952713|Paroxetine|paroxetine|mesh-list
101389124|NCT05952713|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101389125|NCT05952713|Sertraline|sertraline|mesh-list
101389126|NCT05952713|Antidepressive Agents|antidepressive agents|mesh-list
101389127|NCT05952713|Reboxetine|reboxetine|mesh-list
101389190|NCT05944237|Atezolizumab|atezolizumab|mesh-list
101389191|NCT05944237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101389192|NCT05944237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389193|NCT05944237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101389194|NCT05944237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389195|NCT05943795|Docetaxel|docetaxel|mesh-list
101389197|NCT05943795|Tubulin Modulators|tubulin modulators|mesh-ancestor
101389198|NCT05943795|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389199|NCT05943795|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389259|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101389260|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101389261|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389262|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389263|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101389327|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389328|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389329|NCT05890638|Albuterol|albuterol|mesh-list
101389330|NCT05890638|Ipratropium|ipratropium|mesh-list
101389464|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389465|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389541|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389542|NCT05829434|Cytarabine|cytarabine|mesh-list
101389543|NCT05829434|Magrolimab|magrolimab|mesh-list
101389544|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101389545|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
101389614|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101389616|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
101389617|NCT05826574|Rifampin|rifampin|mesh-list
101389618|NCT05826574|Esomeprazole|esomeprazole|mesh-list
101389619|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101389620|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101389621|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101389622|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389680|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
101389681|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
101389682|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101389683|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101389750|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101389751|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
101389752|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101389753|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101389754|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101389755|NCT05750459|Artesunate|artesunate|mesh-list
101389765|NCT05744375|Trastuzumab|trastuzumab|mesh-list
101389838|NCT05721027|Dexamethasone|dexamethasone|mesh-list
101389839|NCT05721027|Ibuprofen|ibuprofen|mesh-list
101389840|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101389841|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
101389842|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
101389843|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101389844|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101389845|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101389846|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
101389847|NCT05721027|Hormones|hormones|mesh-ancestor
101389848|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101389849|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101389850|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101389851|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101389852|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101389897|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101389898|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101389899|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101389900|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
101389970|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390043|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390044|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390045|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
101390046|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390047|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101390110|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101390111|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390182|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101390183|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390184|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101390255|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390256|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
101390257|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390258|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390262|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101390318|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101390319|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390386|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390388|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101390452|NCT05543629|Taxane|taxane|mesh-list
101390459|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101390460|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101390461|NCT05540522|Vaccines|vaccines|mesh-list
101390462|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
101390463|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390464|NCT05536154|Cytarabine|cytarabine|mesh-list
101390465|NCT05536154|Etoposide|etoposide|mesh-list
101390466|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101390524|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101390525|NCT05511038|Aflibercept|aflibercept|mesh-list
101390526|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101390532|NCT05510089|Cytarabine|cytarabine|mesh-list
101390597|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101390598|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101390599|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390605|NCT05475665|Amlodipine|amlodipine|mesh-list
101390665|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
101390666|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101390667|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101390668|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101390735|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101390736|NCT05401916|Acetaminophen|acetaminophen|mesh-list
101390738|NCT05401916|Tramadol|tramadol|mesh-list
101390741|NCT05401916|Analgesics|analgesics|mesh-ancestor
101390807|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101390808|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101390809|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101390810|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101390811|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101390812|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
101390813|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
101390814|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
101390815|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
101390816|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101390817|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
101390818|NCT05382650|Antibodies|antibodies|mesh-list
101390819|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
101390878|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101390879|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101390880|NCT05357482|Sirolimus|sirolimus|mesh-list
101390881|NCT05357482|Plerixafor|plerixafor|mesh-list
101390882|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
101390950|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
101390951|NCT05331664|Triamcinolone|triamcinolone|mesh-list
101391021|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391041|NCT05307874|Aldesleukin|aldesleukin|mesh-list
101391042|NCT05307874|Pembrolizumab|pembrolizumab|mesh-list
101391043|NCT05307874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391044|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391045|NCT05307874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391046|NCT05307874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391047|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101391048|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101391049|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
101391050|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101391051|NCT05290129|Oxytocin|oxytocin|mesh-list
101391052|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
101391053|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101391054|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391055|NCT05289830|Escitalopram|escitalopram|mesh-list
101391056|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101391057|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101391058|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101391059|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391060|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101391061|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
101391062|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391063|NCT05288023|Azithromycin|azithromycin|mesh-list
101391095|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101391164|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101391165|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101391166|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
101391167|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101391168|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
101391169|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
101391170|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
101391171|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101391207|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
101391208|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101391209|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101391210|NCT05250973|Dexamethasone|dexamethasone|mesh-list
101391211|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
101391212|NCT05250973|Bortezomib|bortezomib|mesh-list
101391238|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391239|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101391240|NCT05221840|Durvalumab|durvalumab|mesh-list
101391241|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391242|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391243|NCT05221749|Fluorides|fluorides|mesh-list
101391244|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
101391245|NCT05221749|Protective Agents|protective agents|mesh-ancestor
101391246|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391247|NCT05211323|Bevacizumab|bevacizumab|mesh-list
101391248|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101391250|NCT05211323|Cisplatin|cisplatin|mesh-list
101391314|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101391315|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391316|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101391317|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101391318|NCT05171647|Rituximab|rituximab|mesh-list
101391319|NCT05171647|Gemcitabine|gemcitabine|mesh-list
101391320|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
101391446|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
101391448|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
101391449|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391519|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391520|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
101391521|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391522|NCT05062083|11C-PS13|11c-ps13|mesh-list
101391523|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101391524|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391525|NCT05061134|Durvalumab|durvalumab|mesh-list
101391589|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101391590|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101391591|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
101391596|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
101391661|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
101391662|NCT05003895|Fludarabine|fludarabine|mesh-list
101391663|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101391735|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101391736|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101391737|NCT04964934|Letrozole|letrozole|mesh-list
101391817|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
101391818|NCT04938765|Analgesics|analgesics|mesh-ancestor
101391819|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
101391820|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101391821|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391822|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
101391823|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101391824|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101391825|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
101391826|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101391832|NCT04935931|Naltrexone|naltrexone|mesh-list
101391868|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391869|NCT04923542|Hormones|hormones|mesh-list
101391870|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101391871|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391872|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
101391873|NCT04921189|Thiamine|thiamine|mesh-list
101391874|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
101391875|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
101391879|NCT04921189|Vitamins|vitamins|mesh-ancestor
101391936|NCT04898894|Fludarabine|fludarabine|mesh-list
101391937|NCT04898894|Venetoclax|venetoclax|mesh-list
101391938|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101391939|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
101391940|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101391941|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101391942|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101391943|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
101391944|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392003|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392004|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101392005|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
101392006|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
101392007|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101392071|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101392072|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
101392075|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
101392141|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392142|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101392143|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101392144|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101392221|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392222|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392223|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392224|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392225|NCT04765202|Carisoprodol|carisoprodol|mesh-list
101392226|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101392227|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392276|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101392277|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101392278|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
101392279|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392280|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392281|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392283|NCT04712942|Pevonedistat|pevonedistat|mesh-list
101392284|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101392285|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
101392286|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392287|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392288|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101392289|NCT04711252|Palbociclib|palbociclib|mesh-list
101392290|NCT04711252|Anastrozole|anastrozole|mesh-list
101392343|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
101392344|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101392355|NCT04686305|Carboplatin|carboplatin|mesh-list
101392414|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101392415|NCT04659382|Bevacizumab|bevacizumab|mesh-list
101392416|NCT04659382|Atezolizumab|atezolizumab|mesh-list
101392417|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392483|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101392484|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101392492|NCT04629248|Tacrolimus|tacrolimus|mesh-list
101392632|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392633|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
101392634|NCT04569747|Tamoxifen|tamoxifen|mesh-list
101392636|NCT04569747|Pertuzumab|pertuzumab|mesh-list
101392637|NCT04569747|Letrozole|letrozole|mesh-list
101392638|NCT04569747|Anastrozole|anastrozole|mesh-list
101392639|NCT04569747|Leuprolide|leuprolide|mesh-list
101392702|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101392704|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
101392705|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101392706|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392707|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101392770|NCT04449874|Cetuximab|cetuximab|mesh-list
101392771|NCT04449874|Atezolizumab|atezolizumab|mesh-list
101392772|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101392773|NCT04449874|Inavolisib|inavolisib|mesh-list
101392774|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101392775|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392776|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392778|NCT04449874|Growth Substances|growth substances|mesh-ancestor
101392838|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392839|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
101392840|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101392841|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392842|NCT04419272|Methylphenidate|methylphenidate|mesh-list
101392843|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101392844|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392845|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101392846|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101392847|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101392848|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392849|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
101392850|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101392851|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
101392852|NCT04416984|Fludarabine|fludarabine|mesh-list
101392853|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101392854|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
101392855|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392856|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101392857|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101392858|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
101392859|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101392860|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392861|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101392886|NCT04404088|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101392887|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
101392888|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101392889|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101392891|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101392892|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101392893|NCT04404088|Growth Substances|growth substances|mesh-ancestor
101392894|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101392895|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101392949|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101392950|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393024|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393025|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
101393026|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101393028|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101393029|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101393030|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393031|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101393032|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393091|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393092|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393093|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
101393094|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393095|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393096|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101393097|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101393098|NCT04224493|Growth Substances|growth substances|mesh-ancestor
101393102|NCT04222023|Antibodies|antibodies|mesh-list
101393156|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393231|NCT04164069|Antibodies|antibodies|mesh-list
101393233|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393234|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
101393235|NCT04164069|Calcium|calcium|mesh-list
101393236|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
101393237|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393240|NCT04164069|Growth Substances|growth substances|mesh-ancestor
101393302|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393303|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101393304|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
101393305|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101393306|NCT04115163|Paclitaxel|paclitaxel|mesh-list
101393307|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101393373|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393374|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
101393375|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393376|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393377|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101393378|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393379|NCT04047797|Rituximab|rituximab|mesh-list
101393380|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101393381|NCT04047797|Ixazomib|ixazomib|mesh-list
101393382|NCT04047797|Antibodies|antibodies|mesh-list
101393383|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
101393384|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101393385|NCT04047797|Glycine|glycine|mesh-list
101393386|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
101393387|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393388|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393389|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101393390|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393434|NCT04024436|Fulvestrant|fulvestrant|mesh-list
101393507|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393508|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
101393509|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393579|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101393580|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101393581|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
101393582|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393583|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
101393584|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101393585|NCT03779334|Risdiplam|risdiplam|mesh-list
101393586|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101393587|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101393588|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393589|NCT03776071|Temozolomide|temozolomide|mesh-list
101393590|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393591|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
101393592|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393593|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393594|NCT03774394|Clopidogrel|clopidogrel|mesh-list
101393595|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101393596|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101393597|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101393598|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101393599|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
101393600|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101393601|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393602|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101393603|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
101393604|NCT03766126|Fludarabine|fludarabine|mesh-list
101393605|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101393606|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
101393623|NCT03760822|Ramucirumab|ramucirumab|mesh-list
101393624|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101393625|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393626|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
101393627|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
101393628|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
101393694|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393699|NCT03713801|Metformin|metformin|mesh-list
101393767|NCT03635983|Nivolumab|nivolumab|mesh-list
101393768|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101393839|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101393840|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
101393841|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101393842|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101393843|NCT03527108|Nivolumab|nivolumab|mesh-list
101393908|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
101393909|NCT03467373|Hormones|hormones|mesh-ancestor
101393910|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101393978|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394053|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101394054|NCT03382834|Vorinostat|vorinostat|mesh-list
101394055|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101394056|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394125|NCT03332667|Sargramostim|sargramostim|mesh-list
101394126|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
101394197|NCT03260504|Analgesics|analgesics|mesh-ancestor
101394198|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
101394199|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101394200|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101394201|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101394202|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
101394203|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394204|NCT03259074|Adalimumab|adalimumab|mesh-list
101394205|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101394206|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101394207|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394208|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101394209|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
101394210|NCT03255174|Coagulants|coagulants|mesh-ancestor
101394211|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
101394280|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394281|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394282|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101394283|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394284|NCT03201965|Dexamethasone|dexamethasone|mesh-list
101394285|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
101394286|NCT03201965|Bortezomib|bortezomib|mesh-list
101394287|NCT03201965|Daratumumab|daratumumab|mesh-list
101394288|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101394289|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
101394290|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394291|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101394292|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394335|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101394336|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
101394337|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394338|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394479|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
101394480|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394481|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101394482|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101394483|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394484|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
101394485|NCT02886962|Coagulants|coagulants|mesh-ancestor
101394486|NCT02885753|Leucovorin|leucovorin|mesh-list
101394487|NCT02885753|Folic Acid|folic acid|mesh-list
101394488|NCT02885753|Bevacizumab|bevacizumab|mesh-list
101394489|NCT02885753|Panitumumab|panitumumab|mesh-list
101394490|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
101394491|NCT02885753|Irinotecan|irinotecan|mesh-list
101394492|NCT02885753|Fluorouracil|fluorouracil|mesh-list
101394493|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
101394494|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394495|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394509|NCT02885753|Antidotes|antidotes|mesh-ancestor
101394542|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101394543|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101394544|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101394545|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394546|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101394547|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101394548|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101394549|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394550|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101394607|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101394608|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394609|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394611|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
101394612|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394613|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101394614|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101394615|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
101394671|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394672|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394673|NCT02489318|Androgens|androgens|mesh-list
101394674|NCT02489318|Hormones|hormones|mesh-ancestor
101394675|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101394676|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101394677|NCT02484404|Durvalumab|durvalumab|mesh-list
101394678|NCT02484404|Olaparib|olaparib|mesh-list
101394679|NCT02484404|Cediranib|cediranib|mesh-list
101394680|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101394681|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394682|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101394686|NCT02480803|Levodopa|levodopa|mesh-list
101394743|NCT02355379|Fluorouracil|fluorouracil|mesh-list
101394744|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394751|NCT02354014|Bedaquiline|bedaquiline|mesh-list
101394815|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101394817|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394818|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101394819|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101394820|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101394821|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101394822|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101394823|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101394824|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101394879|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101394880|NCT02046395|Urological Agents|urological agents|mesh-ancestor
101394882|NCT02043678|Prednisolone|prednisolone|mesh-list
101394883|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101394886|NCT02043678|Hormones|hormones|mesh-ancestor
101394951|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101394952|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
101394953|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101394954|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101394955|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101394956|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101394957|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
101394958|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101394959|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101394960|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101394961|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101394962|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
101394963|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101394964|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394965|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101394966|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101394967|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101394968|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
101394969|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101394970|NCT01851642|Albuterol|albuterol|mesh-list
101394971|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101547387|NCT04327401|Hormones|hormones|mesh-ancestor
101395003|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395004|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101395076|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395077|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395078|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
101395146|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101395147|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395149|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
101395222|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101395223|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395225|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
101395237|NCT00085202|Vincristine|vincristine|mesh-list
101395293|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101395294|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101395295|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101395296|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101395297|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395298|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101395299|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
101395300|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101395301|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101395302|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
101395359|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101395360|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101395364|NCT00313261|Clevudine|clevudine|mesh-list
101395508|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101395584|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101395656|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395657|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395658|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395659|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395661|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101395727|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395728|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395729|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101395730|NCT00122811|Diuretics|diuretics|mesh-ancestor
101395731|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
101395765|NCT04542278|Prednisone|prednisone|mesh-list
101395794|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101395795|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395796|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101395864|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395865|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
101395866|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395867|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395868|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395869|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
101395870|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
101395871|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
101395872|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101395873|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101395874|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101395875|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101395927|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395928|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101395929|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101395930|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
101415953|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
101395931|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101395932|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101395933|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101395934|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101395935|NCT00091611|Analgesics|analgesics|mesh-ancestor
101395938|NCT00123201|Dronabinol|dronabinol|mesh-list
101395990|NCT01691833|Vitamin D|vitamin d|mesh-list
101395991|NCT01691833|Vitamins|vitamins|mesh-ancestor
101395992|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
101395993|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101395994|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101396056|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
101396057|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101396058|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
101396059|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396060|NCT00327730|Eperisone|eperisone|mesh-list
101396061|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
101396062|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101396063|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101396064|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396065|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101396066|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396067|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101396068|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101396070|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
101396117|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396119|NCT03883919|Protective Agents|protective agents|mesh-ancestor
101396123|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101396124|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
101396125|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396126|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396127|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101396128|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
101396129|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
101396130|NCT00327808|Hormones|hormones|mesh-ancestor
101396132|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
101396182|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396183|NCT00092196|Aprepitant|aprepitant|mesh-list
101396184|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
101396185|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
101396186|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396192|NCT00315601|Azithromycin|azithromycin|mesh-list
101396252|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101396253|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101396254|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101396255|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396259|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396323|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101396324|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396325|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
101396326|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
101396327|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101396328|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396395|NCT02959957|Cefoxitin|cefoxitin|mesh-list
101396396|NCT02959957|Temocillin|temocillin|mesh-list
101396397|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101396398|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101396466|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101396467|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396468|NCT00328120|Fulvestrant|fulvestrant|mesh-list
101396469|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101396479|NCT00328432|Celecoxib|celecoxib|mesh-list
101396535|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396536|NCT01821833|Paclitaxel|paclitaxel|mesh-list
101396537|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396538|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396539|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
101396540|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
101396541|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
101396542|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396543|NCT00328900|Atropine|atropine|mesh-list
101396544|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101396545|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101396546|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101396547|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
101396548|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396549|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396550|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101396551|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
101396552|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
101396553|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
101396554|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101396555|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101396559|NCT00328939|Enoxaparin|enoxaparin|mesh-list
101396590|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396591|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101396592|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101396663|NCT04716751|Carboplatin|carboplatin|mesh-list
101396664|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101396665|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396735|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101396736|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101396737|NCT00083876|Growth Substances|growth substances|mesh-ancestor
101396738|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
101396808|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396809|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101396880|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101396882|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
101396955|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101396956|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101396957|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101396958|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
101396959|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101396960|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101396961|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101396978|NCT00093288|Bupropion|bupropion|mesh-list
101397021|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397022|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397023|NCT00093366|Analgesics|analgesics|mesh-ancestor
101397024|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
101397025|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397026|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397027|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397028|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397029|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547432|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
101397086|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397087|NCT00325000|Amitriptyline|amitriptyline|mesh-list
101397088|NCT00325000|Sertraline|sertraline|mesh-list
101397089|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
101397090|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101397091|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101397092|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101397093|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397094|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397095|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397096|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
101397097|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397098|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101397099|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397100|NCT00325000|Analgesics|analgesics|mesh-ancestor
101397101|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
101397102|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397143|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397144|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101397145|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
101397146|NCT00084695|Hormones|hormones|mesh-ancestor
101397147|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397148|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101397149|NCT00084695|Protective Agents|protective agents|mesh-ancestor
101397210|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397211|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397213|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397214|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397216|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397217|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397218|NCT02959879|Folfirinox|folfirinox|mesh-list
101397219|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397220|NCT04717609|Ropivacaine|ropivacaine|mesh-list
101397273|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397274|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
101397275|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397344|NCT00085163|Celecoxib|celecoxib|mesh-list
101397345|NCT00085163|Fluorouracil|fluorouracil|mesh-list
101397346|NCT00085163|Calcium|calcium|mesh-list
101397347|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
101397348|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397349|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397414|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101397486|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397487|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397488|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397489|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397490|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101397491|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101397492|NCT00085358|Growth Substances|growth substances|mesh-ancestor
101397493|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397494|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
101397495|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
101397497|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101397498|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101397499|NCT00093678|Analgesics|analgesics|mesh-ancestor
101397500|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
101397501|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101397502|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397503|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101397504|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101397541|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397542|NCT00319618|Docetaxel|docetaxel|mesh-list
101397543|NCT00319618|Gefitinib|gefitinib|mesh-list
101397544|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397545|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
101397546|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
101397547|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
101397548|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397549|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397550|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397551|NCT00124332|Rimonabant|rimonabant|mesh-list
101397552|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101397553|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101397554|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101397555|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397556|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397600|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101397601|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101397602|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
101397603|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101397604|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397605|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101397606|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101397607|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
101397608|NCT04717102|Desflurane|desflurane|mesh-list
101397666|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397667|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101397668|NCT00093912|Nitroprusside|nitroprusside|mesh-list
101397669|NCT00093912|Clevidipine|clevidipine|mesh-list
101397670|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101397671|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
101397672|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101397673|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397674|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101397675|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101397676|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101397710|NCT00327184|PENTA|penta|mesh-list
101397729|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397730|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
101397731|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397732|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101397733|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397734|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397736|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101397737|NCT00327379|Aprotinin|aprotinin|mesh-list
101397738|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
101397739|NCT00327379|Coagulants|coagulants|mesh-ancestor
101397740|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101397741|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101397742|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
101397743|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397744|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397745|NCT00327418|Atorvastatin|atorvastatin|mesh-list
101397746|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101397747|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101397748|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
101397753|NCT00094029|Sunitinib|sunitinib|mesh-list
101397785|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101397786|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101397787|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397788|NCT00086177|Progesterone|progesterone|mesh-list
101397789|NCT00086177|Progestins|progestins|mesh-ancestor
101397790|NCT00086177|Hormones|hormones|mesh-ancestor
101397791|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101397792|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397793|NCT00094146|Octreotide|octreotide|mesh-list
101397851|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397852|NCT05458180|Prednisone|prednisone|mesh-list
101397853|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
101397854|NCT05458180|Etoposide|etoposide|mesh-list
101397855|NCT05458180|Vincristine|vincristine|mesh-list
101397856|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
101397857|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101397858|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
101397859|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101397917|NCT00086489|Tremelimumab|tremelimumab|mesh-list
101397918|NCT00086489|Ipilimumab|ipilimumab|mesh-list
101397919|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547450|NCT00107315|Bevacizumab|bevacizumab|mesh-list
101397920|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101397921|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101397922|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101397923|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
101397925|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
101397983|NCT00124566|Prednisone|prednisone|mesh-list
101397984|NCT00124566|Capecitabine|capecitabine|mesh-list
101397985|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
101397986|NCT00124566|Irofulven|irofulven|mesh-list
101398055|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101398056|NCT00086801|Vinblastine|vinblastine|mesh-list
101398057|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101398058|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101398059|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
101398061|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398125|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398126|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101398127|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101398128|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398129|NCT00086879|Temozolomide|temozolomide|mesh-list
101398130|NCT00086879|Carmustine|carmustine|mesh-list
101398131|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101398132|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101398134|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398135|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398136|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101398137|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398138|NCT00124722|Bromides|bromides|mesh-list
101398189|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101398190|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
101398191|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398192|NCT00322114|Protective Agents|protective agents|mesh-ancestor
101398193|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398194|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101398195|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101398196|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398197|NCT00087074|Sirolimus|sirolimus|mesh-list
101398198|NCT00087074|Temsirolimus|temsirolimus|mesh-list
101398253|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101398254|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101398255|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
101398256|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398257|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398258|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101398259|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398261|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
101398262|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101398263|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101398317|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398318|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
101398319|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398320|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101398321|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101398322|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398323|NCT00419848|Azithromycin|azithromycin|mesh-list
101398324|NCT00419848|Doxycycline|doxycycline|mesh-list
101398325|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398326|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398327|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
101398328|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101398329|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101398330|NCT00094848|Mapatumumab|mapatumumab|mesh-list
101398331|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398333|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
101398334|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101398375|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398376|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415970|NCT00503659|Miotics|miotics|mesh-ancestor
101398377|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101398378|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101398379|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398380|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398381|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101398382|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
101398383|NCT00087464|Tenofovir|tenofovir|mesh-list
101398384|NCT00087464|Emtricitabine|emtricitabine|mesh-list
101398385|NCT00087464|Nevirapine|nevirapine|mesh-list
101398386|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
101398387|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101398388|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101398389|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101398390|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398391|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398392|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101398393|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101398394|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101398395|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101398396|NCT00331045|Alvimopan|alvimopan|mesh-list
101398397|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101398398|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101398399|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
101398424|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101398496|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
101398497|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101398498|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
101398499|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398500|NCT00331435|Verteporfin|verteporfin|mesh-list
101398501|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101398502|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
101398503|NCT00331513|Vorinostat|vorinostat|mesh-list
101398504|NCT00331513|Idarubicin|idarubicin|mesh-list
101398505|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101398558|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101398559|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398560|NCT00331786|Aspirin|aspirin|mesh-list
101398561|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
101398562|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
101398624|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398625|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398626|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398627|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101398629|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101398692|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
101398693|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101398694|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398695|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398696|NCT00332137|Urological Agents|urological agents|mesh-ancestor
101398697|NCT00126789|Fentanyl|fentanyl|mesh-list
101398698|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101398764|NCT05831345|Sufentanil|sufentanil|mesh-list
101398765|NCT05831345|Dsuvia|dsuvia|mesh-list
101398766|NCT05831345|Methadone|methadone|mesh-list
101398767|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101398768|NCT05831345|Narcotics|narcotics|mesh-ancestor
101398769|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101398770|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398771|NCT05831345|Analgesics|analgesics|mesh-ancestor
101398772|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
101398773|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101398774|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101398775|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101398776|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
101398777|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
101398778|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
101398779|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
101398818|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101398819|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101398820|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101398824|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
101398889|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398890|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101398891|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
101398892|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
101398912|NCT05691517|Exatecan|exatecan|mesh-list
101398959|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101398960|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101398961|NCT05628363|Androgens|androgens|mesh-list
101399032|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399033|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
101399034|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399036|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
101399104|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399178|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101399179|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399180|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399181|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399183|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399254|NCT04419493|Heparin|heparin|mesh-list
101399255|NCT04419493|Calcium heparin|calcium heparin|mesh-list
101399256|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101399257|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
101399258|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101399259|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101399260|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399261|NCT04401748|Azacitidine|azacitidine|mesh-list
101399262|NCT04401748|Venetoclax|venetoclax|mesh-list
101399263|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101399264|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
101399312|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399313|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399314|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101399315|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101399316|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
101399317|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399318|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101399319|NCT04302870|Analgesics|analgesics|mesh-ancestor
101399320|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
101399321|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399376|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399377|NCT04078152|Durvalumab|durvalumab|mesh-list
101399378|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399379|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399380|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
101399381|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
101399382|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101399384|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399385|NCT04006288|Aspirin|aspirin|mesh-list
101399386|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
101399439|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
101399440|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399441|NCT03947827|Minocycline|minocycline|mesh-list
101399442|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101399443|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399444|NCT03927989|Nicotine|nicotine|mesh-list
101399445|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101399446|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
101399447|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399448|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399449|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101399450|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101399451|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
101399452|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101399453|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399454|NCT03896503|Topotecan|topotecan|mesh-list
101547456|NCT00107315|Growth Substances|growth substances|mesh-ancestor
101399455|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101399456|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101399457|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399458|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399459|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399460|NCT03843645|Anesthetics|anesthetics|mesh-list
101399461|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101399462|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399463|NCT03803787|Budesonide|budesonide|mesh-list
101399464|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101399465|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101399466|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
101399467|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399468|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399471|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
101399483|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399484|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399555|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399556|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399557|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399558|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101399625|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101399626|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
101399627|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101399628|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399629|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101399630|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
101399631|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101399632|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
101399633|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399634|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101399635|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101399637|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101399638|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101399683|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101399684|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101399685|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101399755|NCT02573493|Cetuximab|cetuximab|mesh-list
101399756|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101399757|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399758|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
101399759|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
101399760|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
101399763|NCT02521493|Cytarabine|cytarabine|mesh-list
101399827|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
101399828|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101399829|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101399898|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
101399899|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101399900|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101399901|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
101399902|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101399903|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
101399904|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101399905|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101399906|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101399907|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101399960|NCT05953168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101399961|NCT05953168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101399962|NCT05953168|Immunoconjugates|immunoconjugates|mesh-ancestor
101399963|NCT05953168|Immunologic Factors|immunologic factors|mesh-ancestor
101399964|NCT05953168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399966|NCT05953142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101399967|NCT05953142|Sympathomimetics|sympathomimetics|mesh-ancestor
101399968|NCT05953142|Autonomic Agents|autonomic agents|mesh-ancestor
101399969|NCT05953142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101399970|NCT05953142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101399971|NCT05953142|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101400023|NCT05952557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400024|NCT05952557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400025|NCT05952557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101400026|NCT05952557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101400092|NCT05951959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400093|NCT05951959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400094|NCT05951959|Immunologic Factors|immunologic factors|mesh-ancestor
101400095|NCT05951959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400163|NCT05951361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400164|NCT05951361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400165|NCT05951361|Immunologic Factors|immunologic factors|mesh-ancestor
101400166|NCT05951361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400167|NCT05951361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400168|NCT05951361|Anesthetics, Local|anesthetics, local|mesh-ancestor
101400169|NCT05951361|Anesthetics|anesthetics|mesh-ancestor
101400170|NCT05951361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101400171|NCT05951361|Sensory System Agents|sensory system agents|mesh-ancestor
101400172|NCT05951361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400173|NCT05951309|Metformin|metformin|mesh-list
101400174|NCT05951309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101400226|NCT05938699|Protective Agents|protective agents|mesh-ancestor
101400227|NCT05938699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101400302|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400303|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101400304|NCT05890898|Analgesics|analgesics|mesh-ancestor
101400305|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
101400306|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400308|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101400309|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
101400310|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400311|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
101400312|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400367|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
101400368|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
101400369|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
101400370|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400371|NCT05811390|Erythritol|erythritol|mesh-list
101400372|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
101400373|NCT05794997|Propranolol|propranolol|mesh-list
101400374|NCT05794997|Atenolol|atenolol|mesh-list
101400435|NCT05752526|Analgesics|analgesics|mesh-ancestor
101400436|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
101400437|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101400438|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400439|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101400440|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400441|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101400442|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400443|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400503|NCT05645718|Vincristine|vincristine|mesh-list
101400504|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
101400505|NCT05645718|Blinatumomab|blinatumomab|mesh-list
101400506|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101400518|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
101400575|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101400576|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101400577|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400579|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101400644|NCT05408429|Vaccines|vaccines|mesh-list
101400645|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101400646|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
101400715|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101400716|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400718|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
101400719|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400720|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400721|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
101400722|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101400723|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101400725|NCT05253833|Protective Agents|protective agents|mesh-ancestor
101400729|NCT05222971|Durvalumab|durvalumab|mesh-list
101400780|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101400781|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400782|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101400783|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101400784|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400785|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
101400786|NCT05086627|Capecitabine|capecitabine|mesh-list
101400787|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
101400788|NCT05086627|Tislelizumab|tislelizumab|mesh-list
101400789|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101400790|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
101400791|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400792|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400793|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101400794|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
101400795|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
101400796|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
101400797|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101400798|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101400799|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400836|NCT05049902|Bismuth|bismuth|mesh-list
101400837|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400838|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101400839|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101400840|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101400841|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101400842|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101400843|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101400844|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101400845|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101400846|NCT05049902|Antacids|antacids|mesh-ancestor
101400847|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101400848|NCT05049902|Diuretics|diuretics|mesh-ancestor
101400849|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
101400850|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101400851|NCT05049902|Expectorants|expectorants|mesh-ancestor
101400852|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
101400894|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101400895|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101400908|NCT04833959|Panitumumab|panitumumab|mesh-list
101400969|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101400970|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101400971|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101400972|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
101401041|NCT04428671|Cemiplimab|cemiplimab|mesh-list
101401042|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401043|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401044|NCT04413890|Dinoprostone|dinoprostone|mesh-list
101401045|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
101401115|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101401116|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401117|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401118|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101401119|NCT04263896|Laxatives|laxatives|mesh-ancestor
101401120|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401121|NCT04182373|Antithrombins|antithrombins|mesh-list
101401122|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
101401123|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101401124|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
101401179|NCT03885089|Infliximab|infliximab|mesh-list
101401180|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101401181|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401182|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
101401183|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101401184|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101401185|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
101401186|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401187|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401247|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
101401248|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101401249|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101401250|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401268|NCT03582774|Edetic Acid|edetic acid|mesh-list
101401269|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101401270|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
101401271|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
101401272|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401273|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
101401274|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101401310|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101401311|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
101401312|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401383|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401384|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401385|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101401386|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101401387|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101401388|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101401389|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401390|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101401391|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101401392|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
101401393|NCT03213977|Hormones|hormones|mesh-ancestor
101401394|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101401395|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101401396|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
101401397|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
101401398|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
101401399|NCT03043872|Carboplatin|carboplatin|mesh-list
101401400|NCT03043872|Etoposide|etoposide|mesh-list
101401401|NCT03043872|Durvalumab|durvalumab|mesh-list
101401402|NCT03043872|Tremelimumab|tremelimumab|mesh-list
101401438|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101401439|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
101401440|NCT02633397|Riociguat|riociguat|mesh-list
101401441|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
101401442|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401443|NCT02594384|Rituximab|rituximab|mesh-list
101401444|NCT02594384|Atezolizumab|atezolizumab|mesh-list
101401445|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101401446|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101401504|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101401505|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101401506|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101401578|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101401579|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401580|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101401581|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
101401584|NCT00914823|Hormones|hormones|mesh-list
101401648|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101401649|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
101401650|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101401651|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401666|NCT00087815|Dexamethasone|dexamethasone|mesh-list
101401718|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401719|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101401720|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
101401721|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
101401722|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
101401723|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
101401724|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101401725|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101401785|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101401786|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401787|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101401788|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101401857|NCT00333346|Narcotics|narcotics|mesh-ancestor
101401858|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101401859|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101401928|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101401929|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101401930|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101401999|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
101402000|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402001|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402003|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
101402004|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101402005|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101402069|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101402070|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101402071|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
101402072|NCT00334672|Hormones|hormones|mesh-ancestor
101402074|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101402137|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
101402138|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402139|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402210|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
101402211|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101402212|NCT00089687|Vanoxerine|vanoxerine|mesh-list
101402282|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101402283|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101402284|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402286|NCT00343369|Dexamethasone|dexamethasone|mesh-list
101402287|NCT00343369|Prednisolone|prednisolone|mesh-list
101402288|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
101402352|NCT00343486|Solabegron|solabegron|mesh-list
101402353|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101402354|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101402355|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101402356|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
101402425|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101402497|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402498|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101402505|NCT00090038|Rituximab|rituximab|mesh-list
101402569|NCT00127998|Artemether|artemether|mesh-list
101402570|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
101402571|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
101402572|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101402573|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101402574|NCT00127998|Amodiaquine|amodiaquine|mesh-list
101402575|NCT00127998|Mefloquine|mefloquine|mesh-list
101402576|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
101402577|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101402578|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101402579|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101402580|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402582|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
101402583|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101402584|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
101402585|NCT00127998|Amebicides|amebicides|mesh-ancestor
101402586|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101402587|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101402588|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101402589|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402590|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101402594|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101402619|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402620|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101402691|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402692|NCT00345202|Atorvastatin|atorvastatin|mesh-list
101402693|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101402694|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101402695|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
101402764|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
101402765|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101402766|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101402834|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402835|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101402836|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101402837|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101402838|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
101402902|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101402903|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101402904|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101402974|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403049|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101403050|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
101403051|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403052|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403053|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
101403054|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403118|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403119|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
101403120|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403121|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403122|NCT00126087|Protective Agents|protective agents|mesh-ancestor
101403123|NCT00347503|Ketorolac|ketorolac|mesh-list
101403187|NCT00426439|Chloroquine|chloroquine|mesh-list
101403188|NCT00426439|Lumefantrine|lumefantrine|mesh-list
101403190|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101403191|NCT00426439|Amebicides|amebicides|mesh-ancestor
101403259|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403260|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403261|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101403262|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403263|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403265|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101403266|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403267|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101403325|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
101403326|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547528|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403396|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403398|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101403400|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
101403467|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403468|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101403469|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101403470|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
101403471|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
101403472|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101403473|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101403474|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101403475|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101403476|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101403477|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101403478|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
101403479|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
101403480|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101403530|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101403531|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101403533|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
101403534|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
101403535|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403536|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101403537|NCT00092300|Valdecoxib|valdecoxib|mesh-list
101403538|NCT00092300|Rofecoxib|rofecoxib|mesh-list
101403539|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101403540|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101403541|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403542|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403543|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101403558|NCT00428428|Isoproterenol|isoproterenol|mesh-list
101403591|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101403592|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403593|NCT00428545|Growth Substances|growth substances|mesh-ancestor
101403594|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403595|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
101403596|NCT00092378|Diclofenac|diclofenac|mesh-list
101403597|NCT00092378|Rofecoxib|rofecoxib|mesh-list
101403598|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101403599|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101403600|NCT00092378|Analgesics|analgesics|mesh-ancestor
101403601|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
101403604|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403655|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101403656|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403657|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403658|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
101403659|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
101403660|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403661|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403662|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101403663|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101403664|NCT05561049|Growth Substances|growth substances|mesh-ancestor
101403665|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
101403666|NCT00424034|Ambrisentan|ambrisentan|mesh-list
101403667|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101403668|NCT05561010|Bupivacaine|bupivacaine|mesh-list
101403669|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
101403670|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
101403671|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403672|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403673|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
101547537|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
101403674|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403675|NCT03448107|Fluorides|fluorides|mesh-list
101403676|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
101500561|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101500562|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101500563|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101500564|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
101500565|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
101500566|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500567|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500568|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500569|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
101500570|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101500571|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101500572|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101500573|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500574|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500575|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500576|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500577|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500584|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
101500585|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500586|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500587|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500588|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500589|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101500590|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500591|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
101500592|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
101500593|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101500595|NCT01313182|Povidone|povidone|mesh-list
101403678|NCT03448107|Protective Agents|protective agents|mesh-ancestor
101403679|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403680|NCT00093314|Ofatumumab|ofatumumab|mesh-list
101403681|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403682|NCT00093353|Cefixime|cefixime|mesh-list
101403683|NCT00093353|Irinotecan|irinotecan|mesh-list
101403684|NCT00093353|Temozolomide|temozolomide|mesh-list
101403685|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101403686|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101403687|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403688|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500596|NCT01313182|Calcium|calcium|mesh-list
101500597|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101500598|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500599|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
101500600|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
101500601|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500602|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500603|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101500604|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500605|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500606|NCT00480194|Xylometazoline|xylometazoline|mesh-list
101500607|NCT00480194|Bromides|bromides|mesh-list
101500608|NCT00480194|Ipratropium|ipratropium|mesh-list
101500609|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
101500610|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101500611|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
101500612|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500613|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500614|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500615|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500616|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101500617|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500619|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500620|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
101500621|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101500622|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101500623|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
101500624|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500625|NCT00505167|Memantine|memantine|mesh-list
101500626|NCT00505167|Donepezil|donepezil|mesh-list
101500627|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101500628|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500629|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500630|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500631|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500632|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500633|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
101500634|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101500635|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101500636|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
101500637|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101500638|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101500639|NCT00480272|Prednisone|prednisone|mesh-list
101500640|NCT00480272|Adalimumab|adalimumab|mesh-list
101500641|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500642|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
101500643|NCT00480272|Hormones|hormones|mesh-ancestor
101500644|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500645|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500646|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101403689|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403690|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403691|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
101403692|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403693|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403694|NCT00093509|Doxorubicin|doxorubicin|mesh-list
101403695|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101403696|NCT00093509|Ifosfamide|ifosfamide|mesh-list
101403697|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
101403698|NCT00093509|Mesna|mesna|mesh-list
101403699|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403700|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403701|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101403702|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101403703|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403704|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403705|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403706|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
101403707|NCT00093509|Protective Agents|protective agents|mesh-ancestor
101403708|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403709|NCT00093548|Vaccines|vaccines|mesh-list
101403710|NCT00093548|Sargramostim|sargramostim|mesh-list
101403711|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101403712|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
101403713|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500647|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500648|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101500665|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
101500666|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500667|NCT00482066|Abatacept|abatacept|mesh-list
101500668|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101500669|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500670|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500671|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500672|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500673|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
101500676|NCT00482183|Pioglitazone|pioglitazone|mesh-list
101500677|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101500678|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500679|NCT01312909|Varenicline|varenicline|mesh-list
101500680|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101500681|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101500682|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500683|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500684|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500685|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500686|NCT00482222|Leucovorin|leucovorin|mesh-list
101500687|NCT00482222|Fluorouracil|fluorouracil|mesh-list
101403714|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101403715|NCT05549895|Dexamethasone|dexamethasone|mesh-list
101403716|NCT05549895|Bupivacaine|bupivacaine|mesh-list
101403717|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403718|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
101403719|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
101403720|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403721|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403722|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403723|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
101403724|NCT05549895|Hormones|hormones|mesh-ancestor
101403725|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403726|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101403727|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403728|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
101403729|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
101500688|NCT00482222|Capecitabine|capecitabine|mesh-list
101500689|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
101500690|NCT00482222|Cetuximab|cetuximab|mesh-list
101500691|NCT00482222|Calcium|calcium|mesh-list
101500692|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
101500693|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101500695|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
101500696|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500697|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500698|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500699|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500700|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
101500701|NCT00482222|Antidotes|antidotes|mesh-ancestor
101500702|NCT00482222|Protective Agents|protective agents|mesh-ancestor
101500703|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
101500704|NCT00482222|Vitamins|vitamins|mesh-ancestor
101500705|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
101500706|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500707|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
101500708|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500709|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101500712|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
101500713|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500714|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500715|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101500716|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500717|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101500718|NCT04518852|Sorafenib|sorafenib|mesh-list
101500719|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500720|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500721|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500722|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500723|NCT01311661|Olodaterol|olodaterol|mesh-list
101500724|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101500725|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
101500726|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500727|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500728|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500729|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500731|NCT00482261|Aspirin|aspirin|mesh-list
101500732|NCT00482261|Dexamethasone|dexamethasone|mesh-list
101500733|NCT00482261|Lenalidomide|lenalidomide|mesh-list
101500734|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101403730|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403731|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
101403732|NCT00093587|Cyclosporine|cyclosporine|mesh-list
101403733|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
101403734|NCT00093587|Busulfan|busulfan|mesh-list
101403735|NCT00093587|Cyclosporins|cyclosporins|mesh-list
101403736|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101403737|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403738|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
101403739|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403740|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403741|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403742|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
101403743|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403744|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500735|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
101500736|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
101500737|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500738|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500739|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101500740|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
101500741|NCT00482261|Hormones|hormones|mesh-ancestor
101500742|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500743|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101500744|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500745|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101500746|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500747|NCT00482261|Analgesics|analgesics|mesh-ancestor
101500748|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
101500749|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500750|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101500751|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101500752|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500753|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101500754|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101500755|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500756|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
101500757|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
101500758|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500759|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500760|NCT00482261|Growth Substances|growth substances|mesh-ancestor
101500761|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500762|NCT04518618|Fentanyl|fentanyl|mesh-list
101500763|NCT04518618|Naloxone|naloxone|mesh-list
101500764|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101500765|NCT04518618|Narcotics|narcotics|mesh-ancestor
101500766|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500767|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500768|NCT04518618|Analgesics|analgesics|mesh-ancestor
101500769|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
101500770|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500771|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101500772|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101500773|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
101500774|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
101500775|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101500776|NCT00480584|Gemcitabine|gemcitabine|mesh-list
101500777|NCT00480584|Capecitabine|capecitabine|mesh-list
101500778|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101500779|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500780|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
101403745|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101403746|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403747|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
101403748|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403749|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
101403750|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101403751|NCT00093626|Sorafenib|sorafenib|mesh-list
101403752|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403753|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101403754|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403755|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403756|NCT05543109|Fentanyl|fentanyl|mesh-list
101403757|NCT05543109|Narcotics|narcotics|mesh-list
101403758|NCT05543109|Propofol|propofol|mesh-list
101403759|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101403760|NCT05543109|Ropivacaine|ropivacaine|mesh-list
101403761|NCT05543109|Anesthetics|anesthetics|mesh-list
101403762|NCT05543109|Sevoflurane|sevoflurane|mesh-list
101403763|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
101403764|NCT05543109|Rocuronium|rocuronium|mesh-list
101403765|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101403766|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403767|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403768|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
101403769|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
101403770|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500781|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500782|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500783|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500784|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500785|NCT01311505|Rifampin|rifampin|mesh-list
101500796|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101500797|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101500798|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101500799|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101500800|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101500801|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101500802|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101500803|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
101500804|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101500805|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
101500806|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500807|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
101500808|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500809|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500810|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101500811|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
101500812|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500813|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500814|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101403771|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101403772|NCT05543109|Analgesics|analgesics|mesh-ancestor
101403773|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101403774|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101403775|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101403776|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101403777|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101403778|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101403779|NCT00093665|Fluorouracil|fluorouracil|mesh-list
101403780|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403781|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
101403782|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403783|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101500816|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500817|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101500818|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101500819|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500820|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500822|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
101500823|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500824|NCT04518540|Protective Agents|protective agents|mesh-ancestor
101500825|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500826|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
101500827|NCT04518540|Vitamins|vitamins|mesh-ancestor
101500828|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
101500829|NCT00480623|Satraplatin|satraplatin|mesh-list
101500830|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500831|NCT01240655|Paclitaxel|paclitaxel|mesh-list
101500832|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101500833|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500834|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101500835|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500836|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500837|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500838|NCT04518189|Lidocaine|lidocaine|mesh-list
101500839|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500840|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
101500841|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500842|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500843|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
101500844|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500845|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101500846|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101500847|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101500848|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500862|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
101500863|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500866|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
101500867|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500868|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101500869|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500870|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500871|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101500872|NCT01309828|Olmesartan|olmesartan|mesh-list
101500873|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101500874|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
101500875|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101500876|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101500877|NCT01309828|Diuretics|diuretics|mesh-ancestor
101500878|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
101403784|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403785|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
101403786|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403788|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101403789|NCT00093704|Bortezomib|bortezomib|mesh-list
101403790|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403791|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
101403792|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403793|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101403794|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403795|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403796|NCT01055314|Dactinomycin|dactinomycin|mesh-list
101403797|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
101403798|NCT01055314|Temozolomide|temozolomide|mesh-list
101403799|NCT01055314|Ifosfamide|ifosfamide|mesh-list
101403800|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
101403802|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101403803|NCT01055314|Irinotecan|irinotecan|mesh-list
101500879|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500880|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101500881|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101500882|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500883|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101500884|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101500885|NCT00482495|Bevacizumab|bevacizumab|mesh-list
101500886|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500887|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500888|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500889|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500890|NCT00482495|Growth Substances|growth substances|mesh-ancestor
101500891|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500892|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500894|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500895|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500896|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500897|NCT00480935|Growth Substances|growth substances|mesh-ancestor
101500898|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500899|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500900|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500901|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500902|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500903|NCT00482573|Epinephrine|epinephrine|mesh-list
101500904|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101500905|NCT00482573|Anesthetics|anesthetics|mesh-list
101500906|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500907|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500908|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101500909|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500914|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101500916|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500917|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500918|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500919|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
101500920|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
101403806|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
101403807|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
101403808|NCT01055314|Camptothecin|camptothecin|mesh-list
101403809|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101403810|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403811|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
101403812|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403813|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403814|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101403815|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
101403816|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403817|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403818|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101403819|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403820|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101403821|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101403822|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403823|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101500921|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
101500922|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500923|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500924|NCT00481013|Valproic Acid|valproic acid|mesh-list
101500925|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
101500926|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500927|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500928|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
101500929|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500930|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500931|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
101500932|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101500933|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500934|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101500935|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101500936|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
101500937|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101500938|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101500939|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500940|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500941|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
101500942|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500943|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101500944|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101500945|NCT01240109|Remifentanil|remifentanil|mesh-list
101500946|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101184624|NCT02345460|Antidotes|antidotes|mesh-ancestor
101500947|NCT01240109|Narcotics|narcotics|mesh-ancestor
101500948|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500949|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500950|NCT01240109|Analgesics|analgesics|mesh-ancestor
101500951|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
101403824|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101403825|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
101403826|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
101403827|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
101403828|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
101403829|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
101403830|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403831|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403832|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101403833|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101403834|NCT00093743|Cyclosporine|cyclosporine|mesh-list
101403835|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
101403836|NCT00093743|Fludarabine|fludarabine|mesh-list
101403837|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
101403838|NCT00093743|Cyclosporins|cyclosporins|mesh-list
101403839|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403840|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101403841|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
101403842|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403843|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403844|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
101500952|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500953|NCT04517526|Bevacizumab|bevacizumab|mesh-list
101500954|NCT04517526|Durvalumab|durvalumab|mesh-list
101500955|NCT04517526|Carboplatin|carboplatin|mesh-list
101500956|NCT04517526|Pemetrexed|pemetrexed|mesh-list
101500957|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500958|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500959|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500960|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101500961|NCT04517526|Growth Substances|growth substances|mesh-ancestor
101500962|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500963|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
101500964|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500965|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500966|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101500967|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101500968|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101500969|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101500970|NCT01309204|Brinzolamide|brinzolamide|mesh-list
101500971|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101500972|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101500973|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101500974|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101500975|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101500976|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500977|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500994|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500996|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500997|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
101500998|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500999|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501000|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
101501001|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501002|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101403846|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403847|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
101403848|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403850|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101403851|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101403852|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403853|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101403854|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
101403855|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403856|NCT00400322|Valganciclovir|valganciclovir|mesh-list
101403857|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
101403858|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403859|NCT00093860|Propranolol|propranolol|mesh-list
101403860|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101403861|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101403862|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
101403863|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501003|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101501004|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101501005|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501006|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501008|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
101501009|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501010|NCT04325191|Protective Agents|protective agents|mesh-ancestor
101501011|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501012|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501013|NCT04517292|Cisplatin|cisplatin|mesh-list
101501014|NCT04517292|Gemcitabine|gemcitabine|mesh-list
101501015|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501016|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501017|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
101501018|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501019|NCT00482846|Melphalan|melphalan|mesh-list
101501020|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101501021|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
101501022|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501023|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501024|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101501025|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101501026|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
101501027|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501028|NCT01308736|Varenicline|varenicline|mesh-list
101501029|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101501030|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101501031|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
101501032|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501043|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101547635|NCT01332227|Ritonavir|ritonavir|mesh-list
101501044|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101501045|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501046|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501047|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
101501048|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403864|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403866|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101403867|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101403868|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
101403869|NCT00402909|Nateglinide|nateglinide|mesh-list
101403870|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101403871|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501049|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101501050|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501051|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101501052|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101501053|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101501054|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101501055|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101501056|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101501057|NCT01240226|Ketoconazole|ketoconazole|mesh-list
101501058|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
101501059|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501060|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101501061|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501062|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501063|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501064|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101501065|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
101501066|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501067|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501068|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101501069|NCT01240824|Aminophylline|aminophylline|mesh-list
101501070|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101501071|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
101501072|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501073|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501074|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101501075|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
101501076|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101501077|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101501078|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501079|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501080|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101501081|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101501082|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
101501083|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501084|NCT01240824|Protective Agents|protective agents|mesh-ancestor
101501086|NCT01240941|Goserelin|goserelin|mesh-list
101501087|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501088|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101501089|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101501090|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501091|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501092|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101501100|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101501101|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501102|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501103|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
101501104|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501105|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101501106|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501107|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101501108|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101403872|NCT02823366|Fenofibrate|fenofibrate|mesh-list
101403873|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101403874|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
101403875|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403876|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101403877|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
101403878|NCT00093977|Hematinics|hematinics|mesh-ancestor
101403879|NCT00094289|Disulfiram|disulfiram|mesh-list
101403880|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101403881|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101403882|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403883|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403884|NCT00094367|Lamivudine|lamivudine|mesh-list
101403885|NCT00094367|Abacavir|abacavir|mesh-list
101403886|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101403887|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101403888|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403889|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403890|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
101403891|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403892|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101501109|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101501110|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101501111|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101501112|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
101501113|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101501114|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501115|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101501116|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101501117|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101501118|NCT01241019|Topiramate|topiramate|mesh-list
101501119|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
101501120|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101501121|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501122|NCT01240928|Exemestane|exemestane|mesh-list
101501123|NCT01240928|Goserelin|goserelin|mesh-list
101501124|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501125|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101501126|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101501127|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501128|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501129|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101501130|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101501131|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501132|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501133|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101501134|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
101501135|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101501136|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101501137|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
101501138|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403893|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101403894|NCT00094406|Dimercaprol|dimercaprol|mesh-list
101403895|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
101403896|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
101403897|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
101403898|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403899|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
101403900|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
101403901|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403902|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403903|NCT00094484|Cinacalcet|cinacalcet|mesh-list
101403904|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101403905|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403906|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101403907|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
101403908|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101403909|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
101403910|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101403911|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101403912|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
101403913|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403914|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403915|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101403916|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101403917|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
101403918|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403919|NCT00428701|Esomeprazole|esomeprazole|mesh-list
101403920|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101403921|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101403922|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101501139|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501140|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101501141|NCT00483093|Cisplatin|cisplatin|mesh-list
101501142|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501143|NCT00483132|Interferons|interferons|mesh-list
101501144|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
101501145|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
101501146|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501147|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
101501148|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501149|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
101501150|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501151|NCT00483210|Fenofibrate|fenofibrate|mesh-list
101501152|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101501153|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
101501154|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403923|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403924|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403926|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101403927|NCT00428818|Trimethoprim|trimethoprim|mesh-list
101403928|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
101403929|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403930|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403931|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
101403932|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101403933|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101403934|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101403935|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101403936|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403937|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403938|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101403939|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101403940|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501155|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101501156|NCT00487994|Atorvastatin|atorvastatin|mesh-list
101501157|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101501158|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101501159|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
101501160|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501179|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501180|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101501181|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501182|NCT01308580|Prednisone|prednisone|mesh-list
101501183|NCT01308580|Prednisolone|prednisolone|mesh-list
101501184|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501185|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
101501186|NCT01308580|Hormones|hormones|mesh-ancestor
101501187|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501188|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501189|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101501190|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501191|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
101501192|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101501193|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101501194|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501195|NCT00483275|Vitamins|vitamins|mesh-ancestor
101501196|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
101501197|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
101501198|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101501199|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
101501200|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501201|NCT00483314|Expectorants|expectorants|mesh-ancestor
101501202|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
101501203|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101501204|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
101501205|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501206|NCT00483314|Protective Agents|protective agents|mesh-ancestor
101501207|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501208|NCT00483314|Antidotes|antidotes|mesh-ancestor
101501209|NCT00483392|Metformin|metformin|mesh-list
101501210|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
101501211|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101403942|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
101403943|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
101403944|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403945|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403946|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101501212|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501213|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
101501214|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
101501215|NCT00483431|Coagulants|coagulants|mesh-ancestor
101501216|NCT00483600|PENTA|penta|mesh-list
101501217|NCT00483600|Fondaparinux|fondaparinux|mesh-list
101501218|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101501232|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101501233|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501234|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501235|NCT02956421|Vaccines|vaccines|mesh-list
101501236|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
101501237|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501238|NCT00483470|Vaccines|vaccines|mesh-list
101501239|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
101501240|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501241|NCT00488306|Tigecycline|tigecycline|mesh-list
101501242|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501243|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501244|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101501245|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501246|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501247|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
101501248|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501249|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101501250|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101501251|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501252|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501253|NCT00483626|Urological Agents|urological agents|mesh-ancestor
101501254|NCT00483795|Citric Acid|citric acid|mesh-list
101501255|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
101501256|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
101501257|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101501258|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
101501259|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
101501260|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501261|NCT05644210|Aspirin|aspirin|mesh-list
101501262|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
101501263|NCT05644210|Prednisone|prednisone|mesh-list
101501264|NCT05644210|Rituximab|rituximab|mesh-list
101501265|NCT05644210|Warfarin|warfarin|mesh-list
101501266|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101501267|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501268|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
101501269|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501270|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501271|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501272|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
101501273|NCT05644210|Hormones|hormones|mesh-ancestor
101501274|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501275|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101501276|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501277|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501278|NCT05644210|Analgesics|analgesics|mesh-ancestor
101501279|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
101501280|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501281|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101501284|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101501285|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101501286|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501287|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
101501288|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
101501289|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
101501290|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101501291|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101501292|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501293|NCT00488384|Acitretin|acitretin|mesh-list
101501294|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
101403947|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101403948|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101403949|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403950|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501295|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101501296|NCT00483834|Bevacizumab|bevacizumab|mesh-list
101501297|NCT00483834|Capecitabine|capecitabine|mesh-list
101501298|NCT00483834|Irinotecan|irinotecan|mesh-list
101501299|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101501300|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501301|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101501302|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101501303|NCT00483834|Growth Substances|growth substances|mesh-ancestor
101501304|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501305|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
101501306|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501307|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
101501308|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501309|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101501310|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501311|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501312|NCT01307449|Vaccines|vaccines|mesh-list
101501313|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101501314|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
101501315|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501316|NCT01307020|Ibuprofen|ibuprofen|mesh-list
101501317|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101501318|NCT01307020|Ketoprofen|ketoprofen|mesh-list
101501319|NCT01307020|Tramadol|tramadol|mesh-list
101501320|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101547688|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
101501321|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501322|NCT01307020|Analgesics|analgesics|mesh-ancestor
101501323|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
101501324|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501325|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501326|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501327|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501328|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101501329|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501330|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501331|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101501332|NCT01307020|Narcotics|narcotics|mesh-ancestor
101501333|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501334|NCT00483743|Budesonide|budesonide|mesh-list
101501335|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501336|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101501337|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
101501338|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501339|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501340|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101501341|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
101501342|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
101501343|NCT00483743|Hormones|hormones|mesh-ancestor
101501344|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501345|NCT00483782|Paclitaxel|paclitaxel|mesh-list
101501346|NCT00483782|Bevacizumab|bevacizumab|mesh-list
101501347|NCT00483782|Carboplatin|carboplatin|mesh-list
101501348|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101501349|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501350|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
101501351|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
101501352|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
101501353|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501354|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101501379|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501380|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501381|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501382|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501383|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101501384|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101501385|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403951|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101403952|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101403953|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101403954|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403956|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
101403957|NCT02415309|Melatonin|melatonin|mesh-list
101403958|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
101403959|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403960|NCT02415309|Protective Agents|protective agents|mesh-ancestor
101403961|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403962|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101403963|NCT05393817|Caffeine|caffeine|mesh-list
101403965|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403966|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101403967|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403968|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101403969|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403970|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101501386|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547698|NCT05649878|Prednisolone|prednisolone|mesh-list
101501387|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
101501388|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101501389|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101501390|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101501391|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
101501392|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
101501393|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501394|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501395|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
101501396|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501397|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101501398|NCT01304329|Empagliflozin|empagliflozin|mesh-list
101501399|NCT01304329|Simvastatin|simvastatin|mesh-list
101501400|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101501401|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101501402|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
101501403|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501426|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501428|NCT00484068|Enalapril|enalapril|mesh-list
101501429|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101501430|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
101501431|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501432|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501433|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101501434|NCT00483860|Topotecan|topotecan|mesh-list
101501435|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101501436|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501437|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101403972|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
101403973|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403974|NCT00403338|Sirolimus|sirolimus|mesh-list
101403975|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101403976|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101403977|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101403978|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101403979|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
101403980|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101403981|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
101403982|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403983|NCT00095069|Gaboxadol|gaboxadol|mesh-list
101501438|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501439|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501440|NCT01241097|Simvastatin|simvastatin|mesh-list
101501441|NCT01241097|Ezetimibe|ezetimibe|mesh-list
101501442|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101501443|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101501444|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
101501445|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501446|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101501447|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101501448|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501449|NCT01303861|Bupropion|bupropion|mesh-list
101501451|NCT01303861|Varenicline|varenicline|mesh-list
101501452|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101501453|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
101501469|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501470|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501471|NCT01303627|Remifentanil|remifentanil|mesh-list
101501472|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101501473|NCT01303627|Narcotics|narcotics|mesh-ancestor
101501474|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501475|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501476|NCT01303627|Analgesics|analgesics|mesh-ancestor
101501477|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
101501478|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501479|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
101501480|NCT01241175|Analgesics|analgesics|mesh-ancestor
101501481|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
101501482|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501483|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501484|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
101501485|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501486|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101501487|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
101501488|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101501489|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501490|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501491|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101501492|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
101501493|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101501494|NCT00484107|Estrogens|estrogens|mesh-list
101501495|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101501496|NCT00484107|Hormones|hormones|mesh-ancestor
101501497|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501498|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501499|NCT01302964|Mirtazapine|mirtazapine|mesh-list
101501500|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
101403984|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101403985|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403986|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101403987|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101403988|NCT00095069|Analgesics|analgesics|mesh-ancestor
101403989|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
101403990|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
101403991|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
101403992|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
101403993|NCT00403533|Atorvastatin|atorvastatin|mesh-list
101403994|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101403995|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101403996|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
101403997|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101403998|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101403999|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101404000|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404001|NCT00095225|Bevacizumab|bevacizumab|mesh-list
101404002|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101404003|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404004|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501501|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501502|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101501503|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
101501504|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
101501505|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501506|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501508|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101501515|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101501517|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
101501518|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101501519|NCT00484055|Gentamicins|gentamicins|mesh-list
101501520|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501521|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501522|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101501523|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501524|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501525|NCT01302691|Losartan|losartan|mesh-list
101501526|NCT01302691|Amlodipine|amlodipine|mesh-list
101501527|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101501528|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101501529|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101501530|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501531|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501532|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101501533|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501534|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501535|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101501536|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101501537|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101501538|NCT01302691|Diuretics|diuretics|mesh-ancestor
101404005|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404006|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101404007|NCT00095225|Growth Substances|growth substances|mesh-ancestor
101404008|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404009|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
101404010|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404011|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404012|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404013|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
101404014|NCT00095264|Hematinics|hematinics|mesh-ancestor
101404015|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
101501539|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
101501540|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101501541|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101501542|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
101501543|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501544|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501545|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101501546|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
101501547|NCT05643820|Ivermectin|ivermectin|mesh-list
101501548|NCT05643820|Permethrin|permethrin|mesh-list
101501549|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101501550|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501552|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501553|NCT01242449|Trastuzumab|trastuzumab|mesh-list
101501554|NCT01242449|Vinorelbine|vinorelbine|mesh-list
101501555|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101501556|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501557|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101501558|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
101501559|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
101501560|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
101501561|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501562|NCT01241162|Decitabine|decitabine|mesh-list
101501563|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501564|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
101501565|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501566|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501567|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501568|NCT00484133|Dobutamine|dobutamine|mesh-list
101501569|NCT00484133|Dopamine|dopamine|mesh-list
101501570|NCT00484133|Enoximone|enoximone|mesh-list
101501571|NCT00484133|Norepinephrine|norepinephrine|mesh-list
101501572|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
101501573|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501574|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101501575|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
101501585|NCT00484133|Protective Agents|protective agents|mesh-ancestor
101501586|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
101501587|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101501588|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101547720|NCT01380080|Rifampin|rifampin|mesh-list
101501589|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101501590|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101501591|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501592|NCT00484341|Doxorubicin|doxorubicin|mesh-list
101501593|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101501594|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501595|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101501596|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501597|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501598|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501599|NCT01242566|Temozolomide|temozolomide|mesh-list
101404017|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404018|NCT00403611|Praziquantel|praziquantel|mesh-list
101404019|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
101404020|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101404021|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501600|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101501601|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
101501602|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501603|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501604|NCT04514835|Capecitabine|capecitabine|mesh-list
101501605|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501606|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501607|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
101501608|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501609|NCT00488813|Cephalosporins|cephalosporins|mesh-list
101501610|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501611|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501612|NCT00484250|Metronidazole|metronidazole|mesh-list
101501613|NCT00484250|Doxycycline|doxycycline|mesh-list
101501614|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501615|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501616|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101501617|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101501618|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
101501619|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101501620|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
101501621|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101501622|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501623|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501624|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501625|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101501626|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101501627|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
101501628|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501629|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501630|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101501631|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101501632|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
101501633|NCT00484328|Ribavirin|ribavirin|mesh-list
101501634|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
101501635|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501636|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
101501637|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501638|NCT00484575|Propofol|propofol|mesh-list
101501639|NCT00484575|Sevoflurane|sevoflurane|mesh-list
101501640|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101501653|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101501654|NCT00488969|Narcotics|narcotics|mesh-ancestor
101501655|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501656|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501657|NCT00488969|Analgesics|analgesics|mesh-ancestor
101501658|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
101501659|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501661|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101501662|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
101501663|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501664|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101501665|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101501666|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501667|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501668|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
101501669|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501670|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501671|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101501672|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501673|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501674|NCT00484731|Bupivacaine|bupivacaine|mesh-list
101501675|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
101501676|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
101404023|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404024|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404025|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404026|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404028|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
101404029|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501677|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501678|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501679|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
101501680|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501681|NCT00484484|Ketamine|ketamine|mesh-list
101501682|NCT00484484|Analgesics|analgesics|mesh-ancestor
101501683|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
101501684|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501685|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501686|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101501687|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101501688|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
101501689|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
101501690|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501691|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101501692|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101501693|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501694|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501695|NCT00484601|Doxorubicin|doxorubicin|mesh-list
101501696|NCT00484601|Ifosfamide|ifosfamide|mesh-list
101501697|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101501698|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501699|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101501700|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501701|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501715|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
101501716|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101501717|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
101501718|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501719|NCT00484809|Etanercept|etanercept|mesh-list
101501720|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501721|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501722|NCT00484809|Analgesics|analgesics|mesh-ancestor
101501723|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
101501724|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501725|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501726|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501727|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501728|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101501729|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101501730|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
101501731|NCT04514094|Fluorides|fluorides|mesh-list
101501732|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
101501733|NCT04514094|Protective Agents|protective agents|mesh-ancestor
101501734|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501735|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101501736|NCT00484926|Aspirin|aspirin|mesh-list
101501737|NCT00484926|Clopidogrel|clopidogrel|mesh-list
101501738|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501739|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501740|NCT00484926|Analgesics|analgesics|mesh-ancestor
101501741|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
101501742|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501743|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501744|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501745|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501746|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101404030|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101404031|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101404032|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101404033|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101404034|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404035|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
101404036|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501747|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101501748|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501749|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101501750|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101501751|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501753|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101501754|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101501755|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101501756|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
101501757|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501758|NCT02275806|Irinotecan|irinotecan|mesh-list
101501759|NCT02275806|Camptothecin|camptothecin|mesh-list
101501760|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501761|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101501762|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501763|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501767|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101501768|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101501769|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101501770|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501771|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501772|NCT02275845|Metformin|metformin|mesh-list
101501773|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101501774|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501775|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101501776|NCT00489398|Epinastine|epinastine|mesh-list
101501777|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501778|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501779|NCT00489398|Analgesics|analgesics|mesh-ancestor
101501780|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
101501781|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501782|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501783|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501784|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501785|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101501786|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101501787|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101501788|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
101501789|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
101501790|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501791|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501793|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501794|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501795|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101501796|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501797|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
101501798|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101501799|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
101501800|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501801|NCT00484991|Verapamil|verapamil|mesh-list
101501802|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101501803|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101501804|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501805|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501806|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101404038|NCT00095459|Bevacizumab|bevacizumab|mesh-list
101404039|NCT00095459|Sorafenib|sorafenib|mesh-list
101404040|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404041|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404042|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404043|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101404044|NCT00095459|Growth Substances|growth substances|mesh-ancestor
101404045|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501807|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501808|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501809|NCT00485121|Ezetimibe|ezetimibe|mesh-list
101501810|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101501811|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101501812|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
101501813|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501814|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101501815|NCT00489437|Heparin|heparin|mesh-list
101501816|NCT00489437|Antibodies|antibodies|mesh-list
101501817|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
101501818|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501819|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
101501820|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101501821|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101501822|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501824|NCT00485160|Indomethacin|indomethacin|mesh-list
101501825|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501826|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501827|NCT00485160|Analgesics|analgesics|mesh-ancestor
101501828|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
101501829|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501830|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501831|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501832|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501833|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101501834|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501845|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101501847|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501848|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501849|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501850|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501851|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101501852|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
101501853|NCT04513821|Minocycline|minocycline|mesh-list
101501854|NCT04513821|Ethanol|ethanol|mesh-list
101501855|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501856|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501857|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101501858|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501859|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501860|NCT00485108|Prednisolone|prednisolone|mesh-list
101501861|NCT00485108|Ketorolac|ketorolac|mesh-list
101501862|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
101501863|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501864|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
101501865|NCT00485108|Hormones|hormones|mesh-ancestor
101501866|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501867|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501868|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101501869|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501870|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501871|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501872|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501873|NCT00485108|Analgesics|analgesics|mesh-ancestor
101404046|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
101404047|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404048|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404049|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404050|NCT00429208|Nicotine|nicotine|mesh-list
101404051|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101404052|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
101404053|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404054|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404055|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101404056|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101404057|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404058|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404059|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404060|NCT00429247|Trastuzumab|trastuzumab|mesh-list
101404061|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101501874|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
101501875|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501876|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101501877|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501878|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501879|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101501880|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101501881|NCT00485238|Acetazolamide|acetazolamide|mesh-list
101501882|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
101501883|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101501884|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501885|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501886|NCT00485238|Diuretics|diuretics|mesh-ancestor
101501887|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
101501888|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501889|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101501890|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
101501891|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501892|NCT04513509|Propranolol|propranolol|mesh-list
101501893|NCT04513509|Metoprolol|metoprolol|mesh-list
101501894|NCT04513509|Digoxin|digoxin|mesh-list
101501895|NCT04513509|Atenolol|atenolol|mesh-list
101501912|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101501913|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101501914|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501915|NCT04513509|Protective Agents|protective agents|mesh-ancestor
101501916|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101501917|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101501918|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101501919|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101501920|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501921|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101501922|NCT00485342|Interferons|interferons|mesh-list
101501923|NCT00485342|Ribavirin|ribavirin|mesh-list
101501924|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
101501925|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
101501926|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101501927|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501928|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
101501929|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501930|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
101501931|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404062|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404064|NCT00095654|Ramipril|ramipril|mesh-list
101404065|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101404066|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404067|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101404068|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
101404069|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404070|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404071|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101404072|NCT00095693|Sorafenib|sorafenib|mesh-list
101404073|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101404074|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404075|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404076|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404077|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501932|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
101501933|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501934|NCT00489593|Olanzapine|olanzapine|mesh-list
101501935|NCT00489593|Fluoxetine|fluoxetine|mesh-list
101501936|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
101501937|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
101501938|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501939|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501940|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101501941|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101501942|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101501943|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501944|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501945|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101501946|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101501947|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501948|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501949|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501950|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
101501951|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101501952|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
101501953|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101501954|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101501957|NCT01241487|Valsartan|valsartan|mesh-list
101501958|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101501959|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101501960|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501961|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501962|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101501963|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501964|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501965|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101501966|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101501967|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101501968|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
101501969|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501970|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
101501971|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101501972|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101501973|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
101501974|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404078|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101404079|NCT01054573|Interferons|interferons|mesh-list
101404080|NCT01054573|Ribavirin|ribavirin|mesh-list
101404081|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404082|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
101404083|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404084|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
101404085|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404086|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
101404087|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404088|NCT00429442|Simvastatin|simvastatin|mesh-list
101404089|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101404090|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101404091|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
101404092|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501975|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101501976|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101501977|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501978|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501979|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101501980|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101501981|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101501982|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501983|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501984|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501985|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501986|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501988|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101501989|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101501990|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501991|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501992|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101501993|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101501994|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501995|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101501996|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
101501997|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
101501998|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
101501999|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
101502000|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502001|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502002|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
101502003|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502004|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
101502005|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502006|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502007|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502008|NCT00485498|Olanzapine|olanzapine|mesh-list
101502009|NCT00485498|Risperidone|risperidone|mesh-list
101502010|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101502011|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
101502012|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502013|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502014|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502015|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502016|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502017|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502018|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502019|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101404093|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101404094|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101404096|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
101404097|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101404098|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
101404099|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404100|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
101404101|NCT00429520|Protective Agents|protective agents|mesh-ancestor
101404102|NCT00429559|Gemcitabine|gemcitabine|mesh-list
101404103|NCT00429559|Topotecan|topotecan|mesh-list
101404104|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404105|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
101404106|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404107|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404108|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101404109|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404110|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404111|NCT00095810|Aripiprazole|aripiprazole|mesh-list
101404112|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
101404113|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101404114|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101404115|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101404116|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101404117|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404118|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
101404119|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
101404120|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502020|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
101502021|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
101502022|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
101502023|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502024|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502025|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502026|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502041|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502042|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502043|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502045|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502046|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101502047|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502048|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502049|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101502050|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502051|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502052|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404121|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404122|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101404123|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101404124|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
101404125|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101404126|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101404127|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101502053|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502054|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502055|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502057|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101502058|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502059|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
101502060|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502061|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
101502062|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101502063|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502064|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101502065|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101502066|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502067|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502068|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502069|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
101502070|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502071|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502072|NCT00489944|Tamoxifen|tamoxifen|mesh-list
101502073|NCT00489944|Sunitinib|sunitinib|mesh-list
101502074|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502075|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502076|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101502077|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101502078|NCT00489944|Growth Substances|growth substances|mesh-ancestor
101502080|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
101502081|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101502082|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502083|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101502118|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502119|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101502120|NCT00490178|Metformin|metformin|mesh-list
101502121|NCT00490178|Fenofibrate|fenofibrate|mesh-list
101502130|NCT00485771|Fluoxetine|fluoxetine|mesh-list
101502131|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
101502132|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
101502133|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528440|NCT04657107|Analgesics|analgesics|mesh-ancestor
101502134|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502136|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502137|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502138|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502139|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502140|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502141|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502142|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502143|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502144|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502145|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
101502146|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101502147|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502148|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101502149|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101502150|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502151|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
101502152|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101404128|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101404129|NCT05234112|Acetic Acid|acetic acid|mesh-list
101404130|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404131|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404132|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
101502153|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502154|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101502155|NCT00485810|Olanzapine|olanzapine|mesh-list
101502156|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
101502157|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
101502158|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502159|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502160|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502161|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502162|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502163|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502164|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502165|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502166|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502167|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502168|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502169|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502171|NCT00490373|Pemetrexed|pemetrexed|mesh-list
101502172|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502173|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502174|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502175|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101502176|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502177|NCT00485823|Olanzapine|olanzapine|mesh-list
101502179|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
101502180|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502181|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502182|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502183|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502184|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502185|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502186|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502214|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502215|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502216|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502217|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502219|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502220|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101502221|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502222|NCT00485901|Haloperidol|haloperidol|mesh-list
101502223|NCT00485901|Olanzapine|olanzapine|mesh-list
101502224|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
101502225|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
101502240|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101502241|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
101502242|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101502243|NCT00490412|Vitamin D|vitamin d|mesh-list
101502244|NCT00490412|Vitamins|vitamins|mesh-ancestor
101502245|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
101502246|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502247|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502248|NCT00485940|Prucalopride|prucalopride|mesh-list
101502249|NCT00485940|Laxatives|laxatives|mesh-ancestor
101502250|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502251|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101502252|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101502253|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
101502254|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502255|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502256|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502257|NCT00486005|Olanzapine|olanzapine|mesh-list
101502258|NCT00486005|Nizatidine|nizatidine|mesh-list
101404134|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404135|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101404136|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404137|NCT00095888|Gemcitabine|gemcitabine|mesh-list
101404138|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404139|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
101404140|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404141|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404142|NCT00429676|Haloperidol|haloperidol|mesh-list
101404143|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
101404144|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
101404145|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
101404146|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404147|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404148|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404149|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101404150|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101404151|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101404152|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101404153|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101404154|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
101502259|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
101502260|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
101502261|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502262|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502263|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502267|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502268|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502269|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502270|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502271|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502272|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502273|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
101502274|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101502275|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101185977|NCT00000918|Ritonavir|ritonavir|mesh-list
101502276|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
101502277|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
101502278|NCT00485979|Docetaxel|docetaxel|mesh-list
101502279|NCT00485979|Trastuzumab|trastuzumab|mesh-list
101502280|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502281|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101502282|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101502283|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101502312|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101502313|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502314|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404155|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404156|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404157|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101404158|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
101404159|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101404160|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
101404161|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404162|NCT00095927|Paclitaxel|paclitaxel|mesh-list
101404163|NCT00095927|Carboplatin|carboplatin|mesh-list
101404164|NCT00095927|Amifostine|amifostine|mesh-list
101404165|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101404166|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404167|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
101404168|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404169|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404170|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404171|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101404172|NCT00095927|Protective Agents|protective agents|mesh-ancestor
101502315|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101502316|NCT04511715|Growth Substances|growth substances|mesh-ancestor
101502317|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502318|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
101502319|NCT00486317|Calcitonin|calcitonin|mesh-list
101502320|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
101502321|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101502322|NCT00486317|Katacalcin|katacalcin|mesh-list
101502324|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502331|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502333|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502334|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502335|NCT00486356|Carboplatin|carboplatin|mesh-list
101502336|NCT00486356|Capecitabine|capecitabine|mesh-list
101502337|NCT00486356|Epirubicin|epirubicin|mesh-list
101502338|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502339|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502340|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
101502341|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502342|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502343|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101502344|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101502345|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502346|NCT00490958|Telmisartan|telmisartan|mesh-list
101502347|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101502348|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101502349|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101502350|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502352|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
101502353|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
101502354|NCT00486213|Vitamins|vitamins|mesh-ancestor
101502355|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
101502356|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502357|NCT00486369|Calcitonin|calcitonin|mesh-list
101502358|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
101502359|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101502360|NCT00486369|Katacalcin|katacalcin|mesh-list
101404174|NCT00429754|Aprepitant|aprepitant|mesh-list
101404175|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
101404176|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
101404177|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404178|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404179|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404180|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101404181|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404182|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404183|NCT00429832|Promethazine|promethazine|mesh-list
101404184|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
101404185|NCT00429832|Ondansetron|ondansetron|mesh-list
101404186|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
101404187|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
101404188|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404189|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404190|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404191|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
101404192|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101502361|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502362|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502363|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502364|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
101502365|NCT00490997|Ketamine|ketamine|mesh-list
101502366|NCT00490997|Propofol|propofol|mesh-list
101502367|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101502368|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502369|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502370|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101502371|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
101502372|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
101502373|NCT00490997|Analgesics|analgesics|mesh-ancestor
101502374|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
101502375|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502376|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101502377|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101502378|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101502379|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502380|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502381|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
101502383|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
101502384|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101502385|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101502386|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502387|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502388|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
101502390|NCT00486486|Bimatoprost|bimatoprost|mesh-list
101502391|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101502392|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101502393|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
101404194|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101404195|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
101404196|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404197|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404198|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101404199|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
101404200|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
101404201|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101404202|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101404203|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101404204|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101404205|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
101404206|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
101404207|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
101404208|NCT00429871|Docetaxel|docetaxel|mesh-list
101404209|NCT00429871|Capecitabine|capecitabine|mesh-list
101404210|NCT00429871|Epirubicin|epirubicin|mesh-list
101404211|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404212|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
101502419|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502420|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502421|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
101502422|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502423|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502424|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101502425|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
101502426|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101502427|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502428|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101502429|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101502430|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502431|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101502432|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101502433|NCT04510935|Anesthetics|anesthetics|mesh-list
101502434|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502435|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502436|NCT00491192|Diclofenac|diclofenac|mesh-list
101502437|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101502438|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101502439|NCT00491192|Analgesics|analgesics|mesh-ancestor
101502440|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
101502441|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502442|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502454|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502456|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101502457|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502458|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502459|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502460|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502461|NCT00486785|Alfuzosin|alfuzosin|mesh-list
101404213|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404214|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404215|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404216|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404217|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
101404218|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101404219|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101404220|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404221|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404222|NCT00095966|Gemcitabine|gemcitabine|mesh-list
101404223|NCT00095966|Sorafenib|sorafenib|mesh-list
101404224|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502462|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101502463|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101502464|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101502465|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502466|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502467|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502468|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502469|NCT00486785|Urological Agents|urological agents|mesh-ancestor
101502470|NCT04324411|Sirolimus|sirolimus|mesh-list
101502471|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101502472|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502473|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502474|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502475|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
101502476|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502477|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
101502478|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502479|NCT00486876|Tofisopam|tofisopam|mesh-list
101502480|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502481|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502482|NCT05643586|Ticagrelor|ticagrelor|mesh-list
101502483|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101502484|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101502485|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101502486|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101502487|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101502488|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
101502489|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547865|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
101502490|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502491|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502492|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
101502493|NCT01242072|Ifosfamide|ifosfamide|mesh-list
101502494|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101502495|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
101502496|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186197|NCT00001296|Interferons|interferons|mesh-list
101502497|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502498|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101502499|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101502500|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502501|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502502|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502525|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101502526|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101502527|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502528|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502529|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404225|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
101404226|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404227|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404228|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404229|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404230|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
101404232|NCT01803594|Niacinamide|niacinamide|mesh-list
101404233|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
101404234|NCT01803594|Vitamins|vitamins|mesh-ancestor
101404235|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
101404236|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404237|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101404238|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
101404239|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404240|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101404241|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
101404242|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
101404243|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404244|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404245|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404246|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404247|NCT00096005|Bortezomib|bortezomib|mesh-list
101404248|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404249|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
101404250|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404251|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
101404252|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404253|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404254|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101404255|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
101404256|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404257|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404258|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101404259|NCT00430144|Belotecan|belotecan|mesh-list
101404260|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101404261|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404264|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404266|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404267|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404268|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101404269|NCT00430261|Growth Substances|growth substances|mesh-ancestor
101404270|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404271|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101404272|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404273|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404274|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404275|NCT00096083|Melphalan|melphalan|mesh-list
101404276|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101502530|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
101502531|NCT01242098|Hormones|hormones|mesh-ancestor
101502532|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502533|NCT01301092|Dulaglutide|dulaglutide|mesh-list
101502534|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502535|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502536|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101502537|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
101502538|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502539|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502540|NCT04510818|Capecitabine|capecitabine|mesh-list
101502541|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502542|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
101502543|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502544|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502545|NCT05642845|Atorvastatin|atorvastatin|mesh-list
101502546|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101502547|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101502548|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
101502549|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502550|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101502551|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101502552|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502553|NCT04510662|Telmisartan|telmisartan|mesh-list
101502554|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101502571|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502572|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502573|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
101502574|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
101502575|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502576|NCT02275962|Rifampin|rifampin|mesh-list
101502577|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101502578|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
101502579|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101502580|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502581|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
101502582|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502583|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502584|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502585|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101502586|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101502587|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101502588|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101502589|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101502590|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101502591|NCT00487032|Fluticasone|fluticasone|mesh-list
101502592|NCT00487032|Xhance|xhance|mesh-list
101404277|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
101404278|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404279|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404280|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101404281|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404282|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
101404283|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404284|NCT01726452|Leucovorin|leucovorin|mesh-list
101404285|NCT01726452|Paclitaxel|paclitaxel|mesh-list
101404286|NCT01726452|Docetaxel|docetaxel|mesh-list
101404288|NCT01726452|Fluorouracil|fluorouracil|mesh-list
101404289|NCT01726452|Capecitabine|capecitabine|mesh-list
101404290|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
101404291|NCT01726452|Epirubicin|epirubicin|mesh-list
101404292|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101404293|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404294|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
101404295|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404296|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
101502593|NCT00487032|Prazosin|prazosin|mesh-list
101502594|NCT00487032|Phenylephrine|phenylephrine|mesh-list
101502595|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
101502596|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502597|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101502598|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
101502599|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502600|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502601|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101502602|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
101502603|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
101502604|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101502605|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101502606|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101502607|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502608|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502609|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502610|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
101502611|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
101502612|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101502617|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101502618|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101502619|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101502620|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101502622|NCT00491426|Tazobactam|tazobactam|mesh-list
101502623|NCT00491426|Piperacillin|piperacillin|mesh-list
101502624|NCT00491426|Amphotericin B|amphotericin b|mesh-list
101502625|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101502626|NCT00491426|Acyclovir|acyclovir|mesh-list
101502627|NCT00491426|Ampicillin|ampicillin|mesh-list
101502628|NCT00491426|Caspofungin|caspofungin|mesh-list
101502629|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101502630|NCT00491426|Anidulafungin|anidulafungin|mesh-list
101502631|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502632|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101502633|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101502634|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101502635|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101502636|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502637|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404297|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404298|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
101404299|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502638|NCT00491426|Amebicides|amebicides|mesh-ancestor
101502639|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
101502640|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
101502641|NCT01300546|Naproxen|naproxen|mesh-list
101502642|NCT01300546|Sumatriptan|sumatriptan|mesh-list
101416122|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101502643|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101502644|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101502645|NCT01300546|Analgesics|analgesics|mesh-ancestor
101502646|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
101502647|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502648|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502649|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502650|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502651|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
101502652|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101502653|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502654|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502655|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101502656|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101502657|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101502658|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
101502659|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502661|NCT00487110|Tropisetron|tropisetron|mesh-list
101502662|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101502663|NCT00487110|Analgesics|analgesics|mesh-ancestor
101502664|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
101502665|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502666|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502668|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
101502669|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
101502670|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502671|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101502672|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101502673|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
101502674|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502675|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502676|NCT00487136|Warfarin|warfarin|mesh-list
101502677|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101502678|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
101502679|NCT00487136|Fenofibrate|fenofibrate|mesh-list
101502680|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101502681|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101502682|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
101502683|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502684|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101502686|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502687|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
101502688|NCT02276001|Cyclosporine|cyclosporine|mesh-list
101502689|NCT02276001|Cyclosporins|cyclosporins|mesh-list
101502690|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502691|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502692|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502693|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
101502694|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502695|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
101502696|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502697|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
101502698|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502699|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101502700|NCT00491582|Hormones|hormones|mesh-list
101502701|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502702|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502703|NCT00487175|Tramadol|tramadol|mesh-list
101502704|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101502705|NCT00487175|Narcotics|narcotics|mesh-ancestor
101502706|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502707|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404300|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404301|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
101404302|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404303|NCT01726452|Antidotes|antidotes|mesh-ancestor
101404304|NCT01726452|Protective Agents|protective agents|mesh-ancestor
101404305|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
101404306|NCT01726452|Vitamins|vitamins|mesh-ancestor
101404307|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
101404308|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502708|NCT00487175|Analgesics|analgesics|mesh-ancestor
101502709|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
101502710|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502711|NCT00487227|Caffeine|caffeine|mesh-list
101502712|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101502713|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502714|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101502715|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502716|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502717|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101502718|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101502719|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
101502720|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502722|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101502723|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502724|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101502725|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101502726|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
101502728|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502730|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101502731|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
101502732|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502733|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502734|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101502735|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101502736|NCT04510233|Ivermectin|ivermectin|mesh-list
101502737|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101502738|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502739|NCT05641909|Fentanyl|fentanyl|mesh-list
101502740|NCT05641909|Remifentanil|remifentanil|mesh-list
101502741|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101502742|NCT05641909|Narcotics|narcotics|mesh-ancestor
101502743|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502744|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502745|NCT05641909|Analgesics|analgesics|mesh-ancestor
101502746|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
101502747|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502748|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101502749|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101502750|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
101502751|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
101502752|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
101502753|NCT02276196|Lixisenatide|lixisenatide|mesh-list
101502754|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502755|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502756|NCT00487422|Prucalopride|prucalopride|mesh-list
101502757|NCT00487422|Laxatives|laxatives|mesh-ancestor
101502758|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502759|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101502768|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
101502769|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502770|NCT04697355|Protective Agents|protective agents|mesh-ancestor
101502771|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502772|NCT04697355|Provitamins|provitamins|mesh-ancestor
101502773|NCT04697355|Vitamins|vitamins|mesh-ancestor
101502774|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
101404310|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404311|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404312|NCT00096317|Ketoconazole|ketoconazole|mesh-list
101404313|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
101404314|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404315|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101404316|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101404317|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404318|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404319|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101404320|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
101404321|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404322|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502775|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101502776|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502777|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101502778|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
101502779|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502780|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101502781|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502782|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101502783|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502784|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502785|NCT00491855|Paclitaxel|paclitaxel|mesh-list
101502786|NCT00491855|Bevacizumab|bevacizumab|mesh-list
101502787|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
101502788|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101502789|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502790|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
101502791|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
101502792|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
101502793|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502794|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101502795|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101502796|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101502797|NCT00491855|Growth Substances|growth substances|mesh-ancestor
101502798|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502799|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
101502800|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101502801|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502802|NCT00487448|Cytarabine|cytarabine|mesh-list
101502803|NCT00487448|Fludarabine|fludarabine|mesh-list
101502804|NCT00487448|Idarubicin|idarubicin|mesh-list
101502805|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502806|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502807|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
101502808|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502809|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502810|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
101502811|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502812|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
101502813|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502814|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502815|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101502816|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101502817|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502818|NCT00506259|Melatonin|melatonin|mesh-list
101502819|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
101404323|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101404325|NCT00096395|Sorafenib|sorafenib|mesh-list
101404326|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404327|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
101404329|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404330|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404331|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404332|NCT00096434|Sorafenib|sorafenib|mesh-list
101404333|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502820|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502821|NCT00506259|Protective Agents|protective agents|mesh-ancestor
101502822|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502823|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502824|NCT00506298|Diflunisal|diflunisal|mesh-list
101502825|NCT00506298|Bezafibrate|bezafibrate|mesh-list
101502826|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101502827|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
101502844|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101502845|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502846|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502847|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502848|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
101502849|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101502850|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502851|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101502852|NCT01242228|Vildagliptin|vildagliptin|mesh-list
101502853|NCT01242228|Saxagliptin|saxagliptin|mesh-list
101502854|NCT01242228|Alogliptin|alogliptin|mesh-list
101502855|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
101502856|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101502857|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502858|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502859|NCT01242228|Incretins|incretins|mesh-ancestor
101502860|NCT01242228|Hormones|hormones|mesh-ancestor
101502861|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502862|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
101502863|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502864|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502865|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101502866|NCT01242306|Acetylcholine|acetylcholine|mesh-list
101502867|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
101502868|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101502869|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
101502870|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502871|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502872|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502873|NCT00492128|Losartan|losartan|mesh-list
101502874|NCT00492128|Amlodipine|amlodipine|mesh-list
101502875|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101502876|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101502877|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101502878|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502879|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502880|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502881|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502882|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
101502883|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101502884|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101502885|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101502897|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502898|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404334|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404336|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404337|NCT00096473|Donepezil|donepezil|mesh-list
101404338|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101404339|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502899|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502901|NCT01300234|Tenofovir|tenofovir|mesh-list
101502902|NCT01300234|Adefovir|adefovir|mesh-list
101502903|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101502904|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
101502905|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502906|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101502907|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502908|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502909|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502910|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101502911|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101502912|NCT01242332|Pregabalin|pregabalin|mesh-list
101502913|NCT01242332|Analgesics|analgesics|mesh-ancestor
101502914|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
101502915|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502916|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502917|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
101502918|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101502919|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502920|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502921|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502922|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101502923|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502924|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502925|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502926|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
101502927|NCT00487773|Budesonide|budesonide|mesh-list
101502928|NCT00487773|Albuterol|albuterol|mesh-list
101502929|NCT00487773|Montelukast|montelukast|mesh-list
101502930|NCT00487773|Vitamins|vitamins|mesh-ancestor
101502931|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
101502932|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502933|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502934|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101502935|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
101502936|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502937|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101502938|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
101502939|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
101502940|NCT00487773|Hormones|hormones|mesh-ancestor
101502941|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502942|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101502943|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101502944|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101502945|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101502946|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502947|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
101502948|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101502949|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101502955|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502957|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101502958|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502959|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101502960|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502961|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502962|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
101502963|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502964|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502966|NCT00492245|Mitomycin|mitomycin|mesh-list
101404340|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404341|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404342|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404343|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404344|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
101404345|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
101404346|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101404347|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404349|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404350|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404351|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404352|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404353|NCT00096551|Metronidazole|metronidazole|mesh-list
101404354|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502967|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101502968|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502969|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
101502970|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502971|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502972|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502973|NCT00487812|Dobutamine|dobutamine|mesh-list
101502974|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101502975|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
101502976|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
101502977|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502978|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502979|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101502980|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101502981|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101502982|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502983|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502984|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502985|NCT00487812|Protective Agents|protective agents|mesh-ancestor
101502986|NCT01299805|Vortioxetine|vortioxetine|mesh-list
101502987|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502988|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502989|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101502990|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502991|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502992|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502993|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502994|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502995|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502996|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502997|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502998|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
101502999|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101503000|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101503001|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101503002|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101503003|NCT00487682|Valacyclovir|valacyclovir|mesh-list
101503004|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
101503005|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503006|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
101503007|NCT04512261|Trastuzumab|trastuzumab|mesh-list
101503008|NCT04512261|Tucatinib|tucatinib|mesh-list
101503009|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404355|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404356|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101404357|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101404358|NCT00095186|Lactoferrin|lactoferrin|mesh-list
101404359|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404360|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
101404361|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101404362|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101404363|NCT00130572|Analgesics|analgesics|mesh-ancestor
101404364|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
101404365|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404366|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404367|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404368|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404369|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101404370|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404371|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
101404372|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101503010|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503011|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101503012|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503013|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503014|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503015|NCT00487799|Ularitide|ularitide|mesh-list
101503016|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101503017|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
101503035|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503037|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503038|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503039|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
101503040|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503041|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503042|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
101503043|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503044|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
101503045|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101503046|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503047|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101503048|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503049|NCT00495326|Efavirenz|efavirenz|mesh-list
101503050|NCT00495326|Nevirapine|nevirapine|mesh-list
101503051|NCT00495326|Rifampin|rifampin|mesh-list
101503052|NCT00495326|Isoniazid|isoniazid|mesh-list
101503053|NCT00495326|Ethambutol|ethambutol|mesh-list
101503054|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101503055|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101503056|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503057|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503058|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
101503059|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503060|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101503061|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101503062|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101503063|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101503064|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101503065|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101503066|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101404373|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404374|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404376|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
101404377|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404378|NCT00430651|Carboplatin|carboplatin|mesh-list
101404379|NCT00430651|Docetaxel|docetaxel|mesh-list
101404380|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404381|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
101404382|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404383|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404384|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404385|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
101404386|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
101404387|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101404388|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101404389|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404390|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404391|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404393|NCT00096668|Paclitaxel|paclitaxel|mesh-list
101404394|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101503067|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
101503068|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101503069|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
101503070|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101503071|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101503072|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101503073|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101503074|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101503079|NCT00492479|Kinetin|kinetin|mesh-list
101503080|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101503081|NCT00492479|Growth Substances|growth substances|mesh-ancestor
101503082|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503083|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
101503084|NCT00495365|Hematinics|hematinics|mesh-ancestor
101503085|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
101503086|NCT00492518|Theophylline|theophylline|mesh-list
101503087|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101503088|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
101503089|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503090|NCT00492518|Expectorants|expectorants|mesh-ancestor
101503091|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503092|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101503093|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
101503094|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503095|NCT00492518|Protective Agents|protective agents|mesh-ancestor
101503096|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503097|NCT00492518|Antidotes|antidotes|mesh-ancestor
101503098|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101503099|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
101503100|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503101|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101503102|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101503103|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404395|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404397|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404398|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404399|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404400|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101404401|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404402|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404403|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
101404404|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
101404405|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
101404406|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404407|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
101404408|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101404409|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
101404410|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101404411|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
101404412|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404413|NCT00430924|Eplerenone|eplerenone|mesh-list
101404414|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101503105|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101503106|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101503107|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
101503108|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503110|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
101503111|NCT00495560|Misoprostol|misoprostol|mesh-list
101503112|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101503113|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
101503114|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101503115|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503116|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101503117|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101503118|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
101503119|NCT00506844|Capecitabine|capecitabine|mesh-list
101503120|NCT00506844|Irinotecan|irinotecan|mesh-list
101503121|NCT00506844|Cetuximab|cetuximab|mesh-list
101503122|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503123|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
101503124|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503125|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503126|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101503127|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503128|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503129|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101503130|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101503131|NCT00506961|Simvastatin|simvastatin|mesh-list
101503132|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101503133|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101503134|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
101503135|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503136|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101503137|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101503138|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503139|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101503140|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
101404415|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
101404416|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404417|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404418|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101404419|NCT00430924|Diuretics|diuretics|mesh-ancestor
101404420|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
101404421|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101404422|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
101503141|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101503142|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101503143|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503144|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503145|NCT00492635|Urological Agents|urological agents|mesh-ancestor
101503146|NCT00507000|Vitamin D|vitamin d|mesh-list
101503147|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
101503148|NCT00507000|Vitamins|vitamins|mesh-ancestor
101503176|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101503177|NCT00507117|Eszopiclone|eszopiclone|mesh-list
101503178|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101503179|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503180|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503181|NCT00492830|Antibodies|antibodies|mesh-list
101503182|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101503183|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
101503184|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503185|NCT01299571|Dutasteride|dutasteride|mesh-list
101503186|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101503187|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101503188|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503189|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503190|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
101503191|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503192|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503193|NCT01243736|Metoclopramide|metoclopramide|mesh-list
101503194|NCT01243736|Simethicone|simethicone|mesh-list
101503195|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
101503196|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
101503197|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503198|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503199|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101503210|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503211|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503212|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503213|NCT01243970|Phenylephrine|phenylephrine|mesh-list
101503214|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
101503215|NCT01243970|Ephedrine|ephedrine|mesh-list
101503216|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101503217|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
101503218|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
101503219|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503220|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503221|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
101503222|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101503223|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
101503224|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503225|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101503226|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101503227|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101503228|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
101503229|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503230|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503231|NCT01243970|Protective Agents|protective agents|mesh-ancestor
101503232|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101503233|NCT04515576|Dulaglutide|dulaglutide|mesh-list
101503234|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101503235|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503236|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101404423|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
101404424|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404425|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
101404426|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404427|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101404428|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101404429|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404430|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404431|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101404432|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101404433|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404434|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404435|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404436|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101503237|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101503238|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503239|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503240|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101503241|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
101503242|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503243|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503244|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
101503245|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
101186938|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503247|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101503248|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503249|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503250|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503251|NCT04511832|Diclofenac|diclofenac|mesh-list
101503252|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101503253|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101503254|NCT04511832|Analgesics|analgesics|mesh-ancestor
101503255|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
101503256|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503257|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503258|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503259|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503260|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101503261|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503262|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503292|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503293|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503294|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101503295|NCT04518462|Bupivacaine|bupivacaine|mesh-list
101503296|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
101503297|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
101503298|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503299|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503300|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
101503301|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503302|NCT00496184|Nifedipine|nifedipine|mesh-list
101503303|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101503304|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503305|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404437|NCT05102409|Lifitegrast|lifitegrast|mesh-list
101404438|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101404439|NCT01053247|Tacrolimus|tacrolimus|mesh-list
101404440|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404441|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
101404442|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404443|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101404444|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404445|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404446|NCT00096863|Haloperidol|haloperidol|mesh-list
101404447|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
101404448|NCT00096863|Ziprasidone|ziprasidone|mesh-list
101404449|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
101404450|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
101404451|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404452|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404453|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404454|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101404455|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101404456|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101404457|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101404458|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101404459|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
101404460|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404461|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404462|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101404463|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101404464|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
101503306|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101503307|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503308|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
101503309|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
101503321|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503322|NCT00493610|Antidotes|antidotes|mesh-ancestor
101503323|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
101503324|NCT02274506|Fludarabine|fludarabine|mesh-list
101503325|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
101503326|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503327|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
101503328|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503329|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503330|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101503331|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
101503332|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503333|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503334|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101503335|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404465|NCT00130767|Finasteride|finasteride|mesh-list
101404466|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101404468|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404469|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404470|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
101404471|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404472|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404473|NCT00130767|Urological Agents|urological agents|mesh-ancestor
101404474|NCT00431080|Paclitaxel|paclitaxel|mesh-list
101404475|NCT00431080|Docetaxel|docetaxel|mesh-list
101404476|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
101404477|NCT00431080|Epirubicin|epirubicin|mesh-list
101404478|NCT00431080|Fluorouracil|fluorouracil|mesh-list
101404479|NCT00431080|Lenograstim|lenograstim|mesh-list
101404480|NCT00431080|Mitogens|mitogens|mesh-list
101404481|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101404482|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404483|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101404484|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101503337|NCT00496223|Sunitinib|sunitinib|mesh-list
101503338|NCT00496223|Dacarbazine|dacarbazine|mesh-list
101503339|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503340|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101503341|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101503342|NCT00496223|Growth Substances|growth substances|mesh-ancestor
101503343|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416144|NCT04085250|Nivolumab|nivolumab|mesh-list
101503344|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
101503345|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503346|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503347|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503348|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101503349|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
101503350|NCT00496301|Gemcitabine|gemcitabine|mesh-list
101503351|NCT00496301|Capecitabine|capecitabine|mesh-list
101503352|NCT00496301|Sorafenib|sorafenib|mesh-list
101503353|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503354|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
101503355|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503356|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503357|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503358|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503359|NCT05141838|Vitamin D|vitamin d|mesh-list
101503360|NCT05141838|Vitamins|vitamins|mesh-ancestor
101503361|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
101503362|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503363|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503364|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
101503365|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101503366|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
101503367|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503368|NCT00493727|Expectorants|expectorants|mesh-ancestor
101503369|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503370|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101503371|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
101503372|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404485|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404486|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404487|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404488|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
101404489|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404490|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404491|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101404492|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
101404493|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101404494|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101404495|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101404496|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404497|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404498|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
101404499|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404500|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101404501|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
101404502|NCT00431119|Azathioprine|azathioprine|mesh-list
101404503|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101404504|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404505|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101404506|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
101404507|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404508|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503373|NCT00493727|Protective Agents|protective agents|mesh-ancestor
101503381|NCT05146479|Fluorides|fluorides|mesh-list
101503382|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
101503383|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
101503384|NCT05146479|Protective Agents|protective agents|mesh-ancestor
101503385|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503386|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101503387|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101503388|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503389|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503390|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
101503391|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503392|NCT01296568|Gemcitabine|gemcitabine|mesh-list
101187099|NCT00002460|Tamoxifen|tamoxifen|mesh-list
101503393|NCT01296568|Pemetrexed|pemetrexed|mesh-list
101503394|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503396|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503397|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503398|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503399|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101503400|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101503401|NCT02598999|Lactoferrin|lactoferrin|mesh-list
101503402|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
101503403|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503404|NCT01296412|Metformin|metformin|mesh-list
101503405|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101503406|NCT01296412|Liraglutide|liraglutide|mesh-list
101404509|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404510|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404511|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
101404512|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404513|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404514|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
101503407|NCT01296412|Glimepiride|glimepiride|mesh-list
101503408|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101503409|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503410|NCT01296412|Incretins|incretins|mesh-ancestor
101503411|NCT01296412|Hormones|hormones|mesh-ancestor
101503412|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503413|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101503414|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
101503415|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503416|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503417|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101503418|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503419|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
101503420|NCT00496652|Zalutumumab|zalutumumab|mesh-list
101503421|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101503422|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503423|NCT02597634|Ibuprofen|ibuprofen|mesh-list
101503424|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101503425|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101503426|NCT02597634|Analgesics|analgesics|mesh-ancestor
101503427|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
101503428|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503429|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503430|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503431|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503432|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101503433|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503434|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503435|NCT02591199|Lidocaine|lidocaine|mesh-list
101503436|NCT02591199|Heparin|heparin|mesh-list
101503437|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
101503438|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
101503439|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503440|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503441|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
101503457|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101503458|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503459|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101503460|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503462|NCT00494156|Heparin|heparin|mesh-list
101503463|NCT00494156|Clopidogrel|clopidogrel|mesh-list
101503464|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101503465|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101503466|NCT00494156|Analgesics|analgesics|mesh-ancestor
101503467|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
101503468|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503469|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503470|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503471|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503472|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101503473|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101503474|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503475|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101503476|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101503477|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547979|NCT00600054|Antibodies|antibodies|mesh-list
101503478|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
101503479|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101503480|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101503481|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101503482|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
101503483|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404515|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404516|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404517|NCT00097019|Bevacizumab|bevacizumab|mesh-list
101404518|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404519|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404520|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404521|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101404522|NCT00097019|Growth Substances|growth substances|mesh-ancestor
101503484|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
101503485|NCT02595489|Vitamin D|vitamin d|mesh-list
101503486|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
101503487|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
101503488|NCT02595489|Vitamins|vitamins|mesh-list
101503489|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
101503490|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503491|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503492|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101503494|NCT00497003|Carvedilol|carvedilol|mesh-list
101503495|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101503496|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101503497|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
101503498|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
101503499|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503508|NCT00497003|Protective Agents|protective agents|mesh-ancestor
101503509|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101503510|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503511|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101503512|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
101503513|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101503514|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101503515|NCT00494312|Pioglitazone|pioglitazone|mesh-list
101503516|NCT00494312|Glyburide|glyburide|mesh-list
101503517|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101503518|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503520|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101503521|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101503522|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101503523|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503524|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503525|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
101503526|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101503527|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503528|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
101503529|NCT02596503|Cefixime|cefixime|mesh-list
101503530|NCT02596503|Irinotecan|irinotecan|mesh-list
101503531|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101503532|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503533|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503534|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503535|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503536|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101503537|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503538|NCT00494429|Morphine|morphine|mesh-list
101503539|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101503540|NCT00494429|Narcotics|narcotics|mesh-ancestor
101547989|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101503541|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503542|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503543|NCT00494429|Analgesics|analgesics|mesh-ancestor
101187246|NCT00002532|Antidotes|antidotes|mesh-ancestor
101503544|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
101503545|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503546|NCT00497120|Acetazolamide|acetazolamide|mesh-list
101503547|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
101503548|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101503549|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404523|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404525|NCT00431197|Ketoconazole|ketoconazole|mesh-list
101404526|NCT00431197|Testosterone|testosterone|mesh-list
101404527|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
101404528|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404529|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101503550|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503551|NCT00497120|Diuretics|diuretics|mesh-ancestor
101503552|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
101503553|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503554|NCT00494468|Zolpidem|zolpidem|mesh-list
101503555|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101503556|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101503557|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503558|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503559|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101503560|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
101503561|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
101503562|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503563|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503564|NCT00497237|Fluticasone|fluticasone|mesh-list
101503583|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
101503584|NCT00497237|Hormones|hormones|mesh-ancestor
101503585|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503586|NCT00497315|Pemetrexed|pemetrexed|mesh-list
101503587|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503588|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503589|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503590|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101503591|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101503592|NCT05142072|Vitamin D|vitamin d|mesh-list
101503593|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
101503594|NCT05142072|Vitamins|vitamins|mesh-ancestor
101503595|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
101503596|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503597|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503598|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101503599|NCT00497354|Anesthetics|anesthetics|mesh-list
101503600|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
101503601|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503602|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503603|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
101503604|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503605|NCT00494624|Prednisolone|prednisolone|mesh-list
101503606|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503607|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
101503608|NCT00494624|Hormones|hormones|mesh-ancestor
101503609|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503610|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503611|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101503612|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503613|NCT00494663|Ketoconazole|ketoconazole|mesh-list
101503614|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
101503615|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503616|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101503617|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101503618|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503619|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503630|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503631|NCT05146674|Urological Agents|urological agents|mesh-ancestor
101503632|NCT00507195|Midazolam|midazolam|mesh-list
101503633|NCT00507195|Propofol|propofol|mesh-list
101503634|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101503635|NCT00507195|Sevoflurane|sevoflurane|mesh-list
101503636|NCT00507195|Desflurane|desflurane|mesh-list
101503637|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503638|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404530|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101404531|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404532|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404533|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101404534|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
101404535|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404536|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404537|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101404538|NCT00431197|Androgens|androgens|mesh-ancestor
101404539|NCT00431197|Hormones|hormones|mesh-ancestor
101404540|NCT00431236|Dexamethasone|dexamethasone|mesh-list
101404541|NCT00431236|Ondansetron|ondansetron|mesh-list
101404542|NCT00431236|Casopitant|casopitant|mesh-list
101404543|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404544|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
101404545|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
101404546|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404547|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404548|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404549|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
101404551|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404552|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404554|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
101404581|NCT00431392|Propranolol|propranolol|mesh-list
101404582|NCT00431392|Phenylephrine|phenylephrine|mesh-list
101404583|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
101404584|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101404585|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101404586|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
101404587|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
101404588|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404589|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404590|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
101404591|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101404592|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
101404593|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
101404594|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101404595|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101404596|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101404597|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
101404598|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404599|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503639|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101503640|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
101503641|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
101503642|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101503643|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101503644|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101503645|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101503646|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
101503647|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
101503648|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503649|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503650|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101503651|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101503652|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
101503653|NCT00497471|Dapsone|dapsone|mesh-list
101503654|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
101503655|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101503656|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101503657|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503658|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101503659|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503660|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503661|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
101503662|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101503663|NCT05146635|Epirubicin|epirubicin|mesh-list
101503664|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101503665|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503666|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101503667|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503668|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503669|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503670|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
101503671|NCT00494741|Azathioprine|azathioprine|mesh-list
101503672|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101503673|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503674|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101503675|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
101404601|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101404602|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101404603|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101404604|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101404605|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
101404606|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101404607|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101404608|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404609|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101404610|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101404611|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101404612|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
101404613|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404614|NCT00130884|Simendan|simendan|mesh-list
101503676|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101503677|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503678|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503679|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503680|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
101503681|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503682|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503683|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
101503686|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
101503687|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101503688|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
101503689|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503690|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503691|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101187396|NCT00002598|Methotrexate|methotrexate|mesh-list
101503692|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503693|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101503694|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101503695|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101503696|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
101503697|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503698|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503700|NCT05148546|Ipilimumab|ipilimumab|mesh-list
101503701|NCT05148546|Relatlimab|relatlimab|mesh-list
101503702|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101503703|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503704|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101503705|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503706|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101503707|NCT00506532|Calfactant|calfactant|mesh-list
101503708|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503709|NCT05149560|Ticagrelor|ticagrelor|mesh-list
101503710|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101503711|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101503712|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101503713|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101503714|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
101503715|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503716|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503717|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503718|NCT00494897|Cytarabine|cytarabine|mesh-list
101503719|NCT00494897|Prednisone|prednisone|mesh-list
101503720|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
101503721|NCT00494897|Methotrexate|methotrexate|mesh-list
101503722|NCT00494897|Vincristine|vincristine|mesh-list
101503723|NCT00494897|Daunorubicin|daunorubicin|mesh-list
101503724|NCT00494897|Asparaginase|asparaginase|mesh-list
101503725|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
101503726|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404616|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
101404617|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101404618|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101404619|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404620|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404621|NCT00130884|Protective Agents|protective agents|mesh-ancestor
101404622|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404623|NCT01052662|Memantine|memantine|mesh-list
101404624|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101404625|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101404626|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
101404627|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404628|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404629|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503727|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
101503728|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503729|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503730|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101503731|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
101503732|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503733|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503734|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101503735|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503736|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
101503737|NCT00494897|Hormones|hormones|mesh-ancestor
101503738|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503739|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101503740|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101503741|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
101503742|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101503743|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503744|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
101503745|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
101503746|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503747|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101503748|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101503749|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
101503750|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503751|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101503752|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
101503753|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
101503754|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
101503755|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101503767|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503768|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101503769|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101503770|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
101503771|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503772|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101503773|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101503774|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
101503775|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
101503776|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503777|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101503778|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101503779|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404630|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101404631|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101404632|NCT00097214|Carboplatin|carboplatin|mesh-list
101404634|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404635|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404636|NCT05049057|Erenumab|erenumab|mesh-list
101404637|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101404638|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404639|NCT05049057|Analgesics|analgesics|mesh-ancestor
101404640|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
101503780|NCT01244360|Resveratrol|resveratrol|mesh-list
101503781|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
101503782|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503783|NCT01244360|Protective Agents|protective agents|mesh-ancestor
101503784|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503785|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503786|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101503787|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
101503789|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503790|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101503791|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503792|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503793|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503794|NCT00497900|Vitamin D|vitamin d|mesh-list
101503795|NCT00497900|Vitamins|vitamins|mesh-ancestor
101503796|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
101503797|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503798|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503799|NCT05143125|Decitabine|decitabine|mesh-list
101503800|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503801|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
101503802|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503803|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503804|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503805|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
101503806|NCT00497939|Urological Agents|urological agents|mesh-ancestor
101503807|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
101503808|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101503809|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503810|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503811|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101503812|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101503813|NCT00498134|Analgesics|analgesics|mesh-ancestor
101503814|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
101503815|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503816|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503817|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503818|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503819|NCT00498251|Albuterol|albuterol|mesh-list
101503823|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503824|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503825|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101503826|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503828|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101503829|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101503830|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101503831|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101503832|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
101503833|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503834|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404641|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404642|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404643|NCT00431665|Heparin|heparin|mesh-list
101404644|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101404645|NCT00431665|Somatostatin|somatostatin|mesh-list
101404646|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101404647|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404648|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
101404649|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101404650|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101404651|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404652|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101404653|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101404654|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101404655|NCT00431665|Hormones|hormones|mesh-ancestor
101404656|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404657|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404658|NCT04703608|Ivermectin|ivermectin|mesh-list
101404659|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101404660|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503835|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101503836|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
101503838|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
101503839|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503840|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
101503841|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503842|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503844|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101503845|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
101503846|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503847|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503848|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503849|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101503850|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101503851|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503852|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101503853|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101503854|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
101503855|NCT05146089|Bosentan|bosentan|mesh-list
101503856|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101503857|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101503858|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503859|NCT02954913|Liver Extracts|liver extracts|mesh-list
101503860|NCT02954913|Hematinics|hematinics|mesh-ancestor
101503861|NCT00502892|Carboplatin|carboplatin|mesh-list
101503862|NCT00502892|Topotecan|topotecan|mesh-list
101503863|NCT00502892|Ifosfamide|ifosfamide|mesh-list
101503864|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503865|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101503866|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503867|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503868|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503869|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101503870|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
101404662|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101404663|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
101404664|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404665|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404666|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101404667|NCT04727073|Diuretics|diuretics|mesh-ancestor
101404668|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
101404670|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
101503871|NCT00502970|Interferons|interferons|mesh-list
101503872|NCT00502970|Ribavirin|ribavirin|mesh-list
101503873|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
101503874|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503875|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
101503876|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503877|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
101503878|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503879|NCT00502970|Hematinics|hematinics|mesh-ancestor
101503880|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
101503881|NCT05149287|Lidocaine|lidocaine|mesh-list
101503882|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
101503883|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
101503884|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503885|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503886|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
101503887|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503888|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101503889|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101503890|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101503891|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503913|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
101503914|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101503915|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101503916|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
101187629|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101503917|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503918|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503919|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503920|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101503921|NCT00503126|Bivalirudin|bivalirudin|mesh-list
101503922|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
101503923|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101503924|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
101503925|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503926|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503927|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
101503928|NCT05145543|Dexamethasone|dexamethasone|mesh-list
101503929|NCT05145543|Fentanyl|fentanyl|mesh-list
101503930|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
101503931|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503932|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
101503933|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
101503934|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503935|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503936|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101503937|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
101503938|NCT05145543|Hormones|hormones|mesh-ancestor
101503939|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503940|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101503941|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503942|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101503943|NCT05145543|Narcotics|narcotics|mesh-ancestor
101503944|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503945|NCT05145543|Analgesics|analgesics|mesh-ancestor
101503963|NCT00503243|Analgesics|analgesics|mesh-ancestor
101404671|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404672|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101404673|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101404674|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404675|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
101503964|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
101503965|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503966|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503967|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503968|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503969|NCT00498992|Vitamin E|vitamin e|mesh-list
101503970|NCT00498992|Lidocaine|lidocaine|mesh-list
101503971|NCT00498992|Vitamins|vitamins|mesh-ancestor
101503972|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
101503973|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503974|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
101503975|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
101503976|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503977|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
101503978|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503979|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101503980|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101503981|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101503982|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503983|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503984|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
101503985|NCT00498992|Protective Agents|protective agents|mesh-ancestor
101503986|NCT02276391|Telmisartan|telmisartan|mesh-list
101503987|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101503988|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101503989|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101503990|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503991|NCT05145270|Sulforaphane|sulforaphane|mesh-list
101503993|NCT05145270|Citalopram|citalopram|mesh-list
101503994|NCT05145270|Escitalopram|escitalopram|mesh-list
101503995|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101503996|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101503997|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503998|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503999|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504000|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
101504001|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504002|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101504006|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504007|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101504008|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101504010|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101504011|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
101504012|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101504013|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101504014|NCT05145270|Protective Agents|protective agents|mesh-ancestor
101504015|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504021|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
101504022|NCT00503321|Tegafur|tegafur|mesh-list
101504023|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504024|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
101504025|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504026|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504027|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101504028|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
101504029|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404676|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404677|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101404678|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101404679|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
101404680|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101404682|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
101404683|NCT00131040|Coagulants|coagulants|mesh-ancestor
101404684|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101404685|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101404686|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101404687|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404688|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404689|NCT00400478|Rituximab|rituximab|mesh-list
101404690|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404691|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404692|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
101404693|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404694|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404695|NCT01052038|Dexamethasone|dexamethasone|mesh-list
101404696|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
101404697|NCT01052038|BB 1101|bb 1101|mesh-list
101404698|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404699|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
101404700|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
101504030|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101504031|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
101504032|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504033|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
101504034|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101504035|NCT00503321|Protective Agents|protective agents|mesh-ancestor
101504036|NCT00503477|Cediranib|cediranib|mesh-list
101504037|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504038|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504039|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504040|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504041|NCT05144295|Lactulose|lactulose|mesh-list
101504042|NCT05144295|Bisacodyl|bisacodyl|mesh-list
101504043|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
101504044|NCT05144295|Lubiprostone|lubiprostone|mesh-list
101504045|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504046|NCT05144295|Cathartics|cathartics|mesh-ancestor
101504047|NCT05144295|Laxatives|laxatives|mesh-ancestor
101504048|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101504049|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504050|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504051|NCT01245452|Methotrexate|methotrexate|mesh-list
101504052|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101504053|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
101504054|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504055|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504056|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504057|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
101504058|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504059|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404701|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404702|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404703|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404704|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
101404705|NCT01052038|Hormones|hormones|mesh-ancestor
101504060|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504061|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504062|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101504063|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504064|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
101504065|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504066|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101504067|NCT00503516|Megestrol|megestrol|mesh-list
101504068|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
101504069|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101504070|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101504071|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101504072|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
101504073|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504077|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101504078|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504079|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
101504080|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101504081|NCT05148195|Leucovorin|leucovorin|mesh-list
101504082|NCT05148195|Docetaxel|docetaxel|mesh-list
101504083|NCT05148195|Irinotecan|irinotecan|mesh-list
101504084|NCT05148195|Calcium|calcium|mesh-list
101504085|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
101504086|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504087|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
101504088|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
101504089|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
101504090|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504091|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504092|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504093|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101504094|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101504095|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504096|NCT05148195|Antidotes|antidotes|mesh-ancestor
101504097|NCT05148195|Protective Agents|protective agents|mesh-ancestor
101504098|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504099|NCT05148195|Vitamins|vitamins|mesh-ancestor
101504100|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
101504101|NCT00499265|Gemcitabine|gemcitabine|mesh-list
101504102|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
101504103|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
101504104|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504105|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
101504106|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504107|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504108|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504109|NCT01246622|Cytarabine|cytarabine|mesh-list
101504110|NCT01246622|Lenalidomide|lenalidomide|mesh-list
101504111|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504112|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
101504113|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504114|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504115|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
101504116|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504117|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504118|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
101504119|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504120|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101504121|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101504122|NCT01246622|Growth Substances|growth substances|mesh-ancestor
101504123|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
101504124|NCT01245530|Donepezil|donepezil|mesh-list
101504125|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101504126|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504127|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504128|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404706|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404707|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404708|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404709|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
101404710|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404711|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404712|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
101504129|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504130|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504131|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
101504132|NCT05148312|Budesonide|budesonide|mesh-list
101504133|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504134|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101504135|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
101504136|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504137|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504138|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101504139|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101504140|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
101504141|NCT05148312|Hormones|hormones|mesh-ancestor
101504142|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504143|NCT01246817|Sirolimus|sirolimus|mesh-list
101504144|NCT01246817|Temsirolimus|temsirolimus|mesh-list
101504145|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
101504146|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504150|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
101504151|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504152|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504153|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101504154|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504155|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101504156|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
101504157|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101504158|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101504159|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101504160|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
101504161|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504162|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101504163|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101504164|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504165|NCT05148975|Dimercaprol|dimercaprol|mesh-list
101504166|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
101504167|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
101504168|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504170|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101504171|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
101504172|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504174|NCT02274740|Lixisenatide|lixisenatide|mesh-list
101504175|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504176|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504177|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
101504179|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
101504180|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504181|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504182|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101504183|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
101504184|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504185|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504186|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101504187|NCT00503594|Cytarabine|cytarabine|mesh-list
101504188|NCT00503594|Methotrexate|methotrexate|mesh-list
101504189|NCT00503594|Vincristine|vincristine|mesh-list
101504190|NCT00503594|Temozolomide|temozolomide|mesh-list
101504191|NCT00503594|Procarbazine|procarbazine|mesh-list
101404713|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101404715|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101404716|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101404717|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404718|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
101404719|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548030|NCT00600990|Vestipitant|vestipitant|mesh-list
101404720|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404721|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101404722|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404723|NCT04711044|Menthol|menthol|mesh-list
101404724|NCT04711044|Histamine|histamine|mesh-list
101404725|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
101504192|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101504193|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
101504194|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504195|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504196|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504197|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
101504198|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504199|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504200|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504201|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504202|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101504203|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504204|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
101504205|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504206|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101504207|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
101504208|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504209|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101504210|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
101504211|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
101504212|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
101504213|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101504214|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
101504215|NCT00499811|Vorinostat|vorinostat|mesh-list
101504216|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504217|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101504230|NCT00499850|Antidotes|antidotes|mesh-ancestor
101504231|NCT00499850|Protective Agents|protective agents|mesh-ancestor
101504232|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504233|NCT00499850|Vitamins|vitamins|mesh-ancestor
101504234|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
101504235|NCT05146713|Propolis|propolis|mesh-list
101504236|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101504238|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504239|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
101504240|NCT00503828|Naproxen|naproxen|mesh-list
101504241|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101504242|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504244|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
101504245|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504246|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504247|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504248|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504249|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
101504250|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101504251|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504252|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404733|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101404734|NCT00432367|Artesunate|artesunate|mesh-list
101404735|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
101404736|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
101404737|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101504253|NCT00500006|Dasatinib|dasatinib|mesh-list
101504254|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504255|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101504256|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504257|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504265|NCT00506727|Amphetamine|amphetamine|mesh-list
101504266|NCT00506727|Adderall|adderall|mesh-list
101504267|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101504268|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101504269|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101504270|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504271|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504272|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504273|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504274|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504275|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101504276|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
101504277|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
101504278|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504279|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
101504294|NCT00500279|Analgesics|analgesics|mesh-ancestor
101504295|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
101504296|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504297|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504298|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504299|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504300|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101504301|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101504302|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504303|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504304|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
101504305|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101504306|NCT01245881|Protective Agents|protective agents|mesh-ancestor
101504307|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504308|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504309|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
101504310|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504311|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101504312|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504313|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504314|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
101504315|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504316|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404739|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
101404740|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101404741|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101404742|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404743|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404744|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
101404745|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
101404746|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101404747|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
101404748|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101404749|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404750|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404751|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101404753|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
101404754|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404756|NCT00432406|Etanercept|etanercept|mesh-list
101404757|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101404758|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404759|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504317|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101504318|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
101504319|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504321|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
101504322|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504323|NCT00500552|Perhexiline|perhexiline|mesh-list
101504324|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101504325|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504326|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504327|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504328|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504329|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
101504330|NCT00508209|Bortezomib|bortezomib|mesh-list
101504331|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504332|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
101504333|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101504334|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504335|NCT00507585|Leucovorin|leucovorin|mesh-list
101504336|NCT00507585|Bevacizumab|bevacizumab|mesh-list
101504337|NCT00507585|Fluorouracil|fluorouracil|mesh-list
101504338|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
101504348|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504350|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
101504351|NCT00507585|Antidotes|antidotes|mesh-ancestor
101504352|NCT00507585|Protective Agents|protective agents|mesh-ancestor
101504353|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504354|NCT00507585|Vitamins|vitamins|mesh-ancestor
101504355|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
101504356|NCT01247714|Phentermine|phentermine|mesh-list
101504357|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101504358|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504359|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
101504360|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101504361|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
101504362|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
101504363|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404760|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404761|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404762|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101404763|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101404765|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
101404766|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404767|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404768|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404769|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
101404770|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
101404771|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101404772|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404773|NCT02957656|Vaccines|vaccines|mesh-list
101404774|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
101404775|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504364|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504365|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504366|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504367|NCT00507663|Atenolol|atenolol|mesh-list
101504368|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101504369|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101504370|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
101504371|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
101504372|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504373|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504374|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101504375|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101504376|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101504377|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504378|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504379|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504380|NCT00508287|Exenatide|exenatide|mesh-list
101504381|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504382|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504383|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101504384|NCT00508287|Incretins|incretins|mesh-ancestor
101504385|NCT00508287|Hormones|hormones|mesh-ancestor
101504386|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504387|NCT00508326|Paclitaxel|paclitaxel|mesh-list
101504388|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101504389|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504390|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101504391|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
101504392|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101504393|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504394|NCT00507858|Dexamethasone|dexamethasone|mesh-list
101504395|NCT00507858|Pemetrexed|pemetrexed|mesh-list
101504396|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504397|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
101504398|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
101504399|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504400|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504401|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101504402|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
101504403|NCT00507858|Hormones|hormones|mesh-ancestor
101504421|NCT00508365|Protective Agents|protective agents|mesh-ancestor
101504422|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101504423|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101404776|NCT00097799|Ritonavir|ritonavir|mesh-list
101404777|NCT00097799|Tipranavir|tipranavir|mesh-list
101404778|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101404779|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101404780|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
101404781|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404782|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404783|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101404784|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101404785|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
101404786|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404787|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101404788|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101404789|NCT01051921|Interferons|interferons|mesh-list
101404790|NCT01051921|Ribavirin|ribavirin|mesh-list
101404791|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404792|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
101404793|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404794|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
101404795|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404796|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101404797|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101404798|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101404799|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101404800|NCT00432757|Ketotifen|ketotifen|mesh-list
101404801|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
101404802|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
101504424|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504425|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
101504426|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101504427|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101504428|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101504429|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
101504430|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504431|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101504433|NCT00500864|Analgesics|analgesics|mesh-ancestor
101504434|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
101504435|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504436|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504437|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
101504438|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504439|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101504440|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
101504441|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101188154|NCT03915366|Valganciclovir|valganciclovir|mesh-list
101504442|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504443|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404803|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101404804|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
101404805|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
101404806|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404807|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404808|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404809|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101404810|NCT00432796|Dalteparin|dalteparin|mesh-list
101404811|NCT00432796|Tinzaparin|tinzaparin|mesh-list
101404812|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101404813|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
101404814|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101404815|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101404816|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404817|NCT00097877|Insulin|insulin|mesh-list
101404818|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101404819|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
101404820|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
101404821|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
101404822|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101404823|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404824|NCT00097916|Memantine|memantine|mesh-list
101404826|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101404827|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
101404828|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404829|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404830|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404831|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101404832|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101404833|NCT00433069|Pioglitazone|pioglitazone|mesh-list
101404834|NCT00433069|Interferons|interferons|mesh-list
101404835|NCT00433069|Ribavirin|ribavirin|mesh-list
101404836|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
101404837|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
101404838|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404839|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
101404846|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101404847|NCT01580371|CKD-581|ckd-581|mesh-list
101404848|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404849|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404850|NCT00403026|Bevacizumab|bevacizumab|mesh-list
101404851|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101404852|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404853|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101404854|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101404856|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404857|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
101404858|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
101404859|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404860|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101404861|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404862|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404863|NCT00098033|Clofarabine|clofarabine|mesh-list
101404864|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404865|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
101404866|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404867|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404869|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404870|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
101404871|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
101404872|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101404873|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504444|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504445|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
101504446|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101504447|NCT00507975|Nicotine|nicotine|mesh-list
101504448|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101504449|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
101504450|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504451|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504452|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101504453|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101504454|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
101504455|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504456|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504476|NCT02954484|Ropivacaine|ropivacaine|mesh-list
101504477|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101504478|NCT02954484|Narcotics|narcotics|mesh-ancestor
101404874|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101404875|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
101404876|NCT00403065|Hormones|hormones|mesh-ancestor
101404877|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404878|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404879|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404880|NCT00098111|Azathioprine|azathioprine|mesh-list
101404881|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
101404882|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404883|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101404884|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404885|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404886|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
101404887|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404888|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404889|NCT04702906|Trimetazidine|trimetazidine|mesh-list
101404890|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
101404891|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
101404892|NCT00131313|Rituximab|rituximab|mesh-list
101404893|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404894|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
101404895|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404896|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404897|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101404898|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
101404899|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404900|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404901|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101504479|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101504480|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504481|NCT02954484|Analgesics|analgesics|mesh-ancestor
101504482|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
101504483|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101504484|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
101504485|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
101504486|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504487|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
101504488|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
101504489|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101504490|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101504491|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504492|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101504493|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101504494|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101504495|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101504496|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101404905|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404906|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101404907|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
101404908|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404909|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404910|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404911|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404912|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
101404913|NCT00433225|Prednisolone|prednisolone|mesh-list
101404914|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101404915|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
101404916|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101404917|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
101404918|NCT00433225|Ketorolac|ketorolac|mesh-list
101404919|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101404920|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
101404921|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404922|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
101504497|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101504498|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504499|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101504500|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101504501|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504502|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
101504503|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101504504|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504505|NCT00501098|Caspofungin|caspofungin|mesh-list
101504506|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
101504507|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504508|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504509|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504510|NCT00501137|Vaccines|vaccines|mesh-list
101504511|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
101504512|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504513|NCT01248260|Folic Acid|folic acid|mesh-list
101504514|NCT01248260|Hematinics|hematinics|mesh-ancestor
101504515|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
101504516|NCT01248260|Vitamins|vitamins|mesh-ancestor
101504518|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404937|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
101404939|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101404940|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404941|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404942|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404943|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404944|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101404945|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101404946|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101404947|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404948|NCT00433342|Floxacillin|floxacillin|mesh-list
101404949|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101404950|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101404951|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101404952|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101404953|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101404954|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101404955|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404956|NCT00131391|Hormones|hormones|mesh-ancestor
101404957|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404958|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404959|NCT00433459|Prednisone|prednisone|mesh-list
101404960|NCT00433459|Prednisolone|prednisolone|mesh-list
101404961|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
101404962|NCT00433459|Dacarbazine|dacarbazine|mesh-list
101404963|NCT00433459|Vincristine|vincristine|mesh-list
101404964|NCT00433459|Procarbazine|procarbazine|mesh-list
101404965|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101404966|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101404967|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
101404968|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101404969|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101404970|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101404972|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404973|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404974|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101404975|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101404976|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
101404977|NCT00433459|Hormones|hormones|mesh-ancestor
101404978|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101404979|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101404980|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101404981|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101404982|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101404983|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101404984|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101404985|NCT00433498|Carboplatin|carboplatin|mesh-list
101404986|NCT00433498|Etoposide|etoposide|mesh-list
101404987|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
101404988|NCT00433498|Pravastatin|pravastatin|mesh-list
101404989|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101404990|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101404991|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101404992|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101404993|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101404994|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101404995|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101404996|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101404997|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
101404998|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101404999|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101405000|NCT00433576|Resveratrol|resveratrol|mesh-list
101405001|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
101405002|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405003|NCT00433576|Protective Agents|protective agents|mesh-ancestor
101405004|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405010|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405011|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405012|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405013|NCT00433732|Naproxen|naproxen|mesh-list
101405014|NCT00433732|Sumatriptan|sumatriptan|mesh-list
101405015|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405016|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405017|NCT00433732|Analgesics|analgesics|mesh-ancestor
101405018|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
101405019|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405020|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405021|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405022|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405023|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
101405024|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101405025|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405026|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405027|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101405028|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101405029|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101405030|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
101405031|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405032|NCT00098423|Cytarabine|cytarabine|mesh-list
101405033|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101405063|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405064|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405065|NCT00433927|Growth Substances|growth substances|mesh-ancestor
101405066|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405067|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405068|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101405069|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405070|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405071|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405073|NCT00433927|Protective Agents|protective agents|mesh-ancestor
101405074|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
101405075|NCT00433927|Vitamins|vitamins|mesh-ancestor
101405076|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
101405077|NCT00433927|Hematinics|hematinics|mesh-ancestor
101405078|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101405079|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101405080|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101405081|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405082|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405083|NCT00131430|Hormones|hormones|mesh-ancestor
101405084|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405085|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405086|NCT00098462|Sirolimus|sirolimus|mesh-list
101405087|NCT00098462|Gefitinib|gefitinib|mesh-list
101405088|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405089|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405095|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405096|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405097|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405098|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405099|NCT00098501|Sirolimus|sirolimus|mesh-list
101405100|NCT00098501|Temsirolimus|temsirolimus|mesh-list
101405101|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
101405102|NCT00098501|EKB 569|ekb 569|mesh-list
101405103|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405104|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405105|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405106|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405107|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
101405108|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405109|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405110|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405111|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405112|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101405117|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405118|NCT00434005|Expectorants|expectorants|mesh-ancestor
101405119|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
101405120|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101405121|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
101405122|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405123|NCT00434005|Protective Agents|protective agents|mesh-ancestor
101405124|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405125|NCT00434005|Antidotes|antidotes|mesh-ancestor
101405126|NCT00434044|Etanercept|etanercept|mesh-list
101405127|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405128|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405129|NCT00434044|Analgesics|analgesics|mesh-ancestor
101405130|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
101405131|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405132|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405133|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405134|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405135|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405136|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405137|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
101405138|NCT00434083|Naproxen|naproxen|mesh-list
101405139|NCT00434083|Sumatriptan|sumatriptan|mesh-list
101405140|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405141|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405142|NCT00434083|Analgesics|analgesics|mesh-ancestor
101405143|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
101405144|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405145|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405147|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405148|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
101405149|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101405150|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405151|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405152|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101405153|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101405154|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101405155|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
101405156|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405157|NCT00098540|Sorafenib|sorafenib|mesh-list
101405158|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405159|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405160|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405161|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405162|NCT00098579|Doxorubicin|doxorubicin|mesh-list
101405163|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101405164|NCT00098579|Alvocidib|alvocidib|mesh-list
101405165|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101405166|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405167|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101405168|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405169|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405170|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405171|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405172|NCT00098579|Growth Substances|growth substances|mesh-ancestor
101405173|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405174|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405175|NCT00098618|Interferons|interferons|mesh-list
101405176|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
101405177|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
101405178|NCT00098618|Sorafenib|sorafenib|mesh-list
101405179|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405180|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
101405181|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405182|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405183|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405184|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405185|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
101405186|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405187|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101405188|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101405189|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405190|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405191|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
101405192|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405193|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
101405195|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405196|NCT01059448|Brodalumab|brodalumab|mesh-list
101405197|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
101405198|NCT00098891|Entinostat|entinostat|mesh-list
101405199|NCT00098891|Isotretinoin|isotretinoin|mesh-list
101405200|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101405201|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
101405202|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405203|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405204|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405205|NCT00098969|Resveratrol|resveratrol|mesh-list
101405206|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
101405207|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405208|NCT00098969|Protective Agents|protective agents|mesh-ancestor
101405214|NCT00099008|Protective Agents|protective agents|mesh-ancestor
101405215|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405216|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405220|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
101405221|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101405222|NCT00099008|Estrogens|estrogens|mesh-ancestor
101405223|NCT00099008|Hormones|hormones|mesh-ancestor
101405224|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405225|NCT00434239|Lenalidomide|lenalidomide|mesh-list
101405234|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101405235|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101405236|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101405237|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405238|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
101405239|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405240|NCT01057147|Protective Agents|protective agents|mesh-ancestor
101405241|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405242|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405243|NCT00099125|Irinotecan|irinotecan|mesh-list
101405244|NCT00099125|Temozolomide|temozolomide|mesh-list
101405245|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101405246|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405247|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405248|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405249|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405250|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101405251|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
101405252|NCT00131703|Chloroquine|chloroquine|mesh-list
101405253|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
101405254|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
101405255|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101405256|NCT00131703|Amodiaquine|amodiaquine|mesh-list
101405257|NCT00131703|Amebicides|amebicides|mesh-ancestor
101405258|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101405259|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101405260|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405261|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
101405265|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405267|NCT01051414|Asunaprevir|asunaprevir|mesh-list
101405268|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405269|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405270|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405271|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
101405272|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101405274|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101405275|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101405276|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101405277|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101487389|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405279|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405280|NCT00099164|Progestins|progestins|mesh-ancestor
101405281|NCT00099164|Hormones|hormones|mesh-ancestor
101405282|NCT00131742|Lamivudine|lamivudine|mesh-list
101405283|NCT00131742|Telbivudine|telbivudine|mesh-list
101405284|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101405285|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101405286|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405287|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405288|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
101405289|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405290|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101405291|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405293|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
101405294|NCT04621149|Famotidine|famotidine|mesh-list
101405295|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101405296|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405297|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101405298|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
101405299|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
101405300|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405301|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405302|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405303|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405304|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
101405305|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
101405306|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
101405307|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
101405308|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101405309|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405310|NCT00099242|Rivastigmine|rivastigmine|mesh-list
101405311|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101405312|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405313|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405314|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
101405315|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405316|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405317|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101405318|NCT00099242|Protective Agents|protective agents|mesh-ancestor
101405319|NCT00099320|Exenatide|exenatide|mesh-list
101405320|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101405321|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405322|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101405323|NCT00099320|Incretins|incretins|mesh-ancestor
101405324|NCT00099320|Hormones|hormones|mesh-ancestor
101405325|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405326|NCT00403650|Iloprost|iloprost|mesh-list
101405327|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405328|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
101405329|NCT00403728|Cyclosporine|cyclosporine|mesh-list
101405330|NCT00403728|Cyclosporins|cyclosporins|mesh-list
101405331|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405332|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405333|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405334|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
101405335|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405336|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
101405337|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405338|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
101405339|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405340|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101405341|NCT00403806|Dexamethasone|dexamethasone|mesh-list
101405342|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
101405343|NCT00403806|BB 1101|bb 1101|mesh-list
101405344|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405345|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
101405346|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
101405347|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405348|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405349|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405350|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
101405351|NCT00403806|Hormones|hormones|mesh-ancestor
101405352|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405353|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101405354|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405355|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405356|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405357|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405358|NCT00400556|Lenograstim|lenograstim|mesh-list
101405359|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101405360|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
101405361|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405363|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405364|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405365|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101405366|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405367|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405368|NCT00099554|Etanercept|etanercept|mesh-list
101405369|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405370|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405371|NCT00099554|Analgesics|analgesics|mesh-ancestor
101405372|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
101405373|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405374|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405375|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405376|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405377|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405378|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405380|NCT00132054|Irinotecan|irinotecan|mesh-list
101405381|NCT00132054|Amrubicin|amrubicin|mesh-list
101405382|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101405383|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405384|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405385|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405386|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405388|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405389|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405390|NCT00099710|Analgesics|analgesics|mesh-ancestor
101405391|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
101405392|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405393|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405394|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405395|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405396|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405397|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405398|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405399|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101405404|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405406|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101405407|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
101405408|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405409|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405410|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101405411|NCT00132093|Diuretics|diuretics|mesh-ancestor
101405412|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
101405413|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101405414|NCT00099788|Ranolazine|ranolazine|mesh-list
101405415|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101405416|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101405417|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405418|NCT00099866|Metformin|metformin|mesh-list
101405419|NCT00099866|Vildagliptin|vildagliptin|mesh-list
101405420|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101405421|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405422|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101405423|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405424|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405425|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405426|NCT00099905|Vildagliptin|vildagliptin|mesh-list
101405427|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101405428|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405429|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101405430|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405431|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405432|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405433|NCT00132210|Interferons|interferons|mesh-list
101405454|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405455|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101405456|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101405457|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101405458|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405460|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101405461|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101405462|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405463|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101405464|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101405465|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101405466|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405467|NCT00100412|Phenylephrine|phenylephrine|mesh-list
101528464|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528465|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528466|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
101528467|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528468|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528469|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
101528470|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528471|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101528472|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528481|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101528482|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528483|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528485|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
101528486|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528487|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528488|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528489|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528490|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101528491|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101528492|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528493|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405468|NCT00100412|Dobutamine|dobutamine|mesh-list
101405469|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
101405470|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101405471|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
101405472|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
101405473|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405474|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405475|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
101405476|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101405477|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
101405478|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
101405479|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101405480|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101405481|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101405482|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
101405483|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405484|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405485|NCT00100412|Protective Agents|protective agents|mesh-ancestor
101405486|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101405487|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101405488|NCT04244058|Amantadine|amantadine|mesh-list
101528494|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528495|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528496|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
101528497|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101528498|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101528499|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
101528500|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101528501|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101528502|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101528503|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101528504|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101528505|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
101528506|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528507|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
101528508|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101528509|NCT04683146|Propranolol|propranolol|mesh-list
101528510|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101528511|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528512|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
101528513|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528514|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101528515|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101528516|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528517|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528518|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528519|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528520|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101528521|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101528522|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
101528523|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
101528524|NCT04816877|Narcotics|narcotics|mesh-ancestor
101528525|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528526|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528527|NCT04816877|Analgesics|analgesics|mesh-ancestor
101405489|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101405490|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101405491|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
101405492|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405493|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
101405494|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405495|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405496|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405497|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405498|NCT04244058|Analgesics|analgesics|mesh-ancestor
101528528|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
101528529|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528530|NCT04800302|Morphine|morphine|mesh-list
101528531|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101528532|NCT04800302|Narcotics|narcotics|mesh-ancestor
101528533|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528534|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528535|NCT04800302|Analgesics|analgesics|mesh-ancestor
101528536|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
101528537|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528538|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
101528539|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101528540|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
101528553|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528554|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
101528555|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528556|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528557|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
101528558|NCT04710719|Hormones|hormones|mesh-ancestor
101528559|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528560|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528561|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
101528562|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
101528563|NCT04627779|Analgesics|analgesics|mesh-ancestor
101528564|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
101528565|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528566|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528567|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528568|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528569|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528570|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528571|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528572|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528573|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528574|NCT04537598|Morphine|morphine|mesh-list
101528575|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101528576|NCT04537598|Narcotics|narcotics|mesh-ancestor
101528577|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528578|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528579|NCT04537598|Analgesics|analgesics|mesh-ancestor
101528580|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
101528581|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528582|NCT04627467|Chloroquine|chloroquine|mesh-list
101528583|NCT04627467|Amebicides|amebicides|mesh-ancestor
101528584|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101528585|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101528586|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528587|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
101528588|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528589|NCT04627623|Antibodies|antibodies|mesh-list
101528590|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
101528591|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
101528592|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528593|NCT04656249|Lenvatinib|lenvatinib|mesh-list
101528594|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528595|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405502|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405503|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
101405504|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405505|NCT00100568|Lamivudine|lamivudine|mesh-list
101405506|NCT00100568|Zidovudine|zidovudine|mesh-list
101405507|NCT00100568|Efavirenz|efavirenz|mesh-list
101405508|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101405509|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101405510|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101405511|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405512|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405513|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
101405514|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405515|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101405516|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405517|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
101405518|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101405519|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101405520|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101405521|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101405522|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101405523|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101405524|NCT00132561|Artesunate|artesunate|mesh-list
101405525|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
101528596|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528597|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528601|NCT04682795|Insulin|insulin|mesh-list
101528602|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101528603|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528604|NCT04655664|Vitamin D|vitamin d|mesh-list
101528609|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528610|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101528611|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101528612|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101528613|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528614|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
101528615|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528616|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528617|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101528618|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528619|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
101528620|NCT04655508|Hormones|hormones|mesh-ancestor
101405526|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
101405527|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
101405528|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101405529|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101405530|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405531|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405532|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
101405533|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
101405534|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101405535|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
101405536|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101405537|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405538|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405539|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101405540|NCT04728659|Desogestrel|desogestrel|mesh-list
101405541|NCT04728659|Ganirelix|ganirelix|mesh-list
101405542|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101405543|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101405544|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101405545|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
101405546|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101528621|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528622|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
101528623|NCT04655040|Caffeine|caffeine|mesh-list
101528624|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101528625|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528626|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101528627|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528628|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528629|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101528630|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101528631|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
101528632|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528633|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
101528634|NCT04626765|Fludarabine|fludarabine|mesh-list
101528635|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528636|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
101528637|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528638|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528639|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101528640|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
101528641|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528642|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528643|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101528644|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
101528645|NCT04626726|Fludarabine|fludarabine|mesh-list
101528646|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528647|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
101528648|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528649|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528650|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101528651|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
101548057|NCT00601692|Docetaxel|docetaxel|mesh-list
101528652|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528653|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405547|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405548|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101405549|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101405550|NCT04728659|Progestins|progestins|mesh-ancestor
101405552|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405553|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
101405554|NCT00132600|Bacitracin|bacitracin|mesh-list
101405555|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101405556|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405557|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101528654|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101528655|NCT04654962|Anesthetics|anesthetics|mesh-list
101528656|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528657|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528658|NCT04626414|Ferric maltol|ferric maltol|mesh-list
101528659|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
101528660|NCT04626414|Hematinics|hematinics|mesh-ancestor
101528661|NCT04654416|Colchicine|colchicine|mesh-list
101528662|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
101528663|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528664|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
101528665|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
101528666|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528667|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528668|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528669|NCT02906150|Cisplatin|cisplatin|mesh-list
101528670|NCT02906150|Carboplatin|carboplatin|mesh-list
101528671|NCT02906150|Pemetrexed|pemetrexed|mesh-list
101528672|NCT02906150|Thymalfasin|thymalfasin|mesh-list
101528673|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528674|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528675|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528676|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101528691|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528692|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528693|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
101528694|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528695|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101528696|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101528697|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528698|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528699|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101528700|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
101528701|NCT02905682|Coagulants|coagulants|mesh-ancestor
101528702|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101528703|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
101528704|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528705|NCT04626258|Fluconazole|fluconazole|mesh-list
101528706|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
101528707|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528708|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101528709|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101528710|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528711|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528712|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101528713|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101528714|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528715|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528716|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101528717|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101528719|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101528720|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101405558|NCT00132639|Docetaxel|docetaxel|mesh-list
101405559|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405560|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
101405561|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
101405562|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
101405563|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405564|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101405566|NCT04728386|Curcumin|curcumin|mesh-list
101405567|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405568|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405570|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
101405571|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405572|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405573|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405574|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405575|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405576|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405577|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405578|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
101405579|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405580|NCT00100646|Ritonavir|ritonavir|mesh-list
101405581|NCT00100646|Lopinavir|lopinavir|mesh-list
101405582|NCT00100646|Lamivudine|lamivudine|mesh-list
101405583|NCT00100646|Stavudine|stavudine|mesh-list
101405584|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101405585|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101405586|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405587|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405588|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405589|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101405606|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405607|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405609|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101405610|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
101405611|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405612|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405613|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101405614|NCT00100880|Lenalidomide|lenalidomide|mesh-list
101405615|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
101405616|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528721|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528722|NCT04626063|Analgesics|analgesics|mesh-ancestor
101528723|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
101528724|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528725|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528726|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
101528727|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528728|NCT04625985|Metformin|metformin|mesh-list
101528729|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101528730|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528731|NCT02905760|Furosemide|furosemide|mesh-list
101528732|NCT02905760|Diuretics|diuretics|mesh-list
101528733|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
101528734|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528743|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101528744|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528745|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
101528746|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528747|NCT04654026|Aspirin|aspirin|mesh-list
101528748|NCT04654026|Clopidogrel|clopidogrel|mesh-list
101528749|NCT04654026|Ticagrelor|ticagrelor|mesh-list
101528750|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528751|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528753|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
101528754|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528755|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528756|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528757|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528758|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101528759|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101528760|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528761|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101528762|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528763|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528764|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
101528765|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101528766|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101528767|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101528768|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
101528769|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528770|NCT04625595|Methyldopa|methyldopa|mesh-list
101528771|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101528772|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
101528773|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
101528774|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528775|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528776|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101405617|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405618|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405619|NCT00100880|Growth Substances|growth substances|mesh-ancestor
101405620|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405621|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405622|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
101405623|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101405624|NCT00100958|Protective Agents|protective agents|mesh-ancestor
101405625|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405626|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405627|NCT00101075|Capecitabine|capecitabine|mesh-list
101405628|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
101405629|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101405630|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
101405631|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405632|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405633|NCT00132912|Vorapaxar|vorapaxar|mesh-list
101405634|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101405635|NCT00403182|Letrozole|letrozole|mesh-list
101405636|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405637|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101405638|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101405639|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405640|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405641|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101405642|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
101528777|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528778|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528779|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528780|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528781|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528782|NCT02905058|Ketoprofen|ketoprofen|mesh-list
101528783|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528784|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528785|NCT02905058|Analgesics|analgesics|mesh-ancestor
101528786|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
101528787|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528788|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528789|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528790|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528791|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528792|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528793|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528794|NCT04653792|Pregabalin|pregabalin|mesh-list
101528795|NCT04653792|Analgesics|analgesics|mesh-ancestor
101528796|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
101528797|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528798|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528806|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101405643|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405644|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405646|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
101405647|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
101405648|NCT00101114|Sorafenib|sorafenib|mesh-list
101405649|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405650|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
101405651|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405652|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405653|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405654|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405655|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
101405656|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405657|NCT00101153|Cytarabine|cytarabine|mesh-list
101405658|NCT00101153|Daunorubicin|daunorubicin|mesh-list
101528808|NCT00557700|Bromides|bromides|mesh-list
101528809|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
101528810|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101528811|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
101528812|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528814|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101528815|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528816|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
101528817|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101528818|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
101528819|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528820|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528821|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
101528822|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
101528823|NCT00557739|Nortriptyline|nortriptyline|mesh-list
101528824|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528825|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
101528826|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101528827|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101528828|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
101528829|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101528830|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101528831|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101528832|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528833|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528834|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528835|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528836|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528838|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101528839|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
101528840|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101528841|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528842|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101528843|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101528844|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101528845|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
101528846|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
101405659|NCT00101153|Tipifarnib|tipifarnib|mesh-list
101405660|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101405661|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
101405662|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405664|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
101405665|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405666|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405667|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
101405668|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405669|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101405670|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101405671|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405672|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405673|NCT00132951|Azithromycin|azithromycin|mesh-list
101405674|NCT00132951|Telithromycin|telithromycin|mesh-list
101405675|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405676|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405677|NCT00400790|Propofol|propofol|mesh-list
101405678|NCT00400790|Desflurane|desflurane|mesh-list
101405679|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101405680|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528847|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101528848|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101528849|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528850|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528851|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528852|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528853|NCT04652739|Prednisolone|prednisolone|mesh-list
101528854|NCT04652739|Lycopene|lycopene|mesh-list
101528855|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528856|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
101528857|NCT04652739|Hormones|hormones|mesh-ancestor
101528858|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528859|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528860|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101528861|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528883|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528884|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416172|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
101528885|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528886|NCT04623879|Ivacaftor|ivacaftor|mesh-list
101528887|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101528888|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528889|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528890|NCT00562068|Prednisolone|prednisolone|mesh-list
101528891|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
101528892|NCT00562068|Doxorubicin|doxorubicin|mesh-list
101528893|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101528894|NCT00562068|Vincristine|vincristine|mesh-list
101528895|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
101528896|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101528897|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
101528898|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405681|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405682|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101405683|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
101405684|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
101405685|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101405686|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101405687|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405688|NCT00135408|Budesonide|budesonide|mesh-list
101405689|NCT00135408|Ipilimumab|ipilimumab|mesh-list
101405690|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101405691|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405692|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101405693|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405695|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101405696|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
101405697|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405698|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528899|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528900|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101528901|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
101528902|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528903|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528904|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101528905|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101528906|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101528907|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528908|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528909|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101528910|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
101528911|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
101528912|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
101528913|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528931|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528932|NCT02903069|Temozolomide|temozolomide|mesh-list
101528933|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101528934|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
101528935|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528936|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528937|NCT04623840|Tadalafil|tadalafil|mesh-list
101528938|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
101528939|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101528940|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101528941|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528942|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528943|NCT04623840|Urological Agents|urological agents|mesh-ancestor
101528945|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
101528946|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
101528947|NCT02902640|Guaifenesin|guaifenesin|mesh-list
101528948|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101528949|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101528950|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528951|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
101405699|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101405700|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101405701|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
101405703|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405704|NCT00101231|Alvocidib|alvocidib|mesh-list
101405705|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405706|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405707|NCT00101231|Growth Substances|growth substances|mesh-ancestor
101405708|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405709|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405710|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528952|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101528953|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101528954|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101528955|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528956|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528957|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101528958|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101528959|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101528960|NCT02902640|Expectorants|expectorants|mesh-ancestor
101528961|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
101528962|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528963|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528964|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
101528965|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528966|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528967|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
101528968|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101528980|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
101528981|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101528982|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101528983|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101528984|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528985|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528986|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101528987|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101528988|NCT02902289|Ibuprofen|ibuprofen|mesh-list
101528989|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101528990|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528991|NCT02902289|Analgesics|analgesics|mesh-ancestor
101528992|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
101528993|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528994|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528995|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101528996|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101528997|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101528998|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528999|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529000|NCT02902133|Acetazolamide|acetazolamide|mesh-list
101529001|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
101529002|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101529003|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529004|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529005|NCT02902133|Diuretics|diuretics|mesh-ancestor
101529006|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
101529007|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529008|NCT04623021|Nafamostat|nafamostat|mesh-list
101529009|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405711|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405712|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
101405713|NCT00101270|Irinotecan|irinotecan|mesh-list
101405714|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405715|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101405716|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101405717|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405718|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405719|NCT00101309|Aldesleukin|aldesleukin|mesh-list
101405720|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405721|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101405722|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405723|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
101405724|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405725|NCT00101348|Bevacizumab|bevacizumab|mesh-list
101405726|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101405727|NCT00101348|Cetuximab|cetuximab|mesh-list
101405728|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101405729|NCT00101348|Antibodies|antibodies|mesh-list
101405730|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
101405731|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101405732|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405733|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101405734|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101405735|NCT00101348|Growth Substances|growth substances|mesh-ancestor
101405736|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405737|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405738|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
101529010|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529011|NCT04623021|Analgesics|analgesics|mesh-ancestor
101529012|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
101529013|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529014|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529015|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529016|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529017|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
101529018|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
101529019|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529020|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529021|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101529022|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101529023|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101529024|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529025|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
101529026|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
101529027|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101529028|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529029|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529030|NCT02901977|Ramipril|ramipril|mesh-list
101405740|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405741|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405742|NCT00101426|Ranirestat|ranirestat|mesh-list
101405743|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405744|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405745|NCT00133185|Losartan|losartan|mesh-list
101405746|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101405747|NCT00133185|Telmisartan|telmisartan|mesh-list
101405748|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101405749|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101405750|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101405751|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101405752|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405753|NCT00133185|Diuretics|diuretics|mesh-ancestor
101405754|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
101405755|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405756|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101405757|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101405758|NCT00135603|Amoxicillin|amoxicillin|mesh-list
101405759|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
101405760|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
101405761|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101405762|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405763|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405764|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101405765|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487390|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101529031|NCT02901977|Doxazosin|doxazosin|mesh-list
101529048|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529049|NCT00553553|Analgesics|analgesics|mesh-ancestor
101529050|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
101529051|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529052|NCT04622982|Vitamin D|vitamin d|mesh-list
101529053|NCT04622982|Vitamins|vitamins|mesh-ancestor
101529054|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
101529055|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529056|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101529057|NCT04622202|Pregabalin|pregabalin|mesh-list
101529058|NCT04622202|Analgesics|analgesics|mesh-ancestor
101529059|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
101529060|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405766|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405767|NCT00133224|Prednisone|prednisone|mesh-list
101405768|NCT00133224|Docetaxel|docetaxel|mesh-list
101405769|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405770|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
101405771|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
101405772|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
101405773|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405774|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405775|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
101405776|NCT00133224|Hormones|hormones|mesh-ancestor
101405777|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405778|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405779|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101405780|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
101529061|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529062|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
101529063|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101529064|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529065|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529066|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101529068|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529069|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529070|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529071|NCT04622358|Rabeprazole|rabeprazole|mesh-list
101529072|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101529073|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101529074|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101529075|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529076|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529077|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101529078|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
101529079|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529080|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101529081|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529082|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529083|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529084|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
101529085|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101529086|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101529106|NCT02901236|Mitomycin|mitomycin|mesh-list
101529107|NCT02901236|Antimetabolites|antimetabolites|mesh-list
101529108|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529109|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529110|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101529111|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101529112|NCT02901236|Growth Substances|growth substances|mesh-ancestor
101529113|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529114|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
101529115|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101529116|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
101529117|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529118|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101529119|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529120|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529121|NCT04621617|Midodrine|midodrine|mesh-list
101529122|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
101529123|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
101405782|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405783|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101405784|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
101405785|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101405786|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405787|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405788|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405790|NCT00135681|Budesonide|budesonide|mesh-list
101405791|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405792|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101405793|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
101405794|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405795|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405796|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101405797|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
101405799|NCT00135681|Hormones|hormones|mesh-ancestor
101405800|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405801|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101405802|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
101405803|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101405804|NCT00135720|Etanercept|etanercept|mesh-list
101529124|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529125|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529126|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101529127|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101529128|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101529129|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529130|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529131|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529132|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529133|NCT01212757|Thalidomide|thalidomide|mesh-list
101529134|NCT01212757|Apremilast|apremilast|mesh-list
101529135|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529136|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529137|NCT01212757|Analgesics|analgesics|mesh-ancestor
101529138|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
101529139|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529140|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529141|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529142|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529151|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529152|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101529153|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101529154|NCT01212757|Growth Substances|growth substances|mesh-ancestor
101529155|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
101405805|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405806|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101405807|NCT00135720|Analgesics|analgesics|mesh-ancestor
101405808|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
101405809|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405810|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405811|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405812|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405813|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101405814|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405815|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
101405816|NCT00101894|Panitumumab|panitumumab|mesh-list
101405817|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
101405818|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101405819|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405820|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101405821|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405822|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529156|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529158|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101529159|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101529160|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529161|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529162|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529164|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101529165|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529166|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101529167|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101529168|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529169|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529170|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101529171|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
101529172|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529173|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529174|NCT02900729|Losartan|losartan|mesh-list
101529175|NCT02900729|Amlodipine|amlodipine|mesh-list
101529176|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101529177|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529178|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101529179|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529180|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529181|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101529182|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529183|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
101529184|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101529185|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101529186|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101529187|NCT02900729|Diuretics|diuretics|mesh-ancestor
101529188|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
101529189|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101529190|NCT04621227|Midazolam|midazolam|mesh-list
101529191|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101529192|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101405823|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
101405824|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405825|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405826|NCT00135759|Naltrexone|naltrexone|mesh-list
101405827|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101405828|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101405829|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405830|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
101405831|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405832|NCT00133341|Parthenolide|parthenolide|mesh-list
101405833|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101405834|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529193|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101529194|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529195|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529196|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101529197|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529198|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529199|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101529200|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
101529201|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
101529202|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
101529203|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
101529204|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529205|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529206|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101529207|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101529214|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529215|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529217|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529218|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529219|NCT01190254|Asenapine|asenapine|mesh-list
101529220|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101529221|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529222|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529223|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529224|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529225|NCT04620954|Nivolumab|nivolumab|mesh-list
101529226|NCT04620954|Oregovomab|oregovomab|mesh-list
101529227|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529228|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529229|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101529230|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529231|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101529232|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
101529233|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529234|NCT04621110|Fentanyl|fentanyl|mesh-list
101529235|NCT04621110|Midazolam|midazolam|mesh-list
101529236|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
101529237|NCT04621110|Ketamine|ketamine|mesh-list
101529238|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101529239|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529240|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529241|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529242|NCT04621110|Analgesics|analgesics|mesh-ancestor
101529243|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
101529244|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529245|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101529246|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101529247|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529248|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529249|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529250|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405835|NCT00133341|Analgesics|analgesics|mesh-ancestor
101405836|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
101405837|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405838|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405839|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405840|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405841|NCT00135837|Verteporfin|verteporfin|mesh-list
101405842|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101405843|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101405844|NCT00133380|Atorvastatin|atorvastatin|mesh-list
101405845|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101405846|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101405847|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
101405848|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405849|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101405850|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101405851|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405852|NCT00102167|Gaboxadol|gaboxadol|mesh-list
101405853|NCT00102167|Analgesics|analgesics|mesh-ancestor
101405854|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
101405855|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101405856|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405857|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
101405858|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
101405860|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405861|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405862|NCT00135876|Dalteparin|dalteparin|mesh-list
101405863|NCT00135876|Tinzaparin|tinzaparin|mesh-list
101405864|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101405865|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
101405866|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101405867|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101405868|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529251|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101529252|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101529253|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
101529254|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
101529255|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101529256|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101529257|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101529258|NCT04621110|Narcotics|narcotics|mesh-ancestor
101405870|NCT00102206|Lopinavir|lopinavir|mesh-list
101405871|NCT00102206|Saquinavir|saquinavir|mesh-list
101405872|NCT00102206|Tenofovir|tenofovir|mesh-list
101405873|NCT00102206|Lamivudine|lamivudine|mesh-list
101405874|NCT00102206|Emtricitabine|emtricitabine|mesh-list
101405875|NCT00102206|Zidovudine|zidovudine|mesh-list
101405876|NCT00102206|Abacavir|abacavir|mesh-list
101405877|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101405878|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101405879|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
101405880|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405881|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405882|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101405883|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101405884|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
101405885|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405886|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101405887|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101405888|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101405889|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101405890|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
101405891|NCT00102284|Levodopa|levodopa|mesh-list
101405892|NCT00102284|Modafinil|modafinil|mesh-list
101405893|NCT00102284|Rivastigmine|rivastigmine|mesh-list
101405894|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101405895|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101405896|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
101405897|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405898|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405899|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405900|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101405901|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101405902|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101405903|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101405904|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101405905|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405906|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
101405910|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101405911|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101405912|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101405913|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405916|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405917|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101405918|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
101405919|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101405920|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101405921|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101405922|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405923|NCT00403962|Paroxetine|paroxetine|mesh-list
101405924|NCT00403962|Vestipitant|vestipitant|mesh-list
101405925|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101405926|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101529259|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101529260|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101529261|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529262|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529263|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
101529264|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
101529265|NCT04620720|Gabapentin|gabapentin|mesh-list
101529266|NCT04620720|Analgesics|analgesics|mesh-ancestor
101529267|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
101529268|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529269|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529270|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
101529271|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101529272|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529273|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529274|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529275|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101529301|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529303|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
101529304|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529305|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529306|NCT04619862|Gabapentin|gabapentin|mesh-list
101529307|NCT04619862|Analgesics|analgesics|mesh-ancestor
101529308|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
101529309|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529310|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529311|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
101529312|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101529313|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529314|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529315|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101529316|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101529317|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101529318|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529319|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529320|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
101405927|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101405928|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405930|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
101405931|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405932|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101405933|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
101405934|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101405935|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101405936|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101405937|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405938|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101405939|NCT00102479|Aripiprazole|aripiprazole|mesh-list
101405940|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
101405943|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101405944|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101405945|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405946|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
101405947|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
101529321|NCT01190839|Infliximab|infliximab|mesh-list
101529329|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
101529330|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529331|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101529332|NCT05424692|Fluorouracil|fluorouracil|mesh-list
101529333|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
101529334|NCT05424692|Irinotecan|irinotecan|mesh-list
101529335|NCT05424692|Cetuximab|cetuximab|mesh-list
101529336|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
101529337|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529338|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101529339|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529340|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529341|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
101529342|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529343|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101529344|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101529345|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529346|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529348|NCT05424692|Vitamins|vitamins|mesh-ancestor
101529349|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
101529350|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
101529351|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101529352|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529353|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529354|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529355|NCT04618965|Analgesics|analgesics|mesh-ancestor
101529356|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
101529357|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529358|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101405948|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101405949|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405950|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101405951|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101405952|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
101405953|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101405954|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101405955|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101405956|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101405957|NCT00135954|Prednisolone|prednisolone|mesh-list
101405958|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
101405959|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101405960|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
101405961|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405962|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405963|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101405964|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
101405965|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405966|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405967|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101405968|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101405969|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
101405970|NCT00135954|Hormones|hormones|mesh-ancestor
101405971|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101405972|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101405973|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
101405974|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
101529361|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529362|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529363|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529364|NCT01190449|Ofatumumab|ofatumumab|mesh-list
101529365|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529366|NCT00562809|Irbesartan|irbesartan|mesh-list
101529367|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529368|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101529369|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101529370|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529371|NCT01190098|Lacosamide|lacosamide|mesh-list
101529372|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
101529373|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101529374|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101529375|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101405975|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101405976|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101405977|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101405978|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405979|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405980|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101405982|NCT00102635|Lonafarnib|lonafarnib|mesh-list
101405983|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101405984|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101405985|NCT00102635|Protective Agents|protective agents|mesh-ancestor
101405986|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405987|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101405988|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101405989|NCT00133419|Vitamins|vitamins|mesh-list
101405990|NCT00133419|Vitamin A|vitamin a|mesh-list
101405991|NCT00133419|Zinc|zinc|mesh-list
101405992|NCT00133419|Trace Elements|trace elements|mesh-list
101405993|NCT00133419|Micronutrients|micronutrients|mesh-list
101405994|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
101405995|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101405996|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
101405997|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529376|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529377|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
101529378|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101529379|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529380|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
101529381|NCT04314739|Resveratrol|resveratrol|mesh-list
101529382|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
101529383|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529384|NCT04314739|Protective Agents|protective agents|mesh-ancestor
101529385|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529386|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529387|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101529388|NCT02885740|Adenosine|adenosine|mesh-list
101529389|NCT02885740|Analgesics|analgesics|mesh-ancestor
101529390|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
101529403|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529404|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529405|NCT01190020|Lubiprostone|lubiprostone|mesh-list
101529406|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101529407|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529408|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529409|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101529410|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529411|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101529412|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529413|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529414|NCT01165996|Decitabine|decitabine|mesh-list
101529415|NCT01165996|Azacitidine|azacitidine|mesh-list
101529416|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101529417|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
101405998|NCT00133419|Protective Agents|protective agents|mesh-ancestor
101405999|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101406000|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406002|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101406003|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101406004|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101406005|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101406006|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
101406007|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406008|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406009|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406010|NCT00135993|Rotigotine|rotigotine|mesh-list
101406011|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
101406012|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
101406013|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406014|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406015|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406016|NCT00102713|Valproic Acid|valproic acid|mesh-list
101406017|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
101406018|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406019|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406021|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406022|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406023|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
101406024|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406025|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406026|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406027|NCT00133458|Albendazole|albendazole|mesh-list
101406028|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
101406029|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101406030|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406031|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
101406038|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406039|NCT00102752|Gemcitabine|gemcitabine|mesh-list
101406040|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406041|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
101406042|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406043|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406044|NCT00102830|Trebananib|trebananib|mesh-list
101406045|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101406046|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101406047|NCT00102830|Growth Substances|growth substances|mesh-ancestor
101406048|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406049|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101406050|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406051|NCT00136110|Valproic Acid|valproic acid|mesh-list
101406052|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
101406053|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406054|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406055|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
101406056|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406057|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406058|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
101406059|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406060|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406061|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406062|NCT00136188|Folic Acid|folic acid|mesh-list
101406063|NCT00136188|Hematinics|hematinics|mesh-ancestor
101406064|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
101406065|NCT00136188|Vitamins|vitamins|mesh-ancestor
101406067|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406069|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101406070|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101529418|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529420|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529421|NCT04619433|Carboplatin|carboplatin|mesh-list
101529422|NCT04619433|Pemetrexed|pemetrexed|mesh-list
101529423|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529424|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529425|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529426|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101529427|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101529428|NCT04619160|Propofol|propofol|mesh-list
101529429|NCT04619160|Sevoflurane|sevoflurane|mesh-list
101529430|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101406071|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
101406072|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406073|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406074|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406075|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
101406076|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101406077|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406078|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
101406079|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406080|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101406081|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406082|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406084|NCT00136266|Vitamins|vitamins|mesh-list
101406085|NCT00136266|Vitamin A|vitamin a|mesh-list
101406086|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
101406087|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
101406088|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406089|NCT00136266|Trace Elements|trace elements|mesh-ancestor
101406090|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101406091|NCT00102947|Daptomycin|daptomycin|mesh-list
101406092|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529431|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529432|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529433|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101529434|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
101529435|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
101529436|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101529437|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101529438|NCT01165684|Insulin|insulin|mesh-list
101529439|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101529440|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
101529441|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
101529442|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101529443|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
101529444|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529445|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529446|NCT01189201|Linagliptin|linagliptin|mesh-list
101529447|NCT01189201|Empagliflozin|empagliflozin|mesh-list
101529448|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529449|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529450|NCT01189201|Incretins|incretins|mesh-ancestor
101529457|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101529458|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
101529459|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
101529462|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529463|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
101529465|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
101529466|NCT01183234|Methylphenidate|methylphenidate|mesh-list
101529467|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101529468|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529469|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101406093|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406094|NCT00136344|Levofloxacin|levofloxacin|mesh-list
101406095|NCT00136344|Cefuroxime|cefuroxime|mesh-list
101406096|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
101406097|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101406098|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406099|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101406100|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101406101|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101406102|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406103|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406104|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406105|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101406106|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101406108|NCT00102986|Lopinavir|lopinavir|mesh-list
101406109|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101406110|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101406111|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
101406112|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406113|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406114|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101406115|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101406116|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
101406117|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406118|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101406119|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101406120|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101406121|NCT00136383|Paroxetine|paroxetine|mesh-list
101406122|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101406123|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101406124|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406125|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406126|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406127|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529470|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101529471|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529472|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406128|NCT00136383|Analgesics|analgesics|mesh-ancestor
101406129|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
101406130|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406131|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
101406132|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406133|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
101406134|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101406135|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
101406136|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101406137|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101406138|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101406142|NCT00103103|Bortezomib|bortezomib|mesh-list
101406143|NCT00103103|Calcium|calcium|mesh-list
101406144|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
101406145|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406146|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406147|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
101406148|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406149|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406150|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406151|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406152|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
101406153|NCT00103103|Antidotes|antidotes|mesh-ancestor
101406154|NCT00103103|Protective Agents|protective agents|mesh-ancestor
101406155|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
101406156|NCT00103103|Vitamins|vitamins|mesh-ancestor
101406157|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
101406158|NCT00133692|Atenolol|atenolol|mesh-list
101406159|NCT00133692|Verapamil|verapamil|mesh-list
101406160|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101406161|NCT00133692|Trandolapril|trandolapril|mesh-list
101406162|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406163|NCT00133692|Diuretics|diuretics|mesh-ancestor
101529473|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
101529474|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529475|NCT04618497|Ketorolac|ketorolac|mesh-list
101529476|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
101529477|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529478|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529479|NCT04618497|Analgesics|analgesics|mesh-ancestor
101529480|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
101406164|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
101406165|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406166|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101406167|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406168|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406169|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101406170|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
101406171|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
101406172|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406173|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101406174|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101406175|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101406176|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101406177|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529481|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529482|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529483|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529484|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529485|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101529486|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529487|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529488|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101529489|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
101529490|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
101529491|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529492|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101529495|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
101529496|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101529497|NCT04618536|Protective Agents|protective agents|mesh-ancestor
101529498|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529499|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
101529500|NCT04651959|Favipiravir|favipiravir|mesh-list
101529501|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
101529502|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529503|NCT01165216|Paclitaxel|paclitaxel|mesh-list
101529504|NCT01165216|Carboplatin|carboplatin|mesh-list
101529505|NCT01165216|Ipilimumab|ipilimumab|mesh-list
101529506|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101529507|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529508|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
101529509|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
101529510|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
101529511|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529512|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529513|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101529514|NCT04652115|Defibrotide|defibrotide|mesh-list
101529515|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101529516|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101529526|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
101529527|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
101529528|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529529|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529530|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
101529531|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406178|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101406179|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406180|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406181|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101406182|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
101406183|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406184|NCT00133731|Heparin|heparin|mesh-list
101406185|NCT00133731|Calcium heparin|calcium heparin|mesh-list
101406186|NCT00133731|Otamixaban|otamixaban|mesh-list
101406187|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
101406188|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101406189|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101406190|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406191|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101406192|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
101406193|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101406194|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101406195|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406196|NCT00103298|Leucovorin|leucovorin|mesh-list
101406197|NCT00103298|Fluorouracil|fluorouracil|mesh-list
101406198|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
101406199|NCT00103298|Melphalan|melphalan|mesh-list
101406200|NCT00103298|Calcium|calcium|mesh-list
101406201|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
101406203|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406233|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101406234|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406235|NCT00133887|Sirolimus|sirolimus|mesh-list
101406236|NCT00133887|Cyclosporine|cyclosporine|mesh-list
101406237|NCT00133887|Tacrolimus|tacrolimus|mesh-list
101406238|NCT00133887|Cyclosporins|cyclosporins|mesh-list
101406239|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406240|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
101406242|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101406243|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406244|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406245|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101406246|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529532|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101529533|NCT04618146|Narcotics|narcotics|mesh-ancestor
101529534|NCT04618146|Analgesics|analgesics|mesh-ancestor
101529535|NCT04651842|Insulin|insulin|mesh-list
101529536|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529537|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529538|NCT05421962|Fentanyl|fentanyl|mesh-list
101529539|NCT05421962|Ketamine|ketamine|mesh-list
101529540|NCT05421962|Analgesics|analgesics|mesh-ancestor
101529541|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
101529542|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529543|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529544|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101529545|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101529546|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
101529547|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
101529548|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529549|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101529550|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101529551|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529552|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529553|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101529554|NCT05421962|Narcotics|narcotics|mesh-ancestor
101529555|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101529556|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
101529557|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101529558|NCT00557817|Hematinics|hematinics|mesh-ancestor
101529559|NCT05419583|Aspirin|aspirin|mesh-list
101529560|NCT05419583|Warfarin|warfarin|mesh-list
101529561|NCT05419583|Apixaban|apixaban|mesh-list
101529562|NCT05419583|Anticoagulants|anticoagulants|mesh-list
101529563|NCT05419583|Edoxaban|edoxaban|mesh-list
101529564|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101529565|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101529566|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529567|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529568|NCT05419583|Analgesics|analgesics|mesh-ancestor
101529569|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
101529570|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529571|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529572|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529573|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529574|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101529575|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101529576|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529577|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101529578|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529579|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
101529580|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101406247|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101406248|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406249|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
101406250|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
101529582|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101529604|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101529606|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529607|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529608|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529609|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
101529610|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101529611|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101529612|NCT04617561|Prednisolone|prednisolone|mesh-list
101529613|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
101529614|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101529615|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101529616|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
101529617|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
101529618|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529619|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
101529620|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
101529621|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529622|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529623|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101529624|NCT04617561|Hormones|hormones|mesh-ancestor
101529625|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529626|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101529627|NCT04617561|Protective Agents|protective agents|mesh-ancestor
101529628|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101529629|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529630|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101529631|NCT04617483|Vaccines|vaccines|mesh-list
101529632|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
101529633|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529634|NCT04617249|Anesthetics|anesthetics|mesh-list
101529635|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529648|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101529649|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
101529650|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
101529651|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529652|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529653|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101529654|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101529655|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529656|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529657|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529658|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529659|NCT00557934|Protective Agents|protective agents|mesh-ancestor
101529660|NCT00558051|Vaccines|vaccines|mesh-list
101529661|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
101529662|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529663|NCT00558090|Morphine|morphine|mesh-list
101529664|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101529665|NCT00558090|Narcotics|narcotics|mesh-ancestor
101529666|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529667|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529668|NCT00558090|Analgesics|analgesics|mesh-ancestor
101529669|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
101529670|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529672|NCT04617015|Ipratropium|ipratropium|mesh-list
101529673|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
101529674|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101529675|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
101529676|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529677|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529678|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101529679|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
101529680|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101406251|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406253|NCT00136539|Doxorubicin|doxorubicin|mesh-list
101406254|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101406255|NCT00136539|Trastuzumab|trastuzumab|mesh-list
101406256|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406257|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
101406258|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406259|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406260|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101406261|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
101487392|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
101529681|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101529682|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529683|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529684|NCT04650828|Tenofovir|tenofovir|mesh-list
101529685|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
101529686|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529687|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101529688|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101529689|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529690|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529691|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101529692|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101529693|NCT04650555|Genistein|genistein|mesh-list
101529694|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101529695|NCT04650555|Protective Agents|protective agents|mesh-ancestor
101529696|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529697|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529698|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101529699|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529716|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529717|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529718|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101529719|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101529720|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101529721|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
101529722|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529723|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529725|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101529726|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101529727|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529728|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
101529729|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529730|NCT05125796|Acetaminophen|acetaminophen|mesh-list
101529731|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101529732|NCT05125796|Ketoprofen|ketoprofen|mesh-list
101529733|NCT05125796|Lidocaine|lidocaine|mesh-list
101529734|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
101529736|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529737|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529738|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
101529739|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529740|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101529741|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101529742|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101529743|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529744|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529745|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529746|NCT05125796|Analgesics|analgesics|mesh-ancestor
101529747|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
101529748|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101529749|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101406262|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406263|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406264|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101406265|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101406266|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101406267|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101406268|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406269|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101406270|NCT00103571|Olanzapine|olanzapine|mesh-list
101406271|NCT00103571|Aripiprazole|aripiprazole|mesh-list
101406272|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
101406273|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
101406274|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406275|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406276|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406277|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101406278|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406279|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406280|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487393|NCT00432549|Topiramate|topiramate|mesh-list
101529750|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529751|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101529752|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529753|NCT04616859|Ethanol|ethanol|mesh-list
101529754|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101529755|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529756|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529757|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529758|NCT04616586|Siltuximab|siltuximab|mesh-list
101529771|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101529772|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
101529773|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529774|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
101529775|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529776|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529777|NCT00563160|Carboplatin|carboplatin|mesh-list
101529778|NCT00563160|Gemcitabine|gemcitabine|mesh-list
101529779|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529780|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101529781|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
101529782|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529784|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101529785|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529786|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
101529787|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
101529788|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529789|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529790|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101529791|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101529792|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101529793|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529794|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529795|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529796|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
101406282|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101406283|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406284|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548097|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406285|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406286|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
101406287|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
101406288|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
101406289|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
101406290|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101406291|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101406292|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101406293|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101406294|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101529797|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101529798|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529799|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
101529800|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101529801|NCT04934228|Clonidine|clonidine|mesh-list
101529802|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529803|NCT04934228|Diuretics|diuretics|mesh-ancestor
101529804|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
101529805|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529806|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101529807|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101529808|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529809|NCT04934228|Analgesics|analgesics|mesh-ancestor
101529810|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
101529811|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529812|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
101529813|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
101529814|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101529815|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101529816|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529817|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529818|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529832|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101529834|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101529835|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529837|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101529838|NCT04881929|Docetaxel|docetaxel|mesh-list
101529839|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529840|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101529841|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101529842|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101529843|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529844|NCT04615767|Inositol|inositol|mesh-list
101529845|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
101529846|NCT04615767|Vitamins|vitamins|mesh-ancestor
101529847|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
101529848|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529849|NCT04615611|Albuterol|albuterol|mesh-list
101529850|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101529851|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
101529852|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406295|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101406297|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406298|NCT00103649|Xaliproden|xaliproden|mesh-list
101406299|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101406300|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101406301|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
101406302|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406303|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406304|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406305|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
101406306|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101406307|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101406308|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406309|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406310|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101406311|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406312|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406313|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
101406314|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
101406315|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406316|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406317|NCT00103727|Risperidone|risperidone|mesh-list
101406318|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101406319|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
101406320|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406321|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406322|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406323|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101406324|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101529853|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529854|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101529855|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
101529856|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
101529858|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101529859|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101529860|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529861|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529862|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529863|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529864|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101529865|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529866|NCT04725812|Eculizumab|eculizumab|mesh-list
101406325|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406326|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406327|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101406328|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
101406329|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101406330|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101406331|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101406332|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406334|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101406335|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101406336|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
101529867|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101529868|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529869|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
101529870|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529871|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
101529872|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
101529873|NCT04713371|Ipilimumab|ipilimumab|mesh-list
101529874|NCT04713371|Sargramostim|sargramostim|mesh-list
101529875|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529876|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
101529877|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529878|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529879|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101529880|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
101529881|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529882|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529883|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101529898|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101529899|NCT04613700|Secretin|secretin|mesh-list
101529900|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101529901|NCT04613700|Hormones|hormones|mesh-ancestor
101416184|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
101529902|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529903|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529904|NCT04675151|Phentolamine|phentolamine|mesh-list
101529905|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101529906|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101529907|NCT04675151|Pilocarpine|pilocarpine|mesh-list
101529908|NCT04675151|Miotics|miotics|mesh-ancestor
101529909|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
101529910|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529911|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529912|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101529913|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101529914|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
101529916|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529917|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101529918|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101529919|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529920|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529921|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
101529922|NCT00563355|Hematinics|hematinics|mesh-ancestor
101529923|NCT00563394|Ofloxacin|ofloxacin|mesh-list
101529924|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101529925|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529926|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529927|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101529928|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101529929|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529930|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529931|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529932|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101406337|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406338|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406339|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406340|NCT00404040|Lactulose|lactulose|mesh-list
101406341|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101406342|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406343|NCT00404040|Laxatives|laxatives|mesh-ancestor
101406344|NCT00103922|Cilomilast|cilomilast|mesh-list
101406345|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101406346|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101406347|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406348|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406349|NCT00134160|Amlodipine|amlodipine|mesh-list
101406350|NCT00134160|Olmesartan|olmesartan|mesh-list
101406351|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101406352|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
101406353|NCT00134160|Calcium|calcium|mesh-list
101406354|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101529933|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101529934|NCT00563433|Ofloxacin|ofloxacin|mesh-list
101529935|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101529936|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529937|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529938|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101529939|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101529940|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529941|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529942|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529943|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101529956|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101529957|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101529960|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101529961|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
101529962|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529963|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529964|NCT04615910|Exenatide|exenatide|mesh-list
101529965|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529966|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529967|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101529968|NCT04615910|Incretins|incretins|mesh-ancestor
101529969|NCT04615910|Hormones|hormones|mesh-ancestor
101529970|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529971|NCT04609397|Hemay005|hemay005|mesh-list
101529972|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
101529973|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101529974|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101529975|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529976|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529977|NCT04587947|Valsartan|valsartan|mesh-list
101529978|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101529979|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529980|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101529981|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101406355|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406356|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406357|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406358|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406359|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406360|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101406361|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101406362|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101406363|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101406364|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406365|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
101406366|NCT00134199|Sibutramine|sibutramine|mesh-list
101406367|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
101406368|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406369|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
101406370|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101406371|NCT04729088|Isosorbide|isosorbide|mesh-list
101406372|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101406373|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101406374|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101406375|NCT04729088|Diuretics|diuretics|mesh-ancestor
101406376|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101406377|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406378|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406379|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101406380|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406382|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101487394|NCT00432549|Almotriptan|almotriptan|mesh-list
101529982|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529983|NCT04612998|Atropine|atropine|mesh-list
101529984|NCT04612998|Ephedrine|ephedrine|mesh-list
101529985|NCT04612998|Metoclopramide|metoclopramide|mesh-list
101529986|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101529987|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101529988|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101529989|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
101529990|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529991|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529992|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101529993|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
101529994|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
101529995|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
101529996|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101529997|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101529998|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
101406383|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406384|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101406385|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101406386|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406387|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406389|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406390|NCT00136773|Amlodipine|amlodipine|mesh-list
101406391|NCT00136773|Benazepril|benazepril|mesh-list
101406392|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406393|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101406394|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406395|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406396|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406397|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406398|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406399|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101406400|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
101406401|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406402|NCT00136851|Amlodipine|amlodipine|mesh-list
101406403|NCT00136851|Benazepril|benazepril|mesh-list
101406404|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406405|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101406406|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406407|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529999|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530000|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530001|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
101530002|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530003|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101530004|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101530020|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530021|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530024|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101530025|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530026|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
101530027|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530028|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101530029|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
101530030|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530031|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101530032|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530033|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101530034|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
101406408|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406409|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406410|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406411|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101406412|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
101406413|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406415|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101406416|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406417|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406418|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101406419|NCT00104273|Protective Agents|protective agents|mesh-ancestor
101530035|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101530036|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
101530037|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101530039|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530040|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530041|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530042|NCT02204345|Paclitaxel|paclitaxel|mesh-list
101530043|NCT02204345|Carboplatin|carboplatin|mesh-list
101530044|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101530045|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530046|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530047|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
101530048|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530049|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530050|NCT02187302|Bevacizumab|bevacizumab|mesh-list
101530052|NCT02187302|Everolimus|everolimus|mesh-list
101530053|NCT02187302|Sorafenib|sorafenib|mesh-list
101530054|NCT02187302|Axitinib|axitinib|mesh-list
101530055|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530059|NCT02187302|Growth Substances|growth substances|mesh-ancestor
101530060|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530061|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530062|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101530063|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101530064|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530092|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530093|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530094|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101530096|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
101530097|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530098|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101530099|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101530100|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101530101|NCT04633044|Betaine|betaine|mesh-list
101530102|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530103|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
101530104|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101530105|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
101530106|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530107|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101530108|NCT04611438|Cannabidiol|cannabidiol|mesh-list
101530109|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
101530110|NCT00563823|Vatalanib|vatalanib|mesh-list
101530111|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101530112|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406420|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406421|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
101406422|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101406423|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406424|NCT00134355|Vatalanib|vatalanib|mesh-list
101406425|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101406426|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406427|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406428|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101406429|NCT00104429|Aplaviroc|aplaviroc|mesh-list
101530125|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530126|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530127|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530128|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
101530129|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101530130|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
101530131|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530133|NCT02092922|Lenograstim|lenograstim|mesh-list
101530134|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101530136|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530137|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101530138|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530139|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530140|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530141|NCT02092454|Benzocaine|benzocaine|mesh-list
101530142|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
101530143|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
101530144|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530145|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530146|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
101530147|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530148|NCT02083289|Latanoprost|latanoprost|mesh-list
101530149|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101530150|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101530151|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
101530152|NCT02081300|Testosterone|testosterone|mesh-list
101530153|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
101530154|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
101530155|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101530156|NCT02081300|Androgens|androgens|mesh-ancestor
101530157|NCT02081300|Hormones|hormones|mesh-ancestor
101530158|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530159|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530160|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530161|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530162|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
101530163|NCT02074007|Benzocaine|benzocaine|mesh-list
101530164|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530165|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
101530166|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
101530167|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530168|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
101530169|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530170|NCT02072954|Asenapine|asenapine|mesh-list
101530171|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101530172|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101530173|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530174|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530199|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530200|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530201|NCT02057315|Analgesics|analgesics|mesh-ancestor
101530202|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
101530203|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406431|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101406432|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406433|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406434|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
101406435|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406436|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101406437|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101406438|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101406439|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101406440|NCT00136968|Voriconazole|voriconazole|mesh-list
101406441|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
101406442|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406443|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101530204|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530205|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530208|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530209|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530210|NCT02047214|Bevacizumab|bevacizumab|mesh-list
101530211|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530212|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530213|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530214|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530215|NCT02047214|Growth Substances|growth substances|mesh-ancestor
101530216|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530217|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530218|NCT02032277|Paclitaxel|paclitaxel|mesh-list
101530219|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
101530220|NCT02032277|Carboplatin|carboplatin|mesh-list
101530221|NCT02032277|Doxorubicin|doxorubicin|mesh-list
101530222|NCT02032277|Veliparib|veliparib|mesh-list
101530223|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101530224|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530225|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530236|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530237|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101530238|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101530239|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530240|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101530241|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101530243|NCT00560976|Hematinics|hematinics|mesh-ancestor
101530244|NCT02026349|Favipiravir|favipiravir|mesh-list
101530245|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
101530246|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530247|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
101530248|NCT04611126|Nivolumab|nivolumab|mesh-list
101530249|NCT04611126|Fludarabine|fludarabine|mesh-list
101530250|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
101530251|NCT04611126|Ipilimumab|ipilimumab|mesh-list
101530252|NCT04611126|Relatlimab|relatlimab|mesh-list
101530253|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530254|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
101530255|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530256|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530257|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101530258|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
101530259|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530260|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530261|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101406444|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101406445|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406446|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406447|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101406448|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
101406449|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406450|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406451|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101530262|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530263|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101530264|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530268|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101530269|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101530270|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530271|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530272|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530273|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530274|NCT04611165|Nivolumab|nivolumab|mesh-list
101530275|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530276|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530277|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101530278|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530279|NCT02014649|Laninamivir|laninamivir|mesh-list
101530280|NCT02014649|Zanamivir|zanamivir|mesh-list
101530281|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
101530282|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530283|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530284|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530285|NCT02014142|Latanoprost|latanoprost|mesh-list
101530286|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101530287|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101530288|NCT04610580|Choline|choline|mesh-list
101530289|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
101530290|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101530316|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101530317|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530318|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101530319|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101530320|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101530321|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530322|NCT04610541|Remdesivir|remdesivir|mesh-list
101530323|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
101530324|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530325|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
101530326|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530327|NCT04677335|Lovastatin|lovastatin|mesh-list
101530328|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101530329|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101530330|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
101530331|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530332|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101530333|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101530334|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530336|NCT04630548|Trace Elements|trace elements|mesh-ancestor
101530337|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
101530338|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530351|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530352|NCT01967810|Growth Substances|growth substances|mesh-ancestor
101530353|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406452|NCT00104468|Troxacitabine|troxacitabine|mesh-list
101406453|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406454|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101406455|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101406461|NCT00137007|Sultamicillin|sultamicillin|mesh-list
101406462|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101406463|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530354|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530355|NCT01165138|Fluticasone|fluticasone|mesh-list
101530357|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530358|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101530359|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
101530360|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530361|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530362|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101530363|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530364|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530365|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101530366|NCT00561054|Cetuximab|cetuximab|mesh-list
101530367|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530368|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530369|NCT04206358|Molgramostim|molgramostim|mesh-list
101530370|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530371|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101530372|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
101530373|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101530374|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530375|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530376|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101530377|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101530378|NCT00561093|Protective Agents|protective agents|mesh-ancestor
101530379|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530380|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
101530381|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101530382|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
101530383|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101530384|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101530385|NCT01165021|Folic Acid|folic acid|mesh-list
101530386|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
101530387|NCT01165021|Dexamethasone|dexamethasone|mesh-list
101530388|NCT01165021|Pemetrexed|pemetrexed|mesh-list
101530389|NCT01165021|Vitamins|vitamins|mesh-ancestor
101530390|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
101530391|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530392|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530393|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
101530394|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
101530395|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530396|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530397|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
101530398|NCT01165021|Hormones|hormones|mesh-ancestor
101530399|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530411|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530412|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530413|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101530414|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530418|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530419|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530420|NCT01952990|Phenylephrine|phenylephrine|mesh-list
101530421|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
101406464|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101406465|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406466|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406468|NCT00137085|Analgesics|analgesics|mesh-ancestor
101406469|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
101406470|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406471|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530422|NCT01952990|Tetracaine|tetracaine|mesh-list
101530423|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
101530424|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
101530425|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530426|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530427|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
101530428|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530429|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101530430|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101530431|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530432|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530433|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530434|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
101530435|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
101530436|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
101530437|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101530438|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530439|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101530440|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
101530441|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101530442|NCT01952990|Protective Agents|protective agents|mesh-ancestor
101530443|NCT04314310|Tenoxicam|tenoxicam|mesh-list
101530444|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530445|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530446|NCT04314310|Analgesics|analgesics|mesh-ancestor
101530447|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
101530448|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530449|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530450|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530451|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530452|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101530453|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530454|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530455|NCT04610307|Anesthetics|anesthetics|mesh-list
101530457|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530458|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
101530459|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101530460|NCT04610502|Antibodies|antibodies|mesh-list
101530461|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
101530462|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530463|NCT01164475|Plerixafor|plerixafor|mesh-list
101530472|NCT01164007|Bevacizumab|bevacizumab|mesh-list
101530473|NCT01164007|Dacarbazine|dacarbazine|mesh-list
101530474|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530475|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530476|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530477|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530478|NCT01164007|Growth Substances|growth substances|mesh-ancestor
101530479|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530480|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530481|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101530482|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
101530483|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530484|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101530485|NCT01941836|Ezetimibe|ezetimibe|mesh-list
101530486|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101530487|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101406472|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101406473|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101406474|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
101406475|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
101406476|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406477|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101530488|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
101530489|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530490|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101530491|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548143|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
101530492|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101530493|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530495|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
101530496|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101530497|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530498|NCT01163851|Bococizumab|bococizumab|mesh-list
101530499|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101530500|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101530501|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
101530502|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530503|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101530504|NCT01917383|Timolol|timolol|mesh-list
101530505|NCT01917383|Latanoprost|latanoprost|mesh-list
101530506|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101530507|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101530508|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530509|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530510|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530511|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530512|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101530513|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101530514|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101530515|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101530516|NCT01163617|Adalimumab|adalimumab|mesh-list
101530519|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530520|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101530521|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530522|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530523|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
101530524|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530525|NCT04629846|Docetaxel|docetaxel|mesh-list
101530526|NCT04629846|Trastuzumab|trastuzumab|mesh-list
101530527|NCT04629846|Pertuzumab|pertuzumab|mesh-list
101530528|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530529|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530541|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530542|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530543|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530544|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530545|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101530546|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530547|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
101530548|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530549|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101530550|NCT04629573|Anesthetics|anesthetics|mesh-list
101530551|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530552|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530553|NCT00564174|Aspirin|aspirin|mesh-list
101530554|NCT00564174|Heparin|heparin|mesh-list
101530555|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101530556|NCT00564174|Tinzaparin|tinzaparin|mesh-list
101530557|NCT00564174|Dalteparin|dalteparin|mesh-list
101530558|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530559|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530560|NCT00564174|Analgesics|analgesics|mesh-ancestor
101530561|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
101406479|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406480|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406481|NCT00104546|Vitamin K|vitamin k|mesh-list
101406482|NCT00104546|Vitamins|vitamins|mesh-ancestor
101406483|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
101406484|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406485|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101406486|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101487395|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
101530566|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101530567|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101530568|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530569|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101530570|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101530571|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530572|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
101530573|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
101530574|NCT01163266|Vortioxetine|vortioxetine|mesh-list
101530575|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
101530576|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101530577|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101530578|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101530579|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530580|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530581|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101530582|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101530583|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101530584|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530585|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530586|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
101530587|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101530604|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101530605|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101530606|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530607|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530608|NCT04629612|Anesthetics|anesthetics|mesh-list
101530609|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530610|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530611|NCT00564213|Mitomycins|mitomycins|mesh-list
101530612|NCT00564213|Mitomycin|mitomycin|mesh-list
101530613|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530614|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530615|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
101530616|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530617|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101530618|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530619|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101530620|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101530621|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
101530622|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530623|NCT00564252|Finasteride|finasteride|mesh-list
101530624|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101530625|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101530626|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530627|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530628|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101406487|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406489|NCT00104546|Coagulants|coagulants|mesh-ancestor
101406490|NCT00134394|Etanercept|etanercept|mesh-list
101406491|NCT00134394|Tacrolimus|tacrolimus|mesh-list
101406492|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406493|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
101406495|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101406496|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406497|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487396|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101530629|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530630|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530631|NCT00564252|Urological Agents|urological agents|mesh-ancestor
101530633|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530634|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
101530635|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530636|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101530637|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530638|NCT01847573|Halofuginone|halofuginone|mesh-list
101530639|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530640|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
101530641|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101530642|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101530643|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530675|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101530676|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101530677|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101530678|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530680|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530681|NCT04609293|Apatinib|apatinib|mesh-list
101530682|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530683|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101530684|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530694|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530695|NCT01811498|Bevacizumab|bevacizumab|mesh-list
101530696|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530697|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530698|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530699|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530700|NCT01811498|Growth Substances|growth substances|mesh-ancestor
101530701|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530706|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101530707|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101530708|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
101530709|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
101530710|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530712|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101530713|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101530714|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101530715|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530716|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530717|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
101530718|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530719|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101406498|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101406499|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406500|NCT00134394|Analgesics|analgesics|mesh-ancestor
101406501|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
101406502|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406503|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530733|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101530734|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101530735|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101530736|NCT00564330|Esomeprazole|esomeprazole|mesh-list
101530737|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101530738|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530739|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101530740|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530741|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530742|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
101530743|NCT01780844|Prednisone|prednisone|mesh-list
101530744|NCT01780844|Tacrolimus|tacrolimus|mesh-list
101530745|NCT01780844|Basiliximab|basiliximab|mesh-list
101530746|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530748|NCT01780844|Hormones|hormones|mesh-ancestor
101530758|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530759|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101530760|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
101530761|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101530762|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530764|NCT01779947|Estrogens|estrogens|mesh-ancestor
101530765|NCT01779947|Hormones|hormones|mesh-ancestor
101530766|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530767|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530768|NCT00564408|Carbachol|carbachol|mesh-list
101530769|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101530770|NCT00564408|Miotics|miotics|mesh-ancestor
101530771|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
101530772|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530773|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530774|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101530775|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
101530776|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530777|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530778|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530779|NCT00564408|Analgesics|analgesics|mesh-ancestor
101530780|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
101530781|NCT00564408|Protective Agents|protective agents|mesh-ancestor
101530782|NCT01773785|Docetaxel|docetaxel|mesh-list
101530783|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530784|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530785|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
101406509|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101406510|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101406511|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406512|NCT00104663|Quinacrine|quinacrine|mesh-list
101406513|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
101406514|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101530786|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530787|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530788|NCT01758458|Interferons|interferons|mesh-list
101530789|NCT01758458|Aldesleukin|aldesleukin|mesh-list
101530790|NCT01758458|Interferon-beta|interferon-beta|mesh-list
101530800|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101530801|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101530802|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
101530803|NCT04608981|Prednisolone|prednisolone|mesh-list
101530804|NCT04608981|Diclofenac|diclofenac|mesh-list
101530805|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530806|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
101530807|NCT04608981|Hormones|hormones|mesh-ancestor
101530808|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530809|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530810|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530811|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530827|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530829|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101530830|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
101530831|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530832|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101530833|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530834|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
101530835|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
101530836|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101530837|NCT01730027|Montelukast|montelukast|mesh-list
101530838|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101530839|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
101530840|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101530841|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
101530842|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530843|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530844|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101530845|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101530846|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530848|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530849|NCT04608669|Analgesics|analgesics|mesh-ancestor
101530851|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530852|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530853|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
101530854|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101530855|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101530856|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101530857|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
101530858|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530859|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101406515|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
101406516|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101406517|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406518|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
101406519|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101406520|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
101406521|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406522|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406523|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530860|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101530861|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530863|NCT04600089|Analgesics|analgesics|mesh-ancestor
101530864|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
101530865|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530866|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530875|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530876|NCT01704365|Vaccines|vaccines|mesh-list
101530877|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
101530878|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530879|NCT01698281|Dexamethasone|dexamethasone|mesh-list
101530880|NCT01698281|Doxorubicin|doxorubicin|mesh-list
101530881|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530882|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
101530883|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
101530884|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530885|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530886|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530887|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
101530888|NCT01698281|Hormones|hormones|mesh-ancestor
101530889|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530890|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530891|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530892|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530893|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101530894|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101530895|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530896|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530897|NCT00565461|Vaccines|vaccines|mesh-list
101530898|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
101530899|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530901|NCT01858883|Gemcitabine|gemcitabine|mesh-list
101530902|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101530903|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530908|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530909|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
101530910|NCT01697072|Cisplatin|cisplatin|mesh-list
101530911|NCT01697072|Capecitabine|capecitabine|mesh-list
101530912|NCT01697072|Epirubicin|epirubicin|mesh-list
101530913|NCT01697072|Rilotumumab|rilotumumab|mesh-list
101530914|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530915|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530916|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
101530917|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530918|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530919|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101530920|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101530921|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530922|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530923|NCT00565500|Ibuprofen|ibuprofen|mesh-list
101406524|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101406526|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
101406527|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101406528|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
101406529|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101406530|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406531|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101406532|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101406533|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406534|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
101530924|NCT00565500|Celecoxib|celecoxib|mesh-list
101530925|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530926|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530927|NCT00565500|Analgesics|analgesics|mesh-ancestor
101530928|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
101530929|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530930|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530931|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530958|NCT04608006|Fentanyl|fentanyl|mesh-list
101530959|NCT04608006|Bupivacaine|bupivacaine|mesh-list
101530960|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
101530961|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
101530962|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530963|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530964|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
101530965|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530966|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101530967|NCT04608006|Narcotics|narcotics|mesh-ancestor
101530968|NCT04608006|Analgesics|analgesics|mesh-ancestor
101530969|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101530970|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101530971|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
101530972|NCT04599621|Uric Acid|uric acid|mesh-list
101530973|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
101530974|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530975|NCT04599621|Protective Agents|protective agents|mesh-ancestor
101530976|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530977|NCT00564525|Amitriptyline|amitriptyline|mesh-list
101530978|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101530980|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101530984|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530985|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530986|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101530987|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101530988|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101530989|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530990|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530991|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530992|NCT04607733|Mirikizumab|mirikizumab|mesh-list
101530993|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530994|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530995|NCT04607733|Analgesics|analgesics|mesh-ancestor
101530996|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
101530997|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530998|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530999|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531000|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531001|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101531002|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531004|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101531005|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406535|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
101406536|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406537|NCT00134511|Atorvastatin|atorvastatin|mesh-list
101406538|NCT00134511|Torcetrapib|torcetrapib|mesh-list
101406539|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101406540|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101406541|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
101406542|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406543|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101531006|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
101531007|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531008|NCT01632137|Protective Agents|protective agents|mesh-ancestor
101531009|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531010|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531011|NCT00565539|Interferons|interferons|mesh-list
101531012|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531013|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
101531014|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531015|NCT04599699|Androgens|androgens|mesh-list
101531016|NCT04599699|Hormones|hormones|mesh-ancestor
101531017|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531018|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531019|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
101531020|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
101531021|NCT01563731|Atorvastatin|atorvastatin|mesh-list
101531022|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101531023|NCT01563731|Simvastatin|simvastatin|mesh-list
101531024|NCT01563731|Pravastatin|pravastatin|mesh-list
101531025|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101531026|NCT01563731|Diuretics|diuretics|mesh-list
101531027|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101531031|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101531032|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531033|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101531034|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101531035|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
101531036|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531037|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101531038|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101531039|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
101531040|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101531041|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101531042|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
101531043|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531044|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101531045|NCT01516346|Hydralazine|hydralazine|mesh-list
101531046|NCT01516346|Isosorbide|isosorbide|mesh-list
101531047|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101531048|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101531049|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101531050|NCT01516346|Diuretics|diuretics|mesh-ancestor
101531077|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101531078|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101531079|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101531080|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531081|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531082|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
101531083|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101531084|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101531085|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101531086|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406544|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101406545|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406546|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
101406547|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101406548|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
101531088|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531089|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531090|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531091|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531092|NCT00565656|Growth Substances|growth substances|mesh-ancestor
101531093|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531115|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531116|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101531117|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101531118|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101531119|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531121|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101531122|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
101531123|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531124|NCT00564642|Expectorants|expectorants|mesh-ancestor
101531125|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
101531126|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101531127|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
101531128|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531129|NCT00564642|Protective Agents|protective agents|mesh-ancestor
101531130|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531131|NCT00564642|Antidotes|antidotes|mesh-ancestor
101531132|NCT00555386|Selenium|selenium|mesh-list
101531133|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
101531134|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531135|NCT00555386|Protective Agents|protective agents|mesh-ancestor
101531136|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531137|NCT00555386|Trace Elements|trace elements|mesh-ancestor
101531138|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
101531139|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101531140|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
101531141|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531142|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
101531143|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531144|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531145|NCT04675697|Etoposide|etoposide|mesh-list
101531157|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
101531160|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
101531161|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531162|NCT04676126|Dorzolamide|dorzolamide|mesh-list
101531163|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101531164|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101531165|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531166|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531167|NCT04675619|Pirfenidone|pirfenidone|mesh-list
101531168|NCT04675619|Analgesics|analgesics|mesh-ancestor
101531169|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
101531170|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531171|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531172|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101531173|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531174|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101406554|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406555|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101406556|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101406557|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406558|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
101531175|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531176|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531177|NCT05305300|Vaccines|vaccines|mesh-list
101531178|NCT05305300|Somatomedin B|somatomedin b|mesh-list
101531179|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
101531180|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531181|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101531182|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101531183|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
101531184|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531185|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531186|NCT04187755|Ceftazidime|ceftazidime|mesh-list
101531187|NCT04187755|Cefepime|cefepime|mesh-list
101531188|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101531189|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531190|NCT00555542|Rituximab|rituximab|mesh-list
101531191|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531192|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531193|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
101531194|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531195|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531196|NCT04606563|Losartan|losartan|mesh-list
101531197|NCT04606563|Valsartan|valsartan|mesh-list
101531198|NCT04606563|Telmisartan|telmisartan|mesh-list
101531199|NCT04606563|Candesartan|candesartan|mesh-list
101531200|NCT04606563|Candesartan cilexetil|candesartan cilexetil|mesh-list
101531201|NCT04606563|Olmesartan|olmesartan|mesh-list
101531202|NCT04606563|Irbesartan|irbesartan|mesh-list
101531203|NCT04606563|Eprosartan|eprosartan|mesh-list
101531204|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101531205|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101531206|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101531207|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101531208|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531216|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531217|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101531221|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
101531222|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531223|NCT01162486|Rifampin|rifampin|mesh-list
101531224|NCT01162486|Rifapentine|rifapentine|mesh-list
101531225|NCT01162486|Midazolam|midazolam|mesh-list
101531226|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101531227|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101531228|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531229|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531230|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101531231|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531232|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531233|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101531234|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
101531235|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
101531236|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
101531237|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
101531238|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531239|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531240|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101531241|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
101531242|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101531243|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531244|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
101531245|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101531246|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531247|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101531248|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101531249|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101531250|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101531251|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101531252|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101531253|NCT01162135|Digoxin|digoxin|mesh-list
101531254|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101531255|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101531256|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531257|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531258|NCT01162135|Protective Agents|protective agents|mesh-ancestor
101531259|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531260|NCT00555776|Gabapentin|gabapentin|mesh-list
101531261|NCT00555776|Analgesics|analgesics|mesh-ancestor
101531262|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
101531263|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531264|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531265|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
101531266|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101531267|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531268|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531269|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531273|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531274|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
101531275|NCT01161628|Rituximab|rituximab|mesh-list
101531276|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531277|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531278|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
101531279|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531280|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531281|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
101531282|NCT04314505|Narcotics|narcotics|mesh-ancestor
101531283|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531284|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531285|NCT04314505|Analgesics|analgesics|mesh-ancestor
101531286|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
101531287|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531288|NCT02885545|Anticoagulants|anticoagulants|mesh-list
101531289|NCT01161472|Alprazolam|alprazolam|mesh-list
101531290|NCT01161472|Fesoterodine|fesoterodine|mesh-list
101531291|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101531292|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531293|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531294|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101531295|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531296|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531297|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
101531298|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
101531300|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531301|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101531302|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101531303|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
101531304|NCT01161472|Urological Agents|urological agents|mesh-ancestor
101531305|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
101531306|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101531307|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
101531308|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531309|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
101531310|NCT04675385|Protective Agents|protective agents|mesh-ancestor
101531311|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
101531312|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101531313|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531314|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531315|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531316|NCT04598061|Analgesics|analgesics|mesh-ancestor
101406560|NCT00104819|Antibodies|antibodies|mesh-list
101406561|NCT00104819|Sargramostim|sargramostim|mesh-list
101406562|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101406563|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
101406564|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406565|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
101406566|NCT00137202|Promethazine|promethazine|mesh-list
101406567|NCT00137202|Ondansetron|ondansetron|mesh-list
101531317|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
101531318|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531319|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101531320|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101531321|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531322|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
101531323|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531324|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531325|NCT04674956|Paclitaxel|paclitaxel|mesh-list
101531326|NCT04674956|Gemcitabine|gemcitabine|mesh-list
101531327|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531328|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531329|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
101531332|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531333|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531334|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
101531335|NCT00564720|Gemcitabine|gemcitabine|mesh-list
101531336|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
101531337|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101531338|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531339|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
101531340|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531341|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531342|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531343|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531344|NCT01160770|Clobazam|clobazam|mesh-list
101531345|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
101531346|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101531347|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531348|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531349|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531369|NCT01160614|Analgesics|analgesics|mesh-ancestor
101531370|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
101531371|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531372|NCT00566124|Insulin|insulin|mesh-list
101531373|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101531374|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
101531375|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
101531376|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
101531377|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
101531378|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
101531379|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101531380|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531381|NCT01159912|Fluticasone|fluticasone|mesh-list
101531383|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531384|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101531385|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
101531386|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531387|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531388|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101531389|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
101531390|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
101531391|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101531392|NCT04606212|Losartan|losartan|mesh-list
101531393|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101531394|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406568|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
101406569|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
101406570|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406571|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406572|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101188606|NCT00003000|Fentanyl|fentanyl|mesh-list
101531395|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101531396|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101531397|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531398|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
101531400|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531401|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531402|NCT04631822|Dexamethasone|dexamethasone|mesh-list
101531403|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531404|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
101531405|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
101531406|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531407|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531408|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531413|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531415|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101531416|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531417|NCT04605705|Analgesics|analgesics|mesh-ancestor
101531418|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
101531419|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531420|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531421|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531422|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531423|NCT00560924|Estradiol|estradiol|mesh-list
101531424|NCT00560924|Estrogens|estrogens|mesh-ancestor
101531425|NCT00560924|Hormones|hormones|mesh-ancestor
101531426|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531427|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531428|NCT00560963|Everolimus|everolimus|mesh-list
101531429|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101531430|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531431|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531432|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531433|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101531434|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
101531436|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531437|NCT01159600|Empagliflozin|empagliflozin|mesh-list
101531438|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101531439|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531440|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101531441|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531442|NCT04631627|Aspirin|aspirin|mesh-list
101531443|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101531444|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531445|NCT04631627|Analgesics|analgesics|mesh-ancestor
101531446|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
101531447|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531448|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531449|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531450|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406578|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406579|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406580|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101406581|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101406582|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406583|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
101531451|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101531452|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101531453|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531454|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101531455|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101531456|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531458|NCT04314193|Prednisolone|prednisolone|mesh-list
101531459|NCT04314193|Methotrexate|methotrexate|mesh-list
101531460|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101531461|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
101531462|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101531463|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531464|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531465|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
101531466|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531468|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
101531469|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531470|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101531471|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101531472|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
101531473|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531474|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101531475|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531476|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
101531501|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101531502|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
101531503|NCT04631315|Difluprednate|difluprednate|mesh-list
101531504|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101531505|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531506|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
101548172|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101531508|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531509|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531510|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531511|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531512|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
101531513|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
101531514|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531515|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531516|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101531517|NCT04631315|Protective Agents|protective agents|mesh-ancestor
101531518|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101531519|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
101531520|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
101531523|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
101531524|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101531525|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101531541|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101531543|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531544|NCT02885311|Naltrexone|naltrexone|mesh-list
101531545|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101531546|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101531547|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531548|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
101531549|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531550|NCT00566241|Mecasermin|mecasermin|mesh-list
101531551|NCT00566241|Growth Substances|growth substances|mesh-ancestor
101531552|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406585|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
101406586|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101406587|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
101406588|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
101406589|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101406590|NCT00104975|Fludarabine|fludarabine|mesh-list
101406591|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
101406592|NCT00104975|Melphalan|melphalan|mesh-list
101406593|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
101406594|NCT00104975|Thiotepa|thiotepa|mesh-list
101406595|NCT00104975|Tacrolimus|tacrolimus|mesh-list
101531553|NCT00561119|Paclitaxel|paclitaxel|mesh-list
101531554|NCT00561119|Gemcitabine|gemcitabine|mesh-list
101531555|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531558|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
101531559|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
101531560|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531561|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531562|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
101531563|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
101531564|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531565|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531566|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101531567|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
101531568|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101531569|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531570|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101531571|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101531572|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101531573|NCT00564993|Dobutamine|dobutamine|mesh-list
101531574|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101531575|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
101531576|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
101531577|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531578|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531579|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101531580|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101531581|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531582|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
101531599|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531600|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101531601|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531602|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531603|NCT04604886|Protective Agents|protective agents|mesh-ancestor
101531605|NCT04595877|Endorphins|endorphins|mesh-list
101531606|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
101531607|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101531608|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531609|NCT04595877|Analgesics|analgesics|mesh-ancestor
101531610|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
101531611|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531612|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531613|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531614|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531615|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
101531616|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531617|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531618|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
101531619|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531620|NCT03454646|Rivastigmine|rivastigmine|mesh-list
101531621|NCT03454646|Donepezil|donepezil|mesh-list
101531622|NCT03454646|Galantamine|galantamine|mesh-list
101406597|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406598|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
101406599|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406600|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406601|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
101406604|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406605|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101406606|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
101531623|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
101531624|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531625|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531626|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
101531627|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531628|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531629|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
101531630|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101531631|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
101531632|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531633|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101531634|NCT03454646|Protective Agents|protective agents|mesh-ancestor
101531635|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
101531636|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531637|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531638|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
101531639|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531640|NCT00566553|Protective Agents|protective agents|mesh-ancestor
101531641|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531653|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
101531654|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101531655|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101531656|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101531657|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101531658|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101531660|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531661|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531662|NCT01157065|Growth Substances|growth substances|mesh-ancestor
101531663|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531664|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531665|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531667|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101531668|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531669|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531670|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531671|NCT01156792|Montelukast|montelukast|mesh-list
101531672|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101531673|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
101531674|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101531675|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
101531677|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531678|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101531679|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101531680|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531682|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101531683|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406608|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101406609|NCT00137358|Amifostine|amifostine|mesh-list
101406610|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101406611|NCT00137358|Protective Agents|protective agents|mesh-ancestor
101406612|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406613|NCT00134667|Verteporfin|verteporfin|mesh-list
101406614|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101406615|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406616|NCT00134706|Carboplatin|carboplatin|mesh-list
101406617|NCT00134706|Docetaxel|docetaxel|mesh-list
101406618|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406619|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
101406620|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
101406621|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
101406622|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406623|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101406624|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101406625|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101406626|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
101406627|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406628|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406629|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406630|NCT00137397|Urological Agents|urological agents|mesh-ancestor
101406631|NCT00134745|Estradiol|estradiol|mesh-list
101531684|NCT04628624|Antioxidants|antioxidants|mesh-list
101531685|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531686|NCT04628624|Protective Agents|protective agents|mesh-ancestor
101531687|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531688|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
101531689|NCT04604028|Lenalidomide|lenalidomide|mesh-list
101531690|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101531691|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
101531692|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531693|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531694|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101531695|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
101531696|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531697|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531698|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101531699|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531700|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531701|NCT04604028|Growth Substances|growth substances|mesh-ancestor
101531716|NCT02884921|Analgesics|analgesics|mesh-ancestor
101531719|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531721|NCT00561704|Losartan|losartan|mesh-list
101406632|NCT00134745|Estrogens|estrogens|mesh-ancestor
101406633|NCT00134745|Hormones|hormones|mesh-ancestor
101406634|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406635|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406636|NCT00105209|Aspirin|aspirin|mesh-list
101406637|NCT00105209|Clopidogrel|clopidogrel|mesh-list
101406638|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101406639|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406640|NCT00105209|Analgesics|analgesics|mesh-ancestor
101406641|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
101406642|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406643|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406644|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101406645|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406646|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101406647|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101406648|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406649|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101406650|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101406651|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406652|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
101406653|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101406654|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101406655|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101406656|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
101406657|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406658|NCT00105287|Fentanyl|fentanyl|mesh-list
101406659|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101406660|NCT00105287|Narcotics|narcotics|mesh-ancestor
101406661|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406662|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406663|NCT00105287|Analgesics|analgesics|mesh-ancestor
101406664|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
101406665|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406666|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101406673|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101406674|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101406675|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406676|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
101406677|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406678|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101406679|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101406680|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531722|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101531724|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101531725|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101531726|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531727|NCT01156051|Guanfacine|guanfacine|mesh-list
101531728|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101531729|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101531730|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101531731|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531732|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
101531733|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531734|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531735|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531736|NCT04595409|Ustekinumab|ustekinumab|mesh-list
101531737|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101531738|NCT04628000|Vitamin D|vitamin d|mesh-list
101531739|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
101531740|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
101531741|NCT04628000|Vitamins|vitamins|mesh-list
101531742|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
101531743|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531744|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101188740|NCT00003090|Aldesleukin|aldesleukin|mesh-list
101531745|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101531746|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
101531747|NCT01155661|Serotonin|serotonin|mesh-list
101531748|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101531749|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101531750|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
101531751|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531752|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531753|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531754|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101531755|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101531756|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101531757|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531758|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
101531759|NCT00565188|Adenosine|adenosine|mesh-list
101531760|NCT00565188|Analgesics|analgesics|mesh-ancestor
101531761|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
101531762|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531763|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531781|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531782|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
101531783|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101531784|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
101531785|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101531786|NCT04603794|Povidone|povidone|mesh-list
101531787|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101531788|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531789|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
101531790|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
101531791|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
101531792|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
101531793|NCT01155583|Dexamethasone|dexamethasone|mesh-list
101531794|NCT01155583|Lenalidomide|lenalidomide|mesh-list
101406681|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406682|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406683|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406684|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101406685|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101406686|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
101406687|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406688|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406689|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101406690|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101531797|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
101531798|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
101531799|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531800|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531801|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531802|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
101531803|NCT01155583|Hormones|hormones|mesh-ancestor
101531804|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531805|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531806|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531807|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
101531808|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531809|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531810|NCT01155583|Growth Substances|growth substances|mesh-ancestor
101531811|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531812|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531813|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
101531814|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531815|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531816|NCT04603131|Vaccines|vaccines|mesh-list
101531817|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
101531818|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531819|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
101531820|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
101531821|NCT04627181|Hematinics|hematinics|mesh-ancestor
101531840|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531841|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101531843|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531845|NCT00561899|Amodiaquine|amodiaquine|mesh-list
101531846|NCT00561899|Artenimol|artenimol|mesh-list
101531847|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
101531848|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101531849|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101531850|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531851|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
101531852|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101531853|NCT01155388|Hematinics|hematinics|mesh-ancestor
101531854|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101531855|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101531856|NCT01155388|Trace Elements|trace elements|mesh-ancestor
101531857|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
101531858|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531859|NCT00565227|Docetaxel|docetaxel|mesh-list
101531860|NCT00565227|Vorinostat|vorinostat|mesh-list
101531861|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531864|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101531865|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531866|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101531867|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406691|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
101406692|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
101406693|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
101406694|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101406695|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
101406696|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101531868|NCT04602273|Azacitidine|azacitidine|mesh-list
101531869|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531870|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
101531871|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531872|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531873|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531874|NCT04313764|Bupivacaine|bupivacaine|mesh-list
101531875|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
101531876|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
101531877|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531878|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531879|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
101531889|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531890|NCT04601688|Growth Substances|growth substances|mesh-ancestor
101531891|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531892|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531893|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531894|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
101531895|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
101531896|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531897|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531898|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
101531899|NCT04601688|Hormones|hormones|mesh-ancestor
101531901|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531902|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101531903|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101531904|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531905|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531906|NCT04313452|Insulin|insulin|mesh-list
101531907|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101531908|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531909|NCT01154218|Crizotinib|crizotinib|mesh-list
101531910|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531911|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531912|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189221|NCT00003576|Fluorouracil|fluorouracil|mesh-list
101531913|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531914|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
101531915|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101531916|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101531917|NCT04601142|Prednisolone|prednisolone|mesh-list
101531918|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
101531919|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101531920|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
101531921|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531922|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
101531923|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
101531924|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531927|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
101531928|NCT04601142|Hormones|hormones|mesh-ancestor
101531929|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531930|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101531931|NCT04601142|Protective Agents|protective agents|mesh-ancestor
101531932|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531933|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531934|NCT04625543|Paclitaxel|paclitaxel|mesh-list
101531935|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101531936|NCT04625543|Cisplatin|cisplatin|mesh-list
101406698|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406699|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101406700|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406701|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406702|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101406703|NCT00105404|Triamcinolone|triamcinolone|mesh-list
101406704|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101531937|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531938|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531939|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101531940|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101531941|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101531942|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531943|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
101531944|NCT04601259|Salicylates|salicylates|mesh-list
101531957|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101531958|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531959|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531961|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101531962|NCT00565383|Narcotics|narcotics|mesh-ancestor
101531963|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531964|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531965|NCT00565383|Analgesics|analgesics|mesh-ancestor
101531966|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
101531967|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531968|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101531969|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101531970|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
101531971|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
101531972|NCT04625426|Protective Agents|protective agents|mesh-list
101531973|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531974|NCT04625114|Gabexate|gabexate|mesh-list
101531975|NCT04625114|Camostat|camostat|mesh-list
101531976|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
101531977|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531978|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531979|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101531980|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101531981|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
101531982|NCT00567099|Aripiprazole|aripiprazole|mesh-list
101531983|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
101531984|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531985|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101531986|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531987|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531990|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
101531991|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531992|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531993|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101531994|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101531995|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
101531996|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101531997|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101531998|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101531999|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101532000|NCT00567177|Cyclosporine|cyclosporine|mesh-list
101532001|NCT00567177|Cyclosporins|cyclosporins|mesh-list
101532002|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532003|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532004|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532005|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
101532016|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406705|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101406706|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101406707|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101406708|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
101406709|NCT00105404|Hormones|hormones|mesh-ancestor
101532017|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532018|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532020|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532022|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
101532023|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532025|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101532026|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101532027|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101532028|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532029|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532030|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532031|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532032|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532033|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
101532034|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532035|NCT04624217|Paclitaxel|paclitaxel|mesh-list
101532036|NCT04624217|Gemcitabine|gemcitabine|mesh-list
101532037|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101532038|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532039|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101532040|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101532041|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101532042|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532043|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101532044|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
101532045|NCT04623866|Valsartan|valsartan|mesh-list
101532046|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532047|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101532048|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101532049|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532050|NCT00567372|Bevacizumab|bevacizumab|mesh-list
101532052|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532053|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532054|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532055|NCT00567372|Growth Substances|growth substances|mesh-ancestor
101532056|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532057|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532058|NCT00562133|Insulin|insulin|mesh-list
101532059|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101532060|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
101532061|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532062|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532063|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101532064|NCT00567411|Apraclonidine|apraclonidine|mesh-list
101532065|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532066|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101532067|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101532082|NCT00567450|Mepivacaine|mepivacaine|mesh-list
101532083|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
101532084|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
101532085|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532086|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532087|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
101532088|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532089|NCT00567528|Ibuprofen|ibuprofen|mesh-list
101532090|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532091|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532092|NCT00567528|Analgesics|analgesics|mesh-ancestor
101406710|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406711|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406712|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101406713|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
101406714|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532093|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
101532094|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532095|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532096|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532097|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532098|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532099|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532100|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532101|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
101532102|NCT00567606|Calcium|calcium|mesh-list
101532103|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101532104|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532105|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101532106|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532107|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532108|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101532109|NCT04590612|Levodopa|levodopa|mesh-list
101532112|NCT04590612|Citalopram|citalopram|mesh-list
101532113|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101532114|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101532115|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101532116|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
101532117|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532118|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532119|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532120|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101532121|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532122|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101532123|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101532124|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532125|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
101532139|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532141|NCT00562289|Aspirin|aspirin|mesh-list
101532142|NCT00562289|Dipyridamole|dipyridamole|mesh-list
101532143|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
101532144|NCT00562289|Apixaban|apixaban|mesh-list
101532145|NCT00562289|Dabigatran|dabigatran|mesh-list
101532146|NCT00562289|Antivitamins K|antivitamins k|mesh-list
101532147|NCT00562289|Clopidogrel|clopidogrel|mesh-list
101532148|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532149|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532150|NCT00562289|Analgesics|analgesics|mesh-ancestor
101532151|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
101532152|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532153|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532154|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532155|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532156|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101532157|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101532158|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532159|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101532160|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532161|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532162|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
101189590|NCT00003900|Irinotecan|irinotecan|mesh-list
101532163|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101532164|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101532165|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101406715|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406717|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101406719|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406720|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406721|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101406722|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532166|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
101532167|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532168|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101532169|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
101532170|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101532171|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
101532173|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101532174|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
101532175|NCT04313218|Misoprostol|misoprostol|mesh-list
101532176|NCT04313218|Carbetocin|carbetocin|mesh-list
101532177|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101532178|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
101532179|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101532180|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532181|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101532182|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532183|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
101532184|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
101532185|NCT00624871|Ibuprofen|ibuprofen|mesh-list
101532202|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532203|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532204|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532205|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532207|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101532208|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
101532209|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101532210|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
101532211|NCT04590183|Tacrolimus|tacrolimus|mesh-list
101532212|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101532213|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
101532214|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532215|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
101532216|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532217|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101532218|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532219|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532220|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532221|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
101532222|NCT04590183|Hormones|hormones|mesh-ancestor
101532223|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532224|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101532225|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532226|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
101532227|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
101532228|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532229|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532230|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101532231|NCT04590183|Protective Agents|protective agents|mesh-ancestor
101532232|NCT04622618|Gabapentin|gabapentin|mesh-list
101532233|NCT04622618|Analgesics|analgesics|mesh-ancestor
101532234|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
101532235|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532239|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406723|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101406724|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101406725|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101406726|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101406727|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406728|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406729|NCT00135018|Celecoxib|celecoxib|mesh-list
101406730|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101406731|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406732|NCT00135018|Analgesics|analgesics|mesh-ancestor
101532240|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532241|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532242|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101532243|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101532252|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532253|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532254|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101532255|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101532257|NCT04622579|Lenalidomide|lenalidomide|mesh-list
101532258|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532259|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532260|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
101532261|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532262|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532263|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532264|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532265|NCT04622579|Growth Substances|growth substances|mesh-ancestor
101532266|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532267|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101532268|NCT01153009|Vortioxetine|vortioxetine|mesh-list
101532269|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101532270|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101532271|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532272|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532273|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532274|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532275|NCT01153009|Analgesics|analgesics|mesh-ancestor
101532276|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
101532277|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532278|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
101532279|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532280|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
101532281|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101532282|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532283|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532284|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101532286|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101532287|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101532288|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101532289|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101532290|NCT04622111|Metformin|metformin|mesh-list
101532291|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532292|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532293|NCT04622033|Brodalumab|brodalumab|mesh-list
101532294|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
101532295|NCT01152580|Melatonin|melatonin|mesh-list
101532296|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
101532297|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532298|NCT01152580|Protective Agents|protective agents|mesh-ancestor
101532299|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532300|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406734|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406735|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406736|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101406737|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406738|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101406739|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532301|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101532302|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
101532303|NCT04621799|Coagulants|coagulants|mesh-ancestor
101532304|NCT04621370|Capecitabine|capecitabine|mesh-list
101532305|NCT04621370|Durvalumab|durvalumab|mesh-list
101532306|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101532307|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
101532308|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532309|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532323|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101532325|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532326|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101532327|NCT01152190|Tadalafil|tadalafil|mesh-list
101532328|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
101532329|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101532330|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101532331|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532332|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532333|NCT01152190|Urological Agents|urological agents|mesh-ancestor
101532334|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
101532335|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101532336|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101532337|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101532338|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532339|NCT01151410|Enalapril|enalapril|mesh-list
101532340|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101532341|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
101532342|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532343|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532344|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532345|NCT00562406|Ranibizumab|ranibizumab|mesh-list
101532346|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532347|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532348|NCT00562406|Growth Substances|growth substances|mesh-ancestor
101532349|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532350|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532351|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532352|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
101532353|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101532354|NCT04588935|Bisoprolol|bisoprolol|mesh-list
101532355|NCT04588935|Perindopril|perindopril|mesh-list
101532356|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532357|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
101532358|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
101532359|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532360|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532361|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101532362|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101532363|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101532364|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532365|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532366|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532383|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532384|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101532385|NCT04649697|Clobetasol|clobetasol|mesh-list
101532386|NCT04649697|Rebamipide|rebamipide|mesh-list
101532387|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532388|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
101532389|NCT04649697|Hormones|hormones|mesh-ancestor
101406740|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406741|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406742|NCT00137709|Lamotrigine|lamotrigine|mesh-list
101406743|NCT00137709|Valproic Acid|valproic acid|mesh-list
101406745|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101406746|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406747|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406748|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101406749|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406750|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101406751|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101406752|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406753|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101406754|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101406755|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406756|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
101406757|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406758|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
101406759|NCT01054144|Dexamethasone|dexamethasone|mesh-list
101406760|NCT01054144|Prednisone|prednisone|mesh-list
101406761|NCT01054144|Lenalidomide|lenalidomide|mesh-list
101532390|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532391|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532392|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101532393|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532394|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
101532395|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532396|NCT04649697|Protective Agents|protective agents|mesh-ancestor
101532397|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532398|NCT04649502|Metformin|metformin|mesh-list
101532399|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532400|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532401|NCT04621253|Dipyrone|dipyrone|mesh-list
101548274|NCT01098097|Ribavirin|ribavirin|mesh-list
101532402|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532403|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532404|NCT04621253|Analgesics|analgesics|mesh-ancestor
101532405|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
101532406|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532407|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532408|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532409|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532410|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
101532411|NCT00567762|Tacrolimus|tacrolimus|mesh-list
101532412|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532413|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
101532414|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532415|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101532416|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532417|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532418|NCT04620785|Methylene Blue|methylene blue|mesh-list
101532419|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532420|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406764|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
101406765|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406766|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406767|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101406769|NCT01054144|Hormones|hormones|mesh-ancestor
101406770|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406771|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101406772|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406773|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
101532421|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
101532430|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101532431|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101532433|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532434|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532435|NCT01151215|Anastrozole|anastrozole|mesh-list
101532436|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101532437|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532438|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101532439|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101532440|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532441|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532442|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101532443|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
101532444|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532445|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532446|NCT04588389|Lidocaine|lidocaine|mesh-list
101532447|NCT04588389|Ropivacaine|ropivacaine|mesh-list
101532448|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
101532449|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
101532450|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532451|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532452|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
101532453|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532454|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101532455|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101532456|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101532457|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532458|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532460|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
101532461|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101532462|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101532463|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532464|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532465|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101532466|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101532467|NCT04588194|Dexamethasone|dexamethasone|mesh-list
101532468|NCT04588194|Rituximab|rituximab|mesh-list
101532469|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532470|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532471|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
101532472|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532474|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532475|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
101532476|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
101532477|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406775|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101406776|NCT01054144|Growth Substances|growth substances|mesh-ancestor
101406777|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
101406778|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
101406779|NCT00137787|Cefepime|cefepime|mesh-list
101406780|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101406781|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406782|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101406783|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101406784|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406785|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406786|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406787|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101406788|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101532478|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532479|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
101532480|NCT04588194|Hormones|hormones|mesh-ancestor
101532481|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532482|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101532502|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
101532503|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532504|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101532506|NCT04619303|Bevacizumab|bevacizumab|mesh-list
101532507|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532508|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532509|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532510|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532511|NCT04619303|Growth Substances|growth substances|mesh-ancestor
101532512|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532513|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532514|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532515|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
101532516|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
101532517|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532518|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532519|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
101532520|NCT04619303|Hormones|hormones|mesh-ancestor
101532521|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532522|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101532523|NCT04619537|Docetaxel|docetaxel|mesh-list
101532524|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532525|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
101532526|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
101532527|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
101532528|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532529|NCT04619381|Clopidogrel|clopidogrel|mesh-list
101532530|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101532531|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101532532|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101532533|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101532534|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
101532535|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532555|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
101532556|NCT00562835|Vitamins|vitamins|mesh-ancestor
101532557|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
101532558|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406790|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101406791|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101406792|NCT04702048|Growth Substances|growth substances|mesh-ancestor
101406793|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406794|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101406795|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406796|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
101406797|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532559|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532560|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
101532561|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
101532562|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532563|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101532564|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
101532565|NCT00562835|Hormones|hormones|mesh-ancestor
101532566|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532567|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101532568|NCT00562835|Protective Agents|protective agents|mesh-ancestor
101532569|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
101532571|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532572|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
101532573|NCT04587141|Hematinics|hematinics|mesh-ancestor
101532574|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101532575|NCT04586790|Epinephrine|epinephrine|mesh-list
101532576|NCT04586790|Racepinephrine|racepinephrine|mesh-list
101532577|NCT04586790|Midodrine|midodrine|mesh-list
101532578|NCT04586790|Norepinephrine|norepinephrine|mesh-list
101532579|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
101532580|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101532581|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101532582|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532583|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532584|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532585|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532586|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101532587|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101532588|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
101532589|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532590|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101532591|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532592|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
101532593|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
101532605|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532606|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101532607|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532608|NCT00568971|Docetaxel|docetaxel|mesh-list
101532609|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532610|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
101532611|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
101532612|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
101532613|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532614|NCT00562913|Sorafenib|sorafenib|mesh-list
101532615|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532616|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532617|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532618|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532619|NCT00569088|Mannitol|mannitol|mesh-list
101532620|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101532621|NCT00569088|Diuretics|diuretics|mesh-ancestor
101532622|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101532623|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532624|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101532625|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101532626|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532627|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
101406799|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101406800|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
101406801|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
101406802|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101406803|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406804|NCT00434668|Cisplatin|cisplatin|mesh-list
101406805|NCT00434668|Docetaxel|docetaxel|mesh-list
101406806|NCT00434668|Vinorelbine|vinorelbine|mesh-list
101406807|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406808|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
101406809|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
101532628|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101532629|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
101532630|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532631|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
101532632|NCT04586361|Protective Agents|protective agents|mesh-ancestor
101532633|NCT04618952|Calcium|calcium|mesh-list
101532634|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101532635|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532636|NCT04619069|Hormones|hormones|mesh-list
101532637|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532638|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532639|NCT04585932|Leuprolide|leuprolide|mesh-list
101532640|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101532641|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
101532642|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101532643|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532644|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101532645|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532646|NCT00569400|Insulin|insulin|mesh-list
101532647|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101532648|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532649|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532650|NCT04618367|Lenvatinib|lenvatinib|mesh-list
101532651|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532660|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532662|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
101532663|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532664|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532665|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101532666|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101532667|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101532668|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532669|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532670|NCT05035316|Aspirin|aspirin|mesh-list
101532671|NCT05035316|Calcium|calcium|mesh-list
101532672|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101532673|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532674|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532675|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532676|NCT05035316|Analgesics|analgesics|mesh-ancestor
101532677|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
101532678|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532679|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532680|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532681|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101532682|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101532683|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532684|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101532685|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532687|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
101532688|NCT04618601|Spironolactone|spironolactone|mesh-list
101406811|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406812|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101406813|NCT00434746|Fezakinumab|fezakinumab|mesh-list
101406814|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406815|NCT00137826|Bevacizumab|bevacizumab|mesh-list
101406816|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101548303|NCT02893826|Nimodipine|nimodipine|mesh-list
101406817|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532689|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101532690|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
101532691|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532692|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532693|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101532694|NCT04618601|Diuretics|diuretics|mesh-ancestor
101532695|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
101532696|NCT00567918|Tacrolimus|tacrolimus|mesh-list
101532697|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532698|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
101532699|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532700|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101532701|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532702|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532703|NCT00569712|Budesonide|budesonide|mesh-list
101532704|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
101532705|NCT00569712|Dimercaprol|dimercaprol|mesh-list
101532706|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532707|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101532708|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
101532709|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532710|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532711|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101532712|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532713|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
101532714|NCT00569712|Hormones|hormones|mesh-ancestor
101532727|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
101532728|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
101532729|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
101532730|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532731|NCT00569790|Bevacizumab|bevacizumab|mesh-list
101532733|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532734|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532735|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532736|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532737|NCT00569790|Growth Substances|growth substances|mesh-ancestor
101532739|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532740|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101532741|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101532742|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532743|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532744|NCT00567957|Remifentanil|remifentanil|mesh-list
101532745|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101532746|NCT00567957|Narcotics|narcotics|mesh-ancestor
101532747|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532748|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532749|NCT00567957|Analgesics|analgesics|mesh-ancestor
101532750|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
101532751|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532752|NCT02940002|Betamethasone|betamethasone|mesh-list
101532754|NCT02940002|Calcipotriene|calcipotriene|mesh-list
101532755|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532756|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
101532757|NCT02940002|Hormones|hormones|mesh-ancestor
101532758|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532759|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406818|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406819|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101406820|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101406821|NCT00137826|Growth Substances|growth substances|mesh-ancestor
101406822|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406823|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101406824|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101406825|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406826|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406827|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
101406828|NCT00434824|Testosterone|testosterone|mesh-list
101532760|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101532761|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532762|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101532763|NCT04618328|Tretinoin|tretinoin|mesh-list
101532764|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532765|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
101532766|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101532767|NCT04617782|Donepezil|donepezil|mesh-list
101532768|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101532769|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532770|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532771|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
101532772|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532773|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532774|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
101532775|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
101532785|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532786|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532787|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101532788|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101532789|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101532790|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101532792|NCT04617626|Azithromycin|azithromycin|mesh-list
101532793|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532794|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532795|NCT04585230|Mineral Oil|mineral oil|mesh-list
101532796|NCT04585230|Emollients|emollients|mesh-ancestor
101532797|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
101532798|NCT00570180|Bortezomib|bortezomib|mesh-list
101532799|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532800|NCT02939846|Trametinib|trametinib|mesh-list
101532801|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532802|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532803|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532804|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532805|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
101532806|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
101532807|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101532808|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101532809|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532810|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532811|NCT02939495|Urological Agents|urological agents|mesh-ancestor
101532812|NCT00570219|Valproic Acid|valproic acid|mesh-list
101532813|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
101532814|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532815|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532816|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
101532817|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532818|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532819|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
101532820|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532821|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101406830|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
101406831|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101406833|NCT00434824|Hormones|hormones|mesh-ancestor
101406834|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406835|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406836|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101406837|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406838|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
101406840|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406841|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532822|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532823|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101532824|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532825|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532826|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532827|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532828|NCT00568074|Repaglinide|repaglinide|mesh-list
101532829|NCT00568074|Acarbose|acarbose|mesh-list
101532830|NCT00568074|Gliquidone|gliquidone|mesh-list
101532831|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532832|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532833|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101532834|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532835|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532836|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
101532837|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101532838|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
101532839|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532840|NCT00568113|Expectorants|expectorants|mesh-ancestor
101532856|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532857|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101532858|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101532859|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532860|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101532861|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532862|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532863|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
101532864|NCT04610879|Carbamazepine|carbamazepine|mesh-list
101532865|NCT04610879|Levetiracetam|levetiracetam|mesh-list
101532866|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
101532869|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532870|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532871|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532872|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532873|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532875|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
101532876|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532877|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101532878|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101532879|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532880|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101532881|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101532882|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
101532883|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101532884|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
101406842|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406843|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406844|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
101406845|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101406846|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101532885|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532886|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
101532887|NCT00570648|Protective Agents|protective agents|mesh-ancestor
101532888|NCT00570726|Ranibizumab|ranibizumab|mesh-list
101532889|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532890|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532891|NCT00570726|Growth Substances|growth substances|mesh-ancestor
101532892|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532893|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
101532894|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532895|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
101532896|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101532897|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101532898|NCT00563069|Midazolam|midazolam|mesh-list
101532899|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101532913|NCT04580355|Amoxicillin|amoxicillin|mesh-list
101532914|NCT04580355|Metronidazole|metronidazole|mesh-list
101532915|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532916|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532917|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101532918|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101532919|NCT00563108|Basiliximab|basiliximab|mesh-list
101532920|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532921|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
101532922|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532923|NCT00570882|Sunitinib|sunitinib|mesh-list
101532924|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532925|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101532926|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101532927|NCT00570882|Growth Substances|growth substances|mesh-ancestor
101532930|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532931|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532932|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532933|NCT00563147|Sirolimus|sirolimus|mesh-list
101532934|NCT00563147|Temsirolimus|temsirolimus|mesh-list
101532935|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
101532936|NCT00563147|Tivozanib|tivozanib|mesh-list
101532937|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532938|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532939|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532940|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532941|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
101532942|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532943|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532944|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532945|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532946|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101532947|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
101532948|NCT00570999|Mitogens|mitogens|mesh-list
101532949|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
101532950|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532951|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
101532952|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101532953|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
101532954|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532955|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532956|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101532957|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532958|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101532959|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101532960|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101532961|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
101406847|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101406848|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406849|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406850|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
101406851|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406852|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406853|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101406854|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406856|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406857|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
101406859|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406861|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101406862|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
101406863|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
101406864|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101406865|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406866|NCT00435058|Timolol|timolol|mesh-list
101406867|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101406868|NCT00435058|Travoprost|travoprost|mesh-list
101406869|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406870|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101406871|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101406872|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532962|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532963|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532977|NCT04615481|Metronidazole|metronidazole|mesh-list
101532978|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532979|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532980|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101532981|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101532982|NCT04614584|Mirtazapine|mirtazapine|mesh-list
101532983|NCT04614584|Methamphetamine|methamphetamine|mesh-list
101532984|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101532985|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532986|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101532987|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
101532988|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
101532989|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532990|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532991|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532992|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101532993|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532994|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532995|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101532996|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101406873|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406874|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406875|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101406876|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101406877|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101406878|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101406879|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101532997|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101532998|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532999|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101533000|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101533001|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
101533002|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101533003|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101533004|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
101533005|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
101533006|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533007|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
101533008|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101533009|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101533010|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533011|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101533012|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
101533013|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533014|NCT00571506|Pioglitazone|pioglitazone|mesh-list
101533015|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
101533016|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533035|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533036|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533037|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101533038|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101533039|NCT00571740|Growth Substances|growth substances|mesh-ancestor
101533040|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533041|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
101533042|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101533044|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533045|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101533046|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533047|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
101533048|NCT00571740|Antidotes|antidotes|mesh-ancestor
101533049|NCT00571740|Protective Agents|protective agents|mesh-ancestor
101533050|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
101533051|NCT00571740|Vitamins|vitamins|mesh-ancestor
101533052|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
101533053|NCT00563342|Ethanol|ethanol|mesh-list
101533054|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101533055|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533056|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533057|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533058|NCT04583046|Iloprost|iloprost|mesh-list
101533059|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101533060|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
101533061|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101533062|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101533063|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533064|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533065|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101533066|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533068|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533069|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533070|NCT04613726|Ondansetron|ondansetron|mesh-list
101533071|NCT04613726|Granisetron|granisetron|mesh-list
101533072|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
101533073|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
101533074|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406881|NCT00435175|Estrogens|estrogens|mesh-ancestor
101406882|NCT00435175|Hormones|hormones|mesh-ancestor
101406883|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101406884|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406885|NCT00135135|Carboplatin|carboplatin|mesh-list
101406886|NCT00135135|Doxorubicin|doxorubicin|mesh-list
101406887|NCT00135135|Irinotecan|irinotecan|mesh-list
101406888|NCT00135135|Etoposide|etoposide|mesh-list
101406889|NCT00135135|Melphalan|melphalan|mesh-list
101406890|NCT00135135|Topotecan|topotecan|mesh-list
101406891|NCT00135135|Gefitinib|gefitinib|mesh-list
101406892|NCT00135135|Tretinoin|tretinoin|mesh-list
101406893|NCT00135135|Isotretinoin|isotretinoin|mesh-list
101406894|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533075|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533090|NCT04613219|Tofacitinib|tofacitinib|mesh-list
101533091|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101533092|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101533093|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533094|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533096|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101533097|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
101533098|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533099|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533100|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533101|NCT00563654|Alfuzosin|alfuzosin|mesh-list
101533102|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101533103|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101533104|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101533105|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533106|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533107|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533108|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533109|NCT00563654|Urological Agents|urological agents|mesh-ancestor
101533110|NCT04613180|Montelukast|montelukast|mesh-list
101533111|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533112|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533113|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101533114|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
101533115|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533116|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533117|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101533118|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101533119|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533120|NCT00571935|Insulin|insulin|mesh-list
101533121|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101533122|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
101533123|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533124|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533125|NCT00572013|Rituximab|rituximab|mesh-list
101533126|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533128|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
101533129|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533130|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533149|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533150|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533151|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533152|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
101406895|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101406896|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101406897|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101406898|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101406899|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406900|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101533153|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533154|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101533155|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101533156|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101533157|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101533158|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533159|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533160|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533161|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
101533163|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533164|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
101533165|NCT04611971|Belimumab|belimumab|mesh-list
101533166|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533167|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
101533168|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533169|NCT00572208|Gabapentin|gabapentin|mesh-list
101533170|NCT00572208|Analgesics|analgesics|mesh-ancestor
101533171|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
101533172|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533173|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533174|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
101533175|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101533176|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101533177|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533178|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101533179|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101533180|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101533181|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533182|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533183|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
101533184|NCT00572364|Olaparib|olaparib|mesh-list
101533185|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101533186|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533187|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533211|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533212|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533213|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533214|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101533215|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533217|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
101533218|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101533219|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533220|NCT00563927|Fluorouracil|fluorouracil|mesh-list
101533221|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533222|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
101533223|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533224|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101533225|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533226|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
101533227|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533228|NCT01150123|Vaccines|vaccines|mesh-list
101533230|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533231|NCT00572559|Vancomycin|vancomycin|mesh-list
101533232|NCT00572559|Linezolid|linezolid|mesh-list
101533233|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101533234|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533235|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101406901|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101406902|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101406903|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
101406904|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101533236|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533237|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533238|NCT04611464|Misoprostol|misoprostol|mesh-list
101533239|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101533258|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
101533259|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533260|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101533261|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101533262|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101533263|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533265|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
101533266|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
101533267|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533268|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533269|NCT01149655|Aripiprazole|aripiprazole|mesh-list
101533270|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
101533271|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101533272|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101533273|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101533274|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533275|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533276|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
101533277|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
101533278|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533279|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533280|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101533281|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101533282|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
101533283|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101533284|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101533285|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101533286|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101533289|NCT00575406|Rituximab|rituximab|mesh-list
101533290|NCT00575406|Doxorubicin|doxorubicin|mesh-list
101533291|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101533292|NCT00575406|Vincristine|vincristine|mesh-list
101533293|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533294|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
101533295|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533296|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533297|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101533310|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533311|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101533312|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533313|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533314|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533315|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
101533316|NCT01149538|Choline|choline|mesh-list
101533317|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
101533318|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101533319|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
101533320|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533321|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533322|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101533323|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
101533324|NCT01149460|Valacyclovir|valacyclovir|mesh-list
101533325|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
101533326|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533328|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101533329|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101533330|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101533331|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
101406906|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
101406907|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406908|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101406909|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
101406910|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406911|NCT00435292|Naproxen|naproxen|mesh-list
101406912|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101406913|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406914|NCT00435292|Analgesics|analgesics|mesh-ancestor
101406915|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
101406916|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406917|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406919|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406920|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
101406921|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101406922|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533332|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533333|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533334|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533335|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533336|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
101533337|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
101533338|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101533339|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101533340|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533341|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533342|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533344|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533345|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533346|NCT00575601|Simvastatin|simvastatin|mesh-list
101533347|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101533348|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101533349|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
101533350|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533351|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101533352|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101533353|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533354|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101533355|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101533356|NCT04600271|Norepinephrine|norepinephrine|mesh-list
101533357|NCT04600271|Analgesics|analgesics|mesh-list
101533358|NCT04600271|Diuretics|diuretics|mesh-list
101533359|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
101533374|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101533375|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
101533376|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
101533377|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533378|NCT04579731|Lactitol|lactitol|mesh-list
101533379|NCT04579731|Cathartics|cathartics|mesh-ancestor
101533380|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533381|NCT00565487|Capecitabine|capecitabine|mesh-list
101533382|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101533383|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406923|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406925|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101406926|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101406927|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101406928|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406929|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101533384|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
101533385|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533386|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533387|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101533388|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533389|NCT04600115|Adenosine|adenosine|mesh-list
101533390|NCT04600115|Regadenoson|regadenoson|mesh-list
101533391|NCT04600115|Analgesics|analgesics|mesh-ancestor
101533392|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
101533393|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533394|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533395|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101533396|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
101533397|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101533398|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
101533399|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
101533400|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548354|NCT00592670|Fluoxetine|fluoxetine|mesh-list
101533401|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533402|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101533403|NCT04600037|Pregabalin|pregabalin|mesh-list
101533404|NCT04600037|Analgesics|analgesics|mesh-ancestor
101533405|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
101533406|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533407|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533408|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
101533409|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101533410|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533412|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101533413|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101533414|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101533415|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533416|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101533417|NCT00575796|Vinblastine|vinblastine|mesh-list
101533418|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533431|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101533432|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101533433|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533434|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533435|NCT00575874|Pioglitazone|pioglitazone|mesh-list
101533436|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533437|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533438|NCT03454217|Oxycodone|oxycodone|mesh-list
101533439|NCT03454217|Tramadol|tramadol|mesh-list
101533440|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101533441|NCT03454217|Narcotics|narcotics|mesh-ancestor
101533442|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533443|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533444|NCT03454217|Analgesics|analgesics|mesh-ancestor
101533445|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
101533446|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533447|NCT00575913|Alfuzosin|alfuzosin|mesh-list
101533448|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101533449|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101533450|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101533451|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533452|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406930|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406931|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
101406932|NCT00435448|Lonidamine|lonidamine|mesh-list
101406933|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406934|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101406935|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406936|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101406937|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
101406938|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101406939|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101406940|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101406941|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101533453|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533454|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533455|NCT00575913|Urological Agents|urological agents|mesh-ancestor
101533456|NCT04579302|Bupivacaine|bupivacaine|mesh-list
101533457|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
101533458|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
101533459|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533460|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533461|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
101533462|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533463|NCT00565682|Etoricoxib|etoricoxib|mesh-list
101533464|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101533465|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101533466|NCT00565682|Analgesics|analgesics|mesh-ancestor
101533467|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
101533468|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533469|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533470|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533471|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533472|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101533473|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101533474|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533475|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533476|NCT00575952|Paclitaxel|paclitaxel|mesh-list
101533477|NCT00575952|Doxorubicin|doxorubicin|mesh-list
101533478|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101533479|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533480|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533481|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533506|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533507|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533508|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101533509|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101533510|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533511|NCT04598594|Nicotine|nicotine|mesh-list
101533512|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101533513|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
101533514|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533515|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533516|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101533517|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101533518|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533519|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533520|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533521|NCT00576069|Fluticasone|fluticasone|mesh-list
101533522|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
101533523|NCT00576069|Prednisone|prednisone|mesh-list
101533524|NCT00576069|Budesonide|budesonide|mesh-list
101533525|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
101406942|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101406944|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
101406945|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101406946|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
101406947|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101406948|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406949|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101406950|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
101406951|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
101406952|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101406953|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
101406954|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406955|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101406956|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
101406957|NCT00435799|Riboflavin|riboflavin|mesh-list
101406958|NCT00435799|Dextrans|dextrans|mesh-list
101406959|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101406960|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
101406961|NCT00435799|Vitamins|vitamins|mesh-ancestor
101406962|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
101406963|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533537|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
101533538|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533540|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533541|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533542|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101533543|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101533544|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101533545|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101533546|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533547|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533548|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533549|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
101533550|NCT00573690|Carboplatin|carboplatin|mesh-list
101533551|NCT00573690|Etoposide|etoposide|mesh-list
101533552|NCT00573690|Pemetrexed|pemetrexed|mesh-list
101533553|NCT00573690|Sorafenib|sorafenib|mesh-list
101533554|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533555|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533556|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101533557|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101533558|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533559|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533560|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101533561|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101533562|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101533563|NCT00576225|Paclitaxel|paclitaxel|mesh-list
101533564|NCT00576225|Carboplatin|carboplatin|mesh-list
101533565|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101533566|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533567|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533568|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533569|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
101406964|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101406965|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101406966|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101406967|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
101406968|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
101406969|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
101406970|NCT00142467|Bevacizumab|bevacizumab|mesh-list
101406971|NCT00142467|Gemcitabine|gemcitabine|mesh-list
101406972|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
101533570|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
101533571|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533572|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
101533573|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101533574|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533575|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101533576|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533577|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
101533578|NCT00576459|Hormones|hormones|mesh-ancestor
101533579|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533580|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533581|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
101533582|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
101533583|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101533584|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101533585|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533586|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533598|NCT00573924|Lansoprazole|lansoprazole|mesh-list
101533599|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
101533600|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101533601|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101533603|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533604|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533605|NCT00573963|Ropivacaine|ropivacaine|mesh-list
101533606|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
101533607|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
101533608|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533609|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533610|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
101533611|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533612|NCT00576615|Propofol|propofol|mesh-list
101533613|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101533614|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533615|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533616|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101533617|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
101533618|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
101533619|NCT00574041|Interferons|interferons|mesh-list
101533620|NCT00574041|Interferon-beta|interferon-beta|mesh-list
101533621|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
101533622|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533623|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
101533624|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533625|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
101533626|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533627|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101533628|NCT00566267|Simvastatin|simvastatin|mesh-list
101533629|NCT00566267|Ezetimibe|ezetimibe|mesh-list
101533630|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101533631|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101533632|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
101533633|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533634|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101533635|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101533636|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533638|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533639|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101533640|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101406974|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406975|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101406976|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101406977|NCT00142467|Growth Substances|growth substances|mesh-ancestor
101406978|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406979|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
101406980|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101406981|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
101406982|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533641|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533642|NCT04596839|Remdesivir|remdesivir|mesh-list
101533643|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
101533644|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533645|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
101533646|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533647|NCT00574470|Infliximab|infliximab|mesh-list
101533648|NCT00574470|Daclizumab|daclizumab|mesh-list
101533649|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101533650|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533662|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533663|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533664|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
101533665|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533666|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533667|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101533668|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
101533669|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533670|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533671|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
101533672|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533673|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101533674|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101533675|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533676|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
101533677|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533678|NCT04596488|Efavirenz|efavirenz|mesh-list
101533679|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101533680|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101533681|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533682|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533683|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
101533684|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533685|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101533686|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101533687|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101533688|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101533690|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101533691|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
101533692|NCT04595942|Midodrine|midodrine|mesh-list
101533693|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
101533694|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
101533695|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533696|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533697|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101533698|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101533699|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101533700|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101533701|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533702|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101406983|NCT00435955|Rituximab|rituximab|mesh-list
101406984|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101406985|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101406986|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
101406987|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406988|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101406989|NCT00436033|Milnacipran|milnacipran|mesh-list
101533703|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533704|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533705|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101533706|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101533707|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
101533708|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533709|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
101533712|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101533713|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
101533714|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101533742|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533743|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101533744|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533745|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
101533746|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
101533747|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101533748|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533749|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101533750|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101533751|NCT00577668|Growth Substances|growth substances|mesh-ancestor
101533752|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
101533753|NCT01147744|Fluticasone|fluticasone|mesh-list
101533754|NCT01147744|Xhance|xhance|mesh-list
101533755|NCT01147744|Montelukast|montelukast|mesh-list
101533756|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533757|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101533758|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
101533759|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533760|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533761|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533777|NCT04313374|Analgesics|analgesics|mesh-ancestor
101533778|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
101533779|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533780|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101533781|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101533782|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533783|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533784|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101533785|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101533786|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101533787|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533788|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533789|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533790|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533791|NCT04313335|Analgesics|analgesics|mesh-ancestor
101533792|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
101533793|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533794|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
101533795|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101533796|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
101533797|NCT00577980|Testosterone|testosterone|mesh-list
101533798|NCT00577980|Androgens|androgens|mesh-ancestor
101533799|NCT00577980|Hormones|hormones|mesh-ancestor
101533800|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533801|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533802|NCT04594343|Disulfiram|disulfiram|mesh-list
101533803|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101406990|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
101406991|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101406992|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101406993|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533804|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101533805|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533806|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533807|NCT01147393|Epratuzumab|epratuzumab|mesh-list
101533808|NCT01147393|Veltuzumab|veltuzumab|mesh-list
101533809|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101533810|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533811|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533813|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
101533814|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533815|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
101533816|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101533825|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533826|NCT00578370|Cyclosporine|cyclosporine|mesh-list
101533827|NCT00578370|Betamethasone|betamethasone|mesh-list
101533828|NCT00578370|Calcipotriene|calcipotriene|mesh-list
101533829|NCT00578370|Cyclosporins|cyclosporins|mesh-list
101533830|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533831|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533832|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533833|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
101533834|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533835|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
101533836|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533837|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533838|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533839|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101533840|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533841|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
101533842|NCT00578370|Hormones|hormones|mesh-ancestor
101533843|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533844|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533845|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533846|NCT04593836|Peppermint oil|peppermint oil|mesh-list
101533847|NCT04593836|Menthol|menthol|mesh-list
101533848|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
101533849|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533850|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
101533851|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
101533852|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533853|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533854|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533855|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
101533856|NCT04593524|Vitamin D|vitamin d|mesh-list
101533857|NCT04593524|Vitamins|vitamins|mesh-ancestor
101533858|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
101533859|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533860|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101533861|NCT00578526|Sunitinib|sunitinib|mesh-list
101533862|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533863|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101533864|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101533865|NCT00578526|Growth Substances|growth substances|mesh-ancestor
101533866|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533867|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
101533868|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101533869|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533870|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533871|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
101533872|NCT04593446|Cathartics|cathartics|mesh-ancestor
101533873|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533874|NCT00566891|Tirofiban|tirofiban|mesh-list
101533875|NCT00566891|Clopidogrel|clopidogrel|mesh-list
101533876|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101406996|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101406997|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101406998|NCT00436033|Analgesics|analgesics|mesh-ancestor
101406999|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
101407000|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407001|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
101407002|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407003|NCT00436072|Irinotecan|irinotecan|mesh-list
101407004|NCT00436072|Cetuximab|cetuximab|mesh-list
101533877|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101533878|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101533879|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101533880|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
101533881|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533882|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533883|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533891|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533892|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533893|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533894|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533895|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101533896|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101533897|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533898|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101533899|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101533900|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533902|NCT04592822|Dabigatran|dabigatran|mesh-list
101533903|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
101533904|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101533905|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101533906|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533907|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533908|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
101533909|NCT00567047|Vildagliptin|vildagliptin|mesh-list
101533910|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533911|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533912|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101533913|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
101533914|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533915|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533916|NCT04592666|Carboplatin|carboplatin|mesh-list
101533917|NCT04592666|Pemetrexed|pemetrexed|mesh-list
101533918|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533919|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533920|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533921|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101533922|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101533923|NCT04592198|Palonosetron|palonosetron|mesh-list
101533924|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
101533925|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
101533926|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533927|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533928|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533929|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101533930|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101533931|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
101533933|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533934|NCT04592081|Dexamethasone|dexamethasone|mesh-list
101407005|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101407006|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407007|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407008|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407009|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407010|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407011|NCT03276052|Bromides|bromides|mesh-list
101407012|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
101533935|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
101533936|NCT04592081|BB 1101|bb 1101|mesh-list
101533937|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533938|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
101533939|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
101533940|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533941|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533942|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533943|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
101533944|NCT04592081|Hormones|hormones|mesh-ancestor
101533945|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533946|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101533947|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533948|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
101533949|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533964|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533965|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533966|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533967|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101533968|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533969|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101533970|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
101533971|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
101533972|NCT00580242|Lenalidomide|lenalidomide|mesh-list
101533973|NCT00580242|Bortezomib|bortezomib|mesh-list
101533974|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
101533975|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533976|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101533977|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101533978|NCT00580242|Growth Substances|growth substances|mesh-ancestor
101533979|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
101533980|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533981|NCT04591457|Insulin|insulin|mesh-list
101533982|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101533983|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
101533984|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101533985|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533986|NCT00580320|Bortezomib|bortezomib|mesh-list
101533987|NCT00580320|Dacarbazine|dacarbazine|mesh-list
101533988|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533989|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101533990|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
101533991|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533992|NCT00580359|Capecitabine|capecitabine|mesh-list
101189816|NCT00004086|Cytarabine|cytarabine|mesh-list
101533993|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101533994|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
101533995|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533996|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533997|NCT00580437|Dobutamine|dobutamine|mesh-list
101533998|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101533999|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
101534000|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
101534001|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534002|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534003|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101534004|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101534005|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101407014|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101407015|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
101407016|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101407017|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
101407018|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407019|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407020|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
101407022|NCT04702360|Elexacaftor|elexacaftor|mesh-list
101407023|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101407024|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407025|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534006|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534007|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534008|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534009|NCT00580437|Protective Agents|protective agents|mesh-ancestor
101534027|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534028|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534029|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101534030|NCT04590638|Epinephrine|epinephrine|mesh-list
101534031|NCT04590638|Racepinephrine|racepinephrine|mesh-list
101534032|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
101534033|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101534034|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101534035|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534036|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534037|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534038|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534039|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101534040|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101534041|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
101534042|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534043|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101534044|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534045|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
101534046|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
101534047|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101534048|NCT00567554|Paclitaxel|paclitaxel|mesh-list
101534049|NCT00567554|Docetaxel|docetaxel|mesh-list
101534050|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101534051|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
101534052|NCT00567554|Bevacizumab|bevacizumab|mesh-list
101534053|NCT00567554|Trastuzumab|trastuzumab|mesh-list
101534054|NCT00567554|Everolimus|everolimus|mesh-list
101534055|NCT00567554|Epirubicin|epirubicin|mesh-list
101534056|NCT00567554|Lapatinib|lapatinib|mesh-list
101534057|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101534058|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534059|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534060|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534061|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534062|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534063|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534064|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
101534065|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534066|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534067|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101534068|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
101534069|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101534077|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534078|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101534079|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101407027|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101407028|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407030|NCT00138060|Irinotecan|irinotecan|mesh-list
101407031|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
101407032|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407033|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407034|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407035|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407036|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
101407037|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407038|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101407039|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407040|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407041|NCT04702009|Antibodies|antibodies|mesh-list
101534080|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534082|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
101534083|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534084|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534085|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101534086|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101534087|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101534088|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534089|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534090|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101534091|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
101534092|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
101534093|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
101534094|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534095|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534096|NCT04590482|Letrozole|letrozole|mesh-list
101534097|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534098|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101534099|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101534100|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534101|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534102|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101534103|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534104|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534105|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534107|NCT00581217|Laxatives|laxatives|mesh-ancestor
101534108|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534109|NCT00567710|Risperidone|risperidone|mesh-list
101534110|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101534111|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
101534112|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534113|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534114|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534115|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101534116|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534117|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534118|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534119|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101534120|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
101534121|NCT04589429|Morphine|morphine|mesh-list
101534122|NCT04589429|Nalbuphine|nalbuphine|mesh-list
101534123|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101534124|NCT04589429|Narcotics|narcotics|mesh-ancestor
101407042|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101407043|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
101407044|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407045|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101407046|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101534125|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534126|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534127|NCT04589429|Analgesics|analgesics|mesh-ancestor
101534128|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
101534129|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534130|NCT04589390|Selexipag|selexipag|mesh-list
101534131|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534132|NCT04577040|Tadalafil|tadalafil|mesh-list
101534133|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
101534134|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101534135|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101534136|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534137|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534148|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534149|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
101534150|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
101534151|NCT04588532|Doxepin|doxepin|mesh-list
101534152|NCT04588532|Histamine|histamine|mesh-list
101534153|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
101534154|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
101534155|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534156|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534157|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534158|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101534159|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101534160|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534161|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101534162|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534163|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534164|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
101534165|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
101534166|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101534169|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534171|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
101534172|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534173|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101534174|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101534175|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101534176|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534177|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534178|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534179|NCT00567788|Bimatoprost|bimatoprost|mesh-list
101534180|NCT00567788|Latanoprost|latanoprost|mesh-list
101534181|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101534182|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101534183|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534184|NCT00581607|Bosentan|bosentan|mesh-list
101534185|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534186|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101534187|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534188|NCT00581685|Celecoxib|celecoxib|mesh-list
101534189|NCT00581685|Pregabalin|pregabalin|mesh-list
101534190|NCT00581685|Analgesics|analgesics|mesh-ancestor
101534191|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
101534192|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534193|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534194|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
101407047|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407048|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407049|NCT00142545|Apomorphine|apomorphine|mesh-list
101407050|NCT00142545|Emetics|emetics|mesh-ancestor
101407051|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407052|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
101407053|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407054|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534195|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101534196|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534197|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534198|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534199|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101534200|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534201|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534202|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534221|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534222|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534223|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534224|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534225|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534226|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534228|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101534229|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101534230|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101534233|NCT04586543|Protective Agents|protective agents|mesh-ancestor
101534234|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534236|NCT04586465|Gemcitabine|gemcitabine|mesh-list
101534237|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
101534238|NCT04586465|Pemetrexed|pemetrexed|mesh-list
101534239|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534240|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534241|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
101534242|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534243|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101534244|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101534245|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534246|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101534247|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101534248|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
101534249|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101534250|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
101534251|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534252|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101534253|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101534254|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101534255|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534256|NCT04585997|Omalizumab|omalizumab|mesh-list
101534257|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101534258|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101534259|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534260|NCT04593108|Letrozole|letrozole|mesh-list
101534271|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101534272|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
101534273|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101534274|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101534275|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534277|NCT04585334|Diclofenac|diclofenac|mesh-list
101534278|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534279|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534280|NCT04585334|Analgesics|analgesics|mesh-ancestor
101534281|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
101407056|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
101407057|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407058|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407059|NCT00106262|Irinotecan|irinotecan|mesh-list
101407060|NCT00106262|Bortezomib|bortezomib|mesh-list
101407061|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101407062|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407063|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407064|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189908|NCT00004164|Leucovorin|leucovorin|mesh-list
101407065|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407066|NCT00106301|Romidepsin|romidepsin|mesh-list
101534282|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534283|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534284|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534285|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534286|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101534287|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534288|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534289|NCT04585412|Palonosetron|palonosetron|mesh-list
101534292|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534293|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534294|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534295|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101534296|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101534299|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534300|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101534301|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534302|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534303|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101534304|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534305|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534306|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534307|NCT00567983|Cyclosporine|cyclosporine|mesh-list
101534308|NCT00567983|Cyclosporins|cyclosporins|mesh-list
101534309|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534310|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534311|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534312|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
101534313|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534314|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
101534315|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534316|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
101534317|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534318|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101534319|NCT00582582|Vitamin D|vitamin d|mesh-list
101534320|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101534321|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101534322|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101534323|NCT00582582|Docetaxel|docetaxel|mesh-list
101534324|NCT00582582|Vitamins|vitamins|mesh-ancestor
101534343|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101534344|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534345|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534346|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534347|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534348|NCT00566904|Analgesics|analgesics|mesh-ancestor
101534349|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407067|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101407068|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407069|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101407070|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407071|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407072|NCT00436267|Fluorouracil|fluorouracil|mesh-list
101407073|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
101407074|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407075|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534350|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534351|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101534354|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101534355|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534357|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101534358|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101534359|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101534360|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101534361|NCT04584515|Itraconazole|itraconazole|mesh-list
101534362|NCT04584515|Rifampin|rifampin|mesh-list
101534363|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
101534364|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534365|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101534366|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101534367|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534368|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534369|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101534370|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534371|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534372|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534373|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101534374|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101534375|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
101534376|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534391|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534392|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534393|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101534395|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534396|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534397|NCT04592211|Paclitaxel|paclitaxel|mesh-list
101534398|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
101534399|NCT04592211|Olaparib|olaparib|mesh-list
101534400|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101534401|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534402|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534403|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534404|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534405|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534406|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101534407|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101534408|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101534409|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534410|NCT04583813|Empagliflozin|empagliflozin|mesh-list
101534411|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101534412|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534413|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407076|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407077|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407078|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
101407079|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407080|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
101407081|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407082|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407083|NCT00138099|Dalteparin|dalteparin|mesh-list
101407084|NCT00138099|Tinzaparin|tinzaparin|mesh-list
101534414|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534415|NCT04576143|Paclitaxel|paclitaxel|mesh-list
101534416|NCT04576143|Docetaxel|docetaxel|mesh-list
101534417|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
101534418|NCT04576143|Epirubicin|epirubicin|mesh-list
101534419|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101534420|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534421|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534422|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534423|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534424|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534425|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534426|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
101534427|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534428|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534429|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101534430|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
101534431|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101534432|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101534433|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101534434|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534435|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534443|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534445|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101534446|NCT04583111|Domperidone|domperidone|mesh-list
101534447|NCT04583111|Sulpiride|sulpiride|mesh-list
101534448|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
101534449|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
101534450|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534451|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534452|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534453|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101534454|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
101534455|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534456|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534457|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101534458|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534459|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534460|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534461|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101534462|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534463|NCT01146613|Varenicline|varenicline|mesh-list
101534464|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101534465|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101534466|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
101534467|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534468|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534469|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534470|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101534471|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101534472|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407085|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101407086|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
101407087|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101407088|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101407089|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407090|NCT00106379|Tenofovir|tenofovir|mesh-list
101407091|NCT00106379|Emtricitabine|emtricitabine|mesh-list
101407092|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101407093|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
101407094|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190029|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407095|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101407096|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101407097|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407098|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534473|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534474|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534475|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190038|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534476|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407100|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101407101|NCT00436423|Gemcitabine|gemcitabine|mesh-list
101407102|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407103|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
101407104|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407105|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407106|NCT00436579|Sorafenib|sorafenib|mesh-list
101407107|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534477|NCT01145755|Analgesics|analgesics|mesh-ancestor
101407108|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407109|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407110|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407112|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407113|NCT00106418|Romidepsin|romidepsin|mesh-list
101407114|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101407115|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407116|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101407117|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534480|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
101407118|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407120|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
101407121|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407122|NCT00437008|Benphothiamine|benphothiamine|mesh-list
101407123|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101407124|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
101534482|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
101534484|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101534485|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
101534486|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534487|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534488|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101534489|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101534490|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
101190264|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
101534491|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534492|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534493|NCT00567060|Piracetam|piracetam|mesh-list
101534494|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101534495|NCT00567060|Protective Agents|protective agents|mesh-ancestor
101534496|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407125|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407126|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
101407127|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
101407128|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407130|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407131|NCT00437164|Insulin|insulin|mesh-list
101407132|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101534497|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
101407133|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407134|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407135|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101407136|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101407137|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407139|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190827|NCT00005796|Lomustine|lomustine|mesh-list
101407141|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407142|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101407143|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407144|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407146|NCT00437359|Anastrozole|anastrozole|mesh-list
101407147|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407148|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101407149|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407150|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101407151|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101407152|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191032|NCT00357240|Ritonavir|ritonavir|mesh-list
101534501|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534502|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407153|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101407154|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
101407155|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407156|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407157|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101407158|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101407159|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101407160|NCT00437476|Ribavirin|ribavirin|mesh-list
101407161|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101407162|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101534505|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534506|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191211|NCT00360594|Acamprosate|acamprosate|mesh-list
101534507|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534508|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534509|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101407164|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407166|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407167|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101407168|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407169|NCT00437554|Glimepiride|glimepiride|mesh-list
101407170|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101407171|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407172|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191376|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101191453|NCT00367068|Baclofen|baclofen|mesh-list
101407173|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407176|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101407177|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407178|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101407179|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407180|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407181|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101534511|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534513|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
101534514|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534515|NCT04582604|Decitabine|decitabine|mesh-list
101534516|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534517|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
101191985|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
101534518|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534519|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407182|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101407183|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
101407184|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407185|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
101407186|NCT00437671|Antibodies|antibodies|mesh-list
101407187|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
101407188|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101407189|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101407190|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
101407191|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407192|NCT00106613|Romidepsin|romidepsin|mesh-list
101407193|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101407194|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407195|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101407196|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407197|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407198|NCT00401180|Docetaxel|docetaxel|mesh-list
101192278|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
101407199|NCT00401180|Temozolomide|temozolomide|mesh-list
101407200|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407201|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
101407202|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407203|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407204|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407205|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101407206|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
101407207|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
101407208|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407209|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407210|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101487397|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407211|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407212|NCT00401219|Estrogens|estrogens|mesh-list
101407213|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101407214|NCT00401219|Progestins|progestins|mesh-list
101407215|NCT00401219|Hormones|hormones|mesh-ancestor
101407216|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407217|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407218|NCT04701463|Calcium|calcium|mesh-list
101407219|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534520|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407220|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407223|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407224|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407225|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407226|NCT00438139|Analgesics|analgesics|mesh-ancestor
101407227|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
101407228|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193024|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193025|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193027|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
101407229|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101407230|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101407231|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193097|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407232|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534522|NCT00590928|Ranitidine|ranitidine|mesh-list
101407234|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407236|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407237|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407238|NCT00438217|Leuprolide|leuprolide|mesh-list
101407239|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101407240|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101407241|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101407242|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
101407243|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407244|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407245|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101407246|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407247|NCT00438217|Hormones|hormones|mesh-ancestor
101407248|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407249|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
101407250|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101407251|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
101407252|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101407253|NCT03279757|Lidocaine|lidocaine|mesh-list
101407254|NCT03279757|Epinephrine|epinephrine|mesh-list
101534523|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101534524|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101407257|NCT03279757|Carticaine|carticaine|mesh-list
101407258|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
101407261|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407262|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407263|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
101407264|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407265|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101193723|NCT01724424|Melatonin|melatonin|mesh-list
101407266|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101407267|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101407268|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407269|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407270|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101193772|NCT01725672|Metformin|metformin|mesh-list
101193849|NCT01729260|Mebendazole|mebendazole|mesh-list
101193934|NCT01048788|Tolvaptan|tolvaptan|mesh-list
101407272|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
101407274|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101407275|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101407276|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
101407277|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101407278|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534527|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407279|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
101407280|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
101407281|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101407282|NCT00438568|Insulin|insulin|mesh-list
101407283|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101407284|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407285|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534528|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407286|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101407287|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101407288|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101407289|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101194170|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
101194218|NCT02242656|Opium|opium|mesh-list
101534540|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407292|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407293|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407295|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101407296|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407298|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407299|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407300|NCT00106886|Folic Acid|folic acid|mesh-list
101194348|NCT02246712|Analgesics|analgesics|mesh-ancestor
101194417|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101407302|NCT00106886|Pyridoxal|pyridoxal|mesh-list
101407303|NCT00106886|Pyridoxine|pyridoxine|mesh-list
101407304|NCT00106886|Vitamins|vitamins|mesh-ancestor
101407305|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
101407306|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407307|NCT00106886|Hematinics|hematinics|mesh-ancestor
101407308|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
101407309|NCT00438841|Thalidomide|thalidomide|mesh-list
101407310|NCT00438841|Dexamethasone|dexamethasone|mesh-list
101407311|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
101407312|NCT00438841|Bortezomib|bortezomib|mesh-list
101407313|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407314|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
101194491|NCT02244762|Hydrocodone|hydrocodone|mesh-list
101407315|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407316|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534548|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534549|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534550|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534551|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534552|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534553|NCT00591162|Tetracycline|tetracycline|mesh-list
101534554|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101407317|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101407319|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194669|NCT00550836|Gemcitabine|gemcitabine|mesh-list
101407321|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101407322|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407323|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
101407324|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
101407325|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407326|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407327|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
101407328|NCT00438841|Hormones|hormones|mesh-ancestor
101407329|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407330|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101407331|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
101194726|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101407332|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101407333|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407334|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101407335|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101407336|NCT00438841|Growth Substances|growth substances|mesh-ancestor
101407337|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
101194797|NCT03833466|Metformin|metformin|mesh-list
101194887|NCT01689870|Ipilimumab|ipilimumab|mesh-list
101407339|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101407340|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
101407341|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407342|NCT00107003|Lapatinib|lapatinib|mesh-list
101407343|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407344|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407345|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407346|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407347|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101407348|NCT00107081|Amoxicillin|amoxicillin|mesh-list
101407349|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
101534565|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534566|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534567|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101181985|NCT02684136|Suvorexant|suvorexant|mesh-list
101534568|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534569|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
101534570|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534571|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
101534572|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534574|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101534575|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534576|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407351|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101407352|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407356|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101407357|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101407358|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101407359|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101407360|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101407361|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
101407362|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407363|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407364|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407365|NCT00439192|Urological Agents|urological agents|mesh-ancestor
101407367|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
101407368|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407370|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407371|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407372|NCT00138138|Methylphenidate|methylphenidate|mesh-list
101407373|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101407374|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407375|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101407376|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407377|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407379|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
101407380|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407381|NCT00439504|Lobeline|lobeline|mesh-list
101407382|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101407383|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
101407384|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407385|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407386|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101407387|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101195045|NCT05767255|Xultophy|xultophy|mesh-list
101407389|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407390|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407391|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
101407392|NCT00439543|Iloprost|iloprost|mesh-list
101407393|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101407394|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
101407395|NCT00107237|Everolimus|everolimus|mesh-list
101407396|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101407397|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407398|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407399|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407400|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407401|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
101534580|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101534581|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
101195639|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
101407402|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407403|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407404|NCT00439699|Memantine|memantine|mesh-list
101407405|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101195645|NCT04131309|Bortezomib|bortezomib|mesh-list
101195731|NCT03786783|Cisplatin|cisplatin|mesh-list
101407415|NCT00439855|Calcium heparin|calcium heparin|mesh-list
101407416|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
101407417|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101407418|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101407419|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407420|NCT00107354|Cytarabine|cytarabine|mesh-list
101407421|NCT00107354|Aldesleukin|aldesleukin|mesh-list
101407422|NCT00107354|Etoposide|etoposide|mesh-list
101407423|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
101195732|NCT03786783|Carboplatin|carboplatin|mesh-list
101195733|NCT03786783|Doxorubicin|doxorubicin|mesh-list
101195823|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
101195824|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195826|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101407424|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101407425|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407426|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101407427|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407429|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534583|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534584|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534585|NCT00591357|Loperamide|loperamide|mesh-list
101195963|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
101196012|NCT02659384|Growth Substances|growth substances|mesh-ancestor
101407436|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407437|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101407438|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101407439|NCT00107354|Analgesics|analgesics|mesh-ancestor
101407440|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
101407441|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407442|NCT00138177|Leucovorin|leucovorin|mesh-list
101407443|NCT00138177|Fluorouracil|fluorouracil|mesh-list
101407444|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
101407445|NCT00138177|Vorinostat|vorinostat|mesh-list
101407446|NCT00138177|Calcium|calcium|mesh-list
101196156|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
101196157|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
101196158|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
101196159|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196160|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196256|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
101407448|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101407450|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
101196325|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101407451|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534586|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
101196527|NCT01386268|Coagulants|coagulants|mesh-ancestor
101196596|NCT01386580|Doxorubicin|doxorubicin|mesh-list
101196648|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101196649|NCT01386658|Analgesics|analgesics|mesh-ancestor
101196650|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
101196653|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407452|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407453|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407454|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407455|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
101407456|NCT00138177|Antidotes|antidotes|mesh-ancestor
101407457|NCT00138177|Protective Agents|protective agents|mesh-ancestor
101407458|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
101407459|NCT00138177|Vitamins|vitamins|mesh-ancestor
101407460|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
101196664|NCT01386736|Vitamin D|vitamin d|mesh-list
101534589|NCT04575675|Valsartan|valsartan|mesh-list
101407461|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101407462|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407463|NCT03279601|Capecitabine|capecitabine|mesh-list
101407464|NCT03279601|Temozolomide|temozolomide|mesh-list
101407465|NCT03279601|Dacarbazine|dacarbazine|mesh-list
101407466|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196802|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101196803|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196804|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407467|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
101407468|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407469|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407470|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101407471|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
101407473|NCT00107393|Trastuzumab|trastuzumab|mesh-list
101407474|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407475|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
101407476|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407477|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407478|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407479|NCT00138216|Irinotecan|irinotecan|mesh-list
101407480|NCT00138216|Vincristine|vincristine|mesh-list
101407481|NCT00138216|Temozolomide|temozolomide|mesh-list
101534590|NCT04575675|Carvedilol|carvedilol|mesh-list
101197054|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407482|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101407483|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407484|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407485|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407486|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407487|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101407488|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
101197349|NCT01390935|Diuretics|diuretics|mesh-ancestor
101407490|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407491|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101407492|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
101407493|NCT00105586|Escitalopram|escitalopram|mesh-list
101407494|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101197597|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101407495|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407496|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407497|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407498|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407499|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
101407500|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407501|NCT00107432|Sorafenib|sorafenib|mesh-list
101407502|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407503|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407504|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407505|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407506|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
101407508|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101407509|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101407510|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
101407511|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407512|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407513|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101407514|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407515|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101407516|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407517|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407518|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407519|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407520|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101407521|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101407522|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101407523|NCT00440128|Docetaxel|docetaxel|mesh-list
101407524|NCT00440128|Casopitant|casopitant|mesh-list
101407525|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407526|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
101407527|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407528|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
101197725|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101197858|NCT01394263|Goserelin|goserelin|mesh-list
101407529|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407531|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
101407532|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407533|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407534|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407535|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101407536|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407537|NCT00440167|Gemcitabine|gemcitabine|mesh-list
101407538|NCT00440167|Capecitabine|capecitabine|mesh-list
101407539|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101407540|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407541|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
101407542|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407543|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198130|NCT01395420|Ceftazidime|ceftazidime|mesh-list
101407547|NCT00107471|Lenograstim|lenograstim|mesh-list
101407548|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101407549|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
101407550|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407551|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101407552|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407553|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407554|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534591|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101407555|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407557|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407558|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407559|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
101407563|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534592|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101198651|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
101407564|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407565|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
101407566|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407567|NCT03279562|Nalmefene|nalmefene|mesh-list
101407568|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101407569|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407570|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
101407571|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407572|NCT00404196|Calcipotriene|calcipotriene|mesh-list
101407573|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407574|NCT00107510|Carboplatin|carboplatin|mesh-list
101407575|NCT00107510|Docetaxel|docetaxel|mesh-list
101198781|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101198869|NCT05271058|Hormones|hormones|mesh-ancestor
101407576|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407577|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
101407578|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407579|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407580|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407581|NCT00440245|Albuterol|albuterol|mesh-list
101534593|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101534594|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
101407582|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101407583|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
101199261|NCT04760912|Bromides|bromides|mesh-list
101407585|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407586|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101407588|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
101534597|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101534598|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199375|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407589|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407590|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101199506|NCT03777462|Gemcitabine|gemcitabine|mesh-list
101407591|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101407592|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101407593|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
101407594|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407595|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407596|NCT00440284|Insulin|insulin|mesh-list
101407597|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407598|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407600|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101407601|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407602|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407603|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407604|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407605|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
101407606|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407607|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101407608|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
101407609|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407610|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101407611|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101407612|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407614|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101534600|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101407615|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101407616|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407617|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407618|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101407619|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
101407620|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
101200032|NCT02578368|Antidotes|antidotes|mesh-ancestor
101407621|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407622|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200086|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101200087|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101534601|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101534602|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101200273|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407623|NCT00440440|Testosterone|testosterone|mesh-list
101407624|NCT00440440|Androgens|androgens|mesh-ancestor
101407626|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407627|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407628|NCT00142896|Morphine|morphine|mesh-list
101407629|NCT00142896|Tramadol|tramadol|mesh-list
101407630|NCT00142896|Naloxone|naloxone|mesh-list
101200517|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101534603|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
101407631|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101407632|NCT00142896|Narcotics|narcotics|mesh-ancestor
101407633|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407634|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407635|NCT00142896|Analgesics|analgesics|mesh-ancestor
101407636|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
101200616|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101534604|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200767|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407640|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407641|NCT00440635|Bortezomib|bortezomib|mesh-list
101407642|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407643|NCT00440674|Paclitaxel|paclitaxel|mesh-list
101200826|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101534605|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
101407644|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101407645|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407647|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407648|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407649|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407650|NCT00440713|Aripiprazole|aripiprazole|mesh-list
101407651|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
101407652|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407653|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101407654|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201075|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101201076|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
101201077|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201078|NCT01402297|Acetovanillone|acetovanillone|mesh-list
101201079|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101201080|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407655|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407656|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407657|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
101407658|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
101407660|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407661|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101407663|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
101407664|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101407665|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101407666|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101407667|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101407669|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101407670|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
101407671|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407672|NCT00440869|Expectorants|expectorants|mesh-ancestor
101407673|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
101201683|NCT01405157|Prednisolone|prednisolone|mesh-list
101407674|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101407675|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
101407676|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407677|NCT00440869|Protective Agents|protective agents|mesh-ancestor
101407678|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407679|NCT00440869|Antidotes|antidotes|mesh-ancestor
101407680|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
101407681|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101407682|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407684|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534608|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101201867|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407685|NCT00441298|Tenofovir|tenofovir|mesh-list
101407686|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
101407687|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407688|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101407689|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101407690|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487398|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101202300|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534609|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534610|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
101407691|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407692|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101407693|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101407694|NCT00441415|Adapalene|adapalene|mesh-list
101407695|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101202844|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
101202989|NCT01414569|Hormones|hormones|mesh-ancestor
101407696|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407698|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
101407699|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407700|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407701|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407703|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407704|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
101534611|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101534613|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534614|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534615|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101534616|NCT04575675|Diuretics|diuretics|mesh-ancestor
101534617|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
101534618|NCT04575675|Hormones|hormones|mesh-ancestor
101534619|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
101534620|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534621|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534622|NCT00568412|Analgesics|analgesics|mesh-ancestor
101534624|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534625|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407706|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101407707|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101407708|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407709|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407710|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203555|NCT01418131|Tacrolimus|tacrolimus|mesh-list
101407711|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407712|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407713|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101407714|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407715|NCT00441532|Lidocaine|lidocaine|mesh-list
101407716|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
101407717|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
101407718|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407719|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407720|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
101407721|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407722|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534626|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534627|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407723|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101407724|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101407725|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407726|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407727|NCT00441649|Methylphenidate|methylphenidate|mesh-list
101407728|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101407729|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407730|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101203999|NCT01421043|Triazolam|triazolam|mesh-list
101534628|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407731|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101204220|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
101407732|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407733|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407734|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
101407735|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407736|NCT00107822|Lidocaine|lidocaine|mesh-list
101407737|NCT00107822|Tetracaine|tetracaine|mesh-list
101407738|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
101407739|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
101407740|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407741|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407742|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
101407743|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407744|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101407745|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101407746|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101407747|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204345|NCT01423019|Synephrine|synephrine|mesh-list
101204346|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101204347|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101204348|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101204349|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407748|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407749|NCT03279328|Petrolatum|petrolatum|mesh-list
101407751|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407753|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101407754|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
101407755|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407756|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534629|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407757|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407758|NCT00441844|Simvastatin|simvastatin|mesh-list
101407759|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101407760|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101407761|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
101407762|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534631|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101319356|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101319358|NCT04733326|Analgesics|analgesics|mesh-ancestor
101319359|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
101319360|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319361|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319362|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319363|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101319364|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101319365|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548436|NCT00596414|Midazolam|midazolam|mesh-list
101319366|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319367|NCT00386984|Octreotide|octreotide|mesh-list
101319368|NCT00386984|Somatostatin|somatostatin|mesh-list
101319369|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319370|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101319371|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329946|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101319373|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319374|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319376|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319377|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319378|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101319379|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319381|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
101319382|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319383|NCT00387179|Protective Agents|protective agents|mesh-ancestor
101319384|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319385|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319387|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
101319388|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319389|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319390|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319392|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319394|NCT05640726|Bevacizumab|bevacizumab|mesh-list
101319395|NCT05640726|Fluorouracil|fluorouracil|mesh-list
101319396|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
101319397|NCT05640726|Calcium|calcium|mesh-list
101319398|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
101319399|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319400|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319401|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319402|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319403|NCT05640726|Growth Substances|growth substances|mesh-ancestor
101319404|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319405|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
101319406|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101319407|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
101319408|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319409|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319410|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319411|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
101319413|NCT05640726|Protective Agents|protective agents|mesh-ancestor
101319414|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
101319415|NCT05640726|Vitamins|vitamins|mesh-ancestor
101319416|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
101319421|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101319422|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
101319423|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
101319424|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319425|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319426|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
101319427|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101319428|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
101319429|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101319430|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101319431|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101319432|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101319433|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101319434|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319435|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319436|NCT03959176|Protective Agents|protective agents|mesh-ancestor
101319437|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101319438|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101319439|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101319440|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101319441|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
101319443|NCT03958981|Cathartics|cathartics|mesh-ancestor
101319444|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319445|NCT03958942|Bupivacaine|bupivacaine|mesh-list
101319446|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319447|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
101319448|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319449|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319450|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
101319451|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319452|NCT03958708|Rifaximin|rifaximin|mesh-list
101319453|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319454|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319455|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319456|NCT05640609|Bevacizumab|bevacizumab|mesh-list
101319457|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319458|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319459|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319460|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319461|NCT05640609|Growth Substances|growth substances|mesh-ancestor
101319463|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
101319465|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
101319466|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
101319467|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319468|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319470|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
101319471|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
101319472|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319473|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319474|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
101319475|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319476|NCT03958396|Remifentanil|remifentanil|mesh-list
101319477|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101319478|NCT03958396|Narcotics|narcotics|mesh-ancestor
101319479|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319480|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319481|NCT03958396|Analgesics|analgesics|mesh-ancestor
101319482|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
101319483|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319484|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
101319485|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101319486|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319487|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319488|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101319489|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101319490|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319491|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319492|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319493|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101319494|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
101319495|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101319496|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319497|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101319498|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101319499|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101319501|NCT03933865|Hydromorphone|hydromorphone|mesh-list
101319502|NCT03933865|Analgesics|analgesics|mesh-ancestor
101319503|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
101319504|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319505|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319506|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101319507|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101319508|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
101319509|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
101319510|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319511|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101319512|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101319513|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319514|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319515|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101319516|NCT03933865|Narcotics|narcotics|mesh-ancestor
101319517|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
101319519|NCT03819322|Velpatasvir|velpatasvir|mesh-list
101319520|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
101319521|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319522|NCT05206175|Methamphetamine|methamphetamine|mesh-list
101319523|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101319524|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319525|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
101319526|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
101319527|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319528|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
101319529|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319530|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319531|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
101319532|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101319533|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101319534|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319535|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101319536|NCT00392899|Tegafur|tegafur|mesh-list
101319537|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319538|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
101319539|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319541|NCT05638893|Metformin|metformin|mesh-list
101319542|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101319543|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319544|NCT00392938|Docetaxel|docetaxel|mesh-list
101319545|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
101319546|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319547|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
101319548|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319549|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319550|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319551|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
101319552|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319553|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319555|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101319556|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101319557|NCT05637567|Analgesics|analgesics|mesh-ancestor
101319558|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
101319559|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319560|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319563|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101319564|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101319565|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319566|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101319567|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101319568|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319570|NCT03432091|Melatonin|melatonin|mesh-list
101319571|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
101319572|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319573|NCT03432091|Protective Agents|protective agents|mesh-ancestor
101319574|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319575|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319577|NCT05634564|Gemcitabine|gemcitabine|mesh-list
101319578|NCT05634564|Tislelizumab|tislelizumab|mesh-list
101319579|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101319580|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319581|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
101319582|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319583|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319584|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319585|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319586|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
101319587|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319588|NCT03152149|Fluticasone|fluticasone|mesh-list
101319589|NCT03152149|Xhance|xhance|mesh-list
101319590|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
101319591|NCT03152149|Olodaterol|olodaterol|mesh-list
101319592|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319593|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101319594|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
101319595|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319596|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319597|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101319598|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
101319599|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319600|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101319601|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
101319602|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101319603|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
101319604|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319605|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319606|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101319607|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101319608|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101319609|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319610|NCT05633472|Vitamin D|vitamin d|mesh-list
101319611|NCT05633472|Vitamins|vitamins|mesh-ancestor
101319612|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
101319613|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319614|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101319615|NCT03151876|Gemcitabine|gemcitabine|mesh-list
101319616|NCT03151876|Busulfan|busulfan|mesh-list
101319617|NCT03151876|Cladribine|cladribine|mesh-list
101319618|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319619|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
101319620|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319621|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319622|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
101319623|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319624|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
101319625|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319626|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101319627|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101319628|NCT03151720|Loratadine|loratadine|mesh-list
101319629|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
101319630|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319631|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101319632|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101319633|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101319634|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
101319635|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
101319636|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319637|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319638|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319640|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319641|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319642|NCT03151525|Infliximab|infliximab|mesh-list
101319643|NCT03151525|Azathioprine|azathioprine|mesh-list
101319644|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101319645|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319646|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319647|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319648|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101319649|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
101319650|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319651|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319652|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319653|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319654|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
101319655|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319656|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
101319657|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
101319658|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101319659|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101319660|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
101319661|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319662|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319663|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319664|NCT00387374|Paclitaxel|paclitaxel|mesh-list
101319665|NCT00387374|Bevacizumab|bevacizumab|mesh-list
101319666|NCT00387374|Carboplatin|carboplatin|mesh-list
101319667|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101319668|NCT00387374|Antibodies|antibodies|mesh-list
101319669|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
101319670|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101319671|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101319672|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319673|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101319674|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319675|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319676|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319677|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319678|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319679|NCT00387374|Growth Substances|growth substances|mesh-ancestor
101319680|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319681|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
101319682|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
101319684|NCT03151369|Analgesics|analgesics|mesh-list
101319685|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101319686|NCT03151369|Narcotics|narcotics|mesh-ancestor
101319687|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319688|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319689|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
101319690|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319691|NCT04712266|Insulin|insulin|mesh-list
101319692|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101319693|NCT04712266|Glucagon|glucagon|mesh-list
101319694|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101319695|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319696|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319697|NCT04712266|Hormones|hormones|mesh-ancestor
101319698|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319699|NCT03912818|Carboplatin|carboplatin|mesh-list
101319700|NCT03912818|Gemcitabine|gemcitabine|mesh-list
101319701|NCT03912818|Doxorubicin|doxorubicin|mesh-list
101319702|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101319703|NCT03912818|Methotrexate|methotrexate|mesh-list
101319704|NCT03912818|Durvalumab|durvalumab|mesh-list
101319705|NCT03912818|Daunorubicin|daunorubicin|mesh-list
101319706|NCT03912818|Vinblastine|vinblastine|mesh-list
101319707|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319708|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319709|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
101319710|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319711|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101319712|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101319713|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101319714|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319715|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101319716|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
101319717|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101319718|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319719|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319720|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101319721|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319722|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
101319724|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548464|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
101319725|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319726|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101319727|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
101319728|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
101319729|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
101319730|NCT03151213|Pregabalin|pregabalin|mesh-list
101319731|NCT03151213|Analgesics|analgesics|mesh-ancestor
101319732|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
101319733|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319734|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319735|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
101319736|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101319737|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319738|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319739|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101319740|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101319741|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101319742|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319743|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101319745|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
101319746|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
101319747|NCT03151174|Vitamins|vitamins|mesh-list
101319748|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
101319749|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319750|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101319751|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101319753|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
101319754|NCT03151096|Vitamins|vitamins|mesh-ancestor
101319755|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
101319756|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319757|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101319758|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319759|NCT03906539|Atorvastatin|atorvastatin|mesh-list
101319760|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101319761|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101319762|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
101319763|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319764|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101319765|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101319766|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319767|NCT00389688|Pemetrexed|pemetrexed|mesh-list
101319768|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319769|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319770|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319771|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101319772|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101319774|NCT05605665|Aldesleukin|aldesleukin|mesh-list
101319775|NCT05605665|Interleukin-2|interleukin-2|mesh-list
101319776|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101319777|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319779|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319780|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
101319781|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319782|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
101319783|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319784|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101319786|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
101319787|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319788|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101319789|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101319790|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
101319791|NCT03150706|Avelumab|avelumab|mesh-list
101319792|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101319793|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319794|NCT03150667|Clopidogrel|clopidogrel|mesh-list
101319795|NCT03150667|Ticagrelor|ticagrelor|mesh-list
101319796|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101319797|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101319798|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101319799|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101319800|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
101319801|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319802|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319803|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319805|NCT03150316|Lenalidomide|lenalidomide|mesh-list
101319806|NCT03150316|CKD-581|ckd-581|mesh-list
101319807|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101319808|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
101319809|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
101319810|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319811|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319812|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101319813|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
101319815|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319816|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101319817|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319818|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319819|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319820|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
101319821|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101319822|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101319823|NCT03150316|Growth Substances|growth substances|mesh-ancestor
101319824|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
101319825|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101319827|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
101319828|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101319829|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101319830|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101319831|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319832|NCT05597553|Pemetrexed|pemetrexed|mesh-list
101319833|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319834|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319835|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319836|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101319837|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101319838|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
101319839|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101319840|NCT03086044|Velpatasvir|velpatasvir|mesh-list
101319841|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
101319842|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319843|NCT03083665|Brivaracetam|brivaracetam|mesh-list
101319844|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
101319846|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101319847|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101319848|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319849|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319850|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319851|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101319852|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101319853|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101319855|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
101319857|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101319858|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319859|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319860|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
101319862|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101319863|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
101319864|NCT00393289|Calcium|calcium|mesh-list
101319865|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101319866|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319867|NCT02285179|Tamoxifen|tamoxifen|mesh-list
101319868|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101319869|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
101319870|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101319871|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319872|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101319873|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319874|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101319875|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101319876|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101319879|NCT02250937|Busulfan|busulfan|mesh-list
101319880|NCT02250937|Venetoclax|venetoclax|mesh-list
101319881|NCT02250937|Cladribine|cladribine|mesh-list
101319882|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101319883|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319884|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319886|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319887|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319888|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
101319889|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319890|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
101319891|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101319892|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101319893|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
101319896|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
101319897|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101319898|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
101319899|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101319900|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
101319901|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319902|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101319903|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101319904|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
101319905|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319906|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101319907|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101319908|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101319910|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101319911|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101319912|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
101319913|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101319914|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319915|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101319916|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101319917|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101319918|NCT04708886|Alendronate|alendronate|mesh-list
101319919|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101319920|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319921|NCT00393328|Ritonavir|ritonavir|mesh-list
101319922|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101319923|NCT00393328|Aripiprazole|aripiprazole|mesh-list
101319924|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101319925|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101319927|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101319928|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319929|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101319930|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101319931|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
101319932|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319933|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101319934|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101319935|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
101319936|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101319937|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101319938|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101319939|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319940|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319941|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
101319942|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
101319943|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319944|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101319945|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101319946|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
101319947|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101319948|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101319949|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101319951|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101319952|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101319954|NCT01807429|Ketamine|ketamine|mesh-list
101319955|NCT01807429|Morphine|morphine|mesh-list
101319956|NCT01807429|Analgesics|analgesics|mesh-ancestor
101319957|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
101319958|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319959|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319960|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101319961|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101319962|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
101319963|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
101319964|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101319965|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101319966|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101319967|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101319968|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319969|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101319970|NCT01807429|Narcotics|narcotics|mesh-ancestor
101319971|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101319972|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101319973|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101319974|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101319975|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101319976|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
101319977|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
101319978|NCT01807078|Ezetimibe|ezetimibe|mesh-list
101319979|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101319980|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101319981|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
101319982|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319983|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101319984|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
101319985|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101319986|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
101319987|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101319988|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101319989|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101319990|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
101319991|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101319992|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101319993|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101319994|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
101319996|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101319998|NCT01807000|Laxatives|laxatives|mesh-ancestor
101319999|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320000|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101320001|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101320002|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
101320003|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320004|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320005|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320006|NCT01806805|Zonisamide|zonisamide|mesh-list
101320007|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
101320008|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101320009|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320010|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320011|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101320012|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320013|NCT00387413|Niacinamide|niacinamide|mesh-list
101320014|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101320015|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101320016|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101320017|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320018|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320019|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320020|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320021|NCT00387413|Analgesics|analgesics|mesh-ancestor
101320022|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
101320023|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320024|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
101320025|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101320026|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
101320027|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
101320028|NCT00387413|Vitamins|vitamins|mesh-ancestor
101320029|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
101320030|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101320031|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
101320032|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320033|NCT05517291|Paclitaxel|paclitaxel|mesh-list
101320034|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320035|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320036|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320037|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320038|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320039|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320041|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101320042|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320043|NCT01806415|Imidazole|imidazole|mesh-list
101320044|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320045|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320046|NCT01806376|Maleic acid|maleic acid|mesh-list
101320047|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320048|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320049|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
101320050|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320051|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320052|NCT01806259|Ketorolac|ketorolac|mesh-list
101320053|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101320054|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101320055|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320056|NCT01806259|Analgesics|analgesics|mesh-ancestor
101320058|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320059|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320060|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320061|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320062|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101320063|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320064|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320065|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
101320066|NCT05482542|Rituximab|rituximab|mesh-list
101320067|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320068|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
101320069|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320070|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320071|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101320072|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
101320073|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320074|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320075|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101320076|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320077|NCT04579757|Tislelizumab|tislelizumab|mesh-list
101320078|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320079|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320081|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101320082|NCT00393445|Incretins|incretins|mesh-ancestor
101320083|NCT00393445|Hormones|hormones|mesh-ancestor
101320084|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320085|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320086|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320087|NCT00393562|Methylphenidate|methylphenidate|mesh-list
101320088|NCT00393562|Modafinil|modafinil|mesh-list
101320089|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101320090|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320091|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101320092|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101320093|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320094|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320095|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
101320096|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320097|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101320098|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101320099|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101320100|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
101320101|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101320103|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320104|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320105|NCT04527107|Aflibercept|aflibercept|mesh-list
101320106|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101320107|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101320108|NCT04527107|Growth Substances|growth substances|mesh-ancestor
101320109|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320110|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320111|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320112|NCT05437887|Fucoidan|fucoidan|mesh-list
101320113|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101320114|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320115|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
101320116|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320117|NCT01805596|Clopidogrel|clopidogrel|mesh-list
101320118|NCT01805596|Ticagrelor|ticagrelor|mesh-list
101320119|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320120|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101320121|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101320122|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101320123|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
101320124|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320125|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320126|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320127|NCT04474223|Dexamethasone|dexamethasone|mesh-list
101320128|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320129|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
101320130|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
101320131|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320132|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320133|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320134|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
101320136|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320137|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101320138|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320139|NCT01466530|Misoprostol|misoprostol|mesh-list
101320140|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101320141|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
101320142|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101320143|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320144|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101320145|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320146|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
101320147|NCT01466452|Aspirin|aspirin|mesh-list
101320148|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101320149|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320150|NCT01466452|Analgesics|analgesics|mesh-ancestor
101320151|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
101320152|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320153|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320154|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320155|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320156|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101320157|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101320158|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320159|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320160|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101320161|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320162|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
101320163|NCT01466374|Antibodies|antibodies|mesh-list
101320164|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
101320165|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101320166|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
101320167|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320169|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320170|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320171|NCT01466101|Pregabalin|pregabalin|mesh-list
101320172|NCT01466101|Analgesics|analgesics|mesh-ancestor
101320173|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
101320174|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320175|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320176|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
101320177|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101320178|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320179|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320180|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101320181|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101320182|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101320183|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320184|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101320185|NCT01465984|Acetaminophen|acetaminophen|mesh-list
101320186|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320187|NCT01465984|Analgesics|analgesics|mesh-ancestor
101320188|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
101320189|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320190|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320191|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
101320192|NCT01465906|Bromides|bromides|mesh-list
101320193|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
101320194|NCT01465906|Tulobuterol|tulobuterol|mesh-list
101320195|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101320196|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
101320197|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320198|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320199|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101320200|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
101320202|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101320203|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
101320204|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320205|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330001|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320207|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101320208|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101320209|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101320210|NCT01465867|Selenium|selenium|mesh-list
101320211|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
101320212|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320213|NCT01465867|Protective Agents|protective agents|mesh-ancestor
101320214|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320215|NCT01465867|Trace Elements|trace elements|mesh-ancestor
101320216|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
101320217|NCT01465828|Clopidogrel|clopidogrel|mesh-list
101320218|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101320219|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320220|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101320221|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101320222|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101320223|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
101320224|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320225|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320226|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320228|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101320229|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320230|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320231|NCT01465399|Mitogens|mitogens|mesh-list
101320232|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320233|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320234|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101320235|NCT05393505|Amoxicillin|amoxicillin|mesh-list
101320236|NCT05393505|Levofloxacin|levofloxacin|mesh-list
101320237|NCT05393505|Meropenem|meropenem|mesh-list
101320238|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
101320239|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
101320240|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101320241|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320242|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101320243|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101320244|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320245|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320246|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320247|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320248|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101320249|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101320250|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101320251|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
101320252|NCT04201457|Trametinib|trametinib|mesh-list
101320253|NCT04201457|Dabrafenib|dabrafenib|mesh-list
101320254|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101320255|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
101320256|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101320257|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101320258|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320259|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320260|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320261|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320262|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320264|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101320265|NCT04201457|Protective Agents|protective agents|mesh-ancestor
101320266|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320267|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101320268|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
101320269|NCT01465009|Aspirin|aspirin|mesh-list
101320270|NCT01465009|Acetaminophen|acetaminophen|mesh-list
101320271|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101320272|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320273|NCT01465009|Analgesics|analgesics|mesh-ancestor
101320274|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
101320275|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320276|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320277|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320278|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320279|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101320280|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101320281|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320282|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320283|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101320284|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320286|NCT00389766|Topotecan|topotecan|mesh-list
101320287|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101320288|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101320289|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320290|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320291|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320292|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320293|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101320294|NCT01464697|Progesterone|progesterone|mesh-list
101320295|NCT01464697|Progestins|progestins|mesh-ancestor
101320296|NCT01464697|Hormones|hormones|mesh-ancestor
101320297|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320298|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320299|NCT04083950|Aspirin|aspirin|mesh-list
101320300|NCT04083950|Vaccines|vaccines|mesh-list
101320301|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
101320302|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320303|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101320304|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320305|NCT04083950|Analgesics|analgesics|mesh-ancestor
101320306|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
101320307|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320308|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320309|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320310|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101320311|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101320312|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320313|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320314|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101320315|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320316|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
101320317|NCT00393679|Artesunate|artesunate|mesh-list
101320318|NCT00393679|Lumefantrine|lumefantrine|mesh-list
101320319|NCT00393679|Artemether|artemether|mesh-list
101320320|NCT00393679|Piperaquine|piperaquine|mesh-list
101320321|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101320322|NCT00393679|Amodiaquine|amodiaquine|mesh-list
101320323|NCT00393679|Artenimol|artenimol|mesh-list
101320324|NCT00393679|Dapsone|dapsone|mesh-list
101320325|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
101320326|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
101320328|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101320329|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320330|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320331|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
101320332|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
101320333|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101320334|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
101320335|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101320336|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320337|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320338|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
101320339|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101320340|NCT00393835|Azithromycin|azithromycin|mesh-list
101320341|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101320342|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320343|NCT01057069|Paclitaxel|paclitaxel|mesh-list
101320344|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101320345|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
101320346|NCT01057069|Carboplatin|carboplatin|mesh-list
101320347|NCT01057069|Doxorubicin|doxorubicin|mesh-list
101320348|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101320349|NCT01057069|Thiotepa|thiotepa|mesh-list
101320350|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320351|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320352|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320354|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320355|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320356|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320357|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
101320358|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320359|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320360|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101320361|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
101320362|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101320363|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101320364|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101320365|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320366|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320367|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101320368|NCT00847834|Irbesartan|irbesartan|mesh-list
101320369|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101320370|NCT00847834|Diuretics|diuretics|mesh-ancestor
101320372|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320373|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101320374|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320375|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320376|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101320377|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101320379|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101320380|NCT00847678|Flucytosine|flucytosine|mesh-list
101320381|NCT00847678|Efungumab|efungumab|mesh-list
101320382|NCT00847678|Amebicides|amebicides|mesh-ancestor
101320383|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101320384|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101320385|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320386|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101320388|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
101320389|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320390|NCT00847639|Lenalidomide|lenalidomide|mesh-list
101320391|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
101320392|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320393|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101320394|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101320395|NCT00847639|Growth Substances|growth substances|mesh-ancestor
101320396|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320397|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320399|NCT00847483|Travoprost|travoprost|mesh-list
101320400|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101320401|NCT00847483|Latanoprost|latanoprost|mesh-list
101320402|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101320403|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101320404|NCT04034927|Olaparib|olaparib|mesh-list
101320405|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101320406|NCT04034927|Tremelimumab|tremelimumab|mesh-list
101320407|NCT04034927|Ipilimumab|ipilimumab|mesh-list
101320408|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101320409|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320410|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320412|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
101320413|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320414|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320415|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101320416|NCT00847366|Tamoxifen|tamoxifen|mesh-list
101320417|NCT00847366|Trastuzumab|trastuzumab|mesh-list
101320418|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320420|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101320421|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
101320422|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320423|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330013|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320424|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101320425|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101320426|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101320427|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101320428|NCT05321160|Ketamine|ketamine|mesh-list
101320430|NCT05321160|Esketamine|esketamine|mesh-list
101320431|NCT05321160|Analgesics|analgesics|mesh-ancestor
101320432|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
101320433|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320434|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320435|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101320436|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101320437|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
101320438|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
101320439|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320440|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101320441|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101320442|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320443|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320444|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101320445|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101320446|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
101320447|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101320448|NCT04009343|Lumefantrine|lumefantrine|mesh-list
101320450|NCT04009343|Piperaquine|piperaquine|mesh-list
101320451|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101320452|NCT04009343|Artenimol|artenimol|mesh-list
101320453|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
101320454|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101320455|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101320456|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320457|NCT03969641|Vaccines|vaccines|mesh-list
101320458|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
101320459|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320460|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
101320461|NCT00847210|Lansoprazole|lansoprazole|mesh-list
101320462|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101320464|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101320465|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320466|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320467|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
101320468|NCT00847171|Trastuzumab|trastuzumab|mesh-list
101320469|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320470|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
101320471|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320473|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101320474|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
101320475|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320476|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320477|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101320478|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320480|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101320481|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320482|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320483|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320485|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320486|NCT00847093|Lidocaine|lidocaine|mesh-list
101320487|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
101320488|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
101320489|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320490|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320491|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
101320492|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320493|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101320494|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101320495|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101320496|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320497|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320498|NCT00847054|Antibodies|antibodies|mesh-list
101320499|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101320500|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
101320501|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320502|NCT00846976|Bicalutamide|bicalutamide|mesh-list
101320503|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
101320504|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
101320505|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320506|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320507|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320509|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101320510|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101320511|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
101320512|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320513|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320514|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320515|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
101320516|NCT03885830|Dasatinib|dasatinib|mesh-list
101320517|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320518|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320519|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320520|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320521|NCT00846703|Dexamethasone|dexamethasone|mesh-list
101320522|NCT00846703|Methotrexate|methotrexate|mesh-list
101320523|NCT00846703|Vincristine|vincristine|mesh-list
101320524|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
101320525|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320526|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
101320527|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
101320528|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320529|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320530|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320531|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
101320533|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320534|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101320535|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320536|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101320537|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
101320538|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101320539|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320540|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
101320541|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320542|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
101320543|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320544|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101320545|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320546|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
101320547|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320548|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101320549|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320550|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320551|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320552|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320553|NCT03772964|Metformin|metformin|mesh-list
101320554|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101320555|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320556|NCT00846625|Triamcinolone|triamcinolone|mesh-list
101320557|NCT00846625|Ranibizumab|ranibizumab|mesh-list
101320558|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101320559|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101320560|NCT00846625|Growth Substances|growth substances|mesh-ancestor
101320561|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320562|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320563|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320564|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320565|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
101320567|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320569|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320570|NCT03721172|Apremilast|apremilast|mesh-list
101320571|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101320572|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320573|NCT03721172|Analgesics|analgesics|mesh-ancestor
101320574|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
101320575|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320576|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320577|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320578|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320579|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101320580|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101320581|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320582|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320583|NCT00846274|Antithrombins|antithrombins|mesh-list
101320584|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
101320585|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101320586|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
101320587|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320588|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320589|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
101320590|NCT00846235|Glycerol|glycerol|mesh-list
101320591|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101320592|NCT00846235|Protective Agents|protective agents|mesh-ancestor
101320593|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320594|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
101320595|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
101320596|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101320597|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320598|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320599|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101320600|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320601|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101320602|NCT00846118|Pitavastatin|pitavastatin|mesh-list
101320603|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101320604|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101320605|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101320606|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
101320607|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320608|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320609|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101320610|NCT00846079|Regadenoson|regadenoson|mesh-list
101320611|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101320612|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101320613|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
101320614|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
101320615|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320616|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320617|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320619|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
101320620|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
101320621|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
101320622|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320623|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320624|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
101320625|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320626|NCT03620942|Phenylephrine|phenylephrine|mesh-list
101320627|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
101320628|NCT03620942|Ephedrine|ephedrine|mesh-list
101320629|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101320630|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101320631|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
101320632|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
101320633|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320634|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320635|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
101320636|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
101320637|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
101320638|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101320639|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101320640|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101320641|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
101320642|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320643|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320644|NCT03620942|Protective Agents|protective agents|mesh-ancestor
101320645|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101320647|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101320648|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101320649|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101320650|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320651|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320652|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
101320653|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320654|NCT00277069|Carboplatin|carboplatin|mesh-list
101320655|NCT00277069|Capecitabine|capecitabine|mesh-list
101320656|NCT00277069|Vinorelbine|vinorelbine|mesh-list
101320657|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320658|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320659|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
101320660|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320661|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320662|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320663|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320664|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320665|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101320666|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
101320667|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
101320668|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
101320669|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320670|NCT00276874|Aripiprazole|aripiprazole|mesh-list
101320671|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
101320672|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101320673|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101320674|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101320675|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320676|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320677|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
101320678|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
101320679|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320680|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320681|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101320682|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101320683|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
101320684|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101320685|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101320686|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101320687|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101320688|NCT00276835|Aldesleukin|aldesleukin|mesh-list
101320689|NCT00276835|Interleukin-2|interleukin-2|mesh-list
101320691|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320692|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101320693|NCT00276835|Analgesics|analgesics|mesh-ancestor
101320694|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
101320695|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320696|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320697|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101320698|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101320699|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
101320700|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320701|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101320702|NCT00276835|Protective Agents|protective agents|mesh-ancestor
101320703|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320704|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320705|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320706|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
101320707|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101320708|NCT00276835|Estrogens|estrogens|mesh-ancestor
101320709|NCT00276835|Hormones|hormones|mesh-ancestor
101320710|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320711|NCT00276796|Paclitaxel|paclitaxel|mesh-list
101320712|NCT00276796|Topotecan|topotecan|mesh-list
101320713|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320714|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320715|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320716|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320717|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320718|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320719|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101320720|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320721|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320722|NCT00276757|Leucovorin|leucovorin|mesh-list
101320723|NCT00276757|Prednisolone|prednisolone|mesh-list
101320724|NCT00276757|Methotrexate|methotrexate|mesh-list
101320725|NCT00276757|Vinblastine|vinblastine|mesh-list
101320726|NCT00276757|Calcium|calcium|mesh-list
101320728|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101320729|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320730|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101320731|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
101320732|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101320733|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320734|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
101320735|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320736|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320737|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
101320738|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320739|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101320740|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320741|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
101320742|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320743|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101320745|NCT00276757|Protective Agents|protective agents|mesh-ancestor
101320746|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
101320747|NCT00276757|Vitamins|vitamins|mesh-ancestor
101320748|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
101320749|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320750|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
101320751|NCT00276757|Hormones|hormones|mesh-ancestor
101320752|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320753|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101320754|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320755|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320756|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320757|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320758|NCT00276718|Carboplatin|carboplatin|mesh-list
101320759|NCT00276718|Etoposide|etoposide|mesh-list
101320760|NCT00276718|Bleomycin|bleomycin|mesh-list
101320761|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320762|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320763|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101320764|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320766|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320767|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101320768|NCT00276679|Temozolomide|temozolomide|mesh-list
101320769|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101320770|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
101320771|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320772|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320773|NCT00276601|Cytarabine|cytarabine|mesh-list
101320774|NCT00276601|Methotrexate|methotrexate|mesh-list
101320775|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
101320776|NCT00276601|Daunorubicin|daunorubicin|mesh-list
101320777|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
101320778|NCT00276601|Tretinoin|tretinoin|mesh-list
101320779|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101320780|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
101320781|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101320782|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320783|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320784|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
101320785|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320786|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320787|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
101320788|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320789|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101320790|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320791|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
101320792|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320793|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101320794|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
101320795|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320796|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101320797|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101320798|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320799|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
101320800|NCT00276523|Interferons|interferons|mesh-list
101320801|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
101320802|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
101320804|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320805|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
101320806|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320807|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
101320808|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320809|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
101320810|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101320811|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
101320812|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320813|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
101320814|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101320815|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320816|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320817|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
101320818|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320819|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320820|NCT00389883|Anesthetics|anesthetics|mesh-list
101320821|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101320822|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320823|NCT00389922|Vinorelbine|vinorelbine|mesh-list
101320824|NCT00389922|Lapatinib|lapatinib|mesh-list
101320825|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320826|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320828|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320829|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320830|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320831|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320832|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320834|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101320835|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
101320836|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320837|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320838|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101320839|NCT00276289|Diuretics|diuretics|mesh-ancestor
101320840|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
101320842|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101320843|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320844|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320845|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320846|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101320847|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
101320848|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320849|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101320850|NCT00394186|Solabegron|solabegron|mesh-list
101320851|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101320852|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101320853|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101320854|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
101320855|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320856|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320857|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320858|NCT00276172|Natalizumab|natalizumab|mesh-list
101320859|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
101320860|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320861|NCT00276133|Atorvastatin|atorvastatin|mesh-list
101320862|NCT00276133|Probucol|probucol|mesh-list
101320863|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101320864|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101320865|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
101320866|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320867|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101320868|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101320869|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320870|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
101320871|NCT00276133|Protective Agents|protective agents|mesh-ancestor
101320872|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320874|NCT00276055|Gemcitabine|gemcitabine|mesh-list
101320876|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320877|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320878|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101320879|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101320880|NCT00276055|Growth Substances|growth substances|mesh-ancestor
101320881|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320882|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320883|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320884|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
101320885|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320887|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320888|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320890|NCT00275938|Ribavirin|ribavirin|mesh-list
101320891|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
101320892|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
101320893|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320894|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
101320895|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320896|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
101320897|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320898|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
101320899|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320901|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
101320902|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320903|NCT00276640|Carboplatin|carboplatin|mesh-list
101320904|NCT00276640|Etoposide|etoposide|mesh-list
101320905|NCT00276640|Vincristine|vincristine|mesh-list
101320906|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330049|NCT00028834|Gemcitabine|gemcitabine|mesh-list
101320907|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320908|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101320909|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101320910|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320911|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320912|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
101320913|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
101320914|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
101320916|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101320917|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
101320918|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320919|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
101320920|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320921|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
101320922|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101320923|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320924|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101320925|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
101320926|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101320927|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320928|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101320929|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101320930|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101320931|NCT05566054|Azacitidine|azacitidine|mesh-list
101320932|NCT05566054|Venetoclax|venetoclax|mesh-list
101320933|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101320934|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
101320935|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320936|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320937|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320938|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101320939|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
101320940|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101320941|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320942|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320943|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101320944|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101320945|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320947|NCT02979977|Afatinib|afatinib|mesh-list
101320948|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320949|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320950|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101320951|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320952|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320953|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101320954|NCT05424757|Laxatives|laxatives|mesh-ancestor
101320956|NCT02921555|Prednisone|prednisone|mesh-list
101320957|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
101320958|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101320959|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101320960|NCT02921555|Prednisolone|prednisolone|mesh-list
101320961|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
101320962|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101320963|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
101320964|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101320965|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
101320966|NCT02921555|Hormones|hormones|mesh-ancestor
101320967|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101320968|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320969|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101320970|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320971|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
101320972|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
101320973|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101320974|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101320975|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101320976|NCT02921555|Protective Agents|protective agents|mesh-ancestor
101320977|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
101320978|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320979|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320980|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101320981|NCT05070585|Protective Agents|protective agents|mesh-ancestor
101320982|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101320983|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320984|NCT00387530|Valganciclovir|valganciclovir|mesh-list
101320985|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101320986|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
101320987|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320988|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101320990|NCT02687906|Vaborbactam|vaborbactam|mesh-list
101320991|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
101320992|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101320993|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101320994|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101320995|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101320996|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
101320997|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101320998|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416292|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
101320999|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101321000|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321002|NCT00390000|Vatalanib|vatalanib|mesh-list
101321003|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321004|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321005|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321006|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101321007|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321008|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321009|NCT04856176|Paclitaxel|paclitaxel|mesh-list
101321010|NCT04856176|Carboplatin|carboplatin|mesh-list
101321012|NCT04856176|Pemetrexed|pemetrexed|mesh-list
101321013|NCT04856176|Molgramostim|molgramostim|mesh-list
101321014|NCT04856176|Sargramostim|sargramostim|mesh-list
101321015|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321016|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321017|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321018|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321019|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321020|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321021|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321022|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101321023|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321024|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101321025|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321026|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
101321027|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321028|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101321029|NCT02632760|Hematinics|hematinics|mesh-ancestor
101321030|NCT04732507|Lidocaine|lidocaine|mesh-list
101321031|NCT04732507|Bupivacaine|bupivacaine|mesh-list
101321032|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
101321033|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
101321034|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321035|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321036|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
101321037|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321038|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101321039|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101321040|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101321041|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101321042|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321043|NCT05047770|Vaccines|vaccines|mesh-list
101321044|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
101321045|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321046|NCT02453984|Atezolizumab|atezolizumab|mesh-list
101321047|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101330058|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
101321048|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321071|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
101321072|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321073|NCT04556617|Prednisone|prednisone|mesh-list
101321074|NCT04556617|Olaparib|olaparib|mesh-list
101321075|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
101321076|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321077|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
101321078|NCT04556617|Hormones|hormones|mesh-ancestor
101321079|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321080|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321081|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101321082|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321083|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101321084|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321085|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321086|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101321087|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
101321088|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101321089|NCT04554862|Ketorolac|ketorolac|mesh-list
101321090|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101321091|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
101321092|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101321093|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101321094|NCT04554862|Analgesics|analgesics|mesh-ancestor
101321095|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
101321096|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321097|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321098|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321099|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321100|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101321101|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321102|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321103|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
101321104|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321105|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101321106|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
101321107|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101321108|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101321109|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101321110|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
101321111|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101321112|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
101321113|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321114|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330061|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
101321115|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101321116|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321118|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101321119|NCT04230499|Sirolimus|sirolimus|mesh-list
101321120|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321121|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321122|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321123|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321124|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
101321125|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321126|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
101321127|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321128|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
101321129|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101321130|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
101321131|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321132|NCT04712435|Expectorants|expectorants|mesh-ancestor
101321133|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101204415|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321134|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101321135|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
101321137|NCT04712435|Protective Agents|protective agents|mesh-ancestor
101321138|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321139|NCT04712435|Antidotes|antidotes|mesh-ancestor
101321140|NCT03977194|Paclitaxel|paclitaxel|mesh-list
101321141|NCT03977194|Carboplatin|carboplatin|mesh-list
101321142|NCT03977194|Atezolizumab|atezolizumab|mesh-list
101321143|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321144|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321145|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321146|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321147|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321148|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321149|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101321150|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321151|NCT04729465|Propofol|propofol|mesh-list
101548534|NCT00600158|Narcotics|narcotics|mesh-ancestor
101321153|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321154|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321156|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
101321157|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
101321158|NCT04712357|Tenofovir|tenofovir|mesh-list
101321159|NCT04712357|Emtricitabine|emtricitabine|mesh-list
101321160|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
101321161|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321162|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101321163|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321164|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321165|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321166|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321167|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321168|NCT00390039|Morphine|morphine|mesh-list
101321169|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101321170|NCT00390039|Narcotics|narcotics|mesh-ancestor
101321171|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321172|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321173|NCT00390039|Analgesics|analgesics|mesh-ancestor
101321174|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
101321176|NCT02966665|Vitamins|vitamins|mesh-list
101321177|NCT02966665|Vitamin E|vitamin e|mesh-list
101321178|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
101321179|NCT02966665|Fexofenadine|fexofenadine|mesh-list
101321180|NCT02966665|Valsartan|valsartan|mesh-list
101321181|NCT02966665|Nitroprusside|nitroprusside|mesh-list
101321182|NCT02966665|Phentolamine|phentolamine|mesh-list
101321183|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101321184|NCT02966665|Norepinephrine|norepinephrine|mesh-list
101321185|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
101321186|NCT02966665|Giapreza|giapreza|mesh-list
101321187|NCT02966665|Acetylcholine|acetylcholine|mesh-list
101321188|NCT02966665|Ranitidine|ranitidine|mesh-list
101321189|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
101321190|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
101321191|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321192|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101321193|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101321195|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321196|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
101321197|NCT02966665|Protective Agents|protective agents|mesh-ancestor
101321198|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101321199|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101321200|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
101321201|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321202|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
101204416|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101321203|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
101321204|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321205|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101321207|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101321208|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101321209|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101321210|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
101321211|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
101321212|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101321213|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101321214|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101321215|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
101321216|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101321217|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101321218|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
101321219|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321220|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101321221|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
101321222|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101321223|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101321224|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101321226|NCT02832544|Warfarin|warfarin|mesh-list
101321227|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
101321228|NCT02832544|Vitamins|vitamins|mesh-ancestor
101321229|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
101321230|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321231|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
101321232|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101321233|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
101321234|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101321235|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101321236|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321237|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321238|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101321239|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101321240|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
101321241|NCT02832544|Coagulants|coagulants|mesh-ancestor
101321242|NCT00006044|Testosterone|testosterone|mesh-list
101321243|NCT00006044|Androgens|androgens|mesh-ancestor
101321244|NCT00006044|Hormones|hormones|mesh-ancestor
101321245|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321246|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321247|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
101321248|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101321249|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101321250|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321251|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321252|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
101321253|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101321254|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321255|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321256|NCT02395705|Paclitaxel|paclitaxel|mesh-list
101321257|NCT02395705|Cisplatin|cisplatin|mesh-list
101321258|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321259|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321260|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321261|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321262|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321263|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321264|NCT00006047|Etoposide|etoposide|mesh-list
101321265|NCT00006047|Rubitecan|rubitecan|mesh-list
101321266|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
101321267|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321268|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321269|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101321270|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321271|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321272|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321273|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101321274|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
101321275|NCT00083824|Estrogens|estrogens|mesh-list
101321276|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101321277|NCT00083824|Hormones|hormones|mesh-ancestor
101321278|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321279|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321280|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101321281|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101321282|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101321283|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
101321284|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101321285|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101321286|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101321287|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101321288|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101321289|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321290|NCT00083902|Thalidomide|thalidomide|mesh-list
101321291|NCT00083902|Dexamethasone|dexamethasone|mesh-list
101321292|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321293|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
101321294|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
101321295|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321296|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321297|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101321298|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
101321300|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321301|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101321302|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321303|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321304|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
101321305|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
101321306|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321307|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321308|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321309|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101321310|NCT00083902|Growth Substances|growth substances|mesh-ancestor
101321311|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
101321312|NCT00006050|Leucovorin|leucovorin|mesh-list
101321313|NCT00006050|Fluorouracil|fluorouracil|mesh-list
101321314|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
101321315|NCT00006050|Calcium|calcium|mesh-list
101321316|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
101321317|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101321318|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321319|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
101321320|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321321|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321322|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321323|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204417|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101321325|NCT00006050|Antidotes|antidotes|mesh-ancestor
101321326|NCT00006050|Protective Agents|protective agents|mesh-ancestor
101321327|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
101321328|NCT00006050|Vitamins|vitamins|mesh-ancestor
101321329|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
101321330|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101321331|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101321332|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330075|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
101321333|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101321334|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321335|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321336|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321337|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101321338|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
101321339|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101321340|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
101321341|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101321342|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
101321343|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321344|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
101321345|NCT04893174|Protective Agents|protective agents|mesh-ancestor
101321346|NCT00084019|Ritonavir|ritonavir|mesh-list
101321347|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101321348|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101321349|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101321351|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321352|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321353|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321354|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321355|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
101321356|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321357|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101321358|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101321359|NCT00084058|Ritonavir|ritonavir|mesh-list
101321360|NCT00084058|Lopinavir|lopinavir|mesh-list
101321361|NCT00084058|Saquinavir|saquinavir|mesh-list
101321362|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101321363|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101321364|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
101321365|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321366|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321368|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321369|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
101321370|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321371|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101321372|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101321373|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
101321374|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321375|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321376|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548544|NCT04325984|Hormones|hormones|mesh-ancestor
101321377|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321380|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101321381|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
101321383|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321384|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321385|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321386|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321387|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321388|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321389|NCT00006056|Cyclosporine|cyclosporine|mesh-list
101321390|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
101321391|NCT00006056|Busulfan|busulfan|mesh-list
101321392|NCT00006056|Methotrexate|methotrexate|mesh-list
101321395|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101321396|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321397|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
101321398|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321400|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321401|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
101321402|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321403|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321404|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101321405|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101321406|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
101321407|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101321408|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321409|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
101321410|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
101321412|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101321413|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321414|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321416|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321417|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
101321418|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321419|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101321421|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101321422|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101321423|NCT00084370|Analgesics|analgesics|mesh-ancestor
101321424|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
101321425|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321426|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321427|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321428|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321429|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101321430|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101321432|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321433|NCT00084448|Celecoxib|celecoxib|mesh-list
101321434|NCT00084448|Paclitaxel|paclitaxel|mesh-list
101321435|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321436|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321437|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321438|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321439|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321440|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321441|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101321442|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101321443|NCT00084448|Analgesics|analgesics|mesh-ancestor
101321444|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
101321445|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321446|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321447|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321448|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321449|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101321450|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101321451|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321452|NCT00084565|Paclitaxel|paclitaxel|mesh-list
101321453|NCT00084565|Topotecan|topotecan|mesh-list
101321454|NCT00084565|Estramustine|estramustine|mesh-list
101321456|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321457|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321458|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321459|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321460|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321461|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321462|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321463|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321464|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321465|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
101321466|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101321467|NCT00084604|Bevacizumab|bevacizumab|mesh-list
101321468|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101321470|NCT00084604|Antibodies|antibodies|mesh-list
101321471|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
101321472|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101321473|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321474|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321475|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101321476|NCT00084604|Growth Substances|growth substances|mesh-ancestor
101321477|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321478|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
101321479|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
101321480|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321481|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321482|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321483|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321485|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
101321486|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321487|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
101321488|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321489|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321490|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
101321491|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321493|NCT00084721|Irinotecan|irinotecan|mesh-list
101321494|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321495|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321496|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321497|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321498|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321499|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101321500|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101321501|NCT00084721|Analgesics|analgesics|mesh-ancestor
101321502|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
101321503|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321504|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321505|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321506|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321507|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101321508|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101321509|NCT00084877|Irinotecan|irinotecan|mesh-list
101321510|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321511|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321512|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321514|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321517|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
101321518|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416315|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
101321519|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321520|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321522|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
101321523|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321524|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321525|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321526|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321527|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321528|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
101321529|NCT00085111|Bevacizumab|bevacizumab|mesh-list
101321530|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101321531|NCT00085111|Antibodies|antibodies|mesh-list
101321532|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
101321533|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101321534|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321535|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321536|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101321537|NCT00085111|Growth Substances|growth substances|mesh-ancestor
101321538|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321539|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
101321540|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
101321541|NCT00085150|Immunotoxins|immunotoxins|mesh-list
101321542|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
101330088|NCT01803555|Hormones|hormones|mesh-ancestor
101321543|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
101321544|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321545|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
101321546|NCT00400075|Azathioprine|azathioprine|mesh-list
101321547|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321548|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
101321549|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321550|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321551|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321552|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
101321553|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321554|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321555|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101321556|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
101321557|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321558|NCT00400114|Irinotecan|irinotecan|mesh-list
101321559|NCT00400114|Sunitinib|sunitinib|mesh-list
101321560|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321561|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321562|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321563|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321564|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321565|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101321566|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101321567|NCT00400114|Growth Substances|growth substances|mesh-ancestor
101321568|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321569|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
101321570|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321571|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101321572|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
101321573|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101321574|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
101321575|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321576|NCT00085228|Docetaxel|docetaxel|mesh-list
101321577|NCT00085228|Oblimersen|oblimersen|mesh-list
101321578|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321579|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321580|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321581|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321582|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321583|NCT00085306|Interferons|interferons|mesh-list
101321584|NCT00085306|Interferon-beta|interferon-beta|mesh-list
101321585|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321586|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
101321587|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321588|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
101321589|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321590|NCT00006077|Levodopa|levodopa|mesh-list
101321591|NCT00006077|Domperidone|domperidone|mesh-list
101321592|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101321593|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101321594|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
101321595|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321596|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321597|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321598|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
101321599|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
101321600|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321601|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101321602|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101321603|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
101321604|NCT04729348|Lenvatinib|lenvatinib|mesh-list
101321605|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321606|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321607|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101321608|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321609|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321611|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
101321612|NCT00085345|Melphalan|melphalan|mesh-list
101321613|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
101321614|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321615|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
101321616|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321617|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321618|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101321619|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321620|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
101321621|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321622|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
101321623|NCT00085345|Protective Agents|protective agents|mesh-ancestor
101321624|NCT00085345|Vitamins|vitamins|mesh-ancestor
101321625|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
101321626|NCT00085384|Interferons|interferons|mesh-list
101321627|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
101321628|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
101321629|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101321630|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321631|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
101321632|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321633|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
101321634|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321636|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321637|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101321638|NCT00006080|Protective Agents|protective agents|mesh-ancestor
101321639|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321640|NCT00085462|Aldesleukin|aldesleukin|mesh-list
101321641|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
101321642|NCT00085462|Fludarabine|fludarabine|mesh-list
101321643|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
101321644|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321645|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
101321646|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321647|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321648|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321649|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
101321650|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321651|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321652|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101416319|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321653|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321654|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
101321655|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321656|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321657|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
101321658|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321660|NCT00085501|Carboplatin|carboplatin|mesh-list
101321661|NCT00085501|Cetuximab|cetuximab|mesh-list
101321662|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321663|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321664|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321665|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321667|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321668|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321669|NCT00006083|Dalteparin|dalteparin|mesh-list
101321670|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
101321671|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101321672|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101321673|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321675|NCT00085579|Sargramostim|sargramostim|mesh-list
101321676|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
101321677|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321678|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321679|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321680|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321681|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
101321682|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321684|NCT00085696|Bortezomib|bortezomib|mesh-list
101321685|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321686|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321687|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
101321688|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321690|NCT00006086|Carboplatin|carboplatin|mesh-list
101321691|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321692|NCT04798638|Osimertinib|osimertinib|mesh-list
101321693|NCT04798638|Complement Factor H|complement factor h|mesh-list
101321694|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321695|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321696|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321697|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321698|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101321699|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321700|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
101321701|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321702|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101321703|NCT00006089|Trastuzumab|trastuzumab|mesh-list
101321704|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101321705|NCT00006089|Antibodies|antibodies|mesh-list
101321706|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
101321707|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101321708|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
101321709|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321710|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321711|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101321712|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
101321714|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101321715|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101321716|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321717|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321719|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101321720|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321721|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101321722|NCT00085969|Incretins|incretins|mesh-ancestor
101321723|NCT00085969|Hormones|hormones|mesh-ancestor
101321724|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101321725|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
101321727|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
101321728|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321729|NCT00086125|Sirolimus|sirolimus|mesh-list
101321730|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321731|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321732|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321733|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321734|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
101321735|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321736|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
101321737|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321738|NCT00086203|Rituximab|rituximab|mesh-list
101321739|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321740|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321741|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
101321742|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321743|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321744|NCT00006095|Irinotecan|irinotecan|mesh-list
101321745|NCT00006095|Vincristine|vincristine|mesh-list
101321746|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101321747|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321748|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321749|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321750|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321751|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321752|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321753|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321754|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321755|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101321756|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101321757|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101321758|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321759|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321760|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101321761|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101321762|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101321763|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
101321764|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101321765|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321766|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101321767|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101321768|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
101321769|NCT00086359|Ritonavir|ritonavir|mesh-list
101321770|NCT00086359|Lopinavir|lopinavir|mesh-list
101321771|NCT00086359|Lamivudine|lamivudine|mesh-list
101321772|NCT00086359|Zidovudine|zidovudine|mesh-list
101321773|NCT00086359|Abacavir|abacavir|mesh-list
101321774|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101321775|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101321776|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101321777|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
101321778|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321779|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321780|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321781|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321782|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
101321783|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321784|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101321785|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101321786|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101321787|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321789|NCT00006098|Bortezomib|bortezomib|mesh-list
101321790|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321791|NCT00086593|Lamotrigine|lamotrigine|mesh-list
101321792|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
101321793|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101321794|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101321795|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321796|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101321797|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321798|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101321799|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101321800|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101321801|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101321802|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101321803|NCT00387569|Vaccines|vaccines|mesh-list
101321804|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
101321805|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321806|NCT04784637|Insulin|insulin|mesh-list
101321807|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101321808|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321809|NCT00086632|Oregovomab|oregovomab|mesh-list
101321810|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321812|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
101321813|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101321814|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101321815|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321816|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321817|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321818|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
101321819|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321820|NCT00006104|Docetaxel|docetaxel|mesh-list
101321821|NCT00006104|Trastuzumab|trastuzumab|mesh-list
101321822|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321823|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321824|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321826|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321827|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321828|NCT00086827|Romidepsin|romidepsin|mesh-list
101321829|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321830|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321831|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101321832|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321833|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321834|NCT00086944|Rituximab|rituximab|mesh-list
101321835|NCT00086944|Carboplatin|carboplatin|mesh-list
101321836|NCT00086944|Etoposide|etoposide|mesh-list
101321837|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
101321838|NCT00086944|Ifosfamide|ifosfamide|mesh-list
101321839|NCT00086944|Oblimersen|oblimersen|mesh-list
101321840|NCT00086944|Lenograstim|lenograstim|mesh-list
101321841|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321842|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321843|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
101321844|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321845|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321846|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321847|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101321848|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321849|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321850|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321851|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101321852|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101321853|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
101321854|NCT00006107|Docetaxel|docetaxel|mesh-list
101321855|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321856|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321857|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321858|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321859|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321860|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
101321861|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321862|NCT00087100|Pemetrexed|pemetrexed|mesh-list
101321863|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321864|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321865|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321866|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101321867|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321868|NCT00006113|Interferons|interferons|mesh-list
101321869|NCT00006113|Aldesleukin|aldesleukin|mesh-list
101321870|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
101321871|NCT00006113|Interleukin-4|interleukin-4|mesh-list
101321872|NCT00006113|Sargramostim|sargramostim|mesh-list
101321873|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321874|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
101321875|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321876|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
101321877|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321878|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101321879|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101321880|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101321881|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321883|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321885|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321886|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321887|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321888|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321889|NCT00087256|Celecoxib|celecoxib|mesh-list
101321890|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101321891|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101321892|NCT00087256|Analgesics|analgesics|mesh-ancestor
101321893|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
101321894|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321895|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321896|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101321897|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101321898|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101321899|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101321900|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321901|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321902|NCT00006116|Gemcitabine|gemcitabine|mesh-list
101321903|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321904|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321905|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
101321906|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321908|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321909|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321910|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101321911|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321912|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321913|NCT04762953|Leucovorin|leucovorin|mesh-list
101321915|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101321916|NCT04762953|Fluorouracil|fluorouracil|mesh-list
101321917|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321918|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321919|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321920|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321921|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321922|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321924|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321925|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321926|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
101321927|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321928|NCT04762953|Antidotes|antidotes|mesh-ancestor
101321929|NCT04762953|Protective Agents|protective agents|mesh-ancestor
101321930|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
101321931|NCT04762953|Vitamins|vitamins|mesh-ancestor
101321932|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
101321933|NCT00087334|Capecitabine|capecitabine|mesh-list
101321934|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
101321935|NCT00087334|Gefitinib|gefitinib|mesh-list
101321936|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321937|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
101321938|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321939|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321940|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321941|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321942|NCT00087373|Metronidazole|metronidazole|mesh-list
101321943|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321944|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101321945|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101321946|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101321947|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
101321948|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321949|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
101321951|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321952|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101321953|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101321954|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321955|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101321956|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321957|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321958|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101321959|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
101321960|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321961|NCT00006122|Cytarabine|cytarabine|mesh-list
101321962|NCT00006122|Etoposide|etoposide|mesh-list
101321963|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
101321964|NCT00006122|Idarubicin|idarubicin|mesh-list
101321965|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
101321966|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321968|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101321969|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101321970|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101321971|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321972|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321973|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
101321974|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
101321975|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101321976|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101321977|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
101321978|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101321980|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
101330105|NCT00000491|Aspirin|aspirin|mesh-list
101321981|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101321982|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101321983|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101321984|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
101321985|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
101204418|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101321986|NCT00087802|Paclitaxel|paclitaxel|mesh-list
101321987|NCT00087802|Carboplatin|carboplatin|mesh-list
101321988|NCT00087802|Gemcitabine|gemcitabine|mesh-list
101321989|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
101321990|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101321991|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101321992|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101321993|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
101321994|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
101321995|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101321996|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101321997|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
101321998|NCT00006125|Doxorubicin|doxorubicin|mesh-list
101321999|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101322000|NCT00006125|Topotecan|topotecan|mesh-list
101322001|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322003|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101322004|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101322005|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322006|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322007|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101322008|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101322009|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322010|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322011|NCT00087880|Bupropion|bupropion|mesh-list
101322012|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101322013|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
101322014|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322015|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101322016|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322017|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322018|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322019|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
101322020|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548587|NCT00601562|Zidovudine|zidovudine|mesh-list
101322021|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322022|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101322023|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101322024|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322025|NCT00088036|Olanzapine|olanzapine|mesh-list
101322026|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
101322027|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
101322028|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322029|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322030|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322031|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322032|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322033|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322034|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322035|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322036|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322037|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322038|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322039|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322040|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
101322041|NCT00088075|Risperidone|risperidone|mesh-list
101322042|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101322043|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
101322044|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322045|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322046|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322047|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322048|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322049|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322050|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322051|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101322052|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
101322053|NCT00088114|Paclitaxel|paclitaxel|mesh-list
101322054|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322055|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322056|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322057|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322058|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322059|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322060|NCT00006131|Valacyclovir|valacyclovir|mesh-list
101322061|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
101322062|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322063|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
101322064|NCT00088231|Vatalanib|vatalanib|mesh-list
101322065|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322066|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322067|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322068|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322069|NCT00088270|Leucovorin|leucovorin|mesh-list
101322070|NCT00088270|Fluorouracil|fluorouracil|mesh-list
101322071|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
101322072|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322073|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322074|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322075|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322076|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
101322077|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322078|NCT00088270|Antidotes|antidotes|mesh-ancestor
101322079|NCT00088270|Protective Agents|protective agents|mesh-ancestor
101322080|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
101322081|NCT00088270|Vitamins|vitamins|mesh-ancestor
101322082|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
101322083|NCT00088387|Valproic Acid|valproic acid|mesh-list
101322084|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322085|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322086|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322088|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322089|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322090|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322091|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
101322092|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
101322093|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322094|NCT00088504|Interferons|interferons|mesh-list
101322095|NCT00088504|Ribavirin|ribavirin|mesh-list
101322096|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
101322097|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
101322098|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101322099|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322100|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
101322101|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322103|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322104|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
101322105|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322106|NCT00006137|Enalapril|enalapril|mesh-list
101322107|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101322108|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
101322109|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322110|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322111|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101322112|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
101322113|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101322114|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
101322115|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322116|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322118|NCT00088582|Pasireotide|pasireotide|mesh-list
101322119|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322120|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101322121|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322122|NCT00088582|Hormones|hormones|mesh-ancestor
101322123|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322124|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322125|NCT00088816|Tegafur|tegafur|mesh-list
101322126|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322127|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322128|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
101322129|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322130|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
101322131|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
101322132|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101322133|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101322134|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
101322135|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
101322136|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322137|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322138|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322139|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101322141|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101322142|NCT00088855|Bortezomib|bortezomib|mesh-list
101322143|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322144|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322145|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101322146|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101322147|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322148|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322149|NCT00088894|Bevacizumab|bevacizumab|mesh-list
101322150|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101322151|NCT00088894|Gemcitabine|gemcitabine|mesh-list
101322152|NCT00088894|Antibodies|antibodies|mesh-list
101322153|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
101322154|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101322155|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322156|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322157|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322158|NCT00088894|Growth Substances|growth substances|mesh-ancestor
101322159|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322160|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322161|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
101322162|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322163|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
101322164|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322166|NCT00006152|Amprenavir|amprenavir|mesh-list
101322167|NCT00006152|Abacavir|abacavir|mesh-list
101322168|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101322169|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101322170|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101322171|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322172|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322173|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101322174|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101322176|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322177|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101322178|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101322179|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101322180|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101322181|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101322182|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
101322183|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322185|NCT00088933|Docetaxel|docetaxel|mesh-list
101322187|NCT00088933|Sargramostim|sargramostim|mesh-list
101322189|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322190|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322191|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322192|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322193|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322194|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322195|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322196|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322197|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101322198|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101322199|NCT00089050|Cyclosporine|cyclosporine|mesh-list
101322200|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
101322201|NCT00089050|Cyclosporins|cyclosporins|mesh-list
101322202|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322203|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322204|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322205|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
101322206|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322207|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
101322208|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322209|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101322210|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322211|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101322212|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322213|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322214|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
101322215|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
101322216|NCT00006155|Carboplatin|carboplatin|mesh-list
101322217|NCT00006155|Semaxinib|semaxinib|mesh-list
101322218|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322219|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322220|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322221|NCT00006155|Growth Substances|growth substances|mesh-ancestor
101322222|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322223|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322224|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322225|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322226|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322227|NCT00089089|Decitabine|decitabine|mesh-list
101322228|NCT00089089|Azacitidine|azacitidine|mesh-list
101322229|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322231|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322232|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322233|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322234|NCT00089167|Thalidomide|thalidomide|mesh-list
101322235|NCT00089167|Dexamethasone|dexamethasone|mesh-list
101322236|NCT00089167|Melphalan|melphalan|mesh-list
101322237|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101322239|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
101322240|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322241|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322242|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322243|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
101322245|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322246|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101322247|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322248|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
101322249|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101322250|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
101322251|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322252|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101322253|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322254|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
101322255|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322256|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322257|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322258|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322259|NCT00089167|Growth Substances|growth substances|mesh-ancestor
101322260|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322261|NCT00089206|Sargramostim|sargramostim|mesh-list
101322262|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
101322263|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
101322264|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322266|NCT00400231|Metformin|metformin|mesh-list
101322267|NCT00400231|Fenofibrate|fenofibrate|mesh-list
101322268|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101322269|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322270|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101322271|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
101322272|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322273|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101322274|NCT00006158|Testosterone|testosterone|mesh-list
101322275|NCT00006158|Androgens|androgens|mesh-ancestor
101322276|NCT00006158|Hormones|hormones|mesh-ancestor
101322277|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322278|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322280|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
101322281|NCT00423826|Fludarabine|fludarabine|mesh-list
101322282|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
101322283|NCT00423826|Busulfan|busulfan|mesh-list
101322284|NCT00423826|Tacrolimus|tacrolimus|mesh-list
101548638|NCT01324388|Dulaglutide|dulaglutide|mesh-list
101322285|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322286|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322287|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
101322288|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322289|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322290|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
101322291|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322292|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
101322293|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322294|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101322295|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322296|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322297|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101322298|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
101322299|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322300|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
101322301|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101322302|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101322303|NCT00423865|Everolimus|everolimus|mesh-list
101322304|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322305|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101322306|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322307|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322308|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322309|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322310|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
101322311|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322312|NCT00423982|Vancomycin|vancomycin|mesh-list
101322313|NCT00423982|Rifampin|rifampin|mesh-list
101322314|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101322315|NCT00423982|Cloxacillin|cloxacillin|mesh-list
101322316|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
101322318|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
101322319|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
101322320|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101322322|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322323|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101322324|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101322325|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101322326|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101322327|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101322328|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101322329|NCT02965261|Fluoxetine|fluoxetine|mesh-list
101322330|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322331|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322332|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322333|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322334|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322335|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
101322336|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322337|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101322338|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
101322339|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322340|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101322341|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101322342|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322343|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
101322344|NCT00390156|Bevacizumab|bevacizumab|mesh-list
101322345|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
101322346|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322347|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
101322348|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322349|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322350|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101322351|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
101322352|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322353|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322354|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101322355|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322356|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322357|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322358|NCT00390156|Growth Substances|growth substances|mesh-ancestor
101322359|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322360|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322361|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322362|NCT00089401|Melphalan|melphalan|mesh-list
101322363|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101322364|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
101322365|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322366|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322367|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101322369|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
101322370|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322371|NCT00089440|Aripiprazole|aripiprazole|mesh-list
101322372|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
101322373|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322374|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322375|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322376|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322377|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322378|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
101322379|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
101322380|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322381|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322382|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101322383|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101322384|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
101322385|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101322387|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101322388|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101322390|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101322391|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101322392|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101322393|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322394|NCT00089557|Capsaicin|capsaicin|mesh-list
101322395|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
101322396|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
101322397|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
101322398|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322399|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322401|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322402|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322403|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322404|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322405|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
101322406|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322407|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
101322408|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322410|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322411|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322412|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101322413|NCT00089830|Protective Agents|protective agents|mesh-ancestor
101322414|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322415|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322416|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322417|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322418|NCT00089830|Growth Substances|growth substances|mesh-ancestor
101322419|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322420|NCT00089869|Olanzapine|olanzapine|mesh-list
101322421|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101322422|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
101322423|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
101322424|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322425|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322426|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322427|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322428|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322429|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322430|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322431|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322432|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322433|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322434|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322435|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322436|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
101322437|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101322438|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
101322439|NCT00006167|Oxandrolone|oxandrolone|mesh-list
101322441|NCT00006167|Hormones|hormones|mesh-ancestor
101322442|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322443|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322444|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
101322445|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
101322446|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101322447|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
101322448|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322449|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322450|NCT00090025|Leucovorin|leucovorin|mesh-list
101322451|NCT00090025|Fluorouracil|fluorouracil|mesh-list
101322452|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
101322453|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322454|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322455|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322456|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322457|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
101322458|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322459|NCT00090025|Antidotes|antidotes|mesh-ancestor
101322461|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
101322462|NCT00090025|Vitamins|vitamins|mesh-ancestor
101322463|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
101322464|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
101322465|NCT04633902|Olaparib|olaparib|mesh-list
101322466|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322467|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322468|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101322470|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101322471|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322472|NCT00090727|AQ4N|aq4n|mesh-list
101322473|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322474|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
101322475|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101322476|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322477|NCT00091039|Metronidazole|metronidazole|mesh-list
101322479|NCT00091039|Carboplatin|carboplatin|mesh-list
101322480|NCT00091039|Vaccines|vaccines|mesh-list
101322481|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101322482|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
101322483|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322484|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322485|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322486|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322487|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322488|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322489|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322490|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322491|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322492|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101322493|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101322494|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101322496|NCT00091078|Oblimersen|oblimersen|mesh-list
101322497|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322498|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322499|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322500|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322501|NCT00091117|Bortezomib|bortezomib|mesh-list
101322502|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322503|NCT00091156|Gefitinib|gefitinib|mesh-list
101322504|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322505|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322506|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322507|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322508|NCT00091195|Romidepsin|romidepsin|mesh-list
101322509|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322510|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322511|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101322512|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322513|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322514|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
101322515|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322516|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322517|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
101322518|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
101322519|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
101322520|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322523|NCT00091312|Irinotecan|irinotecan|mesh-list
101322524|NCT00091312|Calcium|calcium|mesh-list
101322525|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
101322526|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101322527|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322528|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
101322529|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322530|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322531|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322532|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322533|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
101322534|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101322535|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101322536|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322538|NCT00091312|Protective Agents|protective agents|mesh-ancestor
101322539|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
101322540|NCT00091312|Vitamins|vitamins|mesh-ancestor
101322541|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
101322542|NCT04619706|Palmidrol|palmidrol|mesh-list
101322543|NCT04619706|Analgesics|analgesics|mesh-ancestor
101322544|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
101322545|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322546|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322547|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101322548|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101322549|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101322550|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322551|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
101322552|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322553|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101322554|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101322555|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322556|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322558|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322559|NCT00091429|Ranolazine|ranolazine|mesh-list
101322560|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101322561|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322562|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322563|NCT00091468|Nicotine|nicotine|mesh-list
101322564|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101322565|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
101322566|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322567|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322568|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101322569|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101322570|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
101322571|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322572|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322573|NCT00006200|Thalidomide|thalidomide|mesh-list
101322574|NCT00006200|Dacarbazine|dacarbazine|mesh-list
101322575|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322577|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322578|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
101322579|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322580|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322581|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322582|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322583|NCT00006200|Growth Substances|growth substances|mesh-ancestor
101322584|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322585|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322586|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101322587|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
101322588|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322590|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101322591|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101322592|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322593|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
101322594|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322595|NCT00091624|Lenalidomide|lenalidomide|mesh-list
101322596|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
101322597|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322598|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322599|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322600|NCT00091624|Growth Substances|growth substances|mesh-ancestor
101322601|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322602|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322603|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101322604|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322605|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322606|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322607|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322608|NCT00006206|Naltrexone|naltrexone|mesh-list
101322610|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101322611|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101322612|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322613|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
101322614|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322615|NCT00091702|Vaccines|vaccines|mesh-list
101322616|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
101322617|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322618|NCT00091741|Etanercept|etanercept|mesh-list
101330136|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
101322619|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101322620|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101322621|NCT00091741|Analgesics|analgesics|mesh-ancestor
101322622|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
101322623|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322624|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322625|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101322626|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322627|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322628|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322629|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
101322630|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
101322631|NCT00091858|Hematinics|hematinics|mesh-ancestor
101322633|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101322634|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322635|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322636|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322637|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322638|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
101322639|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322640|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322641|NCT00091897|Rituximab|rituximab|mesh-list
101322642|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322643|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322644|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
101322645|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322646|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322647|NCT00006212|Vinblastine|vinblastine|mesh-list
101322648|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322649|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322650|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322651|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322652|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322653|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322655|NCT00091936|Efavirenz|efavirenz|mesh-list
101322656|NCT00091936|Didanosine|didanosine|mesh-list
101322657|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101322658|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101322659|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322660|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322661|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
101322662|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322663|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101322664|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101322665|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101322666|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101322667|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101322668|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101322669|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101322670|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101322671|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
101322672|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101322673|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101322674|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
101322675|NCT02972346|Hormones|hormones|mesh-ancestor
101322676|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322677|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322678|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322679|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322680|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
101322681|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
101322684|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101322685|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322686|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322687|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322688|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322691|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322692|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322693|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322694|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322695|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322696|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322697|NCT00092287|Lanreotide|lanreotide|mesh-list
101322698|NCT00092287|Octreotide|octreotide|mesh-list
101322699|NCT00092287|Somatostatin|somatostatin|mesh-list
101322700|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322701|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322702|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101322703|NCT00092287|Hormones|hormones|mesh-ancestor
101322704|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101322705|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322706|NCT00092326|Acetaminophen|acetaminophen|mesh-list
101322707|NCT00092326|Rofecoxib|rofecoxib|mesh-list
101322708|NCT00092326|Oxycodone|oxycodone|mesh-list
101322709|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101322710|NCT00092326|Analgesics|analgesics|mesh-ancestor
101322711|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
101322712|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322713|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322714|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
101322716|NCT00092326|Narcotics|narcotics|mesh-ancestor
101322717|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322718|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101322719|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101322721|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322722|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101322723|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101322725|NCT00092365|Celecoxib|celecoxib|mesh-list
101322726|NCT00092365|Rofecoxib|rofecoxib|mesh-list
101322727|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101322728|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101322730|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
101322731|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322732|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322733|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101322734|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322735|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101322736|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101322737|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322738|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322739|NCT00092404|Vaccines|vaccines|mesh-list
101322740|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
101322741|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322742|NCT04728880|Remdesivir|remdesivir|mesh-list
101322743|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
101322745|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
101322746|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322748|NCT00093028|Lenalidomide|lenalidomide|mesh-list
101322749|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322750|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
101322751|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322752|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322753|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322754|NCT00093028|Growth Substances|growth substances|mesh-ancestor
101322755|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322757|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322758|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322760|NCT00093184|Bivalirudin|bivalirudin|mesh-list
101322761|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
101322762|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101322763|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
101322764|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322765|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322767|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322768|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
101322769|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322770|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322771|NCT00093223|Paclitaxel|paclitaxel|mesh-list
101322772|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101322773|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322774|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322775|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322776|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322777|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322778|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322779|NCT00093262|Clevidipine|clevidipine|mesh-list
101322780|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101322781|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322782|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322783|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101322784|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322785|NCT00093301|Simendan|simendan|mesh-list
101322786|NCT00093301|Dobutamine|dobutamine|mesh-list
101322787|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101322788|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
101322789|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101322790|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101322791|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322792|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322793|NCT00093301|Protective Agents|protective agents|mesh-ancestor
101322794|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322796|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
101322797|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322798|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101322799|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101322800|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101322801|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
101322802|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322804|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322805|NCT00387608|Veliparib|veliparib|mesh-list
101322806|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101322807|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322808|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322809|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322810|NCT00093613|Sorafenib|sorafenib|mesh-list
101322811|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322812|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322813|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322814|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322815|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
101322816|NCT00093652|Gefitinib|gefitinib|mesh-list
101322817|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322818|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322819|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322820|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322821|NCT00006230|Rubitecan|rubitecan|mesh-list
101322822|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322823|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101322824|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101322825|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322826|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322827|NCT00093769|Rituximab|rituximab|mesh-list
101322828|NCT00093769|Bortezomib|bortezomib|mesh-list
101322829|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101322830|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322832|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322833|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322834|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101322835|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322836|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322837|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322838|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322839|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322840|NCT00006233|Cyclosporine|cyclosporine|mesh-list
101322841|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
101322842|NCT00006233|Fludarabine|fludarabine|mesh-list
101322843|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
101322844|NCT00006233|Cyclosporins|cyclosporins|mesh-list
101322845|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322846|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322848|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322849|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322850|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
101322851|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322852|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322853|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
101322854|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322855|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
101322856|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101322857|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101322858|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101322859|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101322860|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
101204419|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
101322861|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322862|NCT02964715|Empagliflozin|empagliflozin|mesh-list
101322863|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101322864|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322866|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322867|NCT00093886|Clevidipine|clevidipine|mesh-list
101322868|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
101322869|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
101322870|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101322871|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322872|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322873|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101322874|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322875|NCT00093925|Nicardipine|nicardipine|mesh-list
101322876|NCT00093925|Clevidipine|clevidipine|mesh-list
101322877|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101322878|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322879|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322880|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101322881|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322882|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101322883|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
101322885|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101322886|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322887|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
101322888|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
101322889|NCT00094003|Poly I-C|poly i-c|mesh-list
101322890|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
101322891|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322892|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
101322893|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
101322894|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322895|NCT00094081|Tirapazamine|tirapazamine|mesh-list
101322896|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322897|NCT00094120|Squalamine|squalamine|mesh-list
101322898|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101322899|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101322900|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101322901|NCT00094120|Protective Agents|protective agents|mesh-ancestor
101322902|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322903|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322904|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101322905|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101322906|NCT00094120|Growth Substances|growth substances|mesh-ancestor
101322907|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322909|NCT00006245|Alvocidib|alvocidib|mesh-list
101322910|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322911|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322912|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322913|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322914|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322915|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322916|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
101322917|NCT00006245|Growth Substances|growth substances|mesh-ancestor
101322918|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322919|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101322920|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322922|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
101322923|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
101322924|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322925|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322926|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
101322927|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322928|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101322929|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101322930|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322931|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322932|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322934|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322935|NCT00094432|Aripiprazole|aripiprazole|mesh-list
101322936|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
101322937|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322938|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322939|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322940|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322941|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322942|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
101322943|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
101322944|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322945|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322946|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101322947|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101322948|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
101322949|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101322950|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101322951|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101322952|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101322953|NCT00006248|Paclitaxel|paclitaxel|mesh-list
101322954|NCT00006248|Fluorouracil|fluorouracil|mesh-list
101322955|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101322956|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101322957|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
101322958|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
101322959|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
101322960|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322961|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
101322962|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101322963|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101322964|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
101330161|NCT00029497|Analgesics|analgesics|mesh-ancestor
101322965|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322966|NCT00094549|Valproic Acid|valproic acid|mesh-list
101322967|NCT00094549|Olanzapine|olanzapine|mesh-list
101322968|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
101322969|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
101322970|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322971|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322972|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101322973|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101322974|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101322975|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101322976|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101322977|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101322978|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101322979|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101322980|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322981|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322982|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
101322983|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
101322984|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101322985|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
101322986|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
101322987|NCT00094627|Gaboxadol|gaboxadol|mesh-list
101322989|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
101322990|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101322991|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101322992|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
101322993|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
101322994|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
101322995|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322996|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101322997|NCT00094666|Gaboxadol|gaboxadol|mesh-list
101322998|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101322999|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323000|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323001|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323002|NCT00094666|Analgesics|analgesics|mesh-ancestor
101323003|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
101323004|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
101323005|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
101323007|NCT00006251|Cyclosporine|cyclosporine|mesh-list
101323008|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
101323009|NCT00006251|Fludarabine|fludarabine|mesh-list
101323010|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
101323011|NCT00006251|Cyclosporins|cyclosporins|mesh-list
101323012|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323013|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323014|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
101323015|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323016|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323017|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
101323018|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323019|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323020|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
101323021|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323022|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323023|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323024|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101323025|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323026|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101323027|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
101323028|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323029|NCT00094978|Alvocidib|alvocidib|mesh-list
101323030|NCT00094978|Romidepsin|romidepsin|mesh-list
101323031|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323032|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323033|NCT00094978|Growth Substances|growth substances|mesh-ancestor
101323034|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323035|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101323036|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323037|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323038|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323039|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101323040|NCT00095134|Risperidone|risperidone|mesh-list
101323041|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101323042|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
101323043|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323044|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323045|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323046|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101323047|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101323048|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323049|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101323050|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101323051|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
101323052|NCT00006257|Paclitaxel|paclitaxel|mesh-list
101323053|NCT00006257|Semaxinib|semaxinib|mesh-list
101323054|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323055|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323056|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323057|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323058|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323059|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323060|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323061|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323062|NCT00006257|Growth Substances|growth substances|mesh-ancestor
101323063|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323065|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101323066|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323067|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
101323068|NCT00095251|Lorazepam|lorazepam|mesh-list
101323069|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101323070|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323071|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323072|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101323074|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
101323075|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323076|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101323077|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101323078|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101323079|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
101323080|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323081|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323082|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
101323083|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
101323084|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
101323085|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101323087|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101323088|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101323089|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
101323090|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
101323092|NCT00006260|Ifosfamide|ifosfamide|mesh-list
101323093|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323094|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323095|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323096|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323097|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323098|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323099|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323100|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
101323102|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323103|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323104|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323105|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323106|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
101323107|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323108|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
101330171|NCT00000494|Indomethacin|indomethacin|mesh-list
101323109|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323110|NCT00095368|Amoxicillin|amoxicillin|mesh-list
101323111|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323112|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323113|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
101323114|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323116|NCT00006263|Carboplatin|carboplatin|mesh-list
101323117|NCT00006263|Temozolomide|temozolomide|mesh-list
101323118|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323119|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323120|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
101323121|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323123|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
101323125|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101323126|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101323127|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323128|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323129|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
101323130|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
101323131|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323132|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323133|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101323134|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101323135|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
101323136|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101323137|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101323138|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101323139|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101323141|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323142|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
101323143|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323144|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323145|NCT00006269|Irinotecan|irinotecan|mesh-list
101323146|NCT00006269|Octreotide|octreotide|mesh-list
101323147|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101323148|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323149|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323150|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323151|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323152|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101323153|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101323154|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101323155|NCT04476030|Citalopram|citalopram|mesh-list
101323156|NCT04476030|Sertraline|sertraline|mesh-list
101323157|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101323158|NCT04476030|Escitalopram|escitalopram|mesh-list
101323159|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101323160|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101323161|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101323162|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323163|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323164|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
101323165|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323166|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323167|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101323168|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
101323170|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101323171|NCT04476030|Analgesics|analgesics|mesh-ancestor
101323172|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
101323173|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
101323174|NCT00095680|Bortezomib|bortezomib|mesh-list
101323175|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323176|NCT00095719|Aripiprazole|aripiprazole|mesh-list
101323177|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
101323178|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101323179|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101323180|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101323181|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330174|NCT00000494|Analgesics|analgesics|mesh-ancestor
101323182|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323183|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
101323184|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
101323185|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323186|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323187|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101323188|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101323189|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
101323190|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101323191|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101323192|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101323193|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101323194|NCT00095758|Aripiprazole|aripiprazole|mesh-list
101323195|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
101323196|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101323197|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101323198|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101323199|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323200|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323201|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
101323202|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
101323203|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323204|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323205|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101323206|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101323207|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
101323208|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101323209|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101323210|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101323211|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101323213|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101323214|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323215|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323216|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323217|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323218|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323219|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323220|NCT04432428|Sufentanil|sufentanil|mesh-list
101323221|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101323222|NCT04432428|Narcotics|narcotics|mesh-ancestor
101323223|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323224|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323225|NCT04432428|Analgesics|analgesics|mesh-ancestor
101323226|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
101323227|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323229|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101323230|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
101323231|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
101323232|NCT00096070|Gemcitabine|gemcitabine|mesh-list
101323233|NCT00096070|Fluorouracil|fluorouracil|mesh-list
101323234|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
101323235|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323236|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
101323237|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323238|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323239|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323240|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
101323241|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323242|NCT00006275|Calcitriol|calcitriol|mesh-list
101323243|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101323244|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323245|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101323246|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101323247|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323248|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101323249|NCT00006275|Vitamins|vitamins|mesh-ancestor
101323250|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
101323251|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101323253|NCT00096148|Bevacizumab|bevacizumab|mesh-list
101323254|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101323256|NCT00096148|Antibodies|antibodies|mesh-list
101323258|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101323259|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323260|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323261|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323262|NCT00096148|Growth Substances|growth substances|mesh-ancestor
101323263|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323265|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
101323266|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323268|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323269|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
101323270|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323271|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323272|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323273|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323274|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323275|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323276|NCT00096187|Pemetrexed|pemetrexed|mesh-list
101323277|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323278|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323279|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323280|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101323281|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101323282|NCT00096304|Docetaxel|docetaxel|mesh-list
101323283|NCT00096304|Epirubicin|epirubicin|mesh-list
101323284|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323285|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323286|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323288|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323290|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323291|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323292|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323294|NCT00096343|Carboplatin|carboplatin|mesh-list
101323295|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323296|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323297|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323299|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323300|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323302|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101323303|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
101323304|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323305|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323306|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101323307|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
101323308|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
101323309|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101323310|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101323311|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101323312|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101323313|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101323314|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323315|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323316|NCT00096655|Infliximab|infliximab|mesh-list
101323317|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101323318|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323319|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323320|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101323321|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323322|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
101323323|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101323324|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
101323325|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101323326|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323327|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101323328|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101323329|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101323331|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101323332|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101323333|NCT00006299|Analgesics|analgesics|mesh-ancestor
101323334|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
101323335|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323336|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323337|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323338|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323339|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101323340|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101323341|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323342|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323343|NCT00096811|Entecavir|entecavir|mesh-list
101323344|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
101323345|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323346|NCT00096850|Ritonavir|ritonavir|mesh-list
101323347|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101323348|NCT00096850|Rifampin|rifampin|mesh-list
101323349|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101323350|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101323351|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
101323352|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323353|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323354|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323355|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323356|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
101323357|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323358|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101323359|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101323360|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101323361|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
101323362|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323363|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
101323364|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101323365|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101323366|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101323367|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101323368|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101323369|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101323370|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101323372|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101323373|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323374|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323375|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323376|NCT00096967|Growth Substances|growth substances|mesh-ancestor
101323377|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323378|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323381|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323382|NCT00097045|Interferons|interferons|mesh-list
101323383|NCT00097045|Ribavirin|ribavirin|mesh-list
101323384|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
101323385|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323386|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
101323387|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323388|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
101323389|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323390|NCT00097084|Insulin|insulin|mesh-list
101323391|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101323392|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
101323393|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
101323394|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
101323395|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323396|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323398|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101323399|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323400|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101323401|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323402|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
101323403|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323404|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
101323405|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323406|NCT00097123|Misoprostol|misoprostol|mesh-list
101323407|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101323408|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
101323409|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101323410|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323411|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101323412|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101323413|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
101323414|NCT00097279|Metformin|metformin|mesh-list
101323415|NCT00097279|Pioglitazone|pioglitazone|mesh-list
101323416|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
101323417|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
101323418|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323419|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323420|NCT00390273|Metformin|metformin|mesh-list
101323421|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323422|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323423|NCT00097318|Interferons|interferons|mesh-list
101323424|NCT00097318|Interferon-beta|interferon-beta|mesh-list
101323425|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
101323426|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323427|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
101323428|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323429|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
101323430|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323431|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101323432|NCT00097435|Ribavirin|ribavirin|mesh-list
101323433|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
101323434|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323435|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
101323436|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323437|NCT00006326|Ritonavir|ritonavir|mesh-list
101323438|NCT00006326|Indinavir|indinavir|mesh-list
101323439|NCT00006326|Delavirdine|delavirdine|mesh-list
101323440|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101323441|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101323442|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
101323443|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323444|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323445|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323446|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323447|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
101323448|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323449|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101323450|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101323451|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101323452|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101323453|NCT00390312|Morphine|morphine|mesh-list
101323454|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101323455|NCT00390312|Narcotics|narcotics|mesh-ancestor
101323456|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323457|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323458|NCT00390312|Analgesics|analgesics|mesh-ancestor
101323459|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
101323460|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323461|NCT00400387|Riboflavin|riboflavin|mesh-list
101323462|NCT00400387|Thiamine|thiamine|mesh-list
101323463|NCT00400387|Pyridoxine|pyridoxine|mesh-list
101323464|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
101323465|NCT00400387|Folic Acid|folic acid|mesh-list
101323466|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
101323467|NCT00400387|Tocopherols|tocopherols|mesh-list
101323468|NCT00400387|Vitamin E|vitamin e|mesh-list
101323469|NCT00400387|Tocotrienols|tocotrienols|mesh-list
101323470|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
101323471|NCT00400387|Heparin|heparin|mesh-list
101323472|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101323473|NCT00400387|Tinzaparin|tinzaparin|mesh-list
101323474|NCT00400387|Dalteparin|dalteparin|mesh-list
101323475|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323476|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
101323477|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101323478|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101323479|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323480|NCT00400387|Vitamins|vitamins|mesh-ancestor
101323481|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
101323482|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101323483|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323485|NCT00400387|Protective Agents|protective agents|mesh-ancestor
101323486|NCT00400387|Hematinics|hematinics|mesh-ancestor
101323487|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101323488|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
101323489|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
101323490|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323491|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323492|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323493|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323494|NCT00006332|Growth Substances|growth substances|mesh-ancestor
101323495|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323496|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323497|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323499|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
101323500|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101323501|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101323502|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101323503|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323504|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323505|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
101323506|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101323507|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323508|NCT00097903|Camptothecin|camptothecin|mesh-list
101323509|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323510|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323511|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101323512|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323513|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323514|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323515|NCT00097942|Memantine|memantine|mesh-list
101323516|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101323517|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101323518|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
101323519|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101323520|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323521|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323522|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101323523|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101323524|NCT04294836|Curcumin|curcumin|mesh-list
101323525|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101323527|NCT04294836|Analgesics|analgesics|mesh-ancestor
101323528|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
101323529|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323530|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323531|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323532|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323533|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323534|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330193|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323535|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323536|NCT00098137|Olmesartan|olmesartan|mesh-list
101323537|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101323538|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101323539|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101323540|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323541|NCT00098488|Rituximab|rituximab|mesh-list
101323542|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101323543|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323544|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
101323546|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323547|NCT00098527|Romidepsin|romidepsin|mesh-list
101323548|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323549|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323550|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101323551|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323552|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323553|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101323555|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
101323556|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101323557|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
101323558|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323559|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323560|NCT00098605|Lapatinib|lapatinib|mesh-list
101323561|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323562|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101323563|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323564|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323565|NCT00098683|Amifostine|amifostine|mesh-list
101323566|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101323567|NCT00098683|Protective Agents|protective agents|mesh-ancestor
101323568|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323569|NCT00098800|Fenretinide|fenretinide|mesh-list
101323570|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323571|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101323572|NCT00098800|Protective Agents|protective agents|mesh-ancestor
101323573|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323575|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323576|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101323577|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323578|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323579|NCT00098917|Vaccines|vaccines|mesh-list
101323580|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
101323581|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323582|NCT00098995|Tirapazamine|tirapazamine|mesh-list
101323583|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323584|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
101323585|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323586|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101323587|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101323588|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528358|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101323589|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323590|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
101323591|NCT00099502|Interferons|interferons|mesh-list
101323592|NCT00099502|Interferon-beta|interferon-beta|mesh-list
101323593|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
101323594|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
101323595|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323596|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
101323597|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323599|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323600|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101323601|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323602|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323603|NCT00387920|Sunitinib|sunitinib|mesh-list
101323604|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323605|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323606|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323607|NCT00387920|Growth Substances|growth substances|mesh-ancestor
101323608|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323609|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323610|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101323611|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323612|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323613|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
101323614|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101323615|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323616|NCT02888067|Bromides|bromides|mesh-list
101323617|NCT02888067|Rocuronium|rocuronium|mesh-list
101323618|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
101323619|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101323620|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101323621|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101323622|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323623|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323625|NCT00006350|Tacrolimus|tacrolimus|mesh-list
101323626|NCT00006350|Daclizumab|daclizumab|mesh-list
101323627|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323628|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
101323629|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323630|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101323631|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323632|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323633|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323634|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323635|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101323636|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
101323637|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323638|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323639|NCT00400582|Candesartan|candesartan|mesh-list
101323640|NCT00400582|Candesartan cilexetil|candesartan cilexetil|mesh-list
101323641|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101323642|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101323643|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101323644|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323645|NCT00400621|Acetaminophen|acetaminophen|mesh-list
101323647|NCT00400621|Analgesics|analgesics|mesh-ancestor
101323648|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
101323649|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323650|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323651|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
101323652|NCT00006353|Temozolomide|temozolomide|mesh-list
101323653|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323654|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
101323655|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323656|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323657|NCT00400738|Ritonavir|ritonavir|mesh-list
101323658|NCT00400738|Lopinavir|lopinavir|mesh-list
101323659|NCT00400738|Saquinavir|saquinavir|mesh-list
101323660|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101323661|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101323662|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
101323663|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528359|NCT04628325|Furosemide|furosemide|mesh-list
101323664|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323665|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323666|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323667|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
101323668|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323669|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101323670|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101323672|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323673|NCT00099619|Insulin|insulin|mesh-list
101323674|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101323675|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
101323676|NCT00099619|Exenatide|exenatide|mesh-list
101323677|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323678|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323679|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101323680|NCT00099619|Incretins|incretins|mesh-ancestor
101323681|NCT00099619|Hormones|hormones|mesh-ancestor
101323682|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323683|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
101323684|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323685|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323686|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323687|NCT00099736|Cyclosporine|cyclosporine|mesh-list
101323688|NCT00099736|Cyclosporins|cyclosporins|mesh-list
101323689|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101323690|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
101323691|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323692|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323693|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323694|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323695|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323696|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
101323697|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323698|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323699|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101323700|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101323701|NCT04143711|Paclitaxel|paclitaxel|mesh-list
101323702|NCT04143711|Nivolumab|nivolumab|mesh-list
101323703|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323704|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323705|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323706|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323707|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323708|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323709|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101323710|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101323711|NCT00099775|Caspofungin|caspofungin|mesh-list
101323712|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
101323713|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323714|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323715|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323716|NCT00006362|Bortezomib|bortezomib|mesh-list
101323717|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323718|NCT00099892|Vildagliptin|vildagliptin|mesh-list
101323719|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323720|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323721|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101323722|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
101323723|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323724|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323725|NCT00099931|Vildagliptin|vildagliptin|mesh-list
101323726|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101323727|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323728|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101323729|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
101323730|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323731|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323733|NCT00099970|Volociximab|volociximab|mesh-list
101323734|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323735|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
101323736|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323737|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323738|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101323739|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101323740|NCT00099970|Growth Substances|growth substances|mesh-ancestor
101323741|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323742|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323743|NCT00100009|Triamcinolone|triamcinolone|mesh-list
101323744|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101323745|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101323746|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101323747|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323748|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
101323749|NCT00100009|Hormones|hormones|mesh-ancestor
101323750|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323751|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323752|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323753|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
101323754|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323755|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323756|NCT00100126|Amoxicillin|amoxicillin|mesh-list
101323757|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323758|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323759|NCT00100243|Abarelix|abarelix|mesh-list
101323760|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323761|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323762|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323763|NCT04071756|Tazarotene|tazarotene|mesh-list
101323764|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323765|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
101323766|NCT00006368|Edotreotide|edotreotide|mesh-list
101323767|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101323768|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323769|NCT00100477|Etoposide|etoposide|mesh-list
101323770|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
101323771|NCT00100477|Topotecan|topotecan|mesh-list
101323772|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323773|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323774|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323775|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323776|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323777|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323778|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101323779|NCT00100477|Analgesics|analgesics|mesh-ancestor
101323780|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
101323781|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323782|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323783|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
101323784|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101323785|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323786|NCT00006371|Ketoconazole|ketoconazole|mesh-list
101323787|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
101323788|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101323789|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101323790|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101323791|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
101323792|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323793|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
101323794|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323795|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101323796|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101323797|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323798|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323799|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101323800|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323801|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323802|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323803|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101323804|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101323805|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323806|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101323807|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101323808|NCT04062708|Durvalumab|durvalumab|mesh-list
101323809|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101323810|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323811|NCT00100594|Lamivudine|lamivudine|mesh-list
101323812|NCT00100594|Zidovudine|zidovudine|mesh-list
101323813|NCT00100594|Efavirenz|efavirenz|mesh-list
101323814|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101323815|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101323816|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101323818|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323819|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
101323820|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323821|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323822|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323824|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101323825|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101323826|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101323827|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101323828|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101323829|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101323830|NCT00006374|Paclitaxel|paclitaxel|mesh-list
101323831|NCT00006374|Etoposide|etoposide|mesh-list
101323832|NCT00006374|Topotecan|topotecan|mesh-list
101323833|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323834|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323835|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323836|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323837|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323838|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323839|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323840|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323841|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323842|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101323844|NCT00100750|Tipifarnib|tipifarnib|mesh-list
101323845|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323846|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
101323847|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323848|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323849|NCT00006377|Paclitaxel|paclitaxel|mesh-list
101323851|NCT00006377|Doxorubicin|doxorubicin|mesh-list
101323852|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101323853|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323854|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323855|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323856|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323857|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323858|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323859|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101323860|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101323861|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101323862|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323863|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
101323864|NCT01350102|Bacitracin|bacitracin|mesh-list
101323865|NCT01350102|Vitamins|vitamins|mesh-ancestor
101323866|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
101323867|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323868|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
101323869|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323870|NCT01350102|Protective Agents|protective agents|mesh-ancestor
101323871|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101323872|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323873|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101323874|NCT00424060|Sagopilone|sagopilone|mesh-list
101323875|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323876|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101323877|NCT00006380|Antibodies|antibodies|mesh-list
101323878|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
101323879|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101323880|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
101323881|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323882|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323883|NCT00100906|Aldesleukin|aldesleukin|mesh-list
101323884|NCT00100906|Interleukin-2|interleukin-2|mesh-list
101323885|NCT00100906|Tretinoin|tretinoin|mesh-list
101323886|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323887|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101323888|NCT00100906|Analgesics|analgesics|mesh-ancestor
101323889|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
101323890|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323891|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323892|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323893|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101323894|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
101323895|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323896|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
101323897|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323899|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323900|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101323901|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323902|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323903|NCT00006383|Vincristine|vincristine|mesh-list
101323904|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101323905|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323906|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
101323907|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323908|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323909|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323910|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
101323911|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101323912|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101323913|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323914|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101323916|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
101323917|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101323919|NCT00101062|Letrozole|letrozole|mesh-list
101323920|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323921|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101323922|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101323923|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323924|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323925|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101323926|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
101323927|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101323928|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323929|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101323930|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101323931|NCT00101062|Analgesics|analgesics|mesh-ancestor
101323932|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
101323933|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323934|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323935|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101323936|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101323937|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101323939|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323940|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
101323941|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323942|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323943|NCT00101140|Fludarabine|fludarabine|mesh-list
101323944|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
101323945|NCT00101140|Thiotepa|thiotepa|mesh-list
101323946|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101323947|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
101323948|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323949|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323951|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323952|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101323953|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
101323954|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323955|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323956|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
101323957|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101323958|NCT00101179|Azacitidine|azacitidine|mesh-list
101323959|NCT00101179|Entinostat|entinostat|mesh-list
101323960|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101323961|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101323962|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
101323963|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323964|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323965|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101323966|NCT00400777|Amlodipine|amlodipine|mesh-list
101323967|NCT00400777|Valsartan|valsartan|mesh-list
101323968|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101323969|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101323970|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101323971|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101323972|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323973|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101323974|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323975|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
101323976|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101323977|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101323979|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
101323980|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101323981|NCT00400816|Temozolomide|temozolomide|mesh-list
101323982|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101323983|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
101323984|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101323985|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323986|NCT00400855|Fluticasone|fluticasone|mesh-list
101323987|NCT00400855|Xhance|xhance|mesh-list
101323988|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101323989|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101323990|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
101323991|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101323992|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323993|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101323994|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
101323995|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323996|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101323997|NCT00101296|Tipifarnib|tipifarnib|mesh-list
101323998|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323999|NCT00006398|Timolol|timolol|mesh-list
101324000|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324001|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101324002|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101324003|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
101324004|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324005|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324006|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101324007|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101324009|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101324010|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324011|NCT00101335|Analgesics|analgesics|mesh-ancestor
101324012|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
101324013|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324014|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324015|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324016|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324017|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101324018|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101324019|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324020|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324021|NCT00101374|Leflunomide|leflunomide|mesh-list
101324022|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324023|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324024|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324025|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
101324026|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324027|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
101324028|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101324029|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
101324030|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324031|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324032|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101324033|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
101324034|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101324035|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
101324036|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324037|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324038|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101324039|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
101324040|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
101324041|NCT00006401|Protective Agents|protective agents|mesh-ancestor
101324043|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
101324044|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101324045|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101324046|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101324047|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324048|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324049|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
101324050|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
101324051|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324052|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324053|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101324054|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101324056|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101324057|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101324058|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101324059|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101324061|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101324062|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101324063|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101324064|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324065|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
101324066|NCT00101764|Hormones|hormones|mesh-ancestor
101324067|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324068|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324069|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324070|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
101324071|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324072|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324073|NCT00101803|Vildagliptin|vildagliptin|mesh-list
101324075|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324076|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101324077|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324078|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324079|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324080|NCT00101842|Gemcitabine|gemcitabine|mesh-list
101324082|NCT00101842|Cisplatin|cisplatin|mesh-list
101324083|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324084|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
101324085|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324086|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324087|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324088|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101324089|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324090|NCT00102115|Talaporfin|talaporfin|mesh-list
101324091|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324092|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101324093|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324094|NCT00102154|Gaboxadol|gaboxadol|mesh-list
101324095|NCT00102154|Analgesics|analgesics|mesh-ancestor
101324096|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
101324097|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324098|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324099|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
101324100|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
101548687|NCT01095835|Lamivudine|lamivudine|mesh-list
101324101|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
101324102|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324103|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324104|NCT00102271|Oxypurinol|oxypurinol|mesh-list
101324105|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324106|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324108|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101324109|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528360|NCT04628325|Diuretics|diuretics|mesh-ancestor
101324110|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324111|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
101324112|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324113|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324114|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324115|NCT00102388|Vildagliptin|vildagliptin|mesh-list
101324116|NCT00102388|Gliclazide|gliclazide|mesh-list
101324117|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324118|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324119|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101324120|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324121|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324122|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324123|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
101324124|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324125|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101324126|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324127|NCT00102583|Cyclosporine|cyclosporine|mesh-list
101324128|NCT00102583|Cyclosporins|cyclosporins|mesh-list
101324129|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324130|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324132|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
101324133|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324134|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
101324135|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324136|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324137|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324138|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101324139|NCT00102622|Paclitaxel|paclitaxel|mesh-list
101324140|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101324141|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324142|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
101324143|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
101324144|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324145|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324146|NCT00006428|Amitriptyline|amitriptyline|mesh-list
101324147|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101324148|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
101324149|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101324150|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324151|NCT00006428|Analgesics|analgesics|mesh-ancestor
101324152|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
101324153|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324154|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324155|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101324156|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101324157|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101324158|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324159|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
101324160|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324161|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
101324162|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101324163|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324165|NCT00102700|Gemcitabine|gemcitabine|mesh-list
101324166|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324167|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
101324168|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324169|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324170|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324171|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101324172|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324173|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324174|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
101324175|NCT00102778|Ritonavir|ritonavir|mesh-list
101324176|NCT00102778|Lopinavir|lopinavir|mesh-list
101324177|NCT00102778|Aplaviroc|aplaviroc|mesh-list
101324178|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101324179|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101324180|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324181|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324182|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324183|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101324184|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101324185|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
101324186|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324187|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101324188|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101324189|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101324190|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101324192|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324193|NCT00102856|Pramipexole|pramipexole|mesh-list
101324195|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
101324196|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324197|NCT00102856|Protective Agents|protective agents|mesh-ancestor
101324198|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324199|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101324200|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101324201|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
101324202|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
101324203|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324204|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101324205|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324206|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
101324207|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101324208|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
101324209|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101324210|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101324211|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324212|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101324213|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101324214|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
101324215|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324216|NCT00006443|Lamivudine|lamivudine|mesh-list
101324217|NCT00006443|Stavudine|stavudine|mesh-list
101324218|NCT00006443|Nelfinavir|nelfinavir|mesh-list
101324219|NCT00006443|Indinavir|indinavir|mesh-list
101324220|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101324221|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324222|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324223|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324224|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
101324225|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324226|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101324227|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101324228|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101324229|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101324230|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324231|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
101324232|NCT00102973|Carboplatin|carboplatin|mesh-list
101324233|NCT00102973|Doxorubicin|doxorubicin|mesh-list
101324234|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101324235|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324236|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101324237|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101324238|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324239|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324240|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324242|NCT00103051|Gefitinib|gefitinib|mesh-list
101324243|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324244|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324245|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
101324246|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324247|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324248|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324249|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
101324250|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324251|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324252|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324253|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324255|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
101324256|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324257|NCT00103246|Silicon|silicon|mesh-list
101324258|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
101324259|NCT00103246|Trace Elements|trace elements|mesh-ancestor
101324260|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
101324261|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324262|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
101324263|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101324264|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101324265|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324267|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101324268|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324269|NCT00103324|Lapatinib|lapatinib|mesh-list
101324270|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324271|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324272|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324273|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324274|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
101324276|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324277|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324278|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
101324279|NCT00103597|Domperidone|domperidone|mesh-list
101324280|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
101324281|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
101324282|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324283|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324284|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204420|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324285|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101324286|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
101324287|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324288|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324289|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324291|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101324292|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101324293|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324294|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
101324295|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324296|NCT00103753|Deferiprone|deferiprone|mesh-list
101324297|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101324298|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
101324299|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
101324300|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324301|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
101324302|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324303|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101324304|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324306|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
101324307|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324308|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
101324309|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324310|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324311|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101324313|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324314|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324315|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101324316|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101324317|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101324318|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
101324319|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101324320|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324321|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324322|NCT00103948|Donepezil|donepezil|mesh-list
101324323|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101324324|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324325|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324326|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
101324327|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324328|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324329|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
101324330|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101324331|NCT00006458|Antibodies|antibodies|mesh-list
101324332|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
101324333|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101324334|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
101528361|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
101324335|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324336|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324338|NCT03879408|Naproxen|naproxen|mesh-list
101324339|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101324340|NCT03879408|Hydrocodone|hydrocodone|mesh-list
101324341|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324342|NCT03879408|Analgesics|analgesics|mesh-ancestor
101324343|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
101324344|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324345|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324346|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
101324347|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101324348|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324349|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324350|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
101324351|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101324352|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324353|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324354|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101324355|NCT03879408|Narcotics|narcotics|mesh-ancestor
101324356|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324358|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101324359|NCT00104182|Insulin|insulin|mesh-list
101324360|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101324361|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
101324362|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
101324363|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
101324364|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
101324365|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324366|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324367|NCT00104260|Verapamil|verapamil|mesh-list
101324368|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101324369|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101324370|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101324371|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324372|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101324373|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324374|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
101324375|NCT00388076|Paclitaxel|paclitaxel|mesh-list
101324376|NCT00388076|Carboplatin|carboplatin|mesh-list
101324377|NCT00388076|Lapatinib|lapatinib|mesh-list
101324378|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101324379|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324380|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
101324381|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
101324382|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324383|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324384|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324385|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324386|NCT00104689|Capecitabine|capecitabine|mesh-list
101324387|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
101324388|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324389|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
101324390|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324391|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324392|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
101324393|NCT00006461|Etoposide|etoposide|mesh-list
101324394|NCT00006461|Vincristine|vincristine|mesh-list
101324395|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
101324396|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324397|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
101324398|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324399|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324400|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101324401|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
101324402|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324403|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324404|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101324405|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101324406|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101324407|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324408|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324409|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
101324410|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
101324411|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324412|NCT00104767|Celecoxib|celecoxib|mesh-list
101324413|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101324414|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324415|NCT00104767|Analgesics|analgesics|mesh-ancestor
101324416|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
101324417|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324418|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324419|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324420|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324421|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101324422|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101324423|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324424|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324425|NCT02972268|Tamsulosin|tamsulosin|mesh-list
101324426|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
101324427|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101324428|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101324429|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101324430|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
101324431|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324432|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324433|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324434|NCT02972268|Urological Agents|urological agents|mesh-ancestor
101324435|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101324436|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101324437|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
101324438|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
101324439|NCT00104806|Vitamin D|vitamin d|mesh-list
101324440|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
101324441|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101324442|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324443|NCT00104806|Vitamins|vitamins|mesh-ancestor
101324444|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
101324445|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101324446|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324447|NCT00401128|Gemcitabine|gemcitabine|mesh-list
101324448|NCT00401128|Irinotecan|irinotecan|mesh-list
101324449|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324450|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
101324451|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324452|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324453|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101324454|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324455|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324456|NCT00401167|Memantine|memantine|mesh-list
101324457|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101324458|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101324459|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
101324460|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324461|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324462|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204421|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324463|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101324464|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101324465|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101324466|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324467|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324468|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324469|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324470|NCT00104845|Vaccines|vaccines|mesh-list
101324471|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
101324472|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324473|NCT00104923|Fenretinide|fenretinide|mesh-list
101324474|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324475|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101324476|NCT00104923|Protective Agents|protective agents|mesh-ancestor
101324477|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324478|NCT00104962|Lenalidomide|lenalidomide|mesh-list
101324479|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
101324480|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324481|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101324482|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101324483|NCT00104962|Growth Substances|growth substances|mesh-ancestor
101324484|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
101204422|NCT01423370|Tadalafil|tadalafil|mesh-list
101324485|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324486|NCT00006467|Gemcitabine|gemcitabine|mesh-list
101324487|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324488|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
101324489|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324490|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324491|NCT00105040|Levetiracetam|levetiracetam|mesh-list
101324492|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
101324493|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
101324494|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101324495|NCT00006470|Vaccines|vaccines|mesh-list
101324496|NCT00006470|Antibodies|antibodies|mesh-list
101324497|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
101324498|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101324499|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101324500|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
101324501|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324502|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324504|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324505|NCT00105352|Hormones|hormones|mesh-ancestor
101324506|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324507|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324508|NCT03862950|Metformin|metformin|mesh-list
101324509|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324510|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324511|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
101324512|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
101324513|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101324514|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324515|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324516|NCT00105547|Analgesics|analgesics|mesh-ancestor
101324517|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
101324520|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101324521|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324522|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324523|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324524|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101324525|NCT00390624|Mannitol|mannitol|mesh-list
101324526|NCT00390624|Ularitide|ularitide|mesh-list
101324527|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101324528|NCT00390624|Diuretics|diuretics|mesh-ancestor
101324529|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
101324530|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324531|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101324532|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
101324533|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324534|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101324535|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
101324536|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
101324537|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324538|NCT00006476|Suramin|suramin|mesh-list
101324539|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
101324540|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
101324541|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101324542|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324543|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324544|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101324545|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101324546|NCT00105937|Fentanyl|fentanyl|mesh-list
101324547|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101324548|NCT00105937|Narcotics|narcotics|mesh-ancestor
101324549|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324550|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324551|NCT00105937|Analgesics|analgesics|mesh-ancestor
101324552|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
101324553|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324554|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101324555|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101324556|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
101324557|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
101324558|NCT00006479|Leucovorin|leucovorin|mesh-list
101324559|NCT00006479|Fluorouracil|fluorouracil|mesh-list
101324560|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
101324561|NCT00006479|Calcium|calcium|mesh-list
101324562|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
101324563|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101324564|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324565|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
101324566|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324567|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324569|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324570|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
101324571|NCT00006479|Antidotes|antidotes|mesh-ancestor
101324572|NCT00006479|Protective Agents|protective agents|mesh-ancestor
101324573|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
101324574|NCT00006479|Vitamins|vitamins|mesh-ancestor
101324575|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
101324576|NCT00106054|Leucovorin|leucovorin|mesh-list
101324577|NCT00106054|Bevacizumab|bevacizumab|mesh-list
101324578|NCT00106054|Irinotecan|irinotecan|mesh-list
101324579|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101324580|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324581|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101324582|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101324583|NCT00106054|Growth Substances|growth substances|mesh-ancestor
101324584|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324585|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
101324586|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101324587|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324588|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324589|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324590|NCT00106054|Antidotes|antidotes|mesh-ancestor
101324591|NCT00106054|Protective Agents|protective agents|mesh-ancestor
101324592|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
101324593|NCT00106054|Vitamins|vitamins|mesh-ancestor
101324594|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
101324595|NCT00106132|Triamcinolone|triamcinolone|mesh-list
101324596|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101324597|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101324598|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101324599|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324600|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
101324601|NCT00106132|Hormones|hormones|mesh-ancestor
101324602|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324603|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324604|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324605|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
101324606|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324607|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324608|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101324609|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
101324610|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324611|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
101324612|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101324613|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324614|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101324615|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324616|NCT00106288|Amphotericin B|amphotericin b|mesh-list
101324617|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101324618|NCT00106288|Micafungin|micafungin|mesh-list
101324619|NCT00106288|Amebicides|amebicides|mesh-ancestor
101324620|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101324621|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101324622|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324623|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101324624|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
101324625|NCT00006482|Gemcitabine|gemcitabine|mesh-list
101324626|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324627|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324628|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
101324629|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324630|NCT03809988|Letrozole|letrozole|mesh-list
101324631|NCT03809988|Fulvestrant|fulvestrant|mesh-list
101324632|NCT03809988|Palbociclib|palbociclib|mesh-list
101324633|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324634|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101324635|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101324636|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324637|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324638|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101324639|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
101324640|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324641|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324642|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101324643|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101324644|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324645|NCT00106366|Insulin|insulin|mesh-list
101324646|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101324647|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
101324648|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
101324649|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
101324650|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324651|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324653|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101324654|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101324655|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
101324656|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324657|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324658|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324659|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101324660|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101324661|NCT00006485|Irinotecan|irinotecan|mesh-list
101324662|NCT00006485|Alvocidib|alvocidib|mesh-list
101324663|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101324664|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324665|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324666|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324667|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324668|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
101324669|NCT00006485|Growth Substances|growth substances|mesh-ancestor
101324670|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324671|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101324672|NCT00106522|Methotrexate|methotrexate|mesh-list
101324673|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101324674|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
101324675|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101324676|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324677|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324678|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
101324679|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324680|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324681|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324682|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324683|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101324684|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324685|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
101324686|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324687|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324688|NCT00106561|Irbesartan|irbesartan|mesh-list
101324689|NCT00106561|Spironolactone|spironolactone|mesh-list
101324690|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101324691|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
101324692|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324693|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324694|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101324695|NCT00106561|Diuretics|diuretics|mesh-ancestor
101324696|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
101324697|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101324698|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101324699|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101324700|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324701|NCT00106600|Pixantrone|pixantrone|mesh-list
101324702|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101324703|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324704|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324705|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324706|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324707|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
101324708|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101324709|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324710|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324711|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101324713|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
101324714|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324715|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101324716|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101324717|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101324718|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
101324719|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324720|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324721|NCT00401323|Docetaxel|docetaxel|mesh-list
101324722|NCT00401323|Fluorouracil|fluorouracil|mesh-list
101324723|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324724|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
101324725|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
101324726|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324727|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324728|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
101324729|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324730|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324731|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
101324732|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324733|NCT00401362|Naltrexone|naltrexone|mesh-list
101324734|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
101324735|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101324736|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324737|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
101324738|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101324739|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101324740|NCT00106834|Infliximab|infliximab|mesh-list
101324741|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101324742|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101324743|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101324744|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324745|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101324746|NCT00107107|Pramlintide|pramlintide|mesh-list
101324747|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324748|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324749|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
101324750|NCT00107263|Letrozole|letrozole|mesh-list
101324751|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324752|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101324753|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101324754|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324755|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324756|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101324757|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
101324758|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324759|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324760|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101324761|NCT02964949|Edoxaban|edoxaban|mesh-list
101324762|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101324763|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
101324764|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101324765|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324766|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324767|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324768|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
101324769|NCT00107341|Paclitaxel|paclitaxel|mesh-list
101324770|NCT00107341|Carboplatin|carboplatin|mesh-list
101324771|NCT00107341|Bortezomib|bortezomib|mesh-list
101324772|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101324773|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324774|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101324775|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101324776|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101324777|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324778|NCT00107419|Pemetrexed|pemetrexed|mesh-list
101324779|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324781|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324782|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101324783|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324784|NCT03683667|Azithromycin|azithromycin|mesh-list
101324785|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101324786|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324788|NCT00006578|Amprenavir|amprenavir|mesh-list
101324789|NCT00006578|Lamivudine|lamivudine|mesh-list
101324790|NCT00006578|Abacavir|abacavir|mesh-list
101324791|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101324792|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101324793|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324794|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324795|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324796|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101324797|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101324798|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
101324799|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324800|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101324801|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101324802|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101324803|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324804|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101324805|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
101324806|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101324807|NCT00107458|Valproic Acid|valproic acid|mesh-list
101324808|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
101324809|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324810|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324811|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
101324812|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324813|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324814|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
101324815|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101324816|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416345|NCT03890952|Nivolumab|nivolumab|mesh-list
101324817|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101324818|NCT00006617|Lamivudine|lamivudine|mesh-list
101324819|NCT00006617|Zidovudine|zidovudine|mesh-list
101324820|NCT00006617|Abacavir|abacavir|mesh-list
101324821|NCT00006617|Amprenavir|amprenavir|mesh-list
101324822|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101324823|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101324824|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324825|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324826|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
101324827|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324828|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101324829|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101324830|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
101324831|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101324832|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
101324833|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101324834|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101324835|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101324836|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
101324837|NCT00107731|Valproic Acid|valproic acid|mesh-list
101324838|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101324839|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
101324840|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101324841|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101324842|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101324843|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324844|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324845|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324846|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324847|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
101324848|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
101324849|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
101324850|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324851|NCT04712396|Itraconazole|itraconazole|mesh-list
101324852|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
101324853|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324854|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101324855|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101324856|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324857|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324858|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101324859|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
101324860|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324861|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324862|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101324863|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101324864|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324865|NCT00107809|Modafinil|modafinil|mesh-list
101324866|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101324867|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324868|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101324869|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101324870|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101324871|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324872|NCT00006656|Ethanol|ethanol|mesh-list
101324873|NCT00006656|Carmustine|carmustine|mesh-list
101324874|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101324875|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324876|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101324877|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324878|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101324879|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
101324880|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324881|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324882|NCT03667482|Cetuximab|cetuximab|mesh-list
101324883|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101324884|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324885|NCT00107848|Modafinil|modafinil|mesh-list
101324886|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101324887|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324888|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101324889|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101324890|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101324891|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324892|NCT00006695|Iodine|iodine|mesh-list
101324893|NCT00006695|Cytarabine|cytarabine|mesh-list
101324894|NCT00006695|Etoposide|etoposide|mesh-list
101324895|NCT00006695|Melphalan|melphalan|mesh-list
101324896|NCT00006695|Carmustine|carmustine|mesh-list
101324897|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
101324898|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101324899|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324900|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101324901|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101324902|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324903|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324904|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324905|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
101324906|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
101324907|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101324908|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324909|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
101324910|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324911|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101324912|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
101324913|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101324914|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101324915|NCT00006695|Trace Elements|trace elements|mesh-ancestor
101324916|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
101324917|NCT00108004|Pramlintide|pramlintide|mesh-list
101324918|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101324919|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324920|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101324921|NCT00108238|Estradiol|estradiol|mesh-list
101324922|NCT00108238|Progesterone|progesterone|mesh-list
101324923|NCT00108238|Estrogens|estrogens|mesh-ancestor
101324924|NCT00108238|Hormones|hormones|mesh-ancestor
101324925|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101324926|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324927|NCT00108238|Progestins|progestins|mesh-ancestor
101324928|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101324929|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
101324930|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101324931|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101324932|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101324934|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101324935|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324936|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101324937|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324938|NCT00108316|Fluoxetine|fluoxetine|mesh-list
101324939|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101324940|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101324941|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101324942|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324943|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324944|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
101324945|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324946|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101324947|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
101324948|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101324949|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101324950|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101324951|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324952|NCT00108394|Pamidronate|pamidronate|mesh-list
101324953|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101324954|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324955|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
101324956|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101324957|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
101324958|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324959|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101324960|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101324961|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101324962|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101324963|NCT00401440|Misoprostol|misoprostol|mesh-list
101324964|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101324965|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
101324966|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101324967|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324968|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101324969|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101324970|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
101324971|NCT00108667|Levodopa|levodopa|mesh-list
101324972|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101324973|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101324974|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
101324975|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101324976|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324977|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324978|NCT00006773|Bortezomib|bortezomib|mesh-list
101324979|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324980|NCT00108706|Candesartan|candesartan|mesh-list
101324981|NCT00108706|Candesartan cilexetil|candesartan cilexetil|mesh-list
101324982|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101324983|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101324984|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101324985|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324986|NCT03619551|Busulfan|busulfan|mesh-list
101324987|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
101324988|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324989|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101324990|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
101324991|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101324992|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101324993|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101324994|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101324995|NCT00006812|Capecitabine|capecitabine|mesh-list
101324996|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101324997|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
101330293|NCT00029848|Rimonabant|rimonabant|mesh-list
101324998|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101324999|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325000|NCT00006890|Thalidomide|thalidomide|mesh-list
101325001|NCT00006890|Prednisone|prednisone|mesh-list
101325002|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325003|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
101325004|NCT00006890|Hormones|hormones|mesh-ancestor
101325005|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325006|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325007|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325008|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325009|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325010|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
101325012|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325013|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325014|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325015|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325016|NCT00006890|Growth Substances|growth substances|mesh-ancestor
101325017|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325019|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101325020|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101325021|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325022|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325023|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325024|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
101325025|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325026|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101325027|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101325028|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101325029|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325030|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325031|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101325032|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325033|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325034|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
101325035|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325036|NCT00109057|Bevacizumab|bevacizumab|mesh-list
101325037|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325038|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325039|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325040|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325041|NCT00109057|Growth Substances|growth substances|mesh-ancestor
101325042|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325043|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325045|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325046|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325047|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325048|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101325049|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325050|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101325051|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101325052|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101325053|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325054|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325055|NCT00109135|Hormones|hormones|mesh-ancestor
101325056|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325057|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325058|NCT00006929|Suramin|suramin|mesh-list
101325059|NCT00006929|Paclitaxel|paclitaxel|mesh-list
101325060|NCT00006929|Carboplatin|carboplatin|mesh-list
101325061|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325062|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325063|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325064|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325065|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325066|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325067|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
101325069|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101325070|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325071|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101325072|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101325073|NCT00006968|Cyclosporine|cyclosporine|mesh-list
101325074|NCT00006968|Pentostatin|pentostatin|mesh-list
101325075|NCT00006968|Cyclosporins|cyclosporins|mesh-list
101325076|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
101325077|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325078|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325079|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325080|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325081|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
101325082|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325083|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325084|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325085|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101325086|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325087|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101325089|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101325091|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101325092|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325093|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325094|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
101325095|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325096|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325097|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325098|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325099|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101325100|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325101|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
101325102|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325103|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325104|NCT00109564|Acetylcholine|acetylcholine|mesh-list
101325105|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
101325106|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
101325107|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101325108|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
101325109|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325110|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325111|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325112|NCT00109603|Tenofovir|tenofovir|mesh-list
101325113|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
101325114|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325115|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101325116|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325117|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325118|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325119|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101325120|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101325121|NCT00109798|Temozolomide|temozolomide|mesh-list
101325122|NCT00109798|Topotecan|topotecan|mesh-list
101325123|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325124|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
101325125|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325126|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325127|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101325128|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325129|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325130|NCT00109954|Cisplatin|cisplatin|mesh-list
101325131|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325132|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
101325133|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101325134|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101325135|NCT00109993|Prednisolone|prednisolone|mesh-list
101325136|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
101325137|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
101325138|NCT00109993|Tacrolimus|tacrolimus|mesh-list
101325139|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101325140|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
101325141|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325142|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
101325143|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325144|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101325145|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325146|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325147|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325148|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
101325149|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
101325150|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325151|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325152|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
101325153|NCT00109993|Hormones|hormones|mesh-ancestor
101325154|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325155|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101325156|NCT00109993|Protective Agents|protective agents|mesh-ancestor
101325157|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325158|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325159|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325161|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325163|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
101325164|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101325165|NCT00110071|Fludarabine|fludarabine|mesh-list
101325166|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
101325167|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
101325168|NCT00110071|Antibodies|antibodies|mesh-list
101325169|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
101325170|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101325171|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
101325172|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325173|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325174|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325175|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
101325176|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325177|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325178|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101325179|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325180|NCT00110071|Trace Elements|trace elements|mesh-ancestor
101325181|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
101325182|NCT00110188|Sirolimus|sirolimus|mesh-list
101325183|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325184|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325185|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101325186|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325187|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
101325188|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325189|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
101325190|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325191|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101325192|NCT00007202|Didanosine|didanosine|mesh-list
101325193|NCT00007202|Stavudine|stavudine|mesh-list
101325194|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101325195|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101325196|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
101325197|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325198|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325199|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101325200|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101325201|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
101325202|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325203|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
101325204|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101325205|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325206|NCT00110344|Sorafenib|sorafenib|mesh-list
101325207|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325208|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101325210|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325211|NCT00401479|Solabegron|solabegron|mesh-list
101325212|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101325213|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101325214|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101325215|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
101325216|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325217|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325218|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325219|NCT00110578|Aldesleukin|aldesleukin|mesh-list
101325220|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325221|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101325222|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101325223|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
101325224|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325225|NCT00388193|Rituximab|rituximab|mesh-list
101325226|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325227|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325228|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
101325229|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325230|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325231|NCT00110695|Paclitaxel|paclitaxel|mesh-list
101325232|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101325233|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325234|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325235|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325236|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325237|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325238|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325239|NCT00110734|Lidocaine|lidocaine|mesh-list
101325240|NCT00110734|Tetracaine|tetracaine|mesh-list
101325241|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
101325242|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
101325243|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325244|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325246|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325247|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101325248|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101325249|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101325250|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325251|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325252|NCT00110773|Lidocaine|lidocaine|mesh-list
101325253|NCT00110773|Tetracaine|tetracaine|mesh-list
101325254|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
101325255|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
101325256|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325257|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325258|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
101325259|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325260|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101325261|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101325262|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101325263|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325264|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325265|NCT00110851|Metformin|metformin|mesh-list
101325266|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
101325267|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325268|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325269|NCT00110929|Cinacalcet|cinacalcet|mesh-list
101325270|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101325271|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325272|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101325273|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
101325274|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325275|NCT00111046|Ibuprofen|ibuprofen|mesh-list
101325276|NCT00111046|Tramadol|tramadol|mesh-list
101325277|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101325278|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101325279|NCT00111046|Analgesics|analgesics|mesh-ancestor
101325280|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
101325281|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325282|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325283|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325284|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325285|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101325286|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325287|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325288|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101325289|NCT00111046|Narcotics|narcotics|mesh-ancestor
101325290|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325291|NCT00388271|Alfuzosin|alfuzosin|mesh-list
101325292|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101325293|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101325294|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101325295|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101325296|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325297|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325298|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325299|NCT00388271|Urological Agents|urological agents|mesh-ancestor
101325301|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101325302|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101325303|NCT00111124|Analgesics|analgesics|mesh-ancestor
101325304|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
101325305|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325306|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325307|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325308|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325309|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325310|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325311|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
101325312|NCT00111163|Artesunate|artesunate|mesh-list
101325313|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
101325314|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
101325315|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101325316|NCT00111163|Amodiaquine|amodiaquine|mesh-list
101325317|NCT00111163|Dapsone|dapsone|mesh-list
101325318|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
101325319|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
101325320|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101325321|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101325322|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325323|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325324|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
101325325|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
101325326|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101325327|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
101325328|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101325329|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325330|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325331|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101325332|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
101325333|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325334|NCT00111280|Etravirine|etravirine|mesh-list
101325335|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101325336|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325337|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325338|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325339|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
101325340|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325341|NCT00111319|Bortezomib|bortezomib|mesh-list
101325342|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325343|NCT00111397|Interferons|interferons|mesh-list
101325344|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
101325345|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325346|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
101325347|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325349|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101325350|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101325352|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
101325353|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325354|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325355|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325356|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325357|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325358|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325359|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
101325360|NCT00111631|Metformin|metformin|mesh-list
101325361|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101325362|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325363|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325364|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
101325365|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325366|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325367|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101325368|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
101325369|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325370|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325371|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325372|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325373|NCT00111748|Thalidomide|thalidomide|mesh-list
101325374|NCT00111748|Dexamethasone|dexamethasone|mesh-list
101325375|NCT00111748|Bortezomib|bortezomib|mesh-list
101325376|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325377|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
101325378|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
101325379|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325380|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325381|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325382|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
101325383|NCT00111748|Hormones|hormones|mesh-ancestor
101325384|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325385|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325386|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325387|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325388|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
101325389|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
101325390|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325391|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325392|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325393|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325394|NCT00111748|Growth Substances|growth substances|mesh-ancestor
101325395|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325396|NCT00111787|Paclitaxel|paclitaxel|mesh-list
101325397|NCT00111787|Lapatinib|lapatinib|mesh-list
101325398|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325399|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325400|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325401|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325402|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325403|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325404|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101325405|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325406|NCT00111904|Paclitaxel|paclitaxel|mesh-list
101325407|NCT00111904|genexol-PM|genexol-pm|mesh-list
101325408|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325409|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325410|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325411|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325413|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325415|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
101325416|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325417|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101325418|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325419|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330312|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325420|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325421|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101325422|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101325423|NCT00401596|Omalizumab|omalizumab|mesh-list
101325424|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101325425|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101325426|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
101325427|NCT00401635|Carboplatin|carboplatin|mesh-list
101325428|NCT00401635|Doxorubicin|doxorubicin|mesh-list
101325429|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101325430|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325431|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101325432|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101325433|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325434|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325435|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325436|NCT00401674|Paclitaxel|paclitaxel|mesh-list
101325437|NCT00401674|Carboplatin|carboplatin|mesh-list
101325438|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325439|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325440|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325441|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325442|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325443|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325444|NCT00112021|Pramlintide|pramlintide|mesh-list
101325445|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101325446|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325447|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325448|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
101325449|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101325450|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101325451|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325452|NCT00007358|Dexamethasone|dexamethasone|mesh-list
101325453|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325454|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
101325455|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
101325456|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325457|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325458|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325459|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
101325461|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325462|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325463|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325464|NCT00112138|Gabapentin|gabapentin|mesh-list
101325465|NCT00112138|Analgesics|analgesics|mesh-ancestor
101325466|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
101325467|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325468|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325469|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
101325470|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101325471|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101325472|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325473|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101325474|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101325476|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325477|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325478|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
101325479|NCT03330639|Capsaicin|capsaicin|mesh-list
101325480|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
101325481|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325482|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
101325483|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325484|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325485|NCT00007436|Tenofovir|tenofovir|mesh-list
101325486|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
101325487|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325488|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101325489|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325490|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330317|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
101325491|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325493|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101325494|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101325495|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101325496|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
101325497|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325498|NCT00112372|Sirolimus|sirolimus|mesh-list
101325499|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325500|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325501|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101325502|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325503|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
101325504|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325505|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
101325506|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325507|NCT00112528|Bevacizumab|bevacizumab|mesh-list
101325508|NCT00112528|Gemcitabine|gemcitabine|mesh-list
101325509|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
101325510|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325511|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325512|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325513|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325514|NCT00112528|Growth Substances|growth substances|mesh-ancestor
101325515|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325516|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325517|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325518|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
101325519|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325520|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
101325522|NCT00007592|Diuretics|diuretics|mesh-ancestor
101325523|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
101325524|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325525|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101325526|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325527|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325528|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101325529|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101325530|NCT00007631|Tretinoin|tretinoin|mesh-list
101325531|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325532|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
101325533|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325535|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
101325536|NCT00112567|Thiotepa|thiotepa|mesh-list
101325537|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325538|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325539|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
101325540|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325541|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325542|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
101325543|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325544|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325546|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101325547|NCT00112645|Cyclosporine|cyclosporine|mesh-list
101325548|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
101325549|NCT00112645|Methotrexate|methotrexate|mesh-list
101325550|NCT00112645|Melphalan|melphalan|mesh-list
101325551|NCT00112645|Busulfan|busulfan|mesh-list
101325552|NCT00112645|Cyclosporins|cyclosporins|mesh-list
101325553|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101325554|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101325555|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
101325556|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101325557|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325558|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325559|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
101325560|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330323|NCT00030082|Melphalan|melphalan|mesh-list
101325561|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325562|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325563|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325564|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101325565|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325566|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
101325567|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325568|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101325569|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
101325570|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325571|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101325572|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325573|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
101325574|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
101325575|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325576|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325577|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
101325578|NCT00112645|Hormones|hormones|mesh-ancestor
101325579|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325580|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101325581|NCT00112645|Protective Agents|protective agents|mesh-ancestor
101325582|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325583|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
101325584|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101325585|NCT00112684|Alvocidib|alvocidib|mesh-list
101325586|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325587|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325588|NCT00112684|Growth Substances|growth substances|mesh-ancestor
101325589|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325590|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101325591|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325592|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325593|NCT00007670|Lamotrigine|lamotrigine|mesh-list
101325594|NCT00007670|Carbamazepine|carbamazepine|mesh-list
101325595|NCT00007670|Gabapentin|gabapentin|mesh-list
101325596|NCT00007670|Analgesics|analgesics|mesh-ancestor
101325597|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
101325598|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325599|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325600|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
101325601|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101325602|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101325603|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325604|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101325605|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101325606|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101325607|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325608|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325609|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
101325610|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101325611|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325612|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101325613|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101325614|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101325615|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204423|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
101325616|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101325617|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101325618|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
101325619|NCT00112879|Thalidomide|thalidomide|mesh-list
101325620|NCT00112879|Dexamethasone|dexamethasone|mesh-list
101325621|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
101325623|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
101325624|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101325625|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
101325626|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
101325627|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325628|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325629|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325630|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
101325631|NCT00112879|Hormones|hormones|mesh-ancestor
101325632|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325633|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325634|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325635|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325636|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325637|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325638|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
101325639|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
101325640|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101325641|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325642|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325643|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325644|NCT00112879|Growth Substances|growth substances|mesh-ancestor
101325645|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325646|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
101325647|NCT00112879|Protective Agents|protective agents|mesh-ancestor
101325648|NCT00112879|Vitamins|vitamins|mesh-ancestor
101325649|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
101325650|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
101325651|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
101325652|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325653|NCT00112996|Protective Agents|protective agents|mesh-ancestor
101325654|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325655|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
101325656|NCT00112996|Vitamins|vitamins|mesh-ancestor
101325657|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
101325658|NCT00113074|Nicotine|nicotine|mesh-list
101325659|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101325660|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
101325661|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325662|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325663|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101325664|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101325665|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
101325666|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325667|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325668|NCT00113113|Rubitecan|rubitecan|mesh-list
101325669|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325670|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101325671|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325672|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325673|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325674|NCT00007787|Cyclosporine|cyclosporine|mesh-list
101325675|NCT00007787|Tacrolimus|tacrolimus|mesh-list
101325676|NCT00007787|Cyclosporins|cyclosporins|mesh-list
101325677|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
101325678|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325679|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
101325680|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325681|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101325682|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528362|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325683|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325684|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
101325685|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325686|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325687|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325689|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325690|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
101325691|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325692|NCT00113347|Docetaxel|docetaxel|mesh-list
101325693|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101325694|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325695|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325696|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325697|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325698|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325699|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101325700|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325701|NCT00113503|Azathioprine|azathioprine|mesh-list
101325702|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
101325703|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325704|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325705|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325706|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325707|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
101325708|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325709|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325710|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101325711|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
101325712|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
101325713|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325714|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325715|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325716|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325717|NCT00113542|Growth Substances|growth substances|mesh-ancestor
101325718|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325719|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325720|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325721|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101325723|NCT00007826|Antibodies|antibodies|mesh-list
101325724|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101325725|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
101325727|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
101325728|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325729|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101325730|NCT00007826|Antacids|antacids|mesh-ancestor
101325731|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325732|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325733|NCT00007865|Rituximab|rituximab|mesh-list
101325734|NCT00007865|Carboplatin|carboplatin|mesh-list
101325735|NCT00007865|Etoposide|etoposide|mesh-list
101325736|NCT00007865|Ifosfamide|ifosfamide|mesh-list
101325737|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325738|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325739|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
101325740|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325741|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325742|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325743|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101325744|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325745|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325746|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325747|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325748|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
101325750|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101325752|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325753|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325754|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101325755|NCT00113737|Fluoxetine|fluoxetine|mesh-list
101325756|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101325757|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101325758|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101325759|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325760|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325761|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
101325762|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325763|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101325764|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
101325765|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101325766|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101325767|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101325768|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325769|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
101325770|NCT03272295|Menthol|menthol|mesh-list
101325771|NCT03272295|Sorbitol|sorbitol|mesh-list
101325772|NCT03272295|Glycerol|glycerol|mesh-list
101325773|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
101325774|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325775|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101325776|NCT03272295|Protective Agents|protective agents|mesh-ancestor
101325777|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325778|NCT03272295|Cathartics|cathartics|mesh-ancestor
101325779|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325780|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325781|NCT00007904|Tamoxifen|tamoxifen|mesh-list
101325782|NCT00007904|Paclitaxel|paclitaxel|mesh-list
101325783|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
101325784|NCT00007904|Doxorubicin|doxorubicin|mesh-list
101325785|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101325786|NCT00007904|Lenograstim|lenograstim|mesh-list
101325787|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325788|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325789|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325790|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325791|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325792|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325793|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325794|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
101325795|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325796|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325797|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325798|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
101325799|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101325800|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101325801|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101325802|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325803|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325804|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101325805|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101325806|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
101325807|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325808|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101325809|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101325810|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101325811|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101325814|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101325815|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325816|NCT00113854|Mannitol|mannitol|mesh-list
101325817|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101325818|NCT00113854|Diuretics|diuretics|mesh-ancestor
101325819|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
101325820|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325821|NCT00007943|Gemcitabine|gemcitabine|mesh-list
101325822|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325823|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
101325824|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325825|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325826|NCT00113971|Epratuzumab|epratuzumab|mesh-list
101325827|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325828|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325829|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101325830|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101325831|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
101325832|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325834|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325835|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101325836|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
101325837|NCT00007982|Thiotepa|thiotepa|mesh-list
101325838|NCT00007982|Carmustine|carmustine|mesh-list
101325839|NCT00007982|Etoposide|etoposide|mesh-list
101325840|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325841|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
101325842|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325843|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330343|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101325844|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325845|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
101325846|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325847|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325848|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101325849|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325850|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101325851|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325852|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325854|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325855|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325856|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325857|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325858|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325859|NCT00114283|Lapatinib|lapatinib|mesh-list
101325860|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325861|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101325862|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325863|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325864|NCT00114361|Ribavirin|ribavirin|mesh-list
101325865|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101325866|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
101325867|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325868|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
101325869|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325870|NCT00114400|Vitamins|vitamins|mesh-list
101325871|NCT00114400|Folic Acid|folic acid|mesh-list
101325872|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
101325873|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
101325874|NCT00114400|Pyridoxal|pyridoxal|mesh-list
101325876|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
101325877|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
101325878|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325879|NCT00114400|Hematinics|hematinics|mesh-ancestor
101325880|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
101325881|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
101325882|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101325883|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325884|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325885|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
101325886|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101325887|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101325888|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325889|NCT00114478|Epinephrine|epinephrine|mesh-list
101325890|NCT00114478|Albuterol|albuterol|mesh-list
101325891|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101325892|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101325893|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
101325894|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101325895|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325896|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325897|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101325898|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101325899|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
101325900|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101325901|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101325902|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101325903|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
101325904|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
101325905|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101325906|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
101325907|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101325908|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101325909|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
101325910|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101325912|NCT00008021|Cyclosporine|cyclosporine|mesh-list
101325913|NCT00008021|Paclitaxel|paclitaxel|mesh-list
101325914|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101325915|NCT00008021|Antibodies|antibodies|mesh-list
101325916|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
101325917|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101325918|NCT00008021|Cyclosporins|cyclosporins|mesh-list
101325919|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101325920|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325921|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
101325922|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
101325923|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
101325924|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325926|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325927|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325928|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325929|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
101325930|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101325931|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
101325932|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101325933|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101325934|NCT03079440|Capecitabine|capecitabine|mesh-list
101325935|NCT03079440|Temozolomide|temozolomide|mesh-list
101325936|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325937|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
101325938|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325939|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325940|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101325941|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
101325942|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101325943|NCT00008060|Leucovorin|leucovorin|mesh-list
101325944|NCT00008060|Fluorouracil|fluorouracil|mesh-list
101325945|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
101325946|NCT00008060|Irinotecan|irinotecan|mesh-list
101325947|NCT00008060|Calcium|calcium|mesh-list
101325948|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
101325949|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101325950|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325951|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
101325952|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325953|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101325954|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325955|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101325956|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
101325957|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101325958|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101325959|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101325960|NCT00008060|Antidotes|antidotes|mesh-ancestor
101325961|NCT00008060|Protective Agents|protective agents|mesh-ancestor
101325962|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
101325963|NCT00008060|Vitamins|vitamins|mesh-ancestor
101325964|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
101325965|NCT00114868|Vitamins|vitamins|mesh-list
101325966|NCT00114868|Vitamin A|vitamin a|mesh-list
101325967|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
101325968|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
101325969|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325970|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
101325971|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101325972|NCT00114868|Protective Agents|protective agents|mesh-ancestor
101325973|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101325974|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325975|NCT03034200|TIC10 compound|tic10 compound|mesh-list
101325976|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325977|NCT00114946|Bevacizumab|bevacizumab|mesh-list
101325978|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101325979|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101325980|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101325981|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101325982|NCT00114946|Growth Substances|growth substances|mesh-ancestor
101325983|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325984|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
101325986|NCT00115024|Estrogens|estrogens|mesh-ancestor
101325987|NCT00115024|Hormones|hormones|mesh-ancestor
101325988|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101325989|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101325991|NCT00008177|Cyclosporine|cyclosporine|mesh-list
101325992|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
101325993|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101325994|NCT00008177|Fludarabine|fludarabine|mesh-list
101325995|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
101325996|NCT00008177|Antibodies|antibodies|mesh-list
101325997|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
101325998|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101325999|NCT00008177|Cyclosporins|cyclosporins|mesh-list
101326000|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
101326001|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326002|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326003|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326004|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
101326005|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326006|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326007|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326008|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
101326009|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326010|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326011|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326012|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101326013|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101326014|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101326015|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
101326016|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101326017|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101326020|NCT03007407|Durvalumab|durvalumab|mesh-list
101326021|NCT03007407|Tremelimumab|tremelimumab|mesh-list
101326022|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326023|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326024|NCT00115102|Fentanyl|fentanyl|mesh-list
101326025|NCT00115102|Ketamine|ketamine|mesh-list
101326026|NCT00115102|Esketamine|esketamine|mesh-list
101326027|NCT00115102|Analgesics|analgesics|mesh-ancestor
101326028|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
101326029|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326030|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326031|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101326032|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101326033|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
101326034|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
101326035|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326036|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101326037|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101326038|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326039|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326040|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101326041|NCT00115102|Narcotics|narcotics|mesh-ancestor
101326042|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101326043|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
101326044|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101326045|NCT00115219|Etanercept|etanercept|mesh-list
101326046|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101326047|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101326049|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
101326050|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326051|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326052|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326053|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326054|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326055|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326056|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
101326058|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101326059|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101326060|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101326061|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101326062|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
101326063|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326064|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326065|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326067|NCT00115414|Docetaxel|docetaxel|mesh-list
101326069|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326070|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
101326071|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326072|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326073|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101326074|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
101326075|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326076|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326077|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101326078|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326079|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326080|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326081|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101326082|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101326083|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326084|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326085|NCT00115492|Fluticasone|fluticasone|mesh-list
101326087|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101326088|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101326089|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326090|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101326091|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
101326092|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326093|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326094|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101326095|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
101326096|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326097|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101326098|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101326099|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101326100|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101326101|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
101326102|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326103|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326104|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
101326106|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326107|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
101326108|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101326109|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101326110|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
101326111|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326112|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101326113|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326114|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101326115|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326117|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
101326118|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326119|NCT00115570|Insulin|insulin|mesh-list
101326120|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101326121|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
101326122|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
101326123|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
101326124|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
101326125|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
101326126|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
101326127|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101326128|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326129|NCT00115609|Tenofovir|tenofovir|mesh-list
101326130|NCT00115609|Emtricitabine|emtricitabine|mesh-list
101326131|NCT00115609|Efavirenz|efavirenz|mesh-list
101326132|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
101326133|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326134|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101326135|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326136|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326137|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326138|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326139|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326140|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101326141|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101326142|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101326143|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101326144|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101326145|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101326147|NCT00115648|Nevirapine|nevirapine|mesh-list
101326148|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
101326149|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326150|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101326151|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326152|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326153|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
101326154|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326155|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326156|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326158|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101326159|NCT00008294|Leucovorin|leucovorin|mesh-list
101326160|NCT00008294|Dexamethasone|dexamethasone|mesh-list
101326161|NCT00008294|Fluorouracil|fluorouracil|mesh-list
101326162|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
101326163|NCT00008294|Floxuridine|floxuridine|mesh-list
101326164|NCT00008294|Calcium|calcium|mesh-list
101326165|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
101326166|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326167|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
101326168|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
101326169|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326170|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326171|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326172|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
101326173|NCT00008294|Hormones|hormones|mesh-ancestor
101326174|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326175|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101326176|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326177|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326178|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
101326179|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326180|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326181|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326182|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
101326183|NCT00008294|Antidotes|antidotes|mesh-ancestor
101326184|NCT00008294|Protective Agents|protective agents|mesh-ancestor
101326185|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
101326186|NCT00008294|Vitamins|vitamins|mesh-ancestor
101326187|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
101326188|NCT00115687|Nicotine|nicotine|mesh-list
101326189|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101326190|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
101326191|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326192|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326193|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101326194|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101326195|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
101326196|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326197|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326198|NCT00115726|Furosemide|furosemide|mesh-list
101326213|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326215|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326216|NCT00115921|Antimalarials|antimalarials|mesh-list
101326217|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101326218|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101326219|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326220|NCT00008411|Docetaxel|docetaxel|mesh-list
101326221|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326222|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326223|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326224|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326225|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326226|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101326227|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101326228|NCT04727671|Cetrorelix|cetrorelix|mesh-list
101326229|NCT04727671|Menotropins|menotropins|mesh-list
101326230|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
101326231|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101326232|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
101326233|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326234|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326235|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101326236|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101326237|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326238|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101326239|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
101326240|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326241|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326242|NCT00008450|Cyclosporine|cyclosporine|mesh-list
101326243|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
101326244|NCT00008450|Cyclosporins|cyclosporins|mesh-list
101326245|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326246|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326247|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326248|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
101326249|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326250|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
101326251|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326252|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326253|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326254|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101326255|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101326256|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326257|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101326258|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
101326259|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101326260|NCT00008489|Didanosine|didanosine|mesh-list
101326261|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
101326262|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326263|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101326264|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326265|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326266|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
101326267|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326268|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326269|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326270|NCT00116350|Misoprostol|misoprostol|mesh-list
101326271|NCT00116350|Oxytocin|oxytocin|mesh-list
101326272|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
101326273|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326274|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326275|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101326276|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
101326277|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101326278|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326279|NCT00116389|Gemcitabine|gemcitabine|mesh-list
101326280|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101548771|NCT00598377|Cosyntropin|cosyntropin|mesh-list
101326282|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326283|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326284|NCT00116467|Vaccines|vaccines|mesh-list
101326285|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
101326286|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326287|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
101326288|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101326289|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101326290|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326291|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326292|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326293|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
101326294|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326295|NCT00116506|Bevacizumab|bevacizumab|mesh-list
101326296|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101326297|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326298|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326299|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101326300|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101326301|NCT00116506|Growth Substances|growth substances|mesh-ancestor
101326302|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326303|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
101326304|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326305|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326306|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326307|NCT00116545|Troglitazone|troglitazone|mesh-list
101326308|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101326309|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326310|NCT00116623|Indomethacin|indomethacin|mesh-list
101326311|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
101326312|NCT00116623|Analgesics|analgesics|mesh-ancestor
101326313|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
101326314|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326315|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326316|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
101326317|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326318|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101326319|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
101326320|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101326321|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326322|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326323|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326325|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326326|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101326327|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101326328|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326329|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326330|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
101326331|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101326332|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326333|NCT02909322|Hydromorphone|hydromorphone|mesh-list
101326334|NCT02909322|Bupivacaine|bupivacaine|mesh-list
101326335|NCT02909322|Ropivacaine|ropivacaine|mesh-list
101326336|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
101326337|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
101326338|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326339|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326340|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
101326341|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326342|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101326343|NCT02909322|Narcotics|narcotics|mesh-ancestor
101326344|NCT02909322|Analgesics|analgesics|mesh-ancestor
101326345|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326346|NCT00116701|Hematinics|hematinics|mesh-ancestor
101326348|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326349|NCT02752815|Prednisone|prednisone|mesh-list
101326350|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
101326351|NCT02752815|Rituximab|rituximab|mesh-list
101326352|NCT02752815|Vincristine|vincristine|mesh-list
101326353|NCT02752815|Epirubicin|epirubicin|mesh-list
101326354|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326355|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
101326356|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326357|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326358|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101326359|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
101326360|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326361|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326362|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101326363|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326364|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326366|NCT02752815|Hormones|hormones|mesh-ancestor
101326367|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326368|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101326369|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101326370|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326371|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326372|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326373|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101326374|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101326375|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326376|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326377|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
101326378|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204424|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101326379|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326380|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326381|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326382|NCT00388388|Losartan|losartan|mesh-list
101326383|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101326384|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101326385|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101326386|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101326387|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101326388|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326389|NCT00388388|Diuretics|diuretics|mesh-ancestor
101326390|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
101326391|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326392|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101326393|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326394|NCT00117013|Topotecan|topotecan|mesh-list
101326395|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101326396|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326397|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326398|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326399|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326400|NCT02743455|Vaccines|vaccines|mesh-list
101326401|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
101326402|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326403|NCT00117052|Cinacalcet|cinacalcet|mesh-list
101326404|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326405|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326406|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101326407|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326408|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326409|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101326410|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326411|NCT02972450|Vedolizumab|vedolizumab|mesh-list
101326412|NCT02972450|Vaccines|vaccines|mesh-list
101326413|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
101326414|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326415|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326416|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326418|NCT00117208|Mannitol|mannitol|mesh-list
101326419|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101326420|NCT00117208|Diuretics|diuretics|mesh-ancestor
101326421|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
101326422|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326423|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326424|NCT00117247|Hematinics|hematinics|mesh-ancestor
101326425|NCT00388427|Cetuximab|cetuximab|mesh-list
101326426|NCT00388427|Dasatinib|dasatinib|mesh-list
101326427|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326428|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326429|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326430|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326431|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326432|NCT00117364|Sacchachitin|sacchachitin|mesh-list
101326433|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
101326434|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326435|NCT00117364|Protective Agents|protective agents|mesh-ancestor
101326436|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326437|NCT00117403|Vitamins|vitamins|mesh-list
101326438|NCT00117403|Vitamin E|vitamin e|mesh-list
101326439|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
101326440|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
101326441|NCT00117403|Ubiquinone|ubiquinone|mesh-list
101326442|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
101326443|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326444|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
101326445|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326446|NCT00117403|Protective Agents|protective agents|mesh-ancestor
101326447|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
101326448|NCT00117442|Paclitaxel|paclitaxel|mesh-list
101326449|NCT00117442|Carboplatin|carboplatin|mesh-list
101326450|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101326451|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326452|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326453|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326454|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326455|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326457|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101326458|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326459|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101326460|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326461|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326462|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101326463|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101326464|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
101326465|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326466|NCT04727515|Fentanyl|fentanyl|mesh-list
101326467|NCT04727515|Isoflurane|isoflurane|mesh-list
101326468|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101326469|NCT04727515|Narcotics|narcotics|mesh-ancestor
101326470|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326471|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326472|NCT04727515|Analgesics|analgesics|mesh-ancestor
101326473|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
101326474|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326475|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101326476|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101326477|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
101326478|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
101326479|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101326480|NCT00117754|Terbinafine|terbinafine|mesh-list
101326481|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
101326482|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326483|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326484|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326485|NCT00117832|Azelastine|azelastine|mesh-list
101326486|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101326487|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
101326488|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326489|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326491|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
101326492|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101330382|NCT00395941|Pioglitazone|pioglitazone|mesh-list
101326493|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326494|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326495|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101326496|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101326497|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101326498|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
101326499|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
101326500|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326501|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
101326502|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
101326503|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101326504|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
101326505|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101326506|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101326507|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326508|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101326509|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326510|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326511|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101326512|NCT00118066|Calcitriol|calcitriol|mesh-list
101326513|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326514|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326515|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101326516|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326517|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326518|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101326520|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
101326521|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101326522|NCT00118105|Bevacizumab|bevacizumab|mesh-list
101326523|NCT00118105|Capecitabine|capecitabine|mesh-list
101326524|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
101326525|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326526|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326527|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101326528|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101326529|NCT00118105|Growth Substances|growth substances|mesh-ancestor
101326530|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326531|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
101326532|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326533|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
101326534|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326535|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101326536|NCT00118183|Cetuximab|cetuximab|mesh-list
101326537|NCT00118183|Docetaxel|docetaxel|mesh-list
101326538|NCT00118183|Bortezomib|bortezomib|mesh-list
101326539|NCT00118183|Antibodies|antibodies|mesh-list
101326540|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
101326541|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101326542|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
101326543|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326544|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326545|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326546|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326547|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326548|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326549|NCT00390975|Tegaserod|tegaserod|mesh-list
101326550|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101326551|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
101326552|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326553|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326554|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326555|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101326556|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101326557|NCT00118222|Ether|ether|mesh-list
101326558|NCT00118222|Trioxsalen|trioxsalen|mesh-list
101326559|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326560|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326561|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101326562|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101326563|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
101326564|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
101326565|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326566|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326567|NCT00118261|Leucovorin|leucovorin|mesh-list
101326568|NCT00118261|Bevacizumab|bevacizumab|mesh-list
101326569|NCT00118261|Fluorouracil|fluorouracil|mesh-list
101326570|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
101326571|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101326572|NCT00118261|Calcium|calcium|mesh-list
101326573|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
101326574|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326575|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326576|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101326577|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101326578|NCT00118261|Growth Substances|growth substances|mesh-ancestor
101326579|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326580|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
101326581|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326582|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
101326583|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326584|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326585|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326586|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
101326587|NCT00118261|Antidotes|antidotes|mesh-ancestor
101326588|NCT00118261|Protective Agents|protective agents|mesh-ancestor
101326589|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
101326590|NCT00118261|Vitamins|vitamins|mesh-ancestor
101326591|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
101326592|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326593|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326594|NCT00118300|Capecitabine|capecitabine|mesh-list
101326595|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326596|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
101326597|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326598|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326599|NCT02710734|Doxorubicin|doxorubicin|mesh-list
101326600|NCT02710734|Methotrexate|methotrexate|mesh-list
101326601|NCT02710734|Mitomycins|mitomycins|mesh-list
101326602|NCT02710734|Mitomycin|mitomycin|mesh-list
101326603|NCT02710734|Vinblastine|vinblastine|mesh-list
101326604|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326606|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101326607|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326608|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326609|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326610|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101326611|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
101326612|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326613|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326614|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326615|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
101326616|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326617|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101326618|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326619|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
101326620|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326621|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326622|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
101326623|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101326624|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326625|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326626|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326628|NCT00118690|Xhance|xhance|mesh-list
101326629|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101326630|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326631|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101326632|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
101326633|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326634|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326635|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101326636|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
101330388|NCT00030433|Gemcitabine|gemcitabine|mesh-list
101326637|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326638|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101326639|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101326640|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101326641|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101326642|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
101326643|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326644|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326646|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
101326647|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326648|NCT00118768|Interferons|interferons|mesh-list
101326649|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
101326650|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326651|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
101326652|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326653|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
101326654|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326655|NCT00118807|Artesunate|artesunate|mesh-list
101326656|NCT00118807|Chloroquine|chloroquine|mesh-list
101326657|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
101326658|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
101326659|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101326660|NCT00118807|Amodiaquine|amodiaquine|mesh-list
101326661|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
101326662|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101326663|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101326664|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326665|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326666|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
101326667|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
101326668|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101326669|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
101326671|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326672|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101326673|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326674|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326675|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101326677|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
101326678|NCT00118963|Repaglinide|repaglinide|mesh-list
101326679|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101326680|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326681|NCT00119002|Dexamethasone|dexamethasone|mesh-list
101326682|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326683|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
101326684|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
101326685|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326686|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326687|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326688|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
101326690|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326691|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101326692|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326693|NCT00119119|Tocopherols|tocopherols|mesh-list
101326694|NCT00119119|Vitamin E|vitamin e|mesh-list
101326695|NCT00119119|Tocotrienols|tocotrienols|mesh-list
101326696|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
101326697|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
101326698|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326699|NCT00119119|Protective Agents|protective agents|mesh-ancestor
101326700|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326701|NCT00119119|Vitamins|vitamins|mesh-ancestor
101326702|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
101326703|NCT00119236|Irinotecan|irinotecan|mesh-list
101326704|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101326705|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326706|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326707|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326708|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326709|NCT00119314|Gemcitabine|gemcitabine|mesh-list
101326710|NCT00119314|Capecitabine|capecitabine|mesh-list
101326711|NCT00119314|Docetaxel|docetaxel|mesh-list
101326712|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326713|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
101326714|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326715|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326716|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
101326717|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
101326718|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
101326719|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101326720|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101326722|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
101326723|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326724|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326725|NCT00119587|Hematinics|hematinics|mesh-ancestor
101326726|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
101326727|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
101326728|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326729|NCT00119626|Protective Agents|protective agents|mesh-ancestor
101326730|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326731|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
101326732|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101326733|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101326734|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101326735|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326736|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326737|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
101326738|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326739|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326740|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101326741|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326742|NCT02621151|Gemcitabine|gemcitabine|mesh-list
101326744|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326745|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
101326746|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326747|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326748|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326749|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101326750|NCT00120055|Atorvastatin|atorvastatin|mesh-list
101326751|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101326752|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101326753|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
101326754|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326755|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101326756|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101326757|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326758|NCT00120133|Atorvastatin|atorvastatin|mesh-list
101326759|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101326760|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101326761|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
101326762|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326763|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101326764|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101326765|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326766|NCT00120172|Bevacizumab|bevacizumab|mesh-list
101326767|NCT00120172|Capecitabine|capecitabine|mesh-list
101326768|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
101326769|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326770|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326771|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101326772|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101326773|NCT00120172|Growth Substances|growth substances|mesh-ancestor
101326774|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326775|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
101326776|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326777|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
101330394|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101326778|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326779|NCT00402181|Dexamethasone|dexamethasone|mesh-list
101326781|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326782|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
101326783|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
101326784|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326785|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326786|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326787|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
101326789|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326790|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101326791|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326792|NCT04727437|Heparin|heparin|mesh-list
101326793|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101326794|NCT04727437|Tinzaparin|tinzaparin|mesh-list
101326795|NCT04727437|Dalteparin|dalteparin|mesh-list
101326796|NCT04727437|Warfarin|warfarin|mesh-list
101326797|NCT04727437|Anticoagulants|anticoagulants|mesh-list
101326798|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101326799|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101326800|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326801|NCT00120367|Tenofovir|tenofovir|mesh-list
101326802|NCT00120367|Emtricitabine|emtricitabine|mesh-list
101326803|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
101326804|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
101326805|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326806|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101326807|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326808|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326809|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326810|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326811|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326812|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101326813|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101326814|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101326815|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
101326816|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326817|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101326818|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326819|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
101326820|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
101326821|NCT00120484|Vitamins|vitamins|mesh-ancestor
101326822|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
101326823|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326824|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
101326825|NCT00120484|Hematinics|hematinics|mesh-ancestor
101326826|NCT00391014|Amphotericin B|amphotericin b|mesh-list
101326827|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101326828|NCT00391014|Amebicides|amebicides|mesh-ancestor
101326829|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101326830|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101326831|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326832|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101326833|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
101326834|NCT00120601|Naltrexone|naltrexone|mesh-list
101326835|NCT00120601|Acamprosate|acamprosate|mesh-list
101326836|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101326837|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101326838|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326839|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
101326840|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326841|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101326842|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101326843|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101326844|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
101326845|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101326846|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326847|NCT00120640|Progestins|progestins|mesh-ancestor
101326848|NCT00120640|Hormones|hormones|mesh-ancestor
101326850|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326851|NCT00120679|Hematinics|hematinics|mesh-ancestor
101326852|NCT00120718|Fasudil|fasudil|mesh-list
101326853|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101326854|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326855|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326856|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101326857|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326858|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
101326859|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326860|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326861|NCT00120757|Alendronate|alendronate|mesh-list
101326862|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101326863|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326864|NCT00120796|Lamivudine|lamivudine|mesh-list
101326865|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101326866|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101326867|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326868|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326869|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
101326870|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326871|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101326872|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101326873|NCT00120835|Interferons|interferons|mesh-list
101326874|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326875|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
101326876|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326877|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
101326878|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101326879|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101326880|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
101326881|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101326882|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326883|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
101326884|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
101326885|NCT00121030|Hematinics|hematinics|mesh-ancestor
101326886|NCT00121069|Escitalopram|escitalopram|mesh-list
101326887|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101326888|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101326889|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326890|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326891|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326892|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
101326893|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326894|NCT00121147|Travoprost|travoprost|mesh-list
101326895|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101326896|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101326897|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101326898|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101326899|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101326900|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
101326901|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101326902|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326903|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326905|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326906|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326907|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548817|NCT00600405|Ibuprofen|ibuprofen|mesh-list
101326908|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326909|NCT00121303|Cytarabine|cytarabine|mesh-list
101326910|NCT00121303|Daunorubicin|daunorubicin|mesh-list
101326911|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
101326912|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101326913|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
101326914|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326915|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326916|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
101326917|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101326918|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326919|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
101326920|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326921|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101326922|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101326923|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101326924|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326925|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101326927|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
101326928|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
101326929|NCT00121381|Tacrolimus|tacrolimus|mesh-list
101326930|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101326931|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101326932|NCT00121381|Analgesics|analgesics|mesh-ancestor
101326933|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
101326934|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326935|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326936|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326937|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326938|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326939|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326940|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
101326941|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101326942|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326943|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326944|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
101326945|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326946|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101326947|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
101326948|NCT00121459|Psyllium|psyllium|mesh-list
101326949|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
101326950|NCT00121459|Cathartics|cathartics|mesh-ancestor
101326951|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326952|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
101326954|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
101326955|NCT00121498|Anesthetics|anesthetics|mesh-list
101326956|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326957|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326958|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
101326959|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326960|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101326961|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101326962|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101326963|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101326964|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326965|NCT00121615|Etanercept|etanercept|mesh-list
101326966|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101326967|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101326968|NCT00121615|Analgesics|analgesics|mesh-ancestor
101326969|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
101326970|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326971|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326972|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101326973|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101326974|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101326975|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101326976|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
101326977|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101326978|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101326979|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101326980|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101326981|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326982|NCT04711096|Bupivacaine|bupivacaine|mesh-list
101326983|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
101326984|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
101326985|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101326986|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326987|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
101204425|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101204426|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204427|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204428|NCT01423370|Urological Agents|urological agents|mesh-ancestor
101204429|NCT01423435|Beraprost|beraprost|mesh-list
101204430|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101204431|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
101204433|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204434|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204435|NCT01423500|Fludarabine|fludarabine|mesh-list
101204436|NCT01423500|Etoposide|etoposide|mesh-list
101204437|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
101204438|NCT01423500|Thiotepa|thiotepa|mesh-list
101204439|NCT01423500|Treosulfan|treosulfan|mesh-list
101204440|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204441|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101326988|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326989|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
101326991|NCT04705948|Analgesics|analgesics|mesh-ancestor
101326992|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
101326993|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101326994|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101326995|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101326996|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101326997|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
101326998|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
101326999|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101327000|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101327001|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101327002|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327003|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327004|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101327005|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
101327006|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101327007|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327008|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327009|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
101327010|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101327011|NCT00121888|Paroxetine|paroxetine|mesh-list
101327012|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101327013|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101327014|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327015|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327016|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327017|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
101327018|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327019|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101327020|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
101327021|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101327022|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101327023|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101327025|NCT00121966|Insulin|insulin|mesh-list
101327026|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101327027|NCT00121966|Metformin|metformin|mesh-list
101327028|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
101327029|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
101327030|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
101327031|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
101204444|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327032|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
101327033|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101327034|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327035|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
101327036|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101327037|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101327038|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101327039|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101327040|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
101327041|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327042|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327043|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327044|NCT02013492|Propranolol|propranolol|mesh-list
101327045|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101327046|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101327047|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
101327048|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327049|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327050|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327051|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101327052|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101327053|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
101327054|NCT00122356|Alendronate|alendronate|mesh-list
101327055|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101327056|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327057|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101327058|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101327059|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327060|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
101327061|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101327062|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
101327063|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327064|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327065|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101327066|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
101327067|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
101327068|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101327069|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
101327070|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327071|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327072|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
101327073|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327074|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101327076|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327077|NCT00122512|Tenofovir|tenofovir|mesh-list
101327078|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
101327079|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327080|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101327081|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327082|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327083|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327084|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327086|NCT01720407|Imiquimod|imiquimod|mesh-list
101327087|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327088|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
101327089|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327090|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327091|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
101327092|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101327093|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
101327094|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327096|NCT00122590|Lopinavir|lopinavir|mesh-list
101327097|NCT00122590|Nelfinavir|nelfinavir|mesh-list
101327098|NCT00122590|Indinavir|indinavir|mesh-list
101327099|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101327100|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101327101|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101327102|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327103|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327104|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327105|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327106|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
101327107|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327108|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101330445|NCT00030589|Methoxsalen|methoxsalen|mesh-list
101327109|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101327110|NCT00122629|Interferons|interferons|mesh-list
101327111|NCT00122629|Ribavirin|ribavirin|mesh-list
101327112|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
101327113|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
101327114|NCT00122629|Amantadine|amantadine|mesh-list
101327115|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101327116|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327117|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
101327118|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327119|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
101327120|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327121|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
101327122|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327123|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101327124|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101327125|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
101327126|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327127|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101327128|NCT00122629|Analgesics|analgesics|mesh-ancestor
101327129|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
101327130|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327131|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101327132|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101327133|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
101327134|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327136|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327137|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
101327138|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327139|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101327140|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327141|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327142|NCT05637164|Norepinephrine|norepinephrine|mesh-list
101327143|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101327144|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101327145|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
101327146|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327147|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327148|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327149|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
101327150|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
101327151|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327152|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101327153|NCT00129337|Bavituximab|bavituximab|mesh-list
101327154|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327155|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327156|NCT00129298|Tiagabine|tiagabine|mesh-list
101327157|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
101327158|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
101327159|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101327160|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327161|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327162|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
101327163|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327164|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327165|NCT00129181|Levodopa|levodopa|mesh-list
101327166|NCT00129181|Carbidopa|carbidopa|mesh-list
101327167|NCT00129181|Cabergoline|cabergoline|mesh-list
101327168|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101327169|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101327170|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101327171|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
101327172|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327173|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327174|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330448|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101327175|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101327176|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327177|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
101327178|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327179|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
101327181|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101327182|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327183|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101327184|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101327185|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327186|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327187|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327188|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101327189|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
101327190|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101327191|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327192|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101327193|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
101327194|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327195|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327196|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327197|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327198|NCT00819780|Bevacizumab|bevacizumab|mesh-list
101327199|NCT00819780|Panitumumab|panitumumab|mesh-list
101327200|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327201|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327202|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327203|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327204|NCT00819780|Growth Substances|growth substances|mesh-ancestor
101327205|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327206|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327207|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101327208|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
101327209|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327210|NCT00128791|Nitroprusside|nitroprusside|mesh-list
101327211|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101327212|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
101327213|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101327214|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327215|NCT00128752|Beta Carotene|beta carotene|mesh-list
101327216|NCT00128752|Carotenoids|carotenoids|mesh-list
101327217|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
101327218|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327219|NCT00128752|Protective Agents|protective agents|mesh-ancestor
101327220|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327221|NCT00128752|Provitamins|provitamins|mesh-ancestor
101327222|NCT00128752|Vitamins|vitamins|mesh-ancestor
101327223|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
101204561|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101327224|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101327225|NCT05638295|Panitumumab|panitumumab|mesh-list
101327226|NCT05638295|Sotorasib|sotorasib|mesh-list
101327227|NCT05638295|Antibodies|antibodies|mesh-list
101327228|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
101327229|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101327230|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
101327231|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327232|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327233|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101327234|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327235|NCT00063414|Alicaforsen|alicaforsen|mesh-list
101327236|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101327237|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327238|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
101327239|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327240|NCT05638451|Bevacizumab|bevacizumab|mesh-list
101327241|NCT05638451|Temozolomide|temozolomide|mesh-list
101327242|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327243|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327244|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327245|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327246|NCT05638451|Growth Substances|growth substances|mesh-ancestor
101327247|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327248|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327249|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327250|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
101327251|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327252|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101327253|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
101327254|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
101327255|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327256|NCT05638763|Ketoconazole|ketoconazole|mesh-list
101327257|NCT05638763|Dasatinib|dasatinib|mesh-list
101327258|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327259|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101327260|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327261|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327262|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
101327263|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327264|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101327265|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101327266|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101327267|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327268|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327269|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327270|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101327271|NCT00128635|Antibodies|antibodies|mesh-list
101327272|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101327273|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
101327274|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327275|NCT00009048|Levodopa|levodopa|mesh-list
101327276|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101327277|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101327278|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
101327279|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327280|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204579|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
101327281|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327282|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
101327283|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327284|NCT00128557|Vitamin A|vitamin a|mesh-list
101327285|NCT00128557|Vitamins|vitamins|mesh-ancestor
101327286|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
101327287|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327288|NCT00128518|Perindopril|perindopril|mesh-list
101327289|NCT00128518|Indapamide|indapamide|mesh-list
101327290|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101327291|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
101327292|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327293|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327294|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101327295|NCT00128518|Diuretics|diuretics|mesh-ancestor
101327296|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
101327297|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327298|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101327299|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327300|NCT00009204|Perphenazine|perphenazine|mesh-list
101327301|NCT00009204|Citalopram|citalopram|mesh-list
101327302|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101327303|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101327304|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327305|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327306|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327307|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
101327308|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327309|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101327310|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330466|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
101327312|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101327313|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101327314|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101327315|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101327316|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
101327317|NCT00394459|Anesthetics|anesthetics|mesh-list
101204596|NCT01424332|Analgesics|analgesics|mesh-ancestor
101327318|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101327319|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327320|NCT00394498|Lenograstim|lenograstim|mesh-list
101327321|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327322|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
101327323|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327325|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101327326|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101327327|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
101327328|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327329|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327330|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327331|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101327333|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
101327334|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327335|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101327336|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101327337|NCT00009555|Testosterone|testosterone|mesh-list
101327338|NCT00009555|Androgens|androgens|mesh-ancestor
101327339|NCT00009555|Hormones|hormones|mesh-ancestor
101327340|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327341|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327342|NCT00128479|Mifepristone|mifepristone|mesh-list
101327343|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101327344|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
101327345|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101327346|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327347|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101327348|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101327349|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101327350|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
101327351|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101327352|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101327353|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327354|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327355|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
101327356|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101327357|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101327358|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
101327359|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101327360|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
101327361|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327362|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327363|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101327364|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
101327365|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
101327366|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101327367|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
101327368|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327369|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327371|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101327372|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327373|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101327374|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
101327375|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327376|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
101327377|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327378|NCT00128323|Nystatin|nystatin|mesh-list
101327379|NCT00128323|Gentian Violet|gentian violet|mesh-list
101327380|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101327381|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327382|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327383|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
101327384|NCT00128323|Ionophores|ionophores|mesh-ancestor
101327385|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327386|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327387|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101327388|NCT00009672|Morphine|morphine|mesh-list
101327389|NCT00009672|Nortriptyline|nortriptyline|mesh-list
101327390|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101327391|NCT00009672|Narcotics|narcotics|mesh-ancestor
101327392|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101327393|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327394|NCT00009672|Analgesics|analgesics|mesh-ancestor
101327395|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
101327396|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327397|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101327398|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
101327399|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101327400|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101327401|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101327402|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327403|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327404|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
101327405|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327406|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101327407|NCT00018694|Cathartics|cathartics|mesh-ancestor
101327408|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101327409|NCT00018733|Paroxetine|paroxetine|mesh-list
101327410|NCT00018733|Desipramine|desipramine|mesh-list
101327411|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101327412|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101327413|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101327414|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327415|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327416|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
101327417|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327418|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101327419|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
101327420|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101327421|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101327422|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101327423|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327425|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101204648|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101327426|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
101327427|NCT00018850|Haloperidol|haloperidol|mesh-list
101327428|NCT00018850|Ondansetron|ondansetron|mesh-list
101327429|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
101327430|NCT00018850|Nicotine|nicotine|mesh-list
101327431|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101327432|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
101327433|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327434|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327435|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101327436|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101327437|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
101327438|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101327439|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327440|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
101327441|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101327442|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
101327443|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
101327444|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101327445|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101327446|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
101327447|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101327448|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101327449|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101327450|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101327451|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101327452|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
101327453|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101327454|NCT00009750|Cyclosporine|cyclosporine|mesh-list
101327456|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101327457|NCT00009750|Antibodies|antibodies|mesh-list
101327458|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
101327459|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101327460|NCT00009750|Cyclosporins|cyclosporins|mesh-list
101327461|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327462|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327463|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327464|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327465|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327466|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327467|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
101327468|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327469|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327470|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327471|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
101327472|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327473|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
101327474|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101327475|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101327476|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
101327477|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327478|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
101327479|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327480|NCT00019084|Aldesleukin|aldesleukin|mesh-list
101327481|NCT00019084|Vaccines|vaccines|mesh-list
101327482|NCT00019084|Sargramostim|sargramostim|mesh-list
101327483|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
101204671|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101327484|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327485|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327486|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327487|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327489|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327490|NCT00019123|Thalidomide|thalidomide|mesh-list
101327491|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327492|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
101327493|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327494|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
101327495|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327496|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327497|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327498|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327499|NCT00019123|Growth Substances|growth substances|mesh-ancestor
101327500|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327501|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327502|NCT00019240|Cidofovir|cidofovir|mesh-list
101327503|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
101327504|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327505|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327506|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327507|NCT00019357|Aldesleukin|aldesleukin|mesh-list
101327508|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327509|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327510|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327511|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
101327512|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327513|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101327514|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
101327515|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327516|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
101327517|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327518|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101327519|NCT00019396|Protective Agents|protective agents|mesh-ancestor
101327521|NCT00009828|Paclitaxel|paclitaxel|mesh-list
101327522|NCT00009828|Tegafur|tegafur|mesh-list
101327523|NCT00009828|Calcium|calcium|mesh-list
101327525|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327526|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327527|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327528|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327529|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327530|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327531|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327532|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327533|NCT00009828|Antidotes|antidotes|mesh-ancestor
101327534|NCT00009828|Protective Agents|protective agents|mesh-ancestor
101327535|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
101327536|NCT00009828|Vitamins|vitamins|mesh-ancestor
101327537|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
101327538|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327539|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
101327540|NCT00019435|Immunotoxins|immunotoxins|mesh-list
101327541|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
101327543|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327544|NCT00019474|Interferons|interferons|mesh-list
101327545|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
101327546|NCT00019474|Fluorouracil|fluorouracil|mesh-list
101327547|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
101327548|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
101327549|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327550|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327551|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327552|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327553|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
101327554|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327555|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
101327556|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327557|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
101327558|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327559|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327560|NCT00019513|Leucovorin|leucovorin|mesh-list
101327561|NCT00019513|Gemcitabine|gemcitabine|mesh-list
101327562|NCT00019513|Fluorouracil|fluorouracil|mesh-list
101327563|NCT00019513|Calcium|calcium|mesh-list
101327564|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
101327565|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327566|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
101327567|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327569|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327570|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327571|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327572|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
101327573|NCT00019513|Antidotes|antidotes|mesh-ancestor
101327576|NCT00019513|Vitamins|vitamins|mesh-ancestor
101327577|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
101327578|NCT00019552|Irofulven|irofulven|mesh-list
101327579|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327580|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
101327581|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327582|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327583|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
101327584|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327585|NCT00019591|Aldesleukin|aldesleukin|mesh-list
101327586|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327587|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327588|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327589|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
101327590|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327591|NCT00019630|Doxorubicin|doxorubicin|mesh-list
101327592|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101327593|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101327594|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327595|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327596|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327597|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327598|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327599|NCT00019669|Aldesleukin|aldesleukin|mesh-list
101204713|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
101327600|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327602|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327603|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
101327604|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327605|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
101327606|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327607|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101327608|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327609|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327610|NCT00019786|Melphalan|melphalan|mesh-list
101327611|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327612|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
101327613|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327614|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327615|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101327616|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327617|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
101327618|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327619|NCT00019825|Decitabine|decitabine|mesh-list
101327620|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327621|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
101327622|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327623|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327624|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327625|NCT00019864|Leucovorin|leucovorin|mesh-list
101327626|NCT00019864|Doxorubicin|doxorubicin|mesh-list
101327627|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101327628|NCT00019864|Methotrexate|methotrexate|mesh-list
101327629|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
101327630|NCT00019864|Razoxane|razoxane|mesh-list
101327631|NCT00019864|Calcium|calcium|mesh-list
101327632|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
101327633|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327634|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101327635|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327636|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327638|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327639|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327640|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327641|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101327643|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101327644|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327645|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
101327646|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
101327647|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101327648|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327649|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
101327650|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101327651|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327652|NCT00019864|Antidotes|antidotes|mesh-ancestor
101327653|NCT00019864|Protective Agents|protective agents|mesh-ancestor
101327654|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
101327656|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
101327657|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101327658|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327659|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327660|NCT00020176|Cyclosporine|cyclosporine|mesh-list
101327661|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
101327662|NCT00020176|Fludarabine|fludarabine|mesh-list
101327663|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
101327664|NCT00020176|Cyclosporins|cyclosporins|mesh-list
101327665|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327666|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
101327667|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327668|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101327669|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327670|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
101327671|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327673|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101327674|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327675|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
101327676|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327677|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
101327678|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327679|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101327680|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101327681|NCT00020254|Aldesleukin|aldesleukin|mesh-list
101327682|NCT00020254|Nilutamide|nilutamide|mesh-list
101327683|NCT00020254|Vaccines|vaccines|mesh-list
101327684|NCT00020254|Sargramostim|sargramostim|mesh-list
101327685|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
101548930|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101327686|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327687|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327688|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101327689|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101327690|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
101327691|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327692|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
101327693|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327694|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327696|NCT00009984|Fludarabine|fludarabine|mesh-list
101327697|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
101327698|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327699|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327700|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
101327701|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327702|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327703|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
101327704|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327705|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
101327706|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327707|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327708|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327709|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327710|NCT00009984|Growth Substances|growth substances|mesh-ancestor
101327711|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327712|NCT00020332|Docetaxel|docetaxel|mesh-list
101327714|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327715|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327716|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327717|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327718|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327719|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327720|NCT00020332|Growth Substances|growth substances|mesh-ancestor
101327721|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327722|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101327723|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327725|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327726|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
101327727|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327728|NCT00020410|Antibodies|antibodies|mesh-list
101327729|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101327730|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
101327731|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327732|NCT00020449|Paclitaxel|paclitaxel|mesh-list
101327733|NCT00020449|Doxorubicin|doxorubicin|mesh-list
101327734|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101327735|NCT00020449|Interleukin-12|interleukin-12|mesh-list
101327736|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327737|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327738|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327739|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327740|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327741|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327742|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330493|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
101327743|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327744|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327745|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327746|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101327747|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
101327748|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327749|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327750|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327751|NCT00020449|Growth Substances|growth substances|mesh-ancestor
101327752|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327754|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327755|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327756|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
101327757|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327758|NCT00020488|Leucovorin|leucovorin|mesh-list
101327759|NCT00020488|Fluorouracil|fluorouracil|mesh-list
101327760|NCT00020488|Irinotecan|irinotecan|mesh-list
101327761|NCT00020488|Calcium|calcium|mesh-list
101327762|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
101327763|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327764|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327765|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
101327766|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327767|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327768|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327769|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327770|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
101327771|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101327772|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327773|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327774|NCT00020488|Antidotes|antidotes|mesh-ancestor
101327775|NCT00020488|Protective Agents|protective agents|mesh-ancestor
101327776|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
101327777|NCT00020488|Vitamins|vitamins|mesh-ancestor
101327778|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
101327779|NCT00020527|Caspofungin|caspofungin|mesh-list
101327780|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
101327781|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327782|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327783|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327784|NCT00020566|Dactinomycin|dactinomycin|mesh-list
101327785|NCT00020566|Doxorubicin|doxorubicin|mesh-list
101327786|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101327787|NCT00020566|Etoposide|etoposide|mesh-list
101327788|NCT00020566|Vincristine|vincristine|mesh-list
101327789|NCT00020566|Melphalan|melphalan|mesh-list
101327790|NCT00020566|Busulfan|busulfan|mesh-list
101327791|NCT00020566|Ifosfamide|ifosfamide|mesh-list
101327792|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101327793|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327794|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327795|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327796|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327797|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327798|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327799|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327800|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327801|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327802|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327803|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
101327804|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101327805|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327806|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
101327807|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327808|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327809|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327810|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101327811|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327813|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
101327814|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327815|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327816|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327817|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327818|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
101327819|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327821|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101204785|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101327822|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327823|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
101327824|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327825|NCT00020644|Gemcitabine|gemcitabine|mesh-list
101327826|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327827|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
101327828|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327829|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327831|NCT00020761|Irinotecan|irinotecan|mesh-list
101327832|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327833|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327834|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327835|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327836|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327837|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327839|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327840|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327841|NCT00020800|Rituximab|rituximab|mesh-list
101327842|NCT00020800|Fludarabine|fludarabine|mesh-list
101327843|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
101327844|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327845|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327846|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
101327847|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327848|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101327849|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327850|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
101327851|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327852|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327853|NCT00020839|Temozolomide|temozolomide|mesh-list
101327854|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327855|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
101327856|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327857|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327858|NCT00010140|Tamoxifen|tamoxifen|mesh-list
101327859|NCT00010140|Docetaxel|docetaxel|mesh-list
101327860|NCT00010140|Epirubicin|epirubicin|mesh-list
101327861|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327862|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
101327863|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
101327864|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
101327865|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327866|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101327867|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327868|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327870|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101327871|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
101327872|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101327873|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327874|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101327875|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101327876|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101327877|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101327878|NCT00020878|Celecoxib|celecoxib|mesh-list
101327879|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101327880|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204808|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101327882|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
101327883|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101327884|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327885|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101327886|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101327887|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101327888|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101327889|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327890|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327891|NCT00020917|Leucovorin|leucovorin|mesh-list
101327892|NCT00020917|Fluorouracil|fluorouracil|mesh-list
101327894|NCT00020917|Cetuximab|cetuximab|mesh-list
101327895|NCT00020917|Calcium|calcium|mesh-list
101327896|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
101327897|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327898|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327900|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327901|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327902|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327903|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327904|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
101327905|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101327907|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327908|NCT00020917|Antidotes|antidotes|mesh-ancestor
101327909|NCT00020917|Protective Agents|protective agents|mesh-ancestor
101327910|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
101327911|NCT00020917|Vitamins|vitamins|mesh-ancestor
101327912|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
101327913|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327914|NCT00021034|Taurolidine|taurolidine|mesh-list
101327915|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327916|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101327917|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327918|NCT00010179|Lurtotecan|lurtotecan|mesh-list
101327919|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327920|NCT00021073|Leucovorin|leucovorin|mesh-list
101327921|NCT00021073|Fluorouracil|fluorouracil|mesh-list
101327922|NCT00021073|Irinotecan|irinotecan|mesh-list
101327923|NCT00021073|Alvocidib|alvocidib|mesh-list
101327924|NCT00021073|Calcium|calcium|mesh-list
101327925|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
101327926|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101327927|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327929|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327930|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327931|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327932|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327933|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
101327934|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101327935|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101327936|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101327937|NCT00021073|Antidotes|antidotes|mesh-ancestor
101327938|NCT00021073|Protective Agents|protective agents|mesh-ancestor
101327939|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
101327941|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
101327942|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327943|NCT00021073|Growth Substances|growth substances|mesh-ancestor
101327944|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101327945|NCT00021112|Etoposide|etoposide|mesh-list
101327946|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327947|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101327948|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101327951|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327952|NCT00000122|Fluorouracil|fluorouracil|mesh-list
101327953|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
101327954|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327955|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327956|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327957|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101327958|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
101327959|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327960|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
101327961|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101327962|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327963|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
101327964|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327965|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
101327966|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327967|NCT00021307|Carboplatin|carboplatin|mesh-list
101327969|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327970|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101327971|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
101327972|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327973|NCT00021346|Carboplatin|carboplatin|mesh-list
101327974|NCT00021346|Gemcitabine|gemcitabine|mesh-list
101327975|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327976|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101327977|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
101327978|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101327981|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101327982|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101327983|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101327984|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101327985|NCT00021385|Protective Agents|protective agents|mesh-ancestor
101327986|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101327987|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101327988|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101327990|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
101327991|NCT00021463|Lamivudine|lamivudine|mesh-list
101327992|NCT00021463|Zidovudine|zidovudine|mesh-list
101327993|NCT00021463|Efavirenz|efavirenz|mesh-list
101327994|NCT00021463|Nevirapine|nevirapine|mesh-list
101327995|NCT00021463|Abacavir|abacavir|mesh-list
101327996|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
101327997|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101327998|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101327999|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328000|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328001|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
101328002|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328003|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101328004|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101328005|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
101328006|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101328007|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101328009|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101328010|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101328011|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101328012|NCT00021502|Chrysarobin|chrysarobin|mesh-list
101328013|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101328014|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328015|NCT00021502|Analgesics|analgesics|mesh-ancestor
101328016|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
101328017|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328018|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328019|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328020|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328021|NCT00000134|Ganciclovir|ganciclovir|mesh-list
101328022|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101328023|NCT00000134|Foscarnet|foscarnet|mesh-list
101328024|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
101328025|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328026|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328027|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328028|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328029|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101328030|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
101328031|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328032|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
101204872|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101328033|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328034|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328035|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328036|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
101328037|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328038|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328039|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101328041|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328042|NCT00394693|Interferons|interferons|mesh-list
101328043|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
101328044|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328045|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
101328046|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328047|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101328048|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328049|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328050|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328051|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328052|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328054|NCT00021814|Finasteride|finasteride|mesh-list
101328055|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101328056|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101328057|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328058|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328060|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328061|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328062|NCT00021814|Urological Agents|urological agents|mesh-ancestor
101328063|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101328064|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101328065|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101328066|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101328067|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
101328068|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328069|NCT00019318|Romidepsin|romidepsin|mesh-list
101328070|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328072|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101328073|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328074|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328075|NCT00022009|Gemcitabine|gemcitabine|mesh-list
101328076|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328077|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
101328078|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328079|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328080|NCT00388661|Melatonin|melatonin|mesh-list
101328081|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
101328082|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328083|NCT00388661|Protective Agents|protective agents|mesh-ancestor
101328084|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328085|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328086|NCT00022048|Bevacizumab|bevacizumab|mesh-list
101328087|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328088|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328089|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328090|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328091|NCT00022048|Growth Substances|growth substances|mesh-ancestor
101328092|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328093|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328094|NCT00022087|Vitamin D|vitamin d|mesh-list
101328095|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
101328096|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
101328097|NCT00022087|Calcium|calcium|mesh-list
101328098|NCT00022087|Vitamins|vitamins|mesh-ancestor
101328099|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
101328101|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101328102|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101328104|NCT00388700|Bevacizumab|bevacizumab|mesh-list
101328105|NCT00388700|Fluorouracil|fluorouracil|mesh-list
101328106|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328107|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328109|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328110|NCT00388700|Growth Substances|growth substances|mesh-ancestor
101328111|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328112|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328113|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
101328114|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328115|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328116|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328117|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
101328118|NCT00388700|Antidotes|antidotes|mesh-ancestor
101328119|NCT00388700|Protective Agents|protective agents|mesh-ancestor
101328120|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
101328121|NCT00388700|Vitamins|vitamins|mesh-ancestor
101328122|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
101328124|NCT00022126|Cyclosporine|cyclosporine|mesh-list
101328125|NCT00022126|Dexamethasone|dexamethasone|mesh-list
101328126|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
101328127|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
101328128|NCT00022126|Doxorubicin|doxorubicin|mesh-list
101328129|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101328130|NCT00022126|Methotrexate|methotrexate|mesh-list
101328131|NCT00022126|Vincristine|vincristine|mesh-list
101328132|NCT00022126|Daunorubicin|daunorubicin|mesh-list
101328133|NCT00022126|Asparaginase|asparaginase|mesh-list
101328134|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
101328135|NCT00022126|Pegaspargase|pegaspargase|mesh-list
101328136|NCT00022126|Thioguanine|thioguanine|mesh-list
101328137|NCT00022126|Cyclosporins|cyclosporins|mesh-list
101328138|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328139|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
101328140|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328141|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328142|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204926|NCT05386290|Infliximab|infliximab|mesh-list
101328143|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
101328144|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328145|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328146|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101328147|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328149|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
101328150|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328151|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101328152|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
101328153|NCT00022126|Hormones|hormones|mesh-ancestor
101328154|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328155|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101328156|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328157|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328158|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328159|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328160|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101328161|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
101328162|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101328163|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328164|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
101328165|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
101328166|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101328167|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328168|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
101328170|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328171|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328172|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328173|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328174|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
101328175|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101328176|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101328177|NCT00022126|Protective Agents|protective agents|mesh-ancestor
101328179|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
101328180|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328181|NCT00022165|Protective Agents|protective agents|mesh-ancestor
101328182|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328183|NCT00022165|Trace Elements|trace elements|mesh-ancestor
101328184|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
101328186|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
101328187|NCT00022204|Vitamins|vitamins|mesh-ancestor
101328188|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
101328189|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328190|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
101328191|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328192|NCT00022204|Protective Agents|protective agents|mesh-ancestor
101328193|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101328194|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328195|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101328196|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101328197|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
101328198|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101328199|NCT00388739|Prednisolone|prednisolone|mesh-list
101328200|NCT00388739|Budesonide|budesonide|mesh-list
101328201|NCT00388739|Albuterol|albuterol|mesh-list
101328202|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328203|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
101328204|NCT00388739|Hormones|hormones|mesh-ancestor
101328205|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328206|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328207|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101328208|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328209|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
101328210|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328211|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101328212|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101328213|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
101328214|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
101328215|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101328216|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101328217|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101328218|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101328219|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
101328220|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328221|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328223|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328224|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328226|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
101328227|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
101328228|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328230|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328231|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101328232|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328233|NCT00022399|Celecoxib|celecoxib|mesh-list
101328234|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101328235|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328236|NCT00022399|Analgesics|analgesics|mesh-ancestor
101328237|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
101328238|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328239|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328240|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328241|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328242|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101328243|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101328244|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328245|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328247|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101328249|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
101328250|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328251|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328253|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328254|NCT00022438|Aldesleukin|aldesleukin|mesh-list
101328255|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
101328256|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328257|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101204956|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328258|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101328259|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
101328260|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328261|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101328262|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
101548994|NCT02879227|Cisplatin|cisplatin|mesh-list
101328263|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328264|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
101328265|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101328267|NCT00010686|Hormones|hormones|mesh-ancestor
101328268|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328269|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328270|NCT00022555|Vincristine|vincristine|mesh-list
101328271|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
101328272|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328273|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328274|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328275|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328276|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328277|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328278|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101328279|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
101328280|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328282|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
101328283|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101328284|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101328285|NCT00000146|Prednisolone|prednisolone|mesh-list
101328286|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
101328287|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101328289|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328290|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
101328291|NCT00000146|Hormones|hormones|mesh-ancestor
101328292|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328293|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328294|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101328295|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328296|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
101328297|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
101328298|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328299|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101328300|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101328301|NCT00000146|Protective Agents|protective agents|mesh-ancestor
101328302|NCT00010725|Vitamins|vitamins|mesh-list
101328303|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
101328304|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328305|NCT00022594|Lurtotecan|lurtotecan|mesh-list
101328308|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101328309|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
101328310|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328311|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328312|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328313|NCT00022711|Temozolomide|temozolomide|mesh-list
101204978|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101328314|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328315|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
101328316|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328317|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328319|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
101328320|NCT00010842|Selenium|selenium|mesh-list
101328321|NCT00010842|Vitamins|vitamins|mesh-ancestor
101328322|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
101328323|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328324|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
101328325|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328326|NCT00010842|Protective Agents|protective agents|mesh-ancestor
101328327|NCT00010842|Trace Elements|trace elements|mesh-ancestor
101328328|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
101328329|NCT00000152|Aspirin|aspirin|mesh-list
101328330|NCT00000152|Beta Carotene|beta carotene|mesh-list
101328331|NCT00000152|Carotenoids|carotenoids|mesh-list
101328332|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101328333|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328334|NCT00000152|Analgesics|analgesics|mesh-ancestor
101328335|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
101328336|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328337|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328338|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328339|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328340|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101328341|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101328342|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328343|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101328344|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101328345|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328346|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
101328347|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
101328348|NCT00000152|Protective Agents|protective agents|mesh-ancestor
101328349|NCT00000152|Provitamins|provitamins|mesh-ancestor
101328350|NCT00000152|Vitamins|vitamins|mesh-ancestor
101328352|NCT00010881|Antioxidants|antioxidants|mesh-list
101328353|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328354|NCT00010881|Protective Agents|protective agents|mesh-ancestor
101328355|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328356|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
101328357|NCT00022906|Antibodies|antibodies|mesh-list
101328358|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
101328359|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328360|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328362|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
101328363|NCT00022945|Doxorubicin|doxorubicin|mesh-list
101204997|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205020|NCT05385094|Cystatins|cystatins|mesh-list
101328364|NCT00022945|Vincristine|vincristine|mesh-list
101328365|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
101328366|NCT00022945|Antibodies|antibodies|mesh-list
101328367|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328368|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
101328369|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328370|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328371|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328372|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
101328373|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328374|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328375|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101328376|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328377|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328378|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328380|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328381|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
101328382|NCT00022945|Hormones|hormones|mesh-ancestor
101328383|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328384|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101328385|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330532|NCT00000554|Dobutamine|dobutamine|mesh-list
101328386|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328387|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328388|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328391|NCT00023218|Efavirenz|efavirenz|mesh-list
101328392|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101328393|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101328394|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
101328395|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328396|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328397|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101328398|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101328399|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
101328400|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328401|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101328402|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101328403|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101328404|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328405|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101328406|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101328407|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101328408|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101328409|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101328410|NCT00394966|Rolapitant|rolapitant|mesh-list
101328411|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101328412|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328413|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328414|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328416|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101328417|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101328418|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101328419|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
101328420|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328421|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328422|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101328424|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
101328425|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
101328426|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101328427|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101328428|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
101328429|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328430|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328432|NCT02024607|Bevacizumab|bevacizumab|mesh-list
101328433|NCT02024607|Fluorouracil|fluorouracil|mesh-list
101328434|NCT02024607|Capecitabine|capecitabine|mesh-list
101328435|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
101328436|NCT02024607|Irinotecan|irinotecan|mesh-list
101328437|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328438|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328439|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328440|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328441|NCT02024607|Growth Substances|growth substances|mesh-ancestor
101328442|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328443|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328444|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
101328445|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328446|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328447|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328448|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
101328449|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101330545|NCT00012909|Hormones|hormones|mesh-list
101328450|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328451|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328452|NCT02024607|Antidotes|antidotes|mesh-ancestor
101328453|NCT02024607|Protective Agents|protective agents|mesh-ancestor
101328454|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
101328455|NCT02024607|Vitamins|vitamins|mesh-ancestor
101328456|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
101328457|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
101328458|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101328459|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
101328460|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328461|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328462|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101328463|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
101328464|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101328465|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
101328466|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328467|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328468|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101328469|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
101328470|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
101328471|NCT00023296|Protective Agents|protective agents|mesh-ancestor
101328472|NCT00023335|Isoniazid|isoniazid|mesh-list
101328473|NCT00023335|Rifapentine|rifapentine|mesh-list
101328474|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
101328475|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101328476|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328477|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101328478|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101328480|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328481|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101328482|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101328483|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
101328486|NCT00000173|Vitamins|vitamins|mesh-ancestor
101328487|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
101328488|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328489|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101328490|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328491|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328492|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
101328493|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328495|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
101328496|NCT00000173|Protective Agents|protective agents|mesh-ancestor
101328497|NCT00023374|Rifampin|rifampin|mesh-list
101328498|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
101328499|NCT00023374|Ethambutol|ethambutol|mesh-list
101328500|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101328501|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
101328502|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101328503|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328504|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
101328505|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328506|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330547|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328507|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328508|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101328509|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101328510|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101328511|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101328512|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101328513|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101328515|NCT00023413|Rifabutin|rifabutin|mesh-list
101328516|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101328517|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328519|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328520|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
101328521|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328522|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101328523|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101328524|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101328525|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101328526|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101328527|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101328528|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101328529|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101328530|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
101328531|NCT00023530|Thalidomide|thalidomide|mesh-list
101328532|NCT00023530|Fluconazole|fluconazole|mesh-list
101205059|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205060|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328533|NCT00023530|Voriconazole|voriconazole|mesh-list
101328534|NCT00023530|Dexamethasone|dexamethasone|mesh-list
101328535|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328536|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
101328537|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
101328538|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328539|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328540|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101328542|NCT00023530|Hormones|hormones|mesh-ancestor
101328543|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328544|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101328545|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328546|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328547|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
101328548|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
101328549|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101328550|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328551|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328552|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328553|NCT00023530|Growth Substances|growth substances|mesh-ancestor
101328554|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328555|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
101328556|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101328557|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101328558|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328559|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328560|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101328561|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
101328562|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101328563|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101328564|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101328565|NCT00000176|Progesterone|progesterone|mesh-list
101328567|NCT00000176|Progestins|progestins|mesh-ancestor
101328568|NCT00000176|Hormones|hormones|mesh-ancestor
101328569|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328570|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328572|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
101328573|NCT00000179|Trazodone|trazodone|mesh-list
101328574|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
101328575|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
101328576|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328577|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328578|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101328579|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101328580|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101328581|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328582|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101328583|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101328584|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
101328585|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328586|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328587|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101328588|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101328589|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101328590|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101328591|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101328592|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
101328593|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101328594|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
101328595|NCT00023725|Semaxinib|semaxinib|mesh-list
101328596|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328597|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328598|NCT00023725|Growth Substances|growth substances|mesh-ancestor
101328599|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328600|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328601|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328602|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101328603|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328604|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328605|NCT00391404|Alendronate|alendronate|mesh-list
101328606|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101328607|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328609|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
101328610|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
101328611|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101328612|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328613|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328614|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101328615|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328617|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
101328618|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328619|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101328620|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101328621|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328622|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101328623|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101328625|NCT00023842|Mitomycin|mitomycin|mesh-list
101328627|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328628|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328629|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
101328630|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328631|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328632|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328633|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101205091|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
101328634|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
101328635|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328638|NCT00000221|Narcotics|narcotics|mesh-ancestor
101328639|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328640|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328641|NCT00000221|Analgesics|analgesics|mesh-ancestor
101328642|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
101328643|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328644|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101328646|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328647|NCT00023920|Cytarabine|cytarabine|mesh-list
101328648|NCT00023920|Bevacizumab|bevacizumab|mesh-list
101328649|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101328650|NCT00023920|Idarubicin|idarubicin|mesh-list
101328651|NCT00023920|Antibodies|antibodies|mesh-list
101328652|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
101328653|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101328654|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328655|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328656|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328657|NCT00023920|Growth Substances|growth substances|mesh-ancestor
101328658|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328659|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328660|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
101328661|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328662|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
101328663|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328664|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
101328665|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328666|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328667|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328668|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328669|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328670|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328671|NCT00023959|Bevacizumab|bevacizumab|mesh-list
101328672|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101328673|NCT00023959|Fluorouracil|fluorouracil|mesh-list
101328674|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
101328675|NCT00023959|Antibodies|antibodies|mesh-list
101328676|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
101328677|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101328678|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328679|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328680|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328681|NCT00023959|Growth Substances|growth substances|mesh-ancestor
101328682|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328683|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205120|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328684|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
101328685|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
101328686|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328687|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328688|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328689|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
101328690|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328691|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328692|NCT00023998|Leucovorin|leucovorin|mesh-list
101328693|NCT00023998|Doxorubicin|doxorubicin|mesh-list
101328694|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101328695|NCT00023998|Methotrexate|methotrexate|mesh-list
101328696|NCT00023998|Trastuzumab|trastuzumab|mesh-list
101328697|NCT00023998|Etoposide|etoposide|mesh-list
101328698|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
101328699|NCT00023998|Ifosfamide|ifosfamide|mesh-list
101328700|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
101328701|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328702|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328703|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328704|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328705|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328706|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328707|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328708|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101328709|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
101328710|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101328711|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328712|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
101328713|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
101328714|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101328715|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328716|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
101328717|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328718|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328719|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328720|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328721|NCT00023998|Antidotes|antidotes|mesh-ancestor
101328722|NCT00023998|Protective Agents|protective agents|mesh-ancestor
101328723|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
101328724|NCT00023998|Vitamins|vitamins|mesh-ancestor
101328725|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
101328726|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328727|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
101328728|NCT00024115|Antibodies|antibodies|mesh-list
101328729|NCT00024115|Immunotoxins|immunotoxins|mesh-list
101328730|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
101328731|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
101328732|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328733|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
101328734|NCT00024154|Trastuzumab|trastuzumab|mesh-list
101328735|NCT00024154|Gefitinib|gefitinib|mesh-list
101328736|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328738|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101328740|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328741|NCT00011076|Pirfenidone|pirfenidone|mesh-list
101328742|NCT00011076|Analgesics|analgesics|mesh-ancestor
101328743|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
101328744|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328745|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328746|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101328747|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328748|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328749|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328750|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328751|NCT00000248|Pergolide|pergolide|mesh-list
101328752|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
101328753|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
101328754|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328755|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328756|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328757|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
101328759|NCT00024193|Busulfan|busulfan|mesh-list
101328760|NCT00024193|Doxorubicin|doxorubicin|mesh-list
101328761|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101328762|NCT00024193|Etoposide|etoposide|mesh-list
101328763|NCT00024193|Vincristine|vincristine|mesh-list
101328764|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328766|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328767|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328768|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328769|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
101328770|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328771|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328772|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101328773|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328774|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328775|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328776|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328777|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328778|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328779|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328780|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328781|NCT00024232|Antibodies|antibodies|mesh-list
101328782|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101328783|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
101328784|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328785|NCT00024271|Interferons|interferons|mesh-list
101328786|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
101328787|NCT00024271|Gemcitabine|gemcitabine|mesh-list
101328788|NCT00024271|Doxorubicin|doxorubicin|mesh-list
101328789|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101328790|NCT00024271|Mitomycins|mitomycins|mesh-list
101328791|NCT00024271|Mitomycin|mitomycin|mesh-list
101328792|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328793|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328794|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
101328795|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328796|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328797|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328798|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328799|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328800|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
101328801|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328802|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
101328803|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328804|NCT00024310|Folic Acid|folic acid|mesh-list
101328805|NCT00024310|Paclitaxel|paclitaxel|mesh-list
101328806|NCT00024310|Lometrexol|lometrexol|mesh-list
101328807|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328808|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328809|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328810|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328811|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328812|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328813|NCT00024310|Hematinics|hematinics|mesh-ancestor
101328814|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
101328815|NCT00024310|Vitamins|vitamins|mesh-ancestor
101328816|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
101328817|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328818|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328819|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
101328820|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101328821|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328822|NCT00024349|Fluorouracil|fluorouracil|mesh-list
101328823|NCT00024349|Mitomycins|mitomycins|mesh-list
101328824|NCT00024349|Mitomycin|mitomycin|mesh-list
101328825|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
101328826|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328827|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328828|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328829|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328830|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
101328831|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328832|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328833|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
101328834|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328835|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328836|NCT00000251|Isoflurane|isoflurane|mesh-list
101328837|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101328838|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
101328840|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328841|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328842|NCT00024388|Paclitaxel|paclitaxel|mesh-list
101328843|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328844|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328845|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
101328846|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
101328847|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328848|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328850|NCT00024427|Fluorouracil|fluorouracil|mesh-list
101328851|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328852|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
101328853|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328854|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328855|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328856|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
101328857|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328858|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
101328859|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101328860|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
101328861|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
101328862|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101328863|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328864|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328865|NCT00000257|Analgesics|analgesics|mesh-ancestor
101328866|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
101328867|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328868|NCT00024466|Vaccines|vaccines|mesh-list
101328869|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
101328870|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328871|NCT04733131|Abatacept|abatacept|mesh-list
101328872|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101328873|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328874|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101328875|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328876|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328877|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
101328878|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328879|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328880|NCT00024544|Antibodies|antibodies|mesh-list
101328881|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101328882|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
101328883|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328884|NCT00395239|Budesonide|budesonide|mesh-list
101328885|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328886|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101328887|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
101328888|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328889|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328890|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101328891|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
101328892|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
101328893|NCT00395239|Hormones|hormones|mesh-ancestor
101328894|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101328895|NCT00025012|Isotretinoin|isotretinoin|mesh-list
101328896|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101328897|NCT00025051|Celecoxib|celecoxib|mesh-list
101328898|NCT00025051|Mitogens|mitogens|mesh-list
101328899|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101328900|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101328901|NCT00025051|Analgesics|analgesics|mesh-ancestor
101328902|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
101328903|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101328904|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328905|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101328906|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328907|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101328908|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101328909|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328910|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328911|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
101328912|NCT00025090|Fluorouracil|fluorouracil|mesh-list
101328914|NCT00025090|Mitomycin|mitomycin|mesh-list
101328915|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328916|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
101328917|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328918|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328919|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328920|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
101328921|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328922|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101328923|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
101328924|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101328925|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328926|NCT00000368|Paroxetine|paroxetine|mesh-list
101328927|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101328928|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101328929|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101328930|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328931|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101328932|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
101328933|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328934|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101328935|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
101328936|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101328937|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101328938|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101328939|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328940|NCT00025168|Gemcitabine|gemcitabine|mesh-list
101328941|NCT00025168|Irinotecan|irinotecan|mesh-list
101328942|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101328943|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
101328944|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328945|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328946|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101328947|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328948|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328949|NCT00025207|Gefitinib|gefitinib|mesh-list
101328950|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328951|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101328952|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328953|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205235|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
101328954|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
101328955|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328956|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101328957|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328958|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328959|NCT00025285|Thalidomide|thalidomide|mesh-list
101328960|NCT00025285|Carboplatin|carboplatin|mesh-list
101328961|NCT00025285|Irinotecan|irinotecan|mesh-list
101328962|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328963|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101328964|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328965|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328966|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328967|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328968|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
101328969|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328970|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
101328971|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101328972|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101328973|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101328974|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101328975|NCT00025285|Growth Substances|growth substances|mesh-ancestor
101328976|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
101328977|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
101328979|NCT00025324|Carboplatin|carboplatin|mesh-list
101328980|NCT00025324|Etoposide|etoposide|mesh-list
101328981|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101328982|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
101328983|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101328984|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101328985|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101328986|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
101328987|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101328988|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101328989|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101328990|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101328991|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101328992|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101328993|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101328994|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
101328995|NCT00025363|Ifosfamide|ifosfamide|mesh-list
101328996|NCT00025363|Doxorubicin|doxorubicin|mesh-list
101328997|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101328998|NCT00025363|Irinotecan|irinotecan|mesh-list
101328999|NCT00025363|Etoposide|etoposide|mesh-list
101329000|NCT00025363|Vincristine|vincristine|mesh-list
101205254|NCT04203472|Hormones|hormones|mesh-ancestor
101205256|NCT04166071|Naltrexone|naltrexone|mesh-list
101329001|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
101329002|NCT00025363|Tirapazamine|tirapazamine|mesh-list
101329003|NCT00025363|Sargramostim|sargramostim|mesh-list
101329004|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329005|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
101329006|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329007|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329008|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329009|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
101329010|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329011|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329012|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329013|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329014|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329015|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329016|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329017|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101329018|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329019|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329020|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329021|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329022|NCT00025402|Interferons|interferons|mesh-list
101329023|NCT00025402|Cytarabine|cytarabine|mesh-list
101329024|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
101329025|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
101329026|NCT00025402|Busulfan|busulfan|mesh-list
101329027|NCT00025402|Etoposide|etoposide|mesh-list
101329028|NCT00025402|Idarubicin|idarubicin|mesh-list
101329029|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
101329030|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329031|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
101329032|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329033|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329034|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329035|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
101329036|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329037|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329038|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329039|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329040|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329041|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329042|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329043|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
101329044|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329045|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329046|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
101329047|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329048|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
101329049|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329051|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
101329052|NCT00025441|Ifosfamide|ifosfamide|mesh-list
101329053|NCT00025441|Carboplatin|carboplatin|mesh-list
101329054|NCT00025441|Doxorubicin|doxorubicin|mesh-list
101329055|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101329056|NCT00025441|Etoposide|etoposide|mesh-list
101329057|NCT00025441|Vincristine|vincristine|mesh-list
101329058|NCT00025441|Epirubicin|epirubicin|mesh-list
101329059|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329060|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
101329061|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329062|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329063|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329064|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
101329065|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329066|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329067|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329068|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329069|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329070|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329071|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329072|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329073|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329074|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329075|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329076|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329077|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329078|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101329079|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329080|NCT00000395|Folic Acid|folic acid|mesh-list
101329081|NCT00000395|Leucovorin|leucovorin|mesh-list
101329082|NCT00000395|Methotrexate|methotrexate|mesh-list
101329083|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
101329084|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101329085|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
101329086|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329087|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329088|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329089|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
101205313|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101205321|NCT03708198|Bupivacaine|bupivacaine|mesh-list
101329090|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329091|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329092|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329093|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329094|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101329095|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329096|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
101329097|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329098|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329099|NCT00000395|Hematinics|hematinics|mesh-ancestor
101329100|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
101329101|NCT00000395|Vitamins|vitamins|mesh-ancestor
101329102|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
101329103|NCT00000395|Antidotes|antidotes|mesh-ancestor
101329104|NCT00000395|Protective Agents|protective agents|mesh-ancestor
101329105|NCT00025480|Paclitaxel|paclitaxel|mesh-list
101329106|NCT00025480|Carboplatin|carboplatin|mesh-list
101329107|NCT00025480|Tipifarnib|tipifarnib|mesh-list
101329108|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329109|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329110|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329111|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329112|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329113|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329114|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
101329115|NCT00025519|Thalidomide|thalidomide|mesh-list
101329116|NCT00025519|Fludarabine|fludarabine|mesh-list
101329117|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
101329118|NCT00025519|Tacrolimus|tacrolimus|mesh-list
101329119|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329120|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329121|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
101329122|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329123|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329124|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
101329125|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329126|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101329127|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329128|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329129|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101329130|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
101329131|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329132|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329133|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
101329134|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329135|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205344|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101329137|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329138|NCT00025558|Carboplatin|carboplatin|mesh-list
101329139|NCT00025558|Temozolomide|temozolomide|mesh-list
101329140|NCT00025558|Thiotepa|thiotepa|mesh-list
101329141|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329142|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
101329143|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329144|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329145|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
101329146|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329147|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329148|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329149|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
101329151|NCT00025597|Doxorubicin|doxorubicin|mesh-list
101329152|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101329153|NCT00025597|Etoposide|etoposide|mesh-list
101329154|NCT00025597|Vincristine|vincristine|mesh-list
101329155|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329156|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
101329157|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329158|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329159|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329160|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
101329161|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329162|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329163|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329164|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329165|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329166|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329167|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329168|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329169|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329170|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329171|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329172|NCT00025636|Cytarabine|cytarabine|mesh-list
101329173|NCT00025636|Dexamethasone|dexamethasone|mesh-list
101329175|NCT00025636|Melphalan|melphalan|mesh-list
101329176|NCT00025636|Carmustine|carmustine|mesh-list
101329177|NCT00025636|Methotrexate|methotrexate|mesh-list
101329178|NCT00025636|Etoposide|etoposide|mesh-list
101329179|NCT00025636|Vincristine|vincristine|mesh-list
101329180|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329181|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
101329182|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329183|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329184|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329185|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
101329186|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329187|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329188|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329189|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101329190|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
101329191|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
101329192|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329193|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101329194|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
101329195|NCT00025636|Hormones|hormones|mesh-ancestor
101329196|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329197|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329198|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101329200|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329201|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329202|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
101329204|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329205|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101329206|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329207|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329208|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329209|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329211|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329212|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329213|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329214|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329215|NCT00025675|Gefitinib|gefitinib|mesh-list
101329216|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205404|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
101205413|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
101329217|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329219|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329220|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
101329221|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101329222|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329223|NCT00025792|Pramipexole|pramipexole|mesh-list
101329224|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
101329225|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329226|NCT00025792|Protective Agents|protective agents|mesh-ancestor
101329227|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329229|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101329231|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
101329232|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329233|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101329234|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101329235|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101329236|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
101329237|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329238|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329239|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101329240|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101329241|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329242|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329243|NCT00000419|Estrogens|estrogens|mesh-ancestor
101329244|NCT00000419|Hormones|hormones|mesh-ancestor
101329245|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329246|NCT00026104|Paclitaxel|paclitaxel|mesh-list
101329247|NCT00026104|Gemcitabine|gemcitabine|mesh-list
101329249|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329250|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329251|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329252|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329253|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329254|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329255|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329256|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
101329258|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
101329259|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
101329260|NCT00026143|Interleukin-12|interleukin-12|mesh-list
101329261|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329262|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
101329263|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329264|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
101329265|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329266|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101329267|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329268|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329270|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329271|NCT00026182|Rituximab|rituximab|mesh-list
101329272|NCT00026182|Interleukin-12|interleukin-12|mesh-list
101329273|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101329274|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329275|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
101329276|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329277|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329278|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101329279|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329281|NCT00026182|Growth Substances|growth substances|mesh-ancestor
101329282|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329284|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329285|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329286|NCT00026260|Growth Substances|growth substances|mesh-ancestor
101329287|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329289|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329290|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329291|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329292|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329293|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
101329294|NCT00026299|Gefitinib|gefitinib|mesh-list
101329295|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329296|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329297|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329298|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329299|NCT00026338|Gemcitabine|gemcitabine|mesh-list
101329300|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101329301|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329302|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
101329303|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329304|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329305|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329306|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329307|NCT00026377|Leuprolide|leuprolide|mesh-list
101329308|NCT00026377|Goserelin|goserelin|mesh-list
101329309|NCT00026377|Flutamide|flutamide|mesh-list
101329310|NCT00026377|Bicalutamide|bicalutamide|mesh-list
101329311|NCT00026377|Semaxinib|semaxinib|mesh-list
101329312|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101329313|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
101329314|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329315|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329316|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329317|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329318|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
101329319|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
101329320|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329321|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329322|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329323|NCT00026377|Growth Substances|growth substances|mesh-ancestor
101329324|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329325|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329326|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329327|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329328|NCT00026416|Interferons|interferons|mesh-list
101329329|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
101329330|NCT00026416|Thalidomide|thalidomide|mesh-list
101329331|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329332|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
101329333|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329334|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
101329335|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329336|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329337|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
101329338|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329339|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329340|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329341|NCT00026416|Growth Substances|growth substances|mesh-ancestor
101329342|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329343|NCT00026533|Thalidomide|thalidomide|mesh-list
101329344|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329345|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
101549066|NCT01078675|Calcium|calcium|mesh-list
101329346|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329347|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
101329348|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329349|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329350|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329351|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329352|NCT00026533|Growth Substances|growth substances|mesh-ancestor
101329353|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329354|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329355|NCT00026962|Estradiol|estradiol|mesh-list
101329356|NCT00026962|Progesterone|progesterone|mesh-list
101205493|NCT01426165|Analgesics|analgesics|mesh-ancestor
101329357|NCT00026962|Estrogens|estrogens|mesh-ancestor
101329358|NCT00026962|Hormones|hormones|mesh-ancestor
101329359|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329360|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329361|NCT00026962|Progestins|progestins|mesh-ancestor
101329362|NCT00027040|Selegiline|selegiline|mesh-list
101329363|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
101329364|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101329365|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101329366|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101329367|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101329368|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329369|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329370|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101329371|NCT00027040|Protective Agents|protective agents|mesh-ancestor
101329372|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329373|NCT00027079|Naltrexone|naltrexone|mesh-list
101329374|NCT00027079|Ondansetron|ondansetron|mesh-list
101329375|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101329376|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101329377|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329378|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
101329379|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329381|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
101329382|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101329383|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
101329384|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329385|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101329386|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101329388|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329389|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329390|NCT00011778|Bortezomib|bortezomib|mesh-list
101329391|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329392|NCT00000425|Acetaminophen|acetaminophen|mesh-list
101329393|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101329394|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101329395|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101329396|NCT00000425|Analgesics|analgesics|mesh-ancestor
101329397|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
101329398|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329399|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329401|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329402|NCT00000428|Amitriptyline|amitriptyline|mesh-list
101329403|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101329404|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
101329405|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101329406|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101329407|NCT00000428|Analgesics|analgesics|mesh-ancestor
101329408|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
101329409|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329410|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205529|NCT01426399|Metformin|metformin|mesh-list
101329411|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101329412|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101329413|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101329414|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329416|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329417|NCT00027391|Albuterol|albuterol|mesh-list
101329418|NCT00027391|Oxandrolone|oxandrolone|mesh-list
101329419|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101329420|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
101329421|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329422|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329423|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101329424|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
101329425|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
101329426|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329427|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101329428|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101329429|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101329430|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
101329431|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329432|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329433|NCT00027391|Androgens|androgens|mesh-ancestor
101329434|NCT00027391|Hormones|hormones|mesh-ancestor
101329435|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329436|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
101329438|NCT00000461|Pravastatin|pravastatin|mesh-list
101329439|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
101329440|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
101329441|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101329442|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
101329443|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329444|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101329445|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
101329446|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
101329447|NCT00000461|Vitamins|vitamins|mesh-ancestor
101329448|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
101329449|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329450|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101329451|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101329452|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329453|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101329454|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329455|NCT00027508|Trabectedin|trabectedin|mesh-list
101329456|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329457|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
101329458|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329459|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329461|NCT00027547|Cyclosporine|cyclosporine|mesh-list
101329462|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
101329463|NCT00027547|Methotrexate|methotrexate|mesh-list
101329464|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
101329465|NCT00027547|Fludarabine|fludarabine|mesh-list
101329466|NCT00027547|Cyclosporins|cyclosporins|mesh-list
101329467|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101329468|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
101329469|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329470|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329471|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329472|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
101329473|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329474|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329475|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329477|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101329478|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329479|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
101329480|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329481|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329482|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
101329483|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329484|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
101329485|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101329486|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329487|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101329488|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
101329489|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329490|NCT00011895|Lamivudine|lamivudine|mesh-list
101329491|NCT00011895|Zidovudine|zidovudine|mesh-list
101329492|NCT00011895|Efavirenz|efavirenz|mesh-list
101329493|NCT00011895|Abacavir|abacavir|mesh-list
101329494|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101329495|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329496|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329497|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329498|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
101329499|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329501|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329502|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
101329503|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101329504|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329505|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101329506|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101329507|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101329508|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101329509|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
101329510|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329511|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329512|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329513|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329514|NCT00000464|Quinidine|quinidine|mesh-list
101329515|NCT00000464|Amiodarone|amiodarone|mesh-list
101329516|NCT00000464|Sotalol|sotalol|mesh-list
101329517|NCT00000464|Propafenone|propafenone|mesh-list
101329518|NCT00000464|Mexiletine|mexiletine|mesh-list
101329519|NCT00000464|Procainamide|procainamide|mesh-list
101329520|NCT00000464|Imipramine|imipramine|mesh-list
101329521|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101329522|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
101329523|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101329524|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101329525|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329526|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101329527|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101329528|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329529|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329530|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101329531|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101329532|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101329533|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101329534|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101329535|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
101329536|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101329537|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329538|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
101329539|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
101330657|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101416461|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
101329540|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329541|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101329542|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
101329543|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101329544|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101329545|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101329546|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101329547|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
101329548|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101329549|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101329550|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329551|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101329552|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101329554|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101205617|NCT01426971|Ibuprofen|ibuprofen|mesh-list
101329557|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329558|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
101329559|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329560|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329561|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101329562|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329563|NCT00027664|Interferons|interferons|mesh-list
101329564|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
101329565|NCT00027664|Thalidomide|thalidomide|mesh-list
101329566|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329567|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
101329568|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329569|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
101329570|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329571|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329572|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
101329573|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329574|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329575|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329577|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329578|NCT00027703|Bevacizumab|bevacizumab|mesh-list
101329579|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101329580|NCT00027703|Gemcitabine|gemcitabine|mesh-list
101329582|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
101329583|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101329584|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329585|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329586|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329587|NCT00027703|Growth Substances|growth substances|mesh-ancestor
101329588|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329589|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329590|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
101329591|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329592|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
101329593|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329594|NCT00011934|Interferons|interferons|mesh-list
101329595|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
101329596|NCT00011934|Sargramostim|sargramostim|mesh-list
101329597|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329598|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
101329599|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329600|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
101329601|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329602|NCT00027742|Interferons|interferons|mesh-list
101329603|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
101329604|NCT00027742|Temozolomide|temozolomide|mesh-list
101329605|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329606|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
101329607|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549100|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101329608|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329609|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
101329610|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329611|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
101329612|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329613|NCT00027820|Cyclosporine|cyclosporine|mesh-list
101329614|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
101329615|NCT00027820|Fludarabine|fludarabine|mesh-list
101329616|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
101329617|NCT00027820|Cyclosporins|cyclosporins|mesh-list
101329618|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329619|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329620|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
101329621|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329622|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329623|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
101329624|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329625|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329626|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
101329627|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329628|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329629|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329630|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101329631|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329632|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101329633|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
101329634|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329636|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329637|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101329638|NCT00011973|Protective Agents|protective agents|mesh-ancestor
101329639|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329640|NCT00027898|Carboplatin|carboplatin|mesh-list
101329641|NCT00027898|Etoposide|etoposide|mesh-list
101329642|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
101329643|NCT00027898|Bortezomib|bortezomib|mesh-list
101329644|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329645|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329646|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329647|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329648|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329649|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329650|NCT00027937|Aldesleukin|aldesleukin|mesh-list
101329651|NCT00027937|Paclitaxel|paclitaxel|mesh-list
101329652|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
101329653|NCT00027937|Melphalan|melphalan|mesh-list
101329654|NCT00027937|Busulfan|busulfan|mesh-list
101329655|NCT00027937|Thiotepa|thiotepa|mesh-list
101329656|NCT00027937|Sargramostim|sargramostim|mesh-list
101329657|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329658|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329659|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329660|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329661|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329662|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329663|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329664|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
101329665|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329666|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329667|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329668|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
101329669|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329670|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101329671|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329672|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
101329673|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329675|NCT00012051|Dexamethasone|dexamethasone|mesh-list
101329676|NCT00012051|Rituximab|rituximab|mesh-list
101329677|NCT00012051|Methotrexate|methotrexate|mesh-list
101329678|NCT00012051|Etoposide|etoposide|mesh-list
101329679|NCT00012051|Melphalan|melphalan|mesh-list
101329680|NCT00012051|Ifosfamide|ifosfamide|mesh-list
101329681|NCT00012051|Carmustine|carmustine|mesh-list
101330671|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101329682|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101329683|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329684|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
101329685|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329686|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329687|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101329689|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
101329690|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329691|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101329692|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
101329693|NCT00012051|Hormones|hormones|mesh-ancestor
101329694|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329695|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329696|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101329697|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
101329698|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329699|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329701|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329702|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329703|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329704|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101329705|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329706|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329707|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329708|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329709|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329711|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329712|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329713|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
101329714|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101205668|NCT01427192|Acetazolamide|acetazolamide|mesh-list
101329716|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101329717|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101329718|NCT00027976|Analgesics|analgesics|mesh-ancestor
101329719|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
101329720|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329722|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101329724|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101329725|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101329726|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329727|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329728|NCT00000479|Aspirin|aspirin|mesh-list
101329729|NCT00000479|Vitamin E|vitamin e|mesh-list
101329730|NCT00000479|Vitamins|vitamins|mesh-ancestor
101329731|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
101329732|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329733|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101329734|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101329735|NCT00000479|Analgesics|analgesics|mesh-ancestor
101329736|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
101329737|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101329739|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329740|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101329741|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101329742|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329743|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101329744|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101329745|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329746|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
101329747|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
101329748|NCT00000479|Protective Agents|protective agents|mesh-ancestor
101329749|NCT00028132|Tenofovir|tenofovir|mesh-list
101329750|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
101329751|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329752|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101329753|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329754|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329755|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329756|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101329757|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329758|NCT00028171|Tacrolimus|tacrolimus|mesh-list
101329759|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329760|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
101329761|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329762|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101329763|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329764|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329766|NCT00012090|Bicalutamide|bicalutamide|mesh-list
101205685|NCT01427270|Narcotics|narcotics|mesh-ancestor
101205692|NCT01427283|Oxycodone|oxycodone|mesh-list
101329767|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329769|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
101329771|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329772|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329773|NCT00395395|Calcitonin|calcitonin|mesh-list
101329774|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
101329775|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101329776|NCT00395395|Katacalcin|katacalcin|mesh-list
101329777|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101329778|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329779|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101329780|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
101329782|NCT00395434|Combretastatin|combretastatin|mesh-list
101329783|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
101329784|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101329785|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329786|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329787|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329788|NCT00395434|Growth Substances|growth substances|mesh-ancestor
101329789|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329790|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329791|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329792|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329793|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329794|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329795|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329796|NCT00395551|Ranibizumab|ranibizumab|mesh-list
101329797|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101329798|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101329799|NCT00395551|Growth Substances|growth substances|mesh-ancestor
101329800|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329801|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
101329802|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329803|NCT00012129|Annamycin|annamycin|mesh-list
101329804|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329805|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329806|NCT00028288|Daclizumab|daclizumab|mesh-list
101329807|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329808|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
101329809|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329810|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101329811|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101329812|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329813|NCT00000482|Niacin|niacin|mesh-list
101329814|NCT00000482|Clofibrate|clofibrate|mesh-list
101329815|NCT00000482|Estrogens|estrogens|mesh-list
101329816|NCT00000482|Hormones|hormones|mesh-ancestor
101329817|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329818|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329820|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
101329821|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329822|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101329823|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
101329824|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
101329826|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
101329827|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101329828|NCT00028327|Lamivudine|lamivudine|mesh-list
101329829|NCT00028327|Zidovudine|zidovudine|mesh-list
101329831|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101329832|NCT00028327|Nelfinavir|nelfinavir|mesh-list
101329833|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101329834|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329835|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329836|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329837|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
101329838|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329839|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101329840|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329841|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
101329842|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101329843|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329844|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101329845|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101329846|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101329847|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101329848|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101329849|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101329851|NCT00028366|Ritonavir|ritonavir|mesh-list
101329852|NCT00028366|Lopinavir|lopinavir|mesh-list
101329855|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101329857|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101329858|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329859|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329860|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101329861|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329862|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
101329863|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329864|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101329865|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101329866|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101205736|NCT01427582|Trabectedin|trabectedin|mesh-list
101329867|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329870|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101329871|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329872|NCT00012207|Aldesleukin|aldesleukin|mesh-list
101329873|NCT00012207|Prednisone|prednisone|mesh-list
101329874|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
101329875|NCT00012207|Vincristine|vincristine|mesh-list
101329876|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329877|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
101329878|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329879|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329880|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329881|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
101329882|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329883|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329884|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329885|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101329886|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
101329888|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329889|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329890|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329891|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549140|NCT01323530|Capecitabine|capecitabine|mesh-list
101329892|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329893|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329895|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101329896|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
101329897|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329899|NCT00028483|Doxorubicin|doxorubicin|mesh-list
101329900|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
101329901|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329902|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329903|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329904|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329905|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329906|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329907|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329908|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329909|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329911|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329912|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
101329914|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
101329916|NCT00028561|Carboplatin|carboplatin|mesh-list
101329917|NCT00028561|Epothilone B|epothilone b|mesh-list
101329918|NCT00028561|Epothilones|epothilones|mesh-list
101329919|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329920|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329921|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329922|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329923|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329924|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
101329925|NCT00028600|Melphalan|melphalan|mesh-list
101329926|NCT00028600|Methotrexate|methotrexate|mesh-list
101329927|NCT00028600|Fludarabine|fludarabine|mesh-list
101329928|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
101329929|NCT00028600|Tacrolimus|tacrolimus|mesh-list
101205764|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329930|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329931|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
101329932|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329933|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329934|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329935|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
101329936|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329937|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329938|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329939|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101329941|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101329942|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329943|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
101329944|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
101329945|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329947|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101329948|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101329949|NCT00388778|Doxycycline|doxycycline|mesh-list
101329950|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101329951|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101329952|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
101329953|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101329954|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101329955|NCT00012246|Sargramostim|sargramostim|mesh-list
101329956|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
101329957|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
101329958|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329959|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101329961|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
101329962|NCT00028717|Rituximab|rituximab|mesh-list
101329963|NCT00028717|Doxorubicin|doxorubicin|mesh-list
101329964|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101329965|NCT00028717|Vincristine|vincristine|mesh-list
101329966|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101329967|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
101329968|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101329969|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101329970|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101329971|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
101329972|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101329973|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329974|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101329975|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101329976|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101329977|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101329978|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101329979|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101329980|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101329981|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
101329982|NCT00028717|Hormones|hormones|mesh-ancestor
101329983|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101329984|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101329985|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101329986|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
101329987|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
101329988|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
101329989|NCT00028756|Gemcitabine|gemcitabine|mesh-list
101329990|NCT00028756|Doxorubicin|doxorubicin|mesh-list
101329991|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101329992|NCT00028756|Methotrexate|methotrexate|mesh-list
101329993|NCT00028756|Vinblastine|vinblastine|mesh-list
101329994|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101329995|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101329996|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
101329997|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205815|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205816|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101329999|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101330000|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330002|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101330003|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
101330004|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101330005|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330006|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
101330007|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101330008|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101330009|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
101330010|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330011|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101205862|NCT01428388|Growth Substances|growth substances|mesh-ancestor
101205863|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330012|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330014|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330015|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330016|NCT00012324|Doxorubicin|doxorubicin|mesh-list
101330017|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101330019|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330020|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330021|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101330022|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101205922|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205923|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
101330023|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330024|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330025|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330026|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
101330027|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101330028|NCT00028795|Temozolomide|temozolomide|mesh-list
101330029|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330030|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
101330031|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330032|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330033|NCT00012363|Gemcitabine|gemcitabine|mesh-list
101330034|NCT00012363|Irinotecan|irinotecan|mesh-list
101330035|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330036|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
101330037|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330038|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330039|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101330040|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101205987|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330041|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330042|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
101330043|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330044|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330045|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330046|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330048|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101330050|NCT00028834|Antibodies|antibodies|mesh-list
101330051|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
101330052|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101330053|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330054|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101330055|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101330056|NCT00028834|Growth Substances|growth substances|mesh-ancestor
101330057|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330059|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
101330060|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330062|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330063|NCT00028873|Paclitaxel|paclitaxel|mesh-list
101330064|NCT00028873|Docetaxel|docetaxel|mesh-list
101330065|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330066|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330067|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
101206109|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330068|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330069|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330070|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330071|NCT00028912|Carboplatin|carboplatin|mesh-list
101330072|NCT00028912|Bortezomib|bortezomib|mesh-list
101330073|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330074|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101330077|NCT01803555|Budesonide|budesonide|mesh-list
101330078|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
101330079|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101330080|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330081|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101330082|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
101330083|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330084|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330085|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101330086|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
101330089|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330090|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101330091|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101330092|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101330093|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330094|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330095|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330096|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
101330097|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101330098|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101330099|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
101330100|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330101|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101330102|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
101330103|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101330104|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330106|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206290|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
101206291|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330107|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330108|NCT00000491|Analgesics|analgesics|mesh-ancestor
101330109|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
101330110|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330111|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330112|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330113|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330114|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330115|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101330697|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
101330116|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206359|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330117|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101330118|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101330119|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330120|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
101330121|NCT00029380|Cyclosporine|cyclosporine|mesh-list
101330122|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
101330123|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
101330125|NCT00029380|Cyclosporins|cyclosporins|mesh-list
101330126|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101330127|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
101330128|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330129|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330130|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330131|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
101330132|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330133|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330134|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101330135|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330137|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330138|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
101330139|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101330140|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330141|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101330142|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
101330143|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101330144|NCT00029458|Clozapine|clozapine|mesh-list
101330145|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101206420|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330146|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
101330147|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330148|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330149|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330150|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101330151|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101330152|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330153|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330154|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
101330155|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
101330156|NCT00029497|Amitriptyline|amitriptyline|mesh-list
101330157|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101330158|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330159|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101206536|NCT01432028|Estradiol|estradiol|mesh-list
101330160|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330162|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
101330163|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330164|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330165|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101330166|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330167|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330168|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330170|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330172|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101330173|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330175|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
101330176|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330177|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206601|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330179|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330180|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
101330182|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101330183|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101330184|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330185|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330186|NCT00012519|Ritonavir|ritonavir|mesh-list
101330187|NCT00012519|Indinavir|indinavir|mesh-list
101330188|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101330189|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101330190|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101330191|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330192|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206663|NCT01432665|Testosterone|testosterone|mesh-list
101330195|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
101330196|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330197|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101330198|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101330199|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101330200|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101206720|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
101206721|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
101330201|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330202|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330203|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330204|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330205|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330206|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330207|NCT00029770|Acetaminophen|acetaminophen|mesh-list
101206785|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
101206787|NCT01433887|Ribavirin|ribavirin|mesh-list
101330209|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101330211|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330212|NCT00029770|Analgesics|analgesics|mesh-ancestor
101330213|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
101330214|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330215|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330216|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
101330217|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101330218|NCT00029770|Narcotics|narcotics|mesh-ancestor
101330219|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330220|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
101330221|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
101330222|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330223|NCT00012558|Inositol|inositol|mesh-list
101330224|NCT00012558|Lamotrigine|lamotrigine|mesh-list
101330225|NCT00012558|Valproic Acid|valproic acid|mesh-list
101330226|NCT00012558|Risperidone|risperidone|mesh-list
101330227|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
101330228|NCT00012558|Bupropion|bupropion|mesh-list
101330229|NCT00012558|Paroxetine|paroxetine|mesh-list
101330230|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101330231|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
101330232|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330233|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330234|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330235|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101330236|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101330237|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330238|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330239|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101330240|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
101330241|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101330242|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330243|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101330244|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330245|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330246|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101330247|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101330248|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330249|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
101330250|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101330251|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
101330252|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101330253|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330254|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101330256|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101330257|NCT00012558|Vitamins|vitamins|mesh-ancestor
101330258|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
101330259|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101330260|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101330261|NCT00395707|Ranibizumab|ranibizumab|mesh-list
101330262|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101330263|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101330264|NCT00395707|Growth Substances|growth substances|mesh-ancestor
101330265|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330266|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
101330267|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330269|NCT00000500|Carotenoids|carotenoids|mesh-list
101207024|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207025|NCT01435161|Telmisartan|telmisartan|mesh-list
101330270|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101330271|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330272|NCT00000500|Analgesics|analgesics|mesh-ancestor
101330273|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
101330274|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330275|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330276|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330277|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330278|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330279|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101330280|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330281|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101330282|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101330283|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330284|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
101330285|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
101330286|NCT00000500|Protective Agents|protective agents|mesh-ancestor
101330288|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330289|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330290|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101330291|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
101330292|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330294|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101330295|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101330729|NCT00000575|Hormones|hormones|mesh-ancestor
101330296|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101330297|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330298|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330299|NCT00029848|Hormones|hormones|mesh-ancestor
101330300|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330301|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330302|NCT00000503|Streptokinase|streptokinase|mesh-list
101330303|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
101330304|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
101330305|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330306|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101330307|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330309|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101330310|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101330311|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330314|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101330315|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330316|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101330318|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
101330319|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
101330320|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
101330321|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330322|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330324|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330325|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
101330326|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330327|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330328|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101330329|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101330330|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
101207259|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101207269|NCT01436825|Factor VIII|factor viii|mesh-list
101330331|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330332|NCT00000518|Quinidine|quinidine|mesh-list
101330333|NCT00000518|Sotalol|sotalol|mesh-list
101330334|NCT00000518|Mexiletine|mexiletine|mesh-list
101330335|NCT00000518|Procainamide|procainamide|mesh-list
101330336|NCT00000518|Imipramine|imipramine|mesh-list
101330337|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101330338|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101330339|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330340|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330341|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330342|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330344|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
101330345|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
101330347|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101330348|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330349|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330350|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101330351|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330352|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330353|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101330354|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
101330355|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101330356|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101330357|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330358|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330359|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101330360|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101330361|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
101330362|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101330363|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101330364|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101330365|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101330366|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
101330367|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
101330368|NCT00030238|Calcium|calcium|mesh-list
101330369|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330370|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330371|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
101330372|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330373|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330374|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101330375|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330376|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330377|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
101330378|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330379|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330380|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330381|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330383|NCT00395941|Acitretin|acitretin|mesh-list
101330384|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101330385|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330386|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
101330387|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
101330389|NCT00030433|Irinotecan|irinotecan|mesh-list
101330390|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330391|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
101330392|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330393|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330395|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330396|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330397|NCT00030472|Doxorubicin|doxorubicin|mesh-list
101330398|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101330399|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330400|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549266|NCT02891018|Paclitaxel|paclitaxel|mesh-list
101330401|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101330402|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330403|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207495|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101330404|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330406|NCT00000527|Dipyridamole|dipyridamole|mesh-list
101330407|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101330408|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330409|NCT00000527|Analgesics|analgesics|mesh-ancestor
101330410|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
101330411|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330412|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330413|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330414|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330415|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330416|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101330417|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330752|NCT00032149|Bleomycin|bleomycin|mesh-list
101330418|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101330419|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101330420|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330421|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
101330422|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101330423|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
101330424|NCT00030511|Fluorouracil|fluorouracil|mesh-list
101330425|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
101330426|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330427|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330428|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330429|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101330430|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
101330431|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330432|NCT00030550|Thalidomide|thalidomide|mesh-list
101330433|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101330434|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
101330435|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330436|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
101330437|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101330438|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207616|NCT05343507|Ketamine|ketamine|mesh-list
101330439|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101330440|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101330441|NCT00030550|Growth Substances|growth substances|mesh-ancestor
101330442|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
101330443|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330444|NCT00030589|Bexarotene|bexarotene|mesh-list
101330446|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330447|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101330449|NCT00000530|Nifedipine|nifedipine|mesh-list
101330450|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101207659|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101207660|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101330451|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330452|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330453|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330454|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330455|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
101330457|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101330458|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
101330459|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330460|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330461|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330462|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330463|NCT00030745|Gemcitabine|gemcitabine|mesh-list
101330464|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330465|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330467|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330468|NCT00030784|Doxorubicin|doxorubicin|mesh-list
101330469|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101330470|NCT00030784|Ifosfamide|ifosfamide|mesh-list
101330471|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330472|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330473|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101330474|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330770|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
101330475|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330476|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330477|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330478|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
101330479|NCT00030862|Irinotecan|irinotecan|mesh-list
101330480|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330481|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101330482|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330483|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207848|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101207849|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330484|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330485|NCT00000539|Vitamins|vitamins|mesh-list
101330486|NCT00000539|Vitamin E|vitamin e|mesh-list
101330487|NCT00000539|Beta Carotene|beta carotene|mesh-list
101330488|NCT00000539|Warfarin|warfarin|mesh-list
101330489|NCT00000539|Pravastatin|pravastatin|mesh-list
101330490|NCT00000539|Carotenoids|carotenoids|mesh-list
101330491|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
101330492|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330494|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
101330495|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330496|NCT00000539|Protective Agents|protective agents|mesh-ancestor
101330497|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101330498|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
101330499|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101330500|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101330501|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101330502|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330503|NCT00000539|Provitamins|provitamins|mesh-ancestor
101330504|NCT00030979|Donepezil|donepezil|mesh-list
101330505|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101330506|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207915|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
101207916|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207917|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101207918|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207919|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207921|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101207922|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
101207923|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207924|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207925|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101207926|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101207927|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207928|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330507|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330508|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
101330509|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330510|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330511|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
101330512|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
101330514|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101330515|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330517|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
101330518|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330519|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330520|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
101330521|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
101330522|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330523|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330524|NCT00031057|Riboflavin|riboflavin|mesh-list
101330525|NCT00031057|Thiamine|thiamine|mesh-list
101330526|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
101330527|NCT00031057|Vitamins|vitamins|mesh-ancestor
101330528|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
101330529|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330530|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101330531|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
101330533|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101330534|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
101330535|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
101208093|NCT02067182|Dabigatran|dabigatran|mesh-list
101330536|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330537|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330538|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101330539|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101330540|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101330541|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330542|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330543|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330544|NCT00000554|Protective Agents|protective agents|mesh-ancestor
101330546|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330548|NCT00031096|Azelaic acid|azelaic acid|mesh-list
101330549|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330550|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
101330552|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
101330553|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101330554|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
101330555|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330556|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101330557|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101330558|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
101330559|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
101330560|NCT00031291|Antibodies|antibodies|mesh-list
101208151|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330561|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
101330562|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101330563|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101330564|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
101330565|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330566|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
101330567|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101330568|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330569|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330570|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330571|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101330572|NCT00396058|Methylphenidate|methylphenidate|mesh-list
101330573|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101330574|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330575|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101330576|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330577|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208268|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
101330578|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330580|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330581|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101330582|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330583|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330584|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101330585|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101330586|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101330587|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330588|NCT00000563|Dexamethasone|dexamethasone|mesh-list
101330589|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330590|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
101330591|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
101330592|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330593|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330594|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101330595|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
101330596|NCT00000563|Hormones|hormones|mesh-ancestor
101330597|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208331|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330598|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101330599|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330600|NCT00031564|Aldesleukin|aldesleukin|mesh-list
101330601|NCT00031564|Interleukin-2|interleukin-2|mesh-list
101330602|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330603|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330604|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330605|NCT00031564|Analgesics|analgesics|mesh-ancestor
101330606|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
101330607|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330608|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101330609|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101330610|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
101330611|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330613|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101330614|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330615|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
101330616|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208449|NCT01440361|Belimumab|belimumab|mesh-list
101330617|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330618|NCT00031681|Irinotecan|irinotecan|mesh-list
101330619|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101330620|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101330621|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330622|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330623|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330624|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330625|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330626|NCT00031720|Tamoxifen|tamoxifen|mesh-list
101330627|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101330628|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
101330629|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330630|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330631|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101330632|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330633|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101330634|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101330635|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101330636|NCT00000569|Triamcinolone|triamcinolone|mesh-list
101330637|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330638|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
101330639|NCT00000569|Hormones|hormones|mesh-ancestor
101330640|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208570|NCT01440998|Paclitaxel|paclitaxel|mesh-list
101208571|NCT01440998|Carboplatin|carboplatin|mesh-list
101330641|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330642|NCT00031759|Imiquimod|imiquimod|mesh-list
101330643|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101330644|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
101330645|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330646|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330647|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
101330648|NCT01791816|Phenylephrine|phenylephrine|mesh-list
101330649|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
101330650|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101208632|NCT01441388|Bevacizumab|bevacizumab|mesh-list
101208633|NCT01441388|Sunitinib|sunitinib|mesh-list
101330651|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101330652|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
101330653|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
101330654|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330655|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330656|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
101330658|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
101330659|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
101330814|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
101330660|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101330661|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101330662|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101330663|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330664|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330665|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330666|NCT01791816|Protective Agents|protective agents|mesh-ancestor
101208698|NCT01441804|Ribavirin|ribavirin|mesh-list
101330667|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330668|NCT00031798|Methylphenidate|methylphenidate|mesh-list
101330669|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101330670|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330672|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101330673|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330674|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330675|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
101330676|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330678|NCT00031837|Dalteparin|dalteparin|mesh-list
101330679|NCT00031837|Tinzaparin|tinzaparin|mesh-list
101330680|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101330681|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208758|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330682|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
101330683|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330684|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330685|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
101330686|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101330687|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101330688|NCT00031876|Paclitaxel|paclitaxel|mesh-list
101330689|NCT00031876|Capecitabine|capecitabine|mesh-list
101208821|NCT01442532|Midazolam|midazolam|mesh-list
101330690|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330691|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330692|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
101330693|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330694|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330695|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208891|NCT01442818|Analgesics|analgesics|mesh-ancestor
101330696|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330698|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
101330699|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330700|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330701|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330702|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330703|NCT00031954|Paclitaxel|paclitaxel|mesh-list
101330704|NCT00031954|Carboplatin|carboplatin|mesh-list
101330705|NCT00031954|Gemcitabine|gemcitabine|mesh-list
101330706|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330707|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330708|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101330709|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330710|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330839|NCT00032734|Satavaptan|satavaptan|mesh-list
101208958|NCT01443065|Leucovorin|leucovorin|mesh-list
101208959|NCT01443065|Folic Acid|folic acid|mesh-list
101208960|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
101330711|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330712|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330714|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101330715|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330716|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330717|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330718|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330719|NCT00000575|Nedocromil|nedocromil|mesh-list
101330720|NCT00000575|Budesonide|budesonide|mesh-list
101330721|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330722|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101330723|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
101330724|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330725|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330726|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101330727|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
101330730|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101209080|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101330731|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101330732|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
101330733|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101330734|NCT00032032|Paclitaxel|paclitaxel|mesh-list
101330735|NCT00032032|Carboplatin|carboplatin|mesh-list
101330736|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330737|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330738|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
101330739|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330740|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330741|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330742|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101209148|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209154|NCT01444196|Desloratadine|desloratadine|mesh-list
101330743|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330744|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330745|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330746|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330747|NCT00032149|Prednisolone|prednisolone|mesh-list
101416490|NCT00403442|Verteporfin|verteporfin|mesh-list
101330748|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
101330749|NCT00032149|Etoposide|etoposide|mesh-list
101330750|NCT00032149|Vincristine|vincristine|mesh-list
101330751|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
101330753|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209212|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
101330754|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
101330755|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330757|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330758|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
101330759|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330760|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330761|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101330762|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101330763|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101209275|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101330764|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101330765|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330766|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
101330767|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
101330768|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
101330769|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330771|NCT00032149|Hormones|hormones|mesh-ancestor
101209338|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
101330772|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330773|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101330774|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330776|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
101330777|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101330778|NCT00032188|Aldesleukin|aldesleukin|mesh-list
101330779|NCT00032188|Interleukin-2|interleukin-2|mesh-list
101330780|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
101330781|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330782|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330783|NCT00032188|Analgesics|analgesics|mesh-ancestor
101209407|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101209408|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
101209409|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209410|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209411|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101209412|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101209413|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209414|NCT01445743|Vaccines|vaccines|mesh-list
101209415|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
101209416|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209417|NCT01445756|Lidocaine|lidocaine|mesh-list
101209418|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
101209419|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
101209420|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209422|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
101330785|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330786|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330787|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101330788|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101330789|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
101330790|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330791|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101330792|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
101330793|NCT00032305|Visilizumab|visilizumab|mesh-list
101330794|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
101330795|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330796|NCT00000596|Dapsone|dapsone|mesh-list
101330797|NCT00000596|Prednisone|prednisone|mesh-list
101330798|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
101330799|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209454|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330800|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
101330801|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330802|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330803|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101330804|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
101330805|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330806|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209514|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
101330807|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101330808|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330809|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
101330810|NCT00000596|Hormones|hormones|mesh-ancestor
101330811|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330812|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101330813|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330815|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101330816|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101330817|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101330818|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330819|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
101330820|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101330821|NCT00000599|Niacin|niacin|mesh-list
101330822|NCT00000599|Colestipol|colestipol|mesh-list
101330823|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101330824|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
101330825|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330826|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101330827|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
101330828|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
101330829|NCT00000599|Vitamins|vitamins|mesh-ancestor
101209587|NCT01446523|Lactulose|lactulose|mesh-list
101330830|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
101330831|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330832|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
101330833|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
101330834|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330835|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
101330836|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330837|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330838|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101330840|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101209635|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101209636|NCT01447043|Growth Substances|growth substances|mesh-ancestor
101330841|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330842|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
101330843|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330844|NCT00032773|Pentostatin|pentostatin|mesh-list
101330845|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330846|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101330847|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330848|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330849|NCT00032812|Raclopride|raclopride|mesh-list
101330850|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101330851|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101330852|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209699|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
101330853|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330854|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101330855|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101330856|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
101330857|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101330858|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330860|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101330861|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101330862|NCT00032890|Analgesics|analgesics|mesh-ancestor
101330863|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
101330864|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330865|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330866|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101330867|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101330868|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101330870|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330871|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330873|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
101330875|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101330876|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101330877|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101330878|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331733|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331734|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209892|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209916|NCT01448733|Tretinoin|tretinoin|mesh-list
101331735|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
101331737|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331738|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101331739|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
101331740|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331741|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
101331742|NCT00035230|Topiramate|topiramate|mesh-list
101331743|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
101331744|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101331745|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331746|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101331747|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331748|NCT00014391|Ribavirin|ribavirin|mesh-list
101331749|NCT00014391|Palivizumab|palivizumab|mesh-list
101331750|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
101331751|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331752|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
101331753|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331754|NCT00035308|Abetimus|abetimus|mesh-list
101331755|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331756|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
101331757|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331758|NCT00035347|Azithromycin|azithromycin|mesh-list
101331759|NCT00035347|Levofloxacin|levofloxacin|mesh-list
101331760|NCT00035347|Ofloxacin|ofloxacin|mesh-list
101331761|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
101331762|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331763|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331764|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101331765|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101331766|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331767|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330879|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210012|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
101330880|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101330881|NCT00032929|Protective Agents|protective agents|mesh-ancestor
101330882|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331768|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331769|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331770|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101331771|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101210080|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
101331895|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331896|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
101331897|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331898|NCT00014586|Goserelin|goserelin|mesh-list
101331899|NCT00014586|Bicalutamide|bicalutamide|mesh-list
101331900|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101331901|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331902|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
101331903|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331904|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331905|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331906|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
101331907|NCT04732390|Bupivacaine|bupivacaine|mesh-list
101331908|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
101331909|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
101331910|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331911|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331912|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
101331913|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332132|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332133|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332134|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332135|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332136|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332137|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101334400|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101210283|NCT05964413|Vilobelimab|vilobelimab|mesh-list
101334401|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334638|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101334639|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334640|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334641|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334642|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334643|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334644|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334645|NCT00045292|Valacyclovir|valacyclovir|mesh-list
101334646|NCT00045292|Acyclovir|acyclovir|mesh-list
101334647|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
101334648|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334649|NCT00045370|Interferons|interferons|mesh-list
101334650|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
101334651|NCT00045370|Sirolimus|sirolimus|mesh-list
101334652|NCT00045370|Temsirolimus|temsirolimus|mesh-list
101334653|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
101334654|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334655|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
101334656|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334657|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
101334658|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334659|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334660|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334661|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335183|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335184|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101335185|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101330885|NCT00000611|Hormones|hormones|mesh-list
101330886|NCT00000611|Estrogens|estrogens|mesh-list
101330887|NCT00000611|Progestins|progestins|mesh-list
101330888|NCT00000611|Vitamins|vitamins|mesh-ancestor
101330889|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
101330890|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210394|NCT05963334|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210396|NCT05963217|Cyclophosphamide|cyclophosphamide|mesh-list
101335186|NCT00047710|Growth Substances|growth substances|mesh-ancestor
101335187|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335188|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549394|NCT01114204|Hematinics|hematinics|mesh-ancestor
101335189|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335191|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335192|NCT00047749|Ziconotide|ziconotide|mesh-list
101335193|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101335194|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487427|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335256|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335257|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335258|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
101335259|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335261|NCT00048607|Paroxetine|paroxetine|mesh-list
101335262|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101335263|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101210458|NCT05962619|Immunologic Factors|immunologic factors|mesh-ancestor
101210460|NCT05962619|Viscosupplements|viscosupplements|mesh-ancestor
101335264|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101335265|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335266|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101335888|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335889|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101335890|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
101335891|NCT00052936|Hormones|hormones|mesh-ancestor
101335892|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210515|NCT05962034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101335893|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101335894|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101335895|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
101335896|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
101335897|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
101335898|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
101335899|NCT00053092|Rituximab|rituximab|mesh-list
101335900|NCT00053092|Fludarabine|fludarabine|mesh-list
101335901|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
101335902|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335903|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
101335904|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335905|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101335906|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101335907|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
101335908|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335909|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335910|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101335911|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101335912|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335913|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
101335914|NCT00053131|Cytarabine|cytarabine|mesh-list
101335915|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
101335916|NCT00053131|Sargramostim|sargramostim|mesh-list
101335917|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335918|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
101335919|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335920|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335921|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
101335922|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335935|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101335936|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335937|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335938|NCT00053287|Thalidomide|thalidomide|mesh-list
101335939|NCT00053287|Carboplatin|carboplatin|mesh-list
101335940|NCT00053287|Fludarabine|fludarabine|mesh-list
101330891|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330892|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101330893|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101330894|NCT00032968|Buprenorphine|buprenorphine|mesh-list
101335941|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
101335942|NCT00053287|Topotecan|topotecan|mesh-list
101335943|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335944|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101335945|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
101335946|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335947|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101335948|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
101335949|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335950|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101335951|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101335952|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335953|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
101335954|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101335955|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335956|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101335957|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101335958|NCT00053287|Growth Substances|growth substances|mesh-ancestor
101335959|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
101335961|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101335962|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101335963|NCT00053326|Protective Agents|protective agents|mesh-ancestor
101335964|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335965|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101335966|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101335967|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
101335968|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101335970|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101335971|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101335972|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
101335973|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101335974|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101335975|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101335976|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335978|NCT00053638|Lamivudine|lamivudine|mesh-list
101335979|NCT00053638|Efavirenz|efavirenz|mesh-list
101335980|NCT00053638|Abacavir|abacavir|mesh-list
101335981|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
101335982|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101335983|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101335984|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101335985|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101335986|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336006|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336007|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336008|NCT00053872|Vincristine|vincristine|mesh-list
101336009|NCT00053872|Lomustine|lomustine|mesh-list
101336010|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336011|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336012|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336013|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336014|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336015|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336016|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336017|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
101330895|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101330897|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101330898|NCT00032968|Narcotics|narcotics|mesh-ancestor
101330899|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210775|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336028|NCT00053911|Tamoxifen|tamoxifen|mesh-list
101336029|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
101336030|NCT00053911|Docetaxel|docetaxel|mesh-list
101336031|NCT00053911|Fluorouracil|fluorouracil|mesh-list
101336032|NCT00053911|Epirubicin|epirubicin|mesh-list
101336033|NCT00053911|Anastrozole|anastrozole|mesh-list
101336034|NCT00053911|Goserelin|goserelin|mesh-list
101336035|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336036|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
101336037|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336038|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336039|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336040|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
101336041|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336042|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336050|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101336051|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336052|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336053|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101336054|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
101336055|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336056|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336057|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101336058|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101336059|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101336060|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101336061|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101336063|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336064|NCT00054067|Cisplatin|cisplatin|mesh-list
101336065|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336066|NCT00054184|Paclitaxel|paclitaxel|mesh-list
101336067|NCT00054184|Docetaxel|docetaxel|mesh-list
101336068|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101336069|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336070|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336071|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336072|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336073|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336074|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336075|NCT00054340|Cyclosporine|cyclosporine|mesh-list
101336076|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
101336077|NCT00054340|Busulfan|busulfan|mesh-list
101336078|NCT00054340|Methotrexate|methotrexate|mesh-list
101336079|NCT00054340|Cyclosporins|cyclosporins|mesh-list
101210949|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101210950|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
101210951|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
101210952|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
101210953|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210954|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210955|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
101210956|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210957|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210958|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
101210959|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
101336080|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101336081|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336082|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
101336083|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336084|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336085|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336086|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
101336087|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336088|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336089|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101336090|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101336091|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
101336092|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101336093|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336095|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336096|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336097|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101336098|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336099|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
101336100|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330900|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330902|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
101211070|NCT05653193|Interferons|interferons|mesh-list
101330903|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330904|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101330905|NCT00033046|Modafinil|modafinil|mesh-list
101330906|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101330907|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330908|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101336101|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101336102|NCT00054418|Vitamin D|vitamin d|mesh-list
101336103|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
101336104|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
101336105|NCT00054418|Calcium|calcium|mesh-list
101336106|NCT00054418|Vitamins|vitamins|mesh-ancestor
101336107|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
101336108|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211127|NCT05603104|Lamotrigine|lamotrigine|mesh-list
101211128|NCT05603104|Ketamine|ketamine|mesh-list
101336111|NCT00054418|Antacids|antacids|mesh-ancestor
101336137|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336138|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
101336139|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101336140|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336141|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336142|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336143|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336144|NCT00054535|Aldesleukin|aldesleukin|mesh-list
101336146|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
101336147|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336148|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336149|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336150|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336151|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
101336152|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336153|NCT00054574|Panitumumab|panitumumab|mesh-list
101336154|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211190|NCT05586789|Tryptophan|tryptophan|mesh-list
101336155|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336156|NCT00054613|Methoxsalen|methoxsalen|mesh-list
101336157|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101336158|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336159|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
101336176|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101336178|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336179|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211240|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
101336181|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
101336182|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336183|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101336184|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101336185|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
101336186|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
101336187|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101336188|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101336189|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101336190|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101336191|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
101336192|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
101336193|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336194|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336195|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
101336196|NCT00398281|Dutasteride|dutasteride|mesh-list
101336197|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101336198|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101336199|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211308|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101330909|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101330910|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101330911|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330912|NCT00033085|Ondansetron|ondansetron|mesh-list
101336200|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336202|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336203|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336204|NCT00055042|Vitamin E|vitamin e|mesh-list
101336205|NCT00055042|Vitamins|vitamins|mesh-ancestor
101336206|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
101336207|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336208|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
101336209|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336210|NCT00055042|Protective Agents|protective agents|mesh-ancestor
101336211|NCT00055120|Ritonavir|ritonavir|mesh-list
101336212|NCT00055120|Lopinavir|lopinavir|mesh-list
101336213|NCT00055120|Tenofovir|tenofovir|mesh-list
101336214|NCT00055120|Emtricitabine|emtricitabine|mesh-list
101336215|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101336216|NCT00055120|Stavudine|stavudine|mesh-list
101336217|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101336218|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101336235|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336237|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
101336238|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
101211362|NCT05428215|Estrogens|estrogens|mesh-ancestor
101211363|NCT05428215|Hormones|hormones|mesh-ancestor
101211364|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211365|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211366|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101211367|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
101211368|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211369|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101211370|NCT05417646|Empagliflozin|empagliflozin|mesh-list
101336239|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101336240|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101336241|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101336242|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101336243|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
101336244|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336245|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336247|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101336248|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101336249|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101211400|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
101211401|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336250|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336251|NCT00055198|Daptomycin|daptomycin|mesh-list
101336252|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101549445|NCT00623402|Interferons|interferons|mesh-list
101336253|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336254|NCT05525325|Anesthetics|anesthetics|mesh-list
101336255|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336256|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336258|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101336259|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
101336260|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101336261|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101336262|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101336263|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211482|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211483|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211484|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
101211485|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211486|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211487|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101336264|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336265|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
101336266|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336267|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336268|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101336269|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336270|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336271|NCT00055432|Gemcitabine|gemcitabine|mesh-list
101336272|NCT00055432|Pemetrexed|pemetrexed|mesh-list
101336273|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336287|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336289|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
101336290|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
101336291|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
101336292|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336293|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101336294|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101330913|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
101330914|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
101330915|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101330916|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330917|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101330918|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
101330919|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336295|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336296|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101336297|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101336298|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101336299|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
101336300|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
101336301|NCT00055666|Beclomethasone|beclomethasone|mesh-list
101211544|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
101336302|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336303|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
101336304|NCT00055666|Hormones|hormones|mesh-ancestor
101336305|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336306|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336307|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101336308|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101336310|NCT00055822|Fluorouracil|fluorouracil|mesh-list
101336311|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
101336312|NCT00055822|Oblimersen|oblimersen|mesh-list
101336313|NCT00055822|Calcium|calcium|mesh-list
101336314|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
101336315|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336316|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336317|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
101336318|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336319|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336320|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336321|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336322|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
101336324|NCT00055822|Protective Agents|protective agents|mesh-ancestor
101211651|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211652|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336325|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
101336326|NCT00055822|Vitamins|vitamins|mesh-ancestor
101336327|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
101336328|NCT00055861|Bevacizumab|bevacizumab|mesh-list
101336329|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101336330|NCT00055861|Docetaxel|docetaxel|mesh-list
101336331|NCT00055861|Antibodies|antibodies|mesh-list
101336332|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
101336333|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101336334|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336335|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336336|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101211714|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101336358|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101336359|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101336360|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101336361|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101336363|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101336364|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336365|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336366|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336367|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336369|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101336370|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101336371|NCT00055978|Analgesics|analgesics|mesh-ancestor
101336372|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
101336373|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336374|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336375|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336376|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336377|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101336378|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101336379|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456542|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
101330920|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101330921|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101330922|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
101330923|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211836|NCT04979884|Analgesics|analgesics|mesh-ancestor
101336380|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336383|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336384|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101336385|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336387|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
101336388|NCT00056095|Fludarabine|fludarabine|mesh-list
101336413|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336415|NCT00056368|Fluconazole|fluconazole|mesh-list
101336416|NCT00056368|Anidulafungin|anidulafungin|mesh-list
101336417|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
101336418|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211901|NCT04925284|Nivolumab|nivolumab|mesh-list
101336419|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101336420|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336421|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336422|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336423|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101336424|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211964|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
101336425|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336426|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336427|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101336428|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101336429|NCT00056446|Vatalanib|vatalanib|mesh-list
101336430|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336431|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336432|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336433|NCT00056641|Ritonavir|ritonavir|mesh-list
101336434|NCT00056641|Lopinavir|lopinavir|mesh-list
101336435|NCT00056641|Saquinavir|saquinavir|mesh-list
101336436|NCT00056641|Amprenavir|amprenavir|mesh-list
101336437|NCT00056641|Tipranavir|tipranavir|mesh-list
101336438|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101336453|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336454|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336455|NCT05433675|Macitentan|macitentan|mesh-list
101336456|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101336457|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101336458|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212027|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336459|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101336461|NCT00423709|Melphalan|melphalan|mesh-list
101336462|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336463|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336464|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336465|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
101336466|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336467|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336468|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
101212082|NCT04742777|Sirolimus|sirolimus|mesh-list
101336469|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101336471|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336472|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101336473|NCT00056797|Analgesics|analgesics|mesh-ancestor
101336474|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
101336475|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336476|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336477|NCT00056836|Ranibizumab|ranibizumab|mesh-list
101336478|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336479|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101336480|NCT00056836|Growth Substances|growth substances|mesh-ancestor
101336481|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212146|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330924|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330928|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
101330929|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101330930|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101336482|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336484|NCT05495321|Aldesleukin|aldesleukin|mesh-list
101336485|NCT05495321|Interleukin-2|interleukin-2|mesh-list
101336486|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336487|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101336488|NCT05495321|Analgesics|analgesics|mesh-ancestor
101549470|NCT01077739|Antidotes|antidotes|mesh-ancestor
101336489|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
101336490|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336491|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336492|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336493|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336494|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
101336495|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336496|NCT00056875|Mitogens|mitogens|mesh-list
101336497|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336528|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
101336529|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336530|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336531|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101336532|NCT00057265|Lamivudine|lamivudine|mesh-list
101336533|NCT00057265|Telbivudine|telbivudine|mesh-list
101336534|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101336535|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101336537|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336538|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
101336560|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336561|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336562|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336563|NCT00057616|Lenalidomide|lenalidomide|mesh-list
101336564|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
101336565|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336566|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336567|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101336568|NCT00057616|Growth Substances|growth substances|mesh-ancestor
101336569|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336570|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336571|NCT02969746|Charcoal|charcoal|mesh-list
101336573|NCT02969746|Protective Agents|protective agents|mesh-ancestor
101336574|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336576|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336577|NCT00057889|Ipilimumab|ipilimumab|mesh-list
101336578|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101336579|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336580|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101336581|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336582|NCT00057928|Paclitaxel|paclitaxel|mesh-list
101336583|NCT00057928|Gemcitabine|gemcitabine|mesh-list
101336584|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336585|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336586|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336587|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336588|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336589|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336606|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336607|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101330931|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101330933|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330934|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336608|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101336609|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336610|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336611|NCT00058045|Aldesleukin|aldesleukin|mesh-list
101336612|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336613|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336614|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336615|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
101336616|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336617|NCT00058084|Prednisone|prednisone|mesh-list
101336618|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
101336619|NCT00058084|Epothilone B|epothilone b|mesh-list
101336620|NCT00058084|Epothilones|epothilones|mesh-list
101336621|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336622|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
101336623|NCT00058084|Hormones|hormones|mesh-ancestor
101336624|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336625|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336626|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336627|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336628|NCT00058084|Analgesics|analgesics|mesh-ancestor
101336629|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
101336630|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336631|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101336632|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336633|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336635|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336636|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336637|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336638|NCT02969629|Apomorphine|apomorphine|mesh-list
101336639|NCT02969629|Emetics|emetics|mesh-ancestor
101336640|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336641|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
101336642|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336643|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101336644|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
101336645|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
101336646|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336647|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336648|NCT00058201|Leucovorin|leucovorin|mesh-list
101336649|NCT00058201|Gemcitabine|gemcitabine|mesh-list
101336663|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
101336665|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
101336666|NCT00058279|Aldesleukin|aldesleukin|mesh-list
101336667|NCT00058279|Ipilimumab|ipilimumab|mesh-list
101336668|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212687|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212688|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212689|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212690|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336669|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336670|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101336671|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336672|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101336673|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101336674|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
101336675|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336676|NCT00058318|Gemcitabine|gemcitabine|mesh-list
101336677|NCT00058318|Capecitabine|capecitabine|mesh-list
101549504|NCT01304498|Vaccines|vaccines|mesh-list
101336678|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336679|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
101336680|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336681|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212731|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101336682|NCT00058357|Lidocaine|lidocaine|mesh-list
101336683|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
101336684|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
101336685|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336686|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336687|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
101336688|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336689|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101330935|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101330936|NCT00033241|Gemcitabine|gemcitabine|mesh-list
101330937|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101212794|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101330938|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101330939|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
101336690|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101336691|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101336692|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336693|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336696|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336697|NCT00058474|Fluorouracil|fluorouracil|mesh-list
101336698|NCT00058474|Capecitabine|capecitabine|mesh-list
101336699|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
101336700|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
101336701|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336702|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336703|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336704|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336705|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
101336706|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336708|NCT00392262|Valsartan|valsartan|mesh-list
101336709|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101336710|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101336711|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336733|NCT02969473|Cisplatin|cisplatin|mesh-list
101336734|NCT02969473|Docetaxel|docetaxel|mesh-list
101336735|NCT02969473|Fluorouracil|fluorouracil|mesh-list
101336736|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336737|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
101336738|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336739|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212859|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212860|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212861|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212862|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212871|NCT03493685|Irbesartan|irbesartan|mesh-list
101212872|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101212873|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101212874|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101336740|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336742|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336743|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336744|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
101336745|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336746|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
101336747|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336748|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336749|NCT01349907|Asenapine|asenapine|mesh-list
101336750|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101336751|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101336752|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101336753|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336754|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101336755|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101336756|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101336757|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336758|NCT05223582|Prednisone|prednisone|mesh-list
101336759|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
101336760|NCT05223582|Fluzoparib|fluzoparib|mesh-list
101336761|NCT05223582|Androgens|androgens|mesh-list
101336781|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
101336782|NCT02969239|Norepinephrine|norepinephrine|mesh-list
101336783|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101336784|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101336785|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
101336786|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
101336787|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336788|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336789|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
101336790|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
101336791|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
101336792|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101336793|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101336794|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101330940|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330941|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213108|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
101330942|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101330943|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336795|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
101336796|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336797|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336798|NCT02969239|Protective Agents|protective agents|mesh-ancestor
101336800|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336801|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101336802|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336803|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336804|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213169|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336806|NCT00059800|Trace Elements|trace elements|mesh-ancestor
101336807|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
101336808|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336809|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
101336810|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101336811|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101336812|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336813|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
101336814|NCT03216083|Coagulants|coagulants|mesh-ancestor
101336815|NCT00059878|Interferons|interferons|mesh-list
101336816|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
101336817|NCT00059878|Voriconazole|voriconazole|mesh-list
101336818|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336819|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
101336820|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336821|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
101336822|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101336823|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101336824|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336825|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336826|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101336827|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
101336828|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336829|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336830|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101336831|NCT00059917|Camptothecin|camptothecin|mesh-list
101336832|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336833|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336834|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101336835|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336836|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336837|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336838|NCT00060112|Gemcitabine|gemcitabine|mesh-list
101336840|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101336842|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336843|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336844|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101336845|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336846|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336847|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336848|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336849|NCT02968927|Vitamin D|vitamin d|mesh-list
101336850|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
101336851|NCT02968927|Rifabutin|rifabutin|mesh-list
101336852|NCT02968927|Everolimus|everolimus|mesh-list
101336853|NCT02968927|Auranofin|auranofin|mesh-list
101336854|NCT02968927|CC-11050|cc-11050|mesh-list
101336857|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336858|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101336859|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101336860|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336861|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330944|NCT00000620|Insulin|insulin|mesh-list
101330945|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101330946|NCT00000620|Metformin|metformin|mesh-list
101330947|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
101330948|NCT00000620|Pioglitazone|pioglitazone|mesh-list
101330949|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
101330950|NCT00000620|Glimepiride|glimepiride|mesh-list
101336862|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336863|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336865|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336866|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101336867|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336868|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336869|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101336870|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
101213404|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101213406|NCT01757535|Azacitidine|azacitidine|mesh-list
101336871|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336872|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101336873|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101336874|NCT00398515|Sirolimus|sirolimus|mesh-list
101336875|NCT00398515|Lenalidomide|lenalidomide|mesh-list
101336876|NCT00398515|Temsirolimus|temsirolimus|mesh-list
101336877|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
101336878|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
101336879|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336880|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101336881|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101336882|NCT00398515|Growth Substances|growth substances|mesh-ancestor
101336883|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
101336884|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101336885|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101336886|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336887|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336888|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101336889|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101336890|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101336915|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336916|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101336917|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101336918|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
101336919|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336920|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213540|NCT01042379|Cemiplimab|cemiplimab|mesh-list
101213541|NCT01042379|Talazoparib|talazoparib|mesh-list
101213542|NCT01042379|Dostarlimab|dostarlimab|mesh-list
101213543|NCT01042379|Trebananib|trebananib|mesh-list
101213544|NCT01042379|Tucatinib|tucatinib|mesh-list
101213545|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101213546|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
101213547|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213548|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213549|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213550|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
101213551|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
101213552|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213553|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213554|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213555|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101213556|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213557|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213558|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213610|NCT00544115|Cyclosporine|cyclosporine|mesh-list
101213611|NCT00544115|Sirolimus|sirolimus|mesh-list
101213612|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
101213613|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
101213614|NCT00544115|Melphalan|melphalan|mesh-list
101213615|NCT00544115|Busulfan|busulfan|mesh-list
101213616|NCT00544115|Methotrexate|methotrexate|mesh-list
101213617|NCT00544115|Fludarabine|fludarabine|mesh-list
101213618|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
101213619|NCT00544115|Etoposide|etoposide|mesh-list
101213621|NCT00544115|Cyclosporins|cyclosporins|mesh-list
101213622|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213623|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
101213624|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213625|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213626|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101213627|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
101213628|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336921|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101213673|NCT01456507|Oxycodone|oxycodone|mesh-list
101336922|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101336923|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101336924|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101336925|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101336926|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101336927|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
101336928|NCT00060385|Hormones|hormones|mesh-ancestor
101336929|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101336930|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101336931|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101336932|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213747|NCT01460069|Incretins|incretins|mesh-ancestor
101336933|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101336934|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101336935|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
101336936|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
101336937|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101336938|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101336939|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101336940|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101336990|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101336991|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
101336992|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101336993|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101336994|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
101330952|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
101330953|NCT00000620|Acarbose|acarbose|mesh-list
101330954|NCT00000620|Repaglinide|repaglinide|mesh-list
101330955|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101330956|NCT00000620|Metoprolol|metoprolol|mesh-list
101330957|NCT00000620|Felodipine|felodipine|mesh-list
101330958|NCT00000620|Amlodipine|amlodipine|mesh-list
101330959|NCT00000620|Valsartan|valsartan|mesh-list
101336995|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101336996|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101336997|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101336998|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101337000|NCT00060931|Carvedilol|carvedilol|mesh-list
101337001|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101337002|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101337003|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
101337004|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
101213943|NCT01462006|Sirolimus|sirolimus|mesh-list
101213952|NCT01462058|Vitamin D|vitamin d|mesh-list
101337005|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337006|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337007|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101337008|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101337009|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101337010|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
101337011|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337012|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337013|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
101337014|NCT00060931|Protective Agents|protective agents|mesh-ancestor
101337015|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101214034|NCT01463163|Ticagrelor|ticagrelor|mesh-list
101337016|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101337017|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101337018|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
101337019|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101337020|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101337021|NCT00061087|Methylphenidate|methylphenidate|mesh-list
101337022|NCT00061087|Bupropion|bupropion|mesh-list
101337023|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101214070|NCT01463332|Analgesics|analgesics|mesh-ancestor
101337024|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337025|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101337026|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101337027|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101337028|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337029|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
101337030|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214135|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337031|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101337032|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337033|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337034|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101337035|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101337068|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337069|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214203|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337070|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337072|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337073|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337074|NCT00061477|Gemcitabine|gemcitabine|mesh-list
101337075|NCT00061477|Pemetrexed|pemetrexed|mesh-list
101337076|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337077|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
101337091|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337092|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337094|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101549556|NCT01074307|Bisoprolol|bisoprolol|mesh-list
101337095|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337096|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337097|NCT00061594|Ranibizumab|ranibizumab|mesh-list
101214337|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
101337098|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101330960|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101330962|NCT00000620|Candesartan|candesartan|mesh-list
101330963|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
101330964|NCT00000620|Lisinopril|lisinopril|mesh-list
101330965|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
101330966|NCT00000620|Diltiazem|diltiazem|mesh-list
101337099|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101337100|NCT00061594|Growth Substances|growth substances|mesh-ancestor
101337101|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337102|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
101337103|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337104|NCT00061711|Hormones|hormones|mesh-list
101337105|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
101337106|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337107|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337108|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101337109|NCT00061711|Estrogens|estrogens|mesh-ancestor
101337110|NCT00061750|Deferasirox|deferasirox|mesh-list
101337111|NCT00061750|Deferoxamine|deferoxamine|mesh-list
101337112|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101337113|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
101337114|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
101337115|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337116|NCT00061750|Siderophores|siderophores|mesh-ancestor
101337117|NCT00061789|Acetylcholine|acetylcholine|mesh-list
101337118|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
101337119|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101337121|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337122|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337123|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337124|NCT00061867|Doxorubicin|doxorubicin|mesh-list
101337125|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101214550|NCT01468272|Hormones|hormones|mesh-ancestor
101337126|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337127|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337128|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101337129|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337130|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337131|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337132|NCT00061906|Celecoxib|celecoxib|mesh-list
101337133|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101214593|NCT01468545|Iloprost|iloprost|mesh-list
101337134|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337135|NCT00061906|Analgesics|analgesics|mesh-ancestor
101337136|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
101337153|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337154|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
101337155|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337156|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337157|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337158|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
101337159|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214658|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
101214659|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337160|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337161|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101337162|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337163|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101337164|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101549568|NCT01076335|Docetaxel|docetaxel|mesh-list
101337165|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337166|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337167|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
101337168|NCT00398554|Hormones|hormones|mesh-ancestor
101337169|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337170|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101337171|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101337172|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337173|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
101214810|NCT01469988|Hormones|hormones|mesh-ancestor
101337174|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337175|NCT04917900|Paclitaxel|paclitaxel|mesh-list
101337176|NCT04917900|Trastuzumab|trastuzumab|mesh-list
101337177|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101330968|NCT00000620|Hydralazine|hydralazine|mesh-list
101330969|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
101330970|NCT00000620|Reserpine|reserpine|mesh-list
101330971|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
101330972|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
101330973|NCT00000620|Triamterene|triamterene|mesh-list
101214855|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330975|NCT00000620|Simvastatin|simvastatin|mesh-list
101337178|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101337179|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337180|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337181|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337182|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337183|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337184|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337185|NCT05219435|Nivolumab|nivolumab|mesh-list
101337186|NCT05219435|Ipilimumab|ipilimumab|mesh-list
101214917|NCT01470456|Rituximab|rituximab|mesh-list
101214918|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337187|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337188|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337189|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101337190|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337191|NCT00061984|Doxorubicin|doxorubicin|mesh-list
101337192|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101337193|NCT00061984|Ifosfamide|ifosfamide|mesh-list
101337194|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337195|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337196|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101214982|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
101337232|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337233|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337235|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101337236|NCT00392340|Vincristine|vincristine|mesh-list
101337238|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337239|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337240|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101337241|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337242|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337243|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337244|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101337245|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337246|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337247|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337248|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101337249|NCT00062101|Celecoxib|celecoxib|mesh-list
101337250|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101337251|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337252|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337253|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215053|NCT01471678|Tamsulosin|tamsulosin|mesh-list
101337254|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337255|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101337256|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337257|NCT00062101|Analgesics|analgesics|mesh-ancestor
101337258|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
101337259|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337260|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215105|NCT01471886|Ketorolac|ketorolac|mesh-list
101337261|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337262|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337263|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337264|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337265|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
101337266|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337267|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
101337268|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337322|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337323|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101330976|NCT00000620|Fenofibrate|fenofibrate|mesh-list
101330977|NCT00000620|Terazosin|terazosin|mesh-list
101330978|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101330979|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101330980|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101330981|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337324|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
101337325|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101337326|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
101215236|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215237|NCT01472666|Caseins|caseins|mesh-list
101337327|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337328|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
101337329|NCT02967874|Protective Agents|protective agents|mesh-ancestor
101337331|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
101337333|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
101337334|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337335|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101337336|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101337337|NCT00062686|Lapatinib|lapatinib|mesh-list
101337338|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337339|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215367|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215369|NCT01473472|Tenofovir|tenofovir|mesh-list
101337340|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337341|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337343|NCT00062803|Warfarin|warfarin|mesh-list
101337344|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
101337345|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
101337346|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101337347|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101215433|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215435|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
101549595|NCT01105936|Acetaminophen|acetaminophen|mesh-list
101549602|NCT01309659|Iron|iron|mesh-list
101337348|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337350|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101337351|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337352|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337353|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337354|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337373|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337374|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101337375|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215500|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101215501|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
101337377|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337378|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337379|NCT00063583|Pirfenidone|pirfenidone|mesh-list
101337380|NCT00063583|Analgesics|analgesics|mesh-ancestor
101337381|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
101337382|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337385|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337386|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337387|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215585|NCT01475617|Calcium|calcium|mesh-list
101337388|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337389|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101337390|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337391|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337392|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337393|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337394|NCT00064012|Docetaxel|docetaxel|mesh-list
101337395|NCT00064012|Bortezomib|bortezomib|mesh-list
101337396|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337397|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
101337398|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337399|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
101337400|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337401|NCT00064051|Gemcitabine|gemcitabine|mesh-list
101337402|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337403|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
101330982|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101330983|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
101337404|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337405|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337406|NCT02967172|Epinephrine|epinephrine|mesh-list
101337407|NCT02967172|Morphine|morphine|mesh-list
101337408|NCT02967172|Ropivacaine|ropivacaine|mesh-list
101337409|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101337410|NCT02967172|Narcotics|narcotics|mesh-ancestor
101337411|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101337412|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215765|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101215772|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
101337424|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101337426|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101337427|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
101337428|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
101337429|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
101337430|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101337431|NCT00064090|Cytarabine|cytarabine|mesh-list
101337432|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337433|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
101337434|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337435|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337436|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
101337437|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337438|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337439|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
101337440|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337441|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
101337442|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337443|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337444|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101337445|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337446|NCT00064129|Ipilimumab|ipilimumab|mesh-list
101337447|NCT00064129|Sargramostim|sargramostim|mesh-list
101337448|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337449|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337450|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101337451|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337452|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
101337453|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215893|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337455|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337456|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
101337457|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337458|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337459|NCT00064246|Rituximab|rituximab|mesh-list
101337460|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101337461|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101337462|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337463|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
101337464|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337465|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337466|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
101337467|NCT00064285|Alvocidib|alvocidib|mesh-list
101337468|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337469|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337470|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337471|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337472|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
101337473|NCT00064285|Growth Substances|growth substances|mesh-ancestor
101337474|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337506|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
101337507|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
101337508|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
101337509|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
101337510|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101337511|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337513|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101330986|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
101330987|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101330988|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101337514|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
101337515|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
101337516|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337518|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337519|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
101337531|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216072|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101337533|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101337534|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101337535|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337536|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337537|NCT00398827|Analgesics|analgesics|mesh-ancestor
101337538|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
101337539|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337540|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101416552|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101337541|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101337542|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101337543|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101337544|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337545|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337547|NCT00065455|Vitamins|vitamins|mesh-ancestor
101216134|NCT01478685|Paclitaxel|paclitaxel|mesh-list
101337548|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
101337549|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337550|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
101337551|NCT04488081|Cyclosporine|cyclosporine|mesh-list
101337552|NCT04488081|Remdesivir|remdesivir|mesh-list
101337553|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
101337554|NCT04488081|Dexamethasone|dexamethasone|mesh-list
101337555|NCT04488081|Celecoxib|celecoxib|mesh-list
101337556|NCT04488081|Apremilast|apremilast|mesh-list
101337557|NCT04488081|Icatibant|icatibant|mesh-list
101337558|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
101337559|NCT04488081|Famotidine|famotidine|mesh-list
101337560|NCT04488081|Cyclosporins|cyclosporins|mesh-list
101337561|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337562|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
101337563|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
101337564|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101337565|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337566|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337567|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
101337568|NCT04488081|Hormones|hormones|mesh-ancestor
101337569|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216263|NCT01479634|Efavirenz|efavirenz|mesh-list
101337570|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101337571|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337572|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337573|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337574|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337575|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
101337576|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
101216327|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337577|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337578|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101337579|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337580|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101337581|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101337582|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101337583|NCT04488081|Analgesics|analgesics|mesh-ancestor
101337584|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
101337585|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337606|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101337607|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101216406|NCT01480609|Ezogabine|ezogabine|mesh-list
101337608|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101337609|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101337610|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
101337611|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337612|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337613|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101337614|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101330989|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101330990|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101330991|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101337615|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101337616|NCT00065884|Valproic Acid|valproic acid|mesh-list
101337617|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
101337618|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337619|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337620|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
101337621|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337622|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337623|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
101216518|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
101337624|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101337625|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101337626|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337628|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
101337629|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101337630|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337631|NCT00065962|Secretin|secretin|mesh-list
101337632|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337633|NCT00065962|Hormones|hormones|mesh-ancestor
101337634|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337635|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337636|NCT05083754|Temozolomide|temozolomide|mesh-list
101337637|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337638|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
101337647|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101337648|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101337649|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
101337650|NCT00066157|Estradiol|estradiol|mesh-list
101337651|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101337652|NCT00066157|Estrogens|estrogens|mesh-list
101337653|NCT00066157|Progesterone|progesterone|mesh-list
101337654|NCT00066157|Hormones|hormones|mesh-ancestor
101337655|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337656|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216631|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
101337657|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101337659|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101337660|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101337661|NCT00066157|Progestins|progestins|mesh-ancestor
101337662|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101337663|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101337664|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101337665|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101337666|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101337667|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337668|NCT00066196|Dacarbazine|dacarbazine|mesh-list
101337669|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101337670|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
101337671|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337672|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337673|NCT00066274|Leucovorin|leucovorin|mesh-list
101337674|NCT00066274|Fluorouracil|fluorouracil|mesh-list
101337675|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
101337676|NCT00066274|Irinotecan|irinotecan|mesh-list
101337677|NCT00066274|Calcium|calcium|mesh-list
101337678|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
101216745|NCT01482377|Cetuximab|cetuximab|mesh-list
101216750|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337679|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101337680|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337681|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
101337682|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337683|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101337684|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337685|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337686|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
101337688|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101337689|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337690|NCT00066274|Antidotes|antidotes|mesh-ancestor
101330992|NCT00000620|Diuretics|diuretics|mesh-ancestor
101330993|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
101330994|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101330995|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101330996|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101330997|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337691|NCT00066274|Protective Agents|protective agents|mesh-ancestor
101337692|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
101337693|NCT00066274|Vitamins|vitamins|mesh-ancestor
101337694|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
101337695|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
101337696|NCT04401150|Vitamins|vitamins|mesh-ancestor
101337697|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
101337698|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337699|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
101337700|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337701|NCT04401150|Protective Agents|protective agents|mesh-ancestor
101337702|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
101337703|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
101337704|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337705|NCT00066352|Bortezomib|bortezomib|mesh-list
101216874|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337706|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337707|NCT00066391|Irinotecan|irinotecan|mesh-list
101337724|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337725|NCT00066508|Bortezomib|bortezomib|mesh-list
101337727|NCT00066547|Antibodies|antibodies|mesh-list
101337728|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101337729|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
101337730|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337731|NCT00066586|Exemestane|exemestane|mesh-list
101337732|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337733|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101337734|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101337735|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337736|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337737|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101337738|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
101337739|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337740|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337742|NCT00066625|Bortezomib|bortezomib|mesh-list
101337743|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216996|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337744|NCT00066859|Sertraline|sertraline|mesh-list
101337745|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337746|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337747|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101337748|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101337749|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101337750|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337751|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337752|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
101337753|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217052|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
101337754|NCT04235673|Melatonin|melatonin|mesh-list
101337755|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
101337756|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337757|NCT04235673|Protective Agents|protective agents|mesh-ancestor
101337759|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101337760|NCT00067015|Goserelin|goserelin|mesh-list
101337761|NCT00067015|Bicalutamide|bicalutamide|mesh-list
101337762|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101217106|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
101337790|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
101337791|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101337792|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
101337793|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337794|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337795|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
101330998|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
101330999|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
101331000|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
101331001|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331002|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101337797|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101337798|NCT00067405|Micronutrients|micronutrients|mesh-list
101337799|NCT00067405|Trace Elements|trace elements|mesh-list
101337800|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337801|NCT00067444|Paroxetine|paroxetine|mesh-list
101337802|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101337803|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101337804|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101337805|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337806|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337807|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
101337808|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337809|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101337810|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
101337811|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101337812|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101337813|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101337814|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337831|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337832|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101337833|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101337834|NCT02967094|Expectorants|expectorants|mesh-list
101337835|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
101337837|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337838|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101337839|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
101337840|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337841|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337842|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337843|NCT00067600|Calcium|calcium|mesh-list
101337844|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101337845|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337846|NCT05010707|Spironolactone|spironolactone|mesh-list
101337847|NCT05010707|Hormones|hormones|mesh-list
101337848|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337849|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217359|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
101337850|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101337851|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
101337852|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101337853|NCT05010707|Diuretics|diuretics|mesh-ancestor
101337854|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
101337855|NCT00067756|Butyric Acid|butyric acid|mesh-list
101337856|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
101337857|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
101337858|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337859|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337860|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337861|NCT04091880|Vaccines|vaccines|mesh-list
101337862|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
101337863|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337864|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101337865|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101337866|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101337867|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101337868|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217488|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
101337885|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
101337886|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101337887|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331003|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101331004|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101337888|NCT00392457|Ketoconazole|ketoconazole|mesh-list
101337889|NCT00392457|Hormones|hormones|mesh-list
101337890|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101337891|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337892|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
101337893|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337894|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101337895|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101337896|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337897|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217546|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217547|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337898|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101337899|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
101337900|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101337902|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101337903|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101337904|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337905|NCT00068068|Talaporfin|talaporfin|mesh-list
101337906|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217589|NCT01488266|Bupropion|bupropion|mesh-list
101337907|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101337908|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
101337909|NCT00068302|Sirolimus|sirolimus|mesh-list
101337910|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101337911|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337912|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101337913|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337914|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
101337915|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217653|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217654|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101337917|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337918|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
101337919|NCT00068458|Calcium|calcium|mesh-list
101337920|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101337921|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337922|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101337923|NCT00068497|Gefitinib|gefitinib|mesh-list
101337924|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337925|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337937|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337938|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101337939|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101337940|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337941|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337942|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337943|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101337944|NCT00068731|Lycopene|lycopene|mesh-list
101337945|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101337946|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
101337947|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337948|NCT00068731|Protective Agents|protective agents|mesh-ancestor
101337949|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337950|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101337951|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101337952|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101337953|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101337954|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
101337955|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337956|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
101337957|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
101337958|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101337959|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337960|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101337961|NCT00399061|Cyclosporine|cyclosporine|mesh-list
101337962|NCT00399061|Cyclosporins|cyclosporins|mesh-list
101337963|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337964|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337965|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101337966|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
101337967|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331005|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
101331006|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331007|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
101331008|NCT00000620|Protective Agents|protective agents|mesh-ancestor
101331009|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101337968|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
101337969|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101337970|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
101337971|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101337972|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101337973|NCT00069355|Propranolol|propranolol|mesh-list
101337974|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101337975|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101337976|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
101337977|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101337978|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337979|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101337980|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101337981|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101337983|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
101337984|NCT00069550|Donepezil|donepezil|mesh-list
101337985|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101337986|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101337987|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101337988|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
101338005|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
101338006|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338007|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101338009|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101338010|NCT00069901|Paclitaxel|paclitaxel|mesh-list
101338011|NCT00069901|Carboplatin|carboplatin|mesh-list
101338012|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101338013|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338014|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338015|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338016|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338017|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338018|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338019|NCT00069940|Sargramostim|sargramostim|mesh-list
101338020|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
101338021|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338022|NCT00390026|Bevacizumab|bevacizumab|mesh-list
101338023|NCT00390026|Verteporfin|verteporfin|mesh-list
101338024|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338025|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338026|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101338027|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101338028|NCT00390026|Growth Substances|growth substances|mesh-ancestor
101338029|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338030|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
101338031|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101338032|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
101338033|NCT00070057|Celecoxib|celecoxib|mesh-list
101338034|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101338035|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338036|NCT00070057|Analgesics|analgesics|mesh-ancestor
101338037|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
101338038|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338039|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338040|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338041|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338042|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101338043|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101338044|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338045|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338047|NCT00070174|Cyclosporine|cyclosporine|mesh-list
101338065|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101331010|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101331011|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101331012|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
101331013|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101331014|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101331015|NCT00000620|Urological Agents|urological agents|mesh-ancestor
101331016|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101338066|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101338067|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
101338068|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101338071|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
101338072|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338073|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101338074|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101338075|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338076|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338077|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101338078|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
101338080|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
101338081|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101338082|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338083|NCT00070174|Analgesics|analgesics|mesh-ancestor
101338084|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
101338085|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338086|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338087|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
101338088|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
101338089|NCT00070213|Leucovorin|leucovorin|mesh-list
101338090|NCT00070213|Fluorouracil|fluorouracil|mesh-list
101338091|NCT00070213|Capecitabine|capecitabine|mesh-list
101338092|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
101338093|NCT00070213|Calcium|calcium|mesh-list
101338094|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
101217718|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338095|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101338096|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338097|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
101338098|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338099|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338100|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338101|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338102|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
101338103|NCT00070213|Antidotes|antidotes|mesh-ancestor
101338104|NCT00070213|Protective Agents|protective agents|mesh-ancestor
101338105|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
101338106|NCT00070213|Vitamins|vitamins|mesh-ancestor
101338107|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
101338108|NCT00070252|Docetaxel|docetaxel|mesh-list
101338109|NCT00070252|Capecitabine|capecitabine|mesh-list
101338126|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338127|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338128|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338129|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
101338130|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217778|NCT01489228|Benzonidazole|benzonidazole|mesh-list
101338131|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338132|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101338133|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338134|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338135|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338136|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101338137|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338138|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338139|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
101338141|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338143|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331017|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331018|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331020|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101331021|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101338144|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338145|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338146|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338147|NCT03959865|Glucagon|glucagon|mesh-list
101338148|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101338149|NCT03959865|Incretins|incretins|mesh-ancestor
101338150|NCT03959865|Hormones|hormones|mesh-ancestor
101338151|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338152|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338153|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338154|NCT00070486|Celecoxib|celecoxib|mesh-list
101338155|NCT00070486|Zileuton|zileuton|mesh-list
101338156|NCT00070486|Carboplatin|carboplatin|mesh-list
101338157|NCT00070486|Gemcitabine|gemcitabine|mesh-list
101338158|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338159|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338160|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
101338161|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338162|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101338163|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101338165|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
101217952|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217953|NCT01489917|Coagulants|coagulants|mesh-ancestor
101338166|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338167|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338168|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338170|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101338171|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101338186|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
101338187|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338188|NCT00070837|Antibodies|antibodies|mesh-list
101338189|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101338190|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
101218018|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218052|NCT01490255|Amlodipine|amlodipine|mesh-list
101338191|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338193|NCT00071188|Carboplatin|carboplatin|mesh-list
101338194|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338195|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338196|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338197|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338198|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338199|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338200|NCT00071227|Triamcinolone|triamcinolone|mesh-list
101338201|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101338202|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101338203|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101338204|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338205|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
101338207|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338208|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338209|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338210|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
101338211|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338212|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338214|NCT00071266|Lovastatin|lovastatin|mesh-list
101338215|NCT00071266|L 647318|l 647318|mesh-list
101218147|NCT01490749|Everolimus|everolimus|mesh-list
101338217|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101338218|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
101338219|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338220|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101338221|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
101338222|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
101331022|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101331023|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218214|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331024|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101331025|NCT00033280|Temozolomide|temozolomide|mesh-list
101331026|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101331027|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
101338224|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
101338225|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338226|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101338227|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101338228|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218278|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338229|NCT02966743|Midazolam|midazolam|mesh-list
101338230|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
101338231|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101338232|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338233|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338255|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
101338256|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338257|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101338258|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101338259|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101338260|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101338261|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101338262|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338263|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338264|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338265|NCT00071695|Analgesics|analgesics|mesh-ancestor
101338266|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
101338267|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338268|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
101338269|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338270|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
101218405|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338271|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101338272|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
101338273|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338274|NCT00071968|Sirolimus|sirolimus|mesh-list
101338275|NCT00071968|Temsirolimus|temsirolimus|mesh-list
101338278|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338279|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338280|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338281|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
101338282|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338283|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338284|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101338285|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338286|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338287|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
101338301|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
101338302|NCT00390065|Protective Agents|protective agents|mesh-ancestor
101338303|NCT00072007|Prednisone|prednisone|mesh-list
101338304|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
101338305|NCT00072007|Rituximab|rituximab|mesh-list
101338306|NCT00072007|Doxorubicin|doxorubicin|mesh-list
101338307|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101338308|NCT00072007|Vincristine|vincristine|mesh-list
101338309|NCT00072007|Cladribine|cladribine|mesh-list
101338310|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338311|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
101338312|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338313|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338314|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338315|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
101338316|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338317|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338318|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101331028|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331029|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331032|NCT00033319|Hematinics|hematinics|mesh-ancestor
101331033|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
101331034|NCT00033319|Vitamins|vitamins|mesh-ancestor
101331035|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
101338319|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338320|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338321|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338322|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101338323|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338324|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338325|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
101338326|NCT00072007|Hormones|hormones|mesh-ancestor
101338327|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338328|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101338329|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338330|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338331|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338332|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338333|NCT00072046|Interferons|interferons|mesh-list
101338334|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
101338335|NCT00072046|Bevacizumab|bevacizumab|mesh-list
101338336|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338337|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338338|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101338339|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101338340|NCT00072046|Growth Substances|growth substances|mesh-ancestor
101338341|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338342|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101338343|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
101338344|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338345|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
101338346|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
101338347|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101338348|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338349|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
101338369|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101338371|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
101218472|NCT01493050|Calcium|calcium|mesh-list
101338372|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338373|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101338374|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101338375|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
101338376|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338377|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101338378|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
101338379|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338380|NCT04730674|Tetracycline|tetracycline|mesh-list
101338381|NCT04730674|Lidocaine|lidocaine|mesh-list
101338382|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218536|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101218538|NCT01493336|Capecitabine|capecitabine|mesh-list
101338383|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
101338384|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338385|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338386|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
101338387|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338388|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101338389|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101338390|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101338391|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101338392|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338393|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101338394|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338395|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101338396|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338397|NCT03959436|Carbetocin|carbetocin|mesh-list
101338398|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
101338399|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101338400|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338401|NCT00072124|Dacarbazine|dacarbazine|mesh-list
101218667|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
101218669|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
101331036|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331037|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101338402|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338403|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338420|NCT00072163|Growth Substances|growth substances|mesh-ancestor
101338421|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
101338423|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
101338424|NCT00072319|Epirubicin|epirubicin|mesh-list
101338425|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338426|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338427|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338428|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338429|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218729|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338430|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338431|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338432|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
101338433|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338434|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338435|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338436|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
101338437|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101338438|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338439|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338440|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101218793|NCT01495026|Tamsulosin|tamsulosin|mesh-list
101338441|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338442|NCT03959397|Paclitaxel|paclitaxel|mesh-list
101338443|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101338444|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338445|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338446|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338447|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338448|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218855|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338449|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338450|NCT00072436|Gemcitabine|gemcitabine|mesh-list
101338451|NCT00072436|Alvocidib|alvocidib|mesh-list
101338452|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338453|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
101338454|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338455|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338456|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
101338457|NCT00072436|Growth Substances|growth substances|mesh-ancestor
101338458|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338459|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101338460|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338520|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101338521|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
101338522|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338523|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338524|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338525|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338526|NCT00072865|Carboplatin|carboplatin|mesh-list
101338527|NCT00072865|Pemetrexed|pemetrexed|mesh-list
101338528|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338529|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338530|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338531|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101338532|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101338534|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101338535|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338536|NCT00072943|Interferons|interferons|mesh-list
101338537|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
101338538|NCT00072943|Antibodies|antibodies|mesh-list
101338539|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101338540|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
101338541|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338542|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338544|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338546|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331038|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101331039|NCT00033319|Analgesics|analgesics|mesh-ancestor
101331040|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
101219112|NCT01496742|Pemetrexed|pemetrexed|mesh-list
101331041|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331042|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331043|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331044|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101331045|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101331046|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338548|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101338549|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338550|NCT00072982|Borage oil|borage oil|mesh-list
101338551|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338552|NCT03959124|Memantine|memantine|mesh-list
101338553|NCT03959124|Rivastigmine|rivastigmine|mesh-list
101338554|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101338555|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101338556|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
101338557|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338558|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338559|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338560|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101338561|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101338562|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101338563|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338564|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
101338565|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101338566|NCT03959124|Protective Agents|protective agents|mesh-ancestor
101338567|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
101338568|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101338569|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101338570|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338572|NCT02966236|Coagulants|coagulants|mesh-ancestor
101338573|NCT04711291|Tacrolimus|tacrolimus|mesh-list
101338574|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338575|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
101338576|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338577|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101338578|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219381|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338579|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338581|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
101338582|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101338583|NCT04821830|Levodopa|levodopa|mesh-list
101338584|NCT04821830|Carbidopa|carbidopa|mesh-list
101338585|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101338586|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101338587|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101338588|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
101219444|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
101219446|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101338589|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338590|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338591|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338592|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101338593|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338594|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101338595|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
101338596|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
101338597|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101338598|NCT00073411|Escitalopram|escitalopram|mesh-list
101338599|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101338600|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101338601|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101338602|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219510|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219537|NCT01499446|Xhance|xhance|mesh-list
101338603|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331047|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101331048|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101331049|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331050|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
101331051|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101331052|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101331053|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
101331054|NCT00033358|Norgestrel|norgestrel|mesh-list
101331055|NCT00033358|Estradiol|estradiol|mesh-list
101331056|NCT00033358|Estrogens|estrogens|mesh-ancestor
101219569|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101331057|NCT00033358|Hormones|hormones|mesh-ancestor
101338604|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
101338605|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338606|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338607|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
101338608|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338609|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101338610|NCT00073411|Analgesics|analgesics|mesh-ancestor
101338611|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
101338612|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
101338613|NCT02966041|Ondansetron|ondansetron|mesh-list
101338614|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
101338625|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338626|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101338627|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338629|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101338630|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
101338631|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338632|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338633|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101338634|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
101338635|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
101338636|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101338637|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101338638|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101549725|NCT02893709|Omeprazole|omeprazole|mesh-list
101338639|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101338640|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
101338641|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338642|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219639|NCT01500070|Everolimus|everolimus|mesh-list
101338643|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
101338645|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
101338646|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
101338647|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338648|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
101338649|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338650|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338651|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101219689|NCT01500473|Progestins|progestins|mesh-ancestor
101338652|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
101338653|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338654|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338655|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101338656|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338657|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
101338658|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338659|NCT00074074|Infliximab|infliximab|mesh-list
101219783|NCT01500863|Estradiol|estradiol|mesh-list
101338660|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101338661|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338662|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101338663|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338664|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338665|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101338666|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101338667|NCT00392652|Protective Agents|protective agents|mesh-ancestor
101338668|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338669|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331058|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331059|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331060|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101331061|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
101331062|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101338670|NCT00074191|Cytarabine|cytarabine|mesh-list
101219890|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338671|NCT00074191|Dexamethasone|dexamethasone|mesh-list
101338672|NCT00074191|Methotrexate|methotrexate|mesh-list
101338674|NCT00074191|Procarbazine|procarbazine|mesh-list
101338675|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101338676|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
101338677|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
101338678|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338679|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338687|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
101338688|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219954|NCT01501370|Growth Substances|growth substances|mesh-ancestor
101219990|NCT01501422|Estrogens|estrogens|mesh-list
101338689|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338690|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
101338691|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338692|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
101338693|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338694|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101338695|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338696|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
101338697|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338698|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101338699|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
101338700|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338701|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338702|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
101338703|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
101338704|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101338705|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
101338706|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338707|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338708|NCT00392691|Rituximab|rituximab|mesh-list
101338709|NCT00392691|Melphalan|melphalan|mesh-list
101338710|NCT00392691|Vinorelbine|vinorelbine|mesh-list
101338711|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338712|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338713|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
101338714|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338715|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338716|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338717|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
101338718|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338719|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101338720|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338721|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338722|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338723|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338724|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338725|NCT02966080|Heparin|heparin|mesh-list
101338726|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
101338727|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101338728|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101338729|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338730|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
101338731|NCT04767776|Charcoal|charcoal|mesh-list
101338732|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101338733|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
101338734|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101338735|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
101338736|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338737|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338738|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
101338739|NCT04767776|Antidotes|antidotes|mesh-ancestor
101338740|NCT04767776|Protective Agents|protective agents|mesh-ancestor
101338741|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331063|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101331064|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101331065|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101331066|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101331067|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101331068|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101338742|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
101338743|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101338744|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338745|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101338754|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
101338755|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338756|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338757|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
101338758|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101338759|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101338761|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338762|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101338763|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338764|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338765|NCT00074737|Cytarabine|cytarabine|mesh-list
101338766|NCT00074737|Idarubicin|idarubicin|mesh-list
101338767|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338768|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
101338769|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338770|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338772|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338773|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338774|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
101338775|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338776|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338777|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338778|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101338779|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338780|NCT00074776|Lamotrigine|lamotrigine|mesh-list
101338781|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338782|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338784|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338785|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338786|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
101338787|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101338788|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101338789|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101338790|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220381|NCT01503398|Olanzapine|olanzapine|mesh-list
101338791|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101338793|NCT00075010|Valproic Acid|valproic acid|mesh-list
101338794|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338795|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
101338796|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338797|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338798|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338800|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
101338801|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338802|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338804|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101338805|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338806|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338807|NCT04729595|Tempol|tempol|mesh-list
101338808|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
101338809|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338810|NCT04729595|Protective Agents|protective agents|mesh-ancestor
101331069|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331070|NCT02971696|Sorafenib|sorafenib|mesh-list
101331071|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331072|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101331073|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331074|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331075|NCT00033436|Niacinamide|niacinamide|mesh-list
101331077|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
101331078|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
101331079|NCT00033436|Vitamins|vitamins|mesh-ancestor
101331080|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
101331081|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331082|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101331083|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
101331084|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338811|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338812|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101338817|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101338818|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101220573|NCT01503983|Trastuzumab|trastuzumab|mesh-list
101338819|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101338820|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338823|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101338824|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338826|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338827|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101338828|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220633|NCT01504178|Emetics|emetics|mesh-ancestor
101338829|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338830|NCT00075517|Gemcitabine|gemcitabine|mesh-list
101338831|NCT00075517|Docetaxel|docetaxel|mesh-list
101338832|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338833|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
101338834|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338835|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338836|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338837|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338838|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338839|NCT00075556|Capecitabine|capecitabine|mesh-list
101338840|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338841|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
101220701|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338842|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338843|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338845|NCT00075595|Fluorouracil|fluorouracil|mesh-list
101338846|NCT00075595|Irinotecan|irinotecan|mesh-list
101338847|NCT00075595|Calcium|calcium|mesh-list
101338848|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
101338849|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101338850|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338851|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
101338852|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338853|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338854|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338855|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338856|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
101338857|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101338858|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101220828|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331085|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101331086|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
101331087|NCT00000635|Trifluridine|trifluridine|mesh-list
101331088|NCT00000635|Polymyxins|polymyxins|mesh-list
101331089|NCT00000635|Bacitracin|bacitracin|mesh-list
101331090|NCT00000635|Polymyxin B|polymyxin b|mesh-list
101331091|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
101331092|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331093|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
101338859|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338860|NCT00075595|Antidotes|antidotes|mesh-ancestor
101338861|NCT00075595|Protective Agents|protective agents|mesh-ancestor
101220896|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
101338862|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
101338863|NCT00075595|Vitamins|vitamins|mesh-ancestor
101338864|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
101338865|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
101338866|NCT00075634|Doxorubicin|doxorubicin|mesh-list
101338867|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101338868|NCT00075634|Decitabine|decitabine|mesh-list
101338869|NCT00075634|Azacitidine|azacitidine|mesh-list
101338870|NCT00075634|Lenograstim|lenograstim|mesh-list
101338871|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101338872|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
101338873|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338874|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101338875|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101338876|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
101338877|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338878|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338879|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101338880|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101338881|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101338882|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101221018|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
101338883|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338884|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101338902|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338903|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338904|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338905|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338907|NCT00075712|Carboplatin|carboplatin|mesh-list
101338908|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101338909|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338910|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
101338911|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
101338912|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
101338913|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338914|NCT03958500|Methylene Blue|methylene blue|mesh-list
101338915|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338916|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338917|NCT00075751|Carboplatin|carboplatin|mesh-list
101338918|NCT00075751|Gemcitabine|gemcitabine|mesh-list
101338919|NCT00075751|Bortezomib|bortezomib|mesh-list
101338920|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338921|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101338922|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
101338923|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338924|NCT00075868|Octreotide|octreotide|mesh-list
101338925|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101338926|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101338927|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101338928|NCT00075907|Ritonavir|ritonavir|mesh-list
101338929|NCT00075907|Lopinavir|lopinavir|mesh-list
101338930|NCT00075907|Efavirenz|efavirenz|mesh-list
101338931|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101338932|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101338933|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
101338934|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101338935|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338936|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101338937|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101338938|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
101331094|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331095|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331096|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101331097|NCT00033553|Paclitaxel|paclitaxel|mesh-list
101331098|NCT00033553|Carboplatin|carboplatin|mesh-list
101338939|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338940|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101338941|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101338955|NCT00076414|Acetylcholine|acetylcholine|mesh-list
101338956|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101338957|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101338958|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
101338959|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101338960|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338961|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338962|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
101338963|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101338964|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
101338965|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101338966|NCT00399256|Expectorants|expectorants|mesh-ancestor
101338967|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101338968|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101338969|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
101338970|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101338971|NCT00399256|Protective Agents|protective agents|mesh-ancestor
101338972|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338973|NCT00399256|Antidotes|antidotes|mesh-ancestor
101338974|NCT00399295|Naltrexone|naltrexone|mesh-list
101338975|NCT00399295|Hydromorphone|hydromorphone|mesh-list
101338976|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
101338977|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101338978|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338979|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
101338980|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101338981|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101338983|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338985|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
101338986|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101338987|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101338988|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338989|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101338990|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
101338991|NCT00076492|Vitamins|vitamins|mesh-ancestor
101338992|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
101338993|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338994|NCT00076531|Leuprolide|leuprolide|mesh-list
101338995|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101338996|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
101338997|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101338998|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101338999|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101221267|NCT01507077|CKD732|ckd732|mesh-list
101339000|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339001|NCT00076609|Capecitabine|capecitabine|mesh-list
101339002|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339027|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339028|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339029|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339031|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221284|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101339032|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339033|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339034|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339035|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
101339036|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
101339037|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339038|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339039|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339040|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339041|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339042|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339043|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
101339044|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
101339045|NCT03951207|Amlodipine|amlodipine|mesh-list
101339046|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101339047|NCT03951207|Atorvastatin|atorvastatin|mesh-list
101339048|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101339049|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101221418|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
101221419|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
101339050|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
101339051|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339052|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101339053|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101339054|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339069|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
101339070|NCT00077233|Irinotecan|irinotecan|mesh-list
101339071|NCT00077233|Cetuximab|cetuximab|mesh-list
101339072|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339073|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
101339074|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339075|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339076|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339077|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339078|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
101339079|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101339080|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339081|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339082|NCT00077233|Antidotes|antidotes|mesh-ancestor
101339083|NCT00077233|Protective Agents|protective agents|mesh-ancestor
101339084|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
101339085|NCT00077233|Vitamins|vitamins|mesh-ancestor
101339086|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
101339087|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339088|NCT02958631|Losartan|losartan|mesh-list
101339089|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101339090|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339091|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101339092|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101339093|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339094|NCT00077311|Docetaxel|docetaxel|mesh-list
101339095|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
101339096|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
101339097|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339098|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339099|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339100|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339101|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339102|NCT00077311|Hematinics|hematinics|mesh-ancestor
101339103|NCT00077311|Protective Agents|protective agents|mesh-ancestor
101339104|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339105|NCT00077350|Gemcitabine|gemcitabine|mesh-list
101339106|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339107|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
101339108|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339109|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339110|NCT00077389|Carboplatin|carboplatin|mesh-list
101339111|NCT00077389|Doxorubicin|doxorubicin|mesh-list
101339112|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101339113|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339114|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339134|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339135|NCT04551482|Oxytocin|oxytocin|mesh-list
101339136|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
101339137|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101339138|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339140|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339141|NCT00077584|Bosentan|bosentan|mesh-list
101339142|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339143|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101339144|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331100|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331101|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331102|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331103|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339145|NCT00077779|Adalimumab|adalimumab|mesh-list
101339146|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101339147|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339148|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339150|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
101339151|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
101339152|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101339153|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101339154|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339155|NCT00078130|Buprenorphine|buprenorphine|mesh-list
101339156|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101339157|NCT00078130|Naloxone|naloxone|mesh-list
101339158|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101339159|NCT00078130|Narcotics|narcotics|mesh-ancestor
101339160|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339161|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339162|NCT00078130|Analgesics|analgesics|mesh-ancestor
101339163|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
101339164|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339165|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101339166|NCT00399451|Polidocanol|polidocanol|mesh-list
101339167|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101339168|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101339169|NCT04711213|Dexamethasone|dexamethasone|mesh-list
101339170|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
101339183|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
101339184|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339185|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339186|NCT00078247|Lamivudine|lamivudine|mesh-list
101339187|NCT00078247|Zidovudine|zidovudine|mesh-list
101339188|NCT00078247|Abacavir|abacavir|mesh-list
101339189|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101339190|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101339191|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339192|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339193|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
101339194|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339195|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101339196|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101339197|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
101339198|NCT00078442|Interferons|interferons|mesh-list
101339199|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
101339200|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
101339201|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101339202|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339203|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
101339204|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339205|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
101339206|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339207|NCT00078481|Idebenone|idebenone|mesh-list
101339208|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
101339209|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339210|NCT00078481|Protective Agents|protective agents|mesh-ancestor
101339211|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339212|NCT00078598|Rituximab|rituximab|mesh-list
101339213|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
101339214|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339215|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339216|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
101339217|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339218|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339219|NCT00078793|Etanercept|etanercept|mesh-list
101339220|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101339221|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101339222|NCT00078793|Analgesics|analgesics|mesh-ancestor
101339223|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
101339224|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339225|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331104|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331105|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331106|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331107|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
101331109|NCT00033592|Nicotine|nicotine|mesh-list
101331110|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101331111|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
101339226|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339227|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221501|NCT01508104|Everolimus|everolimus|mesh-list
101339228|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101339229|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339230|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
101339231|NCT00078832|Anastrozole|anastrozole|mesh-list
101339232|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339233|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339234|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101339235|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101339236|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339248|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339249|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101339250|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
101339251|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101221550|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101339252|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
101339253|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339254|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339255|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
101339256|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339257|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101339258|NCT00078910|Protective Agents|protective agents|mesh-ancestor
101339259|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339260|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101339261|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339262|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339263|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101339265|NCT00078910|Analgesics|analgesics|mesh-ancestor
101339266|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
101339267|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339268|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339269|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339270|NCT00078988|Carboplatin|carboplatin|mesh-list
101339271|NCT00078988|Etoposide|etoposide|mesh-list
101339272|NCT00078988|Thiotepa|thiotepa|mesh-list
101221677|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101339273|NCT00078988|Isotretinoin|isotretinoin|mesh-list
101339274|NCT00078988|Lenograstim|lenograstim|mesh-list
101339275|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339276|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339277|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339278|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339279|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339280|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339281|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101339282|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
101339283|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339284|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339285|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
101339286|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339287|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339288|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
101339289|NCT00079027|Doxorubicin|doxorubicin|mesh-list
101339290|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101339291|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339292|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339293|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339294|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339295|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331112|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331113|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331114|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101331115|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101331116|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
101339296|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339297|NCT00079105|Prednisolone|prednisolone|mesh-list
101339298|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
101339299|NCT00079105|Etoposide|etoposide|mesh-list
101339317|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339318|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339319|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339320|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339321|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339322|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339323|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
101339325|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339326|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339327|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339329|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
101339330|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339331|NCT03647124|Lenalidomide|lenalidomide|mesh-list
101339332|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
101339333|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339334|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101339335|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101339337|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
101339338|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339339|NCT00079144|Aldesleukin|aldesleukin|mesh-list
101339340|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
101339341|NCT00079144|Fludarabine|fludarabine|mesh-list
101339342|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
101339343|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
101339344|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339345|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
101339346|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339347|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339348|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339349|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
101339350|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339351|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339352|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339353|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339354|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
101339355|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101339356|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101339357|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101339358|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
101339359|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339370|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339372|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101339373|NCT00079261|Prednisone|prednisone|mesh-list
101339374|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
101339375|NCT00079261|Gemcitabine|gemcitabine|mesh-list
101339376|NCT00079261|Doxorubicin|doxorubicin|mesh-list
101339377|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101339378|NCT00079261|Vincristine|vincristine|mesh-list
101339379|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339380|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
101339381|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339382|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339383|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339384|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
101339385|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339386|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339387|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339388|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339389|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
101331117|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331118|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331119|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101331120|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
101331121|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331122|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101331123|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101331124|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331125|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
101331126|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101339390|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339391|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339392|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339393|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339394|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339395|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
101339396|NCT00079261|Hormones|hormones|mesh-ancestor
101339397|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339398|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339399|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339400|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339401|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339402|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339403|NCT00079300|Imiquimod|imiquimod|mesh-list
101339404|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101339405|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
101339406|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339407|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339408|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
101339409|NCT00079378|Decitabine|decitabine|mesh-list
101339410|NCT00079378|Azacitidine|azacitidine|mesh-list
101339411|NCT00079378|Valproic Acid|valproic acid|mesh-list
101339412|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339413|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
101339414|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339415|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339416|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339417|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
101339418|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
101339419|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339420|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339421|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
101339422|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101339434|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339435|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339436|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339437|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339438|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
101339440|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101339441|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101339442|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101339443|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339444|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339445|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339446|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101339447|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339448|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
101339449|NCT00079612|Sorafenib|sorafenib|mesh-list
101339450|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339451|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339452|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331127|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331128|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331129|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
101331130|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
101331131|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101331132|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
101331133|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101339453|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339454|NCT03526107|Theobromine|theobromine|mesh-list
101339455|NCT03526107|Caffeine|caffeine|mesh-list
101339456|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101339457|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339458|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101339459|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339460|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339461|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101339462|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101339463|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
101339464|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339465|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101339466|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
101339467|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339468|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101339469|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
101339470|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
101339471|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
101339472|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339473|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339474|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
101339475|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
101339476|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339477|NCT00079807|Protective Agents|protective agents|mesh-ancestor
101339478|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339479|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
101339480|NCT00079807|Vitamins|vitamins|mesh-ancestor
101339481|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
101339482|NCT00079885|Tigecycline|tigecycline|mesh-list
101339483|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339484|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339485|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101339497|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101339498|NCT00079963|Vitamins|vitamins|mesh-list
101339499|NCT00079963|Vitamin E|vitamin e|mesh-list
101339500|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
101339501|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339502|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
101339503|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339504|NCT00079963|Protective Agents|protective agents|mesh-ancestor
101339505|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
101339506|NCT00392886|Temozolomide|temozolomide|mesh-list
101339507|NCT00392886|Thiotepa|thiotepa|mesh-list
101339508|NCT00392886|Carboplatin|carboplatin|mesh-list
101339509|NCT00392886|Methotrexate|methotrexate|mesh-list
101339510|NCT00392886|Etoposide|etoposide|mesh-list
101339511|NCT00392886|Vincristine|vincristine|mesh-list
101339512|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339513|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
101339514|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339515|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339516|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339517|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
101339518|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339519|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339520|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339521|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101339522|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
101339523|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101339524|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339525|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
101339526|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
101331134|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101331135|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331136|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101339527|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339528|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101339529|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101339530|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339531|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339532|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339533|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339534|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339535|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339536|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
101339537|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339538|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101339539|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
101339540|NCT00080080|Docetaxel|docetaxel|mesh-list
101339541|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339542|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339543|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339544|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339545|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339546|NCT00080158|Mirtazapine|mirtazapine|mesh-list
101339547|NCT00080158|Citalopram|citalopram|mesh-list
101339549|NCT00080158|Fluoxetine|fluoxetine|mesh-list
101339565|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101339566|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101339568|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101339569|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339570|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101549813|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339571|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101339572|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
101339573|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
101339574|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101339575|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101339576|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101339577|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101339578|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101339579|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101339580|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101339581|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101339582|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101339583|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339584|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101339585|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339586|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339587|NCT00080275|Niacin|niacin|mesh-list
101339588|NCT00080275|Simvastatin|simvastatin|mesh-list
101339589|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101339590|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101339591|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
101339592|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339593|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101339594|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101339595|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339596|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
101339597|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
101339598|NCT00080275|Vitamins|vitamins|mesh-ancestor
101339599|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
101339600|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339601|NCT00393003|Anesthetics|anesthetics|mesh-list
101339602|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339603|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339604|NCT00080314|Aripiprazole|aripiprazole|mesh-list
101339605|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
101339622|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101339623|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101339624|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
101339625|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339626|NCT00080431|Daclizumab|daclizumab|mesh-list
101331137|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331138|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331139|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101339627|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339628|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
101339629|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339630|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
101339631|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339632|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339633|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339634|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339635|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339636|NCT03506373|Ixazomib|ixazomib|mesh-list
101339637|NCT03506373|Glycine|glycine|mesh-list
101339638|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339639|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339640|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
101339641|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339642|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
101339643|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339644|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339645|NCT02972411|Acetazolamide|acetazolamide|mesh-list
101339646|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
101339647|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101339648|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339649|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339650|NCT02972411|Diuretics|diuretics|mesh-ancestor
101339651|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
101339652|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339654|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339655|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339656|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339657|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339658|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339659|NCT00080665|Docetaxel|docetaxel|mesh-list
101339660|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
101339661|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339662|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339663|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339675|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339676|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339677|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101339678|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101339679|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101339680|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339681|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339682|NCT04423367|Dexamethasone|dexamethasone|mesh-list
101339683|NCT04423367|Bortezomib|bortezomib|mesh-list
101339684|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339685|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
101339686|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
101339687|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339688|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339689|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101339690|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
101339692|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101339693|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339694|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339695|NCT00080782|Celecoxib|celecoxib|mesh-list
101339696|NCT00080782|Doxorubicin|doxorubicin|mesh-list
101339697|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101339698|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101339699|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339700|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339701|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339702|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339703|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339704|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101331140|NCT00033709|Thalidomide|thalidomide|mesh-list
101331141|NCT00033709|Temozolomide|temozolomide|mesh-list
101331142|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101331143|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
101331144|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331145|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331146|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339705|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101339706|NCT00080782|Analgesics|analgesics|mesh-ancestor
101339707|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
101339708|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339709|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339710|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101339711|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339712|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101339713|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101339714|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101339715|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101339716|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339717|NCT00080977|Aldesleukin|aldesleukin|mesh-list
101339718|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339719|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101339722|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339724|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
101339737|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101339738|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
101339739|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101339740|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339741|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
101339742|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
101339743|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339744|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101339745|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101339746|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
101339747|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339748|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101339749|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101339750|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101339751|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339752|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
101339753|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
101339754|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339755|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339756|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339757|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339758|NCT00081172|Antibodies|antibodies|mesh-list
101339759|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101339760|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
101339761|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339762|NCT03187080|Bupivacaine|bupivacaine|mesh-list
101339763|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
101339764|NCT03187080|Anesthetics|anesthetics|mesh-list
101339765|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339766|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339767|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
101339768|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339769|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
101339770|NCT00081484|Hematinics|hematinics|mesh-ancestor
101339771|NCT00390260|Acetaminophen|acetaminophen|mesh-list
101339772|NCT00390260|Rofecoxib|rofecoxib|mesh-list
101339773|NCT00390260|Hydrocodone|hydrocodone|mesh-list
101339774|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101339775|NCT00390260|Analgesics|analgesics|mesh-ancestor
101339776|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
101339777|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331147|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
101331148|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331149|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
101331150|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331151|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331152|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101331153|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101331154|NCT00033709|Growth Substances|growth substances|mesh-ancestor
101339778|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339780|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339781|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
101339782|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101339783|NCT00390260|Narcotics|narcotics|mesh-ancestor
101339784|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339785|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
101339786|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101339787|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101339793|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339794|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
101339795|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339796|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
101339797|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339798|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339799|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101339800|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101339801|NCT00081757|Growth Substances|growth substances|mesh-ancestor
101339802|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
101339803|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339804|NCT00081796|Capecitabine|capecitabine|mesh-list
101339805|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101339806|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
101339807|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339808|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339809|NCT03152175|Propranolol|propranolol|mesh-list
101339810|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101339811|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101339812|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
101339813|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339814|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339815|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339816|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101339817|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101339818|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
101339819|NCT00399685|Efavirenz|efavirenz|mesh-list
101339820|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
101339821|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101339822|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101339823|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101339824|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339825|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339826|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
101339827|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339828|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101339829|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101339830|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101339831|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101339832|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101339833|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101339834|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339835|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339836|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339837|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339838|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101331155|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
101331156|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101339839|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
101339840|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101339841|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339842|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101339843|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101339844|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101339845|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
101339846|NCT00081835|Antibodies|antibodies|mesh-list
101339847|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
101339848|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101339849|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101339850|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
101339851|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339853|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101339854|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101339855|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339868|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101339869|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339870|NCT00082225|Antibodies|antibodies|mesh-list
101339871|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
101339872|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339873|NCT00082537|Caspofungin|caspofungin|mesh-list
101339874|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101339875|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
101339876|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339877|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339878|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339879|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101339880|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101339881|NCT00082576|Azithromycin|azithromycin|mesh-list
101339882|NCT00082576|Chloroquine|chloroquine|mesh-list
101339883|NCT00082576|Mefloquine|mefloquine|mesh-list
101339884|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339885|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339886|NCT00082576|Amebicides|amebicides|mesh-ancestor
101339887|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101339888|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101339889|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
101339890|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339891|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
101339892|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101339893|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339894|NCT00082966|Bortezomib|bortezomib|mesh-list
101339895|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339896|NCT00083005|Thalidomide|thalidomide|mesh-list
101339897|NCT00083005|Docetaxel|docetaxel|mesh-list
101339898|NCT00083005|Estramustine|estramustine|mesh-list
101339899|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339900|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101339901|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101339902|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
101339903|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339904|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339905|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
101339906|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339907|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
101339908|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101339909|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101339910|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101339911|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101339912|NCT00083005|Growth Substances|growth substances|mesh-ancestor
101339913|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
101339914|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339915|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
101339916|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101339917|NCT00083083|Paclitaxel|paclitaxel|mesh-list
101339918|NCT00083083|Etoposide|etoposide|mesh-list
101339919|NCT00083083|Vinorelbine|vinorelbine|mesh-list
101339920|NCT00083083|Vinblastine|vinblastine|mesh-list
101339937|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101339938|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339939|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101331157|NCT00033748|Antibodies|antibodies|mesh-list
101331158|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
101331159|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101331160|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
101331161|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331162|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339940|NCT03151863|Analgesics|analgesics|mesh-ancestor
101339941|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
101339942|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101339943|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101339944|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101339946|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
101339947|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339948|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339949|NCT03151863|Narcotics|narcotics|mesh-ancestor
101339950|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
101339951|NCT00083161|Etoposide|etoposide|mesh-list
101339952|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101339953|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
101339954|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101339955|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101339956|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101339957|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
101339958|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339959|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339960|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101339961|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101339962|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101339963|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101339964|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339965|NCT00083278|Ipilimumab|ipilimumab|mesh-list
101339966|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101339967|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101339968|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101339969|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339970|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
101339971|NCT00083434|Hematinics|hematinics|mesh-ancestor
101339972|NCT00083590|Huperzine A|huperzine a|mesh-list
101339973|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101339974|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101339975|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101339976|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
101339977|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101339978|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340002|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340003|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340004|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340005|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101340006|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101340007|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
101340008|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340009|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340011|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101340012|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
101340014|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340015|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
101340016|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340017|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
101340018|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340019|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340020|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101340021|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101340022|NCT00083707|Growth Substances|growth substances|mesh-ancestor
101340023|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
101340024|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340025|NCT00083785|Talaporfin|talaporfin|mesh-list
101331164|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
101331165|NCT00000641|Rifampin|rifampin|mesh-list
101331166|NCT00000641|Amikacin|amikacin|mesh-list
101331167|NCT00000641|Ethambutol|ethambutol|mesh-list
101331168|NCT00000641|Clofazimine|clofazimine|mesh-list
101331169|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340026|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340027|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101340028|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
101340029|NCT03151707|Niacinamide|niacinamide|mesh-list
101340036|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101340037|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
101340038|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340039|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101340040|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
101340041|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
101340042|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101340043|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340044|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340045|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340046|NCT03151668|Analgesics|analgesics|mesh-ancestor
101340047|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
101340048|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340049|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101340050|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101340051|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101340052|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
101340053|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340054|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340055|NCT05568082|Itraconazole|itraconazole|mesh-list
101340056|NCT05568082|Sotorasib|sotorasib|mesh-list
101340057|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
101340058|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340059|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101340060|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101340061|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340062|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340063|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101340064|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
101340065|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340066|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340067|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101340068|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101340069|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340070|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340071|NCT05567653|Sulfalene|sulfalene|mesh-list
101340072|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340073|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101340074|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
101340075|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101340076|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101340077|NCT04733508|Exenatide|exenatide|mesh-list
101340078|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340079|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340080|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101340081|NCT04733508|Incretins|incretins|mesh-ancestor
101340082|NCT04733508|Hormones|hormones|mesh-ancestor
101340083|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340084|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101340085|NCT00135304|Vitamin D|vitamin d|mesh-list
101340086|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101340087|NCT00135304|Cinacalcet|cinacalcet|mesh-list
101340088|NCT00135304|Vitamins|vitamins|mesh-ancestor
101340089|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
101340090|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340091|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101340092|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101340093|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101340094|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331170|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331171|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101331172|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340095|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340097|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
101340098|NCT00135499|Rituximab|rituximab|mesh-list
101340099|NCT00135499|Doxorubicin|doxorubicin|mesh-list
101340100|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101340132|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340133|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
101340134|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340135|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101340137|NCT03151434|Analgesics|analgesics|mesh-ancestor
101340138|NCT00135577|Alvimopan|alvimopan|mesh-list
101340139|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340140|NCT00135733|Alefacept|alefacept|mesh-list
101340141|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
101340142|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
101340143|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340144|NCT04061798|Heparin|heparin|mesh-list
101340162|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340163|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340164|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340165|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340166|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
101340167|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
101340168|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340169|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
101340170|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340171|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101340172|NCT00135928|Lenograstim|lenograstim|mesh-list
101340173|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101340174|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
101340175|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340176|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
101340177|NCT00135967|Prednisone|prednisone|mesh-list
101340178|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
101340180|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101340181|NCT00135967|Prednisolone|prednisolone|mesh-list
101340182|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
101340183|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101340184|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
101340185|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340186|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
101340187|NCT00135967|Hormones|hormones|mesh-ancestor
101340188|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340189|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340190|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101340191|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340192|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101340193|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101340194|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
101340195|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340196|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340197|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340198|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340200|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
101340201|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340202|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340216|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340217|NCT03151239|Niacinamide|niacinamide|mesh-list
101340218|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
101340219|NCT03151239|Vitamins|vitamins|mesh-ancestor
101340220|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
101340221|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340223|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331174|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331175|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331176|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101331177|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331178|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101331179|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
101331180|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
101331181|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101340224|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340225|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
101340226|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340227|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340228|NCT00136474|Amifostine|amifostine|mesh-list
101340229|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101340230|NCT00136474|Protective Agents|protective agents|mesh-ancestor
101340231|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340232|NCT00136552|Rituximab|rituximab|mesh-list
101340233|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340234|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340235|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
101340236|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340237|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340238|NCT00136591|Bortezomib|bortezomib|mesh-list
101340239|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340240|NCT03151161|Carboplatin|carboplatin|mesh-list
101340241|NCT03151161|Pemetrexed|pemetrexed|mesh-list
101340242|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340243|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340244|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340245|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101340246|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101340247|NCT00404053|Clopidogrel|clopidogrel|mesh-list
101340248|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101340249|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101340250|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101340251|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101340252|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
101340253|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340254|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340255|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340257|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340258|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340259|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101340260|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340262|NCT00136747|Bupropion|bupropion|mesh-list
101340263|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101340281|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101340282|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101340283|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
101340284|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340285|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340286|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340287|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101340288|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101340289|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
101340290|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101340291|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
101340292|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340293|NCT00136825|Expectorants|expectorants|mesh-ancestor
101340294|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
101340295|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101340296|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
101331182|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101331183|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101331184|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101331185|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101340297|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340298|NCT00136825|Protective Agents|protective agents|mesh-ancestor
101340299|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340300|NCT00136825|Antidotes|antidotes|mesh-ancestor
101340301|NCT00393198|Misoprostol|misoprostol|mesh-list
101340302|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
101340303|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101340304|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
101340305|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101340306|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340307|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101340308|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101340309|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101340310|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101340311|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
101340312|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101340313|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340315|NCT03968822|Lidocaine|lidocaine|mesh-list
101340316|NCT03968822|Bupivacaine|bupivacaine|mesh-list
101340317|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101340318|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
101340319|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
101340329|NCT00136942|Atorvastatin|atorvastatin|mesh-list
101340330|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101340331|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101340332|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
101340333|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340334|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101340335|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101340336|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340337|NCT00136981|Atorvastatin|atorvastatin|mesh-list
101340339|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101340340|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101340341|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
101340342|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340343|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101340344|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101340345|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340346|NCT00137020|Ziprasidone|ziprasidone|mesh-list
101340347|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101340348|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
101340349|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340350|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340351|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340352|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101340353|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101340354|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340355|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340356|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101340357|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
101340358|NCT00137059|Acetaminophen|acetaminophen|mesh-list
101340359|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340360|NCT00137059|Analgesics|analgesics|mesh-ancestor
101340361|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
101340362|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340363|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340364|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
101340365|NCT00137098|Caffeine|caffeine|mesh-list
101340366|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101340367|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340368|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101340369|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331187|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101331188|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331189|NCT00000644|Clarithromycin|clarithromycin|mesh-list
101331190|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331191|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331192|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101331193|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340370|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340371|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101340372|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101340373|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
101340374|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340375|NCT00137254|Insulin|insulin|mesh-list
101340376|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340377|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340378|NCT03151044|Rituximab|rituximab|mesh-list
101340379|NCT03151044|Epirubicin|epirubicin|mesh-list
101340380|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340381|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340398|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340399|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101340400|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101340401|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340402|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340403|NCT03151005|Metformin|metformin|mesh-list
101340404|NCT03151005|Liraglutide|liraglutide|mesh-list
101340405|NCT03151005|Exenatide|exenatide|mesh-list
101340406|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
101340407|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
101340408|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340409|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340410|NCT03151005|Incretins|incretins|mesh-ancestor
101340411|NCT03151005|Hormones|hormones|mesh-ancestor
101340412|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340414|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101340415|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101340416|NCT00137527|Anesthetics|anesthetics|mesh-list
101340417|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340418|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340420|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340421|NCT00137566|Analgesics|analgesics|mesh-ancestor
101340422|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
101340423|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340424|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340425|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
101340426|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101340427|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
101340428|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340429|NCT00137761|Docetaxel|docetaxel|mesh-list
101340430|NCT00137761|Gefitinib|gefitinib|mesh-list
101340431|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340432|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340433|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340434|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340435|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340436|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101340437|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340438|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101340439|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340456|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
101340457|NCT00137995|Melphalan|melphalan|mesh-list
101340458|NCT00137995|Ifosfamide|ifosfamide|mesh-list
101340459|NCT00137995|Carboplatin|carboplatin|mesh-list
101340460|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331194|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331195|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101331196|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331198|NCT02971423|Sulbactam|sulbactam|mesh-list
101331199|NCT02971423|Durlobactam|durlobactam|mesh-list
101331200|NCT02971423|Cilastatin|cilastatin|mesh-list
101340461|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340462|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
101340463|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340464|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340465|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340466|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
101340467|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
101340468|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340469|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340470|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
101340471|NCT00137995|Hormones|hormones|mesh-ancestor
101340472|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340473|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101340474|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101340475|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101340476|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340477|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340478|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340479|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101340480|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
101340481|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
101340482|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340483|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340484|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101340485|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
101340486|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101340487|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
101340488|NCT00138112|Vancomycin|vancomycin|mesh-list
101340489|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340490|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340491|NCT00138229|Aldesleukin|aldesleukin|mesh-list
101340492|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
101340493|NCT00138229|Fludarabine|fludarabine|mesh-list
101340494|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
101340495|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340496|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
101340497|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340498|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340499|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101340500|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
101340510|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101340511|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101340512|NCT02826161|Paclitaxel|paclitaxel|mesh-list
101340513|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101340514|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340515|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340516|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340517|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340518|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340519|NCT00138541|Vildagliptin|vildagliptin|mesh-list
101340520|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340521|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340522|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101340523|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
101340524|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340525|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340526|NCT00138580|Vildagliptin|vildagliptin|mesh-list
101340527|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340528|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331201|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331202|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331203|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
101331204|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340529|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101340530|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
101340531|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340532|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340533|NCT03150771|Aripiprazole|aripiprazole|mesh-list
101340534|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
101340535|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340536|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101340537|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101340538|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340539|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340540|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
101340541|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
101340542|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340543|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340544|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101340545|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101340546|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
101340547|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101340548|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101340549|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101340550|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101340551|NCT00138619|Vildagliptin|vildagliptin|mesh-list
101340552|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340553|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340554|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101340555|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
101340556|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340557|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340559|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101340560|NCT03150732|Narcotics|narcotics|mesh-ancestor
101340561|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340562|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340563|NCT03150732|Analgesics|analgesics|mesh-ancestor
101340564|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
101340588|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340589|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
101340590|NCT00138970|Hormones|hormones|mesh-ancestor
101340591|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340592|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340593|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101340594|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340595|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
101340596|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
101340597|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340598|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340599|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101340600|NCT00138970|Protective Agents|protective agents|mesh-ancestor
101340601|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101340602|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101340603|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
101340604|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340605|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340606|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340607|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340608|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
101340609|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
101340610|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340611|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
101340612|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340613|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101340614|NCT00139009|Cyclosporine|cyclosporine|mesh-list
101340615|NCT00139009|Cyclosporins|cyclosporins|mesh-list
101340616|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331205|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331206|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101331207|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101331208|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101340626|NCT03890666|Albuterol|albuterol|mesh-list
101340627|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101340628|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
101340629|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340630|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340631|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101340632|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101340633|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
101340634|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101340635|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101340636|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101340637|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101340638|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
101340639|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340640|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340641|NCT00139165|Budesonide|budesonide|mesh-list
101340642|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340643|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101340644|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
101340645|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340646|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340647|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101340648|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
101340649|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
101340651|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340652|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
101340653|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101340654|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340656|NCT00139243|Fluorouracil|fluorouracil|mesh-list
101340658|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340659|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
101340660|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340661|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101340662|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340663|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
101340664|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340665|NCT00139243|Antidotes|antidotes|mesh-ancestor
101340666|NCT00139243|Protective Agents|protective agents|mesh-ancestor
101340667|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
101340668|NCT00139243|Vitamins|vitamins|mesh-ancestor
101340669|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
101340670|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340671|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340672|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340673|NCT00139282|Squalamine|squalamine|mesh-list
101340674|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340675|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340676|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101340677|NCT00139282|Protective Agents|protective agents|mesh-ancestor
101340678|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340679|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340680|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101340681|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101340682|NCT00139282|Growth Substances|growth substances|mesh-ancestor
101340707|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101340708|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101340709|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101340710|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340711|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101340712|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331209|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
101331210|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331211|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331212|NCT00389090|Temozolomide|temozolomide|mesh-list
101331213|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101331214|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101340713|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
101340714|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101340715|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
101340716|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340718|NCT03844412|Nortriptyline|nortriptyline|mesh-list
101340719|NCT03844412|Estradiol|estradiol|mesh-list
101340720|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
101340721|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
101340722|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340723|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340724|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
101340725|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340726|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101340727|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101340728|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101340729|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101340730|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340731|NCT03844412|Estrogens|estrogens|mesh-ancestor
101340732|NCT03844412|Hormones|hormones|mesh-ancestor
101340744|NCT00139711|Irinotecan|irinotecan|mesh-list
101340745|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340746|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340747|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340748|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340749|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340750|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101340751|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340752|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340754|NCT03837977|Folic Acid|folic acid|mesh-list
101340755|NCT03837977|Docetaxel|docetaxel|mesh-list
101340756|NCT03837977|Fluorouracil|fluorouracil|mesh-list
101340757|NCT03837977|Irinotecan|irinotecan|mesh-list
101340758|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
101340759|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340760|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340761|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340762|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340763|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340764|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
101340765|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101340766|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340767|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
101340768|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340769|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101340770|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101340771|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340772|NCT03837977|Antidotes|antidotes|mesh-ancestor
101340773|NCT03837977|Protective Agents|protective agents|mesh-ancestor
101340774|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
101340775|NCT03837977|Vitamins|vitamins|mesh-ancestor
101340776|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
101340777|NCT03837977|Hematinics|hematinics|mesh-ancestor
101340778|NCT00404326|Hydralazine|hydralazine|mesh-list
101340779|NCT00404326|Valproic Acid|valproic acid|mesh-list
101340780|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
101340781|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340782|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340783|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
101340784|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340785|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340786|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
101340787|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331216|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331217|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331218|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331219|NCT00033982|Posaconazole|posaconazole|mesh-list
101331220|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
101331221|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331222|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101331223|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101331224|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101340788|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101340789|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101340790|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101340791|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101340792|NCT00139750|Varenicline|varenicline|mesh-list
101340793|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101340794|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101340795|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
101340796|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340797|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340808|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340809|NCT03150459|Rifaximin|rifaximin|mesh-list
101340810|NCT03150459|Simvastatin|simvastatin|mesh-list
101340811|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101340812|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101340813|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
101340814|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340815|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101340816|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101340817|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340818|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340819|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340820|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101340821|NCT00140023|Azithromycin|azithromycin|mesh-list
101340822|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340823|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340824|NCT00140062|Latanoprost|latanoprost|mesh-list
101340825|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101340826|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101340828|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101340829|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340830|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340831|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340832|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340833|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340834|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
101340835|NCT03150420|Antidotes|antidotes|mesh-ancestor
101340836|NCT03150420|Protective Agents|protective agents|mesh-ancestor
101340837|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340838|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
101340839|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340840|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
101340841|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340842|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340843|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
101340844|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
101340845|NCT00140218|Pramipexole|pramipexole|mesh-list
101340846|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
101340847|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340848|NCT00140218|Protective Agents|protective agents|mesh-ancestor
101340849|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340850|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101340851|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101340852|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
101331225|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101331226|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331227|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340853|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
101340854|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340855|NCT00140257|Escitalopram|escitalopram|mesh-list
101340856|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101340857|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101340858|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101340859|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340860|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101340861|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
101340862|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340880|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340881|NCT00140530|Sirolimus|sirolimus|mesh-list
101340882|NCT00140530|Paclitaxel|paclitaxel|mesh-list
101340883|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101340884|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340885|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
101340886|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
101340887|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
101340888|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340889|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101340890|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340891|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101340892|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
101340893|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101340894|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
101340895|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340896|NCT00140569|Interferons|interferons|mesh-list
101340897|NCT00140569|Fludarabine|fludarabine|mesh-list
101340898|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340899|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
101340900|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340901|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
101340903|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101340904|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340905|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101340906|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
101340907|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340908|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340909|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101340910|NCT00140725|Interferons|interferons|mesh-list
101340911|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
101340912|NCT00140725|Lamivudine|lamivudine|mesh-list
101340913|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
101340914|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340915|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
101340916|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101340917|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
101340918|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340919|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101340920|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101340921|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340935|NCT00140920|Diclofenac|diclofenac|mesh-list
101340936|NCT00140920|Rofecoxib|rofecoxib|mesh-list
101340937|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101340938|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340939|NCT00140920|Analgesics|analgesics|mesh-ancestor
101340940|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
101340941|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340942|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340943|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340944|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340945|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101340946|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101340947|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340948|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101340949|NCT03136497|Rituximab|rituximab|mesh-list
101340950|NCT03136497|Venetoclax|venetoclax|mesh-list
101331228|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331229|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101331230|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
101549914|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331231|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340951|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101340952|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101340953|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
101340954|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340955|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340956|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101340957|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101340958|NCT00140998|Estradiol|estradiol|mesh-list
101340959|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101340960|NCT00140998|Estrogens|estrogens|mesh-ancestor
101340961|NCT00140998|Hormones|hormones|mesh-ancestor
101340962|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101340963|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340964|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101340965|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
101340966|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101340967|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101340968|NCT00141154|Celecoxib|celecoxib|mesh-list
101340969|NCT00141154|Loxoprofen|loxoprofen|mesh-list
101340970|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101340971|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340972|NCT00141154|Analgesics|analgesics|mesh-ancestor
101340973|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
101340974|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101340975|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101340976|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101340977|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101340978|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101340979|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101340981|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101340983|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101340984|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101340997|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101340998|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
101340999|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341000|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101341001|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101341002|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341003|NCT02315534|Temozolomide|temozolomide|mesh-list
101341004|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101341005|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
101341006|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341007|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341008|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
101341009|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341010|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
101341011|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101341012|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101341013|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341014|NCT00141310|Urological Agents|urological agents|mesh-ancestor
101341015|NCT00141388|Pregabalin|pregabalin|mesh-list
101341016|NCT00141388|Analgesics|analgesics|mesh-ancestor
101341017|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
101341018|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341019|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341020|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
101341021|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101341022|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341023|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341024|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341025|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101331232|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331234|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101331235|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101331236|NCT00034060|Analgesics|analgesics|mesh-ancestor
101331237|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
101341026|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341027|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341028|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341029|NCT00404404|Paclitaxel|paclitaxel|mesh-list
101341030|NCT00404404|Bevacizumab|bevacizumab|mesh-list
101341031|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101341032|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101341033|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341034|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
101341035|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
101341036|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
101341037|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341038|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341039|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101341040|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101341041|NCT00404404|Growth Substances|growth substances|mesh-ancestor
101341042|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341043|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
101341044|NCT00404482|Cyclosporine|cyclosporine|mesh-list
101341045|NCT00404482|Cyclosporins|cyclosporins|mesh-list
101341053|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
101341054|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341055|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101341056|NCT03073941|Cimetidine|cimetidine|mesh-list
101341057|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101341058|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341059|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101341060|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
101341061|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
101341062|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341063|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341064|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341065|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101341066|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101341067|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341068|NCT00141427|Pregabalin|pregabalin|mesh-list
101341069|NCT00141427|Analgesics|analgesics|mesh-ancestor
101341070|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
101341071|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341072|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341073|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
101341074|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101341075|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341076|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341077|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341078|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101341079|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341080|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341081|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341082|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
101341083|NCT00141544|Estrogens|estrogens|mesh-list
101341084|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
101341085|NCT00141544|Estrone|estrone|mesh-list
101341086|NCT00141544|Testosterone|testosterone|mesh-list
101341087|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
101341088|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
101341089|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101341090|NCT00141544|Hormones|hormones|mesh-ancestor
101341091|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341092|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341093|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101341094|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341095|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
101331238|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331239|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331240|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331241|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331242|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101331243|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331244|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
101341096|NCT00141544|Androgens|androgens|mesh-ancestor
101341097|NCT00141583|Candesartan|candesartan|mesh-list
101341098|NCT00141583|Candesartan cilexetil|candesartan cilexetil|mesh-list
101341099|NCT00141583|Enalapril|enalapril|mesh-list
101341100|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101341101|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101341102|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101341103|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341104|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101341105|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
101341106|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341107|NCT00141700|Rituximab|rituximab|mesh-list
101341108|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341109|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341110|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
101341111|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341112|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341123|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
101341124|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341125|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341126|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101341127|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
101341128|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101341129|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
101341130|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341131|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341132|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101341133|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
101341134|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
101341135|NCT00142051|Protective Agents|protective agents|mesh-ancestor
101341137|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341138|NCT02825979|Sotalol|sotalol|mesh-list
101341139|NCT02825979|Flecainide|flecainide|mesh-list
101341140|NCT02825979|Dronedarone|dronedarone|mesh-list
101341141|NCT02825979|Propafenone|propafenone|mesh-list
101341142|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101341143|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101341144|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101341145|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101341146|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341147|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341148|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341149|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
101341150|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
101341151|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341152|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101341153|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101341154|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341155|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
101341156|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
101341157|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101341158|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
101341159|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101341160|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101341161|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341162|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101341163|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456543|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331246|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331247|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341164|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341165|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101341166|NCT00142246|Amodiaquine|amodiaquine|mesh-list
101341167|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
101341168|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101341169|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101341170|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341171|NCT00142324|Donepezil|donepezil|mesh-list
101341172|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101341173|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341174|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341175|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341176|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341177|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341186|NCT00142480|Bevacizumab|bevacizumab|mesh-list
101341187|NCT00142480|Capecitabine|capecitabine|mesh-list
101341188|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
101341189|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341190|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341191|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101341192|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101341193|NCT00142480|Growth Substances|growth substances|mesh-ancestor
101341194|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341196|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101341197|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
101341198|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341199|NCT02806050|Letrozole|letrozole|mesh-list
101341200|NCT02806050|Palbociclib|palbociclib|mesh-list
101341201|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341202|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101341203|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101341204|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341205|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341206|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101341207|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101341208|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341209|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341210|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101341211|NCT02781792|Temozolomide|temozolomide|mesh-list
101341212|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101341213|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
101341214|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341215|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341216|NCT00142870|Bupropion|bupropion|mesh-list
101341217|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101341218|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
101341219|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341220|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101341221|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101341222|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341223|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341224|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
101341225|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341226|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341227|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101341228|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101341229|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341230|NCT00142948|Naltrexone|naltrexone|mesh-list
101341231|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101341232|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101341233|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341234|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
101341235|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341236|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
101341237|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101341238|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341239|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331248|NCT00034177|Paclitaxel|paclitaxel|mesh-list
101331249|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101331250|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331251|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331252|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
101341240|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341256|NCT00143026|Levodopa|levodopa|mesh-list
101341257|NCT00143026|Carbidopa|carbidopa|mesh-list
101341258|NCT00143026|Entacapone|entacapone|mesh-list
101341259|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101341260|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101341261|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
101341262|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341263|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341264|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341265|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101341266|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341267|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101341268|NCT00404599|Simvastatin|simvastatin|mesh-list
101341269|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101341270|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101341271|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
101341272|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341273|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101341274|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101341275|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341276|NCT00143065|Rituximab|rituximab|mesh-list
101341277|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
101341278|NCT00143065|Fludarabine|fludarabine|mesh-list
101341279|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341280|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341281|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
101341282|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341283|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341285|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101341286|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341287|NCT00143143|Pregabalin|pregabalin|mesh-list
101341288|NCT00143143|Analgesics|analgesics|mesh-ancestor
101341289|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
101341290|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341291|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341292|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
101341293|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101341294|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341295|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341296|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101341297|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101341298|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341344|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
101341346|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341347|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341348|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341350|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
101341351|NCT00143533|Irinotecan|irinotecan|mesh-list
101341352|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101341353|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101341354|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341355|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341356|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341357|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101341358|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341359|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
101341360|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341361|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
101341362|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341363|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341364|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101341365|NCT00393315|Paclitaxel|paclitaxel|mesh-list
101456544|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331253|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331254|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331255|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331256|NCT00389129|Aspirin|aspirin|mesh-list
101331257|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101331258|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341366|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101341367|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341368|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101341369|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101341370|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101341371|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341372|NCT00143689|Ritonavir|ritonavir|mesh-list
101341373|NCT00143689|Lopinavir|lopinavir|mesh-list
101341375|NCT00143689|Zidovudine|zidovudine|mesh-list
101341376|NCT00143689|Nevirapine|nevirapine|mesh-list
101341377|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101341378|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101341379|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
101341380|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341381|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341382|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101341383|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101341384|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
101341385|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341386|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101341387|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101341388|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101341389|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101341390|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
101341391|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101341392|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101341393|NCT00143728|Lamivudine|lamivudine|mesh-list
101341394|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101341395|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101341423|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
101341424|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341425|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101341427|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101341428|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341429|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101341430|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101341431|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341432|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
101341433|NCT00144118|Sevoflurane|sevoflurane|mesh-list
101341435|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101341436|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101341437|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
101341438|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
101341439|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341440|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341441|NCT00144157|Zidovudine|zidovudine|mesh-list
101341442|NCT00144157|Nevirapine|nevirapine|mesh-list
101341443|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
101341444|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341460|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
101341461|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
101341462|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101341463|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341464|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341465|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341466|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101341467|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101341468|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341470|NCT00144274|Expectorants|expectorants|mesh-ancestor
101341471|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
101341472|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
101341473|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
101331259|NCT00389129|Analgesics|analgesics|mesh-ancestor
101331260|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
101331261|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331262|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341474|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101341475|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
101341476|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101341477|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101341478|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341479|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101341480|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341481|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341482|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101341483|NCT00144430|Pentostatin|pentostatin|mesh-list
101341484|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341485|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101341486|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341487|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341488|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101341489|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
101341490|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341492|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101341493|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
101341494|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341495|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341496|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101341497|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
101341498|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101341499|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101341500|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341501|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101341502|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101341519|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341520|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101341521|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341522|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341523|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101341524|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341525|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101341526|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
101341527|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101341528|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341529|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341530|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
101341531|NCT00404794|Hormones|hormones|mesh-ancestor
101341532|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341533|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101341534|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
101341535|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
101341536|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341537|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341538|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101341539|NCT00404794|Protective Agents|protective agents|mesh-ancestor
101341540|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
101341541|NCT00404833|Prednisolone|prednisolone|mesh-list
101341542|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101341543|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
101341544|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101341545|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
101341546|NCT00404833|Chlorambucil|chlorambucil|mesh-list
101341547|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101341548|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
101341549|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101341550|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341551|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101341552|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
101341553|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101341554|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341555|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331263|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331264|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331265|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101331266|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101341556|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341557|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341558|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
101341559|NCT00404833|Hormones|hormones|mesh-ancestor
101341560|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341561|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341590|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341591|NCT03128021|Analgesics|analgesics|mesh-ancestor
101341592|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
101341605|NCT01807494|Cimetidine|cimetidine|mesh-list
101341606|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101341607|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341624|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101341625|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101341626|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101341627|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341628|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341629|NCT05594017|Scopolamine|scopolamine|mesh-list
101341630|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101341631|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101341632|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
101341633|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
101341634|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341635|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341636|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341637|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
101341638|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101341639|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341640|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341641|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341642|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101341643|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
101341645|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
101341646|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341647|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
101341648|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341649|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341650|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101341651|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
101341652|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341653|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341654|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101341655|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341656|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101341657|NCT01807377|Midazolam|midazolam|mesh-list
101341658|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101341659|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101341660|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341661|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341662|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101341663|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341718|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101341720|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341721|NCT00390923|Selegiline|selegiline|mesh-list
101341722|NCT00390923|Nicotine|nicotine|mesh-list
101341723|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101341724|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
101341725|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341726|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341727|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101341728|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101341729|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
101341730|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331267|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341731|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341732|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
101341733|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101341734|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101341735|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101341736|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101341737|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341738|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101341739|NCT00390923|Protective Agents|protective agents|mesh-ancestor
101341740|NCT00425425|Fluorouracil|fluorouracil|mesh-list
101341741|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
101341742|NCT00425425|Cetuximab|cetuximab|mesh-list
101341743|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
101341744|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341745|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101341746|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341747|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101341748|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
101341749|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341750|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101341751|NCT01806948|Ramosetron|ramosetron|mesh-list
101341752|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
101341753|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
101341754|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341795|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101341796|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101341798|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101341799|NCT05227456|Progestins|progestins|mesh-ancestor
101341801|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101341802|NCT01806753|Midazolam|midazolam|mesh-list
101341803|NCT01806753|Propofol|propofol|mesh-list
101341804|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101341805|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341806|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341807|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101341808|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
101341809|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
101341810|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101341811|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101341812|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101341826|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
101341827|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331268|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101331269|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101331271|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
101331272|NCT00013962|Vitamin D|vitamin d|mesh-list
101331273|NCT00013962|Vitamins|vitamins|mesh-ancestor
101331274|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
101341846|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101341847|NCT01806675|Glycine|glycine|mesh-list
101341848|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101341849|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341850|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
101341851|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101341853|NCT02762981|Paclitaxel|paclitaxel|mesh-list
101341854|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101341855|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101341856|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101341857|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
101341858|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
101341859|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
101341860|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341861|NCT05065567|Droperidol|droperidol|mesh-list
101341862|NCT05065567|Haloperidol|haloperidol|mesh-list
101341863|NCT05065567|Ondansetron|ondansetron|mesh-list
101341864|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
101341865|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
101341866|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
101341867|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341868|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341869|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101341870|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
101341871|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
101341872|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101341873|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101341874|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
101341907|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101341908|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341909|NCT01806363|Diuretics|diuretics|mesh-ancestor
101341910|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
101341911|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341912|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101341913|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101341925|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341926|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341928|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341929|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
101341930|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
101341931|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101341932|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101341933|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341934|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341935|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
101341936|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101341937|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
101341938|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
101341939|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341940|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341941|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341942|NCT04749043|Analgesics|analgesics|mesh-ancestor
101331275|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331276|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101331277|NCT00000665|Ganciclovir|ganciclovir|mesh-list
101331278|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101341943|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
101341944|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341946|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
101341947|NCT00393393|Protective Agents|protective agents|mesh-ancestor
101341948|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341949|NCT00405262|Ketorolac|ketorolac|mesh-list
101341950|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101341951|NCT00405262|Bupivacaine|bupivacaine|mesh-list
101341952|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
101341953|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
101341954|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101341955|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341956|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
101341957|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341958|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101341959|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101341960|NCT00405262|Analgesics|analgesics|mesh-ancestor
101341961|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341962|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101341963|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101341964|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341965|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341966|NCT00405301|Rifampin|rifampin|mesh-list
101341967|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
101341968|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101341969|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
101341970|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101341971|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101341972|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
101341973|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101341974|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101341975|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101341976|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101341992|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101341994|NCT00393471|Analgesics|analgesics|mesh-ancestor
101341995|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
101341996|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101341997|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101341998|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101341999|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342000|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342001|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342002|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
101342003|NCT02647892|Lidocaine|lidocaine|mesh-list
101342004|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
101342005|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
101342006|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549974|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342007|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342008|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
101342009|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342010|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101342011|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101342012|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101342013|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101342014|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342016|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101342017|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101342018|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101342019|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101342020|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
101342021|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342022|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331280|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
101331281|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
101331282|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331283|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331284|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331285|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331286|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331287|NCT00034372|Oregovomab|oregovomab|mesh-list
101331288|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331289|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331290|NCT00014001|Olanzapine|olanzapine|mesh-list
101331291|NCT00014001|Risperidone|risperidone|mesh-list
101331292|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101331293|NCT00014001|Ziprasidone|ziprasidone|mesh-list
101331294|NCT00014001|Clozapine|clozapine|mesh-list
101331295|NCT00014001|Perphenazine|perphenazine|mesh-list
101331296|NCT00014001|Fluphenazine|fluphenazine|mesh-list
101331297|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
101331298|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
101331299|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101342023|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342024|NCT02505893|Sirolimus|sirolimus|mesh-list
101342025|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342026|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342027|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342028|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342029|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
101342030|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342031|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
101342032|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342033|NCT04341181|Trastuzumab|trastuzumab|mesh-list
101342062|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342063|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101342064|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101342066|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101342067|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101342068|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101342069|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101342070|NCT02423876|Hydromorphone|hydromorphone|mesh-list
101342071|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342072|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342073|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
101342074|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342075|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101342076|NCT02423876|Narcotics|narcotics|mesh-ancestor
101342077|NCT02423876|Analgesics|analgesics|mesh-ancestor
101342078|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
101342079|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342080|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342081|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101342097|NCT01805817|Hormones|hormones|mesh-ancestor
101342098|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342099|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331300|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
101331301|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331302|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331303|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331304|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101331305|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331306|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331307|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331308|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101331309|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
101331310|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
101331311|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
101331312|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331313|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342100|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101342101|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
101342102|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342103|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101342104|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101342105|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101342106|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101342107|NCT01805817|Trace Elements|trace elements|mesh-ancestor
101342108|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
101342109|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101342110|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
101342111|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101342112|NCT01805817|Diuretics|diuretics|mesh-ancestor
101342113|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
101342114|NCT04206046|Anesthetics|anesthetics|mesh-list
101342115|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342116|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342117|NCT00405418|Insulin|insulin|mesh-list
101342118|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101342119|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
101342120|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
101342121|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101342122|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342123|NCT02157077|Aflibercept|aflibercept|mesh-list
101342124|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101342125|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101342126|NCT02157077|Growth Substances|growth substances|mesh-ancestor
101342127|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342128|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
101342129|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342130|NCT01805700|Caffeine|caffeine|mesh-list
101342131|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101342132|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342133|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101342134|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342135|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342136|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101342137|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101342138|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
101342139|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342140|NCT04033276|Rituximab|rituximab|mesh-list
101342141|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
101342142|NCT04033276|Antibodies|antibodies|mesh-list
101342143|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
101342144|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101342157|NCT00391157|Bortezomib|bortezomib|mesh-list
101342158|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331314|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101331315|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101331316|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331317|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
101331318|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
101331319|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
101331321|NCT00000671|Didanosine|didanosine|mesh-list
101331322|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
101331323|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331324|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331325|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331326|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331327|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
101331328|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331329|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331330|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331331|NCT02971540|Dipyrone|dipyrone|mesh-list
101342159|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
101342160|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
101342161|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342162|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342163|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342164|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
101342165|NCT00391157|Hormones|hormones|mesh-ancestor
101342166|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342167|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101342169|NCT03781063|Fulvestrant|fulvestrant|mesh-list
101342170|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101342171|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342172|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101342173|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101342174|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
101342175|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342176|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342177|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
101342178|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101342179|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
101342180|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101342181|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101342182|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342183|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342184|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
101342185|NCT01903421|Fentanyl|fentanyl|mesh-list
101342186|NCT01903421|Bupivacaine|bupivacaine|mesh-list
101342187|NCT01903421|Anesthetics|anesthetics|mesh-list
101342188|NCT01903421|Propofol|propofol|mesh-list
101342189|NCT01903421|Sevoflurane|sevoflurane|mesh-list
101342190|NCT01903421|Isoflurane|isoflurane|mesh-list
101342191|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
101342192|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342193|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342194|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
101342195|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342196|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101342197|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101342198|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
101342199|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101342200|NCT01903421|Narcotics|narcotics|mesh-ancestor
101331333|NCT02971540|Bupivacaine|bupivacaine|mesh-list
101331334|NCT02971540|Ropivacaine|ropivacaine|mesh-list
101331335|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
101331336|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
101331337|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331338|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331339|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
101331340|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331341|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101331342|NCT02971540|Narcotics|narcotics|mesh-ancestor
101331343|NCT02971540|Analgesics|analgesics|mesh-ancestor
101331344|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101331345|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101331346|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331347|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331348|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
101550001|NCT00593099|Bupropion|bupropion|mesh-list
101331349|NCT00034489|Gemcitabine|gemcitabine|mesh-list
101331350|NCT00034489|Pemetrexed|pemetrexed|mesh-list
101342201|NCT01903421|Analgesics|analgesics|mesh-ancestor
101342202|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101342203|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101342204|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101342205|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
101342206|NCT03734731|Narcotics|narcotics|mesh-ancestor
101342207|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342209|NCT03734731|Analgesics|analgesics|mesh-ancestor
101342225|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342226|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101342227|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101342228|NCT01723839|Growth Substances|growth substances|mesh-ancestor
101342229|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
101342230|NCT03421483|Folic Acid|folic acid|mesh-list
101342231|NCT03421483|Hematinics|hematinics|mesh-ancestor
101342232|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
101342233|NCT03421483|Vitamins|vitamins|mesh-ancestor
101342234|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
101342235|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342236|NCT03363217|Trametinib|trametinib|mesh-list
101342237|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342238|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342239|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342240|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342241|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
101342242|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101342243|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342244|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101342245|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342246|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101342247|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
101342248|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342249|NCT00405496|Difluprednate|difluprednate|mesh-list
101342250|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
101342251|NCT00405496|Hormones|hormones|mesh-ancestor
101342252|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342253|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342254|NCT00405535|Glycine|glycine|mesh-list
101342255|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
101342256|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331351|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331353|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331354|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331355|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331356|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331357|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331358|NCT00396487|Fluorouracil|fluorouracil|mesh-list
101342257|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342258|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342259|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
101342260|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
101342261|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
101342262|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342263|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342264|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101342265|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101342266|NCT00405574|Growth Substances|growth substances|mesh-ancestor
101342267|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342268|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
101342285|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
101342286|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342287|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342290|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
101342291|NCT01646034|Carboplatin|carboplatin|mesh-list
101342292|NCT01646034|Gemcitabine|gemcitabine|mesh-list
101342293|NCT01646034|Doxorubicin|doxorubicin|mesh-list
101342294|NCT01646034|Thiotepa|thiotepa|mesh-list
101342295|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342296|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342297|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342298|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342299|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342300|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342301|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342302|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
101342303|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342304|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342305|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342306|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
101342307|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342308|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342309|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
101342310|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342311|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342312|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101342313|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342314|NCT00391313|Chloroquine|chloroquine|mesh-list
101342315|NCT00391313|Amebicides|amebicides|mesh-ancestor
101342316|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101342317|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101342318|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342319|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
101342320|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342322|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101342323|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342324|NCT01466517|Analgesics|analgesics|mesh-ancestor
101342325|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
101342326|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342327|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342328|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342329|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342342|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101342343|NCT01466478|Vitamins|vitamins|mesh-ancestor
101331359|NCT00396487|Capecitabine|capecitabine|mesh-list
101331360|NCT00396487|Irinotecan|irinotecan|mesh-list
101331361|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
101331362|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331363|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331364|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331365|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331366|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
101342344|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
101342345|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101342346|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342347|NCT00063830|Alicaforsen|alicaforsen|mesh-list
101342348|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342349|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342350|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
101342351|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342352|NCT00062816|Ribavirin|ribavirin|mesh-list
101342353|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
101342354|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342355|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
101342356|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342357|NCT00048113|Alicaforsen|alicaforsen|mesh-list
101342358|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342359|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342360|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
101342361|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342362|NCT01466361|Nicotine|nicotine|mesh-list
101342363|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101342364|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
101342365|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342366|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342367|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101342368|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101342369|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
101342370|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342371|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342372|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
101342373|NCT00001832|Fludarabine|fludarabine|mesh-list
101342374|NCT00001832|Interleukin-2|interleukin-2|mesh-list
101342375|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101342376|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342377|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
101342378|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342379|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342380|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342381|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
101342382|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342383|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342384|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342385|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342386|NCT00001832|Analgesics|analgesics|mesh-ancestor
101342387|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
101342388|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342389|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101342390|NCT01466244|Cetuximab|cetuximab|mesh-list
101342391|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342409|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342411|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
101342412|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342414|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101342415|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342416|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342417|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
101342418|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342419|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342420|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
101342421|NCT00009230|Celecoxib|celecoxib|mesh-list
101331367|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331368|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101331369|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331370|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331371|NCT00000674|Leucovorin|leucovorin|mesh-list
101331372|NCT00000674|Clindamycin|clindamycin|mesh-list
101331373|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
101342422|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101342423|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342424|NCT00009230|Analgesics|analgesics|mesh-ancestor
101342425|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
101342426|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342427|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342428|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342429|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342430|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101342431|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101342432|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342433|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342434|NCT00009581|Acetylcholine|acetylcholine|mesh-list
101342435|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
101342436|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101342437|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
101342438|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342439|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342440|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342441|NCT00009620|Phenobarbital|phenobarbital|mesh-list
101342442|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
101342443|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101342444|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342445|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342446|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101342447|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101342463|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342464|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342465|NCT00009698|Analgesics|analgesics|mesh-ancestor
101342466|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
101342467|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342468|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342469|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101342470|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101342471|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
101342472|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342473|NCT01465893|Vitamin D|vitamin d|mesh-list
101342474|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
101342475|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
101342476|NCT01465893|Vitamins|vitamins|mesh-list
101342477|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
101342478|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342479|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101342480|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342481|NCT00009776|Cyclosporine|cyclosporine|mesh-list
101342482|NCT00009776|Paclitaxel|paclitaxel|mesh-list
101342483|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101342484|NCT00009776|Antibodies|antibodies|mesh-list
101342485|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
101342486|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101342487|NCT00009776|Cyclosporins|cyclosporins|mesh-list
101342488|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342489|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342490|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342491|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342492|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342493|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342494|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
101342495|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342496|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342497|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342498|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
101331374|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
101331375|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
101331376|NCT00000674|Calcium|calcium|mesh-list
101331377|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
101331378|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101331379|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342499|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342500|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101342501|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342502|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101342503|NCT00009815|Leucovorin|leucovorin|mesh-list
101342504|NCT00009815|Etoposide|etoposide|mesh-list
101342505|NCT00009815|Tegafur|tegafur|mesh-list
101342506|NCT00009815|Calcium|calcium|mesh-list
101342507|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
101342508|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342519|NCT00009815|Vitamins|vitamins|mesh-ancestor
101342520|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
101342521|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342522|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
101342523|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101342524|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342525|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101342526|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342527|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342528|NCT00009854|Ethanol|ethanol|mesh-list
101342529|NCT00009854|Carmustine|carmustine|mesh-list
101342530|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101342531|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342532|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342533|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342534|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342535|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
101342536|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342537|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342538|NCT00009893|Leucovorin|leucovorin|mesh-list
101342539|NCT00009893|Gemcitabine|gemcitabine|mesh-list
101342540|NCT00009893|Fluorouracil|fluorouracil|mesh-list
101342541|NCT00009893|Calcium|calcium|mesh-list
101342542|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
101342543|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342544|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
101342545|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342546|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342547|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342548|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342549|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342550|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
101342551|NCT00009893|Antidotes|antidotes|mesh-ancestor
101342552|NCT00009893|Protective Agents|protective agents|mesh-ancestor
101342553|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
101342555|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
101342556|NCT00009971|Fenretinide|fenretinide|mesh-list
101342557|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342558|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101342559|NCT00009971|Protective Agents|protective agents|mesh-ancestor
101342560|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342561|NCT00010010|Exemestane|exemestane|mesh-list
101342562|NCT00010010|Goserelin|goserelin|mesh-list
101342563|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342564|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101342565|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101342566|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342567|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342568|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101342569|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
101342570|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342571|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342572|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101342622|NCT01465113|Omeprazole|omeprazole|mesh-list
101331380|NCT00000674|Antidotes|antidotes|mesh-ancestor
101331381|NCT00000674|Protective Agents|protective agents|mesh-ancestor
101331382|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
101331383|NCT00000674|Vitamins|vitamins|mesh-ancestor
101331385|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331386|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331387|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101342623|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
101342624|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342625|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101342626|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101342627|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101342628|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101342629|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342630|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101342631|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342632|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342633|NCT01465074|Nicotine|nicotine|mesh-list
101342634|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101342635|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
101342636|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342637|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342638|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101342639|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101342640|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
101342641|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342642|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342643|NCT00010283|Beclomethasone|beclomethasone|mesh-list
101342644|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342645|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
101342646|NCT00010283|Hormones|hormones|mesh-ancestor
101342647|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342648|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342649|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101342650|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
101342651|NCT00010322|Toremifene|toremifene|mesh-list
101342652|NCT00010322|Atamestane|atamestane|mesh-list
101342653|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101342654|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342655|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101342669|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342670|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
101342671|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342672|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342673|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
101342674|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342675|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101342676|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342677|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101342678|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342679|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101342680|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
101342681|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342682|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
101342683|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101342684|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
101342685|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342686|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342687|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342688|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
101342689|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342690|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342691|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342692|NCT01464840|Azithromycin|azithromycin|mesh-list
101342693|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331388|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331389|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331390|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
101331391|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101331392|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101331393|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331394|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
101331395|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101342694|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342695|NCT01464801|Resveratrol|resveratrol|mesh-list
101342696|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
101342697|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342698|NCT01464801|Protective Agents|protective agents|mesh-ancestor
101342699|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342700|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342701|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101342702|NCT01464762|Bedaquiline|bedaquiline|mesh-list
101342703|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
101342704|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342705|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342706|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
101342707|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
101342708|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342709|NCT01464723|Ranibizumab|ranibizumab|mesh-list
101342710|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101342711|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101342712|NCT01464723|Growth Substances|growth substances|mesh-ancestor
101342713|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342714|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
101342733|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342734|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342735|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342736|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342737|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342738|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342739|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342740|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101342741|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101342742|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
101342743|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101342744|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
101342745|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342746|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
101342747|NCT01464528|Protective Agents|protective agents|mesh-ancestor
101342748|NCT00393744|Amoxicillin|amoxicillin|mesh-list
101342749|NCT00393744|Pristinamycin|pristinamycin|mesh-list
101342750|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101342751|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101342753|NCT00011297|Lorazepam|lorazepam|mesh-list
101342754|NCT00011297|Analgesics|analgesics|mesh-ancestor
101342755|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
101342756|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342757|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342758|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
101342759|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101342760|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101342761|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101342762|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101342763|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101342764|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101342765|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342766|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342767|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
101342768|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
101342769|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
101342770|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342771|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101342772|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
101331397|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331398|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331399|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101331400|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
101331401|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101342787|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342788|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101342789|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
101342790|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342791|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
101342792|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101342793|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342794|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342795|NCT00847860|Aspirin|aspirin|mesh-list
101342796|NCT00847860|Cilostazol|cilostazol|mesh-list
101342797|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101342798|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101342799|NCT00847860|Analgesics|analgesics|mesh-ancestor
101342800|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
101342801|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101342802|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342803|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101342804|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342805|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101342806|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101342807|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342808|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101342809|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101342810|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342811|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
101342812|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101342813|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
101342814|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101342815|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
101342816|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
101342817|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101342818|NCT00847860|Protective Agents|protective agents|mesh-ancestor
101342819|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101342820|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101342822|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
101342823|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101342824|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
101342825|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342826|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342827|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101342828|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101342829|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101342830|NCT00009932|Paclitaxel|paclitaxel|mesh-list
101342831|NCT00009932|Fenretinide|fenretinide|mesh-list
101342841|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
101342842|NCT00847587|Etonogestrel|etonogestrel|mesh-list
101342843|NCT00847587|Desogestrel|desogestrel|mesh-list
101342844|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342845|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342846|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101342847|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101342848|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101342849|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101342850|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101342851|NCT00847587|Progestins|progestins|mesh-ancestor
101342852|NCT00847587|Hormones|hormones|mesh-ancestor
101342853|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342854|NCT00011765|Fluoxetine|fluoxetine|mesh-list
101342855|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101331402|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
101331403|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331404|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331405|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101331406|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
101331407|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
101331408|NCT00014040|Protective Agents|protective agents|mesh-ancestor
101331409|NCT00034528|Prednisone|prednisone|mesh-list
101331410|NCT00034528|Fludarabine|fludarabine|mesh-list
101331411|NCT00034528|Busulfan|busulfan|mesh-list
101342856|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101342857|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101342858|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342859|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101342860|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
101342861|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342862|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101342863|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
101342864|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101342865|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101342866|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101342867|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342869|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
101342870|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101342871|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342872|NCT00011921|Paclitaxel|paclitaxel|mesh-list
101342873|NCT00011921|Etoposide|etoposide|mesh-list
101342874|NCT00011921|Carboplatin|carboplatin|mesh-list
101342875|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
101342876|NCT00011921|Epirubicin|epirubicin|mesh-list
101342877|NCT00011921|Ifosfamide|ifosfamide|mesh-list
101342878|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342879|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342880|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342881|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342882|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342883|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342884|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342885|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101342886|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342887|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342888|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342889|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
101342890|NCT00011960|Paclitaxel|paclitaxel|mesh-list
101342891|NCT00011960|Cisplatin|cisplatin|mesh-list
101342892|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342893|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342894|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342895|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342896|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342916|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342917|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342918|NCT00012038|Irofulven|irofulven|mesh-list
101342919|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342920|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
101342921|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342922|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342924|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342925|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
101342926|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342927|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342928|NCT00847119|Bevacizumab|bevacizumab|mesh-list
101342929|NCT00847119|Capecitabine|capecitabine|mesh-list
101342930|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331412|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331413|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
101550100|NCT00595985|Sorafenib|sorafenib|mesh-list
101331415|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331416|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331417|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101331418|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331419|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331420|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331421|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
101331422|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
101342931|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342932|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101342933|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101342934|NCT00847119|Growth Substances|growth substances|mesh-ancestor
101342935|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342936|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
101342937|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342938|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
101342939|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342940|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101342941|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101342942|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342943|NCT00847080|Incretins|incretins|mesh-ancestor
101342944|NCT00847080|Hormones|hormones|mesh-ancestor
101342945|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101342946|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101342947|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
101342948|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342949|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342950|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101342969|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
101342970|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101342971|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101342972|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101342973|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
101342974|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101342975|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101342976|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101342977|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
101342978|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
101342979|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
101342980|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101342981|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101342982|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101342983|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101342984|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
101342985|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101342986|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101342987|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
101342988|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101342989|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
101342990|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101342991|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101342992|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101342993|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101342994|NCT00847002|Laxatives|laxatives|mesh-ancestor
101342995|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101342996|NCT00012350|Tipifarnib|tipifarnib|mesh-list
101342997|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550108|NCT00596219|Celecoxib|celecoxib|mesh-list
101331423|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101331424|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101331425|NCT00000677|Sch 39304|sch 39304|mesh-list
101331426|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
101331427|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331428|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
101331429|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101331430|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
101331431|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331432|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
101331433|NCT04711642|Protective Agents|protective agents|mesh-ancestor
101331434|NCT00034606|Gemcitabine|gemcitabine|mesh-list
101342998|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101342999|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101343000|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343001|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
101343002|NCT00012389|Irinotecan|irinotecan|mesh-list
101343003|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343004|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101343005|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343006|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343007|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343008|NCT00846885|Sumatriptan|sumatriptan|mesh-list
101343009|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101343021|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101343023|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343024|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
101343025|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343026|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
101343027|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101343028|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343029|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343030|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343031|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101343032|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
101343033|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343034|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343035|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101343036|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101343037|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101343038|NCT00012467|Amebicides|amebicides|mesh-ancestor
101343039|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101343040|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101343041|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101343042|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
101343043|NCT00012506|Etanercept|etanercept|mesh-list
101343044|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101343045|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101343046|NCT00012506|Analgesics|analgesics|mesh-ancestor
101343047|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
101343048|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343049|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343050|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343051|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343052|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343053|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343054|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
101343055|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
101343056|NCT00012584|Methylphenidate|methylphenidate|mesh-list
101343057|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101343058|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343059|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101331436|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331437|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
101331438|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331440|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331441|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331442|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331443|NCT00034645|Posaconazole|posaconazole|mesh-list
101331444|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
101331445|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343060|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343061|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343062|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343063|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
101343064|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343065|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101343066|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343067|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343068|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343069|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101343070|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
101343085|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
101343086|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343087|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101343088|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101343090|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343091|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343092|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101343093|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
101343094|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
101343095|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
101343096|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101343097|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
101343098|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
101343099|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101343100|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101343101|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101343102|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
101343103|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343104|NCT00846690|Protective Agents|protective agents|mesh-ancestor
101343105|NCT00846651|Phenylephrine|phenylephrine|mesh-list
101343106|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
101343107|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101343108|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
101343109|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
101343110|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343111|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343112|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
101343113|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101343114|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
101343115|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
101343116|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101343117|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101343118|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101343119|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
101343120|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343121|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343122|NCT00846651|Protective Agents|protective agents|mesh-ancestor
101343123|NCT00846612|Bevacizumab|bevacizumab|mesh-list
101343124|NCT00846612|Doxorubicin|doxorubicin|mesh-list
101343125|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101343126|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343127|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343128|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101331446|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101331447|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101331448|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101331449|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101331450|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331451|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331452|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331453|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101331454|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331455|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331456|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331457|NCT00034762|Risperidone|risperidone|mesh-list
101331458|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101343129|NCT00846612|Growth Substances|growth substances|mesh-ancestor
101343130|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343131|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343144|NCT00394056|Paroxetine|paroxetine|mesh-list
101343145|NCT00394056|Vestipitant|vestipitant|mesh-list
101343146|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101343147|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343148|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343149|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343150|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343151|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
101343152|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343153|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101343154|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343155|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343156|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101343157|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343158|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343159|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101343160|NCT00846339|Bupropion|bupropion|mesh-list
101343161|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101343162|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343163|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343164|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101343165|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343166|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343167|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343168|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
101343169|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343170|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343171|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101343172|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343173|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343174|NCT00846144|Copper|copper|mesh-list
101343175|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
101343176|NCT00846144|Trace Elements|trace elements|mesh-ancestor
101343177|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
101343178|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343179|NCT00846144|Antidotes|antidotes|mesh-ancestor
101343180|NCT00846144|Protective Agents|protective agents|mesh-ancestor
101343181|NCT00846144|Emetics|emetics|mesh-ancestor
101343182|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
101343183|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343184|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343185|NCT00845988|Aripiprazole|aripiprazole|mesh-list
101343186|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
101331459|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
101331460|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331461|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331462|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331463|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101331464|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331465|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331466|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331467|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101331468|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
101331469|NCT00000686|Stavudine|stavudine|mesh-list
101331470|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
101331471|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331472|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331473|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331474|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331475|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
101331476|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343187|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343188|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101343189|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343190|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343191|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343206|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101343207|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343208|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343209|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343210|NCT00845910|Growth Substances|growth substances|mesh-ancestor
101343211|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343212|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343213|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343214|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343215|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343216|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343217|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343220|NCT00680628|Tenecteplase|tenecteplase|mesh-list
101343221|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
101343222|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
101343223|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101343224|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101343225|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343226|NCT00013520|Lamivudine|lamivudine|mesh-list
101343227|NCT00013520|Zidovudine|zidovudine|mesh-list
101343228|NCT00013520|Efavirenz|efavirenz|mesh-list
101343229|NCT00013520|Nevirapine|nevirapine|mesh-list
101343230|NCT00013520|Abacavir|abacavir|mesh-list
101343231|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
101343232|NCT00013520|Didanosine|didanosine|mesh-list
101343233|NCT00013520|Stavudine|stavudine|mesh-list
101343234|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101343235|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101343236|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101343237|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101343238|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343239|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343240|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
101343241|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331477|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331478|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331479|NCT00034801|Olanzapine|olanzapine|mesh-list
101331480|NCT00034801|Ziprasidone|ziprasidone|mesh-list
101331481|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
101331483|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331484|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331485|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101331487|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331488|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331489|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331490|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101331491|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101331492|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331493|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343242|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101343243|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101343244|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
101343245|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101343246|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343247|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101343248|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101343249|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101343250|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101343251|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101343252|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101343265|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
101343266|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101343267|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343268|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343270|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343271|NCT00276978|Aripiprazole|aripiprazole|mesh-list
101343272|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343273|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343274|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101343275|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343276|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343277|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343278|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
101343279|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
101343280|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343281|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343282|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101343283|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101343284|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
101343285|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101343286|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101343287|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101343288|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101343291|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331494|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331495|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
101331496|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101331497|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101331498|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
101331499|NCT00014196|Docetaxel|docetaxel|mesh-list
101331500|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331501|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331502|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331503|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331504|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331505|NCT00034840|Valsartan|valsartan|mesh-list
101331506|NCT00034840|Telmisartan|telmisartan|mesh-list
101331507|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101331508|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101343292|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101343293|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343294|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343295|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343296|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343297|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
101343298|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343299|NCT00276861|Gemcitabine|gemcitabine|mesh-list
101343300|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
101343301|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343302|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
101343303|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343304|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343305|NCT00013871|Vaccines|vaccines|mesh-list
101343306|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101343307|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
101343310|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343311|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343312|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343313|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101343314|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101343315|NCT00276705|Thalidomide|thalidomide|mesh-list
101343328|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343329|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343330|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343331|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343332|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
101343333|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101343334|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343335|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343336|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343337|NCT00276705|Growth Substances|growth substances|mesh-ancestor
101343338|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343339|NCT00276666|Vincristine|vincristine|mesh-list
101343340|NCT00276666|Lomustine|lomustine|mesh-list
101343341|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343343|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343344|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343345|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343346|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343347|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343348|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
101331509|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101331510|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331511|NCT00000689|Leucovorin|leucovorin|mesh-list
101331512|NCT00000689|Cytarabine|cytarabine|mesh-list
101331513|NCT00000689|Dexamethasone|dexamethasone|mesh-list
101331514|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
101331515|NCT00000689|Doxorubicin|doxorubicin|mesh-list
101331516|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101331517|NCT00000689|Methotrexate|methotrexate|mesh-list
101331518|NCT00000689|Vincristine|vincristine|mesh-list
101331519|NCT00000689|Bleomycin|bleomycin|mesh-list
101331520|NCT00000689|Sargramostim|sargramostim|mesh-list
101331521|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
101331522|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343349|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101343350|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
101343351|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101343352|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
101343353|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343354|NCT00014105|Carboplatin|carboplatin|mesh-list
101343355|NCT00014105|Temozolomide|temozolomide|mesh-list
101343356|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343357|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343358|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
101343359|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343360|NCT00014144|Gefitinib|gefitinib|mesh-list
101343361|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343362|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101343363|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343364|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343365|NCT00276588|Paclitaxel|paclitaxel|mesh-list
101343366|NCT00276588|Carboplatin|carboplatin|mesh-list
101343367|NCT00276588|Gemcitabine|gemcitabine|mesh-list
101343368|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343369|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343370|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343371|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343372|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343373|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343374|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343375|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
101343376|NCT00276549|Gemcitabine|gemcitabine|mesh-list
101343377|NCT00276549|Docetaxel|docetaxel|mesh-list
101343378|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343390|NCT00014261|Interferons|interferons|mesh-list
101343391|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
101343392|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
101343393|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101343394|NCT00014261|Temozolomide|temozolomide|mesh-list
101343395|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343396|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
101343397|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343398|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343399|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
101343400|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343401|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
101343402|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343404|NCT00014339|Melphalan|melphalan|mesh-list
101343405|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343406|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
101343407|NCT00014339|Hormones|hormones|mesh-ancestor
101343408|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343409|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343410|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101331523|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
101331524|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331525|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331526|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101331527|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
101331528|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331529|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331530|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101331531|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331532|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
101331533|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
101331534|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343411|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343412|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343413|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
101343414|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343415|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101343416|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343417|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
101343418|NCT00014456|Gemcitabine|gemcitabine|mesh-list
101343419|NCT00014456|Docetaxel|docetaxel|mesh-list
101343420|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343421|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
101343422|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343423|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343424|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343425|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343426|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343427|NCT00276393|Insulin|insulin|mesh-list
101343428|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101343429|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343430|NCT00014534|Gemcitabine|gemcitabine|mesh-list
101343431|NCT00014534|Doxorubicin|doxorubicin|mesh-list
101343433|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343434|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343436|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550187|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
101343437|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343438|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343439|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343440|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343441|NCT00014573|Aldesleukin|aldesleukin|mesh-list
101343442|NCT00014573|Paclitaxel|paclitaxel|mesh-list
101343468|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343469|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
101343470|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343471|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343472|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101343473|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343474|NCT00276276|Topotecan|topotecan|mesh-list
101343475|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101343476|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343477|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343478|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343479|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343481|NCT00014651|Analgesics|analgesics|mesh-ancestor
101343482|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
101343483|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331535|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101331536|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
101331538|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331539|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101331540|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101331541|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101331542|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331543|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331544|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101331545|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
101331546|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101331547|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331548|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
101331549|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
101331550|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331551|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331552|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
101331553|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343484|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343485|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343486|NCT00014690|Topotecan|topotecan|mesh-list
101343487|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101343488|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343489|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343490|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343491|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343492|NCT00014729|Isotretinoin|isotretinoin|mesh-list
101343530|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101343531|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
101343532|NCT00276003|Protective Agents|protective agents|mesh-ancestor
101343543|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101343545|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343546|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343547|NCT00015041|Analgesics|analgesics|mesh-ancestor
101343548|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
101343549|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343550|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101343551|NCT00015080|Naltrexone|naltrexone|mesh-list
101343552|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101343553|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101343554|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343555|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
101343556|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343557|NCT00015236|Amantadine|amantadine|mesh-list
101343558|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101343559|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101343560|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
101343561|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343562|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
101343563|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343564|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343565|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331554|NCT00000689|Antidotes|antidotes|mesh-ancestor
101331555|NCT00000689|Protective Agents|protective agents|mesh-ancestor
101331556|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
101331557|NCT00000689|Vitamins|vitamins|mesh-ancestor
101331558|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
101331559|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331560|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331561|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331562|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331563|NCT00034879|Gefitinib|gefitinib|mesh-list
101331564|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331565|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101331566|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331567|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331568|NCT00000707|Pentamidine|pentamidine|mesh-list
101331569|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
101331570|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331571|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101331572|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101331573|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101331574|NCT00014235|Cyclosporine|cyclosporine|mesh-list
101331575|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
101331576|NCT00014235|Fludarabine|fludarabine|mesh-list
101343566|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101343567|NCT00015236|Analgesics|analgesics|mesh-ancestor
101343568|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
101343569|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343570|NCT00015275|Cocaine|cocaine|mesh-list
101343571|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
101343572|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
101343573|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343574|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343575|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
101343576|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343577|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101343578|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101343579|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343580|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343581|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343582|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
101343583|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343584|NCT00275730|Indomethacin|indomethacin|mesh-list
101343585|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101343586|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101343587|NCT00275730|Analgesics|analgesics|mesh-ancestor
101343588|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
101343589|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343590|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343591|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343592|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343593|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
101343594|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
101343606|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343608|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331577|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
101331579|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331580|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331581|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
101331582|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331583|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331584|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
101331585|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331586|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331587|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
101343610|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101343611|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343612|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
101343613|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343614|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343616|NCT00015548|Risperidone|risperidone|mesh-list
101343617|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101343618|NCT00015548|Citalopram|citalopram|mesh-list
101343619|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101343620|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
101343621|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343622|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343623|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343624|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101343625|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101343626|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101343627|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101343628|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101343629|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
101343630|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
101343631|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
101343632|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343633|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343634|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101343635|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101343636|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101343637|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
101343638|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101343639|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
101343640|NCT00275535|Sirolimus|sirolimus|mesh-list
101343641|NCT00275535|Prednisone|prednisone|mesh-list
101343642|NCT00275535|Tacrolimus|tacrolimus|mesh-list
101343643|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
101343644|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101343645|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343646|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
101343647|NCT00275535|Hormones|hormones|mesh-ancestor
101343648|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343649|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343650|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101343652|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343653|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
101343654|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101343655|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343656|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343667|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343668|NCT00015665|Voriconazole|voriconazole|mesh-list
101343669|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
101343670|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343671|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101331588|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331590|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331591|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101331592|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101331593|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101331594|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
101331595|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331596|NCT00000710|Didanosine|didanosine|mesh-list
101331597|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
101331598|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331599|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331600|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331601|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331602|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
101331603|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331604|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331605|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331607|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
101331608|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331609|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331610|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101343672|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101343673|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343674|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343675|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101343676|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
101343677|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343678|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343679|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101343681|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
101343682|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343683|NCT00275457|Protective Agents|protective agents|mesh-ancestor
101343684|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343685|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101343686|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101343687|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
101343688|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
101343689|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343690|NCT00015704|Aldesleukin|aldesleukin|mesh-list
101343691|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343692|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101343693|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101343694|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
101343695|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343696|NCT00275418|Beta Carotene|beta carotene|mesh-list
101343697|NCT00275418|Carotenoids|carotenoids|mesh-list
101343698|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
101343699|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343700|NCT00275418|Protective Agents|protective agents|mesh-ancestor
101343701|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331611|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331613|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331614|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331615|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331616|NCT00014274|Carboplatin|carboplatin|mesh-list
101331617|NCT00014274|Gemcitabine|gemcitabine|mesh-list
101331618|NCT00014274|Methotrexate|methotrexate|mesh-list
101331619|NCT00014274|Vinblastine|vinblastine|mesh-list
101331620|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331621|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331622|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
101331623|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331624|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101331625|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
101331626|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101331627|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331628|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
101331629|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331630|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331631|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331632|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
101343702|NCT00275418|Provitamins|provitamins|mesh-ancestor
101343703|NCT00275418|Vitamins|vitamins|mesh-ancestor
101343704|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
101343705|NCT00015821|Thalidomide|thalidomide|mesh-list
101343706|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343707|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
101343708|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343710|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101343711|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343712|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343713|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343714|NCT00015821|Growth Substances|growth substances|mesh-ancestor
101343715|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343716|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343717|NCT00275184|Metoclopramide|metoclopramide|mesh-list
101343718|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
101343719|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
101416664|NCT00131027|Cytarabine|cytarabine|mesh-list
101343720|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343721|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343722|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343737|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101343738|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343739|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343741|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343742|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343743|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343744|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101343745|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343746|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343747|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343748|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331633|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331634|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331635|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331636|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331637|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331638|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331639|NCT00035035|Gemcitabine|gemcitabine|mesh-list
101331641|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331642|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
101331643|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343749|NCT00015899|Lonafarnib|lonafarnib|mesh-list
101343750|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343751|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343752|NCT00275106|Leucovorin|leucovorin|mesh-list
101343753|NCT00275106|Cytarabine|cytarabine|mesh-list
101343754|NCT00275106|Dexamethasone|dexamethasone|mesh-list
101343755|NCT00275106|Prednisolone|prednisolone|mesh-list
101343756|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
101343757|NCT00275106|Doxorubicin|doxorubicin|mesh-list
101343758|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101343759|NCT00275106|Methotrexate|methotrexate|mesh-list
101343760|NCT00275106|Vincristine|vincristine|mesh-list
101343761|NCT00275106|Daunorubicin|daunorubicin|mesh-list
101343762|NCT00275106|Asparaginase|asparaginase|mesh-list
101343763|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
101343764|NCT00275106|Thioguanine|thioguanine|mesh-list
101343765|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
101343766|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343767|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
101343768|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343769|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343770|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343771|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
101343772|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343773|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343774|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101343775|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101343778|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343779|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101343780|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
101343781|NCT00275106|Hormones|hormones|mesh-ancestor
101343782|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343783|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101343784|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343803|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343804|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343805|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343806|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343807|NCT00015938|Docetaxel|docetaxel|mesh-list
101343808|NCT00015938|Vinorelbine|vinorelbine|mesh-list
101343809|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343810|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343811|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343812|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343813|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343814|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343815|NCT00275067|Temozolomide|temozolomide|mesh-list
101343816|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
101343817|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343818|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
101343819|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343820|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331644|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331645|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331646|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331647|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331649|NCT00000719|Zalcitabine|zalcitabine|mesh-list
101331650|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
101331651|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343822|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101343823|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101343824|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343825|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
101343826|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343827|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101343828|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343829|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
101343830|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343831|NCT00015977|Interleukin-12|interleukin-12|mesh-list
101343832|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101343833|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
101343834|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343835|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343836|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343837|NCT00015977|Growth Substances|growth substances|mesh-ancestor
101343838|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343839|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343840|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
101343841|NCT01678586|Gabapentin|gabapentin|mesh-list
101343842|NCT01678586|Analgesics|analgesics|mesh-ancestor
101343863|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101343864|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
101343866|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101343867|NCT00274950|Carboplatin|carboplatin|mesh-list
101343868|NCT00274950|Etoposide|etoposide|mesh-list
101343869|NCT00274950|Ifosfamide|ifosfamide|mesh-list
101343870|NCT00274950|Bleomycin|bleomycin|mesh-list
101343871|NCT00274950|Vinblastine|vinblastine|mesh-list
101343872|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343873|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101343874|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101343875|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101343876|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343877|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343878|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343879|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
101343880|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101343881|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
101343882|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
101343883|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
101343884|NCT00016016|Cytarabine|cytarabine|mesh-list
101343885|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
101343886|NCT00016016|Alvocidib|alvocidib|mesh-list
101343887|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343888|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
101343889|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343890|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343891|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
101343892|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101343893|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343894|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
101343895|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343897|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
101343909|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343910|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343911|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
101343912|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331652|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331653|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331654|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331655|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
101331656|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331657|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331658|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331659|NCT00014313|Etoposide|etoposide|mesh-list
101331660|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331661|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331662|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101331663|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331665|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331666|NCT00035074|Methotrexate|methotrexate|mesh-list
101331667|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101331668|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
101331669|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101343913|NCT00016055|Temozolomide|temozolomide|mesh-list
101343914|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101343915|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
101343916|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343917|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343918|NCT00016094|Bevacizumab|bevacizumab|mesh-list
101343919|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101343920|NCT00016094|Antibodies|antibodies|mesh-list
101343921|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
101343922|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101343923|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343924|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101343925|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101343926|NCT00016094|Growth Substances|growth substances|mesh-ancestor
101343927|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343928|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
101343929|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
101343930|NCT00130338|Rivastigmine|rivastigmine|mesh-list
101343931|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101343932|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101343933|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343934|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
101343935|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343936|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343937|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101343938|NCT00130338|Protective Agents|protective agents|mesh-ancestor
101343939|NCT00016133|Leucovorin|leucovorin|mesh-list
101343940|NCT00016133|Fluorouracil|fluorouracil|mesh-list
101343941|NCT00016133|Vaccines|vaccines|mesh-list
101343942|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
101343943|NCT00016133|Calcium|calcium|mesh-list
101343944|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
101343945|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
101343946|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343947|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101343948|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
101343949|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343950|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101343951|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101343952|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101343953|NCT00016133|Antidotes|antidotes|mesh-ancestor
101331670|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331671|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331672|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
101331673|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331674|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331675|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
101331676|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331677|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331678|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331679|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
101331680|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331681|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331682|NCT00035113|Epothilones|epothilones|mesh-list
101343954|NCT00016133|Protective Agents|protective agents|mesh-ancestor
101343955|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
101343957|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
101343958|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101343959|NCT00016172|Doxorubicin|doxorubicin|mesh-list
101343960|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101343961|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101416668|NCT00131027|Doxorubicin|doxorubicin|mesh-list
101343980|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101343981|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101343982|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101343983|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
101343985|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101343986|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101343987|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101343988|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101343989|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
101343990|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101343991|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101343992|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
101343993|NCT00394368|Hormones|hormones|mesh-ancestor
101343994|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101343995|NCT01441349|Simvastatin|simvastatin|mesh-list
101343996|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101343997|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101343998|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
101344001|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101344002|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344003|NCT00394407|Insulin|insulin|mesh-list
101344004|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101344005|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101344006|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344007|NCT00130143|Amifostine|amifostine|mesh-list
101344008|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101344009|NCT00130143|Protective Agents|protective agents|mesh-ancestor
101344010|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344011|NCT00016289|Interleukin-12|interleukin-12|mesh-list
101344012|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344013|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
101344014|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344015|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101344016|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101344017|NCT00016289|Growth Substances|growth substances|mesh-ancestor
101344018|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
101344040|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101344041|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331684|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331685|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331686|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331687|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331688|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331689|NCT00000722|Pentamidine|pentamidine|mesh-list
101331690|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
101331691|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331692|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101331693|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101331695|NCT00035152|Paclitaxel|paclitaxel|mesh-list
101331696|NCT00035152|Carboplatin|carboplatin|mesh-list
101331697|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344042|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344043|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344044|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
101344045|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344046|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344047|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344048|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344049|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344050|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
101344051|NCT00130026|Caffeine|caffeine|mesh-list
101344052|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101344053|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344054|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101416685|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
101344055|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344056|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344057|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101344058|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101344059|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
101344060|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344062|NCT00016367|Gemcitabine|gemcitabine|mesh-list
101344063|NCT00016367|Trastuzumab|trastuzumab|mesh-list
101344064|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344065|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344066|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
101344067|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344068|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344069|NCT00129948|Troxacitabine|troxacitabine|mesh-list
101344070|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344071|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101344072|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344073|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
101344074|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344106|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344107|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344108|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101344109|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
101344110|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101344111|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
101344112|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344113|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344114|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101344115|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
101344116|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
101331698|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331700|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331701|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331702|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331703|NCT00014352|Ketoconazole|ketoconazole|mesh-list
101331704|NCT00014352|Docetaxel|docetaxel|mesh-list
101331705|NCT00014352|Doxorubicin|doxorubicin|mesh-list
101331706|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101331707|NCT00014352|Estramustine|estramustine|mesh-list
101331708|NCT00014352|Warfarin|warfarin|mesh-list
101331709|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331710|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331711|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
101331712|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331713|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331714|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101331715|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344117|NCT00016523|Protective Agents|protective agents|mesh-ancestor
101344138|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
101344139|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101344140|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101344141|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
101344142|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344143|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344144|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101344145|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344146|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
101344147|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344148|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101344149|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344150|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101344151|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101344152|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101344153|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101344154|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101344155|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101344156|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101344157|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101344158|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101344159|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101344160|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
101344162|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344163|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101344164|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101344165|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101344166|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101344167|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344168|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
101344169|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344170|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344171|NCT00129519|Imiquimod|imiquimod|mesh-list
101344190|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344191|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344192|NCT00016952|Leucovorin|leucovorin|mesh-list
101344193|NCT00016952|Fluorouracil|fluorouracil|mesh-list
101331716|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331717|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331718|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
101331719|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
101331720|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331721|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101331722|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101331723|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101331724|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331725|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331726|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331727|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101331728|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101331729|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
101331730|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101331731|NCT00035191|Galantamine|galantamine|mesh-list
101331732|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101331773|NCT00014430|Vinorelbine|vinorelbine|mesh-list
101331774|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101331775|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331776|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101331777|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
101331779|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
101331780|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331781|NCT00035425|Vancomycin|vancomycin|mesh-list
101331782|NCT00035425|Linezolid|linezolid|mesh-list
101331783|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331784|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331785|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101331786|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331787|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331789|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
101331790|NCT00000752|Beclomethasone|beclomethasone|mesh-list
101331791|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
101331792|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
101344194|NCT00016952|Irinotecan|irinotecan|mesh-list
101344195|NCT00016952|Calcium|calcium|mesh-list
101344196|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
101344197|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101344198|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344199|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
101344200|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344201|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344202|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344203|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344204|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
101344205|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101344206|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344207|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344208|NCT00016952|Antidotes|antidotes|mesh-ancestor
101344209|NCT00016952|Protective Agents|protective agents|mesh-ancestor
101344210|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
101344211|NCT00016952|Vitamins|vitamins|mesh-ancestor
101344212|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
101344213|NCT00129363|Carvedilol|carvedilol|mesh-list
101344214|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101344215|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101344216|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
101344217|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344218|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344219|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344220|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101344221|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
101344222|NCT00129363|Protective Agents|protective agents|mesh-ancestor
101344223|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101344224|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344225|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101344226|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
101344227|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101344228|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101344229|NCT00016991|Gefitinib|gefitinib|mesh-list
101331793|NCT00000752|Ephedrine|ephedrine|mesh-list
101331794|NCT00000752|Guaifenesin|guaifenesin|mesh-list
101331795|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
101331796|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101331797|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
101331798|NCT00000752|Hormones|hormones|mesh-ancestor
101331799|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331800|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331801|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101331802|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
101331803|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101331804|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
101331805|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331807|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101344230|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344253|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101344254|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344255|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101344256|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101344257|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101344258|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344261|NCT00017108|Fludarabine|fludarabine|mesh-list
101344262|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
101344263|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344264|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
101344265|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344266|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344267|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344268|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
101344269|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344270|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344271|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344272|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344273|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
101344274|NCT00129246|Naltrexone|naltrexone|mesh-list
101344275|NCT00129246|Bupropion|bupropion|mesh-list
101344276|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101344277|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101344278|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344279|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
101344288|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
101344289|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344290|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101344291|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344292|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344294|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101344295|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344296|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
101344297|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344298|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344299|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344300|NCT00129207|Bortezomib|bortezomib|mesh-list
101344301|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344302|NCT00129168|Cytarabine|cytarabine|mesh-list
101331808|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101331809|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
101331810|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
101331811|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331812|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331813|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331814|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331815|NCT00000752|Expectorants|expectorants|mesh-ancestor
101331816|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101331817|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101331818|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
101331819|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101331820|NCT00035464|Azimilide|azimilide|mesh-list
101331821|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101344303|NCT00129168|Daunorubicin|daunorubicin|mesh-list
101344304|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344305|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
101344306|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344307|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344308|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
101344309|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344310|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344311|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
101344312|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344313|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344314|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344315|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344316|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344317|NCT00017186|Gemcitabine|gemcitabine|mesh-list
101344318|NCT00017186|Epirubicin|epirubicin|mesh-list
101344319|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344320|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
101344321|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344322|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344323|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344324|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344325|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344326|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344327|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
101344328|NCT00017225|Melphalan|melphalan|mesh-list
101344329|NCT00017225|Ifosfamide|ifosfamide|mesh-list
101344330|NCT00017225|Dacarbazine|dacarbazine|mesh-list
101344331|NCT00017225|Carboplatin|carboplatin|mesh-list
101344332|NCT00017225|Doxorubicin|doxorubicin|mesh-list
101344333|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101344334|NCT00017225|Etoposide|etoposide|mesh-list
101344335|NCT00017225|Vincristine|vincristine|mesh-list
101344336|NCT00017225|Tretinoin|tretinoin|mesh-list
101344337|NCT00017225|Vindesine|vindesine|mesh-list
101344338|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344339|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
101344340|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344341|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344342|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344343|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
101344344|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344345|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344365|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
101344366|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101344367|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101344368|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101344369|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101344370|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101331822|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101331823|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331824|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331825|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101331826|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331827|NCT00014469|Methotrexate|methotrexate|mesh-list
101331828|NCT00014469|Melphalan|melphalan|mesh-list
101331829|NCT00014469|Busulfan|busulfan|mesh-list
101331830|NCT00014469|Tacrolimus|tacrolimus|mesh-list
101331831|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101331832|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
101331833|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101331834|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331835|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331836|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
101331837|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331838|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331839|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
101331840|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331841|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101331842|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331843|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
101331844|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101331845|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331846|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101344371|NCT00017264|Atrasentan|atrasentan|mesh-list
101344372|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344373|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101344374|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101344375|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344376|NCT00128895|Azathioprine|azathioprine|mesh-list
101344377|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
101344378|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344379|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344380|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344381|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344382|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
101344383|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344384|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344385|NCT00017303|Paclitaxel|paclitaxel|mesh-list
101344386|NCT00017303|Carboplatin|carboplatin|mesh-list
101344387|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344388|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344389|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344390|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344391|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344392|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331848|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
101331849|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101331851|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
101331852|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331853|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101331854|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101331855|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331856|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
101344393|NCT00017342|Cytarabine|cytarabine|mesh-list
101344394|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
101344395|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344396|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
101344397|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344398|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344399|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
101344400|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344415|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344417|NCT00017381|Rituximab|rituximab|mesh-list
101344418|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101344419|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344420|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
101344421|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344422|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344423|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344424|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
101344425|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344426|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344427|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344428|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101344430|NCT00128700|Vatalanib|vatalanib|mesh-list
101344431|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344432|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
101344433|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344434|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416706|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
101344435|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101344436|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344437|NCT00017459|Vinorelbine|vinorelbine|mesh-list
101344438|NCT00017459|Tirapazamine|tirapazamine|mesh-list
101344439|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344440|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344441|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344442|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344443|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344444|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344445|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
101344446|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344447|NCT00017498|Gemcitabine|gemcitabine|mesh-list
101344448|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344449|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
101344450|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344451|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344452|NCT00128544|Telbivudine|telbivudine|mesh-list
101344453|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
101344454|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344455|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101344456|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344457|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344458|NCT00128505|Mifepristone|mifepristone|mesh-list
101344459|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101331857|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331858|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101331859|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101331860|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101331861|NCT00035581|Poly I-C|poly i-c|mesh-list
101331862|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
101331863|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331864|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
101344460|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
101344490|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101344491|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344492|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
101344493|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344494|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344495|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344496|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
101344497|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344498|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344499|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101344500|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344501|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
101344502|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344503|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
101344525|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
101344526|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344527|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344528|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
101344529|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101344530|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101344531|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101344532|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
101344533|NCT00017693|Interleukin-4|interleukin-4|mesh-list
101344534|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344535|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
101344536|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344537|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344538|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344539|NCT00128466|Gentamicins|gentamicins|mesh-list
101344540|NCT00128466|Streptomycin|streptomycin|mesh-list
101344541|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344542|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344543|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101344544|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344545|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344547|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
101344548|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344549|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344550|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344551|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344552|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344553|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344555|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101344556|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
101344557|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344558|NCT00018603|Guanfacine|guanfacine|mesh-list
101344559|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101344575|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344578|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344579|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101344580|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101344581|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
101344582|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344583|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344584|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101344585|NCT00018083|Efavirenz|efavirenz|mesh-list
101344586|NCT00018083|Isoniazid|isoniazid|mesh-list
101331865|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
101331866|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331867|NCT00000758|Fluorouracil|fluorouracil|mesh-list
101331868|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
101331869|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331870|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101331871|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331872|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101331873|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
101331874|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331875|NCT00035620|Lenograstim|lenograstim|mesh-list
101331876|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101331877|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
101331878|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331880|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331881|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
101331882|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101331883|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
101331884|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331885|NCT02971306|Expectorants|expectorants|mesh-ancestor
101331886|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
101331887|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101331889|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331890|NCT02971306|Protective Agents|protective agents|mesh-ancestor
101331891|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331892|NCT02971306|Antidotes|antidotes|mesh-ancestor
101331893|NCT00000761|Interferons|interferons|mesh-list
101331894|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
101331914|NCT04732390|Analgesics|analgesics|mesh-ancestor
101331915|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101331916|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
101331917|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101331918|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331919|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331920|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101331921|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
101331923|NCT00035854|Linezolid|linezolid|mesh-list
101331924|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101331925|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331926|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101331927|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331928|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344587|NCT00018083|Rifabutin|rifabutin|mesh-list
101344588|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101344589|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101344590|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344591|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344592|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
101344593|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344594|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101344595|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344596|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101344597|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101344598|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101344599|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101344600|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
101344601|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344602|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101344603|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101344604|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
101344605|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101344606|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101344607|NCT00018200|Benztropine|benztropine|mesh-list
101344608|NCT00018200|Fluoxetine|fluoxetine|mesh-list
101344609|NCT00018200|Desipramine|desipramine|mesh-list
101344610|NCT00018200|Clomipramine|clomipramine|mesh-list
101344611|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101344612|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101344613|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344614|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344615|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344616|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
101344617|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344631|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344632|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101344633|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101344634|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
101344635|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101344636|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
101344637|NCT00018759|Paroxetine|paroxetine|mesh-list
101344638|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101344639|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101344640|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344641|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331929|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101331930|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101331932|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331933|NCT00000779|Antacids|antacids|mesh-ancestor
101331934|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331935|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101331936|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
101331937|NCT00035893|Poly I-C|poly i-c|mesh-list
101331938|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
101344642|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344643|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
101344644|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344645|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101344647|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101344648|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101344649|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344650|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344651|NCT04734353|Ticagrelor|ticagrelor|mesh-list
101344652|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101344653|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101344654|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101344655|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101344656|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101344657|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
101344658|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344659|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344660|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344661|NCT00018954|Cytarabine|cytarabine|mesh-list
101344662|NCT00018954|Prednisone|prednisone|mesh-list
101344663|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
101344664|NCT00018954|Ifosfamide|ifosfamide|mesh-list
101344665|NCT00018954|Doxorubicin|doxorubicin|mesh-list
101344666|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101344667|NCT00018954|Methotrexate|methotrexate|mesh-list
101344668|NCT00018954|Etoposide|etoposide|mesh-list
101344669|NCT00018954|Vincristine|vincristine|mesh-list
101344670|NCT00018954|Daunorubicin|daunorubicin|mesh-list
101344671|NCT00018954|Asparaginase|asparaginase|mesh-list
101344672|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
101344673|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344674|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
101344675|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344676|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344677|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101344678|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
101344695|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
101344696|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101344697|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101344698|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101344699|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344700|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
101344701|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344702|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344703|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344704|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344705|NCT00018278|Donepezil|donepezil|mesh-list
101344706|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101344707|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344708|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344709|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
101344710|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344711|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344712|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
101344713|NCT00019032|Antibodies|antibodies|mesh-list
101344714|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101331939|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331940|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
101331941|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
101331944|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101331945|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101331946|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331947|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101331948|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
101331949|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101331950|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101331951|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101331952|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
101331953|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344715|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
101344716|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344718|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344719|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344720|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
101344721|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344722|NCT04734119|Anesthetics|anesthetics|mesh-list
101344723|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101344724|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344725|NCT00018356|Testosterone|testosterone|mesh-list
101344726|NCT00018356|Androgens|androgens|mesh-ancestor
101344727|NCT00018356|Hormones|hormones|mesh-ancestor
101344728|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344729|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344730|NCT00019188|Interleukin-12|interleukin-12|mesh-list
101344731|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344732|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
101344733|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344734|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101344754|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344756|NCT00019344|Growth Substances|growth substances|mesh-ancestor
101344757|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344758|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101344759|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344760|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344762|NCT00019383|Sargramostim|sargramostim|mesh-list
101344763|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
101344764|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
101344765|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344766|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344767|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101344768|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344769|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
101344770|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344771|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344772|NCT00019422|Carboplatin|carboplatin|mesh-list
101344773|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344774|NCT00018551|Folic Acid|folic acid|mesh-list
101344775|NCT00018551|Hematinics|hematinics|mesh-ancestor
101344776|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
101344777|NCT00018551|Vitamins|vitamins|mesh-ancestor
101344778|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
101331954|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101331955|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331956|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331957|NCT02971345|Iodine|iodine|mesh-list
101331958|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
101331959|NCT02971345|Epirubicin|epirubicin|mesh-list
101331960|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
101331961|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101331962|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101331963|NCT02971345|Trace Elements|trace elements|mesh-ancestor
101331964|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
101331965|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331966|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101331967|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331968|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344779|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344780|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101344781|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344782|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101344783|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344784|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344785|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101344786|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344787|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101344788|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101344789|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
101344790|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344811|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
101344812|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344813|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101344814|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101344815|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344816|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344817|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101344818|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
101344819|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101344820|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344821|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101344822|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101344823|NCT00019734|Aldesleukin|aldesleukin|mesh-list
101344824|NCT00019734|Vaccines|vaccines|mesh-list
101344825|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
101344826|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344827|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344828|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101344829|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344830|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
101344831|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344832|NCT00019773|Capecitabine|capecitabine|mesh-list
101344833|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
101344834|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344835|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
101344836|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344837|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344838|NCT00019812|Paclitaxel|paclitaxel|mesh-list
101344839|NCT00019812|Trastuzumab|trastuzumab|mesh-list
101344840|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101344841|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101331969|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101331970|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101331971|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331972|NCT00036088|Olanzapine|olanzapine|mesh-list
101331973|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
101331974|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
101331975|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101331976|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331977|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101331978|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101331979|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331980|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331981|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331982|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101331983|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101331984|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101331985|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331986|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101344842|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344843|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344844|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344867|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344868|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
101344869|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344870|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344871|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
101344874|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344875|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101344876|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101344877|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101344878|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344879|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344880|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
101344881|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344882|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
101344883|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101344884|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344885|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101344886|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101344887|NCT00020046|Growth Substances|growth substances|mesh-ancestor
101344888|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101344889|NCT00020124|Doxorubicin|doxorubicin|mesh-list
101344890|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101344891|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344892|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344893|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344894|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344895|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344904|NCT05576675|Dsuvia|dsuvia|mesh-list
101344905|NCT05576675|Hydromorphone|hydromorphone|mesh-list
101344906|NCT05576675|Nalbuphine|nalbuphine|mesh-list
101344907|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101344908|NCT05576675|Narcotics|narcotics|mesh-ancestor
101344909|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101331987|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
101331988|NCT00036127|Aripiprazole|aripiprazole|mesh-list
101331989|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
101331990|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101331991|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101331992|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101331993|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101344910|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344911|NCT05576675|Analgesics|analgesics|mesh-ancestor
101344912|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
101344913|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344914|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101344915|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101344916|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
101344917|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
101344918|NCT00020358|Aldesleukin|aldesleukin|mesh-list
101344919|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
101344922|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344923|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
101344924|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344925|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344926|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
101344927|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344928|NCT00020397|Aldesleukin|aldesleukin|mesh-list
101344929|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344930|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101344931|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101344932|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
101344933|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101344934|NCT00020475|Interleukin-2|interleukin-2|mesh-list
101344935|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101344936|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344937|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101344938|NCT00020475|Analgesics|analgesics|mesh-ancestor
101344939|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
101344940|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344941|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344942|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101344943|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
101344944|NCT05576480|Capecitabine|capecitabine|mesh-list
101344945|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
101344946|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344947|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
101344948|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344949|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344950|NCT00020631|Pirfenidone|pirfenidone|mesh-list
101344951|NCT00020631|Analgesics|analgesics|mesh-ancestor
101344952|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
101344953|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101344954|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344955|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101344956|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101344957|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101344958|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101344959|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344960|NCT05576324|Ivacaftor|ivacaftor|mesh-list
101344961|NCT05576324|Elexacaftor|elexacaftor|mesh-list
101344962|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101344963|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101344964|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344977|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344978|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101344979|NCT00020748|Irinotecan|irinotecan|mesh-list
101344980|NCT00020748|Epirubicin|epirubicin|mesh-list
101344981|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101344982|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101344983|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101344984|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331994|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101331995|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
101331996|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
101331997|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101331998|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101331999|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101332000|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101332001|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
101332002|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101332003|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101332004|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101344985|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344986|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101344987|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101344989|NCT00020787|Fluorouracil|fluorouracil|mesh-list
101344990|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101344991|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
101344992|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101344993|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101344994|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101344995|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
101344996|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101344997|NCT00020865|Levofloxacin|levofloxacin|mesh-list
101344998|NCT00020865|Cefepime|cefepime|mesh-list
101344999|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101345000|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345001|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345002|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345003|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345004|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345005|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345006|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345007|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101345008|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101345009|NCT00020943|Leucovorin|leucovorin|mesh-list
101345010|NCT00020943|Cytarabine|cytarabine|mesh-list
101345011|NCT00020943|Prednisone|prednisone|mesh-list
101345012|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
101345013|NCT00020943|Carmustine|carmustine|mesh-list
101345014|NCT00020943|Rituximab|rituximab|mesh-list
101345015|NCT00020943|Doxorubicin|doxorubicin|mesh-list
101345016|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101345017|NCT00020943|Methotrexate|methotrexate|mesh-list
101345018|NCT00020943|Etoposide|etoposide|mesh-list
101345019|NCT00020943|Vincristine|vincristine|mesh-list
101345020|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
101345022|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
101345023|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345024|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345025|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345026|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
101345027|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345028|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345029|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345030|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345043|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345044|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
101345045|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
101345046|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101345047|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101345048|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345049|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
101332005|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101332006|NCT00000788|Fluconazole|fluconazole|mesh-list
101332007|NCT00000788|Methadone|methadone|mesh-list
101332008|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101332009|NCT00000788|Narcotics|narcotics|mesh-ancestor
101332010|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332011|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332012|NCT00000788|Analgesics|analgesics|mesh-ancestor
101332013|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
101332014|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345050|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345052|NCT00020943|Protective Agents|protective agents|mesh-ancestor
101345053|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
101345054|NCT00020943|Vitamins|vitamins|mesh-ancestor
101345055|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
101345056|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345057|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345059|NCT00021060|Paclitaxel|paclitaxel|mesh-list
101345060|NCT00021060|Bevacizumab|bevacizumab|mesh-list
101345061|NCT00021060|Carboplatin|carboplatin|mesh-list
101345062|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101345063|NCT00021060|Antibodies|antibodies|mesh-list
101345064|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
101345065|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101345066|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345067|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345068|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345069|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345070|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345071|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345072|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101345073|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101345074|NCT00021060|Growth Substances|growth substances|mesh-ancestor
101345075|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345076|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
101345077|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
101345078|NCT00021099|Epothilones|epothilones|mesh-list
101345079|NCT00021099|Epothilone B|epothilone b|mesh-list
101345080|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345081|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345082|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345083|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345084|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345085|NCT05574257|Propofol|propofol|mesh-list
101345086|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101345087|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345088|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345089|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101345090|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
101345091|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
101345092|NCT05574218|Glycine|glycine|mesh-list
101345093|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
101345125|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101345126|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101345127|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101345128|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101416715|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101345129|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101345130|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
101345131|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
101345132|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
101345133|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
101345134|NCT00021216|Bortezomib|bortezomib|mesh-list
101345135|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345136|NCT00021294|Eflornithine|eflornithine|mesh-list
101345151|NCT00021333|Paclitaxel|paclitaxel|mesh-list
101345152|NCT00021333|Cisplatin|cisplatin|mesh-list
101345153|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345154|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332015|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
101332016|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
101332017|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
101332018|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332019|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101332020|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332021|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345155|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345156|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345157|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345158|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345159|NCT00021372|Paclitaxel|paclitaxel|mesh-list
101345160|NCT00021372|Estramustine|estramustine|mesh-list
101345161|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345162|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345163|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345164|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345165|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345166|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345168|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
101345169|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345170|NCT00392093|Estrogens|estrogens|mesh-list
101345171|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101345172|NCT00392093|Hormones|hormones|mesh-ancestor
101345173|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345174|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345175|NCT00018161|Mecamylamine|mecamylamine|mesh-list
101345176|NCT00018161|Nicotine|nicotine|mesh-list
101345177|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101345178|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
101345179|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345180|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345181|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101345182|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101345183|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
101345184|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345185|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345186|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101345187|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101345188|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101345189|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101345190|NCT00021450|Goserelin|goserelin|mesh-list
101345191|NCT00021450|Bicalutamide|bicalutamide|mesh-list
101345192|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345193|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345194|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
101345195|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
101345214|NCT00021528|Buspirone|buspirone|mesh-list
101345215|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
101345216|NCT00021528|Sertraline|sertraline|mesh-list
101345217|NCT00021528|Citalopram|citalopram|mesh-list
101345218|NCT00021528|Nortriptyline|nortriptyline|mesh-list
101345219|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
101345220|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101345221|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101345222|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101345223|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101345224|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345225|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345226|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
101345227|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345228|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345229|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101345230|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345231|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101332022|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332023|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101332024|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
101332025|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345232|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101345233|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
101345235|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101345236|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101345237|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101345238|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101345239|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
101345240|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101345241|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101345242|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101345243|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101345244|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101345245|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101345246|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101345247|NCT00021567|Interferons|interferons|mesh-list
101345248|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
101345249|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345250|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
101345270|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345271|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101345272|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101345273|NCT00021996|Analgesics|analgesics|mesh-ancestor
101345274|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
101345275|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345276|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345277|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345278|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345279|NCT00022074|Gabapentin|gabapentin|mesh-list
101345280|NCT00022074|Analgesics|analgesics|mesh-ancestor
101345281|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
101345282|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345283|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345284|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
101345285|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101345286|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101345287|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345288|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101345289|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101345290|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101345291|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345292|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345293|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
101345294|NCT00022152|Vinorelbine|vinorelbine|mesh-list
101345295|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345296|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345297|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345298|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345299|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345300|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345301|NCT00022191|Paclitaxel|paclitaxel|mesh-list
101345302|NCT00022191|Gemcitabine|gemcitabine|mesh-list
101345303|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345305|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345306|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345307|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345322|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345324|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
101345325|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345326|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345327|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332026|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101332027|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101332028|NCT00036166|Micafungin|micafungin|mesh-list
101332029|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
101332030|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332035|NCT00000794|Atovaquone|atovaquone|mesh-list
101332036|NCT00000794|Calcium|calcium|mesh-list
101345328|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
101345329|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345330|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345331|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345332|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345333|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345335|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101345336|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
101345337|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345338|NCT00022308|Irinotecan|irinotecan|mesh-list
101345339|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345340|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101345341|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345342|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345343|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345344|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
101345345|NCT00022386|Hematinics|hematinics|mesh-ancestor
101345346|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
101345347|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345348|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345349|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345350|NCT00022464|Sirolimus|sirolimus|mesh-list
101345351|NCT00022464|Temsirolimus|temsirolimus|mesh-list
101345352|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
101345353|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101345354|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345355|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345356|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345357|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
101345358|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345359|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345360|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345361|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345362|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345363|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
101345364|NCT00022542|Epothilones|epothilones|mesh-list
101345365|NCT00022542|Epothilone B|epothilone b|mesh-list
101345366|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345367|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345368|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345384|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101345385|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101345386|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
101345387|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345388|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101345389|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101345390|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345391|NCT00022620|Paclitaxel|paclitaxel|mesh-list
101345392|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345393|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345394|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345395|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345396|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345397|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345399|NCT00022737|Cytarabine|cytarabine|mesh-list
101345400|NCT00022737|Cyclosporine|cyclosporine|mesh-list
101345401|NCT00022737|Dexamethasone|dexamethasone|mesh-list
101332037|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
101332038|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101332039|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332040|NCT00000794|Antidotes|antidotes|mesh-ancestor
101332041|NCT00000794|Protective Agents|protective agents|mesh-ancestor
101332042|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
101332043|NCT00000794|Vitamins|vitamins|mesh-ancestor
101332044|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
101332045|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332046|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332047|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101332048|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345402|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
101345403|NCT00022737|Ifosfamide|ifosfamide|mesh-list
101345404|NCT00022737|Methotrexate|methotrexate|mesh-list
101345405|NCT00022737|Etoposide|etoposide|mesh-list
101345406|NCT00022737|Vincristine|vincristine|mesh-list
101345407|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
101345408|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
101345409|NCT00022737|Daunorubicin|daunorubicin|mesh-list
101345410|NCT00022737|Asparaginase|asparaginase|mesh-list
101345411|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
101345412|NCT00022737|Pegaspargase|pegaspargase|mesh-list
101345413|NCT00022737|Cyclosporins|cyclosporins|mesh-list
101345414|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
101345415|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345416|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
101345417|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345418|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345419|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345420|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
101345421|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345422|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345423|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345424|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345425|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
101345426|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
101345427|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345428|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101345429|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
101345430|NCT00022737|Hormones|hormones|mesh-ancestor
101345431|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345449|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
101345451|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
101345452|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345453|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345454|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345455|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
101345456|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101345457|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101345458|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345459|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
101345460|NCT00022893|Antibodies|antibodies|mesh-list
101345461|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
101345462|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345463|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345464|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101345465|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
101345466|NCT00022932|Antibodies|antibodies|mesh-list
101345467|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
101345468|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345469|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345470|NCT00022971|Rituximab|rituximab|mesh-list
101345471|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345472|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345473|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
101345474|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332049|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332050|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101332051|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332052|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
101332053|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101332054|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101345475|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345476|NCT05512754|Ibuprofen|ibuprofen|mesh-list
101345477|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101345478|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101345479|NCT05512754|Analgesics|analgesics|mesh-ancestor
101345480|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
101345481|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345482|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345483|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345484|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345485|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101345486|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345487|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345488|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
101345502|NCT02971878|Expectorants|expectorants|mesh-ancestor
101345503|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
101345504|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101345505|NCT02971878|Antidotes|antidotes|mesh-ancestor
101345506|NCT00023166|Paclitaxel|paclitaxel|mesh-list
101345507|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345508|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345509|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345510|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345511|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345512|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345513|NCT00394992|Bevacizumab|bevacizumab|mesh-list
101345515|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
101345516|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345517|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345518|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101345519|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101345520|NCT00394992|Growth Substances|growth substances|mesh-ancestor
101345521|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345522|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101345523|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345524|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
101345525|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345526|NCT00395031|Ziprasidone|ziprasidone|mesh-list
101345527|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101345528|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
101345529|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345530|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345531|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345532|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101345533|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101345534|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345535|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101345536|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101345537|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
101345538|NCT00395070|Temozolomide|temozolomide|mesh-list
101345539|NCT00395070|Dacarbazine|dacarbazine|mesh-list
101345540|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345541|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
101345542|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345543|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345544|NCT00023244|Cyclosporine|cyclosporine|mesh-list
101345545|NCT00023244|Sirolimus|sirolimus|mesh-list
101345546|NCT00023244|Trimethoprim|trimethoprim|mesh-list
101345547|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
101345548|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101345549|NCT00023244|Prednisone|prednisone|mesh-list
101345550|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
101332055|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332056|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
101332057|NCT00036244|Secretin|secretin|mesh-list
101332058|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101332059|NCT00036244|Hormones|hormones|mesh-ancestor
101332060|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345551|NCT00023244|Tacrolimus|tacrolimus|mesh-list
101345552|NCT00023244|Cyclosporins|cyclosporins|mesh-list
101345553|NCT00023244|Basiliximab|basiliximab|mesh-list
101345562|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
101345563|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101345564|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345565|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345566|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
101345567|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345568|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
101345569|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345570|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345571|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345572|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
101345573|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
101345574|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345575|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101345576|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101345577|NCT00023244|Protective Agents|protective agents|mesh-ancestor
101345578|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101345579|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
101345580|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101345581|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101345582|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101345583|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101345584|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101345585|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101345586|NCT00023283|Buprenorphine|buprenorphine|mesh-list
101345587|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101345588|NCT00023283|Narcotics|narcotics|mesh-ancestor
101345589|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345590|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345591|NCT00023283|Analgesics|analgesics|mesh-ancestor
101345592|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
101345593|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345594|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101345595|NCT00023361|Rifabutin|rifabutin|mesh-list
101345596|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345597|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345598|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101345599|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
101345600|NCT00023400|Nelfinavir|nelfinavir|mesh-list
101345601|NCT00023400|Rifabutin|rifabutin|mesh-list
101345602|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101345603|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101345604|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
101345605|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345606|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345607|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101345608|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101345609|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
101345610|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345611|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345612|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101345613|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
101345614|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
101345615|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101345616|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101345617|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345618|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
101345619|NCT05359172|Coagulants|coagulants|mesh-ancestor
101345620|NCT00023634|Sargramostim|sargramostim|mesh-list
101345649|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
101345650|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101345651|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101345652|NCT02971982|Dexamethasone|dexamethasone|mesh-list
101332061|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332063|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101332064|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101332065|NCT00036283|Analgesics|analgesics|mesh-ancestor
101332066|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
101332067|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332068|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332069|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332070|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332071|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101332072|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101332073|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345653|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
101345654|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
101345655|NCT02971982|Rituximab|rituximab|mesh-list
101345656|NCT02971982|Bortezomib|bortezomib|mesh-list
101345657|NCT02971982|BB 1101|bb 1101|mesh-list
101345658|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345659|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
101345660|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345661|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345662|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345663|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
101345664|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345665|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345666|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345667|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345668|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345669|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
101345670|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
101345671|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345685|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
101345686|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345687|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345689|NCT00023868|Doxorubicin|doxorubicin|mesh-list
101345691|NCT00023868|Fluorouracil|fluorouracil|mesh-list
101345692|NCT00023868|Irinotecan|irinotecan|mesh-list
101345693|NCT00023868|Mitomycins|mitomycins|mesh-list
101345694|NCT00023868|Mitomycin|mitomycin|mesh-list
101345695|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
101345696|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345697|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345698|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345699|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345700|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345701|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345702|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345703|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
101345704|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345705|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345706|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
101345707|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101345710|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
101345711|NCT00023868|Vitamins|vitamins|mesh-ancestor
101345712|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
101345713|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
101345714|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101345715|NCT00023907|Paclitaxel|paclitaxel|mesh-list
101345716|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101332074|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332075|NCT00391638|Interferons|interferons|mesh-list
101332076|NCT00391638|Tenofovir|tenofovir|mesh-list
101332077|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101332078|NCT00391638|Emtricitabine|emtricitabine|mesh-list
101332079|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101332080|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332081|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
101332082|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332083|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332084|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332085|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332086|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332087|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332088|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101345717|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345718|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345719|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345720|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345721|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345722|NCT00023946|Epothilones|epothilones|mesh-list
101345723|NCT00023946|Epothilone B|epothilone b|mesh-list
101345724|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345725|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345726|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345727|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345728|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345729|NCT05268185|Vaccines|vaccines|mesh-list
101345730|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
101345731|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345732|NCT00024063|Orantinib|orantinib|mesh-list
101345733|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101345734|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345749|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345750|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345751|NCT00024180|Romidepsin|romidepsin|mesh-list
101345752|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101345753|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345754|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101345755|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345756|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345757|NCT00024297|Warfarin|warfarin|mesh-list
101345758|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
101345759|NCT00024336|Tamoxifen|tamoxifen|mesh-list
101345760|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101345761|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
101345762|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345763|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345764|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345765|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345766|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101345767|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101345768|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101345769|NCT00024375|Paclitaxel|paclitaxel|mesh-list
101345770|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345771|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345772|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345773|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
101332089|NCT00036361|Aripiprazole|aripiprazole|mesh-list
101332090|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
101332091|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101332092|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101332093|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101332094|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332095|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332096|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
101345774|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345775|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345776|NCT00024414|Paclitaxel|paclitaxel|mesh-list
101345777|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345778|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345779|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345780|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345781|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345782|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345783|NCT00024453|Teicoplanin|teicoplanin|mesh-list
101345784|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345785|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345786|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
101345787|NCT00024492|Analgesics|analgesics|mesh-ancestor
101345788|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
101345789|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345790|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345791|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345792|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345819|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345820|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345822|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
101345823|NCT00025038|Fludarabine|fludarabine|mesh-list
101345824|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
101345825|NCT00025038|Tipifarnib|tipifarnib|mesh-list
101345826|NCT00025038|Isotretinoin|isotretinoin|mesh-list
101345827|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
101345828|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101345829|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
101345830|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345831|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
101345832|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345833|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345834|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345835|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
101345836|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345837|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345838|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345839|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101345840|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
101345858|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101345859|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
101345860|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101345861|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101345862|NCT05055830|Narcotics|narcotics|mesh-ancestor
101345863|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101345864|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
101345865|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
101345866|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
101345867|NCT00025077|Thiotepa|thiotepa|mesh-list
101345868|NCT00025077|Carboplatin|carboplatin|mesh-list
101345869|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345870|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
101345871|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345872|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345873|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345874|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
101345875|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345876|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345877|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101332097|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
101332098|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332099|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332100|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101332101|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101332102|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
101332103|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101332104|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101332105|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101332106|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101332107|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
101332108|NCT00036400|Hematinics|hematinics|mesh-ancestor
101332109|NCT00036439|Infliximab|infliximab|mesh-list
101332110|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101332111|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332112|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332113|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101332114|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332115|NCT00000821|Aldesleukin|aldesleukin|mesh-list
101332116|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332117|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332118|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332119|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
101332120|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332121|NCT00036556|Atrasentan|atrasentan|mesh-list
101332122|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332123|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101332124|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101332125|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332126|NCT00000827|Immune Sera|immune sera|mesh-list
101332127|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
101332128|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332129|NCT00036634|Tenofovir|tenofovir|mesh-list
101332130|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
101332131|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332138|NCT00000851|Didanosine|didanosine|mesh-list
101332139|NCT00000851|Stavudine|stavudine|mesh-list
101332140|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
101332141|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332142|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332143|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332144|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345878|NCT05051891|Prednisone|prednisone|mesh-list
101345879|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
101345880|NCT05051891|Vincristine|vincristine|mesh-list
101345881|NCT05051891|Rituximab|rituximab|mesh-list
101345882|NCT05051891|Doxorubicin|doxorubicin|mesh-list
101345883|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345884|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
101345885|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345886|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101345887|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101345888|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
101345889|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345890|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345891|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101345892|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345893|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
101345894|NCT05051891|Hormones|hormones|mesh-ancestor
101345895|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101345896|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345897|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345898|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345899|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345909|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345910|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345911|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101345912|NCT00025272|Carboplatin|carboplatin|mesh-list
101345913|NCT00025272|Etoposide|etoposide|mesh-list
101345914|NCT00025272|Topotecan|topotecan|mesh-list
101345915|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345916|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101345917|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101345918|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345919|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345920|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345921|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101345922|NCT05023382|Teduglutide|teduglutide|mesh-list
101345923|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101345924|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101345925|NCT05023382|Protective Agents|protective agents|mesh-ancestor
101345926|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345927|NCT00025311|Topotecan|topotecan|mesh-list
101345928|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101345929|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101345930|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345931|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345932|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345933|NCT00025116|Gefitinib|gefitinib|mesh-list
101345934|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345935|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101345936|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345937|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345938|NCT00025350|Gefitinib|gefitinib|mesh-list
101345939|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345940|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101345941|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101345942|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345943|NCT00025389|Paclitaxel|paclitaxel|mesh-list
101345944|NCT00025389|Bevacizumab|bevacizumab|mesh-list
101345945|NCT00025389|Carboplatin|carboplatin|mesh-list
101345946|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101332145|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
101332146|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332147|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332148|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332149|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
101332150|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345947|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345948|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101345949|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101345950|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101345951|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101345952|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101345953|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101345954|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101345955|NCT00025389|Growth Substances|growth substances|mesh-ancestor
101345956|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101345958|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
101345959|NCT00025428|Carboplatin|carboplatin|mesh-list
101345960|NCT00025428|Doxorubicin|doxorubicin|mesh-list
101345961|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101345963|NCT00025428|Vincristine|vincristine|mesh-list
101345964|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101345985|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
101345986|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101345987|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101345988|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101345989|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101345990|NCT00025467|Growth Substances|growth substances|mesh-ancestor
101345991|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
101345992|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101345993|NCT04964414|Budesonide|budesonide|mesh-list
101345994|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
101345995|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101345996|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101345997|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
101345998|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101345999|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346000|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101346001|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
101346002|NCT04964414|Hormones|hormones|mesh-ancestor
101346003|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346004|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
101346005|NCT00025545|Methotrexate|methotrexate|mesh-list
101346006|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346007|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
101346008|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346009|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346010|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346011|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
101346012|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346013|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346014|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346015|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101346016|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
101346017|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101346029|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101346030|NCT00025623|Etoposide|etoposide|mesh-list
101346031|NCT00025623|Vincristine|vincristine|mesh-list
101346032|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346033|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
101346034|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346035|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346036|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346037|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
101346038|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346039|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346040|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346041|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332151|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101332152|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332153|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332154|NCT00036790|Doxorubicin|doxorubicin|mesh-list
101346042|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346043|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346044|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346045|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346046|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346047|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346048|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346049|NCT00025740|Clonazepam|clonazepam|mesh-list
101346051|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101346052|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101346053|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101346054|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346055|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346056|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
101346057|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346058|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101346059|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
101346060|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346061|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101346062|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101346063|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346064|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
101346065|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
101346066|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
101346067|NCT00025779|Guanfacine|guanfacine|mesh-list
101346068|NCT00025779|Methylphenidate|methylphenidate|mesh-list
101346069|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101346070|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346071|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101346072|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101346073|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101346074|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346075|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
101346076|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346077|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101346078|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101346079|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101346080|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101346091|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346092|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101346093|NCT00026052|Protective Agents|protective agents|mesh-ancestor
101346095|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346096|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101346097|NCT00026091|Protective Agents|protective agents|mesh-ancestor
101346098|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346099|NCT00026130|Gemcitabine|gemcitabine|mesh-list
101346100|NCT00026130|Fluorouracil|fluorouracil|mesh-list
101346101|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346102|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
101346103|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346104|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346105|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346106|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
101346107|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346108|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
101346109|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346110|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346111|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346112|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346113|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101346114|NCT04808414|Polymyxins|polymyxins|mesh-list
101346115|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346116|NCT00026364|Leucovorin|leucovorin|mesh-list
101346117|NCT00026364|Fluorouracil|fluorouracil|mesh-list
101332156|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
101332157|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332158|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332159|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101332160|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332161|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332162|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332163|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101332164|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346118|NCT00026364|Irinotecan|irinotecan|mesh-list
101346119|NCT00026364|Gefitinib|gefitinib|mesh-list
101346120|NCT00026364|Calcium|calcium|mesh-list
101346121|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
101346122|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101346123|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346124|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
101346125|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346126|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346127|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346128|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346129|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
101346130|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101346131|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346132|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346133|NCT00026364|Antidotes|antidotes|mesh-ancestor
101346134|NCT00026364|Protective Agents|protective agents|mesh-ancestor
101346135|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
101346136|NCT00026364|Vitamins|vitamins|mesh-ancestor
101346137|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
101346138|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346139|NCT00026403|Gemcitabine|gemcitabine|mesh-list
101346140|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346141|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346142|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
101346143|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346144|NCT00026442|Capecitabine|capecitabine|mesh-list
101346145|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346167|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101346168|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101346169|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101346170|NCT00026520|Growth Substances|growth substances|mesh-ancestor
101346171|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101346172|NCT00026637|Sertraline|sertraline|mesh-list
101346173|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
101346174|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346175|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101346176|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101346177|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101346178|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346179|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346180|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
101346181|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346182|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
101346183|NCT04657094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101346184|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346185|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346186|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346187|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346188|NCT04610684|Carboplatin|carboplatin|mesh-list
101346189|NCT04610684|Etoposide|etoposide|mesh-list
101346190|NCT04610684|Atezolizumab|atezolizumab|mesh-list
101346191|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346192|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101332165|NCT00000857|Interleukin-12|interleukin-12|mesh-list
101332166|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101332167|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
101332168|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346193|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346194|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346195|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346196|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346197|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101346198|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346227|NCT00027300|Natalizumab|natalizumab|mesh-list
101346228|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
101346229|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346230|NCT00395382|Alendronate|alendronate|mesh-list
101346231|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101346233|NCT00027339|Ritonavir|ritonavir|mesh-list
101346234|NCT00027339|Lopinavir|lopinavir|mesh-list
101346235|NCT00027339|Indinavir|indinavir|mesh-list
101346236|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
101346237|NCT00027339|Tenofovir|tenofovir|mesh-list
101346238|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101346239|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101346240|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
101346241|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346242|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346243|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101346244|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101346245|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
101346246|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346262|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
101346263|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346264|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346265|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346266|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346268|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346269|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346270|NCT00027534|Metronidazole|metronidazole|mesh-list
101346271|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346272|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101346273|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101346274|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101346275|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
101346276|NCT00027573|Methotrexate|methotrexate|mesh-list
101346277|NCT00027573|Fludarabine|fludarabine|mesh-list
101346278|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
101346279|NCT00027573|Tacrolimus|tacrolimus|mesh-list
101346280|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346281|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
101346282|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346283|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346284|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346285|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
101346286|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346287|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346288|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346289|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101346290|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
101346291|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101346292|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346293|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
101346294|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346295|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416733|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101346296|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101346297|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346298|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101346299|NCT00027612|Irinotecan|irinotecan|mesh-list
101346300|NCT00027612|Carmustine|carmustine|mesh-list
101346301|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101346302|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346303|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332169|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101332170|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101332171|NCT00000857|Growth Substances|growth substances|mesh-ancestor
101332172|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
101332173|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332174|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
101332175|NCT00036868|Fluorouracil|fluorouracil|mesh-list
101346304|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346336|NCT00027885|Bevacizumab|bevacizumab|mesh-list
101346337|NCT00027885|Docetaxel|docetaxel|mesh-list
101346338|NCT00027885|Doxorubicin|doxorubicin|mesh-list
101346339|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101346340|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346341|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
101346342|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346343|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346344|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346345|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
101346346|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346347|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346348|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346367|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101346368|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
101346369|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101346370|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346371|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346372|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
101346373|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346374|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346375|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346376|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346377|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101346378|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346379|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
101346380|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346381|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346382|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
101346383|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346384|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101346385|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
101346386|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346387|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346388|NCT04022876|Carboplatin|carboplatin|mesh-list
101346390|NCT04022876|Topotecan|topotecan|mesh-list
101346391|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346392|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346393|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346394|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101346395|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346396|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101346397|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346398|NCT00027963|Gabapentin|gabapentin|mesh-list
101346399|NCT00027963|Analgesics|analgesics|mesh-ancestor
101346400|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
101346401|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346402|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346403|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
101346404|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101346405|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101346418|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
101346419|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416746|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346420|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346421|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346422|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101346423|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101332177|NCT00036868|Trastuzumab|trastuzumab|mesh-list
101332178|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332179|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
101332180|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332181|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332182|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332183|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
101332184|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346424|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346425|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346426|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101346427|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
101346429|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101346430|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
101346431|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346432|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101346433|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101346434|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101346435|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346436|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
101346437|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346438|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346439|NCT00395655|Hydralazine|hydralazine|mesh-list
101346440|NCT00395655|Valproic Acid|valproic acid|mesh-list
101346441|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
101346442|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346443|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346444|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
101346445|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346446|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346447|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
101346448|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101346449|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346450|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101346451|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101346452|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
101346454|NCT00392561|Selenium|selenium|mesh-list
101346455|NCT00392561|Vitamins|vitamins|mesh-ancestor
101346456|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
101346457|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346458|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
101346459|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346460|NCT00392561|Protective Agents|protective agents|mesh-ancestor
101346461|NCT00392561|Trace Elements|trace elements|mesh-ancestor
101346462|NCT00028275|Interferons|interferons|mesh-list
101346463|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
101346464|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346465|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
101346466|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346467|NCT03959969|Ibuprofen|ibuprofen|mesh-list
101346485|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101346486|NCT00028314|Nevirapine|nevirapine|mesh-list
101346487|NCT00028314|Abacavir|abacavir|mesh-list
101346488|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101346489|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101346490|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
101346491|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346492|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346493|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101346494|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101346495|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
101346496|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346497|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101332185|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332186|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101332188|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332189|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101332190|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
101346498|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101346499|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101346500|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346501|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101346502|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101346503|NCT00028353|Toremifene|toremifene|mesh-list
101346504|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101346505|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346506|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101346507|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101346508|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
101346509|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346510|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346511|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101346512|NCT03959852|Fentanyl|fentanyl|mesh-list
101346513|NCT03959852|Ketamine|ketamine|mesh-list
101346514|NCT03959852|Analgesics|analgesics|mesh-ancestor
101346515|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
101346516|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346517|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346518|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101346519|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101346520|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
101346521|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
101346522|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101346523|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101346524|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101346544|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346545|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346546|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346547|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
101346548|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101346549|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
101346550|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101346551|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346552|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
101346553|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101346554|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
101346555|NCT00028665|Carmustine|carmustine|mesh-list
101346556|NCT00028665|Rituximab|rituximab|mesh-list
101346557|NCT00028665|Etoposide|etoposide|mesh-list
101346558|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346559|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
101346560|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346561|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346562|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346563|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
101346564|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346565|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346566|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346567|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346568|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346569|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346570|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346571|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346572|NCT03959540|Levodopa|levodopa|mesh-list
101346573|NCT03959540|Opicapone|opicapone|mesh-list
101346574|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101346575|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101346576|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
101346577|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101346578|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332191|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101332192|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332193|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332194|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332195|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332196|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101332197|NCT00036946|Aflibercept|aflibercept|mesh-list
101332198|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101346579|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346599|NCT03959501|Hormones|hormones|mesh-ancestor
101346600|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346601|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101346602|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
101346603|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346604|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346605|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101346606|NCT00028782|Etanidazole|etanidazole|mesh-list
101346608|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346609|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346610|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346611|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101346612|NCT00028821|Estradiol|estradiol|mesh-list
101346613|NCT00028821|Estrogens|estrogens|mesh-ancestor
101346614|NCT00028821|Hormones|hormones|mesh-ancestor
101346615|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346616|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346617|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346618|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346619|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346620|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346621|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346622|NCT03959384|Poractant alfa|poractant alfa|mesh-list
101346623|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101346624|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101346625|NCT00028860|Paclitaxel|paclitaxel|mesh-list
101346626|NCT00028860|Carboplatin|carboplatin|mesh-list
101346627|NCT00028860|Gemcitabine|gemcitabine|mesh-list
101346628|NCT00028860|Ifosfamide|ifosfamide|mesh-list
101346629|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346630|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346631|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346632|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346633|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346634|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346635|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346636|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
101346649|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346650|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
101346651|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346653|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
101346654|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346655|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346656|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346657|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346658|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346659|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
101346660|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
101346661|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101346662|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346663|NCT00028938|Paclitaxel|paclitaxel|mesh-list
101346664|NCT00028938|Carboplatin|carboplatin|mesh-list
101346665|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
101346666|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346667|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346668|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332199|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101332201|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332202|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
101332203|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332204|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
101346669|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346670|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346671|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346672|NCT00028938|Hematinics|hematinics|mesh-ancestor
101346674|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346675|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101346676|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
101346677|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346678|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101346679|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
101346680|NCT00029250|Protective Agents|protective agents|mesh-ancestor
101346681|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346682|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101346683|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101346684|NCT03959150|Capecitabine|capecitabine|mesh-list
101346685|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346686|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
101346687|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346688|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346690|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346691|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346692|NCT00029328|Analgesics|analgesics|mesh-ancestor
101346693|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
101346694|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346695|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346696|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346697|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346698|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101346699|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346700|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
101346715|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
101346716|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346717|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346718|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
101346719|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346720|NCT00392717|Atorvastatin|atorvastatin|mesh-list
101346721|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101346722|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101346723|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
101346724|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346725|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101346726|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101346727|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346729|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346730|NCT03958799|Vaccines|vaccines|mesh-list
101346731|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
101346732|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346733|NCT00029757|Estrogens|estrogens|mesh-list
101346734|NCT00029757|Hormones|hormones|mesh-ancestor
101346735|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346736|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346738|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346739|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
101346740|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346741|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346742|NCT00029835|Rimonabant|rimonabant|mesh-list
101346743|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101346744|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101346745|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101346746|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332205|NCT00036985|Doxorubicin|doxorubicin|mesh-list
101332206|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101332207|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332209|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332210|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332211|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332212|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
101346747|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346748|NCT00029835|Hormones|hormones|mesh-ancestor
101346749|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346750|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346751|NCT00395772|Vitamin K|vitamin k|mesh-list
101346752|NCT00395772|Heparin|heparin|mesh-list
101346753|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
101346754|NCT00395772|Vitamins|vitamins|mesh-ancestor
101346755|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
101346756|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346757|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
101346759|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101346760|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346761|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101346781|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
101346782|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346783|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346784|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101346785|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
101346787|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346788|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101346789|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346790|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101346791|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101346792|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101346793|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346794|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101346795|NCT00030069|Vitamins|vitamins|mesh-ancestor
101346796|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
101346797|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101346798|NCT03958097|Antibodies|antibodies|mesh-list
101346799|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
101346800|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346801|NCT00030342|Interferons|interferons|mesh-list
101346802|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
101346803|NCT00030342|Fluorouracil|fluorouracil|mesh-list
101346804|NCT00030342|Sargramostim|sargramostim|mesh-list
101346805|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
101346806|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346807|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346808|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346809|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346810|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
101346811|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346812|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
101346813|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346814|NCT00030381|Esorubicin|esorubicin|mesh-list
101346815|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101346816|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346817|NCT00030420|Celecoxib|celecoxib|mesh-list
101346818|NCT00030420|Docetaxel|docetaxel|mesh-list
101346819|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346820|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346831|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346832|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101346833|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101346834|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346835|NCT00030459|Vinorelbine|vinorelbine|mesh-list
101346836|NCT00030459|Mitomycins|mitomycins|mesh-list
101346837|NCT00030459|Mitomycin|mitomycin|mesh-list
101332213|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332214|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332215|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101332216|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332217|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346839|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346840|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101346841|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
101346842|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
101346843|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
101346844|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346845|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101346846|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
101346847|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101346848|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346849|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101346850|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346851|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346852|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346853|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346854|NCT03873857|Venetoclax|venetoclax|mesh-list
101346855|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346856|NCT03866408|Pioglitazone|pioglitazone|mesh-list
101346857|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101346858|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346859|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101346860|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346861|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346862|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346863|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346864|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101346865|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346866|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346867|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346868|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346869|NCT00030615|Decitabine|decitabine|mesh-list
101346870|NCT00030615|Azacitidine|azacitidine|mesh-list
101346871|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101346872|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
101346873|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346874|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346875|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346876|NCT03857087|Edetic Acid|edetic acid|mesh-list
101346877|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101346878|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
101346879|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
101346880|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346881|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
101346882|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101346883|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101346899|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101346900|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101346901|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101346902|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346903|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101346904|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346905|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
101346906|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346907|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101346908|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101346909|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101346910|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
101346911|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101346912|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
101346913|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101332218|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332219|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332220|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
101332222|NCT00037063|Riboflavin|riboflavin|mesh-list
101332223|NCT00037063|Thiamine|thiamine|mesh-list
101332224|NCT00037063|Vitamins|vitamins|mesh-ancestor
101332225|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
101332226|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332227|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
101346914|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346915|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
101346916|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
101346917|NCT03852407|Melphalan|melphalan|mesh-list
101346918|NCT03852407|Fludarabine|fludarabine|mesh-list
101346919|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
101346920|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101346921|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
101346922|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346923|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346924|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101346925|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
101346926|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346927|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346928|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101346929|NCT00030693|Metronidazole|metronidazole|mesh-list
101346930|NCT00030693|Vaccines|vaccines|mesh-list
101346931|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
101346932|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346933|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346934|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101346935|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101346936|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101346937|NCT03823274|Aspirin|aspirin|mesh-list
101346938|NCT03823274|Clopidogrel|clopidogrel|mesh-list
101346939|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101346940|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101346941|NCT03823274|Analgesics|analgesics|mesh-ancestor
101346942|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
101346943|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101346944|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346945|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101346946|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101346970|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346972|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
101346973|NCT00030849|Bexarotene|bexarotene|mesh-list
101346974|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346975|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
101346976|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101346977|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
101346978|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346979|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101346980|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346981|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101346982|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101346983|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346984|NCT00030966|Natalizumab|natalizumab|mesh-list
101346985|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
101346986|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101346987|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
101346988|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101346989|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101346990|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101346991|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101346992|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
101346993|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101346994|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101332228|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332229|NCT00037063|Protective Agents|protective agents|mesh-ancestor
101332230|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
101332231|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101332232|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332234|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332235|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332236|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347018|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
101347019|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347020|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347022|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
101347023|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101347024|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101347025|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347026|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347027|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347028|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101347029|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347030|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347031|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347032|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347033|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
101347034|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101347035|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
101347036|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101347037|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347038|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347039|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101347040|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
101347041|NCT00392912|Testosterone|testosterone|mesh-list
101347042|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
101347043|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
101347044|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101347046|NCT00392912|Hormones|hormones|mesh-ancestor
101347062|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101347064|NCT00393107|Rituximab|rituximab|mesh-list
101347065|NCT00393107|Fludarabine|fludarabine|mesh-list
101347066|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347067|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
101347068|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347069|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347070|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101347071|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
101347072|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347073|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347074|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101347075|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347076|NCT04711668|Lidocaine|lidocaine|mesh-list
101347077|NCT04711668|Ketamine|ketamine|mesh-list
101347078|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
101347079|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
101347080|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347081|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347082|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
101347083|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347084|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101347085|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101347086|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101347087|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332237|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332238|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
101332239|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332240|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332241|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332242|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101347089|NCT04711668|Analgesics|analgesics|mesh-ancestor
101347090|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101347091|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101347092|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
101347093|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101347094|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101347095|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347096|NCT00031161|Nitisinone|nitisinone|mesh-list
101347097|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347098|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347099|NCT00031278|Trastuzumab|trastuzumab|mesh-list
101347100|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347101|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347102|NCT00031317|Clozapine|clozapine|mesh-list
101347103|NCT00031317|Paroxetine|paroxetine|mesh-list
101347120|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347121|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
101347122|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
101347123|NCT00396045|Lenalidomide|lenalidomide|mesh-list
101347124|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
101347125|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347126|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101347127|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347128|NCT00396045|Growth Substances|growth substances|mesh-ancestor
101347129|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
101347130|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347131|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101347132|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101347133|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101347134|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
101347135|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347136|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101347137|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101347138|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347140|NCT00031395|Methylphenidate|methylphenidate|mesh-list
101347141|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101347142|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347143|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101347144|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347145|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347146|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347147|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
101347148|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347149|NCT00031395|Analgesics|analgesics|mesh-ancestor
101347150|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
101347151|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347152|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101347153|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
101347154|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
101347155|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101347156|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101347157|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101347170|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
101347171|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101347172|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
101347173|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
101347174|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347175|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
101347176|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332243|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101332244|NCT00037102|Interferons|interferons|mesh-list
101332245|NCT00037102|Interferon-beta|interferon-beta|mesh-list
101332246|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
101332248|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101347177|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347179|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
101347180|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347181|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
101347182|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347183|NCT00031629|Gemcitabine|gemcitabine|mesh-list
101347184|NCT00031629|Docetaxel|docetaxel|mesh-list
101347185|NCT00031629|Lenograstim|lenograstim|mesh-list
101347186|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101347187|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
101347188|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347189|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347190|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347191|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347192|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347193|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101347194|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
101347195|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347196|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
101347197|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101347198|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347199|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101347200|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347201|NCT00031707|Megestrol|megestrol|mesh-list
101347202|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
101347203|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101347204|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101347205|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101347206|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
101347207|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101347208|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347209|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101347210|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101347211|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347212|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347213|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
101347214|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101347215|NCT00031746|Caseins|caseins|mesh-list
101347216|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
101347217|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
101347218|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347219|NCT00031785|Megestrol|megestrol|mesh-list
101347220|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
101347232|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101347233|NCT03151772|Metformin|metformin|mesh-list
101347234|NCT03151772|Disulfiram|disulfiram|mesh-list
101347235|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101347236|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347237|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101347238|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101347239|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347240|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347241|NCT02971644|Cobalt|cobalt|mesh-list
101347242|NCT02971644|Trace Elements|trace elements|mesh-ancestor
101347243|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
101347244|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347245|NCT00031824|Cyclosporine|cyclosporine|mesh-list
101347246|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
101347247|NCT00031824|Prednisone|prednisone|mesh-list
101347248|NCT00031824|Tacrolimus|tacrolimus|mesh-list
101347249|NCT00031824|Cyclosporins|cyclosporins|mesh-list
101347250|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347251|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
101347252|NCT00031824|Hormones|hormones|mesh-ancestor
101332249|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
101347253|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347254|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347255|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347256|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347257|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347258|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
101347259|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101347260|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347261|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347262|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
101347263|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347264|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347265|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347266|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
101347267|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101347268|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101347269|NCT00031863|Rofecoxib|rofecoxib|mesh-list
101347270|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101347271|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101347272|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347273|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347274|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101347275|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101347276|NCT00031863|Analgesics|analgesics|mesh-ancestor
101347277|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
101347278|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347279|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347280|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347281|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347282|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101347283|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
101347301|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347302|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
101347303|NCT00031902|Hormones|hormones|mesh-ancestor
101347304|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347305|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347306|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101347307|NCT00031941|Lenalidomide|lenalidomide|mesh-list
101347308|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
101347309|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347310|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101347311|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347312|NCT00031941|Growth Substances|growth substances|mesh-ancestor
101347313|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
101347314|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347315|NCT00031980|Cyclosporine|cyclosporine|mesh-list
101347316|NCT00031980|Cyclosporins|cyclosporins|mesh-list
101347317|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347318|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347319|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347320|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
101347321|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347322|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
101347323|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347324|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347325|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347328|NCT03151499|BI 409306|bi 409306|mesh-list
101347329|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101347330|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
101347331|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101347332|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347333|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
101347334|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347335|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347336|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347337|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101347338|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101347339|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101332250|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101332251|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332252|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332253|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
101332254|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347340|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101347361|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101347362|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101347363|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101347364|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347365|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347368|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347369|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347370|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101347371|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347372|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347373|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347374|NCT03151460|Dopamine|dopamine|mesh-list
101347375|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
101347376|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101347377|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
101347378|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
101347379|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347380|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347381|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347382|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347383|NCT03151460|Protective Agents|protective agents|mesh-ancestor
101347384|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
101347385|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347386|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101347387|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347388|NCT03151382|Tandospirone|tandospirone|mesh-list
101347389|NCT03151382|Donepezil|donepezil|mesh-list
101347390|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347391|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101347392|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347393|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101347394|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347395|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347413|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101347414|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101347415|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101347416|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101347417|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347418|NCT03151343|Empagliflozin|empagliflozin|mesh-list
101347419|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101347420|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347421|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101347422|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347423|NCT00032175|Gemcitabine|gemcitabine|mesh-list
101347424|NCT00032175|Capecitabine|capecitabine|mesh-list
101347425|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101347426|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
101347427|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347429|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
101347430|NCT04712279|Ivermectin|ivermectin|mesh-list
101347431|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
101347432|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101347433|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101347434|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347435|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347436|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347437|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347438|NCT00032292|Visilizumab|visilizumab|mesh-list
101347439|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
101332255|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332256|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332257|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347440|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347441|NCT03150914|Sirolimus|sirolimus|mesh-list
101347442|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101347443|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347444|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101347445|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347446|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
101347447|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347448|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
101347449|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347450|NCT00032799|Natalizumab|natalizumab|mesh-list
101347451|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
101347452|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347453|NCT03150836|Durvalumab|durvalumab|mesh-list
101347465|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
101347466|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347467|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347468|NCT00032838|Urological Agents|urological agents|mesh-ancestor
101347469|NCT03150797|Melatonin|melatonin|mesh-list
101347470|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
101347471|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347472|NCT03150797|Protective Agents|protective agents|mesh-ancestor
101347473|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347474|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347475|NCT03150680|Clopidogrel|clopidogrel|mesh-list
101347476|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101347477|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101347478|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101347479|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101347480|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
101347481|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347482|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347483|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347484|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
101347485|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101347486|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
101347487|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347488|NCT00396396|Expectorants|expectorants|mesh-ancestor
101347489|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
101347490|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101347491|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
101347492|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347493|NCT00396396|Protective Agents|protective agents|mesh-ancestor
101347494|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347496|NCT00032955|Buprenorphine|buprenorphine|mesh-list
101347497|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101347498|NCT00032955|Naloxone|naloxone|mesh-list
101347499|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101347500|NCT00032955|Narcotics|narcotics|mesh-ancestor
101347501|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347502|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347504|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
101347505|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347506|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101347507|NCT03150524|Verapamil|verapamil|mesh-list
101347508|NCT03150524|Nimodipine|nimodipine|mesh-list
101347509|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101347510|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101347511|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347512|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347513|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101347514|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347515|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
101347516|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101347533|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101332258|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332259|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332260|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
101332261|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332262|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332263|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
101332264|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332265|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101332266|NCT00037141|Ethanol|ethanol|mesh-list
101332267|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101332268|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347534|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347535|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347537|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
101347538|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347539|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101347540|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101347541|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101347542|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347543|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347544|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101347545|NCT00033072|Protective Agents|protective agents|mesh-ancestor
101347546|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347547|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101347548|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101347549|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347550|NCT00033111|Cabergoline|cabergoline|mesh-list
101347551|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101347552|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101347553|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
101347554|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
101347555|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347556|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347557|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347558|NCT00033189|Ubiquinone|ubiquinone|mesh-list
101347559|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
101347560|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
101347561|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347562|NCT00033189|Vitamins|vitamins|mesh-ancestor
101347563|NCT00033267|Sirolimus|sirolimus|mesh-list
101347564|NCT00033267|Temsirolimus|temsirolimus|mesh-list
101347565|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
101347566|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101347567|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347568|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347569|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347570|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
101347571|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347572|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347573|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101347589|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101347591|NCT02984384|Analgesics|analgesics|mesh-ancestor
101347592|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
101347593|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347594|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347595|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347596|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347597|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101347598|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101347599|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347600|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101347601|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101347602|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332269|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332270|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332271|NCT00037180|Leucovorin|leucovorin|mesh-list
101332272|NCT00037180|Celecoxib|celecoxib|mesh-list
101332273|NCT00037180|Fluorouracil|fluorouracil|mesh-list
101332274|NCT00037180|Irinotecan|irinotecan|mesh-list
101332275|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
101347603|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
101347604|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
101347605|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
101347606|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101347607|NCT00033345|Protective Agents|protective agents|mesh-ancestor
101347608|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347609|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347610|NCT00033423|Rituximab|rituximab|mesh-list
101347611|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347612|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347613|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
101347614|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347615|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347616|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101347617|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347618|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101347619|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347620|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347621|NCT00393263|Clobetasol|clobetasol|mesh-list
101347622|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
101347623|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347624|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
101347625|NCT00393263|Hormones|hormones|mesh-ancestor
101347626|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347627|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347628|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101347629|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101347630|NCT00393263|Analgesics|analgesics|mesh-ancestor
101347631|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
101347632|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347633|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347634|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347646|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347647|NCT00033696|Paclitaxel|paclitaxel|mesh-list
101347648|NCT00033696|Etoposide|etoposide|mesh-list
101347649|NCT00033696|Carboplatin|carboplatin|mesh-list
101347650|NCT00033696|Topotecan|topotecan|mesh-list
101347651|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101347652|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347653|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347654|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347655|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347656|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347657|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101347658|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101347659|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347660|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101347662|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
101347663|NCT00033735|Fluorouracil|fluorouracil|mesh-list
101347664|NCT00033735|Irofulven|irofulven|mesh-list
101347665|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
101347666|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347667|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101347668|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347669|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347670|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
101347671|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347672|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101347673|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
101347674|NCT00033813|Oxatomide|oxatomide|mesh-list
101347675|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101347676|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
101347677|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
101332276|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332277|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332278|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332279|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332280|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
101332281|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332282|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101332283|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332284|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332285|NCT00037180|Antidotes|antidotes|mesh-ancestor
101332286|NCT00037180|Protective Agents|protective agents|mesh-ancestor
101332287|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
101332288|NCT00037180|Vitamins|vitamins|mesh-ancestor
101332289|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
101332290|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101332291|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101332292|NCT00037180|Analgesics|analgesics|mesh-ancestor
101332293|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
101332294|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332295|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332296|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347678|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347679|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347680|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347681|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101347682|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101347683|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
101347684|NCT00033891|Infliximab|infliximab|mesh-list
101347685|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101347686|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347687|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347688|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101347689|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101347690|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
101347691|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
101347692|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
101347693|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101347694|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101347695|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347696|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347697|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347698|NCT02149823|Oxytocin|oxytocin|mesh-list
101347717|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347718|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347720|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347721|NCT00034047|Nafarelin|nafarelin|mesh-list
101347722|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101347723|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
101347724|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101347725|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347726|NCT00034086|Ritonavir|ritonavir|mesh-list
101347727|NCT00034086|Lopinavir|lopinavir|mesh-list
101347728|NCT00034086|Tenofovir|tenofovir|mesh-list
101332297|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101332298|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101332300|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
101332301|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347729|NCT00034086|Lamivudine|lamivudine|mesh-list
101347730|NCT00034086|Zidovudine|zidovudine|mesh-list
101347731|NCT00034086|Didanosine|didanosine|mesh-list
101347732|NCT00034086|Stavudine|stavudine|mesh-list
101347733|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101347734|NCT00034086|Vaccines|vaccines|mesh-list
101347735|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101347736|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
101347737|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347738|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101347739|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101347740|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
101347741|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347742|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347743|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101347744|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101347745|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
101347746|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347747|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101347748|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347749|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101347750|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347751|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
101347752|NCT00034125|Tamoxifen|tamoxifen|mesh-list
101347753|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101347754|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
101347764|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347765|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347766|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347767|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347768|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347769|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
101347770|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101347771|NCT00034242|Antibodies|antibodies|mesh-list
101347772|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
101347773|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101347774|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
101347775|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347776|NCT01807325|Pancrelipase|pancrelipase|mesh-list
101347777|NCT01807325|Pancreatin|pancreatin|mesh-list
101347778|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101347779|NCT01807286|Dexamethasone|dexamethasone|mesh-list
101347780|NCT01807286|Melphalan|melphalan|mesh-list
101347781|NCT01807286|Pomalidomide|pomalidomide|mesh-list
101347782|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101347783|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
101347784|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
101347786|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347787|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101347788|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
101347789|NCT01807286|Hormones|hormones|mesh-ancestor
101347790|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347791|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101347792|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347793|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101347794|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
101347795|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347796|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101347797|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101347798|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
101347799|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101347800|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347801|NCT01807286|Growth Substances|growth substances|mesh-ancestor
101347802|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
101347803|NCT00034359|Lamivudine|lamivudine|mesh-list
101347804|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332302|NCT00000893|Efavirenz|efavirenz|mesh-list
101332303|NCT00000893|Nelfinavir|nelfinavir|mesh-list
101332304|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332305|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332306|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332307|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332308|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
101332309|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332310|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101332311|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332312|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101332313|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101332314|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101332315|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101332316|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101332317|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101332318|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332319|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332320|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332321|NCT00396526|Amoxicillin|amoxicillin|mesh-list
101332322|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101332323|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332324|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347805|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347806|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347807|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347808|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
101347809|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347810|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101347811|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101347813|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101347814|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
101347815|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347816|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347817|NCT00034632|Posaconazole|posaconazole|mesh-list
101347818|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
101347831|NCT00034671|Posaconazole|posaconazole|mesh-list
101347832|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
101347833|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347834|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101347835|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101347836|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101347837|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101347838|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347839|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347840|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347841|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101347842|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
101332325|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101332326|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
101332327|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101332328|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101332329|NCT00037531|Sirolimus|sirolimus|mesh-list
101332330|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332331|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332332|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332333|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332334|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
101347843|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101347844|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347845|NCT01806857|Quinidine|quinidine|mesh-list
101347846|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
101347847|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
101347848|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
101347849|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101347850|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101347851|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347852|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347853|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347854|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101347855|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101347856|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
101347857|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101347858|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
101347859|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101347860|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101347861|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347862|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347863|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101347864|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101347865|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
101347866|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101347867|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101347868|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347869|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101347870|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347872|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
101347873|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101347875|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347876|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347888|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
101347890|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
101347891|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
101347892|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347893|NCT00034788|Growth Substances|growth substances|mesh-ancestor
101347894|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347895|NCT00034866|Tipranavir|tipranavir|mesh-list
101347896|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101347897|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
101347898|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101347899|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101347900|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
101347901|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101347902|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347903|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347904|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101347905|NCT00034905|Risperidone|risperidone|mesh-list
101347906|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101347907|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101347908|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
101347909|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332335|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332336|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
101332337|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332338|NCT00037570|Pantoprazole|pantoprazole|mesh-list
101332339|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101332340|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101332341|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101332342|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332343|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332345|NCT00000899|Stavudine|stavudine|mesh-list
101332346|NCT00000899|Nelfinavir|nelfinavir|mesh-list
101332347|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
101332348|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332349|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
101332350|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332351|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332352|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332353|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
101332354|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332355|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347910|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347911|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347912|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101347913|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101347914|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101347915|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347916|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101347917|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
101347918|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
101347919|NCT01806311|Amlodipine|amlodipine|mesh-list
101347920|NCT01806311|Candesartan|candesartan|mesh-list
101347921|NCT01806311|Candesartan cilexetil|candesartan cilexetil|mesh-list
101347922|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101347923|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101347924|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101347925|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347926|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101347927|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347928|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101347929|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101347930|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101347931|NCT00034944|Aprepitant|aprepitant|mesh-list
101347932|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
101347933|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
101347934|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347935|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347936|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101347937|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101347938|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456545|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332356|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101332357|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332358|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332359|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332360|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
101332361|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332362|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332363|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332364|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101332366|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332367|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
101332368|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
101332369|NCT00037609|Capecitabine|capecitabine|mesh-list
101332370|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332371|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
101347952|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347954|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
101347955|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347956|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101347957|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
101347958|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101347959|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101347960|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101347961|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347963|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
101347964|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101347965|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101347966|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101347967|NCT00035061|Pemetrexed|pemetrexed|mesh-list
101347968|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347969|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101347970|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347971|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101347972|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101347973|NCT00393497|Bevacizumab|bevacizumab|mesh-list
101347974|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101347975|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347976|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101347977|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101347978|NCT00393497|Growth Substances|growth substances|mesh-ancestor
101347979|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416771|NCT00131300|Hylan|hylan|mesh-list
101347980|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
101347981|NCT00035100|Epothilones|epothilones|mesh-list
101347982|NCT00035100|Epothilone B|epothilone b|mesh-list
101347983|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
101347984|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
101347985|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
101347986|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347987|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101347988|NCT00035139|Methylphenidate|methylphenidate|mesh-list
101347989|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101347990|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101347991|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101347992|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101347993|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332372|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332373|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332374|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101332375|NCT00037609|Protective Agents|protective agents|mesh-ancestor
101332376|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332377|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101332378|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332379|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101347994|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101347995|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
101347996|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101347997|NCT00035178|Argatroban|argatroban|mesh-list
101347998|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
101348013|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101348014|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
101348015|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348016|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101348017|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101348019|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
101348020|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
101348021|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348022|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348023|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348024|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101348025|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348026|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348027|NCT01806116|Decitabine|decitabine|mesh-list
101348028|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348029|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
101348030|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348031|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348032|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348033|NCT00035451|Sotalol|sotalol|mesh-list
101348034|NCT00035451|Azimilide|azimilide|mesh-list
101348035|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101348036|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101348037|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348038|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348039|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348040|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348041|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101348042|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
101348043|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
101348044|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348045|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101348046|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348047|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348048|NCT01805999|Psyllium|psyllium|mesh-list
101348049|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
101348050|NCT01805999|Cathartics|cathartics|mesh-ancestor
101348051|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348052|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
101348053|NCT00035490|Azimilide|azimilide|mesh-list
101348054|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101348055|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101348056|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348057|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348076|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348077|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348078|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
101348079|NCT04732377|Bupivacaine|bupivacaine|mesh-list
101348080|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
101348081|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
101348082|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332380|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101332381|NCT00037609|Analgesics|analgesics|mesh-ancestor
101332382|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
101332383|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332384|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332385|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332386|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101332387|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348083|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348084|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
101348085|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348086|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101348087|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348088|NCT04732377|Analgesics|analgesics|mesh-ancestor
101348089|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101348090|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101348091|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101348092|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348093|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348094|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348095|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
101348097|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101348098|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348099|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348100|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348101|NCT01805726|Analgesics|analgesics|mesh-ancestor
101348102|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
101348103|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348104|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101348105|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101348106|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101348107|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348108|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348109|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348110|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101348111|NCT01805726|Narcotics|narcotics|mesh-ancestor
101348112|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101348113|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
101348114|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
101348115|NCT00035958|Prednisone|prednisone|mesh-list
101348116|NCT00035958|Etanercept|etanercept|mesh-list
101348117|NCT00035958|Methotrexate|methotrexate|mesh-list
101348136|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348137|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101348138|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348139|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348140|NCT00035958|Analgesics|analgesics|mesh-ancestor
101348141|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
101348142|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348143|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348144|NCT01805687|Zileuton|zileuton|mesh-list
101348145|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348146|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348147|NCT01805687|Analgesics|analgesics|mesh-ancestor
101348148|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
101348149|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348150|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348151|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348152|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348153|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101348154|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348155|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348156|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101348157|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
101348158|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332389|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101332390|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332391|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332392|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332393|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332394|NCT00037882|Interferons|interferons|mesh-list
101332395|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
101348159|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
101348160|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348161|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348162|NCT01805570|Ticagrelor|ticagrelor|mesh-list
101348163|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101348164|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348165|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101348166|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101348167|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101348168|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
101348169|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348170|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348183|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101348184|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348185|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348186|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348187|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
101348188|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
101348189|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348190|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348191|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101348192|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101348193|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
101348194|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101348195|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101348196|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101348197|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101348198|NCT01805453|Losartan|losartan|mesh-list
101348199|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101348200|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101348201|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101348202|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101348203|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348204|NCT00036153|Methotrexate|methotrexate|mesh-list
101348205|NCT00036153|Tacrolimus|tacrolimus|mesh-list
101348206|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101348207|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
101348208|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101348209|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348210|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348211|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
101348212|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348213|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348214|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
101348215|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348216|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101348217|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348218|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
101348219|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348220|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101348221|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101348222|NCT00036231|Secretin|secretin|mesh-list
101348223|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348224|NCT00036231|Hormones|hormones|mesh-ancestor
101348225|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348226|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348227|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101332396|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
101332397|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101332398|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332399|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
101332400|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332401|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
101348228|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101348229|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101348230|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348231|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348232|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348246|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348248|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
101348249|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348250|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348251|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101348252|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101348254|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101348255|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101348256|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101348257|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101348258|NCT00036387|Infliximab|infliximab|mesh-list
101348259|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101348260|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348262|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348263|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348264|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
101348265|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
101348266|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348267|NCT01466543|Udenafil|udenafil|mesh-list
101348268|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101348269|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101348270|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348271|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348272|NCT01466465|Vitamin D|vitamin d|mesh-list
101348273|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
101348274|NCT01466465|Vitamins|vitamins|mesh-ancestor
101348275|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
101348276|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348277|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348278|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348279|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
101348280|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348281|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348282|NCT00036543|Atrasentan|atrasentan|mesh-list
101348283|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348284|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101348285|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101348286|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348287|NCT01466231|Everolimus|everolimus|mesh-list
101348288|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101348289|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101348290|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348291|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348292|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348293|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
101348306|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
101348307|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
101348308|NCT01466114|Norethindrone|norethindrone|mesh-list
101348309|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
101348310|NCT01466114|Progestins|progestins|mesh-list
101348311|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101348312|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101348313|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101348314|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
101348315|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101332402|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332403|NCT00037999|Testosterone|testosterone|mesh-list
101332404|NCT00037999|Androgens|androgens|mesh-ancestor
101332405|NCT00037999|Hormones|hormones|mesh-ancestor
101348316|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348317|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101348318|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101348319|NCT01466114|Hormones|hormones|mesh-ancestor
101348320|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348321|NCT00036777|Carboplatin|carboplatin|mesh-list
101348322|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101348323|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348324|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101348325|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348326|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348327|NCT01465919|Mirtazapine|mirtazapine|mesh-list
101348328|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348329|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348330|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101348331|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
101348332|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
101348333|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348334|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348335|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348336|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101348337|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348338|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348339|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101348340|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101348341|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101348342|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348343|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101348344|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101348345|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
101348346|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101348347|NCT00396513|Metformin|metformin|mesh-list
101348348|NCT00396513|Simvastatin|simvastatin|mesh-list
101348349|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348350|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348351|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101348352|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101348353|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
101348354|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348374|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101348375|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101348376|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348377|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101348378|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101348379|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348380|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348381|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
101348382|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348383|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
101348384|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348385|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
101348386|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101348387|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
101348388|NCT00037011|Antibodies|antibodies|mesh-list
101348389|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101348390|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
101348391|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348392|NCT00037050|Vancomycin|vancomycin|mesh-list
101348393|NCT00037050|Linezolid|linezolid|mesh-list
101348394|NCT00037050|Oxacillin|oxacillin|mesh-list
101348395|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
101348396|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348397|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348398|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101348399|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332406|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332407|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332409|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101332410|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101332411|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
101332412|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
101348400|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348401|NCT00037089|Tegafur|tegafur|mesh-list
101348402|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348403|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
101348404|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348405|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348406|NCT01465568|Denosumab|denosumab|mesh-list
101348407|NCT01465568|Diphosphonates|diphosphonates|mesh-list
101348408|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348409|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348410|NCT00037206|Anidulafungin|anidulafungin|mesh-list
101348430|NCT01465256|Aspirin|aspirin|mesh-list
101348431|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348432|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348433|NCT01465256|Analgesics|analgesics|mesh-ancestor
101348434|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
101348435|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348436|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348437|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348438|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348439|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348440|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348441|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348442|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348443|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101348444|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348445|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
101348446|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
101348447|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348448|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348449|NCT01464983|Aspirin|aspirin|mesh-list
101348450|NCT01464983|Ibuprofen|ibuprofen|mesh-list
101348451|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101348452|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101348453|NCT01464983|Analgesics|analgesics|mesh-ancestor
101348454|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
101348455|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348456|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348457|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348458|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348459|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348460|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348461|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348462|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348463|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101348464|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348465|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
101348480|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348481|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348482|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348483|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348484|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348485|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101348486|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101348489|NCT00037596|Cytarabine|cytarabine|mesh-list
101348490|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
101348491|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348492|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
101348493|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332413|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332414|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332415|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101332416|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101332417|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101348494|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348495|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
101348496|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348497|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348498|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
101348499|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348500|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101348501|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
101348502|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
101348503|NCT00037635|Cinacalcet|cinacalcet|mesh-list
101348504|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101348505|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348506|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101348507|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
101348508|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348509|NCT00037674|Topiramate|topiramate|mesh-list
101348510|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
101348511|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348512|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348513|NCT00037752|Sibutramine|sibutramine|mesh-list
101348514|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348515|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348516|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
101348517|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101348518|NCT01464671|Heparin|heparin|mesh-list
101348519|NCT01464671|Bivalirudin|bivalirudin|mesh-list
101348520|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
101348521|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348522|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348523|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348524|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
101348525|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101348545|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348546|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348547|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
101348548|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
101348550|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
101348551|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348552|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
101348553|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
101348554|NCT00038064|Hematinics|hematinics|mesh-ancestor
101348555|NCT00038181|Thalidomide|thalidomide|mesh-list
101348556|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348557|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
101348558|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348559|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
101348560|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348561|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348562|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101348563|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101348564|NCT00038181|Growth Substances|growth substances|mesh-ancestor
101348565|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
101348566|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348567|NCT00038220|Ritonavir|ritonavir|mesh-list
101348568|NCT00038220|Lopinavir|lopinavir|mesh-list
101348569|NCT00038220|Tenofovir|tenofovir|mesh-list
101348570|NCT00038220|Lamivudine|lamivudine|mesh-list
101348571|NCT00038220|Efavirenz|efavirenz|mesh-list
101348572|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101348573|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101348574|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
101348575|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348576|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348577|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101348578|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101348579|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
101348580|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332419|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332420|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332422|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101332423|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
101348581|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101348582|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101348583|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101348584|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101348607|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348609|NCT00847223|Tipifarnib|tipifarnib|mesh-list
101348610|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348611|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
101348612|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101348613|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348614|NCT00847106|Daclizumab|daclizumab|mesh-list
101348615|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348616|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
101348617|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348618|NCT00396669|Bupropion|bupropion|mesh-list
101348619|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101348620|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
101348621|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348622|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101348623|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101348624|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101348625|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348626|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
101348627|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348628|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348629|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101348630|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101348631|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348632|NCT00846989|Latanoprost|latanoprost|mesh-list
101348633|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101348634|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101348659|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348660|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
101348661|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
101348662|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348663|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348664|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
101348665|NCT00396747|Hormones|hormones|mesh-ancestor
101348666|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348667|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101348668|NCT00396747|Protective Agents|protective agents|mesh-ancestor
101348669|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101348670|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101348671|NCT00846950|Lorazepam|lorazepam|mesh-list
101348672|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101348673|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
101348674|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
101348675|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
101348676|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348677|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348678|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101348679|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101348680|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348681|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101348682|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348683|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101348684|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
101348685|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
101348686|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101348701|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101348702|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348703|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
101348704|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101332425|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332426|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332427|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
101348705|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101348706|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348707|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101348708|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348709|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348710|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348711|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348712|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101348713|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
101348714|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101348715|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348716|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101348717|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101348718|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101348720|NCT00846872|Hormones|hormones|mesh-list
101348721|NCT00846872|Secretagogues|secretagogues|mesh-list
101348722|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348723|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348724|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101348725|NCT00846872|Diuretics|diuretics|mesh-ancestor
101348726|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
101348727|NCT05432778|Letermovir|letermovir|mesh-list
101348728|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101348729|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348730|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348731|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348732|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
101348733|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348734|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
101348735|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
101348736|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348737|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
101348738|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
101348739|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101348740|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348741|NCT00846716|Pioglitazone|pioglitazone|mesh-list
101348742|NCT00846716|Biguanides|biguanides|mesh-list
101348743|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101348744|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348776|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348777|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348778|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348779|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101348780|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101348781|NCT00846326|Fluticasone|fluticasone|mesh-list
101348782|NCT00846326|Xhance|xhance|mesh-list
101348783|NCT00846326|Phenylephrine|phenylephrine|mesh-list
101348784|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
101348785|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348786|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101348856|NCT00277043|Taxane|taxane|mesh-list
101348857|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101348858|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348859|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
101348860|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
101348861|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
101348862|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348864|NCT00276965|Sertraline|sertraline|mesh-list
101348872|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
101348873|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348874|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348875|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
101332428|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332429|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332430|NCT00038116|Protective Agents|protective agents|mesh-ancestor
101332431|NCT00038194|Docetaxel|docetaxel|mesh-list
101332432|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
101332433|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332434|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332435|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101348876|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101348877|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101348878|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
101348879|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348880|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101348881|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348882|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348883|NCT00396786|Enoxaparin|enoxaparin|mesh-list
101348884|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
101348885|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101348886|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
101348887|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101348888|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
101348889|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348890|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348891|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
101348892|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101348893|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101348894|NCT00276848|Vidarabine|vidarabine|mesh-list
101348895|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
101348896|NCT00276848|Fludarabine|fludarabine|mesh-list
101348897|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
101348898|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348899|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
101348900|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348901|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348902|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101348903|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
101348904|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348905|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348906|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101348907|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101348908|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
101348909|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
101348910|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348911|NCT00276809|Cytarabine|cytarabine|mesh-list
101348912|NCT00276809|Dexamethasone|dexamethasone|mesh-list
101348913|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
101348914|NCT00276809|Melphalan|melphalan|mesh-list
101348916|NCT00276809|Fludarabine|fludarabine|mesh-list
101348917|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
101348919|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
101348920|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101348921|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
101348922|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101348923|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101348924|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101348925|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
101348926|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348927|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348928|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101348929|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101348931|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
101348932|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101348961|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348963|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101348964|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101348965|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101332436|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101332437|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332438|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101332439|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332440|NCT00038233|Thalidomide|thalidomide|mesh-list
101348966|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348967|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348968|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
101348969|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
101348970|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
101348971|NCT00276692|Irinotecan|irinotecan|mesh-list
101348972|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101348973|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101348974|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101348975|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101348976|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101348977|NCT00276575|Bevacizumab|bevacizumab|mesh-list
101348978|NCT00276575|Everolimus|everolimus|mesh-list
101348998|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101348999|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
101349000|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349001|NCT00276497|Pioglitazone|pioglitazone|mesh-list
101349002|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101349003|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349005|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101349006|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349007|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101349008|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
101349009|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349010|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101349011|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349012|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349013|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
101349014|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101349015|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349016|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349017|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
101349018|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349019|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349020|NCT00276146|Dipyridamole|dipyridamole|mesh-list
101349021|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101349022|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349023|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349024|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101349025|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349026|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101349027|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
101349028|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349029|NCT04201665|Oxytocin|oxytocin|mesh-list
101349030|NCT04201665|Carbetocin|carbetocin|mesh-list
101349031|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
101349050|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349051|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101349052|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101349053|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349054|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349055|NCT00276029|Etanercept|etanercept|mesh-list
101349056|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349057|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349058|NCT00276029|Analgesics|analgesics|mesh-ancestor
101349059|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
101349060|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349061|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349062|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349063|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349064|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101349065|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349066|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
101349067|NCT00397059|Escitalopram|escitalopram|mesh-list
101332441|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332442|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
101332443|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332444|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
101349068|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101349069|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101349070|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349071|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349072|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349073|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
101349074|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349075|NCT00275951|Cetuximab|cetuximab|mesh-list
101349076|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349077|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349078|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
101349079|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
101349080|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101349081|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101349082|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349083|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349084|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101349096|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
101349097|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101349098|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349099|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349100|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101349101|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349102|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101349103|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101349104|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101349105|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349106|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349107|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349108|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349109|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
101349110|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101349111|NCT00275756|Timolol|timolol|mesh-list
101349112|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101349113|NCT00275756|Dorzolamide|dorzolamide|mesh-list
101349114|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101349115|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101349116|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349117|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349118|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349119|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349120|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101349121|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349122|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101349123|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349124|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349125|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101349126|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349128|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101349129|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349130|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101349131|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101349132|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349134|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
101349135|NCT03957057|Trace Elements|trace elements|mesh-ancestor
101349136|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
101349137|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349138|NCT03957057|Hematinics|hematinics|mesh-ancestor
101349139|NCT00275600|Vitamin E|vitamin e|mesh-list
101349140|NCT00275600|Vitamins|vitamins|mesh-ancestor
101349141|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
101349142|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332445|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332446|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332447|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101332448|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101332449|NCT00038233|Growth Substances|growth substances|mesh-ancestor
101332450|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
101349143|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
101349144|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349145|NCT00275600|Protective Agents|protective agents|mesh-ancestor
101349146|NCT00275522|Sirolimus|sirolimus|mesh-list
101349153|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
101349154|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349155|NCT00275444|Tipranavir|tipranavir|mesh-list
101349156|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101349157|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101349158|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
101349159|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349160|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
101349161|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
101349162|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349163|NCT00275405|Protective Agents|protective agents|mesh-ancestor
101349164|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349165|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101349166|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349167|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101349168|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349169|NCT00275249|Levorphanol|levorphanol|mesh-list
101349170|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101349171|NCT00275249|Narcotics|narcotics|mesh-ancestor
101349172|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349173|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349174|NCT00275249|Analgesics|analgesics|mesh-ancestor
101349175|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
101349176|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349177|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
101349178|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349179|NCT00041535|Miglustat|miglustat|mesh-list
101349180|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349181|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349182|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101349183|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101349184|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
101349185|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349186|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101349187|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101349188|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349189|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
101349190|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101349191|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
101349192|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349193|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349195|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
101349196|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101349197|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
101349198|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349199|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349200|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101349201|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349202|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
101349203|NCT00041574|Protective Agents|protective agents|mesh-ancestor
101349204|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101349205|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349206|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101349207|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349208|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349209|NCT00275093|Sirolimus|sirolimus|mesh-list
101349210|NCT00275093|Temsirolimus|temsirolimus|mesh-list
101349211|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
101332451|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332453|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
101332454|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
101332455|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332456|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101332457|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
101349212|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101349214|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349215|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349216|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
101349227|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
101349228|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
101349229|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349230|NCT03430596|Protective Agents|protective agents|mesh-ancestor
101349231|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349232|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101349233|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101349234|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
101349235|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
101349236|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349237|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101349238|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101349239|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
101349240|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
101349241|NCT00275054|Rituximab|rituximab|mesh-list
101349242|NCT00275054|Fludarabine|fludarabine|mesh-list
101349243|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349244|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
101349245|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349246|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349247|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349248|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
101349249|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349250|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349251|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101349252|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349253|NCT03208179|Azithromycin|azithromycin|mesh-list
101349254|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
101349255|NCT03208179|Piperaquine|piperaquine|mesh-list
101349256|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
101349257|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101349258|NCT03208179|Artenimol|artenimol|mesh-list
101349259|NCT03208179|Artemisinins|artemisinins|mesh-list
101349260|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349262|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
101349263|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101349264|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101349265|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101349266|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349267|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349268|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101349269|NCT00275015|Cytarabine|cytarabine|mesh-list
101349270|NCT00275015|Dexamethasone|dexamethasone|mesh-list
101349271|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
101349272|NCT00275015|Melphalan|melphalan|mesh-list
101349273|NCT00275015|Carmustine|carmustine|mesh-list
101349274|NCT00275015|Fludarabine|fludarabine|mesh-list
101349275|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
101349276|NCT00275015|Etoposide|etoposide|mesh-list
101349277|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349278|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
101349279|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349280|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349281|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349282|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
101349283|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349289|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349290|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101332458|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101332459|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101332460|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
101349291|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
101349292|NCT00275015|Hormones|hormones|mesh-ancestor
101349293|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101349294|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101349295|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349296|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
101349297|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101349298|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101349299|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101349300|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349301|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
101349302|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349303|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
101349304|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349305|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349306|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
101349307|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101349308|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349309|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349310|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101349311|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349312|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101349313|NCT03062826|Aspirin|aspirin|mesh-list
101349314|NCT03062826|Clopidogrel|clopidogrel|mesh-list
101349315|NCT03062826|Ticagrelor|ticagrelor|mesh-list
101349316|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349317|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349318|NCT03062826|Analgesics|analgesics|mesh-ancestor
101349319|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
101349320|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349321|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349322|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349323|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349324|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101349325|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101349327|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101349328|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101349329|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349330|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
101349331|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101349332|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101349333|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101349334|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
101349335|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349336|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
101349337|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349338|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349339|NCT00130364|Analgesics|analgesics|mesh-ancestor
101349340|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
101349341|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349342|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349343|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349344|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349345|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349346|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349347|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
101349348|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101349349|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349350|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349351|NCT00130325|Isoniazid|isoniazid|mesh-list
101349352|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
101349364|NCT00394394|Amiloride|amiloride|mesh-list
101349365|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101349366|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101349367|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332461|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332462|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332463|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101332464|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
101332465|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332466|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332467|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349368|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349369|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349370|NCT00394394|Diuretics|diuretics|mesh-ancestor
101349371|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
101349372|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349373|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101349374|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101349375|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349376|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101349377|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101349378|NCT00130091|Clonidine|clonidine|mesh-list
101349379|NCT00130091|Analgesics|analgesics|mesh-ancestor
101349380|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
101349381|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349382|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349383|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349384|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
101349385|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
101349386|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101349387|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349388|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349389|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349390|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349391|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349392|NCT00130013|Amoxicillin|amoxicillin|mesh-list
101349393|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349394|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349396|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101349397|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
101349398|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
101349399|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349400|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349401|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101349402|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101349403|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101349404|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349405|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349406|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101349407|NCT00129857|Protective Agents|protective agents|mesh-ancestor
101349408|NCT00129818|Famciclovir|famciclovir|mesh-list
101349409|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
101349410|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349411|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101349412|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349413|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349414|NCT00129506|Methotrexate|methotrexate|mesh-list
101349415|NCT00129506|Misoprostol|misoprostol|mesh-list
101349422|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349424|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349425|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349426|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101349427|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349428|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
101349429|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349430|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101349431|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101349432|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101349433|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
101349435|NCT00129233|Valsartan|valsartan|mesh-list
101332468|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332469|NCT00000941|Ritonavir|ritonavir|mesh-list
101332470|NCT00000941|Nelfinavir|nelfinavir|mesh-list
101332471|NCT00000941|Saquinavir|saquinavir|mesh-list
101332472|NCT00000941|Atorvastatin|atorvastatin|mesh-list
101349436|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349437|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101349438|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349439|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349440|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101349441|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349442|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349443|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101349444|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101349446|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349447|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
101349448|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349449|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349450|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
101349451|NCT00712881|Docetaxel|docetaxel|mesh-list
101349452|NCT00712881|Doxorubicin|doxorubicin|mesh-list
101349453|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101349454|NCT00712881|Trastuzumab|trastuzumab|mesh-list
101349455|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349456|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
101349457|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349458|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349459|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349460|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
101349461|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349462|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349463|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101349464|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349465|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101349466|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349467|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101349468|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101349469|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101349470|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349471|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349473|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349474|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
101349475|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349476|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349477|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349478|NCT00129038|Aspirin|aspirin|mesh-list
101349479|NCT00129038|Dipyridamole|dipyridamole|mesh-list
101349480|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101349481|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349482|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349500|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101349501|NCT00470223|Methotrexate|methotrexate|mesh-list
101349502|NCT00470223|Etoposide|etoposide|mesh-list
101349503|NCT00470223|Ifosfamide|ifosfamide|mesh-list
101349504|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349505|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101349506|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101349507|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101349508|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349509|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349510|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101349511|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
101349512|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101349513|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349514|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349515|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
101349516|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349517|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332474|NCT00000941|Pravastatin|pravastatin|mesh-list
101332475|NCT00000941|Calcium|calcium|mesh-list
101332476|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101332477|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332478|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101332479|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101332480|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
101349518|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349519|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
101349520|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349521|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101349522|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101349523|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349524|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
101349525|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101349526|NCT00103389|Docetaxel|docetaxel|mesh-list
101349527|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349528|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349529|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101349530|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349531|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349532|NCT00128921|Bortezomib|bortezomib|mesh-list
101349533|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349534|NCT00128804|Beta Carotene|beta carotene|mesh-list
101349535|NCT00128804|Carotenoids|carotenoids|mesh-list
101349536|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
101349537|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349538|NCT00128804|Protective Agents|protective agents|mesh-ancestor
101349539|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349545|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349547|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349548|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349549|NCT00038376|Interferons|interferons|mesh-list
101349550|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
101349551|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
101349552|NCT00038376|Isotretinoin|isotretinoin|mesh-list
101349553|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349554|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
101349555|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349556|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
101349557|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349558|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349559|NCT00128531|Leuprolide|leuprolide|mesh-list
101349560|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101349561|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
101349562|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101349563|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349564|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101349565|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349566|NCT00038454|Chrysarobin|chrysarobin|mesh-list
101349567|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349568|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349569|NCT00038454|Analgesics|analgesics|mesh-ancestor
101349570|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
101349571|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349572|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349573|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349574|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349575|NCT00128453|Colchicine|colchicine|mesh-list
101349576|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
101349577|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349578|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349579|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
101349580|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349581|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332481|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332482|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101332483|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101332484|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332485|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101332486|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101332487|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332488|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332489|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332490|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
101349582|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349583|NCT00128414|Colchicine|colchicine|mesh-list
101349584|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
101349585|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349586|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349587|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101349588|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349589|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349590|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349591|NCT00038493|Temozolomide|temozolomide|mesh-list
101349592|NCT00038493|Lonafarnib|lonafarnib|mesh-list
101349593|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349594|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
101349595|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349596|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349597|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349598|NCT00038532|Ritonavir|ritonavir|mesh-list
101349599|NCT00038532|Saquinavir|saquinavir|mesh-list
101349600|NCT00038532|Amprenavir|amprenavir|mesh-list
101349601|NCT00038532|Efavirenz|efavirenz|mesh-list
101349602|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101349603|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101349604|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
101349605|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349606|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349607|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101349608|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101349609|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
101349610|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349611|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101349612|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101349623|NCT00038571|Bortezomib|bortezomib|mesh-list
101349624|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349625|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
101349626|NCT05770687|Empagliflozin|empagliflozin|mesh-list
101349627|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101349628|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
101349629|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
101349630|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349631|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101349632|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349633|NCT05770323|Uric Acid|uric acid|mesh-list
101349634|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
101349635|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349636|NCT05770323|Protective Agents|protective agents|mesh-ancestor
101349637|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349638|NCT05769855|Ropivacaine|ropivacaine|mesh-list
101349639|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
101349640|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
101349641|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349642|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349643|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
101349644|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332491|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332492|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101332493|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332495|NCT00014937|Lopinavir|lopinavir|mesh-list
101332496|NCT00014937|Lamivudine|lamivudine|mesh-list
101349645|NCT05769738|Furosemide|furosemide|mesh-list
101349646|NCT05769738|Diuretics|diuretics|mesh-list
101349647|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
101349648|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349649|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101349650|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101349651|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349652|NCT05769725|Docetaxel|docetaxel|mesh-list
101349653|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349654|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
101349655|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
101349656|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
101349657|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349658|NCT05769660|Temozolomide|temozolomide|mesh-list
101349659|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101349660|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
101349661|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349662|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349663|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101349664|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
101349665|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349667|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
101349668|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349669|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
101349670|NCT05768997|Hematinics|hematinics|mesh-ancestor
101349671|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101349672|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
101349673|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349674|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349675|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101349681|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101349682|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349683|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349684|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101349685|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
101349686|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101349687|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349688|NCT05765305|Trace Elements|trace elements|mesh-ancestor
101349689|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
101349690|NCT05762146|Perphenazine|perphenazine|mesh-list
101349691|NCT05762146|Riociguat|riociguat|mesh-list
101349692|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
101349693|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
101349694|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349695|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101349696|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101349697|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349698|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349699|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101349700|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101349701|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
101349702|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349703|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
101349704|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
101349705|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
101349706|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101349707|NCT05760612|Trastuzumab|trastuzumab|mesh-list
101349708|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101349709|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349710|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101349711|NCT05760144|Etonogestrel|etonogestrel|mesh-list
101349712|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101332497|NCT00014937|Zidovudine|zidovudine|mesh-list
101332498|NCT00014937|Didanosine|didanosine|mesh-list
101332499|NCT00014937|Stavudine|stavudine|mesh-list
101332500|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101332501|NCT00014937|Efavirenz|efavirenz|mesh-list
101349713|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
101349714|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101349715|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349716|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101349717|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101349718|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101349719|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349720|NCT05744674|Ropivacaine|ropivacaine|mesh-list
101349721|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
101349722|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
101349723|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349724|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349725|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
101349726|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349727|NCT05736978|Azacitidine|azacitidine|mesh-list
101349728|NCT05736978|Venetoclax|venetoclax|mesh-list
101349729|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349730|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
101349731|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349732|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349733|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349734|NCT05736965|Azacitidine|azacitidine|mesh-list
101349735|NCT05736965|Venetoclax|venetoclax|mesh-list
101349736|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101349738|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349739|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349740|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416821|NCT00140166|Vitamins|vitamins|mesh-ancestor
101349741|NCT05706727|Phenylephrine|phenylephrine|mesh-list
101349742|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
101349743|NCT05706727|Mephentermine|mephentermine|mesh-list
101349744|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101349745|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
101349746|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
101349747|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349749|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
101349750|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101349751|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
101349752|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101349753|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101349754|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349755|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349756|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349757|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349758|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349759|NCT05706727|Protective Agents|protective agents|mesh-ancestor
101349762|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101349763|NCT05697783|Narcotics|narcotics|mesh-ancestor
101349764|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349765|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349766|NCT05697783|Analgesics|analgesics|mesh-ancestor
101349767|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
101349768|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349769|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101349770|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101349771|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
101349772|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
101349773|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
101349774|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
101349775|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
101349776|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101349777|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349778|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349779|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349780|NCT05672225|Analgesics|analgesics|mesh-ancestor
101349781|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
101332502|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101332503|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101332504|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332505|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332506|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332507|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332508|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101349782|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349783|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101349784|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349785|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349786|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349787|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349788|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349789|NCT05663580|Rilpivirine|rilpivirine|mesh-list
101349790|NCT05663580|Cabotegravir|cabotegravir|mesh-list
101349791|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101349792|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101349793|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349794|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349795|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
101349796|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349797|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101349798|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101349799|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101349800|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101349801|NCT05657860|Guanfacine|guanfacine|mesh-list
101349802|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349803|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101349804|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101349805|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349806|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349807|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349808|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349809|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349810|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
101349811|NCT05619627|Anesthetics|anesthetics|mesh-list
101349812|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
101349813|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101349814|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349815|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349816|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349817|NCT05619627|Analgesics|analgesics|mesh-ancestor
101349818|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
101349819|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349822|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101349823|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101349824|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101349825|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349839|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101349840|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349841|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349842|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101349843|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332509|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
101332510|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332511|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101332512|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332513|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101349844|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349845|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349846|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101349847|NCT05595603|Protective Agents|protective agents|mesh-ancestor
101349848|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349849|NCT05568940|Tibolone|tibolone|mesh-list
101349850|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
101349851|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
101349852|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101349853|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349854|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349855|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101349856|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349857|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101349858|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
101349859|NCT05568940|Hormones|hormones|mesh-ancestor
101349860|NCT05562973|Psilocybin|psilocybin|mesh-list
101349861|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
101349862|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349863|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101349864|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
101349865|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349866|NCT05543785|Ketorolac|ketorolac|mesh-list
101349867|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349868|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349869|NCT05543785|Analgesics|analgesics|mesh-ancestor
101349870|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
101349871|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349872|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349874|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349875|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101349876|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349877|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349878|NCT05457465|Cannabidiol|cannabidiol|mesh-list
101349879|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
101349880|NCT05453955|Propofol|propofol|mesh-list
101349881|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101349882|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101349883|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349884|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101349885|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
101349888|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101349889|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101349890|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349891|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
101349892|NCT05427786|Vitamins|vitamins|mesh-ancestor
101349893|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
101349896|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
101349897|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
101349898|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349899|NCT05402553|Ondansetron|ondansetron|mesh-list
101349900|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
101349901|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
101349902|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349903|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349904|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101349905|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
101349906|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
101349907|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101349908|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101349909|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
101349910|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332514|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332515|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
101332516|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101332517|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101332518|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101332519|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101349911|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349912|NCT05379322|Adalimumab|adalimumab|mesh-list
101349913|NCT05379322|Golimumab|golimumab|mesh-list
101349914|NCT05379322|Etanercept|etanercept|mesh-list
101349915|NCT05379322|Upadacitinib|upadacitinib|mesh-list
101349916|NCT05379322|Tofacitinib|tofacitinib|mesh-list
101349917|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101349918|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101349919|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101349920|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101349921|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101349922|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101349923|NCT05379322|Analgesics|analgesics|mesh-ancestor
101349924|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
101349925|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349926|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349927|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101349928|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101349929|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
101349930|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101349931|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349932|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349933|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101349934|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101349935|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349936|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
101349937|NCT05298696|Cilostazol|cilostazol|mesh-list
101349938|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101349939|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
101349940|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101349941|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349942|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101349943|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
101349944|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101349945|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101349946|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349947|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101349948|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349949|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101349950|NCT05298696|Protective Agents|protective agents|mesh-ancestor
101349951|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101349952|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101349954|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
101349955|NCT05287425|Gentamicins|gentamicins|mesh-list
101349956|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101349957|NCT05287425|Povidone|povidone|mesh-list
101349958|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101349959|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101349960|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101349961|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101349962|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349963|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349981|NCT05258721|Protective Agents|protective agents|mesh-ancestor
101349982|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349984|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
101349986|NCT05215730|Trace Elements|trace elements|mesh-ancestor
101349987|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
101332520|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101332522|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
101332523|NCT00000959|Isoniazid|isoniazid|mesh-list
101332524|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
101332525|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332526|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332527|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101349988|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349989|NCT05209074|Ivosidenib|ivosidenib|mesh-list
101349990|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101349991|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101349992|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101349993|NCT05192850|Metformin|metformin|mesh-list
101349994|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101349995|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101349996|NCT05111717|Desflurane|desflurane|mesh-list
101349997|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101349998|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
101349999|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
101350000|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350001|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350002|NCT05105919|Aspirin|aspirin|mesh-list
101350003|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350004|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350005|NCT05105919|Analgesics|analgesics|mesh-ancestor
101350006|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
101350007|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350008|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350009|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350010|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350011|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101350012|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101350013|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350014|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101350015|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101350016|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350018|NCT05054439|Paclitaxel|paclitaxel|mesh-list
101350019|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350020|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350021|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350022|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350023|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350024|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350025|NCT05049603|Atorvastatin|atorvastatin|mesh-list
101350026|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101350027|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101350028|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
101350029|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350043|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350045|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101350046|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101350047|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350048|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350049|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350050|NCT05020457|Paclitaxel|paclitaxel|mesh-list
101350051|NCT05020457|Docetaxel|docetaxel|mesh-list
101350052|NCT05020457|Cisplatin|cisplatin|mesh-list
101350053|NCT05020457|Pemetrexed|pemetrexed|mesh-list
101350054|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350055|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350056|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350057|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350058|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350059|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350060|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350061|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332528|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101332529|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
101332530|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332531|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101332532|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
101350062|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350063|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
101350064|NCT05020444|Fludarabine|fludarabine|mesh-list
101350065|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350066|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
101350067|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350068|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350069|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350070|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
101350071|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350072|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350073|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350074|NCT05012189|Oseltamivir|oseltamivir|mesh-list
101350075|NCT05012189|Baloxavir|baloxavir|mesh-list
101350076|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
101350077|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350078|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350079|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350080|NCT04985721|Tislelizumab|tislelizumab|mesh-list
101350081|NCT04985721|Pamiparib|pamiparib|mesh-list
101350082|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350083|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350084|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101350085|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350086|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350087|NCT04952610|Etripamil|etripamil|mesh-list
101350088|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101350089|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101350101|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350103|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350104|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101350105|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101350106|NCT04859296|Dronabinol|dronabinol|mesh-list
101350107|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
101350108|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350109|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101350110|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350111|NCT04859296|Analgesics|analgesics|mesh-ancestor
101350112|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
101350113|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350114|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101350115|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101350116|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350117|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350119|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350120|NCT04857684|Bevacizumab|bevacizumab|mesh-list
101350121|NCT04857684|Atezolizumab|atezolizumab|mesh-list
101350122|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350123|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350124|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101350125|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101350126|NCT04857684|Growth Substances|growth substances|mesh-ancestor
101350127|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350128|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
101350129|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350130|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350131|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
101350132|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101350133|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350134|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350135|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
101350136|NCT04846348|Promethazine|promethazine|mesh-list
101332533|NCT00000959|Vitamins|vitamins|mesh-ancestor
101332534|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
101332535|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332536|NCT00000962|Nevirapine|nevirapine|mesh-list
101332537|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332538|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350137|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
101350138|NCT04846348|Salicylates|salicylates|mesh-list
101350139|NCT04846348|Emollients|emollients|mesh-list
101350140|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101350141|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101350142|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350143|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350144|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
101350145|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
101350146|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
101350147|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350148|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
101350149|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
101350150|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350164|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101350165|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350166|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101350167|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
101350168|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101350169|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
101350170|NCT04771520|Piperazine|piperazine|mesh-list
101350171|NCT04771520|Mebendazole|mebendazole|mesh-list
101350172|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
101350173|NCT04771520|DMP 777|dmp 777|mesh-list
101350174|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
101350175|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
101350176|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101350177|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350178|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350179|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350180|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350181|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350182|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350183|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350184|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
101350185|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101350186|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
101350187|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350188|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
101350189|NCT04769453|Protective Agents|protective agents|mesh-ancestor
101350190|NCT04765709|Carboplatin|carboplatin|mesh-list
101350191|NCT04765709|Pemetrexed|pemetrexed|mesh-list
101350192|NCT04765709|Durvalumab|durvalumab|mesh-list
101350193|NCT04765709|Vinorelbine|vinorelbine|mesh-list
101350194|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101350195|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350196|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350197|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350198|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101350199|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350200|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350201|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
101350202|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350203|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350205|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350206|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350207|NCT04742699|Lemborexant|lemborexant|mesh-list
101350208|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101350209|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350210|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350211|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101350212|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101332540|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332541|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
101332542|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332543|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332544|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332545|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101350224|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350225|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350226|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350227|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350229|NCT04654689|Protective Agents|protective agents|mesh-ancestor
101350230|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101350232|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101350233|NCT04634838|Trace Elements|trace elements|mesh-ancestor
101350234|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
101350235|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350236|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350237|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
101350238|NCT04629534|Vitamin D|vitamin d|mesh-list
101350239|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101350240|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350241|NCT04629534|Vitamins|vitamins|mesh-ancestor
101350242|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
101350243|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101350252|NCT04602065|Antibodies|antibodies|mesh-list
101350253|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101350254|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
101350255|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350256|NCT04598815|Sirolimus|sirolimus|mesh-list
101350257|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101350258|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350259|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101350260|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350261|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
101350262|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350264|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350265|NCT04584112|Paclitaxel|paclitaxel|mesh-list
101350266|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101350267|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
101350268|NCT04584112|Carboplatin|carboplatin|mesh-list
101350269|NCT04584112|Doxorubicin|doxorubicin|mesh-list
101350270|NCT04584112|Atezolizumab|atezolizumab|mesh-list
101350271|NCT04584112|Molgramostim|molgramostim|mesh-list
101350272|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101350273|NCT04584112|Lenograstim|lenograstim|mesh-list
101350274|NCT04584112|Sargramostim|sargramostim|mesh-list
101350275|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350276|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350277|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350278|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350279|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350280|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350281|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350282|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
101350283|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350284|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350285|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350286|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
101350287|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350292|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350293|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350295|NCT04573777|Evolocumab|evolocumab|mesh-list
101350296|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101350297|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101350298|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101350299|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
101332546|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101332547|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
101332548|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332549|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
101332550|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332551|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332552|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101332553|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
101350300|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350301|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101350302|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
101350303|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350304|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101350305|NCT04507711|Palonosetron|palonosetron|mesh-list
101350306|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
101350307|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
101350308|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350309|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350310|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350311|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101350312|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101350313|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
101350314|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350315|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350316|NCT04499274|Ondansetron|ondansetron|mesh-list
101350317|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
101350318|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
101350319|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350328|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350330|NCT04488159|Fluorouracil|fluorouracil|mesh-list
101350331|NCT04488159|Capecitabine|capecitabine|mesh-list
101350332|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
101350333|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
101350334|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350335|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350336|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350337|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350338|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
101350339|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350340|NCT04488159|Antidotes|antidotes|mesh-ancestor
101350341|NCT04488159|Protective Agents|protective agents|mesh-ancestor
101350342|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
101350343|NCT04488159|Vitamins|vitamins|mesh-ancestor
101350344|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
101350354|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101350355|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
101350356|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350357|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
101332554|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332555|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332556|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350359|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
101350373|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350374|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
101350375|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350376|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101350377|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101350378|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
101350379|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350380|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350381|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101350382|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101350383|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101350384|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101350385|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
101350386|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101350387|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101350388|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350389|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
101350390|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350391|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101350392|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
101350393|NCT04300127|Pioglitazone|pioglitazone|mesh-list
101350394|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101350395|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350396|NCT04296305|Hydromorphone|hydromorphone|mesh-list
101350397|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101350398|NCT04296305|Narcotics|narcotics|mesh-ancestor
101350399|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350400|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350401|NCT04296305|Analgesics|analgesics|mesh-ancestor
101350402|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
101350403|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350404|NCT04266236|Ropivacaine|ropivacaine|mesh-list
101350405|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
101350406|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350407|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350408|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
101350409|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
101350410|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350411|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
101350412|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350413|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101350414|NCT04256343|Protective Agents|protective agents|mesh-ancestor
101350415|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350417|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
101350418|NCT04243629|Pancrelipase|pancrelipase|mesh-list
101350419|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101350420|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350421|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350422|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
101350423|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
101350424|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101350439|NCT04199026|Vincristine|vincristine|mesh-list
101350440|NCT04199026|Everolimus|everolimus|mesh-list
101350441|NCT04199026|Temozolomide|temozolomide|mesh-list
101350442|NCT04199026|Temsirolimus|temsirolimus|mesh-list
101350443|NCT04199026|Ifosfamide|ifosfamide|mesh-list
101350444|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
101350445|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
101350446|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101350447|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101350448|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350449|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101350450|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101350451|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350452|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350453|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101350454|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350455|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332558|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101332559|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101332560|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332561|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332562|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332563|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332564|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
101332565|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350456|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350457|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350458|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101350459|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350460|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
101350461|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350462|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350463|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
101350464|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101350465|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350466|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
101350467|NCT04182997|Dexamethasone|dexamethasone|mesh-list
101350468|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350469|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
101350470|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
101350471|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350472|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350473|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350474|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
101350475|NCT04182997|Hormones|hormones|mesh-ancestor
101350476|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350477|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101350478|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350479|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
101350480|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350481|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350482|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350483|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350484|NCT04167163|Abaloparatide|abaloparatide|mesh-list
101350485|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101350486|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350495|NCT04115111|Durvalumab|durvalumab|mesh-list
101350496|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350497|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350498|NCT04113109|Icatibant|icatibant|mesh-list
101350499|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101350500|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101350501|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350502|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350503|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350504|NCT04113109|Analgesics|analgesics|mesh-ancestor
101350505|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
101350506|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350507|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350508|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350509|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350510|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101350511|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101350512|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101350514|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
101350515|NCT04107038|Anesthetics|anesthetics|mesh-list
101350516|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350517|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332566|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
101332567|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332568|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332569|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332570|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101350518|NCT04042233|Vancomycin|vancomycin|mesh-list
101350519|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101350520|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350521|NCT03982693|Edetic Acid|edetic acid|mesh-list
101350522|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
101350523|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
101350524|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101350525|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
101350526|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
101350527|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350528|NCT03982693|Antidotes|antidotes|mesh-ancestor
101350529|NCT03982693|Protective Agents|protective agents|mesh-ancestor
101350530|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350531|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101350532|NCT03965195|Vaccines|vaccines|mesh-list
101350533|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
101350534|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350535|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
101350536|NCT03942653|Goserelin|goserelin|mesh-list
101350537|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350538|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350539|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350540|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350541|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101350542|NCT03928314|Paclitaxel|paclitaxel|mesh-list
101350543|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350544|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350545|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350546|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350547|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350548|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350549|NCT03878082|Acetaminophen|acetaminophen|mesh-list
101350550|NCT03878082|Propacetamol|propacetamol|mesh-list
101350551|NCT03878082|Analgesics|analgesics|mesh-ancestor
101350552|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
101350553|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350559|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
101350560|NCT03862859|Warfarin|warfarin|mesh-list
101350561|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
101350562|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
101350563|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101350564|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350565|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350566|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350567|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350568|NCT03814941|Anesthetics|anesthetics|mesh-list
101350569|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350570|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350572|NCT03759938|Apixaban|apixaban|mesh-list
101350573|NCT03759938|Edoxaban|edoxaban|mesh-list
101350574|NCT03759938|Dabigatran|dabigatran|mesh-list
101350575|NCT03759938|Anticoagulants|anticoagulants|mesh-list
101350576|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101350577|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
101350578|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101350579|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
101350580|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350581|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350582|NCT03737240|Insulin|insulin|mesh-list
101350583|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101350584|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
101350585|NCT03737240|Liraglutide|liraglutide|mesh-list
101350586|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
101350587|NCT03737240|Xultophy|xultophy|mesh-list
101350588|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101350589|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350590|NCT03737240|Incretins|incretins|mesh-ancestor
101350591|NCT03737240|Hormones|hormones|mesh-ancestor
101332573|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101332574|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332575|NCT00000965|Zidovudine|zidovudine|mesh-list
101332576|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
101332577|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332578|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101350592|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350593|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
101350594|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350595|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350596|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350597|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350599|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350600|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101350601|NCT03596164|Protective Agents|protective agents|mesh-ancestor
101350602|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350612|NCT03525873|Methylphenidate|methylphenidate|mesh-list
101350613|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101350614|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350615|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101350616|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101350617|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101350618|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350619|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
101350620|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350621|NCT03492125|Rituximab|rituximab|mesh-list
101350622|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
101350623|NCT03492125|Venetoclax|venetoclax|mesh-list
101350624|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
101350632|NCT03427463|Narcotics|narcotics|mesh-ancestor
101350633|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350634|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350635|NCT03427463|Analgesics|analgesics|mesh-ancestor
101350636|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
101350637|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350638|NCT03356873|Vitamin D|vitamin d|mesh-list
101350639|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
101350640|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
101350641|NCT03356873|Vitamins|vitamins|mesh-list
101350642|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
101350643|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350644|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101350645|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101350646|NCT03308578|Atorvastatin|atorvastatin|mesh-list
101350647|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101350649|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
101350650|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350651|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101350652|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101350653|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350654|NCT03305341|Molgramostim|molgramostim|mesh-list
101332579|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332580|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332581|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
101332582|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332583|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101350655|NCT03305341|Sargramostim|sargramostim|mesh-list
101350656|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
101350657|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350658|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350659|NCT03255473|Dexamethasone|dexamethasone|mesh-list
101350660|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
101350662|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101350664|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350665|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
101350666|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
101350667|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350668|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350669|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350670|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
101350671|NCT03255473|Hormones|hormones|mesh-ancestor
101350672|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350673|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101350674|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350675|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101350676|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350677|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350678|NCT03176277|Venetoclax|venetoclax|mesh-list
101350679|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350680|NCT03173560|Everolimus|everolimus|mesh-list
101350681|NCT03173560|Lenvatinib|lenvatinib|mesh-list
101350682|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101350683|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101350684|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350685|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350686|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101350687|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
101350688|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350689|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350690|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
101350691|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101350692|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101350693|NCT03098225|Prednisolone|prednisolone|mesh-list
101350694|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
101350720|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350721|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350722|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350723|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350724|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
101350725|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350726|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350727|NCT03017131|Analgesics|analgesics|mesh-ancestor
101350728|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
101350729|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350730|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101350731|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101350732|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
101350733|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350735|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350736|NCT02940301|Nivolumab|nivolumab|mesh-list
101350737|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350738|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350739|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350740|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350742|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
101350743|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350744|NCT02855944|Paclitaxel|paclitaxel|mesh-list
101350748|NCT02855944|Gemcitabine|gemcitabine|mesh-list
101350749|NCT02855944|Rucaparib|rucaparib|mesh-list
101456546|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
101332584|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332585|NCT00015054|Methylphenidate|methylphenidate|mesh-list
101332586|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101332587|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332588|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101332589|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101350750|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101350751|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350752|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350753|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350754|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350755|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350756|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350757|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
101350758|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101350759|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350760|NCT02603848|Ibuprofen|ibuprofen|mesh-list
101350761|NCT02603848|Morphine|morphine|mesh-list
101350762|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101350763|NCT02603848|Narcotics|narcotics|mesh-ancestor
101350764|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350765|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350766|NCT02603848|Analgesics|analgesics|mesh-ancestor
101350767|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
101350768|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350769|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101350770|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350771|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101350772|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350773|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101350774|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350775|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350776|NCT02512887|Anesthetics|anesthetics|mesh-list
101350777|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350778|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350779|NCT02484261|Bortezomib|bortezomib|mesh-list
101350780|NCT02484261|Pravastatin|pravastatin|mesh-list
101350781|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350782|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101350783|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101350784|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
101350785|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350786|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101350787|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101350788|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350789|NCT02471430|Interferons|interferons|mesh-list
101350790|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
101350791|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
101350792|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101350793|NCT02471430|Panobinostat|panobinostat|mesh-list
101350794|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350795|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
101350796|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350797|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
101350799|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101350800|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350801|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350803|NCT02451943|Olaratumab|olaratumab|mesh-list
101350804|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101350805|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350806|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101350807|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101350808|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350809|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350810|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
101350811|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332591|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332592|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
101332593|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332595|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
101332596|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101350812|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350813|NCT02409342|Carboplatin|carboplatin|mesh-list
101350814|NCT02409342|Gemcitabine|gemcitabine|mesh-list
101350815|NCT02409342|Pemetrexed|pemetrexed|mesh-list
101350816|NCT02409342|Atezolizumab|atezolizumab|mesh-list
101350817|NCT02409342|Antibodies|antibodies|mesh-list
101350818|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101350819|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
101350821|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350822|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350823|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
101350824|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350825|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350826|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101350827|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101350828|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350829|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350830|NCT02399085|Lenalidomide|lenalidomide|mesh-list
101350831|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
101350832|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350833|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101350834|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101350844|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101350845|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350855|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101350856|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101350857|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350858|NCT01969227|Ketamine|ketamine|mesh-list
101350859|NCT01969227|Analgesics|analgesics|mesh-ancestor
101350860|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
101350861|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350862|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350863|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101350864|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101350865|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
101350866|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
101350867|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350868|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101350869|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101350870|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332597|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101332598|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101332599|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332600|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350871|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350873|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101350874|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350875|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350876|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
101350877|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350878|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350879|NCT01604135|Riboflavin|riboflavin|mesh-list
101350880|NCT01604135|Dextrans|dextrans|mesh-list
101350881|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
101350882|NCT01604135|Vitamins|vitamins|mesh-ancestor
101350883|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
101350884|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350885|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101350886|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
101350887|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
101350888|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
101350889|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
101350890|NCT00644189|Clofarabine|clofarabine|mesh-list
101350891|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350892|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
101350900|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
101350901|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350902|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101350903|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101350904|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
101350905|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350906|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350907|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101350908|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
101350909|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
101350910|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
101350911|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
101350912|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350913|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101350914|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101350915|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101350916|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350917|NCT00465517|Ganaxolone|ganaxolone|mesh-list
101350918|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
101350919|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350920|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350921|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350922|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
101350923|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
101350924|NCT00289952|Valproic Acid|valproic acid|mesh-list
101350925|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
101350926|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350927|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350928|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
101350929|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350930|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350931|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
101350932|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101350933|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350934|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101350935|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
101350936|NCT05772832|Remifentanil|remifentanil|mesh-list
101350937|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101350938|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101350939|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350940|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101350941|NCT05772832|Analgesics|analgesics|mesh-ancestor
101350942|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
101332601|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332602|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
101332603|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332604|NCT00000971|Zidovudine|zidovudine|mesh-list
101332605|NCT00000971|Didanosine|didanosine|mesh-list
101332607|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
101332608|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332609|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332610|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332611|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332612|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
101332613|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332614|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332615|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332616|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332617|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101332618|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101332619|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332620|NCT00015171|Buprenorphine|buprenorphine|mesh-list
101332621|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101332622|NCT00015171|Naloxone|naloxone|mesh-list
101332623|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101332624|NCT00015171|Narcotics|narcotics|mesh-ancestor
101350943|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350944|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101350945|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101350946|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101350947|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
101350948|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350949|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350950|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101350951|NCT05772832|Narcotics|narcotics|mesh-ancestor
101350952|NCT05772728|Azacitidine|azacitidine|mesh-list
101350953|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
101350954|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101350955|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
101350956|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350957|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350958|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350959|NCT05772728|Analgesics|analgesics|mesh-ancestor
101350960|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
101350967|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
101350968|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101350969|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350970|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101350971|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101350972|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101350973|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332625|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332628|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
101332629|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332630|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101350974|NCT05772624|Nivolumab|nivolumab|mesh-list
101350975|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350976|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350977|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101350978|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350979|NCT05772546|Maleic acid|maleic acid|mesh-list
101350980|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101350981|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101350982|NCT05772377|Carboplatin|carboplatin|mesh-list
101350983|NCT05772377|Cisplatin|cisplatin|mesh-list
101350984|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350985|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
101350986|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101350987|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101350988|NCT05772039|Listerine|listerine|mesh-list
101350989|NCT05772039|Fluorides|fluorides|mesh-list
101350990|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
101350991|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
101350992|NCT05772039|Protective Agents|protective agents|mesh-ancestor
101350993|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101350994|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101350995|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350996|NCT05772013|Azithromycin|azithromycin|mesh-list
101350997|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101350998|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101350999|NCT05771675|Simvastatin|simvastatin|mesh-list
101351000|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101351001|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101351002|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
101351003|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351004|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101351005|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101351006|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351007|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
101351008|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101351009|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101351010|NCT05771181|Vitamin E|vitamin e|mesh-list
101351011|NCT05771181|Tislelizumab|tislelizumab|mesh-list
101351012|NCT05771181|Vitamins|vitamins|mesh-ancestor
101351013|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
101351014|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351015|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351016|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351017|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
101351018|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351019|NCT05771181|Protective Agents|protective agents|mesh-ancestor
101351020|NCT05771038|Alendronate|alendronate|mesh-list
101351021|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101351023|NCT05771012|Cyclosporine|cyclosporine|mesh-list
101351024|NCT05771012|Cyclosporins|cyclosporins|mesh-list
101351025|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351026|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351027|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351028|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
101351029|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351030|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
101351045|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351047|NCT05769946|Hemay005|hemay005|mesh-list
101351048|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351049|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101351050|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101332631|NCT00015210|Nefazodone|nefazodone|mesh-list
101332632|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101332633|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101332634|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101332635|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332636|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332637|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332638|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101332639|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
101332640|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101332641|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101332642|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101332643|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
101332646|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
101332647|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351052|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351053|NCT05768282|Prednisolone|prednisolone|mesh-list
101351054|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351055|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
101351056|NCT05768282|Hormones|hormones|mesh-ancestor
101351057|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351058|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351059|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351060|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351061|NCT05766800|Paclitaxel|paclitaxel|mesh-list
101351062|NCT05766800|Carboplatin|carboplatin|mesh-list
101351063|NCT05766800|Pemetrexed|pemetrexed|mesh-list
101351064|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101351065|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351066|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351067|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351068|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351069|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351070|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351071|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101351072|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101351073|NCT05766410|Letrozole|letrozole|mesh-list
101351074|NCT05766410|Palbociclib|palbociclib|mesh-list
101351075|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351076|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101351077|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101351078|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351079|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351080|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101351081|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351082|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351083|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351084|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101351085|NCT05757011|Bupivacaine|bupivacaine|mesh-list
101351086|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
101351087|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
101351088|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351089|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332648|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332649|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332650|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332651|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
101332652|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332653|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332654|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332655|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332656|NCT00015249|Amantadine|amantadine|mesh-list
101351090|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
101351091|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351096|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351097|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351099|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101351100|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101351101|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351102|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351103|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101351104|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101351105|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351106|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351107|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
101351108|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
101351109|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351110|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101351111|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101351112|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101351113|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
101351114|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
101351116|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101351117|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351118|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101351119|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351120|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351121|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101351122|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101351123|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
101351124|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351125|NCT05702463|Aspirin|aspirin|mesh-list
101351126|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101351127|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101351128|NCT05702463|Analgesics|analgesics|mesh-ancestor
101351129|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
101351130|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351131|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351132|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351133|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351134|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101351135|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101351136|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351137|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101351138|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101351139|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351140|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
101351141|NCT05680584|Melatonin|melatonin|mesh-list
101351142|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
101351143|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
101351144|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351145|NCT05680584|Protective Agents|protective agents|mesh-ancestor
101351146|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351147|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351148|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
101351149|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351150|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101351151|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
101332657|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101332658|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101332659|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
101332660|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332661|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
101332662|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351152|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
101351153|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351154|NCT05646992|Azathioprine|azathioprine|mesh-list
101351155|NCT05646992|Tacrolimus|tacrolimus|mesh-list
101351156|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351157|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
101351158|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351160|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351161|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351162|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
101351168|NCT05637606|Ephedrine|ephedrine|mesh-list
101351169|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
101351170|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101351171|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101351172|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
101351173|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351174|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351175|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351176|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
101351177|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
101351178|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351179|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101351180|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101351181|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101351182|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101351183|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351184|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
101351185|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101351186|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101351187|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101351188|NCT05637606|Protective Agents|protective agents|mesh-ancestor
101351189|NCT05549206|Vaccines|vaccines|mesh-list
101351190|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
101351191|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351192|NCT05533684|Gabapentin|gabapentin|mesh-list
101351194|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
101351195|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351196|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351197|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
101351198|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101351199|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101351200|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351201|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351202|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101351203|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101351204|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351205|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351206|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
101351207|NCT05458479|Fluoxetine|fluoxetine|mesh-list
101351208|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101351209|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101351210|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351211|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351212|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351213|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
101351214|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351215|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101332663|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332664|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332665|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101332666|NCT00015249|Analgesics|analgesics|mesh-ancestor
101332667|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
101332668|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332669|NCT05195242|Dexamethasone|dexamethasone|mesh-list
101332670|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332671|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
101351216|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
101351217|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351218|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101351219|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101351220|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351222|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101351223|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351224|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351225|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
101351226|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351227|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
101351228|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101351229|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
101351230|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351231|NCT05408247|Expectorants|expectorants|mesh-ancestor
101351249|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
101351250|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351251|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351252|NCT05153317|Ivacaftor|ivacaftor|mesh-list
101351253|NCT05153317|Elexacaftor|elexacaftor|mesh-list
101351254|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101351255|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351256|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351257|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101351258|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351259|NCT05112848|Vaccines|vaccines|mesh-list
101351260|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
101351261|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351262|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101351263|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
101351264|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101351265|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
101351266|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101351267|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351268|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101351269|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351270|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351271|NCT05010122|Decitabine|decitabine|mesh-list
101351272|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101351273|NCT05010122|Venetoclax|venetoclax|mesh-list
101351274|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351275|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
101351276|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351277|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351278|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351279|NCT04916418|Ropivacaine|ropivacaine|mesh-list
101351280|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
101351281|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
101351282|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351283|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351284|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
101351285|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351286|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101351287|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101351288|NCT04893096|Felzartamab|felzartamab|mesh-list
101332672|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
101332673|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332674|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332675|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101332676|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
101332677|NCT05195242|Hormones|hormones|mesh-ancestor
101332678|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332679|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351289|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351290|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
101351293|NCT04892511|Labetalol|labetalol|mesh-list
101351294|NCT04892511|Urapidil|urapidil|mesh-list
101351295|NCT04892511|Phenylephrine|phenylephrine|mesh-list
101351296|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101351297|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
101351298|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
101351299|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351300|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351301|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
101351302|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101351303|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
101351304|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351305|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101351306|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101351307|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101351308|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
101351309|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351310|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351311|NCT04892511|Protective Agents|protective agents|mesh-ancestor
101351312|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101351313|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101351314|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101351315|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101351316|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101351317|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101351318|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101351319|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101351320|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
101351321|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101351322|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351323|NCT04855695|Venetoclax|venetoclax|mesh-list
101351324|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
101351325|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
101351326|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351327|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351328|NCT04785118|Scopolamine|scopolamine|mesh-list
101351329|NCT04785118|Ondansetron|ondansetron|mesh-list
101351330|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101351331|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
101351332|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
101351333|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351334|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351335|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101351336|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
101351337|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351338|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101351339|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101351340|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
101351341|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351342|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351343|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101351344|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
101351345|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101351346|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
101351347|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101332680|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332681|NCT00015288|Buprenorphine|buprenorphine|mesh-list
101332682|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101332683|NCT00015288|Naloxone|naloxone|mesh-list
101351348|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
101351349|NCT04752163|Leucovorin|leucovorin|mesh-list
101351350|NCT04752163|Cytarabine|cytarabine|mesh-list
101351351|NCT04752163|Voriconazole|voriconazole|mesh-list
101351352|NCT04752163|Posaconazole|posaconazole|mesh-list
101351353|NCT04752163|Dexamethasone|dexamethasone|mesh-list
101351354|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
101351356|NCT04752163|Cortisone|cortisone|mesh-list
101351357|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
101351358|NCT04752163|Rituximab|rituximab|mesh-list
101351359|NCT04752163|Methotrexate|methotrexate|mesh-list
101351360|NCT04752163|Vincristine|vincristine|mesh-list
101351363|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101351364|NCT04752163|Antibodies|antibodies|mesh-list
101351365|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
101351366|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101351367|NCT04752163|Lenograstim|lenograstim|mesh-list
101351368|NCT04752163|BB 1101|bb 1101|mesh-list
101351387|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351388|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
101351389|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351390|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101351391|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
101351392|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101351393|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351394|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
101351395|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351396|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101351397|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101351398|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
101351399|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351401|NCT04752163|Protective Agents|protective agents|mesh-ancestor
101351402|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
101351403|NCT04752163|Vitamins|vitamins|mesh-ancestor
101351404|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
101351405|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101351406|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101351407|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351408|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351409|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351410|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
101351411|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101351412|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101351413|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101351414|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351415|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101351416|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101351417|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101351418|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101351419|NCT04735926|Calcifediol|calcifediol|mesh-list
101351420|NCT04735926|Vitamins|vitamins|mesh-ancestor
101351421|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
101351422|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351423|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101351424|NCT04720768|Palbociclib|palbociclib|mesh-list
101351425|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351426|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101351433|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101351435|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
101351436|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
101351437|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101351438|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
101351439|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
101351440|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351441|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
101351442|NCT04702256|Hormones|hormones|mesh-ancestor
101351443|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351444|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351445|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101332685|NCT00015288|Narcotics|narcotics|mesh-ancestor
101332686|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332687|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332688|NCT00015288|Analgesics|analgesics|mesh-ancestor
101332689|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
101351446|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351447|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101351448|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101351449|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
101351450|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101351451|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351452|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351453|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351454|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
101351455|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
101351456|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351457|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101351458|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101351459|NCT04702256|Protective Agents|protective agents|mesh-ancestor
101351460|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351461|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101351462|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
101351463|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
101351464|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351466|NCT04671966|Estradiol|estradiol|mesh-list
101351467|NCT04671966|Estrogens|estrogens|mesh-ancestor
101351468|NCT04671966|Hormones|hormones|mesh-ancestor
101351469|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351470|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351471|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101351472|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101351473|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
101351474|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351475|NCT04641702|Atropine|atropine|mesh-list
101351476|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101351477|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351478|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101351480|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351481|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351482|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101351483|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351484|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
101351485|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
101351486|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101351487|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101351488|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
101351489|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351490|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351491|NCT04624750|Mexiletine|mexiletine|mesh-list
101351492|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351493|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101351494|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101351495|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351499|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101351500|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101351501|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351502|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351503|NCT04616807|Mexiletine|mexiletine|mesh-list
101351504|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351505|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101351506|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101351507|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351508|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351509|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
101351510|NCT04608630|Denosumab|denosumab|mesh-list
101332690|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332691|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101332692|NCT05083975|Anesthetics|anesthetics|mesh-list
101332693|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
101332694|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332695|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332696|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
101351511|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101351512|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351514|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101351515|NCT04603183|Letrozole|letrozole|mesh-list
101351516|NCT04603183|Fulvestrant|fulvestrant|mesh-list
101351517|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101351518|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351519|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351520|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351521|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351522|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351523|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101351524|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101351525|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351526|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101351527|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351528|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351529|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351530|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351531|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101351532|NCT04580134|Risperidone|risperidone|mesh-list
101351533|NCT04580134|Clozapine|clozapine|mesh-list
101351534|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101351535|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
101351536|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351537|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351538|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351539|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101351540|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101351541|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351542|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351543|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101351544|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
101351545|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
101351546|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
101351547|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
101351548|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351549|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351550|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101351551|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351552|NCT04529954|Valproic Acid|valproic acid|mesh-list
101351553|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
101351554|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351555|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351556|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
101351557|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351558|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351559|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
101351560|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101351561|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351562|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351563|NCT04525755|Nicotine|nicotine|mesh-list
101351564|NCT04525755|Varenicline|varenicline|mesh-list
101351565|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101351566|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
101351580|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101351581|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
101351582|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101351583|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
101351584|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351585|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101332697|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332698|NCT00000998|Leucovorin|leucovorin|mesh-list
101332699|NCT00000998|Trimetrexate|trimetrexate|mesh-list
101332700|NCT00000998|Calcium|calcium|mesh-list
101332701|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
101332702|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101351586|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351587|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351588|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
101351589|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351590|NCT04437485|Norepinephrine|norepinephrine|mesh-list
101351591|NCT04437485|Bupropion|bupropion|mesh-list
101351592|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
101351593|NCT04437485|Serotonin|serotonin|mesh-list
101351594|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101351595|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101351596|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351597|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101351598|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101351599|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351600|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351601|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
101351602|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351603|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351604|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101351605|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101351606|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351607|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101351608|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101351609|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
101351610|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
101351611|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
101351612|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351613|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101351614|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101351615|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
101351616|NCT04421560|Rituximab|rituximab|mesh-list
101351617|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
101351618|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351619|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351620|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
101351621|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351622|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351623|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101351624|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351626|NCT04332341|Niacin|niacin|mesh-list
101351627|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
101351628|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
101351645|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351646|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351647|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101351648|NCT04318691|Dimercaprol|dimercaprol|mesh-list
101351649|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
101351650|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
101351651|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351652|NCT04278092|Paclitaxel|paclitaxel|mesh-list
101351653|NCT04278092|Cetuximab|cetuximab|mesh-list
101351654|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101351655|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351656|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351657|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351658|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351659|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351660|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351661|NCT04240106|Niraparib|niraparib|mesh-list
101351662|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101351663|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101332703|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332704|NCT00000998|Antidotes|antidotes|mesh-ancestor
101332705|NCT00000998|Protective Agents|protective agents|mesh-ancestor
101332706|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
101332708|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
101332709|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
101351664|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351665|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351666|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351667|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101351668|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101351669|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
101351670|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351671|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351672|NCT04220489|Ketamine|ketamine|mesh-list
101351673|NCT04220489|Analgesics|analgesics|mesh-ancestor
101351674|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
101351675|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351676|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351677|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101351678|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101351679|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
101351680|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
101351681|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351682|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101351683|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101351684|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351685|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351686|NCT04189107|Dexamethasone|dexamethasone|mesh-list
101351704|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351705|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351706|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
101351708|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351709|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351710|NCT03934567|Abexinostat|abexinostat|mesh-list
101351711|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101351712|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351713|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351714|NCT03872388|Capecitabine|capecitabine|mesh-list
101351715|NCT03872388|Atorvastatin|atorvastatin|mesh-list
101351716|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351717|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
101351718|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351719|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351720|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101351721|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101351722|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101351723|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101351724|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351725|NCT03865940|Lidocaine|lidocaine|mesh-list
101351726|NCT03865940|Guanfacine|guanfacine|mesh-list
101351727|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
101351728|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
101351729|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351730|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351731|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
101351732|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351733|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351734|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101351735|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101351736|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101351737|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351738|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101351739|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101351740|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101332710|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332711|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332712|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
101332713|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332714|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351741|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101351742|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
101351760|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101351761|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101351762|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101351763|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
101351764|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101351765|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351766|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101351767|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101351768|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351769|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351770|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
101351771|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101351773|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351774|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101351775|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351776|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351778|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101351779|NCT03589729|Idarubicin|idarubicin|mesh-list
101351780|NCT03589729|Cladribine|cladribine|mesh-list
101351781|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
101351782|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
101351783|NCT03589729|Razoxane|razoxane|mesh-list
101351784|NCT03589729|Calicheamicins|calicheamicins|mesh-list
101351785|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351786|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
101351787|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351788|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351789|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
101351790|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351791|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351792|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
101351793|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351794|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101351795|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101351796|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101351797|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351798|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351821|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101351822|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
101351823|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
101351824|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101351825|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
101351826|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
101351827|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351828|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351829|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351830|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101351831|NCT03467867|Rituximab|rituximab|mesh-list
101351832|NCT03467867|Venetoclax|venetoclax|mesh-list
101351833|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351834|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351835|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
101351836|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351837|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101351838|NCT03390933|Fluoxetine|fluoxetine|mesh-list
101351839|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101351840|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101351842|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351843|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332715|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332716|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332717|NCT00001001|Zidovudine|zidovudine|mesh-list
101351844|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
101351845|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351846|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101351847|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
101351848|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351849|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101351850|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101351851|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351852|NCT03387787|Insulin|insulin|mesh-list
101351853|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101351864|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351865|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
101351866|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
101351867|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
101351868|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351869|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101351870|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
101351872|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101351873|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351874|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101351875|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351876|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101351877|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101351878|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351879|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
101351880|NCT03315897|Hematinics|hematinics|mesh-ancestor
101351881|NCT03299660|Fluorouracil|fluorouracil|mesh-list
101351882|NCT03299660|Capecitabine|capecitabine|mesh-list
101351883|NCT03299660|Avelumab|avelumab|mesh-list
101351884|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
101351885|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351886|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351887|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351888|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351889|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
101351890|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351891|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101351892|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
101351893|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101351894|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101351895|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
101351896|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
101351897|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351898|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351899|NCT03140358|Atropine|atropine|mesh-list
101351900|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101351901|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101351902|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101351903|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
101351904|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351905|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351906|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101351907|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
101351908|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
101351909|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
101351910|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101351911|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101351912|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
101351913|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351914|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351915|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
101351916|NCT02954536|Fluorouracil|fluorouracil|mesh-list
101351917|NCT02954536|Capecitabine|capecitabine|mesh-list
101351918|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
101351919|NCT02954536|Trastuzumab|trastuzumab|mesh-list
101351920|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351922|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101351923|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351924|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
101332718|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
101332719|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332720|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332721|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332722|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332723|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
101332724|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332725|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332726|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332727|NCT05076877|Metformin|metformin|mesh-list
101351925|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101351926|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101351927|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
101351928|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351929|NCT02899611|Valproic Acid|valproic acid|mesh-list
101351930|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
101351931|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101351932|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101351933|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
101351934|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101351935|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351936|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
101351937|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101351938|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351939|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101351940|NCT02750202|Vaccines|vaccines|mesh-list
101351941|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
101351942|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351943|NCT02645266|Aflibercept|aflibercept|mesh-list
101351944|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101351945|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101351946|NCT02645266|Growth Substances|growth substances|mesh-ancestor
101351947|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351948|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
101351949|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351950|NCT02634294|Interferons|interferons|mesh-list
101351951|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
101351952|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
101351953|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101351954|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101351955|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
101351956|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101351957|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
101351958|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351959|NCT02575677|Oxycodone|oxycodone|mesh-list
101351960|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101351961|NCT02575677|Narcotics|narcotics|mesh-ancestor
101351962|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351963|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351964|NCT02575677|Analgesics|analgesics|mesh-ancestor
101351965|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
101351966|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351967|NCT02573831|Oxycodone|oxycodone|mesh-list
101351968|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101351969|NCT02573831|Narcotics|narcotics|mesh-ancestor
101351970|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351971|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351972|NCT02573831|Analgesics|analgesics|mesh-ancestor
101351973|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
101351974|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351975|NCT02571881|Oxycodone|oxycodone|mesh-list
101351976|NCT02571881|Naloxone|naloxone|mesh-list
101351977|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101351978|NCT02571881|Narcotics|narcotics|mesh-ancestor
101351979|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351980|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351981|NCT02571881|Analgesics|analgesics|mesh-ancestor
101332728|NCT05076877|Midazolam|midazolam|mesh-list
101332729|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101332730|NCT05076877|Lazertinib|lazertinib|mesh-list
101332731|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101332732|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351982|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
101351983|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351984|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101351985|NCT02571179|Fentanyl|fentanyl|mesh-list
101351986|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101351987|NCT02571179|Narcotics|narcotics|mesh-ancestor
101351988|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101351989|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101351990|NCT02571179|Analgesics|analgesics|mesh-ancestor
101351991|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
101351992|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101351993|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101351994|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101352010|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352012|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352013|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352014|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352015|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352016|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352017|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
101352018|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352019|NCT02225600|Oxytocin|oxytocin|mesh-list
101352020|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
101352021|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101352022|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352023|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
101352024|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101352025|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352026|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101352027|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352028|NCT02101905|Lapatinib|lapatinib|mesh-list
101352029|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352030|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352031|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352032|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352033|NCT02081404|Esomeprazole|esomeprazole|mesh-list
101352034|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101352035|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352036|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101352037|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352038|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352039|NCT01526603|Carboplatin|carboplatin|mesh-list
101352040|NCT01526603|Etoposide|etoposide|mesh-list
101352041|NCT01526603|Melphalan|melphalan|mesh-list
101352042|NCT01526603|Tretinoin|tretinoin|mesh-list
101352043|NCT01526603|Isotretinoin|isotretinoin|mesh-list
101352044|NCT01526603|Lenograstim|lenograstim|mesh-list
101352045|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352046|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352047|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352048|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352049|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352050|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352051|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352052|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
101352053|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352054|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352055|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
101352061|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101352062|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101352064|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
101352065|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352066|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352067|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101352068|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332733|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101332734|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101332735|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332736|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101332737|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101332738|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101332739|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101332740|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
101352069|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352070|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
101352071|NCT00070070|Sargramostim|sargramostim|mesh-list
101352072|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
101352073|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
101352074|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352075|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352076|NCT02573909|Oxycodone|oxycodone|mesh-list
101352077|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101352079|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101352080|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352081|NCT02573909|Analgesics|analgesics|mesh-ancestor
101352082|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
101352083|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352084|NCT00042315|Vinorelbine|vinorelbine|mesh-list
101352085|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352086|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352087|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352088|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352089|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352090|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352091|NCT00018668|Olanzapine|olanzapine|mesh-list
101352092|NCT00018668|Risperidone|risperidone|mesh-list
101352093|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101352094|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101352095|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
101352096|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352097|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352098|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352099|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101352100|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101352101|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101352102|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101352103|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101352104|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
101352105|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
101352106|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
101352107|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352108|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352109|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101352110|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101352111|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101352112|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
101352113|NCT00042354|Clofarabine|clofarabine|mesh-list
101352114|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352115|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
101352116|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352117|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352118|NCT00042393|Adefovir|adefovir|mesh-list
101352119|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101352120|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
101352121|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352122|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101352123|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101352124|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352125|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352126|NCT00042471|Pramlintide|pramlintide|mesh-list
101352147|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332742|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
101332743|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
101332744|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101332745|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332746|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101332747|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101352149|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101352150|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101352151|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352152|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
101352153|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352155|NCT00038844|Rituximab|rituximab|mesh-list
101352156|NCT00038844|Fludarabine|fludarabine|mesh-list
101352157|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
101352158|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
101352159|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352160|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
101352161|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352162|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352163|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352164|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
101352165|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352167|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352168|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352169|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352170|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
101352171|NCT00018863|Methylphenidate|methylphenidate|mesh-list
101352172|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101352173|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352174|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101352175|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101352176|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101352177|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352178|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
101352179|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352180|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
101352181|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352193|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101352194|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
101352195|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101352196|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101352197|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101352198|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352199|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101352201|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352202|NCT00018941|Aldesleukin|aldesleukin|mesh-list
101352203|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352204|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352205|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352206|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
101352207|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352209|NCT00038961|Fondaparinux|fondaparinux|mesh-list
101352210|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101352211|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
101352212|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101352213|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
101352214|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352215|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352216|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
101352217|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101352218|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101352219|NCT00019019|Paclitaxel|paclitaxel|mesh-list
101352220|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
101352221|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352222|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352223|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332748|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
101332749|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101332750|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101332751|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332752|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352224|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352225|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352226|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352227|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101352228|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101352229|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352230|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352231|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
101352232|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
101352233|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352234|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
101352235|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352236|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352237|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101352238|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101352239|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101352240|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101352241|NCT00019058|Protective Agents|protective agents|mesh-ancestor
101352242|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352263|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
101352264|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352265|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352266|NCT00019136|Aldesleukin|aldesleukin|mesh-list
101352267|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352268|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352269|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352270|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
101352271|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352272|NCT00039117|Cytarabine|cytarabine|mesh-list
101352273|NCT00039117|Daunorubicin|daunorubicin|mesh-list
101352274|NCT00039117|Oblimersen|oblimersen|mesh-list
101352275|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352276|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
101352277|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352278|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352279|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
101352280|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352281|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352282|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
101352283|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352284|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352285|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352286|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352287|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352288|NCT00019175|Aldesleukin|aldesleukin|mesh-list
101352289|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352290|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352291|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352292|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
101352293|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352294|NCT00039156|IDN 5109|idn 5109|mesh-list
101352295|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352296|NCT00019214|Aldesleukin|aldesleukin|mesh-list
101352297|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352298|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352299|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352339|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352340|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
101352341|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352342|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352343|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352344|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
101416875|NCT00140361|Artesunate|artesunate|mesh-list
101352345|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352346|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332754|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
101332755|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332756|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
101332757|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332758|NCT00396604|Maleic acid|maleic acid|mesh-list
101332759|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332760|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332761|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101332762|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
101332763|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332764|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
101332765|NCT00396760|Aprotinin|aprotinin|mesh-list
101332766|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101352347|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352348|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101352349|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
101352350|NCT00019409|Hormones|hormones|mesh-ancestor
101352351|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101352352|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101352353|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101352354|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
101352355|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101352356|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352357|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
101352358|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352359|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352360|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101352361|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101352362|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
101352363|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352364|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352365|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352366|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352367|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352368|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352369|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352370|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352371|NCT00019448|Interleukin-2|interleukin-2|mesh-list
101352372|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352373|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101352374|NCT00019448|Analgesics|analgesics|mesh-ancestor
101352375|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
101352376|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352377|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352378|NCT00019487|Aldesleukin|aldesleukin|mesh-list
101352380|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352381|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352382|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352383|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
101352384|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352385|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352386|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
101352387|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352388|NCT00039351|Prednisone|prednisone|mesh-list
101352389|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
101352390|NCT00039351|Vincristine|vincristine|mesh-list
101352391|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352392|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
101352393|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352394|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101332767|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101332768|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332769|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
101332770|NCT00396760|Coagulants|coagulants|mesh-ancestor
101332771|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101352395|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352396|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
101352397|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352398|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352399|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352400|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101352401|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
101352402|NCT00039351|Hormones|hormones|mesh-ancestor
101352403|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101352404|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101352405|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352406|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352407|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352413|NCT00039390|Gefitinib|gefitinib|mesh-list
101352414|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352415|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
101352416|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352417|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352418|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352419|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352420|NCT00019721|Aldesleukin|aldesleukin|mesh-list
101352421|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
101352422|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352423|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352424|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352425|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
101352426|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352427|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352428|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
101352429|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352430|NCT00019760|Leucovorin|leucovorin|mesh-list
101352431|NCT00019760|Melphalan|melphalan|mesh-list
101352432|NCT00019760|Floxuridine|floxuridine|mesh-list
101352433|NCT00019760|Calcium|calcium|mesh-list
101352434|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
101352435|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352436|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352437|NCT00019760|Antidotes|antidotes|mesh-ancestor
101352438|NCT00019760|Protective Agents|protective agents|mesh-ancestor
101352439|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
101352440|NCT00019760|Vitamins|vitamins|mesh-ancestor
101352441|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
101352442|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352443|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
101352444|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352445|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352446|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352447|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352448|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
101352449|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352450|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
101352451|NCT00039468|Thalidomide|thalidomide|mesh-list
101352452|NCT00039468|Irinotecan|irinotecan|mesh-list
101352453|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101352454|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352455|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352456|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352457|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352458|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352460|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352461|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
101352462|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101352463|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352464|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101352465|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101352466|NCT00039468|Growth Substances|growth substances|mesh-ancestor
101332772|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101332774|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332775|NCT00001007|Zidovudine|zidovudine|mesh-list
101332776|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
101332777|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332778|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332779|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332780|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332781|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
101352467|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
101352468|NCT00019838|Fludarabine|fludarabine|mesh-list
101352469|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
101352470|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101352471|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352472|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352473|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
101352474|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352475|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352476|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
101352477|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352478|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352479|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352480|NCT00019916|Aldesleukin|aldesleukin|mesh-list
101352485|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352486|NCT00039546|Paclitaxel|paclitaxel|mesh-list
101352487|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
101352488|NCT00039546|Gemcitabine|gemcitabine|mesh-list
101352489|NCT00039546|Epirubicin|epirubicin|mesh-list
101352490|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352491|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352492|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352493|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352494|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352495|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352496|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352497|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
101352498|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352499|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352500|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352501|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
101352502|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352503|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352504|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
101352505|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352506|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352507|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352508|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352509|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
101352510|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352511|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352512|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352513|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352514|NCT00019994|Aldesleukin|aldesleukin|mesh-list
101352515|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
101352516|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352517|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352518|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352519|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
101352520|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352521|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352522|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
101352523|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352524|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
101352525|NCT00039663|Pravastatin|pravastatin|mesh-list
101352526|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
101332782|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332783|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332784|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332785|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
101332786|NCT00396799|Estrogens|estrogens|mesh-list
101332787|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101332788|NCT00396799|Hormones|hormones|mesh-ancestor
101352527|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101352528|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352529|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101352530|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101352531|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
101352532|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352533|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101352534|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101352535|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352536|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101352537|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101352538|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
101352539|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352541|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101352542|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352543|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
101352544|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352545|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352546|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352547|NCT00039858|Argatroban|argatroban|mesh-list
101352548|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
101352549|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101352550|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
101352551|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352552|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352553|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
101352557|NCT00020189|Clopidogrel|clopidogrel|mesh-list
101352558|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101352559|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101352560|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101352561|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101352562|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
101352563|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352564|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352565|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352566|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101352567|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101352568|NCT00020189|Analgesics|analgesics|mesh-ancestor
101352569|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
101352570|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352571|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101352572|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352573|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101352574|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101352575|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101352576|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352577|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
101352578|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352579|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
101352580|NCT00020189|Growth Substances|growth substances|mesh-ancestor
101352581|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352582|NCT00039975|Ritonavir|ritonavir|mesh-list
101352583|NCT00039975|Indinavir|indinavir|mesh-list
101352585|NCT00039975|Diltiazem|diltiazem|mesh-list
101352586|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101352587|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101352588|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
101352589|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352590|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352591|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352592|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332789|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332790|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332791|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101332792|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101332793|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
101352593|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
101352594|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352595|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101352596|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101352597|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101352599|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101352600|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352601|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352602|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
101352603|NCT00020267|Interleukin-2|interleukin-2|mesh-list
101352604|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101352605|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352606|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101352607|NCT00020267|Analgesics|analgesics|mesh-ancestor
101352608|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
101352609|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352610|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352611|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352612|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
101352613|NCT00040014|Exemestane|exemestane|mesh-list
101352614|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352615|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101352616|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101352617|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352618|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352619|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101352620|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
101352621|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101352622|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352623|NCT00020345|Gemcitabine|gemcitabine|mesh-list
101352624|NCT00020345|Fluorouracil|fluorouracil|mesh-list
101352625|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352626|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
101352638|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
101352639|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352640|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101352641|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101352642|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
101352643|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352644|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352645|NCT00020462|Aldesleukin|aldesleukin|mesh-list
101352646|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352647|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352648|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352649|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
101352650|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352651|NCT00020501|Leucovorin|leucovorin|mesh-list
101352652|NCT00020501|Fluorouracil|fluorouracil|mesh-list
101352653|NCT00020501|Floxuridine|floxuridine|mesh-list
101352654|NCT00020501|Irinotecan|irinotecan|mesh-list
101352655|NCT00020501|Melphalan|melphalan|mesh-list
101352656|NCT00020501|Calcium|calcium|mesh-list
101352657|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
101352658|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352659|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352660|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
101352661|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352662|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352663|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352664|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352665|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
101352666|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101352667|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332794|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101332795|NCT01786434|Fentanyl|fentanyl|mesh-list
101332796|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101332797|NCT01786434|Narcotics|narcotics|mesh-ancestor
101332798|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332799|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332800|NCT01786434|Analgesics|analgesics|mesh-ancestor
101332801|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
101332802|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352668|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352669|NCT00020501|Antidotes|antidotes|mesh-ancestor
101352670|NCT00020501|Protective Agents|protective agents|mesh-ancestor
101352671|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
101352672|NCT00020501|Vitamins|vitamins|mesh-ancestor
101352673|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
101352674|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352675|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
101352676|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352677|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
101352678|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352679|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
101352680|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352681|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101352682|NCT00020540|Protective Agents|protective agents|mesh-ancestor
101352683|NCT00020579|Entinostat|entinostat|mesh-list
101352684|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352685|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101352686|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352687|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352688|NCT00040209|Levodopa|levodopa|mesh-list
101352689|NCT00040209|Apomorphine|apomorphine|mesh-list
101352690|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101352691|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101352692|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
101352696|NCT00040209|Emetics|emetics|mesh-ancestor
101352697|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
101352698|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352699|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352700|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
101352701|NCT00040248|Daclizumab|daclizumab|mesh-list
101352702|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352703|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
101352704|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352705|NCT00020618|Morphine|morphine|mesh-list
101352706|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101352707|NCT00020618|Narcotics|narcotics|mesh-ancestor
101352708|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101352709|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352710|NCT00020618|Analgesics|analgesics|mesh-ancestor
101352711|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
101352712|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352713|NCT00020657|Ondansetron|ondansetron|mesh-list
101352714|NCT00020657|Granisetron|granisetron|mesh-list
101352715|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
101352716|NCT00020657|Dolasetron|dolasetron|mesh-list
101352717|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
101352718|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
101352719|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352720|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352721|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352722|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
101352723|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352724|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101352725|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101352726|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
101352727|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101352728|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352729|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101352730|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101332803|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101332804|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101332805|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
101332806|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
101332807|NCT00001010|Zidovudine|zidovudine|mesh-list
101332808|NCT00001010|Acyclovir|acyclovir|mesh-list
101332809|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
101352731|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101352732|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101352733|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101352734|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
101352735|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
101352736|NCT00020696|Tirapazamine|tirapazamine|mesh-list
101352737|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352738|NCT02970630|Everolimus|everolimus|mesh-list
101352739|NCT02970630|Tacrolimus|tacrolimus|mesh-list
101352740|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352741|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
101352742|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352743|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101352744|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352745|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352746|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101352747|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352748|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352749|NCT00020735|Toremifene|toremifene|mesh-list
101352750|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101352751|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352752|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101352753|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101352754|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
101352755|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101352756|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352757|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101352758|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
101352759|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352760|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
101352761|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352762|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352763|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352764|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
101352772|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352773|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352774|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352775|NCT00040521|Oprelvekin|oprelvekin|mesh-list
101352776|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352777|NCT00040599|Labetuzumab|labetuzumab|mesh-list
101352778|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416879|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
101352779|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352780|NCT00020930|Cetuximab|cetuximab|mesh-list
101352781|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352782|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352783|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
101352784|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352785|NCT00040794|Paclitaxel|paclitaxel|mesh-list
101352786|NCT00040794|Carboplatin|carboplatin|mesh-list
101352787|NCT00040794|Gefitinib|gefitinib|mesh-list
101352788|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352791|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352792|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352793|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352794|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352795|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352796|NCT00021047|Carboplatin|carboplatin|mesh-list
101352797|NCT00021047|Capecitabine|capecitabine|mesh-list
101352798|NCT00021047|Epirubicin|epirubicin|mesh-list
101352799|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352800|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352801|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
101332810|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332811|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332812|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332813|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332814|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
101332815|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352802|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352803|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352804|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352805|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352806|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352807|NCT00021164|Aldesleukin|aldesleukin|mesh-list
101352808|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
101352809|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352810|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352811|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352812|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
101352813|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352814|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101352815|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
101352816|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352817|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
101352818|NCT00040872|Thiotepa|thiotepa|mesh-list
101352819|NCT00040872|Carboplatin|carboplatin|mesh-list
101352820|NCT00040872|Doxorubicin|doxorubicin|mesh-list
101352821|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101352822|NCT00040872|Etoposide|etoposide|mesh-list
101352823|NCT00040872|Vincristine|vincristine|mesh-list
101352824|NCT00040872|Topotecan|topotecan|mesh-list
101352825|NCT00040872|Isotretinoin|isotretinoin|mesh-list
101352826|NCT00040872|Antibodies|antibodies|mesh-list
101352827|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101352828|NCT00040872|Sargramostim|sargramostim|mesh-list
101352829|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352830|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
101352831|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352832|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352833|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101352834|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
101352835|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352836|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352837|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101352841|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352842|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352843|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352844|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352845|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352846|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101352847|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352848|NCT00021242|Docetaxel|docetaxel|mesh-list
101352849|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352850|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352851|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352852|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352853|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352854|NCT00040950|Rituximab|rituximab|mesh-list
101352855|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101352856|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352857|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
101352858|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352859|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101352860|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101352861|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352862|NCT00021281|Leucovorin|leucovorin|mesh-list
101352863|NCT00021281|Fluorouracil|fluorouracil|mesh-list
101352864|NCT00021281|Irinotecan|irinotecan|mesh-list
101352865|NCT00021281|Calcium|calcium|mesh-list
101352866|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
101352867|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352868|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352869|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
101332816|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332817|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332818|NCT00001013|Leucovorin|leucovorin|mesh-list
101332819|NCT00001013|Trimethoprim|trimethoprim|mesh-list
101332820|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101332821|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
101332822|NCT00001013|Pentamidine|pentamidine|mesh-list
101332823|NCT00001013|Trimetrexate|trimetrexate|mesh-list
101352870|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352871|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352872|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352873|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352874|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
101352875|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101352876|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352877|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352878|NCT00021281|Antidotes|antidotes|mesh-ancestor
101352879|NCT00021281|Protective Agents|protective agents|mesh-ancestor
101352880|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
101352881|NCT00021281|Vitamins|vitamins|mesh-ancestor
101352882|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
101352883|NCT00041106|Gemcitabine|gemcitabine|mesh-list
101352884|NCT00041106|Gefitinib|gefitinib|mesh-list
101352885|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352886|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352887|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
101352888|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352889|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101352890|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352891|NCT00021320|Paclitaxel|paclitaxel|mesh-list
101352892|NCT00021320|Fluorouracil|fluorouracil|mesh-list
101352893|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101352894|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352895|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
101352896|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
101352897|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
101352898|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352899|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
101352900|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352901|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352902|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
101352903|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352904|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
101352905|NCT00041223|Procyanidin|procyanidin|mesh-list
101352906|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
101352907|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352908|NCT00041223|Protective Agents|protective agents|mesh-ancestor
101352909|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352910|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101352914|NCT00021359|Isotretinoin|isotretinoin|mesh-list
101352915|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101352916|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
101352917|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
101352918|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101352919|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352920|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352922|NCT00021359|Hormones|hormones|mesh-ancestor
101352923|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101352924|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101352925|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352926|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
101352927|NCT00041262|Fluorouracil|fluorouracil|mesh-list
101352928|NCT00041262|Epirubicin|epirubicin|mesh-list
101352929|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352930|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
101352931|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352932|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352933|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352934|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
101332824|NCT00001013|Calcium|calcium|mesh-list
101332825|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
101332826|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101332827|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332828|NCT00001013|Antidotes|antidotes|mesh-ancestor
101332829|NCT00001013|Protective Agents|protective agents|mesh-ancestor
101332830|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
101352935|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352936|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101352937|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101352938|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101352939|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101352940|NCT00021398|Leucovorin|leucovorin|mesh-list
101352941|NCT00021398|Fluorouracil|fluorouracil|mesh-list
101352942|NCT00021398|Calcium|calcium|mesh-list
101352943|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
101352944|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101352945|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101352946|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
101352947|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352948|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101352949|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352950|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101352951|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
101352952|NCT00021398|Antidotes|antidotes|mesh-ancestor
101352953|NCT00021398|Protective Agents|protective agents|mesh-ancestor
101352954|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
101352955|NCT00021398|Vitamins|vitamins|mesh-ancestor
101352956|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
101352957|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101352958|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
101352959|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352960|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
101352961|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101352962|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101352963|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352964|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101352965|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352966|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
101352967|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352968|NCT00049023|Octreotide|octreotide|mesh-list
101352969|NCT00049023|Edotreotide|edotreotide|mesh-list
101352970|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352971|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101352972|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101352973|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101352974|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352975|NCT00021671|Metronidazole|metronidazole|mesh-list
101352976|NCT00021671|Nevirapine|nevirapine|mesh-list
101352977|NCT00021671|Erythromycin|erythromycin|mesh-list
101352978|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
101352979|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101352980|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
101352981|NCT00021671|Ampicillin|ampicillin|mesh-list
101352982|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101352983|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101352984|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101352985|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101352989|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101352990|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
101352992|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101352993|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101352994|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101352995|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101352996|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101352997|NCT00049062|Gefitinib|gefitinib|mesh-list
101352998|NCT00049062|Anastrozole|anastrozole|mesh-list
101352999|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353000|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353001|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332831|NCT00001013|Vitamins|vitamins|mesh-ancestor
101332832|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
101332833|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101332834|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332835|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
101353002|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353003|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353004|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101353005|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101353006|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101353007|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
101353008|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353009|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353010|NCT00049101|Leucovorin|leucovorin|mesh-list
101353011|NCT00049101|Fluorouracil|fluorouracil|mesh-list
101353012|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
101353013|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101353014|NCT00049101|Calcium|calcium|mesh-list
101353015|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
101353016|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101353017|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353018|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
101353019|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353020|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353021|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353022|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353023|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
101353024|NCT00049101|Antidotes|antidotes|mesh-ancestor
101353025|NCT00049101|Protective Agents|protective agents|mesh-ancestor
101353026|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
101353027|NCT00049101|Vitamins|vitamins|mesh-ancestor
101353028|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
101353029|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353030|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353031|NCT00394628|Temozolomide|temozolomide|mesh-list
101353032|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353033|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
101353034|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353035|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353036|NCT00049179|Cytarabine|cytarabine|mesh-list
101353037|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
101353038|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353039|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
101353040|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353041|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353042|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
101353043|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353044|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353045|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
101353046|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353047|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353049|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
101353050|NCT00394745|Valsartan|valsartan|mesh-list
101353051|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101353052|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101353053|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101353054|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353055|NCT00049218|Carboplatin|carboplatin|mesh-list
101353056|NCT00049218|Etoposide|etoposide|mesh-list
101353057|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353060|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353061|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353062|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353064|NCT00049296|Docetaxel|docetaxel|mesh-list
101353065|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353066|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353067|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353068|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
101332836|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101332837|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101332838|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332839|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353069|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353070|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353071|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
101353072|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353073|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353074|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353075|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353076|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101353077|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101353078|NCT00049296|Growth Substances|growth substances|mesh-ancestor
101353079|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353080|NCT00021827|Hormones|hormones|mesh-list
101353081|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
101353082|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
101353083|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353084|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353085|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101353086|NCT00049335|Capecitabine|capecitabine|mesh-list
101353087|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353088|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
101353089|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353092|NCT00049374|Dexamethasone|dexamethasone|mesh-list
101353093|NCT00049374|Oblimersen|oblimersen|mesh-list
101353094|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353095|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
101353096|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
101353097|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353098|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353099|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101353100|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
101353101|NCT00049374|Hormones|hormones|mesh-ancestor
101353102|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353103|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353104|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353105|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353106|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
101353107|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353108|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353109|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353110|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101353111|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101353112|NCT00049374|Growth Substances|growth substances|mesh-ancestor
101353113|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353114|NCT00021983|Immunotoxins|immunotoxins|mesh-list
101353115|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
101353116|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
101353117|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353118|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
101353119|NCT00049413|Rituximab|rituximab|mesh-list
101353120|NCT00049413|Pentostatin|pentostatin|mesh-list
101353121|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353122|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
101353123|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353124|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353125|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353126|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
101353127|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353128|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353129|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353134|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353135|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353137|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353138|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353139|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
101332840|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332841|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101332842|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101332843|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101353140|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101353141|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353142|NCT00022139|Paclitaxel|paclitaxel|mesh-list
101353143|NCT00022139|Carboplatin|carboplatin|mesh-list
101353144|NCT00022139|Fluorouracil|fluorouracil|mesh-list
101353145|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353146|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353147|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353148|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353149|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353150|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353152|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353153|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353154|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
101353155|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353156|NCT00049569|Leucovorin|leucovorin|mesh-list
101353157|NCT00049569|Cytarabine|cytarabine|mesh-list
101353158|NCT00049569|Prednisone|prednisone|mesh-list
101353159|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
101353160|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101353161|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101353162|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101353163|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
101353164|NCT00049569|Doxorubicin|doxorubicin|mesh-list
101353165|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101353166|NCT00049569|Methotrexate|methotrexate|mesh-list
101353167|NCT00049569|Etoposide|etoposide|mesh-list
101353168|NCT00049569|Vincristine|vincristine|mesh-list
101353169|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
101353170|NCT00049569|Asparaginase|asparaginase|mesh-list
101353171|NCT00049569|Pegaspargase|pegaspargase|mesh-list
101353172|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
101353173|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353174|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
101353175|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353176|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353177|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353178|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
101353179|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353180|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353181|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353182|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353183|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353184|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353185|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353186|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353187|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
101353188|NCT00049569|Hormones|hormones|mesh-ancestor
101353189|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353190|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353191|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101353192|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
101353193|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101353194|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353195|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
101353196|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
101353197|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101353198|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353199|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353200|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
101353201|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353206|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
101353207|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353208|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353209|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
101332844|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
101332845|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101332846|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101332847|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332848|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
101332849|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332850|NCT04680442|Trastuzumab|trastuzumab|mesh-list
101353210|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353211|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
101353212|NCT00022178|Doxorubicin|doxorubicin|mesh-list
101353213|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101353214|NCT00022178|Fluorouracil|fluorouracil|mesh-list
101353215|NCT00022178|Vincristine|vincristine|mesh-list
101353218|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
101353219|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353220|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353221|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353222|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
101353223|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353224|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353225|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353226|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353227|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353228|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353229|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353230|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
101353231|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353232|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353233|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353234|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353235|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353237|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353238|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
101353239|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353240|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353242|NCT00022217|Carboplatin|carboplatin|mesh-list
101353243|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353244|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353245|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353246|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353247|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353248|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353249|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
101353250|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353251|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101353252|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101353253|NCT00049725|Daclizumab|daclizumab|mesh-list
101353254|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353255|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
101353256|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353257|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101353258|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353259|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
101353260|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101353261|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101353262|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
101353263|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
101353264|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101353265|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353266|NCT00397761|Paclitaxel|paclitaxel|mesh-list
101353267|NCT00397761|Capecitabine|capecitabine|mesh-list
101353268|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101353269|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353270|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353271|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353272|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353273|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
101332852|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101332853|NCT04680442|Maytansine|maytansine|mesh-list
101332854|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101332855|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332856|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101332857|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332858|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353275|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353279|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
101353280|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353281|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101353282|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
101353283|NCT00397800|Rituximab|rituximab|mesh-list
101353284|NCT00397800|Fludarabine|fludarabine|mesh-list
101353285|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
101353286|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353287|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
101353288|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353289|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353290|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353291|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
101353292|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353293|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353294|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353295|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353296|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353297|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
101353299|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353300|NCT00022529|Trastuzumab|trastuzumab|mesh-list
101353301|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353302|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353303|NCT00022607|Thalidomide|thalidomide|mesh-list
101353304|NCT00022607|Bevacizumab|bevacizumab|mesh-list
101353305|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353306|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353307|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101353308|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101353309|NCT00022607|Growth Substances|growth substances|mesh-ancestor
101353310|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353311|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353312|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353313|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
101353314|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
101353315|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353316|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353317|NCT00049998|Topotecan|topotecan|mesh-list
101353318|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101353319|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353320|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353321|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353322|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353323|NCT00022646|Gemcitabine|gemcitabine|mesh-list
101353324|NCT00022646|Pemetrexed|pemetrexed|mesh-list
101353325|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353326|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
101353327|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353328|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353329|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353330|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101353331|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353332|NCT00022685|Epratuzumab|epratuzumab|mesh-list
101353333|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353334|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353335|NCT00022724|Sirolimus|sirolimus|mesh-list
101353336|NCT00022724|Temsirolimus|temsirolimus|mesh-list
101332859|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
101332860|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353337|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
101353340|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353341|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353342|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
101353343|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353344|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353345|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353346|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353347|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353353|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353355|NCT00022880|Antibodies|antibodies|mesh-list
101353356|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
101353357|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353358|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353359|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
101353360|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
101353361|NCT00050271|Vitamins|vitamins|mesh-ancestor
101353362|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
101353363|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353364|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
101353365|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
101353366|NCT00022958|Antibodies|antibodies|mesh-list
101353367|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
101353368|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353369|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353370|NCT00050349|Epothilones|epothilones|mesh-list
101353371|NCT00050349|Epothilone B|epothilone b|mesh-list
101353372|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353373|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353374|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353375|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353376|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353377|NCT00050427|Trabectedin|trabectedin|mesh-list
101353378|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353379|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
101353380|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353381|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353382|NCT00023153|Adefovir|adefovir|mesh-list
101353383|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101353384|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
101353385|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353386|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101353387|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353388|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353389|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353390|NCT00050505|Vaccines|vaccines|mesh-list
101353391|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
101353392|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353393|NCT00050661|Daclizumab|daclizumab|mesh-list
101353394|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353395|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
101353396|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353397|NCT00050817|Clopidogrel|clopidogrel|mesh-list
101353398|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101353399|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101353400|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101353401|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101353402|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
101353403|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101353404|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353405|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353406|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
101353407|NCT00023231|Sirolimus|sirolimus|mesh-list
101353408|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101353409|NCT00023231|Ganciclovir|ganciclovir|mesh-list
101353410|NCT00023231|Prednisone|prednisone|mesh-list
101332862|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
101332863|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
101332864|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332866|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
101332867|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353411|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
101353412|NCT00023231|Atorvastatin|atorvastatin|mesh-list
101353413|NCT00023231|Daclizumab|daclizumab|mesh-list
101353414|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353415|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
101353416|NCT00023231|Hormones|hormones|mesh-ancestor
101353417|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353418|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353420|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353421|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353422|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101353423|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
101353424|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353425|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353426|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353427|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353428|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
101353429|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353430|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
101353431|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
101353432|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
101353433|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353434|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101353435|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101353436|NCT00023231|Protective Agents|protective agents|mesh-ancestor
101353437|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101353438|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101353439|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
101353440|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101353441|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101353442|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
101353443|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101353444|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
101353445|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101353446|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101353447|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
101353448|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101353449|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101353450|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353451|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101353453|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
101353454|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353455|NCT00023348|Isoniazid|isoniazid|mesh-list
101353456|NCT00023348|Rifabutin|rifabutin|mesh-list
101353457|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
101353458|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353459|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353460|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101353461|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101353462|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
101353463|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353464|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101353465|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101353466|NCT00050895|Ritonavir|ritonavir|mesh-list
101353467|NCT00050895|Lopinavir|lopinavir|mesh-list
101353468|NCT00050895|Tenofovir|tenofovir|mesh-list
101353469|NCT00050895|Lamivudine|lamivudine|mesh-list
101353470|NCT00050895|Zidovudine|zidovudine|mesh-list
101353471|NCT00050895|Stavudine|stavudine|mesh-list
101353472|NCT00050895|Efavirenz|efavirenz|mesh-list
101353473|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101353474|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101353475|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
101353476|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353477|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332868|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
101332869|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332870|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332871|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
101332872|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332873|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332874|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
101332875|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332876|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101332877|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353478|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101353479|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101353480|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
101353481|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353482|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101353483|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101353484|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101353485|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353486|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
101353487|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101353488|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101353489|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101353490|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101353491|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101353492|NCT00023387|Isoniazid|isoniazid|mesh-list
101353493|NCT00023387|Rifapentine|rifapentine|mesh-list
101353512|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101353513|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
101353514|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
101353515|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101353516|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101353517|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101353518|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353519|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101353520|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101353522|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101353523|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
101353524|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353525|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353528|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353529|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101353530|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
101353531|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353532|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
101353533|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
101353535|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101353536|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353537|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
101353538|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353539|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353540|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101353541|NCT00051051|Protective Agents|protective agents|mesh-ancestor
101353542|NCT00051090|Lamivudine|lamivudine|mesh-list
101353543|NCT00051090|Efavirenz|efavirenz|mesh-list
101353544|NCT00051090|Abacavir|abacavir|mesh-list
101353545|NCT00051090|Didanosine|didanosine|mesh-list
101353546|NCT00051090|Telbivudine|telbivudine|mesh-list
101353547|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101353548|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353553|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101353554|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332879|NCT00001040|Zalcitabine|zalcitabine|mesh-list
101332880|NCT00001040|Saquinavir|saquinavir|mesh-list
101332881|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
101332882|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332883|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101332884|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353555|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101353556|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101353557|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101353558|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101353559|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101353560|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101353561|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
101353562|NCT00023621|Celecoxib|celecoxib|mesh-list
101353563|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101353564|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101353565|NCT00023621|Analgesics|analgesics|mesh-ancestor
101353566|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
101353567|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353568|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353569|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353570|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353571|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101353572|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101353573|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353574|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353575|NCT00023660|Celecoxib|celecoxib|mesh-list
101353576|NCT00023660|Fluorouracil|fluorouracil|mesh-list
101353577|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353578|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
101353579|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353580|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353581|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353582|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
101353583|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353584|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101353586|NCT00023660|Analgesics|analgesics|mesh-ancestor
101353587|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
101353588|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353589|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353590|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353591|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101353592|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101353593|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353594|NCT00051285|Enoximone|enoximone|mesh-list
101353595|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101353596|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101353597|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101353598|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101353599|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353600|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353601|NCT00051285|Protective Agents|protective agents|mesh-ancestor
101353602|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353603|NCT00023699|Gefitinib|gefitinib|mesh-list
101353604|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353605|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353606|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353607|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353608|NCT00051441|Benzydamine|benzydamine|mesh-list
101353609|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353610|NCT00023738|Doxorubicin|doxorubicin|mesh-list
101353611|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101353612|NCT00023738|Ifosfamide|ifosfamide|mesh-list
101353613|NCT00023738|Dacarbazine|dacarbazine|mesh-list
101332885|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332886|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
101332887|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332888|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101332889|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332890|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101332891|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101332892|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101332893|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101353614|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353615|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353616|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353617|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353620|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353622|NCT00397917|Folic Acid|folic acid|mesh-list
101353623|NCT00397917|Hematinics|hematinics|mesh-ancestor
101353624|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
101353625|NCT00397917|Vitamins|vitamins|mesh-ancestor
101353626|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
101353627|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353628|NCT00397956|Ertapenem|ertapenem|mesh-list
101353629|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353630|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353631|NCT00023777|Cytarabine|cytarabine|mesh-list
101353632|NCT00023777|Daunorubicin|daunorubicin|mesh-list
101353633|NCT00023777|Sargramostim|sargramostim|mesh-list
101353634|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353635|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
101353636|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353637|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353638|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
101353639|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353640|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353641|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
101353642|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353644|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353645|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353646|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353647|NCT00023816|Carbendazim|carbendazim|mesh-list
101353648|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
101353649|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
101353650|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101353651|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353652|NCT00398034|Testosterone|testosterone|mesh-list
101353653|NCT00398034|Androgens|androgens|mesh-ancestor
101353654|NCT00398034|Hormones|hormones|mesh-ancestor
101353655|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353656|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353657|NCT00023855|Doxorubicin|doxorubicin|mesh-list
101353658|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101353659|NCT00023855|Bortezomib|bortezomib|mesh-list
101353660|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353661|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353662|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353663|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353664|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353665|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353666|NCT00023894|Alvocidib|alvocidib|mesh-list
101353667|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353668|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353669|NCT00023894|Growth Substances|growth substances|mesh-ancestor
101353670|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353671|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353672|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353673|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332894|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101332895|NCT00015873|Cytarabine|cytarabine|mesh-list
101332896|NCT00015873|Prednisolone|prednisolone|mesh-list
101332897|NCT00015873|Methotrexate|methotrexate|mesh-list
101332898|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
101353675|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101353676|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
101353677|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353678|NCT00051597|Antibodies|antibodies|mesh-list
101353679|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101353680|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
101353681|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353682|NCT00023972|Gemcitabine|gemcitabine|mesh-list
101353683|NCT00023972|Exatecan|exatecan|mesh-list
101353684|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353685|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
101353686|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353687|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353688|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101353689|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353690|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353691|NCT00024011|Bortezomib|bortezomib|mesh-list
101353692|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353697|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101353698|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101353699|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353700|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101353701|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353702|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353703|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353704|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353705|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353706|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101353707|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101353708|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101353712|NCT00024050|Methotrexate|methotrexate|mesh-list
101353713|NCT00024050|Cyclosporins|cyclosporins|mesh-list
101353714|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353715|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
101353716|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353717|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353718|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353719|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
101353720|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353721|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353722|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353723|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101353724|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
101353725|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101353726|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353727|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
101353728|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
101353729|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353730|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101353731|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353732|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
101353733|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353734|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101353735|NCT00024089|Gefitinib|gefitinib|mesh-list
101353736|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353737|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353738|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353739|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353740|NCT00051831|Ritonavir|ritonavir|mesh-list
101353741|NCT00051831|Saquinavir|saquinavir|mesh-list
101353742|NCT00051831|Tenofovir|tenofovir|mesh-list
101353743|NCT00051831|Emtricitabine|emtricitabine|mesh-list
101353745|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101353746|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101332899|NCT00015873|Vincristine|vincristine|mesh-list
101332900|NCT00015873|Asparaginase|asparaginase|mesh-list
101332901|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101332902|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
101332903|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101332904|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332905|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332906|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
101353747|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
101353748|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353749|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353750|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101353751|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101353752|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
101353753|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353754|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101353755|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101353756|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101353757|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101353758|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101353759|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101353760|NCT00024128|Cyclosporine|cyclosporine|mesh-list
101353761|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
101353762|NCT00024128|Cyclosporins|cyclosporins|mesh-list
101353763|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101353769|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
101353770|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353771|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353772|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101353773|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353774|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
101353775|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353776|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
101353777|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101353779|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353780|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353781|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353782|NCT00024245|Probenecid|probenecid|mesh-list
101353783|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
101353784|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
101353785|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353786|NCT00051987|Bortezomib|bortezomib|mesh-list
101353787|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353788|NCT00024284|Carboplatin|carboplatin|mesh-list
101353789|NCT00024284|Irinotecan|irinotecan|mesh-list
101353790|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353791|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101353792|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353793|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353794|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353795|NCT00052026|Carvedilol|carvedilol|mesh-list
101353796|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101353797|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101353798|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
101353799|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101353800|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353801|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353802|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101353803|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
101353804|NCT00052026|Protective Agents|protective agents|mesh-ancestor
101353805|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101353806|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101353807|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101353808|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
101353809|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101332907|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332908|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332909|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332910|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332911|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101332912|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332913|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
101332914|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353810|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101353811|NCT00024323|Cisplatin|cisplatin|mesh-list
101353812|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353813|NCT00024362|BBR 3464|bbr 3464|mesh-list
101353814|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353815|NCT00024401|Paclitaxel|paclitaxel|mesh-list
101353816|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353817|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353818|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353819|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353820|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353821|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353822|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
101353823|NCT00024440|Fludarabine|fludarabine|mesh-list
101353824|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
101353825|NCT00024440|Oblimersen|oblimersen|mesh-list
101353826|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353827|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
101353828|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353829|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353830|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353831|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
101353832|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353833|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353838|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
101353839|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353840|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
101353841|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353842|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
101353843|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353845|NCT00052221|Hematinics|hematinics|mesh-ancestor
101353846|NCT00024557|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101353847|NCT00024557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353848|NCT00052299|Cytarabine|cytarabine|mesh-list
101353849|NCT00052299|Etoposide|etoposide|mesh-list
101353850|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
101353851|NCT00052299|Idarubicin|idarubicin|mesh-list
101353852|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
101353853|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353854|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353855|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101353856|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353857|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353858|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353859|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353860|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
101353861|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
101353862|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353863|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353864|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
101353865|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353866|NCT00052299|Analgesics|analgesics|mesh-ancestor
101353867|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
101353868|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353869|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101353870|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101353871|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
101353872|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
101353873|NCT00052338|Carboplatin|carboplatin|mesh-list
101353874|NCT00052338|Gemcitabine|gemcitabine|mesh-list
101353875|NCT00052338|Bortezomib|bortezomib|mesh-list
101332915|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101332916|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
101332917|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332918|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101332919|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332920|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
101332921|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353876|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353877|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353878|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
101353879|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353880|NCT04733066|Teduglutide|teduglutide|mesh-list
101353881|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101353882|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101353883|NCT04733066|Protective Agents|protective agents|mesh-ancestor
101353884|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353885|NCT00052377|Aldesleukin|aldesleukin|mesh-list
101353886|NCT00052377|Interleukin-2|interleukin-2|mesh-list
101353887|NCT00052377|Interleukin-12|interleukin-12|mesh-list
101353888|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416900|NCT00131963|Paclitaxel|paclitaxel|mesh-list
101353889|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101353890|NCT00052377|Analgesics|analgesics|mesh-ancestor
101353891|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
101353892|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353893|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353894|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101353895|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101353896|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
101353897|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101353898|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101353899|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
101353900|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101353901|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101353902|NCT00052377|Growth Substances|growth substances|mesh-ancestor
101353903|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353905|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101353906|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
101353907|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353914|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
101353915|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353916|NCT00052455|Vincristine|vincristine|mesh-list
101353917|NCT00052455|Temozolomide|temozolomide|mesh-list
101353918|NCT00052455|Lomustine|lomustine|mesh-list
101353919|NCT00052455|Procarbazine|procarbazine|mesh-list
101353920|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101353921|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353922|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
101353923|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
101353924|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
101353925|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353926|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101353927|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
101353928|NCT00052494|Irinotecan|irinotecan|mesh-list
101353929|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
101353930|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353931|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101353932|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101353933|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353934|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353935|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101353936|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
101353937|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
101353938|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
101353939|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353940|NCT00395174|Coagulants|coagulants|mesh-ancestor
101353941|NCT00395213|Norepinephrine|norepinephrine|mesh-list
101353942|NCT00395213|Serotonin|serotonin|mesh-list
101353943|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101353944|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101332922|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101332923|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
101332924|NCT00015873|Hormones|hormones|mesh-ancestor
101332925|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101332926|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101332927|NCT00015912|Interferons|interferons|mesh-list
101332928|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
101353945|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101353946|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
101353947|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101353948|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353949|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353950|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
101353951|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
101353952|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353953|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101353954|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101353955|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
101353956|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101353957|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101353958|NCT00052611|Celecoxib|celecoxib|mesh-list
101353959|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101353960|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101353961|NCT00052611|Analgesics|analgesics|mesh-ancestor
101353962|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
101353963|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101353964|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353965|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101353966|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101353967|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101353968|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101353969|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101353971|NCT00395252|Gemcitabine|gemcitabine|mesh-list
101353972|NCT00395252|Cetuximab|cetuximab|mesh-list
101353973|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101353974|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
101353975|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353976|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353982|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101353983|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353984|NCT00052728|Tamoxifen|tamoxifen|mesh-list
101353985|NCT00052728|Tipifarnib|tipifarnib|mesh-list
101353986|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101353987|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
101353988|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101353989|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101353990|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101353991|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101353992|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101353993|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101353994|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101353995|NCT00395369|Aprotinin|aprotinin|mesh-list
101353996|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
101353997|NCT00395369|Coagulants|coagulants|mesh-ancestor
101353998|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101353999|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101354000|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
101354001|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354002|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354003|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
101354004|NCT00052845|Docetaxel|docetaxel|mesh-list
101354005|NCT00052845|Estramustine|estramustine|mesh-list
101354006|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354007|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354008|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
101332929|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
101332930|NCT00015912|Thalidomide|thalidomide|mesh-list
101332931|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332932|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
101332933|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332934|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
101332935|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332936|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332937|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
101332938|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354009|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354010|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354011|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354012|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
101354013|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354014|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101354016|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354017|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101354018|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354019|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101354020|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354021|NCT00052845|Analgesics|analgesics|mesh-ancestor
101354022|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
101354023|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354024|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354025|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354027|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
101354028|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354029|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101354030|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101354031|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354032|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354033|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101354034|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101354035|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
101354036|NCT00052923|Carmustine|carmustine|mesh-list
101354038|NCT00052923|Etoposide|etoposide|mesh-list
101354039|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354040|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
101354041|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354042|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354043|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354044|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
101354045|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354046|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354049|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354051|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354053|NCT00025064|Prednisolone|prednisolone|mesh-list
101354054|NCT00025064|Doxorubicin|doxorubicin|mesh-list
101354055|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101354056|NCT00025064|Etoposide|etoposide|mesh-list
101354057|NCT00025064|Vincristine|vincristine|mesh-list
101354058|NCT00025064|Melphalan|melphalan|mesh-list
101354059|NCT00025064|Ifosfamide|ifosfamide|mesh-list
101354060|NCT00025064|Dacarbazine|dacarbazine|mesh-list
101354061|NCT00025064|Bleomycin|bleomycin|mesh-list
101354062|NCT00025064|Vinblastine|vinblastine|mesh-list
101354063|NCT00025064|Procarbazine|procarbazine|mesh-list
101354064|NCT00025064|Chlorambucil|chlorambucil|mesh-list
101354065|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354066|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354067|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354068|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332939|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101332940|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101332941|NCT00015912|Growth Substances|growth substances|mesh-ancestor
101332942|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
101332943|NCT03668431|Trametinib|trametinib|mesh-list
101332944|NCT03668431|Dabrafenib|dabrafenib|mesh-list
101332945|NCT03668431|Spartalizumab|spartalizumab|mesh-list
101354069|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354070|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354071|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354072|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354073|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354074|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354075|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354076|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
101354077|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354078|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354079|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
101354080|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354082|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
101354083|NCT00025064|Hormones|hormones|mesh-ancestor
101354084|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354085|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354086|NCT00053001|Thalidomide|thalidomide|mesh-list
101354087|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
101354088|NCT00053001|Hematinics|hematinics|mesh-ancestor
101354089|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354090|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
101354091|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354092|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
101354093|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354094|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354095|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354096|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354097|NCT00053001|Growth Substances|growth substances|mesh-ancestor
101354098|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354099|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354100|NCT00025103|Dactinomycin|dactinomycin|mesh-list
101354101|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
101354102|NCT00025103|Melphalan|melphalan|mesh-list
101354103|NCT00025103|Carboplatin|carboplatin|mesh-list
101354104|NCT00025103|Doxorubicin|doxorubicin|mesh-list
101354105|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101354106|NCT00025103|Etoposide|etoposide|mesh-list
101354107|NCT00025103|Vincristine|vincristine|mesh-list
101354108|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354109|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
101354110|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354111|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354112|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354113|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
101354114|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354115|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354116|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354117|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354118|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354119|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354120|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354121|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354122|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354129|NCT00053040|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101354130|NCT00053040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354131|NCT00025142|Leucovorin|leucovorin|mesh-list
101354132|NCT00025142|Fluorouracil|fluorouracil|mesh-list
101354133|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
101354134|NCT00025142|Gefitinib|gefitinib|mesh-list
101354135|NCT00025142|Calcium|calcium|mesh-list
101354136|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
101354137|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101332946|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332947|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101332948|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332949|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332950|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101332951|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354138|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354139|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
101354140|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354141|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354142|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354143|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354144|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
101354145|NCT00025142|Antidotes|antidotes|mesh-ancestor
101354146|NCT00025142|Protective Agents|protective agents|mesh-ancestor
101354147|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
101354148|NCT00025142|Vitamins|vitamins|mesh-ancestor
101354149|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
101354150|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101354151|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354152|NCT00053118|Carboplatin|carboplatin|mesh-list
101354153|NCT00053118|Etoposide|etoposide|mesh-list
101354154|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354155|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354156|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354157|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354158|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354159|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354160|NCT00025181|Ipilimumab|ipilimumab|mesh-list
101354161|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
101354162|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354163|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354164|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101354165|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354166|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354167|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
101354168|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354169|NCT00025220|Thalidomide|thalidomide|mesh-list
101354170|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354171|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
101354172|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354173|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
101354174|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354175|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354176|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354177|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354178|NCT00025220|Growth Substances|growth substances|mesh-ancestor
101354179|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354180|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354181|NCT00053157|Sargramostim|sargramostim|mesh-list
101354182|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
101354183|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354184|NCT00025298|Paclitaxel|paclitaxel|mesh-list
101354185|NCT00025298|Carboplatin|carboplatin|mesh-list
101354186|NCT00025298|Amifostine|amifostine|mesh-list
101354187|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354188|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354189|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354190|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354191|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354196|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
101354197|NCT00053196|Methotrexate|methotrexate|mesh-list
101354198|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
101354199|NCT00053196|Fludarabine|fludarabine|mesh-list
101354200|NCT00053196|Busulfan|busulfan|mesh-list
101354201|NCT00053196|Allopurinol|allopurinol|mesh-list
101354203|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101354204|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101354205|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
101332953|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
101332954|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
101332955|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
101332956|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101332957|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101332958|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101332959|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332960|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
101332961|NCT00015951|Cytarabine|cytarabine|mesh-list
101332962|NCT00015951|Bevacizumab|bevacizumab|mesh-list
101354206|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101354207|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354208|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354209|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
101354210|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354211|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354212|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354213|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354214|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101354215|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354216|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
101354217|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354218|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101354219|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101354220|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354221|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101354222|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
101354223|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354224|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354225|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
101354226|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354227|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354228|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
101354229|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101354230|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
101354231|NCT00053196|Protective Agents|protective agents|mesh-ancestor
101354232|NCT00025337|Leucovorin|leucovorin|mesh-list
101354233|NCT00025337|Bevacizumab|bevacizumab|mesh-list
101354234|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101354235|NCT00025337|Fluorouracil|fluorouracil|mesh-list
101354236|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
101354237|NCT00025337|Antibodies|antibodies|mesh-list
101354238|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
101354239|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101354240|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
101354241|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354242|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354243|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354244|NCT00025337|Growth Substances|growth substances|mesh-ancestor
101354245|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354246|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354247|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
101354248|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
101354249|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354250|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354251|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354252|NCT00025337|Antidotes|antidotes|mesh-ancestor
101354253|NCT00025337|Protective Agents|protective agents|mesh-ancestor
101354254|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
101354255|NCT00025337|Vitamins|vitamins|mesh-ancestor
101354256|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
101354257|NCT00025376|Bortezomib|bortezomib|mesh-list
101354258|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354259|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
101354260|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354261|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101354262|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332963|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
101416906|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
101332964|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101332965|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101332966|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101332967|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101332968|NCT00015951|Growth Substances|growth substances|mesh-ancestor
101332969|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354263|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354264|NCT00025454|Tipifarnib|tipifarnib|mesh-list
101354277|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354279|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354281|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354282|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354283|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354284|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354285|NCT00053430|Growth Substances|growth substances|mesh-ancestor
101354286|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354287|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354288|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
101354289|NCT00025610|Carboplatin|carboplatin|mesh-list
101354290|NCT00025610|Doxorubicin|doxorubicin|mesh-list
101354291|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101354292|NCT00025610|Etoposide|etoposide|mesh-list
101354293|NCT00025610|Vincristine|vincristine|mesh-list
101354294|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354295|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
101354296|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354297|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354298|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354299|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
101354300|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354301|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354302|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354303|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354304|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354305|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354306|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354307|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354308|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354309|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354310|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354311|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
101354312|NCT00025649|Melphalan|melphalan|mesh-list
101354313|NCT00025649|Busulfan|busulfan|mesh-list
101354314|NCT00025649|Carboplatin|carboplatin|mesh-list
101354315|NCT00025649|Doxorubicin|doxorubicin|mesh-list
101354316|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101354317|NCT00025649|Etoposide|etoposide|mesh-list
101354318|NCT00025649|Vincristine|vincristine|mesh-list
101354319|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354320|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
101354321|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354322|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354323|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354324|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
101354325|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354326|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354327|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354328|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354329|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101354330|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354346|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
101354347|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101354348|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101354349|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
101354350|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354351|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354352|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101354353|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101332970|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
101332971|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101332972|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
101332973|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332974|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
101354354|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
101354355|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354356|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101354357|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101354358|NCT00053820|Interferons|interferons|mesh-list
101354359|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
101354360|NCT00053820|Aldesleukin|aldesleukin|mesh-list
101354361|NCT00053820|Fluorouracil|fluorouracil|mesh-list
101354362|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
101354363|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354364|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354365|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354366|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354367|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
101354369|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
101354370|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354371|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101354372|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101354373|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101354374|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
101354375|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101354376|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354377|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
101354378|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101354379|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354380|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354381|NCT00053937|Pirfenidone|pirfenidone|mesh-list
101354382|NCT00053937|Analgesics|analgesics|mesh-ancestor
101354383|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
101354384|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354385|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354386|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101354387|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354388|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354389|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354390|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354391|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
101354408|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101354409|NCT00053976|Protective Agents|protective agents|mesh-ancestor
101354410|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354411|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354412|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354413|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
101354414|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
101354415|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354416|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
101354417|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
101354418|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354419|NCT00054054|Docetaxel|docetaxel|mesh-list
101354420|NCT00054054|Fluorouracil|fluorouracil|mesh-list
101354421|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354422|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354423|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354424|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354425|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354426|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
101354428|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354429|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
101354430|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354431|NCT00026078|Docetaxel|docetaxel|mesh-list
101354432|NCT00026078|Ifosfamide|ifosfamide|mesh-list
101354433|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354434|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
101332975|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332976|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332978|NCT00015951|Analgesics|analgesics|mesh-ancestor
101332979|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
101332980|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101332981|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101332982|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101332983|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101332984|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
101332985|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101332986|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
101354435|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354436|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354437|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354438|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354439|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
101354440|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101354441|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101354442|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354443|NCT00026156|Docetaxel|docetaxel|mesh-list
101354444|NCT00026156|Vinorelbine|vinorelbine|mesh-list
101354445|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354446|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354447|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354448|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354449|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354450|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354451|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101354459|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354460|NCT00054210|Paclitaxel|paclitaxel|mesh-list
101354461|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101354462|NCT00054210|Carboplatin|carboplatin|mesh-list
101354463|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101354464|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354465|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354466|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354467|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354468|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354469|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354470|NCT00026234|Dexamethasone|dexamethasone|mesh-list
101354471|NCT00026234|Capecitabine|capecitabine|mesh-list
101354472|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
101354473|NCT00026234|Floxuridine|floxuridine|mesh-list
101354474|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354475|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
101354476|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
101354477|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354478|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354479|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101354480|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
101354481|NCT00026234|Hormones|hormones|mesh-ancestor
101354482|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354483|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354484|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354485|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354486|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
101354487|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354488|NCT00054288|Gemcitabine|gemcitabine|mesh-list
101354489|NCT00054288|Irinotecan|irinotecan|mesh-list
101354490|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354491|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
101354492|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101332987|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332988|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101332989|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354493|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354494|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101354495|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354496|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354497|NCT00026273|Leucovorin|leucovorin|mesh-list
101354498|NCT00026273|Fluorouracil|fluorouracil|mesh-list
101354499|NCT00026273|Irinotecan|irinotecan|mesh-list
101354500|NCT00026273|Calcium|calcium|mesh-list
101354501|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
101354502|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101354503|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354504|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
101354505|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354506|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354507|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354508|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354510|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101354511|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354512|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354513|NCT00026273|Antidotes|antidotes|mesh-ancestor
101354514|NCT00026273|Protective Agents|protective agents|mesh-ancestor
101354515|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
101354516|NCT00026273|Vitamins|vitamins|mesh-ancestor
101354517|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
101354518|NCT00054405|Aldesleukin|aldesleukin|mesh-list
101354519|NCT00054405|Interleukin-2|interleukin-2|mesh-list
101354520|NCT00054405|Interleukin-12|interleukin-12|mesh-list
101354521|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354525|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354526|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354527|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101354528|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101354529|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
101354530|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354531|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354532|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
101354533|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354534|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354536|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354537|NCT00026351|Rituximab|rituximab|mesh-list
101354538|NCT00026351|Pentostatin|pentostatin|mesh-list
101354539|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354540|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354541|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
101354542|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354543|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354544|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101354545|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354546|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354547|NCT00054444|Topotecan|topotecan|mesh-list
101354548|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354549|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101354550|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354551|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354552|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354553|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
101354554|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354555|NCT00054483|Bortezomib|bortezomib|mesh-list
101354556|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354557|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
101354558|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354559|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101354560|NCT00026468|Protective Agents|protective agents|mesh-ancestor
101354561|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354562|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101354563|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354564|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354565|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101332990|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
101332991|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101332992|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
101332993|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101332994|NCT00001076|Protective Agents|protective agents|mesh-ancestor
101332995|NCT00015990|Thalidomide|thalidomide|mesh-list
101332996|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101332997|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
101332998|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101332999|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
101333000|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333001|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333002|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333003|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333004|NCT00015990|Growth Substances|growth substances|mesh-ancestor
101333005|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333006|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333007|NCT00001085|Lamivudine|lamivudine|mesh-list
101333008|NCT00001085|Zidovudine|zidovudine|mesh-list
101333009|NCT00001085|Amprenavir|amprenavir|mesh-list
101333010|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101333011|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333012|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354566|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354567|NCT00026468|Analgesics|analgesics|mesh-ancestor
101354568|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
101354569|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354570|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354571|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354572|NCT00054522|Calcitriol|calcitriol|mesh-list
101354573|NCT00054522|Dexamethasone|dexamethasone|mesh-list
101354574|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354575|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
101354576|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
101354577|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354578|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354579|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101354580|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
101354581|NCT00054522|Hormones|hormones|mesh-ancestor
101354582|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354583|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101354584|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354585|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101354586|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101354587|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101354588|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354589|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101354591|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
101354592|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101354593|NCT00026585|Tamoxifen|tamoxifen|mesh-list
101354594|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101354599|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354600|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101354601|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101333013|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333014|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
101333015|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333016|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101333017|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101333018|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
101333019|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101333020|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
101333021|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354602|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101354603|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101354604|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101354605|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
101354606|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354607|NCT00054600|Methoxsalen|methoxsalen|mesh-list
101354608|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101354609|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354610|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
101354611|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354612|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101354613|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354614|NCT00026819|Rofecoxib|rofecoxib|mesh-list
101354615|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101354616|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101354617|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354618|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354619|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101354620|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354621|NCT00026819|Analgesics|analgesics|mesh-ancestor
101354622|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
101354623|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354624|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354625|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354626|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354627|NCT00054834|Epratuzumab|epratuzumab|mesh-list
101354628|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354629|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354630|NCT00054873|Fluorouracil|fluorouracil|mesh-list
101354631|NCT00054873|Tezacitabine|tezacitabine|mesh-list
101354632|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
101354633|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354634|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354635|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354636|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354637|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
101354638|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354639|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354640|NCT00398385|Gemcitabine|gemcitabine|mesh-list
101354641|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354642|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354643|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
101354644|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354645|NCT00027014|Fentanyl|fentanyl|mesh-list
101354646|NCT00027014|Oxycodone|oxycodone|mesh-list
101354647|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101354648|NCT00027014|Narcotics|narcotics|mesh-ancestor
101354649|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101354650|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354651|NCT00027014|Analgesics|analgesics|mesh-ancestor
101354652|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
101354653|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354654|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101354655|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101354656|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
101354657|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
101354658|NCT00398424|Cisplatin|cisplatin|mesh-list
101354659|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333022|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101333023|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101333024|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
101333025|NCT02970916|Aflibercept|aflibercept|mesh-list
101333026|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333027|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333029|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333030|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333031|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333032|NCT00016068|Valganciclovir|valganciclovir|mesh-list
101333033|NCT00016068|Ganciclovir|ganciclovir|mesh-list
101333034|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101333035|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
101333036|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333037|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333038|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333039|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333040|NCT00016107|Bevacizumab|bevacizumab|mesh-list
101333041|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101333043|NCT00016107|Estramustine|estramustine|mesh-list
101333044|NCT00016107|Antibodies|antibodies|mesh-list
101333045|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
101333046|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101333047|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333048|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333049|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333050|NCT00016107|Growth Substances|growth substances|mesh-ancestor
101333051|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333052|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333053|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
101333054|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333055|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333056|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333057|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333058|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333059|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
101354660|NCT00027053|Trazodone|trazodone|mesh-list
101333060|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333062|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101333063|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101354661|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101354662|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101354663|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101354664|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354682|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354683|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101354684|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101354685|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354686|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354687|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101354688|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
101354689|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354690|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354691|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
101354692|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354693|NCT00055341|Ribavirin|ribavirin|mesh-list
101354694|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101354695|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
101354696|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354697|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
101354698|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354699|NCT00027287|Vitamin E|vitamin e|mesh-list
101354700|NCT00027287|Vitamins|vitamins|mesh-ancestor
101354702|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354703|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
101354704|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354705|NCT00027287|Protective Agents|protective agents|mesh-ancestor
101354706|NCT00055419|Cetuximab|cetuximab|mesh-list
101354707|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354708|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354709|NCT00055536|Natalizumab|natalizumab|mesh-list
101354710|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
101354711|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354712|NCT00027443|Cyclosporine|cyclosporine|mesh-list
101354713|NCT00027443|Cyclosporins|cyclosporins|mesh-list
101354714|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
101354715|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354716|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354717|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354718|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
101354719|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354720|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
101354730|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354732|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354733|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354734|NCT00027599|Bevacizumab|bevacizumab|mesh-list
101354735|NCT00027599|Sargramostim|sargramostim|mesh-list
101354736|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101354737|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354738|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354739|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354740|NCT00027599|Growth Substances|growth substances|mesh-ancestor
101354741|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354742|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354743|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
101354744|NCT00055653|Cyclosporine|cyclosporine|mesh-list
101354745|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
101354746|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
101354747|NCT00055653|Melphalan|melphalan|mesh-list
101354748|NCT00055653|Busulfan|busulfan|mesh-list
101354749|NCT00055653|Fludarabine|fludarabine|mesh-list
101354750|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
101354751|NCT00055653|Cyclosporins|cyclosporins|mesh-list
101354752|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101354753|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354754|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
101354755|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354756|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333064|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333065|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101333066|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101333067|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
101333068|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333069|NCT00016185|Docetaxel|docetaxel|mesh-list
101333070|NCT00016185|Alvocidib|alvocidib|mesh-list
101354757|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101354758|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
101354759|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354760|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354761|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101354762|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354763|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
101354764|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354765|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
101354766|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354767|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
101354768|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101354769|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354770|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
101354771|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
101354772|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354773|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101354774|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
101354775|NCT00055653|Hormones|hormones|mesh-ancestor
101354776|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354777|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101354778|NCT00055653|Protective Agents|protective agents|mesh-ancestor
101354779|NCT00055770|Docetaxel|docetaxel|mesh-list
101354780|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101354781|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354782|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354783|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354784|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354785|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354786|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101354795|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354796|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354797|NCT00027638|Growth Substances|growth substances|mesh-ancestor
101354798|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354799|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354800|NCT00055809|Interferons|interferons|mesh-list
101354801|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
101354802|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
101354803|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101354804|NCT00055809|Bevacizumab|bevacizumab|mesh-list
101354805|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101354807|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
101354808|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101354809|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354810|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354811|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101354812|NCT00055809|Growth Substances|growth substances|mesh-ancestor
101354813|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354814|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354815|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
101354816|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
101354817|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354819|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354820|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
101354821|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101354822|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101354823|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354824|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101354825|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354826|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354827|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101354828|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333071|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333072|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333073|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333074|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333075|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333076|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333077|NCT00016185|Growth Substances|growth substances|mesh-ancestor
101333078|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354829|NCT00027677|Growth Substances|growth substances|mesh-ancestor
101354830|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354831|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
101354833|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354834|NCT00055887|Paclitaxel|paclitaxel|mesh-list
101354835|NCT00055887|Vinorelbine|vinorelbine|mesh-list
101354836|NCT00055887|Carboplatin|carboplatin|mesh-list
101354837|NCT00055887|Gemcitabine|gemcitabine|mesh-list
101354838|NCT00055887|Efaproxiral|efaproxiral|mesh-list
101354839|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101354840|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354841|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
101354842|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
101354843|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
101354844|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354845|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354846|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
101354847|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
101354848|NCT00026039|Estrogens|estrogens|mesh-list
101354849|NCT00026039|Hormones|hormones|mesh-ancestor
101354850|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354851|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354852|NCT00027404|Fluoxetine|fluoxetine|mesh-list
101354853|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101354854|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101354855|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101354877|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101354879|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
101354880|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354881|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354882|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354883|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354884|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
101354885|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101354886|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354887|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354888|NCT00027833|Antidotes|antidotes|mesh-ancestor
101354889|NCT00027833|Protective Agents|protective agents|mesh-ancestor
101354890|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
101354891|NCT00027833|Vitamins|vitamins|mesh-ancestor
101354892|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
101354893|NCT00027872|Tipifarnib|tipifarnib|mesh-list
101354894|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354895|NCT00027911|Sargramostim|sargramostim|mesh-list
101354896|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
101354897|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354898|NCT00027989|Gemcitabine|gemcitabine|mesh-list
101354899|NCT00027989|Doxorubicin|doxorubicin|mesh-list
101354900|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101354901|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354902|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
101354903|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354904|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354905|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354906|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333079|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333080|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333081|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101333082|NCT00001151|Calcitriol|calcitriol|mesh-list
101333083|NCT00001151|Vitamins|vitamins|mesh-ancestor
101333084|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
101333085|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354907|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101354912|NCT00056004|Analgesics|analgesics|mesh-ancestor
101354913|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
101354914|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354915|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354916|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354917|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354918|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101354919|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354920|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354921|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101354922|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101354923|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101354924|NCT00028028|Sirolimus|sirolimus|mesh-list
101354925|NCT00028028|Temsirolimus|temsirolimus|mesh-list
101354926|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
101354927|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101354928|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354929|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354930|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101354931|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
101354932|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354933|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354934|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101354935|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101354936|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101354937|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
101354938|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101354939|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354940|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354941|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354942|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101354943|NCT00056082|Celecoxib|celecoxib|mesh-list
101354944|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101354945|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101354946|NCT00056082|Analgesics|analgesics|mesh-ancestor
101354947|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
101354948|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101354949|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101354950|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101354951|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101354952|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101354953|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101354954|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354955|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354956|NCT04730973|Evolocumab|evolocumab|mesh-list
101354957|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101354958|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101354959|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101354961|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354962|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101354963|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
101354964|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101354965|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101354966|NCT00028418|Clofarabine|clofarabine|mesh-list
101354967|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101354968|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
101354969|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101354970|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101354971|NCT00028496|Metronidazole|metronidazole|mesh-list
101333086|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101354972|NCT00028496|Molgramostim|molgramostim|mesh-list
101354973|NCT00028496|Vaccines|vaccines|mesh-list
101354974|NCT00028496|Sargramostim|sargramostim|mesh-list
101354975|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
101354976|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
101354977|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355003|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101355004|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355005|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355006|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101355007|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355008|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101355009|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101355010|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355011|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355012|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101355014|NCT00028574|Analgesics|analgesics|mesh-ancestor
101355015|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
101355016|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355017|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355018|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
101355019|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101355020|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101355021|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355022|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355023|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101355024|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101355025|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355032|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101355033|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355034|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355035|NCT00056433|Urological Agents|urological agents|mesh-ancestor
101355036|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355037|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
101355038|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101355039|NCT00028613|Antibodies|antibodies|mesh-list
101355040|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101355041|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
101355042|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355043|NCT00028652|Interleukin-12|interleukin-12|mesh-list
101355044|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355045|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
101355046|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355047|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355048|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355049|NCT00028652|Growth Substances|growth substances|mesh-ancestor
101355050|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355051|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355052|NCT00028691|Chlorambucil|chlorambucil|mesh-list
101355053|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355054|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
101355055|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355056|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355057|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
101355059|NCT00028730|Fludarabine|fludarabine|mesh-list
101355060|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
101355061|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101355062|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355063|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
101355064|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355065|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355066|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355067|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
101355068|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355069|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355070|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101355071|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333087|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101333088|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101333089|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101333090|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355072|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
101355074|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
101355075|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355076|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
101355077|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355078|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355079|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
101355080|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355081|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355082|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
101355083|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355084|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355085|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355086|NCT00028886|Interferons|interferons|mesh-list
101355087|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
101355088|NCT00028886|Thalidomide|thalidomide|mesh-list
101355089|NCT00028886|Dexamethasone|dexamethasone|mesh-list
101355090|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
101355091|NCT00028886|Melphalan|melphalan|mesh-list
101355092|NCT00028886|Doxorubicin|doxorubicin|mesh-list
101355093|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101355094|NCT00028886|Vincristine|vincristine|mesh-list
101355095|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355108|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355109|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
101355111|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355112|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101355113|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355114|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355115|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355116|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355117|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
101355118|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355119|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355120|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355121|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355122|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355123|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
101355124|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355125|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355126|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355127|NCT00028886|Growth Substances|growth substances|mesh-ancestor
101355128|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355129|NCT00028925|Carboplatin|carboplatin|mesh-list
101355130|NCT00028925|Topotecan|topotecan|mesh-list
101355131|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355132|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101355133|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355134|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355135|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355136|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
101355139|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101355140|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355141|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101355142|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355143|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
101355144|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355145|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355146|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355147|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
101355148|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355149|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
101333091|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101333092|NCT00016224|Thalidomide|thalidomide|mesh-list
101333094|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
101333095|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333096|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
101333097|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333098|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333099|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333100|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333101|NCT00016224|Growth Substances|growth substances|mesh-ancestor
101355150|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101355151|NCT00398463|Protective Agents|protective agents|mesh-ancestor
101355152|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
101355153|NCT00028964|Doxorubicin|doxorubicin|mesh-list
101355154|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101355155|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355156|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
101355157|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355163|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101355164|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355165|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355166|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355167|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355168|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101355169|NCT00423501|Incretins|incretins|mesh-ancestor
101355170|NCT00423501|Hormones|hormones|mesh-ancestor
101355171|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355172|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355173|NCT00029003|Gefitinib|gefitinib|mesh-list
101355174|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355175|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355176|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355177|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355178|NCT00029042|Infliximab|infliximab|mesh-list
101355179|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101355180|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355181|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355182|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355183|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355184|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
101355186|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
101355187|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355188|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355189|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
101355190|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355191|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101355192|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
101355193|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101355194|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355195|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355196|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101355197|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
101355198|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101355199|NCT00029159|Estrogens|estrogens|mesh-list
101355200|NCT00029159|Androgens|androgens|mesh-list
101355201|NCT00029159|Hormones|hormones|mesh-ancestor
101355202|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355203|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355204|NCT00423696|Leucovorin|leucovorin|mesh-list
101355205|NCT00423696|Bevacizumab|bevacizumab|mesh-list
101355206|NCT00423696|Fluorouracil|fluorouracil|mesh-list
101355207|NCT00423696|Capecitabine|capecitabine|mesh-list
101355208|NCT00423696|Irinotecan|irinotecan|mesh-list
101355209|NCT00423696|Calcium|calcium|mesh-list
101355210|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
101355211|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101333102|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333103|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333104|NCT00016263|Dacarbazine|dacarbazine|mesh-list
101333105|NCT00016263|Oblimersen|oblimersen|mesh-list
101333106|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355212|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355213|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355214|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355215|NCT00423696|Growth Substances|growth substances|mesh-ancestor
101355216|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355217|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355218|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101355219|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
101355220|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355221|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355222|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355223|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
101355224|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101355225|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355226|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355235|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101355236|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355237|NCT00056823|Ranibizumab|ranibizumab|mesh-list
101355238|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355239|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355240|NCT00056823|Growth Substances|growth substances|mesh-ancestor
101355241|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355242|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355243|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355244|NCT00029627|Yohimbine|yohimbine|mesh-list
101355245|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
101355246|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
101355247|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355248|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355249|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101355250|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101355251|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101355252|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
101355253|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355254|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355255|NCT00029627|Urological Agents|urological agents|mesh-ancestor
101355256|NCT02970084|Vitamin K|vitamin k|mesh-list
101355257|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
101355258|NCT02970084|Vitamins|vitamins|mesh-ancestor
101355259|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
101355260|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355261|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101355262|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101355263|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355264|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
101355265|NCT02970084|Coagulants|coagulants|mesh-ancestor
101355266|NCT00056979|Fludarabine|fludarabine|mesh-list
101355267|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
101355268|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355269|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355270|NCT00029822|Alfuzosin|alfuzosin|mesh-list
101355271|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101355272|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101355273|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101355274|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101355275|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355276|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355277|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355278|NCT00029822|Urological Agents|urological agents|mesh-ancestor
101355279|NCT00395681|Propofol|propofol|mesh-list
101355280|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101355281|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355282|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355283|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101355284|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
101333107|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
101333108|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333109|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333110|NCT00016302|Leucovorin|leucovorin|mesh-list
101355285|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
101355286|NCT00395720|Vaccines|vaccines|mesh-list
101355287|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
101355288|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355289|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
101355290|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101355291|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101355292|NCT00395915|Aripiprazole|aripiprazole|mesh-list
101355293|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
101355294|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355295|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101355296|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101355303|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101355305|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
101355306|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101355307|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101355308|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101355309|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101355310|NCT00029861|Rimonabant|rimonabant|mesh-list
101355311|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101355312|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101355313|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101355314|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355315|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355316|NCT00029861|Hormones|hormones|mesh-ancestor
101355317|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355318|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355319|NCT00057369|Dalbavancin|dalbavancin|mesh-list
101355320|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355321|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355322|NCT00057408|Olanzapine|olanzapine|mesh-list
101355323|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
101355324|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
101355325|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
101355326|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355327|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355328|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355329|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101355330|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355331|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355332|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101355333|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101355334|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355335|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355336|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355337|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
101355338|NCT00030056|Molgramostim|molgramostim|mesh-list
101355339|NCT00030056|Sargramostim|sargramostim|mesh-list
101355340|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
101355341|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355342|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355343|NCT00057447|Interferons|interferons|mesh-list
101355344|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
101355345|NCT00057447|Rituximab|rituximab|mesh-list
101355346|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355347|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355348|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
101355349|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355350|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355351|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
101355352|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355353|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
101355354|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355355|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355356|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355357|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355358|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333112|NCT00016302|Dexamethasone|dexamethasone|mesh-list
101333113|NCT00016302|Prednisone|prednisone|mesh-list
101333114|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
101333115|NCT00016302|Doxorubicin|doxorubicin|mesh-list
101333116|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101333117|NCT00016302|Methotrexate|methotrexate|mesh-list
101333118|NCT00016302|Vincristine|vincristine|mesh-list
101355359|NCT00030173|Epothilones|epothilones|mesh-list
101355360|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
101355361|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355362|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355369|NCT00057564|BB 1101|bb 1101|mesh-list
101355370|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355371|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
101355372|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
101355373|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355374|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355375|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355376|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
101355377|NCT00057564|Hormones|hormones|mesh-ancestor
101355378|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355379|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101355380|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355381|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
101355382|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355383|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355384|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355385|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
101355386|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
101355387|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355388|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355389|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355390|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355391|NCT00057564|Growth Substances|growth substances|mesh-ancestor
101355392|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355393|NCT00030368|Paclitaxel|paclitaxel|mesh-list
101355394|NCT00030368|Bortezomib|bortezomib|mesh-list
101355395|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355396|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355397|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355398|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355399|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355400|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355401|NCT00030407|Celecoxib|celecoxib|mesh-list
101355402|NCT00030407|Docetaxel|docetaxel|mesh-list
101355403|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355404|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355405|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355406|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355407|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355408|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101355409|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101355410|NCT00030407|Analgesics|analgesics|mesh-ancestor
101355411|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
101355412|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355413|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355414|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355415|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355416|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101355417|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101355418|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355419|NCT00057642|Sertraline|sertraline|mesh-list
101355420|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101355421|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
101355422|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355423|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101355424|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101355425|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355426|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333119|NCT00016302|Daunorubicin|daunorubicin|mesh-list
101333120|NCT00016302|Asparaginase|asparaginase|mesh-list
101333121|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
101333122|NCT00016302|Pegaspargase|pegaspargase|mesh-list
101333123|NCT00016302|Thioguanine|thioguanine|mesh-list
101333124|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
101333125|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333126|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
101333127|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333128|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355427|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355429|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355430|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101355434|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355435|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355436|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355437|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355438|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101355439|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355440|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355441|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355442|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355443|NCT00057720|Doxorubicin|doxorubicin|mesh-list
101355444|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101355446|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355447|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355448|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355449|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355450|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355451|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355452|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101355453|NCT00030524|Gefitinib|gefitinib|mesh-list
101355454|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355455|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355456|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355457|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355458|NCT00030563|Irinotecan|irinotecan|mesh-list
101355459|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101355460|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355461|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355462|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355463|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355464|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
101355465|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355466|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
101355467|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355468|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
101355469|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355470|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
101355471|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101355472|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101355473|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355474|NCT00057759|Urological Agents|urological agents|mesh-ancestor
101355475|NCT00030641|Docetaxel|docetaxel|mesh-list
101355476|NCT00030641|Oblimersen|oblimersen|mesh-list
101355477|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355478|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355479|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355480|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355481|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355482|NCT00057798|Gemcitabine|gemcitabine|mesh-list
101355483|NCT00057798|Vinorelbine|vinorelbine|mesh-list
101355484|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355486|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355487|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333129|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333130|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
101333131|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333132|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333133|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333134|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355488|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355489|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355490|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355491|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355492|NCT02969733|Lidocaine|lidocaine|mesh-list
101355493|NCT02969733|Ketamine|ketamine|mesh-list
101355494|NCT02969733|Analgesics|analgesics|mesh-ancestor
101355495|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
101355496|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355497|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355498|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101355499|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101355500|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
101355501|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
101355502|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355533|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355535|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355536|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355537|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355538|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355539|NCT00030758|Lenograstim|lenograstim|mesh-list
101355540|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355541|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
101355542|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355543|NCT04730895|Tretinoin|tretinoin|mesh-list
101355544|NCT04730895|Isotretinoin|isotretinoin|mesh-list
101355545|NCT04730895|Vaccines|vaccines|mesh-list
101355546|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
101355547|NCT04730895|Paraproteins|paraproteins|mesh-list
101355552|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355553|NCT00030797|Irinotecan|irinotecan|mesh-list
101355554|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101355555|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355556|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355557|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355558|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355559|NCT00058071|Amifostine|amifostine|mesh-list
101355560|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101355561|NCT00058071|Protective Agents|protective agents|mesh-ancestor
101355562|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355563|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101355564|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101355565|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
101355566|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101355567|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101355568|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355569|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355571|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355572|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101355573|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
101355574|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355575|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101355576|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101355577|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101355578|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
101355579|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101355580|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101355581|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101355582|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101333135|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
101333136|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
101333137|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333138|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101333139|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
101333140|NCT00016302|Hormones|hormones|mesh-ancestor
101355583|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101355584|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355586|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
101355587|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355588|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
101355589|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355590|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355591|NCT00058227|Rituximab|rituximab|mesh-list
101355592|NCT00058227|Fludarabine|fludarabine|mesh-list
101355593|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
101355595|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355596|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355597|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
101355598|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355599|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355600|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355601|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
101355602|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355603|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355604|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355605|NCT00058227|Growth Substances|growth substances|mesh-ancestor
101355606|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355607|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355608|NCT00031070|Cyclosporine|cyclosporine|mesh-list
101355609|NCT00031070|Lamivudine|lamivudine|mesh-list
101355610|NCT00031070|Zidovudine|zidovudine|mesh-list
101355611|NCT00031070|Efavirenz|efavirenz|mesh-list
101355612|NCT00031070|Abacavir|abacavir|mesh-list
101355613|NCT00031070|Vaccines|vaccines|mesh-list
101355614|NCT00031070|Cyclosporins|cyclosporins|mesh-list
101355615|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101355616|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
101355617|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355618|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355641|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355643|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355644|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355645|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355646|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355647|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
101355648|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355649|NCT00058461|Cytarabine|cytarabine|mesh-list
101355650|NCT00058461|Rituximab|rituximab|mesh-list
101355651|NCT00058461|Carboplatin|carboplatin|mesh-list
101355652|NCT00058461|Methotrexate|methotrexate|mesh-list
101355653|NCT00058461|Etoposide|etoposide|mesh-list
101355654|NCT00058461|Ifosfamide|ifosfamide|mesh-list
101355655|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355656|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355657|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
101355658|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355659|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355660|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101355661|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
101355662|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101355663|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355664|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
101355665|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355666|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355671|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355672|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333141|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333142|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333143|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333144|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355673|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355675|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355676|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355677|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
101355678|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
101355679|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355680|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
101355681|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355682|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355683|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101355684|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
101355685|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355686|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355687|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101355688|NCT04711889|Urinastatin|urinastatin|mesh-list
101355689|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101355690|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101355691|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
101355692|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355693|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355694|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101355695|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355696|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
101355697|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355698|NCT00031109|Antacids|antacids|mesh-ancestor
101355699|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355700|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355701|NCT00031148|Mitogens|mitogens|mesh-list
101355702|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355703|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355704|NCT00031187|Docetaxel|docetaxel|mesh-list
101355705|NCT00031187|Doxorubicin|doxorubicin|mesh-list
101355706|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
101355707|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355708|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355709|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355710|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355711|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355712|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355713|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355714|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355715|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355716|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
101355717|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355718|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101355719|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
101355720|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355721|NCT00058890|Gabapentin|gabapentin|mesh-list
101355722|NCT00058890|Analgesics|analgesics|mesh-ancestor
101355723|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
101355724|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355725|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355726|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
101355727|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101355728|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101355729|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355730|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355731|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101355732|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101355733|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355734|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355735|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
101355747|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101333145|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333146|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333147|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101333148|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
101333149|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101355748|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355749|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355750|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355751|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355752|NCT00058968|Analgesics|analgesics|mesh-ancestor
101355753|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
101355754|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355755|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
101355756|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355757|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
101355758|NCT00396227|Pioglitazone|pioglitazone|mesh-list
101355759|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
101355760|NCT00396227|Vildagliptin|vildagliptin|mesh-list
101355761|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101355762|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101355763|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355764|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101355765|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
101355766|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355767|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355768|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
101355769|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101355770|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101355771|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101355772|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101355774|NCT00031499|Doxycycline|doxycycline|mesh-list
101355775|NCT00031499|Penicillins|penicillins|mesh-list
101355776|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101355777|NCT00031499|Penicillin G|penicillin g|mesh-list
101355778|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
101355779|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355780|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355781|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
101355782|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101355783|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101355784|NCT00059358|Interferons|interferons|mesh-list
101355785|NCT00059358|Ribavirin|ribavirin|mesh-list
101355786|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
101355787|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
101355788|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101355789|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355790|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
101355791|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355792|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
101355793|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355794|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
101355795|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355796|NCT00031577|Paclitaxel|paclitaxel|mesh-list
101355797|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101355798|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355801|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355802|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355804|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
101355805|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
101355806|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355807|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355808|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355809|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101355810|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355811|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355812|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
101355813|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355814|NCT00031655|Cyclosporine|cyclosporine|mesh-list
101333150|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333151|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
101333152|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355815|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
101355816|NCT00031655|Fludarabine|fludarabine|mesh-list
101355817|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
101355818|NCT00031655|Cyclosporins|cyclosporins|mesh-list
101355819|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355820|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355821|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
101355822|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355823|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355824|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
101355825|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355827|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
101355828|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355829|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
101355830|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355831|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101355832|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355833|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101355834|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
101355835|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101355836|NCT00059592|Valacyclovir|valacyclovir|mesh-list
101355837|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
101355838|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355839|NCT00031733|Interleukin-12|interleukin-12|mesh-list
101355840|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101355841|NCT00031733|Sargramostim|sargramostim|mesh-list
101355842|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
101355843|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
101355844|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
101355845|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355846|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355847|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355848|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101355849|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101355850|NCT00031733|Growth Substances|growth substances|mesh-ancestor
101355851|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
101355852|NCT00031733|Antacids|antacids|mesh-ancestor
101355853|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355854|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101355855|NCT02969265|Amlodipine|amlodipine|mesh-list
101355856|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
101355857|NCT02969265|Candesartan|candesartan|mesh-list
101355858|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101355859|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101355860|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355861|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355862|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101355863|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355864|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
101355865|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101355866|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101355867|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101355868|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101355869|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
101355870|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355871|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355880|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
101355881|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355882|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355883|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101355884|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101355885|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101355887|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
101355888|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355889|NCT00059631|Analgesics|analgesics|mesh-ancestor
101355890|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
101355891|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333153|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101333154|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333155|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
101355892|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355893|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101355894|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101355895|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355896|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355899|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355900|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101355901|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101355902|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355903|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355904|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101355905|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
101355906|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101355907|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355908|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
101355909|NCT00031928|Mafosfamide|mafosfamide|mesh-list
101355910|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355911|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
101355912|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355913|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355914|NCT00031967|Melatonin|melatonin|mesh-list
101355915|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
101355916|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355918|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355919|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101355920|NCT00059826|Interferons|interferons|mesh-list
101355921|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
101355922|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
101355923|NCT00059826|Fluorouracil|fluorouracil|mesh-list
101355924|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355925|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
101355926|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355927|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355928|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101355929|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
101355930|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355932|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355933|NCT00032045|Ipilimumab|ipilimumab|mesh-list
101355934|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
101355935|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355938|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355939|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101355940|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
101355941|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355943|NCT00059865|Pemetrexed|pemetrexed|mesh-list
101355944|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101355945|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
101355946|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355947|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355948|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355949|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101355950|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101355951|NCT00032084|Bupropion|bupropion|mesh-list
101355952|NCT00032084|Nicotine|nicotine|mesh-list
101355953|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101355954|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
101355955|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101355956|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355958|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101355959|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
101355960|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101355961|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333156|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333157|NCT00016302|Antidotes|antidotes|mesh-ancestor
101333158|NCT00016302|Protective Agents|protective agents|mesh-ancestor
101333159|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
101333160|NCT00016302|Vitamins|vitamins|mesh-ancestor
101333161|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
101333162|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333163|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333164|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333165|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333166|NCT00389285|Sorafenib|sorafenib|mesh-list
101355962|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101355963|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
101355964|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101355965|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101355966|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101355967|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101355968|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
101355969|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101355970|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101355971|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355972|NCT00059904|Aldesleukin|aldesleukin|mesh-list
101355973|NCT00059904|Rituximab|rituximab|mesh-list
101355974|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101355975|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355976|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
101355977|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101355978|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101355979|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101355980|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101355981|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
101355982|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101355983|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101355984|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355985|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101355986|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101355987|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355988|NCT00059943|Docetaxel|docetaxel|mesh-list
101355989|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355990|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
101355991|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
101355992|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
101355993|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101355995|NCT00032162|Doxorubicin|doxorubicin|mesh-list
101355996|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101355997|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101355998|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101355999|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356000|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356001|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356002|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356004|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
101356005|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356006|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
101356007|NCT00060138|Antibodies|antibodies|mesh-list
101356013|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101356014|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
101356016|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356017|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356018|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
101356019|NCT00060255|Melphalan|melphalan|mesh-list
101333167|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333168|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333170|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333171|NCT00016341|Tamoxifen|tamoxifen|mesh-list
101356020|NCT00060255|Busulfan|busulfan|mesh-list
101356021|NCT00060255|Thiotepa|thiotepa|mesh-list
101356022|NCT00060255|Carmustine|carmustine|mesh-list
101356023|NCT00060255|Carboplatin|carboplatin|mesh-list
101356024|NCT00060255|Etoposide|etoposide|mesh-list
101356025|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356026|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
101356027|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356028|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356029|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101356030|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
101356031|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356032|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356033|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101356034|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356035|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356036|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356037|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356038|NCT00060294|Rituximab|rituximab|mesh-list
101356039|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356040|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356041|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
101356042|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356043|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356044|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101356046|NCT00060372|Antibodies|antibodies|mesh-list
101356047|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
101356048|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101356049|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
101356050|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356051|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356052|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101356053|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356055|NCT00060411|Bevacizumab|bevacizumab|mesh-list
101356056|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101356057|NCT00060411|Fluorouracil|fluorouracil|mesh-list
101356058|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
101356059|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101356060|NCT00060411|Antibodies|antibodies|mesh-list
101356061|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
101356062|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101356063|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
101356064|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356065|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101356066|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101356067|NCT00060411|Growth Substances|growth substances|mesh-ancestor
101356068|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356069|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
101356070|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
101356071|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
101356072|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356073|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356074|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356075|NCT00060411|Antidotes|antidotes|mesh-ancestor
101356076|NCT00060411|Protective Agents|protective agents|mesh-ancestor
101356077|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356078|NCT00060411|Vitamins|vitamins|mesh-ancestor
101356079|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
101356080|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101356084|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
101356085|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356086|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356087|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101356088|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
101356089|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101333172|NCT00016341|Paclitaxel|paclitaxel|mesh-list
101333173|NCT00016341|Doxorubicin|doxorubicin|mesh-list
101333174|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101333175|NCT00016341|Megestrol|megestrol|mesh-list
101333176|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
101333177|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333178|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333179|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333180|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333181|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356090|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
101356091|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356092|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356093|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101356094|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
101356095|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
101356096|NCT00060450|Protective Agents|protective agents|mesh-ancestor
101356097|NCT00032747|Vasopressins|vasopressins|mesh-list
101356098|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
101356099|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
101356100|NCT00032747|Coagulants|coagulants|mesh-ancestor
101356101|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101356102|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101356103|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
101356104|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356105|NCT00032786|Natalizumab|natalizumab|mesh-list
101356106|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
101356107|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356108|NCT02968719|Donepezil|donepezil|mesh-list
101356109|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101356110|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356111|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356112|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
101356113|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356114|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356115|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
101356116|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101356117|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356118|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356119|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101356120|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356121|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356122|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356123|NCT00032825|Ketoconazole|ketoconazole|mesh-list
101356124|NCT00032825|Docetaxel|docetaxel|mesh-list
101356125|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356126|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356127|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356128|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356129|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356130|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
101356131|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356132|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101356133|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356134|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356135|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101356136|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356137|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356138|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356139|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101356141|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356142|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356143|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356144|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356145|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
101356146|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333182|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333183|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356147|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
101356148|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356149|NCT00060684|Dexamethasone|dexamethasone|mesh-list
101356150|NCT00060684|Rituximab|rituximab|mesh-list
101356151|NCT00060684|Fludarabine|fludarabine|mesh-list
101356152|NCT00060684|Pixantrone|pixantrone|mesh-list
101356156|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356157|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101356158|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101356159|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
101356160|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
101356161|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356162|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356165|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356166|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356167|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356168|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356169|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356170|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356171|NCT02971475|Analgesics|analgesics|mesh-list
101356172|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
101356173|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356174|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356175|NCT00032942|Lofexidine|lofexidine|mesh-list
101356176|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101356177|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101356178|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356179|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
101356180|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356181|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101356182|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101356183|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101356184|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
101356185|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356186|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356187|NCT00033059|Tolcapone|tolcapone|mesh-list
101356188|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101356189|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101356190|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101356191|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356192|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356193|NCT00060918|Metoprolol|metoprolol|mesh-list
101356194|NCT00060918|Carvedilol|carvedilol|mesh-list
101356195|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101356196|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101356197|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
101356198|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
101356199|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356200|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356201|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101356202|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101356203|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101356204|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
101356205|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356206|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356207|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
101356208|NCT00060918|Protective Agents|protective agents|mesh-ancestor
101356209|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101356210|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356211|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101356212|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
101356213|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101356214|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101356216|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
101356217|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356218|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356219|NCT02968641|Ritonavir|ritonavir|mesh-list
101356220|NCT02968641|Lonafarnib|lonafarnib|mesh-list
101333184|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333185|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333186|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333187|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356221|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101356222|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101356223|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
101356228|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
101356229|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356230|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101356231|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356232|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
101356233|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
101356234|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356235|NCT00033176|Protective Agents|protective agents|mesh-ancestor
101356236|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356237|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356238|NCT00033176|Vitamins|vitamins|mesh-ancestor
101356239|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
101356240|NCT00033215|S 3304|s 3304|mesh-list
101356241|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
101356242|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
101356243|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356244|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356245|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
101356246|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101356247|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101356248|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101356249|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356250|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356251|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
101356252|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356253|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356254|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101356255|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356257|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101356258|NCT00033254|Thalidomide|thalidomide|mesh-list
101356259|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356260|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
101356261|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356262|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
101356263|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356264|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356265|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101356266|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101356267|NCT00033254|Growth Substances|growth substances|mesh-ancestor
101356268|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
101356269|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356271|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101356272|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
101356273|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356274|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356275|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101356276|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101356277|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
101356278|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356279|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356280|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
101356282|NCT00033332|Thalidomide|thalidomide|mesh-list
101356283|NCT00033332|Dexamethasone|dexamethasone|mesh-list
101356284|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101356285|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
101356286|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
101356287|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356288|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356289|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356290|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
101333189|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333190|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333191|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333192|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101333193|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101356292|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356293|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356294|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356298|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356299|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356300|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101356301|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101356302|NCT00033332|Growth Substances|growth substances|mesh-ancestor
101356303|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
101356304|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101356306|NCT00033410|Carboplatin|carboplatin|mesh-list
101356307|NCT00033410|Tirapazamine|tirapazamine|mesh-list
101356308|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356309|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356310|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356311|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356312|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356313|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356314|NCT00061113|Fluoxetine|fluoxetine|mesh-list
101356315|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101356316|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356317|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356318|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356319|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356320|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
101356321|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356322|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101356323|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356324|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356325|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101356326|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356327|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356329|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356330|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101356331|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356332|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356333|NCT00061152|Capsaicin|capsaicin|mesh-list
101356334|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
101356335|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
101356336|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
101356337|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356338|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356340|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
101356341|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
101356342|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356343|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356344|NCT00033605|Octreotide|octreotide|mesh-list
101356345|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356346|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356347|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356348|NCT00033644|Doxorubicin|doxorubicin|mesh-list
101356349|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101356350|NCT00033644|Mitomycins|mitomycins|mesh-list
101356351|NCT00033644|Mitomycin|mitomycin|mesh-list
101356352|NCT00033644|Dacarbazine|dacarbazine|mesh-list
101356353|NCT00033644|Sargramostim|sargramostim|mesh-list
101333194|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101333195|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101333196|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101333197|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101333198|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
101333199|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333200|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101333201|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101333202|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
101333203|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101333204|NCT00001181|Testolactone|testolactone|mesh-list
101333205|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333206|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333207|NCT00016380|Dexamethasone|dexamethasone|mesh-list
101333209|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101333210|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
101356354|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356355|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356356|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356357|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356358|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356359|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356360|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
101356361|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356362|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
101356363|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101356364|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101356365|NCT00033683|Tamoxifen|tamoxifen|mesh-list
101356366|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
101356386|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
101356387|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101356388|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
101356389|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356390|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101356391|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101356392|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356393|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356394|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356396|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356397|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356398|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356399|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101356400|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101356401|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101356402|NCT00061308|Gemcitabine|gemcitabine|mesh-list
101356404|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356405|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
101356406|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356407|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356408|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356409|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356410|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356411|NCT00033722|Folic Acid|folic acid|mesh-list
101356412|NCT00033722|Lometrexol|lometrexol|mesh-list
101333211|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
101333212|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356413|NCT00033722|Hematinics|hematinics|mesh-ancestor
101356414|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356415|NCT00033722|Vitamins|vitamins|mesh-ancestor
101356416|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
101356417|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356418|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356419|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
101356420|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356421|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356422|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101356437|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101356440|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101356441|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101356442|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
101356443|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356444|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356445|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356446|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101356447|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101356448|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
101356449|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
101356450|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356451|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101356452|NCT00061620|Tezacitabine|tezacitabine|mesh-list
101356453|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356454|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356455|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356456|NCT00034151|Paclitaxel|paclitaxel|mesh-list
101356457|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356458|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356459|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356460|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356461|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356462|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356463|NCT00034190|Paclitaxel|paclitaxel|mesh-list
101356464|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356465|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356466|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356467|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356468|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356469|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356470|NCT00034229|Felbamate|felbamate|mesh-list
101356471|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
101356472|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101356473|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101356474|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356475|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356476|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356477|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
101356478|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101356479|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356480|NCT00061776|Capsaicin|capsaicin|mesh-list
101356481|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
101356482|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101356486|NCT00034346|Paclitaxel|paclitaxel|mesh-list
101356487|NCT00034346|Carboplatin|carboplatin|mesh-list
101356488|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356489|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356490|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356491|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356492|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356493|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356494|NCT00034385|Valganciclovir|valganciclovir|mesh-list
101356495|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
101356496|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356497|NCT00034463|Folic Acid|folic acid|mesh-list
101356498|NCT00034463|Vitamins|vitamins|mesh-ancestor
101356500|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356501|NCT00034463|Hematinics|hematinics|mesh-ancestor
101333213|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356502|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356504|NCT02971397|Daunorubicin|daunorubicin|mesh-list
101356505|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356506|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
101356507|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356508|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356509|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
101356510|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356511|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356512|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
101356513|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356514|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101356515|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101356516|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356517|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356518|NCT00396500|Vitamin A|vitamin a|mesh-list
101356519|NCT00396500|Albendazole|albendazole|mesh-list
101356520|NCT00396500|Vitamins|vitamins|mesh-ancestor
101356521|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
101356522|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356523|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356524|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356525|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
101356526|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101356527|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356528|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
101356529|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101356530|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101356531|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356532|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356533|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356534|NCT00034502|Irinotecan|irinotecan|mesh-list
101356535|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356536|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356538|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356539|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356540|NCT00034541|Paclitaxel|paclitaxel|mesh-list
101356541|NCT00034541|Carboplatin|carboplatin|mesh-list
101356543|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356544|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356545|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356546|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356547|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356548|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356549|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356550|NCT00034580|Olanzapine|olanzapine|mesh-list
101356551|NCT00034580|Risperidone|risperidone|mesh-list
101356552|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101356553|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
101356554|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356555|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356556|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356557|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101356564|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
101356565|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356566|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356567|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101356568|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356569|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356570|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
101356571|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356572|NCT00061815|Leucovorin|leucovorin|mesh-list
101356573|NCT00061815|Fluorouracil|fluorouracil|mesh-list
101356574|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
101356575|NCT00061815|Cetuximab|cetuximab|mesh-list
101356576|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
101356577|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356578|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101356579|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356580|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356581|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
101356582|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333214|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101333215|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
101333216|NCT00016380|Hormones|hormones|mesh-ancestor
101333217|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333218|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356583|NCT00061815|Antidotes|antidotes|mesh-ancestor
101356584|NCT00061815|Protective Agents|protective agents|mesh-ancestor
101356585|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
101356586|NCT00061815|Vitamins|vitamins|mesh-ancestor
101356587|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
101356588|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101356589|NCT00061854|Soblidotin|soblidotin|mesh-list
101356590|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356591|NCT00034658|Posaconazole|posaconazole|mesh-list
101356592|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
101356593|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356594|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101356595|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101356596|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101356597|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101356598|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356599|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356600|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356601|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101356602|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356603|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356604|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356605|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
101356606|NCT00398580|Testosterone|testosterone|mesh-list
101356607|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
101356608|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
101356609|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101356610|NCT00398580|Dutasteride|dutasteride|mesh-list
101356611|NCT00398580|Androgens|androgens|mesh-ancestor
101356612|NCT00398580|Hormones|hormones|mesh-ancestor
101356613|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356614|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356615|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101356616|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356617|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
101356618|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101356619|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101356620|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356621|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356622|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356623|NCT00034697|Temozolomide|temozolomide|mesh-list
101356624|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101356625|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
101356626|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356636|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356637|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101356638|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356639|NCT02967939|Tenofovir|tenofovir|mesh-list
101356640|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
101356641|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356642|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101356643|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101356644|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356645|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356646|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101356647|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101356648|NCT00034775|Risperidone|risperidone|mesh-list
101356649|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101356650|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
101356651|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356652|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356653|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356654|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101333219|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333220|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
101333221|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333222|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101333223|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101333224|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
101356655|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356656|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356657|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356658|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101356659|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
101356660|NCT00062127|Thalidomide|thalidomide|mesh-list
101356661|NCT00062127|Irinotecan|irinotecan|mesh-list
101356662|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356663|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356664|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356665|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356666|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356667|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101356668|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
101356669|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356670|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
101356671|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101356672|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356673|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101356674|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101356676|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
101356677|NCT00034853|Naproxen|naproxen|mesh-list
101356678|NCT00034853|Meloxicam|meloxicam|mesh-list
101356679|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101356680|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101356681|NCT00034853|Analgesics|analgesics|mesh-ancestor
101356682|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
101356683|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356684|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356685|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101356687|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
101356688|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101356689|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356690|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356691|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101356692|NCT00034892|Olanzapine|olanzapine|mesh-list
101356703|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101356704|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
101356705|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
101356706|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
101356707|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356708|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356709|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101356710|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356711|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356712|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
101356713|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356714|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101356715|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356716|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356717|NCT00062244|Oblimersen|oblimersen|mesh-list
101356718|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356719|NCT00035009|Aprepitant|aprepitant|mesh-list
101356720|NCT00035009|Paroxetine|paroxetine|mesh-list
101356721|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101356722|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356723|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356724|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356725|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356726|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
101356727|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333225|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333226|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333228|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356728|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101356729|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356730|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356731|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101356732|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356733|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356734|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
101356735|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
101356736|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356737|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356738|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101356739|NCT00062283|Alanosine|alanosine|mesh-list
101356741|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356742|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
101356743|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
101356744|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356745|NCT00035048|Aprepitant|aprepitant|mesh-list
101356746|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
101356747|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
101356748|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356749|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356750|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356751|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101356752|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356753|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356754|NCT00035087|Epothilones|epothilones|mesh-list
101356755|NCT00035087|Epothilone B|epothilone b|mesh-list
101356770|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356771|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356772|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356773|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356774|NCT00035165|Epothilones|epothilones|mesh-list
101356775|NCT00035165|Epothilone B|epothilone b|mesh-list
101356776|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356777|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356778|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356779|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356780|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356781|NCT00035204|Galantamine|galantamine|mesh-list
101356782|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101356783|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356784|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356785|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
101356786|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356787|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356789|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
101356790|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356791|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
101356792|NCT00062478|Camptothecin|camptothecin|mesh-list
101356793|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101356794|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356795|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356796|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101356797|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356798|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356799|NCT00035243|Epothilones|epothilones|mesh-list
101356800|NCT00035243|Epothilone B|epothilone b|mesh-list
101356801|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356802|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356803|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356804|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356805|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356806|NCT00035282|Aprepitant|aprepitant|mesh-list
101333229|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333230|NCT00001202|Testolactone|testolactone|mesh-list
101333231|NCT00001202|Spironolactone|spironolactone|mesh-list
101333233|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101333234|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356807|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
101356808|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
101356809|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356810|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356811|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356812|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101356813|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356814|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356815|NCT00062556|Niacin|niacin|mesh-list
101356816|NCT00062556|Lovastatin|lovastatin|mesh-list
101356817|NCT00062556|L 647318|l 647318|mesh-list
101356818|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
101356834|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
101356835|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356836|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356837|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101356838|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101356839|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101356840|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101356841|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356842|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101356843|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356844|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356845|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356846|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356847|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
101356848|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101356849|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356850|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101356851|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101356852|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356853|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
101356854|NCT00062595|Vitamin K|vitamin k|mesh-list
101356855|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101356856|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101356857|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356858|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
101356859|NCT00062595|Coagulants|coagulants|mesh-ancestor
101356860|NCT00062595|Vitamins|vitamins|mesh-ancestor
101356861|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
101356862|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356863|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101356864|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
101356865|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356866|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101356867|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101356868|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356869|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356870|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356871|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356872|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356873|NCT00062673|Analgesics|analgesics|mesh-ancestor
101356874|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
101356875|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356876|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356877|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356899|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356900|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356901|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
101356902|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356903|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333235|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333236|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333237|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101356904|NCT00035516|Epothilones|epothilones|mesh-list
101356905|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
101356906|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
101356907|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
101356908|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356909|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101356911|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101356912|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101356913|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
101356914|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356915|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356916|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356918|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101356919|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356920|NCT00035984|Exenatide|exenatide|mesh-list
101356921|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101356922|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356923|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101356924|NCT00035984|Incretins|incretins|mesh-ancestor
101356925|NCT00035984|Hormones|hormones|mesh-ancestor
101356926|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101356927|NCT00063141|Irinotecan|irinotecan|mesh-list
101356928|NCT00063141|Cetuximab|cetuximab|mesh-list
101356929|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101356955|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
101356956|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101356957|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101356958|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101356959|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101356960|NCT00036179|Micafungin|micafungin|mesh-list
101356961|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
101356962|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101356963|NCT00036218|Ropinirole|ropinirole|mesh-list
101356964|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101356965|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101356966|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
101356967|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
101356968|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356969|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356970|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356972|NCT00063453|Vitamin E|vitamin e|mesh-list
101356973|NCT00063453|Tocopherols|tocopherols|mesh-list
101356974|NCT00063453|Tocotrienols|tocotrienols|mesh-list
101356975|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
101356976|NCT00063453|Selenium|selenium|mesh-list
101356977|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
101356978|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356979|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
101356981|NCT00063453|Protective Agents|protective agents|mesh-ancestor
101356982|NCT00063453|Trace Elements|trace elements|mesh-ancestor
101356983|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101356984|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101356985|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101356986|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101356987|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101356988|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101356989|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101356990|NCT00036335|Analgesics|analgesics|mesh-ancestor
101356991|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
101356992|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101356993|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
101356994|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101356995|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
101356996|NCT00036374|Infliximab|infliximab|mesh-list
101356997|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101333238|NCT00001202|Diuretics|diuretics|mesh-ancestor
101333239|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
101333240|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333241|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333242|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101356998|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101356999|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357000|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357001|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357002|NCT00036452|Ritonavir|ritonavir|mesh-list
101357003|NCT00036452|Lopinavir|lopinavir|mesh-list
101357004|NCT00036452|Tenofovir|tenofovir|mesh-list
101357005|NCT00036452|Emtricitabine|emtricitabine|mesh-list
101357006|NCT00036452|Stavudine|stavudine|mesh-list
101357007|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101357008|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101357009|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
101357010|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357011|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357012|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101357013|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101357014|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
101357015|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357016|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101357017|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101357018|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101357019|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101357020|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
101357021|NCT02967276|Metformin|metformin|mesh-list
101357022|NCT02967276|Dexamethasone|dexamethasone|mesh-list
101357023|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357024|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
101357025|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
101357026|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357027|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357028|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357029|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
101357030|NCT02967276|Hormones|hormones|mesh-ancestor
101357031|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357032|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357033|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357034|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357035|NCT00036491|Rituximab|rituximab|mesh-list
101357036|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357037|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357038|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
101357039|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357040|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357041|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
101357042|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101357043|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357044|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
101357045|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101357046|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357047|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101357048|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357049|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357050|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357051|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357055|NCT00036764|Epothilones|epothilones|mesh-list
101357056|NCT00036764|Epothilone B|epothilone b|mesh-list
101357057|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357058|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357059|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357060|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357061|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357063|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357064|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
101357065|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357066|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
101357067|NCT00036881|Astringents|astringents|mesh-ancestor
101333243|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333244|NCT00016419|Cyclosporine|cyclosporine|mesh-list
101333245|NCT00016419|Cyclosporins|cyclosporins|mesh-list
101333246|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101333247|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333248|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333249|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333250|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
101357068|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357069|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357070|NCT00063804|Ritonavir|ritonavir|mesh-list
101357071|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101357072|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101357073|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
101357074|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357075|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357076|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101357077|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101357078|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
101357079|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357080|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101357081|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101357082|NCT02967432|Mupirocin|mupirocin|mesh-list
101357083|NCT02967432|Petrolatum|petrolatum|mesh-list
101357084|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357085|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357086|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101357087|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357088|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357090|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357091|NCT00063960|Irinotecan|irinotecan|mesh-list
101357092|NCT00063960|Floxuridine|floxuridine|mesh-list
101357093|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101357094|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357095|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357096|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357097|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357098|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357099|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
101357100|NCT00064116|Rituximab|rituximab|mesh-list
101357101|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357102|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357103|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
101357104|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357105|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357106|NCT00037037|Sargramostim|sargramostim|mesh-list
101357107|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
101357108|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357109|NCT00064194|Vitamin E|vitamin e|mesh-list
101357110|NCT00064194|Selenium|selenium|mesh-list
101357111|NCT00064194|Vitamins|vitamins|mesh-ancestor
101357112|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
101357113|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357114|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
101357115|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357116|NCT00064194|Protective Agents|protective agents|mesh-ancestor
101357117|NCT00064194|Trace Elements|trace elements|mesh-ancestor
101357118|NCT00064233|Dasatinib|dasatinib|mesh-list
101357119|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357120|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357121|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357122|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357123|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
101357124|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357125|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357142|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333251|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333252|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
101333253|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333254|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333255|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357143|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
101357144|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357145|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101357146|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
101357147|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357148|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357150|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
101357151|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357152|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357153|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
101357154|NCT00037115|Hormones|hormones|mesh-ancestor
101357155|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357156|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101357157|NCT00037115|Protective Agents|protective agents|mesh-ancestor
101357158|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101357159|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
101357160|NCT00037154|Urological Agents|urological agents|mesh-ancestor
101357161|NCT00064389|Albuterol|albuterol|mesh-list
101357162|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101357163|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
101357164|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357165|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357166|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101357167|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101357168|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
101357169|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101357170|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101357171|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101357172|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101357173|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
101357174|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357175|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357177|NCT00064428|Fondaparinux|fondaparinux|mesh-list
101357178|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101357179|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
101357180|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101357181|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
101357182|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357183|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357184|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
101357186|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101357187|NCT00064467|Bupropion|bupropion|mesh-list
101357188|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101357189|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
101357190|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101357191|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101357192|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101357193|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101357194|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357195|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
101357196|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357197|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357198|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101357199|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101357200|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357201|NCT00064623|Capsaicin|capsaicin|mesh-list
101357202|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
101357203|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357204|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
101357205|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357206|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357207|NCT00064779|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101333256|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101333257|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
101333258|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101333259|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333260|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
101357208|NCT00064779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357210|NCT00037544|Coagulants|coagulants|mesh-ancestor
101357211|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
101357212|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357213|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357214|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
101357215|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
101357216|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
101357217|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357218|NCT00064857|Pycnogenols|pycnogenols|mesh-list
101357219|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101357220|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
101357221|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357222|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
101357223|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357224|NCT00064857|Protective Agents|protective agents|mesh-ancestor
101357225|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101357226|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
101357227|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101357228|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101357229|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357230|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357231|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
101357232|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357233|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101357234|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101357235|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101357236|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101357237|NCT04730622|Mitogens|mitogens|mesh-list
101357238|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357239|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357240|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101357241|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357242|NCT00064974|Lenalidomide|lenalidomide|mesh-list
101357243|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
101357244|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357245|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357246|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357247|NCT00064974|Growth Substances|growth substances|mesh-ancestor
101357248|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357249|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357250|NCT00037817|Celecoxib|celecoxib|mesh-list
101357251|NCT00037817|Decitabine|decitabine|mesh-list
101357252|NCT00037817|Romidepsin|romidepsin|mesh-list
101357253|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101357254|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101357255|NCT00037817|Analgesics|analgesics|mesh-ancestor
101357256|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
101357257|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357258|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357266|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
101357267|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357268|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101357269|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101357271|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101357272|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
101357273|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
101357274|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
101357275|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
101357276|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357277|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357279|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101333261|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333262|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333263|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333264|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
101357280|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101357282|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
101357283|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357284|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357286|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357287|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101357288|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101357289|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357290|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357291|NCT00038012|Carboplatin|carboplatin|mesh-list
101357292|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357293|NCT00038051|Lintuzumab|lintuzumab|mesh-list
101357294|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357295|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357296|NCT00038090|Thalidomide|thalidomide|mesh-list
101357297|NCT00038090|Dexamethasone|dexamethasone|mesh-list
101357298|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357299|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
101357300|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
101357301|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357302|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357303|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357304|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
101357305|NCT00038090|Hormones|hormones|mesh-ancestor
101357306|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357307|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357308|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357309|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357310|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
101357311|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
101357312|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357313|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357314|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357315|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357316|NCT00038090|Growth Substances|growth substances|mesh-ancestor
101357317|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357318|NCT00065325|Fulvestrant|fulvestrant|mesh-list
101357319|NCT00065325|Exemestane|exemestane|mesh-list
101357320|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357321|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357322|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101357323|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101357324|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
101357325|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357326|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357340|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
101357341|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357342|NCT00398658|Clindamycin|clindamycin|mesh-list
101357343|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
101357344|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
101357345|NCT00398658|Gentamicins|gentamicins|mesh-list
101357346|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357347|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357348|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101357349|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357350|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357351|NCT00038207|Vincristine|vincristine|mesh-list
101357352|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357353|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357354|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357355|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357356|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357357|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333265|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333266|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333267|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333268|NCT01156545|Afatinib|afatinib|mesh-list
101333269|NCT01156545|Simvastatin|simvastatin|mesh-list
101333270|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101333271|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101357358|NCT00398697|Gemcitabine|gemcitabine|mesh-list
101357359|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357361|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357362|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357363|NCT00038246|Thalidomide|thalidomide|mesh-list
101357364|NCT00038246|Paclitaxel|paclitaxel|mesh-list
101357365|NCT00038246|Estramustine|estramustine|mesh-list
101357366|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357367|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357368|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357369|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357370|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357371|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357372|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357373|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
101357374|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357375|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
101357376|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357377|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357378|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357379|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357380|NCT00038246|Growth Substances|growth substances|mesh-ancestor
101357381|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357382|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357383|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
101357384|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357385|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101357386|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357387|NCT00398814|Sorafenib|sorafenib|mesh-list
101357388|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357405|NCT00065637|Teriparatide|teriparatide|mesh-list
101357406|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101357407|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357408|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101357409|NCT00396578|Vancomycin|vancomycin|mesh-list
101357410|NCT00396578|Gentamicins|gentamicins|mesh-list
101357411|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357412|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357413|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101357414|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357415|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357416|NCT00398853|Chromium|chromium|mesh-list
101357417|NCT00398853|Picolinic acid|picolinic acid|mesh-list
101357418|NCT00398853|Trace Elements|trace elements|mesh-ancestor
101357419|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
101357420|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357421|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101357422|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
101357423|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
101357424|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357425|NCT05433896|Dasatinib|dasatinib|mesh-list
101357426|NCT05433896|Omeprazole|omeprazole|mesh-list
101357427|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101357428|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357429|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101357430|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357431|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357432|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357433|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357435|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357436|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357437|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333273|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333274|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101333275|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101333276|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333277|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333278|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357438|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357439|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357440|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101357441|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
101357442|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101357443|NCT00069927|Methylphenidate|methylphenidate|mesh-list
101357444|NCT00069927|Amphetamine|amphetamine|mesh-list
101357445|NCT00069927|Adderall|adderall|mesh-list
101357446|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
101357447|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101357450|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101357451|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101357452|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357454|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357455|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
101357456|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
101357457|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357458|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
101357459|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101357460|NCT00069966|Cytarabine|cytarabine|mesh-list
101357461|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
101357462|NCT00069966|Rituximab|rituximab|mesh-list
101357463|NCT00069966|Pixantrone|pixantrone|mesh-list
101357464|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357465|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357466|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
101357467|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357468|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357469|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357470|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
101357471|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357472|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
101357473|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357474|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357475|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357476|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
101357478|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357479|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357480|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
101357481|NCT00069966|Hormones|hormones|mesh-ancestor
101357482|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357483|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101357484|NCT00069966|Protective Agents|protective agents|mesh-ancestor
101357485|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101357486|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357487|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357488|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
101357489|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101357490|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357491|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
101357492|NCT00065949|Analgesics|analgesics|mesh-ancestor
101357493|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
101357494|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357495|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357496|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
101357497|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101357498|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101357499|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
101333280|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101333281|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333282|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
101333283|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101333284|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101357500|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101357501|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101357502|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357503|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101357504|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
101357505|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101357506|NCT00066027|Doxycycline|doxycycline|mesh-list
101357507|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357508|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357509|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
101357510|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101357511|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101357513|NCT00396734|Modafinil|modafinil|mesh-list
101357514|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
101357515|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357516|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357517|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101357518|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101357519|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101357527|NCT00070083|Vincristine|vincristine|mesh-list
101357528|NCT00070083|Oblimersen|oblimersen|mesh-list
101357529|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357530|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
101357531|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357532|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357533|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357534|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
101357535|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357536|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357537|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101357538|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357539|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101357540|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101357541|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357542|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357543|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357544|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
101357546|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357547|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357548|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357549|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357550|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357551|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357552|NCT00070122|Leucovorin|leucovorin|mesh-list
101357553|NCT00070122|Bevacizumab|bevacizumab|mesh-list
101357554|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101357555|NCT00070122|Fluorouracil|fluorouracil|mesh-list
101357556|NCT00070122|Capecitabine|capecitabine|mesh-list
101357557|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
101357558|NCT00070122|Antibodies|antibodies|mesh-list
101357559|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
101357560|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101357561|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
101357562|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357563|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357564|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357565|NCT00070122|Growth Substances|growth substances|mesh-ancestor
101357566|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357567|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357568|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
101357569|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
101357570|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333285|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101333286|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333287|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333288|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101357571|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357572|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357574|NCT00070122|Protective Agents|protective agents|mesh-ancestor
101357575|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
101357576|NCT00070122|Vitamins|vitamins|mesh-ancestor
101357577|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
101357578|NCT00070161|Donepezil|donepezil|mesh-list
101357579|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101357580|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357581|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357582|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
101357583|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357584|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357585|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
101357586|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
101357587|NCT00070200|Melphalan|melphalan|mesh-list
101357588|NCT00070200|Doxorubicin|doxorubicin|mesh-list
101357589|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101357590|NCT00070200|Etoposide|etoposide|mesh-list
101357591|NCT00070200|Vincristine|vincristine|mesh-list
101357595|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
101357596|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357597|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357598|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357599|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
101357600|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357601|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357602|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101357603|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101357604|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101357605|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357607|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357608|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357609|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357610|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357611|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101357612|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357613|NCT00066339|Gefitinib|gefitinib|mesh-list
101357614|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357615|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357616|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357617|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357618|NCT00070239|Alvocidib|alvocidib|mesh-list
101357619|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101357620|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101357621|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357622|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357623|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357624|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357625|NCT00070239|Growth Substances|growth substances|mesh-ancestor
101357626|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357627|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357628|NCT00070278|Paclitaxel|paclitaxel|mesh-list
101357629|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
101357630|NCT00070278|Gemcitabine|gemcitabine|mesh-list
101357631|NCT00070278|Epirubicin|epirubicin|mesh-list
101357632|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357633|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357634|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357635|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357636|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357637|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357638|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357639|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
101357640|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357641|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333289|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101333290|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101333293|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101333294|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101357642|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357643|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
101357644|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101357645|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357646|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
101357647|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101357648|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101357649|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357650|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357651|NCT00066378|Gefitinib|gefitinib|mesh-list
101357652|NCT00066378|Anastrozole|anastrozole|mesh-list
101357653|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357654|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101357655|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357656|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357657|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357658|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101357659|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101357660|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101357661|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
101357662|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357663|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357671|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
101357672|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357673|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
101357674|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357675|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101357676|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101357677|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
101357678|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357679|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357680|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101357681|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357683|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357684|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
101357685|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357686|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
101357687|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101357688|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357689|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
101357690|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
101357691|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357692|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101357693|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
101357694|NCT00066417|Hormones|hormones|mesh-ancestor
101357695|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357696|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101357697|NCT00066417|Protective Agents|protective agents|mesh-ancestor
101357698|NCT00066456|Docetaxel|docetaxel|mesh-list
101357699|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357700|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357701|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357702|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357703|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357705|NCT00070434|Pyridoxine|pyridoxine|mesh-list
101357706|NCT00070434|Fluorouracil|fluorouracil|mesh-list
101357707|NCT00070434|Capecitabine|capecitabine|mesh-list
101357708|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
101357709|NCT00070434|Irinotecan|irinotecan|mesh-list
101357710|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
101357711|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357712|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
101333295|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
101333296|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333297|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333298|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357713|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357714|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357715|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357716|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357717|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
101357718|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101357719|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101357720|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357721|NCT00070434|Antidotes|antidotes|mesh-ancestor
101357722|NCT00070434|Protective Agents|protective agents|mesh-ancestor
101357723|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
101357724|NCT00070434|Vitamins|vitamins|mesh-ancestor
101357725|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
101357726|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
101357727|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
101357728|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101357729|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357730|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357731|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
101357732|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101357733|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101357734|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357735|NCT00070473|Pemetrexed|pemetrexed|mesh-list
101357736|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357737|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357744|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357745|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357746|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357748|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357749|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
101357750|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357751|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357752|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
101357753|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357754|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357755|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
101357756|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357757|NCT00070629|Paclitaxel|paclitaxel|mesh-list
101357758|NCT00070629|Docetaxel|docetaxel|mesh-list
101357759|NCT00070629|Cisplatin|cisplatin|mesh-list
101357760|NCT00070629|Carboplatin|carboplatin|mesh-list
101357761|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357762|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357763|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357764|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357765|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357766|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357767|NCT01349595|Bortezomib|bortezomib|mesh-list
101357768|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357769|NCT05184920|Nicotine|nicotine|mesh-list
101357770|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101357771|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
101357772|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357773|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357774|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101357775|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101357776|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
101357777|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357778|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357779|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
101357780|NCT02958501|Vitamin D|vitamin d|mesh-list
101357781|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101357782|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357783|NCT02958501|Vitamins|vitamins|mesh-ancestor
101357784|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
101357785|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101357786|NCT00066651|Immunotoxins|immunotoxins|mesh-list
101333299|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101333300|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
101333301|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
101357787|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
101357788|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
101357789|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357790|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
101357791|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
101357792|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357793|NCT00398892|Protective Agents|protective agents|mesh-ancestor
101357794|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357795|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
101357796|NCT00398892|Vitamins|vitamins|mesh-ancestor
101357797|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
101357798|NCT05019794|Infigratinib|infigratinib|mesh-list
101357799|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357800|NCT00066768|Suramin|suramin|mesh-list
101357801|NCT00066768|Gemcitabine|gemcitabine|mesh-list
101357802|NCT00066768|Docetaxel|docetaxel|mesh-list
101357803|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357804|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
101357805|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357806|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357807|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357811|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
101357812|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101357813|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357814|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101357815|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101357816|NCT00066846|Leucovorin|leucovorin|mesh-list
101357817|NCT00066846|Bevacizumab|bevacizumab|mesh-list
101357818|NCT00066846|Fluorouracil|fluorouracil|mesh-list
101357819|NCT00066846|Calcium|calcium|mesh-list
101357820|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
101357821|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101357822|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357823|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101357824|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101357825|NCT00066846|Growth Substances|growth substances|mesh-ancestor
101357826|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357827|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
101357828|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101357829|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
101357830|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357831|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357832|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101357833|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
101357834|NCT00066846|Antidotes|antidotes|mesh-ancestor
101357835|NCT00066846|Protective Agents|protective agents|mesh-ancestor
101357836|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
101357837|NCT00066846|Vitamins|vitamins|mesh-ancestor
101357838|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
101357839|NCT00066885|Calcitriol|calcitriol|mesh-list
101357840|NCT00066885|Docetaxel|docetaxel|mesh-list
101357841|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357842|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357843|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357844|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357845|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357846|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101357847|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357848|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101357849|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101357850|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101357851|NCT00066885|Vitamins|vitamins|mesh-ancestor
101357852|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
101357853|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101357854|NCT04941521|Exenatide|exenatide|mesh-list
101357855|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357856|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357857|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101357858|NCT04941521|Incretins|incretins|mesh-ancestor
101357859|NCT04941521|Hormones|hormones|mesh-ancestor
101333302|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333303|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101333304|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101333305|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101333306|NCT00001262|Copper|copper|mesh-list
101357860|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357861|NCT02966457|Colistin|colistin|mesh-list
101357862|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101357863|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101357864|NCT00067041|Treprostinil|treprostinil|mesh-list
101357865|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101357866|NCT04732364|Bupivacaine|bupivacaine|mesh-list
101357867|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
101357868|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
101357869|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101357870|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357871|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
101357872|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357873|NCT04732598|Paclitaxel|paclitaxel|mesh-list
101357874|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101357876|NCT04732598|Atezolizumab|atezolizumab|mesh-list
101357877|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357878|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357879|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357880|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357881|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357892|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101357893|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
101357894|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
101357895|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357896|NCT00067080|Siderophores|siderophores|mesh-ancestor
101357897|NCT00396851|Metformin|metformin|mesh-list
101357898|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101357899|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357900|NCT00067119|Dipyridamole|dipyridamole|mesh-list
101357901|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101357902|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357903|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101357904|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357905|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101357906|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
101357907|NCT00396929|Paclitaxel|paclitaxel|mesh-list
101357908|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101357909|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357910|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
101357911|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101357912|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101357913|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357914|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101357915|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101357916|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
101357917|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
101357918|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357919|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101357920|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
101357921|NCT00399165|Testosterone|testosterone|mesh-list
101357922|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
101357923|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
101357924|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101357925|NCT00399165|Dutasteride|dutasteride|mesh-list
101357926|NCT00399165|Androgens|androgens|mesh-ancestor
101357927|NCT00399165|Hormones|hormones|mesh-ancestor
101357928|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357929|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357930|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101357931|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357932|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
101357933|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101333307|NCT00001262|Trace Elements|trace elements|mesh-ancestor
101333308|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
101357934|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101357935|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357936|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357937|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
101357938|NCT00067158|Nicotine|nicotine|mesh-list
101357939|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101357940|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
101357941|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101357942|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357943|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101357959|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
101357960|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
101357961|NCT00067353|Protective Agents|protective agents|mesh-ancestor
101357962|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357963|NCT00071136|Gemcitabine|gemcitabine|mesh-list
101357965|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101357966|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
101357967|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357968|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101357969|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357970|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101357971|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101357972|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
101357973|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101357974|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
101357975|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101357976|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
101357977|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357978|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357979|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
101357980|NCT00067431|Valproic Acid|valproic acid|mesh-list
101357981|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
101357982|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101357983|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101357984|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
101357985|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101357986|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357987|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
101357988|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101357989|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101357990|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101357993|NCT00067509|Progestins|progestins|mesh-ancestor
101357994|NCT00067509|Hormones|hormones|mesh-ancestor
101357995|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101357996|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101357997|NCT01349673|Budesonide|budesonide|mesh-list
101357998|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101357999|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101358000|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
101358001|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358002|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358003|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101358004|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
101358005|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
101358016|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358017|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358018|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358019|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101358020|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101358021|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358022|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358023|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358025|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
101358026|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358027|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
101358028|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
101358029|NCT00067548|EKB 569|ekb 569|mesh-list
101358030|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358031|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358032|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333309|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333311|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
101333312|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358033|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358034|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
101358035|NCT03338621|Rifampin|rifampin|mesh-list
101358036|NCT03338621|Isoniazid|isoniazid|mesh-list
101358038|NCT03338621|Ethambutol|ethambutol|mesh-list
101358039|NCT03338621|Bedaquiline|bedaquiline|mesh-list
101358040|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358041|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358042|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101358043|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358044|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358045|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358046|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358047|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101358048|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
101358049|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
101358050|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101358051|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101358052|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101358053|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101358054|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101358055|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101358056|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101358057|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101358058|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101358059|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
101358060|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101358062|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101358063|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358064|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
101358065|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358066|NCT00067626|Chromium|chromium|mesh-list
101358067|NCT00067626|Trace Elements|trace elements|mesh-ancestor
101358068|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
101358069|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358070|NCT00067743|Lenalidomide|lenalidomide|mesh-list
101358084|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358085|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358087|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101358088|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
101358089|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
101358090|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358091|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358092|NCT02599324|Paclitaxel|paclitaxel|mesh-list
101358094|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
101358095|NCT02599324|Cetuximab|cetuximab|mesh-list
101358096|NCT02599324|Everolimus|everolimus|mesh-list
101358097|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101358098|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358099|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
101358100|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
101358101|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358102|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358103|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358104|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101358106|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358107|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358108|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358109|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
101358110|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358111|NCT00067899|Vitamins|vitamins|mesh-list
101333313|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101333314|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101333315|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333316|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333317|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101358112|NCT00067899|Vitamin E|vitamin e|mesh-list
101358113|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
101358114|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358115|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
101358116|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358117|NCT00067899|Protective Agents|protective agents|mesh-ancestor
101358118|NCT00067938|Lamotrigine|lamotrigine|mesh-list
101358119|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
101358120|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101358121|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358122|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358123|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101358124|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358125|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358126|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358127|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358128|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358129|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101358131|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
101358132|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
101358133|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487378|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358166|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358167|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358168|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358169|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101358170|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358171|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358173|NCT00144703|Tacrolimus|tacrolimus|mesh-list
101358174|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358175|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
101358176|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358177|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101358178|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358195|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358196|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358197|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
101358198|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358199|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101358200|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358201|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358202|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358203|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358204|NCT00038480|Ritonavir|ritonavir|mesh-list
101358205|NCT00038480|Lopinavir|lopinavir|mesh-list
101358206|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101358207|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101358208|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
101358209|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358210|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358211|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101358212|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101358213|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
101358214|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358215|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101358216|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101358217|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
101358218|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101358219|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358220|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358221|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333319|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333320|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333321|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101333322|NCT00016887|Interferons|interferons|mesh-list
101333323|NCT00016887|Cytarabine|cytarabine|mesh-list
101358222|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
101358223|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358224|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358225|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358227|NCT00038519|Saquinavir|saquinavir|mesh-list
101358228|NCT00038519|Amprenavir|amprenavir|mesh-list
101358229|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101358230|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101358231|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101358232|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358233|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358234|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101358235|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101358236|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
101358240|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101358241|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
101358242|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358243|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101358245|NCT00202423|Nabiximols|nabiximols|mesh-list
101358246|NCT00202423|Analgesics|analgesics|mesh-ancestor
101358247|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
101358248|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358249|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358250|NCT00202462|Testosterone|testosterone|mesh-list
101358251|NCT00202462|Androgens|androgens|mesh-ancestor
101358252|NCT00202462|Hormones|hormones|mesh-ancestor
101358253|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358254|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358256|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101358257|NCT00038558|Bleomycin|bleomycin|mesh-list
101358258|NCT00038558|Dacarbazine|dacarbazine|mesh-list
101358259|NCT00038558|Vinblastine|vinblastine|mesh-list
101358260|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358261|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358262|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101358263|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358264|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358265|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358266|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358267|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
101358268|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101358270|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101358271|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358272|NCT00038597|Lonafarnib|lonafarnib|mesh-list
101358273|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358274|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358275|NCT00202618|Amlodipine|amlodipine|mesh-list
101358276|NCT00202618|Valsartan|valsartan|mesh-list
101358277|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101358278|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101358279|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358280|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358281|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101358282|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358283|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
101358284|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101358285|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101358287|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101358288|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333324|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
101333325|NCT00016887|Dexamethasone|dexamethasone|mesh-list
101333326|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
101333327|NCT00016887|Melphalan|melphalan|mesh-list
101333328|NCT00016887|Carmustine|carmustine|mesh-list
101333329|NCT00016887|Etoposide|etoposide|mesh-list
101333330|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333331|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
101358289|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
101358290|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358291|NCT00038636|Ritonavir|ritonavir|mesh-list
101358292|NCT00038636|Lopinavir|lopinavir|mesh-list
101358293|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101358294|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101358295|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
101358296|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358297|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358298|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101358299|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101358300|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
101358301|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358302|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101358303|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101358305|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358306|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
101358307|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358311|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
101358312|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358313|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358314|NCT00202891|Sisomicin|sisomicin|mesh-list
101358315|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358316|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358317|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101358318|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358319|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358320|NCT00202969|Cisplatin|cisplatin|mesh-list
101358321|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358322|NCT00203125|Rasagiline|rasagiline|mesh-list
101358323|NCT00203125|Tyramine|tyramine|mesh-list
101358324|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101358325|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358326|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358327|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101358328|NCT00203125|Protective Agents|protective agents|mesh-ancestor
101358329|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358330|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
101358331|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
101358332|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358333|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101358334|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101358335|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101358337|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358338|NCT00203164|Rasagiline|rasagiline|mesh-list
101358339|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101358340|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358341|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358342|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101358343|NCT00203164|Protective Agents|protective agents|mesh-ancestor
101358344|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358345|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
101358347|NCT00203281|Daclizumab|daclizumab|mesh-list
101358348|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
101358349|NCT00203281|Antibodies|antibodies|mesh-list
101358350|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
101358352|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101358353|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358354|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
101358355|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333334|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333335|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
101358356|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101358357|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358358|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358359|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358360|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358361|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101358362|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
101358363|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358364|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358365|NCT00203320|Etanercept|etanercept|mesh-list
101358366|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358367|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358368|NCT00203320|Analgesics|analgesics|mesh-ancestor
101358369|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
101358370|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358371|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358372|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358373|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358374|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358375|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358376|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
101358377|NCT00038792|Mitogens|mitogens|mesh-list
101358378|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358379|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358380|NCT00203359|Etanercept|etanercept|mesh-list
101358381|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358439|NCT00203788|Risperidone|risperidone|mesh-list
101358440|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101358441|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
101358442|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358443|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358444|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358445|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358446|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358447|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358448|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358449|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101358450|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
101358451|NCT00072033|Docetaxel|docetaxel|mesh-list
101358452|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358453|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
101358454|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
101358455|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
101358456|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358457|NCT00203905|Bevacizumab|bevacizumab|mesh-list
101358458|NCT00203905|Fluorouracil|fluorouracil|mesh-list
101358459|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
101358460|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101358461|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358462|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101358463|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101358464|NCT00203905|Growth Substances|growth substances|mesh-ancestor
101358465|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358466|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
101358467|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
101358468|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358473|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358474|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101358475|NCT00072072|Celecoxib|celecoxib|mesh-list
101358476|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101358477|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358478|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358479|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358480|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333336|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333337|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333338|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333339|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358481|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101358482|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101358483|NCT00072072|Analgesics|analgesics|mesh-ancestor
101358484|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
101358485|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101358486|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358487|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101358488|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358489|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101358490|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101358491|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
101358492|NCT00204022|Azathioprine|azathioprine|mesh-list
101358494|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358495|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101358496|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
101358497|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358498|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358499|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358500|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358501|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
101358502|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358503|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358504|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
101358505|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358506|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101358507|NCT00204061|Amisulpride|amisulpride|mesh-list
101358508|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101358509|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101358510|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358511|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358512|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101358513|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101358514|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
101358515|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101358516|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358517|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101358518|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
101358519|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
101358520|NCT02966652|Testosterone|testosterone|mesh-list
101358521|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
101358522|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
101358523|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101358524|NCT02966652|Androgens|androgens|mesh-ancestor
101358525|NCT02966652|Hormones|hormones|mesh-ancestor
101358526|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358527|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358528|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101358529|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358530|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
101358531|NCT00039026|Exenatide|exenatide|mesh-list
101358532|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101358533|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358534|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101358535|NCT00039026|Incretins|incretins|mesh-ancestor
101358536|NCT00039026|Hormones|hormones|mesh-ancestor
101358537|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358538|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101358544|NCT00204451|Estradiol|estradiol|mesh-list
101358545|NCT00204451|Estrogens|estrogens|mesh-ancestor
101358546|NCT00204451|Hormones|hormones|mesh-ancestor
101358547|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358548|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358549|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101358551|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333340|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
101333341|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
101333342|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333343|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101333344|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
101333345|NCT00016887|Hormones|hormones|mesh-ancestor
101333346|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358552|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101358553|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101358554|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101358555|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101358556|NCT00204529|Interferons|interferons|mesh-list
101358557|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
101358558|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
101358559|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101358560|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358561|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
101358562|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358563|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
101358564|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358565|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
101358566|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101358567|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358568|NCT00204568|Doxorubicin|doxorubicin|mesh-list
101358569|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101358570|NCT00204568|Trofosfamide|trofosfamide|mesh-list
101358571|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358572|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358573|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101358574|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358575|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358576|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358577|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358578|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
101358579|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358580|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358581|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
101358583|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358584|NCT00204646|Carboplatin|carboplatin|mesh-list
101358585|NCT00204646|Etoposide|etoposide|mesh-list
101358586|NCT00204646|Doxorubicin|doxorubicin|mesh-list
101358587|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101358589|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358590|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101358591|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101358592|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358593|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358594|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358595|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101358596|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358597|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
101358598|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101358599|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358600|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358601|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358602|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358603|NCT00410878|Hydromorphone|hydromorphone|mesh-list
101358604|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101358605|NCT00410878|Narcotics|narcotics|mesh-ancestor
101358606|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101358607|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358609|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
101358628|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101358630|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333347|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333348|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333349|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333350|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333351|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333352|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
101333353|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333354|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333355|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
101333356|NCT00038389|Rofecoxib|rofecoxib|mesh-list
101358632|NCT00204919|Vitamin D|vitamin d|mesh-list
101358633|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
101358634|NCT00204919|Vitamins|vitamins|mesh-ancestor
101358635|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
101358636|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358637|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101358638|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101358639|NCT00072267|Topotecan|topotecan|mesh-list
101358640|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101358641|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101358642|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101358643|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358644|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358645|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358646|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358647|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
101358648|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358649|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358650|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358651|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358652|NCT00072345|Thalidomide|thalidomide|mesh-list
101358653|NCT00072345|Temozolomide|temozolomide|mesh-list
101358654|NCT00072345|Lomustine|lomustine|mesh-list
101358655|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358656|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
101358657|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358658|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358659|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358660|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
101358661|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358662|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
101358663|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101358664|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101358665|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101358688|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101358689|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101358690|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
101358692|NCT00072462|Anastrozole|anastrozole|mesh-list
101358693|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358694|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101358695|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
101358696|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101358697|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358698|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101358699|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358700|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101358702|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101358703|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101358704|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101358705|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101358706|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101358707|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
101333357|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101333358|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101333359|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333360|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358708|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101358709|NCT00039494|Temozolomide|temozolomide|mesh-list
101358710|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101358711|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101358712|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
101358713|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101358714|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101358715|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101358716|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359178|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359180|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
101359181|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
101359182|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359183|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359184|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359185|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359186|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101359188|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101359189|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101359190|NCT02962921|Insulin|insulin|mesh-list
101359191|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101359461|NCT00209209|Rituximab|rituximab|mesh-list
101359462|NCT00209209|Doxorubicin|doxorubicin|mesh-list
101359463|NCT00209209|Fludarabine|fludarabine|mesh-list
101359464|NCT00209209|Vincristine|vincristine|mesh-list
101359465|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101359466|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
101359467|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101359468|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101359469|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101359470|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
101359471|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101359472|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101359473|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101359474|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101359475|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101359476|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101359477|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101359478|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362186|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362187|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362188|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362189|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
101362190|NCT00402766|Hormones|hormones|mesh-ancestor
101362191|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362192|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362193|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362194|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362195|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362196|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362197|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362198|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362199|NCT00127972|Lamivudine|lamivudine|mesh-list
101362200|NCT00127972|Efavirenz|efavirenz|mesh-list
101362201|NCT00127972|Nevirapine|nevirapine|mesh-list
101362202|NCT00127972|Stavudine|stavudine|mesh-list
101362203|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101362204|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362205|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362206|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362207|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
101333362|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101333363|NCT00038389|Analgesics|analgesics|mesh-ancestor
101333364|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
101333365|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333366|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333367|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101333368|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333369|NCT00038506|Tenofovir|tenofovir|mesh-list
101333370|NCT00038506|Lamivudine|lamivudine|mesh-list
101362229|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101362231|NCT00128245|Analgesics|analgesics|mesh-ancestor
101362232|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
101362233|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362234|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362235|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362236|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362237|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
101362238|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362239|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
101362240|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101362241|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362242|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362243|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101362244|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101362245|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101362246|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362247|NCT00044135|Clevudine|clevudine|mesh-list
101362248|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
101362249|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362250|NCT05561725|Dexamethasone|dexamethasone|mesh-list
101362251|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362252|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
101362253|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
101362254|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362255|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362256|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362257|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
101362258|NCT05561725|Hormones|hormones|mesh-ancestor
101362259|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362272|NCT00044291|Letrozole|letrozole|mesh-list
101362273|NCT00044291|Hormones|hormones|mesh-list
101362274|NCT00044291|Atamestane|atamestane|mesh-list
101362275|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
101362276|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
101362277|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
101362278|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362279|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362281|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101362282|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101362283|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362284|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362285|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362286|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362287|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101362288|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101362289|NCT00078234|Rituximab|rituximab|mesh-list
101362290|NCT00078234|Fludarabine|fludarabine|mesh-list
101362291|NCT00078234|Oblimersen|oblimersen|mesh-list
101362292|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101362293|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362294|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
101362295|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333372|NCT00038506|Abacavir|abacavir|mesh-list
101333373|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101333374|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
101333375|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362296|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362297|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
101362298|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362299|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362301|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
101362302|NCT00078351|Protective Agents|protective agents|mesh-ancestor
101362303|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362304|NCT00044447|Glimepiride|glimepiride|mesh-list
101362305|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101362306|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101362307|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362308|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362309|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
101362310|NCT00397358|Icodextrin|icodextrin|mesh-list
101362311|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
101362312|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101362313|NCT05519917|Afatinib|afatinib|mesh-list
101362314|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362315|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362317|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362318|NCT00078390|S 3304|s 3304|mesh-list
101362319|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
101362320|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
101362321|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362322|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362323|NCT00044486|Posaconazole|posaconazole|mesh-list
101362324|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
101362330|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101362332|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362333|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101362334|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362335|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362336|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362337|NCT05497336|Cetuximab|cetuximab|mesh-list
101362338|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101362339|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362340|NCT00044525|Taxane|taxane|mesh-list
101362341|NCT00044525|IDN 5109|idn 5109|mesh-list
101362342|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362343|NCT00074607|Gemcitabine|gemcitabine|mesh-list
101362344|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362345|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
101362346|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362348|NCT05305885|Pemetrexed|pemetrexed|mesh-list
101362349|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362350|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362351|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362352|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362353|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362354|NCT00044564|IDN 5109|idn 5109|mesh-list
101362355|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362356|NCT00078546|Antibodies|antibodies|mesh-list
101362357|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101362358|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
101362359|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362360|NCT00044642|Lorazepam|lorazepam|mesh-list
101362361|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
101362362|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
101362363|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
101362364|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362365|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362366|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362367|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101333376|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101333377|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333378|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333379|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333380|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101333381|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101362368|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362369|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101362370|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101362371|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362372|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
101362373|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
101362374|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362375|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362376|NCT00044681|Risperidone|risperidone|mesh-list
101362377|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101362378|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
101362379|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362380|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362381|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362382|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101362383|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101362384|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362385|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362386|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101362387|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
101362388|NCT00044720|Sirolimus|sirolimus|mesh-list
101362389|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362390|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362391|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362392|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362393|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
101362394|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362401|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362402|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362403|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362404|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362405|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
101362406|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101362407|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362408|NCT00403039|Ranibizumab|ranibizumab|mesh-list
101362409|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362410|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362411|NCT00403039|Growth Substances|growth substances|mesh-ancestor
101362412|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362413|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362414|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362415|NCT00078858|Cyclosporine|cyclosporine|mesh-list
101362416|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
101362418|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
101362419|NCT00078858|Cyclosporins|cyclosporins|mesh-list
101362420|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362421|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362422|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
101362423|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362424|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362425|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
101362426|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362427|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362428|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
101362429|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362430|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
101362431|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362432|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101362433|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333382|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
101333383|NCT00016926|Capecitabine|capecitabine|mesh-list
101333384|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333385|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
101333386|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333387|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333388|NCT00038545|Paclitaxel|paclitaxel|mesh-list
101362434|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101362435|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
101362436|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362437|NCT00044759|Tazobactam|tazobactam|mesh-list
101362438|NCT00044759|Piperacillin|piperacillin|mesh-list
101362439|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101362440|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362441|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362442|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101362443|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362444|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362445|NCT00044798|Citalopram|citalopram|mesh-list
101362446|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101362447|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101362448|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101362449|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362450|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362451|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
101362452|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362453|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101362454|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
101362455|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362456|NCT00074841|Azithromycin|azithromycin|mesh-list
101362457|NCT00074841|Chloroquine|chloroquine|mesh-list
101362458|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101362459|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
101362460|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
101362461|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101362462|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362469|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101362472|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
101362473|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362474|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362475|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362476|NCT00074841|Filaricides|filaricides|mesh-ancestor
101362477|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
101362478|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
101362479|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362480|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362481|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362482|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101362484|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362485|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
101362486|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362487|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362488|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101362489|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
101362490|NCT00044837|Estradiol|estradiol|mesh-list
101362491|NCT00044837|Estrogens|estrogens|mesh-ancestor
101362492|NCT00044837|Hormones|hormones|mesh-ancestor
101362493|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362494|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362495|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101362496|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
101362497|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101362498|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101362499|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101362500|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101362501|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101333389|NCT00038545|Topotecan|topotecan|mesh-list
101333390|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333391|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333392|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333393|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333394|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362502|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101362503|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362504|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362505|NCT04457557|Ropivacaine|ropivacaine|mesh-list
101362507|NCT04457557|Anesthetics|anesthetics|mesh-list
101362508|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362509|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362510|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
101362511|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362512|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
101362513|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101362514|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
101362515|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101362516|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362517|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101362519|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101362520|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362521|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362522|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101362523|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101362524|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362525|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362526|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
101362527|NCT00397475|Vitamin D|vitamin d|mesh-list
101362528|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101362529|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362530|NCT00397475|Vitamins|vitamins|mesh-ancestor
101362531|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
101362556|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101362557|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362558|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362559|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362560|NCT00044954|Cyclosporine|cyclosporine|mesh-list
101362561|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
101362562|NCT00044954|Fludarabine|fludarabine|mesh-list
101362563|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
101362565|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362566|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362567|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
101362568|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362569|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362570|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
101362571|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362572|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362573|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
101362574|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362575|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101362576|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362577|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101362578|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362579|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101362580|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
101362581|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101362582|NCT00079092|Thalidomide|thalidomide|mesh-list
101362593|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362594|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362596|NCT00044993|Doxorubicin|doxorubicin|mesh-list
101362597|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101362598|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333395|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333396|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101333397|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333398|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333400|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362599|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
101362600|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
101362601|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362602|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362603|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362604|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101362605|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101362606|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362607|NCT04162210|Dexamethasone|dexamethasone|mesh-list
101362608|NCT04162210|Pomalidomide|pomalidomide|mesh-list
101362609|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362610|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
101362611|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
101362612|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362613|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362614|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362615|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
101362616|NCT04162210|Hormones|hormones|mesh-ancestor
101362617|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362618|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362619|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362620|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
101362621|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362622|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362623|NCT04162210|Growth Substances|growth substances|mesh-ancestor
101362624|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362626|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362627|NCT00045149|Aldesleukin|aldesleukin|mesh-list
101362628|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362629|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101362630|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101362631|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
101362632|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362633|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
101362634|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362635|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362636|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362637|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362638|NCT00403156|Ranibizumab|ranibizumab|mesh-list
101362639|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
101362640|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362641|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362642|NCT00403156|Growth Substances|growth substances|mesh-ancestor
101362643|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362644|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362645|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362646|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362647|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362648|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362656|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101362657|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362658|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362660|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101362661|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101362662|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
101362663|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101362664|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362665|NCT04065451|Epinephrine|epinephrine|mesh-list
101362666|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101362667|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101362668|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
101362669|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333401|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333403|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101333404|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333405|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
101333406|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333407|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333409|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362670|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362671|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362672|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101362673|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101362674|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
101362675|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362676|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101362677|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
101362678|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
101362679|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
101362680|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101362681|NCT00045266|Aflibercept|aflibercept|mesh-list
101362682|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101362683|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101362684|NCT00045266|Growth Substances|growth substances|mesh-ancestor
101362685|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362686|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
101362687|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362688|NCT03948568|Tamoxifen|tamoxifen|mesh-list
101362689|NCT03948568|Letrozole|letrozole|mesh-list
101362690|NCT03948568|Anastrozole|anastrozole|mesh-list
101362691|NCT03948568|Exemestane|exemestane|mesh-list
101362692|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362693|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101362694|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101362695|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362696|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362698|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362699|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362700|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362701|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362702|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101362703|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101362704|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101362705|NCT03928366|Remifentanil|remifentanil|mesh-list
101362707|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101362708|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101362709|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362710|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101362711|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
101362712|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
101362713|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101362714|NCT03928366|Narcotics|narcotics|mesh-ancestor
101362715|NCT03928366|Analgesics|analgesics|mesh-ancestor
101362716|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
101362717|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362718|NCT00045422|Interferons|interferons|mesh-list
101362719|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
101362724|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
101362725|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362726|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362727|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362728|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362729|NCT00075192|Leuprolide|leuprolide|mesh-list
101362730|NCT00075192|Bicalutamide|bicalutamide|mesh-list
101362731|NCT00075192|Tremelimumab|tremelimumab|mesh-list
101333410|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101333411|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101333412|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333413|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
101333414|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362732|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101362733|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
101362734|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101362735|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362736|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362737|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362738|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
101362739|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
101362740|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362741|NCT03739411|Temozolomide|temozolomide|mesh-list
101362742|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101362743|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
101362744|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362745|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362746|NCT00045461|Carboplatin|carboplatin|mesh-list
101362747|NCT00045461|Ifosfamide|ifosfamide|mesh-list
101362748|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362749|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101362750|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
101362751|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362753|NCT00075231|Lopinavir|lopinavir|mesh-list
101362754|NCT00075231|Lamivudine|lamivudine|mesh-list
101362755|NCT00075231|Zidovudine|zidovudine|mesh-list
101362756|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101362758|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101362759|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101362760|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
101362761|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362762|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362763|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101362764|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101362765|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
101362766|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101362767|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101362768|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101362769|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101362770|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362771|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
101362772|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101362773|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101362774|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101362775|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101362776|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101362779|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
101362780|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362781|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362782|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101362783|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101362784|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
101362785|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362786|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362787|NCT00079170|Docetaxel|docetaxel|mesh-list
101362788|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362789|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
101362796|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
101333415|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333416|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333417|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333418|NCT00038701|Growth Substances|growth substances|mesh-ancestor
101333419|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362798|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362799|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362800|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101362801|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362802|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101362803|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362804|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362805|NCT00045539|Leucovorin|leucovorin|mesh-list
101362806|NCT00045539|Methotrexate|methotrexate|mesh-list
101362807|NCT00045539|Thiotepa|thiotepa|mesh-list
101362808|NCT00045539|Calcium|calcium|mesh-list
101362809|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
101362810|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101362811|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362812|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101362813|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
101362814|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101362815|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362816|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
101362817|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362818|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362819|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
101362820|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362821|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101362822|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362823|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
101362824|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362825|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101362827|NCT00045539|Protective Agents|protective agents|mesh-ancestor
101362828|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
101362830|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
101362831|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101362832|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
101362833|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101362834|NCT00079248|Progesterone|progesterone|mesh-list
101362835|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101362836|NCT00079248|Estrogens|estrogens|mesh-list
101362837|NCT00079248|Progestins|progestins|mesh-ancestor
101362838|NCT00079248|Hormones|hormones|mesh-ancestor
101362839|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362840|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362842|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101362843|NCT00045617|Vaccines|vaccines|mesh-list
101362844|NCT00045617|Antibodies|antibodies|mesh-list
101362845|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
101362846|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101362847|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
101362848|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
101362849|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362850|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362851|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101362852|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101362853|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101362854|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362855|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362857|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
101362859|NCT03442309|Protective Agents|protective agents|mesh-ancestor
101362879|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362880|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101362881|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
101362882|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
101333420|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333421|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101362884|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
101362886|NCT00079287|Vinorelbine|vinorelbine|mesh-list
101362887|NCT00079287|Docetaxel|docetaxel|mesh-list
101362888|NCT00079287|Carboplatin|carboplatin|mesh-list
101362889|NCT00079287|Gemcitabine|gemcitabine|mesh-list
101362890|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101362891|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362892|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
101362893|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
101362894|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362895|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362896|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362897|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
101362898|NCT00045695|Bortezomib|bortezomib|mesh-list
101362899|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362900|NCT00079365|Gemcitabine|gemcitabine|mesh-list
101362901|NCT00079365|Fluorouracil|fluorouracil|mesh-list
101362902|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362903|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
101362904|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362906|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362907|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
101362908|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362909|NCT00045773|Sertraline|sertraline|mesh-list
101362910|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
101362911|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362912|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101362913|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101362914|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101362915|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362932|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
101362933|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362934|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101362935|NCT00079443|Rituximab|rituximab|mesh-list
101362936|NCT00079443|Fludarabine|fludarabine|mesh-list
101362937|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
101362938|NCT00079443|Romidepsin|romidepsin|mesh-list
101362939|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101362940|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362941|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
101362942|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362943|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101362944|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362945|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
101362946|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362947|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101362948|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101362949|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101362950|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101362951|NCT02599363|Paclitaxel|paclitaxel|mesh-list
101362952|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101362953|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362954|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
101362955|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
101362956|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
101362957|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362958|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101362959|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101362960|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101362961|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362962|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362963|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101362964|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101362965|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362966|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101362967|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101362968|NCT00403429|Capecitabine|capecitabine|mesh-list
101333422|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101333423|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101333424|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101362969|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101362970|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
101362971|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362972|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362973|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
101362974|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101362975|NCT00079560|Dronabinol|dronabinol|mesh-list
101362976|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
101362977|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362978|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101362986|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101362988|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101362989|NCT00046163|Midodrine|midodrine|mesh-list
101362990|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
101362991|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
101362992|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101362993|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101362994|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101362995|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101362996|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101362997|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101362998|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
101362999|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363000|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363001|NCT01409161|Vitamins|vitamins|mesh-list
101363002|NCT01409161|Vitamin A|vitamin a|mesh-list
101363003|NCT01409161|Tretinoin|tretinoin|mesh-list
101363004|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
101363005|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
101363006|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
101363007|NCT01409161|Calicheamicins|calicheamicins|mesh-list
101363008|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
101363009|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363010|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363011|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
101363012|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363013|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
101363014|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363015|NCT01409161|Protective Agents|protective agents|mesh-ancestor
101363016|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101363017|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363018|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
101363019|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
101363020|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
101363021|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363023|NCT00079638|Atorvastatin|atorvastatin|mesh-list
101363024|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101363025|NCT00079638|Simvastatin|simvastatin|mesh-list
101363026|NCT00079638|Ezetimibe|ezetimibe|mesh-list
101363027|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101363028|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101363029|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
101363030|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363031|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101363032|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101363034|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
101363035|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
101363037|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
101363038|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363039|NCT00046241|Bupropion|bupropion|mesh-list
101363040|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101363041|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
101363042|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101363043|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101333425|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333427|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363044|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101363045|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363050|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101363051|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101363052|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363053|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
101363054|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363056|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
101363057|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101363058|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
101363059|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363060|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
101363061|NCT00130468|Protective Agents|protective agents|mesh-ancestor
101363062|NCT00130507|Capecitabine|capecitabine|mesh-list
101363063|NCT00130507|Trastuzumab|trastuzumab|mesh-list
101363064|NCT00130507|Vinorelbine|vinorelbine|mesh-list
101363065|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363066|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
101363067|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363068|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363069|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363070|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363072|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363073|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363074|NCT00130546|Sirolimus|sirolimus|mesh-list
101363075|NCT00130546|Paclitaxel|paclitaxel|mesh-list
101363076|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363077|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363078|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363079|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363080|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363081|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363082|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363083|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363084|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363085|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
101363086|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363087|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
101363088|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363089|NCT00130585|Folic Acid|folic acid|mesh-list
101363090|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
101363091|NCT00130585|Hematinics|hematinics|mesh-ancestor
101363093|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
101363094|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363095|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101363096|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363097|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363098|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
101363099|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
101363100|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
101363101|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363103|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363104|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101363105|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363106|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363107|NCT00130819|Buprenorphine|buprenorphine|mesh-list
101363108|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101363109|NCT00130819|Narcotics|narcotics|mesh-ancestor
101363110|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363111|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363112|NCT00130819|Analgesics|analgesics|mesh-ancestor
101363113|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
101363114|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333429|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
101333430|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101333431|NCT00038935|Factor VIII|factor viii|mesh-list
101333432|NCT00038935|Coagulants|coagulants|mesh-ancestor
101333433|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
101333434|NCT00017004|Hematinics|hematinics|mesh-ancestor
101333436|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101333437|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
101333438|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333439|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
101333440|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333441|NCT00039013|Exenatide|exenatide|mesh-list
101333442|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101363115|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101363116|NCT00130858|Carboplatin|carboplatin|mesh-list
101363132|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363133|NCT00046319|Ambrisentan|ambrisentan|mesh-list
101363134|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101363135|NCT00079833|Esomeprazole|esomeprazole|mesh-list
101363136|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101363137|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363138|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101363139|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363140|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363142|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363143|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363144|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363145|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101363146|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363148|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363149|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363151|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
101363152|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363153|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363154|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363156|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101363157|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363158|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363159|NCT00130936|Carboplatin|carboplatin|mesh-list
101363160|NCT00130936|Capecitabine|capecitabine|mesh-list
101363161|NCT00130936|Epirubicin|epirubicin|mesh-list
101363162|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363163|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363164|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
101363165|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363166|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363167|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363168|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363169|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363170|NCT00130975|Candesartan|candesartan|mesh-list
101363171|NCT00130975|Candesartan cilexetil|candesartan cilexetil|mesh-list
101363172|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101363173|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101363174|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101363181|NCT00131053|Methotrexate|methotrexate|mesh-list
101333443|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333444|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101333445|NCT00039013|Incretins|incretins|mesh-ancestor
101333447|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333448|NCT00039052|Interleukin-4|interleukin-4|mesh-list
101333449|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101363182|NCT00131053|Vincristine|vincristine|mesh-list
101363183|NCT00131053|Asparaginase|asparaginase|mesh-list
101363184|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
101363185|NCT00131053|Pirarubicin|pirarubicin|mesh-list
101363186|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363187|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
101363188|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363189|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363190|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363191|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
101363192|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363193|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363194|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101363195|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363196|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
101363197|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
101363198|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363199|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363200|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
101363201|NCT00131053|Hormones|hormones|mesh-ancestor
101363202|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363203|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363204|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101363205|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
101363206|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101363207|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363209|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363210|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363211|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101363212|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363213|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
101363214|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363215|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363216|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363217|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363218|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363219|NCT00079911|Valacyclovir|valacyclovir|mesh-list
101363220|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
101363221|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363222|NCT00397592|Hormones|hormones|mesh-list
101363223|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363224|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363227|NCT00131326|Protective Agents|protective agents|mesh-ancestor
101363228|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363229|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101363230|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101363231|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101363232|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363233|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363235|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363236|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363238|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
101363239|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101363240|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363241|NCT00079989|Tigecycline|tigecycline|mesh-list
101333450|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
101363242|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363243|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363251|NCT00397709|Isoniazid|isoniazid|mesh-list
101363252|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101363253|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
101363254|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363255|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363257|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363258|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363259|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363260|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101363261|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101363262|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101363263|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101363264|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101363265|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101363266|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101363267|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101363268|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
101363269|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101363270|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
101363271|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
101363272|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363273|NCT00131521|Expectorants|expectorants|mesh-ancestor
101363274|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
101363275|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101363276|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
101363277|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363278|NCT00131521|Protective Agents|protective agents|mesh-ancestor
101363279|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363280|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
101363281|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363282|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101363283|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363284|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
101363285|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
101363286|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101363287|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
101363288|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101363289|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101363290|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363291|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101363292|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363293|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363294|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101363296|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101363297|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
101363298|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363299|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363300|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363301|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101363302|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101363303|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363305|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101363306|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
101363307|NCT00403663|Fentanyl|fentanyl|mesh-list
101363308|NCT00403663|Morphine|morphine|mesh-list
101363309|NCT00403663|Bupivacaine|bupivacaine|mesh-list
101363310|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
101363311|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
101363312|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363313|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363332|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101363333|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101363334|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363335|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101363336|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101363337|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333451|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333452|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333453|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333454|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
101333455|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333456|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101363338|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101363339|NCT00403819|Laxatives|laxatives|mesh-ancestor
101363340|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363341|NCT00403858|Lactulose|lactulose|mesh-list
101363342|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101363343|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363344|NCT00403858|Laxatives|laxatives|mesh-ancestor
101363345|NCT00046553|Mifepristone|mifepristone|mesh-list
101363346|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101363347|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
101363348|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101363349|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363350|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101363351|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101363352|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101363353|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
101363354|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101363355|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101363356|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
101363357|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363358|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
101363359|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101363360|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101363361|NCT00131989|Sorafenib|sorafenib|mesh-list
101363362|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363363|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101363364|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363365|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363366|NCT00132067|Vorinostat|vorinostat|mesh-list
101363367|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363368|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101363369|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363377|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363378|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101363380|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363381|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101363382|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363383|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363384|NCT00132184|Vitamin D|vitamin d|mesh-list
101363385|NCT00132184|Vitamins|vitamins|mesh-ancestor
101363386|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
101363387|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363388|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101363390|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
101363391|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363393|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363394|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363395|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363396|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
101363398|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363399|NCT00132418|Etanercept|etanercept|mesh-list
101363400|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363401|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363402|NCT00132418|Analgesics|analgesics|mesh-ancestor
101363403|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
101363404|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363405|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363406|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363407|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333457|NCT00039091|Ipilimumab|ipilimumab|mesh-list
101333458|NCT00039091|Antibodies|antibodies|mesh-list
101333459|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
101333460|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101333461|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
101333462|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363408|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363409|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363410|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
101363411|NCT00132535|Chloroquine|chloroquine|mesh-list
101363413|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
101363414|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101363415|NCT00132535|Amebicides|amebicides|mesh-ancestor
101363416|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101363417|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101363418|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363419|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
101363420|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363421|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101363422|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363423|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363424|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101363425|NCT00132613|Bleomycin|bleomycin|mesh-list
101363426|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363427|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363429|NCT00132652|Telbivudine|telbivudine|mesh-list
101363430|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101363431|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363432|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363433|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363434|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
101363435|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363436|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101363441|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101363442|NCT00132886|Tolvaptan|tolvaptan|mesh-list
101363443|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101363444|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363445|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
101363446|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363447|NCT00080418|Paclitaxel|paclitaxel|mesh-list
101363448|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363449|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363450|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363451|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363452|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363453|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363456|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
101363457|NCT00132925|Hormones|hormones|mesh-ancestor
101363458|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363459|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363460|NCT00133003|Abciximab|abciximab|mesh-list
101363461|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
101363462|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101363464|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363465|NCT00133042|Omalizumab|omalizumab|mesh-list
101363466|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101363467|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101363468|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
101363469|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
101363470|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101363471|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333464|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101333465|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333467|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333469|NCT00001304|Calcitriol|calcitriol|mesh-list
101363473|NCT00133198|Pramipexole|pramipexole|mesh-list
101363474|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
101363475|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363477|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363478|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101363479|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101363480|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
101363481|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
101363482|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363483|NCT00046826|Thalidomide|thalidomide|mesh-list
101363484|NCT00046826|Docetaxel|docetaxel|mesh-list
101363485|NCT00046826|Estramustine|estramustine|mesh-list
101363486|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363487|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363489|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363490|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363491|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363492|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
101363493|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363494|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
101363495|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363496|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363497|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101363498|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101363499|NCT00046826|Growth Substances|growth substances|mesh-ancestor
101363500|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
101363501|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363502|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
101363503|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363505|NCT00133237|Paclitaxel|paclitaxel|mesh-list
101363506|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363507|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363508|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363509|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363515|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
101363516|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363517|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
101363518|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363522|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
101363523|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363524|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
101363525|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363527|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101363528|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101363529|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363530|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363531|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363532|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
101363533|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363534|NCT00131755|Diazoxide|diazoxide|mesh-list
101363535|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101363536|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
101363537|NCT00133315|Adalimumab|adalimumab|mesh-list
101363538|NCT00133315|Infliximab|infliximab|mesh-list
101363539|NCT00133315|Etanercept|etanercept|mesh-list
101363540|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101363541|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363542|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363543|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333471|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
101333473|NCT00001304|Vitamins|vitamins|mesh-ancestor
101333474|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
101363544|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363545|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363546|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363547|NCT00133315|Analgesics|analgesics|mesh-ancestor
101363548|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
101363549|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363550|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363551|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363552|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
101363553|NCT00080496|Imipenem|imipenem|mesh-list
101363554|NCT00080496|Tigecycline|tigecycline|mesh-list
101363555|NCT00080496|Cilastatin|cilastatin|mesh-list
101363556|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363557|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363558|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101363559|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363560|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363561|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
101363562|NCT00133354|Anastrozole|anastrozole|mesh-list
101363564|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363565|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363566|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363567|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363568|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101363569|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101363570|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363571|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363573|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
101363574|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
101363575|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101363576|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363577|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363583|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101363584|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
101363585|NCT00046904|Etanercept|etanercept|mesh-list
101363586|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363587|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363589|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
101363590|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363591|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363592|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363593|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363594|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363595|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363597|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101363598|NCT00403897|Laxatives|laxatives|mesh-ancestor
101363599|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363600|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101363601|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101363603|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363604|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101363605|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101363606|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363607|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101363608|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
101363609|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363610|NCT00080613|Exemestane|exemestane|mesh-list
101363611|NCT00080613|Hormones|hormones|mesh-list
101407763|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101407764|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101407765|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407768|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407769|NCT00108017|Timolol|timolol|mesh-list
101534644|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
101363612|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363613|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333475|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333476|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101333477|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101363614|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363615|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101363616|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101363617|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363618|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363619|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101363620|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
101363622|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
101363623|NCT00047021|Sargramostim|sargramostim|mesh-list
101363624|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363625|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
101363626|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363627|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363628|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
101363629|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363630|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363631|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
101363632|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363634|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
101363635|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363636|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363637|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363638|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363640|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
101363641|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363642|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101363643|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
101363645|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363646|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363659|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363661|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101363662|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101363663|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363664|NCT00080808|Urological Agents|urological agents|mesh-ancestor
101363665|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101363666|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101363667|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
101363668|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363669|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363670|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101363671|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101363672|NCT00047099|Tamoxifen|tamoxifen|mesh-list
101363673|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
101363676|NCT00047099|Epirubicin|epirubicin|mesh-list
101363677|NCT00047099|Goserelin|goserelin|mesh-list
101363678|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363679|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
101363680|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363681|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363682|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363683|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
101363684|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363685|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363686|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101363687|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363688|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363689|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363691|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363692|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333478|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333479|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101333480|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101333481|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333482|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101333484|NCT00039208|Fluorouracil|fluorouracil|mesh-list
101333485|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
101333486|NCT00039208|Irinotecan|irinotecan|mesh-list
101333487|NCT00039208|Calcium|calcium|mesh-list
101333488|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
101333489|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101333490|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333491|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
101333492|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333493|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333494|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333495|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333496|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
101333497|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101333498|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333499|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333500|NCT00039208|Antidotes|antidotes|mesh-ancestor
101333501|NCT00039208|Protective Agents|protective agents|mesh-ancestor
101333502|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
101333503|NCT00039208|Vitamins|vitamins|mesh-ancestor
101333504|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
101333505|NCT00017121|Sargramostim|sargramostim|mesh-list
101333506|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
101333507|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333508|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101333509|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101333510|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333512|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363693|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363694|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363695|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363696|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101363697|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456547|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333513|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333514|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333515|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333516|NCT00039403|Gemcitabine|gemcitabine|mesh-list
101333517|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101333518|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333519|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
101333520|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333521|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333522|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333524|NCT00039442|Capecitabine|capecitabine|mesh-list
101333525|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333526|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
101333527|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333528|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333529|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
101333530|NCT00039481|Doxorubicin|doxorubicin|mesh-list
101363698|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363699|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363700|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101363701|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101363702|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101363703|NCT00133822|Risperidone|risperidone|mesh-list
101363704|NCT00133822|Sertraline|sertraline|mesh-list
101363705|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101363706|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
101363707|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363708|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363709|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363711|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101363712|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101363717|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101363718|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101363719|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363720|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
101363721|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101363722|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363723|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363724|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
101363725|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363726|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363727|NCT00134095|Irinotecan|irinotecan|mesh-list
101363728|NCT00134095|Tegafur|tegafur|mesh-list
101363729|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101363730|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363731|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363732|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363733|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363734|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363735|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
101363736|NCT00047138|Dactinomycin|dactinomycin|mesh-list
101363737|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
101333531|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101333533|NCT00039481|Razoxane|razoxane|mesh-list
101333535|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333536|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
101333537|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333538|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333539|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333540|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
101333541|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333542|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333543|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333544|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333545|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333546|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333547|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333548|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101333549|NCT00039481|Protective Agents|protective agents|mesh-ancestor
101333550|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333551|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333552|NCT00001322|Leuprolide|leuprolide|mesh-list
101333553|NCT00001322|Estradiol|estradiol|mesh-list
101333554|NCT00001322|Progesterone|progesterone|mesh-list
101363738|NCT00047138|Carboplatin|carboplatin|mesh-list
101363739|NCT00047138|Doxorubicin|doxorubicin|mesh-list
101363740|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101363741|NCT00047138|Etoposide|etoposide|mesh-list
101363742|NCT00047138|Vincristine|vincristine|mesh-list
101363743|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363744|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
101363745|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363746|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363747|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363748|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
101363749|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363750|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363751|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101363752|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363753|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363754|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363755|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363756|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363757|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363758|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363759|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363760|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363761|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363762|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101363763|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101363764|NCT00080847|Prednisone|prednisone|mesh-list
101363765|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
101333555|NCT00001322|Estrogens|estrogens|mesh-ancestor
101333556|NCT00001322|Hormones|hormones|mesh-ancestor
101333557|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333558|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333559|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333560|NCT00001322|Progestins|progestins|mesh-ancestor
101333561|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101333562|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
101333563|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333564|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333565|NCT00039520|Sulindac|sulindac|mesh-list
101333567|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333568|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333569|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333570|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333571|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333572|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101333573|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101333574|NCT00039520|Analgesics|analgesics|mesh-ancestor
101363767|NCT00080847|Doxorubicin|doxorubicin|mesh-list
101363768|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101363780|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363781|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363782|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363783|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363791|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363792|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363793|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363794|NCT00134173|Atorvastatin|atorvastatin|mesh-list
101363795|NCT00134173|Torcetrapib|torcetrapib|mesh-list
101363796|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101363797|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101363798|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
101363799|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363800|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101363801|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101363802|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363804|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363805|NCT00080886|Cytarabine|cytarabine|mesh-list
101363806|NCT00080886|Rituximab|rituximab|mesh-list
101363807|NCT00080886|Etoposide|etoposide|mesh-list
101363808|NCT00080886|Melphalan|melphalan|mesh-list
101363809|NCT00080886|Carmustine|carmustine|mesh-list
101333575|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
101333576|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333577|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333578|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101333579|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333580|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101333581|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333593|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101333594|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
101333595|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333596|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333597|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333598|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363810|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363812|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
101363813|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363814|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363815|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363816|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363817|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363818|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363819|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363820|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363821|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
101363823|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363824|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363825|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363826|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
101363827|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101363829|NCT00134212|Norepinephrine|norepinephrine|mesh-list
101363830|NCT00134212|Dopexamine|dopexamine|mesh-list
101363831|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101363832|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101363833|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101333599|NCT00017160|Doxorubicin|doxorubicin|mesh-list
101333601|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
101333602|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
101333603|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333604|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333605|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333606|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333607|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333608|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333609|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333610|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333611|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
101333612|NCT00039832|Reteplase|reteplase|mesh-list
101363834|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101363835|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363836|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363837|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101363839|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
101363840|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363841|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101363842|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
101363843|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
101363844|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
101363845|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101363846|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
101363847|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
101363848|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
101363849|NCT00134290|Metformin|metformin|mesh-list
101363850|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101363851|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363852|NCT00047216|Tipifarnib|tipifarnib|mesh-list
101363853|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363854|NCT00080925|Cytarabine|cytarabine|mesh-list
101363859|NCT00080925|Doxorubicin|doxorubicin|mesh-list
101363860|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101363861|NCT00080925|Fludarabine|fludarabine|mesh-list
101363862|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
101363864|NCT00080925|Vincristine|vincristine|mesh-list
101363865|NCT00080925|Cyclosporins|cyclosporins|mesh-list
101363866|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363867|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
101363868|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363869|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363870|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101363871|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
101363872|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363873|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363874|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101363875|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363876|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363877|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101363878|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101363879|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363880|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363881|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
101363882|NCT00080925|Hormones|hormones|mesh-ancestor
101363883|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363884|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101363885|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333614|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
101333615|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101333616|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101333617|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101333618|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333619|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
101333621|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
101333622|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101333623|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
101333624|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333625|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333626|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101333627|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
101333628|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
101333629|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333630|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101333631|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101363886|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
101363887|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363888|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
101363889|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363890|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363891|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363892|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363893|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
101363894|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
101363895|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101363896|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101363897|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101363898|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363899|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
101363900|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363902|NCT00047255|Docetaxel|docetaxel|mesh-list
101363903|NCT00047255|Trastuzumab|trastuzumab|mesh-list
101363904|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363905|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363907|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363908|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363909|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363910|NCT00134368|Etanercept|etanercept|mesh-list
101363911|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101363912|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101363913|NCT00134368|Analgesics|analgesics|mesh-ancestor
101363915|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101363916|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363917|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101363918|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101363919|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363920|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101363922|NCT00134485|Atorvastatin|atorvastatin|mesh-list
101363923|NCT00134485|Torcetrapib|torcetrapib|mesh-list
101363924|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101333632|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101333633|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
101333634|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333635|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333636|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101333637|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
101333638|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333639|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333640|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101333641|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
101333642|NCT00040027|Thymalfasin|thymalfasin|mesh-list
101333643|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
101333644|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333646|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333647|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101333649|NCT00001343|Androgens|androgens|mesh-ancestor
101333650|NCT00001343|Hormones|hormones|mesh-ancestor
101333651|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333652|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333653|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
101333654|NCT00040066|Cocaine|cocaine|mesh-list
101333655|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
101363925|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101363926|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
101363927|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363928|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101363950|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
101363951|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
101363952|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101363953|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101363954|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101363955|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101363956|NCT00047294|Growth Substances|growth substances|mesh-ancestor
101363957|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
101363959|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101363960|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363961|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101363962|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363963|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363964|NCT00134641|Gemcitabine|gemcitabine|mesh-list
101363965|NCT00134641|Vinorelbine|vinorelbine|mesh-list
101363966|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101363968|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363970|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363971|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363973|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333658|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333659|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
101333660|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333662|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101333663|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101333664|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101363974|NCT00134680|Trastuzumab|trastuzumab|mesh-list
101363975|NCT00134680|Letrozole|letrozole|mesh-list
101363976|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101363977|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363978|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101363979|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101363980|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101363983|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
101363984|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101363985|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101363987|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101363988|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101363990|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101363991|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101363992|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363993|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101363994|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101363995|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101363996|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101363998|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101363999|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101364000|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364001|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364002|NCT00134875|Buprenorphine|buprenorphine|mesh-list
101364003|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101364004|NCT00134875|Naloxone|naloxone|mesh-list
101364005|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101364006|NCT00134875|Narcotics|narcotics|mesh-ancestor
101364007|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364008|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364009|NCT00134875|Analgesics|analgesics|mesh-ancestor
101364010|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
101364011|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364012|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101364013|NCT00134914|Buprenorphine|buprenorphine|mesh-list
101364014|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101364015|NCT00134914|Narcotics|narcotics|mesh-ancestor
101364016|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364017|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364018|NCT00134914|Analgesics|analgesics|mesh-ancestor
101364019|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
101364020|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364021|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101364022|NCT00134953|Rivastigmine|rivastigmine|mesh-list
101364023|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101364024|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364025|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364026|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
101364027|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364028|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364029|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101333665|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333667|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333669|NCT00040105|Tipifarnib|tipifarnib|mesh-list
101333670|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364030|NCT00134953|Protective Agents|protective agents|mesh-ancestor
101364031|NCT00042861|Leucovorin|leucovorin|mesh-list
101364032|NCT00042861|Fluorouracil|fluorouracil|mesh-list
101364033|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
101364034|NCT00042861|Calcium|calcium|mesh-list
101364035|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
101364036|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101364037|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364038|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
101364039|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364040|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364041|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364042|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364043|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
101364044|NCT00042861|Antidotes|antidotes|mesh-ancestor
101364045|NCT00042861|Protective Agents|protective agents|mesh-ancestor
101364046|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
101364047|NCT00042861|Vitamins|vitamins|mesh-ancestor
101364048|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
101364049|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101364050|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364051|NCT00134992|Prednisolone|prednisolone|mesh-list
101364052|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101364053|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
101364060|NCT00134992|Hormones|hormones|mesh-ancestor
101364061|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364062|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364063|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364064|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364065|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
101364066|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
101364067|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364068|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364069|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101364070|NCT00134992|Protective Agents|protective agents|mesh-ancestor
101364071|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
101364072|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101364073|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364074|NCT00135187|Dexamethasone|dexamethasone|mesh-list
101364075|NCT00135187|Bortezomib|bortezomib|mesh-list
101364076|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364078|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
101364079|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364080|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364081|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364082|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
101364083|NCT00135187|Hormones|hormones|mesh-ancestor
101364084|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364085|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364086|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364087|NCT00145093|Chromium|chromium|mesh-list
101364088|NCT00145093|Trace Elements|trace elements|mesh-ancestor
101364089|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
101364090|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364091|NCT00047450|Citalopram|citalopram|mesh-list
101364093|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364094|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364095|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364096|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364097|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
101364098|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333672|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333673|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333674|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
101333675|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101333676|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333677|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333678|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333679|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
101333680|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333681|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101333682|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101333683|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101364099|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101364100|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
101364101|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364102|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
101364103|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364104|NCT00145171|Apomorphine|apomorphine|mesh-list
101364105|NCT00145171|Emetics|emetics|mesh-ancestor
101364106|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364107|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
101364108|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364109|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364110|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
101364111|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
101364112|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364113|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364114|NCT00145210|Atenolol|atenolol|mesh-list
101364115|NCT00145210|Nebivolol|nebivolol|mesh-list
101364116|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101364117|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101364119|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
101364120|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364121|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364122|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101364128|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
101364129|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101364130|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101364131|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101364132|NCT00081276|Cisplatin|cisplatin|mesh-list
101364133|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364134|NCT00145405|Octreotide|octreotide|mesh-list
101364136|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364137|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364138|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364139|NCT00145444|Olanzapine|olanzapine|mesh-list
101364140|NCT00145444|Ziprasidone|ziprasidone|mesh-list
101364141|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
101364142|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
101364143|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364144|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364146|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101364147|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101364148|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364149|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364150|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101333684|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333685|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101364151|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364153|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364154|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364155|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
101364156|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101364157|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101364158|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
101364159|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
101364161|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101364162|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101364163|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364164|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364165|NCT00145483|Urological Agents|urological agents|mesh-ancestor
101364167|NCT00145522|Estradiol|estradiol|mesh-list
101364168|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
101364169|NCT00145522|Estrogens|estrogens|mesh-ancestor
101364170|NCT00145522|Hormones|hormones|mesh-ancestor
101364171|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364172|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364173|NCT00145522|Progestins|progestins|mesh-ancestor
101364174|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
101364175|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364176|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101364177|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364178|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364179|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101364180|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
101364181|NCT00081315|Amifostine|amifostine|mesh-list
101364182|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101364183|NCT00081315|Protective Agents|protective agents|mesh-ancestor
101364184|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364185|NCT00145561|Ritonavir|ritonavir|mesh-list
101364188|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101364189|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
101364190|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364191|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364192|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101364198|NCT00145639|Carboplatin|carboplatin|mesh-list
101364199|NCT00145639|Doxorubicin|doxorubicin|mesh-list
101364200|NCT00145639|Ifosfamide|ifosfamide|mesh-list
101364201|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364203|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101364204|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364205|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364206|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364207|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101364208|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
101364209|NCT00047567|Zonisamide|zonisamide|mesh-list
101364210|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
101364211|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101364212|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364213|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364214|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101364215|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364216|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101364217|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
101364218|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364219|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
101364220|NCT00145990|Miotics|miotics|mesh-ancestor
101364221|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
101364222|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364223|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364224|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101364225|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101333687|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333688|NCT00040261|Memantine|memantine|mesh-list
101333689|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101364226|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
101364228|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101364229|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
101364230|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364231|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364232|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
101364233|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101364234|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
101364235|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364236|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364237|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
101364238|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364239|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
101364240|NCT00081471|Hematinics|hematinics|mesh-ancestor
101364241|NCT00047645|Interferons|interferons|mesh-list
101364242|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
101364243|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364244|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
101364245|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364246|NCT00146146|Letrozole|letrozole|mesh-list
101364247|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
101364250|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
101364251|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
101364252|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101364253|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364254|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101364255|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101364256|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364257|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364258|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101364259|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
101407770|NCT00108017|Dorzolamide|dorzolamide|mesh-list
101364260|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364261|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364272|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101407772|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364273|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101364274|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101364275|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364277|NCT00146380|Zidovudine|zidovudine|mesh-list
101364278|NCT00146380|Nevirapine|nevirapine|mesh-list
101364279|NCT00146380|Nelfinavir|nelfinavir|mesh-list
101364280|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101364281|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101364282|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364283|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364284|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
101364285|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364286|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101364287|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101364288|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
101364289|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101364290|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101364291|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101364292|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101364293|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
101364294|NCT00081588|Darunavir|darunavir|mesh-list
101364295|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101364296|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101364298|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364299|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364300|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101364301|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101364302|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
101364303|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333691|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
101333692|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333693|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333695|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101333696|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101333698|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
101333699|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364304|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101364305|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101364306|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364307|NCT00047723|Minocycline|minocycline|mesh-list
101364309|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364312|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364313|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101364314|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
101364315|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364316|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364317|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101364318|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
101364321|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364323|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
101364324|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364325|NCT00146575|Sirolimus|sirolimus|mesh-list
101364326|NCT00146575|Paclitaxel|paclitaxel|mesh-list
101364327|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101364337|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364338|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
101364339|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364340|NCT00146614|Sirolimus|sirolimus|mesh-list
101364342|NCT00146614|Tacrolimus|tacrolimus|mesh-list
101364343|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101364344|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
101364345|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101364346|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364347|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364349|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364352|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364353|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101364355|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
101364357|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101364358|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101364359|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364360|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364361|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364362|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
101364364|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101364365|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101364366|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333701|NCT00040378|Vitamin E|vitamin e|mesh-list
101333702|NCT00040378|Tocopherols|tocopherols|mesh-list
101333703|NCT00040378|Tocotrienols|tocotrienols|mesh-list
101333704|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
101333705|NCT00040378|Selenium|selenium|mesh-list
101333706|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
101333707|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364367|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101364368|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101364369|NCT00047762|Growth Substances|growth substances|mesh-ancestor
101364370|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364371|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
101364372|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101364373|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534648|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101364374|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364376|NCT00042978|Etoposide|etoposide|mesh-list
101364377|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
101364378|NCT00042978|Oblimersen|oblimersen|mesh-list
101364379|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364380|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101364381|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101364382|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364383|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364384|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364385|NCT00405730|Ketorolac|ketorolac|mesh-list
101364386|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101364387|NCT00405730|Nepafenac|nepafenac|mesh-list
101364389|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101364390|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101176857|NCT01767792|Bevacizumab|bevacizumab|mesh-list
101364391|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101364392|NCT00405730|Analgesics|analgesics|mesh-ancestor
101364393|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
101364396|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364397|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364398|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101364399|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364400|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364402|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101364403|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101364404|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101364405|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
101364406|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364407|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364408|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101364409|NCT00047801|Docetaxel|docetaxel|mesh-list
101364410|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364411|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
101364412|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364413|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177150|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
101364414|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364415|NCT00146731|Artesunate|artesunate|mesh-list
101364416|NCT00146731|Amodiaquine|amodiaquine|mesh-list
101364417|NCT00146731|Dapsone|dapsone|mesh-list
101364418|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
101364419|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
101364420|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101364421|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101364422|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364423|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364424|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
101364425|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
101364426|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101364427|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
101364428|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101333709|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333710|NCT00040378|Protective Agents|protective agents|mesh-ancestor
101333711|NCT00040378|Trace Elements|trace elements|mesh-ancestor
101333713|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333714|NCT00040417|Fludarabine|fludarabine|mesh-list
101364429|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364430|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364431|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
101364432|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364433|NCT00047840|Docetaxel|docetaxel|mesh-list
101364434|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364435|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
101364436|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364437|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177593|NCT01933776|Vaccines|vaccines|mesh-list
101364438|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364440|NCT00146926|Ephedrine|ephedrine|mesh-list
101364441|NCT00146926|Ketamine|ketamine|mesh-list
101364442|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
101364444|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364445|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364446|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
101177961|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101177962|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177964|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101177965|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364447|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364448|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101364449|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101364450|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101364451|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364452|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364454|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101364455|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101364456|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
101364457|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101364458|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101364459|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364460|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101364461|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
101364462|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
101364463|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101364464|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
101364465|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
101364466|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101364473|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
101178256|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364474|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364476|NCT00147160|Temozolomide|temozolomide|mesh-list
101364477|NCT00147160|Cisplatin|cisplatin|mesh-list
101364478|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101364479|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
101364480|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364482|NCT04732104|Lidocaine|lidocaine|mesh-list
101364483|NCT04732104|Xylometazoline|xylometazoline|mesh-list
101364484|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
101178488|NCT02061384|Calcitriol|calcitriol|mesh-list
101364485|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178623|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
101178699|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364487|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364488|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364489|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
101178853|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
101364490|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364491|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101364492|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101364493|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101364494|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364495|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364496|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101364497|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
101333715|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
101333716|NCT00040417|Lenograstim|lenograstim|mesh-list
101333717|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333718|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
101333719|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364498|NCT00147355|Acetaminophen|acetaminophen|mesh-list
101364499|NCT00147355|Ibuprofen|ibuprofen|mesh-list
101179148|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
101364500|NCT00147355|Codeine|codeine|mesh-list
101364501|NCT00147355|Ondansetron|ondansetron|mesh-list
101364502|NCT00147355|Metoclopramide|metoclopramide|mesh-list
101364503|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101364504|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101364505|NCT00147355|Analgesics|analgesics|mesh-ancestor
101364506|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
101364507|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364508|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364509|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179280|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101364510|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364511|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101364512|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364513|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364515|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
101364516|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
101364517|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364518|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
101364519|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
101364520|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101364521|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101179416|NCT02374164|Febuxostat|febuxostat|mesh-list
101364523|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364524|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101179555|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364525|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101364526|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
101364527|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101364528|NCT00147355|Narcotics|narcotics|mesh-ancestor
101364529|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364530|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
101364531|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
101364532|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
101364533|NCT00048152|Cyclosporine|cyclosporine|mesh-list
101364534|NCT00048152|Cyclosporins|cyclosporins|mesh-list
101364535|NCT00048152|Daclizumab|daclizumab|mesh-list
101364536|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364542|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364543|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364544|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
101364545|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
101364546|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364547|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
101364548|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364549|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364550|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101364552|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101364553|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
101364554|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364555|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364556|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180396|NCT02663622|Methotrexate|methotrexate|mesh-list
101364557|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101364558|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101364559|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364560|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364561|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101364562|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
101364563|NCT04725682|Tacrolimus|tacrolimus|mesh-list
101364564|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364565|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
101180631|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101364566|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364567|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101364569|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333720|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101333721|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101333722|NCT00040495|Pantoprazole|pantoprazole|mesh-list
101333723|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101333724|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101333725|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101364570|NCT00147511|Linezolid|linezolid|mesh-list
101180853|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364571|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364572|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180923|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
101364573|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101364574|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364575|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364577|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364578|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
101364579|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364580|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364581|NCT00048230|Bortezomib|bortezomib|mesh-list
101364582|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364583|NCT00147589|Eplerenone|eplerenone|mesh-list
101181068|NCT02561130|Metformin|metformin|mesh-list
101364584|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101364585|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364586|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364587|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364588|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101364589|NCT00147589|Diuretics|diuretics|mesh-ancestor
101364590|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
101364591|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101364592|NCT00397332|Alefacept|alefacept|mesh-list
101364593|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
101364594|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
101364595|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364596|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
101364598|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
101364599|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
101364601|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
101364602|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
101364603|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364604|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
101364605|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101364606|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101364607|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364612|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
101364613|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364614|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364615|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364616|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101364617|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364618|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364619|NCT00147784|Interferons|interferons|mesh-list
101364620|NCT00147784|Ribavirin|ribavirin|mesh-list
101364621|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364622|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
101364623|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364624|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
101364625|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364627|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364628|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364629|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101364630|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364631|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364632|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
101364633|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101364634|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101181801|NCT02652390|Prednisolone|prednisolone|mesh-list
101181879|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
101364635|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333726|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181953|NCT02666352|Ruzasvir|ruzasvir|mesh-list
101333727|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333728|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
101333729|NCT00040651|Fludarabine|fludarabine|mesh-list
101333730|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
101364637|NCT00147862|Coagulants|coagulants|mesh-ancestor
101364638|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
101364639|NCT00147901|Fludarabine|fludarabine|mesh-list
101364640|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
101364641|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364642|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
101364643|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364644|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364645|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101364646|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
101364647|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364648|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364649|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101364650|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101364651|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
101364652|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101364653|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
101364654|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
101364655|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364656|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364658|NCT02957851|Analgesics|analgesics|mesh-ancestor
101364659|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
101364660|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364661|NCT00147979|Heparin|heparin|mesh-list
101364662|NCT00147979|Calcium heparin|calcium heparin|mesh-list
101364663|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
101364664|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101364665|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101364666|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364668|NCT00148018|Bortezomib|bortezomib|mesh-list
101182578|NCT02747628|Melatonin|melatonin|mesh-list
101364669|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101364670|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
101364671|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
101364672|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364673|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182901|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101182907|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
101182974|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
101182979|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
101364674|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364675|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
101364676|NCT00148018|Hormones|hormones|mesh-ancestor
101364677|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364678|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101364679|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364680|NCT00081822|Cytarabine|cytarabine|mesh-list
101364681|NCT00081822|Clofarabine|clofarabine|mesh-list
101364693|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
101364694|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101183189|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
101183190|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183195|NCT02933034|Manganese|manganese|mesh-list
101364695|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101364696|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183269|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
101364697|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364698|NCT00048425|Protective Agents|protective agents|mesh-ancestor
101364699|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364700|NCT00148135|Carboplatin|carboplatin|mesh-list
101364701|NCT00148135|Gemcitabine|gemcitabine|mesh-list
101364702|NCT00148135|Capecitabine|capecitabine|mesh-list
101364703|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364704|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364705|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
101364706|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364707|NCT00399711|Metformin|metformin|mesh-list
101364708|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
101364709|NCT00399711|Repaglinide|repaglinide|mesh-list
101364711|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364712|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
101364713|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364714|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333732|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
101333733|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333734|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333735|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101183556|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183771|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333736|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
101333737|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333738|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333739|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333741|NCT00040690|Cytarabine|cytarabine|mesh-list
101333742|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
101333743|NCT00040690|Ifosfamide|ifosfamide|mesh-list
101333744|NCT00040690|Doxorubicin|doxorubicin|mesh-list
101333745|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101333746|NCT00040690|Methotrexate|methotrexate|mesh-list
101333747|NCT00040690|Etoposide|etoposide|mesh-list
101333748|NCT00040690|Vincristine|vincristine|mesh-list
101333749|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
101333750|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184224|NCT03716076|Carbetocin|carbetocin|mesh-list
101333751|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
101184371|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
101184447|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333752|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333753|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333754|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101333755|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
101333756|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333757|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364715|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101364716|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
101364717|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101364718|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364719|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184595|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
101364720|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184735|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
101364722|NCT00148291|Vinorelbine|vinorelbine|mesh-list
101364723|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184813|NCT01483872|Heparin|heparin|mesh-list
101184884|NCT01183416|Isotretinoin|isotretinoin|mesh-list
101184959|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101364724|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
101364725|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364726|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
101185336|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185338|NCT00090870|Interferons|interferons|mesh-list
101364727|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364728|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101364730|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185787|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
101364731|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
101364732|NCT00148330|Hormones|hormones|mesh-ancestor
101185940|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
101364733|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364734|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186019|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101364736|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101364737|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101364738|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101333758|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101333759|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101333760|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101333761|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333762|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186391|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
101186464|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
101186465|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186535|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101364739|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364740|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364742|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364743|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364744|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
101364754|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364755|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101364756|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101364757|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101364758|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
101186765|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364759|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364760|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364761|NCT00148408|Montelukast|montelukast|mesh-list
101364762|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101364763|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
101364764|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101186973|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101364765|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364766|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101364767|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364768|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101364769|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101364770|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364771|NCT00048503|Tipifarnib|tipifarnib|mesh-list
101364772|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364773|NCT00148447|Escitalopram|escitalopram|mesh-list
101187199|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101364774|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101364775|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364776|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364777|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364778|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364779|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
101364781|NCT00043134|Decitabine|decitabine|mesh-list
101364782|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364783|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
101364784|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364785|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364786|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364788|NCT00148564|Ziprasidone|ziprasidone|mesh-list
101364789|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
101364790|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
101187568|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187569|NCT00002676|Cobalt|cobalt|mesh-list
101364791|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364792|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364793|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364794|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101364795|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101187803|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364796|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101364797|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101187878|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101187948|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187951|NCT05749614|Lidocaine|lidocaine|mesh-list
101364798|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101364799|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364800|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364801|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364802|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364804|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101364805|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101333763|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101333764|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
101333765|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333766|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188248|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188249|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188250|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
101188251|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188252|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188253|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188254|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188255|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101188256|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101188257|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188258|NCT02829918|Nivolumab|nivolumab|mesh-list
101188259|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188260|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188263|NCT02795988|Fluorouracil|fluorouracil|mesh-list
101333767|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
101333768|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333769|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101364806|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
101364807|NCT00148603|Montelukast|montelukast|mesh-list
101364808|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101364818|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101364819|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364820|NCT00148681|Paclitaxel|paclitaxel|mesh-list
101364821|NCT00148681|Vinorelbine|vinorelbine|mesh-list
101364822|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
101364823|NCT00148681|Doxorubicin|doxorubicin|mesh-list
101364824|NCT00148681|Trastuzumab|trastuzumab|mesh-list
101364825|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101364826|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364827|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
101364828|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
101364829|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
101364830|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364831|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101364832|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
101364833|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364834|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101364835|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101364836|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
101364837|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101364838|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364839|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101364840|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364841|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364842|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101364843|NCT00148720|Capecitabine|capecitabine|mesh-list
101364844|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364845|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
101364846|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364847|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364848|NCT00148837|Interferons|interferons|mesh-list
101364849|NCT00148837|Ribavirin|ribavirin|mesh-list
101364850|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
101364851|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
101364852|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101364853|NCT00148837|Prazosin|prazosin|mesh-list
101364854|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364855|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
101364856|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364857|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
101364858|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364859|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
101364860|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364861|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101364862|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101364863|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101364864|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101364865|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
101364866|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364867|NCT00148876|Capecitabine|capecitabine|mesh-list
101364868|NCT00148876|Trastuzumab|trastuzumab|mesh-list
101364869|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364878|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101364879|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364880|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364881|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333770|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333771|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101333772|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
101333773|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333775|NCT00040690|Protective Agents|protective agents|mesh-ancestor
101333776|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
101333778|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
101333779|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333780|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333781|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333782|NCT00040768|Bortezomib|bortezomib|mesh-list
101333783|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333784|NCT00017238|KRN 5500|krn 5500|mesh-list
101333785|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333786|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101333787|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333788|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333789|NCT00040885|Infliximab|infliximab|mesh-list
101333790|NCT00040885|Docetaxel|docetaxel|mesh-list
101333791|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333792|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
101333793|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
101333794|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333795|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333796|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101364882|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364883|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364884|NCT00149110|Analgesics|analgesics|mesh-ancestor
101364885|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
101364886|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364887|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
101364888|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364889|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
101364890|NCT00149149|Polaprezinc|polaprezinc|mesh-list
101364891|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101364892|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101364893|NCT00149188|Lanreotide|lanreotide|mesh-list
101364894|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364895|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
101364897|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364898|NCT00048776|Cilostazol|cilostazol|mesh-list
101364899|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101364900|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
101364901|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364902|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364903|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101364904|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
101364905|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101333797|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101333798|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
101333799|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101333800|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101333801|NCT00001421|Methimazole|methimazole|mesh-list
101333802|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
101333803|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
101364906|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101364907|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364908|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101364909|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
101364910|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101364911|NCT00048776|Protective Agents|protective agents|mesh-ancestor
101364912|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101417016|NCT00140712|Ropinirole|ropinirole|mesh-list
101364913|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101364914|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364915|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
101364916|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101364917|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364918|NCT00048854|Sertraline|sertraline|mesh-list
101364919|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
101364920|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364921|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101364922|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101364923|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101364924|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364925|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364926|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
101364927|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364928|NCT00081978|Etravirine|etravirine|mesh-list
101364929|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101364930|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101364931|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364932|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364933|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
101364943|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
101364944|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101364945|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101364947|NCT00149578|Gemcitabine|gemcitabine|mesh-list
101364948|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
101364949|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364950|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
101364951|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364952|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364953|NCT00149578|Antidotes|antidotes|mesh-ancestor
101364954|NCT00149578|Protective Agents|protective agents|mesh-ancestor
101364955|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364956|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
101364958|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
101364959|NCT00149617|Buspirone|buspirone|mesh-list
101364960|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101364961|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101364963|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364964|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101364965|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101364966|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
101364967|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364968|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364969|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
101364970|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
101364971|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101364972|NCT00149656|Selenium|selenium|mesh-list
101364973|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
101364974|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333804|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333805|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333807|NCT00017277|Hematinics|hematinics|mesh-ancestor
101333808|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
101364975|NCT00149656|Protective Agents|protective agents|mesh-ancestor
101364976|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364977|NCT00149656|Trace Elements|trace elements|mesh-ancestor
101364978|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
101364979|NCT00082095|Doxorubicin|doxorubicin|mesh-list
101364980|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101364981|NCT00082095|Capecitabine|capecitabine|mesh-list
101364982|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364983|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364984|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101364985|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101364986|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101364987|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364988|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101364989|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
101364990|NCT00149851|Tegaserod|tegaserod|mesh-list
101364991|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101364992|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
101364993|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101364994|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101364995|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101364996|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
101364997|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101364998|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101364999|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101365000|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
101365001|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365004|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365006|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101365007|NCT00049088|Docetaxel|docetaxel|mesh-list
101365008|NCT00049088|Antibodies|antibodies|mesh-list
101365009|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
101365010|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101365011|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365012|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365013|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365014|NCT00049088|Growth Substances|growth substances|mesh-ancestor
101365015|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365016|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365017|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
101365018|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365019|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101365020|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365021|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365022|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
101365023|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101365024|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365025|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101365026|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
101365027|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365028|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365029|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365030|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365031|NCT04725448|Paclitaxel|paclitaxel|mesh-list
101365032|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101365033|NCT04725448|Bevacizumab|bevacizumab|mesh-list
101365034|NCT04725448|Carboplatin|carboplatin|mesh-list
101365035|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101365036|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365037|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365038|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
101365039|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365040|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365041|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101333809|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333810|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333811|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333812|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333813|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
101333814|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333815|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101333816|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333817|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333818|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
101333819|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333821|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101333822|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101333824|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333825|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333826|NCT00017316|Thalidomide|thalidomide|mesh-list
101333827|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333828|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
101333829|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333830|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
101333831|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365042|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101365043|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365044|NCT04725448|Growth Substances|growth substances|mesh-ancestor
101365045|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365046|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101365048|NCT00405925|Zidovudine|zidovudine|mesh-list
101365049|NCT00405925|Abacavir|abacavir|mesh-list
101365050|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101365051|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101365052|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365053|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365054|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
101365055|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365056|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101365057|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101365058|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
101365059|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101365060|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365061|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365062|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365063|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365064|NCT00082212|Cetuximab|cetuximab|mesh-list
101365065|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101365066|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365067|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
101365068|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101365069|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333832|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333833|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333834|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101365070|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101365071|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
101365072|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101365073|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365082|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
101365083|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365084|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365086|NCT00150085|Cyclosporins|cyclosporins|mesh-list
101365087|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365088|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365089|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101365090|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
101365091|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365092|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
101365093|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101365094|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
101365095|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101365096|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101365097|NCT00082251|Niacin|niacin|mesh-list
101365098|NCT00082251|Simvastatin|simvastatin|mesh-list
101365099|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101365100|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101365101|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
101365102|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365103|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101365104|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101365105|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365106|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
101365107|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
101365108|NCT00082251|Vitamins|vitamins|mesh-ancestor
101365109|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
101365110|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365111|NCT00049244|Capecitabine|capecitabine|mesh-list
101365112|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101365113|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
101365114|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365115|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365116|NCT00150124|Methimazole|methimazole|mesh-list
101365117|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
101365118|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
101365119|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101365120|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365121|NCT00049283|Docetaxel|docetaxel|mesh-list
101365122|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101365123|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101365124|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
101365125|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
101365126|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
101365127|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365128|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101365129|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365130|NCT00150241|Varenicline|varenicline|mesh-list
101365131|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101365132|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101365133|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
101365134|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101365135|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101365136|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101365137|NCT00150280|Ibuprofen|ibuprofen|mesh-list
101365138|NCT00150280|Celecoxib|celecoxib|mesh-list
101365139|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101365140|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101365154|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101365155|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101365156|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101365157|NCT00150358|Urological Agents|urological agents|mesh-ancestor
101365158|NCT00049361|Thalidomide|thalidomide|mesh-list
101365159|NCT00049361|Temozolomide|temozolomide|mesh-list
101333877|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333879|NCT00001436|Tamoxifen|tamoxifen|mesh-list
101333880|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101333881|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
101333882|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101333883|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333884|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101333885|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333886|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101333887|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101333888|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101333889|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
101333890|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101333891|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
101333892|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333893|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333894|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101333895|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
101333896|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101333897|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
101333898|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333899|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333900|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101333901|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
101333902|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
101333903|NCT00041548|Protective Agents|protective agents|mesh-ancestor
101333904|NCT00041587|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
101333905|NCT00041587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333907|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333908|NCT00041665|Mitogens|mitogens|mesh-list
101333909|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
101333910|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333911|NCT00041704|Anidulafungin|anidulafungin|mesh-list
101333912|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
101333913|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333914|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101333915|NCT00017472|Antibodies|antibodies|mesh-list
101333916|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
101333917|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101333918|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
101333919|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333920|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333921|NCT00041782|Dalteparin|dalteparin|mesh-list
101333922|NCT00041782|Tinzaparin|tinzaparin|mesh-list
101333923|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101333924|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
101333925|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101333926|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101333927|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333929|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101333930|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
101333931|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101333932|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333933|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101333934|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101333935|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
101333936|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333937|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333938|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
101333939|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101333940|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
101333941|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101333942|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333943|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101333944|NCT00041977|Doxycycline|doxycycline|mesh-list
101333945|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333946|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333947|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
101333948|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101333949|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101333950|NCT00042016|Decitabine|decitabine|mesh-list
101333951|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101333952|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
101333953|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333954|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333956|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101333957|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
101333958|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333959|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333960|NCT00001457|Lamivudine|lamivudine|mesh-list
101333961|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101333962|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101333963|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333964|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333965|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
101333966|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333967|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101333968|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101333969|NCT00042172|Donepezil|donepezil|mesh-list
101333970|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101333971|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101333972|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101333973|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101333974|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101333975|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333976|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
101333977|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
101333978|NCT00017589|Oblimersen|oblimersen|mesh-list
101333979|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101333980|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333982|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
101333983|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
101333984|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333985|NCT00001475|Thalidomide|thalidomide|mesh-list
101333986|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101333987|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
101333988|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101333989|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
101333990|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101333991|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101333992|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101333993|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101333994|NCT00001475|Growth Substances|growth substances|mesh-ancestor
101333995|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
101333996|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101333997|NCT00042328|Valacyclovir|valacyclovir|mesh-list
101333998|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
101333999|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334001|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
101334002|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334003|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
101334004|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334005|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334006|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334007|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334008|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101334009|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
101334010|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334011|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101334012|NCT02970643|Olanzapine|olanzapine|mesh-list
101334013|NCT02970643|Palonosetron|palonosetron|mesh-list
101334014|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
101334015|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
101334017|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334018|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334019|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101334020|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101334021|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101334022|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334030|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101334031|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
101334032|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101334033|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101334034|NCT00017628|Prednisolone|prednisolone|mesh-list
101334035|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
101334036|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
101334037|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101334038|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
101334039|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334040|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
101334041|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334042|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334043|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101334044|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
101334045|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334046|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334047|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101334048|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101334049|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
101334050|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
101334051|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334052|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334055|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334056|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101334057|NCT00017628|Protective Agents|protective agents|mesh-ancestor
101334058|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101334059|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101334060|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101334061|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334062|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487425|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101334063|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334065|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334066|NCT00042562|Analgesics|analgesics|mesh-ancestor
101334067|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
101334068|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334069|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334070|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334071|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
101334072|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101334073|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101334075|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334077|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101334078|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334079|NCT00042679|Carboplatin|carboplatin|mesh-list
101334080|NCT00042679|Gemcitabine|gemcitabine|mesh-list
101334081|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334082|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334084|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334085|NCT00042718|Amoxicillin|amoxicillin|mesh-list
101334089|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
101334090|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101334091|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334092|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334093|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101334094|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101334095|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334096|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334097|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334098|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334099|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101334100|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334101|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101334103|NCT00042796|Azacitidine|azacitidine|mesh-list
101334104|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334105|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
101334106|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334107|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334108|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334109|NCT00042835|Paclitaxel|paclitaxel|mesh-list
101334110|NCT00042835|Etoposide|etoposide|mesh-list
101334111|NCT00042835|Docetaxel|docetaxel|mesh-list
101334112|NCT00042835|Carboplatin|carboplatin|mesh-list
101334113|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
101334114|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101334115|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101334116|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334117|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
101334118|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
101334119|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334120|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334121|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101334122|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334123|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334124|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334125|NCT00017784|Valganciclovir|valganciclovir|mesh-list
101334126|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
101334127|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334129|NCT00042874|Fluorouracil|fluorouracil|mesh-list
101334130|NCT00042874|Irinotecan|irinotecan|mesh-list
101334131|NCT00042874|Alvocidib|alvocidib|mesh-list
101334132|NCT00042874|Calcium|calcium|mesh-list
101334133|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
101334134|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334135|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334136|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
101334137|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334138|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334139|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334140|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101334141|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
101334142|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101334143|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101334145|NCT00042874|Antidotes|antidotes|mesh-ancestor
101334146|NCT00042874|Protective Agents|protective agents|mesh-ancestor
101334148|NCT00042874|Vitamins|vitamins|mesh-ancestor
101334149|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
101334151|NCT00042874|Growth Substances|growth substances|mesh-ancestor
101334152|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334153|NCT00042913|Epratuzumab|epratuzumab|mesh-list
101334154|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101334155|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334156|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
101334157|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334158|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101334159|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334160|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334161|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
101334162|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
101334163|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
101334164|NCT00043069|Estrogens|estrogens|mesh-list
101334165|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
101334166|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
101334167|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101334168|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334170|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
101334171|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101334173|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334174|NCT00043069|Antacids|antacids|mesh-ancestor
101334175|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334176|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334177|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101334178|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101334179|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
101334180|NCT00043147|Prednisone|prednisone|mesh-list
101334182|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101334183|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101334184|NCT00043147|Prednisolone|prednisolone|mesh-list
101334185|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
101334186|NCT00043147|Beclomethasone|beclomethasone|mesh-list
101334187|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101334188|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
101334189|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101334190|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
101334191|NCT00043147|Hormones|hormones|mesh-ancestor
101334192|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101334193|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334194|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101334195|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334196|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
101334197|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
101334198|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334199|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101334200|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101334201|NCT00043147|Protective Agents|protective agents|mesh-ancestor
101334202|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101334203|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
101334204|NCT00017862|Reslizumab|reslizumab|mesh-list
101334205|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101334206|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101334207|NCT00043264|Azithromycin|azithromycin|mesh-list
101334209|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101334211|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101334213|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
101334214|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101334215|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334216|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334217|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101334218|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101334219|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101334220|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101334221|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101334222|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101334223|NCT00043303|Interferons|interferons|mesh-list
101334224|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
101334225|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334226|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
101334227|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334228|NCT00017940|Mitogens|mitogens|mesh-list
101334229|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
101334230|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334232|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101334233|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101334234|NCT02970604|Analgesics|analgesics|mesh-ancestor
101334235|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
101334236|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101334237|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334238|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101334239|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334240|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101334241|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101334242|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334243|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101334244|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101334245|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334246|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
101334247|NCT00043342|Interferons|interferons|mesh-list
101334250|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
101334251|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334252|NCT00043381|Decitabine|decitabine|mesh-list
101334253|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101334254|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
101334255|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334256|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334257|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334258|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
101334259|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101334260|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
101334261|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101334262|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
101334263|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101334264|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101334266|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101334267|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101334268|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487426|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101334270|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101334271|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
101334272|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101334273|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101334274|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
101334275|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101334276|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101334277|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101334278|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101334280|NCT00043576|Docetaxel|docetaxel|mesh-list
101334281|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101334282|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101334283|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101334284|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407775|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101407776|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101407777|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407778|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407779|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534649|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101407780|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101407781|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101407782|NCT00441922|Docetaxel|docetaxel|mesh-list
101407783|NCT00441922|Vinorelbine|vinorelbine|mesh-list
101407784|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407785|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534650|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534651|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407786|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407787|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407788|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407789|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101407790|NCT00441961|Methotrexate|methotrexate|mesh-list
101407791|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101407792|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
101407793|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407794|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407795|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101407797|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407798|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407799|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407800|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407801|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101407802|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101407803|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
101407804|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407805|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101407806|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
101407807|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534652|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407808|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101407809|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101407810|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101407811|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407812|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407813|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407814|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101487399|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
101534653|NCT00568763|Sargramostim|sargramostim|mesh-list
101407815|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101407816|NCT00442234|Monteplase|monteplase|mesh-list
101407817|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101407818|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101407819|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407820|NCT00108095|Ondansetron|ondansetron|mesh-list
101407821|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
101407822|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
101407823|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407824|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407825|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407826|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
101407827|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407828|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101407829|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101407830|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
101407831|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407832|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407833|NCT03278938|Bupropion|bupropion|mesh-list
101407834|NCT03278938|Citalopram|citalopram|mesh-list
101407835|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101407836|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
101407838|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101407839|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407840|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407841|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407842|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
101407843|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407845|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101407846|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101407847|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407848|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101407849|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
101534658|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101407850|NCT03278860|Oxytocin|oxytocin|mesh-list
101407851|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
101407852|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101407853|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407854|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101407856|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101534659|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407857|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101407858|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101407859|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101407860|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407861|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407862|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407863|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101407864|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101407865|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101407867|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407868|NCT00442585|Ibuprofen|ibuprofen|mesh-list
101407869|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101407870|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534661|NCT00583869|Pregabalin|pregabalin|mesh-list
101534662|NCT00583869|Analgesics|analgesics|mesh-ancestor
101534663|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
101534664|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407871|NCT00442585|Analgesics|analgesics|mesh-ancestor
101407872|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
101407873|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407874|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407875|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534665|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407877|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101407878|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407879|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407881|NCT00442741|Epothilones|epothilones|mesh-list
101407882|NCT00442741|Omeprazole|omeprazole|mesh-list
101534666|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
101534667|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101534668|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534669|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407883|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101407884|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407885|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101407886|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407887|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407888|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407889|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
101407890|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
101407891|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
101407892|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
101407893|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101407894|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101407896|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
101407897|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407898|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407899|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407900|NCT00404586|Fluticasone|fluticasone|mesh-list
101407901|NCT00404586|Xhance|xhance|mesh-list
101407902|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407903|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101407904|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
101407905|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407906|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407907|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101407908|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
101407909|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
101407910|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101407911|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101407912|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
101407913|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101407914|NCT00442819|Protective Agents|protective agents|mesh-ancestor
101407915|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534673|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534674|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407917|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101407918|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
101407919|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101407920|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407921|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101407922|NCT00108251|Diuretics|diuretics|mesh-ancestor
101407923|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
101407924|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101407925|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
101407926|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
101407927|NCT00443170|Midazolam|midazolam|mesh-list
101407928|NCT00443170|Caffeine|caffeine|mesh-list
101407929|NCT00443170|Omeprazole|omeprazole|mesh-list
101407930|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101407931|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101534675|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
101534676|NCT00568880|Bortezomib|bortezomib|mesh-list
101534677|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101407932|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407933|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407934|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101407935|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101407936|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407937|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101407938|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
101407939|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
101407940|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
101407941|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
101407942|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407944|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101407945|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101407946|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407947|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101407948|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101407949|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
101407952|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101407953|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407954|NCT00443170|Analgesics|analgesics|mesh-ancestor
101407955|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
101407956|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407957|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101407958|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101407959|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101407960|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407961|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101407962|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101407963|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
101407965|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101407966|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407967|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101407968|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
101407969|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101407970|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407972|NCT00108368|Risperidone|risperidone|mesh-list
101407973|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101407974|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
101407975|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101407976|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101407977|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407978|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101407979|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101407980|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101407981|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101407982|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101407983|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
101407984|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
101407985|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
101407986|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101407987|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101407988|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101407989|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101407990|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101407991|NCT00108446|Lidocaine|lidocaine|mesh-list
101407992|NCT00108446|Fentanyl|fentanyl|mesh-list
101407993|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
101407994|NCT00108446|Naloxone|naloxone|mesh-list
101407995|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
101407996|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
101407997|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534682|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534683|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534684|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101407998|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101407999|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
101408000|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408001|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101408002|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101408003|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101408004|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408005|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408006|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101408007|NCT00108446|Narcotics|narcotics|mesh-ancestor
101408008|NCT00108446|Analgesics|analgesics|mesh-ancestor
101408009|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101408010|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101408011|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
101534685|NCT03451695|Morphine|morphine|mesh-list
101534686|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101408012|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101408013|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
101221967|NCT01510847|Hormones|hormones|mesh-ancestor
101222279|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
101222409|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222413|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
101222482|NCT01513070|Aspirin|aspirin|mesh-list
101222551|NCT01513603|Cytarabine|cytarabine|mesh-list
101222677|NCT01514175|Ibuprofen|ibuprofen|mesh-list
101223016|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
101408014|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408015|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101408016|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101534687|NCT03451695|Narcotics|narcotics|mesh-ancestor
101408018|NCT00138606|Vildagliptin|vildagliptin|mesh-list
101408019|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408020|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408021|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101408022|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101534688|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534689|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534690|NCT03451695|Analgesics|analgesics|mesh-ancestor
101534691|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
101534692|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534694|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101534695|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
101408023|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408024|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408025|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
101408026|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101534696|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408028|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408029|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408030|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408031|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408032|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101408033|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101408034|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101408035|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534697|NCT00569465|Expectorants|expectorants|mesh-ancestor
101408036|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408037|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408038|NCT00443521|Triamcinolone|triamcinolone|mesh-list
101408039|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101408040|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101408041|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101408042|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408043|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
101408045|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408046|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408047|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408048|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
101408049|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408050|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408051|NCT03278431|Albendazole|albendazole|mesh-list
101408052|NCT03278431|Mebendazole|mebendazole|mesh-list
101408053|NCT03278431|Piperazine|piperazine|mesh-list
101408054|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
101408055|NCT03278431|Pyrantel|pyrantel|mesh-list
101408056|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
101408057|NCT03278431|Oxantel|oxantel|mesh-list
101408058|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
101534701|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534702|NCT00569465|Protective Agents|protective agents|mesh-ancestor
101534703|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408059|NCT03278431|DMP 777|dmp 777|mesh-list
101408060|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
101408061|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101408062|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408063|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
101408064|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101408065|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101408066|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408067|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
101408068|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408069|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408071|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
101408072|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408073|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101534704|NCT00569465|Antidotes|antidotes|mesh-ancestor
101221787|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
101408074|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101408076|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408077|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408078|NCT04726332|Prednisone|prednisone|mesh-list
101408079|NCT04726332|Fulvestrant|fulvestrant|mesh-list
101408080|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534706|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101534707|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
101534708|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408081|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
101408082|NCT04726332|Hormones|hormones|mesh-ancestor
101408083|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408084|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408085|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408086|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408087|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101417037|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
101408088|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101408089|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
101408090|NCT00108563|Citalopram|citalopram|mesh-list
101408091|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101408092|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408093|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408094|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408095|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408097|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408098|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101408099|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408100|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408101|NCT00443716|Estrogens|estrogens|mesh-list
101534709|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408103|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408104|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408105|NCT00443794|Aspirin|aspirin|mesh-list
101408106|NCT00443794|Atenolol|atenolol|mesh-list
101408107|NCT00443794|Ramipril|ramipril|mesh-list
101408108|NCT00443794|Simvastatin|simvastatin|mesh-list
101534710|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101534711|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534712|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
101534713|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408109|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101408110|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101408112|NCT00443794|Analgesics|analgesics|mesh-ancestor
101408113|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
101408114|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408115|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408117|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408118|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101408119|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101408120|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408121|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101408122|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101534714|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101408123|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408124|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
101408125|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101408126|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101408127|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
101408128|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408129|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101534715|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101534716|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101408130|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101408131|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
101408132|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101408133|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101408134|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
101408135|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
101408136|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101408137|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101408138|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101534717|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534718|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534719|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408139|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
101408140|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408141|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408142|NCT00443794|Diuretics|diuretics|mesh-ancestor
101408143|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
101408144|NCT00108602|Acetazolamide|acetazolamide|mesh-list
101417042|NCT00140751|Ritonavir|ritonavir|mesh-list
101408145|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
101408146|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101408147|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408148|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408149|NCT00108602|Diuretics|diuretics|mesh-ancestor
101408150|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
101408151|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408152|NCT03278314|Ivacaftor|ivacaftor|mesh-list
101408153|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101534720|NCT00569621|Moxaverine|moxaverine|mesh-list
101408154|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408155|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408156|NCT00443950|Etanercept|etanercept|mesh-list
101408157|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101408158|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101408159|NCT00443950|Analgesics|analgesics|mesh-ancestor
101408160|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
101534721|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
101408161|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408162|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408163|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408165|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408166|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408167|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
101408170|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101408171|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101408172|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
101408173|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408174|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408175|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408177|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101408179|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
101534722|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
101408181|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408182|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
101408183|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101408184|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101408185|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
101408186|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408187|NCT00451360|Diacerein|diacerein|mesh-list
101408190|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408191|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408192|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
101408193|NCT00108797|Coagulants|coagulants|mesh-ancestor
101408195|NCT04698772|Morphine|morphine|mesh-list
101534723|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408197|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
101408198|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408199|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408200|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101408201|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101408202|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
101408203|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
101408204|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408205|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101408206|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101408207|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408208|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534724|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408209|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101408210|NCT04698772|Narcotics|narcotics|mesh-ancestor
101408211|NCT00451594|Dexamethasone|dexamethasone|mesh-list
101408212|NCT00451594|Prednisolone|prednisolone|mesh-list
101408213|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408214|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
101408215|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
101408216|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408217|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408218|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408220|NCT00451594|Hormones|hormones|mesh-ancestor
101408221|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408222|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408223|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408224|NCT00139035|Cyclosporine|cyclosporine|mesh-list
101408225|NCT00139035|Cyclosporins|cyclosporins|mesh-list
101408226|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408227|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408228|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408229|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
101408230|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408231|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
101408232|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408233|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408234|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408235|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101408236|NCT00451672|Bromocriptine|bromocriptine|mesh-list
101408237|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101408238|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101408239|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
101408240|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408241|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408242|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
101408243|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
101408244|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408245|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408246|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
101408247|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101408248|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
101408249|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408250|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408252|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101408253|NCT00451711|Amebicides|amebicides|mesh-ancestor
101408254|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101408255|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101408256|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408257|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101408258|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
101408259|NCT00139074|Valproic Acid|valproic acid|mesh-list
101408260|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101408261|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408262|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408263|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101408264|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101408265|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408266|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408267|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
101408268|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408269|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408270|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
101408271|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408272|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
101408273|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
101534725|NCT00569699|Bevacizumab|bevacizumab|mesh-list
101408278|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
101408279|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408280|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408281|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101408282|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408283|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
101408284|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408285|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408286|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101408287|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
101534726|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101534735|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101534736|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
101534737|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
101408288|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101408289|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408290|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408291|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408292|NCT00143091|Sertraline|sertraline|mesh-list
101408293|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408294|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534738|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534739|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534740|NCT00570050|Insulin|insulin|mesh-list
101408296|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408297|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408298|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408299|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408300|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
101534742|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408309|NCT00452062|Dexamethasone|dexamethasone|mesh-list
101408310|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408311|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
101408312|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
101408313|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408314|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408315|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534743|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408318|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408319|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408321|NCT00108992|Diclofenac|diclofenac|mesh-list
101408322|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101408323|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101408324|NCT00108992|Analgesics|analgesics|mesh-ancestor
101408325|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
101408326|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408327|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408328|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408329|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408330|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101408331|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408332|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408334|NCT00143130|Analgesics|analgesics|mesh-ancestor
101408335|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
101408336|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408337|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408338|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
101408339|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101408340|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408341|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408342|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101408343|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101408344|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101408345|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408346|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408347|NCT00109070|Bevacizumab|bevacizumab|mesh-list
101408348|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408349|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408350|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408351|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101408352|NCT00109070|Growth Substances|growth substances|mesh-ancestor
101408353|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534745|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101408354|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
101408355|NCT00452218|Sorafenib|sorafenib|mesh-list
101408356|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408357|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101408358|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487400|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408359|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408360|NCT00143169|Parecoxib|parecoxib|mesh-list
101408361|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101408362|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101408363|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408364|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408365|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101408366|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101408368|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
101408369|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408370|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534750|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408371|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408372|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408374|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408375|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101408376|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408377|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534751|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101408378|NCT03275116|Bromides|bromides|mesh-list
101408379|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
101408380|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
101408381|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101408382|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
101408383|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534752|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
101408384|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408385|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408386|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408387|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101408388|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101534753|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408389|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101408390|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101408391|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408392|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408393|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
101408394|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101408395|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
101408396|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
101408397|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
101408398|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101408399|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101408400|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408401|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408402|NCT00109148|Hormones|hormones|mesh-ancestor
101408403|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408404|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408405|NCT00452296|Insulin|insulin|mesh-list
101408406|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408407|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408408|NCT00452569|Thalidomide|thalidomide|mesh-list
101408409|NCT00452569|Dexamethasone|dexamethasone|mesh-list
101408410|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408411|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
101408412|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
101408413|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408414|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408415|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408416|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
101408417|NCT00452569|Hormones|hormones|mesh-ancestor
101408418|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408419|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408420|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408421|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408422|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
101408423|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
101408424|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101408425|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408426|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408427|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101408428|NCT00452569|Growth Substances|growth substances|mesh-ancestor
101408429|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
101408430|NCT00143286|Varenicline|varenicline|mesh-list
101408431|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101408432|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101408433|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
101408434|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408435|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408436|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408437|NCT00109187|Omalizumab|omalizumab|mesh-list
101408438|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101408439|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408440|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408444|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
101408445|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408446|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408447|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101408448|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408449|NCT00109226|Bevacizumab|bevacizumab|mesh-list
101408450|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408451|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408452|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408453|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101408455|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408456|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
101408457|NCT00452725|Hormones|hormones|mesh-list
101408458|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408459|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534755|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101534756|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
101534757|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
101534758|NCT00570245|Protective Agents|protective agents|mesh-ancestor
101534759|NCT00570284|Panobinostat|panobinostat|mesh-list
101534760|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408464|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408466|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101408467|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101408468|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
101408469|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408470|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408471|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408473|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
101534770|NCT00570440|Hormones|hormones|mesh-ancestor
101408474|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408475|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101408476|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
101408477|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408478|NCT00452920|Docetaxel|docetaxel|mesh-list
101534771|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408479|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408480|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408481|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
101408482|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408483|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408485|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408486|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408487|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101408488|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408489|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408490|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408491|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534772|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408492|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408493|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408494|NCT00109382|Aspirin|aspirin|mesh-list
101408495|NCT00109382|Clopidogrel|clopidogrel|mesh-list
101408496|NCT00109382|Simvastatin|simvastatin|mesh-list
101408498|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534773|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101534774|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408500|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
101408501|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408502|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408503|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408504|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408505|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101408506|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101408507|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408508|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101408509|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101408510|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408511|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
101408512|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101408513|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101408514|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101408516|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408517|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101408519|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
101408520|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408521|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101408522|NCT00453076|Paclitaxel|paclitaxel|mesh-list
101408523|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101408524|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534777|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101408527|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408528|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408529|NCT00453115|Gemcitabine|gemcitabine|mesh-list
101408530|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
101408531|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101408532|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
101408533|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408534|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408535|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101408536|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101408537|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101408539|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408540|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408541|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408543|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101408544|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101408545|NCT00453232|Etoposide|etoposide|mesh-list
101408546|NCT00453232|Bleomycin|bleomycin|mesh-list
101408547|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408548|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101408549|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101408550|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534779|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408551|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408552|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408553|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408554|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
101408555|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408556|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408557|NCT00143520|Pioglitazone|pioglitazone|mesh-list
101408558|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408559|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408560|NCT00143559|Antibodies|antibodies|mesh-list
101408561|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
101408562|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534780|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101534781|NCT00570479|Growth Substances|growth substances|mesh-ancestor
101408563|NCT00453778|Fluticasone|fluticasone|mesh-list
101408564|NCT00453778|Xhance|xhance|mesh-list
101408565|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408566|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101408567|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
101408568|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534782|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408569|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408570|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408571|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534783|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
101408573|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101408574|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
101408575|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101408576|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101408577|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101408578|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408579|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
101408580|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408585|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101408586|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101408587|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408588|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101408589|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408590|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408591|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101408592|NCT00454168|Sargramostim|sargramostim|mesh-list
101408593|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
101408594|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408595|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
101408596|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101408597|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
101408598|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408599|NCT03274765|Estradiol|estradiol|mesh-list
101408600|NCT03274765|Estrogens|estrogens|mesh-ancestor
101408601|NCT03274765|Hormones|hormones|mesh-ancestor
101534784|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408602|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408605|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101534785|NCT00584298|Octreotide|octreotide|mesh-list
101534786|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408607|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101408608|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101408609|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408610|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408611|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408612|NCT00454402|Urological Agents|urological agents|mesh-ancestor
101534787|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408614|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101408615|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101408616|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
101408617|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408618|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408619|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101408622|NCT00454480|Fludarabine|fludarabine|mesh-list
101534788|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534789|NCT00584376|Pregabalin|pregabalin|mesh-list
101534790|NCT00584376|Analgesics|analgesics|mesh-ancestor
101534791|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
101534792|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534793|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534794|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
101534795|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101534796|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534797|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534798|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534799|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101534800|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534801|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534802|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534803|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101534804|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534805|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
101534806|NCT00570830|Hormones|hormones|mesh-ancestor
101534807|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534808|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534809|NCT00584493|Tremelimumab|tremelimumab|mesh-list
101534810|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534811|NCT04580342|Propranolol|propranolol|mesh-list
101534812|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101534813|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101534814|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101534815|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534816|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534817|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534818|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534819|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101534821|NCT00571142|Bevacizumab|bevacizumab|mesh-list
101534822|NCT00571142|Temazepam|temazepam|mesh-list
101534823|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408623|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
101408624|NCT00454480|Azacitidine|azacitidine|mesh-list
101408627|NCT00454480|Daunorubicin|daunorubicin|mesh-list
101408628|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
101408629|NCT00454480|Clofarabine|clofarabine|mesh-list
101408630|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
101408631|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
101408632|NCT00454480|Tipifarnib|tipifarnib|mesh-list
101408633|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408634|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534828|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534829|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
101534830|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101534831|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534832|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101408636|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408638|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
101408639|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408641|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408642|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408643|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101408644|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
101408645|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101408646|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408647|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101408648|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534835|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
101408649|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408650|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
101408651|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
101408652|NCT00110006|Prednisone|prednisone|mesh-list
101408653|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
101408654|NCT00110006|Rituximab|rituximab|mesh-list
101408655|NCT00110006|Doxorubicin|doxorubicin|mesh-list
101408656|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101408657|NCT00110006|Vincristine|vincristine|mesh-list
101408658|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101534836|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
101534837|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534838|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534839|NCT00584532|Genistein|genistein|mesh-list
101534840|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101534841|NCT00584532|Protective Agents|protective agents|mesh-ancestor
101534842|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534843|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534844|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101534845|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534846|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534850|NCT00584532|Hormones|hormones|mesh-ancestor
101534851|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534852|NCT00584571|Dexetimide|dexetimide|mesh-list
101534853|NCT00584571|Citalopram|citalopram|mesh-list
101534854|NCT00584571|Escitalopram|escitalopram|mesh-list
101534855|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101534856|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101534857|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101534858|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534859|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534860|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
101534861|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534862|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101534863|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101408659|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408660|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
101408661|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408662|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534864|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
101534865|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
101534866|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534867|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101534868|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101408663|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101408664|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
101408665|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408666|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408667|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101408668|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408669|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408670|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101408671|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101534869|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
101534870|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101534871|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534872|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534874|NCT03451500|Carbidopa|carbidopa|mesh-list
101534875|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101534876|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101534877|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101534878|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
101534879|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534880|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534881|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534882|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101534883|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534884|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101534885|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
101534886|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
101534887|NCT00584610|Copper|copper|mesh-list
101534888|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
101534889|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101534890|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
101534891|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101534892|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534893|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101534894|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101534895|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101534896|NCT00584610|Trace Elements|trace elements|mesh-ancestor
101534897|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
101534898|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
101534899|NCT00571298|Gemcitabine|gemcitabine|mesh-list
101534900|NCT00571298|Amifostine|amifostine|mesh-list
101534901|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534902|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534903|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
101534904|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534905|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101408672|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408673|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408674|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
101408675|NCT00110006|Hormones|hormones|mesh-ancestor
101408676|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408677|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408678|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101408679|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408680|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534909|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
101534910|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
101534913|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
101534914|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
101534916|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101534917|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534918|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
101534919|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534920|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534921|NCT04575519|Aspirin|aspirin|mesh-list
101534930|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534931|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101534932|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408681|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408682|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101408684|NCT00454519|Mitomycin|mitomycin|mesh-list
101408685|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408686|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408687|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
101534933|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534934|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101534935|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101534936|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101534938|NCT04573803|Phenytoin|phenytoin|mesh-list
101534939|NCT04573803|Levetiracetam|levetiracetam|mesh-list
101534940|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
101534941|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
101534942|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101534943|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101534945|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534947|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101534948|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101534949|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
101534951|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101534952|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534953|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534954|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534955|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
101534956|NCT04573686|Hematinics|hematinics|mesh-ancestor
101534957|NCT01143337|Methotrexate|methotrexate|mesh-list
101534958|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101534959|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
101534963|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
101408688|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408689|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101408690|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408691|NCT00112749|Infliximab|infliximab|mesh-list
101408692|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101408693|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408694|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101534964|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534965|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534966|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
101534967|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534968|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101534969|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101534970|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
101534972|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101534973|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
101534974|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
101534976|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101534977|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
101534978|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534979|NCT01143259|Alvimopan|alvimopan|mesh-list
101534980|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534981|NCT00571805|Varenicline|varenicline|mesh-list
101534982|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101534983|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101534984|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
101534985|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534986|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534987|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534995|NCT00572078|Sorafenib|sorafenib|mesh-list
101534996|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534997|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101534998|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534999|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535000|NCT00572312|Atorvastatin|atorvastatin|mesh-list
101535001|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101408695|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408696|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408698|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
101408699|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408700|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408701|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408702|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
101408703|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
101535002|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101535003|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
101535004|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408704|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101408705|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101408706|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408707|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408708|NCT00454714|Urological Agents|urological agents|mesh-ancestor
101408709|NCT00143715|Vitamin K|vitamin k|mesh-list
101408710|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
101408711|NCT00143715|Vitamins|vitamins|mesh-ancestor
101535005|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101535006|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101535007|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535008|NCT00585156|Celecoxib|celecoxib|mesh-list
101535009|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535010|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101535011|NCT00585156|Analgesics|analgesics|mesh-ancestor
101535012|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
101535013|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535014|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535015|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408713|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408714|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101408715|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101408716|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408717|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
101408718|NCT00143715|Coagulants|coagulants|mesh-ancestor
101408719|NCT00454831|Chitosan|chitosan|mesh-list
101408720|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101408721|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101535019|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535020|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535021|NCT01142596|Asenapine|asenapine|mesh-list
101535022|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101535023|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101535024|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535025|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535026|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101535027|NCT00572390|Estrogens|estrogens|mesh-list
101535029|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535030|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535031|NCT01142128|Esomeprazole|esomeprazole|mesh-list
101535032|NCT01142128|Pancrelipase|pancrelipase|mesh-list
101535033|NCT01142128|Pancreatin|pancreatin|mesh-list
101535034|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101535035|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535036|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101535037|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535038|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535039|NCT04572867|Diuretics|diuretics|mesh-list
101535040|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
101408722|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
101408723|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408724|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408725|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
101408726|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
101408728|NCT00454831|Coagulants|coagulants|mesh-ancestor
101408729|NCT00110123|Fotemustine|fotemustine|mesh-list
101408730|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408731|NCT00455026|Remifentanil|remifentanil|mesh-list
101408732|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101408733|NCT00455026|Narcotics|narcotics|mesh-ancestor
101535041|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535042|NCT01142089|Rifamycins|rifamycins|mesh-list
101535043|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
101535044|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535045|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535046|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535047|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
101535048|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101535049|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
101535050|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535051|NCT00572663|Expectorants|expectorants|mesh-ancestor
101535052|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
101535053|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101535054|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
101535055|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535056|NCT00572663|Protective Agents|protective agents|mesh-ancestor
101535057|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535059|NCT01140880|Tenofovir|tenofovir|mesh-list
101535060|NCT01140880|Emtricitabine|emtricitabine|mesh-list
101548767|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535061|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101535062|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
101535063|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408734|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408735|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408736|NCT00455026|Analgesics|analgesics|mesh-ancestor
101408737|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
101535070|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
101535071|NCT00572741|Vitamins|vitamins|mesh-ancestor
101535072|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
101535073|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535074|NCT00572819|Misoprostol|misoprostol|mesh-list
101535075|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101535076|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
101408738|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408739|NCT00143325|Varenicline|varenicline|mesh-list
101408740|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101408741|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101408742|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
101408743|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408744|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408745|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408746|NCT00112983|Eculizumab|eculizumab|mesh-list
101408747|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101408748|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408749|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
101408750|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408751|NCT00110162|Hormones|hormones|mesh-list
101408752|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
101408753|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408754|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408755|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
101408756|NCT02273713|Paclitaxel|paclitaxel|mesh-list
101408757|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101408758|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408759|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408760|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535077|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101535078|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535079|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101535080|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535082|NCT03451110|Fluconazole|fluconazole|mesh-list
101535084|NCT03451110|Famotidine|famotidine|mesh-list
101535085|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
101408761|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
101548768|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
101408762|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408763|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101408764|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
101408765|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408766|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101408767|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101408768|NCT02273791|Clomiphene|clomiphene|mesh-list
101408770|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
101408771|NCT02273791|Estradiol|estradiol|mesh-list
101408772|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101408773|NCT02273791|Estrogens|estrogens|mesh-ancestor
101408774|NCT02273791|Hormones|hormones|mesh-ancestor
101408775|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535094|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535095|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535096|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101535097|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101535098|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101535099|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535100|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101535101|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
101535102|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
101535103|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535104|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101408776|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408777|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101408778|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
101408779|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408780|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101408781|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101408782|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
101408783|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101535105|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101408784|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
101408785|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101408786|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101408788|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408789|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408790|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101408791|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
101535106|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101535107|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535108|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101535110|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101535111|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
101535112|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101535113|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101535114|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101408793|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408794|NCT00455416|Selenium|selenium|mesh-list
101408795|NCT00455416|Allicin|allicin|mesh-list
101408796|NCT00455416|Resveratrol|resveratrol|mesh-list
101408798|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
101535126|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535127|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408799|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408800|NCT00455416|Protective Agents|protective agents|mesh-ancestor
101408801|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408802|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408803|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101408804|NCT00455416|Trace Elements|trace elements|mesh-ancestor
101408805|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
101408806|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408807|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101408808|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
101535128|NCT01140061|MK 0873|mk 0873|mesh-list
101535129|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101535130|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101535131|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535132|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535133|NCT04312750|Lidocaine|lidocaine|mesh-list
101535134|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
101535135|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
101535136|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535137|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535138|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
101535139|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535140|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101535141|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101535142|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101535143|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535144|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408809|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101408810|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101408811|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101408812|NCT00143871|Rituximab|rituximab|mesh-list
101408813|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408814|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408815|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
101408816|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408817|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408818|NCT00455572|Vinorelbine|vinorelbine|mesh-list
101408819|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408821|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408822|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535157|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101535158|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535159|NCT01139047|Metronidazole|metronidazole|mesh-list
101535160|NCT01139047|Azelaic acid|azelaic acid|mesh-list
101535161|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535162|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535163|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535164|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101535165|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535166|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408824|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408827|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408828|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101408829|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
101408830|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408831|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101408832|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
101408833|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535168|NCT01139008|Azelaic acid|azelaic acid|mesh-list
101535169|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535170|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535171|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535172|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101535173|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535174|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
101535175|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
101408834|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
101408835|NCT00455806|Amoxicillin|amoxicillin|mesh-list
101408836|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
101535176|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
101535177|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101535178|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101535179|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535180|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535181|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
101535182|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
101535183|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
101535184|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535185|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
101535186|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
101535187|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535188|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101535189|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
101535190|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
101535191|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535192|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535193|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101535194|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101535195|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101535196|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101535197|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101535198|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
101535199|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101535200|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101535201|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101535202|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408838|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101408839|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408840|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101408841|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101408843|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408844|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408845|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101408846|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101408847|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101535203|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535204|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101408848|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
101408849|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101408850|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
101408851|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408852|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408853|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101408854|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101408855|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101408856|NCT00110474|Acetaminophen|acetaminophen|mesh-list
101408857|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101408858|NCT00110474|Analgesics|analgesics|mesh-ancestor
101408859|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
101408860|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408861|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408862|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
101408864|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101408865|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101408866|NCT00113100|Estradiol|estradiol|mesh-list
101408867|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101408868|NCT00113100|Estrogens|estrogens|mesh-ancestor
101408869|NCT00113100|Hormones|hormones|mesh-ancestor
101535205|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535206|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535207|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
101535208|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535209|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101535210|NCT00573638|Latanoprost|latanoprost|mesh-list
101535211|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101535212|NCT01138657|Prednisone|prednisone|mesh-list
101535213|NCT01138657|Adalimumab|adalimumab|mesh-list
101535214|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535215|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
101221796|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101221809|NCT01509560|Everolimus|everolimus|mesh-list
101535216|NCT01138657|Hormones|hormones|mesh-ancestor
101408870|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408871|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408872|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101408874|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101408875|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101408876|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101535243|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408878|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101408880|NCT00143949|Enalapril|enalapril|mesh-list
101408881|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101408882|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101408883|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101408884|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101408885|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535244|NCT00586092|Bevacizumab|bevacizumab|mesh-list
101535245|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535246|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535247|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101535248|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101535249|NCT00586092|Growth Substances|growth substances|mesh-ancestor
101535250|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535251|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535253|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535254|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535255|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535256|NCT00573950|Cilostazol|cilostazol|mesh-list
101535257|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101535258|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
101535259|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535260|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535261|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101535262|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
101535263|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101535264|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101535265|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535266|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101408886|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101408887|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
101408888|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408889|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
101535267|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
101535268|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101535269|NCT00573950|Protective Agents|protective agents|mesh-ancestor
101535270|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101535271|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101535275|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
101535276|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101535277|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
101535278|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
101535279|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535281|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
101535282|NCT00586365|Naproxen|naproxen|mesh-list
101535283|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535284|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101535285|NCT00586365|Analgesics|analgesics|mesh-ancestor
101535286|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
101535287|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535288|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535289|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535290|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535291|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
101535292|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101408890|NCT00456235|Cyclosporine|cyclosporine|mesh-list
101408891|NCT00456235|Tacrolimus|tacrolimus|mesh-list
101408892|NCT00456235|Cyclosporins|cyclosporins|mesh-list
101408893|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101408894|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
101408895|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408896|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101535294|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535295|NCT00574652|Aldesleukin|aldesleukin|mesh-list
101535296|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535297|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101535298|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101535299|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
101535300|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535301|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101535303|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101408898|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408899|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101408900|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408901|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101408902|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
101408903|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101408904|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408905|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
101535304|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535305|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
101535306|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535307|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535308|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
101535309|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101408906|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408907|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101408908|NCT00456313|Fluticasone|fluticasone|mesh-list
101408909|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101408910|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101408911|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
101408912|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408913|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408914|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101408915|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
101408917|NCT00456313|Hormones|hormones|mesh-ancestor
101408918|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408919|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
101535310|NCT00574769|Bevacizumab|bevacizumab|mesh-list
101408920|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408921|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
101408922|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101408923|NCT00110630|Nicotine|nicotine|mesh-list
101408924|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101408925|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
101408926|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101408927|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408928|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101408930|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
101408931|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408932|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408935|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408936|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535311|NCT00574769|Docetaxel|docetaxel|mesh-list
101535312|NCT00574769|Everolimus|everolimus|mesh-list
101535313|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535314|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535315|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408937|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408938|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408939|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
101408940|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408941|NCT00456586|Istradefylline|istradefylline|mesh-list
101408942|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101408943|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101408944|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101535316|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101535317|NCT00574769|Growth Substances|growth substances|mesh-ancestor
101535326|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535327|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535330|NCT00586443|Panitumumab|panitumumab|mesh-list
101408946|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408947|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408948|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408949|NCT00110669|Prednisone|prednisone|mesh-list
101408950|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101408951|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
101408952|NCT00110669|Hormones|hormones|mesh-ancestor
101535331|NCT00586443|Everolimus|everolimus|mesh-list
101535332|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535333|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535334|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101408953|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101408955|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101408956|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101408957|NCT00454558|Riociguat|riociguat|mesh-list
101408958|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
101408959|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408961|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535335|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101408962|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101408963|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101408964|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408965|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408966|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
101408967|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101408968|NCT00110708|Antibodies|antibodies|mesh-list
101408969|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
101408970|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408971|NCT00456820|Bupropion|bupropion|mesh-list
101408972|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101408973|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408974|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408975|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101408976|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408977|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408978|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408980|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408981|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408982|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101408983|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101408984|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101408985|NCT00456898|Codeine|codeine|mesh-list
101408986|NCT00456898|Paroxetine|paroxetine|mesh-list
101408987|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101408988|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101408989|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101408990|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101408991|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101408992|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101408994|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101408995|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101408996|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
101408997|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101408998|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101408999|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101409000|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409001|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101409002|NCT00456898|Narcotics|narcotics|mesh-ancestor
101409005|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
101409006|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535338|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
101409007|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
101409008|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409009|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101409011|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
101409012|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409013|NCT00110747|Lidocaine|lidocaine|mesh-list
101409014|NCT00110747|Tetracaine|tetracaine|mesh-list
101409015|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
101409016|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
101409017|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409018|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409019|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
101409020|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409021|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101409022|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101409023|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101535341|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409024|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409025|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409027|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101409028|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101535342|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535343|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535344|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
101535345|NCT00574925|Esomeprazole|esomeprazole|mesh-list
101535346|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101535347|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535348|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101535349|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535350|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535351|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
101535352|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535353|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
101535357|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
101535358|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409029|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409030|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409031|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409032|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
101409033|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409034|NCT00456976|Selegiline|selegiline|mesh-list
101409035|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
101409036|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409037|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101535359|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409038|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101409039|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101409040|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409041|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409042|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101409043|NCT00456976|Protective Agents|protective agents|mesh-ancestor
101535361|NCT00574964|Temozolomide|temozolomide|mesh-list
101535362|NCT00574964|Carmustine|carmustine|mesh-list
101409046|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409047|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409048|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409049|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409051|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
101409052|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409053|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409054|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535363|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101409055|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
101409056|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409057|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409058|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409059|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
101409060|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101409061|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409063|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101409064|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409065|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409066|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101409067|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
101409068|NCT00457483|Valsartan|valsartan|mesh-list
101535375|NCT01137682|Hormones|hormones|mesh-ancestor
101535376|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535377|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535378|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
101535379|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
101535380|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101535381|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101535382|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535383|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535384|NCT00586794|Urological Agents|urological agents|mesh-ancestor
101535385|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
101535386|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535387|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409069|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101409070|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101409071|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101409072|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101409073|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409074|NCT00457483|Diuretics|diuretics|mesh-ancestor
101409075|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
101409076|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535388|NCT00575354|Sevoflurane|sevoflurane|mesh-list
101535390|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101535391|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101535392|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
101409077|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101409078|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409079|NCT00110864|Insulin|insulin|mesh-list
101409081|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409082|NCT00457678|Dexamethasone|dexamethasone|mesh-list
101409083|NCT00457678|Ranibizumab|ranibizumab|mesh-list
101409084|NCT00457678|Verteporfin|verteporfin|mesh-list
101409085|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409086|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
101535394|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409088|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409089|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409090|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409091|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
101409092|NCT00457678|Hormones|hormones|mesh-ancestor
101409093|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409094|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101409095|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409096|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409097|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101409098|NCT00457678|Growth Substances|growth substances|mesh-ancestor
101409099|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535395|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409101|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
101409102|NCT00457717|Atropine|atropine|mesh-list
101409103|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101409104|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101409105|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101409106|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
101409107|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409109|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101409110|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409112|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
101409113|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101409114|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101409116|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409117|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409118|NCT00110903|Etanercept|etanercept|mesh-list
101409119|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409120|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409121|NCT00110903|Analgesics|analgesics|mesh-ancestor
101409122|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
101409123|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409124|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535397|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535398|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
101409125|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409126|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409127|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409128|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409129|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
101409130|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
101409131|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
101409132|NCT00144144|Giapreza|giapreza|mesh-list
101409133|NCT00144144|Calcium|calcium|mesh-list
101409134|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
101409135|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101409136|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101409137|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409138|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101409139|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101409140|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
101409141|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409142|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409143|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409144|NCT00465673|Doxorubicin|doxorubicin|mesh-list
101409145|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101535400|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
101409147|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409148|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101409149|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101409151|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409153|NCT00144183|Nevirapine|nevirapine|mesh-list
101409154|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
101409155|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409156|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101409157|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409158|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409159|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
101409160|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409161|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101409162|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101409163|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101409164|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409165|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
101409167|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409168|NCT00110981|Etanercept|etanercept|mesh-list
101409169|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409170|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409171|NCT00110981|Analgesics|analgesics|mesh-ancestor
101409172|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
101409173|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409174|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409175|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409176|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409177|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409178|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409179|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
101409180|NCT00465907|Paclitaxel|paclitaxel|mesh-list
101409181|NCT00465907|Carboplatin|carboplatin|mesh-list
101409182|NCT00465907|Irinotecan|irinotecan|mesh-list
101409183|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101409184|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409185|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409186|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
101409187|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
101409188|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409189|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101409190|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101409191|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409192|NCT00113685|Dextrans|dextrans|mesh-list
101409193|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101409194|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
101409195|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
101535401|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409196|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
101409197|NCT00111020|Sorafenib|sorafenib|mesh-list
101409198|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409199|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409200|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409201|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409202|NCT00466063|Deferasirox|deferasirox|mesh-list
101409203|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101409204|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
101409206|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409208|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101409209|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409210|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409211|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409212|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409213|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
101409214|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409215|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409216|NCT00144222|Telmisartan|telmisartan|mesh-list
101409248|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409249|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
101409250|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409251|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101409252|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101409253|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101409254|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409255|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101409256|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
101409257|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409258|NCT00144378|Irinotecan|irinotecan|mesh-list
101409259|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101409260|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101535402|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101409261|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409262|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409263|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409264|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
101409265|NCT00111098|Hematinics|hematinics|mesh-ancestor
101409267|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101409268|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409269|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409270|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101409271|NCT00347698|Growth Substances|growth substances|mesh-ancestor
101409272|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409274|NCT00347737|Teriparatide|teriparatide|mesh-list
101409275|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101409276|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535404|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409277|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101409278|NCT00347815|Buprenorphine|buprenorphine|mesh-list
101409279|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101409280|NCT00347815|Narcotics|narcotics|mesh-ancestor
101409281|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409282|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409283|NCT00347815|Analgesics|analgesics|mesh-ancestor
101409284|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
101409285|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409286|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101409287|NCT00113802|Epratuzumab|epratuzumab|mesh-list
101409288|NCT00113802|Antibodies|antibodies|mesh-list
101409289|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
101409290|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409291|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101409292|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409293|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
101409294|NCT00111137|Hematinics|hematinics|mesh-ancestor
101535407|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
101535408|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
101409296|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101409297|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
101409298|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101409299|NCT00347854|Laxatives|laxatives|mesh-ancestor
101409300|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409301|NCT00347971|Rituximab|rituximab|mesh-list
101535409|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535410|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409302|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101409303|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409304|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
101409305|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409306|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535411|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101535412|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101409308|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101409309|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409310|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101409311|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409312|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409313|NCT00348010|Tramadol|tramadol|mesh-list
101409314|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101409315|NCT00348010|Narcotics|narcotics|mesh-ancestor
101535413|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101409316|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409317|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409319|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
101409320|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409321|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
101535414|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
101535415|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409323|NCT00144417|Isoniazid|isoniazid|mesh-list
101409324|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
101409325|NCT00144417|Ethambutol|ethambutol|mesh-list
101409326|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101409327|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409328|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101409329|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101409330|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535416|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409331|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409333|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101409334|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
101409335|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
101409336|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409337|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101409338|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409339|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101409340|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101409341|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101535417|NCT00575549|Protective Agents|protective agents|mesh-ancestor
101535418|NCT03453684|Vancomycin|vancomycin|mesh-list
101409342|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101409343|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101409345|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
101409346|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101409347|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101409348|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
101409349|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101535419|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535420|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535421|NCT00575627|Interferons|interferons|mesh-list
101535422|NCT00575627|Ribavirin|ribavirin|mesh-list
101535423|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
101535424|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
101535425|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101535426|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535427|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
101535428|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535429|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
101535430|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535431|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
101535432|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535433|NCT00555854|Benzocaine|benzocaine|mesh-list
101535435|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
101535436|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409350|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101409351|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409352|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
101409353|NCT00111215|Coagulants|coagulants|mesh-ancestor
101409354|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101409355|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
101409356|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409357|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
101409358|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
101409359|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
101409360|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409361|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409362|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
101535437|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535438|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
101535439|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535440|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
101535441|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101409364|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101409365|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
101409366|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409367|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409368|NCT00348244|Prednisolone|prednisolone|mesh-list
101409369|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101409370|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
101409371|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101409373|NCT00348244|Ketorolac|ketorolac|mesh-list
101409374|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101409375|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
101409376|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535442|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409378|NCT00348244|Hormones|hormones|mesh-ancestor
101409379|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409380|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535444|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535445|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409381|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101409382|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409384|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
101409385|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409386|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409387|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101409388|NCT00348244|Protective Agents|protective agents|mesh-ancestor
101409389|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409390|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409392|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
101409393|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409394|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101409395|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409396|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409397|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101409398|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
101409399|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101535446|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
101409400|NCT00348361|Fluticasone|fluticasone|mesh-list
101409401|NCT00348361|Xhance|xhance|mesh-list
101409402|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409403|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101409404|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
101409405|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409406|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409407|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101409408|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
101535447|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535448|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535449|NCT04674176|Rifaximin|rifaximin|mesh-list
101535450|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535451|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535452|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535453|NCT04674527|Temozolomide|temozolomide|mesh-list
101535454|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101535455|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
101535464|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
101409410|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101409411|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101409413|NCT00348400|Latanoprost|latanoprost|mesh-list
101409414|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101409415|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101409416|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101409417|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101409418|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101409421|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409422|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409423|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409424|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101409425|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409426|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
101409427|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
101409428|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
101409429|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101409430|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409431|NCT00144456|Vitamins|vitamins|mesh-ancestor
101409432|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
101409433|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
101409434|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101409435|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101409436|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409437|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101409438|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101409439|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
101409440|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101409441|NCT00348517|Laxatives|laxatives|mesh-ancestor
101409442|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409443|NCT00348634|Tegaserod|tegaserod|mesh-list
101409444|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101409445|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
101409446|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409447|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409448|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409449|NCT00348712|Insulin|insulin|mesh-list
101409450|NCT00348712|Metformin|metformin|mesh-list
101409451|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
101409452|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101409453|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101409454|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409455|NCT02964689|Pemetrexed|pemetrexed|mesh-list
101409456|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409457|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409458|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409459|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101409460|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409462|NCT00348985|Belinostat|belinostat|mesh-list
101409463|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409464|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101409465|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409466|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409467|NCT00349024|Povidone|povidone|mesh-list
101409468|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
101409469|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101409470|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
101409471|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409472|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
101409473|NCT00349024|Protective Agents|protective agents|mesh-ancestor
101409474|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
101409475|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
101409476|NCT00111371|Levodopa|levodopa|mesh-list
101409479|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
101409480|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535466|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535467|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535468|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535469|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535470|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
101409481|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409482|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409484|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
101409485|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
101409486|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101409487|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101409488|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409489|NCT00421369|Sertraline|sertraline|mesh-list
101409490|NCT00421369|Reboxetine|reboxetine|mesh-list
101409491|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
101409492|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409493|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101409494|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101409495|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409496|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409497|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409498|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
101409499|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409500|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101409501|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
101409502|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101409506|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409507|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101409508|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101409509|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409510|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409511|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101409512|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409513|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409514|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409515|NCT04729140|Doxycycline|doxycycline|mesh-list
101409516|NCT04729140|Ivermectin|ivermectin|mesh-list
101409517|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101409518|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409519|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
101409520|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101409521|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101409522|NCT00349219|Cisplatin|cisplatin|mesh-list
101409523|NCT00349219|Gemcitabine|gemcitabine|mesh-list
101409524|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101409525|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409526|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409527|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
101409528|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409529|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101409530|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409531|NCT00111449|Etanercept|etanercept|mesh-list
101409532|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409533|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409534|NCT00111449|Analgesics|analgesics|mesh-ancestor
101409535|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
101409536|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409537|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409538|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409539|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409540|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409541|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409542|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
101409543|NCT00349258|Leuprolide|leuprolide|mesh-list
101535473|NCT00199797|Protective Agents|protective agents|mesh-ancestor
101409544|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101409545|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
101409546|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101409547|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409548|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101409549|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409550|NCT00349375|Simvastatin|simvastatin|mesh-list
101409551|NCT00349375|Fenofibrate|fenofibrate|mesh-list
101409552|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101409553|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101409554|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
101409555|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409556|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101409557|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101409558|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409559|NCT00349453|Deferiprone|deferiprone|mesh-list
101409560|NCT00349453|Deferoxamine|deferoxamine|mesh-list
101409561|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101409562|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
101409565|NCT00349453|Siderophores|siderophores|mesh-ancestor
101409567|NCT00349492|Irinotecan|irinotecan|mesh-list
101409568|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409569|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101409570|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101409571|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409572|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409574|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
101409575|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409576|NCT00349531|Protective Agents|protective agents|mesh-ancestor
101409577|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409578|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101409579|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101409580|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
101409582|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409583|NCT00111566|Eptifibatide|eptifibatide|mesh-list
101409584|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101535474|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
101409585|NCT00404703|Bevacizumab|bevacizumab|mesh-list
101409586|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101409587|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409588|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409589|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101409590|NCT00404703|Growth Substances|growth substances|mesh-ancestor
101409591|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409592|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
101409594|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
101409595|NCT00349726|Vitamins|vitamins|mesh-ancestor
101535475|NCT00199797|Vitamins|vitamins|mesh-ancestor
101535476|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
101535478|NCT01137604|Lenvatinib|lenvatinib|mesh-list
101535479|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535480|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535481|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101535482|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101535483|NCT01137604|Growth Substances|growth substances|mesh-ancestor
101535484|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535485|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535486|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535487|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409597|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409598|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
101409599|NCT00111644|Lactams|lactams|mesh-list
101409600|NCT00111644|beta-Lactams|beta-lactams|mesh-list
101409601|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101409602|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409603|NCT00350038|Irbesartan|irbesartan|mesh-list
101409604|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
101409605|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101409606|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101409608|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409609|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101409610|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
101409611|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101409612|NCT00350077|Vitamins|vitamins|mesh-list
101409613|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
101409614|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
101409615|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409616|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
101409617|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409618|NCT00350077|Protective Agents|protective agents|mesh-ancestor
101409619|NCT00114153|Carboplatin|carboplatin|mesh-list
101409620|NCT00114153|Capecitabine|capecitabine|mesh-list
101409621|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409622|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409623|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
101409624|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535488|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409627|NCT00350116|Vitamins|vitamins|mesh-ancestor
101409628|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
101409629|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409630|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
101409631|NCT00350116|Hematinics|hematinics|mesh-ancestor
101409632|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
101535489|NCT03454919|Palbociclib|palbociclib|mesh-list
101535490|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409633|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101409634|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101409636|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409637|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409638|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409640|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
101409643|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409644|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409645|NCT00404781|Aspirin|aspirin|mesh-list
101409646|NCT00404781|Cilostazol|cilostazol|mesh-list
101409647|NCT00404781|Clopidogrel|clopidogrel|mesh-list
101409648|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409649|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409650|NCT00404781|Analgesics|analgesics|mesh-ancestor
101409651|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
101409652|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409653|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409654|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409655|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409656|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101409657|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101409658|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409659|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101409660|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101409662|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
101409663|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101409664|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101409665|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101409666|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
101409667|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409668|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101409669|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
101409670|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101535492|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535493|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535494|NCT00198822|Vitamin A|vitamin a|mesh-list
101535495|NCT00198822|Beta Carotene|beta carotene|mesh-list
101535496|NCT00198822|Carotenoids|carotenoids|mesh-list
101535497|NCT00198822|Vitamins|vitamins|mesh-ancestor
101535498|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
101535499|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535500|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
101535501|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535502|NCT00198822|Protective Agents|protective agents|mesh-ancestor
101409671|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409672|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
101409673|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101409674|NCT00404781|Protective Agents|protective agents|mesh-ancestor
101409675|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101409676|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101409678|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101409679|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
101409680|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409681|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409682|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101409683|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101409684|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
101409685|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409686|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535506|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535507|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409687|NCT00114192|Thalidomide|thalidomide|mesh-list
101409688|NCT00114192|Docetaxel|docetaxel|mesh-list
101409689|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409690|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409691|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
101409692|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
101409693|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409694|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409695|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
101409696|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535508|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
101409697|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
101409698|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101409699|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409700|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101409701|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101409702|NCT00114192|Growth Substances|growth substances|mesh-ancestor
101409703|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
101409704|NCT00350467|Olanzapine|olanzapine|mesh-list
101409705|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101409706|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
101535509|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535510|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535511|NCT05204134|Insulin|insulin|mesh-list
101409707|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
101409708|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409709|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409710|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409711|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101409712|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409713|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409714|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409715|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101409716|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101409717|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409718|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409719|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409720|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
101409721|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101409722|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101409723|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101409724|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101409725|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
101409726|NCT00350662|Deferiprone|deferiprone|mesh-list
101409727|NCT00350662|Deferoxamine|deferoxamine|mesh-list
101409728|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101409729|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
101409730|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
101409731|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409732|NCT00350662|Siderophores|siderophores|mesh-ancestor
101409733|NCT00350818|Azacitidine|azacitidine|mesh-list
101409734|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409735|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
101535512|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101409736|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409737|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409738|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409739|NCT00350857|Carbamazepine|carbamazepine|mesh-list
101409740|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
101409741|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
101409742|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409743|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409744|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409745|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409746|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409747|NCT00350857|Analgesics|analgesics|mesh-ancestor
101409748|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
101535513|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535514|NCT05181436|Chrysarobin|chrysarobin|mesh-list
101535515|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409749|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409750|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101409751|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409752|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409753|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101409754|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409755|NCT00111956|Etanercept|etanercept|mesh-list
101409756|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409758|NCT00111956|Analgesics|analgesics|mesh-ancestor
101535516|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409759|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
101409760|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409761|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409762|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409763|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409764|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409765|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409766|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
101409767|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
101409769|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409770|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101409771|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101409772|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409775|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409776|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409777|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409778|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101409779|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
101409780|NCT00111995|Hematinics|hematinics|mesh-ancestor
101409781|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
101409782|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101409783|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101409784|NCT00351052|Analgesics|analgesics|mesh-ancestor
101409785|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
101409786|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409787|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409788|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409789|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409790|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
101409791|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409792|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
101409793|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101409794|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409795|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409796|NCT00401609|Carboplatin|carboplatin|mesh-list
101409797|NCT00401609|Gemcitabine|gemcitabine|mesh-list
101409799|NCT00401609|Vinorelbine|vinorelbine|mesh-list
101409800|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409801|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409802|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
101409803|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221704|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221705|NCT01509001|Metformin|metformin|mesh-list
101221707|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221708|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221709|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101221710|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221711|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
101221712|NCT01509131|Bisacodyl|bisacodyl|mesh-list
101221714|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221715|NCT01509131|Laxatives|laxatives|mesh-ancestor
101221716|NCT01509144|Vaccines|vaccines|mesh-list
101221717|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
101221718|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221719|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
101221720|NCT01509209|Ephedrine|ephedrine|mesh-list
101221721|NCT01509209|Levocetirizine|levocetirizine|mesh-list
101221722|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221723|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221724|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221725|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
101221726|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221727|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221728|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221729|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101221730|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
101535518|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
101221731|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221732|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101221733|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
101221734|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
101221735|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101221746|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
101221747|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
101221748|NCT01509300|Rituximab|rituximab|mesh-list
101221749|NCT01509300|Fludarabine|fludarabine|mesh-list
101409804|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101409805|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101409806|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101409807|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409808|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
101409809|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
101409810|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
101409811|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
101409812|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101409813|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409814|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409815|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101409816|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409817|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101409818|NCT00351130|Amlodipine|amlodipine|mesh-list
101409820|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101409821|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101409822|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101221750|NCT01509300|Tacrolimus|tacrolimus|mesh-list
101417080|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
101221751|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101221752|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221753|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
101221754|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221755|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221756|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101221757|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
101221758|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221759|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221760|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101221761|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221762|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101221764|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101221765|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101221766|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
101221767|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101221768|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221769|NCT01509365|Clopidogrel|clopidogrel|mesh-list
101409823|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409824|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101409825|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409826|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
101409827|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101409828|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101409829|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101409830|NCT00351169|Escitalopram|escitalopram|mesh-list
101409831|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101409832|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101409833|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409834|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409835|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409836|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
101409837|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409838|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
101409839|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409840|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101409841|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409842|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409843|NCT00401648|Brivaracetam|brivaracetam|mesh-list
101409844|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
101409845|NCT00351286|Simvastatin|simvastatin|mesh-list
101409846|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101409847|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101409848|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
101409849|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409850|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101409851|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101221770|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101535519|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409852|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409854|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101409855|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101409856|NCT00112034|Prednisolone|prednisolone|mesh-list
101409857|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
101409858|NCT00112034|Methotrexate|methotrexate|mesh-list
101409860|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
101409861|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101409862|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
101409863|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101409865|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409867|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409868|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101409869|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
101409870|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409871|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101409872|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101409873|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
101409874|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535520|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409875|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101409877|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
101409878|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
101409879|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409880|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101409881|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
101409882|NCT00112034|Hormones|hormones|mesh-ancestor
101409883|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409884|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101409885|NCT00112034|Protective Agents|protective agents|mesh-ancestor
101409886|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101409887|NCT00114387|Tocopherols|tocopherols|mesh-list
101409888|NCT00114387|Vitamin E|vitamin e|mesh-list
101409889|NCT00114387|Tocotrienols|tocotrienols|mesh-list
101409890|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
101409891|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
101535521|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101409892|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409894|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409896|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
101409897|NCT00351364|Montelukast|montelukast|mesh-list
101409898|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101409899|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409900|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101409901|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101409902|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101409903|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409904|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101409905|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101409906|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409908|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101409909|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
101409910|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409911|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
101409912|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409914|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409915|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409916|NCT00351637|Methadone|methadone|mesh-list
101409917|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101409918|NCT00351637|Narcotics|narcotics|mesh-ancestor
101409919|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409920|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535522|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101409921|NCT00351637|Analgesics|analgesics|mesh-ancestor
101409922|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
101409923|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409924|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
101409925|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409926|NCT00351715|Methadone|methadone|mesh-list
101409927|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101409928|NCT00351715|Narcotics|narcotics|mesh-ancestor
101409929|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409930|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409931|NCT00351715|Analgesics|analgesics|mesh-ancestor
101409932|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
101409933|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409935|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
101409936|NCT00351832|Vildagliptin|vildagliptin|mesh-list
101409937|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101409938|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409939|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101409941|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409942|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409943|NCT00351871|Ribavirin|ribavirin|mesh-list
101409944|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101535524|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
101535525|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409946|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409948|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101409949|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101409950|NCT00351910|Amitriptyline|amitriptyline|mesh-list
101409951|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101409952|NCT00351910|Citalopram|citalopram|mesh-list
101409953|NCT00351910|Bupropion|bupropion|mesh-list
101409954|NCT00351910|Fluoxetine|fluoxetine|mesh-list
101409955|NCT00351910|Paroxetine|paroxetine|mesh-list
101409956|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101409957|NCT00351910|Sertraline|sertraline|mesh-list
101409958|NCT00351910|Escitalopram|escitalopram|mesh-list
101409959|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101409960|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101409961|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101409962|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409963|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101409964|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
101409965|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409966|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101409967|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101409968|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
101409969|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101409970|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101409971|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
101409972|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101409973|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101409974|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101409975|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101409976|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101409977|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409978|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101409980|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
101409981|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101535526|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101535527|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101409983|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101409984|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
101409985|NCT00112346|Gemcitabine|gemcitabine|mesh-list
101409987|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101409988|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
101409989|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101409991|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101409992|NCT00352144|Eszopiclone|eszopiclone|mesh-list
101409993|NCT00352144|Zopiclone|zopiclone|mesh-list
101409994|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101409995|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101409996|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101409997|NCT00352183|Simvastatin|simvastatin|mesh-list
101409998|NCT00352183|Fenofibrate|fenofibrate|mesh-list
101409999|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101410000|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101410001|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
101410002|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410003|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101410004|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101410005|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410006|NCT00112619|Topotecan|topotecan|mesh-list
101410007|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101410008|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410009|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410010|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410011|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410012|NCT00352261|Esomeprazole|esomeprazole|mesh-list
101410013|NCT00352261|Lansoprazole|lansoprazole|mesh-list
101410014|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
101410015|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101410016|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101410017|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101410018|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410019|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410020|NCT00352300|Paclitaxel|paclitaxel|mesh-list
101410021|NCT00352300|Carboplatin|carboplatin|mesh-list
101410022|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101410023|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410024|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410025|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410026|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410027|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410028|NCT00112658|Leucovorin|leucovorin|mesh-list
101410029|NCT00112658|Gemcitabine|gemcitabine|mesh-list
101410030|NCT00112658|Fluorouracil|fluorouracil|mesh-list
101410031|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
101410032|NCT00112658|Irinotecan|irinotecan|mesh-list
101410033|NCT00112658|Calcium|calcium|mesh-list
101410034|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
101410035|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410036|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
101410037|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535529|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410039|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410040|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410041|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410042|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
101410044|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410045|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410047|NCT00112658|Protective Agents|protective agents|mesh-ancestor
101410048|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
101410050|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
101410051|NCT00352339|Aripiprazole|aripiprazole|mesh-list
101410052|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
101410053|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101535530|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101535531|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
101410054|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101410055|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410056|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410057|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410058|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
101535532|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410059|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
101410060|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410061|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410062|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101410063|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101410064|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
101410065|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101410066|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101410067|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101410068|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101410069|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
101410071|NCT00352378|Doxorubicin|doxorubicin|mesh-list
101410072|NCT00352378|Capecitabine|capecitabine|mesh-list
101410073|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410074|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
101410075|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410076|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410077|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101410078|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
101410079|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410081|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101410082|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410083|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410084|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410085|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101410086|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101410087|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410088|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535536|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
101535537|NCT02883478|Vitamins|vitamins|mesh-ancestor
101535538|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
101535539|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410091|NCT00352495|Carboplatin|carboplatin|mesh-list
101410092|NCT00352495|Vinblastine|vinblastine|mesh-list
101410093|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410094|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101410095|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410096|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410097|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410098|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410099|NCT00112697|Docetaxel|docetaxel|mesh-list
101410100|NCT00112697|Fluorouracil|fluorouracil|mesh-list
101410101|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410102|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410103|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410104|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410105|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410107|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410108|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410109|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
101410110|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410111|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
101410113|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101410114|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101410115|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101535542|NCT00197145|Aplaviroc|aplaviroc|mesh-list
101535543|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101410116|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101410118|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410119|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410120|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535544|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101535545|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410122|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101410123|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101410124|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
101410126|NCT00352651|Analgesics|analgesics|mesh-ancestor
101410127|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
101410128|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410129|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410130|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
101410131|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101410132|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410133|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410134|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410136|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410137|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410138|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410139|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
101410140|NCT00112775|Dasatinib|dasatinib|mesh-list
101410141|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410142|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410143|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410144|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410145|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
101410146|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410147|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410148|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101410149|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410150|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410151|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410152|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410153|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101410154|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101410156|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410157|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
101410158|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101410159|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
101410160|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101410161|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101410162|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101410163|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101410164|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101410165|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101410166|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101410167|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101410168|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
101410169|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410170|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410171|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410172|NCT00112853|Etoposide|etoposide|mesh-list
101410173|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
101535548|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
101410175|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101410176|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410177|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101410178|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410179|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410180|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410181|NCT00353002|Lidocaine|lidocaine|mesh-list
101410182|NCT00353002|Tetracaine|tetracaine|mesh-list
101535549|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410184|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
101410185|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410186|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410187|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
101410188|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410189|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101410190|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101410191|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101410192|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410193|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410194|NCT00353041|Lidocaine|lidocaine|mesh-list
101410195|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
101410196|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
101410197|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410198|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410199|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
101410200|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410201|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101221914|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101221915|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101221916|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101221917|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
101221918|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221919|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221920|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
101221921|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
101221922|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
101221923|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221924|NCT01510574|Misoprostol|misoprostol|mesh-list
101221925|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101221926|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
101221927|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221928|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221929|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221930|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221931|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
101221932|NCT01510613|Dexamethasone|dexamethasone|mesh-list
101221933|NCT01510613|Pomalidomide|pomalidomide|mesh-list
101221934|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410203|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101410204|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410205|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410206|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
101410207|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101410208|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410209|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410210|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101221948|NCT01510613|Growth Substances|growth substances|mesh-ancestor
101221949|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221950|NCT01510626|Omalizumab|omalizumab|mesh-list
101221951|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101221952|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101221953|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
101221954|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
101221955|NCT01510665|Cathartics|cathartics|mesh-ancestor
101221956|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221957|NCT01510795|Spironolactone|spironolactone|mesh-list
101221958|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101221959|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
101221960|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221961|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221962|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101221963|NCT01510795|Diuretics|diuretics|mesh-ancestor
101221964|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
101221988|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221989|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
101221990|NCT01511029|Pramipexole|pramipexole|mesh-list
101417081|NCT02261415|Coagulants|coagulants|mesh-ancestor
101221991|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101221992|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221993|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535551|NCT04674137|Glutarimide|glutarimide|mesh-list
101535552|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
101535553|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
101535554|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535555|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535556|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222045|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222046|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222047|NCT01511198|Incretins|incretins|mesh-ancestor
101222048|NCT01511198|Hormones|hormones|mesh-ancestor
101222050|NCT01511211|Dexamethasone|dexamethasone|mesh-list
101222099|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101222100|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222101|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222102|NCT01511302|Budesonide|budesonide|mesh-list
101222104|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410211|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410212|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101410213|NCT00112892|Selenium|selenium|mesh-list
101410214|NCT00112892|Irinotecan|irinotecan|mesh-list
101410215|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101222105|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101222106|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
101222107|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222108|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222109|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101222110|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
101222111|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
101222112|NCT01511302|Hormones|hormones|mesh-ancestor
101410216|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222113|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410217|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222138|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101222139|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101222140|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
101222141|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222142|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222143|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222145|NCT01511562|Etoposide|etoposide|mesh-list
101222146|NCT01511562|Thiotepa|thiotepa|mesh-list
101222147|NCT01511562|Carmustine|carmustine|mesh-list
101222184|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
101222185|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101222186|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101222187|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
101222188|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222189|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222190|NCT01511718|Ondansetron|ondansetron|mesh-list
101222191|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
101222192|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
101222193|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222194|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222195|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222197|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
101222198|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101222199|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101222200|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
101222201|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222202|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222204|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101222212|NCT01511757|Fluconazole|fluconazole|mesh-list
101222213|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
101222214|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222216|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101222217|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222218|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222219|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101410218|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410219|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410220|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
101410221|NCT00112892|Protective Agents|protective agents|mesh-ancestor
101410222|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410223|NCT00112892|Trace Elements|trace elements|mesh-ancestor
101410224|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
101410225|NCT00353665|Riluzole|riluzole|mesh-list
101410226|NCT00353665|Memantine|memantine|mesh-list
101222271|NCT01511848|Deferasirox|deferasirox|mesh-list
101222272|NCT01511848|Deferiprone|deferiprone|mesh-list
101222273|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101222274|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
101222275|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
101222276|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222277|NCT01511874|Leuprolide|leuprolide|mesh-list
101222278|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101222280|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101222281|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222282|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101222283|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410227|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101410228|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101410229|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
101222324|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222325|NCT01512147|Analgesics|analgesics|mesh-ancestor
101222326|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
101222327|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222328|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101222329|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101222330|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101222331|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222380|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222381|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222382|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101222383|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
101222384|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101222385|NCT01512485|Clopidogrel|clopidogrel|mesh-list
101222386|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222387|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101222388|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101222389|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101222430|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101222431|NCT01512901|Betamethasone|betamethasone|mesh-list
101222432|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
101222433|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101222434|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
101222435|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101222436|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222437|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
101222438|NCT01512901|Hormones|hormones|mesh-ancestor
101535565|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535566|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222566|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101222567|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222569|NCT01513668|Acetaminophen|acetaminophen|mesh-list
101222570|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222571|NCT01513668|Analgesics|analgesics|mesh-ancestor
101410230|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410231|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222629|NCT01513941|Interferons|interferons|mesh-list
101222631|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
101222632|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
101222633|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101222634|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222635|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
101222636|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222637|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
101222638|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222639|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
101410232|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410233|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101410234|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101410235|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
101410236|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101222687|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101410237|NCT00353665|Protective Agents|protective agents|mesh-ancestor
101222688|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222689|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222690|NCT01514188|Doxorubicin|doxorubicin|mesh-list
101222691|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101222692|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222693|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101222739|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222740|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222741|NCT01514695|Analgesics|analgesics|mesh-ancestor
101222742|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
101222743|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222744|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101222745|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101222746|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
101222747|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
101222748|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101222749|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101222792|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222793|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222794|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101222795|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
101222796|NCT01514851|Calcium|calcium|mesh-list
101222853|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535567|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535568|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101535569|NCT00197106|Fluticasone|fluticasone|mesh-list
101535571|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101535572|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222854|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
101222855|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
101222856|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222857|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101222858|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535573|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101222859|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535575|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535576|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535577|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101535578|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
101535579|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
101535580|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101535581|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101535582|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101535583|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101410239|NCT05594784|Vincristine|vincristine|mesh-list
101222911|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410241|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410242|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
101410243|NCT05594784|Hormones|hormones|mesh-ancestor
101410244|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410245|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410246|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101410247|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410248|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101410249|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410250|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
101222973|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101222974|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101222977|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
101222978|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
101222979|NCT01515839|Vinpocetine|vinpocetine|mesh-list
101222980|NCT01515839|Huperzine A|huperzine a|mesh-list
101222981|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
101222982|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222983|NCT01515839|Protective Agents|protective agents|mesh-ancestor
101222984|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222985|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
101410251|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410252|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410253|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
101410254|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101223031|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223032|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223033|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223034|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223035|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223036|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223037|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223038|NCT01516255|Incretins|incretins|mesh-ancestor
101223039|NCT01516255|Hormones|hormones|mesh-ancestor
101223040|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223041|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
101223042|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
101535584|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
101223076|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101223077|NCT01516554|Androgens|androgens|mesh-ancestor
101223078|NCT01516554|Hormones|hormones|mesh-ancestor
101223079|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101223080|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223081|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101223082|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223083|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
101223084|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
101223085|NCT01516567|Rituximab|rituximab|mesh-list
101223086|NCT01516567|Doxorubicin|doxorubicin|mesh-list
101223087|NCT01516567|Etoposide|etoposide|mesh-list
101223088|NCT01516567|Vincristine|vincristine|mesh-list
101535585|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535586|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535587|NCT01136746|Insulin|insulin|mesh-list
101535588|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101535589|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
101223126|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223142|NCT01516710|Liver Extracts|liver extracts|mesh-list
101410255|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410256|NCT00353743|Metronidazole|metronidazole|mesh-list
101410257|NCT00353743|Doxycycline|doxycycline|mesh-list
101410258|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410259|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410260|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101410261|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101410263|NCT00113165|Lamotrigine|lamotrigine|mesh-list
101223198|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223199|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223200|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
101223201|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223202|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101223203|NCT01517009|Docetaxel|docetaxel|mesh-list
101223204|NCT01517009|Capecitabine|capecitabine|mesh-list
101223205|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223206|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223207|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223208|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101223209|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223210|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101223211|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
101223212|NCT01517022|Nicotine|nicotine|mesh-list
101223213|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101223214|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
101223215|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101223216|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223217|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101223218|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101223219|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
101223220|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101223222|NCT01517165|Pioglitazone|pioglitazone|mesh-list
101535592|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535593|NCT01136356|Morphine|morphine|mesh-list
101535594|NCT01136356|Buprenorphine|buprenorphine|mesh-list
101535595|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101535596|NCT01136356|Narcotics|narcotics|mesh-ancestor
101535597|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535598|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535599|NCT01136356|Analgesics|analgesics|mesh-ancestor
101535601|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535602|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101535603|NCT00587379|Atorvastatin|atorvastatin|mesh-list
101535604|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101535605|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101535606|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
101535607|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535608|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101535609|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101535610|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535611|NCT04673396|Norcantharidin|norcantharidin|mesh-list
101535612|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535613|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535614|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535615|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
101535616|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535617|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535618|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
101535619|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101535620|NCT00196326|Estradiol|estradiol|mesh-list
101535621|NCT00196326|Estrogens|estrogens|mesh-ancestor
101535622|NCT00196326|Hormones|hormones|mesh-ancestor
101535623|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535631|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101535632|NCT00587496|Aspirin|aspirin|mesh-list
101410264|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
101410265|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101410266|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410267|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410268|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410269|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410270|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101535633|NCT00587496|Valacyclovir|valacyclovir|mesh-list
101535634|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101410271|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410272|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410273|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410274|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101410275|NCT00354094|Reboxetine|reboxetine|mesh-list
101535635|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101535646|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535647|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535648|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
101535649|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
101535650|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535656|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535657|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535658|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
101535660|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410276|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
101410277|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410278|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101410280|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410281|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410282|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
101410283|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410284|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410286|NCT00114816|Capecitabine|capecitabine|mesh-list
101410287|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410288|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410289|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535661|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
101535662|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535663|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101535664|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535665|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
101535666|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535667|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535668|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101535669|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535670|NCT01135498|Bevacizumab|bevacizumab|mesh-list
101410290|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410291|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410292|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410293|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
101410294|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
101410295|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101410296|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410297|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410298|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
101535671|NCT01135498|Capecitabine|capecitabine|mesh-list
101535672|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101535673|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
101535674|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535675|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535676|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101535677|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101535678|NCT01135498|Growth Substances|growth substances|mesh-ancestor
101535679|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535680|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535681|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535682|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
101535683|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535684|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535685|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535686|NCT04610567|Methotrexate|methotrexate|mesh-list
101535687|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101410299|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410300|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410301|NCT00354406|Abciximab|abciximab|mesh-list
101410302|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
101410303|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101410304|NCT00354523|Capecitabine|capecitabine|mesh-list
101410305|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
101410306|NCT00354523|Dacarbazine|dacarbazine|mesh-list
101535688|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
101535689|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101535690|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535691|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535692|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
101535693|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535694|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410307|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410308|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
101410309|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410310|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410311|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410312|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410313|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101410314|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
101410316|NCT00114933|Lopinavir|lopinavir|mesh-list
101410317|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101410318|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101410319|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
101410320|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410321|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410322|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101410323|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101410324|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
101410325|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410326|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101410327|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101410328|NCT00113282|Interleukin-2|interleukin-2|mesh-list
101410329|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410330|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101410331|NCT00113282|Analgesics|analgesics|mesh-ancestor
101410332|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
101410333|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410334|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535696|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535697|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101535698|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535699|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
101535700|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535701|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535702|NCT02883439|Fluticasone|fluticasone|mesh-list
101535703|NCT02883439|Xhance|xhance|mesh-list
101535704|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410336|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410337|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410338|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
101410339|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410340|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535705|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101535706|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
101535707|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535708|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535709|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101535710|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
101410342|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101410343|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410344|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101410345|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410346|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535711|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
101410347|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101410348|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101410349|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
101410350|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410351|NCT00115011|Escitalopram|escitalopram|mesh-list
101410354|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410355|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410356|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410357|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
101410358|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410359|NCT00113594|Olanzapine|olanzapine|mesh-list
101410360|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
101410361|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
101410362|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410363|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410364|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101410365|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101410366|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410367|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410368|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410369|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101410370|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101410371|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410372|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535712|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101535713|NCT00195507|Etanercept|etanercept|mesh-list
101535714|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535715|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101410373|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410374|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
101410375|NCT00426049|Everolimus|everolimus|mesh-list
101410376|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101410377|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410378|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410379|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410380|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410381|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
101535717|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
101535718|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535719|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535720|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535721|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535722|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535723|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410382|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410383|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410384|NCT05594433|Lenograstim|lenograstim|mesh-list
101410385|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101410386|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
101535724|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
101535726|NCT00195429|Prednisone|prednisone|mesh-list
101535728|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535729|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
101535730|NCT00195429|Hormones|hormones|mesh-ancestor
101535731|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535732|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535733|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101535734|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535735|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535736|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
101535737|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101535738|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535739|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410388|NCT00115089|Beclomethasone|beclomethasone|mesh-list
101410389|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410390|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
101410392|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410393|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410394|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101410395|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
101410396|NCT00115128|Lenograstim|lenograstim|mesh-list
101535740|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410398|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
101410399|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410400|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
101410402|NCT00115245|Adefovir|adefovir|mesh-list
101410403|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101410404|NCT00115245|Telbivudine|telbivudine|mesh-list
101410406|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410407|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101410408|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101410409|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410410|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410411|NCT01059526|Ecallantide|ecallantide|mesh-list
101410412|NCT01059526|Analgesics|analgesics|mesh-ancestor
101410413|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
101410414|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410415|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410416|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535741|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410418|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410419|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410421|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101410422|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101410423|NCT00444340|Analgesics|analgesics|mesh-ancestor
101410424|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
101410425|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535742|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101535743|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
101535744|NCT00195351|Metronidazole|metronidazole|mesh-list
101535745|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
101535746|NCT00195351|Tigecycline|tigecycline|mesh-list
101535747|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535748|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535749|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535750|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101535751|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101535752|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535753|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535755|NCT04609748|Cannabidiol|cannabidiol|mesh-list
101535767|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535768|NCT00195273|Cyclosporine|cyclosporine|mesh-list
101535769|NCT00195273|Sirolimus|sirolimus|mesh-list
101535770|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
101535771|NCT00195273|Cyclosporins|cyclosporins|mesh-list
101535772|NCT00195273|Daclizumab|daclizumab|mesh-list
101535773|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535774|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535775|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535776|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
101410426|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410427|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410428|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410429|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101410430|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410431|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
101410432|NCT00444379|Ritonavir|ritonavir|mesh-list
101410433|NCT00444379|Lopinavir|lopinavir|mesh-list
101410434|NCT00444379|Tenofovir|tenofovir|mesh-list
101410435|NCT00444379|Emtricitabine|emtricitabine|mesh-list
101535795|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535796|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410436|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101410438|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101410439|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101410440|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
101410441|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410442|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410443|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101410444|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101410445|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
101410446|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410447|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101410448|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101410449|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101410450|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535797|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535798|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
101535799|NCT00564200|Hormones|hormones|mesh-ancestor
101535800|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535801|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101535802|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535803|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535804|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535805|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
101535806|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101535807|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
101535808|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101535810|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
101535811|NCT00193479|Rituximab|rituximab|mesh-list
101535812|NCT00193479|Vincristine|vincristine|mesh-list
101535813|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
101410451|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101410452|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101410453|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101410454|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101410455|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101410456|NCT00444418|Naltrexone|naltrexone|mesh-list
101410457|NCT00444418|Naloxone|naloxone|mesh-list
101410458|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101410459|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101410460|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410461|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
101410462|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410463|NCT00444574|Methylphenidate|methylphenidate|mesh-list
101410464|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101535814|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535815|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
101535816|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535817|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535818|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101535819|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
101535820|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535821|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535822|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101535823|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535824|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221771|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101535830|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535831|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410465|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410466|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101410467|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101410468|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410469|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410471|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410472|NCT00444652|Enoxaparin|enoxaparin|mesh-list
101410473|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
101410474|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101410475|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101535834|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
101535835|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535836|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535837|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101535838|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535839|NCT00193206|Paclitaxel|paclitaxel|mesh-list
101535840|NCT00193206|Gemcitabine|gemcitabine|mesh-list
101535841|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101535842|NCT00193206|Epirubicin|epirubicin|mesh-list
101535843|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101535844|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535845|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535846|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535847|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535848|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535849|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535850|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
101535851|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101535852|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535853|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101535854|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535855|NCT00193050|Gemcitabine|gemcitabine|mesh-list
101535856|NCT00193050|Docetaxel|docetaxel|mesh-list
101535857|NCT00193050|Epirubicin|epirubicin|mesh-list
101410476|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410477|NCT04699903|Antibodies|antibodies|mesh-list
101410478|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
101410479|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
101410480|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410482|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
101410483|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101410484|NCT00444808|Katacalcin|katacalcin|mesh-list
101535858|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535859|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
101535861|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535862|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535863|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535865|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101535866|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535867|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101535868|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535869|NCT04608734|Midazolam|midazolam|mesh-list
101535870|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101535871|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101410485|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410486|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410487|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101410488|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
101410489|NCT00113828|Cyclosporine|cyclosporine|mesh-list
101410490|NCT00113828|Cyclosporins|cyclosporins|mesh-list
101410491|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410492|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410493|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535872|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535873|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535874|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101535875|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101535876|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101535877|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101535878|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
101535879|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
101535880|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
101535881|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
101535882|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535883|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535884|NCT00192075|Leucovorin|leucovorin|mesh-list
101410495|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410496|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
101410497|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410498|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
101410499|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410500|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101410501|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
101410502|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101410503|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101410504|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101410505|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410506|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410507|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
101410508|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535900|NCT00192036|Gemcitabine|gemcitabine|mesh-list
101535901|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535902|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535903|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
101535904|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535905|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101535906|NCT00191724|Enoxaparin|enoxaparin|mesh-list
101535907|NCT00191724|Protein C|protein c|mesh-list
101535908|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
101535909|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101535910|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101535911|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535912|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535914|NCT00191646|Carboplatin|carboplatin|mesh-list
101535915|NCT00191646|Gemcitabine|gemcitabine|mesh-list
101410511|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410512|NCT05594121|Buprenorphine|buprenorphine|mesh-list
101410513|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101410514|NCT05594121|Narcotics|narcotics|mesh-ancestor
101410515|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410516|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410518|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
101535916|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101535917|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410519|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410520|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101410521|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101410522|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101410523|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101410524|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410525|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410526|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410527|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410528|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101410529|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
101410530|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410531|NCT00445042|Sorafenib|sorafenib|mesh-list
101410532|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410533|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410534|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410535|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410536|NCT00445081|Cyclosporine|cyclosporine|mesh-list
101410537|NCT00445081|Prednisolone|prednisolone|mesh-list
101410538|NCT00445081|Cyclosporins|cyclosporins|mesh-list
101410539|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410540|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
101410541|NCT00445081|Hormones|hormones|mesh-ancestor
101410542|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410543|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410544|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101410545|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410546|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410547|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410548|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410549|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
101410550|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
101410551|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410552|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
101410553|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410554|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101410555|NCT00113906|Melatonin|melatonin|mesh-list
101410556|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
101535918|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535919|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535920|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535921|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535923|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
101535924|NCT00191451|Carboplatin|carboplatin|mesh-list
101535925|NCT00191451|Gemcitabine|gemcitabine|mesh-list
101535926|NCT00191451|Trastuzumab|trastuzumab|mesh-list
101535927|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535928|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535929|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
101535930|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535931|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410557|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410558|NCT00113906|Protective Agents|protective agents|mesh-ancestor
101410559|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410560|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535933|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535934|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535935|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
101535936|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535937|NCT00191139|Cisplatin|cisplatin|mesh-list
101535938|NCT00191139|Gemcitabine|gemcitabine|mesh-list
101535939|NCT00191139|Docetaxel|docetaxel|mesh-list
101535940|NCT00191139|Etoposide|etoposide|mesh-list
101535941|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
101535942|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535943|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410562|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410563|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410564|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101410565|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
101410566|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410568|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101410569|NCT00445276|Diacerein|diacerein|mesh-list
101410570|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410571|NCT00113984|Metronidazole|metronidazole|mesh-list
101535945|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535946|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535947|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535948|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535949|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101535950|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101535951|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101535952|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535954|NCT00564512|Rituximab|rituximab|mesh-list
101535955|NCT00564512|Fludarabine|fludarabine|mesh-list
101535956|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
101535957|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101535958|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
101535959|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535960|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535961|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101535962|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
101535963|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535964|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535965|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101535966|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101535967|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
101535968|NCT00564551|Calcium|calcium|mesh-list
101535969|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101535970|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410573|NCT00113984|Sargramostim|sargramostim|mesh-list
101410574|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
101410575|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410576|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410577|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410578|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101410579|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410580|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410581|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410582|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101535971|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101535972|NCT00190983|Pemetrexed|pemetrexed|mesh-list
101535973|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535975|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535976|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101535977|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535978|NCT00190749|Olanzapine|olanzapine|mesh-list
101535979|NCT00190749|Risperidone|risperidone|mesh-list
101535980|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101535981|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
101410583|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101410584|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101410585|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101410586|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101410587|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410588|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410589|NCT00114023|Imiquimod|imiquimod|mesh-list
101535982|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535983|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535984|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535985|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101535986|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101536000|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536002|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
101536003|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536004|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536005|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536006|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
101536007|NCT04607447|Hormones|hormones|mesh-ancestor
101536008|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536009|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536010|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536011|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101536012|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536013|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
101536014|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536015|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536016|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101536017|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410590|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101410591|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
101410592|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410593|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410594|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
101410596|NCT00445861|Cetuximab|cetuximab|mesh-list
101410597|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536018|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
101536019|NCT00190671|Pemetrexed|pemetrexed|mesh-list
101536020|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536021|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
101536022|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536023|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536024|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101410598|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410599|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410600|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536025|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
101536026|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536027|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536028|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101536029|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536030|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101410608|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410609|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536031|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101410612|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410613|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410614|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101410615|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410616|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
101410617|NCT00445900|Hormones|hormones|mesh-ancestor
101536033|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101410618|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410619|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101410620|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
101410621|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410622|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410623|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101410624|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101410625|NCT00445900|Growth Substances|growth substances|mesh-ancestor
101410626|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
101410628|NCT00115479|Benzocaine|benzocaine|mesh-list
101410629|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101410630|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410632|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
101536034|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536035|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536036|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101536037|NCT04607525|Analgesics|analgesics|mesh-ancestor
101536038|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
101536039|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536040|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101536041|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101536042|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101536043|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
101536044|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536045|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536046|NCT00198276|Bleomycin|bleomycin|mesh-list
101536047|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101536048|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536049|NCT04607642|Manganese|manganese|mesh-list
101536050|NCT04607642|Trace Elements|trace elements|mesh-ancestor
101536051|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
101410633|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410634|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
101410635|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410636|NCT00446017|Milrinone|milrinone|mesh-list
101410637|NCT00446017|Epinephrine|epinephrine|mesh-list
101410638|NCT00446017|Racepinephrine|racepinephrine|mesh-list
101410639|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
101536052|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536053|NCT00588003|Anastrozole|anastrozole|mesh-list
101536054|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536055|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536056|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101536057|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101536058|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410640|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101410641|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101410642|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
101410643|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410644|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410645|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410646|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101410647|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101410648|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
101410649|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410650|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101410651|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536059|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536061|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
101536062|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536063|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536064|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
101536065|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101410654|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101410655|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101410656|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101410657|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
101410658|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101410659|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101410660|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410661|NCT00446017|Protective Agents|protective agents|mesh-ancestor
101410662|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
101410663|NCT00446173|Busulfan|busulfan|mesh-list
101410664|NCT00446173|Sargramostim|sargramostim|mesh-list
101410665|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410666|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
101410667|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410668|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101410669|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101410670|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
101410671|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410672|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410673|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101410675|NCT00446212|Desflurane|desflurane|mesh-list
101410676|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101410677|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536069|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536070|NCT00564590|Protective Agents|protective agents|mesh-ancestor
101410679|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101410680|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
101410682|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101410683|NCT00446329|Cinacalcet|cinacalcet|mesh-list
101410684|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410685|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410686|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101410687|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
101410688|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410689|NCT00446368|Everolimus|everolimus|mesh-list
101410690|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101410691|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410692|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410693|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410694|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410695|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
101410696|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410697|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410698|NCT00401765|Docetaxel|docetaxel|mesh-list
101410699|NCT00401765|Siltuximab|siltuximab|mesh-list
101410700|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410701|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410702|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410703|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410704|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410707|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410708|NCT00446524|Amlodipine|amlodipine|mesh-list
101410709|NCT00446524|Valsartan|valsartan|mesh-list
101410710|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101410711|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101410712|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410713|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410714|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410715|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410716|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
101410717|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101410718|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101410719|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
101410720|NCT00446602|Hematinics|hematinics|mesh-ancestor
101410721|NCT05589753|Acetazolamide|acetazolamide|mesh-list
101410722|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
101536073|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101536074|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101410725|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410727|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
101410728|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410729|NCT00114179|Bevacizumab|bevacizumab|mesh-list
101410730|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101410731|NCT00114179|Gemcitabine|gemcitabine|mesh-list
101410732|NCT00114179|Capecitabine|capecitabine|mesh-list
101410733|NCT00114179|Antibodies|antibodies|mesh-list
101410734|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
101410735|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101410736|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410737|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101410738|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101410739|NCT00114179|Growth Substances|growth substances|mesh-ancestor
101410740|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410741|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
101410742|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
101410743|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410744|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
101410745|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410747|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101410749|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
101410750|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410751|NCT00114257|Decitabine|decitabine|mesh-list
101410752|NCT00114257|Romidepsin|romidepsin|mesh-list
101410753|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410754|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
101410755|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410756|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410757|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536075|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101410758|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101410759|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101410760|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101536077|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
101410761|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
101410764|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
101410765|NCT00404937|Hormones|hormones|mesh-ancestor
101410766|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410767|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410768|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101410769|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101410770|NCT00446836|Paclitaxel|paclitaxel|mesh-list
101410771|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101410772|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101410773|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410776|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410777|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410778|NCT00114374|Escitalopram|escitalopram|mesh-list
101536081|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
101410779|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101410780|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101410781|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101410782|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410783|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410784|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
101410785|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410786|NCT00446953|Betamethasone|betamethasone|mesh-list
101410787|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410788|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
101536082|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101410790|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410791|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410792|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101410793|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
101410794|NCT00447031|Triamcinolone|triamcinolone|mesh-list
101410795|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101410796|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101410797|NCT00447031|Bevacizumab|bevacizumab|mesh-list
101410798|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101410799|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101410800|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410801|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101410802|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101410803|NCT00447031|Growth Substances|growth substances|mesh-ancestor
101410804|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410805|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101410806|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410807|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
101410808|NCT00447031|Hormones|hormones|mesh-ancestor
101410809|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410810|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410811|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
101410812|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410813|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410814|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101536087|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
101410815|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101410816|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101410817|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101410818|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410819|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410821|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101410822|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
101410823|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410824|NCT00115635|Gemcitabine|gemcitabine|mesh-list
101410826|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410827|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
101410828|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410829|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410830|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410831|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410832|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410833|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
101410834|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101410835|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536091|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536092|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101410836|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101410837|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410838|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410839|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410840|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410841|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101410843|NCT00447577|Dexamethasone|dexamethasone|mesh-list
101410844|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101410845|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
101410846|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
101410847|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410848|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410849|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101410850|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
101410852|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410853|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101410854|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410856|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410857|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101410858|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101410859|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101410860|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101410861|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
101410862|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410863|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101410864|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101410865|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410866|NCT00114569|Lorazepam|lorazepam|mesh-list
101410867|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
101536093|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101410868|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
101410869|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
101410870|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101410871|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410873|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101410874|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410875|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101410876|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410877|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410878|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
101410879|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
101410880|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410881|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536094|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410883|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
101410885|NCT00447967|Fluorouracil|fluorouracil|mesh-list
101410886|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
101410887|NCT00447967|Irinotecan|irinotecan|mesh-list
101410888|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
101410889|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410890|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101410891|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410892|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101410893|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
101410894|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410895|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101410896|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101410897|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410898|NCT00447967|Antidotes|antidotes|mesh-ancestor
101410899|NCT00447967|Protective Agents|protective agents|mesh-ancestor
101410900|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
101410902|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
101536096|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536097|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410904|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101410906|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410907|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410908|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101410909|NCT00401856|Diuretics|diuretics|mesh-ancestor
101410910|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
101410911|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101410912|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101410913|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410914|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410915|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410916|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410917|NCT00448396|Epothilone B|epothilone b|mesh-list
101410918|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410919|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
101410920|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410921|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
101410922|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410923|NCT00114686|Valproic Acid|valproic acid|mesh-list
101410924|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101410925|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
101410926|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410927|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101410928|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410929|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410930|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410931|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410932|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410933|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
101410934|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
101410936|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410937|NCT05553678|Midazolam|midazolam|mesh-list
101410938|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101410939|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101410940|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101410941|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410942|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101410943|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101410944|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101410945|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101410946|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
101536098|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536099|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101410948|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
101410949|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
101410950|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101410951|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410953|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
101410954|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536100|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101536101|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
101536102|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101536103|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
101536105|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410955|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
101410956|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410957|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101410958|NCT03276520|Ethanol|ethanol|mesh-list
101410959|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101410960|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410961|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536106|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536107|NCT04605575|Vinorelbine|vinorelbine|mesh-list
101536108|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101536109|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536110|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
101536111|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
101410962|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410963|NCT00114764|Lenograstim|lenograstim|mesh-list
101410964|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101410965|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
101410966|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410967|NCT00448786|Niacinamide|niacinamide|mesh-list
101410968|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
101410969|NCT00448786|Imetelstat|imetelstat|mesh-list
101410970|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101410971|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101410972|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101410974|NCT00448786|Vitamins|vitamins|mesh-ancestor
101410975|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
101410976|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410977|NCT00114803|Calcitonin|calcitonin|mesh-list
101410978|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
101410979|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
101410980|NCT00114803|Katacalcin|katacalcin|mesh-list
101410981|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101410982|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410983|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101410984|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
101410986|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
101410987|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101410988|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101410990|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
101410991|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
101410992|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101410993|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101410994|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
101410995|NCT00402012|Pioglitazone|pioglitazone|mesh-list
101410996|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101410997|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536116|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101410998|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
101410999|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101411000|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411001|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
101411003|NCT03276325|Nalbuphine|nalbuphine|mesh-list
101411004|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411005|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
101411006|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
101411007|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411008|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411009|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411010|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
101411011|NCT03276325|Hormones|hormones|mesh-ancestor
101411012|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411013|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101411014|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411015|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101411016|NCT03276325|Narcotics|narcotics|mesh-ancestor
101411017|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411018|NCT03276325|Analgesics|analgesics|mesh-ancestor
101411019|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
101411020|NCT00449020|Carboplatin|carboplatin|mesh-list
101536119|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536120|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411022|NCT00449020|Irinotecan|irinotecan|mesh-list
101411023|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411024|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411025|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411026|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411027|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411028|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101411029|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411030|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411031|NCT00115752|Valdecoxib|valdecoxib|mesh-list
101411032|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101411033|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101411034|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411035|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411036|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411037|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411038|NCT00115752|Analgesics|analgesics|mesh-ancestor
101411039|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
101411040|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411041|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411042|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411043|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411044|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
101411045|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
101411046|NCT00449137|Leucovorin|leucovorin|mesh-list
101411047|NCT00449137|Fluorouracil|fluorouracil|mesh-list
101411048|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
101411049|NCT00449137|Calcium|calcium|mesh-list
101411050|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
101411051|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101411054|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411055|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101411056|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411057|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411058|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
101411059|NCT00449137|Antidotes|antidotes|mesh-ancestor
101411060|NCT00449137|Protective Agents|protective agents|mesh-ancestor
101411061|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
101411062|NCT00449137|Vitamins|vitamins|mesh-ancestor
101411063|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
101536122|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101411064|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
101411065|NCT00449254|Estrone|estrone|mesh-list
101411066|NCT00449254|Estrogens|estrogens|mesh-ancestor
101411067|NCT00449254|Hormones|hormones|mesh-ancestor
101411068|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411069|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411070|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101411071|NCT00449410|Atorvastatin|atorvastatin|mesh-list
101411072|NCT00449410|Ezetimibe|ezetimibe|mesh-list
101536123|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536124|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101536125|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411074|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411075|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
101411076|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411077|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411078|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101536126|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536127|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101411079|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411080|NCT00449449|Lidocaine|lidocaine|mesh-list
101411082|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
101411083|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411084|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411086|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411087|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101411088|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101411089|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101411090|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411091|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411095|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
101411096|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411097|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536130|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411099|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411100|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411101|NCT00115115|Protective Agents|protective agents|mesh-ancestor
101411103|NCT00449488|Hematinics|hematinics|mesh-ancestor
101411104|NCT00115830|Atorvastatin|atorvastatin|mesh-list
101411105|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101536132|NCT00589485|Trace Elements|trace elements|mesh-ancestor
101536134|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536135|NCT00564941|Deferasirox|deferasirox|mesh-list
101411106|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411107|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411109|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411110|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411111|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411112|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411113|NCT00115154|Imiquimod|imiquimod|mesh-list
101411114|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101411115|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
101411116|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411117|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411118|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
101411120|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
101411121|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411122|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101411123|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
101411124|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536136|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101536137|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
101411125|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411127|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
101411128|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
101411130|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411132|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101411133|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101536138|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
101411135|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411136|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411137|NCT00449683|Terazosin|terazosin|mesh-list
101411138|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101411139|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101411140|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101411141|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
101411142|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411143|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536139|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536140|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101411144|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411146|NCT00449722|Mesalamine|mesalamine|mesh-list
101411147|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411148|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411149|NCT00449722|Analgesics|analgesics|mesh-ancestor
101411150|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
101411151|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411152|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411153|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411155|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
101411156|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411157|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411158|NCT00449839|Insulin|insulin|mesh-list
101411159|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101411161|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
101411162|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101411163|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411165|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101411166|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101411167|NCT00450229|Protective Agents|protective agents|mesh-ancestor
101411168|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411169|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411170|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101411171|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411172|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411173|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
101536141|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101536142|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411174|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411175|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411176|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411177|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411178|NCT00450307|Antibodies|antibodies|mesh-list
101411179|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101411180|NCT00450307|Sargramostim|sargramostim|mesh-list
101411181|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
101536143|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
101536144|NCT00589953|Hematinics|hematinics|mesh-ancestor
101536145|NCT00589992|Ibutilide|ibutilide|mesh-list
101536146|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101536147|NCT00590070|Adenosine|adenosine|mesh-list
101536148|NCT00590070|Nitroprusside|nitroprusside|mesh-list
101536149|NCT00590070|Analgesics|analgesics|mesh-ancestor
101411182|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411183|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
101411184|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101411185|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411186|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101411187|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536150|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
101411189|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411190|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411191|NCT00450736|Analgesics|analgesics|mesh-ancestor
101411192|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
101411193|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411194|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411195|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411196|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411197|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101411198|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101411200|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411201|NCT05536362|Clonidine|clonidine|mesh-list
101411202|NCT05536362|Ketamine|ketamine|mesh-list
101411203|NCT05536362|Propofol|propofol|mesh-list
101411204|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101411205|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411206|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411207|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101536151|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411208|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
101411209|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
101411210|NCT05536362|Analgesics|analgesics|mesh-ancestor
101411211|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
101411212|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411213|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101411214|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101411215|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101411216|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411217|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411218|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411220|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
101411221|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101411222|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101536152|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411223|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101411224|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
101411225|NCT00450853|Granisetron|granisetron|mesh-list
101411226|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
101411227|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
101411228|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411229|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411230|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536153|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101536154|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
101411232|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101411234|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411235|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411236|NCT00450892|Docetaxel|docetaxel|mesh-list
101411237|NCT00450892|Trastuzumab|trastuzumab|mesh-list
101411238|NCT00450892|Lapatinib|lapatinib|mesh-list
101411239|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221772|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101536155|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101536156|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
101411241|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411242|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411243|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411245|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411246|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411248|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
101411249|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
101411250|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
101536157|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
101536158|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536159|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536160|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101536161|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101536162|NCT00565019|Triamcinolone|triamcinolone|mesh-list
101536163|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101536164|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101536165|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101411251|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411252|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411253|NCT00115908|Ribavirin|ribavirin|mesh-list
101411254|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101411255|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
101411256|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411257|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
101411258|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411260|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411261|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411262|NCT00458185|Analgesics|analgesics|mesh-ancestor
101411263|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
101411264|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411265|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411266|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411267|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411268|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411269|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411271|NCT00458263|Hormones|hormones|mesh-list
101411272|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411273|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411274|NCT00458419|Naloxone|naloxone|mesh-list
101536166|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411275|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101536167|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
101536168|NCT00565019|Hormones|hormones|mesh-ancestor
101536169|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536170|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411280|NCT00458458|Norethindrone|norethindrone|mesh-list
101411281|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
101411282|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101411283|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
101411284|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101411285|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536171|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536172|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
101411286|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101411287|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411288|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101411289|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101536173|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536174|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411291|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
101411292|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101411293|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101411294|NCT00458614|Lansoprazole|lansoprazole|mesh-list
101411295|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
101411296|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101411297|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411298|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101411299|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411300|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411302|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101536178|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101536179|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411304|NCT00458731|Antibodies|antibodies|mesh-list
101411305|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
101411306|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101411307|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411308|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101411309|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101411310|NCT00458731|Growth Substances|growth substances|mesh-ancestor
101411311|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411312|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536180|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101536181|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101536182|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536183|NCT00590343|Vatalanib|vatalanib|mesh-list
101536184|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101536186|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536188|NCT04604678|Naltrexone|naltrexone|mesh-list
101411313|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
101411314|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411315|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411316|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411318|NCT03274024|Mitomycin|mitomycin|mesh-list
101411319|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101411322|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411323|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101411324|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411325|NCT00115947|Terlipressin|terlipressin|mesh-list
101411326|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411327|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101411328|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
101411329|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411331|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411332|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411333|NCT00459004|Rimonabant|rimonabant|mesh-list
101411334|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101411335|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101411336|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101411337|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411338|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411339|NCT00459004|Hormones|hormones|mesh-ancestor
101411340|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411341|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411342|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
101411343|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
101411344|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411346|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411347|NCT00115622|Fluticasone|fluticasone|mesh-list
101411348|NCT00115622|Xhance|xhance|mesh-list
101411349|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411350|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101411351|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
101411352|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536189|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411353|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411354|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411355|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
101411357|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101411358|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
101411359|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536190|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411361|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411362|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411363|NCT04728321|Lenvatinib|lenvatinib|mesh-list
101411364|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411365|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411366|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536191|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101536192|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101536193|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
101411367|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411368|NCT00459901|Capecitabine|capecitabine|mesh-list
101411369|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101411370|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101411371|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
101411372|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536194|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411373|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411374|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411375|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411377|NCT00401804|Doxorubicin|doxorubicin|mesh-list
101411378|NCT00401804|Bortezomib|bortezomib|mesh-list
101536195|NCT04604327|Bemiparin|bemiparin|mesh-list
101536196|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
101411379|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411380|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
101411381|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
101411382|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411383|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411384|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411385|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
101411386|NCT00401804|Hormones|hormones|mesh-ancestor
101536197|NCT00590694|Ranibizumab|ranibizumab|mesh-list
101411387|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411389|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411390|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101411391|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101411392|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411393|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536198|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536199|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101411394|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411395|NCT00459940|Pioglitazone|pioglitazone|mesh-list
101411396|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411397|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411398|NCT00460057|Alendronate|alendronate|mesh-list
101411399|NCT00460057|Diphosphonates|diphosphonates|mesh-list
101411400|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101411401|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411402|NCT00401921|Minocycline|minocycline|mesh-list
101411403|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411404|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411405|NCT00460174|Bevacizumab|bevacizumab|mesh-list
101411406|NCT00460174|Gemcitabine|gemcitabine|mesh-list
101411407|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101411408|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411409|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101411410|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101411411|NCT00460174|Growth Substances|growth substances|mesh-ancestor
101411412|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411413|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
101411414|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101411415|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
101411416|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411417|NCT00460213|Valsartan|valsartan|mesh-list
101411418|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411419|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101411420|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101411421|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411422|NCT00460252|Insulin|insulin|mesh-list
101411423|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411424|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536200|NCT00590694|Growth Substances|growth substances|mesh-ancestor
101536201|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411425|NCT00115817|Atorvastatin|atorvastatin|mesh-list
101411426|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411427|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411428|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
101411429|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411430|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411431|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411433|NCT00460369|Artesunate|artesunate|mesh-list
101411435|NCT00460369|Artemether|artemether|mesh-list
101411436|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
101411437|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
101411438|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101411439|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101411440|NCT00460369|Amodiaquine|amodiaquine|mesh-list
101536203|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411441|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
101411442|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101411443|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101411444|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411445|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411446|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
101411447|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
101411448|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101411449|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
101411450|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101536205|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101411452|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411455|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101411456|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411458|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
101411459|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
101411460|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411461|NCT00460642|Cetrorelix|cetrorelix|mesh-list
101411462|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101411463|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
101411464|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101536206|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536207|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101536208|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
101536209|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
101411465|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411466|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
101411467|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411469|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101411470|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
101411471|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411472|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
101411473|NCT00460759|Rifapentine|rifapentine|mesh-list
101411474|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411475|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411476|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101411477|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411478|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411479|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411480|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411481|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101536210|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411482|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
101411483|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
101411484|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
101411485|NCT00460837|Cathartics|cathartics|mesh-ancestor
101411486|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411487|NCT00460876|Topotecan|topotecan|mesh-list
101411488|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101411489|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411490|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411491|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411492|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411493|NCT00460915|Amlodipine|amlodipine|mesh-list
101411494|NCT00460915|Lacidipine|lacidipine|mesh-list
101411495|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101411496|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101411497|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411498|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411499|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536211|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411500|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411501|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
101411503|NCT00460954|Carbidopa|carbidopa|mesh-list
101221835|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
101411504|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101411505|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101411506|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101411508|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411509|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411510|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536212|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536213|NCT00477165|Citalopram|citalopram|mesh-list
101536214|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101411511|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101411512|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411513|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101411514|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
101411515|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
101411516|NCT00461149|Octreotide|octreotide|mesh-list
101411517|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536216|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411519|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411520|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
101411521|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411522|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411523|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101411524|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
101411525|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
101411526|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411527|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101411528|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101411529|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411530|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101411531|NCT00461344|Docetaxel|docetaxel|mesh-list
101411532|NCT00461344|Doxorubicin|doxorubicin|mesh-list
101411533|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536217|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411534|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411535|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411536|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411537|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411538|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101411539|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101411540|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411541|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411542|NCT03273634|Lansoprazole|lansoprazole|mesh-list
101411543|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
101411544|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101536218|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536220|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536221|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101536222|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536223|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536224|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101536225|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101536226|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536227|NCT00476229|Rituximab|rituximab|mesh-list
101536228|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
101536229|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101536230|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536231|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536232|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
101536233|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536234|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536235|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536236|NCT04603976|Erenumab|erenumab|mesh-list
101536237|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101536238|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411546|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101411547|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411548|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411550|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
101411551|NCT03273595|Trastuzumab|trastuzumab|mesh-list
101411553|NCT03273595|Lapatinib|lapatinib|mesh-list
101411554|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101411555|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411556|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411557|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411558|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411559|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411560|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411561|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
101411562|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411563|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536239|NCT04603976|Analgesics|analgesics|mesh-ancestor
101536240|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
101411564|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101411566|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101411567|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536241|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411568|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101411569|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101411570|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411571|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411572|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411573|NCT03273556|Lidocaine|lidocaine|mesh-list
101411574|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
101411575|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
101411576|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411577|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411578|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
101411579|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411580|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101411581|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101411582|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101411583|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411584|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411586|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
101411587|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
101411588|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411589|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411590|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
101411591|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411592|NCT00461422|Ganirelix|ganirelix|mesh-list
101411593|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101411594|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536242|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411597|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
101411598|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
101411599|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
101411600|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411601|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101411602|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101411603|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411604|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
101411605|NCT04697992|Coagulants|coagulants|mesh-ancestor
101411606|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
101411607|NCT04697992|Protective Agents|protective agents|mesh-ancestor
101411609|NCT05483634|Hormones|hormones|mesh-ancestor
101411610|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411611|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411612|NCT00461578|Artesunate|artesunate|mesh-list
101411613|NCT00461578|Dapsone|dapsone|mesh-list
101411614|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
101411615|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
101411616|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101411617|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101411618|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411619|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411621|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
101411622|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101411623|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
101411624|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101411625|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411626|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411627|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
101411628|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411629|NCT00461617|Mitiglinide|mitiglinide|mesh-list
101411630|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411631|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411632|NCT00116064|Lorazepam|lorazepam|mesh-list
101411633|NCT00116064|Paraldehyde|paraldehyde|mesh-list
101411634|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
101411635|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
101411636|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
101411637|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411638|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536243|NCT00476151|Ketamine|ketamine|mesh-list
101536244|NCT00476151|Amitriptyline|amitriptyline|mesh-list
101536245|NCT00476151|Analgesics|analgesics|mesh-ancestor
101536246|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
101411640|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101411641|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411642|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101411643|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101411644|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101411645|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
101411646|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
101411647|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411648|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411649|NCT04728035|Irinotecan|irinotecan|mesh-list
101536247|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536248|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411651|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411652|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411653|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411654|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411655|NCT00461890|Naltrexone|naltrexone|mesh-list
101411656|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101411657|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101411658|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411659|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
101411660|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536249|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101411662|NCT00461968|Ezetimibe|ezetimibe|mesh-list
101411663|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411664|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411665|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
101411666|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411667|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411668|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411670|NCT00116103|Tacrolimus|tacrolimus|mesh-list
101411671|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411672|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
101411673|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411674|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101411675|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411676|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536250|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101411677|NCT02956252|Anesthetics|anesthetics|mesh-list
101411678|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411679|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411680|NCT00462358|Filanesib|filanesib|mesh-list
101411681|NCT00462358|Lenograstim|lenograstim|mesh-list
101411682|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101411683|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
101411684|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411685|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411686|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411687|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411688|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411689|NCT00116181|Etanercept|etanercept|mesh-list
101411690|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411691|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101411692|NCT00116181|Analgesics|analgesics|mesh-ancestor
101411693|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
101411694|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411695|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536251|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
101536252|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
101536253|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411696|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411697|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411698|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411699|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411700|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
101411701|NCT00462397|Paclitaxel|paclitaxel|mesh-list
101411702|NCT00462397|Carboplatin|carboplatin|mesh-list
101411703|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101411704|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411705|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411706|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411707|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411708|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411710|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411711|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411712|NCT00462553|Gemcitabine|gemcitabine|mesh-list
101411713|NCT00462553|Sunitinib|sunitinib|mesh-list
101411714|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101411715|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
101411716|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411717|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411718|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101411719|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536254|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101536255|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101411720|NCT00462553|Growth Substances|growth substances|mesh-ancestor
101411721|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411722|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
101411723|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101411724|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411725|NCT00462592|Budesonide|budesonide|mesh-list
101411726|NCT00462592|Montelukast|montelukast|mesh-list
101411727|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411728|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101411729|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
101411730|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411731|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411732|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411733|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
101411734|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
101411735|NCT00462592|Hormones|hormones|mesh-ancestor
101411736|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411737|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101411738|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
101411739|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101536256|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536257|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411740|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101411741|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411743|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411744|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411746|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101411747|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101411748|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411749|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411750|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411751|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411752|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411753|NCT00462787|Dexamethasone|dexamethasone|mesh-list
101411754|NCT00462787|Topotecan|topotecan|mesh-list
101411755|NCT00462787|Vinorelbine|vinorelbine|mesh-list
101411756|NCT00462787|Thiotepa|thiotepa|mesh-list
101411757|NCT00462787|Clofarabine|clofarabine|mesh-list
101536259|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536260|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101411759|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
101411760|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
101411761|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411762|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411763|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411764|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
101411765|NCT00462787|Hormones|hormones|mesh-ancestor
101411766|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536261|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101536262|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101411767|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101411768|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411769|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
101411770|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101411771|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101411772|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411773|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411774|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101411775|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411776|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411777|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411778|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101411779|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
101411780|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101411781|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411782|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101411783|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
101411784|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101411785|NCT00463021|Vitamins|vitamins|mesh-ancestor
101411786|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
101411787|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411788|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101411789|NCT00116259|Aripiprazole|aripiprazole|mesh-list
101411790|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
101411791|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536263|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101411792|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101411793|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101411794|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411795|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411796|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
101411797|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
101411798|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411799|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411800|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101411801|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101411802|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
101411803|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101411804|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101411805|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101411806|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101411807|NCT00116324|Montelukast|montelukast|mesh-list
101411808|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411809|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101411810|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101411811|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
101411812|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411813|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411814|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101411815|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101411816|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411818|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101411819|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411820|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101411821|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
101411822|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411823|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411824|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101411825|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
101411826|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
101411827|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101411828|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101536265|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
101536266|NCT04603664|Cystatins|cystatins|mesh-list
101536267|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101411829|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101411830|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101411831|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
101411832|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411833|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411834|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101411835|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101411837|NCT00463762|Cefoperazone|cefoperazone|mesh-list
101411838|NCT00463762|Sulperazone|sulperazone|mesh-list
101411839|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101411840|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411841|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101411842|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411843|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411844|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101411846|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101411847|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
101411848|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101411849|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411850|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101411851|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411852|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
101411853|NCT00463879|Galantamine|galantamine|mesh-list
101411854|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101411855|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411856|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411857|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
101411858|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411859|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411860|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101411861|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
101411862|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411863|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
101411864|NCT00463918|Varenicline|varenicline|mesh-list
101411865|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101411866|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101411867|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101411868|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411869|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411870|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411871|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
101411872|NCT00463957|Tadalafil|tadalafil|mesh-list
101411873|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
101411874|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101411875|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101411876|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411877|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536268|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
101411879|NCT00464035|Calcium|calcium|mesh-list
101411880|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101411881|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411883|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411884|NCT00464191|Escitalopram|escitalopram|mesh-list
101411885|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101411886|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101411887|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411888|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411889|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411890|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
101411891|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411892|NCT00464347|Triamcinolone|triamcinolone|mesh-list
101411893|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101411894|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101411896|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101411897|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101411898|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411899|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101411900|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101411901|NCT00464347|Growth Substances|growth substances|mesh-ancestor
101411902|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411903|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
101411904|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101411905|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
101411907|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411908|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101411909|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
101411910|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411911|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411912|NCT00116493|Folic Acid|folic acid|mesh-list
101411913|NCT00116493|Mebendazole|mebendazole|mesh-list
101411914|NCT00116493|Piperazine|piperazine|mesh-list
101411915|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
101411916|NCT00116493|DMP 777|dmp 777|mesh-list
101411917|NCT00116493|Hematinics|hematinics|mesh-ancestor
101411918|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
101411919|NCT00116493|Vitamins|vitamins|mesh-ancestor
101411920|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
101411921|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411922|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
101411923|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
101411924|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101411925|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411926|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
101411927|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
101411928|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
101411929|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411930|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101411931|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411932|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101411933|NCT00464503|Pravastatin|pravastatin|mesh-list
101411934|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411935|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411936|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
101411937|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411938|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536276|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536277|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536278|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101411939|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411941|NCT00116532|Escitalopram|escitalopram|mesh-list
101411942|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101411943|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101411944|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101411945|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411946|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411947|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
101411948|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411950|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101411951|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411952|NCT00464893|Catumaxomab|catumaxomab|mesh-list
101411953|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101411954|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411955|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
101411956|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411957|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101411958|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101411959|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
101411960|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101411961|NCT00464932|Protective Agents|protective agents|mesh-ancestor
101411962|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411963|NCT00464971|Estradiol|estradiol|mesh-list
101411964|NCT00464971|Estrogens|estrogens|mesh-ancestor
101411965|NCT00464971|Hormones|hormones|mesh-ancestor
101411966|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101411967|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411968|NCT00116870|Lovastatin|lovastatin|mesh-list
101411969|NCT00116870|L 647318|l 647318|mesh-list
101411970|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
101411971|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101411972|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101411973|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
101411974|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101411975|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101411976|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101411977|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101411978|NCT00465205|Valacyclovir|valacyclovir|mesh-list
101411979|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
101411980|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101411981|NCT00465244|Levetiracetam|levetiracetam|mesh-list
101411983|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
101411984|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
101411985|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
101411986|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
101411987|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101411988|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101411989|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536283|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536284|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536285|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101411991|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101411992|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101411993|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101411994|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101411997|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101411998|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412000|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101536286|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101536287|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101536288|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101536289|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101536291|NCT01134055|Ranibizumab|ranibizumab|mesh-list
101536292|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101536293|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536294|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536295|NCT01134055|Growth Substances|growth substances|mesh-ancestor
101536296|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536315|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536316|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101536317|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536319|NCT00473889|Carboplatin|carboplatin|mesh-list
101536320|NCT00473889|Vorinostat|vorinostat|mesh-list
101536321|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101536322|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536323|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
101536324|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
101536325|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536326|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536327|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101536328|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536329|NCT00565214|Vitamins|vitamins|mesh-list
101536330|NCT00565214|Vitamin E|vitamin e|mesh-list
101536331|NCT00565214|Selenium|selenium|mesh-list
101536332|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
101536333|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536334|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
101536335|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536336|NCT00565214|Protective Agents|protective agents|mesh-ancestor
101536337|NCT00565214|Trace Elements|trace elements|mesh-ancestor
101536338|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
101536339|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101536340|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
101536341|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536342|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536343|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101536344|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536345|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101536346|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
101536347|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536348|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536349|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101536350|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101412001|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412002|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412003|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
101412004|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412005|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412006|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
101412007|NCT03272425|Allopurinol|allopurinol|mesh-list
101412008|NCT03272425|Lesinurad|lesinurad|mesh-list
101412009|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
101536356|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101536357|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101536358|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
101536359|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536360|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536362|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101536363|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
101536364|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536365|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101536366|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101536367|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101536368|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101536369|NCT04602143|Testosterone|testosterone|mesh-list
101536370|NCT04602143|Androgens|androgens|mesh-ancestor
101536371|NCT04602143|Hormones|hormones|mesh-ancestor
101536372|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536373|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536374|NCT02277678|Morphine|morphine|mesh-list
101536375|NCT02277678|Oxycodone|oxycodone|mesh-list
101536376|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
101536378|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536379|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536380|NCT02277678|Analgesics|analgesics|mesh-ancestor
101536381|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
101536382|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536383|NCT04601675|Dexamethasone|dexamethasone|mesh-list
101536384|NCT04601675|Ranibizumab|ranibizumab|mesh-list
101536385|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536386|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
101536387|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
101536388|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536389|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536390|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536391|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
101536392|NCT04601675|Hormones|hormones|mesh-ancestor
101536393|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536394|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536395|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536396|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536397|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536398|NCT04601675|Growth Substances|growth substances|mesh-ancestor
101536399|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536400|NCT00565292|Anacetrapib|anacetrapib|mesh-list
101536401|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101536402|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536403|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
101536404|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536405|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536406|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
101536407|NCT01580865|Tacrolimus|tacrolimus|mesh-list
101536408|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536409|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
101412010|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412012|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
101412013|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412014|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101412015|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
101412016|NCT03272425|Protective Agents|protective agents|mesh-ancestor
101412017|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412018|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
101412019|NCT00116948|Cimetidine|cimetidine|mesh-list
101536410|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536411|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101536412|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536413|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536414|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101536415|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536416|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101536417|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
101536418|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536419|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536420|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
101536421|NCT00473694|Rocuronium|rocuronium|mesh-list
101536424|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101536425|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101536427|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536428|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536429|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101536430|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536431|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536432|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
101536433|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536434|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101536435|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
101536436|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101536437|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101536438|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101536439|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101536440|NCT04601324|Fluticasone|fluticasone|mesh-list
101536441|NCT04601324|Xhance|xhance|mesh-list
101536442|NCT04601324|Azelastine|azelastine|mesh-list
101536443|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536444|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101536445|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
101536446|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536447|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536448|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101536449|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536450|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101536451|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101536452|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101536453|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536454|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536455|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101536456|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101536457|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
101536458|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
101536459|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536460|NCT00565331|Rituximab|rituximab|mesh-list
101536461|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536462|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536463|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
101412020|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101412021|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412022|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101412023|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
101412024|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
101412025|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412026|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412027|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412028|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101412029|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101412030|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412032|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101412033|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101412035|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412036|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101412037|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101412038|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
101536464|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536465|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536466|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101536467|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101536468|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536469|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
101536470|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536471|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536472|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101536473|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536474|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
101536475|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101536476|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536477|NCT00473382|Ranibizumab|ranibizumab|mesh-list
101536478|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536479|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536480|NCT00473382|Growth Substances|growth substances|mesh-ancestor
101536481|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536482|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536483|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536484|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
101536485|NCT04576364|Analgesics|analgesics|mesh-ancestor
101536486|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
101536487|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536488|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536489|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
101536490|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536491|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101536504|NCT00473265|Teriparatide|teriparatide|mesh-list
101536505|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101412039|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412040|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412041|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101412043|NCT00465439|Epinephrine|epinephrine|mesh-list
101412044|NCT00465439|Racepinephrine|racepinephrine|mesh-list
101412045|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
101412046|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
101412047|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
101412048|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412049|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412050|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
101536506|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536507|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101536508|NCT00472641|Ziprasidone|ziprasidone|mesh-list
101536509|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101536510|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
101536511|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536512|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536513|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536514|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101536515|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101536516|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536517|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536518|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101536519|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
101536520|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
101536523|NCT04571151|Calcipotriene|calcipotriene|mesh-list
101536524|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
101536525|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101536527|NCT01133977|Dacarbazine|dacarbazine|mesh-list
101536528|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536529|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101536530|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536531|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536532|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101536533|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
101536534|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101536535|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101536536|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536537|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536538|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536539|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536540|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536541|NCT00583193|Analgesics|analgesics|mesh-ancestor
101536542|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
101536543|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536545|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536546|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
101536547|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101536548|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536549|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536559|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536560|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536561|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101536562|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536563|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536564|NCT00583349|Paclitaxel|paclitaxel|mesh-list
101412051|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412052|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101412053|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101412054|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101412055|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412056|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412057|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101412058|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101536565|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101536566|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536568|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
101536569|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536570|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536571|NCT01133665|Lenalidomide|lenalidomide|mesh-list
101536572|NCT01133665|Cetuximab|cetuximab|mesh-list
101536573|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
101536574|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536575|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536576|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536577|NCT01133665|Growth Substances|growth substances|mesh-ancestor
101536578|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536579|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536580|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536581|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
101536582|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
101536583|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536584|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
101536585|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536586|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536587|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101536588|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101536589|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101536590|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536592|NCT01133626|Beclomethasone|beclomethasone|mesh-list
101536593|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536594|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
101536595|NCT01133626|Hormones|hormones|mesh-ancestor
101536596|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536597|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536598|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536599|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536600|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101536601|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536602|NCT01133392|Insulin|insulin|mesh-list
101536603|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101536604|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
101536605|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101536606|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536607|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101536608|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101536609|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536610|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536611|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536612|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101536613|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536614|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536615|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101536616|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101536619|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536620|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101536621|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412059|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412060|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412061|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101412062|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101412064|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101412065|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
101412067|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
101412068|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101412069|NCT00116727|Etanercept|etanercept|mesh-list
101412070|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101536622|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536624|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536625|NCT02210364|Capecitabine|capecitabine|mesh-list
101536626|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536627|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
101536628|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536629|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536630|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101536631|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101536632|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536633|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536634|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536635|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536636|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536638|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
101536639|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536640|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536641|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536642|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
101536643|NCT00471237|Alendronate|alendronate|mesh-list
101536644|NCT00471237|Teriparatide|teriparatide|mesh-list
101536645|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101536646|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536647|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536648|NCT04570683|Nivolumab|nivolumab|mesh-list
101536649|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536650|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536651|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101536652|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536653|NCT04570449|Fluoxetine|fluoxetine|mesh-list
101536654|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101536655|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536656|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536657|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536658|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536659|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
101536660|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536661|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101536662|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536663|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536664|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101536665|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101536666|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412071|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412072|NCT00116727|Analgesics|analgesics|mesh-ancestor
101412073|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
101412074|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412075|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412076|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412077|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412078|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412079|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412080|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
101412081|NCT00473551|Sirolimus|sirolimus|mesh-list
101412082|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
101412083|NCT00473551|Rituximab|rituximab|mesh-list
101412084|NCT00473551|Fludarabine|fludarabine|mesh-list
101412085|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
101412086|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536667|NCT00470847|Trastuzumab|trastuzumab|mesh-list
101536668|NCT00470847|Lapatinib|lapatinib|mesh-list
101536669|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536670|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536671|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101536672|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536673|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536674|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
101536675|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101536676|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101536677|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
101536679|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536680|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536707|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536708|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
101536709|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536710|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536711|NCT01133275|Growth Substances|growth substances|mesh-ancestor
101536712|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536714|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
101536715|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536716|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
101536717|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536718|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536720|NCT04570254|Vitamin E|vitamin e|mesh-list
101536721|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
101536722|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
101536723|NCT04570254|Melatonin|melatonin|mesh-list
101536724|NCT04570254|Antioxidants|antioxidants|mesh-list
101536725|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101536726|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
101536727|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536734|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101536735|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101536736|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101536737|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
101536738|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536740|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536741|NCT04570254|Antidotes|antidotes|mesh-ancestor
101536742|NCT00470067|Carboplatin|carboplatin|mesh-list
101412088|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412089|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412090|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101412091|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
101536744|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101536745|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536746|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101536747|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101536748|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101536749|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536750|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536752|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536753|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101536754|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
101536755|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536756|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536757|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101536758|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
101536760|NCT00584636|Hormones|hormones|mesh-ancestor
101536761|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536762|NCT00479817|Paclitaxel|paclitaxel|mesh-list
101536763|NCT00479817|Trebananib|trebananib|mesh-list
101536764|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101536765|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536766|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
101536767|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
101536768|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536769|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536770|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536771|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536772|NCT00479817|Growth Substances|growth substances|mesh-ancestor
101536773|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536774|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536775|NCT04575194|Liraglutide|liraglutide|mesh-list
101536776|NCT04575194|Naltrexone|naltrexone|mesh-list
101536777|NCT04575194|Bupropion|bupropion|mesh-list
101536778|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101536780|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536781|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
101536782|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536783|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101536784|NCT04575194|Incretins|incretins|mesh-ancestor
101536785|NCT04575194|Hormones|hormones|mesh-ancestor
101536788|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536790|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101536791|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536792|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536793|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536795|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536796|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101412092|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412094|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101412095|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412096|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412097|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
101412098|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412099|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536797|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101536798|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536799|NCT00478179|Bupivacaine|bupivacaine|mesh-list
101536800|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101536801|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
101536802|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536803|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536804|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
101536805|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536806|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101536807|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101536808|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536809|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
101536810|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536811|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101536812|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101536813|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536814|NCT00585260|Mannitol|mannitol|mesh-list
101536815|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101536816|NCT00585260|Diuretics|diuretics|mesh-ancestor
101536817|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
101536818|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536819|NCT00475020|Fludarabine|fludarabine|mesh-list
101536820|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
101536821|NCT00475020|Busulfan|busulfan|mesh-list
101536822|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
101536823|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101536824|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536825|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536826|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
101536827|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536828|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536829|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
101536830|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536831|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
101536832|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101536833|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101536834|NCT00585455|Sertraline|sertraline|mesh-list
101536835|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536836|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536837|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101536838|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536839|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536840|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412100|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101412101|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
101412103|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101412104|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
101412105|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412106|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
101412107|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
101412108|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536841|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536842|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
101536846|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536847|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101536848|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101536849|NCT01083966|Growth Substances|growth substances|mesh-ancestor
101536850|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536851|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536852|NCT01132807|Prednisone|prednisone|mesh-list
101536853|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
101536854|NCT01132807|Dacarbazine|dacarbazine|mesh-list
101536855|NCT01132807|Doxorubicin|doxorubicin|mesh-list
101536856|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101536857|NCT01132807|Etoposide|etoposide|mesh-list
101536858|NCT01132807|Bleomycin|bleomycin|mesh-list
101536859|NCT01132807|Vinblastine|vinblastine|mesh-list
101536860|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
101536861|NCT01132807|Procarbazine|procarbazine|mesh-list
101536862|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101536863|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101536864|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
101536865|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536866|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101536867|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101536868|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
101536869|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536870|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536871|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101536872|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101536873|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101536874|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101536875|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536876|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536877|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
101536879|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536880|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536881|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101536882|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101536883|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101536884|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101536885|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536886|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
101536887|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536888|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536890|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101536891|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536892|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101536893|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536894|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536895|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101536896|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536897|NCT01089504|Phenobarbital|phenobarbital|mesh-list
101412111|NCT00473980|Esomeprazole|esomeprazole|mesh-list
101412112|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412113|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412114|NCT00473980|Analgesics|analgesics|mesh-ancestor
101412115|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
101412116|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412117|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412118|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536898|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
101536899|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101536900|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536901|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536902|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101536903|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101536904|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536905|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536909|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101536910|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101536911|NCT03452696|Calcium|calcium|mesh-list
101536912|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536913|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536914|NCT01088997|Milrinone|milrinone|mesh-list
101536915|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101536916|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101536917|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
101536918|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101536919|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101536920|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536921|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536922|NCT01088997|Protective Agents|protective agents|mesh-ancestor
101536923|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536924|NCT00586118|Propofol|propofol|mesh-list
101536925|NCT00586118|Sevoflurane|sevoflurane|mesh-list
101536926|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101536927|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536928|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536929|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101536930|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
101536931|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
101536932|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101536933|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101536935|NCT01088529|Leuprolide|leuprolide|mesh-list
101536936|NCT01088529|Goserelin|goserelin|mesh-list
101536937|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
101536938|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536939|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
101536940|NCT01088529|Hormones|hormones|mesh-ancestor
101536941|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536942|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536943|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536944|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536945|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101536946|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
101536947|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412120|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101412121|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101412122|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412123|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412124|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101412125|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412126|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101412127|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
101412128|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
101536948|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101536949|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536950|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536951|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
101536952|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101536953|NCT00586274|Fludarabine|fludarabine|mesh-list
101536954|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
101536955|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536956|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536957|NCT00586430|Lorazepam|lorazepam|mesh-list
101536958|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
101536959|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
101536960|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
101536961|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536962|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536963|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536964|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101536965|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536966|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101536967|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101536968|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536969|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
101536970|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
101536971|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536972|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536973|NCT04569279|Warfarin|warfarin|mesh-list
101536974|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
101536975|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
101536976|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101536977|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
101536981|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536983|NCT04312204|Gemcitabine|gemcitabine|mesh-list
101536984|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536985|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101536986|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
101536987|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536988|NCT04312282|Itraconazole|itraconazole|mesh-list
101536989|NCT04312282|Rifampin|rifampin|mesh-list
101536990|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
101536991|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536992|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101536993|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101536994|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536995|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536996|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101536997|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
101536998|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536999|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537000|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101537001|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101537002|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
101537003|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101537004|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
101412129|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412130|NCT00474019|Esomeprazole|esomeprazole|mesh-list
101412131|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101412132|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412133|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101412134|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412135|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412136|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412138|NCT00474136|Diclofenac|diclofenac|mesh-list
101537005|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101537006|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101537007|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101537008|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101537009|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101537010|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101537011|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101537012|NCT01087905|Nicotine|nicotine|mesh-list
101537013|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101537014|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
101537015|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537016|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537017|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101537018|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101537019|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
101537020|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537021|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537022|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
101537023|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101537024|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537025|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537026|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
101537027|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537028|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537029|NCT00586976|Ropivacaine|ropivacaine|mesh-list
101537030|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
101537031|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
101537032|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537033|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537034|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
101537035|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537036|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
101537037|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
101537038|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
101537039|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
101537040|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537041|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537042|NCT04568772|Atovaquone|atovaquone|mesh-list
101537043|NCT04568772|Proguanil|proguanil|mesh-list
101537047|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537048|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101537049|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537050|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537051|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537052|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
101537053|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101537054|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101537055|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
101537057|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
101412140|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412141|NCT00474136|Analgesics|analgesics|mesh-ancestor
101412142|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
101412143|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412144|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412145|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412146|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537058|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537060|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537061|NCT01086150|Lidocaine|lidocaine|mesh-list
101537062|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
101537063|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
101537064|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537065|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537066|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
101537067|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537068|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101537069|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101537070|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101537071|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537072|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537073|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101537074|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101537075|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
101537076|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537077|NCT00587249|Antacids|antacids|mesh-ancestor
101537078|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537079|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537081|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537082|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537083|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537084|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
101537085|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537087|NCT00587444|Calcium heparin|calcium heparin|mesh-list
101537088|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
101537089|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101537090|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101537091|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537092|NCT02278302|Ethanol|ethanol|mesh-list
101537093|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
101537094|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101537095|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537096|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537097|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537098|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537099|NCT00587717|Simvastatin|simvastatin|mesh-list
101537100|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101537101|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101537102|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
101537103|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537104|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101537105|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101537106|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537107|NCT01085136|Afatinib|afatinib|mesh-list
101537108|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537109|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101537110|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537117|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101412147|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101412148|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412149|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412150|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412151|NCT00117104|Hematinics|hematinics|mesh-ancestor
101412152|NCT03270709|Vitamin D|vitamin d|mesh-list
101412153|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
101412154|NCT03270709|Vitamins|vitamins|mesh-ancestor
101412155|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
101412156|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537118|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537119|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101537121|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537122|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537123|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
101537124|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537125|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537126|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537127|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537128|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101537129|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537130|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
101537131|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537132|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101537134|NCT00587873|Protective Agents|protective agents|mesh-ancestor
101537135|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
101537137|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
101537138|NCT01084707|Nicotine|nicotine|mesh-list
101537139|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101537140|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
101537141|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537142|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537143|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101537144|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101537145|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
101537146|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537147|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537148|NCT02210598|Oxytocin|oxytocin|mesh-list
101537149|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
101537150|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537151|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537152|NCT03452657|Ranibizumab|ranibizumab|mesh-list
101537153|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101537154|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101537155|NCT03452657|Growth Substances|growth substances|mesh-ancestor
101537156|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537157|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
101537158|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537159|NCT03452501|Infliximab|infliximab|mesh-list
101537160|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101537161|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537162|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537163|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537164|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537165|NCT00588302|Moexipril|moexipril|mesh-list
101537166|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101537167|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
101537168|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537169|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537170|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101537171|NCT01084005|Linagliptin|linagliptin|mesh-list
101537172|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537173|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537174|NCT01084005|Incretins|incretins|mesh-ancestor
101412157|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101412158|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101412159|NCT03270553|Metformin|metformin|mesh-list
101412161|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412162|NCT00117182|Budesonide|budesonide|mesh-list
101412163|NCT00117182|Mannitol|mannitol|mesh-list
101412164|NCT00117182|Bromides|bromides|mesh-list
101412165|NCT00117182|Albuterol|albuterol|mesh-list
101412166|NCT00117182|Ipratropium|ipratropium|mesh-list
101412167|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412168|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101537175|NCT01084005|Hormones|hormones|mesh-ancestor
101537176|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537177|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101537178|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
101537179|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537191|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537192|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101537193|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101412169|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
101412170|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412171|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412172|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101412173|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
101412174|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
101537194|NCT00588926|Remifentanil|remifentanil|mesh-list
101537195|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412176|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412177|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
101412178|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
101412179|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412181|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101537196|NCT00588926|Narcotics|narcotics|mesh-ancestor
101537197|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412183|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412184|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412185|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412186|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101412188|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
101412189|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101412190|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
101412191|NCT00116922|Metformin|metformin|mesh-list
101412192|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
101412193|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101412194|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412195|NCT00116961|Dexamethasone|dexamethasone|mesh-list
101412196|NCT00116961|Bortezomib|bortezomib|mesh-list
101412197|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412198|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
101412199|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
101412200|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412201|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412202|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412203|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
101412204|NCT00116961|Hormones|hormones|mesh-ancestor
101412205|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412206|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412207|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412208|NCT00474721|Acetaminophen|acetaminophen|mesh-list
101412209|NCT00474721|Ibuprofen|ibuprofen|mesh-list
101412210|NCT00474721|Codeine|codeine|mesh-list
101412211|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412212|NCT00474721|Analgesics|analgesics|mesh-ancestor
101412213|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
101412214|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412215|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412216|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
101412217|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412218|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412219|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412220|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101412221|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412222|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537198|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412223|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412224|NCT00474721|Narcotics|narcotics|mesh-ancestor
101412225|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412226|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
101412227|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
101412228|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
101412229|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101412230|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101412231|NCT00117260|Estradiol|estradiol|mesh-list
101537199|NCT00588926|Analgesics|analgesics|mesh-ancestor
101412233|NCT00117260|Hormones|hormones|mesh-ancestor
101412234|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412235|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412236|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101412237|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
101412238|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412239|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101537200|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
101537201|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412240|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101412241|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101412242|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101412243|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101412244|NCT00474838|Metformin|metformin|mesh-list
101412245|NCT00474838|Glimepiride|glimepiride|mesh-list
101412246|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101412247|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412248|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101412249|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412250|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
101412251|NCT00474916|KRN 5500|krn 5500|mesh-list
101412252|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412253|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101412254|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412255|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412256|NCT00475072|Ribavirin|ribavirin|mesh-list
101412257|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101412258|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
101412259|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412260|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
101412261|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412263|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101412264|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412265|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412266|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
101412268|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
101412269|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
101412270|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101412272|NCT00117000|Hormones|hormones|mesh-ancestor
101412273|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412274|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412275|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412276|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412277|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
101412278|NCT02956408|Vitamin D|vitamin d|mesh-list
101412279|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
101412280|NCT02956408|Vitamins|vitamins|mesh-ancestor
101412281|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
101412282|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412283|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101412284|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101537203|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101537204|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537205|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101412285|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
101412288|NCT00475189|Norethindrone|norethindrone|mesh-list
101412289|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101412290|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101412291|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101412292|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
101412293|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412294|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412295|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101412296|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101412297|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
101412298|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101412300|NCT00475189|Hormones|hormones|mesh-ancestor
101412301|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412302|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
101412303|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412304|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412305|NCT00117377|Analgesics|analgesics|mesh-ancestor
101412306|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
101412307|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412308|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412309|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412310|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412311|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
101412312|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412313|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
101412314|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101412315|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412316|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412317|NCT02964195|Rifaximin|rifaximin|mesh-list
101412318|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101412319|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537208|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412321|NCT00475462|Metoprolol|metoprolol|mesh-list
101412322|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101412323|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101412324|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
101412325|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
101412326|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412327|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412328|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101412329|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101412330|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101412332|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412333|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537210|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
101537211|NCT00589238|Carboplatin|carboplatin|mesh-list
101412337|NCT00475618|Protective Agents|protective agents|mesh-ancestor
101412338|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412339|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412340|NCT00117039|Hematinics|hematinics|mesh-ancestor
101412341|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101412342|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101412344|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412345|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412346|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412347|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412349|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
101412350|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412351|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
101412352|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101412354|NCT00117455|Lenograstim|lenograstim|mesh-list
101412355|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101412356|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
101412357|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412358|NCT03270007|Vinorelbine|vinorelbine|mesh-list
101412359|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101412360|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412361|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
101412362|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
101412363|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
101412364|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412365|NCT00475813|Fluticasone|fluticasone|mesh-list
101412366|NCT00475813|Xhance|xhance|mesh-list
101412367|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
101412368|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412369|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101412370|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
101412371|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412372|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412373|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101412374|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
101412375|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
101412377|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101412378|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101412379|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101412380|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412381|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412382|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412384|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101412385|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412386|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
101412387|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412388|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
101412390|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101412391|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412392|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
101412393|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
101412394|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101412395|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101412396|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101412397|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537214|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101537215|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412398|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412399|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412400|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412402|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
101412403|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412404|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
101412405|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101412406|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
101412407|NCT00476164|Rituximab|rituximab|mesh-list
101412408|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412409|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412410|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
101412411|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412412|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412413|NCT00402077|Pramlintide|pramlintide|mesh-list
101412414|NCT00402077|Phentermine|phentermine|mesh-list
101412415|NCT00402077|Sibutramine|sibutramine|mesh-list
101412416|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537216|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537217|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
101412417|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412418|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101412419|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
101412420|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101412421|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
101412422|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
101412423|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412424|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412425|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412426|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412427|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
101412428|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101412430|NCT00476359|Saquinavir|saquinavir|mesh-list
101412431|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101412432|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101412433|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
101412434|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412435|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412436|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101412437|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101412438|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
101412439|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412440|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101412441|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101537222|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537223|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412442|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412444|NCT00476437|Insulin|insulin|mesh-list
101412445|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101412446|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
101412447|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
101412448|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101412449|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412450|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101412451|NCT00117494|Pravastatin|pravastatin|mesh-list
101412452|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101412453|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101412454|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
101412455|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412457|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101412458|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412459|NCT00117533|Ribavirin|ribavirin|mesh-list
101412460|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
101412461|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
101412462|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412463|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
101412464|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537224|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101537226|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101537227|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101412465|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412466|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412467|NCT00117234|Hematinics|hematinics|mesh-ancestor
101412469|NCT00117611|Antibodies|antibodies|mesh-list
101412470|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
101412471|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412472|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101412473|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101412474|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
101412475|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101412476|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101537228|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101537229|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101537230|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537231|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101537232|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
101537233|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537234|NCT01083576|Gentamicins|gentamicins|mesh-list
101412477|NCT04727684|Cetrorelix|cetrorelix|mesh-list
101412478|NCT04727684|Menotropins|menotropins|mesh-list
101412479|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
101412480|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101412481|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
101412482|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412483|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412484|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101537235|NCT01083576|Paromomycin|paromomycin|mesh-list
101537236|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101537237|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537238|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101412485|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412486|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412487|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101412488|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
101412489|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
101412490|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412491|NCT03277261|Teriflunomide|teriflunomide|mesh-list
101537239|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412492|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412493|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412494|NCT03277261|Analgesics|analgesics|mesh-ancestor
101412495|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
101412496|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412497|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537327|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
101537328|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101412498|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412499|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412500|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412501|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
101412503|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101412504|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101412505|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
101412506|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412508|NCT05367336|Morphine|morphine|mesh-list
101412509|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412510|NCT05367336|Narcotics|narcotics|mesh-ancestor
101412511|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412512|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412514|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
101537341|NCT01080300|Analgesics|analgesics|mesh-ancestor
101412515|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412516|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101412517|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101412518|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
101412519|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
101412520|NCT00476515|Rituximab|rituximab|mesh-list
101412521|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412522|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537351|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101412524|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412526|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
101412527|NCT00117689|Tacrolimus|tacrolimus|mesh-list
101412528|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
101537363|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537364|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
101412529|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101412530|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412531|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
101412532|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412533|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101412534|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412535|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221773|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101412536|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101412537|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412538|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101412539|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
101412540|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101412541|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412545|NCT00117273|Estrogens|estrogens|mesh-ancestor
101412546|NCT00117273|Hormones|hormones|mesh-ancestor
101412547|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412548|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412549|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101412550|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
101412551|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412552|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101412553|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101412554|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101412555|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101537388|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537389|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537390|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101537391|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101412556|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101412557|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101412558|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101412559|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
101412560|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412561|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101537392|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
101537393|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101412563|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101412564|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101412566|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412567|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
101412568|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412569|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101412570|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101412571|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101412572|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101537394|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537395|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537396|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412573|NCT00117767|Terbinafine|terbinafine|mesh-list
101412574|NCT00117767|Griseofulvin|griseofulvin|mesh-list
101412575|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
101412576|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412577|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412578|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412580|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412581|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412582|NCT03277066|Analgesics|analgesics|mesh-ancestor
101412583|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
101412584|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412585|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412586|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412587|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412588|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101412589|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412590|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412591|NCT00117351|Bortezomib|bortezomib|mesh-list
101412592|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537398|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
101412593|NCT00118196|Azacitidine|azacitidine|mesh-list
101412594|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
101412595|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412596|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
101412597|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412598|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412599|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412600|NCT00118235|Bevacizumab|bevacizumab|mesh-list
101412601|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101412602|NCT00118235|Irinotecan|irinotecan|mesh-list
101412603|NCT00118235|Antibodies|antibodies|mesh-list
101412604|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
101412605|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101537399|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412606|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412607|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101412608|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101412609|NCT00118235|Growth Substances|growth substances|mesh-ancestor
101412610|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412611|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
101412612|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
101412613|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101537402|NCT01085097|Protective Agents|protective agents|mesh-ancestor
101412614|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101412615|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412616|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412617|NCT00118313|Imiquimod|imiquimod|mesh-list
101412618|NCT00118313|Sargramostim|sargramostim|mesh-list
101412619|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
101412620|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
101412621|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
101412622|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412623|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412624|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101412625|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
101537404|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101412626|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101412627|NCT00118313|Protective Agents|protective agents|mesh-ancestor
101412628|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101412629|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
101412630|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412631|NCT03271021|Minocycline|minocycline|mesh-list
101412632|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101221774|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
101537405|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
101537406|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412634|NCT02273986|Digoxin|digoxin|mesh-list
101412635|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101412637|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412638|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412639|NCT02273986|Protective Agents|protective agents|mesh-ancestor
101412640|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412641|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
101412642|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101412643|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412644|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412645|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101412646|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412647|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101412650|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101412651|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101412652|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101412653|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
101412654|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537407|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537408|NCT01086267|Cetuximab|cetuximab|mesh-list
101537409|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412655|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412656|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101412657|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101412658|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
101412659|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537410|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412660|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101412661|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101412662|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101412663|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101412665|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412666|NCT00477061|Narcotics|narcotics|mesh-ancestor
101412667|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412668|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412669|NCT00477061|Analgesics|analgesics|mesh-ancestor
101412670|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
101412671|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412672|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
101412673|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101412674|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412675|NCT00477373|Valproic Acid|valproic acid|mesh-list
101412676|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
101412677|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412678|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412679|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
101537413|NCT04567290|Ticagrelor|ticagrelor|mesh-list
101412681|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412683|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101412684|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412685|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101412686|NCT00477763|Cyclosporine|cyclosporine|mesh-list
101412687|NCT00477763|Cyclosporins|cyclosporins|mesh-list
101412688|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412689|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412690|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412691|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
101412692|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412693|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
101412695|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
101412696|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412697|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101412698|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
101412699|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101412700|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101412701|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101412702|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101412703|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412704|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
101412705|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412706|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412707|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101412708|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412709|NCT00477880|Cetuximab|cetuximab|mesh-list
101412710|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412711|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412712|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101412713|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412714|NCT00477997|Hormones|hormones|mesh-list
101412715|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412716|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412717|NCT00478075|Bortezomib|bortezomib|mesh-list
101412718|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
101412719|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412720|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412721|NCT00478075|Analgesics|analgesics|mesh-ancestor
101412722|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
101412723|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412724|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412725|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412726|NCT00117078|Hematinics|hematinics|mesh-ancestor
101412728|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412729|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101412730|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412731|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412732|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
101412733|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101412734|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412735|NCT00478504|Letrozole|letrozole|mesh-list
101412736|NCT00478504|Clomiphene|clomiphene|mesh-list
101412737|NCT00478504|Enclomiphene|enclomiphene|mesh-list
101412738|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
101537416|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101412739|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412740|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412741|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101412742|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101412743|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412744|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101412745|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
101412746|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412747|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412748|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101412749|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
101412750|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101412751|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101412752|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101537417|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101537418|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
101412755|NCT00117468|Hormones|hormones|mesh-ancestor
101412756|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412757|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412758|NCT03271879|Empagliflozin|empagliflozin|mesh-list
101412759|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101412760|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412761|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101412762|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412763|NCT00478543|Furosemide|furosemide|mesh-list
101412764|NCT00478543|Diuretics|diuretics|mesh-ancestor
101412765|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
101412766|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412767|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101412768|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537420|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412769|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412771|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101412772|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412773|NCT00478621|Vaccines|vaccines|mesh-list
101412774|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
101412775|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412776|NCT00478660|Adalimumab|adalimumab|mesh-list
101412777|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101412778|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412779|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412780|NCT00478699|Cisplatin|cisplatin|mesh-list
101412781|NCT00478699|Gemcitabine|gemcitabine|mesh-list
101412782|NCT00478699|Docetaxel|docetaxel|mesh-list
101412783|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412784|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412786|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412787|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
101412788|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
101412789|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
101412790|NCT00118976|Lisinopril|lisinopril|mesh-list
101412791|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101412792|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
101412793|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412794|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412795|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101412796|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101537421|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537422|NCT01084161|Morphine|morphine|mesh-list
101412797|NCT00118976|Protective Agents|protective agents|mesh-ancestor
101412798|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412799|NCT00478816|Vaccines|vaccines|mesh-list
101412800|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
101412801|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412802|NCT00478855|Piperacillin|piperacillin|mesh-list
101412803|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101412804|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101412805|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412806|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101537423|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101537424|NCT01084161|Narcotics|narcotics|mesh-ancestor
101412808|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412809|NCT00117546|Methyldopa|methyldopa|mesh-list
101412810|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101412811|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
101412812|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
101412813|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412814|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412815|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101412816|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101412817|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101412818|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
101412819|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412820|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412822|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
101412823|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101412824|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101412825|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412826|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412827|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
101412828|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
101412829|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101412830|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
101412833|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
101412834|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101412835|NCT00119132|Amodiaquine|amodiaquine|mesh-list
101412836|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
101412837|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101412838|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101412839|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412840|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412841|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
101537425|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412842|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
101412843|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101412844|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
101412845|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101412846|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412847|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412848|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101412849|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101412850|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
101537426|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537427|NCT01084161|Analgesics|analgesics|mesh-ancestor
101537428|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
101537429|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537430|NCT01083615|Prednisone|prednisone|mesh-list
101537431|NCT01083615|Docetaxel|docetaxel|mesh-list
101537432|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412851|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412852|NCT00479362|Aspirin|aspirin|mesh-list
101412853|NCT00479362|Warfarin|warfarin|mesh-list
101412854|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101412855|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101412856|NCT00479362|Analgesics|analgesics|mesh-ancestor
101412857|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
101412858|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412859|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412860|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412861|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101412862|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101412863|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101537433|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537434|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101412864|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412865|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101412866|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101412867|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412869|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
101412870|NCT00119171|Capecitabine|capecitabine|mesh-list
101537435|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537436|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537438|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
101412871|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412872|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
101412873|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412874|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412875|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
101412876|NCT00117624|Hematinics|hematinics|mesh-ancestor
101412877|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
101412878|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
101412880|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
101412881|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412882|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
101412883|NCT00479479|Hematinics|hematinics|mesh-ancestor
101412884|NCT00119210|Bupropion|bupropion|mesh-list
101412885|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101412886|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
101412888|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101412889|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101412890|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537439|NCT01083615|Hormones|hormones|mesh-ancestor
101537440|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412891|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412893|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101412894|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412895|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101412896|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101412897|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412899|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537441|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537442|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537443|NCT00591188|Interferons|interferons|mesh-list
101412900|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412902|NCT00479752|Cetuximab|cetuximab|mesh-list
101412903|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412904|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101412905|NCT00119249|Sorafenib|sorafenib|mesh-list
101412906|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412907|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101537444|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
101537445|NCT00591188|Capecitabine|capecitabine|mesh-list
101537446|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537447|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
101412908|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412909|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412911|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
101412912|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537448|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537449|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537450|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
101537451|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412913|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
101412914|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101412915|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101412916|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412917|NCT00479908|Urological Agents|urological agents|mesh-ancestor
101412918|NCT00479986|Pioglitazone|pioglitazone|mesh-list
101412919|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537452|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
101537453|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412920|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412921|NCT00480064|Cytarabine|cytarabine|mesh-list
101412923|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101412924|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
101412925|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412926|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412927|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
101537454|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101412928|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412929|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412930|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
101412931|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412932|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101412933|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
101537455|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412934|NCT00480103|Mineral Oil|mineral oil|mesh-list
101412935|NCT00480103|Emollients|emollients|mesh-ancestor
101412936|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
101412938|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101412939|NCT00480142|Narcotics|narcotics|mesh-ancestor
101537456|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101412941|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412943|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
101412944|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412945|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
101412947|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
101412948|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
101412949|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101412950|NCT00119483|Androgens|androgens|mesh-ancestor
101412952|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412953|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537457|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537458|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412954|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412955|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412957|NCT00480181|Nabilone|nabilone|mesh-list
101412958|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
101412959|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
101537460|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101412960|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412961|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412962|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412963|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101412964|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101412965|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101412966|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101537461|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537462|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101412970|NCT00480298|Prednisolone|prednisolone|mesh-list
101412971|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
101412972|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101412973|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
101412974|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101412975|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
101412976|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
101412977|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101412978|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101412979|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101412980|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
101412981|NCT00480298|Hormones|hormones|mesh-ancestor
101412982|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101412983|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101417145|NCT00140868|Phenobarbital|phenobarbital|mesh-list
101412984|NCT00480298|Protective Agents|protective agents|mesh-ancestor
101412985|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101412986|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412987|NCT00480376|Gentamicins|gentamicins|mesh-list
101412989|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101412990|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101412991|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101412992|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101412993|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101412994|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101412996|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101412997|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101412998|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101412999|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101413000|NCT00117702|Everolimus|everolimus|mesh-list
101413001|NCT00117702|Tacrolimus|tacrolimus|mesh-list
101413002|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413003|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
101413004|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413005|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101537464|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413007|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413008|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101413009|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413010|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413011|NCT00480454|Vaccines|vaccines|mesh-list
101413012|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
101413013|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413014|NCT00480571|Perphenazine|perphenazine|mesh-list
101413015|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
101413016|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
101413017|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413018|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413019|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537465|NCT01080222|Ribavirin|ribavirin|mesh-list
101413020|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101413021|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413022|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413023|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413024|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101413025|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
101413026|NCT00480610|Tacrolimus|tacrolimus|mesh-list
101537466|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101413027|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413028|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
101413029|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413030|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101413031|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413032|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413033|NCT00480649|Fluticasone|fluticasone|mesh-list
101413034|NCT00480649|Xhance|xhance|mesh-list
101413035|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101413036|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413037|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101413038|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
101413039|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413040|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413041|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101413042|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
101413043|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
101413044|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101413045|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101413046|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101413047|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101413048|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413049|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413050|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413052|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413053|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413054|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537468|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413055|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413057|NCT00480844|Sertindole|sertindole|mesh-list
101221775|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413060|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413061|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413062|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413063|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101537469|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
101537470|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537471|NCT03452267|Metformin|metformin|mesh-list
101537472|NCT03452267|Pioglitazone|pioglitazone|mesh-list
101537473|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537474|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537475|NCT01088802|Carboplatin|carboplatin|mesh-list
101537476|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537479|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413064|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413065|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413066|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413067|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101413068|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
101413069|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101413070|NCT00480883|Allopurinol|allopurinol|mesh-list
101413071|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
101537480|NCT03451682|Protective Agents|protective agents|mesh-ancestor
101413072|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413074|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
101413075|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413076|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101413077|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
101413078|NCT00480883|Protective Agents|protective agents|mesh-ancestor
101413079|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413080|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413081|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413082|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413083|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101413084|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
101413085|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413086|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537481|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537482|NCT02210754|Menthol|menthol|mesh-list
101537483|NCT02210754|Nicotine|nicotine|mesh-list
101537484|NCT02210754|Glycerol|glycerol|mesh-list
101537485|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101413087|NCT05236998|Incretins|incretins|mesh-ancestor
101413088|NCT05236998|Hormones|hormones|mesh-ancestor
101413089|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413090|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101413091|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101413092|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413093|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413094|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101413095|NCT01240096|Mirtazapine|mirtazapine|mesh-list
101413096|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
101413097|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413098|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101413099|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
101413100|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
101413101|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413102|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413103|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413104|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101413105|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413106|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413107|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101413108|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101413110|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413111|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101413112|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101413113|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
101413114|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101413115|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101413116|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101413117|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413118|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413119|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413120|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413121|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101413122|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101413123|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
101221776|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537487|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537488|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537489|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101413124|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413125|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413126|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101413127|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101413128|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
101413129|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101413130|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413132|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101413133|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413134|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413135|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
101413136|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101413137|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413138|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413139|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413141|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
101413142|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413143|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101413144|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101413145|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101413146|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413147|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413148|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413150|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101413151|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
101413152|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
101413153|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413154|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413155|NCT01240408|Lenvatinib|lenvatinib|mesh-list
101413156|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413157|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413159|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413160|NCT00481273|Azacitidine|azacitidine|mesh-list
101413161|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101413162|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
101413163|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413164|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413165|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413166|NCT00481312|Midazolam|midazolam|mesh-list
101413167|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
101413168|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101413169|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413170|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413171|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413172|NCT00481312|Analgesics|analgesics|mesh-ancestor
101413173|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
101413174|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413175|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101413176|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101413178|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413179|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413180|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413181|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101413182|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101413183|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413184|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413185|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101413186|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
101413188|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
101413189|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
101413190|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
101413191|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413192|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413193|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
101537490|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101537491|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
101537492|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537493|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537494|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
101413194|NCT00119990|Icodextrin|icodextrin|mesh-list
101413195|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101413196|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
101413197|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
101413198|NCT00481624|Hematinics|hematinics|mesh-ancestor
101413199|NCT00117897|Lenograstim|lenograstim|mesh-list
101413200|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101413201|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
101413202|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413204|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101537499|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
101537500|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413205|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413206|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413207|NCT00481663|Incretins|incretins|mesh-ancestor
101413208|NCT00481663|Hormones|hormones|mesh-ancestor
101413209|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413210|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101413211|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
101413212|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413213|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413214|NCT00481702|Metronidazole|metronidazole|mesh-list
101413215|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
101413216|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413217|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413218|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413219|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413220|NCT00481741|Hemostatics|hemostatics|mesh-list
101413221|NCT00481741|Coagulants|coagulants|mesh-ancestor
101413222|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
101413223|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
101413224|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101413225|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101413227|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
101413229|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101413230|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
101413231|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413232|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
101413233|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413234|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101413235|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413236|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413238|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413239|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101413240|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
101413241|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413242|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537504|NCT04998981|Fenofibrate|fenofibrate|mesh-list
101413243|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413245|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
101413246|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413247|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413248|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
101413249|NCT00481819|Hormones|hormones|mesh-ancestor
101537505|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101413250|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413251|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101413252|NCT00481819|Protective Agents|protective agents|mesh-ancestor
101413253|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101413254|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101413255|NCT02958059|Cefoxitin|cefoxitin|mesh-list
101413256|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413257|NCT00481975|Rimonabant|rimonabant|mesh-list
101413258|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101413259|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101413260|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101413261|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413262|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413264|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413265|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413266|NCT00482209|Misoprostol|misoprostol|mesh-list
101413267|NCT00482209|Mifepristone|mifepristone|mesh-list
101413268|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101413269|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
101537507|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537508|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101413271|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413272|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101413273|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413274|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
101413275|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101413276|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101413277|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101413278|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101413279|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
101413280|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101413281|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101413282|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537509|NCT04573049|Simendan|simendan|mesh-list
101413283|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413284|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
101413285|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101413286|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101413287|NCT00117936|Mitogens|mitogens|mesh-list
101413289|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413292|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101413293|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
101413294|NCT00120185|Interleukin-2|interleukin-2|mesh-list
101413295|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413296|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413297|NCT00120185|Analgesics|analgesics|mesh-ancestor
101413298|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
101413299|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413300|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413302|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413303|NCT00117975|Galiximab|galiximab|mesh-list
101413304|NCT00117975|Rituximab|rituximab|mesh-list
101413305|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413306|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413307|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
101537510|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101537511|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
101413308|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413310|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413311|NCT00482521|Pomalidomide|pomalidomide|mesh-list
101413312|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
101413313|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413314|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101413315|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101413316|NCT00482521|Growth Substances|growth substances|mesh-ancestor
101413317|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
101413318|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413319|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
101413320|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413321|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413322|NCT00120302|Analgesics|analgesics|mesh-ancestor
101413323|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
101413324|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413325|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413326|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413327|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413328|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537512|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101413331|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101413332|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413333|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413335|NCT00482716|Dextrans|dextrans|mesh-list
101413336|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
101413337|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101413338|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
101413339|NCT00482716|Trace Elements|trace elements|mesh-ancestor
101413340|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
101413341|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413342|NCT00482716|Hematinics|hematinics|mesh-ancestor
101413343|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
101413344|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
101413345|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
101413346|NCT00120341|Analgesics|analgesics|mesh-list
101413348|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413349|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413350|NCT00482989|Sifalimumab|sifalimumab|mesh-list
101413351|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
101413352|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413354|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101413355|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
101413356|NCT00483028|Donepezil|donepezil|mesh-list
101413357|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101413358|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413359|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413360|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
101413361|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413362|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413363|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
101413364|NCT00118014|Sertraline|sertraline|mesh-list
101413365|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
101413366|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413367|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101413368|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413369|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537517|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413370|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413371|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413372|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
101413373|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537518|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
101413375|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101413376|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413377|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101413378|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
101413379|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413380|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413381|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537519|NCT04572698|Growth Substances|growth substances|mesh-ancestor
101537520|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413382|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413384|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
101413385|NCT05176470|Fludarabine|fludarabine|mesh-list
101413386|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537521|NCT04572542|Paclitaxel|paclitaxel|mesh-list
101537522|NCT04572542|Apatinib|apatinib|mesh-list
101537523|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101413388|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413389|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413390|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101413391|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
101413392|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413394|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101413395|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413396|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101413397|NCT01241032|Udenafil|udenafil|mesh-list
101537524|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413398|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101413399|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101413400|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413401|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413402|NCT00483067|Cytarabine|cytarabine|mesh-list
101413403|NCT00483067|Cladribine|cladribine|mesh-list
101413404|NCT00483067|Lenograstim|lenograstim|mesh-list
101413405|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537525|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537526|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101413407|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413408|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413409|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
101413410|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413411|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413412|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
101413413|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413414|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101413415|NCT00483106|Methylphenidate|methylphenidate|mesh-list
101413416|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101413417|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413418|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101413419|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413420|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537527|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101413421|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413423|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413424|NCT00118170|Sorafenib|sorafenib|mesh-list
101413425|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413426|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413427|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413428|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413429|NCT00120497|Hormones|hormones|mesh-list
101537531|NCT04991103|Dexamethasone|dexamethasone|mesh-list
101413430|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413432|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101413433|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101413434|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101413435|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
101413436|NCT00483301|Sorafenib|sorafenib|mesh-list
101413437|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101413438|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413439|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413440|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413441|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413442|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101413443|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413444|NCT00120536|Vildagliptin|vildagliptin|mesh-list
101413445|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413446|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413447|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101413448|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
101413449|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537534|NCT04991103|Daratumumab|daratumumab|mesh-list
101537535|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537536|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
101537537|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
101413450|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413451|NCT00483730|Actovegin|actovegin|mesh-list
101413452|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101413453|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413454|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101413455|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413456|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
101413457|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413458|NCT00483730|Protective Agents|protective agents|mesh-ancestor
101413459|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101413461|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101413462|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
101413463|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413464|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
101413465|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413466|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413467|NCT00405171|Nevirapine|nevirapine|mesh-list
101413468|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101413469|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101413470|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413473|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413474|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101413475|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101413476|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101413477|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101413478|NCT00483886|Prucalopride|prucalopride|mesh-list
101413479|NCT00483886|Laxatives|laxatives|mesh-ancestor
101413480|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413481|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101537538|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537539|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537540|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413482|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101413484|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413485|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413486|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413488|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
101413490|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413491|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413492|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413493|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101413494|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413495|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413496|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413497|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101413498|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413499|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413500|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413501|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413502|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
101413504|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413505|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101537542|NCT04991103|Hormones|hormones|mesh-ancestor
101537543|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413507|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
101413508|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413509|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413510|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413511|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413512|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
101413513|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413514|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
101413515|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101537544|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537545|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413517|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413518|NCT01241110|Ofloxacin|ofloxacin|mesh-list
101413519|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101413520|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413521|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413522|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101413523|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101413524|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413525|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413526|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537547|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101413527|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101413528|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101413529|NCT00120653|Metoclopramide|metoclopramide|mesh-list
101413530|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
101413531|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
101413532|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413533|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413534|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413535|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101413536|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101413537|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
101413539|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413540|NCT00484120|Diclofenac|diclofenac|mesh-list
101413541|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413542|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413543|NCT00484120|Analgesics|analgesics|mesh-ancestor
101413544|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
101413545|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413546|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413547|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413548|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413549|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101413550|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413551|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537548|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101537549|NCT04991103|Growth Substances|growth substances|mesh-ancestor
101537550|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
101413552|NCT00484237|Etanercept|etanercept|mesh-list
101413553|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413554|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413555|NCT00484237|Analgesics|analgesics|mesh-ancestor
101413556|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
101413557|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413558|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537552|NCT04572620|Abatacept|abatacept|mesh-list
101537553|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413560|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413561|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101413562|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413563|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
101413564|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
101413565|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
101413566|NCT00120692|Hematinics|hematinics|mesh-ancestor
101413567|NCT00484432|Doxorubicin|doxorubicin|mesh-list
101413569|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413570|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101413571|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101413572|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413573|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413574|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
101413575|NCT00484510|Vitamins|vitamins|mesh-ancestor
101413576|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
101537554|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537556|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537557|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413577|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413578|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
101413579|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413580|NCT00484510|Protective Agents|protective agents|mesh-ancestor
101413581|NCT00120731|Acetazolamide|acetazolamide|mesh-list
101413582|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
101413583|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413584|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
101413585|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101413586|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413587|NCT00120731|Diuretics|diuretics|mesh-ancestor
101413588|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
101413589|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413590|NCT00120731|Expectorants|expectorants|mesh-ancestor
101413591|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
101413592|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
101413593|NCT00484744|Acetaminophen|acetaminophen|mesh-list
101537558|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101413595|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413596|NCT00484744|Analgesics|analgesics|mesh-ancestor
101413597|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
101413598|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413599|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413600|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
101413601|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413603|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413604|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101413605|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413606|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413607|NCT00484822|Heparin|heparin|mesh-list
101413608|NCT00484822|Calcium heparin|calcium heparin|mesh-list
101413609|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
101413610|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101413611|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101413612|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413613|NCT00405210|Docetaxel|docetaxel|mesh-list
101413614|NCT00405210|Sorafenib|sorafenib|mesh-list
101413615|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413616|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
101413617|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
101413618|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
101413619|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413620|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413621|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413622|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
101413623|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
101413624|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101537563|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
101537564|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413625|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
101413626|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413627|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413628|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413629|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101413630|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537565|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
101537566|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413632|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101413633|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101413634|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
101413635|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413636|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413637|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413639|NCT05062356|Epinephrine|epinephrine|mesh-list
101413640|NCT05062356|Bupivacaine|bupivacaine|mesh-list
101537567|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537568|NCT02211066|Clopidogrel|clopidogrel|mesh-list
101413641|NCT05062356|Prilocaine|prilocaine|mesh-list
101413642|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101413643|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
101413644|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
101413645|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413646|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413647|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
101413648|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413649|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101413650|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101413651|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413652|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413653|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413654|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101413655|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101413656|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
101413657|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101413658|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
101413659|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
101413660|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
101413661|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101413662|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413664|NCT05062356|Analgesics|analgesics|mesh-ancestor
101413665|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413666|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413667|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101413668|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413670|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101413671|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101413672|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413673|NCT00485056|Pioglitazone|pioglitazone|mesh-list
101413674|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413675|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413676|NCT00120887|Atorvastatin|atorvastatin|mesh-list
101413677|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101413678|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101413679|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
101413680|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413681|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101413682|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101413683|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537569|NCT02211066|Ticagrelor|ticagrelor|mesh-list
101221777|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413684|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
101413685|NCT00118638|Hematinics|hematinics|mesh-ancestor
101413687|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101413688|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
101413689|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413690|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413691|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101413692|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101413693|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101413694|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413695|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413696|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413697|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413698|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413699|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413701|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537571|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101413704|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413706|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
101413707|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
101413708|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413709|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413710|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101413712|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101413714|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413715|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413716|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413718|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101413719|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
101413720|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537572|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101537573|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101537574|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
101537575|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413721|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413722|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101413723|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
101413724|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101413725|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101413726|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101537576|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413728|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101413729|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101413730|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101413731|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537577|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537578|NCT03450317|Aspirin|aspirin|mesh-list
101537579|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101537580|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101537581|NCT03450317|Analgesics|analgesics|mesh-ancestor
101537582|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
101413732|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413733|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413734|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101413735|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101413736|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537583|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413738|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101413739|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413740|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413741|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413742|NCT02274337|Abivertinib|abivertinib|mesh-list
101413743|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413744|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413745|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413746|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101413747|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413748|NCT00485680|Olanzapine|olanzapine|mesh-list
101413749|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
101413750|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
101413751|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
101413752|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413753|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413754|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537584|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537585|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413755|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101413756|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101413757|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413758|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101413759|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101413760|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413761|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413762|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413763|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413764|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
101413765|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
101413766|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413767|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
101413768|NCT00118794|Lumefantrine|lumefantrine|mesh-list
101413770|NCT00118794|Dapsone|dapsone|mesh-list
101413771|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
101413772|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101413774|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413775|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413776|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413777|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101413778|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413779|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413780|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
101413781|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413782|NCT01241773|Efavirenz|efavirenz|mesh-list
101537586|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537587|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101537588|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101537589|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413784|NCT01241773|Simeprevir|simeprevir|mesh-list
101413785|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101413786|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101413787|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413788|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413789|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
101537590|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537591|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101413790|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413791|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101413792|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101413793|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101413794|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101413795|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101413796|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101413798|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101413799|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101413800|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101413801|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
101413802|NCT00121277|Capecitabine|capecitabine|mesh-list
101413803|NCT00121277|Vorinostat|vorinostat|mesh-list
101413804|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101413805|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
101413806|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413807|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413808|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101413809|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413810|NCT00485797|Methylphenidate|methylphenidate|mesh-list
101413811|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101413812|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413813|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101413814|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413815|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537592|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537593|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
101413816|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413817|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
101413818|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537594|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
101537595|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413820|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101413821|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101413822|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413823|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413824|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
101413825|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413826|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413827|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
101413828|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413829|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413830|NCT00121316|Analgesics|analgesics|mesh-ancestor
101413831|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
101413832|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413833|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413834|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413835|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413836|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
101413837|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101413838|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
101413839|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101413840|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413841|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413843|NCT00118950|Repaglinide|repaglinide|mesh-list
101413844|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537601|NCT03450161|Narcotics|narcotics|mesh-ancestor
101537602|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537603|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537604|NCT03450161|Analgesics|analgesics|mesh-ancestor
101537605|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
101413845|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413846|NCT00486187|Metformin|metformin|mesh-list
101413847|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
101413848|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413849|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413850|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
101413851|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101413852|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413853|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
101413854|NCT00486343|Zileuton|zileuton|mesh-list
101413855|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413856|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413858|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
101413859|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413860|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413861|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413862|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413863|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101413864|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413865|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413866|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101537606|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537607|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101537608|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101537609|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
101413868|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413869|NCT00486421|Prednisone|prednisone|mesh-list
101413870|NCT00486421|Rituximab|rituximab|mesh-list
101413871|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413872|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413873|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
101413874|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413875|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413876|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413877|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
101413878|NCT00486421|Hormones|hormones|mesh-ancestor
101413879|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101413880|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101413881|NCT00486460|Curcumin|curcumin|mesh-list
101413882|NCT00486460|Celecoxib|celecoxib|mesh-list
101413883|NCT00486460|Gemcitabine|gemcitabine|mesh-list
101413884|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101413885|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
101413886|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413887|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413888|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101413889|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101413890|NCT00486460|Analgesics|analgesics|mesh-ancestor
101537610|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
101537611|NCT04565184|Artesunate|artesunate|mesh-list
101413891|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
101413892|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101413893|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413894|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101413895|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101413896|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413897|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101413898|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101413899|NCT00121511|Fluorouracil|fluorouracil|mesh-list
101413900|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
101413901|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413902|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101413903|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413904|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537615|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101537616|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
101537617|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
101413905|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
101413906|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413909|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
101413910|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
101413911|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101413912|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
101413913|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413914|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413915|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413916|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537620|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537621|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413917|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
101413918|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
101413919|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101413920|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
101413921|NCT00486694|Amebicides|amebicides|mesh-ancestor
101413922|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537622|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
101537623|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
101413923|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101413924|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413925|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413926|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101413927|NCT00486772|Calcium|calcium|mesh-list
101413928|NCT00486772|Sevelamer|sevelamer|mesh-list
101413929|NCT00486772|Calcium acetate|calcium acetate|mesh-list
101537627|NCT03452579|Nivolumab|nivolumab|mesh-list
101413930|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101413931|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413932|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
101413933|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
101413934|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413935|NCT00121550|Clarithromycin|clarithromycin|mesh-list
101413936|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101413937|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413938|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101413939|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413940|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413941|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101413942|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101537628|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101413943|NCT01242046|Caffeine|caffeine|mesh-list
101413944|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101413945|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413946|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101413947|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413948|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413949|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101413951|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
101413952|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101413953|NCT01242202|Acarbose|acarbose|mesh-list
101413954|NCT01242202|Voglibose|voglibose|mesh-list
101413955|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101413956|NCT01242202|Miglitol|miglitol|mesh-list
101413957|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
101413958|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101413959|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537629|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537630|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101537631|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101537632|NCT03452579|Growth Substances|growth substances|mesh-ancestor
101537633|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413960|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101413961|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413962|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101413963|NCT00119145|Artesunate|artesunate|mesh-list
101413964|NCT00119145|Amodiaquine|amodiaquine|mesh-list
101413965|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101413966|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
101537634|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
101413967|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101413968|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101413969|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101413970|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413971|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
101537635|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101413972|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
101413973|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101413974|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
101413975|NCT00119184|Anesthetics|anesthetics|mesh-list
101413976|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101413977|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413978|NCT00487123|Valsartan|valsartan|mesh-list
101413979|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101413980|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101413981|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101537636|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537637|NCT04997850|Lenvatinib|lenvatinib|mesh-list
101537638|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537639|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101413982|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101413983|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413984|NCT00487123|Diuretics|diuretics|mesh-ancestor
101413985|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
101413986|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101413987|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101413988|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101413990|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101413991|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101413992|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
101413993|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413994|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101413995|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101537641|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101413997|NCT00487786|Docetaxel|docetaxel|mesh-list
101413998|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101413999|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414000|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
101414001|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414002|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414003|NCT00488137|Prucalopride|prucalopride|mesh-list
101414004|NCT00488137|Laxatives|laxatives|mesh-ancestor
101414005|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101414006|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101414007|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101537642|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101537643|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101537644|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101414009|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414010|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414011|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414012|NCT00488176|Cetirizine|cetirizine|mesh-list
101414013|NCT00488176|Montelukast|montelukast|mesh-list
101414014|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101414015|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101414016|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101537645|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101537646|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101537647|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101537648|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101537649|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
101537650|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537651|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537653|NCT03456947|Pregabalin|pregabalin|mesh-list
101537654|NCT03456947|Analgesics|analgesics|mesh-ancestor
101537655|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
101537656|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537657|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537658|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
101537659|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101537660|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537661|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537662|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101414017|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
101414018|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414019|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414020|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101414021|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101414022|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414023|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101414024|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101414025|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101414026|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
101414027|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
101414028|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414029|NCT00488215|Prucalopride|prucalopride|mesh-list
101414030|NCT00488215|Laxatives|laxatives|mesh-ancestor
101414031|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101414032|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101414033|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101414034|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
101414035|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414036|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414037|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414038|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
101414039|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414040|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537665|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414041|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414042|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101414043|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
101414044|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414045|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
101414046|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414047|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414048|NCT00488566|Lamotrigine|lamotrigine|mesh-list
101414049|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
101414050|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101414051|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101414052|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414053|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101414054|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414055|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101414056|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101414057|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414058|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414059|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101414060|NCT00488722|Goserelin|goserelin|mesh-list
101537669|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537670|NCT04564638|Cyclosporine|cyclosporine|mesh-list
101537671|NCT04564638|Cyclosporins|cyclosporins|mesh-list
101414061|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101414062|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414063|NCT00488761|Tigecycline|tigecycline|mesh-list
101537673|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414064|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414065|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414066|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101414067|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414068|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414069|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
101414070|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101414071|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414072|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101414073|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
101414074|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414075|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414076|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414077|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414079|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101414080|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
101414081|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101414083|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101414084|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
101414085|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414086|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414087|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414088|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
101414089|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414090|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414091|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101414092|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
101414093|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414094|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
101414095|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414096|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537675|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
101414098|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414099|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
101414100|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
101414101|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414102|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414103|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414104|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414105|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414106|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414107|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101414108|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101414109|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101414110|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101414111|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414112|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414113|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414115|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
101414116|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414117|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
101414118|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414119|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
101414120|NCT00489151|Lamivudine|lamivudine|mesh-list
101414121|NCT00489151|Adefovir|adefovir|mesh-list
101414122|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101414123|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101414124|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101414125|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414126|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414127|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
101414128|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537686|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414129|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101414130|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101414132|NCT00145314|Folic Acid|folic acid|mesh-list
101414133|NCT00145314|Fluorouracil|fluorouracil|mesh-list
101414134|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
101537687|NCT04564326|Analgesics|analgesics|mesh-ancestor
101537688|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
101537689|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537690|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101417162|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
101537691|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101537692|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
101537693|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
101537694|NCT03453164|Nivolumab|nivolumab|mesh-list
101537695|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101537696|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537697|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101537698|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537700|NCT03450434|Glutarimide|glutarimide|mesh-list
101537701|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
101537702|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
101537703|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537704|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537705|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537706|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101537707|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537709|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
101537710|NCT00198029|Protective Agents|protective agents|mesh-ancestor
101537711|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537712|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101537713|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101537714|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
101537715|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537716|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537717|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101537718|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
101537719|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
101537720|NCT02215122|Hormones|hormones|mesh-ancestor
101537721|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537722|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
101537723|NCT00196976|Edetic Acid|edetic acid|mesh-list
101537724|NCT00196976|Vaccines|vaccines|mesh-list
101537725|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
101537731|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
101537732|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537733|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101537734|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
101537735|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101537736|NCT04563936|Goserelin|goserelin|mesh-list
101537737|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537738|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537739|NCT04563975|Paclitaxel|paclitaxel|mesh-list
101537740|NCT04563975|Docetaxel|docetaxel|mesh-list
101537741|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101537742|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537743|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537744|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
101537745|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537746|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537747|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
101537748|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101537749|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
101537750|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537751|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537752|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101537753|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101537754|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101414137|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
101414138|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414139|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414140|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414141|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414142|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
101414143|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414144|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101414145|NCT00145314|Antidotes|antidotes|mesh-ancestor
101414146|NCT00145314|Protective Agents|protective agents|mesh-ancestor
101537755|NCT00195650|Adalimumab|adalimumab|mesh-list
101537756|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101537757|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537758|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417167|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
101537759|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
101537760|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101537761|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537762|NCT04560894|Sorafenib|sorafenib|mesh-list
101537763|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537764|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101537765|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537766|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537767|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
101537768|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101537769|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101537770|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537772|NCT04560465|Coagulants|coagulants|mesh-ancestor
101537773|NCT00195494|Etanercept|etanercept|mesh-list
101537774|NCT00195494|Methotrexate|methotrexate|mesh-list
101537775|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101537776|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
101537777|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537778|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537779|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537780|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
101537781|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537782|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537783|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537784|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537785|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101537786|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537787|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
101537788|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537789|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101537790|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101537794|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537795|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537796|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537797|NCT00194987|Prednisone|prednisone|mesh-list
101537798|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
101537799|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101537800|NCT00194987|Antibodies|antibodies|mesh-list
101537801|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
101537802|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101537803|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414148|NCT00145314|Vitamins|vitamins|mesh-ancestor
101414149|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
101414150|NCT00145314|Hematinics|hematinics|mesh-ancestor
101414151|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
101414152|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414153|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414154|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
101414155|NCT00489229|Ramipril|ramipril|mesh-list
101537804|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
101537805|NCT00194987|Hormones|hormones|mesh-ancestor
101537806|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537807|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537808|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537809|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537810|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
101537811|NCT00194792|Paclitaxel|paclitaxel|mesh-list
101537812|NCT00194792|Vinorelbine|vinorelbine|mesh-list
101537813|NCT00194792|Capecitabine|capecitabine|mesh-list
101537814|NCT00194792|Methotrexate|methotrexate|mesh-list
101537815|NCT00194792|Exemestane|exemestane|mesh-list
101537816|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101537817|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101537818|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537819|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
101537820|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
101537821|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537822|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537823|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537824|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
101537825|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101537826|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
101537827|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101537828|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537829|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537830|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537831|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101537832|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537833|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
101537834|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537835|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101537836|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101537837|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101537838|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101537839|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537840|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537841|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
101537842|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101537843|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
101537844|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101537845|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101537846|NCT02486367|Clopidogrel|clopidogrel|mesh-list
101537847|NCT02486367|Ticagrelor|ticagrelor|mesh-list
101537848|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537849|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101537850|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101537851|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101537852|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
101537853|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537854|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537855|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537856|NCT00194675|Testosterone|testosterone|mesh-list
101537857|NCT00194675|Dutasteride|dutasteride|mesh-list
101537858|NCT00194675|Androgens|androgens|mesh-ancestor
101537859|NCT00194675|Hormones|hormones|mesh-ancestor
101414157|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414158|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101414159|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
101414160|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414161|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414162|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101414163|NCT00489385|Ribavirin|ribavirin|mesh-list
101414164|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
101414165|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414166|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
101414167|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414168|NCT01242631|Everolimus|everolimus|mesh-list
101414169|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101414170|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414171|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414172|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414173|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414174|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
101537860|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537861|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537878|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101537879|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101537880|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
101537881|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101537882|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101537883|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101537884|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101537885|NCT04563351|Anesthetics|anesthetics|mesh-list
101537886|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
101537887|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537888|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537889|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
101537890|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537891|NCT00192647|Ribavirin|ribavirin|mesh-list
101537892|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101537893|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
101537894|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
101537895|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537896|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
101537897|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537898|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537899|NCT04563429|Vitamin A|vitamin a|mesh-list
101537900|NCT04563429|Vitamins|vitamins|mesh-ancestor
101537901|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
101537902|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537903|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101537904|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101537905|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101537906|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537907|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414175|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414176|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414178|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
101414179|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414180|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414181|NCT01242904|Icodextrin|icodextrin|mesh-list
101414182|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
101414183|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101414184|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
101414185|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414186|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414187|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101414188|NCT00121979|Racivir|racivir|mesh-list
101414189|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101414190|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414191|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414192|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
101414193|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537908|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101537909|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537910|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537911|NCT00191984|Irinotecan|irinotecan|mesh-list
101537912|NCT00191984|Pemetrexed|pemetrexed|mesh-list
101537913|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101537914|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101537915|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537920|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
101537921|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101537922|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537923|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101537924|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101537925|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101537926|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537927|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537928|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
101537929|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537930|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537932|NCT00191789|Doxorubicin|doxorubicin|mesh-list
101537933|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537934|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537935|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
101537936|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537937|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101537938|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101537939|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101537940|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537941|NCT00191282|Insulin|insulin|mesh-list
101537942|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101537943|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
101537944|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
101537945|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
101414194|NCT00489658|Eflornithine|eflornithine|mesh-list
101414196|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414197|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101414198|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414199|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414200|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414201|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
101414202|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414203|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414204|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
101537946|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
101537947|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
101537948|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537949|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537950|NCT04560231|Remdesivir|remdesivir|mesh-list
101537951|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
101537952|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537953|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
101537954|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537955|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101537956|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101537957|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101537958|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537959|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537960|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101537961|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537962|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537963|NCT00198263|Bleomycin|bleomycin|mesh-list
101537964|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101537965|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537966|NCT00198107|Cycloserine|cycloserine|mesh-list
101537967|NCT00198107|Aripiprazole|aripiprazole|mesh-list
101537968|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
101537969|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101537970|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101537971|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101537972|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537973|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537974|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
101537975|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
101537976|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537977|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537978|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101537980|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
101537981|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101537982|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101537985|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101537986|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537987|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101537988|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
101537989|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101537992|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
101537993|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537994|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101537995|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101537996|NCT00179660|Growth Substances|growth substances|mesh-ancestor
101537997|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
101537998|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537999|NCT00178256|Paclitaxel|paclitaxel|mesh-list
101538000|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101414205|NCT00122018|Fenoldopam|fenoldopam|mesh-list
101414206|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101414207|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
101414208|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414209|NCT00122018|Expectorants|expectorants|mesh-ancestor
101414210|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
101414211|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101414212|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
101414213|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414214|NCT00122018|Protective Agents|protective agents|mesh-ancestor
101414215|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414216|NCT00122018|Antidotes|antidotes|mesh-ancestor
101414217|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101414218|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
101414219|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
101414220|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
101414221|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414222|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101538001|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538002|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538003|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538007|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538008|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538009|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538010|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538011|NCT00177164|Olanzapine|olanzapine|mesh-list
101538012|NCT00177164|Risperidone|risperidone|mesh-list
101538013|NCT00177164|Aripiprazole|aripiprazole|mesh-list
101538014|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101538015|NCT00177164|Ziprasidone|ziprasidone|mesh-list
101538016|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
101538017|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101538018|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
101538019|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538020|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538021|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538023|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538024|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101538025|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101538026|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
101538027|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
101538028|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
101538029|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538030|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538031|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101538032|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101538033|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538034|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
101538035|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
101538036|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101538037|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101538038|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101538039|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101538040|NCT04559841|Simvastatin|simvastatin|mesh-list
101414224|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101414225|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101414226|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538041|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101538042|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101538043|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
101538044|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538045|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101538046|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101538047|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538048|NCT02489942|Empagliflozin|empagliflozin|mesh-list
101538049|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101538050|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538051|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101538056|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538057|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538059|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101538060|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101538061|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101538062|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
101538063|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
101538064|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
101538065|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
101538066|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538067|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538068|NCT00176462|Leucovorin|leucovorin|mesh-list
101538069|NCT00176462|Cytarabine|cytarabine|mesh-list
101538070|NCT00176462|Dexamethasone|dexamethasone|mesh-list
101538071|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
101538072|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
101538073|NCT00176462|Methotrexate|methotrexate|mesh-list
101538074|NCT00176462|Vincristine|vincristine|mesh-list
101538075|NCT00176462|Asparaginase|asparaginase|mesh-list
101538076|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
101538077|NCT00176462|Thioguanine|thioguanine|mesh-list
101538078|NCT00176462|Daunorubicin|daunorubicin|mesh-list
101538079|NCT00176462|Aminopterin|aminopterin|mesh-list
101538080|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538081|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
101538082|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538083|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538084|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538085|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
101538086|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538087|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538088|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101538089|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538090|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
101538091|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
101538092|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538093|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538094|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
101538095|NCT00176462|Hormones|hormones|mesh-ancestor
101538096|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538097|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538098|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101538099|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
101538100|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101538101|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538102|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
101538103|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
101538104|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538105|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101414227|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414228|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414229|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414230|NCT00489775|Analgesics|analgesics|mesh-ancestor
101414231|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
101414232|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538106|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538107|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
101538108|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538109|NCT00176462|Antidotes|antidotes|mesh-ancestor
101538111|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
101538112|NCT00176462|Vitamins|vitamins|mesh-ancestor
101538113|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
101538114|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101538115|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538116|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538117|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538118|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101538119|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101538120|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101538121|NCT00175019|Allopurinol|allopurinol|mesh-list
101538122|NCT00175019|Febuxostat|febuxostat|mesh-list
101538123|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
101538124|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538125|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538126|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
101538127|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538128|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101538130|NCT00175019|Protective Agents|protective agents|mesh-ancestor
101538131|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538132|NCT00174941|Febuxostat|febuxostat|mesh-list
101538133|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
101538134|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538135|NCT00171704|Tamoxifen|tamoxifen|mesh-list
101538136|NCT00171704|Letrozole|letrozole|mesh-list
101538137|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538138|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101538139|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101538140|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538141|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538142|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101538143|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538144|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538145|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538146|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538147|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101538148|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101538149|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101538150|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
101538151|NCT00171314|Letrozole|letrozole|mesh-list
101538152|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538153|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101538154|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101538155|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414233|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
101414234|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414235|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
101414236|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101414237|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
101414238|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101538156|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538157|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101538158|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538159|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538160|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538161|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101538162|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
101538163|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538164|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538165|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538166|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538167|NCT00170846|Everolimus|everolimus|mesh-list
101538168|NCT00170846|Azathioprine|azathioprine|mesh-list
101538169|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101538170|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101538171|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538172|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538173|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538175|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
101538176|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538177|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538178|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
101538179|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538180|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538181|NCT00476606|Ritonavir|ritonavir|mesh-list
101538189|NCT00476606|Stavudine|stavudine|mesh-list
101538190|NCT00476606|Efavirenz|efavirenz|mesh-list
101538191|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101538192|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101538193|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
101538194|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538195|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538196|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101538197|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101538198|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
101538199|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538200|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101538201|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101538202|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101538203|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538204|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
101538205|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101538206|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101538207|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101538208|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101538209|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101538210|NCT04562103|Epinephrine|epinephrine|mesh-list
101538211|NCT04562103|Ropivacaine|ropivacaine|mesh-list
101538212|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
101538213|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
101538214|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538215|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538216|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
101538217|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538218|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101538219|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101538220|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
101538221|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414239|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101414240|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101414241|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414242|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101538222|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538223|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101538224|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101538226|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101538227|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
101538228|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
101538229|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
101538230|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101538231|NCT04561635|Micronutrients|micronutrients|mesh-list
101538232|NCT04561635|Trace Elements|trace elements|mesh-list
101538233|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538234|NCT00479882|Simvastatin|simvastatin|mesh-list
101538235|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101538236|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101538237|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
101538238|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538239|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101538240|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101538241|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538243|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101538244|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538245|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538246|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538247|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538248|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538249|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
101538250|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101538251|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
101538252|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538253|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
101538254|NCT00479687|Protective Agents|protective agents|mesh-ancestor
101538256|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101538257|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538258|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
101538259|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538260|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
101538261|NCT00478244|Busulfan|busulfan|mesh-list
101538262|NCT00478244|Fludarabine|fludarabine|mesh-list
101538263|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
101538264|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538265|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
101538266|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538267|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538268|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538269|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
101414243|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414245|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101414246|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414247|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101414248|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101414249|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101538270|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538271|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538272|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101538273|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538274|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
101538275|NCT00478205|Donepezil|donepezil|mesh-list
101538276|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101538277|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538278|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538279|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
101538280|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538281|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538283|NCT00477971|Dexamethasone|dexamethasone|mesh-list
101538284|NCT00477971|Melphalan|melphalan|mesh-list
101538285|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538286|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
101538287|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
101538288|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538289|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538290|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538291|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
101538292|NCT00477971|Hormones|hormones|mesh-ancestor
101538293|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538294|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538295|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538296|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
101538297|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538298|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
101538301|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538302|NCT00477464|Capecitabine|capecitabine|mesh-list
101538303|NCT00477464|Lapatinib|lapatinib|mesh-list
101538304|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538305|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
101538306|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538307|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538308|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538309|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538310|NCT00477386|Decitabine|decitabine|mesh-list
101538311|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538312|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
101538313|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538315|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538316|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
101538317|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538318|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538319|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538320|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538321|NCT00476996|Methotrexate|methotrexate|mesh-list
101538322|NCT00476996|Leflunomide|leflunomide|mesh-list
101538323|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
101538324|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101538325|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
101538326|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101538327|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538328|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101538329|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
101538330|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538331|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414250|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414252|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101414253|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
101414254|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101414255|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414256|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101538332|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
101538333|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538334|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101538335|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538336|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
101538337|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538338|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538339|NCT00476957|Sirolimus|sirolimus|mesh-list
101538340|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538341|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538342|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101538343|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538344|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
101538345|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538346|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
101538350|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
101538351|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101538352|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
101538353|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538354|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538355|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538356|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101538357|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101538358|NCT00475865|Analgesics|analgesics|mesh-ancestor
101538359|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
101538360|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538361|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538362|NCT00475670|Paclitaxel|paclitaxel|mesh-list
101538363|NCT00475670|Docetaxel|docetaxel|mesh-list
101538364|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101538365|NCT00475670|Trastuzumab|trastuzumab|mesh-list
101538366|NCT00475670|Taxane|taxane|mesh-list
101538367|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101538368|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538369|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538370|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538374|NCT04556760|Prednisolone|prednisolone|mesh-list
101538375|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538376|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
101538377|NCT04556760|Hormones|hormones|mesh-ancestor
101538378|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538379|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538380|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538381|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538382|NCT00474929|Everolimus|everolimus|mesh-list
101538383|NCT00474929|Sorafenib|sorafenib|mesh-list
101538384|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101538385|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538386|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538387|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538388|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538389|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
101538390|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538391|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538392|NCT00474812|Dasatinib|dasatinib|mesh-list
101538393|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414257|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101414259|NCT01243060|Zolpidem|zolpidem|mesh-list
101414260|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101414261|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101414262|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414263|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414264|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101414265|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
101414266|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
101414267|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538394|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538395|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538396|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538397|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
101538398|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
101538399|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538400|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101538401|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538403|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538404|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538405|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538406|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101538408|NCT00472199|Pramipexole|pramipexole|mesh-list
101538409|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
101538410|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538411|NCT00472199|Protective Agents|protective agents|mesh-ancestor
101538412|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538413|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101538414|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101538415|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
101538416|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
101538417|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538418|NCT04556136|Vitamin D|vitamin d|mesh-list
101538419|NCT04556136|Vitamins|vitamins|mesh-ancestor
101538420|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
101538421|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538422|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101538423|NCT00471887|Tremelimumab|tremelimumab|mesh-list
101538424|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538425|NCT04556058|Perindopril|perindopril|mesh-list
101538426|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101538427|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
101538428|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538429|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538430|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101538431|NCT00470834|Bicalutamide|bicalutamide|mesh-list
101538432|NCT00470834|Dutasteride|dutasteride|mesh-list
101538433|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
101538434|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538435|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538436|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538437|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538438|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101538441|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538442|NCT00470366|Paclitaxel|paclitaxel|mesh-list
101538443|NCT00470366|Ifosfamide|ifosfamide|mesh-list
101538444|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101538445|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414268|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414269|NCT00490204|Cetirizine|cetirizine|mesh-list
101414270|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101414271|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101538446|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538447|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538448|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538449|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538450|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538451|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
101538452|NCT02212431|Cysteamine|cysteamine|mesh-list
101538453|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
101538454|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538455|NCT00470093|Interferons|interferons|mesh-list
101538456|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538457|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
101538458|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538460|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538462|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538463|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538464|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101538465|NCT00478595|Rimonabant|rimonabant|mesh-list
101538466|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101538467|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101538468|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101538469|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538470|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538471|NCT00478595|Hormones|hormones|mesh-ancestor
101538472|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538473|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538474|NCT04555707|Betamethasone|betamethasone|mesh-list
101538475|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
101538476|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101538477|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
101538478|NCT04555707|Apremilast|apremilast|mesh-list
101538479|NCT04555707|Calcipotriene|calcipotriene|mesh-list
101538480|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101538481|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538482|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
101538483|NCT04555707|Hormones|hormones|mesh-ancestor
101538484|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538485|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538486|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101538487|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
101538488|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101538489|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101538490|NCT04555707|Analgesics|analgesics|mesh-ancestor
101538491|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
101538492|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538493|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538494|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101538495|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101538496|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538497|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538498|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
101538499|NCT00474188|Dexamethasone|dexamethasone|mesh-list
101538500|NCT00474188|Lenalidomide|lenalidomide|mesh-list
101538501|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538502|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
101538503|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
101538504|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538505|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414272|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101414273|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
101414274|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
101414275|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414276|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538506|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538507|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
101538513|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101538514|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101538515|NCT00474188|Growth Substances|growth substances|mesh-ancestor
101538516|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
101538517|NCT01089647|Budesonide|budesonide|mesh-list
101538518|NCT01089647|Montelukast|montelukast|mesh-list
101538519|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538520|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101538521|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
101538522|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538523|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538524|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101538525|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
101538526|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
101538527|NCT01089647|Hormones|hormones|mesh-ancestor
101538528|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538529|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101538530|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538531|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101538532|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101538533|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538534|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
101538535|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101538536|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101538537|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101538538|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538539|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538540|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
101538541|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538542|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538543|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101538544|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538545|NCT01089608|Azithromycin|azithromycin|mesh-list
101538546|NCT01089608|Povidone|povidone|mesh-list
101538547|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538548|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538549|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
101538550|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
101538551|NCT04554654|Progesterone|progesterone|mesh-list
101538552|NCT04554654|Progestins|progestins|mesh-ancestor
101538553|NCT04554654|Hormones|hormones|mesh-ancestor
101538554|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538555|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538556|NCT04554615|Insulin|insulin|mesh-list
101538557|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101538558|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538559|NCT01089413|Bevacizumab|bevacizumab|mesh-list
101538560|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101538561|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538562|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101538563|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101538564|NCT01089413|Growth Substances|growth substances|mesh-ancestor
101538565|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538566|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
101538567|NCT02212782|Linagliptin|linagliptin|mesh-list
101538568|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101538569|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538570|NCT02212782|Incretins|incretins|mesh-ancestor
101538571|NCT02212782|Hormones|hormones|mesh-ancestor
101414277|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414278|NCT00122096|Valdecoxib|valdecoxib|mesh-list
101414279|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101414280|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101414281|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414282|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414283|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101414284|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101414285|NCT00122096|Analgesics|analgesics|mesh-ancestor
101414286|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
101414287|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414288|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414289|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538572|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538573|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101538580|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538582|NCT02212821|Erythromycin|erythromycin|mesh-list
101538583|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
101538584|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101538585|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
101538586|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538587|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538588|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538589|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101538590|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538591|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538592|NCT01088243|Mesalamine|mesalamine|mesh-list
101538593|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101538594|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101538595|NCT01088243|Analgesics|analgesics|mesh-ancestor
101538596|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
101538597|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538598|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538599|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538600|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538601|NCT04672499|Cortisone|cortisone|mesh-list
101538602|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538603|NCT04554303|Amlodipine|amlodipine|mesh-list
101538604|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101538605|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101538606|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538607|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538608|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101538609|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538610|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
101538611|NCT01088048|Rituximab|rituximab|mesh-list
101538612|NCT01088048|Fludarabine|fludarabine|mesh-list
101538613|NCT01088048|Lenalidomide|lenalidomide|mesh-list
101538614|NCT01088048|Everolimus|everolimus|mesh-list
101538615|NCT01088048|Bortezomib|bortezomib|mesh-list
101538616|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101538617|NCT01088048|Ofatumumab|ofatumumab|mesh-list
101538618|NCT01088048|Idelalisib|idelalisib|mesh-list
101538619|NCT01088048|Chlorambucil|chlorambucil|mesh-list
101538620|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101538621|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538622|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
101538623|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538624|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414290|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414291|NCT00490243|Budesonide|budesonide|mesh-list
101414292|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
101414293|NCT00490243|Montelukast|montelukast|mesh-list
101414294|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414295|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101414296|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
101538625|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538626|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538627|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101538628|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101538629|NCT01088048|Growth Substances|growth substances|mesh-ancestor
101538630|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
101538631|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101538632|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101538633|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538634|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538635|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
101538636|NCT01087970|Carboplatin|carboplatin|mesh-list
101538638|NCT01087970|Cetuximab|cetuximab|mesh-list
101538639|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538640|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538646|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101538647|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538649|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538650|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
101538651|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538652|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101538653|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101538654|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101538655|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101538656|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101538657|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101538658|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
101538659|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
101538660|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538661|NCT01087502|Glimepiride|glimepiride|mesh-list
101538662|NCT01087502|Linagliptin|linagliptin|mesh-list
101538663|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101538664|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101538665|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538666|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101538667|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
101538668|NCT01087502|Incretins|incretins|mesh-ancestor
101538669|NCT01087502|Hormones|hormones|mesh-ancestor
101538670|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538671|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101538672|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101538673|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538674|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538675|NCT02213211|Lumefantrine|lumefantrine|mesh-list
101538676|NCT02213211|Artemether|artemether|mesh-list
101538677|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101538678|NCT02213211|Artemisinins|artemisinins|mesh-list
101538679|NCT02213211|Artemisinin|artemisinin|mesh-list
101538680|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
101538681|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101538682|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101538683|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538684|NCT01086410|Fluticasone|fluticasone|mesh-list
101538685|NCT01086410|Xhance|xhance|mesh-list
101538686|NCT01086410|Prednisolone|prednisolone|mesh-list
101538687|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414297|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414298|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414299|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101414300|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
101414301|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
101414303|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414304|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101414305|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101414306|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101414307|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
101414308|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414309|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414310|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101538688|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101538689|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
101538690|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538691|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538692|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101538693|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
101538694|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
101538695|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101538696|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
101538697|NCT01086410|Hormones|hormones|mesh-ancestor
101538698|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538699|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538700|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538701|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101538702|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101538703|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538704|NCT04553328|Bupivacaine|bupivacaine|mesh-list
101538708|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538709|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
101538710|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538711|NCT01085591|Vancomycin|vancomycin|mesh-list
101538712|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538713|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538714|NCT04552977|Temozolomide|temozolomide|mesh-list
101538715|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538716|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
101538717|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538718|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538719|NCT01085201|Regadenoson|regadenoson|mesh-list
101538720|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101538721|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101538722|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
101538723|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
101538724|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538725|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538726|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538727|NCT02213718|Sufentanil|sufentanil|mesh-list
101538728|NCT02213718|Propofol|propofol|mesh-list
101538729|NCT02213718|Desflurane|desflurane|mesh-list
101538730|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101538731|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538732|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414311|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
101414312|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101414313|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101414314|NCT00490360|Gemcitabine|gemcitabine|mesh-list
101414315|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414316|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414317|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
101414318|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414319|NCT00490399|Gemcitabine|gemcitabine|mesh-list
101414320|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414321|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414322|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
101538733|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101538734|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
101538735|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
101538736|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101538737|NCT02213718|Narcotics|narcotics|mesh-ancestor
101538738|NCT02213718|Analgesics|analgesics|mesh-ancestor
101538739|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
101538740|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538741|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101538742|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101538744|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
101538745|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
101538746|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101538747|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
101538748|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538749|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538750|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101538751|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
101538752|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101538753|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101538754|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101538755|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
101538756|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538757|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538758|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
101538759|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101538760|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
101538761|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
101538762|NCT02213796|Meropenem|meropenem|mesh-list
101538763|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538764|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538765|NCT00179673|Lenalidomide|lenalidomide|mesh-list
101538766|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
101538767|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538768|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101538769|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101538777|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538778|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538779|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538780|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538781|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
101538782|NCT01084655|Hormones|hormones|mesh-ancestor
101414323|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414324|NCT04844385|Paclitaxel|paclitaxel|mesh-list
101414325|NCT04844385|Capecitabine|capecitabine|mesh-list
101414326|NCT04844385|Nedaplatin|nedaplatin|mesh-list
101538783|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538784|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538785|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538786|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
101538787|NCT04552431|Tamsulosin|tamsulosin|mesh-list
101538788|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538789|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538790|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101538791|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101538792|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538793|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538794|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538795|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101538796|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101538797|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101538798|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101538799|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101538800|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101538801|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538802|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538803|NCT04552431|Urological Agents|urological agents|mesh-ancestor
101538804|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
101538805|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101538806|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538807|NCT01084538|Vitamins|vitamins|mesh-ancestor
101538808|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
101538809|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101538810|NCT00179517|Anastrozole|anastrozole|mesh-list
101538811|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538812|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538813|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101538814|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101538815|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538816|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538817|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101538818|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
101538819|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538820|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538821|NCT01083641|Estradiol|estradiol|mesh-list
101538822|NCT01083641|Estrogens|estrogens|mesh-ancestor
101538823|NCT01083641|Hormones|hormones|mesh-ancestor
101538824|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538825|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538826|NCT00179010|Adenosine|adenosine|mesh-list
101538827|NCT00179010|Analgesics|analgesics|mesh-ancestor
101538828|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
101538829|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538830|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538833|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101538840|NCT01083602|Panobinostat|panobinostat|mesh-list
101538841|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538842|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
101538843|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
101538844|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538845|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538846|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538847|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
101538848|NCT01083602|Hormones|hormones|mesh-ancestor
101414327|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101414328|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414329|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414330|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
101414331|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414332|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414333|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414334|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
101414335|NCT00490633|Ethanol|ethanol|mesh-list
101414336|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
101414337|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101414338|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414339|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414340|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414341|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
101414342|NCT00490711|Paclitaxel|paclitaxel|mesh-list
101414343|NCT00490711|Carboplatin|carboplatin|mesh-list
101414344|NCT00490711|Gemcitabine|gemcitabine|mesh-list
101414345|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101414346|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414347|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414348|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
101414349|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414350|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414351|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414352|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
101414353|NCT00122291|Capecitabine|capecitabine|mesh-list
101414354|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414355|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
101414356|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538849|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538850|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538851|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538852|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101538853|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538854|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538855|NCT00178464|Aspirin|aspirin|mesh-list
101538856|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101538857|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101538858|NCT00178464|Analgesics|analgesics|mesh-ancestor
101538859|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
101414357|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414358|NCT00490789|Sirolimus|sirolimus|mesh-list
101414359|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414360|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414361|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101538860|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538861|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538862|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101538863|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101538864|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101538865|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101538866|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538867|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101538868|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101538869|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538870|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
101538871|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
101538872|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101538873|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
101538874|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538875|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
101538876|NCT04671914|Protective Agents|protective agents|mesh-ancestor
101538877|NCT01083485|Oxycodone|oxycodone|mesh-list
101538878|NCT01083485|Naloxone|naloxone|mesh-list
101538879|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101538880|NCT01083485|Narcotics|narcotics|mesh-ancestor
101538881|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538882|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538883|NCT01083485|Analgesics|analgesics|mesh-ancestor
101538884|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
101538885|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538886|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101538887|NCT04551924|Ropivacaine|ropivacaine|mesh-list
101538888|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
101538889|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
101538890|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538891|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538892|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
101538893|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538895|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
101538896|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
101538897|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
101538898|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538899|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538900|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101538903|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101538904|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101538905|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101538906|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
101538907|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
101538908|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538909|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538910|NCT00556088|Paclitaxel|paclitaxel|mesh-list
101538911|NCT00556088|Bevacizumab|bevacizumab|mesh-list
101538912|NCT00556088|Carboplatin|carboplatin|mesh-list
101538913|NCT00556088|Panobinostat|panobinostat|mesh-list
101538914|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101538915|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538916|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538917|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101538918|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538919|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538920|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101538921|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101538922|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101414362|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414364|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414365|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
101414366|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414368|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101414369|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101414370|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101414371|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414372|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
101414373|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
101414374|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414375|NCT00490867|Protective Agents|protective agents|mesh-ancestor
101414376|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414377|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
101414378|NCT00490867|Vitamins|vitamins|mesh-ancestor
101414379|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
101414380|NCT00122330|Eculizumab|eculizumab|mesh-list
101538923|NCT00556088|Growth Substances|growth substances|mesh-ancestor
101538924|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538925|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101538926|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101538927|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538928|NCT00177294|Escitalopram|escitalopram|mesh-list
101538929|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101538930|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101538931|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538932|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538933|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538934|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
101538935|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538936|NCT01082081|Acetaminophen|acetaminophen|mesh-list
101538937|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101538938|NCT01082081|Analgesics|analgesics|mesh-ancestor
101538939|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
101538940|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101538941|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538942|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
101538943|NCT00177216|Zolpidem|zolpidem|mesh-list
101538944|NCT00177216|Escitalopram|escitalopram|mesh-list
101538945|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101538946|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101538947|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101538948|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538949|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538950|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
101538951|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538952|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101538953|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101538954|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414382|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414383|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
101414384|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414385|NCT00490906|Interferons|interferons|mesh-list
101414386|NCT00490906|Interferon-beta|interferon-beta|mesh-list
101414387|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
101414388|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
101414389|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
101414390|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
101414391|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414392|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
101414393|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414394|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
101538955|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101538956|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
101538957|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
101538958|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101538959|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
101538960|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101538961|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538962|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538963|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101538964|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101538965|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101538966|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
101538969|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101538970|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101538971|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
101538972|NCT04551768|Ribavirin|ribavirin|mesh-list
101538973|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
101538974|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538975|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
101538976|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538978|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
101538979|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538980|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101538981|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538982|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538983|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538984|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101538985|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101538986|NCT04551573|Rifapentine|rifapentine|mesh-list
101538987|NCT04551573|Rifampin|rifampin|mesh-list
101538988|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101538989|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
101538990|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101538991|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101538992|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
101538993|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538994|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538995|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538996|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101538997|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101538998|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101538999|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101414395|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414396|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101414397|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414398|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414400|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
101414401|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414402|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101414403|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101414404|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414405|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414406|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101414407|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101539000|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101539001|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101539002|NCT01081145|Guanfacine|guanfacine|mesh-list
101539003|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101539004|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101539005|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101539006|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101539007|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101539008|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417201|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101539009|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539010|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539011|NCT00174915|Allopurinol|allopurinol|mesh-list
101539012|NCT00174915|Febuxostat|febuxostat|mesh-list
101539015|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539016|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
101539017|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539018|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101539019|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
101539020|NCT00174915|Protective Agents|protective agents|mesh-ancestor
101539021|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539023|NCT01080716|Complement Factor H|complement factor h|mesh-list
101539024|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
101539025|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539026|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101539027|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539028|NCT04671446|Autoantibodies|autoantibodies|mesh-list
101539029|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
101539030|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539031|NCT04571489|Gemcitabine|gemcitabine|mesh-list
101539033|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539034|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
101539035|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539036|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539042|NCT00171951|Pasireotide|pasireotide|mesh-list
101539044|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539045|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539046|NCT01080131|Triamcinolone|triamcinolone|mesh-list
101539047|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101539048|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101539049|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101539050|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101414408|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
101414409|NCT00491413|Hematinics|hematinics|mesh-ancestor
101414410|NCT00145665|Telbivudine|telbivudine|mesh-list
101414411|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
101414412|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414413|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101414414|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414415|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414416|NCT00491725|Metformin|metformin|mesh-list
101539051|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539052|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
101539053|NCT01080131|Hormones|hormones|mesh-ancestor
101539054|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539055|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539056|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539057|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
101539058|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539059|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539060|NCT00171873|Octreotide|octreotide|mesh-list
101539061|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539062|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539063|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539064|NCT01087151|Rituximab|rituximab|mesh-list
101539066|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539067|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539068|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
101539069|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539070|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539071|NCT00171834|Epothilones|epothilones|mesh-list
101539072|NCT00171834|Epothilone B|epothilone b|mesh-list
101539073|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
101539074|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
101539075|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
101539076|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539077|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539078|NCT04571996|Acetaminophen|acetaminophen|mesh-list
101539079|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539080|NCT04571996|Analgesics|analgesics|mesh-ancestor
101539081|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
101539082|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539083|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539084|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
101539085|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
101539086|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539087|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539088|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539089|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539090|NCT04671056|Pioglitazone|pioglitazone|mesh-list
101539091|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539092|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539093|NCT01082549|Carboplatin|carboplatin|mesh-list
101539094|NCT01082549|Gemcitabine|gemcitabine|mesh-list
101539095|NCT01082549|Iniparib|iniparib|mesh-list
101539096|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539097|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539098|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
101539099|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539100|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101539101|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539106|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539107|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414417|NCT00491725|Repaglinide|repaglinide|mesh-list
101414418|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414419|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414420|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
101414421|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
101414422|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101539108|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539109|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101539110|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101539111|NCT00171210|Deferasirox|deferasirox|mesh-list
101539112|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101539113|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
101539114|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
101539115|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539116|NCT00171054|Amlodipine|amlodipine|mesh-list
101539117|NCT00171054|Valsartan|valsartan|mesh-list
101539118|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101539119|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101539120|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101539121|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539122|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539123|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101539124|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539125|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539126|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101539127|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101539128|NCT00171054|Diuretics|diuretics|mesh-ancestor
101539129|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539130|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101539131|NCT00174837|Tirapazamine|tirapazamine|mesh-list
101539132|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539133|NCT00179400|Pioglitazone|pioglitazone|mesh-list
101539134|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539135|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539136|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
101539137|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101539138|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539139|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539140|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
101539141|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539142|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539143|NCT00479856|Paclitaxel|paclitaxel|mesh-list
101539144|NCT00479856|Docetaxel|docetaxel|mesh-list
101539145|NCT00479856|Capecitabine|capecitabine|mesh-list
101539146|NCT00479856|Lapatinib|lapatinib|mesh-list
101539147|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101539148|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539149|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
101539150|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
101539151|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
101539152|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539153|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539154|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
101539155|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539156|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539157|NCT04997759|Neostigmine|neostigmine|mesh-list
101539158|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101539159|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539160|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539161|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
101539162|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539163|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539164|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101539165|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
101414423|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101414424|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414425|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414426|NCT00491803|Urological Agents|urological agents|mesh-ancestor
101414427|NCT00122603|Saquinavir|saquinavir|mesh-list
101414428|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
101539166|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539167|NCT00479466|Metformin|metformin|mesh-list
101539168|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539169|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539170|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
101539175|NCT04990778|Venetoclax|venetoclax|mesh-list
101539176|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539177|NCT00479388|Niacin|niacin|mesh-list
101539178|NCT00479388|Atorvastatin|atorvastatin|mesh-list
101539179|NCT00479388|Simvastatin|simvastatin|mesh-list
101539180|NCT00479388|Calcium|calcium|mesh-list
101539181|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101539182|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539183|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101539184|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101539185|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
101539186|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539187|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101539188|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101539189|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539190|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539191|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
101539192|NCT00479388|Vitamins|vitamins|mesh-ancestor
101539193|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
101539194|NCT00479232|Decitabine|decitabine|mesh-list
101539195|NCT00479232|Vorinostat|vorinostat|mesh-list
101539196|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539198|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539199|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539200|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539201|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101539202|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101539203|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539204|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101539205|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101539206|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539207|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539208|NCT00478881|Urological Agents|urological agents|mesh-ancestor
101539210|NCT00556127|Dexamethasone|dexamethasone|mesh-list
101539211|NCT00556127|Prednisone|prednisone|mesh-list
101539212|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
101539213|NCT00556127|Melphalan|melphalan|mesh-list
101539214|NCT00556127|Carmustine|carmustine|mesh-list
101539215|NCT00556127|Rituximab|rituximab|mesh-list
101539216|NCT00556127|Etoposide|etoposide|mesh-list
101539217|NCT00556127|Vincristine|vincristine|mesh-list
101539218|NCT00556127|Epirubicin|epirubicin|mesh-list
101539219|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
101539220|NCT00556127|Lenograstim|lenograstim|mesh-list
101539221|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539222|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
101539223|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539224|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539225|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101539226|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
101539227|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539228|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539229|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101539230|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539231|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539233|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
101539234|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414429|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101414430|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101414431|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
101414432|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414433|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414434|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101414435|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101414436|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
101414437|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539235|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539236|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
101539238|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539239|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539240|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101539254|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101539255|NCT00556205|Bevacizumab|bevacizumab|mesh-list
101539257|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539258|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539259|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101539260|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101539261|NCT00556205|Growth Substances|growth substances|mesh-ancestor
101539262|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539263|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
101539264|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539265|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539267|NCT00478608|Sirolimus|sirolimus|mesh-list
101539268|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101539269|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539270|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101539271|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539272|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
101539273|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539274|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
101539275|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539276|NCT00478140|Trastuzumab|trastuzumab|mesh-list
101539277|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539278|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539279|NCT00478023|Morphine|morphine|mesh-list
101539280|NCT00478023|Tapentadol|tapentadol|mesh-list
101539281|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101539282|NCT00478023|Narcotics|narcotics|mesh-ancestor
101539283|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539284|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539285|NCT00478023|Analgesics|analgesics|mesh-ancestor
101539286|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
101539287|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539288|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101539289|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101539290|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539291|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539292|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
101539293|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539294|NCT00477750|Prednisone|prednisone|mesh-list
101539295|NCT00477750|Lenalidomide|lenalidomide|mesh-list
101539296|NCT00477750|Melphalan|melphalan|mesh-list
101539297|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539298|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
101539299|NCT00477750|Hormones|hormones|mesh-ancestor
101539300|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539301|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539302|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539303|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414438|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101414439|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101414440|NCT00491920|Vitamin D|vitamin d|mesh-list
101414441|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
101414442|NCT00491920|Vitamins|vitamins|mesh-ancestor
101414443|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
101414444|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539307|NCT00477750|Growth Substances|growth substances|mesh-ancestor
101539308|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
101539309|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101539310|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
101539311|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539312|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101539313|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539315|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101539316|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101539317|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101539318|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101539319|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539320|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539321|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101539322|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101539323|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101539324|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
101539325|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539326|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539327|NCT04549935|Prednisolone|prednisolone|mesh-list
101539328|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539330|NCT04549935|Hormones|hormones|mesh-ancestor
101539331|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539332|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539333|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539334|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539335|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101539336|NCT00477633|Norethindrone|norethindrone|mesh-list
101539337|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
101539338|NCT00477633|Estradiol|estradiol|mesh-list
101539339|NCT00477633|Estrogens|estrogens|mesh-ancestor
101539340|NCT00477633|Hormones|hormones|mesh-ancestor
101539341|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539342|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539343|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101539344|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
101539345|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101539346|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101539347|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101539348|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101539349|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101539350|NCT04541823|Propofol|propofol|mesh-list
101539351|NCT04541823|Desflurane|desflurane|mesh-list
101539352|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101539353|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539354|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539355|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101539356|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
101539357|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
101539358|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101539359|NCT00556361|Ketamine|ketamine|mesh-list
101539360|NCT00556361|Analgesics|analgesics|mesh-ancestor
101539361|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
101539362|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539363|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539364|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101539365|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101539366|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
101539367|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
101414445|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414446|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101414448|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101414449|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101414450|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101414451|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539368|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539369|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101539370|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101539371|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539372|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539378|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
101539379|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539380|NCT02210117|Bevacizumab|bevacizumab|mesh-list
101539381|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101539382|NCT02210117|Nivolumab|nivolumab|mesh-list
101539383|NCT02210117|Ipilimumab|ipilimumab|mesh-list
101539384|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
101539385|NCT02210117|Antibodies|antibodies|mesh-list
101539386|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
101539387|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101539388|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
101539389|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539390|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101539391|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101539392|NCT02210117|Growth Substances|growth substances|mesh-ancestor
101539393|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539394|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
101539395|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
101539396|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101539397|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539398|NCT04541277|Cytarabine|cytarabine|mesh-list
101539399|NCT04541277|Azacitidine|azacitidine|mesh-list
101539400|NCT04541277|Decitabine|decitabine|mesh-list
101539401|NCT04541277|Tislelizumab|tislelizumab|mesh-list
101539402|NCT04541277|Idarubicin|idarubicin|mesh-list
101539403|NCT04541277|Lenograstim|lenograstim|mesh-list
101539404|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539405|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
101539406|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539407|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539408|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
101539409|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539410|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539411|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
101539412|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539413|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539414|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539415|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101539416|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101539417|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101539418|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101539419|NCT04540926|Cyclosporine|cyclosporine|mesh-list
101539420|NCT04540926|Cyclosporins|cyclosporins|mesh-list
101539421|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539422|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539423|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539424|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
101539425|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539426|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
101414453|NCT00492037|Conivaptan|conivaptan|mesh-list
101414454|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101414455|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414456|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
101414457|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414458|NCT00402272|Everolimus|everolimus|mesh-list
101414459|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101414460|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414461|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414462|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414463|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414464|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
101414465|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414466|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414467|NCT00492388|Ketamine|ketamine|mesh-list
101414468|NCT00492388|Analgesics|analgesics|mesh-ancestor
101539427|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539428|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
101539429|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539430|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101539431|NCT04540965|Famotidine|famotidine|mesh-list
101539432|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101539433|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539434|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101539435|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
101539436|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
101539437|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539438|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539439|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539448|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539449|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
101539450|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
101539451|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539452|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539453|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539454|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
101539455|NCT04570592|Hormones|hormones|mesh-ancestor
101539456|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539457|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539458|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539459|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101539460|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101539461|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
101539462|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539463|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539464|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101539465|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
101539466|NCT02215395|Estradiol|estradiol|mesh-list
101539467|NCT02215395|Estrogens|estrogens|mesh-ancestor
101539468|NCT02215395|Hormones|hormones|mesh-ancestor
101539469|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539470|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414470|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414471|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414472|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101414473|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101414474|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
101414475|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
101414476|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414477|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101414478|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101414479|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539471|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101539472|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101539473|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101539474|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101539475|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101539476|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
101539477|NCT02215434|Testosterone|testosterone|mesh-list
101539478|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
101539479|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
101539480|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101539481|NCT02215434|Androgens|androgens|mesh-ancestor
101539482|NCT02215434|Hormones|hormones|mesh-ancestor
101539483|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539484|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539485|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539486|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539487|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
101539488|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
101539489|NCT04561076|Paraproteins|paraproteins|mesh-list
101539490|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
101539491|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539492|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
101539493|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101539494|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101539495|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539496|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
101539497|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
101539498|NCT04548219|Mirikizumab|mirikizumab|mesh-list
101539499|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101539500|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539501|NCT04548219|Analgesics|analgesics|mesh-ancestor
101539502|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
101539503|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539504|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539505|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539506|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539507|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101539508|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539509|NCT04547829|Lenograstim|lenograstim|mesh-list
101539510|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101539511|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
101539512|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539514|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
101539515|NCT02211911|Cathartics|cathartics|mesh-ancestor
101539516|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539517|NCT02211911|Laxatives|laxatives|mesh-ancestor
101539518|NCT01131676|Empagliflozin|empagliflozin|mesh-list
101539519|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101539520|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539521|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539522|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539523|NCT04560569|Antibodies|antibodies|mesh-list
101539524|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
101414480|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414481|NCT01243528|Vitamin D|vitamin d|mesh-list
101414482|NCT01243528|Vitamins|vitamins|mesh-ancestor
101414483|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
101414484|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539525|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539526|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
101539527|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101539528|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101539529|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101539530|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539531|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539532|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
101539533|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539534|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539535|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101539536|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539537|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101539539|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101539540|NCT02214498|Diuretics|diuretics|mesh-ancestor
101539541|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539542|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539543|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101539544|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539545|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539546|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101539547|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
101539548|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539549|NCT04560218|Misoprostol|misoprostol|mesh-list
101539550|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101539551|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
101539552|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101539553|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539554|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101539555|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539556|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
101539557|NCT05135104|Palbociclib|palbociclib|mesh-list
101539558|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539559|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539560|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539561|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539562|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
101539563|NCT04540185|Vaccines|vaccines|mesh-list
101539564|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
101539565|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539566|NCT04540185|Protective Agents|protective agents|mesh-ancestor
101539567|NCT01130272|Eluxadoline|eluxadoline|mesh-list
101539568|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539569|NCT04546815|Daptomycin|daptomycin|mesh-list
101539570|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101539571|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539572|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101539573|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
101539574|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101539575|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101539582|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539583|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101539584|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
101539586|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
101539587|NCT04559165|Coagulants|coagulants|mesh-ancestor
101539588|NCT04312048|Isosorbide|isosorbide|mesh-list
101414485|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414487|NCT00492427|Hematinics|hematinics|mesh-ancestor
101414488|NCT00492466|Interferons|interferons|mesh-list
101414489|NCT00492466|Interferon-beta|interferon-beta|mesh-list
101414490|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
101414491|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
101414492|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414493|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
101414494|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414495|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414496|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
101414497|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
101414498|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414499|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414500|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101414501|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
101414502|NCT00492466|Hormones|hormones|mesh-ancestor
101414503|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414504|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101414505|NCT00492466|Protective Agents|protective agents|mesh-ancestor
101414506|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
101414507|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101414508|NCT00492505|Tamoxifen|tamoxifen|mesh-list
101414509|NCT00492505|Sorafenib|sorafenib|mesh-list
101414510|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414511|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414512|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414513|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414514|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101539589|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101539590|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101539591|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101539592|NCT04312048|Diuretics|diuretics|mesh-ancestor
101539593|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539594|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539595|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539596|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101539597|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539598|NCT04311697|Phentolamine|phentolamine|mesh-list
101539599|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101539600|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101539601|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101414515|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
101414516|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414517|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414518|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101414519|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101414520|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101414521|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414522|NCT00492661|Tacrolimus|tacrolimus|mesh-list
101414523|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539602|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
101539603|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539604|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539605|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539606|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101539607|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539608|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539609|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101539610|NCT04311697|Protective Agents|protective agents|mesh-ancestor
101539611|NCT00575861|Zileuton|zileuton|mesh-list
101539612|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101539613|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539614|NCT00575861|Analgesics|analgesics|mesh-ancestor
101539615|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
101539616|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539617|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539618|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539619|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539620|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101539621|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539622|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539623|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101539624|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101539625|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539626|NCT04547088|Apatinib|apatinib|mesh-list
101539627|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539628|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539629|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539630|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539631|NCT01129882|Aripiprazole|aripiprazole|mesh-list
101539632|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
101539633|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101539634|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101539648|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101539649|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
101539650|NCT02278419|Simeprevir|simeprevir|mesh-list
101539651|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
101539652|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539653|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
101539654|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539655|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539656|NCT02882737|Glucagon|glucagon|mesh-list
101539657|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101539658|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539659|NCT02882737|Hormones|hormones|mesh-ancestor
101539660|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539661|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539662|NCT02882737|Incretins|incretins|mesh-ancestor
101539663|NCT02211950|Acarbose|acarbose|mesh-list
101539664|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101539665|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539666|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414524|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
101414525|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414526|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101414527|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414528|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414530|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414531|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539667|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539668|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539669|NCT04559048|Tacrolimus|tacrolimus|mesh-list
101539670|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101539671|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
101539672|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539673|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101539674|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539675|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539677|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
101539678|NCT04538820|BB 1101|bb 1101|mesh-list
101539679|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539680|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
101539681|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
101539682|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539683|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539684|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539685|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
101539686|NCT04538820|Hormones|hormones|mesh-ancestor
101539687|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539688|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539689|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539690|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
101539691|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539692|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539719|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
101539720|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
101539721|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101539722|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539723|NCT04558580|Rufinamide|rufinamide|mesh-list
101539724|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
101539725|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101539726|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101539727|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539728|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539729|NCT02278458|Gemcitabine|gemcitabine|mesh-list
101539730|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539731|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
101539732|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539733|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539734|NCT01128595|Fluticasone|fluticasone|mesh-list
101539736|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539737|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101539738|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
101539739|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539743|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101539744|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101539745|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
101539746|NCT01129336|Diphosphonates|diphosphonates|mesh-list
101539747|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101539748|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539749|NCT01128244|Pyridoxine|pyridoxine|mesh-list
101539750|NCT01128244|Pyridoxal|pyridoxal|mesh-list
101539751|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
101539752|NCT01128244|Vitamins|vitamins|mesh-ancestor
101539753|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
101414532|NCT00402350|Fentanyl|fentanyl|mesh-list
101414533|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101414534|NCT00402350|Narcotics|narcotics|mesh-ancestor
101414535|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414536|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414537|NCT00402350|Analgesics|analgesics|mesh-ancestor
101414538|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
101414539|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414540|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101414541|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101414542|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
101539754|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539755|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
101539756|NCT01127893|Tanezumab|tanezumab|mesh-list
101539757|NCT01127893|Analgesics|analgesics|mesh-ancestor
101539758|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
101539759|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539760|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539761|NCT00576173|Acetaminophen|acetaminophen|mesh-list
101539762|NCT00576173|Tramadol|tramadol|mesh-list
101539763|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539764|NCT00576173|Analgesics|analgesics|mesh-ancestor
101539765|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
101539766|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539767|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539768|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
101539769|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101539770|NCT00576173|Narcotics|narcotics|mesh-ancestor
101539771|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539772|NCT00625339|Lamivudine|lamivudine|mesh-list
101539773|NCT00625339|Entecavir|entecavir|mesh-list
101539774|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101539775|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101539776|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539777|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539778|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
101539779|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539780|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101539781|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101539782|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101539783|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
101539784|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539785|NCT04558463|Oseltamivir|oseltamivir|mesh-list
101539786|NCT04558463|Favipiravir|favipiravir|mesh-list
101539787|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
101539788|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539789|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539790|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539791|NCT01126879|Genistein|genistein|mesh-list
101539792|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101539793|NCT01126879|Protective Agents|protective agents|mesh-ancestor
101539794|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539795|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539796|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101539797|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539798|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539799|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
101539800|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101539801|NCT01126879|Estrogens|estrogens|mesh-ancestor
101539802|NCT01126879|Hormones|hormones|mesh-ancestor
101539803|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539804|NCT04311658|Isosorbide|isosorbide|mesh-list
101539805|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101539806|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101539807|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101414544|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
101414545|NCT00122720|Hematinics|hematinics|mesh-ancestor
101414546|NCT00492934|Menotropins|menotropins|mesh-list
101414547|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101414548|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
101414549|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101414550|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414552|NCT02274454|Calcium|calcium|mesh-list
101414553|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101414554|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414555|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
101414556|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101414557|NCT04760730|Vaccines|vaccines|mesh-list
101414558|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
101414559|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414560|NCT00122759|Ketamine|ketamine|mesh-list
101539808|NCT04311658|Diuretics|diuretics|mesh-ancestor
101539809|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539810|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539826|NCT04539444|Tislelizumab|tislelizumab|mesh-list
101539827|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101539828|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539829|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539830|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539831|NCT00576329|Ketorolac|ketorolac|mesh-list
101539832|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101539833|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539834|NCT00576329|Analgesics|analgesics|mesh-ancestor
101539835|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
101539836|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539837|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539838|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539839|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539840|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101539841|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539842|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539843|NCT02882581|Metformin|metformin|mesh-list
101539844|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539845|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539846|NCT02882347|Somatostatin|somatostatin|mesh-list
101539847|NCT02882347|Hormones|hormones|mesh-ancestor
101539848|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539849|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539850|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
101539851|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539852|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539853|NCT00637468|Aspirin|aspirin|mesh-list
101539854|NCT00637468|Heparin|heparin|mesh-list
101539855|NCT00637468|Acetazolamide|acetazolamide|mesh-list
101539856|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101539857|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
101539858|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101539859|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101539860|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539861|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101414561|NCT00122759|Analgesics|analgesics|mesh-ancestor
101414562|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
101414563|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414564|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414565|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101414566|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101414567|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
101414568|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
101414569|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414570|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101414571|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101414572|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414573|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414574|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
101414575|NCT00493129|Interleukin-2|interleukin-2|mesh-list
101414576|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414577|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101414578|NCT00493129|Analgesics|analgesics|mesh-ancestor
101414579|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
101539862|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101539863|NCT00637468|Analgesics|analgesics|mesh-ancestor
101539864|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
101539865|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539866|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539872|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
101539873|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
101539874|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101539875|NCT00637468|Diuretics|diuretics|mesh-ancestor
101539876|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539877|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101539878|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
101539879|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539880|NCT02278575|Antithrombins|antithrombins|mesh-list
101539882|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101539883|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
101539884|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539885|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539886|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
101539887|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101539888|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
101539889|NCT01126060|Coagulants|coagulants|mesh-ancestor
101539890|NCT01125748|Omalizumab|omalizumab|mesh-list
101539891|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101539892|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101539893|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101539894|NCT04558268|Folic Acid|folic acid|mesh-list
101539895|NCT04558268|Prednisone|prednisone|mesh-list
101539896|NCT04558268|Progesterone|progesterone|mesh-list
101539897|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539898|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
101539899|NCT04558268|Hormones|hormones|mesh-ancestor
101539900|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101539901|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539902|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101539903|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539904|NCT04558268|Progestins|progestins|mesh-ancestor
101414580|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414581|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414582|NCT00126542|Bevacizumab|bevacizumab|mesh-list
101414583|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101414584|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101414586|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
101414587|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101414588|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414589|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101414590|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101414591|NCT00126542|Growth Substances|growth substances|mesh-ancestor
101414592|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414593|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
101414594|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
101414595|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414596|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414597|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414599|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101539905|NCT04558268|Hematinics|hematinics|mesh-ancestor
101539906|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
101539907|NCT04558268|Vitamins|vitamins|mesh-ancestor
101539908|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
101539909|NCT01125514|Furosemide|furosemide|mesh-list
101539910|NCT01125514|Diuretics|diuretics|mesh-ancestor
101539911|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
101539912|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539913|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101539914|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539915|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539916|NCT04545879|Allicin|allicin|mesh-list
101539917|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539918|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101539919|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
101539920|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539921|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101539922|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
101539923|NCT04545879|Protective Agents|protective agents|mesh-ancestor
101539924|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539925|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539926|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101539927|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101539928|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101539930|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539931|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539932|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101539933|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539934|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539935|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
101539936|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539937|NCT04538391|Bupivacaine|bupivacaine|mesh-list
101539938|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
101414600|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
101414601|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414602|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
101414603|NCT01243801|Ketamine|ketamine|mesh-list
101414604|NCT01243801|Analgesics|analgesics|mesh-ancestor
101414605|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
101414606|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414607|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414608|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101414609|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101414610|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
101414611|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
101414612|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539947|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539948|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539949|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101539950|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101539951|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
101539953|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539954|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101539955|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101539957|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539958|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
101539959|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
101539960|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539961|NCT04558424|Protective Agents|protective agents|mesh-ancestor
101539962|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539963|NCT04558424|Vitamins|vitamins|mesh-ancestor
101539964|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
101539965|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
101539966|NCT00576602|Hematinics|hematinics|mesh-ancestor
101539967|NCT02212223|Vitamin D|vitamin d|mesh-list
101539968|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
101539969|NCT02212223|Vitamins|vitamins|mesh-ancestor
101539970|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
101539971|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539972|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101539973|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101539974|NCT00637585|Fexofenadine|fexofenadine|mesh-list
101539975|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101539976|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101539977|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101539978|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
101539979|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
101539980|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539981|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539982|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539983|NCT02214810|Bupivacaine|bupivacaine|mesh-list
101539984|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
101539985|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
101539986|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539987|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539988|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
101539989|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539990|NCT01125046|Bevacizumab|bevacizumab|mesh-list
101539991|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101414613|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101414614|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101414615|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414616|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414617|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101414618|NCT00126620|Sorafenib|sorafenib|mesh-list
101414619|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414620|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414621|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414622|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414623|NCT00493363|Artesunate|artesunate|mesh-list
101414624|NCT00493363|Mefloquine|mefloquine|mesh-list
101414625|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
101414626|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414627|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414628|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414629|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414630|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
101414631|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
101414632|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101414633|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
101414634|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
101539993|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
101539994|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101539995|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539996|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101539997|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101539998|NCT01125046|Growth Substances|growth substances|mesh-ancestor
101539999|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540000|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
101540001|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
101540002|NCT04557878|Mitogens|mitogens|mesh-list
101540003|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
101540009|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540010|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540011|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101540012|NCT01124734|Analgesics|analgesics|mesh-ancestor
101540013|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
101540014|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540015|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540016|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
101540017|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540018|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101540019|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101540020|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540021|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540022|NCT04538976|Urological Agents|urological agents|mesh-ancestor
101540023|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
101540024|NCT04545450|Testosterone|testosterone|mesh-list
101540025|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
101540026|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
101540027|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101414635|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101414637|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
101414638|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414639|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414640|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101414641|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101414642|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414643|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414644|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414645|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101414646|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101414647|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101414648|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
101414649|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414650|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414651|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101414652|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101414653|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101414654|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
101540028|NCT04545450|Dutasteride|dutasteride|mesh-list
101540029|NCT04545450|Androgens|androgens|mesh-ancestor
101540030|NCT04545450|Hormones|hormones|mesh-ancestor
101540031|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540032|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540033|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101540034|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540035|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
101540036|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101540037|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101540038|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540039|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540040|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
101540041|NCT04579133|Durvalumab|durvalumab|mesh-list
101540042|NCT04579133|Olaparib|olaparib|mesh-list
101540043|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540044|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540045|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101540046|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540047|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540048|NCT00576914|Endostatins|endostatins|mesh-list
101540049|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101540050|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101540051|NCT00576914|Growth Substances|growth substances|mesh-ancestor
101540052|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540053|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
101540054|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540055|NCT02212340|Remifentanil|remifentanil|mesh-list
101540056|NCT02212340|Desflurane|desflurane|mesh-list
101540057|NCT02212340|Propofol|propofol|mesh-list
101540058|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101540059|NCT02212340|Narcotics|narcotics|mesh-ancestor
101540060|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414655|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101414656|NCT00493402|Estrogens|estrogens|mesh-ancestor
101414657|NCT00493402|Hormones|hormones|mesh-ancestor
101414658|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414659|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414660|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101414661|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414662|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
101414663|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
101414664|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101414665|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101414666|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414667|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414668|NCT00145938|Urological Agents|urological agents|mesh-ancestor
101414669|NCT00493480|Propranolol|propranolol|mesh-list
101414670|NCT00493480|Carvedilol|carvedilol|mesh-list
101414671|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101414672|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101414673|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
101414674|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414675|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414676|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414677|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101414678|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540061|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540062|NCT02212340|Analgesics|analgesics|mesh-ancestor
101540063|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
101540064|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540065|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101540066|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
101540067|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
101540068|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101540069|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101540071|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101540072|NCT01124617|Narcotics|narcotics|mesh-ancestor
101540073|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540106|NCT00577109|Growth Substances|growth substances|mesh-ancestor
101540107|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540108|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
101540140|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540141|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
101540142|NCT00625495|Esomeprazole|esomeprazole|mesh-list
101414679|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
101414681|NCT00493480|Protective Agents|protective agents|mesh-ancestor
101414682|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101414683|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101414684|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101414685|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101414686|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101540143|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101540144|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540145|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101540146|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540147|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540148|NCT02882425|Selexipag|selexipag|mesh-list
101540149|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540150|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
101540151|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540152|NCT01124149|Mesalamine|mesalamine|mesh-list
101540153|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101540154|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101540155|NCT01124149|Analgesics|analgesics|mesh-ancestor
101540156|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
101540157|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540158|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540159|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540160|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540161|NCT04545099|Neostigmine|neostigmine|mesh-list
101540162|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101540163|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540164|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540165|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
101540166|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540167|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540168|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101540169|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
101540170|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540171|NCT02882269|Capecitabine|capecitabine|mesh-list
101540172|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101540173|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
101540174|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540175|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540176|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
101540177|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101540178|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540180|NCT04537767|Esmolol|esmolol|mesh-list
101540181|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101540182|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101540183|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101540185|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540186|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540187|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540188|NCT01121926|Trazodone|trazodone|mesh-list
101540189|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101540190|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540191|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540192|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540193|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101540194|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101540195|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101540196|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540197|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540198|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540199|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
101414687|NCT01243996|Ibuprofen|ibuprofen|mesh-list
101414688|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101414689|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101414690|NCT01243996|Analgesics|analgesics|mesh-ancestor
101414691|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
101414692|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414693|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414694|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101414695|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414696|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101414697|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414698|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414699|NCT01244113|Propofol|propofol|mesh-list
101414700|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101414701|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414702|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414703|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101414704|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
101414705|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
101414706|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
101414707|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101414708|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101414709|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414710|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414711|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
101540200|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101540201|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
101540202|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
101540203|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101540204|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540205|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540206|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540207|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540222|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101540223|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540224|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
101540225|NCT04537533|Coagulants|coagulants|mesh-ancestor
101540227|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540228|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540229|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101540230|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540231|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
101540232|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540233|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
101540234|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540235|NCT00577850|Alendronate|alendronate|mesh-list
101540236|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
101414712|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414713|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101414714|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101414715|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
101414716|NCT00493987|Testosterone|testosterone|mesh-list
101414717|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
101414718|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
101414719|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101414720|NCT00493987|Dutasteride|dutasteride|mesh-list
101414721|NCT00493987|Androgens|androgens|mesh-ancestor
101414722|NCT00493987|Hormones|hormones|mesh-ancestor
101414723|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540237|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101540238|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540239|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101540240|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540241|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540242|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540243|NCT00577967|Gabapentin|gabapentin|mesh-list
101540244|NCT00577967|Analgesics|analgesics|mesh-ancestor
101540245|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
101540246|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540247|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540248|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
101540249|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101540250|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540251|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540252|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101540253|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101540254|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101540255|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540256|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540257|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
101540259|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540260|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540261|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
101540262|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101540263|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540266|NCT04578470|Vitamin D|vitamin d|mesh-list
101540267|NCT04578470|Vitamins|vitamins|mesh-ancestor
101540268|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
101540269|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540270|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101540271|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
101540272|NCT00578435|Busulfan|busulfan|mesh-list
101540273|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540274|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
101540275|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540276|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540277|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101540279|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540280|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540281|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101540282|NCT04537065|Mydriatics|mydriatics|mesh-list
101540283|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
101540284|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540285|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540286|NCT04544163|Lidocaine|lidocaine|mesh-list
101414724|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414725|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101414726|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414727|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
101414728|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101414731|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540287|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
101540288|NCT04544163|Fentanyl|fentanyl|mesh-list
101540289|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
101540290|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
101540291|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540292|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540293|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
101540294|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540295|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101540296|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101540297|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101540298|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540299|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540300|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101540301|NCT04544163|Narcotics|narcotics|mesh-ancestor
101540302|NCT04544163|Analgesics|analgesics|mesh-ancestor
101540303|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101540304|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101540305|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
101540306|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
101540307|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101540308|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540309|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
101540310|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540311|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
101540312|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101540313|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540314|NCT00578591|Rituximab|rituximab|mesh-list
101540315|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540316|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540317|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
101540318|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540319|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540320|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
101540321|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540322|NCT04543890|Etoposide|etoposide|mesh-list
101540323|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540324|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101540325|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101540326|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101540327|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540328|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540329|NCT04536831|Vitamin D|vitamin d|mesh-list
101540336|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540338|NCT02214966|Ramipril|ramipril|mesh-list
101540339|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540340|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101540341|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101417226|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
101540342|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414732|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
101414733|NCT00494104|Vitamin D|vitamin d|mesh-list
101414734|NCT00494104|Vitamins|vitamins|mesh-ancestor
101414735|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
101414736|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540343|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101540344|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540345|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540346|NCT04536558|Olanzapine|olanzapine|mesh-list
101540347|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
101540348|NCT04536558|Aprepitant|aprepitant|mesh-list
101540349|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
101540350|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
101540351|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540352|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540353|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540354|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101540355|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540356|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540357|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101540358|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101540359|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101540360|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540361|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540362|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540363|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
101540364|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101540365|NCT04557137|Somatostatin|somatostatin|mesh-list
101540366|NCT04557137|Hormones|hormones|mesh-ancestor
101540367|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540368|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540369|NCT04536675|Bromides|bromides|mesh-list
101540370|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
101540371|NCT04536363|Alprostadil|alprostadil|mesh-list
101540372|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101540373|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540374|NCT04536363|Urological Agents|urological agents|mesh-ancestor
101540375|NCT00578825|Ritonavir|ritonavir|mesh-list
101540376|NCT00578825|Lopinavir|lopinavir|mesh-list
101540377|NCT00578825|Ribavirin|ribavirin|mesh-list
101540378|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101540379|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101540380|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540381|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540382|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540383|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101540384|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101540385|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
101540386|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540387|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101540388|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101540415|NCT02215044|Gemcitabine|gemcitabine|mesh-list
101540416|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101540417|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
101540418|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540419|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540420|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101540421|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
101540422|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540423|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414737|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101414739|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414740|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414741|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414742|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414743|NCT00494338|Docetaxel|docetaxel|mesh-list
101540424|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101540425|NCT04556279|Diuretics|diuretics|mesh-ancestor
101540426|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
101540427|NCT02216331|Rifampin|rifampin|mesh-list
101540428|NCT02216331|Rifapentine|rifapentine|mesh-list
101540429|NCT02216331|Bedaquiline|bedaquiline|mesh-list
101540430|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101540431|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
101540432|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540433|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540434|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
101540435|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101540436|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540445|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101540446|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101540447|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540448|NCT04578236|Tretinoin|tretinoin|mesh-list
101540449|NCT04578236|Captopril|captopril|mesh-list
101540450|NCT04578236|Isotretinoin|isotretinoin|mesh-list
101540451|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540452|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
101540453|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540454|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101540455|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540456|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540457|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540458|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540459|NCT04542759|Besifloxacin|besifloxacin|mesh-list
101540460|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101540461|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101540462|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540463|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540464|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101540465|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101540466|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540467|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540468|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540469|NCT04542213|Insulin|insulin|mesh-list
101540470|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101540471|NCT04542213|Linagliptin|linagliptin|mesh-list
101540472|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101540473|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540474|NCT04542213|Incretins|incretins|mesh-ancestor
101540475|NCT04542213|Hormones|hormones|mesh-ancestor
101540476|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540477|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101540478|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540479|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540480|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540481|NCT04542252|Cyclosporine|cyclosporine|mesh-list
101540482|NCT04542252|Cyclosporins|cyclosporins|mesh-list
101540483|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540484|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540485|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540486|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
101540487|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540488|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
101540489|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540490|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540491|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101414745|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414747|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414748|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414749|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101540492|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101540493|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101540517|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101540519|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101540520|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101540521|NCT04532775|Prednisolone|prednisolone|mesh-list
101540522|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
101540523|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
101540524|NCT04532775|Bupivacaine|bupivacaine|mesh-list
101540525|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101540526|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
101540527|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
101540528|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
101540529|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540530|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540531|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
101540532|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540533|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540534|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
101540535|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
101540536|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540537|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
101540538|NCT04532775|Hormones|hormones|mesh-ancestor
101540539|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540540|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101540541|NCT04532775|Protective Agents|protective agents|mesh-ancestor
101540542|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101540543|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540549|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540551|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
101540552|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540553|NCT00579644|Minocycline|minocycline|mesh-list
101540554|NCT00579644|Methotrexate|methotrexate|mesh-list
101540555|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101540556|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
101540557|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540558|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540559|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101540560|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
101540561|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540562|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540563|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540564|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540565|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101540566|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540567|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
101540568|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540569|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101540570|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540571|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540572|NCT04578158|Quercetin|quercetin|mesh-list
101540573|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
101540574|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540575|NCT04578158|Protective Agents|protective agents|mesh-ancestor
101540576|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540577|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
101540578|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
101540579|NCT04532736|Methotrexate|methotrexate|mesh-list
101414750|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101414751|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101414752|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101414753|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414754|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540580|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101540581|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
101540582|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540583|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540584|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101540585|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
101540586|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540587|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540588|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540589|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540590|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101540591|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540592|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
101540593|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540594|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101540595|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540596|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
101540597|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
101540598|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540599|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540600|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
101540602|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540603|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101540604|NCT04532736|Protective Agents|protective agents|mesh-ancestor
101540605|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101540606|NCT04555733|Lemborexant|lemborexant|mesh-list
101540607|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101540608|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540611|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101540612|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540613|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540614|NCT02216994|Mineral Oil|mineral oil|mesh-list
101540615|NCT02216994|Lactulose|lactulose|mesh-list
101540616|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540617|NCT02216994|Emollients|emollients|mesh-ancestor
101540618|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540619|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
101540620|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
101540621|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540622|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540623|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540624|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
101540625|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
101540626|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
101540627|NCT02217189|Astringents|astringents|mesh-ancestor
101540628|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540629|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540630|NCT00579956|Meropenem|meropenem|mesh-list
101540631|NCT00579956|Ceftazidime|ceftazidime|mesh-list
101540632|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540633|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540634|NCT04555304|Paclitaxel|paclitaxel|mesh-list
101540635|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101540636|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101540637|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540638|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
101540639|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
101540640|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414755|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414756|NCT00494377|Analgesics|analgesics|mesh-ancestor
101414757|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
101414760|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414761|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
101414762|NCT00146016|Amantadine|amantadine|mesh-list
101414763|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101414764|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101414765|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
101540641|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540642|NCT04531800|Mitogens|mitogens|mesh-list
101540643|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101540644|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540645|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
101540646|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101540647|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
101540648|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540649|NCT00579995|Expectorants|expectorants|mesh-ancestor
101540650|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540651|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101540652|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
101540653|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540654|NCT00579995|Protective Agents|protective agents|mesh-ancestor
101540655|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540656|NCT00579995|Antidotes|antidotes|mesh-ancestor
101540657|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
101540658|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101540659|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540660|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540661|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101540662|NCT04531371|Analgesics|analgesics|mesh-ancestor
101540663|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
101540664|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540665|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101540666|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101540667|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540668|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540669|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540670|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540671|NCT00580112|Dexamethasone|dexamethasone|mesh-list
101540672|NCT00580112|Trabectedin|trabectedin|mesh-list
101540673|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540674|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
101540675|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
101540676|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540677|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540678|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540679|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
101540680|NCT00580112|Hormones|hormones|mesh-ancestor
101540683|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540684|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101540685|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
101540686|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540687|NCT04531332|Linezolid|linezolid|mesh-list
101540688|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540689|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540690|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101540691|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540692|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414766|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414768|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414769|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414770|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414772|NCT00146016|Analgesics|analgesics|mesh-ancestor
101540693|NCT04530864|Dexamethasone|dexamethasone|mesh-list
101540694|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
101540695|NCT04530864|BB 1101|bb 1101|mesh-list
101540696|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540697|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
101540698|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
101540699|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540700|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540701|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540702|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
101540703|NCT04530864|Hormones|hormones|mesh-ancestor
101540704|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540705|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101540706|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540707|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540708|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540709|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540710|NCT00580190|Alprazolam|alprazolam|mesh-list
101540711|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101540712|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540713|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540714|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101540715|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540716|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101540717|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
101540718|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
101540719|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540720|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540721|NCT04530903|Clonidine|clonidine|mesh-list
101540722|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
101540723|NCT04530903|Analgesics|analgesics|mesh-ancestor
101540724|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
101540725|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540726|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540727|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540728|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
101540729|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
101540730|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101540731|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101540732|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540733|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540734|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540735|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540736|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
101540737|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
101540738|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540739|NCT04530474|Ivermectin|ivermectin|mesh-list
101540740|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101540741|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540742|NCT04554680|Trametinib|trametinib|mesh-list
101540743|NCT04554680|Dabrafenib|dabrafenib|mesh-list
101540744|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540745|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101540746|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540747|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540748|NCT00580424|Norethindrone|norethindrone|mesh-list
101540749|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
101540750|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101540793|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414773|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
101414774|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414776|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
101540794|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540795|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101540796|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101540797|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540798|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540799|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540800|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101540801|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101540802|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101540803|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101540804|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
101540805|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540806|NCT04554524|Paclitaxel|paclitaxel|mesh-list
101540807|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
101540808|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101540809|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540810|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
101540811|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
101540812|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
101540813|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540814|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540815|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101540816|NCT02212652|Vitamin D|vitamin d|mesh-list
101540817|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
101540818|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
101540819|NCT02212652|Vitamins|vitamins|mesh-list
101540820|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
101540821|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540822|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101540823|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540824|NCT02212769|Losartan|losartan|mesh-list
101540825|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101540826|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540827|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101540828|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101540829|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540830|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
101540831|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101540832|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101540833|NCT02217852|Captopril|captopril|mesh-list
101540834|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
101540835|NCT02217852|Nitrendipine|nitrendipine|mesh-list
101540836|NCT02217852|Diuretics|diuretics|mesh-ancestor
101540837|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
101540838|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540839|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101540840|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540841|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540842|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101540843|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540844|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540845|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101540846|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540847|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540848|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
101540849|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
101540850|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540851|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540852|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101540853|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101540883|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
101540884|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
101540885|NCT01120600|Calcium|calcium|mesh-list
101540886|NCT01120600|Vitamins|vitamins|mesh-ancestor
101540887|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
101414777|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414778|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
101414779|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414780|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414781|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101414782|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414783|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414784|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
101540888|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540889|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540890|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101540891|NCT01120600|Antacids|antacids|mesh-ancestor
101540892|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540893|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540894|NCT04577885|Rifampin|rifampin|mesh-list
101540895|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101540898|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540900|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101540901|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540902|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540903|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101540904|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101540905|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101540906|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101540907|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101540908|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101540909|NCT00580931|Niacinamide|niacinamide|mesh-list
101540911|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
101540912|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
101540913|NCT00580931|Vitamins|vitamins|mesh-ancestor
101540914|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
101540915|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540916|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101540917|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
101540918|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540919|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101540920|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
101540921|NCT01120093|Bromides|bromides|mesh-list
101540922|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
101540923|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101540924|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
101540925|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540926|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540927|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101540928|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540929|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101540930|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101540931|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540932|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540933|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540934|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540935|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
101540936|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
101540937|NCT00581009|Sertraline|sertraline|mesh-list
101540938|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
101540939|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101540940|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101540941|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101540942|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540943|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540944|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540945|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
101540946|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540947|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414785|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414786|NCT01244230|Fexofenadine|fexofenadine|mesh-list
101414787|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101414788|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101414789|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101414790|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
101414791|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
101540948|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
101540949|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101540951|NCT02218359|Amikacin|amikacin|mesh-list
101540952|NCT02218359|Fosfomycin|fosfomycin|mesh-list
101540953|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101540954|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540955|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540956|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
101540957|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101540958|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
101540959|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540960|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540961|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101540962|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101540963|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101540970|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540971|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
101540972|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540973|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101540974|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101540975|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540976|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540977|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540978|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540979|NCT02218671|Brotizolam|brotizolam|mesh-list
101540980|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101540981|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540982|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540983|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
101540984|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
101540985|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101540986|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
101540987|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540988|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540989|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101540990|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540991|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
101540992|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101540993|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
101540994|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540995|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540996|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101540997|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101540998|NCT01119898|Diclofenac|diclofenac|mesh-list
101540999|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541000|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541001|NCT01119898|Analgesics|analgesics|mesh-ancestor
101541002|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
101541003|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541004|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541005|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541006|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541007|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101541008|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541009|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541010|NCT01119859|Adalimumab|adalimumab|mesh-list
101414792|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414793|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414794|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414795|NCT01244269|Methylphenidate|methylphenidate|mesh-list
101414796|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101414797|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414798|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101414799|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101414800|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541011|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101541012|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541013|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541014|NCT02278926|Insulin|insulin|mesh-list
101541015|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101541016|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541017|NCT01119703|Vaccines|vaccines|mesh-list
101541018|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
101541019|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541020|NCT02882230|Dolutegravir|dolutegravir|mesh-list
101541021|NCT02882230|Rilpivirine|rilpivirine|mesh-list
101541022|NCT02882230|Elvitegravir|elvitegravir|mesh-list
101541023|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101541024|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101541025|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541026|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541027|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101541028|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101541029|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
101541030|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541031|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101541032|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101541065|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541066|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541067|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
101541068|NCT05092984|Spironolactone|spironolactone|mesh-list
101541069|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101541070|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
101541071|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541072|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541073|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101541082|NCT02213159|Analgesics|analgesics|mesh-ancestor
101541083|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
101541084|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541085|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101541086|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101541087|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101541088|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541089|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541090|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541091|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101541093|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
101541094|NCT02219100|Mifepristone|mifepristone|mesh-list
101541095|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101541097|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101541099|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101541100|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101541101|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101541102|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
101414801|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414803|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414804|NCT00127010|Vaccines|vaccines|mesh-list
101414805|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
101414806|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414807|NCT00494533|Treprostinil|treprostinil|mesh-list
101414808|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101414809|NCT00494572|Montelukast|montelukast|mesh-list
101414810|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101414811|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
101414812|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101414813|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
101414814|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541103|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101541104|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101541105|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
101541106|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541107|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
101541108|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101541109|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101541110|NCT01118377|Capecitabine|capecitabine|mesh-list
101541111|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101541112|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
101541113|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541114|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541115|NCT02219178|Dexamethasone|dexamethasone|mesh-list
101541116|NCT02219178|Lenalidomide|lenalidomide|mesh-list
101541117|NCT02219178|Bortezomib|bortezomib|mesh-list
101541118|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541119|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
101541120|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
101541121|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541122|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541123|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541124|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
101541125|NCT02219178|Hormones|hormones|mesh-ancestor
101541126|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541127|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541128|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541129|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
101541130|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541131|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541132|NCT02219178|Growth Substances|growth substances|mesh-ancestor
101541133|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541134|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
101541135|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101541136|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541137|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
101541143|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101541144|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541145|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541146|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101541147|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101541148|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
101541149|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541150|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101414815|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414816|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101414817|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101414818|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414819|NCT00494611|Cetuximab|cetuximab|mesh-list
101414820|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101414821|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414822|NCT00127049|Gemcitabine|gemcitabine|mesh-list
101414823|NCT00127049|Ifosfamide|ifosfamide|mesh-list
101414824|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417287|NCT00403910|Canrenone|canrenone|mesh-list
101414825|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414826|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
101414827|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414828|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101414829|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
101414830|NCT00494884|Vildagliptin|vildagliptin|mesh-list
101541151|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101541152|NCT04577378|Itraconazole|itraconazole|mesh-list
101541153|NCT04577378|Tretinoin|tretinoin|mesh-list
101541154|NCT04577378|Isotretinoin|isotretinoin|mesh-list
101541155|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
101541156|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541157|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101541158|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101541159|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541160|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541161|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101541162|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
101541163|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541164|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541165|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101541166|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541167|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
101541168|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
101541169|NCT02219412|Aspirin|aspirin|mesh-list
101541170|NCT02219412|Ticagrelor|ticagrelor|mesh-list
101541171|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541172|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541173|NCT02219412|Analgesics|analgesics|mesh-ancestor
101541174|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
101541175|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541176|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541177|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541178|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541179|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101541180|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101541181|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541182|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101541183|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101541184|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414831|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101414832|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414833|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101414834|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
101414835|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414836|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414837|NCT00127088|Docetaxel|docetaxel|mesh-list
101414838|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414839|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414840|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
101414841|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414842|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414843|NCT02957877|Heparin|heparin|mesh-list
101414844|NCT02957877|Calcium heparin|calcium heparin|mesh-list
101414845|NCT02957877|Nadroparin|nadroparin|mesh-list
101414846|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
101414847|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101541185|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
101541186|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101541187|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101541188|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101541189|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
101541190|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541192|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101541193|NCT02211690|Tenofovir|tenofovir|mesh-list
101541194|NCT02211690|Emtricitabine|emtricitabine|mesh-list
101541195|NCT02211690|Dolutegravir|dolutegravir|mesh-list
101541196|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
101541197|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541198|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101541199|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101541200|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541201|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541202|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101541203|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101541210|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541211|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541212|NCT02211846|Mirabegron|mirabegron|mesh-list
101541213|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101541214|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101541215|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101541216|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541217|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541218|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541219|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541220|NCT02211846|Urological Agents|urological agents|mesh-ancestor
101541221|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101541222|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
101541223|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101541224|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101541225|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414848|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101414849|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414850|NCT01244581|Amoxicillin|amoxicillin|mesh-list
101414851|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
101414852|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
101414853|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101414854|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541226|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541227|NCT02219646|Urological Agents|urological agents|mesh-ancestor
101541228|NCT04553510|Bevacizumab|bevacizumab|mesh-list
101541229|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541230|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541231|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541232|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541233|NCT04553510|Growth Substances|growth substances|mesh-ancestor
101541234|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541235|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541236|NCT03453281|Aflibercept|aflibercept|mesh-list
101541237|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541238|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541239|NCT03453281|Growth Substances|growth substances|mesh-ancestor
101541244|NCT01642134|Clopidogrel|clopidogrel|mesh-list
101541245|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541246|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541247|NCT01642134|Analgesics|analgesics|mesh-ancestor
101541248|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
101541249|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541250|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541251|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541252|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541253|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101541254|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101541255|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541256|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101541257|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101541258|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541259|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
101541260|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101541261|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101414855|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414856|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101414857|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414858|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414859|NCT01244659|Tacrolimus|tacrolimus|mesh-list
101414860|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101414861|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
101414862|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541262|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101541263|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
101541264|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541265|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101541266|NCT00581789|Sunitinib|sunitinib|mesh-list
101541267|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541268|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101541269|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541270|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541271|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541272|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541273|NCT00581789|Growth Substances|growth substances|mesh-ancestor
101541274|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541275|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541276|NCT02213588|Antioxidants|antioxidants|mesh-list
101541277|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541278|NCT02213588|Protective Agents|protective agents|mesh-ancestor
101541279|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541281|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
101541282|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
101541283|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
101541284|NCT02213783|Imipenem|imipenem|mesh-list
101541285|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541286|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541287|NCT04552613|Carboplatin|carboplatin|mesh-list
101541288|NCT04552613|Pemetrexed|pemetrexed|mesh-list
101541289|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541290|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541291|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541292|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101541293|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101541294|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
101541295|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541296|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101541297|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541298|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541299|NCT02219490|Ritonavir|ritonavir|mesh-list
101541300|NCT02219490|Ribavirin|ribavirin|mesh-list
101541301|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101414864|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414865|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414866|NCT01244698|Clindamycin|clindamycin|mesh-list
101414867|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
101414868|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
101414869|NCT01244698|Cefazolin|cefazolin|mesh-list
101414870|NCT01244698|Cefadroxil|cefadroxil|mesh-list
101414871|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414872|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541302|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101541303|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
101541304|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541305|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541306|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101541307|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101541308|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
101541309|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541310|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101541311|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101541312|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
101541313|NCT01117051|Prucalopride|prucalopride|mesh-list
101541314|NCT01117051|Laxatives|laxatives|mesh-ancestor
101541315|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541316|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101541317|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101541318|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
101541321|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541322|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
101541323|NCT02211417|Mineral Oil|mineral oil|mesh-list
101541324|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541325|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541326|NCT02211417|Analgesics|analgesics|mesh-ancestor
101541327|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
101541328|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541329|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541330|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541331|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541332|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101541333|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
101541334|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541335|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101541336|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
101541337|NCT02211417|Emollients|emollients|mesh-ancestor
101541338|NCT02279121|Taurolidine|taurolidine|mesh-list
101541339|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101541340|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541341|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101541342|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541343|NCT02218164|Interferons|interferons|mesh-list
101541344|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
101541345|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
101541346|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101541347|NCT02218164|Fluorouracil|fluorouracil|mesh-list
101541348|NCT02218164|Capecitabine|capecitabine|mesh-list
101541349|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
101541350|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414873|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101414874|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414875|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414876|NCT00495118|Risperidone|risperidone|mesh-list
101414877|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101414878|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
101414879|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541351|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101541354|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
101541355|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541356|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
101541357|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541358|NCT04552067|Enoxaparin|enoxaparin|mesh-list
101541359|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
101541360|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101541361|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101541362|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541363|NCT01643187|Vitamins|vitamins|mesh-list
101541364|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
101541365|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541366|NCT01643265|Caseins|caseins|mesh-list
101541367|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
101541368|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
101541369|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541370|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
101541372|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
101541373|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541374|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541375|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
101541376|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541377|NCT04551755|Doxycycline|doxycycline|mesh-list
101541378|NCT04551755|Ivermectin|ivermectin|mesh-list
101541379|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541380|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541382|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101541383|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101541385|NCT01643499|Fluorouracil|fluorouracil|mesh-list
101541386|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
101541387|NCT01643499|Irinotecan|irinotecan|mesh-list
101541388|NCT01643499|Calcium|calcium|mesh-list
101541389|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
101541391|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541392|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
101541393|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541394|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101541395|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541396|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541397|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
101541398|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101541399|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101541400|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541402|NCT01643499|Protective Agents|protective agents|mesh-ancestor
101541403|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
101541404|NCT01643499|Vitamins|vitamins|mesh-ancestor
101541405|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
101541406|NCT01117012|Ivacaftor|ivacaftor|mesh-list
101541407|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101541408|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541409|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414880|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414881|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414882|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101414883|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101414884|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414885|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414886|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101414887|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
101414888|NCT00495313|Metronidazole|metronidazole|mesh-list
101414889|NCT00495313|Doxycycline|doxycycline|mesh-list
101414890|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541412|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
101541413|NCT01116739|Protective Agents|protective agents|mesh-ancestor
101541414|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541415|NCT01640496|Vitamin D|vitamin d|mesh-list
101541416|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
101541417|NCT01640496|Vitamins|vitamins|mesh-ancestor
101541418|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
101541419|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541420|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101541421|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541422|NCT04551248|Vaccines|vaccines|mesh-list
101541423|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101541424|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
101541425|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541426|NCT01640535|Cetirizine|cetirizine|mesh-list
101541427|NCT01640535|Montelukast|montelukast|mesh-list
101541428|NCT01640535|Levocetirizine|levocetirizine|mesh-list
101541432|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
101541433|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541434|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541435|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101541436|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101541437|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541438|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101541439|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101541440|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
101541441|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
101541442|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541443|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101541444|NCT04550936|Isavuconazole|isavuconazole|mesh-list
101541445|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
101541446|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541447|NCT04550858|Rebamipide|rebamipide|mesh-list
101541448|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101541449|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541450|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
101541451|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541452|NCT04550858|Protective Agents|protective agents|mesh-ancestor
101541453|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541454|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541457|NCT01640574|Piperaquine|piperaquine|mesh-list
101541458|NCT01640574|Artenimol|artenimol|mesh-list
101541459|NCT01640574|Artemisinins|artemisinins|mesh-list
101541460|NCT01640574|Amebicides|amebicides|mesh-ancestor
101541461|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101541462|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101541463|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541464|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
101541465|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541466|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541467|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541468|NCT01640574|Analgesics|analgesics|mesh-ancestor
101414892|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101414893|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101414894|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
101414896|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101414897|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
101414898|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414899|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101414900|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101414901|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101414902|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414903|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
101414904|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414905|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414906|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101541470|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541471|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541472|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541473|NCT01640574|Filaricides|filaricides|mesh-ancestor
101541474|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
101541475|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
101541477|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101541478|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541479|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541480|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541481|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541482|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
101541483|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541484|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541486|NCT04529226|Pimozide|pimozide|mesh-list
101541487|NCT04529226|Olanzapine|olanzapine|mesh-list
101541488|NCT04529226|Risperidone|risperidone|mesh-list
101541489|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
101541490|NCT04529226|Clozapine|clozapine|mesh-list
101541491|NCT04529226|Amisulpride|amisulpride|mesh-list
101541492|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101541493|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
101541494|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541495|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541496|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541497|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101541498|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101541499|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541509|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541510|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101541511|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
101541512|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
101541513|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101541514|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
101541515|NCT04310683|Hormones|hormones|mesh-list
101541516|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101414907|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101414908|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414911|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414912|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
101414913|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541517|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541519|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101541520|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101541521|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101541522|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541523|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541524|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541525|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541526|NCT04550702|Urological Agents|urological agents|mesh-ancestor
101541528|NCT01116232|Rituximab|rituximab|mesh-list
101541529|NCT01116232|Tacrolimus|tacrolimus|mesh-list
101541530|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101541531|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541532|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541533|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
101541534|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541535|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541536|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541538|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541539|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541540|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541541|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541542|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101541543|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
101541544|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101541547|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541548|NCT01640691|Vaccines|vaccines|mesh-list
101541549|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
101541550|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541551|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
101541552|NCT01643889|Domperidone|domperidone|mesh-list
101541553|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541554|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541555|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101541556|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101541557|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541558|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541559|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541560|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541561|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
101541562|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
101541563|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541564|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541574|NCT04550078|Antacids|antacids|mesh-ancestor
101541575|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541576|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541577|NCT01205035|Ranibizumab|ranibizumab|mesh-list
101541578|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101541579|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101541580|NCT01205035|Growth Substances|growth substances|mesh-ancestor
101541581|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541582|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541583|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541584|NCT04549844|Bupivacaine|bupivacaine|mesh-list
101541585|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
101414914|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414915|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414916|NCT00495547|Hematinics|hematinics|mesh-ancestor
101414918|NCT00495781|Trace Elements|trace elements|mesh-ancestor
101414921|NCT00405405|Bevacizumab|bevacizumab|mesh-list
101414922|NCT00405405|Cisplatin|cisplatin|mesh-list
101414923|NCT00405405|Docetaxel|docetaxel|mesh-list
101414924|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101541586|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
101541587|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541588|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541589|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
101541590|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541591|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101541592|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
101541593|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
101541594|NCT01204918|Riluzole|riluzole|mesh-list
101541595|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
101541596|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101541597|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101541598|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541599|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541600|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541601|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101541602|NCT01204918|Protective Agents|protective agents|mesh-ancestor
101541603|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
101541604|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101541605|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101541607|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
101541608|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101541609|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
101541610|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541611|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
101541612|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
101541613|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541614|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541615|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541616|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
101541617|NCT04528797|Hormones|hormones|mesh-ancestor
101541618|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541620|NCT04528797|Protective Agents|protective agents|mesh-ancestor
101541621|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541622|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541623|NCT00624481|Teriparatide|teriparatide|mesh-list
101541624|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541625|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541626|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101541627|NCT04529187|Midazolam|midazolam|mesh-list
101541628|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
101541635|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541636|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101541637|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101541639|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541640|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541641|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541642|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101541643|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101541644|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101414925|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101414926|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414927|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101414928|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101414930|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541645|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101541646|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101541647|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
101541648|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
101541649|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
101541650|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
101541651|NCT04549415|Metformin|metformin|mesh-list
101541652|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101541653|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541654|NCT02214368|Propofol|propofol|mesh-list
101541655|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101541656|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541657|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541658|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101541659|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
101541660|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
101541661|NCT01204294|Metformin|metformin|mesh-list
101541662|NCT01204294|Linagliptin|linagliptin|mesh-list
101541664|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541665|NCT01204294|Incretins|incretins|mesh-ancestor
101541666|NCT01204294|Hormones|hormones|mesh-ancestor
101541667|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541668|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101541669|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
101541670|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541671|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541672|NCT01182181|Anastrozole|anastrozole|mesh-list
101541673|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101541674|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541675|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101541676|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101541677|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541678|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541679|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101541680|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
101541681|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541682|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541683|NCT01181986|Exenatide|exenatide|mesh-list
101541684|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101541685|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541686|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101541687|NCT01181986|Incretins|incretins|mesh-ancestor
101541688|NCT01181986|Hormones|hormones|mesh-ancestor
101541689|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541692|NCT04315909|Vitamins|vitamins|mesh-ancestor
101541693|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
101541694|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541695|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
101541696|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541697|NCT04315909|Protective Agents|protective agents|mesh-ancestor
101541699|NCT04315909|Coagulants|coagulants|mesh-ancestor
101541700|NCT01181167|Enoxaparin|enoxaparin|mesh-list
101541701|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
101541702|NCT01181167|Edoxaban|edoxaban|mesh-list
101541703|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
101541704|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101541705|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101541706|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541707|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101541708|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
101414931|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101414932|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
101414933|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
101414934|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
101414935|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414936|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414937|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414939|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101414940|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101414941|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101541709|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101541710|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
101541711|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541712|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
101541713|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101541714|NCT04548557|Antibodies|antibodies|mesh-list
101541715|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
101541716|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101541717|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
101541719|NCT01181128|Factor VIII|factor viii|mesh-list
101541720|NCT01181128|Coagulants|coagulants|mesh-ancestor
101541721|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101541722|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
101541723|NCT04548284|Hormones|hormones|mesh-ancestor
101541724|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541725|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541726|NCT04547894|TMC-310911|tmc-310911|mesh-list
101541727|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
101541728|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541729|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541730|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
101541731|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
101541732|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541733|NCT01644825|Paclitaxel|paclitaxel|mesh-list
101541734|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101541736|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
101541737|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
101541738|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
101541739|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541740|NCT01644864|Ropivacaine|ropivacaine|mesh-list
101541741|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
101541742|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
101541743|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541744|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541745|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
101541746|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541747|NCT04547855|Temozolomide|temozolomide|mesh-list
101541748|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101541749|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
101541750|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541751|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541752|NCT01641510|Clopidogrel|clopidogrel|mesh-list
101541753|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101541754|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101541755|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101541756|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101541757|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101541758|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
101541759|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541760|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414943|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
101414945|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
101414946|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414947|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101414948|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
101541761|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541762|NCT04547621|Temozolomide|temozolomide|mesh-list
101541763|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101541764|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
101541765|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541766|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541769|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541770|NCT04547348|Denosumab|denosumab|mesh-list
101541771|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101541772|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541773|NCT04547426|Nicotine|nicotine|mesh-list
101541774|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101541775|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
101541776|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541777|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541778|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101541779|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101541780|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
101541781|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541782|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541783|NCT01641666|Ribavirin|ribavirin|mesh-list
101541784|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101541785|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
101541786|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
101541787|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541788|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
101541789|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541790|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
101541791|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541792|NCT01203787|Sorafenib|sorafenib|mesh-list
101541793|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541794|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101541795|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541796|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541797|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
101541798|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541799|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541800|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101541801|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541802|NCT01645254|Antimalarials|antimalarials|mesh-list
101541803|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101541804|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101541805|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541807|NCT01181011|Telmisartan|telmisartan|mesh-list
101541808|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
101541809|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101541810|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101541811|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541812|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541813|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541814|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541815|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
101541816|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101541817|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101414949|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414951|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414952|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101414954|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414955|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
101414956|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101414958|NCT00496405|Bevacizumab|bevacizumab|mesh-list
101414959|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101541819|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101541820|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101541821|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541822|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
101541823|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
101541824|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
101541825|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541826|NCT02214602|Doxorubicin|doxorubicin|mesh-list
101541827|NCT02214602|Epirubicin|epirubicin|mesh-list
101541828|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101541841|NCT01580033|Vaccines|vaccines|mesh-list
101541842|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
101541843|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541845|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101541846|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541847|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541848|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541850|NCT01645410|Calcium|calcium|mesh-list
101541851|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541852|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541853|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101541854|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101541855|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
101541856|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541857|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101541858|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101541859|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541860|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
101541861|NCT04546334|Analgesics|analgesics|mesh-ancestor
101541862|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
101541863|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541864|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541865|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
101541866|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541867|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101541869|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101541870|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541871|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541872|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541873|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
101541874|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101541875|NCT04546256|Fluticasone|fluticasone|mesh-list
101541877|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101541878|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101414960|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414961|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101414962|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101414963|NCT00496405|Growth Substances|growth substances|mesh-ancestor
101414964|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414965|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541879|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541880|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101541881|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
101541882|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541883|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541884|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101541885|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
101541888|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101541889|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101541890|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101541891|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541892|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541893|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541894|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
101541895|NCT04546256|Hormones|hormones|mesh-ancestor
101541896|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101541898|NCT01645449|Atorvastatin|atorvastatin|mesh-list
101541899|NCT01645449|Calcium|calcium|mesh-list
101541900|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541901|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541902|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101541903|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101541904|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
101541905|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541906|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101541907|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101541908|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541909|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101541910|NCT01645800|Muramidase|muramidase|mesh-list
101541911|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541913|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101541914|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101541915|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101541917|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
101541918|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541919|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541920|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541921|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101541922|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101541923|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101541924|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101541925|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101541928|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541930|NCT04545788|Cycloserine|cycloserine|mesh-list
101541931|NCT04545788|Bedaquiline|bedaquiline|mesh-list
101541932|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541933|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541934|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101541935|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541936|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541937|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101414966|NCT00496444|Azacitidine|azacitidine|mesh-list
101414967|NCT00496444|Valproic Acid|valproic acid|mesh-list
101414968|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101414969|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
101414970|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101414971|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414972|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414973|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
101541938|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101541939|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
101541940|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
101541942|NCT02756013|Carboplatin|carboplatin|mesh-list
101541943|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101541944|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541945|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
101541946|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
101541947|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
101541948|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541950|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
101541951|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101541952|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101541953|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541958|NCT01646229|Polymyxin B|polymyxin b|mesh-list
101541959|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101541960|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541961|NCT01680081|Adenosine|adenosine|mesh-list
101541962|NCT01680081|Analgesics|analgesics|mesh-ancestor
101541963|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
101541964|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541965|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541966|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101541967|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
101541969|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
101541970|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
101541972|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541974|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101541975|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101541976|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101541977|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
101541978|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541979|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101541980|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101541981|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541982|NCT04544969|Cisplatin|cisplatin|mesh-list
101541983|NCT04544969|Gemcitabine|gemcitabine|mesh-list
101541984|NCT04544969|Docetaxel|docetaxel|mesh-list
101541985|NCT04544969|Fluorouracil|fluorouracil|mesh-list
101541986|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101414975|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101414976|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414977|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
101414978|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101414979|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414980|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101414981|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
101414982|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
101414984|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
101414985|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101414986|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
101414987|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
101414988|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101414989|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101414990|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101414992|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
101541987|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101541989|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541990|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
101541991|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
101541993|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541994|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
101541995|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541996|NCT04541732|Anesthetics|anesthetics|mesh-list
101541997|NCT04541732|Propofol|propofol|mesh-list
101541998|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541999|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542000|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101542001|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542003|NCT01680471|Midazolam|midazolam|mesh-list
101542004|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542005|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101542006|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542007|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542008|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101542009|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542010|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101542017|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542018|NCT02279316|Vitamin D|vitamin d|mesh-list
101542019|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
101542020|NCT02279316|Vitamins|vitamins|mesh-ancestor
101542021|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
101542022|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542023|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101542024|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542025|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
101542026|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101542027|NCT04544228|Ketamine|ketamine|mesh-list
101542030|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101542031|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
101414993|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101414994|NCT00496600|Everolimus|everolimus|mesh-list
101414995|NCT00496600|Epothilone B|epothilone b|mesh-list
101414996|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101414997|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101414998|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101414999|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415000|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415001|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
101415002|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415003|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542032|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542033|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542034|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
101542035|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542036|NCT04544228|Analgesics|analgesics|mesh-ancestor
101542037|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101542038|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542039|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
101542041|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101542042|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542043|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542044|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101542045|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542046|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542047|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101542048|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
101542049|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
101542050|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542051|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
101542052|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542061|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
101542062|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415004|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415006|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415007|NCT00127595|Gemcitabine|gemcitabine|mesh-list
101415008|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
101415009|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101415010|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
101542063|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542064|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101542065|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
101542066|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
101542068|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101542070|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101542071|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
101542072|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542073|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542075|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101542076|NCT01646775|Narcotics|narcotics|mesh-ancestor
101542077|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542078|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542079|NCT01646775|Analgesics|analgesics|mesh-ancestor
101542080|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
101542081|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542082|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542083|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542084|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
101542085|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
101542086|NCT01646853|Fluorouracil|fluorouracil|mesh-list
101542087|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542088|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
101542089|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542090|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101542092|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
101542093|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542094|NCT01647165|Dexamethasone|dexamethasone|mesh-list
101542095|NCT01647165|Lenalidomide|lenalidomide|mesh-list
101542096|NCT01647165|Bortezomib|bortezomib|mesh-list
101542097|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542098|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
101542099|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
101542100|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542101|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542102|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542103|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
101542104|NCT01647165|Hormones|hormones|mesh-ancestor
101542105|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542106|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101542107|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542108|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
101542109|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101542110|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101542111|NCT01647165|Growth Substances|growth substances|mesh-ancestor
101542112|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
101542113|NCT01681134|Tacrolimus|tacrolimus|mesh-list
101542114|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542115|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
101542116|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542117|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101542123|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101542124|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542125|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542126|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542127|NCT04541147|Dexamethasone|dexamethasone|mesh-list
101542128|NCT04541147|Analgesics|analgesics|mesh-list
101415011|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415012|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415013|NCT04665765|Rituximab|rituximab|mesh-list
101415014|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101415015|NCT04665765|Carboplatin|carboplatin|mesh-list
101415016|NCT04665765|Etoposide|etoposide|mesh-list
101415017|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
101415018|NCT04665765|Ifosfamide|ifosfamide|mesh-list
101415019|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
101415020|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
101415021|NCT04665765|Antibodies|antibodies|mesh-list
101415022|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
101415023|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101415024|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
101415025|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101542129|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542130|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
101542131|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
101542132|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542135|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
101542136|NCT04541147|Hormones|hormones|mesh-ancestor
101542137|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542138|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101542139|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542140|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
101542141|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
101542142|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101542143|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101542144|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542145|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
101542146|NCT04541303|Coagulants|coagulants|mesh-ancestor
101542147|NCT02214992|Telmisartan|telmisartan|mesh-list
101542148|NCT02214992|Ramipril|ramipril|mesh-list
101542149|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542150|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101542151|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101542152|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542153|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101542154|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
101542155|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542156|NCT04528095|Clozapine|clozapine|mesh-list
101542157|NCT04528095|Amisulpride|amisulpride|mesh-list
101542158|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101542159|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
101542160|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542161|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542162|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415027|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415028|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415029|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415030|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415031|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415032|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415034|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542163|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101542164|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542165|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542166|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101542167|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
101542168|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
101542170|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
101542171|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101542172|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
101542173|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
101542174|NCT04528056|Ambrisentan|ambrisentan|mesh-list
101542175|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542179|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
101542180|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542181|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542182|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542183|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542184|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542185|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542187|NCT04543565|Pradefovir|pradefovir|mesh-list
101542188|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
101542189|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542190|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101542191|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101542192|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542193|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542194|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101542195|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101542197|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542198|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542199|NCT04543370|Deflazacort|deflazacort|mesh-list
101542200|NCT04543370|Midazolam|midazolam|mesh-list
101542201|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542202|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101542203|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542205|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101542206|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542208|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542209|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
101542210|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
101542211|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
101542212|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
101542213|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542214|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542215|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542216|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542217|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
101542218|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
101542220|NCT01681563|Pentostatin|pentostatin|mesh-list
101542221|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415035|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101415036|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
101415037|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
101415038|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
101542222|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
101542225|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101542226|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
101542227|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542228|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542229|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101542231|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542232|NCT01681680|Metformin|metformin|mesh-list
101542233|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542234|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542235|NCT01647633|Calcium|calcium|mesh-list
101542236|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542237|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542238|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101542239|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542240|NCT01647984|Vitamins|vitamins|mesh-list
101542241|NCT01647984|Vitamin E|vitamin e|mesh-list
101542242|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
101542243|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
101542244|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542245|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
101542246|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542247|NCT01647984|Protective Agents|protective agents|mesh-ancestor
101542249|NCT02215382|Neostigmine|neostigmine|mesh-list
101542253|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
101542254|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542255|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542256|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101542257|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
101542258|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
101542259|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
101542260|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101542261|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101542262|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542263|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542264|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542265|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101542267|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101542268|NCT01682109|Valacyclovir|valacyclovir|mesh-list
101542269|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
101542270|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542271|NCT02215148|Tolvaptan|tolvaptan|mesh-list
101542272|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101542273|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542274|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
101542275|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542276|NCT01682343|Calcium|calcium|mesh-list
101542277|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542278|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542279|NCT01648257|Cabotegravir|cabotegravir|mesh-list
101542280|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101542281|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101542284|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101542285|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101542286|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
101542287|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542288|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
101542289|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101542290|NCT02215460|Azithromycin|azithromycin|mesh-list
101542291|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101415039|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415040|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415041|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415042|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
101415043|NCT00497107|Leucovorin|leucovorin|mesh-list
101415044|NCT00497107|Calcium|calcium|mesh-list
101542293|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
101542294|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
101542295|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101542296|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
101542297|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542298|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542299|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
101542300|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
101542301|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542302|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542303|NCT01648608|Exemestane|exemestane|mesh-list
101542304|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542305|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101542306|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101542307|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542308|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542309|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101542310|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
101542311|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542312|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542313|NCT02215538|Methylphenidate|methylphenidate|mesh-list
101542318|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542319|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542322|NCT01682421|Dexamethasone|dexamethasone|mesh-list
101542323|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
101542324|NCT01682421|BB 1101|bb 1101|mesh-list
101542325|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542326|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542327|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542328|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
101542329|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
101542331|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542332|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
101542333|NCT01682421|Hormones|hormones|mesh-ancestor
101542334|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542336|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542337|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
101542338|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542339|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
101542340|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
101542341|NCT01682499|Calcium|calcium|mesh-list
101542342|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542343|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542344|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101542345|NCT01682499|Analgesics|analgesics|mesh-ancestor
101542347|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542348|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
101415046|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101415047|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415048|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101415050|NCT00497107|Protective Agents|protective agents|mesh-ancestor
101415051|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
101415053|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
101415054|NCT00146289|Telmisartan|telmisartan|mesh-list
101415055|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542349|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542350|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101542351|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
101542352|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101542354|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542355|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
101542356|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101542357|NCT04540055|Anesthetics|anesthetics|mesh-list
101542358|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542359|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542360|NCT01180660|Lidocaine|lidocaine|mesh-list
101542361|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
101542362|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
101542363|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542364|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542365|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
101542366|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542367|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101542369|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101542370|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542371|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542372|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101542373|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101542374|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542377|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
101542378|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542392|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542394|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542395|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542397|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101542398|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542399|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542400|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542403|NCT01649037|Racepinephrine|racepinephrine|mesh-list
101542404|NCT01649037|Norepinephrine|norepinephrine|mesh-list
101542405|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
101542406|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101542407|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101542408|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
101542409|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542410|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542411|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542412|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101415057|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101415058|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415059|NCT01244932|Bupivacaine|bupivacaine|mesh-list
101415060|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
101415061|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
101415062|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542413|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101542414|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
101542415|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542416|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101542418|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
101542419|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
101542420|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101542421|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542422|NCT04539119|Tenofovir|tenofovir|mesh-list
101542423|NCT04539119|Entecavir|entecavir|mesh-list
101542424|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
101542425|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542426|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101542427|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101542428|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542429|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542430|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101542431|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101542433|NCT02279511|Analgesics|analgesics|mesh-ancestor
101542434|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
101542435|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542449|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542450|NCT02279628|Analgesics|analgesics|mesh-ancestor
101542451|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
101542452|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542453|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
101542454|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
101542455|NCT04542629|Trace Elements|trace elements|mesh-list
101542456|NCT04542629|Rituximab|rituximab|mesh-list
101542457|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542458|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542459|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
101542460|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542461|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542462|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
101542463|NCT01683006|Rocuronium|rocuronium|mesh-list
101542464|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101542465|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101542466|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101542467|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542468|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542469|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101542470|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101542471|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101542472|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101542473|NCT02215733|Telmisartan|telmisartan|mesh-list
101542476|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101542477|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101542478|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101542479|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542480|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
101542481|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542482|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101542483|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
101415063|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415065|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415066|NCT01244971|Acarbose|acarbose|mesh-list
101415067|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101415068|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415069|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542484|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542485|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
101542486|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
101542487|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101542488|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
101542489|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542490|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542491|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101542492|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
101542493|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
101542494|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101542495|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542496|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542497|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542509|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
101542511|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
101542512|NCT01201798|Difluprednate|difluprednate|mesh-list
101542513|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542514|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
101542516|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542517|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542518|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101542520|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
101542521|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
101542522|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542523|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542524|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101542526|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101542527|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
101542528|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101542529|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101542530|NCT01201759|Analgesics|analgesics|mesh-ancestor
101542531|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
101542532|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542533|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542534|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542535|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542536|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101542538|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542540|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101542541|NCT04532684|Analgesics|analgesics|mesh-ancestor
101542542|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
101542543|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542545|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
101542546|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101542547|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542548|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542549|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542550|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101542551|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542552|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542553|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415070|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415071|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415073|NCT04599894|Analgesics|analgesics|mesh-ancestor
101415074|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
101415075|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415076|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542554|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101542555|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101542556|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542557|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
101542558|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
101542566|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542568|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
101542570|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542571|NCT01683552|Fexofenadine|fexofenadine|mesh-list
101542572|NCT01683552|Prednisone|prednisone|mesh-list
101542573|NCT01683552|Aprepitant|aprepitant|mesh-list
101542574|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542575|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
101542576|NCT01683552|Hormones|hormones|mesh-ancestor
101542577|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542578|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542579|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101542581|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
101542582|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
101542583|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542584|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542585|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101542587|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542589|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101542590|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101542591|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
101542592|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
101542593|NCT01649544|Amiodarone|amiodarone|mesh-list
101542594|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101542595|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
101542596|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101542597|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542598|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542599|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101542601|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101542602|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542603|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101542604|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101542605|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101542606|NCT04528290|Ozanimod|ozanimod|mesh-list
101542607|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101542608|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542609|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542610|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
101542611|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542612|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
101542613|NCT01179334|Riociguat|riociguat|mesh-list
101542614|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
101542615|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101415078|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101415079|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415080|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415081|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101415082|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101415083|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101415084|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542616|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101542617|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542619|NCT01179334|Urological Agents|urological agents|mesh-ancestor
101542620|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
101542621|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101542622|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101542623|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
101542624|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542627|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101542628|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101542629|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542631|NCT01683747|Coagulants|coagulants|mesh-ancestor
101542632|NCT01178671|Mirtazapine|mirtazapine|mesh-list
101542633|NCT01178671|Sertraline|sertraline|mesh-list
101542634|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
101542635|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101542636|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101542637|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101542638|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542639|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542641|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
101542642|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542643|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101542644|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
101542645|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
101542646|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101542647|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542648|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542649|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101542650|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101542651|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101542652|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
101542654|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101542655|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101542656|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
101542657|NCT04532060|Nystatin|nystatin|mesh-list
101542658|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101542659|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
101542660|NCT04532060|Ionophores|ionophores|mesh-ancestor
101542662|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542663|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101542664|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
101542665|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101542666|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101542667|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542668|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542669|NCT01649739|Urological Agents|urological agents|mesh-ancestor
101415085|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415086|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101415087|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415088|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415090|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415092|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
101415093|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101542670|NCT04532333|Heparin|heparin|mesh-list
101542671|NCT04532333|Bivalirudin|bivalirudin|mesh-list
101542672|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
101542673|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101542674|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101542675|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542676|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
101542677|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101542678|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
101542679|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542680|NCT01649895|Cycloserine|cycloserine|mesh-list
101542681|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101542682|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542683|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101542684|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
101542685|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101542686|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
101542687|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542688|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101542689|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
101542690|NCT01649505|Coagulants|coagulants|mesh-ancestor
101542691|NCT01178086|Rituximab|rituximab|mesh-list
101542696|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542697|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
101542698|NCT04531865|Rituximab|rituximab|mesh-list
101542699|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542700|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542701|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
101542702|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542703|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542704|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101542705|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101542706|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
101542707|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101542708|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542709|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542710|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542711|NCT01643070|Capecitabine|capecitabine|mesh-list
101542712|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
101542713|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101542715|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542716|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542717|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
101542719|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542720|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
101542723|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
101542724|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542725|NCT04531748|Protective Agents|protective agents|mesh-ancestor
101542726|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542727|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542728|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415094|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415095|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415097|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
101415098|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415099|NCT00497341|Cefuroxime|cefuroxime|mesh-list
101415100|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
101415101|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101415102|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415103|NCT00127829|Gefitinib|gefitinib|mesh-list
101415104|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542729|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542730|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101542731|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101542733|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542734|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101542735|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101542736|NCT01177813|Empagliflozin|empagliflozin|mesh-list
101542737|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542738|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542739|NCT01177813|Incretins|incretins|mesh-ancestor
101542740|NCT01177813|Hormones|hormones|mesh-ancestor
101542741|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542742|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101542744|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542746|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101542747|NCT04315831|Buprenorphine|buprenorphine|mesh-list
101542748|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101542749|NCT04315831|Narcotics|narcotics|mesh-ancestor
101542750|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542751|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542752|NCT04315831|Analgesics|analgesics|mesh-ancestor
101542753|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
101542754|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542756|NCT02216045|Ribavirin|ribavirin|mesh-list
101542757|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101542758|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
101542771|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101542772|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542774|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542775|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
101542776|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542778|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
101542779|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101542780|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542781|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101542782|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542783|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542784|NCT01684449|Sirolimus|sirolimus|mesh-list
101542785|NCT01684449|Gemcitabine|gemcitabine|mesh-list
101542789|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542790|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101542791|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542792|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415105|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415107|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415108|NCT00497458|Testosterone|testosterone|mesh-list
101415109|NCT00497458|Androgens|androgens|mesh-ancestor
101415110|NCT00497458|Hormones|hormones|mesh-ancestor
101542793|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
101542794|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101542795|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
101542796|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542797|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
101542798|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
101542799|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
101542801|NCT01684683|Theophylline|theophylline|mesh-list
101542802|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101542803|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
101542804|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542805|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542806|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101542807|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101542809|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542810|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542811|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101542812|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101542813|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101542814|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
101542815|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542816|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101542817|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
101542818|NCT01684800|Coagulants|coagulants|mesh-ancestor
101542823|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101542824|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
101542825|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542827|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
101542828|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101542829|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
101542830|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542831|NCT04531163|Protective Agents|protective agents|mesh-ancestor
101542832|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542833|NCT04531163|Antidotes|antidotes|mesh-ancestor
101542834|NCT01684995|Nicotine|nicotine|mesh-list
101542835|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101542836|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
101542837|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542838|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542839|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101542840|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101542841|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542842|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542843|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542844|NCT01685502|Acarbose|acarbose|mesh-list
101542845|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101542846|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542847|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542848|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542849|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542850|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
101542851|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101542852|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542853|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
101542854|NCT01200355|Posaconazole|posaconazole|mesh-list
101542855|NCT01200355|Micafungin|micafungin|mesh-list
101542856|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
101415111|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415112|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415113|NCT00497497|Bevacizumab|bevacizumab|mesh-list
101415114|NCT00497497|Cetuximab|cetuximab|mesh-list
101415115|NCT00497497|Irinotecan|irinotecan|mesh-list
101542859|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101542860|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101542861|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101542862|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101542863|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542864|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542865|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101542866|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
101542867|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542868|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542869|NCT04527666|Anticoagulants|anticoagulants|mesh-list
101542870|NCT04530500|Androgens|androgens|mesh-list
101542871|NCT04530500|Hormones|hormones|mesh-ancestor
101542872|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542873|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542874|NCT01685658|Acetaminophen|acetaminophen|mesh-list
101542875|NCT01685658|Ketoprofen|ketoprofen|mesh-list
101542876|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101542877|NCT01685658|Analgesics|analgesics|mesh-ancestor
101542878|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
101542880|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542881|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
101542882|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101542883|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542884|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542885|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101542886|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542901|NCT01685853|Laxatives|laxatives|mesh-ancestor
101542902|NCT04530422|Azithromycin|azithromycin|mesh-list
101542903|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
101542904|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
101542905|NCT04530422|Oseltamivir|oseltamivir|mesh-list
101542906|NCT04530422|Ledipasvir|ledipasvir|mesh-list
101542907|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101542908|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542909|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
101542910|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101542911|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101542913|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542914|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101542915|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
101542916|NCT02887573|Mosapride|mosapride|mesh-list
101542917|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542918|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542920|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
101542921|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542922|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542923|NCT01685892|Venetoclax|venetoclax|mesh-list
101542924|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
101542925|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542926|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542927|NCT02887534|Tizanidine|tizanidine|mesh-list
101542928|NCT02887534|Analgesics|analgesics|mesh-ancestor
101542929|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
101542930|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542931|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415116|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415117|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415118|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101415119|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101415121|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415122|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
101415123|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101415124|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415125|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415126|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542933|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101542934|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101542935|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
101542936|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
101542937|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101542938|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101542940|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
101542941|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542942|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542943|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101542944|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101542945|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542946|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542948|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101542955|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101542956|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
101542957|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
101542958|NCT01685970|Cathartics|cathartics|mesh-ancestor
101542959|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542961|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
101542962|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542963|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542964|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101542965|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101542967|NCT01686009|Analgesics|analgesics|mesh-ancestor
101542968|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
101542969|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542970|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542971|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101542972|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542973|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
101542974|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
101542975|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542976|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101542977|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101542978|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542979|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542980|NCT04536662|Dexamethasone|dexamethasone|mesh-list
101542981|NCT04536662|Prednisone|prednisone|mesh-list
101542982|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
101542983|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101542984|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
101542985|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
101542986|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101542987|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415129|NCT00127868|Ciclopirox|ciclopirox|mesh-list
101415130|NCT00127868|Griseofulvin|griseofulvin|mesh-list
101415131|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
101415132|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
101415133|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415134|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101415135|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101415136|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415137|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415138|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101542988|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542989|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
101542991|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101542992|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101542993|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542994|NCT01686321|Rituximab|rituximab|mesh-list
101542996|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542997|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542998|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
101542999|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543001|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543002|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
101543003|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543005|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101543006|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101543007|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543008|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543009|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
101543010|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543011|NCT01686555|Venetoclax|venetoclax|mesh-list
101543012|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543019|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101543020|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543021|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
101543022|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543023|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
101543024|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543025|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
101543028|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543029|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543030|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101543031|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
101543032|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101543033|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
101543034|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543035|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543036|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101543037|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
101543039|NCT02217683|Protective Agents|protective agents|mesh-ancestor
101543040|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101415139|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415140|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415141|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415142|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101415143|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
101415144|NCT00127868|Protective Agents|protective agents|mesh-ancestor
101415145|NCT00127868|Trace Elements|trace elements|mesh-ancestor
101415146|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
101415147|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
101415148|NCT00497536|Insulin|insulin|mesh-list
101415149|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101415150|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
101543041|NCT02217722|Amoxicillin|amoxicillin|mesh-list
101543042|NCT02217722|Metronidazole|metronidazole|mesh-list
101543043|NCT02217722|Doxycycline|doxycycline|mesh-list
101543044|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543045|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543046|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543047|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
101543048|NCT02217839|Octreotide|octreotide|mesh-list
101543050|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543051|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543052|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
101543053|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101543054|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
101543055|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
101543056|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543057|NCT02217956|Bevacizumab|bevacizumab|mesh-list
101543058|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101543059|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543060|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101543061|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101543062|NCT02217956|Growth Substances|growth substances|mesh-ancestor
101543063|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543064|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
101543065|NCT01687140|Cycloserine|cycloserine|mesh-list
101543066|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101543067|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543068|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101543069|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
101543070|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543071|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
101543072|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543073|NCT04535960|Liraglutide|liraglutide|mesh-list
101543074|NCT04535960|Empagliflozin|empagliflozin|mesh-list
101543075|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543076|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543077|NCT04535960|Incretins|incretins|mesh-ancestor
101543079|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543080|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101543081|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543082|NCT04536428|Hemostatics|hemostatics|mesh-list
101543083|NCT04536428|Coagulants|coagulants|mesh-ancestor
101543084|NCT01687374|Hormones|hormones|mesh-list
101543085|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
101543086|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543092|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543094|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101543095|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
101543096|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
101415151|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
101415152|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101415153|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415154|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415156|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101415157|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415160|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
101415161|NCT00127907|Epinephrine|epinephrine|mesh-list
101415162|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101415163|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101543097|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543098|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101543099|NCT01687491|Enoxaparin|enoxaparin|mesh-list
101543100|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
101543101|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101543102|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101543103|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543104|NCT04530227|Paclitaxel|paclitaxel|mesh-list
101543105|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101543107|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101543108|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543109|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
101543110|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
101543111|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
101543112|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543113|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543114|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101543115|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101543118|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101543120|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
101543121|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
101543122|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
101543123|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543125|NCT02218034|Tazarotene|tazarotene|mesh-list
101543128|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
101543129|NCT02218034|Vitamins|vitamins|mesh-ancestor
101543130|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
101543131|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543132|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
101543133|NCT01688154|Procyanidin|procyanidin|mesh-list
101543134|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
101543135|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543136|NCT01688154|Protective Agents|protective agents|mesh-ancestor
101543137|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543138|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543139|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543142|NCT01688349|Hormones|hormones|mesh-ancestor
101543143|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543144|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543145|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
101543146|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101415164|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
101415165|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415166|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415168|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101415169|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101415170|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
101415171|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415172|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101415173|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
101415174|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
101543147|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101543148|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543150|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101543152|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101543153|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101543154|NCT04535804|Analgesics|analgesics|mesh-ancestor
101543155|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
101543156|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543157|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543191|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543192|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543193|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101543194|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101543195|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101543196|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543197|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543198|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101543199|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
101543201|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101543202|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543205|NCT01199068|Efatutazone|efatutazone|mesh-list
101543206|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543207|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101543208|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543209|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543210|NCT01198873|Dronedarone|dronedarone|mesh-list
101543211|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101543212|NCT01198795|Escitalopram|escitalopram|mesh-list
101543213|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101543214|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101543215|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101543217|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543218|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
101543219|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543220|NCT02278913|Insulin|insulin|mesh-list
101543221|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
101543222|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101543223|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543225|NCT02216513|Deferoxamine|deferoxamine|mesh-list
101543226|NCT02216513|Siderophores|siderophores|mesh-ancestor
101543227|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101543228|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
101415176|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101415178|NCT00127907|Coagulants|coagulants|mesh-ancestor
101415179|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101415180|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
101415181|NCT00497809|Lenograstim|lenograstim|mesh-list
101415182|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101415183|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
101415184|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415185|NCT00146484|Insulin|insulin|mesh-list
101415186|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415187|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415188|NCT00402584|Sibutramine|sibutramine|mesh-list
101415189|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
101415190|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415191|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
101543229|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
101543230|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543231|NCT02218775|Aticaprant|aticaprant|mesh-list
101543232|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101543233|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543234|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
101543235|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543236|NCT02216552|Resveratrol|resveratrol|mesh-list
101543237|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
101543238|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543239|NCT02216552|Protective Agents|protective agents|mesh-ancestor
101543240|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543241|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543242|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543243|NCT01198756|Vaccines|vaccines|mesh-list
101543244|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
101543245|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543246|NCT02216487|Irinotecan|irinotecan|mesh-list
101543247|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101543248|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543249|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543250|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543251|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543253|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
101543254|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
101543255|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543256|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543257|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
101543258|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543259|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101543264|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101543266|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543267|NCT01198132|Vitamin D|vitamin d|mesh-list
101543268|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
101543269|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
101543270|NCT01198132|Vitamins|vitamins|mesh-list
101543272|NCT01198132|Interferon-beta|interferon-beta|mesh-list
101543273|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
101543274|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
101543275|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543276|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101543277|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101543278|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415192|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101415193|NCT00498004|Risperidone|risperidone|mesh-list
101415194|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101415195|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101415196|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
101415197|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415198|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415199|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415200|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101415201|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101415202|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415203|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415204|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101415205|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
101543279|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
101543280|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543281|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
101543282|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101543283|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
101543284|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101543285|NCT02219165|Antibodies|antibodies|mesh-list
101543286|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
101543287|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543288|NCT04534478|Prednisone|prednisone|mesh-list
101543289|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543290|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
101543291|NCT04534478|Hormones|hormones|mesh-ancestor
101543292|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543293|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543294|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543295|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543297|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543298|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543299|NCT03772158|Cetirizine|cetirizine|mesh-list
101543300|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101543301|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101543302|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101417347|NCT00404391|Analgesics|analgesics|mesh-ancestor
101543303|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
101543304|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
101543305|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543306|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543307|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543308|NCT01196416|Cisplatin|cisplatin|mesh-list
101543309|NCT01196416|Temozolomide|temozolomide|mesh-list
101543310|NCT01196416|Vinblastine|vinblastine|mesh-list
101543311|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101543312|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
101543313|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543314|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543316|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543317|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101543318|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
101543319|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
101543320|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
101543321|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543322|NCT01196104|Insulin|insulin|mesh-list
101415207|NCT00146523|Mifepristone|mifepristone|mesh-list
101415208|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101415209|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
101415210|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101415211|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543323|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101543324|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
101543328|NCT04534322|Dexamethasone|dexamethasone|mesh-list
101543333|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543334|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543335|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543336|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
101543339|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543340|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543341|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543342|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
101543343|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543344|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101543345|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543346|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
101543347|NCT02219672|Ritonavir|ritonavir|mesh-list
101543348|NCT02219672|Lopinavir|lopinavir|mesh-list
101543349|NCT02219672|Tenofovir|tenofovir|mesh-list
101543350|NCT02219672|Lamivudine|lamivudine|mesh-list
101543351|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
101543352|NCT02219672|Triptolide|triptolide|mesh-list
101543353|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101543354|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101543374|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
101543375|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101543376|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
101543377|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543379|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101543380|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543382|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543383|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543384|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543385|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101543386|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543387|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415212|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101415213|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101415214|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101415216|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101543388|NCT04534452|Phenylephrine|phenylephrine|mesh-list
101543389|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
101543390|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101543391|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
101543392|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
101543393|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543394|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543395|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
101543396|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101543397|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
101543398|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101543399|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101543404|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543407|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543408|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543409|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101543410|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101543411|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
101543412|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543413|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543414|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101543415|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543416|NCT04533867|Ondansetron|ondansetron|mesh-list
101543417|NCT04533867|Palonosetron|palonosetron|mesh-list
101543418|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
101543419|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
101543420|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543421|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543422|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543423|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
101543424|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
101543425|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101543426|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101543427|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
101543428|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543429|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543431|NCT02219867|Analgesics|analgesics|mesh-ancestor
101543432|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
101543433|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543434|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543435|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101543436|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101543437|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
101543438|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
101543446|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543447|NCT02219906|Resveratrol|resveratrol|mesh-list
101543448|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
101543449|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415218|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415219|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415220|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
101415221|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101415222|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101415223|NCT00402623|Quercetin|quercetin|mesh-list
101543452|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543457|NCT04533243|Narcotics|narcotics|mesh-ancestor
101543458|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543459|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543460|NCT04533243|Analgesics|analgesics|mesh-ancestor
101543461|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
101543462|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543463|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101543469|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101543470|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543471|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543473|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
101543474|NCT01195675|Empagliflozin|empagliflozin|mesh-list
101543475|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
101543476|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543477|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543478|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101543479|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101543480|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543481|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543482|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543493|NCT04532931|Pyronaridine|pyronaridine|mesh-list
101543494|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101543495|NCT04532931|Analgesics|analgesics|mesh-ancestor
101543496|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
101543497|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543498|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543499|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
101543500|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
101543501|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543502|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
101543503|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543505|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543506|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
101543507|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101543508|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
101543509|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101543510|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
101543511|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101543513|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101543514|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543515|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543516|NCT01195090|Pioglitazone|pioglitazone|mesh-list
101543517|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101543518|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415225|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415226|NCT00402623|Protective Agents|protective agents|mesh-ancestor
101415227|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415231|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415232|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543519|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543520|NCT01195090|Incretins|incretins|mesh-ancestor
101543521|NCT01195090|Hormones|hormones|mesh-ancestor
101543522|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543523|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101543524|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
101543525|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543526|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543528|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101543529|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
101543530|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101543531|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543536|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101543565|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101543567|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543568|NCT02216747|Prednisone|prednisone|mesh-list
101543569|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543570|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
101543571|NCT02216747|Hormones|hormones|mesh-ancestor
101543572|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543573|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543574|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543575|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543576|NCT02216786|Everolimus|everolimus|mesh-list
101543577|NCT02216786|Fulvestrant|fulvestrant|mesh-list
101543578|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101543579|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101543580|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543581|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543582|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543583|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
101543584|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543589|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
101543590|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543592|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101543593|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543594|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543595|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
101543596|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543597|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543598|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101543599|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
101543602|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101543603|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101415233|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415234|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415235|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
101415236|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415239|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
101415240|NCT00498316|Melphalan|melphalan|mesh-list
101415241|NCT00498316|Busulfan|busulfan|mesh-list
101415242|NCT00498316|Rituximab|rituximab|mesh-list
101415243|NCT00498316|Fludarabine|fludarabine|mesh-list
101415244|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
101415245|NCT00498316|Clofarabine|clofarabine|mesh-list
101543604|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543605|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
101543606|NCT02279186|Coagulants|coagulants|mesh-ancestor
101543608|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101543609|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
101543610|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543611|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543612|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543613|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101543614|NCT01177384|Glimepiride|glimepiride|mesh-list
101543615|NCT01177384|Acarbose|acarbose|mesh-list
101543616|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543618|NCT01177384|Incretins|incretins|mesh-ancestor
101543619|NCT01177384|Hormones|hormones|mesh-ancestor
101543620|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543621|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101543622|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
101543623|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543625|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101543626|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543628|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101543629|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
101543630|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543631|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101543632|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543633|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543634|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
101543637|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101543638|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
101543639|NCT01194154|Hematinics|hematinics|mesh-ancestor
101543640|NCT01640210|Insulin|insulin|mesh-list
101543641|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543642|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543643|NCT01640405|Bevacizumab|bevacizumab|mesh-list
101543644|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101543645|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543646|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101543647|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101543648|NCT01640405|Growth Substances|growth substances|mesh-ancestor
101543649|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543650|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
101543651|NCT01640444|Bevacizumab|bevacizumab|mesh-list
101543652|NCT01640444|Cetuximab|cetuximab|mesh-list
101543655|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101543656|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101415247|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
101415248|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101415249|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415250|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
101415251|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543657|NCT01640444|Growth Substances|growth substances|mesh-ancestor
101543658|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543659|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
101543661|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101543662|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101543663|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101543664|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101543665|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
101543666|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543667|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543668|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543669|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
101543670|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101543672|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101543673|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543674|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101543676|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543677|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
101543678|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543679|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
101543680|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543681|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543682|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101543683|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101543685|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
101543686|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543687|NCT01642667|Saruplase|saruplase|mesh-list
101543688|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101543689|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101543690|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543691|NCT01642745|Mannitol|mannitol|mesh-list
101543692|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
101543694|NCT01642745|Diuretics|diuretics|mesh-ancestor
101543695|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
101543696|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543697|NCT01642745|Miotics|miotics|mesh-ancestor
101543698|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
101543699|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543700|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101543701|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101543702|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
101543703|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101543704|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101543705|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
101543706|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543707|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543708|NCT01640990|GW 328267|gw 328267|mesh-list
101543709|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101543710|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101543711|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
101543712|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
101543713|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543714|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543715|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543716|NCT01642862|Simvastatin|simvastatin|mesh-list
101543717|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101543718|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101415254|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
101415255|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415256|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415257|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101415258|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415259|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101543719|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
101543720|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543721|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101543733|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543734|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
101543735|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
101543736|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101543737|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543738|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543739|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543740|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543741|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543743|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101543744|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101543745|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543746|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101543747|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543748|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
101543749|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
101543751|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
101543752|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
101543753|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101543754|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101543755|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543756|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
101543757|NCT01643135|Coagulants|coagulants|mesh-ancestor
101543758|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
101543759|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101543760|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101543761|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543762|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101543763|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101543764|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543765|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543767|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
101543768|NCT01641419|BB 1101|bb 1101|mesh-list
101543769|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543770|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
101543772|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543773|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543774|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543776|NCT01641419|Hormones|hormones|mesh-ancestor
101543777|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543778|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543779|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415260|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
101415261|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415262|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101415263|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415264|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415265|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101415266|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
101415267|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543796|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543797|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543798|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543799|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
101543800|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543802|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
101543803|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543804|NCT01641575|Gemcitabine|gemcitabine|mesh-list
101543805|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543806|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101543807|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
101543808|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543809|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
101543810|NCT01643447|Urinastatin|urinastatin|mesh-list
101543811|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101543812|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101543813|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
101543814|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543815|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543816|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543818|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543867|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101543868|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543869|NCT01643759|Analgesics|analgesics|mesh-ancestor
101543870|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
101543871|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543872|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101543874|NCT04488237|Vitamins|vitamins|mesh-ancestor
101543875|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
101543876|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543877|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101543878|NCT04528628|Norepinephrine|norepinephrine|mesh-list
101543880|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101543881|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
101543882|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101543884|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
101543885|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543886|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543887|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543888|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
101543889|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
101543890|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543891|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101543892|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101543893|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101543894|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
101543895|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101543896|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
101543897|NCT01641341|Pancrelipase|pancrelipase|mesh-list
101543898|NCT01641341|Pancreatin|pancreatin|mesh-list
101543899|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543900|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543901|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543908|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
101543909|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543910|NCT01680146|Caseins|caseins|mesh-list
101543911|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
101543912|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
101543913|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543914|NCT01680185|Insulin|insulin|mesh-list
101543915|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101543916|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
101543917|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
101543918|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
101543919|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
101415279|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101415280|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415281|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415282|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543920|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
101543921|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543922|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543923|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101543924|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101543925|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101543926|NCT01680263|Analgesics|analgesics|mesh-ancestor
101543927|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
101543928|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543929|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543930|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543931|NCT01601730|Dexetimide|dexetimide|mesh-list
101543932|NCT01601730|Modafinil|modafinil|mesh-list
101543933|NCT01601730|Citalopram|citalopram|mesh-list
101543934|NCT01601730|Escitalopram|escitalopram|mesh-list
101543935|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101543936|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101543937|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101543938|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543939|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543940|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
101543941|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543942|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101543943|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101543944|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
101543945|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
101543946|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543947|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101543948|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101543949|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
101543950|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101543951|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
101543952|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101543953|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101222175|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543954|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101543955|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101543956|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101543958|NCT01644071|Citalopram|citalopram|mesh-list
101543959|NCT01644071|Escitalopram|escitalopram|mesh-list
101543960|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101543961|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101543962|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101543963|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543964|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543966|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543967|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101543977|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101543978|NCT01680536|Maraviroc|maraviroc|mesh-list
101543979|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101543980|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101543981|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543982|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101543983|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101543984|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
101543985|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543986|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101543987|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101543988|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543989|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543990|NCT01602003|Incretins|incretins|mesh-ancestor
101543991|NCT01602003|Hormones|hormones|mesh-ancestor
101415283|NCT00498589|Methotrexate|methotrexate|mesh-list
101415284|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101415285|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
101415286|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101415287|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415288|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101415289|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
101415290|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415291|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415292|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101415293|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415294|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101543992|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543993|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101543994|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
101543995|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543996|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543997|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101543998|NCT01193920|Vaccines|vaccines|mesh-list
101543999|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
101544000|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544001|NCT01644773|Dasatinib|dasatinib|mesh-list
101544002|NCT01644773|Crizotinib|crizotinib|mesh-list
101544003|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544004|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101544005|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544006|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544007|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
101544008|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
101544009|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101544010|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101544011|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544012|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544013|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544014|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544015|NCT01681550|Incretins|incretins|mesh-list
101544016|NCT01681550|Hormones|hormones|mesh-ancestor
101544017|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544018|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544019|NCT01645085|Mannitol|mannitol|mesh-list
101544020|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101544021|NCT01645085|Diuretics|diuretics|mesh-ancestor
101544022|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
101544023|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544024|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
101544025|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544026|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
101544027|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544028|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544029|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101544030|NCT01602861|Spironolactone|spironolactone|mesh-list
101544031|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101544032|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
101544059|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544060|NCT01602900|Rolipram|rolipram|mesh-list
101544061|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544062|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544063|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101544064|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101415295|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415296|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
101415297|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415298|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101415299|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
101544065|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544066|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544067|NCT01645241|Ganirelix|ganirelix|mesh-list
101544068|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
101544069|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544070|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544071|NCT01602939|Cladribine|cladribine|mesh-list
101544072|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544073|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101544074|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
101544075|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544076|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
101544077|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101544078|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
101544079|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544084|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544086|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
101544087|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544088|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101544089|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
101544090|NCT01603134|Protective Agents|protective agents|mesh-ancestor
101544091|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544092|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101544093|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544094|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544095|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101544096|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101544097|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544098|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544099|NCT01603212|Interferons|interferons|mesh-list
101544100|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
101544101|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
101544102|NCT01603212|Aldesleukin|aldesleukin|mesh-list
101544103|NCT01603212|Interleukin-2|interleukin-2|mesh-list
101544104|NCT01603212|Vemurafenib|vemurafenib|mesh-list
101544105|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544106|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
101544107|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544108|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
101544109|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544110|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544111|NCT01603212|Analgesics|analgesics|mesh-ancestor
101544112|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
101544113|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544114|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101544115|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101544116|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101544117|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544118|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544119|NCT01645748|Cisplatin|cisplatin|mesh-list
101544120|NCT01645748|Docetaxel|docetaxel|mesh-list
101544121|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544122|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544123|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544124|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544125|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544126|NCT02484924|Clopidogrel|clopidogrel|mesh-list
101544127|NCT02484924|Ticagrelor|ticagrelor|mesh-list
101544128|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101544129|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101544130|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101544131|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101544132|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
101544133|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544134|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415300|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101415301|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
101415302|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101415303|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415304|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101415305|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101415306|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101544135|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544136|NCT01645826|Diltiazem|diltiazem|mesh-list
101544137|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101544138|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101544139|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544140|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544141|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101544142|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544143|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101544144|NCT01607034|Pramipexole|pramipexole|mesh-list
101544145|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
101544146|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544147|NCT01607034|Protective Agents|protective agents|mesh-ancestor
101544148|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544149|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101544159|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544160|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
101544161|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101544163|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101544164|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544165|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544166|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544167|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544168|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544169|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544170|NCT01646294|Urological Agents|urological agents|mesh-ancestor
101544171|NCT01603758|Ezetimibe|ezetimibe|mesh-list
101544172|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101544173|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101544174|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
101544175|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544176|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101544177|NCT01177228|Vedolizumab|vedolizumab|mesh-list
101544178|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544179|NCT02279342|Febuxostat|febuxostat|mesh-list
101544180|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
101544181|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544182|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101544183|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
101544184|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101544185|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544186|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
101544187|NCT01646567|Betamethasone|betamethasone|mesh-list
101544188|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
101544189|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101544190|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
101544191|NCT01646567|Calcipotriene|calcipotriene|mesh-list
101544192|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101544193|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544194|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
101544195|NCT01646567|Hormones|hormones|mesh-ancestor
101544196|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544197|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544198|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101544199|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
101544200|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
101544201|NCT01681979|Fluticasone|fluticasone|mesh-list
101544202|NCT01681979|Xhance|xhance|mesh-list
101544203|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101544204|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415308|NCT00498901|Leuprolide|leuprolide|mesh-list
101415309|NCT00498901|Goserelin|goserelin|mesh-list
101415310|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415311|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101415312|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101415313|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415314|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415315|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101415316|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
101544205|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101544206|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
101544207|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544208|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544209|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101544210|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
101544211|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
101544212|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101544213|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101544214|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544215|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544216|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544217|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544218|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544225|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101544226|NCT01607580|Prednisolone|prednisolone|mesh-list
101544227|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
101544228|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101544229|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
101544230|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
101544231|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544232|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
101544233|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
101544234|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544235|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544236|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544238|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222203|NCT01511731|Famotidine|famotidine|mesh-list
101544239|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101544240|NCT01607580|Protective Agents|protective agents|mesh-ancestor
101544241|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101544242|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544243|NCT01647152|Ustekinumab|ustekinumab|mesh-list
101544244|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
101544245|NCT01604187|Fentanyl|fentanyl|mesh-list
101544246|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544247|NCT01604187|Narcotics|narcotics|mesh-ancestor
101544248|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544249|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544250|NCT01604187|Analgesics|analgesics|mesh-ancestor
101544251|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
101544252|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544253|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101544254|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101544255|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
101544256|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
101544257|NCT01604382|Remifentanil|remifentanil|mesh-list
101544258|NCT01604382|Bupivacaine|bupivacaine|mesh-list
101544259|NCT01604382|Anesthetics|anesthetics|mesh-list
101544260|NCT01604382|Propofol|propofol|mesh-list
101544261|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
101544262|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544263|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544264|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
101544265|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544266|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101415317|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415318|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415319|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101415320|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
101415321|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101415322|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415323|NCT00498979|Interferons|interferons|mesh-list
101415324|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
101415325|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
101415326|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
101415327|NCT00498979|Dacarbazine|dacarbazine|mesh-list
101415328|NCT00498979|Vinblastine|vinblastine|mesh-list
101544267|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101544268|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
101544269|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544270|NCT01604382|Narcotics|narcotics|mesh-ancestor
101544271|NCT01604382|Analgesics|analgesics|mesh-ancestor
101544272|NCT01682408|Mannitol|mannitol|mesh-list
101544273|NCT01682408|Ranitidine|ranitidine|mesh-list
101544274|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101544275|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101544276|NCT01682408|Diuretics|diuretics|mesh-ancestor
101544277|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
101544278|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544279|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101544280|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544281|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101544282|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
101544283|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
101544284|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544285|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544286|NCT01607970|Oxytocin|oxytocin|mesh-list
101544293|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544294|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544295|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544296|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544297|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
101544298|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101544299|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544300|NCT01604031|Lenalidomide|lenalidomide|mesh-list
101544301|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
101544302|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544303|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101544304|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101544305|NCT01604031|Growth Substances|growth substances|mesh-ancestor
101544306|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
101544307|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544308|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
101544309|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101544310|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101544311|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101544312|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544314|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
101544316|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544317|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544318|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
101544319|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544320|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101544321|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101544322|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101544323|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415329|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415330|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
101415331|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415332|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
101415333|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415334|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101415335|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
101415336|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415337|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415338|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415339|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415340|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415341|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415342|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101415343|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
101415344|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101544324|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544325|NCT01647659|Trametinib|trametinib|mesh-list
101544326|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544327|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101544328|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544329|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544330|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
101544331|NCT01604811|Tamsulosin|tamsulosin|mesh-list
101544332|NCT01604811|Urological Agents|urological agents|mesh-ancestor
101544333|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101544334|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101544335|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101544336|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544337|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544338|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544339|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544340|NCT01683032|Methylphenidate|methylphenidate|mesh-list
101544341|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101544342|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544343|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101544344|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101544345|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544346|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544347|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
101544348|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544349|NCT01604928|Mirabegron|mirabegron|mesh-list
101544350|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101544351|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101544352|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544356|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544357|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222215|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101544358|NCT01604928|Urological Agents|urological agents|mesh-ancestor
101544359|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101544360|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101544361|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
101544362|NCT01683149|Sorafenib|sorafenib|mesh-list
101544363|NCT01683149|Topotecan|topotecan|mesh-list
101544364|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
101544365|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544366|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415345|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
101415346|NCT01245205|Lapatinib|lapatinib|mesh-list
101415347|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415348|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415349|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415350|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544367|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544368|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544369|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101544370|NCT01608555|Tobramycin|tobramycin|mesh-list
101544371|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101544372|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544373|NCT01605084|Ritonavir|ritonavir|mesh-list
101544374|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101544376|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101544377|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101544378|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
101544379|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544380|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544381|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101544382|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101544383|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
101544384|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544385|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101544386|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101544387|NCT01647893|Bivalirudin|bivalirudin|mesh-list
101544388|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
101544389|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101544390|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
101544391|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544392|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544393|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
101544395|NCT01648010|Mitomycin|mitomycin|mesh-list
101544396|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101544397|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544398|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
101544399|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544400|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101544401|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544402|NCT01605318|Irinotecan|irinotecan|mesh-list
101544403|NCT01605318|Labetuzumab|labetuzumab|mesh-list
101544404|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
101544405|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
101544406|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544407|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101544408|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101544409|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544410|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544411|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544412|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544413|NCT01608711|Gemcitabine|gemcitabine|mesh-list
101544414|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101544415|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
101544416|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544417|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544418|NCT01605357|Mannitol|mannitol|mesh-list
101544419|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101544420|NCT01605357|Diuretics|diuretics|mesh-ancestor
101544421|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
101544422|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544423|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101544429|NCT01608750|Vitamins|vitamins|mesh-ancestor
101544430|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
101544431|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544432|NCT01605513|Interferons|interferons|mesh-list
101544433|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415351|NCT01245244|Morphine|morphine|mesh-list
101415352|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101415353|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101415354|NCT01245244|Narcotics|narcotics|mesh-ancestor
101415355|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415356|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415357|NCT01245244|Analgesics|analgesics|mesh-ancestor
101415358|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
101415359|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544434|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
101544435|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544436|NCT04528277|Isoniazid|isoniazid|mesh-list
101544437|NCT04528277|Rifapentine|rifapentine|mesh-list
101544438|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
101544439|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101544440|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544441|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101544442|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101544443|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
101544444|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544445|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101544446|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101544447|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
101544448|NCT01683656|Niacin|niacin|mesh-list
101544449|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101544450|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
101544451|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544452|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101544453|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
101544454|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
101544455|NCT01683656|Vitamins|vitamins|mesh-ancestor
101544456|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
101544457|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544458|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101544459|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101544460|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544461|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
101544462|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101544463|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101544464|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101544465|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544466|NCT01608984|Sufentanil|sufentanil|mesh-list
101544467|NCT01608984|Isoflurane|isoflurane|mesh-list
101544468|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544469|NCT01608984|Narcotics|narcotics|mesh-ancestor
101544470|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544471|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544472|NCT01608984|Analgesics|analgesics|mesh-ancestor
101544473|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
101544474|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544475|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101544476|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101544477|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
101544478|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
101544479|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101544480|NCT01648517|Carboplatin|carboplatin|mesh-list
101544481|NCT01648517|Gemcitabine|gemcitabine|mesh-list
101544482|NCT01648517|Docetaxel|docetaxel|mesh-list
101544483|NCT01648517|Vinorelbine|vinorelbine|mesh-list
101544484|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544485|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101544486|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
101544487|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544488|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415360|NCT00405717|Atorvastatin|atorvastatin|mesh-list
101415361|NCT00405717|Pravastatin|pravastatin|mesh-list
101415362|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101415363|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101415364|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
101415365|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415366|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101415367|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101415368|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415369|NCT00499018|Cytarabine|cytarabine|mesh-list
101415370|NCT00499018|Prednisone|prednisone|mesh-list
101544489|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544490|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544491|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101544492|NCT01609101|Cobalt|cobalt|mesh-list
101544493|NCT01609101|Trace Elements|trace elements|mesh-ancestor
101544497|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544498|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
101544499|NCT01648556|Hormones|hormones|mesh-ancestor
101544500|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544501|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544502|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101544503|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544504|NCT01648595|Fentanyl|fentanyl|mesh-list
101544505|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544506|NCT01648595|Narcotics|narcotics|mesh-ancestor
101544507|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544508|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544509|NCT01648595|Analgesics|analgesics|mesh-ancestor
101544510|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
101544511|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544512|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101544513|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101544514|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
101544515|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
101544516|NCT01648634|Nebivolol|nebivolol|mesh-list
101544517|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101544518|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
101544519|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101544520|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544521|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544522|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544523|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544524|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544525|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544526|NCT01606059|Acetaminophen|acetaminophen|mesh-list
101544527|NCT01606059|Tramadol|tramadol|mesh-list
101544528|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544529|NCT01606059|Analgesics|analgesics|mesh-ancestor
101544530|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
101544531|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544532|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544533|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
101544534|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544535|NCT01606059|Narcotics|narcotics|mesh-ancestor
101544536|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544537|NCT01648712|Heparin|heparin|mesh-list
101544538|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
101544539|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101544540|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101544541|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544542|NCT01688544|Benzimidazole|benzimidazole|mesh-list
101544543|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
101415371|NCT00499018|Rituximab|rituximab|mesh-list
101415372|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
101415373|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
101415374|NCT00499018|Vincristine|vincristine|mesh-list
101415375|NCT00499018|Doxorubicin|doxorubicin|mesh-list
101415376|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101415377|NCT00499018|Lenograstim|lenograstim|mesh-list
101415378|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544544|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101544545|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544546|NCT01688583|Fentanyl|fentanyl|mesh-list
101544547|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544548|NCT01688583|Narcotics|narcotics|mesh-ancestor
101544549|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544550|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544551|NCT01688583|Analgesics|analgesics|mesh-ancestor
101544552|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
101544553|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544554|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101544555|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101544556|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
101544557|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
101544558|NCT01648829|Atorvastatin|atorvastatin|mesh-list
101544559|NCT01648829|Pitavastatin|pitavastatin|mesh-list
101544560|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101544561|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101544562|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
101544563|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544564|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101544570|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544571|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544572|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544573|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544574|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544575|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544577|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
101544578|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
101544579|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
101544580|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544581|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544582|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544583|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101544584|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544585|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101544586|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101544587|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544588|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
101544589|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
101544590|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544591|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544592|NCT01684241|Vaccines|vaccines|mesh-list
101544593|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
101544594|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544595|NCT01688934|Naproxen|naproxen|mesh-list
101544596|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101544597|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544598|NCT01688934|Analgesics|analgesics|mesh-ancestor
101544599|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
101544600|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544601|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544602|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544603|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544604|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
101544605|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101415380|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
101415381|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415382|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415383|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415384|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
101415386|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544606|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544607|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544608|NCT01684319|Caseins|caseins|mesh-list
101544609|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
101544610|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
101544611|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544613|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101544614|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101544615|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544616|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544617|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544619|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544620|NCT02279615|Tamsulosin|tamsulosin|mesh-list
101544621|NCT02279615|Mirabegron|mirabegron|mesh-list
101544622|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101544623|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101544624|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101544625|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544626|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544627|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544628|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544629|NCT02279615|Urological Agents|urological agents|mesh-ancestor
101544630|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101544631|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544635|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544636|NCT01689051|Hormones|hormones|mesh-ancestor
101544637|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544638|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544639|NCT01689051|Incretins|incretins|mesh-ancestor
101544640|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
101544641|NCT01689090|Citric Acid|citric acid|mesh-list
101544642|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
101544643|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
101544644|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
101544645|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101544646|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
101544647|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
101544648|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544649|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101544650|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544651|NCT01689090|Analgesics|analgesics|mesh-ancestor
101544652|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
101544653|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544654|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544655|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544656|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544657|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544658|NCT01689129|Insulin|insulin|mesh-list
101544659|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101544660|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
101544661|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101544662|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544663|NCT01689285|Valacyclovir|valacyclovir|mesh-list
101544664|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
101544665|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544666|NCT01606527|Ibuprofen|ibuprofen|mesh-list
101544667|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101544668|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544669|NCT01606527|Analgesics|analgesics|mesh-ancestor
101415387|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415388|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101415389|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
101415390|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415391|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
101415392|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415393|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415394|NCT00499018|Analgesics|analgesics|mesh-ancestor
101415395|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
101415396|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415397|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415398|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415399|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544670|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
101544671|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544672|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544673|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544674|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544675|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101544676|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544677|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544678|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101544679|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101544680|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544681|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
101544682|NCT01609413|Antacids|antacids|mesh-ancestor
101544683|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544684|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544685|NCT02279966|Vortioxetine|vortioxetine|mesh-list
101544686|NCT02279966|Paroxetine|paroxetine|mesh-list
101544687|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101544688|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101544689|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544690|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544691|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544692|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
101544693|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544694|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101544695|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544696|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544697|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101544698|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101544699|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544700|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101544705|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101544706|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101544707|NCT01684787|Ribavirin|ribavirin|mesh-list
101544708|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101544709|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
101544710|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
101544711|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544712|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
101544713|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544714|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
101544715|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544716|NCT01649258|Granisetron|granisetron|mesh-list
101415400|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101415401|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
101415402|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101415403|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101415404|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415405|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415406|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415407|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544717|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
101544718|NCT01649258|Aprepitant|aprepitant|mesh-list
101544719|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
101544720|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
101544721|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544722|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544723|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544724|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101544725|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101544726|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
101544727|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544728|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544729|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101544731|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
101544732|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101544733|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544734|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544735|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544736|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544737|NCT01609491|Phenylephrine|phenylephrine|mesh-list
101544738|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
101544739|NCT01609491|Norepinephrine|norepinephrine|mesh-list
101544740|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101544741|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
101544742|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
101544743|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544744|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544745|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
101544746|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101544747|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
101544748|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
101544749|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101544750|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101544751|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544752|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544753|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544754|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544755|NCT01609491|Protective Agents|protective agents|mesh-ancestor
101544757|NCT01606878|Doxorubicin|doxorubicin|mesh-list
101544758|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101544759|NCT01606878|Vincristine|vincristine|mesh-list
101544760|NCT01606878|Topotecan|topotecan|mesh-list
101544761|NCT01606878|Crizotinib|crizotinib|mesh-list
101544762|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
101544763|NCT01606878|Razoxane|razoxane|mesh-list
101544764|NCT01606878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101544765|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101544766|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
101544767|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544768|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544769|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101544770|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
101544776|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101544777|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544778|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415408|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415410|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101415411|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
101415412|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101415413|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
101415414|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101415415|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
101415416|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415417|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
101415418|NCT00127985|Hormones|hormones|mesh-ancestor
101415419|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415420|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415421|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101544779|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
101544780|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
101544781|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
101544782|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101544783|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101544784|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101544785|NCT01606878|Protective Agents|protective agents|mesh-ancestor
101544786|NCT01684865|Rituximab|rituximab|mesh-list
101544787|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544788|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544790|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544791|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544793|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101544794|NCT01580163|Narcotics|narcotics|mesh-ancestor
101544795|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544796|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544797|NCT01580163|Analgesics|analgesics|mesh-ancestor
101544798|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
101544799|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544800|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
101544801|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
101544802|NCT01609647|Clopidogrel|clopidogrel|mesh-list
101544803|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101544804|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101544805|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101544806|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101544807|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101544808|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
101544809|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544810|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544811|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544812|NCT01580202|Lamivudine|lamivudine|mesh-list
101544813|NCT01580202|Entecavir|entecavir|mesh-list
101544814|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101544815|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101544816|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544817|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544818|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
101544819|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544820|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101544821|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101544822|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
101544823|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415422|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415425|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415426|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101415427|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101415428|NCT00127985|Protective Agents|protective agents|mesh-ancestor
101544824|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544825|NCT01609881|Ketorolac|ketorolac|mesh-list
101544826|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101544828|NCT01609881|Analgesics|analgesics|mesh-ancestor
101544829|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
101544830|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544831|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544832|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544833|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544834|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101544835|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544836|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544837|NCT01609959|Valsartan|valsartan|mesh-list
101544838|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101544839|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101544845|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544846|NCT01606098|Bevacizumab|bevacizumab|mesh-list
101544847|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544848|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544849|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101544850|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101544851|NCT01606098|Growth Substances|growth substances|mesh-ancestor
101544852|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544853|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
101544854|NCT01649921|Interferons|interferons|mesh-list
101544855|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
101544856|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544857|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
101544858|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544859|NCT01606566|Bleomycin|bleomycin|mesh-list
101544860|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101544861|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544862|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
101544863|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101544865|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544866|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544867|NCT01649999|Peficitinib|peficitinib|mesh-list
101544868|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544869|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544870|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101544871|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
101544872|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544873|NCT01604889|Ipilimumab|ipilimumab|mesh-list
101544874|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101544875|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544876|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101544877|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544878|NCT01685762|Metformin|metformin|mesh-list
101544879|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101544880|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544881|NCT01602822|Ritonavir|ritonavir|mesh-list
101544882|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101544883|NCT01602822|Tenofovir|tenofovir|mesh-list
101544884|NCT01602822|Emtricitabine|emtricitabine|mesh-list
101544885|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101544886|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101544887|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101544888|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
101415429|NCT00424164|Tamoxifen|tamoxifen|mesh-list
101415430|NCT00424164|Lapatinib|lapatinib|mesh-list
101415431|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415432|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101415433|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415434|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415435|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544889|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544890|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544891|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101544892|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101544893|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
101544894|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544895|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101544896|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101544897|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101544898|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101544899|NCT02273154|Buspirone|buspirone|mesh-list
101544900|NCT02273154|Paroxetine|paroxetine|mesh-list
101544901|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101544902|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101544903|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544904|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544905|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544906|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
101544910|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544911|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101544912|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101544913|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544914|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101544915|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101544916|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544917|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101544918|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
101544919|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101544920|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544921|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544922|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
101544923|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101544924|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544925|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544926|NCT02270034|Crizotinib|crizotinib|mesh-list
101544927|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544928|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101544929|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544930|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544931|NCT02273271|Alovudine|alovudine|mesh-list
101544932|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
101544933|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544934|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
101544935|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101544936|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
101544937|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544938|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544939|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101544940|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
101544941|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544942|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544943|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101544944|NCT02270424|Fluticasone|fluticasone|mesh-list
101415436|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101415437|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415438|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101415439|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101415440|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101415441|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415442|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544945|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101544946|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101544947|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544948|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101544949|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
101544950|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544951|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544952|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101544953|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101544954|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
101544955|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101544956|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101544957|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101544958|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544959|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544960|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544961|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544962|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
101544963|NCT02270424|Hormones|hormones|mesh-ancestor
101544964|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544965|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
101544966|NCT01686347|Ropivacaine|ropivacaine|mesh-list
101544967|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
101544968|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
101544969|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544970|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544971|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
101544976|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101544977|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101544978|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
101544979|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544980|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544981|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
101544982|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101544983|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101544984|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101544985|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101544986|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544987|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544988|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544989|NCT01688570|Analgesics|analgesics|mesh-ancestor
101544990|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
101544991|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544992|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544993|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101544994|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
101544995|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
101544996|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
101544997|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101544998|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101544999|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
101545000|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
101545001|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101545002|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
101545003|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101415443|NCT00499135|Alovudine|alovudine|mesh-list
101415444|NCT00499135|Sunitinib|sunitinib|mesh-list
101415445|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415446|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101415447|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101415448|NCT00499135|Growth Substances|growth substances|mesh-ancestor
101415449|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415450|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
101545004|NCT01686464|Valacyclovir|valacyclovir|mesh-list
101545005|NCT01686464|Prednisone|prednisone|mesh-list
101545006|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545007|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
101545008|NCT01686464|Hormones|hormones|mesh-ancestor
101545009|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545010|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545011|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545012|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545013|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
101545014|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545015|NCT02270970|Belimumab|belimumab|mesh-list
101545016|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545017|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
101545018|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545019|NCT01688648|Lidocaine|lidocaine|mesh-list
101545020|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
101545021|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
101545022|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
101545023|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545024|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545025|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
101545026|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545027|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101545028|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101545029|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101545030|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101545031|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545032|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545033|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545034|NCT01688648|Analgesics|analgesics|mesh-ancestor
101545035|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101545041|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545042|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545043|NCT01686659|Analgesics|analgesics|mesh-ancestor
101545044|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
101545045|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545046|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545047|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545048|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545049|NCT02271126|Heparin|heparin|mesh-list
101545050|NCT02271126|Thromboplastin|thromboplastin|mesh-list
101545051|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
101545052|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101545053|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101545054|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545055|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
101545056|NCT02271126|Coagulants|coagulants|mesh-ancestor
101545057|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
101545058|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101545060|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
101545061|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545062|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
101415451|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415452|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415453|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415454|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
101415455|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415456|NCT01245361|Infliximab|infliximab|mesh-list
101545063|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101545064|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545065|NCT02271282|Toremifene|toremifene|mesh-list
101545066|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545067|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545068|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101545069|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101545070|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545071|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545072|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545073|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101545074|NCT01688960|Aflibercept|aflibercept|mesh-list
101545075|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101545096|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101545097|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101545098|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
101545099|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545100|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545101|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101545103|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
101545104|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545105|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545107|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
101545108|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545109|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545110|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545111|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545112|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101545113|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101545114|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545115|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101415458|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415459|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
101415460|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101415461|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415462|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
101415463|NCT00424203|Doxorubicin|doxorubicin|mesh-list
101415464|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101415465|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545116|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101545117|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545118|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
101545119|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101545120|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
101545121|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101545122|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101545124|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
101545125|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101545126|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101545127|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545133|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101545135|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545136|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545137|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101545138|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101545139|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101545140|NCT02271555|Remifentanil|remifentanil|mesh-list
101545141|NCT02271555|Sevoflurane|sevoflurane|mesh-list
101545142|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101545143|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101545144|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
101545145|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
101545146|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545147|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545149|NCT02271555|Narcotics|narcotics|mesh-ancestor
101545150|NCT02271555|Analgesics|analgesics|mesh-ancestor
101545151|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
101545152|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545153|NCT01687205|Tenofovir|tenofovir|mesh-list
101545154|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
101545155|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545156|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101545157|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101545158|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545159|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545161|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101545162|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
101545163|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101545164|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101545165|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545166|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101545167|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101545168|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545169|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545170|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545171|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101545172|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
101545173|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545174|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545175|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101545176|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101415466|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
101415467|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415468|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415469|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101415470|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
101415471|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415472|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415474|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415475|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101545177|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101545179|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545180|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
101545181|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
101545182|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
101545183|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545184|NCT01687439|Vinorelbine|vinorelbine|mesh-list
101545185|NCT01687439|Endostar protein|endostar protein|mesh-list
101545186|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545187|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101545188|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
101545189|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
101545190|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
101545191|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545192|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101545197|NCT01588704|Bevacizumab|bevacizumab|mesh-list
101545199|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101545200|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545201|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101545202|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101545203|NCT01588704|Growth Substances|growth substances|mesh-ancestor
101545204|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545205|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
101545206|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545207|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545208|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101545209|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101545211|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545212|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545213|NCT01689311|Alprostadil|alprostadil|mesh-list
101545214|NCT01689311|Misoprostol|misoprostol|mesh-list
101545215|NCT01689311|Oxytocin|oxytocin|mesh-list
101545216|NCT01689311|Ergonovine|ergonovine|mesh-list
101545217|NCT01689311|Dinoprost|dinoprost|mesh-list
101545218|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
101545219|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
101545220|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545221|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545222|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101545223|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
101545224|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101545225|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545226|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101545227|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
101545228|NCT01689311|Urological Agents|urological agents|mesh-ancestor
101545229|NCT01588782|Ketoconazole|ketoconazole|mesh-list
101545230|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
101545231|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545232|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101415476|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415477|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415479|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415480|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415481|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101415482|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415483|NCT00499525|Paclitaxel|paclitaxel|mesh-list
101415484|NCT00499525|Sorafenib|sorafenib|mesh-list
101415485|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101545233|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101545234|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545235|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545236|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101545237|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545238|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545239|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545240|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101545241|NCT02272101|Vitamin D|vitamin d|mesh-list
101545242|NCT02272101|Vitamins|vitamins|mesh-ancestor
101545243|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
101545244|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545245|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101545246|NCT02278133|Cetuximab|cetuximab|mesh-list
101545247|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101545248|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545249|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
101545250|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545251|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545252|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545253|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545254|NCT01687868|Analgesics|analgesics|mesh-ancestor
101545255|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
101545256|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545257|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101545258|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101545263|NCT01688024|Mitomycins|mitomycins|mesh-list
101545264|NCT01688024|Mitomycin|mitomycin|mesh-list
101545265|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101545266|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545267|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
101545268|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545269|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101545270|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545271|NCT01689623|Simeprevir|simeprevir|mesh-list
101545272|NCT01689623|Atorvastatin|atorvastatin|mesh-list
101545273|NCT01689623|Simvastatin|simvastatin|mesh-list
101545274|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101545275|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101545276|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
101545277|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545278|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101545279|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101545280|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545281|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
101545282|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545283|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
101545285|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
101545286|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545287|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545288|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545289|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101415486|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415487|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415488|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415489|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415490|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545290|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101545291|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101545292|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
101545294|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101545296|NCT02272647|Estrogens|estrogens|mesh-ancestor
101545297|NCT02272647|Hormones|hormones|mesh-ancestor
101545298|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545299|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545300|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101545301|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
101545302|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545303|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101545304|NCT02272647|Progestins|progestins|mesh-ancestor
101545305|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101545306|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101545307|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101545308|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101545309|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545310|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545311|NCT02272764|Itraconazole|itraconazole|mesh-list
101545312|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101545313|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
101545314|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545315|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101545316|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101545317|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545318|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545319|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101545320|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545321|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545322|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222290|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545323|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101545325|NCT01689896|Androgens|androgens|mesh-ancestor
101545326|NCT01689896|Hormones|hormones|mesh-ancestor
101545327|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545328|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545329|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
101545335|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101545337|NCT01316133|Tacrolimus|tacrolimus|mesh-list
101545338|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545339|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
101545340|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545341|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101545342|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545343|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545344|NCT05654064|Fentanyl|fentanyl|mesh-list
101545345|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
101545346|NCT05654064|Remifentanil|remifentanil|mesh-list
101545347|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545348|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545349|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545350|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545351|NCT05654064|Analgesics|analgesics|mesh-ancestor
101545352|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
101545353|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545354|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101545355|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101545356|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101545357|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545358|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415492|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415493|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
101415494|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101415495|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415496|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415497|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415498|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415499|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415500|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415501|NCT00499720|Aztreonam|aztreonam|mesh-list
101415502|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101415503|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415504|NCT05562518|Estrogens|estrogens|mesh-list
101545359|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545360|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101545362|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101545363|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101545364|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
101545365|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
101545366|NCT01687985|Laxatives|laxatives|mesh-list
101545367|NCT01687985|Cathartics|cathartics|mesh-list
101545368|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545369|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
101545370|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545371|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545372|NCT01685255|Tamoxifen|tamoxifen|mesh-list
101545373|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101545374|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545375|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545376|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545377|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545378|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545379|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101545380|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101545381|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101545382|NCT01680965|Ofatumumab|ofatumumab|mesh-list
101545383|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545384|NCT02272998|Ponatinib|ponatinib|mesh-list
101545385|NCT02272998|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101545386|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545387|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545388|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545389|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545390|NCT01683188|Vemurafenib|vemurafenib|mesh-list
101545391|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545392|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545393|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545397|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545398|NCT04417088|Carboplatin|carboplatin|mesh-list
101545399|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545401|NCT01380093|Morphine|morphine|mesh-list
101545402|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101545403|NCT01380093|Narcotics|narcotics|mesh-ancestor
101415505|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101415506|NCT05562518|Hormones|hormones|mesh-ancestor
101415507|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415509|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101415510|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
101415511|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101415512|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
101415513|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101415514|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101545404|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545405|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545406|NCT01380093|Analgesics|analgesics|mesh-ancestor
101545407|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
101545408|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545409|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101545410|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101545411|NCT01379937|Vaccines|vaccines|mesh-list
101545412|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
101545413|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545414|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101545415|NCT03558854|Aspirin|aspirin|mesh-list
101545416|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545417|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545418|NCT03558854|Analgesics|analgesics|mesh-ancestor
101545419|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
101545420|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545421|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545422|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545423|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545424|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101545425|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101545426|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545427|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101545428|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101545429|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545431|NCT01335477|Nintedanib|nintedanib|mesh-list
101545432|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545433|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545434|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545435|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545436|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
101545437|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
101545438|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545439|NCT01371747|Losartan|losartan|mesh-list
101545440|NCT01371747|Spironolactone|spironolactone|mesh-list
101545441|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101545442|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101545443|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101545444|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101545445|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545446|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101545447|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545448|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545449|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545450|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101545451|NCT01371747|Diuretics|diuretics|mesh-ancestor
101545452|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
101545453|NCT01335399|Dexamethasone|dexamethasone|mesh-list
101545454|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
101545455|NCT01335399|Lenalidomide|lenalidomide|mesh-list
101545456|NCT01335399|Elotuzumab|elotuzumab|mesh-list
101415515|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
101415516|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415517|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415518|NCT00499876|Mefloquine|mefloquine|mesh-list
101415519|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
101415520|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415521|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101415522|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545457|NCT01335399|BB 1101|bb 1101|mesh-list
101545458|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545459|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
101545460|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
101545461|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545462|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545463|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545464|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
101545465|NCT01335399|Hormones|hormones|mesh-ancestor
101545469|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
101545470|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545471|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545473|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101545474|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101545475|NCT01335399|Growth Substances|growth substances|mesh-ancestor
101545476|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
101545477|NCT04825262|Tacrolimus|tacrolimus|mesh-list
101545478|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545479|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
101545480|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545481|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101545482|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545483|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545484|NCT01335009|Antibodies|antibodies|mesh-list
101545485|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101545486|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
101545487|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545488|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
101545489|NCT01332630|Dexamethasone|dexamethasone|mesh-list
101545490|NCT01332630|Ranitidine|ranitidine|mesh-list
101545491|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101545492|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545493|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
101545494|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
101545495|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545496|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545497|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545498|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
101545499|NCT01332630|Hormones|hormones|mesh-ancestor
101545500|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545501|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545502|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545503|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101545504|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545505|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545506|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
101545508|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
101545509|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101545510|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
101415523|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
101415524|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
101415525|NCT00146718|Amodiaquine|amodiaquine|mesh-list
101415526|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
101415527|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415528|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101415529|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415530|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101415531|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545512|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545513|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545514|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101545515|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101545516|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101545517|NCT01366209|Pirfenidone|pirfenidone|mesh-list
101545518|NCT01366209|Analgesics|analgesics|mesh-ancestor
101545519|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
101545520|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545521|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545522|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545523|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545524|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545525|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545526|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545549|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
101545550|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
101545551|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101545552|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545553|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
101545554|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101545555|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101545556|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101545557|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101545558|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545559|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
101545560|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545561|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545562|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101545563|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545564|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
101545565|NCT01332318|Promethazine|promethazine|mesh-list
101545567|NCT01332318|Analgesics|analgesics|mesh-ancestor
101545568|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
101545569|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545570|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545571|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
101545572|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101545573|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101545574|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545575|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101545576|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101545577|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101545578|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545579|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545584|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
101545585|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
101545586|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
101545587|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545588|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101545589|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
101545590|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
101545591|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101545592|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
101545593|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
101545594|NCT04828226|Clonidine|clonidine|mesh-list
101415532|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415533|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101415534|NCT00499993|Lanreotide|lanreotide|mesh-list
101415535|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415536|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
101415537|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545596|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
101545597|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545598|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545599|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101545600|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
101545601|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
101545602|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101222390|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
101545603|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101545604|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101545605|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545606|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545607|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545608|NCT01331109|Milnacipran|milnacipran|mesh-list
101545609|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
101545610|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101545611|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101545612|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222451|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
101222452|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101222483|NCT01513070|Isosorbide|isosorbide|mesh-list
101545613|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545614|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545615|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545616|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545617|NCT01331109|Analgesics|analgesics|mesh-ancestor
101545618|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
101222516|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
101545619|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545620|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
101545621|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101545622|NCT01357161|Paclitaxel|paclitaxel|mesh-list
101545623|NCT01357161|Carboplatin|carboplatin|mesh-list
101545624|NCT01357161|Adavosertib|adavosertib|mesh-list
101545625|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101545626|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222583|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101222584|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101222585|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545627|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
101545628|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
101545629|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
101545630|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545631|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545632|NCT01351350|Paclitaxel|paclitaxel|mesh-list
101545633|NCT01351350|Trastuzumab|trastuzumab|mesh-list
101545634|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222647|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545635|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545636|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
101545637|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
101545638|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
101545639|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545640|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101545642|NCT02271503|Carbidopa|carbidopa|mesh-list
101545643|NCT02271503|Levodopa|levodopa|mesh-list
101545644|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101545645|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
101222784|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222787|NCT01514838|Acarbose|acarbose|mesh-list
101545646|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545652|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545653|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101415539|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415540|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415542|NCT04710914|Isoflurane|isoflurane|mesh-list
101415543|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101415544|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101415545|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101415546|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415547|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101545654|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545655|NCT01350804|Abatacept|abatacept|mesh-list
101545656|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101545657|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545658|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101545659|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545660|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545661|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
101222914|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101545662|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545664|NCT02270957|Abatacept|abatacept|mesh-list
101545665|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101545666|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545667|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101545668|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545669|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545670|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
101545671|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545672|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545673|NCT01348542|Trazodone|trazodone|mesh-list
101545674|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101545675|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101545676|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545677|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222975|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101222976|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
101545678|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101545679|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101545680|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101545681|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101545682|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545683|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545684|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
101545685|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101545686|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
101545688|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
101545689|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545690|NCT01193335|Vaccines|vaccines|mesh-list
101545691|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101545692|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
101545693|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545694|NCT02893995|Treprostinil|treprostinil|mesh-list
101545695|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101545696|NCT01342887|Cyclosporine|cyclosporine|mesh-list
101545697|NCT01342887|Etoposide|etoposide|mesh-list
101545698|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
101545699|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
101545700|NCT01342887|Pravastatin|pravastatin|mesh-list
101223168|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223169|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101545701|NCT01342887|Cyclosporins|cyclosporins|mesh-list
101545702|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101545703|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545704|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101545705|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101545706|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415548|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101415549|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101415550|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101415551|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
101415552|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
101415553|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
101415554|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
101415555|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415556|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415557|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101545707|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545708|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545709|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
101223236|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545710|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545711|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
101545712|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545713|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
101545714|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545715|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101545716|NCT01342887|Analgesics|analgesics|mesh-ancestor
101545717|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
101545718|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545720|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101545721|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
101545722|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101545723|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101545724|NCT04445415|Antibodies|antibodies|mesh-list
101545725|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
101545726|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545727|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
101545728|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101545729|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545730|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101545731|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545732|NCT01340664|Metformin|metformin|mesh-list
101545733|NCT01340664|Canagliflozin|canagliflozin|mesh-list
101545734|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545735|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545736|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101545737|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545738|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101545739|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101545740|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101545741|NCT01340625|Norethindrone|norethindrone|mesh-list
101545742|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
101545743|NCT01340625|Estradiol|estradiol|mesh-list
101545744|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101545745|NCT01340625|Estrogens|estrogens|mesh-ancestor
101545746|NCT01340625|Hormones|hormones|mesh-ancestor
101545747|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545748|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545749|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101545750|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
101545751|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101545752|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101545753|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101545754|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101545755|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101545756|NCT04823468|Cisplatin|cisplatin|mesh-list
101545757|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545758|NCT01340196|Tenofovir|tenofovir|mesh-list
101545759|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
101545760|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545761|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101545762|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101415565|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101415566|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
101415567|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545763|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545764|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545765|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101545766|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101545767|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101545768|NCT02893332|Gefitinib|gefitinib|mesh-list
101545769|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545770|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545771|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545772|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545773|NCT04328493|Chloroquine|chloroquine|mesh-list
101545774|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
101545775|NCT04328493|Amebicides|amebicides|mesh-ancestor
101545776|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101545777|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101545778|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545779|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
101545780|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545781|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545782|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545783|NCT04328493|Analgesics|analgesics|mesh-ancestor
101545784|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
101545785|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545786|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545794|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101545795|NCT04396587|Narcotics|narcotics|mesh-ancestor
101545799|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
101545800|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545801|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101545802|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101545804|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
101545805|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
101545806|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
101545807|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545808|NCT01327599|Timolol|timolol|mesh-list
101545810|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101545811|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101545812|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101545813|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101545814|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545815|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545816|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415574|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
101415575|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415576|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101415577|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101415578|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101415579|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415580|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415582|NCT00500422|Doxorubicin|doxorubicin|mesh-list
101415583|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101545824|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545825|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545826|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545827|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545828|NCT02893371|Lamotrigine|lamotrigine|mesh-list
101545832|NCT02893371|Valproic Acid|valproic acid|mesh-list
101545833|NCT02893371|Haloperidol|haloperidol|mesh-list
101545835|NCT02893371|Risperidone|risperidone|mesh-list
101545836|NCT02893371|Aripiprazole|aripiprazole|mesh-list
101545837|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101545838|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101545840|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101545841|NCT02893371|Clozapine|clozapine|mesh-list
101545842|NCT02893371|Asenapine|asenapine|mesh-list
101545843|NCT02893371|Perphenazine|perphenazine|mesh-list
101545844|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
101545860|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545866|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101545867|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
101545868|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101545869|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101545870|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101545871|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101415585|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101415587|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415588|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415589|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415590|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101545879|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101545880|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101545881|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545882|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
101545883|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101545886|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101545887|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101545888|NCT02893371|Analgesics|analgesics|mesh-ancestor
101545889|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
101545890|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
101545891|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
101545892|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101545894|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101545895|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
101545896|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101545897|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
101545898|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
101545899|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101545900|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101545901|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101545902|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101545904|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101545906|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101545907|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101545908|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
101545909|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101545910|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101545911|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101545913|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545914|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101545915|NCT05138978|Listerine|listerine|mesh-list
101545916|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
101545917|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
101545918|NCT05138978|Protective Agents|protective agents|mesh-ancestor
101545919|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545920|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101545921|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545922|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101545923|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101545925|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101415596|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415597|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
101415598|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415600|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101415601|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101415603|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
101415604|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415607|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415608|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
101415609|NCT00146913|Interferons|interferons|mesh-list
101415611|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415612|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
101415613|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415614|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415615|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415616|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545926|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101545927|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545930|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101545931|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545933|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545934|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101545936|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545938|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101545939|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101545941|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
101545942|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101545943|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545944|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545945|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101545946|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101545947|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415618|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
101415619|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415621|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101415622|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101415623|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
101415624|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545948|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545949|NCT04329000|Esomeprazole|esomeprazole|mesh-list
101545950|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101545951|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545954|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545955|NCT01192399|Eculizumab|eculizumab|mesh-list
101545956|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101545957|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545958|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
101545959|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545961|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
101545962|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545964|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545965|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101545966|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101545967|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545968|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545969|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101545970|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
101545971|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545972|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545973|NCT05382091|Naltrexone|naltrexone|mesh-list
101545974|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101545975|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101545976|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545977|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
101545979|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101545980|NCT02894268|Doxycycline|doxycycline|mesh-list
101545981|NCT02894268|Furazolidone|furazolidone|mesh-list
101545982|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101545983|NCT02894268|Esomeprazole|esomeprazole|mesh-list
101545984|NCT02894268|Bismuth|bismuth|mesh-list
101545985|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101545986|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101545987|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101545988|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101545989|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545990|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545991|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
101545992|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101545998|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101545999|NCT01600625|Minocycline|minocycline|mesh-list
101546000|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546001|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546002|NCT01600742|Vorinostat|vorinostat|mesh-list
101546003|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546004|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101546006|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546007|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
101546008|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101546009|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101546010|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
101546011|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546012|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101546013|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101415625|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415626|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415627|NCT01246180|Diclofenac|diclofenac|mesh-list
101415628|NCT01246180|Amiloride|amiloride|mesh-list
101415629|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101415630|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101546014|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546015|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546016|NCT02893488|Lamivudine|lamivudine|mesh-list
101546017|NCT02893488|Dolutegravir|dolutegravir|mesh-list
101546019|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101546020|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546021|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546022|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
101546023|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546024|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101546025|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101546026|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101546027|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101546028|NCT04328883|Aspirin|aspirin|mesh-list
101546029|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101546031|NCT04328883|Analgesics|analgesics|mesh-ancestor
101546032|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
101546033|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546034|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546035|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546036|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546037|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101546038|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101546040|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101546041|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101546043|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
101546044|NCT01600235|Phenylephrine|phenylephrine|mesh-list
101546046|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101546047|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
101546048|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
101546050|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546051|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
101546053|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
101546054|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
101546055|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101546056|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101546057|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101546058|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
101546059|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546060|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546061|NCT01600235|Protective Agents|protective agents|mesh-ancestor
101546069|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546070|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546072|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101546073|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546074|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546075|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101546076|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
101546078|NCT04135092|Aldesleukin|aldesleukin|mesh-list
101546079|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
101546080|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
101546081|NCT04135092|Fludarabine|fludarabine|mesh-list
101546082|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546083|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
101415636|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415637|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101546084|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546085|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546086|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101546087|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
101546090|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101546091|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101546092|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101546093|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101546094|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101546095|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
101546096|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546098|NCT00592215|Mifepristone|mifepristone|mesh-list
101546099|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101546100|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
101546101|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546102|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546103|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101546104|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546105|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
101546106|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101546107|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101546108|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101546109|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101546110|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
101546111|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101546112|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101546113|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
101546114|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546115|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
101546116|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101546117|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101546118|NCT00592332|Alprazolam|alprazolam|mesh-list
101546119|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101546120|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546121|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546122|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101546123|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546124|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546126|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
101546127|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546128|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546129|NCT04477382|Tretinoin|tretinoin|mesh-list
101546133|NCT01600274|Dienogest|dienogest|mesh-list
101546134|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101546135|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101546136|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101546137|NCT01600274|Estradiol|estradiol|mesh-list
101546139|NCT01600274|Nandrolone|nandrolone|mesh-list
101546140|NCT01600274|Estrogens|estrogens|mesh-ancestor
101546141|NCT01600274|Hormones|hormones|mesh-ancestor
101546142|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546143|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546144|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101546145|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
101415639|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415640|NCT01246180|Diuretics|diuretics|mesh-ancestor
101415641|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
101415642|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101415643|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101415644|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415645|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101415646|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101415647|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
101415648|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101546146|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546147|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101546149|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101546150|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101546151|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
101546152|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101546153|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546154|NCT01600274|Androgens|androgens|mesh-ancestor
101546155|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
101546156|NCT01176565|Nicardipine|nicardipine|mesh-list
101546159|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546160|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546161|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546162|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546163|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
101546165|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
101546179|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
101546180|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
101546181|NCT00591708|Citric Acid|citric acid|mesh-list
101546182|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
101546183|NCT00591708|Calcium|calcium|mesh-list
101546184|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
101546185|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546186|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546187|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546189|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101546190|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
101546191|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
101415649|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
101415650|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415651|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
101415652|NCT05561972|Protective Agents|protective agents|mesh-ancestor
101415653|NCT02274610|Docetaxel|docetaxel|mesh-list
101415654|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415655|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415656|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101415657|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415658|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415661|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415662|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101415663|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101415664|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415665|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415666|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101415670|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101415671|NCT00501514|Hormones|hormones|mesh-list
101415672|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546192|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546193|NCT01176058|Fluconazole|fluconazole|mesh-list
101546194|NCT01176058|Anidulafungin|anidulafungin|mesh-list
101546195|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
101546196|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546203|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546204|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546205|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101546208|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546209|NCT02273765|Tenofovir|tenofovir|mesh-list
101546210|NCT02273765|Lamivudine|lamivudine|mesh-list
101546211|NCT02273765|Efavirenz|efavirenz|mesh-list
101546212|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
101546213|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
101546214|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546215|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101415673|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415674|NCT00147186|Hylan|hylan|mesh-list
101415675|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
101415676|NCT00147186|Protective Agents|protective agents|mesh-ancestor
101415677|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415678|NCT00501748|Rituximab|rituximab|mesh-list
101546216|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101546217|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546218|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546219|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101546220|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101546221|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101546222|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101546223|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101546224|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101546226|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101546227|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101546228|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101546229|NCT01607333|Lamotrigine|lamotrigine|mesh-list
101546230|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
101546231|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101546232|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546233|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546234|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546235|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546236|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101546237|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546238|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546239|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546240|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101546242|NCT01601093|Cefoperazone|cefoperazone|mesh-list
101546243|NCT01601093|Sulperazone|sulperazone|mesh-list
101546248|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546249|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101546269|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
101546270|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546278|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
101546279|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546280|NCT01175824|Coagulants|coagulants|mesh-ancestor
101546281|NCT01175707|Vancomycin|vancomycin|mesh-list
101546282|NCT01175707|Daptomycin|daptomycin|mesh-list
101415681|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
101415682|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415683|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415684|NCT00501787|Metformin|metformin|mesh-list
101415685|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546287|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546288|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
101546289|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101546290|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101546291|NCT01175668|Clonidine|clonidine|mesh-list
101546292|NCT01175668|Phenobarbital|phenobarbital|mesh-list
101546293|NCT01175668|Analgesics|analgesics|mesh-ancestor
101546294|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
101546297|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101546298|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
101546299|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
101546300|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101546306|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
101546307|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101546308|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546309|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101546310|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101546311|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
101546314|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101546315|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101546316|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
101546317|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101546318|NCT01601327|Testosterone|testosterone|mesh-list
101546319|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
101546322|NCT01601327|Androgens|androgens|mesh-ancestor
101546324|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546325|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546326|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101546329|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546331|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
101546332|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101546333|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546334|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546335|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101546336|NCT01607762|Olanzapine|olanzapine|mesh-list
101415694|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415695|NCT00501982|Poractant alfa|poractant alfa|mesh-list
101415696|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101415697|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
101546339|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101546340|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101546341|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101546350|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101546351|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
101546352|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
101546353|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
101546354|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546355|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546356|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101546357|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101546358|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546359|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
101546360|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
101546361|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101546362|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101546370|NCT04327947|Protective Agents|protective agents|mesh-ancestor
101546371|NCT01607918|Amoxicillin|amoxicillin|mesh-list
101546372|NCT01607918|Metronidazole|metronidazole|mesh-list
101546373|NCT01607918|Clarithromycin|clarithromycin|mesh-list
101546374|NCT01607918|Lansoprazole|lansoprazole|mesh-list
101546375|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
101546379|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101546380|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101546381|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546382|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546383|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101546384|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101546387|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101546388|NCT01607996|Anesthetics|anesthetics|mesh-list
101546389|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546390|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546391|NCT01601561|Insulin|insulin|mesh-list
101546392|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101546393|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546394|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546396|NCT01601795|Isoflurane|isoflurane|mesh-list
101546397|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101546398|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101546399|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
101415701|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415703|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101415704|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
101546400|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
101546401|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546402|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546403|NCT01601912|Dexetimide|dexetimide|mesh-list
101546413|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546414|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101546415|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101546416|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546421|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546422|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101546423|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101546425|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101546426|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
101546427|NCT01111825|Sirolimus|sirolimus|mesh-list
101546444|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101546445|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101546446|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546447|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546448|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546449|NCT01175473|Metformin|metformin|mesh-list
101546450|NCT01175473|Liraglutide|liraglutide|mesh-list
101546451|NCT01175473|Lixisenatide|lixisenatide|mesh-list
101546452|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546453|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546454|NCT01175473|Incretins|incretins|mesh-ancestor
101546455|NCT01175473|Hormones|hormones|mesh-ancestor
101546456|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546457|NCT01111552|Aripiprazole|aripiprazole|mesh-list
101546458|NCT01111552|Escitalopram|escitalopram|mesh-list
101546461|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415706|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415708|NCT00502060|Gefitinib|gefitinib|mesh-list
101415709|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415710|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101415713|NCT00502099|Interferons|interferons|mesh-list
101546462|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546463|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546464|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
101546465|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546468|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101546469|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546470|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546471|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
101546472|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
101546476|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101546477|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101546478|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101546479|NCT01602185|Memantine|memantine|mesh-list
101546480|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
101546481|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
101546482|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101546486|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546487|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546488|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101546489|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101546492|NCT01602302|Infliximab|infliximab|mesh-list
101546493|NCT01602302|Golimumab|golimumab|mesh-list
101546494|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
101546495|NCT01602302|Etanercept|etanercept|mesh-list
101546496|NCT01602302|Abatacept|abatacept|mesh-list
101546497|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101546498|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546506|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546514|NCT02893722|Oxytocin|oxytocin|mesh-list
101546516|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
101546517|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546518|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415719|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415721|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415723|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415724|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
101415725|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546522|NCT01608269|Lamivudine|lamivudine|mesh-list
101546523|NCT01608269|Abacavir|abacavir|mesh-list
101546525|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101546527|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546528|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
101546529|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546530|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101546531|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101546532|NCT01608347|Folic Acid|folic acid|mesh-list
101546533|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
101546534|NCT01608347|Hematinics|hematinics|mesh-ancestor
101546535|NCT01608347|Vitamins|vitamins|mesh-ancestor
101546536|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
101546537|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546538|NCT04405284|Disinfectants|disinfectants|mesh-list
101546539|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546540|NCT01608464|Cisplatin|cisplatin|mesh-list
101546541|NCT01608464|Docetaxel|docetaxel|mesh-list
101546542|NCT01608464|Fluorouracil|fluorouracil|mesh-list
101546543|NCT01608464|Irinotecan|irinotecan|mesh-list
101546547|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
101546548|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546549|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
101546550|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546551|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546552|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
101546553|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546554|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101546555|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101546556|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546557|NCT01608698|Drospirenone|drospirenone|mesh-list
101546558|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101546563|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
101546564|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546565|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546566|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101546567|NCT01608698|Estrogens|estrogens|mesh-ancestor
101546568|NCT01608698|Hormones|hormones|mesh-ancestor
101546569|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415728|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415729|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415730|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
101415731|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101415732|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101415733|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415734|NCT00502294|Visilizumab|visilizumab|mesh-list
101415738|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101415739|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101415740|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415741|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415742|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415743|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415748|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415750|NCT00147381|Tacrolimus|tacrolimus|mesh-list
101415751|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415752|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
101415753|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415754|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101546570|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101546571|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
101546572|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101546573|NCT01608698|Diuretics|diuretics|mesh-ancestor
101546574|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
101546575|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
101546577|NCT04310254|Edetic Acid|edetic acid|mesh-list
101546578|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101546579|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
101546580|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
101546581|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101546582|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
101546583|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
101546584|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546586|NCT04310254|Protective Agents|protective agents|mesh-ancestor
101415755|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415756|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415757|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415758|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415759|NCT00502567|Leucovorin|leucovorin|mesh-list
101415760|NCT00502567|Docetaxel|docetaxel|mesh-list
101415761|NCT00502567|Fluorouracil|fluorouracil|mesh-list
101415762|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
101415763|NCT00502567|Irinotecan|irinotecan|mesh-list
101415770|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101415771|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415775|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
101415776|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415777|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101415778|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415779|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546587|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546588|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101546590|NCT01603511|Antidotes|antidotes|mesh-ancestor
101546591|NCT01603511|Protective Agents|protective agents|mesh-ancestor
101546592|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546593|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101546594|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546595|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546596|NCT01174186|Adalimumab|adalimumab|mesh-list
101546597|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101546598|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546599|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546600|NCT01609049|Ribavirin|ribavirin|mesh-list
101546601|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101546602|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
101546603|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546604|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
101546605|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546606|NCT01609088|Erythritol|erythritol|mesh-list
101546607|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
101546609|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546611|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546612|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415780|NCT00502567|Antidotes|antidotes|mesh-ancestor
101415781|NCT00502567|Protective Agents|protective agents|mesh-ancestor
101415782|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
101415785|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101415786|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101546614|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
101546615|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546619|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101546621|NCT01609166|Protective Agents|protective agents|mesh-ancestor
101546622|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546623|NCT01609205|Adalimumab|adalimumab|mesh-list
101546624|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101546625|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546626|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546627|NCT01604057|Teriparatide|teriparatide|mesh-list
101546634|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
101546635|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
101546636|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546637|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546638|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546639|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
101546641|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546642|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101546643|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546645|NCT00592566|Coagulants|coagulants|mesh-ancestor
101546647|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
101546648|NCT01111123|Halobetasol|halobetasol|mesh-list
101546649|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101546650|NCT01604330|Baclofen|baclofen|mesh-list
101546651|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101546653|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101546654|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546655|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101546656|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
101546657|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
101546658|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546664|NCT01173679|Rituximab|rituximab|mesh-list
101546665|NCT01173679|Fludarabine|fludarabine|mesh-list
101546666|NCT01173679|Dasatinib|dasatinib|mesh-list
101546668|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546672|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546673|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546675|NCT02881528|Metformin|metformin|mesh-list
101546676|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101415794|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101415795|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101546677|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546678|NCT01609439|Vitamin D|vitamin d|mesh-list
101546679|NCT01609439|Vitamins|vitamins|mesh-ancestor
101546680|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
101546681|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546682|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546683|NCT01110382|Amoxicillin|amoxicillin|mesh-list
101546684|NCT01110382|Meropenem|meropenem|mesh-list
101546685|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
101546686|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
101546696|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
101546697|NCT00592917|Calcium|calcium|mesh-list
101546698|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546699|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546700|NCT00592917|Vitamins|vitamins|mesh-ancestor
101546701|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
101546702|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546703|NCT00592917|Antacids|antacids|mesh-ancestor
101546709|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546710|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546711|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
101546712|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546713|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
101546714|NCT05265325|Hematinics|hematinics|mesh-ancestor
101546715|NCT00593151|Interferons|interferons|mesh-list
101546721|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546722|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
101546723|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546727|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546728|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546730|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101546731|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101546732|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
101546733|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546734|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546735|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415796|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
101415797|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415798|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415799|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415800|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101415801|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415803|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101415804|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101415807|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415809|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415810|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101415811|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101415812|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415813|NCT00502762|Topotecan|topotecan|mesh-list
101415816|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415817|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415818|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415820|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101415821|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101415822|NCT00502879|Analgesics|analgesics|mesh-ancestor
101546740|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546742|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546743|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546744|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
101546745|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546746|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546750|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101546751|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101415824|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415825|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415826|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415827|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101415828|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101546752|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546763|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546764|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546765|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546766|NCT01609907|Valsartan|valsartan|mesh-list
101546767|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101546768|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101546769|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101546771|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546772|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101546773|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101546774|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546775|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101546776|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101546777|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101546778|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
101546779|NCT00593580|Vitamin D|vitamin d|mesh-list
101546780|NCT00593580|Alendronate|alendronate|mesh-list
101546781|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546783|NCT00593580|Vitamins|vitamins|mesh-ancestor
101546784|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
101546785|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546786|NCT04327011|Flucytosine|flucytosine|mesh-list
101546787|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
101546789|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
101546790|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546791|NCT00593619|Iron|iron|mesh-list
101546792|NCT00593619|Dextrans|dextrans|mesh-list
101546793|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101546794|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
101546795|NCT00593619|Trace Elements|trace elements|mesh-ancestor
101546796|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
101546797|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546799|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
101546800|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
101546801|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
101546802|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
101546803|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101546806|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101546807|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101546808|NCT00593658|Protective Agents|protective agents|mesh-ancestor
101546809|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546810|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
101546814|NCT00593697|Trastuzumab|trastuzumab|mesh-list
101546815|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546816|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
101546817|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
101546826|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
101546827|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415830|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
101415832|NCT00503152|Benazepril|benazepril|mesh-list
101415833|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415834|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101415835|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101415836|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415837|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101415838|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
101546828|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546829|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546830|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101546835|NCT00593853|Methylphenidate|methylphenidate|mesh-list
101546836|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101546837|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546838|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101546844|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101546845|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101546851|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546853|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101546854|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546857|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
101546858|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417465|NCT00134069|Irinotecan|irinotecan|mesh-list
101546859|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546860|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546862|NCT01605344|Fluorouracil|fluorouracil|mesh-list
101546863|NCT01605344|Irinotecan|irinotecan|mesh-list
101546865|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
101546866|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546867|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546872|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101415843|NCT00503386|Palonosetron|palonosetron|mesh-list
101415844|NCT00503386|Granisetron|granisetron|mesh-list
101415847|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415848|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415849|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101415850|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101415851|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101546874|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546878|NCT01605344|Vitamins|vitamins|mesh-ancestor
101546879|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
101546880|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101546881|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101546882|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101546883|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101546903|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546904|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
101546905|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101546906|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101546907|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101546908|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546909|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
101546910|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
101546911|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101546912|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101546919|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101546921|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101546922|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546923|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546924|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101546926|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546927|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546928|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101546929|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101546937|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546938|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546941|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101415852|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
101415853|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415856|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101415857|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101415858|NCT00503503|Analgesics|analgesics|mesh-ancestor
101415859|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
101415860|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415861|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546944|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101546945|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546946|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101546948|NCT01605773|Repaglinide|repaglinide|mesh-list
101546949|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546950|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546951|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
101546954|NCT00594555|Cytarabine|cytarabine|mesh-list
101546955|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
101546956|NCT00594555|Cladribine|cladribine|mesh-list
101546957|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546958|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
101546959|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546960|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546961|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
101546962|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546963|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546964|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
101546965|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546966|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101546967|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546968|NCT01605929|Mepivacaine|mepivacaine|mesh-list
101546969|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
101546970|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
101546971|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546972|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546973|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
101546974|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546975|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
101546976|NCT02270606|Leucovorin|leucovorin|mesh-list
101546977|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
101546978|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
101546980|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
101546981|NCT02270606|Calcium|calcium|mesh-list
101546987|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546988|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101546989|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546990|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101546991|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
101546992|NCT02270606|Antidotes|antidotes|mesh-ancestor
101546993|NCT02270606|Protective Agents|protective agents|mesh-ancestor
101546994|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
101546995|NCT02270606|Vitamins|vitamins|mesh-ancestor
101546996|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
101546997|NCT00594633|Donepezil|donepezil|mesh-list
101546998|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101546999|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547000|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547001|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
101547002|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415862|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415864|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101415865|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101415866|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
101415867|NCT00503542|Metronidazole|metronidazole|mesh-list
101415868|NCT00503542|Clindamycin|clindamycin|mesh-list
101415869|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
101415870|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
101547003|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547004|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
101547005|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101547006|NCT01605968|Laxatives|laxatives|mesh-ancestor
101547009|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
101547010|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101547012|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547013|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547014|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
101547015|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547016|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101547018|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101547019|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
101547020|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101547021|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547022|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101547023|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547024|NCT00594867|Aspirin|aspirin|mesh-list
101547025|NCT00594867|Acetaminophen|acetaminophen|mesh-list
101547026|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101547027|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101547028|NCT00594867|Analgesics|analgesics|mesh-ancestor
101547029|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
101547030|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547031|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547032|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547033|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547034|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101547035|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101547036|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547037|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101547038|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101547039|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547041|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
101547042|NCT01606241|Vaccines|vaccines|mesh-list
101547043|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
101547044|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547045|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547046|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547047|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547048|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
101547055|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101547056|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547057|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547058|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547059|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
101547060|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
101547061|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101547063|NCT00595140|Dopamine|dopamine|mesh-list
101547064|NCT00595140|Cabergoline|cabergoline|mesh-list
101415871|NCT00503542|Fluconazole|fluconazole|mesh-list
101415872|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101415874|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101415875|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101415876|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101415877|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415878|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415879|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
101415880|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101415881|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101547065|NCT00595140|Somatostatin|somatostatin|mesh-list
101547066|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
101547067|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547068|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101547069|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547070|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101547071|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
101547072|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
101547074|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547075|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
101547076|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547077|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547078|NCT00595140|Protective Agents|protective agents|mesh-ancestor
101547079|NCT00595140|Hormones|hormones|mesh-ancestor
101547080|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547081|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101547082|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101547083|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
101547084|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101547085|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
101547086|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547087|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
101547088|NCT02271035|Protective Agents|protective agents|mesh-ancestor
101547089|NCT01606358|Carboplatin|carboplatin|mesh-list
101547090|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547092|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
101547093|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
101547094|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101547095|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101547096|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547098|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101547099|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101547100|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547101|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547102|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101547103|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547104|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101547107|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
101547108|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
101415882|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101415884|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415885|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547112|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547113|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547115|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547116|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547117|NCT02271347|Brincidofovir|brincidofovir|mesh-list
101547118|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
101547120|NCT01172938|Thalidomide|thalidomide|mesh-list
101547121|NCT01172938|Apremilast|apremilast|mesh-list
101547122|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101547123|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101547124|NCT01172938|Analgesics|analgesics|mesh-ancestor
101547125|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
101547126|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547127|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547128|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547129|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547130|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101547131|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101547132|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547133|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547134|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547135|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
101547136|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
101547137|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101547138|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547139|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101547140|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101547141|NCT01172938|Growth Substances|growth substances|mesh-ancestor
101547142|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
101547143|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547144|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
101547146|NCT02271464|Capecitabine|capecitabine|mesh-list
101547147|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547148|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
101547149|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547150|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547151|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547153|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547154|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547155|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101547156|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547157|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101547158|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101547160|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
101415887|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101415888|NCT00147615|Eplerenone|eplerenone|mesh-list
101415889|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101415890|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
101415891|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101415892|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415893|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101415894|NCT00147615|Diuretics|diuretics|mesh-ancestor
101415895|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
101415896|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101415897|NCT05561036|Doxorubicin|doxorubicin|mesh-list
101415899|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415900|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415901|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415902|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415903|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415904|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
101415905|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101415906|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101415907|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
101415909|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101415910|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101547161|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547162|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
101547163|NCT04326894|Methotrexate|methotrexate|mesh-list
101547164|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101547165|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
101547166|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101547167|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547168|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547169|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
101547182|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547183|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101547184|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
101547185|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
101547186|NCT01109992|Regadenoson|regadenoson|mesh-list
101547187|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101547189|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
101547190|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
101547191|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547192|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547193|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547194|NCT02892357|Omeprazole|omeprazole|mesh-list
101547195|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101415911|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415912|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415913|NCT00147654|Tamsulosin|tamsulosin|mesh-list
101415914|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101415915|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101415916|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101415917|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101415918|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101415919|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415920|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415921|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547196|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547197|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101547199|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547200|NCT01109524|Cetuximab|cetuximab|mesh-list
101547202|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547203|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547204|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101547205|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
101547206|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
101547207|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
101547208|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547209|NCT01109173|Nepafenac|nepafenac|mesh-list
101547211|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101547212|NCT01109173|Analgesics|analgesics|mesh-ancestor
101547213|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
101547214|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547215|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547217|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547218|NCT02271971|Vitamin D|vitamin d|mesh-list
101547219|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
101547220|NCT02271971|Vitamins|vitamins|mesh-ancestor
101547221|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
101547222|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547223|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101547224|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101547225|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
101547226|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101547227|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101547231|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101547232|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
101547233|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
101547234|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101547235|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
101547236|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547237|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547238|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101547239|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101547240|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101547241|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547242|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
101547243|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101415922|NCT00147654|Urological Agents|urological agents|mesh-ancestor
101415923|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101415924|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101415925|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
101415926|NCT01246921|Fluticasone|fluticasone|mesh-list
101415927|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101415928|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101415929|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
101547244|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
101547245|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547247|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
101547248|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101547249|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
101547250|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547251|NCT01172275|Protective Agents|protective agents|mesh-ancestor
101547252|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547253|NCT01172275|Antidotes|antidotes|mesh-ancestor
101547254|NCT05034952|Acetaminophen|acetaminophen|mesh-list
101547255|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101547256|NCT05034952|Analgesics|analgesics|mesh-ancestor
101547257|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
101547258|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547259|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547260|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
101547262|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547263|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547264|NCT02273102|Tretinoin|tretinoin|mesh-list
101547265|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
101547266|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547267|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
101547268|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
101547270|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101547271|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101547272|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547273|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547274|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101547275|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101547276|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547277|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547278|NCT02272478|Decitabine|decitabine|mesh-list
101547279|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
101547280|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547282|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547283|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547284|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547285|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547287|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
101415932|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101415933|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
101415934|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
101547289|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547295|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547296|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547297|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
101547298|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547299|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
101547300|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101547301|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101547302|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101547303|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547304|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101547305|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101547306|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101547307|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101547309|NCT02272829|Narcotics|narcotics|mesh-ancestor
101547310|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547311|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547312|NCT02272829|Analgesics|analgesics|mesh-ancestor
101547313|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
101547314|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547315|NCT00596115|Pramipexole|pramipexole|mesh-list
101547316|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
101547317|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547318|NCT00596115|Protective Agents|protective agents|mesh-ancestor
101547319|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547320|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101547321|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101547322|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
101547323|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
101547324|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547325|NCT02272868|Rifaximin|rifaximin|mesh-list
101547326|NCT02272868|Omeprazole|omeprazole|mesh-list
101547327|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101547328|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101547329|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547330|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101547331|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547332|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547333|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101547335|NCT02272868|Laxatives|laxatives|mesh-ancestor
101547336|NCT02273453|Oxazepam|oxazepam|mesh-list
101547337|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101547338|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547339|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547340|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101547341|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101547342|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101547343|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
101547344|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
101547345|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547346|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547347|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101547348|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101547349|NCT01108510|Cobicistat|cobicistat|mesh-list
101547351|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101547353|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547354|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
101415935|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101415936|NCT04696939|Carboplatin|carboplatin|mesh-list
101415937|NCT04696939|Etoposide|etoposide|mesh-list
101415938|NCT04696939|Atezolizumab|atezolizumab|mesh-list
101415939|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415940|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415941|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415942|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415943|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415944|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415945|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101415946|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415947|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101415949|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101415950|NCT05560919|Protective Agents|protective agents|mesh-ancestor
101415951|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547358|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101547359|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101547361|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101547362|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101547364|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101547366|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547367|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547368|NCT05015686|Vaccines|vaccines|mesh-list
101547369|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
101547370|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547371|NCT04327245|Tagatose|tagatose|mesh-list
101547372|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101547373|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
101547374|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
101547375|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547376|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
101547377|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
101547378|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547379|NCT04327401|Dexamethasone|dexamethasone|mesh-list
101547380|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547381|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
101547382|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
101547383|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547384|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547385|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547386|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
101547388|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547389|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101547390|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547391|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
101547392|NCT01340027|Mirabegron|mirabegron|mesh-list
101547393|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101547394|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101547395|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
101547396|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417471|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547397|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547398|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415952|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101415954|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415955|NCT05560919|Vitamins|vitamins|mesh-ancestor
101415956|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
101415957|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101415958|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
101415959|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101415960|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101415961|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101415962|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547399|NCT01340027|Urological Agents|urological agents|mesh-ancestor
101547400|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101547401|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101547402|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101547403|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547404|NCT01107925|Clopidogrel|clopidogrel|mesh-list
101547405|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101547407|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101547408|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101547409|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101547410|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
101547411|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547412|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547414|NCT04310293|Hormones|hormones|mesh-list
101547415|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547416|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547417|NCT01339559|Brivaracetam|brivaracetam|mesh-list
101547418|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
101547419|NCT01588847|Sufentanil|sufentanil|mesh-list
101547427|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547429|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547430|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101547431|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101547433|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101547434|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101547435|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101547436|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101547437|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101547438|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101547439|NCT01588847|Narcotics|narcotics|mesh-ancestor
101547440|NCT01588847|Analgesics|analgesics|mesh-ancestor
101547441|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101547442|NCT00107900|Edoxaban|edoxaban|mesh-list
101547443|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101547444|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
101547445|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101547446|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547447|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547448|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547449|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
101547451|NCT00107315|Capecitabine|capecitabine|mesh-list
101547452|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101415963|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415964|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
101415965|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415966|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415967|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101415968|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415969|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
101415971|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
101415972|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101415973|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101415974|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101415975|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101415976|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
101415977|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101415978|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101415979|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
101547453|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547454|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101547455|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101547457|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547458|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
101547459|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547460|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
101547461|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547462|NCT01335971|Sulforaphane|sulforaphane|mesh-list
101547463|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101547464|NCT01335971|Protective Agents|protective agents|mesh-ancestor
101547465|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547466|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547467|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
101547468|NCT00107276|Capecitabine|capecitabine|mesh-list
101547469|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547470|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
101547471|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547472|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547473|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547474|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
101547475|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547476|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547477|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101547478|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101547479|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
101547480|NCT01335698|Ritonavir|ritonavir|mesh-list
101547481|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101547482|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101547483|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101547484|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547485|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547505|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547506|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415980|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101415981|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415982|NCT04063163|Carboplatin|carboplatin|mesh-list
101415983|NCT04063163|Etoposide|etoposide|mesh-list
101415984|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101415985|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101415986|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101415987|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101415988|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101415989|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415990|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101547507|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101547508|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101547509|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101547512|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547513|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
101547514|NCT00107198|Hormones|hormones|mesh-ancestor
101547515|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547516|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101547517|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101547518|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
101547519|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
101547520|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
101547521|NCT00107120|Escitalopram|escitalopram|mesh-list
101547522|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101547523|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101547524|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547525|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547526|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547529|NCT01335464|Nintedanib|nintedanib|mesh-list
101547530|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547531|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101547532|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547533|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547534|NCT00106184|Rituximab|rituximab|mesh-list
101547535|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547536|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547538|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547539|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547540|NCT00598923|Topiramate|topiramate|mesh-list
101547541|NCT00598923|Phenytoin|phenytoin|mesh-list
101547542|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
101547543|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547548|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547549|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101547550|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101547551|NCT02892318|Atezolizumab|atezolizumab|mesh-list
101547552|NCT02892318|Guadecitabine|guadecitabine|mesh-list
101547553|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101415991|NCT00503815|Laxatives|laxatives|mesh-ancestor
101415992|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101415993|NCT01247077|Selenium|selenium|mesh-list
101415994|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
101415995|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101415996|NCT01247077|Protective Agents|protective agents|mesh-ancestor
101415997|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547555|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547557|NCT01334918|Regadenoson|regadenoson|mesh-list
101547558|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
101547559|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101547560|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101547561|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
101547562|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
101547563|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547564|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547565|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547567|NCT00598962|Azithromycin|azithromycin|mesh-list
101547568|NCT00598962|Rifampin|rifampin|mesh-list
101547569|NCT00598962|Rifabutin|rifabutin|mesh-list
101547570|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101547571|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547572|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101547573|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
101547574|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
101547575|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101547576|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547577|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547578|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101547579|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101547580|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101547581|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101547582|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101547583|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101547585|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
101547586|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101547587|NCT01332968|Rituximab|rituximab|mesh-list
101547588|NCT01332968|Doxorubicin|doxorubicin|mesh-list
101547589|NCT01332968|Vincristine|vincristine|mesh-list
101547590|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
101547591|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547592|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
101547593|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547594|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547595|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547596|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
101547597|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547599|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101547600|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547601|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101547602|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101547603|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101547604|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547605|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547606|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
101547608|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547609|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101547611|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
101415998|NCT01247077|Trace Elements|trace elements|mesh-ancestor
101415999|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
101416000|NCT03990467|Tazobactam|tazobactam|mesh-list
101416003|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416004|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416005|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101416006|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416007|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416008|NCT01247311|Vitamin D|vitamin d|mesh-list
101416009|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
101416010|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
101416011|NCT01247311|Vitamins|vitamins|mesh-list
101547612|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
101547613|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
101547614|NCT00599079|Azithromycin|azithromycin|mesh-list
101547615|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101547616|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547617|NCT00599235|Hydralazine|hydralazine|mesh-list
101547618|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
101547619|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
101547620|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101547621|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101547622|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547623|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547624|NCT00599235|Urological Agents|urological agents|mesh-ancestor
101547625|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101547626|NCT00599274|Interferons|interferons|mesh-list
101547627|NCT00599274|Interferon-beta|interferon-beta|mesh-list
101547628|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
101547629|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547630|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
101547631|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547632|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
101547633|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547634|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101547636|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101547637|NCT01332227|Tenofovir|tenofovir|mesh-list
101547638|NCT01332227|Emtricitabine|emtricitabine|mesh-list
101547639|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
101547640|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101547641|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101547643|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547644|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547645|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101547646|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101547647|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
101547648|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547649|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101547650|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101547651|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101416014|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101416015|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101416017|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101416018|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
101416019|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416020|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416021|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
101416022|NCT00503932|Capecitabine|capecitabine|mesh-list
101416023|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416024|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
101416025|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416026|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416027|NCT03981146|Nivolumab|nivolumab|mesh-list
101416028|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547653|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101547654|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101547655|NCT01332149|Pregabalin|pregabalin|mesh-list
101547656|NCT01332149|Analgesics|analgesics|mesh-ancestor
101547657|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
101547658|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547659|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547660|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
101547670|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101547671|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101547673|NCT01326702|Antibodies|antibodies|mesh-list
101547674|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
101547675|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101547676|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
101547677|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547678|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547679|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547680|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547681|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
101547682|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547683|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101547684|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547685|NCT00599625|Pravastatin|pravastatin|mesh-list
101547686|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101547687|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101547689|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547690|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101547691|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101547692|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547693|NCT05650697|Cannabidiol|cannabidiol|mesh-list
101547694|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
101547695|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
101547696|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101547697|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101547699|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
101547700|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101547701|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
101547702|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547703|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
101416031|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416032|NCT01247857|Ropivacaine|ropivacaine|mesh-list
101416033|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
101416034|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
101416035|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416036|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416037|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
101416038|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547704|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
101547705|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547706|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547707|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547708|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
101547709|NCT05649878|Hormones|hormones|mesh-ancestor
101547710|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547711|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101547712|NCT05649878|Protective Agents|protective agents|mesh-ancestor
101547713|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101547714|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547715|NCT01327703|Pancreatin|pancreatin|mesh-list
101547716|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547717|NCT01380080|Efavirenz|efavirenz|mesh-list
101547718|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101547719|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101547721|NCT01380080|Isoniazid|isoniazid|mesh-list
101547722|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
101547723|NCT01380080|Ethambutol|ethambutol|mesh-list
101547724|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
101547725|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101547728|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547729|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
101547730|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547731|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101547732|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101547733|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101547734|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101547735|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101547736|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101547737|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101547738|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101547739|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101547740|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
101547741|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101547742|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
101547743|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101547744|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101547745|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101547746|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101547747|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101547748|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
101547749|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101547750|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
101547751|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
101547752|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101547753|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101547754|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547755|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547756|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416039|NCT04331730|Aflibercept|aflibercept|mesh-list
101416040|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101416041|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416042|NCT04331730|Growth Substances|growth substances|mesh-ancestor
101416043|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416044|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416045|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416046|NCT01248091|Nitroprusside|nitroprusside|mesh-list
101416050|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416052|NCT00503971|Vorinostat|vorinostat|mesh-list
101416053|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416054|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416056|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547757|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547759|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101547760|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101547761|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101547762|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101547763|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547764|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547765|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547766|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547767|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101547768|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101547769|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101547770|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547771|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547772|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547773|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547774|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
101547775|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101547777|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547778|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
101547780|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101547781|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101547782|NCT00591617|Narcotics|narcotics|mesh-ancestor
101547783|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547784|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547785|NCT00591617|Analgesics|analgesics|mesh-ancestor
101547786|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
101547787|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547789|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
101547790|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101416058|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101416059|NCT02274961|Pantoprazole|pantoprazole|mesh-list
101416060|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101416062|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101416063|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416064|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416065|NCT02275039|Gemcitabine|gemcitabine|mesh-list
101416066|NCT02275039|Vaccines|vaccines|mesh-list
101416067|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
101416069|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416070|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
101416071|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416072|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416073|NCT01248403|Paclitaxel|paclitaxel|mesh-list
101416074|NCT01248403|Everolimus|everolimus|mesh-list
101416075|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101416076|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416077|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416078|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416079|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416080|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416081|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101416082|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416083|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416084|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416086|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416088|NCT01248442|Vitamin D|vitamin d|mesh-list
101547791|NCT01357889|Incretins|incretins|mesh-ancestor
101547792|NCT01357889|Hormones|hormones|mesh-ancestor
101547793|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547797|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101547799|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547800|NCT01357616|Timolol|timolol|mesh-list
101547801|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101547802|NCT01357616|Brinzolamide|brinzolamide|mesh-list
101547803|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101547804|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101547805|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101416089|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101416090|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416092|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
101416093|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101416094|NCT01248481|Acarbose|acarbose|mesh-list
101416096|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416097|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416098|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101416099|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416100|NCT01249339|Lobeline|lobeline|mesh-list
101416101|NCT01249339|Nicotine|nicotine|mesh-list
101416103|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
101416104|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416105|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416106|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101416107|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101547806|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547807|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547808|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547810|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101547812|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101547813|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547814|NCT01351025|Atorvastatin|atorvastatin|mesh-list
101547815|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101547816|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101547817|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
101547818|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547819|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101547820|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101547821|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547822|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101547824|NCT01348763|Darunavir|darunavir|mesh-list
101547825|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101547826|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101547827|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547828|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547831|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101547832|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101547833|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101547834|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101547835|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101547836|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101416109|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416110|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416111|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
101416113|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101416114|NCT03809429|Hormones|hormones|mesh-ancestor
101416115|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547837|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101547838|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547839|NCT01346540|Nintedanib|nintedanib|mesh-list
101547840|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547841|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101547842|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547843|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547844|NCT01342913|Fluticasone|fluticasone|mesh-list
101547845|NCT01342913|Xhance|xhance|mesh-list
101547846|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101547847|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547848|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101547849|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
101547850|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547851|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547852|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101547853|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
101547854|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
101547855|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101547856|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101547857|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101547859|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547860|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547866|NCT01342640|Hematinics|hematinics|mesh-ancestor
101547867|NCT01342484|Linagliptin|linagliptin|mesh-list
101547868|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547869|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547870|NCT01342484|Incretins|incretins|mesh-ancestor
101547871|NCT01342484|Hormones|hormones|mesh-ancestor
101547873|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101547874|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547875|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547876|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547877|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101547878|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101547879|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547880|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101547881|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101547883|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547884|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
101547885|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547886|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101547887|NCT01342211|Bococizumab|bococizumab|mesh-list
101547888|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101547889|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101547890|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
101547891|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547892|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547893|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101547894|NCT01342094|Timolol|timolol|mesh-list
101547895|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101416116|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416117|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101416118|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
101416119|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101416120|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
101416121|NCT00504127|Naproxen|naproxen|mesh-list
101416123|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416124|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416125|NCT00504127|Analgesics|analgesics|mesh-ancestor
101416126|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
101416127|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547896|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101547897|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101547898|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101547899|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
101547901|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547903|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101547904|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101547905|NCT01340768|Metformin|metformin|mesh-list
101547906|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101547907|NCT01340768|Glimepiride|glimepiride|mesh-list
101547908|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547909|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547910|NCT01340768|Incretins|incretins|mesh-ancestor
101547912|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547913|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101547914|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
101547915|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547916|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547917|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101547918|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547919|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
101547920|NCT01340300|Metformin|metformin|mesh-list
101547921|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101547926|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
101547927|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547928|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
101547929|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547930|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101547931|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547932|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
101547933|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101547935|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101547936|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547937|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547938|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
101547939|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547940|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416130|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416131|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
101416132|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416133|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416134|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416135|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101416136|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101416137|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101416138|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101416139|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416140|NCT00504205|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101547941|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101547942|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547943|NCT00598338|Prucalopride|prucalopride|mesh-list
101547944|NCT00598338|Laxatives|laxatives|mesh-ancestor
101547945|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101547946|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101547947|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101547948|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
101547949|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101547950|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547951|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547952|NCT00598572|Deferoxamine|deferoxamine|mesh-list
101547953|NCT00598572|Siderophores|siderophores|mesh-ancestor
101547954|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101547955|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
101547957|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547958|NCT00599820|Bevacizumab|bevacizumab|mesh-list
101547959|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547960|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547961|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101547962|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101547963|NCT00599820|Growth Substances|growth substances|mesh-ancestor
101547964|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547965|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
101547966|NCT00599898|Nifedipine|nifedipine|mesh-list
101547967|NCT00599898|Atosiban|atosiban|mesh-list
101547968|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101547969|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547970|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547971|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101547972|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416145|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416146|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416147|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101416148|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416149|NCT01249690|Thalidomide|thalidomide|mesh-list
101416150|NCT01249690|Dexamethasone|dexamethasone|mesh-list
101416151|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
101416152|NCT01249690|Bortezomib|bortezomib|mesh-list
101416154|NCT01249690|Doxorubicin|doxorubicin|mesh-list
101416155|NCT01249690|BB 1101|bb 1101|mesh-list
101416156|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101547973|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
101547974|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
101547975|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101547976|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
101547977|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101547978|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
101547980|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101547985|NCT00600210|Bevacizumab|bevacizumab|mesh-list
101547986|NCT00600210|Carboplatin|carboplatin|mesh-list
101547987|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547988|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547990|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101547991|NCT00600210|Growth Substances|growth substances|mesh-ancestor
101547992|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547993|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
101547994|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
101547996|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101547998|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547999|NCT01326546|Entecavir|entecavir|mesh-list
101548000|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
101548001|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548002|NCT00600600|Tigecycline|tigecycline|mesh-list
101548003|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548004|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548005|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101548006|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548007|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548008|NCT00623064|Gemcitabine|gemcitabine|mesh-list
101548009|NCT00623064|Lapatinib|lapatinib|mesh-list
101548010|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548011|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101548012|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
101548013|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548022|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548023|NCT00623220|Analgesics|analgesics|mesh-ancestor
101416158|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
101416159|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416160|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416161|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416162|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
101416163|NCT01249690|Hormones|hormones|mesh-ancestor
101416164|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416165|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101416166|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416167|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
101416168|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416169|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416171|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
101548024|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
101548025|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548027|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101548028|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101548029|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101548031|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101548032|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548033|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548034|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548036|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548037|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101548038|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548039|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548040|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548041|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548042|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
101548043|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
101548044|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
101548045|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548046|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548047|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548053|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101548055|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548058|NCT00601692|Irinotecan|irinotecan|mesh-list
101548059|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548060|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
101548061|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
101548062|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
101548063|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548064|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101548065|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101548066|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548067|NCT00602004|Losartan|losartan|mesh-list
101548068|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548069|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548070|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101548071|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101416173|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416174|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416175|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101416176|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416177|NCT01249690|Growth Substances|growth substances|mesh-ancestor
101416178|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416179|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101416180|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101416181|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416183|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548072|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548073|NCT00602082|Capecitabine|capecitabine|mesh-list
101548074|NCT00602082|Streptozocin|streptozocin|mesh-list
101548075|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548076|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101548077|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
101548078|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548081|NCT01171963|Vaccines|vaccines|mesh-list
101548082|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
101548083|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548084|NCT01171183|Carvedilol|carvedilol|mesh-list
101548085|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101548086|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101548087|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548088|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548089|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548090|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548091|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548092|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
101548093|NCT01171183|Protective Agents|protective agents|mesh-ancestor
101548094|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101548095|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548096|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548098|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101548099|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101548101|NCT01169779|Lixisenatide|lixisenatide|mesh-list
101548102|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101548103|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548104|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
101548105|NCT01169701|Everolimus|everolimus|mesh-list
101548106|NCT01169701|Tacrolimus|tacrolimus|mesh-list
101548107|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548108|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
101548109|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548110|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101548111|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548112|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548113|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101548118|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
101548119|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548120|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548121|NCT01167907|Ropivacaine|ropivacaine|mesh-list
101548122|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
101548123|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
101416185|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101416186|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101416187|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416188|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
101416189|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
101416190|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
101416191|NCT00504244|Azathioprine|azathioprine|mesh-list
101416192|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
101416193|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417484|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101416194|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416195|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416196|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416197|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
101416198|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416199|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416200|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101416201|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101548124|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548125|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548126|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
101548127|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548128|NCT01115491|Bevacizumab|bevacizumab|mesh-list
101548129|NCT01115491|Temozolomide|temozolomide|mesh-list
101548130|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101548131|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548132|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548133|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101548134|NCT01115491|Growth Substances|growth substances|mesh-ancestor
101548135|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548136|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548137|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101548138|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
101548139|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548140|NCT01113931|Doxycycline|doxycycline|mesh-list
101548141|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548142|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548144|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101548145|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101548146|NCT02881177|Oxytocin|oxytocin|mesh-list
101548147|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
101548148|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548149|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548150|NCT02880787|Rocuronium|rocuronium|mesh-list
101548151|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101548152|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101548153|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101548154|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548155|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548156|NCT01106677|Metformin|metformin|mesh-list
101548157|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101548158|NCT01106677|Canagliflozin|canagliflozin|mesh-list
101548159|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101548160|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548161|NCT01106677|Incretins|incretins|mesh-ancestor
101548162|NCT01106677|Hormones|hormones|mesh-ancestor
101416202|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
101416203|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416204|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416205|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416208|NCT00405444|Narcotics|narcotics|mesh-ancestor
101416209|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416210|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416211|NCT00405444|Analgesics|analgesics|mesh-ancestor
101416212|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
101416213|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416214|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101416215|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101548163|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548164|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101548165|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
101548166|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548167|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548168|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101548169|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101548170|NCT04309357|Plasminogen|plasminogen|mesh-list
101548171|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101548173|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548174|NCT04308343|Methotrexate|methotrexate|mesh-list
101548175|NCT04308343|Letrozole|letrozole|mesh-list
101548176|NCT04308343|Cetrorelix|cetrorelix|mesh-list
101548177|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101548178|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
101548179|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548180|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548181|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101548182|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
101548191|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548193|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101548194|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101548195|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548196|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548197|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101548198|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
101548200|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101548201|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101548202|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101548203|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
101548204|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548205|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548206|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101548207|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101548208|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
101548209|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548210|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101548211|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548212|NCT01103713|Azithromycin|azithromycin|mesh-list
101548213|NCT01103713|Chloroquine|chloroquine|mesh-list
101548214|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548215|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416216|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
101416217|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
101416218|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101416219|NCT00504283|Morphine|morphine|mesh-list
101416220|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101416221|NCT00504283|Narcotics|narcotics|mesh-ancestor
101416222|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416223|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416224|NCT00504283|Analgesics|analgesics|mesh-ancestor
101548216|NCT01103713|Amebicides|amebicides|mesh-ancestor
101548217|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101548218|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101548219|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
101548220|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548221|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101548222|NCT01103245|Spironolactone|spironolactone|mesh-list
101548223|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548224|NCT01103245|Diuretics|diuretics|mesh-ancestor
101548225|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
101548226|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548227|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101548228|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548229|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548230|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101548231|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548232|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548233|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101548235|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
101548236|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101548237|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548238|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548239|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548240|NCT02878837|Analgesics|analgesics|mesh-ancestor
101548241|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
101548242|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548243|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101548257|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
101548258|NCT02880007|Cisplatin|cisplatin|mesh-list
101548259|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548260|NCT04982029|Cannabidiol|cannabidiol|mesh-list
101548261|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
101548262|NCT02880085|Lidocaine|lidocaine|mesh-list
101548263|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
101548264|NCT02880085|Anesthetics|anesthetics|mesh-list
101548265|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548266|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548267|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
101548268|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548269|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548270|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101548271|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101548272|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548273|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548275|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
101548276|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548277|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
101548278|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548279|NCT04407572|Vitamin D|vitamin d|mesh-list
101548280|NCT04407572|Vitamins|vitamins|mesh-list
101548281|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
101548282|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
101548283|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
101416226|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416227|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416228|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416229|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101416230|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416231|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416232|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416233|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416234|NCT00504400|Ranibizumab|ranibizumab|mesh-list
101416235|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548284|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548285|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101548286|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
101548287|NCT04407572|Hematinics|hematinics|mesh-ancestor
101548288|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
101548289|NCT04328636|Analgesics|analgesics|mesh-ancestor
101548290|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
101548291|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548292|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548293|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
101548294|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548295|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548296|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
101548297|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101548298|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548299|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548300|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548302|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548304|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548305|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101548306|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548307|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548308|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548309|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548310|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
101548311|NCT02893280|Aspirin|aspirin|mesh-list
101548312|NCT02893280|Enoxaparin|enoxaparin|mesh-list
101548313|NCT02893280|Streptokinase|streptokinase|mesh-list
101548314|NCT02893280|Clopidogrel|clopidogrel|mesh-list
101548315|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101548316|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548317|NCT02893280|Analgesics|analgesics|mesh-ancestor
101548318|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
101548319|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548320|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548321|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548322|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548323|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101548324|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101548325|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548326|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101548327|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416236|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416237|NCT00504400|Growth Substances|growth substances|mesh-ancestor
101416238|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416239|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416240|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416241|NCT00504439|Simvastatin|simvastatin|mesh-list
101416242|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101548328|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548329|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
101548330|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101548331|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101548332|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101548333|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
101548334|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548336|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101548337|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101548338|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548340|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
101548341|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548342|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
101548343|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
101548344|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101548345|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548346|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548347|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101548348|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101548349|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
101548350|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548351|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101548352|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
101548353|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548355|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101548356|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101548357|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548358|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548359|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548360|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
101548361|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548362|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101548363|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
101548364|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548369|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101548370|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548371|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548372|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548373|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101548374|NCT04327232|Diuretics|diuretics|mesh-ancestor
101548375|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
101548376|NCT00593138|Methylphenidate|methylphenidate|mesh-list
101548377|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101548378|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101548379|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548380|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101548381|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101548382|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548383|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548384|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
101416243|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416244|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
101416245|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416246|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101416247|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101416248|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416249|NCT04054830|Diclofenac|diclofenac|mesh-list
101416250|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416251|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416252|NCT04054830|Analgesics|analgesics|mesh-ancestor
101416253|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
101416254|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416255|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416256|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548385|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548386|NCT00593294|Drospirenone|drospirenone|mesh-list
101548387|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101548388|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548389|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101548390|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548391|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548392|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101548393|NCT00593294|Diuretics|diuretics|mesh-ancestor
101548394|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
101548395|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101548396|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101548397|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101548398|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
101548399|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548400|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101548401|NCT00593294|Estrogens|estrogens|mesh-ancestor
101548402|NCT00593294|Hormones|hormones|mesh-ancestor
101548403|NCT00593996|Vitamin D|vitamin d|mesh-list
101548404|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
101548405|NCT00593996|Vitamins|vitamins|mesh-ancestor
101548406|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
101548407|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548409|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548411|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
101548412|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
101548413|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548414|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548415|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
101548416|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548417|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548418|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101548419|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101548420|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548421|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548422|NCT00595322|Bevacizumab|bevacizumab|mesh-list
101548423|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101548424|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548425|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548426|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416257|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416258|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416259|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416260|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416261|NCT03622775|Daratumumab|daratumumab|mesh-list
101416262|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416263|NCT01249651|Esomeprazole|esomeprazole|mesh-list
101416264|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101416265|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416266|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101416267|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416268|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416269|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
101416270|NCT03999723|Vitamins|vitamins|mesh-ancestor
101416271|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
101416272|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416273|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
101416274|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416275|NCT03999723|Protective Agents|protective agents|mesh-ancestor
101548427|NCT00595322|Growth Substances|growth substances|mesh-ancestor
101548431|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101548432|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
101548433|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548434|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548435|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
101548437|NCT00596414|Meperidine|meperidine|mesh-list
101548438|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101548439|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101548440|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548441|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548442|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101548443|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101548444|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548445|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101548446|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
101548447|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
101548448|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
101548449|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
101548450|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548451|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548452|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101548453|NCT00596414|Narcotics|narcotics|mesh-ancestor
101548454|NCT00596414|Analgesics|analgesics|mesh-ancestor
101548455|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
101416276|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
101416277|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101416278|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101416279|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101416280|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101416281|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416282|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
101416283|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416284|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416285|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101548456|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548457|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101548458|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548459|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101548460|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548461|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548463|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548465|NCT00622934|Hematinics|hematinics|mesh-ancestor
101548466|NCT00597662|Icodextrin|icodextrin|mesh-list
101548467|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
101548468|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101548469|NCT00598052|Escitalopram|escitalopram|mesh-list
101548470|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101548471|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101548472|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548473|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548474|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548475|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
101548476|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548477|NCT04326296|Lenalidomide|lenalidomide|mesh-list
101548478|NCT04326296|Antibodies|antibodies|mesh-list
101548480|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
101548481|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548482|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548483|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101548484|NCT04326296|Growth Substances|growth substances|mesh-ancestor
101548489|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
101548490|NCT00598676|Temsirolimus|temsirolimus|mesh-list
101548491|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101548492|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548493|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548494|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548495|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
101548496|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548497|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548498|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548499|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548500|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548501|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
101548502|NCT00599222|Ranibizumab|ranibizumab|mesh-list
101548503|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548504|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101548505|NCT00599222|Growth Substances|growth substances|mesh-ancestor
101548506|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548507|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548508|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548509|NCT00599534|Montelukast|montelukast|mesh-list
101548510|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101416286|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416287|NCT00403325|Ranibizumab|ranibizumab|mesh-list
101416288|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101416289|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416290|NCT00403325|Growth Substances|growth substances|mesh-ancestor
101416291|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416293|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416294|NCT04725747|Midazolam|midazolam|mesh-list
101416295|NCT04725747|Ketamine|ketamine|mesh-list
101416296|NCT04725747|Analgesics|analgesics|mesh-ancestor
101416297|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
101416298|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416299|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416300|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101548511|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
101548512|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101548513|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548514|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548515|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548516|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101548517|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101548518|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548519|NCT00600158|Lidocaine|lidocaine|mesh-list
101548520|NCT00600158|Hydromorphone|hydromorphone|mesh-list
101548521|NCT00600158|Bupivacaine|bupivacaine|mesh-list
101548524|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548525|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548526|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
101548527|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548528|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548529|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101548530|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101548531|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548532|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548533|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101548535|NCT00600158|Analgesics|analgesics|mesh-ancestor
101548536|NCT04325984|Dexamethasone|dexamethasone|mesh-list
101548537|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548538|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
101548539|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
101548540|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548541|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548542|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101548543|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
101548545|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548546|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101548547|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548548|NCT00600548|Miltefosine|miltefosine|mesh-list
101548549|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101548550|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
101548551|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548552|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548553|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101548558|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
101548559|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101416301|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101416302|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
101416304|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416305|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101416306|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101416307|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416308|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416309|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101416310|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101416311|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101416312|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101416313|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101416314|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
101416316|NCT03546686|Nivolumab|nivolumab|mesh-list
101416317|NCT03546686|Ipilimumab|ipilimumab|mesh-list
101416318|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416320|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101416321|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416322|NCT04725942|Posaconazole|posaconazole|mesh-list
101548560|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
101548561|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
101548562|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
101548564|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101548565|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548566|NCT00623168|Ribavirin|ribavirin|mesh-list
101548567|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
101548568|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548569|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
101548570|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548571|NCT00601016|Imiquimod|imiquimod|mesh-list
101548572|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101548573|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
101548574|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548575|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548576|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
101548577|NCT00601328|Calcitriol|calcitriol|mesh-list
101548578|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101548579|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548580|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101548581|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548582|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548583|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101548584|NCT00601328|Vitamins|vitamins|mesh-ancestor
101548585|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
101416323|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
101416324|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416325|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101416326|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101548586|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101548588|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
101548589|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548590|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101548591|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548592|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548593|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
101548594|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548595|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101548596|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101548597|NCT00601874|Pilocarpine|pilocarpine|mesh-list
101548598|NCT00601874|Miotics|miotics|mesh-ancestor
101548599|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
101548600|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548601|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548602|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101548603|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101548604|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
101548605|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548606|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548607|NCT01326026|Insulin|insulin|mesh-list
101548608|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101548609|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
101548610|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101548611|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548612|NCT01097629|Suvorexant|suvorexant|mesh-list
101548613|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101548614|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101548616|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548617|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101548618|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548619|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548620|NCT04308031|Digoxin|digoxin|mesh-list
101548621|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548622|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101548623|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548629|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548630|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548631|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101548632|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101548633|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548634|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548635|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548636|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101548637|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548639|NCT01324388|Metoprolol|metoprolol|mesh-list
101548640|NCT01324388|Lisinopril|lisinopril|mesh-list
101548641|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548642|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548643|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
101548644|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
101548645|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548646|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548647|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101548648|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101548649|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101548650|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548651|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548652|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548653|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101416328|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101416329|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101416330|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416331|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416332|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101416333|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
101416334|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416335|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416336|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
101548654|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
101548655|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548656|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101548657|NCT01324388|Protective Agents|protective agents|mesh-ancestor
101548658|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101548659|NCT02878681|Ranibizumab|ranibizumab|mesh-list
101548660|NCT02878681|Aflibercept|aflibercept|mesh-list
101548661|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548662|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101548663|NCT02878681|Growth Substances|growth substances|mesh-ancestor
101548664|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548665|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548666|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548667|NCT01324310|Ketoconazole|ketoconazole|mesh-list
101548668|NCT01324310|Romidepsin|romidepsin|mesh-list
101548669|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
101548670|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548671|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101548672|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548673|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548674|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548675|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101548676|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
101548677|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548678|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548679|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101548680|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548681|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548682|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101548683|NCT01102231|Cetuximab|cetuximab|mesh-list
101548684|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101548685|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548686|NCT01095835|Interferons|interferons|mesh-list
101548688|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101548689|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
101548700|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548701|NCT04908865|Belimumab|belimumab|mesh-list
101548702|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548703|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
101548704|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548705|NCT01324232|Quinidine|quinidine|mesh-list
101548706|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
101548707|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
101548708|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
101548709|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101548710|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101548711|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548712|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548713|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416337|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
101416338|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101416339|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101416340|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416341|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101416342|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416343|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101416344|NCT03890952|Bevacizumab|bevacizumab|mesh-list
101416346|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101548714|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101548715|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101548716|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548717|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101548718|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
101548719|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101548720|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101548721|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548722|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548723|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101548724|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101548725|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
101548726|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101548727|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101548728|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548729|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101548730|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548731|NCT02878291|Vaccines|vaccines|mesh-list
101548732|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
101548733|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548734|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
101548735|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
101548749|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548750|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101548751|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548752|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
101548753|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548754|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548755|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101548757|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548758|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101548759|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548760|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101548761|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548762|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548763|NCT02891967|Z 350|z 350|mesh-list
101416347|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416349|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416351|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416352|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416353|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101416354|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416355|NCT03868722|Venetoclax|venetoclax|mesh-list
101416356|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
101416357|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416358|NCT03761511|Niacinamide|niacinamide|mesh-list
101416359|NCT03761511|Niacin|niacin|mesh-list
101416360|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
101416361|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
101416362|NCT03761511|Vitamins|vitamins|mesh-ancestor
101548764|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101548765|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101548766|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548769|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548770|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548772|NCT00598377|Hormones|hormones|mesh-ancestor
101548773|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548774|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548775|NCT00598533|Sirolimus|sirolimus|mesh-list
101548776|NCT00598533|Probucol|probucol|mesh-list
101548777|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548778|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548779|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548780|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548781|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
101548782|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548783|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
101548784|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548785|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548786|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101548787|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101548788|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
101548789|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101548790|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
101548791|NCT00598533|Protective Agents|protective agents|mesh-ancestor
101548792|NCT00599937|Tretinoin|tretinoin|mesh-list
101548793|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548801|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
101548802|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548803|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548804|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548805|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548806|NCT00600093|Analgesics|analgesics|mesh-ancestor
101548807|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
101548808|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548809|NCT00600249|Docetaxel|docetaxel|mesh-list
101548810|NCT00600249|Cetuximab|cetuximab|mesh-list
101548811|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416363|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
101416364|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416365|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416366|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
101416367|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416368|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101416369|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
101416370|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
101416371|NCT02952092|Hematinics|hematinics|mesh-ancestor
101416372|NCT00139152|Omalizumab|omalizumab|mesh-list
101416373|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101416374|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101416375|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
101416376|NCT02824523|Aspirin|aspirin|mesh-list
101416377|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416378|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416379|NCT02824523|Analgesics|analgesics|mesh-ancestor
101416380|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
101416381|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416382|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416383|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548812|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
101548813|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
101548814|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
101548815|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548816|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101548818|NCT00600405|Oxycodone|oxycodone|mesh-list
101548819|NCT00600405|Tamsulosin|tamsulosin|mesh-list
101548820|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101548821|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548822|NCT00600405|Analgesics|analgesics|mesh-ancestor
101548823|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
101548824|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548825|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548826|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548827|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548828|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101548829|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548830|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548831|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101548832|NCT00600405|Narcotics|narcotics|mesh-ancestor
101548833|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548834|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101548835|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101548836|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101548837|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548838|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548839|NCT00600405|Urological Agents|urological agents|mesh-ancestor
101548840|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101548841|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101548842|NCT00600639|Prednisolone|prednisolone|mesh-list
101548843|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101548844|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
101416385|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101416386|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101416387|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416388|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101416389|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416390|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416391|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
101416392|NCT02736422|Xenon|xenon|mesh-list
101416393|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101416394|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
101416395|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
101416396|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548845|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101548846|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
101548848|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101548849|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
101548850|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548851|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
101548852|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548853|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
101548855|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101548856|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548857|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101548858|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548859|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
101548860|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
101548877|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
101548878|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548879|NCT00600873|Protective Agents|protective agents|mesh-ancestor
101548880|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548881|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101548882|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101548883|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
101548884|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
101548885|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548886|NCT00598611|Loratadine|loratadine|mesh-list
101548887|NCT00598611|Desloratadine|desloratadine|mesh-list
101548888|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101548889|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
101548890|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548891|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548892|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548893|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101548894|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101548895|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
101548896|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
101548897|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
101548898|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548899|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101548900|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
101548901|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
101548902|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548903|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
101548904|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
101548905|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548906|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416397|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416398|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
101416399|NCT03721497|Testosterone|testosterone|mesh-list
101416400|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
101416401|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
101416402|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101416403|NCT03721497|Androgens|androgens|mesh-ancestor
101416404|NCT03721497|Hormones|hormones|mesh-ancestor
101416405|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416406|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416407|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101548907|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548908|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
101548909|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101548910|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548911|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548912|NCT00601887|Meloxicam|meloxicam|mesh-list
101548913|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101548914|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101548915|NCT00601887|Analgesics|analgesics|mesh-ancestor
101548916|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
101548917|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548918|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548922|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101548923|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548924|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548925|NCT01325493|Ketamine|ketamine|mesh-list
101548926|NCT01325493|Analgesics|analgesics|mesh-ancestor
101548927|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
101548928|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548929|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548931|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101548932|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
101548933|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
101548934|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548935|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101548936|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101548937|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548938|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548939|NCT01325337|Bimatoprost|bimatoprost|mesh-list
101548940|NCT01325337|Minoxidil|minoxidil|mesh-list
101548941|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101548942|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101548943|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
101548944|NCT01324947|Pomalidomide|pomalidomide|mesh-list
101548945|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
101548946|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548947|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101548948|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101548949|NCT01324947|Growth Substances|growth substances|mesh-ancestor
101548950|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548951|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548952|NCT01101841|Paroxetine|paroxetine|mesh-list
101548953|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101548954|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101548955|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101548956|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416409|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
101416411|NCT03682029|Vitamins|vitamins|mesh-ancestor
101416412|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
101416413|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416414|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
101416415|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416416|NCT03682029|Protective Agents|protective agents|mesh-ancestor
101416417|NCT00139230|Leucovorin|leucovorin|mesh-list
101416418|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
101416419|NCT00139230|Fluorouracil|fluorouracil|mesh-list
101416420|NCT00139230|Docetaxel|docetaxel|mesh-list
101416421|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416422|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
101416423|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416424|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416425|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416426|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
101548957|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548958|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
101548959|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548960|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101548961|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
101548962|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548963|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101548964|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548965|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548966|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
101548967|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101548968|NCT02877511|Protective Agents|protective agents|mesh-ancestor
101548969|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548970|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548971|NCT01324323|Rifampin|rifampin|mesh-list
101548972|NCT01324323|Romidepsin|romidepsin|mesh-list
101548973|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101548974|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
101548975|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101548976|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548977|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
101548978|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548979|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548980|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548981|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101548982|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101548983|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101548984|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101548985|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101548990|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101548991|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548993|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548995|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
101548996|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548997|NCT01323582|Azithromycin|azithromycin|mesh-list
101548998|NCT01323582|Erythromycin|erythromycin|mesh-list
101416427|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416428|NCT00139230|Antidotes|antidotes|mesh-ancestor
101416429|NCT00139230|Protective Agents|protective agents|mesh-ancestor
101416430|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
101416432|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
101416433|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416434|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416435|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416436|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416437|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416438|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101416439|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416440|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416441|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101416442|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101416443|NCT02086175|Rituximab|rituximab|mesh-list
101416444|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416445|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548999|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
101549000|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101549001|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
101549002|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101549003|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549004|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549005|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101549006|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549007|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549008|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
101549009|NCT05367765|Flumatinib|flumatinib|mesh-list
101549010|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549011|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549012|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549013|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549014|NCT01323621|Fluticasone|fluticasone|mesh-list
101549015|NCT01323621|Xhance|xhance|mesh-list
101549016|NCT01323621|Albuterol|albuterol|mesh-list
101549017|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101549018|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549019|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101549020|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
101549021|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549022|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549023|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101549024|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
101549025|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
101549026|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101549027|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101549028|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101549029|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101549030|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
101549031|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549032|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549033|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
101549034|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549035|NCT05645289|Alendronate|alendronate|mesh-list
101549036|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101416446|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
101416447|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416448|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416449|NCT00139269|Docetaxel|docetaxel|mesh-list
101416450|NCT00139269|Fluorouracil|fluorouracil|mesh-list
101416451|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416452|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416453|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416456|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
101549037|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549038|NCT01320033|Doxycycline|doxycycline|mesh-list
101549039|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101549040|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549041|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
101549042|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101549043|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101549044|NCT05644743|Gemcitabine|gemcitabine|mesh-list
101549045|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549046|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101549047|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
101549048|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549049|NCT01317615|Paclitaxel|paclitaxel|mesh-list
101549050|NCT01317615|Carboplatin|carboplatin|mesh-list
101549051|NCT01317615|Everolimus|everolimus|mesh-list
101549052|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101549053|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549054|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549055|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549060|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549061|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549062|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
101549063|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549064|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
101549065|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101549067|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549068|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549069|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101549070|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101549071|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549072|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
101549073|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549074|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549075|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101549076|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549077|NCT01100437|Naltrexone|naltrexone|mesh-list
101549078|NCT01100437|Morphine|morphine|mesh-list
101549079|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101549080|NCT01100437|Narcotics|narcotics|mesh-ancestor
101549081|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549082|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549083|NCT01100437|Analgesics|analgesics|mesh-ancestor
101549084|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
101549085|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549086|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101549087|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101549089|NCT01322490|Sargramostim|sargramostim|mesh-list
101549090|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
101549091|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549092|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416457|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416458|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416459|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
101416460|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549093|NCT01314261|Interferons|interferons|mesh-list
101549094|NCT01314261|Ribavirin|ribavirin|mesh-list
101549095|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549096|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
101549097|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549098|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
101549099|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549101|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101549102|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549103|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
101549104|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
101549105|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
101549106|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549107|NCT01321710|Acetaminophen|acetaminophen|mesh-list
101549108|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549109|NCT01321710|Analgesics|analgesics|mesh-ancestor
101549110|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
101549111|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549112|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549113|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
101549114|NCT01321008|Prednisone|prednisone|mesh-list
101549115|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
101549116|NCT01321008|Doxorubicin|doxorubicin|mesh-list
101549117|NCT01321008|Vincristine|vincristine|mesh-list
101549118|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549119|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
101549120|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549121|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549122|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101549123|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
101549129|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101549130|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549131|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549132|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
101549133|NCT01321008|Hormones|hormones|mesh-ancestor
101549134|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549135|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549136|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101549137|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549138|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549139|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101549141|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101549142|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
101549143|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549144|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549145|NCT01313637|Bromides|bromides|mesh-list
101549155|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101549156|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549157|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
101549158|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549159|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549160|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
101549161|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549162|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101549163|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
101416462|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416463|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
101416464|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416465|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416466|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101416467|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
101416468|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416469|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416470|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101549164|NCT01320722|Protective Agents|protective agents|mesh-ancestor
101549165|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
101549167|NCT01313559|Pasireotide|pasireotide|mesh-list
101549168|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101549169|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549170|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549171|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549172|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549173|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
101549174|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549175|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549176|NCT01313559|Hormones|hormones|mesh-ancestor
101549177|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549185|NCT02890875|Ethanol|ethanol|mesh-list
101549187|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
101549188|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101549189|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101549190|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549191|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101549192|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549202|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549203|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549205|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
101549206|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549207|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549208|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549209|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549210|NCT01318902|Dexamethasone|dexamethasone|mesh-list
101549211|NCT01318902|Ixazomib|ixazomib|mesh-list
101549212|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549213|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
101549214|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
101549215|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549216|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549217|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549218|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
101549219|NCT01318902|Hormones|hormones|mesh-ancestor
101549220|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549221|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549222|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549223|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
101549224|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549225|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416471|NCT00403364|Amoxicillin|amoxicillin|mesh-list
101416472|NCT00403364|Clarithromycin|clarithromycin|mesh-list
101416473|NCT00403364|Tinidazole|tinidazole|mesh-list
101416474|NCT00403364|Pantoprazole|pantoprazole|mesh-list
101416475|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416476|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416477|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101549226|NCT01313858|Golimumab|golimumab|mesh-list
101549227|NCT01313858|Methotrexate|methotrexate|mesh-list
101549228|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101549229|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
101549230|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549231|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549232|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101549233|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
101549234|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549235|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549236|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
101549237|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549238|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101549239|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549240|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
101549241|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549243|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101549244|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549245|NCT01313780|Oxycodone|oxycodone|mesh-list
101549246|NCT01313780|Naloxone|naloxone|mesh-list
101549247|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101549248|NCT01313780|Narcotics|narcotics|mesh-ancestor
101549249|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417529|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
101549250|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549251|NCT01313780|Analgesics|analgesics|mesh-ancestor
101549252|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
101549253|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549254|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101549265|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549267|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101549268|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101549269|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549270|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549271|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549272|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
101549273|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549274|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101549275|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101549276|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549277|NCT01169038|Azithromycin|azithromycin|mesh-list
101549278|NCT01169038|Rifampin|rifampin|mesh-list
101549279|NCT01169038|Ethambutol|ethambutol|mesh-list
101549280|NCT01169038|Levofloxacin|levofloxacin|mesh-list
101549281|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101549282|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549283|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101549284|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
101549285|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
101549286|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101549287|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549288|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549289|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101549290|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101549291|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101549292|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101549293|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101549294|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101549295|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101416478|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416479|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416480|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101416481|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101416482|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101416483|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416484|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101416485|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
101549296|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101549297|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101549298|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549299|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101549300|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101549301|NCT00624754|Budesonide|budesonide|mesh-list
101549302|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
101549303|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549304|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101549305|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
101549306|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549307|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549308|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101549309|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
101549310|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
101549311|NCT00624754|Hormones|hormones|mesh-ancestor
101549312|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549313|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101549314|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101549315|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101549316|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
101549321|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549322|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
101549323|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549324|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
101549325|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101549326|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101549327|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101549328|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101549329|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549330|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
101549331|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549332|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549333|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101549334|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549335|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
101549336|NCT01114672|Vitamin D|vitamin d|mesh-list
101549337|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549338|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549339|NCT01114672|Vitamins|vitamins|mesh-ancestor
101549340|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
101549341|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101549342|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101549343|NCT01114516|Clindamycin|clindamycin|mesh-list
101549344|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
101549345|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
101549346|NCT01114516|Cefazolin|cefazolin|mesh-list
101549347|NCT01114516|Indomethacin|indomethacin|mesh-list
101549348|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549349|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101549350|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549351|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549352|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549353|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549354|NCT01114516|Analgesics|analgesics|mesh-ancestor
101416486|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101416487|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101416488|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101416491|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416492|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416493|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549355|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
101549356|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549357|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549358|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549359|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549360|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
101549361|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
101549362|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549363|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101549364|NCT01313078|Asparaginase|asparaginase|mesh-list
101549365|NCT01313078|Pegaspargase|pegaspargase|mesh-list
101549366|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549367|NCT01114360|Melatonin|melatonin|mesh-list
101549368|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
101549369|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549370|NCT01114360|Protective Agents|protective agents|mesh-ancestor
101549371|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549372|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549373|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101549374|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549375|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549376|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549381|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549382|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549383|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101549385|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549386|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549387|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101549388|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549389|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549390|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549391|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549392|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101549393|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101549395|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101549396|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101549397|NCT01075243|Acetaminophen|acetaminophen|mesh-list
101549398|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549399|NCT01075243|Analgesics|analgesics|mesh-ancestor
101549400|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
101549401|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549402|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549403|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
101549404|NCT01078441|Dexamethasone|dexamethasone|mesh-list
101549405|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
101549406|NCT01078441|Doxorubicin|doxorubicin|mesh-list
101549407|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101549408|NCT01078441|Bortezomib|bortezomib|mesh-list
101549409|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549410|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
101416494|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416495|NCT00403442|Growth Substances|growth substances|mesh-ancestor
101416496|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416497|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416498|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101416499|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
101416500|NCT00139386|Candesartan|candesartan|mesh-list
101416501|NCT00139386|Candesartan cilexetil|candesartan cilexetil|mesh-list
101416502|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101416503|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101416504|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101416505|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416506|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
101416507|NCT00402974|Vitamin K|vitamin k|mesh-list
101416508|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
101416509|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101549411|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549412|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549413|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101549414|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
101549415|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549416|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549417|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101549418|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549419|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
101549420|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
101549421|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549422|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549423|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
101549424|NCT01078441|Hormones|hormones|mesh-ancestor
101549425|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549426|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549427|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101549428|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101549429|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101549430|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549432|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
101549433|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101549434|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101549435|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549436|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549437|NCT00626665|Urological Agents|urological agents|mesh-ancestor
101549438|NCT01090063|Ustekinumab|ustekinumab|mesh-list
101549439|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
101549440|NCT01306214|Empagliflozin|empagliflozin|mesh-list
101549441|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101549442|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549443|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549444|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549446|NCT00623402|Sorafenib|sorafenib|mesh-list
101549447|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549456|NCT01077739|Capecitabine|capecitabine|mesh-list
101549457|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
101549458|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101549459|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416510|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101416511|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416512|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
101416513|NCT00402974|Coagulants|coagulants|mesh-ancestor
101416514|NCT00402974|Vitamins|vitamins|mesh-ancestor
101416515|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
101416516|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416517|NCT01731236|Aspirin|aspirin|mesh-list
101416518|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101416519|NCT01731236|Vancomycin|vancomycin|mesh-list
101416520|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
101416521|NCT01731236|Neomycin|neomycin|mesh-list
101416522|NCT01731236|Choline|choline|mesh-list
101549460|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549461|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101549462|NCT01077739|Growth Substances|growth substances|mesh-ancestor
101549463|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549464|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549465|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
101549466|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549467|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101549468|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101549469|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
101549471|NCT01077739|Protective Agents|protective agents|mesh-ancestor
101549472|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
101549473|NCT01077739|Vitamins|vitamins|mesh-ancestor
101549474|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
101549475|NCT01306058|Sorafenib|sorafenib|mesh-list
101549476|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549477|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549478|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549479|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549480|NCT00626509|Sunitinib|sunitinib|mesh-list
101549481|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549482|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549483|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101549484|NCT00626509|Growth Substances|growth substances|mesh-ancestor
101549485|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549486|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549487|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549488|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549489|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549490|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101549491|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101549492|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101549493|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101549494|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549495|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549496|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549497|NCT02877901|Urological Agents|urological agents|mesh-ancestor
101549498|NCT04306159|Anesthetics|anesthetics|mesh-list
101549499|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549500|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549501|NCT01305200|Calcium|calcium|mesh-list
101549502|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549503|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416523|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416524|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416525|NCT01731236|Analgesics|analgesics|mesh-ancestor
101416526|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
101416527|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416528|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416529|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101416530|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416531|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101416532|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101416533|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416534|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101416535|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101416536|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416537|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
101416538|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416539|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101416540|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416541|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549505|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
101549506|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549507|NCT01074931|Ritonavir|ritonavir|mesh-list
101549508|NCT01074931|Lopinavir|lopinavir|mesh-list
101549509|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101549519|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101549520|NCT04774159|Colchicine|colchicine|mesh-list
101549521|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
101549522|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549523|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549524|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549525|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
101549526|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549527|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549529|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101549530|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
101549531|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549532|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549533|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101549534|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101549535|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101549536|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
101549537|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549538|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549539|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549540|NCT01302938|Urological Agents|urological agents|mesh-ancestor
101549541|NCT01076647|Insulin|insulin|mesh-list
101549542|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101549543|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
101549544|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549545|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549546|NCT04306081|Evolocumab|evolocumab|mesh-list
101549547|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101549548|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101416542|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101416543|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101416544|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
101416545|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416547|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416548|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101416549|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
101416550|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101549549|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549550|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
101549551|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549552|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101549553|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
101549554|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549555|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549557|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101549558|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
101549559|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
101549560|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549561|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549562|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101549563|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101549564|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101549565|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
101549566|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549567|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549569|NCT01076335|Leuprolide|leuprolide|mesh-list
101549570|NCT01076335|Goserelin|goserelin|mesh-list
101549571|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549572|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549573|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549575|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549579|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549580|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549582|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101549583|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549584|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549585|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549586|NCT01074229|Ropivacaine|ropivacaine|mesh-list
101549587|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
101549588|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
101549589|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549590|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549591|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
101549592|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549593|NCT01106014|Selexipag|selexipag|mesh-list
101549594|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101549596|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549597|NCT01105936|Analgesics|analgesics|mesh-ancestor
101549598|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
101549599|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549600|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549601|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
101549603|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101549604|NCT01309659|Trace Elements|trace elements|mesh-ancestor
101549605|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
101549606|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549607|NCT01309659|Hematinics|hematinics|mesh-ancestor
101549608|NCT04989166|Curcumin|curcumin|mesh-list
101549609|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549610|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416551|NCT03510078|Insulin|insulin|mesh-list
101416553|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416554|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
101416555|NCT00139581|Tacrolimus|tacrolimus|mesh-list
101416556|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101416557|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101416558|NCT00139581|Analgesics|analgesics|mesh-ancestor
101416559|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
101416560|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416561|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416562|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549611|NCT04989166|Analgesics|analgesics|mesh-ancestor
101549612|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
101549613|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549614|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549617|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549618|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549619|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549620|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
101549621|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101549622|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549623|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549624|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549625|NCT05320705|Analgesics|analgesics|mesh-ancestor
101549626|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
101549627|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549628|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101549629|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101549630|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101549631|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
101549632|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549633|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549634|NCT01104766|Aripiprazole|aripiprazole|mesh-list
101549635|NCT01104766|Cariprazine|cariprazine|mesh-list
101549636|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
101549637|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101549638|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101549639|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101549644|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549645|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549646|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101549647|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101549648|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
101549649|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101549650|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101549651|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101549652|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101549653|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101549654|NCT02880280|Menotropins|menotropins|mesh-list
101549655|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549656|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416563|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416564|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
101416565|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416566|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
101416567|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101416568|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549657|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101549660|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101549661|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549662|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101549663|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549664|NCT01104376|Efavirenz|efavirenz|mesh-list
101549665|NCT01104376|Voriconazole|voriconazole|mesh-list
101549666|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101549667|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101549668|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549669|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549670|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
101549671|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549672|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101549673|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101549674|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101549675|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101549676|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101549677|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101549678|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
101549679|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101549680|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101549681|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
101549682|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549683|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549684|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101549685|NCT02875873|Methamphetamine|methamphetamine|mesh-list
101549686|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
101549687|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101549688|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549689|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
101549690|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
101549691|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549692|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
101549693|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549694|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549695|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
101549696|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101549697|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101549706|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549707|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101549708|NCT01072357|Growth Substances|growth substances|mesh-ancestor
101549709|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549710|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549711|NCT01072357|Laxatives|laxatives|mesh-ancestor
101549712|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549713|NCT01072201|Triclosan|triclosan|mesh-list
101549714|NCT01072201|Fluorides|fluorides|mesh-list
101549715|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
101549716|NCT01072201|Protective Agents|protective agents|mesh-ancestor
101416569|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416570|NCT03500913|Hormones|hormones|mesh-list
101416571|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416572|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416573|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101416574|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416575|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416576|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416577|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416578|NCT00130481|Atorvastatin|atorvastatin|mesh-list
101416579|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101416580|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416581|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
101549717|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549718|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101549719|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549720|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101549721|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549722|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
101549723|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549724|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549726|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101549727|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549728|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101549729|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549730|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549731|NCT04972396|Metformin|metformin|mesh-list
101549732|NCT04972396|Digoxin|digoxin|mesh-list
101549733|NCT04972396|Warfarin|warfarin|mesh-list
101549734|NCT04972396|Atorvastatin|atorvastatin|mesh-list
101549735|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
101549736|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101549737|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549738|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549739|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101549740|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549741|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
101549742|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549743|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549744|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101549745|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549746|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
101549747|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101549748|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
101549749|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549750|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101549751|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101549752|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101549753|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101549754|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101549755|NCT04972396|Protective Agents|protective agents|mesh-ancestor
101549756|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101549757|NCT04972396|Estrogens|estrogens|mesh-ancestor
101549758|NCT04972396|Hormones|hormones|mesh-ancestor
101549759|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549760|NCT01089361|Ketamine|ketamine|mesh-list
101549761|NCT01089361|Analgesics|analgesics|mesh-ancestor
101549762|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
101549763|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416582|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416583|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101416584|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101416585|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416586|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101416587|NCT00139698|Olmesartan|olmesartan|mesh-list
101416588|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101549764|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549765|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101549769|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549770|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101549771|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101549772|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549773|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549774|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101549775|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101549776|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101549777|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101549778|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549779|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549780|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
101549781|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549782|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101549783|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101549784|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101417549|NCT00141804|Sirolimus|sirolimus|mesh-list
101549785|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101549786|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
101549787|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
101549788|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101549789|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549790|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
101549791|NCT01087489|Lidocaine|lidocaine|mesh-list
101549793|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
101549794|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549795|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549796|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
101549797|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549798|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101549799|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101549800|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101549801|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101549802|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549803|NCT04306627|Amlodipine|amlodipine|mesh-list
101549804|NCT04306627|Perindopril|perindopril|mesh-list
101549805|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
101549806|NCT04306627|Atorvastatin|atorvastatin|mesh-list
101549807|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101549808|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549809|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
101549810|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549811|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549812|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101549814|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101549815|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101549816|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101549817|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101549818|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549819|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
101549820|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101549821|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
101416589|NCT00139698|Diuretics|diuretics|mesh-ancestor
101416590|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
101416591|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416592|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101416593|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101416594|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416595|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101549823|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101549824|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101549825|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101549826|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
101549827|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549828|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101549829|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
101549830|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549831|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101549832|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101549833|NCT04296253|Mitogens|mitogens|mesh-list
101549834|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
101549842|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549844|NCT01102426|Dexamethasone|dexamethasone|mesh-list
101549845|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549847|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
101549848|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549849|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549850|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549851|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
101549853|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549854|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549855|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549856|NCT04308850|Vitamin D|vitamin d|mesh-list
101549857|NCT04308850|Vitamins|vitamins|mesh-ancestor
101549858|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
101549859|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549860|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101549861|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101549862|NCT01101334|Efatutazone|efatutazone|mesh-list
101549863|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549864|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549865|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549866|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549867|NCT01327547|Maraviroc|maraviroc|mesh-list
101549868|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101549869|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101549870|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549871|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101549872|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101549873|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
101549874|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549875|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101549876|NCT01308567|Prednisone|prednisone|mesh-list
101549877|NCT01308567|Docetaxel|docetaxel|mesh-list
101549878|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549879|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
101549880|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101549881|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101549882|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549883|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549884|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
101549885|NCT01308567|Hormones|hormones|mesh-ancestor
101549886|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549887|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416596|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101416597|NCT00130676|Mifepristone|mifepristone|mesh-list
101416598|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101416599|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
101416600|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101416601|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549888|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549889|NCT00592241|Insulin|insulin|mesh-list
101549890|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101549891|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549904|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
101549905|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549906|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549907|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549908|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
101549909|NCT04325061|Hormones|hormones|mesh-ancestor
101549910|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549912|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549915|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549916|NCT01307319|Beclomethasone|beclomethasone|mesh-list
101549917|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549918|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
101549919|NCT01307319|Hormones|hormones|mesh-ancestor
101549920|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549921|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549922|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101549923|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
101549924|NCT04365725|Remdesivir|remdesivir|mesh-list
101549925|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
101549926|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549927|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
101549928|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549929|NCT01080391|Dexamethasone|dexamethasone|mesh-list
101549930|NCT01080391|Lenalidomide|lenalidomide|mesh-list
101549931|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549932|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
101549933|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
101549934|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549935|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549936|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101549937|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
101549938|NCT01080391|Hormones|hormones|mesh-ancestor
101417557|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549939|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101549940|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101549941|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549942|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
101549943|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101549944|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101549945|NCT01080391|Growth Substances|growth substances|mesh-ancestor
101549946|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
101549947|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101549948|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101549949|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101549950|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101549951|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549952|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549964|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
101549965|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549966|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549967|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549968|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549969|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101416602|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101416603|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101416604|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101416605|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
101416606|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101416607|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101416608|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
101416609|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416610|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
101416611|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101549970|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101549971|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549972|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101549973|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101549975|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
101549976|NCT02875717|Aspirin|aspirin|mesh-list
101549977|NCT02875717|Heparin|heparin|mesh-list
101549978|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101549979|NCT02875717|Tinzaparin|tinzaparin|mesh-list
101549980|NCT02875717|Dalteparin|dalteparin|mesh-list
101549981|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
101549982|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101549983|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101549984|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549985|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549986|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549987|NCT02875717|Analgesics|analgesics|mesh-ancestor
101549988|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
101549989|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549990|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549991|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549992|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101549993|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101549994|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101549995|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549996|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
101549998|NCT04334837|Trace Elements|trace elements|mesh-ancestor
101549999|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
101550000|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550002|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101550003|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
101550004|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101550005|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101550006|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101550007|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550008|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550009|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
101550010|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550011|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550012|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101550013|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550014|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550015|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
101550028|NCT00593879|Mecamylamine|mecamylamine|mesh-list
101550029|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550030|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
101550031|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
101550032|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550033|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416612|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101416613|NCT00404274|Casopitant|casopitant|mesh-list
101416614|NCT00404274|Warfarin|warfarin|mesh-list
101416615|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
101416616|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
101416619|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416620|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416621|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101416622|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550034|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101550035|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101550036|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
101550037|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550038|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550039|NCT00594191|Simvastatin|simvastatin|mesh-list
101550040|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101550041|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101550042|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
101550043|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550044|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101550045|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101550046|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550047|NCT00594269|Risperidone|risperidone|mesh-list
101550048|NCT00594269|Citalopram|citalopram|mesh-list
101550049|NCT00594269|Sertraline|sertraline|mesh-list
101550050|NCT00594269|Paroxetine|paroxetine|mesh-list
101550051|NCT00594269|Escitalopram|escitalopram|mesh-list
101550052|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101550053|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
101550054|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550055|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550056|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550057|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101550058|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101550059|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550060|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101550061|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101550062|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
101550063|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101550064|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101550065|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550066|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101550067|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
101550068|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101550069|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550070|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550071|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101550072|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
101550073|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550074|NCT04326959|Triamcinolone|triamcinolone|mesh-list
101550075|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101550076|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101550083|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550084|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
101550085|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550086|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550087|NCT00594737|Memantine|memantine|mesh-list
101416625|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
101416626|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416627|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416628|NCT00130871|Simendan|simendan|mesh-list
101416629|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101416630|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
101416631|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101416632|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101416633|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416634|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416635|NCT00130871|Protective Agents|protective agents|mesh-ancestor
101550088|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101550089|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101550090|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
101550091|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550092|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550093|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550094|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101550095|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101550096|NCT00595049|Bosentan|bosentan|mesh-list
101550097|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550098|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101550099|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550101|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550102|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101550103|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550104|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550105|NCT00596063|Insulin|insulin|mesh-list
101550106|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550107|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550109|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101550110|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101550111|NCT00596219|Analgesics|analgesics|mesh-ancestor
101550112|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
101550113|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550114|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550115|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550116|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101550117|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101550118|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101550119|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550120|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550121|NCT00596297|Bevacizumab|bevacizumab|mesh-list
101550122|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101550123|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550124|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101550125|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101550126|NCT00596297|Growth Substances|growth substances|mesh-ancestor
101550127|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550128|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
101550129|NCT00596375|Lidocaine|lidocaine|mesh-list
101550130|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
101550131|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
101550132|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416636|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416637|NCT00130910|Albendazole|albendazole|mesh-list
101416638|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
101416639|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101416640|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416641|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
101550133|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550134|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
101550135|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550136|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101550137|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101550138|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101550139|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101550148|NCT00596609|Analgesics|analgesics|mesh-ancestor
101550149|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
101550150|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101550151|NCT04326803|Vaccines|vaccines|mesh-list
101550152|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
101550153|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550154|NCT00597233|Insulin|insulin|mesh-list
101550155|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101550156|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
101550157|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
101550158|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
101550159|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
101550160|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550161|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550162|NCT01064401|Interferons|interferons|mesh-list
101550163|NCT01064401|Interferon-beta|interferon-beta|mesh-list
101550164|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
101550165|NCT01064401|Daclizumab|daclizumab|mesh-list
101550166|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101550167|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
101550168|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550169|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
101550170|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550171|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101550172|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101550173|NCT00597389|Propranolol|propranolol|mesh-list
101550174|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101550175|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101550176|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
101550177|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101550178|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550179|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550180|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101550181|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101550182|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
101550183|NCT01306617|Ritonavir|ritonavir|mesh-list
101550184|NCT01306617|Ribavirin|ribavirin|mesh-list
101550185|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101550186|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101550188|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101550189|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550190|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101550191|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101550192|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
101550193|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101550194|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101550195|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101550197|NCT00597623|Adalimumab|adalimumab|mesh-list
101550198|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101550199|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550200|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416642|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101416643|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101416644|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416645|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416646|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416647|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416648|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416649|NCT03226821|Tesamorelin|tesamorelin|mesh-list
101416650|NCT03226821|Growth Substances|growth substances|mesh-ancestor
101416651|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416653|NCT00139815|PENTA|penta|mesh-list
101416654|NCT00139815|Fondaparinux|fondaparinux|mesh-list
101416655|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
101416656|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101416657|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101416658|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416659|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101416660|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
101416661|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101416662|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
101416663|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416665|NCT00131027|Dexamethasone|dexamethasone|mesh-list
101416666|NCT00131027|Prednisolone|prednisolone|mesh-list
101416667|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
101416669|NCT00131027|Methotrexate|methotrexate|mesh-list
101416670|NCT00131027|Etoposide|etoposide|mesh-list
101416671|NCT00131027|Vincristine|vincristine|mesh-list
101416672|NCT00131027|Daunorubicin|daunorubicin|mesh-list
101416673|NCT00131027|Asparaginase|asparaginase|mesh-list
101416674|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
101416675|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416676|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
101416677|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416678|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416679|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101416680|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
101416681|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416682|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416683|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101416684|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101416686|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
101416687|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416688|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416689|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
101416690|NCT00131027|Hormones|hormones|mesh-ancestor
101416691|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416692|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101416693|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101416694|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101416695|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416696|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416697|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101416704|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101416705|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101416707|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416708|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416709|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416710|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416712|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101416713|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101416714|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416716|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101416717|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101416718|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
101416719|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
101416720|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416721|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416722|NCT00131144|Octreotide|octreotide|mesh-list
101416723|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416724|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101416725|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416726|NCT00139893|Metoclopramide|metoclopramide|mesh-list
101416727|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
101416728|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
101416729|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416730|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416731|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416732|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101416734|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
101416735|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416736|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416737|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
101416738|NCT00131183|Androgens|androgens|mesh-ancestor
101416739|NCT00131183|Hormones|hormones|mesh-ancestor
101416740|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416741|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416742|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
101416743|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101416744|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
101416745|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416747|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101416748|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
101416749|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101416750|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101416754|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416756|NCT00131261|Belinostat|belinostat|mesh-list
101416757|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101416758|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
101416759|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
101416760|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416761|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416762|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101416763|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
101416764|NCT00131261|Hormones|hormones|mesh-ancestor
101416765|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416766|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101416767|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416768|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101416770|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416772|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
101416773|NCT00131300|Protective Agents|protective agents|mesh-ancestor
101416774|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416775|NCT00131339|Cycloserine|cycloserine|mesh-list
101416776|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101416777|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416778|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101416779|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
101416780|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416781|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
101416782|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416783|NCT00139971|Gemcitabine|gemcitabine|mesh-list
101416784|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101416785|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
101416786|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416787|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416788|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
101416789|NCT00140010|Hematinics|hematinics|mesh-ancestor
101416790|NCT00131495|Testosterone|testosterone|mesh-list
101416791|NCT00131495|Androgens|androgens|mesh-ancestor
101416792|NCT00131495|Hormones|hormones|mesh-ancestor
101416793|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416794|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416795|NCT04726631|Insulin|insulin|mesh-list
101416796|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101416797|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
101416798|NCT04726631|Protamines|protamines|mesh-list
101416799|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101416800|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416801|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
101416802|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416803|NCT04726631|Coagulants|coagulants|mesh-ancestor
101416804|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
101416805|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416808|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416809|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101416811|NCT03117309|Ipilimumab|ipilimumab|mesh-list
101416812|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416813|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416814|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101416815|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416817|NCT00140166|Niacinamide|niacinamide|mesh-list
101416819|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
101416820|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
101416822|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
101416823|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416824|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101416825|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
101416826|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416827|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101416828|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
101416829|NCT03095274|Durvalumab|durvalumab|mesh-list
101416830|NCT03095274|Tremelimumab|tremelimumab|mesh-list
101416831|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416832|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416833|NCT00131768|Hylan|hylan|mesh-list
101416836|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416838|NCT01248949|Bevacizumab|bevacizumab|mesh-list
101416839|NCT01248949|Carboplatin|carboplatin|mesh-list
101416840|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101416841|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416842|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416843|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
101416844|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416845|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416846|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101416847|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101416848|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101416849|NCT01248949|Growth Substances|growth substances|mesh-ancestor
101416850|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416851|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
101416852|NCT00403637|Maleic acid|maleic acid|mesh-list
101416853|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416854|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416855|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
101416856|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101416858|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416859|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
101416860|NCT04696666|Protective Agents|protective agents|mesh-ancestor
101416862|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101416863|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101416864|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101416865|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416866|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
101416867|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416868|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101416869|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101416870|NCT01248364|Empagliflozin|empagliflozin|mesh-list
101416871|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101416872|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416873|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101416874|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416876|NCT00140361|Lumefantrine|lumefantrine|mesh-list
101416877|NCT00140361|Artemether|artemether|mesh-list
101416880|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101416881|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
101416882|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101416883|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101416884|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416885|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416886|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
101416887|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
101416888|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101416889|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
101416890|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101416891|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416892|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416893|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101416895|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101416896|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
101416897|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416898|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101416899|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416901|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
101416902|NCT00131963|Doxorubicin|doxorubicin|mesh-list
101416903|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101416904|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416905|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
101416907|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
101416908|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416909|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416910|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
101416911|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416912|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416913|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101416914|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
101416915|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101416916|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101416917|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101221778|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101416918|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416919|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416920|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
101416921|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
101416922|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416923|NCT00132119|Nalmefene|nalmefene|mesh-list
101416924|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101416925|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416926|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
101416927|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416929|NCT00132158|Gefitinib|gefitinib|mesh-list
101416930|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101416931|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101416932|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416933|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416934|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416935|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101416936|NCT00140478|Mifepristone|mifepristone|mesh-list
101416937|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101416938|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
101416939|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101416940|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416941|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101416942|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101416943|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101416944|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
101416945|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101416946|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101416947|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
101416948|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101416949|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
101416950|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101416951|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101416952|NCT00140517|Chloroquine|chloroquine|mesh-list
101416953|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
101416954|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
101416955|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101416956|NCT00140517|Amebicides|amebicides|mesh-ancestor
101416957|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101416958|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101416961|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416962|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101416963|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416964|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416965|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101416966|NCT00132236|Nicotine|nicotine|mesh-list
101416967|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101416968|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
101416969|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101416970|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416971|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101416972|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101416973|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
101416974|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101416975|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416976|NCT00132275|Amoxicillin|amoxicillin|mesh-list
101416977|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
101416978|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
101416979|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101416980|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101416981|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101416982|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101416983|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416985|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
101416986|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416987|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
101416989|NCT00140595|Doxorubicin|doxorubicin|mesh-list
101416990|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101416991|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
101416992|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101416993|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101416994|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101416995|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
101416996|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101416997|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101416998|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101416999|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101417000|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417001|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101417002|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417003|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221779|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101417006|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417007|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101417008|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417009|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417011|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417012|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417013|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101417014|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
101417015|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417017|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101417018|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101417019|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
101417020|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
101417021|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417022|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417023|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417025|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
101417026|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
101417027|NCT00132548|Amodiaquine|amodiaquine|mesh-list
101417028|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101417029|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
101417030|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101417031|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101417032|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417033|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417034|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
101417035|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
101417036|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101417038|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101417039|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417040|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417041|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101417043|NCT00140751|Lopinavir|lopinavir|mesh-list
101417044|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101417045|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101417046|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
101417047|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417048|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417049|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101417050|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101417051|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
101417052|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417053|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101417054|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101417055|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
101417056|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
101417057|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101417058|NCT00132587|Protective Agents|protective agents|mesh-ancestor
101417059|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417061|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417062|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101417063|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101417064|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417065|NCT01245673|Lenalidomide|lenalidomide|mesh-list
101417066|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101417067|NCT01245673|Poly ICLC|poly iclc|mesh-list
101417068|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
101417069|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417070|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101417071|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101417073|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101417074|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417075|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
101417076|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
101417077|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101417078|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417079|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417082|NCT00132743|Cilostazol|cilostazol|mesh-list
101417083|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101417084|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
101417085|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417086|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417087|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101417088|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
101417089|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101417090|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417091|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417092|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101417093|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
101417094|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101417095|NCT00132743|Protective Agents|protective agents|mesh-ancestor
101417096|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101417097|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101417098|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417099|NCT00132821|Bupropion|bupropion|mesh-list
101417100|NCT00132821|Nicotine|nicotine|mesh-list
101417101|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101417102|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
101417103|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417104|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417105|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101417107|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
101417108|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417109|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417110|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101417111|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
101417112|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417113|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101417114|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101417115|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417116|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
101417117|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101417118|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101417119|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417120|NCT00132860|Azithromycin|azithromycin|mesh-list
101417121|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417122|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417123|NCT01244815|Asenapine|asenapine|mesh-list
101417124|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101417125|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101221780|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
101417126|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417127|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417129|NCT00132899|Methotrexate|methotrexate|mesh-list
101417130|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101417131|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
101417133|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417134|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101417135|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
101417136|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417137|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417139|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417140|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101417141|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417143|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417144|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101417146|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
101417147|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101417148|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417149|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417150|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101417151|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101417152|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417153|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417154|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
101417155|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
101417156|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101417157|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101417158|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101417159|NCT00132938|Telithromycin|telithromycin|mesh-list
101417160|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417161|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417163|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
101417164|NCT02955706|Vitamins|vitamins|mesh-ancestor
101417165|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
101417166|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417168|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101417169|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
101417170|NCT01244425|Coagulants|coagulants|mesh-ancestor
101417172|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101417173|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417174|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101417175|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101417180|NCT01154439|Cytarabine|cytarabine|mesh-list
101417182|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
101417183|NCT01154439|Idarubicin|idarubicin|mesh-list
101417184|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
101417185|NCT01154439|Everolimus|everolimus|mesh-list
101417186|NCT01154439|Ifosfamide|ifosfamide|mesh-list
101417187|NCT01154439|Carboplatin|carboplatin|mesh-list
101417188|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101417189|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417190|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101417191|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417192|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417193|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417194|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101417196|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
101417197|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417198|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417199|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
101417200|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417202|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101417203|NCT01154439|Analgesics|analgesics|mesh-ancestor
101417204|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
101417205|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417206|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417207|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101417208|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
101417209|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
101417211|NCT00133172|Tacrolimus|tacrolimus|mesh-list
101417212|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417213|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
101417214|NCT00133172|Hormones|hormones|mesh-ancestor
101417215|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417216|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417217|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101417218|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417219|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417221|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101417222|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417223|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417224|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417225|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101417227|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417228|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417229|NCT00141141|Atorvastatin|atorvastatin|mesh-list
101417230|NCT00141141|Simvastatin|simvastatin|mesh-list
101417232|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101417233|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
101417234|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417235|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101417236|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101417237|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417238|NCT00133250|Heparin|heparin|mesh-list
101417239|NCT00133250|Calcium heparin|calcium heparin|mesh-list
101417240|NCT00133250|Abciximab|abciximab|mesh-list
101417241|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
101417242|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101417243|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101417244|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417245|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101417246|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
101417247|NCT00144495|Hematinics|hematinics|mesh-ancestor
101417248|NCT00133328|Valsartan|valsartan|mesh-list
101417249|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417582|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417250|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101417251|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101417252|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417253|NCT00133367|Sirolimus|sirolimus|mesh-list
101417254|NCT00133367|Fludarabine|fludarabine|mesh-list
101417255|NCT00133367|Melphalan|melphalan|mesh-list
101417256|NCT00133367|Tacrolimus|tacrolimus|mesh-list
101417257|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
101417258|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101417259|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417260|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417261|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417262|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
101417263|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417264|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101417265|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417266|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417267|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417268|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417270|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101417271|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
101417272|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101417273|NCT00141258|Pregabalin|pregabalin|mesh-list
101417275|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
101417276|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417277|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417278|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
101417279|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417280|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417281|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417282|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417283|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101417284|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417285|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417286|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417288|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101417289|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101417290|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417291|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417292|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101417293|NCT00403910|Diuretics|diuretics|mesh-ancestor
101417294|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
101417295|NCT00141336|Pregabalin|pregabalin|mesh-list
101417296|NCT00141336|Analgesics|analgesics|mesh-ancestor
101417297|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
101417298|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417299|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417300|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
101417301|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417302|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417303|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417304|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417305|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101417307|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417308|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417310|NCT00133406|Glycine|glycine|mesh-list
101417311|NCT00133406|Vitamins|vitamins|mesh-ancestor
101417312|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
101417313|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417314|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417315|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
101417316|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417317|NCT00133445|Vaccines|vaccines|mesh-list
101417318|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
101417319|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417320|NCT00141375|Pregabalin|pregabalin|mesh-list
101417321|NCT00141375|Analgesics|analgesics|mesh-ancestor
101417322|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
101417323|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417324|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417325|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
101417326|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417327|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417328|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417330|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101417331|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417332|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417333|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417334|NCT00133523|Vaccines|vaccines|mesh-list
101417335|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
101417336|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417337|NCT00133562|Glycine|glycine|mesh-list
101417338|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
101417339|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417340|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417341|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417342|NCT00404391|Acetaminophen|acetaminophen|mesh-list
101417343|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
101417344|NCT00404391|Hydrocodone|hydrocodone|mesh-list
101417345|NCT00404391|Oxycodone|oxycodone|mesh-list
101417346|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101417348|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
101417349|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417350|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417352|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101417354|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417355|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
101417356|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
101417357|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101417358|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417359|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417360|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
101417361|NCT00144807|Rituximab|rituximab|mesh-list
101417362|NCT00144807|Doxorubicin|doxorubicin|mesh-list
101417363|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417364|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
101417365|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417366|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417367|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101417368|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
101417369|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417370|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417371|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101417372|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101417373|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417374|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101417375|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417376|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417377|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
101417378|NCT00133640|Vitamin D|vitamin d|mesh-list
101417379|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417380|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417381|NCT00133640|Vitamins|vitamins|mesh-ancestor
101417382|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
101417383|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101417384|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101417385|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417386|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101417387|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417388|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417389|NCT00404508|Hydralazine|hydralazine|mesh-list
101417390|NCT00404508|Valproic Acid|valproic acid|mesh-list
101417391|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
101417392|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417393|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417395|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417396|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417397|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
101417398|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101417399|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417400|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417401|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417402|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
101417403|NCT00133757|Bupropion|bupropion|mesh-list
101417404|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101417405|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
101417406|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101417407|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101417408|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101417409|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417410|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417411|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
101417412|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417413|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417414|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101417415|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101417416|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417417|NCT00144846|Albuterol|albuterol|mesh-list
101417418|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101417419|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
101417420|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417421|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417422|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101417423|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
101417424|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
101417425|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101417426|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101417427|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101417428|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101417429|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
101417430|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417431|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417432|NCT00133796|Trastuzumab|trastuzumab|mesh-list
101417433|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101417434|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417435|NCT00133874|Retapamulin|retapamulin|mesh-list
101417436|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417437|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417438|NCT00141414|Pregabalin|pregabalin|mesh-list
101417439|NCT00141414|Analgesics|analgesics|mesh-ancestor
101417440|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
101417441|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417442|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417448|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101417459|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417462|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417463|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101417466|NCT00134069|Sorafenib|sorafenib|mesh-list
101417467|NCT00134069|Antibodies|antibodies|mesh-list
101417469|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101417470|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
101417472|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417473|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101417474|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417476|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417477|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101417478|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
101417479|NCT00141570|Estrogens|estrogens|mesh-list
101417480|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
101417481|NCT00141570|Testosterone|testosterone|mesh-list
101417485|NCT00141570|Hormones|hormones|mesh-ancestor
101417486|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417487|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417488|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101417489|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417490|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
101417491|NCT00141570|Androgens|androgens|mesh-ancestor
101417492|NCT00134147|Insulin|insulin|mesh-list
101417493|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101417494|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417495|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
101417496|NCT00403988|Vinorelbine|vinorelbine|mesh-list
101417497|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417498|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101417499|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417500|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
101417501|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417502|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417503|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
101417504|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417505|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101417506|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
101417507|NCT00141648|Prednisolone|prednisolone|mesh-list
101417508|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
101417509|NCT00141648|Doxorubicin|doxorubicin|mesh-list
101417510|NCT00141648|Vincristine|vincristine|mesh-list
101417511|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417512|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
101417513|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417514|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417515|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101417516|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
101417517|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417518|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417519|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101417520|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417521|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101417522|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417523|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417524|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101417525|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417526|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
101417527|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417528|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417530|NCT00141648|Hormones|hormones|mesh-ancestor
101417531|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417532|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101417533|NCT00134420|Clonidine|clonidine|mesh-list
101417534|NCT00134420|Mitogens|mitogens|mesh-list
101417535|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417536|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417537|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417538|NCT00134420|Analgesics|analgesics|mesh-ancestor
101417539|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
101417541|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101417542|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
101417543|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
101417544|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101417545|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101417546|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101417547|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
101417548|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417550|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101417551|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101417552|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101417553|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417554|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
101417555|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417558|NCT00134498|Atorvastatin|atorvastatin|mesh-list
101417559|NCT00134498|Torcetrapib|torcetrapib|mesh-list
101417560|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101417561|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101417562|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
101417563|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417564|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101221782|NCT01509469|Caseins|caseins|mesh-list
101417565|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101417566|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417567|NCT00141843|Factor VIII|factor viii|mesh-list
101417568|NCT00141843|Coagulants|coagulants|mesh-ancestor
101417569|NCT00141882|Memantine|memantine|mesh-list
101417570|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101417571|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101417572|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
101417573|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417574|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417575|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417576|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101417577|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101417578|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101417580|NCT00152295|Hormones|hormones|mesh-ancestor
101417581|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417584|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
101417585|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
101417586|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101417587|NCT00134654|Estrogens|estrogens|mesh-ancestor
101417588|NCT00134654|Hormones|hormones|mesh-ancestor
101246577|NCT01666691|CKD732|ckd732|mesh-list
101246578|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101246579|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101246580|NCT01666691|Growth Substances|growth substances|mesh-ancestor
101246581|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246582|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
101246583|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246584|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101246585|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246586|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246587|NCT01666756|Sorafenib|sorafenib|mesh-list
101246588|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246589|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101246590|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247348|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247349|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247583|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247585|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101247586|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101247587|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247588|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247589|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247590|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
101247591|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
101247592|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
101247593|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
101248049|NCT03099265|Protective Agents|protective agents|mesh-ancestor
101421119|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421120|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421122|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
101421123|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
101421124|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
101421125|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101421126|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101421127|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
101421128|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421314|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421316|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
101421317|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
101421356|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421357|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421358|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
101421359|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421360|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
101421361|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421362|NCT00470743|Ibuprofen|ibuprofen|mesh-list
101421363|NCT00470743|Indomethacin|indomethacin|mesh-list
101421364|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101421365|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101421366|NCT00470743|Analgesics|analgesics|mesh-ancestor
101421371|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421408|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
101421409|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421478|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101421479|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421480|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101421481|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101421482|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
101421483|NCT00471406|Verteporfin|verteporfin|mesh-list
101421484|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101421485|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
101421486|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
101421487|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421489|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421490|NCT00471484|Interferons|interferons|mesh-list
101421491|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
101421492|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
101421493|NCT00471484|Doxorubicin|doxorubicin|mesh-list
101421494|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101421495|NCT00471484|Fluorouracil|fluorouracil|mesh-list
101421496|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
101421497|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421498|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421500|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101421536|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421537|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101421538|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421539|NCT00471679|Ethanol|ethanol|mesh-list
101417589|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417590|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417592|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101417593|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417594|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101417595|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
101417596|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
101417597|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421540|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101421541|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421542|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421543|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421544|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101421545|NCT00149604|Estrogens|estrogens|mesh-list
101421546|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101421547|NCT00149604|Hormones|hormones|mesh-ancestor
101421548|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421549|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421550|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101421551|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
101421552|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101421553|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101421554|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101421555|NCT00471952|Caffeine|caffeine|mesh-list
101421556|NCT00471952|Rizatriptan|rizatriptan|mesh-list
101421557|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101421568|NCT00471991|Dienogest|dienogest|mesh-list
101421585|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101421586|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101421588|NCT00336310|Repaglinide|repaglinide|mesh-list
101421589|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101421590|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421591|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
101421592|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101421593|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101421594|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101421595|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101421596|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421597|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
101421598|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421599|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421600|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101421602|NCT00472225|Rituximab|rituximab|mesh-list
101421643|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
101421644|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101421645|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101421648|NCT00472927|Hormones|hormones|mesh-ancestor
101421649|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421651|NCT00337090|Mirabegron|mirabegron|mesh-list
101421652|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101421653|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101421654|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101421655|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
101421656|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421658|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421701|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421702|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
101421703|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421704|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421705|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101421706|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421707|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421708|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421709|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
101421710|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417598|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417599|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417601|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101421765|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101421766|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101421767|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421768|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421769|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101421770|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101421771|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101421772|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101421773|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101421774|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101421775|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101421777|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101421778|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101421779|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101421780|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
101421821|NCT00337792|Midazolam|midazolam|mesh-list
101421822|NCT00337792|Oxycodone|oxycodone|mesh-list
101421823|NCT00337792|Lorazepam|lorazepam|mesh-list
101421824|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101421825|NCT00337792|Narcotics|narcotics|mesh-ancestor
101421826|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421827|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421828|NCT00337792|Analgesics|analgesics|mesh-ancestor
101421829|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
101421830|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421831|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101421889|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421890|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421891|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421892|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421893|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421894|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
101421895|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421896|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
101421897|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421898|NCT00509470|Amlodipine|amlodipine|mesh-list
101421899|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101421900|NCT00509470|Telmisartan|telmisartan|mesh-list
101421901|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101421902|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101421903|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101421904|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421905|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101421906|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421907|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
101421908|NCT00509470|Diuretics|diuretics|mesh-ancestor
101421909|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
101421910|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101421941|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
101421942|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421943|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421946|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421947|NCT02953210|Dexamethasone|dexamethasone|mesh-list
101421948|NCT02953210|Ketorolac|ketorolac|mesh-list
101421949|NCT02953210|Lidocaine|lidocaine|mesh-list
101421950|NCT02953210|Clonidine|clonidine|mesh-list
101421951|NCT02953210|Fentanyl|fentanyl|mesh-list
101421956|NCT02953210|Propofol|propofol|mesh-list
101421957|NCT02953210|Isoflurane|isoflurane|mesh-list
101421958|NCT02953210|Ranitidine|ranitidine|mesh-list
101421959|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101421960|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101421961|NCT02953210|Rocuronium|rocuronium|mesh-list
101422001|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101422002|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
101422003|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101422004|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101422005|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422006|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101422007|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422008|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101422009|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101422010|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101422011|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101422064|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101422065|NCT00158574|Dapsone|dapsone|mesh-list
101422066|NCT00158574|Mefloquine|mefloquine|mesh-list
101422067|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
101422068|NCT00158574|Proguanil|proguanil|mesh-list
101422069|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
101422070|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101422071|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101422072|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422132|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
101422133|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101422135|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422136|NCT00338650|Adalimumab|adalimumab|mesh-list
101422137|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101422138|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422139|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422140|NCT00158691|Amifostine|amifostine|mesh-list
101422141|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101422142|NCT00158691|Protective Agents|protective agents|mesh-ancestor
101422144|NCT00338767|Fluoxetine|fluoxetine|mesh-list
101422194|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422199|NCT00425191|Docetaxel|docetaxel|mesh-list
101422267|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422268|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
101422269|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422270|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422273|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101422338|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422339|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101422340|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101422406|NCT00150657|Carboplatin|carboplatin|mesh-list
101422407|NCT00150657|Gemcitabine|gemcitabine|mesh-list
101422408|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101422409|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422418|NCT00511771|Tegaserod|tegaserod|mesh-list
101422479|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101422480|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422481|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422482|NCT00150735|Levetiracetam|levetiracetam|mesh-list
101422483|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
101422484|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
101422540|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422541|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101422542|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101422543|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422544|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422545|NCT00511498|Urological Agents|urological agents|mesh-ancestor
101422546|NCT00511576|Docetaxel|docetaxel|mesh-list
101422547|NCT00511576|Mocetinostat|mocetinostat|mesh-list
101422548|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101422605|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101422606|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422607|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101422610|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101422611|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422612|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101422613|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101422614|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
101422615|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422616|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
101422617|NCT00150891|Cyclosporine|cyclosporine|mesh-list
101422618|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
101422619|NCT00150891|Azathioprine|azathioprine|mesh-list
101422620|NCT00150891|Tacrolimus|tacrolimus|mesh-list
101422621|NCT00150891|Cyclosporins|cyclosporins|mesh-list
101422622|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101422623|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
101422624|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422625|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101422626|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422627|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422628|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
101422629|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422630|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
101422631|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101422654|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422655|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101422656|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422657|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101422658|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422659|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
101422660|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101422719|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101422720|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101422721|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
101422722|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101422723|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101422724|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
101422725|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101422729|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
101422787|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
101422858|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101422859|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101422929|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101422930|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101422931|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
101422932|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101422933|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422934|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101422935|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101422936|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
101422937|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101422994|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101422996|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101422997|NCT00166413|Thalidomide|thalidomide|mesh-list
101422998|NCT00166413|Lenalidomide|lenalidomide|mesh-list
101422999|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423000|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
101423001|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423002|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
101423003|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423004|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423059|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423061|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101423062|NCT00516802|Dacarbazine|dacarbazine|mesh-list
101423131|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101423133|NCT05861063|Dezocine|dezocine|mesh-list
101423134|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
101423135|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
101423136|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101423137|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423138|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
101423145|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101423198|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
101423200|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101423201|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423268|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101423269|NCT05859412|Prednisolone|prednisolone|mesh-list
101423270|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
101423271|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101423272|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
101423340|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423343|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423411|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423412|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101423413|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423414|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101423415|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423482|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423483|NCT05494398|Expectorants|expectorants|mesh-ancestor
101423484|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
101423486|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
101423553|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423554|NCT05313529|Incretins|incretins|mesh-ancestor
101423555|NCT05313529|Hormones|hormones|mesh-ancestor
101423556|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101423557|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101423558|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423559|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101423560|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
101423561|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101423618|NCT05188118|Lenvatinib|lenvatinib|mesh-list
101423619|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101423620|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423623|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101423689|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423691|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101423692|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101423697|NCT04841980|Rifaximin|rifaximin|mesh-list
101423759|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423760|NCT04781972|Methylphenidate|methylphenidate|mesh-list
101423761|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101423762|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423763|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101423767|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
101423827|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101423828|NCT04644016|Cyclosporine|cyclosporine|mesh-list
101423829|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
101423830|NCT04644016|Fludarabine|fludarabine|mesh-list
101423898|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101423899|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
101423900|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101423901|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101423902|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
101423903|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423904|NCT04463680|Rifampin|rifampin|mesh-list
101423905|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101423906|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
101423907|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101423908|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101423909|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
101423910|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101423958|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101423959|NCT04341311|Panobinostat|panobinostat|mesh-list
101423960|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101423964|NCT04304014|Sulfalene|sulfalene|mesh-list
101424031|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424032|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424034|NCT04039607|Nivolumab|nivolumab|mesh-list
101424035|NCT04039607|Ipilimumab|ipilimumab|mesh-list
101424036|NCT04039607|Sorafenib|sorafenib|mesh-list
101424037|NCT04039607|Lenvatinib|lenvatinib|mesh-list
101424038|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101424039|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424040|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101424041|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424042|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101424043|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424044|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
101424045|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101424046|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
101424047|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101424088|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101424089|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101424090|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424091|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424155|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424156|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424228|NCT03123913|Androgens|androgens|mesh-ancestor
101424229|NCT03123913|Hormones|hormones|mesh-ancestor
101424230|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424231|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424232|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424233|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424234|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
101424235|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
101424236|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
101424237|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424238|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424293|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101417602|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
101417603|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101417604|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
101417605|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101424294|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424295|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101424304|NCT02636582|Molgramostim|molgramostim|mesh-list
101424364|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
101424365|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424366|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424367|NCT02095184|Letrozole|letrozole|mesh-list
101424436|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424437|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
101424438|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424439|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424440|NCT04694677|Misoprostol|misoprostol|mesh-list
101424441|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
101424442|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101424502|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101424503|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424504|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424505|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
101424506|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424507|NCT00517582|Icatibant|icatibant|mesh-list
101424508|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101424509|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101424510|NCT00517582|Analgesics|analgesics|mesh-ancestor
101424567|NCT00518479|Moxonidine|moxonidine|mesh-list
101424568|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
101424569|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101424570|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101424571|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101424572|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424573|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101424574|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424575|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
101424576|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101424577|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101424578|NCT00518479|Diuretics|diuretics|mesh-ancestor
101424579|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
101424580|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101424581|NCT00166725|Octreotide|octreotide|mesh-list
101424582|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101424583|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101424584|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424585|NCT00518635|Insulin|insulin|mesh-list
101424586|NCT00518635|Hormones|hormones|mesh-list
101424587|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101424588|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424589|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101424590|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
101424591|NCT00151632|Tacrolimus|tacrolimus|mesh-list
101424607|NCT02949232|Hormones|hormones|mesh-ancestor
101424614|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101424615|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
101424616|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
101424619|NCT00518947|Verapamil|verapamil|mesh-list
101424620|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
101424621|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
101424622|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101424623|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424624|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424625|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
101424626|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101424627|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424628|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424672|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424673|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101424674|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
101424740|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
101424741|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424742|NCT00519337|Protective Agents|protective agents|mesh-ancestor
101424743|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
101424744|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101424745|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101424746|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
101424747|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424748|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101424749|NCT00166881|Docetaxel|docetaxel|mesh-list
101424750|NCT00166881|Irinotecan|irinotecan|mesh-list
101424751|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424752|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
101424753|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
101424800|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101424873|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101424874|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101424875|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424876|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101424877|NCT00151983|Methylphenidate|methylphenidate|mesh-list
101424939|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424940|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424942|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101424943|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101424944|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
101424945|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424946|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424947|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424948|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101424949|NCT00521170|Levocetirizine|levocetirizine|mesh-list
101424950|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101424951|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101424952|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
101424953|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
101424954|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101424955|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101424956|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101424993|NCT00521482|Growth Substances|growth substances|mesh-ancestor
101424994|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
101424995|NCT00521521|Docetaxel|docetaxel|mesh-list
101425066|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101425067|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101425068|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101425069|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425135|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
101425136|NCT04726553|Antimalarials|antimalarials|mesh-list
101425137|NCT04726553|Methotrexate|methotrexate|mesh-list
101425138|NCT04726553|Azathioprine|azathioprine|mesh-list
101425207|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425208|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425281|NCT00167583|Cyclosporine|cyclosporine|mesh-list
101425282|NCT00167583|Cyclosporins|cyclosporins|mesh-list
101425283|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425359|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101425360|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425361|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425362|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425365|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425366|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425367|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
101425368|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425369|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425370|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425371|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
101425372|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
101425373|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
101425374|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425375|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
101425376|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
101425412|NCT00524407|Hematinics|hematinics|mesh-ancestor
101425413|NCT00525889|Sirolimus|sirolimus|mesh-list
101425414|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101425415|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101425416|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101425417|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101425481|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101425482|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425483|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101425484|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
101425485|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101425486|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425545|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101425546|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101425547|NCT00524875|Growth Substances|growth substances|mesh-ancestor
101425549|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
101425617|NCT00168051|Coagulants|coagulants|mesh-ancestor
101425618|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
101425619|NCT00526318|Melphalan|melphalan|mesh-list
101425620|NCT00526318|Ifosfamide|ifosfamide|mesh-list
101425621|NCT00526318|Dacarbazine|dacarbazine|mesh-list
101425622|NCT00526318|Carboplatin|carboplatin|mesh-list
101425623|NCT00526318|Doxorubicin|doxorubicin|mesh-list
101425624|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101425625|NCT00526318|Etoposide|etoposide|mesh-list
101425626|NCT00526318|Vincristine|vincristine|mesh-list
101425627|NCT00526318|Topotecan|topotecan|mesh-list
101425628|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
101425629|NCT00526318|Vindesine|vindesine|mesh-list
101425630|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
101425631|NCT00526318|Isotretinoin|isotretinoin|mesh-list
101425632|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101425633|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
101425634|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425635|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101425636|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101425637|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
101425675|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101425676|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101425677|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
101425678|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
101425679|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101425680|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425681|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425682|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
101425740|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425742|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
101425813|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101425814|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101425815|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
101425885|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101425886|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425887|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101425888|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101425890|NCT00516607|Temozolomide|temozolomide|mesh-list
101425954|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101425955|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101425956|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426024|NCT00173862|Gemcitabine|gemcitabine|mesh-list
101426095|NCT04692376|Cyclosporins|cyclosporins|mesh-list
101426097|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426098|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426169|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
101426170|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426171|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101426172|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426173|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426174|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101426175|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101426176|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101426177|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426178|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
101426180|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426229|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101426230|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101426231|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426232|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426233|NCT00527995|Urological Agents|urological agents|mesh-ancestor
101426234|NCT00144833|Ritonavir|ritonavir|mesh-list
101426235|NCT00144833|Lopinavir|lopinavir|mesh-list
101426236|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
101426237|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101426238|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101426239|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
101426240|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426241|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426290|NCT00144911|Fluticasone|fluticasone|mesh-list
101426291|NCT00144911|Xhance|xhance|mesh-list
101426292|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101426293|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101426362|NCT00528619|Pemetrexed|pemetrexed|mesh-list
101426363|NCT00528619|Sunitinib|sunitinib|mesh-list
101426364|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426365|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426366|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426367|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101426368|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101426430|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101426431|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426432|NCT00168792|Tenecteplase|tenecteplase|mesh-list
101426433|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101426501|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
101426502|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426505|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101426506|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101426507|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426508|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426509|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101426510|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101426511|NCT00145301|Analgesics|analgesics|mesh-ancestor
101426512|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
101426513|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101426561|NCT00530413|Phenobarbital|phenobarbital|mesh-list
101426562|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
101426563|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101426564|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101426565|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426566|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101426567|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101426568|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426569|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426625|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
101426626|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101426627|NCT00531973|Doxorubicin|doxorubicin|mesh-list
101426628|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101426693|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101426694|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426695|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
101426765|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101426771|NCT02942758|Tretinoin|tretinoin|mesh-list
101426840|NCT00146042|Erythromycin|erythromycin|mesh-list
101426843|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
101426845|NCT00146042|Trastuzumab|trastuzumab|mesh-list
101426983|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101426984|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
101426985|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426986|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101426987|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101426988|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101426989|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101426990|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
101426991|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101426992|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101426994|NCT00174798|Urological Agents|urological agents|mesh-ancestor
101427045|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
101427046|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
101427047|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101427048|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427049|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101427050|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101427051|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
101427052|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
101427112|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427113|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101427114|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101427184|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
101427185|NCT00169572|Casopitant|casopitant|mesh-list
101427186|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417606|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
101417607|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417608|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
101417609|NCT00134693|Hormones|hormones|mesh-ancestor
101427187|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
101427188|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
101427189|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101427190|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427191|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427192|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
101427193|NCT00169572|Hormones|hormones|mesh-ancestor
101427194|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427248|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101427249|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427250|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427251|NCT02943655|Progestins|progestins|mesh-ancestor
101427252|NCT02943655|Hormones|hormones|mesh-ancestor
101427253|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101427254|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
101427313|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427316|NCT02939248|Morphine|morphine|mesh-list
101427385|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427386|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427387|NCT04836910|Metformin|metformin|mesh-list
101427388|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
101427389|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
101427390|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101427391|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101427451|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101427452|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101427453|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427454|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101427457|NCT02940184|Incretins|incretins|mesh-ancestor
101427522|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
101427523|NCT00169845|Beta Carotene|beta carotene|mesh-list
101427524|NCT00169845|Carotenoids|carotenoids|mesh-list
101427525|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
101427526|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427529|NCT00169845|Vitamins|vitamins|mesh-ancestor
101427593|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
101427594|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427666|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101427667|NCT00175695|Protein C|protein c|mesh-list
101427668|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
101427740|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427741|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427742|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101427743|NCT00148460|Tenecteplase|tenecteplase|mesh-list
101427746|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101427810|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101427811|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101427812|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101427813|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427815|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101427816|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101427817|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101427818|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
101427819|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
101427875|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427876|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101427878|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
101427881|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
101427947|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101427949|NCT02926885|Hematinics|hematinics|mesh-ancestor
101427950|NCT02926846|Vancomycin|vancomycin|mesh-list
101427951|NCT02926846|Gentamicins|gentamicins|mesh-list
101427952|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101427953|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101427954|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101427955|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101427957|NCT02926183|Paclitaxel|paclitaxel|mesh-list
101428014|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428015|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101428016|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101428017|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
101428018|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428019|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428020|NCT00149162|Analgesics|analgesics|mesh-ancestor
101428021|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
101428080|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101428081|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101428083|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
101428084|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428085|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428086|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428087|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428089|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101428143|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428144|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101428145|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428147|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101428212|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101428213|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101428214|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101428279|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428280|NCT05786430|Carboplatin|carboplatin|mesh-list
101428281|NCT05786430|Pemetrexed|pemetrexed|mesh-list
101428282|NCT05786430|Lazertinib|lazertinib|mesh-list
101428289|NCT05786365|Ketamine|ketamine|mesh-list
101428350|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101428352|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101428424|NCT05782712|Analgesics|analgesics|mesh-ancestor
101428425|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
101428426|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101428427|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428428|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101428435|NCT05781516|Prednisolone|prednisolone|mesh-list
101428491|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
101428492|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101428493|NCT05764941|Vinorelbine|vinorelbine|mesh-list
101428494|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101428564|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101428565|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101428638|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
101428639|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428640|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
101428641|NCT05291650|Protective Agents|protective agents|mesh-ancestor
101428709|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428710|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101428711|NCT04992013|Niraparib|niraparib|mesh-list
101428712|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101428714|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101428716|NCT04969263|Vaccines|vaccines|mesh-list
101428717|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
101428718|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428774|NCT04792502|Growth Substances|growth substances|mesh-ancestor
101428775|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428776|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428777|NCT04777422|Defibrotide|defibrotide|mesh-list
101428844|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101428846|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101428847|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101428848|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101428849|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101428915|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101428916|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101428917|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101428918|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101428919|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101428920|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428921|NCT04310176|Bevacizumab|bevacizumab|mesh-list
101428922|NCT04310176|Fluorouracil|fluorouracil|mesh-list
101428923|NCT04310176|Capecitabine|capecitabine|mesh-list
101428924|NCT04310176|Valproic Acid|valproic acid|mesh-list
101428925|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428926|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101428927|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101428928|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101428929|NCT04310176|Growth Substances|growth substances|mesh-ancestor
101428930|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221783|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
101428931|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
101428932|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
101428973|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101428975|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
101428976|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
101428977|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428978|NCT04172987|Tirzepatide|tirzepatide|mesh-list
101428979|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101428980|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101428981|NCT04172987|Incretins|incretins|mesh-ancestor
101428983|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101428984|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
101428985|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429043|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101429044|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429045|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429047|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101429050|NCT03762096|Resveratrol|resveratrol|mesh-list
101429114|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101429116|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101429117|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429118|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
101429119|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429181|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429182|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101429183|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101429184|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101429250|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101429251|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429252|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
101429253|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101429254|NCT02535832|Pioglitazone|pioglitazone|mesh-list
101429255|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101429256|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429257|NCT02425904|Clofarabine|clofarabine|mesh-list
101429258|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101429259|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
101429260|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429261|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429263|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101429313|NCT01711554|Vitamins|vitamins|mesh-ancestor
101429315|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429316|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
101429317|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429318|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101429319|NCT01711554|Growth Substances|growth substances|mesh-ancestor
101429381|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101429382|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
101429383|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429384|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429385|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
101429386|NCT00558961|Chlorambucil|chlorambucil|mesh-list
101429387|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429388|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429389|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429390|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429391|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101429392|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
101429393|NCT00542451|Paclitaxel|paclitaxel|mesh-list
101429394|NCT00542451|Trastuzumab|trastuzumab|mesh-list
101429440|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429441|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429442|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429443|NCT00149981|Everolimus|everolimus|mesh-list
101429444|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101429445|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101429446|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429447|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429448|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101429449|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
101429452|NCT02915731|Vitamin A|vitamin a|mesh-list
101429505|NCT02914015|Ropivacaine|ropivacaine|mesh-list
101417610|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417611|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417612|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101417613|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417614|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
101417615|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
101429506|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
101429507|NCT02914015|Anesthetics|anesthetics|mesh-list
101429508|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101429575|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429576|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
101429577|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
101429580|NCT00150137|Methimazole|methimazole|mesh-list
101429644|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429645|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429717|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429719|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101429720|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429788|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101429789|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101429792|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101429858|NCT00164112|Telithromycin|telithromycin|mesh-list
101429859|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101429860|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101429861|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101429862|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101429863|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101429864|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101429865|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101429866|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429867|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101429868|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101429869|NCT02910817|Metformin|metformin|mesh-list
101429870|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101429871|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101429872|NCT00150722|Atorvastatin|atorvastatin|mesh-list
101429873|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101429874|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101429910|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
101429911|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
101429912|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101429913|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101429914|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101429915|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101429916|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101429917|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101429918|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
101429920|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101429921|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
101429922|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101429924|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
101429969|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101429970|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101430041|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430042|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430043|NCT00171561|Diuretics|diuretics|mesh-ancestor
101430044|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
101430045|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430046|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101430047|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101430048|NCT00151112|Anesthetics|anesthetics|mesh-list
101430107|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
101430108|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430181|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430182|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
101430183|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417616|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417617|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417618|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101417619|NCT00134693|Protective Agents|protective agents|mesh-ancestor
101417620|NCT00152412|Levocetirizine|levocetirizine|mesh-list
101417621|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101417622|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101430184|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
101430185|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101430249|NCT00151541|Adapalene|adapalene|mesh-list
101430250|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101430251|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
101430252|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101430320|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
101430391|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430392|NCT00164736|Ritonavir|ritonavir|mesh-list
101430393|NCT00164736|Lopinavir|lopinavir|mesh-list
101430394|NCT00164736|Lamivudine|lamivudine|mesh-list
101430395|NCT00164736|Zidovudine|zidovudine|mesh-list
101430396|NCT00164736|Nevirapine|nevirapine|mesh-list
101430397|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101430398|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101430399|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
101430400|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101430401|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430426|NCT00172068|Vitamin D|vitamin d|mesh-list
101430455|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101430456|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101430525|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101430595|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
101430596|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101430668|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
101430669|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101430670|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101430739|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101430742|NCT00165087|Doxorubicin|doxorubicin|mesh-list
101430813|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101430814|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
101430815|NCT00152867|Hormones|hormones|mesh-ancestor
101430887|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101430888|NCT00152945|Protective Agents|protective agents|mesh-ancestor
101430959|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
101430960|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
101430961|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101431031|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101431032|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101431033|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101431034|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
101431035|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101431100|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431101|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101431103|NCT02933593|Labetalol|labetalol|mesh-list
101431104|NCT02933593|Hydralazine|hydralazine|mesh-list
101431170|NCT00165516|Protective Agents|protective agents|mesh-ancestor
101431171|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431242|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101431243|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101431244|NCT04690309|Insulin|insulin|mesh-list
101431245|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101431315|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101431316|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101431318|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101431386|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101431387|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101431388|NCT02924311|Growth Substances|growth substances|mesh-ancestor
101431389|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431390|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
101431391|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431392|NCT02924233|Nivolumab|nivolumab|mesh-list
101431393|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101431394|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431450|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101431451|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101431452|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101431453|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101431519|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101431520|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101431521|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101431593|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101431594|NCT02921269|Growth Substances|growth substances|mesh-ancestor
101431667|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431668|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101431669|NCT00154661|Protective Agents|protective agents|mesh-ancestor
101431742|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101431743|NCT00181116|Levetiracetam|levetiracetam|mesh-list
101431744|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
101431745|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
101431746|NCT02918812|Diclofenac|diclofenac|mesh-list
101431812|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
101431813|NCT02909413|Sevoflurane|sevoflurane|mesh-list
101431814|NCT02909413|Desflurane|desflurane|mesh-list
101431815|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101431818|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
101431883|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
101431884|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101431885|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101431886|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101431887|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101431953|NCT00533611|Niacin|niacin|mesh-list
101431954|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432026|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
101432027|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432028|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432097|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
101432098|NCT04686448|Analgesics|analgesics|mesh-ancestor
101432099|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
101432100|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432168|NCT02500147|Metformin|metformin|mesh-list
101432169|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432170|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432171|NCT00182013|Olanzapine|olanzapine|mesh-list
101432172|NCT00182013|Risperidone|risperidone|mesh-list
101432240|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101432241|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432244|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432245|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432246|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432247|NCT04686058|Midazolam|midazolam|mesh-list
101432248|NCT04686058|Meperidine|meperidine|mesh-list
101432249|NCT04686058|Propofol|propofol|mesh-list
101432250|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101432251|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101432252|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432253|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101432254|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
101432271|NCT00156299|Choline|choline|mesh-list
101432301|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432302|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101432303|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432305|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432306|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
101432307|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432370|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101432372|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101432373|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432375|NCT00189072|Gabapentin|gabapentin|mesh-list
101432439|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101432440|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432441|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101432442|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432443|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432444|NCT05468047|Ketamine|ketamine|mesh-list
101432445|NCT05468047|Analgesics|analgesics|mesh-ancestor
101432446|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
101432447|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417623|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
101417624|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
101417625|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417626|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417628|NCT00142038|Docetaxel|docetaxel|mesh-list
101417629|NCT00142038|Capecitabine|capecitabine|mesh-list
101417630|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417631|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417632|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101432448|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432505|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432506|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432507|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101432508|NCT00156884|Cisplatin|cisplatin|mesh-list
101432509|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101432510|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101432511|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432512|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
101432513|NCT00156962|Hematinics|hematinics|mesh-ancestor
101432514|NCT00182442|Olanzapine|olanzapine|mesh-list
101432515|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101432516|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
101432517|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
101432518|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101432519|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432567|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101432568|NCT00189384|Procaine|procaine|mesh-list
101432569|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432570|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432571|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101432572|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432575|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
101432637|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101432638|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101432639|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432640|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432641|NCT00182559|Cyclosporine|cyclosporine|mesh-list
101432642|NCT00182559|Tacrolimus|tacrolimus|mesh-list
101432643|NCT00182559|Cyclosporins|cyclosporins|mesh-list
101432644|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101432645|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
101432646|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432647|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101432648|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101432649|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101432650|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
101432651|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432652|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
101432695|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
101432696|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101432698|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101432699|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101432700|NCT00406796|Growth Substances|growth substances|mesh-ancestor
101432701|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432766|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101432767|NCT00534586|Narcotics|narcotics|mesh-ancestor
101432838|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432839|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
101432840|NCT00157547|Citalopram|citalopram|mesh-list
101432841|NCT00157547|Fluoxetine|fluoxetine|mesh-list
101432842|NCT00157547|Paroxetine|paroxetine|mesh-list
101432844|NCT00157547|Sertraline|sertraline|mesh-list
101432908|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101432909|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101432910|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
101432911|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101432912|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101432913|NCT04686643|Diuretics|diuretics|mesh-ancestor
101432914|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
101432978|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
101432979|NCT00158093|Atenolol|atenolol|mesh-list
101432980|NCT00158093|Nebivolol|nebivolol|mesh-list
101432981|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101432982|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101432983|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101432986|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433044|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101433045|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433118|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
101433119|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433120|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
101433121|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433122|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
101433123|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
101433124|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101433125|NCT00158561|Dapsone|dapsone|mesh-list
101433126|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
101433127|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
101433128|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101433129|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101433130|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433131|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101433132|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433133|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433134|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101433135|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
101433136|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101433137|NCT05169229|Vancomycin|vancomycin|mesh-list
101433138|NCT05169229|Tobramycin|tobramycin|mesh-list
101433174|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101433175|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433176|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101433177|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101433178|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101433179|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101433180|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
101433181|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101433182|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101433183|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101433184|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433185|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433186|NCT00538486|Metformin|metformin|mesh-list
101433187|NCT00538486|Amlodipine|amlodipine|mesh-list
101433188|NCT00538486|Telmisartan|telmisartan|mesh-list
101433189|NCT00538486|Candesartan|candesartan|mesh-list
101433190|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
101433191|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101433192|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433193|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101433194|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101433226|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
101433227|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
101433228|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433301|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101433302|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433304|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433305|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433306|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433307|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101433308|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
101433309|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101433310|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101433311|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433312|NCT00537121|Antidotes|antidotes|mesh-ancestor
101433313|NCT00537121|Protective Agents|protective agents|mesh-ancestor
101433314|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
101433360|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
101433361|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
101433362|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433363|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433365|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101433430|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433431|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
101433432|NCT00538954|Antacids|antacids|mesh-ancestor
101433433|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433434|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101433502|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101433503|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101433571|NCT00159302|Protective Agents|protective agents|mesh-ancestor
101433572|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
101433645|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433646|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101433647|NCT00159458|Gemcitabine|gemcitabine|mesh-list
101433648|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
101433649|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433650|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
101433651|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433652|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433653|NCT00541021|Gemcitabine|gemcitabine|mesh-list
101433654|NCT00541021|Sorafenib|sorafenib|mesh-list
101433655|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101433656|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
101433657|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433659|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101433660|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433703|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101433704|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
101433774|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101433775|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101433848|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
101433849|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101433850|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
101433919|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101433920|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
101433921|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101433929|NCT00542893|Dacarbazine|dacarbazine|mesh-list
101433990|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101433991|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433992|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434060|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
101434061|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434062|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
101434063|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101434064|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101434065|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434067|NCT00543361|Metformin|metformin|mesh-list
101434124|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101434197|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434215|NCT00190905|Analgesics|analgesics|mesh-ancestor
101434268|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
101434269|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101434270|NCT02963181|Urological Agents|urological agents|mesh-ancestor
101434271|NCT00544999|Cytarabine|cytarabine|mesh-list
101434341|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101434353|NCT00545389|Mesalamine|mesalamine|mesh-list
101434414|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101434422|NCT00546130|Cisplatin|cisplatin|mesh-list
101434486|NCT00191256|Paclitaxel|paclitaxel|mesh-list
101434487|NCT00191256|Carboplatin|carboplatin|mesh-list
101434488|NCT00191256|Gemcitabine|gemcitabine|mesh-list
101434489|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101434490|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434491|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101434555|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434556|NCT00547183|Urological Agents|urological agents|mesh-ancestor
101434557|NCT00184626|Insulin|insulin|mesh-list
101434625|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434626|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434627|NCT00184665|Insulin|insulin|mesh-list
101434698|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101434699|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101434700|NCT00191490|Gemcitabine|gemcitabine|mesh-list
101434701|NCT00191490|Docetaxel|docetaxel|mesh-list
101434702|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434703|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101434704|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
101434705|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434708|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
101434710|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
101434711|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101434712|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434713|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434715|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101434716|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101434717|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101434718|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434719|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434720|NCT00184821|Glyburide|glyburide|mesh-list
101434721|NCT00184821|Adenosine|adenosine|mesh-list
101434722|NCT00184821|Diazoxide|diazoxide|mesh-list
101434723|NCT00184821|Annexin A5|annexin a5|mesh-list
101434724|NCT00184821|Analgesics|analgesics|mesh-ancestor
101434725|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
101434746|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434747|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
101434748|NCT00548509|Coagulants|coagulants|mesh-ancestor
101434749|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
101434750|NCT00548704|Razoxane|razoxane|mesh-list
101434751|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101434752|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101434753|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101434754|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101434755|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101434756|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434757|NCT00548704|Protective Agents|protective agents|mesh-ancestor
101434758|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434759|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434760|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
101434761|NCT00184899|Heparin|heparin|mesh-list
101434762|NCT00184899|Calcium heparin|calcium heparin|mesh-list
101434763|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101434764|NCT00184899|Glycerol|glycerol|mesh-list
101434765|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
101434766|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101434767|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101434768|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101434769|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101434770|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101434771|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101434772|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101434773|NCT00184899|Protective Agents|protective agents|mesh-ancestor
101434775|NCT00548821|Cisplatin|cisplatin|mesh-list
101434792|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101434866|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
101434867|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101434868|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101434869|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101434870|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
101434871|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
101434872|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101434934|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101434935|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435006|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101435007|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101435008|NCT02963454|Simendan|simendan|mesh-list
101435009|NCT02963454|Dobutamine|dobutamine|mesh-list
101435010|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101435011|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
101435076|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101435077|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435078|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101435079|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101435080|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435081|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435082|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101435083|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101435084|NCT00551005|Analgesics|analgesics|mesh-ancestor
101435085|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
101435087|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435090|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101435135|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101435136|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101435137|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435207|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435208|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417633|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101435209|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101435210|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101435211|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101435212|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435213|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101435214|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101435215|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435216|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435217|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435218|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101435219|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
101435268|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101435269|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101435270|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101435271|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101435272|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101435273|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
101435274|NCT00162188|Efavirenz|efavirenz|mesh-list
101435275|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101435328|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
101435329|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435402|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435403|NCT00185445|Fludarabine|fludarabine|mesh-list
101435404|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
101435405|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435414|NCT04233034|Verapamil|verapamil|mesh-list
101435472|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101435473|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101435476|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
101435544|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
101435545|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435546|NCT03757585|Expectorants|expectorants|mesh-ancestor
101435547|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
101435548|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101435549|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
101435550|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435610|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101435611|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101435612|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435682|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101435683|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101435684|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101435685|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101435686|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
101435687|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101435688|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101435689|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101435690|NCT00163241|Celecoxib|celecoxib|mesh-list
101435691|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101435692|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101435693|NCT00163241|Analgesics|analgesics|mesh-ancestor
101435694|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
101435695|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435703|NCT02916316|Doxorubicin|doxorubicin|mesh-list
101435739|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101435740|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101435812|NCT00163553|Meperidine|meperidine|mesh-list
101435886|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101435887|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101435888|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
101435889|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435891|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101435892|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101435893|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101435898|NCT05807880|Capecitabine|capecitabine|mesh-list
101435951|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
101435952|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101435953|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101435954|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
101435955|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436024|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417635|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101417636|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
101417637|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
101417638|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101436025|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101436026|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101436027|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
101436092|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436093|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101436094|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436095|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101436096|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101436097|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
101436098|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
101436099|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
101436100|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101436101|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
101436102|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436103|NCT05591105|Acetaminophen|acetaminophen|mesh-list
101436168|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101436170|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101436171|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101436172|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101436173|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436174|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101436175|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436180|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101436226|NCT05024214|Growth Substances|growth substances|mesh-ancestor
101436227|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436228|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
101436230|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436297|NCT04767841|Metformin|metformin|mesh-list
101436298|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101436299|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101436300|NCT04761861|Vildagliptin|vildagliptin|mesh-list
101436371|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
101436372|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101436373|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101436514|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436515|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101436516|NCT03406299|Leucovorin|leucovorin|mesh-list
101436517|NCT03406299|Gemcitabine|gemcitabine|mesh-list
101436518|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
101436587|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
101436588|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
101436591|NCT03311555|Docetaxel|docetaxel|mesh-list
101436660|NCT02427620|Dexamethasone|dexamethasone|mesh-list
101436661|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
101436662|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
101436663|NCT02427620|Rituximab|rituximab|mesh-list
101436664|NCT02427620|Doxorubicin|doxorubicin|mesh-list
101436665|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101436666|NCT02427620|Methotrexate|methotrexate|mesh-list
101436667|NCT02427620|Vincristine|vincristine|mesh-list
101436668|NCT02427620|Daunorubicin|daunorubicin|mesh-list
101436669|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101436670|NCT02427620|Antibodies|antibodies|mesh-list
101436671|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
101436672|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101436673|NCT02427620|BB 1101|bb 1101|mesh-list
101436674|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101436725|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101436727|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101436728|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101436729|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101436730|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101436731|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101436759|NCT02060721|Macitentan|macitentan|mesh-list
101436786|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
101436787|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436932|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437003|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101437004|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101437005|NCT00193323|Gemcitabine|gemcitabine|mesh-list
101437006|NCT00193323|Docetaxel|docetaxel|mesh-list
101437007|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437074|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437146|NCT04899778|Iron|iron|mesh-list
101437149|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
101437150|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
101437224|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
101437225|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437226|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437227|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437228|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
101437229|NCT00176280|Hormones|hormones|mesh-ancestor
101437230|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437231|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101437232|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437233|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
101437234|NCT04723940|Doxycycline|doxycycline|mesh-list
101437235|NCT04723940|Clindamycin|clindamycin|mesh-list
101437236|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
101437237|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
101437238|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101437239|NCT04723940|Cefadroxil|cefadroxil|mesh-list
101437240|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101437241|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101437242|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
101437243|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101437249|NCT00164840|Esomeprazole|esomeprazole|mesh-list
101437277|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437278|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437349|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101437350|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101437420|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437421|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
101437424|NCT04082650|Vitamin D|vitamin d|mesh-list
101437491|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101437492|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101437494|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
101437495|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437561|NCT03413800|Lenalidomide|lenalidomide|mesh-list
101437562|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101437563|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
101437564|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
101437565|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101437566|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437567|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101437568|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
101437633|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437634|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101437706|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437707|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101437708|NCT00166478|Protective Agents|protective agents|mesh-ancestor
101437709|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101437711|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101437775|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
101437780|NCT05124067|Hormones|hormones|mesh-ancestor
101437849|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101437850|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101437851|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
101437852|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101437853|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101437854|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
101437857|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101437858|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101437859|NCT04819399|Catumaxomab|catumaxomab|mesh-list
101437908|NCT00177567|Risperidone|risperidone|mesh-list
101437909|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
101437910|NCT00177567|Mirtazapine|mirtazapine|mesh-list
101437911|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
101437913|NCT00177567|Paroxetine|paroxetine|mesh-list
101437914|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101437975|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
101437976|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101437977|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101437978|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
101437979|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438047|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101438048|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
101438049|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
101438050|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101438051|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438052|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438053|NCT00195312|Bupivacaine|bupivacaine|mesh-list
101438054|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
101438055|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
101438056|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438057|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438058|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
101438064|NCT03888079|Anesthetics|anesthetics|mesh-list
101438105|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101438106|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
101438107|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438174|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438175|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101438176|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438247|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
101438248|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438249|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
101438250|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101438251|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
101438252|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101438253|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101438254|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101438255|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438312|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
101438313|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101438314|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438315|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101438316|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
101438317|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
101438318|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101438320|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
101438321|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101438322|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
101438323|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101438324|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438337|NCT00407342|Alefacept|alefacept|mesh-list
101438374|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101438375|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
101438449|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101438450|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101438451|NCT02903485|Anesthetics|anesthetics|mesh-list
101438452|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101438453|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438454|NCT05995912|Naproxen|naproxen|mesh-list
101438455|NCT05995912|Etoricoxib|etoricoxib|mesh-list
101438456|NCT05995912|Tramadol|tramadol|mesh-list
101438457|NCT05995912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101438458|NCT05995912|Narcotics|narcotics|mesh-ancestor
101438480|NCT05995691|Adalimumab|adalimumab|mesh-list
101438534|NCT05995249|Anticonvulsants|anticonvulsants|mesh-ancestor
101438595|NCT05994742|Vitamins|vitamins|mesh-ancestor
101438662|NCT05994183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101438663|NCT05994183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101438664|NCT05994183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438734|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438735|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101438736|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101438737|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101438739|NCT05904496|Tislelizumab|tislelizumab|mesh-list
101438806|NCT05850520|Growth Substances|growth substances|mesh-ancestor
101438807|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438808|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
101438809|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101438810|NCT05845008|Acetaminophen|acetaminophen|mesh-list
101438876|NCT05812300|Protective Agents|protective agents|mesh-ancestor
101438877|NCT05811351|Prednisone|prednisone|mesh-list
101438878|NCT05811351|Triamcinolone|triamcinolone|mesh-list
101438880|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
101438950|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101438951|NCT05748600|Protective Agents|protective agents|mesh-ancestor
101438952|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417640|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101417641|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417642|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417643|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
101417644|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417645|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101438953|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101438954|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101439019|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
101439020|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101439021|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101439022|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
101439023|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439024|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439025|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101439026|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101439027|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
101439028|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439029|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101439030|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101439031|NCT05663866|Dexamethasone|dexamethasone|mesh-list
101439032|NCT05663866|Methotrexate|methotrexate|mesh-list
101439033|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439034|NCT05663866|Montelukast|montelukast|mesh-list
101439035|NCT05663866|Lazertinib|lazertinib|mesh-list
101439078|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101439079|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
101439080|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439081|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439082|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101439083|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101439084|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439085|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101439086|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101439087|NCT05642026|Ropivacaine|ropivacaine|mesh-list
101439088|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
101439089|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
101439090|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101439148|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439149|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
101439150|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
101439151|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439152|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439218|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
101439219|NCT05518149|Aticaprant|aticaprant|mesh-list
101439220|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101439221|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439293|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
101439294|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439296|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101439365|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101439366|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101439367|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101439371|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101439372|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439373|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439374|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
101439376|NCT05388669|Lazertinib|lazertinib|mesh-list
101439428|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101439429|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439430|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101439431|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
101439432|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
101439433|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439434|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101439435|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101439436|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439437|NCT05356897|Trifluridine|trifluridine|mesh-list
101439438|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101439439|NCT05356897|Trastuzumab|trastuzumab|mesh-list
101439440|NCT05356897|Tucatinib|tucatinib|mesh-list
101439441|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101439442|NCT05356897|Antibodies|antibodies|mesh-list
101439443|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
101439444|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101439445|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
101439446|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439447|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439448|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
101439449|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439450|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
101439451|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101439452|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101439453|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439475|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439476|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439546|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439618|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101439619|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
101439620|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439621|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101439688|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439689|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439690|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101439691|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
101439692|NCT05083169|Hormones|hormones|mesh-ancestor
101439693|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101439694|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101439695|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439696|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
101439697|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439698|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439699|NCT05083169|Growth Substances|growth substances|mesh-ancestor
101439700|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439701|NCT05073679|Naltrexone|naltrexone|mesh-list
101439702|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101439703|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101439704|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439705|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
101439706|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439707|NCT05071664|Golimumab|golimumab|mesh-list
101439708|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101439760|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439761|NCT05050097|Growth Substances|growth substances|mesh-ancestor
101439762|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439763|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439764|NCT05029921|Ustekinumab|ustekinumab|mesh-list
101439765|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
101439766|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101439767|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101439768|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
101439772|NCT05014282|Nicotine|nicotine|mesh-list
101439773|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101439774|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
101439775|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439776|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439777|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101439778|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101439779|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
101439780|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439781|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439782|NCT04956094|Uric Acid|uric acid|mesh-list
101439809|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439810|NCT04929392|Paclitaxel|paclitaxel|mesh-list
101439811|NCT04929392|Carboplatin|carboplatin|mesh-list
101439812|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
101439813|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101439814|NCT04929392|Lenvatinib|lenvatinib|mesh-list
101439815|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101439816|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101439817|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
101439878|NCT04837014|Hydromorphone|hydromorphone|mesh-list
101439879|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101439880|NCT04837014|Analgesics|analgesics|mesh-ancestor
101439881|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
101439882|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101439883|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101439884|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
101439885|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101439886|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101439887|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101439888|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
101439889|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101439890|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439891|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439892|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101439893|NCT04837014|Narcotics|narcotics|mesh-ancestor
101439894|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101439937|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101439938|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101439939|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101439940|NCT04802161|Growth Substances|growth substances|mesh-ancestor
101439941|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
101439942|NCT04801589|Midazolam|midazolam|mesh-list
101439948|NCT04801589|Analgesics|analgesics|mesh-ancestor
101440008|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101440009|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440010|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
101440081|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101440082|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440084|NCT04621435|Trace Elements|trace elements|mesh-ancestor
101440085|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
101440086|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440087|NCT04606381|Lazertinib|lazertinib|mesh-list
101440088|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101440150|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101440151|NCT04531982|Pimavanserin|pimavanserin|mesh-list
101440152|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101440153|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101440154|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101440155|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101440156|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101440157|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440158|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101440159|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101440160|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101440161|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
101440162|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101440163|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440208|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101440425|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
101440427|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440428|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440429|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440430|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
101440431|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440432|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440433|NCT04133636|Growth Substances|growth substances|mesh-ancestor
101440434|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440435|NCT04121260|Daratumumab|daratumumab|mesh-list
101440436|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440437|NCT04108208|Androgens|androgens|mesh-list
101440438|NCT04108208|Hormones|hormones|mesh-ancestor
101440439|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440440|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440441|NCT04108195|Daratumumab|daratumumab|mesh-list
101440442|NCT04108195|Pomalidomide|pomalidomide|mesh-list
101440443|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440444|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
101440445|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440446|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440447|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440448|NCT04108195|Growth Substances|growth substances|mesh-ancestor
101440449|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440450|NCT04091386|Factor VIII|factor viii|mesh-list
101440451|NCT04091386|Coagulants|coagulants|mesh-ancestor
101440452|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
101440454|NCT04077463|Carboplatin|carboplatin|mesh-list
101440472|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101440473|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440474|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440475|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
101440476|NCT04034095|Hormones|hormones|mesh-ancestor
101440477|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440480|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
101440543|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
101440544|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101440545|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101440618|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
101440619|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101440620|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440622|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101440623|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101440624|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
101440686|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440760|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440761|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440762|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
101440763|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101440764|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101440765|NCT03652064|Growth Substances|growth substances|mesh-ancestor
101440828|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440829|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
101440830|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101440831|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101440899|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440901|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440902|NCT03282916|Valacyclovir|valacyclovir|mesh-list
101440903|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
101440972|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440973|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440974|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101440975|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441043|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
101441044|NCT02985957|Hormones|hormones|mesh-ancestor
101441045|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441046|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441047|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101441111|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
101441112|NCT02589600|Calcium|calcium|mesh-list
101441113|NCT02589600|Vitamins|vitamins|mesh-ancestor
101441114|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
101441115|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441116|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101441117|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101441118|NCT02531516|Bicalutamide|bicalutamide|mesh-list
101441119|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
101441183|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441185|NCT02339571|Ipilimumab|ipilimumab|mesh-list
101441186|NCT02339571|Sargramostim|sargramostim|mesh-list
101441255|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101441256|NCT01998971|Analgesics|analgesics|mesh-ancestor
101441257|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
101441258|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
101441259|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101441260|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
101441261|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441323|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441324|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101441396|NCT00980460|Fluorouracil|fluorouracil|mesh-list
101441397|NCT00980460|Irinotecan|irinotecan|mesh-list
101441398|NCT00980460|Vincristine|vincristine|mesh-list
101441399|NCT00980460|Temsirolimus|temsirolimus|mesh-list
101441400|NCT00980460|Camptothecin|camptothecin|mesh-list
101441401|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
101441402|NCT00980460|Razoxane|razoxane|mesh-list
101441403|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
101441404|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
101441405|NCT00980460|Liver Extracts|liver extracts|mesh-list
101441406|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441465|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101441466|NCT00217737|Fluorouracil|fluorouracil|mesh-list
101441467|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
101441468|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
101441469|NCT00217737|Antibodies|antibodies|mesh-list
101417646|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101417647|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417648|NCT02964455|Docetaxel|docetaxel|mesh-list
101417649|NCT02964455|Nedaplatin|nedaplatin|mesh-list
101417650|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417651|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417652|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
101417653|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417654|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417655|NCT00142155|Rituximab|rituximab|mesh-list
101417656|NCT00142155|Antibodies|antibodies|mesh-list
101417657|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101417658|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
101417659|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441470|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
101441471|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101441472|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
101441473|NCT00217737|Calcium|calcium|mesh-list
101441474|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
101441475|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441476|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101441477|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441478|NCT00217737|Growth Substances|growth substances|mesh-ancestor
101441479|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441480|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
101441481|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
101441482|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101441483|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101441521|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
101441522|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101441523|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101441524|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101441526|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441527|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101441528|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
101441529|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441530|NCT02902861|Methotrexate|methotrexate|mesh-list
101441531|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101441532|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
101441533|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101441534|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101441535|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101441536|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
101441537|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441538|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101441539|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
101441573|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
101441574|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
101441575|NCT02902354|Nifedipine|nifedipine|mesh-list
101441576|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101441577|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101441578|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101441579|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101441584|NCT00168623|Vitamin A|vitamin a|mesh-list
101441645|NCT00196131|Analgesics|analgesics|mesh-ancestor
101441646|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
101441648|NCT00168896|Carboplatin|carboplatin|mesh-list
101441649|NCT00168896|Irinotecan|irinotecan|mesh-list
101441650|NCT00168896|Etoposide|etoposide|mesh-list
101441714|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
101441715|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
101441716|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101441718|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101441786|NCT02899507|Amoxicillin|amoxicillin|mesh-list
101441787|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101441788|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
101441789|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
101441857|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101441931|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101441932|NCT02897830|Growth Substances|growth substances|mesh-ancestor
101441937|NCT02897557|Pancrelipase|pancrelipase|mesh-list
101442005|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101442006|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101442007|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101442008|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101442010|NCT00178971|Buspirone|buspirone|mesh-list
101442011|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101442012|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101442013|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101442014|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442015|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442016|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101442017|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
101442018|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101442019|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442063|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101442064|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101442065|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
101442067|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
101442135|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101442136|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442137|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442138|NCT02895529|Itraconazole|itraconazole|mesh-list
101442155|NCT02895061|Vitamins|vitamins|mesh-ancestor
101442204|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
101442205|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101442206|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
101442211|NCT05423821|Anesthetics|anesthetics|mesh-list
101442273|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101442274|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442275|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101442280|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
101442340|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442342|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101442343|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
101442480|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442481|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442482|NCT05379790|Irinotecan|irinotecan|mesh-list
101442483|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101442485|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442546|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442547|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442549|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
101442618|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101442619|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101442620|NCT00171626|Analgesics|analgesics|mesh-ancestor
101442621|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
101442622|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101442623|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442625|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101442626|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101442627|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101442628|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442629|NCT00171665|Diclofenac|diclofenac|mesh-list
101442630|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101442676|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101442677|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101442678|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101442679|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442681|NCT00171782|Diuretics|diuretics|mesh-ancestor
101442745|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101442746|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101442821|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101442822|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101442892|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101442893|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101442894|NCT00172367|Lycopene|lycopene|mesh-list
101442961|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101442962|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442964|NCT00198120|Cycloserine|cycloserine|mesh-list
101528411|NCT01214044|Escitalopram|escitalopram|mesh-list
101528412|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101528413|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101528414|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528415|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528416|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528417|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
101528418|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528419|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101443061|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101443062|NCT00202917|Fludarabine|fludarabine|mesh-list
101443063|NCT00202917|Melphalan|melphalan|mesh-list
101443064|NCT00202917|Thiotepa|thiotepa|mesh-list
101443065|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443066|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443067|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443068|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
101443069|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443070|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101443071|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
101443072|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443073|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
101443074|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
101443075|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
101443076|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101443077|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
101443078|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443079|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101443080|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443081|NCT04677868|Methotrexate|methotrexate|mesh-list
101443082|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101443116|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
101443117|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
101443118|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101443119|NCT00554827|Aminopterin|aminopterin|mesh-list
101443120|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
101443122|NCT00554827|Hematinics|hematinics|mesh-ancestor
101443185|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443186|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101443187|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
101443188|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443257|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443331|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101443332|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101443333|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101443337|NCT00410631|Melphalan|melphalan|mesh-list
101443404|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
101443405|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443476|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443477|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
101443478|NCT00203385|Valproic Acid|valproic acid|mesh-list
101443479|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
101443480|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443481|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443482|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
101443483|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443484|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443485|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
101443486|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443487|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443488|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101443489|NCT00555100|Dexamethasone|dexamethasone|mesh-list
101443490|NCT00555100|Lenalidomide|lenalidomide|mesh-list
101443491|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443535|NCT00407927|Epinastine|epinastine|mesh-list
101443536|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101443537|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
101443538|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
101443572|NCT00203580|Tinzaparin|tinzaparin|mesh-list
101443609|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417660|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101417661|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417662|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417663|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
101443610|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443611|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443612|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101443613|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101443614|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101443615|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
101443616|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101443673|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101443674|NCT00174317|Analgesics|analgesics|mesh-ancestor
101443675|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
101443676|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443677|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443678|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443679|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101443680|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101443681|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101443740|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101443741|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
101443742|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443744|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443745|NCT00174395|Eletriptan|eletriptan|mesh-list
101443746|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101443747|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
101443748|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443749|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443750|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443751|NCT00203775|Risperidone|risperidone|mesh-list
101443752|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101443753|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
101443754|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101443755|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443756|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443757|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101443758|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101443793|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101443795|NCT00203814|Artesunate|artesunate|mesh-list
101443796|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
101443797|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
101443798|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101443799|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
101443800|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101443801|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101443802|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101443803|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443804|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
101443805|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
101443806|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101443807|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
101443808|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101443809|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101443811|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101443851|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443852|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443853|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443854|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101443855|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
101443856|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
101443857|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101443858|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101443859|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
101443861|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101443862|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101443864|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
101443910|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443911|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417664|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101417665|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417666|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417667|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
101417668|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101443912|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101443984|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
101443985|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101443986|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101443987|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101443988|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101443989|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101443990|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101443991|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101443992|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
101443993|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101444000|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
101444048|NCT00174902|Propranolol|propranolol|mesh-list
101444049|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444050|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444051|NCT00174902|Analgesics|analgesics|mesh-ancestor
101444120|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101444192|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444193|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444194|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101444261|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
101444262|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444263|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444264|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101444265|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
101444267|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101444268|NCT04230187|Leucovorin|leucovorin|mesh-list
101444269|NCT04230187|Bevacizumab|bevacizumab|mesh-list
101444270|NCT04230187|Fluorouracil|fluorouracil|mesh-list
101444271|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
101444272|NCT04230187|Irinotecan|irinotecan|mesh-list
101444273|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
101444274|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101444275|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444323|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444325|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
101444326|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101444327|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101444331|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101444332|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
101444334|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101444335|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444336|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
101444337|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444339|NCT04171453|Analgesics|analgesics|mesh-ancestor
101444340|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
101444341|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444342|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444343|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
101444344|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101444345|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101444346|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444347|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101444348|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101444369|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101444370|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444443|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
101444444|NCT03758287|Gefitinib|gefitinib|mesh-list
101444445|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444446|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101444447|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444448|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444449|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
101444450|NCT00204633|Hematinics|hematinics|mesh-ancestor
101444451|NCT00199719|Ribavirin|ribavirin|mesh-list
101444452|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
101444453|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444454|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
101444455|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101444456|NCT03430882|Paclitaxel|paclitaxel|mesh-list
101444457|NCT03430882|Carboplatin|carboplatin|mesh-list
101444458|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101444459|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101444460|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444501|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
101444502|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
101444503|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444504|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444505|NCT00199953|Rabeprazole|rabeprazole|mesh-list
101444569|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101444570|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101444571|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444572|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444573|NCT00176618|Curcumin|curcumin|mesh-list
101444574|NCT00176618|Sulindac|sulindac|mesh-list
101444575|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101444576|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101444577|NCT00176618|Analgesics|analgesics|mesh-ancestor
101444578|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
101444579|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101444580|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444632|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101444633|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101444634|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444635|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101444706|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
101444708|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101444709|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444849|NCT02282215|Lenograstim|lenograstim|mesh-list
101444851|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
101444923|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101444924|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101444925|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
101444926|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101444928|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444995|NCT00200226|Pyridoxal|pyridoxal|mesh-list
101444996|NCT00200226|Pyridoxine|pyridoxine|mesh-list
101445065|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445066|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445067|NCT00200460|Nebivolol|nebivolol|mesh-list
101445068|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445069|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
101445070|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101445071|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101445072|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101445073|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445074|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445075|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445126|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
101445127|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445129|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445130|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445131|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101445132|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
101445192|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445193|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445194|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101445195|NCT00200694|Valsartan|valsartan|mesh-list
101445196|NCT00200694|Ramipril|ramipril|mesh-list
101445197|NCT00200694|Furosemide|furosemide|mesh-list
101445198|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445199|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101445202|NCT00200694|Diuretics|diuretics|mesh-ancestor
101445257|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101445258|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445259|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101445260|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101445261|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101445262|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445263|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445264|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
101445265|NCT00557791|Ranibizumab|ranibizumab|mesh-list
101445321|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101445322|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
101445323|NCT00178373|Modafinil|modafinil|mesh-list
101445394|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445395|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445396|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445397|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
101445398|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101445399|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445400|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445401|NCT00559741|Antidotes|antidotes|mesh-ancestor
101445402|NCT00559741|Protective Agents|protective agents|mesh-ancestor
101445403|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
101445404|NCT00559741|Vitamins|vitamins|mesh-ancestor
101445409|NCT00178763|Cisplatin|cisplatin|mesh-list
101445460|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101445462|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445463|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445464|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445465|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445466|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445467|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445468|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
101445469|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101445470|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101445471|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
101445472|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445473|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
101445474|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445475|NCT00408239|Enoxaparin|enoxaparin|mesh-list
101445476|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
101445477|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101445478|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101445479|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445480|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101445481|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101445509|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101445510|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101445511|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101445512|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
101445577|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101445578|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445579|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445580|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101445581|NCT00560443|Narcotics|narcotics|mesh-ancestor
101445582|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101445584|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
101445585|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101445586|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101445587|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101445588|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101445589|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445590|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
101445598|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
101445636|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
101445637|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445639|NCT00201396|Fluorouracil|fluorouracil|mesh-list
101445710|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101445711|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445712|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445713|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445714|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445716|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101445717|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101445718|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101445719|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
101445720|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101445721|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445722|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445723|NCT00201630|Urological Agents|urological agents|mesh-ancestor
101445724|NCT00179231|Olanzapine|olanzapine|mesh-list
101445725|NCT00179231|Clozapine|clozapine|mesh-list
101445726|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
101445727|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
101445728|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101445729|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445730|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101445762|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
101445763|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
101445764|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101445765|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101445766|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101445767|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445768|NCT04632121|Nicorandil|nicorandil|mesh-list
101445769|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101445770|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101445771|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
101445772|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
101445826|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
101445827|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101445828|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101445897|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101445898|NCT00561067|Protective Agents|protective agents|mesh-ancestor
101445899|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101445900|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445901|NCT00561067|Hematinics|hematinics|mesh-ancestor
101445902|NCT00561106|Valacyclovir|valacyclovir|mesh-list
101445903|NCT00561106|Prednisone|prednisone|mesh-list
101445904|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101445905|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
101445906|NCT00561106|Hormones|hormones|mesh-ancestor
101445907|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101445908|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445909|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101445910|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101445911|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
101445913|NCT00561184|Vaccines|vaccines|mesh-list
101446101|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101446102|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446103|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
101446105|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101446106|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446107|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101446108|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
101446109|NCT00576706|Misoprostol|misoprostol|mesh-list
101446110|NCT00576706|Rebamipide|rebamipide|mesh-list
101446111|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446112|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446113|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101446114|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446115|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101446156|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101446157|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101446158|NCT00577018|Prucalopride|prucalopride|mesh-list
101446229|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446230|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
101446303|NCT00578149|Carboplatin|carboplatin|mesh-list
101446304|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101446305|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446306|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
101446307|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
101446308|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
101446372|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
101446373|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446374|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446443|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101446444|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
101446445|NCT00579592|Rituximab|rituximab|mesh-list
101446446|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
101446447|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101446448|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446449|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
101446450|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446451|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101446454|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
101446510|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446511|NCT00180908|Doxorubicin|doxorubicin|mesh-list
101446512|NCT00180908|Etoposide|etoposide|mesh-list
101446513|NCT00180908|Methotrexate|methotrexate|mesh-list
101446514|NCT00180908|Ifosfamide|ifosfamide|mesh-list
101446515|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101446516|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101446517|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101446518|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101446519|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446520|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446521|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101446522|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
101446572|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101446573|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446574|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101446575|NCT04576975|Analgesics|analgesics|mesh-ancestor
101446579|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101446580|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101446635|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446636|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101446637|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101446638|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
101446704|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
101446705|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446706|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446707|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101446709|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101446710|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101446711|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446712|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446713|NCT04576390|Ondansetron|ondansetron|mesh-list
101446714|NCT04576390|Palonosetron|palonosetron|mesh-list
101446715|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
101446765|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101446766|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446767|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101446768|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
101446770|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446833|NCT00182039|Metoprolol|metoprolol|mesh-list
101446834|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101446835|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101446836|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
101446837|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
101446838|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446899|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101446900|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446901|NCT00585091|Phenylephrine|phenylephrine|mesh-list
101446902|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
101446903|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101446904|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
101446967|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101446968|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101446969|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101446970|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101446971|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
101446972|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101446973|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101446974|NCT00585871|Analgesics|analgesics|mesh-ancestor
101446975|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
101447034|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447035|NCT00209625|Antidotes|antidotes|mesh-ancestor
101447036|NCT00209625|Protective Agents|protective agents|mesh-ancestor
101447037|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447038|NCT00209625|Vitamins|vitamins|mesh-ancestor
101447039|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
101447040|NCT00216528|Risperidone|risperidone|mesh-list
101447041|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101447042|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
101447043|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447044|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447045|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447098|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
101447099|NCT00182351|Coagulants|coagulants|mesh-ancestor
101447100|NCT00587470|Candesartan|candesartan|mesh-list
101447101|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
101447102|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101447103|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101447104|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101447106|NCT00209703|Leucovorin|leucovorin|mesh-list
101447164|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101447165|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101447174|NCT00588016|Itraconazole|itraconazole|mesh-list
101447235|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447236|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447237|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101447307|NCT00182702|Epothilones|epothilones|mesh-list
101447308|NCT00182702|Epothilone B|epothilone b|mesh-list
101447309|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
101447310|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
101447377|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
101447452|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101447453|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447521|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
101447522|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
101447524|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
101447592|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
101447593|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447663|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
101447664|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101447665|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447671|NCT00476008|Memantine|memantine|mesh-list
101447734|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447735|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101447736|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101447737|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
101447738|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447739|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447740|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101447741|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
101447742|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
101447743|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
101447744|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
101447745|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101447746|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101447747|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101447748|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101447749|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447750|NCT00412191|Lamotrigine|lamotrigine|mesh-list
101447751|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
101447752|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101447753|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447754|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447755|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101447783|NCT00475735|Methylphenidate|methylphenidate|mesh-list
101447784|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101447785|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447786|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101447787|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101447788|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101447789|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447790|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
101447791|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101447792|NCT00475657|Pemetrexed|pemetrexed|mesh-list
101447793|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101447794|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101447795|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447843|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101447844|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
101447845|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
101447848|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101447913|NCT00210600|Hematinics|hematinics|mesh-ancestor
101447915|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101447988|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101447989|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101447990|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101447992|NCT00184496|Methadone|methadone|mesh-list
101447993|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101448062|NCT00184847|Acetylcholine|acetylcholine|mesh-list
101448063|NCT00184847|Caffeine|caffeine|mesh-list
101448133|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448134|NCT00218049|Vanoxerine|vanoxerine|mesh-list
101448135|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101448136|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101417669|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417670|NCT00134888|Buprenorphine|buprenorphine|mesh-list
101417671|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101417673|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101417674|NCT00134888|Narcotics|narcotics|mesh-ancestor
101417675|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101417676|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417677|NCT00134888|Analgesics|analgesics|mesh-ancestor
101417678|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
101417679|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417680|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101417681|NCT00134966|Levodopa|levodopa|mesh-list
101417682|NCT00134966|Carbidopa|carbidopa|mesh-list
101417683|NCT00134966|Entacapone|entacapone|mesh-list
101417684|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101448205|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
101448208|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448209|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448210|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448213|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
101448273|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101448274|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101448275|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101448276|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101448277|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448278|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
101448279|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
101448280|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448281|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448282|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101448335|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448336|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101448337|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101448338|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101448339|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101448340|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448342|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101448343|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448344|NCT00218361|Hydromorphone|hydromorphone|mesh-list
101448345|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101448397|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
101448398|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101448399|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
101448400|NCT00186797|Fludarabine|fludarabine|mesh-list
101448402|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
101448469|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101448545|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448546|NCT00188045|Propranolol|propranolol|mesh-list
101448617|NCT00188552|Tocopherols|tocopherols|mesh-list
101448618|NCT00188552|Vitamin E|vitamin e|mesh-list
101448619|NCT00188552|Tocotrienols|tocotrienols|mesh-list
101448620|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
101448621|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
101448622|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101448623|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448624|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448625|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101448626|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101448627|NCT00188552|Protective Agents|protective agents|mesh-ancestor
101448628|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448629|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
101448630|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101448631|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
101448632|NCT00188552|Vitamins|vitamins|mesh-ancestor
101448633|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
101448634|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
101448638|NCT00188630|Expectorants|expectorants|mesh-ancestor
101448678|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101448680|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448681|NCT00409253|Nicardipine|nicardipine|mesh-list
101448682|NCT00409253|Urapidil|urapidil|mesh-list
101448749|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448750|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101448751|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
101448752|NCT00188864|Hormones|hormones|mesh-ancestor
101448818|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448819|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101448892|NCT00189683|Capecitabine|capecitabine|mesh-list
101448893|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101448894|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
101448895|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448961|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101448962|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
101448963|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101448964|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101448965|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449057|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449115|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449116|NCT00190307|Aspirin|aspirin|mesh-list
101449117|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101449118|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101449120|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
101449121|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449122|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449123|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101449124|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101449125|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101449126|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101449127|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449128|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101449129|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101449130|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449132|NCT02963168|Docetaxel|docetaxel|mesh-list
101449133|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449134|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449135|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449136|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449137|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449138|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
101449164|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449165|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449166|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449168|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
101449169|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449170|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449171|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449172|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
101449173|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101449174|NCT00190580|Valsartan|valsartan|mesh-list
101449175|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
101449176|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101449177|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101449179|NCT00220506|Modafinil|modafinil|mesh-list
101449220|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449221|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101449222|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
101449223|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101449224|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101449225|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101449226|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449227|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449228|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449229|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449282|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417685|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101417686|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
101417687|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417688|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417689|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417690|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101417691|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449283|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449284|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449349|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449350|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449351|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449352|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449353|NCT00191087|Analgesics|analgesics|mesh-ancestor
101449354|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
101449416|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101449417|NCT00123305|Plasminogen|plasminogen|mesh-list
101449418|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
101449422|NCT00214110|Tamoxifen|tamoxifen|mesh-list
101449486|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101449487|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449489|NCT00214266|Rituximab|rituximab|mesh-list
101449490|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
101449553|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101449554|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449555|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449556|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449557|NCT00191594|Analgesics|analgesics|mesh-ancestor
101449558|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
101449559|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449560|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
101449561|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449562|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
101449563|NCT00221442|Zonisamide|zonisamide|mesh-list
101449564|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
101449614|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
101449615|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449688|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101449689|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449691|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101449692|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101449756|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449757|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449759|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101449826|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449827|NCT00474487|Vaccines|vaccines|mesh-list
101449828|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
101449829|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449830|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101449896|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101449897|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
101449968|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101449969|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
101449970|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
101449971|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
101449974|NCT00192413|Vaccines|vaccines|mesh-list
101450038|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450039|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450040|NCT00215514|Fluorouracil|fluorouracil|mesh-list
101450109|NCT00192803|Candesartan cilexetil|candesartan cilexetil|mesh-list
101450110|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101450111|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101450112|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101450178|NCT00193076|Carboplatin|carboplatin|mesh-list
101450179|NCT00193076|Gemcitabine|gemcitabine|mesh-list
101450180|NCT00193076|Trastuzumab|trastuzumab|mesh-list
101450187|NCT00193115|Docetaxel|docetaxel|mesh-list
101450252|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450253|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450254|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101450255|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101450323|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450324|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
101450325|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
101450326|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101450395|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
101450396|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
101450397|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450398|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450399|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
101450400|NCT00216177|Adalimumab|adalimumab|mesh-list
101450401|NCT00216177|Infliximab|infliximab|mesh-list
101450402|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101450461|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450462|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101450463|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101450532|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450533|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
101450534|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101450535|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
101450536|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450537|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101450538|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101450539|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
101450540|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450541|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450542|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101450543|NCT00125021|Capecitabine|capecitabine|mesh-list
101450544|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101450545|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101450591|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101450592|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450593|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450594|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101450595|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450596|NCT00193973|Methotrexate|methotrexate|mesh-list
101450597|NCT00193973|Idarubicin|idarubicin|mesh-list
101450659|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450660|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450664|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
101450665|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
101450666|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450725|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450726|NCT00206544|Tamoxifen|tamoxifen|mesh-list
101450727|NCT00206544|Progesterone|progesterone|mesh-list
101450728|NCT00206544|Progestins|progestins|mesh-ancestor
101450729|NCT00206544|Hormones|hormones|mesh-ancestor
101450730|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450731|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450739|NCT00194324|Miconazole|miconazole|mesh-list
101450790|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101450791|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450792|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101450794|NCT00473512|Hormones|hormones|mesh-ancestor
101450795|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101450796|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101450797|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101450846|NCT00125567|Levodopa|levodopa|mesh-list
101450855|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101450856|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450929|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101450930|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101450931|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101450932|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450933|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101450934|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101450935|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101450936|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101450937|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101450938|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450940|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101450991|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101450992|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
101450993|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101450994|NCT00125918|Tadalafil|tadalafil|mesh-list
101450995|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
101450996|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101450997|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101450998|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101450999|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451000|NCT00125918|Urological Agents|urological agents|mesh-ancestor
101451001|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
101451002|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101451003|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101451004|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101451005|NCT00472303|Morphine|morphine|mesh-list
101451006|NCT00472303|Tapentadol|tapentadol|mesh-list
101451049|NCT00194909|Urological Agents|urological agents|mesh-ancestor
101451050|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
101451051|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
101451052|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
101451120|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
101451121|NCT00402506|Pyridoxal|pyridoxal|mesh-list
101451122|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
101451123|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
101451124|NCT00402506|Vitamins|vitamins|mesh-ancestor
101451125|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
101451126|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451127|NCT00207129|Capecitabine|capecitabine|mesh-list
101451128|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451129|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
101451130|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451131|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451132|NCT00402545|Docetaxel|docetaxel|mesh-list
101451133|NCT00402545|Fluorouracil|fluorouracil|mesh-list
101451134|NCT00402545|Cetuximab|cetuximab|mesh-list
101451135|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451136|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
101451137|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
101451138|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
101451139|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451140|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
101451144|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451145|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451147|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451148|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101451149|NCT00126074|Protective Agents|protective agents|mesh-ancestor
101451150|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451152|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
101451153|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451154|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
101451155|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451156|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451157|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
101451158|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451159|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451160|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
101451161|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451163|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
101451164|NCT00409760|Amlodipine|amlodipine|mesh-list
101451226|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451227|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451228|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
101451229|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451298|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
101451299|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451300|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101451373|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451374|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451375|NCT00195689|Adalimumab|adalimumab|mesh-list
101451376|NCT00195689|Antibodies|antibodies|mesh-list
101451377|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101451378|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
101451444|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451445|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
101451446|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
101451447|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101451448|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451449|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101451450|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101451451|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101451452|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
101451453|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451454|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451455|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101451456|NCT00479713|Simvastatin|simvastatin|mesh-list
101451502|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451503|NCT00195806|Valproic Acid|valproic acid|mesh-list
101451504|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
101451505|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451506|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451507|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
101451508|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451509|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451510|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
101451511|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451512|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451513|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451514|NCT00477529|Docetaxel|docetaxel|mesh-list
101451515|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451563|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451564|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101451565|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451566|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451568|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101451569|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101451570|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101451571|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451573|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451575|NCT00202553|Perindopril|perindopril|mesh-list
101451576|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101451577|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451578|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451579|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451580|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101451581|NCT00202592|Perindopril|perindopril|mesh-list
101451582|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101451583|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451612|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101451613|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101451614|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451616|NCT00202787|Leucovorin|leucovorin|mesh-list
101451617|NCT00202787|Cetuximab|cetuximab|mesh-list
101451618|NCT00202787|Fluorouracil|fluorouracil|mesh-list
101451619|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
101451684|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451685|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451686|NCT00203060|Rasagiline|rasagiline|mesh-list
101451687|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101451753|NCT00203138|Rasagiline|rasagiline|mesh-list
101451754|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101451755|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451756|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451757|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101451758|NCT00203138|Protective Agents|protective agents|mesh-ancestor
101451759|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451760|NCT00196547|Montelukast|montelukast|mesh-list
101451761|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101451762|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
101451763|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101451764|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
101451765|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101451766|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451767|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101451768|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101451769|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451809|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
101451810|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101451811|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101417692|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101417693|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
101417694|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417695|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221784|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
101451812|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101451813|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101451814|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451815|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
101451816|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
101451817|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101451818|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451819|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101451820|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101451821|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
101451822|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101451823|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101451824|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101451826|NCT00226356|Betaine|betaine|mesh-list
101451864|NCT00196625|Amprenavir|amprenavir|mesh-list
101451865|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101451866|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101451867|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
101451868|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101451869|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101451870|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101451871|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101451872|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
101451873|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101451882|NCT00208260|Leucovorin|leucovorin|mesh-list
101451928|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
101451929|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451930|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101451933|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101451934|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101451994|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
101451995|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101451996|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
101451997|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101451998|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101451999|NCT00410735|Pranlukast|pranlukast|mesh-list
101452000|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101452001|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
101452002|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101452003|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
101452058|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452059|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452060|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452061|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
101452062|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
101452063|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452064|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452065|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101452066|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101452072|NCT00203450|Zonisamide|zonisamide|mesh-list
101452119|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452120|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101452121|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
101452122|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
101452123|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452125|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
101452126|NCT00208611|Vitamins|vitamins|mesh-list
101452127|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
101452128|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
101452129|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
101452130|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
101452131|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452132|NCT00208611|Hematinics|hematinics|mesh-ancestor
101452133|NCT00203567|Carbamazepine|carbamazepine|mesh-list
101452134|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
101452135|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
101452183|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101452184|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101452185|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101452186|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
101452187|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452253|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
101452254|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101452255|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101452256|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101452257|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452258|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
101452259|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
101452260|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101452261|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
101452319|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452396|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452398|NCT00204191|Tacrolimus|tacrolimus|mesh-list
101452399|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452400|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
101452401|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452402|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101452403|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452404|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452461|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
101452462|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452463|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
101452533|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
101452534|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452535|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101452536|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101452537|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101452538|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452539|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101452540|NCT02962323|Calcium|calcium|mesh-list
101452541|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101452542|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452544|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101452545|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
101452546|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452547|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101452548|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101452549|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452550|NCT00204503|Valproic Acid|valproic acid|mesh-list
101452551|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
101452552|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452553|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452554|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
101452555|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452556|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452557|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
101452582|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
101452583|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452584|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
101452653|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
101452654|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452655|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101452656|NCT00231192|Repaglinide|repaglinide|mesh-list
101452657|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452658|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452659|NCT00204698|Rabeprazole|rabeprazole|mesh-list
101452660|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101452661|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101452662|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101452663|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452664|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452715|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101452716|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452717|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
101452718|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101452719|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
101452720|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452722|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101452723|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
101452724|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
101452725|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
101417697|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417698|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
101417699|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101417700|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101417701|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101452726|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
101452727|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452728|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452729|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101452730|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
101452731|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452732|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101452733|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101452734|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101452735|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452736|NCT00198614|Metoprolol|metoprolol|mesh-list
101452737|NCT00198614|Carvedilol|carvedilol|mesh-list
101452738|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101452739|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101452740|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
101452741|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
101452742|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101452743|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101452744|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101452745|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101452759|NCT00231582|Etoposide|etoposide|mesh-list
101452760|NCT00231582|Carboplatin|carboplatin|mesh-list
101452761|NCT00231582|Epirubicin|epirubicin|mesh-list
101452762|NCT00231582|Ifosfamide|ifosfamide|mesh-list
101452763|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101452764|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101452765|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101452766|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101452767|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101452768|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101452825|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101452826|NCT00199004|Cytarabine|cytarabine|mesh-list
101452827|NCT00199004|Dexamethasone|dexamethasone|mesh-list
101452828|NCT00199004|Prednisolone|prednisolone|mesh-list
101452829|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
101452900|NCT00477412|Rituximab|rituximab|mesh-list
101452901|NCT00477412|Doxorubicin|doxorubicin|mesh-list
101452972|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101452973|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101452975|NCT01086982|Octreotide|octreotide|mesh-list
101453045|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
101453120|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101453121|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
101453122|NCT00205751|Hormones|hormones|mesh-ancestor
101453123|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453124|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101453125|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453126|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101453127|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
101453128|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453129|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101453130|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101453131|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
101453180|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
101453253|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453254|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101453255|NCT00206297|Pramlintide|pramlintide|mesh-list
101453324|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101453325|NCT00206453|Docetaxel|docetaxel|mesh-list
101453326|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453327|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
101453328|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
101453329|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
101453330|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453332|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101453333|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
101453337|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453387|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101453388|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101453389|NCT00424710|Growth Substances|growth substances|mesh-ancestor
101453390|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453391|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
101453392|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453393|NCT00206960|Risperidone|risperidone|mesh-list
101453394|NCT00206960|Clopenthixol|clopenthixol|mesh-list
101453395|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101453396|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
101453397|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453451|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101453453|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
101453454|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101453455|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
101453456|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
101453457|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101453458|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453459|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101453460|NCT00230217|Rasburicase|rasburicase|mesh-list
101453461|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
101453462|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453512|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101453513|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101453514|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
101453586|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
101453587|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101453655|NCT00237198|Letrozole|letrozole|mesh-list
101453656|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101453657|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101453659|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101453724|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453725|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453726|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101453727|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
101453728|NCT01085812|Milnacipran|milnacipran|mesh-list
101453793|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101453794|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101453795|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101453864|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101453865|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101453940|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101453941|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101453943|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
101454007|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454010|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
101454077|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454078|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454079|NCT00234390|Budesonide|budesonide|mesh-list
101454080|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101454081|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101454082|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
101454146|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101454147|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454217|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101454218|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454219|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454287|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101454288|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454289|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454290|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454292|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
101454357|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
101454358|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
101454359|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
101454362|NCT00209963|Gaboxadol|gaboxadol|mesh-list
101454430|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454431|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101454502|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454575|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
101454576|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454577|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
101454578|NCT00234819|Estrogens|estrogens|mesh-list
101454579|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101454580|NCT00234819|Hormones|hormones|mesh-ancestor
101454587|NCT04570306|Belimumab|belimumab|mesh-list
101454643|NCT00237861|Olanzapine|olanzapine|mesh-list
101454644|NCT00237861|Risperidone|risperidone|mesh-list
101454645|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101454646|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101454647|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
101454648|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454649|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454650|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454651|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101454652|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101454653|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101454654|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101454656|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
101454657|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
101454658|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
101454659|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101454660|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101454661|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101454662|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101454698|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101454699|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
101454700|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101454701|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101454702|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101454703|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101454704|NCT04569214|PAZ320|paz320|mesh-list
101454705|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454706|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454767|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101454768|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454769|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101454770|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
101454771|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101454837|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101454838|NCT04566718|Metformin|metformin|mesh-list
101454839|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101454840|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101454911|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
101454982|NCT00211445|Verteporfin|verteporfin|mesh-list
101454983|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101454984|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
101455053|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455054|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
101455087|NCT04680091|Efavirenz|efavirenz|mesh-list
101455120|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455121|NCT04680208|Anesthetics|anesthetics|mesh-list
101455122|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455123|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455124|NCT00211796|Valproic Acid|valproic acid|mesh-list
101455191|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455192|NCT04668976|Gemcitabine|gemcitabine|mesh-list
101455193|NCT04668976|Fluorouracil|fluorouracil|mesh-list
101455194|NCT04668976|Floxuridine|floxuridine|mesh-list
101455195|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
101455197|NCT04668976|Cetuximab|cetuximab|mesh-list
101455198|NCT04668976|Panitumumab|panitumumab|mesh-list
101455199|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101455200|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
101455201|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455202|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455203|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101455204|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
101455205|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455207|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101455253|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
101455254|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101455255|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
101455256|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455257|NCT00556465|Expectorants|expectorants|mesh-ancestor
101455258|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
101455259|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101455260|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
101455261|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455262|NCT00556465|Protective Agents|protective agents|mesh-ancestor
101455263|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455264|NCT00556465|Antidotes|antidotes|mesh-ancestor
101455265|NCT04668469|Acetaminophen|acetaminophen|mesh-list
101455318|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
101417702|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417703|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417704|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
101417705|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101417706|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417708|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101417709|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101417710|NCT04725357|Analgesics|analgesics|mesh-ancestor
101455319|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455320|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455321|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455322|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455323|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101455324|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101455387|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455388|NCT00414336|Antacids|antacids|mesh-ancestor
101455459|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101455460|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101455461|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101455462|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455527|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101455528|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101455529|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
101455598|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455599|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455600|NCT00239967|Hormones|hormones|mesh-ancestor
101455601|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455602|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455603|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
101455664|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455665|NCT00243711|Laxatives|laxatives|mesh-ancestor
101455666|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101455667|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
101455669|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101455734|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455735|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101455947|NCT00215228|Escitalopram|escitalopram|mesh-list
101455948|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101455949|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101455950|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455951|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455952|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455953|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
101455954|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455955|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455956|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
101455957|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455958|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101455959|NCT00215228|Analgesics|analgesics|mesh-ancestor
101455960|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
101455961|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
101455962|NCT00215267|Praziquantel|praziquantel|mesh-list
101455963|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
101455964|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101455965|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101455966|NCT00240708|Risperidone|risperidone|mesh-list
101455967|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101455968|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
101455969|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101455970|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455972|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101455973|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101455974|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101455975|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455976|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101455977|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
101455978|NCT00215345|Celecoxib|celecoxib|mesh-list
101455979|NCT00215345|Docetaxel|docetaxel|mesh-list
101455980|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455981|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
101455982|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
101455983|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
101455984|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101455985|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101455986|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101455987|NCT00215345|Analgesics|analgesics|mesh-ancestor
101455988|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
101455989|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455991|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101455992|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101455993|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101455994|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101455995|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101455996|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
101455997|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456014|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456015|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
101456016|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101456017|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
101456018|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101456019|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456020|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101456021|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456022|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101456023|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101456078|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456079|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456081|NCT00556699|Rituximab|rituximab|mesh-list
101456150|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101456152|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456153|NCT00240864|Acetaminophen|acetaminophen|mesh-list
101456154|NCT00240864|Ibuprofen|ibuprofen|mesh-list
101456155|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101456156|NCT00240864|Analgesics|analgesics|mesh-ancestor
101456160|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
101456219|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101456220|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
101456221|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456222|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456223|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101456224|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
101456288|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456290|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456291|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456292|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456293|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456357|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456358|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456361|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456427|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101456428|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
101456429|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101456430|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456431|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456432|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
101456433|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456495|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101456568|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101456569|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101456570|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
101456642|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101456643|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456644|NCT00412100|Analgesics|analgesics|mesh-ancestor
101456645|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
101456713|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456714|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
101456715|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
101456716|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456717|NCT00217295|Topiramate|topiramate|mesh-list
101456718|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
101456719|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101456720|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456721|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101456722|NCT00245427|Lactams|lactams|mesh-list
101456723|NCT00245427|beta-Lactams|beta-lactams|mesh-list
101456724|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101456725|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456726|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
101456727|NCT00558298|Risperidone|risperidone|mesh-list
101456728|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101456729|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
101456730|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101456789|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456790|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456805|NCT00217529|Docetaxel|docetaxel|mesh-list
101456806|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101456807|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456808|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
101456809|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
101456810|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
101456812|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101456875|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101456876|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456877|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456879|NCT00558454|Hematinics|hematinics|mesh-ancestor
101456948|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101456949|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101456950|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456951|NCT04644406|Trastuzumab|trastuzumab|mesh-list
101456952|NCT04644406|Pertuzumab|pertuzumab|mesh-list
101456953|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101456954|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456955|NCT04643821|Calcitriol|calcitriol|mesh-list
101456956|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
101456957|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101456958|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
101456959|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456960|NCT04643821|Expectorants|expectorants|mesh-ancestor
101456963|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
101457012|NCT00559195|Hematinics|hematinics|mesh-ancestor
101457013|NCT00245934|Etanercept|etanercept|mesh-list
101457014|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101457015|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101457016|NCT00245934|Analgesics|analgesics|mesh-ancestor
101457017|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
101457018|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457019|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457023|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101457024|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
101457025|NCT00218231|Bupropion|bupropion|mesh-list
101457070|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457071|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457072|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457073|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457141|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457143|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101457144|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101457145|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457146|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
101457147|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101457148|NCT00559546|Montelukast|montelukast|mesh-list
101457149|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101457150|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
101457151|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101457152|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
101457153|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101457200|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457201|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101457202|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101457203|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101457204|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101457205|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101457206|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
101457207|NCT00242190|Gemcitabine|gemcitabine|mesh-list
101457208|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
101457209|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457210|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
101457212|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457262|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
101457263|NCT00242268|Simvastatin|simvastatin|mesh-list
101457264|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101457265|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101457266|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
101457267|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457268|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101457269|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101457270|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457271|NCT00246363|Silymarin|silymarin|mesh-list
101457272|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
101457273|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457324|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101457325|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101457326|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457327|NCT00219245|Rivastigmine|rivastigmine|mesh-list
101457328|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101457329|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457331|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
101457389|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101457390|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457391|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457392|NCT00219479|Phenytoin|phenytoin|mesh-list
101457393|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
101457394|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101457395|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101457396|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457397|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457398|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101457399|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101457401|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101457402|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457403|NCT04626973|Ezetimibe|ezetimibe|mesh-list
101457404|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101457444|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
101457445|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457447|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457448|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101457512|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101457513|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457583|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101457584|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457585|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
101457655|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457656|NCT01580683|Protective Agents|protective agents|mesh-ancestor
101457658|NCT00242814|Telmisartan|telmisartan|mesh-list
101457659|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101457660|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101457661|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101457668|NCT04623385|Tretinoin|tretinoin|mesh-list
101457720|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101457721|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
101457722|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457723|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457724|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457731|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
101457788|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
101457789|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101457790|NCT00243009|Cyclosporine|cyclosporine|mesh-list
101457792|NCT00243009|Fludarabine|fludarabine|mesh-list
101457860|NCT00220532|Hematinics|hematinics|mesh-ancestor
101457861|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
101457862|NCT00220532|Vitamins|vitamins|mesh-ancestor
101457877|NCT00243204|Docetaxel|docetaxel|mesh-list
101457933|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457934|NCT04619875|Lactulose|lactulose|mesh-list
101457935|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457936|NCT04619290|Methylene Blue|methylene blue|mesh-list
101457937|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101457938|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457939|NCT04619563|Docetaxel|docetaxel|mesh-list
101457940|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101457941|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
101417711|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
101457942|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
101457943|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
101457944|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457945|NCT00220844|Amitriptyline|amitriptyline|mesh-list
101457993|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101457994|NCT00221000|Methoxsalen|methoxsalen|mesh-list
101457995|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101457996|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
101457997|NCT00243477|Escitalopram|escitalopram|mesh-list
101457998|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101457999|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101458000|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101458001|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458056|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
101458057|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458058|NCT00221312|Alendronate|alendronate|mesh-list
101458061|NCT04616872|Methotrexate|methotrexate|mesh-list
101458127|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
101458128|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101458129|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101458130|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101458137|NCT00563095|Interferons|interferons|mesh-list
101458200|NCT04615702|Imipenem|imipenem|mesh-list
101458201|NCT04615702|Diclofenac|diclofenac|mesh-list
101458202|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101458203|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
101458204|NCT04615702|Secretin|secretin|mesh-list
101458273|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458274|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458347|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101458421|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
101458422|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
101458494|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
101458495|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101458496|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101458499|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458500|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101458560|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101458561|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101458562|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101458563|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
101458564|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
101458630|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458631|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101458702|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101458703|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101458704|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101458705|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101458706|NCT00564538|Tacrolimus|tacrolimus|mesh-list
101458707|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
101458708|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101458709|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101458710|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
101458765|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101458766|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101458767|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
101458768|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101458769|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101458770|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101458771|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
101458772|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
101458832|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
101458833|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101458834|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458901|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101458902|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101458903|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101458904|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101458971|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101458972|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101458973|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
101417712|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101417713|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417714|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417715|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417716|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101417717|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101417718|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458974|NCT04603729|Hormones|hormones|mesh-ancestor
101459046|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
101459047|NCT00252291|Miotics|miotics|mesh-ancestor
101459048|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
101459049|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459050|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459051|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101459052|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101459053|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
101459054|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101459109|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101459110|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101459111|NCT04601701|Growth Substances|growth substances|mesh-ancestor
101459180|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101459181|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101459182|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101459183|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101459184|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101459185|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
101459250|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
101459251|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101459257|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
101459321|NCT04955366|Abatacept|abatacept|mesh-list
101459395|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459396|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
101459397|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459398|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101459399|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459400|NCT00249210|Levofloxacin|levofloxacin|mesh-list
101459401|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101459411|NCT00252798|Paclitaxel|paclitaxel|mesh-list
101459462|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
101459463|NCT04595929|Vitamins|vitamins|mesh-ancestor
101459464|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
101459535|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101459536|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
101459538|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
101459539|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459540|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459606|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101459607|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101459608|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101459609|NCT04593706|BB 1101|bb 1101|mesh-list
101459610|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101459611|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
101459612|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
101459613|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101459614|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459615|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101459616|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
101459617|NCT04593706|Hormones|hormones|mesh-ancestor
101459618|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101459740|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101459741|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459742|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101459743|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101459744|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101459808|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
101459809|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101459810|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101459811|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101459879|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101417719|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417721|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101417722|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
101459880|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101459953|NCT04588090|Cisplatin|cisplatin|mesh-list
101459954|NCT04588090|Paclitaxel|paclitaxel|mesh-list
101459955|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101459956|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101459957|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
101460025|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
101460026|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101460027|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101460028|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
101460029|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460030|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
101460031|NCT04587115|Oxycodone|oxycodone|mesh-list
101460032|NCT04587115|Risperidone|risperidone|mesh-list
101460033|NCT04587115|Ziprasidone|ziprasidone|mesh-list
101460034|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101460035|NCT04587115|Narcotics|narcotics|mesh-ancestor
101460036|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101460037|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460090|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460091|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
101460092|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460161|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460162|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101460163|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101460232|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460233|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101460234|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101460235|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460303|NCT00223691|Octreotide|octreotide|mesh-list
101460304|NCT00223691|Phenylephrine|phenylephrine|mesh-list
101460305|NCT00223691|Acetazolamide|acetazolamide|mesh-list
101460306|NCT00223691|Midodrine|midodrine|mesh-list
101460307|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
101460308|NCT00223691|Ephedrine|ephedrine|mesh-list
101460309|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
101460310|NCT00223691|Ergotamine|ergotamine|mesh-list
101460311|NCT00223691|Bromides|bromides|mesh-list
101460312|NCT00223691|Levodopa|levodopa|mesh-list
101460313|NCT00223691|Carbidopa|carbidopa|mesh-list
101460314|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101460372|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
101460373|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101460446|NCT00254046|Etravirine|etravirine|mesh-list
101460448|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101460517|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101460519|NCT00415116|Docetaxel|docetaxel|mesh-list
101460520|NCT00415116|Lenalidomide|lenalidomide|mesh-list
101460521|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460522|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
101460523|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
101460524|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
101460525|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460526|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
101460527|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460528|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101460582|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101460583|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
101460584|NCT00569101|Tacrolimus|tacrolimus|mesh-list
101460585|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101460586|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
101460587|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460654|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
101460655|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
101460656|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460657|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460658|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101460660|NCT00569920|Hormones|hormones|mesh-ancestor
101460661|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101460663|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460664|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
101460665|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417723|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101417724|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
101417725|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101417727|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417729|NCT00135122|Hormones|hormones|mesh-ancestor
101460666|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460667|NCT00224510|Lamotrigine|lamotrigine|mesh-list
101460668|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
101460712|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101460713|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
101460714|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101460715|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101460716|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
101460717|NCT00254436|Hematinics|hematinics|mesh-ancestor
101460718|NCT00224588|Ketamine|ketamine|mesh-list
101460719|NCT00224588|Analgesics|analgesics|mesh-ancestor
101460720|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
101460721|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101460722|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460723|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101460777|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101460778|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
101460780|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101460851|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
101460852|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101460853|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460919|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101460920|NCT00234897|Adalimumab|adalimumab|mesh-list
101460921|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101460922|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101460923|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101460924|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
101460925|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101460926|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101460928|NCT00572299|Alendronate|alendronate|mesh-list
101460982|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101460983|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101460984|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
101461055|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101461056|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101461060|NCT00225173|Hormones|hormones|mesh-ancestor
101461123|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461195|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101461196|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101461197|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461198|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461199|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461261|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461335|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461407|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461480|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101461481|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101461482|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461483|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101461548|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461550|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
101461551|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
101461552|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101461553|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461554|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
101461555|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101461556|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
101461557|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461558|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101461612|NCT00413426|Urological Agents|urological agents|mesh-ancestor
101461614|NCT00255762|Bevacizumab|bevacizumab|mesh-list
101461615|NCT00255762|Carboplatin|carboplatin|mesh-list
101461685|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101461686|NCT00226538|Analgesics|analgesics|mesh-ancestor
101461687|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
101461688|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101461689|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461690|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101461691|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101461692|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101461693|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461746|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101461747|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461748|NCT00226967|Octreotide|octreotide|mesh-list
101461749|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101461750|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101461751|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461752|NCT00199381|Istradefylline|istradefylline|mesh-list
101461813|NCT00227474|Vaccines|vaccines|mesh-list
101461814|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
101461815|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461816|NCT00227513|Bortezomib|bortezomib|mesh-list
101461817|NCT00227513|Vorinostat|vorinostat|mesh-list
101461818|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461819|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101461820|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461821|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461822|NCT00227630|Pemetrexed|pemetrexed|mesh-list
101461823|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461824|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461825|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461826|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101461827|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101461828|NCT00256230|Disulfiram|disulfiram|mesh-list
101461829|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101461830|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101461831|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101461832|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101461833|NCT00227669|Gemcitabine|gemcitabine|mesh-list
101461834|NCT00227669|Docetaxel|docetaxel|mesh-list
101461865|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101461866|NCT00227708|Docetaxel|docetaxel|mesh-list
101461867|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101461936|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101461937|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101461938|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101461940|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462005|NCT00195715|Adalimumab|adalimumab|mesh-list
101462006|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101462007|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462008|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101462009|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
101462010|NCT00236106|Tacrolimus|tacrolimus|mesh-list
101462011|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101462012|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
101462016|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462070|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101462071|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462142|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101462143|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101462144|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101462216|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
101462217|NCT00236223|Hormones|hormones|mesh-ancestor
101462289|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101462290|NCT00229697|Tamoxifen|tamoxifen|mesh-list
101462291|NCT00229697|Gefitinib|gefitinib|mesh-list
101462292|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101462293|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
101462359|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462360|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462361|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101462362|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101462363|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101462364|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101462365|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101462368|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
101462369|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101462370|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462426|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462427|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462449|NCT00179959|Eusol|eusol|mesh-list
101462499|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101462572|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101462573|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
101462574|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101462575|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101462576|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101462578|NCT00415311|Lectins|lectins|mesh-list
101462641|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462642|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101462717|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462718|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
101462722|NCT00257829|Methazolamide|methazolamide|mesh-list
101462788|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101462789|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
101462790|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101462791|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101462792|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462856|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462858|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462859|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101462926|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101462928|NCT00201305|Protective Agents|protective agents|mesh-ancestor
101462931|NCT00201305|Vitamins|vitamins|mesh-ancestor
101462999|NCT00265824|Growth Substances|growth substances|mesh-ancestor
101463000|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463001|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
101463002|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101463003|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463005|NCT00201695|Dexamethasone|dexamethasone|mesh-list
101463067|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463068|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101463069|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463070|NCT00410540|Morphine|morphine|mesh-list
101463137|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463138|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101463143|NCT00171340|Letrozole|letrozole|mesh-list
101463209|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463210|NCT00202124|Tryptophan|tryptophan|mesh-list
101463211|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101463212|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
101463213|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101463214|NCT00266097|Gemcitabine|gemcitabine|mesh-list
101463215|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
101463216|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101463217|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101463218|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
101463219|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463272|NCT00479674|Bevacizumab|bevacizumab|mesh-list
101463273|NCT00479674|Carboplatin|carboplatin|mesh-list
101463274|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101463343|NCT00478777|Hormones|hormones|mesh-ancestor
101463417|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
101463418|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101463419|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463420|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101463421|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101463422|NCT00231140|Growth Substances|growth substances|mesh-ancestor
101463423|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
101463424|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463425|NCT00231218|Propolis|propolis|mesh-list
101463426|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463427|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
101463428|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101463429|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101463430|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
101463431|NCT00231335|Escitalopram|escitalopram|mesh-list
101463481|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
101463555|NCT04559425|Hormones|hormones|mesh-ancestor
101463556|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101463557|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463558|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463559|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
101463560|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417730|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101417731|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417732|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463561|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463562|NCT00231764|Daclizumab|daclizumab|mesh-list
101463563|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101463564|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
101463565|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463566|NCT04559308|Metformin|metformin|mesh-list
101463567|NCT04559308|Paclitaxel|paclitaxel|mesh-list
101463568|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
101463569|NCT04559308|Doxorubicin|doxorubicin|mesh-list
101463615|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463616|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101463617|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101463618|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
101463686|NCT02212210|Protective Agents|protective agents|mesh-ancestor
101463687|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101463688|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463689|NCT00232076|Cyclosporine|cyclosporine|mesh-list
101463758|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101463759|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101463760|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463827|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101463828|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101463829|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101463830|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101463831|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101463832|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101463833|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101463834|NCT04566211|Antacids|antacids|mesh-ancestor
101463835|NCT00259779|Prednisolone|prednisolone|mesh-list
101463891|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101463892|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101463893|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101463901|NCT00267267|Ezetimibe|ezetimibe|mesh-list
101463963|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
101463964|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101464037|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101464038|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
101464039|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
101464040|NCT00232934|Thalidomide|thalidomide|mesh-list
101464041|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101464042|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
101464043|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464044|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
101464045|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101464046|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101464047|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101464049|NCT00232934|Growth Substances|growth substances|mesh-ancestor
101464050|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
101464051|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101464052|NCT04673812|Fentanyl|fentanyl|mesh-list
101464053|NCT04673812|Bupivacaine|bupivacaine|mesh-list
101464095|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101464096|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101464098|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101464099|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464100|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101464164|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
101464165|NCT00233558|Adalimumab|adalimumab|mesh-list
101464166|NCT00233558|Methotrexate|methotrexate|mesh-list
101464167|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101464233|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101464234|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
101464235|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101464236|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464242|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
101464303|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
101464304|NCT00260520|Dalteparin|dalteparin|mesh-list
101464305|NCT00260520|Tinzaparin|tinzaparin|mesh-list
101464306|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101464375|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464376|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
101464377|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464444|NCT00234416|Gemcitabine|gemcitabine|mesh-list
101464445|NCT00234416|Gefitinib|gefitinib|mesh-list
101464446|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464447|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
101464517|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464519|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464520|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101464521|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
101464522|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101464523|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101464524|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464581|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101464582|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464583|NCT02211625|Analgesics|analgesics|mesh-ancestor
101464584|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
101464651|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101464652|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
101464653|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464654|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101464655|NCT04551781|Prednisone|prednisone|mesh-list
101464658|NCT04551781|Hormones|hormones|mesh-ancestor
101464722|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464723|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101464724|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
101464726|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464794|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464795|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464796|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101464797|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101464801|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
101464866|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101464867|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101464868|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464869|NCT02214433|Pantoprazole|pantoprazole|mesh-list
101464870|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101464871|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101464872|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101464873|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101464874|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464875|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101464877|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
101464878|NCT02212561|Methotrexate|methotrexate|mesh-list
101464879|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
101464880|NCT02212561|Fludarabine|fludarabine|mesh-list
101464881|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101464882|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
101464883|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101464884|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464886|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
101464896|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
101464919|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101464922|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101464923|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101464989|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101464990|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101464991|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101465060|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101465062|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465132|NCT00235937|Anastrozole|anastrozole|mesh-list
101465133|NCT00235937|Goserelin|goserelin|mesh-list
101465134|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101465203|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465204|NCT00236093|Narcotics|narcotics|mesh-ancestor
101465205|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465206|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465276|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101465277|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101465345|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465347|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465356|NCT00236366|Fentanyl|fentanyl|mesh-list
101465418|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101465419|NCT00236483|Narcotics|narcotics|mesh-ancestor
101465420|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465421|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
101465422|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101465423|NCT04545970|Protective Agents|protective agents|mesh-ancestor
101465424|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465425|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
101465426|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101465427|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
101465481|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101465482|NCT02215330|Diuretics|diuretics|mesh-ancestor
101465483|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
101465484|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101465485|NCT02278510|Topotecan|topotecan|mesh-list
101465486|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101465491|NCT04545892|Capsaicin|capsaicin|mesh-list
101465552|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
101465553|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101465554|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101465557|NCT00236717|Analgesics|analgesics|mesh-ancestor
101465623|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101465695|NCT00237302|Topiramate|topiramate|mesh-list
101465696|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
101465697|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101465698|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465766|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101465767|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101465768|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465837|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
101465838|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465839|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
101465840|NCT04543123|Escitalopram|escitalopram|mesh-list
101465841|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101465842|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101465843|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101465844|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465845|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101465846|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
101465847|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465848|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101465849|NCT04539418|Vitamin K|vitamin k|mesh-list
101465850|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
101465851|NCT04539418|Vitamins|vitamins|mesh-ancestor
101465852|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
101465853|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465854|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101465855|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101465857|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
101465892|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
101465893|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465965|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
101465966|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101465967|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101465968|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101465969|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
101465970|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101465971|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101465972|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101465973|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101465974|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101465975|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
101465976|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101465977|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466026|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466027|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
101466028|NCT00269997|Hematinics|hematinics|mesh-ancestor
101466029|NCT00237731|Morphine|morphine|mesh-list
101466101|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466102|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466144|NCT00415701|Propofol|propofol|mesh-list
101466172|NCT04536415|Oseltamivir|oseltamivir|mesh-list
101466173|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
101466174|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466175|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466178|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101466245|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101466246|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
101466248|NCT02216227|Cefazolin|cefazolin|mesh-list
101466249|NCT02216227|Mupirocin|mupirocin|mesh-list
101466250|NCT02216227|Povidone|povidone|mesh-list
101466251|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101466315|NCT02216383|Oxytocin|oxytocin|mesh-list
101466316|NCT02216383|Carbetocin|carbetocin|mesh-list
101466317|NCT02216383|Syntometrine|syntometrine|mesh-list
101466318|NCT02216383|Ergonovine|ergonovine|mesh-list
101466319|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
101466320|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101466321|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466322|NCT00262782|Fludarabine|fludarabine|mesh-list
101466323|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466324|NCT00238394|Cediranib|cediranib|mesh-list
101466325|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466326|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466383|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101466384|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101466385|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101466386|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
101466387|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101466388|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101466389|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
101466390|NCT00263016|Docetaxel|docetaxel|mesh-list
101466391|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101466392|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101466393|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101466446|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
101466447|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466448|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466449|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101466450|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
101466451|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
101466453|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466460|NCT00263133|Sertraline|sertraline|mesh-list
101466509|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101466510|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101466582|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101466583|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101466584|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101466585|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101466586|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101466587|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
101466588|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101466646|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101466647|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
101466871|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101466872|NCT05586373|Analgesics|analgesics|mesh-ancestor
101466873|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
101466874|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101466875|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466876|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101466877|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101466878|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101466879|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467000|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101467001|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467002|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467003|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467004|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467005|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
101467006|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467008|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101467009|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101467010|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467016|NCT04933383|Budesonide|budesonide|mesh-list
101467061|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467138|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101467139|NCT04482621|Decitabine|decitabine|mesh-list
101467211|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467213|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467214|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467215|NCT04108897|Doxycycline|doxycycline|mesh-list
101467216|NCT04108897|Ivermectin|ivermectin|mesh-list
101467217|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101467280|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
101467281|NCT03832010|Hormones|hormones|mesh-ancestor
101467282|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101467283|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467284|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
101467285|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467286|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467287|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467288|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467289|NCT03730649|Sulforaphane|sulforaphane|mesh-list
101467290|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101467291|NCT03730649|Protective Agents|protective agents|mesh-ancestor
101467297|NCT03632720|Vaccines|vaccines|mesh-list
101467341|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
101467343|NCT03521037|Rucaparib|rucaparib|mesh-list
101467344|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467348|NCT03499444|Rucaparib|rucaparib|mesh-list
101467414|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
101467415|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101467416|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467417|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101467418|NCT03397394|Rucaparib|rucaparib|mesh-list
101467419|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467420|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467421|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467480|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101467481|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467482|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101467483|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467484|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101467485|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467487|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467488|NCT02807636|Carboplatin|carboplatin|mesh-list
101467489|NCT02807636|Gemcitabine|gemcitabine|mesh-list
101467490|NCT02807636|Atezolizumab|atezolizumab|mesh-list
101467493|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
101467613|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
101467614|NCT01081951|Paclitaxel|paclitaxel|mesh-list
101467616|NCT01081951|Carboplatin|carboplatin|mesh-list
101467682|NCT04531423|Golimumab|golimumab|mesh-list
101467683|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
101467684|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101467685|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467687|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
101467688|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467689|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101467690|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467691|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467692|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467693|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
101467694|NCT00239252|Interferons|interferons|mesh-list
101467695|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
101467696|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101467697|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
101467703|NCT04531267|Calcium|calcium|mesh-list
101467738|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467739|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467740|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
101467741|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101467742|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101467743|NCT00414323|Analgesics|analgesics|mesh-ancestor
101467744|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
101467745|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
101467746|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
101467747|NCT00263484|Thalidomide|thalidomide|mesh-list
101467748|NCT00263484|Dexamethasone|dexamethasone|mesh-list
101467749|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
101467750|NCT00263484|BB 1101|bb 1101|mesh-list
101467751|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101467752|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
101467753|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
101467754|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101467755|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467756|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101467757|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
101467793|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101467794|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
101467795|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
101467796|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
101467797|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
101467798|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101467799|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467800|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
101467801|NCT02217553|Vitamin D|vitamin d|mesh-list
101467860|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101467861|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467862|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101467863|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101467864|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101467865|NCT00239369|Diuretics|diuretics|mesh-ancestor
101467866|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
101467867|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467868|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101467869|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101467870|NCT04529668|Vitamin D|vitamin d|mesh-list
101467871|NCT04529668|Vitamins|vitamins|mesh-ancestor
101467872|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
101467873|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101467874|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101467875|NCT00239408|Bromides|bromides|mesh-list
101467876|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
101467877|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101467878|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
101467914|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468061|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
101468130|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
101468131|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468132|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468133|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468135|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
101468136|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468137|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
101468138|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101468139|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
101468140|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101468141|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101468142|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468143|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468144|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
101468146|NCT02961075|Anesthetics|anesthetics|mesh-list
101468186|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101468187|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468189|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468258|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101468259|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101468260|NCT00240149|Insulin|insulin|mesh-list
101468261|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101468262|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101468327|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468329|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101468400|NCT00415740|Carbidopa|carbidopa|mesh-list
101468401|NCT00415740|Entacapone|entacapone|mesh-list
101468402|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101468403|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101468404|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101468405|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
101468406|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468407|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468408|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468409|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101468410|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468411|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101468412|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101468413|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
101468414|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
101468415|NCT01649479|Antibodies|antibodies|mesh-list
101468459|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101468460|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468461|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468462|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101468463|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101468464|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101468465|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
101468466|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468467|NCT01649830|Temozolomide|temozolomide|mesh-list
101468468|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101468469|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
101468470|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468471|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101468472|NCT00240656|Carvedilol|carvedilol|mesh-list
101468517|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468518|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101468519|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
101468520|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101468588|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
101468589|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101468662|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101468663|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101468666|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101468734|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101468735|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468802|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101468804|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
101468805|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
101468806|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101468807|NCT00241514|Esomeprazole|esomeprazole|mesh-list
101468842|NCT02219191|Puerarin|puerarin|mesh-list
101468871|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101468872|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101468873|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101468874|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
101468944|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469018|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101469019|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101469020|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
101469021|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469022|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469023|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469024|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101469025|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
101469026|NCT00272805|Protective Agents|protective agents|mesh-ancestor
101469027|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101469028|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101469079|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
101469080|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
101469081|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101469082|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469148|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469150|NCT00242918|Gefitinib|gefitinib|mesh-list
101469151|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469158|NCT00273312|Epothilone B|epothilone b|mesh-list
101469221|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101469222|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
101469223|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469295|NCT00283179|Risperidone|risperidone|mesh-list
101469296|NCT00283179|Aripiprazole|aripiprazole|mesh-list
101469297|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101469298|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
101469299|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469300|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469301|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469302|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101469303|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101469304|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101469305|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101469306|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101469307|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
101469308|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
101469309|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
101469310|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101469311|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101469312|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101469313|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101469314|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101469315|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101469316|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101469317|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469318|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469342|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101469344|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101469345|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101469346|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101469347|NCT00244127|Prednisone|prednisone|mesh-list
101469348|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
101469407|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
101469408|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
101469409|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469472|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101469546|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101469616|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101469617|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469692|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101469693|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101469694|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469768|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
101469837|NCT00274872|Fluorouracil|fluorouracil|mesh-list
101469838|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
101469839|NCT00274872|Calcium|calcium|mesh-list
101469840|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
101469908|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101469909|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101469910|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
101469911|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101469912|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101469913|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
101469977|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101469978|NCT00284583|Lidocaine|lidocaine|mesh-list
101469979|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
101470047|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470048|NCT00284778|Docetaxel|docetaxel|mesh-list
101470049|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470050|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470054|NCT00247247|Entacapone|entacapone|mesh-list
101470118|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101470119|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101470120|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470190|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101470191|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470192|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101470193|NCT00278187|Volociximab|volociximab|mesh-list
101470194|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470195|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101470196|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470197|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470198|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101470199|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101470253|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470254|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470255|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
101470327|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470328|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470329|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
101470330|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
101470332|NCT00248729|Midazolam|midazolam|mesh-list
101470398|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
101470399|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101470401|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470469|NCT00279045|Metformin|metformin|mesh-list
101470470|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
101470471|NCT00279045|Glyburide|glyburide|mesh-list
101470472|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101470473|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470474|NCT00249353|Methylphenidate|methylphenidate|mesh-list
101470481|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
101470537|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470538|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470539|NCT00279162|Betamethasone|betamethasone|mesh-list
101470540|NCT00279162|Calcipotriene|calcipotriene|mesh-list
101470541|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101470542|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
101470609|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101470610|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101470611|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470614|NCT00279435|Visilizumab|visilizumab|mesh-list
101470680|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470681|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101470682|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
101470683|NCT00279747|Naproxen|naproxen|mesh-list
101470684|NCT00279747|Meloxicam|meloxicam|mesh-list
101470685|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101470747|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101470748|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101470749|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101470750|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
101470751|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
101470752|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101470753|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101470754|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101470755|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101470756|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101470757|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101470810|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101470811|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
101470812|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101470884|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101470893|NCT01640782|Vitamins|vitamins|mesh-ancestor
101470959|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101470960|NCT00280098|Docetaxel|docetaxel|mesh-list
101470961|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101470966|NCT00251381|Cetuximab|cetuximab|mesh-list
101471032|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101471033|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101471034|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101471035|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101471101|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
101471102|NCT00251732|Rabeprazole|rabeprazole|mesh-list
101471103|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101471104|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471105|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101471106|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471107|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471108|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471109|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101471110|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101471111|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101471112|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101471113|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471114|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471115|NCT00286962|Insulin|insulin|mesh-list
101471116|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101471117|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471119|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
101471157|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471158|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471159|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471160|NCT00280605|Urological Agents|urological agents|mesh-ancestor
101471161|NCT01134601|Capecitabine|capecitabine|mesh-list
101471162|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471163|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
101471164|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471165|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471166|NCT00252122|Ketamine|ketamine|mesh-list
101471167|NCT00252122|Analgesics|analgesics|mesh-ancestor
101471168|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
101471169|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471170|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471171|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101471172|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101471173|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
101471174|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
101471175|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471176|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101471177|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101471178|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471179|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471180|NCT00287157|Tizanidine|tizanidine|mesh-list
101471181|NCT00287157|Analgesics|analgesics|mesh-ancestor
101471182|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
101471202|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101471203|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
101471274|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101471275|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
101471276|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471346|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101471347|NCT05139667|Tacrolimus|tacrolimus|mesh-list
101471348|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101471349|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
101471350|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471351|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101471352|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471415|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471416|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471417|NCT00252707|Docetaxel|docetaxel|mesh-list
101471419|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471420|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471421|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471422|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
101471423|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471424|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471425|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471426|NCT01680406|Chloroquine|chloroquine|mesh-list
101471427|NCT01680406|Lumefantrine|lumefantrine|mesh-list
101471428|NCT01680406|Artemether|artemether|mesh-list
101471429|NCT01680406|Primaquine|primaquine|mesh-list
101471430|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101471431|NCT01680406|Amebicides|amebicides|mesh-ancestor
101471432|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101471433|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101471434|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471435|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
101471436|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101471437|NCT00287430|Hormones|hormones|mesh-list
101471438|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471439|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471441|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
101471442|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471443|NCT01680718|Vasopressins|vasopressins|mesh-list
101471444|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
101471464|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101471465|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101471467|NCT00252785|Budesonide|budesonide|mesh-list
101471536|NCT00252863|Theophylline|theophylline|mesh-list
101471537|NCT00252863|Albuterol|albuterol|mesh-list
101471538|NCT00252863|Terbutaline|terbutaline|mesh-list
101471539|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
101471540|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101471541|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101471542|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101471543|NCT00252863|Montelukast|montelukast|mesh-list
101471544|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101471545|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101471546|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
101471547|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471548|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471554|NCT00252863|Hormones|hormones|mesh-ancestor
101471597|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
101471598|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101471599|NCT01681693|Metformin|metformin|mesh-list
101471600|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101471602|NCT01681966|Ropivacaine|ropivacaine|mesh-list
101471671|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
101471672|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101471673|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101471674|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
101471685|NCT01683292|Apomorphine|apomorphine|mesh-list
101471742|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
101471743|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
101471744|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
101417742|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101471746|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101471811|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101471812|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471813|NCT01684774|Bupivacaine|bupivacaine|mesh-list
101471814|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
101471815|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
101471816|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471817|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101471879|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471880|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101471881|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101471882|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101471883|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101471884|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101471885|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
101471886|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101471887|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101471888|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101471890|NCT01685125|Dasatinib|dasatinib|mesh-list
101471894|NCT01685125|Hormones|hormones|mesh-ancestor
101471941|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101471942|NCT00281502|Rifaximin|rifaximin|mesh-list
101471943|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101471944|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101471945|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101471946|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
101471947|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
101472012|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101472013|NCT01686529|Growth Substances|growth substances|mesh-ancestor
101472014|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472085|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
101472086|NCT00253799|Protective Agents|protective agents|mesh-ancestor
101472087|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472089|NCT00281931|Rituximab|rituximab|mesh-list
101472155|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
101472156|NCT01687894|Anesthetics|anesthetics|mesh-list
101472157|NCT01687894|Sevoflurane|sevoflurane|mesh-list
101472158|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
101472159|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101472160|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101472161|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472162|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101472163|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101472169|NCT00287976|Irinotecan|irinotecan|mesh-list
101472221|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
101472222|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
101472223|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472224|NCT00254033|Methylphenidate|methylphenidate|mesh-list
101472225|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
101472226|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101472227|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472228|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101472229|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101472230|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472231|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472232|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
101472233|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472281|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101472282|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101472283|NCT00415064|Growth Substances|growth substances|mesh-ancestor
101472284|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
101472285|NCT00415103|Aprepitant|aprepitant|mesh-list
101472352|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
101472353|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101472354|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101472355|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
101472356|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
101472357|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472358|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472359|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472415|NCT00254618|Analgesics|analgesics|mesh-ancestor
101472416|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
101472417|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472418|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472419|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101472420|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472421|NCT00288717|Telmisartan|telmisartan|mesh-list
101472422|NCT00288717|Candesartan|candesartan|mesh-list
101472423|NCT00288717|Candesartan cilexetil|candesartan cilexetil|mesh-list
101472424|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101472425|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101472478|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101472479|NCT01608139|Curcumin|curcumin|mesh-list
101472481|NCT01608139|Vorinostat|vorinostat|mesh-list
101472484|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472549|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472550|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
101472622|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472623|NCT04719104|Protective Agents|protective agents|mesh-ancestor
101472624|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472625|NCT01588795|Vitamin D|vitamin d|mesh-list
101472626|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
101472627|NCT01588795|Diuretics|diuretics|mesh-list
101472691|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101472693|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
101472765|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101472766|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472767|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101472768|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
101472769|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472770|NCT00270348|Ciclesonide|ciclesonide|mesh-list
101472771|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
101472772|NCT00270348|Hormones|hormones|mesh-ancestor
101472773|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472774|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472775|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101472776|NCT00255593|Rituximab|rituximab|mesh-list
101472777|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101472778|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101472779|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
101472780|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472781|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472782|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101472783|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
101472784|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472785|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
101472786|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
101472787|NCT00255710|Fludarabine|fludarabine|mesh-list
101472788|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
101472789|NCT00255710|Tacrolimus|tacrolimus|mesh-list
101472790|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101472791|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
101472792|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472793|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101472794|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101472795|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
101472808|NCT00270426|Benazepril|benazepril|mesh-list
101472809|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101472810|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
101472811|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472880|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101472958|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101472959|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472960|NCT00256256|Incretins|incretins|mesh-ancestor
101472961|NCT00256334|Resveratrol|resveratrol|mesh-list
101472962|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
101472963|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101472964|NCT00256334|Protective Agents|protective agents|mesh-ancestor
101472965|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472966|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101472967|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101472968|NCT01609855|Scopolamine|scopolamine|mesh-list
101472969|NCT01609855|Bromides|bromides|mesh-list
101472970|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101472971|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
101472972|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101472973|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
101472974|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
101472975|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101472976|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472977|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101472978|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
101472979|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101472980|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
101473009|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473010|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101473011|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
101473012|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
101473013|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
101473084|NCT02270788|Protective Agents|protective agents|mesh-ancestor
101473085|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
101473086|NCT02270788|Vitamins|vitamins|mesh-ancestor
101473090|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
101473153|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473154|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
101473155|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473156|NCT02271802|Butyric Acid|butyric acid|mesh-list
101473157|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
101473158|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
101473221|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473294|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473295|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473296|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473297|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473298|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473299|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101473300|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
101473301|NCT02273128|Calcitonin|calcitonin|mesh-list
101473302|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473303|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473304|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101473305|NCT00257387|Cyclosporine|cyclosporine|mesh-list
101473306|NCT00257387|Cyclosporins|cyclosporins|mesh-list
101473307|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101473308|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473310|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
101473351|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473352|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101473353|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101473354|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101473355|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101473357|NCT01601938|Selenium|selenium|mesh-list
101473358|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
101473359|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473360|NCT01601938|Protective Agents|protective agents|mesh-ancestor
101473361|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473362|NCT01601938|Trace Elements|trace elements|mesh-ancestor
101473363|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
101473364|NCT01602055|Azithromycin|azithromycin|mesh-list
101473365|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101473366|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473367|NCT01602250|Ropivacaine|ropivacaine|mesh-list
101473368|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
101473369|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101473370|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
101473371|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
101473372|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473379|NCT00257582|Cetirizine|cetirizine|mesh-list
101473403|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101473404|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101473405|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473406|NCT01602406|Trastuzumab|trastuzumab|mesh-list
101473407|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101473408|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473409|NCT00290628|Cyclosporine|cyclosporine|mesh-list
101473410|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
101473411|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
101473412|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
101473413|NCT00290628|Melphalan|melphalan|mesh-list
101473414|NCT00290628|Busulfan|busulfan|mesh-list
101473415|NCT00290628|Cyclosporins|cyclosporins|mesh-list
101473416|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101473417|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473418|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
101473419|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473462|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473463|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
101417744|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417745|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101417746|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101417747|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
101417748|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417749|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101417750|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101417751|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417752|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
101417753|NCT00135317|Hematinics|hematinics|mesh-ancestor
101417754|NCT00152646|Clopidogrel|clopidogrel|mesh-list
101417755|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101473464|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473465|NCT01602640|Fentanyl|fentanyl|mesh-list
101473466|NCT01602640|Midazolam|midazolam|mesh-list
101473467|NCT01602640|Morphine|morphine|mesh-list
101473468|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101473469|NCT01602640|Narcotics|narcotics|mesh-ancestor
101473470|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473471|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473472|NCT01602640|Analgesics|analgesics|mesh-ancestor
101473473|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
101473474|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101473475|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101473476|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101473477|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
101473478|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
101473479|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101473480|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101473481|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101473482|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101473483|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
101473484|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
101473485|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473486|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473487|NCT00290667|Prednisone|prednisone|mesh-list
101473488|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
101473489|NCT00290667|Rituximab|rituximab|mesh-list
101473490|NCT00290667|Doxorubicin|doxorubicin|mesh-list
101473491|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101473492|NCT00290667|Vincristine|vincristine|mesh-list
101473493|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101473494|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
101473508|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
101473509|NCT00290667|Hormones|hormones|mesh-ancestor
101473510|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101473511|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101473512|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101473513|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473514|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473515|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
101473516|NCT01602757|Lidocaine|lidocaine|mesh-list
101473517|NCT01602757|Tetracaine|tetracaine|mesh-list
101473518|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
101473519|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
101473520|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473522|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
101473568|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101473569|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101473570|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473571|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
101473572|NCT01603030|Prednisolone|prednisolone|mesh-list
101473573|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101473574|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
101473575|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101473576|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
101473577|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101473579|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
101473631|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101473632|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101473633|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
101473634|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
101473702|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101473703|NCT01603498|Protective Agents|protective agents|mesh-ancestor
101473704|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
101473705|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
101473706|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
101473707|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473708|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
101473709|NCT01603654|Protective Agents|protective agents|mesh-ancestor
101473711|NCT01603654|Vitamins|vitamins|mesh-ancestor
101473769|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101473770|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101473772|NCT00290901|Tramadol|tramadol|mesh-list
101473773|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101473774|NCT00290901|Narcotics|narcotics|mesh-ancestor
101473775|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101473776|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101473777|NCT00290901|Analgesics|analgesics|mesh-ancestor
101473778|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
101473836|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101473838|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
101473912|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101473913|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101473984|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101473985|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101474057|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101474058|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
101474059|NCT00271791|Hormones|hormones|mesh-ancestor
101474066|NCT00259064|Gefitinib|gefitinib|mesh-list
101474127|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101474128|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
101474129|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101474140|NCT00272025|Escitalopram|escitalopram|mesh-list
101474198|NCT00291915|Adalimumab|adalimumab|mesh-list
101474199|NCT00291915|Methotrexate|methotrexate|mesh-list
101474200|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101474201|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
101474202|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101474205|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
101474267|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474268|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101474269|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
101474270|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101474271|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101474272|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101474273|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101474274|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
101474275|NCT04718376|Analgesics|analgesics|mesh-ancestor
101474276|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
101474278|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474279|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474280|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101474281|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101474284|NCT00272415|Temozolomide|temozolomide|mesh-list
101474328|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
101474329|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474330|NCT00292344|Rifaximin|rifaximin|mesh-list
101474331|NCT00292344|Loperamide|loperamide|mesh-list
101474399|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
101474400|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101474401|NCT00292890|Insulin|insulin|mesh-list
101474472|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474473|NCT00424970|Diuretics|diuretics|mesh-ancestor
101474474|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
101474475|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474476|NCT01331005|Nepafenac|nepafenac|mesh-list
101474477|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101474543|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101474544|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
101474545|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101474610|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417756|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101474612|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101474613|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474616|NCT00293280|Lomustine|lomustine|mesh-list
101474681|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474682|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101474684|NCT00293358|Etoposide|etoposide|mesh-list
101474753|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101474754|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
101474755|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101474756|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101474757|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
101474758|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474823|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474825|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
101474826|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101474897|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474898|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101474905|NCT00299364|Tibolone|tibolone|mesh-list
101474971|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101474972|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101474973|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101474974|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475044|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101475046|NCT00263315|Amphotericin B|amphotericin b|mesh-list
101475106|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475107|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475109|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101475174|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101475175|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101475176|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475177|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101475179|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101475180|NCT00264212|Diuretics|diuretics|mesh-ancestor
101475181|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
101475182|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475183|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101475184|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475185|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475186|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101475187|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101475188|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101475189|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101475190|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101475191|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475192|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475196|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101475225|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475227|NCT00294606|Protective Agents|protective agents|mesh-ancestor
101475297|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101475298|NCT00300729|Analgesics|analgesics|mesh-ancestor
101475299|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
101475369|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101475370|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101475371|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101475372|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475374|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
101475438|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101475439|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475440|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475441|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475442|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475507|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101475508|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101475509|NCT00295308|Clonidine|clonidine|mesh-list
101475510|NCT00295308|Analgesics|analgesics|mesh-ancestor
101475576|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
101475577|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475650|NCT00295542|Doxazosin|doxazosin|mesh-list
101475651|NCT00295542|Indapamide|indapamide|mesh-list
101417757|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101417758|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101417759|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
101417760|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417761|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417762|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417764|NCT00135434|Lopinavir|lopinavir|mesh-list
101417765|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101417766|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101417767|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101475652|NCT00295542|Quinapril|quinapril|mesh-list
101475653|NCT00295542|Torsemide|torsemide|mesh-list
101475654|NCT00295542|Spirapril|spirapril|mesh-list
101475655|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101475656|NCT00295542|Diuretics|diuretics|mesh-list
101475721|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
101475722|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101475723|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101475724|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475730|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
101475791|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101475792|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101475793|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
101475861|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
101475862|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101475863|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101475936|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101475942|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
101476005|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476006|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
101476007|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
101476008|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476010|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101476076|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476077|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476078|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476079|NCT00268229|Cytarabine|cytarabine|mesh-list
101476080|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
101476081|NCT00268229|Daunorubicin|daunorubicin|mesh-list
101476082|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101476083|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
101476084|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476085|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476139|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
101476140|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476141|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101476142|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
101476210|NCT00296868|Vitamins|vitamins|mesh-ancestor
101476211|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
101476212|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476213|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
101476281|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101476282|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
101476283|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476353|NCT00269555|Hormones|hormones|mesh-ancestor
101476354|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101476423|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476424|NCT00269867|Infliximab|infliximab|mesh-list
101476501|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101476502|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101476503|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476504|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101476505|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101476573|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
101476574|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417768|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
101417769|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417770|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417771|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101417772|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101417773|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
101417774|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476575|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476647|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101476648|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
101476649|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101476650|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101476651|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101476652|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101476716|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
101476717|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
101476718|NCT00306735|Palonosetron|palonosetron|mesh-list
101476719|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
101476720|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
101476721|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101476722|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476723|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476724|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101476725|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101476726|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
101476727|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476728|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476729|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
101476730|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101476731|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
101476732|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101476733|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476734|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101476772|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101476773|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101476774|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476843|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101476844|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
101476845|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476846|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101476850|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101476851|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101476852|NCT00307632|Estradiol|estradiol|mesh-list
101476853|NCT00307632|Estrogens|estrogens|mesh-ancestor
101476854|NCT00307632|Hormones|hormones|mesh-ancestor
101476858|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
101476907|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101476908|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101476909|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101476910|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101476911|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
101476912|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101476913|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101476975|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101476976|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101476977|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
101476978|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
101476979|NCT00272753|Hormones|hormones|mesh-ancestor
101476980|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477042|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477044|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101477045|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101477046|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101477047|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
101477048|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477049|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477050|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477051|NCT00272948|Defibrotide|defibrotide|mesh-list
101477052|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101477053|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101477104|NCT00273299|Diuretics|diuretics|mesh-ancestor
101477105|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
101477106|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477107|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101477175|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101477177|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101477178|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
101477179|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477180|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477181|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477182|NCT00273611|Vitamin D|vitamin d|mesh-list
101477183|NCT00273611|Vitamins|vitamins|mesh-ancestor
101477184|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
101477185|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477186|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101477187|NCT00273689|Albuterol|albuterol|mesh-list
101477188|NCT00273689|Montelukast|montelukast|mesh-list
101477189|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101477190|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
101477191|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101477192|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
101477193|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101477194|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477195|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101477196|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101477229|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101477230|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
101477301|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101477302|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
101477303|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
101477304|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477305|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
101477306|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101477307|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
101477308|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101477309|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477368|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477392|NCT00274352|Adalimumab|adalimumab|mesh-list
101477445|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101477524|NCT00274859|Gemcitabine|gemcitabine|mesh-list
101477586|NCT00315003|Telithromycin|telithromycin|mesh-list
101477587|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101477588|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477589|NCT00277550|Tegaserod|tegaserod|mesh-list
101477590|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101477595|NCT00277589|Iodine|iodine|mesh-list
101477656|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477657|NCT00278174|Interferons|interferons|mesh-list
101477658|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
101477729|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101477730|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101477731|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
101477732|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101477801|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101477802|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101477803|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
101477804|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101477805|NCT00309543|Antidotes|antidotes|mesh-ancestor
101477806|NCT00309543|Protective Agents|protective agents|mesh-ancestor
101477872|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101477874|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101477875|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101477876|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101477877|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101477878|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101477879|NCT00279344|Fentanyl|fentanyl|mesh-list
101477880|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101477936|NCT00279383|Thrombin|thrombin|mesh-list
101477937|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
101477938|NCT00279383|Coagulants|coagulants|mesh-ancestor
101477939|NCT00279422|Visilizumab|visilizumab|mesh-list
101477940|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
101477941|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478009|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101478010|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478011|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
101478012|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
101478013|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
101478014|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478015|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101478016|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478077|NCT00310128|Hormones|hormones|mesh-ancestor
101478078|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478079|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101478080|NCT00310128|Protective Agents|protective agents|mesh-ancestor
101478081|NCT00316563|Dronabinol|dronabinol|mesh-list
101478082|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
101478083|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478084|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101478085|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101478086|NCT00316563|Analgesics|analgesics|mesh-ancestor
101478087|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
101478088|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478089|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101478090|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101478091|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478093|NCT00316563|Hormones|hormones|mesh-ancestor
101478136|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478137|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101478138|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101478139|NCT00280007|Growth Substances|growth substances|mesh-ancestor
101478140|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478141|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
101478142|NCT00316680|Vaccines|vaccines|mesh-list
101478143|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
101478144|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478145|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
101478146|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
101478147|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478148|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478153|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101478154|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478158|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
101478193|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101478194|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478196|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101478197|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101478198|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101478259|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
101478262|NCT00280787|Irinotecan|irinotecan|mesh-list
101478272|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
101478333|NCT00310908|Analgesics|analgesics|mesh-ancestor
101478334|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
101478335|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478336|NCT00281489|Anesthetics|anesthetics|mesh-list
101478337|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101478406|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101478407|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101478408|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
101478409|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478410|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478411|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101478412|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101478413|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101478473|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
101478474|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478475|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478543|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
101478544|NCT00282386|Rofecoxib|rofecoxib|mesh-list
101478545|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478546|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478547|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478548|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101478549|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101478611|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478612|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101478683|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101478684|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101478685|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478686|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478688|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101478689|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478751|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
101478752|NCT00311961|Hormones|hormones|mesh-ancestor
101478753|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101478754|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478755|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101478756|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101478757|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
101478758|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
101478759|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101478760|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101478761|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101478762|NCT00311961|Protective Agents|protective agents|mesh-ancestor
101478763|NCT00283946|Zolpidem|zolpidem|mesh-list
101478812|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101478813|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101478817|NCT00284024|Domperidone|domperidone|mesh-list
101478886|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101478887|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101478888|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101478956|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101478957|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478958|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
101479245|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479246|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101479247|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
101479248|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
101479249|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
101479250|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101479251|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479253|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
101479254|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101479255|NCT00286481|Simvastatin|simvastatin|mesh-list
101479256|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101479257|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101479258|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
101479259|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479260|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101479261|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101479262|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479263|NCT00320034|Albuterol|albuterol|mesh-list
101479264|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101479265|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
101479266|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101479267|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479268|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101479269|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
101479270|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
101479271|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101479272|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101479273|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101479274|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101479275|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
101479347|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479348|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479419|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101479420|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479421|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
101479422|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
101479423|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101479424|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
101479425|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101479426|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479427|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479428|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101479429|NCT00287378|Omalizumab|omalizumab|mesh-list
101479430|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101479435|NCT00320580|Estradiol|estradiol|mesh-list
101479484|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479485|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101479486|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101479553|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479554|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479555|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
101479556|NCT00322413|Hematinics|hematinics|mesh-ancestor
101479624|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479625|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479626|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101479627|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479628|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479694|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101479695|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479696|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479711|NCT00321126|Zinc|zinc|mesh-list
101479763|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479764|NCT00322920|Topotecan|topotecan|mesh-list
101479765|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479766|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101479767|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101479834|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479905|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
101479906|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101479907|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
101479908|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101479909|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479910|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479975|NCT00289445|Folic Acid|folic acid|mesh-list
101479976|NCT00289445|Mitomycins|mitomycins|mesh-list
101479977|NCT00289445|Mitomycin|mitomycin|mesh-list
101479978|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
101479979|NCT00289445|Antidotes|antidotes|mesh-ancestor
101479980|NCT00289445|Protective Agents|protective agents|mesh-ancestor
101479981|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101479982|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
101479983|NCT00289445|Vitamins|vitamins|mesh-ancestor
101479984|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
101479985|NCT00289445|Hematinics|hematinics|mesh-ancestor
101479986|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479987|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101479988|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
101479989|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480040|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480041|NCT00323934|Mocetinostat|mocetinostat|mesh-list
101480042|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101480043|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480110|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480111|NCT00324012|Docetaxel|docetaxel|mesh-list
101480112|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480182|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480183|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480184|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
101480186|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480187|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480189|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101480190|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101480191|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
101480192|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101480193|NCT00291005|Docetaxel|docetaxel|mesh-list
101480194|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480195|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480196|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480240|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480241|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480243|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101480244|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480245|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101480246|NCT00324363|Incretins|incretins|mesh-ancestor
101480247|NCT00324363|Hormones|hormones|mesh-ancestor
101480248|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101480249|NCT00303732|Everolimus|everolimus|mesh-list
101480307|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101480308|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101480309|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
101480310|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
101480311|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
101480380|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
101417775|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101417776|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101417778|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101417779|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101417780|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101417781|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417782|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
101417783|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
101417784|NCT00142428|Cetuximab|cetuximab|mesh-list
101417785|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101417786|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101417787|NCT00135551|Benidipine|benidipine|mesh-list
101480381|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480382|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101480384|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480452|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
101480453|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
101480454|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101480455|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101480456|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101480457|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101480458|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
101480459|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480460|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480461|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101480462|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101480463|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101480464|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101480469|NCT00324831|Hormones|hormones|mesh-ancestor
101480511|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
101480512|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101480513|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101480514|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101480515|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101480580|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101480581|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101480582|NCT00292721|Analgesics|analgesics|mesh-ancestor
101480652|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101480653|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480724|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101480725|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101480726|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101480795|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101480796|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
101480867|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101480941|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101480942|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101480943|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481008|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101481009|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101481010|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101481011|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481012|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481014|NCT00326352|Propofol|propofol|mesh-list
101481015|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101481016|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481017|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481019|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
101481076|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481077|NCT00417950|Acarbose|acarbose|mesh-list
101481078|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101481079|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481080|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481145|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101481146|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
101481148|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481216|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
101481217|NCT00296465|Clomiphene|clomiphene|mesh-list
101481218|NCT00296465|Enclomiphene|enclomiphene|mesh-list
101481219|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
101481220|NCT00296465|Hormones|hormones|mesh-list
101481221|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101481222|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
101481223|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101481224|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
101481283|NCT00296933|Escitalopram|escitalopram|mesh-list
101481284|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101481285|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481350|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
101481423|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481424|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481496|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101481497|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481569|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
101481570|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481571|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481573|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101481574|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101481575|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101481576|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101481577|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101481578|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481579|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101481580|NCT00299039|Narcotics|narcotics|mesh-ancestor
101481581|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101481582|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
101481583|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
101481584|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101481585|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101481586|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101481587|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481588|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481589|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
101481590|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101481591|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481592|NCT00299351|Romidepsin|romidepsin|mesh-list
101481593|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101481617|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101481618|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101481688|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481690|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
101481761|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101481762|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
101481763|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101481764|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481765|NCT00327678|Rituximab|rituximab|mesh-list
101481766|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
101481767|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101481768|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101481769|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
101481828|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101481829|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101481830|NCT00301535|Analgesics|analgesics|mesh-ancestor
101481831|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
101481832|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101481837|NCT00301574|Galantamine|galantamine|mesh-list
101481896|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101481897|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
101481898|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
101481967|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101481968|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
101481969|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482039|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482040|NCT00302822|Tenofovir|tenofovir|mesh-list
101482041|NCT00302822|Emtricitabine|emtricitabine|mesh-list
101482042|NCT00302822|Efavirenz|efavirenz|mesh-list
101482110|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
101482111|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
101482112|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482113|NCT00303290|Interferons|interferons|mesh-list
101482114|NCT00303290|Cytarabine|cytarabine|mesh-list
101482115|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
101482116|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
101482117|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101482118|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482129|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
101482130|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482132|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101482133|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101482134|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482135|NCT00303407|Nadroparin|nadroparin|mesh-list
101482136|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
101482137|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101482138|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101482139|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482140|NCT00303524|Goserelin|goserelin|mesh-list
101482141|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101482142|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482143|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
101482144|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101482145|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101482146|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482149|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482218|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101482219|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101482220|NCT00303836|Analgesics|analgesics|mesh-ancestor
101482290|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482291|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101482292|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101482293|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
101482294|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482295|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482296|NCT00304499|Urological Agents|urological agents|mesh-ancestor
101482297|NCT00304538|Glucagon|glucagon|mesh-list
101482298|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101482299|NCT00304538|Hormones|hormones|mesh-ancestor
101482300|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482301|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482302|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101482303|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101482304|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101482305|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482306|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482307|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
101482308|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482309|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482311|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101482312|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101482313|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101482315|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101482337|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101482339|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
101482408|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101482409|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
101482477|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482478|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482479|NCT00332826|Insulin|insulin|mesh-list
101482480|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101482545|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
101482547|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
101482548|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482549|NCT00329472|Gemcitabine|gemcitabine|mesh-list
101482616|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
101482617|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101482618|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101482619|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482621|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482685|NCT00305825|Bevacizumab|bevacizumab|mesh-list
101482686|NCT00305825|Letrozole|letrozole|mesh-list
101417789|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101482687|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101482688|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482757|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101482758|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482759|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482760|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101482761|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
101482762|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101482763|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482764|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
101482765|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101482766|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482767|NCT00333372|Z 338|z 338|mesh-list
101482769|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101482818|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
101482819|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
101482820|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101482821|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101482890|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101482891|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482892|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101482893|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101482962|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101482963|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101482964|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101482965|NCT00451763|Growth Substances|growth substances|mesh-ancestor
101482966|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482968|NCT00330798|Ketorolac|ketorolac|mesh-list
101483030|NCT00331071|Ortho Evra|ortho evra|mesh-list
101483031|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
101483032|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101483033|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483034|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101483035|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101483098|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101483099|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483100|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101483101|NCT00452231|Cycloserine|cycloserine|mesh-list
101483102|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101483103|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101483104|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101483105|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
101483162|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
101483163|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
101483164|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
101483165|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101483166|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101483233|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101483234|NCT00452855|Narcotics|narcotics|mesh-ancestor
101483235|NCT00452855|Analgesics|analgesics|mesh-ancestor
101483308|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
101483309|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
101483310|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
101483313|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
101483378|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483380|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101483381|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483382|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101483383|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483385|NCT00453908|Alfuzosin|alfuzosin|mesh-list
101483444|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101483445|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
101483446|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101483448|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483450|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483451|NCT00322062|Vitamins|vitamins|mesh-ancestor
101483452|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
101483453|NCT00322062|Laxatives|laxatives|mesh-ancestor
101483454|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483455|NCT00336648|Bevacizumab|bevacizumab|mesh-list
101483456|NCT00336648|Gemcitabine|gemcitabine|mesh-list
101483457|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101483505|NCT00336765|XL647|xl647|mesh-list
101417790|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
101417791|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101417792|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
101417793|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417794|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417795|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101417796|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101417797|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
101417798|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101417799|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101417800|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101417801|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
101417802|NCT00152724|Aspirin|aspirin|mesh-list
101417803|NCT00152724|Celecoxib|celecoxib|mesh-list
101417804|NCT00152724|Indomethacin|indomethacin|mesh-list
101417805|NCT00152724|Nitroprusside|nitroprusside|mesh-list
101417806|NCT00152724|Acetylcholine|acetylcholine|mesh-list
101483506|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483579|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101483580|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101483654|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101483655|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
101483656|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483657|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101483658|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101483659|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483660|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
101483661|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
101483662|NCT00307307|Vitamins|vitamins|mesh-ancestor
101483663|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
101483664|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483665|NCT00337623|Prednisolone|prednisolone|mesh-list
101483666|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101483667|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
101483668|NCT00337623|Hormones|hormones|mesh-ancestor
101483669|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101483670|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483671|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101483672|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101483674|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101483675|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101483676|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101483677|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483678|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101483706|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
101483707|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483709|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101483778|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101483784|NCT00308048|Interferons|interferons|mesh-list
101483851|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
101483852|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
101483853|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101483854|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
101483923|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101483924|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101483925|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
101483994|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101484068|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101484069|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
101484070|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484139|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484140|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484141|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484209|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484210|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484211|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484212|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101484213|NCT00425217|Rituximab|rituximab|mesh-list
101484278|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484279|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101484348|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101484349|NCT00339417|Ivermectin|ivermectin|mesh-list
101484350|NCT00339417|Albendazole|albendazole|mesh-list
101484351|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101484419|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101484420|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
101484421|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
101484490|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101484493|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101484494|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484495|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101484559|NCT00343239|Docetaxel|docetaxel|mesh-list
101484560|NCT00343239|Fluorouracil|fluorouracil|mesh-list
101484561|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101484562|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
101484563|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
101484564|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
101484566|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
101484628|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
101484629|NCT00313235|Vaccines|vaccines|mesh-list
101484630|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
101484631|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484632|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101484633|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101484639|NCT00347802|Bimatoprost|bimatoprost|mesh-list
101484697|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
101484698|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101484700|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484770|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484771|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484844|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101484845|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101484846|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101484917|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
101484918|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101484919|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101484920|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
101484921|NCT00344409|Hematinics|hematinics|mesh-ancestor
101484922|NCT00348582|Ketorolac|ketorolac|mesh-list
101484923|NCT00348582|Nepafenac|nepafenac|mesh-list
101484924|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101484983|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485056|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485057|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
101485058|NCT00315536|Remifentanil|remifentanil|mesh-list
101485059|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101485128|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101485130|NCT00315926|Melatonin|melatonin|mesh-list
101485131|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
101485132|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485133|NCT00315926|Protective Agents|protective agents|mesh-ancestor
101485134|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485135|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485136|NCT00421434|Ribavirin|ribavirin|mesh-list
101485137|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101485138|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
101485139|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
101485140|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
101485141|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485142|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
101485143|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101485144|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
101485187|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101485188|NCT00316160|Bupropion|bupropion|mesh-list
101485189|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101485191|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
101485257|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101485258|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485259|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485328|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101485329|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485330|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101485399|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
101485400|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101485401|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
101485402|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101485418|NCT00317408|Leucovorin|leucovorin|mesh-list
101485474|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
101485475|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101485476|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101485547|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
101485550|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
101485551|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485617|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101485618|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101485619|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101485620|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485621|NCT00317954|Spironolactone|spironolactone|mesh-list
101485622|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101485623|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
101485624|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101485625|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485626|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101485627|NCT00317954|Diuretics|diuretics|mesh-ancestor
101485628|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
101485629|NCT00317993|Simvastatin|simvastatin|mesh-list
101485677|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101485678|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485679|NCT00345735|Analgesics|analgesics|mesh-ancestor
101485750|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101485751|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101485823|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
101485824|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485825|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485895|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101485896|NCT00319787|Gefitinib|gefitinib|mesh-list
101485897|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101485898|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101485899|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485900|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485901|NCT00319865|Thalidomide|thalidomide|mesh-list
101485902|NCT00319865|Dexamethasone|dexamethasone|mesh-list
101485903|NCT00319865|Doxorubicin|doxorubicin|mesh-list
101485904|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101485905|NCT00319865|Bortezomib|bortezomib|mesh-list
101485906|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485907|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
101485908|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
101485909|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485910|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485955|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101485956|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485957|NCT00346749|Fluticasone|fluticasone|mesh-list
101485959|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101485960|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101485961|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101485962|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
101485963|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101485964|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485965|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101485966|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
101485967|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
101485968|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101485969|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101485970|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101486016|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
101486017|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486088|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101486089|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486090|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101486161|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486235|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486236|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101486237|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486238|NCT00352521|Bevacizumab|bevacizumab|mesh-list
101486239|NCT00352521|Irinotecan|irinotecan|mesh-list
101486241|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101486303|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101486304|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101486374|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101486375|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
101486376|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101486441|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486442|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
101486443|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101486513|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101486514|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101486515|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
101486587|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
101486588|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486589|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101486590|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101486591|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101486592|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101486593|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
101486594|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
101486595|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
101486596|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101486597|NCT00324467|Analgesics|analgesics|mesh-ancestor
101486598|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
101486599|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
101486600|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
101486601|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
101486602|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101486603|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101486604|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
101486605|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101486606|NCT00324467|Protective Agents|protective agents|mesh-ancestor
101486611|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
101486644|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101486645|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
101486646|NCT04714554|Relugolix|relugolix|mesh-list
101486714|NCT00324974|Lansoprazole|lansoprazole|mesh-list
101486715|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
101486716|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101486717|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101486718|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101486719|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486720|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486721|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
101486722|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101486723|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101486724|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
101486725|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486726|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486727|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101486775|NCT00354081|Pyridoxine|pyridoxine|mesh-list
101486776|NCT00354081|Pyridoxal|pyridoxal|mesh-list
101486777|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
101486778|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
101486780|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486846|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486847|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101486848|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486849|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
101486850|NCT00426621|Diclofenac|diclofenac|mesh-list
101486851|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101486853|NCT00426621|Analgesics|analgesics|mesh-ancestor
101486854|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
101486855|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101486856|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486857|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101417807|NCT00152724|Capsaicin|capsaicin|mesh-list
101417808|NCT00152724|Clopidogrel|clopidogrel|mesh-list
101417809|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101417878|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417879|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101417885|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
101417950|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101417951|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101417952|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101417953|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101417954|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101417955|NCT00406146|Artesunate|artesunate|mesh-list
101417956|NCT00406146|Lumefantrine|lumefantrine|mesh-list
101417957|NCT00406146|Artemether|artemether|mesh-list
101418019|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
101418021|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
101418022|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101486909|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101486910|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486911|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101486912|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
101486913|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486977|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
101486978|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
101486979|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101486981|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101486982|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101486983|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101486984|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101486985|NCT00419549|Valdecoxib|valdecoxib|mesh-list
101486986|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101487040|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101487041|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101487042|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101487043|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
101487044|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487045|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487046|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487047|NCT04708353|Pregabalin|pregabalin|mesh-list
101487048|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487049|NCT04708353|Analgesics|analgesics|mesh-ancestor
101487050|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
101487051|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487052|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
101487053|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101487054|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487055|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487056|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101487057|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101487058|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101487059|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101487060|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101487092|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487093|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487094|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487163|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418023|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101418089|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418090|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101418091|NCT00153153|Laxatives|laxatives|mesh-ancestor
101418092|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101418093|NCT00136487|Celecoxib|celecoxib|mesh-list
101418094|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101418095|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101418096|NCT00136487|Analgesics|analgesics|mesh-ancestor
101418097|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
101418098|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418099|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418100|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418101|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418102|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101418103|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101487174|NCT00427167|Antacids|antacids|mesh-ancestor
101487234|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487235|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101487236|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101487305|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101487429|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487430|NCT00428064|Cyclosporine|cyclosporine|mesh-list
101487432|NCT00428064|Cyclosporins|cyclosporins|mesh-list
101487433|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487434|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487435|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487436|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
101487437|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487438|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
101487439|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487440|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101487441|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487490|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
101487491|NCT04507412|Hormones|hormones|mesh-ancestor
101487492|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101487493|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101487494|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487495|NCT00428454|Sirolimus|sirolimus|mesh-list
101487558|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487559|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101487560|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487561|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487562|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487563|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487564|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101487565|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101487566|NCT00428649|Selenium|selenium|mesh-list
101487567|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
101487568|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487569|NCT00428649|Protective Agents|protective agents|mesh-ancestor
101487570|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487571|NCT00428649|Trace Elements|trace elements|mesh-ancestor
101487618|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
101487619|NCT00428727|Protective Agents|protective agents|mesh-ancestor
101487622|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101487623|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487624|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487625|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487626|NCT00428766|Farletuzumab|farletuzumab|mesh-list
101487627|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487628|NCT04716569|Ivermectin|ivermectin|mesh-list
101487629|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101487630|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487631|NCT04703127|Lidocaine|lidocaine|mesh-list
101487632|NCT04703127|Tadalafil|tadalafil|mesh-list
101487633|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
101487634|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
101487644|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
101487675|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487748|NCT04704297|Acetaminophen|acetaminophen|mesh-list
101487749|NCT04704297|Ibuprofen|ibuprofen|mesh-list
101487750|NCT04704297|Ketorolac|ketorolac|mesh-list
101487751|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101487752|NCT04704297|Amitriptyline|amitriptyline|mesh-list
101487753|NCT04704297|Bupivacaine|bupivacaine|mesh-list
101487754|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
101487756|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
101487817|NCT00328718|Montelukast|montelukast|mesh-list
101487818|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101487819|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101487820|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
101487821|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101487822|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487885|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101487886|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101487887|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487888|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487889|NCT02957643|Iron|iron|mesh-list
101487952|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101487953|NCT00434031|Trastuzumab|trastuzumab|mesh-list
101487954|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101487955|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
101487956|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487957|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101487958|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101487959|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
101487960|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487961|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101487962|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101487963|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
101487964|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
101487965|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
101487966|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101487967|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101487968|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101487969|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487970|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101487971|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
101487972|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101487973|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487974|NCT01050543|Neostigmine|neostigmine|mesh-list
101487975|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101487976|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101487977|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101487978|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
101487979|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101487980|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487981|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101487991|NCT00329381|Omalizumab|omalizumab|mesh-list
101487993|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101487994|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101487995|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
101487996|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
101487997|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101487998|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
101487999|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101488000|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
101488001|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488005|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488007|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
101488008|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488009|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488010|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488011|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488012|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
101418104|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418105|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418106|NCT00153192|Dronabinol|dronabinol|mesh-list
101418107|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
101418108|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418109|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418143|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101418144|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101418145|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
101488013|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101488014|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488015|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488043|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101488044|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101488045|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488046|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101488047|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101488110|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101488111|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101488112|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101488113|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101488114|NCT00430170|Dipyridamole|dipyridamole|mesh-list
101488176|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101488177|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488251|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
101488252|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488253|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488254|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101488255|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
101488320|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488393|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
101488394|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488395|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101488396|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
101488397|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
101488398|NCT00431145|Vitamins|vitamins|mesh-ancestor
101488399|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
101488400|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488401|NCT00331487|Pioglitazone|pioglitazone|mesh-list
101488402|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
101488403|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101488404|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488405|NCT00331526|Aldesleukin|aldesleukin|mesh-list
101488406|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488407|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488455|NCT00331955|Doxorubicin|doxorubicin|mesh-list
101488456|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101488457|NCT00331955|Vorinostat|vorinostat|mesh-list
101488458|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101488459|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488465|NCT00331994|Metronidazole|metronidazole|mesh-list
101488526|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101488527|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488528|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488529|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
101488530|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101488531|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101488532|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101488533|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101488591|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488592|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
101488593|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488594|NCT00332774|Ketorolac|ketorolac|mesh-list
101488595|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101488596|NCT00332774|Nepafenac|nepafenac|mesh-list
101488597|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101488598|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101488599|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101488600|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101488603|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488604|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488605|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488606|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488607|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101488608|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488609|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488611|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488612|NCT00332852|Letrozole|letrozole|mesh-list
101488613|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488614|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101488616|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488641|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
101488642|NCT00333008|Rituximab|rituximab|mesh-list
101488643|NCT00333008|Vincristine|vincristine|mesh-list
101488644|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488645|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
101488646|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488647|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488708|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101488709|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101488710|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101488711|NCT00333164|Cilostazol|cilostazol|mesh-list
101488712|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101488713|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
101488714|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488774|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101488775|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488776|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101488784|NCT00333632|Fentanyl|fentanyl|mesh-list
101488846|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101488847|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101488848|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
101488849|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488850|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488851|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101488914|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101488987|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101488988|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
101488989|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
101488990|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
101488991|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101488992|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
101488994|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101488995|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
101488996|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101488997|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101489051|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101489053|NCT00334763|Paclitaxel|paclitaxel|mesh-list
101489054|NCT00334763|Bevacizumab|bevacizumab|mesh-list
101489055|NCT00334763|Carboplatin|carboplatin|mesh-list
101489056|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101489057|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489119|NCT00436839|Prednisone|prednisone|mesh-list
101489120|NCT00436839|Docetaxel|docetaxel|mesh-list
101489121|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
101489122|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489123|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101489124|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101489125|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101489126|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489127|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101489128|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
101489129|NCT00436839|Hormones|hormones|mesh-ancestor
101489130|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489131|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489132|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101489133|NCT00436839|Analgesics|analgesics|mesh-ancestor
101489134|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
101489135|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489136|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101418146|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418147|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418148|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101418149|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418150|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101418152|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418153|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101418154|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
101418155|NCT00136565|Hormones|hormones|mesh-ancestor
101418156|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418157|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101418158|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101418159|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
101418160|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418161|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418162|NCT00159627|Rolofylline|rolofylline|mesh-list
101418195|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418196|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
101418197|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101418198|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418199|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418200|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101418201|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101418202|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489138|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489139|NCT00335075|Temozolomide|temozolomide|mesh-list
101489140|NCT00335075|Semustine|semustine|mesh-list
101489141|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101489142|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
101489143|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489144|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489145|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
101489168|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489169|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489170|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489171|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
101489172|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
101489173|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101489174|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101489175|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
101489176|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489234|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
101489235|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101489236|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101489308|NCT00437814|Analgesics|analgesics|mesh-ancestor
101489309|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
101489310|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489311|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418203|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418204|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418205|NCT00136994|Ziprasidone|ziprasidone|mesh-list
101418206|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101418207|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
101418255|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101418256|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101418257|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
101418258|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101489312|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101489313|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101489314|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
101489374|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489375|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489376|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101489378|NCT03277170|Montelukast|montelukast|mesh-list
101489444|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101489445|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101489446|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489447|NCT00336674|Insulin|insulin|mesh-list
101489448|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101489449|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489450|NCT00444522|Alprazolam|alprazolam|mesh-list
101489451|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101489454|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101489509|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489510|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101489511|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
101489512|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101489513|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101489514|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489515|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
101489516|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489517|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101489574|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101489575|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489576|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489577|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
101489578|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489579|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
101489580|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101489581|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101489582|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101489583|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101489586|NCT00444756|Lidocaine|lidocaine|mesh-list
101489636|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489637|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
101489638|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489639|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489641|NCT00337922|Abacavir|abacavir|mesh-list
101489642|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101489650|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
101489702|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
101489703|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101489704|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101489705|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101489706|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101489713|NCT00451386|Ertapenem|ertapenem|mesh-list
101489714|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101489715|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101489716|NCT00338390|Lamivudine|lamivudine|mesh-list
101489717|NCT00338390|Abacavir|abacavir|mesh-list
101489718|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
101489719|NCT00338390|Didanosine|didanosine|mesh-list
101489720|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101489721|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101489722|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489723|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489757|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489758|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
101489760|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
101489761|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
101489762|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101489763|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489764|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101489765|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101489766|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
101489767|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101489768|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489769|NCT00338624|Urological Agents|urological agents|mesh-ancestor
101489770|NCT00338780|Lamivudine|lamivudine|mesh-list
101489779|NCT00451620|Glyburide|glyburide|mesh-list
101489818|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101489819|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101489886|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101489887|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101489888|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101489889|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101489890|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101489892|NCT00446082|Hormones|hormones|mesh-ancestor
101489953|NCT00446472|Becaplermin|becaplermin|mesh-list
101489954|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
101490025|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101490027|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
101490028|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101490029|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101490097|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101490098|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
101490169|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101490170|NCT00447018|Diuretics|diuretics|mesh-ancestor
101490171|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
101490172|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490173|NCT00343070|Escitalopram|escitalopram|mesh-list
101490241|NCT00447369|Valproic Acid|valproic acid|mesh-list
101490242|NCT00447369|Analgesics|analgesics|mesh-ancestor
101490246|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
101490309|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490310|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490311|NCT00344006|Artesunate|artesunate|mesh-list
101490312|NCT00344006|Lumefantrine|lumefantrine|mesh-list
101490313|NCT00344006|Artemether|artemether|mesh-list
101490314|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101490315|NCT00344006|Dapsone|dapsone|mesh-list
101490316|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
101490317|NCT00344006|Proguanil|proguanil|mesh-list
101490318|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
101490319|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101490320|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101490321|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101490322|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490323|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
101490324|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
101490372|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101490373|NCT00447681|Fezakinumab|fezakinumab|mesh-list
101490436|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
101490437|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
101490438|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490507|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101490508|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
101490509|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490510|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490511|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
101490513|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
101490514|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490515|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101490516|NCT00454389|Ranibizumab|ranibizumab|mesh-list
101490517|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101490518|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101490519|NCT00454389|Growth Substances|growth substances|mesh-ancestor
101490520|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490568|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
101490569|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101490570|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101490571|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
101418326|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101418327|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101418328|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101418329|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101418334|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
101418395|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418396|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101418398|NCT00153933|Growth Substances|growth substances|mesh-ancestor
101418469|NCT00154050|Candesartan cilexetil|candesartan cilexetil|mesh-list
101418470|NCT00154050|Quinapril|quinapril|mesh-list
101418471|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101418472|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101418473|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101418474|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418475|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101418535|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418536|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418537|NCT00138593|Vildagliptin|vildagliptin|mesh-list
101418538|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101418539|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418540|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101418541|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
101418542|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101418544|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
101490572|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101528435|NCT01213264|Anesthetics|anesthetics|mesh-list
101490573|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490587|NCT00448383|Adalimumab|adalimumab|mesh-list
101490634|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
101490635|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101490636|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
101490706|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101490707|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101490708|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101490709|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101490710|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490711|NCT00346463|Allopurinol|allopurinol|mesh-list
101490712|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
101490713|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490714|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490715|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
101490716|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490717|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101490718|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
101490719|NCT00346463|Protective Agents|protective agents|mesh-ancestor
101490720|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490769|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101490770|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490771|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418595|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101418596|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101418597|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101418598|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101418664|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
101418665|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101418666|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101418667|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101418733|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101418735|NCT00139256|Betamethasone|betamethasone|mesh-list
101418808|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
101418809|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
101418810|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490772|NCT02273817|Ciclesonide|ciclesonide|mesh-list
101490773|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
101490774|NCT02273817|Hormones|hormones|mesh-ancestor
101490775|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490776|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490777|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101490778|NCT00346853|Fomepizole|fomepizole|mesh-list
101490779|NCT00346853|Antidotes|antidotes|mesh-ancestor
101490780|NCT00346853|Protective Agents|protective agents|mesh-ancestor
101490781|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490791|NCT00346970|Vitamins|vitamins|mesh-ancestor
101490824|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
101490825|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490826|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490827|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101490828|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101490829|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101490830|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490831|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490833|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101490834|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101490835|NCT00455286|Prednisolone|prednisolone|mesh-list
101490836|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
101490837|NCT00455286|Methotrexate|methotrexate|mesh-list
101490883|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101490884|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101490885|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101490886|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101490887|NCT00347399|Growth Substances|growth substances|mesh-ancestor
101490888|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490889|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
101490890|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101490891|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490892|NCT00455442|Mifepristone|mifepristone|mesh-list
101490893|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101490894|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
101490895|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101490896|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101490897|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101490898|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101490899|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101490900|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
101490901|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101490902|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101490903|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
101418876|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101418877|NCT00406380|Growth Substances|growth substances|mesh-ancestor
101418878|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418879|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
101418880|NCT00406497|Difluprednate|difluprednate|mesh-list
101418881|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
101418882|NCT00406497|Hormones|hormones|mesh-ancestor
101418883|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101418884|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101418885|NCT00161655|Etanercept|etanercept|mesh-list
101418886|NCT00161655|Methotrexate|methotrexate|mesh-list
101418887|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101418888|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
101418889|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101419011|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101419012|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101419013|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101419014|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101419015|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101419016|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101419017|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
101419079|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101419080|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419081|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419082|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
101490904|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101490905|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
101490906|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101490907|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101490908|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
101490909|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101490910|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
101490925|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490926|NCT00347750|Lopinavir|lopinavir|mesh-list
101490927|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101490928|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101490929|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
101490930|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490931|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490994|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101490995|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101490996|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101490997|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
101490998|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491007|NCT00455832|Ribavirin|ribavirin|mesh-list
101491065|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491066|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491067|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491068|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
101491069|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491070|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
101491071|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491072|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491073|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491074|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101491075|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
101491077|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101491079|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
101491080|NCT00348413|Methotrexate|methotrexate|mesh-list
101491081|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101491082|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
101491083|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101491084|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
101491085|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101491086|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491087|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101491088|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
101491089|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491090|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491091|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491092|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491093|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101491099|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
101491109|NCT00348452|Celecoxib|celecoxib|mesh-list
101491110|NCT00348452|Tramadol|tramadol|mesh-list
101491111|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101491112|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101491113|NCT00348452|Analgesics|analgesics|mesh-ancestor
101491114|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
101491115|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101491116|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491117|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101491118|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491119|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101491120|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101491121|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491122|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491123|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101491124|NCT00348452|Narcotics|narcotics|mesh-ancestor
101491125|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491126|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101491127|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
101491128|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101491129|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101491130|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101491131|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101491132|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491158|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491159|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
101491160|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
101491161|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
101491162|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101491163|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491164|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491224|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101491226|NCT00348998|Goserelin|goserelin|mesh-list
101491227|NCT00348998|Bicalutamide|bicalutamide|mesh-list
101491228|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101491229|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491230|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491231|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491232|NCT00348998|Growth Substances|growth substances|mesh-ancestor
101491233|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491234|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491235|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101491236|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
101491237|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
101491238|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101491239|NCT00449553|Metformin|metformin|mesh-list
101491240|NCT00449553|Pioglitazone|pioglitazone|mesh-list
101491241|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491242|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491243|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
101491244|NCT00349076|Fluorouracil|fluorouracil|mesh-list
101491245|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491246|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
101491247|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491250|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
101491251|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491253|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491254|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
101491267|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101491268|NCT00456339|Prednisolone|prednisolone|mesh-list
101491338|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
101491339|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491340|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101491341|NCT00349739|Anecortave|anecortave|mesh-list
101491411|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101491412|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491413|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
101491414|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491415|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491416|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101491417|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101491418|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491419|NCT00350441|Urological Agents|urological agents|mesh-ancestor
101491420|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101491421|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
101491422|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101491423|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101491470|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491471|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101491472|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101491473|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491474|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491475|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101491476|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101491477|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491479|NCT00421538|Calcium|calcium|mesh-list
101491480|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101491481|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491530|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491532|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
101491533|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491534|NCT00450645|Heparin|heparin|mesh-list
101491602|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491603|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491609|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
101491674|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491675|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491676|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101491677|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101491678|NCT00352742|Growth Substances|growth substances|mesh-ancestor
101491679|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491680|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
101491681|NCT00352859|Interferons|interferons|mesh-list
101491682|NCT00352859|Gemcitabine|gemcitabine|mesh-list
101491683|NCT00352859|Sorafenib|sorafenib|mesh-list
101491684|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101491685|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
101491686|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491687|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491688|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
101491689|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101491690|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101491691|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491692|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
101491693|NCT00105183|Antibodies|antibodies|mesh-list
101491694|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
101491695|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101491696|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101491697|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
101491698|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101491699|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
101491700|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419083|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101419084|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
101419087|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
101419147|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419148|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101419149|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101419150|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419151|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101419152|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101419153|NCT00140894|Analgesics|analgesics|mesh-ancestor
101419154|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
101419155|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101419156|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101491701|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491705|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491707|NCT00466128|Indomethacin|indomethacin|mesh-list
101491716|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
101491717|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
101491718|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101491719|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101491785|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
101491786|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491787|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
101491788|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491789|NCT00466596|Protective Agents|protective agents|mesh-ancestor
101491790|NCT00353678|Darexaban|darexaban|mesh-list
101491791|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101491792|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
101491793|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101491794|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
101491795|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491796|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491797|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
101491798|NCT00458250|Cyclosporine|cyclosporine|mesh-list
101491799|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
101491800|NCT00458250|Busulfan|busulfan|mesh-list
101491801|NCT00458250|Methotrexate|methotrexate|mesh-list
101491802|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
101491803|NCT00458250|Cyclosporins|cyclosporins|mesh-list
101491804|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491805|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
101491806|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491817|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
101491839|NCT00466791|Methylphenidate|methylphenidate|mesh-list
101491840|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101491841|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491842|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101491843|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101491844|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101491845|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491846|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
101491847|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491848|NCT00353912|Amlodipine|amlodipine|mesh-list
101491849|NCT00353912|Valsartan|valsartan|mesh-list
101491850|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101491851|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101491852|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101491853|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491854|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101491855|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491856|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491857|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101419157|NCT00155064|Losartan|losartan|mesh-list
101419211|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419212|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419213|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101419215|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101419216|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
101419217|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101419218|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
101419273|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419274|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419275|NCT00141245|Pregabalin|pregabalin|mesh-list
101419276|NCT00141245|Analgesics|analgesics|mesh-ancestor
101419342|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
101419343|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419413|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
101419414|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
101419415|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101419487|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101419488|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101419489|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491858|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101491859|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
101491860|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101491861|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491862|NCT00458328|Z 338|z 338|mesh-list
101491863|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101491864|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101491865|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491866|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
101491867|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101491868|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101491870|NCT00354068|Temozolomide|temozolomide|mesh-list
101491879|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
101491880|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
101491956|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101491957|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491958|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101491959|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101492025|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101492026|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101492027|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101492098|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101492099|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101492100|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
101492101|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492102|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
101492103|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
101492104|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101492156|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101492157|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101492158|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101492159|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101492227|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
101419556|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101419557|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101419628|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419630|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
101419632|NCT00505492|Paclitaxel|paclitaxel|mesh-list
101419700|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
101419701|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419703|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101419773|NCT02275897|Methamphetamine|methamphetamine|mesh-list
101419774|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101419775|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419776|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
101419777|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
101419778|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419779|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
101419780|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101419781|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419782|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
101419783|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101492230|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101492231|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492232|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492299|NCT00468351|Hormones|hormones|mesh-ancestor
101492300|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101492301|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492302|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
101492303|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492304|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492305|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101492306|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492307|NCT00468429|Bevacizumab|bevacizumab|mesh-list
101492308|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492361|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492362|NCT00426998|Bevacizumab|bevacizumab|mesh-list
101492363|NCT00426998|Verteporfin|verteporfin|mesh-list
101492364|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492365|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492366|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101492367|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101492368|NCT00426998|Growth Substances|growth substances|mesh-ancestor
101492369|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492370|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
101492371|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101492372|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
101492374|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101492422|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101492423|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492424|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101492425|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
101492426|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492427|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
101492428|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101492429|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101419784|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101419785|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101419786|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101419787|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
101419788|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
101419789|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
101419790|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101419830|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419831|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419832|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101419833|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419835|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101419836|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101419896|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
101419897|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101419898|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
101419899|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101419900|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
101419901|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101419902|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101419903|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
101492430|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
101492431|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101492432|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101492433|NCT00427388|Prednisolone|prednisolone|mesh-list
101492434|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
101492482|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
101492483|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492484|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492485|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492624|NCT00469404|Buprenorphine|buprenorphine|mesh-list
101492625|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101492626|NCT00469404|Narcotics|narcotics|mesh-ancestor
101492627|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492628|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492629|NCT00469404|Analgesics|analgesics|mesh-ancestor
101492630|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
101492631|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492632|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101492633|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
101492634|NCT00460785|Narcotics|narcotics|mesh-ancestor
101492635|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101492636|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492637|NCT00460785|Analgesics|analgesics|mesh-ancestor
101492638|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
101492639|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492640|NCT01054976|Galantamine|galantamine|mesh-list
101492641|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101492642|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492643|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492644|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
101492645|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101492679|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
101492680|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101492681|NCT00428909|Analgesics|analgesics|mesh-ancestor
101492682|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
101492683|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492684|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492685|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
101492686|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492687|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492688|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492689|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492690|NCT00429065|Rituximab|rituximab|mesh-list
101492691|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101492742|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
101492743|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492744|NCT00430001|Docetaxel|docetaxel|mesh-list
101492745|NCT00430001|Trastuzumab|trastuzumab|mesh-list
101492746|NCT00430001|Vinorelbine|vinorelbine|mesh-list
101492747|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492748|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
101492749|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
101492750|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
101492751|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492755|NCT00430079|Imidazole|imidazole|mesh-list
101492810|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
101492880|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101492882|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101492883|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101492884|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101492946|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492947|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101492948|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
101492949|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101492950|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101492951|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492952|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492953|NCT00431054|Docetaxel|docetaxel|mesh-list
101492954|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101492955|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101492956|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101492957|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101492958|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492959|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
101492960|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
101492961|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493003|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101493004|NCT00462111|Indomethacin|indomethacin|mesh-list
101493006|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101493075|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101493076|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
101493147|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493149|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101493150|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493151|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493152|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101493153|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101493215|NCT00463008|Methotrexate|methotrexate|mesh-list
101493216|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101493217|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
101493218|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101493219|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493220|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101493221|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
101493222|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493223|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493224|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
101493225|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493226|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101493227|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101493228|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
101493229|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101493230|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101493231|NCT00463086|Isoniazid|isoniazid|mesh-list
101493237|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
101493270|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101493271|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493272|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493273|NCT00471549|Simvastatin|simvastatin|mesh-list
101493274|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101493275|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101493276|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
101493277|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493278|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101493280|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493333|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176998|NCT01848054|Naloxone|naloxone|mesh-list
101493334|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
101493335|NCT00471627|Pancrelipase|pancrelipase|mesh-list
101493336|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493337|NCT00432887|Caffeine|caffeine|mesh-list
101493338|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101493339|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493340|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101493341|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493397|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493399|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
101493400|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493401|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101493402|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101493403|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101493404|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101493405|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493406|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177071|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
101493457|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493459|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
101493460|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101493461|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
101493462|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493463|NCT00463671|Protective Agents|protective agents|mesh-ancestor
101493464|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493524|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
101493525|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493526|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101493527|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101493528|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101493529|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493530|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101493531|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101493649|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
101493650|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101493651|NCT01050764|Vidarabine|vidarabine|mesh-list
101493720|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101493721|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101493722|NCT01050530|Tolvaptan|tolvaptan|mesh-list
101493723|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101493724|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493725|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
101493785|NCT00464958|Analgesics|analgesics|mesh-ancestor
101493786|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
101493787|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101493788|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493857|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
101493858|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101493859|NCT00465036|Cathartics|cathartics|mesh-ancestor
101493860|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493861|NCT04702061|Anesthetics|anesthetics|mesh-list
101493862|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101493863|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101493864|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
101493865|NCT00465075|Estrogens|estrogens|mesh-list
101493866|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101493867|NCT00465075|Hormones|hormones|mesh-ancestor
101493868|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101493919|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101493920|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
101493921|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
101493939|NCT00435305|Vancomycin|vancomycin|mesh-list
101493991|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493993|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101494064|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494065|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101494066|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
101494067|NCT04697745|Hormones|hormones|mesh-ancestor
101494068|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101494069|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101494070|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494071|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101494072|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494073|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494074|NCT04697745|Analgesics|analgesics|mesh-ancestor
101494075|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
101494076|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101494077|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101494079|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
101494080|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494121|NCT00436787|Fondaparinux|fondaparinux|mesh-list
101494122|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101494123|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
101494124|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101494125|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
101494128|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
101494188|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
101494189|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101494261|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101494262|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494263|NCT00437957|Temozolomide|temozolomide|mesh-list
101494332|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101494333|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101494334|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494335|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494402|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101494403|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101494404|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494415|NCT00474591|PENTA|penta|mesh-list
101494471|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494473|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101494474|NCT00475098|Dalteparin|dalteparin|mesh-list
101494475|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
101494476|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101494477|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101494479|NCT00475137|Lamotrigine|lamotrigine|mesh-list
101494540|NCT00475410|Coagulants|coagulants|mesh-ancestor
101494541|NCT00475527|Amoxicillin|amoxicillin|mesh-list
101494542|NCT00475527|Metronidazole|metronidazole|mesh-list
101494543|NCT00475527|Clarithromycin|clarithromycin|mesh-list
101494544|NCT00475527|Omeprazole|omeprazole|mesh-list
101494545|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101494557|NCT00439049|Naltrexone|naltrexone|mesh-list
101494610|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101494611|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
101494612|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101494613|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494614|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101494615|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
101494678|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101494679|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101494680|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101494681|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101494682|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101494683|NCT00476034|Analgesics|analgesics|mesh-ancestor
101494684|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
101494685|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494742|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494743|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101494814|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101494815|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494816|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101494817|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101494818|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
101494819|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
101494820|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101494821|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101494822|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101494879|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101494880|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101494881|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101495025|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495026|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495027|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101495028|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101495029|NCT00476853|Nevirapine|nevirapine|mesh-list
101495030|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101495031|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101495032|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495033|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495034|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
101495035|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495036|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495086|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495087|NCT00439062|Roxithromycin|roxithromycin|mesh-list
101495088|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495089|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495090|NCT02957162|Atorvastatin|atorvastatin|mesh-list
101495091|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101495093|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
101495094|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495095|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101495096|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101495097|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495098|NCT00441740|Gemcitabine|gemcitabine|mesh-list
101495099|NCT00441740|Docetaxel|docetaxel|mesh-list
101495146|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495147|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
101495148|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101495149|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
101495150|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495216|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495217|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495218|NCT00442403|Chloroquine|chloroquine|mesh-list
101495219|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101495220|NCT00442403|Amebicides|amebicides|mesh-ancestor
101495221|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101495222|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101495223|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495224|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
101495225|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495280|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495281|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495282|NCT00477984|Ethanol|ethanol|mesh-list
101495283|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101495284|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495285|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495286|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495288|NCT00478101|Oxycodone|oxycodone|mesh-list
101495289|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101495290|NCT00478101|Narcotics|narcotics|mesh-ancestor
101495291|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495292|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495300|NCT00440076|Bortezomib|bortezomib|mesh-list
101179017|NCT02271906|Afatinib|afatinib|mesh-list
101495342|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101495343|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101495344|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101495345|NCT00443222|Infliximab|infliximab|mesh-list
101495346|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101495410|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101495411|NCT00440661|Diacerein|diacerein|mesh-list
101495412|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495413|NCT03278444|Trimetazidine|trimetazidine|mesh-list
101495414|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
101495415|NCT00440739|Etoricoxib|etoricoxib|mesh-list
101495416|NCT00440739|Flavoxate|flavoxate|mesh-list
101495417|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101495419|NCT00440739|Analgesics|analgesics|mesh-ancestor
101495420|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
101495477|NCT00440973|Analgesics|analgesics|mesh-ancestor
101495478|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
101495479|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101419905|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101419906|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101419907|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101419908|NCT00142571|Gemcitabine|gemcitabine|mesh-list
101419909|NCT00142571|Docetaxel|docetaxel|mesh-list
101419910|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101419911|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
101419956|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101419957|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
101419958|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101419959|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420024|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101420025|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101420026|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420095|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
101420097|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101495549|NCT00478959|Growth Substances|growth substances|mesh-ancestor
101495550|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495551|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495552|NCT00444236|Esomeprazole|esomeprazole|mesh-list
101495553|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101495554|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101495555|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101495556|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495557|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495616|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495617|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101495618|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
101495619|NCT00444314|Sunitinib|sunitinib|mesh-list
101495620|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495621|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101495622|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101495623|NCT00444314|Growth Substances|growth substances|mesh-ancestor
101495624|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495625|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
101495626|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101495627|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495629|NCT02274051|Kinetin|kinetin|mesh-list
101495630|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
101495631|NCT02274051|Growth Substances|growth substances|mesh-ancestor
101495632|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495633|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
101495634|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101495635|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101495636|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495637|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
101495638|NCT00444470|Coagulants|coagulants|mesh-ancestor
101495639|NCT00444548|Reboxetine|reboxetine|mesh-list
101495640|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
101495649|NCT00444665|Travoprost|travoprost|mesh-list
101495664|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101495665|NCT00479661|Analgesics|analgesics|mesh-ancestor
101495666|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
101495667|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495668|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101495669|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101495670|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101495671|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
101495672|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101495673|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495674|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101495730|NCT00479739|Budesonide|budesonide|mesh-list
101495731|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
101495732|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101495733|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101495734|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101495735|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
101495736|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101495737|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495738|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101495739|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
101495740|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
101495741|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101495742|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
101495743|NCT00479739|Hormones|hormones|mesh-ancestor
101495791|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101495792|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
101495794|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101495795|NCT03279120|Tenofovir|tenofovir|mesh-list
101495796|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
101495797|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
101495798|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101495799|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101495800|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101495801|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495802|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495803|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101495804|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101495850|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101495851|NCT00454259|Narcotics|narcotics|mesh-ancestor
101495852|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495854|NCT00454259|Analgesics|analgesics|mesh-ancestor
101495924|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
101495925|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495926|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101495927|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101495928|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101495929|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101495930|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495932|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101495933|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101495934|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495935|NCT00480246|Perphenazine|perphenazine|mesh-list
101495936|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101495937|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101495938|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101495939|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101495940|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101495941|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101495981|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
101495982|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101496125|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496127|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101496128|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496129|NCT00480597|Gemcitabine|gemcitabine|mesh-list
101496179|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496180|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101496181|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
101496182|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101496183|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101496184|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496185|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496186|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101496187|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101496188|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101496189|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101496190|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101496191|NCT00456677|Minocycline|minocycline|mesh-list
101496192|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496194|NCT00456716|Sorafenib|sorafenib|mesh-list
101496236|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101496237|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496238|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420099|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101420164|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420239|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420240|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
101420313|NCT00156312|Capecitabine|capecitabine|mesh-list
101420314|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420315|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
101420387|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420388|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420389|NCT00144287|Ritonavir|ritonavir|mesh-list
101496307|NCT02956538|Thalidomide|thalidomide|mesh-list
101496308|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101496378|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101496379|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
101496380|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496381|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101496383|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101496448|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101496449|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496450|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496451|NCT00444171|Insulin|insulin|mesh-list
101496516|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101496517|NCT01242384|Silicon|silicon|mesh-list
101496518|NCT01242384|Trace Elements|trace elements|mesh-ancestor
101496519|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
101496520|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496586|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496588|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496712|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496713|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101496714|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101496715|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101496716|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101496717|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496779|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101496780|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496781|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496782|NCT00489138|Ertapenem|ertapenem|mesh-list
101496783|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101496784|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496785|NCT00461396|Interferons|interferons|mesh-list
101496786|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
101496787|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496788|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
101496789|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496790|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101496791|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
101496792|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496842|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101496844|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
101496845|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496846|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496847|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101496848|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
101496849|NCT00461747|Hormones|hormones|mesh-ancestor
101496850|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101496851|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101496906|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
101496907|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101496908|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101496909|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101496912|NCT02893618|Diazoxide|diazoxide|mesh-list
101496977|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420460|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420461|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420462|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420463|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420531|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
101420532|NCT05141422|Efavirenz|efavirenz|mesh-list
101420533|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101420534|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101420535|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420536|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420537|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
101420538|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420539|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101420540|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101496980|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497048|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
101497049|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101497050|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101497051|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497052|NCT00463268|Vitamin D|vitamin d|mesh-list
101497053|NCT00463268|Alendronate|alendronate|mesh-list
101497054|NCT00463268|Calcium|calcium|mesh-list
101497117|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101497118|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
101497119|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497120|NCT00497328|Protective Agents|protective agents|mesh-ancestor
101497122|NCT00497328|Antidotes|antidotes|mesh-ancestor
101497187|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101497188|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497189|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
101497190|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101497191|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101497192|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101497193|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101497254|NCT00497601|Amebicides|amebicides|mesh-ancestor
101497255|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101497256|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101497257|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497258|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497259|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
101497260|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101497261|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101497262|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101497263|NCT00466388|Cevimeline|cevimeline|mesh-list
101497264|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101497265|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
101497266|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497267|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497268|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101497269|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101497270|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
101497313|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101497314|NCT00464165|Rimonabant|rimonabant|mesh-list
101497315|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101497316|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
101497317|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101497318|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101497319|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497320|NCT00464165|Hormones|hormones|mesh-ancestor
101497321|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497322|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497375|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497376|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497448|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497449|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
101497450|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101497451|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
101497452|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497517|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497520|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101497521|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
101497522|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
101497523|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
101497524|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101497525|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497583|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497584|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
101497585|NCT01327495|Testosterone|testosterone|mesh-list
101497586|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
101497587|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
101497588|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101497589|NCT01327495|Acyline|acyline|mesh-list
101497590|NCT01327495|Androgens|androgens|mesh-ancestor
101497591|NCT01327495|Hormones|hormones|mesh-ancestor
101497592|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101497593|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497650|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101497651|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
101497652|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497720|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101497721|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497722|NCT03272009|Interferons|interferons|mesh-list
101497723|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
101497724|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
101497725|NCT03272009|Entecavir|entecavir|mesh-list
101497726|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101497727|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497728|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
101497729|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497730|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
101497731|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497732|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101497733|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101497783|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497784|NCT00492102|Montelukast|montelukast|mesh-list
101497785|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101497786|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
101497852|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101497853|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101497854|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101497855|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497856|NCT02955810|Dexamethasone|dexamethasone|mesh-list
101497857|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
101497858|NCT02955810|Bortezomib|bortezomib|mesh-list
101497859|NCT02955810|Daratumumab|daratumumab|mesh-list
101497860|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497861|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
101497862|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497863|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101497870|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
101497914|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
101497915|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497916|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
101497917|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101497987|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497988|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
101497989|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101497990|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101497991|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101497992|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101497993|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
101497994|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101497995|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101497996|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101497997|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101497998|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
101497999|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498044|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
101498045|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498046|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
101498047|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101498055|NCT00465452|Dopamine|dopamine|mesh-list
101498116|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498117|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101498118|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101498186|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101498187|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101498188|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101498189|NCT00473720|Paclitaxel|paclitaxel|mesh-list
101498190|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101498255|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
101498256|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498257|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498258|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101498260|NCT00473915|Xhance|xhance|mesh-list
101498261|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101498263|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
101498264|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101498265|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498266|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101498267|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498318|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101498319|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498320|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498321|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101498322|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101498323|NCT01365481|Amlodipine|amlodipine|mesh-list
101498324|NCT01365481|Valsartan|valsartan|mesh-list
101498325|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101498326|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498327|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101498328|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101498329|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498330|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101498380|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101498381|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
101498458|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
101498531|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101498532|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101498533|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101498534|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498535|NCT00500604|Diuretics|diuretics|mesh-ancestor
101498536|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
101498595|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498596|NCT01342510|Analgesics|analgesics|mesh-ancestor
101498597|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
101498598|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101498599|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101498600|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
101498601|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101498602|NCT01606345|Valrubicin|valrubicin|mesh-list
101498603|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498604|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101498605|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101498606|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101498656|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
101498657|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101498659|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101498660|NCT00469781|Prednisolone|prednisolone|mesh-list
101498661|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101498662|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
101498663|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101498664|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101498665|NCT00469781|Analgesics|analgesics|mesh-ancestor
101498666|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
101498719|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101498720|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101498792|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101498793|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498794|NCT00599287|Haloperidol|haloperidol|mesh-list
101498795|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
101498796|NCT00599287|Methylphenidate|methylphenidate|mesh-list
101498797|NCT00599287|Rivastigmine|rivastigmine|mesh-list
101498798|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101498799|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498800|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101498801|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101498804|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
101498855|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498857|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101498858|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101498859|NCT00469976|Bevacizumab|bevacizumab|mesh-list
101498860|NCT00469976|Carboplatin|carboplatin|mesh-list
101498861|NCT00469976|Gemcitabine|gemcitabine|mesh-list
101182515|NCT03121716|Cisplatin|cisplatin|mesh-list
101498862|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182550|NCT02708394|Olanzapine|olanzapine|mesh-list
101498918|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
101498991|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101498992|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
101498993|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101498994|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101498995|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101498996|NCT00600535|Hormones|hormones|mesh-ancestor
101498997|NCT00600691|Finasteride|finasteride|mesh-list
101498998|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101498999|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101499000|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499001|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499002|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499006|NCT00623077|Etoposide|etoposide|mesh-list
101499051|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499052|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101499053|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499054|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499120|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
101499121|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499122|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499123|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101499188|NCT00601510|Capecitabine|capecitabine|mesh-list
101499189|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
101499190|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499191|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499192|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
101499193|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499194|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101499195|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499196|NCT00601588|Sertraline|sertraline|mesh-list
101499197|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
101499198|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101499199|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101499200|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499201|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499202|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499203|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499204|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
101499205|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499206|NCT00601666|Zolpidem|zolpidem|mesh-list
101499216|NCT01246362|Etoricoxib|etoricoxib|mesh-list
101499241|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101499242|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
101499312|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499314|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499315|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101499316|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499317|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499318|NCT00470522|Folic Acid|folic acid|mesh-list
101499382|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499383|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
101499384|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101499385|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499386|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
101499387|NCT00493545|Poly ICLC|poly iclc|mesh-list
101499388|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
101499389|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
101499450|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499451|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101183116|NCT02908620|Anesthetics|anesthetics|mesh-list
101499452|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499453|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499454|NCT00476216|Fondaparinux|fondaparinux|mesh-list
101499462|NCT00471185|Acyline|acyline|mesh-list
101499517|NCT00494247|Antibodies|antibodies|mesh-list
101499518|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
101499519|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499520|NCT00471419|Rimexolone|rimexolone|mesh-list
101499521|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
101499522|NCT00471419|Hormones|hormones|mesh-ancestor
101499523|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499524|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499525|NCT01325350|Bimatoprost|bimatoprost|mesh-list
101499528|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101499529|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
101499531|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
101499532|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101499533|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101499534|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499535|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499536|NCT01324999|Urological Agents|urological agents|mesh-ancestor
101499576|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
101499577|NCT01324141|Protective Agents|protective agents|mesh-ancestor
101499578|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101499579|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101499580|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101499581|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101499582|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101499583|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499584|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101499585|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101499586|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101499588|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
101499635|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
101499636|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499637|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499638|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101499639|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
101499640|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
101499642|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499643|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499644|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499645|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101499646|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101499647|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101499648|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
101499649|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101499651|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101499692|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
101499693|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
101499694|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101499695|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101499696|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499697|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101499698|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
101499699|NCT00494715|Valsartan|valsartan|mesh-list
101499700|NCT00494715|Benazepril|benazepril|mesh-list
101499701|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101499702|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101499703|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101499704|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499705|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101499706|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
101499707|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499708|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101499709|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101499710|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420541|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101420542|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101499746|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499747|NCT01323790|Naloxegol|naloxegol|mesh-list
101183412|NCT03036384|Prilocaine|prilocaine|mesh-list
101499748|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101499749|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499750|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
101499751|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499752|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
101499813|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101499814|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101499815|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101499816|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
101499817|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499818|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499819|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101499820|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101499823|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101499875|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499877|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499878|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499879|NCT04325581|Incretins|incretins|mesh-ancestor
101499880|NCT04325581|Hormones|hormones|mesh-ancestor
101499881|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499882|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
101499883|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101499884|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499885|NCT01322386|Vancomycin|vancomycin|mesh-list
101499886|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101499887|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101499888|NCT00495066|Ipilimumab|ipilimumab|mesh-list
101499890|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499936|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499937|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499938|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101499939|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499940|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
101499941|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
101499942|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499943|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499944|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101499945|NCT01244334|Protective Agents|protective agents|mesh-ancestor
101499946|NCT00477542|Clofarabine|clofarabine|mesh-list
101499947|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101499948|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
101499949|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499950|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101499951|NCT00503763|Simvastatin|simvastatin|mesh-list
101499952|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101499953|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101499955|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101499956|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101499957|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101499958|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499959|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101499960|NCT00477581|Exenatide|exenatide|mesh-list
101499961|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101499962|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499963|NCT00477581|Incretins|incretins|mesh-ancestor
101499964|NCT00477581|Hormones|hormones|mesh-ancestor
101499965|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101499966|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101499967|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
101499968|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101499975|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499976|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101499977|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
101499978|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
101499979|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101499980|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101420543|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101420544|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101420545|NCT05148637|Lidocaine|lidocaine|mesh-list
101420546|NCT05148637|Fentanyl|fentanyl|mesh-list
101420547|NCT05148637|Anesthetics|anesthetics|mesh-list
101420548|NCT05148637|Sevoflurane|sevoflurane|mesh-list
101499981|NCT00477776|Metoclopramide|metoclopramide|mesh-list
101499982|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
101499983|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
101499984|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499985|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101499986|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101499987|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101499988|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101500037|NCT01248975|Montelukast|montelukast|mesh-list
101500038|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101500039|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
101500040|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101500109|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101500110|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101500112|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500113|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500114|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500117|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500118|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
101500119|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500120|NCT01247688|Fludarabine|fludarabine|mesh-list
101500121|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
101500122|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500123|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500124|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101500125|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
101500126|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500127|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500128|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101500129|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
101500130|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101500131|NCT00478907|Ketamine|ketamine|mesh-list
101500132|NCT00478907|Thiopental|thiopental|mesh-list
101500133|NCT00478907|Propofol|propofol|mesh-list
101500139|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
101500157|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
101500158|NCT01247961|Dexamethasone|dexamethasone|mesh-list
101500159|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
101500160|NCT01247961|BB 1101|bb 1101|mesh-list
101500230|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101500305|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500306|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101500307|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500375|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
101500376|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
101500377|NCT01315249|Hormones|hormones|mesh-ancestor
101500378|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500379|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
101500380|NCT04207411|Lidocaine|lidocaine|mesh-list
101500381|NCT04207411|Bupivacaine|bupivacaine|mesh-list
101500382|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
101500383|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
101500384|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500385|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500386|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
101500387|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500438|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
101500439|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101500511|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500512|NCT04516317|Analgesics|analgesics|mesh-ancestor
101500513|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
101500514|NCT02891083|Paclitaxel|paclitaxel|mesh-list
101500515|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101500516|NCT02891083|Cisplatin|cisplatin|mesh-list
101500579|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101500581|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101500582|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500583|NCT01313221|Analgesics|analgesics|mesh-ancestor
101500594|NCT01313182|Mupirocin|mupirocin|mesh-list
101500649|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500650|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
101500651|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101500652|NCT00480389|Sorafenib|sorafenib|mesh-list
101500653|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500654|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500655|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500656|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500657|NCT04519710|Rituximab|rituximab|mesh-list
101500658|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
101500659|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101500660|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500661|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
101500662|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500663|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101500664|NCT00482027|Vaccines|vaccines|mesh-list
101500710|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500711|NCT01312129|Analgesics|analgesics|mesh-ancestor
101500786|NCT01311505|Isoniazid|isoniazid|mesh-list
101500787|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101500788|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
101500789|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101500790|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101500793|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500794|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500795|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101500821|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
101500849|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500850|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
101500851|NCT00482378|Pamidronate|pamidronate|mesh-list
101500852|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101500853|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500854|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
101500855|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101500856|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
101500857|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
101500858|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101500859|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500860|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101500861|NCT00482456|Analgesics|analgesics|mesh-ancestor
101500864|NCT00480896|Tacrolimus|tacrolimus|mesh-list
101500910|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
101500911|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101500912|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500913|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101500915|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
101500978|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500979|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101500980|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101500981|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101500982|NCT00482807|Docetaxel|docetaxel|mesh-list
101500983|NCT00482807|Goserelin|goserelin|mesh-list
101500984|NCT00482807|Bicalutamide|bicalutamide|mesh-list
101500985|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101500986|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
101500987|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
101500988|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
101500989|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101500990|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101500991|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
101500992|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
101500993|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101500995|NCT01240148|Lidocaine|lidocaine|mesh-list
101501033|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501034|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501035|NCT04517214|Gemcitabine|gemcitabine|mesh-list
101501036|NCT04517214|Capecitabine|capecitabine|mesh-list
101501037|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501038|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501039|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
101501040|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501041|NCT00483054|Efavirenz|efavirenz|mesh-list
101501042|NCT00483054|Nevirapine|nevirapine|mesh-list
101501094|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101501095|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501096|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101501098|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
101501099|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101501161|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101501162|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101501163|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501165|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101501166|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501167|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501168|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101501169|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101501170|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501171|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501172|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501173|NCT00483366|Gemcitabine|gemcitabine|mesh-list
101501174|NCT00483366|Capecitabine|capecitabine|mesh-list
101501175|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
101501178|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501220|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101501221|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
101501222|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501223|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501224|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
101501225|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101501226|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101501227|NCT00488189|Tazobactam|tazobactam|mesh-list
101501228|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101501229|NCT00488189|Piperacillin|piperacillin|mesh-list
101501230|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501231|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501282|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101501283|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501355|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101501356|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101501357|NCT00483782|Growth Substances|growth substances|mesh-ancestor
101501358|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501359|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
101501360|NCT02890771|Turmeric extract|turmeric extract|mesh-list
101501361|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
101501362|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501363|NCT02890771|Protective Agents|protective agents|mesh-ancestor
101501364|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501365|NCT01306162|Dronedarone|dronedarone|mesh-list
101501367|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
101501368|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101501369|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
101501370|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501371|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501372|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
101501373|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101501374|NCT04515732|Apremilast|apremilast|mesh-list
101501375|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101501376|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501377|NCT04515732|Analgesics|analgesics|mesh-ancestor
101501378|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
101501404|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101501405|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101501406|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501407|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101501408|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101501409|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501410|NCT04515420|Norepinephrine|norepinephrine|mesh-list
101501411|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101501412|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101501413|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501414|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501415|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501416|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501417|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
101501418|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
101501419|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501420|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101501421|NCT00488540|Acetaminophen|acetaminophen|mesh-list
101501422|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101501423|NCT00488540|Analgesics|analgesics|mesh-ancestor
101501424|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
101501425|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501427|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
101501454|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501455|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501456|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101501457|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101501458|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
101501459|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501460|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501462|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
101501463|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101501464|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101501465|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101501466|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101501467|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
101501468|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101501509|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101501510|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501511|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101501512|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101501513|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101501514|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501516|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101501576|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
101501577|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501578|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501579|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101501580|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101501581|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101501582|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501583|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501584|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501641|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101501642|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501643|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101501644|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
101501645|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
101501646|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101501647|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101501648|NCT04514796|Adalimumab|adalimumab|mesh-list
101501649|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101501650|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101501651|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101501652|NCT00488969|Morphine|morphine|mesh-list
101501660|NCT00484692|Bupropion|bupropion|mesh-list
101501702|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501703|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101501704|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
101501705|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
101501706|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
101501707|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501708|NCT00484640|Warfarin|warfarin|mesh-list
101501709|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
101501710|NCT00489164|Sirolimus|sirolimus|mesh-list
101501711|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101501712|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101501713|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101501714|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101501764|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501766|NCT01241409|Rabeprazole|rabeprazole|mesh-list
101501835|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501836|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
101185513|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101501837|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
101528439|NCT04657107|Esketamine|esketamine|mesh-list
101501838|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101501839|NCT00485030|Sirolimus|sirolimus|mesh-list
101501840|NCT00485030|Everolimus|everolimus|mesh-list
101501841|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101501842|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101501843|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101501844|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101501846|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
101501896|NCT04513509|Verapamil|verapamil|mesh-list
101501897|NCT04513509|Nebivolol|nebivolol|mesh-list
101501898|NCT04513509|Bisoprolol|bisoprolol|mesh-list
101501899|NCT04513509|Diltiazem|diltiazem|mesh-list
101501900|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101501901|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101501902|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
101501903|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101501905|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101501906|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101501907|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101501908|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
101501909|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
101501910|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
101501911|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101501955|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502027|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502029|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101502030|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101502031|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
101502032|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502033|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502034|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502035|NCT01302067|Urological Agents|urological agents|mesh-ancestor
101502036|NCT00485550|Methylphenidate|methylphenidate|mesh-list
101502037|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502038|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101502039|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502040|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101502044|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
101502084|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
101502085|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502086|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101502087|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101502088|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101502089|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502090|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
101502092|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502093|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502094|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101502095|NCT00505947|Infliximab|infliximab|mesh-list
101502096|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101502097|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502098|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
101502099|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502100|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502101|NCT00489983|Gemcitabine|gemcitabine|mesh-list
101502102|NCT00489983|Pemetrexed|pemetrexed|mesh-list
101502103|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502104|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
101502105|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502106|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502107|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502108|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101502109|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101502110|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
101502111|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101502112|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
101502113|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502114|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502115|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101502116|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
101502117|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502122|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101502123|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502124|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101502125|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
101502126|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502127|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101502128|NCT00485771|Lamotrigine|lamotrigine|mesh-list
101420549|NCT05148637|Desflurane|desflurane|mesh-list
101420550|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
101420551|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420552|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502129|NCT00485771|Olanzapine|olanzapine|mesh-list
101502187|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502188|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502189|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502190|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502191|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502194|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101502195|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502196|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502197|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502198|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502199|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502201|NCT00485888|Escitalopram|escitalopram|mesh-list
101502202|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101185885|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
101502203|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502204|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502205|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502206|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502207|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
101502208|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502209|NCT00485862|Sertraline|sertraline|mesh-list
101502210|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502211|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502212|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502213|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502218|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
101502226|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
101502227|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502228|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502229|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101502230|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502231|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502232|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502233|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502234|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101502235|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502236|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502237|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502238|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502239|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
101502284|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502285|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101502286|NCT00486083|Methylphenidate|methylphenidate|mesh-list
101502287|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502288|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101502289|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502290|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101502291|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502292|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502293|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502294|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
101502295|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502296|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101502297|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502298|NCT00490685|Sorafenib|sorafenib|mesh-list
101502299|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502300|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101502301|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502302|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502303|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502304|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101420553|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
101420554|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420555|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101420556|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101420557|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101420558|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420559|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420560|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101420561|NCT05148637|Narcotics|narcotics|mesh-ancestor
101420562|NCT05148637|Analgesics|analgesics|mesh-ancestor
101420563|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101420564|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101420565|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
101502305|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101502306|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101502307|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502308|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502309|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502310|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502311|NCT04511715|Bevacizumab|bevacizumab|mesh-list
101502325|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101502326|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
101502327|NCT00490880|Gemcitabine|gemcitabine|mesh-list
101502328|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502395|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502396|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502397|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101502398|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101502400|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502401|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
101502402|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502403|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502404|NCT00486564|Nifurtimox|nifurtimox|mesh-list
101502405|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101502406|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101502407|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101502408|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502409|NCT00486668|Paclitaxel|paclitaxel|mesh-list
101502410|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
101502411|NCT00486668|Doxorubicin|doxorubicin|mesh-list
101502412|NCT00486668|Trastuzumab|trastuzumab|mesh-list
101502413|NCT00486668|Lapatinib|lapatinib|mesh-list
101502414|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101502415|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101502416|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
101502417|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
101502418|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
101502443|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502444|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502445|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101502446|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502447|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502448|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101502449|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502450|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502451|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101502452|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101502453|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101502503|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502504|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502505|NCT00491348|Analgesics|analgesics|mesh-ancestor
101502506|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
101502507|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502508|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
101502509|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101502510|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
101502511|NCT01242098|Fluticasone|fluticasone|mesh-list
101502512|NCT01242098|Beclomethasone|beclomethasone|mesh-list
101502513|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
101502514|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101502515|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502516|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101502517|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
101502518|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502519|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502520|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101502521|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
101502522|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
101502523|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101502524|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101502555|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101502556|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101502557|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502560|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
101502561|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502562|NCT01300819|Rotigotine|rotigotine|mesh-list
101502563|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
101502564|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
101502565|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502566|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502567|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502568|NCT00486980|Peramivir|peramivir|mesh-list
101502614|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
101502615|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101502616|NCT00487032|Protective Agents|protective agents|mesh-ancestor
101502621|NCT00491426|Metronidazole|metronidazole|mesh-list
101502685|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101502760|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101502762|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502763|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502764|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502765|NCT04697355|Beta Carotene|beta carotene|mesh-list
101502766|NCT04697355|Naringenin|naringenin|mesh-list
101502767|NCT04697355|Carotenoids|carotenoids|mesh-list
101502828|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502829|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101502830|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101502831|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101502832|NCT00506298|Analgesics|analgesics|mesh-ancestor
101502833|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
101502834|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101502835|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101502836|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101502837|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101502838|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101502839|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101502840|NCT01242215|Glimepiride|glimepiride|mesh-list
101502841|NCT01242215|Gliclazide|gliclazide|mesh-list
101502842|NCT01242215|Glyburide|glyburide|mesh-list
101502843|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
101502886|NCT00492128|Diuretics|diuretics|mesh-ancestor
101502887|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
101502888|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101502889|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
101502890|NCT00487734|Testosterone|testosterone|mesh-list
101502891|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
101502892|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
101502893|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101502894|NCT00487734|Androgens|androgens|mesh-ancestor
101502896|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101502900|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
101502950|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101502951|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101502952|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
101502953|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101502954|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101502956|NCT01299961|Abatacept|abatacept|mesh-list
101503018|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503019|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503020|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101503021|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503022|NCT00487799|Diuretics|diuretics|mesh-ancestor
101503023|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
101503024|NCT05149170|Antibodies|antibodies|mesh-list
101503025|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101503026|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
101503027|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503028|NCT05149092|Caseins|caseins|mesh-list
101503029|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
101503030|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
101503031|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503032|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
101503033|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503034|NCT00495287|Cytarabine|cytarabine|mesh-list
101503036|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
101503075|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101503076|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101503077|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
101503078|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101503149|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
101503150|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503151|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503155|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101503156|NCT00495872|Sorafenib|sorafenib|mesh-list
101503157|NCT00495872|Dasatinib|dasatinib|mesh-list
101503158|NCT00495872|Lapatinib|lapatinib|mesh-list
101503159|NCT00495872|Valproic Acid|valproic acid|mesh-list
101503160|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
101503161|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503162|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101503163|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101503164|NCT00495872|Growth Substances|growth substances|mesh-ancestor
101503165|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101503166|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503167|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503168|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503169|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503170|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
101503171|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
101503172|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503173|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
101503175|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101503200|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101503201|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101503202|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
101503203|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503204|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503205|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
101503206|NCT01243736|Emollients|emollients|mesh-ancestor
101503207|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
101503208|NCT00492986|Sorafenib|sorafenib|mesh-list
101503209|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503263|NCT01244204|Vitamin D|vitamin d|mesh-list
101503264|NCT01244204|Vitamins|vitamins|mesh-ancestor
101503265|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
101503266|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503267|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503268|NCT00496028|Paclitaxel|paclitaxel|mesh-list
101503269|NCT00496028|Carboplatin|carboplatin|mesh-list
101503270|NCT00496028|Saracatinib|saracatinib|mesh-list
101503271|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101503272|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503273|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101503274|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101503275|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101503276|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503277|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503278|NCT04516278|Bevacizumab|bevacizumab|mesh-list
101503279|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101503280|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503281|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101503282|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101503283|NCT04516278|Growth Substances|growth substances|mesh-ancestor
101503284|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503285|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
101503286|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
101503287|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101503288|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503289|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101503291|NCT01297465|Hormones|hormones|mesh-ancestor
101503310|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101503311|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
101503312|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101503313|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
101503314|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503315|NCT00493610|Expectorants|expectorants|mesh-ancestor
101503316|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503317|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101503318|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
101503319|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187019|NCT00002424|Lamivudine|lamivudine|mesh-list
101503320|NCT00493610|Protective Agents|protective agents|mesh-ancestor
101503374|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503375|NCT00493727|Antidotes|antidotes|mesh-ancestor
101503376|NCT00493766|Panobinostat|panobinostat|mesh-list
101503379|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503380|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503442|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503443|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101503444|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101503445|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101503446|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101503447|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503448|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
101503449|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101503450|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101503451|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
101503452|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
101503453|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101503454|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101503455|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503456|NCT02596035|Nivolumab|nivolumab|mesh-list
101503461|NCT00494156|Aspirin|aspirin|mesh-list
101503500|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503501|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101503502|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101503503|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101503504|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
101503505|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503506|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503507|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
101503565|NCT00497237|Beclomethasone|beclomethasone|mesh-list
101503566|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
101503567|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101503568|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101503569|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101503570|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
101503571|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101503572|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503573|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101503574|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
101503575|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
101503576|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101503577|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101503578|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101503579|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101503580|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
101503581|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101503582|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503620|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101503621|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
101503622|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101503623|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503624|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101503625|NCT05146674|Tadalafil|tadalafil|mesh-list
101503626|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
101503627|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101503628|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101503629|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503684|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503685|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101503756|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101503757|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101503758|NCT00497744|Cefepime|cefepime|mesh-list
101503759|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101503760|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101503761|NCT00495092|Biperiden|biperiden|mesh-list
101503762|NCT00495092|Caffeine|caffeine|mesh-list
101503763|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101503764|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101503765|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101503766|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503788|NCT00506571|Irinotecan|irinotecan|mesh-list
101503821|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101503895|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
101503896|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101503897|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
101503898|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101503899|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101503900|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503901|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503902|NCT00498680|Urological Agents|urological agents|mesh-ancestor
101503903|NCT00498953|Carboplatin|carboplatin|mesh-list
101503904|NCT00498953|Docetaxel|docetaxel|mesh-list
101503905|NCT00498953|Fluorouracil|fluorouracil|mesh-list
101503906|NCT00498953|Lapatinib|lapatinib|mesh-list
101503907|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101503908|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503909|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
101503910|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
101503911|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
101503912|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503946|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
101503947|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101503948|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101503949|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
101503951|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
101503952|NCT00503204|Cediranib|cediranib|mesh-list
101503953|NCT00503204|Lomustine|lomustine|mesh-list
101503954|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503955|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101503956|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101503957|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503958|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101503959|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
101503960|NCT00503243|Mesalamine|mesalamine|mesh-list
101503961|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101503962|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504003|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101504004|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
101504005|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
101504009|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
101504074|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504075|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101504076|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101504147|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504148|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504149|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504169|NCT00499577|Vaccines|vaccines|mesh-list
101504218|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528441|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
101504219|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504220|NCT00499850|Leucovorin|leucovorin|mesh-list
101504221|NCT00499850|Fluorouracil|fluorouracil|mesh-list
101504222|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
101504223|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
101504224|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504225|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101504226|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504227|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504228|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
101504229|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504280|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101504281|NCT03455517|Rituximab|rituximab|mesh-list
101504282|NCT03455517|Venetoclax|venetoclax|mesh-list
101504283|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504284|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504285|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
101504286|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504287|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101504288|NCT04696536|Listerine|listerine|mesh-list
101504289|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101504411|NCT00508365|Carvedilol|carvedilol|mesh-list
101504412|NCT00508365|Lisinopril|lisinopril|mesh-list
101504413|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101504414|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101504415|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
101504416|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101504417|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504418|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504419|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101504420|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
101504457|NCT01247909|Gentamicins|gentamicins|mesh-list
101504458|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
101504459|NCT01247909|Penicillins|penicillins|mesh-list
101504460|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101504461|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504462|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101504463|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504464|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504465|NCT01245998|Dalteparin|dalteparin|mesh-list
101504466|NCT01245998|Tinzaparin|tinzaparin|mesh-list
101504467|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101504468|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
101504469|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101504470|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101504471|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504472|NCT02954484|Acetaminophen|acetaminophen|mesh-list
101504473|NCT02954484|Etoricoxib|etoricoxib|mesh-list
101504474|NCT02954484|Pregabalin|pregabalin|mesh-list
101504475|NCT02954484|Morphine|morphine|mesh-list
101504517|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
101528686|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528687|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
101528688|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528689|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528690|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
101528735|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101528736|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528737|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528739|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101528740|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528741|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
101528742|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101528800|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101528801|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101528802|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528866|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101528867|NCT02903498|Tegafur|tegafur|mesh-list
101528868|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528869|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
101528870|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528871|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528872|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
101528873|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101528874|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101528875|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528876|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101528878|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
101528879|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528880|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101528881|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101528882|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101528914|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
101528915|NCT00562068|Hormones|hormones|mesh-ancestor
101528916|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101528917|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101528918|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101528919|NCT00562185|Carboplatin|carboplatin|mesh-list
101528920|NCT00562185|Doxorubicin|doxorubicin|mesh-list
101528921|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101528922|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528923|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101528924|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101528925|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101528926|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528927|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528928|NCT00562224|Abexinostat|abexinostat|mesh-list
101528929|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101528930|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528970|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
101528971|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101528972|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
101528973|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101528974|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101528975|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
101528976|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101528977|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
101528978|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529032|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101529033|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
101529034|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529035|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529036|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101529037|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101529038|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101529039|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101529040|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529041|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529042|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529043|NCT00553553|Morphine|morphine|mesh-list
101529044|NCT00553553|Remifentanil|remifentanil|mesh-list
101529045|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101529046|NCT00553553|Narcotics|narcotics|mesh-ancestor
101529087|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529088|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
101529089|NCT04622397|Coagulants|coagulants|mesh-ancestor
101529090|NCT02901353|Sirolimus|sirolimus|mesh-list
101529091|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529092|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529093|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101529094|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529095|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
101529096|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529097|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
101529098|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529099|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
101529100|NCT04621461|Astringents|astringents|mesh-ancestor
101529101|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529102|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
101529103|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
101529104|NCT02901236|Bevacizumab|bevacizumab|mesh-list
101529105|NCT02901236|Mitomycins|mitomycins|mesh-list
101529143|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101529144|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101529145|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529146|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529147|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101529148|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
101529149|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
101529150|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529208|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
101529209|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101529210|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101529211|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529212|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
101529213|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101529216|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
101529276|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101529277|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529278|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529279|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
101529280|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101529281|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529282|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529284|NCT02900417|Hormones|hormones|mesh-ancestor
101529285|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529286|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101529287|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
101529288|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529289|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529290|NCT04620837|Tislelizumab|tislelizumab|mesh-list
101529291|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529292|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529293|NCT04620018|Amoxicillin|amoxicillin|mesh-list
101529294|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529295|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529296|NCT02900105|Letrozole|letrozole|mesh-list
101529297|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529298|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101529299|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101529300|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529302|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101529322|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101529323|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101529324|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
101529325|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101529326|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529328|NCT00562770|Valganciclovir|valganciclovir|mesh-list
101529391|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529392|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529393|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101529394|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
101529395|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101529396|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
101529397|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
101529398|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529455|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529456|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529517|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529518|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101529520|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529521|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529522|NCT05423015|Levan|levan|mesh-list
101529523|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529524|NCT04618146|Morphine|morphine|mesh-list
101529525|NCT04618146|Bupivacaine|bupivacaine|mesh-list
101529583|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
101529584|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101529585|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101529586|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
101529587|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101529588|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
101529589|NCT05387408|Narcotics|narcotics|mesh-ancestor
101529590|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529591|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529593|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
101529594|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529595|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
101529596|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101529597|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529598|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529599|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101529600|NCT05376761|Analgesics|analgesics|mesh-ancestor
101529601|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
101529602|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529603|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101529605|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529636|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529638|NCT05349383|Antibodies|antibodies|mesh-list
101529639|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
101529640|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
101529641|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
101529642|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
101529643|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529645|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101529646|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
101529647|NCT00557934|Dobutamine|dobutamine|mesh-list
101529700|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529701|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
101529702|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101529703|NCT04650555|Estrogens|estrogens|mesh-ancestor
101529704|NCT04650555|Hormones|hormones|mesh-ancestor
101529705|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529706|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101529707|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
101529708|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101529709|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
101529710|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
101529711|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529712|NCT05153525|Cisatracurium|cisatracurium|mesh-list
101529713|NCT05153525|Atracurium|atracurium|mesh-list
101529764|NCT00553943|Cytarabine|cytarabine|mesh-list
101529765|NCT00553943|Rituximab|rituximab|mesh-list
101529766|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529767|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529768|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
101529769|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529770|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101529783|NCT00563238|Metoprolol|metoprolol|mesh-list
101529821|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101529822|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101529823|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529824|NCT04616391|Insulin|insulin|mesh-list
101529825|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101529826|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529827|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
101529828|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529829|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529830|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
101529831|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
101529833|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101529884|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101529885|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101529886|NCT04683614|Norepinephrine|norepinephrine|mesh-list
101529887|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101529888|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101529889|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
101529890|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101529891|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529892|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529893|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
101529894|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
101529895|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101529896|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101529897|NCT04613895|Fexuprazan|fexuprazan|mesh-list
101529944|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101529945|NCT00563472|Desogestrel|desogestrel|mesh-list
101529946|NCT00563472|Progesterone|progesterone|mesh-list
101529947|NCT00563472|Progestins|progestins|mesh-ancestor
101529948|NCT00563472|Hormones|hormones|mesh-ancestor
101529949|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529950|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101529951|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101529952|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101529953|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101529954|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
101529955|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101529958|NCT04679597|Capecitabine|capecitabine|mesh-list
101530005|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
101530006|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101530007|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
101530008|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101530009|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530010|NCT00563589|Cyclosporine|cyclosporine|mesh-list
101530011|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
101530012|NCT00563589|Methotrexate|methotrexate|mesh-list
101530013|NCT00563589|Cyclosporins|cyclosporins|mesh-list
101530014|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101530015|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
101530016|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101530017|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530018|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530019|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
101530038|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
101420566|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101530069|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530070|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530071|NCT02179151|Growth Substances|growth substances|mesh-ancestor
101530072|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530073|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530074|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530075|NCT02160665|Tazarotene|tazarotene|mesh-list
101530076|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530077|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
101530078|NCT02138630|Capsaicin|capsaicin|mesh-list
101530079|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
101530080|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530081|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
101530082|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530083|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530084|NCT02137343|Capecitabine|capecitabine|mesh-list
101530085|NCT02137343|Rilotumumab|rilotumumab|mesh-list
101530086|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530087|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530088|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
101530089|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530090|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530091|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
101530113|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530115|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530116|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
101530117|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530118|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530119|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530120|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
101530121|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530122|NCT04611711|Decitabine|decitabine|mesh-list
101530123|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530124|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
101530132|NCT02092922|Filanesib|filanesib|mesh-list
101530175|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101530176|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
101530177|NCT00554918|Prednisolone|prednisolone|mesh-list
101530178|NCT00554918|Docetaxel|docetaxel|mesh-list
101530179|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530180|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
101530181|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
101530182|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530183|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530184|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530185|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
101530186|NCT00554918|Hormones|hormones|mesh-ancestor
101530187|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530188|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530189|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530190|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101530191|NCT04631874|Varenicline|varenicline|mesh-list
101530192|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101530193|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101530194|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
101530195|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530196|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530197|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530198|NCT02057315|Ketoprofen|ketoprofen|mesh-list
101530227|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530228|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530229|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530230|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
101530231|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530232|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530233|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101530234|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
101530235|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101530293|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101530294|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101530295|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
101530296|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101530297|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101420568|NCT00148278|Dobutamine|dobutamine|mesh-list
101420569|NCT00148278|Epinephrine|epinephrine|mesh-list
101420570|NCT00148278|Norepinephrine|norepinephrine|mesh-list
101420571|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101420572|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101420573|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
101420574|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420575|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530298|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
101530301|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530302|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
101530303|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530304|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530305|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530306|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101530307|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101530308|NCT04611243|Vaccines|vaccines|mesh-list
101530309|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
101530310|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530311|NCT00564057|Candesartan|candesartan|mesh-list
101530312|NCT00564057|Candesartan cilexetil|candesartan cilexetil|mesh-list
101530313|NCT00564057|Lercanidipine|lercanidipine|mesh-list
101530314|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101530315|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101530335|NCT04630548|Copper|copper|mesh-list
101530339|NCT01975610|Spebrutinib|spebrutinib|mesh-list
101530340|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101530341|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530342|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530343|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
101530344|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101530345|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530346|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530347|NCT01967810|Bevacizumab|bevacizumab|mesh-list
101530348|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530349|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530350|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530400|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530401|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530402|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530403|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530404|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101530405|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101530406|NCT01165021|Hematinics|hematinics|mesh-ancestor
101530407|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
101530408|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
101530409|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
101530410|NCT00561132|Antacids|antacids|mesh-ancestor
101530466|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
101530467|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530468|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101530469|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101530470|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
101530471|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530531|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101530532|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530533|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101530534|NCT01909427|Methotrexate|methotrexate|mesh-list
101530535|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101530536|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
101530537|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101530538|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530539|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530540|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
101530588|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101530589|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101530590|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101530591|NCT01873703|Azacitidine|azacitidine|mesh-list
101530592|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101530598|NCT01870505|Exemestane|exemestane|mesh-list
101530599|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530600|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101530601|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101530602|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530603|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530644|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101530645|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530646|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530647|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101530648|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101530649|NCT01847573|Growth Substances|growth substances|mesh-ancestor
101530650|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530651|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
101530652|NCT04609254|Acetaminophen|acetaminophen|mesh-list
101530654|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101530655|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530656|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530657|NCT04609254|Analgesics|analgesics|mesh-ancestor
101530658|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
101530659|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530660|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530661|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101530662|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530663|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101530664|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530665|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530666|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
101530667|NCT01846481|Cocaine|cocaine|mesh-list
101530668|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
101530669|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
101530670|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530671|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530672|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
101530673|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530674|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101530679|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
101530685|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530686|NCT04676789|Pegaspargase|pegaspargase|mesh-list
101530687|NCT04676789|Antibodies|antibodies|mesh-list
101530688|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101530689|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
101530690|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530691|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530692|NCT01811576|Hormones|hormones|mesh-list
101530693|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530749|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530750|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530751|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101530752|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530753|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530754|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
101530755|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101530756|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530757|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530812|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101530813|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101530814|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530815|NCT04608981|Analgesics|analgesics|mesh-ancestor
101530816|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
101530817|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530818|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101530819|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530822|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101530824|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
101530825|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530826|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530828|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101530867|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101420576|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530868|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101530869|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
101530870|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
101530871|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101530872|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101530873|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101530874|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530932|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101530933|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101530934|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530935|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530936|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101530937|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101530938|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101530939|NCT01691846|Metformin|metformin|mesh-list
101530940|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101530941|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530942|NCT01658501|Metformin|metformin|mesh-list
101530943|NCT01658501|Liraglutide|liraglutide|mesh-list
101530944|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101530945|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530946|NCT01658501|Incretins|incretins|mesh-ancestor
101530947|NCT01658501|Hormones|hormones|mesh-ancestor
101530948|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101530949|NCT01651871|Cetirizine|cetirizine|mesh-list
101530950|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101530951|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101530952|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101530953|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
101530954|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
101530955|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101530956|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530957|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101530981|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101530982|NCT00564525|Analgesics|analgesics|mesh-ancestor
101530983|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
101531003|NCT01632137|Rebamipide|rebamipide|mesh-list
101531051|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
101531052|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531053|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
101531054|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101531055|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531056|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101531057|NCT01303796|Decitabine|decitabine|mesh-list
101531058|NCT01303796|Sapacitabine|sapacitabine|mesh-list
101531059|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531060|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
101531061|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531062|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531063|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531064|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
101531065|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
101531066|NCT04598880|Cathartics|cathartics|mesh-ancestor
101531067|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531068|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101531070|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
101531071|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531072|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101531073|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531074|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531075|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531076|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101531094|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531098|NCT00564603|BB 1101|bb 1101|mesh-list
101531099|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531100|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
101531101|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
101531102|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531103|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531104|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101531105|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
101531106|NCT00564603|Hormones|hormones|mesh-ancestor
101531107|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420577|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101420578|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101420579|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
101420580|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420581|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101420582|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
101420583|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
101420584|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
101420585|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101420586|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101420587|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101420588|NCT00148278|Protective Agents|protective agents|mesh-ancestor
101531108|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531109|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531110|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
101531111|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531112|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531113|NCT00555347|Modafinil|modafinil|mesh-list
101531114|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101531120|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
101531146|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101531147|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531148|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101531149|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101531150|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531151|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531152|NCT04606836|Bupivacaine|bupivacaine|mesh-list
101531153|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
101531154|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
101531155|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531156|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531209|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101531210|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101531212|NCT00565968|Melphalan|melphalan|mesh-list
101531213|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531214|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531215|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531350|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531352|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
101531353|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
101531354|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531355|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531356|NCT04632758|Crizotinib|crizotinib|mesh-list
101531357|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531358|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531359|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531360|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531361|NCT00566046|Levetiracetam|levetiracetam|mesh-list
101531362|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
101531363|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
101531364|NCT01160614|Oxycodone|oxycodone|mesh-list
101531365|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101531366|NCT01160614|Narcotics|narcotics|mesh-ancestor
101531367|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531368|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531409|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
101531410|NCT04631822|Hormones|hormones|mesh-ancestor
101531411|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531412|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531414|NCT04605705|Chrysarobin|chrysarobin|mesh-list
101531477|NCT04314193|Hormones|hormones|mesh-ancestor
101531478|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531479|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101531480|NCT01159171|Bevacizumab|bevacizumab|mesh-list
101531481|NCT01159171|Capecitabine|capecitabine|mesh-list
101531482|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
101531483|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531484|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531485|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531486|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101531487|NCT01159171|Growth Substances|growth substances|mesh-ancestor
101531488|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531492|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531493|NCT04631315|Prednisolone|prednisolone|mesh-list
101531494|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101531495|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
101531496|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101531497|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
101531498|NCT04631315|Phenylephrine|phenylephrine|mesh-list
101531499|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
101531500|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101531526|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531527|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
101531528|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531529|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531530|NCT04597203|Hydroquinone|hydroquinone|mesh-list
101531531|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
101531532|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531533|NCT04597203|Protective Agents|protective agents|mesh-ancestor
101531534|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531535|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101531536|NCT01158118|Plerixafor|plerixafor|mesh-list
101531537|NCT01158118|Sargramostim|sargramostim|mesh-list
101531538|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
101531539|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531540|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101531542|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
101531584|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531585|NCT00564993|Protective Agents|protective agents|mesh-ancestor
101531586|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
101531587|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101531588|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
101531589|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531590|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101531591|NCT04604886|Dobutamine|dobutamine|mesh-list
101531592|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101531593|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
101531594|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
101531595|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531596|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531597|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101531598|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101531604|NCT04595877|Dipyrone|dipyrone|mesh-list
101531642|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101531643|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101531645|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
101531646|NCT01157182|Estradiol|estradiol|mesh-list
101531647|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101531648|NCT01157182|Estrogens|estrogens|mesh-ancestor
101531649|NCT01157182|Hormones|hormones|mesh-ancestor
101531650|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101531651|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531652|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101531659|NCT01157065|Ranibizumab|ranibizumab|mesh-list
101531702|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531703|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
101531704|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531705|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101531706|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
101531707|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101531708|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101531709|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101531710|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101531711|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531712|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
101531713|NCT01156363|Hematinics|hematinics|mesh-ancestor
101531714|NCT02884921|Acetaminophen|acetaminophen|mesh-list
101531715|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531764|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101531765|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
101531766|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101531767|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
101531768|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
101531772|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531773|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
101531774|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
101531775|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
101531776|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531778|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531779|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101531780|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531823|NCT04627181|Vitamins|vitamins|mesh-ancestor
101531824|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
101531825|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531826|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
101531827|NCT04626752|Fludarabine|fludarabine|mesh-list
101531828|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101531829|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
101531830|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531831|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101531832|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101531833|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
101531834|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531835|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531836|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101531837|NCT01155466|Rasagiline|rasagiline|mesh-list
101531838|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101531839|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101531880|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531882|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101531883|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531884|NCT04601688|Dexamethasone|dexamethasone|mesh-list
101531885|NCT04601688|Bevacizumab|bevacizumab|mesh-list
101531886|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101531887|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101531888|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101531945|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101531947|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
101531948|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
101531949|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101531950|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101531951|NCT04601259|Analgesics|analgesics|mesh-ancestor
101531952|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
101531953|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101531954|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101531955|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101531956|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532007|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
101532008|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532009|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
101532010|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532011|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101532012|NCT00567216|Nadolol|nadolol|mesh-list
101532013|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101532014|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101532015|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532068|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101532069|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532070|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532071|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532072|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532073|NCT00562172|Metformin|metformin|mesh-list
101532074|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
101532075|NCT00562172|Glimepiride|glimepiride|mesh-list
101532076|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532077|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532078|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101532079|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532080|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
101532081|NCT00567450|Ropivacaine|ropivacaine|mesh-list
101532126|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101532127|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
101532128|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532135|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532136|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532137|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532138|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101532140|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
101532186|NCT00624871|Vitamins|vitamins|mesh-ancestor
101532187|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
101532188|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532189|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532190|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532191|NCT00624871|Analgesics|analgesics|mesh-ancestor
101532192|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
101532193|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532194|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532195|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532196|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101532197|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532198|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532199|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
101532200|NCT00624871|Protective Agents|protective agents|mesh-ancestor
101532201|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101532206|NCT04590183|Prednisolone|prednisolone|mesh-list
101532244|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532245|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532246|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
101532248|NCT04622891|Clarithromycin|clarithromycin|mesh-list
101532249|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532250|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532251|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101532256|NCT04622579|Rituximab|rituximab|mesh-list
101532310|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532311|NCT04621487|Amoxicillin|amoxicillin|mesh-list
101532312|NCT04621487|Metronidazole|metronidazole|mesh-list
101532313|NCT04621487|Clarithromycin|clarithromycin|mesh-list
101532314|NCT04621487|Pantoprazole|pantoprazole|mesh-list
101532315|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101532316|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101532317|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101532318|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101532319|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101532320|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532321|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532322|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101532367|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101532368|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
101532369|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532371|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532372|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532373|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532374|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532375|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
101532376|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532377|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
101532378|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532379|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532380|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101532381|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
101532382|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532422|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101532423|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532424|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532425|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532483|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
101532484|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101532485|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101532486|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
101532487|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532488|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532489|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532490|NCT02940314|Urological Agents|urological agents|mesh-ancestor
101532491|NCT04581213|Anesthetics|anesthetics|mesh-list
101532492|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532493|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532494|NCT01151137|Dronedarone|dronedarone|mesh-list
101532495|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101532496|NCT01151098|Buprenorphine|buprenorphine|mesh-list
101532497|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101532499|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532500|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532501|NCT01151098|Analgesics|analgesics|mesh-ancestor
101532505|NCT04619303|Dexamethasone|dexamethasone|mesh-list
101532536|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532537|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532539|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
101532540|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101532541|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
101532542|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532543|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532544|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101532545|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532546|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
101532547|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101532548|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
101532549|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532550|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532551|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
101532552|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
101532553|NCT00568542|Hematinics|hematinics|mesh-ancestor
101532594|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101532595|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101532596|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
101532597|NCT04586790|Coagulants|coagulants|mesh-ancestor
101532598|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101532599|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
101532600|NCT00568815|Rituximab|rituximab|mesh-list
101532601|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101532602|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532603|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
101532604|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532652|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101532653|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532654|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532655|NCT00562952|Telmisartan|telmisartan|mesh-list
101532656|NCT00562952|Bisoprolol|bisoprolol|mesh-list
101532657|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101532658|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101532659|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101532661|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
101532715|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101532716|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101532717|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101532718|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101532719|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
101532720|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532721|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532722|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
101532723|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
101532724|NCT00569751|Paclitaxel|paclitaxel|mesh-list
101532781|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532782|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101532783|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101532784|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
101532791|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532841|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
101532842|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101532843|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
101532844|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532845|NCT00568113|Protective Agents|protective agents|mesh-ancestor
101532846|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532847|NCT00568113|Antidotes|antidotes|mesh-ancestor
101532848|NCT00568152|Aspirin|aspirin|mesh-list
101532849|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101532850|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101532851|NCT00568152|Analgesics|analgesics|mesh-ancestor
101532852|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
101532853|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101532854|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532855|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101532901|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101532902|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420591|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101420592|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
101420593|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420594|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420595|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101420596|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101420597|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
101420598|NCT05594849|Hormones|hormones|mesh-ancestor
101532903|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101532904|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101532905|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101532906|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101532907|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
101532908|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
101532909|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
101532910|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
101532911|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101532912|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532964|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
101532965|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101532966|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101532967|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
101532969|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532970|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101532971|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101532972|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101532973|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101532974|NCT00571155|Levetiracetam|levetiracetam|mesh-list
101532975|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
101532976|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
101533017|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533019|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101533020|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
101533021|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533022|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533023|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101533024|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101533025|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533026|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533027|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533028|NCT00571740|Leucovorin|leucovorin|mesh-list
101533029|NCT00571740|Bevacizumab|bevacizumab|mesh-list
101533030|NCT00571740|Cetuximab|cetuximab|mesh-list
101533031|NCT00571740|Fluorouracil|fluorouracil|mesh-list
101533032|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
101533033|NCT00571740|Calcium|calcium|mesh-list
101533034|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
101533076|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533080|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101533081|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
101533082|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533083|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533084|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101533085|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533086|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533087|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533089|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
101533095|NCT00563615|Tegaserod|tegaserod|mesh-list
101533131|NCT04612634|Vaccines|vaccines|mesh-list
101533132|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
101533133|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533134|NCT04612556|Vaccines|vaccines|mesh-list
101533135|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
101533136|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533138|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101533139|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533140|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533141|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533142|NCT00568347|Fluticasone|fluticasone|mesh-list
101533144|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101533145|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101533146|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533147|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101533148|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
101533162|NCT00568347|Hormones|hormones|mesh-ancestor
101533188|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533189|NCT00563771|Rasburicase|rasburicase|mesh-list
101533190|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
101533191|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533192|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101533193|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101533194|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101533195|NCT04582032|Analgesics|analgesics|mesh-ancestor
101533196|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
101533197|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533198|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533199|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533200|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533201|NCT00563849|Leflunomide|leflunomide|mesh-list
101533202|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533203|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533204|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533205|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
101533206|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533207|NCT04581876|Paclitaxel|paclitaxel|mesh-list
101533208|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101533209|NCT04581876|Raltitrexed|raltitrexed|mesh-list
101533210|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533240|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
101533241|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101533242|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533243|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101533244|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533245|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
101533246|NCT04611776|Paclitaxel|paclitaxel|mesh-list
101533247|NCT04611776|Carboplatin|carboplatin|mesh-list
101533248|NCT04611776|Gemcitabine|gemcitabine|mesh-list
101533249|NCT04611776|Pemetrexed|pemetrexed|mesh-list
101533250|NCT04611776|Atezolizumab|atezolizumab|mesh-list
101533251|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101533252|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533253|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533254|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533256|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533257|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101533264|NCT00572637|Delanzomib|delanzomib|mesh-list
101533298|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
101533300|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533301|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101533302|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101533303|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101533304|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101533305|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101533306|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533307|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533308|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
101533309|NCT00575406|Hormones|hormones|mesh-ancestor
101533360|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533361|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533362|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
101533363|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101533364|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101533365|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
101533366|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533367|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533368|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
101533369|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
101533370|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101533371|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101533372|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533419|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533420|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
101533421|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533422|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101533423|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533424|NCT00575835|Vitamin D|vitamin d|mesh-list
101533425|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
101533426|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
101533427|NCT00575835|Vitamins|vitamins|mesh-list
101533428|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
101533429|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533430|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101533482|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
101533483|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
101533484|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533485|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101533486|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101533487|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101533488|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533489|NCT00573417|Modafinil|modafinil|mesh-list
101533490|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101533491|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533492|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101533493|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101533494|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101533495|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533496|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
101533497|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101533498|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
101533499|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533500|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533501|NCT00565955|Montelukast|montelukast|mesh-list
101533502|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101533503|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533504|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101533505|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
101533526|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101533527|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101533528|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101533529|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533530|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
101533531|NCT00576069|Hormones|hormones|mesh-ancestor
101533532|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533533|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533534|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101533535|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533536|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101533589|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101533590|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
101533591|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533592|NCT00573885|Protective Agents|protective agents|mesh-ancestor
101533593|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533594|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101533595|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101533596|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533597|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101533651|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533652|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533653|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533654|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101533655|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
101533656|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533659|NCT00577161|Fludarabine|fludarabine|mesh-list
101533660|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
101533715|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101533716|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101533717|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533718|NCT04595318|Varenicline|varenicline|mesh-list
101533719|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101533720|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101533721|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533722|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533723|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533724|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533726|NCT00577668|Dexamethasone|dexamethasone|mesh-list
101533727|NCT00577668|Melphalan|melphalan|mesh-list
101533728|NCT00577668|Bortezomib|bortezomib|mesh-list
101533729|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101533730|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
101533731|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
101533732|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101533733|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533734|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101533735|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
101533736|NCT00577668|Hormones|hormones|mesh-ancestor
101533737|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533738|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101533739|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101533740|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101533741|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
101533762|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
101533763|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533764|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101533765|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101533766|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
101533767|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101533768|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101533769|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101533770|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533771|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101533772|NCT04313374|Morphine|morphine|mesh-list
101533773|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101533774|NCT04313374|Narcotics|narcotics|mesh-ancestor
101533775|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101533776|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533817|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101533818|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101533819|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101533820|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533821|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
101533822|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101533823|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533824|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101533884|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101533885|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101533901|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
101533950|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533951|NCT04591847|Vitamin D|vitamin d|mesh-list
101533952|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
101533953|NCT04591847|Vitamins|vitamins|mesh-ancestor
101533954|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
101533955|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101533956|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101533957|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101533958|NCT04591535|Levodopa|levodopa|mesh-list
101533959|NCT04591535|Carbidopa|carbidopa|mesh-list
101533960|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101533961|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101533962|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101533963|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
101534010|NCT00580827|Disulfiram|disulfiram|mesh-list
101534011|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101534012|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101534013|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534014|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534015|NCT00580905|Adenosine|adenosine|mesh-list
101534016|NCT00580905|Nitroprusside|nitroprusside|mesh-list
101534017|NCT00580905|Analgesics|analgesics|mesh-ancestor
101534018|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
101534019|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534020|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534021|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534022|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
101534023|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101534024|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
101534025|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
101534026|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534070|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101534071|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101534072|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101534073|NCT00567554|Growth Substances|growth substances|mesh-ancestor
101534074|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
101534075|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101534076|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101534081|NCT00581139|Midazolam|midazolam|mesh-list
101534138|NCT04577040|Urological Agents|urological agents|mesh-ancestor
101534139|NCT04589234|Gemcitabine|gemcitabine|mesh-list
101534140|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101534141|NCT04589234|Folfirinox|folfirinox|mesh-list
101534142|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534143|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
101534144|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534145|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534146|NCT03453177|Fosfomycin|fosfomycin|mesh-list
101534147|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101534203|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534204|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534205|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534206|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534207|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101534208|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101534209|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534210|NCT04588220|Plasminogen|plasminogen|mesh-list
101534211|NCT04588220|Melatonin|melatonin|mesh-list
101534212|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
101534213|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534214|NCT04588220|Protective Agents|protective agents|mesh-ancestor
101534215|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534216|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534217|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101534218|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101534219|NCT04586543|Docetaxel|docetaxel|mesh-list
101534220|NCT04586543|Selegiline|selegiline|mesh-list
101534261|NCT04593108|Misoprostol|misoprostol|mesh-list
101534339|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
101534340|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534341|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534342|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101534377|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
101534378|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101534379|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101534380|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101534381|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101534382|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101534383|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101534384|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101534386|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534387|NCT04584671|Xenon|xenon|mesh-list
101534388|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101534389|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
101534390|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
101534394|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534436|NCT04583267|Tenofovir|tenofovir|mesh-list
101534437|NCT04583267|Emtricitabine|emtricitabine|mesh-list
101534438|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
101534439|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534440|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101534441|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101534442|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534444|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101536304|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536306|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536307|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101536308|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
101536309|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536310|NCT00474240|Atorvastatin|atorvastatin|mesh-list
101536311|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101536312|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101536313|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
101536314|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536318|NCT00473889|Paclitaxel|paclitaxel|mesh-list
101536351|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
101536352|NCT00565253|Protective Agents|protective agents|mesh-ancestor
101536354|NCT02277600|Cobicistat|cobicistat|mesh-list
101536355|NCT02277600|Fostemsavir|fostemsavir|mesh-list
101536422|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
101536423|NCT00473694|Neostigmine|neostigmine|mesh-list
101536426|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101536492|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
101536493|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101536494|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536495|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536496|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101536497|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
101536498|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101536499|NCT02210325|Azithromycin|azithromycin|mesh-list
101536500|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
101536501|NCT02210325|Solithromycin|solithromycin|mesh-list
101536502|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536503|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101536550|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101536551|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101536552|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536553|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536554|NCT00583271|Ethanol|ethanol|mesh-list
101536555|NCT00583271|Triamcinolone|triamcinolone|mesh-list
101536556|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536558|NCT00583271|Hormones|hormones|mesh-ancestor
101536618|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536681|NCT00584090|Urological Agents|urological agents|mesh-ancestor
101536682|NCT00584168|Dexamethasone|dexamethasone|mesh-list
101536683|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536684|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
101536685|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
101536686|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101536687|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536688|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536689|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
101536690|NCT00584168|Hormones|hormones|mesh-ancestor
101536691|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536692|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536693|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536694|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101536695|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536696|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101536697|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536698|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536699|NCT01133275|Prednisone|prednisone|mesh-list
101536700|NCT01133275|Lenalidomide|lenalidomide|mesh-list
101537111|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537113|NCT00587873|Methotrexate|methotrexate|mesh-list
101537114|NCT00587873|Thioguanine|thioguanine|mesh-list
101537115|NCT00587873|Calcium|calcium|mesh-list
101537116|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
101537120|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
101537180|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537181|NCT01083810|Ritonavir|ritonavir|mesh-list
101537182|NCT01083810|Lopinavir|lopinavir|mesh-list
101537183|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101537184|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101537185|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
101537186|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537187|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537188|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101537189|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101537190|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
101538186|NCT00476606|Zidovudine|zidovudine|mesh-list
101538187|NCT00476606|Nevirapine|nevirapine|mesh-list
101538188|NCT00476606|Didanosine|didanosine|mesh-list
101538299|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538300|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101538371|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
101538372|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538373|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101538439|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101538440|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538509|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538510|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101538511|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538512|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
101538574|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
101538575|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538576|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538577|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101538578|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101538579|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
101420599|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101538581|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538641|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538643|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101538644|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101538645|NCT01087814|Efavirenz|efavirenz|mesh-list
101538648|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101538705|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
101538706|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
101538707|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538770|NCT00179673|Growth Substances|growth substances|mesh-ancestor
101538771|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
101538772|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538773|NCT01084655|Prednisone|prednisone|mesh-list
101538902|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101538967|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538968|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539037|NCT00172185|Teduglutide|teduglutide|mesh-list
101539038|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101539039|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101539040|NCT00172185|Protective Agents|protective agents|mesh-ancestor
101539041|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539103|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101539104|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539105|NCT01085630|Pemetrexed|pemetrexed|mesh-list
101539171|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539172|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539173|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101539174|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539242|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101539243|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539244|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101539245|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
101539246|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
101539247|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101539248|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
101539249|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
101539250|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
101539251|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101539252|NCT00556127|Analgesics|analgesics|mesh-ancestor
101539253|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
101539256|NCT00556205|Sunitinib|sunitinib|mesh-list
101539304|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
101539305|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101539306|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101539373|NCT04571606|Bupivacaine|bupivacaine|mesh-list
101539374|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
101539375|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
101539376|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539377|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539440|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
101539441|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101539442|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539443|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101539444|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539445|NCT04570592|Dexamethasone|dexamethasone|mesh-list
101539446|NCT04570592|Granisetron|granisetron|mesh-list
101539447|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101539576|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101539577|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539578|NCT04559165|Chitosan|chitosan|mesh-list
101539579|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101539580|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101539581|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
101539635|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101539636|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539637|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539638|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
101539640|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539641|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539642|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101420600|NCT00507247|Daptomycin|daptomycin|mesh-list
101420601|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101420602|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420603|NCT00507286|Alprostadil|alprostadil|mesh-list
101420604|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101420605|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420606|NCT00507286|Urological Agents|urological agents|mesh-ancestor
101420607|NCT05143762|Acetaminophen|acetaminophen|mesh-list
101420608|NCT05143762|Dexamethasone|dexamethasone|mesh-list
101420609|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420610|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
101420611|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
101539702|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539703|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539704|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101539705|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101539706|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
101539707|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101539709|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101539710|NCT00576017|Narcotics|narcotics|mesh-ancestor
101539711|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539712|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539713|NCT00576017|Analgesics|analgesics|mesh-ancestor
101539714|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
101539715|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101539716|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101539717|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101539718|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
101539740|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539741|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101539742|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
101539811|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539812|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101539813|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539814|NCT02882308|Durvalumab|durvalumab|mesh-list
101539815|NCT02882308|Olaparib|olaparib|mesh-list
101539816|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539817|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101539818|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101539819|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539820|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101539821|NCT00625456|Molgramostim|molgramostim|mesh-list
101539822|NCT00625456|Sargramostim|sargramostim|mesh-list
101539823|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
101539824|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539825|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101539867|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101539868|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101539869|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101539870|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101539871|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101539939|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
101539940|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101539941|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539942|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
101539943|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540081|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540082|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
101540083|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540084|NCT04205890|Ketamine|ketamine|mesh-list
101540085|NCT04205890|Analgesics|analgesics|mesh-ancestor
101540086|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
101540087|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540088|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540089|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101540090|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101540091|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
101540092|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
101540093|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101540095|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101540096|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540097|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540098|NCT00577109|Leucovorin|leucovorin|mesh-list
101540099|NCT00577109|Bevacizumab|bevacizumab|mesh-list
101540100|NCT00577109|Cetuximab|cetuximab|mesh-list
101540101|NCT00577109|Irinotecan|irinotecan|mesh-list
101540102|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540104|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101540105|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101540109|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101540110|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101540111|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540112|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540113|NCT00577109|Antidotes|antidotes|mesh-ancestor
101540114|NCT00577109|Protective Agents|protective agents|mesh-ancestor
101540115|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
101540117|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
101540118|NCT01124422|Fluticasone|fluticasone|mesh-list
101540119|NCT01124422|Xhance|xhance|mesh-list
101540120|NCT01124422|Bromides|bromides|mesh-list
101540121|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
101540122|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101540123|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540124|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101540125|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
101540126|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540127|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540129|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
101540130|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540131|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101540132|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
101540133|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101540134|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
101540135|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540136|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540137|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101540402|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
101540403|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540404|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540405|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
101540406|NCT02215005|Telmisartan|telmisartan|mesh-list
101540408|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540438|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101540439|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101540440|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101540441|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101540442|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101540443|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101540494|NCT04555694|Cyclosporine|cyclosporine|mesh-list
101540495|NCT04555694|Dexamethasone|dexamethasone|mesh-list
101540496|NCT04555694|Cyclosporins|cyclosporins|mesh-list
101540497|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540498|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
101540499|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
101540500|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540501|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540502|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540503|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
101540504|NCT04555694|Hormones|hormones|mesh-ancestor
101540505|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540506|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101540507|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540508|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540509|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540510|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540511|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
101540512|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
101540513|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540514|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
101540515|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101540516|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101540518|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
101540545|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101540546|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
101540547|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101540548|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540550|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101540609|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540610|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101540681|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540682|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101540751|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101540752|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101540753|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
101540754|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101540755|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540756|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101540757|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101540758|NCT01121575|Crizotinib|crizotinib|mesh-list
101540759|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540760|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101540761|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540762|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540764|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540765|NCT04205851|Gimsilumab|gimsilumab|mesh-list
101540766|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540767|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
101540768|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540856|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540857|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101540859|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540860|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540861|NCT04529811|Rifaximin|rifaximin|mesh-list
101540862|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540863|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540864|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101540865|NCT02218047|Interferons|interferons|mesh-list
101540866|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
101540867|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
101540868|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540869|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
101540870|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540871|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
101540872|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540873|NCT00580814|Methylphenidate|methylphenidate|mesh-list
101540874|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101540876|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101540877|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101541033|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101541034|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
101541035|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541036|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101541037|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101541039|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101541040|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101541041|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541044|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
101541045|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541046|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101541047|NCT04561947|Mitogens|mitogens|mesh-list
101541048|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
101541049|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541050|NCT01118962|Lacosamide|lacosamide|mesh-list
101541051|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
101541052|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101541053|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101541054|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101541055|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541056|NCT00581165|Etanercept|etanercept|mesh-list
101541057|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101541058|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541059|NCT00581165|Analgesics|analgesics|mesh-ancestor
101541060|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
101541061|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541062|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541063|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101541064|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101541074|NCT05092984|Diuretics|diuretics|mesh-ancestor
101541075|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
101541076|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
101541078|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101541079|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541080|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541081|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541138|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541139|NCT02219217|Dolutegravir|dolutegravir|mesh-list
101541140|NCT02219217|Cobicistat|cobicistat|mesh-list
101541141|NCT02219217|Elvitegravir|elvitegravir|mesh-list
101541142|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101541204|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101541205|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101541206|NCT04553393|Decitabine|decitabine|mesh-list
101541207|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101541208|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
101541209|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541630|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101541631|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541632|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101541634|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
101541698|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
101541829|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541830|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101541831|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101541832|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101541833|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541834|NCT01646580|Ciclopirox|ciclopirox|mesh-list
101541835|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
101541836|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541837|NCT04546802|Grazoprevir|grazoprevir|mesh-list
101541838|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
101541839|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
101541840|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101541886|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101541887|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101541954|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101541955|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101542057|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542058|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101542059|NCT04542005|Albuterol|albuterol|mesh-list
101542060|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101542074|NCT01646775|Fentanyl|fentanyl|mesh-list
101542118|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542119|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542120|NCT04543916|Irinotecan|irinotecan|mesh-list
101542121|NCT04543916|Venetoclax|venetoclax|mesh-list
101542122|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101542176|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101542178|NCT04528056|Analgesics|analgesics|mesh-ancestor
101542250|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542251|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101542252|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101542314|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101542315|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542316|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101542317|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101542379|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542380|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
101542381|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101542382|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542383|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542384|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101542385|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101542386|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101542387|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542388|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101542389|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
101542390|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101420612|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420613|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420614|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420615|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
101420616|NCT05143762|Hormones|hormones|mesh-ancestor
101420617|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420618|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101420619|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542391|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101542393|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
101542436|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542437|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101542439|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101542440|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
101542441|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
101542442|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542443|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542444|NCT02279628|Morphine|morphine|mesh-list
101542445|NCT02279628|Ropivacaine|ropivacaine|mesh-list
101542446|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101542447|NCT02279628|Narcotics|narcotics|mesh-ancestor
101542448|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101542498|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101542499|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101542500|NCT01179919|Oseltamivir|oseltamivir|mesh-list
101542501|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
101542502|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542503|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101542504|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542567|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542625|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542626|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
101542692|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101542693|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101542694|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
101542695|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542760|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542761|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
101542762|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542763|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
101542764|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542765|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
101542766|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101542767|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101542768|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101542769|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
101542770|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101542773|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542819|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101542820|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
101542821|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542822|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
101542887|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542888|NCT04530578|Heparin|heparin|mesh-list
101542889|NCT04530578|Calcium heparin|calcium heparin|mesh-list
101542890|NCT04530578|Enoxaparin|enoxaparin|mesh-list
101542891|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101542892|NCT04530578|Tinzaparin|tinzaparin|mesh-list
101542893|NCT04530578|Dalteparin|dalteparin|mesh-list
101542894|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
101542895|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101542896|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101542897|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542898|NCT01685853|Bisacodyl|bisacodyl|mesh-list
101542899|NCT01685853|Cathartics|cathartics|mesh-ancestor
101542900|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101542949|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101542950|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101542951|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
101542952|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542953|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542954|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101543017|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
101543018|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
101543087|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543088|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101543089|NCT04530188|Propofol|propofol|mesh-list
101543090|NCT04530188|Sevoflurane|sevoflurane|mesh-list
101543091|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101543159|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101543160|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101543161|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101543162|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543163|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543164|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101543183|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
101543184|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101543185|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543186|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543187|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101543188|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101543189|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101543190|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101543200|NCT02218658|Brotizolam|brotizolam|mesh-list
101543261|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101543262|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543263|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
101543265|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
101543330|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101543331|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
101543332|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
101543337|NCT04534322|Hormones|hormones|mesh-ancestor
101543400|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101543401|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101543402|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
101543403|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543405|NCT04534452|Protective Agents|protective agents|mesh-ancestor
101543465|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
101543466|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
101543467|NCT04533321|Afatinib|afatinib|mesh-list
101543468|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543472|NCT01195831|Calcipotriene|calcipotriene|mesh-list
101543537|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543538|NCT02216799|Insulin|insulin|mesh-list
101543539|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101543540|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
101543541|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101543542|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543543|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
101543544|NCT02216877|Antacids|antacids|mesh-ancestor
101543545|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543546|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543547|NCT02214563|Vitamin D|vitamin d|mesh-list
101543548|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
101543549|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
101543550|NCT02214563|Vitamins|vitamins|mesh-list
101543551|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
101543552|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543553|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101543554|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101543555|NCT01194973|Eculizumab|eculizumab|mesh-list
101543556|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101543564|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101543566|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
101543586|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543587|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101543588|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101543653|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101543654|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543722|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101543723|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543724|NCT01642940|Ticagrelor|ticagrelor|mesh-list
101543725|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101543726|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101543727|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101543728|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101543729|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101543730|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
101543731|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101543732|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543780|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
101543781|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543782|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543783|NCT01643252|Riboflavin|riboflavin|mesh-list
101543784|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101543785|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101543786|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
101543787|NCT01643252|Vitamins|vitamins|mesh-ancestor
101543788|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
101543789|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543792|NCT01641458|Capecitabine|capecitabine|mesh-list
101543845|NCT01601106|Hormones|hormones|mesh-ancestor
101543846|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101543847|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543848|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101543849|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543850|NCT02750540|Tenofovir|tenofovir|mesh-list
101543851|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
101543852|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543853|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101543854|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101543855|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543856|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101543857|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101543858|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101543902|NCT01680107|Cycloserine|cycloserine|mesh-list
101543903|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101543904|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543905|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101543906|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
101543907|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101543968|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101543969|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
101543970|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
101543971|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101543972|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101543973|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101543974|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
101543975|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101543976|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544033|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544055|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
101544056|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544057|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101544058|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544080|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544081|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544083|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
101544085|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544150|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101544151|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
101544152|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
101544153|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544154|NCT01603251|Ivermectin|ivermectin|mesh-list
101544155|NCT01603251|Lumefantrine|lumefantrine|mesh-list
101544156|NCT01603251|Artemether|artemether|mesh-list
101544157|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101544158|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101544219|NCT01646684|Pasireotide|pasireotide|mesh-list
101544220|NCT01646684|Hormones|hormones|mesh-ancestor
101544221|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101544222|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544223|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
101544224|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101544237|NCT01607580|Hormones|hormones|mesh-ancestor
101544287|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
101544288|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101544289|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544290|NCT01608009|Paclitaxel|paclitaxel|mesh-list
101544291|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101544292|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101544313|NCT01608360|Lidocaine|lidocaine|mesh-list
101544354|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
101544355|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101544425|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101544702|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101544703|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101544704|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101544771|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544773|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101544774|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101544775|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101544840|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101544841|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101544842|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544843|NCT01609998|Vaccines|vaccines|mesh-list
101544907|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544908|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101544909|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
101544972|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544973|NCT05140655|Fulvestrant|fulvestrant|mesh-list
101544974|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101544975|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545036|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101545037|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101545038|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545039|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545040|NCT01686659|Chrysarobin|chrysarobin|mesh-list
101545076|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101545077|NCT01688960|Growth Substances|growth substances|mesh-ancestor
101545078|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545079|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
101545080|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545081|NCT02271360|Cabergoline|cabergoline|mesh-list
101545082|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
101545083|NCT02271360|Calcium|calcium|mesh-list
101545084|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101545085|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545086|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101545087|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101545088|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
101545089|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
101545090|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545091|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545092|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
101545093|NCT02271360|Coagulants|coagulants|mesh-ancestor
101545094|NCT01687049|Red yeast rice|red yeast rice|mesh-list
101545095|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101545102|NCT02271399|Aspirin|aspirin|mesh-list
101545128|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101545129|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101545332|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545333|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545334|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101545336|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
101545394|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545395|NCT01339923|Vaccines|vaccines|mesh-list
101545396|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
101545466|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545467|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101545468|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545527|NCT01365507|Insulin|insulin|mesh-list
101545528|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
101545529|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545530|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545531|NCT02995694|Estradiol|estradiol|mesh-list
101545532|NCT02995694|Estrogens|estrogens|mesh-ancestor
101545533|NCT02995694|Hormones|hormones|mesh-ancestor
101545534|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101545535|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545536|NCT01365468|Everolimus|everolimus|mesh-list
101545537|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101545538|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101545539|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545540|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545541|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101545542|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
101545543|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545544|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545545|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
101545546|NCT04827836|Povidone|povidone|mesh-list
101545547|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101545548|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101545580|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
101545581|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101545582|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101545583|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
101545648|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101545649|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
101545650|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
101545651|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545719|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101545787|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101545788|NCT04328493|Filaricides|filaricides|mesh-ancestor
101545789|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
101545790|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
101545792|NCT04396587|Oxycodone|oxycodone|mesh-list
101545861|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545862|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101545863|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546201|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101546273|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
101546274|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
101546275|NCT01175824|Protamines|protamines|mesh-list
101546276|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101546277|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546342|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
101546343|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546344|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546345|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546346|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101546347|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546348|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546349|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546404|NCT01601912|Citalopram|citalopram|mesh-list
101546405|NCT01601912|Escitalopram|escitalopram|mesh-list
101546406|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101546407|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101546473|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101546474|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101546544|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101546546|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
101546616|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546617|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
101546618|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546689|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101546690|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101546691|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101546692|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546693|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546753|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546754|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546755|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101546756|NCT01173055|Analgesics|analgesics|mesh-ancestor
101546757|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
101546758|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546759|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
101546760|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546901|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101546902|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101546932|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101546933|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101546934|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101546936|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
101546942|NCT01605734|Estrogens|estrogens|mesh-ancestor
101546982|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
101546983|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546984|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546985|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101546986|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
101547049|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547050|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547051|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101547052|NCT02270918|Apixaban|apixaban|mesh-list
101547053|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101547054|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
101547109|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
101547110|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
101547111|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
101547170|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547171|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547172|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101547173|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101547174|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101547175|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547176|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
101547177|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547498|NCT00107198|Vincristine|vincristine|mesh-list
101547499|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101547500|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
101547501|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547502|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101547503|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101547504|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
101547544|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547545|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101547546|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101547668|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101547669|NCT01326702|Rituximab|rituximab|mesh-list
101547726|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101547776|NCT04328870|Oxytocin|oxytocin|mesh-list
101547794|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547795|NCT01357655|Dasatinib|dasatinib|mesh-list
101547796|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547861|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547862|NCT01342796|Vaccines|vaccines|mesh-list
101547863|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
101547864|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547922|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547923|NCT01107535|Palivizumab|palivizumab|mesh-list
101547924|NCT01107535|Antibodies|antibodies|mesh-list
101547925|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101547981|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
101547982|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547983|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101547984|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548048|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
101548049|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101548050|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548051|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548052|NCT00601614|Temozolomide|temozolomide|mesh-list
101548054|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
101548114|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101548115|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548116|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548117|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101548183|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548184|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548185|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548186|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548187|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101548188|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101548189|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
101548190|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548192|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101548244|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101548245|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101548246|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548247|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548248|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548249|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101548250|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101548251|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101548252|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101548253|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101548254|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
101548256|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
101548301|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
101548365|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101548366|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101548367|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548428|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548429|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548487|NCT00598676|Sirolimus|sirolimus|mesh-list
101548488|NCT00598676|Everolimus|everolimus|mesh-list
101548554|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101548555|NCT00600626|Insulin|insulin|mesh-list
101548556|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101548557|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
101548624|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548625|NCT04308031|Protective Agents|protective agents|mesh-ancestor
101548626|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548627|NCT01096849|Levofloxacin|levofloxacin|mesh-list
101548628|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101548690|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548692|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548693|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101548694|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101548695|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101548696|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548697|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101548698|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101548699|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
101548736|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548737|NCT01323920|Methotrexate|methotrexate|mesh-list
101548738|NCT01323920|Bortezomib|bortezomib|mesh-list
101548739|NCT01323920|Tacrolimus|tacrolimus|mesh-list
101548740|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101548741|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
101548742|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548743|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101548744|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101548745|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
101548746|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548747|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548748|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548756|NCT01093885|Ambrisentan|ambrisentan|mesh-list
101548794|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
101548795|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101548796|NCT00600093|Amantadine|amantadine|mesh-list
101548797|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101548798|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101548799|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
101548800|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101548861|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101548862|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101548863|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101548864|NCT00600639|Protective Agents|protective agents|mesh-ancestor
101548866|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101548867|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
101548868|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
101548869|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101548870|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101548871|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101548872|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101548873|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
101548874|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101548875|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101548876|NCT00600873|Pramipexole|pramipexole|mesh-list
101548919|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101548920|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101548921|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101548986|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101548987|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101548988|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101548989|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101549057|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549058|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101549059|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549124|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549125|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549126|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101549127|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101549128|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101549200|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101549201|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101549255|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101549257|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549258|NCT01170364|Sibutramine|sibutramine|mesh-list
101549259|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
101549260|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101549261|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
101549262|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101549263|NCT01170208|Insulin|insulin|mesh-list
101549264|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549317|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549318|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549320|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101549377|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549379|NCT01075321|Everolimus|everolimus|mesh-list
101549380|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
101549449|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549450|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101549451|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549452|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549453|NCT01077739|Leucovorin|leucovorin|mesh-list
101549454|NCT01077739|Bevacizumab|bevacizumab|mesh-list
101549455|NCT01077739|Fluorouracil|fluorouracil|mesh-list
101549510|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101549511|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
101549512|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549513|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549514|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101549515|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101549516|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
101549517|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101549518|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101549576|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101549577|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
101549578|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101549581|NCT01309737|Tofacitinib|tofacitinib|mesh-list
101549640|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549641|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549642|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
101549643|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
101549698|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101549699|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101549700|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101549701|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101549703|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101549704|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101549705|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549766|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101549767|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
101549768|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
101549835|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549836|NCT01082965|Donepezil|donepezil|mesh-list
101549837|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101549838|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101549839|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549840|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
101549841|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101549843|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
101549892|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550142|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101550144|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101550145|NCT00596609|Narcotics|narcotics|mesh-ancestor
101550146|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101550147|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188338|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101188339|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101188361|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
101188362|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188363|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
101188364|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188365|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101188366|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101188367|NCT00002796|Analgesics|analgesics|mesh-ancestor
101188368|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
101188369|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188370|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188371|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188372|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
101188373|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
101188374|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101188375|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101188376|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188377|NCT00002802|Cobalt|cobalt|mesh-list
101188379|NCT00002802|Melphalan|melphalan|mesh-list
101188380|NCT00002802|Ifosfamide|ifosfamide|mesh-list
101188381|NCT00002802|Dacarbazine|dacarbazine|mesh-list
101188382|NCT00002802|Carboplatin|carboplatin|mesh-list
101188383|NCT00002802|Doxorubicin|doxorubicin|mesh-list
101188384|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101188385|NCT00002802|Etoposide|etoposide|mesh-list
101188386|NCT00002802|Vincristine|vincristine|mesh-list
101188387|NCT00002802|Vindesine|vindesine|mesh-list
101188388|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188389|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
101188390|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188391|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188392|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188393|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
101188394|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188395|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188396|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188397|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188398|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188432|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
101188433|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188434|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
101188435|NCT00002838|Fludarabine|fludarabine|mesh-list
101188436|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
101188437|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188438|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
101188439|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188440|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188441|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188442|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
101188459|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188460|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188461|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188463|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
101188464|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188465|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188466|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188467|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188468|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188469|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188470|NCT00002892|Interferons|interferons|mesh-list
101188471|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
101188472|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188473|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
101188474|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188475|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
101188476|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188477|NCT00002898|Dactinomycin|dactinomycin|mesh-list
101188478|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
101188480|NCT00002898|Carboplatin|carboplatin|mesh-list
101188481|NCT00002898|Etoposide|etoposide|mesh-list
101188482|NCT00002898|Vincristine|vincristine|mesh-list
101188484|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188485|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
101188486|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188487|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188488|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188489|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
101188490|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188491|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188492|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188493|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188494|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188495|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188496|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188497|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188498|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188499|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188500|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188501|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101188502|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188529|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101188530|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101188531|NCT00002952|Growth Substances|growth substances|mesh-ancestor
101188532|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
101188533|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188534|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101188536|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188537|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188538|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101188539|NCT00002970|Cytarabine|cytarabine|mesh-list
101188540|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
101188541|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101188542|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101188543|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101188544|NCT00002970|Methotrexate|methotrexate|mesh-list
101188545|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101188546|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
101188547|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101188548|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188549|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188550|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
101188551|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188552|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188584|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188586|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188587|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188588|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
101188589|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188590|NCT00002988|Irinotecan|irinotecan|mesh-list
101188591|NCT00002988|Carmustine|carmustine|mesh-list
101188592|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101188593|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188594|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188595|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188596|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188597|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188598|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
101188599|NCT00002994|Interleukin-2|interleukin-2|mesh-list
101188600|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188631|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188633|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188634|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101188635|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
101188636|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101188637|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188638|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188639|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101188640|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188641|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188642|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188643|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188644|NCT00003048|Amifostine|amifostine|mesh-list
101188645|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101188646|NCT00003048|Protective Agents|protective agents|mesh-ancestor
101188647|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188648|NCT00003054|Paclitaxel|paclitaxel|mesh-list
101188649|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188650|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188651|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188652|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188653|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188654|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188655|NCT00003060|Cyclosporine|cyclosporine|mesh-list
101188656|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
101188657|NCT00003060|Busulfan|busulfan|mesh-list
101188663|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188664|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188665|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
101188666|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188667|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188668|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188669|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101188670|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
101188671|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101188672|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188673|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
101188674|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188675|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188676|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101188677|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188678|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
101188679|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188680|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101188681|NCT00003066|Docetaxel|docetaxel|mesh-list
101188682|NCT00003066|Estramustine|estramustine|mesh-list
101188683|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188684|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188711|NCT00003084|Ketoconazole|ketoconazole|mesh-list
101188712|NCT00003084|Paclitaxel|paclitaxel|mesh-list
101188713|NCT00003084|Etoposide|etoposide|mesh-list
101188714|NCT00003084|Vinblastine|vinblastine|mesh-list
101188715|NCT00003084|Doxorubicin|doxorubicin|mesh-list
101188716|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101188717|NCT00003084|Estramustine|estramustine|mesh-list
101188718|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188719|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188720|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188721|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188722|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188723|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188724|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188725|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188726|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188727|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188728|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
101188729|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188730|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101188731|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101188732|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101188733|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
101188734|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188735|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188736|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101188738|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
101188744|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
101188745|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188746|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
101188747|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188748|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188749|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
101188750|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188751|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
101188753|NCT00003114|Etoposide|etoposide|mesh-list
101188782|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188783|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101188784|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101188785|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
101188786|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188787|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
101188788|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188789|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188790|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
101188791|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188792|NCT00003144|Gemcitabine|gemcitabine|mesh-list
101188794|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188795|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188796|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
101188797|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188798|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101188799|NCT00003144|Protective Agents|protective agents|mesh-ancestor
101188800|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188802|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
101188803|NCT00003150|Rituximab|rituximab|mesh-list
101188863|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188864|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
101188865|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188866|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188867|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101188868|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101188869|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
101188870|NCT00003198|Topotecan|topotecan|mesh-list
101188871|NCT00003198|Ifosfamide|ifosfamide|mesh-list
101188872|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101188873|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188874|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188875|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188876|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188877|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188878|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
101188879|NCT00003204|Prednisone|prednisone|mesh-list
101188880|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
101188881|NCT00003204|Rituximab|rituximab|mesh-list
101188882|NCT00003204|Fludarabine|fludarabine|mesh-list
101188883|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
101188884|NCT00003204|Vincristine|vincristine|mesh-list
101188885|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188886|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
101188887|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188888|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188889|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188890|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
101188891|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188892|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188893|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188901|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
101188902|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188903|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188904|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188905|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188906|NCT00003210|Interleukin-12|interleukin-12|mesh-list
101188907|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188908|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
101188909|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188910|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101188911|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101188912|NCT00003210|Growth Substances|growth substances|mesh-ancestor
101188913|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
101188914|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188916|NCT00003216|Fluorouracil|fluorouracil|mesh-list
101188917|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188918|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
101188919|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188920|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188921|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188922|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
101188923|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188924|NCT00003234|Vinorelbine|vinorelbine|mesh-list
101188925|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188926|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188927|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188928|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188929|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188930|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188931|NCT00003240|Vinorelbine|vinorelbine|mesh-list
101188933|NCT00003240|Mitomycins|mitomycins|mesh-list
101188934|NCT00003240|Mitomycin|mitomycin|mesh-list
101188935|NCT00003240|Vinblastine|vinblastine|mesh-list
101188936|NCT00003240|Vindesine|vindesine|mesh-list
101188937|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188938|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188939|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188940|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188941|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188942|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188948|NCT00003252|Amifostine|amifostine|mesh-list
101188951|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188952|NCT00003264|Gemcitabine|gemcitabine|mesh-list
101188953|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188954|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188955|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
101188956|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188958|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101188959|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188960|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188961|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188962|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188963|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
101188964|NCT00003288|Tirapazamine|tirapazamine|mesh-list
101188965|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188966|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
101188967|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188968|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188969|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188983|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188984|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101188985|NCT00003294|Protective Agents|protective agents|mesh-ancestor
101188987|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188988|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
101188989|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188990|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101188991|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101188992|NCT00003330|Growth Substances|growth substances|mesh-ancestor
101188993|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101188994|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188995|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
101188996|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
101188997|NCT00003336|Melphalan|melphalan|mesh-list
101188998|NCT00003336|Busulfan|busulfan|mesh-list
101188999|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101189000|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189001|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
101189002|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189003|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189004|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189005|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
101189006|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189007|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189008|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189009|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101189010|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
101189011|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
101189012|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189013|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101189014|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
101189015|NCT00003336|Hormones|hormones|mesh-ancestor
101189016|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189017|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101189018|NCT00003336|Protective Agents|protective agents|mesh-ancestor
101189019|NCT00003342|Paclitaxel|paclitaxel|mesh-list
101189020|NCT00003342|Carboplatin|carboplatin|mesh-list
101189021|NCT00003342|Gemcitabine|gemcitabine|mesh-list
101189022|NCT00003342|Doxorubicin|doxorubicin|mesh-list
101189023|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101189024|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189025|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189026|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189027|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189028|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189029|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189030|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189031|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
101189032|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189033|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189069|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
101189070|NCT00003396|Melphalan|melphalan|mesh-list
101189071|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101189072|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189073|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
101189074|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189075|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189076|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101420620|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101420621|NCT05143762|Analgesics|analgesics|mesh-ancestor
101420622|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
101420623|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
101420624|NCT00148356|Paclitaxel|paclitaxel|mesh-list
101420625|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101420626|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420627|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
101420628|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
101420629|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
101420630|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420631|NCT00424281|PENTA|penta|mesh-list
101420632|NCT00424281|Fondaparinux|fondaparinux|mesh-list
101189111|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189112|NCT00003408|Interferons|interferons|mesh-list
101189113|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
101189114|NCT00003408|Aldesleukin|aldesleukin|mesh-list
101189115|NCT00003408|Sargramostim|sargramostim|mesh-list
101189116|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189117|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
101189118|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189119|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
101189176|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189177|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189179|NCT00003552|Fludarabine|fludarabine|mesh-list
101189180|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101189181|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189182|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
101189183|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189184|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189185|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189186|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
101189187|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189188|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189189|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189191|NCT00003558|Paclitaxel|paclitaxel|mesh-list
101189192|NCT00003558|Etoposide|etoposide|mesh-list
101189193|NCT00003558|Carboplatin|carboplatin|mesh-list
101189194|NCT00003558|Fluorouracil|fluorouracil|mesh-list
101189195|NCT00003558|Calcium|calcium|mesh-list
101189196|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
101189197|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189198|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189199|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189200|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189201|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189202|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189203|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101189204|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189205|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
101189206|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189207|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189208|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
101189209|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189210|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189211|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189212|NCT00003558|Antidotes|antidotes|mesh-ancestor
101189213|NCT00003558|Protective Agents|protective agents|mesh-ancestor
101189214|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
101189253|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
101189254|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189255|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189256|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189257|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189258|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
101189259|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189260|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189261|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189263|NCT00003594|Protective Agents|protective agents|mesh-ancestor
101189264|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
101189265|NCT00003594|Vitamins|vitamins|mesh-ancestor
101189266|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
101189267|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
101189268|NCT00003600|Hematinics|hematinics|mesh-ancestor
101189269|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
101189271|NCT00003606|Epirubicin|epirubicin|mesh-list
101189272|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189273|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
101189274|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189275|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189276|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189277|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
101189278|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189279|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189280|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189281|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189282|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189283|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189284|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189285|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189286|NCT00003612|Paclitaxel|paclitaxel|mesh-list
101189318|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189319|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101189320|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101189321|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189322|NCT00003666|Irofulven|irofulven|mesh-list
101189323|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189324|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
101189325|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189326|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189327|NCT00003678|Tamoxifen|tamoxifen|mesh-list
101189328|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101189329|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
101189330|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189360|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189361|NCT00003696|Paclitaxel|paclitaxel|mesh-list
101189362|NCT00003696|Etoposide|etoposide|mesh-list
101189363|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
101189364|NCT00003696|Carboplatin|carboplatin|mesh-list
101189366|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101189367|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189368|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189369|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189370|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189371|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189372|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189373|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189374|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
101189375|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189406|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189407|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189408|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189409|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189410|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189411|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189412|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189413|NCT00003744|Gemcitabine|gemcitabine|mesh-list
101189414|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189415|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
101189416|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189417|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189418|NCT00003762|Gemcitabine|gemcitabine|mesh-list
101189419|NCT00003762|Docetaxel|docetaxel|mesh-list
101189420|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189421|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
101189555|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
101189556|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189636|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
101189637|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189638|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
101189639|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189640|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189641|NCT00003954|Cyclosporine|cyclosporine|mesh-list
101189642|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
101189643|NCT00003954|Melphalan|melphalan|mesh-list
101189644|NCT00003954|Cyclosporins|cyclosporins|mesh-list
101189645|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189695|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189696|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101189697|NCT00003972|Tamoxifen|tamoxifen|mesh-list
101189698|NCT00003972|Paclitaxel|paclitaxel|mesh-list
101189699|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
101189700|NCT00003972|Carboplatin|carboplatin|mesh-list
101189701|NCT00003972|Melphalan|melphalan|mesh-list
101189702|NCT00003972|Busulfan|busulfan|mesh-list
101189703|NCT00003972|Thiotepa|thiotepa|mesh-list
101189704|NCT00003972|Sargramostim|sargramostim|mesh-list
101189705|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189706|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189707|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189708|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189709|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189710|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189713|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189714|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189716|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
101189725|NCT00003984|Lintuzumab|lintuzumab|mesh-list
101189726|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101189727|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189728|NCT00003996|Etoposide|etoposide|mesh-list
101189729|NCT00003996|Carmustine|carmustine|mesh-list
101189730|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189731|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189732|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189733|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189734|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189735|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189736|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189737|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
101189739|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189740|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
101189741|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189742|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
101189743|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189744|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189745|NCT00004014|Doxorubicin|doxorubicin|mesh-list
101189746|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101189747|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189748|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189749|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189750|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189751|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189752|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189774|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189775|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
101189776|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189777|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189778|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
101189779|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189780|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189781|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189782|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
101189783|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189784|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189785|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189786|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189787|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189788|NCT00004062|Azacitidine|azacitidine|mesh-list
101189789|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189790|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
101189791|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189792|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189793|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189794|NCT00004068|Irinotecan|irinotecan|mesh-list
101189795|NCT00004068|Temozolomide|temozolomide|mesh-list
101189796|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189827|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
101189828|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
101189829|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189830|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189831|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
101189832|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189833|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189834|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
101189835|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101189836|NCT00004104|Interferons|interferons|mesh-list
101189837|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
101189838|NCT00004104|Interleukin-2|interleukin-2|mesh-list
101189839|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189840|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
101189841|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189842|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
101189843|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189844|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101189845|NCT00004104|Analgesics|analgesics|mesh-ancestor
101189848|NCT00004110|Etoposide|etoposide|mesh-list
101189849|NCT00004110|Isotretinoin|isotretinoin|mesh-list
101189850|NCT00004110|Antibodies|antibodies|mesh-list
101189851|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101189852|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
101189853|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189854|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189855|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189856|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189857|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189858|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189872|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
101189873|NCT00004128|Busulfan|busulfan|mesh-list
101189874|NCT00004128|Etoposide|etoposide|mesh-list
101189875|NCT00004128|Daunorubicin|daunorubicin|mesh-list
101189876|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189877|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
101189878|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189879|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189880|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189881|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
101189882|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189883|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189884|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189885|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189886|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189887|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189888|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189889|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189890|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
101189891|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
101189892|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189893|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189894|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101189895|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101189921|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189922|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189923|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
101189924|NCT00004164|Antidotes|antidotes|mesh-ancestor
101189925|NCT00004164|Protective Agents|protective agents|mesh-ancestor
101189926|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
101189927|NCT00004164|Vitamins|vitamins|mesh-ancestor
101189928|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
101189929|NCT00004176|Etoposide|etoposide|mesh-list
101189930|NCT00004176|Amifostine|amifostine|mesh-list
101189931|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189932|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189933|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189934|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189935|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189936|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189937|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101189938|NCT00004176|Protective Agents|protective agents|mesh-ancestor
101189939|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189940|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
101189941|NCT00004188|Melphalan|melphalan|mesh-list
101189942|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
101189943|NCT00004188|Cisplatin|cisplatin|mesh-list
101189944|NCT00004188|Carboplatin|carboplatin|mesh-list
101189945|NCT00004188|Doxorubicin|doxorubicin|mesh-list
101189946|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101189947|NCT00004188|Etoposide|etoposide|mesh-list
101189948|NCT00004188|Vincristine|vincristine|mesh-list
101189949|NCT00004188|Topotecan|topotecan|mesh-list
101189950|NCT00004188|Isotretinoin|isotretinoin|mesh-list
101189951|NCT00004188|Lenograstim|lenograstim|mesh-list
101189952|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189954|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189955|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189957|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
101189967|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189968|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189969|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189970|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189971|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189976|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
101189977|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189978|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189979|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
101189980|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189981|NCT00004200|Temozolomide|temozolomide|mesh-list
101189982|NCT00004200|Prinomastat|prinomastat|mesh-list
101189983|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189984|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
101189985|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189986|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189987|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
101189988|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
101189989|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189990|NCT00004206|Leucovorin|leucovorin|mesh-list
101189991|NCT00004206|Fluorouracil|fluorouracil|mesh-list
101189992|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
101189993|NCT00004206|Calcium|calcium|mesh-list
101189994|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
101189995|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101189996|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189997|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
101189998|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189999|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190000|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190001|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190002|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
101190003|NCT00004206|Antidotes|antidotes|mesh-ancestor
101190005|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
101190007|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
101190008|NCT00004212|Exatecan|exatecan|mesh-list
101190009|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101190010|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190011|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190012|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190013|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190014|NCT00004218|Prednisolone|prednisolone|mesh-list
101190015|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
101190016|NCT00004218|Chlorambucil|chlorambucil|mesh-list
101190017|NCT00004218|Doxorubicin|doxorubicin|mesh-list
101190018|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101190019|NCT00004218|Fludarabine|fludarabine|mesh-list
101190020|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
101190021|NCT00004218|Vincristine|vincristine|mesh-list
101190022|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190023|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
101190024|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190025|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190026|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190027|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
101190028|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190055|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190056|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190057|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190058|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190059|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190060|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190061|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190062|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190063|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190064|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190065|NCT00004236|Doxorubicin|doxorubicin|mesh-list
101190066|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101420633|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101420634|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
101420635|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101420636|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
101420637|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420638|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190067|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101190068|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190069|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190070|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190071|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190073|NCT00004242|Gemcitabine|gemcitabine|mesh-list
101190074|NCT00004242|Fluorouracil|fluorouracil|mesh-list
101190075|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
101190076|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190077|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
101190078|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190079|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190080|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190081|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
101190082|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190083|NCT00004248|Aldesleukin|aldesleukin|mesh-list
101190084|NCT00004248|Doxorubicin|doxorubicin|mesh-list
101190085|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101190086|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101190087|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190097|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190098|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
101190099|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190100|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190101|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101190102|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190104|NCT00004260|Interleukin-12|interleukin-12|mesh-list
101190105|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101190106|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190107|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
101190108|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190109|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190110|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190111|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101190112|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101190113|NCT00004260|Growth Substances|growth substances|mesh-ancestor
101190114|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
101190115|NCT00004266|Lisinopril|lisinopril|mesh-list
101190116|NCT00004266|Nifedipine|nifedipine|mesh-list
101190117|NCT00004266|Simvastatin|simvastatin|mesh-list
101190118|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101190119|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101190120|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
101190121|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190122|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101190123|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101190124|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190125|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101190126|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190127|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101190141|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190142|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190143|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190144|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
101190145|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
101190146|NCT00004284|Diuretics|diuretics|mesh-ancestor
101190147|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
101190148|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190149|NCT00004284|Expectorants|expectorants|mesh-ancestor
101190150|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
101190151|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
101190152|NCT00004284|Protective Agents|protective agents|mesh-ancestor
101190153|NCT00004344|Leuprolide|leuprolide|mesh-list
101190154|NCT00004344|Testosterone|testosterone|mesh-list
101190155|NCT00004344|Androgens|androgens|mesh-ancestor
101190156|NCT00004344|Hormones|hormones|mesh-ancestor
101190157|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190158|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190159|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101190160|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190161|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101190162|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
101190163|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190164|NCT00004368|Colchicine|colchicine|mesh-list
101190165|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
101190166|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190167|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190191|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101190192|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190193|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101190194|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
101190195|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190196|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190197|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101190198|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101190199|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101190200|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
101190201|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190202|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101190203|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101190204|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
101190205|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101190206|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101190207|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101190208|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190209|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190210|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
101190211|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190212|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190213|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101190214|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190215|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
101190216|NCT00004422|Antibodies|antibodies|mesh-list
101190217|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
101190218|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101190219|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101190220|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
101190221|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190222|NCT00004440|Ibuprofen|ibuprofen|mesh-list
101190223|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101190224|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101190227|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190228|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190229|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190230|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190231|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101190232|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190233|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190234|NCT00004446|Fluoxetine|fluoxetine|mesh-list
101190235|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101190236|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101190237|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190238|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190239|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190240|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
101190241|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190242|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101190243|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
101190244|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101190245|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101190246|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190247|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190248|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
101190249|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190250|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
101190251|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190252|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190253|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190254|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
101190255|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190256|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190257|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190259|NCT00004482|Prednisone|prednisone|mesh-list
101190267|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190268|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101190271|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190273|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
101190274|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
101190275|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190276|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
101190277|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190278|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101190280|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
101190281|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190282|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101190283|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101190284|NCT00004482|Protective Agents|protective agents|mesh-ancestor
101190285|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
101190287|NCT00004488|Alendronate|alendronate|mesh-list
101190288|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
101190289|NCT00004488|Calcium|calcium|mesh-list
101190290|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101190291|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190293|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
101190294|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101190295|NCT00004488|Antacids|antacids|mesh-ancestor
101190296|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190297|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101190298|NCT00004554|Naltrexone|naltrexone|mesh-list
101190299|NCT00004554|Sertraline|sertraline|mesh-list
101190312|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
101190313|NCT00004578|Ritonavir|ritonavir|mesh-list
101190314|NCT00004578|Lopinavir|lopinavir|mesh-list
101190315|NCT00004578|Lamivudine|lamivudine|mesh-list
101190316|NCT00004578|Stavudine|stavudine|mesh-list
101190317|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101190318|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101190319|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190320|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190321|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190322|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190323|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190324|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
101190325|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190326|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101190327|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190328|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101190329|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190330|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
101190331|NCT00004644|Acyclovir|acyclovir|mesh-list
101190332|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
101190333|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190366|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190367|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190368|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
101190369|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190370|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
101190371|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190372|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101190373|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190374|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
101190375|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190376|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190377|NCT00004728|Aspirin|aspirin|mesh-list
101190378|NCT00004728|Warfarin|warfarin|mesh-list
101190379|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101190380|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101190381|NCT00004728|Analgesics|analgesics|mesh-ancestor
101190382|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
101190383|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190384|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190425|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101190426|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101190427|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101190428|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101190429|NCT00004758|Analgesics|analgesics|mesh-ancestor
101190434|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101190435|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101190437|NCT00004758|Vitamins|vitamins|mesh-ancestor
101190438|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
101190439|NCT00004758|Hormones|hormones|mesh-ancestor
101190440|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190441|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101190443|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
101190444|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
101190445|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
101190480|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190481|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190483|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
101190484|NCT00004854|Protective Agents|protective agents|mesh-ancestor
101190485|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101190486|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190487|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101190488|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
101190489|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101190490|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101190491|NCT00004866|Exatecan|exatecan|mesh-list
101190492|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101190493|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190494|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190495|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190496|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190497|NCT00004872|Endostatins|endostatins|mesh-list
101190498|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190499|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101190500|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101190501|NCT00004872|Growth Substances|growth substances|mesh-ancestor
101190502|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190503|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
101190504|NCT00004878|Cytarabine|cytarabine|mesh-list
101190505|NCT00004878|Methotrexate|methotrexate|mesh-list
101190506|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
101190507|NCT00004878|Fludarabine|fludarabine|mesh-list
101190508|NCT00004878|Idarubicin|idarubicin|mesh-list
101190524|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190525|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
101190526|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190527|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101190528|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101190529|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190530|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190531|NCT00004884|Gemcitabine|gemcitabine|mesh-list
101190532|NCT00004884|Docetaxel|docetaxel|mesh-list
101190533|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190534|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190535|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
101190536|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190537|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190538|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190539|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190540|NCT00004890|Aldesleukin|aldesleukin|mesh-list
101190541|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190542|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190543|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190544|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
101190545|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190546|NCT00004920|Raltitrexed|raltitrexed|mesh-list
101190547|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190548|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190549|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
101190550|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190553|NCT00004926|Vitamin D|vitamin d|mesh-list
101190575|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
101190576|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190577|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190578|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101190579|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101190580|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
101190581|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101190582|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190584|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101190585|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190586|NCT00004998|Lamivudine|lamivudine|mesh-list
101190587|NCT00004998|Zidovudine|zidovudine|mesh-list
101190588|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101190589|NCT00004998|Capravirine|capravirine|mesh-list
101190590|NCT00004998|Nelfinavir|nelfinavir|mesh-list
101190591|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101190592|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190593|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190594|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190595|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
101190596|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190597|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190598|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190599|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
101190600|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101190601|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101190602|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190603|NCT00005010|Irbesartan|irbesartan|mesh-list
101190604|NCT00005010|Pravastatin|pravastatin|mesh-list
101190605|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101190606|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101190607|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
101190614|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101190616|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190617|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190618|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190619|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190620|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190621|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190622|NCT00005028|Paclitaxel|paclitaxel|mesh-list
101190623|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
101190624|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190625|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190626|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190627|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190628|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190629|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190630|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190631|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
101190632|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190633|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
101190634|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190635|NCT00005046|Paclitaxel|paclitaxel|mesh-list
101190636|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190637|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190638|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190639|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190640|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190641|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190660|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101190661|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101190662|NCT00005094|Analgesics|analgesics|mesh-ancestor
101190663|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
101190664|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190665|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190666|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190667|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190668|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101190669|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101190672|NCT00005106|Lamivudine|lamivudine|mesh-list
101190673|NCT00005106|Zidovudine|zidovudine|mesh-list
101190674|NCT00005106|Abacavir|abacavir|mesh-list
101190675|NCT00005106|Stavudine|stavudine|mesh-list
101190676|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101190677|NCT00005106|Nelfinavir|nelfinavir|mesh-list
101190678|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101190679|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190680|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190681|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190682|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
101190683|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190684|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190710|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101190711|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190712|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190713|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101190714|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101190716|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101190717|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190718|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101190719|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190720|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190721|NCT00005580|Fludarabine|fludarabine|mesh-list
101190722|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
101190723|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
101190724|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190725|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190726|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
101190727|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190728|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190729|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
101190730|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190731|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190732|NCT00005586|Leucovorin|leucovorin|mesh-list
101190733|NCT00005586|Fluorouracil|fluorouracil|mesh-list
101190734|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
101190735|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
101190745|NCT00005586|Vitamins|vitamins|mesh-ancestor
101190757|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
101190758|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190759|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190760|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190761|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101190762|NCT00005598|Protective Agents|protective agents|mesh-ancestor
101190763|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190764|NCT00005604|Aldesleukin|aldesleukin|mesh-list
101190765|NCT00005604|Interleukin-2|interleukin-2|mesh-list
101190766|NCT00005604|Interleukin-12|interleukin-12|mesh-list
101190767|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190768|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101190769|NCT00005604|Analgesics|analgesics|mesh-ancestor
101190819|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190820|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190821|NCT00005658|Glycine|glycine|mesh-list
101190826|NCT00005796|Vincristine|vincristine|mesh-list
101190893|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101190894|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190895|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
101190896|NCT00355290|Coagulants|coagulants|mesh-ancestor
101190897|NCT00355446|Bimatoprost|bimatoprost|mesh-list
101190898|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101190899|NCT00355524|Ritonavir|ritonavir|mesh-list
101190900|NCT00355524|Darunavir|darunavir|mesh-list
101190901|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101190902|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101190903|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190956|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101190957|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101190958|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
101190959|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190960|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191029|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191030|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101191098|NCT00357942|Morphine|morphine|mesh-list
101191099|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101191100|NCT00357942|Narcotics|narcotics|mesh-ancestor
101191101|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191169|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191170|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
101191171|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191172|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
101191173|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191243|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191244|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191245|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191317|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
101420639|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
101420640|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101191318|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191319|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191387|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191388|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
101191389|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191390|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101191391|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191457|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191458|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101191530|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191531|NCT00368706|Urological Agents|urological agents|mesh-ancestor
101191533|NCT00368862|Escitalopram|escitalopram|mesh-list
101191534|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101191535|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101191600|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101191601|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
101191674|NCT00372138|Thrombin|thrombin|mesh-list
101191675|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
101191676|NCT00372138|Coagulants|coagulants|mesh-ancestor
101191746|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
101191747|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
101191818|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191819|NCT00376818|Hormones|hormones|mesh-list
101191820|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191821|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191822|NCT00377442|Simvastatin|simvastatin|mesh-list
101191823|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101191824|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101191825|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
101191884|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191885|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191886|NCT00378456|Vitamins|vitamins|mesh-list
101191887|NCT00378456|Leucovorin|leucovorin|mesh-list
101191888|NCT00378456|Folic Acid|folic acid|mesh-list
101191889|NCT00378456|Vitamin A|vitamin a|mesh-list
101191891|NCT00378456|Selenium|selenium|mesh-list
101191892|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
101191952|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101191953|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101191954|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191955|NCT00380640|Trimethoprim|trimethoprim|mesh-list
101192021|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192023|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192024|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192025|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192026|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192027|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101192028|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101192029|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
101192030|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192031|NCT00382980|Antacids|antacids|mesh-ancestor
101192085|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192086|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192157|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192227|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101192228|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192229|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
101192230|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
101192231|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
101192233|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101192295|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192296|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
101192297|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192298|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
101192299|NCT01799460|Hormones|hormones|mesh-ancestor
101192300|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192301|NCT02999724|Gabapentin|gabapentin|mesh-list
101192362|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
101192363|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192364|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101192366|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101420641|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101420642|NCT00148395|Carboplatin|carboplatin|mesh-list
101420643|NCT00148395|Gemcitabine|gemcitabine|mesh-list
101420645|NCT00148395|Mitomycins|mitomycins|mesh-list
101420646|NCT00148395|Mitomycin|mitomycin|mesh-list
101420647|NCT00148395|Vinorelbine|vinorelbine|mesh-list
101420648|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420649|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420650|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
101420651|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420652|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101420653|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
101420654|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101420655|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101420656|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192433|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
101192434|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
101192435|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
101192436|NCT02991768|Budesonide|budesonide|mesh-list
101192437|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192438|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101192439|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
101192440|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192441|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192442|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101192443|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192444|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
101192445|NCT02991768|Hormones|hormones|mesh-ancestor
101192446|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192447|NCT02991612|Rifaximin|rifaximin|mesh-list
101192497|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101192498|NCT02990364|Anesthetics|anesthetics|mesh-list
101192499|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192501|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
101192569|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101192570|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101192571|NCT01271166|Growth Substances|growth substances|mesh-ancestor
101192640|NCT01274130|Metformin|metformin|mesh-list
101192641|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101192642|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192643|NCT01276080|Donepezil|donepezil|mesh-list
101192644|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101192645|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192646|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192647|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192648|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192649|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192650|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
101192651|NCT01276548|Carboplatin|carboplatin|mesh-list
101192652|NCT01276548|genexol-PM|genexol-pm|mesh-list
101192653|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192704|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101192705|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192706|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192773|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
101192774|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192778|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192780|NCT01271010|Rituximab|rituximab|mesh-list
101192844|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
101192845|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192917|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101192918|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
101420657|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101420658|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
101420659|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
101420660|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
101420663|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420664|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420665|NCT05141344|Melatonin|melatonin|mesh-list
101420666|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
101420667|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420668|NCT05141344|Protective Agents|protective agents|mesh-ancestor
101192922|NCT00245856|Dalteparin|dalteparin|mesh-list
101192989|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101193062|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101193063|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
101193064|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193065|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193068|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
101193132|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101193133|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101193134|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101193135|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
101193136|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193137|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193201|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101193202|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193203|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
101193204|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193205|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101193206|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101193236|NCT03216564|Vitamin D|vitamin d|mesh-list
101193267|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193268|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
101193337|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193340|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101193406|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101193407|NCT01834014|Bevacizumab|bevacizumab|mesh-list
101193408|NCT01834014|Cetuximab|cetuximab|mesh-list
101193409|NCT01834014|Fluorouracil|fluorouracil|mesh-list
101193410|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
101193479|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
101193480|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
101193481|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
101193482|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193483|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193484|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101193485|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101193486|NCT01838538|Growth Substances|growth substances|mesh-ancestor
101193487|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193488|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
101193489|NCT01838772|Interferons|interferons|mesh-list
101193490|NCT01838772|Ribavirin|ribavirin|mesh-list
101193491|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193496|NCT01838928|Bupivacaine|bupivacaine|mesh-list
101193542|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193543|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193547|NCT01839864|Analgesics|analgesics|mesh-ancestor
101193617|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101193618|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101193619|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
101193620|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193688|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193689|NCT01724268|Prednisolone|prednisolone|mesh-list
101193690|NCT01724268|Methotrexate|methotrexate|mesh-list
101193691|NCT01724268|Methamphetamine|methamphetamine|mesh-list
101420669|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193692|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101193693|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
101193756|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101193757|NCT01725204|Dasatinib|dasatinib|mesh-list
101193758|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193759|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193760|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193824|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101193825|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101193833|NCT01728948|Sorafenib|sorafenib|mesh-list
101193834|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193838|NCT01729104|Rituximab|rituximab|mesh-list
101193890|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193891|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193892|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193893|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193894|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193895|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193896|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101193897|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193898|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193900|NCT01048944|Nicotine|nicotine|mesh-list
101193901|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101193902|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
101193903|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193904|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193905|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101193906|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101193907|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101193908|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193909|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193910|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101193911|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
101193912|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193913|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101193914|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101193915|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193916|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
101193917|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101193918|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101193919|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193920|NCT01048866|Acetaminophen|acetaminophen|mesh-list
101193921|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
101193931|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101193932|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193933|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194003|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101194004|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194005|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101194070|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101194075|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101194147|NCT02240160|Analgesics|analgesics|mesh-ancestor
101194148|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
101194219|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194220|NCT02242656|Narcotics|narcotics|mesh-ancestor
101194221|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194222|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194223|NCT02242656|Analgesics|analgesics|mesh-ancestor
101194224|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
101194225|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194226|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
101194227|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194228|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
101194229|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194230|NCT02242812|Metoprolol|metoprolol|mesh-list
101194231|NCT02242812|Telmisartan|telmisartan|mesh-list
101194232|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194233|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101194281|NCT02243436|Hormones|hormones|mesh-ancestor
101194282|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194424|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101194425|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101194426|NCT02248428|Growth Substances|growth substances|mesh-ancestor
101194497|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
101194498|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194499|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
101194501|NCT02242734|Hydrocodone|hydrocodone|mesh-list
101194568|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194641|NCT00553644|Bortezomib|bortezomib|mesh-list
101194642|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
101194643|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194644|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101194649|NCT00552240|Ritonavir|ritonavir|mesh-list
101194713|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194714|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101194715|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
101194716|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101194784|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194785|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101194786|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194787|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194855|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194856|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
101194857|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101194858|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101194859|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194925|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194926|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194927|NCT05768230|Protective Agents|protective agents|mesh-ancestor
101194928|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194929|NCT05768204|Prednisolone|prednisolone|mesh-list
101194930|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101194931|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
101194932|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101194933|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
101194992|NCT05767723|Ticagrelor|ticagrelor|mesh-list
101194993|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101194994|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101194995|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101194996|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101194997|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101194998|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
101194999|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195000|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195001|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195057|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195058|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101195059|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
101195070|NCT05761431|Octreotide|octreotide|mesh-list
101195128|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101195129|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195130|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195131|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195132|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195133|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195135|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
101195136|NCT05604599|Propofol|propofol|mesh-list
101195137|NCT05604599|Isoflurane|isoflurane|mesh-list
101195138|NCT05604599|Atracurium|atracurium|mesh-list
101195193|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195194|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
101195195|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
101195196|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
101195197|NCT05419427|Denosumab|denosumab|mesh-list
101195198|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101195337|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195338|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195339|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101195340|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195342|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
101195402|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195403|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
101195404|NCT04797156|Coagulants|coagulants|mesh-ancestor
101195405|NCT04772300|Sirolimus|sirolimus|mesh-list
101195406|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101195407|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195408|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101195409|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195410|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
101195411|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101195412|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
101195413|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195414|NCT04759144|Insulin|insulin|mesh-list
101195415|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101195416|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
101195417|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
101195418|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101195419|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195428|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
101195459|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195460|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101195461|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101195462|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
101195463|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195464|NCT04612920|Acetaminophen|acetaminophen|mesh-list
101195465|NCT04612920|Ibuprofen|ibuprofen|mesh-list
101195466|NCT04612920|Oxycodone|oxycodone|mesh-list
101195467|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195468|NCT04612920|Analgesics|analgesics|mesh-ancestor
101195469|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
101195470|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195471|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195472|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
101195473|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195474|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195475|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195476|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101195477|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195478|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195479|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101195480|NCT04612920|Narcotics|narcotics|mesh-ancestor
101195482|NCT04570293|Lidocaine|lidocaine|mesh-list
101195512|NCT04512105|Pitavastatin|pitavastatin|mesh-list
101195513|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195514|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101195515|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101195516|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101195517|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
101195518|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195519|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195520|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101195576|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195577|NCT04344262|Atracurium|atracurium|mesh-list
101195578|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101195579|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101195584|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101195585|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195586|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195587|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195589|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101195590|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195591|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195592|NCT04291521|Ketamine|ketamine|mesh-list
101195593|NCT04291521|Propofol|propofol|mesh-list
101195594|NCT04291521|Etomidate|etomidate|mesh-list
101195595|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101195596|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195597|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195628|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101195629|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
101195630|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
101195631|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101195632|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195633|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195634|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195635|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195695|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101195696|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101195697|NCT03965689|Pevonedistat|pevonedistat|mesh-list
101195698|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101195699|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195700|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
101195769|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
101195770|NCT03786783|Protective Agents|protective agents|mesh-ancestor
101195771|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101195773|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
101195774|NCT03769181|Cemiplimab|cemiplimab|mesh-list
101195775|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195776|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195777|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101195839|NCT03426904|Leucovorin|leucovorin|mesh-list
101195914|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195915|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195916|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
101195917|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195989|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195990|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195991|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195992|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196060|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101196061|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101196062|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
101196063|NCT02538510|Vorinostat|vorinostat|mesh-list
101196130|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101196131|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196132|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101196202|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101196203|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
101196205|NCT00590122|Levodopa|levodopa|mesh-list
101196273|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196274|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196275|NCT04823442|Urological Agents|urological agents|mesh-ancestor
101196283|NCT01384448|Dobutamine|dobutamine|mesh-list
101196347|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101196348|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
101196349|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196350|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196351|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
101196352|NCT01384994|Folic Acid|folic acid|mesh-list
101196417|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101196418|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196488|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101196560|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196561|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101196629|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101196630|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
101196631|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
101196632|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101196633|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101196697|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196698|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101196699|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101196700|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196701|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196766|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196767|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
101196768|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196769|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101196770|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101196771|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101196772|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196773|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196774|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
101196775|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101196830|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101196831|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
101196832|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196902|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101196903|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101196904|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101196905|NCT01388582|Progestins|progestins|mesh-ancestor
101196906|NCT01388582|Hormones|hormones|mesh-ancestor
101196969|NCT01388855|Vitamin D|vitamin d|mesh-list
101196970|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
101196972|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
101196973|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196974|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101196975|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101196976|NCT01388959|Rituximab|rituximab|mesh-list
101196977|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196978|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196979|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
101196980|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196981|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196982|NCT01389063|Maraviroc|maraviroc|mesh-list
101196983|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101196984|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101196985|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196986|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101196987|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101196988|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
101196989|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196990|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101196991|NCT01389167|Naltrexone|naltrexone|mesh-list
101196992|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101196993|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101197022|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197023|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101197024|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101197025|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101197029|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101197031|NCT01389401|Omeprazole|omeprazole|mesh-list
101197032|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101197033|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197034|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101197035|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197084|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197085|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197086|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101197087|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197088|NCT01389505|Bevacizumab|bevacizumab|mesh-list
101197154|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101197155|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197157|NCT01389791|Rocuronium|rocuronium|mesh-list
101197158|NCT01389791|Analgesics|analgesics|mesh-ancestor
101197159|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
101197160|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197223|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101197224|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101197225|NCT01390324|Analgesics|analgesics|mesh-ancestor
101197226|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
101197227|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197228|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197293|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101197294|NCT01390766|Azathioprine|azathioprine|mesh-list
101197295|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
101197296|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197364|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
101197365|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
101197366|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
101197367|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101197369|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
101197371|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101197432|NCT01391403|Artemisinin|artemisinin|mesh-list
101197433|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
101197434|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101197435|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101197436|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197504|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101197506|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
101197507|NCT01392144|Protective Agents|protective agents|mesh-ancestor
101197509|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
101197510|NCT01392157|Trace Elements|trace elements|mesh-ancestor
101197511|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
101197570|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197571|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101197644|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197645|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
101197719|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
101197720|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420670|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420672|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
101420673|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420674|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420675|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
101420676|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420677|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101197721|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197722|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197739|NCT01393340|Omalizumab|omalizumab|mesh-list
101197791|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197792|NCT01393769|Melphalan|melphalan|mesh-list
101197801|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
101197866|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197867|NCT01394354|Dexamethasone|dexamethasone|mesh-list
101197868|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
101197869|NCT01394354|Doxorubicin|doxorubicin|mesh-list
101197870|NCT01394354|Bortezomib|bortezomib|mesh-list
101197871|NCT01394354|Vorinostat|vorinostat|mesh-list
101197936|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101197937|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197938|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197940|NCT01394471|Oxytocin|oxytocin|mesh-list
101198007|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198008|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
101198009|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
101198010|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
101198149|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
101198151|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198152|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101198153|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101198221|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101198222|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
101198223|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198224|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101198290|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101198291|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101198292|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101198293|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101198361|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
101198362|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198363|NCT01396681|Gemcitabine|gemcitabine|mesh-list
101198364|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198365|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198366|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
101198368|NCT01396707|Capecitabine|capecitabine|mesh-list
101198429|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
101198430|NCT01397097|Etonogestrel|etonogestrel|mesh-list
101198431|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101198432|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
101198499|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198500|NCT05268627|Incretins|incretins|mesh-ancestor
101198573|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101198574|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101198575|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198576|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198577|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198578|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198579|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198581|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
101198640|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101198641|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198642|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198710|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198711|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198713|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198782|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198783|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198784|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198785|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101198808|NCT05271539|Hormones|hormones|mesh-ancestor
101198856|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
101198857|NCT05271058|Triamcinolone|triamcinolone|mesh-list
101198858|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101198859|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101198860|NCT05271058|BB 1101|bb 1101|mesh-list
101198861|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101198863|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
101198928|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
101198929|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101198930|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
101199001|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101199002|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199003|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199004|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199005|NCT05209841|Heparin|heparin|mesh-list
101199006|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
101199007|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101199008|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101199009|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199010|NCT05173142|Gemcitabine|gemcitabine|mesh-list
101199011|NCT05173142|Docetaxel|docetaxel|mesh-list
101199065|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199066|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
101199067|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199211|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199212|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101199214|NCT04919564|Furosemide|furosemide|mesh-list
101199282|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
101199283|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199284|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199355|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
101199356|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101199357|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101199430|NCT04095104|Phentermine|phentermine|mesh-list
101199431|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
101199443|NCT04074512|Copper|copper|mesh-list
101199507|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101199508|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199509|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199510|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199511|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
101199512|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199513|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199514|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
101199576|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199577|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199578|NCT03410355|Cortisone|cortisone|mesh-list
101199579|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199580|NCT03399617|Micronutrients|micronutrients|mesh-list
101199581|NCT03399617|Trace Elements|trace elements|mesh-list
101199582|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199583|NCT03386162|Fulvestrant|fulvestrant|mesh-list
101199584|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101199585|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199586|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101199642|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199643|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
101199644|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199645|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199711|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199712|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199713|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199714|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199780|NCT03011775|Aspirin|aspirin|mesh-list
101199781|NCT03011775|Pioglitazone|pioglitazone|mesh-list
101199782|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101199783|NCT03011775|Ramipril|ramipril|mesh-list
101199784|NCT03011775|Bisoprolol|bisoprolol|mesh-list
101199785|NCT03011775|Isosorbide|isosorbide|mesh-list
101199786|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101199787|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101199788|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
101199789|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
101199790|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101199791|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199792|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101199844|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199987|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199988|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
101199989|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199992|NCT02619552|Prednisone|prednisone|mesh-list
101200060|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101200061|NCT02427581|Poly ICLC|poly iclc|mesh-list
101200062|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
101200063|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
101200064|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200065|NCT02427581|Laxatives|laxatives|mesh-ancestor
101200066|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200274|NCT01360593|Gemcitabine|gemcitabine|mesh-list
101200275|NCT01360593|Capecitabine|capecitabine|mesh-list
101200276|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200277|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
101200343|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200344|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200346|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200347|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101200348|NCT00600015|Sorafenib|sorafenib|mesh-list
101200349|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200350|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200351|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200352|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200353|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101200362|NCT00447122|Gemcitabine|gemcitabine|mesh-list
101200404|NCT01397500|Androgens|androgens|mesh-ancestor
101200405|NCT01397500|Hormones|hormones|mesh-ancestor
101200406|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200407|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200408|NCT01397513|Aspirin|aspirin|mesh-list
101200476|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200477|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101200478|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101200479|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200546|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101200547|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101200548|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200549|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101200550|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101200551|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200552|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101200553|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
101200554|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101200555|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200556|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101200557|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101200558|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101200560|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101200561|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101200562|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200563|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200564|NCT01398371|Protective Agents|protective agents|mesh-ancestor
101200565|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200567|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101200568|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
101200569|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200570|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200571|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200572|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
101200573|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101200574|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
101200575|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200576|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200588|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200589|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200591|NCT01398592|Hormones|hormones|mesh-ancestor
101200659|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200661|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101201028|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201081|NCT01402297|Analgesics|analgesics|mesh-ancestor
101201082|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
101201095|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201096|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201097|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
101201166|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101201168|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
101201247|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101201318|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101201319|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
101201320|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101201321|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
101201322|NCT01403818|Mitiglinide|mitiglinide|mesh-list
101201323|NCT01403818|Calcium|calcium|mesh-list
101201328|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201384|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
101201385|NCT01404156|Leucovorin|leucovorin|mesh-list
101201386|NCT01404156|Paclitaxel|paclitaxel|mesh-list
101201387|NCT01404156|Docetaxel|docetaxel|mesh-list
101201388|NCT01404156|Carboplatin|carboplatin|mesh-list
101201389|NCT01404156|Fluorouracil|fluorouracil|mesh-list
101201458|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201459|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201460|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101201461|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
101201462|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201463|NCT01404377|Ropivacaine|ropivacaine|mesh-list
101201526|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
101201527|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201597|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201675|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101201676|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201735|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201736|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201737|NCT01405339|Budesonide|budesonide|mesh-list
101201738|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201739|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101201740|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
101201741|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201742|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201743|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101201744|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
101201745|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
101201800|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201801|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201802|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201803|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201804|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
101201805|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101201868|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
101201869|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201870|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
101201871|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101201941|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101201942|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101201943|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201944|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101201945|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101201946|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101201947|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
101201948|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201949|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101201951|NCT01406470|Antibodies|antibodies|mesh-list
101202004|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202005|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202006|NCT01407016|Metronidazole|metronidazole|mesh-list
101202007|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202008|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101202011|NCT01407211|Vitamin A|vitamin a|mesh-list
101202079|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101202080|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202081|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202082|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
101202083|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
101202151|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
101202152|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
101202153|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420678|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420679|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101420680|NCT03451825|Avelumab|avelumab|mesh-list
101420681|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101420682|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101420683|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202154|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202155|NCT01408199|Lenalidomide|lenalidomide|mesh-list
101202156|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
101202163|NCT01408342|Rituximab|rituximab|mesh-list
101202219|NCT01408797|Bortezomib|bortezomib|mesh-list
101202220|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202221|NCT01408810|Infliximab|infliximab|mesh-list
101202222|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101202289|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202290|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
101202291|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101202363|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202364|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
101202435|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202436|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
101202506|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101202507|NCT01410370|Endostar protein|endostar protein|mesh-list
101202508|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101202575|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202576|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202577|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
101202578|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101202648|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202649|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202650|NCT01411514|Prednisone|prednisone|mesh-list
101202651|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202718|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202719|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
101202720|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202723|NCT01412073|Oxytocin|oxytocin|mesh-list
101202789|NCT01412632|Narcotics|narcotics|mesh-ancestor
101202790|NCT01412632|Analgesics|analgesics|mesh-ancestor
101202791|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
101202792|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202793|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
101202794|NCT01412645|Resveratrol|resveratrol|mesh-list
101202795|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
101202796|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202797|NCT01412645|Protective Agents|protective agents|mesh-ancestor
101202798|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202799|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202801|NCT01412658|Caseins|caseins|mesh-list
101202856|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101202858|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202859|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202860|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202926|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101202927|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
101202928|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202998|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203000|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
101203001|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
101203069|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
101203070|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203071|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
101203074|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
101203141|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101203142|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
101203143|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
101203144|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203214|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101203215|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101203216|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101203217|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
101420684|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
101420685|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420686|NCT00156897|Orlistat|orlistat|mesh-list
101420687|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203281|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203282|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203284|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203285|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203286|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101203287|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101203288|NCT01416480|Theobromine|theobromine|mesh-list
101203289|NCT01416480|Dipropizine|dipropizine|mesh-list
101203290|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101203345|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203348|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101203419|NCT01417390|Gemcitabine|gemcitabine|mesh-list
101203420|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203421|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203422|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
101203489|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203561|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203563|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
101203564|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
101203565|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203633|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203700|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101203701|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101203702|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203703|NCT01418742|Doxycycline|doxycycline|mesh-list
101203704|NCT01418742|Panitumumab|panitumumab|mesh-list
101203705|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203706|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203707|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
101203708|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101203709|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101203710|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101203711|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203712|NCT01418794|Sirolimus|sirolimus|mesh-list
101203713|NCT01418794|Temsirolimus|temsirolimus|mesh-list
101203714|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
101203726|NCT01419041|Crizotinib|crizotinib|mesh-list
101203760|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203761|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
101203762|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101203763|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101203765|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101203766|NCT01419353|Estrogens|estrogens|mesh-ancestor
101203767|NCT01419353|Hormones|hormones|mesh-ancestor
101203769|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203829|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203903|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203904|NCT01420471|Triamcinolone|triamcinolone|mesh-list
101203905|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101203906|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101203907|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101203908|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101203909|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
101203910|NCT01420471|Hormones|hormones|mesh-ancestor
101203911|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203912|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203913|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203914|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
101203915|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203964|NCT01420822|Fluticasone|fluticasone|mesh-list
101203965|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101203966|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101203967|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
101203968|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203969|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203970|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101203971|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
101203973|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101204040|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204041|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204042|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101204043|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
101204044|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204045|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204046|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
101204047|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101204048|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204049|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101204050|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204051|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
101204052|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
101204053|NCT01421212|Antibodies|antibodies|mesh-list
101204054|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
101189226|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189227|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
101189228|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189229|NCT00003582|Paclitaxel|paclitaxel|mesh-list
101189230|NCT00003582|Fluorouracil|fluorouracil|mesh-list
101189231|NCT00003582|Amifostine|amifostine|mesh-list
101189232|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189591|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189592|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189593|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189594|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189595|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189596|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189597|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189598|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189600|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101189601|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101189602|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
101189603|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189604|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189605|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101189606|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189607|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101189608|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101189609|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101189610|NCT00003912|Carboplatin|carboplatin|mesh-list
101189611|NCT00003912|Doxorubicin|doxorubicin|mesh-list
101189612|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101189613|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189614|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189615|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189616|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189617|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189618|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189619|NCT00003924|Interferons|interferons|mesh-list
101189620|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
101189621|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189622|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
101189623|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189624|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
101189625|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189721|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101189722|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101189723|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101189724|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101189753|NCT00004032|Interferons|interferons|mesh-list
101189754|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
101189755|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189756|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
101189757|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189811|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189812|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101189813|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101189815|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
101189817|NCT00004086|Etoposide|etoposide|mesh-list
101189818|NCT00004086|Ifosfamide|ifosfamide|mesh-list
101189819|NCT00004086|Epratuzumab|epratuzumab|mesh-list
101189820|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189821|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189822|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189823|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189824|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189825|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189859|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189958|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189959|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189960|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190091|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190092|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190093|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190094|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
101190095|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190096|NCT00004254|Raltitrexed|raltitrexed|mesh-list
101190134|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101190135|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101190136|NCT00004266|Protective Agents|protective agents|mesh-ancestor
101190138|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101190139|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
101190140|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190168|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190169|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190170|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190171|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190173|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101190174|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190175|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101190176|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190177|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
101190178|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190179|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190180|NCT00004404|Clotrimazole|clotrimazole|mesh-list
101190181|NCT00004404|Miconazole|miconazole|mesh-list
101190182|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
101190183|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190184|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
101190185|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190186|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190187|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190188|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101190189|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190225|NCT00004440|Analgesics|analgesics|mesh-ancestor
101190226|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
101190260|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
101190261|NCT00004482|Cyclosporins|cyclosporins|mesh-list
101190262|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
101190263|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190265|NCT00004482|Hormones|hormones|mesh-ancestor
101190266|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190300|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101190301|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101190302|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190303|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
101190304|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190305|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
101190306|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101190307|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101190308|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101190309|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190310|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190311|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190334|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101190335|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
101190336|NCT00004650|Estrogens|estrogens|mesh-list
101190337|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101190338|NCT00004650|Hormones|hormones|mesh-ancestor
101190339|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190340|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190341|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101190342|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101190343|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101190344|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
101190345|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190346|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101190347|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101190390|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101190391|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101190394|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
101190395|NCT00004734|Folic Acid|folic acid|mesh-list
101190396|NCT00004734|Pyridoxine|pyridoxine|mesh-list
101190398|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
101190399|NCT00004734|Hematinics|hematinics|mesh-ancestor
101190400|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
101190401|NCT00004734|Vitamins|vitamins|mesh-ancestor
101190402|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
101190403|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190404|NCT00004740|Isoniazid|isoniazid|mesh-list
101190405|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
101190406|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101190407|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190408|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101190409|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101190410|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
101190411|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190412|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101190413|NCT00004758|Pyridoxine|pyridoxine|mesh-list
101190414|NCT00004758|Carbamazepine|carbamazepine|mesh-list
101190415|NCT00004758|Valproic Acid|valproic acid|mesh-list
101190416|NCT00004758|Nitrazepam|nitrazepam|mesh-list
101190417|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101190418|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
101190478|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
101190479|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190560|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101190561|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190563|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190564|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101190565|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190566|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190567|NCT00004938|Fluconazole|fluconazole|mesh-list
101190568|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
101190569|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190570|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101190571|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190572|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190608|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190609|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101190610|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101190611|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190612|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101190613|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101190643|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190644|NCT00005070|Irofulven|irofulven|mesh-list
101190645|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190646|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
101190647|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190648|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190649|NCT00005076|Irinotecan|irinotecan|mesh-list
101190650|NCT00005076|Cetuximab|cetuximab|mesh-list
101190651|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101190704|NCT00005520|Candesartan|candesartan|mesh-list
101190705|NCT00005520|Candesartan cilexetil|candesartan cilexetil|mesh-list
101190706|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101190707|NCT00005520|Diuretics|diuretics|mesh-ancestor
101190708|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
101190709|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190736|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190737|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190738|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190739|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190740|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
101190741|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190743|NCT00005586|Protective Agents|protective agents|mesh-ancestor
101190744|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
101190746|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
101190747|NCT00005592|Rituximab|rituximab|mesh-list
101190749|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101190750|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190751|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
101190752|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190753|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190799|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190800|NCT00005634|Vorinostat|vorinostat|mesh-list
101190801|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190802|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101190803|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190804|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190805|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
101190806|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101190807|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190808|NCT00005646|Paclitaxel|paclitaxel|mesh-list
101190809|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190810|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190814|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190816|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101190817|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190818|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
101190822|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
101190823|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190824|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190825|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190828|NCT00005796|Procarbazine|procarbazine|mesh-list
101190829|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190830|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190831|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190832|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190833|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190834|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190835|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190836|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
101190837|NCT00005802|Cytarabine|cytarabine|mesh-list
101190838|NCT00005802|Aldesleukin|aldesleukin|mesh-list
101190839|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
101190840|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101190841|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101190842|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101190843|NCT00005802|Methotrexate|methotrexate|mesh-list
101190844|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
101190846|NCT00005802|Etoposide|etoposide|mesh-list
101190847|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
101190848|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101190849|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
101190850|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190851|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190852|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190853|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
101190854|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190855|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190856|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
101190857|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190858|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101190859|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190860|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
101190861|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190862|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190863|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190864|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190865|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190866|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
101190867|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190868|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190869|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190870|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190871|NCT00005802|Analgesics|analgesics|mesh-ancestor
101190872|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
101190873|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190874|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
101190875|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101190876|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
101190877|NCT00005814|Cetuximab|cetuximab|mesh-list
101190878|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190879|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101420688|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420689|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101420690|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101420691|NCT03459859|Cytarabine|cytarabine|mesh-list
101420692|NCT03459859|Pevonedistat|pevonedistat|mesh-list
101420693|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190880|NCT00354900|Aprotinin|aprotinin|mesh-list
101190881|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
101190882|NCT00354900|Coagulants|coagulants|mesh-ancestor
101190883|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101190884|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101190885|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190886|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190887|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190888|NCT00355290|Vitamin K|vitamin k|mesh-list
101190889|NCT00355290|Vitamins|vitamins|mesh-ancestor
101190919|NCT00355602|Neomycin|neomycin|mesh-list
101190920|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101190921|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
101190922|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190923|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101190924|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101190925|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101190926|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101190927|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190928|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190929|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101190930|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190931|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
101190932|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190933|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190934|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190935|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101190936|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101190937|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101190938|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101190939|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101190940|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101190941|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101190942|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190943|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190944|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
101190945|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190946|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190947|NCT00356226|Clonidine|clonidine|mesh-list
101190948|NCT00356226|Analgesics|analgesics|mesh-ancestor
101190949|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
101190950|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190951|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190952|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101190954|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
101190955|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101190961|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101190963|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
101190985|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101190986|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190988|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190989|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
101190990|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190991|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190992|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190993|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
101190994|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190995|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190996|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190997|NCT00357084|Prednisone|prednisone|mesh-list
101190998|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
101190999|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101191000|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101191001|NCT00357084|Prednisolone|prednisolone|mesh-list
101191002|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
101191003|NCT00357084|Methotrexate|methotrexate|mesh-list
101191004|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101191005|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
101191006|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191007|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
101191008|NCT00357084|Hormones|hormones|mesh-ancestor
101191009|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191010|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191011|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191012|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191013|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101191014|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
101191015|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191016|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191050|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101191051|NCT00357318|Sunitinib|sunitinib|mesh-list
101191052|NCT00357318|Antibodies|antibodies|mesh-list
101191053|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
101191054|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101191055|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191056|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101191057|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101191058|NCT00357318|Growth Substances|growth substances|mesh-ancestor
101191059|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191060|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
101191061|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
101191062|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101191063|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191064|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191066|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101191067|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191068|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191069|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191070|NCT00357630|Gemcitabine|gemcitabine|mesh-list
101191081|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191082|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191083|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101191084|NCT00357864|Carbachol|carbachol|mesh-list
101191085|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101191086|NCT00357864|Miotics|miotics|mesh-ancestor
101191087|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
101191088|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191089|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191090|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101191091|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
101191092|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191093|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191094|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191095|NCT00357864|Analgesics|analgesics|mesh-ancestor
101191096|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
101191097|NCT00357864|Protective Agents|protective agents|mesh-ancestor
101191102|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191103|NCT00357942|Analgesics|analgesics|mesh-ancestor
101191104|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
101191105|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191106|NCT00358020|Thalidomide|thalidomide|mesh-list
101191107|NCT00358020|Bortezomib|bortezomib|mesh-list
101191108|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191109|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191110|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
101191111|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191112|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
101191113|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191114|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191115|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101191116|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101191117|NCT00358020|Growth Substances|growth substances|mesh-ancestor
101191118|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
101191119|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
101191120|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101191121|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191122|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191123|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101191124|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191125|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191126|NCT00358410|Casopitant|casopitant|mesh-list
101191127|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
101191128|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
101191129|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191130|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191131|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191132|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101191133|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191134|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191135|NCT00358488|Albuterol|albuterol|mesh-list
101191136|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101191137|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101191138|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
101191139|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191216|NCT00360750|Vincristine|vincristine|mesh-list
101191217|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191218|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101191219|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101191220|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101191221|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191222|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191223|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191224|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
101191225|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
101191226|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191227|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191228|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
101191229|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191230|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
101191231|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
101191257|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101191259|NCT00361686|Remifentanil|remifentanil|mesh-list
101191260|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101191261|NCT00361686|Narcotics|narcotics|mesh-ancestor
101191262|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191263|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191264|NCT00361686|Analgesics|analgesics|mesh-ancestor
101191265|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
101191266|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191267|NCT00361920|Prednisone|prednisone|mesh-list
101191268|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191269|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
101191270|NCT00361920|Hormones|hormones|mesh-ancestor
101191271|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191272|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191273|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191274|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191275|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
101191276|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101191277|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191278|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191279|NCT00362310|Indinavir|indinavir|mesh-list
101191280|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101191281|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101191282|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
101191283|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191284|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191285|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101191286|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101191287|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
101191288|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191289|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101191290|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
101191291|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191292|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101191293|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101191294|NCT00362700|Clevudine|clevudine|mesh-list
101191333|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191334|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101191335|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
101191336|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
101191337|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177020|NCT01849770|Mexiletine|mexiletine|mesh-list
101191368|NCT00364806|Metoclopramide|metoclopramide|mesh-list
101191369|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
101191370|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
101191371|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
101191372|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191373|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191374|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191375|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101191377|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
101191378|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191379|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191380|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101191381|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101191382|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191383|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191409|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191410|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101191411|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101191412|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191414|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101191415|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
101191416|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191417|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191418|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191419|NCT00365898|Hydromorphone|hydromorphone|mesh-list
101191420|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101191421|NCT00365898|Narcotics|narcotics|mesh-ancestor
101191422|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191423|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191424|NCT00365898|Analgesics|analgesics|mesh-ancestor
101191425|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
101191426|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191427|NCT00366834|Dexamethasone|dexamethasone|mesh-list
101191428|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
101191429|NCT00366834|Ondansetron|ondansetron|mesh-list
101191430|NCT00366834|Casopitant|casopitant|mesh-list
101191431|NCT00366834|BB 1101|bb 1101|mesh-list
101191432|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191433|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
101191434|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
101191435|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191436|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191437|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191438|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
101191439|NCT00366834|Hormones|hormones|mesh-ancestor
101191440|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191441|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191442|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191444|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191445|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191446|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
101191447|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191448|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101191459|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
101191461|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191462|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191463|NCT00367302|Buprenorphine|buprenorphine|mesh-list
101191464|NCT00367302|Methadone|methadone|mesh-list
101191465|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101191466|NCT00367302|Narcotics|narcotics|mesh-ancestor
101191467|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191468|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191469|NCT00367302|Analgesics|analgesics|mesh-ancestor
101191470|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
101191471|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191472|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101191473|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
101191474|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191475|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
101191476|NCT00367536|Estrogens|estrogens|mesh-list
101191477|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101191478|NCT00367536|Hormones|hormones|mesh-ancestor
101191479|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191480|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191481|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101191482|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101191483|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
101191484|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191485|NCT00367614|Pantoprazole|pantoprazole|mesh-list
101191486|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101191487|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191488|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101191489|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191490|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191491|NCT00368160|Eszopiclone|eszopiclone|mesh-list
101191492|NCT00368160|Zopiclone|zopiclone|mesh-list
101191493|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101191494|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191495|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191496|NCT00368238|Aspirin|aspirin|mesh-list
101191497|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
101191498|NCT00368238|Clopidogrel|clopidogrel|mesh-list
101191499|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101191500|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191501|NCT00368238|Analgesics|analgesics|mesh-ancestor
101191502|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
101191503|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191504|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191505|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191506|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191507|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101191508|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101191509|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191510|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101191511|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101191512|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191513|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
101191514|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101191515|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101191516|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101191517|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
101191518|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191549|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191551|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
101191552|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
101191553|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191554|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191555|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
101191556|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101191557|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191558|NCT00369408|Naltrexone|naltrexone|mesh-list
101191559|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101191560|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101191561|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191562|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
101191563|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191564|NCT00369798|Rolipram|rolipram|mesh-list
101191565|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
101191566|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191567|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101191568|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101191569|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191570|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191571|NCT00369954|Carboplatin|carboplatin|mesh-list
101191572|NCT00369954|Gemcitabine|gemcitabine|mesh-list
101191573|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191574|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177367|NCT03064542|Carbimazole|carbimazole|mesh-list
101191613|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191614|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
101191615|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101191616|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191617|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191652|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101191654|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191655|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191656|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191657|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191658|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
101191659|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
101191696|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191697|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191698|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191699|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
101191701|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191702|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191703|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191704|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191705|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191721|NCT00372762|Furosemide|furosemide|mesh-list
101191722|NCT00372762|Bumetanide|bumetanide|mesh-list
101191723|NCT00372762|Diuretics|diuretics|mesh-ancestor
101191724|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
101191725|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191726|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101191727|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191728|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191729|NCT00373464|Etoricoxib|etoricoxib|mesh-list
101191730|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101191731|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191732|NCT00373464|Analgesics|analgesics|mesh-ancestor
101191733|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
101191734|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191735|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191736|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191737|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191738|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101191739|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101191740|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191741|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191742|NCT00373620|Paclitaxel|paclitaxel|mesh-list
101191743|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101191744|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191748|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191749|NCT00373776|Miltefosine|miltefosine|mesh-list
101191750|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
101191751|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191752|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191753|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101191754|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101191755|NCT00374478|Scopolamine|scopolamine|mesh-list
101191756|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101191757|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101191758|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
101191759|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
101191760|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191761|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191762|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191763|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
101191764|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101191765|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
101191766|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191796|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191797|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191798|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101191799|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191800|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191802|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101191803|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
101191804|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191805|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101191806|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
101191807|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
101191808|NCT00376584|Vitamins|vitamins|mesh-ancestor
101191809|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
101191846|NCT00377988|Norgestimate|norgestimate|mesh-list
101191847|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
101191848|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191849|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191850|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101191851|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101191852|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101191853|NCT00378066|Bevacizumab|bevacizumab|mesh-list
101191854|NCT00378066|Capecitabine|capecitabine|mesh-list
101191855|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
101191856|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101191857|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191858|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101191859|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101191860|NCT00378066|Growth Substances|growth substances|mesh-ancestor
101191871|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
101191872|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191873|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191874|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
101191875|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101191876|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
101191877|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191878|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191879|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
101191880|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101191881|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101191882|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
101191883|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
101191893|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
101191894|NCT00378456|Antioxidants|antioxidants|mesh-list
101191895|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
101191896|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191897|NCT00378456|Trace Elements|trace elements|mesh-ancestor
101191898|NCT00378456|Antidotes|antidotes|mesh-ancestor
101191899|NCT00378456|Protective Agents|protective agents|mesh-ancestor
101191900|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
101191901|NCT00378456|Hematinics|hematinics|mesh-ancestor
101191902|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191903|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101191904|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191906|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191907|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191908|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101191909|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191910|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
101191911|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191912|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
101191913|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191914|NCT00378690|Leuprolide|leuprolide|mesh-list
101191915|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101191916|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
101191917|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191918|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191919|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191920|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191921|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101191922|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
101191923|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191924|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191925|NCT00379158|Micronutrients|micronutrients|mesh-list
101191926|NCT00379158|Trace Elements|trace elements|mesh-list
101191927|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191928|NCT00379626|Hormones|hormones|mesh-list
101221901|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191929|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191930|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191932|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101191933|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
101191934|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191935|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191936|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191937|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191978|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191994|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191995|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191996|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101191998|NCT00381342|Hormones|hormones|mesh-ancestor
101191999|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192000|NCT00381654|MP 412|mp 412|mesh-list
101192001|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192002|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192003|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192004|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420695|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420696|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420697|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
101420698|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420699|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420700|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
101420701|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192006|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
101192007|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101192008|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101192009|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192010|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192011|NCT00381732|Urological Agents|urological agents|mesh-ancestor
101192012|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
101192013|NCT00382044|Hematinics|hematinics|mesh-ancestor
101192014|NCT00382356|Dutasteride|dutasteride|mesh-list
101192015|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101192016|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101192017|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192018|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192019|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
101192020|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192032|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192033|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192034|NCT00383136|Tirofiban|tirofiban|mesh-list
101192035|NCT00383136|Abciximab|abciximab|mesh-list
101192036|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
101192037|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101192038|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101192039|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101192040|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192041|NCT00383214|Epratuzumab|epratuzumab|mesh-list
101192042|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192043|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192044|NCT00383370|Aflibercept|aflibercept|mesh-list
101192045|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101192046|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101192047|NCT00383370|Growth Substances|growth substances|mesh-ancestor
101192048|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192049|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101192050|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192053|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192054|NCT00383682|Mexiletine|mexiletine|mesh-list
101192055|NCT00383682|Morphine|morphine|mesh-list
101192056|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101192057|NCT00383682|Narcotics|narcotics|mesh-ancestor
101192058|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192059|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192060|NCT00383682|Analgesics|analgesics|mesh-ancestor
101192061|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
101192062|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192063|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101192064|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101192065|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101192066|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192067|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192068|NCT00383916|Pantoprazole|pantoprazole|mesh-list
101192069|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101192070|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192071|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101192072|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192073|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192074|NCT00383994|Rituximab|rituximab|mesh-list
101192075|NCT00383994|Sargramostim|sargramostim|mesh-list
101192076|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192077|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192078|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
101192079|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192080|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192081|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
101192082|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101192083|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101192084|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
101192092|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192093|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192094|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101192095|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192096|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
101192097|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192099|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101192100|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
101192101|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
101192102|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192103|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192104|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101178132|NCT01965756|Metformin|metformin|mesh-list
101192105|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101192106|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101192107|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192108|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192109|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192110|NCT00384540|Protective Agents|protective agents|mesh-ancestor
101192111|NCT00384618|Vitamin E|vitamin e|mesh-list
101192112|NCT00384618|Pravastatin|pravastatin|mesh-list
101192113|NCT00384618|Vitamins|vitamins|mesh-ancestor
101192114|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
101192115|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192116|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
101192117|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192118|NCT00384618|Protective Agents|protective agents|mesh-ancestor
101192119|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101192120|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101192121|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
101192122|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101192123|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101192124|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192125|NCT00384696|Nicotine|nicotine|mesh-list
101192126|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101192127|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
101192128|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192129|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192130|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101192131|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101192158|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192159|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
101192160|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101192161|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192162|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192164|NCT00386178|Tocopherols|tocopherols|mesh-list
101192165|NCT00386178|Tocotrienols|tocotrienols|mesh-list
101192166|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
101192167|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
101192168|NCT00386178|Vitamins|vitamins|mesh-ancestor
101192169|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
101192170|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192171|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
101192172|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192173|NCT00386178|Protective Agents|protective agents|mesh-ancestor
101192174|NCT00421824|Capecitabine|capecitabine|mesh-list
101192175|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
101192176|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101192177|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
101192178|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192179|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192180|NCT00421980|Etanercept|etanercept|mesh-list
101192181|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101192182|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101192183|NCT00421980|Analgesics|analgesics|mesh-ancestor
101192184|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
101192185|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192186|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192187|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192188|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192189|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192190|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192191|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
101192192|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101192210|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101192211|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192213|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101192214|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192215|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192216|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192217|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101192218|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101192219|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101192220|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192221|NCT00422682|Paclitaxel|paclitaxel|mesh-list
101192222|NCT00422682|Carboplatin|carboplatin|mesh-list
101192223|NCT00422682|Gemcitabine|gemcitabine|mesh-list
101192224|NCT00422682|Temozolomide|temozolomide|mesh-list
101192225|NCT00422682|Topotecan|topotecan|mesh-list
101192232|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192234|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
101192235|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101192236|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
101192237|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101192238|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101192239|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192240|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101192241|NCT00422994|Ropinirole|ropinirole|mesh-list
101192242|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101192243|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101192244|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
101192245|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
101192246|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192247|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192248|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192249|NCT00423228|Donepezil|donepezil|mesh-list
101192250|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101192251|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192252|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192253|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192254|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192255|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192256|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
101192288|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192289|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101192290|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
101192291|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192292|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192293|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101192294|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101192302|NCT02999724|Analgesics|analgesics|mesh-ancestor
101192303|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
101192304|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192305|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192306|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
101192307|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101192308|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101192309|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192310|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192328|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192329|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192330|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101192331|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101192332|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192333|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
101192334|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192335|NCT02996916|Amlodipine|amlodipine|mesh-list
101192336|NCT02996916|Olmesartan|olmesartan|mesh-list
101192337|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101192338|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101192339|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178342|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101192340|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192341|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101192342|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192343|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
101192344|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101192345|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101192347|NCT02996214|Gemcitabine|gemcitabine|mesh-list
101192348|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101192349|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192350|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101192351|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101192352|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
101192353|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192354|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101192355|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
101192356|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
101192357|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101192358|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192359|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192360|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101192361|NCT02996058|Analgesics|analgesics|mesh-ancestor
101192365|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101192367|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192368|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192369|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192370|NCT02995512|Colchicine|colchicine|mesh-list
101192371|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
101192390|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101192391|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101192392|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101192393|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192394|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192395|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192396|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101192397|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
101192398|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
101192399|NCT02993640|Vasopressins|vasopressins|mesh-list
101192400|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
101192401|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
101192402|NCT02993640|Coagulants|coagulants|mesh-ancestor
101192403|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101192404|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101192405|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
101192406|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192407|NCT02993094|Carboplatin|carboplatin|mesh-list
101192408|NCT02993094|Ixazomib|ixazomib|mesh-list
101192409|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192410|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
101192411|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192412|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192413|NCT02992938|Acetazolamide|acetazolamide|mesh-list
101192414|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
101192415|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101192416|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192417|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192418|NCT02992938|Diuretics|diuretics|mesh-ancestor
101192419|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
101192420|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192421|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101192422|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
101192423|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192424|NCT02992548|Pravastatin|pravastatin|mesh-list
101192425|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101192426|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101192427|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
101192428|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192429|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101192480|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192481|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101192482|NCT02999958|Antidotes|antidotes|mesh-ancestor
101192483|NCT02995746|Dexamethasone|dexamethasone|mesh-list
101192484|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192485|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
101192487|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192505|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101192506|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192507|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192508|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101192509|NCT01270074|Azithromycin|azithromycin|mesh-list
101192510|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101192511|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192512|NCT01270308|Lansoprazole|lansoprazole|mesh-list
101192513|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
101192514|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101192515|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192516|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101192517|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192518|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192519|NCT01270386|Apatinib|apatinib|mesh-list
101192520|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192521|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192522|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192523|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192524|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
101192525|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101192526|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101192527|NCT01270932|Dexamethasone|dexamethasone|mesh-list
101192528|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
101192529|NCT01270932|Lenalidomide|lenalidomide|mesh-list
101192530|NCT01270932|BB 1101|bb 1101|mesh-list
101192531|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192532|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
101192534|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192535|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192536|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192537|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
101192538|NCT01270932|Hormones|hormones|mesh-ancestor
101192539|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192540|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101192541|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192542|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
101192543|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192544|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192545|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
101192546|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101192547|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101192548|NCT01270932|Growth Substances|growth substances|mesh-ancestor
101192549|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
101192550|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
101192551|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101192552|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
101192553|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192579|NCT01271166|Antidotes|antidotes|mesh-ancestor
101192580|NCT01271166|Protective Agents|protective agents|mesh-ancestor
101192581|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
101192582|NCT01271166|Vitamins|vitamins|mesh-ancestor
101192583|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
101192584|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192585|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192586|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101192587|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
101192588|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
101192589|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192590|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192591|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101192592|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192593|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101192594|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101192595|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101192596|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192597|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192598|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192599|NCT01272258|Leronlimab|leronlimab|mesh-list
101192600|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101192601|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101192602|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192603|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101192604|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192605|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
101192606|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192607|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
101192608|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101192610|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101192611|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192612|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192613|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192656|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
101192657|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192658|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
101192659|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
101192660|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101192661|NCT01276704|Estrogens|estrogens|mesh-ancestor
101192663|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192664|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192665|NCT01277172|Rituximab|rituximab|mesh-list
101192666|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101192667|NCT01277172|Antibodies|antibodies|mesh-list
101192668|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
101192669|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101192670|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
101192671|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192672|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192673|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192674|NCT01277640|Dapivirine|dapivirine|mesh-list
101192675|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101192698|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192700|NCT01279512|Metformin|metformin|mesh-list
101192701|NCT01279512|Acarbose|acarbose|mesh-list
101192702|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101192703|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192707|NCT01279668|Montelukast|montelukast|mesh-list
101192708|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101192709|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192710|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101192711|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
101192712|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192713|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192714|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101192715|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101192716|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192717|NCT01279902|Rituximab|rituximab|mesh-list
101192718|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192719|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192720|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
101178756|NCT02201394|Aspirin|aspirin|mesh-list
101192721|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192722|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192723|NCT01278342|Octreotide|octreotide|mesh-list
101192724|NCT01278342|Cabergoline|cabergoline|mesh-list
101192725|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192726|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101192727|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192728|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101192729|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101192730|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
101192731|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
101192732|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192753|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192754|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192755|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192756|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192757|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
101192758|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192759|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192760|NCT01275144|Lorazepam|lorazepam|mesh-list
101192761|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
101192762|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
101192763|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
101192764|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192765|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192766|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192767|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178873|NCT02233296|Lasmiditan|lasmiditan|mesh-list
101192768|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192769|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101192770|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101192771|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192772|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
101192779|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
101192781|NCT01271010|Fludarabine|fludarabine|mesh-list
101192782|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192783|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
101192784|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192785|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192786|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101192787|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
101192788|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192789|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192790|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101192791|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192792|NCT01270620|Propofol|propofol|mesh-list
101192793|NCT01270620|Desflurane|desflurane|mesh-list
101192826|NCT01270152|Vitamins|vitamins|mesh-ancestor
101192827|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
101192828|NCT01274988|Methadone|methadone|mesh-list
101192829|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101192830|NCT01274988|Narcotics|narcotics|mesh-ancestor
101192831|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192832|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192835|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192836|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
101192837|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192838|NCT01278498|Escitalopram|escitalopram|mesh-list
101192869|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192870|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101192871|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101192872|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101192873|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192874|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101192875|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101192876|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
101192877|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101192879|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
101192880|NCT00249288|Hematinics|hematinics|mesh-ancestor
101192881|NCT00249288|Vitamins|vitamins|mesh-ancestor
101192882|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
101192921|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192924|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101192925|NCT00245856|Warfarin|warfarin|mesh-list
101192926|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
101192927|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101192928|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101192957|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101192958|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192959|NCT03804840|Dronabinol|dronabinol|mesh-list
101192960|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
101192961|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192962|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192963|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101192964|NCT03804840|Analgesics|analgesics|mesh-ancestor
101192965|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
101192966|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192967|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101192968|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101192969|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192970|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192971|NCT03804840|Hormones|hormones|mesh-ancestor
101179173|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192997|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192999|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193000|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101193001|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101193002|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101193003|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193004|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193005|NCT03801252|Azithromycin|azithromycin|mesh-list
101193006|NCT03801252|Cefazolin|cefazolin|mesh-list
101193007|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193008|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193009|NCT03800550|Clarithromycin|clarithromycin|mesh-list
101193010|NCT03800550|Bedaquiline|bedaquiline|mesh-list
101193011|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193012|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420702|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420703|NCT05594459|Analgesics|analgesics|mesh-list
101420704|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420705|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
101420706|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420707|NCT00507403|Infliximab|infliximab|mesh-list
101420708|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101420709|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193013|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101193014|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193015|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193016|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101193017|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101193018|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
101193019|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101193020|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
101193021|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193022|NCT05742750|Apatinib|apatinib|mesh-list
101193023|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193055|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
101193056|NCT03467256|Fludarabine|fludarabine|mesh-list
101193058|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193059|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
101193060|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193061|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193066|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101193067|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193069|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
101193070|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193071|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101193072|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
101193073|NCT03467256|Hormones|hormones|mesh-ancestor
101193074|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193075|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101193076|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193077|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
101193078|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101193079|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101193080|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101193081|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193082|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
101193083|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193084|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
101193085|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193126|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193147|NCT05311254|Calcium|calcium|mesh-list
101193148|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193149|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193150|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193151|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193152|NCT03215940|Dronabinol|dronabinol|mesh-list
101193153|NCT03215940|Cannabidiol|cannabidiol|mesh-list
101193154|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
101193155|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
101193156|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193157|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193158|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193159|NCT03215940|Analgesics|analgesics|mesh-ancestor
101193160|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
101193161|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193162|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101193163|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101193164|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193165|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193166|NCT03215940|Hormones|hormones|mesh-ancestor
101193167|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193168|NCT03219528|Rifaximin|rifaximin|mesh-list
101193169|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193170|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193171|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101193172|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101193174|NCT03218514|Dalteparin|dalteparin|mesh-list
101193175|NCT03218514|Tinzaparin|tinzaparin|mesh-list
101193176|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101193177|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
101193178|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101193179|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101193180|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193181|NCT03218124|Remifentanil|remifentanil|mesh-list
101193182|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101193183|NCT03218124|Narcotics|narcotics|mesh-ancestor
101193184|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193185|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193186|NCT03218124|Analgesics|analgesics|mesh-ancestor
101193187|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
101193188|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193189|NCT03217734|Adalimumab|adalimumab|mesh-list
101193190|NCT03217734|Methotrexate|methotrexate|mesh-list
101193191|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101193192|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
101193193|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193194|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193195|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193229|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193230|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193231|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
101193232|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193233|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193234|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101193235|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193237|NCT03216564|Calcitriol|calcitriol|mesh-list
101193238|NCT03216564|Vitamins|vitamins|mesh-ancestor
101193239|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
101193240|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193241|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101193242|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193243|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101193244|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179520|NCT02413320|Docetaxel|docetaxel|mesh-list
101193245|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193246|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101193284|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193285|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193294|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193295|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193297|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101193298|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193299|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193300|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193301|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101193302|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101193303|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193304|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193305|NCT03211572|Tamoxifen|tamoxifen|mesh-list
101193306|NCT03211572|Anastrozole|anastrozole|mesh-list
101193307|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101193308|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
101193309|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193310|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193311|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101193312|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193313|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101193314|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101193315|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101193316|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101193317|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101193318|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193319|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420710|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420711|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420712|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193320|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
101193321|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101193322|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
101193323|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193324|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
101193325|NCT03211650|Protective Agents|protective agents|mesh-ancestor
101193326|NCT03211104|Curcumin|curcumin|mesh-list
101193327|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193328|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193329|NCT03211104|Analgesics|analgesics|mesh-ancestor
101193330|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
101193331|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193332|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193333|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193334|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193335|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193336|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193338|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101193339|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101193341|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
101193342|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193343|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193344|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101193345|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101193346|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101193347|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101193348|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101193349|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101193350|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101193351|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101193352|NCT03210324|Mifepristone|mifepristone|mesh-list
101193353|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101193378|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193379|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193381|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101193382|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193383|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193384|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
101193385|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193386|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193387|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101193388|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
101193389|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193390|NCT01833312|Meperidine|meperidine|mesh-list
101193391|NCT01833312|Buspirone|buspirone|mesh-list
101193392|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101193393|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101193394|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193395|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193396|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193397|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101193398|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
101193399|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193400|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193401|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101193402|NCT01833312|Narcotics|narcotics|mesh-ancestor
101193403|NCT01833312|Analgesics|analgesics|mesh-ancestor
101193443|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
101193444|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
101193445|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
101193446|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193495|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193497|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
101193498|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
101193499|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193500|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193501|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
101193529|NCT01839552|Narcotics|narcotics|mesh-ancestor
101193530|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193531|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193532|NCT01839552|Analgesics|analgesics|mesh-ancestor
101193533|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
101193534|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193535|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101193536|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101193537|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
101193538|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
101193539|NCT01839630|Sorafenib|sorafenib|mesh-list
101193540|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193541|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193545|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193546|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193548|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
101193549|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193550|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193551|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193552|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193553|NCT01834248|Poly I-C|poly i-c|mesh-list
101193567|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
101193568|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193569|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101193570|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193571|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193573|NCT01836432|Paclitaxel|paclitaxel|mesh-list
101193574|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101193576|NCT01836432|Fluorouracil|fluorouracil|mesh-list
101193577|NCT01836432|Capecitabine|capecitabine|mesh-list
101193578|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
101193579|NCT01836432|Irinotecan|irinotecan|mesh-list
101193580|NCT01836432|Folfirinox|folfirinox|mesh-list
101193581|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101193582|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193583|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
101193584|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
101193585|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
101193586|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193587|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193588|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
101193589|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193590|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
101193591|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193592|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101193593|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101193594|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193595|NCT01836432|Antidotes|antidotes|mesh-ancestor
101193596|NCT01836432|Protective Agents|protective agents|mesh-ancestor
101193597|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
101193598|NCT01836432|Vitamins|vitamins|mesh-ancestor
101193599|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
101193600|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101193601|NCT01720056|Verapamil|verapamil|mesh-list
101193602|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193603|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
101193604|NCT01720056|Hormones|hormones|mesh-ancestor
101193605|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193606|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193607|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193608|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
101193609|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193610|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101193611|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101193612|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193613|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193614|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
101193615|NCT01720212|Mirabegron|mirabegron|mesh-list
101193616|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101193621|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193654|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
101193655|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
101193656|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193657|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193658|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
101193659|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193660|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193661|NCT01722630|Protective Agents|protective agents|mesh-ancestor
101193662|NCT01722942|Amiodarone|amiodarone|mesh-list
101193663|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101193664|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
101193665|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101193666|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193667|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193668|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101193710|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193711|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101193740|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193741|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101193742|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
101193743|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193744|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101193745|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
101193746|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
101193747|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101193748|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101193749|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193750|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101193751|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101193752|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101193753|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101193754|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101193761|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193762|NCT01725360|Montelukast|montelukast|mesh-list
101193795|NCT01726686|Ropivacaine|ropivacaine|mesh-list
101193796|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
101193798|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193799|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193800|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
101193801|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193803|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193804|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193805|NCT01726920|Naproxen|naproxen|mesh-list
101193806|NCT01726920|Naratriptan|naratriptan|mesh-list
101193846|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101193847|NCT01729104|Growth Substances|growth substances|mesh-ancestor
101193848|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
101193850|NCT01729260|Piperazine|piperazine|mesh-list
101193851|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
101193852|NCT01729260|DMP 777|dmp 777|mesh-list
101193853|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
101193854|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
101193855|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101193856|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193857|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
101193858|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
101193859|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180158|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
101193860|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193861|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193884|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101193886|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
101193887|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
101193888|NCT01049334|Analgesics|analgesics|mesh-ancestor
101180214|NCT03937986|Cocaine|cocaine|mesh-list
101193889|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
101193922|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193923|NCT01048866|Analgesics|analgesics|mesh-ancestor
101193924|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
101193925|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193926|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193927|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
101193928|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193929|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193930|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193935|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101193936|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193937|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
101193938|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193939|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101193940|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193941|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193942|NCT01046682|Analgesics|analgesics|mesh-ancestor
101193943|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
101193944|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193945|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193946|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193948|NCT01044498|Norinyl|norinyl|mesh-list
101193949|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101193950|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101193951|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101193984|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193985|NCT03409068|Anesthetics|anesthetics|mesh-list
101193986|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193987|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193988|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
101193989|NCT03408054|Oxytocin|oxytocin|mesh-list
101193990|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
101193991|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193992|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194012|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194013|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194014|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
101194015|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101194016|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101194017|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194018|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101194019|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101194020|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194021|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194022|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194023|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101194024|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
101194025|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101194026|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194027|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101180397|NCT02663622|Tacrolimus|tacrolimus|mesh-list
101194028|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101194029|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101194030|NCT03403452|Apatinib|apatinib|mesh-list
101194031|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194032|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194033|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194034|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194035|NCT03403140|Etanercept|etanercept|mesh-list
101194036|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101194037|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101194038|NCT03403140|Analgesics|analgesics|mesh-ancestor
101194039|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
101194040|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194041|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194042|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194043|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194044|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194045|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101194046|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
101194048|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101194049|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194050|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194069|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194071|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194072|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101194073|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194074|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194076|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101194077|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
101194078|NCT03402048|Carboplatin|carboplatin|mesh-list
101194079|NCT03402048|Gemcitabine|gemcitabine|mesh-list
101194080|NCT03402048|Docetaxel|docetaxel|mesh-list
101194081|NCT03402048|Pemetrexed|pemetrexed|mesh-list
101194082|NCT03402048|Vinorelbine|vinorelbine|mesh-list
101194083|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180486|NCT00819546|Everolimus|everolimus|mesh-list
101194084|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194085|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
101194086|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194087|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
101194089|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
101194090|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194091|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101194092|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101194093|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101194094|NCT03401502|Ranolazine|ranolazine|mesh-list
101194095|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101194096|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194097|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194098|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
101194099|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101194100|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
101194101|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
101194102|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194103|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194104|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194105|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101194106|NCT03401346|Analgesics|analgesics|mesh-ancestor
101194107|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
101194108|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194109|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
101194132|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194133|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194134|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194135|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
101194137|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
101194138|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194139|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
101194140|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194141|NCT03400020|Protective Agents|protective agents|mesh-ancestor
101194142|NCT00012012|Amifostine|amifostine|mesh-list
101194143|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101194144|NCT00012012|Protective Agents|protective agents|mesh-ancestor
101194145|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194149|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194150|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194151|NCT02240238|Gemcitabine|gemcitabine|mesh-list
101194152|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194153|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
101194154|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194155|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194156|NCT02241096|Lidocaine|lidocaine|mesh-list
101194157|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
101194158|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
101194159|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194160|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194161|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
101194162|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194163|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101194164|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101194165|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101194166|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194167|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194186|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
101194187|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
101194188|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101194189|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
101194190|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194191|NCT02241876|Expectorants|expectorants|mesh-ancestor
101194192|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194193|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101194194|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
101194195|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194196|NCT02241876|Protective Agents|protective agents|mesh-ancestor
101194197|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194198|NCT02241876|Antidotes|antidotes|mesh-ancestor
101194199|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101194200|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101194201|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
101194202|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101194203|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
101180674|NCT02464176|BB 1101|bb 1101|mesh-list
101420713|NCT00156975|Capecitabine|capecitabine|mesh-list
101420714|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
101420715|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420716|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
101420717|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420718|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420719|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
101420720|NCT05594381|Tegafur|tegafur|mesh-list
101420721|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420722|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101420723|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
101420724|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420725|NCT00148473|Misoprostol|misoprostol|mesh-list
101420726|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101420727|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
101194204|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194205|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194206|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101194207|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194208|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
101194209|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101194210|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194211|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194212|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194214|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194215|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101194216|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101194217|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194234|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101194235|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194237|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
101194238|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
101194239|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194240|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194241|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101194242|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101194243|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101194244|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194268|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194269|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
101194270|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
101194271|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194272|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101194273|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
101194274|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194275|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194276|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
101194277|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
101194278|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194279|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194280|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
101194286|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
101194287|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
101194288|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
101194289|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101194290|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
101194291|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
101194292|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194293|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194294|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101194295|NCT02243826|Analgesics|analgesics|mesh-ancestor
101194296|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
101194297|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194298|NCT02244216|Fenoterol|fenoterol|mesh-list
101194299|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101194300|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
101194301|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194302|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194331|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194332|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101194333|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101194334|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194335|NCT02246244|Escitalopram|escitalopram|mesh-list
101194336|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101194337|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101194338|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194339|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194340|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194341|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
101194342|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194343|NCT02246712|Tramadol|tramadol|mesh-list
101194344|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194345|NCT02246712|Narcotics|narcotics|mesh-ancestor
101194374|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194375|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194376|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194377|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101194378|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101194379|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194380|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101194381|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101194382|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194384|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
101194385|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101194386|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
101194387|NCT02247648|Tramadol|tramadol|mesh-list
101194388|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194389|NCT02247648|Narcotics|narcotics|mesh-ancestor
101194390|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194391|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194392|NCT02247648|Analgesics|analgesics|mesh-ancestor
101194393|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
101194394|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194395|NCT02248428|Clarithromycin|clarithromycin|mesh-list
101194396|NCT02248428|Thalidomide|thalidomide|mesh-list
101194397|NCT02248428|Dexamethasone|dexamethasone|mesh-list
101194398|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
101194399|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101194400|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
101194412|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194413|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
101194414|NCT02248428|Hormones|hormones|mesh-ancestor
101194415|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194416|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101194418|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194419|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101194420|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194421|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101194422|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194423|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
101194427|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
101194428|NCT02248506|Clotrimazole|clotrimazole|mesh-list
101194429|NCT02248506|Miconazole|miconazole|mesh-list
101194430|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101194431|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194432|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
101194433|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101194434|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194435|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194436|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194437|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101194438|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
101194439|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194440|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194441|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101194442|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101194443|NCT02248896|Telmisartan|telmisartan|mesh-list
101194444|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
101194445|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
101194446|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101194447|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101194448|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101194449|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194450|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194451|NCT02249130|Ritonavir|ritonavir|mesh-list
101194452|NCT02249130|Lamivudine|lamivudine|mesh-list
101194453|NCT02249130|Zidovudine|zidovudine|mesh-list
101194454|NCT02249130|Stavudine|stavudine|mesh-list
101194455|NCT02249130|Tipranavir|tipranavir|mesh-list
101194456|NCT02249130|Delavirdine|delavirdine|mesh-list
101194457|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101194458|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101194459|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194460|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194461|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194463|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101194464|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
101194465|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194466|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101194467|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194468|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101194493|NCT02244762|Narcotics|narcotics|mesh-ancestor
101194494|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194495|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194496|NCT02244762|Analgesics|analgesics|mesh-ancestor
101194500|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194502|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194503|NCT02242734|Narcotics|narcotics|mesh-ancestor
101194504|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194505|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194506|NCT02242734|Analgesics|analgesics|mesh-ancestor
101194507|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
101194508|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194509|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
101194510|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194511|NCT02244606|Fluconazole|fluconazole|mesh-list
101194512|NCT02244606|Micafungin|micafungin|mesh-list
101194513|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
101194514|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
101194515|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194516|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101194517|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194518|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194519|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194520|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101194521|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
101194522|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194523|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194524|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101194525|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101194544|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101194545|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194546|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194547|NCT02243358|Gemcitabine|gemcitabine|mesh-list
101194548|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194549|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
101194550|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194551|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194552|NCT00559962|Atorvastatin|atorvastatin|mesh-list
101194553|NCT00559962|Ezetimibe|ezetimibe|mesh-list
101194554|NCT00559962|Fenofibrate|fenofibrate|mesh-list
101194555|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101194556|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101194557|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
101194558|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194559|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101194560|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101194561|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194562|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
101194563|NCT00559104|Carmustine|carmustine|mesh-list
101194564|NCT00559104|Etoposide|etoposide|mesh-list
101194565|NCT00559104|Lenograstim|lenograstim|mesh-list
101194566|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101194567|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
101194569|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194570|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101194571|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
101194572|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194573|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194574|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101194575|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101194576|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101194577|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101194578|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194579|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101194580|NCT00558636|Paclitaxel|paclitaxel|mesh-list
101194581|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101194582|NCT00558636|Carboplatin|carboplatin|mesh-list
101194583|NCT00558636|Sorafenib|sorafenib|mesh-list
101194613|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101194615|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194616|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194617|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101194618|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194619|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101194620|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101194621|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101194622|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194623|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194624|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194625|NCT00557310|Teriparatide|teriparatide|mesh-list
101194664|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194665|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101194666|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101194667|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101194668|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101194670|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101194671|NCT00550836|Panitumumab|panitumumab|mesh-list
101194672|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194673|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
101194693|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101194695|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101194696|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101194698|NCT00552708|Carvedilol|carvedilol|mesh-list
101194699|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101194700|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194701|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194702|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194703|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194704|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101194705|NCT00552708|Protective Agents|protective agents|mesh-ancestor
101194706|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194707|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101194708|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101194709|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194710|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194711|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
101194712|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101194717|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101194718|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
101194719|NCT00556374|Denosumab|denosumab|mesh-list
101194720|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101194721|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101194722|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194723|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101194724|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194725|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194727|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
101194728|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194729|NCT03029676|Fentanyl|fentanyl|mesh-list
101194730|NCT03029676|Midazolam|midazolam|mesh-list
101194731|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
101194732|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194733|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194734|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194757|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101194758|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101194759|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
101194760|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194761|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101194762|NCT04278846|Bupivacaine|bupivacaine|mesh-list
101194763|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
101194764|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
101194765|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194766|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194767|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
101194768|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194770|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194771|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194772|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194773|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194774|NCT03839160|Morphine|morphine|mesh-list
101194775|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194776|NCT03839160|Narcotics|narcotics|mesh-ancestor
101194777|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194778|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194779|NCT03839160|Analgesics|analgesics|mesh-ancestor
101194780|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
101194781|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194782|NCT03838926|Trichostatin A|trichostatin a|mesh-list
101194783|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
101194788|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101194789|NCT03834012|Beclomethasone|beclomethasone|mesh-list
101194790|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194791|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
101194792|NCT03834012|Hormones|hormones|mesh-ancestor
101194819|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
101194820|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194821|NCT05440734|Protective Agents|protective agents|mesh-ancestor
101194822|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194823|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194825|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194826|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194827|NCT05444556|Repaglinide|repaglinide|mesh-list
101194828|NCT05444556|Quinidine|quinidine|mesh-list
101194829|NCT05444556|Digoxin|digoxin|mesh-list
101194830|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
101194831|NCT05444556|Omeprazole|omeprazole|mesh-list
101194833|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101194834|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101194835|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
101194836|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194837|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101181812|NCT02652390|Hormones|hormones|mesh-ancestor
101194838|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101194839|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194840|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101194841|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194842|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101194843|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101194844|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101194845|NCT05444556|Protective Agents|protective agents|mesh-ancestor
101194862|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194863|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101194864|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101181864|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101194865|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194866|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101194867|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194868|NCT05440578|Bevacizumab|bevacizumab|mesh-list
101194870|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101194871|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194872|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101194873|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101194874|NCT05440578|Growth Substances|growth substances|mesh-ancestor
101194875|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194876|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
101194877|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101194878|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194879|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194880|NCT01689558|Endostatins|endostatins|mesh-list
101194881|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194882|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101194883|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101194884|NCT01689558|Growth Substances|growth substances|mesh-ancestor
101194885|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194886|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101194888|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101194889|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194890|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101194891|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194892|NCT05768542|Metoprolol|metoprolol|mesh-list
101194893|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101194894|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194895|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
101194896|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
101194897|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194898|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194899|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101194900|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101194901|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101194902|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194903|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194904|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194906|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194907|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194908|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194909|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194910|NCT05768334|Lubiprostone|lubiprostone|mesh-list
101194911|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101194912|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194947|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101194948|NCT05768204|Protective Agents|protective agents|mesh-ancestor
101194949|NCT05768126|Rivastigmine|rivastigmine|mesh-list
101194950|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101194951|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194952|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194953|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194954|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194955|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194956|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101194957|NCT05768126|Protective Agents|protective agents|mesh-ancestor
101194959|NCT05767827|Epinephrine|epinephrine|mesh-list
101194960|NCT05767827|Racepinephrine|racepinephrine|mesh-list
101194961|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
101194962|NCT05767827|Ropivacaine|ropivacaine|mesh-list
101194963|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
101194964|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
101194965|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
101194966|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194967|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194968|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
101194969|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194970|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101194971|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101194972|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101194983|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101194984|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101194985|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
101194986|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101194987|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194988|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
101194989|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
101194990|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101195002|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195003|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195004|NCT05767723|Analgesics|analgesics|mesh-ancestor
101195005|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
101195006|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195007|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195008|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195009|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101195010|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101195011|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101195012|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195013|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
101195014|NCT05767671|Dimercaprol|dimercaprol|mesh-list
101195015|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
101195016|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
101195017|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195018|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
101195020|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101195021|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101195022|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195023|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195024|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195025|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195026|NCT05767632|Urological Agents|urological agents|mesh-ancestor
101195027|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101195028|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101195029|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195030|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195032|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
101195033|NCT05767515|Metformin|metformin|mesh-list
101195034|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195035|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195036|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
101195037|NCT05767515|Vitamins|vitamins|mesh-ancestor
101195038|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
101195039|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
101195040|NCT05767255|Insulin|insulin|mesh-list
101195041|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101195042|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
101195043|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
101195044|NCT05767255|Liraglutide|liraglutide|mesh-list
101195046|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195047|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195048|NCT05767255|Incretins|incretins|mesh-ancestor
101195049|NCT05767255|Hormones|hormones|mesh-ancestor
101195050|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195051|NCT05767229|Carvedilol|carvedilol|mesh-list
101195052|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101195053|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101195054|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195064|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
101195065|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101195066|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101195067|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101195068|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
101195069|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195071|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195072|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101195073|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195075|NCT05755789|Cefotaxime|cefotaxime|mesh-list
101195076|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101195077|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195078|NCT05753267|Mesalamine|mesalamine|mesh-list
101195079|NCT05753267|Fenofibrate|fenofibrate|mesh-list
101195080|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101195081|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
101195082|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195083|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101195084|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195085|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195086|NCT05753267|Analgesics|analgesics|mesh-ancestor
101195087|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
101195088|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195089|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195090|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195091|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195092|NCT05751343|Bevacizumab|bevacizumab|mesh-list
101195093|NCT05751343|Atezolizumab|atezolizumab|mesh-list
101195094|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195095|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195096|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101195097|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101195098|NCT05751343|Growth Substances|growth substances|mesh-ancestor
101195099|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195100|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
101195101|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101195102|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195103|NCT05647681|Acetaminophen|acetaminophen|mesh-list
101195104|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195105|NCT05647681|Analgesics|analgesics|mesh-ancestor
101195106|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
101195107|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195108|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195109|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
101195111|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
101195112|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195113|NCT05642416|Ropivacaine|ropivacaine|mesh-list
101195114|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
101195115|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
101195116|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195117|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195118|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
101195119|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195120|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
101195121|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101195122|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195123|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195124|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195125|NCT05631028|Analgesics|analgesics|mesh-ancestor
101195126|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
101195127|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195144|NCT05604599|Analgesics|analgesics|mesh-ancestor
101195145|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
101195146|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195147|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101195148|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195149|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195150|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195151|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195152|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195153|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101195154|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
101195155|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
101195156|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101195157|NCT05604599|Narcotics|narcotics|mesh-ancestor
101195158|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101195159|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101195160|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101195161|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101195162|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101195163|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101195164|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101195165|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195166|NCT05543837|Capsaicin|capsaicin|mesh-list
101195167|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
101195168|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
101195169|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
101195170|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195171|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195172|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101195173|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101195174|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101195175|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101195176|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101195177|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195178|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195179|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195180|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195181|NCT05486026|Analgesics|analgesics|mesh-ancestor
101195182|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
101195183|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195184|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101195185|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101195186|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
101195187|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195188|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195189|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
101195190|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
101195191|NCT05468099|Povidone|povidone|mesh-list
101195192|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101195202|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
101195204|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195205|NCT05379686|Hormones|hormones|mesh-ancestor
101195206|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195207|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195209|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195210|NCT05332067|Omalizumab|omalizumab|mesh-list
101195211|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101195212|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101195213|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101195214|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195215|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
101195216|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195217|NCT05323890|Tislelizumab|tislelizumab|mesh-list
101195218|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195219|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195220|NCT05284019|Erenumab|erenumab|mesh-list
101195224|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195225|NCT05284019|Analgesics|analgesics|mesh-ancestor
101195226|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
101195227|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195228|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195229|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101195230|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101195231|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195232|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195233|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195234|NCT05271162|Empagliflozin|empagliflozin|mesh-list
101195235|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101195236|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195237|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195238|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195239|NCT05249634|Testosterone|testosterone|mesh-list
101195240|NCT05249634|Androgens|androgens|mesh-ancestor
101195241|NCT05249634|Hormones|hormones|mesh-ancestor
101195242|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195243|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195244|NCT05217342|Diuretics|diuretics|mesh-list
101195245|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
101195246|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195247|NCT05199714|Pramlintide|pramlintide|mesh-list
101195248|NCT05199714|Pancrelipase|pancrelipase|mesh-list
101195249|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195250|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182486|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101195251|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195252|NCT05193370|Vasopressins|vasopressins|mesh-list
101195253|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
101195254|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
101195255|NCT05193370|Giapreza|giapreza|mesh-list
101195256|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
101195257|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
101195258|NCT05193370|Coagulants|coagulants|mesh-ancestor
101195259|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101195260|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101195262|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195263|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101195264|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
101195265|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195266|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195267|NCT05172947|Resveratrol|resveratrol|mesh-list
101195268|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
101195269|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195270|NCT05172947|Protective Agents|protective agents|mesh-ancestor
101195271|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195272|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195273|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101195274|NCT05170607|Antibodies|antibodies|mesh-list
101195275|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
101195276|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195277|NCT05147220|Teriflunomide|teriflunomide|mesh-list
101195278|NCT05147220|Remibrutinib|remibrutinib|mesh-list
101182539|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
101195279|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195280|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195281|NCT05147220|Analgesics|analgesics|mesh-ancestor
101195282|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
101195283|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195284|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195285|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195286|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195287|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101195288|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
101195289|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101195290|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195291|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195295|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101195296|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195297|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101195298|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
101195299|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195300|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101195301|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101195302|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195303|NCT05065164|Denosumab|denosumab|mesh-list
101195304|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101195305|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195306|NCT05057819|Empagliflozin|empagliflozin|mesh-list
101195307|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101195308|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195309|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195310|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195311|NCT05037812|Ketorolac|ketorolac|mesh-list
101195312|NCT05037812|Clonidine|clonidine|mesh-list
101195313|NCT05037812|Epinephrine|epinephrine|mesh-list
101195314|NCT05037812|Morphine|morphine|mesh-list
101195315|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101195316|NCT05037812|Narcotics|narcotics|mesh-ancestor
101195317|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195318|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195319|NCT05037812|Analgesics|analgesics|mesh-ancestor
101195320|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
101195321|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195322|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195323|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195324|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195325|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195326|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195327|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101182640|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
101195328|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101195329|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
101195330|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101195331|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195332|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
101195333|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
101195341|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101195343|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101195344|NCT05019638|Ketorolac|ketorolac|mesh-list
101195345|NCT05019638|Epinephrine|epinephrine|mesh-list
101195346|NCT05019638|Racepinephrine|racepinephrine|mesh-list
101195347|NCT05019638|Morphine|morphine|mesh-list
101195348|NCT05019638|Bupivacaine|bupivacaine|mesh-list
101195349|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
101195350|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
101195351|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
101195352|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195353|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195354|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
101195355|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195356|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101195357|NCT05019638|Narcotics|narcotics|mesh-ancestor
101195358|NCT05019638|Analgesics|analgesics|mesh-ancestor
101195359|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195360|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195361|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195362|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420728|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420729|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420730|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101420731|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420732|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
101420733|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
101420734|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101420735|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101420736|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101420737|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101195363|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195364|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101195365|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101195366|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
101195367|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101195368|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195369|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
101195370|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
101195371|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101195372|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195375|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195376|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101182695|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
101195377|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195378|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101195379|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101195380|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101195381|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195382|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195383|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195384|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195385|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195386|NCT04854512|Metformin|metformin|mesh-list
101195387|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195388|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195389|NCT04806386|Psyllium|psyllium|mesh-list
101195390|NCT04806386|Cathartics|cathartics|mesh-ancestor
101195391|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195392|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
101195393|NCT04804072|Narcotics|narcotics|mesh-ancestor
101195394|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195395|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195396|NCT04804072|Analgesics|analgesics|mesh-ancestor
101195397|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
101195398|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195399|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
101195400|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101195401|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101195420|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195421|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101195422|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195423|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195424|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195426|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101195427|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101182731|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
101195429|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195430|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101195431|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101195432|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195433|NCT04677959|Fluticasone|fluticasone|mesh-list
101195434|NCT04677959|Xhance|xhance|mesh-list
101195435|NCT04677959|Albuterol|albuterol|mesh-list
101195436|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101195437|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195438|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101195439|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
101195440|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195441|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195442|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101195443|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195444|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
101195445|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101195446|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101195447|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101195448|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195449|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195450|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195451|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195452|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
101195453|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101195455|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101195456|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195457|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101195458|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195481|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195483|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
101195484|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
101195485|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195486|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182813|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101195491|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101195492|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195493|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195494|NCT04531462|Empagliflozin|empagliflozin|mesh-list
101195495|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101195496|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195498|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195499|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
101195500|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101195501|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
101195502|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195503|NCT04520139|Expectorants|expectorants|mesh-ancestor
101195504|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195505|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101195506|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
101195507|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195508|NCT04520139|Protective Agents|protective agents|mesh-ancestor
101195509|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195510|NCT04520139|Antidotes|antidotes|mesh-ancestor
101195521|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
101195522|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
101195523|NCT04505254|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101195524|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195525|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182878|NCT00800514|Analgesics|analgesics|mesh-ancestor
101195526|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101195527|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195528|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195529|NCT04501120|Azacitidine|azacitidine|mesh-list
101195530|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101195531|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
101195532|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195533|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195534|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195535|NCT04477317|Epinephrine|epinephrine|mesh-list
101195536|NCT04477317|Racepinephrine|racepinephrine|mesh-list
101195537|NCT04477317|Nordefrin|nordefrin|mesh-list
101195538|NCT04477317|Mepivacaine|mepivacaine|mesh-list
101195539|NCT04477317|Carticaine|carticaine|mesh-list
101195540|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
101195541|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101195542|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195543|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195544|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195545|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195546|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195547|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101195548|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101195549|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
101195550|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195551|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101195552|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
101195553|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
101195554|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
101195555|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101195556|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
101195557|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
101195558|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195559|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
101195560|NCT04469959|Levodopa|levodopa|mesh-list
101195561|NCT04469959|Carbidopa|carbidopa|mesh-list
101195562|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101195563|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101195564|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101195565|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
101195566|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195567|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195568|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195607|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195608|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195610|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101195611|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101195612|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195613|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195614|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
101195615|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195616|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195617|NCT04288427|Urological Agents|urological agents|mesh-ancestor
101195618|NCT04280601|Vitamin D|vitamin d|mesh-list
101195619|NCT04280601|Vitamins|vitamins|mesh-ancestor
101195620|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
101195621|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195622|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101195623|NCT04263064|Clonidine|clonidine|mesh-list
101195624|NCT04263064|Analgesics|analgesics|mesh-ancestor
101195625|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
101195626|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195636|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195637|NCT04189783|Bupivacaine|bupivacaine|mesh-list
101195638|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
101195640|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195641|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195642|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
101195643|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195646|NCT04131309|Daratumumab|daratumumab|mesh-list
101195647|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195648|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
101195649|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
101195650|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195651|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195652|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195653|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
101195654|NCT04131309|Hormones|hormones|mesh-ancestor
101195655|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195656|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101195657|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195658|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101195659|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
101195660|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101195661|NCT04090567|Olaparib|olaparib|mesh-list
101195662|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
101195663|NCT04090567|Cediranib|cediranib|mesh-list
101195680|NCT04040959|Vitamins|vitamins|mesh-ancestor
101195681|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
101195682|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195683|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101195684|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
101195685|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195686|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101195687|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
101195688|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
101183110|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101195689|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101195690|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195691|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195692|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195701|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
101195702|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
101195703|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195704|NCT03959423|Insulin|insulin|mesh-list
101195705|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195706|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195707|NCT03936998|Vancomycin|vancomycin|mesh-list
101195708|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101195709|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195710|NCT03911505|Miglustat|miglustat|mesh-list
101195711|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195712|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195713|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101195714|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101195715|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
101195716|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195717|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101195718|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195719|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195720|NCT03835065|Calpastatin|calpastatin|mesh-list
101195721|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101195722|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
101195723|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195724|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195726|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
101195727|NCT03786783|Melphalan|melphalan|mesh-list
101195728|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
101195729|NCT03786783|Thiotepa|thiotepa|mesh-list
101195730|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101195734|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101195735|NCT03786783|Etoposide|etoposide|mesh-list
101195736|NCT03786783|Vincristine|vincristine|mesh-list
101195737|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
101195738|NCT03786783|Daunorubicin|daunorubicin|mesh-list
101195739|NCT03786783|Topotecan|topotecan|mesh-list
101195740|NCT03786783|Tretinoin|tretinoin|mesh-list
101195742|NCT03786783|Dinutuximab|dinutuximab|mesh-list
101195743|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
101195744|NCT03786783|Razoxane|razoxane|mesh-list
101195745|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
101195746|NCT03786783|Isotretinoin|isotretinoin|mesh-list
101195747|NCT03786783|Sargramostim|sargramostim|mesh-list
101195748|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101195749|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
101195750|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195765|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
101195766|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
101195767|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101195768|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
101195778|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101195779|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195780|NCT03670056|Nivolumab|nivolumab|mesh-list
101195781|NCT03670056|Ipilimumab|ipilimumab|mesh-list
101183201|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101195782|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195783|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195784|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101195785|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195786|NCT03654833|Bevacizumab|bevacizumab|mesh-list
101195787|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
101195788|NCT03654833|Atezolizumab|atezolizumab|mesh-list
101195789|NCT03654833|Niraparib|niraparib|mesh-list
101195790|NCT03654833|Rucaparib|rucaparib|mesh-list
101195791|NCT03654833|Dostarlimab|dostarlimab|mesh-list
101195792|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195793|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195794|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101195795|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101195797|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195798|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
101195799|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101195800|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195801|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101195802|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195811|NCT03635333|Nicotine|nicotine|mesh-list
101420738|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420739|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420740|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
101420741|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420742|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420743|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101420744|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420745|NCT05594342|Dobutamine|dobutamine|mesh-list
101420746|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101420747|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
101420748|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
101195812|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101195813|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
101195814|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195815|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195816|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101195817|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101195818|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195819|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195820|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195822|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101195825|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195827|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101195828|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
101195829|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195830|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195831|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101195833|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195834|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101195835|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
101195836|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
101195837|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
101195840|NCT03426904|Fluorouracil|fluorouracil|mesh-list
101195841|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
101195842|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
101195843|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195844|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101195845|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195846|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101195847|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
101195848|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195849|NCT03426904|Antidotes|antidotes|mesh-ancestor
101195850|NCT03426904|Protective Agents|protective agents|mesh-ancestor
101195851|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
101195852|NCT03426904|Vitamins|vitamins|mesh-ancestor
101195853|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
101195854|NCT03383575|Azacitidine|azacitidine|mesh-list
101195855|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101195856|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
101195857|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195858|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195859|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195860|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
101195861|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
101195862|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195863|NCT03287778|Pyridoxine|pyridoxine|mesh-list
101195864|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
101195865|NCT03287778|Vitamins|vitamins|mesh-ancestor
101195866|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
101195867|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195868|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
101195869|NCT03273413|Pravastatin|pravastatin|mesh-list
101195870|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101195872|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
101195873|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195874|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101195875|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101195876|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195877|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101195878|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101195879|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
101195880|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195881|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101195882|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195887|NCT03074539|Riociguat|riociguat|mesh-list
101195888|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
101195889|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195890|NCT03030131|Durvalumab|durvalumab|mesh-list
101195891|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195892|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195893|NCT03011021|Liraglutide|liraglutide|mesh-list
101195894|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195895|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195896|NCT03011021|Incretins|incretins|mesh-ancestor
101195897|NCT03011021|Hormones|hormones|mesh-ancestor
101195898|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101195899|NCT02995252|Tenofovir|tenofovir|mesh-list
101195900|NCT02995252|Liver Extracts|liver extracts|mesh-list
101195901|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
101195902|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101195903|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101195904|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101195905|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195906|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195908|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101195909|NCT02995252|Hematinics|hematinics|mesh-ancestor
101195910|NCT02983578|Durvalumab|durvalumab|mesh-list
101195911|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
101195912|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101195913|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
101195918|NCT02932826|Insulin|insulin|mesh-list
101195919|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101195923|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
101195924|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101195925|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101195926|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195927|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195928|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195929|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
101195930|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195931|NCT02834637|Vaccines|vaccines|mesh-list
101195932|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
101195933|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195934|NCT02817360|Losartan|losartan|mesh-list
101195935|NCT02817360|Valsartan|valsartan|mesh-list
101195936|NCT02817360|Carvedilol|carvedilol|mesh-list
101195937|NCT02817360|Candesartan|candesartan|mesh-list
101195939|NCT02817360|Enalapril|enalapril|mesh-list
101195940|NCT02817360|Lisinopril|lisinopril|mesh-list
101195941|NCT02817360|Irbesartan|irbesartan|mesh-list
101195942|NCT02817360|Nebivolol|nebivolol|mesh-list
101195943|NCT02817360|Bisoprolol|bisoprolol|mesh-list
101195944|NCT02817360|Perindopril|perindopril|mesh-list
101195945|NCT02817360|Captopril|captopril|mesh-list
101195946|NCT02817360|Quinapril|quinapril|mesh-list
101195947|NCT02817360|Trandolapril|trandolapril|mesh-list
101195948|NCT02817360|Fosinopril|fosinopril|mesh-list
101195949|NCT02817360|Eprosartan|eprosartan|mesh-list
101195950|NCT02817360|Zofenopril|zofenopril|mesh-list
101195952|NCT02817360|Cilazapril|cilazapril|mesh-list
101195953|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101195954|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101195955|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101195956|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101195957|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195958|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101195959|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101195960|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
101195961|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195962|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195964|NCT02817360|Protective Agents|protective agents|mesh-ancestor
101195965|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101195966|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183478|NCT03061812|Hormones|hormones|mesh-ancestor
101195967|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101195968|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
101195969|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101195970|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101195971|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101195972|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
101195973|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195974|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101195975|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101195976|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101195977|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101195978|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
101195979|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
101195980|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195981|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101195982|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
101195983|NCT02743806|Vedolizumab|vedolizumab|mesh-list
101195984|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101195985|NCT02689778|Pirfenidone|pirfenidone|mesh-list
101195986|NCT02689778|Analgesics|analgesics|mesh-ancestor
101195987|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
101195988|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195993|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195994|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195995|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101195996|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101195997|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101195998|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195999|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196000|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101183525|NCT03080142|Bupivacaine|bupivacaine|mesh-list
101196006|NCT02659384|Bevacizumab|bevacizumab|mesh-list
101196007|NCT02659384|Atezolizumab|atezolizumab|mesh-list
101196008|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196009|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196010|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101196011|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101196013|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196014|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
101196015|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101196016|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196017|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101196018|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101196019|NCT02659384|Analgesics|analgesics|mesh-ancestor
101196020|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
101196021|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196023|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196024|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101196025|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101196026|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101196027|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101196028|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196029|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
101196030|NCT02659306|Metformin|metformin|mesh-list
101196031|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101196032|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196033|NCT02591147|Fluorides|fluorides|mesh-list
101196034|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
101196035|NCT02591147|Protective Agents|protective agents|mesh-ancestor
101196036|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196037|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
101196038|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101196039|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
101196040|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196041|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
101196042|NCT02588872|Protective Agents|protective agents|mesh-ancestor
101196043|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
101196044|NCT02579161|Clindamycin|clindamycin|mesh-list
101196045|NCT02579161|Gentamicins|gentamicins|mesh-list
101196046|NCT02579161|Penicillins|penicillins|mesh-list
101196047|NCT02579161|Ampicillin|ampicillin|mesh-list
101196048|NCT02579161|Cephalosporins|cephalosporins|mesh-list
101196049|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
101196050|NCT02579161|Lincosamides|lincosamides|mesh-list
101196051|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101196052|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196053|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196054|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196055|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196056|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196057|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196058|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101196059|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101196064|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196065|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196066|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101196067|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196068|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101196069|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196070|NCT02419040|Lidocaine|lidocaine|mesh-list
101196071|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
101196072|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
101196073|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196074|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196075|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
101196076|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196077|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101196078|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101196079|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101196080|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196083|NCT02387203|Clarithromycin|clarithromycin|mesh-list
101196084|NCT02387203|Lansoprazole|lansoprazole|mesh-list
101196085|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101196086|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196087|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101196088|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196089|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196090|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101196091|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101196092|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101196093|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101196094|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101196096|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
101196098|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196099|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196100|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
101196101|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196102|NCT02296229|Androgens|androgens|mesh-list
101196103|NCT02296229|Hormones|hormones|mesh-ancestor
101196104|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196105|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196106|NCT02192398|Guanfacine|guanfacine|mesh-list
101196107|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196108|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101196109|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101196110|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196111|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196112|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196113|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196114|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196115|NCT01992653|Prednisone|prednisone|mesh-list
101196116|NCT01992653|Prednisolone|prednisolone|mesh-list
101196117|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
101196118|NCT01992653|Rituximab|rituximab|mesh-list
101196119|NCT01992653|Doxorubicin|doxorubicin|mesh-list
101196121|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
101196122|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196123|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
101196124|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196125|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196126|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101196127|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
101196128|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196129|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196133|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196134|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196135|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196136|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196137|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
101196139|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196140|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101196141|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
101196142|NCT01850303|Gemcitabine|gemcitabine|mesh-list
101196143|NCT01850303|Pemetrexed|pemetrexed|mesh-list
101196144|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196145|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
101196146|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196147|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196148|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196149|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101196150|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101196151|NCT01763671|Paclitaxel|paclitaxel|mesh-list
101196152|NCT01763671|Docetaxel|docetaxel|mesh-list
101196154|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101196155|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196161|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101196162|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101196163|NCT01763671|Growth Substances|growth substances|mesh-ancestor
101196164|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196165|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
101196174|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196175|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101196176|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101196183|NCT01681264|Guanfacine|guanfacine|mesh-list
101196184|NCT01681264|Morphine|morphine|mesh-list
101196185|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101196186|NCT01681264|Narcotics|narcotics|mesh-ancestor
101196187|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196188|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196189|NCT01681264|Analgesics|analgesics|mesh-ancestor
101196190|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
101196191|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196192|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196193|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101196194|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101196195|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196196|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196197|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196198|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196199|NCT01654276|Febuxostat|febuxostat|mesh-list
101196200|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
101196201|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196204|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196206|NCT00590122|Carbidopa|carbidopa|mesh-list
101196207|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101196208|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101196209|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101196210|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
101196211|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196212|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196213|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196214|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101196215|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196216|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101196217|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
101196218|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
101196219|NCT00309192|Triamcinolone|triamcinolone|mesh-list
101196220|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101196221|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101196222|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101196223|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196224|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
101196225|NCT00309192|Hormones|hormones|mesh-ancestor
101196226|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196227|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196228|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196229|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
101196230|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196231|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196232|NCT00110591|Leronlimab|leronlimab|mesh-list
101196233|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101196234|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101196235|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196236|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101196237|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101196238|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
101196239|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196240|NCT01689246|Methylene Blue|methylene blue|mesh-list
101196241|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196242|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196243|NCT01685268|Prednisone|prednisone|mesh-list
101196244|NCT01685268|Prednisolone|prednisolone|mesh-list
101196245|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
101196246|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196247|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
101196249|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196251|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101196253|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101196254|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196255|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196257|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101196258|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101196259|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
101196260|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196261|NCT01683084|Telmisartan|telmisartan|mesh-list
101196262|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196263|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101196264|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101196265|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196266|NCT04823442|Bisoprolol|bisoprolol|mesh-list
101196267|NCT04823442|Mirabegron|mirabegron|mesh-list
101196268|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101196269|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101196270|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196271|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196272|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196276|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196277|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
101196278|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
101196279|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196280|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101196281|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101196282|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101196284|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101196286|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
101196287|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196288|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196289|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101196290|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101196291|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196292|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196293|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196294|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196295|NCT01384448|Protective Agents|protective agents|mesh-ancestor
101196296|NCT01384578|Vitamins|vitamins|mesh-list
101196297|NCT01384578|Vitamin E|vitamin e|mesh-list
101196298|NCT01384578|Tocopherols|tocopherols|mesh-list
101196299|NCT01384578|Tocotrienols|tocotrienols|mesh-list
101196300|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
101196301|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
101196302|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
101196303|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196304|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
101196305|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196306|NCT01384578|Protective Agents|protective agents|mesh-ancestor
101196307|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101196308|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196309|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101196310|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101196311|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
101183820|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
101196313|NCT01384643|Propofol|propofol|mesh-list
101196314|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101196315|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196316|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196317|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101196318|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
101420750|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420751|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101420752|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101246521|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101246522|NCT01666587|Ibuprofen|ibuprofen|mesh-list
101246523|NCT01666587|Antioxidants|antioxidants|mesh-list
101246524|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
101246525|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246526|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246527|NCT01666587|Analgesics|analgesics|mesh-ancestor
101246528|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
101196319|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
101196320|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101196322|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101196323|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101196324|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196326|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101196327|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
101196328|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196329|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101196330|NCT01384695|Proflavine|proflavine|mesh-list
101196333|NCT01384708|Proflavine|proflavine|mesh-list
101196334|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101196335|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196336|NCT01384799|Cisplatin|cisplatin|mesh-list
101196337|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196338|NCT01384812|Dinoprostone|dinoprostone|mesh-list
101196339|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
101196340|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101196341|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196342|NCT01384864|Proflavine|proflavine|mesh-list
101196343|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101196344|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196345|NCT01384903|Antithrombins|antithrombins|mesh-list
101196346|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
101196353|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
101196354|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
101196355|NCT01384994|Fluorouracil|fluorouracil|mesh-list
101196356|NCT01384994|Panitumumab|panitumumab|mesh-list
101196357|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196358|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
101196359|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196360|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196361|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196362|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
101196363|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196364|NCT01384994|Hematinics|hematinics|mesh-ancestor
101196366|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
101196367|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196368|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
101196369|NCT01385020|Red yeast rice|red yeast rice|mesh-list
101196370|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101196371|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
101196372|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196373|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101196374|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101196375|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101196376|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196377|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101196378|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101196379|NCT01385124|Cannabidiol|cannabidiol|mesh-list
101196380|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
101196381|NCT01385228|Prednisone|prednisone|mesh-list
101196382|NCT01385228|Docetaxel|docetaxel|mesh-list
101196383|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196384|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
101246529|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246530|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246531|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246532|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246533|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246534|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246535|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246536|NCT01666587|Protective Agents|protective agents|mesh-ancestor
101246537|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246538|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246539|NCT01666600|Nintedanib|nintedanib|mesh-list
101246540|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246541|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101246542|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246543|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246544|NCT01666665|Metformin|metformin|mesh-list
101246545|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101196385|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
101196386|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
101196387|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196389|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
101196390|NCT01385228|Hormones|hormones|mesh-ancestor
101196391|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196392|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196393|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101196394|NCT01385345|Vitamin D|vitamin d|mesh-list
101196395|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
101196396|NCT01385345|Vitamins|vitamins|mesh-ancestor
101196397|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
101196398|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196399|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101196400|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101196402|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196403|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
101196404|NCT01385527|Hormones|hormones|mesh-ancestor
101196405|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196406|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196407|NCT01385631|Ezetimibe|ezetimibe|mesh-list
101196408|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101196409|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101196410|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
101196411|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196412|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101196413|NCT01385683|Clarithromycin|clarithromycin|mesh-list
101196414|NCT01385683|Dabigatran|dabigatran|mesh-list
101196422|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
101196423|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101196424|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101196425|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
101196427|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101196428|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196429|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196430|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101196431|NCT01385735|Protective Agents|protective agents|mesh-ancestor
101196432|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196433|NCT01385826|Antibodies|antibodies|mesh-list
101196434|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101196435|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
101196436|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196438|NCT01385891|Clofarabine|clofarabine|mesh-list
101196439|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101196440|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196441|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196442|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196443|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196444|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196445|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196446|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
101196447|NCT01385956|Gemcitabine|gemcitabine|mesh-list
101196448|NCT01385956|Pasireotide|pasireotide|mesh-list
101196449|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196450|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
101196451|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196452|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196453|NCT01385956|Hormones|hormones|mesh-ancestor
101196454|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196455|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196456|NCT01386086|Aripiprazole|aripiprazole|mesh-list
101196457|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
101196458|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101196459|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101196460|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101196461|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196462|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196463|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
101196464|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
101196465|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196466|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196467|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101196468|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101196469|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
101196470|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101196471|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101196472|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101196473|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101196474|NCT01386151|Mitogens|mitogens|mesh-list
101196475|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
101196476|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196477|NCT01386164|Vaccines|vaccines|mesh-list
101196478|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
101196479|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196480|NCT01386177|Doxazosin|doxazosin|mesh-list
101196481|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101196482|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
101196483|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196484|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101196485|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
101196489|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101196490|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196491|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196492|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196493|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101196494|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101196495|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101196496|NCT01386229|Ketamine|ketamine|mesh-list
101196499|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
101196500|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196501|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196502|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101196503|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101196504|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
101196505|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
101196506|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196507|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101196508|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101196509|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196510|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196511|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101196512|NCT01386242|Interferons|interferons|mesh-list
101196513|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196514|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
101196515|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196516|NCT01386255|Baclofen|baclofen|mesh-list
101196517|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101196518|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196519|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101196520|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196521|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
101196522|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
101196523|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
101196524|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196525|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196526|NCT01386268|Factor VIII|factor viii|mesh-list
101196528|NCT01386294|Tenofovir|tenofovir|mesh-list
101196529|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
101196530|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196531|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101196532|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101184056|NCT03485976|Ixekizumab|ixekizumab|mesh-list
101196534|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196535|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101196536|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101196537|NCT01386333|Oxytocin|oxytocin|mesh-list
101196538|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
101196539|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101196540|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196541|NCT01386346|Capecitabine|capecitabine|mesh-list
101196542|NCT01386346|Azacitidine|azacitidine|mesh-list
101196543|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
101196544|NCT01386346|Epirubicin|epirubicin|mesh-list
101196545|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196546|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
101196547|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196548|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196549|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196550|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101196551|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196552|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196554|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101196555|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196556|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
101196557|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196562|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196563|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184116|NCT03541356|Carbidopa|carbidopa|mesh-list
101196564|NCT01386502|Pidilizumab|pidilizumab|mesh-list
101196565|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196566|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196567|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
101196568|NCT01386567|Citric Acid|citric acid|mesh-list
101196569|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
101196570|NCT01386567|Enclomiphene|enclomiphene|mesh-list
101196571|NCT01386567|Clomiphene|clomiphene|mesh-list
101196572|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
101196573|NCT01386567|Testosterone|testosterone|mesh-list
101196574|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
101196575|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
101196576|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101196580|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
101196581|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196582|NCT01386567|Androgens|androgens|mesh-ancestor
101196583|NCT01386567|Hormones|hormones|mesh-ancestor
101196584|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196585|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196586|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101196587|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196588|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
101196589|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101196590|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
101196591|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101196592|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
101196593|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101196594|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101196595|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101196597|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101196598|NCT01386580|Trastuzumab|trastuzumab|mesh-list
101196599|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101196600|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196601|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196602|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196603|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196604|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196605|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196606|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
101196607|NCT01386593|Rifampin|rifampin|mesh-list
101196608|NCT01386593|Fluconazole|fluconazole|mesh-list
101196609|NCT01386593|Paroxetine|paroxetine|mesh-list
101196610|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101196611|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196612|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196613|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196614|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196615|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196616|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196617|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101196618|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101184156|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196619|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101196620|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101196621|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196622|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196623|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
101196624|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196625|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101196626|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
101196627|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101196628|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101196634|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101196635|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101196636|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101196637|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101196638|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101196639|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
101196640|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101196641|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101196642|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
101196643|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196644|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101196645|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101196647|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101196651|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196652|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196654|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196662|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101196663|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196666|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
101196667|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196668|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101196669|NCT01386853|Atorvastatin|atorvastatin|mesh-list
101196670|NCT01386853|Pitavastatin|pitavastatin|mesh-list
101196671|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101196672|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101196673|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
101196674|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196675|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101196676|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101196677|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196678|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
101196679|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101196680|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196681|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196682|NCT01386879|Methylene Blue|methylene blue|mesh-list
101196683|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196684|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196686|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
101196687|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101196688|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196689|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101196690|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
101196691|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196692|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196693|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101196694|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101196695|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
101196702|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196703|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196704|NCT01387048|Adapalene|adapalene|mesh-list
101196705|NCT01387048|Azelaic acid|azelaic acid|mesh-list
101196706|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101196707|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101196708|NCT01387048|Analgesics|analgesics|mesh-ancestor
101196709|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
101196710|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196711|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196712|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196713|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101196714|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
101196715|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196716|NCT01387087|Peficitinib|peficitinib|mesh-list
101196717|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196718|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196719|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196720|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
101196721|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196722|NCT01387191|Epoprostenol|epoprostenol|mesh-list
101196723|NCT01387191|Tezosentan|tezosentan|mesh-list
101196724|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196725|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101196726|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
101196727|NCT01387204|Trametinib|trametinib|mesh-list
101196728|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196735|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101196736|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101196737|NCT01387295|Capecitabine|capecitabine|mesh-list
101196738|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
101196739|NCT01387295|Trastuzumab|trastuzumab|mesh-list
101196740|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196741|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
101196742|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196743|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196744|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196745|NCT01387373|Capecitabine|capecitabine|mesh-list
101196746|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
101196747|NCT01387373|Trastuzumab|trastuzumab|mesh-list
101196748|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196749|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
101196750|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196751|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196752|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196753|NCT01387399|Cisplatin|cisplatin|mesh-list
101196754|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196755|NCT01387425|Varenicline|varenicline|mesh-list
101196756|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101196757|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101196758|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
101196759|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196760|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196761|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196763|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
101196764|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
101196765|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101196776|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
101196777|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196778|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
101196779|NCT01387620|Protective Agents|protective agents|mesh-ancestor
101196780|NCT01387880|Everolimus|everolimus|mesh-list
101196781|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101196782|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101196783|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196784|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196785|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196786|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
101196787|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196788|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196789|NCT01387906|Bimatoprost|bimatoprost|mesh-list
101196790|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101196791|NCT01387997|Antibodies|antibodies|mesh-list
101196792|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
101196793|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196794|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
101196795|NCT01388023|Listerine|listerine|mesh-list
101196796|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101196797|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196799|NCT01388036|Esmolol|esmolol|mesh-list
101196800|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101196801|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101196805|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196806|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196807|NCT01388049|Antibodies|antibodies|mesh-list
101196808|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
101196809|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196810|NCT01388062|Antibodies|antibodies|mesh-list
101196811|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
101196812|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196838|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101184394|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101196839|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196840|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196841|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101196843|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
101196844|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196845|NCT01388114|Antibodies|antibodies|mesh-list
101196846|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
101196847|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196848|NCT01388153|Acarbose|acarbose|mesh-list
101196849|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101196850|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196851|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196852|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101196853|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196854|NCT01388270|Heparin|heparin|mesh-list
101196855|NCT01388270|Calcium heparin|calcium heparin|mesh-list
101196856|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
101196857|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101196858|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101196859|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196860|NCT01388322|Enoxaparin|enoxaparin|mesh-list
101196861|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
101196862|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101196863|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101196864|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196909|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101196914|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196915|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101196916|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
101196917|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
101196918|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101196919|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101196920|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101196921|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101196922|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
101196923|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196924|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196927|NCT01388621|Doxorubicin|doxorubicin|mesh-list
101196928|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101196929|NCT01388621|Panitumumab|panitumumab|mesh-list
101196930|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196931|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101196932|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
101196933|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196934|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101196935|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101196936|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101196937|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196938|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101196939|NCT01388660|Clopidogrel|clopidogrel|mesh-list
101196940|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101196941|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101196942|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101196943|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101196944|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
101196945|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196946|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196947|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196948|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
101196949|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101196950|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
101196951|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101196952|NCT01388738|Protective Agents|protective agents|mesh-ancestor
101196953|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196954|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
101196955|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101196956|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
101196957|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196958|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196959|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101196960|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
101196961|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101196962|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
101196963|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196965|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101196966|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
101196967|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
101196968|NCT01388842|Protective Agents|protective agents|mesh-ancestor
101196994|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196995|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
101196996|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196997|NCT01389193|Ibudilast|ibudilast|mesh-list
101196998|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101196999|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
101197000|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197001|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197002|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101197003|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197004|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101197005|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197008|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197010|NCT01389206|Selexipag|selexipag|mesh-list
101197011|NCT01389206|Iloprost|iloprost|mesh-list
101197012|NCT01389206|Macitentan|macitentan|mesh-list
101197013|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101197014|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197015|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101197016|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101197017|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197018|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101197019|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101197020|NCT01389271|Iloprost|iloprost|mesh-list
101197021|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101197036|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197037|NCT01389414|Gemcitabine|gemcitabine|mesh-list
101197038|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
101197039|NCT01389414|Panitumumab|panitumumab|mesh-list
101197040|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197041|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
101197042|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197043|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197044|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197046|NCT01389427|Prednisone|prednisone|mesh-list
101197047|NCT01389427|Temsirolimus|temsirolimus|mesh-list
101197048|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
101197049|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
101197050|NCT01389427|Vincristine|vincristine|mesh-list
101197051|NCT01389427|Rituximab|rituximab|mesh-list
101197052|NCT01389427|Doxorubicin|doxorubicin|mesh-list
101197053|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101197055|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197056|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101197057|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
101197058|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197060|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101197061|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197062|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101197063|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
101197064|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184572|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197065|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101197066|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
101197067|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101197068|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197069|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
101197070|NCT01389427|Hormones|hormones|mesh-ancestor
101197071|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197072|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197073|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101197074|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
101197075|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
101197076|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
101197077|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197078|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101197079|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101197080|NCT01389440|Gemcitabine|gemcitabine|mesh-list
101197081|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101197082|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197083|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
101197089|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197090|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197091|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101197092|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101197093|NCT01389505|Growth Substances|growth substances|mesh-ancestor
101197094|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197096|NCT01389544|Ritonavir|ritonavir|mesh-list
101197097|NCT01389544|Methadone|methadone|mesh-list
101197098|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101197099|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101197111|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197112|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197114|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
101197115|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197116|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
101197117|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197118|NCT01389557|Piperaquine|piperaquine|mesh-list
101197119|NCT01389557|Primaquine|primaquine|mesh-list
101197120|NCT01389557|Artenimol|artenimol|mesh-list
101197121|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
101197123|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101197124|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197125|NCT01389609|Doxazosin|doxazosin|mesh-list
101197126|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101197127|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101197128|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101197129|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101197130|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
101197131|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197132|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197133|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197134|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101197135|NCT01389713|Clomiphene|clomiphene|mesh-list
101197136|NCT01389713|Enclomiphene|enclomiphene|mesh-list
101197137|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
101197138|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101197139|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
101197140|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197141|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197142|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101197143|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
101197144|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197145|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101197146|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101197147|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
101197148|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101197149|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
101197150|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101246546|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209719|NCT01447589|Nelfinavir|nelfinavir|mesh-list
101246547|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
101246548|NCT01666678|Promethazine|promethazine|mesh-list
101246549|NCT01666678|Naproxen|naproxen|mesh-list
101246550|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246551|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246552|NCT01666678|Analgesics|analgesics|mesh-ancestor
101246553|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
101246554|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246555|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246556|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246557|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246558|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
101246559|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246560|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246561|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246562|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101246563|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246564|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246565|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
101246566|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
101246567|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
101246568|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
101246569|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246570|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101246571|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
101246572|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
101246573|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246574|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101246575|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
101246576|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246591|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246592|NCT01666769|Micafungin|micafungin|mesh-list
101246593|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
101246594|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246595|NCT01667094|Meropenem|meropenem|mesh-list
101246596|NCT01667094|Tazobactam|tazobactam|mesh-list
101246597|NCT01667094|Piperacillin|piperacillin|mesh-list
101246598|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
101246599|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
101246600|NCT01667094|Ceftazidime|ceftazidime|mesh-list
101246601|NCT01667094|Cefepime|cefepime|mesh-list
101246602|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101246603|NCT01667094|Ticarcillin|ticarcillin|mesh-list
101246604|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
101246605|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246606|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246607|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101246608|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246609|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246610|NCT01667211|Paclitaxel|paclitaxel|mesh-list
101246611|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101246612|NCT01667211|Nedaplatin|nedaplatin|mesh-list
101246613|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101246614|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246615|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
101246616|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
101246617|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
101246618|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246619|NCT01667263|Tretinoin|tretinoin|mesh-list
101246620|NCT01667263|Danazol|danazol|mesh-list
101246621|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197151|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197152|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197153|NCT01389778|Metformin|metformin|mesh-list
101197161|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197162|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
101197163|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184717|NCT01846182|Pregabalin|pregabalin|mesh-list
101197164|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101197165|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
101197166|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101197167|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197168|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197169|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101197174|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101197176|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
101197177|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
101246622|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
101246623|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246624|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101323252|NCT00096148|Cytarabine|cytarabine|mesh-list
101246625|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246626|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246627|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246628|NCT01667315|Bupivacaine|bupivacaine|mesh-list
101246629|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
101246630|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
101246631|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246632|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246633|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
101246634|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246635|NCT01667445|Morphine|morphine|mesh-list
101246636|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101246637|NCT01667445|Narcotics|narcotics|mesh-ancestor
101246638|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246639|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246640|NCT01667445|Analgesics|analgesics|mesh-ancestor
101246641|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
101246642|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246643|NCT01667484|Adderall|adderall|mesh-list
101246644|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101246645|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246646|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
101246647|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101246648|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246649|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246650|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
101246651|NCT01667523|Capsaicin|capsaicin|mesh-list
101246652|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
101197178|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197179|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197180|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197181|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101197182|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101197183|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197184|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101197185|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101197186|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101197187|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246653|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246654|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
101246655|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246656|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246657|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101246658|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246659|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101246660|NCT01667523|Protective Agents|protective agents|mesh-ancestor
101197188|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197189|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197190|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
101197191|NCT01390012|Dexamethasone|dexamethasone|mesh-list
101197192|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
101197194|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197195|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
101197196|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
101197197|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197198|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197199|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197200|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
101197201|NCT01390012|Hormones|hormones|mesh-ancestor
101197202|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197203|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197204|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197205|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197206|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197207|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197209|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101197210|NCT01390051|Dalteparin|dalteparin|mesh-list
101197211|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
101197212|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101197213|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101197214|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197215|NCT01390311|Azacitidine|azacitidine|mesh-list
101197216|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197217|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
101197218|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197219|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197220|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197221|NCT01390324|Naproxen|naproxen|mesh-list
101197222|NCT01390324|Naratriptan|naratriptan|mesh-list
101197229|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197230|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101197231|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
101197232|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101197233|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197234|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197235|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101197236|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101197237|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101197238|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
101197239|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197240|NCT01390337|Cytarabine|cytarabine|mesh-list
101197241|NCT01390337|Daunorubicin|daunorubicin|mesh-list
101184864|NCT01292070|Histamine|histamine|mesh-list
101197242|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197243|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
101197244|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197245|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197246|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
101197248|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101197249|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
101197250|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197251|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101197252|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101197253|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101246661|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101246662|NCT01667575|Amoxicillin|amoxicillin|mesh-list
101246663|NCT01667575|Clarithromycin|clarithromycin|mesh-list
101246664|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101246665|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
101246666|NCT01667575|Esomeprazole|esomeprazole|mesh-list
101246667|NCT01667575|Bismuth|bismuth|mesh-list
101246668|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101246669|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246670|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246671|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
101246672|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101246673|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246674|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246675|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101246676|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101197254|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197255|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
101197256|NCT01390480|Vitamin D|vitamin d|mesh-list
101197257|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101197258|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197259|NCT01390480|Vitamins|vitamins|mesh-ancestor
101197260|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
101197261|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101197262|NCT01390506|Selenious Acid|selenious acid|mesh-list
101197263|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
101197264|NCT01390506|Trace Elements|trace elements|mesh-ancestor
101197265|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
101197266|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197267|NCT01390519|Everolimus|everolimus|mesh-list
101197268|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101197269|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101197270|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197271|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197272|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101197273|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
101197274|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197275|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197276|NCT01390571|Temozolomide|temozolomide|mesh-list
101197277|NCT01390571|Olaparib|olaparib|mesh-list
101197278|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101197279|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
101197280|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197281|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197282|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101197284|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
101197285|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101197286|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197287|NCT01390662|Vitamin D|vitamin d|mesh-list
101197288|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
101197289|NCT01390662|Vitamins|vitamins|mesh-ancestor
101197290|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
101197291|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197292|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101197297|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197298|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197299|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101197300|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
101197301|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197302|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101197303|NCT01390792|Zanamivir|zanamivir|mesh-list
101197304|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
101246677|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101246678|NCT01667575|Antacids|antacids|mesh-ancestor
101246679|NCT01667575|Diuretics|diuretics|mesh-ancestor
101246680|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
101246681|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246682|NCT01667575|Expectorants|expectorants|mesh-ancestor
101246683|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246684|NCT01667614|Losartan|losartan|mesh-list
101246685|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101246686|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101246687|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101246688|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101246689|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246690|NCT01667692|Azithromycin|azithromycin|mesh-list
101246691|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246692|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246693|NCT01667718|Amoxicillin|amoxicillin|mesh-list
101246694|NCT01667718|Levofloxacin|levofloxacin|mesh-list
101246695|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
101197305|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197306|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197307|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197308|NCT01390805|Valacyclovir|valacyclovir|mesh-list
101197309|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
101197310|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197312|NCT01390883|Fondaparinux|fondaparinux|mesh-list
101197313|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101197314|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
101197315|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101197316|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197317|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197318|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197319|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
101197321|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101197322|NCT01390896|PENTA|penta|mesh-list
101197323|NCT01390896|Fondaparinux|fondaparinux|mesh-list
101197324|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101197325|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
101197326|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101197327|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197328|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197329|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197335|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101197336|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101197337|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197338|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197339|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
101185003|NCT00749658|Bupropion|bupropion|mesh-list
101197340|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197341|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197342|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101197343|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197344|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101197345|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
101197346|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197347|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197348|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101246696|NCT01667718|Lansoprazole|lansoprazole|mesh-list
101246697|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
101246698|NCT01667718|Bismuth|bismuth|mesh-list
101246699|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101246700|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246701|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246702|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246703|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101246704|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101246705|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101246706|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246707|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246708|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101246709|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101246710|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101246711|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246713|NCT01667718|Diuretics|diuretics|mesh-ancestor
101246714|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
101246715|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246716|NCT01667718|Expectorants|expectorants|mesh-ancestor
101246717|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246718|NCT01667874|Gentamicins|gentamicins|mesh-list
101246719|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246720|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246721|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101246722|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246723|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246724|NCT01668043|UB-421|ub-421|mesh-list
101246725|NCT01668043|Antibodies|antibodies|mesh-list
101246726|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
101246727|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246728|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101246729|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
101246730|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197350|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
101197351|NCT01390961|Pheniramine|pheniramine|mesh-list
101197352|NCT01390961|Naphazoline|naphazoline|mesh-list
101197353|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197354|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101197355|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101197356|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
101197357|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197358|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197359|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
101197360|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101197361|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197362|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101197363|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
101197370|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101197372|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101197373|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
101197374|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197375|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197376|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101197377|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101197378|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
101197379|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197380|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101197381|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101197382|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197383|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197384|NCT01391104|Urological Agents|urological agents|mesh-ancestor
101197385|NCT01391156|Minoxidil|minoxidil|mesh-list
101197386|NCT01391156|Finasteride|finasteride|mesh-list
101197387|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101197388|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197389|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101197390|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101197391|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197392|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197393|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
101197394|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197395|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197396|NCT01391156|Urological Agents|urological agents|mesh-ancestor
101197397|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101197398|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101197399|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101197400|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197401|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197402|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197403|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197410|NCT01391260|Gefitinib|gefitinib|mesh-list
101197411|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197412|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101197413|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197414|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197415|NCT01391377|Niacin|niacin|mesh-list
101197416|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101197417|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
101197418|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197419|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101197420|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197421|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
101197422|NCT01391377|Vitamins|vitamins|mesh-ancestor
101197423|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
101197424|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197425|NCT01391390|Melatonin|melatonin|mesh-list
101197426|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
101197427|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197428|NCT01391390|Protective Agents|protective agents|mesh-ancestor
101197429|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197430|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197431|NCT01391403|Artemisinins|artemisinins|mesh-list
101197438|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101197439|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
101197440|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
101185146|NCT05599230|Ivacaftor|ivacaftor|mesh-list
101197441|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197442|NCT01391572|Fluorouracil|fluorouracil|mesh-list
101197443|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197444|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
101197445|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197446|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197447|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101246731|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101246732|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101246733|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246734|NCT01668069|Ondansetron|ondansetron|mesh-list
101246735|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
101246736|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
101246737|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246738|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246739|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246740|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
101246741|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246742|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101246743|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101246744|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
101246745|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246746|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246747|NCT01668121|Budesonide|budesonide|mesh-list
101246748|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
101246749|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101246750|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246751|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101246752|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
101246753|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197448|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
101197449|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197450|NCT01391598|Lidocaine|lidocaine|mesh-list
101197451|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
101197452|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
101197453|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197454|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197455|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
101197456|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197457|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101197458|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101197459|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101197460|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197461|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197462|NCT01391624|Mineral Oil|mineral oil|mesh-list
101197463|NCT01391624|Emollients|emollients|mesh-ancestor
101197464|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
101197465|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
101197466|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101197467|NCT01391689|Protective Agents|protective agents|mesh-ancestor
101197468|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197469|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197470|NCT01391715|Rabeprazole|rabeprazole|mesh-list
101197471|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101197472|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197473|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101197474|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197475|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246754|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246755|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101246756|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246757|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
101246758|NCT01668121|Hormones|hormones|mesh-ancestor
101246759|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246760|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101246761|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101246762|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246763|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246764|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246765|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246766|NCT01668433|Primaquine|primaquine|mesh-list
101246767|NCT01668433|Methylene Blue|methylene blue|mesh-list
101246768|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
101246769|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101246770|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101246771|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246772|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197476|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
101197477|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101197478|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
101197479|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197487|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101197488|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101197489|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197490|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
101197491|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197492|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197493|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
101197494|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101197495|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
101197496|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197497|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197498|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101197499|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197500|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101197501|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
101197502|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197503|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197512|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197513|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101197514|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
101197515|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197516|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101197517|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101197518|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101197519|NCT01392209|Bevacizumab|bevacizumab|mesh-list
101197520|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197521|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197522|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101197523|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101197524|NCT01392209|Growth Substances|growth substances|mesh-ancestor
101197525|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197526|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
101197527|NCT01392287|Memantine|memantine|mesh-list
101246773|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246774|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
101246775|NCT01668446|Estradiol|estradiol|mesh-list
101246776|NCT01668446|Estrogens|estrogens|mesh-ancestor
101246777|NCT01668446|Hormones|hormones|mesh-ancestor
101246778|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246779|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246780|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
101246781|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101246782|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101246783|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246784|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246785|NCT01668446|Urological Agents|urological agents|mesh-ancestor
101246786|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101246787|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246788|NCT01668498|Doxycycline|doxycycline|mesh-list
101246789|NCT01668498|Erythromycin|erythromycin|mesh-list
101246790|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
101246791|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101246792|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
101246793|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246794|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246795|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
101246796|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101246797|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101246798|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246799|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101246800|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246801|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246802|NCT01668550|AZD-0424|azd-0424|mesh-list
101246803|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101246804|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197528|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101197529|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101197530|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
101197531|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197532|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197533|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197534|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101197535|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101197536|NCT01392430|Azithromycin|azithromycin|mesh-list
101197537|NCT01392430|Dapsone|dapsone|mesh-list
101246805|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246806|NCT01668615|Tretinoin|tretinoin|mesh-list
101246807|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246808|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
101246809|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246810|NCT01668680|Celecoxib|celecoxib|mesh-list
101246811|NCT01668680|Capecitabine|capecitabine|mesh-list
101246812|NCT01668680|Methotrexate|methotrexate|mesh-list
101246813|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101246814|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
101246815|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246816|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246817|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101246818|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
101246819|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101246820|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246821|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
101246822|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246823|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101197538|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101197539|NCT01392430|Itraconazole|itraconazole|mesh-list
101197540|NCT01392430|Fluconazole|fluconazole|mesh-list
101197541|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101197542|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197543|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
101185264|NCT00548886|Epinephrine|epinephrine|mesh-list
101197544|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101197545|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101197546|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197547|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197548|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101197549|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
101197550|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197551|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197552|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101197553|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101197554|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101197561|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101197562|NCT01392534|Telmisartan|telmisartan|mesh-list
101197563|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
101197564|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101197565|NCT01392534|Diuretics|diuretics|mesh-ancestor
101197566|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
101197567|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197569|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197572|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101197573|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
101197574|NCT01392612|Hematinics|hematinics|mesh-ancestor
101197575|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
101197576|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
101197577|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101197578|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101197579|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197580|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246824|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101246825|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
101246826|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246827|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101246828|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246829|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246830|NCT01668680|Analgesics|analgesics|mesh-ancestor
101246831|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
101246832|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246833|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246834|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101246835|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246836|NCT01668901|Aspirin|aspirin|mesh-list
101246837|NCT01668901|Warfarin|warfarin|mesh-list
101246838|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246839|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246840|NCT01668901|Analgesics|analgesics|mesh-ancestor
101246841|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
101197581|NCT01392638|Urological Agents|urological agents|mesh-ancestor
101197583|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197584|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197585|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
101197586|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197587|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101197588|NCT01392755|Ritonavir|ritonavir|mesh-list
101197589|NCT01392755|Omeprazole|omeprazole|mesh-list
101197590|NCT01392755|Ranitidine|ranitidine|mesh-list
101197591|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101197592|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101197593|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101197594|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197595|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197596|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197598|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101197599|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
101197600|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197601|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101197602|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101197603|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101197604|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197605|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101197606|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101197607|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
101197608|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
101197609|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197610|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197611|NCT01392768|Levetiracetam|levetiracetam|mesh-list
101197612|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
101197613|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
101197614|NCT01392794|Ramosetron|ramosetron|mesh-list
101197615|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
101197616|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
101197617|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197618|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197619|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197620|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101197621|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
101197622|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246842|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246843|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246844|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246845|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101246846|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101246847|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101246848|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246849|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101246850|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101246851|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246852|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
101246853|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
101246854|NCT01668927|Amoxicillin|amoxicillin|mesh-list
101246855|NCT01668927|Metronidazole|metronidazole|mesh-list
101246856|NCT01668927|Tetracycline|tetracycline|mesh-list
101246857|NCT01668927|Furazolidone|furazolidone|mesh-list
101246858|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
101246859|NCT01668927|Lansoprazole|lansoprazole|mesh-list
101246860|NCT01668927|Bismuth|bismuth|mesh-list
101246861|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101246862|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197623|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197624|NCT01392807|Naloxegol|naloxegol|mesh-list
101197625|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101197626|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197627|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
101197628|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197629|NCT01392833|Prednisone|prednisone|mesh-list
101197630|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
101197631|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101197636|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101197637|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
101197638|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197640|NCT01392833|Hormones|hormones|mesh-ancestor
101197641|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197642|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197643|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197646|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
101197647|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197648|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197649|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101197650|NCT01392833|Protective Agents|protective agents|mesh-ancestor
101197651|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
101197652|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197653|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101197654|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101197655|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
101197656|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101197658|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101197659|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197660|NCT01392898|Incretins|incretins|mesh-ancestor
101197661|NCT01392898|Hormones|hormones|mesh-ancestor
101197662|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197663|NCT01392911|Rifampin|rifampin|mesh-list
101197664|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101246863|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246864|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246865|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101246866|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101246867|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101246868|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246869|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246870|NCT01668927|Antacids|antacids|mesh-ancestor
101246871|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101246872|NCT01668927|Diuretics|diuretics|mesh-ancestor
101246873|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
101246874|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246875|NCT01668927|Expectorants|expectorants|mesh-ancestor
101246876|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
101246877|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101246878|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101246879|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101246880|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101246881|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
101246882|NCT01669044|Propofol|propofol|mesh-list
101246883|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101246884|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197665|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
101197666|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101197667|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185435|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
101197668|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
101197669|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101197670|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197671|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197672|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101197673|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101197674|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101197675|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101197676|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101197677|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101197678|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
101197679|NCT01393080|Cisplatin|cisplatin|mesh-list
101197680|NCT01393080|Paclitaxel|paclitaxel|mesh-list
101197681|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197682|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197683|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101197684|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101197685|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101197686|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101197687|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197688|NCT01393145|Fluticasone|fluticasone|mesh-list
101197689|NCT01393145|Xhance|xhance|mesh-list
101197690|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
101197691|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101197692|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101197693|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197694|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101197695|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
101197696|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197697|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197698|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101197699|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197700|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
101197701|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101197702|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101197703|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101197723|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
101197724|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
101197726|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101197727|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
101197728|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197729|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197730|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101197731|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
101197732|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101197733|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197734|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101197735|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101197736|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101197737|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
101197740|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101197741|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101197742|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197743|NCT01393548|Brompheniramine|brompheniramine|mesh-list
101197744|NCT01393548|Phenylephrine|phenylephrine|mesh-list
101197745|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
101197746|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
101197747|NCT01393548|Ephedrine|ephedrine|mesh-list
101197748|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101197749|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
101197750|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
101197751|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197752|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197753|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
101197754|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101197755|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
101197756|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197757|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101197758|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101197759|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101197760|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
101197761|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197762|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197763|NCT01393548|Protective Agents|protective agents|mesh-ancestor
101197764|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101197765|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101197766|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101197767|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101197768|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
101197769|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
101197770|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101197771|NCT01393574|Melatonin|melatonin|mesh-list
101197772|NCT01393574|Methylphenidate|methylphenidate|mesh-list
101197773|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
101197774|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197778|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101197780|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101197781|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101197782|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
101197783|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197784|NCT01393756|Lenalidomide|lenalidomide|mesh-list
101197785|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
101197786|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197787|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101197788|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101197789|NCT01393756|Growth Substances|growth substances|mesh-ancestor
101197790|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
101197793|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101197794|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
101197795|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197796|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197797|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101197798|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101185616|NCT00000336|Selegiline|selegiline|mesh-list
101197799|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
101197800|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197802|NCT01393782|Giapreza|giapreza|mesh-list
101197803|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
101197804|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101197805|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101197806|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197807|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197808|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197809|NCT01393795|Capsaicin|capsaicin|mesh-list
101197810|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
101197811|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
101197812|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
101197813|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197814|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197815|NCT01393912|Crenolanib|crenolanib|mesh-list
101197816|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197817|NCT01393925|Parecoxib|parecoxib|mesh-list
101197818|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101197819|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101197820|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197821|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197822|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101197823|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101197824|NCT01393925|Analgesics|analgesics|mesh-ancestor
101197825|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
101197826|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197827|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197828|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197829|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101197830|NCT01394029|Deferasirox|deferasirox|mesh-list
101197831|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101197832|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
101197833|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
101197834|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197835|NCT01394094|Calcium|calcium|mesh-list
101197836|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101197837|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197838|NCT01394133|Ritonavir|ritonavir|mesh-list
101197839|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101197840|NCT01394133|Tenofovir|tenofovir|mesh-list
101185678|NCT00000384|Sertraline|sertraline|mesh-list
101197841|NCT01394133|Emtricitabine|emtricitabine|mesh-list
101197842|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101197843|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101197844|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197845|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197846|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197852|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101197853|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101197854|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101197856|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
101197857|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
101197859|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197860|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197861|NCT01394341|Liraglutide|liraglutide|mesh-list
101197862|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101197863|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197864|NCT01394341|Incretins|incretins|mesh-ancestor
101197865|NCT01394341|Hormones|hormones|mesh-ancestor
101197872|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101197873|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
101197874|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
101197875|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197876|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197877|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197878|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
101197879|NCT01394354|Hormones|hormones|mesh-ancestor
101185699|NCT00000402|Calcium|calcium|mesh-list
101197880|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197881|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101197882|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197883|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101197884|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101197885|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101246885|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246886|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246887|NCT01669044|Analgesics|analgesics|mesh-ancestor
101246888|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
101246889|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246890|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101246891|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101246892|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101246893|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
101246894|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246895|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246896|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101197887|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197888|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101197889|NCT01394406|Ketamine|ketamine|mesh-list
101197890|NCT01394406|Analgesics|analgesics|mesh-ancestor
101197891|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
101197892|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197893|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197894|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101197895|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101197896|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
101197897|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
101197898|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197899|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101197900|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101197901|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197902|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197903|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
101197904|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101197905|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
101197906|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197907|NCT01394419|Expectorants|expectorants|mesh-ancestor
101197908|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197909|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101197911|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197912|NCT01394419|Protective Agents|protective agents|mesh-ancestor
101197913|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197914|NCT01394419|Antidotes|antidotes|mesh-ancestor
101197915|NCT01394445|Physostigmine|physostigmine|mesh-list
101197916|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101197917|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197918|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197919|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
101197920|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197921|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197922|NCT01394445|Miotics|miotics|mesh-ancestor
101197923|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
101197924|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197925|NCT01394458|Ethanol|ethanol|mesh-list
101197939|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197942|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197943|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197944|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
101197945|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
101197946|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197947|NCT01394497|Expectorants|expectorants|mesh-ancestor
101197948|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
101197949|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101197950|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
101197951|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246897|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
101246898|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
101246899|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
101246900|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246901|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101246902|NCT01669135|Anesthetics|anesthetics|mesh-list
101246903|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246904|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246905|NCT01669213|Ondansetron|ondansetron|mesh-list
101246906|NCT01669213|Ramosetron|ramosetron|mesh-list
101246907|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
101246908|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
101246909|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246910|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246911|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246912|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
101246913|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
101323264|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
101246914|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101246916|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
101246917|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246918|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246921|NCT01669239|Doxorubicin|doxorubicin|mesh-list
101246922|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101246923|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101246924|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246925|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101246926|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101197952|NCT01394497|Protective Agents|protective agents|mesh-ancestor
101197953|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197954|NCT01394640|Vaccines|vaccines|mesh-list
101197955|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
101185799|NCT00000702|Zidovudine|zidovudine|mesh-list
101197956|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197957|NCT01394653|Ramosetron|ramosetron|mesh-list
101197958|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
101197959|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
101197960|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197961|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197962|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101197963|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101197964|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
101197965|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197966|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197967|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
101197968|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197969|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
101197970|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
101197971|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197972|NCT01394731|Acetaminophen|acetaminophen|mesh-list
101197973|NCT01394731|Meperidine|meperidine|mesh-list
101197974|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101197975|NCT01394731|Analgesics|analgesics|mesh-ancestor
101197976|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
101197977|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197978|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197979|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
101197980|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101197981|NCT01394731|Narcotics|narcotics|mesh-ancestor
101197982|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197983|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101197984|NCT01394757|Ketamine|ketamine|mesh-list
101197985|NCT01394757|Esketamine|esketamine|mesh-list
101197986|NCT01394757|Analgesics|analgesics|mesh-ancestor
101197987|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
101197988|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197989|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197990|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101197991|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101197992|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
101197993|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
101197994|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197995|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101197996|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101198006|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198011|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198013|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198014|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101198015|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101198016|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198017|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101198018|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101198019|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
101198020|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101198021|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101198022|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
101198023|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198024|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198025|NCT01394848|Everolimus|everolimus|mesh-list
101198026|NCT01394848|Clopidogrel|clopidogrel|mesh-list
101198027|NCT01394848|Atorvastatin|atorvastatin|mesh-list
101198028|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101198029|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101198030|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
101198031|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198032|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101198033|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101198034|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198035|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101198036|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101198037|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198038|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
101198039|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198040|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198041|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101198042|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101198043|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101198044|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101198045|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
101198046|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198048|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198049|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198050|NCT01394913|Etanercept|etanercept|mesh-list
101198051|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101198052|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198053|NCT01394913|Analgesics|analgesics|mesh-ancestor
101198054|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
101198055|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198056|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198057|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198058|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198059|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198060|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198061|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
101198062|NCT01395069|Ketorolac|ketorolac|mesh-list
101246927|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246928|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246929|NCT01669291|Leuprolide|leuprolide|mesh-list
101246930|NCT01669291|Cetrorelix|cetrorelix|mesh-list
101246931|NCT01669291|Menotropins|menotropins|mesh-list
101246932|NCT01669291|Ganirelix|ganirelix|mesh-list
101246933|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101246934|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
101246935|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101246936|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246937|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101246938|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246939|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
101246940|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246941|NCT01669304|Verapamil|verapamil|mesh-list
101246942|NCT01669304|Sertraline|sertraline|mesh-list
101246943|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
101246944|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101246945|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101246946|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101246947|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101246948|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246949|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101246950|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
101246951|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246952|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101246953|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101246954|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101246955|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
101246956|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
101246957|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
101246958|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101246959|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198063|NCT01395069|Nepafenac|nepafenac|mesh-list
101198064|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101198071|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198072|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101198073|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198074|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198075|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
101198076|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101246960|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246961|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
101246962|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101246963|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101246964|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246965|NCT01669447|Ranibizumab|ranibizumab|mesh-list
101246966|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101246967|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101246968|NCT01669447|Growth Substances|growth substances|mesh-ancestor
101246970|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
101323267|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
101246971|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246972|NCT01669499|Dexamethasone|dexamethasone|mesh-list
101246973|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
101246974|NCT01669499|BB 1101|bb 1101|mesh-list
101246975|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101246976|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
101246977|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
101198077|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198078|NCT01395147|Vortioxetine|vortioxetine|mesh-list
101198079|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
101198084|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198085|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101198086|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101198087|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198088|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198089|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198090|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
101185894|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198091|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101198092|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101198093|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101198094|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101198095|NCT01395199|Amlodipine|amlodipine|mesh-list
101198096|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101198097|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101198098|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198099|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198100|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198101|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198102|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
101198103|NCT01395251|Prednisolone|prednisolone|mesh-list
101198104|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
101198105|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198106|NCT01395251|Hormones|hormones|mesh-ancestor
101198107|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198108|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198109|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198110|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198111|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
101198112|NCT01395290|Vitamin D|vitamin d|mesh-list
101198113|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198114|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198115|NCT01395290|Vitamins|vitamins|mesh-ancestor
101198116|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
101198117|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198118|NCT01395381|Albendazole|albendazole|mesh-list
101198119|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
101198120|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101198121|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198122|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
101198123|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101198124|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101198125|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
101198126|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
101198127|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
101198128|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198129|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198131|NCT01395420|Avibactam|avibactam|mesh-list
101198132|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198133|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198134|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101198135|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198136|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198137|NCT01395433|Dexetimide|dexetimide|mesh-list
101198138|NCT01395433|Citalopram|citalopram|mesh-list
101198161|NCT01395589|Vitamins|vitamins|mesh-ancestor
101198162|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
101198163|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198164|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198165|NCT01395602|Cabergoline|cabergoline|mesh-list
101198166|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101198167|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101198168|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
101198169|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
101198170|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198171|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198172|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198174|NCT01395654|Isoniazid|isoniazid|mesh-list
101198175|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
101198176|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101198177|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
101198178|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198179|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198180|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
101198181|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101198182|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198183|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198184|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101198185|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101198186|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101198187|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101198188|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101198189|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101198190|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101198191|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101198192|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
101198193|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101198195|NCT01395667|Fluorouracil|fluorouracil|mesh-list
101198196|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
101198197|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198198|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198199|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
101186000|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
101198200|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198201|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198206|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
101198208|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
101198209|NCT01395732|Bosentan|bosentan|mesh-list
101198210|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101198211|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101198212|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198213|NCT01395849|Fluticasone|fluticasone|mesh-list
101198214|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101198215|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101198216|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198217|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101198218|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
101198219|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198220|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198225|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101246978|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101246979|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246980|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101246981|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
101246982|NCT01669499|Hormones|hormones|mesh-ancestor
101246983|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101246984|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101246985|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246986|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
101246987|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101246988|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101246989|NCT01669707|Endostar protein|endostar protein|mesh-list
101246990|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101246991|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101198226|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101198227|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101198228|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
101198229|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198230|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198231|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
101198232|NCT01395849|Hormones|hormones|mesh-ancestor
101198233|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198234|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
101198235|NCT01395862|Fluticasone|fluticasone|mesh-list
101198236|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101198237|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101198238|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198239|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101198240|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
101198241|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198242|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198243|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101198244|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101198245|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198246|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101198247|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101198248|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101198249|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101198250|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
101198251|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198252|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198253|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
101198254|NCT01395862|Hormones|hormones|mesh-ancestor
101198255|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198256|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
101198257|NCT01395875|Fluticasone|fluticasone|mesh-list
101198258|NCT01395875|Xhance|xhance|mesh-list
101198259|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101198260|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101198261|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198262|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101198264|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198265|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198266|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101198267|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
101198268|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198269|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101198270|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101198271|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101246992|NCT01669707|Growth Substances|growth substances|mesh-ancestor
101246993|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101246994|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
101246995|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101246996|NCT01669824|Aspirin|aspirin|mesh-list
101246997|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101246998|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101246999|NCT01669824|Analgesics|analgesics|mesh-ancestor
101247000|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
101247001|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247002|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247003|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247005|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101247006|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101247007|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247008|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101247009|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101247010|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247011|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
101247012|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
101247013|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
101247014|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101247015|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101198272|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101198273|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
101198274|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198275|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198276|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
101198277|NCT01395927|Canagliflozin|canagliflozin|mesh-list
101198278|NCT01395927|Rifampin|rifampin|mesh-list
101198283|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
101198284|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101198285|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198286|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198287|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101198288|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101198289|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101198294|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198295|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198296|NCT01395953|Buspirone|buspirone|mesh-list
101198297|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198298|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198299|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198300|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198301|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198302|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101198303|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
101198304|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198305|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198306|NCT01395992|Asenapine|asenapine|mesh-list
101198307|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101186129|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
101198308|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198309|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198310|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198311|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198312|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
101198313|NCT01396200|Sirolimus|sirolimus|mesh-list
101198314|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
101198315|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101198316|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101198317|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198318|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198319|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198320|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198321|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198322|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101198323|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198324|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
101198325|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198326|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
101198327|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198328|NCT01396291|Asenapine|asenapine|mesh-list
101198329|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101198330|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198331|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198332|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198333|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198334|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101198335|NCT01396304|Calcium|calcium|mesh-list
101198336|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198337|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198338|NCT01396304|Laxatives|laxatives|mesh-ancestor
101198339|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198340|NCT01396564|Metformin|metformin|mesh-list
101198341|NCT01396564|Pioglitazone|pioglitazone|mesh-list
101198342|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198343|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198344|NCT01396642|Emollients|emollients|mesh-list
101198345|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198346|NCT01396655|Docetaxel|docetaxel|mesh-list
101198347|NCT01396655|Doxorubicin|doxorubicin|mesh-list
101198348|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198349|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101198350|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
101198351|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
101198352|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198353|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101198360|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198367|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198369|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
101198370|NCT01396707|Trastuzumab|trastuzumab|mesh-list
101198371|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198372|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
101198373|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198374|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198375|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198376|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
101198377|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198378|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198379|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198380|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198381|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198382|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101198383|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101198384|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198385|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198386|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198387|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
101198388|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101198389|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
101198390|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101198391|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101198392|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198393|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101247016|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247017|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
101247018|NCT01669967|Promethazine|promethazine|mesh-list
101247019|NCT01669967|Lidocaine|lidocaine|mesh-list
101247020|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
101247021|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
101247022|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247023|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247024|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
101247025|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247026|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101247027|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101247028|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101247029|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101247030|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247031|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101247032|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101247033|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
101247034|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
101247035|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247036|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101247037|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
101247038|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
101247039|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198394|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
101198395|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
101198396|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198397|NCT01396733|Protective Agents|protective agents|mesh-ancestor
101198398|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198399|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
101198400|NCT01396733|Vitamins|vitamins|mesh-ancestor
101198401|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
101198403|NCT01397006|Analgesics|analgesics|mesh-ancestor
101198404|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
101198405|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198406|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198407|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
101198408|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101198409|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198410|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198411|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198412|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198413|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198414|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198415|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198416|NCT01397019|Leucovorin|leucovorin|mesh-list
101198417|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
101198418|NCT01397019|Irinotecan|irinotecan|mesh-list
101198419|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198420|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101198421|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101198422|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247040|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101247041|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
101247042|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247043|NCT01670149|Rifaximin|rifaximin|mesh-list
101247044|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247045|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247046|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247047|NCT01670370|Gemcitabine|gemcitabine|mesh-list
101247048|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
101247049|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247050|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101247051|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
101247052|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247053|NCT01670552|Naproxen|naproxen|mesh-list
101247054|NCT01670552|Nimesulide|nimesulide|mesh-list
101247055|NCT01670552|Esomeprazole|esomeprazole|mesh-list
101247057|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101247058|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247059|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101247060|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198423|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198424|NCT01397019|Antidotes|antidotes|mesh-ancestor
101198425|NCT01397019|Protective Agents|protective agents|mesh-ancestor
101198426|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198427|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
101198428|NCT01397019|Vitamins|vitamins|mesh-ancestor
101198433|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101198440|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198442|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
101198443|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198444|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198445|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
101198446|NCT01397214|Megestrol|megestrol|mesh-list
101198447|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198448|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198449|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
101198450|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101198451|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198452|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101198453|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101198454|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101198455|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
101198456|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101198457|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101198458|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101198459|NCT01397305|Pemetrexed|pemetrexed|mesh-list
101198460|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198461|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198462|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198463|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101198464|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101198465|NCT01397331|Propofol|propofol|mesh-list
101198466|NCT01397331|Isoflurane|isoflurane|mesh-list
101198467|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101198468|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198469|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198470|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247061|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247062|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247063|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247064|NCT01670552|Analgesics|analgesics|mesh-ancestor
101247065|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
101247066|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247067|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247068|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247069|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247070|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
101247071|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101247072|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
101247073|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101247074|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
101247075|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247076|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
101198471|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
101198473|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101198474|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
101198475|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
101198476|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198477|NCT05268835|Clindamycin|clindamycin|mesh-list
101198478|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198479|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198480|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101198481|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198482|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198483|NCT05268718|Voriconazole|voriconazole|mesh-list
101198484|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101198485|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101198486|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
101198487|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198488|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101198489|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101198490|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198491|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198492|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101198493|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
101198494|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198495|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198496|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101198497|NCT05268627|Liraglutide|liraglutide|mesh-list
101198498|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198502|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198504|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
101198510|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198511|NCT05267977|Cephalosporins|cephalosporins|mesh-list
101198512|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198513|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198514|NCT05186558|Rituximab|rituximab|mesh-list
101198515|NCT05186558|Gemcitabine|gemcitabine|mesh-list
101198516|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
101198517|NCT05186558|Lenalidomide|lenalidomide|mesh-list
101198518|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198519|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198520|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
101198521|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247077|NCT01670578|Protective Agents|protective agents|mesh-ancestor
101247078|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
101247079|NCT01670812|Rituximab|rituximab|mesh-list
101247080|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247081|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247082|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
101247083|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247084|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247085|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247086|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
101247087|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
101247088|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247089|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247090|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
101247091|NCT01670812|Hormones|hormones|mesh-ancestor
101198522|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198523|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198524|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
101198525|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198526|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101198527|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101198528|NCT05186558|Growth Substances|growth substances|mesh-ancestor
101198529|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
101198530|NCT05092698|Vitamin D|vitamin d|mesh-list
101198531|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
101198532|NCT05092698|Vitamins|vitamins|mesh-ancestor
101198533|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
101198534|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198535|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198536|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198538|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
101198539|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101198540|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198541|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198542|NCT04975269|Diuretics|diuretics|mesh-ancestor
101198543|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
101198544|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198545|NCT04965870|Trifluridine|trifluridine|mesh-list
101198546|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
101198547|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198548|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
101198549|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198550|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101198551|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
101198552|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
101198553|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198554|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198555|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
101198556|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198557|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101198558|NCT04604353|Calcium|calcium|mesh-list
101198559|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198560|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198561|NCT04500756|Metformin|metformin|mesh-list
101198562|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101198563|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198564|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
101198565|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
101198566|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101198567|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101198568|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198569|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247092|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101247093|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101247094|NCT01670812|Protective Agents|protective agents|mesh-ancestor
101247095|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
101247096|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247097|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
101247098|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101247099|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101247100|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101247101|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247102|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
101247103|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247104|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247105|NCT01672359|Choline|choline|mesh-list
101247106|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
101247107|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101247108|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
101247109|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198570|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198571|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198580|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101198582|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
101198583|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
101198584|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
101198585|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198598|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
101186510|NCT00002112|Fluconazole|fluconazole|mesh-list
101198599|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198600|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198601|NCT03283813|Inositol|inositol|mesh-list
101198602|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
101198603|NCT03283813|Vitamins|vitamins|mesh-ancestor
101198604|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
101198605|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198606|NCT03245827|Clomiphene|clomiphene|mesh-list
101198607|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101198608|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
101198609|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198610|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198611|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101198612|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
101198613|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101198614|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101198615|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101198616|NCT03129321|Econazole|econazole|mesh-list
101198617|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
101198618|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198619|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101198620|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101198621|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198622|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198623|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101198625|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198626|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198627|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
101198628|NCT03107611|Tacrolimus|tacrolimus|mesh-list
101198629|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101198630|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198631|NCT03107611|Analgesics|analgesics|mesh-ancestor
101198632|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
101198633|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198634|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198635|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198636|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198637|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198638|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198639|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
101198644|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
101198645|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
101198646|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198647|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198648|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198649|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101198655|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101198656|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101198657|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101198658|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198659|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198660|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101198661|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101198662|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
101198663|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198664|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101198665|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101198666|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101198667|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
101198668|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198670|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101198671|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101198672|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101198673|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101198674|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
101198675|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198676|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198677|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198678|NCT02420912|Nivolumab|nivolumab|mesh-list
101198679|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198680|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198681|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101198682|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198683|NCT02094716|Permethrin|permethrin|mesh-list
101198684|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198685|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198686|NCT01460810|Silicon|silicon|mesh-list
101198687|NCT01460810|Trace Elements|trace elements|mesh-ancestor
101198688|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
101198689|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198690|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
101198691|NCT00667329|Rituximab|rituximab|mesh-list
101198692|NCT00667329|Cladribine|cladribine|mesh-list
101198693|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198694|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
101198695|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198696|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198697|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101198698|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
101198699|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198700|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198701|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101198702|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198703|NCT00492167|Antibodies|antibodies|mesh-list
101198704|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101198705|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
101198706|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198707|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
101198708|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198709|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247110|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247111|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101247112|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
101247113|NCT01673308|Lenalidomide|lenalidomide|mesh-list
101247114|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
101247115|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323287|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247116|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101247117|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101247118|NCT01673308|Growth Substances|growth substances|mesh-ancestor
101247119|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101247120|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247122|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247123|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247124|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247125|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247126|NCT01674556|Gemcitabine|gemcitabine|mesh-list
101247127|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101247128|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
101247129|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247130|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247131|NCT01675115|Aspirin|aspirin|mesh-list
101247132|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247133|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247134|NCT01675115|Analgesics|analgesics|mesh-ancestor
101198714|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198715|NCT05274139|Cytarabine|cytarabine|mesh-list
101198716|NCT05274139|Dexamethasone|dexamethasone|mesh-list
101198717|NCT05274139|Temozolomide|temozolomide|mesh-list
101198718|NCT05274139|Fotemustine|fotemustine|mesh-list
101198719|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198720|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
101198721|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
101198722|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198723|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198724|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198729|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198730|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198731|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198732|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
101198733|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
101198734|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198735|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198736|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
101198737|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101198738|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
101198739|NCT05274113|Dexamethasone|dexamethasone|mesh-list
101198740|NCT05274113|Ropivacaine|ropivacaine|mesh-list
101198741|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198742|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
101198743|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
101247135|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
101247136|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247137|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247138|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247139|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247140|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101247141|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101247142|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247143|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101247144|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101198744|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198745|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198746|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198747|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
101198748|NCT05274113|Hormones|hormones|mesh-ancestor
101198749|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198750|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198751|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198752|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101198753|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
101198754|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198755|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
101198756|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101198757|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
101198758|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198759|NCT05273944|Doxorubicin|doxorubicin|mesh-list
101198760|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101198761|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101198762|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198763|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101198764|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101198765|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198766|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198768|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
101198769|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198770|NCT05273398|Diazepam|diazepam|mesh-list
101198771|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101198772|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
101198773|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
101198774|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
101198775|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198776|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198777|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198778|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101198779|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198780|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101198786|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
101198787|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
101198788|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
101198789|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
101198790|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198791|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198792|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101198793|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198795|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101198796|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
101198797|NCT05272371|Dinutuximab|dinutuximab|mesh-list
101198798|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198799|NCT05271539|Dexamethasone|dexamethasone|mesh-list
101198800|NCT05271539|Ranibizumab|ranibizumab|mesh-list
101198801|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198802|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
101198803|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
101198809|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198811|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198812|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101198813|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101198814|NCT05271539|Growth Substances|growth substances|mesh-ancestor
101198815|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
101198816|NCT05271370|Leronlimab|leronlimab|mesh-list
101198817|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
101198818|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101198819|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101198820|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198821|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101198822|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101198823|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
101198824|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198825|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
101198826|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198827|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
101198828|NCT05271253|Bupivacaine|bupivacaine|mesh-list
101198829|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
101198830|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
101198831|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198832|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198833|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
101198834|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198835|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101198836|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198837|NCT05271253|Analgesics|analgesics|mesh-ancestor
101198838|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101198839|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101198840|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101198841|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
101198842|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198843|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198844|NCT05271188|Anesthetics|anesthetics|mesh-list
101198846|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198847|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198849|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198850|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
101198851|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101198852|NCT05271136|Protective Agents|protective agents|mesh-ancestor
101198853|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198854|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198855|NCT05271058|Dexamethasone|dexamethasone|mesh-list
101198862|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198864|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
101198865|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198866|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198867|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198868|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
101198870|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198871|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198872|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198873|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
101198874|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198875|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198876|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198877|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
101198878|NCT05271045|Vitamin D|vitamin d|mesh-list
101198879|NCT05271045|Vitamin A|vitamin a|mesh-list
101198880|NCT05271045|Vitamins|vitamins|mesh-ancestor
101198881|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
101198882|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198883|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198886|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198888|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198889|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198890|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
101198891|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
101198892|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198894|NCT05270434|Meperidine|meperidine|mesh-list
101198895|NCT05270434|Morphine|morphine|mesh-list
101198896|NCT05270434|Buprenorphine|buprenorphine|mesh-list
101198897|NCT05270434|Analgesics|analgesics|mesh-list
101198898|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101198899|NCT05270434|Narcotics|narcotics|mesh-ancestor
101198900|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198901|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198902|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
101198903|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198904|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101198905|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101198906|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101198907|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198908|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198909|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198910|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
101198911|NCT05270421|Furosemide|furosemide|mesh-list
101198912|NCT05270421|Diuretics|diuretics|mesh-ancestor
101198913|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
101198914|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198915|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101198916|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198917|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198918|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
101198919|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101198920|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198921|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
101198922|NCT05270343|Vitamin D|vitamin d|mesh-list
101198923|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101198925|NCT05270343|Vitamins|vitamins|mesh-ancestor
101198926|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
101198927|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101198931|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198932|NCT05269654|Mannitol|mannitol|mesh-list
101198933|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101198934|NCT05269654|Diuretics|diuretics|mesh-ancestor
101198935|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
101198936|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198937|NCT05253846|Fluorouracil|fluorouracil|mesh-list
101198938|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
101198939|NCT05253846|Irinotecan|irinotecan|mesh-list
101198940|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
101198941|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198942|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101198943|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198944|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198945|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
101198946|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198947|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101198948|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101198949|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198950|NCT05250141|Levodopa|levodopa|mesh-list
101198951|NCT05250141|Carbidopa|carbidopa|mesh-list
101198952|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101198953|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101198954|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
101198955|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198956|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198957|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198958|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101198959|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198960|NCT05248724|Ketorolac|ketorolac|mesh-list
101198961|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101198962|NCT05248724|Epinephrine|epinephrine|mesh-list
101198975|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
101198976|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101198977|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198978|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101198979|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101198980|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101198981|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198982|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198983|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101198984|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101198985|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
101198986|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198987|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101198988|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101198989|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
101198990|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101247145|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247146|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
101247147|NCT01675310|Metformin|metformin|mesh-list
101247148|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247149|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247150|NCT01676649|Paclitaxel|paclitaxel|mesh-list
101247151|NCT01676649|Carboplatin|carboplatin|mesh-list
101247152|NCT01676649|Ipilimumab|ipilimumab|mesh-list
101247153|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210322|NCT05964257|Cholinergic Agents|cholinergic agents|mesh-ancestor
101247154|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247155|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
101247156|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
101247157|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247158|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247159|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247160|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101247161|NCT01676987|Budesonide|budesonide|mesh-list
101198991|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
101198992|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
101198993|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
101198994|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101199000|NCT05232006|Niraparib|niraparib|mesh-list
101199012|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199013|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199014|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
101199015|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199016|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199017|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199018|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101199019|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
101199020|NCT05165875|Lidocaine|lidocaine|mesh-list
101199021|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199022|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
101199023|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199024|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199025|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
101199026|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199027|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199028|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199029|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199030|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199031|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199032|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199033|NCT05162118|Nivolumab|nivolumab|mesh-list
101199034|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199035|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199036|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199040|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199041|NCT05142267|Oxycodone|oxycodone|mesh-list
101199042|NCT05142267|Naloxone|naloxone|mesh-list
101199043|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101199044|NCT05142267|Narcotics|narcotics|mesh-ancestor
101199045|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199046|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199047|NCT05142267|Analgesics|analgesics|mesh-ancestor
101199048|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
101199049|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199050|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101199051|NCT05138029|Dexamethasone|dexamethasone|mesh-list
101247162|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
101247163|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247164|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101247165|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
101247166|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247167|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247168|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101247169|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
101247170|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
101247171|NCT01676987|Hormones|hormones|mesh-ancestor
101247172|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101247173|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101247174|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101247175|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101247176|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
101247177|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247178|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199052|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
101199053|NCT05138029|Ranibizumab|ranibizumab|mesh-list
101199054|NCT05138029|BB 1101|bb 1101|mesh-list
101199055|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199056|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
101199057|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
101199058|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199059|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199060|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199061|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
101199062|NCT05138029|Hormones|hormones|mesh-ancestor
101199063|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199064|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101199071|NCT05138029|Growth Substances|growth substances|mesh-ancestor
101199072|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
101199073|NCT05135039|Canagliflozin|canagliflozin|mesh-list
101199074|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101199075|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199076|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199077|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199079|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101199080|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
101199081|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101199082|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
101199083|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199084|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199085|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
101199086|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
101199087|NCT05088928|Apixaban|apixaban|mesh-list
101199088|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101199089|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
101199090|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101199091|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
101199092|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199093|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199094|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
101199095|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
101199096|NCT05075122|Sargramostim|sargramostim|mesh-list
101199097|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199098|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247179|NCT01677039|Ethanol|ethanol|mesh-list
101247180|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101247181|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247182|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247183|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247184|NCT01677065|Oxycodone|oxycodone|mesh-list
101247185|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247186|NCT01677065|Narcotics|narcotics|mesh-ancestor
101247187|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247188|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247189|NCT01677065|Analgesics|analgesics|mesh-ancestor
101247190|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
101247191|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247192|NCT01677247|Glimepiride|glimepiride|mesh-list
101247193|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101247194|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247195|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247196|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101247198|NCT01677260|Metformin|metformin|mesh-list
101247199|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247200|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247201|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
101247202|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
101247203|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247204|NCT01677650|Methadone|methadone|mesh-list
101247205|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247206|NCT01677650|Narcotics|narcotics|mesh-ancestor
101247207|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199099|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199100|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199101|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
101199102|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199103|NCT05067439|Efavirenz|efavirenz|mesh-list
101199104|NCT05067439|Caffeine|caffeine|mesh-list
101199105|NCT05067439|Omeprazole|omeprazole|mesh-list
101199106|NCT05067439|Abrocitinib|abrocitinib|mesh-list
101199107|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101199108|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199109|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101199110|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199111|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199112|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101199113|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101199114|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
101199115|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199116|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101199122|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199123|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101199124|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101199125|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101199126|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101199127|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101199128|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101199129|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199130|NCT05064137|Listerine|listerine|mesh-list
101199131|NCT05064137|Fluorides|fluorides|mesh-list
101199132|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
101199133|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
101199136|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199137|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101199138|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199139|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
101199140|NCT05052528|Rituximab|rituximab|mesh-list
101199141|NCT05052528|Fludarabine|fludarabine|mesh-list
101199142|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
101199143|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101199144|NCT05052528|Antibodies|antibodies|mesh-list
101199145|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
101199146|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101199147|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199148|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
101199149|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199150|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199151|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101199152|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
101199153|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199154|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199155|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101199156|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199157|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
101199158|NCT05051150|Epinephrine|epinephrine|mesh-list
101199159|NCT05051150|Racepinephrine|racepinephrine|mesh-list
101199160|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
101199161|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199162|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199163|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199164|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199165|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199166|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199167|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101199168|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101199169|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
101199170|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199171|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101199172|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
101199173|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
101199174|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
101199175|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101199176|NCT05045313|Probenecid|probenecid|mesh-list
101199177|NCT05045313|Digoxin|digoxin|mesh-list
101199178|NCT05045313|Warfarin|warfarin|mesh-list
101199179|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
101199180|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199181|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101199182|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199183|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199184|NCT05045313|Protective Agents|protective agents|mesh-ancestor
101199185|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199186|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
101199187|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
101199188|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199189|NCT05007561|Naltrexone|naltrexone|mesh-list
101199207|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199208|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101199209|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199213|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101199216|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
101199217|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199218|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101199219|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199220|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199221|NCT04886284|Ertapenem|ertapenem|mesh-list
101199222|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101199223|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199224|NCT04870333|Ciclesonide|ciclesonide|mesh-list
101199225|NCT04870333|Sotrovimab|sotrovimab|mesh-list
101199226|NCT04870333|Niclosamide|niclosamide|mesh-list
101199227|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
101199228|NCT04870333|Hormones|hormones|mesh-ancestor
101199229|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199230|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199231|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101199232|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
101199233|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199234|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
101199235|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101199236|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
101199237|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101199238|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
101199239|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
101199240|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199241|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199242|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199243|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199244|NCT04801641|Nabilone|nabilone|mesh-list
101199245|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
101199246|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
101199247|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199248|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199249|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199250|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101199251|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101199252|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199253|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101199254|NCT04783376|Insulin|insulin|mesh-list
101199270|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199272|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199273|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199274|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199275|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199276|NCT04706767|Lidocaine|lidocaine|mesh-list
101187186|NCT00002508|Carboplatin|carboplatin|mesh-list
101199277|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
101199278|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199279|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
101199280|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199281|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199285|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199286|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199287|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199288|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199289|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199290|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101199291|NCT04706767|Analgesics|analgesics|mesh-ancestor
101199292|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101199293|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199294|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199295|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199296|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199297|NCT04690686|Paclitaxel|paclitaxel|mesh-list
101199298|NCT04690686|Atezolizumab|atezolizumab|mesh-list
101199299|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101199300|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199301|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199302|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199303|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
101199304|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199305|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199306|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199307|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
101199309|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101199310|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199311|NCT04682626|Vitamins|vitamins|mesh-ancestor
101199312|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
101199313|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101199314|NCT04604691|Blinatumomab|blinatumomab|mesh-list
101199315|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199316|NCT04580381|Natalizumab|natalizumab|mesh-list
101199317|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
101199318|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199345|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199347|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199348|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
101199349|NCT04399746|Vitamin D|vitamin d|mesh-list
101199350|NCT04399746|Azithromycin|azithromycin|mesh-list
101199351|NCT04399746|Ivermectin|ivermectin|mesh-list
101199352|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101199353|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199354|NCT04399746|Vitamins|vitamins|mesh-ancestor
101199358|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199359|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101199361|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
101199362|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199363|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101199364|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101199365|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199366|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199367|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101199368|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101199370|NCT04368091|Temsirolimus|temsirolimus|mesh-list
101199371|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
101199372|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101199373|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199374|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101199376|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
101199377|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199378|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
101199379|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199380|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199381|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199382|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199383|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
101199384|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101199385|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101199386|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199388|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
101199389|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101199390|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
101199391|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199392|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199393|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101199395|NCT04245644|Aspirin|aspirin|mesh-list
101199396|NCT04245644|Metformin|metformin|mesh-list
101199397|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101199398|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199399|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199403|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
101199404|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199405|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199406|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199407|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101199408|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101199409|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199410|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101199411|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101199412|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199413|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
101199414|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
101199415|NCT04238845|Vitamin A|vitamin a|mesh-list
101199416|NCT04238845|Vitamins|vitamins|mesh-ancestor
101199417|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
101199418|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199419|NCT04223037|Vaccines|vaccines|mesh-list
101199420|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
101199421|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199422|NCT04186663|Fluorides|fluorides|mesh-list
101199423|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
101199425|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199426|NCT04108026|Durvalumab|durvalumab|mesh-list
101199427|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199428|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199429|NCT04095104|Topiramate|topiramate|mesh-list
101199432|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199433|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199434|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101199435|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
101247208|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247209|NCT01677650|Analgesics|analgesics|mesh-ancestor
101247210|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
101247211|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247212|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
101247213|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
101247214|NCT01678053|Omeprazole|omeprazole|mesh-list
101247215|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
101247216|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101247217|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101247218|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101247219|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101247220|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101247221|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247222|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
101247223|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247224|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247225|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101247226|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247227|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247228|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101247229|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247231|NCT01678937|Sirolimus|sirolimus|mesh-list
101199436|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101199437|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
101199438|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
101199439|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199440|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199441|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199442|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199444|NCT04074512|Trace Elements|trace elements|mesh-ancestor
101199445|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
101199446|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199447|NCT04044729|Cannabidiol|cannabidiol|mesh-list
101199448|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
101199449|NCT04008082|Lenvatinib|lenvatinib|mesh-list
101199450|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199451|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199452|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199453|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199455|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199456|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199457|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199458|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199459|NCT03967925|Prednisone|prednisone|mesh-list
101199460|NCT03967925|Prednisolone|prednisolone|mesh-list
101199461|NCT03967925|Rituximab|rituximab|mesh-list
101199462|NCT03967925|Belimumab|belimumab|mesh-list
101199463|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199464|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199465|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
101199466|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199467|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247232|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
101247233|NCT01678937|Temsirolimus|temsirolimus|mesh-list
101247234|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
101247235|NCT01678937|Tacrolimus|tacrolimus|mesh-list
101247236|NCT01678937|Cyclosporins|cyclosporins|mesh-list
101247237|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101247238|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
101247239|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247240|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101247241|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247242|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247243|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
101247244|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247245|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247246|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247247|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101247248|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247249|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101199468|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199469|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
101199470|NCT03967925|Hormones|hormones|mesh-ancestor
101199471|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199472|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101199473|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199474|NCT03954743|Vaccines|vaccines|mesh-list
101199475|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
101199476|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199477|NCT03883412|Liraglutide|liraglutide|mesh-list
101199478|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199481|NCT03883412|Hormones|hormones|mesh-ancestor
101199482|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199483|NCT03858621|Fentanyl|fentanyl|mesh-list
101199484|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101199485|NCT03858621|Narcotics|narcotics|mesh-ancestor
101199486|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199487|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199488|NCT03858621|Analgesics|analgesics|mesh-ancestor
101199489|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
101199490|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199491|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101199492|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101199493|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
101199494|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
101199495|NCT03845270|Docetaxel|docetaxel|mesh-list
101199496|NCT03845270|Trastuzumab|trastuzumab|mesh-list
101199497|NCT03845270|Pertuzumab|pertuzumab|mesh-list
101199498|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199499|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199500|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199501|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187426|NCT00002604|Carmustine|carmustine|mesh-list
101199502|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199503|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199505|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101199515|NCT03758170|Dexamethasone|dexamethasone|mesh-list
101199516|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199517|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
101199518|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
101199519|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199520|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199521|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199522|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
101199523|NCT03758170|Hormones|hormones|mesh-ancestor
101199524|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199525|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101199526|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199527|NCT03733119|TIC10 compound|tic10 compound|mesh-list
101199528|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199530|NCT03705338|Anesthetics|anesthetics|mesh-list
101199531|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
101199532|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199533|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199534|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199535|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101199536|NCT03704285|Propofol|propofol|mesh-list
101199537|NCT03704285|Anesthetics|anesthetics|mesh-list
101199538|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
101199539|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199540|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199541|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199542|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101199543|NCT03696537|Fludarabine|fludarabine|mesh-list
101187463|NCT00002616|Aldesleukin|aldesleukin|mesh-list
101199544|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199545|NCT03661996|Lidocaine|lidocaine|mesh-list
101199546|NCT03661996|Epinephrine|epinephrine|mesh-list
101199547|NCT03661996|Capsaicin|capsaicin|mesh-list
101199548|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199549|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
101199550|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199551|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199552|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
101199553|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199554|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199555|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199556|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199557|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199558|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199559|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199560|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199561|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199562|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199569|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
101199570|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101199571|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
101199572|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
101199573|NCT03659799|Insulin|insulin|mesh-list
101199574|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101199575|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
101199587|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101199588|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
101199589|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199590|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199591|NCT03360214|Bupivacaine|bupivacaine|mesh-list
101199592|NCT03360214|Ropivacaine|ropivacaine|mesh-list
101199593|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199594|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
101199595|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199596|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199597|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
101199598|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199599|NCT03359239|Atezolizumab|atezolizumab|mesh-list
101199600|NCT03359239|Poly ICLC|poly iclc|mesh-list
101199601|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199602|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199603|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199604|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199606|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
101199607|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199608|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
101199609|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199610|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199611|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199612|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199613|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
101199614|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101199615|NCT03328676|Protective Agents|protective agents|mesh-ancestor
101199616|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199617|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101199618|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101199619|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
101199620|NCT03315039|Annamycin|annamycin|mesh-list
101199621|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101199622|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199623|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
101199624|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199625|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199626|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199627|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101199628|NCT03289325|Analgesics|analgesics|mesh-ancestor
101199629|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
101199630|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199631|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101199632|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199633|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199634|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199635|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199636|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199637|NCT03276533|Lidocaine|lidocaine|mesh-list
101199638|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
101199639|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199640|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
101199641|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199646|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199647|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199648|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199657|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199658|NCT03254394|Lidocaine|lidocaine|mesh-list
101199659|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199660|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
101199661|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199662|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199663|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
101199664|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199665|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199666|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199667|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199668|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199669|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199670|NCT03203876|Nivolumab|nivolumab|mesh-list
101199671|NCT03203876|Ipilimumab|ipilimumab|mesh-list
101199672|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199673|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199674|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199675|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199676|NCT03191240|Vasopressins|vasopressins|mesh-list
101199677|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
101199678|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
101199679|NCT03191240|Coagulants|coagulants|mesh-ancestor
101199680|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101199681|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101199682|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
101199683|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199684|NCT03180294|Bupropion|bupropion|mesh-list
101199685|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101199686|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
101199687|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101199688|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101199689|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101199690|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199691|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199692|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
101199693|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199694|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199695|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101199696|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101199697|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199698|NCT03071601|Lidocaine|lidocaine|mesh-list
101199699|NCT03071601|Epinephrine|epinephrine|mesh-list
101199700|NCT03071601|Prilocaine|prilocaine|mesh-list
101199701|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101199702|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199703|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
101199704|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199705|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199706|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
101199707|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199708|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199709|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199715|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199716|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199717|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101199718|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101199719|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
101199720|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101199726|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101199727|NCT03061903|Laxatives|laxatives|mesh-ancestor
101199728|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199729|NCT03061643|Docetaxel|docetaxel|mesh-list
101199730|NCT03061643|Androgens|androgens|mesh-list
101199731|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199732|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199733|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199734|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
101199735|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199736|NCT03061643|Hormones|hormones|mesh-ancestor
101199737|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101199738|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199739|NCT03061630|Gemcitabine|gemcitabine|mesh-list
101199740|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199741|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199742|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
101199743|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199744|NCT03055390|Scopolamine|scopolamine|mesh-list
101199745|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
101199746|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101199747|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
101199748|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
101199749|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199750|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199751|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199752|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
101199753|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101199754|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
101199755|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199756|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199757|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101199758|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
101199759|NCT03012672|Cytarabine|cytarabine|mesh-list
101199760|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
101199761|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
101199762|NCT03012672|Cladribine|cladribine|mesh-list
101199763|NCT03012672|Lenograstim|lenograstim|mesh-list
101199764|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199765|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
101199766|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199767|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199768|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
101199769|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199770|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199771|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
101199772|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199773|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101199774|NCT03012672|Analgesics|analgesics|mesh-ancestor
101199775|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
101199776|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199777|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101199778|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101199779|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199793|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101199794|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
101199795|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199796|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101199797|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101199798|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247250|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
101247251|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247252|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247253|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
101247255|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
101247256|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101247257|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
101247258|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247259|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199799|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101199800|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101199801|NCT03011775|Analgesics|analgesics|mesh-ancestor
101199802|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
101199803|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199804|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199825|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101199826|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199827|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101199828|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199829|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
101199830|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199831|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
101199832|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199833|NCT02924480|Lidocaine|lidocaine|mesh-list
101199834|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199835|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
101199836|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199837|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199838|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
101199839|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199840|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101199841|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101199842|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101199843|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101199845|NCT02924064|Metformin|metformin|mesh-list
101199846|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199847|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199848|NCT02889900|Olaparib|olaparib|mesh-list
101199849|NCT02889900|Cediranib|cediranib|mesh-list
101199850|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101199851|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101199852|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199853|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199854|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101199855|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
101199856|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
101199857|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101199858|NCT02879942|Growth Substances|growth substances|mesh-ancestor
101199859|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199860|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
101199861|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199877|NCT02810457|Carboplatin|carboplatin|mesh-list
101199878|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101199879|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199880|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
101199881|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
101199882|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
101199883|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199884|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199885|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101199886|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101199887|NCT02810457|Growth Substances|growth substances|mesh-ancestor
101199888|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199889|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
101199891|NCT02745535|Velpatasvir|velpatasvir|mesh-list
101247260|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101247261|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
101247262|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247263|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101323293|NCT00096343|Paclitaxel|paclitaxel|mesh-list
101247264|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101247265|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247266|NCT01679093|Dexamethasone|dexamethasone|mesh-list
101247267|NCT01679093|Droperidol|droperidol|mesh-list
101247268|NCT01679093|Ondansetron|ondansetron|mesh-list
101247269|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247270|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
101199892|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
101199957|NCT02684253|Nivolumab|nivolumab|mesh-list
101199958|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101199959|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199960|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101199961|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199962|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101199963|NCT02666794|Sufentanil|sufentanil|mesh-list
101199964|NCT02666794|Morphine|morphine|mesh-list
101199965|NCT02666794|Dsuvia|dsuvia|mesh-list
101199966|NCT02666794|Bupivacaine|bupivacaine|mesh-list
101199967|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199968|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
101199969|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199970|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199971|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
101199972|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199973|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101199974|NCT02666794|Narcotics|narcotics|mesh-ancestor
101199975|NCT02666794|Analgesics|analgesics|mesh-ancestor
101199976|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101199977|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101199978|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
101199979|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
101199980|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
101199981|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199983|NCT02642094|Sirolimus|sirolimus|mesh-list
101199984|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101199985|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199986|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101199990|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
101199991|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199993|NCT02619552|Budesonide|budesonide|mesh-list
101199994|NCT02619552|Adalimumab|adalimumab|mesh-list
101200041|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200042|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
101200043|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200044|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200045|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200046|NCT02535650|Tipifarnib|tipifarnib|mesh-list
101200047|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200048|NCT02526017|Nivolumab|nivolumab|mesh-list
101200049|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200050|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200051|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101200052|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200053|NCT02516657|Liraglutide|liraglutide|mesh-list
101200054|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200055|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200056|NCT02516657|Incretins|incretins|mesh-ancestor
101200057|NCT02516657|Hormones|hormones|mesh-ancestor
101200058|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200059|NCT02427581|Poly I-C|poly i-c|mesh-list
101200067|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
101247271|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
101247272|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247273|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247274|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247275|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
101247276|NCT01679093|Hormones|hormones|mesh-ancestor
101247277|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200068|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200069|NCT02423525|Afatinib|afatinib|mesh-list
101187779|NCT00002748|Interleukin-2|interleukin-2|mesh-list
101200070|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200071|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200072|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200073|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200074|NCT02369653|Apixaban|apixaban|mesh-list
101200075|NCT02369653|Anticoagulants|anticoagulants|mesh-list
101200076|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101200077|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
101200078|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101200079|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200080|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200081|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200082|NCT02293109|Leucovorin|leucovorin|mesh-list
101200083|NCT02293109|Cytarabine|cytarabine|mesh-list
101200084|NCT02293109|Dexamethasone|dexamethasone|mesh-list
101200085|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
101200088|NCT02293109|Prednisolone|prednisolone|mesh-list
101200089|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
101200090|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
101200091|NCT02293109|Rituximab|rituximab|mesh-list
101200092|NCT02293109|Doxorubicin|doxorubicin|mesh-list
101200093|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101200094|NCT02293109|Methotrexate|methotrexate|mesh-list
101200095|NCT02293109|Vincristine|vincristine|mesh-list
101200096|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101200097|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
101200098|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
101200099|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200100|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
101200101|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200102|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200103|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101200104|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
101200105|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200106|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200107|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101200108|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200109|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200110|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
101200111|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
101200112|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200113|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200114|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
101200121|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200122|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101200123|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
101200124|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101200125|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200127|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
101200128|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101200129|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101200130|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
101200131|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200138|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187865|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
101200139|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200140|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200141|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101200142|NCT02195986|Estradiol|estradiol|mesh-list
101200143|NCT02195986|Estrogens|estrogens|mesh-ancestor
101200144|NCT02195986|Hormones|hormones|mesh-ancestor
101200145|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200146|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200147|NCT02183883|Afatinib|afatinib|mesh-list
101200148|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200149|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200150|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200151|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200152|NCT01982630|Liraglutide|liraglutide|mesh-list
101200153|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200154|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200155|NCT01982630|Incretins|incretins|mesh-ancestor
101200156|NCT01982630|Hormones|hormones|mesh-ancestor
101200157|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200158|NCT01951469|Pemetrexed|pemetrexed|mesh-list
101200159|NCT01951469|Gefitinib|gefitinib|mesh-list
101200160|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200161|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200162|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200163|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101200164|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101200165|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200166|NCT01940809|Nivolumab|nivolumab|mesh-list
101200167|NCT01940809|Ipilimumab|ipilimumab|mesh-list
101200168|NCT01940809|Trametinib|trametinib|mesh-list
101200169|NCT01940809|Dabrafenib|dabrafenib|mesh-list
101200170|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200171|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200172|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101200173|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200174|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200175|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200176|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101200177|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200178|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200179|NCT01879228|Incretins|incretins|mesh-ancestor
101200180|NCT01879228|Hormones|hormones|mesh-ancestor
101200181|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200182|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101200183|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200184|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200185|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200186|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
101200187|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101200189|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
101200197|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200199|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
101200200|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200201|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200205|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200206|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
101200207|NCT01622998|Nicotine|nicotine|mesh-list
101200208|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101200209|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
101200210|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200211|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200212|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101200213|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101200214|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
101200215|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200216|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200217|NCT01595620|Dronabinol|dronabinol|mesh-list
101200218|NCT01595620|Capsaicin|capsaicin|mesh-list
101200219|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
101200220|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200221|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200222|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200223|NCT01595620|Analgesics|analgesics|mesh-ancestor
101200224|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
101200225|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200226|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101200227|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101200228|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200229|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200230|NCT01595620|Hormones|hormones|mesh-ancestor
101200231|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200232|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
101200233|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
101200234|NCT01591629|Dronabinol|dronabinol|mesh-list
101200235|NCT01591629|Naloxone|naloxone|mesh-list
101200236|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101200237|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200238|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
101200239|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200240|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
101200241|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200242|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200243|NCT01591629|Analgesics|analgesics|mesh-ancestor
101200244|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101200245|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101200246|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200247|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200248|NCT01591629|Hormones|hormones|mesh-ancestor
101200249|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200250|NCT01515306|Paclitaxel|paclitaxel|mesh-list
101200252|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200253|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200254|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
101200255|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200256|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200257|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200258|NCT01513187|Interferons|interferons|mesh-list
101200259|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
101200279|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200280|NCT01354977|Resveratrol|resveratrol|mesh-list
101200281|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
101200282|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200283|NCT01354977|Protective Agents|protective agents|mesh-ancestor
101200284|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200285|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200286|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101200287|NCT01334606|Insulin|insulin|mesh-list
101200288|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200289|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200290|NCT01226732|Capecitabine|capecitabine|mesh-list
101200291|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200292|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
101200293|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200294|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200295|NCT00962988|Bupropion|bupropion|mesh-list
101200296|NCT00962988|Nicotine|nicotine|mesh-list
101200297|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101200298|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
101200299|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200300|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200301|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101200302|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101200303|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
101200304|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200305|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200306|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101200307|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
101200308|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200309|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101200310|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101200311|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200312|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
101200313|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101200314|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101200315|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200316|NCT00768820|Risperidone|risperidone|mesh-list
101200317|NCT00768820|Methylphenidate|methylphenidate|mesh-list
101200318|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101200319|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
101200320|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200321|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200322|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200323|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101200324|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247278|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101247279|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247280|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
101247281|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247282|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101247283|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101247284|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
101247285|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247286|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247287|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247288|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101247289|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200340|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200341|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101200342|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101200354|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101200355|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200356|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101188030|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200357|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101200358|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200359|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200360|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
101200361|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200363|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
101200364|NCT00447122|Lapatinib|lapatinib|mesh-list
101200365|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200366|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
101200367|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200368|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200369|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200370|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200371|NCT00430040|Carvedilol|carvedilol|mesh-list
101200372|NCT00430040|Lisinopril|lisinopril|mesh-list
101200373|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101200374|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101200375|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
101200376|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200377|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200378|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200379|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101200380|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
101200381|NCT00430040|Protective Agents|protective agents|mesh-ancestor
101200382|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101200383|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200384|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101200385|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
101200386|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101200387|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101200388|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101200389|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200390|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200391|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101200392|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
101200393|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101200394|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
101200413|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200414|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200415|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200417|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101200418|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101200419|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200420|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101200421|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101200422|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200423|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
101200424|NCT01397630|Oxytocin|oxytocin|mesh-list
101200425|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
101200426|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101200427|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200428|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
101200429|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200430|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
101200431|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188107|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
101200432|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200433|NCT01397994|Nicorandil|nicorandil|mesh-list
101200434|NCT01397994|Atenolol|atenolol|mesh-list
101200435|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101200436|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101200437|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
101200438|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
101200439|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200440|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200441|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101200442|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101200443|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101200444|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
101200445|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200446|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200447|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
101200448|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
101200449|NCT01397994|Vitamins|vitamins|mesh-ancestor
101200450|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
101200451|NCT01398033|Paclitaxel|paclitaxel|mesh-list
101200452|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200453|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200454|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
101200455|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200456|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200457|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200458|NCT01398046|Dasatinib|dasatinib|mesh-list
101200459|NCT01398046|Rabeprazole|rabeprazole|mesh-list
101200460|NCT01398046|Betaine|betaine|mesh-list
101200461|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200465|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101200466|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200467|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101200468|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
101200469|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101200470|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
101200471|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101200472|NCT01398072|Azithromycin|azithromycin|mesh-list
101200473|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
101200474|NCT01398072|Doxycycline|doxycycline|mesh-list
101200475|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200480|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200481|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200482|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
101200483|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101200484|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101200485|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
101200486|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
101200487|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101200488|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
101200489|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200490|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200491|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200492|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
101200493|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101200494|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101200495|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101200496|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
101200497|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200498|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200499|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101200500|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101247290|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247291|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247292|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101247293|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101247294|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
101247295|NCT01679743|Trastuzumab|trastuzumab|mesh-list
101247296|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247297|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247298|NCT01680094|Panobinostat|panobinostat|mesh-list
101247299|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247300|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101247301|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210471|NCT05962320|Narcotics|narcotics|mesh-ancestor
101247302|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247303|NCT01680120|Anesthetics|anesthetics|mesh-list
101247304|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247305|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247306|NCT01680198|Vitamin D|vitamin d|mesh-list
101247307|NCT01680198|Vitamins|vitamins|mesh-ancestor
101247308|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
101247309|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247310|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101247311|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101200501|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101200502|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
101200503|NCT01398189|Clozapine|clozapine|mesh-list
101200504|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101200505|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
101200506|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200507|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200508|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200509|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101200510|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200511|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200512|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200513|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
101200514|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
101200515|NCT01398202|Vitamin D|vitamin d|mesh-list
101200516|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
101200518|NCT01398202|Calcifediol|calcifediol|mesh-list
101200519|NCT01398202|Vitamins|vitamins|mesh-ancestor
101200520|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
101200521|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200522|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101200523|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101200524|NCT01398267|Lisinopril|lisinopril|mesh-list
101200525|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101200526|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200527|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200528|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200529|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101200530|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101200531|NCT01398267|Protective Agents|protective agents|mesh-ancestor
101247312|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101247313|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247314|NCT05596981|Sorafenib|sorafenib|mesh-list
101247315|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247316|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247317|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247318|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247319|NCT05596968|Sorafenib|sorafenib|mesh-list
101247320|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247321|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247322|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247323|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247324|NCT05596890|Paclitaxel|paclitaxel|mesh-list
101247325|NCT05596890|Carboplatin|carboplatin|mesh-list
101247326|NCT05596890|Tislelizumab|tislelizumab|mesh-list
101247327|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101247328|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247329|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101247330|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101247331|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247332|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247333|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247334|NCT05596669|Ketamine|ketamine|mesh-list
101247335|NCT05596669|Morphine|morphine|mesh-list
101247336|NCT05596669|Analgesics|analgesics|mesh-ancestor
101247337|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
101247338|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247339|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247340|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101247341|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247342|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
101247343|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
101247344|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247345|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101247346|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101247347|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200532|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200533|NCT01398293|Ritonavir|ritonavir|mesh-list
101200534|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
101200535|NCT01398293|Lactams|lactams|mesh-list
101200536|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101200537|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101200538|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101200539|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200582|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200583|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200584|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200585|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200586|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101200587|NCT01398592|Vildagliptin|vildagliptin|mesh-list
101200590|NCT01398592|Incretins|incretins|mesh-ancestor
101200592|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200593|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101200594|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200595|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200596|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200597|NCT01398618|Rifampin|rifampin|mesh-list
101200598|NCT01398618|Isoniazid|isoniazid|mesh-list
101200599|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101200600|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
101200601|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200602|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200603|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
101200604|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101200605|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200606|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200607|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101200608|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101200609|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101200610|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101200611|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101200612|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101200613|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101200614|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101200615|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
101200617|NCT01398657|Androgens|androgens|mesh-list
101200618|NCT01398657|Hormones|hormones|mesh-ancestor
101200619|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200620|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200621|NCT01398670|Insulin|insulin|mesh-list
101200622|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101200623|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
101200624|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200625|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200627|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101200628|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200629|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200630|NCT01398995|Insulin|insulin|mesh-list
101200631|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200632|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200633|NCT01399086|Fulvestrant|fulvestrant|mesh-list
101200634|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101200635|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200636|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101200637|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101200638|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
101200648|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101200649|NCT01399216|Fucoidan|fucoidan|mesh-list
101200650|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101200651|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200652|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
101200653|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200654|NCT01399242|Everolimus|everolimus|mesh-list
101200655|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200656|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
101200657|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200658|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200662|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200663|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
101200664|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200665|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247350|NCT05596669|Narcotics|narcotics|mesh-ancestor
101247351|NCT05596617|Melatonin|melatonin|mesh-list
101247352|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
101247353|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247354|NCT05596617|Protective Agents|protective agents|mesh-ancestor
101247355|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247356|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247357|NCT05596552|Fentanyl|fentanyl|mesh-list
101247358|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
101247359|NCT05596552|Bupivacaine|bupivacaine|mesh-list
101247360|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
101247362|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247363|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247364|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
101247365|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247366|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101247367|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247368|NCT05596552|Analgesics|analgesics|mesh-ancestor
101247369|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101247370|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101247371|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101247372|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
101247373|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247374|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247375|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247376|NCT05596552|Narcotics|narcotics|mesh-ancestor
101247377|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101200667|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101200668|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
101200669|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
101200670|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101200671|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101188295|NCT01096368|Cisplatin|cisplatin|mesh-list
101200672|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200673|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101200674|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101200675|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200676|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200677|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200678|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200679|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101200680|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101200681|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
101200682|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200683|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200684|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101200685|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101200686|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
101247378|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247379|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
101247381|NCT05596227|Narcotics|narcotics|mesh-list
101247382|NCT05596227|Propofol|propofol|mesh-list
101247383|NCT05596227|Anesthetics|anesthetics|mesh-list
101247384|NCT05596227|Sevoflurane|sevoflurane|mesh-list
101247385|NCT05596227|Rocuronium|rocuronium|mesh-list
101247386|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101247387|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247388|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247389|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247390|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
101247391|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247392|NCT05596227|Analgesics|analgesics|mesh-ancestor
101247393|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
101247394|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247395|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247396|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101247397|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101200687|NCT01399463|Paclitaxel|paclitaxel|mesh-list
101200688|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200689|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200690|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
101200691|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200692|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200693|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200694|NCT01399515|Valproic Acid|valproic acid|mesh-list
101200695|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
101200696|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200697|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200698|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
101200699|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200700|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200701|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
101200702|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200703|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200704|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200705|NCT01399645|Insulin|insulin|mesh-list
101200706|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101200707|NCT01399645|Metformin|metformin|mesh-list
101200708|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
101200713|NCT01399645|Hormones|hormones|mesh-ancestor
101200714|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200715|NCT01399840|Talazoparib|talazoparib|mesh-list
101200716|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101200717|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200718|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200719|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200720|NCT01399853|Vaccines|vaccines|mesh-list
101200721|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
101200722|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200723|NCT01400009|Vitamin D|vitamin d|mesh-list
101200724|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
101200725|NCT01400009|Vitamins|vitamins|mesh-ancestor
101200726|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
101200727|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200728|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101200729|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101200733|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200734|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200735|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200736|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200737|NCT01400100|Octreotide|octreotide|mesh-list
101200738|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101200739|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200740|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101200741|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200742|NCT01400165|Pindolol|pindolol|mesh-list
101200743|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101200744|NCT01400165|Trazodone|trazodone|mesh-list
101200745|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
101200746|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200747|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101200748|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200749|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200750|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200751|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101200752|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101200753|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101200754|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200755|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200756|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200757|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
101200758|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101200759|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101200760|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101200761|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
101200762|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101200764|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
101200765|NCT01400191|Metformin|metformin|mesh-list
101200766|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200768|NCT01400217|Beclomethasone|beclomethasone|mesh-list
101200769|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200770|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
101200771|NCT01400217|Hormones|hormones|mesh-ancestor
101200772|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200773|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200774|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200775|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
101200776|NCT01400256|Valsartan|valsartan|mesh-list
101200777|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101200778|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101200779|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101200780|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200781|NCT01400308|Mupirocin|mupirocin|mesh-list
101200782|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200783|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200784|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101200789|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200790|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
101200792|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200793|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200794|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101200795|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200796|NCT01400568|Fluticasone|fluticasone|mesh-list
101200798|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200799|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101200800|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
101200801|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200802|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200809|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
101200810|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200811|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200812|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200813|NCT01400646|Vitamins|vitamins|mesh-list
101200814|NCT01400646|Vitamin K|vitamin k|mesh-list
101200815|NCT01400646|Warfarin|warfarin|mesh-list
101200816|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
101200817|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
101200818|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200819|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
101200820|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101200821|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
101200822|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101247398|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101247399|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101247400|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101247401|NCT05596214|Curcumin|curcumin|mesh-list
101247402|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247403|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247404|NCT05596214|Analgesics|analgesics|mesh-ancestor
101247405|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
101247406|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247407|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101323298|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
101247408|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247409|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200823|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
101200824|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200825|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200827|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101200828|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
101200829|NCT01400646|Coagulants|coagulants|mesh-ancestor
101200830|NCT01400672|Imiquimod|imiquimod|mesh-list
101200831|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101200832|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
101200833|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200834|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200835|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
101200836|NCT01400685|Rituximab|rituximab|mesh-list
101200837|NCT01400685|Lenalidomide|lenalidomide|mesh-list
101200839|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200841|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
101200842|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200843|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200844|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101200845|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101200846|NCT01400685|Growth Substances|growth substances|mesh-ancestor
101200847|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
101200848|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101200849|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
101200850|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200851|NCT01400737|Ibuprofen|ibuprofen|mesh-list
101200852|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101200853|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200854|NCT01400737|Analgesics|analgesics|mesh-ancestor
101200855|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
101200856|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200857|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200858|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200859|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200860|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101200861|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200862|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200863|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
101200865|NCT01400750|Colistin|colistin|mesh-list
101200866|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200867|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200873|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101200874|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101200875|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
101200878|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200880|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200881|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200882|NCT01400828|Desloratadine|desloratadine|mesh-list
101200883|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101247410|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247412|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247414|NCT05596149|Fluorides|fluorides|mesh-list
101247415|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
101247416|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
101247417|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
101247418|NCT05596149|Protective Agents|protective agents|mesh-ancestor
101247419|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247420|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101247421|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247422|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
101247423|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247424|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247425|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247426|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200884|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
101200885|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200886|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200887|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200888|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101200889|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101200890|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
101200891|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
101200893|NCT01400867|Clindamycin|clindamycin|mesh-list
101200894|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
101200895|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
101200896|NCT01400867|Cefazolin|cefazolin|mesh-list
101200897|NCT01400867|Linezolid|linezolid|mesh-list
101200898|NCT01400867|Cephalexin|cephalexin|mesh-list
101200899|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
101200900|NCT01400867|Aztreonam|aztreonam|mesh-list
101200901|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200902|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200903|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101200904|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200905|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200906|NCT01400945|Pantoprazole|pantoprazole|mesh-list
101200907|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101200908|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200909|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101200910|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200911|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200912|NCT01401036|Umirolimus|umirolimus|mesh-list
101200913|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200914|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200915|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
101200917|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
101200918|NCT01401075|Doxifluridine|doxifluridine|mesh-list
101200919|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200920|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101200921|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101200922|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
101200923|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200924|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200925|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
101200926|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200927|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200928|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
101200929|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200930|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
101200931|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101200932|NCT01401179|Clarithromycin|clarithromycin|mesh-list
101200933|NCT01401179|Cefazolin|cefazolin|mesh-list
101200934|NCT01401179|Erythromycin|erythromycin|mesh-list
101200935|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
101200936|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101200938|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200939|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200940|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101200941|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200942|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200948|NCT01401192|Pemetrexed|pemetrexed|mesh-list
101200949|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200954|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101200955|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101200957|NCT01401387|Pancrelipase|pancrelipase|mesh-list
101200958|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200959|NCT01401491|Clozapine|clozapine|mesh-list
101200960|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
101200961|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101200962|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
101200963|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200965|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200966|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101200967|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101200968|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200969|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200970|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
101200971|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
101200972|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101200973|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101200974|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101200975|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200976|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101200977|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
101200978|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101200979|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101200980|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200981|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101200982|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101200983|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101200984|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200985|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200986|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
101200987|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101200988|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200989|NCT01401933|Rifampin|rifampin|mesh-list
101200990|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101200991|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
101200992|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101200993|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200994|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
101200995|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101200996|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200997|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200998|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101200999|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101201000|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101201001|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101201002|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101201003|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101201004|NCT01402024|Aprepitant|aprepitant|mesh-list
101201005|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
101201006|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
101201007|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201008|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201010|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101201011|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201012|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201013|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
101201014|NCT01402076|Midazolam|midazolam|mesh-list
101201015|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201016|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201017|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247427|NCT05596071|Sufentanil|sufentanil|mesh-list
101247428|NCT05596071|Dsuvia|dsuvia|mesh-list
101247429|NCT05596071|Ropivacaine|ropivacaine|mesh-list
101247430|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
101247431|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
101247432|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247433|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247434|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
101247435|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247436|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247437|NCT05596071|Narcotics|narcotics|mesh-ancestor
101247438|NCT05596071|Analgesics|analgesics|mesh-ancestor
101247439|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247440|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247441|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
101247442|NCT05595824|Molnupiravir|molnupiravir|mesh-list
101247443|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
101247444|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247445|NCT05595590|Tislelizumab|tislelizumab|mesh-list
101247446|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201036|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201037|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201038|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101201039|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201040|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201041|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201042|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
101201043|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
101201044|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
101201045|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
101201046|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201047|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201048|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201049|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201050|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201051|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101201052|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101201053|NCT01402089|Growth Substances|growth substances|mesh-ancestor
101201054|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
101201055|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101201056|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101201057|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101201058|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101201059|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
101201060|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
101201061|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201062|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201063|NCT01402193|Anastrozole|anastrozole|mesh-list
101201064|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101201065|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201066|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101201067|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101201069|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201070|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101201071|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101201072|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201073|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201083|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201084|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201085|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201086|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201087|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
101201088|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201089|NCT01402297|Protective Agents|protective agents|mesh-ancestor
101201090|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201091|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101201092|NCT01402336|Cetrorelix|cetrorelix|mesh-list
101201093|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101201094|NCT01402336|Hormones|hormones|mesh-ancestor
101201098|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101201099|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
101201100|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101201101|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101201102|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101201103|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201104|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101201105|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
101201106|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
101201107|NCT01402479|Ramipril|ramipril|mesh-list
101201108|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101201109|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201110|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201119|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
101201120|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201121|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201122|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201123|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201125|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201126|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201128|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
101201130|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
101201131|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
101201132|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201133|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201134|NCT01402622|Propofol|propofol|mesh-list
101201135|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
101201136|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201137|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201138|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201139|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201140|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
101201141|NCT01402674|Phentermine|phentermine|mesh-list
101201142|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101201143|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201144|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
101201145|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101201146|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
101201147|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
101201148|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201149|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
101201150|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201151|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201152|NCT01402843|Valsartan|valsartan|mesh-list
101201153|NCT01402843|Pitavastatin|pitavastatin|mesh-list
101201154|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101201155|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101201156|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101201157|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201158|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101201159|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101201160|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101201161|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
101201162|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201163|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101201164|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
101201165|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101201167|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201169|NCT01402882|Coagulants|coagulants|mesh-ancestor
101201170|NCT01403025|Liraglutide|liraglutide|mesh-list
101201171|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201172|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201173|NCT01403025|Incretins|incretins|mesh-ancestor
101201174|NCT01403025|Hormones|hormones|mesh-ancestor
101201175|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201176|NCT01403103|Vitamin D|vitamin d|mesh-list
101201177|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
101201178|NCT01403103|Vitamins|vitamins|mesh-ancestor
101201179|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
101201180|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201181|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101201182|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101201187|NCT01403181|Ribavirin|ribavirin|mesh-list
101201188|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101201189|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
101201190|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201191|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
101201192|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201193|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
101201194|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201195|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
101201196|NCT01403285|Molgramostim|molgramostim|mesh-list
101201197|NCT01403285|Imiquimod|imiquimod|mesh-list
101201198|NCT01403285|Sargramostim|sargramostim|mesh-list
101201199|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201200|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
101201201|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201202|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201203|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101201204|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
101201205|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201206|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201207|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101201208|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101201209|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
101201210|NCT01403363|Fentanyl|fentanyl|mesh-list
101201211|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101201212|NCT01403363|Narcotics|narcotics|mesh-ancestor
101201213|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201214|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201215|NCT01403363|Analgesics|analgesics|mesh-ancestor
101201216|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
101201217|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201218|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201219|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201220|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
101201221|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
101201222|NCT01403389|Eculizumab|eculizumab|mesh-list
101201223|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101201224|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201225|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
101201226|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201227|NCT01403415|Sirolimus|sirolimus|mesh-list
101201228|NCT01403415|Dexamethasone|dexamethasone|mesh-list
101201229|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
101201230|NCT01403415|Methotrexate|methotrexate|mesh-list
101201231|NCT01403415|Vincristine|vincristine|mesh-list
101201232|NCT01403415|Temsirolimus|temsirolimus|mesh-list
101201233|NCT01403415|Asparaginase|asparaginase|mesh-list
101201234|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
101201235|NCT01403415|Pegaspargase|pegaspargase|mesh-list
101201236|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
101201237|NCT01403415|BB 1101|bb 1101|mesh-list
101201238|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201239|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
101201240|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
101201241|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201242|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201243|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201246|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201248|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201249|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101201250|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
101201251|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101201252|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101201253|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
101201254|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201255|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
101201256|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201257|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101201258|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201259|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
101201264|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101201265|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
101201266|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201267|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201268|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101201269|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
101201270|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201271|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201272|NCT01403415|Analgesics|analgesics|mesh-ancestor
101201273|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
101201274|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101201275|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101201276|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
101201277|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101201278|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
101201279|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201280|NCT01403506|Expectorants|expectorants|mesh-ancestor
101201281|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
101201282|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101201283|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
101201284|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201285|NCT01403506|Protective Agents|protective agents|mesh-ancestor
101201286|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201287|NCT01403506|Antidotes|antidotes|mesh-ancestor
101201288|NCT01403545|Curcumin|curcumin|mesh-list
101201289|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101201290|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201291|NCT01403545|Analgesics|analgesics|mesh-ancestor
101201292|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
101201293|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201294|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201295|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201296|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201297|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201298|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201299|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201300|NCT01403662|Minocycline|minocycline|mesh-list
101201301|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201302|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201303|NCT01403740|Cyclosporine|cyclosporine|mesh-list
101201304|NCT01403740|Rituximab|rituximab|mesh-list
101201306|NCT01403740|Cyclosporins|cyclosporins|mesh-list
101201307|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201308|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201309|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
101201310|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201311|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201312|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201313|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201314|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201315|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
101201316|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201324|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101201325|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201326|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101201327|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201329|NCT01403844|Carotenoids|carotenoids|mesh-list
101201330|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
101201331|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201332|NCT01403844|Protective Agents|protective agents|mesh-ancestor
101201333|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201334|NCT01403896|Plerixafor|plerixafor|mesh-list
101201335|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101201336|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101201337|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
101201338|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201339|NCT01403948|BI 836826|bi 836826|mesh-list
101201351|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
101201352|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201353|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201354|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101201355|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101201356|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201358|NCT01404104|Temsirolimus|temsirolimus|mesh-list
101247447|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247448|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
101247449|NCT05595447|Nivolumab|nivolumab|mesh-list
101247450|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101247451|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247452|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247453|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101247454|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247455|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
101247456|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
101247457|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
101247458|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247459|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
101247460|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
101247461|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247462|NCT05567822|Esmolol|esmolol|mesh-list
101247463|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101201359|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
101201360|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201361|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201362|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201363|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201364|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
101201365|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201366|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201367|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201368|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201369|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101201370|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
101201371|NCT01404117|Interferons|interferons|mesh-list
101201372|NCT01404117|Interferon-beta|interferon-beta|mesh-list
101201373|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
101201374|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
101201375|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201376|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
101201377|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201378|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
101201379|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201380|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101201381|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201382|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201383|NCT01404130|Isotretinoin|isotretinoin|mesh-list
101201390|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
101201391|NCT01404156|Epirubicin|epirubicin|mesh-list
101201392|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101201393|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201394|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
101201395|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
101201396|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
101201397|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201398|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
101201399|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101201400|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201401|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
101201402|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201403|NCT01404156|Antidotes|antidotes|mesh-ancestor
101201404|NCT01404156|Protective Agents|protective agents|mesh-ancestor
101201405|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
101201406|NCT01404156|Vitamins|vitamins|mesh-ancestor
101201407|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
101247464|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101247465|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101247466|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
101247467|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247468|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247469|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247470|NCT05557253|Anesthetics|anesthetics|mesh-list
101247471|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247472|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247473|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
101247474|NCT05539924|Pregabalin|pregabalin|mesh-list
101247475|NCT05539924|Gabapentin|gabapentin|mesh-list
101247476|NCT05539924|Vitamins|vitamins|mesh-ancestor
101247477|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
101247478|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247479|NCT05539924|Analgesics|analgesics|mesh-ancestor
101247480|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
101247481|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247482|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
101247483|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101247484|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101247485|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201408|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101201409|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101201410|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101201411|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201412|NCT01404169|Donepezil|donepezil|mesh-list
101201413|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101201428|NCT01404312|Vitamins|vitamins|mesh-ancestor
101201429|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
101201430|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201431|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
101201432|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
101201433|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201434|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201435|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101201436|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101201437|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
101201438|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201439|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101201440|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101201441|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
101201442|NCT01404338|Halobetasol|halobetasol|mesh-list
101201443|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101201444|NCT01404364|Triamcinolone|triamcinolone|mesh-list
101201445|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
101201446|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201447|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
101201448|NCT01404364|Hormones|hormones|mesh-ancestor
101201449|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201450|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201451|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201452|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
101201453|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
101247486|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101247487|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101247488|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247489|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247490|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247491|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101247492|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101247493|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247494|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
101247495|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
101247496|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
101247497|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101247498|NCT05514782|Protective Agents|protective agents|mesh-ancestor
101247499|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247500|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247502|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
101247503|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247504|NCT05468242|Bevacizumab|bevacizumab|mesh-list
101247505|NCT05468242|Tislelizumab|tislelizumab|mesh-list
101247506|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247507|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247508|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101247509|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101247510|NCT05468242|Growth Substances|growth substances|mesh-ancestor
101247511|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201454|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201455|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201456|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101201457|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201464|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
101201465|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
101201466|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201467|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201468|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
101201469|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201470|NCT01404442|Midazolam|midazolam|mesh-list
101201471|NCT01404442|Ketamine|ketamine|mesh-list
101201472|NCT01404442|Analgesics|analgesics|mesh-ancestor
101201473|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
101201474|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201475|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201476|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101201477|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201478|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
101201479|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
101201480|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201481|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101201482|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101201483|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247512|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
101247513|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
101247514|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
101247515|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
101247516|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247517|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247518|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247519|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101247520|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247521|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247522|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247523|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101247524|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
101247525|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247526|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247528|NCT05423951|Propofol|propofol|mesh-list
101247529|NCT05423951|Rocuronium|rocuronium|mesh-list
101247530|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201496|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201498|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201499|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101201500|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101201501|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101201502|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101201503|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201504|NCT01404507|Abciximab|abciximab|mesh-list
101201505|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
101201506|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101201507|NCT01404598|Naproxen|naproxen|mesh-list
101201508|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
101201509|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101201510|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201511|NCT01404598|Analgesics|analgesics|mesh-ancestor
101201512|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
101201513|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201514|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201515|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201516|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201517|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
101201518|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101201519|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201520|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201521|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101201522|NCT01404637|Tamsulosin|tamsulosin|mesh-list
101201523|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101201524|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101201525|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101201528|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201529|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201530|NCT01404637|Urological Agents|urological agents|mesh-ancestor
101201532|NCT01404676|Vildagliptin|vildagliptin|mesh-list
101201533|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101201534|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201535|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201536|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201537|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
101201538|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101247531|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247532|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247533|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247534|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
101247535|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
101247536|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101247537|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101247538|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101247539|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247540|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247541|NCT05423951|Narcotics|narcotics|mesh-ancestor
101247542|NCT05423951|Analgesics|analgesics|mesh-ancestor
101247543|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
101247544|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247545|NCT05405621|Exatecan|exatecan|mesh-list
101247546|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101247547|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101201539|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201540|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201541|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201542|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
101201543|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201544|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201545|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201546|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201548|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
101201554|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201555|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201556|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
101201557|NCT01404702|Aldesleukin|aldesleukin|mesh-list
101201558|NCT01404702|Interleukin-2|interleukin-2|mesh-list
101201559|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201560|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201561|NCT01404702|Analgesics|analgesics|mesh-ancestor
101201562|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
101201563|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201564|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201565|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101201566|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101201567|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
101201568|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201569|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101201570|NCT01404715|Metformin|metformin|mesh-list
101201571|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
101201572|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201573|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201574|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201575|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201576|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201577|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201578|NCT01404741|Azacitidine|azacitidine|mesh-list
101201579|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101201580|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
101201581|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201582|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201583|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201584|NCT01404767|Metoprolol|metoprolol|mesh-list
101201585|NCT01404767|Esmolol|esmolol|mesh-list
101201586|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101247548|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247549|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247550|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247551|NCT05350696|Morphine|morphine|mesh-list
101247552|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101247553|NCT05350696|Narcotics|narcotics|mesh-ancestor
101323301|NCT00096616|Albuterol|albuterol|mesh-list
101247554|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247556|NCT05350696|Analgesics|analgesics|mesh-ancestor
101247557|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
101247558|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247559|NCT05291156|Cetuximab|cetuximab|mesh-list
101247560|NCT05291156|Avelumab|avelumab|mesh-list
101247561|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247562|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247563|NCT05253118|Pemetrexed|pemetrexed|mesh-list
101247564|NCT05253118|Tislelizumab|tislelizumab|mesh-list
101247565|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247566|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247567|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247568|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101247569|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101247570|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247572|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247573|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247574|NCT05076838|Diazepam|diazepam|mesh-list
101247575|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247576|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
101247577|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
101247578|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
101247579|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247580|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247581|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247582|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101247594|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247595|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247596|NCT05057949|Itraconazole|itraconazole|mesh-list
101247597|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101247598|NCT05057949|Rifampin|rifampin|mesh-list
101247599|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
101247600|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247601|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101247602|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101247603|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201587|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101201588|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
101201589|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
101201590|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201591|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201592|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101201593|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101201594|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101201595|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
101201596|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201599|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101201600|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101201602|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201603|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201604|NCT01404806|Dolutegravir|dolutegravir|mesh-list
101201605|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101201606|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101201607|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201608|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201609|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101201610|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101201611|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
101201612|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201613|NCT01404819|Anesthetics|anesthetics|mesh-list
101201614|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201615|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201616|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101201617|NCT01404871|Clomipramine|clomipramine|mesh-list
101201618|NCT01404871|Escitalopram|escitalopram|mesh-list
101201619|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101201620|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101201626|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201627|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
101201628|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201629|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101201630|NCT01404871|Analgesics|analgesics|mesh-ancestor
101201631|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
101201632|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
101201633|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101201634|NCT01405079|Vinorelbine|vinorelbine|mesh-list
101201635|NCT01405079|Gefitinib|gefitinib|mesh-list
101201636|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201637|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101201638|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
101201639|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
101201640|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
101201641|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201642|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201643|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201644|NCT01405118|Metformin|metformin|mesh-list
101201645|NCT01405118|Tofacitinib|tofacitinib|mesh-list
101201647|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201649|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201650|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247604|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247605|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101247606|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
101247607|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101247608|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247609|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101247611|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
101247612|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247613|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
101247614|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101247615|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101247616|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101247617|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101247618|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101247619|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101247620|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101201651|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201653|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101201654|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101201655|NCT01405131|Prednisolone|prednisolone|mesh-list
101201656|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
101201657|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101201658|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
101201659|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201660|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
101201661|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
101201662|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201663|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201664|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201665|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
101201666|NCT01405131|Hormones|hormones|mesh-ancestor
101201667|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201668|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101201677|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101201678|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
101201679|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201680|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
101201681|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101201682|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101201684|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
101201685|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101201686|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
101201687|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201688|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
101201689|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
101201690|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201691|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201692|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201693|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
101201694|NCT01405157|Hormones|hormones|mesh-ancestor
101201695|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201696|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101201697|NCT01405157|Protective Agents|protective agents|mesh-ancestor
101201698|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101247621|NCT04925960|Epalrestat|epalrestat|mesh-list
101247622|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247623|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247624|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
101247625|NCT04901312|Narcotics|narcotics|mesh-ancestor
101247626|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247627|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247628|NCT04901312|Analgesics|analgesics|mesh-ancestor
101247629|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
101247630|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247632|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
101247633|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247634|NCT04886297|Protective Agents|protective agents|mesh-ancestor
101247635|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247636|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201699|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201700|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
101201701|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101201702|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101201703|NCT01405170|Prednisolone|prednisolone|mesh-list
101201708|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
101201709|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
101201710|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201711|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201712|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201713|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
101201714|NCT01405170|Hormones|hormones|mesh-ancestor
101201715|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201716|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101201717|NCT01405170|Protective Agents|protective agents|mesh-ancestor
101201718|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101201719|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201720|NCT01405235|Paclitaxel|paclitaxel|mesh-list
101201721|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101201722|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101201723|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201724|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
101201725|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
101201726|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
101201727|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201728|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
101201729|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101201730|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101201731|NCT01405248|Protective Agents|protective agents|mesh-ancestor
101201732|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201733|NCT01405326|Adalimumab|adalimumab|mesh-list
101201734|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101201746|NCT01405339|Hormones|hormones|mesh-ancestor
101201747|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201748|NCT01405352|Vitamin A|vitamin a|mesh-list
101201749|NCT01405352|Vitamins|vitamins|mesh-ancestor
101201750|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
101201751|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201752|NCT01405365|Metronidazole|metronidazole|mesh-list
101201753|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201754|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201755|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101201756|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101201757|NCT01405430|Bevacizumab|bevacizumab|mesh-list
101201758|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201759|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201760|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101201761|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101201762|NCT01405430|Growth Substances|growth substances|mesh-ancestor
101201763|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201764|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
101201765|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
101201766|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101201767|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101201768|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101201769|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101201770|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201771|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
101201772|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201773|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201774|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101201775|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201776|NCT01405573|Sorafenib|sorafenib|mesh-list
101201777|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201778|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101201779|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201780|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201781|NCT01405612|Midazolam|midazolam|mesh-list
101201782|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201783|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201784|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201785|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201795|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201797|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201798|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201799|NCT01405846|Gefitinib|gefitinib|mesh-list
101201806|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
101201807|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201808|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201809|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
101201810|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201811|NCT01405989|Ketoconazole|ketoconazole|mesh-list
101201812|NCT01405989|Darexaban|darexaban|mesh-list
101201813|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
101201814|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201815|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101201816|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101201817|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201818|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201819|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101201820|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
101201821|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201822|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201823|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101201824|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101201825|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
101201826|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101201827|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201828|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
101201829|NCT01406002|Rifampin|rifampin|mesh-list
101201830|NCT01406002|Darexaban|darexaban|mesh-list
101201831|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101201832|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
101201833|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201834|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201835|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
101201836|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101201837|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201838|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201839|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101201840|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101201841|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101201842|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101201844|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101201845|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101201847|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101201848|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201849|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
101201850|NCT01406080|Adapalene|adapalene|mesh-list
101201851|NCT01406080|Tretinoin|tretinoin|mesh-list
101201852|NCT01406080|Emollients|emollients|mesh-list
101201853|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101201854|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101201855|NCT01406080|Analgesics|analgesics|mesh-ancestor
101201856|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
101201857|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201858|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201859|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201863|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
101201864|NCT01406132|Peficitinib|peficitinib|mesh-list
101201865|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201866|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201872|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101201873|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
101201874|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201875|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201876|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201877|NCT01406158|Urological Agents|urological agents|mesh-ancestor
101201878|NCT01406171|Isavuconazole|isavuconazole|mesh-list
101201879|NCT01406171|Midazolam|midazolam|mesh-list
101201880|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201881|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201883|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201884|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101201885|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201886|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201887|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201888|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
101201889|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
101201890|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
101201891|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
101201892|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201893|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201894|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
101201895|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201896|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
101201897|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
101201898|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201899|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201900|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101201901|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101201902|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201903|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201904|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201905|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201906|NCT01406262|Incretins|incretins|mesh-ancestor
101201908|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101201909|NCT01406275|Amoxicillin|amoxicillin|mesh-list
101201910|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
101201911|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
101201912|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101201913|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201914|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101201915|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201916|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201917|NCT01406301|PENTA|penta|mesh-list
101201918|NCT01406301|Fondaparinux|fondaparinux|mesh-list
101201919|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101201920|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
101201921|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101201922|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
101201923|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201924|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201925|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
101201926|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101201927|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101201928|NCT01406327|Ambrisentan|ambrisentan|mesh-list
101201929|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101201930|NCT01406392|Misoprostol|misoprostol|mesh-list
101201931|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101201932|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
101201933|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101201934|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201935|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101247637|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101247638|NCT04830410|Levan|levan|mesh-list
101247639|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247640|NCT04810793|Amoxicillin|amoxicillin|mesh-list
101247641|NCT04810793|Levofloxacin|levofloxacin|mesh-list
101247642|NCT04810793|Ofloxacin|ofloxacin|mesh-list
101247643|NCT04810793|Tetracycline|tetracycline|mesh-list
101247644|NCT04810793|Furazolidone|furazolidone|mesh-list
101247645|NCT04810793|Esomeprazole|esomeprazole|mesh-list
101247646|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247647|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247648|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101247649|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247650|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101247651|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247652|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247653|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101247654|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101247655|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101201936|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101201937|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
101201938|NCT01406431|Valsartan|valsartan|mesh-list
101201939|NCT01406431|Pitavastatin|pitavastatin|mesh-list
101201950|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
101201956|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
101201957|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201959|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101201960|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201961|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201962|NCT01406522|Tacrine|tacrine|mesh-list
101201963|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101201964|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201965|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201966|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
101201967|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201968|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201969|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101201970|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
101201971|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201972|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
101201973|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
101201974|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
101201975|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101201976|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101201977|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201978|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201979|NCT01406535|Urological Agents|urological agents|mesh-ancestor
101201980|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101201981|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101201982|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201983|NCT01406639|Ranibizumab|ranibizumab|mesh-list
101201984|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101201985|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101201986|NCT01406639|Growth Substances|growth substances|mesh-ancestor
101201987|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201988|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
101201990|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
101201991|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
101201992|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247656|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247657|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101247658|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101247659|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101247660|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101247661|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101247662|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101247663|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101247664|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101247665|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
101247666|NCT04797832|Hematinics|hematinics|mesh-ancestor
101247667|NCT04684511|Rofecoxib|rofecoxib|mesh-list
101247668|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101247669|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101247670|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247671|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201993|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201994|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
101201995|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201996|NCT01406704|Protective Agents|protective agents|mesh-ancestor
101201997|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
101201998|NCT01406704|Vitamins|vitamins|mesh-ancestor
101201999|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
101202000|NCT01406782|Rituximab|rituximab|mesh-list
101202001|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202002|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202003|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
101202009|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101202010|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101202012|NCT01407211|Vitamins|vitamins|mesh-ancestor
101202013|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
101202014|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202015|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
101202016|NCT01407237|Giapreza|giapreza|mesh-list
101202018|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101202019|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101202020|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
101202021|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202022|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202023|NCT01407289|Insulin|insulin|mesh-list
101202024|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
101202025|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
101202026|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101202027|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202029|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
101202030|NCT01407432|Hematinics|hematinics|mesh-ancestor
101202031|NCT01407432|Vitamins|vitamins|mesh-ancestor
101202032|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
101202033|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202034|NCT01407471|Clobetasol|clobetasol|mesh-list
101202042|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
101202043|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202044|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
101202046|NCT01407484|Prednisone|prednisone|mesh-list
101202047|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202048|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
101202049|NCT01407484|Hormones|hormones|mesh-ancestor
101202050|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202051|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202052|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101202053|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247672|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247673|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247674|NCT04684511|Analgesics|analgesics|mesh-ancestor
101247675|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
101247676|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247677|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247678|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247679|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247680|NCT04650841|Naloxone|naloxone|mesh-list
101247681|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101210845|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101247682|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247684|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247685|NCT04624854|Aspirin|aspirin|mesh-list
101247686|NCT04624854|Clopidogrel|clopidogrel|mesh-list
101247687|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247688|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247689|NCT04624854|Analgesics|analgesics|mesh-ancestor
101247690|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
101247691|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247692|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202054|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101202055|NCT01407679|Alitretinoin|alitretinoin|mesh-list
101202056|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202057|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202058|NCT01407822|Cisplatin|cisplatin|mesh-list
101202059|NCT01407822|Gemcitabine|gemcitabine|mesh-list
101202060|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101202061|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202062|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202063|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
101202064|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202065|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202066|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202067|NCT01407848|Furosemide|furosemide|mesh-list
101202068|NCT01407848|Diuretics|diuretics|mesh-ancestor
101202069|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
101202070|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202071|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101202072|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202073|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202074|NCT01407887|Artesunate|artesunate|mesh-list
101202075|NCT01407887|Amodiaquine|amodiaquine|mesh-list
101202076|NCT01407887|Methylene Blue|methylene blue|mesh-list
101202077|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
101202078|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101202084|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101202085|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
101202086|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202087|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202088|NCT01408004|Everolimus|everolimus|mesh-list
101202089|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101202090|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202092|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202093|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202094|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
101202095|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202096|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202097|NCT01408056|Mupirocin|mupirocin|mesh-list
101202098|NCT01408056|Timolol|timolol|mesh-list
101202099|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101202100|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101202101|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
101202102|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202103|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202104|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202105|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101202106|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101202107|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101202115|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202116|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202117|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
101202118|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
101202119|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202120|NCT01408160|Cytarabine|cytarabine|mesh-list
101202121|NCT01408160|Immunotoxins|immunotoxins|mesh-list
101202122|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202123|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
101202124|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202125|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202126|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
101202127|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202128|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202129|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
101202130|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202131|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
101202132|NCT01408173|Caffeine|caffeine|mesh-list
101202133|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
101202134|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202135|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101202136|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202137|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101202138|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202139|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101202140|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101202141|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
101202142|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202143|NCT01408186|Rabeprazole|rabeprazole|mesh-list
101202144|NCT01408186|Famotidine|famotidine|mesh-list
101202145|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101202146|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202147|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101202148|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202149|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202157|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202158|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101202159|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101202160|NCT01408199|Growth Substances|growth substances|mesh-ancestor
101202161|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
101202162|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202164|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
101202165|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202166|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202167|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
101202168|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202169|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202170|NCT01408394|Ecopipam|ecopipam|mesh-list
101202171|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101202172|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101202173|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101202174|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202175|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101202176|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101202177|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
101202178|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202179|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202180|NCT01408446|Menthol|menthol|mesh-list
101202181|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
101202182|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
101247693|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247694|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247695|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101247696|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101247697|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247698|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101247699|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101247700|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247701|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
101247702|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101247703|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101247704|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101247705|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
101247706|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247707|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
101247708|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247709|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247710|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247711|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247712|NCT04565171|Yimitasvir|yimitasvir|mesh-list
101247713|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
101247714|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247715|NCT04463368|Nivolumab|nivolumab|mesh-list
101247716|NCT04463368|Ipilimumab|ipilimumab|mesh-list
101247717|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247718|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247719|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101247720|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247721|NCT04452344|Analgesics|analgesics|mesh-list
101247722|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247723|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
101247724|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247725|NCT04450407|Insulin|insulin|mesh-list
101202183|NCT01408498|Testosterone|testosterone|mesh-list
101202184|NCT01408498|Androgens|androgens|mesh-ancestor
101202185|NCT01408498|Hormones|hormones|mesh-ancestor
101202186|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202189|NCT01408524|Labetalol|labetalol|mesh-list
101202190|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101202191|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101202192|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202193|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247726|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247727|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247742|NCT04231838|Nicotine|nicotine|mesh-list
101247743|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101247744|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
101247745|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247746|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247747|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101247748|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101202194|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202195|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202196|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
101202197|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101202198|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101202199|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
101202200|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202201|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
101202202|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
101202203|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202204|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101202205|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101202206|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101202207|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101202208|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101202209|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202210|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202211|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
101202212|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202213|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202214|NCT01408680|Ubiquinone|ubiquinone|mesh-list
101202215|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
101202216|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
101202217|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202223|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202224|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202225|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202226|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202227|NCT01408836|Prednisolone|prednisolone|mesh-list
101202228|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101202229|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
101202230|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101202231|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
101202232|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101202234|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202235|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
101202236|NCT01408836|Hormones|hormones|mesh-ancestor
101202237|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202238|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202239|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101202240|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202243|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247749|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101247750|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247751|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247752|NCT04218266|Apixaban|apixaban|mesh-list
101247753|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101247754|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
101247755|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101247756|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
101247758|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247759|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
101247760|NCT04172363|Octenidine|octenidine|mesh-list
101247761|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247762|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101247763|NCT04074603|Insulin|insulin|mesh-list
101247764|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247765|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247766|NCT04068246|Metformin|metformin|mesh-list
101247767|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247768|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247769|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
101247770|NCT04063033|Hematinics|hematinics|mesh-ancestor
101247771|NCT04037605|Ketoconazole|ketoconazole|mesh-list
101247772|NCT04037605|Dexamethasone|dexamethasone|mesh-list
101247773|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
101247774|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
101247775|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101247776|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101247777|NCT04037605|Hormones|hormones|mesh-list
101247778|NCT04037605|Cosyntropin|cosyntropin|mesh-list
101247779|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101247780|NCT04037605|BB 1101|bb 1101|mesh-list
101247781|NCT04037605|Ganirelix|ganirelix|mesh-list
101247782|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202244|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202245|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101202246|NCT01408836|Protective Agents|protective agents|mesh-ancestor
101202247|NCT01408849|Omeprazole|omeprazole|mesh-list
101202248|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101202249|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202250|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101202251|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202252|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202254|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101202255|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202256|NCT01408927|Analgesics|analgesics|mesh-ancestor
101202257|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
101247783|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
101247784|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
101247785|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247786|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247787|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247788|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
101247789|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101247790|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101247791|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247792|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
101247793|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247794|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247795|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
101247796|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247797|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101247798|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101247799|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101247800|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
101247801|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101247802|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
101247803|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247804|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247805|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247806|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247807|NCT03928093|Pregabalin|pregabalin|mesh-list
101202258|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202259|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202260|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202261|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202262|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101202263|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101202264|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202265|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101202266|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101202270|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202271|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202272|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101202273|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101202274|NCT01408953|Growth Substances|growth substances|mesh-ancestor
101202275|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202276|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
101202277|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
101202278|NCT01408979|Analgesics|analgesics|mesh-ancestor
101202279|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
101202280|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202282|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
101202283|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247808|NCT03928093|Analgesics|analgesics|mesh-ancestor
101247809|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
101247810|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247811|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247812|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
101247813|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101247814|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101247815|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247817|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101247818|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247819|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247820|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247821|NCT03907800|Paclitaxel|paclitaxel|mesh-list
101247822|NCT03907800|Carboplatin|carboplatin|mesh-list
101247823|NCT03907800|Trastuzumab|trastuzumab|mesh-list
101247824|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101247825|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247826|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
101247827|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
101323330|NCT00006299|Celecoxib|celecoxib|mesh-list
101247828|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247829|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247830|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202284|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101202285|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
101202286|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101202287|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202288|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202292|NCT01409005|Gemcitabine|gemcitabine|mesh-list
101202293|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202294|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
101202295|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202296|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202297|NCT01409018|Itraconazole|itraconazole|mesh-list
101202298|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
101202299|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
101202301|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101202302|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101202303|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202304|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202305|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101202306|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
101202307|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202308|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202309|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101202310|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101202311|NCT01409148|Antibodies|antibodies|mesh-list
101202312|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101202313|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
101202314|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247831|NCT03894904|Heparin|heparin|mesh-list
101247832|NCT03894904|Papaverine|papaverine|mesh-list
101247833|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
101247834|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101247835|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101247836|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247837|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101247838|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247839|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
101247840|NCT03894904|Urological Agents|urological agents|mesh-ancestor
101247841|NCT03797833|Anesthetics|anesthetics|mesh-list
101247842|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247843|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202315|NCT01409174|Interferons|interferons|mesh-list
101202316|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
101202317|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
101202318|NCT01409174|Aldesleukin|aldesleukin|mesh-list
101202319|NCT01409174|Cisplatin|cisplatin|mesh-list
101202320|NCT01409174|Temozolomide|temozolomide|mesh-list
101202321|NCT01409174|Ipilimumab|ipilimumab|mesh-list
101202322|NCT01409174|Interleukin-2|interleukin-2|mesh-list
101202323|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202324|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
101202325|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202326|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101202328|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202329|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202330|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101202331|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
101202332|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202333|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202336|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202337|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101202338|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101202340|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
101202341|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
101202342|NCT01409187|Aldesleukin|aldesleukin|mesh-list
101202343|NCT01409187|Ipilimumab|ipilimumab|mesh-list
101202344|NCT01409187|Interleukin-2|interleukin-2|mesh-list
101202345|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202346|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
101202347|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202348|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101202351|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
101202352|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202353|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202354|NCT01409187|Analgesics|analgesics|mesh-ancestor
101202355|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
101202356|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202357|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101202358|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101202359|NCT01409278|Ropivacaine|ropivacaine|mesh-list
101202360|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
101202361|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
101202362|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101202365|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202367|NCT01409369|Antidotes|antidotes|mesh-ancestor
101202368|NCT01409369|Protective Agents|protective agents|mesh-ancestor
101202369|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202370|NCT01409395|Metformin|metformin|mesh-list
101202371|NCT01409395|Nizatidine|nizatidine|mesh-list
101202372|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101202373|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202374|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101202375|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202376|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101202377|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
101202378|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
101202379|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202380|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202382|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101202383|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101202384|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202386|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202388|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
101202389|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101202390|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101202391|NCT01409603|Naproxen|naproxen|mesh-list
101202392|NCT01409603|Darexaban|darexaban|mesh-list
101202393|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101202394|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202395|NCT01409603|Analgesics|analgesics|mesh-ancestor
101202396|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
101202397|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202398|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202399|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202400|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202401|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
101202402|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101202403|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202404|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202405|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101202406|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
101202407|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101202408|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
101202409|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
101202410|NCT01409616|Aspirin|aspirin|mesh-list
101202411|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
101202412|NCT01409616|Salicylates|salicylates|mesh-list
101202413|NCT01409616|Darexaban|darexaban|mesh-list
101202414|NCT01409616|Clopidogrel|clopidogrel|mesh-list
101202415|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101202416|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202418|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
101202419|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202420|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202421|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202422|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202423|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101202424|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101202425|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202426|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101202427|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101202428|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202441|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101202442|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
101202444|NCT01409694|Vitamin D|vitamin d|mesh-list
101202445|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
101202446|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
101202447|NCT01409694|Vitamins|vitamins|mesh-list
101202448|NCT01409694|Memantine|memantine|mesh-list
101202449|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
101202450|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202451|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101202452|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202453|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101202454|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101202455|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
101202456|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202457|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202458|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101202459|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101202460|NCT01409733|Doxorubicin|doxorubicin|mesh-list
101202461|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101202462|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202463|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101202464|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101202465|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202466|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202467|NCT01409499|Sorafenib|sorafenib|mesh-list
101202469|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202470|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202471|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202472|NCT01410162|Tacrolimus|tacrolimus|mesh-list
101202473|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202474|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
101202475|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202476|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101202477|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202478|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202479|NCT01410201|Dexamethasone|dexamethasone|mesh-list
101202480|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
101202481|NCT01410201|BB 1101|bb 1101|mesh-list
101202482|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202483|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
101202484|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
101202485|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202486|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202487|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202488|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
101202489|NCT01410201|Hormones|hormones|mesh-ancestor
101202490|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202491|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101202492|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202493|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101202494|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202495|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202496|NCT01410214|Cisplatin|cisplatin|mesh-list
101202497|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101202498|NCT01410214|Vinorelbine|vinorelbine|mesh-list
101202499|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202500|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202501|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202502|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202503|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101202519|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202521|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101202522|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202523|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
101202525|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202526|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202527|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202528|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202529|NCT01410747|Tacrolimus|tacrolimus|mesh-list
101202530|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202531|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
101202532|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202533|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101202534|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202535|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202536|NCT01410916|Eculizumab|eculizumab|mesh-list
101202537|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101202538|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202539|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
101202540|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202542|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
101202543|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
101202544|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202545|NCT01411072|Gemcitabine|gemcitabine|mesh-list
101202546|NCT01411072|Fluorouracil|fluorouracil|mesh-list
101202547|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202549|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202550|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202551|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202552|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
101202553|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202554|NCT01411098|Etoposide|etoposide|mesh-list
101202555|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
101202556|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202557|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101202558|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101202559|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101202560|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202561|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247844|NCT03749174|Anesthetics|anesthetics|mesh-list
101247845|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247846|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247847|NCT03722927|Bupivacaine|bupivacaine|mesh-list
101247848|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
101247849|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
101247850|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247851|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247852|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
101247853|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247854|NCT03681652|Azathioprine|azathioprine|mesh-list
101247855|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247856|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
101247857|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247858|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101247859|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247860|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101247861|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
101202562|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101202563|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101202564|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101202565|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
101202566|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202567|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101202568|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101202569|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202570|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
101202571|NCT01411124|Promethazine|promethazine|mesh-list
101202572|NCT01411124|Gabapentin|gabapentin|mesh-list
101202573|NCT01411124|Analgesics|analgesics|mesh-ancestor
101202574|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
101202579|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101202580|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101202588|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101202590|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
101202591|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
101202592|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
101202593|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202594|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101202595|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
101202596|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
101202597|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101202598|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
101202599|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202600|NCT01411176|Menthol|menthol|mesh-list
101202601|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
101202602|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202603|NCT01411189|Menthol|menthol|mesh-list
101202604|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
101202605|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202606|NCT01411202|Doxycycline|doxycycline|mesh-list
101202607|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101202608|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202609|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
101202610|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101202611|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101202612|NCT01411254|Betamethasone|betamethasone|mesh-list
101202613|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
101202614|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101202615|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
101247862|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247863|NCT03578198|Rituximab|rituximab|mesh-list
101247864|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247865|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247866|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
101247867|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247868|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247869|NCT03571308|Prednisolone|prednisolone|mesh-list
101247870|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
101247871|NCT03571308|Doxorubicin|doxorubicin|mesh-list
101247872|NCT03571308|Vincristine|vincristine|mesh-list
101247873|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
101247874|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101247875|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
101247876|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247877|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247878|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101247879|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
101247880|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247881|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247882|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101247883|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101247884|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101247885|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101202616|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101202618|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
101202619|NCT01411254|Hormones|hormones|mesh-ancestor
101202620|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202621|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202622|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101202623|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
101202624|NCT01411280|Methylphenidate|methylphenidate|mesh-list
101202625|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101202626|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202627|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101202628|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101202629|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202630|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202631|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
101202632|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202633|NCT01411410|Paclitaxel|paclitaxel|mesh-list
101202634|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101202635|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202636|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
101202637|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
101202638|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
101202639|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202640|NCT01411423|Sorafenib|sorafenib|mesh-list
101202641|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202642|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101247886|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247887|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101247888|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101247889|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101247890|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247891|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247892|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
101247893|NCT03571308|Hormones|hormones|mesh-ancestor
101247894|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101247895|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101247896|NCT03554200|Empagliflozin|empagliflozin|mesh-list
101247897|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101247898|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247899|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101247900|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247902|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247903|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101247904|NCT03518086|Analgesics|analgesics|mesh-ancestor
101247905|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
101247907|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247908|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101247909|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202644|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202645|NCT01411436|Sorafenib|sorafenib|mesh-list
101202646|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202647|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202652|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
101202653|NCT01411514|Hormones|hormones|mesh-ancestor
101202654|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202655|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202664|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202665|NCT01411735|Enalapril|enalapril|mesh-list
101202666|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101202667|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
101202668|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202669|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202670|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101202671|NCT01411930|Olanzapine|olanzapine|mesh-list
101202672|NCT01411930|Aripiprazole|aripiprazole|mesh-list
101202673|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
101202674|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
101202675|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202676|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202677|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202678|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101202679|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101202680|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101202681|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101202682|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101202683|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101202684|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202685|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202686|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202687|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
101202688|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
101202690|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
101202691|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101202692|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101202693|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101202694|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101202695|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101202696|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101202697|NCT01411969|Phenylephrine|phenylephrine|mesh-list
101202698|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
101202699|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101202700|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101202701|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
101202702|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202703|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202704|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202705|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
101202706|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
101202707|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202708|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
101202709|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101202710|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
101202711|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101202712|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
101202713|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101202714|NCT01411969|Protective Agents|protective agents|mesh-ancestor
101202715|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
101202716|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101202717|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202721|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202722|NCT01412073|Misoprostol|misoprostol|mesh-list
101202724|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
101202725|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101202726|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202736|NCT01412307|Lenalidomide|lenalidomide|mesh-list
101202737|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101202738|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
101202739|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202740|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101202741|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101202742|NCT01412307|Growth Substances|growth substances|mesh-ancestor
101202743|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
101202744|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202745|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101202746|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
101202747|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202748|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
101202749|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101202750|NCT01412385|Antibodies|antibodies|mesh-list
101202751|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
101202752|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101202753|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
101202754|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
101202755|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202756|NCT01412411|Micronutrients|micronutrients|mesh-list
101202757|NCT01412411|Trace Elements|trace elements|mesh-list
101202758|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202759|NCT01412437|Verapamil|verapamil|mesh-list
101202760|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101202761|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101202762|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202763|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202764|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202765|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202766|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
101202767|NCT01412515|Everolimus|everolimus|mesh-list
101202768|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101202769|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202770|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202771|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247910|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101247911|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101247912|NCT03517176|Paclitaxel|paclitaxel|mesh-list
101247913|NCT03517176|Gemcitabine|gemcitabine|mesh-list
101247914|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101247915|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247916|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
101247917|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
101247918|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
101247919|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247920|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101247921|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
101247922|NCT03512964|Tenofovir|tenofovir|mesh-list
101247923|NCT03512964|Emtricitabine|emtricitabine|mesh-list
101247924|NCT03512964|Dolutegravir|dolutegravir|mesh-list
101247925|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101247926|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
101247927|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247928|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101247929|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101247930|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247939|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
101247940|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
101247941|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101202772|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202773|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
101202774|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202775|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202777|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
101202778|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202779|NCT01412632|Remifentanil|remifentanil|mesh-list
101202780|NCT01412632|Propofol|propofol|mesh-list
101202781|NCT01412632|Prilocaine|prilocaine|mesh-list
101202782|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101202783|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101202784|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202785|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101202786|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
101202787|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
101202788|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101202800|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101202802|NCT01412658|Glycerol|glycerol|mesh-list
101202803|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
101202804|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
101202805|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202806|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101202807|NCT01412658|Protective Agents|protective agents|mesh-ancestor
101202808|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202809|NCT01412671|Sorafenib|sorafenib|mesh-list
101202812|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202813|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202814|NCT01412840|Diclofenac|diclofenac|mesh-list
101202815|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101247942|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
101247943|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247944|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
101247945|NCT03463499|Protective Agents|protective agents|mesh-ancestor
101247947|NCT03366974|Midazolam|midazolam|mesh-list
101247948|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101247949|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101247950|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101247951|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247952|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101247953|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101247954|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101247955|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101247956|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
101247957|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
101247958|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
101247959|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
101247960|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247961|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202816|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202817|NCT01412840|Analgesics|analgesics|mesh-ancestor
101202818|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
101202819|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202820|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202821|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202822|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202823|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101202824|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202825|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202826|NCT01412892|Everolimus|everolimus|mesh-list
101202827|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101202828|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202829|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202830|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202831|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202832|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
101202833|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202834|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202835|NCT01413022|Leucovorin|leucovorin|mesh-list
101202837|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
101202838|NCT01413022|Irinotecan|irinotecan|mesh-list
101202839|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
101202840|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202841|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202842|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202843|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202845|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202846|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101202847|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101202848|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202849|NCT01413022|Antidotes|antidotes|mesh-ancestor
101202850|NCT01413022|Protective Agents|protective agents|mesh-ancestor
101202851|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
101202853|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
101202854|NCT01413048|Carvedilol|carvedilol|mesh-list
101202855|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101202861|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101202862|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
101247962|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101247963|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101247964|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101247965|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101247966|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101247967|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101247975|NCT03340129|Nivolumab|nivolumab|mesh-list
101247976|NCT03340129|Ipilimumab|ipilimumab|mesh-list
101211146|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
101247977|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247978|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247979|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101247980|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101247981|NCT03307746|Rituximab|rituximab|mesh-list
101247982|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247983|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247984|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
101247985|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247986|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101247987|NCT03294083|Cemiplimab|cemiplimab|mesh-list
101247988|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101247989|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101247990|NCT03128398|Domperidone|domperidone|mesh-list
101247991|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
101247992|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
101247993|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101247994|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101247996|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101247997|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
101247998|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101247999|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202863|NCT01413048|Protective Agents|protective agents|mesh-ancestor
101202864|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101202865|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202866|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202867|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
101202868|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101202869|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101202871|NCT01413230|Vitamin D|vitamin d|mesh-list
101202872|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202873|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202874|NCT01413230|Vitamins|vitamins|mesh-ancestor
101202875|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
101248000|NCT03119038|Ketorolac|ketorolac|mesh-list
101248001|NCT03119038|Clonidine|clonidine|mesh-list
101248002|NCT03119038|Epinephrine|epinephrine|mesh-list
101248003|NCT03119038|Bupivacaine|bupivacaine|mesh-list
101248004|NCT03119038|Ropivacaine|ropivacaine|mesh-list
101248005|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
101248006|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
101248007|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248008|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248009|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
101248010|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202876|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101202877|NCT01413477|Calcitriol|calcitriol|mesh-list
101202878|NCT01413477|Betamethasone|betamethasone|mesh-list
101202879|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
101202880|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101202881|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
101202882|NCT01413477|Calcipotriene|calcipotriene|mesh-list
101202883|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
101202884|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202885|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
101202886|NCT01413477|Hormones|hormones|mesh-ancestor
101202887|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202888|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202889|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101202890|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
101202891|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202898|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
101202899|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101202900|NCT01413490|Rimantadine|rimantadine|mesh-list
101202901|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
101202902|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202903|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101202904|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202905|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202906|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
101202907|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202909|NCT01413620|Vitamin E|vitamin e|mesh-list
101202910|NCT01413620|Tocopherols|tocopherols|mesh-list
101202911|NCT01413620|Tocotrienols|tocotrienols|mesh-list
101202912|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
101202913|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
101202914|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202916|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202917|NCT01413620|Protective Agents|protective agents|mesh-ancestor
101202918|NCT01413711|Vigabatrin|vigabatrin|mesh-list
101202919|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
101202920|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202921|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202922|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
101202923|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202924|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202925|NCT01413763|Imiquimod|imiquimod|mesh-list
101202929|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202930|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
101202931|NCT01413854|Diclofenac|diclofenac|mesh-list
101202932|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101202933|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101202934|NCT01413854|Analgesics|analgesics|mesh-ancestor
101202935|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
101202936|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202937|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202938|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202939|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101202940|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101202941|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202942|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248011|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101248012|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101248013|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
101248014|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248015|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248016|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101248017|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101248018|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
101248019|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101248020|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
101248021|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
101248022|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
101248023|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101248024|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101248025|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248026|NCT03119038|Analgesics|analgesics|mesh-ancestor
101248027|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248028|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248029|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101248030|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248031|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101248032|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
101248033|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101248034|NCT03099265|Leucovorin|leucovorin|mesh-list
101248035|NCT03099265|Fluorouracil|fluorouracil|mesh-list
101248036|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
101248037|NCT03099265|Irinotecan|irinotecan|mesh-list
101248038|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
101248039|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248040|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101248041|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248042|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248043|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
101248044|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248045|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101248046|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101248047|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248048|NCT03099265|Antidotes|antidotes|mesh-ancestor
101248050|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
101248051|NCT03099265|Vitamins|vitamins|mesh-ancestor
101248052|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
101248053|NCT03063749|Sirolimus|sirolimus|mesh-list
101248054|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248055|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248056|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101248057|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248058|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
101248059|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248060|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
101248061|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248062|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
101248063|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101248064|NCT03007589|Protective Agents|protective agents|mesh-ancestor
101248065|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248066|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
101248067|NCT02975037|Clarithromycin|clarithromycin|mesh-list
101202943|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
101202944|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101202945|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
101202946|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101202947|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202948|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101202949|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101202950|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101202951|NCT01414231|Cytarabine|cytarabine|mesh-list
101202952|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202953|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
101202954|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202955|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202956|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
101202957|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202958|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101202961|NCT01414465|Orlistat|orlistat|mesh-list
101202962|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202963|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202964|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101202965|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101202966|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101202971|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101202972|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202973|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101202974|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
101202975|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202976|NCT01414556|Incretins|incretins|mesh-ancestor
101202977|NCT01414556|Hormones|hormones|mesh-ancestor
101202978|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202979|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202980|NCT01414569|Dexamethasone|dexamethasone|mesh-list
101202981|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
101202982|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101202983|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
101202984|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
101202985|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101202986|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202987|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202990|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202991|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101202992|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202993|NCT01414608|Paclitaxel|paclitaxel|mesh-list
101202994|NCT01414608|Cisplatin|cisplatin|mesh-list
101202995|NCT01414608|Carboplatin|carboplatin|mesh-list
101202996|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101202997|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101203002|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203003|NCT01414816|Interferons|interferons|mesh-list
101203004|NCT01414816|Interferon-beta|interferon-beta|mesh-list
101203005|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
101203006|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203007|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
101203008|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203009|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
101203010|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203011|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101203012|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
101203013|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101203014|NCT01414868|Montelukast|montelukast|mesh-list
101203015|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
101203016|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101203017|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
101203018|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203019|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203020|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203021|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101203022|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101203023|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203024|NCT01414881|Mipomersen|mipomersen|mesh-list
101203026|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101203027|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
101203028|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203029|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101203030|NCT01414972|Vitamin A|vitamin a|mesh-list
101203031|NCT01414972|Vitamins|vitamins|mesh-ancestor
101203032|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
101203033|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203034|NCT01414998|Nicotine|nicotine|mesh-list
101203035|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101203036|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
101203037|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203038|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203039|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101203040|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101203041|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203042|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203043|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203044|NCT01415011|Afatinib|afatinib|mesh-list
101203048|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203049|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
101203050|NCT01415128|Desipramine|desipramine|mesh-list
101203051|NCT01415128|Omeprazole|omeprazole|mesh-list
101203052|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101203053|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203054|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101203055|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203056|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203057|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203058|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203059|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101203060|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
101203061|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101203062|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101203063|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203064|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203065|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
101203066|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203067|NCT01415141|Ribavirin|ribavirin|mesh-list
101203068|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101203072|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203073|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101203075|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
101203076|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
101203077|NCT01415336|Doxorubicin|doxorubicin|mesh-list
101203078|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101203079|NCT01415336|Capecitabine|capecitabine|mesh-list
101203080|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203081|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
101203082|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203083|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203084|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101203085|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
101203086|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203087|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203088|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101203089|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101203090|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101203091|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101203092|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203093|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203094|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
101203095|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101203096|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101203097|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101203098|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101203099|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203100|NCT01415505|Valsartan|valsartan|mesh-list
101203101|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101203102|NCT01415505|Nebivolol|nebivolol|mesh-list
101203103|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101203104|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101203105|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101203106|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203107|NCT01415505|Diuretics|diuretics|mesh-ancestor
101203108|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
101203109|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203110|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101203111|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203112|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203113|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101203114|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101203115|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101203116|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
101203117|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203118|NCT01415557|Micronutrients|micronutrients|mesh-list
101203119|NCT01415557|Trace Elements|trace elements|mesh-list
101203127|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
101203128|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
101203129|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101203130|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101203131|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101203132|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101203134|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203135|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203136|NCT01415687|Bisacodyl|bisacodyl|mesh-list
101203137|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
101203138|NCT01415687|Citric Acid|citric acid|mesh-list
101203139|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
101203140|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
101203145|NCT01415687|Cathartics|cathartics|mesh-ancestor
101203146|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203147|NCT01415687|Laxatives|laxatives|mesh-ancestor
101203148|NCT01415713|Leucovorin|leucovorin|mesh-list
101203149|NCT01415713|Gemcitabine|gemcitabine|mesh-list
101203150|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
101203151|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203152|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
101203153|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203154|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203155|NCT01415713|Antidotes|antidotes|mesh-ancestor
101203156|NCT01415713|Protective Agents|protective agents|mesh-ancestor
101203157|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203158|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
101203159|NCT01415713|Vitamins|vitamins|mesh-ancestor
101203160|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
101203161|NCT01415765|Prednisone|prednisone|mesh-list
101203162|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
101203163|NCT01415765|Rituximab|rituximab|mesh-list
101203164|NCT01415765|Doxorubicin|doxorubicin|mesh-list
101203165|NCT01415765|Etoposide|etoposide|mesh-list
101203166|NCT01415765|Vincristine|vincristine|mesh-list
101203167|NCT01415765|Pevonedistat|pevonedistat|mesh-list
101248068|NCT02975037|Itraconazole|itraconazole|mesh-list
101248069|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
101248070|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
101248071|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101248072|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101248073|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248074|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248075|NCT02975037|Urological Agents|urological agents|mesh-ancestor
101248076|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248077|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248078|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101248079|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101248080|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101248081|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
101248082|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101248083|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101248084|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
101248085|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248086|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248088|NCT02931890|Docetaxel|docetaxel|mesh-list
101248089|NCT02931890|Carboplatin|carboplatin|mesh-list
101248090|NCT02931890|Capecitabine|capecitabine|mesh-list
101248091|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
101248092|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101248093|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248094|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248095|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248096|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248097|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248098|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101248099|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
101248100|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
101248101|NCT02812862|Olodaterol|olodaterol|mesh-list
101203168|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203169|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
101203170|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203171|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203172|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101203173|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
101203174|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203176|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101248102|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101248103|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
101248104|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248105|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248106|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101248107|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
101248108|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
101248109|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101248110|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
101248111|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248112|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248114|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101248115|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
101248116|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248117|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248119|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101248120|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
101248121|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248122|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248123|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
101248124|NCT02549677|Docetaxel|docetaxel|mesh-list
101248125|NCT02549677|Epirubicin|epirubicin|mesh-list
101248126|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248127|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
101248128|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248129|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248130|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101248131|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
101248132|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248133|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248134|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101248135|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
101203177|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101203178|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101203179|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101203180|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101203181|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203182|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101203183|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
101203184|NCT01415765|Hormones|hormones|mesh-ancestor
101203185|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203186|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101203187|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101203188|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
101203189|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
101203190|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
101203192|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
101203193|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203194|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203195|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203196|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203197|NCT01415791|Bicalutamide|bicalutamide|mesh-list
101203198|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
101203199|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203207|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203208|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
101203209|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203211|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101203212|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
101203218|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203219|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203220|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
101203222|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
101203223|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203224|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203225|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101203226|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
101203227|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203228|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203229|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101203230|NCT01416116|Lidocaine|lidocaine|mesh-list
101203231|NCT01416116|Tramadol|tramadol|mesh-list
101203232|NCT01416116|Capsaicin|capsaicin|mesh-list
101203233|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
101203234|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
101203235|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203236|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203237|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
101203238|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203240|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101203242|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203243|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203244|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101203245|NCT01416116|Narcotics|narcotics|mesh-ancestor
101203246|NCT01416116|Analgesics|analgesics|mesh-ancestor
101203247|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
101203248|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
101203249|NCT01416207|Interferons|interferons|mesh-list
101203250|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
101203251|NCT01416207|Interferon-beta|interferon-beta|mesh-list
101203252|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203253|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
101203254|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203255|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101203256|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
101203257|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203258|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
101203259|NCT01416220|Paroxetine|paroxetine|mesh-list
101203260|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
101203261|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101203262|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203263|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203264|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
101203265|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101203266|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203267|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203268|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101203269|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203270|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203271|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203272|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
101203273|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101203274|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101203280|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101203292|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248136|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248137|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
101323380|NCT04340076|Brodalumab|brodalumab|mesh-list
101248138|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101248139|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101248140|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101248141|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248142|NCT02450253|Tadalafil|tadalafil|mesh-list
101248143|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101248144|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101248145|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101248146|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248147|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248148|NCT02450253|Urological Agents|urological agents|mesh-ancestor
101248149|NCT02257970|Ketoprofen|ketoprofen|mesh-list
101248150|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101248151|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248152|NCT02257970|Analgesics|analgesics|mesh-ancestor
101248153|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
101248154|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248155|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248156|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248157|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248158|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101248159|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203293|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203295|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
101203296|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203297|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
101203298|NCT01416558|Paclitaxel|paclitaxel|mesh-list
101203299|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101203300|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203301|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
101203302|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
101203303|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
101203304|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203305|NCT01416649|Exenatide|exenatide|mesh-list
101203306|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203307|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203308|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101203309|NCT01416649|Incretins|incretins|mesh-ancestor
101203310|NCT01416649|Hormones|hormones|mesh-ancestor
101203311|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203312|NCT01416662|Gemcitabine|gemcitabine|mesh-list
101203313|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203314|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
101203315|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203316|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203317|NCT01416701|Vitamin D|vitamin d|mesh-list
101203318|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
101203319|NCT01416701|Vitamins|vitamins|mesh-list
101203320|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
101203321|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203322|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203323|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203324|NCT01416870|Bicalutamide|bicalutamide|mesh-list
101203325|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
101203326|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203327|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203328|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203329|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203330|NCT01416883|Bicalutamide|bicalutamide|mesh-list
101203331|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
101203332|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203333|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203334|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203335|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203336|NCT01416909|Laxatives|laxatives|mesh-list
101203337|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203338|NCT01416948|Methylphenidate|methylphenidate|mesh-list
101203339|NCT01416948|Galantamine|galantamine|mesh-list
101203340|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101203341|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203342|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101203343|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203344|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203349|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203350|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203351|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101203352|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
101203353|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203354|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
101203355|NCT01416961|Etoposide|etoposide|mesh-list
101203356|NCT01416961|Cisplatin|cisplatin|mesh-list
101203357|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
101203358|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101203359|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203362|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203363|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203364|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
101203365|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203366|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
101203367|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203368|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203369|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101203370|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
101203371|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203372|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203373|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101203374|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101203375|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
101203376|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101203377|NCT01417065|Sirolimus|sirolimus|mesh-list
101203378|NCT01417065|Temsirolimus|temsirolimus|mesh-list
101203379|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
101203380|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101203381|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203382|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203383|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203384|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
101203385|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203386|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203387|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203388|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203389|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101203390|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
101203392|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
101203393|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203394|NCT01417273|Vitamin A|vitamin a|mesh-list
101203395|NCT01417273|Vitamins|vitamins|mesh-ancestor
101203396|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
101203397|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203398|NCT01417351|Vitamin D|vitamin d|mesh-list
101203399|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
101203400|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
101203401|NCT01417351|Vitamins|vitamins|mesh-list
101203402|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
101248160|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248162|NCT05838729|Nivolumab|nivolumab|mesh-list
101248163|NCT05838729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101248164|NCT05838729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248165|NCT05838729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248166|NCT05838729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248167|NCT05838716|Vitamin D|vitamin d|mesh-list
101248168|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
101248169|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
101248170|NCT05838716|Vitamins|vitamins|mesh-list
101248173|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101248174|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101248176|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101248177|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
101248178|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248179|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248180|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
101248181|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101248182|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248183|NCT05838105|Progesterone|progesterone|mesh-list
101248184|NCT05838105|Progestins|progestins|mesh-ancestor
101248185|NCT05838105|Hormones|hormones|mesh-ancestor
101248186|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248187|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248188|NCT05838066|Docetaxel|docetaxel|mesh-list
101248189|NCT05838066|Trastuzumab|trastuzumab|mesh-list
101248190|NCT05838066|Pertuzumab|pertuzumab|mesh-list
101248191|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203403|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203404|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203405|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203406|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
101203407|NCT01417364|Testosterone|testosterone|mesh-list
101203408|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
101203409|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
101203410|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101203411|NCT01417364|Androgens|androgens|mesh-ancestor
101203412|NCT01417364|Hormones|hormones|mesh-ancestor
101203413|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203414|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203415|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101203416|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203417|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
101203418|NCT01417390|Cisplatin|cisplatin|mesh-list
101203425|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
101203426|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101203427|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101203428|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203429|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203430|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203431|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203432|NCT01417429|Galantamine|galantamine|mesh-list
101203433|NCT01417429|Nicotine|nicotine|mesh-list
101203434|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101203435|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
101203436|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203437|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203438|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101203439|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101203440|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203441|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203447|NCT01417494|Leucovorin|leucovorin|mesh-list
101203448|NCT01417494|Bevacizumab|bevacizumab|mesh-list
101203449|NCT01417494|Fluorouracil|fluorouracil|mesh-list
101203450|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
101203451|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101203452|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203453|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101203454|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101203455|NCT01417494|Growth Substances|growth substances|mesh-ancestor
101203456|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203457|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
101203458|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
101203459|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203460|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203461|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203462|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
101203463|NCT01417494|Antidotes|antidotes|mesh-ancestor
101203464|NCT01417494|Protective Agents|protective agents|mesh-ancestor
101203465|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
101203466|NCT01417494|Vitamins|vitamins|mesh-ancestor
101203467|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
101203468|NCT01417572|Lidocaine|lidocaine|mesh-list
101203469|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
101203470|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
101203471|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203472|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203473|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
101203474|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203475|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101203476|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101203477|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101203478|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203479|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203480|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101203481|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101203482|NCT01417754|Toremifene|toremifene|mesh-list
101203483|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101203484|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203485|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101203486|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101203487|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
101203490|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203491|NCT01417767|Decitabine|decitabine|mesh-list
101203492|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101203493|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
101203494|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203495|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203496|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203498|NCT01417806|Pasireotide|pasireotide|mesh-list
101203499|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101203500|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101203501|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203502|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203503|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203504|NCT01417806|Hormones|hormones|mesh-ancestor
101203505|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203506|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203507|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101203508|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101203509|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101203510|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101203511|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101203512|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
101203513|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203515|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203517|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101203518|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
101203519|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
101203520|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203521|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203522|NCT01417923|Vitamin D|vitamin d|mesh-list
101203524|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
101203525|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203526|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203527|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101203528|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
101203529|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203530|NCT01418118|Dobutamine|dobutamine|mesh-list
101203531|NCT01418118|Epinephrine|epinephrine|mesh-list
101203532|NCT01418118|Norepinephrine|norepinephrine|mesh-list
101203533|NCT01418118|Dopexamine|dopexamine|mesh-list
101203534|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101203535|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101203536|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
101203537|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203538|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203539|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203542|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
101203543|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203544|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101203545|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
101203546|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
101203547|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
101203548|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101203549|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101203550|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101203551|NCT01418118|Protective Agents|protective agents|mesh-ancestor
101203552|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203553|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
101203554|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
101203556|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101203557|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203558|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
101203559|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203560|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203566|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203567|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
101203568|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203569|NCT01418157|Acetazolamide|acetazolamide|mesh-list
101203570|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
101203571|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101203572|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203573|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203574|NCT01418157|Diuretics|diuretics|mesh-ancestor
101203575|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
101203576|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203577|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
101203578|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
101203579|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
101203580|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203581|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203582|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
101203583|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203584|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
101203585|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101203586|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
101203587|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203588|NCT01418274|Ritonavir|ritonavir|mesh-list
101203589|NCT01418274|Escitalopram|escitalopram|mesh-list
101203590|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101203591|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101203592|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
101203593|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203594|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203595|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101203596|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101203597|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
101203601|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101203602|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101248192|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248193|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248194|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248195|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248196|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248197|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101248198|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
101248199|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
101248200|NCT05838001|Hormones|hormones|mesh-ancestor
101248201|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248202|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248203|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248204|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248205|NCT05837936|Anesthetics|anesthetics|mesh-list
101248206|NCT05837936|Sevoflurane|sevoflurane|mesh-list
101248207|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248208|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203603|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203604|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203605|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
101203606|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203608|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101203609|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203611|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203612|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203613|NCT01418430|Daclizumab|daclizumab|mesh-list
101203614|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203615|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
101203616|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203617|NCT01418443|Pantoprazole|pantoprazole|mesh-list
101203618|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101203619|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203620|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101203621|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203622|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203623|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101203624|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203625|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101203626|NCT01418534|Isosorbide|isosorbide|mesh-list
101203627|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101203628|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101203629|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101203630|NCT01418534|Diuretics|diuretics|mesh-ancestor
101203632|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203634|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101203635|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203636|NCT01418547|Isosorbide|isosorbide|mesh-list
101203637|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101203638|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101203639|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101203640|NCT01418547|Diuretics|diuretics|mesh-ancestor
101203641|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
101203642|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203643|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203644|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101203645|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248209|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101248210|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101248211|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
101248212|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101248213|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
101248214|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248215|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248216|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
101248217|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248218|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248219|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101248220|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101248221|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101248222|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
101248223|NCT05837806|Tislelizumab|tislelizumab|mesh-list
101248224|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
101248225|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248226|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248227|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
101248228|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
101248229|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248230|NCT05837689|Blinatumomab|blinatumomab|mesh-list
101203646|NCT01418586|Alfuzosin|alfuzosin|mesh-list
101203647|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101203648|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101203649|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101203652|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203653|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203654|NCT01418586|Urological Agents|urological agents|mesh-ancestor
101203656|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101203657|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101203658|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101203659|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
101203660|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203661|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203662|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203663|NCT01418599|Urological Agents|urological agents|mesh-ancestor
101203664|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101203665|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101203666|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203667|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203668|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203669|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203670|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203671|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101203672|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
101203676|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203677|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203678|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203679|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203680|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203681|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101203682|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
101203683|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101203684|NCT01418651|Milnacipran|milnacipran|mesh-list
101203685|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101203686|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203687|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203688|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203689|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203690|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203691|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101203692|NCT01418651|Analgesics|analgesics|mesh-ancestor
101203693|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
101203694|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203695|NCT01418729|Pravastatin|pravastatin|mesh-list
101203696|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101203697|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101203698|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
101203699|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203715|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203716|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203717|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101203718|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203719|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
101203720|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203721|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
101203722|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203723|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101203724|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203727|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203728|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101203729|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203730|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203731|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
101203732|NCT01419119|Vitamin D|vitamin d|mesh-list
101203733|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101203734|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203735|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203736|NCT01419119|Vitamins|vitamins|mesh-ancestor
101203737|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
101203738|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203739|NCT01419132|Furosemide|furosemide|mesh-list
101203740|NCT01419132|Diuretics|diuretics|mesh-list
101203741|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
101203742|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203743|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101203744|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203745|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203746|NCT01419262|Vitamin D|vitamin d|mesh-list
101203747|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
101203748|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
101203749|NCT01419262|Vitamins|vitamins|mesh-list
101203750|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
101203751|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203752|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203753|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203754|NCT01419340|Donepezil|donepezil|mesh-list
101203755|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101203756|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203757|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203758|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203771|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
101203772|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101203773|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101203774|NCT01419366|Donepezil|donepezil|mesh-list
101203775|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101203776|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203777|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203778|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
101203779|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248231|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248232|NCT05837286|Cortisone|cortisone|mesh-list
101248233|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248234|NCT05836857|Cannabidiol|cannabidiol|mesh-list
101248235|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
101248236|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
101248237|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101248238|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101248239|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248240|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
101248241|NCT05836831|Coagulants|coagulants|mesh-ancestor
101248242|NCT05836545|Midazolam|midazolam|mesh-list
101248243|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101248244|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101248245|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248246|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248247|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101248248|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101248249|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248250|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248251|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
101248252|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
101248253|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
101248254|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
101248255|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248256|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248257|NCT05836441|Tacrolimus|tacrolimus|mesh-list
101203780|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203781|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
101203782|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
101203783|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203784|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
101203785|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101203786|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101203787|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203788|NCT01419392|Urological Agents|urological agents|mesh-ancestor
101203789|NCT01419405|Pregabalin|pregabalin|mesh-list
101203790|NCT01419405|Remifentanil|remifentanil|mesh-list
101203791|NCT01419405|Analgesics|analgesics|mesh-ancestor
101203792|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
101203793|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203794|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203795|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
101203796|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101203797|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203798|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203799|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203800|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101203801|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101203802|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203803|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248258|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248259|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
101248260|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248261|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101248262|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248263|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248264|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
101248265|NCT05835999|Everolimus|everolimus|mesh-list
101248266|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101248267|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101248268|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248269|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248270|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248271|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
101248272|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248273|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248274|NCT05835726|Daratumumab|daratumumab|mesh-list
101248276|NCT05834049|Midazolam|midazolam|mesh-list
101248277|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
101248278|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248279|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203805|NCT01419405|Narcotics|narcotics|mesh-ancestor
101203806|NCT01419457|Favipiravir|favipiravir|mesh-list
101203807|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
101203808|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203809|NCT01419548|Paclitaxel|paclitaxel|mesh-list
101203810|NCT01419548|Carboplatin|carboplatin|mesh-list
101203811|NCT01419548|Veliparib|veliparib|mesh-list
101203812|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101203813|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203814|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
101203815|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
101203816|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
101203817|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203818|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101203819|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203820|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101203821|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203823|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203824|NCT01419730|Vitamin D|vitamin d|mesh-list
101203825|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
101203826|NCT01419730|Vitamins|vitamins|mesh-ancestor
101203827|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
101203828|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203830|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203831|NCT01419821|Vitamin D|vitamin d|mesh-list
101203832|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
101203833|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
101203834|NCT01419821|Vitamins|vitamins|mesh-list
101203835|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
101203836|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203837|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101203838|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203840|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
101203841|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203842|NCT01419873|Insulin|insulin|mesh-list
101248280|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101248281|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101248282|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101248283|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101248284|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248285|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248286|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
101248287|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
101248288|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
101248289|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248290|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248291|NCT05833217|Insulin|insulin|mesh-list
101248292|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248293|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248294|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
101248295|NCT05814744|Bupivacaine|bupivacaine|mesh-list
101248296|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
101248297|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
101248298|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248299|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248300|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
101248301|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248302|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101248303|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248304|NCT05814744|Analgesics|analgesics|mesh-ancestor
101248305|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101203843|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101203847|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101203848|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203849|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101203850|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
101203851|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203853|NCT01420094|Acetaminophen|acetaminophen|mesh-list
101203854|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101203855|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101203856|NCT01420094|Analgesics|analgesics|mesh-ancestor
101203857|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
101203858|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203859|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203860|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101203861|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203862|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101203863|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101203864|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203865|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101203866|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101203867|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203868|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
101203869|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
101203870|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101203871|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
101203872|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
101203873|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203874|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203876|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101203877|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203878|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203879|NCT01420328|Simvastatin|simvastatin|mesh-list
101203880|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
101203881|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101203882|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101203883|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
101203884|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203885|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101203886|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101203887|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203888|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101203889|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101203890|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203891|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203892|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
101203893|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101203894|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101203895|NCT01420367|Metronidazole|metronidazole|mesh-list
101203896|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203897|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101203898|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101203899|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101203901|NCT01420406|Vitamins|vitamins|mesh-ancestor
101203902|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
101203916|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203917|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
101203918|NCT01420523|Maraviroc|maraviroc|mesh-list
101203919|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101203920|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101203921|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
101203922|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203923|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101203924|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101203925|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203927|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101203928|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101203929|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101203931|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
101203932|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
101203933|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203934|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203935|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101203936|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101203937|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101203938|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203939|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101203940|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101203941|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101203942|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203943|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203944|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203945|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
101203946|NCT01420666|Acetaminophen|acetaminophen|mesh-list
101203947|NCT01420666|Ibuprofen|ibuprofen|mesh-list
101203948|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101203949|NCT01420666|Analgesics|analgesics|mesh-ancestor
101203952|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203953|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
101203954|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101203955|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101203956|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101203957|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101203958|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203959|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203960|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
101203961|NCT01420692|Gliclazide|gliclazide|mesh-list
101203962|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203963|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203977|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203979|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203980|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203981|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101203982|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
101203983|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203984|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
101203985|NCT01420913|Pregabalin|pregabalin|mesh-list
101203986|NCT01420913|Analgesics|analgesics|mesh-ancestor
101203987|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
101203988|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101203989|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203990|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
101203991|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101203992|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101203993|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203994|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101203995|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101203996|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101203997|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101203998|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101204000|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101204001|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101204002|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101204003|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204004|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204005|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101204006|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
101204007|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
101204008|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204009|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204010|NCT01421121|Vaccines|vaccines|mesh-list
101204011|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
101204012|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204013|NCT01421160|Citric Acid|citric acid|mesh-list
101204014|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
101204015|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
101204016|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101204017|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
101204018|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
101204019|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204020|NCT01421173|Dexamethasone|dexamethasone|mesh-list
101204021|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
101204022|NCT01421173|Rituximab|rituximab|mesh-list
101204023|NCT01421173|Gemcitabine|gemcitabine|mesh-list
101204059|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204061|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101204062|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
101204063|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
101204064|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
101204065|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
101204068|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101204069|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204070|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204071|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101204072|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101204073|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101204077|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101204078|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101204079|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101204080|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204081|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204082|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
101204083|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
101204084|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204085|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204086|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101204087|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101204088|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101204089|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204090|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204091|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204092|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204093|NCT01421706|Clarithromycin|clarithromycin|mesh-list
101204094|NCT01421706|Sibutramine|sibutramine|mesh-list
101248306|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101248307|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101248308|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
101248309|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248310|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248311|NCT05797558|Eplerenone|eplerenone|mesh-list
101248312|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101248313|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
101248314|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
101248315|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248316|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248317|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101248318|NCT05797558|Diuretics|diuretics|mesh-ancestor
101248319|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
101248320|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101248321|NCT05797558|Hormones|hormones|mesh-ancestor
101204095|NCT01421706|Clopidogrel|clopidogrel|mesh-list
101204096|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101204097|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101204098|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101204099|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101204100|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
101204101|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204102|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204103|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204104|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204105|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204106|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101204107|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204108|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101204109|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101204110|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
101204111|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101204112|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
101204113|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101204114|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
101204115|NCT01421901|Ertapenem|ertapenem|mesh-list
101204116|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204117|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204118|NCT01421914|Bupivacaine|bupivacaine|mesh-list
101204119|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
101204120|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
101204121|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204122|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204123|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
101204124|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204125|NCT01421927|Lenalidomide|lenalidomide|mesh-list
101204126|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
101204127|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204128|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101204129|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101204130|NCT01421927|Growth Substances|growth substances|mesh-ancestor
101204135|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101204136|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204137|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204138|NCT01421979|Caffeine|caffeine|mesh-list
101204139|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101204140|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204141|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101204142|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204145|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101204146|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
101204147|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204148|NCT01421992|Methylphenidate|methylphenidate|mesh-list
101204149|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101204150|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204151|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101204152|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101204153|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204154|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204156|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204157|NCT01422018|Bevacizumab|bevacizumab|mesh-list
101204158|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204159|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204160|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101204161|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101204162|NCT01422018|Growth Substances|growth substances|mesh-ancestor
101204163|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204164|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101204165|NCT01422096|Leuprolide|leuprolide|mesh-list
101204166|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101204167|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
101204168|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101204169|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204170|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204171|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204172|NCT01422109|Aspirin|aspirin|mesh-list
101204173|NCT01422109|Clopidogrel|clopidogrel|mesh-list
101204174|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101204175|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204176|NCT01422109|Analgesics|analgesics|mesh-ancestor
101204177|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
101204178|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204179|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204180|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204181|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204182|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101204183|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101204184|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204185|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101204186|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101204187|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204188|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
101204189|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101204190|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101204191|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101204192|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
101204193|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204194|NCT01422122|Vitamin D|vitamin d|mesh-list
101204195|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
101204196|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
101204197|NCT01422122|Vitamins|vitamins|mesh-list
101204198|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
101204199|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204200|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101204201|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204202|NCT01422291|Acetaminophen|acetaminophen|mesh-list
101204203|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
101204204|NCT01422291|Morphine|morphine|mesh-list
101204205|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101204209|NCT01422291|Analgesics|analgesics|mesh-ancestor
101204210|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
101204211|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204212|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204213|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
101204214|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101204215|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204216|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204218|NCT01422317|Vitamin E|vitamin e|mesh-list
101204219|NCT01422317|Tocotrienols|tocotrienols|mesh-list
101204221|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
101204222|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248322|NCT05786820|Pycnogenols|pycnogenols|mesh-list
101248323|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101248324|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
101248325|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248326|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
101248327|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248328|NCT05786820|Protective Agents|protective agents|mesh-ancestor
101248331|NCT05781308|Bevacizumab|bevacizumab|mesh-list
101248332|NCT05781308|Atezolizumab|atezolizumab|mesh-list
101248333|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101248334|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248335|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101248336|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101248337|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248338|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248339|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248340|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101204223|NCT01422317|Protective Agents|protective agents|mesh-ancestor
101204224|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204225|NCT01422317|Vitamins|vitamins|mesh-ancestor
101204226|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
101204227|NCT01422330|Etravirine|etravirine|mesh-list
101204228|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101204229|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101204230|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204231|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204232|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
101204233|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204234|NCT01422460|Mitogens|mitogens|mesh-list
101204235|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101204236|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204237|NCT01422499|Vorinostat|vorinostat|mesh-list
101204238|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204239|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101204240|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204241|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204242|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101204244|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204245|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204246|NCT01422590|Incretins|incretins|mesh-ancestor
101204247|NCT01422590|Hormones|hormones|mesh-ancestor
101204248|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204249|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101204250|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101204251|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204252|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204253|NCT01422603|Clofarabine|clofarabine|mesh-list
101204254|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101204255|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
101204256|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204257|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204258|NCT01422616|Metoprolol|metoprolol|mesh-list
101204259|NCT01422616|Clonidine|clonidine|mesh-list
101204260|NCT01422616|Labetalol|labetalol|mesh-list
101204261|NCT01422616|Hydralazine|hydralazine|mesh-list
101204262|NCT01422616|Nicardipine|nicardipine|mesh-list
101204263|NCT01422616|Phentolamine|phentolamine|mesh-list
101204264|NCT01422616|Urapidil|urapidil|mesh-list
101204265|NCT01422616|Enalaprilat|enalaprilat|mesh-list
101248341|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101248342|NCT05781308|Growth Substances|growth substances|mesh-ancestor
101248343|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248344|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
101248345|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248346|NCT05772156|Methylergonovine|methylergonovine|mesh-list
101248347|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
101248348|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101248349|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248350|NCT05769868|Esmolol|esmolol|mesh-list
101248351|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101248352|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101248353|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101248354|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101248355|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248356|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248357|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248358|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
101248359|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101204266|NCT01422616|Enalapril|enalapril|mesh-list
101204267|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101204268|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
101204269|NCT01422616|Esmolol|esmolol|mesh-list
101204270|NCT01422616|Glycerol|glycerol|mesh-list
101204271|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101204272|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101204273|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
101204274|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
101204275|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204276|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204277|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101204278|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101204279|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101204280|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
101204281|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204282|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204283|NCT01422616|Analgesics|analgesics|mesh-ancestor
101204284|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
101204289|NCT01422616|Protective Agents|protective agents|mesh-ancestor
101204290|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
101204291|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101204292|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101204293|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
101204294|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101204295|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204296|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204297|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101204298|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101204299|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101204300|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
101204301|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101204302|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
101204303|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204304|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
101204305|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204306|NCT01422733|Dexamethasone|dexamethasone|mesh-list
101204307|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
101204308|NCT01422733|Cosyntropin|cosyntropin|mesh-list
101204309|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204310|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
101204311|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
101204312|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204313|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204314|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204315|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
101204316|NCT01422733|Hormones|hormones|mesh-ancestor
101204317|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204318|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204320|NCT01422785|Clindamycin|clindamycin|mesh-list
101204321|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
101204322|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
101204323|NCT01422785|Tretinoin|tretinoin|mesh-list
101204324|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101204325|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204326|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204327|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101204328|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204329|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204331|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204332|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
101204333|NCT01422954|Chloroquine|chloroquine|mesh-list
101204334|NCT01422954|Mefloquine|mefloquine|mesh-list
101204335|NCT01422954|Proguanil|proguanil|mesh-list
101204336|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101204337|NCT01422954|Amebicides|amebicides|mesh-ancestor
101204338|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101204339|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101204340|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204341|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
101204342|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204343|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
101204344|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204350|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204351|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204352|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
101204353|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
101204354|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204355|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101204356|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
101204357|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
101204358|NCT01423032|Fludarabine|fludarabine|mesh-list
101204359|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101204360|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204361|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204362|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204465|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204466|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
101204467|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204468|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204469|NCT01423695|Paclitaxel|paclitaxel|mesh-list
101204471|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101204472|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204473|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101204474|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101204475|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101204476|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204477|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204478|NCT01423708|Everolimus|everolimus|mesh-list
101204479|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101204480|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101204481|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204482|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204483|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204484|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
101204485|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204486|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204487|NCT01423747|Fludarabine|fludarabine|mesh-list
101204488|NCT01423747|Etoposide|etoposide|mesh-list
101204489|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
101204490|NCT01423747|Thiotepa|thiotepa|mesh-list
101204491|NCT01423747|Treosulfan|treosulfan|mesh-list
101204492|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248360|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248361|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248362|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248363|NCT05685615|Polymyxins|polymyxins|mesh-list
101248364|NCT05685615|Polymyxin B|polymyxin b|mesh-list
101248365|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101248366|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248367|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
101248368|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
101248369|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248370|NCT05650996|Calpastatin|calpastatin|mesh-list
101248371|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101248373|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248374|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204493|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204494|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204495|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
101204496|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204497|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101204498|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101204502|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
101204503|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101204504|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
101204505|NCT01423838|Oxybutynin|oxybutynin|mesh-list
101204506|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101204507|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101204508|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101204509|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204510|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204511|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204512|NCT01423838|Urological Agents|urological agents|mesh-ancestor
101204513|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
101204514|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
101204515|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204516|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101204517|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101204518|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
101204520|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
101204521|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101204522|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101204523|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
101204524|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204525|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
101204526|NCT01423864|Hormones|hormones|mesh-ancestor
101204527|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204528|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204529|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101204530|NCT01423864|Protective Agents|protective agents|mesh-ancestor
101204531|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204532|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204533|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
101204534|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
101204535|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204536|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204537|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
101204538|NCT01423955|Hematinics|hematinics|mesh-ancestor
101204539|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
101204540|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204541|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204542|NCT01424111|Escitalopram|escitalopram|mesh-list
101204543|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101204544|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101204545|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204546|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204547|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204548|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
101204549|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204550|NCT01424124|Montelukast|montelukast|mesh-list
101204551|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101204552|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
101204553|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101204554|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
101204555|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204556|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204557|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101204558|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101204559|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204560|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101204562|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
101204563|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204564|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204565|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101204566|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
101204567|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
101204569|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204570|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
101204571|NCT01424176|Pramipexole|pramipexole|mesh-list
101204574|NCT01424176|Protective Agents|protective agents|mesh-ancestor
101204575|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204576|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101204577|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101204578|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
101204580|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204581|NCT01424241|Octreotide|octreotide|mesh-list
101204582|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204583|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204584|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204585|NCT01424319|Atrasentan|atrasentan|mesh-list
101204586|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204587|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101204588|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101204589|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204590|NCT01424332|Aspirin|aspirin|mesh-list
101204591|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
101204592|NCT01424332|Salicylates|salicylates|mesh-list
101204593|NCT01424332|Darexaban|darexaban|mesh-list
101204594|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101204595|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204597|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
101204598|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204599|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204600|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204601|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204602|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101204603|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101204604|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204605|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101204606|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101204607|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204608|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
101204609|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204610|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
101204611|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
101204612|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
101204613|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101204614|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
101204615|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101204616|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
101204617|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
101204618|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101204619|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
101204620|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204621|NCT01424384|Citalopram|citalopram|mesh-list
101204622|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101204623|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101204624|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204625|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204626|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204627|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
101204628|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204629|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101204630|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
101204631|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101204632|NCT01424449|Aripiprazole|aripiprazole|mesh-list
101204633|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
101204634|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101204635|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101204636|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101204637|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204638|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204639|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
101204640|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
101204641|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204642|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204643|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101204644|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101204645|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
101204651|NCT01424618|Ganirelix|ganirelix|mesh-list
101204652|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101204653|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
101204654|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101204655|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204656|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204657|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204659|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204660|NCT01424709|Cisplatin|cisplatin|mesh-list
101204661|NCT01424709|Gemcitabine|gemcitabine|mesh-list
101204662|NCT01424709|Docetaxel|docetaxel|mesh-list
101204664|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204665|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101204666|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
101204667|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204668|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
101204669|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
101204670|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
101204672|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204673|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204674|NCT01424761|Ubiquinone|ubiquinone|mesh-list
101204675|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
101204676|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
101204677|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204678|NCT01424761|Vitamins|vitamins|mesh-ancestor
101204679|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
101204680|NCT01424826|Rifampin|rifampin|mesh-list
101204681|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101204682|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101204683|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
101204684|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204685|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101204686|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101204687|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204688|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204689|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101204690|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
101204691|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204692|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
101204693|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101204694|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101204695|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101204696|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101204697|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101204698|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101204699|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101204700|NCT01424839|Cisplatin|cisplatin|mesh-list
101204701|NCT01424839|Carboplatin|carboplatin|mesh-list
101204702|NCT01424839|Etoposide|etoposide|mesh-list
101204703|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
101204704|NCT01424839|Ifosfamide|ifosfamide|mesh-list
101204705|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
101204706|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204707|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101204708|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101204709|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204710|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204711|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204712|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204714|NCT01424891|Simvastatin|simvastatin|mesh-list
101204715|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101204716|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101204717|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
101204718|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204719|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101204720|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101204721|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204722|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
101204730|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101204731|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101204733|NCT01425099|Prednisone|prednisone|mesh-list
101204734|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204735|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
101204737|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204738|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204739|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101204740|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204741|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101204742|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101204743|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204744|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204745|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101204746|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101204747|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
101204748|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204749|NCT01425125|Tolvaptan|tolvaptan|mesh-list
101204750|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101204751|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204752|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
101204753|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204754|NCT01425164|Carvedilol|carvedilol|mesh-list
101204755|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101204756|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101204757|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
101204758|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204759|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204760|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204761|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101204762|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
101204763|NCT01425164|Protective Agents|protective agents|mesh-ancestor
101204764|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101204765|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204766|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204767|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
101204768|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101204769|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101204770|NCT01425216|Sorafenib|sorafenib|mesh-list
101204771|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204772|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101204773|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204774|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204775|NCT01425242|Amlodipine|amlodipine|mesh-list
101204776|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101204777|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101204778|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204779|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204780|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204781|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204782|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
101204783|NCT01425320|Dapsone|dapsone|mesh-list
101204784|NCT01425320|Adapalene|adapalene|mesh-list
101204786|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248398|NCT05597254|Niacinamide|niacinamide|mesh-list
101248399|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
101248400|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101248401|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
101248402|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248403|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101204787|NCT01425320|Analgesics|analgesics|mesh-ancestor
101204788|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
101204789|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204790|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204796|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101204797|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101204798|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101204799|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204800|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204801|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
101204802|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204803|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101204804|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101204805|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101204806|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
101204807|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204809|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101204810|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204812|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101204813|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101204814|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101204815|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204816|NCT01425424|Vitamin D|vitamin d|mesh-list
101204817|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
101204818|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
101204819|NCT01425424|Vitamins|vitamins|mesh-list
101204820|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
101204821|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204822|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101204823|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204824|NCT01425476|Vitamin D|vitamin d|mesh-list
101204825|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
101204826|NCT01425476|Celecoxib|celecoxib|mesh-list
101204827|NCT01425476|Vitamins|vitamins|mesh-ancestor
101204828|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
101204829|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204830|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101204831|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101204832|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101204833|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204834|NCT01425476|Analgesics|analgesics|mesh-ancestor
101204835|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
101204836|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204837|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204838|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204839|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101204840|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101204841|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204842|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204843|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101204844|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101204845|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101204846|NCT01425580|Metformin|metformin|mesh-list
101248404|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
101248405|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
101248406|NCT05597254|Vitamins|vitamins|mesh-ancestor
101248407|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
101248408|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248409|NCT05576415|Varenicline|varenicline|mesh-list
101248410|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101248411|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101248412|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
101248413|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248414|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248415|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248416|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
101248417|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
101248418|NCT05395052|Nivolumab|nivolumab|mesh-list
101248419|NCT05395052|Trastuzumab|trastuzumab|mesh-list
101248420|NCT05395052|Fludarabine|fludarabine|mesh-list
101248421|NCT05395052|Cetuximab|cetuximab|mesh-list
101248422|NCT05395052|Atezolizumab|atezolizumab|mesh-list
101248423|NCT05395052|Interleukin-2|interleukin-2|mesh-list
101248424|NCT05395052|Avelumab|avelumab|mesh-list
101248425|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101248426|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248427|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
101248428|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204847|NCT01425580|Liraglutide|liraglutide|mesh-list
101204848|NCT01425580|Glimepiride|glimepiride|mesh-list
101204849|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204850|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204851|NCT01425580|Incretins|incretins|mesh-ancestor
101204852|NCT01425580|Hormones|hormones|mesh-ancestor
101204853|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204854|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101204855|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204856|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
101204857|NCT01425619|Lidocaine|lidocaine|mesh-list
101204858|NCT01425619|Prilocaine|prilocaine|mesh-list
101204859|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
101204860|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
101204861|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204862|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204863|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
101204866|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101204867|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101204868|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101204869|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204870|NCT01425658|Clonidine|clonidine|mesh-list
101204871|NCT01425658|Fentanyl|fentanyl|mesh-list
101204873|NCT01425658|Narcotics|narcotics|mesh-ancestor
101204874|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204875|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204877|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
101204878|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204879|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101204880|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101204881|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
101204882|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
101204883|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101204884|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
101204885|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
101204886|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101204887|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101204888|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101204889|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
101204890|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204891|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204892|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
101204893|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101204894|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101204895|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204896|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
101204897|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
101204898|NCT01425736|Cisplatin|cisplatin|mesh-list
101204899|NCT01425736|Docetaxel|docetaxel|mesh-list
101204900|NCT01425736|Fluorouracil|fluorouracil|mesh-list
101204901|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
101204902|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204903|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
101204904|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
101204905|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
101204906|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204907|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
101204908|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101204909|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204910|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
101204911|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204912|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204913|NCT01425775|Vitamin D|vitamin d|mesh-list
101204914|NCT01425775|Vitamins|vitamins|mesh-ancestor
101204915|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
101204916|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204917|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101204918|NCT05386446|Interferons|interferons|mesh-list
101204919|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
101204920|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204921|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
101204922|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204923|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
101204924|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
101204925|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204927|NCT05386290|Mesalamine|mesalamine|mesh-list
101204928|NCT05386290|Ustekinumab|ustekinumab|mesh-list
101204929|NCT05386290|Vedolizumab|vedolizumab|mesh-list
101204930|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101204931|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204932|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
101204933|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101204934|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204935|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101204936|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101204937|NCT05386290|Analgesics|analgesics|mesh-ancestor
101204938|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
101204939|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204940|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204948|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101204949|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
101204950|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204951|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204952|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101204953|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204954|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
101204955|NCT05386160|Ranibizumab|ranibizumab|mesh-list
101204957|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101204958|NCT05386160|Growth Substances|growth substances|mesh-ancestor
101204959|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204960|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
101204961|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204962|NCT05386121|Fentanyl|fentanyl|mesh-list
101204963|NCT05386121|Meperidine|meperidine|mesh-list
101204964|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101204965|NCT05386121|Narcotics|narcotics|mesh-ancestor
101204966|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204967|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204968|NCT05386121|Analgesics|analgesics|mesh-ancestor
101204969|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
101204970|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204971|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101204972|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101204973|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
101204975|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
101204976|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204977|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204979|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204980|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
101204981|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204982|NCT05385887|Metronidazole|metronidazole|mesh-list
101204983|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
101204984|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204985|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204986|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101204987|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101204988|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101204989|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204990|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204991|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204992|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204993|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101204994|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101204995|NCT05385861|Carboplatin|carboplatin|mesh-list
101204996|NCT05385861|Irinotecan|irinotecan|mesh-list
101204998|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101204999|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101205000|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205001|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205003|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101205004|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205005|NCT05385744|Analgesics|analgesics|mesh-ancestor
101205006|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
101205007|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205008|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205009|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205010|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205011|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205012|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
101205013|NCT05385185|Endostatins|endostatins|mesh-list
101205014|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205024|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205025|NCT05385068|Niraparib|niraparib|mesh-list
101205026|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101205027|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205028|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205029|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205030|NCT05385029|Carbimazole|carbimazole|mesh-list
101205031|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
101205032|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205033|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205034|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205035|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
101205036|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101205037|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101205038|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101205039|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205040|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205041|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205042|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205043|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205044|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101205045|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205046|NCT05379374|Morphine|morphine|mesh-list
101205047|NCT05379374|Bupivacaine|bupivacaine|mesh-list
101205048|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
101205049|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
101205050|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205051|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205052|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
101205053|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248429|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248430|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101248431|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
101248432|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248433|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248434|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101248435|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248436|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101248437|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101248439|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
101248440|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248441|NCT05324761|Pregabalin|pregabalin|mesh-list
101248445|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248446|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248447|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
101205054|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101205055|NCT05379374|Narcotics|narcotics|mesh-ancestor
101205056|NCT05379374|Analgesics|analgesics|mesh-ancestor
101205057|NCT05375708|Bevacizumab|bevacizumab|mesh-list
101205058|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205061|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205062|NCT05375708|Growth Substances|growth substances|mesh-ancestor
101205063|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205064|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205065|NCT05176379|Fluconazole|fluconazole|mesh-list
101205066|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
101205067|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205068|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101205069|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101205070|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205071|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205072|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101205073|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205074|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205075|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205076|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101205077|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101205078|NCT05113615|Bromides|bromides|mesh-list
101205079|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
101205081|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
101205082|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205083|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205084|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205090|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205092|NCT04850378|Dalteparin|dalteparin|mesh-list
101205093|NCT04850378|Tinzaparin|tinzaparin|mesh-list
101205094|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101205095|NCT04850378|Apixaban|apixaban|mesh-list
101205096|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101205097|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
101205098|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101205099|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205100|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205101|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205102|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
101205103|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101205104|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101205105|NCT04809103|Cisplatin|cisplatin|mesh-list
101205106|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205107|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101205108|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101205109|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205110|NCT04765371|Dexamethasone|dexamethasone|mesh-list
101205111|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
101205112|NCT04765371|Prednisolone|prednisolone|mesh-list
101205113|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101205114|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
101205115|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101205116|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
101205117|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101205118|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
101205119|NCT04765371|BB 1101|bb 1101|mesh-list
101205121|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
101205122|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
101205123|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205124|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205125|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205126|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
101205128|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205129|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205130|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205131|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205132|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205133|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205134|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101205135|NCT04765371|Protective Agents|protective agents|mesh-ancestor
101205136|NCT04744363|Ustekinumab|ustekinumab|mesh-list
101205137|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
101205138|NCT04729517|Azelastine|azelastine|mesh-list
101205139|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101205141|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205142|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205143|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205144|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205145|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101205146|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205147|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205148|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101205149|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101205150|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101205151|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
101205152|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
101205153|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205154|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
101205155|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101205156|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101205157|NCT04673162|Prednisolone|prednisolone|mesh-list
101205158|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
101205159|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101205166|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205167|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
101205169|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205170|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101205171|NCT04673162|Protective Agents|protective agents|mesh-ancestor
101205172|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205173|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205174|NCT04622020|Anesthetics|anesthetics|mesh-list
101205175|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205176|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205177|NCT04560556|Antibodies|antibodies|mesh-list
101205178|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
101205179|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205180|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
101205181|NCT04425902|Metoprolol|metoprolol|mesh-list
101205182|NCT04425902|Digoxin|digoxin|mesh-list
101205183|NCT04425902|Midazolam|midazolam|mesh-list
101205184|NCT04425902|Caffeine|caffeine|mesh-list
101205185|NCT04425902|Omeprazole|omeprazole|mesh-list
101205186|NCT04425902|Pravastatin|pravastatin|mesh-list
101205187|NCT04425902|Montelukast|montelukast|mesh-list
101205188|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101205189|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101205190|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205191|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205192|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101248448|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101248449|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101248450|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248451|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101248452|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101248453|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101248454|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248455|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101248456|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101248457|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101248458|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248459|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
101248460|NCT05317403|Cytarabine|cytarabine|mesh-list
101248461|NCT05317403|Fludarabine|fludarabine|mesh-list
101248462|NCT05317403|Venetoclax|venetoclax|mesh-list
101248463|NCT05317403|Vorinostat|vorinostat|mesh-list
101248464|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248465|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101248466|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
101248467|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248468|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248469|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
101248470|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248471|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
101248472|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101248473|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101248474|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101248475|NCT05312242|Folic Acid|folic acid|mesh-list
101248476|NCT05312242|Micronutrients|micronutrients|mesh-list
101248477|NCT05312242|Trace Elements|trace elements|mesh-list
101248478|NCT05312242|Hematinics|hematinics|mesh-ancestor
101248479|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
101248480|NCT05312242|Vitamins|vitamins|mesh-ancestor
101205193|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101205194|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101205195|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101205196|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
101205197|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
101205198|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
101205199|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
101205200|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205201|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205202|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101205203|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101248481|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248482|NCT05288829|Ravulizumab|ravulizumab|mesh-list
101248483|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101248484|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248485|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
101248486|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248487|NCT05233566|Ketamine|ketamine|mesh-list
101248488|NCT05233566|Analgesics|analgesics|mesh-ancestor
101248489|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
101248490|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248491|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248492|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101248493|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248494|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
101248495|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
101248496|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248497|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101248498|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101248499|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101248500|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248502|NCT05232344|Progesterone|progesterone|mesh-list
101205204|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205205|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101205206|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101205207|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
101205208|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101205209|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205210|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101205211|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205212|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205213|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101205214|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205215|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205216|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101205217|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101205219|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101205220|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
101205221|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
101205222|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205223|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101205224|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101205225|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101205226|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
101205227|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101205228|NCT04425902|Protective Agents|protective agents|mesh-ancestor
101205229|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101205230|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101205239|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205240|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101205241|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101205242|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205243|NCT04311762|Cisplatin|cisplatin|mesh-list
101205244|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248503|NCT05232344|Estrogens|estrogens|mesh-ancestor
101248504|NCT05232344|Hormones|hormones|mesh-ancestor
101248505|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248506|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248507|NCT05232344|Progestins|progestins|mesh-ancestor
101248508|NCT05210517|Empagliflozin|empagliflozin|mesh-list
101248509|NCT05210517|Benzbromarone|benzbromarone|mesh-list
101248510|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101323484|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
101248511|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248512|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248513|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248514|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
101248515|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
101248516|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248518|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101248519|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248520|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
101248521|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205245|NCT04203472|Budesonide|budesonide|mesh-list
101205246|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205247|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101205248|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
101205249|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205250|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205252|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205253|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
101205255|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205257|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101205258|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101205259|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205260|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
101205261|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205262|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101205263|NCT04072146|Varenicline|varenicline|mesh-list
101205264|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101205265|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101205266|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205267|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205268|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205269|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205271|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101205272|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205273|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205274|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205275|NCT03882463|Insulin|insulin|mesh-list
101205276|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205277|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205278|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
101205279|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205280|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
101205281|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205282|NCT03821649|Naloxone|naloxone|mesh-list
101205283|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101205284|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248522|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248523|NCT05118685|Estrogens|estrogens|mesh-list
101248524|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101248525|NCT05118685|Hormones|hormones|mesh-ancestor
101248526|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101248527|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248528|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101248529|NCT05109650|Antibodies|antibodies|mesh-list
101248530|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
101248531|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
101248532|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248533|NCT05108259|Adalimumab|adalimumab|mesh-list
101248534|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101248535|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101248536|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248537|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
101248538|NCT05069935|Fludarabine|fludarabine|mesh-list
101248539|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101248540|NCT05069935|Antibodies|antibodies|mesh-list
101248541|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
101205285|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
101205286|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205287|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
101205288|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
101205290|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205291|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205292|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
101205293|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205295|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101205296|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205297|NCT03771612|Analgesics|analgesics|mesh-ancestor
101205298|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
101205299|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205300|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205301|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205302|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205303|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
101205307|NCT03734211|Evolocumab|evolocumab|mesh-list
101205308|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101205309|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101205310|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101205311|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
101205312|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205314|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205315|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205316|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101205317|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
101205318|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101205319|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101205320|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205322|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
101205323|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
101205324|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205325|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205326|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
101205327|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101248542|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101248543|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248544|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
101248545|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248546|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248547|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101248548|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
101248549|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248550|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248551|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101248552|NCT05040217|Mitogens|mitogens|mesh-list
101248553|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
101248554|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248555|NCT05032118|Ketamine|ketamine|mesh-list
101248556|NCT05032118|Propofol|propofol|mesh-list
101248557|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101248558|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101248559|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248560|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101248570|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248571|NCT04977908|Insulin|insulin|mesh-list
101248572|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205328|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
101205329|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101205330|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205331|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205332|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101205334|NCT03444753|Ipilimumab|ipilimumab|mesh-list
101205335|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205336|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205337|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101205338|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205339|NCT03142035|Dienogest|dienogest|mesh-list
101205340|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101205341|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
101205342|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101205343|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205345|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101205346|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101205347|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101205348|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205349|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205350|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205351|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205352|NCT02786875|Vitamin D|vitamin d|mesh-list
101205353|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
101205354|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
101205355|NCT02786875|Vitamins|vitamins|mesh-list
101205356|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
101205357|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205358|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101248573|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248574|NCT04954599|Carboplatin|carboplatin|mesh-list
101248575|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
101248576|NCT04954599|Nivolumab|nivolumab|mesh-list
101248577|NCT04954599|Ipilimumab|ipilimumab|mesh-list
101248578|NCT04954599|Atezolizumab|atezolizumab|mesh-list
101248579|NCT04954599|Durvalumab|durvalumab|mesh-list
101248580|NCT04954599|Avelumab|avelumab|mesh-list
101248581|NCT04954599|Cemiplimab|cemiplimab|mesh-list
101248582|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101248583|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248584|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101248585|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248586|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
101248587|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
101248588|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248589|NCT04862234|Dulaglutide|dulaglutide|mesh-list
101248590|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101248591|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248592|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
101248593|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
101248594|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248595|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
101248596|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205359|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101205360|NCT02767882|Dexamethasone|dexamethasone|mesh-list
101205361|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205362|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
101205363|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
101205364|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205365|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205366|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205367|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
101205368|NCT02767882|Hormones|hormones|mesh-ancestor
101205369|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205370|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205371|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205372|NCT02246257|Metformin|metformin|mesh-list
101205373|NCT02246257|Losartan|losartan|mesh-list
101205374|NCT02246257|Simvastatin|simvastatin|mesh-list
101205375|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205376|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205377|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101205378|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101205385|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101205386|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101205387|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101205388|NCT02197221|Bortezomib|bortezomib|mesh-list
101205389|NCT02197221|Melphalan|melphalan|mesh-list
101205390|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205391|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101205392|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
101205393|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205394|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101205395|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248597|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
101248598|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101248599|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
101248600|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248601|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
101248602|NCT04614636|Fludarabine|fludarabine|mesh-list
101248603|NCT04614636|Daratumumab|daratumumab|mesh-list
101248605|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101248606|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
101248607|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248608|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101248609|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101248610|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
101248611|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248612|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248613|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101248614|NCT04573920|Atrasentan|atrasentan|mesh-list
101248615|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101248616|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101205396|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
101205397|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205399|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205400|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205401|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205402|NCT01949714|Epinephrine|epinephrine|mesh-list
101205403|NCT01949714|Racepinephrine|racepinephrine|mesh-list
101205405|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101205406|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101205407|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101205408|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205409|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205410|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205411|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101205412|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101205414|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205415|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205416|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205417|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
101205418|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
101205419|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101205420|NCT00223145|Goserelin|goserelin|mesh-list
101205421|NCT00223145|Bicalutamide|bicalutamide|mesh-list
101205422|NCT00223145|Androgens|androgens|mesh-list
101205423|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205424|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205425|NCT00223145|Hormones|hormones|mesh-ancestor
101205426|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205427|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205428|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
101205429|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205430|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101205431|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101205432|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101205433|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205434|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205435|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205436|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205437|NCT01425827|Analgesics|analgesics|mesh-ancestor
101205438|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
101205439|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205440|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
101205441|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101205442|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
101205443|NCT01425840|Lidocaine|lidocaine|mesh-list
101205444|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
101205445|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
101205446|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205447|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205448|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
101205464|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205465|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205466|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205467|NCT01426074|Bevacizumab|bevacizumab|mesh-list
101205468|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205469|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205470|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101205471|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205472|NCT01426074|Growth Substances|growth substances|mesh-ancestor
101205473|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205474|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205475|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101205476|NCT01426087|Somatostatin|somatostatin|mesh-list
101205477|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205478|NCT01426087|Hormones|hormones|mesh-ancestor
101205479|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205480|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205481|NCT01426100|Telmisartan|telmisartan|mesh-list
101205482|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101205483|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101205484|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101205485|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205486|NCT01426126|genexol-PM|genexol-pm|mesh-list
101205487|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205488|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
101205489|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
101205490|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
101205491|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205494|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
101205495|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205496|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205497|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
101205498|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205499|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101205500|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
101205501|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101205502|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205503|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205504|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101205505|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
101205510|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
101205511|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205512|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101205513|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101205515|NCT01426334|Dasatinib|dasatinib|mesh-list
101205516|NCT01426334|Cyclosporins|cyclosporins|mesh-list
101205517|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205518|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205519|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205520|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
101205521|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205522|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
101205523|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205524|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
101205525|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205526|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101205527|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205528|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205530|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205531|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101248617|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101248618|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101248619|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
101420759|NCT00157053|Coagulants|coagulants|mesh-ancestor
101420760|NCT00507793|Cyclosporine|cyclosporine|mesh-list
101205532|NCT01426464|Latanoprost|latanoprost|mesh-list
101205533|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101205534|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101205535|NCT01426490|Vitamins|vitamins|mesh-list
101205536|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
101205537|NCT01426490|Folic Acid|folic acid|mesh-list
101205538|NCT01426490|Pyridoxine|pyridoxine|mesh-list
101205539|NCT01426490|Pyridoxal|pyridoxal|mesh-list
101205540|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
101205541|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
101205542|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
101205543|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205544|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
101205545|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205546|NCT01426490|Protective Agents|protective agents|mesh-ancestor
101205547|NCT01426490|Hematinics|hematinics|mesh-ancestor
101205548|NCT01426542|Topiramate|topiramate|mesh-list
101205549|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
101205550|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205551|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205552|NCT01426633|Gemcitabine|gemcitabine|mesh-list
101205553|NCT01426633|Trabectedin|trabectedin|mesh-list
101205554|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101205555|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
101205556|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205557|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205558|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101205559|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
101205561|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205562|NCT01426737|Vildagliptin|vildagliptin|mesh-list
101205563|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205564|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205565|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101205566|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205567|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205568|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205569|NCT01426802|Vildagliptin|vildagliptin|mesh-list
101205570|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101205571|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205572|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101205573|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205574|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205575|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205576|NCT01426815|Golimumab|golimumab|mesh-list
101205577|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101205578|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205579|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205580|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
101205581|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205582|NCT01426880|Paclitaxel|paclitaxel|mesh-list
101205583|NCT01426880|Carboplatin|carboplatin|mesh-list
101205594|NCT01426906|Ketoconazole|ketoconazole|mesh-list
101205595|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101205596|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
101205597|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101205598|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205599|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
101205600|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101205601|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205602|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205603|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101205604|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101205605|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101205606|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101205607|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101205608|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101420761|NCT00507793|Sirolimus|sirolimus|mesh-list
101420762|NCT00507793|Cyclosporins|cyclosporins|mesh-list
101420763|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420764|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420765|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420766|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
101420767|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420768|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
101420769|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205609|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
101205610|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101205611|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101205612|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101205613|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
101205614|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205615|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205616|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101205618|NCT01426971|Caffeine|caffeine|mesh-list
101205619|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101205620|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205621|NCT01426971|Analgesics|analgesics|mesh-ancestor
101205622|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
101205623|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205624|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205625|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205626|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205627|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101205628|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205629|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205630|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101205631|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101205632|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101205633|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101205634|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
101205635|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205636|NCT01426984|Methylphenidate|methylphenidate|mesh-list
101205637|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101205638|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205639|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101205640|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101205641|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205642|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205643|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
101205644|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205645|NCT01427114|Prednisolone|prednisolone|mesh-list
101205646|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
101205647|NCT01427114|Rituximab|rituximab|mesh-list
101205654|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
101205655|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205656|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205657|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101205658|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205659|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101205660|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
101205661|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
101205662|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
101205663|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205664|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
101205665|NCT01427114|Hormones|hormones|mesh-ancestor
101205666|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205667|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205669|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
101205670|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101205671|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205672|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205673|NCT01427192|Diuretics|diuretics|mesh-ancestor
101205674|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
101205675|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205676|NCT01427205|Cetuximab|cetuximab|mesh-list
101205677|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205678|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205679|NCT01427244|Trastuzumab|trastuzumab|mesh-list
101205680|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205681|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205682|NCT01427270|Oxycodone|oxycodone|mesh-list
101205683|NCT01427270|Naloxone|naloxone|mesh-list
101205684|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101205686|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205687|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205688|NCT01427270|Analgesics|analgesics|mesh-ancestor
101205689|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
101205690|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205691|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101205693|NCT01427283|Naloxone|naloxone|mesh-list
101205694|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101205695|NCT01427283|Narcotics|narcotics|mesh-ancestor
101205696|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205698|NCT01427283|Analgesics|analgesics|mesh-ancestor
101205699|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
101205700|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205701|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101205702|NCT01427322|Lapatinib|lapatinib|mesh-list
101205703|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205704|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205705|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205706|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205707|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
101205708|NCT01427335|Calcium|calcium|mesh-list
101205709|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101205710|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205711|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101205712|NCT01427387|Linaclotide|linaclotide|mesh-list
101205713|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101205714|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
101205715|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205716|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205717|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
101205718|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101205719|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101205720|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101205729|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205730|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205731|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205732|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205733|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101205734|NCT01427491|Laxatives|laxatives|mesh-ancestor
101205735|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205737|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101205738|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
101205739|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205740|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205742|NCT01427686|Dopamine|dopamine|mesh-list
101205743|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101205744|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
101205745|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
101205746|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205747|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205748|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101205749|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101205750|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101205751|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
101205752|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205753|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205754|NCT01427686|Protective Agents|protective agents|mesh-ancestor
101205755|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
101205756|NCT01427699|Antibodies|antibodies|mesh-list
101205757|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
101205758|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205759|NCT01427842|Vancomycin|vancomycin|mesh-list
101205760|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101205761|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205762|NCT01427868|Maleic acid|maleic acid|mesh-list
101205763|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205765|NCT01427946|Everolimus|everolimus|mesh-list
101205766|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101205767|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205768|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205769|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205770|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205771|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
101205772|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205773|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205775|NCT01427985|Fentanyl|fentanyl|mesh-list
101205776|NCT01427985|Mivacurium|mivacurium|mesh-list
101205777|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101205778|NCT01427985|Narcotics|narcotics|mesh-ancestor
101205779|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205780|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205781|NCT01427985|Analgesics|analgesics|mesh-ancestor
101205782|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
101205783|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205784|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101205785|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101205786|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
101205787|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
101205788|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101205789|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101205790|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
101205796|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101205797|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205798|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205799|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205800|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101205801|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101205802|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101205803|NCT01428037|Misoprostol|misoprostol|mesh-list
101205804|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101205805|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
101205806|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101205807|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205808|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101205809|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205810|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
101205811|NCT01427127|Ramosetron|ramosetron|mesh-list
101205812|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
101205813|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
101205814|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205817|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101205818|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
101205819|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205820|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205821|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101205822|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
101205823|NCT01428154|Hematinics|hematinics|mesh-ancestor
101205824|NCT01428180|Ibuprofen|ibuprofen|mesh-list
101205825|NCT01428180|Indomethacin|indomethacin|mesh-list
101205826|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101205827|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205828|NCT01428180|Analgesics|analgesics|mesh-ancestor
101205829|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
101205830|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205831|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205832|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205833|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205834|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101205835|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205836|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205837|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
101205838|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
101205839|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101205840|NCT01428284|Canagliflozin|canagliflozin|mesh-list
101205841|NCT01428284|Probenecid|probenecid|mesh-list
101205842|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101205843|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205844|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101420788|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420789|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101420790|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420791|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420792|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
101205845|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205846|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
101205847|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
101205848|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205849|NCT01428375|Acetaminophen|acetaminophen|mesh-list
101205850|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205851|NCT01428375|Analgesics|analgesics|mesh-ancestor
101205852|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
101205853|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205854|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205855|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
101205856|NCT01428388|Bevacizumab|bevacizumab|mesh-list
101205857|NCT01428388|Ranibizumab|ranibizumab|mesh-list
101205858|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205859|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205860|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101205861|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205864|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205865|NCT01428414|Paclitaxel|paclitaxel|mesh-list
101205871|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
101205872|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
101205873|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
101205874|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205875|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205876|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101205877|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101205878|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101205879|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205880|NCT01428427|Gemcitabine|gemcitabine|mesh-list
101205881|NCT01428427|Trametinib|trametinib|mesh-list
101205882|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101205884|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205885|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205886|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205887|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205888|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101205889|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
101205890|NCT01428492|Dexamethasone|dexamethasone|mesh-list
101205891|NCT01428492|Bortezomib|bortezomib|mesh-list
101205892|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205893|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
101205894|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
101205895|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205896|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205897|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101205898|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
101205900|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101205901|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101205902|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205903|NCT01428518|Lamotrigine|lamotrigine|mesh-list
101205904|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
101205905|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101205906|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205907|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205908|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101205909|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205910|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101205911|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101205912|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205913|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101205914|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101205916|NCT01428531|Fondaparinux|fondaparinux|mesh-list
101205917|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101205918|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
101205919|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101205920|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205921|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205924|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101205925|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101205928|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101205929|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
101205930|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101205931|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205932|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205933|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205934|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
101205935|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101205936|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101205937|NCT01428622|Olodaterol|olodaterol|mesh-list
101205938|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101205939|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
101205940|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205941|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205942|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205943|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205948|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205949|NCT01428908|Vaccines|vaccines|mesh-list
101205950|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
101205951|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205952|NCT01428986|Maraviroc|maraviroc|mesh-list
101205953|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101205954|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101205955|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205956|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101205957|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101205958|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
101205959|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101205960|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101205961|NCT01429025|Rituximab|rituximab|mesh-list
101205962|NCT01429025|Lenalidomide|lenalidomide|mesh-list
101205963|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101205964|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101205965|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205966|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
101205967|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205968|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205969|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101205970|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205971|NCT01429025|Growth Substances|growth substances|mesh-ancestor
101205972|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205973|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101205974|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
101205975|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205976|NCT01429090|Methantheline|methantheline|mesh-list
101205977|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101205978|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101205979|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205980|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205981|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205982|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205983|NCT01429129|Nicotine|nicotine|mesh-list
101205984|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101205985|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
101205986|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205988|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101205989|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101205990|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205991|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205992|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205993|NCT01429181|Methadone|methadone|mesh-list
101205994|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101205995|NCT01429181|Narcotics|narcotics|mesh-ancestor
101205996|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101205997|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205998|NCT01429181|Analgesics|analgesics|mesh-ancestor
101205999|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
101206000|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206001|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
101206002|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206003|NCT01429337|Midostaurin|midostaurin|mesh-list
101206004|NCT01429337|Staurosporine|staurosporine|mesh-list
101206005|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206006|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101206007|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206008|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206009|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
101206010|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101206011|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101206012|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101206013|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206014|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206015|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
101206016|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206022|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
101206023|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206024|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206025|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
101206026|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206027|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206028|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
101206029|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101206030|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206031|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206032|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206033|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
101206034|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206035|NCT01429545|Nifedipine|nifedipine|mesh-list
101206036|NCT01429545|Vasotocin|vasotocin|mesh-list
101206038|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101206039|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206040|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206041|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206042|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206043|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
101206044|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
101206045|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206046|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206047|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206048|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
101206049|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101206050|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101206051|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206052|NCT01429610|Cytarabine|cytarabine|mesh-list
101206053|NCT01429610|Rituximab|rituximab|mesh-list
101206054|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101206055|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206056|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
101206057|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206058|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206059|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206060|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
101206061|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206062|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
101206063|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206064|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206065|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
101206066|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101206067|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206068|NCT01429701|Gentamicins|gentamicins|mesh-list
101206069|NCT01429701|Polymyxins|polymyxins|mesh-list
101206070|NCT01429701|Polymyxin B|polymyxin b|mesh-list
101206071|NCT01429701|Prednisolone|prednisolone|mesh-list
101206072|NCT01429701|Betamethasone|betamethasone|mesh-list
101206073|NCT01429701|Benzocaine|benzocaine|mesh-list
101206074|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206075|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
101206076|NCT01429701|Hormones|hormones|mesh-ancestor
101206077|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206078|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206079|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101206080|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206081|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206082|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101206083|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206084|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206085|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420793|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101420794|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420795|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420796|NCT00507949|Megestrol|megestrol|mesh-list
101206086|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101206087|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206092|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
101206094|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101206095|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101206096|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206097|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206098|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206099|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206100|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
101206101|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
101206102|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206103|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
101206104|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101206105|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206107|NCT01429818|Glimepiride|glimepiride|mesh-list
101206108|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101206110|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206111|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206112|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
101206113|NCT01429831|Aripiprazole|aripiprazole|mesh-list
101206114|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
101206115|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101206116|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101206117|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101206118|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206119|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206120|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
101206121|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
101206122|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206123|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206124|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101206125|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101206126|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
101206127|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101206128|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101206129|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101206130|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101206131|NCT01429844|Cyclosporine|cyclosporine|mesh-list
101206132|NCT01429844|Tacrolimus|tacrolimus|mesh-list
101206133|NCT01429844|Cyclosporins|cyclosporins|mesh-list
101206134|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206135|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
101206136|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206137|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101206138|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206139|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206140|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
101206141|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206142|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206143|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206144|NCT01429870|Triamcinolone|triamcinolone|mesh-list
101206145|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206146|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
101206147|NCT01429870|Hormones|hormones|mesh-ancestor
101206148|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206149|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206150|NCT01429935|Ibuprofen|ibuprofen|mesh-list
101206151|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206152|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206153|NCT01429935|Analgesics|analgesics|mesh-ancestor
101206154|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
101206155|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206156|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206157|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206158|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206159|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101206161|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206163|NCT01430013|Endostatins|endostatins|mesh-list
101206164|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101206165|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101206166|NCT01430013|Growth Substances|growth substances|mesh-ancestor
101206167|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206168|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
101206169|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206170|NCT01430052|Gemcitabine|gemcitabine|mesh-list
101206171|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206172|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
101206173|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206174|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206175|NCT01430065|Tacrolimus|tacrolimus|mesh-list
101206176|NCT01430065|Peficitinib|peficitinib|mesh-list
101206177|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206178|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
101206179|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206180|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101206181|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206182|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206183|NCT01430078|Niacinamide|niacinamide|mesh-list
101206184|NCT01430078|Peficitinib|peficitinib|mesh-list
101206185|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206186|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206187|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206188|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
101206189|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206190|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
101206191|NCT01430078|Vitamins|vitamins|mesh-ancestor
101206192|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
101206193|NCT01430195|Afamelanotide|afamelanotide|mesh-list
101206194|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206195|NCT01430234|Pancreatin|pancreatin|mesh-list
101206196|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206197|NCT01430260|Ciclesonide|ciclesonide|mesh-list
101206198|NCT01430260|Cetirizine|cetirizine|mesh-list
101206199|NCT01430260|Levocetirizine|levocetirizine|mesh-list
101206200|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
101206202|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206203|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206204|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101206205|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101206206|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101206207|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
101206208|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
101206209|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206210|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206211|NCT01430312|Azelaic acid|azelaic acid|mesh-list
101206212|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206213|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206214|NCT01430520|Escitalopram|escitalopram|mesh-list
101206215|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101206216|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101206217|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206218|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206219|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206220|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
101206221|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206222|NCT01430533|Azelaic acid|azelaic acid|mesh-list
101206223|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206224|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206225|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
101206226|NCT01430650|Urological Agents|urological agents|mesh-ancestor
101206227|NCT01430689|Vaccines|vaccines|mesh-list
101206228|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
101206229|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206230|NCT01430793|Vitamin D|vitamin d|mesh-list
101206231|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
101206232|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
101206233|NCT01430793|Vitamins|vitamins|mesh-list
101206234|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
101206235|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206245|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206246|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206247|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101420797|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
101420798|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101420799|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101420800|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101420801|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
101420802|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420803|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420804|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101420805|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101420806|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101420807|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420808|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
101420809|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101420810|NCT00148551|Triamcinolone|triamcinolone|mesh-list
101420811|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101420813|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101206249|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101206250|NCT01431053|Aspirin|aspirin|mesh-list
101206251|NCT01431053|Exemestane|exemestane|mesh-list
101206252|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206253|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206254|NCT01431053|Analgesics|analgesics|mesh-ancestor
101206255|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
101206256|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206257|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206258|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206259|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206260|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101206261|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101206262|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206263|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101206264|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101206265|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206266|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
101206267|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206268|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101206269|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101206270|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101206271|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206272|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206273|NCT01431092|Melatonin|melatonin|mesh-list
101206274|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
101206275|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206276|NCT01431092|Protective Agents|protective agents|mesh-ancestor
101206277|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206278|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206279|NCT01431118|Camphor|camphor|mesh-list
101206280|NCT01431118|Salicylates|salicylates|mesh-list
101206281|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
101206282|NCT01431118|Menthol|menthol|mesh-list
101206283|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101206284|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206285|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
101206286|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206287|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206288|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206289|NCT01431118|Analgesics|analgesics|mesh-ancestor
101206292|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420814|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420815|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
101420816|NCT00148551|Hormones|hormones|mesh-ancestor
101420817|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420818|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420819|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420820|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
101420821|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420822|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420824|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
101420825|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
101420826|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
101420827|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
101420828|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101206293|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206294|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206295|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101206296|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206297|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206298|NCT01431326|Vancomycin|vancomycin|mesh-list
101206299|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
101206300|NCT01431326|Tazobactam|tazobactam|mesh-list
101206301|NCT01431326|Piperacillin|piperacillin|mesh-list
101206302|NCT01431326|Tobramycin|tobramycin|mesh-list
101206303|NCT01431326|Amikacin|amikacin|mesh-list
101206304|NCT01431326|Cefepime|cefepime|mesh-list
101206305|NCT01431326|Fosfomycin|fosfomycin|mesh-list
101206313|NCT01431326|Spironolactone|spironolactone|mesh-list
101206314|NCT01431326|Pentobarbital|pentobarbital|mesh-list
101206315|NCT01431326|Oxycodone|oxycodone|mesh-list
101206316|NCT01431326|Alfentanil|alfentanil|mesh-list
101206317|NCT01431326|Haloperidol|haloperidol|mesh-list
101206318|NCT01431326|Zolpidem|zolpidem|mesh-list
101206319|NCT01431326|Ziprasidone|ziprasidone|mesh-list
101206320|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101206323|NCT01431326|Warfarin|warfarin|mesh-list
101206324|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
101206325|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
101206326|NCT01431326|Rocuronium|rocuronium|mesh-list
101206327|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
101206328|NCT01431326|Sevelamer|sevelamer|mesh-list
101206329|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206330|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
101206331|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
101206332|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206333|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206334|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206335|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
101206336|NCT01431326|Hormones|hormones|mesh-ancestor
101206337|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206338|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101206339|NCT01431326|Protective Agents|protective agents|mesh-ancestor
101206340|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206341|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101206342|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101206343|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206344|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
101206345|NCT01431326|Coagulants|coagulants|mesh-ancestor
101206346|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101206347|NCT01431326|Narcotics|narcotics|mesh-ancestor
101206348|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206349|NCT01431326|Analgesics|analgesics|mesh-ancestor
101206350|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
101206351|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
101206352|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206353|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206354|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101206355|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101206356|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101206357|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101206358|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101206360|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101206361|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101206362|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101206363|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206364|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101206365|NCT01431326|Diuretics|diuretics|mesh-ancestor
101206366|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
101206367|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101206368|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206369|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206370|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101206371|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
101206372|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206373|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101206374|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101206375|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101206376|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101206377|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101206378|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
101206379|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206380|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101206381|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101206382|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101206390|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
101206392|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101206393|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101206394|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101206395|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206396|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101206397|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101206398|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
101206399|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101206400|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
101206401|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101206402|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101206403|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
101206404|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
101206405|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
101206406|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101206407|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101206408|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
101206409|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101206410|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
101206411|NCT01431352|Letrozole|letrozole|mesh-list
101206412|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206413|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101206414|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101206415|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206416|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206417|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101206418|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206419|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206421|NCT01431404|Etanercept|etanercept|mesh-list
101206422|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206423|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206424|NCT01431404|Analgesics|analgesics|mesh-ancestor
101206425|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
101206426|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206427|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206428|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206429|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206430|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206431|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206432|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
101206433|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
101206434|NCT01431430|Vitamin D|vitamin d|mesh-list
101206435|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206436|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206437|NCT01431430|Vitamins|vitamins|mesh-ancestor
101420829|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101420830|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206438|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
101206439|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101206440|NCT01431443|Theobromine|theobromine|mesh-list
101206441|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101206442|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
101206443|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206444|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206445|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101206446|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206447|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
101206448|NCT01431456|Nadroparin|nadroparin|mesh-list
101206449|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
101206450|NCT01431456|Dabigatran|dabigatran|mesh-list
101206451|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101206452|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
101206453|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101206454|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
101206461|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101206462|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101206463|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101206464|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101206465|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
101206466|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206467|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206468|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206469|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101206470|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
101206471|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206473|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
101206474|NCT01431612|Esmolol|esmolol|mesh-list
101206475|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101206476|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
101206477|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
101206478|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206479|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206480|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
101206481|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101206482|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
101206483|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206484|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101206485|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101206486|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101206487|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206488|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206489|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206490|NCT01431612|Protective Agents|protective agents|mesh-ancestor
101206491|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101206492|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101206493|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101206495|NCT01431690|Anticoagulants|anticoagulants|mesh-list
101206496|NCT01431729|Propolis|propolis|mesh-list
101206497|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206498|NCT01431742|Buprenorphine|buprenorphine|mesh-list
101206499|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101206500|NCT01431742|Narcotics|narcotics|mesh-ancestor
101206501|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206502|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206503|NCT01431742|Analgesics|analgesics|mesh-ancestor
101206504|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
101206505|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206507|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101206508|NCT01431781|Somatostatin|somatostatin|mesh-list
101206509|NCT01431781|Hormones|hormones|mesh-ancestor
101206510|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206511|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206512|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
101206513|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206514|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206515|NCT01431924|Fluticasone|fluticasone|mesh-list
101206516|NCT01431924|Xhance|xhance|mesh-list
101206517|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101206518|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206519|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101206520|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
101206521|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206522|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206523|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101206524|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206525|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206534|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101206537|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101206538|NCT01432028|Progesterone|progesterone|mesh-list
101206539|NCT01432028|Estrogens|estrogens|mesh-ancestor
101206540|NCT01432028|Hormones|hormones|mesh-ancestor
101206541|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206542|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206543|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101206544|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
101206545|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206546|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101206547|NCT01432028|Progestins|progestins|mesh-ancestor
101206548|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101206549|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206550|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101206551|NCT01432028|Diuretics|diuretics|mesh-ancestor
101206552|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
101206553|NCT01432080|Azithromycin|azithromycin|mesh-list
101206554|NCT01432080|Prednisone|prednisone|mesh-list
101206555|NCT01432080|Budesonide|budesonide|mesh-list
101206556|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
101206557|NCT01432080|Montelukast|montelukast|mesh-list
101206558|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101206559|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206560|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
101206561|NCT01432080|Hormones|hormones|mesh-ancestor
101206562|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206563|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206564|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101206565|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206566|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101206568|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206569|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101206570|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206571|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206572|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206573|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101206574|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101206575|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101206576|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206577|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206578|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206579|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101206580|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
101206581|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101206582|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101206583|NCT01432106|Valsartan|valsartan|mesh-list
101206584|NCT01432106|Ramipril|ramipril|mesh-list
101206585|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101206586|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101206587|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101206588|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206589|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101206590|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
101206591|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206592|NCT01432119|Cetuximab|cetuximab|mesh-list
101206602|NCT01432223|Paclitaxel|paclitaxel|mesh-list
101206603|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101206605|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
101206606|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
101206607|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
101206608|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206609|NCT01432249|Etanercept|etanercept|mesh-list
101206610|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206611|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206612|NCT01432249|Analgesics|analgesics|mesh-ancestor
101206613|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
101206614|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206615|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206616|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206617|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206618|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206619|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206620|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
101206621|NCT01432470|Oxytocin|oxytocin|mesh-list
101206622|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
101206623|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206624|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206625|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
101206626|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206627|NCT01432496|Ropivacaine|ropivacaine|mesh-list
101206628|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
101206629|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
101206630|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206631|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206632|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
101206633|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206634|NCT01432522|Epinephrine|epinephrine|mesh-list
101206635|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101206636|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101206637|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206638|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206639|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206640|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206641|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101206642|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101206643|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
101206644|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206645|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101206646|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
101206647|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
101206648|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
101206649|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101206651|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101206652|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206653|NCT01432587|Analgesics|analgesics|mesh-ancestor
101206654|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
101206655|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206656|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206657|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206658|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101206659|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101206660|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206667|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206668|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
101206669|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101206670|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101206671|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206672|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206673|NCT01432665|Urological Agents|urological agents|mesh-ancestor
101206674|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
101206675|NCT01432704|Vitamin D|vitamin d|mesh-list
101206676|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206677|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206678|NCT01432704|Vitamins|vitamins|mesh-ancestor
101206679|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
101206680|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101206681|NCT01432717|Luspatercept|luspatercept|mesh-list
101206682|NCT01432717|Hematinics|hematinics|mesh-ancestor
101206683|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
101206684|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101206685|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101206687|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206688|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206689|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
101206690|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206691|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206692|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101206693|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206694|NCT01432821|Apomorphine|apomorphine|mesh-list
101206695|NCT01432821|Emetics|emetics|mesh-ancestor
101420831|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
101420832|NCT05594186|Coagulants|coagulants|mesh-ancestor
101420833|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420834|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420835|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101420836|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101420837|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101420838|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101420839|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
101420840|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101420841|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101206696|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206697|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
101206698|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206699|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206700|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
101206701|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
101206702|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206703|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206705|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
101206706|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206707|NCT01432873|Protective Agents|protective agents|mesh-ancestor
101206708|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206709|NCT01432873|Trace Elements|trace elements|mesh-ancestor
101206710|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
101206711|NCT01432977|Acetaminophen|acetaminophen|mesh-list
101206712|NCT01432977|Droperidol|droperidol|mesh-list
101206713|NCT01432977|Ondansetron|ondansetron|mesh-list
101206714|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101206715|NCT01432977|Analgesics|analgesics|mesh-ancestor
101206716|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
101206717|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206718|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206719|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
101206722|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206723|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
101206724|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206725|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101206726|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101206727|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
101206728|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206729|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206730|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101206731|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101206732|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101206733|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206734|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101206735|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101206742|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206744|NCT01433614|Capecitabine|capecitabine|mesh-list
101206745|NCT01433614|Epirubicin|epirubicin|mesh-list
101206746|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101206747|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206748|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
101206749|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
101206750|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
101206751|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206752|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206753|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
101206754|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101206755|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101206756|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101206757|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206758|NCT01433627|Hirudins|hirudins|mesh-list
101206759|NCT01433627|Bivalirudin|bivalirudin|mesh-list
101206760|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
101206761|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101206762|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
101206763|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206764|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206766|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101206767|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101206768|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
101206769|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101206770|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206771|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206772|NCT01433705|Regadenoson|regadenoson|mesh-list
101206773|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206774|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101206775|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101206776|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
101206777|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
101206778|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206779|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206780|NCT01433757|Ampicillin|ampicillin|mesh-list
101206781|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206782|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206783|NCT01433770|Alefacept|alefacept|mesh-list
101206784|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206786|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206788|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101206789|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
101206790|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206791|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
101206792|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206793|NCT01433900|Latanoprost|latanoprost|mesh-list
101206794|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101206795|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101206796|NCT01433952|Thiamine|thiamine|mesh-list
101206797|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
101206798|NCT01433952|Vitamins|vitamins|mesh-ancestor
101206799|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
101206800|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206801|NCT01434017|Dexamethasone|dexamethasone|mesh-list
101206802|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
101206803|NCT01434017|Droperidol|droperidol|mesh-list
101206804|NCT01434017|Ondansetron|ondansetron|mesh-list
101206805|NCT01434017|BB 1101|bb 1101|mesh-list
101206806|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101206807|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
101206808|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
101206809|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206816|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206817|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
101206818|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206819|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206820|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
101206821|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
101206822|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101206823|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101206824|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
101206825|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206826|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101206827|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101206828|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101206829|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206830|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101206831|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101206832|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101206833|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
101206835|NCT01434069|Fluorouracil|fluorouracil|mesh-list
101206836|NCT01434069|Pasireotide|pasireotide|mesh-list
101206837|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
101206838|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206839|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206840|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206841|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101206842|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
101206843|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206844|NCT01434069|Antidotes|antidotes|mesh-ancestor
101206845|NCT01434069|Protective Agents|protective agents|mesh-ancestor
101206846|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
101206847|NCT01434069|Vitamins|vitamins|mesh-ancestor
101206848|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
101206849|NCT01434069|Hormones|hormones|mesh-ancestor
101206850|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206851|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
101206852|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206853|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
101206854|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206855|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206856|NCT01434134|Metoprolol|metoprolol|mesh-list
101206857|NCT01434134|Candesartan|candesartan|mesh-list
101206858|NCT01434134|Candesartan cilexetil|candesartan cilexetil|mesh-list
101206859|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206860|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101206861|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
101206862|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
101206863|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206864|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206866|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101206867|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101206868|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206869|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206870|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206871|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101206872|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101206873|NCT01434147|Bevacizumab|bevacizumab|mesh-list
101206874|NCT01434147|Capecitabine|capecitabine|mesh-list
101206875|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
101206876|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101206877|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206878|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101206879|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101206884|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
101206885|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206886|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
101206887|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101206888|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
101206889|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206890|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206891|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101206892|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101206893|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101206894|NCT01434173|Amoxicillin|amoxicillin|mesh-list
101206895|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
101206896|NCT01434173|Clarithromycin|clarithromycin|mesh-list
101206897|NCT01434173|Doxycycline|doxycycline|mesh-list
101206898|NCT01434173|Levofloxacin|levofloxacin|mesh-list
101206899|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
101206900|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
101206901|NCT01434173|Cefuroxime|cefuroxime|mesh-list
101206902|NCT01434173|Telithromycin|telithromycin|mesh-list
101206903|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101206904|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206905|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206906|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101206907|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101206908|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206909|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206910|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206911|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101206912|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
101206913|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206914|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206915|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101206916|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101206917|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101206918|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101206919|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101206920|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101206921|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
101206922|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101206923|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101206924|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101206925|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101420842|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
101420843|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420844|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420845|NCT00148590|Memantine|memantine|mesh-list
101420846|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101420847|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101420848|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
101420849|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420850|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420851|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420852|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101206926|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101206927|NCT01434212|Interferons|interferons|mesh-list
101206929|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
101206930|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
101206931|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206932|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
101206933|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206934|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
101206935|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206936|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
101206937|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206938|NCT01434225|Bumetanide|bumetanide|mesh-list
101206939|NCT01434225|Diuretics|diuretics|mesh-ancestor
101206940|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
101206941|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206942|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101206943|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101206944|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206945|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
101206946|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101206947|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101206948|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101206949|NCT01434303|Trastuzumab|trastuzumab|mesh-list
101206950|NCT01434303|Lapatinib|lapatinib|mesh-list
101206960|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101206961|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206962|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206963|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101206964|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101206965|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
101206966|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206967|NCT01434381|Antacids|antacids|mesh-ancestor
101206968|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206969|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206970|NCT01434394|Cetuximab|cetuximab|mesh-list
101206971|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101206972|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206973|NCT01434459|Gemcitabine|gemcitabine|mesh-list
101206974|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206975|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
101206976|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206977|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206978|NCT01434849|Timolol|timolol|mesh-list
101206979|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206980|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101206981|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101206982|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206983|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206984|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206985|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206986|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101420853|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101206987|NCT01434862|Pramlintide|pramlintide|mesh-list
101206988|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
101206989|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101206990|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206991|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
101206992|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101206993|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
101206994|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206996|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101206997|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101206998|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101206999|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101207000|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207001|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207002|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207003|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207004|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101207005|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101207006|NCT01434901|Bethanechol|bethanechol|mesh-list
101207007|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101207008|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
101207009|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207010|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207011|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101207012|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101207013|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207014|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207015|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207016|NCT01434914|Octenidine|octenidine|mesh-list
101207017|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207029|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101207030|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207031|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101207032|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207033|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207034|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207035|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
101207036|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
101207037|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101207038|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101207039|NCT01435200|Hematinics|hematinics|mesh-ancestor
101207040|NCT01435213|Insulin|insulin|mesh-list
101207041|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101207042|NCT01435213|Ketamine|ketamine|mesh-list
101207043|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101207044|NCT01435213|Atipamezole|atipamezole|mesh-list
101207045|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207046|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207047|NCT01435213|Analgesics|analgesics|mesh-ancestor
101207048|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
101207049|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207050|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101207051|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207052|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
101207053|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
101207054|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207056|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101207057|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207058|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207059|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101207060|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101207061|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207062|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207063|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101207064|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101207065|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101207067|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207068|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207069|NCT01435291|Tacrolimus|tacrolimus|mesh-list
101207070|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207071|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
101207072|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207073|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101207074|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207075|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207077|NCT01435343|Plerixafor|plerixafor|mesh-list
101207078|NCT01435343|Fludarabine|fludarabine|mesh-list
101207079|NCT01435343|Idarubicin|idarubicin|mesh-list
101207080|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207081|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101207082|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
101207083|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207084|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207085|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
101207086|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207087|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
101207088|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207098|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207100|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101207101|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101207102|NCT01435395|Growth Substances|growth substances|mesh-ancestor
101207103|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207104|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
101207105|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101207106|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
101207107|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207108|NCT01435486|Caffeine|caffeine|mesh-list
101207109|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
101207110|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207111|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101207112|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207113|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101207114|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207115|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101207116|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101207117|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
101207118|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207120|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207121|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
101207122|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207123|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207124|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101207125|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
101207126|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207127|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207128|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101207129|NCT01435707|Triamcinolone|triamcinolone|mesh-list
101207130|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101207131|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101207132|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101207133|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207134|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
101207135|NCT01435707|Hormones|hormones|mesh-ancestor
101207136|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207137|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207138|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207139|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
101207140|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207141|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207142|NCT01435837|Caffeine|caffeine|mesh-list
101207143|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101207144|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207145|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101207146|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207147|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207148|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101207149|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101207150|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
101207151|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207153|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101207154|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101207161|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
101207162|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101207163|NCT01435941|Analgesics|analgesics|mesh-ancestor
101207164|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
101207165|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207166|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207167|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207168|NCT01435954|Doxazosin|doxazosin|mesh-list
101207169|NCT01435954|Tamsulosin|tamsulosin|mesh-list
101207170|NCT01435954|Finasteride|finasteride|mesh-list
101207171|NCT01435954|Silodosin|silodosin|mesh-list
101207172|NCT01435954|Terazosin|terazosin|mesh-list
101207173|NCT01435954|Alfuzosin|alfuzosin|mesh-list
101207174|NCT01435954|Dutasteride|dutasteride|mesh-list
101207175|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101207176|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101207177|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101207178|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207179|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207180|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207181|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207182|NCT01435954|Urological Agents|urological agents|mesh-ancestor
101207183|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101207184|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101207185|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207186|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
101207187|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207188|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101207189|NCT01435980|Exenatide|exenatide|mesh-list
101207190|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207191|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207192|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101207193|NCT01435980|Incretins|incretins|mesh-ancestor
101207194|NCT01435980|Hormones|hormones|mesh-ancestor
101207195|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207196|NCT01436123|Everolimus|everolimus|mesh-list
101207197|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101207198|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101207199|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207200|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207201|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207202|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
101207203|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207204|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207205|NCT01436188|Ibuprofen|ibuprofen|mesh-list
101207206|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101207207|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101207208|NCT01436188|Analgesics|analgesics|mesh-ancestor
101207209|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
101207210|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207211|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207212|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207213|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207214|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101207215|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207216|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207218|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
101207219|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207220|NCT01435902|Fluticasone|fluticasone|mesh-list
101207221|NCT01435902|Xhance|xhance|mesh-list
101207222|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207223|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101207224|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
101207231|NCT01436474|Varenicline|varenicline|mesh-list
101207232|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101207233|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101207234|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207235|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207236|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207237|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207238|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101207239|NCT01436513|Estrogens|estrogens|mesh-ancestor
101207241|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207242|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207243|NCT01436539|Adefovir|adefovir|mesh-list
101207244|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101207245|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
101207246|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
101420855|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
101420856|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101420857|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420858|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101420859|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
101420860|NCT00157131|Coagulants|coagulants|mesh-ancestor
101420861|NCT02954029|Hemostatics|hemostatics|mesh-list
101420862|NCT02954029|Coagulants|coagulants|mesh-ancestor
101420863|NCT00508456|Temozolomide|temozolomide|mesh-list
101420864|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101420866|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420868|NCT00508495|Acetaminophen|acetaminophen|mesh-list
101207247|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207248|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101207249|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101207250|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207251|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207252|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101207253|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
101207255|NCT01436578|Posaconazole|posaconazole|mesh-list
101207256|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
101207257|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207258|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101207260|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101207261|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101207262|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101207263|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207264|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207265|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101207266|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
101207267|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207268|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207270|NCT01436825|Coagulants|coagulants|mesh-ancestor
101207271|NCT01436838|Interferons|interferons|mesh-list
101207272|NCT01436838|Interferon-beta|interferon-beta|mesh-list
101207273|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
101207274|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207275|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
101207276|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207277|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
101207278|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207279|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101207280|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
101207281|NCT01436916|Vitamin D|vitamin d|mesh-list
101207282|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207283|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207284|NCT01436916|Vitamins|vitamins|mesh-ancestor
101207285|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
101207286|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101207287|NCT01436929|Silymarin|silymarin|mesh-list
101207288|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
101207289|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207291|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207292|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
101207293|NCT01436994|Carbimazole|carbimazole|mesh-list
101207294|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
101207295|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207296|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
101207309|NCT01437046|Doxazosin|doxazosin|mesh-list
101207310|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101207311|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101207312|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101207313|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101207314|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207315|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207316|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207317|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207318|NCT01437189|Sertraline|sertraline|mesh-list
101207319|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
101207320|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101207321|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101207322|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101207323|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207324|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207325|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207326|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
101207327|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207328|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
101207329|NCT01437228|Povidone|povidone|mesh-list
101207330|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
101207331|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
101207332|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101207333|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207334|NCT01437293|Carbidopa|carbidopa|mesh-list
101207335|NCT01437293|Entacapone|entacapone|mesh-list
101207336|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101207337|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101207338|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
101207339|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207340|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207342|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101207343|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207344|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101207345|NCT01437306|Lofexidine|lofexidine|mesh-list
101207346|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101207347|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101207348|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207349|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
101207350|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207351|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101207352|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101207353|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101207354|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207355|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207356|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207357|NCT01437371|Ramipril|ramipril|mesh-list
101207358|NCT01437371|Enalapril|enalapril|mesh-list
101207361|NCT01437371|Trandolapril|trandolapril|mesh-list
101207362|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101207363|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101207364|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
101207365|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207366|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101207367|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101207368|NCT01437371|Protective Agents|protective agents|mesh-ancestor
101207369|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207371|NCT01437462|Sevoflurane|sevoflurane|mesh-list
101207372|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207373|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207374|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207375|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207376|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
101207377|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
101207378|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101207379|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101207380|NCT01437566|Fulvestrant|fulvestrant|mesh-list
101207381|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101207382|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207383|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101207384|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101207385|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
101207386|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207387|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207388|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
101207389|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101207390|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207391|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207392|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207393|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207394|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207395|NCT01437592|Insulin|insulin|mesh-list
101207396|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207397|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207398|NCT01437618|Bevacizumab|bevacizumab|mesh-list
101207399|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207400|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207401|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101207402|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101207403|NCT01437618|Growth Substances|growth substances|mesh-ancestor
101207404|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207406|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
101207407|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101207408|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207409|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207410|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207411|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207412|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207413|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
101207414|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101207415|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101207416|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207417|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207418|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207419|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207420|NCT01437670|Urological Agents|urological agents|mesh-ancestor
101207422|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
101207424|NCT01437696|Vitamins|vitamins|mesh-list
101207425|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
101207426|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207427|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101207428|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207429|NCT01437748|Bromides|bromides|mesh-list
101207430|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
101207431|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101207432|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
101207433|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207434|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207439|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
101207440|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207441|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207442|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
101207443|NCT01437800|Metformin|metformin|mesh-list
101207444|NCT01437800|Glimepiride|glimepiride|mesh-list
101207445|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207446|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207447|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101207448|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207449|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
101207450|NCT01437813|Metformin|metformin|mesh-list
101207451|NCT01437813|Glimepiride|glimepiride|mesh-list
101207452|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207453|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207454|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101207455|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207456|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
101207457|NCT01437826|Selenium|selenium|mesh-list
101207458|NCT01437826|Antioxidants|antioxidants|mesh-list
101207459|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207460|NCT01437826|Protective Agents|protective agents|mesh-ancestor
101207461|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207462|NCT01437826|Trace Elements|trace elements|mesh-ancestor
101207463|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
101207464|NCT01437839|Apixaban|apixaban|mesh-list
101207465|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101207466|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
101207467|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101207468|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
101207469|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207470|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207471|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
101207472|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101207473|NCT01437982|Prednisolone|prednisolone|mesh-list
101207474|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101207475|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
101207476|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101207477|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
101207478|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101207479|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
101207480|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207481|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
101207482|NCT01437982|Hormones|hormones|mesh-ancestor
101207483|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207484|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207485|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101207486|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207487|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
101207488|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
101207489|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207490|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101207491|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101207492|NCT01437982|Protective Agents|protective agents|mesh-ancestor
101207493|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101207494|NCT01438021|Methotrexate|methotrexate|mesh-list
101207496|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
101207497|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101207498|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207499|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101207500|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
101207501|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207502|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207503|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
101207504|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207505|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101207506|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207507|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
101207508|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207509|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101207510|NCT01438086|Mecasermin|mecasermin|mesh-list
101207513|NCT01438112|Interferons|interferons|mesh-list
101207514|NCT01438112|Gemcitabine|gemcitabine|mesh-list
101207516|NCT01438112|Mitomycin|mitomycin|mesh-list
101207517|NCT01438112|Valrubicin|valrubicin|mesh-list
101207518|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101207519|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
101207520|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207521|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207522|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
101207523|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207524|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101207525|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
101207526|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101207527|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207528|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207529|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101207530|NCT01438190|Metformin|metformin|mesh-list
101207531|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207532|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207533|NCT01438320|Quercetin|quercetin|mesh-list
101207534|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
101207535|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207536|NCT01438320|Protective Agents|protective agents|mesh-ancestor
101207537|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207539|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101207540|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207541|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207542|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207543|NCT05554393|Cytarabine|cytarabine|mesh-list
101207544|NCT05554393|Azacitidine|azacitidine|mesh-list
101207545|NCT05554393|Daunorubicin|daunorubicin|mesh-list
101207546|NCT05554393|Venetoclax|venetoclax|mesh-list
101207547|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101207548|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
101207549|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207550|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207551|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
101207552|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207553|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207554|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
101207555|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207556|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207557|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101207558|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207559|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101207560|NCT05525013|Simvastatin|simvastatin|mesh-list
101207561|NCT05525013|Calcium|calcium|mesh-list
101207562|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207563|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207564|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101207565|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101207566|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
101207567|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207568|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101207569|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101207570|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207571|NCT05465174|Nivolumab|nivolumab|mesh-list
101207572|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207573|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207574|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101207575|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207576|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
101207577|NCT05418088|Fludarabine|fludarabine|mesh-list
101207578|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
101207579|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207580|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
101207581|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207582|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207583|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101207584|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
101207592|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101207593|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101207594|NCT05387525|Analgesics|analgesics|mesh-ancestor
101207595|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
101207596|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207597|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207598|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207599|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207600|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101207601|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207602|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207605|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
101207606|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101207607|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207608|NCT05371275|Palbociclib|palbociclib|mesh-list
101207609|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207610|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101207611|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207612|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207613|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101207614|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101207615|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207617|NCT05343507|Analgesics|analgesics|mesh-ancestor
101207618|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
101207619|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207620|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207621|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101207622|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207623|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
101207624|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
101207625|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207626|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101207627|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101207628|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207629|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207630|NCT05213832|Isoflurane|isoflurane|mesh-list
101207631|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101207632|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
101207633|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
101207634|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207635|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207636|NCT05164159|Propofol|propofol|mesh-list
101207637|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207638|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420869|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101207639|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207640|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207641|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
101207642|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
101207643|NCT05164146|Propofol|propofol|mesh-list
101207644|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207645|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207646|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207647|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207648|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
101207649|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
101207650|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
101207651|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207652|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207653|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207654|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101207661|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207662|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207663|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207664|NCT04965298|Lansoprazole|lansoprazole|mesh-list
101207665|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
101207666|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101207667|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101207668|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101207669|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207670|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207672|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101207673|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101207674|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
101207675|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207676|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207677|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207678|NCT04955470|Midazolam|midazolam|mesh-list
101207679|NCT04955470|Ketamine|ketamine|mesh-list
101207680|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101207681|NCT04955470|Analgesics|analgesics|mesh-ancestor
101207682|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
101207683|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207684|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207685|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101207686|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101207687|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
101207688|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
101207689|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207690|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101207691|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101207692|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207693|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207694|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101207695|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207696|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101207697|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101207698|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101207699|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
101207700|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
101207701|NCT04938557|Insulin|insulin|mesh-list
101207702|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101207703|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207704|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207705|NCT04922567|Prednisone|prednisone|mesh-list
101207706|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
101207707|NCT04922567|Doxorubicin|doxorubicin|mesh-list
101207708|NCT04922567|Vincristine|vincristine|mesh-list
101207709|NCT04922567|Lenalidomide|lenalidomide|mesh-list
101207710|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207711|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
101207712|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207713|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207714|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101207715|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
101207716|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207717|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207718|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101207719|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101420870|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101420871|NCT00508495|Analgesics|analgesics|mesh-ancestor
101420872|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
101420873|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101420874|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420876|NCT00508690|Metronidazole|metronidazole|mesh-list
101420878|NCT00508690|Cefmetazole|cefmetazole|mesh-list
101420879|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420881|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101420882|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101207720|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207721|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101207722|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207723|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207724|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
101207725|NCT04922567|Hormones|hormones|mesh-ancestor
101207726|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207727|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101207733|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101207734|NCT04922567|Growth Substances|growth substances|mesh-ancestor
101207735|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
101207741|NCT04850222|Calcium|calcium|mesh-list
101207742|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207743|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207744|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101207745|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101207746|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207747|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207748|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207749|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
101207750|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101207751|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
101207752|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101207753|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101207754|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101207755|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207757|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101207758|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101207759|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101207760|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207761|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101207762|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207763|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
101207764|NCT04787848|Bromides|bromides|mesh-list
101207765|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
101207766|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
101207767|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101207768|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207769|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
101207770|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207771|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
101207772|NCT04660799|Promethazine|promethazine|mesh-list
101207773|NCT04660799|Prednisone|prednisone|mesh-list
101207774|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
101207775|NCT04660799|Rituximab|rituximab|mesh-list
101207776|NCT04660799|Doxorubicin|doxorubicin|mesh-list
101207777|NCT04660799|Vincristine|vincristine|mesh-list
101207778|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101207779|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
101207780|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207781|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
101207782|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207783|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207784|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101207785|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
101207786|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207787|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207788|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101207789|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207790|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101207791|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207792|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101207793|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207794|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207795|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
101207796|NCT04660799|Hormones|hormones|mesh-ancestor
101207797|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207798|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101207799|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101207800|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
101207807|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207809|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
101207810|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
101207811|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
101207812|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101207813|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
101207814|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207815|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101207816|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
101207817|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101207818|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
101207820|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
101207821|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
101207822|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207823|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207824|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101207825|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101207826|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207827|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207828|NCT04597372|Tamsulosin|tamsulosin|mesh-list
101207829|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101207830|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101207831|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101207832|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
101207833|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207834|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207835|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207836|NCT04597372|Urological Agents|urological agents|mesh-ancestor
101207837|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101207838|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
101207839|NCT04585542|Laxatives|laxatives|mesh-ancestor
101207840|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101207841|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
101207842|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
101207843|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207844|NCT04545060|Sotrovimab|sotrovimab|mesh-list
101207845|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
101207846|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207847|NCT04502602|Niraparib|niraparib|mesh-list
101207850|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207851|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207852|NCT04375202|Colchicine|colchicine|mesh-list
101207853|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
101207854|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207855|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
101207856|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
101207858|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207859|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207860|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
101207861|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101207862|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101207863|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207864|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
101207865|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
101207866|NCT04332393|Metformin|metformin|mesh-list
101207867|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207868|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207869|NCT04329572|Azithromycin|azithromycin|mesh-list
101207870|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
101207871|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101207872|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207873|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
101207874|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101207882|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101207883|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207884|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207885|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101207886|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101207887|NCT04322552|Protective Agents|protective agents|mesh-ancestor
101207888|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207889|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
101207890|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207891|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207892|NCT04189848|Dulaglutide|dulaglutide|mesh-list
101207893|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207894|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207895|NCT04156334|Anesthetics|anesthetics|mesh-list
101207896|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207897|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207898|NCT04078906|SMOFlipid|smoflipid|mesh-list
101207899|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
101207900|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101207901|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101207902|NCT03980171|Lenalidomide|lenalidomide|mesh-list
101207903|NCT03980171|Venetoclax|venetoclax|mesh-list
101207904|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
101207905|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
101207906|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207907|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101207908|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101207909|NCT03980171|Growth Substances|growth substances|mesh-ancestor
101207910|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
101207911|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207912|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207913|NCT03979365|Tacrolimus|tacrolimus|mesh-list
101207914|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101207929|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207930|NCT03671746|Ketorolac|ketorolac|mesh-list
101207931|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101207932|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101207933|NCT03671746|Analgesics|analgesics|mesh-ancestor
101207934|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
101207935|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207936|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207937|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101207938|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207939|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101207940|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207941|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207942|NCT03558724|Bevacizumab|bevacizumab|mesh-list
101207943|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207944|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207945|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101207946|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101207947|NCT03558724|Growth Substances|growth substances|mesh-ancestor
101207948|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207949|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
101207951|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101207952|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207953|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101207954|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207955|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207956|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101207964|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207966|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101207967|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
101207968|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
101207969|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207970|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
101207971|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101207972|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207973|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101207974|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207975|NCT03232346|Buprenorphine|buprenorphine|mesh-list
101207976|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101207977|NCT03232346|Narcotics|narcotics|mesh-ancestor
101207978|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207979|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207980|NCT03232346|Analgesics|analgesics|mesh-ancestor
101207981|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
101207982|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207983|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101207984|NCT03227731|Tenofovir|tenofovir|mesh-list
101207985|NCT03227731|Emtricitabine|emtricitabine|mesh-list
101207986|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101207987|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
101207988|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207989|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101207990|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101207991|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207992|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207993|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101207994|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101207996|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207997|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207998|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
101207999|NCT03193281|Dasatinib|dasatinib|mesh-list
101208000|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208001|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208002|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208003|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208004|NCT03149640|Amikacin|amikacin|mesh-list
101208005|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101208006|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208007|NCT03098355|Interleukin-2|interleukin-2|mesh-list
101208008|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208009|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101208011|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
101208012|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208013|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208014|NCT02986334|Naproxen|naproxen|mesh-list
101208015|NCT02986334|Omeprazole|omeprazole|mesh-list
101208016|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101208017|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208018|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101208019|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208020|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208021|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101208022|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101208023|NCT02986334|Analgesics|analgesics|mesh-ancestor
101208024|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
101208025|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208026|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208029|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
101208030|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101208031|NCT02668289|Anesthetics|anesthetics|mesh-list
101208032|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208033|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208034|NCT02655315|Deferiprone|deferiprone|mesh-list
101208035|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101208036|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
101208037|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
101208038|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208039|NCT02572843|Durvalumab|durvalumab|mesh-list
101208040|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208041|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208042|NCT02436733|Pemetrexed|pemetrexed|mesh-list
101208043|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208044|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208045|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208046|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101208047|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208048|NCT02426502|Cyclosporine|cyclosporine|mesh-list
101208049|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
101208050|NCT02426502|Prednisone|prednisone|mesh-list
101208051|NCT02426502|Azathioprine|azathioprine|mesh-list
101208052|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
101208053|NCT02426502|Cyclosporins|cyclosporins|mesh-list
101208054|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208055|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
101208056|NCT02426502|Hormones|hormones|mesh-ancestor
101208057|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208058|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208059|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101208060|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208061|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208062|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208063|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208064|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
101208065|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
101208066|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208067|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
101208068|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208069|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101208070|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101208071|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101208072|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
101208073|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101208074|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
101208075|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208076|NCT02275156|Evolocumab|evolocumab|mesh-list
101208077|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101208078|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208079|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208080|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
101208081|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208082|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101208083|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208084|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208085|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208086|NCT02124902|Carboplatin|carboplatin|mesh-list
101208087|NCT02124902|Docetaxel|docetaxel|mesh-list
101208088|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208089|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208090|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208091|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208092|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208094|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
101208095|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101208096|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208097|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208098|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208099|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
101208100|NCT01877837|Fludarabine|fludarabine|mesh-list
101208101|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
101208111|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101208112|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
101208113|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101208114|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208115|NCT01781468|Modafinil|modafinil|mesh-list
101208116|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101208117|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208118|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101208119|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101208120|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101208121|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208122|NCT01624142|Evolocumab|evolocumab|mesh-list
101208123|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101208124|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208125|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208126|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
101208127|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208128|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101208129|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208130|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208131|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208132|NCT01375764|Ezetimibe|ezetimibe|mesh-list
101208133|NCT01375764|Evolocumab|evolocumab|mesh-list
101208134|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101208135|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208136|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208137|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
101208138|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208139|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208140|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101208141|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101208142|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208143|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208144|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
101208145|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208146|NCT00523341|Denosumab|denosumab|mesh-list
101208147|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101208148|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208149|NCT00364013|Panitumumab|panitumumab|mesh-list
101208150|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208152|NCT00345839|Cinacalcet|cinacalcet|mesh-list
101208153|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101208154|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208155|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101208156|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
101208157|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208158|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
101208160|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101208161|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208163|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208164|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208165|NCT01438359|Furosemide|furosemide|mesh-list
101208166|NCT01438359|Diuretics|diuretics|mesh-ancestor
101208167|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
101208168|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208169|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101208178|NCT01438515|Mupirocin|mupirocin|mesh-list
101208179|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101208180|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208181|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
101208182|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
101208183|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101208184|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
101208185|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101208186|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101208187|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101208188|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
101208189|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
101208190|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208191|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208192|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208193|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101208194|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101208195|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101208196|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101208197|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101208198|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101208199|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101208200|NCT01438554|Trametinib|trametinib|mesh-list
101208201|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208202|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208203|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208204|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208205|NCT01438567|Oxycodone|oxycodone|mesh-list
101208206|NCT01438567|Naloxone|naloxone|mesh-list
101208207|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101208208|NCT01438567|Narcotics|narcotics|mesh-ancestor
101208209|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208210|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208211|NCT01438567|Analgesics|analgesics|mesh-ancestor
101208212|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
101208213|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208214|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101208215|NCT01438580|Aspirin|aspirin|mesh-list
101208216|NCT01438580|Warfarin|warfarin|mesh-list
101208217|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101208218|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101208219|NCT01438580|Analgesics|analgesics|mesh-ancestor
101208220|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
101208221|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208222|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208223|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208224|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101420883|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101420884|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420885|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420886|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
101420887|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420888|NCT02953522|Folic Acid|folic acid|mesh-list
101420889|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
101420890|NCT02953522|Hematinics|hematinics|mesh-ancestor
101420891|NCT02953522|Vitamins|vitamins|mesh-ancestor
101420892|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
101208225|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101208226|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101208227|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208228|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101208229|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101208230|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208231|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
101208232|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
101208233|NCT01438632|Insulin|insulin|mesh-list
101208234|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208235|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208236|NCT01438723|Metformin|metformin|mesh-list
101208237|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208242|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
101208243|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101208244|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208245|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101208246|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101208247|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101208248|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101208249|NCT01438736|Progestins|progestins|mesh-ancestor
101208250|NCT01438736|Hormones|hormones|mesh-ancestor
101208251|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208252|NCT01438749|Diazepam|diazepam|mesh-list
101208253|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101208254|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
101208255|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
101208256|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
101208257|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208258|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208259|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208260|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101208261|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208262|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101208263|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101208264|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101208265|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101208266|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101208267|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101208269|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
101208270|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
101208271|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
101208272|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208273|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208274|NCT01438866|Fluorides|fluorides|mesh-list
101208275|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
101208276|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
101208277|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
101208278|NCT01438866|Protective Agents|protective agents|mesh-ancestor
101208279|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208280|NCT01438944|Nicotine|nicotine|mesh-list
101208281|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101208282|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
101208283|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208284|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208285|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101208286|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101208287|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
101420893|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420894|NCT00148746|Cyclosporine|cyclosporine|mesh-list
101420895|NCT00148746|Prednisolone|prednisolone|mesh-list
101420896|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
101208288|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208289|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208290|NCT01439100|Oxycodone|oxycodone|mesh-list
101208291|NCT01439100|Naloxone|naloxone|mesh-list
101208292|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101208293|NCT01439100|Narcotics|narcotics|mesh-ancestor
101208294|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208295|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208296|NCT01439100|Analgesics|analgesics|mesh-ancestor
101208297|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
101208298|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208299|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101208300|NCT01439152|Maytansine|maytansine|mesh-list
101208301|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
101208302|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
101208303|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
101208304|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208305|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101208306|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208307|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208308|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208309|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208310|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208311|NCT01439178|Bevacizumab|bevacizumab|mesh-list
101208317|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208318|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
101208319|NCT01439191|Vinorelbine|vinorelbine|mesh-list
101208320|NCT01439191|Antibodies|antibodies|mesh-list
101208321|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
101208322|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208323|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101208324|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208325|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208326|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208327|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208328|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208329|NCT01439230|Donepezil|donepezil|mesh-list
101208330|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101208332|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208333|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
101208334|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208335|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208336|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
101208337|NCT01439243|Donepezil|donepezil|mesh-list
101208338|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101208339|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208340|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208341|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
101208342|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208343|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208344|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
101208345|NCT01439399|Lidocaine|lidocaine|mesh-list
101208346|NCT01439399|Ketamine|ketamine|mesh-list
101208347|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
101208348|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
101208349|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208350|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208351|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
101208352|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208353|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101208354|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101208355|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101208356|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208357|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208359|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101208360|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101208361|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
101208362|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101208363|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101208364|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208365|NCT01439438|Topiramate|topiramate|mesh-list
101208366|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
101208367|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208368|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208369|NCT01439542|Hormones|hormones|mesh-list
101208370|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101208371|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208372|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208373|NCT01439750|Rituximab|rituximab|mesh-list
101208374|NCT01439750|Bortezomib|bortezomib|mesh-list
101208375|NCT01439750|Cladribine|cladribine|mesh-list
101208376|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208377|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208378|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
101208379|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208380|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208381|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208382|NCT01439984|Clomipramine|clomipramine|mesh-list
101208387|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101208388|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208389|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208390|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208391|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
101208392|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208394|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
101208395|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
101208397|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
101208398|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208399|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101208400|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101208401|NCT01440088|Doxorubicin|doxorubicin|mesh-list
101208402|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101208403|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101208404|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208405|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101208406|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101208407|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208408|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208409|NCT01440114|Fentanyl|fentanyl|mesh-list
101208410|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101208411|NCT01440114|Narcotics|narcotics|mesh-ancestor
101208412|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208413|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208414|NCT01440114|Analgesics|analgesics|mesh-ancestor
101208415|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
101208416|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208417|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101208418|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101208419|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
101208420|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
101208421|NCT01440127|Metformin|metformin|mesh-list
101208422|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208423|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208424|NCT01440140|Insulin|insulin|mesh-list
101208425|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208426|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208427|NCT01440270|Cetuximab|cetuximab|mesh-list
101208428|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208429|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208430|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101208431|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101208432|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208433|NCT01440335|Fenoterol|fenoterol|mesh-list
101208434|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101208435|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
101208436|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208437|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208438|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101208439|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
101208440|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
101208441|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
101208442|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101208443|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101208444|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101208445|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101208446|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
101208447|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208448|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208450|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208451|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
101208452|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208453|NCT01440400|Anesthetics|anesthetics|mesh-list
101208454|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208467|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
101208468|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
101208469|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208470|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208471|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208472|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
101208473|NCT01440582|Hormones|hormones|mesh-ancestor
101208474|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208475|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101208476|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208477|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
101208478|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101208479|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101208480|NCT01440582|Growth Substances|growth substances|mesh-ancestor
101208481|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
101208482|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101208483|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208484|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208485|NCT01440608|Albendazole|albendazole|mesh-list
101208486|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
101208487|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101208488|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208489|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
101208490|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101208491|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101208492|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208493|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208494|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208495|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208496|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208497|NCT01440621|Pyridoxine|pyridoxine|mesh-list
101208498|NCT01440621|Modafinil|modafinil|mesh-list
101208499|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101208500|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208501|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101208502|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101208503|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101208504|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208505|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
101208506|NCT01440621|Vitamins|vitamins|mesh-ancestor
101208507|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
101208508|NCT01440673|Aprepitant|aprepitant|mesh-list
101208509|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
101208510|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
101208511|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208512|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208513|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208514|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101208515|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208516|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208517|NCT01440725|Mitogens|mitogens|mesh-list
101208518|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208519|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208520|NCT01440751|Mitomycins|mitomycins|mesh-list
101208521|NCT01440751|Mitomycin|mitomycin|mesh-list
101208529|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
101208530|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
101208531|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208532|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
101208533|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208534|NCT01440790|Protective Agents|protective agents|mesh-ancestor
101208535|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
101208536|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101208537|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101208538|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208539|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208540|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208541|NCT01440842|Insulin|insulin|mesh-list
101208542|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101208543|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208544|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208545|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
101208546|NCT01440933|Analgesics|analgesics|mesh-ancestor
101208547|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
101208548|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208549|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208550|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
101208551|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208552|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101208553|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
101208554|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101208555|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208556|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208557|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101208558|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
101208559|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101208560|NCT01440985|Nicotine|nicotine|mesh-list
101208561|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101208562|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
101208563|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208564|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208565|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101208566|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101208567|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
101208568|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208569|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208572|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101208573|NCT01440998|Dasatinib|dasatinib|mesh-list
101208574|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101208575|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208576|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208577|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208578|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208579|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208580|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208581|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208582|NCT01441128|Crizotinib|crizotinib|mesh-list
101208583|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208584|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208585|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208586|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208587|NCT01441193|Vaccines|vaccines|mesh-list
101208588|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
101208589|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208590|NCT01441206|Rifampin|rifampin|mesh-list
101208594|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208595|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
101208596|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208597|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208598|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208599|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101208600|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101208601|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101208602|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101208603|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101208604|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101208605|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101208606|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
101208607|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208608|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208609|NCT01441232|Incretins|incretins|mesh-ancestor
101208610|NCT01441232|Hormones|hormones|mesh-ancestor
101208611|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208612|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101208613|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208614|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420897|NCT00148746|Prednicarbate|prednicarbate|mesh-list
101420898|NCT00148746|Tacrolimus|tacrolimus|mesh-list
101420899|NCT00148746|Cyclosporins|cyclosporins|mesh-list
101420900|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420901|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
101420902|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420903|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101420904|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420905|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420906|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
101420907|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420908|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
101420909|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208615|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208616|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101208617|NCT01441284|Pramipexole|pramipexole|mesh-list
101208618|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
101208619|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208620|NCT01441284|Protective Agents|protective agents|mesh-ancestor
101208621|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208622|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101208623|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101208624|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
101208625|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
101208626|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208627|NCT01441297|Nintedanib|nintedanib|mesh-list
101208628|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208629|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208630|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208631|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208634|NCT01441388|Sorafenib|sorafenib|mesh-list
101208635|NCT01441388|Axitinib|axitinib|mesh-list
101208636|NCT01441388|Crizotinib|crizotinib|mesh-list
101208637|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208638|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208639|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101208640|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101208641|NCT01441388|Growth Substances|growth substances|mesh-ancestor
101208642|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208643|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
101208644|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208645|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208646|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208647|NCT01441427|Lenograstim|lenograstim|mesh-list
101208648|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101208649|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
101208650|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208651|NCT01441505|Midazolam|midazolam|mesh-list
101208652|NCT01441505|Ketamine|ketamine|mesh-list
101208653|NCT01441505|Analgesics|analgesics|mesh-ancestor
101208654|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
101208655|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208656|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208657|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101208658|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101208659|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
101208660|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
101208661|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208668|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101208669|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101208670|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101208671|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
101208672|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
101208673|NCT01441531|Gabapentin|gabapentin|mesh-list
101208674|NCT01441531|Analgesics|analgesics|mesh-ancestor
101208675|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
101208676|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208677|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208679|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101208680|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101208681|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208682|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101208683|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101208684|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101208685|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208686|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208687|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
101208688|NCT01441557|Amifampridine|amifampridine|mesh-list
101208689|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101208690|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208691|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208692|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101208693|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208694|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208695|NCT01441700|Anesthetics|anesthetics|mesh-list
101208696|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208697|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208699|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101208700|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
101208702|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208703|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
101208704|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208705|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
101208706|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208707|NCT01441869|Metformin|metformin|mesh-list
101208708|NCT01441869|Saxagliptin|saxagliptin|mesh-list
101208709|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208710|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208711|NCT01441869|Incretins|incretins|mesh-ancestor
101208712|NCT01441869|Hormones|hormones|mesh-ancestor
101208713|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208714|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101208715|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
101208716|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208717|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208718|NCT01441908|Pravastatin|pravastatin|mesh-list
101208719|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208720|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208721|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
101208722|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208723|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208724|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101208725|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208726|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
101208727|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208728|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
101208729|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101208730|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101208737|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101208738|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101208739|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208740|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208741|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208742|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101208743|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101208744|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
101208745|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208746|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
101208747|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101208749|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
101208750|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208751|NCT01442025|Infliximab|infliximab|mesh-list
101208752|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101208753|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208754|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
101208755|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101420910|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420911|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
101420912|NCT00148746|Hormones|hormones|mesh-ancestor
101208756|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208757|NCT01442168|Atovaquone|atovaquone|mesh-list
101208759|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
101208760|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101208761|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101208762|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208763|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208764|NCT01442272|Calcifediol|calcifediol|mesh-list
101208765|NCT01442272|Vitamins|vitamins|mesh-ancestor
101208766|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
101208767|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208768|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101208769|NCT01442311|Interferons|interferons|mesh-list
101208770|NCT01442311|Ribavirin|ribavirin|mesh-list
101208771|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
101208772|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
101208773|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101208774|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208775|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
101208776|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208777|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
101208778|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208779|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
101208780|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208781|NCT01442428|Dexamethasone|dexamethasone|mesh-list
101208782|NCT01442428|Naproxen|naproxen|mesh-list
101208783|NCT01442428|Atorvastatin|atorvastatin|mesh-list
101208784|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208785|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
101208786|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
101208787|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208788|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208789|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101208790|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
101208791|NCT01442428|Hormones|hormones|mesh-ancestor
101208792|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101208793|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101208794|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208795|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208796|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208797|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
101208798|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208799|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208800|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101208801|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208802|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101208803|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101208805|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
101208806|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208812|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101208813|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208814|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
101208815|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208816|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208817|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208818|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101208819|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
101208820|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208822|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101208823|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101208824|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208825|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208826|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101208827|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101208828|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101208829|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101208830|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
101208831|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
101208832|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
101208833|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
101208834|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420913|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420914|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101420915|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208835|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208836|NCT01442558|Bupivacaine|bupivacaine|mesh-list
101208837|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
101208838|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
101208839|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208840|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208841|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
101208842|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208843|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
101208844|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101208845|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
101208846|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208847|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
101208848|NCT01442571|Protective Agents|protective agents|mesh-ancestor
101208849|NCT01442610|Rasagiline|rasagiline|mesh-list
101208850|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101208851|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208852|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208853|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101208854|NCT01442610|Protective Agents|protective agents|mesh-ancestor
101208855|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208856|NCT01442662|Gemcitabine|gemcitabine|mesh-list
101208857|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208858|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
101208859|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208860|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208861|NCT01442701|Triclosan|triclosan|mesh-list
101208862|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101208863|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208864|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101208866|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
101208867|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208868|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208869|NCT01442727|Selenium|selenium|mesh-list
101208870|NCT01442727|Selenious Acid|selenious acid|mesh-list
101208871|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
101208872|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
101208873|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208874|NCT01442727|Protective Agents|protective agents|mesh-ancestor
101208875|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208876|NCT01442727|Trace Elements|trace elements|mesh-ancestor
101208877|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
101208878|NCT01442766|Donepezil|donepezil|mesh-list
101208879|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101208880|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208890|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208892|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
101208893|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101208894|NCT01442870|Metformin|metformin|mesh-list
101208895|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208896|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208897|NCT01442909|Docetaxel|docetaxel|mesh-list
101208898|NCT01442909|Pemetrexed|pemetrexed|mesh-list
101208899|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208900|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208901|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208902|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208903|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208904|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208905|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101208906|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208907|NCT01442935|Leucovorin|leucovorin|mesh-list
101208908|NCT01442935|Folic Acid|folic acid|mesh-list
101208909|NCT01442935|Bevacizumab|bevacizumab|mesh-list
101208910|NCT01442935|Cetuximab|cetuximab|mesh-list
101208911|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
101208912|NCT01442935|Irinotecan|irinotecan|mesh-list
101208913|NCT01442935|Fluorouracil|fluorouracil|mesh-list
101208914|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
101208915|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208916|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208917|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101208918|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101208919|NCT01442935|Growth Substances|growth substances|mesh-ancestor
101208920|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208921|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
101208922|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101208923|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101208924|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208925|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208926|NCT01442935|Antidotes|antidotes|mesh-ancestor
101208927|NCT01442935|Protective Agents|protective agents|mesh-ancestor
101208928|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
101208930|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
101208931|NCT01442935|Hematinics|hematinics|mesh-ancestor
101208932|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
101208933|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208934|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208935|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
101208937|NCT01442974|Gemcitabine|gemcitabine|mesh-list
101208938|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101208939|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208940|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
101208941|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
101208942|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
101208943|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208944|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208945|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
101208946|NCT01442987|Irbesartan|irbesartan|mesh-list
101208947|NCT01442987|Atorvastatin|atorvastatin|mesh-list
101208948|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101208949|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101208950|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
101208951|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208956|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101208957|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101208962|NCT01443065|Fluorouracil|fluorouracil|mesh-list
101208963|NCT01443065|Rilotumumab|rilotumumab|mesh-list
101208964|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
101208965|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208966|NCT01443065|Antidotes|antidotes|mesh-ancestor
101208967|NCT01443065|Protective Agents|protective agents|mesh-ancestor
101208968|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208969|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
101208970|NCT01443065|Vitamins|vitamins|mesh-ancestor
101208971|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
101208972|NCT01443065|Hematinics|hematinics|mesh-ancestor
101208973|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208974|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
101208975|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208976|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208977|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208978|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
101208979|NCT01443104|Sirolimus|sirolimus|mesh-list
101208980|NCT01443104|Everolimus|everolimus|mesh-list
101208981|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101208982|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101208983|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208984|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208985|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208986|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
101208987|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208988|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208989|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101208990|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101208991|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101208992|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
101208993|NCT01443117|Vaccines|vaccines|mesh-list
101208994|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
101208995|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208996|NCT01443169|Pregabalin|pregabalin|mesh-list
101208997|NCT01443169|Analgesics|analgesics|mesh-ancestor
101208998|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
101208999|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209000|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209001|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
101209002|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101420917|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101420918|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101420920|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
101420921|NCT00148785|Ritonavir|ritonavir|mesh-list
101420922|NCT00148785|Indinavir|indinavir|mesh-list
101420923|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
101420924|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101209003|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209004|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209005|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101209006|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101209007|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209008|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209009|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209011|NCT01443195|Trace Elements|trace elements|mesh-ancestor
101209012|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
101209013|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209014|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101209015|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101209016|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101209017|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209018|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209019|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209020|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209021|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
101209022|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209023|NCT01443221|Metformin|metformin|mesh-list
101209024|NCT01443221|Mitiglinide|mitiglinide|mesh-list
101209025|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209033|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
101209034|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
101209035|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209036|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209037|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
101209038|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209039|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209040|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101209041|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101209042|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209043|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209044|NCT01443338|Acitretin|acitretin|mesh-list
101209045|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
101209046|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209047|NCT01443377|Panitumumab|panitumumab|mesh-list
101209048|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209049|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209050|NCT01443416|Vaccines|vaccines|mesh-list
101209051|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101209052|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
101209053|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209054|NCT01443429|Beraprost|beraprost|mesh-list
101209055|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209056|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
101209057|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101209058|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101209059|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101209060|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101209061|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209062|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209063|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209064|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209065|NCT01443520|Analgesics|analgesics|mesh-ancestor
101209066|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
101209067|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209068|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
101209069|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209070|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
101209071|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101209072|NCT01443572|Anesthetics|anesthetics|mesh-list
101209073|NCT01443572|Sevoflurane|sevoflurane|mesh-list
101209074|NCT01443572|Desflurane|desflurane|mesh-list
101209075|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209076|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209077|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209078|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101209079|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
101209082|NCT01443650|Alirocumab|alirocumab|mesh-list
101209083|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101209084|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209085|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209086|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
101209087|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209088|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209089|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209090|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209091|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209092|NCT01443676|Bevacizumab|bevacizumab|mesh-list
101209093|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209094|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209102|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209103|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209105|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
101209106|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209107|NCT01443780|Protective Agents|protective agents|mesh-ancestor
101209108|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209109|NCT01443780|Trace Elements|trace elements|mesh-ancestor
101209110|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
101209111|NCT01443806|Oseltamivir|oseltamivir|mesh-list
101209112|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
101209113|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209114|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209115|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209116|NCT01443897|Vitamin D|vitamin d|mesh-list
101209117|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
101209118|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
101209119|NCT01443897|Vitamins|vitamins|mesh-list
101209120|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
101209121|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209122|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101209123|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101209124|NCT01443988|Travoprost|travoprost|mesh-list
101209125|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209126|NCT01444001|Vaccines|vaccines|mesh-list
101209127|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101209128|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
101209129|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209130|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
101209131|NCT01444118|Vaccines|vaccines|mesh-list
101209132|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101209133|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
101209134|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209135|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209136|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209137|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101209138|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
101209139|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209140|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209141|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101209142|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101209143|NCT01444131|Nicotine|nicotine|mesh-list
101209144|NCT01444131|Varenicline|varenicline|mesh-list
101209145|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101209146|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
101209147|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209149|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101209150|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101209151|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
101209152|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209153|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209155|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101209156|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
101209157|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209158|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209159|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209160|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101209161|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101209162|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
101209163|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
101209164|NCT01444248|Metformin|metformin|mesh-list
101209165|NCT01444248|Glimepiride|glimepiride|mesh-list
101209174|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209175|NCT01444352|Vaccines|vaccines|mesh-list
101209176|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101209177|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
101209178|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209179|NCT01444469|Azithromycin|azithromycin|mesh-list
101209180|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209181|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209182|NCT01444521|Irinotecan|irinotecan|mesh-list
101209183|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209184|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101209186|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209187|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209188|NCT01444547|Paclitaxel|paclitaxel|mesh-list
101209189|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101209190|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101209191|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209192|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
101209193|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
101209194|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
101209195|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209196|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
101209197|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101209198|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
101209199|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209200|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209201|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209202|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209203|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
101209205|NCT01444612|Calcium heparin|calcium heparin|mesh-list
101209206|NCT01444612|Enoxaparin|enoxaparin|mesh-list
101209207|NCT01444612|Dalteparin|dalteparin|mesh-list
101209208|NCT01444612|Tinzaparin|tinzaparin|mesh-list
101209209|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101209211|NCT01444612|Fondaparinux|fondaparinux|mesh-list
101209213|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101209214|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101209215|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209216|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101209217|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
101209218|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209219|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209220|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209221|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
101209222|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209223|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101209224|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101209225|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209226|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209227|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
101209228|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101209229|NCT01444807|Sorafenib|sorafenib|mesh-list
101209230|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209231|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101209232|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209233|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209234|NCT01444833|Candesartan|candesartan|mesh-list
101209235|NCT01444833|Candesartan cilexetil|candesartan cilexetil|mesh-list
101209236|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209241|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101209242|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209243|NCT01444846|Analgesics|analgesics|mesh-ancestor
101209244|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
101209245|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209246|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209247|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101209248|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209249|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101420925|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101420926|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209250|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101209251|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
101209252|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209253|NCT01444846|Protective Agents|protective agents|mesh-ancestor
101209254|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101209255|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209256|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101209258|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
101209259|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209260|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101209261|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209262|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209263|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101209264|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209265|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
101209266|NCT01444976|Midazolam|midazolam|mesh-list
101209267|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
101209268|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209269|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209270|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101209271|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101209272|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101209273|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209274|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209276|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
101209277|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
101209278|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
101209279|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209280|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209282|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101209283|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101209284|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209285|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209286|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209287|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101209288|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101209289|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
101209290|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209291|NCT01445119|Carboplatin|carboplatin|mesh-list
101209292|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209293|NCT01445210|Ropivacaine|ropivacaine|mesh-list
101209294|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
101209295|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
101209296|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209297|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209298|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
101209299|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209300|NCT01445223|Ritonavir|ritonavir|mesh-list
101209301|NCT01445223|Lopinavir|lopinavir|mesh-list
101209302|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101209303|NCT01445223|Efavirenz|efavirenz|mesh-list
101209304|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101209305|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101209306|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209307|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209308|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209309|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101209317|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101209318|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101209319|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101209320|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101209321|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101209323|NCT01445236|Tacrolimus|tacrolimus|mesh-list
101209324|NCT01445236|Cyclosporins|cyclosporins|mesh-list
101209325|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209326|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
101209327|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209328|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101209329|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209330|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209331|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
101420927|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420928|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420929|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101420930|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101420931|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
101420932|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420933|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101420934|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101420935|NCT00148824|Vaccines|vaccines|mesh-list
101420936|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101420937|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
101209332|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209333|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209334|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209335|NCT01445262|Levocetirizine|levocetirizine|mesh-list
101209336|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101209337|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101209339|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
101209341|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209342|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209343|NCT01445340|Romidepsin|romidepsin|mesh-list
101209344|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101209345|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209346|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101209347|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209348|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209349|NCT01445379|Ipilimumab|ipilimumab|mesh-list
101209350|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209351|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209352|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101209353|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209354|NCT01445392|Pemetrexed|pemetrexed|mesh-list
101209355|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101209356|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209357|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209358|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209359|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101209360|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101209362|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209363|NCT01445405|Cetuximab|cetuximab|mesh-list
101209364|NCT01445405|Bortezomib|bortezomib|mesh-list
101209365|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209366|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209367|NCT01445418|Carboplatin|carboplatin|mesh-list
101209368|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209369|NCT01445431|Mineral Oil|mineral oil|mesh-list
101209370|NCT01445431|Emollients|emollients|mesh-ancestor
101209371|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209372|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
101209373|NCT01445522|Veliparib|veliparib|mesh-list
101209375|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
101209376|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209377|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209378|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101209379|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
101209380|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209387|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209388|NCT01445561|Analgesics|analgesics|mesh-ancestor
101209389|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
101209390|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209391|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209392|NCT01445587|Bortezomib|bortezomib|mesh-list
101209393|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209394|NCT01445600|Retapamulin|retapamulin|mesh-list
101209395|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209396|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209397|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
101209398|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101209399|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209400|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209401|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209402|NCT01445639|Analgesics|analgesics|mesh-ancestor
101209403|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
101209404|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209405|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101209406|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101209421|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209423|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209424|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209425|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101209426|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101209427|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209428|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209430|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209431|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209432|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
101209433|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209434|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209435|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101209436|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209437|NCT01445938|Lumefantrine|lumefantrine|mesh-list
101209438|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
101209439|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101209440|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101209441|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209442|NCT01445964|Atenolol|atenolol|mesh-list
101209443|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209444|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209445|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
101209446|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
101209447|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209448|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209449|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101209450|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101209451|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101209452|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
101209453|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209455|NCT01446094|Regadenoson|regadenoson|mesh-list
101209456|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101209457|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101209458|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
101209459|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
101209460|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209461|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209462|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209463|NCT01446107|Fluorides|fluorides|mesh-list
101209464|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
101209465|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
101209471|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
101209472|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
101209473|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209474|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209477|NCT01446211|Methotrexate|methotrexate|mesh-list
101209478|NCT01446211|Azathioprine|azathioprine|mesh-list
101209479|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
101209480|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209481|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
101209482|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209483|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209484|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101209485|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
101209486|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209487|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209488|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101209489|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101209490|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
101209491|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101209492|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101209493|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
101209494|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209495|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209496|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101209497|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101209498|NCT01446211|Hormones|hormones|mesh-ancestor
101209499|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101209500|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101209501|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209502|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101209503|NCT01446211|Protective Agents|protective agents|mesh-ancestor
101209504|NCT01446276|Resveratrol|resveratrol|mesh-list
101209505|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
101209506|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209507|NCT01446276|Protective Agents|protective agents|mesh-ancestor
101209508|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209509|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209510|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209511|NCT01446328|Olanzapine|olanzapine|mesh-list
101209512|NCT01446328|Aripiprazole|aripiprazole|mesh-list
101209513|NCT01446328|Amisulpride|amisulpride|mesh-list
101209515|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
101209516|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209517|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209518|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101209519|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101209520|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209521|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209522|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209523|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101209524|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101209525|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101209526|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209527|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209528|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
101209529|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
101209531|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
101209532|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101209533|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101209534|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101209535|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101209536|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101209537|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101209542|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
101209543|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209544|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101209545|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209546|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209547|NCT01446458|Folfirinox|folfirinox|mesh-list
101209548|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209549|NCT01446484|Cyclosporine|cyclosporine|mesh-list
101209550|NCT01446484|Sirolimus|sirolimus|mesh-list
101209551|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
101209552|NCT01446484|Everolimus|everolimus|mesh-list
101209553|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
101209554|NCT01446484|Tacrolimus|tacrolimus|mesh-list
101209555|NCT01446484|Cyclosporins|cyclosporins|mesh-list
101209556|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209557|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
101209558|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209559|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101209560|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209561|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209562|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
101209563|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209564|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209565|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209566|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101209567|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101209568|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209569|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101209570|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101209572|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209573|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209574|NCT01446497|Timolol|timolol|mesh-list
101209575|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101209576|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101209577|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101209578|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
101209579|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209580|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209581|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209582|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209583|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209584|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101209585|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101209586|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101209588|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101209589|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101209590|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
101209591|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209592|NCT01446679|Atorvastatin|atorvastatin|mesh-list
101209593|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209594|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209595|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
101209596|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209597|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209598|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101209599|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209600|NCT01446731|Docetaxel|docetaxel|mesh-list
101209601|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209602|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
101209603|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
101209604|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
101209605|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209606|NCT01446783|Mecasermin|mecasermin|mesh-list
101209607|NCT01446783|Growth Substances|growth substances|mesh-ancestor
101209608|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209609|NCT01446900|Rituximab|rituximab|mesh-list
101209610|NCT01446900|Cladribine|cladribine|mesh-list
101209611|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209617|NCT01446926|Vaccines|vaccines|mesh-list
101209618|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101209619|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
101209620|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209621|NCT01446952|Vitamin E|vitamin e|mesh-list
101209622|NCT01446952|Tocopherols|tocopherols|mesh-list
101209623|NCT01446952|Tocotrienols|tocotrienols|mesh-list
101209624|NCT01446952|Vitamins|vitamins|mesh-ancestor
101209625|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
101209626|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209627|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
101209628|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209629|NCT01446952|Protective Agents|protective agents|mesh-ancestor
101209630|NCT01446978|Vaccines|vaccines|mesh-list
101209631|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
101209632|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209633|NCT01447043|Ranibizumab|ranibizumab|mesh-list
101209634|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101209637|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209638|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
101209639|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209640|NCT01447069|Albuterol|albuterol|mesh-list
101209641|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101209642|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
101209643|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209644|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209645|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101209646|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
101209647|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
101209648|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101209649|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101209650|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101209651|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101209652|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
101209653|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209654|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209655|NCT01447095|Epoprostenol|epoprostenol|mesh-list
101209657|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101420938|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420939|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
101420940|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
101420941|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101420942|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101420943|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101420944|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101420945|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420946|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209658|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209659|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
101209660|NCT01447160|Cortisone|cortisone|mesh-list
101209661|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101209662|NCT01447173|Vitamin D|vitamin d|mesh-list
101209663|NCT01447173|Vitamins|vitamins|mesh-ancestor
101209664|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
101209665|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209666|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101209667|NCT01447212|Hydromorphone|hydromorphone|mesh-list
101209668|NCT01447212|Heroin|heroin|mesh-list
101209669|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101209670|NCT01447212|Narcotics|narcotics|mesh-ancestor
101209671|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209672|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209673|NCT01447212|Analgesics|analgesics|mesh-ancestor
101209674|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
101209675|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209676|NCT01447355|Vitamin D|vitamin d|mesh-list
101209677|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
101209678|NCT01447355|Vitamins|vitamins|mesh-ancestor
101209679|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
101209680|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209681|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101209682|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101209683|NCT01447368|Cinacalcet|cinacalcet|mesh-list
101209684|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101209685|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209686|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101209687|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
101209693|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101209694|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209695|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
101209696|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209697|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
101209698|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209700|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209701|NCT01447485|Valsartan|valsartan|mesh-list
101209702|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209703|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101209704|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101209705|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209706|NCT01447550|Bosentan|bosentan|mesh-list
101209707|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209708|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101209709|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209710|NCT01447563|Clopidogrel|clopidogrel|mesh-list
101209711|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209712|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101209713|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101209714|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101209715|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
101209716|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209717|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209718|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209720|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101209721|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101209722|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209723|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209724|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209725|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101209726|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101209727|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
101209728|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209729|NCT01447654|Losartan|losartan|mesh-list
101209730|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209731|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209732|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101209733|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101209734|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209735|NCT01447797|Irbesartan|irbesartan|mesh-list
101209736|NCT01447797|Atorvastatin|atorvastatin|mesh-list
101209737|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209738|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209739|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
101209740|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209741|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209742|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101209743|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209744|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209745|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101209746|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101209747|NCT01447862|Ibutilide|ibutilide|mesh-list
101209748|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209749|NCT01447875|Propofol|propofol|mesh-list
101209750|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101209751|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209752|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209753|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101209754|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
101209755|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
101209756|NCT01447979|Pancrelipase|pancrelipase|mesh-list
101209757|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101209762|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209763|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
101209764|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209765|NCT01448031|Esomeprazole|esomeprazole|mesh-list
101209766|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101209767|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101209768|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101209769|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209770|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209771|NCT01448070|Insulin|insulin|mesh-list
101209772|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101209773|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209774|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209775|NCT01448096|Rituximab|rituximab|mesh-list
101209776|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101209777|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209778|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
101209779|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209780|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209781|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
101209782|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101209783|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101209784|NCT01448174|Atorvastatin|atorvastatin|mesh-list
101209785|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209786|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209787|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
101209788|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209789|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209790|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101209791|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209792|NCT01448239|Alirocumab|alirocumab|mesh-list
101209793|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101209794|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101209795|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209796|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209797|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
101209798|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209799|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209800|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209801|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209802|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209803|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
101209804|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209805|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101209806|NCT01448291|Etonogestrel|etonogestrel|mesh-list
101209807|NCT01448291|NuvaRing|nuvaring|mesh-list
101209808|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
101209809|NCT01448291|Estradiol|estradiol|mesh-list
101209810|NCT01448291|Estrogens|estrogens|mesh-ancestor
101209811|NCT01448291|Hormones|hormones|mesh-ancestor
101209812|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101209813|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209814|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101209815|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101209816|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101209817|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101209818|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101209819|NCT01448304|Alirocumab|alirocumab|mesh-list
101209820|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101209821|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209822|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209823|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
101209824|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209825|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209826|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209827|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209828|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209829|NCT01448317|Alirocumab|alirocumab|mesh-list
101209830|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101209837|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101209838|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
101209839|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209840|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209841|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
101209842|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209844|NCT01448330|Clopidogrel|clopidogrel|mesh-list
101209845|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101209846|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209847|NCT01448330|Analgesics|analgesics|mesh-ancestor
101209848|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
101209849|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209850|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209851|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101209852|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209853|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101209854|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101209855|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209856|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209857|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101209858|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209859|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
101209860|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101209861|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101209862|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101209863|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
101209864|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209865|NCT01448395|Avibactam|avibactam|mesh-list
101209866|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101209867|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209868|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209869|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209870|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209871|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
101209872|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101209873|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101209874|NCT01448499|Clozapine|clozapine|mesh-list
101209875|NCT01448499|Amisulpride|amisulpride|mesh-list
101209876|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101209877|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
101209878|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209879|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209880|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209881|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101209882|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209883|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209884|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209885|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
101209886|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
101209887|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101209888|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
101209889|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101209890|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
101209891|NCT01448642|Atorvastatin|atorvastatin|mesh-list
101209893|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209894|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
101209895|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209896|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101209897|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101209898|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209899|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
101209900|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101209901|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101209904|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209905|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101209906|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101209908|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209909|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209910|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101209911|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101209912|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
101209913|NCT01448733|Clindamycin|clindamycin|mesh-list
101209914|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
101209915|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
101209917|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101209918|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209919|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209920|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101209921|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209922|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209923|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
101209924|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209925|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
101209926|NCT01448746|Heparin|heparin|mesh-list
101209927|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101209928|NCT01448746|Tinzaparin|tinzaparin|mesh-list
101209929|NCT01448746|Dalteparin|dalteparin|mesh-list
101209930|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
101209931|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101209932|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101209933|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209934|NCT01448772|Dronabinol|dronabinol|mesh-list
101209935|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
101209936|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209937|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101209938|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101209939|NCT01448772|Analgesics|analgesics|mesh-ancestor
101209940|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
101209941|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101209942|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101209943|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101209944|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209945|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209946|NCT01448772|Hormones|hormones|mesh-ancestor
101209947|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101209948|NCT01448798|Thrombin|thrombin|mesh-list
101209949|NCT01448798|Hemostatics|hemostatics|mesh-list
101209950|NCT01448798|Coagulants|coagulants|mesh-ancestor
101209951|NCT01448837|Timolol|timolol|mesh-list
101209953|NCT01448837|Latanoprost|latanoprost|mesh-list
101209954|NCT01448837|Cloprostenol|cloprostenol|mesh-list
101209955|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101209956|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101209957|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
101209958|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101209959|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209960|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209961|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209962|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101209963|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101209964|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101209965|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
101209966|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101209967|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
101209968|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101209969|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101209970|NCT01448993|Azithromycin|azithromycin|mesh-list
101209971|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209972|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209973|NCT01449045|Lumefantrine|lumefantrine|mesh-list
101209975|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
101209976|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
101209977|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101209983|NCT01449110|Protective Agents|protective agents|mesh-ancestor
101209984|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209985|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209986|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101209988|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101209989|NCT01449123|Diuretics|diuretics|mesh-ancestor
101209990|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
101209991|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209992|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101209993|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209994|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
101209995|NCT01449188|Ondansetron|ondansetron|mesh-list
101209996|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101209997|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209998|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101209999|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101210000|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210001|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210002|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210003|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210004|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
101210005|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
101210006|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210007|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210008|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
101210009|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
101210010|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101210011|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101210013|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210014|NCT01449253|Bosentan|bosentan|mesh-list
101210015|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
101210016|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
101210017|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101210018|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101210019|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210020|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210021|NCT01449253|Urological Agents|urological agents|mesh-ancestor
101210022|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101210023|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101210025|NCT01449344|Dexamethasone|dexamethasone|mesh-list
101210026|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
101210027|NCT01449344|Rituximab|rituximab|mesh-list
101210028|NCT01449344|Bortezomib|bortezomib|mesh-list
101210029|NCT01449344|BB 1101|bb 1101|mesh-list
101210030|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210031|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210032|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
101210033|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210034|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210035|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210036|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
101210037|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
101210038|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210039|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210040|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
101210041|NCT01449344|Hormones|hormones|mesh-ancestor
101210042|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210043|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210044|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
101210045|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210046|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210047|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101210048|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
101210049|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
101210050|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210053|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210054|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210055|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
101210056|NCT01449435|Miotics|miotics|mesh-ancestor
101210057|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
101210058|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210059|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210060|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101210061|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101210062|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
101210063|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101210064|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101210065|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
101210066|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210067|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210068|NCT01449448|Triamcinolone|triamcinolone|mesh-list
101210070|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210071|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
101210072|NCT01449448|Hormones|hormones|mesh-ancestor
101210073|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210074|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210075|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210076|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210077|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210079|NCT01449448|Analgesics|analgesics|mesh-ancestor
101210081|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210082|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210083|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210084|NCT01447992|Pancrelipase|pancrelipase|mesh-list
101210085|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210086|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
101210087|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101210088|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210089|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210090|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
101210091|NCT01449552|Coagulants|coagulants|mesh-ancestor
101210092|NCT01449565|Naltrexone|naltrexone|mesh-list
101210093|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101210094|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101210095|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210096|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
101210097|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210098|NCT01449578|Pramipexole|pramipexole|mesh-list
101210099|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
101210100|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210101|NCT01449578|Protective Agents|protective agents|mesh-ancestor
101210102|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210103|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101210104|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101210105|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
101210106|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
101210107|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210109|NCT01449617|Clopidogrel|clopidogrel|mesh-list
101210110|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210111|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210112|NCT01449617|Analgesics|analgesics|mesh-ancestor
101210113|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
101210114|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210115|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210116|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210117|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210118|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210119|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210120|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210121|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101210122|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210123|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210124|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
101210125|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101210126|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101210127|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101210135|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210136|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420947|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420948|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101420949|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101420950|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101420951|NCT00466609|Fluoxetine|fluoxetine|mesh-list
101420952|NCT00466609|Clomipramine|clomipramine|mesh-list
101420953|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
101420954|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210137|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101210138|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
101210139|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101210140|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101210141|NCT01449825|Bevacizumab|bevacizumab|mesh-list
101210142|NCT01449825|Sunitinib|sunitinib|mesh-list
101210143|NCT01449825|Sorafenib|sorafenib|mesh-list
101210144|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210145|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210146|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101210147|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101210148|NCT01449825|Growth Substances|growth substances|mesh-ancestor
101210149|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210150|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
101210151|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101210152|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210153|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210154|NCT01449877|Trimethoprim|trimethoprim|mesh-list
101210155|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101210156|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
101210157|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101210158|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210159|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
101210160|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101210161|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101210162|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101210163|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210164|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210165|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101210166|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101210167|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101210168|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210169|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
101210170|NCT01450163|Pregabalin|pregabalin|mesh-list
101210171|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210172|NCT01450163|Analgesics|analgesics|mesh-ancestor
101210173|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
101210174|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210175|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210176|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
101210177|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101210178|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210179|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210180|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101210181|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101210182|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101210183|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210184|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210185|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101210186|NCT01450995|Sumatriptan|sumatriptan|mesh-list
101210187|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101210188|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101210189|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101210190|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
101210191|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210192|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210193|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210194|NCT01451320|Plasminogen|plasminogen|mesh-list
101210195|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101420955|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101210199|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210200|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
101210201|NCT01451489|Tacrolimus|tacrolimus|mesh-list
101210202|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210203|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
101210204|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210205|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210206|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210207|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
101210208|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210209|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210210|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101210211|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101210212|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210213|NCT01451853|Ebselen|ebselen|mesh-list
101210214|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210215|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210216|NCT01451853|Analgesics|analgesics|mesh-ancestor
101210217|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
101210218|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210219|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210220|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210221|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210222|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101210223|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210224|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
101210225|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210226|NCT01451853|Protective Agents|protective agents|mesh-ancestor
101210227|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210228|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210229|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101210230|NCT01452243|Vitamin D|vitamin d|mesh-list
101210231|NCT01452243|Calcium|calcium|mesh-list
101210232|NCT01452243|Vitamins|vitamins|mesh-ancestor
101210233|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
101210234|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210235|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101210236|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101210237|NCT01452256|Propofol|propofol|mesh-list
101210238|NCT01452256|Desflurane|desflurane|mesh-list
101210239|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101210240|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210241|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210242|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101210243|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
101210244|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
101210245|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101210246|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101210247|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101210248|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
101210249|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210250|NCT01452607|Ebselen|ebselen|mesh-list
101210251|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210252|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210253|NCT01452607|Analgesics|analgesics|mesh-ancestor
101210254|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
101210255|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210256|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210257|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210258|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210259|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101210260|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210261|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
101210262|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210263|NCT01452607|Protective Agents|protective agents|mesh-ancestor
101210264|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210265|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210266|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101210267|NCT01453062|Ofatumumab|ofatumumab|mesh-list
101210268|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210269|NCT01453283|Trabectedin|trabectedin|mesh-list
101210272|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210273|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210275|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101210276|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101210277|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210278|NCT01454869|Heparin|heparin|mesh-list
101210279|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
101210280|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210281|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210282|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210284|NCT05964413|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101210285|NCT05964413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210286|NCT05964413|Immunologic Factors|immunologic factors|mesh-ancestor
101210287|NCT05964413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210289|NCT05964387|Epinephrine|epinephrine|mesh-list
101210290|NCT05964387|Anesthetics, Local|anesthetics, local|mesh-ancestor
101210291|NCT05964387|Anesthetics|anesthetics|mesh-ancestor
101210292|NCT05964387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210293|NCT05964387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210294|NCT05964387|Sensory System Agents|sensory system agents|mesh-ancestor
101210295|NCT05964387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210296|NCT05964387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101210297|NCT05964387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101210298|NCT05964387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101210299|NCT05964387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210300|NCT05964387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210301|NCT05964387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101210302|NCT05964387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101210303|NCT05964387|Adrenergic Agents|adrenergic agents|mesh-ancestor
101210304|NCT05964387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210305|NCT05964387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101210306|NCT05964387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101210307|NCT05964387|Autonomic Agents|autonomic agents|mesh-ancestor
101210308|NCT05964387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101210309|NCT05964387|Respiratory System Agents|respiratory system agents|mesh-ancestor
101210310|NCT05964387|Mydriatics|mydriatics|mesh-ancestor
101210311|NCT05964387|Sympathomimetics|sympathomimetics|mesh-ancestor
101210312|NCT05964387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101210313|NCT05964361|Vaccines|vaccines|mesh-list
101210314|NCT05964361|Immunologic Factors|immunologic factors|mesh-ancestor
101210315|NCT05964361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210316|NCT05964257|Botulinum Toxins|botulinum toxins|mesh-list
101210317|NCT05964257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101210318|NCT05964257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101210319|NCT05964257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101210320|NCT05964257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210321|NCT05964257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210323|NCT05964257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210324|NCT05964257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210325|NCT05964257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101210326|NCT05964257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210327|NCT05964140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101210328|NCT05964140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210329|NCT05964114|Vancomycin|vancomycin|mesh-list
101210330|NCT05964114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210331|NCT05964114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210332|NCT05964101|Paclitaxel|paclitaxel|mesh-list
101210333|NCT05964101|Carboplatin|carboplatin|mesh-list
101210334|NCT05964101|Nivolumab|nivolumab|mesh-list
101210335|NCT05964101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210336|NCT05964101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210337|NCT05964101|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210338|NCT05964101|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210339|NCT05964101|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210340|NCT05964101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210341|NCT05964101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210342|NCT05964101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101210343|NCT05963984|Fulvestrant|fulvestrant|mesh-list
101210344|NCT05963984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210346|NCT05963984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101210347|NCT05963984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101210348|NCT05963984|Hormone Antagonists|hormone antagonists|mesh-ancestor
101210349|NCT05963984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210350|NCT05963984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210351|NCT05963711|Chlorhexidine|chlorhexidine|mesh-list
101210352|NCT05963711|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101210353|NCT05963711|Clindamycin|clindamycin|mesh-list
101420956|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101420957|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101420958|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420959|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101420960|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101420961|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101420962|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420963|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101420964|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
101420965|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101420966|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101210354|NCT05963711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101210355|NCT05963711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210356|NCT05963711|Disinfectants|disinfectants|mesh-ancestor
101210357|NCT05963711|Dermatologic Agents|dermatologic agents|mesh-ancestor
101210358|NCT05963711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210359|NCT05963711|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101210360|NCT05963711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210361|NCT05963711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210363|NCT05963347|Cyclophosphamide|cyclophosphamide|mesh-list
101210364|NCT05963347|Doxorubicin|doxorubicin|mesh-list
101210365|NCT05963347|Vincristine|vincristine|mesh-list
101210366|NCT05963347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210367|NCT05963347|Immunologic Factors|immunologic factors|mesh-ancestor
101210368|NCT05963347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210369|NCT05963347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210370|NCT05963347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210371|NCT05963347|Alkylating Agents|alkylating agents|mesh-ancestor
101210372|NCT05963347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210373|NCT05963347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210374|NCT05963347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101210375|NCT05963347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101210376|NCT05963347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101210377|NCT05963347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101210378|NCT05963347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210379|NCT05963347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210380|NCT05963347|Glucocorticoids|glucocorticoids|mesh-ancestor
101210381|NCT05963347|Hormones|hormones|mesh-ancestor
101210382|NCT05963347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210383|NCT05963347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210384|NCT05963347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210385|NCT05963347|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210386|NCT05963347|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210387|NCT05963347|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210388|NCT05963334|Paclitaxel|paclitaxel|mesh-list
101210389|NCT05963334|Carboplatin|carboplatin|mesh-list
101210390|NCT05963334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210391|NCT05963334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210392|NCT05963334|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210393|NCT05963334|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210395|NCT05963334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210397|NCT05963217|Fludarabine|fludarabine|mesh-list
101210398|NCT05963217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210399|NCT05963217|Immunologic Factors|immunologic factors|mesh-ancestor
101210400|NCT05963217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210401|NCT05963217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210402|NCT05963217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210403|NCT05963217|Alkylating Agents|alkylating agents|mesh-ancestor
101210404|NCT05963217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210405|NCT05963217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420967|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101420968|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420969|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101420970|NCT00157326|Tadalafil|tadalafil|mesh-list
101420971|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
101420972|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101420973|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101420974|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101420975|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101420976|NCT00157326|Urological Agents|urological agents|mesh-ancestor
101420977|NCT00466843|Prednisone|prednisone|mesh-list
101420978|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101420979|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420980|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
101210406|NCT05963217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101210407|NCT05963204|Mannitol|mannitol|mesh-list
101210408|NCT05963204|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101210409|NCT05963204|Diuretics|diuretics|mesh-ancestor
101210410|NCT05963204|Natriuretic Agents|natriuretic agents|mesh-ancestor
101210411|NCT05963204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210412|NCT05963087|Cetuximab|cetuximab|mesh-list
101210413|NCT05963087|Tislelizumab|tislelizumab|mesh-list
101210414|NCT05963087|Dabrafenib|dabrafenib|mesh-list
101210415|NCT05963087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210416|NCT05963087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210417|NCT05963087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101210418|NCT05963087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210419|NCT05963087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210420|NCT05963074|Venetoclax|venetoclax|mesh-list
101210421|NCT05963074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210432|NCT05962970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210433|NCT05962970|Sensory System Agents|sensory system agents|mesh-ancestor
101210434|NCT05962970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210435|NCT05962775|Ethanol|ethanol|mesh-list
101210436|NCT05962775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101210437|NCT05962775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210438|NCT05962775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210439|NCT05962775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210440|NCT05962671|Analgesics, Opioid|analgesics, opioid|mesh-list
101210441|NCT05962671|Anesthetics|anesthetics|mesh-list
101210442|NCT05962671|Sevoflurane|sevoflurane|mesh-list
101210443|NCT05962671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210444|NCT05962671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210445|NCT05962671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101210446|NCT05962671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101210447|NCT05962671|Anesthetics, General|anesthetics, general|mesh-ancestor
101210448|NCT05962671|Narcotics|narcotics|mesh-ancestor
101210449|NCT05962671|Analgesics|analgesics|mesh-ancestor
101210450|NCT05962671|Sensory System Agents|sensory system agents|mesh-ancestor
101210451|NCT05962671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210452|NCT05962632|Fluorides|fluorides|mesh-list
101210453|NCT05962632|Cariostatic Agents|cariostatic agents|mesh-ancestor
101210454|NCT05962632|Protective Agents|protective agents|mesh-ancestor
101210455|NCT05962632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210456|NCT05962619|Hyaluronic Acid|hyaluronic acid|mesh-list
101210457|NCT05962619|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101210459|NCT05962619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210461|NCT05962619|Protective Agents|protective agents|mesh-ancestor
101210470|NCT05962320|Analgesics, Opioid|analgesics, opioid|mesh-list
101210472|NCT05962320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210473|NCT05962320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210474|NCT05962320|Analgesics|analgesics|mesh-ancestor
101210475|NCT05962320|Sensory System Agents|sensory system agents|mesh-ancestor
101420981|NCT00466843|Hormones|hormones|mesh-ancestor
101210476|NCT05962320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210478|NCT05962255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101210479|NCT05962255|Diuretics|diuretics|mesh-ancestor
101210480|NCT05962255|Natriuretic Agents|natriuretic agents|mesh-ancestor
101210481|NCT05962255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210482|NCT05962255|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101210483|NCT05962255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210484|NCT05962255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210485|NCT05962229|Nicotine|nicotine|mesh-list
101210486|NCT05962229|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101210487|NCT05962229|Autonomic Agents|autonomic agents|mesh-ancestor
101210488|NCT05962229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210489|NCT05962229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210490|NCT05962229|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101210491|NCT05962229|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101210492|NCT05962229|Cholinergic Agents|cholinergic agents|mesh-ancestor
101210493|NCT05962229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210494|NCT05962229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210495|NCT05962216|Brexpiprazole|brexpiprazole|mesh-list
101210496|NCT05962216|Serotonin Agents|serotonin agents|mesh-ancestor
101210497|NCT05962216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210498|NCT05962216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210499|NCT05962216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210500|NCT05962216|Dopamine Agonists|dopamine agonists|mesh-ancestor
101210501|NCT05962216|Dopamine Agents|dopamine agents|mesh-ancestor
101210502|NCT05962034|Aspirin|aspirin|mesh-list
101210503|NCT05962034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210504|NCT05962034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210505|NCT05962034|Analgesics|analgesics|mesh-ancestor
101210506|NCT05962034|Sensory System Agents|sensory system agents|mesh-ancestor
101210507|NCT05962034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210508|NCT05962034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210509|NCT05962034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210510|NCT05962034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210511|NCT05962034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210512|NCT05962034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210513|NCT05962034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210516|NCT05962034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210517|NCT05962034|Antipyretics|antipyretics|mesh-ancestor
101210518|NCT05961761|Pembrolizumab|pembrolizumab|mesh-list
101210519|NCT05961761|Propranolol|propranolol|mesh-list
101210520|NCT05961761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210521|NCT05961761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210522|NCT05961761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101210523|NCT05961761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210524|NCT05961761|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101210525|NCT05961761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101210526|NCT05961761|Adrenergic Agents|adrenergic agents|mesh-ancestor
101210527|NCT05961761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210528|NCT05961761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210529|NCT05961761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101210530|NCT05961761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101210531|NCT05961761|Vasodilator Agents|vasodilator agents|mesh-ancestor
101210532|NCT05961709|Cemiplimab|cemiplimab|mesh-list
101210533|NCT05961709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210534|NCT05961709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210535|NCT05961527|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
101210536|NCT05961527|Hallucinogens|hallucinogens|mesh-ancestor
101210537|NCT05961527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210538|NCT05961527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210539|NCT05961527|Serotonin Agents|serotonin agents|mesh-ancestor
101210540|NCT05961527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210541|NCT05961527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210542|NCT05961527|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101210543|NCT05961527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101210544|NCT05961527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210545|NCT05961527|Adrenergic Agents|adrenergic agents|mesh-ancestor
101210546|NCT05961501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101210547|NCT05961488|Calcium|calcium|mesh-list
101210548|NCT05961488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101210549|NCT05961488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210550|NCT05961202|Hydroxychloroquine|hydroxychloroquine|mesh-list
101210551|NCT05961202|Prednisolone|prednisolone|mesh-list
101210552|NCT05961202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210553|NCT05961202|Glucocorticoids|glucocorticoids|mesh-ancestor
101210554|NCT05961202|Hormones|hormones|mesh-ancestor
101210555|NCT05961202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210556|NCT05961202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210557|NCT05961202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210558|NCT05961202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210559|NCT05961202|Antimalarials|antimalarials|mesh-ancestor
101210560|NCT05961202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101210561|NCT05961202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101210562|NCT05961202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210563|NCT05961202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210564|NCT05961202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210565|NCT05961202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210566|NCT05961189|Azithromycin|azithromycin|mesh-list
101210567|NCT05961189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210568|NCT05961189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210569|NCT05961007|Aflibercept|aflibercept|mesh-list
101210570|NCT05961007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101210571|NCT05961007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101210572|NCT05961007|Growth Substances|growth substances|mesh-ancestor
101210573|NCT05961007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210574|NCT05961007|Growth Inhibitors|growth inhibitors|mesh-ancestor
101210577|NCT05960955|Fluorouracil|fluorouracil|mesh-list
101210578|NCT05960955|Oxaliplatin|oxaliplatin|mesh-list
101210579|NCT05960955|Tegafur|tegafur|mesh-list
101210580|NCT05960955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210581|NCT05960955|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210582|NCT05960955|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210583|NCT05960955|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210584|NCT05960955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210585|NCT05960955|Antimetabolites|antimetabolites|mesh-ancestor
101210586|NCT05960955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101210587|NCT05960955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210588|NCT05960955|Immunologic Factors|immunologic factors|mesh-ancestor
101210589|NCT05960955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210590|NCT05960942|Sufentanil|sufentanil|mesh-list
101210591|NCT05960942|Propofol|propofol|mesh-list
101210592|NCT05960942|Esketamine|esketamine|mesh-list
101210593|NCT05960942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101210594|NCT05960942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210595|NCT05960942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210596|NCT05960942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101210597|NCT05960942|Anesthetics, General|anesthetics, general|mesh-ancestor
101210598|NCT05960942|Anesthetics|anesthetics|mesh-ancestor
101210599|NCT05960942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101210600|NCT05960942|Narcotics|narcotics|mesh-ancestor
101210601|NCT05960942|Analgesics|analgesics|mesh-ancestor
101210602|NCT05960942|Sensory System Agents|sensory system agents|mesh-ancestor
101210603|NCT05960942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210604|NCT05960942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101210605|NCT05960942|Antidepressive Agents|antidepressive agents|mesh-ancestor
101210606|NCT05960942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210607|NCT05960929|Calfactant|calfactant|mesh-list
101210608|NCT05960929|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101210609|NCT05960929|Respiratory System Agents|respiratory system agents|mesh-ancestor
101210610|NCT05960864|Celecoxib|celecoxib|mesh-list
101210611|NCT05960864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210612|NCT05960864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210613|NCT05960864|Analgesics|analgesics|mesh-ancestor
101210614|NCT05960864|Sensory System Agents|sensory system agents|mesh-ancestor
101210615|NCT05960864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210616|NCT05960864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210617|NCT05960864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210618|NCT05960864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210619|NCT05960864|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101210620|NCT05960864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210621|NCT05960864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210622|NCT05960864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210623|NCT05960721|Aspirin|aspirin|mesh-list
101210624|NCT05960721|Rivaroxaban|rivaroxaban|mesh-list
101210625|NCT05960721|Clopidogrel|clopidogrel|mesh-list
101210626|NCT05960721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210627|NCT05960721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210628|NCT05960721|Analgesics|analgesics|mesh-ancestor
101210629|NCT05960721|Sensory System Agents|sensory system agents|mesh-ancestor
101210630|NCT05960721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210631|NCT05960721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210632|NCT05960721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210633|NCT05960721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210634|NCT05960721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210635|NCT05960721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210636|NCT05960721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210637|NCT05960721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101210638|NCT05960721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210639|NCT05960721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210640|NCT05960721|Antipyretics|antipyretics|mesh-ancestor
101210641|NCT05960721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101210642|NCT05960721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101210643|NCT05960721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101210644|NCT05960721|Purinergic Agents|purinergic agents|mesh-ancestor
101210645|NCT05960721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210646|NCT05960721|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101210647|NCT05960721|Antithrombins|antithrombins|mesh-ancestor
101210648|NCT05960721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101210649|NCT05960721|Protease Inhibitors|protease inhibitors|mesh-ancestor
101210652|NCT05960708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101210653|NCT05960708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101210654|NCT05960708|Respiratory System Agents|respiratory system agents|mesh-ancestor
101210655|NCT05960656|Empagliflozin|empagliflozin|mesh-list
101210656|NCT05960656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101210657|NCT05960656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210659|NCT05960656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210660|NCT05960617|Empagliflozin|empagliflozin|mesh-list
101210661|NCT05960617|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101210662|NCT05960617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210663|NCT05960617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101210664|NCT05960617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210665|NCT05960578|Golimumab|golimumab|mesh-list
101210666|NCT05960578|Immunoglobulins|immunoglobulins|mesh-list
101210667|NCT05960578|Immunoglobulin G|immunoglobulin g|mesh-list
101210668|NCT05960578|Immunologic Factors|immunologic factors|mesh-ancestor
101210669|NCT05960578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210670|NCT05960578|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101210671|NCT05960578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210672|NCT05960578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210674|NCT05957926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101210676|NCT05957926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210677|NCT05957926|Viscosupplements|viscosupplements|mesh-ancestor
101210678|NCT05957926|Protective Agents|protective agents|mesh-ancestor
101210679|NCT05955365|Aspirin|aspirin|mesh-list
101210680|NCT05955365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101210681|NCT05955365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210682|NCT05955365|Analgesics|analgesics|mesh-ancestor
101210683|NCT05955365|Sensory System Agents|sensory system agents|mesh-ancestor
101210684|NCT05955365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210685|NCT05955365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210686|NCT05955365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210687|NCT05955365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210688|NCT05955365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210689|NCT05955365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210690|NCT05955365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210691|NCT05955365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101210692|NCT05955365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101210693|NCT05955365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210694|NCT05955365|Antipyretics|antipyretics|mesh-ancestor
101210695|NCT05954442|Everolimus|everolimus|mesh-list
101210696|NCT05954442|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101210697|NCT05954442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101210698|NCT05954442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210699|NCT05954442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210700|NCT05954442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210701|NCT05954442|Immunologic Factors|immunologic factors|mesh-ancestor
101210702|NCT05954442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210703|NCT05954442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210704|NCT05928611|Dexamethasone|dexamethasone|mesh-list
101210705|NCT05928611|Dexamethasone acetate|dexamethasone acetate|mesh-list
101210706|NCT05928611|BB 1101|bb 1101|mesh-list
101210707|NCT05928611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101420982|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101420983|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101420984|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101420986|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
101210708|NCT05928611|Antiemetics|antiemetics|mesh-ancestor
101210709|NCT05928611|Autonomic Agents|autonomic agents|mesh-ancestor
101210710|NCT05928611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210711|NCT05928611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210720|NCT05928611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210722|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101210723|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
101210724|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210725|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210726|NCT05917912|Analgesics|analgesics|mesh-ancestor
101210727|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
101210728|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210729|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210730|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101210731|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101210732|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210733|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210765|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
101210766|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210767|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
101210768|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210769|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210770|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210771|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
101210772|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210773|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210774|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101210776|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210777|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
101210778|NCT05887726|Hormones|hormones|mesh-ancestor
101210779|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210780|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210781|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210782|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210783|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210784|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210785|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101210786|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101210787|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101210788|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210789|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101210804|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
101210805|NCT05867550|Alverine|alverine|mesh-list
101210806|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210807|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210808|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210809|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101210810|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
101210811|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210812|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101210813|NCT05867550|Analgesics|analgesics|mesh-ancestor
101210814|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
101210815|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101210816|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210817|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101210818|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101210819|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101210820|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210821|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
101210822|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210823|NCT05867550|Cathartics|cathartics|mesh-ancestor
101210824|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
101210825|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
101210826|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
101210827|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
101210830|NCT05856695|Paclitaxel|paclitaxel|mesh-list
101210831|NCT05856695|Carboplatin|carboplatin|mesh-list
101210832|NCT05856695|Durvalumab|durvalumab|mesh-list
101210833|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210834|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210835|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210836|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210837|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210838|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210839|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210840|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101210841|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210842|NCT05849753|Pancrelipase|pancrelipase|mesh-list
101210843|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210844|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
101210848|NCT05841420|Gemcitabine|gemcitabine|mesh-list
101210849|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210850|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210851|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210852|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210853|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210854|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210855|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101210856|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
101210857|NCT05835284|Silicon|silicon|mesh-list
101210858|NCT05835284|Trace Elements|trace elements|mesh-ancestor
101210859|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
101210860|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210861|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
101210862|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101210863|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101210864|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210865|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101210866|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101210867|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210868|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210869|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210870|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101210871|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
101210872|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101210873|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210874|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101210875|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101210876|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101210877|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
101210878|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101210880|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
101210881|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210882|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210883|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210884|NCT05800275|Capecitabine|capecitabine|mesh-list
101210885|NCT05800275|Trastuzumab|trastuzumab|mesh-list
101210886|NCT05800275|Tucatinib|tucatinib|mesh-list
101210887|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101210888|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
101210889|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210890|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210891|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210892|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101210893|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210894|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
101210895|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101210896|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101210897|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
101210898|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210899|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210900|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210901|NCT05798403|Urological Agents|urological agents|mesh-ancestor
101210902|NCT05796388|Linaclotide|linaclotide|mesh-list
101210903|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
101210904|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
101210905|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210906|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210907|NCT05796089|Carboplatin|carboplatin|mesh-list
101210908|NCT05796089|Etoposide|etoposide|mesh-list
101210909|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
101210910|NCT05796089|Durvalumab|durvalumab|mesh-list
101210911|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210912|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210913|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101210914|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101210915|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210916|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210917|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210930|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101210931|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210933|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210934|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210935|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210936|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210937|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101210938|NCT05739942|Temozolomide|temozolomide|mesh-list
101210939|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210940|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
101210941|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210942|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210943|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
101210944|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101210945|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101210946|NCT05734625|Prednisolone|prednisolone|mesh-list
101210947|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
101210948|NCT05734625|Bupivacaine|bupivacaine|mesh-list
101210960|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101210961|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
101210962|NCT05734625|Hormones|hormones|mesh-ancestor
101210963|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101210964|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101210965|NCT05734625|Protective Agents|protective agents|mesh-ancestor
101210966|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101210967|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210979|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101210980|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
101210981|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101210982|NCT05711940|Psilocybin|psilocybin|mesh-list
101210983|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
101210984|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210985|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101210986|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
101210990|NCT05671510|Docetaxel|docetaxel|mesh-list
101210991|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210992|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
101210993|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
101210994|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
101210995|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210996|NCT05671172|Bupivacaine|bupivacaine|mesh-list
101210997|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
101210998|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
101210999|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211000|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211001|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
101211002|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211003|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
101211004|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101211005|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211006|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211007|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101211008|NCT05665088|Analgesics|analgesics|mesh-ancestor
101211009|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
101211010|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211011|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101211012|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101211013|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101211014|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211020|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211021|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101211022|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101211023|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211024|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211025|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
101211026|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
101211027|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211028|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211029|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101211030|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101211031|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
101211032|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101211033|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101211034|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101211035|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101211036|NCT05660967|Lenalidomide|lenalidomide|mesh-list
101211037|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
101211038|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211039|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101211040|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101211041|NCT05660967|Growth Substances|growth substances|mesh-ancestor
101211042|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
101211043|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211044|NCT05653401|Diclofenac|diclofenac|mesh-list
101211045|NCT05653401|Lidocaine|lidocaine|mesh-list
101211046|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
101211047|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
101211048|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
101211049|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211050|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211051|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
101211052|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211053|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101211054|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101211055|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101211056|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211057|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211058|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101211059|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101211060|NCT05653401|Analgesics|analgesics|mesh-ancestor
101211061|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211062|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101211063|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101211064|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211065|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
101211066|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101211067|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101211068|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
101211069|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211071|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
101211072|NCT05653193|Clotrimazole|clotrimazole|mesh-list
101211073|NCT05653193|Miconazole|miconazole|mesh-list
101211074|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
101211075|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211076|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
101211077|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211078|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101211079|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101211080|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101211081|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211082|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211083|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101211084|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211089|NCT05645913|Anticoagulants|anticoagulants|mesh-list
101211093|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
101211094|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101211095|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
101211096|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101211097|NCT05620901|Prednisolone|prednisolone|mesh-list
101211098|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101211099|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
101211100|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211102|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
101211103|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211104|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211105|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211106|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
101211107|NCT05620901|Hormones|hormones|mesh-ancestor
101211108|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211109|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101211110|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211111|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101211112|NCT05620901|Protective Agents|protective agents|mesh-ancestor
101211113|NCT05618314|Probenecid|probenecid|mesh-list
101211114|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
101211115|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
101211116|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101211117|NCT05615220|Ecopipam|ecopipam|mesh-list
101211118|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101211119|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101211120|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211121|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211122|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211123|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101211124|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
101211125|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211126|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211129|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101211130|NCT05603104|Valproic Acid|valproic acid|mesh-list
101211131|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101211132|NCT05603104|Clozapine|clozapine|mesh-list
101211133|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
101211134|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101211135|NCT05603104|Sertraline|sertraline|mesh-list
101211136|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
101211137|NCT05603104|Esketamine|esketamine|mesh-list
101211138|NCT05603104|Escitalopram|escitalopram|mesh-list
101211139|NCT05603104|Analgesics|analgesics|mesh-ancestor
101211140|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
101211141|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211142|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211143|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101211144|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101211145|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
101211147|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211148|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101211149|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101211150|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211151|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211152|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101211153|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101211154|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211155|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
101211156|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101211157|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211158|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101211159|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101211160|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
101211163|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
101211164|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101211165|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101211166|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101211167|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
101211168|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101211169|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
101211170|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
101211171|NCT05601973|Lazertinib|lazertinib|mesh-list
101211172|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101211173|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211174|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211175|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211176|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211178|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
101211179|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101211180|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211181|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211182|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211183|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101211184|NCT05593055|Diuretics|diuretics|mesh-ancestor
101211185|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
101211186|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101211187|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101211188|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211189|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211191|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101211192|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
101211193|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211194|NCT05578092|Adagrasib|adagrasib|mesh-list
101211195|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211196|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
101211197|NCT05568550|Olaparib|olaparib|mesh-list
101211198|NCT05568550|Androgens|androgens|mesh-list
101211199|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211200|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211201|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211202|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211203|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101211204|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211205|NCT05568550|Hormones|hormones|mesh-ancestor
101211206|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211207|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211208|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
101211209|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101211210|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211211|NCT05546554|Suvorexant|suvorexant|mesh-list
101211212|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101211213|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101211214|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211215|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211216|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101211217|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211218|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211219|NCT05542849|Acarbose|acarbose|mesh-list
101211220|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101211221|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211222|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211223|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211224|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211225|NCT05540574|Zolpidem|zolpidem|mesh-list
101211226|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101211227|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101211228|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211229|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211230|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101211231|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
101211232|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
101211233|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211235|NCT05537883|Bupivacaine|bupivacaine|mesh-list
101211236|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
101211237|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
101211238|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211239|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211241|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211242|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
101211243|NCT05537766|Fludarabine|fludarabine|mesh-list
101211244|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
101211246|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
101211247|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211248|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101211249|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101211250|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
101211251|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211252|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211253|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101211254|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211255|NCT05523934|Capsaicin|capsaicin|mesh-list
101211256|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
101211258|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
101211259|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211260|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211261|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
101211262|NCT05508100|Tislelizumab|tislelizumab|mesh-list
101211263|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211264|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420987|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101420988|NCT00148863|Interferons|interferons|mesh-list
101420989|NCT00148863|Ribavirin|ribavirin|mesh-list
101420990|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
101420991|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
101420992|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
101420993|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101420994|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101420995|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
101211265|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211266|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211267|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
101211268|NCT05501678|Promethazine|promethazine|mesh-list
101211269|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101211270|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101211271|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211272|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211273|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
101211274|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
101211275|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
101211276|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211277|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
101211278|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
101211279|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211280|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101211281|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
101211282|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
101211283|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211284|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211285|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101211286|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
101211287|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
101211288|NCT05498233|Pyridoxine|pyridoxine|mesh-list
101211289|NCT05498233|Doxylamine|doxylamine|mesh-list
101211290|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
101211291|NCT05498233|Vitamins|vitamins|mesh-ancestor
101211292|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
101211293|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211294|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
101211295|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
101211296|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211297|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211298|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101211299|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
101211300|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
101211301|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211302|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211303|NCT05465317|Empagliflozin|empagliflozin|mesh-list
101211304|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101211305|NCT05465317|Glucagon|glucagon|mesh-list
101211306|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101211307|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211309|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211310|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211311|NCT05465317|Hormones|hormones|mesh-ancestor
101211355|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211356|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
101211357|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101211358|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101211359|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101211360|NCT05428215|Estradiol|estradiol|mesh-list
101211361|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101211371|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101211372|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211373|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211374|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211376|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
101211377|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211378|NCT05396859|Decitabine|decitabine|mesh-list
101211379|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
101211380|NCT05396859|Entrectinib|entrectinib|mesh-list
101211381|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101211382|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
101211383|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211384|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211385|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211386|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101211387|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
101211388|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211389|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211390|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211391|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101211392|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
101211393|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211394|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101211402|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211403|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
101211404|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211405|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101211406|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101211407|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101211408|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211409|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211410|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
101211411|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
101211412|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211413|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
101211414|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
101211415|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101211416|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101211417|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
101211418|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211419|NCT05374538|Sotorasib|sotorasib|mesh-list
101211420|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211421|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211422|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211423|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211424|NCT05351801|Dronabinol|dronabinol|mesh-list
101211425|NCT05351801|Nabiximols|nabiximols|mesh-list
101211426|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
101211427|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211428|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211429|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101211430|NCT05351801|Analgesics|analgesics|mesh-ancestor
101211431|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
101211432|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211433|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101211434|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101211435|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211436|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211437|NCT05351801|Hormones|hormones|mesh-ancestor
101211438|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211464|NCT05315713|Atezolizumab|atezolizumab|mesh-list
101211465|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211466|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211467|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211468|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211469|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
101211470|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101211471|NCT05300048|Paclitaxel|paclitaxel|mesh-list
101211472|NCT05300048|Serabelisib|serabelisib|mesh-list
101211473|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101211474|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211475|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
101211476|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
101211477|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
101211478|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211479|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211480|NCT05289323|Neostigmine|neostigmine|mesh-list
101211481|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101211488|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
101211489|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211495|NCT05275738|Niacinamide|niacinamide|mesh-list
101211496|NCT05275738|Niacin|niacin|mesh-list
101211497|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
101211498|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
101211499|NCT05275738|Vitamins|vitamins|mesh-ancestor
101211500|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
101211501|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211502|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101211503|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
101211504|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211505|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101211506|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
101211507|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
101211508|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101211509|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211510|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211511|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101211512|NCT05271552|Analgesics|analgesics|mesh-ancestor
101211513|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
101211514|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211515|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101211516|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101211517|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101211518|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211519|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211520|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211521|NCT05269849|Sirolimus|sirolimus|mesh-list
101211522|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101211523|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211524|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101211525|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211526|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
101211527|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101211528|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
101211529|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211530|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
101211531|NCT05264168|Apixaban|apixaban|mesh-list
101211532|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101211533|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
101211534|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101211535|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
101211536|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211537|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211538|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
101211539|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
101211541|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101211542|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
101211543|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101211545|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211546|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211547|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
101211548|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
101211549|NCT05220722|Nivolumab|nivolumab|mesh-list
101211550|NCT05220722|Ipilimumab|ipilimumab|mesh-list
101211551|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211552|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211553|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211554|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211555|NCT05213650|Methamphetamine|methamphetamine|mesh-list
101211556|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101211557|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211558|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
101211559|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
101211560|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211561|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
101211562|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211563|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211564|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211565|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101211566|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101211567|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211568|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101211569|NCT05203510|Treprostinil|treprostinil|mesh-list
101211570|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101211571|NCT05201547|Paclitaxel|paclitaxel|mesh-list
101211572|NCT05201547|Carboplatin|carboplatin|mesh-list
101211573|NCT05201547|Dostarlimab|dostarlimab|mesh-list
101211574|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101211575|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211576|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
101211577|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
101211578|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
101211579|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211580|NCT05179512|Fluticasone|fluticasone|mesh-list
101211589|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101211590|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
101211591|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
101211592|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101211593|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
101211594|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101211595|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
101211596|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211597|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211598|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101211599|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101211600|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101211601|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211602|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
101211604|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211605|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
101211606|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101211607|NCT05164081|Clindamycin|clindamycin|mesh-list
101211608|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
101211609|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
101211610|NCT05164081|Gentamicins|gentamicins|mesh-list
101211611|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101211613|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
101211614|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101211615|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211616|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211617|NCT05162976|Nivolumab|nivolumab|mesh-list
101211618|NCT05162976|Azacitidine|azacitidine|mesh-list
101211619|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211620|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211621|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211622|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211623|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101211624|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
101211625|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211626|NCT05162183|Liraglutide|liraglutide|mesh-list
101211627|NCT05162183|Glimepiride|glimepiride|mesh-list
101211628|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211629|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211630|NCT05162183|Incretins|incretins|mesh-ancestor
101211631|NCT05162183|Hormones|hormones|mesh-ancestor
101211632|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211633|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101211634|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101211635|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
101211636|NCT05153395|Insulin|insulin|mesh-list
101211637|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101211638|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211639|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211640|NCT05128162|Psilocybin|psilocybin|mesh-list
101211641|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
101211642|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211643|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211644|NCT05113745|Reboxetine|reboxetine|mesh-list
101211645|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
101211646|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211648|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101211649|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211650|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211653|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211657|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211658|NCT05099198|Incretins|incretins|mesh-ancestor
101211660|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211661|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101211662|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
101211663|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211664|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211665|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101211666|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101211667|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
101211668|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101211669|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
101211670|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211671|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211672|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211673|NCT05087992|Bevacizumab|bevacizumab|mesh-list
101211674|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211675|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211676|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101211677|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101211678|NCT05087992|Growth Substances|growth substances|mesh-ancestor
101211679|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211680|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
101211681|NCT05086081|Ticagrelor|ticagrelor|mesh-list
101211682|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101211683|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101211684|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101211685|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101211686|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101211687|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
101211688|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211689|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211690|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211692|NCT05083949|Empagliflozin|empagliflozin|mesh-list
101211693|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211694|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211695|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101211696|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211697|NCT05083455|Enoxaparin|enoxaparin|mesh-list
101211698|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
101211699|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101211700|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
101211701|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101211702|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
101211703|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211704|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211705|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
101211706|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101211707|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101211709|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101211710|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101211711|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
101211712|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211713|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211715|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
101211716|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
101211717|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101211718|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
101211719|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211720|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211721|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101211722|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101211723|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101211724|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211725|NCT05078879|Empagliflozin|empagliflozin|mesh-list
101211726|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101211728|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211729|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211730|NCT05075980|Cisplatin|cisplatin|mesh-list
101211731|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211732|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
101211733|NCT05073237|Estrogens|estrogens|mesh-list
101211734|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101211735|NCT05073237|Hormones|hormones|mesh-ancestor
101211736|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211737|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211738|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101211739|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101211740|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211741|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101211742|NCT05063201|Cariprazine|cariprazine|mesh-list
101211743|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101211744|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101211745|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211746|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211747|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211748|NCT05062304|Fluticasone|fluticasone|mesh-list
101211749|NCT05062304|Xhance|xhance|mesh-list
101211750|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211751|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101211752|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
101211753|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211754|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211755|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101211756|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
101211757|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
101211758|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101211759|NCT05029466|Psilocybin|psilocybin|mesh-list
101211760|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
101211761|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211762|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211763|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
101211764|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101211765|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
101211766|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211767|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
101211768|NCT05018481|Protective Agents|protective agents|mesh-ancestor
101211769|NCT05004259|Daratumumab|daratumumab|mesh-list
101211770|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211771|NCT05002569|Nivolumab|nivolumab|mesh-list
101211772|NCT05002569|Relatlimab|relatlimab|mesh-list
101211773|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211774|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211775|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211776|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211777|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101211778|NCT05001750|Doxycycline|doxycycline|mesh-list
101211779|NCT05001750|Nafcillin|nafcillin|mesh-list
101211780|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101211781|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211782|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
101211783|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
101211784|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101211785|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101211786|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101211787|NCT04997811|Valproic Acid|valproic acid|mesh-list
101211788|NCT04997811|Bezafibrate|bezafibrate|mesh-list
101211789|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
101211790|NCT04997811|Danazol|danazol|mesh-list
101211791|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
101211792|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211793|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211794|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
101211795|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211796|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211797|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
101211798|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101211799|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101211800|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101211801|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101211802|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101211805|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211806|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101211807|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101211808|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101211809|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101211810|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211811|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101211812|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211813|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211814|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101211816|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101211817|NCT04995484|Belzutifan|belzutifan|mesh-list
101211818|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211819|NCT04994522|Belzutifan|belzutifan|mesh-list
101211820|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211821|NCT04979884|Cyclosporine|cyclosporine|mesh-list
101420997|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
101420998|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211822|NCT04979884|Interleukin-2|interleukin-2|mesh-list
101211824|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211825|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211826|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101211827|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
101211828|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211829|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
101211830|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211831|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101211832|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101211833|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101211834|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211835|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101211837|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
101211838|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211839|NCT04971304|Lenograstim|lenograstim|mesh-list
101211840|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101211841|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
101211842|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211843|NCT04968366|Temozolomide|temozolomide|mesh-list
101211844|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101211845|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
101211846|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211847|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211848|NCT04951115|Carboplatin|carboplatin|mesh-list
101211849|NCT04951115|Etoposide|etoposide|mesh-list
101211850|NCT04951115|Durvalumab|durvalumab|mesh-list
101211851|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211852|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101211853|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101211854|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101211855|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211856|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211857|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211858|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
101211859|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211860|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211861|NCT04945213|Biperiden|biperiden|mesh-list
101211862|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101211863|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101211864|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
101211865|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
101211866|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211867|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211868|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101211869|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101211870|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
101211871|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211872|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211873|NCT04938466|Hormones|hormones|mesh-list
101211874|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211875|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211876|NCT04934514|Gemcitabine|gemcitabine|mesh-list
101211885|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211886|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
101211892|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101211893|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211894|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101211895|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
101211896|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101211897|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211898|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211899|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211900|NCT04925284|Bevacizumab|bevacizumab|mesh-list
101211902|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211903|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211904|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101211905|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101211906|NCT04925284|Growth Substances|growth substances|mesh-ancestor
101420999|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
101421000|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421001|NCT00466999|Misoprostol|misoprostol|mesh-list
101421002|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101421003|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
101421004|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211907|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211908|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
101211909|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211910|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211911|NCT04910711|Dolutegravir|dolutegravir|mesh-list
101211912|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101211913|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
101211914|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
101211915|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101211916|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
101211917|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211918|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211919|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101211920|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101211921|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101211922|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101211923|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101211924|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211925|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211926|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101211927|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101211928|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
101211929|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101211930|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101211931|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101211932|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101211933|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211934|NCT04909333|Exenatide|exenatide|mesh-list
101211935|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101211936|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211937|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211938|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101211939|NCT04909333|Incretins|incretins|mesh-ancestor
101211940|NCT04909333|Hormones|hormones|mesh-ancestor
101211941|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211942|NCT04897958|Leuprolide|leuprolide|mesh-list
101211943|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101211944|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
101211945|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101211946|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211948|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211949|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
101211950|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
101211951|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101211952|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
101211953|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211954|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211955|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101211956|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101211957|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101211958|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101211960|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211961|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211962|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211963|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211965|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101211967|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
101211968|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211969|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101211970|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
101211971|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211972|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211973|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101211974|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
101211975|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
101211976|NCT04892732|Hormones|hormones|mesh-ancestor
101211977|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211978|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101211979|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101211980|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101211981|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
101211982|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211983|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211984|NCT04884763|Erenumab|erenumab|mesh-list
101211985|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101211986|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211988|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
101211989|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211990|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211991|NCT04879420|Teriparatide|teriparatide|mesh-list
101211992|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
101211993|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101211994|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211995|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101211996|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101211997|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101211998|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211999|NCT04858009|Paclitaxel|paclitaxel|mesh-list
101212000|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101212001|NCT04858009|Cisplatin|cisplatin|mesh-list
101212002|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101212003|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212004|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
101212005|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
101212006|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212007|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212008|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
101212009|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212010|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212011|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
101212012|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
101212013|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
101212014|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212015|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
101212016|NCT04848519|Nivolumab|nivolumab|mesh-list
101212017|NCT04848519|Avelumab|avelumab|mesh-list
101212018|NCT04848519|Propranolol|propranolol|mesh-list
101212019|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212020|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212021|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212024|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101212025|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
101212026|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212028|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101212029|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101212030|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
101212031|NCT04822337|Dexamethasone|dexamethasone|mesh-list
101212032|NCT04822337|Lenalidomide|lenalidomide|mesh-list
101212033|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212034|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
101212035|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
101212036|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212037|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212038|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101212039|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
101212040|NCT04822337|Hormones|hormones|mesh-ancestor
101212041|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212042|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212043|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212044|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
101212045|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212046|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212047|NCT04822337|Growth Substances|growth substances|mesh-ancestor
101212048|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212049|NCT04808323|Capecitabine|capecitabine|mesh-list
101212050|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
101212051|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421005|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421006|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101421007|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421008|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
101421009|NCT00467116|Gemcitabine|gemcitabine|mesh-list
101421010|NCT00467116|Cetuximab|cetuximab|mesh-list
101421011|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421012|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
101421013|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421014|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421015|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421016|NCT00157482|Simvastatin|simvastatin|mesh-list
101212053|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212054|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212055|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
101212056|NCT04793529|Vitamin D|vitamin d|mesh-list
101212057|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101212058|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212059|NCT04793529|Vitamins|vitamins|mesh-ancestor
101212060|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
101212061|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101212062|NCT04787289|Bevacizumab|bevacizumab|mesh-list
101212063|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212064|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212065|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212066|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212067|NCT04787289|Growth Substances|growth substances|mesh-ancestor
101212068|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212069|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212070|NCT04749641|Vaccines|vaccines|mesh-list
101212071|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
101212072|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212073|NCT04745299|Riluzole|riluzole|mesh-list
101212074|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
101212075|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101212076|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101212077|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212078|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212079|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212080|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101212081|NCT04745299|Protective Agents|protective agents|mesh-ancestor
101212083|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101212084|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212085|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101212086|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212087|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
101212088|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212089|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
101212090|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212091|NCT04730258|Azacitidine|azacitidine|mesh-list
101212092|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212093|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
101212094|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212095|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212096|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212102|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212104|NCT04724239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212105|NCT04724239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212106|NCT04724239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212107|NCT04724239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212108|NCT04724239|Growth Substances|growth substances|mesh-ancestor
101212109|NCT04724239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212110|NCT04724239|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212111|NCT04705727|Budesonide|budesonide|mesh-list
101212112|NCT04705727|Terbutaline|terbutaline|mesh-list
101212113|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
101212114|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101212115|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212116|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101212117|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
101212118|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212119|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212120|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101212121|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
101212122|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
101212123|NCT04705727|Hormones|hormones|mesh-ancestor
101212124|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212125|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101212126|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101212127|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101212128|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
101212129|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212130|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212131|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
101212132|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
101212133|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212134|NCT04674683|Nivolumab|nivolumab|mesh-list
101212135|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212136|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212137|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212138|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212139|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
101212140|NCT04666740|Olaparib|olaparib|mesh-list
101212141|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212142|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212143|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212144|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212145|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101212148|NCT04662944|Aflibercept|aflibercept|mesh-list
101212149|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212150|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212151|NCT04662944|Growth Substances|growth substances|mesh-ancestor
101212152|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212153|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212154|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212155|NCT04661007|Lenalidomide|lenalidomide|mesh-list
101212156|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
101212157|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212158|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212159|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212160|NCT04661007|Growth Substances|growth substances|mesh-ancestor
101212161|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212162|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212163|NCT04644237|Trastuzumab|trastuzumab|mesh-list
101212164|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101212165|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212166|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212167|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
101212171|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101212172|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212174|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212175|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
101212176|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
101212177|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212178|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212180|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
101212181|NCT04624945|Coagulants|coagulants|mesh-ancestor
101212182|NCT04623216|Azacitidine|azacitidine|mesh-list
101212183|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212184|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
101212185|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212186|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212187|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212188|NCT04608474|Evolocumab|evolocumab|mesh-list
101212189|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
101212190|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101421018|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101421019|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101421020|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
101421021|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421022|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101421023|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101421024|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421025|NCT00467194|Sirolimus|sirolimus|mesh-list
101421026|NCT00467194|Bevacizumab|bevacizumab|mesh-list
101421027|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101421028|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421029|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101421030|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212191|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101212192|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101212193|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
101212194|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212195|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101212196|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212197|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212198|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101212199|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
101212200|NCT04600414|Narcotics|narcotics|mesh-ancestor
101212201|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212202|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212204|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
101212205|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212206|NCT04593043|Warfarin|warfarin|mesh-list
101212207|NCT04593043|Dabigatran|dabigatran|mesh-list
101212208|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
101212209|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
101212210|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101212211|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212212|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212213|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212214|NCT04593030|Warfarin|warfarin|mesh-list
101212215|NCT04593030|Apixaban|apixaban|mesh-list
101212216|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
101212217|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101212218|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
101212219|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101212220|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212221|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212222|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212223|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
101212224|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212225|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
101212226|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101212227|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
101212228|NCT04588311|Hematinics|hematinics|mesh-ancestor
101212229|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
101212230|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212231|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212232|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
101212233|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
101212234|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101212235|NCT04518410|Gabexate|gabexate|mesh-list
101212236|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
101212237|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101212238|NCT04518410|Antibodies|antibodies|mesh-list
101212239|NCT04518410|Camostat|camostat|mesh-list
101212240|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
101212241|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421031|NCT00467194|Growth Substances|growth substances|mesh-ancestor
101421032|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421033|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
101421034|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421035|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421036|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101421037|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
101421038|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421039|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
101421040|NCT00148902|Docetaxel|docetaxel|mesh-list
101421041|NCT00148902|Lapatinib|lapatinib|mesh-list
101212242|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
101212243|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212248|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101212250|NCT04507204|Methylphenidate|methylphenidate|mesh-list
101212251|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101212252|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212253|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101212254|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101212255|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101212256|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212257|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
101212258|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212259|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
101212260|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101212261|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212262|NCT04486391|Tislelizumab|tislelizumab|mesh-list
101212263|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212264|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212265|NCT04435834|Propofol|propofol|mesh-list
101212266|NCT04435834|Sevoflurane|sevoflurane|mesh-list
101212267|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101212268|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212269|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212270|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101212271|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
101212272|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
101212273|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101212274|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101212275|NCT04388839|Dactinomycin|dactinomycin|mesh-list
101212276|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
101212277|NCT04388839|Vincristine|vincristine|mesh-list
101212278|NCT04388839|Vinorelbine|vinorelbine|mesh-list
101212279|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212280|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
101212281|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212282|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101212283|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101212284|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
101212285|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212286|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212287|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101212288|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101212289|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
101212290|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
101212291|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212292|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101212293|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212294|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101212295|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101212296|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212297|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101212298|NCT04384484|Rituximab|rituximab|mesh-list
101212299|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
101421042|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421043|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
101421044|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
101421045|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
101421046|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421047|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421048|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421049|NCT05507645|Saruplase|saruplase|mesh-list
101421050|NCT05507645|Anticoagulants|anticoagulants|mesh-list
101421051|NCT05507645|Clopidogrel|clopidogrel|mesh-list
101421052|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421053|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101421054|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101421055|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421056|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101421057|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101212300|NCT04384484|Gemcitabine|gemcitabine|mesh-list
101212301|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
101212302|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212303|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212304|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
101212305|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212306|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101212307|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212308|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
101212309|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212310|NCT04345341|Bupivacaine|bupivacaine|mesh-list
101212311|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
101212312|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
101212318|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101212319|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212320|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212321|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212323|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101212324|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101212325|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101212326|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212327|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
101212328|NCT04331002|Hormones|hormones|mesh-ancestor
101212329|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212330|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212331|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212332|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
101212333|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212334|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212335|NCT04291820|Anesthetics|anesthetics|mesh-list
101212336|NCT04291820|Sevoflurane|sevoflurane|mesh-list
101212338|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212339|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212340|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101212341|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101212342|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
101212343|NCT04279054|Morphine|morphine|mesh-list
101212344|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101212345|NCT04279054|Narcotics|narcotics|mesh-ancestor
101212346|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212347|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212348|NCT04279054|Analgesics|analgesics|mesh-ancestor
101421058|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101421059|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101421060|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
101421061|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421062|NCT03271918|Cabergoline|cabergoline|mesh-list
101421063|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101421064|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101421065|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
101421066|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
101421067|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421068|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421069|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421070|NCT00467467|Alfuzosin|alfuzosin|mesh-list
101421071|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101212349|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
101212350|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212352|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
101212353|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212354|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212355|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212356|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212357|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212358|NCT04263051|Nivolumab|nivolumab|mesh-list
101212359|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212360|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212361|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212362|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212363|NCT04237935|Clopidogrel|clopidogrel|mesh-list
101212364|NCT04237935|Ticagrelor|ticagrelor|mesh-list
101212365|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101212366|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101212367|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101212368|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101212369|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
101212370|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212371|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212372|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212373|NCT04237922|Clopidogrel|clopidogrel|mesh-list
101212374|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101212375|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101212376|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101212377|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101212378|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101212379|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
101212380|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212381|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212387|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212388|NCT04229004|Paclitaxel|paclitaxel|mesh-list
101212389|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101212390|NCT04229004|Gemcitabine|gemcitabine|mesh-list
101212391|NCT04229004|Spartalizumab|spartalizumab|mesh-list
101212392|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101212393|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212394|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
101212395|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
101212396|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212397|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212398|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421072|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101421073|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101421074|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
101421075|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421076|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421077|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212399|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
101212400|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212401|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212402|NCT04228289|Oxytocin|oxytocin|mesh-list
101212404|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212405|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212406|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101212407|NCT04215536|Empagliflozin|empagliflozin|mesh-list
101212408|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101212409|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101212410|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212411|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212412|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212413|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212414|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212415|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
101212416|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101212417|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101212418|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212419|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212420|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212421|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212422|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212424|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
101212425|NCT04169347|Irinotecan|irinotecan|mesh-list
101212426|NCT04169347|Panitumumab|panitumumab|mesh-list
101212427|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212428|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101212429|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101212430|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212431|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212432|NCT04169347|Antidotes|antidotes|mesh-ancestor
101212433|NCT04169347|Protective Agents|protective agents|mesh-ancestor
101212434|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212435|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
101212436|NCT04169347|Vitamins|vitamins|mesh-ancestor
101212437|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
101212438|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212439|NCT04161885|Azacitidine|azacitidine|mesh-list
101212440|NCT04161885|Venetoclax|venetoclax|mesh-list
101212441|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212442|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
101212443|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212444|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212445|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212446|NCT04155424|Eculizumab|eculizumab|mesh-list
101212447|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101212448|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212449|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
101212450|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212451|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
101212452|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
101212453|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212459|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212461|NCT04135937|Nicotine|nicotine|mesh-list
101212462|NCT04135937|Varenicline|varenicline|mesh-list
101212463|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101212464|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
101212465|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212466|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212467|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101212468|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101421078|NCT00467467|Urological Agents|urological agents|mesh-ancestor
101421079|NCT00406887|Difluprednate|difluprednate|mesh-list
101421080|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
101421081|NCT00406887|Hormones|hormones|mesh-ancestor
101421082|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212469|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
101212470|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212471|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212472|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101212473|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
101212474|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101212475|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101212476|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101212477|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101212478|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
101212479|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101212480|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101212481|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212482|NCT04126070|Docetaxel|docetaxel|mesh-list
101212483|NCT04126070|Nivolumab|nivolumab|mesh-list
101212484|NCT04126070|Leuprolide|leuprolide|mesh-list
101212485|NCT04126070|Goserelin|goserelin|mesh-list
101212486|NCT04126070|Androgens|androgens|mesh-list
101212487|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212488|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
101212489|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
101212490|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
101212491|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212492|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212493|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212494|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101212495|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
101212496|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212497|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212498|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212499|NCT04126070|Hormones|hormones|mesh-ancestor
101212500|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212501|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101212502|NCT04120987|Lifitegrast|lifitegrast|mesh-list
101212503|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101212504|NCT04028765|Misoprostol|misoprostol|mesh-list
101212505|NCT04028765|Oxytocin|oxytocin|mesh-list
101212506|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
101212507|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212508|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212509|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101212510|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
101212511|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101212512|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101212513|NCT04019093|Ethanol|ethanol|mesh-list
101212514|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101212515|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212516|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212517|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212518|NCT04003636|Cisplatin|cisplatin|mesh-list
101212519|NCT04003636|Gemcitabine|gemcitabine|mesh-list
101212520|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
101212521|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212522|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212523|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
101212528|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101212529|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
101212579|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212580|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212581|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212582|NCT03937830|Growth Substances|growth substances|mesh-ancestor
101212583|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212584|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212585|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101212586|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101212587|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101421083|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421085|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101421086|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
101421087|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421088|NCT00467545|Telbivudine|telbivudine|mesh-list
101421089|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
101421090|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421091|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101421092|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421093|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421094|NCT00467662|Acyclovir|acyclovir|mesh-list
101421095|NCT00467662|Docosanol|docosanol|mesh-list
101421096|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
101421097|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421098|NCT05497310|Tretinoin|tretinoin|mesh-list
101421099|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
101421100|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421101|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
101421103|NCT00467935|Ranibizumab|ranibizumab|mesh-list
101421104|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101421105|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101421106|NCT00467935|Growth Substances|growth substances|mesh-ancestor
101421107|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421108|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
101421109|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421110|NCT00149019|Antibodies|antibodies|mesh-list
101421111|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101421112|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
101421113|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421114|NCT00468091|Atropine|atropine|mesh-list
101421115|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101421116|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101421117|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101421118|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
101421121|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101421129|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421131|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101421132|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
101421133|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
101421134|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
101421135|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
101421136|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101421137|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421138|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
101421139|NCT00149058|Hematinics|hematinics|mesh-ancestor
101421140|NCT00468520|Oxytocin|oxytocin|mesh-list
101421141|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
101421142|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212588|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212589|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212590|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101212591|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212592|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212593|NCT03936062|Incretins|incretins|mesh-ancestor
101212594|NCT03936062|Hormones|hormones|mesh-ancestor
101212595|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212596|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101212597|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212598|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212599|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212600|NCT03936049|Liraglutide|liraglutide|mesh-list
101212601|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101212602|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212603|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212604|NCT03936049|Incretins|incretins|mesh-ancestor
101212605|NCT03936049|Hormones|hormones|mesh-ancestor
101212606|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212607|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212608|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212609|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212610|NCT03936036|Linagliptin|linagliptin|mesh-list
101212611|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212612|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212613|NCT03936036|Incretins|incretins|mesh-ancestor
101212614|NCT03936036|Hormones|hormones|mesh-ancestor
101212615|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212616|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101212617|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212618|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212619|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212620|NCT03936010|Canagliflozin|canagliflozin|mesh-list
101212621|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101212622|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101212623|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212624|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212625|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212626|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212627|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212628|NCT03934372|Ponatinib|ponatinib|mesh-list
101212629|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212630|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212631|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212632|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212633|NCT03919448|Bevacizumab|bevacizumab|mesh-list
101212634|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212635|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421143|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421144|NCT03271450|Warfarin|warfarin|mesh-list
101421145|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
101421146|NCT03271450|Dabigatran|dabigatran|mesh-list
101421147|NCT03271450|Apixaban|apixaban|mesh-list
101421148|NCT03271450|Edoxaban|edoxaban|mesh-list
101421149|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
101421150|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101421151|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
101421152|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101421153|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
101421154|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421155|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421156|NCT00468754|Insulin|insulin|mesh-list
101212636|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101212637|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101212638|NCT03919448|Growth Substances|growth substances|mesh-ancestor
101212639|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212648|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101212649|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
101212650|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212651|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212652|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101212654|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101212655|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212656|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
101212657|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101212658|NCT03893045|Hematinics|hematinics|mesh-ancestor
101212659|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101212660|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101212661|NCT03877354|Anesthetics|anesthetics|mesh-list
101212662|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212663|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212664|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101212665|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212666|NCT03821272|Vaccines|vaccines|mesh-list
101212667|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
101212668|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212669|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
101212670|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101212671|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212672|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
101212673|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
101212674|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212675|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212676|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101212677|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
101212678|NCT03818737|Hormones|hormones|mesh-ancestor
101212679|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212680|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101212681|NCT03818737|Protective Agents|protective agents|mesh-ancestor
101212682|NCT03777982|Prednisone|prednisone|mesh-list
101212683|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
101212684|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212685|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
101212686|NCT03777982|Hormones|hormones|mesh-ancestor
101212691|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101212692|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212693|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212694|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
101212695|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101212696|NCT03770416|Nivolumab|nivolumab|mesh-list
101212697|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212698|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421158|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421159|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
101421160|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101421161|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421162|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
101421163|NCT00468871|Hormones|hormones|mesh-ancestor
101421164|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101421165|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421166|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
101421167|NCT00468988|Travoprost|travoprost|mesh-list
101421168|NCT00468988|Latanoprost|latanoprost|mesh-list
101421169|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101421170|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101421171|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101212699|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212700|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212701|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101212702|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101212703|NCT03769025|Narcotics|narcotics|mesh-ancestor
101212704|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212705|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212706|NCT03769025|Analgesics|analgesics|mesh-ancestor
101212707|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
101212708|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212709|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101212710|NCT03762473|Tacrolimus|tacrolimus|mesh-list
101212711|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212715|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212716|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212717|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
101212719|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
101212720|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212721|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
101212722|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212723|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101212724|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101212725|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
101212726|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212727|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212728|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101212729|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212730|NCT03759366|Eculizumab|eculizumab|mesh-list
101212732|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212733|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
101212734|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212735|NCT03710343|Metformin|metformin|mesh-list
101212736|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101212737|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212738|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101212739|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212740|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212741|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101212742|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
101212743|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
101212744|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
101212745|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212746|NCT03648021|Acetaminophen|acetaminophen|mesh-list
101212747|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101212748|NCT03648021|Analgesics|analgesics|mesh-ancestor
101212749|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
101212750|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421172|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
101421173|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421174|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421175|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421176|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421177|NCT00469261|Doxycycline|doxycycline|mesh-list
101421178|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421179|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421180|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
101421181|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101421182|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101421183|NCT00469300|Acyclovir|acyclovir|mesh-list
101421184|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
101421185|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421186|NCT04697641|Amoxicillin|amoxicillin|mesh-list
101421187|NCT04697641|Clarithromycin|clarithromycin|mesh-list
101421188|NCT04697641|Pantoprazole|pantoprazole|mesh-list
101421189|NCT04697641|Z 338|z 338|mesh-list
101421190|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421191|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421192|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101421193|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212751|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212752|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
101212753|NCT03613792|Fentanyl|fentanyl|mesh-list
101212754|NCT03613792|Midazolam|midazolam|mesh-list
101212755|NCT03613792|Ketamine|ketamine|mesh-list
101212756|NCT03613792|Remifentanil|remifentanil|mesh-list
101212757|NCT03613792|Analgesics|analgesics|mesh-ancestor
101212758|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
101212759|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212760|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212761|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101212762|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101212763|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
101212764|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
101212765|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212766|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101212767|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101212768|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212769|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212770|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101212772|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101212773|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101212774|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101212775|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101212776|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101212777|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
101212778|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
101212779|NCT03612960|Nicotine|nicotine|mesh-list
101212780|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101212781|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
101212782|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212783|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212784|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101212785|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101212786|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
101212793|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421194|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421195|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101421196|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101421198|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421199|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101421200|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101421201|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
101421202|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421203|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421204|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101421205|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101421206|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101421207|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
101421208|NCT00469495|Anthelmintics|anthelmintics|mesh-list
101421209|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101421210|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421211|NCT00469651|Vaccines|vaccines|mesh-list
101421212|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
101212795|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101212796|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
101212797|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212798|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212799|NCT03595917|Prednisone|prednisone|mesh-list
101212800|NCT03595917|Dasatinib|dasatinib|mesh-list
101212801|NCT03595917|Blinatumomab|blinatumomab|mesh-list
101212802|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212803|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
101212804|NCT03595917|Hormones|hormones|mesh-ancestor
101212805|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212806|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212807|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212808|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212809|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212810|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212811|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212812|NCT03591510|Cytarabine|cytarabine|mesh-list
101212813|NCT03591510|Fludarabine|fludarabine|mesh-list
101212814|NCT03591510|Etoposide|etoposide|mesh-list
101212815|NCT03591510|Daunorubicin|daunorubicin|mesh-list
101212816|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
101212817|NCT03591510|Idarubicin|idarubicin|mesh-list
101212818|NCT03591510|Midostaurin|midostaurin|mesh-list
101212819|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212820|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212821|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
101212822|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212823|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212824|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
101212825|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212826|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101212827|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101212828|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101212829|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212830|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
101212831|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212832|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101212833|NCT03591510|Analgesics|analgesics|mesh-ancestor
101212834|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
101421223|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101421224|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101421225|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421226|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421227|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101421228|NCT00469690|Bromfenac|bromfenac|mesh-list
101421229|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101421230|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101421231|NCT00469690|Analgesics|analgesics|mesh-ancestor
101421232|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
101421233|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421234|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421235|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421236|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421237|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101421238|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421239|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421240|NCT00469768|Dapivirine|dapivirine|mesh-list
101421241|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101212835|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212836|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212837|NCT03584516|Prednisone|prednisone|mesh-list
101212838|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
101212839|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101212840|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101212841|NCT03584516|Prednisolone|prednisolone|mesh-list
101212842|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
101212843|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101212844|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
101212845|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101212846|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
101212847|NCT03584516|Hormones|hormones|mesh-ancestor
101212848|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101212849|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212850|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101212851|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212853|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
101212854|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212855|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101212856|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101212857|NCT03584516|Protective Agents|protective agents|mesh-ancestor
101212858|NCT03575598|Nivolumab|nivolumab|mesh-list
101212875|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212879|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212881|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212882|NCT03440567|Rituximab|rituximab|mesh-list
101212883|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101212884|NCT03440567|Avelumab|avelumab|mesh-list
101212885|NCT03440567|Carboplatin|carboplatin|mesh-list
101212886|NCT03440567|Etoposide|etoposide|mesh-list
101212887|NCT03440567|Ifosfamide|ifosfamide|mesh-list
101212888|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
101212889|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
101212890|NCT03440567|Antibodies|antibodies|mesh-list
101212891|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
101212892|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101212893|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
101421242|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101421243|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
101421244|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421245|NCT00469885|Nicotine|nicotine|mesh-list
101421246|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101421247|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
101421248|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421249|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421250|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101421251|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101421252|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
101421253|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421254|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421255|NCT00469924|Caffeine|caffeine|mesh-list
101421256|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101421257|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421258|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101421259|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421260|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421261|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101421262|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101421263|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
101421264|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212894|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
101212895|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212896|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212897|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101212898|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101212899|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101212900|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101212901|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212902|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212903|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101212904|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
101212905|NCT03425643|Gemcitabine|gemcitabine|mesh-list
101212906|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
101212908|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212909|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212910|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
101212911|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212912|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212913|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212914|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212915|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101212916|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101212917|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
101212918|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101212919|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
101212920|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101212921|NCT03423667|Expectorants|expectorants|mesh-ancestor
101421265|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
101421266|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101421267|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101421268|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421269|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
101421270|NCT00157677|Coagulants|coagulants|mesh-ancestor
101421272|NCT00470041|Zidovudine|zidovudine|mesh-list
101421273|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
101421274|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101421275|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101421276|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212922|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
101212923|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101212924|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
101212925|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212926|NCT03423667|Protective Agents|protective agents|mesh-ancestor
101212927|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212928|NCT03423667|Antidotes|antidotes|mesh-ancestor
101212929|NCT03419897|Tislelizumab|tislelizumab|mesh-list
101212930|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212931|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212933|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
101212934|NCT03406897|Vitamins|vitamins|mesh-ancestor
101212935|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
101212936|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212937|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101212938|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101212939|NCT03377049|Acetazolamide|acetazolamide|mesh-list
101212940|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
101212941|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101212942|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212943|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212944|NCT03377049|Diuretics|diuretics|mesh-ancestor
101212945|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
101212946|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212947|NCT03369223|Nivolumab|nivolumab|mesh-list
101212948|NCT03369223|Ipilimumab|ipilimumab|mesh-list
101212949|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212950|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212955|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212956|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212957|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212958|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212959|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
101212960|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
101212961|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212962|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
101212963|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212964|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101212965|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101212966|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
101212967|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212968|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212969|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101212970|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212971|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212973|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101212974|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
101212975|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212976|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212977|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101212978|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
101212979|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101421277|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421278|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421279|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101421280|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101421281|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
101421282|NCT00157716|Pyridoxal|pyridoxal|mesh-list
101421283|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
101421284|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
101421285|NCT00157716|Vitamins|vitamins|mesh-ancestor
101421286|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
101421287|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421288|NCT00470197|Cytarabine|cytarabine|mesh-list
101421289|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
101421290|NCT00470197|Alvocidib|alvocidib|mesh-list
101421291|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101421292|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
101421293|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421294|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101421295|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
101421296|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421297|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101421298|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
101421299|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421300|NCT00470197|Analgesics|analgesics|mesh-ancestor
101421301|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
101421302|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421303|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101421304|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101421305|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421306|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
101421307|NCT00470197|Growth Substances|growth substances|mesh-ancestor
101421308|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101421309|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
101421310|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101421311|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101421312|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421313|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421318|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101421319|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101421320|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101421321|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101421322|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101421323|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101421324|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101421325|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101421326|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101212980|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212981|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212982|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101212983|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
101212984|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101212985|NCT03335488|Glycerol|glycerol|mesh-list
101212986|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101212987|NCT03335488|Protective Agents|protective agents|mesh-ancestor
101212988|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212989|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212991|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101212992|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
101212993|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212994|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212995|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212996|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101212997|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101212998|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212999|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101213000|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101213001|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
101213002|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
101213003|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213004|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213005|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213006|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213007|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213008|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213009|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213010|NCT03243058|Aldesleukin|aldesleukin|mesh-list
101213011|NCT03243058|Interleukin-2|interleukin-2|mesh-list
101213012|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213013|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213014|NCT03243058|Analgesics|analgesics|mesh-ancestor
101213015|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
101213016|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213017|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213018|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101213019|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101213020|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
101213021|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213022|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
101213029|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213030|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213032|NCT03214510|Hydromorphone|hydromorphone|mesh-list
101213033|NCT03214510|Bupivacaine|bupivacaine|mesh-list
101213034|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
101213035|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
101213036|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213037|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213038|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
101213039|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213040|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101213041|NCT03214510|Narcotics|narcotics|mesh-ancestor
101213042|NCT03214510|Analgesics|analgesics|mesh-ancestor
101213043|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101421328|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421329|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101421330|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
101421331|NCT05391893|Diltiazem|diltiazem|mesh-list
101421332|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101421333|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101421334|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213044|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101213045|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
101213046|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101213047|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213048|NCT03170960|Atezolizumab|atezolizumab|mesh-list
101213049|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213050|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213051|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213052|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213055|NCT03016338|Niraparib|niraparib|mesh-list
101213056|NCT03016338|Dostarlimab|dostarlimab|mesh-list
101213057|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101213058|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213059|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213060|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213061|NCT02966756|Venetoclax|venetoclax|mesh-list
101213062|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213063|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
101213064|NCT02921191|Lenograstim|lenograstim|mesh-list
101213065|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101213066|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
101213067|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213068|NCT02911701|Acetaminophen|acetaminophen|mesh-list
101213069|NCT02911701|Ibuprofen|ibuprofen|mesh-list
101213070|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213071|NCT02911701|Analgesics|analgesics|mesh-ancestor
101213072|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
101213073|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213074|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213075|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
101213076|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101213077|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213078|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213079|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101213080|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213081|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213082|NCT02903368|Prednisone|prednisone|mesh-list
101213083|NCT02903368|Leuprolide|leuprolide|mesh-list
101213084|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
101213085|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213086|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
101213087|NCT02903368|Hormones|hormones|mesh-ancestor
101213088|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213089|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213090|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101213091|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213092|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101213093|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
101213094|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213096|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213097|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213098|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
101213099|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101213100|NCT02899052|Dexamethasone|dexamethasone|mesh-list
101213101|NCT02899052|Venetoclax|venetoclax|mesh-list
101213102|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213103|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
101213104|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
101213105|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213106|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213107|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213109|NCT02899052|Hormones|hormones|mesh-ancestor
101421336|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101421338|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
101421339|NCT00470509|Adalimumab|adalimumab|mesh-list
101421340|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101421341|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101421342|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101421343|NCT05378906|Darunavir|darunavir|mesh-list
101421344|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101421345|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101421346|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
101421347|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101421348|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101421349|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101421350|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101421351|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
101421352|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101421353|NCT00470665|Sirolimus|sirolimus|mesh-list
101421354|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101421355|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213110|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213111|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101213113|NCT02874742|Dexamethasone|dexamethasone|mesh-list
101213114|NCT02874742|Lenalidomide|lenalidomide|mesh-list
101213115|NCT02874742|Bortezomib|bortezomib|mesh-list
101213116|NCT02874742|Daratumumab|daratumumab|mesh-list
101213117|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213118|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
101213119|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
101213120|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213121|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213122|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213123|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
101213124|NCT02874742|Hormones|hormones|mesh-ancestor
101213125|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213126|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101213127|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213128|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
101213129|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101213130|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101213131|NCT02874742|Growth Substances|growth substances|mesh-ancestor
101213132|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
101213133|NCT02757859|Pancrelipase|pancrelipase|mesh-list
101213134|NCT02757859|Pancreatin|pancreatin|mesh-list
101213135|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213136|NCT02749292|Rituximab|rituximab|mesh-list
101213137|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213138|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213139|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
101213140|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213141|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213143|NCT02715609|Temozolomide|temozolomide|mesh-list
101213144|NCT02715609|Disulfiram|disulfiram|mesh-list
101213145|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101213146|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
101213147|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213148|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213149|NCT02715609|Trace Elements|trace elements|mesh-ancestor
101213150|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
101421646|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101421647|NCT00472927|Estrogens|estrogens|mesh-ancestor
101421944|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
101421945|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
101422608|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
101422609|NCT00512980|Hormones|hormones|mesh-ancestor
101423199|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
101424617|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101424618|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101425363|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101425364|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101426096|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
101426179|NCT00531076|Bevacizumab|bevacizumab|mesh-list
101426841|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
101426842|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
101426844|NCT00146042|Docetaxel|docetaxel|mesh-list
101427744|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101427745|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101428713|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101428715|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101429314|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
101429919|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101429923|NCT03782740|Melatonin|melatonin|mesh-list
101431246|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101432371|NCT05469022|Lazertinib|lazertinib|mesh-list
101432984|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101432985|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101433500|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101433501|NCT00540085|Rocuronium|rocuronium|mesh-list
101434706|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
101434707|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
101434714|NCT00161096|Pantoprazole|pantoprazole|mesh-list
101435086|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101435088|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101435890|NCT05807893|Bevacizumab|bevacizumab|mesh-list
101436788|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101436857|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
101436858|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101436860|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101436930|NCT00193011|Fluorouracil|fluorouracil|mesh-list
101436931|NCT00193011|Methotrexate|methotrexate|mesh-list
101437855|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101437856|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
101437912|NCT00177567|Bupropion|bupropion|mesh-list
101438591|NCT05994742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101438592|NCT05994742|Antimetabolites|antimetabolites|mesh-ancestor
101438593|NCT05994742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101438594|NCT05994742|Vitamin B Complex|vitamin b complex|mesh-ancestor
101439368|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101439369|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101439370|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101439769|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101439770|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101439771|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101440209|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101440210|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101440211|NCT04464629|Prednisolone|prednisolone|mesh-list
101440212|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101440279|NCT04392037|Hormones|hormones|mesh-ancestor
101440280|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101440281|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101440348|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101440349|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
101440350|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
101440424|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101440426|NCT04133636|Hormones|hormones|mesh-ancestor
101440766|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
101440768|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
101441525|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101442410|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101442411|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101442479|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101443115|NCT00554827|Folic Acid|folic acid|mesh-list
101443759|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101443792|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
101443794|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101444328|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101444329|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444330|NCT04173364|Ropivacaine|ropivacaine|mesh-list
101444333|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
101444993|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101444994|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
101445482|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
101445508|NCT00560170|Ezetimibe|ezetimibe|mesh-list
101445583|NCT00179114|Baclofen|baclofen|mesh-list
101445914|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
101445915|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101445916|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
101445917|NCT00186849|Ifosfamide|ifosfamide|mesh-list
101445955|NCT00186966|Busulfan|busulfan|mesh-list
101446029|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101446030|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101446031|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
101446049|NCT00575848|Glycine|glycine|mesh-list
101446099|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
101446100|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
101446576|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
101446577|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101446578|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101447240|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
101447305|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101447306|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101448206|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101448207|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101448966|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101448967|NCT00189878|Methotrexate|methotrexate|mesh-list
101448968|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101449024|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101449025|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449027|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
101449028|NCT00189995|Clozapine|clozapine|mesh-list
101449029|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
101449030|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
101449031|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101449032|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101449033|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101449034|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101449035|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101449036|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101449037|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101449038|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101449039|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
101449040|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101449041|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101449042|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101449043|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101449044|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
101449045|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
101449046|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
101449047|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
101449048|NCT00213291|Hematinics|hematinics|mesh-ancestor
101449049|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
101449050|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101449051|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
101449052|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101449053|NCT00190034|Expectorants|expectorants|mesh-ancestor
101449054|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
101449055|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101449056|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
101449060|NCT00190034|Antidotes|antidotes|mesh-ancestor
101449119|NCT00190307|Analgesics|analgesics|mesh-ancestor
101449131|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
101450661|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101450663|NCT00125255|Tetracaine|tetracaine|mesh-list
101451141|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101451142|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101451143|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
101451151|NCT00195104|Cytarabine|cytarabine|mesh-list
101451572|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101451574|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
101451931|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
101451932|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101452543|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101452830|NCT00199004|Rituximab|rituximab|mesh-list
101452899|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
101453866|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101453938|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101454841|NCT02210884|Vitamin D|vitamin d|mesh-list
101454842|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
101454843|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
101454910|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101455807|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101455808|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101455809|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101455810|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101455813|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101455814|NCT00240474|Telmisartan|telmisartan|mesh-list
101455815|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101455816|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101455817|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101455871|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101455879|NCT00214877|Methylene Blue|methylene blue|mesh-list
101455942|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101455943|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
101455944|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101455945|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
101455946|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101455990|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456731|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456732|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101456772|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101456773|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456774|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456775|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
101456776|NCT04646824|Pemetrexed|pemetrexed|mesh-list
101456777|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101456778|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101456779|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101456780|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101456781|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101456782|NCT00217451|Clindamycin|clindamycin|mesh-list
101456783|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
101456784|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
101456785|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
101456786|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101456787|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101456788|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101456804|NCT00217529|Carboplatin|carboplatin|mesh-list
101457020|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101457021|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101457022|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101457446|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101457543|NCT04624360|Hormones|hormones|mesh-ancestor
101458497|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101458498|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101458503|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101459465|NCT00252954|Levetiracetam|levetiracetam|mesh-list
101459466|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
101459534|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101460447|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101461334|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101461617|NCT00255762|Antibodies|antibodies|mesh-list
101462013|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101462014|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101462015|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101464048|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101464885|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101464921|NCT00268593|Hormones|hormones|mesh-ancestor
101465897|NCT04538521|Vitamins|vitamins|mesh-ancestor
101466795|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101466812|NCT05694533|Midazolam|midazolam|mesh-list
101466868|NCT05586373|Dipyrone|dipyrone|mesh-list
101466869|NCT05586373|Ibuprofen|ibuprofen|mesh-list
101466870|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101467544|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
101467545|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101467546|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101467916|NCT02218684|Lacidipine|lacidipine|mesh-list
101467917|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101467984|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
101467985|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
101468057|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101468732|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
101468733|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101469471|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
101469545|NCT00244907|Genistein|genistein|mesh-list
101470686|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101470687|NCT00279747|Analgesics|analgesics|mesh-ancestor
101470698|NCT00250640|Iloprost|iloprost|mesh-list
101471204|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101472480|NCT01608139|Sorafenib|sorafenib|mesh-list
101473025|NCT02270437|Fentanyl|fentanyl|mesh-list
101473986|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
101473987|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
101474055|NCT00291408|Protective Agents|protective agents|mesh-ancestor
101474056|NCT00271791|Prednisone|prednisone|mesh-list
101475039|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101475040|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
101475041|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101475042|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101475043|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101475045|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
101475935|NCT00301860|Cyclosporins|cyclosporins|mesh-list
101476847|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101476848|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101476849|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
101477443|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101477444|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
101477514|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
101478149|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
101478150|NCT00310323|Caffeine|caffeine|mesh-list
101478151|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101478152|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101478261|NCT00280787|Carboplatin|carboplatin|mesh-list
101478959|NCT04718402|Analgesics|analgesics|mesh-ancestor
101479027|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
101479028|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
101479029|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
101479030|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101479099|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101479100|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101479172|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101479173|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101479174|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
101479175|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101479242|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101479243|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101479252|NCT00313287|Clevudine|clevudine|mesh-list
101479483|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101479558|NCT00320853|Vitamins|vitamins|mesh-ancestor
101480250|NCT00303732|Vatalanib|vatalanib|mesh-list
101481286|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101481287|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101481288|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101482119|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
101482120|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101482121|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101482122|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
101482123|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101482124|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101482125|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
101482126|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101482128|NCT00328692|Diuretics|diuretics|mesh-ancestor
101482131|NCT00419718|Insulin|insulin|mesh-list
101482546|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101483447|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
101483449|NCT00322062|Protective Agents|protective agents|mesh-ancestor
101484491|NCT00312299|Protective Agents|protective agents|mesh-ancestor
101484492|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101485548|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101485549|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101485552|NCT00317798|Sirolimus|sirolimus|mesh-list
101486373|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101486444|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
101486980|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101487620|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
101487621|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
101488002|NCT00329459|Naproxen|naproxen|mesh-list
101488003|NCT00329459|Sumatriptan|sumatriptan|mesh-list
101488004|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101488006|NCT00329459|Analgesics|analgesics|mesh-ancestor
101488601|NCT00332774|Analgesics|analgesics|mesh-ancestor
101488602|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
101488610|NCT00431769|Bortezomib|bortezomib|mesh-list
101489137|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101489707|NCT00338312|Testosterone|testosterone|mesh-list
101489708|NCT00338312|Androgens|androgens|mesh-ancestor
101489709|NCT00338312|Hormones|hormones|mesh-ancestor
101489710|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101489711|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101489712|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
101490374|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
101490375|NCT00447759|Ibuprofen|ibuprofen|mesh-list
101490376|NCT00447759|Celecoxib|celecoxib|mesh-list
101490377|NCT00447759|Diclofenac|diclofenac|mesh-list
101490378|NCT00447759|Naproxen|naproxen|mesh-list
101490379|NCT00447759|Meloxicam|meloxicam|mesh-list
101490380|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101490381|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101490382|NCT00447759|Analgesics|analgesics|mesh-ancestor
101490383|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
101490384|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101490782|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101490783|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101490784|NCT00346970|Niacin|niacin|mesh-list
101490785|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101491076|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101491078|NCT00348413|Prednisolone|prednisolone|mesh-list
101491248|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101491249|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101491252|NCT00349115|Thalidomide|thalidomide|mesh-list
101491702|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101491703|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101491704|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101492028|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
101492029|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101492030|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
101492031|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
101492094|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101492095|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101492096|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101492097|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101492229|NCT00426608|Metyrapone|metyrapone|mesh-list
101492487|NCT00469053|Buprenorphine|buprenorphine|mesh-list
101492551|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
101493083|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
101493148|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101493532|NCT00463983|Octreotide|octreotide|mesh-list
101493533|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101493534|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101493535|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101493584|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101493586|NCT03273036|Triamcinolone|triamcinolone|mesh-list
101493587|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101493588|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
101493589|NCT03273036|Hormones|hormones|mesh-ancestor
101493591|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101494120|NCT00436787|PENTA|penta|mesh-list
101494260|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101495092|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101495628|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496052|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
101496053|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496054|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101496055|NCT00455936|Gefitinib|gefitinib|mesh-list
101496056|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101496057|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101496058|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101496059|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496060|NCT00443235|Thalidomide|thalidomide|mesh-list
101496118|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
101496119|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496120|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101496121|NCT04700436|Ezetimibe|ezetimibe|mesh-list
101496122|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101496123|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101496124|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
101496126|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101496589|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101496590|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101496655|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101496656|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101496657|NCT01242579|Maraviroc|maraviroc|mesh-list
101496658|NCT01242579|Dapivirine|dapivirine|mesh-list
101496659|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101496660|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101496661|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101496662|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101496663|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101496664|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
101496665|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496666|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101496667|NCT00460499|Insulin|insulin|mesh-list
101496668|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101496669|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101496670|NCT00495573|Acyclovir|acyclovir|mesh-list
101496671|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
101496672|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101496978|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101497594|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101497649|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101498262|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101498919|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101499526|NCT01325350|Minoxidil|minoxidil|mesh-list
101499527|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101499821|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
101499822|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101500115|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101500116|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101500791|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
101500792|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101501176|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101501177|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
101501219|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
101501461|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101185138|NCT00577356|Docetaxel|docetaxel|mesh-list
101501904|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101502091|NCT00485706|Calcium|calcium|mesh-list
101502192|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
101502193|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
101502329|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101502330|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
101502332|NCT00486174|Methylene Blue|methylene blue|mesh-list
101502394|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101186273|NCT00001698|Ketorolac|ketorolac|mesh-list
101502569|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
101502570|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101502613|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101503152|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101503153|NCT00495872|Lenalidomide|lenalidomide|mesh-list
101503154|NCT00495872|Sunitinib|sunitinib|mesh-list
101503377|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101503378|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101503822|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
101503837|NCT00502658|Vitamins|vitamins|mesh-list
101503892|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101503894|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188006|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504290|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101504291|NCT00500279|Celecoxib|celecoxib|mesh-list
101504292|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101504293|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101504320|NCT01247558|Vitamins|vitamins|mesh-ancestor
101504339|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101504340|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504341|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101504342|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101504343|NCT00507585|Growth Substances|growth substances|mesh-ancestor
101504344|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101504346|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
101504347|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504349|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101504404|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101504405|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101504406|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101504407|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101504408|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101504409|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101504410|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101528473|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101528474|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101528475|NCT00561756|Vaccines|vaccines|mesh-list
101528476|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
101528477|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528478|NCT04824911|Aspirin|aspirin|mesh-list
101528479|NCT04824911|Clopidogrel|clopidogrel|mesh-list
101528480|NCT04824911|Atorvastatin|atorvastatin|mesh-list
101528541|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528542|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
101528544|NCT04710719|Triamcinolone|triamcinolone|mesh-list
101528545|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101528546|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101528547|NCT04710719|Fluorouracil|fluorouracil|mesh-list
101528548|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101528549|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
101528550|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528551|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101528552|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528605|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
101528606|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
101528607|NCT04655664|Vitamins|vitamins|mesh-list
101528608|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
101528677|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101528678|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101528679|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
101528680|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101528682|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101528683|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101528684|NCT02905994|Cytarabine|cytarabine|mesh-list
101528685|NCT02905994|Idarubicin|idarubicin|mesh-list
101528803|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101528804|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101528805|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101528807|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101528862|NCT04652739|Protective Agents|protective agents|mesh-ancestor
101528863|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
101528864|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101528865|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101529047|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101529399|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529400|NCT05309785|Canagliflozin|canagliflozin|mesh-list
101529401|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101529402|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101529451|NCT01189201|Hormones|hormones|mesh-ancestor
101529452|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101529453|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101529454|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
101529464|NCT01188811|Vitamins|vitamins|mesh-ancestor
101529714|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101529715|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101529759|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101529760|NCT04616352|Cefuroxime|cefuroxime|mesh-list
101529761|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
101529762|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101529763|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101530065|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530066|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101530067|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
101530242|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
101530291|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
101530292|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530300|NCT01998035|Romidepsin|romidepsin|mesh-list
101530593|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
101530594|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530595|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101530596|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101530597|NCT01870505|Letrozole|letrozole|mesh-list
101530820|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101530821|NCT01737905|Epinephrine|epinephrine|mesh-list
101530823|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101531095|NCT00564603|Dexamethasone|dexamethasone|mesh-list
101531096|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
101531097|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101531489|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
101531490|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101531491|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
101531769|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101531770|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101531777|NCT04603872|Dasatinib|dasatinib|mesh-list
101532129|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101532130|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
101532131|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
101532132|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
101532133|NCT00562250|Glimepiride|glimepiride|mesh-list
101532134|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101532426|NCT04691063|Carboplatin|carboplatin|mesh-list
101532427|NCT04691063|Etoposide|etoposide|mesh-list
101532428|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
101532429|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532432|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101532725|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101532726|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101532732|NCT00569790|Irinotecan|irinotecan|mesh-list
101532776|NCT00569985|Carmustine|carmustine|mesh-list
101532777|NCT00569985|Etoposide|etoposide|mesh-list
101532778|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
101532779|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101532780|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
101533077|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
101533078|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
101533079|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101533088|NCT04613102|Cannabidiol|cannabidiol|mesh-list
101533299|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533587|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101533588|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101533658|NCT00577161|Rituximab|rituximab|mesh-list
101533887|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101533888|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101533889|NCT00578760|Analgesics|analgesics|mesh-ancestor
101533890|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
101534262|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534263|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101534264|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101534265|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534266|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534267|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101534268|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
101534269|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534270|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534276|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
101534325|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
101534326|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534327|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534328|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101534329|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101534330|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101534331|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534332|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101534333|NCT00566904|Aspirin|aspirin|mesh-list
101534334|NCT00566904|Lidocaine|lidocaine|mesh-list
101534335|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
101534336|NCT00566904|Anesthetics|anesthetics|mesh-list
101534337|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101534338|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534478|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
101534479|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213151|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213152|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101213153|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
101213154|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213155|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
101213156|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101213157|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213158|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213159|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
101213160|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213161|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213162|NCT02707042|Amoxicillin|amoxicillin|mesh-list
101213163|NCT02707042|Azithromycin|azithromycin|mesh-list
101213164|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213165|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213166|NCT02598661|Imetelstat|imetelstat|mesh-list
101213167|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
101213168|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213170|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213171|NCT02586831|Exenatide|exenatide|mesh-list
101213172|NCT02586831|Aldesleukin|aldesleukin|mesh-list
101213173|NCT02586831|Adalimumab|adalimumab|mesh-list
101213174|NCT02586831|Interleukin-2|interleukin-2|mesh-list
101213175|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
101213180|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213181|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213183|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
101213184|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213185|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213186|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101213187|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101213188|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
101213189|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213190|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213191|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101213192|NCT02586831|Incretins|incretins|mesh-ancestor
101213194|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213195|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
101213196|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213197|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
101213198|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213199|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213200|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213201|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213202|NCT02511106|Osimertinib|osimertinib|mesh-list
101213203|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213204|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213205|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213206|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213207|NCT02494882|Dexamethasone|dexamethasone|mesh-list
101213208|NCT02494882|Dasatinib|dasatinib|mesh-list
101213209|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213210|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
101213211|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
101213212|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213213|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213214|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213215|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
101213216|NCT02494882|Hormones|hormones|mesh-ancestor
101213217|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213218|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101213219|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213220|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213221|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213222|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213223|NCT02481830|Nivolumab|nivolumab|mesh-list
101213224|NCT02481830|Topotecan|topotecan|mesh-list
101213225|NCT02481830|Amrubicin|amrubicin|mesh-list
101213226|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213227|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213228|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213229|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534498|NCT00568217|Acetaminophen|acetaminophen|mesh-list
101213230|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101213231|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213232|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213234|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101213235|NCT02425943|Diuretics|diuretics|mesh-ancestor
101213236|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
101213237|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213238|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
101213240|NCT02419495|Folic Acid|folic acid|mesh-list
101213241|NCT02419495|Paclitaxel|paclitaxel|mesh-list
101213242|NCT02419495|Camptothecin|camptothecin|mesh-list
101213243|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
101213244|NCT02419495|Carboplatin|carboplatin|mesh-list
101213245|NCT02419495|Doxorubicin|doxorubicin|mesh-list
101213246|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101213247|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
101213248|NCT02419495|Fluorouracil|fluorouracil|mesh-list
101213249|NCT02419495|Capecitabine|capecitabine|mesh-list
101213250|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
101213251|NCT02419495|Nivolumab|nivolumab|mesh-list
101213257|NCT02419495|Topotecan|topotecan|mesh-list
101213258|NCT02419495|Olaparib|olaparib|mesh-list
101213259|NCT02419495|Calcium|calcium|mesh-list
101213260|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
101213261|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213262|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213263|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213264|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
101213265|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
101213266|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213267|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213268|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
101213269|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213270|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213271|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101213272|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
101213273|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101213274|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101213275|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213276|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213277|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213278|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213279|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213280|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101213281|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101213282|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
101213283|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213284|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101213285|NCT02419495|Antidotes|antidotes|mesh-ancestor
101213286|NCT02419495|Protective Agents|protective agents|mesh-ancestor
101213287|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
101213288|NCT02419495|Vitamins|vitamins|mesh-ancestor
101213289|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
101213290|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101213291|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101213292|NCT02419495|Hematinics|hematinics|mesh-ancestor
101213293|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101213294|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101213295|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
101213296|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213297|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
101213298|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213299|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213300|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213301|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213302|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
101213303|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
101213304|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213305|NCT02220426|Xenon|xenon|mesh-list
101213307|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
101213308|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
101213309|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213310|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213311|NCT02135042|Paclitaxel|paclitaxel|mesh-list
101213312|NCT02135042|Cisplatin|cisplatin|mesh-list
101213313|NCT02135042|Gemcitabine|gemcitabine|mesh-list
101213314|NCT02135042|Fluorouracil|fluorouracil|mesh-list
101213315|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101213316|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213317|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213318|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213319|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101213320|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101213321|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213322|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213323|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
101213324|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213325|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
101213330|NCT02123121|Protective Agents|protective agents|mesh-ancestor
101213331|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213332|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213333|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101213334|NCT02031419|Rituximab|rituximab|mesh-list
101213335|NCT02031419|Spebrutinib|spebrutinib|mesh-list
101213336|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213337|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213339|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213340|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213341|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213342|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213343|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213344|NCT02009579|Nintedanib|nintedanib|mesh-list
101213345|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213346|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213347|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213348|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213349|NCT01959698|Rituximab|rituximab|mesh-list
101213350|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101213351|NCT01959698|Carboplatin|carboplatin|mesh-list
101213352|NCT01959698|Etoposide|etoposide|mesh-list
101213353|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
101213354|NCT01959698|Ifosfamide|ifosfamide|mesh-list
101213355|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
101213356|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
101213357|NCT01959698|Antibodies|antibodies|mesh-list
101213358|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
101213359|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101213360|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
101213361|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213362|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213363|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213364|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213365|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213366|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213367|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213368|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213369|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101213370|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
101213371|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
101213372|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
101213373|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213374|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
101213375|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
101213376|NCT01910402|Ritonavir|ritonavir|mesh-list
101213377|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101213378|NCT01910402|Tenofovir|tenofovir|mesh-list
101213379|NCT01910402|Lamivudine|lamivudine|mesh-list
101213380|NCT01910402|Emtricitabine|emtricitabine|mesh-list
101213381|NCT01910402|Dolutegravir|dolutegravir|mesh-list
101213382|NCT01910402|Abacavir|abacavir|mesh-list
101213383|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101213385|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
101213386|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213387|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213388|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101213389|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101213390|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
101213391|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213392|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101213393|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101213394|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101213395|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101213396|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101213397|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101213398|NCT01772420|Lenalidomide|lenalidomide|mesh-list
101213399|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
101213400|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213403|NCT01772420|Growth Substances|growth substances|mesh-ancestor
101213405|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213407|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213408|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
101213409|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213410|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213411|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213412|NCT01734512|Everolimus|everolimus|mesh-list
101213413|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101213414|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213415|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213416|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213417|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213418|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
101213419|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213420|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213421|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101213422|NCT01728363|Rifampin|rifampin|mesh-list
101213423|NCT01728363|Clindamycin|clindamycin|mesh-list
101213424|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
101213425|NCT01728363|Ticarcillin|ticarcillin|mesh-list
101213426|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
101213427|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213428|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101213429|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
101213430|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
101213431|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101213432|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213433|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213434|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101213435|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101213436|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101213437|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101213438|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101213439|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101213441|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101213442|NCT01614197|Cytarabine|cytarabine|mesh-list
101213443|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
101213444|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101213445|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101213446|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101213447|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
101213448|NCT01614197|Methotrexate|methotrexate|mesh-list
101213449|NCT01614197|Etoposide|etoposide|mesh-list
101213450|NCT01614197|Temsirolimus|temsirolimus|mesh-list
101213451|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213452|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
101213453|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213454|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213455|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101213456|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
101213457|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213458|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213459|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101213460|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101213461|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
101213462|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213463|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213464|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
101213465|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
101213466|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213467|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101213468|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101213469|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213470|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213471|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213472|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
101213473|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213474|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213476|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213477|NCT01422148|Minocycline|minocycline|mesh-list
101213478|NCT01422148|Amiodarone|amiodarone|mesh-list
101534521|NCT00590928|Esomeprazole|esomeprazole|mesh-list
101213479|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213480|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213481|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101213482|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
101213483|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101213484|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213485|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213486|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101213487|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101213488|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101213489|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213490|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101213491|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101213492|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101213493|NCT01341964|Aspirin|aspirin|mesh-list
101213494|NCT01341964|Clopidogrel|clopidogrel|mesh-list
101213495|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101213496|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213497|NCT01341964|Analgesics|analgesics|mesh-ancestor
101213498|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
101213499|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213500|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213501|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213502|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213503|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101213504|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101213505|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213506|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101213507|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101213508|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213509|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
101213510|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101213511|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101213512|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101213513|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
101213514|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101213515|NCT01267812|Rituximab|rituximab|mesh-list
101213516|NCT01267812|Bortezomib|bortezomib|mesh-list
101213517|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213518|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213519|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
101213520|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213521|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213522|NCT01236521|Analgesics|analgesics|mesh-list
101213523|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
101213524|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213525|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213526|NCT01042379|Metformin|metformin|mesh-list
101213527|NCT01042379|Paclitaxel|paclitaxel|mesh-list
101213528|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101213529|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101213530|NCT01042379|Carboplatin|carboplatin|mesh-list
101213532|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
101213533|NCT01042379|Trastuzumab|trastuzumab|mesh-list
101213534|NCT01042379|Irinotecan|irinotecan|mesh-list
101213535|NCT01042379|Durvalumab|durvalumab|mesh-list
101213536|NCT01042379|Letrozole|letrozole|mesh-list
101213537|NCT01042379|Olaparib|olaparib|mesh-list
101213538|NCT01042379|Pertuzumab|pertuzumab|mesh-list
101213559|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213560|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101213561|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101213562|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
101213563|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101213564|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101213565|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101213566|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
101213567|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213568|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101213569|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
101213570|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
101213571|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101213572|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101213573|NCT01042379|Growth Substances|growth substances|mesh-ancestor
101534526|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101213629|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213630|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101213631|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101213632|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
101213633|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213634|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213635|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
101213636|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101213637|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213639|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101213640|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213641|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213642|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213643|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101213644|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
101213645|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213646|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101213647|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101213648|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
101213649|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213651|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
101213652|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
101213653|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213654|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213655|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
101213656|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213657|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101213658|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101213659|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101213660|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213661|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213662|NCT01455636|Micronutrients|micronutrients|mesh-list
101213663|NCT01455636|Trace Elements|trace elements|mesh-list
101213664|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
101213665|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213666|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101213667|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213668|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
101213669|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
101213670|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101213671|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213674|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101213675|NCT01456507|Narcotics|narcotics|mesh-ancestor
101213676|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213677|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213678|NCT01456507|Analgesics|analgesics|mesh-ancestor
101213679|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
101213680|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213681|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101213682|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101213683|NCT01456585|Gemcitabine|gemcitabine|mesh-list
101213684|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213686|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213687|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213688|NCT01456650|Glyburide|glyburide|mesh-list
101213689|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213690|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213691|NCT01457040|Etoposide|etoposide|mesh-list
101213692|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
101213693|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101213694|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213695|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213696|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213697|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213698|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213699|NCT01457508|Edetic Acid|edetic acid|mesh-list
101213700|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
101213701|NCT01457508|Antidotes|antidotes|mesh-ancestor
101213702|NCT01457508|Protective Agents|protective agents|mesh-ancestor
101213710|NCT01458431|Anesthetics|anesthetics|mesh-list
101213711|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
101213712|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
101534530|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
101534531|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
101534532|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101534533|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534534|NCT01145482|Insulin|insulin|mesh-list
101534535|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
101534536|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101534537|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534538|NCT00568295|Acetaminophen|acetaminophen|mesh-list
101534539|NCT00568295|Rofecoxib|rofecoxib|mesh-list
101534541|NCT00568295|Analgesics|analgesics|mesh-ancestor
101534542|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
101534543|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534544|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534545|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
101534546|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101534547|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101213713|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213714|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213715|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
101213716|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213717|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
101213718|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101213719|NCT01459445|Metformin|metformin|mesh-list
101213720|NCT01459445|Drospirenone|drospirenone|mesh-list
101213721|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101213722|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213723|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213724|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101213725|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101213726|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101213727|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
101213728|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213729|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101213730|NCT01459445|Estrogens|estrogens|mesh-ancestor
101213731|NCT01459445|Hormones|hormones|mesh-ancestor
101213732|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213733|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101213734|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
101213735|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101213736|NCT01459445|Diuretics|diuretics|mesh-ancestor
101213737|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
101213738|NCT01460030|Cinacalcet|cinacalcet|mesh-list
101213739|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101213740|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213741|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101213742|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
101213743|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213744|NCT01460069|Liraglutide|liraglutide|mesh-list
101213745|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213746|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213748|NCT01460069|Hormones|hormones|mesh-ancestor
101213749|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101213750|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101213751|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
101213752|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213753|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
101213754|NCT01460212|Citalopram|citalopram|mesh-list
101213755|NCT01460212|Fluoxetine|fluoxetine|mesh-list
101213756|NCT01460212|Paroxetine|paroxetine|mesh-list
101534555|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101534556|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101534557|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534558|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534559|NCT00583518|Hormones|hormones|mesh-list
101534560|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
101534561|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534562|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534563|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101534564|NCT04582136|Sirolimus|sirolimus|mesh-list
101534577|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534578|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213758|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
101213759|NCT01460212|Escitalopram|escitalopram|mesh-list
101213760|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101213761|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101213762|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213763|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213764|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101213765|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
101213766|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213767|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101213768|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101213769|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101213770|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101213771|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213772|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101213773|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101213776|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101213777|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
101213778|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101213779|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101213780|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101213781|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213782|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213783|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
101213784|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101213785|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213786|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101213787|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213788|NCT01460420|Lenalidomide|lenalidomide|mesh-list
101213790|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
101213791|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213792|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101213793|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101213794|NCT01460420|Growth Substances|growth substances|mesh-ancestor
101213795|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
101213796|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213797|NCT01460498|Azacitidine|azacitidine|mesh-list
101213798|NCT01460498|Decitabine|decitabine|mesh-list
101213799|NCT01460498|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
101213800|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101213801|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
101213802|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213803|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213804|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213805|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213806|NCT01460537|Gemcitabine|gemcitabine|mesh-list
101213807|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213808|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534582|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213809|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
101213810|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213811|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
101213812|NCT01460563|Analgesics|analgesics|mesh-ancestor
101213813|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
101213814|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213815|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213816|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
101213817|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213818|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101213819|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
101213820|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101213821|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213822|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213823|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101213825|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213826|NCT01460602|Rituximab|rituximab|mesh-list
101213827|NCT01460602|Bortezomib|bortezomib|mesh-list
101213828|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101213829|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213830|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
101213831|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213832|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213833|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
101213834|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213835|NCT01460667|Acetaminophen|acetaminophen|mesh-list
101213836|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213837|NCT01460667|Analgesics|analgesics|mesh-ancestor
101213838|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
101213839|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213840|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213841|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
101213842|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
101213843|NCT01460693|Dasatinib|dasatinib|mesh-list
101213844|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213845|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213846|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213847|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213849|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101213850|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213851|NCT01460797|Metformin|metformin|mesh-list
101213852|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213853|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213854|NCT01460836|Tobramycin|tobramycin|mesh-list
101213855|NCT01460836|Aztreonam|aztreonam|mesh-list
101213856|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213857|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213858|NCT01460888|Olaparib|olaparib|mesh-list
101213859|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101213860|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213861|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213862|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213863|NCT01460979|Sirolimus|sirolimus|mesh-list
101213864|NCT01460979|Temsirolimus|temsirolimus|mesh-list
101213865|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
101213866|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213867|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213868|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213869|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213870|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
101213871|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213872|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213873|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213874|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213875|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101213876|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
101213877|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
101213878|NCT01461018|Antibodies|antibodies|mesh-list
101213879|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
101213880|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101213881|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101213882|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
101213883|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213884|NCT01461031|Nefopam|nefopam|mesh-list
101213885|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101213886|NCT01461031|Analgesics|analgesics|mesh-ancestor
101213888|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101213889|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213890|NCT01461174|Memantine|memantine|mesh-list
101213891|NCT01461174|Modafinil|modafinil|mesh-list
101213892|NCT01461174|Donepezil|donepezil|mesh-list
101213893|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101213894|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213895|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213896|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101213897|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101213898|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213899|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
101213900|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101213901|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101213902|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
101213903|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101213904|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101213905|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101213906|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101213907|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101213908|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101213909|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
101213910|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
101213912|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
101213913|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213914|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213915|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101213916|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101213917|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213918|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213919|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213920|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101213921|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
101213922|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213923|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213924|NCT01461616|Insulin|insulin|mesh-list
101213925|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101213926|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
101213927|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
101213928|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101213929|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213930|NCT01461746|Docetaxel|docetaxel|mesh-list
101213931|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213932|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
101213933|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
101213934|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
101213935|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213936|NCT01461759|Cisplatin|cisplatin|mesh-list
101213937|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213938|NCT01461772|Carboplatin|carboplatin|mesh-list
101213939|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213940|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101213941|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
101213942|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213944|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101213945|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213946|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101213947|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213948|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
101213949|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213950|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
101213951|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213953|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
101213954|NCT01462058|Vitamins|vitamins|mesh-ancestor
101213955|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
101213956|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213957|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101213958|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101213959|NCT01462149|Carboplatin|carboplatin|mesh-list
101213960|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213961|NCT01462214|Everolimus|everolimus|mesh-list
101213962|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101213963|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213964|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213965|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534587|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213966|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213967|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
101213968|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213969|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213970|NCT01462422|Misoprostol|misoprostol|mesh-list
101213971|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101213972|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
101213973|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101213974|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213975|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101213976|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101213977|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
101213978|NCT01462474|Cisplatin|cisplatin|mesh-list
101213979|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101213980|NCT01462487|Zanamivir|zanamivir|mesh-list
101213981|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
101213982|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213983|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213984|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213985|NCT01462500|Miltefosine|miltefosine|mesh-list
101213986|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
101213987|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101213989|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101213990|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101213991|NCT01462617|Nemiralisib|nemiralisib|mesh-list
101213992|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213993|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101213994|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213995|NCT01462669|Ezogabine|ezogabine|mesh-list
101213996|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
101213997|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101213998|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213999|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
101214000|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
101214001|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214002|NCT01462968|Heparin|heparin|mesh-list
101214003|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
101214004|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101214007|NCT01463046|Cytarabine|cytarabine|mesh-list
101214008|NCT01463046|Daunorubicin|daunorubicin|mesh-list
101214009|NCT01463046|Panobinostat|panobinostat|mesh-list
101214010|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214011|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
101214012|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214013|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214014|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
101214015|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214016|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214017|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
101214018|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214019|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214020|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101214021|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101214023|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101214024|NCT01463150|Clopidogrel|clopidogrel|mesh-list
101214025|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101214026|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214027|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101214028|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101214029|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101214030|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
101214031|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214032|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214033|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214035|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101214036|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214037|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101214038|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101214039|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101214040|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
101214041|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214042|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534595|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101534596|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214043|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214045|NCT01463215|Expectorants|expectorants|mesh-ancestor
101214046|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214047|NCT01463228|Metformin|metformin|mesh-list
101214048|NCT01463228|Canagliflozin|canagliflozin|mesh-list
101214049|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214050|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214051|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101214052|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214053|NCT01463280|Lidocaine|lidocaine|mesh-list
101214054|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
101214055|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
101214056|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214057|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214058|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
101214059|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214060|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101214061|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101214062|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101214063|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214064|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214065|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
101214066|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101214067|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214068|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214069|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101214071|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
101214072|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214073|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101214074|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101214075|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101214076|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
101214077|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214081|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214082|NCT01463592|Iodine|iodine|mesh-list
101214083|NCT01463592|Interferons|interferons|mesh-list
101214084|NCT01463592|Ribavirin|ribavirin|mesh-list
101214085|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
101214086|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
101214087|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
101214088|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214089|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
101214090|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214091|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
101214092|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214093|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
101214094|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214095|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101214096|NCT01463592|Trace Elements|trace elements|mesh-ancestor
101214097|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
101214098|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
101214099|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101214100|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214101|NCT01463735|Vitamin E|vitamin e|mesh-list
101214102|NCT01463735|Vitamins|vitamins|mesh-ancestor
101214103|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
101214104|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214105|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
101214106|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214107|NCT01463735|Protective Agents|protective agents|mesh-ancestor
101214108|NCT01463774|Metformin|metformin|mesh-list
101214109|NCT01463774|Canagliflozin|canagliflozin|mesh-list
101214110|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214111|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214112|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101214113|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214114|NCT01463813|Vitamin D|vitamin d|mesh-list
101214115|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
101214116|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
101214117|NCT01463813|Vitamins|vitamins|mesh-list
101214118|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
101214119|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214120|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101214121|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214122|NCT01463852|Vincristine|vincristine|mesh-list
101214123|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101214124|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214125|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101214126|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101214127|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101214128|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214129|NCT01463865|Ropivacaine|ropivacaine|mesh-list
101214130|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
101214131|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
101214132|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214133|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214134|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
101214136|NCT01463956|Interferons|interferons|mesh-list
101214137|NCT01463956|Ribavirin|ribavirin|mesh-list
101214138|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214139|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
101214140|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214141|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
101214142|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214143|NCT01464008|Interferons|interferons|mesh-list
101214144|NCT01464008|Ribavirin|ribavirin|mesh-list
101214145|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
101214146|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
101214147|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101214148|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214149|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
101214150|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214151|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
101214152|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214153|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
101214155|NCT01464060|Amoxicillin|amoxicillin|mesh-list
101214156|NCT01464060|Metronidazole|metronidazole|mesh-list
101214157|NCT01464060|Clarithromycin|clarithromycin|mesh-list
101214158|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214159|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214160|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101214161|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101214162|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101214163|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214164|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214165|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101214166|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101214167|NCT01464099|Insulin|insulin|mesh-list
101214168|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214169|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
101214170|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
101214171|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101214172|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214173|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214174|NCT01464112|Dexamethasone|dexamethasone|mesh-list
101214175|NCT01464112|Bortezomib|bortezomib|mesh-list
101214176|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214177|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
101214178|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
101214179|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214180|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214181|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101214182|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
101214183|NCT01464112|Hormones|hormones|mesh-ancestor
101214184|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214185|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101214186|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214187|NCT01464125|Azithromycin|azithromycin|mesh-list
101214188|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
101214189|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214190|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214191|NCT01464138|Clindamycin|clindamycin|mesh-list
101214192|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
101214193|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
101214194|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
101214195|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214196|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214197|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101214198|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214199|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214200|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
101214201|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
101214202|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101214204|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214205|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214207|NCT01464242|Protective Agents|protective agents|mesh-ancestor
101214208|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214209|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214210|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101214211|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
101214212|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101214213|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101214214|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214215|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101214216|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
101214217|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214218|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
101214219|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101214220|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
101214221|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101214222|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
101214223|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214224|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214225|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
101214226|NCT01464476|Azimilide|azimilide|mesh-list
101214227|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101214228|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101214229|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214230|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214233|NCT01464489|Atropine|atropine|mesh-list
101214234|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101214235|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101214236|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101214237|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
101214238|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214239|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214240|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101214241|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214242|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
101214243|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
101214244|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101214245|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101214246|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
101214247|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214248|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214249|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101214250|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101214251|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101214252|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
101214253|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214254|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101214255|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101214256|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214257|NCT01466712|Beclomethasone|beclomethasone|mesh-list
101214258|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
101214259|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
101214260|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101214261|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
101214262|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214263|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214264|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101214265|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214266|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101214267|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101214268|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101214269|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
101214270|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214271|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214272|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
101214273|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101214274|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
101214275|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214276|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
101214278|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214279|NCT01466829|Hormones|hormones|mesh-list
101214280|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
101214281|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214282|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214283|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214284|NCT01466855|Topotecan|topotecan|mesh-list
101214285|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101214286|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101214287|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214288|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214289|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214290|NCT01466959|Acetic Acid|acetic acid|mesh-list
101214291|NCT01466959|Retinol acetate|retinol acetate|mesh-list
101214292|NCT01466959|Citric Acid|citric acid|mesh-list
101214293|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
101214294|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
101214295|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101214296|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
101214297|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
101214298|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214299|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101214300|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214301|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214302|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101214305|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101214306|NCT01466959|Protective Agents|protective agents|mesh-ancestor
101214307|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214308|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
101214309|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214310|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214311|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101214312|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
101214313|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214314|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214315|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214316|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214317|NCT01467115|Leucovorin|leucovorin|mesh-list
101214318|NCT01467115|Docetaxel|docetaxel|mesh-list
101214319|NCT01467115|Fluorouracil|fluorouracil|mesh-list
101214320|NCT01467115|Cetuximab|cetuximab|mesh-list
101214321|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
101214322|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
101214323|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214324|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
101214325|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
101214326|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
101214327|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214328|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
101214329|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214331|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
101214332|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214333|NCT01467115|Antidotes|antidotes|mesh-ancestor
101214334|NCT01467115|Protective Agents|protective agents|mesh-ancestor
101214335|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
101214336|NCT01467115|Vitamins|vitamins|mesh-ancestor
101214338|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101214339|NCT01467115|Hematinics|hematinics|mesh-ancestor
101214340|NCT01467141|Insulin|insulin|mesh-list
101214341|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214342|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
101214343|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
101214344|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
101214345|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
101214346|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214347|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214348|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101214349|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101214350|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214351|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101214352|NCT01467258|Amantadine|amantadine|mesh-list
101214353|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101214354|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101214355|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
101214356|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214357|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
101534632|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534633|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534634|NCT00568529|Capecitabine|capecitabine|mesh-list
101534635|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
101534636|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534637|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
101534638|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534639|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534640|NCT00568568|Hormones|hormones|mesh-list
101534641|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101534642|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534643|NCT04575558|Azithromycin|azithromycin|mesh-list
101534655|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534656|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101534657|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214358|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214359|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214360|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214361|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101214362|NCT01467258|Analgesics|analgesics|mesh-ancestor
101214363|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
101214364|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214365|NCT01467297|Levofloxacin|levofloxacin|mesh-list
101214366|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101214367|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214368|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214369|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101214370|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101214371|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214372|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214373|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214374|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101214375|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101214376|NCT01467310|Trametinib|trametinib|mesh-list
101214377|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214378|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214379|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214384|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
101214385|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214386|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214387|NCT01467362|Desonide|desonide|mesh-list
101214388|NCT01467362|V0034CR|v0034cr|mesh-list
101214389|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214390|NCT01467362|Emollients|emollients|mesh-ancestor
101214391|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
101214392|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
101214393|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
101214394|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214395|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214396|NCT01467401|Insulin|insulin|mesh-list
101214397|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214398|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
101214399|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
101214400|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214401|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214402|NCT01467414|Insulin|insulin|mesh-list
101214403|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214404|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214405|NCT01467518|Dolutegravir|dolutegravir|mesh-list
101214406|NCT01467518|Methadone|methadone|mesh-list
101534660|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214407|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101214408|NCT01467518|Narcotics|narcotics|mesh-ancestor
101214409|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214410|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214411|NCT01467518|Analgesics|analgesics|mesh-ancestor
101214412|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
101214413|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214414|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
101214415|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214416|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101214417|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101214418|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214419|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214420|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101214421|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101214422|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
101214423|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214424|NCT01467531|Dolutegravir|dolutegravir|mesh-list
101214425|NCT01467531|Cabotegravir|cabotegravir|mesh-list
101214426|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101214427|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101214428|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214429|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214430|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101214431|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101214432|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
101214433|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214434|NCT01467596|Lidocaine|lidocaine|mesh-list
101214435|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
101214436|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
101214437|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
101214438|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214439|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214440|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
101214441|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214442|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101214443|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101214444|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101214445|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214446|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214448|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214449|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214450|NCT01467687|Verapamil|verapamil|mesh-list
101214451|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101214452|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101214453|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214454|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214460|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101214461|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101214462|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101214463|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214464|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214465|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214466|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
101214467|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214469|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214470|NCT01467986|Sirolimus|sirolimus|mesh-list
101214471|NCT01467986|Irinotecan|irinotecan|mesh-list
101214472|NCT01467986|Temozolomide|temozolomide|mesh-list
101214473|NCT01467986|Dasatinib|dasatinib|mesh-list
101214474|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101214475|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101214476|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214477|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214478|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214479|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101214480|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
101214481|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214482|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214483|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214484|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
101534679|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101534680|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101214485|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214486|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
101214487|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214488|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214489|NCT01468025|Naproxen|naproxen|mesh-list
101214490|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101214491|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101214492|NCT01468025|Analgesics|analgesics|mesh-ancestor
101214493|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
101214494|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214495|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214496|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214497|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214498|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
101214499|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101214500|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214501|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214502|NCT01468038|Trazodone|trazodone|mesh-list
101214503|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101214504|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101214505|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214506|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214507|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101214508|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101214509|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101214510|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214511|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214512|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214513|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
101214514|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101214515|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
101214516|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101214517|NCT01468051|Vaccines|vaccines|mesh-list
101214518|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
101214519|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214520|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101214521|NCT01468051|Antacids|antacids|mesh-ancestor
101214522|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214526|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101214527|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
101214528|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214529|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214531|NCT01468259|Droxidopa|droxidopa|mesh-list
101214532|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101214533|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101214534|NCT01468272|Beclomethasone|beclomethasone|mesh-list
101214535|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
101214536|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101214537|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
101214538|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214539|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214540|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101214541|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214542|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101214543|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101214544|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101214545|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
101214546|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214547|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214548|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214549|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
101214551|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214552|NCT01468285|Betahistine|betahistine|mesh-list
101214553|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214554|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
101214555|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
101214556|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214557|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214558|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534681|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214559|NCT01468389|Capecitabine|capecitabine|mesh-list
101214560|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214561|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
101214562|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214563|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214564|NCT01468415|Phenol|phenol|mesh-list
101214565|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101214566|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214567|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
101214568|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101214569|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101214570|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101214571|NCT01468441|Cetrorelix|cetrorelix|mesh-list
101214572|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
101214573|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101214574|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
101214575|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101214576|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214577|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101214578|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101214579|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214580|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101214581|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
101214582|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
101214583|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214584|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
101214585|NCT01468480|Calcium|calcium|mesh-list
101214586|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214587|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214588|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101214589|NCT01468519|Insulin|insulin|mesh-list
101214590|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214591|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214592|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214594|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214595|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214596|NCT01468571|Spironolactone|spironolactone|mesh-list
101214598|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
101214599|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214600|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214601|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101214602|NCT01468571|Diuretics|diuretics|mesh-ancestor
101214603|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
101214604|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101214605|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101214606|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101214607|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214608|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214609|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214610|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214611|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
101214612|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101214613|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
101214614|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214615|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214616|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214617|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214618|NCT01468714|Ketoconazole|ketoconazole|mesh-list
101214619|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
101214620|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214621|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101214622|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101214623|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214624|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214625|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101214626|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
101214627|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214628|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214629|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101214630|NCT01468740|Prednisone|prednisone|mesh-list
101534699|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101214631|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
101214633|NCT01468740|Doxorubicin|doxorubicin|mesh-list
101214634|NCT01468740|Etoposide|etoposide|mesh-list
101214635|NCT01468740|Vincristine|vincristine|mesh-list
101214636|NCT01468740|Bleomycin|bleomycin|mesh-list
101214637|NCT01468740|Vinblastine|vinblastine|mesh-list
101214638|NCT01468740|Procarbazine|procarbazine|mesh-list
101214639|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214640|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
101214641|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214642|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214643|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101214644|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
101214645|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214646|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214648|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214649|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101214650|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101214651|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214652|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214653|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
101214654|NCT01468740|Hormones|hormones|mesh-ancestor
101214655|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214656|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101214657|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101214660|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
101214661|NCT01469143|Insulin|insulin|mesh-list
101214662|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214663|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
101214664|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
101214665|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
101214666|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214667|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214668|NCT01469169|Iloprost|iloprost|mesh-list
101214669|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214670|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214671|NCT01469338|Prednisone|prednisone|mesh-list
101214672|NCT01469338|Octreotide|octreotide|mesh-list
101214674|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
101214675|NCT01469338|Hormones|hormones|mesh-ancestor
101214676|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214677|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214678|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101214679|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214680|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101214682|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214683|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214684|NCT01469351|Incretins|incretins|mesh-ancestor
101214685|NCT01469351|Hormones|hormones|mesh-ancestor
101214686|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214687|NCT01469416|Clopidogrel|clopidogrel|mesh-list
101214688|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101214689|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214690|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101214691|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101214692|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101214693|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
101214694|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214695|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214696|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214697|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101214698|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101214699|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
101214700|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101214701|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101214702|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214703|NCT01469468|Simvastatin|simvastatin|mesh-list
101214704|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101214705|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101214706|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
101214707|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214709|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101214710|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214711|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
101214712|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214713|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214714|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
101214715|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101214716|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
101214717|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214718|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
101214719|NCT01469507|Protective Agents|protective agents|mesh-ancestor
101214720|NCT01469520|Lamivudine|lamivudine|mesh-list
101214721|NCT01469520|Zidovudine|zidovudine|mesh-list
101214722|NCT01469520|Nevirapine|nevirapine|mesh-list
101214723|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101214724|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101214725|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214726|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214727|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
101214728|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214729|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101214730|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101214731|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
101214732|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101214733|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101214734|NCT01469559|Insulin|insulin|mesh-list
101214735|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214736|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214737|NCT01469572|Everolimus|everolimus|mesh-list
101214738|NCT01469572|Pasireotide|pasireotide|mesh-list
101214739|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101214740|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214741|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214742|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214743|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214744|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
101214745|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214746|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214748|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214751|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214752|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
101214753|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214754|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214755|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
101214756|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
101214757|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
101214758|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
101214759|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101214760|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214761|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214762|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214763|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101214764|NCT01469624|Protective Agents|protective agents|mesh-ancestor
101214765|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214766|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214767|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101214768|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
101214769|NCT01469650|Vitamin D|vitamin d|mesh-list
101214770|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
101214771|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
101214772|NCT01469650|Vitamins|vitamins|mesh-list
101214773|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
101214774|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214775|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101214776|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214777|NCT01469702|Azithromycin|azithromycin|mesh-list
101214778|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214779|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214780|NCT01469884|Cyclosporine|cyclosporine|mesh-list
101214781|NCT01469884|Everolimus|everolimus|mesh-list
101214782|NCT01469884|Tacrolimus|tacrolimus|mesh-list
101214783|NCT01469884|Cyclosporins|cyclosporins|mesh-list
101214784|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214785|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
101214786|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214787|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101214788|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534731|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534732|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
101534733|NCT00569816|Sevoflurane|sevoflurane|mesh-list
101534734|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214789|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214790|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
101214791|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214792|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
101214793|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214794|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101214795|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214796|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214797|NCT01469975|Edetic Acid|edetic acid|mesh-list
101214798|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
101214799|NCT01469975|Antidotes|antidotes|mesh-ancestor
101214800|NCT01469975|Protective Agents|protective agents|mesh-ancestor
101214801|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214802|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
101214803|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
101214804|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214805|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101214806|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
101214807|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101214808|NCT01469988|Testosterone|testosterone|mesh-list
101214809|NCT01469988|Androgens|androgens|mesh-ancestor
101214811|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214812|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214813|NCT01470040|Aspirin|aspirin|mesh-list
101214814|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101214815|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101214816|NCT01470040|Analgesics|analgesics|mesh-ancestor
101214817|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
101214818|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214819|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214820|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214821|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214822|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101214824|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214825|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101214826|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101214827|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214828|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
101214829|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
101214830|NCT01470053|Azelastine|azelastine|mesh-list
101214831|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214832|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
101214833|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101214834|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101214835|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
101214836|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214837|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214838|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101214839|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
101214840|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
101214841|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214842|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214843|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101214844|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101214845|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
101214846|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
101214847|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214848|NCT01470092|Tibolone|tibolone|mesh-list
101214849|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
101214850|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
101214851|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214852|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214853|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101214854|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101214856|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101214857|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
101214858|NCT01470092|Hormones|hormones|mesh-ancestor
101534747|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534748|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534749|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101214859|NCT01470157|Ketamine|ketamine|mesh-list
101214860|NCT01470157|Analgesics|analgesics|mesh-ancestor
101214861|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
101214862|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214863|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214864|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101214865|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101214866|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
101214867|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
101214868|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101214869|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101214870|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101214871|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214872|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214873|NCT01470209|Everolimus|everolimus|mesh-list
101214874|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101214875|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214876|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214877|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214878|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214879|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
101214880|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214881|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214882|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
101214883|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101214884|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101214885|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
101214886|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101214887|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214888|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101214889|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101214890|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101214891|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101214892|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214893|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214894|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214898|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214901|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
101214902|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101214903|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101214904|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101214905|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101214906|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214907|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101214908|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214909|NCT01470352|Analgesics|analgesics|mesh-ancestor
101214910|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
101214911|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214912|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
101214913|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101214914|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
101214915|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
101214916|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214919|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214920|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
101214921|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214922|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214923|NCT01470495|Sorafenib|sorafenib|mesh-list
101214924|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214925|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101214926|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214927|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214928|NCT01470690|Omeprazole|omeprazole|mesh-list
101214929|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101214930|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101534761|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101534762|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101534763|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534764|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
101534765|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101534766|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
101534767|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
101534768|NCT00570440|Estradiol|estradiol|mesh-list
101534769|NCT00570440|Estrogens|estrogens|mesh-ancestor
101214931|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101214932|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214933|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214934|NCT01470742|Capecitabine|capecitabine|mesh-list
101214935|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214936|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
101214937|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214938|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214939|NCT01470794|Flucytosine|flucytosine|mesh-list
101214940|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
101214941|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214942|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
101214943|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214944|NCT01470807|Pancrelipase|pancrelipase|mesh-list
101214945|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101214946|NCT01470937|Acarbose|acarbose|mesh-list
101214947|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101214948|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101214949|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214950|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101214951|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214952|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
101214953|NCT01471067|Rituximab|rituximab|mesh-list
101214954|NCT01471067|Fludarabine|fludarabine|mesh-list
101214955|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
101214956|NCT01471067|Melphalan|melphalan|mesh-list
101214958|NCT01471067|Clofarabine|clofarabine|mesh-list
101214959|NCT01471067|Tacrolimus|tacrolimus|mesh-list
101214960|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
101214961|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101214962|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101214963|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214964|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
101214965|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214966|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101214967|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101214968|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
101214969|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214970|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101214971|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101214974|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101214975|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101214976|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
101214977|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214978|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101214979|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
101214980|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101214981|NCT01471132|Paclitaxel|paclitaxel|mesh-list
101214983|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101214984|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101214985|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
101214986|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
101214987|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
101214988|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214989|NCT01471145|Naltrexone|naltrexone|mesh-list
101214990|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101214991|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101214992|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214993|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
101534776|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101214994|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101214995|NCT01471158|Timolol|timolol|mesh-list
101214996|NCT01471158|Dorzolamide|dorzolamide|mesh-list
101214997|NCT01471158|Maleic acid|maleic acid|mesh-list
101214998|NCT01471158|Brinzolamide|brinzolamide|mesh-list
101214999|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215000|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215001|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101215002|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101215003|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215004|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215005|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215006|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101215007|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101215008|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101215009|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101215010|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101215011|NCT01471262|Liver Extracts|liver extracts|mesh-list
101215012|NCT01471262|Hematinics|hematinics|mesh-ancestor
101215013|NCT01471275|Metformin|metformin|mesh-list
101215014|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215015|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215016|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101215017|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101215018|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215019|NCT01471470|Bevacizumab|bevacizumab|mesh-list
101215020|NCT01471470|Docetaxel|docetaxel|mesh-list
101215021|NCT01471470|Capecitabine|capecitabine|mesh-list
101215022|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215023|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215024|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101215025|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101215026|NCT01471470|Growth Substances|growth substances|mesh-ancestor
101215027|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215028|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
101215029|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101215030|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101215031|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101215032|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215033|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215034|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
101215035|NCT01471535|Interferons|interferons|mesh-list
101215036|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
101215037|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
101215038|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101215039|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215040|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
101215041|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215042|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
101215043|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215044|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
101215045|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
101215046|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101215047|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215049|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
101215050|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101215051|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101215052|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215054|NCT01471678|Dutasteride|dutasteride|mesh-list
101215055|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101215056|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101215057|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101215058|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215059|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215060|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215061|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215062|NCT01471678|Urological Agents|urological agents|mesh-ancestor
101215063|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101215064|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101215065|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215066|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
101215067|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215068|NCT01471704|Verapamil|verapamil|mesh-list
101215069|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101534824|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534825|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101534826|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101534827|NCT00571142|Growth Substances|growth substances|mesh-ancestor
101534833|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101534834|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101534847|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
101534848|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101534906|NCT00571298|Protective Agents|protective agents|mesh-ancestor
101534907|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534908|NCT00571298|Antidotes|antidotes|mesh-ancestor
101534922|NCT04575519|Ibuprofen|ibuprofen|mesh-list
101534923|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101534924|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101534925|NCT04575519|Analgesics|analgesics|mesh-ancestor
101534926|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
101215070|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101215071|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215072|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215073|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215074|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215075|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
101215076|NCT01471730|Thrombin|thrombin|mesh-list
101215077|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
101215078|NCT01471730|Coagulants|coagulants|mesh-ancestor
101215079|NCT01471808|Metformin|metformin|mesh-list
101215080|NCT01471808|Pioglitazone|pioglitazone|mesh-list
101215081|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101215082|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215083|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215084|NCT01471808|Incretins|incretins|mesh-ancestor
101215085|NCT01471808|Hormones|hormones|mesh-ancestor
101215086|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215087|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101215088|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
101215089|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215090|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215091|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101215092|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
101215093|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215094|NCT01471847|Capecitabine|capecitabine|mesh-list
101215095|NCT01471847|Trastuzumab|trastuzumab|mesh-list
101215096|NCT01471847|Lapatinib|lapatinib|mesh-list
101215097|NCT01471847|Dactolisib|dactolisib|mesh-list
101215098|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215099|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
101215100|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215101|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215102|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215103|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215104|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215106|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101215107|NCT01471886|Naproxen|naproxen|mesh-list
101215108|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101215109|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215110|NCT01471886|Analgesics|analgesics|mesh-ancestor
101215111|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
101215112|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215113|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215114|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215115|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101534927|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101534928|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534929|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101534937|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
101534960|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101534961|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101534962|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101534989|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101534990|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101534991|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101534992|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101534993|NCT00585000|Tremelimumab|tremelimumab|mesh-list
101534994|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535016|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535017|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101535018|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535064|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101215116|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101215117|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215118|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215119|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
101215120|NCT01471899|Ketorolac|ketorolac|mesh-list
101215121|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101215122|NCT01471899|Naproxen|naproxen|mesh-list
101215123|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101215124|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215125|NCT01471899|Analgesics|analgesics|mesh-ancestor
101215126|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
101215127|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215128|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215129|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215130|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215131|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101215132|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215133|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215134|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
101215135|NCT01471925|Esomeprazole|esomeprazole|mesh-list
101215136|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101215137|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215138|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101215139|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215140|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215141|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101215142|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215143|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215144|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215145|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215146|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
101215147|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
101215148|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215149|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
101215150|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101215151|NCT01471990|Protective Agents|protective agents|mesh-ancestor
101215152|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535065|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535067|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535068|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101535069|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101535086|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
101535087|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535088|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101535089|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101535090|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535091|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535092|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101535093|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
101535115|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
101215153|NCT01471990|Growth Substances|growth substances|mesh-ancestor
101215154|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215155|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215156|NCT01472016|Docetaxel|docetaxel|mesh-list
101215157|NCT01472016|Cetuximab|cetuximab|mesh-list
101215159|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215160|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
101215161|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
101215162|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
101215163|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215164|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215165|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215166|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215167|NCT01472029|Leucovorin|leucovorin|mesh-list
101215168|NCT01472029|Docetaxel|docetaxel|mesh-list
101215169|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
101215170|NCT01472029|Trastuzumab|trastuzumab|mesh-list
101215171|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215172|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
101215173|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
101215174|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
101215175|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215176|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215177|NCT01472029|Antidotes|antidotes|mesh-ancestor
101215178|NCT01472029|Protective Agents|protective agents|mesh-ancestor
101215179|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215180|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
101215181|NCT01472029|Vitamins|vitamins|mesh-ancestor
101215182|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
101215183|NCT01472055|Fludarabine|fludarabine|mesh-list
101215184|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215185|NCT01472146|Doxorubicin|doxorubicin|mesh-list
101215186|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215187|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101215188|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101215189|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101215190|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215191|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215192|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
101215193|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101215194|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215195|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215196|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101215197|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101215199|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215200|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
101215201|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101535116|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101535117|NCT00585741|Alovudine|alovudine|mesh-list
101535118|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
101535119|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535120|NCT03450798|Anesthetics|anesthetics|mesh-list
101535121|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535122|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535123|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
101535124|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535125|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535145|NCT00573404|Sunitinib|sunitinib|mesh-list
101535146|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
101535147|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535148|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101535149|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101535150|NCT00573404|Growth Substances|growth substances|mesh-ancestor
101535151|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535152|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535153|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535154|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535155|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535156|NCT01139125|Cysteamine|cysteamine|mesh-list
101535217|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535218|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215202|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
101215203|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
101215204|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
101215205|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101215206|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101215207|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101215208|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
101215209|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101215210|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215211|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101215212|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101215213|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101215214|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101215215|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215216|NCT01472406|Pancrelipase|pancrelipase|mesh-list
101215217|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215218|NCT01472497|Pioglitazone|pioglitazone|mesh-list
101215219|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215220|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215222|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101215223|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101215224|NCT01472510|Growth Substances|growth substances|mesh-ancestor
101215225|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215226|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
101215227|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215228|NCT01472640|Liraglutide|liraglutide|mesh-list
101535219|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101535220|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535221|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101535222|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535223|NCT01138501|Factor VIII|factor viii|mesh-list
101535224|NCT01138501|Coagulants|coagulants|mesh-ancestor
101535225|NCT01138150|Naproxen|naproxen|mesh-list
101535226|NCT01138150|Sumatriptan|sumatriptan|mesh-list
101535227|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535228|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101535229|NCT01138150|Analgesics|analgesics|mesh-ancestor
101535230|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
101535231|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535232|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535233|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535234|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535235|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
101535236|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535237|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535238|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535239|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101535240|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101535241|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101535242|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
101535293|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215229|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215230|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215231|NCT01472640|Incretins|incretins|mesh-ancestor
101215233|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215234|NCT01472653|Cetuximab|cetuximab|mesh-list
101215235|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215238|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
101215239|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
101215240|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215241|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101215242|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
101215243|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215244|NCT01472770|Gemcitabine|gemcitabine|mesh-list
101215245|NCT01472770|Capecitabine|capecitabine|mesh-list
101215246|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215247|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
101215248|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215249|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215250|NCT01472783|Veliparib|veliparib|mesh-list
101215251|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101215252|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215253|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215254|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215255|NCT01472796|Vitamin D|vitamin d|mesh-list
101215256|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
101535318|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535319|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
101535320|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
101535321|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
101535322|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
101535323|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535324|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101535325|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215257|NCT01472796|Vitamins|vitamins|mesh-ancestor
101215258|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
101215259|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215260|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101215261|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215262|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101215263|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
101215264|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
101215265|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
101215266|NCT01472913|Coagulants|coagulants|mesh-ancestor
101215267|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101215268|NCT01472926|Plasminogen|plasminogen|mesh-list
101215269|NCT01472926|Tenecteplase|tenecteplase|mesh-list
101215270|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101215271|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101215272|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215273|NCT01472978|Metronidazole|metronidazole|mesh-list
101215274|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215275|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101215276|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101215279|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215280|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215281|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215282|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215283|NCT01473069|Ketoconazole|ketoconazole|mesh-list
101215284|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
101215285|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215286|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101215287|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101215288|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215289|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215290|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101215291|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
101215292|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215293|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215294|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101215296|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215297|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215298|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101215299|NCT01473147|Incretins|incretins|mesh-ancestor
101215300|NCT01473147|Hormones|hormones|mesh-ancestor
101215301|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215303|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101215304|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215305|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101215306|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215307|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215308|NCT01473251|Bevacizumab|bevacizumab|mesh-list
101215309|NCT01473251|Ranibizumab|ranibizumab|mesh-list
101215310|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215311|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215312|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101215313|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101215314|NCT01473251|Growth Substances|growth substances|mesh-ancestor
101215315|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215316|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
101215317|NCT01473277|Triamcinolone|triamcinolone|mesh-list
101215318|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101535336|NCT00586443|Growth Substances|growth substances|mesh-ancestor
101535337|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535340|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101535354|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535355|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535356|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101215319|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101215320|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101215321|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101215322|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215323|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
101215324|NCT01473277|Hormones|hormones|mesh-ancestor
101215325|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215326|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215327|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215328|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
101215329|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215330|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215331|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101215332|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215333|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
101215334|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215335|NCT01473303|Leucovorin|leucovorin|mesh-list
101215336|NCT01473303|Fluorouracil|fluorouracil|mesh-list
101215337|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
101215338|NCT01473303|Irinotecan|irinotecan|mesh-list
101215339|NCT01473303|Calcium|calcium|mesh-list
101215340|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
101215341|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215342|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215343|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
101215344|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215345|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215346|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215347|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215349|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101215350|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101215351|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215353|NCT01473303|Protective Agents|protective agents|mesh-ancestor
101215354|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
101215355|NCT01473303|Vitamins|vitamins|mesh-ancestor
101215356|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
101215357|NCT01473316|Ketoconazole|ketoconazole|mesh-list
101215358|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
101215359|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215360|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101215361|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101215362|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215363|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215364|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101215365|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
101215366|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215368|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101215370|NCT01473472|Emtricitabine|emtricitabine|mesh-list
101215371|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101215372|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
101215373|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215374|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101215375|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101215376|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215377|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215378|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101215379|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101215380|NCT01473537|Calcium|calcium|mesh-list
101215381|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215382|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215383|NCT01473797|Cladribine|cladribine|mesh-list
101535365|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535366|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535369|NCT01137682|Octreotide|octreotide|mesh-list
101535370|NCT01137682|Lanreotide|lanreotide|mesh-list
101535371|NCT01137682|Pasireotide|pasireotide|mesh-list
101535372|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535373|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101535374|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215384|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215385|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215386|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
101215387|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215388|NCT01473810|Endocine|endocine|mesh-list
101215389|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101215390|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
101215391|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215392|NCT01473901|Temozolomide|temozolomide|mesh-list
101215393|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101215394|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
101215395|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215396|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215397|NCT01473914|Vitamins|vitamins|mesh-list
101215398|NCT01473914|Vitamin E|vitamin e|mesh-list
101215399|NCT01473914|Tocopherols|tocopherols|mesh-list
101215400|NCT01473914|Tocotrienols|tocotrienols|mesh-list
101215401|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
101215402|NCT01473914|Zinc|zinc|mesh-list
101215403|NCT01473914|Selenium|selenium|mesh-list
101215404|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
101215405|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215406|NCT01473914|Trace Elements|trace elements|mesh-ancestor
101215407|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
101215408|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215409|NCT01473914|Protective Agents|protective agents|mesh-ancestor
101215411|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
101215412|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215413|NCT01474187|Capecitabine|capecitabine|mesh-list
101215414|NCT01474187|Irinotecan|irinotecan|mesh-list
101215415|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215416|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
101215417|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215418|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215419|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101215420|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101215421|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215422|NCT01474265|Varenicline|varenicline|mesh-list
101215423|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101215424|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101215425|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
101215426|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215427|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215428|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215429|NCT01474304|Acetaminophen|acetaminophen|mesh-list
101215431|NCT01474304|Analgesics|analgesics|mesh-ancestor
101215432|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
101215434|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215436|NCT01474330|Pomalidomide|pomalidomide|mesh-list
101215437|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
101215438|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215439|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101215440|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101215441|NCT01474330|Growth Substances|growth substances|mesh-ancestor
101215442|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
101215443|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215444|NCT01474382|Phentolamine|phentolamine|mesh-list
101215445|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101215446|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101215447|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215448|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101535403|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
101215449|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215450|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215451|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101215453|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
101215454|NCT01474460|Vitamins|vitamins|mesh-ancestor
101215455|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
101215456|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215457|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101215458|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101215459|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215460|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
101215461|NCT01474460|Coagulants|coagulants|mesh-ancestor
101215462|NCT01474473|Calpastatin|calpastatin|mesh-list
101215463|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101215464|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
101215465|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215466|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215467|NCT01474499|Sorbitol|sorbitol|mesh-list
101215468|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101215469|NCT01474499|Glycerol|glycerol|mesh-list
101215470|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101215471|NCT01474499|Protective Agents|protective agents|mesh-ancestor
101215472|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215473|NCT01474499|Cathartics|cathartics|mesh-ancestor
101215474|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215475|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
101215476|NCT01474642|Capecitabine|capecitabine|mesh-list
101215477|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215478|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215479|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
101215480|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215481|NCT01474902|Enoxaparin|enoxaparin|mesh-list
101215482|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
101215483|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101215484|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101215485|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215486|NCT01474967|Metformin|metformin|mesh-list
101215487|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215488|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215489|NCT01475006|AMG 595|amg 595|mesh-list
101215490|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
101215491|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
101215492|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215493|NCT01475019|Orlistat|orlistat|mesh-list
101215494|NCT01475019|Sibutramine|sibutramine|mesh-list
101215495|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215496|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215497|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101215498|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101215499|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
101215502|NCT01475032|Beclomethasone|beclomethasone|mesh-list
101215503|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
101215504|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101215505|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
101215506|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215507|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215508|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101215509|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
101215512|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101215513|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215514|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215515|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215516|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215517|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
101215518|NCT01475032|Hormones|hormones|mesh-ancestor
101215519|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215520|NCT01475227|Zinc|zinc|mesh-list
101215521|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
101215522|NCT01475227|Trace Elements|trace elements|mesh-ancestor
101215523|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
101215524|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215525|NCT01475227|Astringents|astringents|mesh-ancestor
101215526|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
101215527|NCT01475266|Apaziquone|apaziquone|mesh-list
101215528|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215529|NCT01475279|Warfarin|warfarin|mesh-list
101215530|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
101215531|NCT01475318|Letrozole|letrozole|mesh-list
101215532|NCT01475318|Misoprostol|misoprostol|mesh-list
101215533|NCT01475318|Mifepristone|mifepristone|mesh-list
101215534|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215535|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101215536|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101215537|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215538|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215540|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
101215541|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215542|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215543|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101215544|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
101215545|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101215546|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101215547|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215548|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
101215549|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101215550|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101215551|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101215552|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101215553|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
101215554|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101215555|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101215556|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
101215557|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101215558|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101215560|NCT01475552|Clopidogrel|clopidogrel|mesh-list
101215561|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215562|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215563|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101215564|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101215565|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101215566|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101215567|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
101215568|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215569|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
101215570|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
101215571|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
101215572|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101215573|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101215574|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215575|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215576|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215577|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215578|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
101215579|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
101215580|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
101215581|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
101215582|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
101215583|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
101215584|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
101215589|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215590|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101215591|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
101215592|NCT01475617|Hematinics|hematinics|mesh-ancestor
101215593|NCT01475656|Levetiracetam|levetiracetam|mesh-list
101215594|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
101215595|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
101215596|NCT01475708|Doxycycline|doxycycline|mesh-list
101215597|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101215598|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215600|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101215601|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101215602|NCT01475760|Chitosan|chitosan|mesh-list
101215603|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101215604|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101215605|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
101215606|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215607|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101215608|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
101215609|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
101215610|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
101215611|NCT01475760|Coagulants|coagulants|mesh-ancestor
101215612|NCT01475877|Bromfenac|bromfenac|mesh-list
101535456|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535457|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535458|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101535459|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101535460|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
101535461|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535462|NCT00199797|Leucovorin|leucovorin|mesh-list
101535463|NCT00199797|Fluorouracil|fluorouracil|mesh-list
101215613|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101215614|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215615|NCT01475877|Analgesics|analgesics|mesh-ancestor
101215616|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
101215617|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215618|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215619|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215620|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215621|NCT01475890|Vitamin D|vitamin d|mesh-list
101215622|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
101215623|NCT01475890|Vitamins|vitamins|mesh-ancestor
101215624|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
101215625|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215626|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101215627|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215628|NCT01476007|Vitamins|vitamins|mesh-list
101215629|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
101215630|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
101215631|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
101215632|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
101215633|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215634|NCT01476007|Hematinics|hematinics|mesh-ancestor
101215635|NCT01476124|Morphine|morphine|mesh-list
101215636|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101215637|NCT01476124|Narcotics|narcotics|mesh-ancestor
101215638|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101215639|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215641|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
101215642|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215643|NCT01476137|Trametinib|trametinib|mesh-list
101215644|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215645|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215646|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215647|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215648|NCT01476176|Acetaminophen|acetaminophen|mesh-list
101215649|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215650|NCT01476176|Analgesics|analgesics|mesh-ancestor
101215651|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
101215652|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215653|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215654|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
101215655|NCT01476189|Acetaminophen|acetaminophen|mesh-list
101215656|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215657|NCT01476189|Analgesics|analgesics|mesh-ancestor
101215658|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
101215659|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215660|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215661|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
101215662|NCT01476215|Acetaminophen|acetaminophen|mesh-list
101215663|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215664|NCT01476215|Analgesics|analgesics|mesh-ancestor
101215666|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215667|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215669|NCT01476280|Palonosetron|palonosetron|mesh-list
101215670|NCT01476280|Ramosetron|ramosetron|mesh-list
101215671|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
101215672|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
101215673|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215674|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215675|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215676|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101215677|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101535471|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535472|NCT00199797|Antidotes|antidotes|mesh-ancestor
101215678|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
101215679|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215680|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215681|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101215682|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101215683|NCT01476358|Vitamin A|vitamin a|mesh-list
101215684|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
101215685|NCT01476358|Vitamins|vitamins|mesh-ancestor
101215686|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
101215687|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215688|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
101215689|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215690|NCT01476358|Protective Agents|protective agents|mesh-ancestor
101215691|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101215692|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215693|NCT01476410|Doxorubicin|doxorubicin|mesh-list
101215694|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101215695|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101215696|NCT01476410|Dacarbazine|dacarbazine|mesh-list
101215697|NCT01476410|Vinblastine|vinblastine|mesh-list
101215698|NCT01476410|Antibodies|antibodies|mesh-list
101215699|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
101215700|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101215701|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
101215702|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101215703|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
101215704|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215705|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101215706|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215707|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101215708|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101215709|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215710|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215711|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101215712|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
101215713|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101215714|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101215715|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
101215716|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101215717|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
101215718|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
101215719|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
101215720|NCT01476488|Tacrolimus|tacrolimus|mesh-list
101215721|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215722|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
101215723|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215724|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101215725|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215726|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215727|NCT01476592|Resveratrol|resveratrol|mesh-list
101215728|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
101215729|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215730|NCT01476592|Protective Agents|protective agents|mesh-ancestor
101215731|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215732|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215733|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101215734|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
101215735|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101215736|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101215737|NCT01476683|Racecadotril|racecadotril|mesh-list
101215738|NCT01476683|Thiorphan|thiorphan|mesh-list
101215739|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
101215740|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215742|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215743|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215744|NCT01476774|Buprenorphine|buprenorphine|mesh-list
101215745|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101215746|NCT01476774|Narcotics|narcotics|mesh-ancestor
101215747|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101215748|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215749|NCT01476774|Analgesics|analgesics|mesh-ancestor
101215750|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
101215751|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215752|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101215753|NCT01476800|Ketoconazole|ketoconazole|mesh-list
101215754|NCT01476800|Mirabegron|mirabegron|mesh-list
101215755|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
101215756|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215757|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101215758|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101215759|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215760|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215761|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101215762|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
101215763|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215764|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215766|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101215767|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101215768|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101215769|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
101215770|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215771|NCT01476800|Urological Agents|urological agents|mesh-ancestor
101215773|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101215774|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101215775|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101215776|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
101215777|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215778|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215779|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215780|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
101215781|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215782|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
101215783|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215784|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215785|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101215786|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
101215787|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215788|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215789|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101215791|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
101215792|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
101215793|NCT01477034|Vitamins|vitamins|mesh-list
101215794|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
101215795|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215796|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101215797|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215798|NCT01477060|Metformin|metformin|mesh-list
101215799|NCT01477060|Lapatinib|lapatinib|mesh-list
101215800|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101215801|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215802|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215803|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215804|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215805|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215806|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101215807|NCT01477073|Hormones|hormones|mesh-ancestor
101215808|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215809|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215810|NCT01477112|Beta Carotene|beta carotene|mesh-list
101215811|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215812|NCT01477112|Provitamins|provitamins|mesh-ancestor
101215813|NCT01477112|Vitamins|vitamins|mesh-ancestor
101215814|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
101215815|NCT01477151|Anesthetics|anesthetics|mesh-list
101215816|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101215817|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215818|NCT01477190|Morphine|morphine|mesh-list
101215819|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101215820|NCT01477190|Narcotics|narcotics|mesh-ancestor
101215821|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101215822|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215823|NCT01477190|Analgesics|analgesics|mesh-ancestor
101215824|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
101215825|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215826|NCT01477203|Escitalopram|escitalopram|mesh-list
101215827|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101215828|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101535503|NCT00198822|Provitamins|provitamins|mesh-ancestor
101535504|NCT05214976|Paclitaxel|paclitaxel|mesh-list
101535505|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101215829|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215830|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215831|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215833|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215834|NCT01477242|Ondansetron|ondansetron|mesh-list
101215835|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
101215836|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
101215837|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215838|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215839|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215840|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
101215841|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101215842|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101215843|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101215844|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
101215845|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215846|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215847|NCT01477268|Sertraline|sertraline|mesh-list
101215848|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
101215849|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101215850|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101215851|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101215852|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215853|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215854|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215855|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
101215856|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215857|NCT01477294|Caffeine|caffeine|mesh-list
101215858|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101215859|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215860|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101215862|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215863|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101215865|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
101215866|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215867|NCT01477385|Fluorides|fluorides|mesh-list
101215868|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
101215869|NCT01477385|Protective Agents|protective agents|mesh-ancestor
101215870|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215871|NCT01477411|Digoxin|digoxin|mesh-list
101215872|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101215873|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101215874|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215875|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215876|NCT01477411|Protective Agents|protective agents|mesh-ancestor
101215877|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215878|NCT01477424|Warfarin|warfarin|mesh-list
101215879|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
101215880|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
101215881|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215882|NCT01477489|Veliparib|veliparib|mesh-list
101215883|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101215884|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215885|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215886|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215887|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101215888|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101215889|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
101215890|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215891|NCT01477580|Antacids|antacids|mesh-ancestor
101215892|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215895|NCT01477606|Daunorubicin|daunorubicin|mesh-list
101215896|NCT01477606|Midostaurin|midostaurin|mesh-list
101215897|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101215898|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
101215899|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215900|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101215901|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
101221736|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101221738|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221739|NCT01509261|Lansoprazole|lansoprazole|mesh-list
101221740|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
101221741|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221742|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221743|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101221744|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221745|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215902|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101215903|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101215904|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
101215905|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215906|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101215907|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101215908|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101215909|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215910|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101215911|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101215912|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101215913|NCT01477632|Norethindrone|norethindrone|mesh-list
101215914|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
101215916|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101215917|NCT01477632|Estrogens|estrogens|mesh-ancestor
101215918|NCT01477632|Hormones|hormones|mesh-ancestor
101215919|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101215920|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215921|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101215922|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
101215923|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101215924|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101215925|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101215926|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101215927|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101215928|NCT01477736|Oxybutynin|oxybutynin|mesh-list
101215929|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
101215930|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101215931|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101215932|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101215933|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215934|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215935|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
101215936|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215937|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215938|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101215939|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215940|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
101215941|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
101215942|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101215943|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101215944|NCT01477736|Urological Agents|urological agents|mesh-ancestor
101215945|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
101215946|NCT01477801|Vitamin D|vitamin d|mesh-list
101215947|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101215948|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215949|NCT01477801|Vitamins|vitamins|mesh-ancestor
101215950|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
101215951|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101215952|NCT01477840|Misoprostol|misoprostol|mesh-list
101215953|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101215954|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
101215955|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101215956|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215957|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101215958|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101215959|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
101215960|NCT01477931|Bupropion|bupropion|mesh-list
101215961|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101215962|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
101215963|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101215964|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101215965|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101215966|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215967|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215968|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
101215969|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101215970|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215971|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101215972|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101215973|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215974|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101215975|NCT01477983|Flecainide|flecainide|mesh-list
101215976|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101215977|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101215978|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101215979|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215980|NCT01478022|Ibuprofen|ibuprofen|mesh-list
101215981|NCT01478022|Isosorbide|isosorbide|mesh-list
101215982|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101215983|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101215984|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101215985|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215986|NCT01478022|Analgesics|analgesics|mesh-ancestor
101215987|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
101215988|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101215989|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215990|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101215991|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101215992|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101215993|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215994|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215995|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101215996|NCT01478022|Diuretics|diuretics|mesh-ancestor
101215997|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
101215998|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
101215999|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101216000|NCT01478074|Cytarabine|cytarabine|mesh-list
101216001|NCT01478074|Fludarabine|fludarabine|mesh-list
101216002|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216003|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101216004|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
101216005|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216006|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101216007|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
101216008|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216009|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
101216010|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216011|NCT01478165|Palonosetron|palonosetron|mesh-list
101216012|NCT01478165|Anesthetics|anesthetics|mesh-list
101216013|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216014|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216016|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
101216017|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216018|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216019|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101216020|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101216021|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
101216022|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216023|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216024|NCT01478230|Nicotine|nicotine|mesh-list
101216025|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101216026|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
101216027|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216028|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216029|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101216030|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101216031|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
101216032|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216033|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216034|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
101535533|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535534|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101216035|NCT01478282|Dabigatran|dabigatran|mesh-list
101216036|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101216037|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
101216038|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101216039|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
101216040|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216041|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216042|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
101216043|NCT01478308|Metformin|metformin|mesh-list
101216047|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216048|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216049|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216050|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216051|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216052|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216053|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216054|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
101216055|NCT01478308|Hormones|hormones|mesh-ancestor
101216056|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216057|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216058|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
101216059|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101216060|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
101216061|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216062|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
101216063|NCT01478386|Protective Agents|protective agents|mesh-ancestor
101216064|NCT01478490|Metoprolol|metoprolol|mesh-list
101216065|NCT01478490|Mirabegron|mirabegron|mesh-list
101216066|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101216067|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101216068|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
101216069|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
101216070|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216071|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216073|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101216074|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101216075|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
101216076|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216077|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216078|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101216079|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101216080|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101216081|NCT01478490|Urological Agents|urological agents|mesh-ancestor
101216083|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101216084|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101216085|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101216086|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
101216087|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216088|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216089|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216090|NCT01478503|Urological Agents|urological agents|mesh-ancestor
101216091|NCT01478529|Mirabegron|mirabegron|mesh-list
101216092|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101216093|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101216094|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101216095|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
101216096|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216097|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216098|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216099|NCT01478529|Urological Agents|urological agents|mesh-ancestor
101216100|NCT01478568|Desipramine|desipramine|mesh-list
101216101|NCT01478568|Mirabegron|mirabegron|mesh-list
101216102|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101216103|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101216104|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101216105|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
101216106|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216107|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216108|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216109|NCT01478568|Urological Agents|urological agents|mesh-ancestor
101535540|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101535541|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
101216110|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101216111|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
101216112|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101216113|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216114|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101216115|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101216116|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216117|NCT01478607|Capsaicin|capsaicin|mesh-list
101216120|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
101216121|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216122|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216124|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101216125|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216126|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216127|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
101216128|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216129|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216130|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101216131|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
101216132|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216133|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
101216136|NCT01478685|Azacitidine|azacitidine|mesh-list
101216137|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101216138|NCT01478685|Cc-486|cc-486|mesh-list
101216139|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101216140|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216141|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216142|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216143|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216144|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216145|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101216146|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
101216147|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216148|NCT01478724|Caseins|caseins|mesh-list
101216149|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
101216150|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
101216151|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216152|NCT01478737|Dexamethasone|dexamethasone|mesh-list
101216153|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
101216154|NCT01478737|BB 1101|bb 1101|mesh-list
101216155|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216156|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
101216157|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
101216158|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216159|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216160|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216161|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
101216162|NCT01478737|Hormones|hormones|mesh-ancestor
101216163|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216164|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216165|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216166|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
101216167|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216168|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216169|NCT01478997|Acetaminophen|acetaminophen|mesh-list
101216170|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101216171|NCT01478997|Analgesics|analgesics|mesh-ancestor
101216172|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
101216173|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216174|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216175|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
101216176|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101216177|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
101216178|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216179|NCT01479036|Docetaxel|docetaxel|mesh-list
101216180|NCT01479036|Epirubicin|epirubicin|mesh-list
101216181|NCT01479036|Endostatins|endostatins|mesh-list
101216182|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216183|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216184|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216185|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216186|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535546|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101535547|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101216187|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101216188|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101216189|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101216190|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216191|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101216192|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101216193|NCT01479036|Growth Substances|growth substances|mesh-ancestor
101216195|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
101216196|NCT01479088|Cinacalcet|cinacalcet|mesh-list
101216197|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216198|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216199|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
101216200|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
101216201|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216202|NCT01479114|Lenograstim|lenograstim|mesh-list
101216203|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101216204|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
101216205|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216206|NCT01479179|Trastuzumab|trastuzumab|mesh-list
101216207|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101216208|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216209|NCT01479192|Fenretinide|fenretinide|mesh-list
101216210|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216211|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101216212|NCT01479192|Protective Agents|protective agents|mesh-ancestor
101216213|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216214|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
101216215|NCT01479231|Lansoprazole|lansoprazole|mesh-list
101216216|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101216217|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216218|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101216219|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216220|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216221|NCT01479244|Molgramostim|molgramostim|mesh-list
101216222|NCT01479244|Sargramostim|sargramostim|mesh-list
101216223|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
101216224|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216225|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216226|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101216228|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101216229|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216230|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
101216231|NCT01479296|Vaccines|vaccines|mesh-list
101216232|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
101216233|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216235|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216236|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
101216237|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101216238|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101216239|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216240|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216241|NCT01479504|Cisplatin|cisplatin|mesh-list
101216242|NCT01479504|Docetaxel|docetaxel|mesh-list
101216243|NCT01479504|Nedaplatin|nedaplatin|mesh-list
101216244|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216245|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216246|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216247|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216248|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216249|NCT01479556|Pregabalin|pregabalin|mesh-list
101216250|NCT01479556|Analgesics|analgesics|mesh-ancestor
101216251|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
101216252|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216253|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216254|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
101216255|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216256|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216257|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216258|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216259|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101216260|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101216261|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535557|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101535558|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535559|NCT04312438|Caseins|caseins|mesh-list
101535560|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
101535561|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
101535562|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535563|NCT04312360|Metronidazole|metronidazole|mesh-list
101535564|NCT04312360|Fosfomycin|fosfomycin|mesh-list
101216262|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101216264|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101216265|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101216266|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216267|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216268|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
101216269|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216270|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101216271|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216272|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101216273|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101216274|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101216275|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101216276|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
101216277|NCT01479751|Ketamine|ketamine|mesh-list
101216278|NCT01479751|Rocuronium|rocuronium|mesh-list
101216279|NCT01479751|Analgesics|analgesics|mesh-ancestor
101216280|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
101216281|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216282|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216283|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101216284|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101216285|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
101216286|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
101216287|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216288|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101216289|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101216290|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216291|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216292|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101216293|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
101216294|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216295|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216296|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216297|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
101216298|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101216299|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101216300|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101216301|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101216302|NCT01479881|Cyclosporine|cyclosporine|mesh-list
101216303|NCT01479881|Simeprevir|simeprevir|mesh-list
101216304|NCT01479881|Tacrolimus|tacrolimus|mesh-list
101216305|NCT01479881|Cyclosporins|cyclosporins|mesh-list
101216307|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
101216308|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216309|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101216311|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216312|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
101216313|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216314|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
101216315|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101216316|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
101216317|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
101216318|NCT01479920|Fluoxetine|fluoxetine|mesh-list
101216319|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101216320|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101216321|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216322|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535590|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
101535591|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101535624|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535625|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101535626|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
101535627|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101535628|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101216323|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216324|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
101216325|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216326|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101216328|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101216329|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101216330|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216331|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216332|NCT01479933|Vitamin D|vitamin d|mesh-list
101216333|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
101216334|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
101216335|NCT01479933|Vitamins|vitamins|mesh-list
101216336|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
101216337|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216338|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101216339|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216340|NCT01480050|Temozolomide|temozolomide|mesh-list
101216341|NCT01480050|Mibefradil|mibefradil|mesh-list
101216342|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101216343|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
101216344|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216345|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216346|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101216347|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216349|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216350|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216351|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216352|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101216353|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216354|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216355|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
101216356|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101216357|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216358|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216360|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216361|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216362|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216363|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216364|NCT01480323|Aldesleukin|aldesleukin|mesh-list
101216365|NCT01480323|Ipilimumab|ipilimumab|mesh-list
101216366|NCT01480323|Interleukin-2|interleukin-2|mesh-list
101216367|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101216368|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216369|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101216370|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216371|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101216372|NCT01480323|Analgesics|analgesics|mesh-ancestor
101216373|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
101216374|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216375|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216376|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101216377|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101216378|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
101216379|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216380|NCT01480336|Amiodarone|amiodarone|mesh-list
101216381|NCT01480336|Ranolazine|ranolazine|mesh-list
101216382|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101216383|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216384|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101216385|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535629|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101535637|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
101535638|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535639|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535640|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535641|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535642|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101535643|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101535644|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535645|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101535652|NCT00195663|Methotrexate|methotrexate|mesh-list
101535653|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101535654|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
101535655|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101216386|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216387|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101216388|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101216389|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216390|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216391|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101216392|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101216393|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101216394|NCT01480492|Telbivudine|telbivudine|mesh-list
101216395|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
101216396|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216397|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101216398|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216399|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216400|NCT01480531|Clevidipine|clevidipine|mesh-list
101216401|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216402|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216403|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216404|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216405|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216407|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
101216408|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216409|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216411|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101216412|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
101216413|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216414|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101216415|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
101216416|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101216417|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101216418|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
101216419|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216420|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101216422|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216423|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216425|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101216426|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101216427|NCT01480752|Analgesics|analgesics|mesh-ancestor
101216428|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
101216429|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216430|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216431|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216432|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101216433|NCT01480765|Pregabalin|pregabalin|mesh-list
101216434|NCT01480765|Ketamine|ketamine|mesh-list
101216435|NCT01480765|Analgesics|analgesics|mesh-ancestor
101216436|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
101216437|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216438|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216439|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101216440|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101216441|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
101216442|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
101216443|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216444|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101216445|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101216446|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216447|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216448|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
101216449|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216450|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216451|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216452|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101216453|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101216454|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101216455|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
101216456|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101216457|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101216458|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101216459|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
101216460|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101216461|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216462|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101216463|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101216464|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101216465|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
101216466|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101216467|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101216468|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101216469|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101216471|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
101216472|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216473|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101216474|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216475|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216476|NCT01480817|Sorafenib|sorafenib|mesh-list
101216477|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216478|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216479|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216480|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216481|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
101216482|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
101216483|NCT01480869|Vitamin D|vitamin d|mesh-list
101216484|NCT01480869|Calcium|calcium|mesh-list
101216485|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216486|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216487|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101216488|NCT01480869|Vitamins|vitamins|mesh-ancestor
101216489|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
101216490|NCT01480986|Irinotecan|irinotecan|mesh-list
101216491|NCT01480986|Octreotide|octreotide|mesh-list
101216492|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216493|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101216494|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101216495|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216496|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216497|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216498|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216499|NCT01481194|Dexamethasone|dexamethasone|mesh-list
101216500|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
101216501|NCT01481194|Doxorubicin|doxorubicin|mesh-list
101216502|NCT01481194|Lenalidomide|lenalidomide|mesh-list
101216504|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101216505|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
101216506|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216507|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535725|NCT00195429|Sirolimus|sirolimus|mesh-list
101535756|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
101535757|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101535758|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101535759|NCT04609748|Analgesics|analgesics|mesh-ancestor
101535760|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
101535761|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535762|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535763|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535764|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535765|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101535766|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101535777|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535778|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
101535779|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101535780|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
101535781|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101535782|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101535783|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101535784|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216508|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101216509|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
101216510|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216511|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216512|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101216513|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216514|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
101216515|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
101216516|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216517|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216519|NCT01481194|Hormones|hormones|mesh-ancestor
101216520|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216521|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216522|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101216523|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101216524|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101216525|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216526|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101216527|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101216528|NCT01481194|Growth Substances|growth substances|mesh-ancestor
101216529|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
101216531|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
101216532|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101216533|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216534|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216535|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216536|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216537|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216538|NCT01481259|Pemetrexed|pemetrexed|mesh-list
101216539|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216540|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216541|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216542|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101216543|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101535785|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101535786|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
101535787|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101535788|NCT00564200|Dexamethasone|dexamethasone|mesh-list
101535789|NCT00564200|Fludarabine|fludarabine|mesh-list
101535790|NCT00564200|Bortezomib|bortezomib|mesh-list
101535791|NCT00564200|Melphalan|melphalan|mesh-list
101535792|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101535793|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
101535794|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
101535826|NCT00193479|Hormones|hormones|mesh-ancestor
101535827|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101535828|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101535829|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101535885|NCT00192075|Folic Acid|folic acid|mesh-list
101535886|NCT00192075|Gemcitabine|gemcitabine|mesh-list
101535887|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
101535888|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
101535889|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101535890|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
101535891|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101535892|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101535893|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101535894|NCT00192075|Antidotes|antidotes|mesh-ancestor
101535895|NCT00192075|Protective Agents|protective agents|mesh-ancestor
101535896|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
101535897|NCT00192075|Vitamins|vitamins|mesh-ancestor
101535898|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
101535899|NCT00192075|Hematinics|hematinics|mesh-ancestor
101216544|NCT01481311|Bromides|bromides|mesh-list
101216545|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
101216546|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
101216547|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216548|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101216549|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101216550|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216551|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216552|NCT01481350|Urological Agents|urological agents|mesh-ancestor
101216553|NCT01481389|Theobromine|theobromine|mesh-list
101216554|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101216555|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
101216556|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216557|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216558|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101216559|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
101216560|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216561|NCT01481454|Vaccines|vaccines|mesh-list
101216562|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
101216563|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216564|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
101216565|NCT01481519|Dexamethasone|dexamethasone|mesh-list
101535987|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101535988|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101535989|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101535990|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
101535991|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
101535992|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
101535993|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101535994|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101535995|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101535996|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101535997|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101535998|NCT04607447|Dexamethasone|dexamethasone|mesh-list
101216566|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
101216567|NCT01481519|Povidone|povidone|mesh-list
101216568|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
101216569|NCT01481519|BB 1101|bb 1101|mesh-list
101216570|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216571|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
101216586|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101216587|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216588|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101216590|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
101216591|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
101216592|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216593|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216594|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216596|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
101216597|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101216598|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101216599|NCT01481610|Analgesics|analgesics|mesh-ancestor
101216600|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
101216601|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216602|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216603|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216604|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101216605|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101216606|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216607|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216608|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101216609|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
101216610|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216611|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
101216612|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
101216613|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
101216614|NCT01481714|Citric Acid|citric acid|mesh-list
101216615|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
101216616|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101216617|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
101216618|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
101216619|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216620|NCT01481714|Cathartics|cathartics|mesh-ancestor
101216621|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216622|NCT01481714|Antacids|antacids|mesh-ancestor
101216623|NCT01481831|Palonosetron|palonosetron|mesh-list
101216624|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
101216625|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
101216626|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216627|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216628|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216629|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101216630|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101216632|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216633|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216642|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101535999|NCT04607447|Atorvastatin|atorvastatin|mesh-list
101536001|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
101216643|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101216644|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216645|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101216646|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101216647|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101216648|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216649|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216650|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101216651|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216652|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101216653|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216654|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101216655|NCT01481844|Antacids|antacids|mesh-ancestor
101216656|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
101216657|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101216658|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
101216659|NCT01481870|Sorafenib|sorafenib|mesh-list
101216660|NCT01481870|Sunitinib|sunitinib|mesh-list
101216661|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216662|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216663|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216664|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216665|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101216666|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101216667|NCT01481870|Growth Substances|growth substances|mesh-ancestor
101216668|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216669|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
101216670|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101216671|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101216672|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
101216673|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216674|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216675|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101216676|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101216677|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101216678|NCT01482052|Vaccines|vaccines|mesh-list
101216679|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
101216680|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216681|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101216682|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101216683|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101216684|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
101216685|NCT01482117|Cilostazol|cilostazol|mesh-list
101216686|NCT01482117|Clopidogrel|clopidogrel|mesh-list
101216687|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101216688|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101216689|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101216690|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101216691|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
101216692|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216693|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216694|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216695|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101216696|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
101216697|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216698|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101216699|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
101216700|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101216701|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101216702|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216703|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101216716|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216717|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216719|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101216720|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216721|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216722|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216723|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101216724|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
101216725|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536071|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536072|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216726|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216727|NCT01482338|Drospirenone|drospirenone|mesh-list
101216728|NCT01482338|Desogestrel|desogestrel|mesh-list
101216729|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101216730|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
101216731|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216732|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216733|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101216734|NCT01482338|Diuretics|diuretics|mesh-ancestor
101216735|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
101216736|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101216737|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101216738|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101216739|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
101216740|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101216741|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101216742|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101216743|NCT01482338|Progestins|progestins|mesh-ancestor
101216746|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101216747|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101216748|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216749|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216751|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216752|NCT01482416|Estrogens|estrogens|mesh-list
101216753|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
101216754|NCT01482416|Hormones|hormones|mesh-ancestor
101216755|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216756|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216757|NCT01482442|Sorafenib|sorafenib|mesh-list
101216758|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216759|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216760|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216761|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216762|NCT01482468|Palonosetron|palonosetron|mesh-list
101216763|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
101216764|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
101216765|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216766|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216767|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216768|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101216769|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101216771|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216772|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216773|NCT01482559|Dopamine|dopamine|mesh-list
101216774|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101216775|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
101216776|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
101216777|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216778|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216779|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
101216780|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216781|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216782|NCT01482559|Protective Agents|protective agents|mesh-ancestor
101216783|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
101216784|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101216785|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
101216786|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216787|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
101216788|NCT01482624|Protective Agents|protective agents|mesh-ancestor
101216789|NCT01482728|Dasatinib|dasatinib|mesh-list
101216790|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216791|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216792|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216793|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216794|NCT01482754|Rituximab|rituximab|mesh-list
101216795|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101216796|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216797|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
101216798|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216799|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101216800|NCT01482897|Prednisolone|prednisolone|mesh-list
101216801|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101216803|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101216804|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
101216805|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101216806|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
101216807|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101216808|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
101216809|NCT01482897|Hormones|hormones|mesh-ancestor
101216810|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216811|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216812|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216813|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216814|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
101216815|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
101216816|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216817|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216818|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101216819|NCT01482897|Protective Agents|protective agents|mesh-ancestor
101216820|NCT01482936|Oxycodone|oxycodone|mesh-list
101216821|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101216822|NCT01482936|Narcotics|narcotics|mesh-ancestor
101216823|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216824|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216825|NCT01482936|Analgesics|analgesics|mesh-ancestor
101216826|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
101216827|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216828|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
101216829|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216830|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216831|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216832|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216833|NCT01483053|Agomelatine|agomelatine|mesh-list
101216834|NCT01483053|Escitalopram|escitalopram|mesh-list
101216835|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101216836|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101216837|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216838|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216839|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216840|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
101216841|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216842|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101216843|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216844|NCT01483248|Interferons|interferons|mesh-list
101216846|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216847|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
101216848|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216849|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101216850|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216851|NCT01483274|Vaccines|vaccines|mesh-list
101216852|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
101216853|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216854|NCT01483300|Cisplatin|cisplatin|mesh-list
101216855|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216856|NCT01483365|Progesterone|progesterone|mesh-list
101216857|NCT01483365|Progestins|progestins|mesh-ancestor
101216858|NCT01483365|Hormones|hormones|mesh-ancestor
101216859|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216860|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216861|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
101216862|NCT01483508|Procyanidin|procyanidin|mesh-list
101216863|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
101216864|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216865|NCT01483508|Protective Agents|protective agents|mesh-ancestor
101216866|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216867|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101216868|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101216869|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216870|NCT01483638|Axitinib|axitinib|mesh-list
101216871|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216872|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216873|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216875|NCT01483729|Ritonavir|ritonavir|mesh-list
101216876|NCT01483729|Lactams|lactams|mesh-list
101216877|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101536078|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
101216878|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101216879|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
101216880|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216881|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216882|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101216883|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101216884|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
101216885|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216886|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101216887|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101216888|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101216890|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101216891|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216892|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101216893|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216894|NCT01483859|Liver Extracts|liver extracts|mesh-list
101216895|NCT01483859|Hematinics|hematinics|mesh-ancestor
101216896|NCT01483911|Gontivimab|gontivimab|mesh-list
101216897|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
101216898|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216899|NCT01484015|Cefepime|cefepime|mesh-list
101216900|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101216901|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216902|NCT01484080|Paclitaxel|paclitaxel|mesh-list
101216903|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101216904|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101216905|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216906|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101216907|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101216908|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101216909|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216910|NCT01484145|Terbinafine|terbinafine|mesh-list
101216911|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
101216912|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101216913|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216914|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216915|NCT01484171|Idarubicin|idarubicin|mesh-list
101216916|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101216917|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216918|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101216919|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101216920|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216921|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216922|NCT01484184|Levodopa|levodopa|mesh-list
101216926|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
101216927|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216928|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216929|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216930|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101216931|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101216932|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101216933|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101216934|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101216935|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
101216936|NCT01484262|Liraglutide|liraglutide|mesh-list
101216937|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101216938|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216939|NCT01484262|Incretins|incretins|mesh-ancestor
101216940|NCT01484262|Hormones|hormones|mesh-ancestor
101216941|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216942|NCT01484327|Carvedilol|carvedilol|mesh-list
101216943|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101216944|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101216945|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
101216946|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216947|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216948|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216949|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101216950|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
101216951|NCT01484327|Protective Agents|protective agents|mesh-ancestor
101216952|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101216953|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536079|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101536080|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536083|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101536084|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101216954|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101216955|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
101216956|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101216957|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101216958|NCT01484457|Pancrelipase|pancrelipase|mesh-list
101216959|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216960|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101216961|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
101216962|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216963|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101216964|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101216965|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
101216966|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101216967|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216968|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101216969|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101216970|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101216971|NCT01484717|Nicotine|nicotine|mesh-list
101216972|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101216974|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216975|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216976|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101216977|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101216978|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
101216979|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101216980|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216981|NCT01484756|Micronutrients|micronutrients|mesh-list
101216982|NCT01484756|Trace Elements|trace elements|mesh-list
101216983|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216984|NCT01484964|Peficitinib|peficitinib|mesh-list
101216985|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216986|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216987|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101216988|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
101216989|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216990|NCT01484990|Levodopa|levodopa|mesh-list
101216991|NCT01484990|Carbidopa|carbidopa|mesh-list
101216992|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
101216993|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101216994|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101216995|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
101216997|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216999|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101217000|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217001|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101217002|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
101217003|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
101217004|NCT01485003|Natalizumab|natalizumab|mesh-list
101217005|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
101217006|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217007|NCT01485068|Paclitaxel|paclitaxel|mesh-list
101217008|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217009|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217010|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217011|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217012|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217013|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217014|NCT01485081|Paclitaxel|paclitaxel|mesh-list
101217015|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217016|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217017|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217018|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217019|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217020|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217021|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
101536085|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536086|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536088|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536089|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536090|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101217022|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101217023|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
101217024|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217025|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101217026|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217027|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217028|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217030|NCT01485185|Donepezil|donepezil|mesh-list
101217031|NCT01485185|Analgesics|analgesics|mesh-ancestor
101217032|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
101217033|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217034|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217035|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
101217036|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217037|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217038|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217039|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217040|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101217041|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101217042|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217043|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217045|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101217046|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217047|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217048|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
101217049|NCT01485198|Acetaminophen|acetaminophen|mesh-list
101217050|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217051|NCT01485198|Analgesics|analgesics|mesh-ancestor
101217053|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217054|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217055|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
101217056|NCT01485211|Riboflavin|riboflavin|mesh-list
101217057|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
101217058|NCT01485211|Vitamins|vitamins|mesh-ancestor
101217059|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
101217060|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217061|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101217062|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217063|NCT01485224|Thalidomide|thalidomide|mesh-list
101217064|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217065|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
101217066|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217067|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
101217068|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101217069|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217070|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101217071|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101217072|NCT01485224|Growth Substances|growth substances|mesh-ancestor
101217073|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
101217086|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217087|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217088|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217089|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217090|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101217091|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
101217092|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217093|NCT01485445|Fluticasone|fluticasone|mesh-list
101217094|NCT01485445|Xhance|xhance|mesh-list
101217095|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217096|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101217097|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
101217098|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217099|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217100|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101217101|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
101217102|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217103|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101217104|NCT01485562|Misoprostol|misoprostol|mesh-list
101217105|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101217107|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101217108|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217109|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101217110|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217111|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
101217112|NCT01485653|Mepivacaine|mepivacaine|mesh-list
101217113|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
101217114|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
101217115|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217116|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217117|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
101217118|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217119|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
101217120|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
101217121|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217122|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
101217123|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217124|NCT01485692|Promethazine|promethazine|mesh-list
101217125|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
101217126|NCT01485692|Midazolam|midazolam|mesh-list
101217127|NCT01485692|Haloperidol|haloperidol|mesh-list
101217129|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
101217130|NCT01485692|Ziprasidone|ziprasidone|mesh-list
101217131|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101217132|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101217133|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217134|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217135|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217136|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217137|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217138|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101217139|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
101217140|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
101217141|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
101217144|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217145|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
101217146|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
101217147|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217148|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217149|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101217150|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101217151|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101217152|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217153|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
101217154|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101217155|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
101217156|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101217157|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101217158|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
101217159|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217160|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101217161|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
101217162|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
101217163|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101217164|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101217165|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
101217166|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
101217167|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101217168|NCT01485718|Cathartics|cathartics|mesh-ancestor
101217169|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217170|NCT01485731|Nelfinavir|nelfinavir|mesh-list
101217171|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101217172|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101217173|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
101217174|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217175|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217176|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101217177|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101217178|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
101217179|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217180|NCT01485744|Leucovorin|leucovorin|mesh-list
101217181|NCT01485744|Fluorouracil|fluorouracil|mesh-list
101217184|NCT01485744|Folfirinox|folfirinox|mesh-list
101217185|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
101536112|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
101536113|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536114|NCT00589134|Ganirelix|ganirelix|mesh-list
101217186|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217187|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217188|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217189|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217190|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
101217191|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217192|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101217193|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101217194|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217195|NCT01485744|Antidotes|antidotes|mesh-ancestor
101217196|NCT01485744|Protective Agents|protective agents|mesh-ancestor
101217197|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
101217198|NCT01485744|Vitamins|vitamins|mesh-ancestor
101217199|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
101217200|NCT01485822|Travoprost|travoprost|mesh-list
101217201|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101217202|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101217203|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101217204|NCT01485835|Dexamethasone|dexamethasone|mesh-list
101217205|NCT01485835|Bortezomib|bortezomib|mesh-list
101217206|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217208|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
101217209|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217210|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217211|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217212|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
101217213|NCT01485835|Hormones|hormones|mesh-ancestor
101217214|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101217215|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101217216|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217217|NCT01485848|Paclitaxel|paclitaxel|mesh-list
101217218|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217219|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217220|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217226|NCT01485926|Trastuzumab|trastuzumab|mesh-list
101217227|NCT01485926|Lapatinib|lapatinib|mesh-list
101217228|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217229|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217230|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217231|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217232|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217233|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101217234|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217235|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217236|NCT01485939|Lidocaine|lidocaine|mesh-list
101217237|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
101217238|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
101217239|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217240|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217241|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
101217242|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217243|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101217244|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101217245|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101217246|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217247|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217249|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101217250|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
101217251|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217252|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217253|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101217254|NCT01486004|Simeprevir|simeprevir|mesh-list
101217255|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
101217256|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217257|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
101217258|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217259|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217260|NCT01486017|Peficitinib|peficitinib|mesh-list
101217261|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536117|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536128|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101536129|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
101217262|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217263|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217264|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
101217265|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217266|NCT01486082|Amoxicillin|amoxicillin|mesh-list
101217267|NCT01486082|Clarithromycin|clarithromycin|mesh-list
101217268|NCT01486082|Omeprazole|omeprazole|mesh-list
101217269|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101217270|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217271|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101217272|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217273|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101217274|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217275|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217276|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101217277|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101217278|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101217279|NCT01485809|Gefitinib|gefitinib|mesh-list
101217280|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217281|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217282|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217283|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217284|NCT01486251|Axitinib|axitinib|mesh-list
101217285|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217286|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217287|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217288|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217289|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
101217290|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
101217298|NCT01486433|Analgesics|analgesics|mesh-ancestor
101217299|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
101217300|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217301|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217302|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217303|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217304|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101217305|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101217306|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217307|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101217308|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101217309|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217310|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
101217311|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101217312|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101217313|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
101217314|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101217315|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101217316|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
101217317|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
101217318|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217319|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217320|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217321|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
101217322|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217323|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217324|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217326|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217327|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217328|NCT01486485|Analgesics|analgesics|mesh-ancestor
101217329|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
101217330|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217331|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217332|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217333|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217334|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
101217335|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
101217336|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536131|NCT00589485|Cobalt|cobalt|mesh-list
101217337|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217338|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101217339|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101217340|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101217341|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217342|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
101217344|NCT01486511|Hematinics|hematinics|mesh-ancestor
101217345|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101217346|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
101217347|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
101217348|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101217349|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
101217350|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
101217351|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101217352|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
101217353|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
101217355|NCT01486602|Carboplatin|carboplatin|mesh-list
101217356|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217357|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217358|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217363|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
101217364|NCT01486706|Analgesics|analgesics|mesh-ancestor
101217365|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
101217366|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217367|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217368|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
101217369|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217370|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217371|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217372|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217373|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101217374|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101217375|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217376|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217377|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
101217378|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101217379|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101217380|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217381|NCT01486706|Urological Agents|urological agents|mesh-ancestor
101217382|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101217383|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
101217384|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217385|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
101217386|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
101217387|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101217388|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217389|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217390|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
101217391|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
101217392|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101217393|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217394|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217396|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101217397|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217398|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217399|NCT01486901|Insulin|insulin|mesh-list
101217400|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101217401|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
101217402|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
101217403|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
101217404|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217405|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217406|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
101217407|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217408|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217409|NCT01486940|Insulin|insulin|mesh-list
101217410|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101217411|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
101217412|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
101217413|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
101217414|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
101217415|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
101217416|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217417|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217418|NCT01486953|Sevoflurane|sevoflurane|mesh-list
101217419|NCT01486953|Desflurane|desflurane|mesh-list
101217420|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101217421|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101217422|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
101217423|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
101217424|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217425|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217426|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101217427|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101217428|NCT01486979|Estradiol|estradiol|mesh-list
101217429|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101217430|NCT01486979|Estrogens|estrogens|mesh-ancestor
101217431|NCT01486979|Hormones|hormones|mesh-ancestor
101217432|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101217433|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217435|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
101217436|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101217437|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101217439|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101217440|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217441|NCT01487096|Teriflunomide|teriflunomide|mesh-list
101217442|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217443|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217444|NCT01487096|Analgesics|analgesics|mesh-ancestor
101217445|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
101217446|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217447|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217448|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217449|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217450|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217451|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
101217452|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
101217453|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101217454|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217455|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101217456|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101217457|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217458|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217459|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217462|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217463|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217464|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217465|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217466|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217467|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217468|NCT01487278|Misoprostol|misoprostol|mesh-list
101217469|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101217470|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
101217471|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101217472|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217473|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101217474|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217475|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
101217476|NCT01487304|Hormones|hormones|mesh-list
101217477|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101217478|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217479|NCT01487317|Rivastigmine|rivastigmine|mesh-list
101217480|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101217481|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217482|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217483|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217484|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217485|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217486|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101217487|NCT01487317|Protective Agents|protective agents|mesh-ancestor
101217489|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217490|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217491|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
101217492|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217493|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217494|NCT01487395|Donepezil|donepezil|mesh-list
101217495|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101217496|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217497|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217498|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217499|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217500|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217501|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
101217502|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
101217503|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217504|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217505|NCT01487421|Insulin|insulin|mesh-list
101217507|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
101217508|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
101217509|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217510|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217514|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217515|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217516|NCT01487512|Analgesics|analgesics|mesh-ancestor
101217517|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
101217518|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217519|NCT01487564|Hydromorphone|hydromorphone|mesh-list
101217520|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101217521|NCT01487564|Narcotics|narcotics|mesh-ancestor
101217522|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217523|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217524|NCT01487564|Analgesics|analgesics|mesh-ancestor
101217525|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
101217526|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217527|NCT01487629|Bevacizumab|bevacizumab|mesh-list
101217528|NCT01487629|Ranibizumab|ranibizumab|mesh-list
101217529|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101217530|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217531|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101217532|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101217533|NCT01487629|Growth Substances|growth substances|mesh-ancestor
101217534|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217535|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
101217536|NCT01487785|Gemcitabine|gemcitabine|mesh-list
101217537|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217538|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
101217539|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217540|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217541|NCT01487798|Insulin|insulin|mesh-list
101217542|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101217543|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
101217544|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
101217545|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101217548|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
101217549|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
101217550|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101217551|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217552|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217553|NCT01487993|Metformin|metformin|mesh-list
101217554|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217555|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217557|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101217558|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
101217559|NCT01488201|Brodalumab|brodalumab|mesh-list
101217560|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217561|NCT01488227|Vitamin D|vitamin d|mesh-list
101217562|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
101217563|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
101217564|NCT01488227|Vitamins|vitamins|mesh-list
101217565|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
101217566|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217567|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101217568|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101217569|NCT01488253|Sirolimus|sirolimus|mesh-list
101217570|NCT01488253|Temsirolimus|temsirolimus|mesh-list
101217571|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
101217572|NCT01488253|Tacrolimus|tacrolimus|mesh-list
101217573|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217574|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
101217575|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217576|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101217577|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217578|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217579|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101536175|NCT00565097|Lanreotide|lanreotide|mesh-list
101536176|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217580|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217581|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101217582|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217583|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
101217584|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217585|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101217586|NCT01488266|Milnacipran|milnacipran|mesh-list
101217587|NCT01488266|Aripiprazole|aripiprazole|mesh-list
101217588|NCT01488266|Mirtazapine|mirtazapine|mesh-list
101217604|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101217606|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101217607|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
101217608|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101217609|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101217610|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217611|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101217613|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217614|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
101217615|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101217616|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101217617|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101217618|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101217619|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101217620|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101217621|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101217622|NCT01488266|Analgesics|analgesics|mesh-ancestor
101217623|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
101217624|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101217625|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
101217626|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
101217627|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217628|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101217629|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101217630|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101217631|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
101217632|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101217633|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217634|NCT01488305|Micronutrients|micronutrients|mesh-list
101217635|NCT01488305|Trace Elements|trace elements|mesh-list
101217636|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217637|NCT01488344|Nintedanib|nintedanib|mesh-list
101217638|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217639|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217640|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217641|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217642|NCT01488396|Cyclosporine|cyclosporine|mesh-list
101217643|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101217644|NCT01488396|Cyclosporins|cyclosporins|mesh-list
101217645|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217646|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217647|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217648|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
101217649|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217663|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101217664|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101217665|NCT01488552|Metformin|metformin|mesh-list
101217666|NCT01488552|Paclitaxel|paclitaxel|mesh-list
101217667|NCT01488552|Gemcitabine|gemcitabine|mesh-list
101217668|NCT01488552|Folfirinox|folfirinox|mesh-list
101217669|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101217670|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217671|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
101217672|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217673|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217674|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217675|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217676|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
101217677|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217678|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217679|NCT01488565|Azacitidine|azacitidine|mesh-list
101217680|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217681|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
101217682|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217683|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217684|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217686|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101217687|NCT01488656|Antioxidants|antioxidants|mesh-list
101217688|NCT01488656|Vitamins|vitamins|mesh-ancestor
101217689|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
101217690|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217691|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101217692|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217693|NCT01488656|Protective Agents|protective agents|mesh-ancestor
101217694|NCT01488734|Vitamin D|vitamin d|mesh-list
101217695|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
101217696|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
101217697|NCT01488734|Vitamins|vitamins|mesh-list
101217698|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
101217699|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217700|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101217701|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101217702|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101217703|NCT01488773|Montelukast|montelukast|mesh-list
101217704|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101217705|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
101217706|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217707|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217708|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101217709|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
101217710|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101217711|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101217712|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101217713|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
101217714|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217715|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217716|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101217717|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
101217734|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217735|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217736|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101217737|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217738|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
101217739|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
101217740|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217742|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101217743|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217744|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101217745|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217746|NCT01489072|Remifentanil|remifentanil|mesh-list
101217747|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101217748|NCT01489072|Narcotics|narcotics|mesh-ancestor
101217749|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217750|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217751|NCT01489072|Analgesics|analgesics|mesh-ancestor
101217752|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
101217753|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217754|NCT01489124|Imipenem|imipenem|mesh-list
101217755|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101217756|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217757|NCT01489137|Remifentanil|remifentanil|mesh-list
101217758|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101217759|NCT01489137|Narcotics|narcotics|mesh-ancestor
101217760|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217761|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217762|NCT01489137|Analgesics|analgesics|mesh-ancestor
101217763|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
101217764|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217766|NCT01489202|Chromium|chromium|mesh-list
101217767|NCT01489202|Everolimus|everolimus|mesh-list
101217768|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101217769|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101217770|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217771|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217772|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217773|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
101217774|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217775|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536204|NCT00565175|Famotidine|famotidine|mesh-list
101217776|NCT01489202|Trace Elements|trace elements|mesh-ancestor
101217777|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
101217779|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217780|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
101217781|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217782|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101217787|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
101217788|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217789|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217790|NCT01489319|Analgesics|analgesics|mesh-ancestor
101217791|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
101217792|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217793|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217794|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217795|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217796|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101217797|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217798|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217799|NCT01489371|Doxorubicin|doxorubicin|mesh-list
101217800|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101217801|NCT01489371|Interleukin-12|interleukin-12|mesh-list
101217802|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101217803|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217804|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101217805|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101217806|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217807|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217808|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101217809|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
101217810|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217811|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101217812|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101217813|NCT01489371|Growth Substances|growth substances|mesh-ancestor
101217814|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
101217816|NCT01489410|Doxorubicin|doxorubicin|mesh-list
101217817|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101217818|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
101217819|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101217820|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217821|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101217822|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101217823|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217824|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217825|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101217826|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217827|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217828|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217829|NCT01489488|Riociguat|riociguat|mesh-list
101217830|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
101217831|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217832|NCT01489566|Fluorouracil|fluorouracil|mesh-list
101217833|NCT01489566|Mitomycins|mitomycins|mesh-list
101217834|NCT01489566|Mitomycin|mitomycin|mesh-list
101217835|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
101217836|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217837|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217838|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217839|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217840|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
101217841|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217842|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101217843|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
101217844|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101217845|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217846|NCT01489592|Turmeric extract|turmeric extract|mesh-list
101217848|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217849|NCT01489592|Protective Agents|protective agents|mesh-ancestor
101217850|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217851|NCT01489631|Sufentanil|sufentanil|mesh-list
101217852|NCT01489631|Gabapentin|gabapentin|mesh-list
101217853|NCT01489631|Bupivacaine|bupivacaine|mesh-list
101217854|NCT01489631|Ropivacaine|ropivacaine|mesh-list
101217855|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
101217856|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
101536215|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101217858|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217859|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
101217860|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217861|NCT01489631|Analgesics|analgesics|mesh-ancestor
101217862|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
101217863|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217864|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217865|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217866|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101217867|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101217868|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217869|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217870|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
101217871|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101217872|NCT01489631|Narcotics|narcotics|mesh-ancestor
101217873|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101217874|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101217875|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
101217876|NCT01489644|Metformin|metformin|mesh-list
101217877|NCT01489644|Repaglinide|repaglinide|mesh-list
101217878|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217879|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217880|NCT01489683|Lidocaine|lidocaine|mesh-list
101217881|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
101217882|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
101217883|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217884|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217885|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
101217886|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217887|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101217888|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101217889|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101217890|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217891|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217892|NCT01489696|Tamsulosin|tamsulosin|mesh-list
101217893|NCT01489696|Mirabegron|mirabegron|mesh-list
101217894|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101217895|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101217896|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101217897|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
101217898|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217899|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217900|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217901|NCT01489696|Urological Agents|urological agents|mesh-ancestor
101217902|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101217903|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101217904|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101217905|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
101217906|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101217907|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101217908|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217909|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217910|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217911|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217913|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101217914|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101217916|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101217917|NCT01489852|Estrogens|estrogens|mesh-ancestor
101217918|NCT01489852|Hormones|hormones|mesh-ancestor
101217919|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101217920|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217921|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101217922|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
101217923|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101217924|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101217926|NCT01489865|Veliparib|veliparib|mesh-list
101217927|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
101217928|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217929|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101217930|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217931|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101217933|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217934|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101217935|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217936|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
101217937|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101217938|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101217939|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101217940|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217941|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217942|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
101217943|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217944|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217945|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101217946|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217947|NCT01489917|Heparin|heparin|mesh-list
101217948|NCT01489917|Hemostatics|hemostatics|mesh-list
101217949|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
101217950|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101217951|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101217954|NCT01489943|Pioglitazone|pioglitazone|mesh-list
101217956|NCT01489943|Omeprazole|omeprazole|mesh-list
101217957|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101217958|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101217959|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101217960|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217961|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217962|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101217963|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101217964|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217965|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101217966|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
101217967|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
101217968|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
101217969|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
101217970|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217971|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217972|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101217973|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101217974|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
101217975|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101217976|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101217977|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217978|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217979|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101217980|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101217981|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101217983|NCT01489982|Doxepin|doxepin|mesh-list
101217984|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101217985|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217986|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217987|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101217988|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101217989|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
101217990|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217991|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
101217992|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
101217993|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217994|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217995|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
101217996|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
101217997|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217998|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217999|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218001|NCT01490047|Doxorubicin|doxorubicin|mesh-list
101218002|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101218003|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101218004|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218005|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101218006|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101218007|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218008|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218009|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218010|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218012|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
101536258|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101218013|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218014|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218015|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218016|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218017|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218019|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
101218020|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
101218021|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218022|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218023|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
101218024|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218025|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218026|NCT01490203|Edetic Acid|edetic acid|mesh-list
101218027|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
101218028|NCT01490203|Antidotes|antidotes|mesh-ancestor
101218029|NCT01490203|Protective Agents|protective agents|mesh-ancestor
101218030|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218031|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
101218032|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
101218033|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218034|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101218035|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
101218036|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101218037|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101218038|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101218039|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218040|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101218041|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101218042|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218043|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218044|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
101218045|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218047|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101218048|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101218049|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
101218050|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218051|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101218053|NCT01490255|Ranolazine|ranolazine|mesh-list
101218054|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101218055|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101218056|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218057|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218058|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218059|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218060|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
101218061|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218062|NCT01490268|Sufentanil|sufentanil|mesh-list
101218064|NCT01490268|Hydromorphone|hydromorphone|mesh-list
101218065|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101218066|NCT01490268|Narcotics|narcotics|mesh-ancestor
101218067|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218068|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218069|NCT01490268|Analgesics|analgesics|mesh-ancestor
101218070|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
101218071|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218072|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101218073|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101218074|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
101218075|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
101218076|NCT01490333|Vitamin D|vitamin d|mesh-list
101218077|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
101218078|NCT01490333|Vitamins|vitamins|mesh-ancestor
101218079|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
101218080|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218081|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101218082|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218083|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101218084|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
101218085|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218086|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101218087|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101218088|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101218089|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
101536264|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218091|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101218092|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101218093|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218094|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
101218095|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
101218096|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218097|NCT01490437|Dexamethasone|dexamethasone|mesh-list
101218099|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218100|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218101|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
101218102|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
101218103|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218104|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218105|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
101218107|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218108|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101218109|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218110|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218111|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218112|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101218113|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101218114|NCT01490476|Everolimus|everolimus|mesh-list
101218115|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218116|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218117|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
101218118|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218119|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101218120|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101218121|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218122|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218123|NCT01490567|Donepezil|donepezil|mesh-list
101218124|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101218125|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218126|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218127|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
101218128|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218129|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218130|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
101218131|NCT01490658|Metformin|metformin|mesh-list
101218132|NCT01490658|Repaglinide|repaglinide|mesh-list
101218133|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218134|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218135|NCT01490671|Tenofovir|tenofovir|mesh-list
101218136|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
101218137|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218138|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101218139|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101218140|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218141|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218142|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101218143|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101218144|NCT01490749|Carboplatin|carboplatin|mesh-list
101218145|NCT01490749|Capecitabine|capecitabine|mesh-list
101218146|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
101218148|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218149|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218150|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
101218151|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218152|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101218153|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101218154|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218155|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218156|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
101218157|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218158|NCT01490762|Insulin|insulin|mesh-list
101218159|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218160|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218161|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218162|NCT01490905|Ibuprofen|ibuprofen|mesh-list
101218163|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218164|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218165|NCT01490905|Analgesics|analgesics|mesh-ancestor
101536269|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218167|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218168|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218169|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218170|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218171|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101218172|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218173|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218176|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
101218177|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
101218178|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
101218179|NCT01490944|Trace Elements|trace elements|mesh-ancestor
101218180|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
101218181|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218182|NCT01490944|Hematinics|hematinics|mesh-ancestor
101218184|NCT01490996|Curcumin|curcumin|mesh-list
101218185|NCT01490996|Capecitabine|capecitabine|mesh-list
101218186|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218187|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
101218188|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218189|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218190|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218191|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218192|NCT01490996|Analgesics|analgesics|mesh-ancestor
101218193|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
101218194|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218195|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218196|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218197|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218198|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218199|NCT01491009|Midazolam|midazolam|mesh-list
101218200|NCT01491009|Remifentanil|remifentanil|mesh-list
101218201|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101218202|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101218203|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218204|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218205|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101218206|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101218207|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218208|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101218209|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
101218210|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
101218211|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
101218212|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
101218213|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218215|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101218216|NCT01491009|Narcotics|narcotics|mesh-ancestor
101218217|NCT01491009|Analgesics|analgesics|mesh-ancestor
101218218|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
101218219|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218220|NCT01491048|Tacrine|tacrine|mesh-list
101218221|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101218222|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218223|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218224|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
101218225|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218226|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218227|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101218228|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
101218229|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218230|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
101218231|NCT01491061|Ranolazine|ranolazine|mesh-list
101218232|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218233|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218234|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218235|NCT01491100|Interferons|interferons|mesh-list
101218236|NCT01491100|Interferon-beta|interferon-beta|mesh-list
101218237|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
101218238|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218239|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
101218240|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218242|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218243|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101218244|NCT01491139|Olaparib|olaparib|mesh-list
101218245|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218248|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536270|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536271|NCT00474903|Aspirin|aspirin|mesh-list
101536274|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101536275|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101536279|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101536280|NCT00474903|Analgesics|analgesics|mesh-ancestor
101536281|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
101536282|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218249|NCT01491191|Palmidrol|palmidrol|mesh-list
101218250|NCT01491191|Analgesics|analgesics|mesh-ancestor
101218251|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
101218252|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218253|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218254|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218255|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218256|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218257|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218258|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
101218259|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218260|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101218261|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101218262|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218263|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218264|NCT01491191|Hormones|hormones|mesh-ancestor
101218265|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218266|NCT01491204|Paclitaxel|paclitaxel|mesh-list
101218267|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218268|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218269|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218270|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218271|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218272|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218273|NCT01491217|Paclitaxel|paclitaxel|mesh-list
101218274|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218275|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218276|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218277|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218279|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218280|NCT01491256|Atorvastatin|atorvastatin|mesh-list
101218281|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101218282|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101218283|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
101218284|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218285|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101218286|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101218287|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218288|NCT01491295|Tenofovir|tenofovir|mesh-list
101218289|NCT01491295|Lamivudine|lamivudine|mesh-list
101218290|NCT01491295|Adefovir|adefovir|mesh-list
101218291|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
101218292|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218293|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101218294|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101218295|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218296|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218297|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101218298|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101218300|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218301|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218302|NCT01491321|Analgesics|analgesics|mesh-ancestor
101218303|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
101218304|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218305|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218306|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218307|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218308|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101536297|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
101536298|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101536299|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101536300|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101536301|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101536302|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101536303|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101536305|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101536701|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101536702|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
101536703|NCT01133275|Hormones|hormones|mesh-ancestor
101536704|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536705|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536706|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101536728|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101536729|NCT04570254|Protective Agents|protective agents|mesh-ancestor
101536730|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101536731|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101536732|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101536733|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101536739|NCT04570254|Expectorants|expectorants|mesh-ancestor
101536786|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101536787|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101536789|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101536843|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101536844|NCT01083966|Bevacizumab|bevacizumab|mesh-list
101536845|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101536906|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
101536907|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
101536908|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101536978|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101536979|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
101536980|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537044|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
101537045|NCT04568772|Esomeprazole|esomeprazole|mesh-list
101537046|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221788|NCT01509521|Ephedrine|ephedrine|mesh-list
101537206|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101537207|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218309|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101218310|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218311|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
101218313|NCT01491503|Montelukast|montelukast|mesh-list
101218314|NCT01491503|Levocetirizine|levocetirizine|mesh-list
101218315|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101218316|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
101218317|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101218318|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
101218319|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218321|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101218322|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101218323|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218324|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101218325|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101218326|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
101218327|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
101218328|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218329|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101218330|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101218331|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101218332|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101218333|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
101218335|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101218336|NCT01492062|Pancrelipase|pancrelipase|mesh-list
101218337|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218338|NCT01492114|Resveratrol|resveratrol|mesh-list
101218339|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
101218340|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218341|NCT01492114|Protective Agents|protective agents|mesh-ancestor
101218342|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218343|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218344|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101218345|NCT01492153|Insulin|insulin|mesh-list
101218346|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218347|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
101218348|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
101218349|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
101218350|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218351|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218352|NCT01492166|Insulin|insulin|mesh-list
101218353|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218354|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218355|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218356|NCT01492179|Lidocaine|lidocaine|mesh-list
101218357|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218358|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
101218359|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218360|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218361|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
101218362|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218363|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101218364|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101218365|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218366|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218367|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218369|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218370|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218371|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218372|NCT01492218|Insulin|insulin|mesh-list
101218373|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218374|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218375|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218376|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101218377|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218378|NCT01492504|Asunaprevir|asunaprevir|mesh-list
101218379|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
101218380|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218381|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218382|NCT01492543|Tegafur|tegafur|mesh-list
101537219|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537220|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218383|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218384|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
101218385|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218386|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218387|NCT01492556|Etoposide|etoposide|mesh-list
101218388|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218389|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218390|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101218391|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101218392|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218393|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218397|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218398|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218400|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218401|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101218402|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
101218403|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101218404|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218406|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218407|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
101218408|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101218409|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
101218410|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101218411|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101218412|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218413|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218414|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218415|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218416|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
101218417|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218419|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101218420|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218421|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218422|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101218423|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
101218424|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
101218425|NCT01492725|Plasminogen|plasminogen|mesh-list
101218426|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101218427|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101218428|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101218429|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218430|NCT01492881|Doxorubicin|doxorubicin|mesh-list
101218431|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101218433|NCT01492881|Vorinostat|vorinostat|mesh-list
101218434|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101218435|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218436|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101218437|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101218438|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218439|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218440|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101218441|NCT01492894|Cyclosporine|cyclosporine|mesh-list
101218442|NCT01492894|Sirolimus|sirolimus|mesh-list
101218444|NCT01492894|Cyclosporins|cyclosporins|mesh-list
101218445|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218446|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
101218447|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218448|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101218449|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218450|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218451|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
101218452|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218453|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
101218454|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218455|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101218456|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101218457|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218458|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
101537240|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537242|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101537243|NCT04568265|Entecavir|entecavir|mesh-list
101537244|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
101537245|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537247|NCT04568304|Gemcitabine|gemcitabine|mesh-list
101537248|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537249|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218459|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
101218460|NCT01492920|Vitamins|vitamins|mesh-ancestor
101218461|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
101218462|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218463|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
101218464|NCT01492959|Insulin|insulin|mesh-list
101218465|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218466|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218467|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218468|NCT01492985|Vaccines|vaccines|mesh-list
101218469|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
101218480|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
101218481|NCT01493102|Vasopressins|vasopressins|mesh-list
101218482|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
101218483|NCT01493102|Norepinephrine|norepinephrine|mesh-list
101218484|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101218485|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101218486|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
101218487|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218488|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218489|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218490|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
101218491|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
101218492|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218493|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101218494|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
101218495|NCT01493102|Coagulants|coagulants|mesh-ancestor
101218496|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101218497|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
101218498|NCT01493115|Insulin|insulin|mesh-list
101218499|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101218500|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
101218501|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218502|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218503|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
101218504|NCT01493154|Vaccines|vaccines|mesh-list
101218505|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
101218506|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218507|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218508|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218509|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101218510|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
101218511|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218512|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218513|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101218514|NCT01493310|Paclitaxel|paclitaxel|mesh-list
101218515|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101218516|NCT01493310|Mifepristone|mifepristone|mesh-list
101218517|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218518|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218519|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218520|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218521|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218522|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218523|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101218524|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
101218525|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101218526|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218527|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101218528|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101218529|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101218530|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
101218531|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101218532|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101218533|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
101218534|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218535|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
101218537|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101218540|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
101218541|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218542|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218544|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101218545|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218546|NCT01493440|Atosiban|atosiban|mesh-list
101218547|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
101218548|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218549|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218550|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
101218551|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101218552|NCT01493479|Rituximab|rituximab|mesh-list
101218553|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101218554|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218555|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
101218556|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218557|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218558|NCT01493570|BI 409306|bi 409306|mesh-list
101218559|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101218560|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218561|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218562|NCT01493622|Minocycline|minocycline|mesh-list
101218563|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101218564|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218565|NCT01493635|Analgesics|analgesics|mesh-list
101218566|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
101218567|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218568|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218569|NCT01493648|Vitamin D|vitamin d|mesh-list
101218570|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
101218571|NCT01493648|Vitamins|vitamins|mesh-ancestor
101218572|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
101218573|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218574|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101218575|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218576|NCT01493674|Folic Acid|folic acid|mesh-list
101218577|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
101218578|NCT01493674|Hematinics|hematinics|mesh-ancestor
101218579|NCT01493674|Vitamins|vitamins|mesh-ancestor
101218580|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
101218581|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218582|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
101218583|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101218584|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
101218585|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101218586|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218587|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101218588|NCT01493843|Paclitaxel|paclitaxel|mesh-list
101218589|NCT01493843|Bevacizumab|bevacizumab|mesh-list
101218590|NCT01493843|Carboplatin|carboplatin|mesh-list
101218591|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218592|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218594|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218595|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218596|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218597|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101218598|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101218599|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101218600|NCT01493843|Growth Substances|growth substances|mesh-ancestor
101218601|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218602|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
101218603|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
101218604|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101218605|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101218606|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101218607|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218608|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
101537250|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
101218609|NCT01493973|Hematinics|hematinics|mesh-ancestor
101218610|NCT01493986|Ropivacaine|ropivacaine|mesh-list
101218611|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218612|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
101218613|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218614|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218618|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101218619|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101218620|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101218621|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101218622|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101218623|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
101218624|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218625|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218626|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218627|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101218628|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101218629|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218630|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
101218631|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101218632|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101218634|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218635|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101218636|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101218637|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218638|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
101218639|NCT01494155|Capecitabine|capecitabine|mesh-list
101218640|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218641|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
101218642|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218643|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218644|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
101218645|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101218646|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101218647|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218648|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218649|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218650|NCT01494259|Epinephrine|epinephrine|mesh-list
101218651|NCT01494259|Bupivacaine|bupivacaine|mesh-list
101218652|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218653|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
101218654|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218655|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218656|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
101218657|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218658|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101218659|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101218660|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
101218661|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218662|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218663|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101218664|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101218665|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
101218666|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101218670|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101218671|NCT01494311|Lidocaine|lidocaine|mesh-list
101218672|NCT01494311|Tetracaine|tetracaine|mesh-list
101218673|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218674|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
101218675|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218676|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218677|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
101218678|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218679|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101218680|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101218681|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218682|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218683|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218684|NCT01494363|Leucovorin|leucovorin|mesh-list
101218685|NCT01494363|Fluorouracil|fluorouracil|mesh-list
101218686|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
101218687|NCT01494363|Irinotecan|irinotecan|mesh-list
101218688|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
101218689|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218691|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218692|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218693|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
101218694|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218695|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101218696|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101218697|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218698|NCT01494363|Antidotes|antidotes|mesh-ancestor
101218699|NCT01494363|Protective Agents|protective agents|mesh-ancestor
101218700|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
101218701|NCT01494363|Vitamins|vitamins|mesh-ancestor
101218702|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
101218703|NCT01494402|Aspirin|aspirin|mesh-list
101218704|NCT01494402|Esomeprazole|esomeprazole|mesh-list
101218705|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101218706|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218707|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101218708|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218709|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218710|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218711|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218712|NCT01494402|Analgesics|analgesics|mesh-ancestor
101218713|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
101218714|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218715|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218716|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218717|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218718|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101218719|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101218720|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101218721|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101218722|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
101218723|NCT01494415|Paclitaxel|paclitaxel|mesh-list
101218724|NCT01494415|Carboplatin|carboplatin|mesh-list
101218725|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218726|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218727|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218728|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218730|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218732|NCT01494597|Isavuconazole|isavuconazole|mesh-list
101218733|NCT01494597|Cyclosporins|cyclosporins|mesh-list
101218734|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218735|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218736|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101218737|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
101218738|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218739|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
101218740|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218741|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
101218742|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218743|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101218745|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101218746|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218747|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
101218748|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218749|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218750|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
101218751|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218752|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101218753|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101218754|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218755|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218756|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218757|NCT01494688|Paclitaxel|paclitaxel|mesh-list
101218758|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101218759|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218760|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
101218761|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
101218762|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
101218763|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218764|NCT01494714|Petrolatum|petrolatum|mesh-list
101218765|NCT01494714|Emollients|emollients|mesh-ancestor
101218767|NCT01494727|Amlodipine|amlodipine|mesh-list
101218768|NCT01494727|Valsartan|valsartan|mesh-list
101537251|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537252|NCT01082640|Febuxostat|febuxostat|mesh-list
101537253|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
101537254|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537255|NCT00589862|Clopidogrel|clopidogrel|mesh-list
101537256|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537257|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101537258|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101537259|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101537260|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
101537262|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218769|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
101218770|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101218771|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101218772|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218773|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218774|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218775|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218776|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
101218777|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101218778|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101218779|NCT01494740|Vaccines|vaccines|mesh-list
101218780|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
101218781|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218782|NCT01494805|Ranibizumab|ranibizumab|mesh-list
101218783|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101218784|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101218785|NCT01494805|Growth Substances|growth substances|mesh-ancestor
101218786|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218787|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
101218788|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218789|NCT01494857|Adalimumab|adalimumab|mesh-list
101218790|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101218791|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218792|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101218794|NCT01495026|Dutasteride|dutasteride|mesh-list
101218795|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101218796|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101218797|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101218798|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
101218799|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218800|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218801|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218802|NCT01495026|Urological Agents|urological agents|mesh-ancestor
101218803|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101218804|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101218805|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218806|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
101218807|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218808|NCT01495039|Nystatin|nystatin|mesh-list
101218809|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101218810|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218811|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
101218812|NCT01495039|Ionophores|ionophores|mesh-ancestor
101218813|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218814|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218815|NCT01495104|Valproic Acid|valproic acid|mesh-list
101218816|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
101218817|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218818|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218819|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
101218820|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218821|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218822|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
101218823|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101218824|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218825|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218827|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
101218828|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101218829|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
101218830|NCT01495117|Povidone|povidone|mesh-list
101218831|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101218832|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101218833|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218834|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
101218835|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
101218836|NCT01495117|Trace Elements|trace elements|mesh-ancestor
101218837|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
101218838|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218839|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
101218840|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
101218841|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
101218842|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218843|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101218844|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218845|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218847|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101218848|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101218849|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218850|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218851|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218853|NCT01495195|Donepezil|donepezil|mesh-list
101218854|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101218856|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218857|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
101218858|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218859|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218860|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
101218861|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
101218862|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101218863|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101218864|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101218865|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101218866|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101218867|NCT01495195|Protective Agents|protective agents|mesh-ancestor
101218868|NCT01495208|Aflibercept|aflibercept|mesh-list
101218869|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101218870|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101218871|NCT01495208|Growth Substances|growth substances|mesh-ancestor
101218872|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218873|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
101218874|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218875|NCT01495260|Vitamin E|vitamin e|mesh-list
101218876|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
101218877|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
101218878|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101218879|NCT01495260|Vitamins|vitamins|mesh-ancestor
101218880|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
101218881|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218882|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
101218883|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101218884|NCT01495260|Expectorants|expectorants|mesh-ancestor
101218885|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
101218886|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101218887|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
101218888|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218889|NCT01495260|Protective Agents|protective agents|mesh-ancestor
101218890|NCT01495260|Antidotes|antidotes|mesh-ancestor
101218891|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
101218892|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
101218893|NCT01495338|Cetirizine|cetirizine|mesh-list
101218894|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101218895|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101218896|NCT01495338|Analgesics|analgesics|mesh-ancestor
101218897|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
101218898|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218899|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218900|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218901|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537264|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
101537265|NCT00589901|Capecitabine|capecitabine|mesh-list
101537266|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537267|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
101537268|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537269|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537270|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101537271|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
101218902|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101218903|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101218904|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101218905|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
101218906|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
101218907|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218908|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218909|NCT01495351|Bortezomib|bortezomib|mesh-list
101218910|NCT01495351|Veliparib|veliparib|mesh-list
101218911|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218912|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101218913|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218914|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218915|NCT01495377|Remifentanil|remifentanil|mesh-list
101218916|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101218917|NCT01495377|Narcotics|narcotics|mesh-ancestor
101218918|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218922|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218924|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218925|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218926|NCT01495520|Ranolazine|ranolazine|mesh-list
101218927|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101218928|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101218929|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218931|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
101218932|NCT01495624|Ropivacaine|ropivacaine|mesh-list
101218933|NCT01495624|Anesthetics|anesthetics|mesh-list
101218934|NCT01495624|BB 1101|bb 1101|mesh-list
101218935|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101218936|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
101218937|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
101218938|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218939|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218940|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218941|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
101218942|NCT01495624|Hormones|hormones|mesh-ancestor
101218943|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218944|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101218945|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218946|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
101218947|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218948|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218949|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
101218950|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218951|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
101218952|NCT01495715|Idebenone|idebenone|mesh-list
101218953|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
101218954|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218955|NCT01495715|Protective Agents|protective agents|mesh-ancestor
101218956|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218957|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
101218958|NCT01495806|Cathartics|cathartics|mesh-ancestor
101218959|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218960|NCT01495845|Clopidogrel|clopidogrel|mesh-list
101218961|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101218962|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101218963|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101218964|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101218965|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
101218966|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218967|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218968|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218970|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218971|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101218972|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218973|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218974|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
101218975|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101218976|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101218977|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218978|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218979|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
101218980|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101218981|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218982|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101218983|NCT01495949|Thiopental|thiopental|mesh-list
101218984|NCT01495949|Etomidate|etomidate|mesh-list
101218985|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101218986|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101218987|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218988|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101218989|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
101218990|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
101218991|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
101218994|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101218995|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218996|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
101218997|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101218998|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101218999|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101219000|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101219001|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219002|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
101219003|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219004|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219005|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101219006|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219008|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
101219009|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
101219010|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219011|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219012|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
101219013|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219014|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101219015|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101219016|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101219017|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101219018|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219019|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
101219020|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101219021|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101219022|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219024|NCT01496196|Coagulants|coagulants|mesh-ancestor
101219025|NCT01496261|Aspirin|aspirin|mesh-list
101219026|NCT01496261|Clopidogrel|clopidogrel|mesh-list
101219027|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101219028|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219029|NCT01496261|Analgesics|analgesics|mesh-ancestor
101219030|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
101219031|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219032|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219033|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219034|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219035|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101219036|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101219037|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219038|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101219039|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101219040|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219041|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
101219042|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101219043|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101219044|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101219045|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
101219046|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219048|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101219049|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219050|NCT01496326|Analgesics|analgesics|mesh-ancestor
101219051|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
101219052|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219053|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219054|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219055|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219056|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101219057|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219058|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219059|NCT01496417|Abatacept|abatacept|mesh-list
101219060|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101219061|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219062|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101219063|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219065|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
101219066|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219067|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219068|NCT01496443|Glimepiride|glimepiride|mesh-list
101219069|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101219070|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219071|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219072|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219073|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
101219075|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101219076|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219077|NCT01496521|Analgesics|analgesics|mesh-ancestor
101219078|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
101219079|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219080|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219081|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219082|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219083|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101219084|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101219085|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219086|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101219087|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101219088|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219089|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
101219090|NCT01496534|Carboplatin|carboplatin|mesh-list
101219091|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219092|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
101219093|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219094|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219095|NCT01496690|Pregabalin|pregabalin|mesh-list
101219096|NCT01496690|Analgesics|analgesics|mesh-ancestor
101219097|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
101219098|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219099|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219100|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
101219101|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101219102|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101219103|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219104|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101219105|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101219106|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101219107|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219108|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101219111|NCT01496742|Carboplatin|carboplatin|mesh-list
101219113|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101219114|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219115|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
101219116|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
101219117|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
101219118|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219119|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101219120|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219121|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219122|NCT01496742|Growth Substances|growth substances|mesh-ancestor
101219123|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219124|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219125|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219126|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101219127|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101219128|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
101219129|NCT01496911|Levocetirizine|levocetirizine|mesh-list
101219130|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101219131|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101219132|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
101219133|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
101219134|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219135|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219136|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219137|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
101219138|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
101219139|NCT01496989|Interleukin-12|interleukin-12|mesh-list
101219141|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
101219142|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219143|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219144|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219145|NCT01496989|Growth Substances|growth substances|mesh-ancestor
101219146|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219147|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219148|NCT01497002|Cytarabine|cytarabine|mesh-list
101219149|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219150|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
101219151|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219152|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219153|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
101219154|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219155|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219156|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
101219157|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219158|NCT01497041|Docetaxel|docetaxel|mesh-list
101219159|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
101219160|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219161|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
101219162|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
101219163|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
101219164|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219165|NCT01497093|Thalidomide|thalidomide|mesh-list
101219166|NCT01497093|Dexamethasone|dexamethasone|mesh-list
101219167|NCT01497093|Bortezomib|bortezomib|mesh-list
101219168|NCT01497093|Pomalidomide|pomalidomide|mesh-list
101219169|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219170|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
101219171|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
101219172|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219173|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219174|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219175|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
101219176|NCT01497093|Hormones|hormones|mesh-ancestor
101219177|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219178|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219179|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219180|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
101219181|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219182|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219183|NCT01497093|Growth Substances|growth substances|mesh-ancestor
101219184|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219185|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219186|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
101219187|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219188|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219189|NCT01497132|Vitamin D|vitamin d|mesh-list
101219190|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
101219191|NCT01497132|Vitamins|vitamins|mesh-ancestor
101219192|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
101219193|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219194|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101219195|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101219196|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
101219197|NCT01497145|Hematinics|hematinics|mesh-ancestor
101537272|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537273|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537274|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101537275|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537276|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
101537277|NCT00590174|Aspirin|aspirin|mesh-list
101537278|NCT00590174|Clopidogrel|clopidogrel|mesh-list
101537279|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101537280|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101537281|NCT00590174|Analgesics|analgesics|mesh-ancestor
101537282|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
101219198|NCT01497288|Fentanyl|fentanyl|mesh-list
101219199|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101219200|NCT01497288|Narcotics|narcotics|mesh-ancestor
101219201|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219202|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219203|NCT01497288|Analgesics|analgesics|mesh-ancestor
101219204|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
101219205|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219206|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101219207|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101219208|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
101219209|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
101219211|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
101219212|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219213|NCT01497431|Selenium|selenium|mesh-list
101219214|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
101219215|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
101219216|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219217|NCT01497431|Protective Agents|protective agents|mesh-ancestor
101219220|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
101219221|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101219222|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219224|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219225|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219226|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219227|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219228|NCT01497470|Paclitaxel|paclitaxel|mesh-list
101219229|NCT01497470|Carboplatin|carboplatin|mesh-list
101219230|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101219231|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219232|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
101219233|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
101219234|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
101219235|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219236|NCT01497483|Cyclosporine|cyclosporine|mesh-list
101219237|NCT01497483|Pravastatin|pravastatin|mesh-list
101219238|NCT01497483|Cyclosporins|cyclosporins|mesh-list
101219239|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219240|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219241|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219242|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
101219243|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219244|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
101219245|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219246|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
101219247|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219248|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101219249|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219250|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219251|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
101219252|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101219253|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101219254|NCT01497522|Vildagliptin|vildagliptin|mesh-list
101219256|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537283|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219257|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101219258|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
101219259|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219260|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219261|NCT01497535|Insulin|insulin|mesh-list
101219262|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219263|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
101219264|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
101219265|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219266|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219267|NCT01497548|Methylphenidate|methylphenidate|mesh-list
101219268|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101219269|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219270|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101219271|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101219272|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101219273|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219274|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
101219275|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219276|NCT01497561|Insulin|insulin|mesh-list
101219277|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219278|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
101219279|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
101219280|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
101219281|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
101219282|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219283|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219284|NCT01497574|Insulin|insulin|mesh-list
101219285|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219286|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
101219287|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
101219288|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219289|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219290|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
101219291|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219292|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219294|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219295|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
101219296|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
101219297|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
101219298|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
101219299|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219300|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219302|NCT01497626|Lapatinib|lapatinib|mesh-list
101219303|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219304|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219305|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219306|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219307|NCT01497652|Rasagiline|rasagiline|mesh-list
101219308|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101219309|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219310|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219311|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101219312|NCT01497652|Protective Agents|protective agents|mesh-ancestor
101219313|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219314|NCT01497717|Adalimumab|adalimumab|mesh-list
101219315|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101219316|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219317|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219318|NCT01497873|Topotecan|topotecan|mesh-list
101219319|NCT01497873|Belotecan|belotecan|mesh-list
101219320|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101219321|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101219322|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219323|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219324|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219325|NCT01497912|Atorvastatin|atorvastatin|mesh-list
101219326|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219327|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219328|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
101219329|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219330|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101219331|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101219332|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219333|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
101219334|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
101219335|NCT01497977|Estrogens|estrogens|mesh-ancestor
101219336|NCT01497977|Hormones|hormones|mesh-ancestor
101219337|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219338|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219340|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219341|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219342|NCT01498003|Tirofiban|tirofiban|mesh-list
101219343|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101219344|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101219345|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219346|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101219347|NCT01498016|Busulfan|busulfan|mesh-list
101219348|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
101219349|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219350|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219351|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
101219352|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219353|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101219354|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219355|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101219356|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
101219357|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101219358|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
101219359|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219360|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219361|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101219362|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
101219363|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
101219365|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
101219366|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219367|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219368|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
101219369|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101219370|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219373|NCT01498380|Analgesics|analgesics|mesh-ancestor
101219374|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
101219375|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219376|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101219377|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101219378|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101219379|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
101219380|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219382|NCT01498406|Vitamin D|vitamin d|mesh-list
101219383|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
101219384|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
101219385|NCT01498406|Vitamins|vitamins|mesh-list
101219386|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
101219387|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219388|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101219389|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101219390|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101219391|NCT01498562|Gefitinib|gefitinib|mesh-list
101219392|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
101219393|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219394|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219395|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219396|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219397|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101219398|NCT01498718|Vaccines|vaccines|mesh-list
101219399|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
101219400|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219401|NCT01498783|Fluorouracil|fluorouracil|mesh-list
101219402|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
101219403|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219404|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219405|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219406|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219407|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
101219408|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219409|NCT01498796|Ketorolac|ketorolac|mesh-list
101219410|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101537284|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537285|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537286|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537287|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101537288|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101537289|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537290|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537291|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101537292|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537293|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
101537294|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101537295|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101537296|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101219411|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219412|NCT01498796|Analgesics|analgesics|mesh-ancestor
101219413|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
101219414|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219415|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219416|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219417|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219418|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101219419|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219420|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219421|NCT01498809|Midodrine|midodrine|mesh-list
101219422|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
101219423|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
101219424|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219425|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219426|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101219427|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101219428|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101219429|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101219430|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
101219431|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219432|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219433|NCT01498835|Sunitinib|sunitinib|mesh-list
101219434|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219435|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219436|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219437|NCT01498835|Growth Substances|growth substances|mesh-ancestor
101219438|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219439|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219440|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219441|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219442|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219443|NCT01498861|Dolutegravir|dolutegravir|mesh-list
101219445|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101219447|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101219448|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219449|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219451|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101219452|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
101219453|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219454|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219455|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101219456|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101219457|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219458|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101219459|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
101537297|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
101537298|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219460|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219461|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219462|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101219463|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101219464|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101219465|NCT01498900|Repaglinide|repaglinide|mesh-list
101219466|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219467|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219468|NCT01498913|Repaglinide|repaglinide|mesh-list
101219469|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219470|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219471|NCT01498926|Insulin|insulin|mesh-list
101219472|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219473|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
101219474|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219475|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219476|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
101219477|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219478|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219480|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
101219481|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219482|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219483|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219484|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
101219485|NCT01499069|Fesoterodine|fesoterodine|mesh-list
101219486|NCT01499069|Propiverine|propiverine|mesh-list
101219487|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101219488|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101219489|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
101219490|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219491|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219492|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219493|NCT01499069|Urological Agents|urological agents|mesh-ancestor
101219494|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
101219495|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
101219496|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219497|NCT01499108|Liraglutide|liraglutide|mesh-list
101219498|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219499|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219500|NCT01499108|Incretins|incretins|mesh-ancestor
101219501|NCT01499108|Hormones|hormones|mesh-ancestor
101219502|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219503|NCT01499121|Sunitinib|sunitinib|mesh-list
101219504|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219505|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219506|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219507|NCT01499121|Growth Substances|growth substances|mesh-ancestor
101219508|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219509|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219511|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219512|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219513|NCT01499225|Doxycycline|doxycycline|mesh-list
101219514|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219515|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219516|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
101219517|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101219518|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101219519|NCT01499251|Temozolomide|temozolomide|mesh-list
101219520|NCT01499251|Macitentan|macitentan|mesh-list
101219521|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101219522|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
101219523|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219525|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
101219526|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101219527|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101219528|NCT01499407|Abciximab|abciximab|mesh-list
101219529|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
101219530|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101219531|NCT01499433|Caspofungin|caspofungin|mesh-list
101219532|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
101219533|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219534|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537299|NCT00590213|Bicalutamide|bicalutamide|mesh-list
101219535|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219536|NCT01499446|Fluticasone|fluticasone|mesh-list
101219538|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219539|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101219540|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
101219541|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219542|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219543|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101219544|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
101219545|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
101219546|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101219547|NCT01499485|Acetazolamide|acetazolamide|mesh-list
101219548|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
101219549|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101219550|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219551|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219552|NCT01499485|Diuretics|diuretics|mesh-ancestor
101219553|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
101219554|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219555|NCT01499589|Anesthetics|anesthetics|mesh-list
101219556|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219557|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219558|NCT01499602|Norethindrone|norethindrone|mesh-list
101219559|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
101219560|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101219561|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
101219562|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219563|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219564|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101219565|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101219566|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101219567|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101219568|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
101219570|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101219571|NCT01499641|Prednisolone|prednisolone|mesh-list
101219572|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
101219573|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101219574|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
101219575|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219576|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
101219577|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
101219578|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219579|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219580|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219581|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
101219582|NCT01499641|Hormones|hormones|mesh-ancestor
101219583|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219584|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101219585|NCT01499641|Protective Agents|protective agents|mesh-ancestor
101219586|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219587|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219589|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101219590|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219591|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101219592|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219593|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219594|NCT01499758|Atorvastatin|atorvastatin|mesh-list
101219595|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219596|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219597|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
101219598|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219599|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101219600|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101219601|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219605|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
101219606|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219607|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101219608|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101219609|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219610|NCT01499875|Penicillin V|penicillin v|mesh-list
101219611|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219612|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537300|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
101537301|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537302|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219614|NCT01500005|Vitamins|vitamins|mesh-ancestor
101219615|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
101219616|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219617|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101219618|NCT01500018|Phentermine|phentermine|mesh-list
101219620|NCT01500018|Analgesics|analgesics|mesh-ancestor
101219621|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
101219622|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219623|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219624|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101219625|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101219627|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
101219628|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219629|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101219630|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101219631|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219632|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219633|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101219634|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
101219635|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101219636|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
101219637|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
101219638|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
101219640|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101219641|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219642|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219643|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219644|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219645|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
101219646|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219647|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219648|NCT01500161|Cytarabine|cytarabine|mesh-list
101219649|NCT01500161|Fludarabine|fludarabine|mesh-list
101219650|NCT01500161|Etoposide|etoposide|mesh-list
101219651|NCT01500161|Melphalan|melphalan|mesh-list
101219652|NCT01500161|Busulfan|busulfan|mesh-list
101219653|NCT01500161|Carmustine|carmustine|mesh-list
101219654|NCT01500161|Clofarabine|clofarabine|mesh-list
101219655|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219656|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219657|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
101219658|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219659|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219660|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
101219661|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219662|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101219663|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101219664|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101219665|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219667|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219668|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101219669|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
101219670|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101219671|NCT01500408|Interferons|interferons|mesh-list
101219672|NCT01500408|Interferon-beta|interferon-beta|mesh-list
101219673|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
101219674|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219675|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
101219676|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219677|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
101219678|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219679|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101219680|NCT01500473|Desogestrel|desogestrel|mesh-list
101219683|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101219684|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
101219685|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219686|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219687|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101219688|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101537303|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537304|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537305|NCT00590408|Ubiquinone|ubiquinone|mesh-list
101219691|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219692|NCT01500538|Vorinostat|vorinostat|mesh-list
101219693|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219694|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101219695|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219696|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219697|NCT01500577|Nimesulide|nimesulide|mesh-list
101219698|NCT01500577|Simvastatin|simvastatin|mesh-list
101219699|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219700|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219702|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219703|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101219704|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101219705|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219706|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101219707|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219708|NCT01500577|Analgesics|analgesics|mesh-ancestor
101219709|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
101219710|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219711|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219712|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219713|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219714|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101219716|NCT01500590|Irbesartan|irbesartan|mesh-list
101219717|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101219718|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
101219719|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219720|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219721|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101219722|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101219723|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101219724|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
101219725|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
101219726|NCT01500785|Simendan|simendan|mesh-list
101219727|NCT01500785|Vitamins|vitamins|mesh-ancestor
101219728|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
101219729|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219730|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
101219731|NCT01500785|Hematinics|hematinics|mesh-ancestor
101219732|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101219733|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
101219734|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101219735|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101219736|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219737|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219738|NCT01500785|Protective Agents|protective agents|mesh-ancestor
101219739|NCT01500824|Crizotinib|crizotinib|mesh-list
101219740|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219741|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101219742|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219743|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219744|NCT01500837|Levofloxacin|levofloxacin|mesh-list
101219745|NCT01500837|Ofloxacin|ofloxacin|mesh-list
101219746|NCT01500837|Rifampin|rifampin|mesh-list
101219747|NCT01500837|Clindamycin|clindamycin|mesh-list
101219748|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
101219749|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
101219750|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101219751|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219752|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101219753|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101219754|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101219755|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219757|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219758|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101219759|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101219760|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101219761|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
101219762|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
101219763|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101219764|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101219765|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101219766|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101219767|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101219768|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101219769|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101219770|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101219772|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101219774|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
101219775|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
101219776|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
101219777|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
101219778|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219779|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219780|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
101219781|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101219782|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101219784|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101219785|NCT01500863|Progesterone|progesterone|mesh-list
101219786|NCT01500863|Estrogens|estrogens|mesh-ancestor
101219787|NCT01500863|Hormones|hormones|mesh-ancestor
101219788|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219789|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219790|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101219792|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219793|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101219794|NCT01500863|Progestins|progestins|mesh-ancestor
101219795|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
101219796|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219797|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219798|NCT01500915|Ranibizumab|ranibizumab|mesh-list
101219799|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219800|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219801|NCT01500915|Growth Substances|growth substances|mesh-ancestor
101219802|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219803|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219804|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219805|NCT01500928|Insulin|insulin|mesh-list
101219806|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219807|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219808|NCT01500980|Chloroquine|chloroquine|mesh-list
101219809|NCT01500980|Primaquine|primaquine|mesh-list
101219810|NCT01500980|Amebicides|amebicides|mesh-ancestor
101219811|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101219812|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101219813|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101219814|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
101219815|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219816|NCT01500993|Fluorouracil|fluorouracil|mesh-list
101219817|NCT01500993|Capecitabine|capecitabine|mesh-list
101219818|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
101219819|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219820|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219821|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219822|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219823|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
101219824|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219825|NCT01501032|Pancrelipase|pancrelipase|mesh-list
101219826|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219827|NCT01501084|Exenatide|exenatide|mesh-list
101219828|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101219829|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219830|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101219831|NCT01501084|Incretins|incretins|mesh-ancestor
101219832|NCT01501084|Hormones|hormones|mesh-ancestor
101219834|NCT01501123|Midazolam|midazolam|mesh-list
101219835|NCT01501123|Haloperidol|haloperidol|mesh-list
101219836|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
101219837|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101219838|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101219839|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219840|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219841|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101219842|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101219843|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101219844|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101537306|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
101537307|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
101537308|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537309|NCT00590408|Vitamins|vitamins|mesh-ancestor
101537310|NCT00590447|Rituximab|rituximab|mesh-list
101537311|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101537312|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219845|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
101219846|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
101219847|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
101219848|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
101219849|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219850|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219851|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
101219852|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
101219853|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219854|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219855|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101219856|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101219857|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
101219858|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101219859|NCT01501136|Dexamethasone|dexamethasone|mesh-list
101219860|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
101219861|NCT01501136|Cisplatin|cisplatin|mesh-list
101219862|NCT01501136|Gemcitabine|gemcitabine|mesh-list
101219863|NCT01501136|Etoposide|etoposide|mesh-list
101219864|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
101219865|NCT01501136|Ifosfamide|ifosfamide|mesh-list
101219866|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
101219867|NCT01501136|Pegaspargase|pegaspargase|mesh-list
101219868|NCT01501136|Asparaginase|asparaginase|mesh-list
101219869|NCT01501136|BB 1101|bb 1101|mesh-list
101219871|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219872|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
101219873|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
101219874|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219875|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219876|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219877|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
101219878|NCT01501136|Hormones|hormones|mesh-ancestor
101219879|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219880|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219881|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219882|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
101219883|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219884|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219885|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219886|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
101219887|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101219888|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101219889|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101219891|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
101219892|NCT01501136|Protective Agents|protective agents|mesh-ancestor
101219893|NCT01501149|Dexamethasone|dexamethasone|mesh-list
101219894|NCT01501149|Gemcitabine|gemcitabine|mesh-list
101219895|NCT01501149|Etoposide|etoposide|mesh-list
101219896|NCT01501149|Pegaspargase|pegaspargase|mesh-list
101219897|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219898|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
101219899|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
101219900|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219901|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219902|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219903|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
101219904|NCT01501149|Hormones|hormones|mesh-ancestor
101219905|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219906|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219907|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219908|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101219909|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
101219910|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219913|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101537313|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
101537314|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537315|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101219914|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219915|NCT01501214|Atosiban|atosiban|mesh-list
101219916|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
101219917|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219918|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219919|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
101219920|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219921|NCT01501253|Amlodipine|amlodipine|mesh-list
101219922|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101219923|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101219924|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101219925|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219926|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101219927|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219929|NCT01501344|Calcium|calcium|mesh-list
101219930|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101219931|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219933|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
101219934|NCT01501370|Lenalidomide|lenalidomide|mesh-list
101219935|NCT01501370|Vorinostat|vorinostat|mesh-list
101219936|NCT01501370|BB 1101|bb 1101|mesh-list
101219937|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101219938|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
101219939|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
101219940|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101219941|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219942|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101219943|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
101219944|NCT01501370|Hormones|hormones|mesh-ancestor
101219945|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219946|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219947|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101219948|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
101219949|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101219950|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219951|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
101219952|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101219953|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101219955|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101219956|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101219958|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
101219959|NCT01501396|Mirtazapine|mirtazapine|mesh-list
101219960|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
101219961|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101219962|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101219963|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
101219964|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
101219965|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101219966|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219967|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219968|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101219969|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101219970|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101219971|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101219972|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101219973|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101219974|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
101219975|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101219976|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101219977|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
101219978|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101219979|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101219980|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101219981|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101219982|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
101219983|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101219984|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101537316|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101537317|NCT01081626|Hormones|hormones|mesh-ancestor
101219985|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101219986|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101219988|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
101219989|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101219991|NCT01501422|Hormones|hormones|mesh-ancestor
101219992|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219993|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219994|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
101219995|NCT01501435|Fenofibrate|fenofibrate|mesh-list
101219996|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219997|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219998|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
101219999|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220000|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101220001|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101220002|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101220004|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101220005|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
101220006|NCT01501448|Estradiol|estradiol|mesh-list
101220007|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101220008|NCT01501448|Estrogens|estrogens|mesh-ancestor
101220009|NCT01501448|Hormones|hormones|mesh-ancestor
101220010|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220011|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220012|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101220013|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
101220014|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101220015|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101220016|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101220017|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101220018|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101220019|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101220020|NCT01501487|Paclitaxel|paclitaxel|mesh-list
101220021|NCT01501487|Docetaxel|docetaxel|mesh-list
101220022|NCT01501487|Trastuzumab|trastuzumab|mesh-list
101220023|NCT01501487|Pertuzumab|pertuzumab|mesh-list
101220024|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101220025|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220026|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
101220027|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
101220028|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
101220029|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220030|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220031|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101220032|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101220033|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220034|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220035|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101220036|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220037|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220038|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220039|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220040|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
101220041|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
101220042|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220043|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101220044|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
101220045|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
101220046|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220047|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220048|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220049|NCT01501669|Capecitabine|capecitabine|mesh-list
101220050|NCT01501669|Irinotecan|irinotecan|mesh-list
101220051|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101220052|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
101220053|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220054|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220055|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101220056|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101220057|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537318|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537319|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220058|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
101220059|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220060|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220061|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220062|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220063|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220064|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101220065|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
101220066|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220067|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220068|NCT01501708|Voriconazole|voriconazole|mesh-list
101220069|NCT01501708|Amphotericin B|amphotericin b|mesh-list
101220070|NCT01501708|Caspofungin|caspofungin|mesh-list
101220071|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
101220072|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220073|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101220074|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101220076|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220077|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101220078|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
101220079|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220080|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220081|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101220082|NCT01501708|Amebicides|amebicides|mesh-ancestor
101220083|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101220084|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101220085|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220086|NCT01501747|Acetaminophen|acetaminophen|mesh-list
101220088|NCT01501747|Ibuprofen|ibuprofen|mesh-list
101220089|NCT01501747|Caffeine|caffeine|mesh-list
101220090|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101220091|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220092|NCT01501747|Analgesics|analgesics|mesh-ancestor
101220093|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
101220094|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220095|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220096|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220097|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220098|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101220099|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220100|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220101|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
101220102|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101220103|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101220104|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101220105|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101220106|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
101220107|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220108|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220109|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220110|NCT01501760|Bevacizumab|bevacizumab|mesh-list
101220111|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220112|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220113|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101220114|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101220115|NCT01501760|Growth Substances|growth substances|mesh-ancestor
101220116|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220117|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
101220118|NCT01501786|Ketamine|ketamine|mesh-list
101220119|NCT01501786|Propofol|propofol|mesh-list
101220120|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101220121|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220122|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220123|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101220124|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
101220125|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
101220126|NCT01501786|Analgesics|analgesics|mesh-ancestor
101220127|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
101220128|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220129|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101220130|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101220131|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101220133|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220134|NCT01501799|Adapalene|adapalene|mesh-list
101220135|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101220136|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220138|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220139|NCT01501799|Analgesics|analgesics|mesh-ancestor
101220140|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
101220141|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220142|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220143|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220144|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220145|NCT01501890|Algestone|algestone|mesh-list
101220146|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
101220147|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
101220148|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101220149|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
101220150|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220151|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220152|NCT01501890|Progestins|progestins|mesh-ancestor
101220153|NCT01501890|Hormones|hormones|mesh-ancestor
101220154|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101220155|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101220156|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101220157|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
101220158|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101220159|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101220160|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101220161|NCT01501916|Vitamin D|vitamin d|mesh-list
101220162|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
101220163|NCT01501916|Vitamins|vitamins|mesh-ancestor
101220164|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
101220165|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220166|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101220167|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220168|NCT01501942|Glycine|glycine|mesh-list
101220169|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
101220170|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220171|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220172|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220173|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
101220174|NCT01501968|Colistin|colistin|mesh-list
101220175|NCT01501968|Vitamins|vitamins|mesh-ancestor
101220176|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
101220177|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220178|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
101220179|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220180|NCT01501968|Protective Agents|protective agents|mesh-ancestor
101220181|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220182|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220183|NCT01502020|Imiquimod|imiquimod|mesh-list
101220185|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
101220186|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220187|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220188|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
101220189|NCT01502046|Dronabinol|dronabinol|mesh-list
101220190|NCT01502046|Cannabidiol|cannabidiol|mesh-list
101220191|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
101220192|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
101220193|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220194|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220195|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220196|NCT01502046|Analgesics|analgesics|mesh-ancestor
101220197|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
101220198|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220199|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101220200|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101220201|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220202|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220203|NCT01502046|Hormones|hormones|mesh-ancestor
101220204|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220205|NCT01502202|Pemetrexed|pemetrexed|mesh-list
101220206|NCT01502202|Gefitinib|gefitinib|mesh-list
101220207|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220208|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220209|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220210|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101220211|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101220215|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
101220216|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220217|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220220|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101220221|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220222|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220223|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
101220224|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220225|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220226|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
101220227|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101220228|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
101220229|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220230|NCT01502280|Protective Agents|protective agents|mesh-ancestor
101220231|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220232|NCT01502280|Vitamins|vitamins|mesh-ancestor
101220233|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
101220234|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101220235|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220236|NCT01502358|Vaccines|vaccines|mesh-list
101220237|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
101220238|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220239|NCT01502592|Ipilimumab|ipilimumab|mesh-list
101220240|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220241|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220242|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101220243|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220244|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101220245|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101220247|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
101220248|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101220249|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
101220250|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220251|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220252|NCT01502774|Cyclosporine|cyclosporine|mesh-list
101220253|NCT01502774|Cyclosporins|cyclosporins|mesh-list
101220254|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220255|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220256|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220257|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
101220258|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220259|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
101220260|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220261|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220262|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220263|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101220264|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
101220265|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220266|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101220267|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101220268|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220269|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220270|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
101220271|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
101220272|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
101220273|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220274|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220275|NCT01502904|Sirolimus|sirolimus|mesh-list
101220276|NCT01502904|Pravastatin|pravastatin|mesh-list
101220277|NCT01502904|Pitavastatin|pitavastatin|mesh-list
101220278|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220279|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220280|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101220281|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220282|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
101220283|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220284|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
101220285|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220286|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220287|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220288|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101220289|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101220290|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
101220291|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101220292|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101220293|NCT01502943|Atorvastatin|atorvastatin|mesh-list
101220294|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220295|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220296|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101220297|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101220298|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
101220299|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101220300|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101220302|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
101220303|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101220304|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
101220305|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101220306|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220307|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220308|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220309|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
101220310|NCT01503060|Lidocaine|lidocaine|mesh-list
101220311|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
101220312|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
101220313|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220314|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220315|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
101220316|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220317|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101220318|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101220319|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101220320|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220321|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220322|NCT01503216|Vitamin D|vitamin d|mesh-list
101220323|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
101220324|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
101220325|NCT01503216|Vitamins|vitamins|mesh-ancestor
101220326|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
101220327|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220328|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101220329|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220330|NCT01503242|Cyclosporine|cyclosporine|mesh-list
101220331|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
101220332|NCT01503242|Fludarabine|fludarabine|mesh-list
101220333|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
101220334|NCT01503242|Antibodies|antibodies|mesh-list
101220335|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101220336|NCT01503242|Cyclosporins|cyclosporins|mesh-list
101220337|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
101220338|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220339|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220340|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101220341|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
101220342|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220343|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220344|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220345|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
101220346|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220347|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220348|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220349|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101220350|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101220351|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101220352|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
101220353|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220354|NCT01503359|Glycine|glycine|mesh-list
101220355|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
101220356|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220357|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220358|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220359|NCT01503372|Leucovorin|leucovorin|mesh-list
101220360|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
101220361|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220362|NCT01503372|Antidotes|antidotes|mesh-ancestor
101220363|NCT01503372|Protective Agents|protective agents|mesh-ancestor
101220367|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
101220368|NCT01503385|Celecoxib|celecoxib|mesh-list
101537320|NCT01080768|Amlodipine|amlodipine|mesh-list
101537321|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101537322|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101220370|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220371|NCT01503385|Analgesics|analgesics|mesh-ancestor
101220372|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
101220373|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220374|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220375|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220376|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220377|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101220378|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101220379|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220380|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220382|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
101220383|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
101220384|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220385|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220386|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220387|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220388|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220389|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220390|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220391|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101220392|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101220393|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220394|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220395|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220396|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
101220397|NCT01503424|Olanzapine|olanzapine|mesh-list
101220398|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
101220399|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
101220400|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220401|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220402|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220403|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220404|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220405|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220406|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220407|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101220408|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101220409|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220410|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220411|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220412|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
101220413|NCT01503437|Olanzapine|olanzapine|mesh-list
101220414|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
101220415|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
101220416|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220417|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220418|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220419|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220420|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220421|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220422|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220423|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101220424|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101220425|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220426|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220427|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220428|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
101220429|NCT01503450|Olanzapine|olanzapine|mesh-list
101220430|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
101220431|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
101220432|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220433|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220434|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220435|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101220436|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220437|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537323|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537324|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537325|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220439|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101220440|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101220441|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220442|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220444|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
101220445|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
101220446|NCT01503502|Flumatinib|flumatinib|mesh-list
101220447|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220448|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101220449|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220450|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220451|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
101220452|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101220453|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101220454|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101220455|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220456|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220457|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220458|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220459|NCT01503580|Urological Agents|urological agents|mesh-ancestor
101220460|NCT01503593|Calcium|calcium|mesh-list
101220461|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220462|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220463|NCT01503658|Aspirin|aspirin|mesh-list
101220464|NCT01503658|Clopidogrel|clopidogrel|mesh-list
101220465|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101220466|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220467|NCT01503658|Analgesics|analgesics|mesh-ancestor
101220468|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
101220469|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220470|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220471|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220472|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220473|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101220474|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101220475|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220476|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101220477|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101220478|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220479|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
101220480|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101220481|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101220482|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101220483|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
101220484|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220485|NCT01503671|Atorvastatin|atorvastatin|mesh-list
101220486|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101220488|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
101220489|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220490|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101220491|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101220492|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220493|NCT01503736|Citric Acid|citric acid|mesh-list
101220494|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
101220495|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
101220496|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
101220497|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101220498|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
101220499|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
101220500|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220501|NCT01503736|Hematinics|hematinics|mesh-ancestor
101220502|NCT01503788|Midazolam|midazolam|mesh-list
101220503|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101220504|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101220505|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220506|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220507|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101220508|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220509|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220510|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101220511|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
101220513|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
101220514|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
101220515|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220516|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220517|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
101220518|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
101220519|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101220520|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
101220521|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220522|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220523|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101220524|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
101220525|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101220526|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
101220527|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220528|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220529|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
101220530|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
101220531|NCT01503801|Protective Agents|protective agents|mesh-ancestor
101220532|NCT01503905|Tamoxifen|tamoxifen|mesh-list
101220533|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
101220534|NCT01503905|Docetaxel|docetaxel|mesh-list
101220535|NCT01503905|Trastuzumab|trastuzumab|mesh-list
101220536|NCT01503905|Epirubicin|epirubicin|mesh-list
101220537|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220539|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220540|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220541|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101220542|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
101220543|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220544|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220545|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101220546|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
101220547|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
101220548|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
101220549|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220550|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101220551|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101220552|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101220553|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220554|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101220555|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
101220556|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220557|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101220558|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101220559|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101220560|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101220562|NCT01503918|Valganciclovir|valganciclovir|mesh-list
101220563|NCT01503918|Acyclovir|acyclovir|mesh-list
101220564|NCT01503918|Ganciclovir|ganciclovir|mesh-list
101220565|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101220566|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
101220567|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220568|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101220569|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220570|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220571|NCT01503983|Capecitabine|capecitabine|mesh-list
101220572|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
101220574|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101220575|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
101220576|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220577|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220578|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220579|NCT01504074|Triamcinolone|triamcinolone|mesh-list
101220580|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101220581|NCT01504074|Levobunolol|levobunolol|mesh-list
101220582|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220583|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
101220584|NCT01504074|Hormones|hormones|mesh-ancestor
101220585|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101537326|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220586|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220587|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220588|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101220589|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220590|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101220591|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101220593|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220594|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
101220595|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
101220596|NCT01504126|Propranolol|propranolol|mesh-list
101220597|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101220598|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101220599|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
101220600|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220601|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220602|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220603|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101220604|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101220605|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
101220606|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101220607|NCT01504139|Estradiol|estradiol|mesh-list
101220608|NCT01504139|Progesterone|progesterone|mesh-list
101220609|NCT01504139|Estrogens|estrogens|mesh-ancestor
101220610|NCT01504139|Hormones|hormones|mesh-ancestor
101220611|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220612|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220613|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101220614|NCT01504139|Progestins|progestins|mesh-ancestor
101220615|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101220616|NCT01504178|Levodopa|levodopa|mesh-list
101220617|NCT01504178|Apomorphine|apomorphine|mesh-list
101220618|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101220619|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101220620|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101220621|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220622|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220623|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220624|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220625|NCT01504178|Analgesics|analgesics|mesh-ancestor
101220626|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
101220627|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220628|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
101220629|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220630|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
101220631|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101220632|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101220634|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
101220635|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220636|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
101220637|NCT01504256|Leucovorin|leucovorin|mesh-list
101220638|NCT01504256|Docetaxel|docetaxel|mesh-list
101220639|NCT01504256|Fluorouracil|fluorouracil|mesh-list
101220640|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
101220641|NCT01504256|Catumaxomab|catumaxomab|mesh-list
101220642|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101220643|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
101220644|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220645|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
101220646|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
101220647|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
101220648|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220649|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
101220650|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101220651|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220652|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
101220653|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220654|NCT01504256|Antidotes|antidotes|mesh-ancestor
101220655|NCT01504256|Protective Agents|protective agents|mesh-ancestor
101220656|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
101220657|NCT01504256|Vitamins|vitamins|mesh-ancestor
101220658|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
101220659|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220661|NCT01504282|Mitomycin|mitomycin|mesh-list
101220662|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101220663|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220664|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
101220665|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220666|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101220667|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220668|NCT01504295|Metadoxine|metadoxine|mesh-list
101220671|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101220672|NCT01504334|Pirfenidone|pirfenidone|mesh-list
101220673|NCT01504334|Analgesics|analgesics|mesh-ancestor
101220674|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
101220675|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220676|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220677|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101220678|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101220679|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220680|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220681|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220682|NCT01504347|Vaccines|vaccines|mesh-list
101220683|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
101220684|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220685|NCT01504386|Ropivacaine|ropivacaine|mesh-list
101220686|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
101220687|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
101220688|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220689|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220690|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
101220691|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220692|NCT01504490|Bexarotene|bexarotene|mesh-list
101220693|NCT01504490|Efatutazone|efatutazone|mesh-list
101220694|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220695|NCT01504503|Donepezil|donepezil|mesh-list
101220696|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101220697|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220698|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220699|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220700|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220702|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
101220703|NCT01504516|Donepezil|donepezil|mesh-list
101220704|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101220705|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220706|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220707|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220708|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220709|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220710|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
101220711|NCT01504542|Vaccines|vaccines|mesh-list
101220712|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
101220713|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220714|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101220715|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
101220716|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220717|NCT01504620|Insulin|insulin|mesh-list
101220718|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101220719|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220720|NCT01504646|Lyprinol|lyprinol|mesh-list
101220721|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101220722|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101220723|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220724|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220725|NCT01504659|Ketamine|ketamine|mesh-list
101220726|NCT01504659|Analgesics|analgesics|mesh-ancestor
101220727|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
101220728|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220729|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220730|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101220731|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101220732|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
101220733|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
101220734|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220735|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101220736|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101220737|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220738|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220739|NCT01504724|Bevacizumab|bevacizumab|mesh-list
101220740|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101220741|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537329|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101220742|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101220743|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101220744|NCT01504724|Growth Substances|growth substances|mesh-ancestor
101220745|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220746|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
101220747|NCT01504776|Bortezomib|bortezomib|mesh-list
101220748|NCT01504776|Panobinostat|panobinostat|mesh-list
101220749|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220750|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101220751|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220752|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220753|NCT01504828|Ramipril|ramipril|mesh-list
101220754|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101220755|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
101220756|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220757|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220758|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101220759|NCT01504906|Cyclosporine|cyclosporine|mesh-list
101220760|NCT01504906|Ticagrelor|ticagrelor|mesh-list
101220761|NCT01504906|Cyclosporins|cyclosporins|mesh-list
101220762|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220763|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220764|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101220765|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
101220766|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220767|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
101220768|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220769|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
101220770|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101220771|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101220772|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101220773|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101220774|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101220775|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101220777|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220778|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
101220779|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220780|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101220781|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220782|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220783|NCT01505049|Vaccines|vaccines|mesh-list
101220784|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
101220785|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220786|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
101220787|NCT01505088|Dexamethasone|dexamethasone|mesh-list
101220788|NCT01505088|Prednisolone|prednisolone|mesh-list
101220789|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101220790|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
101220791|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101220792|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
101220793|NCT01505088|Citric Acid|citric acid|mesh-list
101220794|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
101220795|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101220796|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101220797|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101220798|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
101220799|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101220800|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101220801|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
101220802|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
101220803|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220804|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220805|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220806|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
101220807|NCT01505088|Hormones|hormones|mesh-ancestor
101220808|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101220809|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101220810|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220811|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
101220812|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101220813|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
101220814|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
101220815|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220816|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101220817|NCT01505088|Protective Agents|protective agents|mesh-ancestor
101220818|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101220819|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220820|NCT01505127|Amoxicillin|amoxicillin|mesh-list
101220823|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
101220824|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101220825|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101220826|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101220827|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220829|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101220830|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101220832|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220833|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101220834|NCT01505218|Propofol|propofol|mesh-list
101220835|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101220836|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220837|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220838|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101220839|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
101220840|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
101220841|NCT01505231|Vasopressins|vasopressins|mesh-list
101220842|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
101220843|NCT01505231|Norepinephrine|norepinephrine|mesh-list
101220844|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101220846|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
101220847|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220848|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220849|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220850|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
101220851|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
101220852|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220853|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101220854|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
101220855|NCT01505231|Coagulants|coagulants|mesh-ancestor
101220856|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101220857|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
101220858|NCT01505283|Lidocaine|lidocaine|mesh-list
101220859|NCT01505283|Sufentanil|sufentanil|mesh-list
101220860|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
101220861|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
101220862|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220863|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220864|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
101220865|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220866|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101220867|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101220868|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101220869|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220870|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220871|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101220872|NCT01505283|Narcotics|narcotics|mesh-ancestor
101220873|NCT01505283|Analgesics|analgesics|mesh-ancestor
101220874|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101220875|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101220876|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
101220877|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101220878|NCT01505413|Gemcitabine|gemcitabine|mesh-list
101220879|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
101220880|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101220881|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101220882|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
101220883|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220884|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220885|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101220886|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220888|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
101220889|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101220890|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220891|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101220892|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220893|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
101220894|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101220895|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101220897|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220898|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537330|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101537331|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537332|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101537333|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101537334|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537335|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
101537336|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537337|NCT03452306|Metformin|metformin|mesh-list
101537338|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101537339|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220899|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220901|NCT01505504|Mirtazapine|mirtazapine|mesh-list
101220902|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
101220903|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220904|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101220905|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
101220906|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
101220907|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220908|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220909|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220910|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101220911|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101220912|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220913|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101220914|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101220915|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101220916|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
101220917|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101220918|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101220919|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
101220920|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101220921|NCT01505777|Mosapride|mosapride|mesh-list
101220922|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101220923|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101220924|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
101220925|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220926|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220927|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220928|NCT01505790|Clopidogrel|clopidogrel|mesh-list
101220929|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101220930|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101220931|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101220932|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101220933|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101220934|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
101220935|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220936|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220937|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220938|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101220939|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
101220940|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220941|NCT01505894|BI 409306|bi 409306|mesh-list
101220942|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101220943|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220944|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220945|NCT01505920|Lidocaine|lidocaine|mesh-list
101220946|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
101220947|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
101220948|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101220949|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220950|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
101220951|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220952|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101220953|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101220954|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101220955|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220956|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220957|NCT01505946|Thrombin|thrombin|mesh-list
101220958|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
101220959|NCT01505946|Coagulants|coagulants|mesh-ancestor
101220960|NCT01505998|Amlodipine|amlodipine|mesh-list
101220961|NCT01505998|Benazepril|benazepril|mesh-list
101220962|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101220963|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101220964|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220965|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220966|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220967|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220968|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
101220969|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101220970|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
101220973|NCT01506011|Benazepril|benazepril|mesh-list
101220974|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101220975|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101220976|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101220977|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220978|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101220979|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220980|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
101220981|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101220982|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
101220983|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220984|NCT01506024|Tacrine|tacrine|mesh-list
101220985|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101220986|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220987|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101220988|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220989|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220990|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220991|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101220992|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
101220993|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101220994|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
101220995|NCT01506037|Desloratadine|desloratadine|mesh-list
101220996|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101220997|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
101220998|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101220999|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221000|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221001|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221002|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221003|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221004|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
101221005|NCT01506050|Desloratadine|desloratadine|mesh-list
101221006|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101221007|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
101221008|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221009|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221010|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221011|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221012|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221013|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221014|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
101221015|NCT01506063|Levocetirizine|levocetirizine|mesh-list
101221016|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221017|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221019|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
101221020|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221021|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221022|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221023|NCT01506076|Levocetirizine|levocetirizine|mesh-list
101221024|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221025|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101537342|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
101221026|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221027|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
101221028|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221029|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221030|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221031|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101221032|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
101221034|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221035|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
101221036|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101221037|NCT01506167|Leucovorin|leucovorin|mesh-list
101221038|NCT01506167|Folic Acid|folic acid|mesh-list
101221039|NCT01506167|Bevacizumab|bevacizumab|mesh-list
101221040|NCT01506167|Fluorouracil|fluorouracil|mesh-list
101221041|NCT01506167|Capecitabine|capecitabine|mesh-list
101221042|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
101221044|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
101221045|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221046|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221066|NCT01506336|Sunitinib|sunitinib|mesh-list
101221067|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221068|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221069|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221070|NCT01506336|Growth Substances|growth substances|mesh-ancestor
101221071|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221072|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221073|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221074|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221075|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221076|NCT01506388|Misoprostol|misoprostol|mesh-list
101221077|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101221078|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
101221079|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221080|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221081|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221082|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221083|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
101221084|NCT01506414|Rituximab|rituximab|mesh-list
101221085|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221086|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221087|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
101221088|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221089|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221090|NCT01506505|Aspirin|aspirin|mesh-list
101221091|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101221092|NCT01506505|Lisinopril|lisinopril|mesh-list
101221093|NCT01506505|Simvastatin|simvastatin|mesh-list
101221094|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101221095|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101221096|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
101221097|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221098|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101221099|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101221100|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221101|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101221102|NCT01506505|Diuretics|diuretics|mesh-ancestor
101221103|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
101221104|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221105|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101221106|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101221107|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101221109|NCT01506505|Analgesics|analgesics|mesh-ancestor
101221110|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
101221111|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221112|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221113|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221114|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101221115|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101221116|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101221117|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101221119|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101221120|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
101221121|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101221122|NCT01506505|Protective Agents|protective agents|mesh-ancestor
101221123|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
101221124|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221125|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
101221126|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221127|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221128|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101221129|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
101221130|NCT01506557|Vitamin D|vitamin d|mesh-list
101221131|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101221132|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221133|NCT01506557|Vitamins|vitamins|mesh-ancestor
101221134|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
101221135|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101221136|NCT01506570|Vaccines|vaccines|mesh-list
101221137|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
101221138|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221139|NCT01506622|Fentanyl|fentanyl|mesh-list
101221140|NCT01506622|Propofol|propofol|mesh-list
101221141|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101221142|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101221143|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221144|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101221145|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
101221146|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
101221147|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101221148|NCT01506622|Narcotics|narcotics|mesh-ancestor
101221149|NCT01506622|Analgesics|analgesics|mesh-ancestor
101221150|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
101221151|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221152|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101221153|NCT01506635|Timolol|timolol|mesh-list
101221154|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101221155|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101221156|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221157|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221158|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221159|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221160|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101221161|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101221162|NCT01506713|Clopidogrel|clopidogrel|mesh-list
101221163|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101221165|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101221166|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101221167|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
101221168|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221169|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221170|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221171|NCT01506739|Donepezil|donepezil|mesh-list
101221172|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101221173|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221174|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221175|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
101221176|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221177|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221179|NCT01506752|Donepezil|donepezil|mesh-list
101221180|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101221181|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221183|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
101221184|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221185|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221186|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
101221187|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
101221188|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101221189|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
101221190|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221191|NCT01506765|Expectorants|expectorants|mesh-ancestor
101221192|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
101221193|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101221194|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
101221195|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221196|NCT01506765|Protective Agents|protective agents|mesh-ancestor
101221197|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221198|NCT01506765|Antidotes|antidotes|mesh-ancestor
101221199|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
101221200|NCT01506791|Ephedrine|ephedrine|mesh-list
101221201|NCT01506791|Desloratadine|desloratadine|mesh-list
101221202|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101221203|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
101221204|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221205|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221206|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221207|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221208|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221209|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221210|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
101221211|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101221212|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
101221213|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221214|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101221215|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
101221216|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
101221217|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101221218|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101221219|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
101221220|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221221|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
101221222|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101221223|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101221224|NCT01506804|Prednisolone|prednisolone|mesh-list
101221225|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
101221226|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101221227|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
101221228|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221229|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
101221230|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
101221231|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221232|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221233|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221234|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
101221235|NCT01506804|Hormones|hormones|mesh-ancestor
101221236|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221237|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101221238|NCT01506804|Protective Agents|protective agents|mesh-ancestor
101221239|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101221240|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221241|NCT01506895|Darapladib|darapladib|mesh-list
101221242|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
101221243|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221244|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221245|NCT01506921|Ketamine|ketamine|mesh-list
101221246|NCT01506921|Esketamine|esketamine|mesh-list
101221248|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
101221249|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221250|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221251|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101221252|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101221253|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
101221254|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
101221255|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101221256|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101221258|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221259|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221260|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
101221261|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101221262|NCT01507064|Sorafenib|sorafenib|mesh-list
101221263|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221264|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221265|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221266|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221268|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221269|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221270|NCT01507077|Growth Substances|growth substances|mesh-ancestor
101221271|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221272|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221273|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221274|NCT01507194|Ondansetron|ondansetron|mesh-list
101221275|NCT01507194|Vestipitant|vestipitant|mesh-list
101221276|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
101221277|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
101221278|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221279|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221280|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221281|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
101221282|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
101221283|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101221285|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
101221286|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221287|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221288|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101221289|NCT01507272|Liraglutide|liraglutide|mesh-list
101221290|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221291|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221292|NCT01507272|Incretins|incretins|mesh-ancestor
101221293|NCT01507272|Hormones|hormones|mesh-ancestor
101221294|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221295|NCT01507285|Liraglutide|liraglutide|mesh-list
101221296|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221297|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221298|NCT01507285|Incretins|incretins|mesh-ancestor
101221299|NCT01507285|Hormones|hormones|mesh-ancestor
101221300|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221301|NCT01507311|Liraglutide|liraglutide|mesh-list
101221302|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221303|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221304|NCT01507311|Incretins|incretins|mesh-ancestor
101221305|NCT01507311|Hormones|hormones|mesh-ancestor
101221306|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221307|NCT01507337|Liraglutide|liraglutide|mesh-list
101221308|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221309|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221310|NCT01507337|Incretins|incretins|mesh-ancestor
101221311|NCT01507337|Hormones|hormones|mesh-ancestor
101221312|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221313|NCT01507363|Gabapentin|gabapentin|mesh-list
101221314|NCT01507363|Analgesics|analgesics|mesh-ancestor
101221315|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
101221316|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221317|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221318|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
101221319|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101221320|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101221321|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101221322|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101221323|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101221324|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101221325|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221326|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221327|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
101221328|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101221329|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221330|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221331|NCT01507389|Liraglutide|liraglutide|mesh-list
101221332|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221336|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221337|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
101221338|NCT01507428|Misonidazole|misonidazole|mesh-list
101221339|NCT01507428|Paclitaxel|paclitaxel|mesh-list
101221340|NCT01507428|Carboplatin|carboplatin|mesh-list
101221341|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101221342|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101221343|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101221344|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221345|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101221346|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101221347|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101221348|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221349|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101221350|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
101221351|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
101221352|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221353|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101221354|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101221355|NCT01507454|Estradiol|estradiol|mesh-list
101221356|NCT01507454|Estrogens|estrogens|mesh-ancestor
101221357|NCT01507454|Hormones|hormones|mesh-ancestor
101221358|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221359|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221360|NCT01507467|Nimorazole|nimorazole|mesh-list
101221361|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101221362|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101221363|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101221364|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221365|NCT01507480|Bevacizumab|bevacizumab|mesh-list
101221366|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221367|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221368|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221369|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221370|NCT01507480|Growth Substances|growth substances|mesh-ancestor
101221371|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221372|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221373|NCT01507519|Sirolimus|sirolimus|mesh-list
101221374|NCT01507519|Temsirolimus|temsirolimus|mesh-list
101221375|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
101221376|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101221377|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221378|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101221379|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221381|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221382|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
101221383|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221384|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221385|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221386|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221387|NCT01507558|Dexamethasone|dexamethasone|mesh-list
101221388|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
101221389|NCT01507558|BB 1101|bb 1101|mesh-list
101221390|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221391|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
101221392|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
101221393|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221394|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221395|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221396|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
101221397|NCT01507558|Hormones|hormones|mesh-ancestor
101221398|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221399|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101221400|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221401|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
101221402|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221403|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221404|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
101221405|NCT01507597|Glucagon|glucagon|mesh-list
101221406|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101221407|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221408|NCT01507597|Hormones|hormones|mesh-ancestor
101221412|NCT01507701|Clonidine|clonidine|mesh-list
101221413|NCT01507701|Analgesics|analgesics|mesh-ancestor
101221414|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
101221415|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221416|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221417|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101221420|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101221421|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101221422|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101221423|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221424|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221425|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221426|NCT01507727|Tolvaptan|tolvaptan|mesh-list
101221427|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101221428|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221429|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
101221430|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221431|NCT01507740|Bevacizumab|bevacizumab|mesh-list
101221432|NCT01507740|Sorafenib|sorafenib|mesh-list
101221433|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221434|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221435|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221436|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221437|NCT01507740|Growth Substances|growth substances|mesh-ancestor
101221438|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221439|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221440|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221441|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221442|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221443|NCT01507792|Loratadine|loratadine|mesh-list
101221444|NCT01507792|Omeprazole|omeprazole|mesh-list
101221445|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
101221446|NCT01507792|Histamine|histamine|mesh-list
101221447|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221448|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221449|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221450|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221451|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
101221452|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
101221453|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101221454|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101221455|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101221456|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
101221457|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
101221458|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221459|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221460|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
101221461|NCT01507857|Vaccines|vaccines|mesh-list
101221462|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
101221463|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221464|NCT01507922|Fenoverine|fenoverine|mesh-list
101221465|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
101221466|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
101221467|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221468|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221470|NCT01507974|Amoxicillin|amoxicillin|mesh-list
101221471|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
101221472|NCT01507974|Cephalexin|cephalexin|mesh-list
101221473|NCT01507974|Cefuroxime|cefuroxime|mesh-list
101221474|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
101221475|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101221476|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101221477|NCT01507974|Trimethoprim|trimethoprim|mesh-list
101221478|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
101221479|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221480|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
101221481|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101221483|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101221484|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101221493|NCT01508000|Panitumumab|panitumumab|mesh-list
101221494|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221495|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221496|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221497|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221498|NCT01508000|Growth Substances|growth substances|mesh-ancestor
101221499|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221500|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221503|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101221504|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221505|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221506|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221507|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221508|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
101221509|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221510|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221511|NCT01507610|Sumatriptan|sumatriptan|mesh-list
101221512|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101221513|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101221514|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101221515|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
101221516|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221517|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221518|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221519|NCT01508143|Misoprostol|misoprostol|mesh-list
101221520|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101221521|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
101221522|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221523|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221524|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221525|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221526|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
101221527|NCT01508182|Metformin|metformin|mesh-list
101221528|NCT01508182|Canagliflozin|canagliflozin|mesh-list
101221529|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221530|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221531|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101221532|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221533|NCT01508195|Metformin|metformin|mesh-list
101221534|NCT01508195|Canagliflozin|canagliflozin|mesh-list
101221535|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221536|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221537|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101221538|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221539|NCT01508221|Vitamin E|vitamin e|mesh-list
101221540|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
101221541|NCT01508221|Vitamins|vitamins|mesh-ancestor
101221542|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
101221543|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221544|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
101221545|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221546|NCT01508221|Protective Agents|protective agents|mesh-ancestor
101221547|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101221548|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221549|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101221551|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
101221554|NCT01508260|Diuretics|diuretics|mesh-ancestor
101221555|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
101221556|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221557|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101221558|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101221559|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221560|NCT01508286|Ribavirin|ribavirin|mesh-list
101221561|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
101221562|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221563|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
101221564|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221565|NCT01508364|Sorafenib|sorafenib|mesh-list
101221566|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221567|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221568|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221569|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221570|NCT01508429|Misoprostol|misoprostol|mesh-list
101221571|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101221572|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
101221573|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221574|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221575|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101221576|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221577|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
101221578|NCT01508468|Rituximab|rituximab|mesh-list
101221579|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
101221580|NCT01508468|Giapreza|giapreza|mesh-list
101221581|NCT01508468|Calcium|calcium|mesh-list
101221582|NCT01508468|Diuretics|diuretics|mesh-list
101221583|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
101221584|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
101221585|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
101221586|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
101221587|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221588|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221589|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
101221590|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221591|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221592|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101221593|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
101221594|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101221595|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221596|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221597|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221598|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101221599|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101221600|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
101221601|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
101221602|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221603|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101221604|NCT01508494|Galantamine|galantamine|mesh-list
101221605|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101537343|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221606|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221607|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221608|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
101221609|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221610|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221611|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101221612|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
101221613|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221614|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
101221615|NCT01508572|Bevacizumab|bevacizumab|mesh-list
101221616|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221617|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221618|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221619|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221620|NCT01508572|Growth Substances|growth substances|mesh-ancestor
101221621|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221622|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221624|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
101221625|NCT01508611|Protective Agents|protective agents|mesh-ancestor
101221629|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101221630|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101221631|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221632|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221633|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221634|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221635|NCT01508637|Urological Agents|urological agents|mesh-ancestor
101221636|NCT01508663|Everolimus|everolimus|mesh-list
101221637|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
101221638|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101221639|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221640|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221641|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221642|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221643|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
101221644|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221645|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221646|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
101221647|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101221648|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101221649|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
101221650|NCT01508806|Liraglutide|liraglutide|mesh-list
101221651|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221652|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221653|NCT01508806|Incretins|incretins|mesh-ancestor
101221654|NCT01508806|Hormones|hormones|mesh-ancestor
101221655|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221656|NCT01508845|Vitamin D|vitamin d|mesh-list
101221657|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
101221658|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
101221659|NCT01508845|Vitamins|vitamins|mesh-list
101221660|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
101221662|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101221663|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101221664|NCT01508858|Liraglutide|liraglutide|mesh-list
101221665|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
101221666|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101221667|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221668|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221670|NCT01508858|Hormones|hormones|mesh-ancestor
101221671|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221672|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101221673|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
101221674|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101221675|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101221676|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101221678|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101221679|NCT01508858|Estrogens|estrogens|mesh-ancestor
101221680|NCT01508884|Imiquimod|imiquimod|mesh-list
101221681|NCT01508884|Vaccines|vaccines|mesh-list
101221682|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
101221683|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221684|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101221685|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221686|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
101221687|NCT01508897|Liraglutide|liraglutide|mesh-list
101221688|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221689|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221690|NCT01508897|Incretins|incretins|mesh-ancestor
101221691|NCT01508897|Hormones|hormones|mesh-ancestor
101221692|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221693|NCT01508923|Liraglutide|liraglutide|mesh-list
101221694|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221695|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221696|NCT01508923|Incretins|incretins|mesh-ancestor
101221697|NCT01508923|Hormones|hormones|mesh-ancestor
101221698|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221699|NCT01508949|Liraglutide|liraglutide|mesh-list
101221700|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221701|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176742|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176743|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101176745|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101176746|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101176747|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101176748|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101176749|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176750|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101176751|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101176752|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101176753|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101176754|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
101176755|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176756|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176757|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101176758|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101176759|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
101176760|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101176761|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101176762|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
101176763|NCT01822548|Metformin|metformin|mesh-list
101176764|NCT01822548|Vildagliptin|vildagliptin|mesh-list
101176765|NCT01822548|Glyburide|glyburide|mesh-list
101176766|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101176767|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176768|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101176769|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
101176770|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176771|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176772|NCT01825122|Nadolol|nadolol|mesh-list
101176773|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101176774|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101176775|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
101176776|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176777|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176778|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176779|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101176780|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101176781|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
101176782|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
101176783|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176784|NCT01825512|Deferasirox|deferasirox|mesh-list
101176785|NCT01825512|Deferiprone|deferiprone|mesh-list
101176786|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101176787|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
101176788|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
101176789|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176790|NCT01827462|Vaccines|vaccines|mesh-list
101176791|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
101176792|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176793|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
101176794|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176795|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101176796|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176797|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176798|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
101176799|NCT01828476|Navitoclax|navitoclax|mesh-list
101176800|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
101176801|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101176802|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101176803|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101176804|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176805|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176806|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101176807|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176808|NCT01828554|Capecitabine|capecitabine|mesh-list
101176809|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101176810|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
101176811|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176812|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176813|NCT01834404|Topiramate|topiramate|mesh-list
101176814|NCT01834404|Phentermine|phentermine|mesh-list
101176815|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
101176816|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101176817|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176818|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101176819|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
101176820|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101176821|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
101176822|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
101176823|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176824|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
101176825|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176826|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176827|NCT01835262|Ketamine|ketamine|mesh-list
101176828|NCT01835262|Morphine|morphine|mesh-list
101176829|NCT01835262|Analgesics|analgesics|mesh-ancestor
101176830|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
101176831|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176832|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176833|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101176835|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
101176836|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
101176837|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101176838|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101176839|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101176840|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176841|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176842|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101176843|NCT01835262|Narcotics|narcotics|mesh-ancestor
101176844|NCT01835496|Deferiprone|deferiprone|mesh-list
101176845|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101176846|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
101176847|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
101176848|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176849|NCT01766076|Atorvastatin|atorvastatin|mesh-list
101176850|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101176851|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101176852|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
101176853|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176854|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101176855|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101176856|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176858|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
101176859|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101176860|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176861|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101176862|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101176863|NCT01767792|Growth Substances|growth substances|mesh-ancestor
101176864|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176865|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
101176866|NCT01797822|Dexamethasone|dexamethasone|mesh-list
101176867|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
101176868|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101176869|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
101176870|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
101176871|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176872|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176873|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101176874|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
101176875|NCT01797822|Hormones|hormones|mesh-ancestor
101176876|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101176877|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101176878|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176879|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101176880|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101176881|NCT01809054|Aspirin|aspirin|mesh-list
101176882|NCT01809054|Fondaparinux|fondaparinux|mesh-list
101176883|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101176884|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101176885|NCT01809054|Analgesics|analgesics|mesh-ancestor
101176886|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
101176887|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176888|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176889|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101176890|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101176891|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101176892|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101176893|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176894|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101176895|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101176897|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
101176898|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101176899|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
101176900|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101176901|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
101176902|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
101176903|NCT01833546|Gemcitabine|gemcitabine|mesh-list
101176904|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101176905|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
101176906|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176907|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176908|NCT01842594|Sirolimus|sirolimus|mesh-list
101176909|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
101176910|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101176911|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101176912|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101176913|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176914|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
101176915|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101176916|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
101176917|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176918|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176919|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176920|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
101176921|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101176922|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101176923|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101176924|NCT01843920|Trimethoprim|trimethoprim|mesh-list
101176925|NCT01843920|Polymyxins|polymyxins|mesh-list
101176926|NCT01843920|Polymyxin B|polymyxin b|mesh-list
101176927|NCT01843920|Prednisolone|prednisolone|mesh-list
101176928|NCT01843920|Timolol|timolol|mesh-list
101176929|NCT01843920|Dorzolamide|dorzolamide|mesh-list
101176930|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101176931|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
101176932|NCT01843920|Hormones|hormones|mesh-ancestor
101176933|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101176934|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176935|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101176936|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176937|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101176938|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101176939|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
101176940|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176941|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176942|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101176943|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101176944|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101176945|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101176946|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
101176947|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101176948|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101176949|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101176950|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176951|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101176952|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101176953|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101176954|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101176955|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101176956|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101176957|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101176958|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101176959|NCT01844388|Laxatives|laxatives|mesh-ancestor
101176960|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101176961|NCT01845636|Atropine|atropine|mesh-list
101176962|NCT01845636|Donepezil|donepezil|mesh-list
101176964|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101176965|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101176966|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176967|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176968|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
101176969|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101176970|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176971|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
101176972|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101176973|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101176974|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101176975|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
101176976|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101176977|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101176978|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
101176979|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
101176980|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
101176981|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101176982|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101176983|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
101176984|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176985|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101176986|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176987|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101176988|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
101176989|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101176990|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176991|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101176992|NCT01846728|Estrogens|estrogens|mesh-list
101176993|NCT01846728|Hormones|hormones|mesh-ancestor
101176994|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101176995|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101176996|NCT01848054|Buprenorphine|buprenorphine|mesh-list
101176997|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101176999|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101177000|NCT01848054|Narcotics|narcotics|mesh-ancestor
101177001|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177002|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177003|NCT01848054|Analgesics|analgesics|mesh-ancestor
101177004|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
101177005|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177006|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101177007|NCT01849068|Ezetimibe|ezetimibe|mesh-list
101177008|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101177009|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101177010|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
101177011|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177012|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101177014|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101177015|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101177016|NCT01849692|Growth Substances|growth substances|mesh-ancestor
101177017|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177018|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
101177019|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177021|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101177022|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101177023|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101177024|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177025|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177026|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
101177027|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101177028|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101177029|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177030|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
101177031|NCT01850394|Coagulants|coagulants|mesh-ancestor
101177032|NCT01852344|Methylphenidate|methylphenidate|mesh-list
101177033|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101177034|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177035|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101177036|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101177037|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177038|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177039|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
101177040|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177041|NCT01856712|Naltrexone|naltrexone|mesh-list
101177042|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101177043|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101177044|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177045|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
101177046|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177047|NCT01858428|Paclitaxel|paclitaxel|mesh-list
101177048|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101177049|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177050|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177051|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177052|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177053|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177054|NCT01861002|Cytarabine|cytarabine|mesh-list
101177055|NCT01861002|Methotrexate|methotrexate|mesh-list
101177056|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
101177057|NCT01861002|Azacitidine|azacitidine|mesh-list
101177058|NCT01861002|Fludarabine|fludarabine|mesh-list
101177059|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101177060|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
101177061|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177062|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177063|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177064|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
101177065|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177066|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177067|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177068|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177069|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101177070|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177072|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177073|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101177074|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
101177075|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177076|NCT01870596|Cytarabine|cytarabine|mesh-list
101177077|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177078|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
101177079|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177080|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177081|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
101177082|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177083|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177084|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
101177085|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177086|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
101177087|NCT01875510|SMOFlipid|smoflipid|mesh-list
101177088|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101177089|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101177090|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101177091|NCT01876212|Dasatinib|dasatinib|mesh-list
101177092|NCT01876212|Vaccines|vaccines|mesh-list
101177093|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
101177094|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177095|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177096|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177097|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177098|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177099|NCT01876992|Metformin|metformin|mesh-list
101177100|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177101|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177102|NCT01877538|Donepezil|donepezil|mesh-list
101177103|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101177104|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177105|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177106|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
101177107|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177108|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177109|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
101177110|NCT01878006|Morphine|morphine|mesh-list
101177111|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101177112|NCT01878006|Narcotics|narcotics|mesh-ancestor
101177113|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177114|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177115|NCT01878006|Analgesics|analgesics|mesh-ancestor
101177116|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
101177117|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177118|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101177119|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
101177120|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101177121|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101177122|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177123|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177124|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
101177125|NCT05327088|Nalbuphine|nalbuphine|mesh-list
101177126|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101177127|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177128|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177129|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177130|NCT05327088|Analgesics|analgesics|mesh-ancestor
101177131|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
101177132|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177133|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101177134|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101177135|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101177136|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177137|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177138|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177139|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101177140|NCT05327088|Narcotics|narcotics|mesh-ancestor
101177141|NCT05290194|Capecitabine|capecitabine|mesh-list
101177142|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101177143|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177144|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
101177145|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177147|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177148|NCT05228574|Amiloride|amiloride|mesh-list
101177149|NCT05228574|Diuretics|diuretics|mesh-ancestor
101177151|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177152|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101177153|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101177154|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177155|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177156|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
101177157|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101177158|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101177159|NCT04774068|Romidepsin|romidepsin|mesh-list
101177160|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177161|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101177162|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177163|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101177164|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177165|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177166|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101177167|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
101177168|NCT04103034|Coagulants|coagulants|mesh-ancestor
101177169|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101177170|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
101177171|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177172|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
101177173|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
101177174|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177175|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
101177176|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177177|NCT01643460|Ethanol|ethanol|mesh-list
101177178|NCT01643460|Paclitaxel|paclitaxel|mesh-list
101177179|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101177180|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101177181|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177182|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177183|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177184|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177185|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177186|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101177187|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177188|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177189|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177190|NCT00954876|Capecitabine|capecitabine|mesh-list
101177191|NCT00954876|Cetuximab|cetuximab|mesh-list
101177192|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177193|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
101177194|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177195|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177196|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177197|NCT05746728|Tislelizumab|tislelizumab|mesh-list
101177198|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177199|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177200|NCT05714670|Curcumin|curcumin|mesh-list
101177201|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101177202|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177203|NCT05714670|Analgesics|analgesics|mesh-ancestor
101177204|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
101177205|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177206|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177208|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177209|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177210|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177211|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177212|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101177213|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
101177214|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
101177216|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101177217|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177218|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177219|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177220|NCT05472948|Capecitabine|capecitabine|mesh-list
101177221|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177222|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
101177223|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177224|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177225|NCT05215470|Nivolumab|nivolumab|mesh-list
101177226|NCT05215470|Ipilimumab|ipilimumab|mesh-list
101177227|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177228|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177229|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101177230|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177231|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101177232|NCT05206500|Amoxicillin|amoxicillin|mesh-list
101177233|NCT05206500|Metronidazole|metronidazole|mesh-list
101177234|NCT05206500|Clindamycin|clindamycin|mesh-list
101177235|NCT05206500|Linezolid|linezolid|mesh-list
101177236|NCT05206500|Tetracycline|tetracycline|mesh-list
101177237|NCT05206500|Penicillins|penicillins|mesh-list
101177238|NCT05206500|Ampicillin|ampicillin|mesh-list
101177239|NCT05206500|Fosfomycin|fosfomycin|mesh-list
101177241|NCT05206500|Cephalosporins|cephalosporins|mesh-list
101177242|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
101177243|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177244|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101177245|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101177246|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101177247|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177248|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177249|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101177250|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101177266|NCT05151588|Docetaxel|docetaxel|mesh-list
101177267|NCT05151588|Fluorouracil|fluorouracil|mesh-list
101177268|NCT05151588|Cisplatin|cisplatin|mesh-list
101177269|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177270|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177271|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177272|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177273|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177274|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
101177275|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177276|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177277|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
101177278|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177279|NCT04929834|Emollients|emollients|mesh-list
101177280|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177281|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101177282|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101177283|NCT04470804|Cyclosporine|cyclosporine|mesh-list
101177284|NCT04470804|Sirolimus|sirolimus|mesh-list
101177285|NCT04470804|Temsirolimus|temsirolimus|mesh-list
101177286|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
101177287|NCT04470804|Cyclosporins|cyclosporins|mesh-list
101177288|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177289|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177290|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177291|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
101177292|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177293|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
101177294|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177295|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177296|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177297|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101177298|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101177299|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101177300|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177301|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177302|NCT04418466|Risperidone|risperidone|mesh-list
101177303|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101177304|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
101177305|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177306|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177307|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177308|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101177309|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101177310|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177311|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101177312|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101177313|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
101177315|NCT04360044|Cannabidiol|cannabidiol|mesh-list
101177316|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
101177317|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
101177318|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177319|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101177320|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177321|NCT04360044|Analgesics|analgesics|mesh-ancestor
101177322|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
101177323|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177324|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101177325|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101177326|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177327|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177328|NCT04360044|Hormones|hormones|mesh-ancestor
101177329|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177330|NCT04337814|Ibuprofen|ibuprofen|mesh-list
101177331|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
101177332|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101177335|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
101177336|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177337|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177338|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177339|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177340|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101177341|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177342|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177343|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
101177344|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
101177345|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177346|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101177347|NCT04336332|Azithromycin|azithromycin|mesh-list
101177348|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
101177349|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101177350|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177351|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
101177352|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101177353|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101177354|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177355|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177356|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177357|NCT04230408|Paclitaxel|paclitaxel|mesh-list
101177358|NCT04230408|Carboplatin|carboplatin|mesh-list
101177359|NCT04230408|Durvalumab|durvalumab|mesh-list
101177360|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101177361|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177362|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177363|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177364|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177365|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177366|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177368|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
101177369|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
101177370|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177371|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177373|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177374|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177375|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101177376|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177377|NCT02004522|Ofatumumab|ofatumumab|mesh-list
101177378|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177379|NCT01472562|Rituximab|rituximab|mesh-list
101177380|NCT01472562|Lenalidomide|lenalidomide|mesh-list
101177381|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177382|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177383|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
101177384|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177385|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177386|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101177387|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101177388|NCT01472562|Growth Substances|growth substances|mesh-ancestor
101177389|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
101177390|NCT01430442|Sumatriptan|sumatriptan|mesh-list
101177391|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101177392|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101177393|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101177394|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
101177395|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177396|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177399|NCT01420926|Decitabine|decitabine|mesh-list
101177400|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177401|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177402|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
101177403|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177404|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177405|NCT01881828|Metformin|metformin|mesh-list
101177406|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177407|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177408|NCT01887132|Donepezil|donepezil|mesh-list
101177409|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101177410|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177411|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177412|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
101177413|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177414|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177415|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
101177416|NCT01887990|Ketamine|ketamine|mesh-list
101177417|NCT01887990|Analgesics|analgesics|mesh-ancestor
101177418|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
101177419|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177420|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177421|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101177422|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101177424|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
101177425|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177426|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101177427|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101177428|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177429|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177430|NCT01890642|Lidocaine|lidocaine|mesh-list
101177431|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
101177432|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
101177433|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177434|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177435|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
101177436|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177437|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101177438|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101177439|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101177440|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177441|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177442|NCT01891968|Bortezomib|bortezomib|mesh-list
101177443|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177445|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
101177446|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
101177447|NCT01901250|Protective Agents|protective agents|mesh-ancestor
101177448|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177449|NCT01904526|Guanfacine|guanfacine|mesh-list
101177450|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177451|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101177452|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101177453|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101177454|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177455|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177456|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177457|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177458|NCT01906866|Melatonin|melatonin|mesh-list
101177459|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
101177460|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177461|NCT01906866|Protective Agents|protective agents|mesh-ancestor
101177462|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177463|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177464|NCT01907334|Fluticasone|fluticasone|mesh-list
101177466|NCT01907334|Albuterol|albuterol|mesh-list
101177467|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101177468|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101177469|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
101177470|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177471|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101177472|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
101177473|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177474|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177475|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101177476|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
101177477|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177478|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101177479|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101177480|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101177481|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101177482|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177483|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177484|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177485|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
101177486|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177487|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
101177488|NCT01907334|Hormones|hormones|mesh-ancestor
101177489|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177490|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
101177492|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101177493|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
101177494|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101177495|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101177496|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
101177497|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
101177498|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
101177499|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
101177500|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177501|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177502|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
101177503|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177504|NCT01908972|Prednisolone|prednisolone|mesh-list
101177505|NCT01908972|Propranolol|propranolol|mesh-list
101177506|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177507|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
101177508|NCT01908972|Hormones|hormones|mesh-ancestor
101177509|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177510|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177511|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101177512|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177513|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101177514|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101177515|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177516|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177517|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177518|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101177519|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177520|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
101177521|NCT01910064|Adapalene|adapalene|mesh-list
101177522|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101177523|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177524|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101177525|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177526|NCT01910064|Analgesics|analgesics|mesh-ancestor
101177527|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
101177528|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177529|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177530|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177531|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177532|NCT01912716|Indomethacin|indomethacin|mesh-list
101177533|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101177534|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177535|NCT01912716|Analgesics|analgesics|mesh-ancestor
101177536|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
101177537|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177538|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177539|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177540|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177541|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
101177542|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
101177543|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177544|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101177545|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177546|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177548|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177549|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
101177550|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101177551|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101177552|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101177553|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177554|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177555|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177556|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177557|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
101177558|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101177559|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
101177560|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101177561|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101177562|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177563|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101177564|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177565|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101177566|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177569|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101177570|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177571|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177572|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177573|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177575|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177576|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177577|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101177578|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177579|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101177580|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
101177581|NCT01932060|Oxytocin|oxytocin|mesh-list
101177582|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
101177583|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177584|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177585|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
101177586|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
101177587|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
101177588|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177589|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101177590|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101177591|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101177592|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
101177594|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
101177595|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177596|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101177597|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
101177598|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101177599|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101177600|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
101177601|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177602|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177603|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101177604|NCT01937598|Liraglutide|liraglutide|mesh-list
101177605|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177606|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177607|NCT01937598|Incretins|incretins|mesh-ancestor
101177608|NCT01937598|Hormones|hormones|mesh-ancestor
101177609|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177610|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101177611|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
101177612|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177613|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177614|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101177615|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101177616|NCT01942668|Estradiol|estradiol|mesh-list
101177617|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101177618|NCT01942668|Progesterone|progesterone|mesh-list
101177619|NCT01942668|Estrogens|estrogens|mesh-ancestor
101177620|NCT01942668|Hormones|hormones|mesh-ancestor
101177621|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177622|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177623|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101177624|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
101177625|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177626|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101177627|NCT01942668|Progestins|progestins|mesh-ancestor
101177628|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
101177629|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
101177630|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101177631|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101177632|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177633|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177634|NCT01948518|Urological Agents|urological agents|mesh-ancestor
101177635|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
101177636|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101177637|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177638|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177639|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177641|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
101177642|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
101177643|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
101177644|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
101177645|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177646|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177647|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177648|NCT01951950|Nicardipine|nicardipine|mesh-list
101177649|NCT01951950|Esmolol|esmolol|mesh-list
101177650|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101177651|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101177652|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101177653|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177654|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177655|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177656|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177657|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177658|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101177659|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177660|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101177661|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
101177662|NCT01953432|Doxazosin|doxazosin|mesh-list
101177663|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177664|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101177665|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101177666|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101177667|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177668|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177669|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177670|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177671|NCT01955382|Artesunate|artesunate|mesh-list
101177672|NCT01955382|Amodiaquine|amodiaquine|mesh-list
101177673|NCT01955382|Charcoal|charcoal|mesh-list
101177674|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
101177675|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101177676|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101177677|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177678|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177679|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
101177680|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
101177681|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101177682|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
101177683|NCT01955382|Antidotes|antidotes|mesh-ancestor
101177684|NCT01955382|Protective Agents|protective agents|mesh-ancestor
101177685|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177686|NCT01957410|Ketamine|ketamine|mesh-list
101177687|NCT01957410|Analgesics|analgesics|mesh-ancestor
101177688|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
101177689|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177690|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177691|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101177692|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101177693|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
101177694|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
101177695|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177696|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101177698|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177699|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177700|NCT01958112|Trametinib|trametinib|mesh-list
101177701|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177702|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177704|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177705|NCT05739786|Vitamin D|vitamin d|mesh-list
101177706|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
101177707|NCT05739786|Vitamins|vitamins|mesh-ancestor
101177708|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
101177709|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177710|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101177711|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101177712|NCT05739630|Cytarabine|cytarabine|mesh-list
101177713|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
101177714|NCT05739630|Busulfan|busulfan|mesh-list
101177715|NCT05739630|Fludarabine|fludarabine|mesh-list
101177716|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
101177717|NCT05739630|Tacrolimus|tacrolimus|mesh-list
101177718|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177719|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
101177720|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177722|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101177723|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
101177724|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177725|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177726|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101177727|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177728|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
101177729|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
101177730|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177731|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101177732|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177733|NCT05739630|Analgesics|analgesics|mesh-ancestor
101177734|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
101177735|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177736|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101177737|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101177741|NCT05738616|Lenvatinib|lenvatinib|mesh-list
101177742|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177743|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177744|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177745|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177746|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101177747|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101177748|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177749|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
101177750|NCT05738382|Cetrorelix|cetrorelix|mesh-list
101177751|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101177752|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
101177753|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177754|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177755|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
101177756|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177757|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
101177758|NCT05737680|Colchicine|colchicine|mesh-list
101177759|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
101177761|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101177762|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177763|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177764|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177765|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177767|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177768|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177769|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177770|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177771|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101177772|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177773|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177774|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177775|NCT05725200|Gemcitabine|gemcitabine|mesh-list
101177776|NCT05725200|Methotrexate|methotrexate|mesh-list
101177777|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
101177778|NCT05725200|Trastuzumab|trastuzumab|mesh-list
101177779|NCT05725200|Cetuximab|cetuximab|mesh-list
101177780|NCT05725200|Everolimus|everolimus|mesh-list
101177781|NCT05725200|Venetoclax|venetoclax|mesh-list
101177782|NCT05725200|Dasatinib|dasatinib|mesh-list
101177783|NCT05725200|Palbociclib|palbociclib|mesh-list
101177784|NCT05725200|Crizotinib|crizotinib|mesh-list
101177785|NCT05725200|Panobinostat|panobinostat|mesh-list
101177786|NCT05725200|Talazoparib|talazoparib|mesh-list
101177787|NCT05725200|Idelalisib|idelalisib|mesh-list
101177788|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177789|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
101177790|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177791|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177792|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101177793|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101177794|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101177795|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
101177796|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101177797|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177798|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
101177799|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177800|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101177801|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101177802|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
101177803|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177804|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101177805|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101177806|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177807|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101177808|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101177809|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
101177810|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101177811|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
101177812|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177813|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177814|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101177815|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
101177817|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
101177818|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177819|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177820|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101177822|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
101177823|NCT05721144|Protective Agents|protective agents|mesh-ancestor
101177824|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
101177825|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101537344|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537345|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
101177826|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177827|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101177828|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101177829|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177830|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177831|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
101177832|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177833|NCT05574894|Hormones|hormones|mesh-list
101177834|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177835|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177836|NCT05567952|Ritonavir|ritonavir|mesh-list
101177837|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
101177838|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101177839|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101177840|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
101177841|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177842|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177843|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101177844|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101177845|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
101177846|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177847|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101177848|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101177850|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101177851|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101177852|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177853|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177854|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101177855|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101177856|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101177857|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101177858|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
101177859|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
101177860|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
101177861|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
101177862|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177863|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177864|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
101177865|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101177866|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
101177867|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177868|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
101177869|NCT05436288|Protective Agents|protective agents|mesh-ancestor
101177870|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
101177871|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101177872|NCT05245734|Antibodies|antibodies|mesh-list
101177873|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
101177874|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101177875|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
101177876|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177878|NCT05242692|Ketamine|ketamine|mesh-list
101177879|NCT05242692|Esketamine|esketamine|mesh-list
101177880|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101177881|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177882|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177883|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101177884|NCT05242692|Analgesics|analgesics|mesh-ancestor
101177885|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
101177886|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177887|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101177888|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101177889|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101177890|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
101177891|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177892|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177893|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101177894|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101177895|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
101177896|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
101177897|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101177898|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101177899|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
101177900|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101177901|NCT05087940|Diuretics|diuretics|mesh-list
101177902|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
101177903|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
101177904|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177905|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177906|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177907|NCT04922658|Vinorelbine|vinorelbine|mesh-list
101177908|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101177909|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177910|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177911|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177912|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177913|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177914|NCT04883346|Liraglutide|liraglutide|mesh-list
101177915|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101177916|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177917|NCT04883346|Incretins|incretins|mesh-ancestor
101177918|NCT04883346|Hormones|hormones|mesh-ancestor
101177919|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101177920|NCT04438902|Osimertinib|osimertinib|mesh-list
101177921|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177922|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101177923|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177924|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177925|NCT04329390|Anticoagulants|anticoagulants|mesh-list
101177926|NCT04177602|Trifluridine|trifluridine|mesh-list
101177927|NCT04177602|Capecitabine|capecitabine|mesh-list
101177928|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101177929|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
101177930|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177931|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177933|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177934|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
101177935|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101177936|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101177937|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177938|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
101177939|NCT03868956|Coagulants|coagulants|mesh-ancestor
101177940|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
101177941|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101177942|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101177943|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101177944|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177945|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177946|NCT03616236|Buprenorphine|buprenorphine|mesh-list
101177947|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
101177949|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101177950|NCT03616236|Narcotics|narcotics|mesh-ancestor
101177951|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101177952|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177953|NCT03616236|Analgesics|analgesics|mesh-ancestor
101177954|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
101177956|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101177958|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
101177959|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
101177960|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101177966|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177967|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177968|NCT03366480|Paclitaxel|paclitaxel|mesh-list
101177969|NCT03366480|Carboplatin|carboplatin|mesh-list
101177970|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101177971|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101177972|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
101177973|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
101177974|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
101177975|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177976|NCT02867124|Naltrexone|naltrexone|mesh-list
101177977|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101177978|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101177979|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101177980|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
101177981|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177982|NCT02534376|Simvastatin|simvastatin|mesh-list
101177984|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101177985|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101177986|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
101177987|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177988|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101177989|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101177990|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101177991|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
101177992|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101177993|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101177994|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101177995|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101177996|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101177997|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
101177998|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101177999|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178000|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101178001|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178002|NCT02065596|Fludarabine|fludarabine|mesh-list
101178003|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
101178004|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178005|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101178006|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
101178007|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178008|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101178009|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
101178010|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178011|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
101178012|NCT01976286|Salicylates|salicylates|mesh-list
101178013|NCT01976286|Glycolic acid|glycolic acid|mesh-list
101178014|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178015|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
101178016|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
101178017|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178018|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101178019|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178020|NCT01976286|Analgesics|analgesics|mesh-ancestor
101178021|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
101178022|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178023|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178024|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178025|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178026|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101178027|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178028|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178053|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
101178054|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101178055|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101178056|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101178057|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178058|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178060|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178061|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178062|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101178063|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178064|NCT01239030|Methylphenidate|methylphenidate|mesh-list
101178065|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101178066|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178067|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101178068|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101178069|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178070|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178071|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
101178073|NCT01086540|Acetaminophen|acetaminophen|mesh-list
101178074|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
101178075|NCT01086540|Promethazine|promethazine|mesh-list
101178076|NCT01086540|Prednisone|prednisone|mesh-list
101178077|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
101178078|NCT01086540|Rituximab|rituximab|mesh-list
101178079|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101178080|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178081|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
101178082|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178083|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178084|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178085|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
101178086|NCT01086540|Hormones|hormones|mesh-ancestor
101178087|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178088|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178089|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178090|NCT01086540|Analgesics|analgesics|mesh-ancestor
101178091|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
101178092|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178093|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
101178094|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
101178095|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
101178096|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178097|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101178098|NCT01086540|Protective Agents|protective agents|mesh-ancestor
101178099|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101178100|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178101|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178102|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178103|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
101178104|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101178105|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
101178106|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
101178107|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178108|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178109|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101178111|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178112|NCT01962870|Vasopressins|vasopressins|mesh-list
101178113|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
101178114|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
101178115|NCT01962870|Coagulants|coagulants|mesh-ancestor
101178116|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178117|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101178118|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
101178119|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178120|NCT01965366|Dexamethasone|dexamethasone|mesh-list
101178121|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178123|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
101178124|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178125|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178126|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178127|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
101178129|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178130|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178131|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178134|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178135|NCT01967862|Listerine|listerine|mesh-list
101178136|NCT01967862|Fluorides|fluorides|mesh-list
101178137|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
101178138|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
101178139|NCT01967862|Protective Agents|protective agents|mesh-ancestor
101178140|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178141|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101178142|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178143|NCT01976988|Heparin|heparin|mesh-list
101178144|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
101178145|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101178146|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101178147|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178148|NCT01980654|Rituximab|rituximab|mesh-list
101178149|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101178150|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178151|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
101178152|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178153|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178154|NCT01984398|Citric Acid|citric acid|mesh-list
101178155|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
101178156|NCT01984398|Enclomiphene|enclomiphene|mesh-list
101178157|NCT01984398|Clomiphene|clomiphene|mesh-list
101178158|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
101178159|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
101178160|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101178161|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
101178162|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
101178163|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178164|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101178165|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
101178166|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178167|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178168|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101178169|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
101178170|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101178171|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101178172|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101178173|NCT01987752|Timolol|timolol|mesh-list
101178174|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101178175|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101178176|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
101178177|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101178178|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178179|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101178180|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101178181|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178182|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178183|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178184|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178185|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178186|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101178187|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178188|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101178189|NCT01988922|Ketamine|ketamine|mesh-list
101178190|NCT01988922|Analgesics|analgesics|mesh-ancestor
101178191|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
101178192|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178193|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178194|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101178195|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101178197|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
101178198|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178199|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101178200|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101178201|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178202|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178203|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
101178204|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178205|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101178206|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178207|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178208|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178209|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178210|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
101178211|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
101178212|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178213|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
101178215|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
101178216|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
101178217|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101178218|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101178219|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178220|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
101178221|NCT01998438|Coagulants|coagulants|mesh-ancestor
101178222|NCT01999530|Prazosin|prazosin|mesh-list
101178223|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178224|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101178225|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101178226|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101178227|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178228|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178229|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178230|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178231|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
101178232|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
101178233|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101178234|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101178235|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101178236|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178237|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178238|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178239|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
101178240|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178241|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101178242|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101178243|NCT02002650|Indomethacin|indomethacin|mesh-list
101178244|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101178245|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178246|NCT02002650|Analgesics|analgesics|mesh-ancestor
101178247|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
101178248|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178249|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178250|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178251|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178252|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
101178253|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
101178254|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101178255|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101178257|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178258|NCT02004132|Testosterone|testosterone|mesh-list
101178259|NCT02004132|Androgens|androgens|mesh-ancestor
101178260|NCT02004132|Hormones|hormones|mesh-ancestor
101178261|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178262|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178263|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
101178265|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101178266|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178267|NCT02004366|Incretins|incretins|mesh-ancestor
101178268|NCT02004366|Hormones|hormones|mesh-ancestor
101178269|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178270|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101178271|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
101178272|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178273|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178274|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
101178275|NCT02004990|Povidone|povidone|mesh-list
101178276|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
101178277|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
101178278|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101178279|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178280|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
101178281|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101178282|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178283|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178284|NCT02011464|Bupivacaine|bupivacaine|mesh-list
101178285|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178286|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
101178287|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178288|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178289|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
101178290|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178291|NCT02058420|Tocotrienols|tocotrienols|mesh-list
101178292|NCT02058420|Vitamin E|vitamin e|mesh-list
101178293|NCT02058420|Tocopherols|tocopherols|mesh-list
101178294|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
101178295|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178296|NCT02058420|Protective Agents|protective agents|mesh-ancestor
101178297|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178298|NCT02058420|Vitamins|vitamins|mesh-ancestor
101178299|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
101178300|NCT02020278|Tolvaptan|tolvaptan|mesh-list
101178301|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
101178302|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178303|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
101178304|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178305|NCT02024646|Brodalumab|brodalumab|mesh-list
101178306|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101178307|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178308|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
101178309|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178310|NCT02024724|Dexamethasone|dexamethasone|mesh-list
101178311|NCT02024724|Triamcinolone|triamcinolone|mesh-list
101178312|NCT02024724|Bupivacaine|bupivacaine|mesh-list
101178313|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178314|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
101178315|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
101178316|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178317|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178318|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178319|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
101178320|NCT02024724|Hormones|hormones|mesh-ancestor
101178321|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178322|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178323|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178324|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178325|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
101178326|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178327|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
101178330|NCT02025426|Ephedrine|ephedrine|mesh-list
101178331|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101178332|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
101178333|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
101178334|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178335|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178336|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
101178337|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178338|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
101178339|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
101178340|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101178341|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178343|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178344|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178345|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178346|NCT02025426|Protective Agents|protective agents|mesh-ancestor
101178347|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101178348|NCT02028780|Dabigatran|dabigatran|mesh-list
101178349|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
101178350|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101178351|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
101178352|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178353|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178354|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
101178355|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
101178356|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101178357|NCT02029872|Mupirocin|mupirocin|mesh-list
101178358|NCT02029872|Calcium|calcium|mesh-list
101178359|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101178360|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178361|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101178362|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178363|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
101178364|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178365|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101178366|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101178367|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178368|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178370|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178371|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101178372|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
101178373|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178374|NCT02032212|Nicotine|nicotine|mesh-list
101178375|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101178376|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
101178377|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178378|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178379|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101178380|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101178381|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178382|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178383|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178384|NCT02032758|Propranolol|propranolol|mesh-list
101178385|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101178386|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101178387|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178388|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178389|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178390|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178391|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178392|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178393|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
101178394|NCT02036424|Dexamethasone|dexamethasone|mesh-list
101178395|NCT02036424|Bevacizumab|bevacizumab|mesh-list
101178396|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101178397|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178398|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101178399|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101178400|NCT02036424|Growth Substances|growth substances|mesh-ancestor
101178401|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178402|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
101178403|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178404|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
101178405|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
101178406|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178407|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178408|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
101178409|NCT02036424|Hormones|hormones|mesh-ancestor
101178410|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178411|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178412|NCT02044380|Afatinib|afatinib|mesh-list
101178413|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178414|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101178415|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178416|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178417|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
101178418|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
101178419|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101178420|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178421|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178422|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178423|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178424|NCT02047032|Urological Agents|urological agents|mesh-ancestor
101178425|NCT02047500|Paclitaxel|paclitaxel|mesh-list
101178426|NCT02047500|Gemcitabine|gemcitabine|mesh-list
101178427|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101178428|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178429|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
101178430|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
101178431|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
101178432|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178433|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101178434|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
101178435|NCT02054754|HU 211|hu 211|mesh-list
101178436|NCT02054754|Dronabinol|dronabinol|mesh-list
101178437|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178438|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
101178439|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
101178440|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178441|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178442|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178443|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101178444|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101178445|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178446|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178447|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101178448|NCT02054754|Protective Agents|protective agents|mesh-ancestor
101178449|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
101178450|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101178451|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178452|NCT02054754|Analgesics|analgesics|mesh-ancestor
101178453|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
101178454|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
101178455|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
101178457|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178460|NCT02057640|Panobinostat|panobinostat|mesh-list
101178461|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178462|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
101178463|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
101178464|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178465|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178466|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178467|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
101178468|NCT02057640|Hormones|hormones|mesh-ancestor
101178469|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178470|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178471|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178472|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
101178473|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178474|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178475|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101178476|NCT02059902|Lidocaine|lidocaine|mesh-list
101178477|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178478|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
101178479|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178480|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178481|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
101178482|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178483|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178484|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101178485|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101178486|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178487|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178489|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
101178490|NCT02061384|Tretinoin|tretinoin|mesh-list
101178491|NCT02061384|Isotretinoin|isotretinoin|mesh-list
101178492|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178493|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
101178494|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178495|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101178496|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178497|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101178498|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178499|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178500|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178501|NCT02061384|Vitamins|vitamins|mesh-ancestor
101178502|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
101178503|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101178504|NCT02061774|Acetaminophen|acetaminophen|mesh-list
101178505|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178506|NCT02061774|Analgesics|analgesics|mesh-ancestor
101178507|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
101178508|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178509|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178510|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
101178511|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
101178512|NCT02062710|Promethazine|promethazine|mesh-list
101178513|NCT02062710|Phenylephrine|phenylephrine|mesh-list
101178514|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
101178517|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
101178518|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
101178519|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178520|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178524|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
101178525|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101178526|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178527|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101178528|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178529|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178530|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178531|NCT02062710|Protective Agents|protective agents|mesh-ancestor
101178532|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101178533|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178534|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178535|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178537|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
101178538|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
101178539|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178540|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101178541|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
101178542|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
101178543|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101178544|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
101178545|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178546|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
101178547|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101178548|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101178550|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101178551|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
101178552|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101178553|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178554|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178555|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178556|NCT02069184|Acetaminophen|acetaminophen|mesh-list
101178557|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178558|NCT02069184|Analgesics|analgesics|mesh-ancestor
101178559|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
101178560|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178561|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178562|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
101178563|NCT02134314|Complement C1s|complement c1s|mesh-list
101178564|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101178565|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
101178566|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
101178567|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178568|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101178569|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101178570|NCT02135016|Lidocaine|lidocaine|mesh-list
101178571|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178572|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
101178573|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178574|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178575|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
101178576|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178577|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178578|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101178579|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101178580|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178581|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178582|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
101178583|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178584|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101178585|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178586|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178587|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178588|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178589|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
101178590|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
101178591|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178592|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
101178593|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178594|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
101178595|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
101178596|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101178597|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
101178598|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
101178599|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178600|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178601|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178602|NCT02139540|Analgesics|analgesics|mesh-ancestor
101178603|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
101178604|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178605|NCT02148588|Lidocaine|lidocaine|mesh-list
101178606|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178607|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
101178608|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178609|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178610|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
101178611|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178612|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178613|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101178614|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101178615|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178616|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178617|NCT02149524|Trastuzumab|trastuzumab|mesh-list
101178618|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101178619|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178620|NCT02154048|Dexamethasone|dexamethasone|mesh-list
101178621|NCT02154048|Ropivacaine|ropivacaine|mesh-list
101178622|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178624|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
101178625|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178626|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178627|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178628|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
101178629|NCT02154048|Hormones|hormones|mesh-ancestor
101178630|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178631|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101178632|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178633|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178634|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
101178635|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178636|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
101178637|NCT02156154|Acetaminophen|acetaminophen|mesh-list
101178638|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178639|NCT02156154|Analgesics|analgesics|mesh-ancestor
101178640|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
101178641|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178642|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178643|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
101178644|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
101178645|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101178646|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178647|NCT02159976|Amoxicillin|amoxicillin|mesh-list
101178648|NCT02159976|Metronidazole|metronidazole|mesh-list
101178649|NCT02159976|Clarithromycin|clarithromycin|mesh-list
101178650|NCT02159976|Tetracycline|tetracycline|mesh-list
101178651|NCT02159976|Pantoprazole|pantoprazole|mesh-list
101178652|NCT02159976|Bismuth|bismuth|mesh-list
101178653|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101178654|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178655|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101178656|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101178657|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101178658|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178659|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178660|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101178661|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101178662|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101178663|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178664|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101178665|NCT02159976|Antacids|antacids|mesh-ancestor
101178666|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
101178667|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101178668|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101178669|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101178670|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178671|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178672|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178674|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178675|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101178676|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178677|NCT02160990|Exenatide|exenatide|mesh-list
101178678|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101178679|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178680|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101178682|NCT02160990|Hormones|hormones|mesh-ancestor
101178683|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178684|NCT02164422|Guanfacine|guanfacine|mesh-list
101178685|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178686|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101178687|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101178688|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101178689|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178690|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178691|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178692|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178693|NCT02170662|Bimatoprost|bimatoprost|mesh-list
101178694|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178695|NCT02173392|Brodalumab|brodalumab|mesh-list
101178696|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
101178697|NCT02178540|Tobramycin|tobramycin|mesh-list
101178698|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101178700|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
101178701|NCT02178696|Citalopram|citalopram|mesh-list
101178702|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101178703|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101178704|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101178705|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178706|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178707|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178708|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
101178709|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178710|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101178711|NCT02179788|Metformin|metformin|mesh-list
101178712|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101178713|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178714|NCT02180100|Fluconazole|fluconazole|mesh-list
101178715|NCT02180100|Terconazole|terconazole|mesh-list
101178716|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
101178717|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178718|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101178719|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101178720|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178721|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178722|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101178723|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
101178724|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101178725|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178726|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101178727|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101178728|NCT02181426|Ketorolac|ketorolac|mesh-list
101178729|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101178730|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178731|NCT02181426|Analgesics|analgesics|mesh-ancestor
101178732|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
101178733|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178734|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178736|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178737|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101178738|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178739|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178740|NCT02192814|Lacosamide|lacosamide|mesh-list
101178741|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
101178742|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101178743|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101178744|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178745|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178746|NCT02195232|Quercetin|quercetin|mesh-list
101178747|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
101178748|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178749|NCT02195232|Protective Agents|protective agents|mesh-ancestor
101178750|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178751|NCT02196168|Cisplatin|cisplatin|mesh-list
101178752|NCT02196168|Adavosertib|adavosertib|mesh-list
101178753|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178754|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178755|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178757|NCT02201394|Ticagrelor|ticagrelor|mesh-list
101178758|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101178759|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178760|NCT02201394|Analgesics|analgesics|mesh-ancestor
101178761|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
101178762|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178763|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178764|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101178765|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101178766|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101178767|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101178768|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178769|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101178770|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101178771|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178772|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
101178773|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101178774|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101178775|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101178776|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
101178777|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178778|NCT02203578|Romidepsin|romidepsin|mesh-list
101178779|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101178780|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178781|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101178782|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178783|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178784|NCT02206776|Midazolam|midazolam|mesh-list
101178785|NCT02206776|Ketamine|ketamine|mesh-list
101178786|NCT02206776|Analgesics|analgesics|mesh-ancestor
101178787|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
101178788|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178789|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178790|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101178791|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101178792|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
101178794|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178795|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101178796|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101178797|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178798|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178799|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101178800|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178801|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101178802|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101178803|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101178804|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
101178805|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
101178806|NCT02209272|Lidocaine|lidocaine|mesh-list
101178807|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
101178808|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
101178809|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
101178810|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178811|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178812|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
101178813|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178814|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178815|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101178816|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101178817|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178818|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178819|NCT02214420|Ribavirin|ribavirin|mesh-list
101178820|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
101178821|NCT02214420|Simeprevir|simeprevir|mesh-list
101178822|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
101178824|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
101178825|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178826|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
101178827|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178828|NCT02215200|Lenograstim|lenograstim|mesh-list
101178829|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
101178830|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101178831|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101178832|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
101178833|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178834|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101178835|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
101178836|NCT02218320|Dolutegravir|dolutegravir|mesh-list
101178837|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101178838|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101178839|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
101178840|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178841|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101178842|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101178843|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178844|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178845|NCT02222610|Ranibizumab|ranibizumab|mesh-list
101178846|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101178847|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101178848|NCT02222610|Growth Substances|growth substances|mesh-ancestor
101178849|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178850|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
101178851|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178854|NCT02223702|Metronidazole|metronidazole|mesh-list
101178855|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101178856|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178857|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101178858|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101178859|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178860|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178861|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178862|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101178863|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101178864|NCT02225106|Methylphenidate|methylphenidate|mesh-list
101178865|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101178866|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178867|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101178868|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101178869|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101178870|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178871|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
101178872|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178874|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101178875|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
101178876|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178877|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178878|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178879|NCT02233998|Listerine|listerine|mesh-list
101178880|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
101178881|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101178882|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178883|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
101178884|NCT02233998|Protective Agents|protective agents|mesh-ancestor
101178885|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178886|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
101178887|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
101178888|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178889|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
101178890|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178891|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178892|NCT02239380|Lorazepam|lorazepam|mesh-list
101178893|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
101178894|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
101178895|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
101178896|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178897|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178898|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101178899|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178901|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101178902|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101178903|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101178904|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
101178905|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
101178906|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178907|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178908|NCT02239770|Nicotine|nicotine|mesh-list
101178909|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101178910|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
101178911|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178912|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178913|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101178914|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101178915|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178916|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178917|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178919|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101178920|NCT02241486|Narcotics|narcotics|mesh-ancestor
101178921|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178922|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178923|NCT02241486|Analgesics|analgesics|mesh-ancestor
101178924|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
101178925|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178926|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101178927|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101178928|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
101178929|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
101178930|NCT02244918|Nicotine|nicotine|mesh-list
101178931|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101178932|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
101178933|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101178934|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178936|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101178937|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178938|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178939|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178941|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178942|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101178943|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101178944|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
101178945|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101178946|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178947|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101178948|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101178949|NCT02251236|Tenofovir|tenofovir|mesh-list
101178950|NCT02251236|Emtricitabine|emtricitabine|mesh-list
101178951|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101178952|NCT02251236|Cobicistat|cobicistat|mesh-list
101178953|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101178954|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101178955|NCT02251236|Elvitegravir|elvitegravir|mesh-list
101178956|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
101178957|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178958|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101178959|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101178960|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178961|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178962|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101178963|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101178964|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101178965|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101178966|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101178967|NCT02251938|Sirolimus|sirolimus|mesh-list
101178968|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101178969|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178970|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101178971|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178972|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
101178973|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101178974|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
101178975|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178976|NCT02258412|Ethanol|ethanol|mesh-list
101178977|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
101178978|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
101178979|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101178980|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178981|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178982|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
101178983|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
101178984|NCT02260440|Azacitidine|azacitidine|mesh-list
101178985|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101178986|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101178987|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101178988|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178989|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101178990|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
101178991|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101178992|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
101178993|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101178994|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101178995|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101178996|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101178997|NCT02267538|Analgesics|analgesics|mesh-ancestor
101178998|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
101178999|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179000|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101179001|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179002|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179003|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179004|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179005|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179006|NCT02267772|Acetaminophen|acetaminophen|mesh-list
101179007|NCT02267772|Morphine|morphine|mesh-list
101179008|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101179009|NCT02267772|Narcotics|narcotics|mesh-ancestor
101179010|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179011|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179012|NCT02267772|Analgesics|analgesics|mesh-ancestor
101179013|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
101179014|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179015|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179016|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
101179018|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179019|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101179020|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179021|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179022|NCT02274870|Bupivacaine|bupivacaine|mesh-list
101179023|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179024|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
101179025|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179026|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179027|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
101179028|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179029|NCT02276274|Alogliptin|alogliptin|mesh-list
101179030|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101179031|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179033|NCT02276274|Hormones|hormones|mesh-ancestor
101179034|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179035|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101179037|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179038|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179039|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101179040|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
101179041|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101179042|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179043|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179044|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179045|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
101179046|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101179047|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
101179048|NCT02282514|Rituximab|rituximab|mesh-list
101179049|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
101179050|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179051|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
101179052|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179053|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179054|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179055|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
101179056|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179057|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179058|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101179059|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179060|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179062|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
101179063|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179064|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179065|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
101179066|NCT02282514|Hormones|hormones|mesh-ancestor
101179067|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179068|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101179069|NCT02282514|Protective Agents|protective agents|mesh-ancestor
101179070|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101179071|NCT02282904|Sirolimus|sirolimus|mesh-list
101179072|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
101179073|NCT02282904|Busulfan|busulfan|mesh-list
101179074|NCT02282904|Fludarabine|fludarabine|mesh-list
101179075|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179076|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
101179077|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179078|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179079|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179080|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
101179081|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179082|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179083|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101179084|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101179085|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179086|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101179087|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
101179088|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101179089|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
101179090|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101179091|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179092|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179093|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179094|NCT02284386|Bupivacaine|bupivacaine|mesh-list
101179095|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179096|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
101179097|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179098|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179099|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
101179100|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179101|NCT02284464|Prednisone|prednisone|mesh-list
101179102|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179103|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
101179104|NCT02284464|Hormones|hormones|mesh-ancestor
101179105|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179106|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179107|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101179108|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179109|NCT02284854|Carbamazepine|carbamazepine|mesh-list
101179110|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101179111|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
101179112|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
101179113|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101179114|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179115|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179116|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101179117|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179118|NCT02284854|Analgesics|analgesics|mesh-ancestor
101179119|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
101179120|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179121|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179122|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179123|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179124|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101179125|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101179126|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101179128|NCT02285634|Phenylephrine|phenylephrine|mesh-list
101179129|NCT02285634|Epinephrine|epinephrine|mesh-list
101179130|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
101179131|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179132|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
101179133|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179134|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179135|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
101179136|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179137|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101179138|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101179139|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179140|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179141|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179142|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179143|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179144|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179145|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179146|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101179147|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101179149|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101179150|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101179151|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
101179152|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
101179153|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101179154|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101179155|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
101179156|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101179157|NCT02285634|Protective Agents|protective agents|mesh-ancestor
101179158|NCT02287350|Diclofenac|diclofenac|mesh-list
101179159|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101179160|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179161|NCT02287350|Analgesics|analgesics|mesh-ancestor
101179162|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
101179163|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179164|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179166|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179167|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101179168|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179169|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179170|NCT02288364|Lidocaine|lidocaine|mesh-list
101179171|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179172|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
101179174|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179175|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
101179176|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179177|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101179178|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101179179|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101179180|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179181|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179182|NCT02289222|Dexamethasone|dexamethasone|mesh-list
101179183|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
101179184|NCT02289222|Pomalidomide|pomalidomide|mesh-list
101179185|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179186|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
101179187|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
101179188|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179189|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179190|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179191|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
101179192|NCT02289222|Hormones|hormones|mesh-ancestor
101179193|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179194|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101179195|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179196|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179197|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101179198|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179199|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
101179200|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101179201|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101179203|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
101179204|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
101179205|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101179206|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
101179207|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179208|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179209|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101179210|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
101179211|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101179212|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101179213|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179214|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179215|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179216|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179217|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
101179218|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
101179219|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179220|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179221|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179222|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101179223|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101179224|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101179225|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179226|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179227|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101179229|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179230|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
101179231|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179232|NCT02299050|Bromocriptine|bromocriptine|mesh-list
101179233|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101179234|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101179235|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
101179236|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179237|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179238|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
101179239|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
101179240|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179241|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179242|NCT02302092|Cefepime|cefepime|mesh-list
101179243|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101179244|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179245|NCT02303184|Aflibercept|aflibercept|mesh-list
101179246|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101179247|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101179248|NCT02303184|Growth Substances|growth substances|mesh-ancestor
101179249|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179250|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
101179251|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179252|NCT02304432|Cycloserine|cycloserine|mesh-list
101179253|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101179254|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179255|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101179256|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
101179257|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101179258|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
101179259|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179260|NCT02307318|Hemostatics|hemostatics|mesh-list
101179261|NCT02307318|Coagulants|coagulants|mesh-ancestor
101179262|NCT02312622|Irinotecan|irinotecan|mesh-list
101179263|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
101179264|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101179265|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101179266|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179267|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179268|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179269|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101179270|NCT02314104|Ropivacaine|ropivacaine|mesh-list
101179271|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179272|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
101179273|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179274|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179275|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
101179276|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179278|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101179279|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101179281|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
101179282|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179283|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179284|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101179285|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101179286|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179287|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101179288|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101179290|NCT02330094|Analgesics|analgesics|mesh-ancestor
101179291|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
101179292|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179293|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179294|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
101179295|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101179296|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101179297|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179298|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101179299|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101179300|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101179301|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179302|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179304|NCT02330172|Neostigmine|neostigmine|mesh-list
101179305|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101179306|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179307|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179308|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
101179309|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179310|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179311|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101179312|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
101179313|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179314|NCT02331108|Propofol|propofol|mesh-list
101179315|NCT02331108|Anesthetics|anesthetics|mesh-list
101179316|NCT02331108|Sevoflurane|sevoflurane|mesh-list
101179317|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101179318|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179319|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179320|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101179321|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
101179322|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101179323|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101179324|NCT02332902|Everolimus|everolimus|mesh-list
101179325|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101179326|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101179327|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179328|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179329|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179330|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
101179331|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179332|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179333|NCT02340156|Temozolomide|temozolomide|mesh-list
101179334|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179335|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
101179336|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179337|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179338|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
101179339|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
101179340|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101179341|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101179342|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101179343|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179344|NCT02351700|Ibuprofen|ibuprofen|mesh-list
101179345|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101179346|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179347|NCT02351700|Analgesics|analgesics|mesh-ancestor
101179348|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
101179349|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179351|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179352|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179353|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101179354|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179355|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179356|NCT02353806|Amlodipine|amlodipine|mesh-list
101179357|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101179358|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101179359|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179360|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179361|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101179362|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179363|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
101179364|NCT02354352|Eplerenone|eplerenone|mesh-list
101179365|NCT02354352|Spironolactone|spironolactone|mesh-list
101179366|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101179367|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
101179368|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179369|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179370|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101179371|NCT02354352|Diuretics|diuretics|mesh-ancestor
101179372|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
101179373|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101179374|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
101179375|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179377|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179378|NCT02357706|Analgesics|analgesics|mesh-ancestor
101179379|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
101179380|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179381|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179382|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
101179383|NCT02359110|Gabapentin|gabapentin|mesh-list
101179384|NCT02359110|Analgesics|analgesics|mesh-ancestor
101179385|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
101179386|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179387|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179388|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
101179389|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101179390|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101179391|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179392|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101537346|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101537347|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101537348|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179393|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101179394|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101179395|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179396|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179397|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
101179398|NCT02360124|Fluorides|fluorides|mesh-list
101179399|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
101179400|NCT02360124|Protective Agents|protective agents|mesh-ancestor
101179401|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179402|NCT02369172|Bupropion|bupropion|mesh-list
101179403|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101179404|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
101179405|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101179406|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101179407|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101179408|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179409|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179410|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
101179411|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179412|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179413|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101179414|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101179415|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179417|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
101179418|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179420|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101179421|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101179422|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179423|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
101179424|NCT02374398|Coagulants|coagulants|mesh-ancestor
101179426|NCT02377752|Olaratumab|olaratumab|mesh-list
101179427|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101179428|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179429|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101179430|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101179431|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179432|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179433|NCT02379858|Alvimopan|alvimopan|mesh-list
101179434|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179435|NCT02384070|Aspirin|aspirin|mesh-list
101179436|NCT02384070|Bivalirudin|bivalirudin|mesh-list
101179437|NCT02384070|Clopidogrel|clopidogrel|mesh-list
101179438|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101179439|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179440|NCT02384070|Analgesics|analgesics|mesh-ancestor
101179441|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
101179442|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179443|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179444|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179445|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179446|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101179447|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101179448|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179449|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101179450|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101179451|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179452|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
101179453|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101179454|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101179455|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101179456|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
101179457|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179458|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
101179459|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101179460|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
101179461|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
101179462|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101179463|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101179464|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101179465|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179466|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179467|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179468|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179469|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179470|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179471|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
101179472|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
101179473|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
101179474|NCT02391714|Povidone|povidone|mesh-list
101179475|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101179476|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179477|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
101179478|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
101179479|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
101179480|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101179481|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
101179482|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
101179483|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179484|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179485|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179486|NCT02391714|Analgesics|analgesics|mesh-ancestor
101179487|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
101179488|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179489|NCT02395692|Temozolomide|temozolomide|mesh-list
101179490|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179491|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
101179492|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179493|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179494|NCT02397954|Ranibizumab|ranibizumab|mesh-list
101179495|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101179496|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101179497|NCT02397954|Growth Substances|growth substances|mesh-ancestor
101179498|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179499|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
101179500|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179501|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101179502|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101179503|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101179504|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179505|NCT02401542|Docetaxel|docetaxel|mesh-list
101179506|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179507|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
101179508|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
101179509|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
101179510|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179511|NCT02411916|Misoprostol|misoprostol|mesh-list
101179512|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101179513|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
101179514|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101179515|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179516|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101179517|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179518|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
101179519|NCT02413320|Paclitaxel|paclitaxel|mesh-list
101179521|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
101179522|NCT02413320|Carboplatin|carboplatin|mesh-list
101179523|NCT02413320|Doxorubicin|doxorubicin|mesh-list
101179524|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101179525|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179526|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
101179527|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
101179528|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
101179529|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179530|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179531|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
101179532|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179533|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179534|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179535|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
101179536|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101179537|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101179538|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101179539|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101179540|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179541|NCT05718882|Lenvatinib|lenvatinib|mesh-list
101179542|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179543|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101179544|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179545|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179546|NCT05718492|Leucovorin|leucovorin|mesh-list
101179547|NCT05718492|Fluorouracil|fluorouracil|mesh-list
101179548|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
101179549|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
101179550|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179551|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101179552|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179553|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179554|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
101179556|NCT05718492|Antidotes|antidotes|mesh-ancestor
101179557|NCT05718492|Protective Agents|protective agents|mesh-ancestor
101179558|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
101179560|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
101179561|NCT05718258|Venglustat|venglustat|mesh-list
101179562|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179563|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179564|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
101179565|NCT05718024|Remifentanil|remifentanil|mesh-list
101179566|NCT05718024|Propofol|propofol|mesh-list
101179567|NCT05718024|Esketamine|esketamine|mesh-list
101179568|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101179569|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179570|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179571|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179572|NCT05718024|Analgesics|analgesics|mesh-ancestor
101179573|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
101179574|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179575|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101179576|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179577|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179578|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179580|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179581|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101179582|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
101179583|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
101179584|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101179585|NCT05718024|Narcotics|narcotics|mesh-ancestor
101179586|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
101179587|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101179588|NCT05717790|Gemcitabine|gemcitabine|mesh-list
101179589|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
101179590|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179591|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101179592|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
101179593|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179594|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179596|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179597|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179598|NCT05589792|Acetazolamide|acetazolamide|mesh-list
101179599|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
101179600|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101179601|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179602|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179604|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
101179605|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179606|NCT05543694|Bupivacaine|bupivacaine|mesh-list
101179607|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
101179608|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
101179609|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179610|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179611|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
101179612|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179613|NCT05495568|Adalimumab|adalimumab|mesh-list
101179614|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101179616|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179617|NCT05358834|Melatonin|melatonin|mesh-list
101179618|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
101179619|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179620|NCT05358834|Protective Agents|protective agents|mesh-ancestor
101179621|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179622|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179623|NCT05317806|Metformin|metformin|mesh-list
101179624|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101179625|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179626|NCT05273346|Analgesics|analgesics|mesh-list
101179627|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
101179628|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179629|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179630|NCT05105256|Prednisolone|prednisolone|mesh-list
101179631|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179632|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
101179633|NCT05105256|Hormones|hormones|mesh-ancestor
101179634|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179635|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179636|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101179637|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179638|NCT04916886|Vaccines|vaccines|mesh-list
101179639|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
101179640|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179641|NCT04907682|Ribavirin|ribavirin|mesh-list
101179642|NCT04907682|Favipiravir|favipiravir|mesh-list
101179643|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
101179644|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179645|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
101179646|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179647|NCT04840992|Vaccines|vaccines|mesh-list
101179648|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
101179649|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179650|NCT04793022|Anesthetics|anesthetics|mesh-list
101179651|NCT04793022|Propofol|propofol|mesh-list
101179652|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179653|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179654|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101179655|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101179656|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
101179660|NCT04750902|Fluorides|fluorides|mesh-list
101179661|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
101179662|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
101179663|NCT04750902|Protective Agents|protective agents|mesh-ancestor
101179664|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179665|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101179666|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179667|NCT04621500|Vitamin D|vitamin d|mesh-list
101179668|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
101179669|NCT04621500|Vitamins|vitamins|mesh-ancestor
101179670|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
101179671|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179672|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101179673|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101179674|NCT04567524|Risperidone|risperidone|mesh-list
101179675|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101179676|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
101179677|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179678|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179679|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179680|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101179681|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101179682|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179683|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101179684|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101179687|NCT04547790|Cathartics|cathartics|mesh-ancestor
101179688|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179689|NCT04481412|Cetirizine|cetirizine|mesh-list
101179690|NCT04481412|Ethanol|ethanol|mesh-list
101179691|NCT04481412|Minoxidil|minoxidil|mesh-list
101179692|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101179693|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179694|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179695|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179696|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101179697|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101179698|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101179699|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
101179700|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
101179701|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179702|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179703|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101537349|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101221902|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179704|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
101179705|NCT04317300|Varenicline|varenicline|mesh-list
101179706|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101179707|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101179708|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
101179709|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179710|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179711|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179712|NCT04143204|Insulin|insulin|mesh-list
101179713|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101179714|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179715|NCT04031508|SMOFlipid|smoflipid|mesh-list
101179716|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101179717|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101179718|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101179719|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
101179720|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101179721|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
101179722|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101179723|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
101179724|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179725|NCT03252522|Micronutrients|micronutrients|mesh-list
101179726|NCT03252522|Trace Elements|trace elements|mesh-list
101179727|NCT03252522|Antioxidants|antioxidants|mesh-list
101179728|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179729|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179730|NCT03252522|Protective Agents|protective agents|mesh-ancestor
101179731|NCT03191370|Anesthetics|anesthetics|mesh-list
101179732|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
101179733|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179734|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179735|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
101179736|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179737|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
101179738|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179739|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179740|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101179741|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179742|NCT03149874|Vaccines|vaccines|mesh-list
101179743|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
101179744|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179745|NCT02834052|Poly I-C|poly i-c|mesh-list
101179746|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
101179747|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101179749|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179750|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179751|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101179752|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179753|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
101179754|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
101179755|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179756|NCT02834052|Laxatives|laxatives|mesh-ancestor
101179757|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179758|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
101179759|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179760|NCT02756364|Fulvestrant|fulvestrant|mesh-list
101179761|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101179762|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179763|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101179764|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101179765|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
101179766|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179767|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179769|NCT02519322|Ipilimumab|ipilimumab|mesh-list
101179770|NCT02519322|Relatlimab|relatlimab|mesh-list
101179771|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
101179772|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
101179773|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179774|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179775|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101179776|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179777|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
101179778|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179779|NCT02460042|Paclitaxel|paclitaxel|mesh-list
101179780|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101179781|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179782|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
101179783|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
101179784|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
101179785|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179786|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
101179787|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
101179788|NCT02272842|Vitamins|vitamins|mesh-ancestor
101179789|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
101179790|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179791|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
101179792|NCT02272842|Hematinics|hematinics|mesh-ancestor
101179794|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101179795|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179796|NCT05722548|Analgesics|analgesics|mesh-ancestor
101179797|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
101179798|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179799|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179800|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179801|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179802|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
101179803|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
101179804|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101179805|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101179806|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179807|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179808|NCT05722002|Acetaminophen|acetaminophen|mesh-list
101179809|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179810|NCT05722002|Analgesics|analgesics|mesh-ancestor
101179811|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
101179815|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101179816|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
101179817|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179818|NCT05721300|Interferons|interferons|mesh-list
101179819|NCT05721300|Tenofovir|tenofovir|mesh-list
101179820|NCT05721300|Entecavir|entecavir|mesh-list
101179821|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179822|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
101179823|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179824|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101179825|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101179826|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179827|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179829|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101179830|NCT05720442|Mosapride|mosapride|mesh-list
101179831|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179832|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101179833|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101179834|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
101179835|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179836|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179837|NCT05719818|Diphosphonates|diphosphonates|mesh-list
101179838|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101179839|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179840|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
101179842|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101179843|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179844|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179845|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179846|NCT05719506|Analgesics|analgesics|mesh-ancestor
101179847|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
101179848|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179849|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101179850|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179851|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179852|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179853|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179854|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179855|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101179856|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101179857|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
101179858|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
101179859|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101179860|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101179861|NCT05717166|Hormones|hormones|mesh-list
101179862|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101179863|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179864|NCT05716932|Ranibizumab|ranibizumab|mesh-list
101179865|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101179866|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101179867|NCT05716932|Growth Substances|growth substances|mesh-ancestor
101179868|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179869|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
101179870|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179871|NCT05715840|Paclitaxel|paclitaxel|mesh-list
101179873|NCT05715840|Carboplatin|carboplatin|mesh-list
101179874|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101179875|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179876|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
101179877|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
101179878|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
101179879|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179880|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101179881|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101179882|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101179883|NCT05715840|Growth Substances|growth substances|mesh-ancestor
101179884|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179885|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
101179886|NCT05713734|Thrombin|thrombin|mesh-list
101179887|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
101179890|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101179891|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179892|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179893|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179894|NCT05698758|Analgesics|analgesics|mesh-ancestor
101179895|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
101179896|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179897|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101179898|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101179899|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101179900|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
101179901|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179902|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179903|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
101179904|NCT05665062|Fludarabine|fludarabine|mesh-list
101179905|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179906|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
101179907|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179908|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179909|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179910|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
101179911|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179912|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179913|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101179914|NCT05557812|Eugenol|eugenol|mesh-list
101179915|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
101179916|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
101179917|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
101179918|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
101179919|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101179920|NCT05557812|Protective Agents|protective agents|mesh-ancestor
101179921|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179922|NCT05557812|Hematinics|hematinics|mesh-ancestor
101179923|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179924|NCT05549466|Gemcitabine|gemcitabine|mesh-list
101179925|NCT05549466|Capecitabine|capecitabine|mesh-list
101179926|NCT05549466|Docetaxel|docetaxel|mesh-list
101179927|NCT05549466|Apatinib|apatinib|mesh-list
101179928|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101179929|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
101179930|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179931|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179932|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101179933|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101179934|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101179935|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101179936|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537350|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101179937|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
101179938|NCT05436678|Celecoxib|celecoxib|mesh-list
101179939|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101179940|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101179941|NCT05436678|Analgesics|analgesics|mesh-ancestor
101179942|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
101179943|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179944|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179945|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101179946|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179947|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101179948|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101179949|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179950|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179951|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101179952|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179953|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101179954|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101179955|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179956|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101179957|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101179959|NCT05425056|Temsirolimus|temsirolimus|mesh-list
101179960|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
101179961|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101179962|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101179963|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101179964|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179965|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
101179966|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179967|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
101179968|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179969|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101179970|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101179971|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179972|NCT05352282|Fentanyl|fentanyl|mesh-list
101179973|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101179974|NCT05352282|Narcotics|narcotics|mesh-ancestor
101179975|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179976|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179977|NCT05352282|Analgesics|analgesics|mesh-ancestor
101179978|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
101179979|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179980|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101179981|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101179982|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
101179983|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
101179984|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
101179985|NCT05322330|Fludarabine|fludarabine|mesh-list
101179986|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101179987|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
101179988|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179989|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101179990|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101179991|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
101179992|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101179993|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179994|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101179995|NCT05312892|Amlodipine|amlodipine|mesh-list
101179996|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
101179997|NCT05312892|Moxonidine|moxonidine|mesh-list
101179998|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101179999|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180000|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180001|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101180002|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180004|NCT05309616|Ixekizumab|ixekizumab|mesh-list
101180005|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180006|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
101180007|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
101180008|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
101180009|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180010|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180011|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180012|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180013|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180014|NCT05251038|Leucovorin|leucovorin|mesh-list
101180015|NCT05251038|Paclitaxel|paclitaxel|mesh-list
101180016|NCT05251038|Gemcitabine|gemcitabine|mesh-list
101180017|NCT05251038|Fluorouracil|fluorouracil|mesh-list
101180018|NCT05251038|Irinotecan|irinotecan|mesh-list
101180019|NCT05251038|Sotorasib|sotorasib|mesh-list
101180020|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101180021|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180022|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101180023|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101180024|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180025|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180026|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180027|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
101180028|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180029|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
101180030|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180031|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101180032|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101180033|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180034|NCT05251038|Antidotes|antidotes|mesh-ancestor
101180035|NCT05251038|Protective Agents|protective agents|mesh-ancestor
101180036|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
101180037|NCT05251038|Vitamins|vitamins|mesh-ancestor
101180038|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
101180039|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180042|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
101180043|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101180044|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101180045|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
101180046|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180047|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180048|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180050|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
101180051|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180052|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101180053|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101180054|NCT05091372|Growth Substances|growth substances|mesh-ancestor
101180055|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
101180056|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180058|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
101180059|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
101180060|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180061|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180062|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180063|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101180064|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101180065|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
101180066|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180067|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180069|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
101180070|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180072|NCT04924062|Gemcitabine|gemcitabine|mesh-list
101180073|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
101180074|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180075|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180076|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
101180077|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180078|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180079|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180080|NCT04876638|Minocycline|minocycline|mesh-list
101180081|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101180082|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180083|NCT04754334|Insulin|insulin|mesh-list
101180084|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101180085|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180086|NCT04748796|Landiolol|landiolol|mesh-list
101180087|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101180088|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101180089|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180090|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180091|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180092|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180093|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101180095|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101180096|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180098|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101180099|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
101180100|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101180101|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101180102|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180103|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180104|NCT04599816|Protective Agents|protective agents|mesh-ancestor
101180105|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180109|NCT04534218|Aspirin|aspirin|mesh-list
101180110|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
101180111|NCT04534218|Capecitabine|capecitabine|mesh-list
101180112|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180113|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
101180114|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180115|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180116|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101180117|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
101180118|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180119|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180120|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101180121|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180122|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
101180123|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101180124|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101180125|NCT04534218|Analgesics|analgesics|mesh-ancestor
101180126|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
101180127|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180128|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180129|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101180130|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101180131|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101180132|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101180133|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180135|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101180136|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180138|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
101180139|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180140|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180141|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180142|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101180143|NCT04509414|Analgesics|analgesics|mesh-ancestor
101180144|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
101180145|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180146|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101180147|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180148|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180149|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180150|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180151|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180152|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180153|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101180154|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101180155|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101180156|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180157|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
101180159|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
101180160|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
101180161|NCT04320342|Beclomethasone|beclomethasone|mesh-list
101180162|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
101180163|NCT04320342|Bromides|bromides|mesh-list
101180164|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
101180165|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101180166|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
101180167|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180168|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180169|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101180170|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
101180171|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101180172|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101180173|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180174|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180175|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180176|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180177|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
101180178|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180179|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
101180180|NCT04320342|Hormones|hormones|mesh-ancestor
101180181|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180182|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180183|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101180184|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101180185|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
101180186|NCT04307550|Ethanol|ethanol|mesh-list
101180187|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101180188|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180189|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180190|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180191|NCT04134000|Atezolizumab|atezolizumab|mesh-list
101180192|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180193|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180194|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180195|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180196|NCT04095858|Methotrexate|methotrexate|mesh-list
101180198|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101180199|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
101180200|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101180201|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180202|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180203|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
101180204|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180205|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180206|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180207|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180208|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101180209|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180210|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
101180211|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180212|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101180213|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101180216|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180217|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
101180218|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180219|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180220|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
101180221|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180222|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101180223|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101180224|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101180225|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180226|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180227|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
101180228|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180229|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101180230|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180231|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101180233|NCT03873402|Ipilimumab|ipilimumab|mesh-list
101180234|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180235|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180236|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180237|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180238|NCT03813030|Lidocaine|lidocaine|mesh-list
101180239|NCT03813030|Prilocaine|prilocaine|mesh-list
101180240|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180241|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
101180242|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180243|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180244|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
101180245|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180246|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101180247|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101180248|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101180249|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180250|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180251|NCT03778944|Dopamine|dopamine|mesh-list
101180252|NCT03778944|Mannitol|mannitol|mesh-list
101180253|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101180254|NCT03778944|Diuretics|diuretics|mesh-ancestor
101180255|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
101180256|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180257|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101180258|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
101180259|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
101180266|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180267|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180268|NCT03640728|Tenofovir|tenofovir|mesh-list
101180269|NCT03640728|Entecavir|entecavir|mesh-list
101180270|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
101180271|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180272|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101180273|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101180274|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180275|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180276|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101180277|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101180284|NCT03529110|Trastuzumab|trastuzumab|mesh-list
101180285|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101180286|NCT03529110|Maytansine|maytansine|mesh-list
101180287|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
101180288|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180289|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180290|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101180291|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101180292|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101180293|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180294|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180295|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
101180296|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
101180297|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
101180298|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180299|NCT03502746|Nivolumab|nivolumab|mesh-list
101180300|NCT03502746|Ramucirumab|ramucirumab|mesh-list
101180301|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180302|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180303|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180304|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180305|NCT03436368|Anesthetics|anesthetics|mesh-list
101180306|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180307|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180308|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101180309|NCT03393780|Hormones|hormones|mesh-ancestor
101180310|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180311|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180312|NCT03367572|Dexamethasone|dexamethasone|mesh-list
101180313|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
101180314|NCT03367572|Olanzapine|olanzapine|mesh-list
101180315|NCT03367572|Palonosetron|palonosetron|mesh-list
101180316|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
101180317|NCT03367572|Ichthammol|ichthammol|mesh-list
101180318|NCT03367572|BB 1101|bb 1101|mesh-list
101180319|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180320|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
101180321|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
101180322|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180323|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180324|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180325|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
101180326|NCT03367572|Hormones|hormones|mesh-ancestor
101180327|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180328|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180329|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180330|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101180331|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101180332|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180333|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101180334|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101180335|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101180336|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180337|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180338|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180339|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
101180340|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
101180341|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180342|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101180343|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101180344|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180345|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101180346|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
101180347|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
101180348|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180349|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180350|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101180353|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
101180354|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180355|NCT03202758|Durvalumab|durvalumab|mesh-list
101180356|NCT03202758|Tremelimumab|tremelimumab|mesh-list
101180357|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180358|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180359|NCT03122262|Tenofovir|tenofovir|mesh-list
101180360|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101180361|NCT03122262|Dolutegravir|dolutegravir|mesh-list
101180362|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101180363|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
101180364|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180365|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101180366|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101180367|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180369|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101180370|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101180371|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101180372|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101180373|NCT03051282|Enalapril|enalapril|mesh-list
101180374|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101180375|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
101180376|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180377|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180378|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101180379|NCT03042546|Calcium|calcium|mesh-list
101180380|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101180381|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180382|NCT02734602|Ketamine|ketamine|mesh-list
101180383|NCT02734602|Analgesics|analgesics|mesh-ancestor
101180384|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
101180385|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180386|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180387|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101180388|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180389|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
101180390|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
101180391|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180392|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180393|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180394|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180395|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180398|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101180399|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
101180400|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101180401|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180402|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180403|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
101180404|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180405|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180406|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180407|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180408|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101180409|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180410|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
101180411|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180412|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101180413|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101180414|NCT02420652|Aspirin|aspirin|mesh-list
101180415|NCT02420652|Metformin|metformin|mesh-list
101180416|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101180417|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180418|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101180419|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101180420|NCT02420652|Analgesics|analgesics|mesh-ancestor
101180421|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
101180422|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180423|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180424|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180425|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101180426|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101180427|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180428|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101180429|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101180430|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180431|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
101180432|NCT02257242|Rituximab|rituximab|mesh-list
101180433|NCT02257242|Vincristine|vincristine|mesh-list
101180434|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101180435|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180436|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180437|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
101180438|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180439|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180440|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101180441|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
101180442|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
101180443|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180444|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180445|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101180446|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
101180447|NCT02034630|Busulfan|busulfan|mesh-list
101180448|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
101180449|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180450|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180451|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
101180452|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180453|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101180454|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180455|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101180456|NCT02025036|Capecitabine|capecitabine|mesh-list
101180457|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
101180458|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180459|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
101180460|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180461|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180462|NCT01768338|Ofatumumab|ofatumumab|mesh-list
101180463|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180487|NCT00819546|Midostaurin|midostaurin|mesh-list
101180488|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101180489|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101180490|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180491|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180492|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180493|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
101180494|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180495|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180496|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101180497|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
101180498|NCT00596154|Busulfan|busulfan|mesh-list
101180499|NCT00596154|Thiotepa|thiotepa|mesh-list
101180500|NCT00596154|Rituximab|rituximab|mesh-list
101180501|NCT00596154|Methotrexate|methotrexate|mesh-list
101180503|NCT00596154|Procarbazine|procarbazine|mesh-list
101180504|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180505|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
101180506|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180507|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101180508|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101180509|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
101180510|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180511|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180512|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101180513|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180514|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101180515|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
101180516|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101180517|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101180518|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
101180519|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180520|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180521|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101180522|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101180523|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101180524|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
101180525|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
101180526|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180527|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180529|NCT00281658|Lapatinib|lapatinib|mesh-list
101180530|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101180531|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180532|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
101180533|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
101180534|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
101180535|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180536|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101180537|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180538|NCT02417844|Tamsulosin|tamsulosin|mesh-list
101180539|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101180540|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101180541|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101180542|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180543|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180544|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180545|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180546|NCT02417844|Urological Agents|urological agents|mesh-ancestor
101180547|NCT02418312|Famotidine|famotidine|mesh-list
101180548|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
101180549|NCT02418312|Histamine|histamine|mesh-list
101180550|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101180551|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180552|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
101180553|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
101180554|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180555|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180556|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180557|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
101180558|NCT02421354|Nivolumab|nivolumab|mesh-list
101180559|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180560|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180561|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180562|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180563|NCT02422290|Ketamine|ketamine|mesh-list
101180564|NCT02422290|Analgesics|analgesics|mesh-ancestor
101180565|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
101180566|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180567|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180568|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101180569|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180570|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
101180572|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180573|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180574|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180575|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180576|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180578|NCT02430090|Sufentanil|sufentanil|mesh-list
101180579|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
101180580|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101180581|NCT02430090|Narcotics|narcotics|mesh-ancestor
101180582|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180583|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180584|NCT02430090|Analgesics|analgesics|mesh-ancestor
101180585|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
101180586|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180587|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180588|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180589|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
101180590|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
101180591|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180592|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
101180593|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
101180594|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180595|NCT02431650|Primaquine|primaquine|mesh-list
101180596|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
101180597|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101180598|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101180599|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180600|NCT02437344|Naltrexone|naltrexone|mesh-list
101180601|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101180602|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101180603|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180604|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
101180605|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180606|NCT02440308|Bombesin|bombesin|mesh-list
101180607|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180608|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180609|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180610|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
101180611|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101180612|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101180613|NCT02448654|Tolcapone|tolcapone|mesh-list
101180614|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101180616|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
101180617|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180618|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180619|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
101180620|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101180621|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101180622|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180624|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101180625|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101180626|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180627|NCT02462148|Dexamethasone|dexamethasone|mesh-list
101180628|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
101180629|NCT02462148|Epinephrine|epinephrine|mesh-list
101180630|NCT02462148|Bupivacaine|bupivacaine|mesh-list
101180632|NCT02462148|BB 1101|bb 1101|mesh-list
101180633|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180634|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
101180635|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
101180636|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180637|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180638|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180639|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
101180640|NCT02462148|Hormones|hormones|mesh-ancestor
101180641|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180642|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180643|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180644|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
101180645|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180646|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180647|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180648|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
101180649|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180651|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180652|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180653|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180654|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180655|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101180656|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101180657|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101180658|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
101180659|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
101180660|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
101180661|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101180662|NCT02462382|Ropivacaine|ropivacaine|mesh-list
101180663|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180664|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
101180665|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180666|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180667|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
101180668|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180669|NCT02464176|Dexamethasone|dexamethasone|mesh-list
101180670|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
101180671|NCT02464176|Epinephrine|epinephrine|mesh-list
101180672|NCT02464176|Bupivacaine|bupivacaine|mesh-list
101180673|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101180675|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180676|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
101180677|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
101180678|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180679|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180680|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180681|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
101180683|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180684|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180685|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180686|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
101180687|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180688|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180689|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180690|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
101180691|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180692|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
101180693|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180694|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180695|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180696|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180697|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101180698|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101180699|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101180700|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
101180701|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
101180702|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
101180703|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101180704|NCT02468700|Dexamethasone|dexamethasone|mesh-list
101180705|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180706|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
101180707|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
101180708|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180709|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180710|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180711|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
101180712|NCT02468700|Hormones|hormones|mesh-ancestor
101180713|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180714|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180715|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180716|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
101180717|NCT02472522|Ropivacaine|ropivacaine|mesh-list
101180718|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
101180719|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180720|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180721|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180722|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101180723|NCT02472522|Analgesics|analgesics|mesh-ancestor
101180724|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
101180725|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180726|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101180727|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180728|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180729|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180730|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180731|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180732|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
101180733|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
101180734|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
101180735|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180736|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
101180737|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
101180738|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180739|NCT02484222|Fentanyl|fentanyl|mesh-list
101180740|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101180741|NCT02484222|Narcotics|narcotics|mesh-ancestor
101180742|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180743|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180744|NCT02484222|Analgesics|analgesics|mesh-ancestor
101180745|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
101180746|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180747|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180748|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180749|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
101180750|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
101180751|NCT02486016|Fentanyl|fentanyl|mesh-list
101180752|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101180753|NCT02486016|Narcotics|narcotics|mesh-ancestor
101180754|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180755|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180756|NCT02486016|Analgesics|analgesics|mesh-ancestor
101180757|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
101180758|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180759|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180760|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180761|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
101180762|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
101180763|NCT02486328|Midazolam|midazolam|mesh-list
101180764|NCT02486328|Meperidine|meperidine|mesh-list
101180765|NCT02486328|Remifentanil|remifentanil|mesh-list
101180766|NCT02486328|Propofol|propofol|mesh-list
101180767|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180768|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180769|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180770|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180771|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
101180772|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
101180773|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180774|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101180775|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101180776|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101180777|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
101180778|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
101180779|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180780|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180781|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101180782|NCT02486328|Narcotics|narcotics|mesh-ancestor
101180783|NCT02486328|Analgesics|analgesics|mesh-ancestor
101180784|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
101180785|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180786|NCT02491788|Suvorexant|suvorexant|mesh-list
101180787|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101180788|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180789|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180790|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180791|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101180792|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180793|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180794|NCT02491944|Osimertinib|osimertinib|mesh-list
101180795|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180796|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101180797|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180798|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180799|NCT02492802|Posaconazole|posaconazole|mesh-list
101180800|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
101180801|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180802|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101180803|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101180804|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101180805|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101180806|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101180807|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180808|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180809|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101180810|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
101180811|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180812|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180813|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
101180814|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180815|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180817|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101180818|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101180819|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101180820|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101180821|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180822|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180823|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180824|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180825|NCT02500836|Cocaine|cocaine|mesh-list
101180826|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101180827|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180828|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
101180829|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180830|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180831|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
101180832|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180833|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101180834|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101180835|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101180836|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180837|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180838|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
101180839|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180840|NCT02508636|Leuprolide|leuprolide|mesh-list
101180841|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101180842|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
101180843|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101180845|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180846|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180847|NCT02513940|Ibutilide|ibutilide|mesh-list
101180848|NCT02513940|Testosterone|testosterone|mesh-list
101180849|NCT02513940|Progesterone|progesterone|mesh-list
101180850|NCT02513940|Androgens|androgens|mesh-ancestor
101180851|NCT02513940|Hormones|hormones|mesh-ancestor
101180852|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180854|NCT02513940|Progestins|progestins|mesh-ancestor
101180855|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101180856|NCT02515890|Midazolam|midazolam|mesh-list
101180857|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
101180858|NCT02515890|Ketamine|ketamine|mesh-list
101180859|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101180860|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180861|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180862|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101180863|NCT02515890|Analgesics|analgesics|mesh-ancestor
101180864|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
101180865|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180866|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101180867|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180868|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180869|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180870|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180871|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180872|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101180873|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101180874|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
101180875|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
101180876|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101180877|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101180878|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101180879|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101180880|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101180881|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101180882|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
101180883|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
101180885|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180886|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
101180887|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180888|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180889|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
101180890|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180891|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101180892|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101180893|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101180894|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101180895|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180896|NCT02525718|Dexamethasone|dexamethasone|mesh-list
101180897|NCT02525718|Epinephrine|epinephrine|mesh-list
101180898|NCT02525718|Bupivacaine|bupivacaine|mesh-list
101180899|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101180900|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
101180902|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180903|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180904|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101180905|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
101180906|NCT02525718|Hormones|hormones|mesh-ancestor
101180907|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180908|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101180909|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180910|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
101180911|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
101180912|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101180913|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
101180914|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101180915|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101180916|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
101180917|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180918|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180919|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101180920|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101180922|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
101180925|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101180926|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
101180927|NCT02527512|Povidone|povidone|mesh-list
101180928|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
101180929|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
101180930|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101180931|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180932|NCT02529072|Nivolumab|nivolumab|mesh-list
101180933|NCT02529072|Vaccines|vaccines|mesh-list
101180934|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
101180935|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180936|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180937|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180938|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101180939|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180941|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101180942|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101180943|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180944|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180945|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
101180946|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101180947|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101180949|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
101180950|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180951|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101180952|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101180953|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180954|NCT02536248|Incretins|incretins|mesh-ancestor
101180955|NCT02536248|Hormones|hormones|mesh-ancestor
101180956|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101180957|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101180958|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
101180959|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180960|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180961|NCT02538042|Nicotine|nicotine|mesh-list
101180962|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101180963|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
101180964|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101180965|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180966|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101180967|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101180968|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
101180969|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180970|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180971|NCT02538354|Riboflavin|riboflavin|mesh-list
101180972|NCT02538354|Vitamins|vitamins|mesh-ancestor
101180973|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
101180974|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180975|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
101180976|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101180977|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101180978|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
101180979|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101180980|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101180981|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180982|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
101180983|NCT02540226|Coagulants|coagulants|mesh-ancestor
101180984|NCT02541864|Amoxicillin|amoxicillin|mesh-list
101180985|NCT02541864|Metronidazole|metronidazole|mesh-list
101180986|NCT02541864|Clarithromycin|clarithromycin|mesh-list
101180987|NCT02541864|Tetracycline|tetracycline|mesh-list
101180988|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
101180989|NCT02541864|Pantoprazole|pantoprazole|mesh-list
101180990|NCT02541864|Bismuth|bismuth|mesh-list
101180991|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101180992|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101180993|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101180994|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101180995|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101180996|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101180997|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180998|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101180999|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181000|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101181001|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181002|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101181004|NCT02542410|Cabergoline|cabergoline|mesh-list
101181005|NCT02542410|Norethindrone|norethindrone|mesh-list
101181006|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
101181007|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101181008|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101181009|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101181010|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
101181011|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101181012|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181013|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101181014|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101181015|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101181016|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101181017|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
101181018|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
101181019|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181020|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181021|NCT02544984|Azithromycin|azithromycin|mesh-list
101181022|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181023|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181024|NCT02547012|Amoxicillin|amoxicillin|mesh-list
101181025|NCT02547012|Levofloxacin|levofloxacin|mesh-list
101181026|NCT02547012|Ofloxacin|ofloxacin|mesh-list
101181027|NCT02547012|Tetracycline|tetracycline|mesh-list
101181028|NCT02547012|Esomeprazole|esomeprazole|mesh-list
101181029|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181030|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181031|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101181032|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181033|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101181034|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181035|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181036|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101181037|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101181038|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101181039|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181040|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101181041|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181042|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101181043|NCT02548728|Oxytocin|oxytocin|mesh-list
101181044|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
101181045|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101181046|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181047|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
101181048|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101181049|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101181050|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101181051|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
101181052|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181053|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181054|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181055|NCT02560038|Paclitaxel|paclitaxel|mesh-list
101181056|NCT02560038|Gemcitabine|gemcitabine|mesh-list
101181057|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101181058|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181059|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
101181060|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
101181061|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
101181062|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181063|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181064|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
101181065|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101181066|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101181067|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
101181069|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
101181070|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
101181071|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101181072|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181073|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101181074|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181075|NCT02562066|Amifampridine|amifampridine|mesh-list
101181076|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101181077|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181078|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181079|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101181080|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181081|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181082|NCT02562924|Prednisone|prednisone|mesh-list
101181083|NCT02562924|Budesonide|budesonide|mesh-list
101181084|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181085|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
101181086|NCT02562924|Hormones|hormones|mesh-ancestor
101181087|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181088|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181089|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181090|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181091|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101181092|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
101181093|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181094|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101181095|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
101181096|NCT02563860|Lovastatin|lovastatin|mesh-list
101181097|NCT02563860|L 647318|l 647318|mesh-list
101181098|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
101181099|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101181100|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101181102|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181103|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101181104|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101181105|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181106|NCT02568852|Anesthetics|anesthetics|mesh-list
101181107|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181108|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181109|NCT02570022|Bupivacaine|bupivacaine|mesh-list
101181110|NCT02570022|Ropivacaine|ropivacaine|mesh-list
101181111|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
101181112|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
101181113|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181114|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181115|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
101181116|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181117|NCT02572752|Nintedanib|nintedanib|mesh-list
101181118|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181119|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101181120|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181121|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181122|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
101181123|NCT02577042|Atorvastatin|atorvastatin|mesh-list
101181124|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101181125|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101181126|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
101181127|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181128|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101181129|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101181130|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181131|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101181132|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101181133|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
101181134|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181135|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101181136|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101181137|NCT02582970|Bevacizumab|bevacizumab|mesh-list
101181138|NCT02582970|Fluorouracil|fluorouracil|mesh-list
101181139|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
101181140|NCT02582970|Irinotecan|irinotecan|mesh-list
101181141|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181142|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181143|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101181144|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101181145|NCT02582970|Growth Substances|growth substances|mesh-ancestor
101181146|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181147|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
101181148|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
101181149|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181150|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181153|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101181154|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101181155|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181156|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
101181157|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
101181158|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181159|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
101181160|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101181161|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101181162|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101181163|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181164|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181165|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
101181166|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181167|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181168|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101181169|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181171|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
101181172|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181173|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181174|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181175|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
101181176|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
101181177|NCT05248152|Acetaminophen|acetaminophen|mesh-list
101181178|NCT05248152|Ibuprofen|ibuprofen|mesh-list
101181179|NCT05248152|Pregabalin|pregabalin|mesh-list
101181180|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101181181|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101181182|NCT05248152|Analgesics|analgesics|mesh-ancestor
101181183|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
101181184|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181185|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181186|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181187|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181188|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101181189|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181190|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181191|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
101181192|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101181193|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181194|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101181195|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101181196|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101181197|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181198|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181199|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
101181200|NCT05247684|Paclitaxel|paclitaxel|mesh-list
101181201|NCT05247684|Carboplatin|carboplatin|mesh-list
101181202|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101181203|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181204|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
101181205|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
101181206|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
101181207|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181208|NCT05184348|Acitretin|acitretin|mesh-list
101181209|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
101181210|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
101181213|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
101181214|NCT05132166|Temsirolimus|temsirolimus|mesh-list
101181215|NCT05132166|Vedolizumab|vedolizumab|mesh-list
101181216|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101181217|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101537352|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537353|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537354|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
101537355|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
101181218|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181219|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181220|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181221|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
101181222|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181223|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181224|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181225|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181226|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101181227|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
101181229|NCT04808466|Paclitaxel|paclitaxel|mesh-list
101181230|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101181231|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181232|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101181233|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101181234|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101181235|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181236|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
101181237|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101181238|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
101181239|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181240|NCT03907176|Acetaminophen|acetaminophen|mesh-list
101181241|NCT03907176|Ibuprofen|ibuprofen|mesh-list
101181242|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101181243|NCT03907176|Analgesics|analgesics|mesh-ancestor
101181244|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
101181245|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181246|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181247|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
101181248|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101181249|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181250|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181251|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101181252|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181253|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181254|NCT03675672|Misoprostol|misoprostol|mesh-list
101181255|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101181256|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
101181257|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101181258|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181259|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101181260|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181261|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
101181262|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
101181263|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101181264|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
101181265|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181266|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
101181267|NCT02108496|Protective Agents|protective agents|mesh-ancestor
101181268|NCT02056236|Midazolam|midazolam|mesh-list
101181269|NCT02056236|Levetiracetam|levetiracetam|mesh-list
101181270|NCT02056236|Valproic Acid|valproic acid|mesh-list
101181271|NCT02056236|Lorazepam|lorazepam|mesh-list
101181272|NCT02056236|Thiopental|thiopental|mesh-list
101181273|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
101181274|NCT02056236|Propofol|propofol|mesh-list
101181275|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181276|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181277|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181279|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
101181280|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
101181281|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101181282|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101181283|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101181284|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181285|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
101181286|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
101181287|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181288|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181289|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
101181290|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181291|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
101181292|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
101181293|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
101181294|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181295|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181296|NCT01962246|Capecitabine|capecitabine|mesh-list
101181297|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
101181298|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181299|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
101181300|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181301|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181302|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101181303|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
101181304|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181305|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101181306|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
101181307|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181308|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
101181309|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101181311|NCT04945122|Pitavastatin|pitavastatin|mesh-list
101181312|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101181313|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101181314|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
101181315|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181316|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101181317|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101181318|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181319|NCT04227366|Methotrexate|methotrexate|mesh-list
101181320|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101181321|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
101181322|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101181323|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181324|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181325|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
101181326|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181327|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181328|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101181329|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181330|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101181331|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181332|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
101181333|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181334|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101181335|NCT03560466|Prednisone|prednisone|mesh-list
101181336|NCT03560466|Prednisolone|prednisolone|mesh-list
101181337|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181338|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
101181339|NCT03560466|Hormones|hormones|mesh-ancestor
101181340|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181341|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181342|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181343|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181344|NCT03376698|Colchicine|colchicine|mesh-list
101181346|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181347|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
101181348|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
101181349|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
101181350|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181351|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181352|NCT03295734|Losartan|losartan|mesh-list
101181353|NCT03295734|Perindopril|perindopril|mesh-list
101181354|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101181355|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101181356|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101181357|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101181358|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181359|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101181360|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
101181361|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181362|NCT02595684|Tadalafil|tadalafil|mesh-list
101181363|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101181364|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101181365|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101181366|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181367|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181368|NCT02595684|Urological Agents|urological agents|mesh-ancestor
101181369|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
101181370|NCT02604810|Antibodies|antibodies|mesh-list
101181371|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
101181372|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101181373|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101181374|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
101181375|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
101181376|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181377|NCT02607618|Vancomycin|vancomycin|mesh-list
101181378|NCT02607618|Iclaprim|iclaprim|mesh-list
101181379|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181380|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181381|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101181382|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181383|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181384|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
101181385|NCT05732064|Esketamine|esketamine|mesh-list
101181386|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181387|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181388|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181389|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101181390|NCT05732064|Analgesics|analgesics|mesh-ancestor
101181391|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
101181392|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181393|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101181394|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101181395|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101181396|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
101181397|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181398|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181399|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
101181400|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181401|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101181402|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
101181403|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181404|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
101181432|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101181434|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181435|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101181436|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181437|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101181438|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181439|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101181441|NCT05386524|Bevacizumab|bevacizumab|mesh-list
101181442|NCT05386524|Doxorubicin|doxorubicin|mesh-list
101181443|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101181444|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181445|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181446|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101181447|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101181448|NCT05386524|Growth Substances|growth substances|mesh-ancestor
101181449|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181450|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
101181451|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101181452|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101181453|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101181454|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181455|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181456|NCT04965714|Nivolumab|nivolumab|mesh-list
101181457|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181458|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181459|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101181460|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181461|NCT04787562|Imipenem|imipenem|mesh-list
101181462|NCT04787562|Cilastatin|cilastatin|mesh-list
101181463|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101181464|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181465|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
101181466|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181467|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181468|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
101181469|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
101181470|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181472|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
101181473|NCT04355130|Vitamins|vitamins|mesh-ancestor
101181474|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
101181475|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181476|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
101181477|NCT04355130|Hematinics|hematinics|mesh-ancestor
101181479|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101181480|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181481|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181482|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
101181483|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181484|NCT04107168|Bevacizumab|bevacizumab|mesh-list
101181485|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
101181486|NCT04107168|Nivolumab|nivolumab|mesh-list
101181487|NCT04107168|Ipilimumab|ipilimumab|mesh-list
101181490|NCT04107168|Tremelimumab|tremelimumab|mesh-list
101181491|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181492|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181493|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101181494|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101181495|NCT04107168|Growth Substances|growth substances|mesh-ancestor
101181496|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181497|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
101181498|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101181499|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181500|NCT03958344|Prednisolone|prednisolone|mesh-list
101181501|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101181502|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
101181503|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101181504|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
101181505|NCT03958344|Triamcinolone|triamcinolone|mesh-list
101181506|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101181507|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
101181508|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181509|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
101181510|NCT03958344|Hormones|hormones|mesh-ancestor
101181511|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181512|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181513|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181514|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181515|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
101181516|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
101181517|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181518|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181519|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101181520|NCT03958344|Protective Agents|protective agents|mesh-ancestor
101181521|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
101181523|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
101181524|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
101181525|NCT02960646|Rituximab|rituximab|mesh-list
101181526|NCT02960646|Fludarabine|fludarabine|mesh-list
101181527|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
101181528|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101181529|NCT02960646|Tacrolimus|tacrolimus|mesh-list
101181530|NCT02960646|Antibodies|antibodies|mesh-list
101181531|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
101181532|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101181533|NCT02960646|Lenograstim|lenograstim|mesh-list
101181534|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181535|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
101181536|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181537|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181538|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101181539|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
101181540|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181541|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181542|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101181543|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181544|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
101181545|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101181546|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101181547|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181548|NCT02517684|Prednisolone|prednisolone|mesh-list
101181549|NCT02517684|Infliximab|infliximab|mesh-list
101181550|NCT02517684|Azathioprine|azathioprine|mesh-list
101181551|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181552|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
101181553|NCT02517684|Hormones|hormones|mesh-ancestor
101181554|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181555|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181556|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181557|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181558|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181559|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101181560|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
101181561|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181562|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
101181563|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181564|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181565|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181566|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
101181567|NCT01448616|Tenofovir|tenofovir|mesh-list
101181568|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
101181569|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181570|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101181571|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101181572|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181573|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181574|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101181575|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101181576|NCT00074412|Nevirapine|nevirapine|mesh-list
101181577|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101181578|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101181579|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181580|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181581|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
101181582|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181583|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101181584|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101181585|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101181586|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101181587|NCT02618772|Midazolam|midazolam|mesh-list
101181588|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101181589|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181590|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181591|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181592|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101181593|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101181594|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181595|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101181596|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
101181597|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
101181598|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
101181599|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
101181600|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181601|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181602|NCT02620878|Pancrelipase|pancrelipase|mesh-list
101181603|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181604|NCT02624700|Pemetrexed|pemetrexed|mesh-list
101181605|NCT02624700|Sorafenib|sorafenib|mesh-list
101181606|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181607|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181608|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181609|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101181610|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101181611|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101181612|NCT02631954|Voriconazole|voriconazole|mesh-list
101181613|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
101181614|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181615|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101181616|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181617|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181618|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181619|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101181620|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
101181621|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181622|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181623|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101181624|NCT02632812|Naproxen|naproxen|mesh-list
101181625|NCT02632812|Rebamipide|rebamipide|mesh-list
101181626|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101181627|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101181628|NCT02632812|Analgesics|analgesics|mesh-ancestor
101181629|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
101181630|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181631|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181632|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181633|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181634|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
101181635|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101181636|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181637|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181638|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101181639|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181640|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
101181641|NCT02632812|Protective Agents|protective agents|mesh-ancestor
101181642|NCT02634684|Amphetamine|amphetamine|mesh-list
101181643|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
101181644|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101181645|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181646|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
101181647|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
101181648|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181649|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
101181650|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181651|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181653|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101181654|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101181655|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181656|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101181657|NCT02635542|Cisatracurium|cisatracurium|mesh-list
101181658|NCT02635542|Succinylcholine|succinylcholine|mesh-list
101181659|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101181660|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101181661|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181662|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181663|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
101181664|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
101181665|NCT05585658|Hematinics|hematinics|mesh-ancestor
101181666|NCT05510856|Lacosamide|lacosamide|mesh-list
101181667|NCT05510856|Gabapentin|gabapentin|mesh-list
101181668|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101181669|NCT05510856|Analgesics|analgesics|mesh-ancestor
101181670|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
101181671|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181672|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181673|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
101181674|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101181675|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101181676|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181677|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181678|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101181679|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101181680|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181681|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181682|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
101181683|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101181684|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101181685|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181686|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
101181687|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
101181688|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101181689|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101181690|NCT05281770|Erenumab|erenumab|mesh-list
101181691|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101181692|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181693|NCT05281770|Analgesics|analgesics|mesh-ancestor
101181694|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
101181695|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181696|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181697|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
101181698|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181699|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181700|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181701|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101181702|NCT05225610|Analgesics|analgesics|mesh-ancestor
101181703|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
101181704|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181705|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101181706|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101181707|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101181708|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
101181709|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181710|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181712|NCT05150652|Letrozole|letrozole|mesh-list
101181713|NCT05150652|Anastrozole|anastrozole|mesh-list
101181714|NCT05150652|Exemestane|exemestane|mesh-list
101181715|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181716|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101181717|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101181718|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181719|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181720|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101181721|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
101181722|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181723|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181724|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181725|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101181726|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101181727|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101181728|NCT04511052|Carotenoids|carotenoids|mesh-list
101181729|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
101181730|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181731|NCT04511052|Protective Agents|protective agents|mesh-ancestor
101181732|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181733|NCT03693846|Nivolumab|nivolumab|mesh-list
101181734|NCT03693846|Ipilimumab|ipilimumab|mesh-list
101181735|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181736|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181737|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101181738|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181739|NCT03529890|Nivolumab|nivolumab|mesh-list
101181740|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181741|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181742|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101181743|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181744|NCT03441048|Cytarabine|cytarabine|mesh-list
101181745|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
101181746|NCT03441048|Cladribine|cladribine|mesh-list
101181747|NCT03441048|Lintuzumab|lintuzumab|mesh-list
101181748|NCT03441048|Lenograstim|lenograstim|mesh-list
101181749|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101181750|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
101181751|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181752|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181753|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
101181754|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181755|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181756|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
101181757|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181758|NCT03441048|Analgesics|analgesics|mesh-ancestor
101181759|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
101181760|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181761|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101181762|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101181763|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181764|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101181765|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101181766|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
101181767|NCT02828592|Fludarabine|fludarabine|mesh-list
101181768|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
101181769|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181770|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
101181771|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181772|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101181773|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101181774|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
101181775|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181776|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181777|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101181778|NCT02369406|Lamivudine|lamivudine|mesh-list
101181779|NCT02369406|Zidovudine|zidovudine|mesh-list
101181780|NCT02369406|Nevirapine|nevirapine|mesh-list
101181781|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101181782|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101181783|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181784|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181785|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
101181786|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181787|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101181789|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
101181790|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101181791|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101181792|NCT02649192|Vitamin D|vitamin d|mesh-list
101181793|NCT02649192|Vitamin A|vitamin a|mesh-list
101181794|NCT02649192|Vitamins|vitamins|mesh-ancestor
101181795|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
101181796|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181797|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101181798|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
101181799|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101181800|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101181802|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
101181803|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101181804|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
101181805|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101181806|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
101181807|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
101181808|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181809|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181810|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181811|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
101181813|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181814|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101181815|NCT02652390|Protective Agents|protective agents|mesh-ancestor
101181816|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101181817|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181818|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
101181819|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
101181820|NCT02653560|Citric Acid|citric acid|mesh-list
101181821|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
101181822|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
101181823|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101181824|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
101181825|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
101181826|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181827|NCT02653560|Diuretics|diuretics|mesh-ancestor
101181828|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
101181829|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181830|NCT02653560|Expectorants|expectorants|mesh-ancestor
101181831|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
101181832|NCT02653560|Cathartics|cathartics|mesh-ancestor
101181833|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181834|NCT02653872|Itraconazole|itraconazole|mesh-list
101181835|NCT02653872|Verapamil|verapamil|mesh-list
101181836|NCT02653872|Diltiazem|diltiazem|mesh-list
101181837|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
101181838|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181839|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101181840|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181841|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181842|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181843|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101181844|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
101181845|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181846|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181847|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101181848|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101181849|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101181850|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101181851|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101181852|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
101181853|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101181854|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
101181856|NCT02655354|Prazosin|prazosin|mesh-list
101181857|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101181858|NCT02655354|Mirtazapine|mirtazapine|mesh-list
101181859|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
101181860|NCT02655354|Trazodone|trazodone|mesh-list
101181861|NCT02655354|Sertraline|sertraline|mesh-list
101181862|NCT02655354|Fluoxetine|fluoxetine|mesh-list
101181863|NCT02655354|Paroxetine|paroxetine|mesh-list
101181865|NCT02655354|Citalopram|citalopram|mesh-list
101181866|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101181867|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101181869|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181870|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181871|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181872|NCT02655354|Analgesics|analgesics|mesh-ancestor
101181873|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
101181874|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181875|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
101181876|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181877|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
101181878|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101181880|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101181881|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101181882|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101181883|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181884|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
101181885|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101181886|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181887|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181888|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
101181889|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
101181890|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
101181891|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181892|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101181893|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
101181894|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
101181895|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101181896|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
101181897|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
101181898|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101181899|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101181900|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101181901|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101181902|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101181903|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101181904|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101181905|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101181906|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101181907|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101181908|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101181909|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101181910|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101181911|NCT02657928|Letrozole|letrozole|mesh-list
101181912|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181913|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101181914|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101181915|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181916|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181917|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101181918|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
101181919|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101181920|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181921|NCT02658240|Epinephrine|epinephrine|mesh-list
101181922|NCT02658240|Ropivacaine|ropivacaine|mesh-list
101181923|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
101181924|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
101181925|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181926|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181927|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
101181928|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181929|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101181930|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101181931|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101181932|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181933|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181934|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101181935|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101181936|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
101181937|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101181938|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101181939|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
101181940|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
101181941|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101181942|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
101181943|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
101181944|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181945|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
101181946|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101181947|NCT02665260|Cantharidin|cantharidin|mesh-list
101181948|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181949|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181951|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181952|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
101181954|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
101181955|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101181956|NCT02673138|Canagliflozin|canagliflozin|mesh-list
101181957|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101181958|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181959|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101181960|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181961|NCT02673372|Ketamine|ketamine|mesh-list
101181962|NCT02673372|Morphine|morphine|mesh-list
101181963|NCT02673372|Analgesics|analgesics|mesh-ancestor
101181964|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
101181965|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181966|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181967|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101181968|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101181969|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
101181970|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
101181971|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181972|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101181973|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101181974|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181975|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181976|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101181977|NCT02673372|Narcotics|narcotics|mesh-ancestor
101181978|NCT02682498|Bupivacaine|bupivacaine|mesh-list
101181979|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
101181980|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
101181981|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181982|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181983|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
101181984|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101181986|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101181987|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101181988|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101181989|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101181990|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101181991|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101181992|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181994|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101181995|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101181996|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101181997|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101181998|NCT02695446|Minocycline|minocycline|mesh-list
101181999|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101182000|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182001|NCT02698566|Ranibizumab|ranibizumab|mesh-list
101182002|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101182003|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101182004|NCT02698566|Growth Substances|growth substances|mesh-ancestor
101182005|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182006|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
101182007|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182008|NCT02701062|Warfarin|warfarin|mesh-list
101182009|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
101182010|NCT02701062|Dabigatran|dabigatran|mesh-list
101182011|NCT02701062|Apixaban|apixaban|mesh-list
101182012|NCT02701062|Anticoagulants|anticoagulants|mesh-list
101182013|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101182014|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
101182015|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101182016|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
101182017|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182018|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182019|NCT02704104|Hemostatics|hemostatics|mesh-list
101182020|NCT02704104|Coagulants|coagulants|mesh-ancestor
101182022|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
101182023|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182024|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101182025|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182026|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101182027|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
101182028|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182030|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
101182031|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182032|NCT02708238|Emollients|emollients|mesh-ancestor
101182033|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182034|NCT02709018|Losartan|losartan|mesh-list
101182035|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101182036|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101182037|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101182038|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101182039|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182040|NCT02713230|Bupivacaine|bupivacaine|mesh-list
101182041|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
101182042|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
101182043|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182044|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182045|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
101182046|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182047|NCT02713698|Propofol|propofol|mesh-list
101182048|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182049|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182050|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182051|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101182052|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
101182053|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
101182054|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101182055|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101182056|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101182057|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182058|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182059|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182060|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182061|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101182062|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
101182063|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182064|NCT02716818|Dexamethasone|dexamethasone|mesh-list
101182065|NCT02716818|Prednisone|prednisone|mesh-list
101182066|NCT02716818|Prednisolone|prednisolone|mesh-list
101182067|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
101182068|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101182069|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101182070|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101182071|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
101182072|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182073|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
101182074|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
101182075|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182076|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182077|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182078|NCT02716818|Hormones|hormones|mesh-ancestor
101182079|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182080|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101182081|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182082|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
101182083|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101182084|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182085|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101182086|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182087|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182088|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182089|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182090|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101182091|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182092|NCT02726178|Ibuprofen|ibuprofen|mesh-list
101182093|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101182094|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182096|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
101182097|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182098|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182099|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182100|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101182101|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101182102|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182103|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182104|NCT02733588|Glucagon|glucagon|mesh-list
101182105|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101182106|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182107|NCT02733588|Hormones|hormones|mesh-ancestor
101182108|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182109|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182110|NCT02733588|Incretins|incretins|mesh-ancestor
101182111|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
101182112|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182113|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101182114|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182115|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182116|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
101182117|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182118|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182119|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182121|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182122|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182123|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101182124|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101182125|NCT05444088|Growth Substances|growth substances|mesh-ancestor
101182126|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182127|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
101182128|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
101182129|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101182130|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101182131|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182132|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182133|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182134|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101182135|NCT05443932|Diuretics|diuretics|mesh-ancestor
101182136|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
101182137|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101182138|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182139|NCT05443308|Acetazolamide|acetazolamide|mesh-list
101182140|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
101182141|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101182142|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182143|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182144|NCT05443308|Diuretics|diuretics|mesh-ancestor
101182145|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
101182146|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182147|NCT05442996|Antibodies|antibodies|mesh-list
101182148|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
101182149|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
101182150|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
101182151|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182153|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182154|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182155|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
101182156|NCT05439564|Morphine|morphine|mesh-list
101182157|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182158|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182159|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182160|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182161|NCT05439564|Analgesics|analgesics|mesh-ancestor
101182162|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
101182163|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182164|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101182165|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101182166|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101182167|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182168|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182169|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182170|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101182171|NCT05439564|Narcotics|narcotics|mesh-ancestor
101182172|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101182173|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182174|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182175|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182176|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101182177|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
101182178|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182179|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182180|NCT05266404|Incretins|incretins|mesh-ancestor
101182181|NCT05266404|Hormones|hormones|mesh-ancestor
101182182|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182183|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101182184|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
101182185|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182186|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182187|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101182188|NCT05122494|Capecitabine|capecitabine|mesh-list
101182189|NCT05122494|Lapatinib|lapatinib|mesh-list
101182190|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101182191|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
101182192|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182193|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182194|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182195|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182196|NCT05063604|Citalopram|citalopram|mesh-list
101182197|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101182198|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101182199|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182200|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182201|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182202|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
101182203|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182204|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101182205|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
101182206|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182207|NCT04978428|Cannabidiol|cannabidiol|mesh-list
101182208|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
101182209|NCT04780464|Prednisone|prednisone|mesh-list
101182210|NCT04780464|Prednisolone|prednisolone|mesh-list
101182211|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
101182212|NCT04780464|Doxorubicin|doxorubicin|mesh-list
101182213|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101182214|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101182215|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
101182216|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182217|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101182218|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101182219|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
101182220|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182221|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182223|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101182224|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101182225|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182226|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182227|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182228|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
101182229|NCT04780464|Hormones|hormones|mesh-ancestor
101182230|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182231|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101182232|NCT04495608|Fluconazole|fluconazole|mesh-list
101204371|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182233|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
101182234|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182235|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101182236|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182237|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182238|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182239|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101182240|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
101182241|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182242|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182243|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101182250|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182251|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182252|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182253|NCT03770130|Analgesics|analgesics|mesh-ancestor
101182254|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
101182255|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182256|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101182257|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101182258|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101182259|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182260|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182261|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182262|NCT05452434|Mirabegron|mirabegron|mesh-list
101182263|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
101182264|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101182265|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101182266|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182267|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182268|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182269|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182270|NCT05452434|Urological Agents|urological agents|mesh-ancestor
101182271|NCT05450328|Epoprostenol|epoprostenol|mesh-list
101182272|NCT05450328|Milrinone|milrinone|mesh-list
101182273|NCT05450328|Tezosentan|tezosentan|mesh-list
101182274|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101182275|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101182276|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
101182277|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101182278|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101182279|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182280|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182281|NCT05450328|Protective Agents|protective agents|mesh-ancestor
101182282|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182283|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101182284|NCT05448924|Hormones|hormones|mesh-list
101182285|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182286|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182287|NCT05447364|Pregabalin|pregabalin|mesh-list
101182288|NCT05447364|Analgesics|analgesics|mesh-ancestor
101182289|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
101182290|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182291|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182292|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
101182293|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101182295|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182296|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101182297|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101182298|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101182299|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182300|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182301|NCT05418036|Sotalol|sotalol|mesh-list
101182302|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101182303|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101182304|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182305|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182306|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182307|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182308|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101182309|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
101182310|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
101182311|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182312|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101182313|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101182314|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101182315|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182316|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182317|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182318|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182319|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101182320|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
101182321|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182322|NCT04727424|Budesonide|budesonide|mesh-list
101182323|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
101182324|NCT04727424|Fluoxetine|fluoxetine|mesh-list
101182325|NCT04727424|Maleic acid|maleic acid|mesh-list
101182326|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182327|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101182328|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
101182329|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182330|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182331|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101182332|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
101182333|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
101182334|NCT04727424|Hormones|hormones|mesh-ancestor
101182335|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182336|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182337|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182338|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101182339|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101182340|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182341|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182342|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
101182343|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101182344|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
101182345|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182346|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101182347|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182348|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101182349|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101182350|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182351|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101182352|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101182353|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
101182354|NCT04522206|Oxycodone|oxycodone|mesh-list
101182355|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101182356|NCT04522206|Narcotics|narcotics|mesh-ancestor
101182357|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182358|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182359|NCT04522206|Analgesics|analgesics|mesh-ancestor
101182360|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
101182361|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182362|NCT04505592|Tenecteplase|tenecteplase|mesh-list
101182363|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101182364|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101182365|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182366|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
101182367|NCT04415892|Capsaicin|capsaicin|mesh-list
101182368|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
101182369|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182370|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
101182371|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182372|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182373|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101182374|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182375|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101182376|NCT04415892|Protective Agents|protective agents|mesh-ancestor
101182377|NCT04176354|Letrozole|letrozole|mesh-list
101182378|NCT04176354|Palbociclib|palbociclib|mesh-list
101182379|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
101182380|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182381|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101182382|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182383|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182384|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101182385|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
101182386|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182387|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182388|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182389|NCT04128540|Fentanyl|fentanyl|mesh-list
101182390|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101182391|NCT04128540|Narcotics|narcotics|mesh-ancestor
101182392|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182394|NCT04128540|Analgesics|analgesics|mesh-ancestor
101182395|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
101182396|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182397|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101182398|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101182399|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
101182400|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
101182401|NCT04104438|Everolimus|everolimus|mesh-list
101182402|NCT04104438|Basiliximab|basiliximab|mesh-list
101182403|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101182404|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182405|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182406|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182407|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101182408|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
101182409|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182410|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182411|NCT03703206|Anesthetics|anesthetics|mesh-list
101182412|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
101182413|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182414|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182415|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
101182416|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182417|NCT03443856|Nivolumab|nivolumab|mesh-list
101182418|NCT03443856|Ipilimumab|ipilimumab|mesh-list
101182419|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182420|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182421|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101182422|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182423|NCT03086616|Irinotecan|irinotecan|mesh-list
101182424|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101182425|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182426|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182427|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182428|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182429|NCT02952924|Midazolam|midazolam|mesh-list
101182430|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101182431|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182432|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182433|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182434|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101182435|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101182436|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182437|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101182438|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
101182439|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
101182440|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
101182441|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
101182442|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182443|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182444|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
101182445|NCT02905578|Paclitaxel|paclitaxel|mesh-list
101182446|NCT02905578|Gemcitabine|gemcitabine|mesh-list
101182447|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101182448|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182449|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
101182450|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
101182451|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
101182452|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182453|NCT02905578|Vitamins|vitamins|mesh-ancestor
101182454|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
101182455|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182456|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101537356|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101537357|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101537358|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
101182457|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
101182458|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
101182459|NCT02905578|Protective Agents|protective agents|mesh-ancestor
101182460|NCT00677586|Liver Extracts|liver extracts|mesh-list
101182461|NCT00677586|Hematinics|hematinics|mesh-ancestor
101182462|NCT05453448|Tenofovir|tenofovir|mesh-list
101182463|NCT05453448|Entecavir|entecavir|mesh-list
101182464|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
101182465|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182466|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101182467|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101182468|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182469|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182471|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101182472|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
101182473|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182474|NCT05444478|Lenvatinib|lenvatinib|mesh-list
101182475|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182476|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182477|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182478|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182479|NCT05354466|Neostigmine|neostigmine|mesh-list
101182480|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101182481|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182482|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182483|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182484|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182485|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182487|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
101182488|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182489|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
101182490|NCT04095624|Narcotics|narcotics|mesh-ancestor
101182491|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182492|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182493|NCT04095624|Analgesics|analgesics|mesh-ancestor
101182494|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
101182495|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182496|NCT03745716|Azacitidine|azacitidine|mesh-list
101182497|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101182498|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
101182499|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182500|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182501|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182502|NCT03341676|Dexamethasone|dexamethasone|mesh-list
101182503|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182504|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
101182505|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
101182507|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182508|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182509|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
101182510|NCT03341676|Hormones|hormones|mesh-ancestor
101182511|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182512|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101182513|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182514|NCT03121716|Gemcitabine|gemcitabine|mesh-list
101182516|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101182517|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
101182518|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182519|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182520|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
101182521|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
101182522|NCT02714634|Methotrexate|methotrexate|mesh-list
101182523|NCT02714634|Leflunomide|leflunomide|mesh-list
101182524|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101182525|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
101182526|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101182527|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182528|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101182529|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
101182530|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182531|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182532|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182533|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182534|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101182535|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101182536|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
101182537|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101182538|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101182540|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101182541|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101182542|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182543|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101182544|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182545|NCT02714634|Analgesics|analgesics|mesh-ancestor
101182546|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
101182547|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182548|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182549|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182551|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
101182552|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
101182553|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182554|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182555|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182556|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101182557|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101182558|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182559|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182560|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101182561|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101182562|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182563|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182564|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182565|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
101182566|NCT00553800|Bevacizumab|bevacizumab|mesh-list
101182567|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101182568|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182569|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182570|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101182571|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101182572|NCT00553800|Growth Substances|growth substances|mesh-ancestor
101182573|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182574|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
101182575|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182576|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182577|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182579|NCT02747628|Nicotine|nicotine|mesh-list
101182580|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101182581|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
101182582|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182583|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182584|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101182585|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101182586|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182587|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182588|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182589|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
101182590|NCT02747628|Protective Agents|protective agents|mesh-ancestor
101182591|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182592|NCT02754570|Pilocarpine|pilocarpine|mesh-list
101182593|NCT02754570|Miotics|miotics|mesh-ancestor
101182594|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
101182595|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182596|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182597|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
101182598|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101182599|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182600|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182601|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182602|NCT02765256|Promethazine|promethazine|mesh-list
101182603|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
101182605|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
101182606|NCT02765256|Neomycin|neomycin|mesh-list
101182607|NCT02765256|Fluconazole|fluconazole|mesh-list
101182608|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
101182609|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101182610|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182611|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101182612|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182613|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182614|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182615|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182616|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101182617|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182618|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
101182619|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101182620|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101182621|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
101182622|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182623|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182624|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101182625|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101182626|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
101182627|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182628|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101182629|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
101182630|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
101182631|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182632|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101182633|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101182634|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182635|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182636|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
101182637|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
101182638|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
101182639|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182641|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
101182642|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182643|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101182644|NCT02765256|Laxatives|laxatives|mesh-ancestor
101182645|NCT02767128|Citric Acid|citric acid|mesh-list
101182646|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
101182647|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
101182648|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101182649|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
101182650|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
101182651|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182652|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
101182653|NCT02769702|Hormones|hormones|mesh-ancestor
101182654|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182655|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182656|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101182657|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182658|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101182659|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182660|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182661|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
101182662|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
101182663|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182664|NCT02773758|Fluorides|fluorides|mesh-list
101182665|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
101182666|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
101182667|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
101182668|NCT02773758|Protective Agents|protective agents|mesh-ancestor
101182669|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182671|NCT02774226|Vitamin E|vitamin e|mesh-list
101182672|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
101182673|NCT02774226|Antioxidants|antioxidants|mesh-list
101182674|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
101182675|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182676|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182677|NCT02774226|Protective Agents|protective agents|mesh-ancestor
101182678|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
101182679|NCT02775240|Maribavir|maribavir|mesh-list
101182680|NCT02775240|Digoxin|digoxin|mesh-list
101182681|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
101182682|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101182683|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101182684|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182685|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182686|NCT02775240|Protective Agents|protective agents|mesh-ancestor
101537359|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537360|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101182687|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182688|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
101182689|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
101182690|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101182691|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101182692|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182693|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
101182694|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182696|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182697|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
101182698|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101182699|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101182700|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101182701|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182703|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182704|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182705|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182706|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
101182707|NCT05348148|Cetirizine|cetirizine|mesh-list
101182708|NCT05348148|Phenylephrine|phenylephrine|mesh-list
101182709|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
101182710|NCT05348148|Levocetirizine|levocetirizine|mesh-list
101182711|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182712|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182713|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101182714|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
101182715|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101182716|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
101182717|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
101182718|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182719|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182720|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182721|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101182722|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101182723|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182724|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
101182725|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
101182726|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182727|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
101182728|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101182729|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
101182730|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101182732|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101182733|NCT05348148|Protective Agents|protective agents|mesh-ancestor
101182734|NCT05456022|Doxorubicin|doxorubicin|mesh-list
101182735|NCT05456022|Quercetin|quercetin|mesh-list
101182736|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101182737|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182738|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101182739|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182740|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182741|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182742|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
101182743|NCT05456022|Protective Agents|protective agents|mesh-ancestor
101182744|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182745|NCT05453916|Rifaximin|rifaximin|mesh-list
101182746|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
101182747|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101182748|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182749|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182750|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101182751|NCT05273814|Bevacizumab|bevacizumab|mesh-list
101182752|NCT05273814|Tislelizumab|tislelizumab|mesh-list
101182753|NCT05273814|Pemetrexed|pemetrexed|mesh-list
101182754|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
101182755|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182756|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182757|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101182758|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101182759|NCT05273814|Growth Substances|growth substances|mesh-ancestor
101182760|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182761|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
101182762|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182763|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182764|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101182765|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101182766|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
101182767|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101182768|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182769|NCT04784208|Hormones|hormones|mesh-list
101182770|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182771|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182772|NCT04024878|Nivolumab|nivolumab|mesh-list
101182773|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182774|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182775|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101182776|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182777|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
101182778|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101182779|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101182780|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101182781|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182782|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182783|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182784|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182785|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182786|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101182787|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182788|NCT02529930|Vaccines|vaccines|mesh-list
101182789|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
101182790|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182791|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
101182792|NCT00039780|Protective Agents|protective agents|mesh-ancestor
101182793|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182794|NCT04763226|Furosemide|furosemide|mesh-list
101182795|NCT04763226|Diuretics|diuretics|mesh-ancestor
101182796|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
101182797|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182798|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
101182799|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182800|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182801|NCT04549428|Atezolizumab|atezolizumab|mesh-list
101182802|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101182803|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182804|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182805|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182806|NCT04340856|Bisacodyl|bisacodyl|mesh-list
101182807|NCT04340856|Laxatives|laxatives|mesh-list
101182808|NCT04340856|Cathartics|cathartics|mesh-ancestor
101182809|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101182810|NCT04040790|Phenylephrine|phenylephrine|mesh-list
101182811|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
101182812|NCT04040790|Tropicamide|tropicamide|mesh-list
101182814|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
101182816|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182817|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182818|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
101182819|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101182820|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
101182821|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
101182822|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101182823|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101182824|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101182825|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
101182826|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182828|NCT04040790|Protective Agents|protective agents|mesh-ancestor
101182829|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101182830|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101182831|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182832|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101182833|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101182834|NCT03556800|Estradiol|estradiol|mesh-list
101182835|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101182836|NCT03556800|Estrogens|estrogens|mesh-ancestor
101182837|NCT03556800|Hormones|hormones|mesh-ancestor
101182838|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182839|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182840|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101182841|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
101182842|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101182843|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101182844|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
101182845|NCT04741620|Capsaicin|capsaicin|mesh-list
101182846|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
101182847|NCT04741620|Citric Acid|citric acid|mesh-list
101182848|NCT04741620|Piperine|piperine|mesh-list
101182849|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
101182850|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182851|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
101182852|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182853|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182854|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
101182855|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101182856|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
101182858|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182859|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182860|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182861|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101182862|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182863|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
101182864|NCT04741620|Protective Agents|protective agents|mesh-ancestor
101182865|NCT01785420|Trastuzumab|trastuzumab|mesh-list
101182866|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101182867|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182868|NCT00800514|Amantadine|amantadine|mesh-list
101182869|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101182870|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101182871|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
101182872|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182873|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
101182874|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182875|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182876|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182877|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182879|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
101182880|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182881|NCT02780622|Oseltamivir|oseltamivir|mesh-list
101182882|NCT02780622|Warfarin|warfarin|mesh-list
101182883|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
101182884|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
101182885|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182886|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182887|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182888|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
101182889|NCT02791308|Tacrolimus|tacrolimus|mesh-list
101182890|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101182891|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101182893|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
101182894|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182895|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182896|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182897|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101182898|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
101182899|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101182900|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
101182902|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182903|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182905|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182906|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182908|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101182909|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101182910|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101182911|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101182912|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182913|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182914|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182915|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101182916|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101182917|NCT02813070|Flutemetamol|flutemetamol|mesh-list
101182918|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101182919|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182920|NCT02815644|Empagliflozin|empagliflozin|mesh-list
101182921|NCT02815644|Linagliptin|linagliptin|mesh-list
101182922|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101182923|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182924|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101182925|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182926|NCT02815644|Incretins|incretins|mesh-ancestor
101182927|NCT02815644|Hormones|hormones|mesh-ancestor
101182928|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182929|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101182930|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
101182931|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101182932|NCT02820324|Morphine|morphine|mesh-list
101182933|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101182934|NCT02820324|Narcotics|narcotics|mesh-ancestor
101182936|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182937|NCT02820324|Analgesics|analgesics|mesh-ancestor
101182938|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
101182939|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182940|NCT02821338|Lamotrigine|lamotrigine|mesh-list
101182941|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
101182942|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101182943|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182944|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182945|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101182946|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182947|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101182948|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101182949|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182950|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101182951|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101182953|NCT02835846|Hormones|hormones|mesh-ancestor
101182954|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182955|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182956|NCT02844582|Prednisone|prednisone|mesh-list
101182957|NCT02844582|Cortisone|cortisone|mesh-list
101182958|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101182959|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
101182960|NCT02844582|Hormones|hormones|mesh-ancestor
101182961|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101182962|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182963|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101182964|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101182965|NCT02845752|Bromides|bromides|mesh-list
101182966|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
101182967|NCT02845752|Olodaterol|olodaterol|mesh-list
101182968|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101182969|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
101182970|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182971|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182972|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101182973|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
101182975|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101182976|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
101182977|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182978|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182980|NCT02849184|Suvorexant|suvorexant|mesh-list
101182981|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101182982|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101182983|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182984|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182985|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101182986|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101182987|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101182988|NCT02862912|Fentanyl|fentanyl|mesh-list
101182989|NCT02862912|Bupivacaine|bupivacaine|mesh-list
101182990|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
101182991|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
101182992|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
101182993|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101182994|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182995|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
101182996|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101182997|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101182998|NCT02862912|Narcotics|narcotics|mesh-ancestor
101182999|NCT02862912|Analgesics|analgesics|mesh-ancestor
101183000|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101183001|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183002|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
101183003|NCT02864706|Cyclosporine|cyclosporine|mesh-list
101183004|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
101183005|NCT02864706|Everolimus|everolimus|mesh-list
101183006|NCT02864706|Cyclosporins|cyclosporins|mesh-list
101183007|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183008|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183009|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183010|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
101183011|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183012|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
101183013|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183014|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183015|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183017|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101183018|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101183019|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183020|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101183021|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101183022|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
101183023|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183024|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
101183025|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101183026|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183027|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
101183028|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183029|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
101183030|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183031|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183032|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
101183033|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
101183034|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183035|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101183036|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101183037|NCT02880228|Dexamethasone|dexamethasone|mesh-list
101183038|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
101183039|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
101183040|NCT02880228|Lenalidomide|lenalidomide|mesh-list
101183041|NCT02880228|Ichthammol|ichthammol|mesh-list
101183042|NCT02880228|BB 1101|bb 1101|mesh-list
101183043|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183044|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
101183045|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
101183046|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183047|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183048|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183049|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
101183050|NCT02880228|Hormones|hormones|mesh-ancestor
101183051|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183052|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183053|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183054|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101183055|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101183056|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183057|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
101183058|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101183059|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101183060|NCT02880228|Growth Substances|growth substances|mesh-ancestor
101183061|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
101183062|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183063|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183064|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183065|NCT02880852|Belimumab|belimumab|mesh-list
101183066|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183067|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
101183068|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183069|NCT02887404|Analgesics|analgesics|mesh-list
101183070|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
101183071|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183072|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183073|NCT02889510|Liraglutide|liraglutide|mesh-list
101183074|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101183075|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183076|NCT02889510|Incretins|incretins|mesh-ancestor
101183077|NCT02889510|Hormones|hormones|mesh-ancestor
101183078|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183079|NCT02902770|Ketorolac|ketorolac|mesh-list
101183080|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
101183081|NCT02902770|Lidocaine|lidocaine|mesh-list
101183082|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183083|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
101183084|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183085|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183086|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
101183087|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183088|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183089|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101183090|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183091|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183092|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183093|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101183094|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183096|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183097|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183098|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101183099|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183100|NCT02907918|Trastuzumab|trastuzumab|mesh-list
101183101|NCT02907918|Letrozole|letrozole|mesh-list
101183102|NCT02907918|Palbociclib|palbociclib|mesh-list
101183103|NCT02907918|Goserelin|goserelin|mesh-list
101183104|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101183105|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183106|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101183107|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101183108|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183109|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183111|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
101183112|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183113|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183114|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101183115|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183117|NCT02908620|Tetracaine|tetracaine|mesh-list
101183118|NCT02908620|Benzocaine|benzocaine|mesh-list
101183119|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183120|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183121|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183122|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
101183123|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183124|NCT02911818|Liraglutide|liraglutide|mesh-list
101183125|NCT02911818|Phentermine|phentermine|mesh-list
101183126|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101183127|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183128|NCT02911818|Incretins|incretins|mesh-ancestor
101183129|NCT02911818|Hormones|hormones|mesh-ancestor
101183130|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183131|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101183132|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
101183133|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
101183134|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
101183135|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
101183136|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183137|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183138|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183139|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183140|NCT02912364|Carbamazepine|carbamazepine|mesh-list
101183141|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
101183142|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
101183143|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
101183144|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101183145|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183146|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183147|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183148|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183149|NCT02912364|Analgesics|analgesics|mesh-ancestor
101183150|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
101183151|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183152|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183153|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183154|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183155|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101183156|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101183157|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101183158|NCT02913924|Clonazepam|clonazepam|mesh-list
101183159|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
101183160|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
101183161|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
101183162|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183163|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183165|NCT02917122|Sertraline|sertraline|mesh-list
101183166|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
101183167|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183168|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101183169|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101183170|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183171|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183172|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183173|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
101183174|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183175|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
101183176|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101183177|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101183178|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183179|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
101183180|NCT02922582|Coagulants|coagulants|mesh-ancestor
101183181|NCT02925858|Ketamine|ketamine|mesh-list
101183182|NCT02925858|Analgesics|analgesics|mesh-ancestor
101183183|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
101183184|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183185|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183186|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101183187|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183188|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
101183191|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101183192|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101183193|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183194|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183196|NCT02933034|Trace Elements|trace elements|mesh-ancestor
101183197|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
101183198|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183199|NCT02937168|Reslizumab|reslizumab|mesh-list
101183200|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101183202|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183203|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101183204|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
101183205|NCT02937558|Glucagon|glucagon|mesh-list
101183206|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101183207|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183208|NCT02937558|Hormones|hormones|mesh-ancestor
101183209|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183210|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183211|NCT02937558|Incretins|incretins|mesh-ancestor
101183212|NCT02938494|Tazarotene|tazarotene|mesh-list
101183213|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183214|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
101183215|NCT02941692|Oxytocin|oxytocin|mesh-list
101183216|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
101183217|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183218|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183219|NCT02953860|Fulvestrant|fulvestrant|mesh-list
101183220|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183221|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183222|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101183223|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101183224|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
101183225|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183226|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183227|NCT02956044|Metformin|metformin|mesh-list
101183228|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101183229|NCT02956044|Glimepiride|glimepiride|mesh-list
101183230|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
101183231|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101183232|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183233|NCT02956044|Incretins|incretins|mesh-ancestor
101183234|NCT02956044|Hormones|hormones|mesh-ancestor
101183235|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183236|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101183237|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183238|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183239|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183240|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183242|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
101183243|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
101183244|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101183245|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101183246|NCT02956122|Prednisolone|prednisolone|mesh-list
101183247|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
101183248|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101183249|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
101183250|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
101183251|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
101183252|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183253|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
101183254|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
101183255|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183256|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183257|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183258|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
101183259|NCT02956122|Hormones|hormones|mesh-ancestor
101183260|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183263|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183264|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183265|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183266|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183267|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101183268|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101183270|NCT02956746|Antibodies|antibodies|mesh-list
101183271|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
101183272|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101183273|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101183274|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
101183275|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183276|NCT02967354|Tryptophan|tryptophan|mesh-list
101183277|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101183278|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101183279|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
101183280|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183281|NCT02968134|Posaconazole|posaconazole|mesh-list
101183282|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
101183283|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183284|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101183285|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101183286|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101183287|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101183288|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101183289|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183290|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183291|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101183292|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
101183293|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183294|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183295|NCT02968368|Ferric maltol|ferric maltol|mesh-list
101183296|NCT02968368|Hematinics|hematinics|mesh-ancestor
101183297|NCT02968914|Benralizumab|benralizumab|mesh-list
101183298|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101183299|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
101183300|NCT02970162|Amifampridine|amifampridine|mesh-list
101183301|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101183302|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183303|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183304|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101183305|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183306|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183308|NCT02970552|Progestins|progestins|mesh-ancestor
101183309|NCT02970552|Hormones|hormones|mesh-ancestor
101183310|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183311|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183312|NCT02978508|Permethrin|permethrin|mesh-list
101183313|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183314|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183315|NCT02881008|Entecavir|entecavir|mesh-list
101183316|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
101183317|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183318|NCT02988882|Dexamethasone|dexamethasone|mesh-list
101183319|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183320|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
101183321|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
101183322|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183323|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183324|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183325|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
101183326|NCT02988882|Hormones|hormones|mesh-ancestor
101183327|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183328|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183329|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183330|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
101183331|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
101183332|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101183333|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183334|NCT03009162|Lasmiditan|lasmiditan|mesh-list
101183335|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101183336|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
101183337|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183338|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183339|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183340|NCT03009396|Clarithromycin|clarithromycin|mesh-list
101183341|NCT03009396|Rifabutin|rifabutin|mesh-list
101183342|NCT03009396|Clofazimine|clofazimine|mesh-list
101183343|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183344|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183345|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101183346|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183347|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183348|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101183349|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101183350|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101183351|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
101183352|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183353|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
101183354|NCT03012594|Lanreotide|lanreotide|mesh-list
101183355|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183356|NCT03017508|Riluzole|riluzole|mesh-list
101183357|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
101183359|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101183360|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183361|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183362|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183363|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101183364|NCT03017508|Protective Agents|protective agents|mesh-ancestor
101183365|NCT03020004|Ritonavir|ritonavir|mesh-list
101183366|NCT03020004|Ribavirin|ribavirin|mesh-list
101183367|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101183368|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101183369|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101183370|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183371|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183372|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183373|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101183374|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101183375|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
101183376|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183377|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101183378|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101183379|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
101183380|NCT03020082|Ritonavir|ritonavir|mesh-list
101183381|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101183382|NCT03020082|Ribavirin|ribavirin|mesh-list
101183383|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101183384|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101183385|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183386|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183387|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183388|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101183389|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101183390|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
101183391|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183392|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101183393|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101183394|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
101183395|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
101183396|NCT03026556|Apixaban|apixaban|mesh-list
101183397|NCT03026556|Dabigatran|dabigatran|mesh-list
101183398|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101183399|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
101183400|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101183401|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183402|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183403|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183404|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
101183405|NCT03035760|Oxfendazole|oxfendazole|mesh-list
101183406|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
101183407|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101183408|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183409|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
101183410|NCT03036384|Sufentanil|sufentanil|mesh-list
101183411|NCT03036384|Morphine|morphine|mesh-list
101183413|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101183414|NCT03036384|Narcotics|narcotics|mesh-ancestor
101183415|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183416|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183417|NCT03036384|Analgesics|analgesics|mesh-ancestor
101183418|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
101183419|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183420|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101183421|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183422|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
101183423|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
101183424|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183425|NCT03040362|Lasmiditan|lasmiditan|mesh-list
101183426|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101183427|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
101183428|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183429|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183430|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183431|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101183432|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
101183433|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
101183434|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183435|NCT03044418|Propofol|propofol|mesh-list
101183436|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
101183437|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183438|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183439|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101183440|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183441|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
101183442|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
101183443|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
101183444|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
101183445|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183446|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
101183447|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101183448|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183449|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101183450|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183451|NCT03057132|Protective Agents|protective agents|mesh-list
101183452|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183453|NCT03057366|Paclitaxel|paclitaxel|mesh-list
101183454|NCT03057366|Docetaxel|docetaxel|mesh-list
101183455|NCT03057366|Carboplatin|carboplatin|mesh-list
101183456|NCT03057366|Pevonedistat|pevonedistat|mesh-list
101183457|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101183458|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183459|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
101183460|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
101183461|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
101183462|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183463|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183464|NCT03060486|Hybenx|hybenx|mesh-list
101183465|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
101183466|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
101183467|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183468|NCT03061812|Dexamethasone|dexamethasone|mesh-list
101183469|NCT03061812|Topotecan|topotecan|mesh-list
101183470|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
101183471|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183472|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
101183474|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183475|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183476|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183479|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183480|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101183481|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183482|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101183483|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101183484|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183485|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183487|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
101183488|NCT03070470|Ritonavir|ritonavir|mesh-list
101183489|NCT03070470|Lopinavir|lopinavir|mesh-list
101183490|NCT03070470|Chloroquine|chloroquine|mesh-list
101183491|NCT03070470|Verapamil|verapamil|mesh-list
101183492|NCT03070470|Dofetilide|dofetilide|mesh-list
101183493|NCT03070470|Diltiazem|diltiazem|mesh-list
101183494|NCT03070470|Ranolazine|ranolazine|mesh-list
101183495|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101183496|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101183497|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
101183498|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183499|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183500|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101183501|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101183502|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
101183503|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183504|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101183505|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101183506|NCT03070470|Amebicides|amebicides|mesh-ancestor
101183507|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101183508|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101183509|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
101183510|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183511|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183512|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183513|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101183514|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183515|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101183516|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
101183517|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101183518|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183519|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101183520|NCT03070548|Talazoparib|talazoparib|mesh-list
101183521|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101183522|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183523|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183524|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183526|NCT03080142|Ropivacaine|ropivacaine|mesh-list
101183527|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183528|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
101183529|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183530|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183531|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
101183532|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183533|NCT03088800|Ibuprofen|ibuprofen|mesh-list
101183534|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101183535|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183536|NCT03088800|Analgesics|analgesics|mesh-ancestor
101183537|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
101183538|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183539|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183540|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183541|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183542|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101537361|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101183543|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183544|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183546|NCT03096444|Ketamine|ketamine|mesh-list
101183547|NCT03096444|Amitriptyline|amitriptyline|mesh-list
101183548|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183549|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
101183550|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183551|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183553|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183554|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183555|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101183557|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183558|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183559|NCT03096444|Analgesics|analgesics|mesh-ancestor
101183560|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101183561|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183562|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
101183563|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101183564|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101183565|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183566|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101183567|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
101183568|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183569|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183570|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101183571|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101183572|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183574|NCT03107754|Anesthetics|anesthetics|mesh-list
101183575|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183576|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183577|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183578|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
101183579|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183580|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183581|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101183582|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183583|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183584|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183585|NCT03124758|Chrysarobin|chrysarobin|mesh-list
101183586|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101183587|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183588|NCT03124758|Analgesics|analgesics|mesh-ancestor
101183589|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
101183590|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183591|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183592|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183593|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183594|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
101183595|NCT03148236|Vitamins|vitamins|mesh-ancestor
101183596|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
101183597|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183598|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
101183599|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183600|NCT03148236|Protective Agents|protective agents|mesh-ancestor
101183601|NCT03174366|Denosumab|denosumab|mesh-list
101183602|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101183603|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183604|NCT03177798|Icatibant|icatibant|mesh-list
101183606|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183607|NCT03177798|Analgesics|analgesics|mesh-ancestor
101183608|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
101183609|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183610|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183611|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183612|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183613|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101183614|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101183615|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183616|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101183617|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183618|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
101183619|NCT05093790|Aspirin|aspirin|mesh-list
101183620|NCT05093790|Ticagrelor|ticagrelor|mesh-list
101183621|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101183622|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183623|NCT05093790|Analgesics|analgesics|mesh-ancestor
101183624|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
101183625|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183626|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183627|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183628|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183629|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101183630|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101183631|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183632|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101183633|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101183634|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183635|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
101183636|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101183637|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101183638|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101183639|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
101183640|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183641|NCT04933344|Daptomycin|daptomycin|mesh-list
101183642|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183643|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183644|NCT05406180|Vaccines|vaccines|mesh-list
101183645|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
101183646|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183647|NCT05405478|Omalizumab|omalizumab|mesh-list
101183648|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101183649|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101183650|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
101183651|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
101183652|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183653|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183654|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
101183655|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183656|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
101183657|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
101183658|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183659|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183660|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101183661|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101183663|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101183664|NCT03137160|Ixekizumab|ixekizumab|mesh-list
101183665|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183666|NCT02856126|Sorafenib|sorafenib|mesh-list
101183667|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183668|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101183669|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183670|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183671|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
101183672|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101183673|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101183674|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101183675|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183676|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183677|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
101183678|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183679|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183680|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101183681|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183682|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
101183683|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101183684|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183685|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101183686|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
101183687|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183688|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183689|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183690|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183691|NCT04426500|Bupivacaine|bupivacaine|mesh-list
101183692|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183693|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
101183694|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183695|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183696|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
101183697|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183698|NCT04131192|Gemcitabine|gemcitabine|mesh-list
101183699|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101183700|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
101183701|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183703|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
101183704|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183705|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183706|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
101183707|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
101183708|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101183709|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
101183710|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183711|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
101183712|NCT03883074|Protective Agents|protective agents|mesh-ancestor
101183713|NCT03883074|Antacids|antacids|mesh-ancestor
101183714|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183715|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183716|NCT03670836|Misoprostol|misoprostol|mesh-list
101183717|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101183718|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
101183719|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183720|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183721|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101183722|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101183723|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
101183724|NCT03607656|Docetaxel|docetaxel|mesh-list
101183725|NCT03607656|Capecitabine|capecitabine|mesh-list
101183726|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
101183727|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183728|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
101183729|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
101183730|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
101183731|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183732|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101183733|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
101183734|NCT03409614|Cemiplimab|cemiplimab|mesh-list
101183735|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101183736|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183737|NCT02651844|Mifepristone|mifepristone|mesh-list
101183738|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
101183739|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
101183740|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183741|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183742|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101183743|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101183744|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101183745|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
101183746|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101183747|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101183748|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
101183749|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183750|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
101183751|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101183752|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101183753|NCT01463670|Lenalidomide|lenalidomide|mesh-list
101183754|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
101183755|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183756|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101183757|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101183758|NCT01463670|Growth Substances|growth substances|mesh-ancestor
101183759|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
101183760|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101183761|NCT00151398|Donepezil|donepezil|mesh-list
101183762|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101183763|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183764|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183765|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
101183766|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183767|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183768|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
101183769|NCT03181308|Nivolumab|nivolumab|mesh-list
101183770|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101183772|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101183773|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183774|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
101183775|NCT03202134|Anesthetics|anesthetics|mesh-list
101183776|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183777|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183778|NCT03202134|Narcotics|narcotics|mesh-ancestor
101183779|NCT03202134|Analgesics|analgesics|mesh-ancestor
101183780|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
101183781|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183782|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
101183783|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
101183784|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183785|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101183786|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101183787|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183788|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183790|NCT03218592|Emtricitabine|emtricitabine|mesh-list
101183791|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101183792|NCT03218592|Dolutegravir|dolutegravir|mesh-list
101183793|NCT03218592|Maraviroc|maraviroc|mesh-list
101183794|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
101183795|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183796|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101183797|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101183798|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183799|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183800|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101183801|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101183802|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
101183803|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101183804|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101183805|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101183806|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101183807|NCT03219294|Bromides|bromides|mesh-list
101183808|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
101183809|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
101183810|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101183811|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101183812|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101183813|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183814|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183815|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101183816|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101183817|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
101183818|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183819|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183821|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101183822|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183823|NCT03223272|Reserpine|reserpine|mesh-list
101183824|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101183825|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101183826|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101183827|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183828|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183829|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183830|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101183831|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101183832|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183833|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183834|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183835|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183836|NCT03239106|Apremilast|apremilast|mesh-list
101183837|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101183838|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183839|NCT03239106|Analgesics|analgesics|mesh-ancestor
101183840|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
101183841|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183842|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183843|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101183844|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101183845|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101183846|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101183847|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183848|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183849|NCT03257202|Clindamycin|clindamycin|mesh-list
101183850|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
101183851|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
101183852|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
101183853|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183854|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183855|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101183856|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101183857|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183858|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183859|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101183860|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
101183861|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183862|NCT03278886|Naltrexone|naltrexone|mesh-list
101183863|NCT03278886|Nalmefene|nalmefene|mesh-list
101183864|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101183865|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101183866|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183867|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
101183868|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183869|NCT03285984|Listerine|listerine|mesh-list
101183870|NCT03285984|Fluorides|fluorides|mesh-list
101183871|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
101183872|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
101183873|NCT03285984|Protective Agents|protective agents|mesh-ancestor
101183874|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183875|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101183876|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183877|NCT03287310|Albuterol|albuterol|mesh-list
101183878|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101183879|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
101183880|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183881|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183882|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101183883|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
101183884|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
101183885|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101183886|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101183887|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101183888|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101183889|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183890|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183891|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183892|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101183893|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101183894|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101183895|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183896|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183897|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101183898|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183899|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183900|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
101183901|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183902|NCT03315780|Dulaglutide|dulaglutide|mesh-list
101183903|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101183904|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183905|NCT03334734|Isoniazid|isoniazid|mesh-list
101183906|NCT03334734|Macozinone|macozinone|mesh-list
101183907|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
101183908|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183909|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183910|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101183911|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101183912|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
101183913|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183914|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101183915|NCT03336450|Midazolam|midazolam|mesh-list
101183916|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101183917|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101183918|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183919|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183920|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101183921|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101183922|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101183923|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101183924|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
101183925|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
101183926|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
101183927|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
101183928|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183929|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183930|NCT03340350|Minocycline|minocycline|mesh-list
101183931|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101183932|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101183933|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
101183934|NCT03341910|Tazarotene|tazarotene|mesh-list
101183935|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
101183936|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
101183937|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
101183938|NCT03341910|Vitamins|vitamins|mesh-ancestor
101183939|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
101183940|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183941|NCT03343080|Lidocaine|lidocaine|mesh-list
101183942|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
101183943|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
101183944|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183945|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183946|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
101183947|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183948|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101183949|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101183950|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101183951|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101183952|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183954|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101183955|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
101183956|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
101183957|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183958|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183959|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183960|NCT03375294|Analgesics|analgesics|mesh-ancestor
101183961|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
101183962|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183963|NCT03395808|Tramadol|tramadol|mesh-list
101183964|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101183965|NCT03395808|Narcotics|narcotics|mesh-ancestor
101183966|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183967|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183968|NCT03395808|Analgesics|analgesics|mesh-ancestor
101183969|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
101183970|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183971|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
101183972|NCT03395886|Remifentanil|remifentanil|mesh-list
101183973|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101183974|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183975|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183976|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101183977|NCT03395886|Analgesics|analgesics|mesh-ancestor
101183978|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
101183979|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101183980|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101183981|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101183982|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101183983|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101183984|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101183985|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183986|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101183987|NCT03395886|Narcotics|narcotics|mesh-ancestor
101183988|NCT03426228|Progesterone|progesterone|mesh-list
101183989|NCT03426228|Estrogens|estrogens|mesh-list
101183990|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183991|NCT03426228|Hormones|hormones|mesh-ancestor
101183992|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183993|NCT03426228|Progestins|progestins|mesh-ancestor
101183994|NCT03430050|Progesterone|progesterone|mesh-list
101183995|NCT03430050|Progestins|progestins|mesh-ancestor
101183996|NCT03430050|Hormones|hormones|mesh-ancestor
101183997|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101183998|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537365|NCT00590603|Bortezomib|bortezomib|mesh-list
101537366|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
101537367|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537368|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
101537369|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101183999|NCT03440424|Lemborexant|lemborexant|mesh-list
101184000|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
101184001|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184002|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184003|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101184004|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101184005|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184006|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184007|NCT03448068|Ketamine|ketamine|mesh-list
101184008|NCT03448068|Analgesics|analgesics|mesh-ancestor
101184009|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
101184010|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184011|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184012|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101184013|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101184014|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
101184015|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
101184016|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184017|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101184018|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101184019|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184020|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184021|NCT03453060|Thrombin|thrombin|mesh-list
101184022|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
101184023|NCT03453060|Coagulants|coagulants|mesh-ancestor
101184024|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
101184025|NCT03459612|Promethazine|promethazine|mesh-list
101184026|NCT03459612|Lasmiditan|lasmiditan|mesh-list
101184027|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101184028|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101184029|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184030|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184031|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184032|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
101184033|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
101184034|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184035|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
101184036|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
101184037|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184038|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101184039|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
101184040|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
101184041|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184042|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184043|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101184044|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
101184045|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184046|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101184047|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
101184048|NCT03463512|Racecadotril|racecadotril|mesh-list
101184049|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
101184050|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184051|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
101184052|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184053|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184054|NCT03473184|Diacerein|diacerein|mesh-list
101184055|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184057|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184058|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101184059|NCT03496974|Antibodies|antibodies|mesh-list
101184060|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
101184061|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101184062|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
101184063|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184064|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184065|NCT03503292|Ondansetron|ondansetron|mesh-list
101184066|NCT03503292|Granisetron|granisetron|mesh-list
101184067|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
101184068|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
101184069|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184070|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184071|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184072|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
101184073|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184074|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101184075|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101184077|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184078|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184079|NCT03506724|Labetalol|labetalol|mesh-list
101184080|NCT03506724|Nifedipine|nifedipine|mesh-list
101184081|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101184082|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184083|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184084|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101184085|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184086|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
101184087|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
101184088|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184089|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101184090|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101184091|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184092|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184093|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184094|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
101184095|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
101184096|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184097|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101184098|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101184100|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
101184101|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
101184102|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184103|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184104|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184105|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
101184106|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101184107|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184108|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
101184109|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184110|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
101184111|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
101184112|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
101184113|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184114|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101184115|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101184117|NCT03541356|Levodopa|levodopa|mesh-list
101184118|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
101184119|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101184120|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101184121|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
101184122|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184123|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184124|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184125|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101184126|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184127|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
101184128|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184129|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184130|NCT03572478|Nivolumab|nivolumab|mesh-list
101184131|NCT03572478|Rucaparib|rucaparib|mesh-list
101184132|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101184133|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184134|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101184135|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184136|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101184137|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184140|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184141|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184142|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
101184143|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184144|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101184145|NCT03593538|Metformin|metformin|mesh-list
101184146|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184147|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184148|NCT03610464|Amphetamine|amphetamine|mesh-list
101184149|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101184150|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184151|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
101184152|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
101184153|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184154|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
101184155|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184157|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184158|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101184159|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101184160|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184161|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101184164|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101184165|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
101184166|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184167|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101184168|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
101184169|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
101184170|NCT03615534|Vitamins|vitamins|mesh-ancestor
101184171|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
101184172|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184173|NCT03630198|Lidocaine|lidocaine|mesh-list
101184174|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184175|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
101184176|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184177|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184178|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
101184179|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184180|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101184181|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101184182|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101184183|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184184|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184185|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101184186|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101184187|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184188|NCT03655080|Paclitaxel|paclitaxel|mesh-list
101184189|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101184190|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101184191|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184192|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
101184193|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
101184194|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
101184195|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184196|NCT03674970|Nicotine|nicotine|mesh-list
101184197|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101184198|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
101184199|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184200|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184201|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101184202|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101184203|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184204|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184205|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184206|NCT03704376|Clonidine|clonidine|mesh-list
101184207|NCT03704376|Ropivacaine|ropivacaine|mesh-list
101184208|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184209|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
101184210|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184211|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184212|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
101184213|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184214|NCT03704376|Analgesics|analgesics|mesh-ancestor
101184215|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184216|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
101184217|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
101184218|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101184219|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101184220|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101184221|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184222|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184223|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184225|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
101184226|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184227|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184229|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
101184230|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184231|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
101184232|NCT03889158|Vaccines|vaccines|mesh-list
101184233|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
101184234|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184235|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
101184236|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184237|NCT03889158|Protective Agents|protective agents|mesh-ancestor
101184238|NCT03889158|Vitamins|vitamins|mesh-ancestor
101184239|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
101184240|NCT04138758|Bromides|bromides|mesh-list
101184241|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
101184242|NCT04138758|Olodaterol|olodaterol|mesh-list
101184243|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101184244|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
101184245|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184246|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184247|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101184248|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
101184249|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
101184250|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101184251|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184252|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184253|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184254|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
101184255|NCT04323852|Vitamin D|vitamin d|mesh-list
101184256|NCT04323852|Vitamins|vitamins|mesh-ancestor
101184257|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
101184258|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184259|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101184260|NCT04420572|Betamethasone|betamethasone|mesh-list
101184261|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184262|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
101184263|NCT04420572|Hormones|hormones|mesh-ancestor
101184264|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184265|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184266|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101184267|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
101184268|NCT03541980|Acetaminophen|acetaminophen|mesh-list
101184269|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184270|NCT03541980|Analgesics|analgesics|mesh-ancestor
101184271|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
101184272|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184273|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184274|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
101184275|NCT04511520|Trimetazidine|trimetazidine|mesh-list
101184276|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
101184277|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
101184278|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184279|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
101184280|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184281|NCT04335552|Azithromycin|azithromycin|mesh-list
101184282|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
101184283|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184284|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184285|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
101184286|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101184287|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101184288|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184289|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184290|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184291|NCT04284930|Bupivacaine|bupivacaine|mesh-list
101184292|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184293|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
101184294|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184295|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184296|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
101184297|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184298|NCT04267770|Insulin|insulin|mesh-list
101184299|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101184300|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184301|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184303|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
101184304|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
101184305|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184306|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
101184307|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184308|NCT04204200|Protective Agents|protective agents|mesh-ancestor
101184309|NCT04179474|Erenumab|erenumab|mesh-list
101184310|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101184311|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184312|NCT04179474|Analgesics|analgesics|mesh-ancestor
101184313|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
101184314|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184315|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184316|NCT04150224|Macozinone|macozinone|mesh-list
101184317|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
101184318|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184319|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184320|NCT04112160|Ketorolac|ketorolac|mesh-list
101184321|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101184322|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184323|NCT04112160|Analgesics|analgesics|mesh-ancestor
101184324|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
101184325|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184326|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184327|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184328|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184329|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101184330|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184331|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184332|NCT04102956|Kallikreins|kallikreins|mesh-list
101184333|NCT04102956|Coagulants|coagulants|mesh-ancestor
101184334|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
101184335|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
101184336|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184337|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184338|NCT04053270|Afamelanotide|afamelanotide|mesh-list
101184339|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184340|NCT03976752|Tenofovir|tenofovir|mesh-list
101184341|NCT03976752|Emtricitabine|emtricitabine|mesh-list
101184342|NCT03976752|Cobicistat|cobicistat|mesh-list
101184343|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
101184344|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101184345|NCT03976752|Elvitegravir|elvitegravir|mesh-list
101184346|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
101184347|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184348|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101184349|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101184350|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184351|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184352|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101184353|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101184354|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101184355|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101184356|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101184357|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
101184358|NCT03962634|Tetracaine|tetracaine|mesh-list
101184359|NCT03962634|Carticaine|carticaine|mesh-list
101184360|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184361|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
101184362|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184363|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184364|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
101184365|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184366|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101184367|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101184368|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184369|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184370|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184372|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
101184373|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
101184374|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101184375|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
101184376|NCT03933774|Tretinoin|tretinoin|mesh-list
101184377|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184378|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
101537370|NCT00590603|Protective Agents|protective agents|mesh-ancestor
101184379|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184380|NCT03933618|Anastrozole|anastrozole|mesh-list
101184381|NCT03933618|Clomiphene|clomiphene|mesh-list
101184382|NCT03933618|Enclomiphene|enclomiphene|mesh-list
101184383|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
101184384|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184385|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101184386|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184387|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101184388|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101184389|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184390|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101184391|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
101184392|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184393|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184396|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184397|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101184398|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101184399|NCT03930264|Azathioprine|azathioprine|mesh-list
101184400|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
101184401|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184402|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184403|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184404|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184405|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
101184406|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184407|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184408|NCT03861000|BPN14770|bpn14770|mesh-list
101184409|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
101184410|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101184411|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184412|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184413|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101184414|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101184415|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
101184416|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101184417|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101184418|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184420|NCT03856164|Coagulants|coagulants|mesh-ancestor
101184421|NCT03849690|Esomeprazole|esomeprazole|mesh-list
101184422|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101184423|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184424|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101184425|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184426|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184427|NCT03822078|Denosumab|denosumab|mesh-list
101184428|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101184429|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184430|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
101184431|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101184432|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101184433|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184434|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
101184435|NCT03806556|Coagulants|coagulants|mesh-ancestor
101184436|NCT03812328|Enoxaparin|enoxaparin|mesh-list
101184437|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
101184438|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101184439|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101184440|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184441|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
101184442|NCT03805386|Narcotics|narcotics|mesh-ancestor
101184443|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184444|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184445|NCT03805386|Analgesics|analgesics|mesh-ancestor
101184446|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
101184448|NCT03796260|Entrectinib|entrectinib|mesh-list
101184449|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184450|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184451|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184453|NCT03796182|Abrocitinib|abrocitinib|mesh-list
101184454|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184455|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184456|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184457|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184458|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184459|NCT03730116|Bisoprolol|bisoprolol|mesh-list
101184460|NCT03730116|Perindopril|perindopril|mesh-list
101184461|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184462|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
101184463|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
101184464|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184465|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184466|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101184467|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101184468|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101184469|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184470|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184471|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184472|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101184473|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
101184474|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184475|NCT03370536|Ibutilide|ibutilide|mesh-list
101184476|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101184477|NCT03161964|Propranolol|propranolol|mesh-list
101184478|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101184479|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101184480|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184481|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184482|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184483|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184484|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101184485|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184486|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
101184487|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
101184488|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101184489|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101184490|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101184491|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184492|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184493|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184494|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184495|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184496|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101184497|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184498|NCT03042780|Folfirinox|folfirinox|mesh-list
101184499|NCT03042780|Lenograstim|lenograstim|mesh-list
101184500|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101184501|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
101184502|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184503|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184504|NCT02985840|Dexamethasone|dexamethasone|mesh-list
101184505|NCT02985840|Ondansetron|ondansetron|mesh-list
101184506|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184507|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
101184508|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
101184509|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184510|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184511|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184512|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
101184513|NCT02985840|Hormones|hormones|mesh-ancestor
101184514|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184515|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101184516|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184517|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
101184518|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184519|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101184520|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101184521|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
101184522|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184523|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184524|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
101184526|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101184527|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184528|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184529|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184530|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184531|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
101184532|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184533|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184534|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101184535|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101184536|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
101184537|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184538|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184539|NCT02966184|Albuterol|albuterol|mesh-list
101184540|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101184541|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
101184542|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184543|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184544|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101184545|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
101184546|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
101184547|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184548|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101184549|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101184551|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184552|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184553|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184554|NCT02774148|Acetaminophen|acetaminophen|mesh-list
101184555|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184556|NCT02774148|Analgesics|analgesics|mesh-ancestor
101184557|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
101184558|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184559|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184560|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
101184561|NCT02744352|Ropivacaine|ropivacaine|mesh-list
101184562|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184563|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
101184564|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184565|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184566|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
101184567|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184568|NCT02587650|Ceritinib|ceritinib|mesh-list
101184569|NCT02587650|Entrectinib|entrectinib|mesh-list
101184570|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184571|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184573|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184574|NCT02514252|Fentanyl|fentanyl|mesh-list
101184575|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101184576|NCT02514252|Narcotics|narcotics|mesh-ancestor
101184577|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184578|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184579|NCT02514252|Analgesics|analgesics|mesh-ancestor
101184580|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
101184581|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184582|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101184583|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101184584|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
101184585|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
101184586|NCT02434146|Phenylephrine|phenylephrine|mesh-list
101184587|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
101184588|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101184589|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
101184590|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
101184591|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184592|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184593|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
101184594|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101184596|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
101184597|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101184598|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101184599|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101184600|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184601|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184602|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184603|NCT02434146|Protective Agents|protective agents|mesh-ancestor
101184604|NCT02382588|Ganciclovir|ganciclovir|mesh-list
101184605|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
101184606|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184607|NCT02345460|Leucovorin|leucovorin|mesh-list
101184608|NCT02345460|Fluorouracil|fluorouracil|mesh-list
101184609|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
101184610|NCT02345460|Irinotecan|irinotecan|mesh-list
101184611|NCT02345460|Calcium|calcium|mesh-list
101184612|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
101184613|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101184614|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184615|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
101184616|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184617|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184618|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184619|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184620|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
101184621|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101184622|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101184623|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184625|NCT02345460|Protective Agents|protective agents|mesh-ancestor
101184626|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
101184627|NCT02345460|Vitamins|vitamins|mesh-ancestor
101184628|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
101184629|NCT02345772|Docetaxel|docetaxel|mesh-list
101184631|NCT02345772|Fulvestrant|fulvestrant|mesh-list
101184632|NCT02345772|Pertuzumab|pertuzumab|mesh-list
101184633|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184634|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
101184635|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
101184636|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
101184637|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184638|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101184639|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101184640|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101184641|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101184642|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
101184643|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184644|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184645|NCT02280252|Paclitaxel|paclitaxel|mesh-list
101184646|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101184647|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184648|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
101184649|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
101184650|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
101184651|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184652|NCT02140788|Metformin|metformin|mesh-list
101184653|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184654|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184655|NCT02133534|Atorvastatin|atorvastatin|mesh-list
101184656|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101184657|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101184659|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184661|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101184662|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184663|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101184664|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184665|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184666|NCT02015910|Incretins|incretins|mesh-ancestor
101184667|NCT02015910|Hormones|hormones|mesh-ancestor
101184668|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184669|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101184670|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
101184671|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184672|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184673|NCT01980342|Efavirenz|efavirenz|mesh-list
101184674|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101184675|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101184676|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184677|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184678|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
101184679|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184680|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101184681|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101184682|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101184683|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101184684|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101184685|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101184686|NCT01881984|Glycerol|glycerol|mesh-list
101184687|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101184688|NCT01881984|Protective Agents|protective agents|mesh-ancestor
101184689|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184690|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
101184691|NCT01878786|Everolimus|everolimus|mesh-list
101184692|NCT01878786|Tacrolimus|tacrolimus|mesh-list
101184693|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184694|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
101184695|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184696|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101184697|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184698|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184699|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101184700|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184701|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184702|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101184703|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101184704|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
101184705|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184706|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184707|NCT01851174|Paclitaxel|paclitaxel|mesh-list
101184708|NCT01851174|Gemcitabine|gemcitabine|mesh-list
101184709|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101184711|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
101184712|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
101184713|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
101184714|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184715|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184716|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
101184718|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101184719|NCT01846182|Analgesics|analgesics|mesh-ancestor
101184720|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
101184721|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184722|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184723|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
101184724|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101184725|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184726|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184727|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101184728|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101184729|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101184730|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184731|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101184732|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101184733|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101184734|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184736|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
101184737|NCT01800162|Methotrexate|methotrexate|mesh-list
101184738|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101184739|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
101184740|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184741|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184742|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184743|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
101184744|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184745|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184746|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184747|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184748|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101184749|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184750|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
101184751|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184752|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101184753|NCT01756560|Bupivacaine|bupivacaine|mesh-list
101184754|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
101184755|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
101184756|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184757|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184758|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
101184759|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184760|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
101184761|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101184762|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184763|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101184764|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101184765|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184766|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184767|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
101184768|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184769|NCT01717482|Metformin|metformin|mesh-list
101184770|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101184771|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184772|NCT01702896|Interleukin-2|interleukin-2|mesh-list
101184773|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184774|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184775|NCT01702896|Analgesics|analgesics|mesh-ancestor
101184776|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
101184777|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184778|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184779|NCT01683864|Cisplatin|cisplatin|mesh-list
101184780|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184781|NCT01608906|Heparin|heparin|mesh-list
101184782|NCT01608906|Calcium heparin|calcium heparin|mesh-list
101184783|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
101184784|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101184785|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101184786|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184787|NCT01602198|Rivastigmine|rivastigmine|mesh-list
101184788|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101184789|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184790|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184791|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184792|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184793|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184794|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101184795|NCT01602198|Protective Agents|protective agents|mesh-ancestor
101184796|NCT01545648|Denosumab|denosumab|mesh-list
101184797|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101184798|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184799|NCT01527942|Acetaminophen|acetaminophen|mesh-list
101184800|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184801|NCT01527942|Analgesics|analgesics|mesh-ancestor
101184802|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
101184803|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184804|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184805|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
101184806|NCT01507584|Bimatoprost|bimatoprost|mesh-list
101184807|NCT01507584|Brinzolamide|brinzolamide|mesh-list
101184808|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184809|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
101184810|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184811|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184812|NCT01483872|Tigecycline|tigecycline|mesh-list
101184814|NCT01483872|Calcium heparin|calcium heparin|mesh-list
101184815|NCT01483872|Anticoagulants|anticoagulants|mesh-list
101184816|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184817|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101184818|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101184819|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184820|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184821|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101184822|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184823|NCT01385280|Exemestane|exemestane|mesh-list
101184824|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101184825|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101184826|NCT01385280|Estradiol|estradiol|mesh-list
101184827|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101184828|NCT01385280|Estrogens|estrogens|mesh-ancestor
101184829|NCT01385280|Hormones|hormones|mesh-ancestor
101184830|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184831|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184832|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101184833|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
101184834|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101184835|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101184836|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184837|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101184838|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101184839|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184840|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184841|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101184842|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
101184844|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
101184845|NCT01350258|Melphalan|melphalan|mesh-list
101184846|NCT01350258|Thiotepa|thiotepa|mesh-list
101184847|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184848|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101184849|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
101184850|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184851|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184852|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
101184853|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184854|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101184855|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
101184856|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101184858|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
101184859|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101184860|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101184861|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184862|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184863|NCT01302444|Urological Agents|urological agents|mesh-ancestor
101184865|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
101184866|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
101184867|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184868|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184869|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184871|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101184872|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101184873|NCT01284504|Analgesics|analgesics|mesh-ancestor
101184874|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
101184875|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184876|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184877|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101184878|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101184879|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
101184880|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101184881|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184882|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184883|NCT01183416|Tretinoin|tretinoin|mesh-list
101184885|NCT01183416|Antibodies|antibodies|mesh-list
101184886|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101184887|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
101184888|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184889|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184890|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
101184891|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
101184892|NCT01169610|Varenicline|varenicline|mesh-list
101184893|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101184894|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101184895|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184896|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184897|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184898|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184899|NCT01166724|Sirolimus|sirolimus|mesh-list
101184900|NCT01166724|Tacrolimus|tacrolimus|mesh-list
101184901|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101184902|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
101184903|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184904|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101184905|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184906|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184907|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184908|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184909|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101184910|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184911|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
101184913|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
101184914|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101184915|NCT01151904|Latanoprost|latanoprost|mesh-list
101184916|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101184917|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101184918|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101184919|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
101184920|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184921|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184922|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184923|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101184924|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101184925|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101184926|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101184927|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101184928|NCT01115244|Dapsone|dapsone|mesh-list
101184929|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101184930|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
101184931|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101184932|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101184933|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101184934|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184935|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184936|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
101184937|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101184938|NCT01031550|Propofol|propofol|mesh-list
101184939|NCT01031550|Isoflurane|isoflurane|mesh-list
101184940|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101184941|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101184942|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184943|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101184944|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
101184945|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
101184946|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101184947|NCT00986310|Fluoxetine|fluoxetine|mesh-list
101184948|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101184949|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101184950|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184951|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184952|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184953|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
101184954|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184955|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101184956|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
101184957|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101184958|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101184960|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184961|NCT00907218|Varenicline|varenicline|mesh-list
101184962|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101184964|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
101184965|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184966|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184967|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184968|NCT00903396|Palonosetron|palonosetron|mesh-list
101184969|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
101184970|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
101184971|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101184972|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184973|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101184974|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
101184975|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101184976|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
101184977|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101184978|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184979|NCT00875394|Metformin|metformin|mesh-list
101184980|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101184981|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
101184982|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101184983|NCT00875394|Incretins|incretins|mesh-ancestor
101184984|NCT00875394|Hormones|hormones|mesh-ancestor
101184985|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101184986|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101184987|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
101184988|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184989|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184990|NCT00832572|Ranolazine|ranolazine|mesh-list
101184991|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101184992|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101184993|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184994|NCT00811590|Everolimus|everolimus|mesh-list
101184995|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101184996|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101184997|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101184998|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101184999|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101185000|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
101185001|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185002|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185004|NCT00749658|Varenicline|varenicline|mesh-list
101185005|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101185006|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185007|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185008|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101185009|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185010|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185011|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185012|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
101185013|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185014|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185015|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101185016|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185017|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185018|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101185019|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101185020|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
101185021|NCT00738972|Valsartan|valsartan|mesh-list
101185022|NCT00738972|Simvastatin|simvastatin|mesh-list
101185023|NCT00738972|Ezetimibe|ezetimibe|mesh-list
101185024|NCT00738972|Pravastatin|pravastatin|mesh-list
101185025|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101185026|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101185027|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
101185028|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185029|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101185030|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101185031|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185032|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185033|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101185034|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101185036|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101185037|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185038|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
101185039|NCT00704496|Ephedrine|ephedrine|mesh-list
101185040|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101185041|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
101185042|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185043|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185044|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101185045|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185046|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
101185047|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101185048|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101185049|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
101185050|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185051|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185052|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185053|NCT00692094|Melatonin|melatonin|mesh-list
101185054|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
101185055|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185056|NCT00692094|Protective Agents|protective agents|mesh-ancestor
101185057|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185058|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185059|NCT00676026|Zolpidem|zolpidem|mesh-list
101185060|NCT00676026|Fluoxetine|fluoxetine|mesh-list
101185061|NCT00676026|Progesterone|progesterone|mesh-list
101185062|NCT00676026|Progestins|progestins|mesh-ancestor
101185064|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101185065|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185066|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101185067|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185068|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185069|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185070|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185071|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
101185072|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101185073|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185074|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185075|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101185076|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185077|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185079|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101185080|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185081|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101185082|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
101185083|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
101185084|NCT00656916|Fluticasone|fluticasone|mesh-list
101185085|NCT00656916|Xhance|xhance|mesh-list
101185086|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185087|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101185088|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
101185089|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185090|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185091|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101185092|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185093|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
101185094|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101185095|NCT00619242|Sorafenib|sorafenib|mesh-list
101185096|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185097|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101185098|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185099|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185100|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
101185101|NCT00601848|Trioxsalen|trioxsalen|mesh-list
101185102|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185103|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
101185104|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101185105|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
101185106|NCT00586716|Antibodies|antibodies|mesh-list
101185107|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
101185108|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101185109|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101185110|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
101185111|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185113|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101185114|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101185115|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
101185116|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185117|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101185118|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101185119|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185120|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101185121|NCT00570258|Fulvestrant|fulvestrant|mesh-list
101185122|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185123|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101185124|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185125|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185126|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101185127|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101185128|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101185129|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
101185130|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101185131|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185132|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
101185133|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185134|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
101185135|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185136|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185137|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185139|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185140|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
101185141|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
101185142|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
101185143|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185145|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185147|NCT05599230|Elexacaftor|elexacaftor|mesh-list
101185148|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101185149|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185150|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185151|NCT05403762|Protective Agents|protective agents|mesh-list
101185152|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185153|NCT05164614|Teriparatide|teriparatide|mesh-list
101185154|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185155|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185156|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101185157|NCT05001048|Phenylephrine|phenylephrine|mesh-list
101185158|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
101185159|NCT05001048|Synephrine|synephrine|mesh-list
101185160|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101185161|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
101185162|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
101185163|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185164|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185165|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
101185166|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101185167|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
101185168|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185169|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101185170|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101185171|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101185172|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185173|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185174|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185175|NCT05001048|Protective Agents|protective agents|mesh-ancestor
101185176|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101185177|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
101185179|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
101185180|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185181|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
101185182|NCT04810572|Silymarin|silymarin|mesh-list
101185183|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
101185184|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185186|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185187|NCT04575090|Simvastatin|simvastatin|mesh-list
101185188|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101185189|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101185190|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
101185191|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185192|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101185193|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101185194|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185195|NCT04100772|Vaccines|vaccines|mesh-list
101185196|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
101185197|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185198|NCT04043520|Estradiol|estradiol|mesh-list
101185199|NCT04043520|Estrogens|estrogens|mesh-list
101185200|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
101185201|NCT04043520|Hormones|hormones|mesh-ancestor
101185202|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101185203|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185204|NCT03582930|Calfactant|calfactant|mesh-list
101185205|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
101185206|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185207|NCT03472872|Acetaminophen|acetaminophen|mesh-list
101185208|NCT03472872|Ketorolac|ketorolac|mesh-list
101185209|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101185210|NCT03472872|Analgesics|analgesics|mesh-ancestor
101185211|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
101185212|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185213|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185214|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
101185216|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185217|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101185218|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101185219|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185220|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185221|NCT03301038|Rifampin|rifampin|mesh-list
101185222|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101185223|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
101185224|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185225|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185226|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
101185227|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185228|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185229|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185230|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101185231|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101185232|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101185233|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101185234|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101185235|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101185236|NCT02411526|Risperidone|risperidone|mesh-list
101185237|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101185238|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
101185239|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185240|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185241|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185242|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101185243|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101185244|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185245|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185246|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101185247|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
101185249|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185250|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101185251|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185252|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185253|NCT00558870|Morphine|morphine|mesh-list
101185254|NCT00558870|Methadone|methadone|mesh-list
101185255|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185256|NCT00558870|Narcotics|narcotics|mesh-ancestor
101185257|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185258|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185259|NCT00558870|Analgesics|analgesics|mesh-ancestor
101185260|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
101185261|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185262|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
101185263|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185265|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101185266|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101185267|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185268|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185269|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185270|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185271|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101185272|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101185273|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
101185274|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185275|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101185276|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185277|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
101185278|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
101185279|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101185280|NCT00538980|Dasatinib|dasatinib|mesh-list
101185281|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185282|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101185283|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185284|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185285|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
101185286|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185287|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101185288|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185289|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185290|NCT00506064|Melatonin|melatonin|mesh-list
101185291|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
101185292|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185293|NCT00506064|Protective Agents|protective agents|mesh-ancestor
101185294|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185295|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185296|NCT00503880|Cytarabine|cytarabine|mesh-list
101185297|NCT00503880|Clofarabine|clofarabine|mesh-list
101185298|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101185299|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
101185300|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185301|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185302|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
101185303|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185304|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101185305|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
101185306|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185307|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
101185308|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185309|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
101185310|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101185311|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
101185312|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185313|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101185314|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185315|NCT00145704|Vitamin D|vitamin d|mesh-list
101185316|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
101185317|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
101185318|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
101185319|NCT00145704|Diphosphonates|diphosphonates|mesh-list
101185320|NCT00145704|Vitamins|vitamins|mesh-list
101185321|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
101185322|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185323|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185324|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101185325|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101185326|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185327|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185328|NCT00108342|Nicotine|nicotine|mesh-list
101185329|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101185330|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
101185331|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185332|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185333|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101185334|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101185335|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
101185337|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185339|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
101185340|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
101185341|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
101185342|NCT00090870|Thalidomide|thalidomide|mesh-list
101185343|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185344|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
101185345|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185346|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
101185347|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185348|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101185349|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
101185350|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185351|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101185352|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101185353|NCT00090870|Growth Substances|growth substances|mesh-ancestor
101185354|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
101185355|NCT00074724|Dobutamine|dobutamine|mesh-list
101185356|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101185357|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
101185358|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
101185359|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185360|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185361|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
101185362|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101185363|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101185364|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185365|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185366|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185367|NCT00074724|Protective Agents|protective agents|mesh-ancestor
101185368|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
101185369|NCT00058188|Vitamin D|vitamin d|mesh-list
101185370|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
101185371|NCT00058188|Calcium|calcium|mesh-list
101185372|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185373|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185374|NCT00058188|Vitamins|vitamins|mesh-ancestor
101185375|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
101185376|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101185377|NCT00003726|Lepirudin|lepirudin|mesh-list
101185378|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
101185379|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101185380|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
101185381|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185382|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185383|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
101185384|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101185385|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101185386|NCT02595996|Propranolol|propranolol|mesh-list
101185387|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101185388|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101185389|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185390|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185391|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185392|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185393|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101185394|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185395|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
101185396|NCT04422210|Carboplatin|carboplatin|mesh-list
101185397|NCT04422210|Etoposide|etoposide|mesh-list
101185398|NCT04422210|Atezolizumab|atezolizumab|mesh-list
101185400|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185401|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101185402|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101185403|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101185405|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185406|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101185407|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101185409|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185410|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
101185411|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
101185412|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185413|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185414|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101185415|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101185416|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101185417|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185418|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185419|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185420|NCT00000138|Acyclovir|acyclovir|mesh-list
101185421|NCT00000138|Prednisolone|prednisolone|mesh-list
101185422|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101185423|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
101185424|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101185425|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
101185426|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101185427|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
101185428|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185429|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
101185430|NCT00000138|Hormones|hormones|mesh-ancestor
101185431|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101185432|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185433|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101185434|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185436|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
101185437|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185438|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101185439|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101185440|NCT00000138|Protective Agents|protective agents|mesh-ancestor
101185441|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
101185442|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185443|NCT00000174|Rivastigmine|rivastigmine|mesh-list
101185444|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101185445|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185446|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185447|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
101185448|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185449|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185450|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101185451|NCT00000174|Protective Agents|protective agents|mesh-ancestor
101185452|NCT00000192|Lamotrigine|lamotrigine|mesh-list
101185453|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
101185454|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101185455|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185456|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185457|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185458|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185459|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101185460|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101185461|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185462|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185463|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101185464|NCT00000198|Piracetam|piracetam|mesh-list
101185465|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101185466|NCT00000198|Protective Agents|protective agents|mesh-ancestor
101185468|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
101185469|NCT00000204|Buprenorphine|buprenorphine|mesh-list
101185470|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185471|NCT00000204|Narcotics|narcotics|mesh-ancestor
101185472|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185473|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185474|NCT00000204|Analgesics|analgesics|mesh-ancestor
101185475|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
101185476|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185477|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185479|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185480|NCT00000210|Narcotics|narcotics|mesh-ancestor
101185481|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185482|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185483|NCT00000210|Analgesics|analgesics|mesh-ancestor
101185484|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
101185485|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185486|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185487|NCT00000222|Buprenorphine|buprenorphine|mesh-list
101185488|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185489|NCT00000222|Narcotics|narcotics|mesh-ancestor
101185490|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185491|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185492|NCT00000222|Analgesics|analgesics|mesh-ancestor
101185493|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
101185494|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185495|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185496|NCT00000228|Buprenorphine|buprenorphine|mesh-list
101185497|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185498|NCT00000228|Narcotics|narcotics|mesh-ancestor
101185499|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185500|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185501|NCT00000228|Analgesics|analgesics|mesh-ancestor
101185502|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
101185503|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185504|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185505|NCT00000234|Buprenorphine|buprenorphine|mesh-list
101185506|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185507|NCT00000234|Narcotics|narcotics|mesh-ancestor
101185508|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185509|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185510|NCT00000234|Analgesics|analgesics|mesh-ancestor
101185511|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
101185512|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185514|NCT00000240|Buprenorphine|buprenorphine|mesh-list
101185515|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185516|NCT00000240|Narcotics|narcotics|mesh-ancestor
101185517|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185518|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185519|NCT00000240|Analgesics|analgesics|mesh-ancestor
101185520|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
101185521|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185522|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185523|NCT00000246|Flumazenil|flumazenil|mesh-list
101185524|NCT00000246|Antidotes|antidotes|mesh-ancestor
101185525|NCT00000246|Protective Agents|protective agents|mesh-ancestor
101185526|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185527|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
101185528|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
101185529|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185530|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185531|NCT00000264|Ethanol|ethanol|mesh-list
101185532|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
101185533|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101185534|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185535|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185536|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185537|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101185538|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
101204372|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101185539|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
101185540|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101185541|NCT00000264|Analgesics|analgesics|mesh-ancestor
101185542|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
101185543|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185544|NCT00000270|Cocaine|cocaine|mesh-list
101185545|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
101185546|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
101185547|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185548|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185549|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
101185550|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185551|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101185552|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101185553|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185554|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185555|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185557|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185558|NCT00000276|Bupropion|bupropion|mesh-list
101185559|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101185560|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185561|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185562|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101185563|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185564|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185565|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185566|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
101185567|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185568|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185569|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101185570|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185571|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185572|NCT00000282|Pemoline|pemoline|mesh-list
101185573|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101185574|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185575|NCT00000294|Carvedilol|carvedilol|mesh-list
101185576|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101185577|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101185578|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185579|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185580|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185581|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185582|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185583|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
101185584|NCT00000294|Protective Agents|protective agents|mesh-ancestor
101185585|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101185586|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185587|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185588|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
101185589|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101185590|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101185591|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
101185592|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101185593|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185594|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101185595|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185596|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185597|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185598|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
101185599|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185600|NCT00000318|Buprenorphine|buprenorphine|mesh-list
101185601|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101185602|NCT00000318|Narcotics|narcotics|mesh-ancestor
101185603|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185604|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185605|NCT00000318|Analgesics|analgesics|mesh-ancestor
101185606|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
101185607|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185608|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185609|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
101185610|NCT00000330|Narcotics|narcotics|mesh-ancestor
101185611|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185612|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185613|NCT00000330|Analgesics|analgesics|mesh-ancestor
101185614|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
101185615|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185617|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185618|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185619|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101185620|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101185621|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101185622|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185623|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185624|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101185626|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185627|NCT00000342|Risperidone|risperidone|mesh-list
101185628|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101185629|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
101185630|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185631|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185632|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185633|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101185634|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101185635|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185636|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185637|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101185638|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
101185639|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
101185640|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
101185641|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
101185642|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185643|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185644|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185645|NCT00000354|Lofexidine|lofexidine|mesh-list
101185646|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185647|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185648|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185649|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
101185650|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185651|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101185652|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101185653|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101185654|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185655|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185657|NCT00000372|Cycloserine|cycloserine|mesh-list
101185658|NCT00000372|Clozapine|clozapine|mesh-list
101185659|NCT00000372|Glycine|glycine|mesh-list
101185660|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101185661|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185662|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101185663|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
101185664|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185665|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
101185666|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185667|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101185668|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
101185669|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185670|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185671|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101185672|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101185673|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101185674|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185675|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
101185676|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
101185677|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
101185679|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185680|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185681|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101185682|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185683|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185684|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185685|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185686|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
101185687|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185688|NCT00000390|Imipramine|imipramine|mesh-list
101185689|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101185690|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
101185691|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101185692|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101185693|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101185694|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185695|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185696|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
101185697|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185698|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185700|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185701|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185703|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101185704|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185705|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185706|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
101185707|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185708|NCT00000444|Nicotine|nicotine|mesh-list
101185709|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101185710|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
101185711|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185712|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185714|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101185715|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
101185716|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101185717|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185719|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101185720|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101185721|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185722|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
101185723|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185724|NCT00000510|Aspirin|aspirin|mesh-list
101185725|NCT00000510|Dipyridamole|dipyridamole|mesh-list
101185726|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101185727|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101185728|NCT00000510|Analgesics|analgesics|mesh-ancestor
101185729|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
101185730|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101185731|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185732|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101185733|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101185734|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101185735|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101185736|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185737|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101185738|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101185739|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185740|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
101185741|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101185742|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
101185743|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
101185744|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
101185745|NCT00000600|Vitamins|vitamins|mesh-list
101185746|NCT00000600|Vitamin E|vitamin e|mesh-list
101185747|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
101185748|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185749|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
101185750|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185751|NCT00000600|Protective Agents|protective agents|mesh-ancestor
101185752|NCT00000636|Pyridoxine|pyridoxine|mesh-list
101185753|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
101185754|NCT00000636|Rifampin|rifampin|mesh-list
101185755|NCT00000636|Isoniazid|isoniazid|mesh-list
101185756|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
101185757|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101185758|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
101185759|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185760|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185761|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
101185762|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185763|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185764|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185765|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101185766|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101185767|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101185768|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101185769|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101185770|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101185771|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101185772|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101185773|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
101185774|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101185775|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
101185776|NCT00000636|Vitamins|vitamins|mesh-ancestor
101185777|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
101185779|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
101185780|NCT00000648|Penicillins|penicillins|mesh-list
101185781|NCT00000648|Penicillin G|penicillin g|mesh-list
101185782|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
101185783|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
101185784|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185785|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185786|NCT00000654|Fialuridine|fialuridine|mesh-list
101185788|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185789|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185790|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185791|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185793|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101185794|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185795|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101185796|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101185797|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185798|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185800|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
101185801|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185802|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185803|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185804|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185805|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
101185806|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185807|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185808|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185809|NCT00000714|Leucovorin|leucovorin|mesh-list
101185810|NCT00000714|Trimetrexate|trimetrexate|mesh-list
101185811|NCT00000714|Calcium|calcium|mesh-list
101185812|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
101185813|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185814|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185815|NCT00000714|Antidotes|antidotes|mesh-ancestor
101185816|NCT00000714|Protective Agents|protective agents|mesh-ancestor
101185817|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
101185818|NCT00000714|Vitamins|vitamins|mesh-ancestor
101185819|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
101185820|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
101185821|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185822|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101185823|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
101185824|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185825|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185826|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101185827|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185828|NCT00000732|Zidovudine|zidovudine|mesh-list
101185829|NCT00000732|Trimethoprim|trimethoprim|mesh-list
101185830|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
101185831|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101185832|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
101185833|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185834|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185835|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185836|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185837|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
101185838|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185839|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185840|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185841|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101185843|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101185844|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101185845|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101185846|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101185847|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101185848|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185849|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185850|NCT00000738|Zidovudine|zidovudine|mesh-list
101185851|NCT00000738|Nimodipine|nimodipine|mesh-list
101185852|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
101185853|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185854|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185855|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185856|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185857|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
101185858|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185859|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185860|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185861|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101185862|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101185863|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101185864|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101185865|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185866|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
101185867|NCT00000750|Zidovudine|zidovudine|mesh-list
101185868|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
101185869|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185870|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185871|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185872|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185873|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
101185874|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185875|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185876|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185877|NCT00000804|Indinavir|indinavir|mesh-list
101185878|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101185879|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101185880|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
101185881|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185882|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185883|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185884|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185886|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185887|NCT00000810|Zidovudine|zidovudine|mesh-list
101185888|NCT00000810|Didanosine|didanosine|mesh-list
101185889|NCT00000810|Delavirdine|delavirdine|mesh-list
101185890|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
101185891|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185892|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185893|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185895|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
101185896|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185897|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185898|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185899|NCT00000834|Lamivudine|lamivudine|mesh-list
101185900|NCT00000834|Zidovudine|zidovudine|mesh-list
101185901|NCT00000834|Methotrexate|methotrexate|mesh-list
101185902|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101185903|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
101185904|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101185905|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185906|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101185907|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
101185908|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185909|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101185910|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
101185911|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185912|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101185913|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101185914|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
101185915|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101185916|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185917|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185918|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
101185919|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185920|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185921|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185922|NCT00000864|Zidovudine|zidovudine|mesh-list
101537371|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185923|NCT00000864|Abacavir|abacavir|mesh-list
101185924|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
101185925|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185926|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185927|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185928|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185929|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
101185930|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185931|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185932|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185933|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
101185934|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
101185935|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101185936|NCT00000894|Ganciclovir|ganciclovir|mesh-list
101185937|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101185938|NCT00000894|Cidofovir|cidofovir|mesh-list
101185939|NCT00000894|Probenecid|probenecid|mesh-list
101185941|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185942|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185943|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185944|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185945|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
101185946|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
101185947|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101185948|NCT00000912|Efavirenz|efavirenz|mesh-list
101185949|NCT00000912|Abacavir|abacavir|mesh-list
101185950|NCT00000912|Adefovir|adefovir|mesh-list
101185951|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101185952|NCT00000912|Nelfinavir|nelfinavir|mesh-list
101185953|NCT00000912|Indinavir|indinavir|mesh-list
101185954|NCT00000912|Saquinavir|saquinavir|mesh-list
101185955|NCT00000912|Amprenavir|amprenavir|mesh-list
101185956|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185957|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101185958|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185959|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185960|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
101185961|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185962|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101185963|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185964|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101185965|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101185966|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101185967|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101185968|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185969|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185970|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101185971|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101185972|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
101185973|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101185974|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101185975|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
101185976|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101185978|NCT00000918|Indinavir|indinavir|mesh-list
101185979|NCT00000918|Saquinavir|saquinavir|mesh-list
101185980|NCT00000918|Amprenavir|amprenavir|mesh-list
101185981|NCT00000918|Lamivudine|lamivudine|mesh-list
101185982|NCT00000918|Zidovudine|zidovudine|mesh-list
101185983|NCT00000918|Didanosine|didanosine|mesh-list
101185984|NCT00000918|Stavudine|stavudine|mesh-list
101185985|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
101185986|NCT00000918|Efavirenz|efavirenz|mesh-list
101185987|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101185988|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101185989|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
101185990|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185991|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101185992|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101185993|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101185994|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
101185995|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101185996|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101185997|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101185998|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101185999|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186001|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186002|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186003|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101186004|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186005|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186006|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101186007|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
101186008|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186009|NCT00000924|Ritonavir|ritonavir|mesh-list
101186010|NCT00000924|Nelfinavir|nelfinavir|mesh-list
101186011|NCT00000924|Nevirapine|nevirapine|mesh-list
101186012|NCT00000924|Didanosine|didanosine|mesh-list
101186013|NCT00000924|Stavudine|stavudine|mesh-list
101186014|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186015|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186016|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186017|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186018|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186020|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186021|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
101186022|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186023|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186024|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186025|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186026|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186027|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186028|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186029|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
101186031|NCT00000936|Cyclosporins|cyclosporins|mesh-list
101186032|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186033|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186034|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186035|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
101186036|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186037|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
101186038|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186039|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
101186040|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101186041|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101186042|NCT00000942|Nevirapine|nevirapine|mesh-list
101186043|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186044|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186045|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186046|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186047|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
101186048|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186049|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186050|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186051|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186052|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186053|NCT00000948|Aldesleukin|aldesleukin|mesh-list
101186054|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186055|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186056|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186057|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
101186058|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186059|NCT00000954|Didanosine|didanosine|mesh-list
101186060|NCT00000954|Zalcitabine|zalcitabine|mesh-list
101186061|NCT00000954|Doxorubicin|doxorubicin|mesh-list
101186062|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101186063|NCT00000954|Bleomycin|bleomycin|mesh-list
101186064|NCT00000954|Vincristine|vincristine|mesh-list
101186065|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101186066|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186067|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101186068|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101186069|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186070|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186071|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101186072|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
101186073|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
101186074|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
101186075|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
101186076|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186077|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186080|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186081|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186082|NCT00000960|Zidovudine|zidovudine|mesh-list
101186083|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
101186084|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186085|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186086|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186087|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186088|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
101186089|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186090|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186091|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186092|NCT00000990|Zidovudine|zidovudine|mesh-list
101186093|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
101186094|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186095|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186096|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186097|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186098|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
101186099|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186100|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186101|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186102|NCT00000996|Doxorubicin|doxorubicin|mesh-list
101186103|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101186104|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101186105|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186106|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101186107|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101186108|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186109|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186110|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
101186111|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186112|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
101186113|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186114|NCT00001044|Antacids|antacids|mesh-ancestor
101186115|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186116|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101186117|NCT00001062|Ganciclovir|ganciclovir|mesh-list
101186118|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101186119|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
101186120|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186121|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186122|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186123|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186124|NCT00001068|Lamivudine|lamivudine|mesh-list
101186125|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186126|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186127|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186128|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186130|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186131|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186132|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186133|NCT00001080|Lamivudine|lamivudine|mesh-list
101186134|NCT00001080|Vaccines|vaccines|mesh-list
101186135|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101186136|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
101186137|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186138|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186141|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186143|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186144|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186145|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186146|NCT00001104|Zidovudine|zidovudine|mesh-list
101186147|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
101186148|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186149|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186150|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186151|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186152|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
101186153|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186154|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186155|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186156|NCT00001110|Dimercaprol|dimercaprol|mesh-list
101186157|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
101186158|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
101186159|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186160|NCT00001122|Efavirenz|efavirenz|mesh-list
101186161|NCT00001122|Didanosine|didanosine|mesh-list
101186162|NCT00001122|Stavudine|stavudine|mesh-list
101186163|NCT00001122|Nelfinavir|nelfinavir|mesh-list
101186164|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186165|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186166|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186167|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186168|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
101186169|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186170|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186172|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186173|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101186174|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186175|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186176|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186177|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186178|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186179|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186180|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186181|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
101186182|NCT00001128|Azithromycin|azithromycin|mesh-list
101186183|NCT00001128|Paromomycin|paromomycin|mesh-list
101186184|NCT00001128|Interleukin-12|interleukin-12|mesh-list
101186185|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186186|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186187|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186188|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
101186189|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186190|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101186191|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101186192|NCT00001128|Growth Substances|growth substances|mesh-ancestor
101186193|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
101186194|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186195|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186196|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186198|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
101186199|NCT00001296|Melphalan|melphalan|mesh-list
101186200|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186201|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
101186202|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186203|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101186204|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
101186205|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186206|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101186207|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186208|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
101186209|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186211|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186212|NCT00001428|Fluorouracil|fluorouracil|mesh-list
101186213|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
101186214|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186215|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101186216|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186217|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186218|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
101186219|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186220|NCT00001440|Interleukin-2|interleukin-2|mesh-list
101186221|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186222|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101186223|NCT00001440|Analgesics|analgesics|mesh-ancestor
101186224|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
101186225|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101186226|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186227|NCT00001446|Thalidomide|thalidomide|mesh-list
101186228|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186229|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
101186230|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186231|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
101186232|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186233|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186234|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101186235|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101186236|NCT00001446|Growth Substances|growth substances|mesh-ancestor
101186237|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
101186238|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186239|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
101186240|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186241|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
101186242|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186244|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
101186245|NCT00001626|Cyclosporins|cyclosporins|mesh-list
101186246|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101186247|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186248|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
101186249|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186250|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101186251|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101186252|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
101186253|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186254|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186255|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101186256|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186257|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
101186258|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186259|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
101186260|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101186261|NCT00001680|Thalidomide|thalidomide|mesh-list
101186262|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101186263|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
101186264|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186265|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
101186266|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186267|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186268|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101186269|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101186270|NCT00001680|Growth Substances|growth substances|mesh-ancestor
101186271|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
101186272|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186274|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101186275|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101186276|NCT00001698|Analgesics|analgesics|mesh-ancestor
101186277|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
101186278|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101186279|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186280|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101186281|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101186282|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101186283|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186284|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186285|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
101186286|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
101186287|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101186288|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
101186289|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101186290|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186291|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101186292|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
101186293|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101186294|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
101186295|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186296|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101186297|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101186298|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
101186299|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
101186300|NCT00001716|Protective Agents|protective agents|mesh-ancestor
101186301|NCT00001812|Nystatin|nystatin|mesh-list
101186302|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186303|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186304|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
101186305|NCT00001812|Ionophores|ionophores|mesh-ancestor
101186306|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101186307|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186308|NCT00001842|Dexamethasone|dexamethasone|mesh-list
101186309|NCT00001842|Lenograstim|lenograstim|mesh-list
101186310|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101186311|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
101186312|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
101186313|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101186314|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186315|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101186316|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
101186317|NCT00001842|Hormones|hormones|mesh-ancestor
101186318|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186319|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101186320|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186321|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186322|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
101186323|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
101186324|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101186325|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186326|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186327|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186328|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101186329|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101186331|NCT00001854|Ribavirin|ribavirin|mesh-list
101186332|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
101186333|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186334|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
101186335|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186336|NCT00001860|Octreotide|octreotide|mesh-list
101186337|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101186338|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101186339|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186340|NCT00001890|Estrogens|estrogens|mesh-list
101186341|NCT00001890|Hormones|hormones|mesh-ancestor
101186342|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186343|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186344|NCT00001944|Vinorelbine|vinorelbine|mesh-list
101186345|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101186346|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186347|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
101186348|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
101186349|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
101186350|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186351|NCT00001968|Ritonavir|ritonavir|mesh-list
101186352|NCT00001968|Amprenavir|amprenavir|mesh-list
101186353|NCT00001968|Lamivudine|lamivudine|mesh-list
101186354|NCT00001968|Abacavir|abacavir|mesh-list
101186355|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186356|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186357|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186358|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186359|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186360|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186361|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186362|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
101186363|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186364|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186365|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186366|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186367|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186368|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101186369|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
101186370|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186371|NCT00001998|Nystatin|nystatin|mesh-list
101186372|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186373|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186374|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
101186375|NCT00001998|Ionophores|ionophores|mesh-ancestor
101186376|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101186377|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186378|NCT00002010|Fluconazole|fluconazole|mesh-list
101186379|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
101186380|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186381|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186382|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186383|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186384|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186385|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186386|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186387|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186388|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186389|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186390|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186392|NCT00002022|Hematinics|hematinics|mesh-ancestor
101186393|NCT00002028|Didanosine|didanosine|mesh-list
101186394|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
101186395|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186396|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186397|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186398|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186399|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
101186400|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186401|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186402|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186403|NCT00002034|Zidovudine|zidovudine|mesh-list
101186404|NCT00002034|Ganciclovir|ganciclovir|mesh-list
101186405|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101186406|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
101186407|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186408|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186409|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186410|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186411|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
101186412|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186413|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186414|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186415|NCT00002040|Fluconazole|fluconazole|mesh-list
101186416|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
101186417|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186418|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186419|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186420|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186421|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186422|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186423|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186424|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186425|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186426|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186427|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186428|NCT00002046|Zidovudine|zidovudine|mesh-list
101186429|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
101186430|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186431|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186432|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186433|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186434|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
101186435|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186436|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186437|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186438|NCT00002052|Amoxicillin|amoxicillin|mesh-list
101186439|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
101186440|NCT00002052|Ampicillin|ampicillin|mesh-list
101186441|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186442|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186443|NCT00002058|Clofazimine|clofazimine|mesh-list
101186444|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101186445|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
101186446|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186447|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186448|NCT00002064|Clindamycin|clindamycin|mesh-list
101186449|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
101186450|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
101186451|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
101186452|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186453|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186454|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101186455|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186456|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186457|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
101186458|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186459|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186460|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101186462|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101186463|NCT00002070|Sargramostim|sargramostim|mesh-list
101186466|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
101186467|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186468|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186469|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186470|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186471|NCT00002076|Fluconazole|fluconazole|mesh-list
101186472|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
101186473|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186474|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186475|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186476|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186477|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186480|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186481|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186482|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186483|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186484|NCT00002082|Azithromycin|azithromycin|mesh-list
101186485|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186486|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186487|NCT00002094|Atevirdine|atevirdine|mesh-list
101186488|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186489|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186490|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186491|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186492|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
101186493|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186494|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
101186495|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
101186496|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186497|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186498|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186499|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
101186500|NCT00002106|Ranitidine|ranitidine|mesh-list
101186501|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
101186502|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101186503|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101186504|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101186505|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
101186506|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
101186507|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101186508|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186509|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186511|NCT00002112|Nystatin|nystatin|mesh-list
101186512|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
101186513|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186514|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186515|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186516|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186517|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186518|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186519|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186520|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186521|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186522|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186523|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186524|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186525|NCT00002112|Ionophores|ionophores|mesh-ancestor
101186526|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101186527|NCT00002118|Zalcitabine|zalcitabine|mesh-list
101186528|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
101186529|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186530|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186531|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186532|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186533|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
101186534|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186536|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186537|NCT00002124|Lamivudine|lamivudine|mesh-list
101186538|NCT00002124|Zidovudine|zidovudine|mesh-list
101186539|NCT00002124|Delavirdine|delavirdine|mesh-list
101186540|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186541|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186542|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186543|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186544|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
101186545|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186546|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186547|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186548|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
101186549|NCT00002130|Vesnarinone|vesnarinone|mesh-list
101186550|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186551|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
101186553|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186554|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
101186555|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186556|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101186557|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101186558|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186559|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186560|NCT00002130|Protective Agents|protective agents|mesh-ancestor
101186561|NCT00002142|Cidofovir|cidofovir|mesh-list
101186562|NCT00002142|Probenecid|probenecid|mesh-list
101186563|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
101186564|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
101186565|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101186566|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
101186567|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186568|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186569|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186570|NCT00002148|OPC 14117|opc 14117|mesh-list
101186571|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101186572|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
101186573|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186574|NCT00002148|Protective Agents|protective agents|mesh-ancestor
101186575|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186576|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
101186578|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
101186579|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101186580|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101186581|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101186582|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
101186583|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186584|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186585|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101186586|NCT00002154|Protective Agents|protective agents|mesh-ancestor
101186587|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186588|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
101186589|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
101186590|NCT00002154|Vitamins|vitamins|mesh-ancestor
101186591|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
101186592|NCT00002160|Ziconotide|ziconotide|mesh-list
101186593|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101186594|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101186595|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186596|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101186597|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186598|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101186599|NCT00002160|Protective Agents|protective agents|mesh-ancestor
101186600|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101186601|NCT00002160|Analgesics|analgesics|mesh-ancestor
101186602|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
101186603|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101186604|NCT00002166|Nevirapine|nevirapine|mesh-list
101186605|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186606|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186607|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186608|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186609|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
101186610|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186611|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186612|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186613|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186614|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186615|NCT00002178|Ritonavir|ritonavir|mesh-list
101186616|NCT00002178|Nelfinavir|nelfinavir|mesh-list
101186617|NCT00002178|Saquinavir|saquinavir|mesh-list
101186618|NCT00002178|Delavirdine|delavirdine|mesh-list
101186619|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186620|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186621|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186622|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186623|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186624|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186625|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186626|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
101186627|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186629|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186630|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186631|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186632|NCT00002184|Lamivudine|lamivudine|mesh-list
101186633|NCT00002184|Zidovudine|zidovudine|mesh-list
101186634|NCT00002184|Stavudine|stavudine|mesh-list
101186635|NCT00002184|Adefovir|adefovir|mesh-list
101186636|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101186637|NCT00002184|Nelfinavir|nelfinavir|mesh-list
101186638|NCT00002184|Saquinavir|saquinavir|mesh-list
101186639|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186640|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186641|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186642|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186643|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
101186644|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186645|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186646|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186647|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
101186648|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186649|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186650|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186651|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186652|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186653|NCT00002190|Lamivudine|lamivudine|mesh-list
101186654|NCT00002190|Zidovudine|zidovudine|mesh-list
101186655|NCT00002190|Saquinavir|saquinavir|mesh-list
101186656|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186657|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186658|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186659|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186660|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
101186661|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186662|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186663|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186664|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
101186665|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186666|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186667|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186668|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186669|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186670|NCT00002202|Indinavir|indinavir|mesh-list
101186672|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186673|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186674|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186675|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186676|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186677|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186678|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186679|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
101186680|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186681|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101186682|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
101186683|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186684|NCT00002208|Lamivudine|lamivudine|mesh-list
101186685|NCT00002208|Zidovudine|zidovudine|mesh-list
101186686|NCT00002208|Stavudine|stavudine|mesh-list
101186688|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186689|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186690|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186691|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186692|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
101186693|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186694|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186695|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186696|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
101186697|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186698|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186699|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186700|NCT00002214|Capravirine|capravirine|mesh-list
101186701|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186702|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186703|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186704|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186705|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
101186706|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186707|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186708|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186709|NCT00002220|Efavirenz|efavirenz|mesh-list
101186710|NCT00002220|Adefovir|adefovir|mesh-list
101186711|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101186713|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186714|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186715|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186716|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186717|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
101186718|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186719|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186720|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186721|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186722|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101186723|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101186724|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101186725|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186726|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186727|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186728|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186729|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186730|NCT00002226|Semaxinib|semaxinib|mesh-list
101186731|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101186732|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101186733|NCT00002226|Growth Substances|growth substances|mesh-ancestor
101186734|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186735|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
101186736|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186737|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101186738|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186739|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186740|NCT00002238|Interferons|interferons|mesh-list
101186741|NCT00002238|Zidovudine|zidovudine|mesh-list
101186742|NCT00002238|Interferon-beta|interferon-beta|mesh-list
101186743|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
101186744|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186745|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
101186746|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186747|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
101186748|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186749|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186750|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186751|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186752|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186753|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186754|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
101186755|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186756|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101186757|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
101186758|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
101186759|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186760|NCT00002256|Zalcitabine|zalcitabine|mesh-list
101186761|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
101186762|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186763|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186764|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186766|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
101186767|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186768|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186769|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186770|NCT00002274|Didanosine|didanosine|mesh-list
101186771|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
101186772|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186773|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186774|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186775|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186776|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
101186777|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186778|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186779|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186780|NCT00002280|Didanosine|didanosine|mesh-list
101186781|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
101186782|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186783|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186784|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186785|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186786|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
101186787|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186788|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186789|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186790|NCT00002286|Zidovudine|zidovudine|mesh-list
101186791|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
101186792|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186793|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186794|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186795|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186796|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
101186797|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186798|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186799|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186800|NCT00002292|Pentamidine|pentamidine|mesh-list
101186801|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
101186802|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186803|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186804|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186805|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101186806|NCT00002298|Ribavirin|ribavirin|mesh-list
101186807|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
101186808|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186809|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
101186810|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186811|NCT00002304|Fluconazole|fluconazole|mesh-list
101186812|NCT00002304|Ketoconazole|ketoconazole|mesh-list
101186813|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
101186814|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186815|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186816|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186817|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186818|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186819|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186820|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186821|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186822|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186823|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101186824|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101186825|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186826|NCT00002316|Amphotericin B|amphotericin b|mesh-list
101186827|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101186828|NCT00002316|Amebicides|amebicides|mesh-ancestor
101186829|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186830|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186831|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186832|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186833|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
101186834|NCT00002322|Zidovudine|zidovudine|mesh-list
101186835|NCT00002322|Atevirdine|atevirdine|mesh-list
101186836|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
101186837|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186839|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186840|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186841|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
101186842|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186843|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186844|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186845|NCT00002328|Azithromycin|azithromycin|mesh-list
101186846|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101186847|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186848|NCT00002334|Zidovudine|zidovudine|mesh-list
101186849|NCT00002334|Zalcitabine|zalcitabine|mesh-list
101186850|NCT00002334|Saquinavir|saquinavir|mesh-list
101186851|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
101186852|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186853|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186854|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186855|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186856|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
101186857|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186858|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186859|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186860|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186861|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186863|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186864|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186865|NCT00002340|Atovaquone|atovaquone|mesh-list
101186866|NCT00002340|Pentamidine|pentamidine|mesh-list
101186867|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186868|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
101186869|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101186870|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101186871|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186872|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186873|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
101186874|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101186875|NCT00002346|Adefovir|adefovir|mesh-list
101186876|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
101186877|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
101186878|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186879|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186880|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186881|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186882|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186883|NCT00002352|Lobucavir|lobucavir|mesh-list
101186884|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186885|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186886|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186887|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186888|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
101186889|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186890|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186891|NCT00002358|Sorivudine|sorivudine|mesh-list
101186892|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
101186893|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186894|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186895|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186896|NCT00002364|Abacavir|abacavir|mesh-list
101186897|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186898|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186899|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186900|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186902|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186903|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186904|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186906|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
101186907|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186908|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101186909|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186910|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186911|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186912|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186913|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186914|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101186915|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186916|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186917|NCT00002376|Lamivudine|lamivudine|mesh-list
101186918|NCT00002376|Zidovudine|zidovudine|mesh-list
101186919|NCT00002376|Didanosine|didanosine|mesh-list
101186920|NCT00002376|Stavudine|stavudine|mesh-list
101186921|NCT00002376|Indinavir|indinavir|mesh-list
101186922|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186923|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186924|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186925|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186926|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
101186927|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186928|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186929|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186930|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
101186931|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186932|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186933|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186935|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186937|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186939|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186940|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186941|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186942|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
101186943|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186944|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186945|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186946|NCT00002388|Abacavir|abacavir|mesh-list
101186947|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186948|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186949|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186950|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186951|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
101186952|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186953|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186954|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186955|NCT00002394|Terbinafine|terbinafine|mesh-list
101186956|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
101186957|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186958|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186959|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186960|NCT00002400|Lamivudine|lamivudine|mesh-list
101186961|NCT00002400|Zidovudine|zidovudine|mesh-list
101186962|NCT00002400|Delavirdine|delavirdine|mesh-list
101186963|NCT00002400|Indinavir|indinavir|mesh-list
101186964|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186965|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186966|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186967|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186968|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
101186969|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186970|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186971|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186972|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
101186974|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186975|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186976|NCT00002406|Indinavir|indinavir|mesh-list
101186977|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101186978|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101186979|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186980|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186981|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186982|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101186983|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101186984|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
101186985|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186986|NCT00002412|Didanosine|didanosine|mesh-list
101186987|NCT00002412|Stavudine|stavudine|mesh-list
101186988|NCT00002412|Emivirine|emivirine|mesh-list
101186989|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
101186990|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101186991|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
101186992|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101186993|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101186994|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101186995|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
101186996|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101186997|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
101186998|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101186999|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187000|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187001|NCT00002418|Nevirapine|nevirapine|mesh-list
101187002|NCT00002418|Didanosine|didanosine|mesh-list
101187003|NCT00002418|Stavudine|stavudine|mesh-list
101187004|NCT00002418|Emivirine|emivirine|mesh-list
101187005|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
101187006|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187007|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187008|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187009|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187010|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
101187011|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187012|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187013|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101537372|NCT00590603|Vitamins|vitamins|mesh-ancestor
101537373|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
101537374|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
101537375|NCT01085097|Prednisone|prednisone|mesh-list
101187014|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101187015|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101187016|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187017|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
101187018|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
101187020|NCT00002424|Stavudine|stavudine|mesh-list
101187021|NCT00002424|Indinavir|indinavir|mesh-list
101187022|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187023|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187024|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187025|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187026|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
101187027|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187028|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187029|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187030|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
101187031|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101187032|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101187033|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
101187034|NCT00002430|Lamivudine|lamivudine|mesh-list
101187035|NCT00002430|Stavudine|stavudine|mesh-list
101187036|NCT00002430|Nelfinavir|nelfinavir|mesh-list
101187037|NCT00002430|Indinavir|indinavir|mesh-list
101187038|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187039|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187040|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187041|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187042|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
101187043|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187044|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187045|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187046|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101187047|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101187048|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
101187049|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
101187050|NCT00002436|Lamivudine|lamivudine|mesh-list
101187051|NCT00002436|Zidovudine|zidovudine|mesh-list
101187052|NCT00002436|Zalcitabine|zalcitabine|mesh-list
101187053|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187054|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187055|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187056|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187057|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
101187058|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187059|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187060|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187061|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
101187062|NCT00002442|Lamivudine|lamivudine|mesh-list
101187063|NCT00002442|Stavudine|stavudine|mesh-list
101187064|NCT00002442|Nelfinavir|nelfinavir|mesh-list
101187065|NCT00002442|Indinavir|indinavir|mesh-list
101187066|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187067|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187068|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187069|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187070|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
101187071|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187072|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187073|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187074|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101187075|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101187076|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
101187077|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
101187078|NCT00002448|Ritonavir|ritonavir|mesh-list
101187079|NCT00002448|Saquinavir|saquinavir|mesh-list
101187080|NCT00002448|Efavirenz|efavirenz|mesh-list
101187081|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101187082|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101187083|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
101187084|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187085|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187086|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101204374|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187087|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187088|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
101187089|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187090|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101187091|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101187092|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101187093|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187094|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101187095|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101187096|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101187097|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101187098|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101187100|NCT00002460|Goserelin|goserelin|mesh-list
101187101|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101187102|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187103|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187104|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187105|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187106|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187107|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101187108|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101187109|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101187110|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
101187111|NCT00002466|Ifosfamide|ifosfamide|mesh-list
101187112|NCT00002466|Doxorubicin|doxorubicin|mesh-list
101187113|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187114|NCT00002466|Etoposide|etoposide|mesh-list
101187115|NCT00002466|Vincristine|vincristine|mesh-list
101187116|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187117|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
101187118|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187119|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187120|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187121|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
101187122|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187123|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187124|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187125|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187126|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187127|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187128|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187129|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187130|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187131|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187132|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187133|NCT00002472|Etoposide|etoposide|mesh-list
101187134|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187135|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187136|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187137|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187138|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187139|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187140|NCT00002478|Etoposide|etoposide|mesh-list
101187141|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187142|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187143|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187144|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187145|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187146|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187148|NCT00002490|Mitomycin|mitomycin|mesh-list
101187149|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
101187150|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187151|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187152|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
101187153|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187154|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187155|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187156|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101187157|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
101187158|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187159|NCT00002496|Cobalt|cobalt|mesh-list
101187160|NCT00002496|Fluorouracil|fluorouracil|mesh-list
101187161|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187162|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
101187163|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187164|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187165|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187166|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
101187167|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187169|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
101187170|NCT00002502|Cytarabine|cytarabine|mesh-list
101187171|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
101187172|NCT00002502|Busulfan|busulfan|mesh-list
101187173|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187174|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
101187175|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187176|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187177|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187178|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
101187179|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187180|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187181|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187182|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187183|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
101187184|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
101187185|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187187|NCT00002508|Etoposide|etoposide|mesh-list
101187188|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187189|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187190|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187191|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187192|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187193|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187194|NCT00002526|Doxorubicin|doxorubicin|mesh-list
101187195|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187196|NCT00002526|Ifosfamide|ifosfamide|mesh-list
101187197|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187198|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187200|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187201|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187202|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187203|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187204|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
101187205|NCT00002532|Leucovorin|leucovorin|mesh-list
101187206|NCT00002532|Cytarabine|cytarabine|mesh-list
101187207|NCT00002532|Dexamethasone|dexamethasone|mesh-list
101187208|NCT00002532|Prednisolone|prednisolone|mesh-list
101187209|NCT00002532|Methotrexate|methotrexate|mesh-list
101187210|NCT00002532|Etoposide|etoposide|mesh-list
101187212|NCT00002532|Asparaginase|asparaginase|mesh-list
101187213|NCT00002532|Ifosfamide|ifosfamide|mesh-list
101187214|NCT00002532|Idarubicin|idarubicin|mesh-list
101187215|NCT00002532|Vindesine|vindesine|mesh-list
101187216|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
101187217|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187218|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
101187219|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
101187220|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187221|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187222|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187223|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
101187224|NCT00002532|Hormones|hormones|mesh-ancestor
101187225|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187226|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187227|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187228|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187229|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187230|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187231|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187232|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
101187233|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187234|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187235|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187236|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187237|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187238|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
101187239|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187240|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187241|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187242|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187243|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187244|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
101187245|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187247|NCT00002532|Protective Agents|protective agents|mesh-ancestor
101187248|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
101187251|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187252|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187253|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
101187254|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187255|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187256|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187257|NCT00002544|Docetaxel|docetaxel|mesh-list
101187258|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
101187259|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187260|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187261|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187262|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187263|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187264|NCT00002544|Analgesics|analgesics|mesh-ancestor
101187265|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
101187266|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187267|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187268|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187269|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187270|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187271|NCT00002550|Etoposide|etoposide|mesh-list
101187272|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187273|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187274|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187275|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187277|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187278|NCT00002556|Interferons|interferons|mesh-list
101187279|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
101187280|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
101187281|NCT00002556|Prednisone|prednisone|mesh-list
101187282|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
101187283|NCT00002556|Melphalan|melphalan|mesh-list
101187284|NCT00002556|Carmustine|carmustine|mesh-list
101187285|NCT00002556|Vincristine|vincristine|mesh-list
101187286|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187287|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
101187288|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187289|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187290|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187291|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
101187292|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187293|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187294|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187295|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187296|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
101187297|NCT00002556|Hormones|hormones|mesh-ancestor
101187298|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187299|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187300|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
101187301|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187302|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187303|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187304|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187305|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187306|NCT00002562|Paclitaxel|paclitaxel|mesh-list
101187307|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187308|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187309|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187310|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187311|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187312|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187313|NCT00002568|Paclitaxel|paclitaxel|mesh-list
101187314|NCT00002568|Cisplatin|cisplatin|mesh-list
101187315|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187316|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187317|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187318|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187319|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
101537376|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
101537377|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101537378|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101187320|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187321|NCT00002574|Interferons|interferons|mesh-list
101187322|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
101187323|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
101187324|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187325|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
101187327|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
101187328|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187329|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187330|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101187331|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187332|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187333|NCT00002580|Tamoxifen|tamoxifen|mesh-list
101187334|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
101187335|NCT00002580|Fluorouracil|fluorouracil|mesh-list
101187336|NCT00002580|Methotrexate|methotrexate|mesh-list
101187338|NCT00002580|Goserelin|goserelin|mesh-list
101187339|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187340|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
101187341|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187342|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187343|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187344|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
101187345|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187346|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187347|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187348|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
101187349|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187350|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187351|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187352|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187353|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187354|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187355|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187356|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187357|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101187358|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187359|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187360|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187361|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101187362|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101187363|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101187364|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101187365|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
101187366|NCT00002586|Vitamin E|vitamin e|mesh-list
101187367|NCT00002586|Tocopherols|tocopherols|mesh-list
101187368|NCT00002586|Tocotrienols|tocotrienols|mesh-list
101187369|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
101187370|NCT00002586|Tretinoin|tretinoin|mesh-list
101187371|NCT00002586|Isotretinoin|isotretinoin|mesh-list
101187372|NCT00002586|Vitamins|vitamins|mesh-ancestor
101187373|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
101187374|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187375|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
101187376|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187377|NCT00002586|Protective Agents|protective agents|mesh-ancestor
101187378|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187379|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
101187380|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187381|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
101187382|NCT00002592|Busulfan|busulfan|mesh-list
101187383|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187384|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
101187385|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187386|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187387|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187388|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
101187389|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187390|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187391|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187392|NCT00002598|Interferons|interferons|mesh-list
101187393|NCT00002598|Cytarabine|cytarabine|mesh-list
101187394|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
101187395|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
101187397|NCT00002598|Etoposide|etoposide|mesh-list
101187398|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
101187399|NCT00002598|Sargramostim|sargramostim|mesh-list
101187400|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187401|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
101187402|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187404|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187406|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187407|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187408|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187409|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187410|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187411|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187412|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187413|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
101187414|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187415|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187416|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187417|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187418|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187419|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187420|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187421|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
101187422|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187424|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
101187425|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187427|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101187428|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187429|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
101187430|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187431|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187432|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187433|NCT00002610|Dactinomycin|dactinomycin|mesh-list
101187434|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
101187435|NCT00002610|Carboplatin|carboplatin|mesh-list
101187436|NCT00002610|Doxorubicin|doxorubicin|mesh-list
101187437|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187438|NCT00002610|Etoposide|etoposide|mesh-list
101187439|NCT00002610|Vincristine|vincristine|mesh-list
101187440|NCT00002610|Lenograstim|lenograstim|mesh-list
101187441|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187442|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
101187443|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187444|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187445|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187446|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
101187447|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187448|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187449|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187450|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187451|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187452|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187453|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187454|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187455|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101187456|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187457|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187458|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187459|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101187460|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187461|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101187462|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187464|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
101187465|NCT00002616|Thiotepa|thiotepa|mesh-list
101187466|NCT00002616|Carboplatin|carboplatin|mesh-list
101187467|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187468|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
101187469|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187470|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187471|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187472|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
101187473|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221904|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187474|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187475|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187476|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101187477|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101187478|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
101187479|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187481|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
101187483|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187484|NCT00002634|Etoposide|etoposide|mesh-list
101187485|NCT00002634|Vincristine|vincristine|mesh-list
101187486|NCT00002634|Antibodies|antibodies|mesh-list
101187487|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101187488|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187489|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
101187490|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187491|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187492|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187493|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
101187494|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187495|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187496|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187497|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187498|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187499|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187500|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187501|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187502|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187503|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187504|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187505|NCT00002634|Trace Elements|trace elements|mesh-ancestor
101187506|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
101187507|NCT00002646|Tamoxifen|tamoxifen|mesh-list
101187508|NCT00002646|Fenretinide|fenretinide|mesh-list
101187509|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101187510|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187511|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187512|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187513|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187514|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187515|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101187516|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101187517|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101187518|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
101187519|NCT00002646|Protective Agents|protective agents|mesh-ancestor
101187521|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
101187522|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
101187523|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101187524|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187525|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187526|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
101187527|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101187528|NCT00002658|Cytarabine|cytarabine|mesh-list
101187529|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
101187530|NCT00002658|Etoposide|etoposide|mesh-list
101187531|NCT00002658|Daunorubicin|daunorubicin|mesh-list
101187532|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
101187533|NCT00002658|Idarubicin|idarubicin|mesh-list
101187534|NCT00002658|Tretinoin|tretinoin|mesh-list
101187536|NCT00002658|Amsacrine|amsacrine|mesh-list
101187537|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187538|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
101187539|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187540|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187541|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187542|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
101187543|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187544|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187545|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187546|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187547|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187548|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187549|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187550|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187551|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
101187552|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
101187553|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187554|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187555|NCT00002658|Analgesics|analgesics|mesh-ancestor
101187556|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
101187557|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187558|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
101187559|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187560|NCT00002664|Sargramostim|sargramostim|mesh-list
101187561|NCT00002664|Edrecolomab|edrecolomab|mesh-list
101187562|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
101187563|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187564|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101187565|NCT00002670|Cobalt|cobalt|mesh-list
101187566|NCT00002670|Trace Elements|trace elements|mesh-ancestor
101187567|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
101187570|NCT00002676|Cytarabine|cytarabine|mesh-list
101187571|NCT00002676|Dexamethasone|dexamethasone|mesh-list
101187572|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
101187573|NCT00002676|Carmustine|carmustine|mesh-list
101187574|NCT00002676|Doxorubicin|doxorubicin|mesh-list
101187575|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187576|NCT00002676|Methotrexate|methotrexate|mesh-list
101187577|NCT00002676|Vincristine|vincristine|mesh-list
101187578|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187579|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
101187580|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187581|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187582|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187583|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
101187584|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187585|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187586|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187587|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187589|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
101187590|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187591|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187592|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
101187593|NCT00002676|Hormones|hormones|mesh-ancestor
101187594|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187595|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187596|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187597|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187598|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187599|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187600|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187601|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187602|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187603|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187605|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187606|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187607|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187608|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
101187609|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187610|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187611|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187612|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187613|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187614|NCT00002676|Trace Elements|trace elements|mesh-ancestor
101187615|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
101187616|NCT00002682|Amoxicillin|amoxicillin|mesh-list
101187617|NCT00002682|Metronidazole|metronidazole|mesh-list
101187618|NCT00002682|Clarithromycin|clarithromycin|mesh-list
101187619|NCT00002682|Tetracycline|tetracycline|mesh-list
101187620|NCT00002682|Omeprazole|omeprazole|mesh-list
101187621|NCT00002682|Bismuth|bismuth|mesh-list
101187622|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
101187623|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101187624|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187625|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101187626|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101187627|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101187628|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187630|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187631|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187632|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101187633|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101187634|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101187635|NCT00002682|Antacids|antacids|mesh-ancestor
101537379|NCT01085097|Prednisolone|prednisolone|mesh-list
101537380|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
101187636|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
101187637|NCT00002688|Cyclosporine|cyclosporine|mesh-list
101187638|NCT00002688|Etoposide|etoposide|mesh-list
101187639|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
101187640|NCT00002688|Cyclosporins|cyclosporins|mesh-list
101187641|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187642|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187643|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187644|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187645|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187646|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187647|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187648|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
101187649|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187650|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
101187651|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187652|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187653|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187654|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101187655|NCT00002688|Analgesics|analgesics|mesh-ancestor
101187656|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
101187657|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187658|NCT00002700|Leucovorin|leucovorin|mesh-list
101187659|NCT00002700|Cytarabine|cytarabine|mesh-list
101187660|NCT00002700|Dexamethasone|dexamethasone|mesh-list
101187661|NCT00002700|Prednisone|prednisone|mesh-list
101187662|NCT00002700|Prednisolone|prednisolone|mesh-list
101187663|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
101187664|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101187665|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101187666|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101187667|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
101187668|NCT00002700|Doxorubicin|doxorubicin|mesh-list
101187669|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187670|NCT00002700|Methotrexate|methotrexate|mesh-list
101187671|NCT00002700|Vincristine|vincristine|mesh-list
101187672|NCT00002700|Daunorubicin|daunorubicin|mesh-list
101187673|NCT00002700|Asparaginase|asparaginase|mesh-list
101187674|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
101187677|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187678|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
101187679|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187680|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187681|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187682|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
101187683|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187684|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187685|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187686|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187687|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
101187688|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
101187689|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187690|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187691|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
101187692|NCT00002700|Hormones|hormones|mesh-ancestor
101187693|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187694|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187695|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187696|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187697|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187698|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187699|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187700|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187701|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187702|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187703|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
101187704|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187705|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187706|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187707|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
101187708|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187709|NCT00002700|Antidotes|antidotes|mesh-ancestor
101187710|NCT00002700|Protective Agents|protective agents|mesh-ancestor
101187711|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
101187712|NCT00002700|Vitamins|vitamins|mesh-ancestor
101187713|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
101187714|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187715|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187716|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187717|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187718|NCT00002700|Analgesics|analgesics|mesh-ancestor
101187719|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
101187720|NCT00002718|Cytarabine|cytarabine|mesh-list
101187721|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
101187722|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
101187723|NCT00002718|Thiotepa|thiotepa|mesh-list
101187724|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101187725|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187727|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187728|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187729|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187730|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
101187731|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187732|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187733|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187734|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187735|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
101187736|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
101187737|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187738|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187739|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
101187740|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
101187741|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187742|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187743|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
101187745|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187746|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101187747|NCT00002718|Protective Agents|protective agents|mesh-ancestor
101187749|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
101187750|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187751|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
101187752|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187753|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187754|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187755|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187756|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
101187757|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187758|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
101187759|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187760|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187761|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101187762|NCT00002730|Protective Agents|protective agents|mesh-ancestor
101187763|NCT00002742|Amphotericin B|amphotericin b|mesh-list
101187764|NCT00002742|Nystatin|nystatin|mesh-list
101187765|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101187766|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
101187767|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
101187768|NCT00002742|Amebicides|amebicides|mesh-ancestor
101187769|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101187770|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101187771|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187772|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101187773|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
101187774|NCT00002742|Ionophores|ionophores|mesh-ancestor
101187775|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101187776|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187777|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101187778|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187780|NCT00002748|Vaccines|vaccines|mesh-list
101187781|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187782|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101187783|NCT00002748|Analgesics|analgesics|mesh-ancestor
101187784|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
101187785|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187786|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187787|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
101187788|NCT00002754|Antibodies|antibodies|mesh-list
101187789|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101187790|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
101187791|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187792|NCT00002760|Ketoconazole|ketoconazole|mesh-list
101187793|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
101187794|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
101187795|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
101187796|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
101187797|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
101187798|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101187799|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
101187800|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187801|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101187802|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101187804|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187805|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101187806|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187807|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187808|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187809|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101187811|NCT00002772|Paclitaxel|paclitaxel|mesh-list
101187812|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
101187813|NCT00002772|Carboplatin|carboplatin|mesh-list
101187814|NCT00002772|Doxorubicin|doxorubicin|mesh-list
101187815|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187816|NCT00002772|Thiotepa|thiotepa|mesh-list
101187817|NCT00002772|Carmustine|carmustine|mesh-list
101187818|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187819|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187820|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187821|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187822|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187823|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187824|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187825|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
101187826|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187827|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187828|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187829|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
101187830|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187831|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187832|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187833|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187834|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187835|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101187836|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187837|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187838|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187839|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101187840|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101187841|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101187842|NCT00002778|Sargramostim|sargramostim|mesh-list
101187843|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
101187844|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187845|NCT00002784|Tamoxifen|tamoxifen|mesh-list
101187846|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
101187847|NCT00002784|Doxorubicin|doxorubicin|mesh-list
101187848|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101187849|NCT00002784|Fluorouracil|fluorouracil|mesh-list
101187850|NCT00002784|Methotrexate|methotrexate|mesh-list
101187851|NCT00002784|Epirubicin|epirubicin|mesh-list
101187852|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187853|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
101187854|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187855|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187856|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101187857|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
101187858|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187859|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187861|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187862|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101187863|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101187864|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187866|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187867|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187868|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187869|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187870|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187871|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187872|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187873|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101187874|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187875|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187876|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187877|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101187879|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101187880|NCT00002790|Cyclosporine|cyclosporine|mesh-list
101187883|NCT00002790|Cyclosporins|cyclosporins|mesh-list
101187884|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101187885|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
101187886|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187887|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187888|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101187889|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
101187890|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187891|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187892|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
101187893|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101187894|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101187895|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187896|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
101187897|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187898|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101187899|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
101187900|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187901|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101187902|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101187903|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101187904|NCT05752110|Ketamine|ketamine|mesh-list
101187905|NCT05752110|Analgesics|analgesics|mesh-ancestor
101187906|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
101187907|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187908|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187909|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101187910|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101187911|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
101187912|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
101187913|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101187914|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101187915|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101187916|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101187917|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187918|NCT05751876|Dienogest|dienogest|mesh-list
101187919|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101187920|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
101187921|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101187922|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187923|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101187924|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101187925|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101187926|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101187927|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187928|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187929|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101187930|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187931|NCT05751252|Ganirelix|ganirelix|mesh-list
101187932|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
101187933|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101187934|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187935|NCT00002628|Paclitaxel|paclitaxel|mesh-list
101187936|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
101187937|NCT00002628|Carboplatin|carboplatin|mesh-list
101187938|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101187939|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187940|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
101187941|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
101187942|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
101187943|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187944|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101187945|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
101187946|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187947|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101187949|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
101187950|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101187952|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
101187953|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
101187954|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101187955|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187956|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
101187957|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187958|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101187959|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101187960|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101187961|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101187962|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187963|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101187965|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187966|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101187967|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101187968|NCT05748990|Insulin|insulin|mesh-list
101187969|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
101187970|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101187971|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187972|NCT05677698|Peppermint oil|peppermint oil|mesh-list
101187973|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
101187974|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
101187975|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101187976|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187977|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101187978|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
101187979|NCT05588388|Bevacizumab|bevacizumab|mesh-list
101187980|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101187981|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187983|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101187984|NCT05588388|Growth Substances|growth substances|mesh-ancestor
101187985|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187986|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
101187988|NCT05516628|Atezolizumab|atezolizumab|mesh-list
101187989|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101187990|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101187991|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101187992|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101187993|NCT05516628|Growth Substances|growth substances|mesh-ancestor
101187994|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101187995|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
101187996|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101187997|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101187998|NCT05497674|Rifampin|rifampin|mesh-list
101187999|NCT05497674|Probenecid|probenecid|mesh-list
101188000|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101188001|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
101188002|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101188003|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188004|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
101188005|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188007|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188008|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101188009|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101188010|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101188011|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101188012|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101188013|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101188014|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
101188015|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
101188016|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188017|NCT05408910|Rifaximin|rifaximin|mesh-list
101188018|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101188019|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188020|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101188021|NCT05360628|Allopurinol|allopurinol|mesh-list
101188022|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
101188023|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188024|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188025|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
101188026|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537381|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101188027|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101188028|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
101188029|NCT05360628|Protective Agents|protective agents|mesh-ancestor
101188031|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
101188032|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188033|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101188034|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188035|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188037|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188038|NCT05218668|Fasudil|fasudil|mesh-list
101188039|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101188040|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101188041|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188042|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101188043|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188044|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
101188045|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101188047|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
101188048|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188049|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188050|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188051|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188052|NCT05048940|Vaccines|vaccines|mesh-list
101188053|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
101188054|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188055|NCT04836780|Dexamethasone|dexamethasone|mesh-list
101188056|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188057|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
101188058|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
101188059|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188060|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188061|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101188062|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
101188063|NCT04836780|Hormones|hormones|mesh-ancestor
101188064|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188065|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188066|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188067|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
101188068|NCT04740294|Analgesics|analgesics|mesh-ancestor
101188069|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
101188070|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188071|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188072|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
101188073|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188074|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101188075|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
101188076|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101188077|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101188078|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188079|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101188080|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
101188081|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101188083|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188084|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188085|NCT04610736|Temozolomide|temozolomide|mesh-list
101188086|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188087|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
101188088|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188089|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188090|NCT04529538|Vaccines|vaccines|mesh-list
101188091|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
101188092|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188093|NCT04521114|Leronlimab|leronlimab|mesh-list
101188094|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
101188095|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101188096|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101188097|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188098|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101188099|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101188100|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
101188101|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188102|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
101188103|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188104|NCT04519164|Eplerenone|eplerenone|mesh-list
101188105|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
101188106|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101188108|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188109|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188111|NCT04519164|Diuretics|diuretics|mesh-ancestor
101188112|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
101188113|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101188114|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
101188115|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101188116|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188117|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
101188118|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188119|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188120|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188121|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188122|NCT04360824|Enoxaparin|enoxaparin|mesh-list
101188123|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
101188124|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101188125|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101188126|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188127|NCT04331652|Anesthetics|anesthetics|mesh-list
101188128|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188129|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188130|NCT04168710|Bupivacaine|bupivacaine|mesh-list
101188131|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
101188132|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
101188133|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188134|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188135|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
101188136|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188137|NCT04016142|Paclitaxel|paclitaxel|mesh-list
101188138|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101188139|NCT04016142|Carboplatin|carboplatin|mesh-list
101188140|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188141|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188142|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188143|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188144|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188145|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188146|NCT03915678|Atezolizumab|atezolizumab|mesh-list
101188147|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101188148|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188149|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188150|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188151|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188152|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
101188153|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188155|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
101188156|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
101188157|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188158|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101188159|NCT03874338|Colchicine|colchicine|mesh-list
101188160|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
101188161|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188162|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188163|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188164|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188165|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188166|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188167|NCT03846570|Beclomethasone|beclomethasone|mesh-list
101188168|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
101188169|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101188170|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
101188171|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188172|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188173|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101188174|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
101188175|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101188176|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101188177|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101188178|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
101188179|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101188180|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188181|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188182|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
101188183|NCT03846570|Hormones|hormones|mesh-ancestor
101188184|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188185|NCT03838848|Carboplatin|carboplatin|mesh-list
101188186|NCT03838848|Pemetrexed|pemetrexed|mesh-list
101188187|NCT03838848|Antibodies|antibodies|mesh-list
101188188|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
101188189|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
101188190|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188191|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188192|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188193|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188194|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101188195|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188197|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188198|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188199|NCT03782376|Ustekinumab|ustekinumab|mesh-list
101188200|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188203|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188204|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
101188205|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188206|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188207|NCT03737370|Docetaxel|docetaxel|mesh-list
101188208|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188209|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188210|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188211|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188212|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188213|NCT03701490|Progesterone|progesterone|mesh-list
101188214|NCT03701490|Progestins|progestins|mesh-ancestor
101188215|NCT03701490|Hormones|hormones|mesh-ancestor
101188216|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188217|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188218|NCT03691974|Fasinumab|fasinumab|mesh-list
101188219|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101188220|NCT03691974|Analgesics|analgesics|mesh-ancestor
101188221|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
101188222|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188223|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188224|NCT03652428|Paclitaxel|paclitaxel|mesh-list
101188225|NCT03652428|Gemcitabine|gemcitabine|mesh-list
101188226|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188227|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188228|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188229|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188230|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188231|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188232|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188233|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
101188234|NCT03580044|Aztreonam|aztreonam|mesh-list
101188235|NCT03580044|Avibactam|avibactam|mesh-list
101188236|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101188237|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188238|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101188239|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188240|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188241|NCT03459222|Nivolumab|nivolumab|mesh-list
101188242|NCT03459222|Ipilimumab|ipilimumab|mesh-list
101188243|NCT03459222|Relatlimab|relatlimab|mesh-list
101188244|NCT03459222|Linrodostat|linrodostat|mesh-list
101188245|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188246|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188247|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188261|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101188262|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188264|NCT02795988|Capecitabine|capecitabine|mesh-list
101188265|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
101188266|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188267|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
101188268|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188269|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188270|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188271|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
101188272|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188273|NCT02782104|Esketamine|esketamine|mesh-list
101188274|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
101188275|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101188276|NCT01821690|Buspirone|buspirone|mesh-list
101188289|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101188290|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101188291|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
101188292|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188293|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188294|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
101188296|NCT01096368|Carboplatin|carboplatin|mesh-list
101188297|NCT01096368|Etoposide|etoposide|mesh-list
101188298|NCT01096368|Vincristine|vincristine|mesh-list
101221935|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
101221936|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
101221937|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221938|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221939|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221940|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
101221941|NCT01510613|Hormones|hormones|mesh-ancestor
101221942|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221943|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101221944|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221945|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
101221946|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221947|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221965|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
101221966|NCT01510847|Androgens|androgens|mesh-ancestor
101221968|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221969|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221970|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101221971|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101221972|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221973|NCT01510977|Bisacodyl|bisacodyl|mesh-list
101221974|NCT01510977|Cathartics|cathartics|mesh-ancestor
101221975|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101221976|NCT01510977|Laxatives|laxatives|mesh-ancestor
101221977|NCT01510990|Gefitinib|gefitinib|mesh-list
101221978|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221979|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221980|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221981|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221982|NCT01511003|Tacrolimus|tacrolimus|mesh-list
101221983|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221984|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
101221985|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221986|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101221987|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221994|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101221995|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221996|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221997|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221998|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221999|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
101222000|NCT01511029|Protective Agents|protective agents|mesh-ancestor
101222001|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101222002|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101222003|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
101222004|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
101222005|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222006|NCT01511146|Gemcitabine|gemcitabine|mesh-list
101222007|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
101222008|NCT01511146|Mitomycins|mitomycins|mesh-list
101222009|NCT01511146|Mitomycin|mitomycin|mesh-list
101222010|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101222011|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
101222012|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222013|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222014|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101222015|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
101222016|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101222017|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222018|NCT01511159|Insulin|insulin|mesh-list
101222019|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101222020|NCT01511159|Liraglutide|liraglutide|mesh-list
101222021|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222022|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222023|NCT01511159|Incretins|incretins|mesh-ancestor
101222024|NCT01511159|Hormones|hormones|mesh-ancestor
101222025|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222026|NCT01511172|Metformin|metformin|mesh-list
101222027|NCT01511172|Liraglutide|liraglutide|mesh-list
101222028|NCT01511172|Glimepiride|glimepiride|mesh-list
101222029|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222030|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222031|NCT01511172|Incretins|incretins|mesh-ancestor
101222032|NCT01511172|Hormones|hormones|mesh-ancestor
101222033|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222034|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222035|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222036|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
101222037|NCT01511185|Liraglutide|liraglutide|mesh-list
101222038|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222039|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222040|NCT01511185|Incretins|incretins|mesh-ancestor
101222041|NCT01511185|Hormones|hormones|mesh-ancestor
101222042|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222043|NCT01511198|Metformin|metformin|mesh-list
101222044|NCT01511198|Liraglutide|liraglutide|mesh-list
101222049|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222051|NCT01511211|Ropivacaine|ropivacaine|mesh-list
101222052|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222053|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
101222054|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
101222055|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222056|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222057|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222058|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
101222059|NCT01511211|Hormones|hormones|mesh-ancestor
101222060|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222061|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101222062|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222063|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
101222064|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
101222065|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222066|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
101222067|NCT01511237|Lamivudine|lamivudine|mesh-list
101222068|NCT01511237|Zidovudine|zidovudine|mesh-list
101222069|NCT01511237|Nevirapine|nevirapine|mesh-list
101222070|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101222071|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101222072|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222073|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222074|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
101222075|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222076|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101222077|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101222078|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
101222079|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101222080|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101222081|NCT01511263|Amiodarone|amiodarone|mesh-list
101222082|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
101222084|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
101222085|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222086|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
101222087|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
101222088|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222089|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222090|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101222091|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101222092|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101222093|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222094|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101222095|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101222096|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101222097|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
101222098|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222114|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222115|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222116|NCT01511302|Analgesics|analgesics|mesh-ancestor
101222117|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
101222118|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222119|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101222120|NCT01511367|Fluticasone|fluticasone|mesh-list
101222121|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101222122|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101222123|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
101222124|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222125|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222126|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101222127|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
101222128|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
101222129|NCT01511367|Hormones|hormones|mesh-ancestor
101222130|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222131|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
101222132|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222133|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
101222134|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101222135|NCT01511471|Ticagrelor|ticagrelor|mesh-list
101222136|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222137|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101222148|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222149|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222150|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101222151|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222152|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222153|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222154|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101222155|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
101222156|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
101222157|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222158|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222159|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
101222160|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222161|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101222162|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
101222163|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101222164|NCT01511627|Anesthetics|anesthetics|mesh-list
101222165|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222166|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222167|NCT01511692|Liraglutide|liraglutide|mesh-list
101222168|NCT01511692|Glimepiride|glimepiride|mesh-list
101222169|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222170|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222171|NCT01511692|Incretins|incretins|mesh-ancestor
101222172|NCT01511692|Hormones|hormones|mesh-ancestor
101222173|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222174|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222176|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
101222177|NCT01511705|Ondansetron|ondansetron|mesh-list
101222178|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
101222179|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
101222180|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222181|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222182|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222183|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
101222205|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222206|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
101222207|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
101222208|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
101222209|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222210|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222211|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222220|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
101222221|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222222|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222223|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101222224|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101222225|NCT01511770|Fluconazole|fluconazole|mesh-list
101222226|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
101222227|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222228|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
101222229|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101537383|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101537384|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
101537386|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222230|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222231|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222232|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101222233|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
101222234|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222235|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222236|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101222237|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101222238|NCT01511822|Inositol|inositol|mesh-list
101222239|NCT01511822|Drospirenone|drospirenone|mesh-list
101222240|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
101222241|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101222242|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
101222243|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
101222244|NCT01511822|Estradiol|estradiol|mesh-list
101222245|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
101222246|NCT01511822|Estrogens|estrogens|mesh-ancestor
101222247|NCT01511822|Hormones|hormones|mesh-ancestor
101222248|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222249|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222250|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101222251|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
101222252|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101222253|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101222254|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101222255|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101222256|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
101222257|NCT01511822|Vitamins|vitamins|mesh-ancestor
101222258|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
101222259|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101222260|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
101222261|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101222262|NCT01511822|Diuretics|diuretics|mesh-ancestor
101222263|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
101222264|NCT01511835|Folic Acid|folic acid|mesh-list
101222265|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
101222266|NCT01511835|Inositol|inositol|mesh-list
101222267|NCT01511835|Hematinics|hematinics|mesh-ancestor
101222268|NCT01511835|Vitamins|vitamins|mesh-ancestor
101222269|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
101222270|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222284|NCT01511887|Ibuprofen|ibuprofen|mesh-list
101222285|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222286|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222287|NCT01511887|Analgesics|analgesics|mesh-ancestor
101222288|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
101222289|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222291|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222292|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222293|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101222294|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222295|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222296|NCT01511991|Sevoflurane|sevoflurane|mesh-list
101222297|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222298|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101222299|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
101222301|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222302|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222303|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101222304|NCT01512004|Propiverine|propiverine|mesh-list
101222305|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101222306|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101222307|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
101222308|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222309|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222310|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222311|NCT01512004|Urological Agents|urological agents|mesh-ancestor
101222312|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
101221905|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222313|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
101222314|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222315|NCT01512017|Petrolatum|petrolatum|mesh-list
101222316|NCT01512017|Emollients|emollients|mesh-ancestor
101222317|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
101222318|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
101222319|NCT01512147|Propofol|propofol|mesh-list
101222320|NCT01512147|Isoflurane|isoflurane|mesh-list
101222321|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101222322|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222323|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222332|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222333|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222334|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101222335|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
101222336|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
101222337|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101222338|NCT01512173|Propranolol|propranolol|mesh-list
101222339|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101222340|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101222341|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222342|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222343|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222344|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222345|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222346|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101222347|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
101222348|NCT01512199|Paclitaxel|paclitaxel|mesh-list
101222349|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101222350|NCT01512199|Trastuzumab|trastuzumab|mesh-list
101222351|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101222352|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222353|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222354|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
101222355|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
101222356|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
101222357|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222358|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101222359|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
101222360|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222361|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
101222362|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101222363|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222364|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222365|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222366|NCT01512355|Analgesics|analgesics|mesh-ancestor
101222367|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
101222368|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222369|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101222370|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101222371|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101222372|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222373|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222374|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222375|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101222376|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101222377|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101222378|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222379|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222391|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222392|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222393|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222394|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
101222395|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101222396|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
101222397|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
101222398|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222399|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222400|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222401|NCT01512511|Analgesics|analgesics|mesh-ancestor
101222402|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
101222403|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222404|NCT01512537|Vitamin D|vitamin d|mesh-list
101222405|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
101222406|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
101222407|NCT01512537|Vitamins|vitamins|mesh-list
101222408|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
101222410|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101222411|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101222412|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
101222414|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
101222415|NCT01512680|Insulin|insulin|mesh-list
101222416|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222417|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222418|NCT01512784|Vaccines|vaccines|mesh-list
101222419|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
101222420|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222421|NCT01512862|Calcitriol|calcitriol|mesh-list
101222422|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101222423|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222424|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101222425|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222426|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222427|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101222428|NCT01512862|Vitamins|vitamins|mesh-ancestor
101222429|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
101222439|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222440|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222441|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101222442|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
101222443|NCT01512914|Ropivacaine|ropivacaine|mesh-list
101222444|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
101222445|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
101222446|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222447|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222448|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
101222449|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222450|NCT01512953|Lansoprazole|lansoprazole|mesh-list
101222453|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222454|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101222455|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222456|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222457|NCT01512966|Aflibercept|aflibercept|mesh-list
101222458|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101222459|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101222460|NCT01512966|Growth Substances|growth substances|mesh-ancestor
101222461|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222462|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
101222463|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222464|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
101222465|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101222466|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222467|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101222468|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
101222469|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222470|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222471|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222472|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222473|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
101222474|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101222475|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222476|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101222477|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
101222478|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222479|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222480|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222481|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222484|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
101222485|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
101222486|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222487|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222488|NCT01513070|Analgesics|analgesics|mesh-ancestor
101222489|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
101222490|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222491|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222492|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222493|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222494|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101222495|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101222496|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222497|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222498|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101222499|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222500|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
101222501|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101222502|NCT01513070|Diuretics|diuretics|mesh-ancestor
101222503|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
101222504|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
101222505|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101222506|NCT01513083|Trastuzumab|trastuzumab|mesh-list
101222507|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
101222508|NCT01513083|Maytansine|maytansine|mesh-list
101222509|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101222510|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222511|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222512|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
101222513|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
101222514|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
101222515|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222517|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
101222518|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
101222519|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222520|NCT01513174|Olaparib|olaparib|mesh-list
101222521|NCT01513174|Gefitinib|gefitinib|mesh-list
101222522|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101222523|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222524|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222525|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222526|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101222527|NCT01513200|Heparin|heparin|mesh-list
101222528|NCT01513200|Calcium heparin|calcium heparin|mesh-list
101222529|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
101222530|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101222531|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101222532|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222533|NCT01513499|Oxytocin|oxytocin|mesh-list
101222534|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
101222535|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101222536|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222537|NCT01513525|Liraglutide|liraglutide|mesh-list
101222538|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222539|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222540|NCT01513525|Incretins|incretins|mesh-ancestor
101222541|NCT01513525|Hormones|hormones|mesh-ancestor
101222542|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222543|NCT01513564|Morphine|morphine|mesh-list
101222544|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222545|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222546|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101222547|NCT01513564|Narcotics|narcotics|mesh-ancestor
101222548|NCT01513564|Analgesics|analgesics|mesh-ancestor
101222549|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
101222550|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222552|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
101222553|NCT01513603|Cladribine|cladribine|mesh-list
101222554|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101222555|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
101222556|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222557|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222558|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
101222559|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222560|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222561|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
101222562|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222563|NCT01513603|Analgesics|analgesics|mesh-ancestor
101222564|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
101222565|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222572|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
101222573|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222574|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222575|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
101537387|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222576|NCT01513681|Lamotrigine|lamotrigine|mesh-list
101222577|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
101222578|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101222579|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222580|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222581|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101222582|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222586|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101222587|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101222588|NCT01513720|Lamotrigine|lamotrigine|mesh-list
101222589|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
101222590|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101222591|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222592|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222593|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101222594|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222595|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101222596|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101222597|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222598|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101222599|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101222600|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
101222601|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101222602|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222603|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222604|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222605|NCT01513772|Analgesics|analgesics|mesh-ancestor
101222606|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
101222607|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222608|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101222609|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101222610|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101222611|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222612|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222613|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222614|NCT01513785|Amoxicillin|amoxicillin|mesh-list
101222615|NCT01513785|Rabeprazole|rabeprazole|mesh-list
101222616|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222617|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222618|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101222619|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222620|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101222621|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222622|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222623|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101222624|NCT01513863|Metronidazole|metronidazole|mesh-list
101222625|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222626|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222627|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101222628|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101222640|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222641|NCT01514019|Acebutolol|acebutolol|mesh-list
101222642|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222643|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101222644|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
101222645|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
101222646|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222648|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101222649|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101222650|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101222651|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222652|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222653|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222654|NCT01514110|Paclitaxel|paclitaxel|mesh-list
101222655|NCT01514110|Carboplatin|carboplatin|mesh-list
101222656|NCT01514110|Everolimus|everolimus|mesh-list
101222657|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222658|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222659|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
101222660|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
101222661|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
101222662|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222663|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101222664|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101222665|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222666|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222667|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
101222668|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222669|NCT01514123|Bevacizumab|bevacizumab|mesh-list
101222670|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101222671|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222672|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101222673|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101222674|NCT01514123|Growth Substances|growth substances|mesh-ancestor
101222675|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222676|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
101222678|NCT01514175|Ketorolac|ketorolac|mesh-list
101222679|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222680|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222681|NCT01514175|Analgesics|analgesics|mesh-ancestor
101222682|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
101222683|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222684|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222685|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222694|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222695|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222696|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222697|NCT01514227|Aspirin|aspirin|mesh-list
101222698|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222699|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222700|NCT01514227|Analgesics|analgesics|mesh-ancestor
101222701|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
101222702|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222703|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222704|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222705|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222706|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101222707|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101222708|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222709|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222710|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101222711|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222712|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
101222713|NCT01514266|Curcumin|curcumin|mesh-list
101222714|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101222715|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101222716|NCT01514266|Analgesics|analgesics|mesh-ancestor
101222717|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
101222718|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222719|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222720|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222721|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222722|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222723|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222724|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222725|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
101222726|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101222727|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
101222728|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101222729|NCT01514487|Liraglutide|liraglutide|mesh-list
101222730|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222731|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222732|NCT01514487|Incretins|incretins|mesh-ancestor
101222733|NCT01514487|Hormones|hormones|mesh-ancestor
101222734|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222735|NCT01514695|Fentanyl|fentanyl|mesh-list
101222737|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101222738|NCT01514695|Narcotics|narcotics|mesh-ancestor
101222750|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101222751|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101222752|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
101222753|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
101222754|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222755|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222757|NCT01514721|Travoprost|travoprost|mesh-list
101222758|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222759|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101222760|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101222761|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
101222762|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222763|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222764|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222765|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101222766|NCT01514812|Digoxin|digoxin|mesh-list
101222767|NCT01514812|Darexaban|darexaban|mesh-list
101222768|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101222769|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101222770|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222771|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222772|NCT01514812|Protective Agents|protective agents|mesh-ancestor
101222773|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222774|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101222775|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
101222776|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101222777|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
101222778|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
101222779|NCT01514825|Darexaban|darexaban|mesh-list
101222780|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101222781|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
101222782|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101222783|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
101222785|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222786|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
101222788|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
101222789|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
101222790|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222791|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222797|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101222798|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222799|NCT01514851|Antacids|antacids|mesh-ancestor
101222800|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222801|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222802|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
101222803|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222804|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222805|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101222806|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222807|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222808|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222809|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222810|NCT01514942|Folic Acid|folic acid|mesh-list
101222811|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
101222812|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
101222813|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
101222814|NCT01514942|Inositol|inositol|mesh-list
101222815|NCT01514942|Manganese|manganese|mesh-list
101222816|NCT01514942|Hematinics|hematinics|mesh-ancestor
101222817|NCT01514942|Vitamins|vitamins|mesh-ancestor
101222818|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
101222819|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222820|NCT01514942|Trace Elements|trace elements|mesh-ancestor
101222821|NCT01514968|Cyclosporine|cyclosporine|mesh-list
101222822|NCT01514968|Ritonavir|ritonavir|mesh-list
101222823|NCT01514968|Cyclosporins|cyclosporins|mesh-list
101222824|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222825|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222826|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222827|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
101222828|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222829|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
101222830|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222831|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101222832|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101222833|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101222834|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101222835|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101222836|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
101222837|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101222838|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101222839|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
101222840|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101222841|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101537400|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101537401|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101537403|NCT00590837|Lomustine|lomustine|mesh-list
101222842|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
101222843|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222844|NCT01515020|Vancomycin|vancomycin|mesh-list
101222845|NCT01515020|Daptomycin|daptomycin|mesh-list
101222846|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222847|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222848|NCT01515228|Paclitaxel|paclitaxel|mesh-list
101222849|NCT01515228|Everolimus|everolimus|mesh-list
101222850|NCT01515228|Cilostazol|cilostazol|mesh-list
101222851|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101222852|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222860|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101222861|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
101222862|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222863|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101222864|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
101222865|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222866|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101222867|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
101222868|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101222869|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101222870|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101222871|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
101222872|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101222873|NCT01515228|Protective Agents|protective agents|mesh-ancestor
101222874|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101222875|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101222876|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
101222877|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101222878|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222879|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222880|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101222881|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101222882|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222883|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
101222884|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222886|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
101222887|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
101222888|NCT01515553|Liraglutide|liraglutide|mesh-list
101222889|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222890|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222891|NCT01515553|Incretins|incretins|mesh-ancestor
101222892|NCT01515553|Hormones|hormones|mesh-ancestor
101222893|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222894|NCT01515579|Liraglutide|liraglutide|mesh-list
101222895|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222896|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222897|NCT01515579|Incretins|incretins|mesh-ancestor
101222898|NCT01515579|Hormones|hormones|mesh-ancestor
101222899|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222900|NCT01515592|Liraglutide|liraglutide|mesh-list
101222901|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101222902|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222903|NCT01515592|Incretins|incretins|mesh-ancestor
101222904|NCT01515592|Hormones|hormones|mesh-ancestor
101222905|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222906|NCT01515683|Anesthetics|anesthetics|mesh-list
101222907|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101222908|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222909|NCT01515774|Pramipexole|pramipexole|mesh-list
101222910|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
101222912|NCT01515774|Protective Agents|protective agents|mesh-ancestor
101222913|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222915|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101222916|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
101222917|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
101222918|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222919|NCT01515813|Tenofovir|tenofovir|mesh-list
101222920|NCT01515813|Emtricitabine|emtricitabine|mesh-list
101222921|NCT01515813|Efavirenz|efavirenz|mesh-list
101222922|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101537414|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537415|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101222923|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
101222924|NCT01515813|Pravastatin|pravastatin|mesh-list
101222925|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
101222926|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222927|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101222928|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101222929|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222930|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222931|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101222932|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101222933|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101222934|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101222935|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101222936|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101222937|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101222938|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101222939|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101222940|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101222941|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
101222942|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101222943|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101222944|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
101222945|NCT01515826|Dexamethasone|dexamethasone|mesh-list
101222946|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
101222947|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101222948|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101222949|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101222950|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
101222951|NCT01515826|BB 1101|bb 1101|mesh-list
101222952|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101222953|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
101222954|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
101222955|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101222956|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101222957|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101222958|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
101222959|NCT01515826|Hormones|hormones|mesh-ancestor
101222960|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101222961|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101222962|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222963|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
101222964|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222965|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101222966|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101222967|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222968|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101222969|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101222970|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101222971|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
101222972|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101222986|NCT01515839|Vitamins|vitamins|mesh-ancestor
101222987|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
101222988|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
101222989|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101222990|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101222991|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
101222992|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101222993|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101222994|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
101222995|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101222996|NCT01515839|Expectorants|expectorants|mesh-ancestor
101222997|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
101222998|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101222999|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101223000|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
101223001|NCT01515852|Anesthetics|anesthetics|mesh-list
101223002|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101223003|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223004|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
101223005|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
101223006|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101223007|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223008|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101223009|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223010|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223011|NCT01516060|Efavirenz|efavirenz|mesh-list
101223012|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101223013|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101223014|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223015|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223017|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223018|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101223019|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101223020|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
101223021|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101223022|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101223023|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101223024|NCT01516138|Insulin|insulin|mesh-list
101223025|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223026|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223027|NCT01516255|Liraglutide|liraglutide|mesh-list
101223029|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223030|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223043|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101223044|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101223045|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223046|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223047|NCT01514903|Urological Agents|urological agents|mesh-ancestor
101223048|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
101223049|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
101223050|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223051|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223052|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223053|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223054|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223055|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223056|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223057|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101223058|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
101223059|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223060|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223061|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
101223062|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101223063|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101223064|NCT01516450|Belimumab|belimumab|mesh-list
101223065|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223066|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
101223067|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223068|NCT01516463|Bacitracin|bacitracin|mesh-list
101223069|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101223070|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223071|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223072|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
101223073|NCT01516554|Testosterone|testosterone|mesh-list
101223074|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
101223075|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
101223089|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223090|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
101223091|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223092|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101223093|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101223094|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
101223095|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223096|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223097|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101223098|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101223099|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101223100|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223101|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101223102|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223103|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223104|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223105|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223106|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101223107|NCT01516580|Cytarabine|cytarabine|mesh-list
101223108|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
101223109|NCT01516580|Rituximab|rituximab|mesh-list
101223110|NCT01516580|Doxorubicin|doxorubicin|mesh-list
101223111|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101223112|NCT01516580|Methotrexate|methotrexate|mesh-list
101223113|NCT01516580|Vincristine|vincristine|mesh-list
101223114|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223115|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
101223116|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223117|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101223118|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101223119|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
101223120|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223121|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223122|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101223123|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101223124|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101223125|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101223127|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223128|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101223129|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
101223130|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101223131|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101223132|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
101223133|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101223134|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101223135|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101223136|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
101223137|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223138|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101223139|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
101223140|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
101223141|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
101223143|NCT01516710|Hematinics|hematinics|mesh-ancestor
101223144|NCT01516723|Sirolimus|sirolimus|mesh-list
101223145|NCT01516723|Everolimus|everolimus|mesh-list
101223146|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
101223147|NCT01516723|Temsirolimus|temsirolimus|mesh-list
101223148|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101223149|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223150|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223151|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101223152|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
101223153|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223154|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223155|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101223156|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223157|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101223158|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
101223159|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
101223160|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223161|NCT01516814|Heparin|heparin|mesh-list
101223162|NCT01516814|Calcium heparin|calcium heparin|mesh-list
101223163|NCT01516814|Warfarin|warfarin|mesh-list
101223164|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
101223165|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
101223166|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101223167|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101223170|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
101223171|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101223172|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
101223173|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223174|NCT01516840|Heparin|heparin|mesh-list
101223175|NCT01516840|Calcium heparin|calcium heparin|mesh-list
101223176|NCT01516840|Warfarin|warfarin|mesh-list
101223177|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
101223178|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
101223179|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101223180|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101223181|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223182|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101223183|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
101223184|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101223185|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
101537495|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537496|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101537497|NCT02210754|Protective Agents|protective agents|mesh-ancestor
101221822|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221823|NCT01509742|Incretins|incretins|mesh-ancestor
101221825|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221826|NCT01509755|Liraglutide|liraglutide|mesh-list
101221827|NCT01509755|Glimepiride|glimepiride|mesh-list
101221828|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221829|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221830|NCT01509755|Incretins|incretins|mesh-ancestor
101221831|NCT01509755|Hormones|hormones|mesh-ancestor
101221832|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221833|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101221834|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221836|NCT01509911|Gemcitabine|gemcitabine|mesh-list
101221837|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101221838|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
101221839|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221840|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221841|NCT01509976|Triclosan|triclosan|mesh-list
101221842|NCT01509976|Triclocarban|triclocarban|mesh-list
101221843|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101221844|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537502|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537503|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537513|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101537514|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537515|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537516|NCT04573049|Protective Agents|protective agents|mesh-ancestor
101537528|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537529|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101537530|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537532|NCT04991103|Lenalidomide|lenalidomide|mesh-list
101537533|NCT04991103|Bortezomib|bortezomib|mesh-list
101537541|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
101537559|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537560|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101537562|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
101537570|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101537598|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537599|NCT03450161|Fentanyl|fentanyl|mesh-list
101537600|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101537612|NCT04565184|Lumefantrine|lumefantrine|mesh-list
101537613|NCT04565184|Artemether|artemether|mesh-list
101537618|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101537619|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101537624|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
101537625|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
101537626|NCT03452579|Bevacizumab|bevacizumab|mesh-list
101537663|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101537664|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101537666|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101537668|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537672|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101537676|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537677|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
101537678|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101537679|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
101537680|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101537681|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101537682|NCT04564326|Fentanyl|fentanyl|mesh-list
101537683|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101537684|NCT04564326|Narcotics|narcotics|mesh-ancestor
101537685|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537726|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
101537727|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537728|NCT00196976|Antidotes|antidotes|mesh-ancestor
101537729|NCT00196976|Protective Agents|protective agents|mesh-ancestor
101537730|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
101537791|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101537792|NCT00195494|Analgesics|analgesics|mesh-ancestor
101537793|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
101537862|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
101537863|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101537865|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537866|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
101537867|NCT00194012|Aripiprazole|aripiprazole|mesh-list
101537868|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
101537869|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101537870|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101537871|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101537872|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101537873|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101537874|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
101537875|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
101537876|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101537877|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537916|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101537917|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101537918|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101537919|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101537983|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101537991|NCT00179660|Lenalidomide|lenalidomide|mesh-list
101538052|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101538053|NCT04559568|Midazolam|midazolam|mesh-list
101538054|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101538055|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101538058|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101538110|NCT00176462|Protective Agents|protective agents|mesh-ancestor
101538182|NCT00476606|Nelfinavir|nelfinavir|mesh-list
101538183|NCT00476606|Indinavir|indinavir|mesh-list
101538184|NCT00476606|Saquinavir|saquinavir|mesh-list
101538185|NCT00476606|Lamivudine|lamivudine|mesh-list
101538774|NCT01084655|Docetaxel|docetaxel|mesh-list
101538775|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101538776|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
101538834|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
101538835|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
101538836|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101538837|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101538838|NCT01083602|Dexamethasone|dexamethasone|mesh-list
101539102|NCT04550949|Denosumab|denosumab|mesh-list
101539643|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101539644|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
101539645|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101539646|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101539647|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101539693|NCT00575978|Hydralazine|hydralazine|mesh-list
101539694|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101539695|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
101539696|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101539697|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101539698|NCT04539054|Caffeine|caffeine|mesh-list
101539699|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101539700|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101539701|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101539708|NCT00576017|Fentanyl|fentanyl|mesh-list
101539945|NCT04545801|Analgesics|analgesics|mesh-ancestor
101539946|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
101539952|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
101540004|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540007|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101540008|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
101540074|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540076|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
101540077|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540078|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101540079|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101540080|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540138|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101540139|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101540210|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
101540211|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101540212|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
101540213|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540214|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101540215|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101540216|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
101540217|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
101540218|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
101540219|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540220|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
101540221|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101540226|NCT02216058|Sirolimus|sirolimus|mesh-list
101540264|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101540265|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540330|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
101540331|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
101540332|NCT04536831|Vitamins|vitamins|mesh-list
101540333|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
101540334|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540335|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101540337|NCT02214966|Telmisartan|telmisartan|mesh-list
101540390|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
101540391|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101540392|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
101540393|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101540394|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540395|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
101540396|NCT04535973|Hormones|hormones|mesh-list
101540397|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101540398|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540399|NCT04536051|Acetaminophen|acetaminophen|mesh-list
101540400|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101540401|NCT04536051|Analgesics|analgesics|mesh-ancestor
101540409|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101540410|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101540411|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540412|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101540413|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
101540414|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540437|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540769|NCT02882113|Tacrolimus|tacrolimus|mesh-list
101540770|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101540771|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
101540772|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540773|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101540774|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540775|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540776|NCT04530045|Piperacillin|piperacillin|mesh-list
101540777|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101540778|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101540779|NCT01121536|Modafinil|modafinil|mesh-list
101540780|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101540781|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540782|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
101540783|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101540784|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101540785|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540786|NCT00580619|Methyldopa|methyldopa|mesh-list
101540787|NCT00580619|Trimethaphan|trimethaphan|mesh-list
101540788|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
101540789|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540790|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101540791|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
101540792|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
101540854|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101540855|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540858|NCT04577846|Cephalexin|cephalexin|mesh-list
101540878|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101540879|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101540880|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
101540881|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101540882|NCT01120600|Vitamin D|vitamin d|mesh-list
101540896|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
101540899|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
101540964|NCT02218398|Albuterol|albuterol|mesh-list
101540965|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101540966|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
101540967|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101540968|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101540969|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101541042|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101541240|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541241|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
101541242|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101541243|NCT01642134|Aspirin|aspirin|mesh-list
101541353|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101541429|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101541430|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
101541431|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101541500|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101541501|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101541502|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
101541503|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
101541504|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
101541505|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101541506|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101541507|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101541508|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101541565|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101541566|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
101541567|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101541568|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
101541569|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
101541570|NCT04550078|Calcium|calcium|mesh-list
101541571|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101541572|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101541573|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101541629|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101541956|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101541957|NCT01646229|Polymyxins|polymyxins|mesh-list
101542011|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101542012|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
101542013|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
101542014|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
101542015|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
101542016|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101542054|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101542055|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
101542056|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101542505|NCT01201798|Prednisolone|prednisolone|mesh-list
101542506|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101542507|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
101542508|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101542560|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101542561|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101542562|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101542564|NCT01200589|Ofatumumab|ofatumumab|mesh-list
101542565|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101542630|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
101543165|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101543167|NCT04529525|Ivermectin|ivermectin|mesh-list
101543168|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101543169|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543170|NCT02216409|Magrolimab|magrolimab|mesh-list
101543171|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101543172|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101543173|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101543174|NCT05126121|Amoxicillin|amoxicillin|mesh-list
101543175|NCT05126121|Clarithromycin|clarithromycin|mesh-list
101543176|NCT05126121|Levofloxacin|levofloxacin|mesh-list
101543177|NCT05126121|Ofloxacin|ofloxacin|mesh-list
101543178|NCT05126121|Tetracycline|tetracycline|mesh-list
101543179|NCT05126121|Tinidazole|tinidazole|mesh-list
101543180|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101543181|NCT05126121|Furazolidone|furazolidone|mesh-list
101543182|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543557|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101543558|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
101543559|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101543560|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
101543561|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
101543562|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101543563|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
101544034|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544035|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101544037|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
101544038|NCT01681667|Ibuprofen|ibuprofen|mesh-list
101544039|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101544040|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101544041|NCT01681667|Analgesics|analgesics|mesh-ancestor
101544042|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
101544043|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101544044|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544045|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101544046|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101544047|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101544048|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101544049|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101544050|NCT01600365|Ganciclovir|ganciclovir|mesh-list
101544051|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101544052|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
101544053|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
101544054|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101544082|NCT01603134|Allopurinol|allopurinol|mesh-list
101544426|NCT01608750|Folic Acid|folic acid|mesh-list
101544427|NCT01608750|Hematinics|hematinics|mesh-ancestor
101544428|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
101544494|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
101544495|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101544496|NCT01648556|Prednisone|prednisone|mesh-list
101544565|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101544567|NCT01688700|Paclitaxel|paclitaxel|mesh-list
101544568|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
101544569|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101544632|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101544633|NCT01689051|Glucagon|glucagon|mesh-list
101544634|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
101544701|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101544772|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545130|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101545131|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545132|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101545193|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101545195|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101545196|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
101545198|NCT01588704|Pemetrexed|pemetrexed|mesh-list
101545260|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
101545261|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101545262|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545330|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
101545331|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101545864|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101545865|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101545928|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
101545929|NCT01193218|Empagliflozin|empagliflozin|mesh-list
101545932|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101545994|NCT02894268|Antacids|antacids|mesh-ancestor
101545995|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101545996|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101545997|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
101546063|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101546064|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101546065|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101546066|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
101546067|NCT00592137|Calcium|calcium|mesh-list
101546068|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101546071|NCT04455776|Propofol|propofol|mesh-list
101546131|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
101546132|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
101546272|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101546819|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101546820|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101546821|NCT01601522|Ranitidine|ranitidine|mesh-list
101546822|NCT01601522|Desloratadine|desloratadine|mesh-list
101546823|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
101546824|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
101546825|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101546884|NCT00593463|Cycloserine|cycloserine|mesh-list
101546885|NCT00593463|Verapamil|verapamil|mesh-list
101546886|NCT00593463|Diltiazem|diltiazem|mesh-list
101546887|NCT00593463|Isradipine|isradipine|mesh-list
101546888|NCT00593463|Nifedipine|nifedipine|mesh-list
101546889|NCT00593463|Gabapentin|gabapentin|mesh-list
101546890|NCT00593463|Naloxone|naloxone|mesh-list
101546891|NCT00593463|Analgesics|analgesics|mesh-ancestor
101546892|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
101546893|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101546894|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101546895|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
101546896|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101546897|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101546898|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101546899|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101546900|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101546920|NCT00592410|Insulin|insulin|mesh-list
101547178|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101547179|NCT02271542|Propofol|propofol|mesh-list
101547180|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101547181|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547228|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
101547229|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101547230|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101547291|NCT02272517|Escitalopram|escitalopram|mesh-list
101547292|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101547293|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101547294|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547355|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547356|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101547357|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101547365|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
101547420|NCT01588847|Bupivacaine|bupivacaine|mesh-list
101547421|NCT01588847|Anesthetics|anesthetics|mesh-list
101547422|NCT01588847|Propofol|propofol|mesh-list
101547423|NCT01588847|Sevoflurane|sevoflurane|mesh-list
101547424|NCT01588847|Rocuronium|rocuronium|mesh-list
101547425|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
101547426|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101547486|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547488|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101547489|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
101547490|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101547491|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101547492|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101547493|NCT00107198|Prednisone|prednisone|mesh-list
101547494|NCT00107198|Cortisone|cortisone|mesh-list
101547495|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
101547496|NCT00107198|Doxorubicin|doxorubicin|mesh-list
101547497|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101547547|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547598|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101547607|NCT01332968|Hormones|hormones|mesh-ancestor
101547662|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101547663|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101547664|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101547665|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101547666|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101547667|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101548485|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
101548486|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101549193|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101549194|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549195|NCT01312467|Metformin|metformin|mesh-list
101549196|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101549197|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549198|NCT01310127|Nepafenac|nepafenac|mesh-list
101549199|NCT01310127|Bromfenac|bromfenac|mesh-list
101549204|NCT01310127|Analgesics|analgesics|mesh-ancestor
101549893|NCT02890719|Ribavirin|ribavirin|mesh-list
101549894|NCT02890719|Grazoprevir|grazoprevir|mesh-list
101549895|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
101549896|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101549897|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
101549902|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101549953|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101549955|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
101549956|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101549957|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
101549958|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101549959|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
101549960|NCT04327427|Aspirin|aspirin|mesh-list
101549961|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101549962|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101549963|NCT04327427|Analgesics|analgesics|mesh-ancestor
101550016|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101550017|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550019|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101550020|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
101550021|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
101550022|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
101550023|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
101550024|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101550025|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550026|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
101550027|NCT00593801|Hematinics|hematinics|mesh-ancestor
101550077|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101550078|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101550079|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
101550080|NCT04326959|Hormones|hormones|mesh-ancestor
101550081|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101550082|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101550140|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101550141|NCT00596531|Acamprosate|acamprosate|mesh-list
101550143|NCT00596609|Morphine|morphine|mesh-list
101221781|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221906|NCT01510522|Metformin|metformin|mesh-list
101222630|NCT01513941|Ribavirin|ribavirin|mesh-list
101223028|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
101188301|NCT01096368|Lenograstim|lenograstim|mesh-list
101188302|NCT01096368|Mesna|mesna|mesh-list
101188303|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188304|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
101188305|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188306|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188307|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188309|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188310|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188311|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188312|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188313|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188314|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188315|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188316|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188317|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188318|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188319|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188320|NCT01096368|Protective Agents|protective agents|mesh-ancestor
101188321|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
101188322|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188323|NCT00978822|Clevidipine|clevidipine|mesh-list
101188324|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101188325|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101188326|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188327|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101188328|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188329|NCT00577200|Midazolam|midazolam|mesh-list
101188330|NCT00577200|Sufentanil|sufentanil|mesh-list
101188331|NCT00577200|Propofol|propofol|mesh-list
101188332|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101188333|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188334|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188335|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101188336|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
101188337|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
101188340|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101188341|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101188342|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
101188343|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
101188344|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101188345|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188346|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101188347|NCT00577200|Narcotics|narcotics|mesh-ancestor
101188348|NCT00577200|Analgesics|analgesics|mesh-ancestor
101188349|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
101188350|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188351|NCT00002796|Interferons|interferons|mesh-list
101188352|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
101188353|NCT00002796|Indomethacin|indomethacin|mesh-list
101188354|NCT00002796|Fluorouracil|fluorouracil|mesh-list
101188355|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
101188356|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
101188357|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188358|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188359|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188360|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188399|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188400|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188401|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188402|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188403|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188404|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188405|NCT00002802|Trace Elements|trace elements|mesh-ancestor
101188406|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
101188407|NCT00002814|Paclitaxel|paclitaxel|mesh-list
101188408|NCT00002814|Topotecan|topotecan|mesh-list
101188409|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188410|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188411|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188412|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188413|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188414|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188415|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101188416|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188417|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188418|NCT00002832|Cyclosporine|cyclosporine|mesh-list
101188419|NCT00002832|Decitabine|decitabine|mesh-list
101188420|NCT00002832|Cyclosporins|cyclosporins|mesh-list
101188421|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
101188422|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188423|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188424|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188425|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188426|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
101188427|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188428|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188429|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188430|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101188431|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188443|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188444|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188445|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188446|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188447|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
101188448|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
101188449|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188450|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
101188451|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188452|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188453|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188454|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
101188455|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188456|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188457|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188458|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
101188503|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101188504|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188505|NCT00002904|Trabectedin|trabectedin|mesh-list
101188506|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188507|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
101188508|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188509|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188510|NCT00002928|Paclitaxel|paclitaxel|mesh-list
101188511|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188512|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188513|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188514|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188515|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188516|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188518|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188519|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
101188520|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188521|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188522|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188523|NCT00002946|Penclomedine|penclomedine|mesh-list
101188524|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188525|NCT00002952|Interleukin-12|interleukin-12|mesh-list
101188526|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188527|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
101188528|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188553|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
101188554|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188555|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101188556|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188557|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
101188558|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188559|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188560|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
101188561|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188562|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188563|NCT00002976|Estrogens|estrogens|mesh-list
101188565|NCT00002976|Hormones|hormones|mesh-ancestor
101188566|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188567|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188568|NCT00002982|Cytarabine|cytarabine|mesh-list
101188569|NCT00002982|Carboplatin|carboplatin|mesh-list
101188570|NCT00002982|Etoposide|etoposide|mesh-list
101188571|NCT00002982|Melphalan|melphalan|mesh-list
101188572|NCT00002982|Ifosfamide|ifosfamide|mesh-list
101188573|NCT00002982|Carmustine|carmustine|mesh-list
101188574|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188575|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188576|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188577|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188578|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188579|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188580|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188581|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
101188582|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
101188583|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101188585|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
101188602|NCT00002994|Analgesics|analgesics|mesh-ancestor
101188603|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
101188604|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188605|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188623|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188624|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
101188625|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188626|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188627|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188628|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
101188629|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188630|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188632|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
101188685|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188686|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188687|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188688|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188689|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
101188690|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188691|NCT00003072|Paclitaxel|paclitaxel|mesh-list
101188692|NCT00003072|Carboplatin|carboplatin|mesh-list
101188693|NCT00003072|Amifostine|amifostine|mesh-list
101188694|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188695|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188696|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188704|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188705|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
101188706|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188707|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188708|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188709|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
101188710|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188754|NCT00003114|Procarbazine|procarbazine|mesh-list
101188755|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188756|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
101188757|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188758|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188759|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188760|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
101188761|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188762|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188763|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188764|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188765|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188766|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188767|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188769|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188770|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188771|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188772|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188773|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188774|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188775|NCT00003126|Aldesleukin|aldesleukin|mesh-list
101188776|NCT00003126|Interleukin-2|interleukin-2|mesh-list
101188777|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188778|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101188779|NCT00003126|Analgesics|analgesics|mesh-ancestor
101188780|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
101188781|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188804|NCT00003150|Doxorubicin|doxorubicin|mesh-list
101188806|NCT00003150|Vincristine|vincristine|mesh-list
101188807|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188808|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
101188809|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188810|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101188811|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188812|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
101188813|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188814|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188815|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188816|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188817|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188818|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101188819|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188820|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188821|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188822|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
101188823|NCT00003150|Hormones|hormones|mesh-ancestor
101188824|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188825|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188826|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188827|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188828|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188829|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188830|NCT00003156|Topotecan|topotecan|mesh-list
101188831|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101188832|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101188833|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188834|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188835|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188837|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
101188838|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188839|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188840|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
101188841|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188842|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101188843|NCT00003018|Leucovorin|leucovorin|mesh-list
101188844|NCT00003018|Fluorouracil|fluorouracil|mesh-list
101188845|NCT00003018|Mitomycins|mitomycins|mesh-list
101188846|NCT00003018|Mitomycin|mitomycin|mesh-list
101188847|NCT00003018|Dipyridamole|dipyridamole|mesh-list
101188848|NCT00003018|Calcium|calcium|mesh-list
101188849|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
101188850|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101188851|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188852|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
101188853|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188854|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188855|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188856|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188857|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
101188858|NCT00003018|Antidotes|antidotes|mesh-ancestor
101188859|NCT00003018|Protective Agents|protective agents|mesh-ancestor
101188860|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
101188861|NCT00003018|Vitamins|vitamins|mesh-ancestor
101188862|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
101188894|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101188895|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101188896|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
101188897|NCT00003204|Hormones|hormones|mesh-ancestor
101188898|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101188899|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188900|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101188932|NCT00003240|Ifosfamide|ifosfamide|mesh-list
101188970|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
101188971|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188972|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188973|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101188974|NCT00003294|Paclitaxel|paclitaxel|mesh-list
101188975|NCT00003294|Carboplatin|carboplatin|mesh-list
101188976|NCT00003294|Amifostine|amifostine|mesh-list
101188977|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101188978|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188979|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
101188980|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188981|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188982|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189034|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189035|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189036|NCT00003348|Carmustine|carmustine|mesh-list
101189037|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
101189038|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189039|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
101189040|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189041|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189042|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189043|NCT00003360|Antibodies|antibodies|mesh-list
101189044|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101189045|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
101189046|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189047|NCT00003372|Topotecan|topotecan|mesh-list
101189048|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101189049|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189050|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189051|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189052|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189053|NCT00003378|Paclitaxel|paclitaxel|mesh-list
101189054|NCT00003378|Carboplatin|carboplatin|mesh-list
101189055|NCT00003378|Gemcitabine|gemcitabine|mesh-list
101189056|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189057|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189058|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189059|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189061|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189062|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189063|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
101189065|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189066|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
101189067|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189068|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189077|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
101189078|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189079|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189080|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189081|NCT00003402|Dexamethasone|dexamethasone|mesh-list
101189082|NCT00003402|Paclitaxel|paclitaxel|mesh-list
101189083|NCT00003402|Etoposide|etoposide|mesh-list
101189084|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
101189085|NCT00003402|Melphalan|melphalan|mesh-list
101189086|NCT00003402|Carmustine|carmustine|mesh-list
101189087|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189088|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189089|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189090|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189091|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189092|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189093|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189094|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
101189095|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189096|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189097|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189098|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
101189099|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189100|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101189101|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
101189102|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
101189103|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189104|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101189105|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
101189106|NCT00003402|Hormones|hormones|mesh-ancestor
101189107|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189108|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101189109|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189110|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189120|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189121|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101189122|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101189124|NCT00003414|Aldesleukin|aldesleukin|mesh-list
101189125|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
101189126|NCT00003414|Cyclosporine|cyclosporine|mesh-list
101189127|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
101189128|NCT00003414|Busulfan|busulfan|mesh-list
101189129|NCT00003414|Cyclosporins|cyclosporins|mesh-list
101189130|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189131|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
101189132|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189133|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189134|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189135|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
101189136|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189137|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189138|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189139|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
101189140|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189141|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189142|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
101189143|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189144|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101189145|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101189146|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101189147|NCT00003426|Gemcitabine|gemcitabine|mesh-list
101189148|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189149|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
101189150|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189151|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189152|NCT00003462|Busulfan|busulfan|mesh-list
101189153|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
101189154|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189155|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189156|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
101189157|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189158|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189159|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189160|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189161|NCT00003528|Raltitrexed|raltitrexed|mesh-list
101189162|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189163|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
101189164|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189165|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189166|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101189167|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189168|NCT00003540|Gemcitabine|gemcitabine|mesh-list
101189169|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189170|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
101189171|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189172|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189173|NCT00003546|Gemcitabine|gemcitabine|mesh-list
101189174|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189175|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
101189178|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
101189215|NCT00003558|Vitamins|vitamins|mesh-ancestor
101189216|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
101189217|NCT00003564|Procarbazine|procarbazine|mesh-list
101189233|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189234|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189235|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189236|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189237|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189238|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
101189239|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189240|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189241|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
101189242|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189243|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101189244|NCT00003582|Protective Agents|protective agents|mesh-ancestor
101189245|NCT00003594|Leucovorin|leucovorin|mesh-list
101189246|NCT00003594|Fluorouracil|fluorouracil|mesh-list
101189247|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
101189248|NCT00003594|Irinotecan|irinotecan|mesh-list
101189249|NCT00003594|Calcium|calcium|mesh-list
101189250|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
101189251|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101189252|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189287|NCT00003612|Carboplatin|carboplatin|mesh-list
101189288|NCT00003612|Trastuzumab|trastuzumab|mesh-list
101189289|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189290|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189291|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189292|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189293|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189294|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189295|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101189297|NCT00003624|Amifostine|amifostine|mesh-list
101189298|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189299|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189300|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189301|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189302|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189303|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189304|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101189305|NCT00003624|Protective Agents|protective agents|mesh-ancestor
101189306|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189307|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
101189308|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189309|NCT00003636|Carboplatin|carboplatin|mesh-list
101189310|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189311|NCT00003642|Fluorouracil|fluorouracil|mesh-list
101189312|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189313|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
101189314|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189315|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189316|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189317|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
101189331|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189332|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101189333|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189334|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101189335|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101189336|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101189337|NCT00003684|Theophylline|theophylline|mesh-list
101189338|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101189339|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
101189340|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189341|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189342|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101189343|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
101189344|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101189345|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189346|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189347|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
101189348|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101189349|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101189350|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
101189351|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101189352|NCT00003690|Carboplatin|carboplatin|mesh-list
101189353|NCT00003690|Alvocidib|alvocidib|mesh-list
101189354|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189355|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
101189356|NCT00003690|Growth Substances|growth substances|mesh-ancestor
101189357|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189358|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101189359|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189376|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189377|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189378|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
101189379|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189380|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189381|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189382|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189383|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189384|NCT00003708|Temozolomide|temozolomide|mesh-list
101189385|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189386|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
101189387|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189388|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189390|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189391|NCT00003720|Semaxinib|semaxinib|mesh-list
101189392|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101189393|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101189394|NCT00003720|Growth Substances|growth substances|mesh-ancestor
101189395|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189396|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
101189397|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189398|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101189399|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189400|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189401|NCT00003732|Paclitaxel|paclitaxel|mesh-list
101189402|NCT00003732|Carboplatin|carboplatin|mesh-list
101189403|NCT00003732|Topotecan|topotecan|mesh-list
101189404|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189405|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189422|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189423|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189424|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189425|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189426|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189427|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
101189428|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189429|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189430|NCT00003780|Gemcitabine|gemcitabine|mesh-list
101189431|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189432|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
101189433|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189434|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189436|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189437|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
101189438|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189439|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189440|NCT00003792|Lenograstim|lenograstim|mesh-list
101189441|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189442|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
101189443|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189444|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
101189445|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189446|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101189447|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189448|NCT00003804|Dactinomycin|dactinomycin|mesh-list
101189449|NCT00003804|Vincristine|vincristine|mesh-list
101189450|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189451|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189452|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189453|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189454|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189455|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189456|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101189457|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189458|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189459|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101189460|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189461|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101189462|NCT00003828|Vinorelbine|vinorelbine|mesh-list
101189463|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189464|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189465|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189466|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189467|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189468|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189469|NCT00003834|Leucovorin|leucovorin|mesh-list
101189470|NCT00003834|Fluorouracil|fluorouracil|mesh-list
101189471|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
101189472|NCT00003834|Calcium|calcium|mesh-list
101189473|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
101189474|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101189475|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189476|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
101189477|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189478|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189479|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189480|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189481|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
101189482|NCT00003834|Antidotes|antidotes|mesh-ancestor
101189483|NCT00003834|Protective Agents|protective agents|mesh-ancestor
101189484|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
101189485|NCT00003834|Vitamins|vitamins|mesh-ancestor
101189486|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
101189487|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
101189488|NCT00003846|Thiotepa|thiotepa|mesh-list
101189489|NCT00003846|Carboplatin|carboplatin|mesh-list
101189490|NCT00003846|Vincristine|vincristine|mesh-list
101189491|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189492|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
101189493|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189494|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189495|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189496|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
101189497|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189498|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189499|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189500|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189501|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189502|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189503|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189504|NCT00003852|Paclitaxel|paclitaxel|mesh-list
101189505|NCT00003852|Etoposide|etoposide|mesh-list
101189506|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
101189507|NCT00003852|Carboplatin|carboplatin|mesh-list
101189508|NCT00003852|Epirubicin|epirubicin|mesh-list
101189509|NCT00003852|Ifosfamide|ifosfamide|mesh-list
101189510|NCT00003852|Thiotepa|thiotepa|mesh-list
101189511|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189512|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189513|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189514|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189515|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189517|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189518|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
101189519|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189520|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189521|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189522|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
101189523|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189524|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189525|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189526|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189527|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189529|NCT00003858|Analgesics|analgesics|mesh-ancestor
101189530|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
101189531|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189532|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189533|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189534|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189535|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189536|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189537|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189538|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
101189539|NCT00003870|Methotrexate|methotrexate|mesh-list
101189541|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101189542|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189543|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
101189544|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189545|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189546|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189548|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189549|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189550|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189551|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101189552|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
101189553|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101189554|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189557|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189558|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101189559|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101189560|NCT00003876|Carmustine|carmustine|mesh-list
101189561|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189562|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
101189563|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189564|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189565|NCT00003888|Docetaxel|docetaxel|mesh-list
101189566|NCT00003888|Fluorouracil|fluorouracil|mesh-list
101189567|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189568|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189569|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189570|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189571|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189572|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
101189573|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189574|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189575|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
101189576|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189577|NCT00003894|Thalidomide|thalidomide|mesh-list
101189578|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189579|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
101189580|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189581|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
101189582|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101189583|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189584|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101189585|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101189587|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
101189588|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189589|NCT00003900|Docetaxel|docetaxel|mesh-list
101189634|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189646|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189647|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189648|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
101189649|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189650|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
101189651|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189652|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189653|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189654|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101189655|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189656|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189657|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101189658|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
101189659|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101189660|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189661|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
101189663|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
101189682|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
101189683|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
101189684|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189685|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101189686|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
101189688|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189689|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101189690|NCT00003960|Protective Agents|protective agents|mesh-ancestor
101189691|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101189692|NCT00003966|Defibrotide|defibrotide|mesh-list
101189693|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101189694|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101189711|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189712|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
101189846|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
101189847|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189972|NCT00004194|Fludarabine|fludarabine|mesh-list
101189973|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
101189974|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189975|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190072|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190103|NCT00004260|Rituximab|rituximab|mesh-list
101190172|NCT00004380|Methocarbamol|methocarbamol|mesh-list
101190190|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
101190269|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190270|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190272|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190430|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
101190431|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190432|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101190433|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101190436|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
101190573|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190574|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101190670|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190671|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191026|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
101191027|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
101191028|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191890|NCT00378456|Zinc|zinc|mesh-list
101192087|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101192088|NCT00384306|Prednisolone|prednisolone|mesh-list
101192089|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192090|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
101192091|NCT00384306|Hormones|hormones|mesh-ancestor
101192154|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192155|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192156|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
101192226|NCT00422682|Iniparib|iniparib|mesh-list
101192775|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192776|NCT01272180|Vaccines|vaccines|mesh-list
101192777|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
101193826|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193827|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
101193828|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101193829|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193830|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
101193832|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194283|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
101194284|NCT02243436|Protective Agents|protective agents|mesh-ancestor
101194285|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101194349|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
101194351|NCT02246868|Factor VIII|factor viii|mesh-list
101195199|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195200|NCT05411107|Iloprost|iloprost|mesh-list
101195201|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101195203|NCT05379686|Glucagon|glucagon|mesh-list
101195261|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
101195334|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101195335|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101195336|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195580|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101195581|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195582|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195583|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
101195588|NCT04330638|Siltuximab|siltuximab|mesh-list
101196419|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196420|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101196421|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101196486|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196487|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196559|NCT01386398|Vorinostat|vorinostat|mesh-list
101197027|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197028|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101197030|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198080|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198081|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101198082|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101198083|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199068|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199069|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101199070|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101199134|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
101199135|NCT05064137|Protective Agents|protective agents|mesh-ancestor
101199210|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
101200133|NCT02293109|Protective Agents|protective agents|mesh-ancestor
101200134|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
101200135|NCT02293109|Vitamins|vitamins|mesh-ancestor
101200136|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
101200137|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200202|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200203|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200204|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200666|NCT01399346|Insulin|insulin|mesh-list
101200731|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101200732|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
101200804|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
101200805|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
101200806|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101200807|NCT01400633|Decitabine|decitabine|mesh-list
101200808|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200876|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
101200877|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200950|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200951|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
101200952|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200953|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201018|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201020|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201021|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201022|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201023|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
101201024|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
101201025|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
101201026|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
101201027|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201598|NCT01404793|Rocuronium|rocuronium|mesh-list
101201601|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101201669|NCT01405131|Protective Agents|protective agents|mesh-ancestor
101201670|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101201671|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201673|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
101201674|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202437|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
101202438|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
101202439|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101202440|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
101202504|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
101202505|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
101203423|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203488|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203562|NCT01418144|Ropivacaine|ropivacaine|mesh-list
101204055|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101204056|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101204057|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
101204058|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
101204060|NCT01421368|Tenofovir|tenofovir|mesh-list
101204074|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204075|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101204076|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101204143|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204144|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
101204217|NCT01422317|Tocopherols|tocopherols|mesh-list
101204373|NCT01423175|Clofarabine|clofarabine|mesh-list
101204375|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
101221907|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204414|NCT01423305|Hormones|hormones|mesh-ancestor
101221908|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221909|NCT01510548|Adalimumab|adalimumab|mesh-list
101221910|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101221911|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221912|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221913|NCT01510561|Gemcitabine|gemcitabine|mesh-list
101204376|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204377|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204378|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
101204470|NCT01423695|Trastuzumab|trastuzumab|mesh-list
101204568|NCT01424137|Hormones|hormones|mesh-ancestor
101204663|NCT01424709|Irinotecan|irinotecan|mesh-list
101204736|NCT01425099|Hormones|hormones|mesh-ancestor
101204811|NCT01425411|Valsartan|valsartan|mesh-list
101204876|NCT01425658|Analgesics|analgesics|mesh-ancestor
101205017|NCT05385185|Growth Substances|growth substances|mesh-ancestor
101205080|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101204379|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101205294|NCT03771612|Naproxen|naproxen|mesh-list
101205492|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
101205774|NCT01427985|Atropine|atropine|mesh-list
101205915|NCT01428531|PENTA|penta|mesh-list
101204380|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101206494|NCT01431690|Warfarin|warfarin|mesh-list
101206765|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
101207119|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
101207254|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101204381|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101207604|NCT05382312|GSK656|gsk656|mesh-list
101207819|NCT04636632|Aprepitant|aprepitant|mesh-list
101208701|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
101208929|NCT01442935|Vitamins|vitamins|mesh-ancestor
101209204|NCT01444612|Heparin|heparin|mesh-list
101210108|NCT01449617|Aspirin|aspirin|mesh-list
101210673|NCT05957926|Hyaluronic Acid|hyaluronic acid|mesh-list
101210675|NCT05957926|Immunologic Factors|immunologic factors|mesh-ancestor
101210750|NCT05894239|Taxane|taxane|mesh-list
101210751|NCT05894239|Inavolisib|inavolisib|mesh-list
101210752|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210753|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
101210754|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101210755|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210756|NCT05888389|Anesthetics|anesthetics|mesh-list
101210757|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
101210758|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204382|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211987|NCT04884763|Analgesics|analgesics|mesh-ancestor
101212322|NCT04331002|Triamcinolone|triamcinolone|mesh-list
101212531|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212532|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101212533|NCT03975231|Trametinib|trametinib|mesh-list
101212534|NCT03975231|Dabrafenib|dabrafenib|mesh-list
101212535|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212536|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212537|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212932|NCT03406897|Vitamin D|vitamin d|mesh-list
101213338|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
101204383|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101213475|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101213620|NCT00544115|Tacrolimus|tacrolimus|mesh-list
101213824|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
101214330|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204384|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
101204385|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101204386|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101204387|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
101204388|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101204389|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204390|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101214681|NCT01469351|Liraglutide|liraglutide|mesh-list
101204391|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101204392|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
101204393|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
101204394|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101204395|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
101204396|NCT01423292|Bupivacaine|bupivacaine|mesh-list
101204397|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
101204398|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
101204399|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204400|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204401|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
101204402|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204403|NCT01423305|Budesonide|budesonide|mesh-list
101204404|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
101204405|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
101204406|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204407|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101204408|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
101204409|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204410|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204411|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101215232|NCT01472640|Hormones|hormones|mesh-ancestor
101215302|NCT01473173|Esomeprazole|esomeprazole|mesh-list
101216082|NCT01478503|Mirabegron|mirabegron|mesh-list
101216227|NCT01479283|Cefazolin|cefazolin|mesh-list
101216708|NCT01482156|Everolimus|everolimus|mesh-list
101216973|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
101217044|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
101217248|NCT01485978|Ramipril|ramipril|mesh-list
101217395|NCT01486888|Insulin|insulin|mesh-list
101217815|NCT01489410|Ethanol|ethanol|mesh-list
101217912|NCT01489709|Urological Agents|urological agents|mesh-ancestor
101217982|NCT01489982|Zopiclone|zopiclone|mesh-list
101218046|NCT01490229|Ezetimibe|ezetimibe|mesh-list
101218098|NCT01490437|Pemetrexed|pemetrexed|mesh-list
101218241|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
101219110|NCT01496742|Bevacizumab|bevacizumab|mesh-list
101219223|NCT01497444|Sorafenib|sorafenib|mesh-list
101219293|NCT01497600|Insulin|insulin|mesh-list
101219364|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101219619|NCT01500018|Ketamine|ketamine|mesh-list
101219666|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
101219791|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
101219932|NCT01501370|Dexamethasone|dexamethasone|mesh-list
101220075|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220213|NCT01502241|Temozolomide|temozolomide|mesh-list
101220301|NCT01503008|Metformin|metformin|mesh-list
101220561|NCT01503918|Valacyclovir|valacyclovir|mesh-list
101204412|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
101220845|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101221043|NCT01506167|Irinotecan|irinotecan|mesh-list
101221118|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
101221380|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
101204413|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
101188608|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101188609|NCT00003000|Narcotics|narcotics|mesh-ancestor
101188610|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188611|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188613|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
101188614|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101188615|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101188616|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101188617|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
101188618|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
101188619|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
101188620|NCT00003012|Fluorouracil|fluorouracil|mesh-list
101188621|NCT00003012|Methotrexate|methotrexate|mesh-list
101188622|NCT00003012|Epirubicin|epirubicin|mesh-list
101188658|NCT00003060|Methotrexate|methotrexate|mesh-list
101188659|NCT00003060|Cyclosporins|cyclosporins|mesh-list
101188660|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101188661|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
101188662|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188697|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
101188698|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
101188699|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188700|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101188701|NCT00003072|Protective Agents|protective agents|mesh-ancestor
101188702|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188703|NCT00003078|Fluorouracil|fluorouracil|mesh-list
101188737|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188739|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188741|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101188742|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101188743|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101188943|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101188944|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
101188945|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101188946|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101188947|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101188949|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
101188950|NCT00003252|Protective Agents|protective agents|mesh-ancestor
101189219|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189220|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189222|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189223|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
101189224|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189225|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189626|NCT00003930|Paclitaxel|paclitaxel|mesh-list
101189627|NCT00003930|Gemcitabine|gemcitabine|mesh-list
101189628|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189629|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189630|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189631|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189632|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189633|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189662|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189664|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
101189665|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101189666|NCT00003960|Prednisolone|prednisolone|mesh-list
101189667|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
101189668|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
101189670|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101189671|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
101189672|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189673|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
101189674|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189675|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101189676|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189677|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
101189678|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189679|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189680|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189681|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101189715|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189717|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189718|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101189719|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
101189720|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101189758|NCT00004050|Interleukin-2|interleukin-2|mesh-list
101189759|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189760|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101189761|NCT00004050|Analgesics|analgesics|mesh-ancestor
101189762|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
101189763|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101189764|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189766|NCT00004056|Thioguanine|thioguanine|mesh-list
101189767|NCT00004056|Melphalan|melphalan|mesh-list
101189768|NCT00004056|Daunorubicin|daunorubicin|mesh-list
101189769|NCT00004056|Asparaginase|asparaginase|mesh-list
101189770|NCT00004056|Lenograstim|lenograstim|mesh-list
101189771|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101189772|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
101189773|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189797|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189798|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189799|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189800|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189801|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189802|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
101189803|NCT00004074|Carboplatin|carboplatin|mesh-list
101189804|NCT00004074|Trastuzumab|trastuzumab|mesh-list
101189805|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101189806|NCT00004074|Interleukin-12|interleukin-12|mesh-list
101189807|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189808|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101189809|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189810|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
101189814|NCT00004074|Growth Substances|growth substances|mesh-ancestor
101189860|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
101189861|NCT00004122|Interferons|interferons|mesh-list
101189862|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
101189863|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
101189864|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189865|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
101189866|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101189867|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
101189868|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189869|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101189870|NCT00004128|Cytarabine|cytarabine|mesh-list
101189896|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101189897|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101189898|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189899|NCT00004158|Melphalan|melphalan|mesh-list
101189900|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189901|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
101189902|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189903|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189904|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101189905|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101189906|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
101189907|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189909|NCT00004164|Docetaxel|docetaxel|mesh-list
101189910|NCT00004164|Fluorouracil|fluorouracil|mesh-list
101189911|NCT00004164|Calcium|calcium|mesh-list
101189912|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
101189913|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101189914|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
101189915|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
101189916|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
101189917|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101189918|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101189919|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101189920|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
101189956|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101189961|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101189962|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101189963|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101189964|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101189965|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101189966|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190030|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101190031|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101190032|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190033|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190034|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190035|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190036|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
101190037|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101190039|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190040|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190041|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190042|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
101190043|NCT00004218|Hormones|hormones|mesh-ancestor
101190044|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190045|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101190046|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
101190047|NCT00004224|Etoposide|etoposide|mesh-list
101190048|NCT00004224|Vincristine|vincristine|mesh-list
101190049|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190050|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
101190051|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190052|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190053|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190054|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
101190088|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101190089|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190090|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190128|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190129|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
101190130|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
101190131|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190132|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101190133|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190348|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
101190349|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101190350|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190351|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
101190352|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190353|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
101190354|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190355|NCT00004686|Prednisone|prednisone|mesh-list
101190356|NCT00004686|Methotrexate|methotrexate|mesh-list
101190357|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190358|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
101190359|NCT00004686|Hormones|hormones|mesh-ancestor
101190360|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190361|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190362|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101190363|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190364|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101190365|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
101190385|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190386|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190387|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101190388|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101190389|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190392|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190419|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190420|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190421|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
101190422|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101190423|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190424|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
101190446|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190447|NCT00004770|Protective Agents|protective agents|mesh-ancestor
101190448|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190449|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
101190450|NCT00004770|Vitamins|vitamins|mesh-ancestor
101190451|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
101190452|NCT00004776|Topiramate|topiramate|mesh-list
101190453|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
101190454|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101190455|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190456|NCT00004794|Cidofovir|cidofovir|mesh-list
101190457|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
101190458|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190459|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190460|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190462|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
101190463|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190464|NCT00004842|Budesonide|budesonide|mesh-list
101190465|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101190466|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101190467|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
101190469|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190470|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101190471|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
101190472|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
101190473|NCT00004842|Hormones|hormones|mesh-ancestor
101190474|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101190475|NCT00004854|Carvedilol|carvedilol|mesh-list
101190476|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101190477|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101190509|NCT00004878|Tacrolimus|tacrolimus|mesh-list
101190510|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101190511|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
101190512|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101190513|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190514|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190515|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
101190516|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190517|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190518|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
101190519|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190520|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101190521|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190522|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
101190523|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190551|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101190552|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190554|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
101190555|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
101190556|NCT00004926|Vitamins|vitamins|mesh-ancestor
101190557|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
101190558|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190559|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101190562|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
101190652|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101190653|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190654|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190655|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190656|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101190657|NCT00005088|Cisplatin|cisplatin|mesh-list
101190658|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190659|NCT00005094|Celecoxib|celecoxib|mesh-list
101190685|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190686|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
101190687|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101190688|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101190689|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190690|NCT00005118|Ritonavir|ritonavir|mesh-list
101190691|NCT00005118|Indinavir|indinavir|mesh-list
101190692|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101190693|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101190694|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
101190695|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190696|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190698|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190699|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
101190700|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190701|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101190702|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190703|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
101190754|NCT00005598|Azacitidine|azacitidine|mesh-list
101190755|NCT00005598|Amifostine|amifostine|mesh-list
101190756|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101190770|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
101190771|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101190772|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190774|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190775|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
101190776|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190777|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101190778|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
101190779|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101190780|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101190781|NCT00005604|Growth Substances|growth substances|mesh-ancestor
101190782|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
101190783|NCT00005610|Sargramostim|sargramostim|mesh-list
101190784|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
101190785|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190786|NCT00005616|Antibodies|antibodies|mesh-list
101190787|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101190788|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
101190789|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190790|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
101190791|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101190792|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
101190793|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190794|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101190795|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101190796|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
101190797|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190798|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190811|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
101190812|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
101190813|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190815|NCT00005652|Rituximab|rituximab|mesh-list
101190890|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
101190891|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190892|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101190904|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190905|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190906|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190907|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190908|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
101190909|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190910|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101190911|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101190912|NCT00355602|Metronidazole|metronidazole|mesh-list
101190913|NCT00355602|Vancomycin|vancomycin|mesh-list
101190914|NCT00355602|Clarithromycin|clarithromycin|mesh-list
101190915|NCT00355602|Doxycycline|doxycycline|mesh-list
101190916|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
101190917|NCT00355602|Rifaximin|rifaximin|mesh-list
101190918|NCT00355602|Cefuroxime|cefuroxime|mesh-list
101190964|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101190965|NCT00356460|Mitogens|mitogens|mesh-list
101190966|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
101190967|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101190968|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101190969|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
101190970|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190971|NCT00356616|Tenofovir|tenofovir|mesh-list
101190972|NCT00356616|Abacavir|abacavir|mesh-list
101190973|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
101190974|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190975|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101190976|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101190977|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101190978|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101190979|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101190980|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101190981|NCT00356772|Azithromycin|azithromycin|mesh-list
101190982|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101190983|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101190984|NCT00356850|Azithromycin|azithromycin|mesh-list
101190987|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
101191017|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
101191018|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191019|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191020|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191021|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101191022|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191023|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
101191024|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191025|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101191031|NCT00357084|Protective Agents|protective agents|mesh-ancestor
101191033|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101191034|NCT00357240|Omeprazole|omeprazole|mesh-list
101191035|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101191036|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101191037|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
101191038|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191039|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191040|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101191041|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101191042|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
101191043|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191044|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101191045|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101191046|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101191047|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191048|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101191049|NCT00357318|Bevacizumab|bevacizumab|mesh-list
101191071|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191072|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
101191073|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191074|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191075|NCT00357708|Decitabine|decitabine|mesh-list
101191076|NCT00357708|Azacitidine|azacitidine|mesh-list
101191077|NCT00357708|Vorinostat|vorinostat|mesh-list
101191078|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191079|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
101191080|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191140|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191141|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191142|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191143|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101191144|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101191145|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101191146|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
101191147|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191148|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191149|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
101191150|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191151|NCT00358566|Gemcitabine|gemcitabine|mesh-list
101191152|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191153|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
101191154|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191155|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191156|NCT00359112|Metformin|metformin|mesh-list
101191157|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191158|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191159|NCT00359190|Lapatinib|lapatinib|mesh-list
101191160|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191161|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101191162|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191163|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191164|NCT00359658|Cyclosporine|cyclosporine|mesh-list
101191165|NCT00359658|Prednisolone|prednisolone|mesh-list
101191166|NCT00359658|Cyclosporins|cyclosporins|mesh-list
101191167|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191168|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191174|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191175|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191176|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101191177|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191178|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
101191180|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191181|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101191182|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191184|NCT00359814|Cyclosporins|cyclosporins|mesh-list
101191185|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191186|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191187|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191188|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
101191189|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191190|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
101191191|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191192|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191193|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191194|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101191195|NCT00359892|Obatoclax|obatoclax|mesh-list
101191196|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191197|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191198|NCT00359970|Azithromycin|azithromycin|mesh-list
101191199|NCT00359970|Loperamide|loperamide|mesh-list
101191200|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
101191201|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101191202|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191203|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191205|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
101191206|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101191207|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191208|NCT00360438|Rasburicase|rasburicase|mesh-list
101191209|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
101191210|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191212|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101191213|NCT00360750|Cytarabine|cytarabine|mesh-list
101191214|NCT00360750|Carboplatin|carboplatin|mesh-list
101191215|NCT00360750|Etoposide|etoposide|mesh-list
101191232|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
101191233|NCT00360984|Insulin|insulin|mesh-list
101191234|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101191235|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
101191236|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191237|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191238|NCT00361452|Epinephrine|epinephrine|mesh-list
101191239|NCT00361452|Albuterol|albuterol|mesh-list
101191240|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101191241|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101191242|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
101191246|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101191247|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101191248|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
101191249|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191250|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191251|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191253|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
101191254|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101191255|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
101191258|NCT00361686|Tramadol|tramadol|mesh-list
101191295|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
101191296|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191297|NCT00362778|Insulin|insulin|mesh-list
101191298|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191299|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191300|NCT00362934|Atorvastatin|atorvastatin|mesh-list
101191301|NCT00362934|Simvastatin|simvastatin|mesh-list
101191302|NCT00362934|Fenofibrate|fenofibrate|mesh-list
101191303|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101191304|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101191305|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
101191306|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191307|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101191308|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101191309|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191310|NCT00363090|Prednisone|prednisone|mesh-list
101191311|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
101191312|NCT00363090|Doxorubicin|doxorubicin|mesh-list
101191313|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
101191314|NCT00363090|Vincristine|vincristine|mesh-list
101191315|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
101191316|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191320|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101191321|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
101191322|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191323|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191324|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101191325|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101191326|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101191327|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101191328|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191329|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191330|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
101191331|NCT00363090|Hormones|hormones|mesh-ancestor
101191332|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191338|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101191340|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
101191341|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101191342|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191343|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191344|NCT00363948|Incretins|incretins|mesh-ancestor
101191345|NCT00363948|Hormones|hormones|mesh-ancestor
101191346|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191347|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101191348|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
101191349|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191350|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191351|NCT00364026|Darusentan|darusentan|mesh-list
101191352|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101191353|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191354|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
101191355|NCT00364260|Hematinics|hematinics|mesh-ancestor
101191356|NCT00364572|Etanercept|etanercept|mesh-list
101191357|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101191358|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191359|NCT00364572|Analgesics|analgesics|mesh-ancestor
101191360|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
101191361|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191362|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191363|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191364|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191365|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191366|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101191367|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
101191384|NCT00365040|Mitomycins|mitomycins|mesh-list
101191385|NCT00365040|Mitomycin|mitomycin|mesh-list
101191386|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101191392|NCT00365586|Ketoprofen|ketoprofen|mesh-list
101191393|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101191394|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191395|NCT00365586|Analgesics|analgesics|mesh-ancestor
101191396|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
101191397|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191398|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191399|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191400|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191401|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101191402|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191403|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191405|NCT00365742|Red yeast rice|red yeast rice|mesh-list
101191407|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101191408|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
101191413|NCT00365820|Tegaserod|tegaserod|mesh-list
101191449|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101191450|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
101191451|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191452|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
101191454|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
101191455|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191456|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101191460|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
101191519|NCT00368238|Hematinics|hematinics|mesh-ancestor
101191520|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
101191521|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191522|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191523|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
101191524|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
101191525|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101191526|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101191527|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
101191528|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191529|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191536|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191537|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191538|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191539|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
101191540|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191541|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101191542|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101191543|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
101191544|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101191545|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101191546|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
101191547|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
101191548|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101191550|NCT00369096|Bemiparin|bemiparin|mesh-list
101191575|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
101191576|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191577|NCT00370188|Topiramate|topiramate|mesh-list
101191578|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
101191580|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191581|NCT00370266|Triamcinolone|triamcinolone|mesh-list
101191582|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191583|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
101191584|NCT00370266|Hormones|hormones|mesh-ancestor
101191585|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191586|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191587|NCT00370422|Triamcinolone|triamcinolone|mesh-list
101191588|NCT00370422|Bevacizumab|bevacizumab|mesh-list
101191589|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101191590|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191591|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101191592|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101191593|NCT00370422|Growth Substances|growth substances|mesh-ancestor
101191594|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191595|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
101191596|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191597|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
101191598|NCT00370422|Hormones|hormones|mesh-ancestor
101191599|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191602|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191603|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101191604|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101191605|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191606|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191608|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
101191609|NCT00370656|Amitriptyline|amitriptyline|mesh-list
101191610|NCT00370656|Analgesics|analgesics|mesh-ancestor
101191611|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
101191612|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191618|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101191619|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101191620|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101191621|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191622|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191623|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101191624|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101191625|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191626|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
101191627|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
101191628|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101191629|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191630|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101191633|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101191634|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101191635|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101191636|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191637|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191638|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
101191639|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191640|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191641|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101191642|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191643|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
101191644|NCT00370968|Astringents|astringents|mesh-ancestor
101191645|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191646|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
101191647|NCT00371124|Atropine|atropine|mesh-list
101177465|NCT01907334|Xhance|xhance|mesh-list
101191648|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101191649|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101191650|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101191651|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101191660|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101191661|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101191662|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
101191663|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191664|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191665|NCT00371592|Acyclovir|acyclovir|mesh-list
101191666|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
101191667|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191668|NCT00371904|Rituximab|rituximab|mesh-list
101191669|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101191670|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101191671|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
101191672|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191673|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101191677|NCT00372216|Clopidogrel|clopidogrel|mesh-list
101191678|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101191679|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101191680|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101191681|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101191682|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
101191683|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191684|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191685|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191686|NCT00372294|Clindamycin|clindamycin|mesh-list
101191687|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
101191688|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
101191689|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
101191690|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
101191691|NCT00372294|Dexamethasone|dexamethasone|mesh-list
101191692|NCT00372294|Prednisolone|prednisolone|mesh-list
101191693|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191694|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
101191695|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
101191706|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101191707|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191708|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191709|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
101191710|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101191711|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101191712|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101177568|NCT01929642|Everolimus|everolimus|mesh-list
101191714|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
101191715|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101191716|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191717|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191718|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101191719|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191720|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191767|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191768|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101191769|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
101191770|NCT00373542|Ropinirole|ropinirole|mesh-list
101191771|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101191772|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101191773|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
101191774|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
101191775|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191776|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191777|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191778|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
101191779|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
101191780|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101191781|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191782|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
101191783|NCT00375258|Coagulants|coagulants|mesh-ancestor
101191784|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
101191785|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191786|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191787|NCT00376038|Metformin|metformin|mesh-list
101191788|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101191789|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191790|NCT00376272|Valsartan|valsartan|mesh-list
101191791|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101177703|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191792|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101191793|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101191794|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191795|NCT00376428|Gentamicins|gentamicins|mesh-list
101191810|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191811|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
101191812|NCT00376662|Hormones|hormones|mesh-list
101191813|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191814|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191815|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191816|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
101191817|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101191826|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191827|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101191828|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101191829|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191830|NCT00377910|Lidocaine|lidocaine|mesh-list
101191831|NCT00377910|Polidocanol|polidocanol|mesh-list
101191832|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
101191833|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
101191834|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191835|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191836|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
101191837|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191838|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101191839|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101191840|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101191841|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101191842|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191843|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
101191844|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101191845|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
101191861|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191862|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
101191863|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101191864|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
101191865|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191866|NCT00378144|Acetaminophen|acetaminophen|mesh-list
101191867|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
101191869|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101191870|NCT00378144|Analgesics|analgesics|mesh-ancestor
101191938|NCT00380484|Budesonide|budesonide|mesh-list
101191939|NCT00380484|Montelukast|montelukast|mesh-list
101191940|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101191941|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101191942|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
101191943|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191944|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191945|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101191946|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
101191947|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
101191948|NCT00380484|Hormones|hormones|mesh-ancestor
101191949|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101191950|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101191951|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
101191956|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101191957|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101191958|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
101191959|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101191960|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101191961|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101191962|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101191963|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191964|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101191965|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101191966|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101177932|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
101191968|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101191969|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101191970|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
101191971|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101191972|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101191973|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191974|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101191975|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
101191976|NCT00381030|Protective Agents|protective agents|mesh-ancestor
101191977|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101191979|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101191980|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
101191981|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101191982|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101191983|NCT00381264|Nabilone|nabilone|mesh-list
101191984|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
101191986|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101191987|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101191988|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101191989|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101191990|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101191991|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101191992|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101191993|NCT00381342|Exenatide|exenatide|mesh-list
101191997|NCT00381342|Incretins|incretins|mesh-ancestor
101192051|NCT00383526|Vaccines|vaccines|mesh-list
101192052|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
101192132|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192133|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192134|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192135|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
101192136|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192138|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101192139|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101192140|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
101192141|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192142|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192143|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192144|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192145|NCT00385554|UC-781|uc-781|mesh-list
101192146|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192147|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
101192148|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192149|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
101192150|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
101192151|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192153|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
101192163|NCT00386178|Vitamin E|vitamin e|mesh-list
101192193|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
101192194|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192195|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101192196|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101192197|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192198|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192199|NCT00422526|Progesterone|progesterone|mesh-list
101192200|NCT00422526|Progestins|progestins|mesh-ancestor
101192201|NCT00422526|Hormones|hormones|mesh-ancestor
101192202|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192203|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192204|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
101192205|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101192206|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101192207|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
101192208|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192209|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192212|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
101192257|NCT01799616|Pamidronate|pamidronate|mesh-list
101192258|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101192259|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192260|NCT01799850|Pioglitazone|pioglitazone|mesh-list
101192261|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101192262|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192263|NCT01792050|Paclitaxel|paclitaxel|mesh-list
101192264|NCT01792050|Docetaxel|docetaxel|mesh-list
101192265|NCT01792050|Tryptophan|tryptophan|mesh-list
101192266|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101192267|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192268|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
101192269|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
101192270|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
101192271|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192272|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101192273|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
101192274|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192275|NCT01790100|Ribavirin|ribavirin|mesh-list
101192276|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
101192277|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192279|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192280|NCT01799460|Cyclosporine|cyclosporine|mesh-list
101192281|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
101192282|NCT01799460|Tacrolimus|tacrolimus|mesh-list
101192283|NCT01799460|Cyclosporins|cyclosporins|mesh-list
101192284|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
101192285|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
101192286|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
101192287|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192311|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101192312|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101192313|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192314|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192315|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
101192316|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101192317|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101192318|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192320|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192321|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192322|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192323|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192325|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101192326|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192327|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
101192372|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192373|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
101192374|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
101192375|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
101192376|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192377|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192378|NCT02994888|Cetuximab|cetuximab|mesh-list
101192379|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192380|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192381|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
101192382|NCT02993718|Propofol|propofol|mesh-list
101192383|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101192384|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192385|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192386|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101192387|NCT02993718|Analgesics|analgesics|mesh-ancestor
101192388|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
101192389|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192430|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101192431|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192432|NCT02992392|Dextrans|dextrans|mesh-list
101192448|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101192449|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192450|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192451|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
101192452|NCT02990286|Rituximab|rituximab|mesh-list
101192453|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192454|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192455|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
101192456|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192457|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192458|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101192459|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101178459|NCT02057640|Ixazomib|ixazomib|mesh-list
101192460|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
101192461|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101192462|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192463|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192464|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192465|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
101192466|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
101192467|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
101192468|NCT02999958|Antioxidants|antioxidants|mesh-list
101192469|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
101192470|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192471|NCT02999958|Protective Agents|protective agents|mesh-ancestor
101192472|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192473|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
101192475|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
101192476|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
101192477|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
101192478|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192479|NCT02999958|Expectorants|expectorants|mesh-ancestor
101192488|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192489|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192490|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
101192491|NCT02995746|Hormones|hormones|mesh-ancestor
101192492|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192493|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101192494|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192495|NCT02990364|Lidocaine|lidocaine|mesh-list
101192496|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
101192500|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192502|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192503|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101192504|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101192554|NCT01271088|Expectorants|expectorants|mesh-ancestor
101192555|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192556|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101192558|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192559|NCT01271088|Protective Agents|protective agents|mesh-ancestor
101192560|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192561|NCT01271088|Antidotes|antidotes|mesh-ancestor
101192563|NCT01271166|Bevacizumab|bevacizumab|mesh-list
101192564|NCT01271166|Fluorouracil|fluorouracil|mesh-list
101192565|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
101192566|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
101192567|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192568|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192572|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192573|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
101192574|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
101192575|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192576|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101192577|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192578|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
101192614|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192615|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192616|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101192617|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192619|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101192620|NCT01273506|Narcotics|narcotics|mesh-ancestor
101192621|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192622|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192623|NCT01273506|Analgesics|analgesics|mesh-ancestor
101192624|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
101192625|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192626|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101192627|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101192628|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192629|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192630|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
101192631|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192632|NCT01273662|Axitinib|axitinib|mesh-list
101192633|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192634|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101192635|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192636|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192637|NCT01273974|Vaccines|vaccines|mesh-list
101192638|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
101192639|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192654|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
101192655|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
101192676|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192677|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
101192678|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192679|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
101192680|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101192681|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101192682|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101192683|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192684|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192685|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192686|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192687|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192688|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101192689|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192691|NCT01279434|Vitamin E|vitamin e|mesh-list
101192692|NCT01279434|Tocopherols|tocopherols|mesh-list
101192693|NCT01279434|Tocotrienols|tocotrienols|mesh-list
101192694|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
101192695|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
101192696|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192697|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
101192699|NCT01279434|Protective Agents|protective agents|mesh-ancestor
101192733|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192734|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192735|NCT01277718|Rabeprazole|rabeprazole|mesh-list
101192736|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
101192737|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192738|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101192739|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192740|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192741|NCT01276236|Maraviroc|maraviroc|mesh-list
101192742|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
101192743|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
101192744|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192745|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101192746|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192747|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
101192748|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192749|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
101192750|NCT01275222|Everolimus|everolimus|mesh-list
101192751|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
101192752|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101192794|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101192795|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192796|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192797|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101192798|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
101192799|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
101192800|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101192801|NCT01270464|Reslizumab|reslizumab|mesh-list
101192802|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101192803|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
101192804|NCT01279590|Atorvastatin|atorvastatin|mesh-list
101192805|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101192806|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101192807|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
101192808|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192809|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101192810|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101192811|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192812|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101192813|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
101192814|NCT01271790|Ribavirin|ribavirin|mesh-list
101192815|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
101192816|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192817|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
101192818|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192819|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
101192820|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192821|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
101192822|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
101192823|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192824|NCT01270152|Protective Agents|protective agents|mesh-ancestor
101192825|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192839|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101192840|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101178935|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101192841|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192842|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192843|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192846|NCT01279980|Anesthetics|anesthetics|mesh-list
101192847|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
101192848|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192849|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192850|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
101192851|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192852|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
101192853|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
101192854|NCT00249834|Hormones|hormones|mesh-ancestor
101192855|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192856|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192857|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101192858|NCT00249444|Mirtazapine|mirtazapine|mesh-list
101192859|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
101192860|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101192861|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
101192862|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
101192863|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
101192864|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192865|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192866|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192867|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101192868|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101192883|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192884|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
101192885|NCT00247962|Etanercept|etanercept|mesh-list
101192886|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101192887|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101192888|NCT00247962|Analgesics|analgesics|mesh-ancestor
101192889|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
101179032|NCT02276274|Incretins|incretins|mesh-ancestor
101192891|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192892|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192893|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101192894|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192895|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192896|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
101192897|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192898|NCT00247416|Dexamethasone|dexamethasone|mesh-list
101192899|NCT00247416|Carboplatin|carboplatin|mesh-list
101192900|NCT00247416|Gemcitabine|gemcitabine|mesh-list
101192901|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192902|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
101192903|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
101192904|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101192906|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101192907|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
101192908|NCT00247416|Hormones|hormones|mesh-ancestor
101192909|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192910|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101192911|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192912|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101192914|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192915|NCT00246012|Dacarbazine|dacarbazine|mesh-list
101192916|NCT00246012|Intetumumab|intetumumab|mesh-list
101192919|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192920|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192923|NCT00245856|Tinzaparin|tinzaparin|mesh-list
101192929|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192930|NCT00242580|Triamcinolone|triamcinolone|mesh-list
101192931|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
101192932|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
101192933|NCT00242580|Verteporfin|verteporfin|mesh-list
101192934|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
101192935|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101192936|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
101192937|NCT00242580|Hormones|hormones|mesh-ancestor
101192938|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192939|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192940|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101192941|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
101192942|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192943|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192944|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
101192945|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
101192946|NCT00241644|Vaccines|vaccines|mesh-list
101192947|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
101192948|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192949|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101192950|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101192951|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101192952|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101192953|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192954|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
101192955|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101192956|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192972|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101192973|NCT03804372|Tenofovir|tenofovir|mesh-list
101192974|NCT03804372|Rituximab|rituximab|mesh-list
101192975|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101192976|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101192977|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
101192978|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192981|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101192982|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101192983|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101192984|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101192985|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192986|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101192987|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101192988|NCT03803124|Tolvaptan|tolvaptan|mesh-list
101192990|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101192991|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
101192992|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101192993|NCT03802032|Lidocaine|lidocaine|mesh-list
101192994|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
101192995|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
101192996|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101192998|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
101193026|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193028|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101193029|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193030|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
101193031|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101193032|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101193033|NCT05338398|Benzydamine|benzydamine|mesh-list
101193034|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193035|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101193036|NCT04581408|Ivacaftor|ivacaftor|mesh-list
101193037|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
101193038|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101179289|NCT02330094|Gabapentin|gabapentin|mesh-list
101193039|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193041|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
101193042|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193043|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193044|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193045|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101193046|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101193047|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101193052|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193053|NCT03467256|Cytarabine|cytarabine|mesh-list
101193054|NCT03467256|Dexamethasone|dexamethasone|mesh-list
101193057|NCT03467256|Etoposide|etoposide|mesh-list
101193086|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193087|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101193088|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193089|NCT02017704|Leucovorin|leucovorin|mesh-list
101193090|NCT02017704|Fluorouracil|fluorouracil|mesh-list
101193091|NCT02017704|Capecitabine|capecitabine|mesh-list
101193092|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
101193093|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
101193094|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193095|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193098|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
101193099|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193100|NCT02017704|Antidotes|antidotes|mesh-ancestor
101193101|NCT02017704|Protective Agents|protective agents|mesh-ancestor
101193102|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
101193103|NCT02017704|Vitamins|vitamins|mesh-ancestor
101193104|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
101193105|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
101193106|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101193107|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
101193108|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
101193109|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193110|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193111|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193112|NCT01622322|Analgesics|analgesics|mesh-ancestor
101193113|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
101193114|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193115|NCT05313282|Apatinib|apatinib|mesh-list
101193116|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193117|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193118|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193119|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193120|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
101193121|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101193122|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
101193123|NCT05311722|Ketamine|ketamine|mesh-list
101193124|NCT05311722|Tramadol|tramadol|mesh-list
101193125|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101193127|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193128|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193129|NCT05311722|Analgesics|analgesics|mesh-ancestor
101193130|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
101193131|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193138|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101193139|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101193140|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
101193141|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
101193142|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101193143|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101193144|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101193145|NCT05311722|Narcotics|narcotics|mesh-ancestor
101193146|NCT05311254|Fosfomycin|fosfomycin|mesh-list
101193196|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
101193197|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193198|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193199|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
101193200|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193207|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193208|NCT03216876|Ursolic acid|ursolic acid|mesh-list
101193209|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193210|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101193211|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193212|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101193213|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193214|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193215|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193216|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193217|NCT03216876|Analgesics|analgesics|mesh-ancestor
101193218|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
101193219|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193220|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193221|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193222|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193223|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101193224|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193225|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
101193226|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101193227|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101193228|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101193247|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101193248|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101193249|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
101193250|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193251|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193252|NCT03214536|Ropivacaine|ropivacaine|mesh-list
101193253|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
101193254|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193255|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193256|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
101193257|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
101193258|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193259|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
101193260|NCT03214770|Calcium|calcium|mesh-list
101193261|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101193262|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193263|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101193264|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
101193265|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101193266|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101193269|NCT03213444|Fluorouracil|fluorouracil|mesh-list
101193270|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193271|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
101193272|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193273|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193274|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193275|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
101193276|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193277|NCT03212820|Methamphetamine|methamphetamine|mesh-list
101193278|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101193279|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193280|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
101193281|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
101193282|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193283|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
101193286|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
101193287|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101193288|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101193289|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193290|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101193293|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
101193296|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
101193354|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
101193355|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193356|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193357|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
101193358|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101193359|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101193360|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
101193361|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
101193362|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
101193363|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
101193364|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193365|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
101193366|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101193367|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
101193368|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
101193369|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
101193370|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101193371|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193372|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193373|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
101193374|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101193375|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193376|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193404|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
101193405|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193411|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193412|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193413|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101193414|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101193415|NCT01834014|Growth Substances|growth substances|mesh-ancestor
101193416|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193417|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
101193418|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
101193419|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193420|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193421|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193422|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
101193423|NCT01834170|Gemcitabine|gemcitabine|mesh-list
101193424|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193425|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
101193426|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193427|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193428|NCT01835184|Vemurafenib|vemurafenib|mesh-list
101193429|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193430|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193431|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193432|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193433|NCT01835340|Anesthetics|anesthetics|mesh-list
101193434|NCT01835340|Propofol|propofol|mesh-list
101193435|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193436|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193437|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101193438|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101193439|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
101193440|NCT01836120|Docetaxel|docetaxel|mesh-list
101193441|NCT01836120|Raltitrexed|raltitrexed|mesh-list
101193442|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193447|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193448|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
101193449|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101193450|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193451|NCT01836822|Dimercaprol|dimercaprol|mesh-list
101193452|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
101193453|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
101193454|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193455|NCT01836900|Hemostatics|hemostatics|mesh-list
101193456|NCT01836900|Coagulants|coagulants|mesh-ancestor
101193457|NCT01837992|Primaquine|primaquine|mesh-list
101193458|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
101193459|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101193460|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101193461|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193462|NCT01838460|Lobeline|lobeline|mesh-list
101193463|NCT01838460|Nicotine|nicotine|mesh-list
101193464|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101193465|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
101193466|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193467|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193468|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101193469|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101193470|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
101179768|NCT02519322|Nivolumab|nivolumab|mesh-list
101193471|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193472|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193473|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
101193474|NCT01838538|Paclitaxel|paclitaxel|mesh-list
101193475|NCT01838538|Bevacizumab|bevacizumab|mesh-list
101193476|NCT01838538|Carboplatin|carboplatin|mesh-list
101193477|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101193478|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193492|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
101193493|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193494|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
101193502|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193503|NCT01839084|Isoflurane|isoflurane|mesh-list
101193504|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
101193505|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
101193506|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
101193507|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193508|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193509|NCT01839240|Cytarabine|cytarabine|mesh-list
101193510|NCT01839240|Azacitidine|azacitidine|mesh-list
101193511|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
101193512|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193513|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
101193514|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193515|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193516|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
101193517|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193518|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193519|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
101179793|NCT05722548|Indomethacin|indomethacin|mesh-list
101193520|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193521|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193522|NCT01839240|Analgesics|analgesics|mesh-ancestor
101193523|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
101193524|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193525|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101193526|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101193527|NCT01839552|Fentanyl|fentanyl|mesh-list
101193528|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101193554|NCT01834248|Decitabine|decitabine|mesh-list
101193555|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
101193556|NCT01834248|Poly ICLC|poly iclc|mesh-list
101193557|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193558|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
101193559|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193560|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193561|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193562|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
101193563|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
101179841|NCT05719506|Ketamine|ketamine|mesh-list
101193564|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193565|NCT01834248|Laxatives|laxatives|mesh-ancestor
101193566|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101193622|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193623|NCT01720212|Urological Agents|urological agents|mesh-ancestor
101193624|NCT01720290|Metformin|metformin|mesh-list
101193625|NCT01720290|Repaglinide|repaglinide|mesh-list
101193626|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193627|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193628|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101193629|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193630|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193631|NCT01721382|Incretins|incretins|mesh-ancestor
101193632|NCT01721382|Hormones|hormones|mesh-ancestor
101193633|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193634|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
101193635|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
101193636|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193637|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193638|NCT01721616|Azithromycin|azithromycin|mesh-list
101193639|NCT01721616|Cefazolin|cefazolin|mesh-list
101193640|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193642|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
101193643|NCT01721694|Azithromycin|azithromycin|mesh-list
101193644|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101193645|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193646|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101193647|NCT01722396|Vitamin D|vitamin d|mesh-list
101193648|NCT01722396|Vitamins|vitamins|mesh-ancestor
101193649|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
101193650|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193651|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101193652|NCT01722630|Dopamine|dopamine|mesh-list
101193653|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101193669|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101193670|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101193671|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193672|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101193673|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101193674|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101193675|NCT01723800|Carboplatin|carboplatin|mesh-list
101193676|NCT01723800|Pemetrexed|pemetrexed|mesh-list
101193677|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193678|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193679|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193680|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101193681|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101193682|NCT01724190|Vitamin D|vitamin d|mesh-list
101193683|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
101193684|NCT01724190|Vitamins|vitamins|mesh-ancestor
101193685|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
101193686|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193687|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101193694|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193695|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193696|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101193697|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
101193698|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193699|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193700|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
101193701|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193702|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101193703|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193704|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
101193705|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193706|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101193707|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193708|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
101193709|NCT01724268|Hormones|hormones|mesh-ancestor
101193712|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
101193713|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193714|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101193715|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
101193716|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
101193717|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193718|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
101193719|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
101193720|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101193721|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193722|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101193724|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
101193725|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193726|NCT01724424|Protective Agents|protective agents|mesh-ancestor
101193727|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193728|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193729|NCT01724814|Insulin|insulin|mesh-list
101193730|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193731|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193732|NCT01725048|Mirtazapine|mirtazapine|mesh-list
101193733|NCT01725048|Citalopram|citalopram|mesh-list
101193734|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101193735|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101193736|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101193737|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193738|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193739|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
101193763|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101193764|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
101193765|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101193766|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
101193767|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193768|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193769|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101193770|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101193771|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193773|NCT01725672|Glimepiride|glimepiride|mesh-list
101193774|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101193775|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193776|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101193777|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101193778|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
101193779|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101193780|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
101193781|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101193782|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
101193783|NCT01726530|Fentanyl|fentanyl|mesh-list
101193784|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101193785|NCT01726530|Narcotics|narcotics|mesh-ancestor
101193786|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101193787|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193788|NCT01726530|Analgesics|analgesics|mesh-ancestor
101193789|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
101193790|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193791|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101193792|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101193793|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
101193794|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
101193802|NCT01726764|Metformin|metformin|mesh-list
101193807|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193808|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193809|NCT01726920|Analgesics|analgesics|mesh-ancestor
101193810|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
101193811|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193812|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193813|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193814|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193815|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
101193816|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101193817|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193818|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193819|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101193820|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
101193821|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101193822|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
101193823|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101193835|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101193836|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193837|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193839|NCT01729104|Lenalidomide|lenalidomide|mesh-list
101180094|NCT04625946|Metformin|metformin|mesh-list
101180097|NCT04599816|Simendan|simendan|mesh-list
101193840|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193841|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193842|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
101193843|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193844|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193845|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101193862|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193864|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
101193865|NCT01729806|Ipilimumab|ipilimumab|mesh-list
101193866|NCT01729806|Antibodies|antibodies|mesh-list
101193867|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
101193868|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101193869|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
101193870|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193871|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193872|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193873|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101193874|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193875|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
101193876|NCT01724658|Testosterone|testosterone|mesh-list
101193877|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
101193878|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
101193879|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
101193880|NCT01724658|Androgens|androgens|mesh-ancestor
101193881|NCT01724658|Hormones|hormones|mesh-ancestor
101193882|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101193883|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193885|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193952|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
101193953|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101193954|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193955|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101193956|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101193957|NCT01042938|Curcumin|curcumin|mesh-list
101193958|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101193959|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101193960|NCT01042938|Analgesics|analgesics|mesh-ancestor
101193961|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
101193962|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101193963|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101193964|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101193965|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101193966|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193967|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193968|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193969|NCT01042158|Ambrisentan|ambrisentan|mesh-list
101193970|NCT01042158|Tadalafil|tadalafil|mesh-list
101193971|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
101193972|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101193973|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101193974|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101193975|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101193976|NCT01042158|Urological Agents|urological agents|mesh-ancestor
101193977|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101193978|NCT03405870|SMOFlipid|smoflipid|mesh-list
101193979|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
101193980|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
101193981|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101193982|NCT03409458|Avelumab|avelumab|mesh-list
101193983|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193993|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
101193994|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
101193995|NCT03407976|Apatinib|apatinib|mesh-list
101193996|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101193997|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101193998|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101193999|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194000|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194001|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194006|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194007|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
101194008|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
101194009|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194010|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101180351|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
101194011|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194047|NCT03402984|Z 338|z 338|mesh-list
101194051|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194052|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194053|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194054|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194055|NCT03402438|Fulacimstat|fulacimstat|mesh-list
101194056|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194057|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194058|NCT03402204|Ubenimex|ubenimex|mesh-list
101194059|NCT03402204|Simvastatin|simvastatin|mesh-list
101194060|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101194061|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101194062|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
101194063|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194064|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101194065|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101194066|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194067|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101194068|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
101194110|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101194111|NCT03401268|Antibodies|antibodies|mesh-list
101194112|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
101194113|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194114|NCT03400722|Clomiphene|clomiphene|mesh-list
101194115|NCT03400722|Hormones|hormones|mesh-list
101194116|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194117|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194118|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101194119|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
101194120|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
101194121|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
101194122|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101194123|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
101194124|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
101194125|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
101194127|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
101194128|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101194129|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101194130|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194131|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194168|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
101194171|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194173|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
101194174|NCT02241564|Temsirolimus|temsirolimus|mesh-list
101194175|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
101194176|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194177|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194178|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194179|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101180623|NCT02452866|Secnidazole|secnidazole|mesh-list
101194180|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
101194181|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194182|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194183|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101194184|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194185|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101194245|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194246|NCT02243124|Dexamethasone|dexamethasone|mesh-list
101194247|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194248|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
101194249|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
101194250|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194251|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194252|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194253|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
101194254|NCT02243124|Hormones|hormones|mesh-ancestor
101194255|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194256|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101194257|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194258|NCT02243436|Cytarabine|cytarabine|mesh-list
101194259|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
101194260|NCT02243436|Etoposide|etoposide|mesh-list
101194261|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
101194262|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194263|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101194264|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101194265|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101194266|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194267|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194303|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101194304|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194305|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
101194306|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
101194307|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101194308|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101194309|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101194310|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101194311|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194312|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101180901|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
101194313|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194315|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101194316|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101194317|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101194318|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194319|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194320|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194321|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194322|NCT02244294|Urological Agents|urological agents|mesh-ancestor
101194323|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
101194324|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
101194325|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101194326|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101194327|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194328|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194329|NCT02244528|Urological Agents|urological agents|mesh-ancestor
101194330|NCT02245464|Telmisartan|telmisartan|mesh-list
101194346|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194347|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194350|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194352|NCT02246868|Coagulants|coagulants|mesh-ancestor
101194353|NCT02247258|Azathioprine|azathioprine|mesh-list
101194354|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
101194355|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194356|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101194357|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194358|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101194359|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
101194360|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194361|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194362|NCT02247414|Aspirin|aspirin|mesh-list
101194363|NCT02247414|Heparin|heparin|mesh-list
101194364|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
101194365|NCT02247414|Tinzaparin|tinzaparin|mesh-list
101194366|NCT02247414|Dalteparin|dalteparin|mesh-list
101194367|NCT02247414|Dipyridamole|dipyridamole|mesh-list
101194368|NCT02247414|Warfarin|warfarin|mesh-list
101194369|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101194370|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101194371|NCT02247414|Analgesics|analgesics|mesh-ancestor
101194372|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
101194373|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194383|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
101194401|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194402|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101194403|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101194404|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
101194405|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194406|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194407|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101194408|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194410|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
101194411|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194469|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101194470|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
101194472|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101194473|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194474|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194475|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101194476|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
101194477|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
101194478|NCT02249442|Ritonavir|ritonavir|mesh-list
101194479|NCT02249442|Tipranavir|tipranavir|mesh-list
101194480|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101194481|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101194482|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194483|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194484|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194485|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101194486|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101194487|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
101194488|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194489|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101194490|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194492|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101194526|NCT02245308|Bupropion|bupropion|mesh-list
101194527|NCT02245308|Nicotine|nicotine|mesh-list
101194528|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101194529|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
101194530|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194531|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194532|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
101194533|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
101194534|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
101194535|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194536|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194537|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101194538|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
101194539|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101194540|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101194541|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101194542|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194543|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
101194584|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101194585|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194586|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
101194587|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
101194588|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
101194589|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194590|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194591|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194592|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
101194593|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194594|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
101194595|NCT00558558|Hormones|hormones|mesh-ancestor
101194596|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194597|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194598|NCT00557622|Paroxetine|paroxetine|mesh-list
101194599|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101194600|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101194601|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194602|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194603|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194604|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
101194605|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194606|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101194607|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
101194609|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
101194610|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101194611|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194612|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
101194614|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
101194626|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101194627|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194628|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101194629|NCT00555438|PENTA|penta|mesh-list
101194630|NCT00555438|Fondaparinux|fondaparinux|mesh-list
101194631|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
101194632|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
101194633|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
101194634|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194635|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194636|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194637|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
101194638|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101194639|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101194640|NCT00553644|Lenalidomide|lenalidomide|mesh-list
101194645|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101194646|NCT00553644|Growth Substances|growth substances|mesh-ancestor
101194647|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
101181408|NCT05730660|Quercetin|quercetin|mesh-list
101194650|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
101194651|NCT00552240|Tenofovir|tenofovir|mesh-list
101194652|NCT00552240|Emtricitabine|emtricitabine|mesh-list
101194653|NCT00552240|Nevirapine|nevirapine|mesh-list
101194654|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
101194655|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101194656|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
101194657|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194658|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194659|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101194660|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101194661|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
101194662|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101194663|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101181440|NCT05419674|Antacids|antacids|mesh-ancestor
101194674|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194675|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194676|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101194677|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101194678|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101194679|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
101194680|NCT00550680|Hematinics|hematinics|mesh-ancestor
101194681|NCT00556920|Carvedilol|carvedilol|mesh-list
101194682|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101194684|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194685|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194686|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194687|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194688|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194689|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
101194690|NCT00556920|Protective Agents|protective agents|mesh-ancestor
101194691|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101194692|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194694|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
101194735|NCT03029676|Narcotics|narcotics|mesh-ancestor
101194736|NCT03029676|Analgesics|analgesics|mesh-ancestor
101194737|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
101194738|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194739|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101194740|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101194741|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
101194742|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101194743|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101194744|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101194745|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101194746|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
101194747|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
101194748|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194749|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194750|NCT04270344|Valsartan|valsartan|mesh-list
101194751|NCT04270344|Pitavastatin|pitavastatin|mesh-list
101194752|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101194753|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101194754|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101194755|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194756|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101194793|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194795|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101194796|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194798|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101194799|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194800|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
101194801|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
101194802|NCT03830034|Iron|iron|mesh-list
101194803|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
101194804|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
101194805|NCT03830034|Trace Elements|trace elements|mesh-ancestor
101194806|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
101194807|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194808|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
101194809|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
101194810|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194811|NCT03838068|Anesthetics|anesthetics|mesh-list
101194812|NCT03838068|Procaine|procaine|mesh-list
101194813|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
101194814|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194815|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101194816|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
101194817|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194818|NCT05440734|Melatonin|melatonin|mesh-list
101194824|NCT05447208|Hormones|hormones|mesh-list
101194846|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194847|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
101194848|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
101194849|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101194850|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101194851|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101194852|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101194853|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
101194854|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101194860|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101194861|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101194913|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194914|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
101194915|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101194916|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
101194917|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194918|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
101194919|NCT05768243|Protective Agents|protective agents|mesh-ancestor
101194920|NCT05768230|Simendan|simendan|mesh-list
101194921|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101194922|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
101194923|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101194924|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101194934|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101194935|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
101194936|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101194937|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
101194938|NCT05768204|Hormones|hormones|mesh-ancestor
101194939|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101194940|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101194941|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101194942|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101194943|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
101194944|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
101194945|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101194946|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101194973|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101194974|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101194975|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101194976|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101194978|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101194979|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101194980|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101194981|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
101194982|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195055|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101195056|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195060|NCT05767229|Protective Agents|protective agents|mesh-ancestor
101195061|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101195062|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101195063|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101195140|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101195141|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101195142|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195143|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195221|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101195222|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
101195223|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
101195292|NCT05078827|Fluorouracil|fluorouracil|mesh-list
101195293|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
101195294|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195373|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101195374|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101195487|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
101195488|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195489|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101195569|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
101195571|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101195572|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
101195573|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
101195574|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
101195575|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195598|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101195599|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
101195600|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
101195601|NCT04291521|Analgesics|analgesics|mesh-ancestor
101195602|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
101195603|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101195604|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
101195605|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101195606|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101195664|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195665|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195666|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195667|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101195668|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
101195670|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101195676|NCT04040959|Niacinamide|niacinamide|mesh-list
101195677|NCT04040959|Niacin|niacin|mesh-list
101195678|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
101195679|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
101195751|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101195752|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101195753|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
101195754|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101195755|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101195756|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101195757|NCT03786783|Vitamins|vitamins|mesh-ancestor
101195758|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
101195759|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101195760|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101195761|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101195762|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101195763|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101195764|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
101195832|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101195920|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101195921|NCT02846623|Atezolizumab|atezolizumab|mesh-list
101195922|NCT02846623|Venetoclax|venetoclax|mesh-list
101196002|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196004|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101196005|NCT02659384|Aspirin|aspirin|mesh-list
101196081|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196082|NCT02387203|Amoxicillin|amoxicillin|mesh-list
101196169|NCT01696435|Vitamin D|vitamin d|mesh-list
101196170|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
101196171|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
101196172|NCT01696435|Vitamins|vitamins|mesh-list
101196173|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
101196250|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196252|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101196331|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101196332|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196415|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101196416|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196497|NCT01386229|Etomidate|etomidate|mesh-list
101196498|NCT01386229|Analgesics|analgesics|mesh-ancestor
101196577|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
101196578|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101196579|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
101196655|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
101196656|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
101196657|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196658|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
101196659|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196660|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
101196661|NCT01386671|Metformin|metformin|mesh-list
101196665|NCT01386736|Vitamins|vitamins|mesh-ancestor
101196729|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101196730|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196731|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196732|NCT01387243|Orlistat|orlistat|mesh-list
101196733|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196734|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196813|NCT01388075|Rifampin|rifampin|mesh-list
101196814|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101196815|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
101196816|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101196817|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196818|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
101196819|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101196820|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196821|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196822|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
101196823|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101196824|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
101196825|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
101196826|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
101196827|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
101196828|NCT01388088|Amiloride|amiloride|mesh-list
101196829|NCT01388088|Spironolactone|spironolactone|mesh-list
101196833|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196834|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101196835|NCT01388088|Diuretics|diuretics|mesh-ancestor
101196836|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
101196837|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
101196842|NCT01388101|Antibodies|antibodies|mesh-list
101196865|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101196866|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196867|NCT01388439|Oseltamivir|oseltamivir|mesh-list
101196868|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
101196869|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101196870|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196871|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196872|NCT01388517|Vitamin D|vitamin d|mesh-list
101196873|NCT01388517|Calcitriol|calcitriol|mesh-list
101196874|NCT01388517|Petrolatum|petrolatum|mesh-list
101196875|NCT01388517|Tacrolimus|tacrolimus|mesh-list
101196877|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
101196878|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196879|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101196880|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101196881|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
101196882|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101196883|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101196884|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101196885|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101196886|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101196887|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101196888|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101196889|NCT01388517|Emollients|emollients|mesh-ancestor
101196890|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
101196891|NCT01388582|Copper|copper|mesh-list
101196892|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
101196893|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
101196894|NCT01388582|Etonogestrel|etonogestrel|mesh-list
101196895|NCT01388582|Desogestrel|desogestrel|mesh-list
101196896|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
101196897|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101196898|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101196899|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101196900|NCT01388582|Trace Elements|trace elements|mesh-ancestor
101196901|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
101196907|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101196908|NCT01388595|Fluticasone|fluticasone|mesh-list
101196910|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101196911|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101196912|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
101196913|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101196926|NCT01388621|Gemcitabine|gemcitabine|mesh-list
101197006|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197007|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101197009|NCT01389206|Bosentan|bosentan|mesh-list
101197100|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
101197101|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101197102|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197103|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101197104|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101197105|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
101197106|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197107|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101197108|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101197109|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101197110|NCT01389544|Narcotics|narcotics|mesh-ancestor
101197113|NCT01389544|Analgesics|analgesics|mesh-ancestor
101197170|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
101197171|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101197172|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101197173|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101197193|NCT01390012|BB 1101|bb 1101|mesh-list
101197247|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197330|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
101197331|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101197332|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101197333|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
101197334|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
101197405|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
101197406|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101197407|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
101197408|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101197409|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
101197480|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197481|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101197482|NCT01392014|Piperaquine|piperaquine|mesh-list
101197483|NCT01392014|Primaquine|primaquine|mesh-list
101197484|NCT01392014|Artenimol|artenimol|mesh-list
101197485|NCT01392014|Artemisinins|artemisinins|mesh-list
101197486|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
101197556|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101197557|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101197558|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101197559|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
101197560|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101197632|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
101197633|NCT01392833|Prednisolone|prednisolone|mesh-list
101197634|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
101197635|NCT01392833|Azathioprine|azathioprine|mesh-list
101197639|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
101197704|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101197705|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
101197706|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197707|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197708|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
101197710|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101197711|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
101197712|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
101197713|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101197714|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101197715|NCT01393288|Lorazepam|lorazepam|mesh-list
101197716|NCT01393288|Ondansetron|ondansetron|mesh-list
101197717|NCT01393288|Aprepitant|aprepitant|mesh-list
101197718|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
101197775|NCT01393574|Protective Agents|protective agents|mesh-ancestor
101197776|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101197777|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101197779|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101197847|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101197848|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101197849|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
101197850|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101197851|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101197926|NCT01394458|Heparin|heparin|mesh-list
101197927|NCT01394458|Citric Acid|citric acid|mesh-list
101197928|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
101197929|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
101197930|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101197931|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
101197932|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
101197933|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197934|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101197935|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101197941|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
101197997|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101197998|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101197999|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
101198000|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198001|NCT01394770|Amlodipine|amlodipine|mesh-list
101198002|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101198003|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
101198004|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198005|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198012|NCT01394796|Protective Agents|protective agents|mesh-ancestor
101198065|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101198066|NCT01395069|Analgesics|analgesics|mesh-ancestor
101198067|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
101198068|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198069|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198139|NCT01395433|Escitalopram|escitalopram|mesh-list
101198140|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101198141|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101198142|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101198143|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198144|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198145|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
101198146|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198147|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101198148|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101198154|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
101198155|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101198156|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
101198157|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101198158|NCT01395485|Brodalumab|brodalumab|mesh-list
101198159|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
101198160|NCT01395589|Vitamin D|vitamin d|mesh-list
101198202|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198203|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
101198204|NCT01395667|Antidotes|antidotes|mesh-ancestor
101198205|NCT01395667|Protective Agents|protective agents|mesh-ancestor
101198279|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101198280|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
101198281|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101198282|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198354|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101198355|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101198356|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198357|NCT01396668|Gemcitabine|gemcitabine|mesh-list
101198358|NCT01396668|Capecitabine|capecitabine|mesh-list
101198359|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198434|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198435|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101198436|NCT01397175|Everolimus|everolimus|mesh-list
101198437|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101198438|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101198439|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101198441|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101198505|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
101198506|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
101198507|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101198508|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101198509|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
101198586|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198587|NCT04415333|Butyric Acid|butyric acid|mesh-list
101198588|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
101198589|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
101198590|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198591|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198592|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198593|NCT03524170|Atezolizumab|atezolizumab|mesh-list
101198594|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101198595|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198596|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101198597|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101198650|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101198652|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101198653|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101198654|NCT02607956|Dolutegravir|dolutegravir|mesh-list
101198725|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
101198726|NCT05274139|Hormones|hormones|mesh-ancestor
101198727|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101198728|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198804|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198805|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198806|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101198807|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
101198810|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101198884|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
101198885|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
101198887|NCT05270889|Tislelizumab|tislelizumab|mesh-list
101198963|NCT05248724|Racepinephrine|racepinephrine|mesh-list
101198964|NCT05248724|Morphine|morphine|mesh-list
101198965|NCT05248724|Ropivacaine|ropivacaine|mesh-list
101198966|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
101198967|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101198968|NCT05248724|Narcotics|narcotics|mesh-ancestor
101198969|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101198970|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101198971|NCT05248724|Analgesics|analgesics|mesh-ancestor
101198972|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
101186934|NCT00002382|Saquinavir|saquinavir|mesh-list
101198973|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101198974|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
101199037|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199038|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
101199039|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199117|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101199118|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
101199119|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101199120|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101199121|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
101199190|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101199191|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101199192|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199193|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
101199194|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101199196|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
101199198|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101199199|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
101199200|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101199201|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199202|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101199203|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
101199204|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199205|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199206|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
101199215|NCT04919564|Diuretics|diuretics|mesh-ancestor
101199255|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101199256|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101199257|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199258|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
101199259|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101199260|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101199262|NCT04760912|Anesthetics|anesthetics|mesh-list
101199263|NCT04760912|Rocuronium|rocuronium|mesh-list
101199264|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101199265|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199266|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
101199267|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
101199268|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
101199269|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101199271|NCT04710641|Sorafenib|sorafenib|mesh-list
101199332|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
101199333|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101199334|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
101199335|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199336|NCT04476745|Vitamin D|vitamin d|mesh-list
101199337|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
101199338|NCT04476745|Vitamins|vitamins|mesh-ancestor
101199339|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
101199340|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199341|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101199342|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101199343|NCT04433390|Naloxegol|naloxegol|mesh-list
101199344|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101199346|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
101199400|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101199401|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101199402|NCT04245644|Analgesics|analgesics|mesh-ancestor
101199479|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199480|NCT03883412|Incretins|incretins|mesh-ancestor
101199563|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101199564|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101199565|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
101199566|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101199567|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
101199568|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
101199649|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199650|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101199651|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101199653|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101199654|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101199655|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101199656|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199721|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
101199722|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
101199723|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
101199724|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101199725|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
101199805|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199806|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101199807|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101199808|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101199809|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
101199810|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
101199811|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
101199812|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101199813|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
101199814|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
101199815|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
101199816|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101199817|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101199818|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
101199819|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101199820|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101199821|NCT03011775|Diuretics|diuretics|mesh-ancestor
101199822|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
101199823|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
101199824|NCT02960997|Sirolimus|sirolimus|mesh-list
101199862|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
101199863|NCT02873819|Sargramostim|sargramostim|mesh-list
101199864|NCT02873819|Poly ICLC|poly iclc|mesh-list
101199865|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101199866|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
101199867|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101199868|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101199869|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101199870|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
101199871|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101199872|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101199873|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101199874|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
101199875|NCT02810457|Paclitaxel|paclitaxel|mesh-list
101199876|NCT02810457|Bevacizumab|bevacizumab|mesh-list
101199995|NCT02619552|Infliximab|infliximab|mesh-list
101199996|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
101199997|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101199998|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
101199999|NCT02619552|Hormones|hormones|mesh-ancestor
101200000|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200001|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200002|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101200003|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200004|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101200005|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
101200006|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101200007|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101200008|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
101200009|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101200010|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200011|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
101200012|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200013|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200014|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
101200015|NCT02578368|Leucovorin|leucovorin|mesh-list
101200016|NCT02578368|Docetaxel|docetaxel|mesh-list
101200018|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
101200019|NCT02578368|Trastuzumab|trastuzumab|mesh-list
101200020|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
101200021|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200022|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
101200023|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
101200024|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
101200025|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200026|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200027|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
101200028|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101200029|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101200030|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
101200031|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200033|NCT02578368|Protective Agents|protective agents|mesh-ancestor
101200034|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
101200035|NCT02578368|Vitamins|vitamins|mesh-ancestor
101200036|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
101200037|NCT02539225|Paclitaxel|paclitaxel|mesh-list
101200038|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
101200039|NCT02539225|Ramucirumab|ramucirumab|mesh-list
101200040|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101200116|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200117|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101200118|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101200119|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101200120|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101200126|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
101200190|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101200191|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200192|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101200193|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200194|NCT01729754|Etanercept|etanercept|mesh-list
101200195|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101200196|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101200198|NCT01729754|Analgesics|analgesics|mesh-ancestor
101200260|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
101200261|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200262|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
101200263|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200264|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
101200265|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200266|NCT01433965|Lenalidomide|lenalidomide|mesh-list
101200267|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
101200268|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200269|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101200270|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101200271|NCT01433965|Growth Substances|growth substances|mesh-ancestor
101200272|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
101200278|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200325|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101200326|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200327|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101200328|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
101200329|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101200330|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
101200331|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101200332|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101200334|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
101200335|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200336|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101200337|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200338|NCT00678730|Analgesics|analgesics|mesh-ancestor
101200339|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
101200395|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101200396|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200397|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101200398|NCT00066963|Fluorides|fluorides|mesh-list
101200399|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
101200400|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
101200401|NCT00066963|Protective Agents|protective agents|mesh-ancestor
101200402|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200403|NCT01397500|Testosterone|testosterone|mesh-list
101200409|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101200410|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101200411|NCT01397513|Analgesics|analgesics|mesh-ancestor
101200412|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
101200416|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101200462|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101200463|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200464|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200540|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200541|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200542|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101200543|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101200544|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
101188202|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
101200545|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101200577|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
101200578|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
101200579|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
101200580|NCT01398384|Protective Agents|protective agents|mesh-ancestor
101200639|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101200640|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200641|NCT01399151|Vitamin D|vitamin d|mesh-list
101200642|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
101200643|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
101200644|NCT01399151|Vitamins|vitamins|mesh-list
101200645|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
101200646|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200647|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101200709|NCT01399645|Liraglutide|liraglutide|mesh-list
101200710|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101200711|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101200712|NCT01399645|Incretins|incretins|mesh-ancestor
101200785|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200786|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200787|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
101200788|NCT01400464|Prednisone|prednisone|mesh-list
101200791|NCT01400464|Hormones|hormones|mesh-ancestor
101200868|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101200869|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101200870|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101200871|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101200872|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101200892|NCT01400867|Vancomycin|vancomycin|mesh-list
101200943|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101200944|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101200945|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101200946|NCT01401192|Cisplatin|cisplatin|mesh-list
101200947|NCT01401192|Gemcitabine|gemcitabine|mesh-list
101201029|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101201030|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101201031|NCT01402089|Sunitinib|sunitinib|mesh-list
101201032|NCT01402089|Midazolam|midazolam|mesh-list
101201033|NCT01402089|Caffeine|caffeine|mesh-list
101201034|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201035|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201111|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201112|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101201113|NCT01402583|Ribavirin|ribavirin|mesh-list
101201114|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
101201115|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201116|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
101201117|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101201118|NCT01402596|Midazolam|midazolam|mesh-list
101201183|NCT01403168|Analgesics|analgesics|mesh-list
101201184|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
101201185|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201186|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201260|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201261|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101201262|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101201263|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
101201340|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101201341|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201342|NCT01404000|Charcoal|charcoal|mesh-list
101201343|NCT01404000|Antidotes|antidotes|mesh-ancestor
101201344|NCT01404000|Protective Agents|protective agents|mesh-ancestor
101201345|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201346|NCT01404013|Montelukast|montelukast|mesh-list
101201348|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101201349|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
101201350|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
101201414|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101201415|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201416|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
101201417|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201418|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201419|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
101201420|NCT01404182|Vaccines|vaccines|mesh-list
101201421|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
101201422|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201423|NCT01404312|Pyridoxine|pyridoxine|mesh-list
101201424|NCT01404312|Pyridoxal|pyridoxal|mesh-list
101201425|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
101201426|NCT01404312|Isoniazid|isoniazid|mesh-list
101201427|NCT01404312|Rifapentine|rifapentine|mesh-list
101201484|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201485|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101201486|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101201487|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101201488|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201489|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201490|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
101201491|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
101201492|NCT01404468|Lidocaine|lidocaine|mesh-list
101201493|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
101201494|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
101201495|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101201497|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
101201549|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101201550|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101201551|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101201552|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101201553|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
101201621|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101201622|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101201623|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201625|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101201704|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
101201705|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
101201706|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
101201707|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101201786|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101201787|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101201788|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101201789|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
101201790|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
101201791|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
101201792|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
101201793|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
101201794|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101201796|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
101201860|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101201861|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
101201862|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101201952|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
101201953|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101201954|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101201955|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
101201958|NCT01406496|Insulin|insulin|mesh-list
101202035|NCT01407471|Spironolactone|spironolactone|mesh-list
101202036|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101202037|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
101202038|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101202039|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202040|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101202041|NCT01407471|Diuretics|diuretics|mesh-ancestor
101202045|NCT01407471|Hormones|hormones|mesh-ancestor
101202108|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202109|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
101202110|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202112|NCT01408095|Globalagliatin|globalagliatin|mesh-list
101202113|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101202114|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101202187|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202188|NCT01408524|Diltiazem|diltiazem|mesh-list
101202267|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202268|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
101202269|NCT01408953|Bevacizumab|bevacizumab|mesh-list
101202349|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101202350|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202429|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
101202430|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101202431|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101202432|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101202433|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
101202434|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202443|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
101202509|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101202510|NCT01410370|Growth Substances|growth substances|mesh-ancestor
101202511|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202512|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
101202513|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202515|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
101202516|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101202517|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101202518|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101202520|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
101202581|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101202582|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101202583|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101202584|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101202585|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202586|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
101202587|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101202656|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101202657|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202658|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
101202659|NCT01411670|Protein C|protein c|mesh-list
101202660|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
101202661|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101202662|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101202663|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202727|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
101202730|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101202731|NCT01412294|Capecitabine|capecitabine|mesh-list
101202732|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202733|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101202734|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
101202735|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202810|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101202811|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101202892|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101202893|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
101202894|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101202895|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101202896|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101202897|NCT01413477|Vitamins|vitamins|mesh-ancestor
101202967|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
101202968|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101202969|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
101202970|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
101203045|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203046|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101203047|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203120|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203121|NCT01415596|Albuterol|albuterol|mesh-list
101203122|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101203123|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
101203125|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203126|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101203200|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203201|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203202|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203203|NCT01415895|Clonidine|clonidine|mesh-list
101203204|NCT01415895|Naltrexone|naltrexone|mesh-list
101203205|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101203206|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
101203210|NCT01415895|Analgesics|analgesics|mesh-ancestor
101203275|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101203276|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
101203277|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
101203278|NCT01416337|Trametinib|trametinib|mesh-list
101203279|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101203291|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
101203360|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101203361|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101203442|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203443|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
101203444|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101203445|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
101203446|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
101203514|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101203516|NCT01417897|Insulin|insulin|mesh-list
101203598|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101203599|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101203600|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101203673|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101203674|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101203675|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
101203759|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101203768|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101203770|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101203844|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101203845|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101203846|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
101203875|NCT01420302|Insulin|insulin|mesh-list
101204024|NCT01421173|Melphalan|melphalan|mesh-list
101204025|NCT01421173|Busulfan|busulfan|mesh-list
101204026|NCT01421173|Vorinostat|vorinostat|mesh-list
101204027|NCT01421173|BB 1101|bb 1101|mesh-list
101204028|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204131|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
101204132|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204134|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
101204206|NCT01422291|Narcotics|narcotics|mesh-ancestor
101204207|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101204285|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101204286|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101204287|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101204288|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
101204363|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
101204364|NCT01423123|Paclitaxel|paclitaxel|mesh-list
101204365|NCT01423123|Trastuzumab|trastuzumab|mesh-list
101204366|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101204367|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204368|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
101204369|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
101204370|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
101204442|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101204443|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
101204445|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101204447|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204448|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204449|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204450|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
101204451|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101204452|NCT01423539|Rituximab|rituximab|mesh-list
101204453|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
101204454|NCT01423539|Navitoclax|navitoclax|mesh-list
101204455|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101204456|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101204457|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
101204458|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204459|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204460|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204461|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
101204462|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204463|NCT01423591|Infliximab|infliximab|mesh-list
101204464|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101204499|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101204500|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101204501|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101204572|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
101204573|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101204646|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
101204647|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101204649|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101204650|NCT01424618|Leuprolide|leuprolide|mesh-list
101204723|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101204724|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204725|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
101204726|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
101204727|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204728|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101204729|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
101204791|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101204792|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101204793|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
101204794|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101204795|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
101204864|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101204865|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101204941|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101204942|NCT05386186|Glimepiride|glimepiride|mesh-list
101204943|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
101204944|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101204945|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101204946|NCT05386186|Incretins|incretins|mesh-ancestor
101204947|NCT05386186|Hormones|hormones|mesh-ancestor
101205015|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101205016|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101205018|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205019|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
101205021|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
101205022|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
101205023|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205085|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205086|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
101205087|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101205088|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205089|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205160|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
101205161|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205162|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
101205163|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
101205164|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205165|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205168|NCT04673162|Hormones|hormones|mesh-ancestor
101205231|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
101205232|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101205233|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101205234|NCT04425902|Analgesics|analgesics|mesh-ancestor
101205236|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101205237|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101205238|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101205304|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101205305|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205306|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205379|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
101205380|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205381|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101205382|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101205383|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205384|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101205449|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205450|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101205451|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
101205452|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
101205453|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205454|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205455|NCT01425996|Camptothecin|camptothecin|mesh-list
101205456|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101205457|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205458|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101205459|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101205460|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205461|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205462|NCT01426022|Ethanol|ethanol|mesh-list
101205463|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101205506|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101205507|NCT01426256|Vitamin D|vitamin d|mesh-list
101205509|NCT01426256|Vitamins|vitamins|mesh-ancestor
101205514|NCT01426334|Cyclosporine|cyclosporine|mesh-list
101205584|NCT01426880|Lapatinib|lapatinib|mesh-list
101205585|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101205586|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205587|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
101205588|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
101205589|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
101205590|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205591|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101205592|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101205648|NCT01427114|Vincristine|vincristine|mesh-list
101205649|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101205650|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
101205651|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205652|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101205653|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101205721|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101205722|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101205723|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
101205724|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101205725|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101205726|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101205727|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101205728|NCT01427478|Afatinib|afatinib|mesh-list
101205741|NCT01427686|Dobutamine|dobutamine|mesh-list
101205791|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101205792|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
101205793|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
101205794|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
101205795|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
101205866|NCT01428414|Carboplatin|carboplatin|mesh-list
101205867|NCT01428414|Trastuzumab|trastuzumab|mesh-list
101205868|NCT01428414|Epirubicin|epirubicin|mesh-list
101205869|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101205870|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101205944|NCT01428817|Carbetocin|carbetocin|mesh-list
101205945|NCT01428817|Oxytocin|oxytocin|mesh-list
101205946|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
101205947|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
101206017|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206018|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
101206019|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101206020|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
101206021|NCT01429415|Analgesics|analgesics|mesh-ancestor
101206088|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206089|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
101206090|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
101206091|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101206093|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
101206160|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206162|NCT01430013|Endostar protein|endostar protein|mesh-list
101206236|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
101206237|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101206238|NCT01430806|Dronedarone|dronedarone|mesh-list
101206239|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101206240|NCT01430910|Ceftazidime|ceftazidime|mesh-list
101206241|NCT01430910|Avibactam|avibactam|mesh-list
101206242|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101206243|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101206244|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101206248|NCT01430923|Latanoprost|latanoprost|mesh-list
101206306|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
101206307|NCT01431326|Nafcillin|nafcillin|mesh-list
101206308|NCT01431326|Cidofovir|cidofovir|mesh-list
101206309|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
101206310|NCT01431326|Bosentan|bosentan|mesh-list
101206311|NCT01431326|Labetalol|labetalol|mesh-list
101206312|NCT01431326|Nifedipine|nifedipine|mesh-list
101206383|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
101206384|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
101206385|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
101206386|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101206387|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
101206388|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101206389|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
101206455|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206456|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206457|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
101206458|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101206459|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101206460|NCT01431495|Clopidogrel|clopidogrel|mesh-list
101206472|NCT01431612|Phenylephrine|phenylephrine|mesh-list
101206526|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101206527|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101206528|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101206529|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101206530|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
101206531|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101206532|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206533|NCT01432028|Drospirenone|drospirenone|mesh-list
101206535|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
101206593|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
101206594|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101206595|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206596|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101206597|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206598|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206599|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101206600|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
101206661|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101206662|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
101206664|NCT01432665|Androgens|androgens|mesh-ancestor
101206665|NCT01432665|Hormones|hormones|mesh-ancestor
101206666|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206736|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101206737|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
101206738|NCT01433445|Panobinostat|panobinostat|mesh-list
101206739|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101206740|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
101206741|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101206743|NCT01433614|Paclitaxel|paclitaxel|mesh-list
101206810|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206811|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101206812|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
101206813|NCT01434017|Hormones|hormones|mesh-ancestor
101206814|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101206815|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101206880|NCT01434147|Growth Substances|growth substances|mesh-ancestor
101206881|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206882|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
101206883|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101206951|NCT01434303|Entinostat|entinostat|mesh-list
101206952|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
101206953|NCT01434303|Antibodies|antibodies|mesh-list
101206954|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
101206955|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101206956|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
101206957|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
101206958|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101206959|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207018|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101207019|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
101207020|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
101207021|NCT01435083|Coagulants|coagulants|mesh-ancestor
101207022|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
101207023|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
101207026|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
101207027|NCT01435161|Nifedipine|nifedipine|mesh-list
101207028|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101207089|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101207090|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101207091|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101207092|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207093|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101207094|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101207095|NCT01435395|Bevacizumab|bevacizumab|mesh-list
101207096|NCT01435395|Temozolomide|temozolomide|mesh-list
101207097|NCT01435395|Bortezomib|bortezomib|mesh-list
101207099|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207155|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
101207156|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
101207157|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207158|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207159|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207160|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
101207225|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207226|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207227|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101207228|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
101207229|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
101207230|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
101207240|NCT01436513|Hormones|hormones|mesh-ancestor
101207297|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
101207298|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101207299|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207300|NCT01437007|TKM-080301|tkm-080301|mesh-list
101207301|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101207302|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207303|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207304|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
101207305|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
101207306|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101207307|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101207308|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101207359|NCT01437371|Lisinopril|lisinopril|mesh-list
101207360|NCT01437371|Captopril|captopril|mesh-list
101207436|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
101207437|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
101207438|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
101207511|NCT01438086|Growth Substances|growth substances|mesh-ancestor
101207512|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207515|NCT01438112|Mitomycins|mitomycins|mesh-list
101207585|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207586|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207587|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101207588|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101207589|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
101207590|NCT05387525|Diclofenac|diclofenac|mesh-list
101207591|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
101207655|NCT05111431|Analgesics|analgesics|mesh-ancestor
101207656|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
101207657|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207658|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
101207671|NCT04956939|Levodopa|levodopa|mesh-list
101207728|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101207729|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
101207730|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
101207731|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
101207732|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101207740|NCT04850222|Fluoxetine|fluoxetine|mesh-list
101207801|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
101207802|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
101207803|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
101207804|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101207805|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
101207806|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101207808|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
101207875|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101207876|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101207877|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101207878|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101207879|NCT04322552|Apatinib|apatinib|mesh-list
101207880|NCT04322552|Digoxin|digoxin|mesh-list
101207881|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101207957|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101207958|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
101207959|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101207960|NCT03416127|Metformin|metformin|mesh-list
101207961|NCT03416127|Propolis|propolis|mesh-list
101207962|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101207963|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101207965|NCT03293069|Deferiprone|deferiprone|mesh-list
101208027|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208028|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101208102|NCT01877837|Melphalan|melphalan|mesh-list
101208103|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
101208104|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208105|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101208106|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
101208107|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208108|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101208109|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
101208110|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208170|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101208171|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208172|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
101208173|NCT01438372|Hematinics|hematinics|mesh-ancestor
101208174|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
101208175|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
101208176|NCT01438515|Doxycycline|doxycycline|mesh-list
101208177|NCT01438515|Rifampin|rifampin|mesh-list
101208238|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208239|NCT01438736|Etonogestrel|etonogestrel|mesh-list
101208240|NCT01438736|Desogestrel|desogestrel|mesh-list
101208241|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101208312|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101208313|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208314|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101208315|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101208316|NCT01439178|Growth Substances|growth substances|mesh-ancestor
101208383|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
101208384|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
101208385|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101208386|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101208396|NCT01440062|Vitamins|vitamins|mesh-list
101208455|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208456|NCT01440439|Insulin|insulin|mesh-list
101208457|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101208459|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
101208460|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101208461|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208462|NCT01440582|Dexamethasone|dexamethasone|mesh-list
101208463|NCT01440582|Lenalidomide|lenalidomide|mesh-list
101208464|NCT01440582|Bortezomib|bortezomib|mesh-list
101208465|NCT01440582|Panobinostat|panobinostat|mesh-list
101208466|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101208522|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
101208523|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101208524|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
101208525|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208526|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101208527|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208528|NCT01440790|Vitamins|vitamins|mesh-list
101208591|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
101208592|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
101208593|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101208662|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
101208663|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101208664|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208665|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208666|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
101208667|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
101208732|NCT01441934|Urological Agents|urological agents|mesh-ancestor
101208733|NCT01441986|Amantadine|amantadine|mesh-list
101208734|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
101208735|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
101208736|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
101208807|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
101208808|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101208809|NCT01442519|Mitomycins|mitomycins|mesh-list
101208810|NCT01442519|Mitomycin|mitomycin|mesh-list
101208811|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
101208881|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101208882|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
101208883|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101208884|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101208885|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
101208886|NCT01442818|Hydromorphone|hydromorphone|mesh-list
101208887|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101208888|NCT01442818|Narcotics|narcotics|mesh-ancestor
101208889|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101208952|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101208953|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
101208954|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101208955|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101208961|NCT01443065|Panitumumab|panitumumab|mesh-list
101209026|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209027|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
101209028|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
101209029|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
101209030|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
101209031|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209032|NCT01443325|Lidocaine|lidocaine|mesh-list
101209095|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101209096|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101209097|NCT01443676|Growth Substances|growth substances|mesh-ancestor
101209098|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209099|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
101209100|NCT01443741|Insulin|insulin|mesh-list
101209101|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101209104|NCT01443780|Selenium|selenium|mesh-list
101209166|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101209167|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209168|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101209169|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209170|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
101209171|NCT01444339|Vaccines|vaccines|mesh-list
101209172|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
101209173|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
101209210|NCT01444612|PENTA|penta|mesh-list
101209237|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
101209238|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
101209239|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209240|NCT01444846|Ebselen|ebselen|mesh-list
101209310|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101209311|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
101209313|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101209314|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101209315|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101209316|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101209322|NCT01445236|Cyclosporine|cyclosporine|mesh-list
101209381|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209382|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
101209383|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101209384|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101209385|NCT01445561|Interleukin-2|interleukin-2|mesh-list
101209386|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209466|NCT01446107|Protective Agents|protective agents|mesh-ancestor
101209467|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209468|NCT01446120|Insulin|insulin|mesh-list
101209469|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101209470|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
101209476|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
101209538|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
101209539|NCT01446445|Valganciclovir|valganciclovir|mesh-list
101209540|NCT01446445|Ganciclovir|ganciclovir|mesh-list
101209541|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
101209612|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101209613|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
101209614|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209615|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101209616|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101209688|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101209689|NCT01447394|Interferons|interferons|mesh-list
101209690|NCT01447394|Ribavirin|ribavirin|mesh-list
101209691|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
101209692|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
101209758|NCT01448018|Ranibizumab|ranibizumab|mesh-list
101209759|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101209760|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101209761|NCT01448018|Growth Substances|growth substances|mesh-ancestor
101209831|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
101209832|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
101209833|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101209834|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101209835|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
101209836|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209902|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101209903|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101209907|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
101209978|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101209979|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101209980|NCT01449110|Resveratrol|resveratrol|mesh-list
101209981|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
101209982|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101209987|NCT01449123|Mannitol|mannitol|mesh-list
101210051|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101210052|NCT01449357|Zalutumumab|zalutumumab|mesh-list
101210128|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
101210129|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210130|NCT01449799|Fluticasone|fluticasone|mesh-list
101210131|NCT01449799|Xhance|xhance|mesh-list
101210132|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101210133|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101210134|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
101210196|NCT01451320|Streptokinase|streptokinase|mesh-list
101210197|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101210198|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101210270|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101210271|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
101210274|NCT01454700|Insulin|insulin|mesh-list
101210345|NCT05963984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210422|NCT05963048|Rituximab|rituximab|mesh-list
101210423|NCT05963048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210424|NCT05963048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210425|NCT05963048|Immunologic Factors|immunologic factors|mesh-ancestor
101210426|NCT05963048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210427|NCT05963048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101210428|NCT05962970|Ropivacaine|ropivacaine|mesh-list
101210429|NCT05962970|Anesthetics, Local|anesthetics, local|mesh-ancestor
101210430|NCT05962970|Anesthetics|anesthetics|mesh-ancestor
101210431|NCT05962970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101210575|NCT05961007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210576|NCT05960955|Docetaxel|docetaxel|mesh-list
101210650|NCT05960721|Anticoagulants|anticoagulants|mesh-ancestor
101210651|NCT05960708|Omalizumab|omalizumab|mesh-list
101210735|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101210759|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101210760|NCT05887726|Prednisone|prednisone|mesh-list
101210761|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
101210762|NCT05887726|Rituximab|rituximab|mesh-list
101210763|NCT05887726|Vincristine|vincristine|mesh-list
101210764|NCT05887726|Epirubicin|epirubicin|mesh-list
101210846|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101210847|NCT05841420|Paclitaxel|paclitaxel|mesh-list
101210922|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
101210923|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101210924|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101210925|NCT05772429|Cannabidiol|cannabidiol|mesh-list
101210926|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
101210927|NCT05743270|Paclitaxel|paclitaxel|mesh-list
101210928|NCT05743270|Carboplatin|carboplatin|mesh-list
101210929|NCT05743270|Nivolumab|nivolumab|mesh-list
101210932|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
101211015|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101211016|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211017|NCT05662306|Aripiprazole|aripiprazole|mesh-list
101211018|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
101211019|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
101211085|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211086|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211087|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
101211088|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101211161|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211162|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
101211234|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211312|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211313|NCT05465317|Incretins|incretins|mesh-ancestor
101211337|NCT05450562|Atezolizumab|atezolizumab|mesh-list
101211338|NCT05450562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101211339|NCT05450562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211340|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101211341|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211342|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
101211343|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211344|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
101211345|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101211346|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211347|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101211348|NCT05433480|Fulvestrant|fulvestrant|mesh-list
101211349|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101211350|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211351|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
101211352|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
101211353|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
101211354|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101211395|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
101211396|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211397|NCT05378113|Lidocaine|lidocaine|mesh-list
101211398|NCT05378113|Ondansetron|ondansetron|mesh-list
101211399|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
101211582|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
101211583|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
101211584|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101211585|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101211586|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
101211587|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101211588|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101211654|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
101211655|NCT05099198|Glimepiride|glimepiride|mesh-list
101211656|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101211659|NCT05099198|Hormones|hormones|mesh-ancestor
101211727|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211803|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
101211804|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
101211815|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
101211877|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101211878|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101211879|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
101211880|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101211881|NCT04932980|Aflibercept|aflibercept|mesh-list
101211882|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101211883|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101211884|NCT04932980|Growth Substances|growth substances|mesh-ancestor
101211891|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
101211947|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101211966|NCT04892732|Budesonide|budesonide|mesh-list
101212022|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212023|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101212097|NCT04725201|Heparin|heparin|mesh-list
101212098|NCT04725201|Calcium heparin|calcium heparin|mesh-list
101212099|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
101212100|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
101212101|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101212103|NCT04724239|Bevacizumab|bevacizumab|mesh-list
101212168|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
101212169|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212170|NCT04635826|Adderall|adderall|mesh-list
101212173|NCT04629781|Docetaxel|docetaxel|mesh-list
101212244|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
101212245|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212246|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212247|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
101212249|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
101212313|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101212314|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212315|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
101212316|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212317|NCT04332744|Talazoparib|talazoparib|mesh-list
101212382|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212383|NCT04233021|Osimertinib|osimertinib|mesh-list
101212384|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212385|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101212386|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212454|NCT04140305|Ozanimod|ozanimod|mesh-list
101212455|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
101212456|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212457|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101212458|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
101212460|NCT04135937|Bupropion|bupropion|mesh-list
101212524|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212525|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101212526|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212527|NCT03978598|Etonogestrel|etonogestrel|mesh-list
101212640|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
101212641|NCT03900637|Letrozole|letrozole|mesh-list
101212642|NCT03900637|Leuprolide|leuprolide|mesh-list
101212643|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212644|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
101212645|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101212646|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101212647|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212712|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
101212713|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101212714|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101212718|NCT03761056|Fludarabine|fludarabine|mesh-list
101212787|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101212788|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212790|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
101212791|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
101212792|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101212876|NCT03450343|Azacitidine|azacitidine|mesh-list
101212877|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101212878|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
101212880|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101212951|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101212952|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101212953|NCT03355976|Nivolumab|nivolumab|mesh-list
101212954|NCT03355976|Ipilimumab|ipilimumab|mesh-list
101213023|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213024|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
101213025|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101213026|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213027|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101213028|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
101213031|NCT03214510|Fentanyl|fentanyl|mesh-list
101213095|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101213176|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
101213177|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
101213178|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101213179|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101213182|NCT02586831|Analgesics|analgesics|mesh-ancestor
101213252|NCT02419495|Irinotecan|irinotecan|mesh-list
101213253|NCT02419495|Pemetrexed|pemetrexed|mesh-list
101213254|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
101213255|NCT02419495|Ipilimumab|ipilimumab|mesh-list
101213256|NCT02419495|Daunorubicin|daunorubicin|mesh-list
101213326|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213327|NCT02123121|Resveratrol|resveratrol|mesh-list
101213328|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
101213329|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213401|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101213402|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101213574|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
101213575|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101213650|NCT01455350|Lidocaine|lidocaine|mesh-list
101213703|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101213705|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
101213706|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101213707|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
101213708|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
101213709|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
101213774|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101213775|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
101213789|NCT01460420|Bortezomib|bortezomib|mesh-list
101213848|NCT01460706|Edotreotide|edotreotide|mesh-list
101214005|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101214006|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214078|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214079|NCT01463371|Azithromycin|azithromycin|mesh-list
101214080|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
101214154|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214231|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214232|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214303|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
101214304|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214380|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101214381|NCT01467323|Insulin|insulin|mesh-list
101214382|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
101214383|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
101214455|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101214456|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214457|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
101214458|NCT01467804|Sertraline|sertraline|mesh-list
101214459|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
101214468|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
101214523|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101214524|NCT01468155|Dabigatran|dabigatran|mesh-list
101214525|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
101214530|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
101214597|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
101214673|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101214747|NCT01469572|Hormones|hormones|mesh-ancestor
101214749|NCT01469598|Gemcitabine|gemcitabine|mesh-list
101214750|NCT01469598|Docetaxel|docetaxel|mesh-list
101214823|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
101214895|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101214896|NCT01470339|Analgesics|analgesics|mesh-ancestor
101214897|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
101214972|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
101214973|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101215048|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101215198|NCT01472263|Protective Agents|protective agents|mesh-ancestor
101215277|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101215278|NCT01473043|Axitinib|axitinib|mesh-list
101215352|NCT01473303|Antidotes|antidotes|mesh-ancestor
101215430|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101215452|NCT01474460|Vitamin K|vitamin k|mesh-list
101215510|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
101215511|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
101215586|NCT01475617|Vitamins|vitamins|mesh-ancestor
101215587|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
101215588|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101215665|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
101215668|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
101215741|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
101215894|NCT01477606|Cytarabine|cytarabine|mesh-list
101215915|NCT01477632|Estradiol|estradiol|mesh-list
101216044|NCT01478308|Prednisone|prednisone|mesh-list
101216045|NCT01478308|Docetaxel|docetaxel|mesh-list
101216046|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101216118|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
101216119|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
101216123|NCT01478633|Galantamine|galantamine|mesh-list
101216194|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216348|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101216421|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
101216424|NCT01480752|Lornoxicam|lornoxicam|mesh-list
101216503|NCT01481194|Bortezomib|bortezomib|mesh-list
101216572|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
101216573|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101216574|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101216575|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101216576|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
101216577|NCT01481519|Hormones|hormones|mesh-ancestor
101216578|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101216579|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101216580|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101216581|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
101216582|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216583|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216584|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
101216585|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
101216595|NCT01481610|Diclofenac|diclofenac|mesh-list
101216634|NCT01481844|Amoxicillin|amoxicillin|mesh-list
101216635|NCT01481844|Metronidazole|metronidazole|mesh-list
101216636|NCT01481844|Clarithromycin|clarithromycin|mesh-list
101216637|NCT01481844|Tetracycline|tetracycline|mesh-list
101216638|NCT01481844|Tinidazole|tinidazole|mesh-list
101216639|NCT01481844|Lansoprazole|lansoprazole|mesh-list
101216640|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
101216641|NCT01481844|Bismuth|bismuth|mesh-list
101216704|NCT01482117|Protective Agents|protective agents|mesh-ancestor
101216705|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
101216706|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
101216707|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216709|NCT01482156|Dactolisib|dactolisib|mesh-list
101216710|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101216711|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101216712|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101216713|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101216714|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101216715|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
101216718|NCT01482299|Everolimus|everolimus|mesh-list
101216770|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
101216845|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
101216923|NCT01484184|Buspirone|buspirone|mesh-list
101216924|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
101216925|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101216998|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217074|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217075|NCT01485315|Mannitol|mannitol|mesh-list
101217076|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
101217077|NCT01485315|Diuretics|diuretics|mesh-ancestor
101217078|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
101217079|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217080|NCT01485367|Adapalene|adapalene|mesh-list
101217081|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217082|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217083|NCT01485367|Analgesics|analgesics|mesh-ancestor
101217084|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
101217085|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217142|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
101217143|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217221|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
101217222|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217223|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217224|NCT01485926|Carboplatin|carboplatin|mesh-list
101217225|NCT01485926|Docetaxel|docetaxel|mesh-list
101217291|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
101217292|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101217293|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217294|NCT01486433|Aspirin|aspirin|mesh-list
101217295|NCT01486433|Simvastatin|simvastatin|mesh-list
101217296|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217297|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217325|NCT01486485|Nafamostat|nafamostat|mesh-list
101217360|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
101217361|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217362|NCT01486706|Gabapentin|gabapentin|mesh-list
101217434|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
101217438|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
101217511|NCT01487512|Hydromorphone|hydromorphone|mesh-list
101217512|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
101217513|NCT01487512|Narcotics|narcotics|mesh-ancestor
101217590|NCT01488266|Fluoxetine|fluoxetine|mesh-list
101217591|NCT01488266|Paroxetine|paroxetine|mesh-list
101217592|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
101217593|NCT01488266|Sertraline|sertraline|mesh-list
101217594|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
101217595|NCT01488266|Escitalopram|escitalopram|mesh-list
101217596|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
101217597|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
101217598|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101217599|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217600|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101217601|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
101217602|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217603|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217605|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101217650|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
101217651|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217652|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
101217655|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
101217656|NCT01488526|Tenofovir|tenofovir|mesh-list
101217657|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
101217658|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217659|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
101217660|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
101217661|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101217662|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101217719|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
101217720|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
101217721|NCT01488838|Cisplatin|cisplatin|mesh-list
101217722|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101217723|NCT01488955|Fosfomycin|fosfomycin|mesh-list
101217724|NCT01488955|Ibuprofen|ibuprofen|mesh-list
101217725|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101217726|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101217727|NCT01488955|Analgesics|analgesics|mesh-ancestor
101217728|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
101217729|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101217730|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101217731|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101217732|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101217733|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
101217783|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
101217784|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
101217785|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101217786|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
101217857|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101217932|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
101218011|NCT01490047|Analgesics|analgesics|mesh-ancestor
101218090|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218166|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
101218175|NCT01490944|Folic Acid|folic acid|mesh-list
101218246|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
101218247|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101218320|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218334|NCT01491867|Travoprost|travoprost|mesh-list
101218394|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
101218395|NCT01492608|Analgesics|analgesics|mesh-ancestor
101218396|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
101218399|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
101218470|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218471|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
101218473|NCT01493050|Sevelamer|sevelamer|mesh-list
101218474|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
101218475|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218476|NCT01493050|Antacids|antacids|mesh-ancestor
101218477|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101218478|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101218479|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
101218539|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218615|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
101218616|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101218617|NCT01493999|Clopidogrel|clopidogrel|mesh-list
101218633|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
101218690|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101218766|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
101218826|NCT01495117|Iodine|iodine|mesh-list
101218846|NCT01495169|Iloperidone|iloperidone|mesh-list
101218919|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101218920|NCT01495377|Analgesics|analgesics|mesh-ancestor
101218921|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
101218992|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
101218993|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
101219007|NCT01496105|Lidocaine|lidocaine|mesh-list
101219064|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101219074|NCT01496521|Aspirin|aspirin|mesh-list
101219140|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
101219218|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219219|NCT01497431|Trace Elements|trace elements|mesh-ancestor
101219301|NCT01497626|Bortezomib|bortezomib|mesh-list
101219371|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101219372|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101219602|NCT01499771|Atorvastatin|atorvastatin|mesh-list
101219603|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
101219604|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101219681|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
101219682|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
101219690|NCT01500473|Hormones|hormones|mesh-ancestor
101219756|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101219773|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
101219833|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101219911|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101219912|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
101219987|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101220087|NCT01501747|Cephalexin|cephalexin|mesh-list
101220137|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
101220212|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101220214|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
101220218|NCT01502267|Bortezomib|bortezomib|mesh-list
101220364|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101220365|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
101220366|NCT01503372|Vitamins|vitamins|mesh-ancestor
101220438|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101220592|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
101220669|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
101220670|NCT01504321|Moxonidine|moxonidine|mesh-list
101220821|NCT01505127|Clarithromycin|clarithromycin|mesh-list
101220822|NCT01505127|Lansoprazole|lansoprazole|mesh-list
101220900|NCT01505439|Urological Agents|urological agents|mesh-ancestor
101220971|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101220972|NCT01506011|Amlodipine|amlodipine|mesh-list
101221047|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
101221048|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
101221049|NCT01506167|Growth Substances|growth substances|mesh-ancestor
101221050|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221051|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
101221052|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
101221053|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221054|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
101221055|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221056|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
101221057|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
101221058|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
101221059|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221060|NCT01506167|Antidotes|antidotes|mesh-ancestor
101221061|NCT01506167|Protective Agents|protective agents|mesh-ancestor
101221062|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
101221063|NCT01506167|Vitamins|vitamins|mesh-ancestor
101221064|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
101221065|NCT01506167|Hematinics|hematinics|mesh-ancestor
101221108|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
101221182|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221257|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
101221333|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221334|NCT01507389|Incretins|incretins|mesh-ancestor
101221335|NCT01507389|Hormones|hormones|mesh-ancestor
101221409|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
101221410|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221411|NCT01507597|Incretins|incretins|mesh-ancestor
101221485|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
101221486|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221487|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221488|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101221489|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
101221490|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101221491|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
101221492|NCT01508000|Bevacizumab|bevacizumab|mesh-list
101221502|NCT01508104|Dactolisib|dactolisib|mesh-list
101221552|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
101221553|NCT01508260|Furosemide|furosemide|mesh-list
101221626|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221627|NCT01508637|Terazosin|terazosin|mesh-list
101221628|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
101221702|NCT01508949|Incretins|incretins|mesh-ancestor
101221703|NCT01508949|Hormones|hormones|mesh-ancestor
101221848|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221849|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
101221850|NCT01510015|Risperidone|risperidone|mesh-list
101221851|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
101221852|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
101221853|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221854|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221855|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221856|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
101221857|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101221858|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101221859|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101221860|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
101221861|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
101221862|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
101221863|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221864|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221865|NCT01510132|Timolol|timolol|mesh-list
101221866|NCT01510132|Travoprost|travoprost|mesh-list
101221867|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
101221868|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
101221869|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221870|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221871|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221872|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221873|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
101221874|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
101221875|NCT01510171|Ticagrelor|ticagrelor|mesh-list
101221876|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
101221877|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
101221878|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
101221879|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
101221880|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
101221881|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
101221882|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221883|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221884|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221885|NCT01510288|Ipilimumab|ipilimumab|mesh-list
101221886|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101221887|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221888|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101221889|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221890|NCT01510366|Vaccines|vaccines|mesh-list
101221891|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
101221892|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221893|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
101221894|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
101221895|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
101221896|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101221897|NCT01510509|Everolimus|everolimus|mesh-list
101221898|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101221899|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221900|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101176734|NCT01820754|Paclitaxel|paclitaxel|mesh-list
101176735|NCT01820754|Carboplatin|carboplatin|mesh-list
101176736|NCT01820754|Ipilimumab|ipilimumab|mesh-list
101176737|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
101176738|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101176739|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
101176740|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
101176741|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
101176744|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
101177013|NCT01849692|Ranibizumab|ranibizumab|mesh-list
101177240|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
101177334|NCT04337814|Analgesics|analgesics|mesh-ancestor
101177721|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101177955|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101177957|NCT03551730|Enoxaparin|enoxaparin|mesh-list
101178059|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
101178214|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178369|NCT02030574|Gemcitabine|gemcitabine|mesh-list
101178456|NCT02054754|Hormones|hormones|mesh-ancestor
101178521|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
101178522|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
101178523|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
101178536|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
101178823|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101178900|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101179061|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
101179127|NCT02285634|Lidocaine|lidocaine|mesh-list
101179202|NCT02289222|Growth Substances|growth substances|mesh-ancestor
101179277|NCT02321748|Montelukast|montelukast|mesh-list
101179350|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101179425|NCT02377752|Doxorubicin|doxorubicin|mesh-list
101179579|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101179657|NCT04776018|Daratumumab|daratumumab|mesh-list
101179658|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101179659|NCT04750902|Listerine|listerine|mesh-list
101179812|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101179814|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
101179888|NCT05713734|Coagulants|coagulants|mesh-ancestor
101179889|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
101180040|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
101180041|NCT05217498|Istradefylline|istradefylline|mesh-list
101180049|NCT05091372|Lenalidomide|lenalidomide|mesh-list
101180197|NCT04095858|Tacrolimus|tacrolimus|mesh-list
101180215|NCT03937986|Suvorexant|suvorexant|mesh-list
101180615|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
101180844|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101180921|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101180924|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
101181003|NCT02541864|Antacids|antacids|mesh-ancestor
101181151|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101181152|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
101181228|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
101181310|NCT04945122|Atorvastatin|atorvastatin|mesh-list
101181488|NCT04107168|Atezolizumab|atezolizumab|mesh-list
101181489|NCT04107168|Durvalumab|durvalumab|mesh-list
101181788|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
101181868|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
101182021|NCT02705352|Fluorouracil|fluorouracil|mesh-list
101182029|NCT02708238|Simethicone|simethicone|mesh-list
101182095|NCT02726178|Analgesics|analgesics|mesh-ancestor
101182393|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101182470|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
101182702|NCT05349396|Eszopiclone|eszopiclone|mesh-list
101182857|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
101182935|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101183095|NCT02902770|Analgesics|analgesics|mesh-ancestor
101183164|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101183241|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101183473|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
101183486|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
101183552|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
101183702|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101184099|NCT03509766|Histamine|histamine|mesh-list
101184550|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101184630|NCT02345772|Trastuzumab|trastuzumab|mesh-list
101184870|NCT01284504|Celecoxib|celecoxib|mesh-list
101185248|NCT00564876|Dasatinib|dasatinib|mesh-list
101185399|NCT04422210|Venetoclax|venetoclax|mesh-list
101185404|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101185478|NCT00000210|Buprenorphine|buprenorphine|mesh-list
101185556|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
101185625|NCT00000336|Protective Agents|protective agents|mesh-ancestor
101185702|NCT00000438|Naltrexone|naltrexone|mesh-list
101185778|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186030|NCT00000936|Cyclosporine|cyclosporine|mesh-list
101186171|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
101186478|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
101186479|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
101186552|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101186628|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
101186862|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
101186936|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
101187168|NCT00002496|Trace Elements|trace elements|mesh-ancestor
101187249|NCT00002532|Vitamins|vitamins|mesh-ancestor
101187250|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
101187326|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101187405|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
101187423|NCT00002598|Analgesics|analgesics|mesh-ancestor
101187482|NCT00002634|Doxorubicin|doxorubicin|mesh-list
101187726|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
101187882|NCT00002790|Methotrexate|methotrexate|mesh-list
101187964|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
101188036|NCT05312112|Venetoclax|venetoclax|mesh-list
101188110|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
101188277|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
101188278|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
101188279|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
101188280|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101188281|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
101188282|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
101188283|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
101188284|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101188285|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101188286|NCT01394016|Fulvestrant|fulvestrant|mesh-list
101188287|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
101188288|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101222083|NCT01511263|Diuretics|diuretics|mesh-list
101222300|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
101222736|NCT01514695|Midazolam|midazolam|mesh-list
101222756|NCT01514721|Timolol|timolol|mesh-list
101223186|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101223188|NCT01516866|Fluorides|fluorides|mesh-list
101223189|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
101223190|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
101223191|NCT01516866|Protective Agents|protective agents|mesh-ancestor
101223192|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223193|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
101223194|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223195|NCT01516996|Docetaxel|docetaxel|mesh-list
101223196|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
101223197|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223221|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223223|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101223224|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101223225|NCT01517308|Interferons|interferons|mesh-list
101223226|NCT01517308|Ribavirin|ribavirin|mesh-list
101223227|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
101223228|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
101223229|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
101223230|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101223231|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
101223232|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
101223233|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
101223234|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101223235|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
101221785|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221786|NCT01509521|Phenylephrine|phenylephrine|mesh-list
101221789|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
101221790|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
101221791|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
101221792|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
101221793|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
101221794|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221795|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
101221797|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
101221798|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
101221799|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
101221800|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
101221801|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
101221802|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
101221803|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
101221804|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221805|NCT01509521|Protective Agents|protective agents|mesh-ancestor
101221806|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
101221807|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
101221808|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
101221810|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
101221811|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
101221812|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
101221813|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
101221814|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
101221815|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
101221816|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
101221817|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
101221818|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
101221819|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
101221820|NCT01509742|Liraglutide|liraglutide|mesh-list
101221821|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
101221824|NCT01509742|Hormones|hormones|mesh-ancestor
101221845|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
101221846|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
101221847|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
